id|nct_id|result_group_id|ctgov_group_code|period|reason|count
255343|NCT03489551|822982|P1|Overall Study|Withdrawal by Subject|2
255344|NCT03407430|822997|P2|Washout|Protocol Violation|0
255345|NCT03407430|822998|P1|Washout|Protocol Violation|1
255346|NCT03405818|823030|P1|Overall Study|Lost to Follow-up|4
255347|NCT03405818|823030|P1|Overall Study|Withdrawal by Subject|4
255348|NCT03349099|823138|P2|Overall Study|Stone migrated from the kidney|0
255349|NCT03349099|823139|P1|Overall Study|Stone migrated from the kidney|1
255350|NCT03349099|823138|P2|Overall Study|Physician Decision|4
255351|NCT03349099|823139|P1|Overall Study|Physician Decision|3
255354|NCT03274453|823247|P4|Overall Study|Surgery Cancelled|0
255355|NCT03274453|823248|P3|Overall Study|Surgery Cancelled|0
255356|NCT03274453|823249|P2|Overall Study|Surgery Cancelled|1
255357|NCT03274453|823250|P1|Overall Study|Surgery Cancelled|0
255358|NCT03274453|823247|P4|Overall Study|Physician Decision|3
255359|NCT03274453|823248|P3|Overall Study|Physician Decision|0
255360|NCT03274453|823249|P2|Overall Study|Physician Decision|0
255361|NCT03274453|823250|P1|Overall Study|Physician Decision|2
255362|NCT03274453|823247|P4|Overall Study|Lost to Follow-up|1
255363|NCT03274453|823248|P3|Overall Study|Lost to Follow-up|4
255364|NCT03274453|823249|P2|Overall Study|Lost to Follow-up|5
255365|NCT03274453|823250|P1|Overall Study|Lost to Follow-up|2
255366|NCT03256552|823275|P1|Overall Study|Withdrawal by Subject|2
255367|NCT03256552|823275|P1|Overall Study|Adverse Event|1
255368|NCT03256552|823275|P1|Overall Study|Physician Decision|1
255369|NCT03256552|823275|P1|Overall Study|Protocol Violation|1
255370|NCT03255733|823297|P1|Overall Study|Lost to Follow-up|4
255371|NCT03255655|823304|P2|Overall Study|Lost to Follow-up|4
255372|NCT03255655|823305|P1|Overall Study|Lost to Follow-up|7
255373|NCT03254602|823313|P1|Overall Study|Lost to Follow-up|4
255374|NCT03238924|823338|P2|Overall Study|Withdrawal by Subject|2
255375|NCT03238924|823339|P1|Overall Study|Withdrawal by Subject|2
255376|NCT03238001|823349|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
255377|NCT03238001|823349|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
255378|NCT03238001|823349|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
255379|NCT03238001|823349|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
255380|NCT03238001|823349|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
255381|NCT03238001|823349|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
255382|NCT03238001|823349|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
255383|NCT03238001|823349|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
255384|NCT03231371|823394|P1|Overall Study|chose or were ineligible to have MRI|12
255385|NCT03231371|823394|P1|Overall Study|Withdrawal by Subject|1
255386|NCT03218163|823404|P1|Overall Study|Study termination|1
255387|NCT03217968|823408|P1|Overall Study|Protocol Violation|6
255388|NCT03217968|823408|P1|Overall Study|Lost to Follow-up|1
255389|NCT03217968|823408|P1|Overall Study|Withdrawal by Subject|4
255390|NCT03217968|823408|P1|Overall Study|Failed the training test|1
255391|NCT03191552|823420|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
255392|NCT03191552|823421|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
255393|NCT03191552|823422|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
255394|NCT03191552|823420|P3|Overall Study|Lost to Follow-up|0
255395|NCT03191552|823421|P2|Overall Study|Lost to Follow-up|0
255396|NCT03191552|823422|P1|Overall Study|Lost to Follow-up|1
255397|NCT03180138|823492|P3|Overall Study|Found to be >24 mon after randomization|3
255398|NCT03180138|823493|P2|Overall Study|Found to be >24 mon after randomization|0
255399|NCT03180138|823494|P1|Overall Study|Found to be >24 mon after randomization|3
255400|NCT03180138|823492|P3|Overall Study|No prior immunization records|6
255401|NCT03180138|823493|P2|Overall Study|No prior immunization records|0
255402|NCT03180138|823494|P1|Overall Study|No prior immunization records|17
255403|NCT03180138|823492|P3|Overall Study|Mobile-phone could not be verified|15
255404|NCT03180138|823493|P2|Overall Study|Mobile-phone could not be verified|13
255405|NCT03180138|823494|P1|Overall Study|Mobile-phone could not be verified|2
255406|NCT03151226|823527|P1|Overall Study|not wear device correctly|1
255407|NCT03151226|823527|P1|Overall Study|Withdrawal by Subject|2
255414|NCT03128307|823580|P1|Overall Study|Withdrawal by Subject|5
255415|NCT03128307|823580|P1|Overall Study|Lost to Follow-up|29
255416|NCT03124784|823627|P1|Overall Study|Computer/Equip Malfunction|1
255417|NCT03124784|823627|P1|Overall Study|Adverse Event|1
255418|NCT03124199|823643|P1|Overall Study|Lost to Follow-up|4
255419|NCT03123354|823671|P1|Overall Study|Physician Decision|6
255420|NCT03110900|823745|P2|Overall Study|Sponsor withdrew|1
255421|NCT03110900|823746|P1|Overall Study|Sponsor withdrew|1
255424|NCT03073798|823828|P1|Overall Study|Withdrawal by Subject|1
255425|NCT03073798|823828|P1|Overall Study|Adverse Event|1
290759|NCT01729754|981059|P7|Part 3|Death|0
255426|NCT03072719|823841|P2|Overall Study|Adverse Event|1
255427|NCT03072719|823842|P1|Overall Study|Adverse Event|1
255428|NCT03069313|823988|P1|Overall Study|Adverse Event|5
255429|NCT03065933|823995|P1|Overall Study|study terminated|5
255430|NCT03055221|824023|P1|Overall Study|Study terminated by Sponsor|3
255431|NCT03055221|824023|P1|Overall Study|Physician Decision|1
255432|NCT03055221|824023|P1|Overall Study|Death|6
255433|NCT03055221|824023|P1|Overall Study|Withdrawal by Subject|4
255434|NCT03055221|824023|P1|Overall Study|Adverse Event|2
255435|NCT03044431|824222|P1|Overall Study|Lost to Follow-up|59
255436|NCT03035916|824330|P3|Overall Study|Puncture failed|0
255437|NCT03035916|824331|P2|Overall Study|Puncture failed|2
255438|NCT03035916|824332|P1|Overall Study|Puncture failed|0
255439|NCT03029650|824404|P2|Washout (1 Week)|Physician Decision|1
255440|NCT03029650|824405|P1|Washout (1 Week)|Physician Decision|0
255441|NCT03029650|824404|P2|Washout (1 Week)|Withdrawal by Subject|1
255442|NCT03029650|824405|P1|Washout (1 Week)|Withdrawal by Subject|1
255443|NCT03023137|824514|P2|Overall Study|Lost the baby in a car accident|0
255444|NCT03023137|824515|P1|Overall Study|Lost the baby in a car accident|1
255445|NCT03023137|824514|P2|Overall Study|Protocol Violation|4
255446|NCT03023137|824515|P1|Overall Study|Protocol Violation|0
255447|NCT03023137|824514|P2|Overall Study|Lost to Follow-up|1
255448|NCT03023137|824515|P1|Overall Study|Lost to Follow-up|1
255449|NCT03023137|824514|P2|Overall Study|Multiple pregnancy|4
255450|NCT03023137|824515|P1|Overall Study|Multiple pregnancy|2
255451|NCT03022422|824573|P6|Overall Study|3 subjects consented but not vaccinated|0
255452|NCT03022422|824574|P5|Overall Study|3 subjects consented but not vaccinated|0
255453|NCT03022422|824575|P4|Overall Study|3 subjects consented but not vaccinated|0
255454|NCT03022422|824576|P3|Overall Study|3 subjects consented but not vaccinated|3
255455|NCT03022422|824577|P2|Overall Study|3 subjects consented but not vaccinated|0
255456|NCT03022422|824578|P1|Overall Study|3 subjects consented but not vaccinated|0
255457|NCT03021304|824640|P1|Overall Study|Lack of Efficacy|1
255458|NCT03020576|824647|P2|Overall Study|Withdrawal by Subject|2
255459|NCT03020576|824648|P1|Overall Study|Withdrawal by Subject|1
255460|NCT03018106|824718|P2|Overall Study|Lost to Follow-up|1
255461|NCT03018106|824719|P1|Overall Study|Lost to Follow-up|0
255462|NCT03017612|824727|P1|Overall Study|Adverse Event|2
255463|NCT03016078|824735|P1|Overall Study|Protocol Violation|1
255464|NCT03016078|824735|P1|Overall Study|Protocol Violation|1
255465|NCT03011099|824748|P2|Overall Study|Withdrawal by Subject|2
255466|NCT03011099|824749|P1|Overall Study|Withdrawal by Subject|0
255467|NCT03005067|824784|P2|Overall Study|Protocol Violation|1
255468|NCT03005067|824785|P1|Overall Study|Protocol Violation|0
255469|NCT03005067|824784|P2|Overall Study|Other (reason not specified)|1
255470|NCT03005067|824785|P1|Overall Study|Other (reason not specified)|3
255471|NCT03005067|824784|P2|Overall Study|Adverse Event|3
255472|NCT03005067|824785|P1|Overall Study|Adverse Event|4
255473|NCT03005067|824784|P2|Overall Study|Withdrawal by Subject|2
255474|NCT03005067|824785|P1|Overall Study|Withdrawal by Subject|3
255475|NCT02990910|824861|P2|Overall Study|Lack of Efficacy|10
255476|NCT02990910|824862|P1|Overall Study|Lack of Efficacy|6
255477|NCT02988622|824883|P1|Overall Study|Lost to Follow-up|17
255478|NCT02988219|824907|P2|Overall Study|Withdrawal by Subject|2
255479|NCT02988219|824908|P1|Overall Study|Withdrawal by Subject|0
255480|NCT02988219|824907|P2|Overall Study|Lack of Efficacy|1
255481|NCT02988219|824908|P1|Overall Study|Lack of Efficacy|1
255482|NCT02987205|824928|P1|Overall Study|Withdrawal by Subject|3
255483|NCT02987205|824928|P1|Overall Study|Adverse Event|1
255484|NCT02977572|824963|P2|Overall Study|Exclusion criterion|2
255485|NCT02977572|824964|P1|Overall Study|Exclusion criterion|2
255486|NCT02974543|824988|P2|Overall Study|Withdrawal by Subject|0
255487|NCT02974543|824989|P1|Overall Study|Withdrawal by Subject|1
255488|NCT02971670|825013|P4|Overall Study|Withdrawal by Subject|2
255489|NCT02971670|825014|P3|Overall Study|Withdrawal by Subject|1
255490|NCT02971670|825015|P2|Overall Study|Withdrawal by Subject|1
255491|NCT02971670|825016|P1|Overall Study|Withdrawal by Subject|4
255492|NCT02968173|825034|P1|Overall Study|Withdrawal by Subject|1
255493|NCT02966509|825117|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
255494|NCT02966509|825118|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
255495|NCT02966509|825117|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
255496|NCT02966509|825118|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
255497|NCT02966509|825117|P2|6 Month Satisfaction Survey|Refused to Answer|11
255498|NCT02966509|825118|P1|6 Month Satisfaction Survey|Refused to Answer|8
255499|NCT02966509|825117|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
255500|NCT02966509|825118|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
255501|NCT02966509|825117|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
255502|NCT02966509|825118|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
255503|NCT02966509|825117|P2|6 Month Satisfaction Survey|Death|33
255504|NCT02966509|825118|P1|6 Month Satisfaction Survey|Death|36
255505|NCT02966509|825117|P2|4-Month Satisfaction Decision Survey|Refused to Answer|2
255506|NCT02966509|825118|P1|4-Month Satisfaction Decision Survey|Refused to Answer|0
255507|NCT02966509|825117|P2|4-Month Satisfaction Decision Survey|Lost to Follow-up|1
255508|NCT02966509|825118|P1|4-Month Satisfaction Decision Survey|Lost to Follow-up|1
255593|NCT02937870|825745|P1|Overall Study|Adverse Event|1
255509|NCT02966509|825117|P2|4-Month Satisfaction Decision Survey|Withdrawal by Subject|3
255510|NCT02966509|825118|P1|4-Month Satisfaction Decision Survey|Withdrawal by Subject|2
255511|NCT02966509|825117|P2|4-Month Satisfaction Decision Survey|Death|25
255512|NCT02966509|825118|P1|4-Month Satisfaction Decision Survey|Death|22
255513|NCT02966509|825117|P2|Baseline Satisfaction Survey|Refused to Answer|2
255514|NCT02966509|825118|P1|Baseline Satisfaction Survey|Refused to Answer|1
255515|NCT02966509|825117|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
255516|NCT02966509|825118|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
255517|NCT02966509|825117|P2|Baseline Satisfaction Survey|Death|1
255518|NCT02966509|825118|P1|Baseline Satisfaction Survey|Death|0
255519|NCT02966509|825117|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
255520|NCT02966509|825118|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
255521|NCT02966015|825144|P2|Inclusion Visit|did not answer questionnaire|3
255522|NCT02966015|825145|P1|Inclusion Visit|did not answer questionnaire|8
255523|NCT02966002|825151|P1|Overall Study|Lost to Follow-up|1
255524|NCT02966002|825151|P1|Overall Study|Adverse Event|1
255525|NCT02966002|825151|P1|Overall Study|Withdrawal by Subject|2
255526|NCT02965833|825158|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
255527|NCT02965833|825159|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
255528|NCT02965833|825158|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
255529|NCT02965833|825159|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
255530|NCT02965833|825158|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
255531|NCT02965833|825159|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
255532|NCT02965833|825158|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
255533|NCT02965833|825159|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
255534|NCT02965833|825158|P2|Period 1, First 30 Days of Wear|Adverse Event|1
255535|NCT02965833|825159|P1|Period 1, First 30 Days of Wear|Adverse Event|0
255536|NCT02965820|825165|P2|Period 2, Second 30 Days|Adverse Event|1
255537|NCT02965820|825166|P1|Period 2, Second 30 Days|Adverse Event|1
255538|NCT02962882|825182|P1|Overall Study|Transfer from ICU|32
255539|NCT02962882|825182|P1|Overall Study|Withdrawal by Subject|2
255540|NCT02962882|825182|P1|Overall Study|Adverse Event|2
255541|NCT02961244|825193|P2|Overall Study|İnadequate data|2
255542|NCT02961244|825194|P1|Overall Study|İnadequate data|0
255543|NCT02961244|825193|P2|Overall Study|Lost to Follow-up|2
255544|NCT02961244|825194|P1|Overall Study|Lost to Follow-up|0
255545|NCT02961244|825193|P2|Overall Study|Surgery plan change after study approval|2
255546|NCT02961244|825194|P1|Overall Study|Surgery plan change after study approval|0
255547|NCT02961244|825193|P2|Overall Study|Withdrawal by Subject|2
255548|NCT02961244|825194|P1|Overall Study|Withdrawal by Subject|1
255549|NCT02961244|825193|P2|Overall Study|Protocol Violation|1
255550|NCT02961244|825194|P1|Overall Study|Protocol Violation|0
255551|NCT02956460|825292|P2|Lens 1|Lost to Follow-up|0
255552|NCT02956460|825293|P1|Lens 1|Lost to Follow-up|1
255553|NCT02951767|825325|P1|Overall Study|Lost to Follow-up|1
255554|NCT02951767|825325|P1|Overall Study|Death|59
255555|NCT02951767|825325|P1|Overall Study|Withdrawal by Subject|5
255556|NCT02951767|825325|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
255557|NCT02948582|825504|P6|Washout Period 4|Adverse Event|0
255558|NCT02948582|825505|P5|Washout Period 4|Adverse Event|0
255559|NCT02948582|825506|P4|Washout Period 4|Adverse Event|0
255560|NCT02948582|825507|P3|Washout Period 4|Adverse Event|1
255561|NCT02948582|825508|P2|Washout Period 4|Adverse Event|0
255562|NCT02948582|825509|P1|Washout Period 4|Adverse Event|1
255563|NCT02948582|825504|P6|Washout Period 2|personal reasons|0
255564|NCT02948582|825505|P5|Washout Period 2|personal reasons|0
255565|NCT02948582|825506|P4|Washout Period 2|personal reasons|1
255566|NCT02948582|825507|P3|Washout Period 2|personal reasons|0
255567|NCT02948582|825508|P2|Washout Period 2|personal reasons|0
255568|NCT02948582|825509|P1|Washout Period 2|personal reasons|0
255569|NCT02948582|825504|P6|Washout Period 2|Adverse Event|0
255570|NCT02948582|825505|P5|Washout Period 2|Adverse Event|0
255571|NCT02948582|825506|P4|Washout Period 2|Adverse Event|0
255572|NCT02948582|825507|P3|Washout Period 2|Adverse Event|0
255573|NCT02948582|825508|P2|Washout Period 2|Adverse Event|1
255574|NCT02948582|825509|P1|Washout Period 2|Adverse Event|0
255575|NCT02948582|825504|P6|Washout Period 1|Protocol Violation|1
255576|NCT02948582|825505|P5|Washout Period 1|Protocol Violation|0
255577|NCT02948582|825506|P4|Washout Period 1|Protocol Violation|0
255578|NCT02948582|825507|P3|Washout Period 1|Protocol Violation|0
255579|NCT02948582|825508|P2|Washout Period 1|Protocol Violation|0
255580|NCT02948582|825509|P1|Washout Period 1|Protocol Violation|0
255581|NCT02948582|825504|P6|Washout Period 1|Adverse Event|0
255582|NCT02948582|825505|P5|Washout Period 1|Adverse Event|0
255583|NCT02948582|825506|P4|Washout Period 1|Adverse Event|0
255584|NCT02948582|825507|P3|Washout Period 1|Adverse Event|0
255585|NCT02948582|825508|P2|Washout Period 1|Adverse Event|2
255586|NCT02948582|825509|P1|Washout Period 1|Adverse Event|0
255587|NCT02947022|825617|P1|Overall Study|Study Stopped|1
255588|NCT02945254|825638|P2|Overall Study|Withdrawal by Subject|0
255589|NCT02945254|825639|P1|Overall Study|Withdrawal by Subject|1
255590|NCT02945254|825638|P2|Overall Study|Lost to Follow-up|0
255591|NCT02945254|825639|P1|Overall Study|Lost to Follow-up|1
255592|NCT02937870|825745|P1|Overall Study|Protocol Deviation|2
255594|NCT02935894|825785|P1|Overall Study|Subject dismissed|1
255595|NCT02923245|825858|P2|Overall Study|ultrasound order was cancelled|1
255596|NCT02923245|825859|P1|Overall Study|ultrasound order was cancelled|2
255597|NCT02920957|825953|P2|Second Intervention: 1 Month|Lost to Follow-up|1
255598|NCT02920957|825954|P1|Second Intervention: 1 Month|Lost to Follow-up|0
255599|NCT02920957|825953|P2|First Intervention : 1 Month|Adverse Event|0
255600|NCT02920957|825954|P1|First Intervention : 1 Month|Adverse Event|1
255601|NCT02920957|825953|P2|First Intervention : 1 Month|Lost to Follow-up|0
255602|NCT02920957|825954|P1|First Intervention : 1 Month|Lost to Follow-up|1
255603|NCT02920957|825953|P2|First Intervention : 1 Month|Withdrawal by Subject|0
255604|NCT02920957|825954|P1|First Intervention : 1 Month|Withdrawal by Subject|2
255605|NCT02915978|826050|P3|Overall Study|Adverse Event|0
255606|NCT02915978|826051|P2|Overall Study|Adverse Event|1
255607|NCT02915978|826052|P1|Overall Study|Adverse Event|2
255608|NCT02915302|826104|P2|Overall Study|Other|0
255609|NCT02915302|826105|P1|Overall Study|Other|1
255610|NCT02915302|826104|P2|Overall Study|Withdrawal by Subject|29
255611|NCT02915302|826105|P1|Overall Study|Withdrawal by Subject|22
255612|NCT02915302|826104|P2|Overall Study|Lost to Follow-up|22
255613|NCT02915302|826105|P1|Overall Study|Lost to Follow-up|19
255614|NCT02915302|826104|P2|Overall Study|Protocol Violation|27
255615|NCT02915302|826105|P1|Overall Study|Protocol Violation|20
255616|NCT02915302|826104|P2|Overall Study|Adverse Event|0
255617|NCT02915302|826105|P1|Overall Study|Adverse Event|3
255618|NCT02914236|826115|P1|Overall Study|Lost to Follow-up|1
255619|NCT02912650|826127|P4|Overall Study|Adverse Event|0
255620|NCT02912650|826128|P3|Overall Study|Adverse Event|1
255621|NCT02912650|826129|P2|Overall Study|Adverse Event|0
255622|NCT02912650|826130|P1|Overall Study|Adverse Event|0
255623|NCT02912650|826127|P4|Overall Study|Withdrawal by Subject|5
255624|NCT02912650|826128|P3|Overall Study|Withdrawal by Subject|1
255625|NCT02912650|826129|P2|Overall Study|Withdrawal by Subject|0
255626|NCT02912650|826130|P1|Overall Study|Withdrawal by Subject|1
255627|NCT02903238|826250|P1|Overall Study|Lost to Follow-up|4
255628|NCT02901054|826259|P1|Overall Study|Withdrawal by Subject|3
255629|NCT02901054|826259|P1|Overall Study|Physician Decision|1
255630|NCT02895347|826265|P2|Overall Study|Withdrawal by Subject|1
255631|NCT02895347|826266|P1|Overall Study|Withdrawal by Subject|3
255632|NCT02886338|826293|P1|Overall Study|Withdrawal by Subject|1
255633|NCT02882152|826318|P2|Overall Study|Lost to Follow-up|0
255634|NCT02882152|826319|P1|Overall Study|Lost to Follow-up|1
255635|NCT02877082|826383|P1|Overall Study|Trial was closed early|5
255636|NCT02873429|826435|P2|16 Weeks|Lost to Follow-up|0
255637|NCT02873429|826436|P1|16 Weeks|Lost to Follow-up|3
255638|NCT02873429|826435|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
255639|NCT02873429|826436|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
255640|NCT02873429|826435|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
255641|NCT02873429|826436|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
255642|NCT02871375|826461|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
255643|NCT02871375|826462|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
255644|NCT02865083|826516|P2|Overall Study|Early Termination|1
255645|NCT02865083|826517|P1|Overall Study|Early Termination|3
255646|NCT02862730|826572|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
255647|NCT02862730|826573|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
255648|NCT02862730|826574|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
255649|NCT02862730|826575|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
255650|NCT02862730|826576|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
255651|NCT02862730|826577|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
255652|NCT02862730|826578|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
255653|NCT02862730|826572|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
255654|NCT02862730|826573|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
255655|NCT02862730|826574|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
255656|NCT02862730|826575|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
255657|NCT02862730|826576|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
255658|NCT02862730|826577|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
255659|NCT02862730|826578|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
255660|NCT02862730|826572|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
255661|NCT02862730|826573|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
255662|NCT02862730|826574|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
255663|NCT02862730|826575|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
255664|NCT02862730|826576|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
255665|NCT02862730|826577|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
255666|NCT02862730|826578|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
255667|NCT02862730|826572|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
255668|NCT02862730|826573|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
255669|NCT02862730|826574|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
255670|NCT02862730|826575|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
255671|NCT02862730|826576|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
255672|NCT02862730|826577|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
255673|NCT02862730|826578|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
255674|NCT02862600|826633|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
290760|NCT01729754|981060|P6|Part 3|Death|2
255675|NCT02862600|826633|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
255676|NCT02862600|826633|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
255677|NCT02862600|826633|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
255678|NCT02862574|826643|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
255679|NCT02862574|826644|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
255680|NCT02862574|826645|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
255681|NCT02862574|826643|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
255682|NCT02862574|826644|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
255683|NCT02862574|826645|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
255684|NCT02862574|826643|P3|Double-Blind Treatment Period|Adverse Event|0
255685|NCT02862574|826644|P2|Double-Blind Treatment Period|Adverse Event|1
255686|NCT02862574|826645|P1|Double-Blind Treatment Period|Adverse Event|0
255687|NCT02862106|826669|P2|Overall Study|Subjects moved to other city|0
255688|NCT02862106|826670|P1|Overall Study|Subjects moved to other city|1
255689|NCT02862106|826669|P2|Overall Study|Withdrawal by Subject|0
255690|NCT02862106|826670|P1|Overall Study|Withdrawal by Subject|2
255691|NCT02862106|826669|P2|Overall Study|Lost to Follow-up|5
255692|NCT02862106|826670|P1|Overall Study|Lost to Follow-up|15
255693|NCT02862106|826669|P2|Overall Study|Protocol Violation|1
255694|NCT02862106|826670|P1|Overall Study|Protocol Violation|16
255695|NCT02862106|826669|P2|Overall Study|Adverse Event|0
255696|NCT02862106|826670|P1|Overall Study|Adverse Event|4
255697|NCT02856880|826728|P1|Overall Study|Withdrawal of consent|1
255698|NCT02855411|826752|P1|Overall Study|Does not meet entrance criteria|14
255699|NCT02855411|826752|P1|Overall Study|Study terminated by sponsor|21
255700|NCT02852434|826785|P2|Overall Study|Unsuccessful Dilator Procedure|0
255701|NCT02852434|826786|P1|Overall Study|Unsuccessful Dilator Procedure|2
255702|NCT02852434|826785|P2|Overall Study|Withdrawal by Subject|1
255703|NCT02852434|826786|P1|Overall Study|Withdrawal by Subject|0
255704|NCT02849678|826819|P2|Overall Study|Protocol Violation|6
255705|NCT02849678|826820|P1|Overall Study|Protocol Violation|3
255706|NCT02847260|826851|P1|Overall Study|Physician Decision|1
255707|NCT02847260|826851|P1|Overall Study|Clinical Deterioration|1
255708|NCT02847260|826851|P1|Overall Study|Withdrawal by Subject|2
255709|NCT02847260|826851|P1|Overall Study|Adverse Event|3
255710|NCT02846558|826902|P4|Overall Study|Lost to Follow-up|0
255711|NCT02846558|826903|P3|Overall Study|Lost to Follow-up|0
255712|NCT02846558|826904|P2|Overall Study|Lost to Follow-up|0
255713|NCT02846558|826905|P1|Overall Study|Lost to Follow-up|2
255714|NCT02846558|826902|P4|Overall Study|Withdrawal by Subject|2
255715|NCT02846558|826903|P3|Overall Study|Withdrawal by Subject|2
255716|NCT02846558|826904|P2|Overall Study|Withdrawal by Subject|4
255717|NCT02846558|826905|P1|Overall Study|Withdrawal by Subject|5
255718|NCT02846558|826902|P4|Overall Study|Adverse Event|0
255719|NCT02846558|826903|P3|Overall Study|Adverse Event|0
255720|NCT02846558|826904|P2|Overall Study|Adverse Event|0
255721|NCT02846558|826905|P1|Overall Study|Adverse Event|1
255722|NCT02844543|826957|P1|Overall Study|Did not meet eligibility criteria|1
255723|NCT02844543|826957|P1|Overall Study|Withdrawal by Subject|4
255724|NCT02838901|827019|P2|Overall Study|Lost to Follow-up|1
255725|NCT02838901|827020|P1|Overall Study|Lost to Follow-up|1
255726|NCT02838901|827019|P2|Overall Study|Withdrawal by Subject|1
255727|NCT02838901|827020|P1|Overall Study|Withdrawal by Subject|1
255728|NCT02837952|827050|P2|Overall Study|Medication Error|0
255729|NCT02837952|827051|P1|Overall Study|Medication Error|1
255730|NCT02837952|827050|P2|Overall Study|Withdrawal by Subject|5
255731|NCT02837952|827051|P1|Overall Study|Withdrawal by Subject|4
255732|NCT02837952|827050|P2|Overall Study|Adverse Event|1
255733|NCT02837952|827051|P1|Overall Study|Adverse Event|0
255734|NCT02836249|827065|P2|Overall Study|Still on Study|55
255735|NCT02836249|827066|P1|Overall Study|Still on Study|121
255736|NCT02836249|827065|P2|Overall Study|Lost to Follow-up|1
255737|NCT02836249|827066|P1|Overall Study|Lost to Follow-up|0
255738|NCT02836249|827065|P2|Overall Study|Withdrew Consent|1
255739|NCT02836249|827066|P1|Overall Study|Withdrew Consent|0
255740|NCT02836249|827065|P2|Overall Study|Pregnancy|0
255741|NCT02836249|827066|P1|Overall Study|Pregnancy|2
255742|NCT02836249|827065|P2|Overall Study|Randomized but Never Treated|1
255743|NCT02836249|827066|P1|Overall Study|Randomized but Never Treated|0
255744|NCT02836236|827084|P2|Overall Study|Still on Study|49
255745|NCT02836236|827085|P1|Overall Study|Still on Study|101
255746|NCT02836236|827084|P2|Overall Study|Investigator's Discretion|0
255747|NCT02836236|827085|P1|Overall Study|Investigator's Discretion|1
255748|NCT02836236|827084|P2|Overall Study|Adverse Event|1
255749|NCT02836236|827085|P1|Overall Study|Adverse Event|0
255750|NCT02836236|827084|P2|Overall Study|Withdrew Consent|0
255751|NCT02836236|827085|P1|Overall Study|Withdrew Consent|2
255752|NCT02836236|827084|P2|Overall Study|Randomized but Never Treated|0
255753|NCT02836236|827085|P1|Overall Study|Randomized but Never Treated|1
255754|NCT02832375|827123|P2|Overall Study|Withdrawal of Consent|0
255755|NCT02832375|827124|P1|Overall Study|Withdrawal of Consent|1
255756|NCT02832375|827123|P2|Overall Study|Lost to Follow-up|0
255757|NCT02832375|827124|P1|Overall Study|Lost to Follow-up|1
255758|NCT02829996|827143|P5|Overall Study|Withdrawal by Subject|0
255759|NCT02829996|827144|P4|Overall Study|Withdrawal by Subject|0
255760|NCT02829996|827145|P3|Overall Study|Withdrawal by Subject|0
255761|NCT02829996|827146|P2|Overall Study|Withdrawal by Subject|0
255762|NCT02829996|827147|P1|Overall Study|Withdrawal by Subject|1
255763|NCT02829775|827170|P1|Overall Study|Disease remission|1
255764|NCT02829775|827170|P1|Overall Study|Withdrawal by Subject|3
255765|NCT02829775|827170|P1|Overall Study|Death|1
255766|NCT02829138|827186|P2|Overall Study|Withdrawal by Subject|0
255767|NCT02829138|827187|P1|Overall Study|Withdrawal by Subject|1
255768|NCT02826421|827223|P4|Overall Study|Reason not given|0
255769|NCT02826421|827224|P3|Overall Study|Reason not given|1
255770|NCT02826421|827225|P2|Overall Study|Reason not given|0
255771|NCT02826421|827226|P1|Overall Study|Reason not given|1
255772|NCT02826421|827223|P4|Overall Study|Withdrawal by Subject|1
255773|NCT02826421|827224|P3|Overall Study|Withdrawal by Subject|1
255774|NCT02826421|827225|P2|Overall Study|Withdrawal by Subject|3
255775|NCT02826421|827226|P1|Overall Study|Withdrawal by Subject|1
255776|NCT02826421|827223|P4|Overall Study|Adverse Event|1
255777|NCT02826421|827224|P3|Overall Study|Adverse Event|0
255778|NCT02826421|827225|P2|Overall Study|Adverse Event|0
255779|NCT02826421|827226|P1|Overall Study|Adverse Event|1
255780|NCT02823964|827251|P1|Overall Study|Withdrawal by Subject|1
255781|NCT02823964|827251|P1|Overall Study|Lack of Efficacy|1
255782|NCT02823964|827251|P1|Overall Study|Physician Decision|1
255783|NCT02823964|827251|P1|Overall Study|Adverse Event|2
255784|NCT02815735|827343|P2|Second Intervention (4 Weeks)|Protocol Violation|0
255785|NCT02815735|827344|P1|Second Intervention (4 Weeks)|Protocol Violation|1
255786|NCT02815735|827343|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
255787|NCT02815735|827344|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
255788|NCT02815735|827343|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
255789|NCT02815735|827344|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
255790|NCT02815735|827343|P2|First Intervention (4 Weeks)|Discomfort|0
255791|NCT02815735|827344|P1|First Intervention (4 Weeks)|Discomfort|1
255792|NCT02815397|827359|P1|Overall Study|Physician Decision|2
255793|NCT02814643|827368|P2|Overall Study|Withdrawal by Subject|2
255794|NCT02814643|827369|P1|Overall Study|Withdrawal by Subject|1
255795|NCT02814643|827368|P2|Overall Study|Lost to Follow-up|1
255796|NCT02814643|827369|P1|Overall Study|Lost to Follow-up|0
255797|NCT02809833|827468|P1|Overall Study|Missing Information|52
255798|NCT02809833|827468|P1|Overall Study|Not Specified|5
255799|NCT02809833|827468|P1|Overall Study|Adverse Event (AE)|24
255800|NCT02809833|827468|P1|Overall Study|Lost to Follow-up|35
255801|NCT02809833|827468|P1|Overall Study|Withdrawal by Subject|34
255802|NCT02809833|827468|P1|Overall Study|Noncompliance|1
255803|NCT02809833|827468|P1|Overall Study|Remission/Treatment No Longer Needed|3
255804|NCT02809833|827468|P1|Overall Study|Lack of Efficacy|89
255805|NCT02809833|827468|P1|Overall Study|Intolerance|54
255806|NCT02809833|827468|P1|Overall Study|Death|3
255807|NCT02806505|827603|P2|Overall Study|Insufficient therapeutic response|4
255808|NCT02806505|827604|P1|Overall Study|Insufficient therapeutic response|2
255809|NCT02806505|827603|P2|Overall Study|Failure to return|1
255810|NCT02806505|827604|P1|Overall Study|Failure to return|0
255811|NCT02806505|827603|P2|Overall Study|Did not cooperate/refused treatment|3
255812|NCT02806505|827604|P1|Overall Study|Did not cooperate/refused treatment|3
255813|NCT02806505|827603|P2|Overall Study|Death|0
255814|NCT02806505|827604|P1|Overall Study|Death|4
255815|NCT02806505|827603|P2|Overall Study|Adverse event/intercurrent illness|3
255816|NCT02806505|827604|P1|Overall Study|Adverse event/intercurrent illness|1
255817|NCT02805907|827616|P2|Overall Study|Lost to Follow-up|3
255818|NCT02805907|827617|P1|Overall Study|Lost to Follow-up|3
255819|NCT02802878|827631|P2|Overall Study|Protocol Violation|0
255820|NCT02802878|827632|P1|Overall Study|Protocol Violation|1
255821|NCT02802878|827631|P2|Overall Study|Withdrawal by Subject|3
255822|NCT02802878|827632|P1|Overall Study|Withdrawal by Subject|3
255823|NCT02802592|827646|P1|Overall Study|Study terminated due to loss of funding|4
255824|NCT02801396|827674|P6|Period 1|Withdrawal by Subject|0
255825|NCT02801396|827675|P5|Period 1|Withdrawal by Subject|1
255826|NCT02801396|827676|P4|Period 1|Withdrawal by Subject|0
255827|NCT02801396|827677|P3|Period 1|Withdrawal by Subject|0
255828|NCT02801396|827678|P2|Period 1|Withdrawal by Subject|0
255829|NCT02801396|827679|P1|Period 1|Withdrawal by Subject|0
255830|NCT02799082|827724|P2|Overall Study|Protocol Violation|1
255831|NCT02799082|827725|P1|Overall Study|Protocol Violation|0
255832|NCT02799082|827724|P2|Overall Study|Refused second PDT or withdraw consent|3
255833|NCT02799082|827725|P1|Overall Study|Refused second PDT or withdraw consent|4
255834|NCT02799069|827762|P3|Overall Study|Protocol Violation|2
255835|NCT02799069|827763|P2|Overall Study|Protocol Violation|0
255836|NCT02799069|827764|P1|Overall Study|Protocol Violation|1
255837|NCT02799069|827762|P3|Overall Study|Withdrawal by Subject|3
255838|NCT02799069|827763|P2|Overall Study|Withdrawal by Subject|4
255839|NCT02799069|827764|P1|Overall Study|Withdrawal by Subject|4
255840|NCT02799069|827762|P3|Overall Study|Lost to Follow-up|0
255841|NCT02799069|827763|P2|Overall Study|Lost to Follow-up|1
255842|NCT02799069|827764|P1|Overall Study|Lost to Follow-up|1
255843|NCT02799069|827762|P3|Overall Study|Lack of Efficacy|0
255844|NCT02799069|827763|P2|Overall Study|Lack of Efficacy|0
255845|NCT02799069|827764|P1|Overall Study|Lack of Efficacy|2
255846|NCT02799069|827762|P3|Overall Study|Adverse Event|2
255847|NCT02799069|827763|P2|Overall Study|Adverse Event|2
255848|NCT02799069|827764|P1|Overall Study|Adverse Event|0
255849|NCT02797080|827878|P1|Overall Study|Withdrawal by Subject|1
255850|NCT02797080|827878|P1|Overall Study|Lost to Follow-up|1
255851|NCT02796963|827886|P4|Overall Study|Lost to Follow-up|72
255852|NCT02796963|827887|P3|Overall Study|Lost to Follow-up|69
255853|NCT02796963|827888|P2|Overall Study|Lost to Follow-up|76
255854|NCT02796963|827889|P1|Overall Study|Lost to Follow-up|89
255855|NCT02796651|827951|P1|Overall Study|Not specified|10
255856|NCT02796651|827951|P1|Overall Study|Lack of Efficacy|1
255857|NCT02796651|827951|P1|Overall Study|Protocol Violation|4
255858|NCT02796651|827951|P1|Overall Study|Withdrawal by Subject|4
255859|NCT02796651|827951|P1|Overall Study|Lost to Follow-up|1
255860|NCT02796651|827951|P1|Overall Study|Adverse Event|6
255861|NCT02794480|828032|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
255862|NCT02794480|828033|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
255863|NCT02794480|828034|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
255864|NCT02794480|828035|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
255865|NCT02794480|828032|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
255866|NCT02794480|828033|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
255867|NCT02794480|828034|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
255868|NCT02794480|828035|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
255869|NCT02794480|828032|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
255870|NCT02794480|828033|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
255871|NCT02794480|828034|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
255872|NCT02794480|828035|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
255873|NCT02794480|828032|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
255874|NCT02794480|828033|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
255875|NCT02794480|828034|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
255876|NCT02794480|828035|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
255877|NCT02794480|828032|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
255878|NCT02794480|828033|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
255879|NCT02794480|828034|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
255880|NCT02794480|828035|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
255881|NCT02793947|828055|P2|Overall Study|Physician Decision|5
255882|NCT02793947|828056|P1|Overall Study|Physician Decision|1
255883|NCT02793947|828055|P2|Overall Study|Death|0
255884|NCT02793947|828056|P1|Overall Study|Death|1
255885|NCT02792062|828143|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
255886|NCT02792062|828144|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
255887|NCT02792062|828145|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
255888|NCT02792062|828146|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
255889|NCT02792062|828147|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
255890|NCT02792062|828148|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
255891|NCT02791659|828199|P2|Overall Study|Protocol Violation|1
255892|NCT02791659|828200|P1|Overall Study|Protocol Violation|0
255893|NCT02791269|828208|P2|Overall Study|Lost to Follow-up|1
255894|NCT02791269|828209|P1|Overall Study|Lost to Follow-up|0
255895|NCT02788357|828231|P2|Overall Study|Lost to Follow-up|0
255896|NCT02788357|828232|P1|Overall Study|Lost to Follow-up|3
255897|NCT02786927|828301|P1|Overall Study|Protocol Violation|4
255898|NCT02786927|828301|P1|Overall Study|Adverse Event|1
255899|NCT02784106|828382|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
255900|NCT02784106|828383|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
255901|NCT02784106|828384|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
255902|NCT02784106|828385|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
255903|NCT02784106|828382|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
255904|NCT02784106|828383|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
255905|NCT02784106|828384|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
255906|NCT02784106|828385|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
255907|NCT02784106|828382|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
255908|NCT02784106|828383|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
255909|NCT02784106|828384|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
255910|NCT02784106|828385|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
255911|NCT02784106|828382|P4|Double-Blind Treatment Period (12 Weeks)|Not specified|0
255912|NCT02784106|828383|P3|Double-Blind Treatment Period (12 Weeks)|Not specified|0
255913|NCT02784106|828384|P2|Double-Blind Treatment Period (12 Weeks)|Not specified|0
255914|NCT02784106|828385|P1|Double-Blind Treatment Period (12 Weeks)|Not specified|2
255915|NCT02784106|828382|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
255916|NCT02784106|828383|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
255917|NCT02784106|828384|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
255918|NCT02784106|828385|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
255919|NCT02784106|828382|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
255920|NCT02784106|828383|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
255921|NCT02784106|828384|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
255922|NCT02784106|828385|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
255923|NCT02782676|828446|P2|Overall Study|Lost to Follow-up|1
290761|NCT01729754|981061|P5|Part 3|Death|0
255924|NCT02782676|828447|P1|Overall Study|Lost to Follow-up|0
255925|NCT02782169|828477|P2|Overall Study|Lost to Follow-up|2
255926|NCT02782169|828478|P1|Overall Study|Lost to Follow-up|1
255927|NCT02781818|828495|P3|Overall Study|Lost to Follow-up|1
255928|NCT02781818|828496|P2|Overall Study|Lost to Follow-up|2
255929|NCT02781818|828497|P1|Overall Study|Lost to Follow-up|4
255930|NCT02780167|828590|P5|Overall Study|Other|2
255931|NCT02780167|828591|P4|Overall Study|Other|1
255932|NCT02780167|828592|P3|Overall Study|Other|3
255933|NCT02780167|828593|P2|Overall Study|Other|0
255934|NCT02780167|828594|P1|Overall Study|Other|0
255935|NCT02780167|828590|P5|Overall Study|Withdrawal by Subject|4
255936|NCT02780167|828591|P4|Overall Study|Withdrawal by Subject|3
255937|NCT02780167|828592|P3|Overall Study|Withdrawal by Subject|4
255938|NCT02780167|828593|P2|Overall Study|Withdrawal by Subject|4
255939|NCT02780167|828594|P1|Overall Study|Withdrawal by Subject|6
255940|NCT02780167|828590|P5|Overall Study|Protocol Violation|2
255941|NCT02780167|828591|P4|Overall Study|Protocol Violation|1
255942|NCT02780167|828592|P3|Overall Study|Protocol Violation|1
255943|NCT02780167|828593|P2|Overall Study|Protocol Violation|5
255944|NCT02780167|828594|P1|Overall Study|Protocol Violation|5
255945|NCT02780167|828590|P5|Overall Study|No longer meets eligibility criteria|1
255946|NCT02780167|828591|P4|Overall Study|No longer meets eligibility criteria|1
255947|NCT02780167|828592|P3|Overall Study|No longer meets eligibility criteria|0
255948|NCT02780167|828593|P2|Overall Study|No longer meets eligibility criteria|0
255949|NCT02780167|828594|P1|Overall Study|No longer meets eligibility criteria|0
255950|NCT02780167|828590|P5|Overall Study|Does not meet entrance criteria|0
255951|NCT02780167|828591|P4|Overall Study|Does not meet entrance criteria|0
255952|NCT02780167|828592|P3|Overall Study|Does not meet entrance criteria|1
255953|NCT02780167|828593|P2|Overall Study|Does not meet entrance criteria|0
255954|NCT02780167|828594|P1|Overall Study|Does not meet entrance criteria|0
255955|NCT02780167|828590|P5|Overall Study|Lost to Follow-up|0
255956|NCT02780167|828591|P4|Overall Study|Lost to Follow-up|0
255957|NCT02780167|828592|P3|Overall Study|Lost to Follow-up|1
255958|NCT02780167|828593|P2|Overall Study|Lost to Follow-up|0
255959|NCT02780167|828594|P1|Overall Study|Lost to Follow-up|2
255960|NCT02780167|828590|P5|Overall Study|Lack of Efficacy|0
255961|NCT02780167|828591|P4|Overall Study|Lack of Efficacy|1
255962|NCT02780167|828592|P3|Overall Study|Lack of Efficacy|6
255963|NCT02780167|828593|P2|Overall Study|Lack of Efficacy|5
255964|NCT02780167|828594|P1|Overall Study|Lack of Efficacy|6
255965|NCT02780167|828590|P5|Overall Study|Adverse Event|8
255966|NCT02780167|828591|P4|Overall Study|Adverse Event|12
255967|NCT02780167|828592|P3|Overall Study|Adverse Event|8
255968|NCT02780167|828593|P2|Overall Study|Adverse Event|8
255969|NCT02780167|828594|P1|Overall Study|Adverse Event|9
255970|NCT02777242|828763|P1|Overall Study|Withdrawal by Subject|1
255971|NCT02777242|828763|P1|Overall Study|Sponsor's request|1
255972|NCT02777242|828763|P1|Overall Study|Multiple|1
255973|NCT02777242|828763|P1|Overall Study|Lost to Follow-up|1
255974|NCT02777242|828763|P1|Overall Study|Other|2
255975|NCT02777125|828769|P2|Overall Study|Protocol Violation|12
255976|NCT02777125|828770|P1|Overall Study|Protocol Violation|8
255977|NCT02777125|828769|P2|Overall Study|Assent form violation|23
255978|NCT02777125|828770|P1|Overall Study|Assent form violation|21
255979|NCT02777125|828769|P2|Overall Study|Consent form violation|12
255980|NCT02777125|828770|P1|Overall Study|Consent form violation|14
255981|NCT02774278|828823|P1|Overall Study|Protocol Violation|2
255982|NCT02774278|828823|P1|Overall Study|Withdrawal by Subject|3
255983|NCT02774278|828823|P1|Overall Study|Administrative reasons|6
255984|NCT02774278|828823|P1|Overall Study|Refused treatment/did not cooperate|9
255985|NCT02774278|828823|P1|Overall Study|Adverse event/intercurrent illness|16
255986|NCT02774278|828823|P1|Overall Study|Death|29
255987|NCT02774278|828823|P1|Overall Study|Lack of Efficacy|199
255988|NCT02770248|828881|P2|Overall Study|Randomized in error, prior to treatment|1
255989|NCT02770248|828882|P1|Overall Study|Randomized in error, prior to treatment|0
255990|NCT02770248|828881|P2|Overall Study|Adverse Event|1
255991|NCT02770248|828882|P1|Overall Study|Adverse Event|0
255992|NCT02769858|828894|P1|Overall Study|Withdrawal by Subject|2
255993|NCT02768194|828911|P6|Period 3|Other (Reason not specified)|0
255994|NCT02768194|828912|P5|Period 3|Other (Reason not specified)|0
255995|NCT02768194|828913|P4|Period 3|Other (Reason not specified)|0
255996|NCT02768194|828914|P3|Period 3|Other (Reason not specified)|0
255997|NCT02768194|828915|P2|Period 3|Other (Reason not specified)|1
255998|NCT02768194|828916|P1|Period 3|Other (Reason not specified)|0
255999|NCT02768194|828911|P6|Period 2|Other (Reason not specified)|0
256000|NCT02768194|828912|P5|Period 2|Other (Reason not specified)|0
256001|NCT02768194|828913|P4|Period 2|Other (Reason not specified)|0
256002|NCT02768194|828914|P3|Period 2|Other (Reason not specified)|0
256003|NCT02768194|828915|P2|Period 2|Other (Reason not specified)|0
256004|NCT02768194|828916|P1|Period 2|Other (Reason not specified)|1
256005|NCT02768194|828911|P6|Period 1|Adverse Event|0
256006|NCT02768194|828912|P5|Period 1|Adverse Event|0
256007|NCT02768194|828913|P4|Period 1|Adverse Event|1
256008|NCT02768194|828914|P3|Period 1|Adverse Event|0
256009|NCT02768194|828915|P2|Period 1|Adverse Event|0
256010|NCT02768194|828916|P1|Period 1|Adverse Event|0
256011|NCT02767765|828933|P1|Overall Study|Withdrawal by Subject|1
256012|NCT02767765|828933|P1|Overall Study|Non-Compliance|1
256013|NCT02767765|828933|P1|Overall Study|Investigator decision|1
256014|NCT02767765|828933|P1|Overall Study|Lost to Follow-up|2
256015|NCT02767765|828933|P1|Overall Study|Insufficient response|1
256016|NCT02767765|828933|P1|Overall Study|Death|1
256017|NCT02767765|828933|P1|Overall Study|Adverse Event|4
256018|NCT02766400|828944|P2|Overall Study|Withdrawal by Subject|0
256019|NCT02766400|828945|P1|Overall Study|Withdrawal by Subject|1
256020|NCT02766400|828944|P2|Overall Study|Death|2
256021|NCT02766400|828945|P1|Overall Study|Death|1
256022|NCT02766283|828951|P1|Overall Study|Lost to Follow-up|27
256023|NCT02763189|829016|P2|Overall Study|Device failure|2
256024|NCT02763189|829017|P1|Overall Study|Device failure|0
256025|NCT02762370|829027|P2|Overall Study|Protocol Violation|0
256026|NCT02762370|829028|P1|Overall Study|Protocol Violation|1
256027|NCT02761733|829050|P4|Overall Study|Cognitive Impairment|0
256028|NCT02761733|829051|P3|Overall Study|Cognitive Impairment|1
256029|NCT02761733|829052|P2|Overall Study|Cognitive Impairment|0
256030|NCT02761733|829053|P1|Overall Study|Cognitive Impairment|5
256031|NCT02761733|829050|P4|Overall Study|Discharged from Study Site|11
256032|NCT02761733|829051|P3|Overall Study|Discharged from Study Site|25
256033|NCT02761733|829052|P2|Overall Study|Discharged from Study Site|9
256034|NCT02761733|829053|P1|Overall Study|Discharged from Study Site|10
256035|NCT02761733|829050|P4|Overall Study|Withdrawal by Subject|0
256036|NCT02761733|829051|P3|Overall Study|Withdrawal by Subject|0
256037|NCT02761733|829052|P2|Overall Study|Withdrawal by Subject|0
256038|NCT02761733|829053|P1|Overall Study|Withdrawal by Subject|2
256039|NCT02761733|829050|P4|Overall Study|Physician Decision|0
256040|NCT02761733|829051|P3|Overall Study|Physician Decision|0
256041|NCT02761733|829052|P2|Overall Study|Physician Decision|0
256042|NCT02761733|829053|P1|Overall Study|Physician Decision|4
256043|NCT02761733|829050|P4|Overall Study|Lost to Follow-up|3
256044|NCT02761733|829051|P3|Overall Study|Lost to Follow-up|0
256045|NCT02761733|829052|P2|Overall Study|Lost to Follow-up|7
256046|NCT02761733|829053|P1|Overall Study|Lost to Follow-up|6
256047|NCT02761733|829050|P4|Overall Study|Death|1
256048|NCT02761733|829051|P3|Overall Study|Death|1
256049|NCT02761733|829052|P2|Overall Study|Death|5
256050|NCT02761733|829053|P1|Overall Study|Death|3
256051|NCT02761629|829085|P2|Overall Study|Randomized But Not Treated|4
256052|NCT02761629|829086|P1|Overall Study|Randomized But Not Treated|8
256053|NCT02761629|829085|P2|Overall Study|Lost to Follow-up|1
256054|NCT02761629|829086|P1|Overall Study|Lost to Follow-up|4
256055|NCT02761629|829085|P2|Overall Study|Other|2
256056|NCT02761629|829086|P1|Overall Study|Other|0
256057|NCT02761629|829085|P2|Overall Study|Withdrawal by Subject|3
256058|NCT02761629|829086|P1|Overall Study|Withdrawal by Subject|0
256059|NCT02761629|829085|P2|Overall Study|Protocol Violation|2
256060|NCT02761629|829086|P1|Overall Study|Protocol Violation|2
256061|NCT02761629|829085|P2|Overall Study|Did not Cooperate/Refused Treatment|4
256062|NCT02761629|829086|P1|Overall Study|Did not Cooperate/Refused Treatment|2
256063|NCT02761629|829085|P2|Overall Study|Failure to Return|4
256064|NCT02761629|829086|P1|Overall Study|Failure to Return|2
256065|NCT02761629|829085|P2|Overall Study|Insufficient Therapeutic Response|7
256066|NCT02761629|829086|P1|Overall Study|Insufficient Therapeutic Response|2
256067|NCT02761629|829085|P2|Overall Study|Adverse Event/Intercurrent Illness|5
256068|NCT02761629|829086|P1|Overall Study|Adverse Event/Intercurrent Illness|7
256069|NCT02760810|829106|P1|Overall Study|Protocol Violation|1
256070|NCT02760654|829114|P2|Overall Study|Withdrawal by Subject|3
256071|NCT02760654|829115|P1|Overall Study|Withdrawal by Subject|4
256072|NCT02760654|829114|P2|Overall Study|Lost to Follow-up|3
256073|NCT02760654|829115|P1|Overall Study|Lost to Follow-up|3
256074|NCT02759692|829139|P2|Period 2|Test article no longer available|1
256075|NCT02759692|829140|P1|Period 2|Test article no longer available|0
256076|NCT02759692|829139|P2|Period 2|Lost to Follow-up|0
256077|NCT02759692|829140|P1|Period 2|Lost to Follow-up|1
256078|NCT02759692|829139|P2|Period 1|Miss-Randomized|1
256079|NCT02759692|829140|P1|Period 1|Miss-Randomized|1
256080|NCT02759692|829139|P2|Period 1|No longer meets eligibility criteria.|0
256081|NCT02759692|829140|P1|Period 1|No longer meets eligibility criteria.|1
256082|NCT02759692|829139|P2|Period 1|Test article no longer available|1
256083|NCT02759692|829140|P1|Period 1|Test article no longer available|1
256084|NCT02759471|829156|P1|Overall Study|discomfort|2
256085|NCT02758613|829170|P4|Treatment|Withdrawal by Subject|0
256086|NCT02758613|829171|P3|Treatment|Withdrawal by Subject|1
256087|NCT02758613|829172|P2|Treatment|Withdrawal by Subject|0
256088|NCT02758613|829173|P1|Treatment|Withdrawal by Subject|1
256089|NCT02758613|829170|P4|Treatment|Physician and Sponsor Decision|0
256090|NCT02758613|829171|P3|Treatment|Physician and Sponsor Decision|0
256091|NCT02758613|829172|P2|Treatment|Physician and Sponsor Decision|0
256092|NCT02758613|829173|P1|Treatment|Physician and Sponsor Decision|1
256093|NCT02758171|829200|P2|Wash-out|Other reason|0
256094|NCT02758171|829201|P1|Wash-out|Other reason|1
256095|NCT02758171|829200|P2|Wash-out|Withdrawal by Subject|0
256096|NCT02758171|829201|P1|Wash-out|Withdrawal by Subject|1
256097|NCT02756637|829234|P2|Overall Study|Did not complete curative therapy|0
256098|NCT02756637|829235|P1|Overall Study|Did not complete curative therapy|33
256099|NCT02756637|829234|P2|Overall Study|No available NLR value|44
256100|NCT02756637|829235|P1|Overall Study|No available NLR value|44
256101|NCT02756637|829234|P2|Overall Study|Not eligible for initial SWOG study|10
256102|NCT02756637|829235|P1|Overall Study|Not eligible for initial SWOG study|10
256103|NCT02755805|829274|P2|Overall Study|Withdrawal by Subject|2
256104|NCT02755805|829275|P1|Overall Study|Withdrawal by Subject|0
256105|NCT02755805|829274|P2|Overall Study|Refused assessments|0
256106|NCT02755805|829275|P1|Overall Study|Refused assessments|1
256107|NCT02755805|829274|P2|Overall Study|Lost to Follow-up|2
256108|NCT02755805|829275|P1|Overall Study|Lost to Follow-up|1
256109|NCT02755090|829289|P2|Overall Study|equipment malfunction|0
256110|NCT02755090|829290|P1|Overall Study|equipment malfunction|1
256111|NCT02754492|829302|P4|Overall Study|Venous access issues not resulting in AE|4
256112|NCT02754492|829303|P3|Overall Study|Venous access issues not resulting in AE|0
256113|NCT02754492|829304|P2|Overall Study|Venous access issues not resulting in AE|0
256114|NCT02754492|829305|P1|Overall Study|Venous access issues not resulting in AE|0
256115|NCT02754492|829302|P4|Overall Study|Adverse Event|13
256116|NCT02754492|829303|P3|Overall Study|Adverse Event|0
256117|NCT02754492|829304|P2|Overall Study|Adverse Event|0
256118|NCT02754492|829305|P1|Overall Study|Adverse Event|0
256119|NCT02754492|829302|P4|Overall Study|Equipment malfuntion|5
256120|NCT02754492|829303|P3|Overall Study|Equipment malfuntion|2
256121|NCT02754492|829304|P2|Overall Study|Equipment malfuntion|0
256122|NCT02754492|829305|P1|Overall Study|Equipment malfuntion|0
256123|NCT02754492|829302|P4|Overall Study|Withdrawal by Subject|0
256124|NCT02754492|829303|P3|Overall Study|Withdrawal by Subject|0
256125|NCT02754492|829304|P2|Overall Study|Withdrawal by Subject|0
256126|NCT02754492|829305|P1|Overall Study|Withdrawal by Subject|2
256127|NCT02754492|829302|P4|Overall Study|Protocol Violation|1
256128|NCT02754492|829303|P3|Overall Study|Protocol Violation|0
256129|NCT02754492|829304|P2|Overall Study|Protocol Violation|2
256130|NCT02754492|829305|P1|Overall Study|Protocol Violation|2
256131|NCT02754440|829321|P4|Overall Study|Subject issues not resulting in AE|12
256132|NCT02754440|829322|P3|Overall Study|Subject issues not resulting in AE|0
256133|NCT02754440|829323|P2|Overall Study|Subject issues not resulting in AE|0
256134|NCT02754440|829324|P1|Overall Study|Subject issues not resulting in AE|0
256135|NCT02754440|829321|P4|Overall Study|Equipment failure|7
256136|NCT02754440|829322|P3|Overall Study|Equipment failure|5
256137|NCT02754440|829323|P2|Overall Study|Equipment failure|5
256138|NCT02754440|829324|P1|Overall Study|Equipment failure|0
256139|NCT02754440|829321|P4|Overall Study|Withdrawal by Subject|1
256140|NCT02754440|829322|P3|Overall Study|Withdrawal by Subject|0
256141|NCT02754440|829323|P2|Overall Study|Withdrawal by Subject|0
256142|NCT02754440|829324|P1|Overall Study|Withdrawal by Subject|0
256143|NCT02754440|829321|P4|Overall Study|Adverse Event|9
256144|NCT02754440|829322|P3|Overall Study|Adverse Event|0
256145|NCT02754440|829323|P2|Overall Study|Adverse Event|1
256146|NCT02754440|829324|P1|Overall Study|Adverse Event|3
256147|NCT02754440|829321|P4|Overall Study|Protocol Violation|6
256148|NCT02754440|829322|P3|Overall Study|Protocol Violation|2
256149|NCT02754440|829323|P2|Overall Study|Protocol Violation|2
256150|NCT02754440|829324|P1|Overall Study|Protocol Violation|3
256151|NCT02753075|829393|P3|Overall Study|Physician Decision|0
256152|NCT02753075|829394|P2|Overall Study|Physician Decision|1
256153|NCT02753075|829395|P1|Overall Study|Physician Decision|3
256154|NCT02753075|829393|P3|Overall Study|Withdrawal of Consent|3
256155|NCT02753075|829394|P2|Overall Study|Withdrawal of Consent|1
256156|NCT02753075|829395|P1|Overall Study|Withdrawal of Consent|1
256157|NCT02753075|829393|P3|Overall Study|Lost to Follow-up|0
256158|NCT02753075|829394|P2|Overall Study|Lost to Follow-up|0
256159|NCT02753075|829395|P1|Overall Study|Lost to Follow-up|2
256160|NCT02753075|829393|P3|Overall Study|Adverse Event|0
256161|NCT02753075|829394|P2|Overall Study|Adverse Event|1
256162|NCT02753075|829395|P1|Overall Study|Adverse Event|2
256163|NCT02752802|829422|P2|Overall Study|Contrast Volume Not Collected|0
256164|NCT02752802|829423|P1|Overall Study|Contrast Volume Not Collected|1
256165|NCT02752633|829432|P1|Overall Study|Withdrawal by Subject|1
256166|NCT02751450|829461|P2|Overall Study|Adverse Event|0
256167|NCT02751450|829462|P1|Overall Study|Adverse Event|1
256168|NCT02751320|829474|P1|Overall Study|Withdrawal by Subject|1
256169|NCT02751320|829474|P1|Overall Study|Adverse Event|2
256170|NCT02750943|829512|P2|Overall Study|Withdrawal by Subject|7
256171|NCT02750943|829513|P1|Overall Study|Withdrawal by Subject|5
256172|NCT02750943|829512|P2|Overall Study|Lost to Follow-up|2
256173|NCT02750943|829513|P1|Overall Study|Lost to Follow-up|1
256174|NCT02750930|829527|P1|Overall Study|Study closed/terminated|8
256175|NCT02750813|829539|P2|Period 1, First 14 Days of Wear|Reason not given|1
256176|NCT02750813|829540|P1|Period 1, First 14 Days of Wear|Reason not given|0
256177|NCT02750813|829539|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
256178|NCT02750813|829540|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
256179|NCT02750709|829549|P6|Treatment Period 1|Adverse Event|1
256180|NCT02750709|829550|P5|Treatment Period 1|Adverse Event|0
256181|NCT02750709|829551|P4|Treatment Period 1|Adverse Event|0
256182|NCT02750709|829552|P3|Treatment Period 1|Adverse Event|0
256183|NCT02750709|829553|P2|Treatment Period 1|Adverse Event|0
256184|NCT02750709|829554|P1|Treatment Period 1|Adverse Event|0
290762|NCT01729754|981062|P4|Part 3|Death|0
256185|NCT02750345|829593|P6|Intervention 1|Adverse Event|0
256186|NCT02750345|829594|P5|Intervention 1|Adverse Event|1
256187|NCT02750345|829595|P4|Intervention 1|Adverse Event|0
256188|NCT02750345|829596|P3|Intervention 1|Adverse Event|0
256189|NCT02750345|829597|P2|Intervention 1|Adverse Event|0
256190|NCT02750345|829598|P1|Intervention 1|Adverse Event|0
256191|NCT02750332|829624|P2|Treatment Period 1|Withdrawal by Subject|1
256192|NCT02750332|829625|P1|Treatment Period 1|Withdrawal by Subject|0
256193|NCT02748213|829686|P2|Overall Study|Not Specified|29
256194|NCT02748213|829687|P1|Overall Study|Not Specified|30
256195|NCT02748213|829686|P2|Overall Study|Failure to Return|0
256196|NCT02748213|829687|P1|Overall Study|Failure to Return|1
256197|NCT02748213|829686|P2|Overall Study|Refused Treatment*|6
256198|NCT02748213|829687|P1|Overall Study|Refused Treatment*|6
256199|NCT02748213|829686|P2|Overall Study|Protocol Violation|4
256200|NCT02748213|829687|P1|Overall Study|Protocol Violation|6
256201|NCT02748213|829686|P2|Overall Study|Violation of Selection Criteria|0
256202|NCT02748213|829687|P1|Overall Study|Violation of Selection Criteria|2
256203|NCT02748213|829686|P2|Overall Study|Insufficient Therapeutic Response|57
256204|NCT02748213|829687|P1|Overall Study|Insufficient Therapeutic Response|56
256205|NCT02748213|829686|P2|Overall Study|Death|3
256206|NCT02748213|829687|P1|Overall Study|Death|5
256207|NCT02748213|829686|P2|Overall Study|Adverse Event or Intercurrent Illness|11
256208|NCT02748213|829687|P1|Overall Study|Adverse Event or Intercurrent Illness|5
256209|NCT02748213|829686|P2|Overall Study|Abnormal Laboratory Test|0
256210|NCT02748213|829687|P1|Overall Study|Abnormal Laboratory Test|1
256211|NCT02748213|829686|P2|Overall Study|Withdrawal Prior to Treatment|2
256212|NCT02748213|829687|P1|Overall Study|Withdrawal Prior to Treatment|1
256213|NCT02746679|829723|P2|Overall Study|Lost to Follow-up|6
256214|NCT02746679|829724|P1|Overall Study|Lost to Follow-up|4
256215|NCT02745392|829808|P4|Overall Study|Lost to Follow-up|0
256216|NCT02745392|829809|P3|Overall Study|Lost to Follow-up|0
256217|NCT02745392|829810|P2|Overall Study|Lost to Follow-up|1
256218|NCT02745392|829811|P1|Overall Study|Lost to Follow-up|0
256219|NCT02743962|829827|P2|Overall Study|Atrophic vaginitis diagnosed|0
256220|NCT02743962|829828|P1|Overall Study|Atrophic vaginitis diagnosed|1
256221|NCT02743780|829863|P5|Part 3 (7 Days)|Adverse Event|0
256222|NCT02743780|829864|P4|Part 3 (7 Days)|Adverse Event|0
256223|NCT02743780|829865|P3|Part 3 (7 Days)|Adverse Event|1
256224|NCT02743780|829866|P2|Part 3 (7 Days)|Adverse Event|0
256225|NCT02743780|829867|P1|Part 3 (7 Days)|Adverse Event|0
256226|NCT02743117|829923|P2|Overall Study|Other|0
256227|NCT02743117|829924|P1|Overall Study|Other|1
256228|NCT02743117|829923|P2|Overall Study|Lost to Follow-up|1
256229|NCT02743117|829924|P1|Overall Study|Lost to Follow-up|0
256230|NCT02742818|829949|P2|Overall Study|Protocol Violation|1
256231|NCT02742818|829950|P1|Overall Study|Protocol Violation|0
256232|NCT02742818|829949|P2|Overall Study|Adverse Event|1
256233|NCT02742818|829950|P1|Overall Study|Adverse Event|0
256234|NCT02741245|829996|P5|Overall Study|Withdrawal by Subject|0
256235|NCT02741245|829997|P4|Overall Study|Withdrawal by Subject|1
256236|NCT02741245|829998|P3|Overall Study|Withdrawal by Subject|0
256237|NCT02741245|829999|P2|Overall Study|Withdrawal by Subject|0
256238|NCT02741245|830000|P1|Overall Study|Withdrawal by Subject|0
256239|NCT02741245|829996|P5|Overall Study|Protocol Violation|0
256240|NCT02741245|829997|P4|Overall Study|Protocol Violation|1
256241|NCT02741245|829998|P3|Overall Study|Protocol Violation|0
256242|NCT02741245|829999|P2|Overall Study|Protocol Violation|1
256243|NCT02741245|830000|P1|Overall Study|Protocol Violation|0
256244|NCT02741245|829996|P5|Overall Study|Adverse Event|2
256245|NCT02741245|829997|P4|Overall Study|Adverse Event|2
256246|NCT02741245|829998|P3|Overall Study|Adverse Event|0
256247|NCT02741245|829999|P2|Overall Study|Adverse Event|0
256248|NCT02741245|830000|P1|Overall Study|Adverse Event|0
256249|NCT02739594|830113|P2|Overall Study|Not Specified|2
256250|NCT02739594|830114|P1|Overall Study|Not Specified|6
256251|NCT02739594|830113|P2|Overall Study|Elevated Serum Creatinine|1
256252|NCT02739594|830114|P1|Overall Study|Elevated Serum Creatinine|0
256253|NCT02739594|830113|P2|Overall Study|Lost to Follow-up|1
256254|NCT02739594|830114|P1|Overall Study|Lost to Follow-up|0
256255|NCT02739594|830113|P2|Overall Study|Withdrawal by Subject|1
256256|NCT02739594|830114|P1|Overall Study|Withdrawal by Subject|1
256257|NCT02739594|830113|P2|Overall Study|Administrative Reasons|3
256258|NCT02739594|830114|P1|Overall Study|Administrative Reasons|1
256259|NCT02739594|830113|P2|Overall Study|Renal Insufficiency|6
256260|NCT02739594|830114|P1|Overall Study|Renal Insufficiency|4
256261|NCT02739594|830113|P2|Overall Study|Death|2
256262|NCT02739594|830114|P1|Overall Study|Death|4
256263|NCT02739594|830113|P2|Overall Study|Protocol Violation|6
256264|NCT02739594|830114|P1|Overall Study|Protocol Violation|5
256265|NCT02739594|830113|P2|Overall Study|Violation of Eligibility Criteria|2
256266|NCT02739594|830114|P1|Overall Study|Violation of Eligibility Criteria|1
256267|NCT02739594|830113|P2|Overall Study|Undesired Event|4
256268|NCT02739594|830114|P1|Overall Study|Undesired Event|3
256269|NCT02739321|830146|P2|Overall Study|Withdrawal by Subject|2
256270|NCT02739321|830147|P1|Overall Study|Withdrawal by Subject|1
256271|NCT02739321|830146|P2|Overall Study|Lost to Follow-up|1
256272|NCT02739321|830147|P1|Overall Study|Lost to Follow-up|1
256273|NCT02739321|830146|P2|Overall Study|Lack of Efficacy|1
256274|NCT02739321|830147|P1|Overall Study|Lack of Efficacy|1
256275|NCT02738333|830210|P3|Overall Study|Lost to Follow-up|0
256276|NCT02738333|830211|P2|Overall Study|Lost to Follow-up|0
256277|NCT02738333|830212|P1|Overall Study|Lost to Follow-up|1
256278|NCT02738333|830210|P3|Overall Study|Death|0
256279|NCT02738333|830211|P2|Overall Study|Death|0
256280|NCT02738333|830212|P1|Overall Study|Death|1
256281|NCT02738138|830288|P2|Overall Study|Other - not further specified|0
256282|NCT02738138|830289|P1|Overall Study|Other - not further specified|1
256283|NCT02738138|830288|P2|Overall Study|Lost to Follow-up|0
256284|NCT02738138|830289|P1|Overall Study|Lost to Follow-up|2
256285|NCT02738138|830288|P2|Overall Study|Adverse Event|1
256286|NCT02738138|830289|P1|Overall Study|Adverse Event|0
256287|NCT02737852|830296|P1|Overall Study|Withdrawal by Subject|2
256288|NCT02737618|830306|P1|Overall Study|Withdrawal by Subject|9
256289|NCT02737592|830311|P1|Overall Study|Withdrawal by Subject|1
256290|NCT02736721|830316|P1|Overall Study|Other|5
256291|NCT02736721|830316|P1|Overall Study|Lost to Follow-up|3
256292|NCT02736721|830316|P1|Overall Study|Adverse Event|8
256293|NCT02735200|830338|P2|Overall Study|Withdrawal by Subject|0
256294|NCT02735200|830339|P1|Overall Study|Withdrawal by Subject|8
256295|NCT02735200|830338|P2|Overall Study|Lost to Follow-up|5
256296|NCT02735200|830339|P1|Overall Study|Lost to Follow-up|0
256297|NCT02734810|830372|P2|Overall Study|Lack of Efficacy|0
256298|NCT02734810|830373|P1|Overall Study|Lack of Efficacy|1
256299|NCT02734810|830372|P2|Overall Study|Adverse Event|0
256300|NCT02734810|830373|P1|Overall Study|Adverse Event|1
256301|NCT02734212|830414|P2|Overall Study|Lost to Follow-up|10
256302|NCT02734212|830415|P1|Overall Study|Lost to Follow-up|5
256303|NCT02732639|830445|P1|Overall Study|Lost to Follow-up|1
256304|NCT02732561|830458|P2|Overall Study|Withdrawal by Subject|0
256305|NCT02732561|830459|P1|Overall Study|Withdrawal by Subject|1
256306|NCT02732561|830458|P2|Overall Study|Lost to Follow-up|1
256307|NCT02732561|830459|P1|Overall Study|Lost to Follow-up|1
256308|NCT02732327|830469|P2|Overall Study|Protocol Violation|1
256309|NCT02732327|830470|P1|Overall Study|Protocol Violation|0
256310|NCT02732210|830478|P2|Overall Study|Missing|8
256311|NCT02732210|830479|P1|Overall Study|Missing|0
256312|NCT02732210|830478|P2|Overall Study|Other|103
256313|NCT02732210|830479|P1|Overall Study|Other|35
256314|NCT02732210|830478|P2|Overall Study|Death|15
256315|NCT02732210|830479|P1|Overall Study|Death|4
256316|NCT02732210|830478|P2|Overall Study|Lost to Follow-up|57
256317|NCT02732210|830479|P1|Overall Study|Lost to Follow-up|5
256318|NCT02732210|830478|P2|Overall Study|Withdrawal by Subject|87
256319|NCT02732210|830479|P1|Overall Study|Withdrawal by Subject|28
256320|NCT02732210|830478|P2|Overall Study|Study Ended|13
256321|NCT02732210|830479|P1|Overall Study|Study Ended|13
256322|NCT02732210|830478|P2|Overall Study|Site Closed|11
256323|NCT02732210|830479|P1|Overall Study|Site Closed|0
256324|NCT02731131|830531|P2|Overall Study|Refused Therapy|1
256325|NCT02731131|830532|P1|Overall Study|Refused Therapy|0
256326|NCT02731131|830531|P2|Overall Study|Psychiatric Disorder|1
256327|NCT02731131|830532|P1|Overall Study|Psychiatric Disorder|0
256328|NCT02730819|830548|P1|Overall Study|Lost to Follow-up|9
256329|NCT02730728|830557|P3|Overall Study|Lack of Efficacy|1
256330|NCT02730728|830558|P2|Overall Study|Lack of Efficacy|1
256331|NCT02730728|830559|P1|Overall Study|Lack of Efficacy|0
256332|NCT02730728|830557|P3|Overall Study|Withdrawal by Subject|0
256333|NCT02730728|830558|P2|Overall Study|Withdrawal by Subject|1
256334|NCT02730728|830559|P1|Overall Study|Withdrawal by Subject|0
256335|NCT02730598|830578|P2|Overall Study|Unrelated Injury affecting outcomes.|0
256336|NCT02730598|830579|P1|Overall Study|Unrelated Injury affecting outcomes.|1
256337|NCT02730598|830578|P2|Overall Study|Protocol Violation|1
256338|NCT02730598|830579|P1|Overall Study|Protocol Violation|0
256339|NCT02730598|830578|P2|Overall Study|Withdrawal by Subject|3
256340|NCT02730598|830579|P1|Overall Study|Withdrawal by Subject|3
256341|NCT02730351|830599|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
256342|NCT02730351|830600|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
256343|NCT02730351|830599|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
256344|NCT02730351|830600|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
256345|NCT02730351|830599|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
256346|NCT02730351|830600|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
256347|NCT02730351|830599|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
256348|NCT02730351|830600|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
256349|NCT02730351|830599|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
256350|NCT02730351|830600|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
256351|NCT02726022|830692|P1|Overall Study|Treatment Failure and Poor Compliance|1
256352|NCT02726022|830692|P1|Overall Study|Poor Compliance|13
256353|NCT02726022|830692|P1|Overall Study|Treatment Failure|8
256354|NCT02726022|830692|P1|Overall Study|Adverse Event|14
256355|NCT02725788|830703|P2|Overall Study|Protocol Violation|1
256356|NCT02725788|830704|P1|Overall Study|Protocol Violation|0
256357|NCT02725788|830703|P2|Overall Study|Lost to Follow-up|1
256358|NCT02725788|830704|P1|Overall Study|Lost to Follow-up|1
256359|NCT02724644|830712|P2|Overall Study|Administrative|0
256360|NCT02724644|830713|P1|Overall Study|Administrative|1
256361|NCT02724644|830712|P2|Overall Study|Withdrawal by Subject|1
256362|NCT02724644|830713|P1|Overall Study|Withdrawal by Subject|7
256363|NCT02724644|830712|P2|Overall Study|Lost to Follow-up|2
256364|NCT02724644|830713|P1|Overall Study|Lost to Follow-up|6
256365|NCT02724644|830712|P2|Overall Study|Adverse Event|1
256366|NCT02724644|830713|P1|Overall Study|Adverse Event|7
256367|NCT02724111|830747|P2|Overall Study|Protocol Violation|5
256368|NCT02724111|830748|P1|Overall Study|Protocol Violation|2
256369|NCT02723201|830771|P3|Second Intervention Period|Adverse Event|0
256370|NCT02723201|830772|P2|Second Intervention Period|Adverse Event|0
256371|NCT02723201|830773|P1|Second Intervention Period|Adverse Event|1
256372|NCT02723201|830771|P3|Second Intervention Period|Protocol Violation|0
256373|NCT02723201|830772|P2|Second Intervention Period|Protocol Violation|0
256374|NCT02723201|830773|P1|Second Intervention Period|Protocol Violation|1
256375|NCT02723188|830832|P3|Overall Study|Withdrawal by Subject|0
256376|NCT02723188|830833|P2|Overall Study|Withdrawal by Subject|0
256377|NCT02723188|830834|P1|Overall Study|Withdrawal by Subject|1
256378|NCT02722967|830848|P3|Overall Study|Non-adherence of the patch to the skin|2
256379|NCT02722967|830849|P2|Overall Study|Non-adherence of the patch to the skin|0
256380|NCT02722967|830850|P1|Overall Study|Non-adherence of the patch to the skin|0
256381|NCT02722967|830848|P3|Overall Study|Physician Decision|0
256382|NCT02722967|830849|P2|Overall Study|Physician Decision|0
256383|NCT02722967|830850|P1|Overall Study|Physician Decision|1
256384|NCT02722967|830848|P3|Overall Study|Withdrawal by Subject|1
256385|NCT02722967|830849|P2|Overall Study|Withdrawal by Subject|0
256386|NCT02722967|830850|P1|Overall Study|Withdrawal by Subject|1
256387|NCT02722967|830848|P3|Overall Study|Non-compliance with patch wearing|1
256388|NCT02722967|830849|P2|Overall Study|Non-compliance with patch wearing|1
256389|NCT02722967|830850|P1|Overall Study|Non-compliance with patch wearing|2
256390|NCT02722967|830848|P3|Overall Study|Lost to Follow-up|0
256391|NCT02722967|830849|P2|Overall Study|Lost to Follow-up|1
256392|NCT02722967|830850|P1|Overall Study|Lost to Follow-up|0
256393|NCT02722967|830848|P3|Overall Study|Adverse Event|0
256394|NCT02722967|830849|P2|Overall Study|Adverse Event|0
256395|NCT02722967|830850|P1|Overall Study|Adverse Event|1
256396|NCT02722278|830864|P2|Overall Study|Site closure not study related|1
256397|NCT02722278|830865|P1|Overall Study|Site closure not study related|0
256398|NCT02722278|830864|P2|Overall Study|Subject declined after tx assignment|1
256399|NCT02722278|830865|P1|Overall Study|Subject declined after tx assignment|0
256400|NCT02722278|830864|P2|Overall Study|High PSA pre-study/ not eligible|1
256401|NCT02722278|830865|P1|Overall Study|High PSA pre-study/ not eligible|0
256402|NCT02722278|830864|P2|Overall Study|Protocol Violation|0
256403|NCT02722278|830865|P1|Overall Study|Protocol Violation|1
256404|NCT02722278|830864|P2|Overall Study|Lost to Follow-up|0
256405|NCT02722278|830865|P1|Overall Study|Lost to Follow-up|2
256406|NCT02722278|830864|P2|Overall Study|Adverse Event|1
256407|NCT02722278|830865|P1|Overall Study|Adverse Event|4
256408|NCT02722278|830864|P2|Overall Study|Withdrawal by Subject|3
256409|NCT02722278|830865|P1|Overall Study|Withdrawal by Subject|5
256410|NCT02722044|830889|P1|Overall Study|Did Not Meet Criteria at Week 14|1
256411|NCT02722044|830889|P1|Overall Study|Withdrawal by Subject|1
256412|NCT02722044|830889|P1|Overall Study|Physician Decision|1
256413|NCT02722044|830889|P1|Overall Study|Adverse Event|2
256414|NCT02718898|830962|P2|Overall Study|Lost to Follow-up|0
256415|NCT02718898|830963|P1|Overall Study|Lost to Follow-up|2
256416|NCT02718898|830962|P2|Overall Study|Lack of Efficacy|0
256417|NCT02718898|830963|P1|Overall Study|Lack of Efficacy|1
256418|NCT02718898|830962|P2|Overall Study|Physician Decision|0
256419|NCT02718898|830963|P1|Overall Study|Physician Decision|1
256420|NCT02718898|830962|P2|Overall Study|Adverse Event|1
256421|NCT02718898|830963|P1|Overall Study|Adverse Event|5
256422|NCT02717754|830997|P6|Overall Study|Incorrect Infusion Duration|20
256423|NCT02717754|830998|P5|Overall Study|Incorrect Infusion Duration|20
256424|NCT02717754|830999|P4|Overall Study|Incorrect Infusion Duration|10
256425|NCT02717754|831000|P3|Overall Study|Incorrect Infusion Duration|0
256426|NCT02717754|831001|P2|Overall Study|Incorrect Infusion Duration|0
256427|NCT02717754|831002|P1|Overall Study|Incorrect Infusion Duration|0
256428|NCT02716779|831033|P3|Combination Therapy|Adverse Event|1
256429|NCT02716779|831034|P2|Combination Therapy|Adverse Event|2
256430|NCT02716779|831035|P1|Combination Therapy|Adverse Event|0
256431|NCT02716779|831033|P3|Monotherapy|Adverse Event|1
256432|NCT02716779|831034|P2|Monotherapy|Adverse Event|1
256433|NCT02716779|831035|P1|Monotherapy|Adverse Event|0
256434|NCT02716298|831108|P2|First Intervention (1 Month)|Lens discomfort|1
256435|NCT02716298|831109|P1|First Intervention (1 Month)|Lens discomfort|1
256436|NCT02714062|831127|P3|Overall Study|Protocol Violation|0
256437|NCT02714062|831128|P2|Overall Study|Protocol Violation|1
256438|NCT02714062|831129|P1|Overall Study|Protocol Violation|0
256439|NCT02714062|831127|P3|Overall Study|Withdrawal by Subject|1
256440|NCT02714062|831128|P2|Overall Study|Withdrawal by Subject|0
256441|NCT02714062|831129|P1|Overall Study|Withdrawal by Subject|1
256442|NCT02714062|831127|P3|Overall Study|Adverse Event|2
256443|NCT02714062|831128|P2|Overall Study|Adverse Event|0
256444|NCT02714062|831129|P1|Overall Study|Adverse Event|0
256445|NCT02713594|831175|P2|Overall Study|Lost to Follow-up|374
256446|NCT02713594|831176|P1|Overall Study|Lost to Follow-up|358
256447|NCT02713594|831175|P2|Overall Study|Withdrawal by Subject|22
256448|NCT02713594|831176|P1|Overall Study|Withdrawal by Subject|32
256449|NCT02712333|831194|P2|First Period|Withdrawal by Subject|2
256450|NCT02712333|831195|P1|First Period|Withdrawal by Subject|3
256451|NCT02711995|831232|P1|Washout (90 Days)|Conflicting medication|1
256452|NCT02710292|831307|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
256453|NCT02710292|831308|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
256454|NCT02710292|831307|P2|Period 1, First 10 Days of Wear|Adverse Event|1
256455|NCT02710292|831308|P1|Period 1, First 10 Days of Wear|Adverse Event|0
256456|NCT02709577|831317|P4|Overall Study|Withdrawal by Subject|0
256457|NCT02709577|831318|P3|Overall Study|Withdrawal by Subject|2
256458|NCT02709577|831319|P2|Overall Study|Withdrawal by Subject|3
256459|NCT02709577|831320|P1|Overall Study|Withdrawal by Subject|2
256460|NCT02709577|831317|P4|Overall Study|procedural complication|0
256461|NCT02709577|831318|P3|Overall Study|procedural complication|0
256462|NCT02709577|831319|P2|Overall Study|procedural complication|1
256463|NCT02709577|831320|P1|Overall Study|procedural complication|0
256464|NCT02709577|831317|P4|Overall Study|non-accommodating anatomy|0
256465|NCT02709577|831318|P3|Overall Study|non-accommodating anatomy|0
256466|NCT02709577|831319|P2|Overall Study|non-accommodating anatomy|1
256467|NCT02709577|831320|P1|Overall Study|non-accommodating anatomy|0
256468|NCT02709096|831334|P2|Overall Study|non-compliance|1
256469|NCT02709096|831335|P1|Overall Study|non-compliance|1
256470|NCT02708524|831345|P4|Overall Study|Subject lost study lens|0
256471|NCT02708524|831346|P3|Overall Study|Subject lost study lens|0
256472|NCT02708524|831347|P2|Overall Study|Subject lost study lens|0
256473|NCT02708524|831348|P1|Overall Study|Subject lost study lens|1
256474|NCT02708524|831345|P4|Overall Study|Did not wear lens at final visit|0
256475|NCT02708524|831346|P3|Overall Study|Did not wear lens at final visit|0
256476|NCT02708524|831347|P2|Overall Study|Did not wear lens at final visit|1
256477|NCT02708524|831348|P1|Overall Study|Did not wear lens at final visit|0
256478|NCT02708524|831345|P4|Overall Study|Dispensed incorrect study lens|0
256479|NCT02708524|831346|P3|Overall Study|Dispensed incorrect study lens|1
256480|NCT02708524|831347|P2|Overall Study|Dispensed incorrect study lens|1
256481|NCT02708524|831348|P1|Overall Study|Dispensed incorrect study lens|0
256482|NCT02708524|831345|P4|Overall Study|Withdrawal by Subject|0
256483|NCT02708524|831346|P3|Overall Study|Withdrawal by Subject|0
256484|NCT02708524|831347|P2|Overall Study|Withdrawal by Subject|1
256485|NCT02708524|831348|P1|Overall Study|Withdrawal by Subject|1
256486|NCT02708524|831345|P4|Overall Study|Protocol Violation|0
256487|NCT02708524|831346|P3|Overall Study|Protocol Violation|0
256488|NCT02708524|831347|P2|Overall Study|Protocol Violation|1
256489|NCT02708524|831348|P1|Overall Study|Protocol Violation|0
256490|NCT02708524|831345|P4|Overall Study|Lost to Follow-up|0
256491|NCT02708524|831346|P3|Overall Study|Lost to Follow-up|1
256492|NCT02708524|831347|P2|Overall Study|Lost to Follow-up|1
256493|NCT02708524|831348|P1|Overall Study|Lost to Follow-up|1
256494|NCT02708524|831345|P4|Overall Study|Lens Discomfort|0
256495|NCT02708524|831346|P3|Overall Study|Lens Discomfort|1
256496|NCT02708524|831347|P2|Overall Study|Lens Discomfort|0
256497|NCT02708524|831348|P1|Overall Study|Lens Discomfort|1
256498|NCT02708524|831345|P4|Overall Study|Adverse Event|0
256499|NCT02708524|831346|P3|Overall Study|Adverse Event|0
256500|NCT02708524|831347|P2|Overall Study|Adverse Event|1
256501|NCT02708524|831348|P1|Overall Study|Adverse Event|0
256502|NCT02708355|831397|P3|Overall Study|Adverse Event|0
256503|NCT02708355|831398|P2|Overall Study|Adverse Event|0
256504|NCT02708355|831399|P1|Overall Study|Adverse Event|1
256505|NCT02708277|831412|P2|Overall Study|Lost to Follow-up|4
256506|NCT02708277|831413|P1|Overall Study|Lost to Follow-up|7
256507|NCT02707640|831456|P2|Overall Study|Sponsor Discretion|0
256508|NCT02707640|831457|P1|Overall Study|Sponsor Discretion|1
256509|NCT02707640|831456|P2|Overall Study|Participant's Personal Decision|2
256510|NCT02707640|831457|P1|Overall Study|Participant's Personal Decision|1
256511|NCT02707640|831456|P2|Overall Study|Withdrawal by Subject|1
256512|NCT02707640|831457|P1|Overall Study|Withdrawal by Subject|0
256513|NCT02707640|831456|P2|Overall Study|Physician Decision|0
256514|NCT02707640|831457|P1|Overall Study|Physician Decision|2
256515|NCT02707640|831456|P2|Overall Study|Death|2
256516|NCT02707640|831457|P1|Overall Study|Death|1
256517|NCT02707640|831456|P2|Overall Study|Adverse Event|2
256518|NCT02707640|831457|P1|Overall Study|Adverse Event|4
256519|NCT02706717|831482|P2|Overall Study|Death|1
256520|NCT02706717|831483|P1|Overall Study|Death|0
256521|NCT02706717|831482|P2|Overall Study|Physician Decision|1
256522|NCT02706717|831483|P1|Overall Study|Physician Decision|0
256523|NCT02706717|831482|P2|Overall Study|Lost to Follow-up|1
256524|NCT02706717|831483|P1|Overall Study|Lost to Follow-up|0
256525|NCT02706717|831482|P2|Overall Study|Withdrawal by Subject|8
256526|NCT02706717|831483|P1|Overall Study|Withdrawal by Subject|1
256527|NCT02706327|831504|P3|Overall Study|Lost to Follow-up|2
256528|NCT02706327|831505|P2|Overall Study|Lost to Follow-up|1
256529|NCT02706327|831506|P1|Overall Study|Lost to Follow-up|1
256530|NCT02705716|831558|P2|Overall Study|Withdrawal of Consent|1
256531|NCT02705716|831559|P1|Overall Study|Withdrawal of Consent|1
256532|NCT02705716|831558|P2|Overall Study|Protocol Violation|0
256533|NCT02705716|831559|P1|Overall Study|Protocol Violation|3
256534|NCT02705716|831558|P2|Overall Study|Adverse Event|1
256535|NCT02705716|831559|P1|Overall Study|Adverse Event|0
256536|NCT02704689|831580|P1|Overall Study|Study device not implanted|2
256537|NCT02704689|831580|P1|Overall Study|Physician Decision|1
256538|NCT02702011|831639|P4|Overall Study|Withdrawal by Subject|0
256539|NCT02702011|831640|P3|Overall Study|Withdrawal by Subject|0
256540|NCT02702011|831641|P2|Overall Study|Withdrawal by Subject|1
256541|NCT02702011|831642|P1|Overall Study|Withdrawal by Subject|0
256542|NCT02701361|831669|P3|Overall Study|incarceration|1
256543|NCT02701361|831670|P2|Overall Study|incarceration|0
256544|NCT02701361|831671|P1|Overall Study|incarceration|0
256545|NCT02701361|831669|P3|Overall Study|timed out in rehab center|0
256546|NCT02701361|831670|P2|Overall Study|timed out in rehab center|1
256547|NCT02701361|831671|P1|Overall Study|timed out in rehab center|0
256548|NCT02701361|831669|P3|Overall Study|Withdrawal by Subject|0
256549|NCT02701361|831670|P2|Overall Study|Withdrawal by Subject|0
256550|NCT02701361|831671|P1|Overall Study|Withdrawal by Subject|4
256551|NCT02701361|831669|P3|Overall Study|Lost to Follow-up|1
256552|NCT02701361|831670|P2|Overall Study|Lost to Follow-up|2
256553|NCT02701361|831671|P1|Overall Study|Lost to Follow-up|5
256554|NCT02701296|831712|P2|Overall Study|Incomplete Data|2
256555|NCT02701296|831713|P1|Overall Study|Incomplete Data|0
256556|NCT02699892|831746|P1|Overall Study|Other|36
256557|NCT02699684|831751|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
256558|NCT02699684|831752|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
256559|NCT02699593|831769|P2|Period 2|Torn Contact Lens|0
256560|NCT02699593|831770|P1|Period 2|Torn Contact Lens|1
256561|NCT02699593|831769|P2|Period 2|Lost Contact Lens|1
256562|NCT02699593|831770|P1|Period 2|Lost Contact Lens|0
256563|NCT02699593|831769|P2|Period 2|Adverse Event|1
256564|NCT02699593|831770|P1|Period 2|Adverse Event|1
256565|NCT02699593|831769|P2|Period 1|Adverse Event|1
256566|NCT02699593|831770|P1|Period 1|Adverse Event|1
256567|NCT02699593|831769|P2|Period 1|Withdrawal by Subject|1
256568|NCT02699593|831770|P1|Period 1|Withdrawal by Subject|0
256569|NCT02699593|831769|P2|Period 1|Protocol Violation|1
256570|NCT02699593|831770|P1|Period 1|Protocol Violation|0
256571|NCT02699593|831769|P2|Period 1|Torn Contact Len|3
256572|NCT02699593|831770|P1|Period 1|Torn Contact Len|4
256573|NCT02699593|831769|P2|Period 1|Unsatisfactory Visual Response|1
256574|NCT02699593|831770|P1|Period 1|Unsatisfactory Visual Response|0
256575|NCT02698436|831787|P2|Overall Study|Non-compliance with study regimen|0
256576|NCT02698436|831788|P1|Overall Study|Non-compliance with study regimen|1
256577|NCT02698436|831787|P2|Overall Study|Lost to Follow-up|4
256578|NCT02698436|831788|P1|Overall Study|Lost to Follow-up|2
256579|NCT02698436|831787|P2|Overall Study|Withdrawal by Subject|3
256580|NCT02698436|831788|P1|Overall Study|Withdrawal by Subject|3
256581|NCT02698436|831787|P2|Overall Study|Adverse Event|0
256582|NCT02698436|831788|P1|Overall Study|Adverse Event|1
256583|NCT02698423|831828|P2|Overall Study|Lost to Follow-up|24
256584|NCT02698423|831829|P1|Overall Study|Lost to Follow-up|19
256585|NCT02696317|831852|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
256586|NCT02696317|831853|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
256587|NCT02696317|831852|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
256588|NCT02696317|831853|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
256589|NCT02696226|831897|P4|Overall Study|Study terminated - lack of enrollment|0
256590|NCT02696226|831898|P3|Overall Study|Study terminated - lack of enrollment|2
256591|NCT02696226|831899|P2|Overall Study|Study terminated - lack of enrollment|0
256592|NCT02696226|831900|P1|Overall Study|Study terminated - lack of enrollment|1
256593|NCT02694978|831941|P2|Overall Study|Other-Withdrew prior to dosing|8
256594|NCT02694978|831942|P1|Overall Study|Other-Withdrew prior to dosing|9
256595|NCT02694978|831941|P2|Overall Study|Other-Personal reasons|3
256596|NCT02694978|831942|P1|Overall Study|Other-Personal reasons|3
256597|NCT02694978|831941|P2|Overall Study|Other-Protocol noncompliant|1
256598|NCT02694978|831942|P1|Overall Study|Other-Protocol noncompliant|2
256599|NCT02694978|831941|P2|Overall Study|Other-Unable to be reached|1
256600|NCT02694978|831942|P1|Overall Study|Other-Unable to be reached|0
256601|NCT02694978|831941|P2|Overall Study|Other-Investigator’s decision|0
256602|NCT02694978|831942|P1|Overall Study|Other-Investigator’s decision|1
256603|NCT02694978|831941|P2|Overall Study|Other-Decision of Participant|1
256604|NCT02694978|831942|P1|Overall Study|Other-Decision of Participant|6
256605|NCT02694978|831941|P2|Overall Study|Death|1
256606|NCT02694978|831942|P1|Overall Study|Death|4
256607|NCT02694978|831941|P2|Overall Study|Lost to Follow-up|17
256608|NCT02694978|831942|P1|Overall Study|Lost to Follow-up|14
256609|NCT02694978|831941|P2|Overall Study|Withdrawal by Subject|19
256610|NCT02694978|831942|P1|Overall Study|Withdrawal by Subject|22
256611|NCT02694978|831941|P2|Overall Study|Adverse Event|9
256612|NCT02694978|831942|P1|Overall Study|Adverse Event|10
256613|NCT02694744|831956|P2|Overall Study|Taking potassium supplement: exclusion 6|1
256614|NCT02694744|831957|P1|Overall Study|Taking potassium supplement: exclusion 6|0
256615|NCT02694744|831956|P2|Overall Study|Lost to Follow-up|0
256616|NCT02694744|831957|P1|Overall Study|Lost to Follow-up|1
256617|NCT02694744|831956|P2|Overall Study|Physician Decision|2
256618|NCT02694744|831957|P1|Overall Study|Physician Decision|1
256619|NCT02694744|831956|P2|Overall Study|Withdrawal by Subject|1
256620|NCT02694744|831957|P1|Overall Study|Withdrawal by Subject|2
256621|NCT02694744|831956|P2|Overall Study|Adverse Event|1
290763|NCT01729754|981063|P3|Part 3|Death|0
256622|NCT02694744|831957|P1|Overall Study|Adverse Event|2
256623|NCT02694718|831965|P1|Overall Study|Withdrawal by Subject|1
256624|NCT02694718|831965|P1|Overall Study|Death|1
256625|NCT02694536|831995|P1|Overall Study|Not Specified|22
256626|NCT02694536|831995|P1|Overall Study|Death|8
256627|NCT02694536|831995|P1|Overall Study|Withdrawal by Subject|8
256628|NCT02694536|831995|P1|Overall Study|Study Drug-Related Adverse Event|1
256629|NCT02694536|831995|P1|Overall Study|Lost to Follow-up|1
256630|NCT02694536|831995|P1|Overall Study|Progressive Disease|40
256631|NCT02692703|832048|P1|Overall Study|Not Specified|1
256632|NCT02692703|832048|P1|Overall Study|Lost to Follow-up|1
256635|NCT02691507|832097|P2|Overall Study|Missed Visit 3|1
256636|NCT02691507|832098|P1|Overall Study|Missed Visit 3|0
256637|NCT02690727|832273|P2|Overall Study|Adverse Event|2
256638|NCT02690727|832274|P1|Overall Study|Adverse Event|2
256639|NCT02689804|832286|P2|Overall Study|Withdrawal by Subject|0
256640|NCT02689804|832287|P1|Overall Study|Withdrawal by Subject|2
256641|NCT02689206|832318|P5|Overall Study|Withdrawal by Subject|0
256642|NCT02689206|832319|P4|Overall Study|Withdrawal by Subject|0
256643|NCT02689206|832320|P3|Overall Study|Withdrawal by Subject|1
256644|NCT02689206|832321|P2|Overall Study|Withdrawal by Subject|0
256645|NCT02689206|832322|P1|Overall Study|Withdrawal by Subject|1
256646|NCT02689206|832318|P5|Overall Study|Physician Decision|0
256647|NCT02689206|832319|P4|Overall Study|Physician Decision|0
256648|NCT02689206|832320|P3|Overall Study|Physician Decision|0
256649|NCT02689206|832321|P2|Overall Study|Physician Decision|0
256650|NCT02689206|832322|P1|Overall Study|Physician Decision|1
256651|NCT02689206|832318|P5|Overall Study|Other: Reached stopping criteria|4
256652|NCT02689206|832319|P4|Overall Study|Other: Reached stopping criteria|3
256653|NCT02689206|832320|P3|Overall Study|Other: Reached stopping criteria|2
256654|NCT02689206|832321|P2|Overall Study|Other: Reached stopping criteria|1
256655|NCT02689206|832322|P1|Overall Study|Other: Reached stopping criteria|0
256656|NCT02689206|832318|P5|Overall Study|Protocol Violation|2
256657|NCT02689206|832319|P4|Overall Study|Protocol Violation|1
256658|NCT02689206|832320|P3|Overall Study|Protocol Violation|0
256659|NCT02689206|832321|P2|Overall Study|Protocol Violation|0
256660|NCT02689206|832322|P1|Overall Study|Protocol Violation|1
256661|NCT02689206|832318|P5|Overall Study|Adverse Event|2
256662|NCT02689206|832319|P4|Overall Study|Adverse Event|0
256663|NCT02689206|832320|P3|Overall Study|Adverse Event|1
256664|NCT02689206|832321|P2|Overall Study|Adverse Event|0
256665|NCT02689206|832322|P1|Overall Study|Adverse Event|0
256666|NCT02688153|832528|P2|Overall Study|Conversion to Commercial Valve|0
256667|NCT02688153|832529|P1|Overall Study|Conversion to Commercial Valve|3
256668|NCT02688153|832528|P2|Overall Study|Valve Explant|0
256669|NCT02688153|832529|P1|Overall Study|Valve Explant|1
256670|NCT02688153|832528|P2|Overall Study|Withdrawal by Subject|2
256671|NCT02688153|832529|P1|Overall Study|Withdrawal by Subject|4
256672|NCT02688153|832528|P2|Overall Study|Death|5
256673|NCT02688153|832529|P1|Overall Study|Death|7
256674|NCT02685488|832620|P2|Overall Study|Withdrawal by Subject|1
256675|NCT02685488|832621|P1|Overall Study|Withdrawal by Subject|0
256676|NCT02685202|832635|P1|Overall Study|Lost to Follow-up|9
256677|NCT02683746|832781|P2|Overall Study|Physician Decision|1
256678|NCT02683746|832782|P1|Overall Study|Physician Decision|2
256679|NCT02683746|832781|P2|Overall Study|Withdrawal by Subject|5
256680|NCT02683746|832782|P1|Overall Study|Withdrawal by Subject|6
256681|NCT02683746|832781|P2|Overall Study|Lost to Follow-up|6
256682|NCT02683746|832782|P1|Overall Study|Lost to Follow-up|5
256683|NCT02683746|832781|P2|Overall Study|Adverse Event|2
256684|NCT02683746|832782|P1|Overall Study|Adverse Event|3
256685|NCT02681510|832897|P1|Overall Study|Lost to Follow-up|9
256686|NCT02681510|832897|P1|Overall Study|Withdrawal by Subject|1
256687|NCT02678923|832930|P2|Overall Study|Did Not Return for Study Visits|0
256688|NCT02678923|832931|P1|Overall Study|Did Not Return for Study Visits|1
256689|NCT02678923|832930|P2|Overall Study|Lost to Follow-up|0
256690|NCT02678923|832931|P1|Overall Study|Lost to Follow-up|1
256691|NCT02678923|832930|P2|Overall Study|Withdrawal by Subject|2
256692|NCT02678923|832931|P1|Overall Study|Withdrawal by Subject|3
256693|NCT02678923|832930|P2|Overall Study|Protocol Deviation (Not Dosed)|3
256694|NCT02678923|832931|P1|Overall Study|Protocol Deviation (Not Dosed)|1
256695|NCT02678676|832947|P2|Overall Study|Unconfirmed for lost to follow-up|67
256696|NCT02678676|832948|P1|Overall Study|Unconfirmed for lost to follow-up|85
256697|NCT02678676|832947|P2|Overall Study|Lost to Follow-up|151
256698|NCT02678676|832948|P1|Overall Study|Lost to Follow-up|171
256699|NCT02678676|832947|P2|Overall Study|Withdrawal by Subject|5
256700|NCT02678676|832948|P1|Overall Study|Withdrawal by Subject|13
256701|NCT02678676|832947|P2|Overall Study|Death|649
256702|NCT02678676|832948|P1|Overall Study|Death|619
256703|NCT02678286|832958|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
256704|NCT02678286|832959|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
256705|NCT02678286|832958|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
256706|NCT02678286|832959|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
256707|NCT02678286|832958|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
256708|NCT02678286|832959|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
290764|NCT01729754|981064|P2|Part 3|Death|0
256709|NCT02678286|832958|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
256710|NCT02678286|832959|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
256711|NCT02678286|832958|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
256712|NCT02678286|832959|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
256713|NCT02675907|833041|P2|Study Overall|Lost to Follow-up|2
256714|NCT02675907|833042|P1|Study Overall|Lost to Follow-up|0
256715|NCT02675907|833041|P2|Study Overall|Withdrawal by Subject|2
256716|NCT02675907|833042|P1|Study Overall|Withdrawal by Subject|2
256717|NCT02675907|833041|P2|Study Overall|Lack of Efficacy|0
256718|NCT02675907|833042|P1|Study Overall|Lack of Efficacy|1
256719|NCT02675907|833041|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
256720|NCT02675907|833042|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
256721|NCT02675907|833041|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
256722|NCT02675907|833042|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
256723|NCT02675634|833072|P6|Test Period 2|Adverse Event|1
256724|NCT02675634|833073|P5|Test Period 2|Adverse Event|0
256725|NCT02675634|833074|P4|Test Period 2|Adverse Event|0
256726|NCT02675634|833075|P3|Test Period 2|Adverse Event|0
256727|NCT02675634|833076|P2|Test Period 2|Adverse Event|0
256728|NCT02675634|833077|P1|Test Period 2|Adverse Event|0
256729|NCT02675634|833072|P6|Test Period 2|Lack of Efficacy|0
256730|NCT02675634|833073|P5|Test Period 2|Lack of Efficacy|0
256731|NCT02675634|833074|P4|Test Period 2|Lack of Efficacy|0
256732|NCT02675634|833075|P3|Test Period 2|Lack of Efficacy|0
256733|NCT02675634|833076|P2|Test Period 2|Lack of Efficacy|0
256734|NCT02675634|833077|P1|Test Period 2|Lack of Efficacy|1
256735|NCT02675634|833072|P6|Test Period 1|Device deficiency that did not lead to A|0
256736|NCT02675634|833073|P5|Test Period 1|Device deficiency that did not lead to A|0
256737|NCT02675634|833074|P4|Test Period 1|Device deficiency that did not lead to A|0
256738|NCT02675634|833075|P3|Test Period 1|Device deficiency that did not lead to A|1
256739|NCT02675634|833076|P2|Test Period 1|Device deficiency that did not lead to A|0
256740|NCT02675634|833077|P1|Test Period 1|Device deficiency that did not lead to A|0
256741|NCT02675634|833072|P6|Test Period 1|Adverse Event|0
256742|NCT02675634|833073|P5|Test Period 1|Adverse Event|0
256743|NCT02675634|833074|P4|Test Period 1|Adverse Event|1
256744|NCT02675634|833075|P3|Test Period 1|Adverse Event|0
256745|NCT02675634|833076|P2|Test Period 1|Adverse Event|1
256746|NCT02675634|833077|P1|Test Period 1|Adverse Event|0
256747|NCT02674334|833096|P2|Overall Study|NIRS not recording|0
256748|NCT02674334|833097|P1|Overall Study|NIRS not recording|1
256749|NCT02674334|833096|P2|Overall Study|participant difficulty breathing|0
256750|NCT02674334|833097|P1|Overall Study|participant difficulty breathing|1
256751|NCT02674334|833096|P2|Overall Study|Lost to Follow-up|3
256752|NCT02674334|833097|P1|Overall Study|Lost to Follow-up|5
256753|NCT02673619|833114|P4|Overall Study|Lack of Efficacy|0
256754|NCT02673619|833115|P3|Overall Study|Lack of Efficacy|1
256755|NCT02673619|833116|P2|Overall Study|Lack of Efficacy|0
256756|NCT02673619|833117|P1|Overall Study|Lack of Efficacy|0
256757|NCT02673619|833114|P4|Overall Study|Adverse Event|0
256758|NCT02673619|833115|P3|Overall Study|Adverse Event|1
256759|NCT02673619|833116|P2|Overall Study|Adverse Event|0
256760|NCT02673619|833117|P1|Overall Study|Adverse Event|0
256761|NCT02673619|833114|P4|Overall Study|Withdrawal by Subject|0
256762|NCT02673619|833115|P3|Overall Study|Withdrawal by Subject|1
256763|NCT02673619|833116|P2|Overall Study|Withdrawal by Subject|1
256764|NCT02673619|833117|P1|Overall Study|Withdrawal by Subject|1
256765|NCT02673619|833114|P4|Overall Study|Lost to Follow-up|0
256766|NCT02673619|833115|P3|Overall Study|Lost to Follow-up|0
256767|NCT02673619|833116|P2|Overall Study|Lost to Follow-up|0
256768|NCT02673619|833117|P1|Overall Study|Lost to Follow-up|1
256769|NCT02673489|833209|P2|Follow Up Period|Unable to return for follow-up|1
256770|NCT02673489|833210|P1|Follow Up Period|Unable to return for follow-up|0
256771|NCT02673489|833209|P2|Follow Up Period|Unable to return for week 24 follow-up|1
256772|NCT02673489|833210|P1|Follow Up Period|Unable to return for week 24 follow-up|0
256773|NCT02673489|833209|P2|Treatment Period|Adverse Event|1
256774|NCT02673489|833210|P1|Treatment Period|Adverse Event|0
256775|NCT02673489|833209|P2|Treatment Period|Participant was incarcerated|1
256776|NCT02673489|833210|P1|Treatment Period|Participant was incarcerated|0
256777|NCT02673489|833209|P2|Treatment Period|Participant moved to another province|0
256778|NCT02673489|833210|P1|Treatment Period|Participant moved to another province|1
256779|NCT02673489|833209|P2|Treatment Period|Participant request to discontinue|1
256780|NCT02673489|833210|P1|Treatment Period|Participant request to discontinue|1
256781|NCT02673489|833209|P2|Treatment Period|Lost to Follow-up|0
256782|NCT02673489|833210|P1|Treatment Period|Lost to Follow-up|3
256783|NCT02671760|833232|P3|Overall Study|Lost to Follow-up|0
256784|NCT02671760|833233|P2|Overall Study|Lost to Follow-up|1
256785|NCT02671760|833234|P1|Overall Study|Lost to Follow-up|0
256786|NCT02671461|833263|P3|Follow-up|Administrative Reason by Sponsor|0
256787|NCT02671461|833264|P2|Follow-up|Administrative Reason by Sponsor|1
256788|NCT02671461|833265|P1|Follow-up|Administrative Reason by Sponsor|0
256789|NCT02671461|833263|P3|Follow-up|Lost to Follow-up|1
256790|NCT02671461|833264|P2|Follow-up|Lost to Follow-up|0
256791|NCT02671461|833265|P1|Follow-up|Lost to Follow-up|0
256792|NCT02671461|833263|P3|Follow-up|Withdrawal by Subject|0
256793|NCT02671461|833264|P2|Follow-up|Withdrawal by Subject|0
256794|NCT02671461|833265|P1|Follow-up|Withdrawal by Subject|1
256795|NCT02671461|833263|P3|Treatment|Lost to Follow-up|0
256796|NCT02671461|833264|P2|Treatment|Lost to Follow-up|0
256797|NCT02671461|833265|P1|Treatment|Lost to Follow-up|1
256798|NCT02671461|833263|P3|Treatment|Administrative Reason by Sponsor|4
256799|NCT02671461|833264|P2|Treatment|Administrative Reason by Sponsor|3
256800|NCT02671461|833265|P1|Treatment|Administrative Reason by Sponsor|1
256801|NCT02671461|833263|P3|Treatment|Adverse Event|1
256802|NCT02671461|833264|P2|Treatment|Adverse Event|0
256803|NCT02671461|833265|P1|Treatment|Adverse Event|0
256804|NCT02670473|833307|P1|Overall Study|Withdrawal by Subject|1
256805|NCT02669095|833366|P2|Overall Study|Visit 5 assessments not completed|1
256806|NCT02669095|833367|P1|Overall Study|Visit 5 assessments not completed|0
256807|NCT02669095|833366|P2|Overall Study|Torn Lens|1
256808|NCT02669095|833367|P1|Overall Study|Torn Lens|0
256809|NCT02669095|833366|P2|Overall Study|Unsatisfactory Lens Fitting|1
256810|NCT02669095|833367|P1|Overall Study|Unsatisfactory Lens Fitting|0
256811|NCT02669095|833366|P2|Overall Study|Adverse Event|0
256812|NCT02669095|833367|P1|Overall Study|Adverse Event|1
256813|NCT02669043|833375|P1|Overall Study|Didn't meet I/E criteria|4
256814|NCT02668822|833402|P2|Overall Study|Study Terminated by Sponsor|9
256815|NCT02668822|833403|P1|Overall Study|Study Terminated by Sponsor|7
256816|NCT02668822|833402|P2|Overall Study|Protocol Violation|0
256817|NCT02668822|833403|P1|Overall Study|Protocol Violation|2
256818|NCT02668783|833425|P2|Overall Study|Withdrawal by Subject|0
256819|NCT02668783|833426|P1|Overall Study|Withdrawal by Subject|1
256820|NCT02668783|833425|P2|Overall Study|Subject moved|0
256821|NCT02668783|833426|P1|Overall Study|Subject moved|1
256822|NCT02668783|833425|P2|Overall Study|Study terminated by sponsor|10
256823|NCT02668783|833426|P1|Overall Study|Study terminated by sponsor|9
256824|NCT02668783|833425|P2|Overall Study|Protocol Violation|1
256825|NCT02668783|833426|P1|Overall Study|Protocol Violation|2
256826|NCT02668783|833425|P2|Overall Study|Pregnancy|1
256827|NCT02668783|833426|P1|Overall Study|Pregnancy|0
256828|NCT02667288|833463|P1|Overall Study|Withdrawal by Subject|5
256829|NCT02667288|833463|P1|Overall Study|Lost to Follow-up|3
256830|NCT02667288|833463|P1|Overall Study|Protocol Violation|5
256831|NCT02667275|833470|P2|Overall Study|Discontinued early without completing|1
256832|NCT02667275|833471|P1|Overall Study|Discontinued early without completing|0
256833|NCT02667275|833470|P2|Overall Study|Withdrawal by Subject|5
256834|NCT02667275|833471|P1|Overall Study|Withdrawal by Subject|0
256835|NCT02667275|833470|P2|Overall Study|Lost to Follow-up|2
256836|NCT02667275|833471|P1|Overall Study|Lost to Follow-up|0
256837|NCT02667275|833470|P2|Overall Study|Protocol Violation|7
256838|NCT02667275|833471|P1|Overall Study|Protocol Violation|11
256839|NCT02667236|833481|P2|Overall Study|Withdrawal by Subject|0
256840|NCT02667236|833482|P1|Overall Study|Withdrawal by Subject|2
256841|NCT02667236|833481|P2|Overall Study|Adverse Event|1
256842|NCT02667236|833482|P1|Overall Study|Adverse Event|1
256843|NCT02666222|833507|P1|Overall Study|Death|2
256844|NCT02665455|833515|P1|Overall Study|Protocol Violation|1
256845|NCT02665455|833515|P1|Overall Study|Adverse Event|1
256846|NCT02665455|833515|P1|Overall Study|Lost to Follow-up|1
256847|NCT02665455|833515|P1|Overall Study|Withdrawal by Subject|6
256848|NCT02665286|833522|P3|Overall Study|Lost to Follow-up|1
256849|NCT02665286|833523|P2|Overall Study|Lost to Follow-up|2
256850|NCT02665286|833524|P1|Overall Study|Lost to Follow-up|3
256851|NCT02663453|833627|P2|Overall Study|Withdrawal by Subject|0
256852|NCT02663453|833628|P1|Overall Study|Withdrawal by Subject|1
256853|NCT02663453|833627|P2|Overall Study|Death|4
256854|NCT02663453|833628|P1|Overall Study|Death|4
256855|NCT02662556|833675|P1|Overall Study|Lack of Efficacy|4
256856|NCT02662556|833675|P1|Overall Study|Adverse Event|4
256857|NCT02661594|833697|P4|Overall Study|Protocol Violation|0
256858|NCT02661594|833698|P3|Overall Study|Protocol Violation|1
256859|NCT02661594|833699|P2|Overall Study|Protocol Violation|0
256860|NCT02661594|833700|P1|Overall Study|Protocol Violation|1
256861|NCT02658149|833743|P2|Overall Study|Physician Decision|0
256862|NCT02658149|833744|P1|Overall Study|Physician Decision|1
256863|NCT02657031|833789|P2|Overall Study|Adverse Event|2
256864|NCT02657031|833790|P1|Overall Study|Adverse Event|1
256865|NCT02654145|833832|P1|Overall Study|Withdrawal by Subject|5
256866|NCT02654145|833832|P1|Overall Study|Protocol Violation|1
256867|NCT02654145|833832|P1|Overall Study|Lack of Efficacy|1
256868|NCT02653495|833889|P2|Overall Study|Screening Failure|0
256869|NCT02653495|833890|P1|Overall Study|Screening Failure|10
256870|NCT02653495|833889|P2|Overall Study|Lost to Follow-up|0
256871|NCT02653495|833890|P1|Overall Study|Lost to Follow-up|2
256872|NCT02651922|833924|P1|Overall Study|due to exclusion criteria|2
256873|NCT02651467|833944|P3|Overall Study|Other (Not specified)|2
256874|NCT02651467|833945|P2|Overall Study|Other (Not specified)|0
256875|NCT02651467|833946|P1|Overall Study|Other (Not specified)|1
256876|NCT02651467|833944|P3|Overall Study|Withdrawal by Subject|2
256877|NCT02651467|833945|P2|Overall Study|Withdrawal by Subject|0
256878|NCT02651467|833946|P1|Overall Study|Withdrawal by Subject|0
256879|NCT02651194|833965|P1|Overall Study|Not Specified|2
256880|NCT02651194|833965|P1|Overall Study|Lost to Follow-up|3
256881|NCT02649634|834005|P2|Overall Study|Lost to Follow-up|1
256882|NCT02649634|834006|P1|Overall Study|Lost to Follow-up|0
256883|NCT02649634|834005|P2|Overall Study|Withdrawal by Subject|5
256884|NCT02649634|834006|P1|Overall Study|Withdrawal by Subject|3
256885|NCT02648438|834065|P3|Overall Study|Withdrawal by Subject|0
256886|NCT02648438|834066|P2|Overall Study|Withdrawal by Subject|1
256887|NCT02648438|834067|P1|Overall Study|Withdrawal by Subject|1
256888|NCT02648438|834065|P3|Overall Study|Protocol Violation|0
256889|NCT02648438|834066|P2|Overall Study|Protocol Violation|0
256890|NCT02648438|834067|P1|Overall Study|Protocol Violation|2
256891|NCT02648438|834065|P3|Overall Study|Eligibility criteria not fulfilled|0
256892|NCT02648438|834066|P2|Overall Study|Eligibility criteria not fulfilled|2
256893|NCT02648438|834067|P1|Overall Study|Eligibility criteria not fulfilled|0
256894|NCT02648204|834111|P4|Overall Study|Adverse Event|0
256895|NCT02648204|834112|P3|Overall Study|Adverse Event|1
256896|NCT02648204|834113|P2|Overall Study|Adverse Event|0
256897|NCT02648204|834114|P1|Overall Study|Adverse Event|0
256898|NCT02648204|834111|P4|Overall Study|Death|2
256899|NCT02648204|834112|P3|Overall Study|Death|2
256900|NCT02648204|834113|P2|Overall Study|Death|1
256901|NCT02648204|834114|P1|Overall Study|Death|1
256902|NCT02648204|834111|P4|Overall Study|Missing follow-up information|2
256903|NCT02648204|834112|P3|Overall Study|Missing follow-up information|4
256904|NCT02648204|834113|P2|Overall Study|Missing follow-up information|4
256905|NCT02648204|834114|P1|Overall Study|Missing follow-up information|4
256906|NCT02648204|834111|P4|Overall Study|Lost to Follow-up|6
256907|NCT02648204|834112|P3|Overall Study|Lost to Follow-up|4
256908|NCT02648204|834113|P2|Overall Study|Lost to Follow-up|8
256909|NCT02648204|834114|P1|Overall Study|Lost to Follow-up|5
256910|NCT02648204|834111|P4|Overall Study|Withdrawal by Subject|6
256911|NCT02648204|834112|P3|Overall Study|Withdrawal by Subject|2
256912|NCT02648204|834113|P2|Overall Study|Withdrawal by Subject|8
256913|NCT02648204|834114|P1|Overall Study|Withdrawal by Subject|12
256914|NCT02647944|834247|P2|Overall Study|Adverse Event|0
256915|NCT02647944|834248|P1|Overall Study|Adverse Event|2
256916|NCT02647944|834247|P2|Overall Study|Withdrawal by Subject|3
256917|NCT02647944|834248|P1|Overall Study|Withdrawal by Subject|0
256918|NCT02647905|834272|P1|Overall Study|Withdrawal by Subject|2
256919|NCT02647905|834272|P1|Overall Study|Lost to Follow-up|1
256920|NCT02647320|834282|P5|Overall Study|Disposition Missing Due to Fire at Site|4
256921|NCT02647320|834283|P4|Overall Study|Disposition Missing Due to Fire at Site|3
256922|NCT02647320|834284|P3|Overall Study|Disposition Missing Due to Fire at Site|4
256923|NCT02647320|834285|P2|Overall Study|Disposition Missing Due to Fire at Site|3
256924|NCT02647320|834286|P1|Overall Study|Disposition Missing Due to Fire at Site|2
256925|NCT02647320|834282|P5|Overall Study|Lack of Efficacy|0
256926|NCT02647320|834283|P4|Overall Study|Lack of Efficacy|1
256927|NCT02647320|834284|P3|Overall Study|Lack of Efficacy|0
256928|NCT02647320|834285|P2|Overall Study|Lack of Efficacy|0
256929|NCT02647320|834286|P1|Overall Study|Lack of Efficacy|0
256930|NCT02647320|834282|P5|Overall Study|Develop anemia|0
256931|NCT02647320|834283|P4|Overall Study|Develop anemia|0
256932|NCT02647320|834284|P3|Overall Study|Develop anemia|0
256933|NCT02647320|834285|P2|Overall Study|Develop anemia|0
256934|NCT02647320|834286|P1|Overall Study|Develop anemia|1
256935|NCT02647320|834282|P5|Overall Study|Lost to Follow-up|0
256936|NCT02647320|834283|P4|Overall Study|Lost to Follow-up|0
256937|NCT02647320|834284|P3|Overall Study|Lost to Follow-up|0
256938|NCT02647320|834285|P2|Overall Study|Lost to Follow-up|1
256939|NCT02647320|834286|P1|Overall Study|Lost to Follow-up|1
256940|NCT02647320|834282|P5|Overall Study|Reason not provided|2
256941|NCT02647320|834283|P4|Overall Study|Reason not provided|0
256942|NCT02647320|834284|P3|Overall Study|Reason not provided|1
256943|NCT02647320|834285|P2|Overall Study|Reason not provided|0
256944|NCT02647320|834286|P1|Overall Study|Reason not provided|0
256945|NCT02647320|834282|P5|Overall Study|Study terminated by sponsor|2
256946|NCT02647320|834283|P4|Overall Study|Study terminated by sponsor|1
256947|NCT02647320|834284|P3|Overall Study|Study terminated by sponsor|1
256948|NCT02647320|834285|P2|Overall Study|Study terminated by sponsor|1
256949|NCT02647320|834286|P1|Overall Study|Study terminated by sponsor|1
256950|NCT02647320|834282|P5|Overall Study|Persistent hyperglycemia|1
256951|NCT02647320|834283|P4|Overall Study|Persistent hyperglycemia|1
256952|NCT02647320|834284|P3|Overall Study|Persistent hyperglycemia|1
256953|NCT02647320|834285|P2|Overall Study|Persistent hyperglycemia|1
256954|NCT02647320|834286|P1|Overall Study|Persistent hyperglycemia|0
256955|NCT02647320|834282|P5|Overall Study|Withdrawal by Subject|7
256956|NCT02647320|834283|P4|Overall Study|Withdrawal by Subject|2
256957|NCT02647320|834284|P3|Overall Study|Withdrawal by Subject|2
256958|NCT02647320|834285|P2|Overall Study|Withdrawal by Subject|4
256959|NCT02647320|834286|P1|Overall Study|Withdrawal by Subject|7
256960|NCT02647320|834282|P5|Overall Study|Protocol Violation|0
256961|NCT02647320|834283|P4|Overall Study|Protocol Violation|0
256962|NCT02647320|834284|P3|Overall Study|Protocol Violation|3
256963|NCT02647320|834285|P2|Overall Study|Protocol Violation|0
256964|NCT02647320|834286|P1|Overall Study|Protocol Violation|0
256965|NCT02647320|834282|P5|Overall Study|Adverse Event|1
256966|NCT02647320|834283|P4|Overall Study|Adverse Event|2
256967|NCT02647320|834284|P3|Overall Study|Adverse Event|3
256968|NCT02647320|834285|P2|Overall Study|Adverse Event|1
290765|NCT01729754|981065|P1|Part 3|Death|0
256969|NCT02647320|834286|P1|Overall Study|Adverse Event|0
256970|NCT02644356|834542|P1|Overall Study|Withdrawal by Subject|2
256971|NCT02644122|834552|P1|Overall Study|Withdrawal by Subject|1
256972|NCT02644109|834562|P2|Overall Study|Adverse Event|4
256973|NCT02644109|834563|P1|Overall Study|Adverse Event|0
256974|NCT02644096|834571|P2|Overall Study|Withdrawal by Subject|25
256975|NCT02644096|834572|P1|Overall Study|Withdrawal by Subject|28
256976|NCT02643394|834606|P2|Overall Study|Protocol Violation|5
256977|NCT02643394|834607|P1|Overall Study|Protocol Violation|4
256978|NCT02643251|834617|P2|Overall Study|PI Decision to terminate patient|0
256979|NCT02643251|834618|P1|Overall Study|PI Decision to terminate patient|1
256980|NCT02643251|834617|P2|Overall Study|Protocol Violation|0
256981|NCT02643251|834618|P1|Overall Study|Protocol Violation|1
256982|NCT02643251|834617|P2|Overall Study|Lost to Follow-up|1
256983|NCT02643251|834618|P1|Overall Study|Lost to Follow-up|4
256984|NCT02643251|834617|P2|Overall Study|Withdrawal by Subject|0
256985|NCT02643251|834618|P1|Overall Study|Withdrawal by Subject|2
256986|NCT02643251|834617|P2|Overall Study|Adverse Event|1
256987|NCT02643251|834618|P1|Overall Study|Adverse Event|3
256988|NCT02642679|834700|P1|Overall Study|Physician Decision|1
256989|NCT02642679|834700|P1|Overall Study|Physician Decision|1
256990|NCT02642679|834700|P1|Overall Study|Withdrawal by Subject|1
256991|NCT02642432|834741|P1|Overall Study|Not Specified|3
256992|NCT02642432|834741|P1|Overall Study|Lost to Follow-up|2
256993|NCT02642432|834741|P1|Overall Study|Withdrew Consent|1
256994|NCT02642432|834741|P1|Overall Study|Adverse Event|2
256995|NCT02642159|834749|P2|Overall Study|Other than specified above|3
256996|NCT02642159|834750|P1|Overall Study|Other than specified above|10
256997|NCT02642159|834749|P2|Overall Study|Poor compliance to study protocol|0
256998|NCT02642159|834750|P1|Overall Study|Poor compliance to study protocol|1
256999|NCT02642159|834749|P2|Overall Study|Withdrawal by Subject|1
257000|NCT02642159|834750|P1|Overall Study|Withdrawal by Subject|9
257001|NCT02642159|834749|P2|Overall Study|Adverse Event|4
257002|NCT02642159|834750|P1|Overall Study|Adverse Event|10
257003|NCT02642159|834749|P2|Overall Study|Randomized but not treated|0
257004|NCT02642159|834750|P1|Overall Study|Randomized but not treated|1
257005|NCT02641379|834975|P11|Overall Study|PCR positive|0
257006|NCT02641379|834976|P10|Overall Study|PCR positive|0
257007|NCT02641379|834977|P9|Overall Study|PCR positive|0
257008|NCT02641379|834978|P8|Overall Study|PCR positive|0
257009|NCT02641379|834979|P7|Overall Study|PCR positive|1
257010|NCT02641379|834980|P6|Overall Study|PCR positive|0
257011|NCT02641379|834981|P5|Overall Study|PCR positive|0
257012|NCT02641379|834982|P4|Overall Study|PCR positive|0
257013|NCT02641379|834983|P3|Overall Study|PCR positive|0
257014|NCT02641379|834984|P2|Overall Study|PCR positive|0
257015|NCT02641379|834985|P1|Overall Study|PCR positive|0
257016|NCT02641379|834975|P11|Overall Study|Missing PCR result at Week 8|0
257017|NCT02641379|834976|P10|Overall Study|Missing PCR result at Week 8|1
257018|NCT02641379|834977|P9|Overall Study|Missing PCR result at Week 8|0
257019|NCT02641379|834978|P8|Overall Study|Missing PCR result at Week 8|0
257020|NCT02641379|834979|P7|Overall Study|Missing PCR result at Week 8|0
257021|NCT02641379|834980|P6|Overall Study|Missing PCR result at Week 8|0
257022|NCT02641379|834981|P5|Overall Study|Missing PCR result at Week 8|0
257023|NCT02641379|834982|P4|Overall Study|Missing PCR result at Week 8|0
257024|NCT02641379|834983|P3|Overall Study|Missing PCR result at Week 8|0
257025|NCT02641379|834984|P2|Overall Study|Missing PCR result at Week 8|0
257026|NCT02641379|834985|P1|Overall Study|Missing PCR result at Week 8|0
257027|NCT02641379|834975|P11|Overall Study|Participant treated after Week 24|0
257028|NCT02641379|834976|P10|Overall Study|Participant treated after Week 24|0
257029|NCT02641379|834977|P9|Overall Study|Participant treated after Week 24|1
257030|NCT02641379|834978|P8|Overall Study|Participant treated after Week 24|0
257031|NCT02641379|834979|P7|Overall Study|Participant treated after Week 24|0
257032|NCT02641379|834980|P6|Overall Study|Participant treated after Week 24|0
257033|NCT02641379|834981|P5|Overall Study|Participant treated after Week 24|0
257034|NCT02641379|834982|P4|Overall Study|Participant treated after Week 24|0
257035|NCT02641379|834983|P3|Overall Study|Participant treated after Week 24|0
257036|NCT02641379|834984|P2|Overall Study|Participant treated after Week 24|0
257037|NCT02641379|834985|P1|Overall Study|Participant treated after Week 24|0
257038|NCT02641379|834975|P11|Overall Study|Participant’s PCR high|0
257039|NCT02641379|834976|P10|Overall Study|Participant’s PCR high|0
257040|NCT02641379|834977|P9|Overall Study|Participant’s PCR high|0
257041|NCT02641379|834978|P8|Overall Study|Participant’s PCR high|1
257042|NCT02641379|834979|P7|Overall Study|Participant’s PCR high|0
257043|NCT02641379|834980|P6|Overall Study|Participant’s PCR high|0
257044|NCT02641379|834981|P5|Overall Study|Participant’s PCR high|0
257045|NCT02641379|834982|P4|Overall Study|Participant’s PCR high|0
257046|NCT02641379|834983|P3|Overall Study|Participant’s PCR high|0
257047|NCT02641379|834984|P2|Overall Study|Participant’s PCR high|0
257048|NCT02641379|834985|P1|Overall Study|Participant’s PCR high|0
257049|NCT02641379|834975|P11|Overall Study|Negative PCR result|0
257050|NCT02641379|834976|P10|Overall Study|Negative PCR result|1
257051|NCT02641379|834977|P9|Overall Study|Negative PCR result|0
257052|NCT02641379|834978|P8|Overall Study|Negative PCR result|0
257053|NCT02641379|834979|P7|Overall Study|Negative PCR result|0
257054|NCT02641379|834980|P6|Overall Study|Negative PCR result|0
257055|NCT02641379|834981|P5|Overall Study|Negative PCR result|0
257056|NCT02641379|834982|P4|Overall Study|Negative PCR result|0
257057|NCT02641379|834983|P3|Overall Study|Negative PCR result|0
257058|NCT02641379|834984|P2|Overall Study|Negative PCR result|0
257059|NCT02641379|834985|P1|Overall Study|Negative PCR result|0
257060|NCT02641379|834975|P11|Overall Study|No 2 Log drop at Week 12|1
257061|NCT02641379|834976|P10|Overall Study|No 2 Log drop at Week 12|0
257062|NCT02641379|834977|P9|Overall Study|No 2 Log drop at Week 12|0
257063|NCT02641379|834978|P8|Overall Study|No 2 Log drop at Week 12|0
257064|NCT02641379|834979|P7|Overall Study|No 2 Log drop at Week 12|0
257065|NCT02641379|834980|P6|Overall Study|No 2 Log drop at Week 12|0
257066|NCT02641379|834981|P5|Overall Study|No 2 Log drop at Week 12|0
257067|NCT02641379|834982|P4|Overall Study|No 2 Log drop at Week 12|0
257068|NCT02641379|834983|P3|Overall Study|No 2 Log drop at Week 12|0
257069|NCT02641379|834984|P2|Overall Study|No 2 Log drop at Week 12|0
257070|NCT02641379|834985|P1|Overall Study|No 2 Log drop at Week 12|0
257071|NCT02641379|834975|P11|Overall Study|Non-response Week 12|0
257072|NCT02641379|834976|P10|Overall Study|Non-response Week 12|0
257073|NCT02641379|834977|P9|Overall Study|Non-response Week 12|0
257074|NCT02641379|834978|P8|Overall Study|Non-response Week 12|1
257075|NCT02641379|834979|P7|Overall Study|Non-response Week 12|0
257076|NCT02641379|834980|P6|Overall Study|Non-response Week 12|0
257077|NCT02641379|834981|P5|Overall Study|Non-response Week 12|0
257078|NCT02641379|834982|P4|Overall Study|Non-response Week 12|0
257079|NCT02641379|834983|P3|Overall Study|Non-response Week 12|0
257080|NCT02641379|834984|P2|Overall Study|Non-response Week 12|0
257081|NCT02641379|834985|P1|Overall Study|Non-response Week 12|0
257082|NCT02641379|834975|P11|Overall Study|Participant showed weight reduction|0
257083|NCT02641379|834976|P10|Overall Study|Participant showed weight reduction|0
257084|NCT02641379|834977|P9|Overall Study|Participant showed weight reduction|0
257085|NCT02641379|834978|P8|Overall Study|Participant showed weight reduction|1
257086|NCT02641379|834979|P7|Overall Study|Participant showed weight reduction|0
257087|NCT02641379|834980|P6|Overall Study|Participant showed weight reduction|0
257088|NCT02641379|834981|P5|Overall Study|Participant showed weight reduction|0
257089|NCT02641379|834982|P4|Overall Study|Participant showed weight reduction|0
257090|NCT02641379|834983|P3|Overall Study|Participant showed weight reduction|0
257091|NCT02641379|834984|P2|Overall Study|Participant showed weight reduction|0
257092|NCT02641379|834985|P1|Overall Study|Participant showed weight reduction|0
257093|NCT02641379|834975|P11|Overall Study|Source data not found|0
257094|NCT02641379|834976|P10|Overall Study|Source data not found|0
257095|NCT02641379|834977|P9|Overall Study|Source data not found|0
257096|NCT02641379|834978|P8|Overall Study|Source data not found|0
257097|NCT02641379|834979|P7|Overall Study|Source data not found|0
257098|NCT02641379|834980|P6|Overall Study|Source data not found|1
257099|NCT02641379|834981|P5|Overall Study|Source data not found|0
257100|NCT02641379|834982|P4|Overall Study|Source data not found|0
257101|NCT02641379|834983|P3|Overall Study|Source data not found|0
257102|NCT02641379|834984|P2|Overall Study|Source data not found|0
257103|NCT02641379|834985|P1|Overall Study|Source data not found|0
257104|NCT02641379|834975|P11|Overall Study|Lost to Follow-up|0
257105|NCT02641379|834976|P10|Overall Study|Lost to Follow-up|0
257106|NCT02641379|834977|P9|Overall Study|Lost to Follow-up|1
257107|NCT02641379|834978|P8|Overall Study|Lost to Follow-up|0
257108|NCT02641379|834979|P7|Overall Study|Lost to Follow-up|0
257109|NCT02641379|834980|P6|Overall Study|Lost to Follow-up|0
257110|NCT02641379|834981|P5|Overall Study|Lost to Follow-up|0
257111|NCT02641379|834982|P4|Overall Study|Lost to Follow-up|0
257112|NCT02641379|834983|P3|Overall Study|Lost to Follow-up|0
257113|NCT02641379|834984|P2|Overall Study|Lost to Follow-up|0
257114|NCT02641379|834985|P1|Overall Study|Lost to Follow-up|0
257115|NCT02641379|834975|P11|Overall Study|Participation in sili rescue study|0
257116|NCT02641379|834976|P10|Overall Study|Participation in sili rescue study|0
257117|NCT02641379|834977|P9|Overall Study|Participation in sili rescue study|0
257118|NCT02641379|834978|P8|Overall Study|Participation in sili rescue study|0
257119|NCT02641379|834979|P7|Overall Study|Participation in sili rescue study|0
257120|NCT02641379|834980|P6|Overall Study|Participation in sili rescue study|1
257121|NCT02641379|834981|P5|Overall Study|Participation in sili rescue study|0
257122|NCT02641379|834982|P4|Overall Study|Participation in sili rescue study|0
257123|NCT02641379|834983|P3|Overall Study|Participation in sili rescue study|0
257124|NCT02641379|834984|P2|Overall Study|Participation in sili rescue study|0
257125|NCT02641379|834985|P1|Overall Study|Participation in sili rescue study|0
257126|NCT02641379|834975|P11|Overall Study|Protocol Violation|0
257127|NCT02641379|834976|P10|Overall Study|Protocol Violation|0
257128|NCT02641379|834977|P9|Overall Study|Protocol Violation|1
257129|NCT02641379|834978|P8|Overall Study|Protocol Violation|0
257130|NCT02641379|834979|P7|Overall Study|Protocol Violation|0
257131|NCT02641379|834980|P6|Overall Study|Protocol Violation|0
257132|NCT02641379|834981|P5|Overall Study|Protocol Violation|2
257133|NCT02641379|834982|P4|Overall Study|Protocol Violation|0
257134|NCT02641379|834983|P3|Overall Study|Protocol Violation|0
257135|NCT02641379|834984|P2|Overall Study|Protocol Violation|0
257136|NCT02641379|834985|P1|Overall Study|Protocol Violation|0
257137|NCT02641379|834975|P11|Overall Study|Blood could not be drawn|0
257138|NCT02641379|834976|P10|Overall Study|Blood could not be drawn|0
257139|NCT02641379|834977|P9|Overall Study|Blood could not be drawn|0
257140|NCT02641379|834978|P8|Overall Study|Blood could not be drawn|0
257141|NCT02641379|834979|P7|Overall Study|Blood could not be drawn|0
257142|NCT02641379|834980|P6|Overall Study|Blood could not be drawn|0
257143|NCT02641379|834981|P5|Overall Study|Blood could not be drawn|1
257144|NCT02641379|834982|P4|Overall Study|Blood could not be drawn|0
257145|NCT02641379|834983|P3|Overall Study|Blood could not be drawn|0
257146|NCT02641379|834984|P2|Overall Study|Blood could not be drawn|0
257147|NCT02641379|834985|P1|Overall Study|Blood could not be drawn|0
257148|NCT02641379|834975|P11|Overall Study|Baseline viral load unavailable|0
257149|NCT02641379|834976|P10|Overall Study|Baseline viral load unavailable|0
257150|NCT02641379|834977|P9|Overall Study|Baseline viral load unavailable|0
257151|NCT02641379|834978|P8|Overall Study|Baseline viral load unavailable|0
257152|NCT02641379|834979|P7|Overall Study|Baseline viral load unavailable|0
257153|NCT02641379|834980|P6|Overall Study|Baseline viral load unavailable|0
257154|NCT02641379|834981|P5|Overall Study|Baseline viral load unavailable|0
257155|NCT02641379|834982|P4|Overall Study|Baseline viral load unavailable|1
257156|NCT02641379|834983|P3|Overall Study|Baseline viral load unavailable|0
257157|NCT02641379|834984|P2|Overall Study|Baseline viral load unavailable|0
257158|NCT02641379|834985|P1|Overall Study|Baseline viral load unavailable|0
257159|NCT02641379|834975|P11|Overall Study|Inclusion criteria not fulfilled|0
257160|NCT02641379|834976|P10|Overall Study|Inclusion criteria not fulfilled|0
257161|NCT02641379|834977|P9|Overall Study|Inclusion criteria not fulfilled|0
257162|NCT02641379|834978|P8|Overall Study|Inclusion criteria not fulfilled|0
257163|NCT02641379|834979|P7|Overall Study|Inclusion criteria not fulfilled|0
257164|NCT02641379|834980|P6|Overall Study|Inclusion criteria not fulfilled|0
257165|NCT02641379|834981|P5|Overall Study|Inclusion criteria not fulfilled|0
257166|NCT02641379|834982|P4|Overall Study|Inclusion criteria not fulfilled|1
257167|NCT02641379|834983|P3|Overall Study|Inclusion criteria not fulfilled|0
257168|NCT02641379|834984|P2|Overall Study|Inclusion criteria not fulfilled|0
257169|NCT02641379|834985|P1|Overall Study|Inclusion criteria not fulfilled|0
257170|NCT02641379|834975|P11|Overall Study|PCR sample for Week 4 not drawn|0
257171|NCT02641379|834976|P10|Overall Study|PCR sample for Week 4 not drawn|0
257172|NCT02641379|834977|P9|Overall Study|PCR sample for Week 4 not drawn|0
257173|NCT02641379|834978|P8|Overall Study|PCR sample for Week 4 not drawn|0
257174|NCT02641379|834979|P7|Overall Study|PCR sample for Week 4 not drawn|0
257175|NCT02641379|834980|P6|Overall Study|PCR sample for Week 4 not drawn|0
257176|NCT02641379|834981|P5|Overall Study|PCR sample for Week 4 not drawn|0
257177|NCT02641379|834982|P4|Overall Study|PCR sample for Week 4 not drawn|1
257178|NCT02641379|834983|P3|Overall Study|PCR sample for Week 4 not drawn|0
257179|NCT02641379|834984|P2|Overall Study|PCR sample for Week 4 not drawn|0
257180|NCT02641379|834985|P1|Overall Study|PCR sample for Week 4 not drawn|0
257181|NCT02641379|834975|P11|Overall Study|PCR positive at Week 28|0
257182|NCT02641379|834976|P10|Overall Study|PCR positive at Week 28|0
257183|NCT02641379|834977|P9|Overall Study|PCR positive at Week 28|0
257184|NCT02641379|834978|P8|Overall Study|PCR positive at Week 28|0
257185|NCT02641379|834979|P7|Overall Study|PCR positive at Week 28|0
257186|NCT02641379|834980|P6|Overall Study|PCR positive at Week 28|0
257187|NCT02641379|834981|P5|Overall Study|PCR positive at Week 28|0
257188|NCT02641379|834982|P4|Overall Study|PCR positive at Week 28|0
257189|NCT02641379|834983|P3|Overall Study|PCR positive at Week 28|1
257190|NCT02641379|834984|P2|Overall Study|PCR positive at Week 28|0
257191|NCT02641379|834985|P1|Overall Study|PCR positive at Week 28|0
257192|NCT02641379|834975|P11|Overall Study|No PCR at baseline|0
257193|NCT02641379|834976|P10|Overall Study|No PCR at baseline|0
257194|NCT02641379|834977|P9|Overall Study|No PCR at baseline|0
257195|NCT02641379|834978|P8|Overall Study|No PCR at baseline|0
257196|NCT02641379|834979|P7|Overall Study|No PCR at baseline|0
257197|NCT02641379|834980|P6|Overall Study|No PCR at baseline|0
257198|NCT02641379|834981|P5|Overall Study|No PCR at baseline|0
257199|NCT02641379|834982|P4|Overall Study|No PCR at baseline|0
257200|NCT02641379|834983|P3|Overall Study|No PCR at baseline|1
257201|NCT02641379|834984|P2|Overall Study|No PCR at baseline|0
257202|NCT02641379|834985|P1|Overall Study|No PCR at baseline|0
257203|NCT02641379|834975|P11|Overall Study|PCR not performed at Week 12|0
257204|NCT02641379|834976|P10|Overall Study|PCR not performed at Week 12|0
257205|NCT02641379|834977|P9|Overall Study|PCR not performed at Week 12|0
257206|NCT02641379|834978|P8|Overall Study|PCR not performed at Week 12|0
257207|NCT02641379|834979|P7|Overall Study|PCR not performed at Week 12|0
257208|NCT02641379|834980|P6|Overall Study|PCR not performed at Week 12|0
257209|NCT02641379|834981|P5|Overall Study|PCR not performed at Week 12|0
257210|NCT02641379|834982|P4|Overall Study|PCR not performed at Week 12|0
257211|NCT02641379|834983|P3|Overall Study|PCR not performed at Week 12|1
257212|NCT02641379|834984|P2|Overall Study|PCR not performed at Week 12|0
257213|NCT02641379|834985|P1|Overall Study|PCR not performed at Week 12|0
257214|NCT02641379|834975|P11|Overall Study|PCR positive at Week 48|0
257215|NCT02641379|834976|P10|Overall Study|PCR positive at Week 48|0
257216|NCT02641379|834977|P9|Overall Study|PCR positive at Week 48|0
257217|NCT02641379|834978|P8|Overall Study|PCR positive at Week 48|0
257218|NCT02641379|834979|P7|Overall Study|PCR positive at Week 48|0
257219|NCT02641379|834980|P6|Overall Study|PCR positive at Week 48|0
257220|NCT02641379|834981|P5|Overall Study|PCR positive at Week 48|0
257221|NCT02641379|834982|P4|Overall Study|PCR positive at Week 48|0
257222|NCT02641379|834983|P3|Overall Study|PCR positive at Week 48|0
257223|NCT02641379|834984|P2|Overall Study|PCR positive at Week 48|1
257224|NCT02641379|834985|P1|Overall Study|PCR positive at Week 48|0
257225|NCT02641379|834975|P11|Overall Study|PCR positive at Week 68|0
257226|NCT02641379|834976|P10|Overall Study|PCR positive at Week 68|0
257227|NCT02641379|834977|P9|Overall Study|PCR positive at Week 68|0
257228|NCT02641379|834978|P8|Overall Study|PCR positive at Week 68|0
257229|NCT02641379|834979|P7|Overall Study|PCR positive at Week 68|0
257230|NCT02641379|834980|P6|Overall Study|PCR positive at Week 68|0
257231|NCT02641379|834981|P5|Overall Study|PCR positive at Week 68|0
257232|NCT02641379|834982|P4|Overall Study|PCR positive at Week 68|0
257233|NCT02641379|834983|P3|Overall Study|PCR positive at Week 68|0
257234|NCT02641379|834984|P2|Overall Study|PCR positive at Week 68|1
257235|NCT02641379|834985|P1|Overall Study|PCR positive at Week 68|0
257236|NCT02641379|834975|P11|Overall Study|Financial problems|0
257237|NCT02641379|834976|P10|Overall Study|Financial problems|0
257238|NCT02641379|834977|P9|Overall Study|Financial problems|0
257239|NCT02641379|834978|P8|Overall Study|Financial problems|0
257240|NCT02641379|834979|P7|Overall Study|Financial problems|0
257241|NCT02641379|834980|P6|Overall Study|Financial problems|0
257242|NCT02641379|834981|P5|Overall Study|Financial problems|0
257243|NCT02641379|834982|P4|Overall Study|Financial problems|0
257244|NCT02641379|834983|P3|Overall Study|Financial problems|0
257245|NCT02641379|834984|P2|Overall Study|Financial problems|1
257246|NCT02641379|834985|P1|Overall Study|Financial problems|0
257247|NCT02641379|834975|P11|Overall Study|Therapy stopped due to misunderstanding|0
257248|NCT02641379|834976|P10|Overall Study|Therapy stopped due to misunderstanding|0
257249|NCT02641379|834977|P9|Overall Study|Therapy stopped due to misunderstanding|0
257250|NCT02641379|834978|P8|Overall Study|Therapy stopped due to misunderstanding|0
257251|NCT02641379|834979|P7|Overall Study|Therapy stopped due to misunderstanding|0
257252|NCT02641379|834980|P6|Overall Study|Therapy stopped due to misunderstanding|0
257253|NCT02641379|834981|P5|Overall Study|Therapy stopped due to misunderstanding|0
257254|NCT02641379|834982|P4|Overall Study|Therapy stopped due to misunderstanding|0
257255|NCT02641379|834983|P3|Overall Study|Therapy stopped due to misunderstanding|0
257256|NCT02641379|834984|P2|Overall Study|Therapy stopped due to misunderstanding|0
257257|NCT02641379|834985|P1|Overall Study|Therapy stopped due to misunderstanding|1
257258|NCT02641379|834975|P11|Overall Study|Participant stopped study/treatment|0
257259|NCT02641379|834976|P10|Overall Study|Participant stopped study/treatment|0
257260|NCT02641379|834977|P9|Overall Study|Participant stopped study/treatment|1
257261|NCT02641379|834978|P8|Overall Study|Participant stopped study/treatment|0
257262|NCT02641379|834979|P7|Overall Study|Participant stopped study/treatment|2
257263|NCT02641379|834980|P6|Overall Study|Participant stopped study/treatment|1
257264|NCT02641379|834981|P5|Overall Study|Participant stopped study/treatment|0
257265|NCT02641379|834982|P4|Overall Study|Participant stopped study/treatment|0
257266|NCT02641379|834983|P3|Overall Study|Participant stopped study/treatment|1
257267|NCT02641379|834984|P2|Overall Study|Participant stopped study/treatment|3
257268|NCT02641379|834985|P1|Overall Study|Participant stopped study/treatment|1
257269|NCT02641379|834975|P11|Overall Study|Participant showed relapse|0
257270|NCT02641379|834976|P10|Overall Study|Participant showed relapse|0
257271|NCT02641379|834977|P9|Overall Study|Participant showed relapse|0
257272|NCT02641379|834978|P8|Overall Study|Participant showed relapse|0
257273|NCT02641379|834979|P7|Overall Study|Participant showed relapse|1
257274|NCT02641379|834980|P6|Overall Study|Participant showed relapse|0
257275|NCT02641379|834981|P5|Overall Study|Participant showed relapse|0
257276|NCT02641379|834982|P4|Overall Study|Participant showed relapse|0
257277|NCT02641379|834983|P3|Overall Study|Participant showed relapse|0
257278|NCT02641379|834984|P2|Overall Study|Participant showed relapse|0
257279|NCT02641379|834985|P1|Overall Study|Participant showed relapse|1
257280|NCT02641379|834975|P11|Overall Study|PCR positive at follow up 2|0
257281|NCT02641379|834976|P10|Overall Study|PCR positive at follow up 2|0
257282|NCT02641379|834977|P9|Overall Study|PCR positive at follow up 2|0
257283|NCT02641379|834978|P8|Overall Study|PCR positive at follow up 2|0
257284|NCT02641379|834979|P7|Overall Study|PCR positive at follow up 2|0
257285|NCT02641379|834980|P6|Overall Study|PCR positive at follow up 2|0
257286|NCT02641379|834981|P5|Overall Study|PCR positive at follow up 2|0
257287|NCT02641379|834982|P4|Overall Study|PCR positive at follow up 2|0
257288|NCT02641379|834983|P3|Overall Study|PCR positive at follow up 2|0
257289|NCT02641379|834984|P2|Overall Study|PCR positive at follow up 2|0
257290|NCT02641379|834985|P1|Overall Study|PCR positive at follow up 2|1
257291|NCT02641379|834975|P11|Overall Study|PCR positive at Week 24|0
257292|NCT02641379|834976|P10|Overall Study|PCR positive at Week 24|1
257293|NCT02641379|834977|P9|Overall Study|PCR positive at Week 24|0
257294|NCT02641379|834978|P8|Overall Study|PCR positive at Week 24|8
257295|NCT02641379|834979|P7|Overall Study|PCR positive at Week 24|3
257296|NCT02641379|834980|P6|Overall Study|PCR positive at Week 24|6
257297|NCT02641379|834981|P5|Overall Study|PCR positive at Week 24|0
257298|NCT02641379|834982|P4|Overall Study|PCR positive at Week 24|0
257299|NCT02641379|834983|P3|Overall Study|PCR positive at Week 24|62
257300|NCT02641379|834984|P2|Overall Study|PCR positive at Week 24|21
257301|NCT02641379|834985|P1|Overall Study|PCR positive at Week 24|15
257302|NCT02641379|834975|P11|Overall Study|Participant cannot be reached|1
257303|NCT02641379|834976|P10|Overall Study|Participant cannot be reached|2
257304|NCT02641379|834977|P9|Overall Study|Participant cannot be reached|0
257305|NCT02641379|834978|P8|Overall Study|Participant cannot be reached|1
257306|NCT02641379|834979|P7|Overall Study|Participant cannot be reached|0
257307|NCT02641379|834980|P6|Overall Study|Participant cannot be reached|1
257308|NCT02641379|834981|P5|Overall Study|Participant cannot be reached|2
257309|NCT02641379|834982|P4|Overall Study|Participant cannot be reached|8
257310|NCT02641379|834983|P3|Overall Study|Participant cannot be reached|0
257311|NCT02641379|834984|P2|Overall Study|Participant cannot be reached|4
257312|NCT02641379|834985|P1|Overall Study|Participant cannot be reached|4
257313|NCT02641379|834975|P11|Overall Study|Participant’s compliance|1
257314|NCT02641379|834976|P10|Overall Study|Participant’s compliance|1
257315|NCT02641379|834977|P9|Overall Study|Participant’s compliance|1
257316|NCT02641379|834978|P8|Overall Study|Participant’s compliance|0
257317|NCT02641379|834979|P7|Overall Study|Participant’s compliance|0
257318|NCT02641379|834980|P6|Overall Study|Participant’s compliance|2
257319|NCT02641379|834981|P5|Overall Study|Participant’s compliance|0
257320|NCT02641379|834982|P4|Overall Study|Participant’s compliance|1
257321|NCT02641379|834983|P3|Overall Study|Participant’s compliance|0
257322|NCT02641379|834984|P2|Overall Study|Participant’s compliance|1
257323|NCT02641379|834985|P1|Overall Study|Participant’s compliance|0
257324|NCT02641379|834975|P11|Overall Study|Participant unable to attend study visit|0
257325|NCT02641379|834976|P10|Overall Study|Participant unable to attend study visit|2
257326|NCT02641379|834977|P9|Overall Study|Participant unable to attend study visit|0
257327|NCT02641379|834978|P8|Overall Study|Participant unable to attend study visit|1
257328|NCT02641379|834979|P7|Overall Study|Participant unable to attend study visit|1
257329|NCT02641379|834980|P6|Overall Study|Participant unable to attend study visit|1
257330|NCT02641379|834981|P5|Overall Study|Participant unable to attend study visit|5
257331|NCT02641379|834982|P4|Overall Study|Participant unable to attend study visit|2
257332|NCT02641379|834983|P3|Overall Study|Participant unable to attend study visit|1
257333|NCT02641379|834984|P2|Overall Study|Participant unable to attend study visit|10
257334|NCT02641379|834985|P1|Overall Study|Participant unable to attend study visit|4
257335|NCT02641379|834975|P11|Overall Study|Lack of Efficacy|0
257336|NCT02641379|834976|P10|Overall Study|Lack of Efficacy|0
257337|NCT02641379|834977|P9|Overall Study|Lack of Efficacy|0
257338|NCT02641379|834978|P8|Overall Study|Lack of Efficacy|5
257339|NCT02641379|834979|P7|Overall Study|Lack of Efficacy|0
257340|NCT02641379|834980|P6|Overall Study|Lack of Efficacy|2
257341|NCT02641379|834981|P5|Overall Study|Lack of Efficacy|0
257342|NCT02641379|834982|P4|Overall Study|Lack of Efficacy|0
257343|NCT02641379|834983|P3|Overall Study|Lack of Efficacy|2
257344|NCT02641379|834984|P2|Overall Study|Lack of Efficacy|0
257345|NCT02641379|834985|P1|Overall Study|Lack of Efficacy|0
257346|NCT02641379|834975|P11|Overall Study|Adverse Event|5
257347|NCT02641379|834976|P10|Overall Study|Adverse Event|1
257348|NCT02641379|834977|P9|Overall Study|Adverse Event|1
257349|NCT02641379|834978|P8|Overall Study|Adverse Event|0
257350|NCT02641379|834979|P7|Overall Study|Adverse Event|5
257351|NCT02641379|834980|P6|Overall Study|Adverse Event|1
257352|NCT02641379|834981|P5|Overall Study|Adverse Event|5
257353|NCT02641379|834982|P4|Overall Study|Adverse Event|2
257354|NCT02641379|834983|P3|Overall Study|Adverse Event|2
257355|NCT02641379|834984|P2|Overall Study|Adverse Event|8
257356|NCT02641379|834985|P1|Overall Study|Adverse Event|7
257357|NCT02641379|834975|P11|Overall Study|Withdrawal of informed consent|0
257358|NCT02641379|834976|P10|Overall Study|Withdrawal of informed consent|0
257359|NCT02641379|834977|P9|Overall Study|Withdrawal of informed consent|0
257360|NCT02641379|834978|P8|Overall Study|Withdrawal of informed consent|1
257361|NCT02641379|834979|P7|Overall Study|Withdrawal of informed consent|0
257362|NCT02641379|834980|P6|Overall Study|Withdrawal of informed consent|0
257363|NCT02641379|834981|P5|Overall Study|Withdrawal of informed consent|0
257364|NCT02641379|834982|P4|Overall Study|Withdrawal of informed consent|0
257365|NCT02641379|834983|P3|Overall Study|Withdrawal of informed consent|0
257366|NCT02641379|834984|P2|Overall Study|Withdrawal of informed consent|1
257367|NCT02641379|834985|P1|Overall Study|Withdrawal of informed consent|0
257368|NCT02641379|834975|P11|Overall Study|Exclusion criterion during screening|0
257369|NCT02641379|834976|P10|Overall Study|Exclusion criterion during screening|0
257370|NCT02641379|834977|P9|Overall Study|Exclusion criterion during screening|0
257371|NCT02641379|834978|P8|Overall Study|Exclusion criterion during screening|0
257372|NCT02641379|834979|P7|Overall Study|Exclusion criterion during screening|0
257373|NCT02641379|834980|P6|Overall Study|Exclusion criterion during screening|0
257374|NCT02641379|834981|P5|Overall Study|Exclusion criterion during screening|2
257375|NCT02641379|834982|P4|Overall Study|Exclusion criterion during screening|1
257376|NCT02641379|834983|P3|Overall Study|Exclusion criterion during screening|0
257377|NCT02641379|834984|P2|Overall Study|Exclusion criterion during screening|0
257378|NCT02641379|834985|P1|Overall Study|Exclusion criterion during screening|1
257379|NCT02640482|835061|P2|Overall Study|Lost to Follow-up|0
257380|NCT02640482|835062|P1|Overall Study|Lost to Follow-up|3
257381|NCT02640404|835074|P2|Overall Study|Withdrawal by Subject|0
257382|NCT02640404|835075|P1|Overall Study|Withdrawal by Subject|1
257383|NCT02640404|835074|P2|Overall Study|Protocol Violation|0
257384|NCT02640404|835075|P1|Overall Study|Protocol Violation|1
257385|NCT02640157|835086|P3|Overall Study|Randomized in error; did not receive Tx|0
257386|NCT02640157|835087|P2|Overall Study|Randomized in error; did not receive Tx|1
257387|NCT02640157|835088|P1|Overall Study|Randomized in error; did not receive Tx|0
257388|NCT02640157|835086|P3|Overall Study|Lost to Follow-up|7
257389|NCT02640157|835087|P2|Overall Study|Lost to Follow-up|2
257390|NCT02640157|835088|P1|Overall Study|Lost to Follow-up|9
257391|NCT02640157|835086|P3|Overall Study|Withdrew consent|2
257392|NCT02640157|835087|P2|Overall Study|Withdrew consent|0
257393|NCT02640157|835088|P1|Overall Study|Withdrew consent|2
257394|NCT02640157|835086|P3|Overall Study|Adverse Event|1
257395|NCT02640157|835087|P2|Overall Study|Adverse Event|2
257396|NCT02640157|835088|P1|Overall Study|Adverse Event|2
257397|NCT02639338|835107|P2|Overall Study|Randomized but Not Treated|1
257398|NCT02639338|835108|P1|Overall Study|Randomized but Not Treated|0
257399|NCT02639338|835107|P2|Overall Study|Death|0
257400|NCT02639338|835108|P1|Overall Study|Death|1
257401|NCT02639338|835107|P2|Overall Study|Withdrew Consent|2
257402|NCT02639338|835108|P1|Overall Study|Withdrew Consent|1
257403|NCT02639338|835107|P2|Overall Study|Lost to Follow-up|2
257404|NCT02639338|835108|P1|Overall Study|Lost to Follow-up|2
257405|NCT02639247|835126|P2|Overall Study|Protocol Violation|0
257406|NCT02639247|835127|P1|Overall Study|Protocol Violation|1
257407|NCT02639247|835126|P2|Overall Study|Withdrew Consent|1
257408|NCT02639247|835127|P1|Overall Study|Withdrew Consent|0
257409|NCT02639247|835126|P2|Overall Study|Death|0
257410|NCT02639247|835127|P1|Overall Study|Death|2
257411|NCT02639247|835126|P2|Overall Study|Lost to Follow-up|1
257412|NCT02639247|835127|P1|Overall Study|Lost to Follow-up|2
257413|NCT02639052|835143|P1|Overall Study|Lost to Follow-up|1
257414|NCT02638493|835160|P3|Overall Study|Inability to provide semen samples|0
257415|NCT02638493|835161|P2|Overall Study|Inability to provide semen samples|0
257416|NCT02638493|835162|P1|Overall Study|Inability to provide semen samples|2
257417|NCT02638259|835193|P2|Treatment Period 2|Withdrawal by Subject|7
257418|NCT02638259|835194|P1|Treatment Period 2|Withdrawal by Subject|1
257419|NCT02638259|835193|P2|Treatment Period 2|Adverse Event|4
257420|NCT02638259|835194|P1|Treatment Period 2|Adverse Event|5
257421|NCT02638259|835193|P2|Treatment Period 1|Withdrawn per sponsor decision|2
257422|NCT02638259|835194|P1|Treatment Period 1|Withdrawn per sponsor decision|0
257423|NCT02638259|835193|P2|Treatment Period 1|Withdrawal by Subject|6
257424|NCT02638259|835194|P1|Treatment Period 1|Withdrawal by Subject|4
257425|NCT02638259|835193|P2|Treatment Period 1|Protocol Violation|3
257426|NCT02638259|835194|P1|Treatment Period 1|Protocol Violation|0
257427|NCT02638259|835193|P2|Treatment Period 1|Lack of Efficacy|1
257428|NCT02638259|835194|P1|Treatment Period 1|Lack of Efficacy|0
257429|NCT02638259|835193|P2|Treatment Period 1|Death|1
257430|NCT02638259|835194|P1|Treatment Period 1|Death|0
257431|NCT02638259|835193|P2|Treatment Period 1|Adverse Event|5
257432|NCT02638259|835194|P1|Treatment Period 1|Adverse Event|1
257433|NCT02638129|835206|P2|Overall Study|Study terminated|30
257434|NCT02638129|835207|P1|Overall Study|Study terminated|28
257435|NCT02637323|835380|P2|Overall Study|Protocol Violation|1
257436|NCT02637323|835381|P1|Overall Study|Protocol Violation|0
257437|NCT02637323|835380|P2|Overall Study|Lost to Follow-up|0
257438|NCT02637323|835381|P1|Overall Study|Lost to Follow-up|2
257439|NCT02637063|835392|P3|Overall Study|Withdrawal by Subject|3
257440|NCT02637063|835393|P2|Overall Study|Withdrawal by Subject|2
257441|NCT02637063|835394|P1|Overall Study|Withdrawal by Subject|2
257442|NCT02637063|835392|P3|Overall Study|Lost to Follow-up|3
257443|NCT02637063|835393|P2|Overall Study|Lost to Follow-up|2
257444|NCT02637063|835394|P1|Overall Study|Lost to Follow-up|3
257445|NCT02637037|835422|P2|Overall Study|Adverse Event|0
257446|NCT02637037|835423|P1|Overall Study|Adverse Event|1
257447|NCT02637037|835422|P2|Overall Study|Withdrawal by Subject|1
257448|NCT02637037|835423|P1|Overall Study|Withdrawal by Subject|2
257449|NCT02637037|835422|P2|Overall Study|Positive drug screen at admission|0
257450|NCT02637037|835423|P1|Overall Study|Positive drug screen at admission|1
257451|NCT02636907|835489|P1|Overall Study|Withdrawal by Subject|2
257452|NCT02636907|835489|P1|Overall Study|Adverse Event|2
257453|NCT02636595|835496|P1|Overall Study|Not specified|1
257454|NCT02636595|835496|P1|Overall Study|Lost to Follow-up|1
257455|NCT02635204|835518|P2|Overall Study|Lost to Follow-up|1
257456|NCT02635204|835519|P1|Overall Study|Lost to Follow-up|1
257457|NCT02635204|835518|P2|Overall Study|Adverse Event|0
257458|NCT02635204|835519|P1|Overall Study|Adverse Event|1
257459|NCT02634788|835533|P4|Overall Study|Withdrawal by Subject|0
257460|NCT02634788|835534|P3|Overall Study|Withdrawal by Subject|1
257461|NCT02634788|835535|P2|Overall Study|Withdrawal by Subject|1
257462|NCT02634788|835536|P1|Overall Study|Withdrawal by Subject|0
257463|NCT02634788|835533|P4|Overall Study|Lost to Follow-up|0
257464|NCT02634788|835534|P3|Overall Study|Lost to Follow-up|0
257465|NCT02634788|835535|P2|Overall Study|Lost to Follow-up|1
257466|NCT02634788|835536|P1|Overall Study|Lost to Follow-up|0
257467|NCT02634788|835533|P4|Overall Study|Lack of Efficacy|4
257468|NCT02634788|835534|P3|Overall Study|Lack of Efficacy|1
257469|NCT02634788|835535|P2|Overall Study|Lack of Efficacy|0
257470|NCT02634788|835536|P1|Overall Study|Lack of Efficacy|4
257471|NCT02634788|835533|P4|Overall Study|Adverse Event|1
257472|NCT02634788|835534|P3|Overall Study|Adverse Event|3
257473|NCT02634788|835535|P2|Overall Study|Adverse Event|8
257474|NCT02634788|835536|P1|Overall Study|Adverse Event|0
257475|NCT02634346|835605|P3|Overall Study|Protocol Violation|0
257476|NCT02634346|835606|P2|Overall Study|Protocol Violation|1
257477|NCT02634346|835607|P1|Overall Study|Protocol Violation|0
257478|NCT02634346|835605|P3|Overall Study|Lost to Follow-up|0
257479|NCT02634346|835606|P2|Overall Study|Lost to Follow-up|0
257480|NCT02634346|835607|P1|Overall Study|Lost to Follow-up|1
257481|NCT02634346|835605|P3|Overall Study|Lack of Efficacy|8
257482|NCT02634346|835606|P2|Overall Study|Lack of Efficacy|2
257483|NCT02634346|835607|P1|Overall Study|Lack of Efficacy|1
257484|NCT02634346|835605|P3|Overall Study|Adverse Event|7
257485|NCT02634346|835606|P2|Overall Study|Adverse Event|2
257486|NCT02634346|835607|P1|Overall Study|Adverse Event|2
257487|NCT02634346|835605|P3|Overall Study|Withdrawal by Subject|8
257488|NCT02634346|835606|P2|Overall Study|Withdrawal by Subject|9
257489|NCT02634346|835607|P1|Overall Study|Withdrawal by Subject|8
257490|NCT02633787|835735|P1|Overall Study|Withdrawal by Subject|1
257491|NCT02633215|835747|P2|Overall Study|Lost to Follow-up|3
257492|NCT02633215|835748|P1|Overall Study|Lost to Follow-up|2
257493|NCT02632838|835760|P2|Overall Study|Lost to Follow-up|2
257494|NCT02632838|835761|P1|Overall Study|Lost to Follow-up|0
257495|NCT02632838|835760|P2|Overall Study|Withdrawal by Subject|0
257496|NCT02632838|835761|P1|Overall Study|Withdrawal by Subject|3
257497|NCT02632110|835801|P10|Overall Study|Withdrawal by Subject|1
257498|NCT02632110|835802|P9|Overall Study|Withdrawal by Subject|1
257499|NCT02632110|835803|P8|Overall Study|Withdrawal by Subject|3
257500|NCT02632110|835804|P7|Overall Study|Withdrawal by Subject|3
257501|NCT02632110|835805|P6|Overall Study|Withdrawal by Subject|1
257502|NCT02632110|835806|P5|Overall Study|Withdrawal by Subject|1
257503|NCT02632110|835807|P4|Overall Study|Withdrawal by Subject|0
257504|NCT02632110|835808|P3|Overall Study|Withdrawal by Subject|0
257505|NCT02632110|835809|P2|Overall Study|Withdrawal by Subject|1
257506|NCT02632110|835810|P1|Overall Study|Withdrawal by Subject|1
257507|NCT02630563|836303|P1|Overall Study|Administrative|1
257508|NCT02628938|836340|P3|Overall Study|Failure to comply with the instructions|3
257509|NCT02628938|836341|P2|Overall Study|Failure to comply with the instructions|0
257510|NCT02628938|836342|P1|Overall Study|Failure to comply with the instructions|3
257511|NCT02628938|836340|P3|Overall Study|Did not attend the follow up recall|1
257512|NCT02628938|836341|P2|Overall Study|Did not attend the follow up recall|2
257513|NCT02628938|836342|P1|Overall Study|Did not attend the follow up recall|2
257514|NCT02628418|836358|P2|Overall Study|Lost to Follow-up|2
257515|NCT02628418|836359|P1|Overall Study|Lost to Follow-up|1
257516|NCT02627144|836434|P1|Overall Study|Other|17
257517|NCT02627144|836434|P1|Overall Study|Enrolled, not treated|6
257518|NCT02627144|836434|P1|Overall Study|Lost to Follow-up|8
257519|NCT02627144|836434|P1|Overall Study|Administrative reasons|65
257520|NCT02627144|836434|P1|Overall Study|Refusal of treatment / poor cooperation|38
257521|NCT02627144|836434|P1|Overall Study|Death from other cause|8
257522|NCT02627144|836434|P1|Overall Study|Death from cancer|20
257523|NCT02627144|836434|P1|Overall Study|Cancer progression|171
257524|NCT02627144|836434|P1|Overall Study|Serious adverse event|32
257525|NCT02625259|836532|P5|First Intervention (Day 1)|Withdrawal by Subject|0
257526|NCT02625259|836533|P4|First Intervention (Day 1)|Withdrawal by Subject|1
257527|NCT02625259|836534|P3|First Intervention (Day 1)|Withdrawal by Subject|0
257528|NCT02625259|836535|P2|First Intervention (Day 1)|Withdrawal by Subject|0
257529|NCT02625259|836536|P1|First Intervention (Day 1)|Withdrawal by Subject|0
257530|NCT02625259|836532|P5|First Intervention (Day 1)|Adverse Event|0
257531|NCT02625259|836533|P4|First Intervention (Day 1)|Adverse Event|0
257532|NCT02625259|836534|P3|First Intervention (Day 1)|Adverse Event|0
257533|NCT02625259|836535|P2|First Intervention (Day 1)|Adverse Event|1
257534|NCT02625259|836536|P1|First Intervention (Day 1)|Adverse Event|2
257535|NCT02625259|836532|P5|First Intervention (Day 1)|Other|0
257536|NCT02625259|836533|P4|First Intervention (Day 1)|Other|0
257537|NCT02625259|836534|P3|First Intervention (Day 1)|Other|1
257538|NCT02625259|836535|P2|First Intervention (Day 1)|Other|0
257539|NCT02625259|836536|P1|First Intervention (Day 1)|Other|0
257540|NCT02625233|836573|P2|Overall Study|Adverse Event|0
257541|NCT02625233|836574|P1|Overall Study|Adverse Event|2
257542|NCT02625220|836582|P1|Overall Study|Study discontinued at site|2
257543|NCT02625220|836582|P1|Overall Study|Protocol Violation|1
257544|NCT02625220|836582|P1|Overall Study|Lost to Follow-up|2
257545|NCT02625220|836582|P1|Overall Study|Adverse Event|2
257546|NCT02624791|836682|P6|Overall Study|Withdrawal by Subject|0
257547|NCT02624791|836683|P5|Overall Study|Withdrawal by Subject|0
257548|NCT02624791|836684|P4|Overall Study|Withdrawal by Subject|0
257549|NCT02624791|836685|P3|Overall Study|Withdrawal by Subject|0
257550|NCT02624791|836686|P2|Overall Study|Withdrawal by Subject|0
257551|NCT02624791|836687|P1|Overall Study|Withdrawal by Subject|2
257552|NCT02622568|836694|P2|Overall Study|Lost to Follow-up|5
257553|NCT02622568|836695|P1|Overall Study|Lost to Follow-up|5
257554|NCT02622321|836705|P4|Overall Study|Withdrawal by Subject|0
257555|NCT02622321|836706|P3|Overall Study|Withdrawal by Subject|0
257556|NCT02622321|836707|P2|Overall Study|Withdrawal by Subject|0
257557|NCT02622321|836708|P1|Overall Study|Withdrawal by Subject|1
257558|NCT02622321|836705|P4|Overall Study|Ongoing treatment with emicizumab|7
257559|NCT02622321|836706|P3|Overall Study|Ongoing treatment with emicizumab|49
257560|NCT02622321|836707|P2|Overall Study|Ongoing treatment with emicizumab|13
257561|NCT02622321|836708|P1|Overall Study|Ongoing treatment with emicizumab|31
257562|NCT02622321|836705|P4|Overall Study|Ongoing in safety follow-up|0
257563|NCT02622321|836706|P3|Overall Study|Ongoing in safety follow-up|0
257564|NCT02622321|836707|P2|Overall Study|Ongoing in safety follow-up|0
257565|NCT02622321|836708|P1|Overall Study|Ongoing in safety follow-up|3
257566|NCT02622321|836705|P4|Overall Study|Ongoing treatment with no emicizumab|0
257567|NCT02622321|836706|P3|Overall Study|Ongoing treatment with no emicizumab|0
257568|NCT02622321|836707|P2|Overall Study|Ongoing treatment with no emicizumab|5
257569|NCT02622321|836708|P1|Overall Study|Ongoing treatment with no emicizumab|0
257570|NCT02621034|836754|P3|Overall Study|Lost to Follow-up|5
257571|NCT02621034|836755|P2|Overall Study|Lost to Follow-up|2
257572|NCT02621034|836756|P1|Overall Study|Lost to Follow-up|3
257573|NCT02619812|836782|P4|Overall Study|Withdrawal by Subject|2
257574|NCT02619812|836783|P3|Overall Study|Withdrawal by Subject|1
257575|NCT02619812|836784|P2|Overall Study|Withdrawal by Subject|0
257576|NCT02619812|836785|P1|Overall Study|Withdrawal by Subject|0
257577|NCT02615990|836962|P2|Overall Study|study terminated|1
257578|NCT02615990|836963|P1|Overall Study|study terminated|1
257579|NCT02614079|837107|P1|Overall Study|Withdrawal by Subject|1
257580|NCT02613910|837111|P1|Overall Study|Termination of study|1
257581|NCT02613871|837160|P1|Overall Study|On Study|111
257582|NCT02613403|837179|P5|Overall Study|Withdrawal by Subject|0
257583|NCT02613403|837180|P4|Overall Study|Withdrawal by Subject|0
257584|NCT02613403|837181|P3|Overall Study|Withdrawal by Subject|0
257585|NCT02613403|837182|P2|Overall Study|Withdrawal by Subject|0
257586|NCT02613403|837183|P1|Overall Study|Withdrawal by Subject|2
257587|NCT02613403|837179|P5|Overall Study|Lost to Follow-up|0
257588|NCT02613403|837180|P4|Overall Study|Lost to Follow-up|0
257589|NCT02613403|837181|P3|Overall Study|Lost to Follow-up|0
257590|NCT02613403|837182|P2|Overall Study|Lost to Follow-up|1
257591|NCT02613403|837183|P1|Overall Study|Lost to Follow-up|0
257592|NCT02612610|837229|P4|Overall Study|Cough Improvement|0
257593|NCT02612610|837230|P3|Overall Study|Cough Improvement|1
257594|NCT02612610|837231|P2|Overall Study|Cough Improvement|0
257595|NCT02612610|837232|P1|Overall Study|Cough Improvement|0
257596|NCT02612610|837229|P4|Overall Study|Noncompliance|0
257597|NCT02612610|837230|P3|Overall Study|Noncompliance|0
257598|NCT02612610|837231|P2|Overall Study|Noncompliance|0
257599|NCT02612610|837232|P1|Overall Study|Noncompliance|1
257600|NCT02612610|837229|P4|Overall Study|Physician Decision|0
257601|NCT02612610|837230|P3|Overall Study|Physician Decision|0
257602|NCT02612610|837231|P2|Overall Study|Physician Decision|1
257603|NCT02612610|837232|P1|Overall Study|Physician Decision|0
257604|NCT02612610|837229|P4|Overall Study|Lack of Efficacy|1
257605|NCT02612610|837230|P3|Overall Study|Lack of Efficacy|0
257606|NCT02612610|837231|P2|Overall Study|Lack of Efficacy|2
257607|NCT02612610|837232|P1|Overall Study|Lack of Efficacy|1
257608|NCT02612610|837229|P4|Overall Study|Protocol Violation|0
257609|NCT02612610|837230|P3|Overall Study|Protocol Violation|1
257610|NCT02612610|837231|P2|Overall Study|Protocol Violation|1
257611|NCT02612610|837232|P1|Overall Study|Protocol Violation|0
257612|NCT02612610|837229|P4|Overall Study|Lost to Follow-up|0
257613|NCT02612610|837230|P3|Overall Study|Lost to Follow-up|0
257614|NCT02612610|837231|P2|Overall Study|Lost to Follow-up|1
257615|NCT02612610|837232|P1|Overall Study|Lost to Follow-up|0
257616|NCT02612610|837229|P4|Overall Study|Adverse Event|10
257617|NCT02612610|837230|P3|Overall Study|Adverse Event|3
257618|NCT02612610|837231|P2|Overall Study|Adverse Event|2
257619|NCT02612610|837232|P1|Overall Study|Adverse Event|2
257620|NCT02612610|837229|P4|Overall Study|Withdrawal by Subject|2
257621|NCT02612610|837230|P3|Overall Study|Withdrawal by Subject|0
257622|NCT02612610|837231|P2|Overall Study|Withdrawal by Subject|1
257623|NCT02612610|837232|P1|Overall Study|Withdrawal by Subject|1
257624|NCT02612077|837474|P1|Overall Study|Unknown reason|2
257625|NCT02612077|837474|P1|Overall Study|Disease Progression|3
257626|NCT02612077|837474|P1|Overall Study|Enrollment in a Clinical Trial|1
257627|NCT02612077|837474|P1|Overall Study|Moved or Changed Medical Team|23
257628|NCT02612077|837474|P1|Overall Study|Death|377
257629|NCT02612077|837474|P1|Overall Study|Lost to Follow-up|20
257630|NCT02612077|837474|P1|Overall Study|Protocol Violation|28
257631|NCT02612077|837474|P1|Overall Study|Withdrawal by Subject|9
257632|NCT02612077|837474|P1|Overall Study|Adverse Event|3
257633|NCT02612064|837486|P2|Overall Study|Not Specified|2
257634|NCT02612064|837487|P1|Overall Study|Not Specified|0
257635|NCT02612064|837486|P2|Overall Study|Withdrawal by Subject|1
257636|NCT02612064|837487|P1|Overall Study|Withdrawal by Subject|1
257637|NCT02609672|837544|P2|Overall Study|Lost to Follow-up|1
257638|NCT02609672|837545|P1|Overall Study|Lost to Follow-up|3
257639|NCT02609659|837579|P1|Overall Study|Not Specified|1
257640|NCT02609659|837579|P1|Overall Study|Lost to Follow-up|6
257641|NCT02609659|837579|P1|Overall Study|Adverse Event|1
257642|NCT02609633|837589|P2|Overall Study|Reason not Specified|1
257643|NCT02609633|837590|P1|Overall Study|Reason not Specified|2
257644|NCT02609633|837589|P2|Overall Study|Non-Compliant with Study Procedures|0
257645|NCT02609633|837590|P1|Overall Study|Non-Compliant with Study Procedures|2
257646|NCT02609633|837589|P2|Overall Study|Protocol Deviation|0
257647|NCT02609633|837590|P1|Overall Study|Protocol Deviation|1
257648|NCT02609633|837589|P2|Overall Study|Consent Withdrawn|1
257649|NCT02609633|837590|P1|Overall Study|Consent Withdrawn|0
257650|NCT02609399|837617|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
257651|NCT02609399|837618|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
257652|NCT02609399|837617|P2|Influenza Season 2016-2017|Lost to Follow-up|5
257653|NCT02609399|837618|P1|Influenza Season 2016-2017|Lost to Follow-up|8
257654|NCT02609399|837617|P2|Influenza Season 2015-2016|Lost to Follow-up|2
257655|NCT02609399|837618|P1|Influenza Season 2015-2016|Lost to Follow-up|3
257656|NCT02609178|837630|P6|First Crown|Withdrawal by Subject|0
257657|NCT02609178|837631|P5|First Crown|Withdrawal by Subject|0
257658|NCT02609178|837632|P4|First Crown|Withdrawal by Subject|1
257659|NCT02609178|837633|P3|First Crown|Withdrawal by Subject|1
257660|NCT02609178|837634|P2|First Crown|Withdrawal by Subject|0
257661|NCT02609178|837635|P1|First Crown|Withdrawal by Subject|0
257662|NCT02607956|837709|P2|Overall Study|Lost to Follow-up|5
257663|NCT02607956|837710|P1|Overall Study|Lost to Follow-up|8
257664|NCT02607956|837709|P2|Overall Study|Withdrawal by Subject|8
257665|NCT02607956|837710|P1|Overall Study|Withdrawal by Subject|7
257666|NCT02607956|837709|P2|Overall Study|Protocol Violation|1
257667|NCT02607956|837710|P1|Overall Study|Protocol Violation|2
257668|NCT02607956|837709|P2|Overall Study|Non-Compliance with Study Drug|1
257669|NCT02607956|837710|P1|Overall Study|Non-Compliance with Study Drug|0
257670|NCT02607956|837709|P2|Overall Study|Investigator's Decision|0
257671|NCT02607956|837710|P1|Overall Study|Investigator's Decision|3
257672|NCT02607956|837709|P2|Overall Study|Death|2
257673|NCT02607956|837710|P1|Overall Study|Death|1
257674|NCT02607956|837709|P2|Overall Study|Adverse Event|1
257675|NCT02607956|837710|P1|Overall Study|Adverse Event|3
257676|NCT02607956|837709|P2|Overall Study|Still on Study|307
257677|NCT02607956|837710|P1|Overall Study|Still on Study|296
257678|NCT02607956|837709|P2|Overall Study|Randomized and Never Treated|5
257679|NCT02607956|837710|P1|Overall Study|Randomized and Never Treated|7
257680|NCT02607800|837724|P2|Overall Study|Randomized/Enrolled but Not Treated|1
257681|NCT02607800|837725|P1|Overall Study|Randomized/Enrolled but Not Treated|1
257682|NCT02607800|837724|P2|Overall Study|Withdrew Consent|0
257683|NCT02607800|837725|P1|Overall Study|Withdrew Consent|2
257684|NCT02607800|837724|P2|Overall Study|Lost to Follow-up|10
257685|NCT02607800|837725|P1|Overall Study|Lost to Follow-up|7
257686|NCT02607735|837743|P2|Overall Study|Withdrew Consent|0
257687|NCT02607735|837744|P1|Overall Study|Withdrew Consent|2
257688|NCT02607735|837743|P2|Overall Study|Lost to Follow-up|0
257689|NCT02607735|837744|P1|Overall Study|Lost to Follow-up|4
257690|NCT02607735|837743|P2|Overall Study|Randomized/ Enrolled but Never Treated|0
257691|NCT02607735|837744|P1|Overall Study|Randomized/ Enrolled but Never Treated|1
257692|NCT02606279|837772|P2|Overall Study|Lost to Follow-up|1
257693|NCT02606279|837773|P1|Overall Study|Lost to Follow-up|0
257694|NCT02605928|837785|P1|Overall Study|Lack of Efficacy|5
257695|NCT02605928|837785|P1|Overall Study|Model tuning phase|28
257696|NCT02604589|837881|P3|Overall Study|catheter dislodgement|1
257697|NCT02604589|837882|P2|Overall Study|catheter dislodgement|0
257698|NCT02604589|837883|P1|Overall Study|catheter dislodgement|0
257699|NCT02604550|837911|P2|Overall Study|Incomplete data using paper journal|19
257700|NCT02604550|837912|P1|Overall Study|Incomplete data using paper journal|18
257701|NCT02604550|837911|P2|Overall Study|Withdrawal by Subject|1
257702|NCT02604550|837912|P1|Overall Study|Withdrawal by Subject|0
257703|NCT02604550|837911|P2|Overall Study|Lost to Follow-up|6
257704|NCT02604550|837912|P1|Overall Study|Lost to Follow-up|7
257705|NCT02604407|837939|P3|Overall Study|Other|4
257706|NCT02604407|837940|P2|Overall Study|Other|1
257707|NCT02604407|837941|P1|Overall Study|Other|3
257708|NCT02604407|837939|P3|Overall Study|Lack of Efficacy|0
257709|NCT02604407|837940|P2|Overall Study|Lack of Efficacy|0
257710|NCT02604407|837941|P1|Overall Study|Lack of Efficacy|1
257711|NCT02604407|837939|P3|Overall Study|Lost to Follow-up|2
257712|NCT02604407|837940|P2|Overall Study|Lost to Follow-up|1
257713|NCT02604407|837941|P1|Overall Study|Lost to Follow-up|2
257714|NCT02604407|837939|P3|Overall Study|Withdrawal by Subject|5
257715|NCT02604407|837940|P2|Overall Study|Withdrawal by Subject|3
257716|NCT02604407|837941|P1|Overall Study|Withdrawal by Subject|3
257717|NCT02604407|837939|P3|Overall Study|Protocol Violation|0
257718|NCT02604407|837940|P2|Overall Study|Protocol Violation|0
257719|NCT02604407|837941|P1|Overall Study|Protocol Violation|2
257720|NCT02604407|837939|P3|Overall Study|Adverse Event|5
257721|NCT02604407|837940|P2|Overall Study|Adverse Event|7
257722|NCT02604407|837941|P1|Overall Study|Adverse Event|0
257723|NCT02604342|837954|P2|Overall Study|Ongoing|25
257724|NCT02604342|837955|P1|Overall Study|Ongoing|52
257725|NCT02604342|837954|P2|Overall Study|Withdrawal by Subject|3
257726|NCT02604342|837955|P1|Overall Study|Withdrawal by Subject|3
257727|NCT02604342|837954|P2|Overall Study|Progression of disease|0
257728|NCT02604342|837955|P1|Overall Study|Progression of disease|1
257729|NCT02604342|837954|P2|Overall Study|Death|7
257730|NCT02604342|837955|P1|Overall Study|Death|16
257731|NCT02604264|838007|P2|Overall Study|Had central venous catheter <21 days|242
257732|NCT02604264|838008|P1|Overall Study|Had central venous catheter <21 days|200
257733|NCT02604017|838035|P2|Overall Study|Not Specified|0
257734|NCT02604017|838036|P1|Overall Study|Not Specified|1
257735|NCT02604017|838035|P2|Overall Study|Lost to Follow-up|6
257736|NCT02604017|838036|P1|Overall Study|Lost to Follow-up|5
257737|NCT02604017|838035|P2|Overall Study|Withdrew Consent|2
257738|NCT02604017|838036|P1|Overall Study|Withdrew Consent|0
257739|NCT02603952|838065|P4|Overall Study|Received oseltamivir by error|1
257740|NCT02603952|838066|P3|Overall Study|Received oseltamivir by error|0
257741|NCT02603952|838067|P2|Overall Study|Received oseltamivir by error|0
257742|NCT02603952|838068|P1|Overall Study|Received oseltamivir by error|0
257743|NCT02603952|838065|P4|Overall Study|Withdrawal by Subject|0
257744|NCT02603952|838066|P3|Overall Study|Withdrawal by Subject|0
257745|NCT02603952|838067|P2|Overall Study|Withdrawal by Subject|0
257746|NCT02603952|838068|P1|Overall Study|Withdrawal by Subject|1
257747|NCT02603107|838115|P2|Optional Extension Phase|Still in Study|213
257748|NCT02603107|838116|P1|Optional Extension Phase|Still in Study|241
257749|NCT02603107|838115|P2|Randomized Phase|Lost to Follow-up|3
257750|NCT02603107|838116|P1|Randomized Phase|Lost to Follow-up|0
257751|NCT02603107|838115|P2|Randomized Phase|Withdrew Consent|14
257752|NCT02603107|838116|P1|Randomized Phase|Withdrew Consent|8
257753|NCT02603107|838115|P2|Randomized Phase|Protocol Violation|0
257754|NCT02603107|838116|P1|Randomized Phase|Protocol Violation|1
257755|NCT02603107|838115|P2|Randomized Phase|Non-Compliance with Study Drug|1
257756|NCT02603107|838116|P1|Randomized Phase|Non-Compliance with Study Drug|1
257757|NCT02603107|838115|P2|Randomized Phase|Investigator's Discretion|1
257758|NCT02603107|838116|P1|Randomized Phase|Investigator's Discretion|0
257759|NCT02603107|838115|P2|Randomized Phase|Death|1
257760|NCT02603107|838116|P1|Randomized Phase|Death|1
257761|NCT02603107|838115|P2|Randomized Phase|Adverse Event|0
257762|NCT02603107|838116|P1|Randomized Phase|Adverse Event|2
257763|NCT02603107|838115|P2|Randomized Phase|Still in Study|27
257764|NCT02603107|838116|P1|Randomized Phase|Still in Study|32
257765|NCT02603107|838115|P2|Randomized Phase|Randomized and Never Treated|1
257766|NCT02603107|838116|P1|Randomized Phase|Randomized and Never Treated|0
257767|NCT02601573|838147|P5|Overall Study|Withdrawal by Subject|0
257768|NCT02601573|838148|P4|Overall Study|Withdrawal by Subject|1
257769|NCT02601573|838149|P3|Overall Study|Withdrawal by Subject|0
257770|NCT02601573|838150|P2|Overall Study|Withdrawal by Subject|1
257771|NCT02601573|838151|P1|Overall Study|Withdrawal by Subject|0
257772|NCT02601573|838147|P5|Overall Study|Lost to Follow-up|2
257773|NCT02601573|838148|P4|Overall Study|Lost to Follow-up|0
257774|NCT02601573|838149|P3|Overall Study|Lost to Follow-up|1
257775|NCT02601573|838150|P2|Overall Study|Lost to Follow-up|3
257776|NCT02601573|838151|P1|Overall Study|Lost to Follow-up|0
257777|NCT02601560|838186|P8|Overall Study|Other|0
257778|NCT02601560|838187|P7|Overall Study|Other|1
257779|NCT02601560|838188|P6|Overall Study|Other|0
257780|NCT02601560|838189|P5|Overall Study|Other|0
257781|NCT02601560|838190|P4|Overall Study|Other|0
257782|NCT02601560|838191|P3|Overall Study|Other|0
257783|NCT02601560|838192|P2|Overall Study|Other|0
257784|NCT02601560|838193|P1|Overall Study|Other|0
257785|NCT02600871|838377|P2|Overall Study|Lost to Follow-up|10
257786|NCT02600871|838378|P1|Overall Study|Lost to Follow-up|13
257787|NCT02600845|838388|P1|Overall Study|Consent Withdrawal|5
257788|NCT02600845|838388|P1|Overall Study|Non-compliance with Study Procedures|10
257789|NCT02600845|838388|P1|Overall Study|Reason Not Specified|3
257790|NCT02600351|838450|P4|Overall Study|Randomized but Not Treated|3
257791|NCT02600351|838451|P3|Overall Study|Randomized but Not Treated|1
257792|NCT02600351|838452|P2|Overall Study|Randomized but Not Treated|0
257793|NCT02600351|838453|P1|Overall Study|Randomized but Not Treated|1
257794|NCT02600351|838450|P4|Overall Study|Lost to Follow-up|0
257795|NCT02600351|838451|P3|Overall Study|Lost to Follow-up|0
257796|NCT02600351|838452|P2|Overall Study|Lost to Follow-up|0
257797|NCT02600351|838453|P1|Overall Study|Lost to Follow-up|1
257798|NCT02600351|838450|P4|Overall Study|Lack of Efficacy|2
257799|NCT02600351|838451|P3|Overall Study|Lack of Efficacy|5
257800|NCT02600351|838452|P2|Overall Study|Lack of Efficacy|0
257801|NCT02600351|838453|P1|Overall Study|Lack of Efficacy|3
257802|NCT02599129|838485|P2|Overall Study|Withdrawal by Subject|1
257803|NCT02599129|838486|P1|Overall Study|Withdrawal by Subject|2
257804|NCT02599129|838485|P2|Overall Study|Lost to Follow-up|0
257805|NCT02599129|838486|P1|Overall Study|Lost to Follow-up|1
257806|NCT02599129|838485|P2|Overall Study|Lack of Efficacy|2
257807|NCT02599129|838486|P1|Overall Study|Lack of Efficacy|2
257808|NCT02598934|838502|P2|Overall Study|Protocol Violation|2
257809|NCT02598934|838503|P1|Overall Study|Protocol Violation|1
257810|NCT02598934|838502|P2|Overall Study|Administrative|1
257811|NCT02598934|838503|P1|Overall Study|Administrative|2
257812|NCT02598934|838502|P2|Overall Study|Withdrawal by Subject|3
257813|NCT02598934|838503|P1|Overall Study|Withdrawal by Subject|2
257814|NCT02598934|838502|P2|Overall Study|Failure to Return|3
257815|NCT02598934|838503|P1|Overall Study|Failure to Return|3
257816|NCT02598934|838502|P2|Overall Study|Adverse Event|13
257817|NCT02598934|838503|P1|Overall Study|Adverse Event|11
257818|NCT02598622|838515|P2|Overall Study|Physician Decision|0
257819|NCT02598622|838516|P1|Overall Study|Physician Decision|3
257820|NCT02598622|838515|P2|Overall Study|Withdrawal by Subject|0
257821|NCT02598622|838516|P1|Overall Study|Withdrawal by Subject|3
257822|NCT02598193|838543|P1|Overall Study|Does not want to take Nintedanib|1
257823|NCT02598193|838543|P1|Overall Study|Listed in active lung transplant list|1
257824|NCT02598193|838543|P1|Overall Study|Withdrawal by Subject|1
257825|NCT02598193|838543|P1|Overall Study|Adverse Event|13
257826|NCT02598128|838551|P4|Period A: Days -7 to -1|Adverse Event|0
257827|NCT02598128|838552|P3|Period A: Days -7 to -1|Adverse Event|0
257828|NCT02598128|838553|P2|Period A: Days -7 to -1|Adverse Event|0
257829|NCT02598128|838554|P1|Period A: Days -7 to -1|Adverse Event|1
257830|NCT02597855|838577|P2|Overall Study|Lost to Follow-up|1
257831|NCT02597855|838578|P1|Overall Study|Lost to Follow-up|2
257832|NCT02597049|838627|P3|Overall Study|Noncompliant with Study Visits|0
257833|NCT02597049|838628|P2|Overall Study|Noncompliant with Study Visits|0
257834|NCT02597049|838629|P1|Overall Study|Noncompliant with Study Visits|1
257835|NCT02597049|838627|P3|Overall Study|Death|0
257836|NCT02597049|838628|P2|Overall Study|Death|0
257837|NCT02597049|838629|P1|Overall Study|Death|2
257838|NCT02597049|838627|P3|Overall Study|Adverse Event|0
257839|NCT02597049|838628|P2|Overall Study|Adverse Event|0
257840|NCT02597049|838629|P1|Overall Study|Adverse Event|2
257841|NCT02597049|838627|P3|Overall Study|Withdrawal by Subject|1
257842|NCT02597049|838628|P2|Overall Study|Withdrawal by Subject|2
257843|NCT02597049|838629|P1|Overall Study|Withdrawal by Subject|2
257844|NCT02597049|838627|P3|Overall Study|Lost to Follow-up|2
257845|NCT02597049|838628|P2|Overall Study|Lost to Follow-up|3
257846|NCT02597049|838629|P1|Overall Study|Lost to Follow-up|0
257847|NCT02596958|838667|P1|Overall Study|Excluded Due to Second Line Treatment|9
257848|NCT02596958|838667|P1|Overall Study|Missing|32
257849|NCT02596958|838667|P1|Overall Study|Lost to Follow-up|33
257850|NCT02596958|838667|P1|Overall Study|Administrative Reasons/Other|231
257851|NCT02596958|838667|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
257852|NCT02596958|838667|P1|Overall Study|Death From Other Cause|33
257853|NCT02596958|838667|P1|Overall Study|Death From Cancer|112
257854|NCT02596958|838667|P1|Overall Study|Cancer Progression|441
257855|NCT02596958|838667|P1|Overall Study|Serious Adverse Drug Reactions|44
257856|NCT02596945|838679|P1|Overall Study|Missing|1
257857|NCT02596945|838679|P1|Overall Study|Withdrawal by Subject|1
257858|NCT02596945|838679|P1|Overall Study|Other Erythropoietin stimulating agent|4
257859|NCT02596945|838679|P1|Overall Study|Change to hemodialysis|15
257860|NCT02596945|838679|P1|Overall Study|Other|32
257861|NCT02596945|838679|P1|Overall Study|No documentation of study drug dosing|3
257862|NCT02596854|838690|P1|Overall Study|Withdrawn|8
257863|NCT02596620|838696|P2|Overall Study|Lost to Follow-up|1
257864|NCT02596620|838697|P1|Overall Study|Lost to Follow-up|1
257865|NCT02596009|838739|P6|Overall Study|Administrative problems|0
257866|NCT02596009|838740|P5|Overall Study|Administrative problems|0
257867|NCT02596009|838741|P4|Overall Study|Administrative problems|0
257868|NCT02596009|838742|P3|Overall Study|Administrative problems|0
257869|NCT02596009|838743|P2|Overall Study|Administrative problems|1
257870|NCT02596009|838744|P1|Overall Study|Administrative problems|0
257871|NCT02595502|838757|P2|Period 3|Received Incorrect Treatment at period 3|1
257872|NCT02595502|838758|P1|Period 3|Received Incorrect Treatment at period 3|0
257873|NCT02595502|838757|P2|Period 3|Lost to Follow-up|0
257874|NCT02595502|838758|P1|Period 3|Lost to Follow-up|1
257875|NCT02595502|838757|P2|Period 3|Protocol Violation|1
257876|NCT02595502|838758|P1|Period 3|Protocol Violation|0
257877|NCT02595502|838757|P2|Period 2|Received incorrect lens at Period 1|1
257878|NCT02595502|838758|P1|Period 2|Received incorrect lens at Period 1|0
257879|NCT02595502|838757|P2|Period 2|Adverse Event|1
257880|NCT02595502|838758|P1|Period 2|Adverse Event|1
257881|NCT02595502|838757|P2|Period 1|Lost to Follow-up|1
257882|NCT02595502|838758|P1|Period 1|Lost to Follow-up|0
257883|NCT02595502|838757|P2|Period 1|Withdrawal by Subject|0
257884|NCT02595502|838758|P1|Period 1|Withdrawal by Subject|1
257885|NCT02595502|838757|P2|Period 1|Adverse Event|1
257886|NCT02595502|838758|P1|Period 1|Adverse Event|0
257887|NCT02595450|838764|P1|Overall Study|Enrolled, but not treated|8
257888|NCT02595450|838764|P1|Overall Study|Unspecified (only completed 1 cycle)|73
257889|NCT02593773|838779|P1|Overall Study|Death|1
257890|NCT02593773|838779|P1|Overall Study|Study Terminated by Sponsor|31
257891|NCT02593773|838779|P1|Overall Study|Voluntary Withdrawal|3
257892|NCT02591290|838829|P1|Overall Study|Withdrawal by Subject|2
257893|NCT02591238|838839|P4|Overall Study|personal circumstances|0
257894|NCT02591238|838840|P3|Overall Study|personal circumstances|0
257895|NCT02591238|838841|P2|Overall Study|personal circumstances|1
257896|NCT02591238|838842|P1|Overall Study|personal circumstances|0
257897|NCT02591238|838839|P4|Overall Study|personal circumstances|1
257898|NCT02591238|838840|P3|Overall Study|personal circumstances|0
257899|NCT02591238|838841|P2|Overall Study|personal circumstances|0
257900|NCT02591238|838842|P1|Overall Study|personal circumstances|0
257901|NCT02591238|838839|P4|Overall Study|influenza|1
257902|NCT02591238|838840|P3|Overall Study|influenza|0
257903|NCT02591238|838841|P2|Overall Study|influenza|0
257904|NCT02591238|838842|P1|Overall Study|influenza|0
257905|NCT02591238|838839|P4|Overall Study|Withdrawal by Subject|1
257906|NCT02591238|838840|P3|Overall Study|Withdrawal by Subject|0
257907|NCT02591238|838841|P2|Overall Study|Withdrawal by Subject|0
257908|NCT02591238|838842|P1|Overall Study|Withdrawal by Subject|0
257909|NCT02591238|838839|P4|Overall Study|Pregnancy|0
257910|NCT02591238|838840|P3|Overall Study|Pregnancy|0
257911|NCT02591238|838841|P2|Overall Study|Pregnancy|0
257912|NCT02591238|838842|P1|Overall Study|Pregnancy|1
257913|NCT02590939|838878|P2|Overall Study|Failed the nociceptive test|1
257914|NCT02590939|838879|P1|Overall Study|Failed the nociceptive test|2
257915|NCT02590939|838878|P2|Overall Study|Withdrawal by Subject|1
257916|NCT02590939|838879|P1|Overall Study|Withdrawal by Subject|3
257917|NCT02590588|838899|P1|Overall Study|Adverse Event|1
257918|NCT02590562|838907|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
257919|NCT02590003|838966|P2|Overall Study|Death|2
257920|NCT02590003|838967|P1|Overall Study|Death|1
257921|NCT02587819|839014|P1|Overall Study|Lost to Follow-up|1
257922|NCT02587819|839014|P1|Overall Study|Adverse Event|1
257923|NCT02587234|839023|P2|Overall Study|Lost to Follow-up|2
257924|NCT02587234|839024|P1|Overall Study|Lost to Follow-up|0
257925|NCT02587234|839023|P2|Overall Study|Withdrawal by Subject|1
257926|NCT02587234|839024|P1|Overall Study|Withdrawal by Subject|1
257927|NCT02586805|839049|P4|Overall Study|Physician Decision|0
257928|NCT02586805|839050|P3|Overall Study|Physician Decision|0
257929|NCT02586805|839051|P2|Overall Study|Physician Decision|0
257930|NCT02586805|839052|P1|Overall Study|Physician Decision|1
257931|NCT02586805|839049|P4|Overall Study|Lost to Follow-up|0
257932|NCT02586805|839050|P3|Overall Study|Lost to Follow-up|1
257933|NCT02586805|839051|P2|Overall Study|Lost to Follow-up|0
257934|NCT02586805|839052|P1|Overall Study|Lost to Follow-up|0
257935|NCT02586805|839049|P4|Overall Study|Adverse Event|0
257936|NCT02586805|839050|P3|Overall Study|Adverse Event|1
257937|NCT02586805|839051|P2|Overall Study|Adverse Event|0
257938|NCT02586805|839052|P1|Overall Study|Adverse Event|2
257939|NCT02586805|839049|P4|Overall Study|Withdrawal by Subject|2
257940|NCT02586805|839050|P3|Overall Study|Withdrawal by Subject|1
257941|NCT02586805|839051|P2|Overall Study|Withdrawal by Subject|1
257942|NCT02586805|839052|P1|Overall Study|Withdrawal by Subject|3
257943|NCT02586506|839074|P1|Overall Study|Other Reason|2
257944|NCT02586506|839074|P1|Overall Study|Lost to Follow-up|1
257945|NCT02586506|839074|P1|Overall Study|Protocol Violation|6
257946|NCT02586493|839080|P1|Overall Study|Withdrawal by Subject|1
257947|NCT02586493|839080|P1|Overall Study|Lost to Follow-up|1
257948|NCT02586493|839080|P1|Overall Study|Protocol Violation|6
257949|NCT02586493|839080|P1|Overall Study|Adverse Event|4
257950|NCT02585999|839086|P1|Overall Study|Protocol Violation|1
257951|NCT02585999|839086|P1|Overall Study|Lost to Follow-up|1
257952|NCT02585778|839113|P2|Overall Study|Other than specified above|2
257953|NCT02585778|839114|P1|Overall Study|Other than specified above|6
257954|NCT02585778|839113|P2|Overall Study|Randomized but not treated|2
257955|NCT02585778|839114|P1|Overall Study|Randomized but not treated|1
257956|NCT02585778|839113|P2|Overall Study|Death|1
257957|NCT02585778|839114|P1|Overall Study|Death|0
257958|NCT02585778|839113|P2|Overall Study|Poor compliance to study protocol|2
257959|NCT02585778|839114|P1|Overall Study|Poor compliance to study protocol|0
257960|NCT02585778|839113|P2|Overall Study|Participant did not wish to continue|4
257961|NCT02585778|839114|P1|Overall Study|Participant did not wish to continue|9
257962|NCT02585778|839113|P2|Overall Study|Adverse Event|4
257963|NCT02585778|839114|P1|Overall Study|Adverse Event|17
257964|NCT02584660|839285|P2|Overall Study|Other|1
257965|NCT02584660|839286|P1|Overall Study|Other|0
257966|NCT02584660|839285|P2|Overall Study|Withdrawal by Subject|2
257967|NCT02584660|839286|P1|Overall Study|Withdrawal by Subject|0
257968|NCT02584660|839285|P2|Overall Study|Protocol Violation|1
257969|NCT02584660|839286|P1|Overall Study|Protocol Violation|0
257970|NCT02584660|839285|P2|Overall Study|Lost to Follow-up|4
257971|NCT02584660|839286|P1|Overall Study|Lost to Follow-up|3
257972|NCT02584660|839285|P2|Overall Study|Adverse Event|0
257973|NCT02584660|839286|P1|Overall Study|Adverse Event|4
257974|NCT02584504|839305|P3|Open-label Treatment|Entered but not treated|1
257975|NCT02584504|839306|P2|Open-label Treatment|Entered but not treated|1
257976|NCT02584504|839307|P1|Open-label Treatment|Entered but not treated|0
257977|NCT02584504|839305|P3|Open-label Treatment|Ongoing in the study|52
257978|NCT02584504|839306|P2|Open-label Treatment|Ongoing in the study|49
257979|NCT02584504|839307|P1|Open-label Treatment|Ongoing in the study|54
257980|NCT02584504|839305|P3|Open-label Treatment|Adverse Event|0
257981|NCT02584504|839306|P2|Open-label Treatment|Adverse Event|1
257982|NCT02584504|839307|P1|Open-label Treatment|Adverse Event|0
257983|NCT02584504|839305|P3|Open-label Treatment|Participant withdrew consent|2
257984|NCT02584504|839306|P2|Open-label Treatment|Participant withdrew consent|0
257985|NCT02584504|839307|P1|Open-label Treatment|Participant withdrew consent|0
257986|NCT02584504|839305|P3|Double-blind Treatment|Family Matter|0
257987|NCT02584504|839306|P2|Double-blind Treatment|Family Matter|1
257988|NCT02584504|839307|P1|Double-blind Treatment|Family Matter|0
257989|NCT02584504|839305|P3|Double-blind Treatment|Adverse Event|0
257990|NCT02584504|839306|P2|Double-blind Treatment|Adverse Event|1
257991|NCT02584504|839307|P1|Double-blind Treatment|Adverse Event|0
257992|NCT02584504|839305|P3|Double-blind Treatment|Participant withdrew consent|1
257993|NCT02584504|839306|P2|Double-blind Treatment|Participant withdrew consent|0
257994|NCT02584504|839307|P1|Double-blind Treatment|Participant withdrew consent|0
257995|NCT02583425|839358|P1|Treatment Period|Adverse Event|1
257996|NCT02583425|839358|P1|Baseline|Did not meet continued criteria|5
257997|NCT02583425|839358|P1|Screening|Did not meet entry criteria|12
257998|NCT02582983|839363|P1|Overall Study|Adverse Event|1
257999|NCT02582983|839363|P1|Overall Study|Withdrawal by Subject|2
258000|NCT02582983|839363|P1|Overall Study|Death|3
258001|NCT02582684|839378|P1|Overall Study|Found to be ineligible after enrollment|2
258002|NCT02582684|839378|P1|Overall Study|Subject withdrew consent|1
258003|NCT02582684|839378|P1|Overall Study|Subject not able to get to clinic|10
258004|NCT02582684|839378|P1|Overall Study|Unable to contact subject/parent|4
258005|NCT02582632|839397|P1|Overall Study|Not Specified|1
258006|NCT02582242|839412|P2|Overall Study|Unclassified|1
258007|NCT02582242|839413|P1|Overall Study|Unclassified|2
258008|NCT02582242|839412|P2|Overall Study|Withdrawal by Subject|11
258009|NCT02582242|839413|P1|Overall Study|Withdrawal by Subject|11
258010|NCT02582242|839412|P2|Overall Study|Lost to Follow-up|1
258011|NCT02582242|839413|P1|Overall Study|Lost to Follow-up|0
258012|NCT02582242|839412|P2|Overall Study|Protocol Violation|1
258013|NCT02582242|839413|P1|Overall Study|Protocol Violation|3
258014|NCT02582242|839412|P2|Overall Study|Adverse Event|3
258015|NCT02582242|839413|P1|Overall Study|Adverse Event|4
258016|NCT02581410|839470|P2|Overall Study|Migrated/moved from study area|1
258017|NCT02581410|839471|P1|Overall Study|Migrated/moved from study area|0
258018|NCT02581410|839470|P2|Overall Study|Withdrawal by Subject|1
258019|NCT02581410|839471|P1|Overall Study|Withdrawal by Subject|0
258020|NCT02581410|839470|P2|Overall Study|Adverse Event|1
258021|NCT02581410|839471|P1|Overall Study|Adverse Event|2
258022|NCT02580357|839516|P3|Overall Study|Protocol Violation|0
258023|NCT02580357|839517|P2|Overall Study|Protocol Violation|0
258024|NCT02580357|839518|P1|Overall Study|Protocol Violation|1
258025|NCT02580357|839516|P3|Overall Study|Lost to Follow-up|0
258026|NCT02580357|839517|P2|Overall Study|Lost to Follow-up|0
258027|NCT02580357|839518|P1|Overall Study|Lost to Follow-up|2
258028|NCT02580240|839535|P2|Overall Study|Physician Decision|0
258029|NCT02580240|839536|P1|Overall Study|Physician Decision|2
258030|NCT02579772|839544|P2|Overall Study|flu-like illness, orthopedic trauma|1
258031|NCT02579772|839545|P1|Overall Study|flu-like illness, orthopedic trauma|1
258032|NCT02579772|839544|P2|Overall Study|Usage of additional antioxidants|0
258033|NCT02579772|839545|P1|Overall Study|Usage of additional antioxidants|1
258034|NCT02579772|839544|P2|Overall Study|Withdrawal by Subject|1
258035|NCT02579772|839545|P1|Overall Study|Withdrawal by Subject|0
258036|NCT02579603|839565|P2|Overall Study|Other than stated|0
258037|NCT02579603|839566|P1|Overall Study|Other than stated|1
258038|NCT02579603|839565|P2|Overall Study|Adverse Event|2
258039|NCT02579603|839566|P1|Overall Study|Adverse Event|2
258040|NCT02579603|839565|P2|Overall Study|Not treated|0
258041|NCT02579603|839566|P1|Overall Study|Not treated|1
258042|NCT02578992|839592|P2|Overall Study|equipment not available or malfunction|3
258043|NCT02578992|839593|P1|Overall Study|equipment not available or malfunction|3
258044|NCT02578706|839608|P3|Overall Study|Physician Decision|0
258045|NCT02578706|839609|P2|Overall Study|Physician Decision|1
258046|NCT02578706|839610|P1|Overall Study|Physician Decision|0
258047|NCT02578706|839608|P3|Overall Study|Lost to Follow-up|0
258048|NCT02578706|839609|P2|Overall Study|Lost to Follow-up|4
258049|NCT02578706|839610|P1|Overall Study|Lost to Follow-up|0
258050|NCT02578706|839608|P3|Overall Study|Withdrawal by Subject|0
258051|NCT02578706|839609|P2|Overall Study|Withdrawal by Subject|0
258052|NCT02578706|839610|P1|Overall Study|Withdrawal by Subject|1
258053|NCT02578316|839687|P1|Extension Phase|Progression of disease|6
258054|NCT02578186|839716|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
258055|NCT02578186|839717|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
258056|NCT02578186|839716|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
258057|NCT02578186|839717|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
258058|NCT02577718|839723|P1|Overall Study|Withdrawal by Subject|2
258059|NCT02577718|839723|P1|Overall Study|Death|6
258060|NCT02577315|839758|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
258061|NCT02577315|839759|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
258062|NCT02577107|839777|P2|Overall Study|Protocol deviation|1
258063|NCT02577107|839778|P1|Overall Study|Protocol deviation|0
258064|NCT02577016|839792|P2|Overall Study|Physician Decision|1
258065|NCT02577016|839793|P1|Overall Study|Physician Decision|0
258066|NCT02577016|839792|P2|Overall Study|Adverse Event|1
258067|NCT02577016|839793|P1|Overall Study|Adverse Event|2
258068|NCT02577003|839811|P2|Overall Study|Withdrawal by Subject|1
258069|NCT02577003|839812|P1|Overall Study|Withdrawal by Subject|0
258070|NCT02577003|839811|P2|Overall Study|Adverse Event|4
258071|NCT02577003|839812|P1|Overall Study|Adverse Event|2
258072|NCT02576938|839833|P3|Overall Study|Met Exclusion Criteria|0
258073|NCT02576938|839834|P2|Overall Study|Met Exclusion Criteria|1
258074|NCT02576938|839835|P1|Overall Study|Met Exclusion Criteria|0
258075|NCT02576938|839833|P3|Overall Study|Physician Decision|0
258076|NCT02576938|839834|P2|Overall Study|Physician Decision|1
258077|NCT02576938|839835|P1|Overall Study|Physician Decision|0
258078|NCT02576938|839833|P3|Overall Study|Lost to Follow-up|1
258079|NCT02576938|839834|P2|Overall Study|Lost to Follow-up|0
258080|NCT02576938|839835|P1|Overall Study|Lost to Follow-up|2
258081|NCT02576938|839833|P3|Overall Study|Lack of Efficacy|0
258082|NCT02576938|839834|P2|Overall Study|Lack of Efficacy|4
258083|NCT02576938|839835|P1|Overall Study|Lack of Efficacy|9
258084|NCT02576938|839833|P3|Overall Study|Withdrawal by Subject|4
258085|NCT02576938|839834|P2|Overall Study|Withdrawal by Subject|2
258086|NCT02576938|839835|P1|Overall Study|Withdrawal by Subject|3
258087|NCT02576938|839833|P3|Overall Study|Protocol Violation|1
258088|NCT02576938|839834|P2|Overall Study|Protocol Violation|1
258089|NCT02576938|839835|P1|Overall Study|Protocol Violation|1
258090|NCT02576938|839833|P3|Overall Study|Adverse Event|6
258091|NCT02576938|839834|P2|Overall Study|Adverse Event|3
258092|NCT02576938|839835|P1|Overall Study|Adverse Event|5
258093|NCT02576639|839868|P5|Overall Study|Physician Decision|1
258094|NCT02576639|839869|P4|Overall Study|Physician Decision|0
258095|NCT02576639|839870|P3|Overall Study|Physician Decision|0
258096|NCT02576639|839871|P2|Overall Study|Physician Decision|0
258097|NCT02576639|839872|P1|Overall Study|Physician Decision|0
258098|NCT02576639|839868|P5|Overall Study|Adverse Event|2
258099|NCT02576639|839869|P4|Overall Study|Adverse Event|1
258100|NCT02576639|839870|P3|Overall Study|Adverse Event|1
258101|NCT02576639|839871|P2|Overall Study|Adverse Event|0
258102|NCT02576639|839872|P1|Overall Study|Adverse Event|1
258103|NCT02576639|839868|P5|Overall Study|Withdrawal by Subject|1
258104|NCT02576639|839869|P4|Overall Study|Withdrawal by Subject|0
258105|NCT02576639|839870|P3|Overall Study|Withdrawal by Subject|1
258106|NCT02576639|839871|P2|Overall Study|Withdrawal by Subject|2
258107|NCT02576639|839872|P1|Overall Study|Withdrawal by Subject|1
258108|NCT02576535|839929|P1|Overall Study|Withdrawal by Subject|2
258109|NCT02576145|839953|P2|Overall Study|Tetanus Titers Decreased|1
258110|NCT02576145|839954|P1|Overall Study|Tetanus Titers Decreased|0
258111|NCT02576145|839953|P2|Overall Study|Acute rejection|0
258112|NCT02576145|839954|P1|Overall Study|Acute rejection|1
258113|NCT02576145|839953|P2|Overall Study|Withdrawal by Subject|0
258114|NCT02576145|839954|P1|Overall Study|Withdrawal by Subject|1
258115|NCT02576145|839953|P2|Overall Study|Adverse Event|0
258116|NCT02576145|839954|P1|Overall Study|Adverse Event|1
258117|NCT02575911|839996|P1|Overall Study|Lost to Follow-up|1
258118|NCT02574845|840025|P6|Overall Study|Adverse Event|1
258119|NCT02574845|840026|P5|Overall Study|Adverse Event|0
258120|NCT02574845|840027|P4|Overall Study|Adverse Event|0
258121|NCT02574845|840028|P3|Overall Study|Adverse Event|0
258122|NCT02574845|840029|P2|Overall Study|Adverse Event|1
258123|NCT02574845|840030|P1|Overall Study|Adverse Event|0
258124|NCT02574845|840025|P6|Overall Study|Consent withdrawn further participation|0
258125|NCT02574845|840026|P5|Overall Study|Consent withdrawn further participation|1
258126|NCT02574845|840027|P4|Overall Study|Consent withdrawn further participation|0
258127|NCT02574845|840028|P3|Overall Study|Consent withdrawn further participation|0
258128|NCT02574845|840029|P2|Overall Study|Consent withdrawn further participation|0
258129|NCT02574845|840030|P1|Overall Study|Consent withdrawn further participation|0
258130|NCT02574260|840060|P1|Overall Study|Disease Progression|1
258131|NCT02574247|840069|P3|Overall Study|Did not meet inclusion criteria|5
258132|NCT02574247|840070|P2|Overall Study|Did not meet inclusion criteria|3
258133|NCT02574247|840071|P1|Overall Study|Did not meet inclusion criteria|4
258134|NCT02574247|840069|P3|Overall Study|Withdrawal by Subject|0
258135|NCT02574247|840070|P2|Overall Study|Withdrawal by Subject|0
258136|NCT02574247|840071|P1|Overall Study|Withdrawal by Subject|1
258137|NCT02573870|840085|P2|Overall Study|Other: Fail to Meet Visit|2
258138|NCT02573870|840086|P1|Overall Study|Other: Fail to Meet Visit|0
258139|NCT02573870|840085|P2|Overall Study|Lost to Follow-up|1
258140|NCT02573870|840086|P1|Overall Study|Lost to Follow-up|0
258141|NCT02573870|840085|P2|Overall Study|Other: Reached defined stopping criteria|1
258142|NCT02573870|840086|P1|Overall Study|Other: Reached defined stopping criteria|0
258143|NCT02573870|840085|P2|Overall Study|Lack of Efficacy|1
258144|NCT02573870|840086|P1|Overall Study|Lack of Efficacy|0
258145|NCT02573870|840085|P2|Overall Study|Adverse Event|2
258146|NCT02573870|840086|P1|Overall Study|Adverse Event|0
258147|NCT02573467|840096|P4|Post-treatment Follow up Epoch|Technical problems|0
258148|NCT02573467|840097|P3|Post-treatment Follow up Epoch|Technical problems|1
258149|NCT02573467|840098|P2|Post-treatment Follow up Epoch|Technical problems|0
258150|NCT02573467|840099|P1|Post-treatment Follow up Epoch|Technical problems|0
258151|NCT02573467|840096|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
258152|NCT02573467|840097|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
258153|NCT02573467|840098|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
258154|NCT02573467|840099|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
258155|NCT02573467|840096|P4|Post-treatment Follow up Epoch|Death|1
258156|NCT02573467|840097|P3|Post-treatment Follow up Epoch|Death|0
258157|NCT02573467|840098|P2|Post-treatment Follow up Epoch|Death|1
258158|NCT02573467|840099|P1|Post-treatment Follow up Epoch|Death|1
258159|NCT02573467|840096|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
258160|NCT02573467|840097|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
258161|NCT02573467|840098|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
258162|NCT02573467|840099|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
258163|NCT02573467|840096|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
258164|NCT02573467|840097|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
258165|NCT02573467|840098|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
258166|NCT02573467|840099|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
258167|NCT02573467|840096|P4|Double-blind Treatment Epoch|Adverse Event|0
258168|NCT02573467|840097|P3|Double-blind Treatment Epoch|Adverse Event|1
258169|NCT02573467|840098|P2|Double-blind Treatment Epoch|Adverse Event|0
258170|NCT02573467|840099|P1|Double-blind Treatment Epoch|Adverse Event|1
258171|NCT02573467|840096|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
258172|NCT02573467|840097|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
258173|NCT02573467|840098|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
258174|NCT02573467|840099|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
258175|NCT02570165|840299|P7|Overall Study|Withdrawal Request by GSK|0
258176|NCT02570165|840300|P6|Overall Study|Withdrawal Request by GSK|0
258177|NCT02570165|840301|P5|Overall Study|Withdrawal Request by GSK|0
258178|NCT02570165|840302|P4|Overall Study|Withdrawal Request by GSK|0
258179|NCT02570165|840303|P3|Overall Study|Withdrawal Request by GSK|2
258180|NCT02570165|840304|P2|Overall Study|Withdrawal Request by GSK|0
258181|NCT02570165|840305|P1|Overall Study|Withdrawal Request by GSK|0
258182|NCT02570165|840299|P7|Overall Study|Par. did not Meet Continuation Criteria|0
258183|NCT02570165|840300|P6|Overall Study|Par. did not Meet Continuation Criteria|1
258184|NCT02570165|840301|P5|Overall Study|Par. did not Meet Continuation Criteria|0
258185|NCT02570165|840302|P4|Overall Study|Par. did not Meet Continuation Criteria|0
258186|NCT02570165|840303|P3|Overall Study|Par. did not Meet Continuation Criteria|0
258187|NCT02570165|840304|P2|Overall Study|Par. did not Meet Continuation Criteria|0
258188|NCT02570165|840305|P1|Overall Study|Par. did not Meet Continuation Criteria|0
258189|NCT02570165|840299|P7|Overall Study|Withdrawal by Subject|0
258190|NCT02570165|840300|P6|Overall Study|Withdrawal by Subject|0
258191|NCT02570165|840301|P5|Overall Study|Withdrawal by Subject|1
258192|NCT02570165|840302|P4|Overall Study|Withdrawal by Subject|2
258193|NCT02570165|840303|P3|Overall Study|Withdrawal by Subject|0
258194|NCT02570165|840304|P2|Overall Study|Withdrawal by Subject|0
258195|NCT02570165|840305|P1|Overall Study|Withdrawal by Subject|0
258196|NCT02570165|840299|P7|Overall Study|Physician Decision|0
258197|NCT02570165|840300|P6|Overall Study|Physician Decision|0
258198|NCT02570165|840301|P5|Overall Study|Physician Decision|0
258199|NCT02570165|840302|P4|Overall Study|Physician Decision|0
258200|NCT02570165|840303|P3|Overall Study|Physician Decision|0
258201|NCT02570165|840304|P2|Overall Study|Physician Decision|1
258202|NCT02570165|840305|P1|Overall Study|Physician Decision|0
258203|NCT02570165|840299|P7|Overall Study|Lost to Follow-up|0
258204|NCT02570165|840300|P6|Overall Study|Lost to Follow-up|0
258205|NCT02570165|840301|P5|Overall Study|Lost to Follow-up|0
258206|NCT02570165|840302|P4|Overall Study|Lost to Follow-up|1
258207|NCT02570165|840303|P3|Overall Study|Lost to Follow-up|1
258208|NCT02570165|840304|P2|Overall Study|Lost to Follow-up|0
258209|NCT02570165|840305|P1|Overall Study|Lost to Follow-up|0
258210|NCT02570165|840299|P7|Overall Study|Par. Reached Stopping Criteria|0
258211|NCT02570165|840300|P6|Overall Study|Par. Reached Stopping Criteria|1
258212|NCT02570165|840301|P5|Overall Study|Par. Reached Stopping Criteria|1
258213|NCT02570165|840302|P4|Overall Study|Par. Reached Stopping Criteria|2
258214|NCT02570165|840303|P3|Overall Study|Par. Reached Stopping Criteria|0
258215|NCT02570165|840304|P2|Overall Study|Par. Reached Stopping Criteria|1
258216|NCT02570165|840305|P1|Overall Study|Par. Reached Stopping Criteria|1
258217|NCT02570165|840299|P7|Overall Study|Lack of Efficacy|0
258218|NCT02570165|840300|P6|Overall Study|Lack of Efficacy|0
258219|NCT02570165|840301|P5|Overall Study|Lack of Efficacy|4
258220|NCT02570165|840302|P4|Overall Study|Lack of Efficacy|0
258221|NCT02570165|840303|P3|Overall Study|Lack of Efficacy|0
258222|NCT02570165|840304|P2|Overall Study|Lack of Efficacy|1
258223|NCT02570165|840305|P1|Overall Study|Lack of Efficacy|0
258224|NCT02570165|840299|P7|Overall Study|Adverse Event|0
258225|NCT02570165|840300|P6|Overall Study|Adverse Event|0
258226|NCT02570165|840301|P5|Overall Study|Adverse Event|0
258227|NCT02570165|840302|P4|Overall Study|Adverse Event|0
258228|NCT02570165|840303|P3|Overall Study|Adverse Event|2
258229|NCT02570165|840304|P2|Overall Study|Adverse Event|0
258230|NCT02570165|840305|P1|Overall Study|Adverse Event|1
258231|NCT02570126|840330|P2|Overall Study|Withdrawal by Subject|7
258232|NCT02570126|840331|P1|Overall Study|Withdrawal by Subject|3
258233|NCT02570126|840330|P2|Overall Study|Protocol Violation|1
258234|NCT02570126|840331|P1|Overall Study|Protocol Violation|0
258235|NCT02570126|840330|P2|Overall Study|Violation Of Procedures GSK|1
258236|NCT02570126|840331|P1|Overall Study|Violation Of Procedures GSK|0
258237|NCT02570126|840330|P2|Overall Study|Unable To Arrange Visit 3|0
258238|NCT02570126|840331|P1|Overall Study|Unable To Arrange Visit 3|1
258239|NCT02570126|840330|P2|Overall Study|Lost to Follow-up|0
258240|NCT02570126|840331|P1|Overall Study|Lost to Follow-up|2
258241|NCT02569996|840366|P1|Overall Study|Unknown reason|1
258242|NCT02569996|840366|P1|Overall Study|Complete remission|7
258243|NCT02569996|840366|P1|Overall Study|Lost to Follow-up|5
258244|NCT02569996|840366|P1|Overall Study|Withdrawal by Subject|5
258245|NCT02569996|840366|P1|Overall Study|Non-compliance|9
258246|NCT02569996|840366|P1|Overall Study|New anti-lymphoma treatment|1
258247|NCT02569996|840366|P1|Overall Study|Progression of the disease|18
258248|NCT02569996|840366|P1|Overall Study|Physician Decision|3
258249|NCT02569996|840366|P1|Overall Study|Adverse Event|6
258250|NCT02569957|840378|P2|Overall Study|Withdrawal by Subject|1
258251|NCT02569957|840379|P1|Overall Study|Withdrawal by Subject|0
258252|NCT02569437|840430|P2|Overall Study|Lost to Follow-up|14
258253|NCT02569437|840431|P1|Overall Study|Lost to Follow-up|12
258254|NCT02568384|840495|P1|Overall Study|Mobile devices incompatible with App|2
258255|NCT02568254|840509|P6|Period 3|Unstatisfactory Lens fitting|0
258256|NCT02568254|840510|P5|Period 3|Unstatisfactory Lens fitting|1
258257|NCT02568254|840511|P4|Period 3|Unstatisfactory Lens fitting|0
258258|NCT02568254|840512|P3|Period 3|Unstatisfactory Lens fitting|0
258259|NCT02568254|840513|P2|Period 3|Unstatisfactory Lens fitting|0
258260|NCT02568254|840514|P1|Period 3|Unstatisfactory Lens fitting|0
258261|NCT02568254|840509|P6|Period 2|Adverse Event|0
258262|NCT02568254|840510|P5|Period 2|Adverse Event|0
258263|NCT02568254|840511|P4|Period 2|Adverse Event|0
258264|NCT02568254|840512|P3|Period 2|Adverse Event|1
258265|NCT02568254|840513|P2|Period 2|Adverse Event|0
258266|NCT02568254|840514|P1|Period 2|Adverse Event|0
258267|NCT02567552|840524|P2|Overall Study|Adverse Event|1
258268|NCT02567552|840525|P1|Overall Study|Adverse Event|0
258269|NCT02567188|840555|P1|Overall Study|Protocol Violation|5
258270|NCT02567188|840555|P1|Overall Study|Started Hemodialysis|2
258271|NCT02567188|840555|P1|Overall Study|Moved and Changed Clinic|1
258272|NCT02567188|840555|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
258273|NCT02567188|840555|P1|Overall Study|Withdrawal by Subject|1
258274|NCT02567188|840555|P1|Overall Study|Adverse Event|1
258275|NCT02567188|840555|P1|Overall Study|Lost to Follow-up|5
258276|NCT02567188|840555|P1|Overall Study|Terminated Mircera Treatment|9
258277|NCT02567188|840555|P1|Overall Study|Death|10
258278|NCT02566759|840601|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
258279|NCT02566759|840602|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258280|NCT02566759|840603|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258281|NCT02566759|840604|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258282|NCT02566759|840605|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258283|NCT02566759|840606|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258284|NCT02566759|840607|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258285|NCT02566759|840608|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258286|NCT02566759|840609|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258287|NCT02566759|840610|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258288|NCT02566759|840611|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258289|NCT02566759|840612|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258290|NCT02566759|840613|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258291|NCT02566759|840614|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258292|NCT02566759|840615|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258293|NCT02566759|840616|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258294|NCT02566759|840617|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
258295|NCT02566759|840601|P17|All Parts|Other|0
258296|NCT02566759|840602|P16|All Parts|Other|0
258297|NCT02566759|840603|P15|All Parts|Other|0
258298|NCT02566759|840604|P14|All Parts|Other|2
258299|NCT02566759|840605|P13|All Parts|Other|0
258300|NCT02566759|840606|P12|All Parts|Other|0
258301|NCT02566759|840607|P11|All Parts|Other|0
258302|NCT02566759|840608|P10|All Parts|Other|0
258303|NCT02566759|840609|P9|All Parts|Other|0
258304|NCT02566759|840610|P8|All Parts|Other|0
258305|NCT02566759|840611|P7|All Parts|Other|0
258306|NCT02566759|840612|P6|All Parts|Other|0
258307|NCT02566759|840613|P5|All Parts|Other|0
258308|NCT02566759|840614|P4|All Parts|Other|0
258309|NCT02566759|840615|P3|All Parts|Other|0
258310|NCT02566759|840616|P2|All Parts|Other|0
258311|NCT02566759|840617|P1|All Parts|Other|0
258312|NCT02566759|840601|P17|All Parts|Adverse Event|0
258313|NCT02566759|840602|P16|All Parts|Adverse Event|0
258314|NCT02566759|840603|P15|All Parts|Adverse Event|0
258315|NCT02566759|840604|P14|All Parts|Adverse Event|3
258316|NCT02566759|840605|P13|All Parts|Adverse Event|1
258317|NCT02566759|840606|P12|All Parts|Adverse Event|0
258318|NCT02566759|840607|P11|All Parts|Adverse Event|0
258319|NCT02566759|840608|P10|All Parts|Adverse Event|0
258320|NCT02566759|840609|P9|All Parts|Adverse Event|0
258321|NCT02566759|840610|P8|All Parts|Adverse Event|0
258322|NCT02566759|840611|P7|All Parts|Adverse Event|0
258323|NCT02566759|840612|P6|All Parts|Adverse Event|0
258324|NCT02566759|840613|P5|All Parts|Adverse Event|0
258325|NCT02566759|840614|P4|All Parts|Adverse Event|0
258326|NCT02566759|840615|P3|All Parts|Adverse Event|0
258327|NCT02566759|840616|P2|All Parts|Adverse Event|0
258328|NCT02566759|840617|P1|All Parts|Adverse Event|0
258329|NCT02566759|840601|P17|All Parts|Withdrawal by Subject|0
258330|NCT02566759|840602|P16|All Parts|Withdrawal by Subject|0
258331|NCT02566759|840603|P15|All Parts|Withdrawal by Subject|0
258332|NCT02566759|840604|P14|All Parts|Withdrawal by Subject|0
258333|NCT02566759|840605|P13|All Parts|Withdrawal by Subject|0
258334|NCT02566759|840606|P12|All Parts|Withdrawal by Subject|0
258335|NCT02566759|840607|P11|All Parts|Withdrawal by Subject|0
258336|NCT02566759|840608|P10|All Parts|Withdrawal by Subject|0
258337|NCT02566759|840609|P9|All Parts|Withdrawal by Subject|0
258338|NCT02566759|840610|P8|All Parts|Withdrawal by Subject|0
258339|NCT02566759|840611|P7|All Parts|Withdrawal by Subject|0
258340|NCT02566759|840612|P6|All Parts|Withdrawal by Subject|0
258341|NCT02566759|840613|P5|All Parts|Withdrawal by Subject|0
258342|NCT02566759|840614|P4|All Parts|Withdrawal by Subject|0
258343|NCT02566759|840615|P3|All Parts|Withdrawal by Subject|0
258344|NCT02566759|840616|P2|All Parts|Withdrawal by Subject|1
258345|NCT02566759|840617|P1|All Parts|Withdrawal by Subject|0
258346|NCT02566005|840770|P2|Overall Study|labor after randomization|4
258347|NCT02566005|840771|P1|Overall Study|labor after randomization|0
258348|NCT02566005|840770|P2|Overall Study|did not receive foley|1
258349|NCT02566005|840771|P1|Overall Study|did not receive foley|0
258350|NCT02566005|840770|P2|Overall Study|received foley|0
258351|NCT02566005|840771|P1|Overall Study|received foley|8
258352|NCT02566005|840770|P2|Overall Study|vaginal bleeding|1
258353|NCT02566005|840771|P1|Overall Study|vaginal bleeding|0
258354|NCT02565381|840848|P3|Overall Study|Lost to Follow-up|1
258355|NCT02565381|840849|P2|Overall Study|Lost to Follow-up|0
258356|NCT02565381|840850|P1|Overall Study|Lost to Follow-up|1
258357|NCT02564211|840888|P1|Overall Study|Adverse Event|4
258358|NCT02564055|840900|P6|Overall Study|Withdrawal by Subject|10
258359|NCT02564055|840901|P5|Overall Study|Withdrawal by Subject|10
258360|NCT02564055|840902|P4|Overall Study|Withdrawal by Subject|3
258361|NCT02564055|840903|P3|Overall Study|Withdrawal by Subject|3
258362|NCT02564055|840904|P2|Overall Study|Withdrawal by Subject|4
258363|NCT02564055|840905|P1|Overall Study|Withdrawal by Subject|4
258364|NCT02564055|840900|P6|Overall Study|Physician Decision|0
258365|NCT02564055|840901|P5|Overall Study|Physician Decision|0
258366|NCT02564055|840902|P4|Overall Study|Physician Decision|0
258367|NCT02564055|840903|P3|Overall Study|Physician Decision|1
258368|NCT02564055|840904|P2|Overall Study|Physician Decision|0
258369|NCT02564055|840905|P1|Overall Study|Physician Decision|0
258370|NCT02564055|840900|P6|Overall Study|Lost to Follow-up|0
258371|NCT02564055|840901|P5|Overall Study|Lost to Follow-up|1
258372|NCT02564055|840902|P4|Overall Study|Lost to Follow-up|2
258373|NCT02564055|840903|P3|Overall Study|Lost to Follow-up|4
258374|NCT02564055|840904|P2|Overall Study|Lost to Follow-up|1
258375|NCT02564055|840905|P1|Overall Study|Lost to Follow-up|0
258376|NCT02564055|840900|P6|Overall Study|Reached stopping criteria|1
258377|NCT02564055|840901|P5|Overall Study|Reached stopping criteria|0
258378|NCT02564055|840902|P4|Overall Study|Reached stopping criteria|0
258379|NCT02564055|840903|P3|Overall Study|Reached stopping criteria|0
258380|NCT02564055|840904|P2|Overall Study|Reached stopping criteria|0
258381|NCT02564055|840905|P1|Overall Study|Reached stopping criteria|0
258382|NCT02564055|840900|P6|Overall Study|Protocol Violation|0
258383|NCT02564055|840901|P5|Overall Study|Protocol Violation|0
258384|NCT02564055|840902|P4|Overall Study|Protocol Violation|0
258385|NCT02564055|840903|P3|Overall Study|Protocol Violation|0
258386|NCT02564055|840904|P2|Overall Study|Protocol Violation|0
258387|NCT02564055|840905|P1|Overall Study|Protocol Violation|1
258388|NCT02564055|840900|P6|Overall Study|Adverse Event|1
258389|NCT02564055|840901|P5|Overall Study|Adverse Event|4
258390|NCT02564055|840902|P4|Overall Study|Adverse Event|1
258391|NCT02564055|840903|P3|Overall Study|Adverse Event|4
258392|NCT02564055|840904|P2|Overall Study|Adverse Event|0
258393|NCT02564055|840905|P1|Overall Study|Adverse Event|1
258394|NCT02564042|841159|P6|Overall Study|Withdrawal by Subject|12
258395|NCT02564042|841160|P5|Overall Study|Withdrawal by Subject|10
258396|NCT02564042|841161|P4|Overall Study|Withdrawal by Subject|2
258397|NCT02564042|841162|P3|Overall Study|Withdrawal by Subject|2
258398|NCT02564042|841163|P2|Overall Study|Withdrawal by Subject|3
258399|NCT02564042|841164|P1|Overall Study|Withdrawal by Subject|5
258400|NCT02564042|841159|P6|Overall Study|Physician Decision|0
258401|NCT02564042|841160|P5|Overall Study|Physician Decision|0
258402|NCT02564042|841161|P4|Overall Study|Physician Decision|1
258403|NCT02564042|841162|P3|Overall Study|Physician Decision|0
258404|NCT02564042|841163|P2|Overall Study|Physician Decision|0
258405|NCT02564042|841164|P1|Overall Study|Physician Decision|1
258406|NCT02564042|841159|P6|Overall Study|Lost to Follow-up|1
258407|NCT02564042|841160|P5|Overall Study|Lost to Follow-up|1
258408|NCT02564042|841161|P4|Overall Study|Lost to Follow-up|0
258409|NCT02564042|841162|P3|Overall Study|Lost to Follow-up|1
258410|NCT02564042|841163|P2|Overall Study|Lost to Follow-up|1
258411|NCT02564042|841164|P1|Overall Study|Lost to Follow-up|1
258412|NCT02564042|841159|P6|Overall Study|Adverse Event|1
258413|NCT02564042|841160|P5|Overall Study|Adverse Event|0
258414|NCT02564042|841161|P4|Overall Study|Adverse Event|0
258415|NCT02564042|841162|P3|Overall Study|Adverse Event|3
258416|NCT02564042|841163|P2|Overall Study|Adverse Event|4
258417|NCT02564042|841164|P1|Overall Study|Adverse Event|4
258418|NCT02563899|841421|P4|Overall Study|Withdrawal by Subject|0
258419|NCT02563899|841422|P3|Overall Study|Withdrawal by Subject|1
258420|NCT02563899|841423|P2|Overall Study|Withdrawal by Subject|0
258421|NCT02563899|841424|P1|Overall Study|Withdrawal by Subject|0
258422|NCT02563899|841421|P4|Overall Study|Protocol Violation|0
258423|NCT02563899|841422|P3|Overall Study|Protocol Violation|0
258424|NCT02563899|841423|P2|Overall Study|Protocol Violation|0
258425|NCT02563899|841424|P1|Overall Study|Protocol Violation|1
258426|NCT02563106|841486|P2|Overall Study|Other reason - not specified|1
258427|NCT02563106|841487|P1|Overall Study|Other reason - not specified|2
258428|NCT02563106|841486|P2|Overall Study|Physician Decision|1
258429|NCT02563106|841487|P1|Overall Study|Physician Decision|3
258430|NCT02563106|841486|P2|Overall Study|Lost to Follow-up|2
258431|NCT02563106|841487|P1|Overall Study|Lost to Follow-up|3
258432|NCT02563106|841486|P2|Overall Study|Use of non-permitted concurrent therapy|2
258433|NCT02563106|841487|P1|Overall Study|Use of non-permitted concurrent therapy|1
258434|NCT02563106|841486|P2|Overall Study|Protocol Violation|0
258435|NCT02563106|841487|P1|Overall Study|Protocol Violation|1
258436|NCT02563106|841486|P2|Overall Study|Adverse Event|15
258437|NCT02563106|841487|P1|Overall Study|Adverse Event|17
258438|NCT02563106|841486|P2|Overall Study|Withdrawal by Subject|8
258439|NCT02563106|841487|P1|Overall Study|Withdrawal by Subject|7
258440|NCT02561806|841545|P2|Overall Study|Withdrawal by Subject|2
258441|NCT02561806|841546|P1|Overall Study|Withdrawal by Subject|0
258442|NCT02561806|841545|P2|Overall Study|Adverse Event|2
258443|NCT02561806|841546|P1|Overall Study|Adverse Event|0
258444|NCT02561806|841545|P2|Overall Study|Protocol Violation|0
258445|NCT02561806|841546|P1|Overall Study|Protocol Violation|1
258446|NCT02561572|841609|P2|Overall Study|Protocol Violation|1
258447|NCT02561572|841610|P1|Overall Study|Protocol Violation|0
258448|NCT02561572|841609|P2|Overall Study|Inadequate time before surgery|1
258449|NCT02561572|841610|P1|Overall Study|Inadequate time before surgery|2
258450|NCT02561195|841632|P6|Overall Study|Randomized but not treated|0
258451|NCT02561195|841633|P5|Overall Study|Randomized but not treated|0
258452|NCT02561195|841634|P4|Overall Study|Randomized but not treated|0
258453|NCT02561195|841635|P3|Overall Study|Randomized but not treated|0
258454|NCT02561195|841636|P2|Overall Study|Randomized but not treated|0
258455|NCT02561195|841637|P1|Overall Study|Randomized but not treated|1
258456|NCT02561195|841632|P6|Overall Study|Withdrawal by Subject|0
258457|NCT02561195|841633|P5|Overall Study|Withdrawal by Subject|6
258458|NCT02561195|841634|P4|Overall Study|Withdrawal by Subject|2
258459|NCT02561195|841635|P3|Overall Study|Withdrawal by Subject|4
258460|NCT02561195|841636|P2|Overall Study|Withdrawal by Subject|4
258461|NCT02561195|841637|P1|Overall Study|Withdrawal by Subject|3
258462|NCT02561195|841632|P6|Overall Study|Death|0
258463|NCT02561195|841633|P5|Overall Study|Death|0
258464|NCT02561195|841634|P4|Overall Study|Death|2
258465|NCT02561195|841635|P3|Overall Study|Death|0
258466|NCT02561195|841636|P2|Overall Study|Death|1
258467|NCT02561195|841637|P1|Overall Study|Death|2
258468|NCT02561195|841632|P6|Overall Study|Protocol Violation|2
258469|NCT02561195|841633|P5|Overall Study|Protocol Violation|5
258470|NCT02561195|841634|P4|Overall Study|Protocol Violation|2
258471|NCT02561195|841635|P3|Overall Study|Protocol Violation|1
258472|NCT02561195|841636|P2|Overall Study|Protocol Violation|0
258473|NCT02561195|841637|P1|Overall Study|Protocol Violation|1
258474|NCT02561195|841632|P6|Overall Study|Other|1
258475|NCT02561195|841633|P5|Overall Study|Other|5
258476|NCT02561195|841634|P4|Overall Study|Other|7
258477|NCT02561195|841635|P3|Overall Study|Other|1
258478|NCT02561195|841636|P2|Overall Study|Other|3
258479|NCT02561195|841637|P1|Overall Study|Other|7
258480|NCT02561195|841632|P6|Overall Study|No longer willing to participate|3
258481|NCT02561195|841633|P5|Overall Study|No longer willing to participate|1
258482|NCT02561195|841634|P4|Overall Study|No longer willing to participate|4
258483|NCT02561195|841635|P3|Overall Study|No longer willing to participate|0
258484|NCT02561195|841636|P2|Overall Study|No longer willing to participate|4
258485|NCT02561195|841637|P1|Overall Study|No longer willing to participate|2
258486|NCT02561195|841632|P6|Overall Study|No longer meets eligibility criteria|1
258487|NCT02561195|841633|P5|Overall Study|No longer meets eligibility criteria|4
258488|NCT02561195|841634|P4|Overall Study|No longer meets eligibility criteria|4
258489|NCT02561195|841635|P3|Overall Study|No longer meets eligibility criteria|0
258490|NCT02561195|841636|P2|Overall Study|No longer meets eligibility criteria|1
258491|NCT02561195|841637|P1|Overall Study|No longer meets eligibility criteria|0
258492|NCT02561195|841632|P6|Overall Study|Lost to Follow-up|3
258493|NCT02561195|841633|P5|Overall Study|Lost to Follow-up|3
258494|NCT02561195|841634|P4|Overall Study|Lost to Follow-up|2
258495|NCT02561195|841635|P3|Overall Study|Lost to Follow-up|0
258496|NCT02561195|841636|P2|Overall Study|Lost to Follow-up|4
258497|NCT02561195|841637|P1|Overall Study|Lost to Follow-up|3
258498|NCT02561195|841632|P6|Overall Study|Adverse Event|0
258499|NCT02561195|841633|P5|Overall Study|Adverse Event|4
258500|NCT02561195|841634|P4|Overall Study|Adverse Event|3
258501|NCT02561195|841635|P3|Overall Study|Adverse Event|0
258502|NCT02561195|841636|P2|Overall Study|Adverse Event|5
258503|NCT02561195|841637|P1|Overall Study|Adverse Event|4
258504|NCT02559622|841789|P4|Overall Study|Patient/guardian decision|1
258505|NCT02559622|841790|P3|Overall Study|Patient/guardian decision|0
258506|NCT02559622|841791|P2|Overall Study|Patient/guardian decision|2
258507|NCT02559622|841792|P1|Overall Study|Patient/guardian decision|1
258508|NCT02559622|841789|P4|Overall Study|Adverse Event|2
258509|NCT02559622|841790|P3|Overall Study|Adverse Event|2
258510|NCT02559622|841791|P2|Overall Study|Adverse Event|2
258511|NCT02559622|841792|P1|Overall Study|Adverse Event|0
258512|NCT02559622|841789|P4|Overall Study|Progressive disease|0
258513|NCT02559622|841790|P3|Overall Study|Progressive disease|0
258514|NCT02559622|841791|P2|Overall Study|Progressive disease|1
258515|NCT02559622|841792|P1|Overall Study|Progressive disease|0
258516|NCT02559414|841874|P3|Overall Study|Other|1
258517|NCT02559414|841875|P2|Overall Study|Other|1
258518|NCT02559414|841876|P1|Overall Study|Other|0
258519|NCT02559414|841874|P3|Overall Study|Withdrawal by Subject|1
258520|NCT02559414|841875|P2|Overall Study|Withdrawal by Subject|0
258521|NCT02559414|841876|P1|Overall Study|Withdrawal by Subject|1
258522|NCT02559414|841874|P3|Overall Study|Lost to Follow-up|0
258523|NCT02559414|841875|P2|Overall Study|Lost to Follow-up|1
258524|NCT02559414|841876|P1|Overall Study|Lost to Follow-up|0
258525|NCT02558790|841933|P1|Overall Study|Screen Fail|3
258526|NCT02558790|841933|P1|Overall Study|Withdrawal by Subject|1
258527|NCT02558790|841933|P1|Overall Study|Physician Decision|1
258528|NCT02558790|841933|P1|Overall Study|Lost to Follow-up|2
258529|NCT02557646|842015|P1|Overall Study|Other|14
258530|NCT02557646|842015|P1|Overall Study|Lost to Follow-up|17
258531|NCT02557646|842015|P1|Overall Study|Withdrawal by Subject|18
258532|NCT02557646|842015|P1|Overall Study|Lack of Efficacy|186
258533|NCT02557646|842015|P1|Overall Study|Death|1
258534|NCT02557646|842015|P1|Overall Study|Adverse Event|40
258535|NCT02557399|842040|P2|Overall Study|Withdrawal by Subject|1
258536|NCT02557399|842041|P1|Overall Study|Withdrawal by Subject|1
258537|NCT02557399|842040|P2|Overall Study|Protocol-defined stopping criteria|1
258538|NCT02557399|842041|P1|Overall Study|Protocol-defined stopping criteria|0
258539|NCT02557399|842040|P2|Overall Study|Protocol Violation|1
258540|NCT02557399|842041|P1|Overall Study|Protocol Violation|0
258541|NCT02557399|842040|P2|Overall Study|Adverse Event|5
258542|NCT02557399|842041|P1|Overall Study|Adverse Event|6
258543|NCT02556632|842101|P3|Overall Study|Treatment or Change Delay|1
258544|NCT02556632|842102|P2|Overall Study|Treatment or Change Delay|0
258545|NCT02556632|842103|P1|Overall Study|Treatment or Change Delay|0
258546|NCT02556632|842101|P3|Overall Study|Disliked Study Procedures|1
258547|NCT02556632|842102|P2|Overall Study|Disliked Study Procedures|0
258548|NCT02556632|842103|P1|Overall Study|Disliked Study Procedures|0
258549|NCT02556632|842101|P3|Overall Study|Ineligible|0
258550|NCT02556632|842102|P2|Overall Study|Ineligible|1
258551|NCT02556632|842103|P1|Overall Study|Ineligible|0
258552|NCT02556632|842101|P3|Overall Study|Did Not Start RT|0
258553|NCT02556632|842102|P2|Overall Study|Did Not Start RT|1
258554|NCT02556632|842103|P1|Overall Study|Did Not Start RT|0
258555|NCT02556632|842101|P3|Overall Study|Possibly Related Adverse Event|1
258556|NCT02556632|842102|P2|Overall Study|Possibly Related Adverse Event|0
258557|NCT02556632|842103|P1|Overall Study|Possibly Related Adverse Event|0
258558|NCT02556632|842101|P3|Overall Study|Related Adverse Event|0
258559|NCT02556632|842102|P2|Overall Study|Related Adverse Event|1
258560|NCT02556632|842103|P1|Overall Study|Related Adverse Event|0
258561|NCT02556632|842101|P3|Overall Study|Unrelated Adverse Event|3
258562|NCT02556632|842102|P2|Overall Study|Unrelated Adverse Event|0
258563|NCT02556632|842103|P1|Overall Study|Unrelated Adverse Event|1
258564|NCT02556632|842101|P3|Overall Study|Withdrew (Unrelated Medical)|0
258565|NCT02556632|842102|P2|Overall Study|Withdrew (Unrelated Medical)|0
258566|NCT02556632|842103|P1|Overall Study|Withdrew (Unrelated Medical)|1
258567|NCT02556632|842101|P3|Overall Study|Changed Mind|0
258568|NCT02556632|842102|P2|Overall Study|Changed Mind|1
258569|NCT02556632|842103|P1|Overall Study|Changed Mind|0
258570|NCT02556632|842101|P3|Overall Study|Personal Issues|1
258571|NCT02556632|842102|P2|Overall Study|Personal Issues|1
258572|NCT02556632|842103|P1|Overall Study|Personal Issues|0
258573|NCT02556632|842101|P3|Overall Study|No Reason|1
258574|NCT02556632|842102|P2|Overall Study|No Reason|0
258575|NCT02556632|842103|P1|Overall Study|No Reason|1
258576|NCT02556632|842101|P3|Overall Study|Disliked Intervention|1
258577|NCT02556632|842102|P2|Overall Study|Disliked Intervention|1
258578|NCT02556632|842103|P1|Overall Study|Disliked Intervention|1
258579|NCT02556632|842101|P3|Overall Study|Lost to Follow-up|0
258580|NCT02556632|842102|P2|Overall Study|Lost to Follow-up|0
258581|NCT02556632|842103|P1|Overall Study|Lost to Follow-up|1
258582|NCT02556307|842121|P1|Overall Study|Enrolled but not treated|2
258583|NCT02556307|842121|P1|Overall Study|Change to triple therapy|4
258584|NCT02556307|842121|P1|Overall Study|Lost to Follow-up|36
258585|NCT02556307|842121|P1|Overall Study|Premature treatment interruption|11
258586|NCT02556138|842131|P1|Overall Study|Withdrawal by Subject|1
258587|NCT02555722|842139|P2|Month 2|Adverse Event|0
258588|NCT02555722|842140|P1|Month 2|Adverse Event|3
258589|NCT02555722|842139|P2|Month 1|Withdrawal by Subject|0
258590|NCT02555722|842140|P1|Month 1|Withdrawal by Subject|2
258591|NCT02555722|842139|P2|Week 2|Lens Discomfort|1
258592|NCT02555722|842140|P1|Week 2|Lens Discomfort|0
258593|NCT02555722|842139|P2|Week 1|Withdrawal by Subject|0
258594|NCT02555722|842140|P1|Week 1|Withdrawal by Subject|1
258595|NCT02555618|842307|P2|Overall Study|Sponsor's Circumstances|0
258596|NCT02555618|842308|P1|Overall Study|Sponsor's Circumstances|1
258597|NCT02554981|842365|P1|Overall Study|Other Miscellaneous Reasons|3
258598|NCT02554981|842365|P1|Overall Study|Administrative Reasons|1
258599|NCT02554981|842365|P1|Overall Study|Adverse Event|1
258600|NCT02554877|842393|P4|Overall Study|No longer willing to participate|0
258601|NCT02554877|842394|P3|Overall Study|No longer willing to participate|2
258602|NCT02554877|842395|P2|Overall Study|No longer willing to participate|2
258603|NCT02554877|842396|P1|Overall Study|No longer willing to participate|0
258604|NCT02554877|842393|P4|Overall Study|Insufficient clinical response|0
258605|NCT02554877|842394|P3|Overall Study|Insufficient clinical response|0
258606|NCT02554877|842395|P2|Overall Study|Insufficient clinical response|0
258607|NCT02554877|842396|P1|Overall Study|Insufficient clinical response|4
258608|NCT02554877|842393|P4|Overall Study|Other|3
258609|NCT02554877|842394|P3|Overall Study|Other|0
258610|NCT02554877|842395|P2|Overall Study|Other|3
258611|NCT02554877|842396|P1|Overall Study|Other|1
258612|NCT02554877|842393|P4|Overall Study|Protocol Violation|0
258613|NCT02554877|842394|P3|Overall Study|Protocol Violation|1
258614|NCT02554877|842395|P2|Overall Study|Protocol Violation|1
258615|NCT02554877|842396|P1|Overall Study|Protocol Violation|3
258616|NCT02554877|842393|P4|Overall Study|No longer met eligibility criteria|1
258617|NCT02554877|842394|P3|Overall Study|No longer met eligibility criteria|1
258618|NCT02554877|842395|P2|Overall Study|No longer met eligibility criteria|0
258619|NCT02554877|842396|P1|Overall Study|No longer met eligibility criteria|1
258620|NCT02554877|842393|P4|Overall Study|Did not meet entrance criteria|0
258621|NCT02554877|842394|P3|Overall Study|Did not meet entrance criteria|1
258622|NCT02554877|842395|P2|Overall Study|Did not meet entrance criteria|0
258623|NCT02554877|842396|P1|Overall Study|Did not meet entrance criteria|0
258624|NCT02554877|842393|P4|Overall Study|Lost to Follow-up|2
258625|NCT02554877|842394|P3|Overall Study|Lost to Follow-up|1
258626|NCT02554877|842395|P2|Overall Study|Lost to Follow-up|1
258627|NCT02554877|842396|P1|Overall Study|Lost to Follow-up|1
258628|NCT02554877|842393|P4|Overall Study|Adverse Event|1
258629|NCT02554877|842394|P3|Overall Study|Adverse Event|0
258630|NCT02554877|842395|P2|Overall Study|Adverse Event|0
258631|NCT02554877|842396|P1|Overall Study|Adverse Event|2
258632|NCT02554279|842460|P2|Overall Study|Other reason|6
258633|NCT02554279|842461|P1|Overall Study|Other reason|19
258634|NCT02554279|842460|P2|Overall Study|Protocol Violation|1
258635|NCT02554279|842461|P1|Overall Study|Protocol Violation|2
258636|NCT02554279|842460|P2|Overall Study|Withdrawal by Subject|4
258637|NCT02554279|842461|P1|Overall Study|Withdrawal by Subject|6
258638|NCT02554279|842460|P2|Overall Study|Lost to Follow-up|2
258639|NCT02554279|842461|P1|Overall Study|Lost to Follow-up|3
258640|NCT02554279|842460|P2|Overall Study|Adverse Event|5
258641|NCT02554279|842461|P1|Overall Study|Adverse Event|2
258642|NCT02553772|842495|P2|Overall Study|Other Miscellaneous Reasons|1
258643|NCT02553772|842496|P1|Overall Study|Other Miscellaneous Reasons|0
258644|NCT02553772|842495|P2|Overall Study|Lack of Efficacy|0
258645|NCT02553772|842496|P1|Overall Study|Lack of Efficacy|1
258646|NCT02553772|842495|P2|Overall Study|Withdrawal of Consent|1
258647|NCT02553772|842496|P1|Overall Study|Withdrawal of Consent|1
258648|NCT02553772|842495|P2|Overall Study|Lost to Follow-up|1
258649|NCT02553772|842496|P1|Overall Study|Lost to Follow-up|2
258650|NCT02553772|842495|P2|Overall Study|Adverse Event|3
258651|NCT02553772|842496|P1|Overall Study|Adverse Event|2
258652|NCT02553629|842512|P2|Overall Study|Logistic reasons|6
258653|NCT02553629|842513|P1|Overall Study|Logistic reasons|3
258654|NCT02553538|842529|P2|Overall Study|Died or Left Network|56
258655|NCT02553538|842530|P1|Overall Study|Died or Left Network|54
258656|NCT02553538|842529|P2|Overall Study|Could Not Reach by Telephone|0
258657|NCT02553538|842530|P1|Overall Study|Could Not Reach by Telephone|133
258658|NCT02553421|842552|P2|Overall Study|Improper Device Placement|0
258659|NCT02553421|842553|P1|Overall Study|Improper Device Placement|3
258660|NCT02553421|842552|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
258661|NCT02553421|842553|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
258662|NCT02553421|842552|P2|Overall Study|Lost to Follow-up|1
258663|NCT02553421|842553|P1|Overall Study|Lost to Follow-up|21
258664|NCT02552303|842584|P4|Follow-Up|ineligible|0
258665|NCT02552303|842585|P3|Follow-Up|ineligible|0
258666|NCT02552303|842586|P2|Follow-Up|ineligible|2
258667|NCT02552303|842587|P1|Follow-Up|ineligible|0
258668|NCT02552303|842584|P4|Follow-Up|Lost to Follow-up|0
258669|NCT02552303|842585|P3|Follow-Up|Lost to Follow-up|1
258670|NCT02552303|842586|P2|Follow-Up|Lost to Follow-up|0
258671|NCT02552303|842587|P1|Follow-Up|Lost to Follow-up|0
258672|NCT02552303|842584|P4|Allocation|ineligible|0
258673|NCT02552303|842585|P3|Allocation|ineligible|0
258674|NCT02552303|842586|P2|Allocation|ineligible|1
258675|NCT02552303|842587|P1|Allocation|ineligible|1
258676|NCT02552303|842584|P4|Allocation|Withdrawal by Subject|1
258677|NCT02552303|842585|P3|Allocation|Withdrawal by Subject|1
258678|NCT02552303|842586|P2|Allocation|Withdrawal by Subject|1
258679|NCT02552303|842587|P1|Allocation|Withdrawal by Subject|2
258680|NCT02550288|842644|P5|Overall Study|Withdrawal by Subject|0
258681|NCT02550288|842645|P4|Overall Study|Withdrawal by Subject|1
258682|NCT02550288|842646|P3|Overall Study|Withdrawal by Subject|0
258683|NCT02550288|842647|P2|Overall Study|Withdrawal by Subject|0
258684|NCT02550288|842648|P1|Overall Study|Withdrawal by Subject|0
258685|NCT02550288|842644|P5|Overall Study|Participant moved|0
258686|NCT02550288|842645|P4|Overall Study|Participant moved|1
258687|NCT02550288|842646|P3|Overall Study|Participant moved|0
258688|NCT02550288|842647|P2|Overall Study|Participant moved|0
258689|NCT02550288|842648|P1|Overall Study|Participant moved|0
258690|NCT02550288|842644|P5|Overall Study|Protocol Violation|3
258691|NCT02550288|842645|P4|Overall Study|Protocol Violation|0
258692|NCT02550288|842646|P3|Overall Study|Protocol Violation|1
258693|NCT02550288|842647|P2|Overall Study|Protocol Violation|2
258694|NCT02550288|842648|P1|Overall Study|Protocol Violation|2
258695|NCT02550288|842644|P5|Overall Study|Physician Decision|0
258696|NCT02550288|842645|P4|Overall Study|Physician Decision|1
258697|NCT02550288|842646|P3|Overall Study|Physician Decision|0
258698|NCT02550288|842647|P2|Overall Study|Physician Decision|0
258699|NCT02550288|842648|P1|Overall Study|Physician Decision|0
258700|NCT02550288|842644|P5|Overall Study|Adverse Event|0
258701|NCT02550288|842645|P4|Overall Study|Adverse Event|0
258702|NCT02550288|842646|P3|Overall Study|Adverse Event|0
258703|NCT02550288|842647|P2|Overall Study|Adverse Event|1
258704|NCT02550288|842648|P1|Overall Study|Adverse Event|0
258705|NCT02549573|842803|P2|Overall Study|Protocol Violation|1
258706|NCT02549573|842804|P1|Overall Study|Protocol Violation|0
258707|NCT02549573|842803|P2|Overall Study|Withdrawal by Subject|2
258708|NCT02549573|842804|P1|Overall Study|Withdrawal by Subject|0
258709|NCT02549027|842846|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
258710|NCT02549027|842847|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
258711|NCT02549027|842848|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
258712|NCT02549027|842849|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
258713|NCT02549027|842850|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
258714|NCT02549027|842851|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
258715|NCT02549027|842846|P6|Washout After Period 4|Withdrawal by Subject|0
258716|NCT02549027|842847|P5|Washout After Period 4|Withdrawal by Subject|0
258717|NCT02549027|842848|P4|Washout After Period 4|Withdrawal by Subject|1
258718|NCT02549027|842849|P3|Washout After Period 4|Withdrawal by Subject|1
258719|NCT02549027|842850|P2|Washout After Period 4|Withdrawal by Subject|1
258720|NCT02549027|842851|P1|Washout After Period 4|Withdrawal by Subject|0
258721|NCT02548455|842979|P1|Overall Study|Visit not completed|173
258722|NCT02548455|842979|P1|Overall Study|Lost to Follow-up|14
258723|NCT02548455|842979|P1|Overall Study|Death|26
258724|NCT02548455|842979|P1|Overall Study|Withdrawal by Subject|27
258725|NCT02548156|842983|P6|Washout Period 1|Lost to Follow-up|0
258726|NCT02548156|842984|P5|Washout Period 1|Lost to Follow-up|1
258727|NCT02548156|842985|P4|Washout Period 1|Lost to Follow-up|0
258728|NCT02548156|842986|P3|Washout Period 1|Lost to Follow-up|0
258729|NCT02548156|842987|P2|Washout Period 1|Lost to Follow-up|0
258730|NCT02548156|842988|P1|Washout Period 1|Lost to Follow-up|0
258731|NCT02548078|843007|P2|Overall Study|Lost to Follow-up|3
258732|NCT02548078|843008|P1|Overall Study|Lost to Follow-up|1
258733|NCT02548078|843007|P2|Overall Study|Moved from study area|3
258734|NCT02548078|843008|P1|Overall Study|Moved from study area|3
258735|NCT02548078|843007|P2|Overall Study|Serious adverse event/Adverse event|0
258736|NCT02548078|843008|P1|Overall Study|Serious adverse event/Adverse event|1
258737|NCT02547454|843239|P1|Overall Study|No data|11
258738|NCT02547454|843239|P1|Overall Study|Other|39
258739|NCT02547454|843239|P1|Overall Study|Lost to Follow-up|26
258740|NCT02547454|843239|P1|Overall Study|Death|38
258741|NCT02547454|843239|P1|Overall Study|Due to no further need to treat|4
258742|NCT02547454|843239|P1|Overall Study|Due to transplantation|1
258743|NCT02547454|843239|P1|Overall Study|Due to hemodialysis|53
258744|NCT02546986|843298|P2|Survival Follow-Up Phase|Lost to Follow-up|2
258745|NCT02546986|843299|P1|Survival Follow-Up Phase|Lost to Follow-up|2
258746|NCT02546986|843298|P2|Survival Follow-Up Phase|Alive|16
258747|NCT02546986|843299|P1|Survival Follow-Up Phase|Alive|13
258748|NCT02546986|843298|P2|Survival Follow-Up Phase|Death|12
258749|NCT02546986|843299|P1|Survival Follow-Up Phase|Death|18
258750|NCT02546986|843298|P2|Survival Follow-Up Phase|Missing Status|5
258751|NCT02546986|843299|P1|Survival Follow-Up Phase|Missing Status|3
258752|NCT02546986|843298|P2|Treatment Period|Miscellaneous|9
258753|NCT02546986|843299|P1|Treatment Period|Miscellaneous|7
258754|NCT02546986|843298|P2|Treatment Period|Study Terminated by Sponsor|1
258755|NCT02546986|843299|P1|Treatment Period|Study Terminated by Sponsor|0
258756|NCT02546986|843298|P2|Treatment Period|Non-compliance with Study Drug|1
258757|NCT02546986|843299|P1|Treatment Period|Non-compliance with Study Drug|0
258758|NCT02546986|843298|P2|Treatment Period|Withdrawal by Subject|1
258759|NCT02546986|843299|P1|Treatment Period|Withdrawal by Subject|1
258760|NCT02546986|843298|P2|Treatment Period|Protocol Violation|0
258761|NCT02546986|843299|P1|Treatment Period|Protocol Violation|1
258762|NCT02546986|843298|P2|Treatment Period|Physician Decision|2
258763|NCT02546986|843299|P1|Treatment Period|Physician Decision|1
258764|NCT02546986|843298|P2|Treatment Period|Death|4
258765|NCT02546986|843299|P1|Treatment Period|Death|3
258766|NCT02546986|843298|P2|Treatment Period|Symptomatic Deterioration|3
258767|NCT02546986|843299|P1|Treatment Period|Symptomatic Deterioration|4
258768|NCT02546986|843298|P2|Treatment Period|Adverse Event|6
258769|NCT02546986|843299|P1|Treatment Period|Adverse Event|14
258770|NCT02546986|843298|P2|Treatment Period|Progressive Disease|22
258771|NCT02546986|843299|P1|Treatment Period|Progressive Disease|20
258772|NCT02546609|843325|P3|Overall Study|travel or work schedule restriction|2
258773|NCT02546609|843326|P2|Overall Study|travel or work schedule restriction|0
258774|NCT02546609|843327|P1|Overall Study|travel or work schedule restriction|0
258775|NCT02546609|843325|P3|Overall Study|Lost to Follow-up|1
258776|NCT02546609|843326|P2|Overall Study|Lost to Follow-up|3
258777|NCT02546609|843327|P1|Overall Study|Lost to Follow-up|2
258778|NCT02546609|843325|P3|Overall Study|Protocol Violation|1
258779|NCT02546609|843326|P2|Overall Study|Protocol Violation|1
258780|NCT02546609|843327|P1|Overall Study|Protocol Violation|0
258781|NCT02546609|843325|P3|Overall Study|Adverse Event|1
258782|NCT02546609|843326|P2|Overall Study|Adverse Event|6
258783|NCT02546609|843327|P1|Overall Study|Adverse Event|0
258784|NCT02546609|843325|P3|Overall Study|Withdrawal by Subject|2
258785|NCT02546609|843326|P2|Overall Study|Withdrawal by Subject|1
258786|NCT02546609|843327|P1|Overall Study|Withdrawal by Subject|0
258787|NCT02545868|843371|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
258788|NCT02545868|843372|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
258789|NCT02545868|843373|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
258790|NCT02545543|843446|P2|Overall Study|Enrolment of subject at >1 study site|1
258791|NCT02545543|843447|P1|Overall Study|Enrolment of subject at >1 study site|1
258792|NCT02545543|843446|P2|Overall Study|Noncomplaince|0
258793|NCT02545543|843447|P1|Overall Study|Noncomplaince|1
258794|NCT02545543|843446|P2|Overall Study|Withdrawal by Subject|8
258795|NCT02545543|843447|P1|Overall Study|Withdrawal by Subject|9
258796|NCT02545543|843446|P2|Overall Study|Physician Decision|0
258797|NCT02545543|843447|P1|Overall Study|Physician Decision|3
258798|NCT02545543|843446|P2|Overall Study|Lost to Follow-up|25
258799|NCT02545543|843447|P1|Overall Study|Lost to Follow-up|67
258800|NCT02545322|843471|P1|Overall Study|Withdrawal by Subject|3
258801|NCT02544074|843527|P21|Overall Study|Tablet error|0
258802|NCT02544074|843528|P20|Overall Study|Tablet error|0
258803|NCT02544074|843529|P19|Overall Study|Tablet error|0
258804|NCT02544074|843530|P18|Overall Study|Tablet error|0
258805|NCT02544074|843531|P17|Overall Study|Tablet error|0
258806|NCT02544074|843532|P16|Overall Study|Tablet error|0
258807|NCT02544074|843533|P15|Overall Study|Tablet error|0
258808|NCT02544074|843534|P14|Overall Study|Tablet error|0
258809|NCT02544074|843535|P13|Overall Study|Tablet error|0
258810|NCT02544074|843536|P12|Overall Study|Tablet error|0
258811|NCT02544074|843537|P11|Overall Study|Tablet error|0
258812|NCT02544074|843538|P10|Overall Study|Tablet error|1
258813|NCT02544074|843539|P9|Overall Study|Tablet error|0
258814|NCT02544074|843540|P8|Overall Study|Tablet error|0
258815|NCT02544074|843541|P7|Overall Study|Tablet error|0
258816|NCT02544074|843542|P6|Overall Study|Tablet error|1
258817|NCT02544074|843543|P5|Overall Study|Tablet error|0
258818|NCT02544074|843544|P4|Overall Study|Tablet error|0
258819|NCT02544074|843545|P3|Overall Study|Tablet error|0
258820|NCT02544074|843546|P2|Overall Study|Tablet error|0
258821|NCT02544074|843547|P1|Overall Study|Tablet error|0
258822|NCT02544074|843527|P21|Overall Study|Withdrawal by Subject|0
258823|NCT02544074|843528|P20|Overall Study|Withdrawal by Subject|0
258824|NCT02544074|843529|P19|Overall Study|Withdrawal by Subject|0
258825|NCT02544074|843530|P18|Overall Study|Withdrawal by Subject|0
258826|NCT02544074|843531|P17|Overall Study|Withdrawal by Subject|0
258827|NCT02544074|843532|P16|Overall Study|Withdrawal by Subject|0
258828|NCT02544074|843533|P15|Overall Study|Withdrawal by Subject|0
258829|NCT02544074|843534|P14|Overall Study|Withdrawal by Subject|0
258830|NCT02544074|843535|P13|Overall Study|Withdrawal by Subject|0
258831|NCT02544074|843536|P12|Overall Study|Withdrawal by Subject|0
258832|NCT02544074|843537|P11|Overall Study|Withdrawal by Subject|0
258833|NCT02544074|843538|P10|Overall Study|Withdrawal by Subject|0
258834|NCT02544074|843539|P9|Overall Study|Withdrawal by Subject|0
258835|NCT02544074|843540|P8|Overall Study|Withdrawal by Subject|0
258836|NCT02544074|843541|P7|Overall Study|Withdrawal by Subject|0
258837|NCT02544074|843542|P6|Overall Study|Withdrawal by Subject|0
258838|NCT02544074|843543|P5|Overall Study|Withdrawal by Subject|0
258839|NCT02544074|843544|P4|Overall Study|Withdrawal by Subject|0
258840|NCT02544074|843545|P3|Overall Study|Withdrawal by Subject|0
258841|NCT02544074|843546|P2|Overall Study|Withdrawal by Subject|1
258842|NCT02544074|843547|P1|Overall Study|Withdrawal by Subject|0
258843|NCT02543918|843583|P2|Overall Study|Adverse Event|1
258844|NCT02543918|843584|P1|Overall Study|Adverse Event|1
258845|NCT02543918|843583|P2|Overall Study|Withdrawal by Subject|1
258846|NCT02543918|843584|P1|Overall Study|Withdrawal by Subject|1
258847|NCT02543918|843583|P2|Overall Study|Lost to Follow-up|1
258848|NCT02543918|843584|P1|Overall Study|Lost to Follow-up|1
258849|NCT02543918|843583|P2|Overall Study|Never treated|1
258850|NCT02543918|843584|P1|Overall Study|Never treated|0
258851|NCT02543528|843590|P5|Extended Wear Period|Withdrawal by Subject|0
258852|NCT02543528|843591|P4|Extended Wear Period|Withdrawal by Subject|5
258853|NCT02543528|843592|P3|Extended Wear Period|Withdrawal by Subject|10
258854|NCT02543528|843593|P2|Extended Wear Period|Withdrawal by Subject|9
258855|NCT02543528|843594|P1|Extended Wear Period|Withdrawal by Subject|4
258856|NCT02543528|843590|P5|Extended Wear Period|Lost to Follow-up|0
258857|NCT02543528|843591|P4|Extended Wear Period|Lost to Follow-up|1
258858|NCT02543528|843592|P3|Extended Wear Period|Lost to Follow-up|0
258859|NCT02543528|843593|P2|Extended Wear Period|Lost to Follow-up|1
258860|NCT02543528|843594|P1|Extended Wear Period|Lost to Follow-up|2
258861|NCT02543528|843590|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
258862|NCT02543528|843591|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
258863|NCT02543528|843592|P3|Extended Wear Period|Unsatisfactory Lens Fitting|1
258864|NCT02543528|843593|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
258865|NCT02543528|843594|P1|Extended Wear Period|Unsatisfactory Lens Fitting|0
258866|NCT02543528|843590|P5|Extended Wear Period|Missed too many scheduled visits|0
258867|NCT02543528|843591|P4|Extended Wear Period|Missed too many scheduled visits|3
258868|NCT02543528|843592|P3|Extended Wear Period|Missed too many scheduled visits|0
258869|NCT02543528|843593|P2|Extended Wear Period|Missed too many scheduled visits|0
258870|NCT02543528|843594|P1|Extended Wear Period|Missed too many scheduled visits|1
258871|NCT02543528|843590|P5|Extended Wear Period|Adverse Event|0
258872|NCT02543528|843591|P4|Extended Wear Period|Adverse Event|3
258873|NCT02543528|843592|P3|Extended Wear Period|Adverse Event|17
258874|NCT02543528|843593|P2|Extended Wear Period|Adverse Event|11
258875|NCT02543528|843594|P1|Extended Wear Period|Adverse Event|16
258876|NCT02543528|843590|P5|Adaptation Period|Adverse Event|2
258877|NCT02543528|843591|P4|Adaptation Period|Adverse Event|0
258878|NCT02543528|843592|P3|Adaptation Period|Adverse Event|0
258879|NCT02543528|843593|P2|Adaptation Period|Adverse Event|0
258880|NCT02543528|843594|P1|Adaptation Period|Adverse Event|0
258881|NCT02543528|843590|P5|Adaptation Period|Lost to Follow-up|14
258882|NCT02543528|843591|P4|Adaptation Period|Lost to Follow-up|0
258883|NCT02543528|843592|P3|Adaptation Period|Lost to Follow-up|0
258884|NCT02543528|843593|P2|Adaptation Period|Lost to Follow-up|0
258885|NCT02543528|843594|P1|Adaptation Period|Lost to Follow-up|0
258886|NCT02543528|843590|P5|Adaptation Period|Lens Handling Difficultes|8
258887|NCT02543528|843591|P4|Adaptation Period|Lens Handling Difficultes|0
258888|NCT02543528|843592|P3|Adaptation Period|Lens Handling Difficultes|0
258889|NCT02543528|843593|P2|Adaptation Period|Lens Handling Difficultes|0
258890|NCT02543528|843594|P1|Adaptation Period|Lens Handling Difficultes|0
258891|NCT02543528|843590|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
258892|NCT02543528|843591|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
258893|NCT02543528|843592|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
258894|NCT02543528|843593|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
258895|NCT02543528|843594|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
258896|NCT02542943|843630|P3|Overall Study|Withdrawal by Subject|0
258897|NCT02542943|843631|P2|Overall Study|Withdrawal by Subject|1
258898|NCT02542943|843632|P1|Overall Study|Withdrawal by Subject|0
258899|NCT02542943|843630|P3|Overall Study|Lost to Follow-up|0
258900|NCT02542943|843631|P2|Overall Study|Lost to Follow-up|0
258901|NCT02542943|843632|P1|Overall Study|Lost to Follow-up|1
258902|NCT02542072|843687|P2|Second Intervention (1 Month)|Lens discomfort|0
258903|NCT02542072|843688|P1|Second Intervention (1 Month)|Lens discomfort|1
258904|NCT02542072|843687|P2|Second Intervention (1 Month)|Lost to Follow-up|0
258905|NCT02542072|843688|P1|Second Intervention (1 Month)|Lost to Follow-up|1
258906|NCT02542072|843687|P2|First Intervention (1 Month)|Protocol Violation|0
258907|NCT02542072|843688|P1|First Intervention (1 Month)|Protocol Violation|1
258908|NCT02542072|843687|P2|First Intervention (1 Month)|Lens discomfort|2
258909|NCT02542072|843688|P1|First Intervention (1 Month)|Lens discomfort|1
258910|NCT02542072|843687|P2|First Intervention (1 Month)|Lost to Follow-up|0
258911|NCT02542072|843688|P1|First Intervention (1 Month)|Lost to Follow-up|2
258912|NCT02542072|843687|P2|First Intervention (1 Month)|Adverse Event|1
258913|NCT02542072|843688|P1|First Intervention (1 Month)|Adverse Event|1
258914|NCT02540850|843807|P3|Overall Study|Lost to Follow-up|34
258915|NCT02540850|843808|P2|Overall Study|Lost to Follow-up|66
258916|NCT02540850|843809|P1|Overall Study|Lost to Follow-up|69
258917|NCT02540356|843880|P2|Overall Study|Terminated due to disease progression|0
258918|NCT02540356|843881|P1|Overall Study|Terminated due to disease progression|1
258919|NCT02540265|843915|P3|Overall Study|Lost to Follow-up|1
258920|NCT02540265|843916|P2|Overall Study|Lost to Follow-up|0
258921|NCT02540265|843917|P1|Overall Study|Lost to Follow-up|0
258922|NCT02540213|843937|P1|Overall Study|Enrolled but not treated|2
258923|NCT02540213|843937|P1|Overall Study|Consent withdrawn|7
258924|NCT02540213|843937|P1|Overall Study|Lack of Efficacy|6
258925|NCT02540213|843937|P1|Overall Study|Kidney transplant|3
258926|NCT02540213|843937|P1|Overall Study|Administrative reasons|3
258927|NCT02540213|843937|P1|Overall Study|Death/adverse event|18
258928|NCT02539797|843989|P3|Overall Study|Lost to Follow-up|0
258929|NCT02539797|843990|P2|Overall Study|Lost to Follow-up|1
258930|NCT02539797|843991|P1|Overall Study|Lost to Follow-up|0
258931|NCT02539134|844008|P6|Overall Study|Lost to Follow-up|0
258932|NCT02539134|844009|P5|Overall Study|Lost to Follow-up|0
258933|NCT02539134|844010|P4|Overall Study|Lost to Follow-up|0
258934|NCT02539134|844011|P3|Overall Study|Lost to Follow-up|0
258935|NCT02539134|844012|P2|Overall Study|Lost to Follow-up|0
258936|NCT02539134|844013|P1|Overall Study|Lost to Follow-up|1
258937|NCT02538107|844095|P1|Overall Study|Not recorded|7
258938|NCT02538107|844095|P1|Overall Study|Other|7
258939|NCT02538107|844095|P1|Overall Study|Surgery|1
258940|NCT02538107|844095|P1|Overall Study|Adverse Event|4
258941|NCT02538107|844095|P1|Overall Study|Administrative reason|5
258942|NCT02538107|844095|P1|Overall Study|Death|4
258943|NCT02538107|844095|P1|Overall Study|Withdrawal by Subject|17
258944|NCT02538107|844095|P1|Overall Study|No further treatment necessary|18
258945|NCT02538107|844095|P1|Overall Study|Administration of other ESA|11
258946|NCT02538107|844095|P1|Overall Study|Necessity of dialysis|20
258947|NCT02538107|844095|P1|Overall Study|Missing|5
258948|NCT02538107|844095|P1|Overall Study|Did not receive any Mircera dose|11
258949|NCT02537522|844128|P4|Phase II - Period 1 Bilateral|Adverse Event|1
258950|NCT02537522|844129|P3|Phase II - Period 1 Bilateral|Adverse Event|0
258951|NCT02537522|844130|P2|Phase II - Period 1 Bilateral|Adverse Event|0
258952|NCT02537522|844131|P1|Phase II - Period 1 Bilateral|Adverse Event|0
258953|NCT02537522|844128|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
258954|NCT02537522|844129|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
258955|NCT02537522|844130|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
258956|NCT02537522|844131|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
258957|NCT02537522|844128|P4|Phase I - Contralateral|incorrect randomization|0
258958|NCT02537522|844129|P3|Phase I - Contralateral|incorrect randomization|0
258959|NCT02537522|844130|P2|Phase I - Contralateral|incorrect randomization|1
258960|NCT02537522|844131|P1|Phase I - Contralateral|incorrect randomization|0
258961|NCT02537522|844128|P4|Phase I - Contralateral|Withdrawal by Subject|0
258962|NCT02537522|844129|P3|Phase I - Contralateral|Withdrawal by Subject|0
258963|NCT02537522|844130|P2|Phase I - Contralateral|Withdrawal by Subject|1
258964|NCT02537522|844131|P1|Phase I - Contralateral|Withdrawal by Subject|0
258965|NCT02537522|844128|P4|Phase I - Contralateral|Subject no longer eligible|0
258966|NCT02537522|844129|P3|Phase I - Contralateral|Subject no longer eligible|0
258967|NCT02537522|844130|P2|Phase I - Contralateral|Subject no longer eligible|7
258968|NCT02537522|844131|P1|Phase I - Contralateral|Subject no longer eligible|15
258969|NCT02536781|844141|P2|Overall Study|Lost to Follow-up|0
258970|NCT02536781|844142|P1|Overall Study|Lost to Follow-up|2
258971|NCT02536664|844152|P2|Overall Study|Missing|20
258972|NCT02536664|844153|P1|Overall Study|Missing|53
258973|NCT02536664|844152|P2|Overall Study|Other|24
258974|NCT02536664|844153|P1|Overall Study|Other|18
258975|NCT02536664|844152|P2|Overall Study|Withdrawal by Subject|5
258976|NCT02536664|844153|P1|Overall Study|Withdrawal by Subject|8
258977|NCT02536664|844152|P2|Overall Study|Intolerability|6
258978|NCT02536664|844153|P1|Overall Study|Intolerability|8
258979|NCT02536664|844152|P2|Overall Study|Death due to other reason|2
258980|NCT02536664|844153|P1|Overall Study|Death due to other reason|3
258981|NCT02536664|844152|P2|Overall Study|Death due to lymphoma|1
258982|NCT02536664|844153|P1|Overall Study|Death due to lymphoma|2
258983|NCT02536664|844152|P2|Overall Study|Progression|18
258984|NCT02536664|844153|P1|Overall Study|Progression|13
258985|NCT02536664|844152|P2|Overall Study|Inadequate completion of documentation|4
258986|NCT02536664|844153|P1|Overall Study|Inadequate completion of documentation|2
258987|NCT02536313|844173|P2|Overall Study|Lack of Efficacy|1
258988|NCT02536313|844174|P1|Overall Study|Lack of Efficacy|0
258989|NCT02535741|844190|P1|Overall Study|Missing data|6
258990|NCT02535741|844190|P1|Overall Study|Exclusion criteria: Bilateral implant|4
258991|NCT02535741|844190|P1|Overall Study|Lost to Follow-up|10
258992|NCT02535741|844190|P1|Overall Study|Withdrawal by Subject|9
258993|NCT02535741|844190|P1|Overall Study|Adverse Event|3
258994|NCT02535416|844207|P9|Overall Study|Family bereavement overseas|0
258995|NCT02535416|844208|P8|Overall Study|Family bereavement overseas|0
258996|NCT02535416|844209|P7|Overall Study|Family bereavement overseas|0
258997|NCT02535416|844210|P6|Overall Study|Family bereavement overseas|0
258998|NCT02535416|844211|P5|Overall Study|Family bereavement overseas|0
258999|NCT02535416|844212|P4|Overall Study|Family bereavement overseas|0
259000|NCT02535416|844213|P3|Overall Study|Family bereavement overseas|0
259001|NCT02535416|844214|P2|Overall Study|Family bereavement overseas|0
259002|NCT02535416|844215|P1|Overall Study|Family bereavement overseas|1
259003|NCT02534935|844327|P3|Overall Study|Lost to Follow-up|1
259004|NCT02534935|844328|P2|Overall Study|Lost to Follow-up|1
259005|NCT02534935|844329|P1|Overall Study|Lost to Follow-up|0
259006|NCT02534935|844327|P3|Overall Study|Adverse Event|0
259007|NCT02534935|844328|P2|Overall Study|Adverse Event|2
259008|NCT02534935|844329|P1|Overall Study|Adverse Event|0
259009|NCT02534935|844327|P3|Overall Study|No longer meets the eligibility criteria|0
259010|NCT02534935|844328|P2|Overall Study|No longer meets the eligibility criteria|3
259011|NCT02534935|844329|P1|Overall Study|No longer meets the eligibility criteria|0
259012|NCT02534935|844327|P3|Overall Study|Withdrawal by Subject|3
259013|NCT02534935|844328|P2|Overall Study|Withdrawal by Subject|3
259014|NCT02534935|844329|P1|Overall Study|Withdrawal by Subject|0
259015|NCT02534935|844327|P3|Overall Study|No longer willing to participate|1
259016|NCT02534935|844328|P2|Overall Study|No longer willing to participate|1
259017|NCT02534935|844329|P1|Overall Study|No longer willing to participate|0
259018|NCT02534493|844487|P1|Overall Study|Withdrawal by Subject|1
259019|NCT02534493|844487|P1|Overall Study|Lost to Follow-up|1
259020|NCT02534324|844498|P2|Overall Study|Adverse Event|0
259021|NCT02534324|844499|P1|Overall Study|Adverse Event|1
259022|NCT02534324|844498|P2|Overall Study|Lost to Follow-up|7
259023|NCT02534324|844499|P1|Overall Study|Lost to Follow-up|20
259024|NCT02534324|844498|P2|Overall Study|Protocol Violation|1
259025|NCT02534324|844499|P1|Overall Study|Protocol Violation|4
259026|NCT02533999|844518|P2|Overall Study|Randomized but intervention not received|1
259027|NCT02533999|844519|P1|Overall Study|Randomized but intervention not received|0
259028|NCT02533999|844518|P2|Overall Study|Adverse Event|1
259029|NCT02533999|844519|P1|Overall Study|Adverse Event|0
259030|NCT02533999|844518|P2|Overall Study|Protocol Violation|0
259031|NCT02533999|844519|P1|Overall Study|Protocol Violation|3
259032|NCT02533999|844518|P2|Overall Study|Lost to Follow-up|5
259033|NCT02533999|844519|P1|Overall Study|Lost to Follow-up|3
259034|NCT02533570|844551|P3|Overall Study|Adverse Event|1
259035|NCT02533570|844552|P2|Overall Study|Adverse Event|1
259036|NCT02533570|844553|P1|Overall Study|Adverse Event|0
259037|NCT02533531|844564|P1|Overall Study|Device did not turn on|1
259038|NCT02533401|844596|P1|Overall Study|Violation of Selection Criteria|1
259039|NCT02533401|844596|P1|Overall Study|Lost to Follow-up|1
259040|NCT02533401|844596|P1|Overall Study|Insufficient Response/Progressed Disease|1
259041|NCT02533401|844596|P1|Overall Study|Death|5
259042|NCT02533401|844596|P1|Overall Study|Adverse Event/Intercurrent Disease|3
259043|NCT02533258|844604|P1|Overall Study|Lack of Efficacy|2
259044|NCT02533258|844604|P1|Overall Study|Progression of pleural effusion|1
259045|NCT02533258|844604|P1|Overall Study|Economic factor|1
259046|NCT02533258|844604|P1|Overall Study|Other|1
259047|NCT02533258|844604|P1|Overall Study|Death|2
259048|NCT02533258|844604|P1|Overall Study|Adverse Event|1
259049|NCT02532374|844698|P1|Overall Study|Physician Decision|1
259050|NCT02532374|844698|P1|Overall Study|Withdrawal by Subject|1
259051|NCT02532179|844722|P1|Overall Study|Subject received depot steroid injection|1
259052|NCT02532179|844722|P1|Overall Study|Pregnancy|1
259053|NCT02532179|844722|P1|Overall Study|Lost to Follow-up|1
259054|NCT02531698|844758|P2|Overall Study|Lost to Follow-up|0
259055|NCT02531698|844759|P1|Overall Study|Lost to Follow-up|1
259056|NCT02531698|844758|P2|Overall Study|Protocol Violation|0
259057|NCT02531698|844759|P1|Overall Study|Protocol Violation|2
259058|NCT02531698|844758|P2|Overall Study|Withdrawal by Subject|1
259059|NCT02531698|844759|P1|Overall Study|Withdrawal by Subject|6
259060|NCT02531698|844758|P2|Overall Study|Adverse Event|1
259061|NCT02531698|844759|P1|Overall Study|Adverse Event|2
259062|NCT02531646|845006|P3|Overall Study|equip. image processing issue|0
259063|NCT02531646|845007|P2|Overall Study|equip. image processing issue|1
259064|NCT02531646|845008|P1|Overall Study|equip. image processing issue|5
259065|NCT02531373|845031|P9|Overall Study|Withdrawal by Subject|0
259066|NCT02531373|845032|P8|Overall Study|Withdrawal by Subject|0
259067|NCT02531373|845033|P7|Overall Study|Withdrawal by Subject|0
259068|NCT02531373|845034|P6|Overall Study|Withdrawal by Subject|0
259069|NCT02531373|845035|P5|Overall Study|Withdrawal by Subject|3
259070|NCT02531373|845036|P4|Overall Study|Withdrawal by Subject|0
259071|NCT02531373|845037|P3|Overall Study|Withdrawal by Subject|0
259072|NCT02531373|845038|P2|Overall Study|Withdrawal by Subject|0
259073|NCT02531373|845039|P1|Overall Study|Withdrawal by Subject|0
259074|NCT02531373|845031|P9|Overall Study|Withdrawal by Parent/Guardian|3
259075|NCT02531373|845032|P8|Overall Study|Withdrawal by Parent/Guardian|1
259076|NCT02531373|845033|P7|Overall Study|Withdrawal by Parent/Guardian|4
259077|NCT02531373|845034|P6|Overall Study|Withdrawal by Parent/Guardian|3
259078|NCT02531373|845035|P5|Overall Study|Withdrawal by Parent/Guardian|0
259079|NCT02531373|845036|P4|Overall Study|Withdrawal by Parent/Guardian|0
259080|NCT02531373|845037|P3|Overall Study|Withdrawal by Parent/Guardian|0
259081|NCT02531373|845038|P2|Overall Study|Withdrawal by Parent/Guardian|0
259082|NCT02531373|845039|P1|Overall Study|Withdrawal by Parent/Guardian|0
259083|NCT02531373|845031|P9|Overall Study|Protocol Violation|1
259084|NCT02531373|845032|P8|Overall Study|Protocol Violation|0
259085|NCT02531373|845033|P7|Overall Study|Protocol Violation|1
259086|NCT02531373|845034|P6|Overall Study|Protocol Violation|1
259087|NCT02531373|845035|P5|Overall Study|Protocol Violation|0
259088|NCT02531373|845036|P4|Overall Study|Protocol Violation|0
259089|NCT02531373|845037|P3|Overall Study|Protocol Violation|0
259090|NCT02531373|845038|P2|Overall Study|Protocol Violation|0
259091|NCT02531373|845039|P1|Overall Study|Protocol Violation|0
259092|NCT02531373|845031|P9|Overall Study|Physician Decision|0
259093|NCT02531373|845032|P8|Overall Study|Physician Decision|0
259094|NCT02531373|845033|P7|Overall Study|Physician Decision|0
259095|NCT02531373|845034|P6|Overall Study|Physician Decision|1
259096|NCT02531373|845035|P5|Overall Study|Physician Decision|2
259097|NCT02531373|845036|P4|Overall Study|Physician Decision|0
259098|NCT02531373|845037|P3|Overall Study|Physician Decision|0
259099|NCT02531373|845038|P2|Overall Study|Physician Decision|0
259100|NCT02531373|845039|P1|Overall Study|Physician Decision|0
259101|NCT02531373|845031|P9|Overall Study|Lost to Follow-up|0
259102|NCT02531373|845032|P8|Overall Study|Lost to Follow-up|0
259103|NCT02531373|845033|P7|Overall Study|Lost to Follow-up|2
259104|NCT02531373|845034|P6|Overall Study|Lost to Follow-up|2
259105|NCT02531373|845035|P5|Overall Study|Lost to Follow-up|0
259106|NCT02531373|845036|P4|Overall Study|Lost to Follow-up|0
259107|NCT02531373|845037|P3|Overall Study|Lost to Follow-up|0
259108|NCT02531373|845038|P2|Overall Study|Lost to Follow-up|0
259109|NCT02531373|845039|P1|Overall Study|Lost to Follow-up|0
259110|NCT02531373|845031|P9|Overall Study|Lack of Efficacy|5
259111|NCT02531373|845032|P8|Overall Study|Lack of Efficacy|8
259112|NCT02531373|845033|P7|Overall Study|Lack of Efficacy|4
259113|NCT02531373|845034|P6|Overall Study|Lack of Efficacy|2
259114|NCT02531373|845035|P5|Overall Study|Lack of Efficacy|3
259115|NCT02531373|845036|P4|Overall Study|Lack of Efficacy|0
259116|NCT02531373|845037|P3|Overall Study|Lack of Efficacy|0
259117|NCT02531373|845038|P2|Overall Study|Lack of Efficacy|0
259118|NCT02531373|845039|P1|Overall Study|Lack of Efficacy|0
259119|NCT02530671|845102|P2|Overall Study|Withdrawal by Subject|0
259120|NCT02530671|845103|P1|Overall Study|Withdrawal by Subject|1
259121|NCT02530671|845102|P2|Overall Study|Lost to Follow-up|0
259122|NCT02530671|845103|P1|Overall Study|Lost to Follow-up|2
259123|NCT02530125|845128|P1|Followed for Survival for 2 Years|Early termination of study|3
259124|NCT02530125|845128|P1|Completed Treatment|Early termination of study|1
259125|NCT02529995|845142|P2|Part B|Discontinued Study|5
259126|NCT02529995|845143|P1|Part B|Discontinued Study|6
259127|NCT02529995|845142|P2|Part B|Ongoing Study at Data Cut-off|7
259128|NCT02529995|845143|P1|Part B|Ongoing Study at Data Cut-off|0
259129|NCT02529995|845142|P2|Part A|Discontinued Study|0
259130|NCT02529995|845143|P1|Part A|Discontinued Study|1
259131|NCT02529995|845142|P2|Part A|Ongoing Study at Data Cut-off|16
259132|NCT02529995|845143|P1|Part A|Ongoing Study at Data Cut-off|14
259133|NCT02529488|845177|P1|Overall Study|Death|3
259134|NCT02529488|845177|P1|Overall Study|Adverse Event|1
259135|NCT02528331|845202|P1|Overall Study|Withdrawal by Subject|2
259136|NCT02528305|845209|P1|Overall Study|Physician Decision|1
259137|NCT02528305|845209|P1|Overall Study|Adverse Event|1
259138|NCT02528305|845209|P1|Overall Study|Withdrawal by Subject|1
259139|NCT02527161|845262|P1|Overall Study|Consent violation|4
259140|NCT02527161|845262|P1|Overall Study|MRI contraindication|2
259141|NCT02527161|845262|P1|Overall Study|Delay in or unfit for surgery|5
259142|NCT02527161|845262|P1|Overall Study|Exclusion RA diagnosis|1
259143|NCT02527161|845262|P1|Overall Study|Exclusion for excessive deformity|1
259144|NCT02527161|845262|P1|Overall Study|Exclusion for BMI|2
259145|NCT02527161|845262|P1|Overall Study|Shape Match not used in surgery|2
259146|NCT02527161|845262|P1|Overall Study|Withdrawal by Subject|6
259147|NCT02527161|845262|P1|Overall Study|Failed MRI|39
259148|NCT02527148|845281|P2|Overall Study|Did not receive study intervention|0
259149|NCT02527148|845282|P1|Overall Study|Did not receive study intervention|1
259150|NCT02526550|845300|P1|Overall Study|Lost to Follow-up|1
259151|NCT02526524|845312|P6|Overall Study|Sponsor Decision|0
259152|NCT02526524|845313|P5|Overall Study|Sponsor Decision|0
259153|NCT02526524|845314|P4|Overall Study|Sponsor Decision|0
259154|NCT02526524|845315|P3|Overall Study|Sponsor Decision|0
259155|NCT02526524|845316|P2|Overall Study|Sponsor Decision|0
259156|NCT02526524|845317|P1|Overall Study|Sponsor Decision|1
259157|NCT02526524|845312|P6|Overall Study|Physician Decision|0
259158|NCT02526524|845313|P5|Overall Study|Physician Decision|1
259159|NCT02526524|845314|P4|Overall Study|Physician Decision|0
259160|NCT02526524|845315|P3|Overall Study|Physician Decision|0
259161|NCT02526524|845316|P2|Overall Study|Physician Decision|0
259162|NCT02526524|845317|P1|Overall Study|Physician Decision|0
259163|NCT02526524|845312|P6|Overall Study|Loss of Glucose Control|0
259164|NCT02526524|845313|P5|Overall Study|Loss of Glucose Control|2
259165|NCT02526524|845314|P4|Overall Study|Loss of Glucose Control|0
259166|NCT02526524|845315|P3|Overall Study|Loss of Glucose Control|3
259167|NCT02526524|845316|P2|Overall Study|Loss of Glucose Control|0
259168|NCT02526524|845317|P1|Overall Study|Loss of Glucose Control|0
259169|NCT02526524|845312|P6|Overall Study|Protocol Violation|3
259170|NCT02526524|845313|P5|Overall Study|Protocol Violation|4
259171|NCT02526524|845314|P4|Overall Study|Protocol Violation|3
259172|NCT02526524|845315|P3|Overall Study|Protocol Violation|5
259173|NCT02526524|845316|P2|Overall Study|Protocol Violation|1
259174|NCT02526524|845317|P1|Overall Study|Protocol Violation|3
259175|NCT02526524|845312|P6|Overall Study|Lost to Follow-up|5
259176|NCT02526524|845313|P5|Overall Study|Lost to Follow-up|2
259177|NCT02526524|845314|P4|Overall Study|Lost to Follow-up|1
259178|NCT02526524|845315|P3|Overall Study|Lost to Follow-up|8
259179|NCT02526524|845316|P2|Overall Study|Lost to Follow-up|3
259180|NCT02526524|845317|P1|Overall Study|Lost to Follow-up|2
259181|NCT02526524|845312|P6|Overall Study|Adverse Event|8
259182|NCT02526524|845313|P5|Overall Study|Adverse Event|6
259183|NCT02526524|845314|P4|Overall Study|Adverse Event|2
259184|NCT02526524|845315|P3|Overall Study|Adverse Event|4
259185|NCT02526524|845316|P2|Overall Study|Adverse Event|2
259186|NCT02526524|845317|P1|Overall Study|Adverse Event|3
259187|NCT02526524|845312|P6|Overall Study|Withdrawal by Subject|5
259188|NCT02526524|845313|P5|Overall Study|Withdrawal by Subject|9
259189|NCT02526524|845314|P4|Overall Study|Withdrawal by Subject|1
259190|NCT02526524|845315|P3|Overall Study|Withdrawal by Subject|6
259191|NCT02526524|845316|P2|Overall Study|Withdrawal by Subject|3
259192|NCT02526524|845317|P1|Overall Study|Withdrawal by Subject|3
259193|NCT02526290|845331|P1|Overall Study|Physician Decision|1
259194|NCT02526290|845331|P1|Overall Study|Withdrawal by Subject|4
259195|NCT02526290|845331|P1|Overall Study|Adverse Event|3
259196|NCT02525094|845416|P2|Overall Study|Not Treated|1
259197|NCT02525094|845417|P1|Overall Study|Not Treated|1
259198|NCT02525094|845416|P2|Overall Study|Withdrawal by Subject|6
259199|NCT02525094|845417|P1|Overall Study|Withdrawal by Subject|5
259200|NCT02525094|845416|P2|Overall Study|Lost to Follow-up|1
259201|NCT02525094|845417|P1|Overall Study|Lost to Follow-up|2
259202|NCT02524665|845444|P1|Overall Study|Lost to Follow-up|1
259203|NCT02524288|845495|P1|Overall Study|Physician Decision|2
259204|NCT02524288|845495|P1|Overall Study|Pregnancy|22
259205|NCT02524288|845495|P1|Overall Study|Withdrawal by Subject|76
259206|NCT02524288|845495|P1|Overall Study|Subject Moved|32
259207|NCT02524288|845495|P1|Overall Study|Study Terminated By Sponsor|1417
259208|NCT02524288|845495|P1|Overall Study|Site Discontinued Study Participation|1
259209|NCT02524288|845495|P1|Overall Study|Screen Failure|2
259210|NCT02524288|845495|P1|Overall Study|Protocol Violation|6
259211|NCT02524288|845495|P1|Overall Study|Pregnancy Wish|6
259212|NCT02524288|845495|P1|Overall Study|Non-Compliance With Study Drug|14
259213|NCT02524288|845495|P1|Overall Study|Non-Compliance With Protocol|32
259214|NCT02524288|845495|P1|Overall Study|Lost to Follow-up|216
259215|NCT02524288|845495|P1|Overall Study|Adverse Event|115
259216|NCT02524158|845505|P2|6-month Assessment|Lost to Follow-up|20
259217|NCT02524158|845506|P1|6-month Assessment|Lost to Follow-up|21
259218|NCT02524158|845505|P2|6-month Assessment|Withdrawal by Subject|1
259219|NCT02524158|845506|P1|6-month Assessment|Withdrawal by Subject|1
259220|NCT02524158|845505|P2|12-weeks Assessment|Lost to Follow-up|12
259221|NCT02524158|845506|P1|12-weeks Assessment|Lost to Follow-up|18
259222|NCT02524158|845505|P2|12-weeks Assessment|Withdrawal by Subject|1
259223|NCT02524158|845506|P1|12-weeks Assessment|Withdrawal by Subject|1
259224|NCT02522624|845535|P2|Overall Study|Technical failure|0
259225|NCT02522624|845536|P1|Overall Study|Technical failure|1
259226|NCT02520726|845554|P2|Overall Study|Lost to Follow-up|2
259227|NCT02520726|845555|P1|Overall Study|Lost to Follow-up|3
259228|NCT02519855|845569|P2|Overall Study|Lost to Follow-up|3
259229|NCT02519855|845570|P1|Overall Study|Lost to Follow-up|3
259230|NCT02519855|845569|P2|Overall Study|Adverse Event|1
259231|NCT02519855|845570|P1|Overall Study|Adverse Event|0
259232|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
259233|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
259234|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
259235|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
259236|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
259237|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
259238|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
259239|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
259240|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
259241|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
259242|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
259243|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
259244|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Death|1
259245|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Death|0
259246|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Death|0
259247|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
259248|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
259249|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
259250|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
259251|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
259252|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
259253|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Adverse Event|1
259254|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Adverse Event|0
259255|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Adverse Event|0
259256|NCT02519842|845588|P3|Optional Extension: Cycles 2-6|Physician Decision|5
259257|NCT02519842|845589|P2|Optional Extension: Cycles 2-6|Physician Decision|0
259258|NCT02519842|845590|P1|Optional Extension: Cycles 2-6|Physician Decision|0
259259|NCT02519842|845588|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
259260|NCT02519842|845589|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
259261|NCT02519842|845590|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
259262|NCT02519842|845588|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
259263|NCT02519842|845589|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
259264|NCT02519842|845590|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
259265|NCT02519842|845588|P3|Base Study: Cycle 1|Adverse Event|0
259266|NCT02519842|845589|P2|Base Study: Cycle 1|Adverse Event|0
259267|NCT02519842|845590|P1|Base Study: Cycle 1|Adverse Event|1
259268|NCT02519842|845588|P3|Base Study: Cycle 1|Screening Failure|0
259269|NCT02519842|845589|P2|Base Study: Cycle 1|Screening Failure|1
259270|NCT02519842|845590|P1|Base Study: Cycle 1|Screening Failure|1
259271|NCT02519712|845609|P1|Overall Study|Accruals are donors|2
259272|NCT02519712|845609|P1|Overall Study|Disease Progression|1
259273|NCT02519712|845609|P1|Overall Study|Disease Relapse|1
259274|NCT02519595|845616|P3|Overall Study|Protocol Violation|16
259275|NCT02519595|845617|P2|Overall Study|Protocol Violation|22
259276|NCT02519595|845618|P1|Overall Study|Protocol Violation|8
259277|NCT02518048|845649|P1|Overall Study|Withdrawal by Subject|1
259278|NCT02517515|845678|P2|Overall Study|Not Specified|0
259279|NCT02517515|845679|P1|Overall Study|Not Specified|1
259280|NCT02517515|845678|P2|Overall Study|Lost to Follow-up|0
259281|NCT02517515|845679|P1|Overall Study|Lost to Follow-up|1
259282|NCT02517515|845678|P2|Overall Study|Withdrew Consent|1
259283|NCT02517515|845679|P1|Overall Study|Withdrew Consent|0
259284|NCT02517515|845678|P2|Overall Study|Adverse Event|1
259285|NCT02517515|845679|P1|Overall Study|Adverse Event|0
259286|NCT02516410|845730|P2|Overall Study|Withdrawal by Subject|1
259287|NCT02516410|845731|P1|Overall Study|Withdrawal by Subject|0
259288|NCT02516410|845730|P2|Overall Study|Adverse Event|1
259289|NCT02516410|845731|P1|Overall Study|Adverse Event|0
259290|NCT02516306|845760|P2|Period 2: Day 8 - 91|Protocol Violation|2
259291|NCT02516306|845761|P1|Period 2: Day 8 - 91|Protocol Violation|1
259292|NCT02516163|845767|P1|Overall Study|MRI contraindication exclusion|6
259293|NCT02516163|845767|P1|Overall Study|Data not recorded|2
259294|NCT02516163|845767|P1|Overall Study|Use of incorrect measurement technique|5
259295|NCT02516163|845767|P1|Overall Study|Unfit/delay in surgery|3
259296|NCT02516163|845767|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
259297|NCT02516163|845767|P1|Overall Study|Withdrawal by Subject|1
259298|NCT02516098|845781|P2|Period 2|Withdrawal by Subject|1
259299|NCT02516098|845782|P1|Period 2|Withdrawal by Subject|0
259300|NCT02516098|845781|P2|Washout After Period 1|Adverse Event|1
259301|NCT02516098|845782|P1|Washout After Period 1|Adverse Event|0
259302|NCT02516098|845781|P2|Period 1|Protocol Violation|0
259303|NCT02516098|845782|P1|Period 1|Protocol Violation|1
259304|NCT02515994|845796|P2|Overall Study|Withdrawal by Subject|0
259305|NCT02515994|845797|P1|Overall Study|Withdrawal by Subject|2
259306|NCT02515994|845796|P2|Overall Study|Adverse Event|1
259307|NCT02515994|845797|P1|Overall Study|Adverse Event|3
259308|NCT02515994|845796|P2|Overall Study|No Longer Meets Eligibility Criteria|1
259309|NCT02515994|845797|P1|Overall Study|No Longer Meets Eligibility Criteria|2
259310|NCT02515994|845796|P2|Overall Study|Protocol Violation|5
259311|NCT02515994|845797|P1|Overall Study|Protocol Violation|3
259312|NCT02515279|845824|P1|Overall Study|Other|22
259313|NCT02515279|845824|P1|Overall Study|End-of-treatment visit not attended|17
259314|NCT02515279|845824|P1|Overall Study|Withdrawal by Subject|18
259315|NCT02515279|845824|P1|Overall Study|Lost to Follow-up|9
259316|NCT02515279|845824|P1|Overall Study|Lack of Efficacy|31
259317|NCT02515279|845824|P1|Overall Study|Adverse Event|7
259318|NCT02515045|845843|P3|Overall Study|Lost to Follow-up|1
259319|NCT02515045|845844|P2|Overall Study|Lost to Follow-up|1
259320|NCT02515045|845845|P1|Overall Study|Lost to Follow-up|0
259321|NCT02515045|845843|P3|Overall Study|Adverse Event|3
259322|NCT02515045|845844|P2|Overall Study|Adverse Event|3
259323|NCT02515045|845845|P1|Overall Study|Adverse Event|0
259324|NCT02514772|845882|P2|Overall Study|Withdrawal by Subject|1
259325|NCT02514772|845883|P1|Overall Study|Withdrawal by Subject|2
259326|NCT02514772|845882|P2|Overall Study|Death|1
259327|NCT02514772|845883|P1|Overall Study|Death|0
259328|NCT02514772|845882|P2|Overall Study|Adverse Event|0
259329|NCT02514772|845883|P1|Overall Study|Adverse Event|1
259330|NCT02514473|845897|P2|Overall Study|Other|1
259331|NCT02514473|845898|P1|Overall Study|Other|1
259332|NCT02514473|845897|P2|Overall Study|Lost to Follow-up|1
259333|NCT02514473|845898|P1|Overall Study|Lost to Follow-up|0
259334|NCT02514473|845897|P2|Overall Study|Withdrawal by Subject|1
259335|NCT02514473|845898|P1|Overall Study|Withdrawal by Subject|2
259336|NCT02514473|845897|P2|Overall Study|Adverse Event|2
259337|NCT02514473|845898|P1|Overall Study|Adverse Event|0
259338|NCT02513771|845941|P2|Overall Study|Not being able to get to clinic|0
259339|NCT02513771|845942|P1|Overall Study|Not being able to get to clinic|1
259340|NCT02513771|845941|P2|Overall Study|Lost to Follow-up|1
259341|NCT02513771|845942|P1|Overall Study|Lost to Follow-up|1
259342|NCT02513550|845981|P3|Overall Study|Death|2
259343|NCT02513550|845982|P2|Overall Study|Death|0
259344|NCT02513550|845983|P1|Overall Study|Death|1
259345|NCT02513550|845981|P3|Overall Study|Due to personal business|1
259346|NCT02513550|845982|P2|Overall Study|Due to personal business|0
259347|NCT02513550|845983|P1|Overall Study|Due to personal business|2
259348|NCT02513550|845981|P3|Overall Study|Met exclusion criteria and was not dosed|1
259349|NCT02513550|845982|P2|Overall Study|Met exclusion criteria and was not dosed|0
259350|NCT02513550|845983|P1|Overall Study|Met exclusion criteria and was not dosed|0
259351|NCT02513550|845981|P3|Overall Study|Site terminated by sponsor|3
259352|NCT02513550|845982|P2|Overall Study|Site terminated by sponsor|1
259353|NCT02513550|845983|P1|Overall Study|Site terminated by sponsor|1
259354|NCT02513550|845981|P3|Overall Study|Physician Decision|4
259355|NCT02513550|845982|P2|Overall Study|Physician Decision|0
259356|NCT02513550|845983|P1|Overall Study|Physician Decision|2
259357|NCT02513550|845981|P3|Overall Study|Protocol Violation|4
259358|NCT02513550|845982|P2|Overall Study|Protocol Violation|1
259359|NCT02513550|845983|P1|Overall Study|Protocol Violation|1
259360|NCT02513550|845981|P3|Overall Study|Lack of Efficacy|6
259361|NCT02513550|845982|P2|Overall Study|Lack of Efficacy|5
259362|NCT02513550|845983|P1|Overall Study|Lack of Efficacy|4
259363|NCT02513550|845981|P3|Overall Study|Lost to Follow-up|11
259364|NCT02513550|845982|P2|Overall Study|Lost to Follow-up|7
259365|NCT02513550|845983|P1|Overall Study|Lost to Follow-up|9
259366|NCT02513550|845981|P3|Overall Study|Adverse Event|17
259367|NCT02513550|845982|P2|Overall Study|Adverse Event|13
259368|NCT02513550|845983|P1|Overall Study|Adverse Event|5
259369|NCT02513550|845981|P3|Overall Study|Withdrawal by Subject|25
259370|NCT02513550|845982|P2|Overall Study|Withdrawal by Subject|11
259371|NCT02513550|845983|P1|Overall Study|Withdrawal by Subject|11
259372|NCT02513160|846050|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
259373|NCT02513160|846051|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
259374|NCT02513160|846052|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
259375|NCT02513160|846053|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
259376|NCT02513160|846050|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
259377|NCT02513160|846051|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
259378|NCT02513160|846052|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
259379|NCT02513160|846053|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
259380|NCT02513160|846050|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
259381|NCT02513160|846051|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
259382|NCT02513160|846052|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
259383|NCT02513160|846053|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
259384|NCT02513160|846050|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
259385|NCT02513160|846051|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
259386|NCT02513160|846052|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
259387|NCT02513160|846053|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
259388|NCT02513160|846050|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
259389|NCT02513160|846051|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
259390|NCT02513160|846052|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
259391|NCT02513160|846053|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
259392|NCT02513160|846050|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
259393|NCT02513160|846051|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
259394|NCT02513160|846052|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
259395|NCT02513160|846053|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
259396|NCT02513160|846050|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
259397|NCT02513160|846051|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
259398|NCT02513160|846052|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
259399|NCT02513160|846053|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
259400|NCT02513160|846050|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
259401|NCT02513160|846051|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
259402|NCT02513160|846052|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
259403|NCT02513160|846053|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
259404|NCT02513160|846050|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
259405|NCT02513160|846051|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
259406|NCT02513160|846052|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
259407|NCT02513160|846053|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
259408|NCT02513160|846050|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
259409|NCT02513160|846051|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
259410|NCT02513160|846052|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
259411|NCT02513160|846053|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
259412|NCT02513160|846050|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
259413|NCT02513160|846051|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
259414|NCT02513160|846052|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
259415|NCT02513160|846053|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
259416|NCT02513160|846050|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
259417|NCT02513160|846051|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
259418|NCT02513160|846052|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
259419|NCT02513160|846053|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
259420|NCT02513095|846090|P2|Overall Study|Stampede resulted in transfers out of ER|16
259421|NCT02513095|846091|P1|Overall Study|Stampede resulted in transfers out of ER|14
259422|NCT02511782|846260|P3|Overall Study|Withdrawal by Subject|0
259423|NCT02511782|846261|P2|Overall Study|Withdrawal by Subject|0
259424|NCT02511782|846262|P1|Overall Study|Withdrawal by Subject|1
259425|NCT02511431|846291|P6|Treatment|Lost to Follow-up|1
259426|NCT02511431|846292|P5|Treatment|Lost to Follow-up|0
259427|NCT02511431|846293|P4|Treatment|Lost to Follow-up|0
259428|NCT02511431|846294|P3|Treatment|Lost to Follow-up|1
259429|NCT02511431|846295|P2|Treatment|Lost to Follow-up|0
259430|NCT02511431|846296|P1|Treatment|Lost to Follow-up|0
259431|NCT02510820|846316|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
259432|NCT02510820|846317|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
259433|NCT02510820|846316|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
259434|NCT02510820|846317|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
259435|NCT02510014|846357|P2|Treatment Period|Incarceration, pregnancy, misc|5
259436|NCT02510014|846358|P1|Treatment Period|Incarceration, pregnancy, misc|29
259437|NCT02510014|846357|P2|Treatment Period|Protocol Violation|4
259438|NCT02510014|846358|P1|Treatment Period|Protocol Violation|4
259439|NCT02510014|846357|P2|Treatment Period|Withdrawn by the investigator|1
259440|NCT02510014|846358|P1|Treatment Period|Withdrawn by the investigator|7
259441|NCT02510014|846357|P2|Treatment Period|Withdrawal by Subject|24
259442|NCT02510014|846358|P1|Treatment Period|Withdrawal by Subject|67
259443|NCT02510014|846357|P2|Treatment Period|Physician Decision|0
259444|NCT02510014|846358|P1|Treatment Period|Physician Decision|5
259445|NCT02510014|846357|P2|Treatment Period|Lost to Follow-up|19
259446|NCT02510014|846358|P1|Treatment Period|Lost to Follow-up|80
259447|NCT02510014|846357|P2|Treatment Period|Withdrawal symptoms|0
259448|NCT02510014|846358|P1|Treatment Period|Withdrawal symptoms|3
259449|NCT02510014|846357|P2|Treatment Period|Adverse Event|4
259450|NCT02510014|846358|P1|Treatment Period|Adverse Event|11
259451|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Not specified|1
259452|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Not specified|19
259453|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
259454|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
259455|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
259456|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
259457|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
259458|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
259459|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
259460|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
259461|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
259462|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
259463|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
259464|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
259465|NCT02510014|846357|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
259466|NCT02510014|846358|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
259467|NCT02508194|846380|P2|Overall Study|Principal Investigator Decision|2
259468|NCT02508194|846381|P1|Overall Study|Principal Investigator Decision|1
259469|NCT02508194|846380|P2|Overall Study|Error in Randomization|3
259470|NCT02508194|846381|P1|Overall Study|Error in Randomization|1
259471|NCT02508194|846380|P2|Overall Study|Withdrawal by Subject|18
259472|NCT02508194|846381|P1|Overall Study|Withdrawal by Subject|20
259473|NCT02508194|846380|P2|Overall Study|Lost to Follow-up|18
259474|NCT02508194|846381|P1|Overall Study|Lost to Follow-up|25
259475|NCT02508194|846380|P2|Overall Study|Death|3
259476|NCT02508194|846381|P1|Overall Study|Death|5
259477|NCT02507752|846430|P1|Overall Study|Participant didn't perform visit Week 24|1
259478|NCT02507752|846430|P1|Overall Study|Participant didn't perform visit Week 12|1
259479|NCT02507752|846430|P1|Overall Study|Infusion reaction at first infusion|1
259480|NCT02507752|846430|P1|Overall Study|Lost to Follow-up|7
259481|NCT02507752|846430|P1|Overall Study|Protocol Violation|6
259482|NCT02507752|846430|P1|Overall Study|Adverse Event|1
259483|NCT02507375|846474|P2|Overall Study|Adverse Event|1
259484|NCT02507375|846475|P1|Overall Study|Adverse Event|0
259485|NCT02507375|846474|P2|Overall Study|Refused treatment|1
259486|NCT02507375|846475|P1|Overall Study|Refused treatment|0
259487|NCT02507375|846474|P2|Overall Study|Death|1
259488|NCT02507375|846475|P1|Overall Study|Death|0
259489|NCT02507375|846474|P2|Overall Study|Progressive Disease|5
259490|NCT02507375|846475|P1|Overall Study|Progressive Disease|4
259491|NCT02507219|846492|P6|Overall Study|Withdrawal by Subject|0
259492|NCT02507219|846493|P5|Overall Study|Withdrawal by Subject|1
259493|NCT02507219|846494|P4|Overall Study|Withdrawal by Subject|0
259494|NCT02507219|846495|P3|Overall Study|Withdrawal by Subject|0
259495|NCT02507219|846496|P2|Overall Study|Withdrawal by Subject|0
259496|NCT02507219|846497|P1|Overall Study|Withdrawal by Subject|0
259497|NCT02507219|846492|P6|Overall Study|Physician Decision|0
259498|NCT02507219|846493|P5|Overall Study|Physician Decision|0
259499|NCT02507219|846494|P4|Overall Study|Physician Decision|0
259500|NCT02507219|846495|P3|Overall Study|Physician Decision|0
259501|NCT02507219|846496|P2|Overall Study|Physician Decision|0
259502|NCT02507219|846497|P1|Overall Study|Physician Decision|1
259503|NCT02506881|846509|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
259504|NCT02506881|846510|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
259505|NCT02506881|846511|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
259506|NCT02506881|846512|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
259507|NCT02506881|846509|P4|First Intervention (Day 1)|Withdrawal by Subject|0
259508|NCT02506881|846510|P3|First Intervention (Day 1)|Withdrawal by Subject|0
259509|NCT02506881|846511|P2|First Intervention (Day 1)|Withdrawal by Subject|0
259510|NCT02506881|846512|P1|First Intervention (Day 1)|Withdrawal by Subject|1
259511|NCT02506881|846509|P4|First Intervention (Day 1)|Protocol Violation|0
259512|NCT02506881|846510|P3|First Intervention (Day 1)|Protocol Violation|1
259513|NCT02506881|846511|P2|First Intervention (Day 1)|Protocol Violation|0
259514|NCT02506881|846512|P1|First Intervention (Day 1)|Protocol Violation|0
259515|NCT02506257|846565|P4|Overall Study|Protocol Violation|0
259516|NCT02506257|846566|P3|Overall Study|Protocol Violation|1
259517|NCT02506257|846567|P2|Overall Study|Protocol Violation|0
259518|NCT02506257|846568|P1|Overall Study|Protocol Violation|0
259519|NCT02506257|846565|P4|Overall Study|Adverse Event|0
259520|NCT02506257|846566|P3|Overall Study|Adverse Event|3
259521|NCT02506257|846567|P2|Overall Study|Adverse Event|2
259522|NCT02506257|846568|P1|Overall Study|Adverse Event|0
259523|NCT02506101|846600|P2|Overall Study|No enrollment and staff unavailability|0
259524|NCT02506101|846601|P1|Overall Study|No enrollment and staff unavailability|1
259525|NCT02506101|846600|P2|Overall Study|Transportation issues|0
259526|NCT02506101|846601|P1|Overall Study|Transportation issues|1
259527|NCT02505334|846617|P2|Extension Treatment Period|Unclassified|0
259528|NCT02505334|846618|P1|Extension Treatment Period|Unclassified|3
259529|NCT02505334|846617|P2|Extension Treatment Period|Withdrawal by Subject|0
259530|NCT02505334|846618|P1|Extension Treatment Period|Withdrawal by Subject|6
259531|NCT02505334|846617|P2|Extension Treatment Period|Lack of Efficacy|0
259532|NCT02505334|846618|P1|Extension Treatment Period|Lack of Efficacy|4
259533|NCT02505334|846617|P2|Extension Treatment Period|Adverse Event|0
259534|NCT02505334|846618|P1|Extension Treatment Period|Adverse Event|5
259535|NCT02505334|846617|P2|Main Treatment Period|Unclassified|10
259536|NCT02505334|846618|P1|Main Treatment Period|Unclassified|4
259537|NCT02505334|846617|P2|Main Treatment Period|Withdrawal by Subject|8
259538|NCT02505334|846618|P1|Main Treatment Period|Withdrawal by Subject|1
259539|NCT02505334|846617|P2|Main Treatment Period|Protocol Violation|1
259540|NCT02505334|846618|P1|Main Treatment Period|Protocol Violation|0
259541|NCT02505334|846617|P2|Main Treatment Period|Lack of Efficacy|17
259542|NCT02505334|846618|P1|Main Treatment Period|Lack of Efficacy|7
259543|NCT02505334|846617|P2|Main Treatment Period|Adverse Event|3
259544|NCT02505334|846618|P1|Main Treatment Period|Adverse Event|3
259545|NCT02504541|846727|P1|Overall Study|Multiple|5
259546|NCT02504541|846727|P1|Overall Study|Other|2
259547|NCT02504541|846727|P1|Overall Study|Termination by Sponsor|1
259548|NCT02504541|846727|P1|Overall Study|Protocol Violation|2
259549|NCT02504541|846727|P1|Overall Study|Met Stopping Criteria|1
259550|NCT02504541|846727|P1|Overall Study|Lost to Follow-up|1
259551|NCT02504541|846727|P1|Overall Study|Withdrawal by Subject|4
259552|NCT02504541|846727|P1|Overall Study|Adverse Event|4
259553|NCT02504502|846733|P2|Crossover to Enhanced Report|Lost to Follow-up|0
259554|NCT02504502|846734|P1|Crossover to Enhanced Report|Lost to Follow-up|5
259555|NCT02504502|846733|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
259556|NCT02504502|846734|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
259557|NCT02504320|846744|P4|Treatment Period 3|Adverse Event|0
259558|NCT02504320|846745|P3|Treatment Period 3|Adverse Event|1
259559|NCT02504320|846746|P2|Treatment Period 3|Adverse Event|0
259560|NCT02504320|846747|P1|Treatment Period 3|Adverse Event|0
259561|NCT02504320|846744|P4|Treatment Period 3|Positive Drug Screen|1
259562|NCT02504320|846745|P3|Treatment Period 3|Positive Drug Screen|0
259563|NCT02504320|846746|P2|Treatment Period 3|Positive Drug Screen|0
259564|NCT02504320|846747|P1|Treatment Period 3|Positive Drug Screen|0
259565|NCT02504320|846744|P4|Treatment Period 2|Positive Drug Screen|0
259566|NCT02504320|846745|P3|Treatment Period 2|Positive Drug Screen|0
259567|NCT02504320|846746|P2|Treatment Period 2|Positive Drug Screen|1
259568|NCT02504320|846747|P1|Treatment Period 2|Positive Drug Screen|0
259569|NCT02504320|846744|P4|Treatment Period 1|Positive Drug Screen|0
259570|NCT02504320|846745|P3|Treatment Period 1|Positive Drug Screen|1
259571|NCT02504320|846746|P2|Treatment Period 1|Positive Drug Screen|0
259572|NCT02504320|846747|P1|Treatment Period 1|Positive Drug Screen|0
259573|NCT02504294|846767|P2|Overall Study|Lost to Follow-up|7
259574|NCT02504294|846768|P1|Overall Study|Lost to Follow-up|6
259575|NCT02504294|846767|P2|Overall Study|Physician Decision|2
259576|NCT02504294|846768|P1|Overall Study|Physician Decision|1
259577|NCT02504294|846767|P2|Overall Study|Protocol Violation|26
259578|NCT02504294|846768|P1|Overall Study|Protocol Violation|27
259579|NCT02504294|846767|P2|Overall Study|Withdrawal by Subject|1
259580|NCT02504294|846768|P1|Overall Study|Withdrawal by Subject|7
259581|NCT02504294|846767|P2|Overall Study|Adverse Event|12
259582|NCT02504294|846768|P1|Overall Study|Adverse Event|15
259583|NCT02503865|846797|P3|Overall Study|Refused treatment|2
259584|NCT02503865|846798|P2|Overall Study|Refused treatment|39
259585|NCT02503865|846799|P1|Overall Study|Refused treatment|4
259586|NCT02503865|846797|P3|Overall Study|Moved out of area|0
259587|NCT02503865|846798|P2|Overall Study|Moved out of area|8
259588|NCT02503865|846799|P1|Overall Study|Moved out of area|1
259589|NCT02503787|846819|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
259590|NCT02503787|846819|P1|Implant to 3 Month Endpoint|Adverse Event|2
259591|NCT02503787|846819|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
259592|NCT02503787|846819|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
259593|NCT02503787|846819|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
259594|NCT02503787|846819|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
259595|NCT02503787|846819|P1|Enrollment|Unable to be programmed|1
259596|NCT02503787|846819|P1|Enrollment|Inability to implant system|1
259597|NCT02503787|846819|P1|Enrollment|Protocol Violation|1
259598|NCT02503787|846819|P1|Enrollment|Adverse Event|1
259599|NCT02503787|846819|P1|Enrollment|Study closure|1
259600|NCT02503787|846819|P1|Enrollment|Lost to Follow-up|1
259601|NCT02503787|846819|P1|Enrollment|Insurance issue|2
259602|NCT02503787|846819|P1|Enrollment|Physician Decision|2
259603|NCT02503787|846819|P1|Enrollment|Inclusion/exclusion criteria not met|4
259604|NCT02503787|846819|P1|Enrollment|Withdrawal by Subject|6
259605|NCT02503215|846842|P1|Overall Study|Unable to use positive airway pressure|2
259606|NCT02503215|846842|P1|Overall Study|Unable to wear compression stockings|1
259607|NCT02503085|846848|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
259608|NCT02503085|846849|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
259609|NCT02503085|846850|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
259610|NCT02503085|846851|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
259611|NCT02502734|846890|P2|Washout Period|Adverse Event|0
259612|NCT02502734|846891|P1|Washout Period|Adverse Event|1
259613|NCT02502734|846890|P2|Double-blind Treatment Period 1|Adverse Event|0
259614|NCT02502734|846891|P1|Double-blind Treatment Period 1|Adverse Event|1
259615|NCT02502526|846902|P3|Overall Study|Enrollment suspension|1
259616|NCT02502526|846903|P2|Overall Study|Enrollment suspension|1
259617|NCT02502526|846904|P1|Overall Study|Enrollment suspension|4
259618|NCT02502526|846902|P3|Overall Study|Disqualified due to cataract grading|1
259619|NCT02502526|846903|P2|Overall Study|Disqualified due to cataract grading|0
259620|NCT02502526|846904|P1|Overall Study|Disqualified due to cataract grading|0
259621|NCT02502526|846902|P3|Overall Study|Withdrawal by Subject|1
259622|NCT02502526|846903|P2|Overall Study|Withdrawal by Subject|1
259623|NCT02502526|846904|P1|Overall Study|Withdrawal by Subject|0
259624|NCT02502526|846902|P3|Overall Study|Lost to Follow-up|3
259625|NCT02502526|846903|P2|Overall Study|Lost to Follow-up|2
259626|NCT02502526|846904|P1|Overall Study|Lost to Follow-up|2
259627|NCT02502149|846990|P5|Intermediate|Discontinued prematurely|0
259628|NCT02502149|846991|P4|Intermediate|Discontinued prematurely|0
259629|NCT02502149|846992|P3|Intermediate|Discontinued prematurely|0
259630|NCT02502149|846993|P2|Intermediate|Discontinued prematurely|0
259631|NCT02502149|846994|P1|Intermediate|Discontinued prematurely|1
259632|NCT02500758|847138|P2|Second Intervention (2 Minutes)|Protocol Violation|1
259633|NCT02500758|847139|P1|Second Intervention (2 Minutes)|Protocol Violation|1
259634|NCT02500758|847138|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
259635|NCT02500758|847139|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
259636|NCT02500758|847138|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
259637|NCT02500758|847139|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
259638|NCT02500758|847138|P2|Washout (1 Week)|Lost to Follow-up|2
259639|NCT02500758|847139|P1|Washout (1 Week)|Lost to Follow-up|2
259640|NCT02500758|847138|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
259641|NCT02500758|847139|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
259642|NCT02500537|847162|P2|Overall Study|Withdrawal by Subject|0
259643|NCT02500537|847163|P1|Overall Study|Withdrawal by Subject|1
259644|NCT02500537|847162|P2|Overall Study|Lost to Follow-up|1
259645|NCT02500537|847163|P1|Overall Study|Lost to Follow-up|0
259646|NCT02500537|847162|P2|Overall Study|Death|0
259647|NCT02500537|847163|P1|Overall Study|Death|2
259648|NCT02500056|847232|P2|Overall Study|Death|1
259649|NCT02500056|847233|P1|Overall Study|Death|3
259650|NCT02500056|847232|P2|Overall Study|Recurrence|0
259651|NCT02500056|847233|P1|Overall Study|Recurrence|1
259652|NCT02500056|847232|P2|Overall Study|Lost to Follow-up|7
259653|NCT02500056|847233|P1|Overall Study|Lost to Follow-up|3
259654|NCT02499952|847243|P1|Overall Study|Death|9
259655|NCT02499952|847243|P1|Overall Study|Lost to Follow-up|1
259656|NCT02499575|847261|P2|Overall Study|Protocol Violation|1
259657|NCT02499575|847262|P1|Overall Study|Protocol Violation|0
259658|NCT02498821|847274|P2|Overall Study|Screen failure|5
259659|NCT02498821|847275|P1|Overall Study|Screen failure|3
259660|NCT02498678|847304|P2|Overall Study|interference from the surgical team|2
259661|NCT02498678|847305|P1|Overall Study|interference from the surgical team|0
259662|NCT02498652|847321|P2|Overall Study|Protocol Violation|1
259663|NCT02498652|847322|P1|Overall Study|Protocol Violation|0
259664|NCT02497976|847432|P2|Overall Study|Moved out of area|1
259665|NCT02497976|847433|P1|Overall Study|Moved out of area|0
259666|NCT02497976|847432|P2|Overall Study|Withdrawal by Subject|0
259667|NCT02497976|847433|P1|Overall Study|Withdrawal by Subject|2
259668|NCT02497781|847451|P2|Overall Study|Lost to Follow-up|1
259669|NCT02497781|847452|P1|Overall Study|Lost to Follow-up|1
259670|NCT02497781|847451|P2|Overall Study|Randomised but not treated|1
259671|NCT02497781|847452|P1|Overall Study|Randomised but not treated|1
259672|NCT02497781|847451|P2|Overall Study|Lack of Efficacy|1
259673|NCT02497781|847452|P1|Overall Study|Lack of Efficacy|0
259674|NCT02497781|847451|P2|Overall Study|Withdrawal by Subject|0
259675|NCT02497781|847452|P1|Overall Study|Withdrawal by Subject|2
259676|NCT02497755|847515|P2|Overall Study|Protocol Violation|0
259677|NCT02497755|847516|P1|Overall Study|Protocol Violation|1
259678|NCT02496533|847583|P2|Overall Study|Late for radiologic testing|2
259679|NCT02496533|847584|P1|Overall Study|Late for radiologic testing|0
259680|NCT02496533|847583|P2|Overall Study|Patient did not complete all measures|4
259681|NCT02496533|847584|P1|Overall Study|Patient did not complete all measures|0
259682|NCT02496533|847583|P2|Overall Study|Lack of data on outcome|0
259683|NCT02496533|847584|P1|Overall Study|Lack of data on outcome|3
259684|NCT02496221|847596|P2|Treatment Period 2 - 4 Days|Physician Decision|0
259685|NCT02496221|847597|P1|Treatment Period 2 - 4 Days|Physician Decision|1
259686|NCT02496221|847596|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
259687|NCT02496221|847597|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
259688|NCT02496221|847596|P2|Treatment Period 2 - 4 Days|Adverse Event|1
259689|NCT02496221|847597|P1|Treatment Period 2 - 4 Days|Adverse Event|0
259690|NCT02496039|847631|P1|Overall Study|Protocol Violation|1
259691|NCT02496039|847631|P1|Overall Study|Adverse Event|3
259692|NCT02496000|847646|P3|Overall Study|undetermined|0
259693|NCT02496000|847647|P2|Overall Study|undetermined|1
259694|NCT02496000|847648|P1|Overall Study|undetermined|0
259695|NCT02496000|847646|P3|Overall Study|Non-compliance or lack of cooperation|0
259696|NCT02496000|847647|P2|Overall Study|Non-compliance or lack of cooperation|2
259697|NCT02496000|847648|P1|Overall Study|Non-compliance or lack of cooperation|0
259698|NCT02496000|847646|P3|Overall Study|Protocol Violation|1
259699|NCT02496000|847647|P2|Overall Study|Protocol Violation|0
259700|NCT02496000|847648|P1|Overall Study|Protocol Violation|0
259701|NCT02496000|847646|P3|Overall Study|Lost to Follow-up|1
259702|NCT02496000|847647|P2|Overall Study|Lost to Follow-up|0
259703|NCT02496000|847648|P1|Overall Study|Lost to Follow-up|1
259704|NCT02496000|847646|P3|Overall Study|Withdrawal by Subject|0
259705|NCT02496000|847647|P2|Overall Study|Withdrawal by Subject|2
259706|NCT02496000|847648|P1|Overall Study|Withdrawal by Subject|1
259707|NCT02495948|847657|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
259708|NCT02495948|847658|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
259709|NCT02495948|847657|P2|Period 1, First 30 Days of Wear|Adverse Event|1
259710|NCT02495948|847658|P1|Period 1, First 30 Days of Wear|Adverse Event|0
259711|NCT02494596|847733|P3|Overall Study|Refused Treatment|0
259712|NCT02494596|847734|P2|Overall Study|Refused Treatment|1
259713|NCT02494596|847735|P1|Overall Study|Refused Treatment|0
259714|NCT02494596|847733|P3|Overall Study|Adverse Event|0
259715|NCT02494596|847734|P2|Overall Study|Adverse Event|1
259716|NCT02494596|847735|P1|Overall Study|Adverse Event|0
259717|NCT02494596|847733|P3|Overall Study|Insufficient Therapeutic Response|1
259718|NCT02494596|847734|P2|Overall Study|Insufficient Therapeutic Response|3
259719|NCT02494596|847735|P1|Overall Study|Insufficient Therapeutic Response|3
259720|NCT02493855|847787|P3|Overall Study|Withdrawal by Subject|0
259721|NCT02493855|847788|P2|Overall Study|Withdrawal by Subject|0
259722|NCT02493855|847789|P1|Overall Study|Withdrawal by Subject|1
259723|NCT02493855|847787|P3|Overall Study|Adverse Event|0
259724|NCT02493855|847788|P2|Overall Study|Adverse Event|1
259725|NCT02493855|847789|P1|Overall Study|Adverse Event|0
259726|NCT02493855|847787|P3|Overall Study|Non-compliance|0
259727|NCT02493855|847788|P2|Overall Study|Non-compliance|0
259728|NCT02493855|847789|P1|Overall Study|Non-compliance|1
259729|NCT02493127|847799|P2|Overall Study|Lost to Follow-up|1
259730|NCT02493127|847800|P1|Overall Study|Lost to Follow-up|1
259731|NCT02492984|847833|P2|Overall Study|Withdrawal by Subject|0
259732|NCT02492984|847834|P1|Overall Study|Withdrawal by Subject|1
259733|NCT02492984|847833|P2|Overall Study|Protocol Violation|0
259734|NCT02492984|847834|P1|Overall Study|Protocol Violation|1
259735|NCT02492984|847833|P2|Overall Study|Adverse Event|0
259736|NCT02492984|847834|P1|Overall Study|Adverse Event|1
259737|NCT02492841|847857|P3|Overall Study|Lost to Follow-up|35
259738|NCT02492841|847858|P2|Overall Study|Lost to Follow-up|31
259739|NCT02492841|847859|P1|Overall Study|Lost to Follow-up|34
259740|NCT02492763|847874|P4|Overall Study|Study Terminated by Sponsor|10
259741|NCT02492763|847875|P3|Overall Study|Study Terminated by Sponsor|6
259742|NCT02492763|847876|P2|Overall Study|Study Terminated by Sponsor|10
259743|NCT02492763|847877|P1|Overall Study|Study Terminated by Sponsor|13
259744|NCT02492763|847874|P4|Overall Study|Screen Failure|1
259745|NCT02492763|847875|P3|Overall Study|Screen Failure|0
259746|NCT02492763|847876|P2|Overall Study|Screen Failure|0
259747|NCT02492763|847877|P1|Overall Study|Screen Failure|0
259748|NCT02492763|847874|P4|Overall Study|Non-Compliance With Study Drug|0
259749|NCT02492763|847875|P3|Overall Study|Non-Compliance With Study Drug|0
259750|NCT02492763|847876|P2|Overall Study|Non-Compliance With Study Drug|1
259751|NCT02492763|847877|P1|Overall Study|Non-Compliance With Study Drug|0
259752|NCT02492763|847874|P4|Overall Study|Lost to Follow-up|0
259753|NCT02492763|847875|P3|Overall Study|Lost to Follow-up|1
259754|NCT02492763|847876|P2|Overall Study|Lost to Follow-up|0
259755|NCT02492763|847877|P1|Overall Study|Lost to Follow-up|0
259756|NCT02492763|847874|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
259757|NCT02492763|847875|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
259758|NCT02492763|847876|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
259759|NCT02492763|847877|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
259760|NCT02492763|847874|P4|Overall Study|Death|0
259761|NCT02492763|847875|P3|Overall Study|Death|1
259762|NCT02492763|847876|P2|Overall Study|Death|0
259763|NCT02492763|847877|P1|Overall Study|Death|0
259764|NCT02492763|847874|P4|Overall Study|Adverse Event|2
259765|NCT02492763|847875|P3|Overall Study|Adverse Event|1
259766|NCT02492763|847876|P2|Overall Study|Adverse Event|1
259767|NCT02492763|847877|P1|Overall Study|Adverse Event|3
259768|NCT02492763|847874|P4|Overall Study|Withdrawal by Subject|0
259769|NCT02492763|847875|P3|Overall Study|Withdrawal by Subject|1
259770|NCT02492763|847876|P2|Overall Study|Withdrawal by Subject|2
259771|NCT02492763|847877|P1|Overall Study|Withdrawal by Subject|0
259772|NCT02492165|847948|P4|Overall Study|Withdrawal by Subject|0
259773|NCT02492165|847949|P3|Overall Study|Withdrawal by Subject|0
259774|NCT02492165|847950|P2|Overall Study|Withdrawal by Subject|1
259775|NCT02492165|847951|P1|Overall Study|Withdrawal by Subject|0
259776|NCT02491892|847995|P2|Overall Study|Lost to Follow-up|0
259777|NCT02491892|847996|P1|Overall Study|Lost to Follow-up|1
259778|NCT02491892|847995|P2|Overall Study|Refused Treatment|0
259779|NCT02491892|847996|P1|Overall Study|Refused Treatment|1
259780|NCT02491892|847995|P2|Overall Study|Lack of Efficacy|36
259781|NCT02491892|847996|P1|Overall Study|Lack of Efficacy|37
259782|NCT02491892|847995|P2|Overall Study|Death|1
259783|NCT02491892|847996|P1|Overall Study|Death|1
259784|NCT02491892|847995|P2|Overall Study|Adverse Event|1
259785|NCT02491892|847996|P1|Overall Study|Adverse Event|1
259786|NCT02491073|848042|P2|Overall Study|screen failure|0
259787|NCT02491073|848043|P1|Overall Study|screen failure|1
259788|NCT02490475|848084|P4|Period 2: Extension Phase|Adverse Event|0
259789|NCT02490475|848085|P3|Period 2: Extension Phase|Adverse Event|1
259790|NCT02490475|848086|P2|Period 2: Extension Phase|Adverse Event|0
259791|NCT02490475|848087|P1|Period 2: Extension Phase|Adverse Event|0
259792|NCT02490475|848084|P4|Period 2: Extension Phase|Refused Treatment|1
259793|NCT02490475|848085|P3|Period 2: Extension Phase|Refused Treatment|0
259794|NCT02490475|848086|P2|Period 2: Extension Phase|Refused Treatment|0
259795|NCT02490475|848087|P1|Period 2: Extension Phase|Refused Treatment|0
259796|NCT02490475|848084|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
259797|NCT02490475|848085|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
259798|NCT02490475|848086|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
259799|NCT02490475|848087|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
259800|NCT02490475|848084|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
259801|NCT02490475|848085|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
259802|NCT02490475|848086|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
259803|NCT02490475|848087|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
259804|NCT02490475|848084|P4|Period 1: First 6 Cycles|Refused Treatment|0
259805|NCT02490475|848085|P3|Period 1: First 6 Cycles|Refused Treatment|0
259806|NCT02490475|848086|P2|Period 1: First 6 Cycles|Refused Treatment|0
259807|NCT02490475|848087|P1|Period 1: First 6 Cycles|Refused Treatment|1
259808|NCT02490475|848084|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
259809|NCT02490475|848085|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
259810|NCT02490475|848086|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
259811|NCT02490475|848087|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
259812|NCT02490475|848084|P4|Period 1: First 6 Cycles|Adverse Event|1
259813|NCT02490475|848085|P3|Period 1: First 6 Cycles|Adverse Event|0
259814|NCT02490475|848086|P2|Period 1: First 6 Cycles|Adverse Event|1
259815|NCT02490475|848087|P1|Period 1: First 6 Cycles|Adverse Event|2
259816|NCT02489799|848176|P2|Overall Study|Death|1
259817|NCT02489799|848177|P1|Overall Study|Death|0
259818|NCT02489799|848176|P2|Overall Study|Withdrawal by Subject|1
259819|NCT02489799|848177|P1|Overall Study|Withdrawal by Subject|1
259820|NCT02489799|848176|P2|Overall Study|Failure to Maintain Eligibility|6
259821|NCT02489799|848177|P1|Overall Study|Failure to Maintain Eligibility|4
259822|NCT02489799|848176|P2|Overall Study|Lost to Follow-up|1
259823|NCT02489799|848177|P1|Overall Study|Lost to Follow-up|4
259824|NCT02488980|848204|P3|Overall Study|Protocol Violation|2
259825|NCT02488980|848205|P2|Overall Study|Protocol Violation|2
259826|NCT02488980|848206|P1|Overall Study|Protocol Violation|2
259827|NCT02488681|848223|P1|Overall Study|Implant unsuccessful|7
259828|NCT02487771|848258|P2|Overall Study|Withdrawal by Subject|5
259829|NCT02487771|848259|P1|Overall Study|Withdrawal by Subject|3
259830|NCT02487771|848258|P2|Overall Study|Moved out of area|6
259831|NCT02487771|848259|P1|Overall Study|Moved out of area|5
259832|NCT02487771|848258|P2|Overall Study|Lost to Follow-up|3
259833|NCT02487771|848259|P1|Overall Study|Lost to Follow-up|2
259834|NCT02487498|848409|P2|Period: Period 2|Physician Decision|0
259835|NCT02487498|848410|P1|Period: Period 2|Physician Decision|1
259836|NCT02487498|848409|P2|Period: Period 2|Death|1
259837|NCT02487498|848410|P1|Period: Period 2|Death|0
259838|NCT02487498|848409|P2|Period: Period 2|Lost to Follow-up|1
259839|NCT02487498|848410|P1|Period: Period 2|Lost to Follow-up|1
259840|NCT02487498|848409|P2|Period: Period 2|Subject/guardian decision|1
259841|NCT02487498|848410|P1|Period: Period 2|Subject/guardian decision|2
259842|NCT02487498|848409|P2|Period: Period 2|Adverse Event|2
259843|NCT02487498|848410|P1|Period: Period 2|Adverse Event|2
259844|NCT02487498|848409|P2|Period: Washout|Non-compliance with study treatment|1
259845|NCT02487498|848410|P1|Period: Washout|Non-compliance with study treatment|0
259846|NCT02487498|848409|P2|Period: Washout|Physician Decision|0
259847|NCT02487498|848410|P1|Period: Washout|Physician Decision|1
259848|NCT02487498|848409|P2|Period: Washout|Lack of Efficacy|1
259849|NCT02487498|848410|P1|Period: Washout|Lack of Efficacy|1
259850|NCT02487498|848409|P2|Period: Washout|Subject/guardian decision|5
259851|NCT02487498|848410|P1|Period: Washout|Subject/guardian decision|0
259852|NCT02487498|848409|P2|Period: Period 1|Protocol deviation|0
259853|NCT02487498|848410|P1|Period: Period 1|Protocol deviation|1
259854|NCT02487498|848409|P2|Period: Period 1|Physician Decision|1
259855|NCT02487498|848410|P1|Period: Period 1|Physician Decision|0
259856|NCT02487498|848409|P2|Period: Period 1|Lack of Efficacy|0
259857|NCT02487498|848410|P1|Period: Period 1|Lack of Efficacy|1
259858|NCT02487498|848409|P2|Period: Period 1|Lost to Follow-up|2
259859|NCT02487498|848410|P1|Period: Period 1|Lost to Follow-up|0
259860|NCT02487498|848409|P2|Period: Period 1|Subject/guardian decision|4
259861|NCT02487498|848410|P1|Period: Period 1|Subject/guardian decision|2
259862|NCT02487498|848409|P2|Period: Period 1|Adverse Event|4
259863|NCT02487498|848410|P1|Period: Period 1|Adverse Event|2
259864|NCT02487446|848433|P2|Period 2|Adverse Event|2
259865|NCT02487446|848434|P1|Period 2|Adverse Event|6
259866|NCT02487446|848433|P2|Period 2|Withdrawal by Subject|1
259867|NCT02487446|848434|P1|Period 2|Withdrawal by Subject|1
259868|NCT02487446|848433|P2|Period 2|Lost to Follow-up|1
259869|NCT02487446|848434|P1|Period 2|Lost to Follow-up|1
259870|NCT02487446|848433|P2|Period 2|Protocol deviation|1
259871|NCT02487446|848434|P1|Period 2|Protocol deviation|0
259872|NCT02487446|848433|P2|Washout|Adverse Event|2
259873|NCT02487446|848434|P1|Washout|Adverse Event|2
259874|NCT02487446|848433|P2|Washout|Withdrawal by Subject|4
259875|NCT02487446|848434|P1|Washout|Withdrawal by Subject|1
259876|NCT02487446|848433|P2|Washout|Lost to Follow-up|2
259877|NCT02487446|848434|P1|Washout|Lost to Follow-up|0
259878|NCT02487446|848433|P2|Period 1|Adverse Event|5
259879|NCT02487446|848434|P1|Period 1|Adverse Event|5
259880|NCT02487446|848433|P2|Period 1|Withdrawal by Subject|0
259881|NCT02487446|848434|P1|Period 1|Withdrawal by Subject|2
259882|NCT02487446|848433|P2|Period 1|Lost to Follow-up|0
259883|NCT02487446|848434|P1|Period 1|Lost to Follow-up|2
259884|NCT02487446|848433|P2|Period 1|Protocol deviation|2
259885|NCT02487446|848434|P1|Period 1|Protocol deviation|3
259886|NCT02487446|848433|P2|Period 1|Lack of Efficacy|0
259887|NCT02487446|848434|P1|Period 1|Lack of Efficacy|1
259888|NCT02487446|848433|P2|Period 1|Physician Decision|1
259889|NCT02487446|848434|P1|Period 1|Physician Decision|0
259890|NCT02487199|848459|P2|Overall Study|Withdrew Consent|1
259891|NCT02487199|848460|P1|Overall Study|Withdrew Consent|0
259892|NCT02487030|848479|P7|Overall Study|Death|0
259893|NCT02487030|848480|P6|Overall Study|Death|0
259894|NCT02487030|848481|P5|Overall Study|Death|1
259895|NCT02487030|848482|P4|Overall Study|Death|0
259896|NCT02487030|848483|P3|Overall Study|Death|0
259897|NCT02487030|848484|P2|Overall Study|Death|0
259898|NCT02487030|848485|P1|Overall Study|Death|0
259899|NCT02487030|848479|P7|Overall Study|Adverse Event|0
259900|NCT02487030|848480|P6|Overall Study|Adverse Event|0
259901|NCT02487030|848481|P5|Overall Study|Adverse Event|0
259902|NCT02487030|848482|P4|Overall Study|Adverse Event|1
259903|NCT02487030|848483|P3|Overall Study|Adverse Event|0
259904|NCT02487030|848484|P2|Overall Study|Adverse Event|0
259905|NCT02487030|848485|P1|Overall Study|Adverse Event|0
259906|NCT02487030|848479|P7|Overall Study|Lost to Follow-up|0
259907|NCT02487030|848480|P6|Overall Study|Lost to Follow-up|1
259908|NCT02487030|848481|P5|Overall Study|Lost to Follow-up|0
259909|NCT02487030|848482|P4|Overall Study|Lost to Follow-up|1
259910|NCT02487030|848483|P3|Overall Study|Lost to Follow-up|1
259911|NCT02487030|848484|P2|Overall Study|Lost to Follow-up|0
259912|NCT02487030|848485|P1|Overall Study|Lost to Follow-up|0
259913|NCT02487030|848479|P7|Overall Study|Lack of Efficacy|0
259914|NCT02487030|848480|P6|Overall Study|Lack of Efficacy|0
259915|NCT02487030|848481|P5|Overall Study|Lack of Efficacy|1
259916|NCT02487030|848482|P4|Overall Study|Lack of Efficacy|0
259917|NCT02487030|848483|P3|Overall Study|Lack of Efficacy|1
259918|NCT02487030|848484|P2|Overall Study|Lack of Efficacy|4
259919|NCT02487030|848485|P1|Overall Study|Lack of Efficacy|2
259920|NCT02486952|848516|P1|Overall Study|Other|2
259921|NCT02486952|848516|P1|Overall Study|Lost to Follow-up|26
259922|NCT02486952|848516|P1|Overall Study|Lack of Efficacy|3
259923|NCT02486952|848516|P1|Overall Study|Death|15
259924|NCT02486952|848516|P1|Overall Study|Adverse Event|1
259925|NCT02486952|848516|P1|Overall Study|Not Started Induction Therapy|3
259926|NCT02485483|848523|P2|Overall Study|Discontinued after baseline|0
259927|NCT02485483|848524|P1|Overall Study|Discontinued after baseline|39
259928|NCT02485483|848523|P2|Overall Study|Depression at baseline|0
259929|NCT02485483|848524|P1|Overall Study|Depression at baseline|15
259930|NCT02485353|848539|P1|Overall Study|Disease Progression|1
259931|NCT02485353|848539|P1|Overall Study|Death|1
259932|NCT02485301|848546|P2|Overall Study|Other|4
259933|NCT02485301|848547|P1|Overall Study|Other|3
259934|NCT02485301|848546|P2|Overall Study|Lost to Follow-up|17
259935|NCT02485301|848547|P1|Overall Study|Lost to Follow-up|17
259936|NCT02485301|848546|P2|Overall Study|Migrated/moved from study area|19
259937|NCT02485301|848547|P1|Overall Study|Migrated/moved from study area|10
259938|NCT02485301|848546|P2|Overall Study|Withdrawal by Subject|7
259939|NCT02485301|848547|P1|Overall Study|Withdrawal by Subject|6
259940|NCT02485301|848546|P2|Overall Study|Protocol Violation|1
259941|NCT02485301|848547|P1|Overall Study|Protocol Violation|0
259942|NCT02485301|848546|P2|Overall Study|Serious Adverse Events|1
259943|NCT02485301|848547|P1|Overall Study|Serious Adverse Events|2
259944|NCT02485158|848597|P1|Overall Study|expected drug side effect|1
259945|NCT02485158|848597|P1|Overall Study|Withdrawal by Subject|3
259946|NCT02484911|848686|P2|Overall Study|Protocol Violation|1
259947|NCT02484911|848687|P1|Overall Study|Protocol Violation|2
259948|NCT02484911|848686|P2|Overall Study|Withdrawal by Subject|1
259949|NCT02484911|848687|P1|Overall Study|Withdrawal by Subject|2
259950|NCT02484729|848729|P10|Overall Study|Failure of IntelliCap Error|1
259951|NCT02484729|848730|P9|Overall Study|Failure of IntelliCap Error|0
259952|NCT02484729|848731|P8|Overall Study|Failure of IntelliCap Error|0
259953|NCT02484729|848732|P7|Overall Study|Failure of IntelliCap Error|0
259954|NCT02484729|848733|P6|Overall Study|Failure of IntelliCap Error|0
259955|NCT02484729|848734|P5|Overall Study|Failure of IntelliCap Error|0
259956|NCT02484729|848735|P4|Overall Study|Failure of IntelliCap Error|0
259957|NCT02484729|848736|P3|Overall Study|Failure of IntelliCap Error|0
259958|NCT02484729|848737|P2|Overall Study|Failure of IntelliCap Error|0
259959|NCT02484729|848738|P1|Overall Study|Failure of IntelliCap Error|0
259960|NCT02483975|848936|P2|Overall Study|Physician Decision|0
259961|NCT02483975|848937|P1|Overall Study|Physician Decision|2
259962|NCT02483975|848936|P2|Overall Study|Lost to Follow-up|1
259963|NCT02483975|848937|P1|Overall Study|Lost to Follow-up|0
259964|NCT02483975|848936|P2|Overall Study|Adverse Event|1
259965|NCT02483975|848937|P1|Overall Study|Adverse Event|0
259966|NCT02483611|848954|P3|Overall Study|Protocol Violation|1
259967|NCT02483611|848955|P2|Overall Study|Protocol Violation|0
259968|NCT02483611|848956|P1|Overall Study|Protocol Violation|0
259969|NCT02483585|849053|P2|Open-label Treatment Phase|Lost to Follow-up|5
259970|NCT02483585|849054|P1|Open-label Treatment Phase|Lost to Follow-up|3
259971|NCT02483585|849053|P2|Open-label Treatment Phase|Withdrawal by Subject|14
259972|NCT02483585|849054|P1|Open-label Treatment Phase|Withdrawal by Subject|18
259973|NCT02483585|849053|P2|Open-label Treatment Phase|Decision by Sponsor|1
259974|NCT02483585|849054|P1|Open-label Treatment Phase|Decision by Sponsor|0
259975|NCT02483585|849053|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
259976|NCT02483585|849054|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
259977|NCT02483585|849053|P2|Double-blind Treatment Phase|Lost to Follow-up|2
259978|NCT02483585|849054|P1|Double-blind Treatment Phase|Lost to Follow-up|3
259979|NCT02483585|849053|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
259980|NCT02483585|849054|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
259981|NCT02483585|849053|P2|Double-blind Treatment Phase|Decision by Sponsor|1
259982|NCT02483585|849054|P1|Double-blind Treatment Phase|Decision by Sponsor|1
259983|NCT02482805|849092|P3|Overall Study|Lost to Follow-up|0
259984|NCT02482805|849093|P2|Overall Study|Lost to Follow-up|4
259985|NCT02482805|849094|P1|Overall Study|Lost to Follow-up|4
259986|NCT02482571|849108|P1|Overall Study|Withdrawal by Subject|4
259987|NCT02482571|849108|P1|Overall Study|Scanner or Respiract failure|3
259988|NCT02482571|849108|P1|Overall Study|Adverse Event|1
259989|NCT02482428|849120|P5|Overall Study|subject/guardian decision|2
259990|NCT02482428|849121|P4|Overall Study|subject/guardian decision|0
259991|NCT02482428|849122|P3|Overall Study|subject/guardian decision|0
259992|NCT02482428|849123|P2|Overall Study|subject/guardian decision|2
259993|NCT02482428|849124|P1|Overall Study|subject/guardian decision|4
259994|NCT02482428|849120|P5|Overall Study|protocol deviation|0
259995|NCT02482428|849121|P4|Overall Study|protocol deviation|0
259996|NCT02482428|849122|P3|Overall Study|protocol deviation|0
259997|NCT02482428|849123|P2|Overall Study|protocol deviation|1
259998|NCT02482428|849124|P1|Overall Study|protocol deviation|1
259999|NCT02482428|849120|P5|Overall Study|Physician Decision|1
260000|NCT02482428|849121|P4|Overall Study|Physician Decision|0
260001|NCT02482428|849122|P3|Overall Study|Physician Decision|0
260002|NCT02482428|849123|P2|Overall Study|Physician Decision|0
260003|NCT02482428|849124|P1|Overall Study|Physician Decision|0
260004|NCT02482428|849120|P5|Overall Study|Lost to Follow-up|4
260005|NCT02482428|849121|P4|Overall Study|Lost to Follow-up|2
260006|NCT02482428|849122|P3|Overall Study|Lost to Follow-up|1
260007|NCT02482428|849123|P2|Overall Study|Lost to Follow-up|9
260008|NCT02482428|849124|P1|Overall Study|Lost to Follow-up|4
260009|NCT02482298|849147|P3|Overall Study|Lost to Follow-up|0
260010|NCT02482298|849148|P2|Overall Study|Lost to Follow-up|1
260011|NCT02482298|849149|P1|Overall Study|Lost to Follow-up|0
260012|NCT02482298|849147|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
260013|NCT02482298|849148|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
260014|NCT02482298|849149|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
260015|NCT02482298|849147|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
260016|NCT02482298|849148|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
260017|NCT02482298|849149|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
260018|NCT02482298|849147|P3|Overall Study|Withdrawal by Subject|2
260019|NCT02482298|849148|P2|Overall Study|Withdrawal by Subject|1
260020|NCT02482298|849149|P1|Overall Study|Withdrawal by Subject|2
260021|NCT02482129|849171|P2|Overall Study|Criteria not met|0
260022|NCT02482129|849172|P1|Overall Study|Criteria not met|1
260023|NCT02482129|849171|P2|Overall Study|Withdrawal by Subject|0
260024|NCT02482129|849172|P1|Overall Study|Withdrawal by Subject|2
260025|NCT02482129|849171|P2|Overall Study|Adverse Event|0
260026|NCT02482129|849172|P1|Overall Study|Adverse Event|1
260027|NCT02482129|849171|P2|Overall Study|Criteria not met-prior to treatment|0
260028|NCT02482129|849172|P1|Overall Study|Criteria not met-prior to treatment|1
260029|NCT02482129|849171|P2|Overall Study|Unable to draw blood-prior to treatment|0
260030|NCT02482129|849172|P1|Overall Study|Unable to draw blood-prior to treatment|1
260031|NCT02482129|849171|P2|Overall Study|Withdrawal by subject-prior to treatment|1
260032|NCT02482129|849172|P1|Overall Study|Withdrawal by subject-prior to treatment|0
260033|NCT02482129|849171|P2|Overall Study|Adverse Event-prior to treatment|1
260034|NCT02482129|849172|P1|Overall Study|Adverse Event-prior to treatment|0
260035|NCT02481934|849199|P1|Overall Study|Death|2
260036|NCT02480712|849278|P1|Overall Study|Lack of Efficacy|1
260037|NCT02480712|849278|P1|Overall Study|Death|1
260038|NCT02480712|849278|P1|Overall Study|Withdrew Consent|3
260039|NCT02480712|849278|P1|Overall Study|Lost to Follow-up|5
260040|NCT02480712|849278|P1|Overall Study|Enrolled but Never Treated|1
260041|NCT02480621|849297|P2|Follow Up|Lost to Follow-up|2
260042|NCT02480621|849298|P1|Follow Up|Lost to Follow-up|4
260043|NCT02480621|849297|P2|Randomization|Surgeon did not give intervention|1
260044|NCT02480621|849298|P1|Randomization|Surgeon did not give intervention|0
260045|NCT02480621|849297|P2|Randomization|Withdrawal by Subject|0
260046|NCT02480621|849298|P1|Randomization|Withdrawal by Subject|1
260047|NCT02480153|849375|P2|Overall Study|Randomized but not treated|1
260048|NCT02480153|849376|P1|Overall Study|Randomized but not treated|0
260049|NCT02480153|849375|P2|Overall Study|Withdrew treatment; continued in study|14
260050|NCT02480153|849376|P1|Overall Study|Withdrew treatment; continued in study|6
260051|NCT02480153|849375|P2|Overall Study|Discontinued from treatment and study|12
260052|NCT02480153|849376|P1|Overall Study|Discontinued from treatment and study|5
260053|NCT02480010|849384|P2|Overall Study|Refused Treatment|3
260054|NCT02480010|849385|P1|Overall Study|Refused Treatment|0
260055|NCT02480010|849384|P2|Overall Study|Insufficient therapeutic response|29
260056|NCT02480010|849385|P1|Overall Study|Insufficient therapeutic response|31
260057|NCT02480010|849384|P2|Overall Study|Death|0
260058|NCT02480010|849385|P1|Overall Study|Death|1
260059|NCT02480010|849384|P2|Overall Study|Adverse Event|1
260060|NCT02480010|849385|P1|Overall Study|Adverse Event|3
260061|NCT02479412|849447|P9|Overall Study|Randomization to wrong PK sampling group|0
260062|NCT02479412|849448|P8|Overall Study|Randomization to wrong PK sampling group|0
260063|NCT02479412|849449|P7|Overall Study|Randomization to wrong PK sampling group|0
260064|NCT02479412|849450|P6|Overall Study|Randomization to wrong PK sampling group|0
260065|NCT02479412|849451|P5|Overall Study|Randomization to wrong PK sampling group|1
260066|NCT02479412|849452|P4|Overall Study|Randomization to wrong PK sampling group|0
260067|NCT02479412|849453|P3|Overall Study|Randomization to wrong PK sampling group|0
260068|NCT02479412|849454|P2|Overall Study|Randomization to wrong PK sampling group|0
260069|NCT02479412|849455|P1|Overall Study|Randomization to wrong PK sampling group|0
260070|NCT02479412|849447|P9|Overall Study|Study-specific withdrawal criteria|1
260071|NCT02479412|849448|P8|Overall Study|Study-specific withdrawal criteria|1
260072|NCT02479412|849449|P7|Overall Study|Study-specific withdrawal criteria|0
260073|NCT02479412|849450|P6|Overall Study|Study-specific withdrawal criteria|0
260074|NCT02479412|849451|P5|Overall Study|Study-specific withdrawal criteria|0
260075|NCT02479412|849452|P4|Overall Study|Study-specific withdrawal criteria|1
260076|NCT02479412|849453|P3|Overall Study|Study-specific withdrawal criteria|1
260077|NCT02479412|849454|P2|Overall Study|Study-specific withdrawal criteria|0
260078|NCT02479412|849455|P1|Overall Study|Study-specific withdrawal criteria|0
260079|NCT02479412|849447|P9|Overall Study|Adverse Event|0
260080|NCT02479412|849448|P8|Overall Study|Adverse Event|0
260081|NCT02479412|849449|P7|Overall Study|Adverse Event|0
260082|NCT02479412|849450|P6|Overall Study|Adverse Event|0
260083|NCT02479412|849451|P5|Overall Study|Adverse Event|0
260084|NCT02479412|849452|P4|Overall Study|Adverse Event|0
260085|NCT02479412|849453|P3|Overall Study|Adverse Event|1
260086|NCT02479412|849454|P2|Overall Study|Adverse Event|0
260087|NCT02479412|849455|P1|Overall Study|Adverse Event|0
260088|NCT02479139|849532|P6|Overall Study|Other Miscellaneous Reasons|0
260089|NCT02479139|849533|P5|Overall Study|Other Miscellaneous Reasons|1
260090|NCT02479139|849534|P4|Overall Study|Other Miscellaneous Reasons|1
260091|NCT02479139|849535|P3|Overall Study|Other Miscellaneous Reasons|1
260092|NCT02479139|849536|P2|Overall Study|Other Miscellaneous Reasons|0
260093|NCT02479139|849537|P1|Overall Study|Other Miscellaneous Reasons|1
260094|NCT02479139|849532|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
260095|NCT02479139|849533|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
260096|NCT02479139|849534|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
260097|NCT02479139|849535|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
260098|NCT02479139|849536|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
260099|NCT02479139|849537|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
260100|NCT02479139|849532|P6|Overall Study|Withdrew Consent|1
260101|NCT02479139|849533|P5|Overall Study|Withdrew Consent|1
260102|NCT02479139|849534|P4|Overall Study|Withdrew Consent|4
260103|NCT02479139|849535|P3|Overall Study|Withdrew Consent|1
260104|NCT02479139|849536|P2|Overall Study|Withdrew Consent|6
260105|NCT02479139|849537|P1|Overall Study|Withdrew Consent|5
260106|NCT02479139|849532|P6|Overall Study|Lost to Follow-up|5
260107|NCT02479139|849533|P5|Overall Study|Lost to Follow-up|3
260108|NCT02479139|849534|P4|Overall Study|Lost to Follow-up|2
260109|NCT02479139|849535|P3|Overall Study|Lost to Follow-up|4
260110|NCT02479139|849536|P2|Overall Study|Lost to Follow-up|4
260111|NCT02479139|849537|P1|Overall Study|Lost to Follow-up|2
260112|NCT02478632|849570|P2|Overall Study|Other (Withdrawal from parent study)|5
260113|NCT02478632|849571|P1|Overall Study|Other (Withdrawal from parent study)|4
260114|NCT02478372|849598|P2|Overall Study|Death|2
260115|NCT02478372|849599|P1|Overall Study|Death|0
260116|NCT02478372|849598|P2|Overall Study|Lost to Follow-up|4
260117|NCT02478372|849599|P1|Overall Study|Lost to Follow-up|1
260118|NCT02478372|849598|P2|Overall Study|Protocol Violation|8
260119|NCT02478372|849599|P1|Overall Study|Protocol Violation|12
260120|NCT02478164|849621|P1|Overall Study|Withdrawal by Subject|1
260121|NCT02478164|849621|P1|Overall Study|Adverse Event|1
260122|NCT02478164|849621|P1|Overall Study|Lack of Efficacy|13
260123|NCT02477605|849634|P2|Overall Study|Administered gas during surgery|1
260124|NCT02477605|849635|P1|Overall Study|Administered gas during surgery|0
260125|NCT02477605|849634|P2|Overall Study|Withdrawal by Subject|1
260126|NCT02477605|849635|P1|Overall Study|Withdrawal by Subject|0
260127|NCT02477605|849634|P2|Overall Study|Lost to Follow-up|2
260128|NCT02477605|849635|P1|Overall Study|Lost to Follow-up|0
260129|NCT02477605|849634|P2|Overall Study|Discontinued prior to treatment|0
260130|NCT02477605|849635|P1|Overall Study|Discontinued prior to treatment|1
260131|NCT02477527|849649|P1|Overall Study|Screen Failure|3
260132|NCT02477527|849649|P1|Overall Study|Withdrawal by Subject|1
260133|NCT02477527|849649|P1|Overall Study|Lost to Follow-up|2
260134|NCT02477020|849659|P2|Overall Study|Lack of Efficacy|5
260135|NCT02477020|849660|P1|Overall Study|Lack of Efficacy|14
260136|NCT02477020|849659|P2|Overall Study|Reason not Specified|1
260137|NCT02477020|849660|P1|Overall Study|Reason not Specified|3
260138|NCT02477020|849659|P2|Overall Study|Voluntary Withdrawal|16
260139|NCT02477020|849660|P1|Overall Study|Voluntary Withdrawal|7
260140|NCT02477020|849659|P2|Overall Study|Pretreatment Event/Adverse Event|6
260141|NCT02477020|849660|P1|Overall Study|Pretreatment Event/Adverse Event|6
260142|NCT02476994|849690|P2|Overall Study|Based on feedback from FDA|0
260143|NCT02476994|849691|P1|Overall Study|Based on feedback from FDA|1
260144|NCT02476617|849760|P1|Overall Study|Lost to Follow-up|1
260145|NCT02476617|849760|P1|Overall Study|Adverse Event|1
260146|NCT02476422|849789|P2|Overall Study|Subject/guardian decision|1
260147|NCT02476422|849790|P1|Overall Study|Subject/guardian decision|0
260148|NCT02476175|849820|P1|Overall Study|Adverse Event|2
260149|NCT02475980|849844|P1|Overall Study|Withdrawal by Subject|1
260150|NCT02475980|849844|P1|Overall Study|Lost to Follow-up|4
260151|NCT02475564|849855|P2|Overall Study|Intense Menstrual bleeding|0
260152|NCT02475564|849856|P1|Overall Study|Intense Menstrual bleeding|1
260153|NCT02475564|849855|P2|Overall Study|Lost to Follow-up|1
260154|NCT02475564|849856|P1|Overall Study|Lost to Follow-up|2
260155|NCT02475564|849855|P2|Overall Study|Withdrawal by Subject|0
260156|NCT02475564|849856|P1|Overall Study|Withdrawal by Subject|1
260157|NCT02475395|849868|P2|Overall Study|Protocol Violation|3
260158|NCT02475395|849869|P1|Overall Study|Protocol Violation|30
260159|NCT02475278|849879|P1|Overall Study|Reason Not Specified|1
260160|NCT02475278|849879|P1|Overall Study|Lost to Follow-up|1
260161|NCT02474589|849926|P2|Overall Study|Inability to complete study procedures|1
260162|NCT02474589|849927|P1|Overall Study|Inability to complete study procedures|5
260163|NCT02474589|849926|P2|Overall Study|Withdrawal by Subject|0
260164|NCT02474589|849927|P1|Overall Study|Withdrawal by Subject|4
260165|NCT02474589|849926|P2|Overall Study|Protocol Violation|1
260166|NCT02474589|849927|P1|Overall Study|Protocol Violation|4
260167|NCT02474589|849926|P2|Overall Study|Lost to Follow-up|1
260168|NCT02474589|849927|P1|Overall Study|Lost to Follow-up|6
260169|NCT02474589|849926|P2|Overall Study|Adverse Event|2
260170|NCT02474589|849927|P1|Overall Study|Adverse Event|6
260171|NCT02474082|849957|P2|Overall Study|Protocol deviation|1
260172|NCT02474082|849958|P1|Overall Study|Protocol deviation|0
260173|NCT02474082|849957|P2|Overall Study|Non-compliance with study treatment|2
260174|NCT02474082|849958|P1|Overall Study|Non-compliance with study treatment|0
260175|NCT02474082|849957|P2|Overall Study|Participant/guardian decision|2
260176|NCT02474082|849958|P1|Overall Study|Participant/guardian decision|1
260177|NCT02474082|849957|P2|Overall Study|Dose tapering not achieved|4
260178|NCT02474082|849958|P1|Overall Study|Dose tapering not achieved|0
260179|NCT02474082|849957|P2|Overall Study|Lost to Follow-up|2
260180|NCT02474082|849958|P1|Overall Study|Lost to Follow-up|2
260181|NCT02474082|849957|P2|Overall Study|Withdrawal of informed consent|11
260182|NCT02474082|849958|P1|Overall Study|Withdrawal of informed consent|1
260183|NCT02474082|849957|P2|Overall Study|Adverse Event|32
260184|NCT02474082|849958|P1|Overall Study|Adverse Event|2
260185|NCT02473640|850032|P1|Treatment Period 1|Adverse Event|1
260186|NCT02473523|850041|P1|Overall Study|Lost to Follow-up|1
260187|NCT02473523|850041|P1|Overall Study|Death|1
260188|NCT02473510|850062|P2|Overall Study|Lost to Follow-up|2
260189|NCT02473510|850063|P1|Overall Study|Lost to Follow-up|1
260190|NCT02473471|850077|P1|Overall Study|Lost to Follow-up|1
260191|NCT02473471|850077|P1|Overall Study|poor oral hygiene|2
260192|NCT02473445|850108|P1|Overall Study|Sponsor Decision|20
260193|NCT02473445|850108|P1|Overall Study|Withdrawal by Subject|2
260194|NCT02473367|850114|P1|Period 4|Lost to Follow-up|1
260195|NCT02473367|850114|P1|Wait 1|Withdrawal by Subject|1
260196|NCT02472977|850135|P3|Overall Study|Subject request to discontinue treatment|0
260197|NCT02472977|850136|P2|Overall Study|Subject request to discontinue treatment|1
260198|NCT02472977|850137|P1|Overall Study|Subject request to discontinue treatment|0
260199|NCT02472977|850135|P3|Overall Study|Study drug toxicity|2
260200|NCT02472977|850136|P2|Overall Study|Study drug toxicity|0
260201|NCT02472977|850137|P1|Overall Study|Study drug toxicity|2
260202|NCT02472977|850135|P3|Overall Study|Withdrawal by Subject|0
260203|NCT02472977|850136|P2|Overall Study|Withdrawal by Subject|1
260204|NCT02472977|850137|P1|Overall Study|Withdrawal by Subject|0
260205|NCT02472977|850135|P3|Overall Study|Disease progression|6
260206|NCT02472977|850136|P2|Overall Study|Disease progression|25
260207|NCT02472977|850137|P1|Overall Study|Disease progression|4
260208|NCT02472886|850163|P3|Overall Study|Lack of Efficacy|1
260209|NCT02472886|850164|P2|Overall Study|Lack of Efficacy|2
260210|NCT02472886|850165|P1|Overall Study|Lack of Efficacy|0
260211|NCT02472847|850193|P2|Overall Study|Withdrawal by Subject|5
260212|NCT02472847|850194|P1|Overall Study|Withdrawal by Subject|1
260213|NCT02472756|850200|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
260214|NCT02472756|850200|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
260215|NCT02472756|850200|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
260216|NCT02472756|850200|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
260217|NCT02472756|850200|P1|Induction (Approximately 6 Months)|Adverse Event|1
260218|NCT02472639|850208|P2|Overall Study|Physician Decision|3
260219|NCT02472639|850209|P1|Overall Study|Physician Decision|4
260220|NCT02472366|850258|P2|Overall Study|Lost to Follow-up|0
260221|NCT02472366|850259|P1|Overall Study|Lost to Follow-up|1
260222|NCT02471755|850275|P2|Overall Study|Lost to Follow-up|1
260223|NCT02471755|850276|P1|Overall Study|Lost to Follow-up|0
260224|NCT02471755|850275|P2|Overall Study|Withdrawal by Subject|0
260225|NCT02471755|850276|P1|Overall Study|Withdrawal by Subject|1
260226|NCT02471612|850292|P1|Overall Study|Lost to Follow-up|2
260227|NCT02471183|850314|P1|Extended Treatment Period|Lack of Efficacy|1
260228|NCT02471183|850314|P1|Main Treatment Period|Withdrawal by Subject|1
260229|NCT02471183|850314|P1|Main Treatment Period|Adverse Event|1
260230|NCT02470429|850350|P2|Overall Study|Withdrawal by Subject|0
260231|NCT02470429|850351|P1|Overall Study|Withdrawal by Subject|1
260232|NCT02470429|850350|P2|Overall Study|Adverse Event|0
260233|NCT02470429|850351|P1|Overall Study|Adverse Event|1
260234|NCT02470403|850369|P5|Overall Study|Subject/guardian decision|0
260235|NCT02470403|850370|P4|Overall Study|Subject/guardian decision|4
260236|NCT02470403|850371|P3|Overall Study|Subject/guardian decision|0
260237|NCT02470403|850372|P2|Overall Study|Subject/guardian decision|0
260238|NCT02470403|850373|P1|Overall Study|Subject/guardian decision|1
260239|NCT02470403|850369|P5|Overall Study|Lost to Follow-up|0
260240|NCT02470403|850370|P4|Overall Study|Lost to Follow-up|0
260241|NCT02470403|850371|P3|Overall Study|Lost to Follow-up|0
260242|NCT02470403|850372|P2|Overall Study|Lost to Follow-up|1
260243|NCT02470403|850373|P1|Overall Study|Lost to Follow-up|0
260244|NCT02470403|850369|P5|Overall Study|Adverse Event|0
260245|NCT02470403|850370|P4|Overall Study|Adverse Event|0
260246|NCT02470403|850371|P3|Overall Study|Adverse Event|0
260247|NCT02470403|850372|P2|Overall Study|Adverse Event|0
260248|NCT02470403|850373|P1|Overall Study|Adverse Event|1
260249|NCT02469961|850442|P2|Overall Study|Physician Decision|1
260250|NCT02469961|850443|P1|Overall Study|Physician Decision|4
260251|NCT02469415|850478|P1|Overall Study|Investigational agent placed on hold|2
260252|NCT02469415|850478|P1|Overall Study|Withdrawal by Subject|1
260253|NCT02469298|850486|P4|Overall Study|Withdrawal by Subject|1
260254|NCT02469298|850487|P3|Overall Study|Withdrawal by Subject|0
260255|NCT02469298|850488|P2|Overall Study|Withdrawal by Subject|0
260256|NCT02469298|850489|P1|Overall Study|Withdrawal by Subject|0
260257|NCT02469298|850486|P4|Overall Study|Physician Decision|1
260258|NCT02469298|850487|P3|Overall Study|Physician Decision|0
260259|NCT02469298|850488|P2|Overall Study|Physician Decision|0
260260|NCT02469298|850489|P1|Overall Study|Physician Decision|0
260261|NCT02469298|850486|P4|Overall Study|Lost to Follow-up|0
260262|NCT02469298|850487|P3|Overall Study|Lost to Follow-up|1
260263|NCT02469298|850488|P2|Overall Study|Lost to Follow-up|0
260264|NCT02469298|850489|P1|Overall Study|Lost to Follow-up|1
260265|NCT02469298|850486|P4|Overall Study|Protocol Violation|0
260266|NCT02469298|850487|P3|Overall Study|Protocol Violation|1
260267|NCT02469298|850488|P2|Overall Study|Protocol Violation|1
260268|NCT02469298|850489|P1|Overall Study|Protocol Violation|0
260269|NCT02469246|850629|P2|Overall Study|Lost to Follow-up|0
260270|NCT02469246|850630|P1|Overall Study|Lost to Follow-up|3
260271|NCT02469246|850629|P2|Overall Study|Withdrew Consent|6
260272|NCT02469246|850630|P1|Overall Study|Withdrew Consent|9
260273|NCT02469246|850629|P2|Overall Study|Protocol Violation|1
260274|NCT02469246|850630|P1|Overall Study|Protocol Violation|0
260275|NCT02469246|850629|P2|Overall Study|Non-Compliance with Study Drug|0
260276|NCT02469246|850630|P1|Overall Study|Non-Compliance with Study Drug|1
260277|NCT02469246|850629|P2|Overall Study|Investigator's Discretion|0
260278|NCT02469246|850630|P1|Overall Study|Investigator's Discretion|1
260279|NCT02469246|850629|P2|Overall Study|Lack of Efficacy|0
260280|NCT02469246|850630|P1|Overall Study|Lack of Efficacy|1
260281|NCT02469246|850629|P2|Overall Study|Death|0
260282|NCT02469246|850630|P1|Overall Study|Death|1
260283|NCT02469246|850629|P2|Overall Study|Adverse Event|5
260284|NCT02469246|850630|P1|Overall Study|Adverse Event|6
260285|NCT02469246|850629|P2|Overall Study|Still in Study up to the Data Cut Date|264
260286|NCT02469246|850630|P1|Overall Study|Still in Study up to the Data Cut Date|258
260287|NCT02469246|850629|P2|Overall Study|Randomized and Never Treated|6
260288|NCT02469246|850630|P1|Overall Study|Randomized and Never Treated|5
260289|NCT02469168|850648|P2|Overall Study|Trial closed|0
260290|NCT02469168|850649|P1|Overall Study|Trial closed|1
260291|NCT02468414|850701|P2|Overall Study|Screen Failure|0
260292|NCT02468414|850702|P1|Overall Study|Screen Failure|1
260293|NCT02468414|850701|P2|Overall Study|Poor in-vitro secreting TARGTs|0
260294|NCT02468414|850702|P1|Overall Study|Poor in-vitro secreting TARGTs|1
260295|NCT02468414|850701|P2|Overall Study|Early Study Termination by Sponsor|0
260296|NCT02468414|850702|P1|Overall Study|Early Study Termination by Sponsor|1
260297|NCT02466659|850762|P2|Overall Study|Lost to Follow-up|2
260298|NCT02466659|850763|P1|Overall Study|Lost to Follow-up|5
260299|NCT02466425|850773|P2|Overall Study|Withdrawal by Parent/Guardian|0
260300|NCT02466425|850774|P1|Overall Study|Withdrawal by Parent/Guardian|2
260301|NCT02466425|850773|P2|Overall Study|Other|3
260302|NCT02466425|850774|P1|Overall Study|Other|1
260303|NCT02466425|850773|P2|Overall Study|Withdrawal by Subject|1
260304|NCT02466425|850774|P1|Overall Study|Withdrawal by Subject|0
260305|NCT02466425|850773|P2|Overall Study|Protocol Violation|0
260306|NCT02466425|850774|P1|Overall Study|Protocol Violation|1
260307|NCT02466425|850773|P2|Overall Study|Lost to Follow-up|0
260308|NCT02466425|850774|P1|Overall Study|Lost to Follow-up|3
260309|NCT02466425|850773|P2|Overall Study|Lack of Efficacy|1
260310|NCT02466425|850774|P1|Overall Study|Lack of Efficacy|4
260311|NCT02466425|850773|P2|Overall Study|Adverse Event|11
260312|NCT02466425|850774|P1|Overall Study|Adverse Event|3
260313|NCT02465866|850794|P4|Period 3|Withdrawal by Subject|0
260314|NCT02465866|850795|P3|Period 3|Withdrawal by Subject|0
260315|NCT02465866|850796|P2|Period 3|Withdrawal by Subject|1
260316|NCT02465866|850797|P1|Period 3|Withdrawal by Subject|0
260317|NCT02465489|850883|P1|Overall Study|Adverse Event|5
260318|NCT02465463|850912|P2|Overall Study|Protocol Violation|0
260319|NCT02465463|850913|P1|Overall Study|Protocol Violation|1
260320|NCT02465463|850912|P2|Overall Study|Death|0
260321|NCT02465463|850913|P1|Overall Study|Death|1
260322|NCT02465463|850912|P2|Overall Study|Lost to Follow-up|1
260323|NCT02465463|850913|P1|Overall Study|Lost to Follow-up|2
260324|NCT02465203|850960|P3|Overall Study|Patient/guardian decision|1
260325|NCT02465203|850961|P2|Overall Study|Patient/guardian decision|1
260326|NCT02465203|850962|P1|Overall Study|Patient/guardian decision|1
260327|NCT02465203|850960|P3|Overall Study|New therapy for study indication|0
260328|NCT02465203|850961|P2|Overall Study|New therapy for study indication|0
260329|NCT02465203|850962|P1|Overall Study|New therapy for study indication|4
260330|NCT02465203|850960|P3|Overall Study|Study terminated by sponsor|11
260331|NCT02465203|850961|P2|Overall Study|Study terminated by sponsor|34
260332|NCT02465203|850962|P1|Overall Study|Study terminated by sponsor|50
260333|NCT02465203|850960|P3|Overall Study|Protocol Violation|1
260334|NCT02465203|850961|P2|Overall Study|Protocol Violation|1
260335|NCT02465203|850962|P1|Overall Study|Protocol Violation|1
260336|NCT02463409|851057|P1|Overall Study|Screen failure|1
260337|NCT02463409|851057|P1|Overall Study|Withdrawal by Subject|1
260338|NCT02463331|851065|P2|Overall Study|Physician Decision|0
260339|NCT02463331|851066|P1|Overall Study|Physician Decision|3
260340|NCT02463331|851065|P2|Overall Study|Lack of Efficacy|0
260341|NCT02463331|851066|P1|Overall Study|Lack of Efficacy|6
260342|NCT02463331|851065|P2|Overall Study|Pregnancy|3
260343|NCT02463331|851066|P1|Overall Study|Pregnancy|2
260344|NCT02463331|851065|P2|Overall Study|Lost to Follow-up|1
260345|NCT02463331|851066|P1|Overall Study|Lost to Follow-up|1
260346|NCT02463331|851065|P2|Overall Study|Adverse Event|2
260347|NCT02463331|851066|P1|Overall Study|Adverse Event|4
260348|NCT02463097|851082|P1|Overall Study|Withdrawal by Subject|1
260349|NCT02462720|851088|P2|Part 2|Protocol Violation|1
260350|NCT02462720|851089|P1|Part 2|Protocol Violation|0
260351|NCT02462720|851088|P2|Part 2|Withdrawal by Subject|0
260352|NCT02462720|851089|P1|Part 2|Withdrawal by Subject|1
260353|NCT02462473|851099|P1|Overall Study|Other|3
260354|NCT02462473|851099|P1|Overall Study|Death|1
260355|NCT02461589|851206|P10|Overall Study|Withdrawal from trial before exposure|1
260356|NCT02461589|851207|P9|Overall Study|Withdrawal from trial before exposure|0
260357|NCT02461589|851208|P8|Overall Study|Withdrawal from trial before exposure|0
260358|NCT02461589|851209|P7|Overall Study|Withdrawal from trial before exposure|0
260359|NCT02461589|851210|P6|Overall Study|Withdrawal from trial before exposure|0
260360|NCT02461589|851211|P5|Overall Study|Withdrawal from trial before exposure|0
260361|NCT02461589|851212|P4|Overall Study|Withdrawal from trial before exposure|0
260362|NCT02461589|851213|P3|Overall Study|Withdrawal from trial before exposure|0
260363|NCT02461589|851214|P2|Overall Study|Withdrawal from trial before exposure|0
260364|NCT02461589|851215|P1|Overall Study|Withdrawal from trial before exposure|0
260365|NCT02461589|851206|P10|Overall Study|Missing follow-up information|0
260366|NCT02461589|851207|P9|Overall Study|Missing follow-up information|0
260367|NCT02461589|851208|P8|Overall Study|Missing follow-up information|0
260368|NCT02461589|851209|P7|Overall Study|Missing follow-up information|1
260369|NCT02461589|851210|P6|Overall Study|Missing follow-up information|0
260370|NCT02461589|851211|P5|Overall Study|Missing follow-up information|0
260371|NCT02461589|851212|P4|Overall Study|Missing follow-up information|0
260372|NCT02461589|851213|P3|Overall Study|Missing follow-up information|0
260373|NCT02461589|851214|P2|Overall Study|Missing follow-up information|1
260374|NCT02461589|851215|P1|Overall Study|Missing follow-up information|1
260375|NCT02461589|851206|P10|Overall Study|Unclassified|2
260376|NCT02461589|851207|P9|Overall Study|Unclassified|0
260377|NCT02461589|851208|P8|Overall Study|Unclassified|0
260378|NCT02461589|851209|P7|Overall Study|Unclassified|1
260379|NCT02461589|851210|P6|Overall Study|Unclassified|0
260380|NCT02461589|851211|P5|Overall Study|Unclassified|0
260381|NCT02461589|851212|P4|Overall Study|Unclassified|0
260382|NCT02461589|851213|P3|Overall Study|Unclassified|0
260383|NCT02461589|851214|P2|Overall Study|Unclassified|0
260384|NCT02461589|851215|P1|Overall Study|Unclassified|0
260385|NCT02461589|851206|P10|Overall Study|Death|0
260386|NCT02461589|851207|P9|Overall Study|Death|0
260387|NCT02461589|851208|P8|Overall Study|Death|1
260388|NCT02461589|851209|P7|Overall Study|Death|0
260389|NCT02461589|851210|P6|Overall Study|Death|0
260390|NCT02461589|851211|P5|Overall Study|Death|0
260391|NCT02461589|851212|P4|Overall Study|Death|0
260392|NCT02461589|851213|P3|Overall Study|Death|0
260393|NCT02461589|851214|P2|Overall Study|Death|0
260394|NCT02461589|851215|P1|Overall Study|Death|0
260395|NCT02461589|851206|P10|Overall Study|Lost to Follow-up|1
260396|NCT02461589|851207|P9|Overall Study|Lost to Follow-up|3
260397|NCT02461589|851208|P8|Overall Study|Lost to Follow-up|1
260398|NCT02461589|851209|P7|Overall Study|Lost to Follow-up|3
260399|NCT02461589|851210|P6|Overall Study|Lost to Follow-up|1
260400|NCT02461589|851211|P5|Overall Study|Lost to Follow-up|1
260401|NCT02461589|851212|P4|Overall Study|Lost to Follow-up|3
260402|NCT02461589|851213|P3|Overall Study|Lost to Follow-up|2
260403|NCT02461589|851214|P2|Overall Study|Lost to Follow-up|0
260404|NCT02461589|851215|P1|Overall Study|Lost to Follow-up|0
260405|NCT02461589|851206|P10|Overall Study|Withdrawal by Subject|1
260406|NCT02461589|851207|P9|Overall Study|Withdrawal by Subject|3
260407|NCT02461589|851208|P8|Overall Study|Withdrawal by Subject|3
260408|NCT02461589|851209|P7|Overall Study|Withdrawal by Subject|1
260409|NCT02461589|851210|P6|Overall Study|Withdrawal by Subject|2
260410|NCT02461589|851211|P5|Overall Study|Withdrawal by Subject|1
260411|NCT02461589|851212|P4|Overall Study|Withdrawal by Subject|2
260412|NCT02461589|851213|P3|Overall Study|Withdrawal by Subject|3
260413|NCT02461589|851214|P2|Overall Study|Withdrawal by Subject|1
260414|NCT02461589|851215|P1|Overall Study|Withdrawal by Subject|5
260415|NCT02461290|851300|P1|Overall Study|Lost to Follow-up|3
260416|NCT02461290|851300|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
260417|NCT02461134|851307|P1|Overall Study|Adverse Event|1
260418|NCT02460991|851315|P2|Overall Study|Withdrawal by Subject|2
260419|NCT02460991|851316|P1|Overall Study|Withdrawal by Subject|0
260420|NCT02460822|851322|P1|Overall Study|Withdrawal by Subject|1
260421|NCT02460159|851339|P2|Overall Study|Withdrawal by Subject|0
260422|NCT02460159|851340|P1|Overall Study|Withdrawal by Subject|2
260423|NCT02460159|851339|P2|Overall Study|Adverse Event|1
260424|NCT02460159|851340|P1|Overall Study|Adverse Event|4
260441|NCT02459093|851393|P2|Overall Study|Lost to Follow-up|7
260442|NCT02459093|851394|P1|Overall Study|Lost to Follow-up|6
260443|NCT02459093|851393|P2|Overall Study|Protocol Violation|11
260444|NCT02459093|851394|P1|Overall Study|Protocol Violation|6
260445|NCT02458287|851438|P4|Overall Study|Relocated Out of State|1
260446|NCT02458287|851439|P3|Overall Study|Relocated Out of State|0
260447|NCT02458287|851440|P2|Overall Study|Relocated Out of State|0
260448|NCT02458287|851441|P1|Overall Study|Relocated Out of State|0
260449|NCT02458287|851438|P4|Overall Study|Withdrawal by Subject|1
260450|NCT02458287|851439|P3|Overall Study|Withdrawal by Subject|2
260451|NCT02458287|851440|P2|Overall Study|Withdrawal by Subject|2
260452|NCT02458287|851441|P1|Overall Study|Withdrawal by Subject|0
260453|NCT02458287|851438|P4|Overall Study|Protocol Violation|0
260454|NCT02458287|851439|P3|Overall Study|Protocol Violation|0
260455|NCT02458287|851440|P2|Overall Study|Protocol Violation|1
260456|NCT02458287|851441|P1|Overall Study|Protocol Violation|0
260457|NCT02458287|851438|P4|Overall Study|Lost to Follow-up|0
260458|NCT02458287|851439|P3|Overall Study|Lost to Follow-up|1
260459|NCT02458287|851440|P2|Overall Study|Lost to Follow-up|1
260460|NCT02458287|851441|P1|Overall Study|Lost to Follow-up|0
260461|NCT02458287|851438|P4|Overall Study|Adverse Event|1
260462|NCT02458287|851439|P3|Overall Study|Adverse Event|0
260463|NCT02458287|851440|P2|Overall Study|Adverse Event|0
260464|NCT02458287|851441|P1|Overall Study|Adverse Event|0
260465|NCT02457611|851490|P1|Overall Study|Lost to Follow-up|3
260466|NCT02457247|851506|P4|Period 2|Voluntary Withdrawal|0
260467|NCT02457247|851507|P3|Period 2|Voluntary Withdrawal|0
260468|NCT02457247|851508|P2|Period 2|Voluntary Withdrawal|1
260469|NCT02457247|851509|P1|Period 2|Voluntary Withdrawal|1
260470|NCT02457247|851506|P4|Period 2|Lost to Follow-up|0
260471|NCT02457247|851507|P3|Period 2|Lost to Follow-up|0
260472|NCT02457247|851508|P2|Period 2|Lost to Follow-up|1
260473|NCT02457247|851509|P1|Period 2|Lost to Follow-up|0
260474|NCT02457247|851506|P4|Period 2|Significant Protocol Deviation|0
260475|NCT02457247|851507|P3|Period 2|Significant Protocol Deviation|0
260476|NCT02457247|851508|P2|Period 2|Significant Protocol Deviation|0
260477|NCT02457247|851509|P1|Period 2|Significant Protocol Deviation|1
260478|NCT02457247|851506|P4|Period 2|Pretreatment Event/Adverse Event|0
260479|NCT02457247|851507|P3|Period 2|Pretreatment Event/Adverse Event|0
260480|NCT02457247|851508|P2|Period 2|Pretreatment Event/Adverse Event|1
260481|NCT02457247|851509|P1|Period 2|Pretreatment Event/Adverse Event|0
260482|NCT02457247|851506|P4|Period 1|Voluntary Withdrawal|0
260483|NCT02457247|851507|P3|Period 1|Voluntary Withdrawal|0
260484|NCT02457247|851508|P2|Period 1|Voluntary Withdrawal|0
260485|NCT02457247|851509|P1|Period 1|Voluntary Withdrawal|1
260486|NCT02457247|851506|P4|Period 1|Significant Protocol Deviation|0
260487|NCT02457247|851507|P3|Period 1|Significant Protocol Deviation|0
260488|NCT02457247|851508|P2|Period 1|Significant Protocol Deviation|1
260489|NCT02457247|851509|P1|Period 1|Significant Protocol Deviation|1
260490|NCT02457247|851506|P4|Period 1|Pretreatment Event/Adverse Event|0
260491|NCT02457247|851507|P3|Period 1|Pretreatment Event/Adverse Event|0
260492|NCT02457247|851508|P2|Period 1|Pretreatment Event/Adverse Event|1
260493|NCT02457247|851509|P1|Period 1|Pretreatment Event/Adverse Event|0
260494|NCT02455518|851533|P4|Overall Study|Protocol Violation|3
260495|NCT02455518|851534|P3|Overall Study|Protocol Violation|1
260496|NCT02455518|851535|P2|Overall Study|Protocol Violation|1
260497|NCT02455518|851536|P1|Overall Study|Protocol Violation|0
260498|NCT02455050|851554|P4|Treatment Period 2|Lost to Follow-up|1
260499|NCT02455050|851555|P3|Treatment Period 2|Lost to Follow-up|2
260500|NCT02455050|851556|P2|Treatment Period 2|Lost to Follow-up|0
260501|NCT02455050|851557|P1|Treatment Period 2|Lost to Follow-up|1
260502|NCT02455050|851554|P4|Treatment Period 1|Lost to Follow-up|2
260503|NCT02455050|851555|P3|Treatment Period 1|Lost to Follow-up|1
260504|NCT02455050|851556|P2|Treatment Period 1|Lost to Follow-up|1
260505|NCT02455050|851557|P1|Treatment Period 1|Lost to Follow-up|1
260506|NCT02454959|851621|P1|Overall Study|Adverse Event|2
260507|NCT02454959|851621|P1|Overall Study|Withdrawal by Subject|3
260508|NCT02454959|851621|P1|Overall Study|Physician Decision|1
260509|NCT02454959|851621|P1|Overall Study|Protocol-Specified Criteria|3
260510|NCT02454608|851642|P3|Open Label Period|Withdrawal by Subject|8
260511|NCT02454608|851643|P2|Open Label Period|Withdrawal by Subject|0
260512|NCT02454608|851644|P1|Open Label Period|Withdrawal by Subject|0
260513|NCT02454608|851642|P3|Open Label Period|Lost to Follow-up|11
260514|NCT02454608|851643|P2|Open Label Period|Lost to Follow-up|0
260515|NCT02454608|851644|P1|Open Label Period|Lost to Follow-up|0
260516|NCT02454608|851642|P3|Double-Blind Period|Lack of Efficacy|0
260517|NCT02454608|851643|P2|Double-Blind Period|Lack of Efficacy|2
260518|NCT02454608|851644|P1|Double-Blind Period|Lack of Efficacy|0
260519|NCT02454101|851736|P2|Overall Study|Lost to Follow-up|4
260520|NCT02454101|851737|P1|Overall Study|Lost to Follow-up|3
260521|NCT02454101|851736|P2|Overall Study|Adverse Event|3
260522|NCT02454101|851737|P1|Overall Study|Adverse Event|2
260523|NCT02453321|851797|P3|Overall Study|Deep Venous Thrombosis|0
260524|NCT02453321|851798|P2|Overall Study|Deep Venous Thrombosis|1
260525|NCT02453321|851799|P1|Overall Study|Deep Venous Thrombosis|0
260526|NCT02453321|851797|P3|Overall Study|Weakness|2
260527|NCT02453321|851798|P2|Overall Study|Weakness|1
260528|NCT02453321|851799|P1|Overall Study|Weakness|1
260529|NCT02452892|851831|P4|Follow-up|Subject left town on Day 42|0
260530|NCT02452892|851832|P3|Follow-up|Subject left town on Day 42|0
260531|NCT02452892|851833|P2|Follow-up|Subject left town on Day 42|0
260532|NCT02452892|851834|P1|Follow-up|Subject left town on Day 42|1
260533|NCT02452892|851831|P4|Follow-up|Withdrawal by Subject|1
260534|NCT02452892|851832|P3|Follow-up|Withdrawal by Subject|0
260535|NCT02452892|851833|P2|Follow-up|Withdrawal by Subject|0
260536|NCT02452892|851834|P1|Follow-up|Withdrawal by Subject|0
260537|NCT02452892|851831|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
260538|NCT02452892|851832|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
260539|NCT02452892|851833|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
260540|NCT02452892|851834|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
260541|NCT02452892|851831|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
260542|NCT02452892|851832|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
260543|NCT02452892|851833|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
260544|NCT02452892|851834|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
260545|NCT02452892|851831|P4|Week 1 Initial Randommization|Lost to Follow-up|0
260546|NCT02452892|851832|P3|Week 1 Initial Randommization|Lost to Follow-up|1
260547|NCT02452892|851833|P2|Week 1 Initial Randommization|Lost to Follow-up|0
260548|NCT02452892|851834|P1|Week 1 Initial Randommization|Lost to Follow-up|0
260549|NCT02452892|851831|P4|Week 1 Initial Randommization|Adverse Event|0
260550|NCT02452892|851832|P3|Week 1 Initial Randommization|Adverse Event|0
260551|NCT02452892|851833|P2|Week 1 Initial Randommization|Adverse Event|0
260552|NCT02452892|851834|P1|Week 1 Initial Randommization|Adverse Event|1
260553|NCT02452320|851906|P2|Overall Study|Adverse Event|1
260554|NCT02452320|851907|P1|Overall Study|Adverse Event|0
260555|NCT02451917|851919|P2|First Intervention (24 Weeks)|Adverse Event|2
260556|NCT02451917|851920|P1|First Intervention (24 Weeks)|Adverse Event|0
260557|NCT02451917|851919|P2|First Intervention (24 Weeks)|Death|1
260558|NCT02451917|851920|P1|First Intervention (24 Weeks)|Death|0
260559|NCT02451917|851919|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
260560|NCT02451917|851920|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
260561|NCT02451358|851942|P4|Overall Study|Protocol Violation|0
260562|NCT02451358|851943|P3|Overall Study|Protocol Violation|1
260563|NCT02451358|851944|P2|Overall Study|Protocol Violation|1
260564|NCT02451358|851945|P1|Overall Study|Protocol Violation|0
260565|NCT02451358|851942|P4|Overall Study|Withdrawal by Subject|0
260566|NCT02451358|851943|P3|Overall Study|Withdrawal by Subject|0
260567|NCT02451358|851944|P2|Overall Study|Withdrawal by Subject|1
260568|NCT02451358|851945|P1|Overall Study|Withdrawal by Subject|1
260569|NCT02450539|852051|P2|Overall Study|On study treatment/follow up|25
260570|NCT02450539|852052|P1|Overall Study|On study treatment/follow up|27
260571|NCT02450539|852051|P2|Overall Study|Lost to Follow-up|1
260572|NCT02450539|852052|P1|Overall Study|Lost to Follow-up|4
260573|NCT02450539|852051|P2|Overall Study|Withdrawal by Subject|7
260574|NCT02450539|852052|P1|Overall Study|Withdrawal by Subject|19
260575|NCT02449915|852089|P2|Overall Study|Abnormal preop lab|1
260576|NCT02449915|852090|P1|Overall Study|Abnormal preop lab|0
260577|NCT02449915|852089|P2|Overall Study|Intraoperative surgical findings|1
260578|NCT02449915|852090|P1|Overall Study|Intraoperative surgical findings|1
260579|NCT02449915|852089|P2|Overall Study|Withdrawal by Subject|2
260580|NCT02449915|852090|P1|Overall Study|Withdrawal by Subject|0
260581|NCT02449915|852089|P2|Overall Study|Exclusion criteria - drug use|0
260582|NCT02449915|852090|P1|Overall Study|Exclusion criteria - drug use|1
260583|NCT02449902|852098|P2|Overall Study|Withdrawal by Subject|1
260584|NCT02449902|852099|P1|Overall Study|Withdrawal by Subject|0
260585|NCT02449902|852098|P2|Overall Study|Adverse Event|1
260586|NCT02449902|852099|P1|Overall Study|Adverse Event|0
260587|NCT02449044|852154|P1|Overall Study|Sponsor Discontinued Trial|3
260588|NCT02449044|852154|P1|Overall Study|Physician Decision|9
260589|NCT02449044|852154|P1|Overall Study|Met Withdrawal Criteria|7
260590|NCT02449044|852154|P1|Overall Study|Adverse Event|30
260591|NCT02449044|852154|P1|Overall Study|Withdrawal by Subject|13
260592|NCT02449044|852154|P1|Overall Study|Lost to Follow-up|2
260593|NCT02449018|852175|P2|Overall Study|Patient decision|0
260594|NCT02449018|852176|P1|Overall Study|Patient decision|2
260595|NCT02449018|852175|P2|Overall Study|Protocol deviation|0
260596|NCT02449018|852176|P1|Overall Study|Protocol deviation|4
260597|NCT02449018|852175|P2|Overall Study|Adverse Event|1
260598|NCT02449018|852176|P1|Overall Study|Adverse Event|5
260599|NCT02449018|852175|P2|Overall Study|Administrative problems|0
260600|NCT02449018|852176|P1|Overall Study|Administrative problems|1
260601|NCT02449018|852175|P2|Overall Study|Abnormal laboratory value|1
260602|NCT02449018|852176|P1|Overall Study|Abnormal laboratory value|0
260603|NCT02448810|852245|P8|Overall Study|Other (unspecified)|0
260604|NCT02448810|852246|P7|Overall Study|Other (unspecified)|2
260605|NCT02448810|852247|P6|Overall Study|Other (unspecified)|0
260606|NCT02448810|852248|P5|Overall Study|Other (unspecified)|0
260607|NCT02448810|852249|P4|Overall Study|Other (unspecified)|0
260608|NCT02448810|852250|P3|Overall Study|Other (unspecified)|0
260609|NCT02448810|852251|P2|Overall Study|Other (unspecified)|0
260610|NCT02448810|852252|P1|Overall Study|Other (unspecified)|0
260611|NCT02448810|852245|P8|Overall Study|Lost to Follow-up|0
260612|NCT02448810|852246|P7|Overall Study|Lost to Follow-up|0
260613|NCT02448810|852247|P6|Overall Study|Lost to Follow-up|0
260614|NCT02448810|852248|P5|Overall Study|Lost to Follow-up|0
260615|NCT02448810|852249|P4|Overall Study|Lost to Follow-up|0
260616|NCT02448810|852250|P3|Overall Study|Lost to Follow-up|0
260617|NCT02448810|852251|P2|Overall Study|Lost to Follow-up|1
260618|NCT02448810|852252|P1|Overall Study|Lost to Follow-up|0
260619|NCT02448810|852245|P8|Overall Study|Other (Progressive disease)|5
260620|NCT02448810|852246|P7|Overall Study|Other (Progressive disease)|14
260621|NCT02448810|852247|P6|Overall Study|Other (Progressive disease)|9
260622|NCT02448810|852248|P5|Overall Study|Other (Progressive disease)|23
260623|NCT02448810|852249|P4|Overall Study|Other (Progressive disease)|3
260624|NCT02448810|852250|P3|Overall Study|Other (Progressive disease)|0
260625|NCT02448810|852251|P2|Overall Study|Other (Progressive disease)|2
260626|NCT02448810|852252|P1|Overall Study|Other (Progressive disease)|2
260627|NCT02448810|852245|P8|Overall Study|Death|0
260628|NCT02448810|852246|P7|Overall Study|Death|0
260629|NCT02448810|852247|P6|Overall Study|Death|0
260630|NCT02448810|852248|P5|Overall Study|Death|1
260631|NCT02448810|852249|P4|Overall Study|Death|0
260632|NCT02448810|852250|P3|Overall Study|Death|1
260633|NCT02448810|852251|P2|Overall Study|Death|0
260634|NCT02448810|852252|P1|Overall Study|Death|1
260635|NCT02448810|852245|P8|Overall Study|Other (study terminated by sponsor)|1
260636|NCT02448810|852246|P7|Overall Study|Other (study terminated by sponsor)|2
260637|NCT02448810|852247|P6|Overall Study|Other (study terminated by sponsor)|2
260638|NCT02448810|852248|P5|Overall Study|Other (study terminated by sponsor)|4
260639|NCT02448810|852249|P4|Overall Study|Other (study terminated by sponsor)|0
260640|NCT02448810|852250|P3|Overall Study|Other (study terminated by sponsor)|0
260641|NCT02448810|852251|P2|Overall Study|Other (study terminated by sponsor)|0
260642|NCT02448810|852252|P1|Overall Study|Other (study terminated by sponsor)|0
260643|NCT02448810|852245|P8|Overall Study|Withdrawal by Subject|2
260644|NCT02448810|852246|P7|Overall Study|Withdrawal by Subject|0
260645|NCT02448810|852247|P6|Overall Study|Withdrawal by Subject|5
260646|NCT02448810|852248|P5|Overall Study|Withdrawal by Subject|3
260647|NCT02448810|852249|P4|Overall Study|Withdrawal by Subject|0
260648|NCT02448810|852250|P3|Overall Study|Withdrawal by Subject|1
260649|NCT02448810|852251|P2|Overall Study|Withdrawal by Subject|0
260650|NCT02448810|852252|P1|Overall Study|Withdrawal by Subject|0
260651|NCT02448810|852245|P8|Overall Study|Adverse Event|0
260652|NCT02448810|852246|P7|Overall Study|Adverse Event|0
260653|NCT02448810|852247|P6|Overall Study|Adverse Event|0
260654|NCT02448810|852248|P5|Overall Study|Adverse Event|0
260655|NCT02448810|852249|P4|Overall Study|Adverse Event|0
260656|NCT02448810|852250|P3|Overall Study|Adverse Event|1
260657|NCT02448810|852251|P2|Overall Study|Adverse Event|0
260658|NCT02448810|852252|P1|Overall Study|Adverse Event|0
260659|NCT02448563|852322|P2|Overall Study|Withdrawal by Subject|1
260660|NCT02448563|852323|P1|Overall Study|Withdrawal by Subject|0
260661|NCT02448563|852322|P2|Overall Study|Lost to Follow-up|10
260662|NCT02448563|852323|P1|Overall Study|Lost to Follow-up|16
260663|NCT02448537|852345|P3|Overall Study|Withdrawal by Subject|1
260664|NCT02448537|852346|P2|Overall Study|Withdrawal by Subject|1
260665|NCT02448537|852347|P1|Overall Study|Withdrawal by Subject|1
260666|NCT02447848|852361|P1|Overall Study|Withdrawal by Subject|4
260667|NCT02447848|852361|P1|Overall Study|Lack of Efficacy|4
260668|NCT02447848|852361|P1|Overall Study|Patient discharged|3
260669|NCT02447458|852373|P6|Overall Study|Other|0
260670|NCT02447458|852374|P5|Overall Study|Other|0
260671|NCT02447458|852375|P4|Overall Study|Other|0
260672|NCT02447458|852376|P3|Overall Study|Other|1
260673|NCT02447458|852377|P2|Overall Study|Other|0
260674|NCT02447458|852378|P1|Overall Study|Other|0
260675|NCT02447432|852476|P2|Epoch 001|Lost to Follow-up|3
260676|NCT02447432|852477|P1|Epoch 001|Lost to Follow-up|1
260677|NCT02447432|852476|P2|Epoch 001|Migrated/moved from study area|5
260678|NCT02447432|852477|P1|Epoch 001|Migrated/moved from study area|3
260679|NCT02447432|852476|P2|Epoch 001|Withdrawal by Subject|4
260680|NCT02447432|852477|P1|Epoch 001|Withdrawal by Subject|0
260681|NCT02447432|852476|P2|Epoch 001|Adverse Event|1
260682|NCT02447432|852477|P1|Epoch 001|Adverse Event|1
260683|NCT02447328|852509|P1|Overall Study|Withdrawal by Subject|1
260684|NCT02447029|852521|P2|Overall Study|Withdrawal by Subject|2
260685|NCT02447029|852522|P1|Overall Study|Withdrawal by Subject|3
260686|NCT02446990|852542|P2|Overall Study|Withdrawal by Subject|199
260687|NCT02446990|852543|P1|Overall Study|Withdrawal by Subject|231
260688|NCT02446990|852542|P2|Overall Study|Physician Decision|0
260689|NCT02446990|852543|P1|Overall Study|Physician Decision|1
260690|NCT02446990|852542|P2|Overall Study|Lost to Follow-up|1
260691|NCT02446990|852543|P1|Overall Study|Lost to Follow-up|3
260692|NCT02446990|852542|P2|Overall Study|Death|458
260693|NCT02446990|852543|P1|Overall Study|Death|485
260694|NCT02446743|852577|P2|Overall Study|Other|3
260695|NCT02446743|852578|P1|Overall Study|Other|2
260696|NCT02446743|852577|P2|Overall Study|Adverse Event|1
260697|NCT02446743|852578|P1|Overall Study|Adverse Event|1
260698|NCT02446743|852577|P2|Overall Study|Lost to Follow-up|0
260699|NCT02446743|852578|P1|Overall Study|Lost to Follow-up|1
260700|NCT02446743|852577|P2|Overall Study|Withdrawal by Subject|1
260701|NCT02446743|852578|P1|Overall Study|Withdrawal by Subject|1
260702|NCT02446717|852710|P5|Overall Study|Withdrew consent|0
260703|NCT02446717|852711|P4|Overall Study|Withdrew consent|1
260704|NCT02446717|852712|P3|Overall Study|Withdrew consent|0
260705|NCT02446717|852713|P2|Overall Study|Withdrew consent|0
260706|NCT02446717|852714|P1|Overall Study|Withdrew consent|0
260707|NCT02446717|852710|P5|Overall Study|Lost to Follow-up|1
260708|NCT02446717|852711|P4|Overall Study|Lost to Follow-up|0
260709|NCT02446717|852712|P3|Overall Study|Lost to Follow-up|1
260710|NCT02446717|852713|P2|Overall Study|Lost to Follow-up|1
260711|NCT02446717|852714|P1|Overall Study|Lost to Follow-up|0
260712|NCT02446717|852710|P5|Overall Study|Adverse Event|0
260713|NCT02446717|852711|P4|Overall Study|Adverse Event|0
260714|NCT02446717|852712|P3|Overall Study|Adverse Event|1
260715|NCT02446717|852713|P2|Overall Study|Adverse Event|0
260716|NCT02446717|852714|P1|Overall Study|Adverse Event|0
260717|NCT02446171|852795|P4|Overall Study|Withdrawal by Subject|0
260718|NCT02446171|852796|P3|Overall Study|Withdrawal by Subject|2
260719|NCT02446171|852797|P2|Overall Study|Withdrawal by Subject|0
260720|NCT02446171|852798|P1|Overall Study|Withdrawal by Subject|0
260721|NCT02446015|852869|P2|Overall Study|Withdrawal by Subject|0
260722|NCT02446015|852870|P1|Overall Study|Withdrawal by Subject|1
260723|NCT02446015|852869|P2|Overall Study|Adverse Event|1
260724|NCT02446015|852870|P1|Overall Study|Adverse Event|0
260725|NCT02445755|852894|P1|Overall Study|Screen Failure|5
260726|NCT02445755|852894|P1|Overall Study|Protocol Violation|6
260727|NCT02445755|852894|P1|Overall Study|Withdrawal by Subject|2
260728|NCT02445573|852903|P2|Overall Study|Lost to Follow-up|1
260729|NCT02445573|852904|P1|Overall Study|Lost to Follow-up|0
260730|NCT02445573|852903|P2|Overall Study|Withdrawal by Subject|1
260731|NCT02445573|852904|P1|Overall Study|Withdrawal by Subject|1
260732|NCT02444533|853012|P2|Overall Study|Only gave post-procedure complications|2
260733|NCT02444533|853013|P1|Overall Study|Only gave post-procedure complications|2
260734|NCT02444533|853012|P2|Overall Study|Not able to complete forms|2
260735|NCT02444533|853013|P1|Overall Study|Not able to complete forms|0
260736|NCT02444182|853029|P2|Overall Study|Lost to Follow-up|4
260737|NCT02444182|853030|P1|Overall Study|Lost to Follow-up|0
260738|NCT02444182|853029|P2|Overall Study|non-compliance|1
260739|NCT02444182|853030|P1|Overall Study|non-compliance|2
260740|NCT02443883|853042|P4|Overall Study|Randomized, but never treated|1
260741|NCT02443883|853043|P3|Overall Study|Randomized, but never treated|1
260742|NCT02443883|853044|P2|Overall Study|Randomized, but never treated|0
260743|NCT02443883|853045|P1|Overall Study|Randomized, but never treated|2
260744|NCT02443883|853042|P4|Overall Study|Withdrawal by Subject|1
260745|NCT02443883|853043|P3|Overall Study|Withdrawal by Subject|2
260746|NCT02443883|853044|P2|Overall Study|Withdrawal by Subject|0
260747|NCT02443883|853045|P1|Overall Study|Withdrawal by Subject|1
260748|NCT02443883|853042|P4|Overall Study|Physician Decision|3
260749|NCT02443883|853043|P3|Overall Study|Physician Decision|0
260750|NCT02443883|853044|P2|Overall Study|Physician Decision|1
260751|NCT02443883|853045|P1|Overall Study|Physician Decision|2
260752|NCT02443883|853042|P4|Overall Study|Lost to Follow-up|0
260753|NCT02443883|853043|P3|Overall Study|Lost to Follow-up|0
260754|NCT02443883|853044|P2|Overall Study|Lost to Follow-up|2
260755|NCT02443883|853045|P1|Overall Study|Lost to Follow-up|1
260756|NCT02443883|853042|P4|Overall Study|Adverse Event|2
260757|NCT02443883|853043|P3|Overall Study|Adverse Event|1
260758|NCT02443883|853044|P2|Overall Study|Adverse Event|2
260759|NCT02443883|853045|P1|Overall Study|Adverse Event|0
260760|NCT02443740|853084|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260761|NCT02443740|853085|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260762|NCT02443740|853086|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260763|NCT02443740|853087|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260764|NCT02443740|853088|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260765|NCT02443740|853089|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
260766|NCT02443740|853090|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260767|NCT02443740|853091|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260768|NCT02443740|853092|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260769|NCT02443740|853093|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260770|NCT02443740|853094|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
260771|NCT02443740|853084|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
260772|NCT02443740|853085|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
260773|NCT02443740|853086|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
260774|NCT02443740|853087|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
260775|NCT02443740|853088|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
260776|NCT02443740|853089|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
260777|NCT02443740|853090|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
260778|NCT02443740|853091|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
260779|NCT02443740|853092|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
260780|NCT02443740|853093|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
260781|NCT02443740|853094|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
260782|NCT02443740|853084|P11|Intervention Period 1 (3 Days)|Adverse Event|0
260783|NCT02443740|853085|P10|Intervention Period 1 (3 Days)|Adverse Event|0
260784|NCT02443740|853086|P9|Intervention Period 1 (3 Days)|Adverse Event|0
260785|NCT02443740|853087|P8|Intervention Period 1 (3 Days)|Adverse Event|0
260786|NCT02443740|853088|P7|Intervention Period 1 (3 Days)|Adverse Event|0
260787|NCT02443740|853089|P6|Intervention Period 1 (3 Days)|Adverse Event|1
260788|NCT02443740|853090|P5|Intervention Period 1 (3 Days)|Adverse Event|0
260789|NCT02443740|853091|P4|Intervention Period 1 (3 Days)|Adverse Event|0
260790|NCT02443740|853092|P3|Intervention Period 1 (3 Days)|Adverse Event|0
260791|NCT02443740|853093|P2|Intervention Period 1 (3 Days)|Adverse Event|0
260792|NCT02443740|853094|P1|Intervention Period 1 (3 Days)|Adverse Event|0
260793|NCT02443402|853275|P2|Overall Study|Screen Failure|2
260794|NCT02443402|853276|P1|Overall Study|Screen Failure|1
260795|NCT02443402|853275|P2|Overall Study|Withdrawal by Subject|1
260796|NCT02443402|853276|P1|Overall Study|Withdrawal by Subject|3
260797|NCT02443103|853336|P1|Overall Study|Noncompliance|1
260798|NCT02443103|853336|P1|Overall Study|Adverse Event|2
260799|NCT02442804|853343|P2|Overall Study|Adverse Event|0
260800|NCT02442804|853344|P1|Overall Study|Adverse Event|1
260801|NCT02442804|853343|P2|Overall Study|Withdrawal by Subject|1
260802|NCT02442804|853344|P1|Overall Study|Withdrawal by Subject|0
260803|NCT02442349|853383|P1|Overall Study|On-going Study at Data Cut-off|149
260804|NCT02442349|853383|P1|Overall Study|Withdrawal by Subject|8
260805|NCT02442349|853383|P1|Overall Study|Death|14
260806|NCT02442310|853388|P1|Overall Study|Withdrawal by Subject|1
260807|NCT02442310|853388|P1|Overall Study|Adverse Event|2
260808|NCT02442284|853410|P1|Overall Study|Not Specified|1
260809|NCT02442284|853410|P1|Overall Study|Lost to Follow-up|3
260810|NCT02442284|853410|P1|Overall Study|Withdrew Consent|2
260811|NCT02442284|853410|P1|Overall Study|Adverse Event|1
260812|NCT02442271|853417|P1|Overall Study|Not Specified|1
260813|NCT02442271|853417|P1|Overall Study|Lost to Follow-up|1
260814|NCT02442271|853417|P1|Overall Study|Withdrew Consent|1
260815|NCT02442271|853417|P1|Overall Study|Adverse Event|1
260816|NCT02441946|853444|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
260817|NCT02441946|853445|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
260818|NCT02441946|853446|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
260819|NCT02441946|853444|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
260820|NCT02441946|853445|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
260821|NCT02441946|853446|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
260822|NCT02441946|853444|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
260823|NCT02441946|853445|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
260824|NCT02441946|853446|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
260825|NCT02441946|853444|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
260826|NCT02441946|853445|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
260827|NCT02441946|853446|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
260828|NCT02441946|853444|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
260829|NCT02441946|853445|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
260830|NCT02441946|853446|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
260831|NCT02441946|853444|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
260832|NCT02441946|853445|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
260833|NCT02441946|853446|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
260834|NCT02441946|853444|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
260835|NCT02441946|853445|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
260836|NCT02441946|853446|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
260837|NCT02441946|853444|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
260838|NCT02441946|853445|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
260839|NCT02441946|853446|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
260840|NCT02441946|853444|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
260841|NCT02441946|853445|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
260842|NCT02441946|853446|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
260843|NCT02441517|853458|P1|Overall Study|Study Terminated by Sponsor|1
260844|NCT02441517|853458|P1|Overall Study|Withdrawal by Subject|2
260845|NCT02441517|853458|P1|Overall Study|Lost to Follow-up|1
260846|NCT02441218|853470|P2|Overall Study|Lost to Follow-up|1
260847|NCT02441218|853471|P1|Overall Study|Lost to Follow-up|2
260848|NCT02441218|853470|P2|Overall Study|Withdrawal by Subject|58
260849|NCT02441218|853471|P1|Overall Study|Withdrawal by Subject|73
260850|NCT02441218|853470|P2|Overall Study|Death|553
260851|NCT02441218|853471|P1|Overall Study|Death|503
260852|NCT02441179|853497|P2|Overall Study|Withdrawal by Subject|1
260853|NCT02441179|853498|P1|Overall Study|Withdrawal by Subject|1
260854|NCT02441114|853516|P1|Washout2|Withdrawal by Subject|4
260855|NCT02439138|853579|P1|Overall Study|PI decision to terminate the study|2
260856|NCT02439138|853579|P1|Overall Study|Adverse Event|1
260857|NCT02438137|853635|P2|Overall Study|Physician Decision|1
260858|NCT02438137|853636|P1|Overall Study|Physician Decision|0
260859|NCT02438137|853635|P2|Overall Study|Withdrawal by Subject|3
260860|NCT02438137|853636|P1|Overall Study|Withdrawal by Subject|4
260861|NCT02438137|853635|P2|Overall Study|Adverse Event|0
260862|NCT02438137|853636|P1|Overall Study|Adverse Event|1
260863|NCT02438137|853635|P2|Overall Study|Lost to Follow-up|2
260864|NCT02438137|853636|P1|Overall Study|Lost to Follow-up|3
260865|NCT02437903|853644|P1|Overall Study|Lost to Follow-up|3
260866|NCT02437903|853644|P1|Overall Study|Withdrawal by Subject|1
260867|NCT02437903|853644|P1|Overall Study|Adverse Event|1
260868|NCT02437513|853652|P1|Overall Study|Withdrawal by Subject|2
260869|NCT02437409|853660|P1|Overall Study|Screening failure|12
260870|NCT02437409|853660|P1|Overall Study|Withdrawal by Subject|3
260871|NCT02437305|853675|P2|Overall Study|Lost to Follow-up|12
260872|NCT02437305|853676|P1|Overall Study|Lost to Follow-up|18
260873|NCT02437162|853704|P3|Overall Study|Randomized but not treated|1
260874|NCT02437162|853705|P2|Overall Study|Randomized but not treated|0
260875|NCT02437162|853706|P1|Overall Study|Randomized but not treated|0
260876|NCT02437162|853704|P3|Overall Study|Withdrawal by Subject|0
260877|NCT02437162|853705|P2|Overall Study|Withdrawal by Subject|0
260878|NCT02437162|853706|P1|Overall Study|Withdrawal by Subject|3
260879|NCT02437162|853704|P3|Overall Study|Protocol Violation|0
260880|NCT02437162|853705|P2|Overall Study|Protocol Violation|1
260881|NCT02437162|853706|P1|Overall Study|Protocol Violation|0
260882|NCT02436811|853717|P3|Overall Study|Lost to Follow-up|7
260883|NCT02436811|853718|P2|Overall Study|Lost to Follow-up|9
260884|NCT02436811|853719|P1|Overall Study|Lost to Follow-up|2
260885|NCT02436577|853733|P6|Overall Study|Protocol Deviation|0
260886|NCT02436577|853734|P5|Overall Study|Protocol Deviation|0
260887|NCT02436577|853735|P4|Overall Study|Protocol Deviation|0
260888|NCT02436577|853736|P3|Overall Study|Protocol Deviation|0
260889|NCT02436577|853737|P2|Overall Study|Protocol Deviation|1
260890|NCT02436577|853738|P1|Overall Study|Protocol Deviation|0
260891|NCT02436330|853793|P2|Cohort 6|Withdrawal by Subject|1
260892|NCT02436330|853794|P1|Cohort 6|Withdrawal by Subject|1
260893|NCT02436330|853793|P2|Cohort 6|Lost to Follow-up|0
260894|NCT02436330|853794|P1|Cohort 6|Lost to Follow-up|2
260895|NCT02436330|853793|P2|Cohort 5|Withdrawal by Subject|2
260896|NCT02436330|853794|P1|Cohort 5|Withdrawal by Subject|3
260897|NCT02436330|853793|P2|Cohort 5|Lost to Follow-up|2
260898|NCT02436330|853794|P1|Cohort 5|Lost to Follow-up|3
260899|NCT02436330|853793|P2|Cohort 4|Withdrawal by Subject|0
260900|NCT02436330|853794|P1|Cohort 4|Withdrawal by Subject|1
260901|NCT02436330|853793|P2|Cohort 4|Lost to Follow-up|0
260902|NCT02436330|853794|P1|Cohort 4|Lost to Follow-up|1
260903|NCT02436330|853793|P2|Cohort 3|Withdrawal by Subject|0
260904|NCT02436330|853794|P1|Cohort 3|Withdrawal by Subject|4
260905|NCT02436330|853793|P2|Cohort 3|Lost to Follow-up|0
260906|NCT02436330|853794|P1|Cohort 3|Lost to Follow-up|1
260907|NCT02436330|853793|P2|Cohort 2|Withdrawal by Subject|3
260908|NCT02436330|853794|P1|Cohort 2|Withdrawal by Subject|2
260909|NCT02436330|853793|P2|Cohort 2|Lost to Follow-up|0
260910|NCT02436330|853794|P1|Cohort 2|Lost to Follow-up|2
260911|NCT02436330|853793|P2|Cohort 1|Withdrawal by Subject|1
260912|NCT02436330|853794|P1|Cohort 1|Withdrawal by Subject|0
260913|NCT02436330|853793|P2|Cohort 1|Lost to Follow-up|2
260914|NCT02436330|853794|P1|Cohort 1|Lost to Follow-up|5
260915|NCT02436304|853839|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
260916|NCT02436304|853840|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
260917|NCT02436304|853841|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
260918|NCT02436304|853839|P3|Overall Study|Withdrawal by Subject|0
260919|NCT02436304|853840|P2|Overall Study|Withdrawal by Subject|1
260920|NCT02436304|853841|P1|Overall Study|Withdrawal by Subject|0
260921|NCT02436304|853839|P3|Overall Study|Lost to Follow-up|0
260922|NCT02436304|853840|P2|Overall Study|Lost to Follow-up|1
260923|NCT02436304|853841|P1|Overall Study|Lost to Follow-up|0
260924|NCT02435966|853870|P3|Overall Study|Withdrawal by Subject|0
260925|NCT02435966|853871|P2|Overall Study|Withdrawal by Subject|1
260926|NCT02435966|853872|P1|Overall Study|Withdrawal by Subject|0
260927|NCT02435836|853880|P1|Overall Study|AE of Worsening Schizophrenia|96
260928|NCT02435836|853880|P1|Overall Study|Met Withdrawal Criteria|7
260929|NCT02435836|853880|P1|Overall Study|Protocol Violation|6
260930|NCT02435836|853880|P1|Overall Study|Noncompliance|27
260931|NCT02435836|853880|P1|Overall Study|Sponsor discontinued trial|167
260932|NCT02435836|853880|P1|Overall Study|Adverse Event|44
260933|NCT02435836|853880|P1|Overall Study|Insufficient Clinical Response|26
260934|NCT02435836|853880|P1|Overall Study|Withdrawal by Subject|236
260935|NCT02435836|853880|P1|Overall Study|Lack of Efficacy|1
260936|NCT02435836|853880|P1|Overall Study|Lost to Follow-up|21
260937|NCT02435277|853900|P4|Overall Study|Withdrawal by Subject|0
260938|NCT02435277|853901|P3|Overall Study|Withdrawal by Subject|0
260939|NCT02435277|853902|P2|Overall Study|Withdrawal by Subject|0
260940|NCT02435277|853903|P1|Overall Study|Withdrawal by Subject|1
260941|NCT02435277|853900|P4|Overall Study|Adverse Event|0
260942|NCT02435277|853901|P3|Overall Study|Adverse Event|0
260943|NCT02435277|853902|P2|Overall Study|Adverse Event|1
260944|NCT02435277|853903|P1|Overall Study|Adverse Event|1
260945|NCT02434939|853919|P2|Overall Study|Adverse Event|1
260946|NCT02434939|853920|P1|Overall Study|Adverse Event|0
260947|NCT02434939|853919|P2|Overall Study|Withdrawal by Subject|0
260948|NCT02434939|853920|P1|Overall Study|Withdrawal by Subject|3
260949|NCT02434939|853919|P2|Overall Study|Lack of Efficacy|48
260950|NCT02434939|853920|P1|Overall Study|Lack of Efficacy|34
260951|NCT02434471|854047|P1|Overall Study|Physician Decision|9
260952|NCT02433834|854066|P1|Overall Study|Physician Decision|1
260953|NCT02433834|854066|P1|Overall Study|Adverse Event|6
260954|NCT02433834|854066|P1|Overall Study|Withdrawal by Subject|14
260955|NCT02433834|854066|P1|Overall Study|Lost to Follow-up|6
260956|NCT02433834|854066|P1|Overall Study|Protocol Violation|3
260957|NCT02433834|854066|P1|Overall Study|Protocol-specified criteria|7
260958|NCT02433483|854124|P1|Overall Study|Other antineoplastic therapy/HSCT|1
260959|NCT02433483|854124|P1|Overall Study|Unacceptable toxicity|1
260960|NCT02433340|854151|P4|Overall Study|Not Specified|0
260961|NCT02433340|854152|P3|Overall Study|Not Specified|0
260962|NCT02433340|854153|P2|Overall Study|Not Specified|1
260963|NCT02433340|854154|P1|Overall Study|Not Specified|0
260964|NCT02433340|854151|P4|Overall Study|Required Alternative/Prohibited Therapy|0
260965|NCT02433340|854152|P3|Overall Study|Required Alternative/Prohibited Therapy|0
260966|NCT02433340|854153|P2|Overall Study|Required Alternative/Prohibited Therapy|0
260967|NCT02433340|854154|P1|Overall Study|Required Alternative/Prohibited Therapy|1
260968|NCT02433340|854151|P4|Overall Study|Lost to Follow-up|0
260969|NCT02433340|854152|P3|Overall Study|Lost to Follow-up|0
260970|NCT02433340|854153|P2|Overall Study|Lost to Follow-up|1
260971|NCT02433340|854154|P1|Overall Study|Lost to Follow-up|0
260972|NCT02433340|854151|P4|Overall Study|Withdrawal by Subject|2
260973|NCT02433340|854152|P3|Overall Study|Withdrawal by Subject|1
260974|NCT02433340|854153|P2|Overall Study|Withdrawal by Subject|0
260975|NCT02433340|854154|P1|Overall Study|Withdrawal by Subject|1
260976|NCT02433340|854151|P4|Overall Study|Adverse Event|0
260977|NCT02433340|854152|P3|Overall Study|Adverse Event|1
260978|NCT02433340|854153|P2|Overall Study|Adverse Event|0
260979|NCT02433340|854154|P1|Overall Study|Adverse Event|0
260980|NCT02432105|855067|P3|Overall Study|Randomized in error|2
260981|NCT02432105|855068|P2|Overall Study|Randomized in error|0
260982|NCT02432105|855069|P1|Overall Study|Randomized in error|0
260983|NCT02432105|855067|P3|Overall Study|Culture positive for yeast|0
260984|NCT02432105|855068|P2|Overall Study|Culture positive for yeast|1
260985|NCT02432105|855069|P1|Overall Study|Culture positive for yeast|0
260986|NCT02432105|855067|P3|Overall Study|Withdrawal by Subject|1
260987|NCT02432105|855068|P2|Overall Study|Withdrawal by Subject|0
260988|NCT02432105|855069|P1|Overall Study|Withdrawal by Subject|1
260989|NCT02432105|855067|P3|Overall Study|Lost to Follow-up|0
260990|NCT02432105|855068|P2|Overall Study|Lost to Follow-up|1
260991|NCT02432105|855069|P1|Overall Study|Lost to Follow-up|1
260992|NCT02432040|855086|P2|Overall Study|Physician Decision|1
260993|NCT02432040|855087|P1|Overall Study|Physician Decision|1
260994|NCT02432040|855086|P2|Overall Study|Lost to Follow-up|5
260995|NCT02432040|855087|P1|Overall Study|Lost to Follow-up|4
260996|NCT02432040|855086|P2|Overall Study|Lack of Efficacy|0
260997|NCT02432040|855087|P1|Overall Study|Lack of Efficacy|3
260998|NCT02430870|855200|P8|Part 2|Other Reason Not Specified|1
260999|NCT02430870|855201|P7|Part 2|Other Reason Not Specified|0
261000|NCT02430870|855202|P6|Part 2|Other Reason Not Specified|0
261001|NCT02430870|855203|P5|Part 2|Other Reason Not Specified|0
261002|NCT02430870|855204|P4|Part 2|Other Reason Not Specified|0
261003|NCT02430870|855205|P3|Part 2|Other Reason Not Specified|0
261004|NCT02430870|855206|P2|Part 2|Other Reason Not Specified|0
261005|NCT02430870|855207|P1|Part 2|Other Reason Not Specified|0
261006|NCT02430870|855200|P8|Part 2|Voluntary Withdrawal|0
261007|NCT02430870|855201|P7|Part 2|Voluntary Withdrawal|1
261008|NCT02430870|855202|P6|Part 2|Voluntary Withdrawal|0
261009|NCT02430870|855203|P5|Part 2|Voluntary Withdrawal|0
261010|NCT02430870|855204|P4|Part 2|Voluntary Withdrawal|0
261011|NCT02430870|855205|P3|Part 2|Voluntary Withdrawal|0
261012|NCT02430870|855206|P2|Part 2|Voluntary Withdrawal|0
261013|NCT02430870|855207|P1|Part 2|Voluntary Withdrawal|0
261014|NCT02430532|855281|P2|Overall Study|Adverse Event|1
261015|NCT02430532|855282|P1|Overall Study|Adverse Event|0
261016|NCT02430532|855281|P2|Overall Study|Consent Withdrawn|2
261017|NCT02430532|855282|P1|Overall Study|Consent Withdrawn|0
261018|NCT02430532|855281|P2|Overall Study|Sponsor Decision to Stop Study Early|25
261019|NCT02430532|855282|P1|Overall Study|Sponsor Decision to Stop Study Early|30
261020|NCT02429791|855322|P2|Overall Study|Withdrawal by Subject|7
261021|NCT02429791|855323|P1|Overall Study|Withdrawal by Subject|3
261022|NCT02429791|855322|P2|Overall Study|Protocol Violation|4
261023|NCT02429791|855323|P1|Overall Study|Protocol Violation|1
261024|NCT02429791|855322|P2|Overall Study|Lost to Follow-up|2
261025|NCT02429791|855323|P1|Overall Study|Lost to Follow-up|1
261026|NCT02429791|855322|P2|Overall Study|Lack of Efficacy|1
261027|NCT02429791|855323|P1|Overall Study|Lack of Efficacy|2
261028|NCT02429791|855322|P2|Overall Study|Physician Decision|2
261029|NCT02429791|855323|P1|Overall Study|Physician Decision|0
261030|NCT02429791|855322|P2|Overall Study|Adverse Event|2
261031|NCT02429791|855323|P1|Overall Study|Adverse Event|6
261032|NCT02429258|855395|P2|Overall Study|Protocol Violation|1
261033|NCT02429258|855396|P1|Overall Study|Protocol Violation|0
261034|NCT02429258|855395|P2|Overall Study|Withdrawal by Subject|0
261035|NCT02429258|855396|P1|Overall Study|Withdrawal by Subject|2
261036|NCT02428413|855433|P2|Overall Study|Nurse Refusal|0
261037|NCT02428413|855434|P1|Overall Study|Nurse Refusal|1
261038|NCT02428413|855433|P2|Overall Study|Missed Cases|2
261039|NCT02428413|855434|P1|Overall Study|Missed Cases|1
261040|NCT02428413|855433|P2|Overall Study|Case Cancelled|0
261041|NCT02428413|855434|P1|Overall Study|Case Cancelled|2
261042|NCT02428413|855433|P2|Overall Study|Protocol Violation|2
261043|NCT02428413|855434|P1|Overall Study|Protocol Violation|1
261044|NCT02428413|855433|P2|Overall Study|Device to measure WAG malfunctioned|5
261045|NCT02428413|855434|P1|Overall Study|Device to measure WAG malfunctioned|3
261046|NCT02428231|855448|P2|Overall Study|Adverse Event|0
261047|NCT02428231|855449|P1|Overall Study|Adverse Event|3
261048|NCT02428231|855448|P2|Overall Study|Required Symptomatic Therapy|1
261049|NCT02428231|855449|P1|Overall Study|Required Symptomatic Therapy|0
261050|NCT02428231|855448|P2|Overall Study|Not Specified|16
261051|NCT02428231|855449|P1|Overall Study|Not Specified|10
261052|NCT02427984|855466|P3|Overall Study|Lost to Follow-up|18
261053|NCT02427984|855467|P2|Overall Study|Lost to Follow-up|5
261054|NCT02427984|855468|P1|Overall Study|Lost to Follow-up|13
261055|NCT02427477|855510|P2|Period 1|Adverse Event|0
261056|NCT02427477|855511|P1|Period 1|Adverse Event|1
261057|NCT02427399|855524|P5|Overall Study|Protocol Violation|15
261058|NCT02427399|855525|P4|Overall Study|Protocol Violation|18
261059|NCT02427399|855526|P3|Overall Study|Protocol Violation|12
261060|NCT02427399|855527|P2|Overall Study|Protocol Violation|16
261061|NCT02427399|855528|P1|Overall Study|Protocol Violation|14
261062|NCT02426541|855552|P2|Overall Study|Protocol Violation|0
261063|NCT02426541|855553|P1|Overall Study|Protocol Violation|1
261064|NCT02425826|855570|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
261065|NCT02425826|855571|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
261066|NCT02425826|855572|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
261067|NCT02425826|855570|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
261068|NCT02425826|855571|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
261069|NCT02425826|855572|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
261070|NCT02425826|855570|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
261071|NCT02425826|855571|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
261072|NCT02425826|855572|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
261073|NCT02425826|855570|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
261074|NCT02425826|855571|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
261075|NCT02425826|855572|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
261076|NCT02425826|855570|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
261077|NCT02425826|855571|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
261078|NCT02425826|855572|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
261079|NCT02425826|855570|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
261080|NCT02425826|855571|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
261081|NCT02425826|855572|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
261082|NCT02425826|855570|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
261083|NCT02425826|855571|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
261084|NCT02425826|855572|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
261085|NCT02425826|855570|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
261086|NCT02425826|855571|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
261087|NCT02425826|855572|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
261088|NCT02425826|855570|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
261089|NCT02425826|855571|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
261090|NCT02425826|855572|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
261091|NCT02425826|855570|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
261092|NCT02425826|855571|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
261093|NCT02425826|855572|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
261094|NCT02424591|855628|P2|Overall Study|Protocol Violation|3
261095|NCT02424591|855629|P1|Overall Study|Protocol Violation|2
261096|NCT02424578|855641|P2|Overall Study|Withdrawal by Subject|1
261097|NCT02424578|855642|P1|Overall Study|Withdrawal by Subject|0
261098|NCT02424565|855648|P2|Period 1 (D0)|Protocol Violation|1
261099|NCT02424565|855649|P1|Period 1 (D0)|Protocol Violation|0
261100|NCT02424149|855668|P2|Overall Study|Withdrawal by Subject|1
261101|NCT02424149|855669|P1|Overall Study|Withdrawal by Subject|0
261102|NCT02424149|855668|P2|Overall Study|surgery cancelled|0
261103|NCT02424149|855669|P1|Overall Study|surgery cancelled|2
261104|NCT02423798|855730|P1|Overall Study|Withdrawal by Subject|3
261105|NCT02423291|855796|P1|Overall Study|Adverse Event|1
261106|NCT02423291|855796|P1|Overall Study|Lack of Efficacy|14
261107|NCT02423109|855811|P2|Lens 1|Adverse Event|0
261108|NCT02423109|855812|P1|Lens 1|Adverse Event|1
261109|NCT02422797|855822|P2|Overall Study|Withdrawal by Subject|7
261110|NCT02422797|855823|P1|Overall Study|Withdrawal by Subject|2
261111|NCT02422797|855822|P2|Overall Study|Other; Reached stopping criteria|1
261112|NCT02422797|855823|P1|Overall Study|Other; Reached stopping criteria|1
261113|NCT02422797|855822|P2|Overall Study|Protocol Violation|3
261114|NCT02422797|855823|P1|Overall Study|Protocol Violation|0
261115|NCT02422797|855822|P2|Overall Study|Lost to Follow-up|1
261116|NCT02422797|855823|P1|Overall Study|Lost to Follow-up|1
261117|NCT02422797|855822|P2|Overall Study|Lack of Efficacy|2
261118|NCT02422797|855823|P1|Overall Study|Lack of Efficacy|1
261119|NCT02422797|855822|P2|Overall Study|Physician Decision|1
261120|NCT02422797|855823|P1|Overall Study|Physician Decision|0
261121|NCT02422797|855822|P2|Overall Study|Adverse Event|1
261122|NCT02422797|855823|P1|Overall Study|Adverse Event|11
261123|NCT02422303|855904|P2|Overall Study|Lost to Follow-up|1
261124|NCT02422303|855905|P1|Overall Study|Lost to Follow-up|1
261125|NCT02421419|855914|P3|Overall Study|Physician Decision|1
261126|NCT02421419|855915|P2|Overall Study|Physician Decision|0
261127|NCT02421419|855916|P1|Overall Study|Physician Decision|0
261128|NCT02421120|856001|P1|Overall Study|Adverse Event|1
261129|NCT02420262|856030|P2|Overall Study|Unclassified|1
261130|NCT02420262|856031|P1|Overall Study|Unclassified|0
261131|NCT02420262|856030|P2|Overall Study|Withdrawal by Subject|4
261132|NCT02420262|856031|P1|Overall Study|Withdrawal by Subject|1
261133|NCT02420262|856030|P2|Overall Study|Adverse Event|0
261134|NCT02420262|856031|P1|Overall Study|Adverse Event|1
261135|NCT02420093|856057|P2|Overall Study|Withdrawal by Subject|1
261136|NCT02420093|856058|P1|Overall Study|Withdrawal by Subject|1
261137|NCT02419937|856101|P2|Overall Study|Lost to Follow-up|0
261138|NCT02419937|856102|P1|Overall Study|Lost to Follow-up|1
261139|NCT02419755|856110|P2|Overall Study|Withdrawal by Subject|0
261140|NCT02419755|856111|P1|Overall Study|Withdrawal by Subject|1
261141|NCT02419755|856110|P2|Overall Study|Ineligible|0
261142|NCT02419755|856111|P1|Overall Study|Ineligible|1
261143|NCT02419755|856110|P2|Overall Study|Relapse|1
261144|NCT02419755|856111|P1|Overall Study|Relapse|0
261145|NCT02419755|856110|P2|Overall Study|Death|3
261146|NCT02419755|856111|P1|Overall Study|Death|1
261147|NCT02419469|856147|P1|Overall Study|Withdrawal by Subject|1
261148|NCT02419313|856151|P2|Second Intervention|Lost to Follow-up|0
261149|NCT02419313|856152|P1|Second Intervention|Lost to Follow-up|1
261150|NCT02419313|856151|P2|First Intervention|Lost to Follow-up|0
261151|NCT02419313|856152|P1|First Intervention|Lost to Follow-up|2
261152|NCT02419001|856164|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
261153|NCT02419001|856165|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
261154|NCT02418468|856193|P2|Overall Study|Withdrawal of informed consent|1
261155|NCT02418468|856194|P1|Overall Study|Withdrawal of informed consent|1
261156|NCT02418468|856193|P2|Overall Study|Adverse Event|0
261157|NCT02418468|856194|P1|Overall Study|Adverse Event|1
261158|NCT02417961|856244|P1|Overall Study|Withdrawal by Subject|2
261159|NCT02417961|856244|P1|Overall Study|Lost to Follow-up|1
261160|NCT02417961|856244|P1|Overall Study|Adverse Event|1
261161|NCT02417753|856254|P1|Overall Study|Death|1
261162|NCT02417532|856264|P1|Overall Study|unable to complete exercises|4
261163|NCT02416934|856348|P2|Overall Study|re-operation|0
261164|NCT02416934|856349|P1|Overall Study|re-operation|1
261165|NCT02416934|856348|P2|Overall Study|surgery started late|1
261166|NCT02416934|856349|P1|Overall Study|surgery started late|0
261167|NCT02416934|856348|P2|Overall Study|Protocol Violation|1
261168|NCT02416934|856349|P1|Overall Study|Protocol Violation|0
261169|NCT02416934|856348|P2|Overall Study|recruited during continuing renewal proc|1
261170|NCT02416934|856349|P1|Overall Study|recruited during continuing renewal proc|0
261171|NCT02416934|856348|P2|Overall Study|Withdrawal by Subject|0
261172|NCT02416934|856349|P1|Overall Study|Withdrawal by Subject|1
261173|NCT02416934|856348|P2|Overall Study|Lost to Follow-up|2
261174|NCT02416934|856349|P1|Overall Study|Lost to Follow-up|0
261175|NCT02416934|856348|P2|Overall Study|given steroids|2
261176|NCT02416934|856349|P1|Overall Study|given steroids|1
261177|NCT02416180|856359|P1|Overall Study|Withdrawal by Subject|1
261178|NCT02415959|856371|P5|Overall Study|Protocol Violation|0
261179|NCT02415959|856372|P4|Overall Study|Protocol Violation|1
261180|NCT02415959|856373|P3|Overall Study|Protocol Violation|0
261181|NCT02415959|856374|P2|Overall Study|Protocol Violation|0
261182|NCT02415959|856375|P1|Overall Study|Protocol Violation|0
261183|NCT02415959|856371|P5|Overall Study|Adverse Event|0
261184|NCT02415959|856372|P4|Overall Study|Adverse Event|0
261185|NCT02415959|856373|P3|Overall Study|Adverse Event|0
261186|NCT02415959|856374|P2|Overall Study|Adverse Event|1
261187|NCT02415959|856375|P1|Overall Study|Adverse Event|0
261188|NCT02415127|856521|P2|Overall Study|Adverse Event|0
261189|NCT02415127|856522|P1|Overall Study|Adverse Event|1
261190|NCT02414828|856540|P4|Overall Study|Lost to Follow-up|2
261191|NCT02414828|856541|P3|Overall Study|Lost to Follow-up|1
261192|NCT02414828|856542|P2|Overall Study|Lost to Follow-up|1
261193|NCT02414828|856543|P1|Overall Study|Lost to Follow-up|0
261194|NCT02414152|856581|P1|Overall Study|Lack of Efficacy|1
261195|NCT02414152|856581|P1|Overall Study|Withdrawal by Subject|1
261196|NCT02413593|856598|P1|Overall Study|Adverse Event|1
261197|NCT02413593|856598|P1|Overall Study|Lost to Follow-up|3
261198|NCT02413489|856610|P3|Overall Study|Study Terminated By Sponsor|1
261199|NCT02413489|856611|P2|Overall Study|Study Terminated By Sponsor|13
261200|NCT02413489|856612|P1|Overall Study|Study Terminated By Sponsor|2
261201|NCT02413489|856610|P3|Overall Study|Withdrawal by Subject|0
261202|NCT02413489|856611|P2|Overall Study|Withdrawal by Subject|0
261203|NCT02413489|856612|P1|Overall Study|Withdrawal by Subject|2
261204|NCT02413489|856610|P3|Overall Study|Death|4
261205|NCT02413489|856611|P2|Overall Study|Death|3
261206|NCT02413489|856612|P1|Overall Study|Death|11
261207|NCT02413346|856634|P2|Overall Study|Other Miscellaneous Reasons|3
261208|NCT02413346|856635|P1|Overall Study|Other Miscellaneous Reasons|4
261209|NCT02413346|856634|P2|Overall Study|Protocol Violation|0
261210|NCT02413346|856635|P1|Overall Study|Protocol Violation|2
261211|NCT02413346|856634|P2|Overall Study|Lost to Follow-up|21
261212|NCT02413346|856635|P1|Overall Study|Lost to Follow-up|17
261213|NCT02413346|856634|P2|Overall Study|Withdrawal by Subject|40
261214|NCT02413346|856635|P1|Overall Study|Withdrawal by Subject|30
261215|NCT02413346|856634|P2|Overall Study|Adverse Event|6
261216|NCT02413346|856635|P1|Overall Study|Adverse Event|6
261217|NCT02413333|856645|P2|Period 2|Protocol Deviation|0
261218|NCT02413333|856646|P1|Period 2|Protocol Deviation|1
261219|NCT02413333|856645|P2|Period 1|Reason Not Specified|1
261220|NCT02413333|856646|P1|Period 1|Reason Not Specified|0
261221|NCT02413333|856645|P2|Period 1|Adverse Event|0
261222|NCT02413333|856646|P1|Period 1|Adverse Event|1
261223|NCT02413294|856654|P1|Overall Study|Withdrawal by Subject|1
261224|NCT02412657|856709|P3|Overall Study|Protocol Violation|3
261225|NCT02412657|856710|P2|Overall Study|Protocol Violation|2
261226|NCT02412657|856711|P1|Overall Study|Protocol Violation|0
261227|NCT02412657|856709|P3|Overall Study|Lost to Follow-up|0
261228|NCT02412657|856710|P2|Overall Study|Lost to Follow-up|0
261229|NCT02412657|856711|P1|Overall Study|Lost to Follow-up|1
261230|NCT02411747|856760|P2|Overall Study|Protocol Violation|4
261231|NCT02411747|856761|P1|Overall Study|Protocol Violation|2
261232|NCT02411747|856760|P2|Overall Study|Withdrawal by Subject|0
261233|NCT02411747|856761|P1|Overall Study|Withdrawal by Subject|1
261234|NCT02411578|856769|P2|Crossover Trial Phase|Pregnancy|1
261235|NCT02411578|856770|P1|Crossover Trial Phase|Pregnancy|0
261236|NCT02411539|856812|P2|Overall Study|Confounding medical condition|1
261237|NCT02411539|856813|P1|Overall Study|Confounding medical condition|0
261238|NCT02411539|856812|P2|Overall Study|Lost to Follow-up|0
261239|NCT02411539|856813|P1|Overall Study|Lost to Follow-up|2
261240|NCT02411292|856901|P1|Overall Study|Lost to Follow-up|3
261241|NCT02411292|856901|P1|Overall Study|Death|2
261242|NCT02411292|856901|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
261243|NCT02411201|856907|P1|Overall Study|Age group completed|2
261244|NCT02411201|856907|P1|Overall Study|Withdrawal by Subject|2
261245|NCT02411201|856907|P1|Overall Study|Adverse Event|2
261246|NCT02411110|856920|P2|Treatment Period 2|Personal Reasons|2
261247|NCT02411110|856921|P1|Treatment Period 2|Personal Reasons|0
261248|NCT02411110|856920|P2|Treatment Period 2|Lost to Follow-up|2
261249|NCT02411110|856921|P1|Treatment Period 2|Lost to Follow-up|0
261250|NCT02411110|856920|P2|Treatment Period 2|Adverse Event|0
261251|NCT02411110|856921|P1|Treatment Period 2|Adverse Event|1
261252|NCT02411110|856920|P2|Treatment Period 1|Other Miscellaneous Reasons|0
261253|NCT02411110|856921|P1|Treatment Period 1|Other Miscellaneous Reasons|2
261254|NCT02411110|856920|P2|Treatment Period 1|Personal Reasons|5
261255|NCT02411110|856921|P1|Treatment Period 1|Personal Reasons|2
261256|NCT02411110|856920|P2|Treatment Period 1|Lost to Follow-up|0
261257|NCT02411110|856921|P1|Treatment Period 1|Lost to Follow-up|1
261258|NCT02411110|856920|P2|Treatment Period 1|Adverse Event|2
261259|NCT02411110|856921|P1|Treatment Period 1|Adverse Event|4
261260|NCT02410824|856948|P2|First Intervention (One Week)|Headache|1
261261|NCT02410824|856949|P1|First Intervention (One Week)|Headache|0
261262|NCT02410343|856983|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
261263|NCT02410343|856984|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
261264|NCT02410343|856983|P2|Extension Period (12 Months)|Adverse Event|0
261265|NCT02410343|856984|P1|Extension Period (12 Months)|Adverse Event|1
261266|NCT02410343|856983|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
261267|NCT02410343|856984|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
261268|NCT02410343|856983|P2|Core Period (24 Weeks)|Adverse Event|0
261269|NCT02410343|856984|P1|Core Period (24 Weeks)|Adverse Event|1
261270|NCT02410200|857035|P1|Overall Study|Adverse Event|2
261271|NCT02408068|857098|P6|Treatment 3 (1.5 Days)|Adverse Event|0
261272|NCT02408068|857099|P5|Treatment 3 (1.5 Days)|Adverse Event|0
261273|NCT02408068|857100|P4|Treatment 3 (1.5 Days)|Adverse Event|0
261274|NCT02408068|857101|P3|Treatment 3 (1.5 Days)|Adverse Event|1
261275|NCT02408068|857102|P2|Treatment 3 (1.5 Days)|Adverse Event|0
261276|NCT02408068|857103|P1|Treatment 3 (1.5 Days)|Adverse Event|0
261277|NCT02407704|857130|P4|Overall Study|Withdrawal by Subject|0
261278|NCT02407704|857131|P3|Overall Study|Withdrawal by Subject|1
261279|NCT02407704|857132|P2|Overall Study|Withdrawal by Subject|0
261280|NCT02407704|857133|P1|Overall Study|Withdrawal by Subject|0
261281|NCT02407704|857130|P4|Overall Study|Protocol Violation|1
261282|NCT02407704|857131|P3|Overall Study|Protocol Violation|0
261283|NCT02407704|857132|P2|Overall Study|Protocol Violation|0
261284|NCT02407704|857133|P1|Overall Study|Protocol Violation|0
261285|NCT02407704|857130|P4|Overall Study|Lost to Follow-up|2
261286|NCT02407704|857131|P3|Overall Study|Lost to Follow-up|0
261287|NCT02407704|857132|P2|Overall Study|Lost to Follow-up|0
261288|NCT02407704|857133|P1|Overall Study|Lost to Follow-up|0
261289|NCT02406586|857231|P3|Overall Study|Withdrawal by Subject|0
261290|NCT02406586|857232|P2|Overall Study|Withdrawal by Subject|0
261291|NCT02406586|857233|P1|Overall Study|Withdrawal by Subject|1
261292|NCT02406586|857231|P3|Overall Study|Lost to Follow-up|2
261293|NCT02406586|857232|P2|Overall Study|Lost to Follow-up|4
261294|NCT02406586|857233|P1|Overall Study|Lost to Follow-up|0
261295|NCT02404649|857367|P2|Overall Study|Adverse Event|2
261296|NCT02404649|857368|P1|Overall Study|Adverse Event|1
261297|NCT02404545|857376|P2|Overall Study|Sponsor Termination|6
261298|NCT02404545|857377|P1|Overall Study|Sponsor Termination|6
261299|NCT02404493|857386|P2|Overall Study|Adverse Event|1
261300|NCT02404493|857387|P1|Overall Study|Adverse Event|1
261301|NCT02404389|857632|P5|Overall Study|Subject/guardian decision|1
261302|NCT02404389|857633|P4|Overall Study|Subject/guardian decision|1
261303|NCT02404389|857634|P3|Overall Study|Subject/guardian decision|0
261304|NCT02404389|857635|P2|Overall Study|Subject/guardian decision|0
261305|NCT02404389|857636|P1|Overall Study|Subject/guardian decision|1
261306|NCT02404389|857632|P5|Overall Study|Adverse Event|2
261307|NCT02404389|857633|P4|Overall Study|Adverse Event|0
261308|NCT02404389|857634|P3|Overall Study|Adverse Event|1
261309|NCT02404389|857635|P2|Overall Study|Adverse Event|0
261310|NCT02404389|857636|P1|Overall Study|Adverse Event|1
261311|NCT02404103|857674|P2|Overall Study|Lost to Follow-up|3
261312|NCT02404103|857675|P1|Overall Study|Lost to Follow-up|3
261313|NCT02404103|857674|P2|Overall Study|Adverse Event|0
261314|NCT02404103|857675|P1|Overall Study|Adverse Event|1
261315|NCT02403674|857708|P2|Overall Study|Protocol Violation|2
261316|NCT02403674|857709|P1|Overall Study|Protocol Violation|4
261317|NCT02403674|857708|P2|Overall Study|Pregnancy|1
261318|NCT02403674|857709|P1|Overall Study|Pregnancy|1
261319|NCT02403674|857708|P2|Overall Study|Not treated with study drug|2
261320|NCT02403674|857709|P1|Overall Study|Not treated with study drug|4
261321|NCT02403674|857708|P2|Overall Study|Physician Decision|2
261322|NCT02403674|857709|P1|Overall Study|Physician Decision|2
261323|NCT02403674|857708|P2|Overall Study|Withdrawal by Subject|11
261324|NCT02403674|857709|P1|Overall Study|Withdrawal by Subject|8
261325|NCT02403674|857708|P2|Overall Study|Noncompliance with study drug|2
261326|NCT02403674|857709|P1|Overall Study|Noncompliance with study drug|1
261327|NCT02403674|857708|P2|Overall Study|Lost to Follow-up|7
261328|NCT02403674|857709|P1|Overall Study|Lost to Follow-up|6
261329|NCT02403674|857708|P2|Overall Study|Lack of Efficacy|10
261330|NCT02403674|857709|P1|Overall Study|Lack of Efficacy|18
261331|NCT02403674|857708|P2|Overall Study|Death|3
261332|NCT02403674|857709|P1|Overall Study|Death|1
261333|NCT02403674|857708|P2|Overall Study|Adverse Event|23
261334|NCT02403674|857709|P1|Overall Study|Adverse Event|10
261335|NCT02403206|857750|P2|Overall Study|Reason not given|4
261336|NCT02403206|857751|P1|Overall Study|Reason not given|2
261337|NCT02403206|857750|P2|Overall Study|Withdrawal by Subject|3
261338|NCT02403206|857751|P1|Overall Study|Withdrawal by Subject|3
261339|NCT02403206|857750|P2|Overall Study|Physician Decision|0
261340|NCT02403206|857751|P1|Overall Study|Physician Decision|2
261341|NCT02403206|857750|P2|Overall Study|Lost to Follow-up|3
261342|NCT02403206|857751|P1|Overall Study|Lost to Follow-up|4
261343|NCT02403180|857762|P2|Period 2 (5 Days)|Withdrawal by Subject|1
261344|NCT02403180|857763|P1|Period 2 (5 Days)|Withdrawal by Subject|0
261345|NCT02403180|857762|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
261346|NCT02403180|857763|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
261347|NCT02402933|857792|P1|Overall Study|Sponsor Decision|10
261348|NCT02402933|857792|P1|Overall Study|Withdrawal by Subject|4
261349|NCT02402322|857810|P3|Follow-up|Withdrawal by Subject|24
261350|NCT02402322|857811|P2|Follow-up|Withdrawal by Subject|3
261351|NCT02402322|857812|P1|Follow-up|Withdrawal by Subject|6
261352|NCT02402322|857810|P3|Pretreatment|Withdrawal by Subject|1
261353|NCT02402322|857811|P2|Pretreatment|Withdrawal by Subject|1
261354|NCT02402322|857812|P1|Pretreatment|Withdrawal by Subject|3
261355|NCT02401867|857881|P1|Analysis|Cervical assay could not be conducted|9
261356|NCT02401867|857881|P1|Specimen Collection|Didn't receive 1 or more tests|10
261357|NCT02401529|857901|P2|Overall Study|Protocol Violation|0
261358|NCT02401529|857902|P1|Overall Study|Protocol Violation|5
261359|NCT02401529|857901|P2|Overall Study|Physician Decision|6
261360|NCT02401529|857902|P1|Overall Study|Physician Decision|2
261361|NCT02401529|857901|P2|Overall Study|Lost to Follow-up|1
261362|NCT02401529|857902|P1|Overall Study|Lost to Follow-up|2
261363|NCT02401256|857967|P1|Overall Study|Withdrawal by Subject|12
261364|NCT02401256|857967|P1|Overall Study|Adverse Event|5
261365|NCT02401230|857976|P3|Overall Study|Lost to Follow-up|3
261366|NCT02401230|857977|P2|Overall Study|Lost to Follow-up|3
261367|NCT02401230|857978|P1|Overall Study|Lost to Follow-up|1
261368|NCT02401230|857976|P3|Overall Study|Withdrawal by Subject|1
261369|NCT02401230|857977|P2|Overall Study|Withdrawal by Subject|1
261370|NCT02401230|857978|P1|Overall Study|Withdrawal by Subject|2
261371|NCT02401230|857976|P3|Overall Study|Adverse Event|0
261372|NCT02401230|857977|P2|Overall Study|Adverse Event|2
261373|NCT02401230|857978|P1|Overall Study|Adverse Event|3
261374|NCT02400580|858037|P2|Overall Study|Adverse Event|0
261375|NCT02400580|858038|P1|Overall Study|Adverse Event|1
261376|NCT02400580|858037|P2|Overall Study|Withdrawal by Subject|1
261377|NCT02400580|858038|P1|Overall Study|Withdrawal by Subject|1
261378|NCT02400346|858054|P1|Overall Study|Lost to Follow-up|1
261379|NCT02400346|858054|P1|Overall Study|Administrative or other reason(s)|2
261380|NCT02400346|858054|P1|Overall Study|Withdrawal by Subject|7
261381|NCT02400346|858054|P1|Overall Study|Non-compliance with IMP|1
261382|NCT02400346|858054|P1|Overall Study|Lack of Efficacy|9
261383|NCT02400346|858054|P1|Overall Study|Adverse Event|24
261384|NCT02400333|858062|P4|Overall Study|Protocol Violation|1
261385|NCT02400333|858063|P3|Overall Study|Protocol Violation|2
261386|NCT02400333|858064|P2|Overall Study|Protocol Violation|0
261387|NCT02400333|858065|P1|Overall Study|Protocol Violation|1
261388|NCT02400333|858062|P4|Overall Study|Withdrawal by Subject|1
261389|NCT02400333|858063|P3|Overall Study|Withdrawal by Subject|0
261390|NCT02400333|858064|P2|Overall Study|Withdrawal by Subject|1
261391|NCT02400333|858065|P1|Overall Study|Withdrawal by Subject|0
261392|NCT02399163|858129|P1|Overall Study|Withdrawal by Participant|5
261393|NCT02399163|858129|P1|Overall Study|Protocol Deviation|2
261394|NCT02399163|858129|P1|Overall Study|Adverse Event|2
261395|NCT02397915|858174|P4|Period 1|Physician Decision|0
261396|NCT02397915|858175|P3|Period 1|Physician Decision|0
261397|NCT02397915|858176|P2|Period 1|Physician Decision|0
261398|NCT02397915|858177|P1|Period 1|Physician Decision|1
261399|NCT02397915|858174|P4|Period 1|Protocol Violation|0
261400|NCT02397915|858175|P3|Period 1|Protocol Violation|0
261401|NCT02397915|858176|P2|Period 1|Protocol Violation|1
261402|NCT02397915|858177|P1|Period 1|Protocol Violation|0
261403|NCT02397694|858276|P2|Open Label Extension Phase|Withdrawal by Subject|0
261404|NCT02397694|858277|P1|Open Label Extension Phase|Withdrawal by Subject|1
261405|NCT02397694|858276|P2|Open Label Extension Phase|Still on Study Drug|30
261406|NCT02397694|858277|P1|Open Label Extension Phase|Still on Study Drug|61
261407|NCT02397694|858276|P2|Double-Blinded Phase|Lost to Follow-up|1
261408|NCT02397694|858277|P1|Double-Blinded Phase|Lost to Follow-up|1
261409|NCT02397694|858276|P2|Double-Blinded Phase|Withdrawal by Subject|0
261410|NCT02397694|858277|P1|Double-Blinded Phase|Withdrawal by Subject|1
261411|NCT02397694|858276|P2|Double-Blinded Phase|Non-compliance with study drug|2
261412|NCT02397694|858277|P1|Double-Blinded Phase|Non-compliance with study drug|0
261413|NCT02397694|858276|P2|Double-Blinded Phase|Adverse Event|0
261414|NCT02397694|858277|P1|Double-Blinded Phase|Adverse Event|1
261415|NCT02397655|858315|P1|Overall Study|data not completed|1301
261416|NCT02396537|858345|P2|Overall Study|Protocol Violation|1
261417|NCT02396537|858346|P1|Overall Study|Protocol Violation|0
261418|NCT02396316|858354|P2|Overall Study|Treatment unblinded|1
261419|NCT02396316|858355|P1|Overall Study|Treatment unblinded|0
261420|NCT02396316|858354|P2|Overall Study|Protocol Violation|1
261421|NCT02396316|858355|P1|Overall Study|Protocol Violation|0
261422|NCT02396316|858354|P2|Overall Study|Progressive disease|3
261423|NCT02396316|858355|P1|Overall Study|Progressive disease|6
261424|NCT02396316|858354|P2|Overall Study|Physician Decision|0
261425|NCT02396316|858355|P1|Overall Study|Physician Decision|1
261426|NCT02395822|858453|P1|Overall Study|Death|1
261427|NCT02395822|858453|P1|Overall Study|Withdrawal by Subject|1
261428|NCT02395653|858461|P1|Overall Study|Lost to Follow-up|1
261429|NCT02395653|858461|P1|Overall Study|Withdrawal by Subject|1
261430|NCT02395653|858461|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
261431|NCT02395653|858461|P1|Overall Study|Investigator Decision at Screening|1
261432|NCT02395653|858461|P1|Overall Study|SSEC Application But With 0 Dose|1
261433|NCT02395653|858461|P1|Overall Study|Consent Withdrawn at Screening|1
261434|NCT02395653|858461|P1|Overall Study|Exclusion Criteria Met at Screening|4
261435|NCT02395536|858470|P2|Overall Study|Insurance issue|1
261436|NCT02395536|858471|P1|Overall Study|Insurance issue|0
261437|NCT02395536|858470|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
261438|NCT02395536|858471|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
261439|NCT02395536|858470|P2|Overall Study|Withdrawal by Subject|17
261440|NCT02395536|858471|P1|Overall Study|Withdrawal by Subject|9
261441|NCT02395536|858470|P2|Overall Study|Physician Decision|6
261442|NCT02395536|858471|P1|Overall Study|Physician Decision|4
261443|NCT02395536|858470|P2|Overall Study|Death|0
261444|NCT02395536|858471|P1|Overall Study|Death|2
261445|NCT02395536|858470|P2|Overall Study|Lost to Follow-up|4
261446|NCT02395536|858471|P1|Overall Study|Lost to Follow-up|4
261447|NCT02395302|858477|P1|Overall Study|Physician Decision|2
261448|NCT02395302|858477|P1|Overall Study|Withdrawal by Subject|2
261449|NCT02395302|858477|P1|Overall Study|Run In Failure|7
261450|NCT02395302|858477|P1|Overall Study|Screen Failure|3
261451|NCT02395055|858497|P2|Overall Study|Withdrawal by Subject|3
261452|NCT02395055|858498|P1|Overall Study|Withdrawal by Subject|7
261453|NCT02394925|858508|P1|Overall Study|Unsatisfactory Visual Response|5
261454|NCT02394925|858508|P1|Overall Study|No longer meet eligibility criteria|1
261455|NCT02394925|858508|P1|Overall Study|Protocol Violation|5
261456|NCT02394925|858508|P1|Overall Study|Lost to Follow-up|9
261457|NCT02394925|858508|P1|Overall Study|Lens handling difficulities|5
261458|NCT02394925|858508|P1|Overall Study|Lens Discomfort|3
261459|NCT02394925|858508|P1|Overall Study|Adverse Event|1
261460|NCT02394808|858516|P2|Period 2|Lost to Follow-up|0
261461|NCT02394808|858517|P1|Period 2|Lost to Follow-up|1
261462|NCT02394808|858516|P2|Period 1|Unsatisfactory lens fitting|1
261463|NCT02394808|858517|P1|Period 1|Unsatisfactory lens fitting|0
261464|NCT02394756|858525|P6|Period 2|Unsatisfactory Visual Response|0
261465|NCT02394756|858526|P5|Period 2|Unsatisfactory Visual Response|1
261466|NCT02394756|858527|P4|Period 2|Unsatisfactory Visual Response|0
261467|NCT02394756|858528|P3|Period 2|Unsatisfactory Visual Response|0
261468|NCT02394756|858529|P2|Period 2|Unsatisfactory Visual Response|0
261469|NCT02394756|858530|P1|Period 2|Unsatisfactory Visual Response|0
261470|NCT02394756|858525|P6|Period 1|Withdrawal by Subject|0
261471|NCT02394756|858526|P5|Period 1|Withdrawal by Subject|0
261472|NCT02394756|858527|P4|Period 1|Withdrawal by Subject|1
261473|NCT02394756|858528|P3|Period 1|Withdrawal by Subject|1
261474|NCT02394756|858529|P2|Period 1|Withdrawal by Subject|1
261475|NCT02394756|858530|P1|Period 1|Withdrawal by Subject|0
261476|NCT02394756|858525|P6|Period 1|Lens Discomfort|1
261477|NCT02394756|858526|P5|Period 1|Lens Discomfort|0
261478|NCT02394756|858527|P4|Period 1|Lens Discomfort|0
261479|NCT02394756|858528|P3|Period 1|Lens Discomfort|0
261480|NCT02394756|858529|P2|Period 1|Lens Discomfort|0
261481|NCT02394756|858530|P1|Period 1|Lens Discomfort|0
261482|NCT02394665|858544|P3|Overall Study|Physician Decision|0
261483|NCT02394665|858545|P2|Overall Study|Physician Decision|0
261484|NCT02394665|858546|P1|Overall Study|Physician Decision|1
261485|NCT02394600|858568|P2|Overall Study|Protocol Violation|0
261486|NCT02394600|858569|P1|Overall Study|Protocol Violation|1
261487|NCT02394600|858568|P2|Overall Study|Withdrawal by Subject|1
261488|NCT02394600|858569|P1|Overall Study|Withdrawal by Subject|0
261489|NCT02394600|858568|P2|Overall Study|Lost to Follow-up|1
261490|NCT02394600|858569|P1|Overall Study|Lost to Follow-up|0
261491|NCT02394600|858568|P2|Overall Study|Adverse Event|0
261492|NCT02394600|858569|P1|Overall Study|Adverse Event|3
261493|NCT02393950|858598|P2|Overall Study|Withdrawal by Subject|1
261494|NCT02393950|858599|P1|Overall Study|Withdrawal by Subject|0
261495|NCT02393950|858598|P2|Overall Study|Adverse Event|0
261496|NCT02393950|858599|P1|Overall Study|Adverse Event|1
261497|NCT02393547|858673|P1|Overall Study|Lost to Follow-up|1
261498|NCT02393547|858673|P1|Overall Study|Withdrawal by Subject|3
261499|NCT02393547|858673|P1|Overall Study|Adverse Event|2
261500|NCT02393209|858682|P4|Overall Study|Lost to Follow-up|0
261501|NCT02393209|858683|P3|Overall Study|Lost to Follow-up|0
261502|NCT02393209|858684|P2|Overall Study|Lost to Follow-up|1
261503|NCT02393209|858685|P1|Overall Study|Lost to Follow-up|0
261504|NCT02393209|858682|P4|Overall Study|Patient Seen by Another Oncologist|0
261505|NCT02393209|858683|P3|Overall Study|Patient Seen by Another Oncologist|0
261506|NCT02393209|858684|P2|Overall Study|Patient Seen by Another Oncologist|1
261507|NCT02393209|858685|P1|Overall Study|Patient Seen by Another Oncologist|0
261508|NCT02393209|858682|P4|Overall Study|Death from Legionella Infection|0
261509|NCT02393209|858683|P3|Overall Study|Death from Legionella Infection|0
261510|NCT02393209|858684|P2|Overall Study|Death from Legionella Infection|1
261511|NCT02393209|858685|P1|Overall Study|Death from Legionella Infection|0
261512|NCT02393209|858682|P4|Overall Study|Death due to Disease Progression|0
261513|NCT02393209|858683|P3|Overall Study|Death due to Disease Progression|0
261514|NCT02393209|858684|P2|Overall Study|Death due to Disease Progression|2
261515|NCT02393209|858685|P1|Overall Study|Death due to Disease Progression|2
261516|NCT02393209|858682|P4|Overall Study|Death|0
261517|NCT02393209|858683|P3|Overall Study|Death|0
261518|NCT02393209|858684|P2|Overall Study|Death|2
261519|NCT02393209|858685|P1|Overall Study|Death|2
261520|NCT02393209|858682|P4|Overall Study|Withdrawal by Patient|0
261521|NCT02393209|858683|P3|Overall Study|Withdrawal by Patient|0
261522|NCT02393209|858684|P2|Overall Study|Withdrawal by Patient|0
261523|NCT02393209|858685|P1|Overall Study|Withdrawal by Patient|1
261524|NCT02393209|858682|P4|Overall Study|Study Terminated by Sponsor|0
261525|NCT02393209|858683|P3|Overall Study|Study Terminated by Sponsor|0
261526|NCT02393209|858684|P2|Overall Study|Study Terminated by Sponsor|1
261527|NCT02393209|858685|P1|Overall Study|Study Terminated by Sponsor|1
261528|NCT02392624|858774|P3|Overall Study|Other|1
261529|NCT02392624|858775|P2|Overall Study|Other|1
261530|NCT02392624|858776|P1|Overall Study|Other|49
261531|NCT02392624|858774|P3|Overall Study|Sponsor/Investigator Decision|0
261532|NCT02392624|858775|P2|Overall Study|Sponsor/Investigator Decision|1
261533|NCT02392624|858776|P1|Overall Study|Sponsor/Investigator Decision|2
261534|NCT02392624|858774|P3|Overall Study|Protocol Violation|1
261535|NCT02392624|858775|P2|Overall Study|Protocol Violation|0
261536|NCT02392624|858776|P1|Overall Study|Protocol Violation|0
261537|NCT02392624|858774|P3|Overall Study|Pregnancy|0
261538|NCT02392624|858775|P2|Overall Study|Pregnancy|0
261539|NCT02392624|858776|P1|Overall Study|Pregnancy|1
261540|NCT02392624|858774|P3|Overall Study|Adverse Event|2
261541|NCT02392624|858775|P2|Overall Study|Adverse Event|1
261542|NCT02392624|858776|P1|Overall Study|Adverse Event|4
261543|NCT02392624|858774|P3|Overall Study|Withdrawal by Subject|9
261544|NCT02392624|858775|P2|Overall Study|Withdrawal by Subject|12
261545|NCT02392624|858776|P1|Overall Study|Withdrawal by Subject|15
261546|NCT02392377|858791|P2|Overall Study|Withdrawal by Subject|1
261547|NCT02392377|858792|P1|Overall Study|Withdrawal by Subject|0
261548|NCT02392247|858816|P1|Overall Study|Surgery cancelled; no data|1
261549|NCT02392247|858816|P1|Overall Study|Withdrawal by Subject|1
261550|NCT02392234|858827|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
261551|NCT02392234|858828|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
261552|NCT02392234|858829|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
261553|NCT02392234|858830|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
261554|NCT02392234|858831|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
261555|NCT02392234|858832|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
261556|NCT02392234|858827|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
261557|NCT02392234|858828|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
261558|NCT02392234|858829|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
261559|NCT02392234|858830|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
261560|NCT02392234|858831|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
261561|NCT02392234|858832|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
261562|NCT02392234|858827|P6|Treatment Period 1 (8 Weeks)|Other|0
261563|NCT02392234|858828|P5|Treatment Period 1 (8 Weeks)|Other|0
261564|NCT02392234|858829|P4|Treatment Period 1 (8 Weeks)|Other|0
261565|NCT02392234|858830|P3|Treatment Period 1 (8 Weeks)|Other|0
261566|NCT02392234|858831|P2|Treatment Period 1 (8 Weeks)|Other|0
261567|NCT02392234|858832|P1|Treatment Period 1 (8 Weeks)|Other|1
261568|NCT02392234|858827|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
261569|NCT02392234|858828|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
261570|NCT02392234|858829|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
261571|NCT02392234|858830|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
261572|NCT02392234|858831|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
261573|NCT02392234|858832|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
261574|NCT02392234|858827|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
261575|NCT02392234|858828|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
261576|NCT02392234|858829|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
261577|NCT02392234|858830|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
261578|NCT02392234|858831|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
261579|NCT02392234|858832|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
261580|NCT02392234|858827|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
261581|NCT02392234|858828|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
261582|NCT02392234|858829|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
261583|NCT02392234|858830|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
261584|NCT02392234|858831|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
261585|NCT02392234|858832|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
261586|NCT02392234|858827|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
261587|NCT02392234|858828|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
261588|NCT02392234|858829|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
261589|NCT02392234|858830|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
261590|NCT02392234|858831|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
261591|NCT02392234|858832|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
261592|NCT02392234|858827|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
261593|NCT02392234|858828|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
261594|NCT02392234|858829|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
261595|NCT02392234|858830|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
261596|NCT02392234|858831|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
261597|NCT02392234|858832|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
261598|NCT02392000|858864|P1|Overall Study|Lost to Follow-up|8
261599|NCT02392000|858864|P1|Overall Study|Withdrawal by Subject|1
261600|NCT02392000|858864|P1|Overall Study|Greater than mild sleep apnea exclusion|18
261601|NCT02391311|858887|P2|Overall Study|deemed ineligible after baseline|1
261602|NCT02391311|858888|P1|Overall Study|deemed ineligible after baseline|1
261603|NCT02391311|858887|P2|Overall Study|Lost to Follow-up|1
261604|NCT02391311|858888|P1|Overall Study|Lost to Follow-up|2
261605|NCT02391116|858896|P1|Survival Follow-up|Ongoing with Survival Follow-up|12
261606|NCT02391116|858896|P1|Survival Follow-up|Withdrawal by Subject|2
261607|NCT02391116|858896|P1|Active Follow-up|Switching to Other Therapy|2
261608|NCT02391116|858896|P1|Active Follow-up|Withdrawal by Subject|1
261609|NCT02391116|858896|P1|Safety Follow-up|Deterioration of General Conditions|3
261610|NCT02391116|858896|P1|Safety Follow-up|No Follow Up|1
261611|NCT02391116|858896|P1|Safety Follow-up|Switching to Other Therapy|4
261612|NCT02391116|858896|P1|Safety Follow-up|Withdrawal by Subject|4
261613|NCT02391116|858896|P1|Safety Follow-up|Adverse Event|1
261614|NCT02391116|858896|P1|Treatment|Ongoing with Treatment|1
261615|NCT02391116|858896|P1|Treatment|AE with Clinical PD|3
261616|NCT02391116|858896|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
261617|NCT02391116|858896|P1|Treatment|Protocol Violation|1
261618|NCT02391116|858896|P1|Treatment|Withdrawal by Subject|1
261619|NCT02391038|858949|P3|Overall Study|Progressive disease|6
261620|NCT02391038|858950|P2|Overall Study|Progressive disease|3
261621|NCT02391038|858951|P1|Overall Study|Progressive disease|3
261622|NCT02390219|859065|P1|Overall Study|Other|2
261623|NCT02390219|859065|P1|Overall Study|Lost to Follow-up|2
261624|NCT02390219|859065|P1|Overall Study|Withdrawal by Subject|1
261625|NCT02390219|859065|P1|Overall Study|Adverse Event|6
261626|NCT02390219|859065|P1|Overall Study|Physician Decision|1
261627|NCT02390219|859065|P1|Overall Study|Death|1
261628|NCT02390167|859075|P1|Overall Study|Lost to Follow-up|1
261629|NCT02389829|859158|P2|Overall Study|Lost to Follow-up|1
261630|NCT02389829|859159|P1|Overall Study|Lost to Follow-up|0
261631|NCT02389452|859171|P1|Overall Study|Enrolled but Not Eligible for Study|6
261632|NCT02389452|859171|P1|Overall Study|Withdrawal by Subject|5
261633|NCT02389452|859171|P1|Overall Study|Adverse Event|1
261634|NCT02389452|859171|P1|Overall Study|Lost to Follow-up|13
261635|NCT02388776|859281|P1|Overall Study|Lost to Follow-up|1
261636|NCT02388776|859281|P1|Overall Study|Death|1
261637|NCT02388763|859286|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
261638|NCT02388763|859287|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
261639|NCT02388763|859286|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
261640|NCT02388763|859287|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
261641|NCT02388347|859322|P5|Overall Study|Withdrawal by Subject|0
261642|NCT02388347|859323|P4|Overall Study|Withdrawal by Subject|0
261643|NCT02388347|859324|P3|Overall Study|Withdrawal by Subject|1
261644|NCT02388347|859325|P2|Overall Study|Withdrawal by Subject|0
261645|NCT02388347|859326|P1|Overall Study|Withdrawal by Subject|0
261646|NCT02388295|859405|P3|Treatment Weeks 3 to 12|Adverse Event|0
261647|NCT02388295|859406|P2|Treatment Weeks 3 to 12|Adverse Event|1
261648|NCT02388295|859407|P1|Treatment Weeks 3 to 12|Adverse Event|1
261649|NCT02388295|859405|P3|Dose Escalation Week 2|Determined not eligible|1
261650|NCT02388295|859406|P2|Dose Escalation Week 2|Determined not eligible|1
261651|NCT02388295|859407|P1|Dose Escalation Week 2|Determined not eligible|1
261652|NCT02388295|859405|P3|Dose Escalation Week 2|Protocol Violation|0
261653|NCT02388295|859406|P2|Dose Escalation Week 2|Protocol Violation|1
261654|NCT02388295|859407|P1|Dose Escalation Week 2|Protocol Violation|0
261655|NCT02388295|859405|P3|Dose Escalation Week 1|Determined not eligible|1
261656|NCT02388295|859406|P2|Dose Escalation Week 1|Determined not eligible|1
261657|NCT02388295|859407|P1|Dose Escalation Week 1|Determined not eligible|1
261658|NCT02388295|859405|P3|Dose Escalation Week 1|Adverse Event|1
261659|NCT02388295|859406|P2|Dose Escalation Week 1|Adverse Event|2
261660|NCT02388295|859407|P1|Dose Escalation Week 1|Adverse Event|1
261661|NCT02388269|859425|P3|Overall Study|Screen Failure|10
261662|NCT02388269|859426|P2|Overall Study|Screen Failure|0
261663|NCT02388269|859427|P1|Overall Study|Screen Failure|0
261664|NCT02388269|859425|P3|Overall Study|Protocol Violation|0
261665|NCT02388269|859426|P2|Overall Study|Protocol Violation|0
261666|NCT02388269|859427|P1|Overall Study|Protocol Violation|2
261667|NCT02388269|859425|P3|Overall Study|no diary data|0
261668|NCT02388269|859426|P2|Overall Study|no diary data|0
261669|NCT02388269|859427|P1|Overall Study|no diary data|3
261670|NCT02388269|859425|P3|Overall Study|less than 50% stimulations|0
261671|NCT02388269|859426|P2|Overall Study|less than 50% stimulations|0
261672|NCT02388269|859427|P1|Overall Study|less than 50% stimulations|1
261673|NCT02388269|859425|P3|Overall Study|Withdrawal by Subject|0
261674|NCT02388269|859426|P2|Overall Study|Withdrawal by Subject|2
261675|NCT02388269|859427|P1|Overall Study|Withdrawal by Subject|1
261676|NCT02388269|859425|P3|Overall Study|Adverse Event|0
261677|NCT02388269|859426|P2|Overall Study|Adverse Event|0
261678|NCT02388269|859427|P1|Overall Study|Adverse Event|2
261679|NCT02388191|859459|P2|Overall Study|Patient did not receive IUD|0
261680|NCT02388191|859460|P1|Overall Study|Patient did not receive IUD|1
261681|NCT02388074|859474|P1|Overall Study|Sample Not Returned|1
261682|NCT02388074|859474|P1|Overall Study|Lost in Transit|2
261683|NCT02387996|859478|P1|Overall Study|Poor/Non-Compliance|1
261684|NCT02387996|859478|P1|Overall Study|Lost to Follow-up|1
261685|NCT02387996|859478|P1|Overall Study|Subject Withdrew Consent|1
261686|NCT02387996|859478|P1|Overall Study|Subject Request to Discontinue Treatment|9
261687|NCT02387996|859478|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
261688|NCT02387996|859478|P1|Overall Study|Study Drug Toxicity|14
261689|NCT02387996|859478|P1|Overall Study|Disease Progression|144
261690|NCT02387983|859489|P1|Overall Study|Withdrawal by Subject|2
261691|NCT02387983|859489|P1|Overall Study|Protocol Violation|1
261692|NCT02387983|859489|P1|Overall Study|Adverse Event|4
261693|NCT02387580|859548|P6|Overall Study|Withdrawal by Subject|0
261694|NCT02387580|859549|P5|Overall Study|Withdrawal by Subject|0
261695|NCT02387580|859550|P4|Overall Study|Withdrawal by Subject|1
261696|NCT02387580|859551|P3|Overall Study|Withdrawal by Subject|0
261697|NCT02387580|859552|P2|Overall Study|Withdrawal by Subject|0
261698|NCT02387580|859553|P1|Overall Study|Withdrawal by Subject|0
261699|NCT02384538|859651|P2|Overall Study|Not Specified|3
261700|NCT02384538|859652|P1|Overall Study|Not Specified|1
261701|NCT02384538|859651|P2|Overall Study|Withdrew Consent|4
261702|NCT02384538|859652|P1|Overall Study|Withdrew Consent|0
261703|NCT02384538|859651|P2|Overall Study|Lack of Efficacy|4
261704|NCT02384538|859652|P1|Overall Study|Lack of Efficacy|4
261705|NCT02384538|859651|P2|Overall Study|Adverse Event|4
261706|NCT02384538|859652|P1|Overall Study|Adverse Event|1
261707|NCT02383862|859691|P2|3 Month Follow up|Lost to Follow-up|21
261708|NCT02383862|859692|P1|3 Month Follow up|Lost to Follow-up|23
261709|NCT02383758|859725|P2|Overall Study|Withdrawal by Subject|2
261710|NCT02383758|859726|P1|Overall Study|Withdrawal by Subject|0
261711|NCT02383576|859744|P2|Overall Study|Administrative/Other|4
261712|NCT02383576|859745|P1|Overall Study|Administrative/Other|2
261713|NCT02383576|859744|P2|Overall Study|Investigator's Decision|1
261714|NCT02383576|859745|P1|Overall Study|Investigator's Decision|0
261715|NCT02383576|859744|P2|Overall Study|Withdrew Consent|6
261716|NCT02383576|859745|P1|Overall Study|Withdrew Consent|1
261717|NCT02383576|859744|P2|Overall Study|Lost to Follow-up|1
261718|NCT02383576|859745|P1|Overall Study|Lost to Follow-up|7
261719|NCT02383576|859744|P2|Overall Study|Death|33
261720|NCT02383576|859745|P1|Overall Study|Death|53
261723|NCT02382640|859882|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
261724|NCT02382640|859883|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
261725|NCT02382640|859884|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
261726|NCT02382640|859885|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
261727|NCT02382133|859923|P1|Overall Study|pressure injury both sites|1
261728|NCT02382133|859923|P1|Overall Study|arterial catheter loss|4
261729|NCT02382133|859923|P1|Overall Study|Physician Decision|2
261730|NCT02382133|859923|P1|Overall Study|transfer out of ICU|4
261731|NCT02382133|859923|P1|Overall Study|Death|22
261732|NCT02381795|859928|P1|Overall Study|Study Terminated|2
261733|NCT02381795|859928|P1|Overall Study|Withdrawal by Subject|1
261734|NCT02380742|859999|P2|Overall Study|Withdrawal by Subject|0
261735|NCT02380742|860000|P1|Overall Study|Withdrawal by Subject|1
261736|NCT02380287|860020|P8|Overall Study|Adverse Event|0
261737|NCT02380287|860021|P7|Overall Study|Adverse Event|0
261738|NCT02380287|860022|P6|Overall Study|Adverse Event|0
261739|NCT02380287|860023|P5|Overall Study|Adverse Event|0
261740|NCT02380287|860024|P4|Overall Study|Adverse Event|0
261741|NCT02380287|860025|P3|Overall Study|Adverse Event|1
261742|NCT02380287|860026|P2|Overall Study|Adverse Event|0
261743|NCT02380287|860027|P1|Overall Study|Adverse Event|0
261744|NCT02380248|860043|P1|Overall Study|Withdrawal by Subject|3
261745|NCT02380248|860043|P1|Overall Study|Lost to Follow-up|11
261746|NCT02379637|860050|P2|Overall Study|Withdrawal by Subject|0
261747|NCT02379637|860051|P1|Overall Study|Withdrawal by Subject|1
261748|NCT02379637|860050|P2|Overall Study|Adverse Event|0
261749|NCT02379637|860051|P1|Overall Study|Adverse Event|1
261750|NCT02379637|860050|P2|Overall Study|Protocol Violation|1
261751|NCT02379637|860051|P1|Overall Study|Protocol Violation|0
261752|NCT02378961|860088|P4|Overall Study|Death|0
261753|NCT02378961|860089|P3|Overall Study|Death|1
261754|NCT02378961|860090|P2|Overall Study|Death|0
261755|NCT02378961|860091|P1|Overall Study|Death|0
261756|NCT02378961|860088|P4|Overall Study|Lack of Efficacy|1
261757|NCT02378961|860089|P3|Overall Study|Lack of Efficacy|0
261758|NCT02378961|860090|P2|Overall Study|Lack of Efficacy|2
261759|NCT02378961|860091|P1|Overall Study|Lack of Efficacy|4
261760|NCT02378935|860128|P7|Overall Study|Death|0
261761|NCT02378935|860129|P6|Overall Study|Death|0
261762|NCT02378935|860130|P5|Overall Study|Death|0
261763|NCT02378935|860131|P4|Overall Study|Death|0
261764|NCT02378935|860132|P3|Overall Study|Death|1
261765|NCT02378935|860133|P2|Overall Study|Death|0
261766|NCT02378935|860134|P1|Overall Study|Death|0
261767|NCT02378935|860128|P7|Overall Study|Lack of Efficacy|0
261768|NCT02378935|860129|P6|Overall Study|Lack of Efficacy|0
261769|NCT02378935|860130|P5|Overall Study|Lack of Efficacy|0
261770|NCT02378935|860131|P4|Overall Study|Lack of Efficacy|6
261771|NCT02378935|860132|P3|Overall Study|Lack of Efficacy|2
261772|NCT02378935|860133|P2|Overall Study|Lack of Efficacy|0
261773|NCT02378935|860134|P1|Overall Study|Lack of Efficacy|10
261774|NCT02378506|860206|P1|Overall Study|Randomized But Not Treated|1
261775|NCT02378506|860206|P1|Overall Study|Adverse Event|14
261776|NCT02378506|860206|P1|Overall Study|Death|1
261777|NCT02378506|860206|P1|Overall Study|Protocol Violation|2
261778|NCT02378506|860206|P1|Overall Study|Withdrawal by Subject|4
261779|NCT02378506|860206|P1|Overall Study|Lack of Efficacy|3
261780|NCT02377427|860225|P2|Overall Study|Withdrawal by Subject|0
261781|NCT02377427|860226|P1|Overall Study|Withdrawal by Subject|2
261782|NCT02377427|860225|P2|Overall Study|Other: AE of Asthma Exacerbation|0
261783|NCT02377427|860226|P1|Overall Study|Other: AE of Asthma Exacerbation|1
261784|NCT02377427|860225|P2|Overall Study|Physician Decision|0
261785|NCT02377427|860226|P1|Overall Study|Physician Decision|1
261786|NCT02376166|860278|P1|Overall Study|Discontinued metformin early|2
261787|NCT02376166|860278|P1|Overall Study|Adverse Event|1
261788|NCT02375724|860305|P2|Overall Study|Adverse Event|4
261789|NCT02375724|860306|P1|Overall Study|Adverse Event|2
261790|NCT02375724|860305|P2|Overall Study|Protocol Violation|0
261791|NCT02375724|860306|P1|Overall Study|Protocol Violation|1
261792|NCT02375724|860305|P2|Overall Study|Lost to Follow-up|0
261793|NCT02375724|860306|P1|Overall Study|Lost to Follow-up|1
261794|NCT02375724|860305|P2|Overall Study|Withdrawal by Subject|1
261795|NCT02375724|860306|P1|Overall Study|Withdrawal by Subject|1
261796|NCT02375724|860305|P2|Overall Study|Lack of Efficacy|1
261797|NCT02375724|860306|P1|Overall Study|Lack of Efficacy|1
261798|NCT02375373|860316|P1|Overall Study|Withdrawal by Subject|11
261799|NCT02375347|860320|P1|Overall Study|Protocol Violation|1
261800|NCT02374593|860326|P2|Overall Study|non-compliant|0
261801|NCT02374593|860327|P1|Overall Study|non-compliant|2
261802|NCT02374346|860370|P1|Overall Study|operated or discharged during weekend|48
261803|NCT02373202|860402|P4|Overall Study|Not specified|0
261804|NCT02373202|860403|P3|Overall Study|Not specified|0
261805|NCT02373202|860404|P2|Overall Study|Not specified|1
261806|NCT02373202|860405|P1|Overall Study|Not specified|0
261807|NCT02373202|860402|P4|Overall Study|Lack of Efficacy|0
261808|NCT02373202|860403|P3|Overall Study|Lack of Efficacy|1
261809|NCT02373202|860404|P2|Overall Study|Lack of Efficacy|0
261810|NCT02373202|860405|P1|Overall Study|Lack of Efficacy|0
261811|NCT02373202|860402|P4|Overall Study|Adverse Event|1
261812|NCT02373202|860403|P3|Overall Study|Adverse Event|2
261813|NCT02373202|860404|P2|Overall Study|Adverse Event|5
261814|NCT02373202|860405|P1|Overall Study|Adverse Event|2
261815|NCT02372071|860500|P1|Overall Study|Protocol Violation|18
261816|NCT02372058|860505|P1|Overall Study|Withdrawal by Subject|3
261817|NCT02371759|860534|P8|Overall Study|Withdrawal by Subject|1
261818|NCT02371759|860535|P7|Overall Study|Withdrawal by Subject|0
261819|NCT02371759|860536|P6|Overall Study|Withdrawal by Subject|0
261820|NCT02371759|860537|P5|Overall Study|Withdrawal by Subject|0
261821|NCT02371759|860538|P4|Overall Study|Withdrawal by Subject|0
261822|NCT02371759|860539|P3|Overall Study|Withdrawal by Subject|0
261823|NCT02371759|860540|P2|Overall Study|Withdrawal by Subject|0
261824|NCT02371759|860541|P1|Overall Study|Withdrawal by Subject|0
261825|NCT02371759|860534|P8|Overall Study|Protocol Violation|3
261826|NCT02371759|860535|P7|Overall Study|Protocol Violation|0
261827|NCT02371759|860536|P6|Overall Study|Protocol Violation|1
261828|NCT02371759|860537|P5|Overall Study|Protocol Violation|3
261829|NCT02371759|860538|P4|Overall Study|Protocol Violation|0
261830|NCT02371759|860539|P3|Overall Study|Protocol Violation|1
261831|NCT02371759|860540|P2|Overall Study|Protocol Violation|1
261832|NCT02371759|860541|P1|Overall Study|Protocol Violation|3
261833|NCT02371616|860753|P2|Overall Study|Other (Not specified)|5
261834|NCT02371616|860754|P1|Overall Study|Other (Not specified)|1
261835|NCT02371616|860753|P2|Overall Study|Withdrawal of Consent|0
261836|NCT02371616|860754|P1|Overall Study|Withdrawal of Consent|1
261837|NCT02371616|860753|P2|Overall Study|Adverse Event|1
261838|NCT02371616|860754|P1|Overall Study|Adverse Event|0
261839|NCT02371616|860753|P2|Overall Study|Protocol Violation|1
261840|NCT02371616|860754|P1|Overall Study|Protocol Violation|2
261841|NCT02370914|860766|P1|Overall Study|Protocol Violation|2
261842|NCT02370667|860773|P3|Overall Study|Lost to Follow-up|0
261843|NCT02370667|860774|P2|Overall Study|Lost to Follow-up|1
261844|NCT02370667|860775|P1|Overall Study|Lost to Follow-up|0
261845|NCT02370615|860839|P2|Overall Study|Adverse Event|0
261846|NCT02370615|860840|P1|Overall Study|Adverse Event|1
261847|NCT02370602|860883|P6|Overall Study|Pretreatment Event/Adverse Event|0
261848|NCT02370602|860884|P5|Overall Study|Pretreatment Event/Adverse Event|0
261849|NCT02370602|860885|P4|Overall Study|Pretreatment Event/Adverse Event|0
261850|NCT02370602|860886|P3|Overall Study|Pretreatment Event/Adverse Event|0
261851|NCT02370602|860887|P2|Overall Study|Pretreatment Event/Adverse Event|0
261852|NCT02370602|860888|P1|Overall Study|Pretreatment Event/Adverse Event|1
261853|NCT02370537|860982|P3|Part B|Withdrawal by Subject|0
261854|NCT02370537|860983|P2|Part B|Withdrawal by Subject|1
261855|NCT02370537|860984|P1|Part B|Withdrawal by Subject|0
261856|NCT02370537|860982|P3|Part B|Not randomised to receive treatment|259
261857|NCT02370537|860983|P2|Part B|Not randomised to receive treatment|2
261858|NCT02370537|860984|P1|Part B|Not randomised to receive treatment|1
261859|NCT02370537|860982|P3|Part A (Open-label Recruitment)|Adverse Event|1
261860|NCT02370537|860983|P2|Part A (Open-label Recruitment)|Adverse Event|0
261861|NCT02370537|860984|P1|Part A (Open-label Recruitment)|Adverse Event|0
261862|NCT02370537|860982|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
261863|NCT02370537|860983|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
261864|NCT02370537|860984|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
261865|NCT02370420|861033|P2|Overall Study|Lost to Follow-up|9
261866|NCT02370420|861034|P1|Overall Study|Lost to Follow-up|11
261867|NCT02370420|861033|P2|Overall Study|Physician Decision|3
261868|NCT02370420|861034|P1|Overall Study|Physician Decision|3
261869|NCT02370394|861071|P2|Overall Study|Withdrawal by Subject|1
261870|NCT02370394|861072|P1|Overall Study|Withdrawal by Subject|0
261871|NCT02370394|861071|P2|Overall Study|Lost to Follow-up|1
261872|NCT02370394|861072|P1|Overall Study|Lost to Follow-up|2
261873|NCT02370121|861088|P2|Overall Study|Lost to Follow-up|1
261874|NCT02370121|861089|P1|Overall Study|Lost to Follow-up|1
261875|NCT02369848|861127|P1|Overall Study|Lost to Follow-up|1
261876|NCT02369848|861127|P1|Overall Study|Withdrawal by Subject|2
261877|NCT02369848|861127|P1|Overall Study|Death|1
261878|NCT02369510|861192|P3|Overall Study|Epidural Activation|5
261879|NCT02369510|861193|P2|Overall Study|Epidural Activation|1
261880|NCT02369510|861194|P1|Overall Study|Epidural Activation|1
261881|NCT02369510|861192|P3|Overall Study|Spilled Medication|1
261882|NCT02369510|861193|P2|Overall Study|Spilled Medication|2
261883|NCT02369510|861194|P1|Overall Study|Spilled Medication|1
261884|NCT02369341|861225|P2|Overall Study|Migrated/moved from study area|0
261885|NCT02369341|861226|P1|Overall Study|Migrated/moved from study area|1
261886|NCT02368314|861293|P2|Overall Study|Adverse Event|2
261887|NCT02368314|861294|P1|Overall Study|Adverse Event|1
261888|NCT02368314|861293|P2|Overall Study|Withdrawal by Subject|1
261889|NCT02368314|861294|P1|Overall Study|Withdrawal by Subject|2
261890|NCT02367885|861316|P3|Overall Study|Withdrawal by Subject|0
261891|NCT02367885|861317|P2|Overall Study|Withdrawal by Subject|0
261892|NCT02367885|861318|P1|Overall Study|Withdrawal by Subject|1
261893|NCT02367885|861316|P3|Overall Study|Lost to Follow-up|0
261894|NCT02367885|861317|P2|Overall Study|Lost to Follow-up|0
261895|NCT02367885|861318|P1|Overall Study|Lost to Follow-up|1
261896|NCT02367131|861585|P1|Overall Study|Other than stated above|20
261897|NCT02367131|861585|P1|Overall Study|No change/progressive disease|78
261898|NCT02367131|861585|P1|Overall Study|Improvement/remission|2
261899|NCT02367131|861585|P1|Overall Study|Request by patient|54
261900|NCT02367131|861585|P1|Overall Study|No visit since the first visit|4
261901|NCT02367131|861585|P1|Overall Study|Adverse Event|64
261902|NCT02366936|861652|P1|Overall Study|Physician Decision|2
261903|NCT02366936|861652|P1|Overall Study|Lost to Follow-up|4
261904|NCT02366936|861652|P1|Overall Study|Withdrawal by Subject|2
261905|NCT02366923|861657|P1|Overall Study|High Astigmatism|3
261906|NCT02366923|861657|P1|Overall Study|Positive Slit Lamp Findings|2
261907|NCT02366923|861657|P1|Overall Study|Withdrawal by Subject|1
261908|NCT02366910|861670|P1|Overall Study|Screen Failure|3
261909|NCT02366910|861670|P1|Overall Study|Withdrawal by Subject|2
261910|NCT02366767|861684|P2|Overall Study|left for home after 1 day at camp|0
261911|NCT02366767|861685|P1|Overall Study|left for home after 1 day at camp|1
261912|NCT02366689|861698|P3|Overall Study|Pregnancy|1
261913|NCT02366689|861699|P2|Overall Study|Pregnancy|1
261914|NCT02366689|861700|P1|Overall Study|Pregnancy|0
261915|NCT02366689|861698|P3|Overall Study|Lost to Follow-up|0
261916|NCT02366689|861699|P2|Overall Study|Lost to Follow-up|2
261917|NCT02366689|861700|P1|Overall Study|Lost to Follow-up|3
261918|NCT02366689|861698|P3|Overall Study|Withdrawal by Subject|1
261919|NCT02366689|861699|P2|Overall Study|Withdrawal by Subject|0
261920|NCT02366689|861700|P1|Overall Study|Withdrawal by Subject|1
261921|NCT02366637|861752|P2|Second Intervention Period|Study Terminated by Sponsor|1
261922|NCT02366637|861753|P1|Second Intervention Period|Study Terminated by Sponsor|1
261923|NCT02366637|861752|P2|First Intervention Period|Study Terminated by Sponsor|4
261924|NCT02366637|861753|P1|First Intervention Period|Study Terminated by Sponsor|6
261925|NCT02366637|861752|P2|First Intervention Period|Adverse Event|1
261926|NCT02366637|861753|P1|First Intervention Period|Adverse Event|0
261927|NCT02365519|861802|P3|Randomized and Treated|Withdrawal by Subject|1
261928|NCT02365519|861803|P2|Randomized and Treated|Withdrawal by Subject|1
261929|NCT02365519|861804|P1|Randomized and Treated|Withdrawal by Subject|0
261930|NCT02365519|861802|P3|Randomized and Treated|Adverse Event|0
261931|NCT02365519|861803|P2|Randomized and Treated|Adverse Event|1
261932|NCT02365519|861804|P1|Randomized and Treated|Adverse Event|0
261933|NCT02365298|861825|P2|Period 2|Protocol Violation|1
261934|NCT02365298|861826|P1|Period 2|Protocol Violation|0
261935|NCT02365298|861825|P2|Period 2|Test Article longer available|1
261936|NCT02365298|861826|P1|Period 2|Test Article longer available|0
261937|NCT02365298|861825|P2|Period 2|Discontinued at request of Sponsor|0
261938|NCT02365298|861826|P1|Period 2|Discontinued at request of Sponsor|1
261939|NCT02365298|861825|P2|Period 2|incorrect Rx dispensed|0
261940|NCT02365298|861826|P1|Period 2|incorrect Rx dispensed|1
261941|NCT02364999|861844|P2|Overall Study|Study ongoing|194
261942|NCT02364999|861845|P1|Overall Study|Study ongoing|179
261943|NCT02364999|861844|P2|Overall Study|Randomized but did not receive treatment|3
261944|NCT02364999|861845|P1|Overall Study|Randomized but did not receive treatment|2
261945|NCT02364999|861844|P2|Overall Study|Other|1
261946|NCT02364999|861845|P1|Overall Study|Other|1
261947|NCT02364999|861844|P2|Overall Study|Withdrawal by Subject|10
261948|NCT02364999|861845|P1|Overall Study|Withdrawal by Subject|13
261949|NCT02364999|861844|P2|Overall Study|Protocol Violation|2
261950|NCT02364999|861845|P1|Overall Study|Protocol Violation|2
261951|NCT02364999|861844|P2|Overall Study|Objective Progression Or Relapse|0
261952|NCT02364999|861845|P1|Overall Study|Objective Progression Or Relapse|3
261953|NCT02364999|861844|P2|Overall Study|Global Deterioration Of Health Status|2
261954|NCT02364999|861845|P1|Overall Study|Global Deterioration Of Health Status|0
261955|NCT02364999|861844|P2|Overall Study|Lost to Follow-up|11
261956|NCT02364999|861845|P1|Overall Study|Lost to Follow-up|9
261957|NCT02364999|861844|P2|Overall Study|Death|99
261958|NCT02364999|861845|P1|Overall Study|Death|109
261959|NCT02364180|861875|P1|Overall Study|Screen Fail|1
261960|NCT02363478|861888|P1|Overall Study|Adverse Event|4
261961|NCT02363478|861888|P1|Overall Study|Lost to Follow-up|4
261962|NCT02363439|861895|P1|Overall Study|Lack of Efficacy|4
261963|NCT02362412|861908|P2|Treatment Period III|Lost to Follow-up|1
261964|NCT02362412|861909|P1|Treatment Period III|Lost to Follow-up|0
261965|NCT02362360|861943|P2|Period 1|Withdrawal by Subject|1
261966|NCT02362360|861944|P1|Period 1|Withdrawal by Subject|2
261967|NCT02362360|861943|P2|Period 1|Lack of Efficacy|0
261968|NCT02362360|861944|P1|Period 1|Lack of Efficacy|1
261969|NCT02361580|861982|P2|Overall Study|Lost to Follow-up|3
261970|NCT02361580|861983|P1|Overall Study|Lost to Follow-up|6
261971|NCT02360995|861996|P3|Overall Study|Withdrawal by Subject|0
261972|NCT02360995|861997|P2|Overall Study|Withdrawal by Subject|1
261973|NCT02360995|861998|P1|Overall Study|Withdrawal by Subject|0
261974|NCT02360995|861996|P3|Overall Study|Lost to Follow-up|2
261975|NCT02360995|861997|P2|Overall Study|Lost to Follow-up|0
261976|NCT02360995|861998|P1|Overall Study|Lost to Follow-up|2
261977|NCT02360475|862025|P4|Overall Study|Migrated/moved from study area|1
261978|NCT02360475|862026|P3|Overall Study|Migrated/moved from study area|0
261979|NCT02360475|862027|P2|Overall Study|Migrated/moved from study area|0
261980|NCT02360475|862028|P1|Overall Study|Migrated/moved from study area|0
261981|NCT02360475|862025|P4|Overall Study|Withdrawal by Subject|0
261982|NCT02360475|862026|P3|Overall Study|Withdrawal by Subject|2
261983|NCT02360475|862027|P2|Overall Study|Withdrawal by Subject|1
261984|NCT02360475|862028|P1|Overall Study|Withdrawal by Subject|0
261985|NCT02360475|862025|P4|Overall Study|Lost to Follow-up|4
261986|NCT02360475|862026|P3|Overall Study|Lost to Follow-up|6
261987|NCT02360475|862027|P2|Overall Study|Lost to Follow-up|12
261988|NCT02360475|862028|P1|Overall Study|Lost to Follow-up|4
261989|NCT02360228|862089|P3|Overall Study|Unstable symptoms during screening|1
261990|NCT02360228|862090|P2|Overall Study|Unstable symptoms during screening|0
261991|NCT02360228|862091|P1|Overall Study|Unstable symptoms during screening|0
261992|NCT02360228|862089|P3|Overall Study|Self-discontinued medication|0
261993|NCT02360228|862090|P2|Overall Study|Self-discontinued medication|1
261994|NCT02360228|862091|P1|Overall Study|Self-discontinued medication|0
261995|NCT02360228|862089|P3|Overall Study|Withdrawal by Subject|0
261996|NCT02360228|862090|P2|Overall Study|Withdrawal by Subject|0
261997|NCT02360228|862091|P1|Overall Study|Withdrawal by Subject|1
261998|NCT02359903|862196|P2|Overall Study|Adverse Event|2
261999|NCT02359903|862197|P1|Overall Study|Adverse Event|0
262000|NCT02359890|862205|P1|Overall Study|Never treated with study catheter|6
262001|NCT02359890|862205|P1|Overall Study|Not meeting eligibility|4
262002|NCT02359877|862215|P4|Overall Study|Adverse Event|1
262003|NCT02359877|862216|P3|Overall Study|Adverse Event|0
262004|NCT02359877|862217|P2|Overall Study|Adverse Event|0
262005|NCT02359877|862218|P1|Overall Study|Adverse Event|0
262006|NCT02359877|862215|P4|Overall Study|Withdrawal by Subject|2
262007|NCT02359877|862216|P3|Overall Study|Withdrawal by Subject|0
262008|NCT02359877|862217|P2|Overall Study|Withdrawal by Subject|0
262009|NCT02359877|862218|P1|Overall Study|Withdrawal by Subject|1
262010|NCT02359851|862268|P1|Overall Study|Disease progression|1
262011|NCT02359851|862268|P1|Overall Study|Death|1
262012|NCT02359435|862278|P2|Overall Study|Lost to Follow-up|4
262013|NCT02359435|862279|P1|Overall Study|Lost to Follow-up|4
262014|NCT02359045|862339|P2|Overall Study|Adverse Event|1
262015|NCT02359045|862340|P1|Overall Study|Adverse Event|0
262016|NCT02359045|862339|P2|Overall Study|Lost to Follow-up|1
262017|NCT02359045|862340|P1|Overall Study|Lost to Follow-up|1
262018|NCT02359045|862339|P2|Overall Study|Eligibility criteria not fulfilled|1
262019|NCT02359045|862340|P1|Overall Study|Eligibility criteria not fulfilled|3
262020|NCT02358863|862577|P1|Overall Study|Physician Decision|3
262021|NCT02358668|862584|P3|Overall Study|Withdrawal by Subject|0
262022|NCT02358668|862585|P2|Overall Study|Withdrawal by Subject|1
262023|NCT02358668|862586|P1|Overall Study|Withdrawal by Subject|0
262024|NCT02358668|862584|P3|Overall Study|Adverse Event|0
262025|NCT02358668|862585|P2|Overall Study|Adverse Event|0
262026|NCT02358668|862586|P1|Overall Study|Adverse Event|2
262027|NCT02358044|862728|P2|Overall Study|Withdrawal by Subject|4
262028|NCT02358044|862729|P1|Overall Study|Withdrawal by Subject|0
262029|NCT02358044|862728|P2|Overall Study|Physician Decision|1
262030|NCT02358044|862729|P1|Overall Study|Physician Decision|0
262031|NCT02358044|862728|P2|Overall Study|Lost to Follow-up|1
262032|NCT02358044|862729|P1|Overall Study|Lost to Follow-up|2
262033|NCT02358044|862728|P2|Overall Study|Adverse Event|1
262034|NCT02358044|862729|P1|Overall Study|Adverse Event|0
262035|NCT02357940|862747|P2|Overall Study|Investigator's judgement|1
262036|NCT02357940|862748|P1|Overall Study|Investigator's judgement|0
262037|NCT02357940|862747|P2|Overall Study|Adverse Event|1
262038|NCT02357940|862748|P1|Overall Study|Adverse Event|0
262039|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
262040|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
262041|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
262042|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
262043|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
262044|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
262045|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
262046|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
262047|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
262048|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
262049|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
262050|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
262051|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
262052|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
262053|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
262054|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
262055|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
262056|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
262057|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
262058|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
262059|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
262060|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
262061|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
262062|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
262063|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
262064|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
262065|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
262066|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
262067|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
262068|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
262069|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
262070|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
262071|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
262072|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
262073|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
262074|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
262075|NCT02357901|862875|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
262076|NCT02357901|862876|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
262077|NCT02357901|862877|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
262078|NCT02357901|862878|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
262079|NCT02357901|862875|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
262080|NCT02357901|862876|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
262081|NCT02357901|862877|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
262082|NCT02357901|862878|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
262083|NCT02357459|862939|P3|Overall Study|Job Commitments|1
262084|NCT02357459|862940|P2|Overall Study|Job Commitments|0
262085|NCT02357459|862941|P1|Overall Study|Job Commitments|0
262086|NCT02357459|862939|P3|Overall Study|Pre-planned Knee surgery|2
262087|NCT02357459|862940|P2|Overall Study|Pre-planned Knee surgery|0
262088|NCT02357459|862941|P1|Overall Study|Pre-planned Knee surgery|0
262089|NCT02357459|862939|P3|Overall Study|Incarceration|1
262090|NCT02357459|862940|P2|Overall Study|Incarceration|0
262091|NCT02357459|862941|P1|Overall Study|Incarceration|0
262092|NCT02357459|862939|P3|Overall Study|Instruction from PCP|0
262093|NCT02357459|862940|P2|Overall Study|Instruction from PCP|0
262094|NCT02357459|862941|P1|Overall Study|Instruction from PCP|1
262095|NCT02357459|862939|P3|Overall Study|Patient Relocated|0
262096|NCT02357459|862940|P2|Overall Study|Patient Relocated|0
262097|NCT02357459|862941|P1|Overall Study|Patient Relocated|2
262098|NCT02357459|862939|P3|Overall Study|Lack of Efficacy|4
262099|NCT02357459|862940|P2|Overall Study|Lack of Efficacy|4
262100|NCT02357459|862941|P1|Overall Study|Lack of Efficacy|7
262101|NCT02357459|862939|P3|Overall Study|Lost to Follow-up|0
262102|NCT02357459|862940|P2|Overall Study|Lost to Follow-up|3
262103|NCT02357459|862941|P1|Overall Study|Lost to Follow-up|1
262104|NCT02357459|862939|P3|Overall Study|Protocol Violation|0
262105|NCT02357459|862940|P2|Overall Study|Protocol Violation|1
262106|NCT02357459|862941|P1|Overall Study|Protocol Violation|1
262107|NCT02357459|862939|P3|Overall Study|Physician Decision|0
262108|NCT02357459|862940|P2|Overall Study|Physician Decision|2
262109|NCT02357459|862941|P1|Overall Study|Physician Decision|0
262110|NCT02357459|862939|P3|Overall Study|Withdrawal by Subject|3
262111|NCT02357459|862940|P2|Overall Study|Withdrawal by Subject|3
262112|NCT02357459|862941|P1|Overall Study|Withdrawal by Subject|5
262113|NCT02357459|862939|P3|Overall Study|Adverse Event|1
262114|NCT02357459|862940|P2|Overall Study|Adverse Event|1
262115|NCT02357459|862941|P1|Overall Study|Adverse Event|0
262116|NCT02357342|862985|P2|First 6 Months|Death|0
262117|NCT02357342|862986|P1|First 6 Months|Death|2
262118|NCT02356783|863050|P2|Overall Study|Lost to Follow-up|3
262119|NCT02356783|863051|P1|Overall Study|Lost to Follow-up|1
262120|NCT02356588|863061|P2|Overall Study|Protocol Violation|1
262121|NCT02356588|863062|P1|Overall Study|Protocol Violation|0
262122|NCT02356588|863061|P2|Overall Study|Withdrawal by Subject|0
262123|NCT02356588|863062|P1|Overall Study|Withdrawal by Subject|1
262124|NCT02356588|863061|P2|Overall Study|Adverse Event|2
262125|NCT02356588|863062|P1|Overall Study|Adverse Event|0
262126|NCT02356588|863061|P2|Overall Study|Lack of Efficacy|10
262127|NCT02356588|863062|P1|Overall Study|Lack of Efficacy|4
262128|NCT02356562|863096|P2|Overall Study|site closure|0
262129|NCT02356562|863097|P1|Overall Study|site closure|1
262130|NCT02356562|863096|P2|Overall Study|Re-entered treatment in a previous study|0
262131|NCT02356562|863097|P1|Overall Study|Re-entered treatment in a previous study|1
262132|NCT02356562|863096|P2|Overall Study|Withdrawal by Subject|1
262133|NCT02356562|863097|P1|Overall Study|Withdrawal by Subject|0
262134|NCT02355743|863130|P1|Overall Study|Lost to Follow-up|1
262135|NCT02355743|863130|P1|Overall Study|Withdrawal by Subject|1
262136|NCT02355691|863138|P2|Overall Study|Loss of Research Personnel|9
262137|NCT02355691|863139|P1|Overall Study|Loss of Research Personnel|7
262138|NCT02355028|863158|P2|Overall Study|Deemed ineligible after randomization|4
262139|NCT02355028|863159|P1|Overall Study|Deemed ineligible after randomization|8
262140|NCT02355028|863158|P2|Overall Study|Withdrawal by Subject|1
262141|NCT02355028|863159|P1|Overall Study|Withdrawal by Subject|1
262142|NCT02355028|863158|P2|Overall Study|Adverse Event|0
262143|NCT02355028|863159|P1|Overall Study|Adverse Event|2
262144|NCT02354599|863226|P6|Overall Study|Withdrawal by Subject|0
262145|NCT02354599|863227|P5|Overall Study|Withdrawal by Subject|0
262146|NCT02354599|863228|P4|Overall Study|Withdrawal by Subject|0
262147|NCT02354599|863229|P3|Overall Study|Withdrawal by Subject|0
262148|NCT02354599|863230|P2|Overall Study|Withdrawal by Subject|1
262149|NCT02354599|863231|P1|Overall Study|Withdrawal by Subject|1
262150|NCT02354599|863226|P6|Overall Study|Pretreatment Event/Adverse Event|1
262151|NCT02354599|863227|P5|Overall Study|Pretreatment Event/Adverse Event|0
262152|NCT02354599|863228|P4|Overall Study|Pretreatment Event/Adverse Event|0
262153|NCT02354599|863229|P3|Overall Study|Pretreatment Event/Adverse Event|0
262154|NCT02354599|863230|P2|Overall Study|Pretreatment Event/Adverse Event|0
262155|NCT02354599|863231|P1|Overall Study|Pretreatment Event/Adverse Event|0
262156|NCT02353871|863303|P2|Overall Study|Lost to Follow-up|0
262157|NCT02353871|863304|P1|Overall Study|Lost to Follow-up|2
262158|NCT02353871|863303|P2|Overall Study|Consent withdrawn|8
262159|NCT02353871|863304|P1|Overall Study|Consent withdrawn|1
262160|NCT02353871|863303|P2|Overall Study|Protocol deviation|1
262161|NCT02353871|863304|P1|Overall Study|Protocol deviation|0
262162|NCT02353572|863337|P1|Overall Study|Study terminated|2
262163|NCT02353572|863337|P1|Overall Study|Withdrawal by Subject|1
262164|NCT02353468|863341|P1|Overall Study|Study terminated|3
262165|NCT02353442|863347|P2|Overall Study|Withdrawal by Subject|4
262166|NCT02353442|863348|P1|Overall Study|Withdrawal by Subject|3
262167|NCT02352779|863402|P3|Overall Study|No Reason|1
262168|NCT02352779|863403|P2|Overall Study|No Reason|0
262169|NCT02352779|863404|P1|Overall Study|No Reason|0
262170|NCT02352779|863402|P3|Overall Study|Other Medical Reason|1
262171|NCT02352779|863403|P2|Overall Study|Other Medical Reason|0
262172|NCT02352779|863404|P1|Overall Study|Other Medical Reason|0
262173|NCT02352779|863402|P3|Overall Study|Absence of Symptoms|0
262174|NCT02352779|863403|P2|Overall Study|Absence of Symptoms|0
262175|NCT02352779|863404|P1|Overall Study|Absence of Symptoms|1
262176|NCT02352779|863402|P3|Overall Study|Study Related Symptoms|0
262177|NCT02352779|863403|P2|Overall Study|Study Related Symptoms|0
262178|NCT02352779|863404|P1|Overall Study|Study Related Symptoms|1
262179|NCT02352779|863402|P3|Overall Study|Changed Mind|0
262180|NCT02352779|863403|P2|Overall Study|Changed Mind|0
262181|NCT02352779|863404|P1|Overall Study|Changed Mind|1
262182|NCT02352779|863402|P3|Overall Study|Disliked Intervention|0
262183|NCT02352779|863403|P2|Overall Study|Disliked Intervention|0
262184|NCT02352779|863404|P1|Overall Study|Disliked Intervention|1
262185|NCT02352779|863402|P3|Overall Study|Feeling Overwhelmed|0
262186|NCT02352779|863403|P2|Overall Study|Feeling Overwhelmed|0
262187|NCT02352779|863404|P1|Overall Study|Feeling Overwhelmed|1
262188|NCT02352779|863402|P3|Overall Study|Too Many Forms|0
262189|NCT02352779|863403|P2|Overall Study|Too Many Forms|0
262190|NCT02352779|863404|P1|Overall Study|Too Many Forms|2
262191|NCT02352779|863402|P3|Overall Study|Personal Issues|0
262192|NCT02352779|863403|P2|Overall Study|Personal Issues|1
262193|NCT02352779|863404|P1|Overall Study|Personal Issues|1
262194|NCT02351960|863419|P2|Overall Study|Significant Protocol Deviation|5
262195|NCT02351960|863420|P1|Overall Study|Significant Protocol Deviation|0
262196|NCT02351960|863419|P2|Overall Study|Voluntary Withdrawal|4
262197|NCT02351960|863420|P1|Overall Study|Voluntary Withdrawal|5
262198|NCT02351960|863419|P2|Overall Study|Pretreatment Event/Adverse Event|3
262199|NCT02351960|863420|P1|Overall Study|Pretreatment Event/Adverse Event|6
262200|NCT02351934|863441|P2|Follow-Up|2 ERAS Components Noncompliant|4
262201|NCT02351934|863442|P1|Follow-Up|2 ERAS Components Noncompliant|0
262202|NCT02351934|863441|P2|Follow-Up|1 ERAS Component Noncompliant|6
262203|NCT02351934|863442|P1|Follow-Up|1 ERAS Component Noncompliant|0
262204|NCT02351934|863441|P2|Follow-Up|No documentation|0
262205|NCT02351934|863442|P1|Follow-Up|No documentation|2
262206|NCT02351934|863441|P2|Follow-Up|Hypotension|0
262207|NCT02351934|863442|P1|Follow-Up|Hypotension|3
262208|NCT02351934|863441|P2|Follow-Up|Early dismissal|0
262209|NCT02351934|863442|P1|Follow-Up|Early dismissal|3
262210|NCT02351934|863441|P2|Follow-Up|Acute Kidney Injury|0
262211|NCT02351934|863442|P1|Follow-Up|Acute Kidney Injury|1
262212|NCT02351934|863441|P2|Follow-Up|POD weight<pre-op weight|0
262213|NCT02351934|863442|P1|Follow-Up|POD weight<pre-op weight|3
262214|NCT02351934|863441|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
262215|NCT02351934|863442|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
262216|NCT02351934|863441|P2|Allocation|Hypotension preventing administration|0
262217|NCT02351934|863442|P1|Allocation|Hypotension preventing administration|2
262218|NCT02351934|863441|P2|Allocation|POD weight<pre-op weight|0
262219|NCT02351934|863442|P1|Allocation|POD weight<pre-op weight|3
262220|NCT02351817|863458|P2|Period 2|Protocol Violation|0
262221|NCT02351817|863459|P1|Period 2|Protocol Violation|1
262222|NCT02351817|863458|P2|Period 2|Adverse Event|2
262223|NCT02351817|863459|P1|Period 2|Adverse Event|0
262224|NCT02351817|863458|P2|Period 1|Lack of Efficacy|1
262225|NCT02351817|863459|P1|Period 1|Lack of Efficacy|0
262226|NCT02351817|863458|P2|Period 1|Adverse Event|2
262227|NCT02351817|863459|P1|Period 1|Adverse Event|1
262228|NCT02349711|863526|P2|Overall Study|Lost to Follow-up|1
262229|NCT02349711|863527|P1|Overall Study|Lost to Follow-up|1
262230|NCT02349711|863526|P2|Overall Study|Withdrawal by Subject|1
262231|NCT02349711|863527|P1|Overall Study|Withdrawal by Subject|2
262232|NCT02349542|863560|P1|Overall Study|Withdrawal by Subject|5
262233|NCT02349451|863569|P4|Overall Study|Withdrawal by Subject|1
262234|NCT02349451|863570|P3|Overall Study|Withdrawal by Subject|2
262235|NCT02349451|863571|P2|Overall Study|Withdrawal by Subject|1
262236|NCT02349451|863572|P1|Overall Study|Withdrawal by Subject|0
262237|NCT02349360|863621|P2|Overall Study|Withdrawal by Subject|1
262238|NCT02349360|863622|P1|Overall Study|Withdrawal by Subject|0
262239|NCT02349295|863633|P5|IR (Week 16-24)|Lack of Efficacy|1
262240|NCT02349295|863634|P4|IR (Week 16-24)|Lack of Efficacy|0
262241|NCT02349295|863635|P3|IR (Week 16-24)|Lack of Efficacy|0
262242|NCT02349295|863636|P2|IR (Week 16-24)|Lack of Efficacy|0
262243|NCT02349295|863637|P1|IR (Week 16-24)|Lack of Efficacy|0
262244|NCT02349295|863633|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
262245|NCT02349295|863634|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
262246|NCT02349295|863635|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
262247|NCT02349295|863636|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
262248|NCT02349295|863637|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
262249|NCT02349295|863633|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
262250|NCT02349295|863634|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
262251|NCT02349295|863635|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
262252|NCT02349295|863636|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
262253|NCT02349295|863637|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
262254|NCT02349295|863633|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
262255|NCT02349295|863634|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
262256|NCT02349295|863635|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
262257|NCT02349295|863636|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
262258|NCT02349295|863637|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
262259|NCT02349295|863633|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
262260|NCT02349295|863634|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
262261|NCT02349295|863635|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
262262|NCT02349295|863636|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
262263|NCT02349295|863637|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
262264|NCT02349295|863633|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
262265|NCT02349295|863634|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
262266|NCT02349295|863635|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
262267|NCT02349295|863636|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
262268|NCT02349295|863637|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
262269|NCT02349061|863740|P2|Overall Study|Other|1
262270|NCT02349061|863741|P1|Overall Study|Other|3
262271|NCT02349061|863740|P2|Overall Study|Physician Decision|0
262272|NCT02349061|863741|P1|Overall Study|Physician Decision|1
262273|NCT02349061|863740|P2|Overall Study|Lack of Efficacy|0
262274|NCT02349061|863741|P1|Overall Study|Lack of Efficacy|1
262275|NCT02349061|863740|P2|Overall Study|Adverse Event|3
262276|NCT02349061|863741|P1|Overall Study|Adverse Event|4
262277|NCT02349048|863749|P2|Overall Study|Lost to Follow-up|0
262278|NCT02349048|863750|P1|Overall Study|Lost to Follow-up|1
262279|NCT02349048|863749|P2|Overall Study|Withdrawal by Subject|0
262280|NCT02349048|863750|P1|Overall Study|Withdrawal by Subject|4
262281|NCT02348723|863772|P2|Overall Study|Adverse Event|1
262282|NCT02348723|863773|P1|Overall Study|Adverse Event|3
262283|NCT02348723|863772|P2|Overall Study|Reason other than specified|1
262284|NCT02348723|863773|P1|Overall Study|Reason other than specified|1
262285|NCT02348723|863772|P2|Overall Study|Consent withdrawn|3
262286|NCT02348723|863773|P1|Overall Study|Consent withdrawn|1
262287|NCT02348723|863772|P2|Overall Study|Lost to Follow-up|1
262288|NCT02348723|863773|P1|Overall Study|Lost to Follow-up|1
262289|NCT02348723|863772|P2|Overall Study|Non-compliant with Protocol|0
262290|NCT02348723|863773|P1|Overall Study|Non-compliant with Protocol|1
262291|NCT02348723|863772|P2|Overall Study|No ablation|20
262292|NCT02348723|863773|P1|Overall Study|No ablation|21
262293|NCT02347774|863840|P3|On Study Treatment|ranomized in error|1
262294|NCT02347774|863841|P2|On Study Treatment|ranomized in error|0
262295|NCT02347774|863842|P1|On Study Treatment|ranomized in error|0
262296|NCT02347774|863840|P3|On Study Treatment|Met Prolonged QT criteria|0
262297|NCT02347774|863841|P2|On Study Treatment|Met Prolonged QT criteria|0
262298|NCT02347774|863842|P1|On Study Treatment|Met Prolonged QT criteria|1
262299|NCT02347774|863840|P3|On Study Treatment|Lost to Follow-up|1
262300|NCT02347774|863841|P2|On Study Treatment|Lost to Follow-up|6
262301|NCT02347774|863842|P1|On Study Treatment|Lost to Follow-up|2
262302|NCT02347774|863840|P3|On Study Treatment|withdrew consent|12
262303|NCT02347774|863841|P2|On Study Treatment|withdrew consent|8
262304|NCT02347774|863842|P1|On Study Treatment|withdrew consent|9
262305|NCT02347774|863840|P3|On Study Treatment|Protocol Violation|1
262306|NCT02347774|863841|P2|On Study Treatment|Protocol Violation|0
262307|NCT02347774|863842|P1|On Study Treatment|Protocol Violation|0
262308|NCT02347774|863840|P3|On Study Treatment|non-complicance with study medication|0
262309|NCT02347774|863841|P2|On Study Treatment|non-complicance with study medication|2
262310|NCT02347774|863842|P1|On Study Treatment|non-complicance with study medication|0
262311|NCT02347774|863840|P3|On Study Treatment|Lack of Efficacy|2
262312|NCT02347774|863841|P2|On Study Treatment|Lack of Efficacy|0
262313|NCT02347774|863842|P1|On Study Treatment|Lack of Efficacy|3
262314|NCT02347774|863840|P3|On Study Treatment|Adverse Event|19
262315|NCT02347774|863841|P2|On Study Treatment|Adverse Event|15
262316|NCT02347774|863842|P1|On Study Treatment|Adverse Event|9
262317|NCT02347774|863840|P3|Study Participation|randomized in error|1
262318|NCT02347774|863841|P2|Study Participation|randomized in error|0
262319|NCT02347774|863842|P1|Study Participation|randomized in error|0
262320|NCT02347774|863840|P3|Study Participation|incarceration|0
262321|NCT02347774|863841|P2|Study Participation|incarceration|0
262322|NCT02347774|863842|P1|Study Participation|incarceration|1
262323|NCT02347774|863840|P3|Study Participation|non-compliance with study drug|0
262324|NCT02347774|863841|P2|Study Participation|non-compliance with study drug|1
262325|NCT02347774|863842|P1|Study Participation|non-compliance with study drug|0
262326|NCT02347774|863840|P3|Study Participation|Met Prolonged QT criteria|0
262327|NCT02347774|863841|P2|Study Participation|Met Prolonged QT criteria|0
262328|NCT02347774|863842|P1|Study Participation|Met Prolonged QT criteria|1
262329|NCT02347774|863840|P3|Study Participation|withdrew consent|1
262330|NCT02347774|863841|P2|Study Participation|withdrew consent|1
262331|NCT02347774|863842|P1|Study Participation|withdrew consent|1
262332|NCT02347774|863840|P3|Study Participation|Adverse Event|6
262333|NCT02347774|863841|P2|Study Participation|Adverse Event|4
262334|NCT02347774|863842|P1|Study Participation|Adverse Event|1
262335|NCT02347774|863840|P3|Study Participation|Withdrawal by Subject|15
262336|NCT02347774|863841|P2|Study Participation|Withdrawal by Subject|9
262337|NCT02347774|863842|P1|Study Participation|Withdrawal by Subject|8
262338|NCT02347774|863840|P3|Study Participation|Lost to Follow-up|2
262339|NCT02347774|863841|P2|Study Participation|Lost to Follow-up|6
262340|NCT02347774|863842|P1|Study Participation|Lost to Follow-up|3
262341|NCT02347761|863898|P3|On Study Treatment|Adverse Event|20
262342|NCT02347761|863899|P2|On Study Treatment|Adverse Event|8
262343|NCT02347761|863900|P1|On Study Treatment|Adverse Event|10
262344|NCT02347761|863898|P3|On Study Treatment|durg not working|1
262345|NCT02347761|863899|P2|On Study Treatment|durg not working|1
262346|NCT02347761|863900|P1|On Study Treatment|durg not working|0
262347|NCT02347761|863898|P3|On Study Treatment|investigator discretion|0
262348|NCT02347761|863899|P2|On Study Treatment|investigator discretion|0
262349|NCT02347761|863900|P1|On Study Treatment|investigator discretion|2
262350|NCT02347761|863898|P3|On Study Treatment|Lost to Follow-up|1
262351|NCT02347761|863899|P2|On Study Treatment|Lost to Follow-up|1
262352|NCT02347761|863900|P1|On Study Treatment|Lost to Follow-up|2
262353|NCT02347761|863898|P3|On Study Treatment|dissastisfaction with device|4
262354|NCT02347761|863899|P2|On Study Treatment|dissastisfaction with device|1
262355|NCT02347761|863900|P1|On Study Treatment|dissastisfaction with device|2
262356|NCT02347761|863898|P3|On Study Treatment|move/travel|5
262357|NCT02347761|863899|P2|On Study Treatment|move/travel|6
262358|NCT02347761|863900|P1|On Study Treatment|move/travel|2
262359|NCT02347761|863898|P3|On Study Treatment|Withdrawal by Subject|5
262360|NCT02347761|863899|P2|On Study Treatment|Withdrawal by Subject|3
262361|NCT02347761|863900|P1|On Study Treatment|Withdrawal by Subject|7
262362|NCT02347761|863898|P3|On Study Treatment|non-compliance with study medication|2
262363|NCT02347761|863899|P2|On Study Treatment|non-compliance with study medication|0
262364|NCT02347761|863900|P1|On Study Treatment|non-compliance with study medication|0
262365|NCT02347761|863898|P3|On Study Treatment|Lack of Efficacy|4
262366|NCT02347761|863899|P2|On Study Treatment|Lack of Efficacy|3
262367|NCT02347761|863900|P1|On Study Treatment|Lack of Efficacy|2
262368|NCT02347761|863898|P3|All Collected|moved/travel|0
262369|NCT02347761|863899|P2|All Collected|moved/travel|1
262370|NCT02347761|863900|P1|All Collected|moved/travel|0
262371|NCT02347761|863898|P3|All Collected|exacerbation of COPD|1
262372|NCT02347761|863899|P2|All Collected|exacerbation of COPD|0
262373|NCT02347761|863900|P1|All Collected|exacerbation of COPD|0
262374|NCT02347761|863898|P3|All Collected|instillation site pain|1
262375|NCT02347761|863899|P2|All Collected|instillation site pain|0
262376|NCT02347761|863900|P1|All Collected|instillation site pain|0
262377|NCT02347761|863898|P3|All Collected|invetigator disretion|0
262378|NCT02347761|863899|P2|All Collected|invetigator disretion|0
262379|NCT02347761|863900|P1|All Collected|invetigator disretion|2
262380|NCT02347761|863898|P3|All Collected|Withdrawal by Subject|22
262381|NCT02347761|863899|P2|All Collected|Withdrawal by Subject|11
262382|NCT02347761|863900|P1|All Collected|Withdrawal by Subject|11
262383|NCT02347761|863898|P3|All Collected|Lost to Follow-up|3
262384|NCT02347761|863899|P2|All Collected|Lost to Follow-up|2
262385|NCT02347761|863900|P1|All Collected|Lost to Follow-up|3
262386|NCT02347761|863898|P3|All Collected|Death|0
262387|NCT02347761|863899|P2|All Collected|Death|0
262388|NCT02347761|863900|P1|All Collected|Death|1
262389|NCT02347657|863961|P2|Overall Study|Other|3
262390|NCT02347657|863962|P1|Overall Study|Other|3
262391|NCT02347657|863961|P2|Overall Study|Randomized but not treated|0
262392|NCT02347657|863962|P1|Overall Study|Randomized but not treated|1
262393|NCT02347657|863961|P2|Overall Study|Withdrawal by Subject|7
262394|NCT02347657|863962|P1|Overall Study|Withdrawal by Subject|6
262395|NCT02347657|863961|P2|Overall Study|Adverse Event|4
262396|NCT02347657|863962|P1|Overall Study|Adverse Event|8
262397|NCT02347657|863961|P2|Overall Study|Physician Decision|1
262398|NCT02347657|863962|P1|Overall Study|Physician Decision|0
262399|NCT02347189|864019|P1|Overall Study|No primary outcome data available|2
262400|NCT02347189|864019|P1|Overall Study|No implant attempted of study device|9
262401|NCT02347176|864027|P4|Overall Study|Other|0
262402|NCT02347176|864028|P3|Overall Study|Other|2
262403|NCT02347176|864029|P2|Overall Study|Other|2
262404|NCT02347176|864030|P1|Overall Study|Other|1
262405|NCT02347176|864027|P4|Overall Study|Withdrawal by Subject|3
262406|NCT02347176|864028|P3|Overall Study|Withdrawal by Subject|5
262407|NCT02347176|864029|P2|Overall Study|Withdrawal by Subject|5
262408|NCT02347176|864030|P1|Overall Study|Withdrawal by Subject|9
262409|NCT02347176|864027|P4|Overall Study|Lost to Follow-up|1
262410|NCT02347176|864028|P3|Overall Study|Lost to Follow-up|1
262411|NCT02347176|864029|P2|Overall Study|Lost to Follow-up|3
262412|NCT02347176|864030|P1|Overall Study|Lost to Follow-up|2
262413|NCT02347085|864113|P1|Overall Study|Protocol Criteria|2
262414|NCT02347085|864113|P1|Overall Study|Lost to Follow-up|1
262415|NCT02347085|864113|P1|Overall Study|Withdrawal by Subject|4
262416|NCT02347085|864113|P1|Overall Study|Lack of Efficacy|1
262417|NCT02347085|864113|P1|Overall Study|Adverse Event|2
262418|NCT02347072|864135|P1|Overall Study|Disc due to Protocol-specified Criteria|6
262419|NCT02347072|864135|P1|Overall Study|Protocol Violation|1
262420|NCT02347072|864135|P1|Overall Study|Lost to Follow-up|2
262421|NCT02347072|864135|P1|Overall Study|Physician Decision|1
262422|NCT02347072|864135|P1|Overall Study|Withdrawal by Subject|6
262423|NCT02347072|864135|P1|Overall Study|Adverse Event|2
262424|NCT02346877|864169|P2|Overall Study|Missing|0
262425|NCT02346877|864170|P1|Overall Study|Missing|5
262426|NCT02346877|864169|P2|Overall Study|Sponsor Decision|0
262427|NCT02346877|864170|P1|Overall Study|Sponsor Decision|12
262428|NCT02346877|864169|P2|Overall Study|Administrative Decision|0
262429|NCT02346877|864170|P1|Overall Study|Administrative Decision|1
262430|NCT02346877|864169|P2|Overall Study|Adverse Event|0
262431|NCT02346877|864170|P1|Overall Study|Adverse Event|1
262432|NCT02346721|864180|P1|Overall Study|Lack of Efficacy|1
262433|NCT02346721|864180|P1|Overall Study|Withdrew Consent|3
262434|NCT02345330|864215|P1|Overall Study|Progressive Disease|2
262435|NCT02345330|864215|P1|Overall Study|Death|1
262436|NCT02345252|864227|P2|Overall Study|Still in Study up to the Data Cut Date|300
262437|NCT02345252|864228|P1|Overall Study|Still in Study up to the Data Cut Date|304
262438|NCT02345252|864227|P2|Overall Study|Randomized but Never Treated|2
262439|NCT02345252|864228|P1|Overall Study|Randomized but Never Treated|0
262440|NCT02345252|864227|P2|Overall Study|Lost to Follow-up|3
262441|NCT02345252|864228|P1|Overall Study|Lost to Follow-up|2
262442|NCT02345252|864227|P2|Overall Study|Withdrew Consent|9
262443|NCT02345252|864228|P1|Overall Study|Withdrew Consent|7
262444|NCT02345252|864227|P2|Overall Study|Protocol Violation|0
262445|NCT02345252|864228|P1|Overall Study|Protocol Violation|1
262446|NCT02345252|864227|P2|Overall Study|Investigator's Discretion|1
262447|NCT02345252|864228|P1|Overall Study|Investigator's Discretion|0
262448|NCT02345252|864227|P2|Overall Study|Death|1
262449|NCT02345252|864228|P1|Overall Study|Death|1
262450|NCT02345252|864227|P2|Overall Study|Adverse Event|0
262451|NCT02345252|864228|P1|Overall Study|Adverse Event|1
262452|NCT02345226|864244|P2|Overall Study|Still in Study up to the Data Cut Date|409
262453|NCT02345226|864245|P1|Overall Study|Still in Study up to the Data Cut Date|405
262454|NCT02345226|864244|P2|Overall Study|Randomized but Never Treated|4
262455|NCT02345226|864245|P1|Overall Study|Randomized but Never Treated|2
262456|NCT02345226|864244|P2|Overall Study|Lost to Follow-up|6
262457|NCT02345226|864245|P1|Overall Study|Lost to Follow-up|7
262458|NCT02345226|864244|P2|Overall Study|Withdrew Consent|16
262459|NCT02345226|864245|P1|Overall Study|Withdrew Consent|18
262460|NCT02345226|864244|P2|Overall Study|Non-Compliance with Study Drug|0
262461|NCT02345226|864245|P1|Overall Study|Non-Compliance with Study Drug|1
262462|NCT02345226|864244|P2|Overall Study|Investigator's Discretion|1
262463|NCT02345226|864245|P1|Overall Study|Investigator's Discretion|3
262464|NCT02345226|864244|P2|Overall Study|Lack of Efficacy|0
262465|NCT02345226|864245|P1|Overall Study|Lack of Efficacy|1
262466|NCT02345226|864244|P2|Overall Study|Pregnancy|1
262467|NCT02345226|864245|P1|Overall Study|Pregnancy|0
262468|NCT02345226|864244|P2|Overall Study|Death|0
262469|NCT02345226|864245|P1|Overall Study|Death|1
262470|NCT02345226|864244|P2|Overall Study|Adverse Event|4
262471|NCT02345226|864245|P1|Overall Study|Adverse Event|2
262472|NCT02344745|864278|P2|Overall Study|Data collection sheets were lost|0
262473|NCT02344745|864279|P1|Overall Study|Data collection sheets were lost|2
262474|NCT02344342|864311|P4|Overall Study|Industry partner dropped out|10
262475|NCT02344342|864312|P3|Overall Study|Industry partner dropped out|14
262476|NCT02344342|864313|P2|Overall Study|Industry partner dropped out|9
262477|NCT02344342|864314|P1|Overall Study|Industry partner dropped out|11
262478|NCT02343159|864369|P3|Overall Study|Enrollment Error|0
262479|NCT02343159|864370|P2|Overall Study|Enrollment Error|0
262480|NCT02343159|864371|P1|Overall Study|Enrollment Error|1
262481|NCT02343159|864369|P3|Overall Study|Sponsor Decision|0
262482|NCT02343159|864370|P2|Overall Study|Sponsor Decision|1
262483|NCT02343159|864371|P1|Overall Study|Sponsor Decision|0
262484|NCT02343159|864369|P3|Overall Study|Adverse Event|2
262485|NCT02343159|864370|P2|Overall Study|Adverse Event|4
262486|NCT02343159|864371|P1|Overall Study|Adverse Event|4
262487|NCT02343159|864369|P3|Overall Study|Lost to Follow-up|2
262488|NCT02343159|864370|P2|Overall Study|Lost to Follow-up|2
262489|NCT02343159|864371|P1|Overall Study|Lost to Follow-up|0
262490|NCT02343159|864369|P3|Overall Study|Withdrawal by Subject|2
262491|NCT02343159|864370|P2|Overall Study|Withdrawal by Subject|0
262492|NCT02343159|864371|P1|Overall Study|Withdrawal by Subject|3
262493|NCT02343159|864369|P3|Overall Study|Physician Decision|1
262494|NCT02343159|864370|P2|Overall Study|Physician Decision|0
262495|NCT02343159|864371|P1|Overall Study|Physician Decision|2
262496|NCT02343159|864369|P3|Overall Study|Early Study Termination|23
262497|NCT02343159|864370|P2|Overall Study|Early Study Termination|19
262498|NCT02343159|864371|P1|Overall Study|Early Study Termination|16
262499|NCT02343003|864415|P2|Overall Study|terminated by sponsor|0
262500|NCT02343003|864416|P1|Overall Study|terminated by sponsor|2
262501|NCT02343003|864415|P2|Overall Study|exclusion criteria met|1
262502|NCT02343003|864416|P1|Overall Study|exclusion criteria met|1
262503|NCT02343003|864415|P2|Overall Study|Death|1
262504|NCT02343003|864416|P1|Overall Study|Death|0
262505|NCT02343003|864415|P2|Overall Study|Protocol Violation|0
262506|NCT02343003|864416|P1|Overall Study|Protocol Violation|1
262507|NCT02343003|864415|P2|Overall Study|Lost to Follow-up|1
262508|NCT02343003|864416|P1|Overall Study|Lost to Follow-up|5
262509|NCT02343003|864415|P2|Overall Study|Withdrawal by Subject|4
262510|NCT02343003|864416|P1|Overall Study|Withdrawal by Subject|9
262511|NCT02342704|864434|P2|Overall Study|Adverse Event|3
262512|NCT02342704|864435|P1|Overall Study|Adverse Event|1
262513|NCT02342704|864434|P2|Overall Study|Lost to Follow-up|1
262514|NCT02342704|864435|P1|Overall Study|Lost to Follow-up|2
262515|NCT02342704|864434|P2|Overall Study|Withdrawal by Subject|0
262516|NCT02342704|864435|P1|Overall Study|Withdrawal by Subject|1
262517|NCT02342704|864434|P2|Overall Study|Not Specified|1
262518|NCT02342704|864435|P1|Overall Study|Not Specified|0
262519|NCT02342704|864434|P2|Overall Study|Sponsor Termination|43
262520|NCT02342704|864435|P1|Overall Study|Sponsor Termination|49
262521|NCT02342704|864434|P2|Overall Study|Physician Decision|3
262522|NCT02342704|864435|P1|Overall Study|Physician Decision|0
262523|NCT02342548|864472|P3|Overall Study|Other|1
262524|NCT02342548|864473|P2|Overall Study|Other|1
262525|NCT02342548|864474|P1|Overall Study|Other|1
262526|NCT02342548|864472|P3|Overall Study|Withdrawal by Subject|4
262527|NCT02342548|864473|P2|Overall Study|Withdrawal by Subject|3
262528|NCT02342548|864474|P1|Overall Study|Withdrawal by Subject|1
262529|NCT02342548|864472|P3|Overall Study|Protocol Violation|0
262530|NCT02342548|864473|P2|Overall Study|Protocol Violation|1
262531|NCT02342548|864474|P1|Overall Study|Protocol Violation|0
262532|NCT02342548|864472|P3|Overall Study|Study terminated by sponsor|25
262533|NCT02342548|864473|P2|Overall Study|Study terminated by sponsor|39
262534|NCT02342548|864474|P1|Overall Study|Study terminated by sponsor|20
262535|NCT02342548|864472|P3|Overall Study|Lost to Follow-up|0
262536|NCT02342548|864473|P2|Overall Study|Lost to Follow-up|1
262537|NCT02342548|864474|P1|Overall Study|Lost to Follow-up|0
262538|NCT02342548|864472|P3|Overall Study|Adverse Event|13
262539|NCT02342548|864473|P2|Overall Study|Adverse Event|17
262540|NCT02342548|864474|P1|Overall Study|Adverse Event|12
262541|NCT02342418|864518|P2|Overall Study|Adverse Event|1
262542|NCT02342418|864519|P1|Overall Study|Adverse Event|0
262543|NCT02342288|864529|P2|Overall Study|coordinator not available|2
262544|NCT02342288|864530|P1|Overall Study|coordinator not available|0
262545|NCT02342288|864529|P2|Overall Study|subject cannot tolerate numbing drops|1
262546|NCT02342288|864530|P1|Overall Study|subject cannot tolerate numbing drops|0
262547|NCT02342288|864529|P2|Overall Study|coordinator contaminated with blood|1
262548|NCT02342288|864530|P1|Overall Study|coordinator contaminated with blood|0
262549|NCT02342288|864529|P2|Overall Study|Withdrawal by Subject|0
262550|NCT02342288|864530|P1|Overall Study|Withdrawal by Subject|1
262551|NCT02342288|864529|P2|Overall Study|anesthesia leak in system|0
262552|NCT02342288|864530|P1|Overall Study|anesthesia leak in system|1
262553|NCT02342288|864529|P2|Overall Study|no protocol anesthesiologist available|2
262554|NCT02342288|864530|P1|Overall Study|no protocol anesthesiologist available|3
262555|NCT02342223|864536|P1|Overall Study|Lost to Follow-up|1
262556|NCT02341482|864708|P1|Overall Study|Adverse Event|1
262557|NCT02341417|864737|P3|Overall Study|Death|1
262558|NCT02341417|864738|P2|Overall Study|Death|0
262559|NCT02341417|864739|P1|Overall Study|Death|0
262560|NCT02341417|864737|P3|Overall Study|Decision by sponsor|0
262561|NCT02341417|864738|P2|Overall Study|Decision by sponsor|0
262562|NCT02341417|864739|P1|Overall Study|Decision by sponsor|2
262563|NCT02341417|864737|P3|Overall Study|Withdrawal by Subject|0
262564|NCT02341417|864738|P2|Overall Study|Withdrawal by Subject|2
262565|NCT02341417|864739|P1|Overall Study|Withdrawal by Subject|0
262566|NCT02340520|864802|P1|Overall Study|Withdrawal by Subject|1
262567|NCT02340520|864802|P1|Overall Study|Patient did not take drug as specified|1
262568|NCT02340520|864802|P1|Overall Study|Lost to Follow-up|1
262569|NCT02340000|864850|P2|Time Period 2|Lost to Follow-up|8
262570|NCT02340000|864851|P1|Time Period 2|Lost to Follow-up|10
262571|NCT02340000|864850|P2|Time Period 2|Withdrawal by Subject|7
262572|NCT02340000|864851|P1|Time Period 2|Withdrawal by Subject|9
262573|NCT02340000|864850|P2|Time Period 1|Lost to Follow-up|7
262574|NCT02340000|864851|P1|Time Period 1|Lost to Follow-up|6
262575|NCT02340000|864850|P2|Time Period 1|Withdrawal by Subject|8
262576|NCT02340000|864851|P1|Time Period 1|Withdrawal by Subject|6
262577|NCT02339584|864905|P2|Overall Study|Withdrawal by Subject|4
262578|NCT02339584|864906|P1|Overall Study|Withdrawal by Subject|2
262579|NCT02339584|864905|P2|Overall Study|Protocol Violation|1
262580|NCT02339584|864906|P1|Overall Study|Protocol Violation|1
262581|NCT02339584|864905|P2|Overall Study|Physician Decision|2
262582|NCT02339584|864906|P1|Overall Study|Physician Decision|1
262583|NCT02339584|864905|P2|Overall Study|Lack of Efficacy|1
262584|NCT02339584|864906|P1|Overall Study|Lack of Efficacy|0
262585|NCT02339584|864905|P2|Overall Study|Adverse Event|7
262586|NCT02339584|864906|P1|Overall Study|Adverse Event|11
262587|NCT02339506|864912|P2|Washout (Period 2)|Withdrawal by Subject|0
262588|NCT02339506|864913|P1|Washout (Period 2)|Withdrawal by Subject|2
262589|NCT02339506|864912|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
262590|NCT02339506|864913|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
262591|NCT02339155|864944|P2|Overall Study|Withdrawal by Subject|4
262592|NCT02339155|864945|P1|Overall Study|Withdrawal by Subject|4
262593|NCT02339155|864944|P2|Overall Study|Physician Decision|1
262594|NCT02339155|864945|P1|Overall Study|Physician Decision|2
262595|NCT02339155|864944|P2|Overall Study|Lost to Follow-up|9
262596|NCT02339155|864945|P1|Overall Study|Lost to Follow-up|8
262597|NCT02339155|864944|P2|Overall Study|Death|1
262598|NCT02339155|864945|P1|Overall Study|Death|1
262599|NCT02339155|864944|P2|Overall Study|Adverse Event|6
262600|NCT02339155|864945|P1|Overall Study|Adverse Event|0
262601|NCT02338843|864977|P2|Overall Study|Discontinued prior to randomizat|0
262602|NCT02338843|864978|P1|Overall Study|Discontinued prior to randomizat|1
262603|NCT02338843|864977|P2|Overall Study|Subject Recovered|2
262604|NCT02338843|864978|P1|Overall Study|Subject Recovered|0
262605|NCT02338843|864977|P2|Overall Study|Withdrawal by Subject|2
262606|NCT02338843|864978|P1|Overall Study|Withdrawal by Subject|0
262607|NCT02338843|864977|P2|Overall Study|Physician Decision|0
262608|NCT02338843|864978|P1|Overall Study|Physician Decision|1
262609|NCT02338843|864977|P2|Overall Study|Death|53
262610|NCT02338843|864978|P1|Overall Study|Death|40
262611|NCT02338843|864977|P2|Overall Study|Adverse Event|1
262612|NCT02338843|864978|P1|Overall Study|Adverse Event|2
262613|NCT02338492|865006|P1|Overall Study|Reason not captured above|6
262614|NCT02338492|865006|P1|Overall Study|Lost to Follow-up|4
262615|NCT02338492|865006|P1|Overall Study|Adverse Event|3
262616|NCT02338492|865006|P1|Overall Study|Death|32
262617|NCT02337491|865063|P2|Overall Study|On Treatment|0
262618|NCT02337491|865064|P1|Overall Study|On Treatment|2
262619|NCT02337491|865063|P2|Overall Study|Progressive Disease|28
262620|NCT02337491|865064|P1|Overall Study|Progressive Disease|44
262621|NCT02337491|865063|P2|Overall Study|Withdrawal by Subject|0
262622|NCT02337491|865064|P1|Overall Study|Withdrawal by Subject|3
262623|NCT02337491|865063|P2|Overall Study|Adverse Event|1
262624|NCT02337491|865064|P1|Overall Study|Adverse Event|0
262625|NCT02337491|865063|P2|Overall Study|Death|1
262626|NCT02337491|865064|P1|Overall Study|Death|1
262627|NCT02336607|865112|P4|Overall Study|Withdrawal by Subject|20
262628|NCT02336607|865113|P3|Overall Study|Withdrawal by Subject|0
262629|NCT02336607|865114|P2|Overall Study|Withdrawal by Subject|2
262630|NCT02336607|865115|P1|Overall Study|Withdrawal by Subject|0
262631|NCT02336607|865112|P4|Overall Study|Adverse Event|26
262632|NCT02336607|865113|P3|Overall Study|Adverse Event|2
262633|NCT02336607|865114|P2|Overall Study|Adverse Event|2
262634|NCT02336607|865115|P1|Overall Study|Adverse Event|0
262635|NCT02336607|865112|P4|Overall Study|Protocol Violation|3
262636|NCT02336607|865113|P3|Overall Study|Protocol Violation|1
262637|NCT02336607|865114|P2|Overall Study|Protocol Violation|1
262638|NCT02336607|865115|P1|Overall Study|Protocol Violation|0
262639|NCT02336607|865112|P4|Overall Study|Lost to Follow-up|21
262640|NCT02336607|865113|P3|Overall Study|Lost to Follow-up|0
262641|NCT02336607|865114|P2|Overall Study|Lost to Follow-up|1
262642|NCT02336607|865115|P1|Overall Study|Lost to Follow-up|2
262643|NCT02336607|865112|P4|Overall Study|Lack of Efficacy|2
262644|NCT02336607|865113|P3|Overall Study|Lack of Efficacy|0
262645|NCT02336607|865114|P2|Overall Study|Lack of Efficacy|0
262646|NCT02336607|865115|P1|Overall Study|Lack of Efficacy|1
262647|NCT02336607|865112|P4|Overall Study|Physician Decision|15
262648|NCT02336607|865113|P3|Overall Study|Physician Decision|3
262649|NCT02336607|865114|P2|Overall Study|Physician Decision|4
262650|NCT02336607|865115|P1|Overall Study|Physician Decision|1
262651|NCT02336425|865229|P4|Overall Study|Study terminated.|3
262652|NCT02336425|865230|P3|Overall Study|Study terminated.|3
262653|NCT02336425|865231|P2|Overall Study|Study terminated.|2
262654|NCT02336425|865232|P1|Overall Study|Study terminated.|2
262655|NCT02336178|865282|P1|Overall Study|Other|1
262656|NCT02336178|865282|P1|Overall Study|Withdrawal by Subject|1
262657|NCT02336178|865282|P1|Overall Study|Protocol Violation|1
262658|NCT02336178|865282|P1|Overall Study|Lost to Follow-up|1
262659|NCT02335489|865396|P1|Overall Study|Lack of Efficacy|1
262660|NCT02335489|865396|P1|Overall Study|Physician Decision|2
262661|NCT02335489|865396|P1|Overall Study|Withdrawal by Subject|2
262662|NCT02335489|865396|P1|Overall Study|Lost to Follow-up|1
262663|NCT02335489|865396|P1|Overall Study|Sponsor terminated study|4
262664|NCT02335346|865400|P1|Overall Study|Withdrawal by Subject|1
262665|NCT02335346|865400|P1|Overall Study|Adverse Event|11
262666|NCT02332889|865711|P1|Overall Study|Physician Decision|1
262667|NCT02332798|865718|P3|Overall Study|Abnormal laboratory findings|0
262668|NCT02332798|865719|P2|Overall Study|Abnormal laboratory findings|0
262669|NCT02332798|865720|P1|Overall Study|Abnormal laboratory findings|1
262670|NCT02332798|865718|P3|Overall Study|Positive urine drug test|0
262671|NCT02332798|865719|P2|Overall Study|Positive urine drug test|1
262672|NCT02332798|865720|P1|Overall Study|Positive urine drug test|0
262673|NCT02332798|865718|P3|Overall Study|Unwilling to participate in study|1
262674|NCT02332798|865719|P2|Overall Study|Unwilling to participate in study|1
262675|NCT02332798|865720|P1|Overall Study|Unwilling to participate in study|0
262676|NCT02332707|865788|P18|Overall Study|Withdrawal by Subject|0
262677|NCT02332707|865789|P17|Overall Study|Withdrawal by Subject|0
262678|NCT02332707|865790|P16|Overall Study|Withdrawal by Subject|0
262679|NCT02332707|865791|P15|Overall Study|Withdrawal by Subject|0
262680|NCT02332707|865792|P14|Overall Study|Withdrawal by Subject|0
262681|NCT02332707|865793|P13|Overall Study|Withdrawal by Subject|0
262682|NCT02332707|865794|P12|Overall Study|Withdrawal by Subject|0
262683|NCT02332707|865795|P11|Overall Study|Withdrawal by Subject|0
262684|NCT02332707|865796|P10|Overall Study|Withdrawal by Subject|3
262685|NCT02332707|865797|P9|Overall Study|Withdrawal by Subject|0
262686|NCT02332707|865798|P8|Overall Study|Withdrawal by Subject|0
262687|NCT02332707|865799|P7|Overall Study|Withdrawal by Subject|0
262688|NCT02332707|865800|P6|Overall Study|Withdrawal by Subject|0
262689|NCT02332707|865801|P5|Overall Study|Withdrawal by Subject|0
262690|NCT02332707|865802|P4|Overall Study|Withdrawal by Subject|0
262691|NCT02332707|865803|P3|Overall Study|Withdrawal by Subject|1
262692|NCT02332707|865804|P2|Overall Study|Withdrawal by Subject|0
262693|NCT02332707|865805|P1|Overall Study|Withdrawal by Subject|0
262694|NCT02332707|865788|P18|Overall Study|Physician Decision|0
262695|NCT02332707|865789|P17|Overall Study|Physician Decision|0
262696|NCT02332707|865790|P16|Overall Study|Physician Decision|0
262697|NCT02332707|865791|P15|Overall Study|Physician Decision|0
262698|NCT02332707|865792|P14|Overall Study|Physician Decision|0
262699|NCT02332707|865793|P13|Overall Study|Physician Decision|1
262700|NCT02332707|865794|P12|Overall Study|Physician Decision|0
262701|NCT02332707|865795|P11|Overall Study|Physician Decision|0
262702|NCT02332707|865796|P10|Overall Study|Physician Decision|0
262703|NCT02332707|865797|P9|Overall Study|Physician Decision|0
262704|NCT02332707|865798|P8|Overall Study|Physician Decision|0
262705|NCT02332707|865799|P7|Overall Study|Physician Decision|0
262706|NCT02332707|865800|P6|Overall Study|Physician Decision|0
262707|NCT02332707|865801|P5|Overall Study|Physician Decision|0
262708|NCT02332707|865802|P4|Overall Study|Physician Decision|1
262709|NCT02332707|865803|P3|Overall Study|Physician Decision|0
262710|NCT02332707|865804|P2|Overall Study|Physician Decision|0
262711|NCT02332707|865805|P1|Overall Study|Physician Decision|0
262712|NCT02332707|865788|P18|Overall Study|Lost to Follow-up|0
262713|NCT02332707|865789|P17|Overall Study|Lost to Follow-up|0
262714|NCT02332707|865790|P16|Overall Study|Lost to Follow-up|0
262715|NCT02332707|865791|P15|Overall Study|Lost to Follow-up|0
262716|NCT02332707|865792|P14|Overall Study|Lost to Follow-up|0
262717|NCT02332707|865793|P13|Overall Study|Lost to Follow-up|3
262718|NCT02332707|865794|P12|Overall Study|Lost to Follow-up|0
262719|NCT02332707|865795|P11|Overall Study|Lost to Follow-up|2
262720|NCT02332707|865796|P10|Overall Study|Lost to Follow-up|0
262721|NCT02332707|865797|P9|Overall Study|Lost to Follow-up|0
262722|NCT02332707|865798|P8|Overall Study|Lost to Follow-up|0
262723|NCT02332707|865799|P7|Overall Study|Lost to Follow-up|0
262724|NCT02332707|865800|P6|Overall Study|Lost to Follow-up|1
262725|NCT02332707|865801|P5|Overall Study|Lost to Follow-up|0
262726|NCT02332707|865802|P4|Overall Study|Lost to Follow-up|0
262727|NCT02332707|865803|P3|Overall Study|Lost to Follow-up|0
262728|NCT02332707|865804|P2|Overall Study|Lost to Follow-up|0
262729|NCT02332707|865805|P1|Overall Study|Lost to Follow-up|0
262730|NCT02332707|865788|P18|Overall Study|Adverse Event|0
262731|NCT02332707|865789|P17|Overall Study|Adverse Event|0
262732|NCT02332707|865790|P16|Overall Study|Adverse Event|0
262733|NCT02332707|865791|P15|Overall Study|Adverse Event|0
262734|NCT02332707|865792|P14|Overall Study|Adverse Event|0
262735|NCT02332707|865793|P13|Overall Study|Adverse Event|1
262736|NCT02332707|865794|P12|Overall Study|Adverse Event|0
262737|NCT02332707|865795|P11|Overall Study|Adverse Event|0
262738|NCT02332707|865796|P10|Overall Study|Adverse Event|0
262739|NCT02332707|865797|P9|Overall Study|Adverse Event|0
262740|NCT02332707|865798|P8|Overall Study|Adverse Event|0
262741|NCT02332707|865799|P7|Overall Study|Adverse Event|0
262742|NCT02332707|865800|P6|Overall Study|Adverse Event|0
262743|NCT02332707|865801|P5|Overall Study|Adverse Event|0
262744|NCT02332707|865802|P4|Overall Study|Adverse Event|0
262745|NCT02332707|865803|P3|Overall Study|Adverse Event|0
262746|NCT02332707|865804|P2|Overall Study|Adverse Event|0
262747|NCT02332707|865805|P1|Overall Study|Adverse Event|0
262748|NCT02332590|865899|P2|Overall Study|Other than specified above|5
262749|NCT02332590|865900|P1|Overall Study|Other than specified above|6
262750|NCT02332590|865899|P2|Overall Study|Randomized but not treated|0
262751|NCT02332590|865900|P1|Overall Study|Randomized but not treated|1
262752|NCT02332590|865899|P2|Overall Study|Poor compliance to protocol|1
262753|NCT02332590|865900|P1|Overall Study|Poor compliance to protocol|3
262754|NCT02332590|865899|P2|Overall Study|Lack of Efficacy|2
262755|NCT02332590|865900|P1|Overall Study|Lack of Efficacy|4
262756|NCT02332590|865899|P2|Overall Study|Adverse Event|11
262757|NCT02332590|865900|P1|Overall Study|Adverse Event|15
262758|NCT02332239|865964|P2|Overall Study|Lost to Follow-up|6
262759|NCT02332239|865965|P1|Overall Study|Lost to Follow-up|4
262760|NCT02331446|866012|P4|Overall Study|Lost before baseline analysis|0
262761|NCT02331446|866013|P3|Overall Study|Lost before baseline analysis|1
262762|NCT02331446|866014|P2|Overall Study|Lost before baseline analysis|1
262763|NCT02331446|866015|P1|Overall Study|Lost before baseline analysis|0
262764|NCT02331446|866012|P4|Overall Study|Physician Decision|1
262765|NCT02331446|866013|P3|Overall Study|Physician Decision|0
262766|NCT02331446|866014|P2|Overall Study|Physician Decision|1
262767|NCT02331446|866015|P1|Overall Study|Physician Decision|0
262768|NCT02331446|866012|P4|Overall Study|Disease|1
262769|NCT02331446|866013|P3|Overall Study|Disease|2
262770|NCT02331446|866014|P2|Overall Study|Disease|2
262771|NCT02331446|866015|P1|Overall Study|Disease|0
262772|NCT02331446|866012|P4|Overall Study|Personal Problem|0
262773|NCT02331446|866013|P3|Overall Study|Personal Problem|0
262774|NCT02331446|866014|P2|Overall Study|Personal Problem|0
262775|NCT02331446|866015|P1|Overall Study|Personal Problem|2
262776|NCT02331446|866012|P4|Overall Study|Lost to Follow-up|1
262777|NCT02331446|866013|P3|Overall Study|Lost to Follow-up|0
262778|NCT02331446|866014|P2|Overall Study|Lost to Follow-up|1
262779|NCT02331446|866015|P1|Overall Study|Lost to Follow-up|2
262780|NCT02330055|866203|P2|Overall Study|participant did not sleep|1
262781|NCT02330055|866204|P1|Overall Study|participant did not sleep|0
262782|NCT02330055|866203|P2|Overall Study|data for less than 60 minutes|3
262783|NCT02330055|866204|P1|Overall Study|data for less than 60 minutes|3
262784|NCT02330055|866203|P2|Overall Study|participant forgot to wear device|5
262785|NCT02330055|866204|P1|Overall Study|participant forgot to wear device|5
262786|NCT02330055|866203|P2|Overall Study|technical issues|0
262787|NCT02330055|866204|P1|Overall Study|technical issues|2
262788|NCT02329730|866251|P12|Overall Study|Withdrawal by Subject|0
262789|NCT02329730|866252|P11|Overall Study|Withdrawal by Subject|0
262790|NCT02329730|866253|P10|Overall Study|Withdrawal by Subject|1
262791|NCT02329730|866254|P9|Overall Study|Withdrawal by Subject|1
262792|NCT02329730|866255|P8|Overall Study|Withdrawal by Subject|1
262793|NCT02329730|866256|P7|Overall Study|Withdrawal by Subject|1
262794|NCT02329730|866257|P6|Overall Study|Withdrawal by Subject|0
262795|NCT02329730|866258|P5|Overall Study|Withdrawal by Subject|1
262796|NCT02329730|866259|P4|Overall Study|Withdrawal by Subject|0
262797|NCT02329730|866260|P3|Overall Study|Withdrawal by Subject|0
262798|NCT02329730|866261|P2|Overall Study|Withdrawal by Subject|0
262799|NCT02329730|866262|P1|Overall Study|Withdrawal by Subject|0
262800|NCT02329730|866251|P12|Overall Study|Protocol Violation|0
262801|NCT02329730|866252|P11|Overall Study|Protocol Violation|0
262802|NCT02329730|866253|P10|Overall Study|Protocol Violation|0
262803|NCT02329730|866254|P9|Overall Study|Protocol Violation|0
262804|NCT02329730|866255|P8|Overall Study|Protocol Violation|0
262805|NCT02329730|866256|P7|Overall Study|Protocol Violation|0
262806|NCT02329730|866257|P6|Overall Study|Protocol Violation|2
262807|NCT02329730|866258|P5|Overall Study|Protocol Violation|2
262808|NCT02329730|866259|P4|Overall Study|Protocol Violation|0
262809|NCT02329730|866260|P3|Overall Study|Protocol Violation|0
262810|NCT02329730|866261|P2|Overall Study|Protocol Violation|0
262811|NCT02329730|866262|P1|Overall Study|Protocol Violation|0
262812|NCT02329431|866373|P2|Overall Study|Lost to Follow-up|13
262813|NCT02329431|866374|P1|Overall Study|Lost to Follow-up|20
262814|NCT02329223|866393|P3|Overall Study|Adverse Event|0
262815|NCT02329223|866394|P2|Overall Study|Adverse Event|1
262816|NCT02329223|866395|P1|Overall Study|Adverse Event|0
262817|NCT02329223|866393|P3|Overall Study|Physician Decision|1
262818|NCT02329223|866394|P2|Overall Study|Physician Decision|0
262819|NCT02329223|866395|P1|Overall Study|Physician Decision|0
262820|NCT02329223|866393|P3|Overall Study|Withdrawal by Subject|5
262821|NCT02329223|866394|P2|Overall Study|Withdrawal by Subject|2
262822|NCT02329223|866395|P1|Overall Study|Withdrawal by Subject|1
262823|NCT02328937|866445|P6|Period 2|Adverse Event|0
262824|NCT02328937|866446|P5|Period 2|Adverse Event|0
262825|NCT02328937|866447|P4|Period 2|Adverse Event|0
262826|NCT02328937|866448|P3|Period 2|Adverse Event|1
262827|NCT02328937|866449|P2|Period 2|Adverse Event|0
262828|NCT02328937|866450|P1|Period 2|Adverse Event|0
262829|NCT02328937|866445|P6|Period 1|Lost to Follow-up|0
262830|NCT02328937|866446|P5|Period 1|Lost to Follow-up|0
262831|NCT02328937|866447|P4|Period 1|Lost to Follow-up|1
262832|NCT02328937|866448|P3|Period 1|Lost to Follow-up|0
262833|NCT02328937|866449|P2|Period 1|Lost to Follow-up|0
262834|NCT02328937|866450|P1|Period 1|Lost to Follow-up|0
262835|NCT02327013|866530|P5|Overall Study|Withdrawal before treatment|0
262836|NCT02327013|866531|P4|Overall Study|Withdrawal before treatment|0
262837|NCT02327013|866532|P3|Overall Study|Withdrawal before treatment|5
262838|NCT02327013|866533|P2|Overall Study|Withdrawal before treatment|1
262839|NCT02327013|866534|P1|Overall Study|Withdrawal before treatment|2
262840|NCT02327013|866530|P5|Overall Study|Protocol Violation|1
262841|NCT02327013|866531|P4|Overall Study|Protocol Violation|0
262842|NCT02327013|866532|P3|Overall Study|Protocol Violation|3
262843|NCT02327013|866533|P2|Overall Study|Protocol Violation|0
262844|NCT02327013|866534|P1|Overall Study|Protocol Violation|0
262845|NCT02327013|866530|P5|Overall Study|Administrative or other reason(s)|1
262846|NCT02327013|866531|P4|Overall Study|Administrative or other reason(s)|1
262847|NCT02327013|866532|P3|Overall Study|Administrative or other reason(s)|11
262848|NCT02327013|866533|P2|Overall Study|Administrative or other reason(s)|5
262849|NCT02327013|866534|P1|Overall Study|Administrative or other reason(s)|1
262850|NCT02327013|866530|P5|Overall Study|Lost to Follow-up|0
262851|NCT02327013|866531|P4|Overall Study|Lost to Follow-up|0
262852|NCT02327013|866532|P3|Overall Study|Lost to Follow-up|5
262853|NCT02327013|866533|P2|Overall Study|Lost to Follow-up|4
262854|NCT02327013|866534|P1|Overall Study|Lost to Follow-up|2
262855|NCT02327013|866530|P5|Overall Study|Withdrawal of Consent|0
262856|NCT02327013|866531|P4|Overall Study|Withdrawal of Consent|0
262857|NCT02327013|866532|P3|Overall Study|Withdrawal of Consent|3
262858|NCT02327013|866533|P2|Overall Study|Withdrawal of Consent|0
262859|NCT02327013|866534|P1|Overall Study|Withdrawal of Consent|1
262860|NCT02327013|866530|P5|Overall Study|Non-compliance with IMP|0
262861|NCT02327013|866531|P4|Overall Study|Non-compliance with IMP|0
262862|NCT02327013|866532|P3|Overall Study|Non-compliance with IMP|7
262863|NCT02327013|866533|P2|Overall Study|Non-compliance with IMP|2
262864|NCT02327013|866534|P1|Overall Study|Non-compliance with IMP|1
262865|NCT02327013|866530|P5|Overall Study|Lack of Efficacy|1
262866|NCT02327013|866531|P4|Overall Study|Lack of Efficacy|0
262867|NCT02327013|866532|P3|Overall Study|Lack of Efficacy|5
262868|NCT02327013|866533|P2|Overall Study|Lack of Efficacy|0
262869|NCT02327013|866534|P1|Overall Study|Lack of Efficacy|2
262870|NCT02327013|866530|P5|Overall Study|Adverse Event|1
262871|NCT02327013|866531|P4|Overall Study|Adverse Event|0
262872|NCT02327013|866532|P3|Overall Study|Adverse Event|3
262873|NCT02327013|866533|P2|Overall Study|Adverse Event|4
262874|NCT02327013|866534|P1|Overall Study|Adverse Event|4
262875|NCT02325713|866745|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262876|NCT02325713|866746|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262877|NCT02325713|866747|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262878|NCT02325713|866748|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262879|NCT02325713|866749|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262880|NCT02325713|866750|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262881|NCT02325713|866751|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
262882|NCT02325713|866752|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262883|NCT02325713|866753|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262884|NCT02325713|866754|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262885|NCT02325713|866755|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262886|NCT02325713|866756|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262887|NCT02325713|866757|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262888|NCT02325713|866758|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262889|NCT02325713|866759|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262890|NCT02325713|866760|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
262891|NCT02325713|866745|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262892|NCT02325713|866746|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262893|NCT02325713|866747|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262894|NCT02325713|866748|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262895|NCT02325713|866749|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262896|NCT02325713|866750|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262897|NCT02325713|866751|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262898|NCT02325713|866752|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262899|NCT02325713|866753|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262900|NCT02325713|866754|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262901|NCT02325713|866755|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262902|NCT02325713|866756|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262903|NCT02325713|866757|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262904|NCT02325713|866758|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262905|NCT02325713|866759|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
262906|NCT02325713|866760|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
262907|NCT02325713|866745|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262908|NCT02325713|866746|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262909|NCT02325713|866747|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262910|NCT02325713|866748|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262911|NCT02325713|866749|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262912|NCT02325713|866750|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
262913|NCT02325713|866751|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262914|NCT02325713|866752|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262915|NCT02325713|866753|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262916|NCT02325713|866754|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262917|NCT02325713|866755|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262918|NCT02325713|866756|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262919|NCT02325713|866757|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262920|NCT02325713|866758|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262921|NCT02325713|866759|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262922|NCT02325713|866760|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
262923|NCT02325518|866855|P2|Overall Study|Withdrawal by Subject|1
262924|NCT02325518|866856|P1|Overall Study|Withdrawal by Subject|0
262925|NCT02325518|866855|P2|Overall Study|Physician Decision|1
262926|NCT02325518|866856|P1|Overall Study|Physician Decision|0
262927|NCT02325518|866855|P2|Overall Study|Adverse Event|1
262928|NCT02325518|866856|P1|Overall Study|Adverse Event|4
262929|NCT02322892|866991|P2|Overall Study|Protocol Violation|0
262930|NCT02322892|866992|P1|Overall Study|Protocol Violation|1
262931|NCT02322892|866991|P2|Overall Study|Met exclusion criteria|1
262932|NCT02322892|866992|P1|Overall Study|Met exclusion criteria|0
262933|NCT02322892|866991|P2|Overall Study|Surgery cancelled|2
262934|NCT02322892|866992|P1|Overall Study|Surgery cancelled|1
262935|NCT02322879|867008|P2|First Intervention|Physician Decision|0
262936|NCT02322879|867009|P1|First Intervention|Physician Decision|1
262937|NCT02322866|867017|P2|Overall Study|Other Miscellaneous Reasons|6
262938|NCT02322866|867018|P1|Overall Study|Other Miscellaneous Reasons|6
262939|NCT02322866|867017|P2|Overall Study|Lack of Efficacy|1
262940|NCT02322866|867018|P1|Overall Study|Lack of Efficacy|3
262941|NCT02322866|867017|P2|Overall Study|Noncompliance with Treatment|4
262942|NCT02322866|867018|P1|Overall Study|Noncompliance with Treatment|3
262943|NCT02322866|867017|P2|Overall Study|Protocol Violation|0
262944|NCT02322866|867018|P1|Overall Study|Protocol Violation|1
262945|NCT02322866|867017|P2|Overall Study|Lost to Follow-up|39
262946|NCT02322866|867018|P1|Overall Study|Lost to Follow-up|36
262947|NCT02322866|867017|P2|Overall Study|Withdrawal of Consent|25
262948|NCT02322866|867018|P1|Overall Study|Withdrawal of Consent|16
262949|NCT02322866|867017|P2|Overall Study|Adverse Event|11
262950|NCT02322866|867018|P1|Overall Study|Adverse Event|6
262951|NCT02322775|867055|P2|Overall Study|Not willing to perform all FU visits|1
262952|NCT02322775|867056|P1|Overall Study|Not willing to perform all FU visits|0
262953|NCT02322775|867055|P2|Overall Study|Withdrawal by Subject|4
262954|NCT02322775|867056|P1|Overall Study|Withdrawal by Subject|3
262955|NCT02322775|867055|P2|Overall Study|Protocol Violation|0
262956|NCT02322775|867056|P1|Overall Study|Protocol Violation|1
262957|NCT02322775|867055|P2|Overall Study|Lost to Follow-up|1
262958|NCT02322775|867056|P1|Overall Study|Lost to Follow-up|0
262959|NCT02322775|867055|P2|Overall Study|Adverse Event|0
262960|NCT02322775|867056|P1|Overall Study|Adverse Event|1
262961|NCT02322749|867082|P6|Period 3|Withdrawal by Subject|0
262962|NCT02322749|867083|P5|Period 3|Withdrawal by Subject|0
262963|NCT02322749|867084|P4|Period 3|Withdrawal by Subject|0
262964|NCT02322749|867085|P3|Period 3|Withdrawal by Subject|1
262965|NCT02322749|867086|P2|Period 3|Withdrawal by Subject|0
262966|NCT02322749|867087|P1|Period 3|Withdrawal by Subject|0
262967|NCT02322749|867082|P6|Period 2|Withdrawal by Subject|0
262968|NCT02322749|867083|P5|Period 2|Withdrawal by Subject|0
262969|NCT02322749|867084|P4|Period 2|Withdrawal by Subject|1
262970|NCT02322749|867085|P3|Period 2|Withdrawal by Subject|0
262971|NCT02322749|867086|P2|Period 2|Withdrawal by Subject|0
262972|NCT02322749|867087|P1|Period 2|Withdrawal by Subject|0
262973|NCT02322749|867082|P6|Period 2|Adverse Event|0
262974|NCT02322749|867083|P5|Period 2|Adverse Event|0
262975|NCT02322749|867084|P4|Period 2|Adverse Event|1
262976|NCT02322749|867085|P3|Period 2|Adverse Event|0
262977|NCT02322749|867086|P2|Period 2|Adverse Event|0
262978|NCT02322749|867087|P1|Period 2|Adverse Event|0
262979|NCT02322216|867117|P2|Overall Study|Withdrawal by Subject|4
262980|NCT02322216|867118|P1|Overall Study|Withdrawal by Subject|1
262981|NCT02322216|867117|P2|Overall Study|Adverse Event|0
262982|NCT02322216|867118|P1|Overall Study|Adverse Event|1
262983|NCT02321436|867131|P2|Overall Study|Lost to Follow-up|1
262984|NCT02321436|867132|P1|Overall Study|Lost to Follow-up|0
262985|NCT02321436|867131|P2|Overall Study|Withdrawal by Subject|0
262986|NCT02321436|867132|P1|Overall Study|Withdrawal by Subject|1
262987|NCT02320903|867151|P3|Overall Study|Lost to Follow-up|5
262988|NCT02320903|867152|P2|Overall Study|Lost to Follow-up|5
262989|NCT02320903|867153|P1|Overall Study|Lost to Follow-up|0
262990|NCT02320903|867151|P3|Overall Study|Exited therapy; no longer eligible|2
262991|NCT02320903|867152|P2|Overall Study|Exited therapy; no longer eligible|2
262992|NCT02320903|867153|P1|Overall Study|Exited therapy; no longer eligible|8
262993|NCT02320903|867151|P3|Overall Study|Withdrawal by Subject|9
262994|NCT02320903|867152|P2|Overall Study|Withdrawal by Subject|9
262995|NCT02320903|867153|P1|Overall Study|Withdrawal by Subject|0
262996|NCT02320721|867257|P2|Overall Study|Other than specified above|20
262997|NCT02320721|867258|P1|Overall Study|Other than specified above|15
262998|NCT02320721|867257|P2|Overall Study|Hypoglycemia|0
262999|NCT02320721|867258|P1|Overall Study|Hypoglycemia|1
263000|NCT02320721|867257|P2|Overall Study|Randomized but not treated|1
263001|NCT02320721|867258|P1|Overall Study|Randomized but not treated|0
263002|NCT02320721|867257|P2|Overall Study|Poor compliance to protocol|7
263003|NCT02320721|867258|P1|Overall Study|Poor compliance to protocol|3
263004|NCT02320721|867257|P2|Overall Study|Lack of Efficacy|0
263005|NCT02320721|867258|P1|Overall Study|Lack of Efficacy|2
263006|NCT02320721|867257|P2|Overall Study|Adverse Event|6
263007|NCT02320721|867258|P1|Overall Study|Adverse Event|6
263008|NCT02320487|867313|P1|Overall Study|Adverse Event|11
263009|NCT02320487|867313|P1|Overall Study|Death|3
263010|NCT02320487|867313|P1|Overall Study|Withdrawal by Subject|1
263011|NCT02320487|867313|P1|Overall Study|Physician Decision|5
263012|NCT02320487|867313|P1|Overall Study|Reason not Specified|1
263013|NCT02320396|867333|P2|Overall Study|Withdrawal by Subject|0
263014|NCT02320396|867334|P1|Overall Study|Withdrawal by Subject|2
263015|NCT02320396|867333|P2|Overall Study|Protocol Violation|1
263016|NCT02320396|867334|P1|Overall Study|Protocol Violation|0
263017|NCT02320396|867333|P2|Overall Study|Pregnancy|1
263018|NCT02320396|867334|P1|Overall Study|Pregnancy|0
263019|NCT02320396|867333|P2|Overall Study|Adverse Event|2
263020|NCT02320396|867334|P1|Overall Study|Adverse Event|2
263021|NCT02320149|867376|P2|Overall Study|Other Miscellaneous Reasons|3
263022|NCT02320149|867377|P1|Overall Study|Other Miscellaneous Reasons|2
263023|NCT02320149|867376|P2|Overall Study|Lack of Efficacy|1
263024|NCT02320149|867377|P1|Overall Study|Lack of Efficacy|0
263025|NCT02320149|867376|P2|Overall Study|Noncompliance with Study Treatment|2
263026|NCT02320149|867377|P1|Overall Study|Noncompliance with Study Treatment|7
263027|NCT02320149|867376|P2|Overall Study|Protocol Violation|1
263028|NCT02320149|867377|P1|Overall Study|Protocol Violation|2
263029|NCT02320149|867376|P2|Overall Study|Lost to Follow-up|34
263030|NCT02320149|867377|P1|Overall Study|Lost to Follow-up|21
263031|NCT02320149|867376|P2|Overall Study|Withdrawal of Consent|32
263032|NCT02320149|867377|P1|Overall Study|Withdrawal of Consent|28
263033|NCT02320149|867376|P2|Overall Study|Adverse Event|7
263034|NCT02320149|867377|P1|Overall Study|Adverse Event|3
263035|NCT02319668|867423|P2|Overall Study|Other (Not specified)|2
263036|NCT02319668|867424|P1|Overall Study|Other (Not specified)|0
263037|NCT02319525|867438|P2|Overall Study|Withdrawal by Subject|1
263038|NCT02319525|867439|P1|Overall Study|Withdrawal by Subject|2
263039|NCT02319148|867475|P4|Second Intervention Period|Other|1
263040|NCT02319148|867476|P3|Second Intervention Period|Other|0
263041|NCT02319148|867477|P2|Second Intervention Period|Other|0
263042|NCT02319148|867478|P1|Second Intervention Period|Other|0
263043|NCT02319148|867475|P4|Second Intervention Period|No longer willing to participate|0
263044|NCT02319148|867476|P3|Second Intervention Period|No longer willing to participate|0
263045|NCT02319148|867477|P2|Second Intervention Period|No longer willing to participate|1
263046|NCT02319148|867478|P1|Second Intervention Period|No longer willing to participate|0
263047|NCT02319148|867475|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
263048|NCT02319148|867476|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
263049|NCT02319148|867477|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
263050|NCT02319148|867478|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
263051|NCT02319044|867541|P3|Overall Study|Not treated|2
263052|NCT02319044|867542|P2|Overall Study|Not treated|2
263053|NCT02319044|867543|P1|Overall Study|Not treated|0
263054|NCT02319044|867541|P3|Overall Study|Study specific discontinuation criteria|1
263055|NCT02319044|867542|P2|Overall Study|Study specific discontinuation criteria|2
263056|NCT02319044|867543|P1|Overall Study|Study specific discontinuation criteria|2
263057|NCT02319044|867541|P3|Overall Study|Adverse Event|8
263058|NCT02319044|867542|P2|Overall Study|Adverse Event|2
263059|NCT02319044|867543|P1|Overall Study|Adverse Event|17
263060|NCT02319044|867541|P3|Overall Study|Condition under investigation worsened|46
263061|NCT02319044|867542|P2|Overall Study|Condition under investigation worsened|50
263062|NCT02319044|867543|P1|Overall Study|Condition under investigation worsened|100
263063|NCT02319044|867541|P3|Overall Study|Withdrawal by Subject|6
263064|NCT02319044|867542|P2|Overall Study|Withdrawal by Subject|3
263065|NCT02319044|867543|P1|Overall Study|Withdrawal by Subject|3
263066|NCT02319044|867541|P3|Overall Study|Death, PI/sponsor decision, med history|4
263067|NCT02319044|867542|P2|Overall Study|Death, PI/sponsor decision, med history|1
263068|NCT02319044|867543|P1|Overall Study|Death, PI/sponsor decision, med history|0
263069|NCT02319031|867599|P2|Treatment Period|Death|0
263070|NCT02319031|867600|P1|Treatment Period|Death|1
263071|NCT02318940|867612|P2|Overall Study|lost the record|0
263072|NCT02318940|867613|P1|Overall Study|lost the record|1
263073|NCT02318797|867627|P2|Overall Study|Lost to Follow-up|96
263074|NCT02318797|867628|P1|Overall Study|Lost to Follow-up|85
263075|NCT02318797|867627|P2|Overall Study|Death|6
263076|NCT02318797|867628|P1|Overall Study|Death|3
263077|NCT02318693|867668|P2|Overall Study|Protocol Violation|1
263078|NCT02318693|867669|P1|Overall Study|Protocol Violation|0
263079|NCT02317809|867712|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
263080|NCT02317809|867713|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
263081|NCT02317809|867712|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
263082|NCT02317809|867713|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
263083|NCT02317510|867802|P2|Overall Study|Adverse Event|1
263084|NCT02317510|867803|P1|Overall Study|Adverse Event|0
263085|NCT02317016|867831|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
263086|NCT02317016|867831|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
263087|NCT02317016|867831|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
263088|NCT02317016|867831|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
263089|NCT02317016|867831|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
263090|NCT02317016|867831|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
263091|NCT02317016|867831|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
263092|NCT02316769|867859|P2|Overall Study|Withdrawal by Subject|0
263093|NCT02316769|867860|P1|Overall Study|Withdrawal by Subject|1
263094|NCT02316769|867859|P2|Overall Study|Physician Decision|0
263095|NCT02316769|867860|P1|Overall Study|Physician Decision|1
263096|NCT02316613|867877|P1|Overall Study|Did not met selection criteria|14
263097|NCT02316613|867877|P1|Overall Study|No data and duplicate cases|5
263098|NCT02316613|867877|P1|Overall Study|Participant moved/changed medical team|11
263099|NCT02316613|867877|P1|Overall Study|Lymphoma transformation|2
263100|NCT02316613|867877|P1|Overall Study|Lost to Follow-up|9
263101|NCT02316613|867877|P1|Overall Study|Death|63
263102|NCT02316548|867916|P2|Overall Study|Protocol Violation|1
263103|NCT02316548|867917|P1|Overall Study|Protocol Violation|0
263104|NCT02315560|868049|P1|Overall Study|noncompliance by subjects|3
263105|NCT02314637|868096|P2|Overall Study|Other Reason|0
263106|NCT02314637|868097|P1|Overall Study|Other Reason|1
263107|NCT02314637|868096|P2|Overall Study|Withdrawal by Subject|4
263108|NCT02314637|868097|P1|Overall Study|Withdrawal by Subject|5
263109|NCT02314637|868096|P2|Overall Study|Physician Decision|2
263110|NCT02314637|868097|P1|Overall Study|Physician Decision|5
263111|NCT02314637|868096|P2|Overall Study|Lack of Efficacy|0
263112|NCT02314637|868097|P1|Overall Study|Lack of Efficacy|1
263113|NCT02314637|868096|P2|Overall Study|Adverse Event|8
263114|NCT02314637|868097|P1|Overall Study|Adverse Event|4
263115|NCT02314117|868162|P2|Overall Study|No post-discontinuation follow-up|19
263116|NCT02314117|868163|P1|Overall Study|No post-discontinuation follow-up|21
263117|NCT02314117|868162|P2|Overall Study|Withdrawal by Subject|2
263118|NCT02314117|868163|P1|Overall Study|Withdrawal by Subject|2
263119|NCT02314117|868162|P2|Overall Study|On Treatment|6
263120|NCT02314117|868163|P1|Overall Study|On Treatment|10
263121|NCT02314117|868162|P2|Overall Study|Lost to Follow-up|11
263122|NCT02314117|868163|P1|Overall Study|Lost to Follow-up|8
263123|NCT02313766|868219|P3|Overall Study|Adverse Event|0
263124|NCT02313766|868220|P2|Overall Study|Adverse Event|1
263125|NCT02313766|868221|P1|Overall Study|Adverse Event|0
263126|NCT02313766|868219|P3|Overall Study|Lost to Follow-up|0
263127|NCT02313766|868220|P2|Overall Study|Lost to Follow-up|2
263128|NCT02313766|868221|P1|Overall Study|Lost to Follow-up|0
263129|NCT02313766|868219|P3|Overall Study|surgery cancelled|0
263130|NCT02313766|868220|P2|Overall Study|surgery cancelled|0
263131|NCT02313766|868221|P1|Overall Study|surgery cancelled|1
263132|NCT02313558|868258|P2|Overall Study|Lost to Follow-up|4
263133|NCT02313558|868259|P1|Overall Study|Lost to Follow-up|4
263134|NCT02313558|868258|P2|Overall Study|Withdrawal by Subject|0
263135|NCT02313558|868259|P1|Overall Study|Withdrawal by Subject|2
263136|NCT02313233|868273|P2|Overall Study|Administrative reason|1
263137|NCT02313233|868274|P1|Overall Study|Administrative reason|1
263138|NCT02313233|868273|P2|Overall Study|Withdrawal by Subject|2
263139|NCT02313233|868274|P1|Overall Study|Withdrawal by Subject|1
263140|NCT02313155|868296|P2|Overall Study|Lost to Follow-up|1
263141|NCT02313155|868297|P1|Overall Study|Lost to Follow-up|0
263142|NCT02311881|868492|P3|Overall Study|Serious Adverse Event|0
263143|NCT02311881|868493|P2|Overall Study|Serious Adverse Event|1
263144|NCT02311881|868494|P1|Overall Study|Serious Adverse Event|0
263145|NCT02311881|868492|P3|Overall Study|Participant taking another medication|1
263146|NCT02311881|868493|P2|Overall Study|Participant taking another medication|0
263147|NCT02311881|868494|P1|Overall Study|Participant taking another medication|0
263148|NCT02311881|868492|P3|Overall Study|Medical Monitor Discretion|1
263149|NCT02311881|868493|P2|Overall Study|Medical Monitor Discretion|0
263150|NCT02311881|868494|P1|Overall Study|Medical Monitor Discretion|0
263151|NCT02311881|868492|P3|Overall Study|Physician Decision|1
263152|NCT02311881|868493|P2|Overall Study|Physician Decision|0
263153|NCT02311881|868494|P1|Overall Study|Physician Decision|0
263154|NCT02311881|868492|P3|Overall Study|Non-Compliance|2
263155|NCT02311881|868493|P2|Overall Study|Non-Compliance|0
263156|NCT02311881|868494|P1|Overall Study|Non-Compliance|1
263157|NCT02311881|868492|P3|Overall Study|Protocol Deviation|0
263158|NCT02311881|868493|P2|Overall Study|Protocol Deviation|0
263159|NCT02311881|868494|P1|Overall Study|Protocol Deviation|1
263160|NCT02311881|868492|P3|Overall Study|Sponsor Decision|1
263161|NCT02311881|868493|P2|Overall Study|Sponsor Decision|1
263162|NCT02311881|868494|P1|Overall Study|Sponsor Decision|1
263163|NCT02311881|868492|P3|Overall Study|Withdrawal by Subject|4
263164|NCT02311881|868493|P2|Overall Study|Withdrawal by Subject|1
263165|NCT02311881|868494|P1|Overall Study|Withdrawal by Subject|3
263166|NCT02311881|868492|P3|Overall Study|Subject has border line pregnancy test|0
263167|NCT02311881|868493|P2|Overall Study|Subject has border line pregnancy test|0
263168|NCT02311881|868494|P1|Overall Study|Subject has border line pregnancy test|1
263169|NCT02311881|868492|P3|Overall Study|Lack of Efficacy|0
263170|NCT02311881|868493|P2|Overall Study|Lack of Efficacy|2
263171|NCT02311881|868494|P1|Overall Study|Lack of Efficacy|1
263172|NCT02311881|868492|P3|Overall Study|Not Specified|1
263173|NCT02311881|868493|P2|Overall Study|Not Specified|0
263174|NCT02311881|868494|P1|Overall Study|Not Specified|0
263175|NCT02311881|868492|P3|Overall Study|Withdrawal of consent|17
263176|NCT02311881|868493|P2|Overall Study|Withdrawal of consent|16
263177|NCT02311881|868494|P1|Overall Study|Withdrawal of consent|14
263178|NCT02311881|868492|P3|Overall Study|Protocol Violation|3
263179|NCT02311881|868493|P2|Overall Study|Protocol Violation|2
263180|NCT02311881|868494|P1|Overall Study|Protocol Violation|1
263181|NCT02311881|868492|P3|Overall Study|Lost to Follow-up|2
263182|NCT02311881|868493|P2|Overall Study|Lost to Follow-up|3
263183|NCT02311881|868494|P1|Overall Study|Lost to Follow-up|3
263184|NCT02311881|868492|P3|Overall Study|Adverse Event|8
263185|NCT02311881|868493|P2|Overall Study|Adverse Event|15
263186|NCT02311881|868494|P1|Overall Study|Adverse Event|7
263187|NCT02311881|868492|P3|Overall Study|Did not meet the study criteria|0
263188|NCT02311881|868493|P2|Overall Study|Did not meet the study criteria|2
263189|NCT02311881|868494|P1|Overall Study|Did not meet the study criteria|2
263190|NCT02311153|868547|P2|Overall Study|Lost to Follow-up|7
263191|NCT02311153|868548|P1|Overall Study|Lost to Follow-up|5
263192|NCT02310789|868564|P1|Overall Study|Adverse Event|1
263193|NCT02310750|868584|P16|HP Washout 2|Lost to Follow-up|0
263194|NCT02310750|868585|P15|HP Washout 2|Lost to Follow-up|0
263195|NCT02310750|868586|P14|HP Washout 2|Lost to Follow-up|0
263196|NCT02310750|868587|P13|HP Washout 2|Lost to Follow-up|0
263197|NCT02310750|868588|P12|HP Washout 2|Lost to Follow-up|0
263198|NCT02310750|868589|P11|HP Washout 2|Lost to Follow-up|0
263199|NCT02310750|868590|P10|HP Washout 2|Lost to Follow-up|0
263200|NCT02310750|868591|P9|HP Washout 2|Lost to Follow-up|0
263201|NCT02310750|868592|P8|HP Washout 2|Lost to Follow-up|0
263202|NCT02310750|868593|P7|HP Washout 2|Lost to Follow-up|7
263203|NCT02310750|868594|P6|HP Washout 2|Lost to Follow-up|0
263204|NCT02310750|868595|P5|HP Washout 2|Lost to Follow-up|1
263205|NCT02310750|868596|P4|HP Washout 2|Lost to Follow-up|0
263206|NCT02310750|868597|P3|HP Washout 2|Lost to Follow-up|0
263207|NCT02310750|868598|P2|HP Washout 2|Lost to Follow-up|0
263208|NCT02310750|868599|P1|HP Washout 2|Lost to Follow-up|0
263209|NCT02310750|868584|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263210|NCT02310750|868585|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263211|NCT02310750|868586|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263212|NCT02310750|868587|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263213|NCT02310750|868588|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263214|NCT02310750|868589|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263215|NCT02310750|868590|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263216|NCT02310750|868591|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
263217|NCT02310750|868592|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
263218|NCT02310750|868593|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263219|NCT02310750|868594|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263220|NCT02310750|868595|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263221|NCT02310750|868596|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263222|NCT02310750|868597|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263223|NCT02310750|868598|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263224|NCT02310750|868599|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
263225|NCT02310750|868584|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263226|NCT02310750|868585|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263227|NCT02310750|868586|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263228|NCT02310750|868587|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263229|NCT02310750|868588|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263230|NCT02310750|868589|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263231|NCT02310750|868590|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
263232|NCT02310750|868591|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
263233|NCT02310750|868592|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
263234|NCT02310750|868593|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263235|NCT02310750|868594|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263236|NCT02310750|868595|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263237|NCT02310750|868596|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263238|NCT02310750|868597|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263239|NCT02310750|868598|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263240|NCT02310750|868599|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
263241|NCT02310750|868584|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263242|NCT02310750|868585|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263243|NCT02310750|868586|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263244|NCT02310750|868587|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263245|NCT02310750|868588|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263246|NCT02310750|868589|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263247|NCT02310750|868590|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
263248|NCT02310750|868591|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263249|NCT02310750|868592|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263250|NCT02310750|868593|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263251|NCT02310750|868594|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263252|NCT02310750|868595|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263253|NCT02310750|868596|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263254|NCT02310750|868597|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263255|NCT02310750|868598|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263256|NCT02310750|868599|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
263257|NCT02310750|868584|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263258|NCT02310750|868585|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263259|NCT02310750|868586|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263260|NCT02310750|868587|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263261|NCT02310750|868588|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263262|NCT02310750|868589|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263263|NCT02310750|868590|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
263264|NCT02310750|868591|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
263265|NCT02310750|868592|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263266|NCT02310750|868593|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263267|NCT02310750|868594|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
263268|NCT02310750|868595|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263269|NCT02310750|868596|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
263270|NCT02310750|868597|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263271|NCT02310750|868598|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263272|NCT02310750|868599|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
263273|NCT02310750|868584|P16|HP Washout 1|Lost to Follow-up|0
263274|NCT02310750|868585|P15|HP Washout 1|Lost to Follow-up|0
263275|NCT02310750|868586|P14|HP Washout 1|Lost to Follow-up|0
263276|NCT02310750|868587|P13|HP Washout 1|Lost to Follow-up|0
263277|NCT02310750|868588|P12|HP Washout 1|Lost to Follow-up|0
263278|NCT02310750|868589|P11|HP Washout 1|Lost to Follow-up|0
263279|NCT02310750|868590|P10|HP Washout 1|Lost to Follow-up|0
263280|NCT02310750|868591|P9|HP Washout 1|Lost to Follow-up|0
263281|NCT02310750|868592|P8|HP Washout 1|Lost to Follow-up|0
263282|NCT02310750|868593|P7|HP Washout 1|Lost to Follow-up|3
263283|NCT02310750|868594|P6|HP Washout 1|Lost to Follow-up|2
263284|NCT02310750|868595|P5|HP Washout 1|Lost to Follow-up|2
263285|NCT02310750|868596|P4|HP Washout 1|Lost to Follow-up|1
263286|NCT02310750|868597|P3|HP Washout 1|Lost to Follow-up|1
263287|NCT02310750|868598|P2|HP Washout 1|Lost to Follow-up|0
263288|NCT02310750|868599|P1|HP Washout 1|Lost to Follow-up|0
263289|NCT02310750|868584|P16|HP Period 1|Withdrawal by Subject|0
263290|NCT02310750|868585|P15|HP Period 1|Withdrawal by Subject|0
263291|NCT02310750|868586|P14|HP Period 1|Withdrawal by Subject|0
263292|NCT02310750|868587|P13|HP Period 1|Withdrawal by Subject|0
263293|NCT02310750|868588|P12|HP Period 1|Withdrawal by Subject|0
263294|NCT02310750|868589|P11|HP Period 1|Withdrawal by Subject|0
263295|NCT02310750|868590|P10|HP Period 1|Withdrawal by Subject|0
263296|NCT02310750|868591|P9|HP Period 1|Withdrawal by Subject|0
263297|NCT02310750|868592|P8|HP Period 1|Withdrawal by Subject|0
263298|NCT02310750|868593|P7|HP Period 1|Withdrawal by Subject|0
263299|NCT02310750|868594|P6|HP Period 1|Withdrawal by Subject|0
263300|NCT02310750|868595|P5|HP Period 1|Withdrawal by Subject|0
263301|NCT02310750|868596|P4|HP Period 1|Withdrawal by Subject|1
263302|NCT02310750|868597|P3|HP Period 1|Withdrawal by Subject|0
263303|NCT02310750|868598|P2|HP Period 1|Withdrawal by Subject|0
263304|NCT02310750|868599|P1|HP Period 1|Withdrawal by Subject|1
263305|NCT02310750|868584|P16|HP Period 1|Lost to Follow-up|0
263306|NCT02310750|868585|P15|HP Period 1|Lost to Follow-up|0
263307|NCT02310750|868586|P14|HP Period 1|Lost to Follow-up|0
263308|NCT02310750|868587|P13|HP Period 1|Lost to Follow-up|0
263309|NCT02310750|868588|P12|HP Period 1|Lost to Follow-up|0
263310|NCT02310750|868589|P11|HP Period 1|Lost to Follow-up|0
263311|NCT02310750|868590|P10|HP Period 1|Lost to Follow-up|0
263312|NCT02310750|868591|P9|HP Period 1|Lost to Follow-up|0
263313|NCT02310750|868592|P8|HP Period 1|Lost to Follow-up|0
263314|NCT02310750|868593|P7|HP Period 1|Lost to Follow-up|1
263315|NCT02310750|868594|P6|HP Period 1|Lost to Follow-up|0
263316|NCT02310750|868595|P5|HP Period 1|Lost to Follow-up|0
263317|NCT02310750|868596|P4|HP Period 1|Lost to Follow-up|0
263318|NCT02310750|868597|P3|HP Period 1|Lost to Follow-up|0
263319|NCT02310750|868598|P2|HP Period 1|Lost to Follow-up|0
263320|NCT02310750|868599|P1|HP Period 1|Lost to Follow-up|0
263321|NCT02310646|869040|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
263322|NCT02310646|869041|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
263323|NCT02310646|869040|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
263324|NCT02310646|869041|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
263325|NCT02310581|869069|P4|Overall Study|Withdrawal by Subject|1
263326|NCT02310581|869070|P3|Overall Study|Withdrawal by Subject|0
263327|NCT02310581|869071|P2|Overall Study|Withdrawal by Subject|1
263328|NCT02310581|869072|P1|Overall Study|Withdrawal by Subject|2
263329|NCT02310581|869069|P4|Overall Study|Adverse Event|0
263330|NCT02310581|869070|P3|Overall Study|Adverse Event|1
263331|NCT02310581|869071|P2|Overall Study|Adverse Event|1
263332|NCT02310581|869072|P1|Overall Study|Adverse Event|1
263333|NCT02310568|869111|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
263334|NCT02310568|869112|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
263335|NCT02310568|869113|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
263336|NCT02310568|869114|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
263337|NCT02310568|869115|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
263338|NCT02310568|869111|P5|Stage 2 (4 Weeks)|Protocol Violation|0
263339|NCT02310568|869112|P4|Stage 2 (4 Weeks)|Protocol Violation|1
263340|NCT02310568|869113|P3|Stage 2 (4 Weeks)|Protocol Violation|0
263341|NCT02310568|869114|P2|Stage 2 (4 Weeks)|Protocol Violation|0
263342|NCT02310568|869115|P1|Stage 2 (4 Weeks)|Protocol Violation|0
263343|NCT02310568|869111|P5|Stage 2 (4 Weeks)|Adverse Event|1
263344|NCT02310568|869112|P4|Stage 2 (4 Weeks)|Adverse Event|1
263345|NCT02310568|869113|P3|Stage 2 (4 Weeks)|Adverse Event|0
263346|NCT02310568|869114|P2|Stage 2 (4 Weeks)|Adverse Event|0
263347|NCT02310568|869115|P1|Stage 2 (4 Weeks)|Adverse Event|0
263348|NCT02310568|869111|P5|Stage 2 (4 Weeks)|Other|0
263349|NCT02310568|869112|P4|Stage 2 (4 Weeks)|Other|0
263350|NCT02310568|869113|P3|Stage 2 (4 Weeks)|Other|1
263351|NCT02310568|869114|P2|Stage 2 (4 Weeks)|Other|1
263352|NCT02310568|869115|P1|Stage 2 (4 Weeks)|Other|0
263353|NCT02310568|869111|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
263354|NCT02310568|869112|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
263355|NCT02310568|869113|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
263356|NCT02310568|869114|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
263357|NCT02310568|869115|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
263358|NCT02310568|869111|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
263359|NCT02310568|869112|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
263360|NCT02310568|869113|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
263361|NCT02310568|869114|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
263362|NCT02310568|869115|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
263363|NCT02310568|869111|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
263364|NCT02310568|869112|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
263365|NCT02310568|869113|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
263366|NCT02310568|869114|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
263367|NCT02310568|869115|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
263368|NCT02310568|869111|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
263369|NCT02310568|869112|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
263370|NCT02310568|869113|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
263371|NCT02310568|869114|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
263372|NCT02310568|869115|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
263373|NCT02310568|869111|P5|Stage 1 ( 4 Weeks)|Other|0
263374|NCT02310568|869112|P4|Stage 1 ( 4 Weeks)|Other|0
263375|NCT02310568|869113|P3|Stage 1 ( 4 Weeks)|Other|0
263376|NCT02310568|869114|P2|Stage 1 ( 4 Weeks)|Other|1
263377|NCT02310568|869115|P1|Stage 1 ( 4 Weeks)|Other|1
263378|NCT02310568|869111|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
263379|NCT02310568|869112|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
263380|NCT02310568|869113|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
263381|NCT02310568|869114|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
263382|NCT02310568|869115|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
263383|NCT02310568|869111|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
263384|NCT02310568|869112|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
263385|NCT02310568|869113|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
263386|NCT02310568|869114|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
263387|NCT02310568|869115|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
263388|NCT02310126|869195|P2|Period 1 (15 Minutes)|Protocol Violation|1
263389|NCT02310126|869196|P1|Period 1 (15 Minutes)|Protocol Violation|0
263390|NCT02310126|869195|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
263391|NCT02310126|869196|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
263392|NCT02309723|869205|P3|Overall Study|Withdrawal by Subject|24
263393|NCT02309723|869206|P2|Overall Study|Withdrawal by Subject|23
263394|NCT02309723|869207|P1|Overall Study|Withdrawal by Subject|24
263395|NCT02309411|869224|P3|Overall Study|Withdrawal by Subject|0
263396|NCT02309411|869225|P2|Overall Study|Withdrawal by Subject|1
263397|NCT02309411|869226|P1|Overall Study|Withdrawal by Subject|1
263398|NCT02309411|869224|P3|Overall Study|Physician Decision|0
263399|NCT02309411|869225|P2|Overall Study|Physician Decision|0
263400|NCT02309411|869226|P1|Overall Study|Physician Decision|1
263401|NCT02309294|869245|P1|Overall Study|Withdrawal by Subject|2
263402|NCT02309112|869252|P3|Overall Study|Lost to Follow-up|0
263403|NCT02309112|869253|P2|Overall Study|Lost to Follow-up|1
263404|NCT02309112|869254|P1|Overall Study|Lost to Follow-up|0
263405|NCT02309112|869252|P3|Overall Study|Withdrawal by Subject|1
263406|NCT02309112|869253|P2|Overall Study|Withdrawal by Subject|0
263407|NCT02309112|869254|P1|Overall Study|Withdrawal by Subject|1
263408|NCT02308748|869290|P10|Period 5|Adverse Event|0
263409|NCT02308748|869291|P9|Period 5|Adverse Event|1
263410|NCT02308748|869292|P8|Period 5|Adverse Event|0
263411|NCT02308748|869293|P7|Period 5|Adverse Event|0
263412|NCT02308748|869294|P6|Period 5|Adverse Event|0
263413|NCT02308748|869295|P5|Period 5|Adverse Event|0
263414|NCT02308748|869296|P4|Period 5|Adverse Event|0
263415|NCT02308748|869297|P3|Period 5|Adverse Event|0
263416|NCT02308748|869298|P2|Period 5|Adverse Event|0
263417|NCT02308748|869299|P1|Period 5|Adverse Event|1
263418|NCT02308748|869290|P10|Period 3|Protocol Violation|1
263419|NCT02308748|869291|P9|Period 3|Protocol Violation|0
263420|NCT02308748|869292|P8|Period 3|Protocol Violation|0
263421|NCT02308748|869293|P7|Period 3|Protocol Violation|0
263422|NCT02308748|869294|P6|Period 3|Protocol Violation|0
263423|NCT02308748|869295|P5|Period 3|Protocol Violation|0
263424|NCT02308748|869296|P4|Period 3|Protocol Violation|0
263425|NCT02308748|869297|P3|Period 3|Protocol Violation|0
263426|NCT02308748|869298|P2|Period 3|Protocol Violation|0
263427|NCT02308748|869299|P1|Period 3|Protocol Violation|0
263428|NCT02308748|869290|P10|Period 2|Adverse Event|0
263429|NCT02308748|869291|P9|Period 2|Adverse Event|0
263430|NCT02308748|869292|P8|Period 2|Adverse Event|1
263431|NCT02308748|869293|P7|Period 2|Adverse Event|0
263432|NCT02308748|869294|P6|Period 2|Adverse Event|0
263433|NCT02308748|869295|P5|Period 2|Adverse Event|0
263434|NCT02308748|869296|P4|Period 2|Adverse Event|0
263435|NCT02308748|869297|P3|Period 2|Adverse Event|0
263436|NCT02308748|869298|P2|Period 2|Adverse Event|0
263437|NCT02308748|869299|P1|Period 2|Adverse Event|0
263438|NCT02308748|869290|P10|Period 1|Withdrawal by Subject|0
263439|NCT02308748|869291|P9|Period 1|Withdrawal by Subject|0
263440|NCT02308748|869292|P8|Period 1|Withdrawal by Subject|0
263441|NCT02308748|869293|P7|Period 1|Withdrawal by Subject|0
263442|NCT02308748|869294|P6|Period 1|Withdrawal by Subject|0
263443|NCT02308748|869295|P5|Period 1|Withdrawal by Subject|0
263444|NCT02308748|869296|P4|Period 1|Withdrawal by Subject|0
263445|NCT02308748|869297|P3|Period 1|Withdrawal by Subject|1
263446|NCT02308748|869298|P2|Period 1|Withdrawal by Subject|0
263447|NCT02308748|869299|P1|Period 1|Withdrawal by Subject|0
263448|NCT02308124|869344|P3|Overall Study|Adverse Event|2
263449|NCT02308124|869345|P2|Overall Study|Adverse Event|2
263450|NCT02308124|869346|P1|Overall Study|Adverse Event|0
263451|NCT02308124|869344|P3|Overall Study|Lost to Follow-up|6
263452|NCT02308124|869345|P2|Overall Study|Lost to Follow-up|6
263453|NCT02308124|869346|P1|Overall Study|Lost to Follow-up|6
263454|NCT02307266|869438|P3|Overall Study|Lost to Follow-up|0
263455|NCT02307266|869439|P2|Overall Study|Lost to Follow-up|0
263456|NCT02307266|869440|P1|Overall Study|Lost to Follow-up|3
263457|NCT02307266|869438|P3|Overall Study|Withdrawal by Subject|1
263458|NCT02307266|869439|P2|Overall Study|Withdrawal by Subject|0
263459|NCT02307266|869440|P1|Overall Study|Withdrawal by Subject|2
263460|NCT02307266|869438|P3|Overall Study|Adverse Event|5
263461|NCT02307266|869439|P2|Overall Study|Adverse Event|1
263462|NCT02307266|869440|P1|Overall Study|Adverse Event|3
263463|NCT02305446|869482|P1|Overall Study|Adverse Event|1
263464|NCT02305381|869490|P3|Overall Study|Unclassified|7
263465|NCT02305381|869491|P2|Overall Study|Unclassified|5
263466|NCT02305381|869492|P1|Overall Study|Unclassified|5
263467|NCT02305238|869605|P3|Overall Study|Randomized failure|8
263468|NCT02305238|869606|P2|Overall Study|Randomized failure|0
263469|NCT02305238|869607|P1|Overall Study|Randomized failure|0
263470|NCT02305238|869605|P3|Overall Study|Withdrawal by Subject|0
263471|NCT02305238|869606|P2|Overall Study|Withdrawal by Subject|2
263472|NCT02305238|869607|P1|Overall Study|Withdrawal by Subject|2
263473|NCT02305238|869605|P3|Overall Study|Adverse Event|0
263474|NCT02305238|869606|P2|Overall Study|Adverse Event|1
263475|NCT02305238|869607|P1|Overall Study|Adverse Event|3
263476|NCT02305238|869605|P3|Overall Study|Physician Decision|0
263477|NCT02305238|869606|P2|Overall Study|Physician Decision|0
263478|NCT02305238|869607|P1|Overall Study|Physician Decision|1
263479|NCT02305238|869605|P3|Overall Study|Protocol Violation|0
263480|NCT02305238|869606|P2|Overall Study|Protocol Violation|1
263481|NCT02305238|869607|P1|Overall Study|Protocol Violation|0
263482|NCT02305238|869605|P3|Overall Study|Logistical difficulties|0
263483|NCT02305238|869606|P2|Overall Study|Logistical difficulties|1
263484|NCT02305238|869607|P1|Overall Study|Logistical difficulties|1
263485|NCT02305238|869605|P3|Overall Study|Progressive disease|0
263486|NCT02305238|869606|P2|Overall Study|Progressive disease|2
263487|NCT02305238|869607|P1|Overall Study|Progressive disease|4
263488|NCT02305238|869605|P3|Overall Study|Death|0
263489|NCT02305238|869606|P2|Overall Study|Death|0
263490|NCT02305238|869607|P1|Overall Study|Death|2
263491|NCT02304926|869639|P2|Overall Study|Lost to Follow-up|1
263492|NCT02304926|869640|P1|Overall Study|Lost to Follow-up|2
263493|NCT02303704|869732|P2|Overall Study|Protocol Violation|9
263494|NCT02303704|869733|P1|Overall Study|Protocol Violation|5
263495|NCT02302807|869751|P2|Overall Study|Death|322
263496|NCT02302807|869752|P1|Overall Study|Death|345
263497|NCT02302807|869751|P2|Overall Study|Lost to Follow-up|3
263498|NCT02302807|869752|P1|Overall Study|Lost to Follow-up|3
263499|NCT02302807|869751|P2|Overall Study|Withdrawal by Subject|9
263500|NCT02302807|869752|P1|Overall Study|Withdrawal by Subject|27
263501|NCT02302716|869799|P2|Overall Study|Protocol Violation|1
263502|NCT02302716|869800|P1|Overall Study|Protocol Violation|0
263503|NCT02302716|869799|P2|Overall Study|Withdrawal by Subject|7
263504|NCT02302716|869800|P1|Overall Study|Withdrawal by Subject|13
263505|NCT02302716|869799|P2|Overall Study|Physician Decision|4
263506|NCT02302716|869800|P1|Overall Study|Physician Decision|3
263507|NCT02302716|869799|P2|Overall Study|Lost to Follow-up|4
263508|NCT02302716|869800|P1|Overall Study|Lost to Follow-up|2
263509|NCT02302716|869799|P2|Overall Study|Lack of Efficacy|1
263510|NCT02302716|869800|P1|Overall Study|Lack of Efficacy|0
263511|NCT02302716|869799|P2|Overall Study|Death|1
263512|NCT02302716|869800|P1|Overall Study|Death|0
263513|NCT02302716|869799|P2|Overall Study|Adverse Event|1
263514|NCT02302716|869800|P1|Overall Study|Adverse Event|1
263515|NCT02301975|869874|P3|Overall Study|Withdrawal by Subject|11
263516|NCT02301975|869875|P2|Overall Study|Withdrawal by Subject|12
263517|NCT02301975|869876|P1|Overall Study|Withdrawal by Subject|15
263518|NCT02301975|869874|P3|Overall Study|Physician Decision|3
263519|NCT02301975|869875|P2|Overall Study|Physician Decision|2
263520|NCT02301975|869876|P1|Overall Study|Physician Decision|4
263521|NCT02301975|869874|P3|Overall Study|Lost to Follow-up|2
263522|NCT02301975|869875|P2|Overall Study|Lost to Follow-up|2
263523|NCT02301975|869876|P1|Overall Study|Lost to Follow-up|0
263524|NCT02301975|869874|P3|Overall Study|Protocol Violation|3
263525|NCT02301975|869875|P2|Overall Study|Protocol Violation|5
263526|NCT02301975|869876|P1|Overall Study|Protocol Violation|3
263527|NCT02301975|869874|P3|Overall Study|Lack of Efficacy|1
263528|NCT02301975|869875|P2|Overall Study|Lack of Efficacy|1
263529|NCT02301975|869876|P1|Overall Study|Lack of Efficacy|1
263530|NCT02301975|869874|P3|Overall Study|Adverse Event|2
263531|NCT02301975|869875|P2|Overall Study|Adverse Event|3
263532|NCT02301975|869876|P1|Overall Study|Adverse Event|8
263533|NCT02301936|869904|P2|Overall Study|Lost to Follow-up|0
263534|NCT02301936|869905|P1|Overall Study|Lost to Follow-up|1
263535|NCT02301429|869927|P1|Overall Study|not acceptable vascular anatomy|3
263536|NCT02301169|869953|P2|Overall Study|Adverse Event|0
263537|NCT02301169|869954|P1|Overall Study|Adverse Event|1
263538|NCT02300558|869968|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
263539|NCT02300558|869968|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
263540|NCT02300558|869968|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
263541|NCT02300558|869968|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
263542|NCT02300311|869981|P2|Overall Study|Refused to continue taking medication|0
263543|NCT02300311|869982|P1|Overall Study|Refused to continue taking medication|18
263544|NCT02300311|869981|P2|Overall Study|Other than the reason specified|0
263545|NCT02300311|869982|P1|Overall Study|Other than the reason specified|1
263546|NCT02300129|869994|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
263547|NCT02300129|869995|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
263548|NCT02300129|869996|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
263549|NCT02300129|869997|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
263550|NCT02300129|869994|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
263551|NCT02300129|869995|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
263552|NCT02300129|869996|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
263553|NCT02300129|869997|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
263554|NCT02300129|869994|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
263555|NCT02300129|869995|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
263556|NCT02300129|869996|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
263557|NCT02300129|869997|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
263558|NCT02300103|870007|P1|Overall Study|Withdrew Consent|2
263559|NCT02300103|870007|P1|Overall Study|Protocol Violation|1
263560|NCT02300103|870007|P1|Overall Study|Lack of Efficacy|3
263561|NCT02299635|870104|P1|Overall Study|Other|3
263562|NCT02299635|870104|P1|Overall Study|Withdrawal by Subject|2
263563|NCT02299635|870104|P1|Overall Study|Objective progression or relapse|10
263564|NCT02299635|870104|P1|Overall Study|Global deterioration of health status|1
263565|NCT02299635|870104|P1|Overall Study|Death|1
263566|NCT02299635|870104|P1|Overall Study|Adverse Event|2
263567|NCT02299427|870125|P2|Overall Study|not adherent to dog website use|0
263568|NCT02299427|870126|P1|Overall Study|not adherent to dog website use|21
263569|NCT02299427|870125|P2|Overall Study|Lost to Follow-up|3
263570|NCT02299427|870126|P1|Overall Study|Lost to Follow-up|1
263571|NCT02299427|870125|P2|Overall Study|Withdrawal by Subject|0
263572|NCT02299427|870126|P1|Overall Study|Withdrawal by Subject|1
263573|NCT02299336|870145|P1|Overall Study|Lost to Follow-up|1
263574|NCT02299336|870145|P1|Overall Study|Death|1
263575|NCT02299336|870145|P1|Overall Study|Adverse Event|1
263576|NCT02299336|870145|P1|Overall Study|Withdrawal by Subject|11
263577|NCT02299206|870169|P1|Overall Study|Withdrawal by Subject|1
263578|NCT02299206|870169|P1|Overall Study|Lost to Follow-up|1
263579|NCT02299076|870230|P2|Overall Study|Fraudulent Entries|14
263580|NCT02299076|870231|P1|Overall Study|Fraudulent Entries|20
263581|NCT02298868|870239|P1|Overall Study|Patient underwent transplant|1
263582|NCT02298868|870239|P1|Overall Study|Death|1
263583|NCT02298868|870239|P1|Overall Study|Adverse Event|1
263584|NCT02298192|870310|P2|Overall Study|Adverse Event|2
263585|NCT02298192|870311|P1|Overall Study|Adverse Event|6
263586|NCT02298192|870310|P2|Overall Study|Lost to Follow-up|1
263587|NCT02298192|870311|P1|Overall Study|Lost to Follow-up|2
263588|NCT02298192|870310|P2|Overall Study|Withdrawal by Subject|1
263589|NCT02298192|870311|P1|Overall Study|Withdrawal by Subject|6
263590|NCT02298192|870310|P2|Overall Study|Withdrawal criteria|0
263591|NCT02298192|870311|P1|Overall Study|Withdrawal criteria|2
263592|NCT02298192|870310|P2|Overall Study|Unclassified|2
263593|NCT02298192|870311|P1|Overall Study|Unclassified|3
263594|NCT02297841|870323|P1|Overall Study|Protocol Violation|7
263595|NCT02297841|870323|P1|Overall Study|Withdrawal by Subject|1
263596|NCT02297815|870329|P2|Overall Study|Lost to Follow-up|140
263597|NCT02297815|870330|P1|Overall Study|Lost to Follow-up|236
263598|NCT02296931|870395|P2|Overall Study|Protocol Violation|2
263599|NCT02296931|870396|P1|Overall Study|Protocol Violation|0
263600|NCT02296840|870404|P2|Overall Study|Lost to Follow-up|17
263601|NCT02296840|870405|P1|Overall Study|Lost to Follow-up|6
263602|NCT02296840|870404|P2|Overall Study|Protocol Violation|1
263603|NCT02296840|870405|P1|Overall Study|Protocol Violation|2
263604|NCT02296840|870404|P2|Overall Study|Adverse Event|1
263605|NCT02296840|870405|P1|Overall Study|Adverse Event|1
263606|NCT02296476|870420|P3|Overall Study|Disease Progression|2
263607|NCT02296476|870421|P2|Overall Study|Disease Progression|4
263608|NCT02296476|870422|P1|Overall Study|Disease Progression|6
263609|NCT02296138|870477|P2|Overall Study|Other than specified|13
263610|NCT02296138|870478|P1|Overall Study|Other than specified|15
263611|NCT02296138|870477|P2|Overall Study|Patients with data irregularities|11
263612|NCT02296138|870478|P1|Overall Study|Patients with data irregularities|10
263613|NCT02296138|870477|P2|Overall Study|Not Treated|1
263614|NCT02296138|870478|P1|Overall Study|Not Treated|1
263615|NCT02296138|870477|P2|Overall Study|Withdrawal by Subject|131
263616|NCT02296138|870478|P1|Overall Study|Withdrawal by Subject|184
263617|NCT02296138|870477|P2|Overall Study|Lost to Follow-up|12
263618|NCT02296138|870478|P1|Overall Study|Lost to Follow-up|9
263619|NCT02296138|870477|P2|Overall Study|Protocol Violation|36
263620|NCT02296138|870478|P1|Overall Study|Protocol Violation|35
263621|NCT02296138|870477|P2|Overall Study|Lack of Efficacy|37
263622|NCT02296138|870478|P1|Overall Study|Lack of Efficacy|59
263623|NCT02296138|870477|P2|Overall Study|Adverse Event|259
263624|NCT02296138|870478|P1|Overall Study|Adverse Event|348
263625|NCT02295774|870519|P1|Overall Study|Withdrawal by Subject|2
263626|NCT02295774|870519|P1|Overall Study|Lost to Follow-up|1
263627|NCT02295644|870527|P4|Overall Study|Did not meet inclusion criterion|2
263628|NCT02295644|870528|P3|Overall Study|Did not meet inclusion criterion|1
263629|NCT02295644|870529|P2|Overall Study|Did not meet inclusion criterion|0
263630|NCT02295644|870530|P1|Overall Study|Did not meet inclusion criterion|0
263631|NCT02295280|870550|P2|Overall Study|Adverse Event|1
263632|NCT02295280|870551|P1|Overall Study|Adverse Event|0
263633|NCT02295020|870559|P2|Overall Study|Withdrawal by Subject|2
263634|NCT02295020|870560|P1|Overall Study|Withdrawal by Subject|3
263635|NCT02295020|870559|P2|Overall Study|Adverse Event|1
263636|NCT02295020|870560|P1|Overall Study|Adverse Event|0
263637|NCT02294773|870592|P2|Overall Study|Withdrawal by Subject|2
263638|NCT02294773|870593|P1|Overall Study|Withdrawal by Subject|0
263639|NCT02294734|870609|P2|Overall Study|Withdrawal by Subject|2
263640|NCT02294734|870610|P1|Overall Study|Withdrawal by Subject|4
263641|NCT02294734|870609|P2|Overall Study|Physician Decision|1
263642|NCT02294734|870610|P1|Overall Study|Physician Decision|2
263643|NCT02294734|870609|P2|Overall Study|Lost to Follow-up|0
263644|NCT02294734|870610|P1|Overall Study|Lost to Follow-up|2
263645|NCT02294734|870609|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
263646|NCT02294734|870610|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
263647|NCT02294734|870609|P2|Overall Study|Adverse Event|5
263648|NCT02294734|870610|P1|Overall Study|Adverse Event|5
263649|NCT02294682|870662|P2|Overall Study|Could not swallow pills|0
263650|NCT02294682|870663|P1|Overall Study|Could not swallow pills|1
263651|NCT02294604|870706|P3|Overall Study|Culture contamination|0
263652|NCT02294604|870707|P2|Overall Study|Culture contamination|2
263653|NCT02294604|870708|P1|Overall Study|Culture contamination|1
263654|NCT02294604|870706|P3|Overall Study|Did not provide samples for culture|0
263655|NCT02294604|870707|P2|Overall Study|Did not provide samples for culture|1
263656|NCT02294604|870708|P1|Overall Study|Did not provide samples for culture|0
263657|NCT02294474|870727|P2|Overall Study|Other than specified above|12
263658|NCT02294474|870728|P1|Overall Study|Other than specified above|12
263659|NCT02294474|870727|P2|Overall Study|Protocol Violation|2
263660|NCT02294474|870728|P1|Overall Study|Protocol Violation|4
263661|NCT02294474|870727|P2|Overall Study|Lack of Efficacy|1
263662|NCT02294474|870728|P1|Overall Study|Lack of Efficacy|2
263663|NCT02294474|870727|P2|Overall Study|Adverse Event|7
263664|NCT02294474|870728|P1|Overall Study|Adverse Event|7
263665|NCT02294461|870752|P2|Overall Study|Miscellaneous|32
263666|NCT02294461|870753|P1|Overall Study|Miscellaneous|11
263667|NCT02294461|870752|P2|Overall Study|Adverse Event|10
263668|NCT02294461|870753|P1|Overall Study|Adverse Event|11
263669|NCT02294461|870752|P2|Overall Study|Disease Progression|39
263670|NCT02294461|870753|P1|Overall Study|Disease Progression|23
263671|NCT02294461|870752|P2|Overall Study|Withdrawal by Subject|45
263672|NCT02294461|870753|P1|Overall Study|Withdrawal by Subject|14
263673|NCT02294461|870752|P2|Overall Study|Protocol Violation|2
263674|NCT02294461|870753|P1|Overall Study|Protocol Violation|0
263675|NCT02294461|870752|P2|Overall Study|Death|3
263676|NCT02294461|870753|P1|Overall Study|Death|3
263677|NCT02294019|870805|P1|Overall Study|Withdrawal by Subject|1
263678|NCT02294019|870805|P1|Overall Study|Other|1
263679|NCT02294019|870805|P1|Overall Study|Lost to Follow-up|31
263680|NCT02294019|870805|P1|Overall Study|Protocol Violation|68
263681|NCT02294019|870805|P1|Overall Study|Adverse Event|2
263682|NCT02293902|870813|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
263683|NCT02293902|870814|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
263684|NCT02293902|870815|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
263685|NCT02293902|870816|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
263686|NCT02293902|870817|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
263687|NCT02293902|870813|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
263688|NCT02293902|870814|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
263689|NCT02293902|870815|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
263690|NCT02293902|870816|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
263691|NCT02293902|870817|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
263692|NCT02293902|870813|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
263693|NCT02293902|870814|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
263694|NCT02293902|870815|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
263695|NCT02293902|870816|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
263696|NCT02293902|870817|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
263697|NCT02293902|870813|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
263698|NCT02293902|870814|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
263699|NCT02293902|870815|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
263700|NCT02293902|870816|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
263701|NCT02293902|870817|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
263702|NCT02293902|870813|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
263703|NCT02293902|870814|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
263704|NCT02293902|870815|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
263705|NCT02293902|870816|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
263706|NCT02293902|870817|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
263707|NCT02293863|870879|P3|Overall Study|Reason Not Specified|2
263708|NCT02293863|870880|P2|Overall Study|Reason Not Specified|2
263709|NCT02293863|870881|P1|Overall Study|Reason Not Specified|0
263710|NCT02293863|870879|P3|Overall Study|Withdrawal by Subject|1
263711|NCT02293863|870880|P2|Overall Study|Withdrawal by Subject|3
263712|NCT02293863|870881|P1|Overall Study|Withdrawal by Subject|3
263713|NCT02293863|870879|P3|Overall Study|Lost to Follow-up|2
263714|NCT02293863|870880|P2|Overall Study|Lost to Follow-up|2
263715|NCT02293863|870881|P1|Overall Study|Lost to Follow-up|2
263716|NCT02293863|870879|P3|Overall Study|Death|4
263717|NCT02293863|870880|P2|Overall Study|Death|6
263718|NCT02293863|870881|P1|Overall Study|Death|4
263719|NCT02293538|870946|P2|Overall Study|Withdrawal by Subject|1
263720|NCT02293538|870947|P1|Overall Study|Withdrawal by Subject|0
263721|NCT02293538|870946|P2|Overall Study|Lost to Follow-up|0
263722|NCT02293538|870947|P1|Overall Study|Lost to Follow-up|1
263723|NCT02293538|870946|P2|Overall Study|Adverse Event|1
263724|NCT02293538|870947|P1|Overall Study|Adverse Event|0
263725|NCT02293395|870962|P2|Overall Study|Withdrawal by Subject|7
263726|NCT02293395|870963|P1|Overall Study|Withdrawal by Subject|8
263727|NCT02293395|870962|P2|Overall Study|Lost to Follow-up|0
263728|NCT02293395|870963|P1|Overall Study|Lost to Follow-up|1
263729|NCT02292849|870972|P3|Overall Study|Physician Decision|0
263730|NCT02292849|870973|P2|Overall Study|Physician Decision|0
263731|NCT02292849|870974|P1|Overall Study|Physician Decision|4
263732|NCT02292849|870972|P3|Overall Study|Lost to Follow-up|2
263733|NCT02292849|870973|P2|Overall Study|Lost to Follow-up|2
263734|NCT02292849|870974|P1|Overall Study|Lost to Follow-up|0
263735|NCT02292212|871095|P1|ViE Phase|Protocol Violation|2
263736|NCT02292212|871095|P1|ViE Phase|Withdrawal by Subject|1
263737|NCT02291861|871139|P4|Overall Study|Not specified|1
263738|NCT02291861|871140|P3|Overall Study|Not specified|0
263739|NCT02291861|871141|P2|Overall Study|Not specified|0
263740|NCT02291861|871142|P1|Overall Study|Not specified|0
263741|NCT02291861|871139|P4|Overall Study|Lost to Follow-up|0
263742|NCT02291861|871140|P3|Overall Study|Lost to Follow-up|4
263743|NCT02291861|871141|P2|Overall Study|Lost to Follow-up|1
263744|NCT02291861|871142|P1|Overall Study|Lost to Follow-up|2
263745|NCT02291861|871139|P4|Overall Study|Noncompliance|1
263746|NCT02291861|871140|P3|Overall Study|Noncompliance|2
263747|NCT02291861|871141|P2|Overall Study|Noncompliance|1
263748|NCT02291861|871142|P1|Overall Study|Noncompliance|1
263749|NCT02291861|871139|P4|Overall Study|Withdrawal by Subject|4
263750|NCT02291861|871140|P3|Overall Study|Withdrawal by Subject|1
263751|NCT02291861|871141|P2|Overall Study|Withdrawal by Subject|2
263752|NCT02291861|871142|P1|Overall Study|Withdrawal by Subject|1
263753|NCT02291861|871139|P4|Overall Study|Protocol Violation|1
263754|NCT02291861|871140|P3|Overall Study|Protocol Violation|0
263755|NCT02291861|871141|P2|Overall Study|Protocol Violation|0
263756|NCT02291861|871142|P1|Overall Study|Protocol Violation|1
263757|NCT02291861|871139|P4|Overall Study|Death|1
263758|NCT02291861|871140|P3|Overall Study|Death|1
263759|NCT02291861|871141|P2|Overall Study|Death|0
263760|NCT02291861|871142|P1|Overall Study|Death|0
263761|NCT02291861|871139|P4|Overall Study|Adverse Event|2
263762|NCT02291861|871140|P3|Overall Study|Adverse Event|1
263763|NCT02291861|871141|P2|Overall Study|Adverse Event|4
263764|NCT02291861|871142|P1|Overall Study|Adverse Event|2
263765|NCT02291679|871205|P3|Overall Study|Not Specified|2
263766|NCT02291679|871206|P2|Overall Study|Not Specified|4
263767|NCT02291679|871207|P1|Overall Study|Not Specified|2
263768|NCT02291679|871205|P3|Overall Study|Insufficient Therapeutic Response|7
263769|NCT02291679|871206|P2|Overall Study|Insufficient Therapeutic Response|5
263770|NCT02291679|871207|P1|Overall Study|Insufficient Therapeutic Response|5
263771|NCT02291679|871205|P3|Overall Study|Lost to Follow-up|9
263772|NCT02291679|871206|P2|Overall Study|Lost to Follow-up|10
263773|NCT02291679|871207|P1|Overall Study|Lost to Follow-up|12
263774|NCT02291679|871205|P3|Overall Study|Withdrew Consent|15
263775|NCT02291679|871206|P2|Overall Study|Withdrew Consent|10
263776|NCT02291679|871207|P1|Overall Study|Withdrew Consent|18
263777|NCT02291679|871205|P3|Overall Study|Protocol Violation|7
263778|NCT02291679|871206|P2|Overall Study|Protocol Violation|1
263779|NCT02291679|871207|P1|Overall Study|Protocol Violation|5
263780|NCT02291679|871205|P3|Overall Study|Adverse Event|19
263781|NCT02291679|871206|P2|Overall Study|Adverse Event|12
263782|NCT02291679|871207|P1|Overall Study|Adverse Event|2
263783|NCT02291510|871240|P4|Overall Study|Adverse Event|1
263784|NCT02291510|871241|P3|Overall Study|Adverse Event|0
263785|NCT02291510|871242|P2|Overall Study|Adverse Event|0
263786|NCT02291510|871243|P1|Overall Study|Adverse Event|0
263787|NCT02291419|871259|P2|Overall Study|Early study termination|5
263788|NCT02291419|871260|P1|Overall Study|Early study termination|1
263789|NCT02291237|871278|P2|Overall Study|Subject Required Prohibited Medication|0
263790|NCT02291237|871279|P1|Overall Study|Subject Required Prohibited Medication|2
263791|NCT02291237|871278|P2|Overall Study|Lost to Follow-up|2
263792|NCT02291237|871279|P1|Overall Study|Lost to Follow-up|0
263793|NCT02291237|871278|P2|Overall Study|Withdrew Consent|11
263794|NCT02291237|871279|P1|Overall Study|Withdrew Consent|11
263795|NCT02291237|871278|P2|Overall Study|Investigator's Discretion|3
263796|NCT02291237|871279|P1|Overall Study|Investigator's Discretion|0
263797|NCT02291237|871278|P2|Overall Study|Adverse Event|3
263798|NCT02291237|871279|P1|Overall Study|Adverse Event|1
263799|NCT02291237|871278|P2|Overall Study|Study Terminated by Sponsor|67
263800|NCT02291237|871279|P1|Overall Study|Study Terminated by Sponsor|72
263801|NCT02290821|871297|P2|Overall Study|Lost to Follow-up|2
263802|NCT02290821|871298|P1|Overall Study|Lost to Follow-up|3
263803|NCT02290821|871297|P2|Overall Study|Unable or unwilling to cooperate with|0
263804|NCT02290821|871298|P1|Overall Study|Unable or unwilling to cooperate with|2
263805|NCT02290821|871297|P2|Overall Study|Withdrawal by Subject|1
263806|NCT02290821|871298|P1|Overall Study|Withdrawal by Subject|1
263807|NCT02290691|871306|P2|Overall Study|Lost to Follow-up|7
263808|NCT02290691|871307|P1|Overall Study|Lost to Follow-up|7
263809|NCT02290691|871306|P2|Overall Study|Withdrawal by Subject|1
263810|NCT02290691|871307|P1|Overall Study|Withdrawal by Subject|1
263811|NCT02290691|871306|P2|Overall Study|Noncompliance|1
263812|NCT02290691|871307|P1|Overall Study|Noncompliance|0
263813|NCT02289963|871357|P2|Overall Study|Other than specified above|2
263814|NCT02289963|871358|P1|Overall Study|Other than specified above|0
263815|NCT02289963|871357|P2|Overall Study|End treatment visit outside visit window|4
263816|NCT02289963|871358|P1|Overall Study|End treatment visit outside visit window|0
263817|NCT02289963|871357|P2|Overall Study|Last injection missed|2
263818|NCT02289963|871358|P1|Overall Study|Last injection missed|2
263819|NCT02289963|871357|P2|Overall Study|Withdrawal by Subject|0
263820|NCT02289963|871358|P1|Overall Study|Withdrawal by Subject|1
263821|NCT02289963|871357|P2|Overall Study|Poor compliance to protocol|0
263822|NCT02289963|871358|P1|Overall Study|Poor compliance to protocol|1
263823|NCT02289963|871357|P2|Overall Study|Adverse Event|2
263824|NCT02289963|871358|P1|Overall Study|Adverse Event|1
263825|NCT02289833|871408|P2|Overall Study|Death|8
263826|NCT02289833|871409|P1|Overall Study|Death|15
263827|NCT02289833|871408|P2|Overall Study|Lost to Follow-up|0
263828|NCT02289833|871409|P1|Overall Study|Lost to Follow-up|2
263829|NCT02289833|871408|P2|Overall Study|Disease Progression|3
263830|NCT02289833|871409|P1|Overall Study|Disease Progression|0
263831|NCT02289833|871408|P2|Overall Study|Clinical Progression|1
263832|NCT02289833|871409|P1|Overall Study|Clinical Progression|0
263833|NCT02289833|871408|P2|Overall Study|Continued Participation in Study|8
263834|NCT02289833|871409|P1|Overall Study|Continued Participation in Study|12
263835|NCT02289820|871447|P7|Overall Study|withdrawal of consent|0
263836|NCT02289820|871448|P6|Overall Study|withdrawal of consent|0
263837|NCT02289820|871449|P5|Overall Study|withdrawal of consent|0
263838|NCT02289820|871450|P4|Overall Study|withdrawal of consent|0
263839|NCT02289820|871451|P3|Overall Study|withdrawal of consent|0
263840|NCT02289820|871452|P2|Overall Study|withdrawal of consent|1
263841|NCT02289820|871453|P1|Overall Study|withdrawal of consent|0
263842|NCT02289820|871447|P7|Overall Study|Lost to Follow-up|1
263843|NCT02289820|871448|P6|Overall Study|Lost to Follow-up|1
263844|NCT02289820|871449|P5|Overall Study|Lost to Follow-up|0
263845|NCT02289820|871450|P4|Overall Study|Lost to Follow-up|1
263846|NCT02289820|871451|P3|Overall Study|Lost to Follow-up|3
263847|NCT02289820|871452|P2|Overall Study|Lost to Follow-up|0
263848|NCT02289820|871453|P1|Overall Study|Lost to Follow-up|0
263849|NCT02289820|871447|P7|Overall Study|Death|0
263850|NCT02289820|871448|P6|Overall Study|Death|0
263851|NCT02289820|871449|P5|Overall Study|Death|0
263852|NCT02289820|871450|P4|Overall Study|Death|0
263853|NCT02289820|871451|P3|Overall Study|Death|1
263854|NCT02289820|871452|P2|Overall Study|Death|0
263855|NCT02289820|871453|P1|Overall Study|Death|0
263856|NCT02289820|871447|P7|Overall Study|Withdrawal by Subject|1
263857|NCT02289820|871448|P6|Overall Study|Withdrawal by Subject|0
263858|NCT02289820|871449|P5|Overall Study|Withdrawal by Subject|0
263859|NCT02289820|871450|P4|Overall Study|Withdrawal by Subject|1
263860|NCT02289820|871451|P3|Overall Study|Withdrawal by Subject|2
263861|NCT02289820|871452|P2|Overall Study|Withdrawal by Subject|1
263862|NCT02289820|871453|P1|Overall Study|Withdrawal by Subject|2
263863|NCT02289742|871571|P4|Third Wear Period|Reason not given|1
263864|NCT02289742|871572|P3|Third Wear Period|Reason not given|0
263865|NCT02289742|871573|P2|Third Wear Period|Reason not given|0
263866|NCT02289742|871574|P1|Third Wear Period|Reason not given|0
263867|NCT02289742|871571|P4|Third Wear Period|Adverse Event|0
263868|NCT02289742|871572|P3|Third Wear Period|Adverse Event|0
263869|NCT02289742|871573|P2|Third Wear Period|Adverse Event|1
263870|NCT02289742|871574|P1|Third Wear Period|Adverse Event|0
263871|NCT02289742|871571|P4|First Wear Period|Other prior to treatment|1
263872|NCT02289742|871572|P3|First Wear Period|Other prior to treatment|0
263873|NCT02289742|871573|P2|First Wear Period|Other prior to treatment|0
263874|NCT02289742|871574|P1|First Wear Period|Other prior to treatment|0
263875|NCT02289742|871571|P4|First Wear Period|Adverse Event|0
263876|NCT02289742|871572|P3|First Wear Period|Adverse Event|1
263877|NCT02289742|871573|P2|First Wear Period|Adverse Event|0
263878|NCT02289742|871574|P1|First Wear Period|Adverse Event|0
263879|NCT02289742|871571|P4|First Wear Period|Adverse event prior to treatment|0
263880|NCT02289742|871572|P3|First Wear Period|Adverse event prior to treatment|0
263881|NCT02289742|871573|P2|First Wear Period|Adverse event prior to treatment|1
263882|NCT02289742|871574|P1|First Wear Period|Adverse event prior to treatment|0
263883|NCT02289469|871593|P2|Overall Study|Unable to match a control|0
263884|NCT02289469|871594|P1|Overall Study|Unable to match a control|6
263885|NCT02289456|871602|P1|Monotherapy Period|Miscellaneous|1
263886|NCT02289456|871602|P1|Monotherapy Period|Study Terminated by Sponsor|2
263887|NCT02289456|871602|P1|Monotherapy Period|Withdrawal by Subject|2
263888|NCT02289456|871602|P1|Monotherapy Period|Symptomatic Deterioration|1
263889|NCT02289456|871602|P1|Monotherapy Period|Progressive Disease (PD)|8
263890|NCT02289456|871602|P1|Monotherapy Period|Adverse Event|1
263891|NCT02289456|871602|P1|Monotherapy Period|Death|1
263892|NCT02289456|871602|P1|Induction Period|Miscellaneous|1
263893|NCT02289456|871602|P1|Induction Period|Withdrawal by Subject|2
263894|NCT02289456|871602|P1|Induction Period|Symptomatic Deterioration|4
263895|NCT02289456|871602|P1|Induction Period|Progressive Disease (PD)|4
263896|NCT02289456|871602|P1|Induction Period|Adverse Event|11
263897|NCT02289456|871602|P1|Induction Period|Death|2
263898|NCT02289079|871637|P2|Overall Study|Lost to Follow-up|1
263899|NCT02289079|871638|P1|Overall Study|Lost to Follow-up|0
263900|NCT02289079|871637|P2|Overall Study|Physician Decision|0
263901|NCT02289079|871638|P1|Overall Study|Physician Decision|2
263902|NCT02288312|871680|P3|Overall Study|Pregnancy|0
263903|NCT02288312|871681|P2|Overall Study|Pregnancy|0
263904|NCT02288312|871682|P1|Overall Study|Pregnancy|1
263905|NCT02288091|871720|P1|Overall Study|Screen fail|7
263906|NCT02288091|871720|P1|Overall Study|Lost to Follow-up|1
263907|NCT02287883|871730|P2|Overall Study|Non-response to survey|237
263908|NCT02287883|871731|P1|Overall Study|Non-response to survey|229
263909|NCT02287883|871730|P2|Overall Study|No longer eligible|182
263910|NCT02287883|871731|P1|Overall Study|No longer eligible|222
263911|NCT02287883|871730|P2|Overall Study|Death|7
263912|NCT02287883|871731|P1|Overall Study|Death|8
263913|NCT02287623|871896|P2|Overall Study|Protocol Violation|1
263914|NCT02287623|871897|P1|Overall Study|Protocol Violation|0
263915|NCT02287610|871913|P1|Overall Study|Excluded-investigator non-responsiveness|5
263916|NCT02287610|871913|P1|Overall Study|Withdrawal by Subject|8
263917|NCT02287610|871913|P1|Overall Study|Lost to Follow-up|3
263918|NCT02287402|871952|P1|Follow-up|Voluntary Withdrawal|2
263919|NCT02287402|871952|P1|Follow-up|Lost to Follow-up|1
263920|NCT02287402|871952|P1|Treatment Period|Voluntary Withdrawal|10
263921|NCT02287402|871952|P1|Treatment Period|Adverse Event|17
263922|NCT02287025|872057|P2|Overall Study|Screening failed|1
263923|NCT02287025|872058|P1|Overall Study|Screening failed|1
263924|NCT02287025|872057|P2|Overall Study|Withdrawal by Subject|2
263925|NCT02287025|872058|P1|Overall Study|Withdrawal by Subject|2
263926|NCT02287025|872057|P2|Overall Study|Adverse Event|4
263927|NCT02287025|872058|P1|Overall Study|Adverse Event|2
263928|NCT02287025|872057|P2|Overall Study|Progression of disease|2
263929|NCT02287025|872058|P1|Overall Study|Progression of disease|3
263930|NCT02287025|872057|P2|Overall Study|Not treated|0
263931|NCT02287025|872058|P1|Overall Study|Not treated|2
263932|NCT02286193|872234|P1|Overall Study|Referred: Declined service|38
263933|NCT02286193|872234|P1|Overall Study|Referred: unable to reach/resource sent|104
263934|NCT02286193|872234|P1|Overall Study|Referred: CRS unable to make contact|62
263935|NCT02286102|872241|P2|Overall Study|Screen Failure|1
263936|NCT02286102|872242|P1|Overall Study|Screen Failure|1
263937|NCT02285998|872254|P2|Overall Study|Other Reasons|10
263938|NCT02285998|872255|P1|Overall Study|Other Reasons|7
263939|NCT02285998|872254|P2|Overall Study|Withdrawal by Subject|61
263940|NCT02285998|872255|P1|Overall Study|Withdrawal by Subject|53
263941|NCT02285998|872254|P2|Overall Study|Lost to Follow-up|172
263942|NCT02285998|872255|P1|Overall Study|Lost to Follow-up|176
263943|NCT02285998|872254|P2|Overall Study|Physician Decision|2
263944|NCT02285998|872255|P1|Overall Study|Physician Decision|1
263945|NCT02285998|872254|P2|Overall Study|Adverse Event|8
263946|NCT02285998|872255|P1|Overall Study|Adverse Event|9
263947|NCT02285777|872307|P2|Overall Study|Lost to Follow-up|2
263948|NCT02285777|872308|P1|Overall Study|Lost to Follow-up|4
263949|NCT02285777|872307|P2|Overall Study|Withdrawal by Subject|1
263950|NCT02285777|872308|P1|Overall Study|Withdrawal by Subject|1
263951|NCT02285270|872340|P1|Overall Study|Determined to be ineligible|1
263952|NCT02285270|872340|P1|Overall Study|Physician Decision|3
263953|NCT02285270|872340|P1|Overall Study|Lost to Follow-up|1
263954|NCT02284893|872348|P2|52 Week (Long Term)|Non-Compliance|3
263955|NCT02284893|872349|P1|52 Week (Long Term)|Non-Compliance|2
263956|NCT02284893|872348|P2|52 Week (Long Term)|Lost to Follow-up|2
263957|NCT02284893|872349|P1|52 Week (Long Term)|Lost to Follow-up|2
263958|NCT02284893|872348|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
263959|NCT02284893|872349|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
263960|NCT02284893|872348|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
263961|NCT02284893|872349|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
263962|NCT02284893|872348|P2|52 Week (Long Term)|Adverse Event|1
263963|NCT02284893|872349|P1|52 Week (Long Term)|Adverse Event|3
263964|NCT02284893|872348|P2|26 Week (Short Term)|Other|1
263965|NCT02284893|872349|P1|26 Week (Short Term)|Other|1
263966|NCT02284893|872348|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
263967|NCT02284893|872349|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
263968|NCT02284893|872348|P2|26 Week (Short Term)|Lost to Follow-up|1
263969|NCT02284893|872349|P1|26 Week (Short Term)|Lost to Follow-up|3
263970|NCT02284893|872348|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
263971|NCT02284893|872349|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
263972|NCT02284893|872348|P2|26 Week (Short Term)|Discontinuation by the subject|2
263973|NCT02284893|872349|P1|26 Week (Short Term)|Discontinuation by the subject|2
263974|NCT02284893|872348|P2|26 Week (Short Term)|Adverse Event|9
263975|NCT02284893|872349|P1|26 Week (Short Term)|Adverse Event|1
263976|NCT02284347|872448|P1|Overall Study|Withdrawn prior to treatment|1
263977|NCT02284347|872448|P1|Overall Study|Lost to Follow-up|2
263978|NCT02284243|872456|P2|Overall Study|Adverse Event|0
263979|NCT02284243|872457|P1|Overall Study|Adverse Event|1
263980|NCT02284243|872456|P2|Overall Study|Lack of Efficacy|3
263981|NCT02284243|872457|P1|Overall Study|Lack of Efficacy|3
263982|NCT02283788|872553|P4|Overall Study|Withdrawal by Subject|1
263983|NCT02283788|872554|P3|Overall Study|Withdrawal by Subject|0
263984|NCT02283788|872555|P2|Overall Study|Withdrawal by Subject|1
263985|NCT02283788|872556|P1|Overall Study|Withdrawal by Subject|0
263986|NCT02283788|872553|P4|Overall Study|Adverse Event|1
263987|NCT02283788|872554|P3|Overall Study|Adverse Event|5
263988|NCT02283788|872555|P2|Overall Study|Adverse Event|3
263989|NCT02283788|872556|P1|Overall Study|Adverse Event|1
263990|NCT02283411|872572|P1|Overall Study|Screen Failed|28
263991|NCT02283411|872572|P1|Overall Study|Withdrawal by Subject|3
263992|NCT02283268|872580|P1|Overall Study|Withdrawal by Subject|1
263993|NCT02282982|872641|P1|Overall Study|Other, not specified|18
263994|NCT02282982|872641|P1|Overall Study|Palivizumab is ended|11
263995|NCT02282982|872641|P1|Overall Study|Lack of product|156
263996|NCT02282982|872641|P1|Overall Study|Death|4
263997|NCT02282982|872641|P1|Overall Study|Withdrew consent|2
263998|NCT02282982|872641|P1|Overall Study|Lost to Follow-up|15
263999|NCT02282813|872659|P3|Overall Study|Administrative reasons|0
264000|NCT02282813|872660|P2|Overall Study|Administrative reasons|1
264001|NCT02282813|872661|P1|Overall Study|Administrative reasons|0
264002|NCT02282813|872659|P3|Overall Study|Lack of Efficacy|0
264003|NCT02282813|872660|P2|Overall Study|Lack of Efficacy|0
264004|NCT02282813|872661|P1|Overall Study|Lack of Efficacy|1
264005|NCT02282813|872659|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
264006|NCT02282813|872660|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
264007|NCT02282813|872661|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
264008|NCT02282813|872659|P3|Overall Study|Lost to Follow-up|1
264009|NCT02282813|872660|P2|Overall Study|Lost to Follow-up|0
264010|NCT02282813|872661|P1|Overall Study|Lost to Follow-up|2
264011|NCT02282813|872659|P3|Overall Study|Physician Decision|1
264012|NCT02282813|872660|P2|Overall Study|Physician Decision|3
264013|NCT02282813|872661|P1|Overall Study|Physician Decision|0
264014|NCT02282813|872659|P3|Overall Study|Subject non-compliance|0
264015|NCT02282813|872660|P2|Overall Study|Subject non-compliance|4
264016|NCT02282813|872661|P1|Overall Study|Subject non-compliance|1
264017|NCT02282813|872659|P3|Overall Study|Adverse Event|1
264018|NCT02282813|872660|P2|Overall Study|Adverse Event|10
264019|NCT02282813|872661|P1|Overall Study|Adverse Event|3
264020|NCT02282813|872659|P3|Overall Study|Withdrawal by Subject|0
264021|NCT02282813|872660|P2|Overall Study|Withdrawal by Subject|5
264022|NCT02282813|872661|P1|Overall Study|Withdrawal by Subject|4
264023|NCT02282631|872707|P2|Overall Study|Lost to Follow-up|0
264024|NCT02282631|872708|P1|Overall Study|Lost to Follow-up|2
264025|NCT02282605|872749|P3|Overall Study|negative SA result on Day -1|0
264026|NCT02282605|872750|P2|Overall Study|negative SA result on Day -1|0
264027|NCT02282605|872751|P1|Overall Study|negative SA result on Day -1|3
264028|NCT02282527|872773|P2|Overall Study|Lack of home health aid|0
264029|NCT02282527|872774|P1|Overall Study|Lack of home health aid|1
264030|NCT02282527|872773|P2|Overall Study|Lost to Follow-up|1
264031|NCT02282527|872774|P1|Overall Study|Lost to Follow-up|0
264032|NCT02281773|872789|P5|Overall Study|Other Reason|1
264033|NCT02281773|872790|P4|Overall Study|Other Reason|3
264034|NCT02281773|872791|P3|Overall Study|Other Reason|2
264035|NCT02281773|872792|P2|Overall Study|Other Reason|4
264036|NCT02281773|872793|P1|Overall Study|Other Reason|0
264037|NCT02281773|872789|P5|Overall Study|Withdrawal by Subject|8
264038|NCT02281773|872790|P4|Overall Study|Withdrawal by Subject|6
264039|NCT02281773|872791|P3|Overall Study|Withdrawal by Subject|6
264040|NCT02281773|872792|P2|Overall Study|Withdrawal by Subject|8
264041|NCT02281773|872793|P1|Overall Study|Withdrawal by Subject|2
264042|NCT02281773|872789|P5|Overall Study|Lost to Follow-up|10
264043|NCT02281773|872790|P4|Overall Study|Lost to Follow-up|2
264044|NCT02281773|872791|P3|Overall Study|Lost to Follow-up|6
264045|NCT02281773|872792|P2|Overall Study|Lost to Follow-up|2
264046|NCT02281773|872793|P1|Overall Study|Lost to Follow-up|2
264047|NCT02281773|872789|P5|Overall Study|Protocol Violation|2
264048|NCT02281773|872790|P4|Overall Study|Protocol Violation|2
264049|NCT02281773|872791|P3|Overall Study|Protocol Violation|0
264050|NCT02281773|872792|P2|Overall Study|Protocol Violation|0
264051|NCT02281773|872793|P1|Overall Study|Protocol Violation|1
264052|NCT02281773|872789|P5|Overall Study|Adverse Event|9
264053|NCT02281773|872790|P4|Overall Study|Adverse Event|8
264054|NCT02281773|872791|P3|Overall Study|Adverse Event|4
264055|NCT02281773|872792|P2|Overall Study|Adverse Event|1
264056|NCT02281773|872793|P1|Overall Study|Adverse Event|6
264057|NCT02281357|872934|P2|Overall Study|Withdrawal by Subject|3
264058|NCT02281357|872935|P1|Overall Study|Withdrawal by Subject|4
264059|NCT02281357|872934|P2|Overall Study|Lost to Follow-up|0
264060|NCT02281357|872935|P1|Overall Study|Lost to Follow-up|1
264061|NCT02281357|872934|P2|Overall Study|Adverse Event|1
264062|NCT02281357|872935|P1|Overall Study|Adverse Event|2
264063|NCT02281318|872949|P2|Overall Study|Withdrawal by Subject|2
264064|NCT02281318|872950|P1|Overall Study|Withdrawal by Subject|6
264065|NCT02281318|872949|P2|Overall Study|Physician Decision|0
264066|NCT02281318|872950|P1|Overall Study|Physician Decision|2
264067|NCT02281318|872949|P2|Overall Study|Lost to Follow-up|1
264068|NCT02281318|872950|P1|Overall Study|Lost to Follow-up|2
264069|NCT02281318|872949|P2|Overall Study|Lack of Efficacy|0
264070|NCT02281318|872950|P1|Overall Study|Lack of Efficacy|2
264071|NCT02281318|872949|P2|Overall Study|Adverse Event|2
264072|NCT02281318|872950|P1|Overall Study|Adverse Event|2
264073|NCT02280499|873053|P1|Overall Study|Adverse Event|5
264074|NCT02280499|873053|P1|Overall Study|Lost to Follow-up|42
264075|NCT02280499|873053|P1|Overall Study|Death|14
264076|NCT02280473|873061|P2|Overall Study|Lost to Follow-up|1
264077|NCT02280473|873062|P1|Overall Study|Lost to Follow-up|0
264078|NCT02280473|873061|P2|Overall Study|Lack of Efficacy|1
264079|NCT02280473|873062|P1|Overall Study|Lack of Efficacy|0
264080|NCT02280473|873061|P2|Overall Study|Adverse Event|1
264081|NCT02280473|873062|P1|Overall Study|Adverse Event|1
264082|NCT02280187|873081|P1|Overall Study|Lost to Follow-up|218
264083|NCT02279420|873187|P1|Overall Study|Lost to Follow-up|23
264084|NCT02279407|873195|P4|Overall Study|Adverse Event|0
264085|NCT02279407|873196|P3|Overall Study|Adverse Event|2
264086|NCT02279407|873197|P2|Overall Study|Adverse Event|1
264087|NCT02279407|873198|P1|Overall Study|Adverse Event|1
264088|NCT02279407|873195|P4|Overall Study|Withdrawal by Subject|1
264089|NCT02279407|873196|P3|Overall Study|Withdrawal by Subject|1
264090|NCT02279407|873197|P2|Overall Study|Withdrawal by Subject|0
264091|NCT02279407|873198|P1|Overall Study|Withdrawal by Subject|1
264092|NCT02279407|873195|P4|Overall Study|Couldn't swallow IP; noncompliance|0
264093|NCT02279407|873196|P3|Overall Study|Couldn't swallow IP; noncompliance|2
264094|NCT02279407|873197|P2|Overall Study|Couldn't swallow IP; noncompliance|0
264095|NCT02279407|873198|P1|Overall Study|Couldn't swallow IP; noncompliance|0
264096|NCT02278614|873254|P2|Overall Study|left eye was not eligible|0
264097|NCT02278614|873255|P1|Overall Study|left eye was not eligible|1
264098|NCT02278614|873254|P2|Overall Study|Adverse Event|0
264099|NCT02278614|873255|P1|Overall Study|Adverse Event|1
264100|NCT02278614|873254|P2|Overall Study|Withdrawal by Subject|5
264101|NCT02278614|873255|P1|Overall Study|Withdrawal by Subject|3
264102|NCT02278003|873302|P2|Overall Study|Recognition task improperly completed|0
264103|NCT02278003|873303|P1|Overall Study|Recognition task improperly completed|7
264104|NCT02278003|873302|P2|Overall Study|Not Treated|0
264105|NCT02278003|873303|P1|Overall Study|Not Treated|1
264106|NCT02278003|873302|P2|Overall Study|Withdrawal by Subject|0
264107|NCT02278003|873303|P1|Overall Study|Withdrawal by Subject|11
264108|NCT02277769|873314|P3|Overall Study|Other than specified above|5
264109|NCT02277769|873315|P2|Overall Study|Other than specified above|8
264110|NCT02277769|873316|P1|Overall Study|Other than specified above|12
264111|NCT02277769|873314|P3|Overall Study|Adverse Event|4
264112|NCT02277769|873315|P2|Overall Study|Adverse Event|2
264113|NCT02277769|873316|P1|Overall Study|Adverse Event|14
264114|NCT02277769|873314|P3|Overall Study|Lack of Efficacy|4
264115|NCT02277769|873315|P2|Overall Study|Lack of Efficacy|0
264116|NCT02277769|873316|P1|Overall Study|Lack of Efficacy|17
264117|NCT02277769|873314|P3|Overall Study|Protocol Violation|5
264118|NCT02277769|873315|P2|Overall Study|Protocol Violation|3
264119|NCT02277769|873316|P1|Overall Study|Protocol Violation|3
264120|NCT02277743|873387|P3|Overall Study|Other than specified above|16
264121|NCT02277743|873388|P2|Overall Study|Other than specified above|5
264122|NCT02277743|873389|P1|Overall Study|Other than specified above|18
264123|NCT02277743|873387|P3|Overall Study|Lack of Efficacy|3
264124|NCT02277743|873388|P2|Overall Study|Lack of Efficacy|4
264125|NCT02277743|873389|P1|Overall Study|Lack of Efficacy|11
264126|NCT02277743|873387|P3|Overall Study|Adverse Event|6
264127|NCT02277743|873388|P2|Overall Study|Adverse Event|6
264128|NCT02277743|873389|P1|Overall Study|Adverse Event|10
264129|NCT02277743|873387|P3|Overall Study|Protocol Violation|1
264130|NCT02277743|873388|P2|Overall Study|Protocol Violation|1
264131|NCT02277743|873389|P1|Overall Study|Protocol Violation|1
264132|NCT02277691|873457|P1|Overall Study|Used Other Antihypertensive Drug|1
264133|NCT02277691|873457|P1|Overall Study|Lack of Efficacy|5
264134|NCT02277691|873457|P1|Overall Study|Voluntary Withdrawal|7
264135|NCT02277691|873457|P1|Overall Study|Pretreatment Event/Adverse Event|33
264136|NCT02277119|873503|P3|Overall Study|Protocol Violation|7
264137|NCT02277119|873504|P2|Overall Study|Protocol Violation|3
264138|NCT02277119|873505|P1|Overall Study|Protocol Violation|2
264139|NCT02277119|873503|P3|Overall Study|Lack of Efficacy|1
264140|NCT02277119|873504|P2|Overall Study|Lack of Efficacy|1
264141|NCT02277119|873505|P1|Overall Study|Lack of Efficacy|1
264142|NCT02276612|873532|P2|Overall Study|Lost to Follow-up|0
264143|NCT02276612|873533|P1|Overall Study|Lost to Follow-up|1
264144|NCT02276612|873532|P2|Overall Study|Withdrew Consent|0
264145|NCT02276612|873533|P1|Overall Study|Withdrew Consent|1
264146|NCT02276612|873532|P2|Overall Study|Pregnancy|0
264147|NCT02276612|873533|P1|Overall Study|Pregnancy|1
264148|NCT02276612|873532|P2|Overall Study|Death|0
264149|NCT02276612|873533|P1|Overall Study|Death|1
264150|NCT02276560|873556|P3|Overall Study|Adverse Event|0
264151|NCT02276560|873557|P2|Overall Study|Adverse Event|0
264152|NCT02276560|873558|P1|Overall Study|Adverse Event|1
264153|NCT02276222|873679|P2|Overall Study|subject withdrew after randomization|0
264154|NCT02276222|873680|P1|Overall Study|subject withdrew after randomization|1
264155|NCT02276222|873679|P2|Overall Study|sheduling conflict|0
264156|NCT02276222|873680|P1|Overall Study|sheduling conflict|1
264157|NCT02276222|873679|P2|Overall Study|Physician Decision|1
264158|NCT02276222|873680|P1|Overall Study|Physician Decision|2
264159|NCT02276222|873679|P2|Overall Study|Lost to Follow-up|5
264160|NCT02276222|873680|P1|Overall Study|Lost to Follow-up|15
264161|NCT02276222|873679|P2|Overall Study|sponsor decision|3
264162|NCT02276222|873680|P1|Overall Study|sponsor decision|0
264163|NCT02276222|873679|P2|Overall Study|non compliance with study medication|2
264164|NCT02276222|873680|P1|Overall Study|non compliance with study medication|6
264165|NCT02276222|873679|P2|Overall Study|Withdrawal by Subject|33
264166|NCT02276222|873680|P1|Overall Study|Withdrawal by Subject|79
264167|NCT02276222|873679|P2|Overall Study|Protocol Violation|2
264168|NCT02276222|873680|P1|Overall Study|Protocol Violation|3
264169|NCT02276222|873679|P2|Overall Study|Lack of Efficacy|3
264170|NCT02276222|873680|P1|Overall Study|Lack of Efficacy|13
264171|NCT02276222|873679|P2|Overall Study|Death|4
264172|NCT02276222|873680|P1|Overall Study|Death|3
264173|NCT02276222|873679|P2|Overall Study|Adverse Event|11
264174|NCT02276222|873680|P1|Overall Study|Adverse Event|62
264175|NCT02276040|873704|P1|Overall Study|Physician Decision|15
264176|NCT02275611|873728|P4|Inpatient Withdrawal|Withdrawal by Subject|0
264177|NCT02275611|873729|P3|Inpatient Withdrawal|Withdrawal by Subject|0
264178|NCT02275611|873730|P2|Inpatient Withdrawal|Withdrawal by Subject|0
264179|NCT02275611|873731|P1|Inpatient Withdrawal|Withdrawal by Subject|1
264180|NCT02275546|873743|P2|Treatment Period 2|Protocol Violation|1
264181|NCT02275546|873744|P1|Treatment Period 2|Protocol Violation|0
264182|NCT02275546|873743|P2|Treatment Period 2|Withdrawal by Subject|1
264183|NCT02275546|873744|P1|Treatment Period 2|Withdrawal by Subject|2
264184|NCT02275481|873754|P2|Overall Study|Physician Decision|1
264185|NCT02275481|873755|P1|Overall Study|Physician Decision|0
264186|NCT02275481|873754|P2|Overall Study|all other reasons combined|1
264187|NCT02275481|873755|P1|Overall Study|all other reasons combined|2
264188|NCT02275481|873754|P2|Overall Study|Withdrawal by Subject|0
264189|NCT02275481|873755|P1|Overall Study|Withdrawal by Subject|3
264190|NCT02275481|873754|P2|Overall Study|Lost to Follow-up|0
264191|NCT02275481|873755|P1|Overall Study|Lost to Follow-up|2
264192|NCT02275481|873754|P2|Overall Study|Death|1
264193|NCT02275481|873755|P1|Overall Study|Death|2
264194|NCT02275364|873761|P2|Period 1|Other reason|0
264195|NCT02275364|873762|P1|Period 1|Other reason|1
264196|NCT02275364|873761|P2|Period 1|Withdrawal by Subject|0
264197|NCT02275364|873762|P1|Period 1|Withdrawal by Subject|1
264198|NCT02275052|873823|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
264199|NCT02275052|873824|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
264200|NCT02275052|873825|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
264201|NCT02275052|873826|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
264202|NCT02275052|873823|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
264203|NCT02275052|873824|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
264204|NCT02275052|873825|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
264205|NCT02275052|873826|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
264206|NCT02275052|873823|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
264207|NCT02275052|873824|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
264208|NCT02275052|873825|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
264209|NCT02275052|873826|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
264210|NCT02275052|873823|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
264211|NCT02275052|873824|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
264212|NCT02275052|873825|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
264213|NCT02275052|873826|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
264214|NCT02275052|873823|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
264215|NCT02275052|873824|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
264216|NCT02275052|873825|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
264217|NCT02275052|873826|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
264218|NCT02275052|873823|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
264219|NCT02275052|873824|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
264220|NCT02275052|873825|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
264221|NCT02275052|873826|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
264222|NCT02275052|873823|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
264223|NCT02275052|873824|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
264224|NCT02275052|873825|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
264225|NCT02275052|873826|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
264226|NCT02275052|873823|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
264227|NCT02275052|873824|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
264228|NCT02275052|873825|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
264229|NCT02275052|873826|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
264230|NCT02275052|873823|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
264231|NCT02275052|873824|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
264232|NCT02275052|873825|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
264233|NCT02275052|873826|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
264234|NCT02275052|873823|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
264235|NCT02275052|873824|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
264236|NCT02275052|873825|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
264237|NCT02275052|873826|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
264238|NCT02275052|873823|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
264239|NCT02275052|873824|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
264240|NCT02275052|873825|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
264241|NCT02275052|873826|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
264242|NCT02274948|873840|P2|Overall Study|Left the area|3
264243|NCT02274948|873841|P1|Overall Study|Left the area|4
264244|NCT02274948|873840|P2|Overall Study|Stopped on family Practitioner advice|5
264245|NCT02274948|873841|P1|Overall Study|Stopped on family Practitioner advice|2
264246|NCT02274948|873840|P2|Overall Study|Withdrawal by Subject|58
264247|NCT02274948|873841|P1|Overall Study|Withdrawal by Subject|64
264248|NCT02274948|873840|P2|Overall Study|Lost to Follow-up|25
264249|NCT02274948|873841|P1|Overall Study|Lost to Follow-up|28
264250|NCT02274792|873882|P1|Overall Study|Sponsor Decision|2
264251|NCT02274792|873882|P1|Overall Study|Protocol Specified Criteria|2
264252|NCT02274792|873882|P1|Overall Study|Lost to Follow-up|8
264253|NCT02274792|873882|P1|Overall Study|Withdrawal by Subject|13
264254|NCT02274766|873892|P2|Overall Study|Adverse Event|1
264255|NCT02274766|873893|P1|Overall Study|Adverse Event|0
264256|NCT02274766|873892|P2|Overall Study|Subject Unwilling to Proceed|1
264257|NCT02274766|873893|P1|Overall Study|Subject Unwilling to Proceed|0
264258|NCT02274766|873892|P2|Overall Study|Did Not Receive Study Drug|1
264259|NCT02274766|873893|P1|Overall Study|Did Not Receive Study Drug|1
264260|NCT02274766|873892|P2|Overall Study|Withdrawal by Subject|6
264261|NCT02274766|873893|P1|Overall Study|Withdrawal by Subject|3
264262|NCT02274558|873939|P3|Overall Study|Physician Decision|1
264263|NCT02274558|873940|P2|Overall Study|Physician Decision|2
264264|NCT02274558|873941|P1|Overall Study|Physician Decision|0
264265|NCT02274558|873939|P3|Overall Study|Lost to Follow-up|1
264266|NCT02274558|873940|P2|Overall Study|Lost to Follow-up|1
264267|NCT02274558|873941|P1|Overall Study|Lost to Follow-up|2
264268|NCT02274558|873939|P3|Overall Study|Death|1
264269|NCT02274558|873940|P2|Overall Study|Death|0
264270|NCT02274558|873941|P1|Overall Study|Death|0
264271|NCT02274558|873939|P3|Overall Study|Withdrawal by Subject|4
264272|NCT02274558|873940|P2|Overall Study|Withdrawal by Subject|5
264273|NCT02274558|873941|P1|Overall Study|Withdrawal by Subject|1
264274|NCT02274558|873939|P3|Overall Study|Non-compliance|0
264275|NCT02274558|873940|P2|Overall Study|Non-compliance|1
264276|NCT02274558|873941|P1|Overall Study|Non-compliance|2
264277|NCT02274558|873939|P3|Overall Study|Adverse Event|2
264278|NCT02274558|873940|P2|Overall Study|Adverse Event|4
264279|NCT02274558|873941|P1|Overall Study|Adverse Event|2
264280|NCT02273973|873957|P2|Overall Study|Reason not specified|1
264281|NCT02273973|873958|P1|Overall Study|Reason not specified|0
264282|NCT02273973|873957|P2|Overall Study|Physician Decision|1
264283|NCT02273973|873958|P1|Overall Study|Physician Decision|0
264284|NCT02273973|873957|P2|Overall Study|Lost to Follow-up|1
264285|NCT02273973|873958|P1|Overall Study|Lost to Follow-up|0
264286|NCT02273973|873957|P2|Overall Study|Progression of disease|2
264287|NCT02273973|873958|P1|Overall Study|Progression of disease|0
264288|NCT02273973|873957|P2|Overall Study|Protocol Violation|0
264289|NCT02273973|873958|P1|Overall Study|Protocol Violation|1
264290|NCT02273973|873957|P2|Overall Study|Non-compliance|0
264291|NCT02273973|873958|P1|Overall Study|Non-compliance|1
264292|NCT02273973|873957|P2|Overall Study|Death|0
264293|NCT02273973|873958|P1|Overall Study|Death|1
264294|NCT02273973|873957|P2|Overall Study|Withdrawal by Subject|3
264295|NCT02273973|873958|P1|Overall Study|Withdrawal by Subject|2
264296|NCT02273973|873957|P2|Overall Study|Adverse Event|0
264297|NCT02273973|873958|P1|Overall Study|Adverse Event|4
264298|NCT02273908|874000|P2|Overall Study|Withdrawal by Subject|2
264299|NCT02273908|874001|P1|Overall Study|Withdrawal by Subject|4
264300|NCT02273908|874000|P2|Overall Study|Did not meet entrance criteria|2
264301|NCT02273908|874001|P1|Overall Study|Did not meet entrance criteria|3
264302|NCT02273908|874000|P2|Overall Study|Lost to Follow-up|1
264303|NCT02273908|874001|P1|Overall Study|Lost to Follow-up|10
264304|NCT02273908|874000|P2|Overall Study|Adverse Event|0
264305|NCT02273908|874001|P1|Overall Study|Adverse Event|16
264306|NCT02273752|874023|P1|Overall Study|Trial was terminated early|2
264307|NCT02273180|874067|P2|Overall Study|Other than specified above|10
264308|NCT02273180|874068|P1|Overall Study|Other than specified above|21
264309|NCT02273180|874067|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
264310|NCT02273180|874068|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
264311|NCT02273180|874067|P2|Overall Study|Randomized but not treated|0
264312|NCT02273180|874068|P1|Overall Study|Randomized but not treated|1
264313|NCT02273180|874067|P2|Overall Study|Protocol Violation|7
264314|NCT02273180|874068|P1|Overall Study|Protocol Violation|1
264315|NCT02273180|874067|P2|Overall Study|Lack of Efficacy|0
264316|NCT02273180|874068|P1|Overall Study|Lack of Efficacy|1
264317|NCT02273180|874067|P2|Overall Study|Adverse Event|2
264318|NCT02273180|874068|P1|Overall Study|Adverse Event|2
264319|NCT02273167|874093|P3|Overall Study|Various|8
264320|NCT02273167|874094|P2|Overall Study|Various|9
264321|NCT02273167|874095|P1|Overall Study|Various|10
264322|NCT02273167|874093|P3|Overall Study|Withdrawal by Subject|11
264323|NCT02273167|874094|P2|Overall Study|Withdrawal by Subject|12
264324|NCT02273167|874095|P1|Overall Study|Withdrawal by Subject|10
264325|NCT02273167|874093|P3|Overall Study|Lost to Follow-up|1
264326|NCT02273167|874094|P2|Overall Study|Lost to Follow-up|1
264327|NCT02273167|874095|P1|Overall Study|Lost to Follow-up|0
264328|NCT02273167|874093|P3|Overall Study|Protocol Violation|1
264329|NCT02273167|874094|P2|Overall Study|Protocol Violation|1
264330|NCT02273167|874095|P1|Overall Study|Protocol Violation|3
264331|NCT02273167|874093|P3|Overall Study|Adverse Event|0
264332|NCT02273167|874094|P2|Overall Study|Adverse Event|0
264333|NCT02273167|874095|P1|Overall Study|Adverse Event|1
264334|NCT02273141|874120|P2|Overall Study|Various|6
264335|NCT02273141|874121|P1|Overall Study|Various|6
264336|NCT02273141|874120|P2|Overall Study|Withdrawal by Subject|15
264337|NCT02273141|874121|P1|Overall Study|Withdrawal by Subject|10
264338|NCT02273141|874120|P2|Overall Study|Lost to Follow-up|3
264339|NCT02273141|874121|P1|Overall Study|Lost to Follow-up|1
264340|NCT02273141|874120|P2|Overall Study|Adverse Event|1
264341|NCT02273141|874121|P1|Overall Study|Adverse Event|0
264342|NCT02273050|874189|P3|Overall Study|Protocol Violation|4
264343|NCT02273050|874190|P2|Overall Study|Protocol Violation|1
264344|NCT02273050|874191|P1|Overall Study|Protocol Violation|3
264345|NCT02273050|874189|P3|Overall Study|Lost to Follow-up|3
264346|NCT02273050|874190|P2|Overall Study|Lost to Follow-up|2
264347|NCT02273050|874191|P1|Overall Study|Lost to Follow-up|0
264348|NCT02273050|874189|P3|Overall Study|Withdrawal by Subject|16
264349|NCT02273050|874190|P2|Overall Study|Withdrawal by Subject|14
264350|NCT02273050|874191|P1|Overall Study|Withdrawal by Subject|17
264351|NCT02273050|874189|P3|Overall Study|Lack of Efficacy|1
264352|NCT02273050|874190|P2|Overall Study|Lack of Efficacy|1
264353|NCT02273050|874191|P1|Overall Study|Lack of Efficacy|0
264354|NCT02273050|874189|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
264355|NCT02273050|874190|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
264356|NCT02273050|874191|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
264357|NCT02273050|874189|P3|Overall Study|Death|1
264358|NCT02273050|874190|P2|Overall Study|Death|0
264359|NCT02273050|874191|P1|Overall Study|Death|0
264360|NCT02273050|874189|P3|Overall Study|Adverse Event|3
264361|NCT02273050|874190|P2|Overall Study|Adverse Event|3
264362|NCT02273050|874191|P1|Overall Study|Adverse Event|4
264363|NCT02272803|874219|P2|Overall Study|Withdrawal by Subject|0
264364|NCT02272803|874220|P1|Overall Study|Withdrawal by Subject|1
264365|NCT02272803|874219|P2|Overall Study|Poor/non-compliance|1
264366|NCT02272803|874220|P1|Overall Study|Poor/non-compliance|0
264367|NCT02272803|874219|P2|Overall Study|Subject moved to care facility|1
264368|NCT02272803|874220|P1|Overall Study|Subject moved to care facility|0
264369|NCT02272803|874219|P2|Overall Study|Maximum clinical benefit|1
264370|NCT02272803|874220|P1|Overall Study|Maximum clinical benefit|1
264371|NCT02272803|874219|P2|Overall Study|Subj request to discontinue study trt|4
264372|NCT02272803|874220|P1|Overall Study|Subj request to discontinue study trt|1
264373|NCT02272803|874219|P2|Overall Study|Study drug toxicity|4
264374|NCT02272803|874220|P1|Overall Study|Study drug toxicity|1
264375|NCT02272803|874219|P2|Overall Study|Adverse Event unrelated to study drug|4
264376|NCT02272803|874220|P1|Overall Study|Adverse Event unrelated to study drug|1
264377|NCT02272803|874219|P2|Overall Study|Disease progression|2
264378|NCT02272803|874220|P1|Overall Study|Disease progression|4
264379|NCT02272725|874233|P2|Overall Study|equipment malfunction|0
264380|NCT02272725|874234|P1|Overall Study|equipment malfunction|2
264381|NCT02271984|874244|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264382|NCT02271984|874245|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264383|NCT02271984|874246|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264384|NCT02271984|874247|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264385|NCT02271984|874248|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
264386|NCT02271984|874249|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264387|NCT02271984|874250|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
264388|NCT02271984|874251|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264389|NCT02271984|874252|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264390|NCT02271984|874253|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264391|NCT02271984|874254|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264392|NCT02271984|874255|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
264393|NCT02271945|874344|P2|Overall Study|Other|1
264394|NCT02271945|874345|P1|Overall Study|Other|1
264395|NCT02271945|874344|P2|Overall Study|Withdrawal by Subject|1
264396|NCT02271945|874345|P1|Overall Study|Withdrawal by Subject|1
264397|NCT02271945|874344|P2|Overall Study|Death|3
264398|NCT02271945|874345|P1|Overall Study|Death|3
264399|NCT02271880|874383|P2|Overall Study|Premature discontinuation of study|4
264400|NCT02271880|874384|P1|Overall Study|Premature discontinuation of study|3
264401|NCT02271854|874390|P1|Overall Study|Lost to Follow-up|1
264402|NCT02271854|874390|P1|Overall Study|Unable or unwilling to cooperate with st|1
264403|NCT02271854|874390|P1|Overall Study|Withdrawal by Subject|2
264404|NCT02271529|874430|P1|Overall Study|Withdrawal by Subject|1
264405|NCT02270944|874467|P2|Overall Study|Withdrawal by Subject|1
264406|NCT02270944|874468|P1|Overall Study|Withdrawal by Subject|2
264407|NCT02270944|874467|P2|Overall Study|Lost to Follow-up|4
264408|NCT02270944|874468|P1|Overall Study|Lost to Follow-up|9
264409|NCT02270684|874484|P2|Overall Study|Study terminated|0
264410|NCT02270684|874485|P1|Overall Study|Study terminated|1
264411|NCT02270684|874484|P2|Overall Study|Lost to Follow-up|3
264412|NCT02270684|874485|P1|Overall Study|Lost to Follow-up|0
264413|NCT02270515|874491|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
264414|NCT02270515|874491|P1|Intervention Period 3: 12-18 Months|Death|3
264415|NCT02270515|874491|P1|Intervention Period 3: 12-18 Months|Received transplant|2
264416|NCT02270515|874491|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
264417|NCT02270515|874491|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
264418|NCT02270515|874491|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
264419|NCT02270515|874491|P1|Intervention Period 2: 6-12 Months|Death|5
264420|NCT02270515|874491|P1|Intervention Period 2: 6-12 Months|Received transplant|1
264421|NCT02270515|874491|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
264422|NCT02270515|874491|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
264423|NCT02270515|874491|P1|Intervention Period 1: 0-6 Months|Death|7
264424|NCT02270515|874491|P1|Intervention Period 1: 0-6 Months|Received transplant|3
264425|NCT02270515|874491|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
264426|NCT02270515|874491|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
264427|NCT02269943|874508|P2|Follow-Up Survival Period|Alive|8
264428|NCT02269943|874509|P1|Follow-Up Survival Period|Alive|2
264429|NCT02269943|874508|P2|Follow-Up Survival Period|Lost to Follow-up|2
264430|NCT02269943|874509|P1|Follow-Up Survival Period|Lost to Follow-up|0
264431|NCT02269943|874508|P2|Follow-Up Survival Period|Death|16
264432|NCT02269943|874509|P1|Follow-Up Survival Period|Death|3
264433|NCT02269943|874508|P2|Treatment Period|Symptomatic Deterioration|2
264434|NCT02269943|874509|P1|Treatment Period|Symptomatic Deterioration|0
264435|NCT02269943|874508|P2|Treatment Period|Progressive Disease|17
264436|NCT02269943|874509|P1|Treatment Period|Progressive Disease|5
264437|NCT02269943|874508|P2|Treatment Period|Adverse Event|10
264438|NCT02269943|874509|P1|Treatment Period|Adverse Event|1
264439|NCT02269943|874508|P2|Treatment Period|Death|1
264440|NCT02269943|874509|P1|Treatment Period|Death|0
264441|NCT02269709|874537|P1|Six Month Follow-up|Lost to Follow-up|12
264442|NCT02269709|874537|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
264443|NCT02269709|874537|P1|Time of Enrollment|Withdrawal by Subject|3
264444|NCT02269657|874542|P1|Overall Study|Protocol Violation|3
264445|NCT02269475|874562|P2|Overall Study|Withdrawal by Subject|1
264446|NCT02269475|874563|P1|Overall Study|Withdrawal by Subject|0
264447|NCT02269475|874562|P2|Overall Study|Meet Exclusion Criteria No. 17|0
264448|NCT02269475|874563|P1|Overall Study|Meet Exclusion Criteria No. 17|3
264449|NCT02269098|874576|P2|Overall Study|Lost to Follow-up|9
264450|NCT02269098|874577|P1|Overall Study|Lost to Follow-up|14
264451|NCT02268864|874624|P3|Overall Study|Death|0
264452|NCT02268864|874625|P2|Overall Study|Death|1
264453|NCT02268864|874626|P1|Overall Study|Death|0
264454|NCT02268864|874624|P3|Overall Study|Withdrawal by Subject|0
264455|NCT02268864|874625|P2|Overall Study|Withdrawal by Subject|0
264456|NCT02268864|874626|P1|Overall Study|Withdrawal by Subject|2
264457|NCT02268526|874651|P3|Overall Study|Subject/guardian decision|3
264458|NCT02268526|874652|P2|Overall Study|Subject/guardian decision|7
264459|NCT02268526|874653|P1|Overall Study|Subject/guardian decision|0
264460|NCT02268526|874651|P3|Overall Study|Physician Decision|1
264461|NCT02268526|874652|P2|Overall Study|Physician Decision|0
264462|NCT02268526|874653|P1|Overall Study|Physician Decision|0
264463|NCT02268526|874651|P3|Overall Study|protocol deviation|0
264464|NCT02268526|874652|P2|Overall Study|protocol deviation|1
264465|NCT02268526|874653|P1|Overall Study|protocol deviation|0
264466|NCT02268526|874651|P3|Overall Study|Death|0
264467|NCT02268526|874652|P2|Overall Study|Death|11
264468|NCT02268526|874653|P1|Overall Study|Death|1
264469|NCT02268526|874651|P3|Overall Study|Adverse Event|1
264470|NCT02268526|874652|P2|Overall Study|Adverse Event|2
264471|NCT02268526|874653|P1|Overall Study|Adverse Event|0
264472|NCT02268396|874674|P1|Overall Study|2 Subjects no Day 29 Assessment|2
264473|NCT02268396|874674|P1|Overall Study|Protocol-Specified Criteria|2
264474|NCT02268396|874674|P1|Overall Study|Lost to Follow-up|2
264475|NCT02268396|874674|P1|Overall Study|Withdrawal by Subject|1
264476|NCT02268396|874674|P1|Overall Study|Administrative|2
264477|NCT02268396|874674|P1|Overall Study|Adverse Event|3
264478|NCT02268214|874686|P3|Overall Study|Other reasons|3
264479|NCT02268214|874687|P2|Overall Study|Other reasons|2
264480|NCT02268214|874688|P1|Overall Study|Other reasons|3
264481|NCT02268214|874686|P3|Overall Study|Poor/non-compliance|2
264482|NCT02268214|874687|P2|Overall Study|Poor/non-compliance|0
264483|NCT02268214|874688|P1|Overall Study|Poor/non-compliance|2
264484|NCT02268214|874686|P3|Overall Study|Subject request to discontinue treatment|4
264485|NCT02268214|874687|P2|Overall Study|Subject request to discontinue treatment|5
264486|NCT02268214|874688|P1|Overall Study|Subject request to discontinue treatment|6
264487|NCT02268214|874686|P3|Overall Study|Withdrawal by Subject|6
264488|NCT02268214|874687|P2|Overall Study|Withdrawal by Subject|2
264489|NCT02268214|874688|P1|Overall Study|Withdrawal by Subject|3
264490|NCT02268214|874686|P3|Overall Study|Adverse Event|9
264491|NCT02268214|874687|P2|Overall Study|Adverse Event|8
264492|NCT02268214|874688|P1|Overall Study|Adverse Event|6
264493|NCT02268214|874686|P3|Overall Study|Lack of Efficacy|1
264494|NCT02268214|874687|P2|Overall Study|Lack of Efficacy|0
264495|NCT02268214|874688|P1|Overall Study|Lack of Efficacy|1
264496|NCT02268214|874686|P3|Overall Study|Lost to Follow-up|2
264497|NCT02268214|874687|P2|Overall Study|Lost to Follow-up|2
264498|NCT02268214|874688|P1|Overall Study|Lost to Follow-up|2
264499|NCT02268214|874686|P3|Overall Study|Pregnancy|1
264500|NCT02268214|874687|P2|Overall Study|Pregnancy|2
264501|NCT02268214|874688|P1|Overall Study|Pregnancy|1
264502|NCT02268214|874686|P3|Overall Study|Subject no longer meets study criteria|0
264503|NCT02268214|874687|P2|Overall Study|Subject no longer meets study criteria|2
264504|NCT02268214|874688|P1|Overall Study|Subject no longer meets study criteria|0
264505|NCT02268058|874718|P4|Overall Study|Protocol Violation|0
264506|NCT02268058|874719|P3|Overall Study|Protocol Violation|0
264507|NCT02268058|874720|P2|Overall Study|Protocol Violation|0
264508|NCT02268058|874721|P1|Overall Study|Protocol Violation|1
264509|NCT02267824|874763|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
264510|NCT02267824|874764|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
264511|NCT02267824|874763|P2|Overall Study|Protocol Violation|0
264512|NCT02267824|874764|P1|Overall Study|Protocol Violation|3
264513|NCT02267824|874763|P2|Overall Study|Lost to Follow-up|0
264514|NCT02267824|874764|P1|Overall Study|Lost to Follow-up|4
264515|NCT02267824|874763|P2|Overall Study|Pregnancy|1
264516|NCT02267824|874764|P1|Overall Study|Pregnancy|1
264517|NCT02267187|874807|P1|Overall Study|Physician Decision|2
264518|NCT02267135|874815|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
264519|NCT02267135|874816|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
264520|NCT02267135|874815|P2|Period 2 (Randomized Set)|Adverse Event|0
264521|NCT02267135|874816|P1|Period 2 (Randomized Set)|Adverse Event|2
264522|NCT02267135|874815|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
264523|NCT02267135|874816|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
264524|NCT02267135|874815|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
264525|NCT02267135|874816|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
264526|NCT02267135|874815|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
264527|NCT02267135|874816|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
264528|NCT02266875|874856|P2|Overall Study|Lost to Follow-up|0
264529|NCT02266875|874857|P1|Overall Study|Lost to Follow-up|2
264530|NCT02266875|874856|P2|Overall Study|Withdrawal by Subject|0
264531|NCT02266875|874857|P1|Overall Study|Withdrawal by Subject|9
264532|NCT02266381|874935|P3|Overall Study|Physician Decision|4
264533|NCT02266381|874936|P2|Overall Study|Physician Decision|5
264534|NCT02266381|874937|P1|Overall Study|Physician Decision|3
264535|NCT02265796|875004|P2|Overall Study|Withdrawal by Subject|1
264536|NCT02265796|875005|P1|Overall Study|Withdrawal by Subject|1
264537|NCT02265796|875004|P2|Overall Study|started on excluded medication|0
264538|NCT02265796|875005|P1|Overall Study|started on excluded medication|1
264539|NCT02265796|875004|P2|Overall Study|Death|0
264540|NCT02265796|875005|P1|Overall Study|Death|1
264541|NCT02265237|875023|P4|As Treated (Overall Study)|Other|1
264542|NCT02265237|875024|P3|As Treated (Overall Study)|Other|3
264543|NCT02265237|875025|P2|As Treated (Overall Study)|Other|0
264544|NCT02265237|875026|P1|As Treated (Overall Study)|Other|2
264545|NCT02265237|875023|P4|As Treated (Overall Study)|Lost to Follow-up|0
264546|NCT02265237|875024|P3|As Treated (Overall Study)|Lost to Follow-up|6
264547|NCT02265237|875025|P2|As Treated (Overall Study)|Lost to Follow-up|2
264548|NCT02265237|875026|P1|As Treated (Overall Study)|Lost to Follow-up|1
264549|NCT02265237|875023|P4|As Treated (Overall Study)|Withdrawal by Subject|0
264550|NCT02265237|875024|P3|As Treated (Overall Study)|Withdrawal by Subject|1
264551|NCT02265237|875025|P2|As Treated (Overall Study)|Withdrawal by Subject|0
264552|NCT02265237|875026|P1|As Treated (Overall Study)|Withdrawal by Subject|1
264553|NCT02265237|875023|P4|As Treated (Overall Study)|Adverse Event|0
264554|NCT02265237|875024|P3|As Treated (Overall Study)|Adverse Event|0
264555|NCT02265237|875025|P2|As Treated (Overall Study)|Adverse Event|1
264556|NCT02265237|875026|P1|As Treated (Overall Study)|Adverse Event|1
264557|NCT02264821|875056|P3|Overall Study|Protocol Violation|6
264558|NCT02264821|875057|P2|Overall Study|Protocol Violation|3
264559|NCT02264821|875058|P1|Overall Study|Protocol Violation|1
264560|NCT02263365|875120|P2|Overall Study|Physician Decision|18
264561|NCT02263365|875121|P1|Overall Study|Physician Decision|22
264562|NCT02262754|875176|P3|Overall Study|Other|2
264563|NCT02262754|875177|P2|Overall Study|Other|0
264564|NCT02262754|875178|P1|Overall Study|Other|4
264565|NCT02262754|875176|P3|Overall Study|Withdrawal by Subject|1
264566|NCT02262754|875177|P2|Overall Study|Withdrawal by Subject|0
264567|NCT02262754|875178|P1|Overall Study|Withdrawal by Subject|1
264568|NCT02262754|875176|P3|Overall Study|Protocol Violation|0
264569|NCT02262754|875177|P2|Overall Study|Protocol Violation|0
264570|NCT02262754|875178|P1|Overall Study|Protocol Violation|1
264571|NCT02262754|875176|P3|Overall Study|Study terminated by sponsor|4
264572|NCT02262754|875177|P2|Overall Study|Study terminated by sponsor|4
264573|NCT02262754|875178|P1|Overall Study|Study terminated by sponsor|5
264574|NCT02262754|875176|P3|Overall Study|No longer meets eligibility criteria|0
264575|NCT02262754|875177|P2|Overall Study|No longer meets eligibility criteria|1
264576|NCT02262754|875178|P1|Overall Study|No longer meets eligibility criteria|0
264577|NCT02262754|875176|P3|Overall Study|Lost to Follow-up|1
264578|NCT02262754|875177|P2|Overall Study|Lost to Follow-up|0
264579|NCT02262754|875178|P1|Overall Study|Lost to Follow-up|0
264580|NCT02262754|875176|P3|Overall Study|Lack of Efficacy|1
264581|NCT02262754|875177|P2|Overall Study|Lack of Efficacy|0
264582|NCT02262754|875178|P1|Overall Study|Lack of Efficacy|2
264583|NCT02262754|875176|P3|Overall Study|Adverse Event|0
264584|NCT02262754|875177|P2|Overall Study|Adverse Event|4
264585|NCT02262754|875178|P1|Overall Study|Adverse Event|3
264586|NCT02261974|875314|P2|Overall Study|Adverse Event|0
264587|NCT02261974|875315|P1|Overall Study|Adverse Event|1
264588|NCT02261974|875314|P2|Overall Study|Lost to Follow-up|0
264589|NCT02261974|875315|P1|Overall Study|Lost to Follow-up|2
264590|NCT02261974|875314|P2|Overall Study|Received partial treatment; FU to 1 mo|1
264591|NCT02261974|875315|P1|Overall Study|Received partial treatment; FU to 1 mo|3
264592|NCT02261974|875314|P2|Overall Study|Missed treatment cut-off date|3
264593|NCT02261974|875315|P1|Overall Study|Missed treatment cut-off date|6
264594|NCT02261974|875314|P2|Overall Study|Pregnancy|1
264595|NCT02261974|875315|P1|Overall Study|Pregnancy|0
264596|NCT02261974|875314|P2|Overall Study|Withdrawal by Subject|2
264597|NCT02261974|875315|P1|Overall Study|Withdrawal by Subject|3
264598|NCT02261493|875359|P3|Overall Study|Adverse Event|0
264599|NCT02261493|875360|P2|Overall Study|Adverse Event|1
264600|NCT02261493|875361|P1|Overall Study|Adverse Event|0
264601|NCT02261493|875359|P3|Overall Study|Lack of Efficacy|0
264602|NCT02261493|875360|P2|Overall Study|Lack of Efficacy|1
264603|NCT02261493|875361|P1|Overall Study|Lack of Efficacy|0
264604|NCT02261493|875359|P3|Overall Study|Pregnancy|0
264605|NCT02261493|875360|P2|Overall Study|Pregnancy|2
264606|NCT02261493|875361|P1|Overall Study|Pregnancy|1
264607|NCT02261493|875359|P3|Overall Study|Lost to Follow-up|8
264608|NCT02261493|875360|P2|Overall Study|Lost to Follow-up|27
264609|NCT02261493|875361|P1|Overall Study|Lost to Follow-up|14
264610|NCT02261493|875359|P3|Overall Study|Personal Reasons|16
264611|NCT02261493|875360|P2|Overall Study|Personal Reasons|14
264612|NCT02261493|875361|P1|Overall Study|Personal Reasons|14
264613|NCT02261493|875359|P3|Overall Study|Protocol Violation|0
264614|NCT02261493|875360|P2|Overall Study|Protocol Violation|0
264615|NCT02261493|875361|P1|Overall Study|Protocol Violation|1
264616|NCT02261493|875359|P3|Overall Study|Undisclosed alcohol abuse|0
264617|NCT02261493|875360|P2|Overall Study|Undisclosed alcohol abuse|1
264618|NCT02261493|875361|P1|Overall Study|Undisclosed alcohol abuse|0
264619|NCT02261493|875359|P3|Overall Study|Physician Decision|0
264620|NCT02261493|875360|P2|Overall Study|Physician Decision|1
264621|NCT02261493|875361|P1|Overall Study|Physician Decision|0
264622|NCT02261493|875359|P3|Overall Study|Noncompliance|2
264623|NCT02261493|875360|P2|Overall Study|Noncompliance|0
264624|NCT02261493|875361|P1|Overall Study|Noncompliance|0
264625|NCT02261467|875389|P2|Overall Study|Adverse Event|1
264626|NCT02261467|875390|P1|Overall Study|Adverse Event|1
264627|NCT02261467|875389|P2|Overall Study|Lost to Follow-up|13
264628|NCT02261467|875390|P1|Overall Study|Lost to Follow-up|2
264629|NCT02261467|875389|P2|Overall Study|Personal Reasons|22
264630|NCT02261467|875390|P1|Overall Study|Personal Reasons|17
264631|NCT02261467|875389|P2|Overall Study|Protocol Violation|1
264632|NCT02261467|875390|P1|Overall Study|Protocol Violation|0
264633|NCT02261467|875389|P2|Overall Study|Enrolled in Error|0
264634|NCT02261467|875390|P1|Overall Study|Enrolled in Error|1
264635|NCT02260986|875432|P3|Overall Study|Pregnancy|0
264636|NCT02260986|875433|P2|Overall Study|Pregnancy|0
264637|NCT02260986|875434|P1|Overall Study|Pregnancy|2
264638|NCT02260986|875432|P3|Overall Study|Lost to Follow-up|3
264639|NCT02260986|875433|P2|Overall Study|Lost to Follow-up|0
264640|NCT02260986|875434|P1|Overall Study|Lost to Follow-up|4
264641|NCT02260986|875432|P3|Overall Study|Lack of investigation product supply|1
264642|NCT02260986|875433|P2|Overall Study|Lack of investigation product supply|0
264643|NCT02260986|875434|P1|Overall Study|Lack of investigation product supply|2
264644|NCT02260986|875432|P3|Overall Study|Incorrect randomization|0
264645|NCT02260986|875433|P2|Overall Study|Incorrect randomization|1
264646|NCT02260986|875434|P1|Overall Study|Incorrect randomization|0
264647|NCT02260986|875432|P3|Overall Study|Withdrawal by Subject|9
264648|NCT02260986|875433|P2|Overall Study|Withdrawal by Subject|4
264649|NCT02260986|875434|P1|Overall Study|Withdrawal by Subject|17
264650|NCT02260986|875432|P3|Overall Study|Car accident|1
264651|NCT02260986|875433|P2|Overall Study|Car accident|0
264652|NCT02260986|875434|P1|Overall Study|Car accident|0
264653|NCT02260986|875432|P3|Overall Study|Protocol Violation|16
264654|NCT02260986|875433|P2|Overall Study|Protocol Violation|5
264655|NCT02260986|875434|P1|Overall Study|Protocol Violation|14
264656|NCT02260986|875432|P3|Overall Study|Lack of Efficacy|0
264657|NCT02260986|875433|P2|Overall Study|Lack of Efficacy|3
264658|NCT02260986|875434|P1|Overall Study|Lack of Efficacy|27
264659|NCT02260986|875432|P3|Overall Study|Adverse Event|11
264660|NCT02260986|875433|P2|Overall Study|Adverse Event|0
264661|NCT02260986|875434|P1|Overall Study|Adverse Event|24
264662|NCT02260882|875552|P2|Overall Study|Protocol Violation|1
264663|NCT02260882|875553|P1|Overall Study|Protocol Violation|0
264664|NCT02260791|875577|P2|Overall Study|Protocol deviation|3
264665|NCT02260791|875578|P1|Overall Study|Protocol deviation|2
264666|NCT02260791|875577|P2|Overall Study|Screen failure|1
264667|NCT02260791|875578|P1|Overall Study|Screen failure|0
264668|NCT02260791|875577|P2|Overall Study|Withdrawal by Subject|16
264669|NCT02260791|875578|P1|Overall Study|Withdrawal by Subject|11
264670|NCT02260791|875577|P2|Overall Study|Death|0
264671|NCT02260791|875578|P1|Overall Study|Death|1
264672|NCT02260791|875577|P2|Overall Study|Adverse Event|9
264673|NCT02260791|875578|P1|Overall Study|Adverse Event|13
264674|NCT02260791|875577|P2|Overall Study|Lack of Efficacy|1
264675|NCT02260791|875578|P1|Overall Study|Lack of Efficacy|2
264676|NCT02260791|875577|P2|Overall Study|Lost to Follow-up|4
264677|NCT02260791|875578|P1|Overall Study|Lost to Follow-up|4
264678|NCT02260492|875617|P3|Overall Study|Withdrawal by Subject|2
264679|NCT02260492|875618|P2|Overall Study|Withdrawal by Subject|2
264680|NCT02260492|875619|P1|Overall Study|Withdrawal by Subject|3
264681|NCT02260492|875617|P3|Overall Study|Physician Decision|1
264682|NCT02260492|875618|P2|Overall Study|Physician Decision|0
264683|NCT02260492|875619|P1|Overall Study|Physician Decision|2
264684|NCT02260492|875617|P3|Overall Study|Lost to Follow-up|0
264685|NCT02260492|875618|P2|Overall Study|Lost to Follow-up|9
264686|NCT02260492|875619|P1|Overall Study|Lost to Follow-up|12
264687|NCT02260492|875617|P3|Overall Study|Death|0
264688|NCT02260492|875618|P2|Overall Study|Death|1
264689|NCT02260492|875619|P1|Overall Study|Death|0
264690|NCT02260492|875617|P3|Overall Study|Adverse Event|2
264691|NCT02260492|875618|P2|Overall Study|Adverse Event|1
264692|NCT02260492|875619|P1|Overall Study|Adverse Event|6
264693|NCT02259400|875655|P2|Overall Study|Death|2
264694|NCT02259400|875656|P1|Overall Study|Death|0
264695|NCT02259348|875688|P1|Overall Study|Death|4
264696|NCT02259348|875688|P1|Overall Study|Donors|6
264697|NCT02258529|875700|P1|Overall Study|Adverse Event|1
264698|NCT02258529|875700|P1|Overall Study|Study Terminated by Sponsor|9
264699|NCT02258334|875746|P4|Overall Study|Adverse Event|0
264700|NCT02258334|875747|P3|Overall Study|Adverse Event|0
264701|NCT02258334|875748|P2|Overall Study|Adverse Event|0
264702|NCT02258334|875749|P1|Overall Study|Adverse Event|1
264703|NCT02257918|875778|P3|Overall Study|Pregnancy|1
264704|NCT02257918|875779|P2|Overall Study|Pregnancy|0
264705|NCT02257918|875780|P1|Overall Study|Pregnancy|0
264706|NCT02257918|875778|P3|Overall Study|Withdrawal by Subject|1
264707|NCT02257918|875779|P2|Overall Study|Withdrawal by Subject|0
264708|NCT02257918|875780|P1|Overall Study|Withdrawal by Subject|0
264709|NCT02257918|875778|P3|Overall Study|Lost to Follow-up|0
264710|NCT02257918|875779|P2|Overall Study|Lost to Follow-up|1
264711|NCT02257918|875780|P1|Overall Study|Lost to Follow-up|4
264712|NCT02257684|875830|P1|Overall Study|Sponsor's Decision|1
264713|NCT02257684|875830|P1|Overall Study|Lack of Efficacy|1
264714|NCT02257684|875830|P1|Overall Study|Adverse Event|2
264715|NCT02257385|875840|P2|Overall Study|Withdrawal by Subject|4
264716|NCT02257385|875841|P1|Overall Study|Withdrawal by Subject|4
264717|NCT02257385|875840|P2|Overall Study|Lost to Follow-up|1
264718|NCT02257385|875841|P1|Overall Study|Lost to Follow-up|0
264719|NCT02257385|875840|P2|Overall Study|Protocol Violation|7
264720|NCT02257385|875841|P1|Overall Study|Protocol Violation|5
264721|NCT02257385|875840|P2|Overall Study|Lack of Efficacy|2
264722|NCT02257385|875841|P1|Overall Study|Lack of Efficacy|1
264723|NCT02257385|875840|P2|Overall Study|Adverse Event|8
264724|NCT02257385|875841|P1|Overall Study|Adverse Event|12
264725|NCT02257372|875851|P2|Overall Study|Withdrew consent|0
264726|NCT02257372|875852|P1|Overall Study|Withdrew consent|1
264727|NCT02257372|875851|P2|Overall Study|Lost to Follow-up|1
264728|NCT02257372|875852|P1|Overall Study|Lost to Follow-up|0
264729|NCT02257372|875851|P2|Overall Study|Protocol Violation|1
264730|NCT02257372|875852|P1|Overall Study|Protocol Violation|1
264731|NCT02257372|875851|P2|Overall Study|Lack of Efficacy|1
264732|NCT02257372|875852|P1|Overall Study|Lack of Efficacy|2
264733|NCT02257372|875851|P2|Overall Study|Adverse Event|7
264734|NCT02257372|875852|P1|Overall Study|Adverse Event|3
264735|NCT02256982|875862|P2|Overall Study|Disease Progression|1
264736|NCT02256982|875863|P1|Overall Study|Disease Progression|0
264737|NCT02256969|875872|P3|Overall Study|Screenfailed or withdrew|1
264738|NCT02256969|875873|P2|Overall Study|Screenfailed or withdrew|1
264739|NCT02256969|875874|P1|Overall Study|Screenfailed or withdrew|2
264740|NCT02256891|875893|P2|Overall Study|Equipment Malfunction|1
264741|NCT02256891|875894|P1|Overall Study|Equipment Malfunction|0
264742|NCT02256891|875893|P2|Overall Study|Screen Fail|4
264743|NCT02256891|875894|P1|Overall Study|Screen Fail|5
264744|NCT02256891|875893|P2|Overall Study|Physician Decision|3
264745|NCT02256891|875894|P1|Overall Study|Physician Decision|7
264746|NCT02256891|875893|P2|Overall Study|Lost to Follow-up|3
264747|NCT02256891|875894|P1|Overall Study|Lost to Follow-up|0
264748|NCT02256891|875893|P2|Overall Study|Death|2
264749|NCT02256891|875894|P1|Overall Study|Death|0
264750|NCT02256553|875918|P1|Period III|Adverse Event|3
264751|NCT02256553|875918|P1|Period II|Subject Moved|1
264752|NCT02256553|875918|P1|Period II|Adverse Event|1
264753|NCT02256553|875918|P1|Period I|Protocol Violation|1
264754|NCT02256553|875918|P1|Period I|Adverse Event|5
264755|NCT02256488|875931|P4|Overall Study|Withdrawal by Subject|2
264756|NCT02256488|875932|P3|Overall Study|Withdrawal by Subject|0
264757|NCT02256488|875933|P2|Overall Study|Withdrawal by Subject|0
264758|NCT02256488|875934|P1|Overall Study|Withdrawal by Subject|1
264759|NCT02256488|875931|P4|Overall Study|OTHER|1
264760|NCT02256488|875932|P3|Overall Study|OTHER|1
264761|NCT02256488|875933|P2|Overall Study|OTHER|0
264762|NCT02256488|875934|P1|Overall Study|OTHER|1
264763|NCT02256488|875931|P4|Overall Study|Lost to Follow-up|3
264764|NCT02256488|875932|P3|Overall Study|Lost to Follow-up|9
264765|NCT02256488|875933|P2|Overall Study|Lost to Follow-up|6
264766|NCT02256488|875934|P1|Overall Study|Lost to Follow-up|6
264767|NCT02256436|875950|P2|Overall Study|Ongoing in Study|67
264768|NCT02256436|875951|P1|Overall Study|Ongoing in Study|108
264769|NCT02256436|875950|P2|Overall Study|Withdrawal by Subject|30
264770|NCT02256436|875951|P1|Overall Study|Withdrawal by Subject|7
264771|NCT02256436|875950|P2|Overall Study|Protocol Violation|0
264772|NCT02256436|875951|P1|Overall Study|Protocol Violation|1
264773|NCT02256436|875950|P2|Overall Study|Physician Decision|3
264774|NCT02256436|875951|P1|Overall Study|Physician Decision|1
264775|NCT02256436|875950|P2|Overall Study|Lost to Follow-up|1
264776|NCT02256436|875951|P1|Overall Study|Lost to Follow-up|1
264777|NCT02256436|875950|P2|Overall Study|Death|158
264778|NCT02256436|875951|P1|Overall Study|Death|137
264779|NCT02256436|875950|P2|Overall Study|Adverse Event|13
264780|NCT02256436|875951|P1|Overall Study|Adverse Event|15
264781|NCT02255565|876031|P3|Overall Study|Withdrawal by Subject|0
264782|NCT02255565|876032|P2|Overall Study|Withdrawal by Subject|1
264783|NCT02255565|876033|P1|Overall Study|Withdrawal by Subject|0
264784|NCT02255279|876094|P2|Overall Study|Withdrawal by Subject|6
264785|NCT02255279|876095|P1|Overall Study|Withdrawal by Subject|3
264786|NCT02255279|876094|P2|Overall Study|Protocol Violation|1
264787|NCT02255279|876095|P1|Overall Study|Protocol Violation|0
264788|NCT02255279|876094|P2|Overall Study|Lost to Follow-up|2
264789|NCT02255279|876095|P1|Overall Study|Lost to Follow-up|2
264790|NCT02255149|876121|P1|Overall Study|Implant Failure|1
264791|NCT02255149|876121|P1|Overall Study|Withdrawal by PI|1
264792|NCT02255149|876121|P1|Overall Study|Withdrawal by Subject|1
264793|NCT02255149|876121|P1|Overall Study|Lost to Follow-up|2
264794|NCT02255097|876125|P1|Overall Study|Treatment Ongoing|36
264795|NCT02255097|876125|P1|Overall Study|Allocated but not treated|1
264796|NCT02255097|876125|P1|Overall Study|Withdrawal by Subject|2
264797|NCT02255097|876125|P1|Overall Study|Progressive Disease|80
264798|NCT02255097|876125|P1|Overall Study|Physician Decision|1
264799|NCT02255097|876125|P1|Overall Study|Lost to Follow-up|1
264800|NCT02255097|876125|P1|Overall Study|Death|2
264801|NCT02255097|876125|P1|Overall Study|Excluded Medication|1
264802|NCT02255097|876125|P1|Overall Study|Complete Response|1
264803|NCT02255097|876125|P1|Overall Study|Clinical Progression|23
264804|NCT02255097|876125|P1|Overall Study|Adverse Event|24
264805|NCT02254772|876146|P1|Overall Study|Withdrawal by Subject|1
264806|NCT02254772|876146|P1|Overall Study|Ineligible|1
264807|NCT02254551|876152|P1|Dose Escalation|Dose-limiting toxicity|2
264808|NCT02254551|876152|P1|Dose Escalation|Physician Decision|1
264809|NCT02254486|876162|P2|Overall Study|Various|12
264810|NCT02254486|876163|P1|Overall Study|Various|12
264811|NCT02254486|876162|P2|Overall Study|GFR<60mL/min|21
264812|NCT02254486|876163|P1|Overall Study|GFR<60mL/min|16
264813|NCT02254486|876162|P2|Overall Study|Withdrawal by Subject|15
264814|NCT02254486|876163|P1|Overall Study|Withdrawal by Subject|17
264815|NCT02254486|876162|P2|Overall Study|Protocol Violation|2
264816|NCT02254486|876163|P1|Overall Study|Protocol Violation|1
264817|NCT02254486|876162|P2|Overall Study|Lost to Follow-up|4
264818|NCT02254486|876163|P1|Overall Study|Lost to Follow-up|2
264819|NCT02254486|876162|P2|Overall Study|Lack of Efficacy|0
264820|NCT02254486|876163|P1|Overall Study|Lack of Efficacy|1
264821|NCT02254486|876162|P2|Overall Study|Adverse Event|1
264822|NCT02254486|876163|P1|Overall Study|Adverse Event|1
264823|NCT02254460|876179|P2|Overall Study|Adverse Event|0
264824|NCT02254460|876180|P1|Overall Study|Adverse Event|1
264825|NCT02254421|876188|P2|Overall Study|Withdrew Consent|1
264826|NCT02254421|876189|P1|Overall Study|Withdrew Consent|1
264827|NCT02254421|876188|P2|Overall Study|Death|2
264828|NCT02254421|876189|P1|Overall Study|Death|0
264829|NCT02254421|876188|P2|Overall Study|Randomized but Not Treated|0
264830|NCT02254421|876189|P1|Overall Study|Randomized but Not Treated|1
264831|NCT02254304|876203|P2|Overall Study|Personal decision|0
264832|NCT02254304|876204|P1|Overall Study|Personal decision|1
264833|NCT02254304|876203|P2|Overall Study|Personal causes|1
264834|NCT02254304|876204|P1|Overall Study|Personal causes|4
264835|NCT02254304|876203|P2|Overall Study|Injection site pain and Injection fear|0
264836|NCT02254304|876204|P1|Overall Study|Injection site pain and Injection fear|1
264837|NCT02254304|876203|P2|Overall Study|Withdrawal by Subject|0
264838|NCT02254304|876204|P1|Overall Study|Withdrawal by Subject|3
264839|NCT02254304|876203|P2|Overall Study|Protocol Violation|0
264840|NCT02254304|876204|P1|Overall Study|Protocol Violation|1
264841|NCT02254304|876203|P2|Overall Study|Lost to Follow-up|2
264842|NCT02254304|876204|P1|Overall Study|Lost to Follow-up|2
264843|NCT02254304|876203|P2|Overall Study|Adverse Event|1
264844|NCT02254304|876204|P1|Overall Study|Adverse Event|2
264845|NCT02253654|876276|P2|Overall Study|Did Not Receive Study Treatment|1
264846|NCT02253654|876277|P1|Overall Study|Did Not Receive Study Treatment|4
264847|NCT02253654|876276|P2|Overall Study|Death|7
264848|NCT02253654|876277|P1|Overall Study|Death|4
264849|NCT02253654|876276|P2|Overall Study|Lost to Follow-up|5
264850|NCT02253654|876277|P1|Overall Study|Lost to Follow-up|2
264851|NCT02253654|876276|P2|Overall Study|Decision by Sponsor|1
264852|NCT02253654|876277|P1|Overall Study|Decision by Sponsor|1
264853|NCT02253654|876276|P2|Overall Study|Withdrawal by Subject|4
264854|NCT02253654|876277|P1|Overall Study|Withdrawal by Subject|12
264855|NCT02253147|876539|P1|Overall Study|Withdrawal by Subject|1
264856|NCT02253147|876539|P1|Overall Study|Lost to Follow-up|2
264857|NCT02253147|876539|P1|Overall Study|Conditional re-treatment at W52|5
264858|NCT02253147|876539|P1|Overall Study|Did not consent to study extension|9
264859|NCT02253147|876539|P1|Overall Study|Protocol Violation|30
264860|NCT02252965|876573|P2|Overall Study|Other|5
264861|NCT02252965|876574|P1|Overall Study|Other|4
264862|NCT02252965|876573|P2|Overall Study|Withdrawal by Subject|9
264863|NCT02252965|876574|P1|Overall Study|Withdrawal by Subject|7
264864|NCT02252965|876573|P2|Overall Study|Lack of Efficacy|2
264865|NCT02252965|876574|P1|Overall Study|Lack of Efficacy|0
264866|NCT02252965|876573|P2|Overall Study|Protocol Violation|5
264867|NCT02252965|876574|P1|Overall Study|Protocol Violation|4
264868|NCT02252965|876573|P2|Overall Study|Lost to Follow-up|8
264869|NCT02252965|876574|P1|Overall Study|Lost to Follow-up|16
264870|NCT02252965|876573|P2|Overall Study|Adverse Event|14
264871|NCT02252965|876574|P1|Overall Study|Adverse Event|9
264872|NCT02252939|876601|P1|Overall Study|Lost to Follow-up|3
264873|NCT02252146|876688|P1|Overall Study|Inability to travel to study site|1
264874|NCT02252146|876688|P1|Overall Study|Entered hospice care|1
264875|NCT02252146|876688|P1|Overall Study|Lack of Efficacy|4
264876|NCT02252016|876701|P2|Overall Study|Withdrawal by Subject|2
264877|NCT02252016|876702|P1|Overall Study|Withdrawal by Subject|0
264878|NCT02252016|876701|P2|Overall Study|Physician Decision|0
264879|NCT02252016|876702|P1|Overall Study|Physician Decision|1
264880|NCT02252016|876701|P2|Overall Study|Lost to Follow-up|1
264881|NCT02252016|876702|P1|Overall Study|Lost to Follow-up|2
264882|NCT02251990|876716|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
264883|NCT02251990|876717|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
264884|NCT02251990|876716|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
264885|NCT02251990|876717|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
264886|NCT02251990|876716|P2|Period 1 (Double-blind [DB])|Not Treated|0
264887|NCT02251990|876717|P1|Period 1 (Double-blind [DB])|Not Treated|1
264888|NCT02251990|876716|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
264889|NCT02251990|876717|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
264890|NCT02251990|876716|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
264891|NCT02251990|876717|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
264892|NCT02251990|876716|P2|Period 1 (Double-blind [DB])|Adverse Event|1
264893|NCT02251990|876717|P1|Period 1 (Double-blind [DB])|Adverse Event|1
264894|NCT02251912|876734|P2|Overall Study|Adverse Event|2
264895|NCT02251912|876735|P1|Overall Study|Adverse Event|0
264896|NCT02251912|876734|P2|Overall Study|Withdrawal by Subject|3
264897|NCT02251912|876735|P1|Overall Study|Withdrawal by Subject|2
264898|NCT02251717|876764|P2|Overall Study|Withdrew Consent|0
264899|NCT02251717|876765|P1|Overall Study|Withdrew Consent|1
264900|NCT02251717|876764|P2|Overall Study|Adverse Event|1
264901|NCT02251717|876765|P1|Overall Study|Adverse Event|0
264902|NCT02251652|876777|P1|Overall Study|Withdrawal by Subject|1
264903|NCT02250443|876828|P1|Overall Study|Adverse Event|3
264904|NCT02250443|876828|P1|Overall Study|Administrative problems|7
264905|NCT02250274|876843|P2|Overall Study|Insufficient blood draw amount|6
264906|NCT02250274|876844|P1|Overall Study|Insufficient blood draw amount|7
264907|NCT02248818|876918|P9|Randomised Study|Administrative - randomization error|0
264908|NCT02248818|876919|P8|Randomised Study|Administrative - randomization error|0
264909|NCT02248818|876920|P7|Randomised Study|Administrative - randomization error|0
264910|NCT02248818|876921|P6|Randomised Study|Administrative - randomization error|8
264911|NCT02248818|876922|P5|Randomised Study|Administrative - randomization error|0
264912|NCT02248818|876923|P4|Randomised Study|Administrative - randomization error|0
264913|NCT02248818|876924|P3|Randomised Study|Administrative - randomization error|0
264914|NCT02248818|876925|P2|Randomised Study|Administrative - randomization error|0
264915|NCT02248818|876926|P1|Randomised Study|Administrative - randomization error|0
264916|NCT02248818|876918|P9|Screening|Lost to Follow-up|7
264917|NCT02248818|876919|P8|Screening|Lost to Follow-up|0
264918|NCT02248818|876920|P7|Screening|Lost to Follow-up|0
264919|NCT02248818|876921|P6|Screening|Lost to Follow-up|0
264920|NCT02248818|876922|P5|Screening|Lost to Follow-up|0
264921|NCT02248818|876923|P4|Screening|Lost to Follow-up|0
264922|NCT02248818|876924|P3|Screening|Lost to Follow-up|0
264923|NCT02248818|876925|P2|Screening|Lost to Follow-up|0
264924|NCT02248818|876926|P1|Screening|Lost to Follow-up|0
264925|NCT02248818|876918|P9|Screening|Withdrawal by Subject|6
264926|NCT02248818|876919|P8|Screening|Withdrawal by Subject|0
264927|NCT02248818|876920|P7|Screening|Withdrawal by Subject|0
264928|NCT02248818|876921|P6|Screening|Withdrawal by Subject|0
264929|NCT02248818|876922|P5|Screening|Withdrawal by Subject|0
264930|NCT02248818|876923|P4|Screening|Withdrawal by Subject|0
264931|NCT02248818|876924|P3|Screening|Withdrawal by Subject|0
264932|NCT02248818|876925|P2|Screening|Withdrawal by Subject|0
264933|NCT02248818|876926|P1|Screening|Withdrawal by Subject|0
264934|NCT02248818|876918|P9|Screening|Physician Decision|73
264935|NCT02248818|876919|P8|Screening|Physician Decision|0
264936|NCT02248818|876920|P7|Screening|Physician Decision|0
264937|NCT02248818|876921|P6|Screening|Physician Decision|0
264938|NCT02248818|876922|P5|Screening|Physician Decision|0
264939|NCT02248818|876923|P4|Screening|Physician Decision|0
264940|NCT02248818|876924|P3|Screening|Physician Decision|0
264941|NCT02248818|876925|P2|Screening|Physician Decision|0
264942|NCT02248818|876926|P1|Screening|Physician Decision|0
264943|NCT02248818|876918|P9|Screening|Study fully enrolled|14
264944|NCT02248818|876919|P8|Screening|Study fully enrolled|0
264945|NCT02248818|876920|P7|Screening|Study fully enrolled|0
264946|NCT02248818|876921|P6|Screening|Study fully enrolled|0
264947|NCT02248818|876922|P5|Screening|Study fully enrolled|0
264948|NCT02248818|876923|P4|Screening|Study fully enrolled|0
264949|NCT02248818|876924|P3|Screening|Study fully enrolled|0
264950|NCT02248818|876925|P2|Screening|Study fully enrolled|0
264951|NCT02248818|876926|P1|Screening|Study fully enrolled|0
264952|NCT02248818|876918|P9|Screening|Protocol Violation|7
264953|NCT02248818|876919|P8|Screening|Protocol Violation|0
264954|NCT02248818|876920|P7|Screening|Protocol Violation|0
264955|NCT02248818|876921|P6|Screening|Protocol Violation|0
264956|NCT02248818|876922|P5|Screening|Protocol Violation|0
264957|NCT02248818|876923|P4|Screening|Protocol Violation|0
264958|NCT02248818|876924|P3|Screening|Protocol Violation|0
264959|NCT02248818|876925|P2|Screening|Protocol Violation|0
264960|NCT02248818|876926|P1|Screening|Protocol Violation|0
264961|NCT02248675|877089|P2|Overall Study|Lost to Follow-up|1
264962|NCT02248675|877090|P1|Overall Study|Lost to Follow-up|3
264963|NCT02248480|877117|P2|Overall Study|Other:Physician Decision|1
264964|NCT02248480|877118|P1|Overall Study|Other:Physician Decision|0
264965|NCT02248480|877117|P2|Overall Study|Entry Criteria Not Met|1
264966|NCT02248480|877118|P1|Overall Study|Entry Criteria Not Met|0
264967|NCT02248480|877117|P2|Overall Study|Withdrawal by Subject|4
264968|NCT02248480|877118|P1|Overall Study|Withdrawal by Subject|2
264969|NCT02248480|877117|P2|Overall Study|Adverse Event|2
264970|NCT02248480|877118|P1|Overall Study|Adverse Event|11
264971|NCT02248480|877117|P2|Overall Study|Lack of Efficacy|6
264972|NCT02248480|877118|P1|Overall Study|Lack of Efficacy|4
264973|NCT02247960|877185|P2|Catheter Removed|Lost to Follow-up|10
264974|NCT02247960|877186|P1|Catheter Removed|Lost to Follow-up|7
264975|NCT02247960|877185|P2|Patient Consent and Randomization|Withdrawal by Subject|4
264976|NCT02247960|877186|P1|Patient Consent and Randomization|Withdrawal by Subject|0
264977|NCT02247960|877185|P2|Patient Consent and Randomization|Physician Decision|2
264978|NCT02247960|877186|P1|Patient Consent and Randomization|Physician Decision|2
264979|NCT02247401|877225|P3|Overall Study|Lost to Follow-up|1
264980|NCT02247401|877226|P2|Overall Study|Lost to Follow-up|1
264981|NCT02247401|877227|P1|Overall Study|Lost to Follow-up|1
264982|NCT02247401|877225|P3|Overall Study|Withdrawal by Subject|1
264983|NCT02247401|877226|P2|Overall Study|Withdrawal by Subject|1
264984|NCT02247401|877227|P1|Overall Study|Withdrawal by Subject|4
264985|NCT02247401|877225|P3|Overall Study|Adverse Event|0
264986|NCT02247401|877226|P2|Overall Study|Adverse Event|0
264987|NCT02247401|877227|P1|Overall Study|Adverse Event|1
264988|NCT02247011|877257|P1|Overall Study|Poor quality of radiological results|125
264989|NCT02246998|877278|P4|Overall Study|Randomized but Never Dosed|1
264990|NCT02246998|877279|P3|Overall Study|Randomized but Never Dosed|2
264991|NCT02246998|877280|P2|Overall Study|Randomized but Never Dosed|2
264992|NCT02246998|877281|P1|Overall Study|Randomized but Never Dosed|1
264993|NCT02246998|877278|P4|Overall Study|Lost to Follow-up|1
264994|NCT02246998|877279|P3|Overall Study|Lost to Follow-up|0
264995|NCT02246998|877280|P2|Overall Study|Lost to Follow-up|0
264996|NCT02246998|877281|P1|Overall Study|Lost to Follow-up|1
264997|NCT02246998|877278|P4|Overall Study|Adverse Event|0
264998|NCT02246998|877279|P3|Overall Study|Adverse Event|1
264999|NCT02246998|877280|P2|Overall Study|Adverse Event|1
265000|NCT02246998|877281|P1|Overall Study|Adverse Event|0
265001|NCT02246764|877394|P3|Overall Study|Protocol Violation|1
265002|NCT02246764|877395|P2|Overall Study|Protocol Violation|1
265003|NCT02246764|877396|P1|Overall Study|Protocol Violation|2
265004|NCT02246764|877394|P3|Overall Study|Physician Decision|1
265005|NCT02246764|877395|P2|Overall Study|Physician Decision|2
265006|NCT02246764|877396|P1|Overall Study|Physician Decision|0
265007|NCT02246764|877394|P3|Overall Study|Disallowed Concomitant Medication|0
265008|NCT02246764|877395|P2|Overall Study|Disallowed Concomitant Medication|0
265009|NCT02246764|877396|P1|Overall Study|Disallowed Concomitant Medication|1
265010|NCT02246764|877394|P3|Overall Study|Withdrawal by Subject|1
265011|NCT02246764|877395|P2|Overall Study|Withdrawal by Subject|0
265012|NCT02246764|877396|P1|Overall Study|Withdrawal by Subject|0
265013|NCT02246764|877394|P3|Overall Study|Adverse Event|1
265014|NCT02246764|877395|P2|Overall Study|Adverse Event|29
265015|NCT02246764|877396|P1|Overall Study|Adverse Event|15
265016|NCT02246673|877409|P5|Overall Study|Protocol Violation|0
265017|NCT02246673|877410|P4|Overall Study|Protocol Violation|1
265018|NCT02246673|877411|P3|Overall Study|Protocol Violation|0
265019|NCT02246673|877412|P2|Overall Study|Protocol Violation|0
265020|NCT02246673|877413|P1|Overall Study|Protocol Violation|0
265021|NCT02246673|877409|P5|Overall Study|Lost to Follow-up|0
265022|NCT02246673|877410|P4|Overall Study|Lost to Follow-up|1
265023|NCT02246673|877411|P3|Overall Study|Lost to Follow-up|0
265024|NCT02246673|877412|P2|Overall Study|Lost to Follow-up|0
265025|NCT02246673|877413|P1|Overall Study|Lost to Follow-up|0
265026|NCT02246673|877409|P5|Overall Study|Withdrawal by Subject|1
265027|NCT02246673|877410|P4|Overall Study|Withdrawal by Subject|0
265028|NCT02246673|877411|P3|Overall Study|Withdrawal by Subject|0
265029|NCT02246673|877412|P2|Overall Study|Withdrawal by Subject|0
265030|NCT02246673|877413|P1|Overall Study|Withdrawal by Subject|0
265031|NCT02246673|877409|P5|Overall Study|Sponsor Decision|0
265032|NCT02246673|877410|P4|Overall Study|Sponsor Decision|0
265033|NCT02246673|877411|P3|Overall Study|Sponsor Decision|0
265034|NCT02246673|877412|P2|Overall Study|Sponsor Decision|0
265035|NCT02246673|877413|P1|Overall Study|Sponsor Decision|1
265036|NCT02246660|877521|P3|Overall Study|Death|1
265037|NCT02246660|877522|P2|Overall Study|Death|0
265038|NCT02246660|877523|P1|Overall Study|Death|0
265039|NCT02246660|877521|P3|Overall Study|Withdrawal by Subject|0
265040|NCT02246660|877522|P2|Overall Study|Withdrawal by Subject|1
265041|NCT02246660|877523|P1|Overall Study|Withdrawal by Subject|0
265042|NCT02246621|877533|P2|Overall Study|On Study Treatment/ Follow Up|133
265043|NCT02246621|877534|P1|Overall Study|On Study Treatment/ Follow Up|257
265044|NCT02246621|877533|P2|Overall Study|Lost to Follow-up|1
265045|NCT02246621|877534|P1|Overall Study|Lost to Follow-up|3
265046|NCT02246621|877533|P2|Overall Study|Withdrawal by Subject|14
265047|NCT02246621|877534|P1|Overall Study|Withdrawal by Subject|36
265048|NCT02246582|877560|P2|Overall Study|Withdrawal by Subject|4
265049|NCT02246582|877561|P1|Overall Study|Withdrawal by Subject|3
265050|NCT02246166|877582|P2|Overall Study|Protocol Violation|0
265051|NCT02246166|877583|P1|Overall Study|Protocol Violation|1
265052|NCT02246114|877619|P2|Overall Study|miscarriage|0
265053|NCT02246114|877620|P1|Overall Study|miscarriage|1
265054|NCT02245412|877654|P3|Overall Study|Other|0
265055|NCT02245412|877655|P2|Overall Study|Other|0
265056|NCT02245412|877656|P1|Overall Study|Other|1
265057|NCT02245412|877654|P3|Overall Study|Biopsy did not confirm GI GVHD|0
265058|NCT02245412|877655|P2|Overall Study|Biopsy did not confirm GI GVHD|0
265059|NCT02245412|877656|P1|Overall Study|Biopsy did not confirm GI GVHD|1
265060|NCT02245412|877654|P3|Overall Study|Withdrawal by Subject|0
265061|NCT02245412|877655|P2|Overall Study|Withdrawal by Subject|1
265062|NCT02245412|877656|P1|Overall Study|Withdrawal by Subject|1
265063|NCT02245412|877654|P3|Overall Study|Physician Decision|0
265064|NCT02245412|877655|P2|Overall Study|Physician Decision|1
265065|NCT02245412|877656|P1|Overall Study|Physician Decision|1
265066|NCT02245412|877654|P3|Overall Study|Death|0
265067|NCT02245412|877655|P2|Overall Study|Death|1
265068|NCT02245412|877656|P1|Overall Study|Death|1
265069|NCT02244944|877690|P1|Overall Study|Study Terminated|1
265070|NCT02244944|877690|P1|Overall Study|Withdrawal by Subject|1
265071|NCT02244619|877702|P2|Overall Study|Did not receive study intervention|21
265072|NCT02244619|877703|P1|Overall Study|Did not receive study intervention|8
265073|NCT02244580|877721|P1|Overall Study|No cancer tissues available|241
265074|NCT02243293|877759|P22|Overall Study|Randomized but did'nt receive study drug|0
265075|NCT02243293|877760|P21|Overall Study|Randomized but did'nt receive study drug|0
265076|NCT02243293|877761|P20|Overall Study|Randomized but did'nt receive study drug|1
265077|NCT02243293|877762|P19|Overall Study|Randomized but did'nt receive study drug|0
265078|NCT02243293|877763|P18|Overall Study|Randomized but did'nt receive study drug|0
265079|NCT02243293|877764|P17|Overall Study|Randomized but did'nt receive study drug|0
265080|NCT02243293|877765|P16|Overall Study|Randomized but did'nt receive study drug|0
265081|NCT02243293|877766|P15|Overall Study|Randomized but did'nt receive study drug|0
265082|NCT02243293|877767|P14|Overall Study|Randomized but did'nt receive study drug|0
265083|NCT02243293|877768|P13|Overall Study|Randomized but did'nt receive study drug|0
265084|NCT02243293|877769|P12|Overall Study|Randomized but did'nt receive study drug|0
265085|NCT02243293|877770|P11|Overall Study|Randomized but did'nt receive study drug|0
265086|NCT02243293|877771|P10|Overall Study|Randomized but did'nt receive study drug|1
265087|NCT02243293|877772|P9|Overall Study|Randomized but did'nt receive study drug|0
265088|NCT02243293|877773|P8|Overall Study|Randomized but did'nt receive study drug|0
265089|NCT02243293|877774|P7|Overall Study|Randomized but did'nt receive study drug|0
265090|NCT02243293|877775|P6|Overall Study|Randomized but did'nt receive study drug|0
265091|NCT02243293|877776|P5|Overall Study|Randomized but did'nt receive study drug|1
265092|NCT02243293|877777|P4|Overall Study|Randomized but did'nt receive study drug|0
265093|NCT02243293|877778|P3|Overall Study|Randomized but did'nt receive study drug|0
265094|NCT02243293|877779|P2|Overall Study|Randomized but did'nt receive study drug|0
265095|NCT02243293|877780|P1|Overall Study|Randomized but did'nt receive study drug|0
265096|NCT02243293|877759|P22|Overall Study|Enrolled into a Re-treatment Study|0
265097|NCT02243293|877760|P21|Overall Study|Enrolled into a Re-treatment Study|0
265098|NCT02243293|877761|P20|Overall Study|Enrolled into a Re-treatment Study|0
265099|NCT02243293|877762|P19|Overall Study|Enrolled into a Re-treatment Study|0
265100|NCT02243293|877763|P18|Overall Study|Enrolled into a Re-treatment Study|0
265101|NCT02243293|877764|P17|Overall Study|Enrolled into a Re-treatment Study|0
265102|NCT02243293|877765|P16|Overall Study|Enrolled into a Re-treatment Study|0
265103|NCT02243293|877766|P15|Overall Study|Enrolled into a Re-treatment Study|1
265104|NCT02243293|877767|P14|Overall Study|Enrolled into a Re-treatment Study|0
265105|NCT02243293|877768|P13|Overall Study|Enrolled into a Re-treatment Study|0
265106|NCT02243293|877769|P12|Overall Study|Enrolled into a Re-treatment Study|0
265107|NCT02243293|877770|P11|Overall Study|Enrolled into a Re-treatment Study|0
265108|NCT02243293|877771|P10|Overall Study|Enrolled into a Re-treatment Study|0
265109|NCT02243293|877772|P9|Overall Study|Enrolled into a Re-treatment Study|0
265110|NCT02243293|877773|P8|Overall Study|Enrolled into a Re-treatment Study|0
265111|NCT02243293|877774|P7|Overall Study|Enrolled into a Re-treatment Study|0
265112|NCT02243293|877775|P6|Overall Study|Enrolled into a Re-treatment Study|0
265113|NCT02243293|877776|P5|Overall Study|Enrolled into a Re-treatment Study|0
265114|NCT02243293|877777|P4|Overall Study|Enrolled into a Re-treatment Study|0
265115|NCT02243293|877778|P3|Overall Study|Enrolled into a Re-treatment Study|0
265116|NCT02243293|877779|P2|Overall Study|Enrolled into a Re-treatment Study|0
265117|NCT02243293|877780|P1|Overall Study|Enrolled into a Re-treatment Study|0
265118|NCT02243293|877759|P22|Overall Study|Lost to Follow-up|2
265119|NCT02243293|877760|P21|Overall Study|Lost to Follow-up|1
265120|NCT02243293|877761|P20|Overall Study|Lost to Follow-up|0
265121|NCT02243293|877762|P19|Overall Study|Lost to Follow-up|0
265122|NCT02243293|877763|P18|Overall Study|Lost to Follow-up|1
265123|NCT02243293|877764|P17|Overall Study|Lost to Follow-up|3
265124|NCT02243293|877765|P16|Overall Study|Lost to Follow-up|0
265125|NCT02243293|877766|P15|Overall Study|Lost to Follow-up|0
265126|NCT02243293|877767|P14|Overall Study|Lost to Follow-up|0
265127|NCT02243293|877768|P13|Overall Study|Lost to Follow-up|0
265128|NCT02243293|877769|P12|Overall Study|Lost to Follow-up|2
265129|NCT02243293|877770|P11|Overall Study|Lost to Follow-up|0
265130|NCT02243293|877771|P10|Overall Study|Lost to Follow-up|0
265131|NCT02243293|877772|P9|Overall Study|Lost to Follow-up|0
265132|NCT02243293|877773|P8|Overall Study|Lost to Follow-up|0
265133|NCT02243293|877774|P7|Overall Study|Lost to Follow-up|3
265134|NCT02243293|877775|P6|Overall Study|Lost to Follow-up|0
265135|NCT02243293|877776|P5|Overall Study|Lost to Follow-up|0
265136|NCT02243293|877777|P4|Overall Study|Lost to Follow-up|1
265137|NCT02243293|877778|P3|Overall Study|Lost to Follow-up|1
265138|NCT02243293|877779|P2|Overall Study|Lost to Follow-up|1
265139|NCT02243293|877780|P1|Overall Study|Lost to Follow-up|0
265140|NCT02243293|877759|P22|Overall Study|Withdrawal by Subject|1
265141|NCT02243293|877760|P21|Overall Study|Withdrawal by Subject|0
265142|NCT02243293|877761|P20|Overall Study|Withdrawal by Subject|0
265143|NCT02243293|877762|P19|Overall Study|Withdrawal by Subject|0
265144|NCT02243293|877763|P18|Overall Study|Withdrawal by Subject|0
265145|NCT02243293|877764|P17|Overall Study|Withdrawal by Subject|0
265146|NCT02243293|877765|P16|Overall Study|Withdrawal by Subject|0
265147|NCT02243293|877766|P15|Overall Study|Withdrawal by Subject|0
265148|NCT02243293|877767|P14|Overall Study|Withdrawal by Subject|0
265149|NCT02243293|877768|P13|Overall Study|Withdrawal by Subject|0
265150|NCT02243293|877769|P12|Overall Study|Withdrawal by Subject|1
265151|NCT02243293|877770|P11|Overall Study|Withdrawal by Subject|0
265152|NCT02243293|877771|P10|Overall Study|Withdrawal by Subject|1
265153|NCT02243293|877772|P9|Overall Study|Withdrawal by Subject|0
265154|NCT02243293|877773|P8|Overall Study|Withdrawal by Subject|0
265155|NCT02243293|877774|P7|Overall Study|Withdrawal by Subject|0
265156|NCT02243293|877775|P6|Overall Study|Withdrawal by Subject|0
265157|NCT02243293|877776|P5|Overall Study|Withdrawal by Subject|0
265158|NCT02243293|877777|P4|Overall Study|Withdrawal by Subject|0
265159|NCT02243293|877778|P3|Overall Study|Withdrawal by Subject|0
265160|NCT02243293|877779|P2|Overall Study|Withdrawal by Subject|0
265161|NCT02243293|877780|P1|Overall Study|Withdrawal by Subject|1
265162|NCT02243293|877759|P22|Overall Study|Adverse Event|0
265163|NCT02243293|877760|P21|Overall Study|Adverse Event|1
265164|NCT02243293|877761|P20|Overall Study|Adverse Event|0
265165|NCT02243293|877762|P19|Overall Study|Adverse Event|0
265166|NCT02243293|877763|P18|Overall Study|Adverse Event|0
265167|NCT02243293|877764|P17|Overall Study|Adverse Event|0
265168|NCT02243293|877765|P16|Overall Study|Adverse Event|1
265169|NCT02243293|877766|P15|Overall Study|Adverse Event|0
265170|NCT02243293|877767|P14|Overall Study|Adverse Event|0
265171|NCT02243293|877768|P13|Overall Study|Adverse Event|0
265172|NCT02243293|877769|P12|Overall Study|Adverse Event|0
265173|NCT02243293|877770|P11|Overall Study|Adverse Event|0
265174|NCT02243293|877771|P10|Overall Study|Adverse Event|0
265175|NCT02243293|877772|P9|Overall Study|Adverse Event|0
265176|NCT02243293|877773|P8|Overall Study|Adverse Event|0
265177|NCT02243293|877774|P7|Overall Study|Adverse Event|0
265178|NCT02243293|877775|P6|Overall Study|Adverse Event|0
265179|NCT02243293|877776|P5|Overall Study|Adverse Event|0
265180|NCT02243293|877777|P4|Overall Study|Adverse Event|0
265181|NCT02243293|877778|P3|Overall Study|Adverse Event|0
265182|NCT02243293|877779|P2|Overall Study|Adverse Event|0
265183|NCT02243293|877780|P1|Overall Study|Adverse Event|1
265184|NCT02243280|877879|P11|Treated|Lost to Follow-up|2
265185|NCT02243280|877880|P10|Treated|Lost to Follow-up|0
265186|NCT02243280|877881|P9|Treated|Lost to Follow-up|1
265187|NCT02243280|877882|P8|Treated|Lost to Follow-up|0
265188|NCT02243280|877883|P7|Treated|Lost to Follow-up|0
265189|NCT02243280|877884|P6|Treated|Lost to Follow-up|0
265190|NCT02243280|877885|P5|Treated|Lost to Follow-up|0
265191|NCT02243280|877886|P4|Treated|Lost to Follow-up|0
265192|NCT02243280|877887|P3|Treated|Lost to Follow-up|0
265193|NCT02243280|877888|P2|Treated|Lost to Follow-up|0
265194|NCT02243280|877889|P1|Treated|Lost to Follow-up|0
265195|NCT02243280|877879|P11|Treated|Adverse Event|1
265196|NCT02243280|877880|P10|Treated|Adverse Event|0
265197|NCT02243280|877881|P9|Treated|Adverse Event|0
265198|NCT02243280|877882|P8|Treated|Adverse Event|0
265199|NCT02243280|877883|P7|Treated|Adverse Event|0
265200|NCT02243280|877884|P6|Treated|Adverse Event|0
265201|NCT02243280|877885|P5|Treated|Adverse Event|0
265202|NCT02243280|877886|P4|Treated|Adverse Event|0
265203|NCT02243280|877887|P3|Treated|Adverse Event|0
265204|NCT02243280|877888|P2|Treated|Adverse Event|0
265205|NCT02243280|877889|P1|Treated|Adverse Event|1
265206|NCT02243202|877944|P4|Overall Study|Randomized but not received treatment|1
265207|NCT02243202|877945|P3|Overall Study|Randomized but not received treatment|0
265208|NCT02243202|877946|P2|Overall Study|Randomized but not received treatment|0
265209|NCT02243202|877947|P1|Overall Study|Randomized but not received treatment|0
265210|NCT02243202|877944|P4|Overall Study|Other|2
265211|NCT02243202|877945|P3|Overall Study|Other|1
265212|NCT02243202|877946|P2|Overall Study|Other|3
265213|NCT02243202|877947|P1|Overall Study|Other|1
265214|NCT02243202|877944|P4|Overall Study|Withdrawal by Subject|4
265215|NCT02243202|877945|P3|Overall Study|Withdrawal by Subject|4
265216|NCT02243202|877946|P2|Overall Study|Withdrawal by Subject|6
265217|NCT02243202|877947|P1|Overall Study|Withdrawal by Subject|7
265218|NCT02243202|877944|P4|Overall Study|Protocol Violation|1
265219|NCT02243202|877945|P3|Overall Study|Protocol Violation|2
265220|NCT02243202|877946|P2|Overall Study|Protocol Violation|1
265221|NCT02243202|877947|P1|Overall Study|Protocol Violation|3
265222|NCT02243202|877944|P4|Overall Study|Lost to Follow-up|11
265223|NCT02243202|877945|P3|Overall Study|Lost to Follow-up|14
265224|NCT02243202|877946|P2|Overall Study|Lost to Follow-up|9
265225|NCT02243202|877947|P1|Overall Study|Lost to Follow-up|9
265226|NCT02243202|877944|P4|Overall Study|Adverse Event|4
265227|NCT02243202|877945|P3|Overall Study|Adverse Event|10
265228|NCT02243202|877946|P2|Overall Study|Adverse Event|6
265229|NCT02243202|877947|P1|Overall Study|Adverse Event|5
265230|NCT02243176|877983|P2|Overall Study|Adverse Event|2
265231|NCT02243176|877984|P1|Overall Study|Adverse Event|2
265232|NCT02243176|877983|P2|Overall Study|Withdrawal by Subject|7
265233|NCT02243176|877984|P1|Overall Study|Withdrawal by Subject|8
265234|NCT02243176|877983|P2|Overall Study|Protocol Violation|1
265235|NCT02243176|877984|P1|Overall Study|Protocol Violation|2
265236|NCT02243176|877983|P2|Overall Study|protocol specified withdrawal critera|3
265237|NCT02243176|877984|P1|Overall Study|protocol specified withdrawal critera|1
265238|NCT02243176|877983|P2|Overall Study|Other reason|2
265239|NCT02243176|877984|P1|Overall Study|Other reason|1
265240|NCT02243046|878009|P3|Overall Study|Lost to Follow-up|4
265241|NCT02243046|878010|P2|Overall Study|Lost to Follow-up|1
265242|NCT02243046|878011|P1|Overall Study|Lost to Follow-up|1
265243|NCT02242643|878066|P2|Overall Study|Withdrawal by subject at Visit 2|1
265244|NCT02242643|878067|P1|Overall Study|Withdrawal by subject at Visit 2|0
265245|NCT02242643|878066|P2|Overall Study|Language barrier|0
265246|NCT02242643|878067|P1|Overall Study|Language barrier|1
265247|NCT02242643|878066|P2|Overall Study|Protocol requirements not followed|0
265248|NCT02242643|878067|P1|Overall Study|Protocol requirements not followed|1
265249|NCT02242643|878066|P2|Overall Study|Consent withdrawal by parent|0
265250|NCT02242643|878067|P1|Overall Study|Consent withdrawal by parent|1
265251|NCT02242643|878066|P2|Overall Study|Non-compliance|0
265252|NCT02242643|878067|P1|Overall Study|Non-compliance|1
265253|NCT02242643|878066|P2|Overall Study|Child placed in foster care by family|1
265254|NCT02242643|878067|P1|Overall Study|Child placed in foster care by family|0
265255|NCT02242643|878066|P2|Overall Study|Lost to Follow-up|61
265256|NCT02242643|878067|P1|Overall Study|Lost to Follow-up|54
265257|NCT02242643|878066|P2|Overall Study|Migrated/moved from study area|3
265258|NCT02242643|878067|P1|Overall Study|Migrated/moved from study area|1
265259|NCT02242643|878066|P2|Overall Study|Withdrawal by Subject|10
265260|NCT02242643|878067|P1|Overall Study|Withdrawal by Subject|15
265261|NCT02242643|878066|P2|Overall Study|Protocol Violation|2
265262|NCT02242643|878067|P1|Overall Study|Protocol Violation|1
265263|NCT02242305|878122|P2|Overall Study|Lost to Follow-up|0
265264|NCT02242305|878123|P1|Overall Study|Lost to Follow-up|2
265265|NCT02242305|878122|P2|Overall Study|Subject withdraws inform consent|4
265266|NCT02242305|878123|P1|Overall Study|Subject withdraws inform consent|0
265267|NCT02242305|878122|P2|Overall Study|Non-compliance dosing regimen or visit|2
265268|NCT02242305|878123|P1|Overall Study|Non-compliance dosing regimen or visit|2
265269|NCT02242305|878122|P2|Overall Study|Adverse Event|0
265270|NCT02242305|878123|P1|Overall Study|Adverse Event|1
265271|NCT02242305|878122|P2|Overall Study|Without spasm-like pain during 3 weeks|4
265272|NCT02242305|878123|P1|Overall Study|Without spasm-like pain during 3 weeks|1
265273|NCT02242201|878144|P3|Overall Study|preoperative opioid consumption|0
265274|NCT02242201|878145|P2|Overall Study|preoperative opioid consumption|1
265275|NCT02242201|878146|P1|Overall Study|preoperative opioid consumption|0
265276|NCT02242201|878144|P3|Overall Study|postponed surgery|1
265277|NCT02242201|878145|P2|Overall Study|postponed surgery|0
265278|NCT02242201|878146|P1|Overall Study|postponed surgery|0
265279|NCT02242201|878144|P3|Overall Study|changed surgical procedure|0
265280|NCT02242201|878145|P2|Overall Study|changed surgical procedure|0
265281|NCT02242201|878146|P1|Overall Study|changed surgical procedure|1
265282|NCT02242201|878144|P3|Overall Study|planned post-op anticoagulation|0
265283|NCT02242201|878145|P2|Overall Study|planned post-op anticoagulation|0
265284|NCT02242201|878146|P1|Overall Study|planned post-op anticoagulation|1
265285|NCT02242201|878144|P3|Overall Study|preoperative identified neuropathy|0
265286|NCT02242201|878145|P2|Overall Study|preoperative identified neuropathy|0
265287|NCT02242201|878146|P1|Overall Study|preoperative identified neuropathy|2
265288|NCT02241889|878184|P6|Overall Study|Withdrawal by Subject|1
265289|NCT02241889|878185|P5|Overall Study|Withdrawal by Subject|0
265290|NCT02241889|878186|P4|Overall Study|Withdrawal by Subject|0
265291|NCT02241889|878187|P3|Overall Study|Withdrawal by Subject|0
265292|NCT02241889|878188|P2|Overall Study|Withdrawal by Subject|0
265293|NCT02241889|878189|P1|Overall Study|Withdrawal by Subject|0
265294|NCT02241889|878184|P6|Overall Study|device issues|0
265295|NCT02241889|878185|P5|Overall Study|device issues|0
265296|NCT02241889|878186|P4|Overall Study|device issues|0
265297|NCT02241889|878187|P3|Overall Study|device issues|1
265298|NCT02241889|878188|P2|Overall Study|device issues|0
265299|NCT02241889|878189|P1|Overall Study|device issues|0
265300|NCT02241785|878224|P1|Overall Study|Adverse Event|1
265301|NCT02241785|878224|P1|Overall Study|Lost to Follow-up|2
265302|NCT02241785|878224|P1|Overall Study|Withdrawal by Subject|1
265303|NCT02241785|878224|P1|Overall Study|Sponsor Termination|43
265304|NCT02241551|878238|P2|Overall Study|Adverse Event|0
265305|NCT02241551|878239|P1|Overall Study|Adverse Event|1
265306|NCT02241187|878263|P1|Overall Study|Protocol closed due to lack of accrual.|2
265307|NCT02240628|878291|P2|Overall Study|Physician Decision|5
265308|NCT02240628|878292|P1|Overall Study|Physician Decision|6
265309|NCT02240368|878326|P3|Overall Study|Entropy failed to detect more than 50%|1
265310|NCT02240368|878327|P2|Overall Study|Entropy failed to detect more than 50%|0
265311|NCT02240368|878328|P1|Overall Study|Entropy failed to detect more than 50%|0
265312|NCT02240368|878326|P3|Overall Study|Surgery lasted less then 20 minutes|0
265313|NCT02240368|878327|P2|Overall Study|Surgery lasted less then 20 minutes|0
265314|NCT02240368|878328|P1|Overall Study|Surgery lasted less then 20 minutes|1
265315|NCT02239978|878379|P2|Overall Study|Withdrawal by Subject|0
265316|NCT02239978|878380|P1|Overall Study|Withdrawal by Subject|2
265317|NCT02239939|878397|P2|Overall Study|Lost to Follow-up|1
265318|NCT02239939|878398|P1|Overall Study|Lost to Follow-up|0
265319|NCT02239939|878397|P2|Overall Study|Withdrawal by Subject|1
265320|NCT02239939|878398|P1|Overall Study|Withdrawal by Subject|1
265321|NCT02239939|878397|P2|Overall Study|Adverse Event|0
265322|NCT02239939|878398|P1|Overall Study|Adverse Event|1
265323|NCT02239926|878414|P2|Overall Study|Withdrawal by Subject|1
265324|NCT02239926|878415|P1|Overall Study|Withdrawal by Subject|0
265325|NCT02239692|878440|P2|Overall Study|Other reason|0
265326|NCT02239692|878441|P1|Overall Study|Other reason|1
265327|NCT02239692|878440|P2|Overall Study|Withdrawal by Subject|5
265328|NCT02239692|878441|P1|Overall Study|Withdrawal by Subject|3
265329|NCT02239692|878440|P2|Overall Study|Lost to Follow-up|4
265330|NCT02239692|878441|P1|Overall Study|Lost to Follow-up|1
265331|NCT02239692|878440|P2|Overall Study|Physician Decision|1
265332|NCT02239692|878441|P1|Overall Study|Physician Decision|0
265333|NCT02239692|878440|P2|Overall Study|Adverse Event|1
265334|NCT02239692|878441|P1|Overall Study|Adverse Event|0
265335|NCT02239692|878440|P2|Overall Study|Incomplete colonoscopy|2
265336|NCT02239692|878441|P1|Overall Study|Incomplete colonoscopy|1
265337|NCT02239679|878460|P3|Overall Study|Withdrawal by Subject|1
265338|NCT02239679|878461|P2|Overall Study|Withdrawal by Subject|3
265339|NCT02239679|878462|P1|Overall Study|Withdrawal by Subject|2
265340|NCT02239679|878460|P3|Overall Study|Lost to Follow-up|0
265341|NCT02239679|878461|P2|Overall Study|Lost to Follow-up|0
265342|NCT02239679|878462|P1|Overall Study|Lost to Follow-up|1
265343|NCT02239094|878693|P1|Overall Study|Remitted before started|1
265344|NCT02239094|878693|P1|Overall Study|Withdrawal by Subject|1
265345|NCT02238483|878712|P2|Overall Study|Illness in family member|0
265346|NCT02238483|878713|P1|Overall Study|Illness in family member|1
265347|NCT02238483|878712|P2|Overall Study|Completion status not recorded|1
265348|NCT02238483|878713|P1|Overall Study|Completion status not recorded|1
265349|NCT02238483|878712|P2|Overall Study|Withdrawn due to physician decision|0
265350|NCT02238483|878713|P1|Overall Study|Withdrawn due to physician decision|1
265351|NCT02238483|878712|P2|Overall Study|Adverse Event|3
265352|NCT02238483|878713|P1|Overall Study|Adverse Event|7
265353|NCT02238483|878712|P2|Overall Study|Death|0
265354|NCT02238483|878713|P1|Overall Study|Death|1
265355|NCT02238483|878712|P2|Overall Study|Protocol Violation|2
265356|NCT02238483|878713|P1|Overall Study|Protocol Violation|1
265357|NCT02238483|878712|P2|Overall Study|Lost to Follow-up|1
265358|NCT02238483|878713|P1|Overall Study|Lost to Follow-up|1
265359|NCT02238483|878712|P2|Overall Study|Withdrawal by Subject|7
265360|NCT02238483|878713|P1|Overall Study|Withdrawal by Subject|2
265361|NCT02238379|878751|P2|Overall Study|Lost to Follow-up|0
265362|NCT02238379|878752|P1|Overall Study|Lost to Follow-up|1
265363|NCT02238080|878778|P1|Overall Study|Other|4
265364|NCT02238080|878778|P1|Overall Study|Withdrawal by Subject|2
265365|NCT02238080|878778|P1|Overall Study|Treatment interrupted|6
265366|NCT02238080|878778|P1|Overall Study|Death|13
265367|NCT02238067|878792|P1|Overall Study|Not completed survey at Month 6|45
265368|NCT02237118|878837|P2|Overall Study|consent withdrawn|0
265369|NCT02237118|878838|P1|Overall Study|consent withdrawn|1
265370|NCT02237118|878837|P2|Overall Study|Protocol Violation|1
265371|NCT02237118|878838|P1|Overall Study|Protocol Violation|0
265372|NCT02236611|878875|P2|Overall Study|Withdrew consent|4
265373|NCT02236611|878876|P1|Overall Study|Withdrew consent|9
265374|NCT02236611|878875|P2|Overall Study|Protocol deviation|5
265375|NCT02236611|878876|P1|Overall Study|Protocol deviation|3
265376|NCT02236611|878875|P2|Overall Study|Lost to Follow-up|2
265377|NCT02236611|878876|P1|Overall Study|Lost to Follow-up|0
265378|NCT02236611|878875|P2|Overall Study|Lack of Efficacy|7
265379|NCT02236611|878876|P1|Overall Study|Lack of Efficacy|4
265380|NCT02236611|878875|P2|Overall Study|Adverse Event|16
265381|NCT02236611|878876|P1|Overall Study|Adverse Event|10
265382|NCT02236598|878884|P2|Overall Study|Withdrawal by Subject|1
265383|NCT02236598|878885|P1|Overall Study|Withdrawal by Subject|0
265384|NCT02236598|878884|P2|Overall Study|Adverse Event|1
265385|NCT02236598|878885|P1|Overall Study|Adverse Event|0
265386|NCT02236130|878921|P2|Overall Study|Lost to Follow-up|12
265387|NCT02236130|878922|P1|Overall Study|Lost to Follow-up|7
265388|NCT02235454|878972|P1|Overall Study|Withdrawal by Subject|2
265389|NCT02235311|878978|P2|Overall Study|Protocol Violation|1
265390|NCT02235311|878979|P1|Overall Study|Protocol Violation|0
265391|NCT02235311|878978|P2|Overall Study|Lost to Follow-up|1
265392|NCT02235311|878979|P1|Overall Study|Lost to Follow-up|0
265393|NCT02235077|878997|P2|Overall Study|Physician Decision|1
265394|NCT02235077|878998|P1|Overall Study|Physician Decision|0
265395|NCT02235077|878997|P2|Overall Study|Withdrawal by Subject|5
265396|NCT02235077|878998|P1|Overall Study|Withdrawal by Subject|8
265397|NCT02235077|878997|P2|Overall Study|Lost to Follow-up|6
265398|NCT02235077|878998|P1|Overall Study|Lost to Follow-up|5
265399|NCT02235077|878997|P2|Overall Study|Death|7
265400|NCT02235077|878998|P1|Overall Study|Death|5
265401|NCT02234479|879066|P2|Overall Study|Withdrawal by Subject|3
265402|NCT02234479|879067|P1|Overall Study|Withdrawal by Subject|1
265403|NCT02234362|879077|P1|Overall Study|Withdrawal by Subject|3
265404|NCT02234362|879077|P1|Overall Study|Lost to Follow-up|6
265405|NCT02234362|879077|P1|Overall Study|Not eligible after first screening visit|17
265406|NCT02233803|879158|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
265407|NCT02233803|879159|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
265408|NCT02233803|879158|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
265409|NCT02233803|879159|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
265410|NCT02233803|879158|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
265411|NCT02233803|879159|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
265412|NCT02233803|879158|P2|Washout Period (4-Wks)|Physician Decision|0
265413|NCT02233803|879159|P1|Washout Period (4-Wks)|Physician Decision|1
265414|NCT02233803|879158|P2|Washout Period (4-Wks)|Lost to Follow-up|1
265415|NCT02233803|879159|P1|Washout Period (4-Wks)|Lost to Follow-up|0
265416|NCT02233803|879158|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
265417|NCT02233803|879159|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
265418|NCT02233803|879158|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
265419|NCT02233803|879159|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
265420|NCT02233803|879158|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
265421|NCT02233803|879159|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
265422|NCT02233803|879158|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
265423|NCT02233803|879159|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
265424|NCT02233647|879169|P1|Overall Study|Adverse Event|1
265425|NCT02233309|879198|P1|Overall Study|Physician Decision|5
265426|NCT02232880|879232|P1|Overall Study|study stopped prior to randomization|1
265427|NCT02232698|879241|P2|Overall Study|Withdrawal by Subject|11
265428|NCT02232698|879242|P1|Overall Study|Withdrawal by Subject|0
265429|NCT02232698|879241|P2|Overall Study|Allocated to control group|3
265430|NCT02232698|879242|P1|Overall Study|Allocated to control group|0
265431|NCT02232698|879241|P2|Overall Study|Non-compliance with study device|4
265432|NCT02232698|879242|P1|Overall Study|Non-compliance with study device|1
265433|NCT02232698|879241|P2|Overall Study|Had device-associated symptoms|0
265434|NCT02232698|879242|P1|Overall Study|Had device-associated symptoms|7
265435|NCT02232698|879241|P2|Overall Study|Met exclusion criteria|1
265436|NCT02232698|879242|P1|Overall Study|Met exclusion criteria|1
265437|NCT02232698|879241|P2|Overall Study|Pregnancy|1
265438|NCT02232698|879242|P1|Overall Study|Pregnancy|1
265439|NCT02231918|879277|P3|Overall Study|Adverse Event|1
265440|NCT02231918|879278|P2|Overall Study|Adverse Event|0
265441|NCT02231918|879279|P1|Overall Study|Adverse Event|0
265442|NCT02231918|879277|P3|Overall Study|Withdrawal by Subject|0
265443|NCT02231918|879278|P2|Overall Study|Withdrawal by Subject|1
265444|NCT02231918|879279|P1|Overall Study|Withdrawal by Subject|0
265445|NCT02231580|879343|P2|Overall Study|Adverse Event|0
265446|NCT02231580|879344|P1|Overall Study|Adverse Event|5
265447|NCT02231164|879461|P2|Overall Study|Withdrawal by Subject|2
265448|NCT02231164|879462|P1|Overall Study|Withdrawal by Subject|1
265449|NCT02231164|879461|P2|Overall Study|Lack of Efficacy|3
265450|NCT02231164|879462|P1|Overall Study|Lack of Efficacy|4
265451|NCT02231164|879461|P2|Overall Study|Adverse Event|1
265452|NCT02231164|879462|P1|Overall Study|Adverse Event|1
265453|NCT02230956|879490|P3|Overall Study|Other Miscellaneous Reason|2
265454|NCT02230956|879491|P2|Overall Study|Other Miscellaneous Reason|1
265455|NCT02230956|879492|P1|Overall Study|Other Miscellaneous Reason|0
265456|NCT02230956|879490|P3|Overall Study|Protocol Violation|1
265457|NCT02230956|879491|P2|Overall Study|Protocol Violation|1
265458|NCT02230956|879492|P1|Overall Study|Protocol Violation|0
265459|NCT02230956|879490|P3|Overall Study|Personal Reasons|1
265460|NCT02230956|879491|P2|Overall Study|Personal Reasons|1
265461|NCT02230956|879492|P1|Overall Study|Personal Reasons|2
265462|NCT02230956|879490|P3|Overall Study|Lost to Follow-up|2
265463|NCT02230956|879491|P2|Overall Study|Lost to Follow-up|1
265464|NCT02230956|879492|P1|Overall Study|Lost to Follow-up|1
265465|NCT02230956|879490|P3|Overall Study|Lack of Efficacy|1
265466|NCT02230956|879491|P2|Overall Study|Lack of Efficacy|1
265467|NCT02230956|879492|P1|Overall Study|Lack of Efficacy|1
265468|NCT02230956|879490|P3|Overall Study|Adverse Event|0
265469|NCT02230956|879491|P2|Overall Study|Adverse Event|1
265470|NCT02230956|879492|P1|Overall Study|Adverse Event|1
265471|NCT02230904|879514|P2|Overall Study|Safety follow up could not take place|1
265552|NCT02229396|879836|P1|Overall Study|Death|1
265472|NCT02230904|879515|P1|Overall Study|Safety follow up could not take place|0
265473|NCT02230683|879548|P1|Overall Study|Adverse Event|1
265474|NCT02230670|879565|P2|Overall Study|Progression to Child-Pugh C|2
265475|NCT02230670|879566|P1|Overall Study|Progression to Child-Pugh C|1
265476|NCT02230670|879565|P2|Overall Study|Protocol Violation|1
265477|NCT02230670|879566|P1|Overall Study|Protocol Violation|0
265478|NCT02230670|879565|P2|Overall Study|Physician Decision|1
265479|NCT02230670|879566|P1|Overall Study|Physician Decision|0
265480|NCT02230670|879565|P2|Overall Study|Withdrawal by Subject|2
265481|NCT02230670|879566|P1|Overall Study|Withdrawal by Subject|2
265482|NCT02230670|879565|P2|Overall Study|Adverse Event|2
265483|NCT02230670|879566|P1|Overall Study|Adverse Event|1
265484|NCT02230384|879605|P2|Phase 2 - Switch|Adverse Event|0
265485|NCT02230384|879606|P1|Phase 2 - Switch|Adverse Event|2
265486|NCT02230384|879605|P2|Phase 2 - Switch|Lost to Follow-up|0
265487|NCT02230384|879606|P1|Phase 2 - Switch|Lost to Follow-up|1
265488|NCT02230384|879605|P2|Phase 2 - Switch|Withdrawal by Subject|1
265489|NCT02230384|879606|P1|Phase 2 - Switch|Withdrawal by Subject|0
265490|NCT02230384|879605|P2|Phase 1|Physician Decision|1
265491|NCT02230384|879606|P1|Phase 1|Physician Decision|0
265492|NCT02230384|879605|P2|Phase 1|Lost to Follow-up|0
265493|NCT02230384|879606|P1|Phase 1|Lost to Follow-up|1
265494|NCT02230332|879614|P2|Overall Study|Protocol Violation|0
265495|NCT02230332|879615|P1|Overall Study|Protocol Violation|1
265496|NCT02230332|879614|P2|Overall Study|Lost to Follow-up|0
265497|NCT02230332|879615|P1|Overall Study|Lost to Follow-up|1
265498|NCT02230332|879614|P2|Overall Study|Adverse Event|1
265499|NCT02230332|879615|P1|Overall Study|Adverse Event|2
265500|NCT02230306|879631|P1|Overall Study|Did not receive study treatment|1
265501|NCT02230085|879642|P1|Overall Study|Withdrawal by Subject|3
265502|NCT02230085|879642|P1|Overall Study|Physician Decision|1
265503|NCT02229864|879646|P1|3 - Year Visit|Death|2
265504|NCT02229864|879646|P1|2 - Year Visit|Missed Visits|1
265505|NCT02229539|879701|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
265506|NCT02229539|879702|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
265507|NCT02229539|879703|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
265508|NCT02229539|879701|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
265509|NCT02229539|879702|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
265510|NCT02229539|879703|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
265511|NCT02229539|879701|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
265512|NCT02229539|879702|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
265513|NCT02229539|879703|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
265514|NCT02229539|879701|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
265515|NCT02229539|879702|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
265516|NCT02229539|879703|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
265517|NCT02229539|879701|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
265518|NCT02229539|879702|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
265519|NCT02229539|879703|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
265520|NCT02229539|879701|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
265521|NCT02229539|879702|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
265522|NCT02229539|879703|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
265523|NCT02229539|879701|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
265524|NCT02229539|879702|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
265525|NCT02229539|879703|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
265526|NCT02229539|879701|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
265527|NCT02229539|879702|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
265528|NCT02229539|879703|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
265529|NCT02229539|879701|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
265530|NCT02229539|879702|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
265531|NCT02229539|879703|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
265532|NCT02229396|879834|P3|Overall Study|Other Eligibility criteria|0
265533|NCT02229396|879835|P2|Overall Study|Other Eligibility criteria|2
265534|NCT02229396|879836|P1|Overall Study|Other Eligibility criteria|0
265535|NCT02229396|879834|P3|Overall Study|Withdrawal by Subject|16
265536|NCT02229396|879835|P2|Overall Study|Withdrawal by Subject|9
265537|NCT02229396|879836|P1|Overall Study|Withdrawal by Subject|15
265538|NCT02229396|879834|P3|Overall Study|Withdrew; no record on termination page|4
265539|NCT02229396|879835|P2|Overall Study|Withdrew; no record on termination page|5
265540|NCT02229396|879836|P1|Overall Study|Withdrew; no record on termination page|2
265541|NCT02229396|879834|P3|Overall Study|Patient was incorrectly randomized|1
265542|NCT02229396|879835|P2|Overall Study|Patient was incorrectly randomized|0
265543|NCT02229396|879836|P1|Overall Study|Patient was incorrectly randomized|0
265544|NCT02229396|879834|P3|Overall Study|Protocol deviation; compliance|0
265545|NCT02229396|879835|P2|Overall Study|Protocol deviation; compliance|0
265546|NCT02229396|879836|P1|Overall Study|Protocol deviation; compliance|1
265547|NCT02229396|879834|P3|Overall Study|Lost to Follow-up|11
265548|NCT02229396|879835|P2|Overall Study|Lost to Follow-up|5
265549|NCT02229396|879836|P1|Overall Study|Lost to Follow-up|4
265550|NCT02229396|879834|P3|Overall Study|Death|1
265551|NCT02229396|879835|P2|Overall Study|Death|3
265553|NCT02229396|879834|P3|Overall Study|Adverse Event|5
265554|NCT02229396|879835|P2|Overall Study|Adverse Event|5
265555|NCT02229396|879836|P1|Overall Study|Adverse Event|2
265556|NCT02229383|879867|P2|Overall Study|Randomized in error|0
265557|NCT02229383|879868|P1|Overall Study|Randomized in error|1
265558|NCT02229383|879867|P2|Overall Study|Investigator decision|4
265559|NCT02229383|879868|P1|Overall Study|Investigator decision|1
265560|NCT02229383|879867|P2|Overall Study|Death|1
265561|NCT02229383|879868|P1|Overall Study|Death|0
265562|NCT02229383|879867|P2|Overall Study|Fire at the study center|4
265563|NCT02229383|879868|P1|Overall Study|Fire at the study center|2
265564|NCT02229383|879867|P2|Overall Study|Withdrawal by Subject|9
265565|NCT02229383|879868|P1|Overall Study|Withdrawal by Subject|5
265566|NCT02229383|879867|P2|Overall Study|Lost to Follow-up|2
265567|NCT02229383|879868|P1|Overall Study|Lost to Follow-up|4
265568|NCT02229383|879867|P2|Overall Study|Adverse Event|4
265569|NCT02229383|879868|P1|Overall Study|Adverse Event|9
265588|NCT02229214|879979|P2|Overall Study|Withdrawal by Subject|0
265589|NCT02229214|879980|P1|Overall Study|Withdrawal by Subject|4
265590|NCT02229214|879979|P2|Overall Study|Adverse Event|0
265591|NCT02229214|879980|P1|Overall Study|Adverse Event|2
265592|NCT02228980|880004|P4|Overall Study|Withdrawal by Subject|3
265593|NCT02228980|880005|P3|Overall Study|Withdrawal by Subject|2
265594|NCT02228980|880006|P2|Overall Study|Withdrawal by Subject|3
265595|NCT02228980|880007|P1|Overall Study|Withdrawal by Subject|3
265596|NCT02228980|880004|P4|Overall Study|Protocol Violation|0
265597|NCT02228980|880005|P3|Overall Study|Protocol Violation|0
265598|NCT02228980|880006|P2|Overall Study|Protocol Violation|0
265599|NCT02228980|880007|P1|Overall Study|Protocol Violation|7
265600|NCT02228980|880004|P4|Overall Study|Adverse Event|0
265601|NCT02228980|880005|P3|Overall Study|Adverse Event|0
265602|NCT02228980|880006|P2|Overall Study|Adverse Event|0
265603|NCT02228980|880007|P1|Overall Study|Adverse Event|14
265604|NCT02228720|880029|P1|Open Label - Day 30|Lost to Follow-up|1
265605|NCT02228395|880037|P3|First Intervention Period|Unable to comply with study dates|1
265606|NCT02228395|880038|P2|First Intervention Period|Unable to comply with study dates|1
265607|NCT02228395|880039|P1|First Intervention Period|Unable to comply with study dates|0
265608|NCT02228395|880037|P3|First Intervention Period|No longer willing to participate|0
265609|NCT02228395|880038|P2|First Intervention Period|No longer willing to participate|0
265610|NCT02228395|880039|P1|First Intervention Period|No longer willing to participate|1
265611|NCT02227784|880122|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
265612|NCT02227784|880123|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
265613|NCT02227784|880124|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
265614|NCT02227784|880125|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
265615|NCT02227784|880126|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
265616|NCT02227784|880122|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
265617|NCT02227784|880123|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
265618|NCT02227784|880124|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
265619|NCT02227784|880125|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
265620|NCT02227784|880126|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
265621|NCT02227784|880122|P5|Open-Label Extension Phase (OLE)|Death|1
265622|NCT02227784|880123|P4|Open-Label Extension Phase (OLE)|Death|0
265623|NCT02227784|880124|P3|Open-Label Extension Phase (OLE)|Death|0
265624|NCT02227784|880125|P2|Open-Label Extension Phase (OLE)|Death|0
265625|NCT02227784|880126|P1|Open-Label Extension Phase (OLE)|Death|0
265626|NCT02227784|880122|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
265627|NCT02227784|880123|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
265628|NCT02227784|880124|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
265629|NCT02227784|880125|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
265630|NCT02227784|880126|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
265631|NCT02227784|880122|P5|Double-Blind Phase|Withdrawal by Subject|0
265632|NCT02227784|880123|P4|Double-Blind Phase|Withdrawal by Subject|2
265633|NCT02227784|880124|P3|Double-Blind Phase|Withdrawal by Subject|5
265634|NCT02227784|880125|P2|Double-Blind Phase|Withdrawal by Subject|1
265635|NCT02227784|880126|P1|Double-Blind Phase|Withdrawal by Subject|2
265636|NCT02227784|880122|P5|Double-Blind Phase|Sponsor Decision|0
265637|NCT02227784|880123|P4|Double-Blind Phase|Sponsor Decision|32
265638|NCT02227784|880124|P3|Double-Blind Phase|Sponsor Decision|14
265639|NCT02227784|880125|P2|Double-Blind Phase|Sponsor Decision|15
265640|NCT02227784|880126|P1|Double-Blind Phase|Sponsor Decision|34
265641|NCT02227784|880122|P5|Double-Blind Phase|Protocol Violation|0
265642|NCT02227784|880123|P4|Double-Blind Phase|Protocol Violation|1
265643|NCT02227784|880124|P3|Double-Blind Phase|Protocol Violation|1
265644|NCT02227784|880125|P2|Double-Blind Phase|Protocol Violation|0
265645|NCT02227784|880126|P1|Double-Blind Phase|Protocol Violation|0
265646|NCT02227784|880122|P5|Double-Blind Phase|Physician Decision|0
265647|NCT02227784|880123|P4|Double-Blind Phase|Physician Decision|1
265648|NCT02227784|880124|P3|Double-Blind Phase|Physician Decision|0
265649|NCT02227784|880125|P2|Double-Blind Phase|Physician Decision|0
265650|NCT02227784|880126|P1|Double-Blind Phase|Physician Decision|1
265651|NCT02227784|880122|P5|Double-Blind Phase|Adverse Event|0
265652|NCT02227784|880123|P4|Double-Blind Phase|Adverse Event|3
265653|NCT02227784|880124|P3|Double-Blind Phase|Adverse Event|1
265654|NCT02227784|880125|P2|Double-Blind Phase|Adverse Event|2
265655|NCT02227784|880126|P1|Double-Blind Phase|Adverse Event|3
265656|NCT02227368|880182|P2|Overall Study|Adverse Event|0
265657|NCT02227368|880183|P1|Overall Study|Adverse Event|1
265658|NCT02227368|880182|P2|Overall Study|Lost to Follow-up|0
265659|NCT02227368|880183|P1|Overall Study|Lost to Follow-up|1
265660|NCT02227368|880182|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
265661|NCT02227368|880183|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
265662|NCT02227108|880241|P1|Overall Study|Adverse Event|6
265663|NCT02227108|880241|P1|Overall Study|Investigator discretion|1
265664|NCT02227108|880241|P1|Overall Study|Initiation of alternative therapy|2
265665|NCT02227108|880241|P1|Overall Study|Progressive disease|17
265666|NCT02227108|880241|P1|Overall Study|Other|3
265667|NCT02227108|880241|P1|Overall Study|Did not receive treatment|2
265668|NCT02226562|880270|P2|Overall Study|Lost to Follow-up|1
265669|NCT02226562|880271|P1|Overall Study|Lost to Follow-up|0
265670|NCT02226549|880289|P2|Overall Study|Lost to Follow-up|1
265671|NCT02226549|880290|P1|Overall Study|Lost to Follow-up|0
265672|NCT02226549|880289|P2|Overall Study|Randomized but Never Treated|0
265673|NCT02226549|880290|P1|Overall Study|Randomized but Never Treated|1
265674|NCT02226198|880300|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
265675|NCT02226198|880301|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
265676|NCT02226198|880302|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
265677|NCT02226198|880300|P3|Lead-in Phase|Protocol Violation|0
265678|NCT02226198|880301|P2|Lead-in Phase|Protocol Violation|0
265679|NCT02226198|880302|P1|Lead-in Phase|Protocol Violation|1
265680|NCT02226172|880375|P1|Overall Study|Ongoing in study|3
265681|NCT02226172|880375|P1|Overall Study|Death|1
265682|NCT02226172|880375|P1|Overall Study|Other|4
265683|NCT02226172|880375|P1|Overall Study|Subject refused further follow-up|5
265684|NCT02226003|880397|P3|Overall Study|Withdrawal by Subject|3
265685|NCT02226003|880398|P2|Overall Study|Withdrawal by Subject|0
265686|NCT02226003|880399|P1|Overall Study|Withdrawal by Subject|0
265687|NCT02226003|880397|P3|Overall Study|Lost to Follow-up|3
265688|NCT02226003|880398|P2|Overall Study|Lost to Follow-up|1
265689|NCT02226003|880399|P1|Overall Study|Lost to Follow-up|2
265690|NCT02224846|880446|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
265691|NCT02224846|880447|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
265692|NCT02224846|880446|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
265693|NCT02224846|880447|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
265694|NCT02224846|880446|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
265695|NCT02224846|880447|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
265696|NCT02224846|880446|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
265697|NCT02224846|880447|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
265698|NCT02224846|880446|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
265699|NCT02224846|880447|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
265700|NCT02224846|880446|P2|Period 2 (Month 12 to Month 24)|Death|0
265701|NCT02224846|880447|P1|Period 2 (Month 12 to Month 24)|Death|1
265702|NCT02224846|880446|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
265703|NCT02224846|880447|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
265704|NCT02224846|880446|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
265705|NCT02224846|880447|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
265706|NCT02224846|880446|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
265707|NCT02224846|880447|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
265708|NCT02224846|880446|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
265709|NCT02224846|880447|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
265710|NCT02224846|880446|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
265711|NCT02224846|880447|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
265712|NCT02224846|880446|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
265713|NCT02224846|880447|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
265714|NCT02224846|880446|P2|Period 1 (Month 3)|Sponsor Decision|1
265715|NCT02224846|880447|P1|Period 1 (Month 3)|Sponsor Decision|2
265716|NCT02224846|880446|P2|Period 1 (Month 3)|Withdrawal by Subject|18
265717|NCT02224846|880447|P1|Period 1 (Month 3)|Withdrawal by Subject|8
265718|NCT02224846|880446|P2|Period 1 (Month 3)|Protocol Violation|8
265719|NCT02224846|880447|P1|Period 1 (Month 3)|Protocol Violation|4
265720|NCT02224846|880446|P2|Period 1 (Month 3)|Lost to Follow-up|8
265721|NCT02224846|880447|P1|Period 1 (Month 3)|Lost to Follow-up|3
265722|NCT02224846|880446|P2|Period 1 (Month 3)|Adverse Event|1
265723|NCT02224846|880447|P1|Period 1 (Month 3)|Adverse Event|2
265724|NCT02224664|880483|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
265725|NCT02224664|880484|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
265726|NCT02224664|880485|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
265727|NCT02224664|880486|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
265728|NCT02224664|880487|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
265729|NCT02224664|880483|P5|Dose Escalation Period (21 Days)|Adverse Event|7
265730|NCT02224664|880484|P4|Dose Escalation Period (21 Days)|Adverse Event|2
265731|NCT02224664|880485|P3|Dose Escalation Period (21 Days)|Adverse Event|2
265732|NCT02224664|880486|P2|Dose Escalation Period (21 Days)|Adverse Event|0
265733|NCT02224664|880487|P1|Dose Escalation Period (21 Days)|Adverse Event|0
265734|NCT02224664|880483|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
265735|NCT02224664|880484|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
265736|NCT02224664|880485|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
265737|NCT02224664|880486|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
265738|NCT02224664|880487|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
265739|NCT02224625|880567|P1|Sensitization|Adverse Event|55
265740|NCT02224625|880567|P1|Irritation|Adverse Event|6
265741|NCT02224053|880597|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
265742|NCT02224053|880597|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
265743|NCT02224053|880597|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
265744|NCT02224053|880597|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
265745|NCT02224053|880597|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
265746|NCT02223754|880643|P2|Period 2|Test Article No Longer Available|1
265747|NCT02223754|880644|P1|Period 2|Test Article No Longer Available|0
265748|NCT02223754|880643|P2|Period 2|Lost to Follow-up|0
265749|NCT02223754|880644|P1|Period 2|Lost to Follow-up|1
265750|NCT02223754|880643|P2|Period 2|Lens Discomfort|1
265751|NCT02223754|880644|P1|Period 2|Lens Discomfort|1
265752|NCT02223754|880643|P2|Period 2|Protocol Violation|0
265753|NCT02223754|880644|P1|Period 2|Protocol Violation|1
265754|NCT02223754|880643|P2|Period 2|Adverse Event|1
265755|NCT02223754|880644|P1|Period 2|Adverse Event|0
265756|NCT02223754|880643|P2|Period 1|Unsatisfactory Visual Response|1
265757|NCT02223754|880644|P1|Period 1|Unsatisfactory Visual Response|0
265758|NCT02223754|880643|P2|Period 1|Test Article No Longer Available|5
265759|NCT02223754|880644|P1|Period 1|Test Article No Longer Available|1
265760|NCT02223754|880643|P2|Period 1|Withdrawal by Subject|4
265761|NCT02223754|880644|P1|Period 1|Withdrawal by Subject|0
265762|NCT02223754|880643|P2|Period 1|Protocol Violation|4
265763|NCT02223754|880644|P1|Period 1|Protocol Violation|2
265764|NCT02223754|880643|P2|Period 1|Lost to Follow-up|1
265765|NCT02223754|880644|P1|Period 1|Lost to Follow-up|0
265766|NCT02223754|880643|P2|Period 1|Adverse Event|0
265767|NCT02223754|880644|P1|Period 1|Adverse Event|1
265768|NCT02223715|880664|P1|Overall Study|Lost to Follow-up|73
265769|NCT02223715|880664|P1|Overall Study|Death|31
265770|NCT02223364|880742|P3|Overall Study|Physician Decision|0
265771|NCT02223364|880743|P2|Overall Study|Physician Decision|0
265772|NCT02223364|880744|P1|Overall Study|Physician Decision|1
265773|NCT02223364|880742|P3|Overall Study|subject expired before surgery|0
265774|NCT02223364|880743|P2|Overall Study|subject expired before surgery|0
265775|NCT02223364|880744|P1|Overall Study|subject expired before surgery|1
265776|NCT02223364|880742|P3|Overall Study|Protocol Violation|3
265777|NCT02223364|880743|P2|Overall Study|Protocol Violation|0
265778|NCT02223364|880744|P1|Overall Study|Protocol Violation|3
265779|NCT02222818|880859|P2|Period 1|Eligibility criteria not met|3
265780|NCT02222818|880860|P1|Period 1|Eligibility criteria not met|0
265781|NCT02222558|880867|P6|Period 3|Withdrawal by Subject|1
265782|NCT02222558|880868|P5|Period 3|Withdrawal by Subject|0
265783|NCT02222558|880869|P4|Period 3|Withdrawal by Subject|0
265784|NCT02222558|880870|P3|Period 3|Withdrawal by Subject|0
265785|NCT02222558|880871|P2|Period 3|Withdrawal by Subject|0
265786|NCT02222558|880872|P1|Period 3|Withdrawal by Subject|0
265787|NCT02222558|880867|P6|Period 1: Single Dose|Withdrawal by Subject|0
265788|NCT02222558|880868|P5|Period 1: Single Dose|Withdrawal by Subject|0
265789|NCT02222558|880869|P4|Period 1: Single Dose|Withdrawal by Subject|0
265790|NCT02222558|880870|P3|Period 1: Single Dose|Withdrawal by Subject|0
265791|NCT02222558|880871|P2|Period 1: Single Dose|Withdrawal by Subject|0
265792|NCT02222558|880872|P1|Period 1: Single Dose|Withdrawal by Subject|4
265793|NCT02222493|880888|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
265794|NCT02222493|880889|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
265795|NCT02222493|880888|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
265796|NCT02222493|880889|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
265797|NCT02222493|880888|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
265798|NCT02222493|880889|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
265799|NCT02222493|880888|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
265800|NCT02222493|880889|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
265801|NCT02222493|880888|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
265802|NCT02222493|880889|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
265803|NCT02222493|880888|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
265804|NCT02222493|880889|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
265805|NCT02222493|880888|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
265806|NCT02222493|880889|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
265807|NCT02222493|880888|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
265808|NCT02222493|880889|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
265809|NCT02222493|880888|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
265810|NCT02222493|880889|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
265811|NCT02222493|880888|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
265812|NCT02222493|880889|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
265813|NCT02222493|880888|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
265814|NCT02222493|880889|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
265815|NCT02222493|880888|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
265816|NCT02222493|880889|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
265817|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
265818|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
265819|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
265820|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
265821|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
265822|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
265823|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
265824|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
265825|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
265826|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
265827|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
265828|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
265829|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
265830|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
265831|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
265832|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
265833|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
265834|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
265835|NCT02222493|880888|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
265836|NCT02222493|880889|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
265837|NCT02222246|881007|P2|Overall Study|Physician Decision|1
265838|NCT02222246|881008|P1|Overall Study|Physician Decision|0
265839|NCT02222246|881007|P2|Overall Study|No Emergency Department Visits|26
265840|NCT02222246|881008|P1|Overall Study|No Emergency Department Visits|27
265841|NCT02222207|881036|P1|Overall Study|Adverse Event|1
265842|NCT02222207|881036|P1|Overall Study|Other reasons|2
265843|NCT02222207|881036|P1|Overall Study|Death|1
265844|NCT02221674|881080|P3|Overall Study|Lost to Follow-up|0
265845|NCT02221674|881081|P2|Overall Study|Lost to Follow-up|0
265846|NCT02221674|881082|P1|Overall Study|Lost to Follow-up|1
265847|NCT02221648|881098|P2|Overall Study|Withdrawal by Subject|3
265848|NCT02221648|881099|P1|Overall Study|Withdrawal by Subject|3
265849|NCT02220998|881115|P2|Overall Study|Lost to Follow-up|4
265850|NCT02220998|881116|P1|Overall Study|Lost to Follow-up|4
265851|NCT02220998|881115|P2|Overall Study|Lack of Efficacy|5
265852|NCT02220998|881116|P1|Overall Study|Lack of Efficacy|0
265853|NCT02220998|881115|P2|Overall Study|Death|0
265854|NCT02220998|881116|P1|Overall Study|Death|2
265855|NCT02220998|881115|P2|Overall Study|Randomized but Never Treated|2
265856|NCT02220998|881116|P1|Overall Study|Randomized but Never Treated|1
265857|NCT02220920|881134|P2|Overall Study|Conflict with the stopping criteria|2
265858|NCT02220920|881135|P1|Overall Study|Conflict with the stopping criteria|1
265859|NCT02220920|881134|P2|Overall Study|Withdrawal by Subject|0
265860|NCT02220920|881135|P1|Overall Study|Withdrawal by Subject|1
265861|NCT02220920|881134|P2|Overall Study|Lack of Efficacy|1
265862|NCT02220920|881135|P1|Overall Study|Lack of Efficacy|0
265863|NCT02220920|881134|P2|Overall Study|Adverse Event|0
265864|NCT02220920|881135|P1|Overall Study|Adverse Event|1
265865|NCT02220764|881151|P2|Overall Study|Death|0
265866|NCT02220764|881152|P1|Overall Study|Death|1
265867|NCT02220764|881151|P2|Overall Study|Lost to Follow-up|1
265868|NCT02220764|881152|P1|Overall Study|Lost to Follow-up|3
265869|NCT02220205|881164|P2|Overall Study|Withdrawal by Subject|0
265870|NCT02220205|881165|P1|Overall Study|Withdrawal by Subject|1
265871|NCT02219932|881190|P2|Overall Study|Adverse Event|21
265872|NCT02219932|881191|P1|Overall Study|Adverse Event|23
265873|NCT02219932|881190|P2|Overall Study|Lost to Follow-up|2
265874|NCT02219932|881191|P1|Overall Study|Lost to Follow-up|4
265875|NCT02219932|881190|P2|Overall Study|Pregnancy|0
265876|NCT02219932|881191|P1|Overall Study|Pregnancy|1
265877|NCT02219932|881190|P2|Overall Study|Protocol Violation|6
265878|NCT02219932|881191|P1|Overall Study|Protocol Violation|10
265879|NCT02219932|881190|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
265880|NCT02219932|881191|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
265881|NCT02219932|881190|P2|Overall Study|Consent Withdrawn|7
265882|NCT02219932|881191|P1|Overall Study|Consent Withdrawn|11
265883|NCT02219932|881190|P2|Overall Study|Investigator Decision|1
265884|NCT02219932|881191|P1|Overall Study|Investigator Decision|0
265885|NCT02219932|881190|P2|Overall Study|Death|1
265886|NCT02219932|881191|P1|Overall Study|Death|1
265887|NCT02219932|881190|P2|Overall Study|Not Specified|11
265888|NCT02219932|881191|P1|Overall Study|Not Specified|5
265889|NCT02219685|881207|P2|Blinded Treatment Phase|Withdrew Consent|0
265890|NCT02219685|881208|P1|Blinded Treatment Phase|Withdrew Consent|1
265891|NCT02219685|881207|P2|Blinded Treatment Phase|Lost to Follow-up|0
265892|NCT02219685|881208|P1|Blinded Treatment Phase|Lost to Follow-up|1
265893|NCT02219477|881314|P3|Overall Study|Withdrawal by Subject|0
265894|NCT02219477|881315|P2|Overall Study|Withdrawal by Subject|1
265895|NCT02219477|881316|P1|Overall Study|Withdrawal by Subject|0
265896|NCT02219477|881314|P3|Overall Study|Adverse Event|1
265897|NCT02219477|881315|P2|Overall Study|Adverse Event|1
265898|NCT02219477|881316|P1|Overall Study|Adverse Event|0
265899|NCT02219464|881344|P2|Overall Study|catheter malfunction|0
265900|NCT02219464|881345|P1|Overall Study|catheter malfunction|1
265901|NCT02219464|881344|P2|Overall Study|case cancelled|0
265902|NCT02219464|881345|P1|Overall Study|case cancelled|1
265903|NCT02219464|881344|P2|Overall Study|Withdrawal by Subject|0
265904|NCT02219464|881345|P1|Overall Study|Withdrawal by Subject|1
265905|NCT02219087|881505|P2|Overall Study|Randomization envelope pulled out of seq|1
265906|NCT02219087|881506|P1|Overall Study|Randomization envelope pulled out of seq|0
265907|NCT02218697|881526|P2|Overall Study|Withdrawal by Subject|3
265908|NCT02218697|881527|P1|Overall Study|Withdrawal by Subject|2
265909|NCT02218697|881526|P2|Overall Study|Unwilling to be vaccinated in left arm|1
265910|NCT02218697|881527|P1|Overall Study|Unwilling to be vaccinated in left arm|0
265911|NCT02218697|881526|P2|Overall Study|Adverse Event|2
265912|NCT02218697|881527|P1|Overall Study|Adverse Event|0
265913|NCT02218268|881576|P2|24 Hour Washout|Physician Decision|9
265914|NCT02218268|881577|P1|24 Hour Washout|Physician Decision|11
265915|NCT02218216|881585|P3|Overall Study|Study terminated before completed|0
265916|NCT02218216|881586|P2|Overall Study|Study terminated before completed|0
265917|NCT02218216|881587|P1|Overall Study|Study terminated before completed|6
265918|NCT02217982|881619|P2|Overall Study|Adverse Event|1
265919|NCT02217982|881620|P1|Overall Study|Adverse Event|0
265920|NCT02217982|881619|P2|Overall Study|Trial discontinued|0
265921|NCT02217982|881620|P1|Overall Study|Trial discontinued|1
265922|NCT02217878|881630|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
265923|NCT02217878|881631|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
265924|NCT02217878|881630|P2|Overall Study|required morphine due to chest pain|2
265925|NCT02217878|881631|P1|Overall Study|required morphine due to chest pain|1
265926|NCT02217280|881723|P1|Overall Study|Post-consent sceen fail|2
265927|NCT02217280|881723|P1|Overall Study|Withdrawal by Subject|2
265928|NCT02216591|881739|P2|Overall Study|Lost to Follow-up|1
265929|NCT02216591|881740|P1|Overall Study|Lost to Follow-up|0
265930|NCT02216526|881753|P3|Overall Study|Hospitalization|3
265931|NCT02216526|881754|P2|Overall Study|Hospitalization|1
265932|NCT02216526|881755|P1|Overall Study|Hospitalization|2
265933|NCT02216526|881753|P3|Overall Study|Protocol Violation|2
265934|NCT02216526|881754|P2|Overall Study|Protocol Violation|0
265935|NCT02216526|881755|P1|Overall Study|Protocol Violation|2
265936|NCT02216526|881753|P3|Overall Study|Death|3
265937|NCT02216526|881754|P2|Overall Study|Death|1
265938|NCT02216526|881755|P1|Overall Study|Death|0
265939|NCT02216526|881753|P3|Overall Study|Adverse Event|0
265940|NCT02216526|881754|P2|Overall Study|Adverse Event|1
265941|NCT02216526|881755|P1|Overall Study|Adverse Event|1
265942|NCT02216357|881873|P2|Overall Study|Inclusion or exclusion criteria not met|1
265943|NCT02216357|881874|P1|Overall Study|Inclusion or exclusion criteria not met|2
265944|NCT02216123|881900|P2|Overall Study|Withdrawal by Subject|0
265945|NCT02216123|881901|P1|Overall Study|Withdrawal by Subject|2
265946|NCT02216123|881900|P2|Overall Study|Lost to Follow-up|2
265947|NCT02216123|881901|P1|Overall Study|Lost to Follow-up|4
265948|NCT02215954|881993|P3|Overall Study|Not exposed|3
265949|NCT02215954|881994|P2|Overall Study|Not exposed|1
265950|NCT02215954|881995|P1|Overall Study|Not exposed|1
265951|NCT02215954|881993|P3|Overall Study|Withdrawal by Subject|2
265952|NCT02215954|881994|P2|Overall Study|Withdrawal by Subject|0
265953|NCT02215954|881995|P1|Overall Study|Withdrawal by Subject|0
265954|NCT02215954|881993|P3|Overall Study|Adverse Event|1
265955|NCT02215954|881994|P2|Overall Study|Adverse Event|0
265956|NCT02215954|881995|P1|Overall Study|Adverse Event|0
265957|NCT02215252|882018|P3|Overall Study|Other|1
265958|NCT02215252|882019|P2|Overall Study|Other|1
265959|NCT02215252|882020|P1|Overall Study|Other|0
265960|NCT02215252|882018|P3|Overall Study|Withdrawal by Subject|0
265961|NCT02215252|882019|P2|Overall Study|Withdrawal by Subject|0
265962|NCT02215252|882020|P1|Overall Study|Withdrawal by Subject|1
265963|NCT02215252|882018|P3|Overall Study|Protocol Violation|0
265964|NCT02215252|882019|P2|Overall Study|Protocol Violation|1
265965|NCT02215252|882020|P1|Overall Study|Protocol Violation|0
265966|NCT02215252|882018|P3|Overall Study|Does not Meet Entrance Criteria|0
265967|NCT02215252|882019|P2|Overall Study|Does not Meet Entrance Criteria|1
265968|NCT02215252|882020|P1|Overall Study|Does not Meet Entrance Criteria|0
265969|NCT02215252|882018|P3|Overall Study|Lost to Follow-up|1
265970|NCT02215252|882019|P2|Overall Study|Lost to Follow-up|0
265971|NCT02215252|882020|P1|Overall Study|Lost to Follow-up|0
265972|NCT02215252|882018|P3|Overall Study|Adverse Event|2
265973|NCT02215252|882019|P2|Overall Study|Adverse Event|5
265974|NCT02215252|882020|P1|Overall Study|Adverse Event|1
265975|NCT02214225|882144|P3|Overall Study|randomized in error, not vaccinated|1
265976|NCT02214225|882145|P2|Overall Study|randomized in error, not vaccinated|1
265977|NCT02214225|882146|P1|Overall Study|randomized in error, not vaccinated|2
265978|NCT02214225|882144|P3|Overall Study|Death|1
265979|NCT02214225|882145|P2|Overall Study|Death|0
265980|NCT02214225|882146|P1|Overall Study|Death|5
265981|NCT02214225|882144|P3|Overall Study|Withdrawal by Subject|2
265982|NCT02214225|882145|P2|Overall Study|Withdrawal by Subject|0
265983|NCT02214225|882146|P1|Overall Study|Withdrawal by Subject|2
265984|NCT02214225|882144|P3|Overall Study|Lost to Follow-up|18
265985|NCT02214225|882145|P2|Overall Study|Lost to Follow-up|18
265986|NCT02214225|882146|P1|Overall Study|Lost to Follow-up|46
265987|NCT02214186|882205|P2|Overall Study|Protocol Violation|1
265988|NCT02214186|882206|P1|Overall Study|Protocol Violation|1
265989|NCT02214186|882205|P2|Overall Study|Lost to Follow-up|1
265990|NCT02214186|882206|P1|Overall Study|Lost to Follow-up|1
265991|NCT02214121|882231|P3|Part B|Lost to Follow-up|1
265992|NCT02214121|882232|P2|Part B|Lost to Follow-up|0
265993|NCT02214121|882233|P1|Part B|Lost to Follow-up|0
265994|NCT02214121|882231|P3|Part B|Dev. of study-specific withdrawal crit.|0
265995|NCT02214121|882232|P2|Part B|Dev. of study-specific withdrawal crit.|2
265996|NCT02214121|882233|P1|Part B|Dev. of study-specific withdrawal crit.|0
265997|NCT02214121|882231|P3|Part B|Patient decision|0
265998|NCT02214121|882232|P2|Part B|Patient decision|1
265999|NCT02214121|882233|P1|Part B|Patient decision|0
266000|NCT02214121|882231|P3|Part A|Other|0
266001|NCT02214121|882232|P2|Part A|Other|0
266002|NCT02214121|882233|P1|Part A|Other|1
266003|NCT02214121|882231|P3|Part A|Dev. of study-specific withdrawal crit.|0
266004|NCT02214121|882232|P2|Part A|Dev. of study-specific withdrawal crit.|0
266005|NCT02214121|882233|P1|Part A|Dev. of study-specific withdrawal crit.|4
266006|NCT02214121|882231|P3|Part A|Patient decision|0
266007|NCT02214121|882232|P2|Part A|Patient decision|0
266008|NCT02214121|882233|P1|Part A|Patient decision|2
266009|NCT02213666|882325|P1|Overall Study|Withdrawal by Subject|1
266010|NCT02213510|882331|P2|Overall Study|Lost to Follow-up|0
266011|NCT02213510|882332|P1|Overall Study|Lost to Follow-up|1
266012|NCT02213510|882331|P2|Overall Study|Death|1
266013|NCT02213510|882332|P1|Overall Study|Death|0
266014|NCT02213198|882390|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
266015|NCT02213198|882391|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
266016|NCT02213198|882390|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
266017|NCT02213198|882391|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
266018|NCT02213198|882390|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
266019|NCT02213198|882391|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
266020|NCT02213198|882390|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
266021|NCT02213198|882391|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
266022|NCT02213198|882390|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
266023|NCT02213198|882391|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
266024|NCT02213198|882390|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
266025|NCT02213198|882391|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
266026|NCT02213198|882390|P2|Baseline|incarcerated,violent|1
266027|NCT02213198|882391|P1|Baseline|incarcerated,violent|0
266028|NCT02213198|882390|P2|Baseline|Lost to Follow-up|21
266029|NCT02213198|882391|P1|Baseline|Lost to Follow-up|40
266030|NCT02213198|882390|P2|Baseline|transferred out of clinic|9
266031|NCT02213198|882391|P1|Baseline|transferred out of clinic|7
266032|NCT02213198|882390|P2|Baseline|Withdrawal by Subject|11
266033|NCT02213198|882391|P1|Baseline|Withdrawal by Subject|34
266034|NCT02213198|882390|P2|Baseline|No show for intake|9
266035|NCT02213198|882391|P1|Baseline|No show for intake|7
266036|NCT02213055|882401|P2|Overall Study|Did not Return to School|0
266037|NCT02213055|882402|P1|Overall Study|Did not Return to School|5
266038|NCT02213055|882401|P2|Overall Study|Did not meet Inclusion Criteria|0
266039|NCT02213055|882402|P1|Overall Study|Did not meet Inclusion Criteria|6
266040|NCT02213055|882401|P2|Overall Study|Had another Treatment during the Study|0
266041|NCT02213055|882402|P1|Overall Study|Had another Treatment during the Study|3
266042|NCT02213055|882401|P2|Overall Study|Did not have Live Lice|0
266043|NCT02213055|882402|P1|Overall Study|Did not have Live Lice|8
266044|NCT02213055|882401|P2|Overall Study|Documentation Issue during Study|0
266045|NCT02213055|882402|P1|Overall Study|Documentation Issue during Study|10
266046|NCT02213055|882401|P2|Overall Study|Documentation Issue at Enrollment|0
266047|NCT02213055|882402|P1|Overall Study|Documentation Issue at Enrollment|1
266048|NCT02213055|882401|P2|Overall Study|Protocol was not Followed during Study|0
266049|NCT02213055|882402|P1|Overall Study|Protocol was not Followed during Study|1
266050|NCT02213055|882401|P2|Overall Study|Protocol was not Followed at Enrollment|0
266051|NCT02213055|882402|P1|Overall Study|Protocol was not Followed at Enrollment|5
266052|NCT02212457|882440|P6|Overall Study|Other|1
266053|NCT02212457|882441|P5|Overall Study|Other|0
266054|NCT02212457|882442|P4|Overall Study|Other|1
266055|NCT02212457|882443|P3|Overall Study|Other|2
266056|NCT02212457|882444|P2|Overall Study|Other|1
266057|NCT02212457|882445|P1|Overall Study|Other|2
266058|NCT02212457|882440|P6|Overall Study|Protocol Violation|3
266059|NCT02212457|882441|P5|Overall Study|Protocol Violation|2
266060|NCT02212457|882442|P4|Overall Study|Protocol Violation|1
266061|NCT02212457|882443|P3|Overall Study|Protocol Violation|0
266062|NCT02212457|882444|P2|Overall Study|Protocol Violation|1
266063|NCT02212457|882445|P1|Overall Study|Protocol Violation|2
266064|NCT02212457|882440|P6|Overall Study|Lost to Follow-up|4
266065|NCT02212457|882441|P5|Overall Study|Lost to Follow-up|8
266066|NCT02212457|882442|P4|Overall Study|Lost to Follow-up|1
266067|NCT02212457|882443|P3|Overall Study|Lost to Follow-up|4
266068|NCT02212457|882444|P2|Overall Study|Lost to Follow-up|7
266069|NCT02212457|882445|P1|Overall Study|Lost to Follow-up|6
266070|NCT02212457|882440|P6|Overall Study|Withdrawal by Subject|4
266071|NCT02212457|882441|P5|Overall Study|Withdrawal by Subject|5
266072|NCT02212457|882442|P4|Overall Study|Withdrawal by Subject|6
266073|NCT02212457|882443|P3|Overall Study|Withdrawal by Subject|8
266074|NCT02212457|882444|P2|Overall Study|Withdrawal by Subject|10
266075|NCT02212457|882445|P1|Overall Study|Withdrawal by Subject|8
266076|NCT02212457|882440|P6|Overall Study|Adverse Event|1
266077|NCT02212457|882441|P5|Overall Study|Adverse Event|0
266078|NCT02212457|882442|P4|Overall Study|Adverse Event|2
266079|NCT02212457|882443|P3|Overall Study|Adverse Event|2
266080|NCT02212457|882444|P2|Overall Study|Adverse Event|2
266081|NCT02212457|882445|P1|Overall Study|Adverse Event|1
266082|NCT02212301|882483|P2|Period 1|Lost to Follow-up|1
266083|NCT02212301|882484|P1|Period 1|Lost to Follow-up|0
266084|NCT02212197|882495|P3|Overall Study|Need for radiotherapy|0
266085|NCT02212197|882496|P2|Overall Study|Need for radiotherapy|0
266086|NCT02212197|882497|P1|Overall Study|Need for radiotherapy|1
266087|NCT02210208|882573|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
266088|NCT02210208|882573|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
266089|NCT02210208|882573|P1|Period A (Graft Site)|Withdrawal by Subject|1
266090|NCT02210091|882593|P2|Overall Study|Withdrawal by Sponsor|1
266091|NCT02210091|882594|P1|Overall Study|Withdrawal by Sponsor|0
266092|NCT02210091|882593|P2|Overall Study|Physician Decision|1
266093|NCT02210091|882594|P1|Overall Study|Physician Decision|0
266094|NCT02210000|882672|P2|Overall Study|Physician Decision|1
266095|NCT02210000|882673|P1|Overall Study|Physician Decision|0
266096|NCT02210000|882672|P2|Overall Study|Lost to Follow-up|2
266097|NCT02210000|882673|P1|Overall Study|Lost to Follow-up|0
266098|NCT02210000|882672|P2|Overall Study|Adverse Event|5
266099|NCT02210000|882673|P1|Overall Study|Adverse Event|1
266100|NCT02210000|882672|P2|Overall Study|Withdrawal by Subject|1
266101|NCT02210000|882673|P1|Overall Study|Withdrawal by Subject|7
266102|NCT02210000|882672|P2|Overall Study|Study Terminated|12
266103|NCT02210000|882673|P1|Overall Study|Study Terminated|11
266104|NCT02209766|882699|P5|Overall Study|Withdrawal by Subject|0
266105|NCT02209766|882700|P4|Overall Study|Withdrawal by Subject|1
266106|NCT02209766|882701|P3|Overall Study|Withdrawal by Subject|0
266107|NCT02209766|882702|P2|Overall Study|Withdrawal by Subject|0
266108|NCT02209766|882703|P1|Overall Study|Withdrawal by Subject|0
266109|NCT02209506|882754|P5|Overall Study|Withdrawal by Subject|1
266110|NCT02209506|882755|P4|Overall Study|Withdrawal by Subject|0
266111|NCT02209506|882756|P3|Overall Study|Withdrawal by Subject|0
266112|NCT02209506|882757|P2|Overall Study|Withdrawal by Subject|0
266113|NCT02209506|882758|P1|Overall Study|Withdrawal by Subject|0
266114|NCT02209454|882833|P2|Second Period|Adverse Event|0
266115|NCT02209454|882834|P1|Second Period|Adverse Event|1
266116|NCT02209181|882871|P4|Overall Study|Withdrawal by Subject|0
266117|NCT02209181|882872|P3|Overall Study|Withdrawal by Subject|0
266118|NCT02209181|882873|P2|Overall Study|Withdrawal by Subject|1
266119|NCT02209181|882874|P1|Overall Study|Withdrawal by Subject|0
266120|NCT02209181|882871|P4|Overall Study|Adverse Event|0
266121|NCT02209181|882872|P3|Overall Study|Adverse Event|1
266122|NCT02209181|882873|P2|Overall Study|Adverse Event|0
266123|NCT02209181|882874|P1|Overall Study|Adverse Event|1
266124|NCT02207907|883102|P2|Overall Study|Pregnancy|1
266125|NCT02207907|883103|P1|Overall Study|Pregnancy|0
266126|NCT02207907|883102|P2|Overall Study|Did not meet study criteria|0
266127|NCT02207907|883103|P1|Overall Study|Did not meet study criteria|3
266128|NCT02207907|883102|P2|Overall Study|Withdrawal by Subject|6
266129|NCT02207907|883103|P1|Overall Study|Withdrawal by Subject|5
266130|NCT02207907|883102|P2|Overall Study|Lost to Follow-up|1
266131|NCT02207907|883103|P1|Overall Study|Lost to Follow-up|3
266132|NCT02207829|883121|P2|Overall Study|Withdrew consent|14
266133|NCT02207829|883122|P1|Overall Study|Withdrew consent|18
266134|NCT02207829|883121|P2|Overall Study|Protocol deviation|4
266135|NCT02207829|883122|P1|Overall Study|Protocol deviation|5
266136|NCT02207829|883121|P2|Overall Study|Lost to Follow-up|2
266137|NCT02207829|883122|P1|Overall Study|Lost to Follow-up|2
266138|NCT02207829|883121|P2|Overall Study|Lack of Efficacy|5
266139|NCT02207829|883122|P1|Overall Study|Lack of Efficacy|7
266140|NCT02207829|883121|P2|Overall Study|Adverse Event|9
266141|NCT02207829|883122|P1|Overall Study|Adverse Event|10
266142|NCT02207634|883141|P2|Overall Study|Lost to Follow-up|0
266143|NCT02207634|883142|P1|Overall Study|Lost to Follow-up|1
266144|NCT02207634|883141|P2|Overall Study|Withdrawal by Subject|31
266145|NCT02207634|883142|P1|Overall Study|Withdrawal by Subject|21
266146|NCT02207621|883157|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
266147|NCT02207621|883158|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
266148|NCT02207621|883159|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
266149|NCT02207621|883157|P3|Overall Study|Death|0
266150|NCT02207621|883158|P2|Overall Study|Death|0
266151|NCT02207621|883159|P1|Overall Study|Death|2
266152|NCT02207621|883157|P3|Overall Study|Protocol Violation|6
266153|NCT02207621|883158|P2|Overall Study|Protocol Violation|10
266154|NCT02207621|883159|P1|Overall Study|Protocol Violation|4
266155|NCT02207621|883157|P3|Overall Study|Physician Decision|2
266156|NCT02207621|883158|P2|Overall Study|Physician Decision|2
266157|NCT02207621|883159|P1|Overall Study|Physician Decision|1
266158|NCT02207621|883157|P3|Overall Study|Disallowed Concurrent Medication|2
266159|NCT02207621|883158|P2|Overall Study|Disallowed Concurrent Medication|5
266160|NCT02207621|883159|P1|Overall Study|Disallowed Concurrent Medication|2
266161|NCT02207621|883157|P3|Overall Study|Lack of Efficacy|4
266162|NCT02207621|883158|P2|Overall Study|Lack of Efficacy|2
266163|NCT02207621|883159|P1|Overall Study|Lack of Efficacy|10
266164|NCT02207621|883157|P3|Overall Study|Lost to Follow-up|3
266165|NCT02207621|883158|P2|Overall Study|Lost to Follow-up|0
266166|NCT02207621|883159|P1|Overall Study|Lost to Follow-up|1
266167|NCT02207621|883157|P3|Overall Study|Non-Compliant|1
266168|NCT02207621|883158|P2|Overall Study|Non-Compliant|3
266169|NCT02207621|883159|P1|Overall Study|Non-Compliant|3
266170|NCT02207621|883157|P3|Overall Study|Withdrawal by Subject|13
266171|NCT02207621|883158|P2|Overall Study|Withdrawal by Subject|9
266172|NCT02207621|883159|P1|Overall Study|Withdrawal by Subject|9
266173|NCT02207621|883157|P3|Overall Study|Adverse Event|132
266174|NCT02207621|883158|P2|Overall Study|Adverse Event|15
266175|NCT02207621|883159|P1|Overall Study|Adverse Event|71
266176|NCT02207608|883172|P2|Overall Study|Adverse Event|0
266177|NCT02207608|883173|P1|Overall Study|Adverse Event|1
266178|NCT02207530|883197|P1|Overall Study|Adverse Event|8
266179|NCT02207530|883197|P1|Overall Study|Patient decision to stop study treatment|5
266180|NCT02207530|883197|P1|Overall Study|Worsening condition under investigation|78
266181|NCT02207491|883211|P2|Overall Study|Protocol Violation|5
266182|NCT02207491|883212|P1|Overall Study|Protocol Violation|3
266183|NCT02207491|883211|P2|Overall Study|Physician Decision|0
266184|NCT02207491|883212|P1|Overall Study|Physician Decision|2
266185|NCT02207491|883211|P2|Overall Study|Lack of Efficacy|0
266186|NCT02207491|883212|P1|Overall Study|Lack of Efficacy|3
266187|NCT02207491|883211|P2|Overall Study|Lost to Follow-up|1
266188|NCT02207491|883212|P1|Overall Study|Lost to Follow-up|0
266189|NCT02207491|883211|P2|Overall Study|Non-compliant|1
266190|NCT02207491|883212|P1|Overall Study|Non-compliant|0
266191|NCT02207491|883211|P2|Overall Study|Withdrawal by Subject|2
266192|NCT02207491|883212|P1|Overall Study|Withdrawal by Subject|3
266193|NCT02207491|883211|P2|Overall Study|Adverse Event|4
266194|NCT02207491|883212|P1|Overall Study|Adverse Event|20
266195|NCT02207413|883237|P6|Overall Study|Migrated/moved from study area|0
266196|NCT02207413|883238|P5|Overall Study|Migrated/moved from study area|1
266197|NCT02207413|883239|P4|Overall Study|Migrated/moved from study area|0
266198|NCT02207413|883240|P3|Overall Study|Migrated/moved from study area|0
266199|NCT02207413|883241|P2|Overall Study|Migrated/moved from study area|0
266200|NCT02207413|883242|P1|Overall Study|Migrated/moved from study area|0
266201|NCT02207413|883237|P6|Overall Study|Adverse Event|1
266202|NCT02207413|883238|P5|Overall Study|Adverse Event|2
266203|NCT02207413|883239|P4|Overall Study|Adverse Event|0
266204|NCT02207413|883240|P3|Overall Study|Adverse Event|0
266205|NCT02207413|883241|P2|Overall Study|Adverse Event|0
266206|NCT02207413|883242|P1|Overall Study|Adverse Event|0
266207|NCT02207413|883237|P6|Overall Study|Lost to Follow-up|5
266208|NCT02207413|883238|P5|Overall Study|Lost to Follow-up|1
266209|NCT02207413|883239|P4|Overall Study|Lost to Follow-up|1
266210|NCT02207413|883240|P3|Overall Study|Lost to Follow-up|0
266211|NCT02207413|883241|P2|Overall Study|Lost to Follow-up|0
266212|NCT02207413|883242|P1|Overall Study|Lost to Follow-up|0
266213|NCT02207413|883237|P6|Overall Study|Withdrawal by Subject|7
266214|NCT02207413|883238|P5|Overall Study|Withdrawal by Subject|3
266215|NCT02207413|883239|P4|Overall Study|Withdrawal by Subject|0
266216|NCT02207413|883240|P3|Overall Study|Withdrawal by Subject|0
266217|NCT02207413|883241|P2|Overall Study|Withdrawal by Subject|0
266218|NCT02207413|883242|P1|Overall Study|Withdrawal by Subject|1
266219|NCT02207400|883338|P2|Overall Study|Positive Urine Pregnancy Test|1
266220|NCT02207400|883339|P1|Overall Study|Positive Urine Pregnancy Test|0
266221|NCT02207400|883338|P2|Overall Study|Withdrawal by Subject|4
266222|NCT02207400|883339|P1|Overall Study|Withdrawal by Subject|8
266223|NCT02207400|883338|P2|Overall Study|Protocol Violation|1
266224|NCT02207400|883339|P1|Overall Study|Protocol Violation|1
266225|NCT02207400|883338|P2|Overall Study|Lost to Follow-up|7
266226|NCT02207400|883339|P1|Overall Study|Lost to Follow-up|6
266227|NCT02207400|883338|P2|Overall Study|Adverse Event|1
266228|NCT02207400|883339|P1|Overall Study|Adverse Event|1
266229|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
266230|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
266231|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
266232|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
266233|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
266234|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
266235|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
266236|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
266237|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
266238|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266239|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266240|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
266241|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266242|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266243|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266244|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266245|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266246|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
266247|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266248|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266249|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
266250|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266251|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266252|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266253|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266254|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266255|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
266256|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
266257|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
266258|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
266259|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
266260|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
266261|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
266262|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
266263|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
266264|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
266265|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
266266|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
266267|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
266268|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
266269|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
266270|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
266271|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
266272|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
266273|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
266274|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
266275|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
266276|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
266277|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
266278|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
266279|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
266280|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
266281|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
266282|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
266283|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266284|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
266285|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266286|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266287|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266288|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266289|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266290|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266291|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
266292|NCT02207244|883360|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
266293|NCT02207244|883361|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
266294|NCT02207244|883362|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
266295|NCT02207244|883363|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
266296|NCT02207244|883364|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
266297|NCT02207244|883365|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
266298|NCT02207244|883366|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
266299|NCT02207244|883367|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
266300|NCT02207244|883368|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
266301|NCT02207244|883360|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
266302|NCT02207244|883361|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
266303|NCT02207244|883362|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
266304|NCT02207244|883363|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
266305|NCT02207244|883364|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
266306|NCT02207244|883365|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
266307|NCT02207244|883366|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
266308|NCT02207244|883367|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
266309|NCT02207244|883368|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
266310|NCT02207244|883360|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
266311|NCT02207244|883361|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
266312|NCT02207244|883362|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
266313|NCT02207244|883363|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
266314|NCT02207244|883364|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
266315|NCT02207244|883365|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
266316|NCT02207244|883366|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
266317|NCT02207244|883367|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
266318|NCT02207244|883368|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
266319|NCT02207244|883360|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
266320|NCT02207244|883361|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
266321|NCT02207244|883362|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
266322|NCT02207244|883363|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
266323|NCT02207244|883364|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
266324|NCT02207244|883365|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
266325|NCT02207244|883366|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
266326|NCT02207244|883367|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
266327|NCT02207244|883368|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
266328|NCT02207244|883360|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
266329|NCT02207244|883361|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
266330|NCT02207244|883362|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
266331|NCT02207244|883363|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
266332|NCT02207244|883364|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
266333|NCT02207244|883365|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
266334|NCT02207244|883366|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
266335|NCT02207244|883367|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
266336|NCT02207244|883368|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
266337|NCT02207244|883360|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266338|NCT02207244|883361|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266339|NCT02207244|883362|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266340|NCT02207244|883363|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
266341|NCT02207244|883364|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266342|NCT02207244|883365|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266343|NCT02207244|883366|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266344|NCT02207244|883367|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266345|NCT02207244|883368|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
266346|NCT02207244|883360|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
266347|NCT02207244|883361|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
266348|NCT02207244|883362|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
266349|NCT02207244|883363|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
266350|NCT02207244|883364|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
266351|NCT02207244|883365|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
266352|NCT02207244|883366|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
266353|NCT02207244|883367|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
266354|NCT02207244|883368|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
266355|NCT02207244|883360|P9|Placebo Controlled Period: Week 0 - 16|Other|0
266356|NCT02207244|883361|P8|Placebo Controlled Period: Week 0 - 16|Other|0
266357|NCT02207244|883362|P7|Placebo Controlled Period: Week 0 - 16|Other|0
266358|NCT02207244|883363|P6|Placebo Controlled Period: Week 0 - 16|Other|0
266359|NCT02207244|883364|P5|Placebo Controlled Period: Week 0 - 16|Other|0
266360|NCT02207244|883365|P4|Placebo Controlled Period: Week 0 - 16|Other|0
266361|NCT02207244|883366|P3|Placebo Controlled Period: Week 0 - 16|Other|0
266362|NCT02207244|883367|P2|Placebo Controlled Period: Week 0 - 16|Other|1
266363|NCT02207244|883368|P1|Placebo Controlled Period: Week 0 - 16|Other|0
266364|NCT02207244|883360|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
266365|NCT02207244|883361|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
266366|NCT02207244|883362|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
266367|NCT02207244|883363|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
266368|NCT02207244|883364|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
266369|NCT02207244|883365|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
266370|NCT02207244|883366|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
266371|NCT02207244|883367|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
266372|NCT02207244|883368|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
266373|NCT02207244|883360|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266374|NCT02207244|883361|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266375|NCT02207244|883362|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266376|NCT02207244|883363|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266377|NCT02207244|883364|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266378|NCT02207244|883365|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266379|NCT02207244|883366|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
266380|NCT02207244|883367|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
266381|NCT02207244|883368|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
266382|NCT02207244|883360|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266383|NCT02207244|883361|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266384|NCT02207244|883362|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266385|NCT02207244|883363|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266386|NCT02207244|883364|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266387|NCT02207244|883365|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266388|NCT02207244|883366|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266389|NCT02207244|883367|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
266390|NCT02207244|883368|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
266391|NCT02207244|883360|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
266392|NCT02207244|883361|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
266393|NCT02207244|883362|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
266394|NCT02207244|883363|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
266395|NCT02207244|883364|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
266396|NCT02207244|883365|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
266397|NCT02207244|883366|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
266398|NCT02207244|883367|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
266399|NCT02207244|883368|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
266400|NCT02207244|883360|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266401|NCT02207244|883361|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266402|NCT02207244|883362|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266403|NCT02207244|883363|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266404|NCT02207244|883364|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266405|NCT02207244|883365|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266406|NCT02207244|883366|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
266407|NCT02207244|883367|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266408|NCT02207244|883368|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
266409|NCT02207244|883360|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
266410|NCT02207244|883361|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
266411|NCT02207244|883362|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
266412|NCT02207244|883363|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
266413|NCT02207244|883364|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
266414|NCT02207244|883365|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
266415|NCT02207244|883366|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
266416|NCT02207244|883367|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
266417|NCT02207244|883368|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
266418|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
266419|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
266420|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
266421|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Other|3
266422|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Other|2
266423|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Other|0
266424|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
266425|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
266426|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
266427|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
266428|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
266429|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
266430|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
266431|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
266432|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
266433|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
266434|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
266435|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
266436|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
266437|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
266438|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
266439|NCT02207231|883409|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
266440|NCT02207231|883410|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
266441|NCT02207231|883411|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
266442|NCT02207231|883409|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
266443|NCT02207231|883410|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
266444|NCT02207231|883411|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
266445|NCT02207231|883409|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
266446|NCT02207231|883410|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266447|NCT02207231|883411|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
266448|NCT02207231|883409|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
266449|NCT02207231|883410|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
266450|NCT02207231|883411|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
266451|NCT02207231|883409|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
266452|NCT02207231|883410|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
266453|NCT02207231|883411|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
266454|NCT02207231|883409|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
266455|NCT02207231|883410|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
266456|NCT02207231|883411|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
266457|NCT02207231|883409|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
266458|NCT02207231|883410|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
266459|NCT02207231|883411|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
266460|NCT02207088|883443|P1|Overall Study|Adverse Event|2
266461|NCT02206607|883458|P5|Second Intervention Period|Insufficient Clinical Response|0
266462|NCT02206607|883459|P4|Second Intervention Period|Insufficient Clinical Response|1
266463|NCT02206607|883460|P3|Second Intervention Period|Insufficient Clinical Response|0
266464|NCT02206607|883461|P2|Second Intervention Period|Insufficient Clinical Response|0
266465|NCT02206607|883462|P1|Second Intervention Period|Insufficient Clinical Response|0
266466|NCT02206607|883458|P5|Open-Label Run-In|Withdrawal by Subject|0
266467|NCT02206607|883459|P4|Open-Label Run-In|Withdrawal by Subject|0
266468|NCT02206607|883460|P3|Open-Label Run-In|Withdrawal by Subject|0
266469|NCT02206607|883461|P2|Open-Label Run-In|Withdrawal by Subject|0
266470|NCT02206607|883462|P1|Open-Label Run-In|Withdrawal by Subject|3
266471|NCT02205814|883518|P4|Overall Study|not compliant with study procedures|0
266472|NCT02205814|883519|P3|Overall Study|not compliant with study procedures|1
266473|NCT02205814|883520|P2|Overall Study|not compliant with study procedures|0
266474|NCT02205814|883521|P1|Overall Study|not compliant with study procedures|0
266475|NCT02205814|883518|P4|Overall Study|Withdrawal by Subject|1
266476|NCT02205814|883519|P3|Overall Study|Withdrawal by Subject|2
266477|NCT02205814|883520|P2|Overall Study|Withdrawal by Subject|1
266478|NCT02205814|883521|P1|Overall Study|Withdrawal by Subject|0
266479|NCT02205814|883518|P4|Overall Study|Protocol Violation|1
266480|NCT02205814|883519|P3|Overall Study|Protocol Violation|0
266481|NCT02205814|883520|P2|Overall Study|Protocol Violation|0
266482|NCT02205814|883521|P1|Overall Study|Protocol Violation|1
266483|NCT02205814|883518|P4|Overall Study|Physician Decision|0
266484|NCT02205814|883519|P3|Overall Study|Physician Decision|1
266485|NCT02205814|883520|P2|Overall Study|Physician Decision|0
266486|NCT02205814|883521|P1|Overall Study|Physician Decision|0
266487|NCT02205814|883518|P4|Overall Study|Lack of Efficacy|1
266488|NCT02205814|883519|P3|Overall Study|Lack of Efficacy|1
266489|NCT02205814|883520|P2|Overall Study|Lack of Efficacy|0
266490|NCT02205814|883521|P1|Overall Study|Lack of Efficacy|1
266491|NCT02205814|883518|P4|Overall Study|Lost to Follow-up|1
266492|NCT02205814|883519|P3|Overall Study|Lost to Follow-up|0
266493|NCT02205814|883520|P2|Overall Study|Lost to Follow-up|0
266494|NCT02205814|883521|P1|Overall Study|Lost to Follow-up|0
266495|NCT02205476|883574|P2|Overall Study|Study termination by Sponsor|3
266496|NCT02205476|883575|P1|Overall Study|Study termination by Sponsor|7
266497|NCT02205333|883614|P9|Overall Study|Withdrawal by Subject|0
266498|NCT02205333|883615|P8|Overall Study|Withdrawal by Subject|0
266499|NCT02205333|883616|P7|Overall Study|Withdrawal by Subject|2
266500|NCT02205333|883617|P6|Overall Study|Withdrawal by Subject|0
266501|NCT02205333|883618|P5|Overall Study|Withdrawal by Subject|0
266502|NCT02205333|883619|P4|Overall Study|Withdrawal by Subject|1
266503|NCT02205333|883620|P3|Overall Study|Withdrawal by Subject|0
266504|NCT02205333|883621|P2|Overall Study|Withdrawal by Subject|0
266505|NCT02205333|883622|P1|Overall Study|Withdrawal by Subject|1
266506|NCT02205333|883614|P9|Overall Study|Death|0
266507|NCT02205333|883615|P8|Overall Study|Death|2
266508|NCT02205333|883616|P7|Overall Study|Death|3
266509|NCT02205333|883617|P6|Overall Study|Death|3
266510|NCT02205333|883618|P5|Overall Study|Death|5
266511|NCT02205333|883619|P4|Overall Study|Death|6
266512|NCT02205333|883620|P3|Overall Study|Death|2
266513|NCT02205333|883621|P2|Overall Study|Death|6
266514|NCT02205333|883622|P1|Overall Study|Death|5
266515|NCT02204579|883818|P1|Overall Study|Screen failures|2
266516|NCT02204449|883872|P2|Overall Study|Withdrawal by Subject|1
266517|NCT02204449|883873|P1|Overall Study|Withdrawal by Subject|0
266518|NCT02204449|883872|P2|Overall Study|Death|1
266519|NCT02204449|883873|P1|Overall Study|Death|0
266520|NCT02204449|883872|P2|Overall Study|Lost to Follow-up|9
266521|NCT02204449|883873|P1|Overall Study|Lost to Follow-up|7
266522|NCT02204410|883883|P1|Overall Study|Withdrawal by Subject|3
266523|NCT02204410|883883|P1|Overall Study|Protocol Violation|1
266524|NCT02204410|883883|P1|Overall Study|Physician Decision|2
266525|NCT02204410|883883|P1|Overall Study|Lost to Follow-up|5
266526|NCT02204371|883888|P1|Overall Study|Adverse Event|1
266527|NCT02204319|883911|P1|Overall Study|Withdrawal by Subject|2
266528|NCT02204319|883911|P1|Overall Study|Pregnancy|1
266529|NCT02204007|883919|P2|Overall Study|Surgery Canceled|1
266530|NCT02204007|883920|P1|Overall Study|Surgery Canceled|1
266531|NCT02203916|883931|P3|Overall Study|Reason Not Specified|1
266532|NCT02203916|883932|P2|Overall Study|Reason Not Specified|2
266533|NCT02203916|883933|P1|Overall Study|Reason Not Specified|0
266534|NCT02203916|883931|P3|Overall Study|Lack of Efficacy|0
266535|NCT02203916|883932|P2|Overall Study|Lack of Efficacy|0
266536|NCT02203916|883933|P1|Overall Study|Lack of Efficacy|3
266537|NCT02203916|883931|P3|Overall Study|Voluntary Withdrawal|8
266538|NCT02203916|883932|P2|Overall Study|Voluntary Withdrawal|3
266539|NCT02203916|883933|P1|Overall Study|Voluntary Withdrawal|3
266540|NCT02203916|883931|P3|Overall Study|Lost to Follow-up|0
266541|NCT02203916|883932|P2|Overall Study|Lost to Follow-up|1
266542|NCT02203916|883933|P1|Overall Study|Lost to Follow-up|0
266543|NCT02203916|883931|P3|Overall Study|Major Protocol Deviation|0
266544|NCT02203916|883932|P2|Overall Study|Major Protocol Deviation|1
266545|NCT02203916|883933|P1|Overall Study|Major Protocol Deviation|1
266546|NCT02203916|883931|P3|Overall Study|Pretreatment Event/Adverse Event|2
266547|NCT02203916|883932|P2|Overall Study|Pretreatment Event/Adverse Event|3
266548|NCT02203916|883933|P1|Overall Study|Pretreatment Event/Adverse Event|1
266549|NCT02203721|884003|P2|Overall Study|Illness|1
266550|NCT02203721|884004|P1|Overall Study|Illness|0
266551|NCT02203721|884003|P2|Overall Study|Death|2
266552|NCT02203721|884004|P1|Overall Study|Death|0
266553|NCT02203721|884003|P2|Overall Study|Lost to Follow-up|0
266554|NCT02203721|884004|P1|Overall Study|Lost to Follow-up|1
266555|NCT02203331|884107|P6|Overall Study|Lost to Follow-up|0
266556|NCT02203331|884108|P5|Overall Study|Lost to Follow-up|1
266557|NCT02203331|884109|P4|Overall Study|Lost to Follow-up|0
266558|NCT02203331|884110|P3|Overall Study|Lost to Follow-up|0
266559|NCT02203331|884111|P2|Overall Study|Lost to Follow-up|0
266560|NCT02203331|884112|P1|Overall Study|Lost to Follow-up|0
266561|NCT02203331|884107|P6|Overall Study|Protocol Violation|0
266562|NCT02203331|884108|P5|Overall Study|Protocol Violation|1
266563|NCT02203331|884109|P4|Overall Study|Protocol Violation|1
266564|NCT02203331|884110|P3|Overall Study|Protocol Violation|0
266565|NCT02203331|884111|P2|Overall Study|Protocol Violation|2
266566|NCT02203331|884112|P1|Overall Study|Protocol Violation|0
266567|NCT02203331|884107|P6|Overall Study|Lack of Efficacy|1
266568|NCT02203331|884108|P5|Overall Study|Lack of Efficacy|0
266569|NCT02203331|884109|P4|Overall Study|Lack of Efficacy|0
266570|NCT02203331|884110|P3|Overall Study|Lack of Efficacy|1
266571|NCT02203331|884111|P2|Overall Study|Lack of Efficacy|2
266572|NCT02203331|884112|P1|Overall Study|Lack of Efficacy|0
266573|NCT02203331|884107|P6|Overall Study|Other Reasons|0
266574|NCT02203331|884108|P5|Overall Study|Other Reasons|0
266575|NCT02203331|884109|P4|Overall Study|Other Reasons|2
266576|NCT02203331|884110|P3|Overall Study|Other Reasons|0
266577|NCT02203331|884111|P2|Overall Study|Other Reasons|2
266578|NCT02203331|884112|P1|Overall Study|Other Reasons|1
266579|NCT02203331|884107|P6|Overall Study|Adverse Event|3
266580|NCT02203331|884108|P5|Overall Study|Adverse Event|3
266581|NCT02203331|884109|P4|Overall Study|Adverse Event|4
266582|NCT02203331|884110|P3|Overall Study|Adverse Event|3
266583|NCT02203331|884111|P2|Overall Study|Adverse Event|8
266584|NCT02203331|884112|P1|Overall Study|Adverse Event|4
266585|NCT02203331|884107|P6|Overall Study|Withdrawal by Subject|3
266586|NCT02203331|884108|P5|Overall Study|Withdrawal by Subject|0
266587|NCT02203331|884109|P4|Overall Study|Withdrawal by Subject|0
266588|NCT02203331|884110|P3|Overall Study|Withdrawal by Subject|1
266589|NCT02203331|884111|P2|Overall Study|Withdrawal by Subject|0
266590|NCT02203331|884112|P1|Overall Study|Withdrawal by Subject|1
266591|NCT02203331|884107|P6|Overall Study|Pregnancy|0
266592|NCT02203331|884108|P5|Overall Study|Pregnancy|2
266593|NCT02203331|884109|P4|Overall Study|Pregnancy|0
266594|NCT02203331|884110|P3|Overall Study|Pregnancy|0
266595|NCT02203331|884111|P2|Overall Study|Pregnancy|0
266596|NCT02203331|884112|P1|Overall Study|Pregnancy|1
266597|NCT02203149|884171|P5|Part 2|Adverse Event|1
266598|NCT02203149|884172|P4|Part 2|Adverse Event|1
266599|NCT02203149|884173|P3|Part 2|Adverse Event|0
266600|NCT02203149|884174|P2|Part 2|Adverse Event|0
266601|NCT02203149|884175|P1|Part 2|Adverse Event|0
266602|NCT02203149|884171|P5|Part 2|Withdrawal by Subject|0
266603|NCT02203149|884172|P4|Part 2|Withdrawal by Subject|1
266604|NCT02203149|884173|P3|Part 2|Withdrawal by Subject|0
266605|NCT02203149|884174|P2|Part 2|Withdrawal by Subject|0
266606|NCT02203149|884175|P1|Part 2|Withdrawal by Subject|0
266607|NCT02203149|884171|P5|Part 2|Death|0
266608|NCT02203149|884172|P4|Part 2|Death|1
266609|NCT02203149|884173|P3|Part 2|Death|1
266610|NCT02203149|884174|P2|Part 2|Death|0
266611|NCT02203149|884175|P1|Part 2|Death|0
266612|NCT02203149|884171|P5|Part 1|Adverse Event|0
266613|NCT02203149|884172|P4|Part 1|Adverse Event|0
266614|NCT02203149|884173|P3|Part 1|Adverse Event|0
266615|NCT02203149|884174|P2|Part 1|Adverse Event|1
266616|NCT02203149|884175|P1|Part 1|Adverse Event|0
266617|NCT02203032|884208|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
266618|NCT02203032|884209|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
266619|NCT02203032|884210|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
266620|NCT02203032|884211|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
266621|NCT02203032|884208|P4|Blinded Phase (Week 16 to Week 44)|Death|1
266622|NCT02203032|884209|P3|Blinded Phase (Week 16 to Week 44)|Death|0
266623|NCT02203032|884210|P2|Blinded Phase (Week 16 to Week 44)|Death|0
266624|NCT02203032|884211|P1|Blinded Phase (Week 16 to Week 44)|Death|0
266625|NCT02203032|884208|P4|Blinded Phase (Week 16 to Week 44)|Other|15
266626|NCT02203032|884209|P3|Blinded Phase (Week 16 to Week 44)|Other|1
266627|NCT02203032|884210|P2|Blinded Phase (Week 16 to Week 44)|Other|4
266628|NCT02203032|884211|P1|Blinded Phase (Week 16 to Week 44)|Other|0
266629|NCT02203032|884208|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
266630|NCT02203032|884209|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
266631|NCT02203032|884210|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
266632|NCT02203032|884211|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
266633|NCT02203032|884208|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
266634|NCT02203032|884209|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
266635|NCT02203032|884210|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
266636|NCT02203032|884211|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
266637|NCT02203032|884208|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
266638|NCT02203032|884209|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
266639|NCT02203032|884210|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
266640|NCT02203032|884211|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
266641|NCT02203032|884208|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
266642|NCT02203032|884209|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
266643|NCT02203032|884210|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
266644|NCT02203032|884211|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
266645|NCT02203032|884208|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
266646|NCT02203032|884209|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
266647|NCT02203032|884210|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
266648|NCT02203032|884211|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
266649|NCT02203032|884208|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
266650|NCT02203032|884209|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
266651|NCT02203032|884210|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
266652|NCT02203032|884211|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
266653|NCT02203032|884208|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
266654|NCT02203032|884209|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
266655|NCT02203032|884210|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
266656|NCT02203032|884211|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
266657|NCT02203032|884208|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
266658|NCT02203032|884209|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
266659|NCT02203032|884210|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
266660|NCT02203032|884211|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
266661|NCT02203032|884208|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
266662|NCT02203032|884209|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
266663|NCT02203032|884210|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
266664|NCT02203032|884211|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
266665|NCT02202980|884239|P14|Overall Study|Withdrew Consent|0
266666|NCT02202980|884240|P13|Overall Study|Withdrew Consent|0
266667|NCT02202980|884241|P12|Overall Study|Withdrew Consent|0
266668|NCT02202980|884242|P11|Overall Study|Withdrew Consent|0
266669|NCT02202980|884243|P10|Overall Study|Withdrew Consent|0
266670|NCT02202980|884244|P9|Overall Study|Withdrew Consent|1
266671|NCT02202980|884245|P8|Overall Study|Withdrew Consent|0
266672|NCT02202980|884246|P7|Overall Study|Withdrew Consent|0
266673|NCT02202980|884247|P6|Overall Study|Withdrew Consent|0
266674|NCT02202980|884248|P5|Overall Study|Withdrew Consent|0
266675|NCT02202980|884249|P4|Overall Study|Withdrew Consent|0
266676|NCT02202980|884250|P3|Overall Study|Withdrew Consent|2
266677|NCT02202980|884251|P2|Overall Study|Withdrew Consent|1
266678|NCT02202980|884252|P1|Overall Study|Withdrew Consent|0
266679|NCT02202980|884239|P14|Overall Study|Lost to Follow-up|0
266680|NCT02202980|884240|P13|Overall Study|Lost to Follow-up|1
266681|NCT02202980|884241|P12|Overall Study|Lost to Follow-up|0
266682|NCT02202980|884242|P11|Overall Study|Lost to Follow-up|0
266683|NCT02202980|884243|P10|Overall Study|Lost to Follow-up|0
266684|NCT02202980|884244|P9|Overall Study|Lost to Follow-up|1
266685|NCT02202980|884245|P8|Overall Study|Lost to Follow-up|1
266686|NCT02202980|884246|P7|Overall Study|Lost to Follow-up|0
266687|NCT02202980|884247|P6|Overall Study|Lost to Follow-up|0
266688|NCT02202980|884248|P5|Overall Study|Lost to Follow-up|0
266689|NCT02202980|884249|P4|Overall Study|Lost to Follow-up|1
266690|NCT02202980|884250|P3|Overall Study|Lost to Follow-up|1
266691|NCT02202980|884251|P2|Overall Study|Lost to Follow-up|1
266692|NCT02202980|884252|P1|Overall Study|Lost to Follow-up|0
266693|NCT02202980|884239|P14|Overall Study|Protocol Violation|0
266694|NCT02202980|884240|P13|Overall Study|Protocol Violation|0
266695|NCT02202980|884241|P12|Overall Study|Protocol Violation|0
266696|NCT02202980|884242|P11|Overall Study|Protocol Violation|0
266697|NCT02202980|884243|P10|Overall Study|Protocol Violation|0
266698|NCT02202980|884244|P9|Overall Study|Protocol Violation|0
266699|NCT02202980|884245|P8|Overall Study|Protocol Violation|0
266700|NCT02202980|884246|P7|Overall Study|Protocol Violation|0
266701|NCT02202980|884247|P6|Overall Study|Protocol Violation|0
266702|NCT02202980|884248|P5|Overall Study|Protocol Violation|3
266703|NCT02202980|884249|P4|Overall Study|Protocol Violation|3
266704|NCT02202980|884250|P3|Overall Study|Protocol Violation|0
266705|NCT02202980|884251|P2|Overall Study|Protocol Violation|0
266706|NCT02202980|884252|P1|Overall Study|Protocol Violation|0
266707|NCT02202980|884239|P14|Overall Study|Lack of Efficacy|0
266708|NCT02202980|884240|P13|Overall Study|Lack of Efficacy|10
266709|NCT02202980|884241|P12|Overall Study|Lack of Efficacy|3
266710|NCT02202980|884242|P11|Overall Study|Lack of Efficacy|0
266711|NCT02202980|884243|P10|Overall Study|Lack of Efficacy|0
266712|NCT02202980|884244|P9|Overall Study|Lack of Efficacy|2
266713|NCT02202980|884245|P8|Overall Study|Lack of Efficacy|2
266714|NCT02202980|884246|P7|Overall Study|Lack of Efficacy|11
266715|NCT02202980|884247|P6|Overall Study|Lack of Efficacy|1
266716|NCT02202980|884248|P5|Overall Study|Lack of Efficacy|3
266717|NCT02202980|884249|P4|Overall Study|Lack of Efficacy|0
266718|NCT02202980|884250|P3|Overall Study|Lack of Efficacy|7
266719|NCT02202980|884251|P2|Overall Study|Lack of Efficacy|0
266720|NCT02202980|884252|P1|Overall Study|Lack of Efficacy|1
266721|NCT02202785|884341|P3|Overall Study|Reason not Specified|13
266722|NCT02202785|884342|P2|Overall Study|Reason not Specified|7
266723|NCT02202785|884343|P1|Overall Study|Reason not Specified|10
266724|NCT02202785|884341|P3|Overall Study|Lost to Follow-up|0
266725|NCT02202785|884342|P2|Overall Study|Lost to Follow-up|1
266726|NCT02202785|884343|P1|Overall Study|Lost to Follow-up|0
266727|NCT02202785|884341|P3|Overall Study|Withdrawal by Subject|0
266728|NCT02202785|884342|P2|Overall Study|Withdrawal by Subject|1
266729|NCT02202785|884343|P1|Overall Study|Withdrawal by Subject|0
266730|NCT02202785|884341|P3|Overall Study|Study Terminated by Sponsor|4
266731|NCT02202785|884342|P2|Overall Study|Study Terminated by Sponsor|6
266732|NCT02202785|884343|P1|Overall Study|Study Terminated by Sponsor|1
266733|NCT02202759|884380|P3|Overall Study|Reason not Specified|10
266734|NCT02202759|884381|P2|Overall Study|Reason not Specified|11
266735|NCT02202759|884382|P1|Overall Study|Reason not Specified|4
266736|NCT02202759|884380|P3|Overall Study|Withdrawal by Subject|1
266737|NCT02202759|884381|P2|Overall Study|Withdrawal by Subject|1
266738|NCT02202759|884382|P1|Overall Study|Withdrawal by Subject|2
266739|NCT02202759|884380|P3|Overall Study|Study Terminated by Sponsor|3
266740|NCT02202759|884381|P2|Overall Study|Study Terminated by Sponsor|3
266741|NCT02202759|884382|P1|Overall Study|Study Terminated by Sponsor|3
266742|NCT02202538|884416|P1|Overall Study|Investigator Decision|1
266743|NCT02202538|884416|P1|Overall Study|Did not meet all inclusion criteria|2
266744|NCT02202538|884416|P1|Overall Study|Withdrawal by Subject|5
266745|NCT02202317|884427|P1|Overall Study|Lost to Follow-up|1
266746|NCT02202161|884454|P8|Overall Study|Withdrawal by Subject|0
266747|NCT02202161|884455|P7|Overall Study|Withdrawal by Subject|0
266748|NCT02202161|884456|P6|Overall Study|Withdrawal by Subject|0
266749|NCT02202161|884457|P5|Overall Study|Withdrawal by Subject|1
266750|NCT02202161|884458|P4|Overall Study|Withdrawal by Subject|0
266751|NCT02202161|884459|P3|Overall Study|Withdrawal by Subject|0
266752|NCT02202161|884460|P2|Overall Study|Withdrawal by Subject|0
266753|NCT02202161|884461|P1|Overall Study|Withdrawal by Subject|0
266754|NCT02202161|884454|P8|Overall Study|Physician Decision|3
266755|NCT02202161|884455|P7|Overall Study|Physician Decision|0
266756|NCT02202161|884456|P6|Overall Study|Physician Decision|0
266757|NCT02202161|884457|P5|Overall Study|Physician Decision|0
266758|NCT02202161|884458|P4|Overall Study|Physician Decision|0
266759|NCT02202161|884459|P3|Overall Study|Physician Decision|0
266760|NCT02202161|884460|P2|Overall Study|Physician Decision|0
266761|NCT02202161|884461|P1|Overall Study|Physician Decision|0
266762|NCT02202161|884454|P8|Overall Study|Did not meet continuation criteria|3
266763|NCT02202161|884455|P7|Overall Study|Did not meet continuation criteria|0
266764|NCT02202161|884456|P6|Overall Study|Did not meet continuation criteria|0
266765|NCT02202161|884457|P5|Overall Study|Did not meet continuation criteria|0
266766|NCT02202161|884458|P4|Overall Study|Did not meet continuation criteria|0
266767|NCT02202161|884459|P3|Overall Study|Did not meet continuation criteria|0
266768|NCT02202161|884460|P2|Overall Study|Did not meet continuation criteria|0
266769|NCT02202161|884461|P1|Overall Study|Did not meet continuation criteria|0
266770|NCT02202161|884454|P8|Overall Study|Adverse Event|0
266771|NCT02202161|884455|P7|Overall Study|Adverse Event|0
266772|NCT02202161|884456|P6|Overall Study|Adverse Event|1
266773|NCT02202161|884457|P5|Overall Study|Adverse Event|0
266774|NCT02202161|884458|P4|Overall Study|Adverse Event|0
266775|NCT02202161|884459|P3|Overall Study|Adverse Event|0
266776|NCT02202161|884460|P2|Overall Study|Adverse Event|1
266777|NCT02202161|884461|P1|Overall Study|Adverse Event|1
266778|NCT02201953|884621|P2|Overall Study|Death|3
266779|NCT02201953|884622|P1|Overall Study|Death|0
266780|NCT02201953|884621|P2|Overall Study|Adverse Event|5
266781|NCT02201953|884622|P1|Overall Study|Adverse Event|0
266782|NCT02201953|884621|P2|Overall Study|Withdrew Consent|5
266783|NCT02201953|884622|P1|Overall Study|Withdrew Consent|2
266784|NCT02201953|884621|P2|Overall Study|Lost to Follow-up|8
266785|NCT02201953|884622|P1|Overall Study|Lost to Follow-up|8
266786|NCT02201953|884621|P2|Overall Study|Lack of Efficacy|30
266787|NCT02201953|884622|P1|Overall Study|Lack of Efficacy|9
266788|NCT02201953|884621|P2|Overall Study|Randomized but Never Treated|5
266789|NCT02201953|884622|P1|Overall Study|Randomized but Never Treated|1
266790|NCT02201940|884640|P2|Overall Study|Adverse Event|1
266791|NCT02201940|884641|P1|Overall Study|Adverse Event|0
266792|NCT02201940|884640|P2|Overall Study|Death|0
266793|NCT02201940|884641|P1|Overall Study|Death|1
266794|NCT02201940|884640|P2|Overall Study|Investigator's Discretion|1
266795|NCT02201940|884641|P1|Overall Study|Investigator's Discretion|1
266796|NCT02201940|884640|P2|Overall Study|Withdrew Consent|1
266797|NCT02201940|884641|P1|Overall Study|Withdrew Consent|2
266798|NCT02201940|884640|P2|Overall Study|Lost to Follow-up|0
266799|NCT02201940|884641|P1|Overall Study|Lost to Follow-up|5
266800|NCT02201940|884640|P2|Overall Study|Lack of Efficacy|113
266801|NCT02201940|884641|P1|Overall Study|Lack of Efficacy|2
266802|NCT02201940|884640|P2|Overall Study|Randomized/Enrolled but Never Treated|0
266803|NCT02201940|884641|P1|Overall Study|Randomized/Enrolled but Never Treated|1
266804|NCT02201901|884660|P3|Overall Study|Adverse Event|0
266805|NCT02201901|884661|P2|Overall Study|Adverse Event|1
266806|NCT02201901|884662|P1|Overall Study|Adverse Event|1
266807|NCT02201901|884660|P3|Overall Study|Withdrew Consent|2
266808|NCT02201901|884661|P2|Overall Study|Withdrew Consent|0
266809|NCT02201901|884662|P1|Overall Study|Withdrew Consent|2
266810|NCT02201901|884660|P3|Overall Study|Lost to Follow-up|2
266811|NCT02201901|884661|P2|Overall Study|Lost to Follow-up|3
266812|NCT02201901|884662|P1|Overall Study|Lost to Follow-up|2
266813|NCT02201901|884660|P3|Overall Study|Death|3
266814|NCT02201901|884661|P2|Overall Study|Death|3
266815|NCT02201901|884662|P1|Overall Study|Death|3
266816|NCT02201901|884660|P3|Overall Study|Lack of Efficacy|6
266817|NCT02201901|884661|P2|Overall Study|Lack of Efficacy|1
266818|NCT02201901|884662|P1|Overall Study|Lack of Efficacy|7
266819|NCT02201901|884660|P3|Overall Study|Randomized but never treated|0
266820|NCT02201901|884661|P2|Overall Study|Randomized but never treated|1
266821|NCT02201901|884662|P1|Overall Study|Randomized but never treated|0
266822|NCT02201784|884693|P2|Overall Study|Failure to achieve adequate block|0
266823|NCT02201784|884694|P1|Overall Study|Failure to achieve adequate block|2
266824|NCT02201524|884712|P4|Overall Study|Other|0
266825|NCT02201524|884713|P3|Overall Study|Other|0
266826|NCT02201524|884714|P2|Overall Study|Other|1
266827|NCT02201524|884715|P1|Overall Study|Other|1
266828|NCT02201524|884712|P4|Overall Study|Withdrawal by Subject|1
266829|NCT02201524|884713|P3|Overall Study|Withdrawal by Subject|1
266830|NCT02201524|884714|P2|Overall Study|Withdrawal by Subject|0
266831|NCT02201524|884715|P1|Overall Study|Withdrawal by Subject|0
266832|NCT02201524|884712|P4|Overall Study|Protocol Violation|1
266833|NCT02201524|884713|P3|Overall Study|Protocol Violation|0
266834|NCT02201524|884714|P2|Overall Study|Protocol Violation|0
266835|NCT02201524|884715|P1|Overall Study|Protocol Violation|0
266836|NCT02201524|884712|P4|Overall Study|No longer meets eligibility criteria|2
266837|NCT02201524|884713|P3|Overall Study|No longer meets eligibility criteria|0
266838|NCT02201524|884714|P2|Overall Study|No longer meets eligibility criteria|0
266839|NCT02201524|884715|P1|Overall Study|No longer meets eligibility criteria|0
266840|NCT02201524|884712|P4|Overall Study|Lost to Follow-up|0
266841|NCT02201524|884713|P3|Overall Study|Lost to Follow-up|2
266842|NCT02201524|884714|P2|Overall Study|Lost to Follow-up|0
266843|NCT02201524|884715|P1|Overall Study|Lost to Follow-up|0
266844|NCT02201524|884712|P4|Overall Study|Insufficient clinical response|0
266845|NCT02201524|884713|P3|Overall Study|Insufficient clinical response|0
266846|NCT02201524|884714|P2|Overall Study|Insufficient clinical response|0
266847|NCT02201524|884715|P1|Overall Study|Insufficient clinical response|1
266848|NCT02201524|884712|P4|Overall Study|Adverse Event|0
266849|NCT02201524|884713|P3|Overall Study|Adverse Event|1
266850|NCT02201524|884714|P2|Overall Study|Adverse Event|2
266851|NCT02201524|884715|P1|Overall Study|Adverse Event|0
266852|NCT02200510|884926|P2|Overall Study|potential COI - joined study team|0
266853|NCT02200510|884927|P1|Overall Study|potential COI - joined study team|1
266854|NCT02200510|884926|P2|Overall Study|Lost to Follow-up|1
266855|NCT02200510|884927|P1|Overall Study|Lost to Follow-up|7
266856|NCT02200510|884926|P2|Overall Study|Protocol Violation|1
266857|NCT02200510|884927|P1|Overall Study|Protocol Violation|0
266858|NCT02200510|884926|P2|Overall Study|Death|1
266859|NCT02200510|884927|P1|Overall Study|Death|1
266860|NCT02199795|884950|P2|Overall Study|withdrew due to shoulder pain|0
266861|NCT02199795|884951|P1|Overall Study|withdrew due to shoulder pain|1
266862|NCT02199795|884950|P2|Overall Study|no longer met inclusion criteria|0
266863|NCT02199795|884951|P1|Overall Study|no longer met inclusion criteria|1
266864|NCT02199509|884979|P2|Overall Study|Misunderstood titration schedule|0
266865|NCT02199509|884980|P1|Overall Study|Misunderstood titration schedule|1
266866|NCT02199509|884979|P2|Overall Study|Suicidal Ideation|1
266867|NCT02199509|884980|P1|Overall Study|Suicidal Ideation|0
266868|NCT02198963|885005|P1|Overall Study|Withdrawal by Subject|6
266869|NCT02198963|885005|P1|Overall Study|Adverse Event|1
266870|NCT02198235|885047|P3|Overall Study|Lost to Follow-up|2
266871|NCT02198235|885048|P2|Overall Study|Lost to Follow-up|2
266872|NCT02198235|885049|P1|Overall Study|Lost to Follow-up|3
266873|NCT02198040|885069|P3|Overall Study|Withdrawal by Subject|1
266874|NCT02198040|885070|P2|Overall Study|Withdrawal by Subject|0
266875|NCT02198040|885071|P1|Overall Study|Withdrawal by Subject|0
266876|NCT02198040|885069|P3|Overall Study|Work reasons|0
266877|NCT02198040|885070|P2|Overall Study|Work reasons|1
266878|NCT02198040|885071|P1|Overall Study|Work reasons|0
266879|NCT02197806|885101|P4|Overall Study|Adverse Event|1
266880|NCT02197806|885102|P3|Overall Study|Adverse Event|0
266881|NCT02197806|885103|P2|Overall Study|Adverse Event|1
266882|NCT02197806|885104|P1|Overall Study|Adverse Event|0
266883|NCT02197247|885155|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
266884|NCT02197247|885155|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
266885|NCT02197247|885155|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
266886|NCT02197247|885155|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
266887|NCT02197247|885155|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
266888|NCT02197247|885155|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
266889|NCT02197247|885155|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
266890|NCT02197247|885155|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
266891|NCT02197234|885200|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
266892|NCT02197234|885200|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
266893|NCT02197234|885200|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
266894|NCT02197234|885200|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
266895|NCT02197234|885200|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
266896|NCT02197234|885200|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
266897|NCT02197234|885200|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
266898|NCT02197130|885222|P3|Overall Study|Other|3
266899|NCT02197130|885223|P2|Overall Study|Other|0
266900|NCT02197130|885224|P1|Overall Study|Other|1
266901|NCT02197130|885222|P3|Overall Study|Withdrawal by Subject|4
266902|NCT02197130|885223|P2|Overall Study|Withdrawal by Subject|3
266903|NCT02197130|885224|P1|Overall Study|Withdrawal by Subject|0
266904|NCT02197130|885222|P3|Overall Study|Does not meet entrance criteria|1
266905|NCT02197130|885223|P2|Overall Study|Does not meet entrance criteria|0
266906|NCT02197130|885224|P1|Overall Study|Does not meet entrance criteria|0
266907|NCT02197130|885222|P3|Overall Study|Lost to Follow-up|1
266908|NCT02197130|885223|P2|Overall Study|Lost to Follow-up|0
266909|NCT02197130|885224|P1|Overall Study|Lost to Follow-up|2
266910|NCT02197130|885222|P3|Overall Study|Death|0
266911|NCT02197130|885223|P2|Overall Study|Death|1
266912|NCT02197130|885224|P1|Overall Study|Death|0
266913|NCT02197130|885222|P3|Overall Study|Adverse Event|23
266914|NCT02197130|885223|P2|Overall Study|Adverse Event|4
266915|NCT02197130|885224|P1|Overall Study|Adverse Event|13
266916|NCT02196714|885316|P4|Overall Study|Protocol Violation|0
266917|NCT02196714|885317|P3|Overall Study|Protocol Violation|1
266918|NCT02196714|885318|P2|Overall Study|Protocol Violation|0
266919|NCT02196714|885319|P1|Overall Study|Protocol Violation|0
266920|NCT02196701|885441|P1|Overall Study|Non-adherence to Protocol|1
266921|NCT02196701|885441|P1|Overall Study|Lost to Follow-up|1
266922|NCT02196701|885441|P1|Overall Study|Adverse Event|1
266923|NCT02196675|885500|P3|Overall Study|Death|1
266924|NCT02196675|885501|P2|Overall Study|Death|0
266925|NCT02196675|885502|P1|Overall Study|Death|0
266926|NCT02196675|885500|P3|Overall Study|Protocol Violation|0
266927|NCT02196675|885501|P2|Overall Study|Protocol Violation|1
266928|NCT02196675|885502|P1|Overall Study|Protocol Violation|0
266929|NCT02196675|885500|P3|Overall Study|Intra-operative surgical exclusion|0
266930|NCT02196675|885501|P2|Overall Study|Intra-operative surgical exclusion|1
266931|NCT02196675|885502|P1|Overall Study|Intra-operative surgical exclusion|1
266932|NCT02196675|885500|P3|Overall Study|Withdrawal by Subject|0
266933|NCT02196675|885501|P2|Overall Study|Withdrawal by Subject|0
266934|NCT02196675|885502|P1|Overall Study|Withdrawal by Subject|1
266935|NCT02196259|885525|P3|Overall Study|Partial data analysis|0
266936|NCT02196259|885526|P2|Overall Study|Partial data analysis|3
266937|NCT02196259|885527|P1|Overall Study|Partial data analysis|0
266938|NCT02196259|885525|P3|Overall Study|Researcher choice|1
266939|NCT02196259|885526|P2|Overall Study|Researcher choice|0
266940|NCT02196259|885527|P1|Overall Study|Researcher choice|0
266941|NCT02196077|885555|P1|Overall Study|Protocol Violation|24
266942|NCT02196077|885555|P1|Overall Study|Lost to Follow-up|3
266943|NCT02196077|885555|P1|Overall Study|Physician Decision|1
266944|NCT02196077|885555|P1|Overall Study|Withdrawal by Subject|14
266945|NCT02196077|885555|P1|Overall Study|Lack of Efficacy|1
266946|NCT02196077|885555|P1|Overall Study|Adverse Event|4
266947|NCT02195986|885605|P3|Overall Study|Non-compliance|0
266948|NCT02195986|885606|P2|Overall Study|Non-compliance|1
266949|NCT02195986|885607|P1|Overall Study|Non-compliance|0
266950|NCT02195986|885605|P3|Overall Study|Protocol Violation|1
266951|NCT02195986|885606|P2|Overall Study|Protocol Violation|1
266952|NCT02195986|885607|P1|Overall Study|Protocol Violation|0
266953|NCT02195986|885605|P3|Overall Study|Family Emergency|1
266954|NCT02195986|885606|P2|Overall Study|Family Emergency|0
266955|NCT02195986|885607|P1|Overall Study|Family Emergency|0
266956|NCT02195986|885605|P3|Overall Study|Withdrawal by Subject|0
266957|NCT02195986|885606|P2|Overall Study|Withdrawal by Subject|3
266958|NCT02195986|885607|P1|Overall Study|Withdrawal by Subject|0
266959|NCT02195986|885605|P3|Overall Study|Adverse Event|0
266960|NCT02195986|885606|P2|Overall Study|Adverse Event|0
266961|NCT02195986|885607|P1|Overall Study|Adverse Event|3
266962|NCT02195700|885633|P2|Overall Study|Lost to Follow-up|1
266963|NCT02195700|885634|P1|Overall Study|Lost to Follow-up|1
266964|NCT02195700|885633|P2|Overall Study|Withdrawal by Subject|2
266965|NCT02195700|885634|P1|Overall Study|Withdrawal by Subject|3
266966|NCT02195700|885633|P2|Overall Study|Adverse Event|2
266967|NCT02195700|885634|P1|Overall Study|Adverse Event|1
266968|NCT02195700|885633|P2|Overall Study|Noncompliance|0
266969|NCT02195700|885634|P1|Overall Study|Noncompliance|1
266970|NCT02195700|885633|P2|Overall Study|Protocol Violation|2
266971|NCT02195700|885634|P1|Overall Study|Protocol Violation|0
266972|NCT02195687|885656|P2|Overall Study|Lost to Follow-up|1
266973|NCT02195687|885657|P1|Overall Study|Lost to Follow-up|4
266974|NCT02195687|885656|P2|Overall Study|Personal Reasons|1
266975|NCT02195687|885657|P1|Overall Study|Personal Reasons|1
266976|NCT02195583|885673|P1|Overall Study|Other Reason|2
266977|NCT02195583|885673|P1|Overall Study|Adverse Event|2
266978|NCT02195583|885673|P1|Overall Study|Withdrawal by Subject|4
266979|NCT02195583|885673|P1|Overall Study|Lost to Follow-up|1
266980|NCT02195427|885707|P2|Overall Study|Conditional re-treatment at W52|1
266981|NCT02195427|885708|P1|Overall Study|Conditional re-treatment at W52|2
266982|NCT02195427|885707|P2|Overall Study|Protocol Violation|14
266983|NCT02195427|885708|P1|Overall Study|Protocol Violation|7
266984|NCT02195427|885707|P2|Overall Study|Lost to Follow-up|1
266985|NCT02195427|885708|P1|Overall Study|Lost to Follow-up|0
266986|NCT02195427|885707|P2|Overall Study|Withdrawal by Subject|2
266987|NCT02195427|885708|P1|Overall Study|Withdrawal by Subject|4
266988|NCT02195427|885707|P2|Overall Study|Did not consent to study extension|9
266989|NCT02195427|885708|P1|Overall Study|Did not consent to study extension|13
266990|NCT02194699|885779|P2|With Potential to Receive 52 Weeks of IP|Other|16
266991|NCT02194699|885780|P1|With Potential to Receive 52 Weeks of IP|Other|24
266992|NCT02194699|885779|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
266993|NCT02194699|885780|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
266994|NCT02194699|885779|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
266995|NCT02194699|885780|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
266996|NCT02194699|885779|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
266997|NCT02194699|885780|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
266998|NCT02194699|885779|P2|With Potential to Receive 52 Weeks of IP|Death|3
266999|NCT02194699|885780|P1|With Potential to Receive 52 Weeks of IP|Death|1
267000|NCT02194699|885779|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
267001|NCT02194699|885780|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
267002|NCT02194699|885779|P2|Randomised|Duplicate patient|1
267003|NCT02194699|885780|P1|Randomised|Duplicate patient|2
267004|NCT02194699|885779|P2|Randomised|Without potential for 52 weeks of IP|5
267005|NCT02194699|885780|P1|Randomised|Without potential for 52 weeks of IP|5
267006|NCT02194699|885779|P2|Randomised|Did not receive treatment|5
267007|NCT02194699|885780|P1|Randomised|Did not receive treatment|1
267008|NCT02194621|885888|P3|Overall Study|Withdrawal by Subject|7
267009|NCT02194621|885889|P2|Overall Study|Withdrawal by Subject|4
267010|NCT02194621|885890|P1|Overall Study|Withdrawal by Subject|4
267011|NCT02194621|885888|P3|Overall Study|6 withdrew prior to randomization|2
267012|NCT02194621|885889|P2|Overall Study|6 withdrew prior to randomization|2
267013|NCT02194621|885890|P1|Overall Study|6 withdrew prior to randomization|2
267014|NCT02194062|885923|P3|Overall Study|Lost to Follow-up|5
267015|NCT02194062|885924|P2|Overall Study|Lost to Follow-up|2
267016|NCT02194062|885925|P1|Overall Study|Lost to Follow-up|2
267017|NCT02193828|885940|P4|Overall Study|Withdrawal by Subject|1
267018|NCT02193828|885941|P3|Overall Study|Withdrawal by Subject|1
267019|NCT02193828|885942|P2|Overall Study|Withdrawal by Subject|0
267020|NCT02193828|885943|P1|Overall Study|Withdrawal by Subject|0
267021|NCT02193178|886016|P1|Overall Study|Dry eyes|1
267022|NCT02193178|886016|P1|Overall Study|Lost to Follow-up|1
267023|NCT02193165|886066|P3|6 Week Product Use|Lost to Follow-up|0
267024|NCT02193165|886067|P2|6 Week Product Use|Lost to Follow-up|1
267025|NCT02193165|886068|P1|6 Week Product Use|Lost to Follow-up|0
267026|NCT02193165|886066|P3|4 Week Product Use|Lost to Follow-up|1
267027|NCT02193165|886067|P2|4 Week Product Use|Lost to Follow-up|1
267028|NCT02193165|886068|P1|4 Week Product Use|Lost to Follow-up|1
267029|NCT02193087|886095|P4|Overall Study|Did Not Receive Any Vaccination|1
267030|NCT02193087|886096|P3|Overall Study|Did Not Receive Any Vaccination|0
267031|NCT02193087|886097|P2|Overall Study|Did Not Receive Any Vaccination|3
267032|NCT02193087|886098|P1|Overall Study|Did Not Receive Any Vaccination|2
267033|NCT02193087|886095|P4|Overall Study|Other Reason Not Specified|9
267034|NCT02193087|886096|P3|Overall Study|Other Reason Not Specified|1
267035|NCT02193087|886097|P2|Overall Study|Other Reason Not Specified|2
267036|NCT02193087|886098|P1|Overall Study|Other Reason Not Specified|7
267037|NCT02193087|886095|P4|Overall Study|Withdrawal by Subject|19
267038|NCT02193087|886096|P3|Overall Study|Withdrawal by Subject|1
267039|NCT02193087|886097|P2|Overall Study|Withdrawal by Subject|3
267040|NCT02193087|886098|P1|Overall Study|Withdrawal by Subject|10
267041|NCT02193087|886095|P4|Overall Study|Protocol Violation|2
267042|NCT02193087|886096|P3|Overall Study|Protocol Violation|1
267043|NCT02193087|886097|P2|Overall Study|Protocol Violation|0
267044|NCT02193087|886098|P1|Overall Study|Protocol Violation|2
267045|NCT02193087|886095|P4|Overall Study|Lost to Follow-up|37
267046|NCT02193087|886096|P3|Overall Study|Lost to Follow-up|4
267047|NCT02193087|886097|P2|Overall Study|Lost to Follow-up|6
267048|NCT02193087|886098|P1|Overall Study|Lost to Follow-up|14
267049|NCT02193087|886095|P4|Overall Study|Adverse Event|11
267050|NCT02193087|886096|P3|Overall Study|Adverse Event|0
267051|NCT02193087|886097|P2|Overall Study|Adverse Event|0
267052|NCT02193087|886098|P1|Overall Study|Adverse Event|2
267053|NCT02193074|886143|P2|Overall Study|Adverse Event|13
267054|NCT02193074|886144|P1|Overall Study|Adverse Event|16
267055|NCT02193074|886143|P2|Overall Study|Withdrawal by Subject|2
267056|NCT02193074|886144|P1|Overall Study|Withdrawal by Subject|1
267057|NCT02192905|886176|P1|Overall Study|Lost to Follow-up|1
267058|NCT02192606|886240|P2|Overall Study|3D equipment rep unable to join|1
267059|NCT02192606|886241|P1|Overall Study|3D equipment rep unable to join|0
267060|NCT02192606|886240|P2|Overall Study|Physician Decision|2
267061|NCT02192606|886241|P1|Overall Study|Physician Decision|1
267062|NCT02192606|886240|P2|Overall Study|surgery type was changed|1
267063|NCT02192606|886241|P1|Overall Study|surgery type was changed|1
267064|NCT02192164|886272|P1|Overall Study|Did not meet the exclusion criteria|1
267065|NCT02192164|886272|P1|Overall Study|Physician Decision|4
267066|NCT02192164|886272|P1|Overall Study|Withdrawal by Subject|1
267067|NCT02192164|886272|P1|Overall Study|Other|8
267068|NCT02191579|886315|P2|Treatment 2|Multiple Reasons Specified|25
267069|NCT02191579|886316|P1|Treatment 2|Multiple Reasons Specified|0
267070|NCT02191579|886315|P2|Treatment 1|Multiple Reasons Specified|58
267071|NCT02191579|886316|P1|Treatment 1|Multiple Reasons Specified|27
267072|NCT02191267|886331|P3|Overall Study|Withdrawal by Subject|0
267073|NCT02191267|886332|P2|Overall Study|Withdrawal by Subject|0
267074|NCT02191267|886333|P1|Overall Study|Withdrawal by Subject|1
267075|NCT02191137|886344|P1|Follow-up|Adverse Event|1
267076|NCT02191137|886344|P1|Follow-up|Ongoing/unknown|2
267077|NCT02191137|886344|P1|Follow-up|Lost to Follow-up|2
267078|NCT02191137|886344|P1|Treatment|Other|1
267079|NCT02191137|886344|P1|Treatment|Adverse Event|2
267080|NCT02191137|886344|P1|Treatment|Withdrawal by Subject|3
267081|NCT02191137|886344|P1|Treatment|Death|4
267082|NCT02191046|886374|P2|Overall Study|low compliance|1
267083|NCT02191046|886375|P1|Overall Study|low compliance|5
267084|NCT02190604|886413|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267085|NCT02190604|886414|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267086|NCT02190604|886415|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267087|NCT02190604|886416|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267088|NCT02190604|886417|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267089|NCT02190604|886418|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
267090|NCT02190604|886419|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267091|NCT02190604|886420|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267092|NCT02190604|886421|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267093|NCT02190604|886422|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267094|NCT02190604|886423|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267095|NCT02190604|886424|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267096|NCT02190604|886425|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267097|NCT02190604|886426|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267098|NCT02190604|886427|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267099|NCT02190604|886428|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267100|NCT02190604|886429|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267101|NCT02190604|886430|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267102|NCT02190604|886431|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
267103|NCT02190604|886413|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267104|NCT02190604|886414|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267105|NCT02190604|886415|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267106|NCT02190604|886416|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267107|NCT02190604|886417|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
267108|NCT02190604|886418|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267109|NCT02190604|886419|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267110|NCT02190604|886420|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267111|NCT02190604|886421|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267112|NCT02190604|886422|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267113|NCT02190604|886423|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267114|NCT02190604|886424|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267115|NCT02190604|886425|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267116|NCT02190604|886426|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267117|NCT02190604|886427|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267118|NCT02190604|886428|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267119|NCT02190604|886429|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267120|NCT02190604|886430|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267121|NCT02190604|886431|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
267122|NCT02190591|886622|P2|Overall Study|face presentation so she was ineligible|1
267123|NCT02190591|886623|P1|Overall Study|face presentation so she was ineligible|0
267124|NCT02190591|886622|P2|Overall Study|did not use peanut ball as instructed|2
267125|NCT02190591|886623|P1|Overall Study|did not use peanut ball as instructed|0
267126|NCT02190591|886622|P2|Overall Study|Protocol Violation|0
267127|NCT02190591|886623|P1|Overall Study|Protocol Violation|1
267128|NCT02190591|886622|P2|Overall Study|Withdrawal by Subject|8
267129|NCT02190591|886623|P1|Overall Study|Withdrawal by Subject|1
267130|NCT02190435|886635|P2|Overall Study|3 consented screen fails|0
267131|NCT02190435|886636|P1|Overall Study|3 consented screen fails|3
267132|NCT02190435|886635|P2|Overall Study|First 12 patients were lead-ins|0
267133|NCT02190435|886636|P1|Overall Study|First 12 patients were lead-ins|12
267134|NCT02189941|886655|P3|Overall Study|Non-compliance|1
267135|NCT02189941|886656|P2|Overall Study|Non-compliance|0
267136|NCT02189941|886657|P1|Overall Study|Non-compliance|0
267137|NCT02189863|886685|P2|First 2 Weeks|Motion Sickness|2
267138|NCT02189863|886686|P1|First 2 Weeks|Motion Sickness|4
267139|NCT02189837|886701|P4|Overall Study|Sponsor Decision|1
267140|NCT02189837|886702|P3|Overall Study|Sponsor Decision|0
267141|NCT02189837|886703|P2|Overall Study|Sponsor Decision|0
267142|NCT02189837|886704|P1|Overall Study|Sponsor Decision|0
267143|NCT02189837|886701|P4|Overall Study|Withdrawal by Subject|1
267144|NCT02189837|886702|P3|Overall Study|Withdrawal by Subject|3
267145|NCT02189837|886703|P2|Overall Study|Withdrawal by Subject|1
267146|NCT02189837|886704|P1|Overall Study|Withdrawal by Subject|2
267147|NCT02189759|886734|P4|Overall Study|Lost to Follow-up|5
267148|NCT02189759|886735|P3|Overall Study|Lost to Follow-up|2
267149|NCT02189759|886736|P2|Overall Study|Lost to Follow-up|0
267150|NCT02189759|886737|P1|Overall Study|Lost to Follow-up|0
267151|NCT02189252|886783|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
267152|NCT02189252|886784|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
267153|NCT02189252|886785|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
267154|NCT02189252|886786|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
267155|NCT02189252|886783|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
267156|NCT02189252|886784|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
267157|NCT02189252|886785|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
267158|NCT02189252|886786|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
267159|NCT02188849|886845|P2|Overall Study|Lost to Follow-up|8
267160|NCT02188849|886846|P1|Overall Study|Lost to Follow-up|3
267161|NCT02188784|886860|P2|Overall Study|Physician Decision|3
267162|NCT02188784|886861|P1|Overall Study|Physician Decision|2
267163|NCT02188784|886860|P2|Overall Study|Withdrawal by Subject|9
267164|NCT02188784|886861|P1|Overall Study|Withdrawal by Subject|3
267165|NCT02188784|886860|P2|Overall Study|Lost to Follow-up|0
267166|NCT02188784|886861|P1|Overall Study|Lost to Follow-up|1
267167|NCT02188784|886860|P2|Overall Study|Death|1
267168|NCT02188784|886861|P1|Overall Study|Death|3
267169|NCT02187861|886897|P4|Overall Study|Alive in Study Follow-Up|31
267170|NCT02187861|886898|P3|Overall Study|Alive in Study Follow-Up|26
267171|NCT02187861|886899|P2|Overall Study|Alive in Study Follow-Up|10
267172|NCT02187861|886900|P1|Overall Study|Alive in Study Follow-Up|4
267173|NCT02187861|886897|P4|Overall Study|Other|1
267174|NCT02187861|886898|P3|Overall Study|Other|6
267175|NCT02187861|886899|P2|Overall Study|Other|2
267176|NCT02187861|886900|P1|Overall Study|Other|0
267177|NCT02187861|886897|P4|Overall Study|Withdrawal by Subject|3
267178|NCT02187861|886898|P3|Overall Study|Withdrawal by Subject|2
267179|NCT02187861|886899|P2|Overall Study|Withdrawal by Subject|0
267180|NCT02187861|886900|P1|Overall Study|Withdrawal by Subject|0
267181|NCT02187861|886897|P4|Overall Study|Progressive Disease|11
267182|NCT02187861|886898|P3|Overall Study|Progressive Disease|13
267183|NCT02187861|886899|P2|Overall Study|Progressive Disease|35
267184|NCT02187861|886900|P1|Overall Study|Progressive Disease|3
267185|NCT02187861|886897|P4|Overall Study|Physician Decision|3
267186|NCT02187861|886898|P3|Overall Study|Physician Decision|0
267187|NCT02187861|886899|P2|Overall Study|Physician Decision|1
267188|NCT02187861|886900|P1|Overall Study|Physician Decision|0
267189|NCT02187861|886897|P4|Overall Study|Lack of Efficacy|0
267190|NCT02187861|886898|P3|Overall Study|Lack of Efficacy|0
267191|NCT02187861|886899|P2|Overall Study|Lack of Efficacy|1
267192|NCT02187861|886900|P1|Overall Study|Lack of Efficacy|0
267193|NCT02187861|886897|P4|Overall Study|Death|2
267194|NCT02187861|886898|P3|Overall Study|Death|1
267195|NCT02187861|886899|P2|Overall Study|Death|3
267196|NCT02187861|886900|P1|Overall Study|Death|0
267197|NCT02187861|886897|P4|Overall Study|Adverse Event|0
267198|NCT02187861|886898|P3|Overall Study|Adverse Event|3
267199|NCT02187861|886899|P2|Overall Study|Adverse Event|1
267200|NCT02187861|886900|P1|Overall Study|Adverse Event|2
267201|NCT02187809|886996|P1|Overall Study|The study was terminated|3
267202|NCT02187744|887008|P2|Treatment|Participant refused continued treatment|1
267203|NCT02187744|887009|P1|Treatment|Participant refused continued treatment|1
267204|NCT02187744|887008|P2|Treatment|Not specified|0
267205|NCT02187744|887009|P1|Treatment|Not specified|2
267206|NCT02187744|887008|P2|Treatment|Lost to Follow-up|1
267207|NCT02187744|887009|P1|Treatment|Lost to Follow-up|0
267208|NCT02187744|887008|P2|Treatment|Related adverse event, not serious|2
267209|NCT02187744|887009|P1|Treatment|Related adverse event, not serious|0
267210|NCT02187744|887008|P2|Treatment|Related adverse event, serious non-fatal|1
267211|NCT02187744|887009|P1|Treatment|Related adverse event, serious non-fatal|0
267212|NCT02187744|887008|P2|Treatment|Death|0
267213|NCT02187744|887009|P1|Treatment|Death|1
267214|NCT02187744|887008|P2|Study|Related adverse event, serious non-fatal|1
267215|NCT02187744|887009|P1|Study|Related adverse event, serious non-fatal|0
267216|NCT02187744|887008|P2|Study|Death|0
267217|NCT02187744|887009|P1|Study|Death|1
267218|NCT02187744|887008|P2|Study|Related adverse event, not serious|2
267219|NCT02187744|887009|P1|Study|Related adverse event, not serious|0
267220|NCT02187744|887008|P2|Study|Lost to Follow-up|2
267221|NCT02187744|887009|P1|Study|Lost to Follow-up|0
267222|NCT02187744|887008|P2|Study|Not specified|1
267223|NCT02187744|887009|P1|Study|Not specified|2
267224|NCT02187744|887008|P2|Study|Participant refused further follow-up|0
267225|NCT02187744|887009|P1|Study|Participant refused further follow-up|1
267226|NCT02187055|887028|P3|Overall Study|Death|0
267227|NCT02187055|887029|P2|Overall Study|Death|0
267228|NCT02187055|887030|P1|Overall Study|Death|2
267229|NCT02187055|887028|P3|Overall Study|Adverse Event|36
267230|NCT02187055|887029|P2|Overall Study|Adverse Event|26
267231|NCT02187055|887030|P1|Overall Study|Adverse Event|21
267232|NCT02187055|887028|P3|Overall Study|Withdrawal by Subject|11
267233|NCT02187055|887029|P2|Overall Study|Withdrawal by Subject|11
267234|NCT02187055|887030|P1|Overall Study|Withdrawal by Subject|11
267235|NCT02187055|887028|P3|Overall Study|Pregnancy|0
267236|NCT02187055|887029|P2|Overall Study|Pregnancy|1
267237|NCT02187055|887030|P1|Overall Study|Pregnancy|3
267238|NCT02187055|887028|P3|Overall Study|Protocol Violation|4
267239|NCT02187055|887029|P2|Overall Study|Protocol Violation|9
267240|NCT02187055|887030|P1|Overall Study|Protocol Violation|9
267241|NCT02187055|887028|P3|Overall Study|Other|3
267242|NCT02187055|887029|P2|Overall Study|Other|6
267243|NCT02187055|887030|P1|Overall Study|Other|5
267244|NCT02187055|887028|P3|Overall Study|No longer willing to participate|10
267245|NCT02187055|887029|P2|Overall Study|No longer willing to participate|8
267246|NCT02187055|887030|P1|Overall Study|No longer willing to participate|6
267247|NCT02187055|887028|P3|Overall Study|No longer meets eligibility criteria|0
267248|NCT02187055|887029|P2|Overall Study|No longer meets eligibility criteria|2
267249|NCT02187055|887030|P1|Overall Study|No longer meets eligibility criteria|0
267250|NCT02187055|887028|P3|Overall Study|Lost to Follow-up|3
267251|NCT02187055|887029|P2|Overall Study|Lost to Follow-up|7
267252|NCT02187055|887030|P1|Overall Study|Lost to Follow-up|2
267253|NCT02187055|887028|P3|Overall Study|Lack of Efficacy|7
267254|NCT02187055|887029|P2|Overall Study|Lack of Efficacy|3
267255|NCT02187055|887030|P1|Overall Study|Lack of Efficacy|10
267256|NCT02187029|887132|P4|Overall Study|Withdrawal by Subject|0
267257|NCT02187029|887133|P3|Overall Study|Withdrawal by Subject|0
267258|NCT02187029|887134|P2|Overall Study|Withdrawal by Subject|0
267259|NCT02187029|887135|P1|Overall Study|Withdrawal by Subject|1
267260|NCT02187029|887132|P4|Overall Study|Study Terminated by Sponsor|3
267261|NCT02187029|887133|P3|Overall Study|Study Terminated by Sponsor|10
267262|NCT02187029|887134|P2|Overall Study|Study Terminated by Sponsor|0
267263|NCT02187029|887135|P1|Overall Study|Study Terminated by Sponsor|0
267264|NCT02187029|887132|P4|Overall Study|Adverse Event|0
267265|NCT02187029|887133|P3|Overall Study|Adverse Event|1
267266|NCT02187029|887134|P2|Overall Study|Adverse Event|1
267267|NCT02187029|887135|P1|Overall Study|Adverse Event|0
267268|NCT02186873|887246|P2|Overall Study|Withdrawal by Subject|2
267269|NCT02186873|887247|P1|Overall Study|Withdrawal by Subject|7
267270|NCT02186873|887246|P2|Overall Study|Lost to Follow-up|2
267271|NCT02186873|887247|P1|Overall Study|Lost to Follow-up|1
267272|NCT02186873|887246|P2|Overall Study|Lack of Efficacy|1
267273|NCT02186873|887247|P1|Overall Study|Lack of Efficacy|0
267274|NCT02186873|887246|P2|Overall Study|Adverse Event|3
267275|NCT02186873|887247|P1|Overall Study|Adverse Event|1
267276|NCT02186223|887292|P1|Overall Study|Device in place less than 48 hours|9
267277|NCT02186223|887292|P1|Overall Study|Death|3
267278|NCT02186223|887292|P1|Overall Study|Unable to obtain femoral access|3
267279|NCT02186223|887292|P1|Overall Study|Not eligible for device placement|6
267280|NCT02185534|887322|P6|First Washout Period|Protocol Violation|1
267281|NCT02185534|887323|P5|First Washout Period|Protocol Violation|0
267282|NCT02185534|887324|P4|First Washout Period|Protocol Violation|0
267283|NCT02185534|887325|P3|First Washout Period|Protocol Violation|0
267284|NCT02185534|887326|P2|First Washout Period|Protocol Violation|0
267285|NCT02185534|887327|P1|First Washout Period|Protocol Violation|0
267286|NCT02185534|887322|P6|First Washout Period|Withdrawal by Subject|0
267287|NCT02185534|887323|P5|First Washout Period|Withdrawal by Subject|1
267288|NCT02185534|887324|P4|First Washout Period|Withdrawal by Subject|0
267289|NCT02185534|887325|P3|First Washout Period|Withdrawal by Subject|0
267290|NCT02185534|887326|P2|First Washout Period|Withdrawal by Subject|0
267291|NCT02185534|887327|P1|First Washout Period|Withdrawal by Subject|1
267292|NCT02185534|887322|P6|First Period|Withdrawal by Subject|0
267293|NCT02185534|887323|P5|First Period|Withdrawal by Subject|0
267294|NCT02185534|887324|P4|First Period|Withdrawal by Subject|1
267295|NCT02185534|887325|P3|First Period|Withdrawal by Subject|0
267296|NCT02185534|887326|P2|First Period|Withdrawal by Subject|0
267297|NCT02185534|887327|P1|First Period|Withdrawal by Subject|0
267298|NCT02183675|887513|P6|Treatment Period 2 (10 Days)|Adverse Event|2
267299|NCT02183675|887514|P5|Treatment Period 2 (10 Days)|Adverse Event|0
267300|NCT02183675|887515|P4|Treatment Period 2 (10 Days)|Adverse Event|0
267301|NCT02183675|887516|P3|Treatment Period 2 (10 Days)|Adverse Event|0
267302|NCT02183675|887517|P2|Treatment Period 2 (10 Days)|Adverse Event|0
267303|NCT02183675|887518|P1|Treatment Period 2 (10 Days)|Adverse Event|0
267304|NCT02183519|887542|P2|Overall Study|Did not respond to cough inducter|3
267305|NCT02183519|887543|P1|Overall Study|Did not respond to cough inducter|0
267306|NCT02183519|887542|P2|Overall Study|computer error|0
267307|NCT02183519|887543|P1|Overall Study|computer error|3
267308|NCT02182895|887551|P2|Overall Study|Discharged from hospital within 24 hours|4
267309|NCT02182895|887552|P1|Overall Study|Discharged from hospital within 24 hours|2
267310|NCT02181790|887583|P2|Overall Study|study terminated|0
267311|NCT02181790|887584|P1|Overall Study|study terminated|2
267312|NCT02181673|887594|P3|Week 24-Week 60|Physician Decision|1
267313|NCT02181673|887595|P2|Week 24-Week 60|Physician Decision|0
267314|NCT02181673|887596|P1|Week 24-Week 60|Physician Decision|0
267315|NCT02181673|887594|P3|Week 24-Week 60|Lost to Follow-up|1
267316|NCT02181673|887595|P2|Week 24-Week 60|Lost to Follow-up|0
267317|NCT02181673|887596|P1|Week 24-Week 60|Lost to Follow-up|0
267318|NCT02181673|887594|P3|Week 24-Week 60|Lack of Efficacy|1
267319|NCT02181673|887595|P2|Week 24-Week 60|Lack of Efficacy|0
267320|NCT02181673|887596|P1|Week 24-Week 60|Lack of Efficacy|0
267321|NCT02181673|887594|P3|Week 24-Week 60|Pregnancy|1
267322|NCT02181673|887595|P2|Week 24-Week 60|Pregnancy|0
267323|NCT02181673|887596|P1|Week 24-Week 60|Pregnancy|0
267324|NCT02181673|887594|P3|Week 24-Week 60|Withdrawal by Subject|2
267325|NCT02181673|887595|P2|Week 24-Week 60|Withdrawal by Subject|2
267326|NCT02181673|887596|P1|Week 24-Week 60|Withdrawal by Subject|0
267327|NCT02181673|887594|P3|Week 24-Week 60|Other|1
267328|NCT02181673|887595|P2|Week 24-Week 60|Other|2
267329|NCT02181673|887596|P1|Week 24-Week 60|Other|0
267330|NCT02181673|887594|P3|Week 24-Week 60|Adverse Event|10
267331|NCT02181673|887595|P2|Week 24-Week 60|Adverse Event|4
267332|NCT02181673|887596|P1|Week 24-Week 60|Adverse Event|0
267333|NCT02181673|887594|P3|Up to Week 24|Randomized not Treated|1
267334|NCT02181673|887595|P2|Up to Week 24|Randomized not Treated|0
267335|NCT02181673|887596|P1|Up to Week 24|Randomized not Treated|0
267336|NCT02181673|887594|P3|Up to Week 24|Other|3
267337|NCT02181673|887595|P2|Up to Week 24|Other|0
267338|NCT02181673|887596|P1|Up to Week 24|Other|2
267339|NCT02181673|887594|P3|Up to Week 24|Withdrawal by Subject|1
267340|NCT02181673|887595|P2|Up to Week 24|Withdrawal by Subject|0
267341|NCT02181673|887596|P1|Up to Week 24|Withdrawal by Subject|10
267342|NCT02181673|887594|P3|Up to Week 24|Physician Decision|3
267343|NCT02181673|887595|P2|Up to Week 24|Physician Decision|0
267344|NCT02181673|887596|P1|Up to Week 24|Physician Decision|0
267345|NCT02181673|887594|P3|Up to Week 24|Lost to Follow-up|0
267346|NCT02181673|887595|P2|Up to Week 24|Lost to Follow-up|0
267347|NCT02181673|887596|P1|Up to Week 24|Lost to Follow-up|1
267348|NCT02181673|887594|P3|Up to Week 24|Lack of Efficacy|0
267349|NCT02181673|887595|P2|Up to Week 24|Lack of Efficacy|0
267350|NCT02181673|887596|P1|Up to Week 24|Lack of Efficacy|1
267351|NCT02181673|887594|P3|Up to Week 24|Death|0
267352|NCT02181673|887595|P2|Up to Week 24|Death|0
267353|NCT02181673|887596|P1|Up to Week 24|Death|1
267354|NCT02181673|887594|P3|Up to Week 24|Adverse Event|3
267355|NCT02181673|887595|P2|Up to Week 24|Adverse Event|0
267356|NCT02181673|887596|P1|Up to Week 24|Adverse Event|2
267357|NCT02181634|887623|P1|Overall Study|Patient opted to proceed to surgery|1
267358|NCT02181634|887623|P1|Overall Study|Symptomatic progression|1
267359|NCT02181634|887623|P1|Overall Study|Max number of dose reduction|1
267360|NCT02181634|887623|P1|Overall Study|Ineligible|1
267361|NCT02181634|887623|P1|Overall Study|Treatment delayed greater than 4 weeks|3
267362|NCT02181634|887623|P1|Overall Study|Death|2
267363|NCT02181634|887623|P1|Overall Study|Withdrawal by Subject|5
267364|NCT02181634|887623|P1|Overall Study|Physician Decision|8
267365|NCT02181634|887623|P1|Overall Study|Adverse Event|17
267366|NCT02181634|887623|P1|Overall Study|Lack of Efficacy|33
267367|NCT02181504|887672|P3|Overall Study|Adverse Event|1
267368|NCT02181504|887673|P2|Overall Study|Adverse Event|1
267369|NCT02181504|887674|P1|Overall Study|Adverse Event|1
267370|NCT02180438|887784|P1|Overall Study|Lost to Follow-up|1
267371|NCT02180061|887802|P2|Overall Study|Continuing in Study|2
267372|NCT02180061|887803|P1|Overall Study|Continuing in Study|19
267373|NCT02180061|887802|P2|Overall Study|Progressive Disease|4
267374|NCT02180061|887803|P1|Overall Study|Progressive Disease|9
267375|NCT02180061|887802|P2|Overall Study|Clinical Progression|0
267376|NCT02180061|887803|P1|Overall Study|Clinical Progression|3
267377|NCT02180061|887802|P2|Overall Study|Adverse Event|2
267378|NCT02180061|887803|P1|Overall Study|Adverse Event|3
267379|NCT02179398|887856|P2|Overall Study|Lost to Follow-up|1
267380|NCT02179398|887857|P1|Overall Study|Lost to Follow-up|0
267381|NCT02179398|887856|P2|Overall Study|Lack of obligatory data|3
267382|NCT02179398|887857|P1|Overall Study|Lack of obligatory data|3
267383|NCT02178995|887877|P9|Open Label|Adverse Event|0
267384|NCT02178995|887878|P8|Open Label|Adverse Event|0
267385|NCT02178995|887879|P7|Open Label|Adverse Event|0
267386|NCT02178995|887880|P6|Open Label|Adverse Event|0
267387|NCT02178995|887881|P5|Open Label|Adverse Event|0
267388|NCT02178995|887882|P4|Open Label|Adverse Event|0
267389|NCT02178995|887883|P3|Open Label|Adverse Event|0
267390|NCT02178995|887884|P2|Open Label|Adverse Event|0
267391|NCT02178995|887885|P1|Open Label|Adverse Event|2
267392|NCT02178995|887877|P9|Double Blind|Lost to Follow-up|0
267393|NCT02178995|887878|P8|Double Blind|Lost to Follow-up|1
267394|NCT02178995|887879|P7|Double Blind|Lost to Follow-up|0
267395|NCT02178995|887880|P6|Double Blind|Lost to Follow-up|0
267396|NCT02178995|887881|P5|Double Blind|Lost to Follow-up|0
267397|NCT02178995|887882|P4|Double Blind|Lost to Follow-up|0
267398|NCT02178995|887883|P3|Double Blind|Lost to Follow-up|0
267399|NCT02178995|887884|P2|Double Blind|Lost to Follow-up|1
267400|NCT02178995|887885|P1|Double Blind|Lost to Follow-up|0
267401|NCT02178995|887877|P9|Double Blind|Adverse Event|1
267402|NCT02178995|887878|P8|Double Blind|Adverse Event|1
267403|NCT02178995|887879|P7|Double Blind|Adverse Event|0
267404|NCT02178995|887880|P6|Double Blind|Adverse Event|1
267405|NCT02178995|887881|P5|Double Blind|Adverse Event|0
267406|NCT02178995|887882|P4|Double Blind|Adverse Event|0
267407|NCT02178995|887883|P3|Double Blind|Adverse Event|0
267408|NCT02178995|887884|P2|Double Blind|Adverse Event|0
267409|NCT02178995|887885|P1|Double Blind|Adverse Event|0
267410|NCT02178787|887958|P2|Overall Study|Physician Decision|0
267411|NCT02178787|887959|P1|Overall Study|Physician Decision|1
267412|NCT02178787|887958|P2|Overall Study|No TCD window|7
267413|NCT02178787|887959|P1|Overall Study|No TCD window|3
267414|NCT02178787|887958|P2|Overall Study|Withdrawal by Subject|2
267415|NCT02178787|887959|P1|Overall Study|Withdrawal by Subject|0
267416|NCT02178787|887958|P2|Overall Study|Lost to Follow-up|0
267417|NCT02178787|887959|P1|Overall Study|Lost to Follow-up|1
267418|NCT02178059|887988|P2|Washout|Physician Decision|0
267419|NCT02178059|887989|P1|Washout|Physician Decision|1
267420|NCT02177266|888007|P2|Overall Study|Withdrawal by Subject|0
267421|NCT02177266|888008|P1|Overall Study|Withdrawal by Subject|1
267422|NCT02177266|888007|P2|Overall Study|Adverse Event|1
267423|NCT02177266|888008|P1|Overall Study|Adverse Event|0
267424|NCT02177136|888030|P3|Overall Study|Protocol Violation|1
267425|NCT02177136|888031|P2|Overall Study|Protocol Violation|0
267426|NCT02177136|888032|P1|Overall Study|Protocol Violation|0
267427|NCT02177136|888030|P3|Overall Study|Adverse Event|3
267428|NCT02177136|888031|P2|Overall Study|Adverse Event|2
267429|NCT02177136|888032|P1|Overall Study|Adverse Event|3
267430|NCT02177136|888030|P3|Overall Study|Discontinued due to pruritus|0
267431|NCT02177136|888031|P2|Overall Study|Discontinued due to pruritus|3
267432|NCT02177136|888032|P1|Overall Study|Discontinued due to pruritus|1
267433|NCT02177136|888030|P3|Overall Study|Withdrawal by Subject|0
267434|NCT02177136|888031|P2|Overall Study|Withdrawal by Subject|0
267435|NCT02177136|888032|P1|Overall Study|Withdrawal by Subject|2
267436|NCT02177032|888065|P4|Overall Study|Withdrawal by Subject|0
267437|NCT02177032|888066|P3|Overall Study|Withdrawal by Subject|1
267438|NCT02177032|888067|P2|Overall Study|Withdrawal by Subject|0
267439|NCT02177032|888068|P1|Overall Study|Withdrawal by Subject|1
267440|NCT02177032|888065|P4|Overall Study|OTHER|0
267441|NCT02177032|888066|P3|Overall Study|OTHER|1
267442|NCT02177032|888067|P2|Overall Study|OTHER|0
267443|NCT02177032|888068|P1|Overall Study|OTHER|2
267444|NCT02177032|888065|P4|Overall Study|Lost to Follow-up|0
267445|NCT02177032|888066|P3|Overall Study|Lost to Follow-up|0
267446|NCT02177032|888067|P2|Overall Study|Lost to Follow-up|2
267447|NCT02177032|888068|P1|Overall Study|Lost to Follow-up|0
267448|NCT02177032|888065|P4|Overall Study|ADMINISTRATIVE REASON|0
267449|NCT02177032|888066|P3|Overall Study|ADMINISTRATIVE REASON|1
267450|NCT02177032|888067|P2|Overall Study|ADMINISTRATIVE REASON|0
267451|NCT02177032|888068|P1|Overall Study|ADMINISTRATIVE REASON|2
267452|NCT02176655|888106|P1|Overall Study|Subjects did not treat|6
267453|NCT02176642|888129|P2|Overall Study|Withdrawal by Subject|1
267454|NCT02176642|888130|P1|Overall Study|Withdrawal by Subject|0
267455|NCT02176525|888160|P8|Overall Study|not treated|0
267456|NCT02176525|888161|P7|Overall Study|not treated|0
267457|NCT02176525|888162|P6|Overall Study|not treated|1
267458|NCT02176525|888163|P5|Overall Study|not treated|0
267459|NCT02176525|888164|P4|Overall Study|not treated|0
267460|NCT02176525|888165|P3|Overall Study|not treated|0
267461|NCT02176525|888166|P2|Overall Study|not treated|0
267462|NCT02176525|888167|P1|Overall Study|not treated|1
267463|NCT02176525|888160|P8|Overall Study|Adverse Event|0
267464|NCT02176525|888161|P7|Overall Study|Adverse Event|1
267465|NCT02176525|888162|P6|Overall Study|Adverse Event|0
267466|NCT02176525|888163|P5|Overall Study|Adverse Event|1
267467|NCT02176525|888164|P4|Overall Study|Adverse Event|1
267468|NCT02176525|888165|P3|Overall Study|Adverse Event|0
267469|NCT02176525|888166|P2|Overall Study|Adverse Event|0
267470|NCT02176525|888167|P1|Overall Study|Adverse Event|0
267471|NCT02176421|888344|P1|Overall Study|Adverse Event|1
267472|NCT02176421|888344|P1|Overall Study|Lost to Follow-up|4
267473|NCT02176356|888353|P1|Overall Study|Other Miscellaneous Reasons|2
267474|NCT02176356|888353|P1|Overall Study|Personal Reasons|3
267475|NCT02176356|888353|P1|Overall Study|Lost to Follow-up|4
267476|NCT02176356|888353|P1|Overall Study|Screen Failure|14
267477|NCT02176018|888383|P2|Overall Study|Withdrawal by Subject|2
267478|NCT02176018|888384|P1|Overall Study|Withdrawal by Subject|1
267479|NCT02176018|888383|P2|Overall Study|Protocol Violation|1
267480|NCT02176018|888384|P1|Overall Study|Protocol Violation|1
267481|NCT02176018|888383|P2|Overall Study|Lost to Follow-up|1
267482|NCT02176018|888384|P1|Overall Study|Lost to Follow-up|3
267483|NCT02176018|888383|P2|Overall Study|Adverse Event|2
267484|NCT02176018|888384|P1|Overall Study|Adverse Event|0
267485|NCT02175771|888416|P9|Treatment Period|Not specified|0
267486|NCT02175771|888417|P8|Treatment Period|Not specified|2
267487|NCT02175771|888418|P7|Treatment Period|Not specified|0
267488|NCT02175771|888419|P6|Treatment Period|Not specified|0
267489|NCT02175771|888420|P5|Treatment Period|Not specified|1
267490|NCT02175771|888421|P4|Treatment Period|Not specified|3
267491|NCT02175771|888422|P3|Treatment Period|Not specified|0
267492|NCT02175771|888423|P2|Treatment Period|Not specified|1
267493|NCT02175771|888424|P1|Treatment Period|Not specified|0
267494|NCT02175771|888416|P9|Treatment Period|Lack of Efficacy|0
267495|NCT02175771|888417|P8|Treatment Period|Lack of Efficacy|1
267496|NCT02175771|888418|P7|Treatment Period|Lack of Efficacy|0
267497|NCT02175771|888419|P6|Treatment Period|Lack of Efficacy|1
267498|NCT02175771|888420|P5|Treatment Period|Lack of Efficacy|0
267499|NCT02175771|888421|P4|Treatment Period|Lack of Efficacy|0
267500|NCT02175771|888422|P3|Treatment Period|Lack of Efficacy|0
267501|NCT02175771|888423|P2|Treatment Period|Lack of Efficacy|0
267502|NCT02175771|888424|P1|Treatment Period|Lack of Efficacy|0
267503|NCT02175771|888416|P9|Treatment Period|Lost to Follow-up|2
267504|NCT02175771|888417|P8|Treatment Period|Lost to Follow-up|2
267505|NCT02175771|888418|P7|Treatment Period|Lost to Follow-up|1
267506|NCT02175771|888419|P6|Treatment Period|Lost to Follow-up|2
267507|NCT02175771|888420|P5|Treatment Period|Lost to Follow-up|1
267508|NCT02175771|888421|P4|Treatment Period|Lost to Follow-up|3
267509|NCT02175771|888422|P3|Treatment Period|Lost to Follow-up|1
267510|NCT02175771|888423|P2|Treatment Period|Lost to Follow-up|3
267511|NCT02175771|888424|P1|Treatment Period|Lost to Follow-up|0
267512|NCT02175771|888416|P9|Treatment Period|Disease progression|0
267513|NCT02175771|888417|P8|Treatment Period|Disease progression|2
267514|NCT02175771|888418|P7|Treatment Period|Disease progression|0
267515|NCT02175771|888419|P6|Treatment Period|Disease progression|0
267516|NCT02175771|888420|P5|Treatment Period|Disease progression|0
267517|NCT02175771|888421|P4|Treatment Period|Disease progression|0
267518|NCT02175771|888422|P3|Treatment Period|Disease progression|0
267519|NCT02175771|888423|P2|Treatment Period|Disease progression|0
267520|NCT02175771|888424|P1|Treatment Period|Disease progression|0
267521|NCT02175771|888416|P9|Treatment Period|Protocol Violation|0
267522|NCT02175771|888417|P8|Treatment Period|Protocol Violation|1
267523|NCT02175771|888418|P7|Treatment Period|Protocol Violation|0
267524|NCT02175771|888419|P6|Treatment Period|Protocol Violation|0
267525|NCT02175771|888420|P5|Treatment Period|Protocol Violation|0
267526|NCT02175771|888421|P4|Treatment Period|Protocol Violation|0
267527|NCT02175771|888422|P3|Treatment Period|Protocol Violation|0
267528|NCT02175771|888423|P2|Treatment Period|Protocol Violation|0
267529|NCT02175771|888424|P1|Treatment Period|Protocol Violation|0
267530|NCT02175771|888416|P9|Treatment Period|Noncompliance|1
267531|NCT02175771|888417|P8|Treatment Period|Noncompliance|0
267532|NCT02175771|888418|P7|Treatment Period|Noncompliance|0
267533|NCT02175771|888419|P6|Treatment Period|Noncompliance|0
267534|NCT02175771|888420|P5|Treatment Period|Noncompliance|0
267535|NCT02175771|888421|P4|Treatment Period|Noncompliance|0
267536|NCT02175771|888422|P3|Treatment Period|Noncompliance|2
267537|NCT02175771|888423|P2|Treatment Period|Noncompliance|1
267538|NCT02175771|888424|P1|Treatment Period|Noncompliance|0
267539|NCT02175771|888416|P9|Treatment Period|Withdrawal by Subject|2
267540|NCT02175771|888417|P8|Treatment Period|Withdrawal by Subject|9
267541|NCT02175771|888418|P7|Treatment Period|Withdrawal by Subject|2
267542|NCT02175771|888419|P6|Treatment Period|Withdrawal by Subject|4
267543|NCT02175771|888420|P5|Treatment Period|Withdrawal by Subject|2
267544|NCT02175771|888421|P4|Treatment Period|Withdrawal by Subject|6
267545|NCT02175771|888422|P3|Treatment Period|Withdrawal by Subject|3
267546|NCT02175771|888423|P2|Treatment Period|Withdrawal by Subject|9
267547|NCT02175771|888424|P1|Treatment Period|Withdrawal by Subject|0
267548|NCT02175771|888416|P9|Treatment Period|Adverse Event|1
267549|NCT02175771|888417|P8|Treatment Period|Adverse Event|0
267550|NCT02175771|888418|P7|Treatment Period|Adverse Event|2
267551|NCT02175771|888419|P6|Treatment Period|Adverse Event|3
267552|NCT02175771|888420|P5|Treatment Period|Adverse Event|1
267553|NCT02175771|888421|P4|Treatment Period|Adverse Event|1
267554|NCT02175771|888422|P3|Treatment Period|Adverse Event|1
267555|NCT02175771|888423|P2|Treatment Period|Adverse Event|2
267556|NCT02175771|888424|P1|Treatment Period|Adverse Event|0
267557|NCT02175771|888416|P9|Run-In Period (Pre-assignment)|Not specified|0
267558|NCT02175771|888417|P8|Run-In Period (Pre-assignment)|Not specified|0
267559|NCT02175771|888418|P7|Run-In Period (Pre-assignment)|Not specified|0
267560|NCT02175771|888419|P6|Run-In Period (Pre-assignment)|Not specified|0
267561|NCT02175771|888420|P5|Run-In Period (Pre-assignment)|Not specified|0
267562|NCT02175771|888421|P4|Run-In Period (Pre-assignment)|Not specified|0
267563|NCT02175771|888422|P3|Run-In Period (Pre-assignment)|Not specified|0
267564|NCT02175771|888423|P2|Run-In Period (Pre-assignment)|Not specified|0
267565|NCT02175771|888424|P1|Run-In Period (Pre-assignment)|Not specified|8
267566|NCT02175771|888416|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267567|NCT02175771|888417|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267568|NCT02175771|888418|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267569|NCT02175771|888419|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267570|NCT02175771|888420|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267571|NCT02175771|888421|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267572|NCT02175771|888422|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267573|NCT02175771|888423|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
267574|NCT02175771|888424|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
267575|NCT02175771|888416|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267576|NCT02175771|888417|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267577|NCT02175771|888418|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267578|NCT02175771|888419|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267579|NCT02175771|888420|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267580|NCT02175771|888421|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267581|NCT02175771|888422|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267582|NCT02175771|888423|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
267583|NCT02175771|888424|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
267584|NCT02175771|888416|P9|Run-In Period (Pre-assignment)|Adverse Event|0
267585|NCT02175771|888417|P8|Run-In Period (Pre-assignment)|Adverse Event|0
267586|NCT02175771|888418|P7|Run-In Period (Pre-assignment)|Adverse Event|0
267587|NCT02175771|888419|P6|Run-In Period (Pre-assignment)|Adverse Event|0
267588|NCT02175771|888420|P5|Run-In Period (Pre-assignment)|Adverse Event|0
267589|NCT02175771|888421|P4|Run-In Period (Pre-assignment)|Adverse Event|0
267590|NCT02175771|888422|P3|Run-In Period (Pre-assignment)|Adverse Event|0
267591|NCT02175771|888423|P2|Run-In Period (Pre-assignment)|Adverse Event|0
267592|NCT02175771|888424|P1|Run-In Period (Pre-assignment)|Adverse Event|9
267593|NCT02175771|888416|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267594|NCT02175771|888417|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267595|NCT02175771|888418|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267596|NCT02175771|888419|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267597|NCT02175771|888420|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267598|NCT02175771|888421|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267599|NCT02175771|888422|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267600|NCT02175771|888423|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
267601|NCT02175771|888424|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
267602|NCT02175771|888416|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267603|NCT02175771|888417|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267604|NCT02175771|888418|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267605|NCT02175771|888419|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267606|NCT02175771|888420|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267607|NCT02175771|888421|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267608|NCT02175771|888422|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267609|NCT02175771|888423|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
267610|NCT02175771|888424|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
267611|NCT02175771|888416|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267612|NCT02175771|888417|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267613|NCT02175771|888418|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267614|NCT02175771|888419|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267615|NCT02175771|888420|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267616|NCT02175771|888421|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267617|NCT02175771|888422|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267618|NCT02175771|888423|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
267619|NCT02175771|888424|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
267620|NCT02175745|888482|P1|Overall Study|Not Eligible|1
267621|NCT02175368|888487|P1|Overall Study|Lost to Follow-up|1
267622|NCT02175199|888510|P2|Overall Study|Sponsor Decision|0
267623|NCT02175199|888511|P1|Overall Study|Sponsor Decision|1
267624|NCT02175199|888510|P2|Overall Study|Randomized in Error|0
267625|NCT02175199|888511|P1|Overall Study|Randomized in Error|1
267626|NCT02175199|888510|P2|Overall Study|Withdrawal by Subject|5
267627|NCT02175199|888511|P1|Overall Study|Withdrawal by Subject|1
267628|NCT02175121|888525|P5|Overall Study|Time issues|0
267629|NCT02175121|888526|P4|Overall Study|Time issues|0
267630|NCT02175121|888527|P3|Overall Study|Time issues|1
267631|NCT02175121|888528|P2|Overall Study|Time issues|0
267632|NCT02175121|888529|P1|Overall Study|Time issues|0
267633|NCT02175121|888525|P5|Overall Study|Schedule conflict|0
267634|NCT02175121|888526|P4|Overall Study|Schedule conflict|0
267635|NCT02175121|888527|P3|Overall Study|Schedule conflict|1
267636|NCT02175121|888528|P2|Overall Study|Schedule conflict|0
267637|NCT02175121|888529|P1|Overall Study|Schedule conflict|0
267638|NCT02175121|888525|P5|Overall Study|Personal emergency|1
267639|NCT02175121|888526|P4|Overall Study|Personal emergency|0
267640|NCT02175121|888527|P3|Overall Study|Personal emergency|0
267641|NCT02175121|888528|P2|Overall Study|Personal emergency|0
267642|NCT02175121|888529|P1|Overall Study|Personal emergency|0
267643|NCT02175121|888525|P5|Overall Study|Lost to Follow-up|0
267644|NCT02175121|888526|P4|Overall Study|Lost to Follow-up|1
267645|NCT02175121|888527|P3|Overall Study|Lost to Follow-up|0
267646|NCT02175121|888528|P2|Overall Study|Lost to Follow-up|1
267647|NCT02175121|888529|P1|Overall Study|Lost to Follow-up|0
267648|NCT02175121|888525|P5|Overall Study|Lack of Efficacy|0
267649|NCT02175121|888526|P4|Overall Study|Lack of Efficacy|0
267650|NCT02175121|888527|P3|Overall Study|Lack of Efficacy|0
267651|NCT02175121|888528|P2|Overall Study|Lack of Efficacy|0
267652|NCT02175121|888529|P1|Overall Study|Lack of Efficacy|1
267653|NCT02174861|888656|P1|Overall Study|Lost to Follow-up|26
267654|NCT02174861|888656|P1|Overall Study|Withdrawal by Subject|124
267655|NCT02174861|888656|P1|Overall Study|Decision by sponsor|8
267656|NCT02173769|888668|P1|Overall Study|Protocol Violation|4
267657|NCT02173704|888681|P2|Overall Study|Withdrawal by Subject|4
267658|NCT02173704|888682|P1|Overall Study|Withdrawal by Subject|9
267659|NCT02173704|888681|P2|Overall Study|Protocol Violation|0
267660|NCT02173704|888682|P1|Overall Study|Protocol Violation|1
267661|NCT02173704|888681|P2|Overall Study|Other|0
267662|NCT02173704|888682|P1|Overall Study|Other|1
267663|NCT02173704|888681|P2|Overall Study|Lost to Follow-up|0
267664|NCT02173704|888682|P1|Overall Study|Lost to Follow-up|1
267665|NCT02173704|888681|P2|Overall Study|Adverse Event|0
267666|NCT02173704|888682|P1|Overall Study|Adverse Event|1
267667|NCT02173548|888708|P2|Overall Study|Withdrawal by Subject|0
267668|NCT02173548|888709|P1|Overall Study|Withdrawal by Subject|1
267669|NCT02173548|888708|P2|Overall Study|Lost to Follow-up|2
267670|NCT02173548|888709|P1|Overall Study|Lost to Follow-up|0
267671|NCT02173054|888821|P3|Overall Study|Withdrawal by Subject|1
267672|NCT02173054|888822|P2|Overall Study|Withdrawal by Subject|0
267673|NCT02173054|888823|P1|Overall Study|Withdrawal by Subject|0
267674|NCT02173054|888821|P3|Overall Study|lack of compliance|0
267675|NCT02173054|888822|P2|Overall Study|lack of compliance|0
267676|NCT02173054|888823|P1|Overall Study|lack of compliance|1
267677|NCT02172625|888868|P2|Overall Study|car accident|1
267678|NCT02172625|888869|P1|Overall Study|car accident|0
267679|NCT02172625|888868|P2|Overall Study|Pregnancy|1
267680|NCT02172625|888869|P1|Overall Study|Pregnancy|0
267681|NCT02172625|888868|P2|Overall Study|Adverse Event|1
267682|NCT02172625|888869|P1|Overall Study|Adverse Event|0
267683|NCT02172040|888891|P4|Overall Study|Family emergency abroad|1
267684|NCT02172040|888892|P3|Overall Study|Family emergency abroad|0
267685|NCT02172040|888893|P2|Overall Study|Family emergency abroad|0
267686|NCT02172040|888894|P1|Overall Study|Family emergency abroad|0
267687|NCT02172040|888891|P4|Overall Study|Not available for Day 13 & 14 visits|0
267688|NCT02172040|888892|P3|Overall Study|Not available for Day 13 & 14 visits|1
267689|NCT02172040|888893|P2|Overall Study|Not available for Day 13 & 14 visits|0
267690|NCT02172040|888894|P1|Overall Study|Not available for Day 13 & 14 visits|0
267691|NCT02172040|888891|P4|Overall Study|Withdrawal by Subject|0
267692|NCT02172040|888892|P3|Overall Study|Withdrawal by Subject|1
267693|NCT02172040|888893|P2|Overall Study|Withdrawal by Subject|0
267694|NCT02172040|888894|P1|Overall Study|Withdrawal by Subject|0
267695|NCT02172040|888891|P4|Overall Study|Protocol Violation|0
267696|NCT02172040|888892|P3|Overall Study|Protocol Violation|0
267697|NCT02172040|888893|P2|Overall Study|Protocol Violation|1
267698|NCT02172040|888894|P1|Overall Study|Protocol Violation|0
267699|NCT02172040|888891|P4|Overall Study|Adverse Event|0
267700|NCT02172040|888892|P3|Overall Study|Adverse Event|0
267701|NCT02172040|888893|P2|Overall Study|Adverse Event|2
267702|NCT02172040|888894|P1|Overall Study|Adverse Event|0
267703|NCT02170779|889096|P2|Overall Study|Lost to Follow-up|1
267704|NCT02170779|889097|P1|Overall Study|Lost to Follow-up|0
267705|NCT02170779|889096|P2|Overall Study|Withdrawal by Subject|0
267706|NCT02170779|889097|P1|Overall Study|Withdrawal by Subject|1
267707|NCT02170688|889124|P5|Overall Study|Physician Decision|0
267708|NCT02170688|889125|P4|Overall Study|Physician Decision|0
267709|NCT02170688|889126|P3|Overall Study|Physician Decision|1
267710|NCT02170688|889127|P2|Overall Study|Physician Decision|0
267711|NCT02170688|889128|P1|Overall Study|Physician Decision|0
267712|NCT02170688|889124|P5|Overall Study|Full dose not received|0
267713|NCT02170688|889125|P4|Overall Study|Full dose not received|0
267714|NCT02170688|889126|P3|Overall Study|Full dose not received|0
267715|NCT02170688|889127|P2|Overall Study|Full dose not received|1
267716|NCT02170688|889128|P1|Overall Study|Full dose not received|0
267717|NCT02170688|889124|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
267718|NCT02170688|889125|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
267719|NCT02170688|889126|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
267720|NCT02170688|889127|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
267721|NCT02170688|889128|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
267722|NCT02170207|889301|P1|Overall Study|Case report forms unavailable|5
267723|NCT02170077|889312|P3|Overall Study|Exacerbation of seizures|1
267724|NCT02170077|889313|P2|Overall Study|Exacerbation of seizures|2
267725|NCT02170077|889314|P1|Overall Study|Exacerbation of seizures|0
267726|NCT02170077|889312|P3|Overall Study|Exclusion criteria|5
267727|NCT02170077|889313|P2|Overall Study|Exclusion criteria|2
267728|NCT02170077|889314|P1|Overall Study|Exclusion criteria|2
267729|NCT02170077|889312|P3|Overall Study|Lost to Follow-up|0
267730|NCT02170077|889313|P2|Overall Study|Lost to Follow-up|1
267731|NCT02170077|889314|P1|Overall Study|Lost to Follow-up|0
267732|NCT02170077|889312|P3|Overall Study|Adverse Event|4
267733|NCT02170077|889313|P2|Overall Study|Adverse Event|4
267734|NCT02170077|889314|P1|Overall Study|Adverse Event|4
267735|NCT02170077|889312|P3|Overall Study|Withdrawal by Subject|2
267736|NCT02170077|889313|P2|Overall Study|Withdrawal by Subject|4
267737|NCT02170077|889314|P1|Overall Study|Withdrawal by Subject|3
267738|NCT02170064|889325|P3|Overall Study|Physician Decision|0
267739|NCT02170064|889326|P2|Overall Study|Physician Decision|1
267740|NCT02170064|889327|P1|Overall Study|Physician Decision|1
267741|NCT02170064|889325|P3|Overall Study|Withdrawal by Subject|1
267742|NCT02170064|889326|P2|Overall Study|Withdrawal by Subject|1
267743|NCT02170064|889327|P1|Overall Study|Withdrawal by Subject|5
267744|NCT02170025|889343|P2|Overall Study|Adverse Event|0
267745|NCT02170025|889344|P1|Overall Study|Adverse Event|2
267746|NCT02169414|889492|P4|Overall Study|Adverse Event|0
267747|NCT02169414|889493|P3|Overall Study|Adverse Event|0
267748|NCT02169414|889494|P2|Overall Study|Adverse Event|1
267749|NCT02169414|889495|P1|Overall Study|Adverse Event|0
267750|NCT02169414|889492|P4|Overall Study|Withdrawal by Subject|0
267751|NCT02169414|889493|P3|Overall Study|Withdrawal by Subject|0
267752|NCT02169414|889494|P2|Overall Study|Withdrawal by Subject|0
267753|NCT02169414|889495|P1|Overall Study|Withdrawal by Subject|1
267754|NCT02169336|889536|P3|Overall Study|Subject declined to continue dosing|1
267755|NCT02169336|889537|P2|Overall Study|Subject declined to continue dosing|0
267756|NCT02169336|889538|P1|Overall Study|Subject declined to continue dosing|0
267757|NCT02169336|889536|P3|Overall Study|Physician Decision|1
267758|NCT02169336|889537|P2|Overall Study|Physician Decision|0
267759|NCT02169336|889538|P1|Overall Study|Physician Decision|0
267760|NCT02169336|889536|P3|Overall Study|Withdrawal by Subject|0
267761|NCT02169336|889537|P2|Overall Study|Withdrawal by Subject|0
267762|NCT02169336|889538|P1|Overall Study|Withdrawal by Subject|1
267763|NCT02169336|889536|P3|Overall Study|Adverse Event|1
267764|NCT02169336|889537|P2|Overall Study|Adverse Event|3
267765|NCT02169336|889538|P1|Overall Study|Adverse Event|2
267766|NCT02169336|889536|P3|Overall Study|Lack of Efficacy|0
267767|NCT02169336|889537|P2|Overall Study|Lack of Efficacy|1
267768|NCT02169336|889538|P1|Overall Study|Lack of Efficacy|1
267769|NCT02168816|889561|P2|Overall Study|Lost to Follow-up|2
267770|NCT02168816|889562|P1|Overall Study|Lost to Follow-up|2
267771|NCT02168777|889573|P3|Overall Study|Other reason|0
267772|NCT02168777|889574|P2|Overall Study|Other reason|1
267773|NCT02168777|889575|P1|Overall Study|Other reason|0
267774|NCT02168777|889573|P3|Overall Study|Clinical disease progression|2
267775|NCT02168777|889574|P2|Overall Study|Clinical disease progression|1
267776|NCT02168777|889575|P1|Overall Study|Clinical disease progression|0
267777|NCT02168777|889573|P3|Overall Study|Radiological disease progression|5
267778|NCT02168777|889574|P2|Overall Study|Radiological disease progression|5
267779|NCT02168777|889575|P1|Overall Study|Radiological disease progression|0
267780|NCT02168777|889573|P3|Overall Study|Disease recurrence|1
267781|NCT02168777|889574|P2|Overall Study|Disease recurrence|0
267782|NCT02168777|889575|P1|Overall Study|Disease recurrence|0
267783|NCT02168777|889573|P3|Overall Study|Adverse Event|1
267784|NCT02168777|889574|P2|Overall Study|Adverse Event|0
267785|NCT02168777|889575|P1|Overall Study|Adverse Event|1
267786|NCT02168777|889573|P3|Overall Study|Withdrawal by Subject|2
267787|NCT02168777|889574|P2|Overall Study|Withdrawal by Subject|0
267788|NCT02168777|889575|P1|Overall Study|Withdrawal by Subject|1
267789|NCT02168491|889652|P1|Overall Study|Withdrawal by Subject|1
267790|NCT02168478|889658|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
267791|NCT02168478|889658|P1|Overall Study|Did Not Consent to Participation|2
267792|NCT02168478|889658|P1|Overall Study|Withdrawal by Subject|1
267793|NCT02168439|889664|P2|Overall Study|Protocol Violation|2
267794|NCT02168439|889665|P1|Overall Study|Protocol Violation|0
267795|NCT02168387|889683|P2|Overall Study|Death|0
267796|NCT02168387|889684|P1|Overall Study|Death|1
267797|NCT02168387|889683|P2|Overall Study|Planned exubation|3
267798|NCT02168387|889684|P1|Overall Study|Planned exubation|6
267799|NCT02168270|889716|P1|Overall Study|Lack of Efficacy|4
267800|NCT02167893|889723|P1|Overall Study|Case report forms not collected|68
267801|NCT02167893|889723|P1|Overall Study|Investigator health reasons|10
267802|NCT02167893|889723|P1|Overall Study|Investigator transferred|85
267803|NCT02167139|889761|P4|Transition-extension|Lost to Follow-up|0
267804|NCT02167139|889762|P3|Transition-extension|Lost to Follow-up|0
267805|NCT02167139|889763|P2|Transition-extension|Lost to Follow-up|0
267806|NCT02167139|889764|P1|Transition-extension|Lost to Follow-up|1
267807|NCT02167139|889761|P4|Transition-extension|Other|0
267808|NCT02167139|889762|P3|Transition-extension|Other|1
267809|NCT02167139|889763|P2|Transition-extension|Other|0
267810|NCT02167139|889764|P1|Transition-extension|Other|1
267811|NCT02167139|889761|P4|Transition-extension|Lack of Efficacy|1
267812|NCT02167139|889762|P3|Transition-extension|Lack of Efficacy|1
267813|NCT02167139|889763|P2|Transition-extension|Lack of Efficacy|0
267814|NCT02167139|889764|P1|Transition-extension|Lack of Efficacy|0
267815|NCT02167139|889761|P4|Transition-extension|Withdrawal by Subject|1
267816|NCT02167139|889762|P3|Transition-extension|Withdrawal by Subject|4
267817|NCT02167139|889763|P2|Transition-extension|Withdrawal by Subject|0
267818|NCT02167139|889764|P1|Transition-extension|Withdrawal by Subject|2
267819|NCT02167139|889761|P4|Transition-extension|Adverse Event|3
267820|NCT02167139|889762|P3|Transition-extension|Adverse Event|2
267821|NCT02167139|889763|P2|Transition-extension|Adverse Event|0
267822|NCT02167139|889764|P1|Transition-extension|Adverse Event|2
267823|NCT02167139|889761|P4|Randomised, Double-blind|Other|0
267824|NCT02167139|889762|P3|Randomised, Double-blind|Other|0
267825|NCT02167139|889763|P2|Randomised, Double-blind|Other|0
267826|NCT02167139|889764|P1|Randomised, Double-blind|Other|3
267827|NCT02167139|889761|P4|Randomised, Double-blind|Lack of Efficacy|0
267828|NCT02167139|889762|P3|Randomised, Double-blind|Lack of Efficacy|0
267829|NCT02167139|889763|P2|Randomised, Double-blind|Lack of Efficacy|2
267830|NCT02167139|889764|P1|Randomised, Double-blind|Lack of Efficacy|1
267831|NCT02167139|889761|P4|Randomised, Double-blind|Adverse Event|0
267832|NCT02167139|889762|P3|Randomised, Double-blind|Adverse Event|0
267833|NCT02167139|889763|P2|Randomised, Double-blind|Adverse Event|9
267834|NCT02167139|889764|P1|Randomised, Double-blind|Adverse Event|2
267835|NCT02167139|889761|P4|Randomised, Double-blind|Withdrawal by Subject|0
267836|NCT02167139|889762|P3|Randomised, Double-blind|Withdrawal by Subject|0
267837|NCT02167139|889763|P2|Randomised, Double-blind|Withdrawal by Subject|8
267838|NCT02167139|889764|P1|Randomised, Double-blind|Withdrawal by Subject|11
267839|NCT02166697|889778|P1|Overall Study|Protocol Violation|347
267840|NCT02166476|889789|P2|Overall Study|Unable to Come for Visit|3
267841|NCT02166476|889790|P1|Overall Study|Unable to Come for Visit|0
267842|NCT02166476|889789|P2|Overall Study|Physician Decision|0
267843|NCT02166476|889790|P1|Overall Study|Physician Decision|1
267844|NCT02166476|889789|P2|Overall Study|Lost to Follow-up|10
267845|NCT02166476|889790|P1|Overall Study|Lost to Follow-up|5
267846|NCT02166476|889789|P2|Overall Study|Adverse Event|3
267847|NCT02166476|889790|P1|Overall Study|Adverse Event|3
267848|NCT02166476|889789|P2|Overall Study|Withdrawal by Subject|7
267849|NCT02166476|889790|P1|Overall Study|Withdrawal by Subject|5
267850|NCT02165826|889835|P3|Down-Titration Period|Reason Not Specified|2
267851|NCT02165826|889836|P2|Down-Titration Period|Reason Not Specified|0
267852|NCT02165826|889837|P1|Down-Titration Period|Reason Not Specified|1
267853|NCT02165826|889835|P3|Down-Titration Period|Voluntary Withdrawal|2
267854|NCT02165826|889836|P2|Down-Titration Period|Voluntary Withdrawal|1
267855|NCT02165826|889837|P1|Down-Titration Period|Voluntary Withdrawal|2
267856|NCT02165826|889835|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
267857|NCT02165826|889836|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
267858|NCT02165826|889837|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
267859|NCT02165826|889835|P3|Main Treatment Period|Did Not Receive Study Drug|0
267860|NCT02165826|889836|P2|Main Treatment Period|Did Not Receive Study Drug|2
267861|NCT02165826|889837|P1|Main Treatment Period|Did Not Receive Study Drug|0
267862|NCT02165826|889835|P3|Main Treatment Period|Reason Not Specified|16
267863|NCT02165826|889836|P2|Main Treatment Period|Reason Not Specified|5
267864|NCT02165826|889837|P1|Main Treatment Period|Reason Not Specified|8
267865|NCT02165826|889835|P3|Main Treatment Period|Lack of Efficacy|0
267866|NCT02165826|889836|P2|Main Treatment Period|Lack of Efficacy|0
267867|NCT02165826|889837|P1|Main Treatment Period|Lack of Efficacy|2
267868|NCT02165826|889835|P3|Main Treatment Period|Voluntary Withdrawal|21
267869|NCT02165826|889836|P2|Main Treatment Period|Voluntary Withdrawal|23
267870|NCT02165826|889837|P1|Main Treatment Period|Voluntary Withdrawal|23
267871|NCT02165826|889835|P3|Main Treatment Period|Lost to Follow-up|1
267872|NCT02165826|889836|P2|Main Treatment Period|Lost to Follow-up|2
267873|NCT02165826|889837|P1|Main Treatment Period|Lost to Follow-up|4
267874|NCT02165826|889835|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
267875|NCT02165826|889836|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
267876|NCT02165826|889837|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
267877|NCT02165826|889835|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
267878|NCT02165826|889836|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
267879|NCT02165826|889837|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
267880|NCT02164929|889948|P4|Overall Study|Failed regional block|0
267881|NCT02164929|889949|P3|Overall Study|Failed regional block|1
267882|NCT02164929|889950|P2|Overall Study|Failed regional block|0
267883|NCT02164929|889951|P1|Overall Study|Failed regional block|0
267884|NCT02164929|889948|P4|Overall Study|Converted to open procedure|2
267885|NCT02164929|889949|P3|Overall Study|Converted to open procedure|0
267886|NCT02164929|889950|P2|Overall Study|Converted to open procedure|0
267887|NCT02164929|889951|P1|Overall Study|Converted to open procedure|1
267888|NCT02164916|889995|P2|Overall Study|Not eligible|5
267889|NCT02164916|889996|P1|Overall Study|Not eligible|2
267890|NCT02164916|889995|P2|Overall Study|Reason under review|6
267891|NCT02164916|889996|P1|Overall Study|Reason under review|1
267892|NCT02164916|889995|P2|Overall Study|Not protocol specified|1
267893|NCT02164916|889996|P1|Overall Study|Not protocol specified|5
267894|NCT02164916|889995|P2|Overall Study|Progression|26
267895|NCT02164916|889996|P1|Overall Study|Progression|37
267896|NCT02164916|889995|P2|Overall Study|Refusal unrelated to adverse event|7
267897|NCT02164916|889996|P1|Overall Study|Refusal unrelated to adverse event|3
267898|NCT02164916|889995|P2|Overall Study|Death|1
267899|NCT02164916|889996|P1|Overall Study|Death|1
267900|NCT02164916|889995|P2|Overall Study|Adverse Event|8
267901|NCT02164916|889996|P1|Overall Study|Adverse Event|3
267902|NCT02164539|890019|P7|Treatment Phase C (1 Week)|Physician Decision|1
267903|NCT02164539|890020|P6|Treatment Phase C (1 Week)|Physician Decision|0
267904|NCT02164539|890021|P5|Treatment Phase C (1 Week)|Physician Decision|0
267905|NCT02164539|890022|P4|Treatment Phase C (1 Week)|Physician Decision|0
267906|NCT02164539|890023|P3|Treatment Phase C (1 Week)|Physician Decision|0
267907|NCT02164539|890024|P2|Treatment Phase C (1 Week)|Physician Decision|0
267908|NCT02164539|890025|P1|Treatment Phase C (1 Week)|Physician Decision|0
267909|NCT02164539|890019|P7|Treatment Phase C (1 Week)|Adverse Event|1
267910|NCT02164539|890020|P6|Treatment Phase C (1 Week)|Adverse Event|0
267911|NCT02164539|890021|P5|Treatment Phase C (1 Week)|Adverse Event|0
267912|NCT02164539|890022|P4|Treatment Phase C (1 Week)|Adverse Event|0
267913|NCT02164539|890023|P3|Treatment Phase C (1 Week)|Adverse Event|0
267914|NCT02164539|890024|P2|Treatment Phase C (1 Week)|Adverse Event|0
267915|NCT02164539|890025|P1|Treatment Phase C (1 Week)|Adverse Event|0
267916|NCT02164539|890019|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
267917|NCT02164539|890020|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
267918|NCT02164539|890021|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
267919|NCT02164539|890022|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
267920|NCT02164539|890023|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
267921|NCT02164539|890024|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
267922|NCT02164539|890025|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
267923|NCT02164539|890019|P7|Treatment Phase B (1 Week)|Physician Decision|1
267924|NCT02164539|890020|P6|Treatment Phase B (1 Week)|Physician Decision|0
267925|NCT02164539|890021|P5|Treatment Phase B (1 Week)|Physician Decision|1
267926|NCT02164539|890022|P4|Treatment Phase B (1 Week)|Physician Decision|0
267927|NCT02164539|890023|P3|Treatment Phase B (1 Week)|Physician Decision|0
267928|NCT02164539|890024|P2|Treatment Phase B (1 Week)|Physician Decision|0
267929|NCT02164539|890025|P1|Treatment Phase B (1 Week)|Physician Decision|0
267930|NCT02164539|890019|P7|Treatment Phase B (1 Week)|Adverse Event|0
267931|NCT02164539|890020|P6|Treatment Phase B (1 Week)|Adverse Event|0
267932|NCT02164539|890021|P5|Treatment Phase B (1 Week)|Adverse Event|2
267933|NCT02164539|890022|P4|Treatment Phase B (1 Week)|Adverse Event|0
267934|NCT02164539|890023|P3|Treatment Phase B (1 Week)|Adverse Event|0
267935|NCT02164539|890024|P2|Treatment Phase B (1 Week)|Adverse Event|0
267936|NCT02164539|890025|P1|Treatment Phase B (1 Week)|Adverse Event|0
267937|NCT02164539|890019|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
267938|NCT02164539|890020|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
267939|NCT02164539|890021|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
267940|NCT02164539|890022|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
267941|NCT02164539|890023|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
267942|NCT02164539|890024|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
267943|NCT02164539|890025|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
267944|NCT02164318|890087|P4|Overall Study|Withdrawal by Subject|1
267945|NCT02164318|890088|P3|Overall Study|Withdrawal by Subject|0
267946|NCT02164318|890089|P2|Overall Study|Withdrawal by Subject|1
267947|NCT02164318|890090|P1|Overall Study|Withdrawal by Subject|0
267948|NCT02163915|890113|P5|Overall Study|Physician Decision|0
267949|NCT02163915|890114|P4|Overall Study|Physician Decision|1
267950|NCT02163915|890115|P3|Overall Study|Physician Decision|0
267951|NCT02163915|890116|P2|Overall Study|Physician Decision|0
267952|NCT02163915|890117|P1|Overall Study|Physician Decision|0
267953|NCT02163915|890113|P5|Overall Study|Study termination|2
267954|NCT02163915|890114|P4|Overall Study|Study termination|0
267955|NCT02163915|890115|P3|Overall Study|Study termination|0
267956|NCT02163915|890116|P2|Overall Study|Study termination|0
267957|NCT02163915|890117|P1|Overall Study|Study termination|1
267958|NCT02163915|890113|P5|Overall Study|Withdrawal by Subject|2
267959|NCT02163915|890114|P4|Overall Study|Withdrawal by Subject|2
267960|NCT02163915|890115|P3|Overall Study|Withdrawal by Subject|2
267961|NCT02163915|890116|P2|Overall Study|Withdrawal by Subject|0
267962|NCT02163915|890117|P1|Overall Study|Withdrawal by Subject|2
267963|NCT02163733|890172|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
267964|NCT02163733|890173|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
267965|NCT02163733|890174|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
267966|NCT02163733|890172|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
267967|NCT02163733|890173|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
267968|NCT02163733|890174|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
267969|NCT02163538|890211|P2|Overall Study|Physician Decision|1
267970|NCT02163538|890212|P1|Overall Study|Physician Decision|0
267971|NCT02163538|890211|P2|Overall Study|Protocol Violation|0
267972|NCT02163538|890212|P1|Overall Study|Protocol Violation|1
267973|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Various reasons|16
267974|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
267975|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Subject Compliance|17
267976|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Death|8
267977|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Protocol Violation|2
267978|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
267979|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Physician Decision|8
267980|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
267981|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
267982|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
267983|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Hypokalemia|9
267984|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
267985|NCT02163499|890228|P1|Extended Dosing Phase: ZS|Adverse Event|51
267986|NCT02163499|890228|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
267987|NCT02163499|890228|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
267988|NCT02163499|890228|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
267989|NCT02163499|890228|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
267990|NCT02163499|890228|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
267991|NCT02163395|890250|P1|Overall Study|Adverse Event|1
267992|NCT02163395|890250|P1|Overall Study|Lost to Follow-up|3
267993|NCT02163395|890250|P1|Overall Study|Withdrawal by Subject|1
267994|NCT02163187|890259|P2|Overall Study|Progressive disease|0
267995|NCT02163187|890260|P1|Overall Study|Progressive disease|1
267996|NCT02163187|890259|P2|Overall Study|Device removed|0
267997|NCT02163187|890260|P1|Overall Study|Device removed|1
267998|NCT02162862|890284|P3|Overall Study|Subject did not feel the med was needed|4
267999|NCT02162862|890285|P2|Overall Study|Subject did not feel the med was needed|0
268000|NCT02162862|890286|P1|Overall Study|Subject did not feel the med was needed|0
268001|NCT02162862|890284|P3|Overall Study|Lost to Follow-up|0
268002|NCT02162862|890285|P2|Overall Study|Lost to Follow-up|11
268003|NCT02162862|890286|P1|Overall Study|Lost to Follow-up|0
268004|NCT02162758|890299|P2|Overall Study|Study termination|1
268005|NCT02162758|890300|P1|Overall Study|Study termination|0
268006|NCT02161757|890334|P3|Treatment Through Study Completion|Other|12
268007|NCT02161757|890335|P2|Treatment Through Study Completion|Other|7
268008|NCT02161757|890336|P1|Treatment Through Study Completion|Other|3
268009|NCT02161757|890334|P3|Treatment Through Study Completion|Lost to Follow-up|1
268010|NCT02161757|890335|P2|Treatment Through Study Completion|Lost to Follow-up|0
268011|NCT02161757|890336|P1|Treatment Through Study Completion|Lost to Follow-up|3
268012|NCT02161757|890334|P3|Treatment Through Study Completion|Withdrawal by Subject|21
268013|NCT02161757|890335|P2|Treatment Through Study Completion|Withdrawal by Subject|21
268014|NCT02161757|890336|P1|Treatment Through Study Completion|Withdrawal by Subject|28
268015|NCT02161757|890334|P3|Treatment Through Study Completion|Protocol Violation|1
268016|NCT02161757|890335|P2|Treatment Through Study Completion|Protocol Violation|5
268017|NCT02161757|890336|P1|Treatment Through Study Completion|Protocol Violation|2
268018|NCT02161757|890334|P3|Treatment Through Study Completion|Adverse Event|5
268019|NCT02161757|890335|P2|Treatment Through Study Completion|Adverse Event|16
268020|NCT02161757|890336|P1|Treatment Through Study Completion|Adverse Event|30
268021|NCT02161757|890334|P3|Randomised Through Start Treatment|Did not receive treatment|0
268022|NCT02161757|890335|P2|Randomised Through Start Treatment|Did not receive treatment|2
268023|NCT02161757|890336|P1|Randomised Through Start Treatment|Did not receive treatment|3
268024|NCT02161549|890393|P2|Overall Study|Physician Decision|2
268025|NCT02161549|890394|P1|Overall Study|Physician Decision|6
268026|NCT02161146|890430|P5|Overall Study|Other Miscellaneous Reasons|0
268027|NCT02161146|890431|P4|Overall Study|Other Miscellaneous Reasons|0
268028|NCT02161146|890432|P3|Overall Study|Other Miscellaneous Reasons|0
268029|NCT02161146|890433|P2|Overall Study|Other Miscellaneous Reasons|1
268030|NCT02161146|890434|P1|Overall Study|Other Miscellaneous Reasons|0
268031|NCT02161146|890430|P5|Overall Study|Personal Reasons|1
268032|NCT02161146|890431|P4|Overall Study|Personal Reasons|2
268033|NCT02161146|890432|P3|Overall Study|Personal Reasons|0
268034|NCT02161146|890433|P2|Overall Study|Personal Reasons|1
268035|NCT02161146|890434|P1|Overall Study|Personal Reasons|0
268036|NCT02161146|890430|P5|Overall Study|Lost to Follow-up|0
268037|NCT02161146|890431|P4|Overall Study|Lost to Follow-up|0
268038|NCT02161146|890432|P3|Overall Study|Lost to Follow-up|0
268039|NCT02161146|890433|P2|Overall Study|Lost to Follow-up|1
268040|NCT02161146|890434|P1|Overall Study|Lost to Follow-up|0
268041|NCT02161146|890430|P5|Overall Study|Adverse Event|0
268042|NCT02161146|890431|P4|Overall Study|Adverse Event|1
268043|NCT02161146|890432|P3|Overall Study|Adverse Event|0
268044|NCT02161146|890433|P2|Overall Study|Adverse Event|1
268045|NCT02161146|890434|P1|Overall Study|Adverse Event|1
268046|NCT02161016|890447|P1|Overall Study|withdrawn by IRB|1
268047|NCT02160977|890478|P2|Six Months After Surgery|Lost to Follow-up|1
268048|NCT02160977|890479|P1|Six Months After Surgery|Lost to Follow-up|2
268049|NCT02160977|890478|P2|Three Months After Surgery|Lost to Follow-up|2
268050|NCT02160977|890479|P1|Three Months After Surgery|Lost to Follow-up|0
268051|NCT02160977|890478|P2|Six Weeks After Surgery|Lost to Follow-up|0
268052|NCT02160977|890479|P1|Six Weeks After Surgery|Lost to Follow-up|1
268053|NCT02160314|890506|P2|Overall Study|Lost to Follow-up|1
268054|NCT02160314|890507|P1|Overall Study|Lost to Follow-up|0
268055|NCT02160314|890506|P2|Overall Study|Withdrawal by Subject|2
268056|NCT02160314|890507|P1|Overall Study|Withdrawal by Subject|1
268057|NCT02160314|890506|P2|Overall Study|Protocol Violation|4
268058|NCT02160314|890507|P1|Overall Study|Protocol Violation|0
268059|NCT02160314|890506|P2|Overall Study|Adverse Event|6
268060|NCT02160314|890507|P1|Overall Study|Adverse Event|0
268061|NCT02160002|890515|P2|Overall Study|Withdrawal by Subject|1
268062|NCT02160002|890516|P1|Overall Study|Withdrawal by Subject|2
268063|NCT02159950|890548|P2|Overall Study|Progression|1
268064|NCT02159950|890549|P1|Overall Study|Progression|0
268065|NCT02159950|890548|P2|Overall Study|Adverse Event|1
268066|NCT02159950|890549|P1|Overall Study|Adverse Event|0
268067|NCT02159482|890621|P1|Overall Study|Physician Decision|3
268068|NCT02159482|890621|P1|Overall Study|Withdrawal by Subject|2
268069|NCT02159469|890626|P1|Overall Study|Multiple|29
268070|NCT02159469|890626|P1|Overall Study|Other|1
268071|NCT02159469|890626|P1|Overall Study|Met Stopping Criteria|3
268072|NCT02159469|890626|P1|Overall Study|Sponsor's request|2
268073|NCT02159469|890626|P1|Overall Study|Lost to Follow-up|1
268074|NCT02159469|890626|P1|Overall Study|Withdrawal by Subject|9
268075|NCT02159469|890626|P1|Overall Study|Non-compliance|2
268076|NCT02159469|890626|P1|Overall Study|Adverse Event|5
268077|NCT02159469|890626|P1|Overall Study|Missing Completion status|1
268078|NCT02159365|890631|P1|Overall Study|Other|1
268079|NCT02159365|890631|P1|Overall Study|Subject Withdrew Consent|1
268080|NCT02159365|890631|P1|Overall Study|Subject Request to Discontinue Treatment|1
268081|NCT02159365|890631|P1|Overall Study|Study Drug Toxicity|1
268082|NCT02159365|890631|P1|Overall Study|Lost to Follow-up|1
268083|NCT02159365|890631|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
268084|NCT02159365|890631|P1|Overall Study|Disease Progression|11
268085|NCT02159352|890637|P2|Overall Study|Withdrawal by Subject|1
268086|NCT02159352|890638|P1|Overall Study|Withdrawal by Subject|0
268087|NCT02159352|890637|P2|Overall Study|Adverse Event|1
268088|NCT02159352|890638|P1|Overall Study|Adverse Event|3
268089|NCT02159040|890713|P1|Overall Study|Death|1
268090|NCT02158975|890726|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
268091|NCT02158936|890736|P2|Overall Study|Lost to Follow-up|1
268092|NCT02158936|890737|P1|Overall Study|Lost to Follow-up|0
268093|NCT02158936|890736|P2|Overall Study|Physician Decision|13
268094|NCT02158936|890737|P1|Overall Study|Physician Decision|15
268095|NCT02158936|890736|P2|Overall Study|Withdrawal by Subject|16
268096|NCT02158936|890737|P1|Overall Study|Withdrawal by Subject|15
268097|NCT02158936|890736|P2|Overall Study|Adverse Event|24
268098|NCT02158936|890737|P1|Overall Study|Adverse Event|39
268099|NCT02158936|890736|P2|Overall Study|Azacitidine tx discontinued|46
268100|NCT02158936|890737|P1|Overall Study|Azacitidine tx discontinued|53
268101|NCT02158936|890736|P2|Overall Study|Study closed/ terminated|77
268102|NCT02158936|890737|P1|Overall Study|Study closed/ terminated|57
268103|NCT02158728|890779|P1|Overall Study|no qualified dataset|24
268104|NCT02158728|890779|P1|Overall Study|no procedure according to CIP done|3
268105|NCT02158442|890796|P2|Overall Study|Perfusion staff not available|0
268106|NCT02158442|890797|P1|Overall Study|Perfusion staff not available|1
268107|NCT02158442|890796|P2|Overall Study|Withdrawal by Subject|0
268108|NCT02158442|890797|P1|Overall Study|Withdrawal by Subject|1
268109|NCT02158364|890803|P1|Overall Study|Protocol Deviation|50
268110|NCT02158364|890803|P1|Overall Study|Case report forms uncollected|10
268111|NCT02158247|890821|P1|Overall Study|Invisible vocal cords|5
268112|NCT02158039|890837|P1|Overall Study|Screen Failure|9
268113|NCT02158039|890837|P1|Overall Study|Withdrawal by Subject|1
268114|NCT02157948|890844|P2|Overall Study|Decision by Sponsor|1
268115|NCT02157948|890845|P1|Overall Study|Decision by Sponsor|0
268116|NCT02157948|890844|P2|Overall Study|Protocol Specified Criteria|1
268117|NCT02157948|890845|P1|Overall Study|Protocol Specified Criteria|2
268118|NCT02157948|890844|P2|Overall Study|Lost to Follow-up|2
268119|NCT02157948|890845|P1|Overall Study|Lost to Follow-up|3
268120|NCT02157948|890844|P2|Overall Study|Withdrawal by Subject|5
268121|NCT02157948|890845|P1|Overall Study|Withdrawal by Subject|4
268122|NCT02157935|890857|P2|Overall Study|Adverse Event|5
268123|NCT02157935|890858|P1|Overall Study|Adverse Event|3
268124|NCT02157935|890857|P2|Overall Study|Death|4
268125|NCT02157935|890858|P1|Overall Study|Death|4
268126|NCT02157935|890857|P2|Overall Study|Lack of Efficacy|1
268127|NCT02157935|890858|P1|Overall Study|Lack of Efficacy|0
268128|NCT02157935|890857|P2|Overall Study|Other|12
268129|NCT02157935|890858|P1|Overall Study|Other|5
268130|NCT02157935|890857|P2|Overall Study|Progressive disease|2
268131|NCT02157935|890858|P1|Overall Study|Progressive disease|0
268132|NCT02157935|890857|P2|Overall Study|Protocol Violation|0
268133|NCT02157935|890858|P1|Overall Study|Protocol Violation|1
268134|NCT02157935|890857|P2|Overall Study|Screen failure|2
268135|NCT02157935|890858|P1|Overall Study|Screen failure|1
268136|NCT02157935|890857|P2|Overall Study|Withdrawal by Subject|39
268137|NCT02157935|890858|P1|Overall Study|Withdrawal by Subject|25
268138|NCT02157883|890884|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
268139|NCT02157883|890884|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
268140|NCT02157883|890884|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
268141|NCT02157883|890884|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
268142|NCT02157883|890884|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
268143|NCT02157623|890915|P2|Overall Study|Physician Decision|3
268144|NCT02157623|890916|P1|Overall Study|Physician Decision|4
268145|NCT02157376|890924|P2|Overall Study|Investigator's misjudgement|2
268146|NCT02157376|890925|P1|Overall Study|Investigator's misjudgement|1
268147|NCT02157376|890924|P2|Overall Study|Not treated|3
268148|NCT02157376|890925|P1|Overall Study|Not treated|8
268149|NCT02157376|890924|P2|Overall Study|Withdrawal by Subject|8
268150|NCT02157376|890925|P1|Overall Study|Withdrawal by Subject|3
268151|NCT02157376|890924|P2|Overall Study|Eligibility criteria not fulfilled|1
268152|NCT02157376|890925|P1|Overall Study|Eligibility criteria not fulfilled|0
268153|NCT02157376|890924|P2|Overall Study|Death|4
268154|NCT02157376|890925|P1|Overall Study|Death|10
268155|NCT02157298|890935|P2|Overall Study|Withdrawal by Subject|0
268156|NCT02157298|890936|P1|Overall Study|Withdrawal by Subject|1
268157|NCT02157298|890935|P2|Overall Study|Poor/Non-compliance|0
268158|NCT02157298|890936|P1|Overall Study|Poor/Non-compliance|1
268159|NCT02157298|890935|P2|Overall Study|Subject no longer meets study criteria|2
268160|NCT02157298|890936|P1|Overall Study|Subject no longer meets study criteria|1
268161|NCT02157298|890935|P2|Overall Study|Adverse Event|0
268162|NCT02157298|890936|P1|Overall Study|Adverse Event|1
268163|NCT02157116|890975|P1|Overall Study|Failed Screening|2
268164|NCT02157116|890975|P1|Overall Study|Physician Decision|3
268165|NCT02157116|890975|P1|Overall Study|Withdrawal by Subject|4
268166|NCT02156466|890995|P5|Overall Study|Quantiferon Positivity|0
268167|NCT02156466|890996|P4|Overall Study|Quantiferon Positivity|1
268168|NCT02156466|890997|P3|Overall Study|Quantiferon Positivity|0
268169|NCT02156466|890998|P2|Overall Study|Quantiferon Positivity|0
268170|NCT02156466|890999|P1|Overall Study|Quantiferon Positivity|0
268171|NCT02156466|890995|P5|Overall Study|Adverse Event|0
268172|NCT02156466|890996|P4|Overall Study|Adverse Event|1
268173|NCT02156466|890997|P3|Overall Study|Adverse Event|1
268174|NCT02156466|890998|P2|Overall Study|Adverse Event|0
268175|NCT02156466|890999|P1|Overall Study|Adverse Event|0
268176|NCT02156271|891180|P2|Overall Study|Physician Decision|3
268177|NCT02156271|891181|P1|Overall Study|Physician Decision|4
268178|NCT02155985|891220|P3|Overall Study|Lost to Follow-up|0
268179|NCT02155985|891221|P2|Overall Study|Lost to Follow-up|0
268180|NCT02155985|891222|P1|Overall Study|Lost to Follow-up|1
268181|NCT02155985|891220|P3|Overall Study|Withdrawal by Subject|1
268182|NCT02155985|891221|P2|Overall Study|Withdrawal by Subject|0
268183|NCT02155985|891222|P1|Overall Study|Withdrawal by Subject|0
268184|NCT02155881|891289|P2|Overall Study|Inappropriately randomized|2
268185|NCT02155881|891290|P1|Overall Study|Inappropriately randomized|2
268186|NCT02155881|891289|P2|Overall Study|Withdrawal by Subject|2
268187|NCT02155881|891290|P1|Overall Study|Withdrawal by Subject|0
268188|NCT02155322|891342|P1|Overall Study|Withdrawal by Subject|4
268189|NCT02155322|891342|P1|Overall Study|Relapse/Recurrence|8
268190|NCT02155322|891342|P1|Overall Study|Physician Decision|1
268191|NCT02155322|891342|P1|Overall Study|Adverse Event|1
268192|NCT02155309|891349|P3|Overall Study|Protocol Violation|1
268193|NCT02155309|891350|P2|Overall Study|Protocol Violation|0
268194|NCT02155309|891351|P1|Overall Study|Protocol Violation|0
268195|NCT02155283|891358|P1|Overall Study|Protocol Violation|3
268196|NCT02155283|891358|P1|Overall Study|Withdrawal by Subject|1
268197|NCT02155283|891358|P1|Overall Study|Lost to Follow-up|3
268198|NCT02154425|891385|P1|Screening Period|Adverse Event|1
268199|NCT02154139|891444|P1|Overall Study|Investigator transferred|3
268200|NCT02154139|891444|P1|Overall Study|Other|2
268201|NCT02154139|891444|P1|Overall Study|Injection not administered|2
268202|NCT02154087|891452|P1|Overall Study|Study Termination|1
268203|NCT02154061|891458|P2|Overall Study|enrolled but not vaccinated|0
268204|NCT02154061|891459|P1|Overall Study|enrolled but not vaccinated|1
268205|NCT02154061|891458|P2|Overall Study|Pregnancy|0
268206|NCT02154061|891459|P1|Overall Study|Pregnancy|1
268207|NCT02153827|891480|P2|Overall Study|Lost to Follow-up|9
268208|NCT02153827|891481|P1|Overall Study|Lost to Follow-up|3
268209|NCT02153788|891497|P2|Overall Study|Physician Decision|1
268210|NCT02153788|891498|P1|Overall Study|Physician Decision|2
268211|NCT02153736|891518|P2|Overall Study|Withdrawal by Subject|1
268212|NCT02153736|891519|P1|Overall Study|Withdrawal by Subject|0
268213|NCT02153736|891518|P2|Overall Study|Death|1
268214|NCT02153736|891519|P1|Overall Study|Death|0
268215|NCT02153736|891518|P2|Overall Study|Medical status change made ineligible|0
268216|NCT02153736|891519|P1|Overall Study|Medical status change made ineligible|1
268217|NCT02153736|891518|P2|Overall Study|Lost to Follow-up|0
268218|NCT02153736|891519|P1|Overall Study|Lost to Follow-up|1
268219|NCT02153398|891579|P5|Overall Study|Adverse Event|0
268220|NCT02153398|891580|P4|Overall Study|Adverse Event|1
268221|NCT02153398|891581|P3|Overall Study|Adverse Event|1
268222|NCT02153398|891582|P2|Overall Study|Adverse Event|0
268223|NCT02153398|891583|P1|Overall Study|Adverse Event|0
268224|NCT02153398|891579|P5|Overall Study|Withdrawal by Subject|0
268225|NCT02153398|891580|P4|Overall Study|Withdrawal by Subject|0
268226|NCT02153398|891581|P3|Overall Study|Withdrawal by Subject|0
268227|NCT02153398|891582|P2|Overall Study|Withdrawal by Subject|0
268228|NCT02153398|891583|P1|Overall Study|Withdrawal by Subject|1
268229|NCT02153346|891705|P1|Overall Study|Lost to Follow-up|11
268230|NCT02153086|891779|P1|Overall Study|Other|2
268231|NCT02153086|891779|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
268232|NCT02152605|891795|P2|Overall Study|Withdrew consent|2
268233|NCT02152605|891796|P1|Overall Study|Withdrew consent|4
268234|NCT02152605|891795|P2|Overall Study|Lost to Follow-up|0
268235|NCT02152605|891796|P1|Overall Study|Lost to Follow-up|1
268236|NCT02152605|891795|P2|Overall Study|Protocol deviation|4
268237|NCT02152605|891796|P1|Overall Study|Protocol deviation|1
268238|NCT02152605|891795|P2|Overall Study|Lack of Efficacy|4
268239|NCT02152605|891796|P1|Overall Study|Lack of Efficacy|7
268240|NCT02152605|891795|P2|Overall Study|Adverse Event|8
268241|NCT02152605|891796|P1|Overall Study|Adverse Event|6
268242|NCT02152566|891806|P1|Overall Study|Withdrawal by Subject|2
268243|NCT02152566|891806|P1|Overall Study|Lost to Follow-up|1
268244|NCT02152371|891812|P2|Overall Study|Reason Not Given|1
268245|NCT02152371|891813|P1|Overall Study|Reason Not Given|0
268246|NCT02152371|891812|P2|Overall Study|Physician Decision|2
268247|NCT02152371|891813|P1|Overall Study|Physician Decision|0
268248|NCT02152371|891812|P2|Overall Study|Lack of Efficacy|1
268249|NCT02152371|891813|P1|Overall Study|Lack of Efficacy|0
268250|NCT02152371|891812|P2|Overall Study|Lost to Follow-up|0
268251|NCT02152371|891813|P1|Overall Study|Lost to Follow-up|1
268252|NCT02152371|891812|P2|Overall Study|Protocol Violation|3
268253|NCT02152371|891813|P1|Overall Study|Protocol Violation|2
268254|NCT02152371|891812|P2|Overall Study|Withdrawal by Subject|7
268255|NCT02152371|891813|P1|Overall Study|Withdrawal by Subject|3
268256|NCT02152371|891812|P2|Overall Study|Adverse Event|2
268257|NCT02152371|891813|P1|Overall Study|Adverse Event|6
268258|NCT02152007|891849|P1|Overall Study|Withdrawal by Subject|1
268259|NCT02151981|891910|P2|Overall Study|Eligibility criteria not fulfilled|1
268260|NCT02151981|891911|P1|Overall Study|Eligibility criteria not fulfilled|0
268261|NCT02151981|891910|P2|Overall Study|Ongoing Study at Data Cut-off|95
268262|NCT02151981|891911|P1|Overall Study|Ongoing Study at Data Cut-off|224
268263|NCT02151981|891910|P2|Overall Study|Withdrawal by Subject|18
268264|NCT02151981|891911|P1|Overall Study|Withdrawal by Subject|19
268265|NCT02151981|891910|P2|Overall Study|Lost to Follow-up|0
268266|NCT02151981|891911|P1|Overall Study|Lost to Follow-up|1
268267|NCT02151981|891910|P2|Overall Study|Death|26
268268|NCT02151981|891911|P1|Overall Study|Death|35
268269|NCT02151851|891929|P2|Overall Study|Adverse Event|28
268270|NCT02151851|891930|P1|Overall Study|Adverse Event|6
268271|NCT02151851|891929|P2|Overall Study|Subject entered into study in error|1
268272|NCT02151851|891930|P1|Overall Study|Subject entered into study in error|0
268273|NCT02151851|891929|P2|Overall Study|Low compliance to study visits|1
268274|NCT02151851|891930|P1|Overall Study|Low compliance to study visits|0
268275|NCT02151851|891929|P2|Overall Study|Medical impairment|0
268276|NCT02151851|891930|P1|Overall Study|Medical impairment|1
268277|NCT02151851|891929|P2|Overall Study|Withdrawal by Subject|5
268278|NCT02151851|891930|P1|Overall Study|Withdrawal by Subject|2
268279|NCT02151851|891929|P2|Overall Study|Protocol Violation|1
268280|NCT02151851|891930|P1|Overall Study|Protocol Violation|0
268281|NCT02151851|891929|P2|Overall Study|Lack of Efficacy|94
268282|NCT02151851|891930|P1|Overall Study|Lack of Efficacy|67
268283|NCT02151786|891942|P1|Overall Study|Unavailability of Information|8
268284|NCT02151786|891942|P1|Overall Study|Randomized, not Treated|1
268285|NCT02151786|891942|P1|Overall Study|Outside the Contract Period|1
268286|NCT02151786|891942|P1|Overall Study|Unavailability of Case Report Form|26
268287|NCT02151773|891953|P1|Overall Study|Protocol Deviation|64
268288|NCT02151643|891963|P5|Overall Study|High Ferritin levels|1
268289|NCT02151643|891964|P4|Overall Study|High Ferritin levels|2
268290|NCT02151643|891965|P3|Overall Study|High Ferritin levels|2
268291|NCT02151643|891966|P2|Overall Study|High Ferritin levels|3
268292|NCT02151643|891967|P1|Overall Study|High Ferritin levels|3
268293|NCT02151643|891963|P5|Overall Study|Hyperphosphataemia|1
268294|NCT02151643|891964|P4|Overall Study|Hyperphosphataemia|0
268295|NCT02151643|891965|P3|Overall Study|Hyperphosphataemia|0
268296|NCT02151643|891966|P2|Overall Study|Hyperphosphataemia|0
268297|NCT02151643|891967|P1|Overall Study|Hyperphosphataemia|1
268298|NCT02151643|891963|P5|Overall Study|Withdrawal by Subject|1
268299|NCT02151643|891964|P4|Overall Study|Withdrawal by Subject|1
268300|NCT02151643|891965|P3|Overall Study|Withdrawal by Subject|1
268301|NCT02151643|891966|P2|Overall Study|Withdrawal by Subject|1
268302|NCT02151643|891967|P1|Overall Study|Withdrawal by Subject|0
268303|NCT02151643|891963|P5|Overall Study|Adverse Event|0
268304|NCT02151643|891964|P4|Overall Study|Adverse Event|4
268305|NCT02151643|891965|P3|Overall Study|Adverse Event|1
268306|NCT02151643|891966|P2|Overall Study|Adverse Event|0
268307|NCT02151643|891967|P1|Overall Study|Adverse Event|2
268308|NCT02151461|892008|P4|Overall Study|Treatment discontinuation|0
268309|NCT02151461|892009|P3|Overall Study|Treatment discontinuation|1
268310|NCT02151461|892010|P2|Overall Study|Treatment discontinuation|0
268311|NCT02151461|892011|P1|Overall Study|Treatment discontinuation|0
268312|NCT02151461|892008|P4|Overall Study|Withdrawal by Subject|1
268313|NCT02151461|892009|P3|Overall Study|Withdrawal by Subject|1
268314|NCT02151461|892010|P2|Overall Study|Withdrawal by Subject|0
268315|NCT02151461|892011|P1|Overall Study|Withdrawal by Subject|1
268316|NCT02151461|892008|P4|Overall Study|Lost to Follow-up|1
268317|NCT02151461|892009|P3|Overall Study|Lost to Follow-up|1
268318|NCT02151461|892010|P2|Overall Study|Lost to Follow-up|0
268319|NCT02151461|892011|P1|Overall Study|Lost to Follow-up|0
268320|NCT02151461|892008|P4|Overall Study|Adverse Event|2
268321|NCT02151461|892009|P3|Overall Study|Adverse Event|0
268322|NCT02151461|892010|P2|Overall Study|Adverse Event|1
268323|NCT02151461|892011|P1|Overall Study|Adverse Event|5
268324|NCT02151058|892067|P3|Overall Study|Lost to Follow-up|2
268325|NCT02151058|892068|P2|Overall Study|Lost to Follow-up|0
268326|NCT02151058|892069|P1|Overall Study|Lost to Follow-up|1
268327|NCT02151058|892067|P3|Overall Study|Withdrawal by Subject|3
268328|NCT02151058|892068|P2|Overall Study|Withdrawal by Subject|1
268329|NCT02151058|892069|P1|Overall Study|Withdrawal by Subject|1
268330|NCT02150954|892103|P2|Overall Study|Protocol Violation|0
268331|NCT02150954|892104|P1|Overall Study|Protocol Violation|1
268332|NCT02150343|892180|P4|Overall Study|Not specified|2
268333|NCT02150343|892181|P3|Overall Study|Not specified|0
268334|NCT02150343|892182|P2|Overall Study|Not specified|6
268335|NCT02150343|892183|P1|Overall Study|Not specified|2
268336|NCT02150343|892180|P4|Overall Study|Lost to Follow-up|3
268337|NCT02150343|892181|P3|Overall Study|Lost to Follow-up|2
268338|NCT02150343|892182|P2|Overall Study|Lost to Follow-up|4
268339|NCT02150343|892183|P1|Overall Study|Lost to Follow-up|4
268340|NCT02150343|892180|P4|Overall Study|Withdrawal by Subject|4
268341|NCT02150343|892181|P3|Overall Study|Withdrawal by Subject|9
268342|NCT02150343|892182|P2|Overall Study|Withdrawal by Subject|10
268343|NCT02150343|892183|P1|Overall Study|Withdrawal by Subject|13
268344|NCT02150343|892180|P4|Overall Study|Adverse Event|1
268345|NCT02150343|892181|P3|Overall Study|Adverse Event|1
268346|NCT02150343|892182|P2|Overall Study|Adverse Event|0
268347|NCT02150343|892183|P1|Overall Study|Adverse Event|2
268348|NCT02150213|892221|P1|Overall Study|Withdrawal by Subject|1
268349|NCT02150213|892221|P1|Overall Study|Lost to Follow-up|1
268350|NCT02149875|892247|P3|Overall Study|Physician Decision|2
268351|NCT02149875|892248|P2|Overall Study|Physician Decision|2
268352|NCT02149875|892249|P1|Overall Study|Physician Decision|1
268353|NCT02149875|892247|P3|Overall Study|Withdrawal by Subject|2
268354|NCT02149875|892248|P2|Overall Study|Withdrawal by Subject|2
268355|NCT02149875|892249|P1|Overall Study|Withdrawal by Subject|3
268356|NCT02149875|892247|P3|Overall Study|Lost to Follow-up|5
268357|NCT02149875|892248|P2|Overall Study|Lost to Follow-up|4
268358|NCT02149875|892249|P1|Overall Study|Lost to Follow-up|3
268359|NCT02149264|892278|P1|Overall Study|Protocol Violation|1
268360|NCT02149264|892278|P1|Overall Study|Physician Decision|3
268361|NCT02149264|892278|P1|Overall Study|Adverse Event|7
268362|NCT02149264|892278|P1|Overall Study|Withdrawal by Subject|9
268363|NCT02149108|892293|P2|Overall Study|Lost to Follow-up|0
268364|NCT02149108|892294|P1|Overall Study|Lost to Follow-up|1
268365|NCT02149108|892293|P2|Overall Study|Refusal to continue trial medication|11
268366|NCT02149108|892294|P1|Overall Study|Refusal to continue trial medication|15
268367|NCT02149108|892293|P2|Overall Study|Other not defined above|2
268368|NCT02149108|892294|P1|Overall Study|Other not defined above|0
268369|NCT02149108|892293|P2|Overall Study|Other Adverse Event (AE)|18
268370|NCT02149108|892294|P1|Overall Study|Other Adverse Event (AE)|8
268371|NCT02149108|892293|P2|Overall Study|Worsening/adverse event cancer disease|32
268372|NCT02149108|892294|P1|Overall Study|Worsening/adverse event cancer disease|31
268373|NCT02149108|892293|P2|Overall Study|Progressive Disease (PD)|318
268374|NCT02149108|892294|P1|Overall Study|Progressive Disease (PD)|324
268375|NCT02149108|892293|P2|Overall Study|Not treated|2
268376|NCT02149108|892294|P1|Overall Study|Not treated|1
268377|NCT02148718|892311|P1|Overall Study|Discontinued Study Prematurely|5
268378|NCT02148718|892311|P1|Overall Study|Protocol Violation|26
268379|NCT02148445|892359|P2|Overall Study|Death|3
268380|NCT02148445|892360|P1|Overall Study|Death|1
268381|NCT02147691|892435|P2|Overall Study|Lost to Follow-up|1
268382|NCT02147691|892436|P1|Overall Study|Lost to Follow-up|0
268383|NCT02147691|892435|P2|Overall Study|Adverse Event|0
268384|NCT02147691|892436|P1|Overall Study|Adverse Event|2
268385|NCT02147691|892435|P2|Overall Study|Withdrawal by Subject|0
268386|NCT02147691|892436|P1|Overall Study|Withdrawal by Subject|2
268387|NCT02147587|892482|P2|Overall Study|Lack of Efficacy|1
268388|NCT02147587|892483|P1|Overall Study|Lack of Efficacy|2
268389|NCT02147587|892482|P2|Overall Study|Adverse Event|4
268390|NCT02147587|892483|P1|Overall Study|Adverse Event|9
268391|NCT02147561|892503|P1|Overall Study|Subjects who didn’t receive BOTOX|1
268392|NCT02147561|892503|P1|Overall Study|Lost to Follow-up|3
268393|NCT02147288|892524|P10|Overall Study|complications from concurrent hernia rep|0
268394|NCT02147288|892525|P9|Overall Study|complications from concurrent hernia rep|0
268395|NCT02147288|892526|P8|Overall Study|complications from concurrent hernia rep|0
268396|NCT02147288|892527|P7|Overall Study|complications from concurrent hernia rep|0
268397|NCT02147288|892528|P6|Overall Study|complications from concurrent hernia rep|0
268398|NCT02147288|892529|P5|Overall Study|complications from concurrent hernia rep|0
268399|NCT02147288|892530|P4|Overall Study|complications from concurrent hernia rep|0
268400|NCT02147288|892531|P3|Overall Study|complications from concurrent hernia rep|0
268401|NCT02147288|892532|P2|Overall Study|complications from concurrent hernia rep|1
268402|NCT02147288|892533|P1|Overall Study|complications from concurrent hernia rep|0
268403|NCT02147288|892524|P10|Overall Study|post-operative hematoma|0
268404|NCT02147288|892525|P9|Overall Study|post-operative hematoma|0
268405|NCT02147288|892526|P8|Overall Study|post-operative hematoma|0
268406|NCT02147288|892527|P7|Overall Study|post-operative hematoma|0
268407|NCT02147288|892528|P6|Overall Study|post-operative hematoma|0
268408|NCT02147288|892529|P5|Overall Study|post-operative hematoma|0
268409|NCT02147288|892530|P4|Overall Study|post-operative hematoma|0
268410|NCT02147288|892531|P3|Overall Study|post-operative hematoma|0
268411|NCT02147288|892532|P2|Overall Study|post-operative hematoma|1
268412|NCT02147288|892533|P1|Overall Study|post-operative hematoma|1
268413|NCT02147184|892541|P2|Overall Study|Other|0
268414|NCT02147184|892542|P1|Overall Study|Other|1
268415|NCT02147184|892541|P2|Overall Study|Physician Decision|2
268416|NCT02147184|892542|P1|Overall Study|Physician Decision|0
268417|NCT02147184|892541|P2|Overall Study|Moved out of state|3
268418|NCT02147184|892542|P1|Overall Study|Moved out of state|3
268419|NCT02147184|892541|P2|Overall Study|Pregnancy|0
268420|NCT02147184|892542|P1|Overall Study|Pregnancy|6
268421|NCT02147184|892541|P2|Overall Study|Study Burden|7
268422|NCT02147184|892542|P1|Overall Study|Study Burden|11
268423|NCT02147184|892541|P2|Overall Study|Lost to Follow-up|15
268424|NCT02147184|892542|P1|Overall Study|Lost to Follow-up|28
268425|NCT02147093|892562|P2|Period 2|Protocol Violation|0
268426|NCT02147093|892563|P1|Period 2|Protocol Violation|2
268427|NCT02147093|892562|P2|Period 1|Lost to Follow-up|1
268428|NCT02147093|892563|P1|Period 1|Lost to Follow-up|0
268429|NCT02146599|892571|P1|Overall Study|Failed to meet inclusion criteria|5
268430|NCT02146352|892584|P1|Overall Study|Patient entered hospice care|1
268431|NCT02146352|892584|P1|Overall Study|Death|1
268432|NCT02146326|892602|P4|Overall Study|Unable to complete interview|6
268433|NCT02146326|892603|P3|Overall Study|Unable to complete interview|10
268434|NCT02146326|892604|P2|Overall Study|Unable to complete interview|0
268435|NCT02146326|892605|P1|Overall Study|Unable to complete interview|0
268436|NCT02146326|892602|P4|Overall Study|Death|4
268437|NCT02146326|892603|P3|Overall Study|Death|4
268438|NCT02146326|892604|P2|Overall Study|Death|0
268439|NCT02146326|892605|P1|Overall Study|Death|0
268440|NCT02146326|892602|P4|Overall Study|Incarcerated|8
268441|NCT02146326|892603|P3|Overall Study|Incarcerated|3
268442|NCT02146326|892604|P2|Overall Study|Incarcerated|0
268443|NCT02146326|892605|P1|Overall Study|Incarcerated|0
268444|NCT02146326|892602|P4|Overall Study|Separated from mental health center|0
268445|NCT02146326|892603|P3|Overall Study|Separated from mental health center|0
268446|NCT02146326|892604|P2|Overall Study|Separated from mental health center|33
268447|NCT02146326|892605|P1|Overall Study|Separated from mental health center|23
268448|NCT02146326|892602|P4|Overall Study|Withdrawal by Subject|11
268449|NCT02146326|892603|P3|Overall Study|Withdrawal by Subject|15
268450|NCT02146326|892604|P2|Overall Study|Withdrawal by Subject|1
268451|NCT02146326|892605|P1|Overall Study|Withdrawal by Subject|2
268452|NCT02146326|892602|P4|Overall Study|Lost to Follow-up|19
268453|NCT02146326|892603|P3|Overall Study|Lost to Follow-up|11
268454|NCT02146326|892604|P2|Overall Study|Lost to Follow-up|3
268455|NCT02146326|892605|P1|Overall Study|Lost to Follow-up|3
268456|NCT02146248|892767|P1|Overall Study|Withdrawal by Subject|2
268457|NCT02146105|892775|P1|Overall Study|Withdrawal by Subject|5
268458|NCT02146105|892775|P1|Overall Study|Adverse Event|1
268459|NCT02145468|892826|P2|Overall Study|Withdrawal by Subject|8
268460|NCT02145468|892827|P1|Overall Study|Withdrawal by Subject|5
268461|NCT02145156|892915|P3|Overall Study|No match to vaccination records|41
268462|NCT02145156|892916|P2|Overall Study|No match to vaccination records|52
268463|NCT02145156|892917|P1|Overall Study|No match to vaccination records|60
268464|NCT02144337|892971|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
268465|NCT02144337|892972|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
268466|NCT02144337|892971|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
268467|NCT02144337|892972|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
268468|NCT02144337|892971|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
268469|NCT02144337|892972|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
268470|NCT02144337|892971|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
268471|NCT02144337|892972|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
268472|NCT02144337|892971|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
268473|NCT02144337|892972|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
268474|NCT02144220|893001|P1|Overall Study|Protocol Violation|1
268475|NCT02144220|893001|P1|Overall Study|Withdrawal by Subject|2
268476|NCT02144220|893001|P1|Overall Study|Physician Decision|3
268477|NCT02144220|893001|P1|Overall Study|Lack of Efficacy|4
268478|NCT02144220|893001|P1|Overall Study|technology incompatibility|9
268479|NCT02144012|893011|P2|Overall Study|Other|0
268480|NCT02144012|893012|P1|Overall Study|Other|3
268481|NCT02144012|893011|P2|Overall Study|Study Terminated by Sponsor|12
268482|NCT02144012|893012|P1|Overall Study|Study Terminated by Sponsor|18
268483|NCT02144012|893011|P2|Overall Study|Withdrawal by Subject|3
268484|NCT02144012|893012|P1|Overall Study|Withdrawal by Subject|11
268485|NCT02144012|893011|P2|Overall Study|Death|0
268486|NCT02144012|893012|P1|Overall Study|Death|1
268487|NCT02144012|893011|P2|Overall Study|Adverse Event|0
268488|NCT02144012|893012|P1|Overall Study|Adverse Event|1
268489|NCT02143947|893049|P2|Overall Study|Lost to Follow-up|2
268490|NCT02143947|893050|P1|Overall Study|Lost to Follow-up|4
268491|NCT02143583|893065|P3|Overall Study|husband illness|1
268492|NCT02143583|893066|P2|Overall Study|husband illness|0
268493|NCT02143583|893067|P1|Overall Study|husband illness|0
268494|NCT02143583|893065|P3|Overall Study|Withdrawal by Subject|1
268495|NCT02143583|893066|P2|Overall Study|Withdrawal by Subject|0
268496|NCT02143583|893067|P1|Overall Study|Withdrawal by Subject|1
268497|NCT02143141|893080|P2|Overall Study|pain scores at 24 hours not collected|0
268498|NCT02143141|893081|P1|Overall Study|pain scores at 24 hours not collected|1
268499|NCT02142738|893093|P2|Overall Study|Ongoing in Study|82
268500|NCT02142738|893094|P1|Overall Study|Ongoing in Study|107
268501|NCT02142738|893093|P2|Overall Study|Withdrawal by Subject|5
268502|NCT02142738|893094|P1|Overall Study|Withdrawal by Subject|5
268503|NCT02142738|893093|P2|Overall Study|Progressive Disease|1
268504|NCT02142738|893094|P1|Overall Study|Progressive Disease|0
268505|NCT02142738|893093|P2|Overall Study|Death|55
268506|NCT02142738|893094|P1|Overall Study|Death|33
268507|NCT02142738|893093|P2|Overall Study|Adverse Event|8
268508|NCT02142738|893094|P1|Overall Study|Adverse Event|9
268509|NCT02142712|893107|P4|Overall Study|Lost to Follow-up|0
268510|NCT02142712|893108|P3|Overall Study|Lost to Follow-up|1
268511|NCT02142712|893109|P2|Overall Study|Lost to Follow-up|1
268512|NCT02142712|893110|P1|Overall Study|Lost to Follow-up|1
268513|NCT02142504|893133|P3|Overall Study|Reason Not Specified|4
268514|NCT02142504|893134|P2|Overall Study|Reason Not Specified|5
268515|NCT02142504|893135|P1|Overall Study|Reason Not Specified|4
268516|NCT02142504|893133|P3|Overall Study|Physician Decision|3
268517|NCT02142504|893134|P2|Overall Study|Physician Decision|1
268518|NCT02142504|893135|P1|Overall Study|Physician Decision|0
268519|NCT02142504|893133|P3|Overall Study|Pregnancy|2
268520|NCT02142504|893134|P2|Overall Study|Pregnancy|4
268521|NCT02142504|893135|P1|Overall Study|Pregnancy|4
268522|NCT02142504|893133|P3|Overall Study|Withdrawal by Subject|11
268523|NCT02142504|893134|P2|Overall Study|Withdrawal by Subject|9
268524|NCT02142504|893135|P1|Overall Study|Withdrawal by Subject|7
268525|NCT02142504|893133|P3|Overall Study|Lost to Follow-up|17
268526|NCT02142504|893134|P2|Overall Study|Lost to Follow-up|19
268527|NCT02142504|893135|P1|Overall Study|Lost to Follow-up|12
268528|NCT02142504|893133|P3|Overall Study|Adverse Event|4
268529|NCT02142504|893134|P2|Overall Study|Adverse Event|3
268530|NCT02142504|893135|P1|Overall Study|Adverse Event|2
268531|NCT02142504|893133|P3|Overall Study|Protocol Violation|2
268532|NCT02142504|893134|P2|Overall Study|Protocol Violation|1
268533|NCT02142504|893135|P1|Overall Study|Protocol Violation|2
268534|NCT02141997|893377|P4|Overall Study|Not specified|0
268535|NCT02141997|893378|P3|Overall Study|Not specified|0
268536|NCT02141997|893379|P2|Overall Study|Not specified|4
268537|NCT02141997|893380|P1|Overall Study|Not specified|1
268538|NCT02141997|893377|P4|Overall Study|Withdrew consent|0
268539|NCT02141997|893378|P3|Overall Study|Withdrew consent|3
268540|NCT02141997|893379|P2|Overall Study|Withdrew consent|0
268541|NCT02141997|893380|P1|Overall Study|Withdrew consent|1
268542|NCT02141997|893377|P4|Overall Study|Participant noncompliance|0
268543|NCT02141997|893378|P3|Overall Study|Participant noncompliance|0
268544|NCT02141997|893379|P2|Overall Study|Participant noncompliance|0
268545|NCT02141997|893380|P1|Overall Study|Participant noncompliance|1
268546|NCT02141997|893377|P4|Overall Study|Adverse Event|1
268547|NCT02141997|893378|P3|Overall Study|Adverse Event|0
268548|NCT02141997|893379|P2|Overall Study|Adverse Event|2
268549|NCT02141997|893380|P1|Overall Study|Adverse Event|0
268550|NCT02141984|893418|P1|Overall Study|Lack of Efficacy|2
268551|NCT02141854|893437|P6|Treatment Period|Lost to Follow-up|1
268552|NCT02141854|893438|P5|Treatment Period|Lost to Follow-up|0
268553|NCT02141854|893439|P4|Treatment Period|Lost to Follow-up|1
268554|NCT02141854|893440|P3|Treatment Period|Lost to Follow-up|1
268555|NCT02141854|893441|P2|Treatment Period|Lost to Follow-up|1
268556|NCT02141854|893442|P1|Treatment Period|Lost to Follow-up|0
268557|NCT02141854|893437|P6|Treatment Period|Disease progression|18
268558|NCT02141854|893438|P5|Treatment Period|Disease progression|0
268559|NCT02141854|893439|P4|Treatment Period|Disease progression|3
268560|NCT02141854|893440|P3|Treatment Period|Disease progression|1
268561|NCT02141854|893441|P2|Treatment Period|Disease progression|2
268562|NCT02141854|893442|P1|Treatment Period|Disease progression|0
268563|NCT02141854|893437|P6|Treatment Period|Withdrawal by Subject|7
268564|NCT02141854|893438|P5|Treatment Period|Withdrawal by Subject|4
268565|NCT02141854|893439|P4|Treatment Period|Withdrawal by Subject|3
268566|NCT02141854|893440|P3|Treatment Period|Withdrawal by Subject|3
268567|NCT02141854|893441|P2|Treatment Period|Withdrawal by Subject|2
268568|NCT02141854|893442|P1|Treatment Period|Withdrawal by Subject|0
268569|NCT02141854|893437|P6|Treatment Period|Adverse Event|2
268570|NCT02141854|893438|P5|Treatment Period|Adverse Event|2
268571|NCT02141854|893439|P4|Treatment Period|Adverse Event|0
268572|NCT02141854|893440|P3|Treatment Period|Adverse Event|2
268573|NCT02141854|893441|P2|Treatment Period|Adverse Event|2
268574|NCT02141854|893442|P1|Treatment Period|Adverse Event|0
268575|NCT02141854|893437|P6|Treatment Period|Not specified|2
268576|NCT02141854|893438|P5|Treatment Period|Not specified|1
268577|NCT02141854|893439|P4|Treatment Period|Not specified|0
268578|NCT02141854|893440|P3|Treatment Period|Not specified|2
268579|NCT02141854|893441|P2|Treatment Period|Not specified|1
268580|NCT02141854|893442|P1|Treatment Period|Not specified|0
268581|NCT02141854|893437|P6|Treatment Period|Pregnancy|0
268582|NCT02141854|893438|P5|Treatment Period|Pregnancy|0
268583|NCT02141854|893439|P4|Treatment Period|Pregnancy|0
268584|NCT02141854|893440|P3|Treatment Period|Pregnancy|0
268585|NCT02141854|893441|P2|Treatment Period|Pregnancy|1
268586|NCT02141854|893442|P1|Treatment Period|Pregnancy|0
268587|NCT02141854|893437|P6|Treatment Period|Lack of Efficacy|7
268588|NCT02141854|893438|P5|Treatment Period|Lack of Efficacy|1
268589|NCT02141854|893439|P4|Treatment Period|Lack of Efficacy|1
268590|NCT02141854|893440|P3|Treatment Period|Lack of Efficacy|0
268591|NCT02141854|893441|P2|Treatment Period|Lack of Efficacy|0
268592|NCT02141854|893442|P1|Treatment Period|Lack of Efficacy|0
268593|NCT02141854|893437|P6|Treatment Period|Noncompliance|0
268594|NCT02141854|893438|P5|Treatment Period|Noncompliance|0
268595|NCT02141854|893439|P4|Treatment Period|Noncompliance|1
268596|NCT02141854|893440|P3|Treatment Period|Noncompliance|0
268597|NCT02141854|893441|P2|Treatment Period|Noncompliance|0
268598|NCT02141854|893442|P1|Treatment Period|Noncompliance|0
268599|NCT02141854|893437|P6|Treatment Period|Protocol Violation|1
268600|NCT02141854|893438|P5|Treatment Period|Protocol Violation|2
268601|NCT02141854|893439|P4|Treatment Period|Protocol Violation|2
268602|NCT02141854|893440|P3|Treatment Period|Protocol Violation|0
268603|NCT02141854|893441|P2|Treatment Period|Protocol Violation|1
268604|NCT02141854|893442|P1|Treatment Period|Protocol Violation|0
268605|NCT02141854|893437|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268606|NCT02141854|893438|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268607|NCT02141854|893439|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268608|NCT02141854|893440|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268609|NCT02141854|893441|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268610|NCT02141854|893442|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
268611|NCT02141854|893437|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268612|NCT02141854|893438|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268613|NCT02141854|893439|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268614|NCT02141854|893440|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268615|NCT02141854|893441|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268616|NCT02141854|893442|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
268617|NCT02141854|893437|P6|Run-In Period (Pre-assignment)|Adverse Event|0
268618|NCT02141854|893438|P5|Run-In Period (Pre-assignment)|Adverse Event|0
268619|NCT02141854|893439|P4|Run-In Period (Pre-assignment)|Adverse Event|0
268620|NCT02141854|893440|P3|Run-In Period (Pre-assignment)|Adverse Event|0
268621|NCT02141854|893441|P2|Run-In Period (Pre-assignment)|Adverse Event|0
268622|NCT02141854|893442|P1|Run-In Period (Pre-assignment)|Adverse Event|10
268623|NCT02141854|893437|P6|Run-In Period (Pre-assignment)|Not specified|0
268624|NCT02141854|893438|P5|Run-In Period (Pre-assignment)|Not specified|0
268625|NCT02141854|893439|P4|Run-In Period (Pre-assignment)|Not specified|0
268626|NCT02141854|893440|P3|Run-In Period (Pre-assignment)|Not specified|0
268627|NCT02141854|893441|P2|Run-In Period (Pre-assignment)|Not specified|0
268628|NCT02141854|893442|P1|Run-In Period (Pre-assignment)|Not specified|14
268629|NCT02141854|893437|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268630|NCT02141854|893438|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268631|NCT02141854|893439|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268632|NCT02141854|893440|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268633|NCT02141854|893441|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268634|NCT02141854|893442|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
268635|NCT02141854|893437|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268636|NCT02141854|893438|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268637|NCT02141854|893439|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268638|NCT02141854|893440|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268639|NCT02141854|893441|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268640|NCT02141854|893442|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
268641|NCT02141854|893437|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268642|NCT02141854|893438|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268643|NCT02141854|893439|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268644|NCT02141854|893440|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268645|NCT02141854|893441|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268646|NCT02141854|893442|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
268647|NCT02141633|893496|P2|Overall Study|Physician Decision|0
268648|NCT02141633|893497|P1|Overall Study|Physician Decision|1
268649|NCT02141620|893505|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
268650|NCT02141620|893506|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
268651|NCT02141516|893583|P3|Overall Study|Other|0
268652|NCT02141516|893584|P2|Overall Study|Other|3
268653|NCT02141516|893585|P1|Overall Study|Other|0
268654|NCT02141516|893583|P3|Overall Study|Lost to Follow-up|0
268655|NCT02141516|893584|P2|Overall Study|Lost to Follow-up|1
268656|NCT02141516|893585|P1|Overall Study|Lost to Follow-up|0
268657|NCT02141516|893583|P3|Overall Study|Adverse Event|0
268658|NCT02141516|893584|P2|Overall Study|Adverse Event|1
268659|NCT02141516|893585|P1|Overall Study|Adverse Event|0
268660|NCT02141360|893635|P3|Overall Study|Study Terminated before Visit|0
268661|NCT02141360|893636|P2|Overall Study|Study Terminated before Visit|0
268662|NCT02141360|893637|P1|Overall Study|Study Terminated before Visit|1
268663|NCT02141360|893635|P3|Overall Study|Withdrawal by Subject|0
268664|NCT02141360|893636|P2|Overall Study|Withdrawal by Subject|0
268665|NCT02141360|893637|P1|Overall Study|Withdrawal by Subject|6
268666|NCT02141217|893647|P2|Overall Study|Surgical Intervention|1
268667|NCT02141217|893648|P1|Overall Study|Surgical Intervention|1
268668|NCT02141217|893647|P2|Overall Study|Physician Decision|0
268669|NCT02141217|893648|P1|Overall Study|Physician Decision|1
268670|NCT02141217|893647|P2|Overall Study|Lost to Follow-up|1
268671|NCT02141217|893648|P1|Overall Study|Lost to Follow-up|1
268672|NCT02141217|893647|P2|Overall Study|Withdrawal by Subject|0
268673|NCT02141217|893648|P1|Overall Study|Withdrawal by Subject|6
268674|NCT02141217|893647|P2|Overall Study|Protocol Violation|4
268675|NCT02141217|893648|P1|Overall Study|Protocol Violation|1
268676|NCT02141217|893647|P2|Overall Study|Adverse Event|2
268677|NCT02141217|893648|P1|Overall Study|Adverse Event|1
268678|NCT02140762|893710|P2|Overall Study|Other|1
268679|NCT02140762|893711|P1|Overall Study|Other|0
268680|NCT02140762|893710|P2|Overall Study|Withdrawal by Subject|4
268681|NCT02140762|893711|P1|Overall Study|Withdrawal by Subject|6
268682|NCT02140762|893710|P2|Overall Study|Protocol Violation|1
268683|NCT02140762|893711|P1|Overall Study|Protocol Violation|1
268684|NCT02140762|893710|P2|Overall Study|Lost to Follow-up|5
268685|NCT02140762|893711|P1|Overall Study|Lost to Follow-up|9
268686|NCT02140762|893710|P2|Overall Study|Adverse Event|1
268687|NCT02140762|893711|P1|Overall Study|Adverse Event|1
268688|NCT02140645|893757|P6|Overall Study|Not linked|70896
268689|NCT02140645|893758|P5|Overall Study|Not linked|3286
268690|NCT02140645|893759|P4|Overall Study|Not linked|13833
268691|NCT02140645|893760|P3|Overall Study|Not linked|4236
268692|NCT02140645|893761|P2|Overall Study|Not linked|61654
268693|NCT02140645|893762|P1|Overall Study|Not linked|5489
268694|NCT02140164|893871|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
268695|NCT02140060|893892|P6|Overall Study|Lack of Efficacy|0
268696|NCT02140060|893893|P5|Overall Study|Lack of Efficacy|0
268697|NCT02140060|893894|P4|Overall Study|Lack of Efficacy|1
268698|NCT02140060|893895|P3|Overall Study|Lack of Efficacy|0
268699|NCT02140060|893896|P2|Overall Study|Lack of Efficacy|0
268700|NCT02140060|893897|P1|Overall Study|Lack of Efficacy|0
268701|NCT02140060|893892|P6|Overall Study|Adverse Event|1
268702|NCT02140060|893893|P5|Overall Study|Adverse Event|1
268703|NCT02140060|893894|P4|Overall Study|Adverse Event|1
268704|NCT02140060|893895|P3|Overall Study|Adverse Event|0
268705|NCT02140060|893896|P2|Overall Study|Adverse Event|0
268706|NCT02140060|893897|P1|Overall Study|Adverse Event|0
268707|NCT02139982|893922|P10|Overall Study|Lack of Efficacy|0
268708|NCT02139982|893923|P9|Overall Study|Lack of Efficacy|0
268709|NCT02139982|893924|P8|Overall Study|Lack of Efficacy|0
268710|NCT02139982|893925|P7|Overall Study|Lack of Efficacy|0
268711|NCT02139982|893926|P6|Overall Study|Lack of Efficacy|0
268712|NCT02139982|893927|P5|Overall Study|Lack of Efficacy|0
268713|NCT02139982|893928|P4|Overall Study|Lack of Efficacy|1
268714|NCT02139982|893929|P3|Overall Study|Lack of Efficacy|0
268715|NCT02139982|893930|P2|Overall Study|Lack of Efficacy|1
268716|NCT02139982|893931|P1|Overall Study|Lack of Efficacy|0
268717|NCT02139943|893976|P3|Overall Study|eGFR Withdrawal Criteria|1
268718|NCT02139943|893977|P2|Overall Study|eGFR Withdrawal Criteria|0
268719|NCT02139943|893978|P1|Overall Study|eGFR Withdrawal Criteria|0
268720|NCT02139943|893976|P3|Overall Study|Participant in Poor Compliance|1
268721|NCT02139943|893977|P2|Overall Study|Participant in Poor Compliance|0
268722|NCT02139943|893978|P1|Overall Study|Participant in Poor Compliance|1
268723|NCT02139943|893976|P3|Overall Study|Participant wishes to discontinue|0
268724|NCT02139943|893977|P2|Overall Study|Participant wishes to discontinue|0
268725|NCT02139943|893978|P1|Overall Study|Participant wishes to discontinue|2
268726|NCT02139943|893976|P3|Overall Study|Other|1
268727|NCT02139943|893977|P2|Overall Study|Other|0
268728|NCT02139943|893978|P1|Overall Study|Other|0
268729|NCT02139943|893976|P3|Overall Study|Withdrawal by Subject|0
268730|NCT02139943|893977|P2|Overall Study|Withdrawal by Subject|3
268731|NCT02139943|893978|P1|Overall Study|Withdrawal by Subject|4
268732|NCT02139943|893976|P3|Overall Study|Lost to Follow-up|2
268733|NCT02139943|893977|P2|Overall Study|Lost to Follow-up|2
268734|NCT02139943|893978|P1|Overall Study|Lost to Follow-up|3
268735|NCT02139943|893976|P3|Overall Study|Adverse Event|2
268736|NCT02139943|893977|P2|Overall Study|Adverse Event|1
268737|NCT02139943|893978|P1|Overall Study|Adverse Event|0
268738|NCT02139644|894003|P6|Treatment Period|Not specified|1
268739|NCT02139644|894004|P5|Treatment Period|Not specified|0
268740|NCT02139644|894005|P4|Treatment Period|Not specified|1
268741|NCT02139644|894006|P3|Treatment Period|Not specified|1
268742|NCT02139644|894007|P2|Treatment Period|Not specified|3
268743|NCT02139644|894008|P1|Treatment Period|Not specified|0
268744|NCT02139644|894003|P6|Treatment Period|Lack of Efficacy|4
268745|NCT02139644|894004|P5|Treatment Period|Lack of Efficacy|1
268746|NCT02139644|894005|P4|Treatment Period|Lack of Efficacy|0
268747|NCT02139644|894006|P3|Treatment Period|Lack of Efficacy|1
268748|NCT02139644|894007|P2|Treatment Period|Lack of Efficacy|0
268749|NCT02139644|894008|P1|Treatment Period|Lack of Efficacy|0
268750|NCT02139644|894003|P6|Treatment Period|Lost to Follow-up|1
268751|NCT02139644|894004|P5|Treatment Period|Lost to Follow-up|1
268752|NCT02139644|894005|P4|Treatment Period|Lost to Follow-up|1
268753|NCT02139644|894006|P3|Treatment Period|Lost to Follow-up|1
268754|NCT02139644|894007|P2|Treatment Period|Lost to Follow-up|0
268755|NCT02139644|894008|P1|Treatment Period|Lost to Follow-up|0
268756|NCT02139644|894003|P6|Treatment Period|Disease progression|2
268757|NCT02139644|894004|P5|Treatment Period|Disease progression|1
268758|NCT02139644|894005|P4|Treatment Period|Disease progression|1
268759|NCT02139644|894006|P3|Treatment Period|Disease progression|0
268760|NCT02139644|894007|P2|Treatment Period|Disease progression|0
268761|NCT02139644|894008|P1|Treatment Period|Disease progression|0
268762|NCT02139644|894003|P6|Treatment Period|Protocol Violation|1
268763|NCT02139644|894004|P5|Treatment Period|Protocol Violation|1
268764|NCT02139644|894005|P4|Treatment Period|Protocol Violation|1
268765|NCT02139644|894006|P3|Treatment Period|Protocol Violation|0
268766|NCT02139644|894007|P2|Treatment Period|Protocol Violation|0
268767|NCT02139644|894008|P1|Treatment Period|Protocol Violation|0
268768|NCT02139644|894003|P6|Treatment Period|Non-compliance|0
268769|NCT02139644|894004|P5|Treatment Period|Non-compliance|0
268770|NCT02139644|894005|P4|Treatment Period|Non-compliance|1
268771|NCT02139644|894006|P3|Treatment Period|Non-compliance|0
268772|NCT02139644|894007|P2|Treatment Period|Non-compliance|0
268773|NCT02139644|894008|P1|Treatment Period|Non-compliance|0
268774|NCT02139644|894003|P6|Treatment Period|Withdrawal by Subject|2
268775|NCT02139644|894004|P5|Treatment Period|Withdrawal by Subject|3
268776|NCT02139644|894005|P4|Treatment Period|Withdrawal by Subject|2
268777|NCT02139644|894006|P3|Treatment Period|Withdrawal by Subject|2
268778|NCT02139644|894007|P2|Treatment Period|Withdrawal by Subject|0
268779|NCT02139644|894008|P1|Treatment Period|Withdrawal by Subject|0
268780|NCT02139644|894003|P6|Treatment Period|Adverse Event|6
268781|NCT02139644|894004|P5|Treatment Period|Adverse Event|1
268782|NCT02139644|894005|P4|Treatment Period|Adverse Event|2
268783|NCT02139644|894006|P3|Treatment Period|Adverse Event|3
268784|NCT02139644|894007|P2|Treatment Period|Adverse Event|0
268785|NCT02139644|894008|P1|Treatment Period|Adverse Event|0
268786|NCT02139644|894003|P6|Run-In Period (Pre-assignment)|Not specified|0
268787|NCT02139644|894004|P5|Run-In Period (Pre-assignment)|Not specified|0
268788|NCT02139644|894005|P4|Run-In Period (Pre-assignment)|Not specified|0
268789|NCT02139644|894006|P3|Run-In Period (Pre-assignment)|Not specified|0
268790|NCT02139644|894007|P2|Run-In Period (Pre-assignment)|Not specified|0
268791|NCT02139644|894008|P1|Run-In Period (Pre-assignment)|Not specified|6
268792|NCT02139644|894003|P6|Run-In Period (Pre-assignment)|Adverse Event|0
268793|NCT02139644|894004|P5|Run-In Period (Pre-assignment)|Adverse Event|0
268794|NCT02139644|894005|P4|Run-In Period (Pre-assignment)|Adverse Event|0
268795|NCT02139644|894006|P3|Run-In Period (Pre-assignment)|Adverse Event|0
268796|NCT02139644|894007|P2|Run-In Period (Pre-assignment)|Adverse Event|0
268797|NCT02139644|894008|P1|Run-In Period (Pre-assignment)|Adverse Event|3
268798|NCT02139644|894003|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268799|NCT02139644|894004|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268800|NCT02139644|894005|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268801|NCT02139644|894006|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268802|NCT02139644|894007|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
268803|NCT02139644|894008|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
268804|NCT02139644|894003|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268805|NCT02139644|894004|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268806|NCT02139644|894005|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268807|NCT02139644|894006|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268808|NCT02139644|894007|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
268809|NCT02139644|894008|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
268810|NCT02139644|894003|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268811|NCT02139644|894004|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268812|NCT02139644|894005|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268813|NCT02139644|894006|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268814|NCT02139644|894007|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
268815|NCT02139644|894008|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
268816|NCT02139644|894003|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268817|NCT02139644|894004|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268818|NCT02139644|894005|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268819|NCT02139644|894006|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268820|NCT02139644|894007|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
268821|NCT02139644|894008|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
268822|NCT02139644|894003|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268823|NCT02139644|894004|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268824|NCT02139644|894005|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268825|NCT02139644|894006|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268826|NCT02139644|894007|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
268827|NCT02139644|894008|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
268828|NCT02139046|894106|P5|Overall Study|Other Miscellaneous Reasons|12
268829|NCT02139046|894107|P4|Overall Study|Other Miscellaneous Reasons|9
268830|NCT02139046|894108|P3|Overall Study|Other Miscellaneous Reasons|4
268831|NCT02139046|894109|P2|Overall Study|Other Miscellaneous Reasons|9
268832|NCT02139046|894110|P1|Overall Study|Other Miscellaneous Reasons|10
268833|NCT02139046|894106|P5|Overall Study|Withdrawal due to a Gout Flare|1
268834|NCT02139046|894107|P4|Overall Study|Withdrawal due to a Gout Flare|0
268835|NCT02139046|894108|P3|Overall Study|Withdrawal due to a Gout Flare|1
268836|NCT02139046|894109|P2|Overall Study|Withdrawal due to a Gout Flare|1
268837|NCT02139046|894110|P1|Overall Study|Withdrawal due to a Gout Flare|1
268838|NCT02139046|894106|P5|Overall Study|Lack of Efficacy|2
268839|NCT02139046|894107|P4|Overall Study|Lack of Efficacy|1
268840|NCT02139046|894108|P3|Overall Study|Lack of Efficacy|2
268841|NCT02139046|894109|P2|Overall Study|Lack of Efficacy|1
268842|NCT02139046|894110|P1|Overall Study|Lack of Efficacy|0
268843|NCT02139046|894106|P5|Overall Study|Voluntary Withdrawal|16
268844|NCT02139046|894107|P4|Overall Study|Voluntary Withdrawal|15
268845|NCT02139046|894108|P3|Overall Study|Voluntary Withdrawal|10
268846|NCT02139046|894109|P2|Overall Study|Voluntary Withdrawal|8
268847|NCT02139046|894110|P1|Overall Study|Voluntary Withdrawal|20
268848|NCT02139046|894106|P5|Overall Study|Lost to Follow-up|13
268849|NCT02139046|894107|P4|Overall Study|Lost to Follow-up|18
268850|NCT02139046|894108|P3|Overall Study|Lost to Follow-up|16
268851|NCT02139046|894109|P2|Overall Study|Lost to Follow-up|16
268852|NCT02139046|894110|P1|Overall Study|Lost to Follow-up|13
268853|NCT02139046|894106|P5|Overall Study|Major Protocol Deviation|6
268854|NCT02139046|894107|P4|Overall Study|Major Protocol Deviation|12
268855|NCT02139046|894108|P3|Overall Study|Major Protocol Deviation|16
268856|NCT02139046|894109|P2|Overall Study|Major Protocol Deviation|10
268857|NCT02139046|894110|P1|Overall Study|Major Protocol Deviation|9
268858|NCT02139046|894106|P5|Overall Study|Pretreatment Event/Adverse Event|7
268859|NCT02139046|894107|P4|Overall Study|Pretreatment Event/Adverse Event|13
268860|NCT02139046|894108|P3|Overall Study|Pretreatment Event/Adverse Event|10
268861|NCT02139046|894109|P2|Overall Study|Pretreatment Event/Adverse Event|9
268862|NCT02139046|894110|P1|Overall Study|Pretreatment Event/Adverse Event|9
268863|NCT02138838|894150|P2|Overall Study|Withdrawal by Subject|5
268864|NCT02138838|894151|P1|Overall Study|Withdrawal by Subject|1
268865|NCT02138838|894150|P2|Overall Study|Study Closure|6
268866|NCT02138838|894151|P1|Overall Study|Study Closure|7
268867|NCT02138825|894169|P2|Safety Follow-up|withdrawn due to lung transplant|1
268868|NCT02138825|894170|P1|Safety Follow-up|withdrawn due to lung transplant|0
268869|NCT02138825|894169|P2|Safety Follow-up|treatment unblinded|1
268870|NCT02138825|894170|P1|Safety Follow-up|treatment unblinded|0
268871|NCT02138825|894169|P2|Safety Follow-up|too unwell to attend the visit|1
268872|NCT02138825|894170|P1|Safety Follow-up|too unwell to attend the visit|0
268873|NCT02138825|894169|P2|Safety Follow-up|progressive disease|2
268874|NCT02138825|894170|P1|Safety Follow-up|progressive disease|0
268875|NCT02138825|894169|P2|Safety Follow-up|logistical difficulties|1
268876|NCT02138825|894170|P1|Safety Follow-up|logistical difficulties|0
268877|NCT02138825|894169|P2|Safety Follow-up|withdrawal by PI|0
268878|NCT02138825|894170|P1|Safety Follow-up|withdrawal by PI|1
268879|NCT02138825|894169|P2|Safety Follow-up|clinic worsening|0
268880|NCT02138825|894170|P1|Safety Follow-up|clinic worsening|1
268881|NCT02138825|894169|P2|Safety Follow-up|Withdrawal by Subject|3
268882|NCT02138825|894170|P1|Safety Follow-up|Withdrawal by Subject|5
268883|NCT02138825|894169|P2|Safety Follow-up|Death|5
268884|NCT02138825|894170|P1|Safety Follow-up|Death|11
268885|NCT02138825|894169|P2|Safety Follow-up|Adverse Event|3
268886|NCT02138825|894170|P1|Safety Follow-up|Adverse Event|4
268887|NCT02138825|894169|P2|Long-term Extension|Study termination by sponsor|38
268888|NCT02138825|894170|P1|Long-term Extension|Study termination by sponsor|32
268889|NCT02138825|894169|P2|Main Study Treatment|Medical decision|0
268890|NCT02138825|894170|P1|Main Study Treatment|Medical decision|1
268891|NCT02138825|894169|P2|Main Study Treatment|Withdrawal by Subject|1
268892|NCT02138825|894170|P1|Main Study Treatment|Withdrawal by Subject|3
268893|NCT02138825|894169|P2|Main Study Treatment|Study terminated by sponsor|9
268894|NCT02138825|894170|P1|Main Study Treatment|Study terminated by sponsor|10
268895|NCT02138825|894169|P2|Main Study Treatment|Sponsor decision|18
268896|NCT02138825|894170|P1|Main Study Treatment|Sponsor decision|12
268897|NCT02138825|894169|P2|Main Study Treatment|Protocol Violation|2
268898|NCT02138825|894170|P1|Main Study Treatment|Protocol Violation|2
268899|NCT02138825|894169|P2|Main Study Treatment|Death|2
268900|NCT02138825|894170|P1|Main Study Treatment|Death|1
268901|NCT02138825|894169|P2|Main Study Treatment|Adverse Event|3
268902|NCT02138825|894170|P1|Main Study Treatment|Adverse Event|11
268903|NCT02138747|894188|P4|Treatment Period 2|Other - Miscellaneous|0
268904|NCT02138747|894189|P3|Treatment Period 2|Other - Miscellaneous|0
268905|NCT02138747|894190|P2|Treatment Period 2|Other - Miscellaneous|0
268906|NCT02138747|894191|P1|Treatment Period 2|Other - Miscellaneous|3
268907|NCT02138747|894188|P4|Treatment Period 2|Withdrawal by Subject|2
268908|NCT02138747|894189|P3|Treatment Period 2|Withdrawal by Subject|1
268909|NCT02138747|894190|P2|Treatment Period 2|Withdrawal by Subject|4
268910|NCT02138747|894191|P1|Treatment Period 2|Withdrawal by Subject|5
268911|NCT02138747|894188|P4|Treatment Period 2|Protocol Violation|0
268912|NCT02138747|894189|P3|Treatment Period 2|Protocol Violation|0
268913|NCT02138747|894190|P2|Treatment Period 2|Protocol Violation|0
268914|NCT02138747|894191|P1|Treatment Period 2|Protocol Violation|1
268915|NCT02138747|894188|P4|Treatment Period 2|Lost to Follow-up|0
268916|NCT02138747|894189|P3|Treatment Period 2|Lost to Follow-up|0
268917|NCT02138747|894190|P2|Treatment Period 2|Lost to Follow-up|0
268918|NCT02138747|894191|P1|Treatment Period 2|Lost to Follow-up|2
268919|NCT02138747|894188|P4|Treatment Period 2|Adverse Event|1
268920|NCT02138747|894189|P3|Treatment Period 2|Adverse Event|1
268921|NCT02138747|894190|P2|Treatment Period 2|Adverse Event|3
268922|NCT02138747|894191|P1|Treatment Period 2|Adverse Event|6
268923|NCT02138747|894188|P4|Treatment Period 1|Other - Miscellaneous|0
268924|NCT02138747|894189|P3|Treatment Period 1|Other - Miscellaneous|0
268925|NCT02138747|894190|P2|Treatment Period 1|Other - Miscellaneous|4
268926|NCT02138747|894191|P1|Treatment Period 1|Other - Miscellaneous|2
268927|NCT02138747|894188|P4|Treatment Period 1|Withdrawal by Subject|3
268928|NCT02138747|894189|P3|Treatment Period 1|Withdrawal by Subject|1
268929|NCT02138747|894190|P2|Treatment Period 1|Withdrawal by Subject|4
268930|NCT02138747|894191|P1|Treatment Period 1|Withdrawal by Subject|8
268931|NCT02138747|894188|P4|Treatment Period 1|Protocol Violation|0
268932|NCT02138747|894189|P3|Treatment Period 1|Protocol Violation|0
268933|NCT02138747|894190|P2|Treatment Period 1|Protocol Violation|2
268934|NCT02138747|894191|P1|Treatment Period 1|Protocol Violation|0
268935|NCT02138747|894188|P4|Treatment Period 1|Lost to Follow-up|0
268936|NCT02138747|894189|P3|Treatment Period 1|Lost to Follow-up|1
268937|NCT02138747|894190|P2|Treatment Period 1|Lost to Follow-up|1
268938|NCT02138747|894191|P1|Treatment Period 1|Lost to Follow-up|0
268939|NCT02138747|894188|P4|Treatment Period 1|Adverse Event|1
268940|NCT02138747|894189|P3|Treatment Period 1|Adverse Event|2
268941|NCT02138747|894190|P2|Treatment Period 1|Adverse Event|14
268942|NCT02138747|894191|P1|Treatment Period 1|Adverse Event|10
268943|NCT02137785|894519|P2|Overall Study|subject moved out of state|0
268944|NCT02137785|894520|P1|Overall Study|subject moved out of state|1
268945|NCT02137785|894519|P2|Overall Study|Withdrawal by Subject|4
268946|NCT02137785|894520|P1|Overall Study|Withdrawal by Subject|1
268947|NCT02137785|894519|P2|Overall Study|Lost to Follow-up|0
268948|NCT02137785|894520|P1|Overall Study|Lost to Follow-up|1
268949|NCT02137772|894628|P2|Overall Study|Not treated|2
268950|NCT02137772|894629|P1|Overall Study|Not treated|3
268951|NCT02137772|894628|P2|Overall Study|Non-compliance with study drug|0
268952|NCT02137772|894629|P1|Overall Study|Non-compliance with study drug|1
268953|NCT02137772|894628|P2|Overall Study|Withdrawal by Subject|17
268954|NCT02137772|894629|P1|Overall Study|Withdrawal by Subject|28
268955|NCT02137772|894628|P2|Overall Study|Physician Decision|5
268956|NCT02137772|894629|P1|Overall Study|Physician Decision|15
268957|NCT02137772|894628|P2|Overall Study|Lost to Follow-up|4
268958|NCT02137772|894629|P1|Overall Study|Lost to Follow-up|8
268959|NCT02137772|894628|P2|Overall Study|Death|44
268960|NCT02137772|894629|P1|Overall Study|Death|71
268961|NCT02137772|894628|P2|Overall Study|Adverse Event|3
268962|NCT02137772|894629|P1|Overall Study|Adverse Event|6
268963|NCT02137226|894706|P5|Period 2 (Re - Randomization)|Other Reason|1
268964|NCT02137226|894707|P4|Period 2 (Re - Randomization)|Other Reason|1
268965|NCT02137226|894708|P3|Period 2 (Re - Randomization)|Other Reason|1
268966|NCT02137226|894709|P2|Period 2 (Re - Randomization)|Other Reason|0
268967|NCT02137226|894710|P1|Period 2 (Re - Randomization)|Other Reason|0
268968|NCT02137226|894706|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
268969|NCT02137226|894707|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
268970|NCT02137226|894708|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
268971|NCT02137226|894709|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
268972|NCT02137226|894710|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
268973|NCT02137226|894706|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
268974|NCT02137226|894707|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
268975|NCT02137226|894708|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
268976|NCT02137226|894709|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
268977|NCT02137226|894710|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
268978|NCT02137226|894706|P5|Period 2 (Re - Randomization)|Physician Decision|0
268979|NCT02137226|894707|P4|Period 2 (Re - Randomization)|Physician Decision|1
268980|NCT02137226|894708|P3|Period 2 (Re - Randomization)|Physician Decision|0
268981|NCT02137226|894709|P2|Period 2 (Re - Randomization)|Physician Decision|0
268982|NCT02137226|894710|P1|Period 2 (Re - Randomization)|Physician Decision|0
268983|NCT02137226|894706|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
268984|NCT02137226|894707|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
268985|NCT02137226|894708|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
268986|NCT02137226|894709|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
268987|NCT02137226|894710|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
268988|NCT02137226|894706|P5|Period 2 (Re - Randomization)|Adverse Event|4
268989|NCT02137226|894707|P4|Period 2 (Re - Randomization)|Adverse Event|1
268990|NCT02137226|894708|P3|Period 2 (Re - Randomization)|Adverse Event|3
268991|NCT02137226|894709|P2|Period 2 (Re - Randomization)|Adverse Event|0
268992|NCT02137226|894710|P1|Period 2 (Re - Randomization)|Adverse Event|0
268993|NCT02137226|894706|P5|Period 1 (Initial Randomization)|Other Reason|0
268994|NCT02137226|894707|P4|Period 1 (Initial Randomization)|Other Reason|0
268995|NCT02137226|894708|P3|Period 1 (Initial Randomization)|Other Reason|0
268996|NCT02137226|894709|P2|Period 1 (Initial Randomization)|Other Reason|3
268997|NCT02137226|894710|P1|Period 1 (Initial Randomization)|Other Reason|1
268998|NCT02137226|894706|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
268999|NCT02137226|894707|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
269000|NCT02137226|894708|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
269001|NCT02137226|894709|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
269002|NCT02137226|894710|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
269003|NCT02137226|894706|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
269004|NCT02137226|894707|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
269005|NCT02137226|894708|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
269006|NCT02137226|894709|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
269007|NCT02137226|894710|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
269008|NCT02137226|894706|P5|Period 1 (Initial Randomization)|Physician Decision|0
269009|NCT02137226|894707|P4|Period 1 (Initial Randomization)|Physician Decision|0
269010|NCT02137226|894708|P3|Period 1 (Initial Randomization)|Physician Decision|0
269011|NCT02137226|894709|P2|Period 1 (Initial Randomization)|Physician Decision|3
269012|NCT02137226|894710|P1|Period 1 (Initial Randomization)|Physician Decision|1
269013|NCT02137226|894706|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
269014|NCT02137226|894707|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
269015|NCT02137226|894708|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
269016|NCT02137226|894709|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
269017|NCT02137226|894710|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
269018|NCT02137226|894706|P5|Period 1 (Initial Randomization)|Adverse Event|0
269019|NCT02137226|894707|P4|Period 1 (Initial Randomization)|Adverse Event|0
269020|NCT02137226|894708|P3|Period 1 (Initial Randomization)|Adverse Event|0
269021|NCT02137226|894709|P2|Period 1 (Initial Randomization)|Adverse Event|3
269022|NCT02137226|894710|P1|Period 1 (Initial Randomization)|Adverse Event|3
269023|NCT02136914|894724|P2|Overall Study|Death|1
269024|NCT02136914|894725|P1|Overall Study|Death|0
269025|NCT02136914|894724|P2|Overall Study|Lack of Efficacy|0
269026|NCT02136914|894725|P1|Overall Study|Lack of Efficacy|1
269027|NCT02136914|894724|P2|Overall Study|Did Not Receive Study Drug|0
269028|NCT02136914|894725|P1|Overall Study|Did Not Receive Study Drug|2
269029|NCT02136914|894724|P2|Overall Study|Lost to Follow-up|1
269030|NCT02136914|894725|P1|Overall Study|Lost to Follow-up|1
269031|NCT02136914|894724|P2|Overall Study|Subject Unwilling to Proceed|2
269032|NCT02136914|894725|P1|Overall Study|Subject Unwilling to Proceed|7
269033|NCT02136914|894724|P2|Overall Study|Withdrawal by Subject|10
269034|NCT02136914|894725|P1|Overall Study|Withdrawal by Subject|3
269035|NCT02136914|894724|P2|Overall Study|Sponsor's Decision to Stop the Study|7
269036|NCT02136914|894725|P1|Overall Study|Sponsor's Decision to Stop the Study|7
269037|NCT02136134|894800|P2|Overall Study|Subjects randomized but not treated|8
269038|NCT02136134|894801|P1|Overall Study|Subjects randomized but not treated|10
269039|NCT02136134|894800|P2|Overall Study|Ongoing|207
269040|NCT02136134|894801|P1|Overall Study|Ongoing|185
269041|NCT02136134|894800|P2|Overall Study|Other|3
269042|NCT02136134|894801|P1|Overall Study|Other|3
269043|NCT02136134|894800|P2|Overall Study|Withdrawal by Subject|4
269044|NCT02136134|894801|P1|Overall Study|Withdrawal by Subject|14
269045|NCT02136134|894800|P2|Overall Study|Death|29
269046|NCT02136134|894801|P1|Overall Study|Death|35
269047|NCT02135848|894839|P2|Overall Study|Withdrawal by Subject|1
269048|NCT02135848|894840|P1|Overall Study|Withdrawal by Subject|1
269049|NCT02135848|894839|P2|Overall Study|Adverse Event|0
269050|NCT02135848|894840|P1|Overall Study|Adverse Event|2
269051|NCT02135692|894898|P1|Overall Study|Withdrawal by Subject|15
269052|NCT02135692|894898|P1|Overall Study|Lost to Follow-up|4
269053|NCT02135692|894898|P1|Overall Study|Study closed/terminated|153
269054|NCT02135692|894898|P1|Overall Study|Product commercially available|159
269055|NCT02135692|894898|P1|Overall Study|Subject met Liver Stopping Criteria|1
269056|NCT02135692|894898|P1|Overall Study|Protocol Violation|2
269057|NCT02135692|894898|P1|Overall Study|Lack of Efficacy|2
269058|NCT02135692|894898|P1|Overall Study|Adverse Event|3
269059|NCT02135614|894917|P2|Overall Study|Lost to Follow-up|0
269060|NCT02135614|894918|P1|Overall Study|Lost to Follow-up|3
269061|NCT02135614|894917|P2|Overall Study|Withdrew Consent|2
269062|NCT02135614|894918|P1|Overall Study|Withdrew Consent|2
269063|NCT02135614|894917|P2|Overall Study|Investigator's Discretion|1
269064|NCT02135614|894918|P1|Overall Study|Investigator's Discretion|0
269065|NCT02135614|894917|P2|Overall Study|Death|0
269066|NCT02135614|894918|P1|Overall Study|Death|1
269067|NCT02135614|894917|P2|Overall Study|Adverse Event|1
269068|NCT02135614|894918|P1|Overall Study|Adverse Event|0
269069|NCT02135614|894917|P2|Overall Study|Randomized but Not Treated|1
269070|NCT02135614|894918|P1|Overall Study|Randomized but Not Treated|2
269071|NCT02135445|894932|P2|Overall Study|Withdrawal by Subject|0
269072|NCT02135445|894933|P1|Overall Study|Withdrawal by Subject|1
269073|NCT02135445|894932|P2|Overall Study|Lost to Follow-up|0
269074|NCT02135445|894933|P1|Overall Study|Lost to Follow-up|1
269075|NCT02135029|895017|P3|Overall Study|Death|0
269076|NCT02135029|895018|P2|Overall Study|Death|1
269077|NCT02135029|895019|P1|Overall Study|Death|0
269078|NCT02135029|895017|P3|Overall Study|Other|0
269079|NCT02135029|895018|P2|Overall Study|Other|1
269080|NCT02135029|895019|P1|Overall Study|Other|0
269081|NCT02135029|895017|P3|Overall Study|Withdrawal by Subject|1
269082|NCT02135029|895018|P2|Overall Study|Withdrawal by Subject|0
269083|NCT02135029|895019|P1|Overall Study|Withdrawal by Subject|2
269084|NCT02135029|895017|P3|Overall Study|Lost to Follow-up|0
269085|NCT02135029|895018|P2|Overall Study|Lost to Follow-up|1
269086|NCT02135029|895019|P1|Overall Study|Lost to Follow-up|0
269087|NCT02135029|895017|P3|Overall Study|Adverse Event|2
269088|NCT02135029|895018|P2|Overall Study|Adverse Event|2
269089|NCT02135029|895019|P1|Overall Study|Adverse Event|2
269090|NCT02134977|895124|P1|Overall Study|Protocol Deviation|102
269091|NCT02134925|895158|P2|Overall Study|Cancel|6
269092|NCT02134925|895159|P1|Overall Study|Cancel|1
269093|NCT02134925|895158|P2|Overall Study|Withdrawal by Subject|0
269094|NCT02134925|895159|P1|Overall Study|Withdrawal by Subject|1
269095|NCT02134587|895173|P1|Overall Study|Did not completed all meetings|30
269096|NCT02134015|895279|P2|Overall Study|Withdrawal by Subject|7
269097|NCT02134015|895280|P1|Overall Study|Withdrawal by Subject|3
269098|NCT02134015|895279|P2|Overall Study|Adverse Event|10
269099|NCT02134015|895280|P1|Overall Study|Adverse Event|9
269100|NCT02134015|895279|P2|Overall Study|Study terminated by sponsor|3
269101|NCT02134015|895280|P1|Overall Study|Study terminated by sponsor|2
269102|NCT02134015|895279|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
269103|NCT02134015|895280|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
269104|NCT02134015|895279|P2|Overall Study|Clinical progression|7
269105|NCT02134015|895280|P1|Overall Study|Clinical progression|14
269106|NCT02134015|895279|P2|Overall Study|Reason not provided|2
269107|NCT02134015|895280|P1|Overall Study|Reason not provided|1
269108|NCT02134015|895279|P2|Overall Study|Death|1
269109|NCT02134015|895280|P1|Overall Study|Death|2
269110|NCT02134015|895279|P2|Overall Study|Protocol Violation|1
269111|NCT02134015|895280|P1|Overall Study|Protocol Violation|0
269112|NCT02133664|895318|P2|Overall Study|Adverse Event|6
269113|NCT02133664|895319|P1|Overall Study|Adverse Event|3
269114|NCT02133664|895318|P2|Overall Study|Lost to Follow-up|1
269115|NCT02133664|895319|P1|Overall Study|Lost to Follow-up|2
269116|NCT02133508|895335|P1|Overall Study|Lost to Follow-up|2
269117|NCT02133508|895335|P1|Overall Study|Death|12
269118|NCT02133508|895335|P1|Overall Study|Decision of Investigator or Sponsor|1
269119|NCT02133352|895343|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
269120|NCT02133131|895374|P7|Overall Study|Protocol Violation|1
269121|NCT02133131|895375|P6|Overall Study|Protocol Violation|0
269122|NCT02133131|895376|P5|Overall Study|Protocol Violation|0
269123|NCT02133131|895377|P4|Overall Study|Protocol Violation|0
269124|NCT02133131|895378|P3|Overall Study|Protocol Violation|0
269125|NCT02133131|895379|P2|Overall Study|Protocol Violation|0
269126|NCT02133131|895380|P1|Overall Study|Protocol Violation|0
269127|NCT02133131|895374|P7|Overall Study|Ongoing in study|11
269128|NCT02133131|895375|P6|Overall Study|Ongoing in study|14
269129|NCT02133131|895376|P5|Overall Study|Ongoing in study|15
269130|NCT02133131|895377|P4|Overall Study|Ongoing in study|0
269131|NCT02133131|895378|P3|Overall Study|Ongoing in study|0
269132|NCT02133131|895379|P2|Overall Study|Ongoing in study|0
269133|NCT02133131|895380|P1|Overall Study|Ongoing in study|0
269134|NCT02133131|895374|P7|Overall Study|Status not recorded|0
269135|NCT02133131|895375|P6|Overall Study|Status not recorded|0
269136|NCT02133131|895376|P5|Overall Study|Status not recorded|0
269137|NCT02133131|895377|P4|Overall Study|Status not recorded|4
269138|NCT02133131|895378|P3|Overall Study|Status not recorded|1
269139|NCT02133131|895379|P2|Overall Study|Status not recorded|5
269140|NCT02133131|895380|P1|Overall Study|Status not recorded|4
269141|NCT02133131|895374|P7|Overall Study|Lost to Follow-up|0
269142|NCT02133131|895375|P6|Overall Study|Lost to Follow-up|0
269143|NCT02133131|895376|P5|Overall Study|Lost to Follow-up|0
269144|NCT02133131|895377|P4|Overall Study|Lost to Follow-up|1
269145|NCT02133131|895378|P3|Overall Study|Lost to Follow-up|0
269146|NCT02133131|895379|P2|Overall Study|Lost to Follow-up|0
269147|NCT02133131|895380|P1|Overall Study|Lost to Follow-up|1
269148|NCT02133131|895374|P7|Overall Study|Adverse Event|0
269149|NCT02133131|895375|P6|Overall Study|Adverse Event|0
269150|NCT02133131|895376|P5|Overall Study|Adverse Event|0
269151|NCT02133131|895377|P4|Overall Study|Adverse Event|1
269152|NCT02133131|895378|P3|Overall Study|Adverse Event|0
269153|NCT02133131|895379|P2|Overall Study|Adverse Event|0
269154|NCT02133131|895380|P1|Overall Study|Adverse Event|0
269155|NCT02132949|895434|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
269156|NCT02132949|895435|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
269157|NCT02132949|895434|P2|Adjuvant Treatment Period|Protocol Deviation|0
269158|NCT02132949|895435|P1|Adjuvant Treatment Period|Protocol Deviation|1
269159|NCT02132949|895434|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
269160|NCT02132949|895435|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
269161|NCT02132949|895434|P2|Adjuvant Treatment Period|Physician Decision|0
269162|NCT02132949|895435|P1|Adjuvant Treatment Period|Physician Decision|1
269163|NCT02132949|895434|P2|Adjuvant Treatment Period|Disease Relapse|1
269164|NCT02132949|895435|P1|Adjuvant Treatment Period|Disease Relapse|0
269165|NCT02132949|895434|P2|Adjuvant Treatment Period|Disease Progression|1
269166|NCT02132949|895435|P1|Adjuvant Treatment Period|Disease Progression|0
269167|NCT02132949|895434|P2|Adjuvant Treatment Period|Reason unspecified|1
269168|NCT02132949|895435|P1|Adjuvant Treatment Period|Reason unspecified|0
269169|NCT02132949|895434|P2|Adjuvant Treatment Period|Adverse Event|6
269170|NCT02132949|895435|P1|Adjuvant Treatment Period|Adverse Event|4
269171|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
269172|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
269173|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Adverse Event|3
269174|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Adverse Event|6
269175|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Disease Progression|1
269176|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Disease Progression|1
269177|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
269178|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
269179|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Physician Decision|0
269180|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Physician Decision|2
269181|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
269182|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
269183|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Reason unspecified|1
269184|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Reason unspecified|3
269185|NCT02132949|895434|P2|Neoadjuvant Treatment Period|Early surgery|3
269186|NCT02132949|895435|P1|Neoadjuvant Treatment Period|Early surgery|4
269187|NCT02132767|895528|P2|Overall Study|Lost to Follow-up|4
269188|NCT02132767|895529|P1|Overall Study|Lost to Follow-up|4
269189|NCT02132767|895528|P2|Overall Study|Withdrawal by Subject|9
269190|NCT02132767|895529|P1|Overall Study|Withdrawal by Subject|10
269191|NCT02132767|895528|P2|Overall Study|Death|2
269192|NCT02132767|895529|P1|Overall Study|Death|3
269193|NCT02132637|895551|P2|Study Period 2 (Crossover)|Physician Decision|0
269194|NCT02132637|895552|P1|Study Period 2 (Crossover)|Physician Decision|2
269195|NCT02132637|895551|P2|Study Period 2 (Crossover)|Adverse Event|1
269196|NCT02132637|895552|P1|Study Period 2 (Crossover)|Adverse Event|0
269197|NCT02132637|895551|P2|Study Period 1|Physician Decision|0
269198|NCT02132637|895552|P1|Study Period 1|Physician Decision|1
269199|NCT02132637|895551|P2|Study Period 1|Withdrawal by Subject|4
269200|NCT02132637|895552|P1|Study Period 1|Withdrawal by Subject|0
269201|NCT02132611|895576|P1|Overall Study|Death|2
269202|NCT02132247|895594|P2|Overall Study|Protocol Violation|0
269203|NCT02132247|895595|P1|Overall Study|Protocol Violation|1
269204|NCT02132117|895624|P2|Overall Study|Other Miscellaneous Reasons|0
269205|NCT02132117|895625|P1|Overall Study|Other Miscellaneous Reasons|2
269206|NCT02132117|895624|P2|Overall Study|Personal Reasons|2
269207|NCT02132117|895625|P1|Overall Study|Personal Reasons|1
269208|NCT02132117|895624|P2|Overall Study|Lost to Follow-up|2
269209|NCT02132117|895625|P1|Overall Study|Lost to Follow-up|2
269210|NCT02132117|895624|P2|Overall Study|Adverse Event|1
269211|NCT02132117|895625|P1|Overall Study|Adverse Event|6
269212|NCT02131662|895646|P5|Overall Study|Not treated|3
269213|NCT02131662|895647|P4|Overall Study|Not treated|2
269214|NCT02131662|895648|P3|Overall Study|Not treated|2
269215|NCT02131662|895649|P2|Overall Study|Not treated|0
269216|NCT02131662|895650|P1|Overall Study|Not treated|2
269217|NCT02131662|895646|P5|Overall Study|Lost to Follow-up|0
269218|NCT02131662|895647|P4|Overall Study|Lost to Follow-up|9
269219|NCT02131662|895648|P3|Overall Study|Lost to Follow-up|0
269220|NCT02131662|895649|P2|Overall Study|Lost to Follow-up|3
269221|NCT02131662|895650|P1|Overall Study|Lost to Follow-up|1
269222|NCT02131662|895646|P5|Overall Study|Withdrawal by Subject|6
269223|NCT02131662|895647|P4|Overall Study|Withdrawal by Subject|5
269224|NCT02131662|895648|P3|Overall Study|Withdrawal by Subject|1
269225|NCT02131662|895649|P2|Overall Study|Withdrawal by Subject|5
269226|NCT02131662|895650|P1|Overall Study|Withdrawal by Subject|1
269227|NCT02131662|895646|P5|Overall Study|Lack of Efficacy|1
269228|NCT02131662|895647|P4|Overall Study|Lack of Efficacy|0
269229|NCT02131662|895648|P3|Overall Study|Lack of Efficacy|0
269230|NCT02131662|895649|P2|Overall Study|Lack of Efficacy|0
269231|NCT02131662|895650|P1|Overall Study|Lack of Efficacy|1
269232|NCT02131662|895646|P5|Overall Study|Wish for pregnancy|1
269233|NCT02131662|895647|P4|Overall Study|Wish for pregnancy|0
269234|NCT02131662|895648|P3|Overall Study|Wish for pregnancy|0
269235|NCT02131662|895649|P2|Overall Study|Wish for pregnancy|0
269236|NCT02131662|895650|P1|Overall Study|Wish for pregnancy|0
269237|NCT02131662|895646|P5|Overall Study|Pregnancy|0
269238|NCT02131662|895647|P4|Overall Study|Pregnancy|1
269239|NCT02131662|895648|P3|Overall Study|Pregnancy|0
269240|NCT02131662|895649|P2|Overall Study|Pregnancy|1
269241|NCT02131662|895650|P1|Overall Study|Pregnancy|0
269242|NCT02131662|895646|P5|Overall Study|Adverse Event|3
269243|NCT02131662|895647|P4|Overall Study|Adverse Event|1
269244|NCT02131662|895648|P3|Overall Study|Adverse Event|1
269245|NCT02131662|895649|P2|Overall Study|Adverse Event|1
269246|NCT02131662|895650|P1|Overall Study|Adverse Event|0
269247|NCT02131662|895646|P5|Overall Study|Other|4
269248|NCT02131662|895647|P4|Overall Study|Other|3
269249|NCT02131662|895648|P3|Overall Study|Other|3
269250|NCT02131662|895649|P2|Overall Study|Other|4
269251|NCT02131662|895650|P1|Overall Study|Other|2
269252|NCT02131662|895646|P5|Overall Study|Protocol Violation|0
269253|NCT02131662|895647|P4|Overall Study|Protocol Violation|0
269254|NCT02131662|895648|P3|Overall Study|Protocol Violation|0
269255|NCT02131662|895649|P2|Overall Study|Protocol Violation|0
269256|NCT02131662|895650|P1|Overall Study|Protocol Violation|1
269257|NCT02131636|895696|P2|Overall Study|Adverse Event|1
269258|NCT02131636|895697|P1|Overall Study|Adverse Event|4
269259|NCT02131636|895696|P2|Overall Study|Lost to Follow-up|0
269260|NCT02131636|895697|P1|Overall Study|Lost to Follow-up|4
269261|NCT02131636|895696|P2|Overall Study|Personal Reasons|4
269262|NCT02131636|895697|P1|Overall Study|Personal Reasons|4
269263|NCT02131532|895713|P1|Overall Study|Other health conditions|2
269264|NCT02131532|895713|P1|Overall Study|Physician Decision|1
269265|NCT02131532|895713|P1|Overall Study|Withdrawal by Subject|1
269266|NCT02131324|895805|P2|Overall Study|Lost to Follow-up|1
269267|NCT02131324|895806|P1|Overall Study|Lost to Follow-up|1
269268|NCT02131324|895805|P2|Overall Study|Withdrawal by Subject|2
269269|NCT02131324|895806|P1|Overall Study|Withdrawal by Subject|1
269270|NCT02131311|895812|P1|Overall Study|Lost to Follow-up|1
269271|NCT02131311|895812|P1|Overall Study|Protocol Violation|1
269272|NCT02131311|895812|P1|Overall Study|Adverse Event|2
269273|NCT02131272|895824|P2|Overall Study|Withdrawal Criteria|0
269274|NCT02131272|895825|P1|Overall Study|Withdrawal Criteria|1
269275|NCT02131272|895824|P2|Overall Study|Withdrawal by Subject|1
269276|NCT02131272|895825|P1|Overall Study|Withdrawal by Subject|0
269277|NCT02131272|895824|P2|Overall Study|Withdrawal by parent|1
269278|NCT02131272|895825|P1|Overall Study|Withdrawal by parent|0
269279|NCT02131233|895845|P2|Overall Study|Withdrawal by Subject|11
269280|NCT02131233|895846|P1|Overall Study|Withdrawal by Subject|18
269281|NCT02131233|895845|P2|Overall Study|Pregnancy|0
269282|NCT02131233|895846|P1|Overall Study|Pregnancy|4
269283|NCT02131233|895845|P2|Overall Study|Physician Decision|0
269284|NCT02131233|895846|P1|Overall Study|Physician Decision|7
269285|NCT02131233|895845|P2|Overall Study|Non-Compliance With Study Drug|5
269286|NCT02131233|895846|P1|Overall Study|Non-Compliance With Study Drug|8
269287|NCT02131233|895845|P2|Overall Study|Lost to Follow-up|13
269288|NCT02131233|895846|P1|Overall Study|Lost to Follow-up|14
269289|NCT02131233|895845|P2|Overall Study|Lack of Efficacy|3
269290|NCT02131233|895846|P1|Overall Study|Lack of Efficacy|6
269291|NCT02131233|895845|P2|Overall Study|Death|1
269292|NCT02131233|895846|P1|Overall Study|Death|0
269293|NCT02131233|895845|P2|Overall Study|Adverse Event|6
269294|NCT02131233|895846|P1|Overall Study|Adverse Event|7
269295|NCT02131233|895845|P2|Overall Study|Not Treated|3
269296|NCT02131233|895846|P1|Overall Study|Not Treated|2
269297|NCT02131064|895880|P2|Overall Study|Other|0
269298|NCT02131064|895881|P1|Overall Study|Other|1
269299|NCT02131064|895880|P2|Overall Study|Ongoing|207
269300|NCT02131064|895881|P1|Overall Study|Ongoing|214
269301|NCT02131064|895880|P2|Overall Study|Withdrawal by Subject|14
269302|NCT02131064|895881|P1|Overall Study|Withdrawal by Subject|6
269303|NCT02131064|895880|P2|Overall Study|Lost to Follow-up|1
269304|NCT02131064|895881|P1|Overall Study|Lost to Follow-up|0
269305|NCT02131064|895880|P2|Overall Study|Death|1
269306|NCT02131064|895881|P1|Overall Study|Death|0
269307|NCT02130284|896144|P1|Overall Study|Screen Failure|1
269308|NCT02130284|896144|P1|Overall Study|Subject was screened as backup for study|3
269309|NCT02130284|896144|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
269310|NCT02130284|896144|P1|Overall Study|Subject Withdrew Consent|1
269311|NCT02130284|896144|P1|Overall Study|Withdrawal by Subject|3
269312|NCT02130193|896170|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
269313|NCT02130193|896171|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
269314|NCT02130193|896172|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
269315|NCT02130193|896170|P3|Part B: 52-week Double-blind Period|Physician Decision|1
269316|NCT02130193|896171|P2|Part B: 52-week Double-blind Period|Physician Decision|0
269317|NCT02130193|896172|P1|Part B: 52-week Double-blind Period|Physician Decision|0
269318|NCT02130193|896170|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
269319|NCT02130193|896171|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
269320|NCT02130193|896172|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
269321|NCT02130193|896170|P3|Part B: 52-week Double-blind Period|Adverse Event|3
269322|NCT02130193|896171|P2|Part B: 52-week Double-blind Period|Adverse Event|5
269323|NCT02130193|896172|P1|Part B: 52-week Double-blind Period|Adverse Event|0
269324|NCT02129777|896256|P7|Open-Label Period|Study Termination|39
269325|NCT02129777|896257|P6|Open-Label Period|Study Termination|10
269326|NCT02129777|896258|P5|Open-Label Period|Study Termination|0
269327|NCT02129777|896259|P4|Open-Label Period|Study Termination|0
269328|NCT02129777|896260|P3|Open-Label Period|Study Termination|0
269329|NCT02129777|896261|P2|Open-Label Period|Study Termination|0
269330|NCT02129777|896262|P1|Open-Label Period|Study Termination|0
269331|NCT02129777|896256|P7|Open-Label Period|Withdrawal by Subject|3
269332|NCT02129777|896257|P6|Open-Label Period|Withdrawal by Subject|1
269333|NCT02129777|896258|P5|Open-Label Period|Withdrawal by Subject|0
269334|NCT02129777|896259|P4|Open-Label Period|Withdrawal by Subject|0
269335|NCT02129777|896260|P3|Open-Label Period|Withdrawal by Subject|0
269336|NCT02129777|896261|P2|Open-Label Period|Withdrawal by Subject|0
269337|NCT02129777|896262|P1|Open-Label Period|Withdrawal by Subject|0
269338|NCT02129777|896256|P7|Open-Label Period|Lost to Follow-up|1
269339|NCT02129777|896257|P6|Open-Label Period|Lost to Follow-up|1
269340|NCT02129777|896258|P5|Open-Label Period|Lost to Follow-up|0
269341|NCT02129777|896259|P4|Open-Label Period|Lost to Follow-up|0
269342|NCT02129777|896260|P3|Open-Label Period|Lost to Follow-up|0
269343|NCT02129777|896261|P2|Open-Label Period|Lost to Follow-up|0
269344|NCT02129777|896262|P1|Open-Label Period|Lost to Follow-up|0
269345|NCT02129777|896256|P7|Open-Label Period|Lack of Efficacy|5
269346|NCT02129777|896257|P6|Open-Label Period|Lack of Efficacy|0
269347|NCT02129777|896258|P5|Open-Label Period|Lack of Efficacy|0
269348|NCT02129777|896259|P4|Open-Label Period|Lack of Efficacy|0
269349|NCT02129777|896260|P3|Open-Label Period|Lack of Efficacy|0
269350|NCT02129777|896261|P2|Open-Label Period|Lack of Efficacy|0
269351|NCT02129777|896262|P1|Open-Label Period|Lack of Efficacy|0
269352|NCT02129777|896256|P7|Double-Blind Period|Other|0
269353|NCT02129777|896257|P6|Double-Blind Period|Other|0
269354|NCT02129777|896258|P5|Double-Blind Period|Other|0
269355|NCT02129777|896259|P4|Double-Blind Period|Other|0
269356|NCT02129777|896260|P3|Double-Blind Period|Other|0
269357|NCT02129777|896261|P2|Double-Blind Period|Other|2
269358|NCT02129777|896262|P1|Double-Blind Period|Other|1
269359|NCT02129777|896256|P7|Double-Blind Period|Lack of Efficacy|0
269360|NCT02129777|896257|P6|Double-Blind Period|Lack of Efficacy|0
269361|NCT02129777|896258|P5|Double-Blind Period|Lack of Efficacy|2
269362|NCT02129777|896259|P4|Double-Blind Period|Lack of Efficacy|3
269363|NCT02129777|896260|P3|Double-Blind Period|Lack of Efficacy|0
269364|NCT02129777|896261|P2|Double-Blind Period|Lack of Efficacy|1
269365|NCT02129777|896262|P1|Double-Blind Period|Lack of Efficacy|3
269366|NCT02129777|896256|P7|Double-Blind Period|Pregnancy|0
269367|NCT02129777|896257|P6|Double-Blind Period|Pregnancy|0
269368|NCT02129777|896258|P5|Double-Blind Period|Pregnancy|1
269369|NCT02129777|896259|P4|Double-Blind Period|Pregnancy|0
269370|NCT02129777|896260|P3|Double-Blind Period|Pregnancy|0
269371|NCT02129777|896261|P2|Double-Blind Period|Pregnancy|0
269372|NCT02129777|896262|P1|Double-Blind Period|Pregnancy|0
269373|NCT02129777|896256|P7|Double-Blind Period|Withdrawal by Subject|0
269374|NCT02129777|896257|P6|Double-Blind Period|Withdrawal by Subject|0
269375|NCT02129777|896258|P5|Double-Blind Period|Withdrawal by Subject|3
269376|NCT02129777|896259|P4|Double-Blind Period|Withdrawal by Subject|2
269377|NCT02129777|896260|P3|Double-Blind Period|Withdrawal by Subject|3
269378|NCT02129777|896261|P2|Double-Blind Period|Withdrawal by Subject|4
269379|NCT02129777|896262|P1|Double-Blind Period|Withdrawal by Subject|2
269380|NCT02129777|896256|P7|Double-Blind Period|Lost to Follow-up|0
269381|NCT02129777|896257|P6|Double-Blind Period|Lost to Follow-up|0
269382|NCT02129777|896258|P5|Double-Blind Period|Lost to Follow-up|0
269383|NCT02129777|896259|P4|Double-Blind Period|Lost to Follow-up|2
269384|NCT02129777|896260|P3|Double-Blind Period|Lost to Follow-up|1
269385|NCT02129777|896261|P2|Double-Blind Period|Lost to Follow-up|1
269386|NCT02129777|896262|P1|Double-Blind Period|Lost to Follow-up|1
269387|NCT02129777|896256|P7|Double-Blind Period|Adverse Event|0
269388|NCT02129777|896257|P6|Double-Blind Period|Adverse Event|0
269389|NCT02129777|896258|P5|Double-Blind Period|Adverse Event|1
269390|NCT02129777|896259|P4|Double-Blind Period|Adverse Event|0
269391|NCT02129777|896260|P3|Double-Blind Period|Adverse Event|0
269392|NCT02129777|896261|P2|Double-Blind Period|Adverse Event|0
269393|NCT02129777|896262|P1|Double-Blind Period|Adverse Event|0
269394|NCT02129608|896378|P3|Overall Study|Withdrawal by Subject|2
269395|NCT02129608|896379|P2|Overall Study|Withdrawal by Subject|0
269396|NCT02129608|896380|P1|Overall Study|Withdrawal by Subject|0
269397|NCT02129608|896378|P3|Overall Study|Lost to Follow-up|1
269398|NCT02129608|896379|P2|Overall Study|Lost to Follow-up|1
269399|NCT02129608|896380|P1|Overall Study|Lost to Follow-up|0
269400|NCT02129192|896393|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
269401|NCT02129192|896394|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
269402|NCT02129062|896411|P1|Overall Study|Disease Progression|2
269403|NCT02129062|896411|P1|Overall Study|Death|1
269404|NCT02128997|896418|P2|Overall Study|Lost to Follow-up|11
269405|NCT02128997|896419|P1|Overall Study|Lost to Follow-up|6
269406|NCT02128932|896434|P3|Overall Study|No reason for withdrawal|7
269407|NCT02128932|896435|P2|Overall Study|No reason for withdrawal|11
269408|NCT02128932|896436|P1|Overall Study|No reason for withdrawal|12
269409|NCT02128932|896434|P3|Overall Study|Lost to Follow-up|1
269410|NCT02128932|896435|P2|Overall Study|Lost to Follow-up|1
269411|NCT02128932|896436|P1|Overall Study|Lost to Follow-up|2
269412|NCT02128932|896434|P3|Overall Study|Death|2
269413|NCT02128932|896435|P2|Overall Study|Death|0
269414|NCT02128932|896436|P1|Overall Study|Death|2
269415|NCT02128932|896434|P3|Overall Study|Withdrawal by Subject|8
269416|NCT02128932|896435|P2|Overall Study|Withdrawal by Subject|7
269417|NCT02128932|896436|P1|Overall Study|Withdrawal by Subject|11
269418|NCT02128542|896493|P2|Overall Study|Withdrew Consent|0
269419|NCT02128542|896494|P1|Overall Study|Withdrew Consent|1
269420|NCT02128542|896493|P2|Overall Study|Lost to Follow-up|0
269421|NCT02128542|896494|P1|Overall Study|Lost to Follow-up|3
269422|NCT02128490|896512|P5|Overall Study|Other Miscellaneous Reasons|1
269423|NCT02128490|896513|P4|Overall Study|Other Miscellaneous Reasons|1
269424|NCT02128490|896514|P3|Overall Study|Other Miscellaneous Reasons|2
269425|NCT02128490|896515|P2|Overall Study|Other Miscellaneous Reasons|0
269426|NCT02128490|896516|P1|Overall Study|Other Miscellaneous Reasons|0
269427|NCT02128490|896512|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
269428|NCT02128490|896513|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
269429|NCT02128490|896514|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
269430|NCT02128490|896515|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
269431|NCT02128490|896516|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
269432|NCT02128490|896512|P5|Overall Study|Lack of Efficacy|0
269433|NCT02128490|896513|P4|Overall Study|Lack of Efficacy|0
269434|NCT02128490|896514|P3|Overall Study|Lack of Efficacy|0
269435|NCT02128490|896515|P2|Overall Study|Lack of Efficacy|1
269436|NCT02128490|896516|P1|Overall Study|Lack of Efficacy|0
269437|NCT02128490|896512|P5|Overall Study|Voluntary Withdrawal|2
269438|NCT02128490|896513|P4|Overall Study|Voluntary Withdrawal|1
269439|NCT02128490|896514|P3|Overall Study|Voluntary Withdrawal|1
269440|NCT02128490|896515|P2|Overall Study|Voluntary Withdrawal|3
269441|NCT02128490|896516|P1|Overall Study|Voluntary Withdrawal|3
269442|NCT02128490|896512|P5|Overall Study|Lost to Follow-up|1
269443|NCT02128490|896513|P4|Overall Study|Lost to Follow-up|1
269444|NCT02128490|896514|P3|Overall Study|Lost to Follow-up|1
269445|NCT02128490|896515|P2|Overall Study|Lost to Follow-up|0
269446|NCT02128490|896516|P1|Overall Study|Lost to Follow-up|0
269447|NCT02128490|896512|P5|Overall Study|Major Protocol Deviation|2
269448|NCT02128490|896513|P4|Overall Study|Major Protocol Deviation|2
269449|NCT02128490|896514|P3|Overall Study|Major Protocol Deviation|0
269450|NCT02128490|896515|P2|Overall Study|Major Protocol Deviation|2
269451|NCT02128490|896516|P1|Overall Study|Major Protocol Deviation|1
269452|NCT02128490|896512|P5|Overall Study|Pretreatment Event/Adverse Event|0
269453|NCT02128490|896513|P4|Overall Study|Pretreatment Event/Adverse Event|1
269454|NCT02128490|896514|P3|Overall Study|Pretreatment Event/Adverse Event|1
269455|NCT02128490|896515|P2|Overall Study|Pretreatment Event/Adverse Event|0
269456|NCT02128490|896516|P1|Overall Study|Pretreatment Event/Adverse Event|1
269457|NCT02128269|896538|P1|Treatment Period|Physician Decision|1
269458|NCT02128269|896538|P1|Treatment Period|Adverse Event|1
269459|NCT02128217|896544|P2|Overall Study|Lost to Follow-up|1
269460|NCT02128217|896545|P1|Overall Study|Lost to Follow-up|0
269461|NCT02127372|896681|P2|Overall Study|Withdrawal by Subject|0
269462|NCT02127372|896682|P1|Overall Study|Withdrawal by Subject|1
269463|NCT02127307|896692|P1|Overall Study|Other than specified above|169
269464|NCT02127307|896692|P1|Overall Study|Death|101
269465|NCT02127307|896692|P1|Overall Study|Lost to Follow-up|2
269466|NCT02127307|896692|P1|Overall Study|Protocol Violation|36
269467|NCT02127281|896698|P2|Overall Study|Lost to Follow-up|0
269468|NCT02127281|896699|P1|Overall Study|Lost to Follow-up|1
269469|NCT02126839|896727|P2|Overall Study|Not specified|5
269470|NCT02126839|896728|P1|Overall Study|Not specified|5
269471|NCT02126839|896727|P2|Overall Study|Lost to Follow-up|4
269472|NCT02126839|896728|P1|Overall Study|Lost to Follow-up|1
269473|NCT02126839|896727|P2|Overall Study|Sponsor request|1
269474|NCT02126839|896728|P1|Overall Study|Sponsor request|0
269475|NCT02126839|896727|P2|Overall Study|Protocol Violation|3
269476|NCT02126839|896728|P1|Overall Study|Protocol Violation|2
269477|NCT02126839|896727|P2|Overall Study|Withdrawal by parent/guardian|0
269478|NCT02126839|896728|P1|Overall Study|Withdrawal by parent/guardian|1
269479|NCT02126839|896727|P2|Overall Study|Withdrawal by Subject|0
269480|NCT02126839|896728|P1|Overall Study|Withdrawal by Subject|1
269481|NCT02126839|896727|P2|Overall Study|Adverse Event|1
269482|NCT02126839|896728|P1|Overall Study|Adverse Event|0
269483|NCT02126670|896755|P4|Overall Study|Withdrawal by Subject|1
269484|NCT02126670|896756|P3|Overall Study|Withdrawal by Subject|0
269485|NCT02126670|896757|P2|Overall Study|Withdrawal by Subject|0
269486|NCT02126670|896758|P1|Overall Study|Withdrawal by Subject|1
269487|NCT02125877|896810|P2|Overall Study|Adverse Event|4
269488|NCT02125877|896811|P1|Overall Study|Adverse Event|6
269489|NCT02125877|896810|P2|Overall Study|Protocol deviation|1
269490|NCT02125877|896811|P1|Overall Study|Protocol deviation|4
269491|NCT02125877|896810|P2|Overall Study|Withdrawal by Subject|1
269492|NCT02125877|896811|P1|Overall Study|Withdrawal by Subject|2
269493|NCT02125877|896810|P2|Overall Study|Participant/guardian decision|2
269494|NCT02125877|896811|P1|Overall Study|Participant/guardian decision|0
269495|NCT02125877|896810|P2|Overall Study|Administrative problems|1
269496|NCT02125877|896811|P1|Overall Study|Administrative problems|0
269497|NCT02125877|896810|P2|Overall Study|Death|1
269498|NCT02125877|896811|P1|Overall Study|Death|0
269499|NCT02125877|896810|P2|Overall Study|Physician Decision|0
269500|NCT02125877|896811|P1|Overall Study|Physician Decision|1
269501|NCT02125838|896841|P2|Overall Study|Lost to Follow-up|4
269502|NCT02125838|896842|P1|Overall Study|Lost to Follow-up|4
269503|NCT02125734|896860|P2|Period 2|Adverse Event|1
269504|NCT02125734|896861|P1|Period 2|Adverse Event|0
269505|NCT02125604|896871|P1|Overall Study|Adverse Event|20
269506|NCT02125604|896871|P1|Overall Study|Consent Withdrawn|4
269507|NCT02125604|896871|P1|Overall Study|Lost to Follow-up|2
269508|NCT02125604|896871|P1|Overall Study|Investigator Decision|1
269509|NCT02125604|896871|P1|Overall Study|Not Specified|4
269510|NCT02124798|896917|P1|Overall Study|Lost to Follow-up|1
269511|NCT02124798|896917|P1|Overall Study|Adverse Event|3
269512|NCT02124161|896975|P2|Overall Study|Lost to Follow-up|4
269513|NCT02124161|896976|P1|Overall Study|Lost to Follow-up|3
269514|NCT02124161|896975|P2|Overall Study|No longer meets eligibility criteria|4
269515|NCT02124161|896976|P1|Overall Study|No longer meets eligibility criteria|5
269516|NCT02124161|896975|P2|Overall Study|Does not meet entrance criteria|3
269517|NCT02124161|896976|P1|Overall Study|Does not meet entrance criteria|2
269518|NCT02124161|896975|P2|Overall Study|Adverse Event|0
269519|NCT02124161|896976|P1|Overall Study|Adverse Event|2
269520|NCT02124161|896975|P2|Overall Study|Withdrawal by Subject|2
269521|NCT02124161|896976|P1|Overall Study|Withdrawal by Subject|1
269522|NCT02124161|896975|P2|Overall Study|Protocol Violation|1
269523|NCT02124161|896976|P1|Overall Study|Protocol Violation|2
269524|NCT02124161|896975|P2|Overall Study|Death|0
269525|NCT02124161|896976|P1|Overall Study|Death|1
269526|NCT02124161|896975|P2|Overall Study|Other unspecified|1
269527|NCT02124161|896976|P1|Overall Study|Other unspecified|0
269528|NCT02123472|897043|P2|Period 2 (7 Days)|Withdrawal by Subject|1
269529|NCT02123472|897044|P1|Period 2 (7 Days)|Withdrawal by Subject|0
269530|NCT02123459|897054|P2|Washout Period (1 Day)|Adverse Event|0
269531|NCT02123459|897055|P1|Washout Period (1 Day)|Adverse Event|1
269532|NCT02123446|897065|P2|Washout Period (1 Day)|Physician Decision|0
269533|NCT02123446|897066|P1|Washout Period (1 Day)|Physician Decision|1
269534|NCT02122146|897164|P8|Part 1: Dose Escalation|Other|2
269535|NCT02122146|897165|P7|Part 1: Dose Escalation|Other|1
269536|NCT02122146|897166|P6|Part 1: Dose Escalation|Other|1
269537|NCT02122146|897167|P5|Part 1: Dose Escalation|Other|0
269538|NCT02122146|897168|P4|Part 1: Dose Escalation|Other|0
269539|NCT02122146|897169|P3|Part 1: Dose Escalation|Other|0
269540|NCT02122146|897170|P2|Part 1: Dose Escalation|Other|0
269541|NCT02122146|897171|P1|Part 1: Dose Escalation|Other|1
269542|NCT02122146|897164|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
269543|NCT02122146|897165|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
269544|NCT02122146|897166|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
269545|NCT02122146|897167|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
269546|NCT02122146|897168|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
269547|NCT02122146|897169|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
269548|NCT02122146|897170|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
269549|NCT02122146|897171|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
269550|NCT02122146|897164|P8|Part 1: Dose Escalation|Lost to Follow-up|0
269551|NCT02122146|897165|P7|Part 1: Dose Escalation|Lost to Follow-up|0
269552|NCT02122146|897166|P6|Part 1: Dose Escalation|Lost to Follow-up|0
269553|NCT02122146|897167|P5|Part 1: Dose Escalation|Lost to Follow-up|1
269554|NCT02122146|897168|P4|Part 1: Dose Escalation|Lost to Follow-up|0
269555|NCT02122146|897169|P3|Part 1: Dose Escalation|Lost to Follow-up|1
269556|NCT02122146|897170|P2|Part 1: Dose Escalation|Lost to Follow-up|0
269557|NCT02122146|897171|P1|Part 1: Dose Escalation|Lost to Follow-up|0
269558|NCT02122146|897164|P8|Part 1: Dose Escalation|Death|0
269559|NCT02122146|897165|P7|Part 1: Dose Escalation|Death|0
269560|NCT02122146|897166|P6|Part 1: Dose Escalation|Death|0
269561|NCT02122146|897167|P5|Part 1: Dose Escalation|Death|0
269562|NCT02122146|897168|P4|Part 1: Dose Escalation|Death|0
269563|NCT02122146|897169|P3|Part 1: Dose Escalation|Death|1
269564|NCT02122146|897170|P2|Part 1: Dose Escalation|Death|1
269565|NCT02122146|897171|P1|Part 1: Dose Escalation|Death|0
269566|NCT02121847|897432|P1|Overall Study|Adverse Event|2
269567|NCT02121847|897432|P1|Overall Study|Administrative Reasons|1
269568|NCT02121808|897451|P1|Overall Study|Technical problem|3
269569|NCT02121795|897462|P2|Overall Study|Still in Study up to the Data Cut Date|316
269570|NCT02121795|897463|P1|Overall Study|Still in Study up to the Data Cut Date|315
269571|NCT02121795|897462|P2|Overall Study|Lost to Follow-up|1
269572|NCT02121795|897463|P1|Overall Study|Lost to Follow-up|2
269573|NCT02121795|897462|P2|Overall Study|Withdrew Consent|10
269574|NCT02121795|897463|P1|Overall Study|Withdrew Consent|10
269575|NCT02121795|897462|P2|Overall Study|Protocol Violation|2
269576|NCT02121795|897463|P1|Overall Study|Protocol Violation|0
269577|NCT02121795|897462|P2|Overall Study|Non-Compliance with Study Drug|1
269578|NCT02121795|897463|P1|Overall Study|Non-Compliance with Study Drug|1
269579|NCT02121795|897462|P2|Overall Study|Investigator's Discretion|0
269580|NCT02121795|897463|P1|Overall Study|Investigator's Discretion|1
269581|NCT02121795|897462|P2|Overall Study|Adverse Event|0
269582|NCT02121795|897463|P1|Overall Study|Adverse Event|4
269583|NCT02121795|897462|P2|Overall Study|Randomized but Never Treated|4
269584|NCT02121795|897463|P1|Overall Study|Randomized but Never Treated|1
269585|NCT02121535|897479|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
269586|NCT02121535|897480|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
269587|NCT02121535|897479|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
269588|NCT02121535|897480|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
269589|NCT02121522|897503|P1|Overall Study|Adverse Event|1
269590|NCT02121509|897510|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
269591|NCT02121509|897511|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
269592|NCT02121509|897512|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
269593|NCT02121509|897513|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
269594|NCT02121509|897510|P4|Washout Period (35 Days)|Withdrawal by Subject|0
269595|NCT02121509|897511|P3|Washout Period (35 Days)|Withdrawal by Subject|0
269596|NCT02121509|897512|P2|Washout Period (35 Days)|Withdrawal by Subject|3
269597|NCT02121509|897513|P1|Washout Period (35 Days)|Withdrawal by Subject|0
269598|NCT02121509|897510|P4|Washout Period (35 Days)|Adverse Event|0
269599|NCT02121509|897511|P3|Washout Period (35 Days)|Adverse Event|0
269600|NCT02121509|897512|P2|Washout Period (35 Days)|Adverse Event|1
269601|NCT02121509|897513|P1|Washout Period (35 Days)|Adverse Event|1
269602|NCT02121210|897584|P2|Overall Study|Other than specified above|2
269603|NCT02121210|897585|P1|Overall Study|Other than specified above|0
269604|NCT02121210|897584|P2|Overall Study|Lack of Efficacy|0
269605|NCT02121210|897585|P1|Overall Study|Lack of Efficacy|2
269606|NCT02121210|897584|P2|Overall Study|Adverse Event|7
269607|NCT02121210|897585|P1|Overall Study|Adverse Event|5
269608|NCT02120833|897610|P2|Overall Study|Lost to Follow-up|1
269609|NCT02120833|897611|P1|Overall Study|Lost to Follow-up|1
269610|NCT02120833|897610|P2|Overall Study|Withdrawal by Subject|0
269611|NCT02120833|897611|P1|Overall Study|Withdrawal by Subject|2
269612|NCT02120833|897610|P2|Overall Study|Adverse Event|0
269613|NCT02120833|897611|P1|Overall Study|Adverse Event|1
269614|NCT02120664|897770|P5|Overall Study|Withdrawal by Subject|0
269615|NCT02120664|897771|P4|Overall Study|Withdrawal by Subject|1
269616|NCT02120664|897772|P3|Overall Study|Withdrawal by Subject|0
269617|NCT02120664|897773|P2|Overall Study|Withdrawal by Subject|0
269618|NCT02120664|897774|P1|Overall Study|Withdrawal by Subject|0
269619|NCT02120625|897792|P1|Overall Study|Physician Decision|2
269620|NCT02120417|897807|P2|Overall Study|Other unspecified|4
269621|NCT02120417|897808|P1|Overall Study|Other unspecified|5
269622|NCT02120417|897807|P2|Overall Study|Physician Decision|3
269623|NCT02120417|897808|P1|Overall Study|Physician Decision|2
269624|NCT02120417|897807|P2|Overall Study|Noncompliance with study treatment|2
269625|NCT02120417|897808|P1|Overall Study|Noncompliance with study treatment|0
269626|NCT02120417|897807|P2|Overall Study|Disease progression|45
269627|NCT02120417|897808|P1|Overall Study|Disease progression|41
269628|NCT02120417|897807|P2|Overall Study|Participant decision|4
269629|NCT02120417|897808|P1|Overall Study|Participant decision|4
269630|NCT02120417|897807|P2|Overall Study|Adverse Event|9
269631|NCT02120417|897808|P1|Overall Study|Adverse Event|3
269632|NCT02120417|897807|P2|Overall Study|Death|1
269633|NCT02120417|897808|P1|Overall Study|Death|5
269634|NCT02120300|897830|P4|Overall Study|Lost to Follow-up|0
269635|NCT02120300|897831|P3|Overall Study|Lost to Follow-up|0
269636|NCT02120300|897832|P2|Overall Study|Lost to Follow-up|0
269637|NCT02120300|897833|P1|Overall Study|Lost to Follow-up|1
269638|NCT02120300|897830|P4|Overall Study|Lack of Efficacy|1
269639|NCT02120300|897831|P3|Overall Study|Lack of Efficacy|0
269640|NCT02120300|897832|P2|Overall Study|Lack of Efficacy|0
269641|NCT02120300|897833|P1|Overall Study|Lack of Efficacy|0
269642|NCT02120300|897830|P4|Overall Study|Enrolled but Never Treated|0
269643|NCT02120300|897831|P3|Overall Study|Enrolled but Never Treated|0
269644|NCT02120300|897832|P2|Overall Study|Enrolled but Never Treated|0
269645|NCT02120300|897833|P1|Overall Study|Enrolled but Never Treated|2
269646|NCT02120027|897871|P2|Overall Study|Withdrawal by Subject|25
269647|NCT02120027|897872|P1|Overall Study|Withdrawal by Subject|33
269648|NCT02120027|897871|P2|Overall Study|Study terminated by Sponsor|47
269649|NCT02120027|897872|P1|Overall Study|Study terminated by Sponsor|45
269650|NCT02120027|897871|P2|Overall Study|Protocol Violation|21
269651|NCT02120027|897872|P1|Overall Study|Protocol Violation|18
269652|NCT02120027|897871|P2|Overall Study|Physician Decision|3
269653|NCT02120027|897872|P1|Overall Study|Physician Decision|4
269654|NCT02120027|897871|P2|Overall Study|Other|0
269655|NCT02120027|897872|P1|Overall Study|Other|4
269656|NCT02120027|897871|P2|Overall Study|Lost to Follow-up|13
269657|NCT02120027|897872|P1|Overall Study|Lost to Follow-up|5
269658|NCT02120027|897871|P2|Overall Study|Lack of Efficacy|5
269659|NCT02120027|897872|P1|Overall Study|Lack of Efficacy|3
269660|NCT02120027|897871|P2|Overall Study|Adverse Event|5
269661|NCT02120027|897872|P1|Overall Study|Adverse Event|4
269662|NCT02119936|897897|P1|Overall Study|Lost to Follow-up|10
269663|NCT02119676|897931|P4|Overall Study|Did not receive study med|5
269664|NCT02119676|897932|P3|Overall Study|Did not receive study med|4
269665|NCT02119676|897933|P2|Overall Study|Did not receive study med|2
269666|NCT02119676|897934|P1|Overall Study|Did not receive study med|2
269667|NCT02119676|897931|P4|Overall Study|Other, unspecified|4
269668|NCT02119676|897932|P3|Overall Study|Other, unspecified|3
269669|NCT02119676|897933|P2|Overall Study|Other, unspecified|1
269670|NCT02119676|897934|P1|Overall Study|Other, unspecified|2
269671|NCT02119676|897931|P4|Overall Study|Protocol deviation|0
269672|NCT02119676|897932|P3|Overall Study|Protocol deviation|1
269673|NCT02119676|897933|P2|Overall Study|Protocol deviation|0
269674|NCT02119676|897934|P1|Overall Study|Protocol deviation|0
269675|NCT02119676|897931|P4|Overall Study|Lost to Follow-up|0
269676|NCT02119676|897932|P3|Overall Study|Lost to Follow-up|1
269677|NCT02119676|897933|P2|Overall Study|Lost to Follow-up|0
269678|NCT02119676|897934|P1|Overall Study|Lost to Follow-up|0
269679|NCT02119676|897931|P4|Overall Study|Noncompliance|0
269680|NCT02119676|897932|P3|Overall Study|Noncompliance|0
269681|NCT02119676|897933|P2|Overall Study|Noncompliance|1
269682|NCT02119676|897934|P1|Overall Study|Noncompliance|0
269683|NCT02119676|897931|P4|Overall Study|Death|1
269684|NCT02119676|897932|P3|Overall Study|Death|2
269685|NCT02119676|897933|P2|Overall Study|Death|3
269686|NCT02119676|897934|P1|Overall Study|Death|9
269687|NCT02119676|897931|P4|Overall Study|Physician Decision|2
269688|NCT02119676|897932|P3|Overall Study|Physician Decision|3
269689|NCT02119676|897933|P2|Overall Study|Physician Decision|2
269690|NCT02119676|897934|P1|Overall Study|Physician Decision|4
269691|NCT02119676|897931|P4|Overall Study|Patient decision, inc. consent withdrawn|6
269692|NCT02119676|897932|P3|Overall Study|Patient decision, inc. consent withdrawn|5
269693|NCT02119676|897933|P2|Overall Study|Patient decision, inc. consent withdrawn|5
269694|NCT02119676|897934|P1|Overall Study|Patient decision, inc. consent withdrawn|4
269695|NCT02119676|897931|P4|Overall Study|Disease progression|73
269696|NCT02119676|897932|P3|Overall Study|Disease progression|68
269697|NCT02119676|897933|P2|Overall Study|Disease progression|55
269698|NCT02119676|897934|P1|Overall Study|Disease progression|53
269699|NCT02119676|897931|P4|Overall Study|Adverse Event|10
269700|NCT02119676|897932|P3|Overall Study|Adverse Event|10
269701|NCT02119676|897933|P2|Overall Study|Adverse Event|17
269702|NCT02119676|897934|P1|Overall Study|Adverse Event|9
269703|NCT02119663|897966|P2|Overall Study|Study Terminated by the Sponsor|4
269704|NCT02119663|897967|P1|Overall Study|Study Terminated by the Sponsor|3
269705|NCT02119663|897966|P2|Overall Study|Subject decision|1
269706|NCT02119663|897967|P1|Overall Study|Subject decision|0
269707|NCT02119663|897966|P2|Overall Study|Other unspecified|0
269708|NCT02119663|897967|P1|Overall Study|Other unspecified|2
269709|NCT02119663|897966|P2|Overall Study|Physician Decision|2
269710|NCT02119663|897967|P1|Overall Study|Physician Decision|1
269711|NCT02119663|897966|P2|Overall Study|Death|2
269712|NCT02119663|897967|P1|Overall Study|Death|3
269713|NCT02119663|897966|P2|Overall Study|Adverse Event|5
269714|NCT02119663|897967|P1|Overall Study|Adverse Event|5
269715|NCT02119663|897966|P2|Overall Study|Disease progression|27
269716|NCT02119663|897967|P1|Overall Study|Disease progression|26
269717|NCT02119650|897985|P2|Overall Study|Multiple reasons for termination|1
269718|NCT02119650|897986|P1|Overall Study|Multiple reasons for termination|2
269719|NCT02119650|897985|P2|Overall Study|Physician Decision|2
269720|NCT02119650|897986|P1|Overall Study|Physician Decision|0
269721|NCT02119650|897985|P2|Overall Study|Study terminated by the sponsor|0
269722|NCT02119650|897986|P1|Overall Study|Study terminated by the sponsor|1
269723|NCT02119650|897985|P2|Overall Study|Noncompliance with study treatment|1
269724|NCT02119650|897986|P1|Overall Study|Noncompliance with study treatment|1
269725|NCT02119650|897985|P2|Overall Study|Death|1
269726|NCT02119650|897986|P1|Overall Study|Death|5
269727|NCT02119650|897985|P2|Overall Study|Disease progression|14
269728|NCT02119650|897986|P1|Overall Study|Disease progression|11
269729|NCT02119650|897985|P2|Overall Study|Subject decision|3
269730|NCT02119650|897986|P1|Overall Study|Subject decision|2
269731|NCT02119650|897985|P2|Overall Study|Adverse Event|4
269732|NCT02119650|897986|P1|Overall Study|Adverse Event|3
269733|NCT02119325|898000|P2|Washout Period 1|Adverse Event|1
269734|NCT02119325|898001|P1|Washout Period 1|Adverse Event|0
269735|NCT02119299|898045|P1|Overall Study|Pregnancy|1
269736|NCT02119299|898045|P1|Overall Study|Lack of Efficacy|1
269737|NCT02119299|898045|P1|Overall Study|Withdrawal by Subject|7
269738|NCT02119286|898059|P3|Overall Study|Withdrawal by Subject|0
269739|NCT02119286|898060|P2|Overall Study|Withdrawal by Subject|1
269740|NCT02119286|898061|P1|Overall Study|Withdrawal by Subject|4
269741|NCT02119286|898059|P3|Overall Study|Lost to Follow-up|1
269742|NCT02119286|898060|P2|Overall Study|Lost to Follow-up|0
269743|NCT02119286|898061|P1|Overall Study|Lost to Follow-up|2
269744|NCT02119286|898059|P3|Overall Study|Lack of Efficacy|4
269745|NCT02119286|898060|P2|Overall Study|Lack of Efficacy|3
269746|NCT02119286|898061|P1|Overall Study|Lack of Efficacy|11
269747|NCT02119286|898059|P3|Overall Study|Adverse Event|2
269748|NCT02119286|898060|P2|Overall Study|Adverse Event|7
269749|NCT02119286|898061|P1|Overall Study|Adverse Event|9
269750|NCT02119104|898072|P1|Overall Study|Protocol Violation|16
269751|NCT02118961|898078|P2|Overall Study|Withdrawal by Subject|0
269752|NCT02118961|898079|P1|Overall Study|Withdrawal by Subject|1
269753|NCT02118896|898107|P10|Overall Study|Miscellaneous|0
269754|NCT02118896|898108|P9|Overall Study|Miscellaneous|0
269755|NCT02118896|898109|P8|Overall Study|Miscellaneous|0
269756|NCT02118896|898110|P7|Overall Study|Miscellaneous|0
269757|NCT02118896|898111|P6|Overall Study|Miscellaneous|4
269758|NCT02118896|898112|P5|Overall Study|Miscellaneous|0
269759|NCT02118896|898113|P4|Overall Study|Miscellaneous|2
269760|NCT02118896|898114|P3|Overall Study|Miscellaneous|0
269761|NCT02118896|898115|P2|Overall Study|Miscellaneous|2
269762|NCT02118896|898116|P1|Overall Study|Miscellaneous|1
269763|NCT02118896|898107|P10|Overall Study|Prohibited medication|0
269764|NCT02118896|898108|P9|Overall Study|Prohibited medication|0
269765|NCT02118896|898109|P8|Overall Study|Prohibited medication|0
269766|NCT02118896|898110|P7|Overall Study|Prohibited medication|0
269767|NCT02118896|898111|P6|Overall Study|Prohibited medication|3
269768|NCT02118896|898112|P5|Overall Study|Prohibited medication|1
269769|NCT02118896|898113|P4|Overall Study|Prohibited medication|0
269770|NCT02118896|898114|P3|Overall Study|Prohibited medication|0
269771|NCT02118896|898115|P2|Overall Study|Prohibited medication|0
269772|NCT02118896|898116|P1|Overall Study|Prohibited medication|0
269773|NCT02118896|898107|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
269774|NCT02118896|898108|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
269775|NCT02118896|898109|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
269776|NCT02118896|898110|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
269777|NCT02118896|898111|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
269778|NCT02118896|898112|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
269779|NCT02118896|898113|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
269780|NCT02118896|898114|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
269781|NCT02118896|898115|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
269782|NCT02118896|898116|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
269783|NCT02118896|898107|P10|Overall Study|Lost to Follow-up|0
269784|NCT02118896|898108|P9|Overall Study|Lost to Follow-up|0
269785|NCT02118896|898109|P8|Overall Study|Lost to Follow-up|0
269786|NCT02118896|898110|P7|Overall Study|Lost to Follow-up|0
269787|NCT02118896|898111|P6|Overall Study|Lost to Follow-up|1
269788|NCT02118896|898112|P5|Overall Study|Lost to Follow-up|2
269789|NCT02118896|898113|P4|Overall Study|Lost to Follow-up|0
269790|NCT02118896|898114|P3|Overall Study|Lost to Follow-up|1
269791|NCT02118896|898115|P2|Overall Study|Lost to Follow-up|2
269792|NCT02118896|898116|P1|Overall Study|Lost to Follow-up|1
269793|NCT02118896|898107|P10|Overall Study|Pregnancy|0
269794|NCT02118896|898108|P9|Overall Study|Pregnancy|0
269795|NCT02118896|898109|P8|Overall Study|Pregnancy|0
269796|NCT02118896|898110|P7|Overall Study|Pregnancy|1
269797|NCT02118896|898111|P6|Overall Study|Pregnancy|3
269798|NCT02118896|898112|P5|Overall Study|Pregnancy|1
269799|NCT02118896|898113|P4|Overall Study|Pregnancy|0
269800|NCT02118896|898114|P3|Overall Study|Pregnancy|0
269801|NCT02118896|898115|P2|Overall Study|Pregnancy|1
269802|NCT02118896|898116|P1|Overall Study|Pregnancy|1
269803|NCT02118896|898107|P10|Overall Study|Non-compliance|0
269804|NCT02118896|898108|P9|Overall Study|Non-compliance|0
269805|NCT02118896|898109|P8|Overall Study|Non-compliance|1
269806|NCT02118896|898110|P7|Overall Study|Non-compliance|0
269807|NCT02118896|898111|P6|Overall Study|Non-compliance|1
269808|NCT02118896|898112|P5|Overall Study|Non-compliance|0
269809|NCT02118896|898113|P4|Overall Study|Non-compliance|5
269810|NCT02118896|898114|P3|Overall Study|Non-compliance|1
269811|NCT02118896|898115|P2|Overall Study|Non-compliance|1
269812|NCT02118896|898116|P1|Overall Study|Non-compliance|2
269813|NCT02118896|898107|P10|Overall Study|Consent withdrawn|0
269814|NCT02118896|898108|P9|Overall Study|Consent withdrawn|0
269815|NCT02118896|898109|P8|Overall Study|Consent withdrawn|0
269816|NCT02118896|898110|P7|Overall Study|Consent withdrawn|0
269817|NCT02118896|898111|P6|Overall Study|Consent withdrawn|4
269818|NCT02118896|898112|P5|Overall Study|Consent withdrawn|1
269819|NCT02118896|898113|P4|Overall Study|Consent withdrawn|4
269820|NCT02118896|898114|P3|Overall Study|Consent withdrawn|3
269821|NCT02118896|898115|P2|Overall Study|Consent withdrawn|0
269822|NCT02118896|898116|P1|Overall Study|Consent withdrawn|2
269823|NCT02118896|898107|P10|Overall Study|Adverse Event|0
269824|NCT02118896|898108|P9|Overall Study|Adverse Event|4
269825|NCT02118896|898109|P8|Overall Study|Adverse Event|1
269826|NCT02118896|898110|P7|Overall Study|Adverse Event|1
269827|NCT02118896|898111|P6|Overall Study|Adverse Event|9
269828|NCT02118896|898112|P5|Overall Study|Adverse Event|5
269829|NCT02118896|898113|P4|Overall Study|Adverse Event|5
269830|NCT02118896|898114|P3|Overall Study|Adverse Event|4
269831|NCT02118896|898115|P2|Overall Study|Adverse Event|4
269832|NCT02118896|898116|P1|Overall Study|Adverse Event|5
269833|NCT02118896|898107|P10|Overall Study|Death|0
269834|NCT02118896|898108|P9|Overall Study|Death|0
269835|NCT02118896|898109|P8|Overall Study|Death|0
269836|NCT02118896|898110|P7|Overall Study|Death|0
269837|NCT02118896|898111|P6|Overall Study|Death|1
269838|NCT02118896|898112|P5|Overall Study|Death|3
269839|NCT02118896|898113|P4|Overall Study|Death|6
269840|NCT02118896|898114|P3|Overall Study|Death|4
269841|NCT02118896|898115|P2|Overall Study|Death|0
269842|NCT02118896|898116|P1|Overall Study|Death|4
269843|NCT02118792|898206|P2|Overall Study|Randomised but not treated|0
269844|NCT02118792|898207|P1|Overall Study|Randomised but not treated|1
269845|NCT02118792|898206|P2|Overall Study|Other|6
269846|NCT02118792|898207|P1|Overall Study|Other|1
269847|NCT02118792|898206|P2|Overall Study|Withdrawal by parent/guardian|20
269848|NCT02118792|898207|P1|Overall Study|Withdrawal by parent/guardian|14
269849|NCT02118792|898206|P2|Overall Study|Adverse Event|4
269850|NCT02118792|898207|P1|Overall Study|Adverse Event|5
269851|NCT02118792|898206|P2|Overall Study|Lost to Follow-up|4
269852|NCT02118792|898207|P1|Overall Study|Lost to Follow-up|4
269853|NCT02118792|898206|P2|Overall Study|Withdrawal by Subject|3
269854|NCT02118792|898207|P1|Overall Study|Withdrawal by Subject|6
269855|NCT02118766|898249|P2|Overall Study|Other|1
269856|NCT02118766|898250|P1|Overall Study|Other|3
269857|NCT02118766|898249|P2|Overall Study|Withdrawal by parent/guardian|18
269858|NCT02118766|898250|P1|Overall Study|Withdrawal by parent/guardian|12
269859|NCT02118766|898249|P2|Overall Study|Lost to Follow-up|4
269860|NCT02118766|898250|P1|Overall Study|Lost to Follow-up|5
269861|NCT02118766|898249|P2|Overall Study|Withdrawal by Subject|6
269862|NCT02118766|898250|P1|Overall Study|Withdrawal by Subject|3
269863|NCT02118766|898249|P2|Overall Study|Adverse Event|2
269864|NCT02118766|898250|P1|Overall Study|Adverse Event|7
269865|NCT02118597|898272|P1|Overall Study|Investigator's decision|1
269866|NCT02118597|898272|P1|Overall Study|Serious Adverse Event|1
269867|NCT02118597|898272|P1|Overall Study|Sponsor terminated the study|14
269868|NCT02117687|898314|P2|Overall Study|Other Reasons|1
269869|NCT02117687|898315|P1|Overall Study|Other Reasons|1
269870|NCT02117687|898314|P2|Overall Study|Adverse Event|2
269871|NCT02117687|898315|P1|Overall Study|Adverse Event|0
269872|NCT02117687|898314|P2|Overall Study|Lost to Follow-up|1
269873|NCT02117687|898315|P1|Overall Study|Lost to Follow-up|0
269874|NCT02117570|898350|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
269875|NCT02117570|898351|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
269876|NCT02117570|898352|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
269877|NCT02117570|898350|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
269878|NCT02117570|898351|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
269879|NCT02117570|898352|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
269880|NCT02117570|898350|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
269881|NCT02117570|898351|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
269882|NCT02117570|898352|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
269883|NCT02117570|898350|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
269884|NCT02117570|898351|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
269885|NCT02117570|898352|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
269886|NCT02117570|898350|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
269887|NCT02117570|898351|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
269888|NCT02117570|898352|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
269889|NCT02117570|898350|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
269890|NCT02117570|898351|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
269891|NCT02117570|898352|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
269892|NCT02117570|898350|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
269893|NCT02117570|898351|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
269894|NCT02117570|898352|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
269895|NCT02117544|898402|P2|Period 1|Lost to follow-up (prior to treatment)|0
269896|NCT02117544|898403|P1|Period 1|Lost to follow-up (prior to treatment)|2
269897|NCT02117479|898418|P2|Overall Study|Other unspecified|7
269898|NCT02117479|898419|P1|Overall Study|Other unspecified|11
269899|NCT02117479|898418|P2|Overall Study|Physician Decision|2
269900|NCT02117479|898419|P1|Overall Study|Physician Decision|7
269901|NCT02117479|898418|P2|Overall Study|Study terminated by the sponsor|6
269902|NCT02117479|898419|P1|Overall Study|Study terminated by the sponsor|4
269903|NCT02117479|898418|P2|Overall Study|Noncompliance with study treatment|0
269904|NCT02117479|898419|P1|Overall Study|Noncompliance with study treatment|1
269905|NCT02117479|898418|P2|Overall Study|Disease progression|108
269906|NCT02117479|898419|P1|Overall Study|Disease progression|104
269907|NCT02117479|898418|P2|Overall Study|Subject decision|9
269908|NCT02117479|898419|P1|Overall Study|Subject decision|8
269909|NCT02117479|898418|P2|Overall Study|Adverse Event|16
269910|NCT02117479|898419|P1|Overall Study|Adverse Event|8
269911|NCT02117479|898418|P2|Overall Study|Death|8
269912|NCT02117479|898419|P1|Overall Study|Death|13
269913|NCT02117414|898437|P2|Overall Study|Withdrawal by Subject|4
269914|NCT02117414|898438|P1|Overall Study|Withdrawal by Subject|10
269915|NCT02117414|898437|P2|Overall Study|Death|2
269916|NCT02117414|898438|P1|Overall Study|Death|5
269917|NCT02117050|898482|P1|Overall Study|Subject Enrolled but not Dosed|1
269918|NCT02116972|898497|P3|Overall Study|scheduling conflicts and relocation|6
269919|NCT02116972|898498|P2|Overall Study|scheduling conflicts and relocation|3
269920|NCT02116972|898499|P1|Overall Study|scheduling conflicts and relocation|3
269921|NCT02116972|898497|P3|Overall Study|Lack of Efficacy|5
269922|NCT02116972|898498|P2|Overall Study|Lack of Efficacy|6
269923|NCT02116972|898499|P1|Overall Study|Lack of Efficacy|6
269924|NCT02116972|898497|P3|Overall Study|Lost to Follow-up|1
269925|NCT02116972|898498|P2|Overall Study|Lost to Follow-up|3
269926|NCT02116972|898499|P1|Overall Study|Lost to Follow-up|4
269927|NCT02116972|898497|P3|Overall Study|Protocol Violation|1
269928|NCT02116972|898498|P2|Overall Study|Protocol Violation|0
269929|NCT02116972|898499|P1|Overall Study|Protocol Violation|1
269930|NCT02116972|898497|P3|Overall Study|Withdrawal by Subject|5
269931|NCT02116972|898498|P2|Overall Study|Withdrawal by Subject|1
269932|NCT02116972|898499|P1|Overall Study|Withdrawal by Subject|1
269933|NCT02116972|898497|P3|Overall Study|Adverse Event|1
269934|NCT02116972|898498|P2|Overall Study|Adverse Event|4
269935|NCT02116972|898499|P1|Overall Study|Adverse Event|4
269936|NCT02116803|898531|P2|Overall Study|Death|0
269937|NCT02116803|898532|P1|Overall Study|Death|1
269938|NCT02116803|898531|P2|Overall Study|Study terminated by sponsor|1
269939|NCT02116803|898532|P1|Overall Study|Study terminated by sponsor|2
269940|NCT02116803|898531|P2|Overall Study|Progressive disease|0
269941|NCT02116803|898532|P1|Overall Study|Progressive disease|4
269942|NCT02116803|898531|P2|Overall Study|Physician Decision|0
269943|NCT02116803|898532|P1|Overall Study|Physician Decision|1
269944|NCT02116803|898531|P2|Overall Study|Adverse Event|1
269945|NCT02116803|898532|P1|Overall Study|Adverse Event|2
269946|NCT02116621|898540|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
269947|NCT02116621|898541|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
269948|NCT02116621|898540|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
269949|NCT02116621|898541|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
269950|NCT02116621|898540|P2|Twelve Month Follow-up|Lost to Follow-up|1
269951|NCT02116621|898541|P1|Twelve Month Follow-up|Lost to Follow-up|0
269952|NCT02116621|898540|P2|Twelve Month Follow-up|Withdrawal by Subject|0
269953|NCT02116621|898541|P1|Twelve Month Follow-up|Withdrawal by Subject|1
269954|NCT02116621|898540|P2|Six Month Follow-up|Did not complete follow-up survey|1
269955|NCT02116621|898541|P1|Six Month Follow-up|Did not complete follow-up survey|1
269956|NCT02116621|898540|P2|Six Month Follow-up|Lost to Follow-up|1
269957|NCT02116621|898541|P1|Six Month Follow-up|Lost to Follow-up|2
269958|NCT02116621|898540|P2|Six Month Follow-up|Withdrawal by Subject|1
269959|NCT02116621|898541|P1|Six Month Follow-up|Withdrawal by Subject|1
269960|NCT02116621|898540|P2|Three Month Follow-up|Did not complete follow-up survey|4
269961|NCT02116621|898541|P1|Three Month Follow-up|Did not complete follow-up survey|14
269962|NCT02116621|898540|P2|Three Month Follow-up|Lost to Follow-up|1
269963|NCT02116621|898541|P1|Three Month Follow-up|Lost to Follow-up|0
269964|NCT02116621|898540|P2|Three Month Follow-up|Withdrawal by Subject|1
269965|NCT02116621|898541|P1|Three Month Follow-up|Withdrawal by Subject|4
269966|NCT02116621|898540|P2|Three Month Follow-up|Death|1
269967|NCT02116621|898541|P1|Three Month Follow-up|Death|1
269968|NCT02116621|898540|P2|Baseline|Withdrawal by Subject|4
269969|NCT02116621|898541|P1|Baseline|Withdrawal by Subject|0
269970|NCT02116582|898629|P1|Overall Study|Other: Miscellaneous|9
269971|NCT02116582|898629|P1|Overall Study|Withdrawal by Subject|8
269972|NCT02116582|898629|P1|Overall Study|Protocol Violation|3
269973|NCT02116582|898629|P1|Overall Study|Progressive Disease|140
269974|NCT02116582|898629|P1|Overall Study|Death|7
269975|NCT02116582|898629|P1|Overall Study|Adverse Event|17
269976|NCT02116582|898629|P1|Overall Study|Enrolled but Never Received Study Drug|1
269977|NCT02116530|898639|P2|Overall Study|Other Medical Problems|2
269978|NCT02116530|898640|P1|Overall Study|Other Medical Problems|2
269979|NCT02116530|898639|P2|Overall Study|Lost to Follow-up|0
269980|NCT02116530|898640|P1|Overall Study|Lost to Follow-up|1
269981|NCT02116530|898639|P2|Overall Study|Physician Decision|0
269982|NCT02116530|898640|P1|Overall Study|Physician Decision|1
269983|NCT02116530|898639|P2|Overall Study|Adverse Event|0
269984|NCT02116530|898640|P1|Overall Study|Adverse Event|4
269985|NCT02116530|898639|P2|Overall Study|Withdrawal by Subject|2
269986|NCT02116530|898640|P1|Overall Study|Withdrawal by Subject|1
269987|NCT02116361|898658|P4|Overall Study|Investigator Decision - Relapse|5
269988|NCT02116361|898659|P3|Overall Study|Investigator Decision - Relapse|8
269989|NCT02116361|898660|P2|Overall Study|Investigator Decision - Relapse|7
269990|NCT02116361|898661|P1|Overall Study|Investigator Decision - Relapse|9
269991|NCT02116361|898658|P4|Overall Study|Personal Reasons|9
269992|NCT02116361|898659|P3|Overall Study|Personal Reasons|4
269993|NCT02116361|898660|P2|Overall Study|Personal Reasons|6
269994|NCT02116361|898661|P1|Overall Study|Personal Reasons|6
269995|NCT02116361|898658|P4|Overall Study|Lost to Follow-up|5
269996|NCT02116361|898659|P3|Overall Study|Lost to Follow-up|7
269997|NCT02116361|898660|P2|Overall Study|Lost to Follow-up|5
269998|NCT02116361|898661|P1|Overall Study|Lost to Follow-up|4
269999|NCT02116361|898658|P4|Overall Study|Lack of Efficacy|3
270000|NCT02116361|898659|P3|Overall Study|Lack of Efficacy|4
270001|NCT02116361|898660|P2|Overall Study|Lack of Efficacy|7
270002|NCT02116361|898661|P1|Overall Study|Lack of Efficacy|5
270003|NCT02116361|898658|P4|Overall Study|Other Reasons|3
270004|NCT02116361|898659|P3|Overall Study|Other Reasons|3
270005|NCT02116361|898660|P2|Overall Study|Other Reasons|3
270006|NCT02116361|898661|P1|Overall Study|Other Reasons|3
270007|NCT02116361|898658|P4|Overall Study|Adverse Event|3
270008|NCT02116361|898659|P3|Overall Study|Adverse Event|0
270009|NCT02116361|898660|P2|Overall Study|Adverse Event|0
270010|NCT02116361|898661|P1|Overall Study|Adverse Event|1
270011|NCT02116361|898658|P4|Overall Study|Physician Decision|0
270012|NCT02116361|898659|P3|Overall Study|Physician Decision|0
270013|NCT02116361|898660|P2|Overall Study|Physician Decision|3
270014|NCT02116361|898661|P1|Overall Study|Physician Decision|2
270015|NCT02116361|898658|P4|Overall Study|Protocol Violation|2
270016|NCT02116361|898659|P3|Overall Study|Protocol Violation|0
270017|NCT02116361|898660|P2|Overall Study|Protocol Violation|0
270018|NCT02116361|898661|P1|Overall Study|Protocol Violation|1
270019|NCT02116361|898658|P4|Overall Study|Pregnancy|1
270020|NCT02116361|898659|P3|Overall Study|Pregnancy|0
270021|NCT02116361|898660|P2|Overall Study|Pregnancy|0
270022|NCT02116361|898661|P1|Overall Study|Pregnancy|0
270023|NCT02116309|898698|P2|Overall Study|Lost to Follow-up|1
270024|NCT02116309|898699|P1|Overall Study|Lost to Follow-up|0
270025|NCT02115815|898723|P7|Overall Study|Missed appointment, randomized in error|0
270026|NCT02115815|898724|P6|Overall Study|Missed appointment, randomized in error|1
270027|NCT02115815|898725|P5|Overall Study|Missed appointment, randomized in error|0
270028|NCT02115815|898726|P4|Overall Study|Missed appointment, randomized in error|0
270029|NCT02115815|898727|P3|Overall Study|Missed appointment, randomized in error|0
270030|NCT02115815|898728|P2|Overall Study|Missed appointment, randomized in error|0
270031|NCT02115815|898729|P1|Overall Study|Missed appointment, randomized in error|0
270032|NCT02115815|898723|P7|Overall Study|Not enough drug to dose participant|0
270033|NCT02115815|898724|P6|Overall Study|Not enough drug to dose participant|1
270034|NCT02115815|898725|P5|Overall Study|Not enough drug to dose participant|0
270035|NCT02115815|898726|P4|Overall Study|Not enough drug to dose participant|0
270036|NCT02115815|898727|P3|Overall Study|Not enough drug to dose participant|0
270037|NCT02115815|898728|P2|Overall Study|Not enough drug to dose participant|0
270038|NCT02115815|898729|P1|Overall Study|Not enough drug to dose participant|0
270039|NCT02115815|898723|P7|Overall Study|Withdrawal by Subject|0
270040|NCT02115815|898724|P6|Overall Study|Withdrawal by Subject|0
270041|NCT02115815|898725|P5|Overall Study|Withdrawal by Subject|0
270042|NCT02115815|898726|P4|Overall Study|Withdrawal by Subject|0
270043|NCT02115815|898727|P3|Overall Study|Withdrawal by Subject|0
270044|NCT02115815|898728|P2|Overall Study|Withdrawal by Subject|0
270045|NCT02115815|898729|P1|Overall Study|Withdrawal by Subject|2
270046|NCT02115321|898850|P2|Overall Study|Death|0
270047|NCT02115321|898851|P1|Overall Study|Death|1
270048|NCT02115269|898871|P1|Overall Study|Didn't take study drug|2
270049|NCT02115269|898871|P1|Overall Study|Withdrawal by Subject|2
270050|NCT02115269|898871|P1|Overall Study|Moved to another city|7
270051|NCT02115269|898871|P1|Overall Study|Did not complete patient diary|3
270052|NCT02115269|898871|P1|Overall Study|Lost to Follow-up|43
270053|NCT02115256|898891|P2|Overall Study|Withdrawal by Subject|1
270054|NCT02115256|898892|P1|Overall Study|Withdrawal by Subject|0
270055|NCT02114931|898906|P2|Overall Study|Other|1
270056|NCT02114931|898907|P1|Overall Study|Other|2
270057|NCT02114931|898906|P2|Overall Study|Physician Decision|2
270058|NCT02114931|898907|P1|Overall Study|Physician Decision|1
270059|NCT02114931|898906|P2|Overall Study|Lost to Follow-up|3
270060|NCT02114931|898907|P1|Overall Study|Lost to Follow-up|3
270061|NCT02114931|898906|P2|Overall Study|Adverse Event|6
270062|NCT02114931|898907|P1|Overall Study|Adverse Event|4
270063|NCT02114931|898906|P2|Overall Study|Withdrawal by Subject|18
270064|NCT02114931|898907|P1|Overall Study|Withdrawal by Subject|15
270065|NCT02114892|898923|P2|Overall Study|Lost to Follow-up|2
270066|NCT02114892|898924|P1|Overall Study|Lost to Follow-up|1
270067|NCT02114268|898964|P6|Overall Study|Withdrawn by site due to noncompliance|0
270068|NCT02114268|898965|P5|Overall Study|Withdrawn by site due to noncompliance|0
270069|NCT02114268|898966|P4|Overall Study|Withdrawn by site due to noncompliance|0
270070|NCT02114268|898967|P3|Overall Study|Withdrawn by site due to noncompliance|0
270071|NCT02114268|898968|P2|Overall Study|Withdrawn by site due to noncompliance|0
270072|NCT02114268|898969|P1|Overall Study|Withdrawn by site due to noncompliance|1
270073|NCT02114268|898964|P6|Overall Study|Withdrawal by Subject|1
270074|NCT02114268|898965|P5|Overall Study|Withdrawal by Subject|0
270075|NCT02114268|898966|P4|Overall Study|Withdrawal by Subject|0
270076|NCT02114268|898967|P3|Overall Study|Withdrawal by Subject|0
270077|NCT02114268|898968|P2|Overall Study|Withdrawal by Subject|0
270078|NCT02114268|898969|P1|Overall Study|Withdrawal by Subject|1
270079|NCT02114268|898964|P6|Overall Study|Lost to Follow-up|2
270080|NCT02114268|898965|P5|Overall Study|Lost to Follow-up|0
270081|NCT02114268|898966|P4|Overall Study|Lost to Follow-up|0
270082|NCT02114268|898967|P3|Overall Study|Lost to Follow-up|1
270083|NCT02114268|898968|P2|Overall Study|Lost to Follow-up|1
270084|NCT02114268|898969|P1|Overall Study|Lost to Follow-up|4
270085|NCT02114203|899038|P3|Overall Study|Withdrawal by Subject|0
270086|NCT02114203|899039|P2|Overall Study|Withdrawal by Subject|1
270087|NCT02114203|899040|P1|Overall Study|Withdrawal by Subject|0
270088|NCT02114203|899038|P3|Overall Study|Adverse Event|0
270089|NCT02114203|899039|P2|Overall Study|Adverse Event|1
270090|NCT02114203|899040|P1|Overall Study|Adverse Event|0
270091|NCT02114177|899074|P2|Overall Study|Other|1
270092|NCT02114177|899075|P1|Overall Study|Other|2
270093|NCT02114177|899074|P2|Overall Study|Withdrawal by Subject|1
270094|NCT02114177|899075|P1|Overall Study|Withdrawal by Subject|6
270095|NCT02114177|899074|P2|Overall Study|Lost to Follow-up|2
270096|NCT02114177|899075|P1|Overall Study|Lost to Follow-up|1
270097|NCT02114151|899099|P1|Overall Study|Withdrawal by Subject|5
270098|NCT02114151|899099|P1|Overall Study|Lost to Follow-up|1
270099|NCT02114151|899099|P1|Overall Study|Death|1
270100|NCT02113579|899116|P2|Overall Study|Lost to Follow-up|2
270101|NCT02113579|899117|P1|Overall Study|Lost to Follow-up|6
270102|NCT02113579|899116|P2|Overall Study|Withdrawal by Subject|2
270103|NCT02113579|899117|P1|Overall Study|Withdrawal by Subject|3
270104|NCT02113579|899116|P2|Overall Study|Adverse Event|0
270105|NCT02113579|899117|P1|Overall Study|Adverse Event|1
270106|NCT02113449|899141|P1|Overall Study|Adverse Event|4
270107|NCT02113436|899157|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
270108|NCT02113436|899158|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
270109|NCT02113436|899159|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
270110|NCT02113436|899160|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
270111|NCT02113436|899157|P4|Period 2: 16 Weeks|Physician Decision|0
270112|NCT02113436|899158|P3|Period 2: 16 Weeks|Physician Decision|2
270113|NCT02113436|899159|P2|Period 2: 16 Weeks|Physician Decision|0
270114|NCT02113436|899160|P1|Period 2: 16 Weeks|Physician Decision|0
270115|NCT02113436|899157|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
270116|NCT02113436|899158|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
270117|NCT02113436|899159|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
270118|NCT02113436|899160|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
270119|NCT02113436|899157|P4|Period 2: 16 Weeks|Adverse Event|5
270120|NCT02113436|899158|P3|Period 2: 16 Weeks|Adverse Event|4
270121|NCT02113436|899159|P2|Period 2: 16 Weeks|Adverse Event|0
270122|NCT02113436|899160|P1|Period 2: 16 Weeks|Adverse Event|0
270123|NCT02113436|899157|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
270124|NCT02113436|899158|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
270125|NCT02113436|899159|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
270126|NCT02113436|899160|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
270127|NCT02113436|899157|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
270128|NCT02113436|899158|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
270129|NCT02113436|899159|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
270130|NCT02113436|899160|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
270131|NCT02113436|899157|P4|Period 1: 8 Weeks|Protocol Violation|0
270132|NCT02113436|899158|P3|Period 1: 8 Weeks|Protocol Violation|0
270133|NCT02113436|899159|P2|Period 1: 8 Weeks|Protocol Violation|0
270134|NCT02113436|899160|P1|Period 1: 8 Weeks|Protocol Violation|1
270135|NCT02113436|899157|P4|Period 1: 8 Weeks|Adverse Event|0
270136|NCT02113436|899158|P3|Period 1: 8 Weeks|Adverse Event|0
270137|NCT02113436|899159|P2|Period 1: 8 Weeks|Adverse Event|0
270138|NCT02113436|899160|P1|Period 1: 8 Weeks|Adverse Event|1
270139|NCT02113124|899183|P2|Overall Study|Unable to retrieve blood sample|1
270140|NCT02113124|899184|P1|Overall Study|Unable to retrieve blood sample|1
270141|NCT02113007|899190|P1|Overall Study|Progressive disease|2
270142|NCT02112448|899198|P2|Overall Study|required heparin so could not use ketoro|0
270143|NCT02112448|899199|P1|Overall Study|required heparin so could not use ketoro|1
270144|NCT02112448|899198|P2|Overall Study|Physician Decision|6
270145|NCT02112448|899199|P1|Overall Study|Physician Decision|4
270146|NCT02112448|899198|P2|Overall Study|Protocol Violation|2
270147|NCT02112448|899199|P1|Overall Study|Protocol Violation|1
270148|NCT02112448|899198|P2|Overall Study|lab values precluding use of ketorolac|2
270149|NCT02112448|899199|P1|Overall Study|lab values precluding use of ketorolac|2
270150|NCT02111603|899247|P1|Overall Study|Withdrawal by Subject|1
270151|NCT02111369|899256|P1|Overall Study|Withdrawal by Subject|1
270152|NCT02111369|899256|P1|Overall Study|Lost to Follow-up|2
270153|NCT02111096|899302|P3|Overall Study|Withdrawal by Subject|8
270154|NCT02111096|899303|P2|Overall Study|Withdrawal by Subject|2
270155|NCT02111096|899304|P1|Overall Study|Withdrawal by Subject|4
270156|NCT02111096|899302|P3|Overall Study|Terminated by Sponsor|54
270157|NCT02111096|899303|P2|Overall Study|Terminated by Sponsor|35
270158|NCT02111096|899304|P1|Overall Study|Terminated by Sponsor|53
270159|NCT02111096|899302|P3|Overall Study|Protocol Violation|1
270160|NCT02111096|899303|P2|Overall Study|Protocol Violation|0
270161|NCT02111096|899304|P1|Overall Study|Protocol Violation|1
270162|NCT02111096|899302|P3|Overall Study|Physician Decision|0
270163|NCT02111096|899303|P2|Overall Study|Physician Decision|1
270164|NCT02111096|899304|P1|Overall Study|Physician Decision|0
270165|NCT02111096|899302|P3|Overall Study|Lost to Follow Up|1
270166|NCT02111096|899303|P2|Overall Study|Lost to Follow Up|1
270167|NCT02111096|899304|P1|Overall Study|Lost to Follow Up|1
270168|NCT02111096|899302|P3|Overall Study|Non-Compliance with Study Drug|0
270169|NCT02111096|899303|P2|Overall Study|Non-Compliance with Study Drug|1
270170|NCT02111096|899304|P1|Overall Study|Non-Compliance with Study Drug|1
270171|NCT02111096|899302|P3|Overall Study|Adverse Event|2
270172|NCT02111096|899303|P2|Overall Study|Adverse Event|1
270173|NCT02111096|899304|P1|Overall Study|Adverse Event|4
270174|NCT02111083|899352|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
270175|NCT02111083|899353|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
270176|NCT02110693|899371|P2|Overall Study|Other|0
270177|NCT02110693|899372|P1|Overall Study|Other|1
270178|NCT02110693|899371|P2|Overall Study|technical difficulties|4
270179|NCT02110693|899372|P1|Overall Study|technical difficulties|6
270180|NCT02110693|899371|P2|Overall Study|skipped assessment|18
270181|NCT02110693|899372|P1|Overall Study|skipped assessment|15
270182|NCT02110693|899371|P2|Overall Study|Withdrawal by Subject|7
270183|NCT02110693|899372|P1|Overall Study|Withdrawal by Subject|6
270184|NCT02110238|899418|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
270185|NCT02110238|899419|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
270186|NCT02110238|899418|P2|14 Week Blinded Extension Phase|Protocol Violation|3
270187|NCT02110238|899419|P1|14 Week Blinded Extension Phase|Protocol Violation|2
270188|NCT02110238|899418|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
270189|NCT02110238|899419|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
270190|NCT02110238|899418|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
270191|NCT02110238|899419|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
270192|NCT02110238|899418|P2|14 Week Blinded Extension Phase|Adverse Event|1
270193|NCT02110238|899419|P1|14 Week Blinded Extension Phase|Adverse Event|1
270194|NCT02110238|899418|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
270195|NCT02110238|899419|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
270196|NCT02110238|899418|P2|12 Week Pivotal Phase|Protocol Violation|1
270197|NCT02110238|899419|P1|12 Week Pivotal Phase|Protocol Violation|0
270198|NCT02110238|899418|P2|12 Week Pivotal Phase|Physician Decision|2
270199|NCT02110238|899419|P1|12 Week Pivotal Phase|Physician Decision|0
270200|NCT02110238|899418|P2|12 Week Pivotal Phase|Lost to Follow-up|0
270201|NCT02110238|899419|P1|12 Week Pivotal Phase|Lost to Follow-up|2
270202|NCT02110238|899418|P2|12 Week Pivotal Phase|Lack of Efficacy|3
270203|NCT02110238|899419|P1|12 Week Pivotal Phase|Lack of Efficacy|2
270204|NCT02110238|899418|P2|12 Week Pivotal Phase|Adverse Event|0
270205|NCT02110238|899419|P1|12 Week Pivotal Phase|Adverse Event|3
270206|NCT02109484|899461|P8|Overall Study|Moved away from study area|1
270207|NCT02109484|899462|P7|Overall Study|Moved away from study area|1
270208|NCT02109484|899463|P6|Overall Study|Moved away from study area|0
270209|NCT02109484|899464|P5|Overall Study|Moved away from study area|0
270210|NCT02109484|899465|P4|Overall Study|Moved away from study area|0
270211|NCT02109484|899466|P3|Overall Study|Moved away from study area|0
270212|NCT02109484|899467|P2|Overall Study|Moved away from study area|0
270213|NCT02109484|899468|P1|Overall Study|Moved away from study area|0
270214|NCT02109484|899461|P8|Overall Study|Death|2
270215|NCT02109484|899462|P7|Overall Study|Death|0
270216|NCT02109484|899463|P6|Overall Study|Death|0
270217|NCT02109484|899464|P5|Overall Study|Death|0
270218|NCT02109484|899465|P4|Overall Study|Death|0
270219|NCT02109484|899466|P3|Overall Study|Death|0
270220|NCT02109484|899467|P2|Overall Study|Death|0
270221|NCT02109484|899468|P1|Overall Study|Death|0
270222|NCT02109484|899461|P8|Overall Study|Physician Decision|0
270223|NCT02109484|899462|P7|Overall Study|Physician Decision|0
270224|NCT02109484|899463|P6|Overall Study|Physician Decision|0
270225|NCT02109484|899464|P5|Overall Study|Physician Decision|2
270226|NCT02109484|899465|P4|Overall Study|Physician Decision|0
270227|NCT02109484|899466|P3|Overall Study|Physician Decision|0
270228|NCT02109484|899467|P2|Overall Study|Physician Decision|0
270229|NCT02109484|899468|P1|Overall Study|Physician Decision|0
270230|NCT02109484|899461|P8|Overall Study|Withdrawal by Subject|0
270231|NCT02109484|899462|P7|Overall Study|Withdrawal by Subject|1
270232|NCT02109484|899463|P6|Overall Study|Withdrawal by Subject|1
270233|NCT02109484|899464|P5|Overall Study|Withdrawal by Subject|1
270234|NCT02109484|899465|P4|Overall Study|Withdrawal by Subject|0
270235|NCT02109484|899466|P3|Overall Study|Withdrawal by Subject|0
270236|NCT02109484|899467|P2|Overall Study|Withdrawal by Subject|0
270237|NCT02109484|899468|P1|Overall Study|Withdrawal by Subject|0
270238|NCT02109484|899461|P8|Overall Study|Lost to Follow-up|0
270239|NCT02109484|899462|P7|Overall Study|Lost to Follow-up|1
270240|NCT02109484|899463|P6|Overall Study|Lost to Follow-up|0
270241|NCT02109484|899464|P5|Overall Study|Lost to Follow-up|1
270242|NCT02109484|899465|P4|Overall Study|Lost to Follow-up|1
270243|NCT02109484|899466|P3|Overall Study|Lost to Follow-up|0
270244|NCT02109484|899467|P2|Overall Study|Lost to Follow-up|0
270245|NCT02109484|899468|P1|Overall Study|Lost to Follow-up|0
270246|NCT02109445|899524|P1|Overall Study|Adverse Event|1
270247|NCT02109445|899524|P1|Overall Study|Symptomatic deterioration|2
270248|NCT02109172|899557|P6|Overall Study|Death|0
270249|NCT02109172|899558|P5|Overall Study|Death|1
270250|NCT02109172|899559|P4|Overall Study|Death|0
270251|NCT02109172|899560|P3|Overall Study|Death|0
270252|NCT02109172|899561|P2|Overall Study|Death|0
270253|NCT02109172|899562|P1|Overall Study|Death|0
270254|NCT02109172|899557|P6|Overall Study|Adverse Event|1
270255|NCT02109172|899558|P5|Overall Study|Adverse Event|0
270256|NCT02109172|899559|P4|Overall Study|Adverse Event|0
270257|NCT02109172|899560|P3|Overall Study|Adverse Event|1
270258|NCT02109172|899561|P2|Overall Study|Adverse Event|0
270259|NCT02109172|899562|P1|Overall Study|Adverse Event|0
270260|NCT02109172|899557|P6|Overall Study|Withdrawal by Subject|0
270261|NCT02109172|899558|P5|Overall Study|Withdrawal by Subject|0
270262|NCT02109172|899559|P4|Overall Study|Withdrawal by Subject|1
270263|NCT02109172|899560|P3|Overall Study|Withdrawal by Subject|0
270264|NCT02109172|899561|P2|Overall Study|Withdrawal by Subject|0
270265|NCT02109172|899562|P1|Overall Study|Withdrawal by Subject|1
270266|NCT02109133|899583|P2|Overall Study|Lost to Follow-up|0
270267|NCT02109133|899584|P1|Overall Study|Lost to Follow-up|1
270268|NCT02109107|899596|P1|Overall Study|Lost to Follow-up|2
270269|NCT02108951|899618|P1|Overall Study|Study Terminated by Sponsor|14
270270|NCT02108951|899618|P1|Overall Study|Patient's/guardian's decision|1
270271|NCT02108951|899618|P1|Overall Study|Lost to Follow-up|1
270272|NCT02108652|899656|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
270273|NCT02108652|899656|P1|Overall Study|Withdrawal by Subject|8
270274|NCT02108652|899656|P1|Overall Study|Lost to Follow-up|2
270275|NCT02108652|899656|P1|Overall Study|Death|226
270276|NCT02107898|899825|P2|Overall Study|Randomized but not treated|1
270277|NCT02107898|899826|P1|Overall Study|Randomized but not treated|0
270278|NCT02107898|899825|P2|Overall Study|Consent withdrawn by participant|1
270279|NCT02107898|899826|P1|Overall Study|Consent withdrawn by participant|2
270280|NCT02107898|899825|P2|Overall Study|Participant moved|2
270281|NCT02107898|899826|P1|Overall Study|Participant moved|0
270282|NCT02107898|899825|P2|Overall Study|Poor compliance to protocol|1
270283|NCT02107898|899826|P1|Overall Study|Poor compliance to protocol|0
270284|NCT02107898|899825|P2|Overall Study|Adverse Event|7
270285|NCT02107898|899826|P1|Overall Study|Adverse Event|4
270286|NCT02107703|899880|P2|Overall Study|On study treatment/follow up|152
270287|NCT02107703|899881|P1|Overall Study|On study treatment/follow up|319
270288|NCT02107703|899880|P2|Overall Study|Lost to Follow-up|4
270289|NCT02107703|899881|P1|Overall Study|Lost to Follow-up|6
270290|NCT02107703|899880|P2|Overall Study|Withdrawal by Subject|19
270291|NCT02107703|899881|P1|Overall Study|Withdrawal by Subject|36
270292|NCT02107482|899913|P1|Overall Study|Lack of Efficacy|1
270293|NCT02107482|899913|P1|Overall Study|Lost to Follow-up|1
270294|NCT02107482|899913|P1|Overall Study|inconveinence|2
270295|NCT02107313|899950|P2|Overall Study|One participant did not do the FED cohor|1
270296|NCT02107313|899951|P1|Overall Study|One participant did not do the FED cohor|0
270297|NCT02107274|899961|P2|Control Phase|Adverse Event|1
270298|NCT02107274|899962|P1|Control Phase|Adverse Event|0
270299|NCT02107274|899961|P2|Control Phase|Death|0
270300|NCT02107274|899962|P1|Control Phase|Death|2
270301|NCT02107274|899961|P2|Control Phase|Lost to Follow-up|1
270302|NCT02107274|899962|P1|Control Phase|Lost to Follow-up|1
270303|NCT02107274|899961|P2|Treatment vs. Placebo|Lost to Follow-up|2
270304|NCT02107274|899962|P1|Treatment vs. Placebo|Lost to Follow-up|0
270305|NCT02107274|899961|P2|Treatment vs. Placebo|Adverse Event|0
270306|NCT02107274|899962|P1|Treatment vs. Placebo|Adverse Event|3
270307|NCT02107196|899976|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
270308|NCT02107196|899977|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
270309|NCT02107196|899976|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
270310|NCT02107196|899977|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
270311|NCT02107196|899976|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
270312|NCT02107196|899977|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
270313|NCT02107196|899976|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
270314|NCT02107196|899977|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
270315|NCT02107196|899976|P2|12-week Treatment Period|Reason Missing|8
270316|NCT02107196|899977|P1|12-week Treatment Period|Reason Missing|11
270317|NCT02107196|899976|P2|12-week Treatment Period|Protocol Violation|8
270318|NCT02107196|899977|P1|12-week Treatment Period|Protocol Violation|7
270319|NCT02107196|899976|P2|12-week Treatment Period|Withdrawal by Subject|12
270320|NCT02107196|899977|P1|12-week Treatment Period|Withdrawal by Subject|15
270321|NCT02107196|899976|P2|12-week Treatment Period|Physician Decision|1
270322|NCT02107196|899977|P1|12-week Treatment Period|Physician Decision|0
270323|NCT02107196|899976|P2|12-week Treatment Period|Lost to Follow-up|6
270324|NCT02107196|899977|P1|12-week Treatment Period|Lost to Follow-up|3
270325|NCT02107196|899976|P2|12-week Treatment Period|Lack of Efficacy|1
270326|NCT02107196|899977|P1|12-week Treatment Period|Lack of Efficacy|2
270327|NCT02107196|899976|P2|12-week Treatment Period|Adverse Event|3
270328|NCT02107196|899977|P1|12-week Treatment Period|Adverse Event|6
270329|NCT02107014|899990|P1|Overall Study|Withdrew before drug: moving interstate|1
270330|NCT02106923|900072|P6|Overall Study|Protocol Violation|1
270331|NCT02106923|900073|P5|Overall Study|Protocol Violation|0
270332|NCT02106923|900074|P4|Overall Study|Protocol Violation|0
270333|NCT02106923|900075|P3|Overall Study|Protocol Violation|0
270334|NCT02106923|900076|P2|Overall Study|Protocol Violation|0
270335|NCT02106923|900077|P1|Overall Study|Protocol Violation|0
270336|NCT02106832|900125|P4|Overall Study|Technical problems|0
270337|NCT02106832|900126|P3|Overall Study|Technical problems|0
270338|NCT02106832|900127|P2|Overall Study|Technical problems|1
270339|NCT02106832|900128|P1|Overall Study|Technical problems|0
270340|NCT02106832|900125|P4|Overall Study|Withdrawal by Subject|7
270341|NCT02106832|900126|P3|Overall Study|Withdrawal by Subject|10
270342|NCT02106832|900127|P2|Overall Study|Withdrawal by Subject|17
270343|NCT02106832|900128|P1|Overall Study|Withdrawal by Subject|17
270344|NCT02106832|900125|P4|Overall Study|Protocol Violation|1
270345|NCT02106832|900126|P3|Overall Study|Protocol Violation|0
270346|NCT02106832|900127|P2|Overall Study|Protocol Violation|0
270347|NCT02106832|900128|P1|Overall Study|Protocol Violation|0
270348|NCT02106832|900125|P4|Overall Study|Physician Decision|0
270349|NCT02106832|900126|P3|Overall Study|Physician Decision|0
270350|NCT02106832|900127|P2|Overall Study|Physician Decision|0
270351|NCT02106832|900128|P1|Overall Study|Physician Decision|1
270352|NCT02106832|900125|P4|Overall Study|Lost to Follow-up|3
270353|NCT02106832|900126|P3|Overall Study|Lost to Follow-up|1
270354|NCT02106832|900127|P2|Overall Study|Lost to Follow-up|1
270355|NCT02106832|900128|P1|Overall Study|Lost to Follow-up|0
270356|NCT02106832|900125|P4|Overall Study|Deterioration of general conditions|0
270357|NCT02106832|900126|P3|Overall Study|Deterioration of general conditions|1
270358|NCT02106832|900127|P2|Overall Study|Deterioration of general conditions|0
270359|NCT02106832|900128|P1|Overall Study|Deterioration of general conditions|0
270360|NCT02106832|900125|P4|Overall Study|Death|4
270361|NCT02106832|900126|P3|Overall Study|Death|1
270362|NCT02106832|900127|P2|Overall Study|Death|4
270363|NCT02106832|900128|P1|Overall Study|Death|4
270364|NCT02106832|900125|P4|Overall Study|Adverse Event|0
270365|NCT02106832|900126|P3|Overall Study|Adverse Event|3
270366|NCT02106832|900127|P2|Overall Study|Adverse Event|2
270367|NCT02106832|900128|P1|Overall Study|Adverse Event|1
270368|NCT02106403|900195|P6|Follow-Up Visit 3|Other Reason|1
270369|NCT02106403|900196|P5|Follow-Up Visit 3|Other Reason|0
270370|NCT02106403|900197|P4|Follow-Up Visit 3|Other Reason|0
270371|NCT02106403|900198|P3|Follow-Up Visit 3|Other Reason|0
270372|NCT02106403|900199|P2|Follow-Up Visit 3|Other Reason|0
270373|NCT02106403|900200|P1|Follow-Up Visit 3|Other Reason|0
270374|NCT02106156|900223|P3|Overall Study|Relocation/Change of Physician|0
270375|NCT02106156|900224|P2|Overall Study|Relocation/Change of Physician|1
270376|NCT02106156|900225|P1|Overall Study|Relocation/Change of Physician|40
270377|NCT02106156|900223|P3|Overall Study|Hospitalization/Surgical Intervention|0
270378|NCT02106156|900224|P2|Overall Study|Hospitalization/Surgical Intervention|0
270379|NCT02106156|900225|P1|Overall Study|Hospitalization/Surgical Intervention|6
270380|NCT02106156|900223|P3|Overall Study|Change of Laboratory Parameter|0
270381|NCT02106156|900224|P2|Overall Study|Change of Laboratory Parameter|0
270382|NCT02106156|900225|P1|Overall Study|Change of Laboratory Parameter|10
270383|NCT02106156|900223|P3|Overall Study|Unplanned Event|0
270384|NCT02106156|900224|P2|Overall Study|Unplanned Event|2
270385|NCT02106156|900225|P1|Overall Study|Unplanned Event|82
270386|NCT02106156|900223|P3|Overall Study|Lost to Follow-up|0
270387|NCT02106156|900224|P2|Overall Study|Lost to Follow-up|8
270388|NCT02106156|900225|P1|Overall Study|Lost to Follow-up|451
270389|NCT02106156|900223|P3|Overall Study|Patients Request|0
270390|NCT02106156|900224|P2|Overall Study|Patients Request|9
270391|NCT02106156|900225|P1|Overall Study|Patients Request|307
270392|NCT02106156|900223|P3|Overall Study|Lack of Compliance|0
270393|NCT02106156|900224|P2|Overall Study|Lack of Compliance|7
270394|NCT02106156|900225|P1|Overall Study|Lack of Compliance|211
270395|NCT02106156|900223|P3|Overall Study|Concomitant Disease|0
270396|NCT02106156|900224|P2|Overall Study|Concomitant Disease|2
270397|NCT02106156|900225|P1|Overall Study|Concomitant Disease|74
270398|NCT02106156|900223|P3|Overall Study|Lack of Virological Response|0
270399|NCT02106156|900224|P2|Overall Study|Lack of Virological Response|8
270400|NCT02106156|900225|P1|Overall Study|Lack of Virological Response|1044
270401|NCT02106156|900223|P3|Overall Study|Lack of Tolerability|0
270402|NCT02106156|900224|P2|Overall Study|Lack of Tolerability|3
270403|NCT02106156|900225|P1|Overall Study|Lack of Tolerability|305
270404|NCT02106156|900223|P3|Overall Study|Patient Died|0
270405|NCT02106156|900224|P2|Overall Study|Patient Died|0
270406|NCT02106156|900225|P1|Overall Study|Patient Died|19
270407|NCT02105987|900249|P6|Continuation Phase|Protocol Violation|0
270408|NCT02105987|900250|P5|Continuation Phase|Protocol Violation|1
270409|NCT02105987|900251|P4|Continuation Phase|Protocol Violation|0
270410|NCT02105987|900252|P3|Continuation Phase|Protocol Violation|0
270411|NCT02105987|900253|P2|Continuation Phase|Protocol Violation|0
270412|NCT02105987|900254|P1|Continuation Phase|Protocol Violation|0
270413|NCT02105987|900249|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
270414|NCT02105987|900250|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
270415|NCT02105987|900251|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
270416|NCT02105987|900252|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
270417|NCT02105987|900253|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
270418|NCT02105987|900254|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
270419|NCT02105987|900249|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
270420|NCT02105987|900250|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
270421|NCT02105987|900251|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
270422|NCT02105987|900252|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
270423|NCT02105987|900253|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
270424|NCT02105987|900254|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
270425|NCT02105987|900249|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
270426|NCT02105987|900250|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
270427|NCT02105987|900251|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
270428|NCT02105987|900252|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
270429|NCT02105987|900253|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
270430|NCT02105987|900254|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
270431|NCT02105987|900249|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
270432|NCT02105987|900250|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
270433|NCT02105987|900251|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
270434|NCT02105987|900252|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
270435|NCT02105987|900253|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
270436|NCT02105987|900254|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
270437|NCT02105987|900249|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
270438|NCT02105987|900250|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
270439|NCT02105987|900251|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
270440|NCT02105987|900252|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
270441|NCT02105987|900253|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
270442|NCT02105987|900254|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
270443|NCT02105987|900249|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
270444|NCT02105987|900250|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
270445|NCT02105987|900251|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
270446|NCT02105987|900252|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
270447|NCT02105987|900253|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
270448|NCT02105987|900254|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
270449|NCT02105987|900249|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
270450|NCT02105987|900250|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
270451|NCT02105987|900251|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
270452|NCT02105987|900252|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
270453|NCT02105987|900253|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
270454|NCT02105987|900254|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
270455|NCT02105987|900249|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
270456|NCT02105987|900250|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
270457|NCT02105987|900251|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
270458|NCT02105987|900252|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
270459|NCT02105987|900253|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
270460|NCT02105987|900254|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
270461|NCT02105987|900249|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
270462|NCT02105987|900250|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
270463|NCT02105987|900251|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
270464|NCT02105987|900252|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
270465|NCT02105987|900253|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
270466|NCT02105987|900254|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
270467|NCT02105987|900249|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
270468|NCT02105987|900250|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
270469|NCT02105987|900251|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
270470|NCT02105987|900252|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
270471|NCT02105987|900253|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
270472|NCT02105987|900254|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
270473|NCT02105987|900249|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
270474|NCT02105987|900250|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
270475|NCT02105987|900251|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
270476|NCT02105987|900252|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
270477|NCT02105987|900253|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
270478|NCT02105987|900254|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
270479|NCT02105987|900249|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
270480|NCT02105987|900250|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
270481|NCT02105987|900251|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
270482|NCT02105987|900252|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
270483|NCT02105987|900253|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
270484|NCT02105987|900254|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
270485|NCT02105987|900249|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
270486|NCT02105987|900250|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
270487|NCT02105987|900251|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
270488|NCT02105987|900252|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
270489|NCT02105987|900253|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
270490|NCT02105987|900254|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
270491|NCT02105974|900308|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
270492|NCT02105974|900309|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
270493|NCT02105974|900310|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
270494|NCT02105974|900308|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
270495|NCT02105974|900309|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
270496|NCT02105974|900310|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
270497|NCT02105974|900308|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
270498|NCT02105974|900309|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
270499|NCT02105974|900310|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
270500|NCT02105974|900308|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
270501|NCT02105974|900309|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
270502|NCT02105974|900310|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
270503|NCT02105974|900308|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
270504|NCT02105974|900309|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
270505|NCT02105974|900310|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
270506|NCT02105974|900308|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
270507|NCT02105974|900309|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
270508|NCT02105974|900310|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
270509|NCT02105974|900308|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
270510|NCT02105974|900309|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
270511|NCT02105974|900310|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
270512|NCT02105974|900308|P3|2 Week Run-in Period|Investigator discretion|0
270513|NCT02105974|900309|P2|2 Week Run-in Period|Investigator discretion|0
270514|NCT02105974|900310|P1|2 Week Run-in Period|Investigator discretion|8
270515|NCT02105974|900308|P3|2 Week Run-in Period|Withdrew consent|0
270516|NCT02105974|900309|P2|2 Week Run-in Period|Withdrew consent|0
270517|NCT02105974|900310|P1|2 Week Run-in Period|Withdrew consent|23
270518|NCT02105974|900308|P3|2 Week Run-in Period|Lost to Follow-up|0
270519|NCT02105974|900309|P2|2 Week Run-in Period|Lost to Follow-up|0
270520|NCT02105974|900310|P1|2 Week Run-in Period|Lost to Follow-up|2
270521|NCT02105974|900308|P3|2 Week Run-in Period|Study closed/terminated|0
270522|NCT02105974|900309|P2|2 Week Run-in Period|Study closed/terminated|0
270523|NCT02105974|900310|P1|2 Week Run-in Period|Study closed/terminated|1
270524|NCT02105974|900308|P3|2 Week Run-in Period|Adverse Event|0
270525|NCT02105974|900309|P2|2 Week Run-in Period|Adverse Event|0
270526|NCT02105974|900310|P1|2 Week Run-in Period|Adverse Event|6
270527|NCT02105974|900308|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
270528|NCT02105974|900309|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
270529|NCT02105974|900310|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
270530|NCT02105974|900308|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
270531|NCT02105974|900309|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
270532|NCT02105974|900310|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
270533|NCT02105961|900323|P3|Overall Study|Withdrawal by Subject|11
270534|NCT02105961|900324|P2|Overall Study|Withdrawal by Subject|7
270535|NCT02105961|900325|P1|Overall Study|Withdrawal by Subject|15
270536|NCT02105961|900323|P3|Overall Study|Physician Decision|2
270537|NCT02105961|900324|P2|Overall Study|Physician Decision|3
270538|NCT02105961|900325|P1|Overall Study|Physician Decision|3
270539|NCT02105961|900323|P3|Overall Study|Lost to Follow-up|1
270540|NCT02105961|900324|P2|Overall Study|Lost to Follow-up|0
270541|NCT02105961|900325|P1|Overall Study|Lost to Follow-up|2
270542|NCT02105961|900323|P3|Overall Study|Lack of Efficacy|3
270543|NCT02105961|900324|P2|Overall Study|Lack of Efficacy|0
270544|NCT02105961|900325|P1|Overall Study|Lack of Efficacy|3
270545|NCT02105961|900323|P3|Overall Study|Adverse Event|13
270546|NCT02105961|900324|P2|Overall Study|Adverse Event|7
270547|NCT02105961|900325|P1|Overall Study|Adverse Event|18
270548|NCT02105948|900349|P4|Overall Study|Withdrawal by Subject|11
270549|NCT02105948|900350|P3|Overall Study|Withdrawal by Subject|10
270550|NCT02105948|900351|P2|Overall Study|Withdrawal by Subject|10
270551|NCT02105948|900352|P1|Overall Study|Withdrawal by Subject|15
270552|NCT02105948|900349|P4|Overall Study|Physician Decision|2
270553|NCT02105948|900350|P3|Overall Study|Physician Decision|2
270554|NCT02105948|900351|P2|Overall Study|Physician Decision|2
270555|NCT02105948|900352|P1|Overall Study|Physician Decision|2
270556|NCT02105948|900349|P4|Overall Study|Lost to Follow-up|1
270557|NCT02105948|900350|P3|Overall Study|Lost to Follow-up|2
270558|NCT02105948|900351|P2|Overall Study|Lost to Follow-up|0
270559|NCT02105948|900352|P1|Overall Study|Lost to Follow-up|0
270560|NCT02105948|900349|P4|Overall Study|Lack of Efficacy|2
270561|NCT02105948|900350|P3|Overall Study|Lack of Efficacy|3
270562|NCT02105948|900351|P2|Overall Study|Lack of Efficacy|1
270563|NCT02105948|900352|P1|Overall Study|Lack of Efficacy|0
270564|NCT02105948|900349|P4|Overall Study|Adverse Event|11
270565|NCT02105948|900350|P3|Overall Study|Adverse Event|11
270566|NCT02105948|900351|P2|Overall Study|Adverse Event|7
270567|NCT02105948|900352|P1|Overall Study|Adverse Event|10
270568|NCT02105701|900393|P4|Overall Study|Death|0
270569|NCT02105701|900394|P3|Overall Study|Death|0
270570|NCT02105701|900395|P2|Overall Study|Death|0
270571|NCT02105701|900396|P1|Overall Study|Death|1
270572|NCT02105701|900393|P4|Overall Study|Withdrawal by Subject|1
270573|NCT02105701|900394|P3|Overall Study|Withdrawal by Subject|0
270574|NCT02105701|900395|P2|Overall Study|Withdrawal by Subject|1
270575|NCT02105701|900396|P1|Overall Study|Withdrawal by Subject|2
270576|NCT02105701|900393|P4|Overall Study|Protocol Violation|0
270577|NCT02105701|900394|P3|Overall Study|Protocol Violation|1
270578|NCT02105701|900395|P2|Overall Study|Protocol Violation|0
270579|NCT02105701|900396|P1|Overall Study|Protocol Violation|0
270580|NCT02105701|900393|P4|Overall Study|Lost to Follow-up|1
270581|NCT02105701|900394|P3|Overall Study|Lost to Follow-up|2
270582|NCT02105701|900395|P2|Overall Study|Lost to Follow-up|0
270583|NCT02105701|900396|P1|Overall Study|Lost to Follow-up|1
270584|NCT02105688|900420|P2|Overall Study|Withdrawal by Subject|2
270585|NCT02105688|900421|P1|Overall Study|Withdrawal by Subject|4
270586|NCT02105688|900420|P2|Overall Study|Protocol Violation|1
270587|NCT02105688|900421|P1|Overall Study|Protocol Violation|0
270588|NCT02105688|900420|P2|Overall Study|Physician Decision|1
270589|NCT02105688|900421|P1|Overall Study|Physician Decision|0
270590|NCT02105688|900420|P2|Overall Study|Lost to Follow-up|4
270591|NCT02105688|900421|P1|Overall Study|Lost to Follow-up|9
270592|NCT02105688|900420|P2|Overall Study|Adverse Event|1
270593|NCT02105688|900421|P1|Overall Study|Adverse Event|1
270594|NCT02105688|900420|P2|Overall Study|Ongoing|90
270595|NCT02105688|900421|P1|Overall Study|Ongoing|12
270596|NCT02105662|900431|P1|Overall Study|Withdrawal by Subject|1
270597|NCT02105662|900431|P1|Overall Study|Lost to Follow-up|5
270598|NCT02105636|900440|P2|Overall Study|Not Reported|0
270599|NCT02105636|900441|P1|Overall Study|Not Reported|3
270600|NCT02105636|900440|P2|Overall Study|Reason Not Specified|2
270601|NCT02105636|900441|P1|Overall Study|Reason Not Specified|0
270602|NCT02105636|900440|P2|Overall Study|Poor/Non-compliance|1
270603|NCT02105636|900441|P1|Overall Study|Poor/Non-compliance|0
270604|NCT02105636|900440|P2|Overall Study|Maximum Clinical Benefit|1
270605|NCT02105636|900441|P1|Overall Study|Maximum Clinical Benefit|1
270606|NCT02105636|900440|P2|Overall Study|Subject Withdrew Consent|1
270607|NCT02105636|900441|P1|Overall Study|Subject Withdrew Consent|4
270608|NCT02105636|900440|P2|Overall Study|Subject Request to Discontinue Treatment|6
270609|NCT02105636|900441|P1|Overall Study|Subject Request to Discontinue Treatment|4
270610|NCT02105636|900440|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
270611|NCT02105636|900441|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
270612|NCT02105636|900440|P2|Overall Study|Study Drug Toxicity|11
270613|NCT02105636|900441|P1|Overall Study|Study Drug Toxicity|9
270614|NCT02105636|900440|P2|Overall Study|Disease Progression|83
270615|NCT02105636|900441|P1|Overall Study|Disease Progression|162
270616|NCT02105467|900453|P2|Period 3|Lost to Follow-up|1
270617|NCT02105467|900454|P1|Period 3|Lost to Follow-up|0
270618|NCT02105467|900453|P2|Period 2|Withdrawal by Subject|2
270619|NCT02105467|900454|P1|Period 2|Withdrawal by Subject|0
270620|NCT02105467|900453|P2|Period 2|Death|0
270621|NCT02105467|900454|P1|Period 2|Death|1
270622|NCT02105467|900453|P2|Period 2|Lost to Follow-up|0
270623|NCT02105467|900454|P1|Period 2|Lost to Follow-up|1
270624|NCT02105467|900453|P2|Period 1|Death|0
270625|NCT02105467|900454|P1|Period 1|Death|1
270626|NCT02105467|900453|P2|Period 1|Lost to Follow-up|0
270627|NCT02105467|900454|P1|Period 1|Lost to Follow-up|1
270628|NCT02105454|900466|P1|Overall Study|Withdrawal by Subject|1
270629|NCT02105285|900553|P3|Overall Study|Withdrawal by Subject|0
270630|NCT02105285|900554|P2|Overall Study|Withdrawal by Subject|0
270631|NCT02105285|900555|P1|Overall Study|Withdrawal by Subject|1
270632|NCT02105285|900553|P3|Overall Study|Protocol Violation|0
270633|NCT02105285|900554|P2|Overall Study|Protocol Violation|1
270634|NCT02105285|900555|P1|Overall Study|Protocol Violation|0
270635|NCT02105285|900553|P3|Overall Study|Adverse Event|0
270636|NCT02105285|900554|P2|Overall Study|Adverse Event|1
270637|NCT02105285|900555|P1|Overall Study|Adverse Event|1
270638|NCT02105272|900574|P2|Overall Study|Withdrawal by Subject|0
270639|NCT02105272|900575|P1|Overall Study|Withdrawal by Subject|2
270640|NCT02105272|900574|P2|Overall Study|Protocol Violation|0
270641|NCT02105272|900575|P1|Overall Study|Protocol Violation|2
270642|NCT02105272|900574|P2|Overall Study|Physician Decision|1
270643|NCT02105272|900575|P1|Overall Study|Physician Decision|0
270644|NCT02105272|900574|P2|Overall Study|Adverse Event|2
270645|NCT02105272|900575|P1|Overall Study|Adverse Event|1
270646|NCT02105012|900591|P1|Overall Study|Lack of Efficacy|1
270647|NCT02105012|900591|P1|Overall Study|Adverse Event|1
270648|NCT02105012|900591|P1|Overall Study|Physician Decision|3
270649|NCT02105012|900591|P1|Overall Study|Protocol Violation|4
270650|NCT02105012|900591|P1|Overall Study|Lost to Follow-up|4
270651|NCT02105012|900591|P1|Overall Study|Protocol Specified Criteria|9
270652|NCT02105012|900591|P1|Overall Study|Withdrawal by Subject|11
270653|NCT02104947|900625|P2|Overall Study|Other than stated above|3
270654|NCT02104947|900626|P1|Overall Study|Other than stated above|2
270655|NCT02104947|900625|P2|Overall Study|Adverse Event|38
270656|NCT02104947|900626|P1|Overall Study|Adverse Event|57
270657|NCT02104947|900625|P2|Overall Study|Protocol Violation|8
270658|NCT02104947|900626|P1|Overall Study|Protocol Violation|6
270659|NCT02104947|900625|P2|Overall Study|Lost to Follow-up|4
270660|NCT02104947|900626|P1|Overall Study|Lost to Follow-up|4
270661|NCT02104947|900625|P2|Overall Study|Withdrawal by Subject|3
270662|NCT02104947|900626|P1|Overall Study|Withdrawal by Subject|10
270663|NCT02104895|900644|P2|Overall Study|Withdrawal by Subject|14
270664|NCT02104895|900645|P1|Overall Study|Withdrawal by Subject|0
270665|NCT02104804|900685|P2|Overall Study|Withdrawal by Subject|12
270666|NCT02104804|900686|P1|Overall Study|Withdrawal by Subject|4
270667|NCT02104804|900685|P2|Overall Study|Adverse Event|3
270668|NCT02104804|900686|P1|Overall Study|Adverse Event|4
270669|NCT02104804|900685|P2|Overall Study|Protocol Violation|1
270670|NCT02104804|900686|P1|Overall Study|Protocol Violation|0
270671|NCT02104804|900685|P2|Overall Study|Other listed|1
270672|NCT02104804|900686|P1|Overall Study|Other listed|2
270673|NCT02104804|900685|P2|Overall Study|Study specific discontinuation criteria|1
270674|NCT02104804|900686|P1|Overall Study|Study specific discontinuation criteria|6
270675|NCT02104804|900685|P2|Overall Study|Did not take study medication|1
270676|NCT02104804|900686|P1|Overall Study|Did not take study medication|0
270677|NCT02104505|900704|P2|Second Intervention (14 Days)|Adverse Event|0
270678|NCT02104505|900705|P1|Second Intervention (14 Days)|Adverse Event|2
270679|NCT02104505|900704|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
270680|NCT02104505|900705|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
270681|NCT02104505|900704|P2|First Intervention (14 Days)|exclusionary condition|1
270682|NCT02104505|900705|P1|First Intervention (14 Days)|exclusionary condition|0
270683|NCT02104505|900704|P2|First Intervention (14 Days)|Lost to Follow-up|1
270684|NCT02104505|900705|P1|First Intervention (14 Days)|Lost to Follow-up|0
270685|NCT02104505|900704|P2|First Intervention (14 Days)|Withdrawal by Subject|1
270686|NCT02104505|900705|P1|First Intervention (14 Days)|Withdrawal by Subject|0
270687|NCT02104505|900704|P2|First Intervention (14 Days)|Adverse Event|0
270688|NCT02104505|900705|P1|First Intervention (14 Days)|Adverse Event|2
270689|NCT02103439|900757|P2|Overall Study|Withdrawal by Subject|1
270690|NCT02103439|900758|P1|Overall Study|Withdrawal by Subject|3
270691|NCT02103439|900757|P2|Overall Study|Adverse Event|2
270692|NCT02103439|900758|P1|Overall Study|Adverse Event|0
270693|NCT02103062|900850|P2|Overall Study|Death|1
270694|NCT02103062|900851|P1|Overall Study|Death|0
270695|NCT02103062|900850|P2|Overall Study|Progressive Disease|20
270696|NCT02103062|900851|P1|Overall Study|Progressive Disease|17
270697|NCT02103062|900850|P2|Overall Study|Adverse Event|2
270698|NCT02103062|900851|P1|Overall Study|Adverse Event|1
270699|NCT02102490|900942|P1|Overall Study|Lost to Follow-up|1
270700|NCT02102490|900942|P1|Overall Study|Death|5
270701|NCT02102490|900942|P1|Overall Study|Adverse Event|3
270702|NCT02102464|900956|P3|Randomized Study|Withdrawal by Subject|0
270703|NCT02102464|900957|P2|Randomized Study|Withdrawal by Subject|1
270704|NCT02102464|900958|P1|Randomized Study|Withdrawal by Subject|0
270705|NCT02102399|900977|P2|Overall Study|Withdrawal by Subject|4
270706|NCT02102399|900978|P1|Overall Study|Withdrawal by Subject|6
270707|NCT02102204|901026|P1|Overall Study|Ongoing|5
270708|NCT02102204|901026|P1|Overall Study|Sponsor Decision|5
270709|NCT02102204|901026|P1|Overall Study|Lost to Follow-up|65
270710|NCT02102204|901026|P1|Overall Study|Death|92
270711|NCT02102204|901026|P1|Overall Study|Withdrawal by Subject|137
270712|NCT02101983|901037|P2|Overall Study|Physician Decision|0
270713|NCT02101983|901038|P1|Overall Study|Physician Decision|1
270714|NCT02101359|901050|P2|Overall Study|Protocol Violation|2
270715|NCT02101359|901051|P1|Overall Study|Protocol Violation|0
270716|NCT02101359|901050|P2|Overall Study|Lost to Follow-up|0
270717|NCT02101359|901051|P1|Overall Study|Lost to Follow-up|1
270718|NCT02101359|901050|P2|Overall Study|Withdrawal by Subject|4
270719|NCT02101359|901051|P1|Overall Study|Withdrawal by Subject|5
270720|NCT02101359|901050|P2|Overall Study|Not included|13
270721|NCT02101359|901051|P1|Overall Study|Not included|23
270722|NCT02101294|901057|P1|Overall Study|Lost to Follow-up|6
270723|NCT02101294|901057|P1|Overall Study|Withdrawal by Subject|5
270724|NCT02101112|901077|P6|Overall Study|Withdrawal by Subject|0
270725|NCT02101112|901078|P5|Overall Study|Withdrawal by Subject|1
270726|NCT02101112|901079|P4|Overall Study|Withdrawal by Subject|0
270727|NCT02101112|901080|P3|Overall Study|Withdrawal by Subject|0
270728|NCT02101112|901081|P2|Overall Study|Withdrawal by Subject|0
270729|NCT02101112|901082|P1|Overall Study|Withdrawal by Subject|0
270730|NCT02101112|901077|P6|Overall Study|Adverse Event|0
270731|NCT02101112|901078|P5|Overall Study|Adverse Event|0
270732|NCT02101112|901079|P4|Overall Study|Adverse Event|0
270733|NCT02101112|901080|P3|Overall Study|Adverse Event|1
270734|NCT02101112|901081|P2|Overall Study|Adverse Event|0
270735|NCT02101112|901082|P1|Overall Study|Adverse Event|0
270736|NCT02101021|901112|P5|Overall Study|Study Terminated by Sponsor|1
270737|NCT02101021|901113|P4|Overall Study|Study Terminated by Sponsor|1
270738|NCT02101021|901114|P3|Overall Study|Study Terminated by Sponsor|1
270739|NCT02101021|901115|P2|Overall Study|Study Terminated by Sponsor|0
270740|NCT02101021|901116|P1|Overall Study|Study Terminated by Sponsor|1
270741|NCT02101021|901112|P5|Overall Study|Lost to Follow-up|0
270742|NCT02101021|901113|P4|Overall Study|Lost to Follow-up|0
270743|NCT02101021|901114|P3|Overall Study|Lost to Follow-up|0
270744|NCT02101021|901115|P2|Overall Study|Lost to Follow-up|0
270745|NCT02101021|901116|P1|Overall Study|Lost to Follow-up|1
270746|NCT02101021|901112|P5|Overall Study|Withdrew Consent from study|0
270747|NCT02101021|901113|P4|Overall Study|Withdrew Consent from study|2
270748|NCT02101021|901114|P3|Overall Study|Withdrew Consent from study|0
270749|NCT02101021|901115|P2|Overall Study|Withdrew Consent from study|1
270750|NCT02101021|901116|P1|Overall Study|Withdrew Consent from study|1
270751|NCT02101021|901112|P5|Overall Study|Death|3
270752|NCT02101021|901113|P4|Overall Study|Death|0
270753|NCT02101021|901114|P3|Overall Study|Death|6
270754|NCT02101021|901115|P2|Overall Study|Death|3
270755|NCT02101021|901116|P1|Overall Study|Death|4
270756|NCT02100839|901165|P2|Multiple Ascending Dose|Withdrawal by Subject|0
270757|NCT02100839|901166|P1|Multiple Ascending Dose|Withdrawal by Subject|2
270758|NCT02100839|901165|P2|Multiple Ascending Dose|Adverse Event|0
270759|NCT02100839|901166|P1|Multiple Ascending Dose|Adverse Event|2
270760|NCT02100670|901193|P4|Overall Study|Withdrawal by Subject|0
270761|NCT02100670|901194|P3|Overall Study|Withdrawal by Subject|0
270762|NCT02100670|901195|P2|Overall Study|Withdrawal by Subject|0
270763|NCT02100670|901196|P1|Overall Study|Withdrawal by Subject|1
270764|NCT02100670|901193|P4|Overall Study|Physician Decision|0
270765|NCT02100670|901194|P3|Overall Study|Physician Decision|0
270766|NCT02100670|901195|P2|Overall Study|Physician Decision|1
270767|NCT02100670|901196|P1|Overall Study|Physician Decision|0
270768|NCT02100670|901193|P4|Overall Study|Poor Efficacy|0
270769|NCT02100670|901194|P3|Overall Study|Poor Efficacy|0
270770|NCT02100670|901195|P2|Overall Study|Poor Efficacy|1
270771|NCT02100670|901196|P1|Overall Study|Poor Efficacy|0
270772|NCT02100670|901193|P4|Overall Study|No swelling no pain|0
270773|NCT02100670|901194|P3|Overall Study|No swelling no pain|0
270774|NCT02100670|901195|P2|Overall Study|No swelling no pain|0
270775|NCT02100670|901196|P1|Overall Study|No swelling no pain|1
270776|NCT02100670|901193|P4|Overall Study|Withdrawal of Consent|0
270777|NCT02100670|901194|P3|Overall Study|Withdrawal of Consent|1
270778|NCT02100670|901195|P2|Overall Study|Withdrawal of Consent|1
270779|NCT02100670|901196|P1|Overall Study|Withdrawal of Consent|0
270780|NCT02100670|901193|P4|Overall Study|Protocol Violation|1
270781|NCT02100670|901194|P3|Overall Study|Protocol Violation|0
270782|NCT02100670|901195|P2|Overall Study|Protocol Violation|1
270783|NCT02100670|901196|P1|Overall Study|Protocol Violation|0
270784|NCT02100670|901193|P4|Overall Study|Lost to Follow-up|0
270785|NCT02100670|901194|P3|Overall Study|Lost to Follow-up|0
270786|NCT02100670|901195|P2|Overall Study|Lost to Follow-up|0
270787|NCT02100670|901196|P1|Overall Study|Lost to Follow-up|1
270788|NCT02100670|901193|P4|Overall Study|Adverse Event|0
270789|NCT02100670|901194|P3|Overall Study|Adverse Event|3
270790|NCT02100670|901195|P2|Overall Study|Adverse Event|3
270791|NCT02100670|901196|P1|Overall Study|Adverse Event|10
270792|NCT02100644|901256|P3|LTG Escalation Phase|Withdrawal by Subject|0
270793|NCT02100644|901257|P2|LTG Escalation Phase|Withdrawal by Subject|0
270794|NCT02100644|901258|P1|LTG Escalation Phase|Withdrawal by Subject|3
270795|NCT02100644|901256|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
270796|NCT02100644|901257|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
270797|NCT02100644|901258|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
270798|NCT02100644|901256|P3|LTG Escalation Phase|Adverse Event|0
270799|NCT02100644|901257|P2|LTG Escalation Phase|Adverse Event|0
270800|NCT02100644|901258|P1|LTG Escalation Phase|Adverse Event|9
270801|NCT02100514|901283|P2|Overall Study|Other|11
270802|NCT02100514|901284|P1|Overall Study|Other|9
270803|NCT02100514|901283|P2|Overall Study|Withdrawal by Subject|37
270804|NCT02100514|901284|P1|Overall Study|Withdrawal by Subject|12
270805|NCT02100514|901283|P2|Overall Study|Protocol Violation|1
270806|NCT02100514|901284|P1|Overall Study|Protocol Violation|1
270807|NCT02100514|901283|P2|Overall Study|Did Not Meet Entrance Criteria|1
270808|NCT02100514|901284|P1|Overall Study|Did Not Meet Entrance Criteria|0
270809|NCT02100514|901283|P2|Overall Study|Lost to Follow-up|17
270810|NCT02100514|901284|P1|Overall Study|Lost to Follow-up|5
270811|NCT02100514|901283|P2|Overall Study|Death|2
270812|NCT02100514|901284|P1|Overall Study|Death|2
270813|NCT02100514|901283|P2|Overall Study|Adverse Event|5
270814|NCT02100514|901284|P1|Overall Study|Adverse Event|0
270815|NCT02100475|901344|P2|Overall Study|Withdrawal criteria|0
270816|NCT02100475|901345|P1|Overall Study|Withdrawal criteria|1
270817|NCT02100475|901344|P2|Overall Study|Unclassified|2
270818|NCT02100475|901345|P1|Overall Study|Unclassified|1
270819|NCT02100228|901395|P2|Overall Study|Death|1
270820|NCT02100228|901396|P1|Overall Study|Death|1
270821|NCT02100228|901395|P2|Overall Study|Adverse Event|12
270822|NCT02100228|901396|P1|Overall Study|Adverse Event|16
270823|NCT02100228|901395|P2|Overall Study|Withdrawal by Subject|37
270824|NCT02100228|901396|P1|Overall Study|Withdrawal by Subject|27
270825|NCT02100228|901395|P2|Overall Study|Lost to Follow-up|1
270826|NCT02100228|901396|P1|Overall Study|Lost to Follow-up|0
270827|NCT02100228|901395|P2|Overall Study|Non-compliance|3
270828|NCT02100228|901396|P1|Overall Study|Non-compliance|0
270829|NCT02100228|901395|P2|Overall Study|Inclusion/Exclusion criteria not met|16
270830|NCT02100228|901396|P1|Overall Study|Inclusion/Exclusion criteria not met|12
270831|NCT02100228|901395|P2|Overall Study|Administrative reason|1
270832|NCT02100228|901396|P1|Overall Study|Administrative reason|0
270833|NCT02100228|901395|P2|Overall Study|Other|19
270834|NCT02100228|901396|P1|Overall Study|Other|19
270835|NCT02099838|901442|P2|Overall Study|Withdrawal by Subject|1
270836|NCT02099838|901443|P1|Overall Study|Withdrawal by Subject|0
270837|NCT02099838|901442|P2|Overall Study|Lost to Follow-up|1
270838|NCT02099838|901443|P1|Overall Study|Lost to Follow-up|3
270839|NCT02099838|901442|P2|Overall Study|Death|0
270840|NCT02099838|901443|P1|Overall Study|Death|1
270841|NCT02099708|901473|P1|Overall Study|Other|29
270842|NCT02099708|901473|P1|Overall Study|Lost to Follow-up|141
270843|NCT02099708|901473|P1|Overall Study|Data Not Available|30
270844|NCT02099682|901484|P1|Overall Study|Other|29
270845|NCT02099682|901484|P1|Overall Study|Lost to Follow-up|31
270846|NCT02099682|901484|P1|Overall Study|Data Not Available|51
270847|NCT02099344|901510|P2|Overall Study|Physician Decision|0
270848|NCT02099344|901511|P1|Overall Study|Physician Decision|1
270849|NCT02099110|901546|P5|Overall Study|Physician Decision|1
270850|NCT02099110|901547|P4|Overall Study|Physician Decision|2
270851|NCT02099110|901548|P3|Overall Study|Physician Decision|1
270852|NCT02099110|901549|P2|Overall Study|Physician Decision|0
270853|NCT02099110|901550|P1|Overall Study|Physician Decision|3
270854|NCT02099110|901546|P5|Overall Study|Non-compliance with study drug|1
270855|NCT02099110|901547|P4|Overall Study|Non-compliance with study drug|0
270856|NCT02099110|901548|P3|Overall Study|Non-compliance with study drug|0
270857|NCT02099110|901549|P2|Overall Study|Non-compliance with study drug|0
270858|NCT02099110|901550|P1|Overall Study|Non-compliance with study drug|2
270859|NCT02099110|901546|P5|Overall Study|Screen failure|1
270860|NCT02099110|901547|P4|Overall Study|Screen failure|0
270861|NCT02099110|901548|P3|Overall Study|Screen failure|0
270862|NCT02099110|901549|P2|Overall Study|Screen failure|0
270863|NCT02099110|901550|P1|Overall Study|Screen failure|0
270864|NCT02099110|901546|P5|Overall Study|Death|0
270865|NCT02099110|901547|P4|Overall Study|Death|0
270866|NCT02099110|901548|P3|Overall Study|Death|0
270867|NCT02099110|901549|P2|Overall Study|Death|1
270868|NCT02099110|901550|P1|Overall Study|Death|0
270869|NCT02099110|901546|P5|Overall Study|Lost to Follow-up|6
270870|NCT02099110|901547|P4|Overall Study|Lost to Follow-up|5
270871|NCT02099110|901548|P3|Overall Study|Lost to Follow-up|11
270872|NCT02099110|901549|P2|Overall Study|Lost to Follow-up|12
270873|NCT02099110|901550|P1|Overall Study|Lost to Follow-up|6
270874|NCT02099110|901546|P5|Overall Study|Adverse Event|2
270875|NCT02099110|901547|P4|Overall Study|Adverse Event|3
270876|NCT02099110|901548|P3|Overall Study|Adverse Event|2
270877|NCT02099110|901549|P2|Overall Study|Adverse Event|5
270878|NCT02099110|901550|P1|Overall Study|Adverse Event|3
270879|NCT02099110|901546|P5|Overall Study|Withdrawal by Subject|13
270880|NCT02099110|901547|P4|Overall Study|Withdrawal by Subject|9
270881|NCT02099110|901548|P3|Overall Study|Withdrawal by Subject|13
270882|NCT02099110|901549|P2|Overall Study|Withdrawal by Subject|11
270883|NCT02099110|901550|P1|Overall Study|Withdrawal by Subject|7
270884|NCT02099110|901546|P5|Overall Study|Participant moved|2
270885|NCT02099110|901547|P4|Overall Study|Participant moved|0
270886|NCT02099110|901548|P3|Overall Study|Participant moved|1
270887|NCT02099110|901549|P2|Overall Study|Participant moved|1
270888|NCT02099110|901550|P1|Overall Study|Participant moved|1
270889|NCT02099110|901546|P5|Overall Study|Protocol Violation|1
270890|NCT02099110|901547|P4|Overall Study|Protocol Violation|3
270891|NCT02099110|901548|P3|Overall Study|Protocol Violation|0
270892|NCT02099110|901549|P2|Overall Study|Protocol Violation|1
270893|NCT02099110|901550|P1|Overall Study|Protocol Violation|2
270894|NCT02098746|901624|P1|Overall Study|Data Not Available After Treatment|1
270895|NCT02098746|901624|P1|Overall Study|Enrolled 15 Days After the First Dose|1
270896|NCT02098746|901624|P1|Overall Study|Other Miscellaneous Reasons|1
270897|NCT02098746|901624|P1|Overall Study|Changes of Investigator|2
270898|NCT02098733|901632|P1|Overall Study|Lost to Follow-up|5
270899|NCT02098733|901632|P1|Overall Study|Data Not Available|5
270900|NCT02098395|901646|P4|Overall Study|Unclassified|2
270901|NCT02098395|901647|P3|Overall Study|Unclassified|3
270902|NCT02098395|901648|P2|Overall Study|Unclassified|0
270903|NCT02098395|901649|P1|Overall Study|Unclassified|0
270904|NCT02098395|901646|P4|Overall Study|Lost to Follow-up|3
270905|NCT02098395|901647|P3|Overall Study|Lost to Follow-up|0
270906|NCT02098395|901648|P2|Overall Study|Lost to Follow-up|1
270907|NCT02098395|901649|P1|Overall Study|Lost to Follow-up|2
270908|NCT02098395|901646|P4|Overall Study|Adverse Event|2
270909|NCT02098395|901647|P3|Overall Study|Adverse Event|34
270910|NCT02098395|901648|P2|Overall Study|Adverse Event|19
270911|NCT02098395|901649|P1|Overall Study|Adverse Event|12
270912|NCT02098395|901646|P4|Overall Study|Withdrawal by Subject|13
270913|NCT02098395|901647|P3|Overall Study|Withdrawal by Subject|5
270914|NCT02098395|901648|P2|Overall Study|Withdrawal by Subject|10
270915|NCT02098395|901649|P1|Overall Study|Withdrawal by Subject|10
270916|NCT02098395|901646|P4|Overall Study|Protocol Violation|7
270917|NCT02098395|901647|P3|Overall Study|Protocol Violation|0
270918|NCT02098395|901648|P2|Overall Study|Protocol Violation|2
270919|NCT02098395|901649|P1|Overall Study|Protocol Violation|2
270920|NCT02098109|901676|P2|Overall Study|Protocol Violation|0
270921|NCT02098109|901677|P1|Overall Study|Protocol Violation|3
270922|NCT02097823|901755|P2|Overall Study|Withdrawal by Subject|1
270923|NCT02097823|901756|P1|Overall Study|Withdrawal by Subject|1
270924|NCT02097745|901771|P1|Overall Study|Reason Not Specified|96
270925|NCT02097745|901771|P1|Overall Study|Administrative/Other|27
270926|NCT02097745|901771|P1|Overall Study|Failure to Return|14
270927|NCT02097745|901771|P1|Overall Study|Death|16
270928|NCT02097745|901771|P1|Overall Study|Adverse Event|25
270929|NCT02097719|901807|P2|Overall Study|Adverse Event|0
270930|NCT02097719|901808|P1|Overall Study|Adverse Event|2
270931|NCT02097719|901807|P2|Overall Study|Lost to Follow-up|1
270932|NCT02097719|901808|P1|Overall Study|Lost to Follow-up|0
270933|NCT02097719|901807|P2|Overall Study|Subject Withdrew Consent|0
270934|NCT02097719|901808|P1|Overall Study|Subject Withdrew Consent|1
270935|NCT02097472|901828|P8|Received Vaccination 2|Adverse Event|0
270936|NCT02097472|901829|P7|Received Vaccination 2|Adverse Event|1
270937|NCT02097472|901830|P6|Received Vaccination 2|Adverse Event|0
270938|NCT02097472|901831|P5|Received Vaccination 2|Adverse Event|0
270939|NCT02097472|901832|P4|Received Vaccination 2|Adverse Event|0
270940|NCT02097472|901833|P3|Received Vaccination 2|Adverse Event|0
270941|NCT02097472|901834|P2|Received Vaccination 2|Adverse Event|0
270942|NCT02097472|901835|P1|Received Vaccination 2|Adverse Event|0
270943|NCT02097290|902266|P1|Overall Study|Attempt|8
270944|NCT02097290|902266|P1|Overall Study|Total Withdrawals|3
270945|NCT02097290|902266|P1|Overall Study|Death|6
270946|NCT02097238|902276|P1|Overall Study|Progressive Disease|17
270947|NCT02097238|902276|P1|Overall Study|Physician Decision|1
270948|NCT02097238|902276|P1|Overall Study|Death|1
270949|NCT02097134|902282|P1|Overall Study|Refusal of Further Protocol Therapy|1
270950|NCT02097134|902282|P1|Overall Study|Progressive Disease|3
270951|NCT02097134|902282|P1|Overall Study|Non-Protocol Therapy|1
270952|NCT02097134|902282|P1|Overall Study|Physician Decision|4
270953|NCT02097108|902286|P1|Overall Study|patient was abroad for 6 months|1
270954|NCT02097108|902286|P1|Overall Study|Adverse Event|1
270955|NCT02097056|902293|P1|Overall Study|Not specified|2
270956|NCT02097056|902293|P1|Overall Study|Adverse Event|37
270957|NCT02097056|902293|P1|Overall Study|Lost to Follow-up|2
270958|NCT02097056|902293|P1|Overall Study|Withdrawal by Subject|15
270959|NCT02097056|902293|P1|Overall Study|Protocol Violation|2
270960|NCT02097030|902301|P2|First Intervention (3 Days)|Visual Acuity|1
270961|NCT02097030|902302|P1|First Intervention (3 Days)|Visual Acuity|0
270962|NCT02097030|902301|P2|First Intervention (3 Days)|Lost to Follow-up|0
270963|NCT02097030|902302|P1|First Intervention (3 Days)|Lost to Follow-up|1
270964|NCT02096952|902363|P1|Overall Study|Adverse Event|1
270965|NCT02096900|902369|P2|Overall Study|Surgery cancelled- medication received|1
270966|NCT02096900|902370|P1|Overall Study|Surgery cancelled- medication received|1
270967|NCT02096900|902369|P2|Overall Study|Did not receive medication|1
270968|NCT02096900|902370|P1|Overall Study|Did not receive medication|3
270969|NCT02096835|902422|P3|Overall Study|Lost to Follow-up|1
270970|NCT02096835|902423|P2|Overall Study|Lost to Follow-up|0
270971|NCT02096835|902424|P1|Overall Study|Lost to Follow-up|1
270972|NCT02096835|902422|P3|Overall Study|converted to open procedures|0
270973|NCT02096835|902423|P2|Overall Study|converted to open procedures|0
270974|NCT02096835|902424|P1|Overall Study|converted to open procedures|1
270975|NCT02096835|902422|P3|Overall Study|Withdrawal by Subject|0
270976|NCT02096835|902423|P2|Overall Study|Withdrawal by Subject|0
270977|NCT02096835|902424|P1|Overall Study|Withdrawal by Subject|1
270978|NCT02096744|902441|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
270979|NCT02096744|902442|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
270980|NCT02096744|902441|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
270981|NCT02096744|902442|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
270982|NCT02096744|902441|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
270983|NCT02096744|902442|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
270984|NCT02096705|902496|P2|Follow-up|Subjects not reporting status|2
270985|NCT02096705|902497|P1|Follow-up|Subjects not reporting status|1
270986|NCT02096705|902496|P2|Follow-up|Adverse Event|2
270987|NCT02096705|902497|P1|Follow-up|Adverse Event|2
270988|NCT02096705|902496|P2|Follow-up|Withdrawal by Subject|0
270989|NCT02096705|902497|P1|Follow-up|Withdrawal by Subject|1
270990|NCT02096705|902496|P2|Treatment|Other|1
270991|NCT02096705|902497|P1|Treatment|Other|1
270992|NCT02096705|902496|P2|Treatment|Withdrawal by Subject|0
270993|NCT02096705|902497|P1|Treatment|Withdrawal by Subject|1
270994|NCT02096705|902496|P2|Treatment|Subject request to discontinue treatment|1
270995|NCT02096705|902497|P1|Treatment|Subject request to discontinue treatment|1
270996|NCT02096705|902496|P2|Treatment|Adverse Event|3
270997|NCT02096705|902497|P1|Treatment|Adverse Event|6
270998|NCT02096042|902595|P3|Overall Study|Disease Progression|0
270999|NCT02096042|902596|P2|Overall Study|Disease Progression|0
271000|NCT02096042|902597|P1|Overall Study|Disease Progression|1
271001|NCT02095873|902606|P2|Second Intervention (8 Weeks)|Protocol Violation|0
271002|NCT02095873|902607|P1|Second Intervention (8 Weeks)|Protocol Violation|1
271003|NCT02095873|902606|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
271004|NCT02095873|902607|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
271005|NCT02095873|902606|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
271006|NCT02095873|902607|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
271007|NCT02095691|902619|P1|Overall Study|Physician Decision|1
271008|NCT02095535|902651|P1|Recruitment|Protocol Violation|2
271009|NCT02095223|902657|P2|Overall Study|Withdrawal by Subject|0
271010|NCT02095223|902658|P1|Overall Study|Withdrawal by Subject|1
271011|NCT02095197|902668|P2|Overall Study|Lost to Follow-up|3
271012|NCT02095197|902669|P1|Overall Study|Lost to Follow-up|0
271013|NCT02095158|902681|P1|Overall Study|Other Miscellaneous Reasons|1
271014|NCT02095158|902681|P1|Overall Study|Protocol Violation|1
271015|NCT02095158|902681|P1|Overall Study|Personal Reasons|35
271016|NCT02095158|902681|P1|Overall Study|Lost to Follow-up|20
271017|NCT02095158|902681|P1|Overall Study|Pregnancy|1
271018|NCT02095158|902681|P1|Overall Study|Lack of Efficacy|3
271019|NCT02095158|902681|P1|Overall Study|Adverse Event|14
271020|NCT02095106|902688|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
271021|NCT02095106|902689|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
271022|NCT02094937|902705|P4|12 Weeks in Period 2|Randomized incorrectly|0
271023|NCT02094937|902706|P3|12 Weeks in Period 2|Randomized incorrectly|0
271024|NCT02094937|902707|P2|12 Weeks in Period 2|Randomized incorrectly|1
271025|NCT02094937|902708|P1|12 Weeks in Period 2|Randomized incorrectly|0
271026|NCT02094937|902705|P4|12 Weeks in Period 2|Withdrawal by Subject|0
271027|NCT02094937|902706|P3|12 Weeks in Period 2|Withdrawal by Subject|2
271028|NCT02094937|902707|P2|12 Weeks in Period 2|Withdrawal by Subject|2
271029|NCT02094937|902708|P1|12 Weeks in Period 2|Withdrawal by Subject|0
271030|NCT02094937|902705|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
271031|NCT02094937|902706|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
271032|NCT02094937|902707|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
271033|NCT02094937|902708|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
271034|NCT02094937|902705|P4|12 Weeks in Period 2|Lack of Efficacy|0
271035|NCT02094937|902706|P3|12 Weeks in Period 2|Lack of Efficacy|0
271036|NCT02094937|902707|P2|12 Weeks in Period 2|Lack of Efficacy|1
271037|NCT02094937|902708|P1|12 Weeks in Period 2|Lack of Efficacy|0
271038|NCT02094937|902705|P4|12 Weeks in Period 2|Adverse Event|1
271039|NCT02094937|902706|P3|12 Weeks in Period 2|Adverse Event|4
271040|NCT02094937|902707|P2|12 Weeks in Period 2|Adverse Event|2
271041|NCT02094937|902708|P1|12 Weeks in Period 2|Adverse Event|0
271042|NCT02094937|902705|P4|8 Weeks in Period 1|Withdrawal by Subject|0
271043|NCT02094937|902706|P3|8 Weeks in Period 1|Withdrawal by Subject|0
271044|NCT02094937|902707|P2|8 Weeks in Period 1|Withdrawal by Subject|0
271045|NCT02094937|902708|P1|8 Weeks in Period 1|Withdrawal by Subject|4
271046|NCT02094937|902705|P4|8 Weeks in Period 1|Physician Decision|0
271047|NCT02094937|902706|P3|8 Weeks in Period 1|Physician Decision|0
271048|NCT02094937|902707|P2|8 Weeks in Period 1|Physician Decision|0
271049|NCT02094937|902708|P1|8 Weeks in Period 1|Physician Decision|1
271050|NCT02094937|902705|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
271051|NCT02094937|902706|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
271052|NCT02094937|902707|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
271053|NCT02094937|902708|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
271054|NCT02094937|902705|P4|8 Weeks in Period 1|Protocol Violation|0
271055|NCT02094937|902706|P3|8 Weeks in Period 1|Protocol Violation|0
271056|NCT02094937|902707|P2|8 Weeks in Period 1|Protocol Violation|0
271057|NCT02094937|902708|P1|8 Weeks in Period 1|Protocol Violation|2
271058|NCT02094937|902705|P4|8 Weeks in Period 1|Lack of Efficacy|0
271059|NCT02094937|902706|P3|8 Weeks in Period 1|Lack of Efficacy|0
271060|NCT02094937|902707|P2|8 Weeks in Period 1|Lack of Efficacy|0
271061|NCT02094937|902708|P1|8 Weeks in Period 1|Lack of Efficacy|3
271062|NCT02094937|902705|P4|8 Weeks in Period 1|Adverse Event|0
271063|NCT02094937|902706|P3|8 Weeks in Period 1|Adverse Event|0
271064|NCT02094937|902707|P2|8 Weeks in Period 1|Adverse Event|0
271065|NCT02094937|902708|P1|8 Weeks in Period 1|Adverse Event|9
271066|NCT02094898|902738|P1|Overall Study|Lack of Efficacy|1
271067|NCT02094898|902738|P1|Overall Study|Adverse Event|2
271068|NCT02094898|902738|P1|Overall Study|Clinical Worsening|2
271069|NCT02094885|902785|P2|Overall Study|Withdrawn due to age|0
271070|NCT02094885|902786|P1|Overall Study|Withdrawn due to age|1
271071|NCT02094885|902785|P2|Overall Study|Death|5
271072|NCT02094885|902786|P1|Overall Study|Death|1
271073|NCT02094677|902800|P2|Overall Study|Screening|1
271074|NCT02094677|902801|P1|Overall Study|Screening|3
271075|NCT02094612|902880|P2|Overall Study|Never started ADHD medication|23
271076|NCT02094612|902881|P1|Overall Study|Never started ADHD medication|32
271077|NCT02094612|902880|P2|Overall Study|Lost to Follow-up|47
271078|NCT02094612|902881|P1|Overall Study|Lost to Follow-up|47
271079|NCT02094573|902901|P2|Overall Study|Ongoing|76
271080|NCT02094573|902902|P1|Overall Study|Ongoing|64
271081|NCT02094573|902901|P2|Overall Study|Randomized but not treated|0
271082|NCT02094573|902902|P1|Overall Study|Randomized but not treated|3
271083|NCT02094573|902901|P2|Overall Study|Withdrawal by Subject|4
271084|NCT02094573|902902|P1|Overall Study|Withdrawal by Subject|2
271085|NCT02094573|902901|P2|Overall Study|Non-compliance with study drug|1
271086|NCT02094573|902902|P1|Overall Study|Non-compliance with study drug|0
271087|NCT02094573|902901|P2|Overall Study|Death|1
271088|NCT02094573|902902|P1|Overall Study|Death|7
271089|NCT02094573|902901|P2|Overall Study|Adverse Event|9
271090|NCT02094573|902902|P1|Overall Study|Adverse Event|3
271091|NCT02094573|902901|P2|Overall Study|Clinical Progressive Disease|3
271092|NCT02094573|902902|P1|Overall Study|Clinical Progressive Disease|4
271093|NCT02094573|902901|P2|Overall Study|Documented Progressive Disease|16
271094|NCT02094573|902902|P1|Overall Study|Documented Progressive Disease|29
271095|NCT02094300|902984|P1|Overall Study|Still be eligible for follow-up|3
271096|NCT02094300|902984|P1|Overall Study|Lost to Follow-up|10
271097|NCT02094300|902984|P1|Overall Study|Death|7
271098|NCT02094261|902988|P1|Overall Study|Ongoing Study at Data Cut-off|181
271099|NCT02094261|902988|P1|Overall Study|Withdrawal by Subject|4
271100|NCT02094261|902988|P1|Overall Study|Lost to Follow-up|1
271101|NCT02094261|902988|P1|Overall Study|Death|24
271102|NCT02093923|903030|P5|Overall Study|Screen failure after randomization|0
271103|NCT02093923|903031|P4|Overall Study|Screen failure after randomization|1
271104|NCT02093923|903032|P3|Overall Study|Screen failure after randomization|0
271105|NCT02093923|903033|P2|Overall Study|Screen failure after randomization|0
271106|NCT02093923|903034|P1|Overall Study|Screen failure after randomization|0
271107|NCT02093923|903030|P5|Overall Study|Lost to Follow-up|0
271108|NCT02093923|903031|P4|Overall Study|Lost to Follow-up|1
271109|NCT02093923|903032|P3|Overall Study|Lost to Follow-up|0
271110|NCT02093923|903033|P2|Overall Study|Lost to Follow-up|0
271111|NCT02093923|903034|P1|Overall Study|Lost to Follow-up|0
271112|NCT02093897|903089|P1|Overall Study|Adverse event, non-fatal|1
271113|NCT02093897|903089|P1|Overall Study|Planned age group closure - no's reached|17
271114|NCT02093897|903089|P1|Overall Study|Physician Decision|1
271115|NCT02093689|903192|P3|Overall Study|Physician Decision|0
271116|NCT02093689|903193|P2|Overall Study|Physician Decision|0
271117|NCT02093689|903194|P1|Overall Study|Physician Decision|4
271118|NCT02093520|903202|P2|Overall Study|Not treated|22
271119|NCT02093520|903203|P1|Overall Study|Not treated|6
271120|NCT02093390|903215|P2|Overall Study|Withdrawal by Subject|1
271121|NCT02093390|903216|P1|Overall Study|Withdrawal by Subject|0
271122|NCT02093351|903255|P3|Overall Study|Death|0
271123|NCT02093351|903256|P2|Overall Study|Death|1
271124|NCT02093351|903257|P1|Overall Study|Death|0
271125|NCT02093351|903255|P3|Overall Study|Condition under investigation worsened|2
271126|NCT02093351|903256|P2|Overall Study|Condition under investigation worsened|0
271127|NCT02093351|903257|P1|Overall Study|Condition under investigation worsened|2
271128|NCT02093351|903255|P3|Overall Study|Adverse Event|1
271129|NCT02093351|903256|P2|Overall Study|Adverse Event|1
271130|NCT02093351|903257|P1|Overall Study|Adverse Event|0
271131|NCT02093221|903313|P5|Overall Study|Study termination|7
271132|NCT02093221|903314|P4|Overall Study|Study termination|6
271133|NCT02093221|903315|P3|Overall Study|Study termination|4
271134|NCT02093221|903316|P2|Overall Study|Study termination|5
271135|NCT02093221|903317|P1|Overall Study|Study termination|6
271136|NCT02093221|903313|P5|Overall Study|Protocol Violation|0
271137|NCT02093221|903314|P4|Overall Study|Protocol Violation|0
271138|NCT02093221|903315|P3|Overall Study|Protocol Violation|0
271139|NCT02093221|903316|P2|Overall Study|Protocol Violation|1
271140|NCT02093221|903317|P1|Overall Study|Protocol Violation|0
271141|NCT02093221|903313|P5|Overall Study|Death|0
271142|NCT02093221|903314|P4|Overall Study|Death|0
271143|NCT02093221|903315|P3|Overall Study|Death|0
271144|NCT02093221|903316|P2|Overall Study|Death|1
271145|NCT02093221|903317|P1|Overall Study|Death|0
271146|NCT02093221|903313|P5|Overall Study|Lost to Follow-up|0
271147|NCT02093221|903314|P4|Overall Study|Lost to Follow-up|1
271148|NCT02093221|903315|P3|Overall Study|Lost to Follow-up|1
271149|NCT02093221|903316|P2|Overall Study|Lost to Follow-up|0
271150|NCT02093221|903317|P1|Overall Study|Lost to Follow-up|2
271151|NCT02093221|903313|P5|Overall Study|Withdrawal by Subject|1
271152|NCT02093221|903314|P4|Overall Study|Withdrawal by Subject|1
271153|NCT02093221|903315|P3|Overall Study|Withdrawal by Subject|4
271154|NCT02093221|903316|P2|Overall Study|Withdrawal by Subject|1
271155|NCT02093221|903317|P1|Overall Study|Withdrawal by Subject|1
271156|NCT02093221|903313|P5|Overall Study|Adverse Event|0
271157|NCT02093221|903314|P4|Overall Study|Adverse Event|0
271158|NCT02093221|903315|P3|Overall Study|Adverse Event|0
271159|NCT02093221|903316|P2|Overall Study|Adverse Event|0
271160|NCT02093221|903317|P1|Overall Study|Adverse Event|1
271161|NCT02093026|903354|P1|Overall Study|Other|157
271162|NCT02093026|903354|P1|Overall Study|Death|10
271163|NCT02093026|903354|P1|Overall Study|Adverse Event|26
271164|NCT02092961|903376|P3|Overall Study|Adverse Event|0
271165|NCT02092961|903377|P2|Overall Study|Adverse Event|4
271166|NCT02092961|903378|P1|Overall Study|Adverse Event|2
271167|NCT02092961|903376|P3|Overall Study|Dev. of study specific discont. criteria|0
271168|NCT02092961|903377|P2|Overall Study|Dev. of study specific discont. criteria|0
271169|NCT02092961|903378|P1|Overall Study|Dev. of study specific discont. criteria|3
271170|NCT02092961|903376|P3|Overall Study|Lack of therapeutic response|3
271171|NCT02092961|903377|P2|Overall Study|Lack of therapeutic response|1
271172|NCT02092961|903378|P1|Overall Study|Lack of therapeutic response|2
271173|NCT02092961|903376|P3|Overall Study|Study stopped|12
271174|NCT02092961|903377|P2|Overall Study|Study stopped|9
271175|NCT02092961|903378|P1|Overall Study|Study stopped|13
271176|NCT02092961|903376|P3|Overall Study|Not reported|1
271177|NCT02092961|903377|P2|Overall Study|Not reported|0
271178|NCT02092961|903378|P1|Overall Study|Not reported|1
271179|NCT02092662|903414|P2|Overall Study|Lost to Follow-up|0
271180|NCT02092662|903415|P1|Overall Study|Lost to Follow-up|13
271181|NCT02092389|903474|P1|Overall Study|Not specified|5
271182|NCT02092389|903474|P1|Overall Study|Adverse Event|1
271183|NCT02092350|903486|P2|Overall Study|Withdrawal by Subject|2
271184|NCT02092350|903487|P1|Overall Study|Withdrawal by Subject|2
271185|NCT02092350|903486|P2|Overall Study|Screen Failure|0
271186|NCT02092350|903487|P1|Overall Study|Screen Failure|1
271187|NCT02092350|903486|P2|Overall Study|Physician Decision|1
271188|NCT02092350|903487|P1|Overall Study|Physician Decision|1
271189|NCT02092350|903486|P2|Overall Study|Protocol Violation|0
271190|NCT02092350|903487|P1|Overall Study|Protocol Violation|1
271191|NCT02092350|903486|P2|Overall Study|Lost to Follow-up|1
271192|NCT02092350|903487|P1|Overall Study|Lost to Follow-up|3
271193|NCT02092350|903486|P2|Overall Study|Death|5
271194|NCT02092350|903487|P1|Overall Study|Death|2
271195|NCT02092350|903486|P2|Overall Study|Adverse Event|3
271196|NCT02092350|903487|P1|Overall Study|Adverse Event|0
271197|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
271198|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
271199|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
271200|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Protocol Violation|11
271201|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Pregnancy|1
271202|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Physician Decision|10
271203|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
271204|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
271205|NCT02092285|903515|P1|Maintenance Phase & Follow-up|Adverse Event|22
271206|NCT02092285|903515|P1|Induction Phase|Lack of Efficacy|14
271207|NCT02092285|903515|P1|Induction Phase|Withdrawal by Subject|2
271208|NCT02092285|903515|P1|Induction Phase|Relapse/Recurrence|7
271209|NCT02092285|903515|P1|Induction Phase|Pregnancy|1
271210|NCT02092285|903515|P1|Induction Phase|Physician Decision|4
271211|NCT02092285|903515|P1|Induction Phase|Adverse Event|7
271212|NCT02092220|903519|P2|Period 2|Nausea, Anxiety, Inconvenience|1
271213|NCT02092220|903520|P1|Period 2|Nausea, Anxiety, Inconvenience|0
271214|NCT02092220|903519|P2|Period 2|Severe Hypoglycaemia|0
271215|NCT02092220|903520|P1|Period 2|Severe Hypoglycaemia|1
271216|NCT02092220|903519|P2|Period 1|Unrelated Illness|2
271217|NCT02092220|903520|P1|Period 1|Unrelated Illness|0
271218|NCT02092116|903593|P2|Overall Study|Adverse Event|1
271219|NCT02092116|903594|P1|Overall Study|Adverse Event|0
271220|NCT02092116|903593|P2|Overall Study|Withdrawal by Subject|3
271221|NCT02092116|903594|P1|Overall Study|Withdrawal by Subject|0
271222|NCT02091986|903606|P3|Overall Study|Adverse Event|2
271223|NCT02091986|903607|P2|Overall Study|Adverse Event|0
271224|NCT02091986|903608|P1|Overall Study|Adverse Event|0
271225|NCT02091986|903606|P3|Overall Study|Withdrawal by Subject|3
271226|NCT02091986|903607|P2|Overall Study|Withdrawal by Subject|8
271227|NCT02091986|903608|P1|Overall Study|Withdrawal by Subject|4
271228|NCT02091986|903606|P3|Overall Study|Lost to Follow-up|0
271229|NCT02091986|903607|P2|Overall Study|Lost to Follow-up|0
271230|NCT02091986|903608|P1|Overall Study|Lost to Follow-up|1
271231|NCT02091986|903606|P3|Overall Study|7 rand in error 1 patient decision|3
271232|NCT02091986|903607|P2|Overall Study|7 rand in error 1 patient decision|3
271233|NCT02091986|903608|P1|Overall Study|7 rand in error 1 patient decision|2
271234|NCT02091960|903655|P1|Overall Study|On Study at Data Cut-off|12
271235|NCT02091960|903655|P1|Overall Study|Miscellaneous Reasons|31
271236|NCT02091960|903655|P1|Overall Study|Withdrawal by Subject|1
271237|NCT02091960|903655|P1|Overall Study|Death|7
271240|NCT02091752|903710|P1|Overall Study|Adverse Event|1
271241|NCT02091752|903710|P1|Overall Study|Study terminated by Sponsor|2
271242|NCT02091739|903724|P5|EP: 48 Weeks|Withdrawal by Subject|6
271243|NCT02091739|903725|P4|EP: 48 Weeks|Withdrawal by Subject|2
271244|NCT02091739|903726|P3|EP: 48 Weeks|Withdrawal by Subject|0
271245|NCT02091739|903727|P2|EP: 48 Weeks|Withdrawal by Subject|0
271246|NCT02091739|903728|P1|EP: 48 Weeks|Withdrawal by Subject|0
271247|NCT02091739|903724|P5|EP: 48 Weeks|Adverse Event|6
271248|NCT02091739|903725|P4|EP: 48 Weeks|Adverse Event|2
271249|NCT02091739|903726|P3|EP: 48 Weeks|Adverse Event|0
271250|NCT02091739|903727|P2|EP: 48 Weeks|Adverse Event|0
271251|NCT02091739|903728|P1|EP: 48 Weeks|Adverse Event|0
271252|NCT02091739|903724|P5|EP: 48 Weeks|Death|2
271253|NCT02091739|903725|P4|EP: 48 Weeks|Death|3
271254|NCT02091739|903726|P3|EP: 48 Weeks|Death|0
271255|NCT02091739|903727|P2|EP: 48 Weeks|Death|0
271256|NCT02091739|903728|P1|EP: 48 Weeks|Death|0
271257|NCT02091739|903724|P5|EP: 48 Weeks|Other|0
271258|NCT02091739|903725|P4|EP: 48 Weeks|Other|1
271259|NCT02091739|903726|P3|EP: 48 Weeks|Other|0
271260|NCT02091739|903727|P2|EP: 48 Weeks|Other|0
271261|NCT02091739|903728|P1|EP: 48 Weeks|Other|0
271262|NCT02091739|903724|P5|MP: 16 Weeks|Lost to Follow-up|0
271263|NCT02091739|903725|P4|MP: 16 Weeks|Lost to Follow-up|0
271264|NCT02091739|903726|P3|MP: 16 Weeks|Lost to Follow-up|1
271265|NCT02091739|903727|P2|MP: 16 Weeks|Lost to Follow-up|0
271266|NCT02091739|903728|P1|MP: 16 Weeks|Lost to Follow-up|0
271267|NCT02091739|903724|P5|MP: 16 Weeks|Withdrawal by Subject|0
271268|NCT02091739|903725|P4|MP: 16 Weeks|Withdrawal by Subject|0
271269|NCT02091739|903726|P3|MP: 16 Weeks|Withdrawal by Subject|0
271270|NCT02091739|903727|P2|MP: 16 Weeks|Withdrawal by Subject|4
271271|NCT02091739|903728|P1|MP: 16 Weeks|Withdrawal by Subject|3
271272|NCT02091739|903724|P5|MP: 16 Weeks|Adverse Event|0
271273|NCT02091739|903725|P4|MP: 16 Weeks|Adverse Event|0
271274|NCT02091739|903726|P3|MP: 16 Weeks|Adverse Event|1
271275|NCT02091739|903727|P2|MP: 16 Weeks|Adverse Event|1
271276|NCT02091739|903728|P1|MP: 16 Weeks|Adverse Event|1
271277|NCT02091726|903747|P1|Overall Study|Lost to Follow-up|6
271278|NCT02091414|903764|P1|Overall Study|Death|2
271279|NCT02091414|903764|P1|Overall Study|Withdrawal by Subject|2
271280|NCT02090855|903776|P1|Overall Study|no evaluable Standard of Truth results|2
271281|NCT02090764|903789|P2|Overall Study|Lost to Follow-up|2
271282|NCT02090764|903790|P1|Overall Study|Lost to Follow-up|2
271283|NCT02090764|903789|P2|Overall Study|Intercurrent illness and other|1
271284|NCT02090764|903790|P1|Overall Study|Intercurrent illness and other|1
271285|NCT02090764|903789|P2|Overall Study|Withdrawal by Subject|1
271286|NCT02090764|903790|P1|Overall Study|Withdrawal by Subject|2
271287|NCT02090764|903789|P2|Overall Study|Lack of Efficacy|13
271288|NCT02090764|903790|P1|Overall Study|Lack of Efficacy|0
271289|NCT02090764|903789|P2|Overall Study|Adverse Event|3
271290|NCT02090764|903790|P1|Overall Study|Adverse Event|1
271291|NCT02090413|903799|P3|Overall Study|Lost to Follow-up|0
271292|NCT02090413|903800|P2|Overall Study|Lost to Follow-up|1
271293|NCT02090413|903801|P1|Overall Study|Lost to Follow-up|1
271294|NCT02090413|903799|P3|Overall Study|Not Specified|0
271295|NCT02090413|903800|P2|Overall Study|Not Specified|1
271296|NCT02090413|903801|P1|Overall Study|Not Specified|2
271297|NCT02090413|903799|P3|Overall Study|Investigator Decision|0
271298|NCT02090413|903800|P2|Overall Study|Investigator Decision|1
271299|NCT02090413|903801|P1|Overall Study|Investigator Decision|1
271300|NCT02090413|903799|P3|Overall Study|Withdrawal by Subject|2
271301|NCT02090413|903800|P2|Overall Study|Withdrawal by Subject|2
271302|NCT02090413|903801|P1|Overall Study|Withdrawal by Subject|2
271303|NCT02090413|903799|P3|Overall Study|Flushing event|1
271304|NCT02090413|903800|P2|Overall Study|Flushing event|0
271305|NCT02090413|903801|P1|Overall Study|Flushing event|2
271306|NCT02090413|903799|P3|Overall Study|Adverse Event|20
271307|NCT02090413|903800|P2|Overall Study|Adverse Event|15
271308|NCT02090413|903801|P1|Overall Study|Adverse Event|11
271309|NCT02089737|903887|P1|Overall Study|Not treated|1
271310|NCT02089737|903887|P1|Overall Study|Survey form not completed|5
271311|NCT02089347|903896|P2|Overall Study|Protocol Violation|0
271312|NCT02089347|903897|P1|Overall Study|Protocol Violation|1
271313|NCT02088957|903937|P2|Overall Study|Lack of Efficacy|0
271314|NCT02088957|903938|P1|Overall Study|Lack of Efficacy|1
271315|NCT02088177|903954|P1|Overall Study|Lost to Follow-up|3
271316|NCT02087943|903966|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
271317|NCT02087943|903967|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
271318|NCT02087943|903968|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
271319|NCT02087943|903969|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
271320|NCT02087943|903970|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
271321|NCT02087943|903966|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
271322|NCT02087943|903967|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
271323|NCT02087943|903968|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
271324|NCT02087943|903969|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
271325|NCT02087943|903970|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
271326|NCT02087943|903966|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
271327|NCT02087943|903967|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
271328|NCT02087943|903968|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
271329|NCT02087943|903969|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
271330|NCT02087943|903970|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
271331|NCT02087943|903966|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
271332|NCT02087943|903967|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
271333|NCT02087943|903968|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
271334|NCT02087943|903969|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
271335|NCT02087943|903970|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
271336|NCT02087943|903966|P5|Active Treatment Phase Week 12-24|Adverse Event|1
271337|NCT02087943|903967|P4|Active Treatment Phase Week 12-24|Adverse Event|0
271338|NCT02087943|903968|P3|Active Treatment Phase Week 12-24|Adverse Event|2
271339|NCT02087943|903969|P2|Active Treatment Phase Week 12-24|Adverse Event|1
271340|NCT02087943|903970|P1|Active Treatment Phase Week 12-24|Adverse Event|0
271341|NCT02087943|903966|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
271342|NCT02087943|903967|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
271343|NCT02087943|903968|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
271344|NCT02087943|903969|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
271345|NCT02087943|903970|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
271346|NCT02087943|903966|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
271347|NCT02087943|903967|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
271348|NCT02087943|903968|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
271349|NCT02087943|903969|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
271350|NCT02087943|903970|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
271351|NCT02087943|903966|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
271352|NCT02087943|903967|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
271353|NCT02087943|903968|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
271354|NCT02087943|903969|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
271355|NCT02087943|903970|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
271356|NCT02087943|903966|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
271357|NCT02087943|903967|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
271358|NCT02087943|903968|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
271359|NCT02087943|903969|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
271360|NCT02087943|903970|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
271361|NCT02087943|903966|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
271362|NCT02087943|903967|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
271363|NCT02087943|903968|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
271364|NCT02087943|903969|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
271365|NCT02087943|903970|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
271366|NCT02087774|903996|P2|Overall Study|Were absent day of data collection|20
271367|NCT02087774|903997|P1|Overall Study|Were absent day of data collection|8
271368|NCT02087670|904017|P2|Overall Study|Withdrawal by Subject|2
271369|NCT02087670|904018|P1|Overall Study|Withdrawal by Subject|3
271370|NCT02087423|904054|P3|Overall Study|Ongoing treatment at data cutoff|18
271371|NCT02087423|904055|P2|Overall Study|Ongoing treatment at data cutoff|0
271372|NCT02087423|904056|P1|Overall Study|Ongoing treatment at data cutoff|10
271373|NCT02087423|904054|P3|Overall Study|Adverse Event|3
271374|NCT02087423|904055|P2|Overall Study|Adverse Event|24
271375|NCT02087423|904056|P1|Overall Study|Adverse Event|2
271376|NCT02087423|904054|P3|Overall Study|Withdrawal by Subject|2
271377|NCT02087423|904055|P2|Overall Study|Withdrawal by Subject|7
271378|NCT02087423|904056|P1|Overall Study|Withdrawal by Subject|5
271379|NCT02087423|904054|P3|Overall Study|Physician Decision|35
271380|NCT02087423|904055|P2|Overall Study|Physician Decision|174
271381|NCT02087423|904056|P1|Overall Study|Physician Decision|86
271382|NCT02087241|904080|P4|Overall Study|Study Terminated by Sponsor|4
271383|NCT02087241|904081|P3|Overall Study|Study Terminated by Sponsor|0
271384|NCT02087241|904082|P2|Overall Study|Study Terminated by Sponsor|2
271385|NCT02087241|904083|P1|Overall Study|Study Terminated by Sponsor|0
271386|NCT02087241|904080|P4|Overall Study|Progressive Disease|1
271387|NCT02087241|904081|P3|Overall Study|Progressive Disease|0
271388|NCT02087241|904082|P2|Overall Study|Progressive Disease|0
271389|NCT02087241|904083|P1|Overall Study|Progressive Disease|0
271390|NCT02087241|904080|P4|Overall Study|Withdrawal by Subject|1
271391|NCT02087241|904081|P3|Overall Study|Withdrawal by Subject|0
271392|NCT02087241|904082|P2|Overall Study|Withdrawal by Subject|0
271393|NCT02087241|904083|P1|Overall Study|Withdrawal by Subject|1
271394|NCT02087241|904080|P4|Overall Study|Death|1
271395|NCT02087241|904081|P3|Overall Study|Death|1
271396|NCT02087241|904082|P2|Overall Study|Death|1
271397|NCT02087241|904083|P1|Overall Study|Death|2
271398|NCT02087176|904109|P1|Overall Study|Study Terminated by Sponsor|2
271399|NCT02087176|904109|P1|Overall Study|Censored|19
271400|NCT02087176|904109|P1|Overall Study|Death|10
271401|NCT02087176|904109|P1|Overall Study|Withdrawal by Subject|1
271402|NCT02087059|904114|P1|Overall Study|Lost to Follow-up|1
271403|NCT02087059|904114|P1|Overall Study|Adverse Event|5
271404|NCT02087059|904114|P1|Overall Study|Disease Progression|1
271405|NCT02086591|904161|P1|Overall Study|protocol terminated|3
271406|NCT02086591|904161|P1|Overall Study|Withdrawal by Subject|1
271407|NCT02086591|904161|P1|Overall Study|Adverse Event|1
271412|NCT02085161|904194|P4|Overall Study|Other Reason|1
271413|NCT02085161|904195|P3|Overall Study|Other Reason|1
271414|NCT02085161|904196|P2|Overall Study|Other Reason|0
271415|NCT02085161|904197|P1|Overall Study|Other Reason|1
271416|NCT02085161|904194|P4|Overall Study|Withdrawal by Subject|3
271417|NCT02085161|904195|P3|Overall Study|Withdrawal by Subject|0
271418|NCT02085161|904196|P2|Overall Study|Withdrawal by Subject|4
271419|NCT02085161|904197|P1|Overall Study|Withdrawal by Subject|2
271420|NCT02085161|904194|P4|Overall Study|Protocol Violation|1
271421|NCT02085161|904195|P3|Overall Study|Protocol Violation|0
271422|NCT02085161|904196|P2|Overall Study|Protocol Violation|1
271423|NCT02085161|904197|P1|Overall Study|Protocol Violation|0
271424|NCT02085161|904194|P4|Overall Study|Adverse Event|5
271425|NCT02085161|904195|P3|Overall Study|Adverse Event|4
271426|NCT02085161|904196|P2|Overall Study|Adverse Event|5
271427|NCT02085161|904197|P1|Overall Study|Adverse Event|8
271428|NCT02085161|904194|P4|Overall Study|Not Treated|0
271429|NCT02085161|904195|P3|Overall Study|Not Treated|0
271430|NCT02085161|904196|P2|Overall Study|Not Treated|0
271431|NCT02085161|904197|P1|Overall Study|Not Treated|1
271432|NCT02084238|904265|P1|Overall Study|Lost to Follow-up|2
271433|NCT02084134|904278|P2|Overall Study|Death|1
271434|NCT02084134|904279|P1|Overall Study|Death|0
271435|NCT02084134|904278|P2|Overall Study|Protocol Violation|2
271436|NCT02084134|904279|P1|Overall Study|Protocol Violation|4
271437|NCT02084082|904289|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
271438|NCT02084082|904290|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
271439|NCT02084082|904291|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
271440|NCT02084082|904292|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
271441|NCT02084082|904289|P4|Washout Period 1 (35 Days)|Adverse Event|1
271442|NCT02084082|904290|P3|Washout Period 1 (35 Days)|Adverse Event|1
271443|NCT02084082|904291|P2|Washout Period 1 (35 Days)|Adverse Event|0
271444|NCT02084082|904292|P1|Washout Period 1 (35 Days)|Adverse Event|0
271445|NCT02084056|904333|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
271446|NCT02084056|904334|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
271447|NCT02084056|904335|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
271448|NCT02084056|904336|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
271449|NCT02084056|904333|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
271450|NCT02084056|904334|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
271451|NCT02084056|904335|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
271452|NCT02084056|904336|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
271453|NCT02083965|904368|P2|Treatment Period|Not Specified|0
271454|NCT02083965|904369|P1|Treatment Period|Not Specified|1
271455|NCT02083380|904486|P3|Overall Study|Other|6
271456|NCT02083380|904487|P2|Overall Study|Other|4
271457|NCT02083380|904488|P1|Overall Study|Other|8
271458|NCT02083380|904486|P3|Overall Study|Lost to Follow-up|3
271459|NCT02083380|904487|P2|Overall Study|Lost to Follow-up|3
271460|NCT02083380|904488|P1|Overall Study|Lost to Follow-up|5
271461|NCT02083380|904486|P3|Overall Study|Adverse Event|1
271462|NCT02083380|904487|P2|Overall Study|Adverse Event|0
271463|NCT02083380|904488|P1|Overall Study|Adverse Event|0
271464|NCT02083380|904486|P3|Overall Study|Physician Decision|3
271465|NCT02083380|904487|P2|Overall Study|Physician Decision|6
271466|NCT02083380|904488|P1|Overall Study|Physician Decision|1
271467|NCT02083380|904486|P3|Overall Study|Withdrawal by Subject|7
271468|NCT02083380|904487|P2|Overall Study|Withdrawal by Subject|3
271469|NCT02083380|904488|P1|Overall Study|Withdrawal by Subject|9
271470|NCT02083380|904486|P3|Overall Study|Lack of Efficacy|64
271471|NCT02083380|904487|P2|Overall Study|Lack of Efficacy|79
271472|NCT02083380|904488|P1|Overall Study|Lack of Efficacy|68
271473|NCT02083185|904593|P3|Overall Study|Did not Receive Study Drug|0
271474|NCT02083185|904594|P2|Overall Study|Did not Receive Study Drug|2
271475|NCT02083185|904595|P1|Overall Study|Did not Receive Study Drug|0
271476|NCT02083185|904593|P3|Overall Study|Study Terminated by Sponsor|0
271477|NCT02083185|904594|P2|Overall Study|Study Terminated by Sponsor|1
271478|NCT02083185|904595|P1|Overall Study|Study Terminated by Sponsor|0
271479|NCT02083185|904593|P3|Overall Study|Reason not Specified|5
271480|NCT02083185|904594|P2|Overall Study|Reason not Specified|6
271481|NCT02083185|904595|P1|Overall Study|Reason not Specified|9
271482|NCT02083185|904593|P3|Overall Study|Death|1
271483|NCT02083185|904594|P2|Overall Study|Death|2
271484|NCT02083185|904595|P1|Overall Study|Death|2
271485|NCT02083185|904593|P3|Overall Study|Withdrawal by Subject|1
271486|NCT02083185|904594|P2|Overall Study|Withdrawal by Subject|15
271487|NCT02083185|904595|P1|Overall Study|Withdrawal by Subject|9
271488|NCT02083185|904593|P3|Overall Study|Lost to Follow-up|0
271489|NCT02083185|904594|P2|Overall Study|Lost to Follow-up|3
271490|NCT02083185|904595|P1|Overall Study|Lost to Follow-up|0
271491|NCT02082912|904692|P2|Overall Study|Physician Decision|1
271492|NCT02082912|904693|P1|Overall Study|Physician Decision|0
271493|NCT02082262|904757|P1|Overall Study|Adverse Event|48
271494|NCT02082262|904757|P1|Overall Study|Withdrawal by Subject|3
271495|NCT02082184|904763|P2|Overall Study|Subject non-compliance|1
271496|NCT02082184|904764|P1|Overall Study|Subject non-compliance|0
271497|NCT02082184|904763|P2|Overall Study|Lost to Follow-up|2
271498|NCT02082184|904764|P1|Overall Study|Lost to Follow-up|0
271499|NCT02082184|904763|P2|Overall Study|Protocol Violation|6
271500|NCT02082184|904764|P1|Overall Study|Protocol Violation|0
271501|NCT02082184|904763|P2|Overall Study|Withdrawal by Subject|2
271502|NCT02082184|904764|P1|Overall Study|Withdrawal by Subject|3
271503|NCT02082184|904763|P2|Overall Study|Device associated symptoms|0
271504|NCT02082184|904764|P1|Overall Study|Device associated symptoms|5
271505|NCT02082184|904763|P2|Overall Study|Medical diagnosis|2
271506|NCT02082184|904764|P1|Overall Study|Medical diagnosis|1
271507|NCT02082184|904763|P2|Overall Study|Adverse Event|0
271508|NCT02082184|904764|P1|Overall Study|Adverse Event|1
271509|NCT02082158|904789|P6|Overall Study|Failed Fit-testing|7
271510|NCT02082158|904790|P5|Overall Study|Failed Fit-testing|3
271511|NCT02082158|904791|P4|Overall Study|Failed Fit-testing|4
271512|NCT02082158|904792|P3|Overall Study|Failed Fit-testing|14
271513|NCT02082158|904793|P2|Overall Study|Failed Fit-testing|8
271514|NCT02082158|904794|P1|Overall Study|Failed Fit-testing|8
271515|NCT02082158|904789|P6|Overall Study|Withdrawal by Subject|0
271516|NCT02082158|904790|P5|Overall Study|Withdrawal by Subject|1
271517|NCT02082158|904791|P4|Overall Study|Withdrawal by Subject|0
271518|NCT02082158|904792|P3|Overall Study|Withdrawal by Subject|0
271519|NCT02082158|904793|P2|Overall Study|Withdrawal by Subject|0
271520|NCT02082158|904794|P1|Overall Study|Withdrawal by Subject|0
271521|NCT02081859|904816|P2|Overall Study|Other reasons|0
271522|NCT02081859|904817|P1|Overall Study|Other reasons|2
271523|NCT02081859|904816|P2|Overall Study|< 4 embryos|23
271524|NCT02081859|904817|P1|Overall Study|< 4 embryos|27
271525|NCT02081859|904816|P2|Overall Study|Unanticipated freeze all cycle|6
271526|NCT02081859|904817|P1|Overall Study|Unanticipated freeze all cycle|2
271527|NCT02081859|904816|P2|Overall Study|No sperm|0
271528|NCT02081859|904817|P1|Overall Study|No sperm|1
271529|NCT02081859|904816|P2|Overall Study|No fertilization|2
271530|NCT02081859|904817|P1|Overall Study|No fertilization|2
271531|NCT02081690|904825|P1|Overall Study|Withdrawal by Subject|1
271532|NCT02081690|904825|P1|Overall Study|Physician Decision|3
271533|NCT02081690|904825|P1|Overall Study|Death|3
271534|NCT02081677|904836|P4|Overall Study|Unsatisfactory Lens Fitting|0
271535|NCT02081677|904837|P3|Overall Study|Unsatisfactory Lens Fitting|0
271536|NCT02081677|904838|P2|Overall Study|Unsatisfactory Lens Fitting|1
271537|NCT02081677|904839|P1|Overall Study|Unsatisfactory Lens Fitting|0
271538|NCT02081677|904836|P4|Overall Study|Not comfortable with lens care system|0
271539|NCT02081677|904837|P3|Overall Study|Not comfortable with lens care system|0
271540|NCT02081677|904838|P2|Overall Study|Not comfortable with lens care system|0
271541|NCT02081677|904839|P1|Overall Study|Not comfortable with lens care system|1
271542|NCT02081677|904836|P4|Overall Study|No Longer Meets Eligibility Criteria|0
271543|NCT02081677|904837|P3|Overall Study|No Longer Meets Eligibility Criteria|1
271544|NCT02081677|904838|P2|Overall Study|No Longer Meets Eligibility Criteria|0
271545|NCT02081677|904839|P1|Overall Study|No Longer Meets Eligibility Criteria|0
271546|NCT02081677|904836|P4|Overall Study|Adverse Event|0
271547|NCT02081677|904837|P3|Overall Study|Adverse Event|1
271548|NCT02081677|904838|P2|Overall Study|Adverse Event|0
271549|NCT02081677|904839|P1|Overall Study|Adverse Event|0
271550|NCT02081599|904931|P2|Period 2：Open-label Period|Withdrawal by Subject|0
271551|NCT02081599|904932|P1|Period 2：Open-label Period|Withdrawal by Subject|2
271552|NCT02081599|904931|P2|Period 2：Open-label Period|Physician Decision|0
271553|NCT02081599|904932|P1|Period 2：Open-label Period|Physician Decision|1
271554|NCT02081599|904931|P2|Period 2：Open-label Period|Lack of Efficacy|4
271555|NCT02081599|904932|P1|Period 2：Open-label Period|Lack of Efficacy|2
271556|NCT02081599|904931|P2|Period 2：Open-label Period|Adverse Event|0
271557|NCT02081599|904932|P1|Period 2：Open-label Period|Adverse Event|1
271558|NCT02081599|904931|P2|Period 1：Double-blind Period|stopping criteria|0
271559|NCT02081599|904932|P1|Period 1：Double-blind Period|stopping criteria|1
271560|NCT02081599|904931|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
271561|NCT02081599|904932|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
271562|NCT02081599|904931|P2|Period 1：Double-blind Period|Protocol Violation|1
271563|NCT02081599|904932|P1|Period 1：Double-blind Period|Protocol Violation|0
271564|NCT02081599|904931|P2|Period 1：Double-blind Period|Physician Decision|0
271565|NCT02081599|904932|P1|Period 1：Double-blind Period|Physician Decision|1
271566|NCT02081599|904931|P2|Period 1：Double-blind Period|Lack of Efficacy|1
271567|NCT02081599|904932|P1|Period 1：Double-blind Period|Lack of Efficacy|2
271568|NCT02081599|904931|P2|Period 1：Double-blind Period|Adverse Event|0
271569|NCT02081599|904932|P1|Period 1：Double-blind Period|Adverse Event|3
271570|NCT02081586|904950|P4|Overall Study|Head injury not related to study|0
271571|NCT02081586|904951|P3|Overall Study|Head injury not related to study|1
271572|NCT02081586|904952|P2|Overall Study|Head injury not related to study|0
271573|NCT02081586|904953|P1|Overall Study|Head injury not related to study|0
271574|NCT02081586|904950|P4|Overall Study|Lost to Follow-up|1
271575|NCT02081586|904951|P3|Overall Study|Lost to Follow-up|0
271576|NCT02081586|904952|P2|Overall Study|Lost to Follow-up|1
271577|NCT02081586|904953|P1|Overall Study|Lost to Follow-up|0
271578|NCT02081183|905044|P2|Overall Study|Not specified|3
271579|NCT02081183|905045|P1|Overall Study|Not specified|3
271580|NCT02081183|905044|P2|Overall Study|Protocol Violation|0
271581|NCT02081183|905045|P1|Overall Study|Protocol Violation|1
271582|NCT02081183|905044|P2|Overall Study|Lost to Follow-up|1
271583|NCT02081183|905045|P1|Overall Study|Lost to Follow-up|0
271584|NCT02081079|905061|P2|Overall Study|Lost to Follow-up|0
271585|NCT02081079|905062|P1|Overall Study|Lost to Follow-up|1
271586|NCT02081079|905061|P2|Overall Study|Lack of Efficacy|2
271587|NCT02081079|905062|P1|Overall Study|Lack of Efficacy|3
271588|NCT02081001|905135|P12|Overall Study|Adverse Event|0
271589|NCT02081001|905136|P11|Overall Study|Adverse Event|0
271590|NCT02081001|905137|P10|Overall Study|Adverse Event|0
271591|NCT02081001|905138|P9|Overall Study|Adverse Event|0
271592|NCT02081001|905139|P8|Overall Study|Adverse Event|0
271593|NCT02081001|905140|P7|Overall Study|Adverse Event|0
271594|NCT02081001|905141|P6|Overall Study|Adverse Event|0
271595|NCT02081001|905142|P5|Overall Study|Adverse Event|1
271596|NCT02081001|905143|P4|Overall Study|Adverse Event|0
271597|NCT02081001|905144|P3|Overall Study|Adverse Event|0
271598|NCT02081001|905145|P2|Overall Study|Adverse Event|0
271599|NCT02081001|905146|P1|Overall Study|Adverse Event|0
271600|NCT02080832|905213|P3|Overall Study|Lost to Follow-up|2
271601|NCT02080832|905214|P2|Overall Study|Lost to Follow-up|2
271602|NCT02080832|905215|P1|Overall Study|Lost to Follow-up|0
271603|NCT02080832|905213|P3|Overall Study|Excluded from analysis by MRI|14
271604|NCT02080832|905214|P2|Overall Study|Excluded from analysis by MRI|10
271605|NCT02080832|905215|P1|Overall Study|Excluded from analysis by MRI|9
271606|NCT02080481|905273|P2|Overall Study|Never received a block.|0
271607|NCT02080481|905274|P1|Overall Study|Never received a block.|1
271608|NCT02080091|905292|P1|Overall Study|Other|1
271609|NCT02080091|905292|P1|Overall Study|Withdrawal by Subject|1
271610|NCT02080091|905292|P1|Overall Study|Death|1
271611|NCT02080091|905292|P1|Overall Study|Study Terminated|22
271612|NCT02079844|905301|P3|Treatment Period 2|Voluntary Withdrawal|0
271613|NCT02079844|905302|P2|Treatment Period 2|Voluntary Withdrawal|1
271614|NCT02079844|905303|P1|Treatment Period 2|Voluntary Withdrawal|0
271615|NCT02079844|905301|P3|Treatment Period 1|Voluntary Withdrawal|2
271616|NCT02079844|905302|P2|Treatment Period 1|Voluntary Withdrawal|0
271617|NCT02079844|905303|P1|Treatment Period 1|Voluntary Withdrawal|0
271618|NCT02079805|905361|P2|Overall Study|Voluntary Withdrawal|1
271619|NCT02079805|905362|P1|Overall Study|Voluntary Withdrawal|0
271620|NCT02079805|905361|P2|Overall Study|Pretreatment Event/Adverse Event|1
271621|NCT02079805|905362|P1|Overall Study|Pretreatment Event/Adverse Event|0
271622|NCT02079649|905384|P4|Overall Study|Randomization error (prior to treatment)|0
271623|NCT02079649|905385|P3|Overall Study|Randomization error (prior to treatment)|1
271624|NCT02079649|905386|P2|Overall Study|Randomization error (prior to treatment)|0
271625|NCT02079649|905387|P1|Overall Study|Randomization error (prior to treatment)|1
271626|NCT02079649|905384|P4|Overall Study|Withdrawal by Subject|1
271627|NCT02079649|905385|P3|Overall Study|Withdrawal by Subject|0
271628|NCT02079649|905386|P2|Overall Study|Withdrawal by Subject|0
271629|NCT02079649|905387|P1|Overall Study|Withdrawal by Subject|0
271630|NCT02079649|905384|P4|Overall Study|Lost to Follow-up|1
271631|NCT02079649|905385|P3|Overall Study|Lost to Follow-up|0
271632|NCT02079649|905386|P2|Overall Study|Lost to Follow-up|0
271633|NCT02079649|905387|P1|Overall Study|Lost to Follow-up|0
271634|NCT02079610|905404|P2|Overall Study|Withdrawal by Subject|1
271635|NCT02079610|905405|P1|Overall Study|Withdrawal by Subject|1
271636|NCT02079532|905415|P1|Overall Study|Not specified|3
271637|NCT02079532|905415|P1|Overall Study|Inclusion into ReFIRST|3
271638|NCT02079532|905415|P1|Overall Study|Administrative problems|1
271639|NCT02079532|905415|P1|Overall Study|Withdrawal by Subject|1
271640|NCT02079532|905415|P1|Overall Study|Protocol Violation|3
271641|NCT02079532|905415|P1|Overall Study|Lack of Efficacy|9
271642|NCT02079532|905415|P1|Overall Study|Additional or changed therapy|2
271643|NCT02079532|905415|P1|Overall Study|Adverse Event|7
271644|NCT02079519|905437|P1|Overall Study|Adverse Event|1
271645|NCT02079519|905437|P1|Overall Study|Disease Progression|9
271646|NCT02077374|905495|P2|Overall Study|Protocol Violation|1
271647|NCT02077374|905496|P1|Overall Study|Protocol Violation|0
271648|NCT02077374|905495|P2|Overall Study|Withdrawal by Subject|1
271649|NCT02077374|905496|P1|Overall Study|Withdrawal by Subject|0
271650|NCT02077140|905517|P5|Overall Study|Withdrawal by Subject|2
271651|NCT02077140|905518|P4|Overall Study|Withdrawal by Subject|2
271652|NCT02077140|905519|P3|Overall Study|Withdrawal by Subject|0
271653|NCT02077140|905520|P2|Overall Study|Withdrawal by Subject|1
271654|NCT02077140|905521|P1|Overall Study|Withdrawal by Subject|0
271655|NCT02077140|905517|P5|Overall Study|Lost to Follow-up|3
271656|NCT02077140|905518|P4|Overall Study|Lost to Follow-up|2
271657|NCT02077140|905519|P3|Overall Study|Lost to Follow-up|2
271658|NCT02077140|905520|P2|Overall Study|Lost to Follow-up|1
271659|NCT02077140|905521|P1|Overall Study|Lost to Follow-up|4
271660|NCT02076334|905725|P4|Overall Study|muscle soreness|1
271661|NCT02076334|905726|P3|Overall Study|muscle soreness|0
271662|NCT02076334|905727|P2|Overall Study|muscle soreness|0
271663|NCT02076334|905728|P1|Overall Study|muscle soreness|0
271664|NCT02076334|905725|P4|Overall Study|Lost to Follow-up|0
271665|NCT02076334|905726|P3|Overall Study|Lost to Follow-up|1
271666|NCT02076334|905727|P2|Overall Study|Lost to Follow-up|1
271667|NCT02076334|905728|P1|Overall Study|Lost to Follow-up|0
271668|NCT02076334|905725|P4|Overall Study|Protocol Violation|0
271669|NCT02076334|905726|P3|Overall Study|Protocol Violation|0
271670|NCT02076334|905727|P2|Overall Study|Protocol Violation|0
271671|NCT02076334|905728|P1|Overall Study|Protocol Violation|1
271672|NCT02076178|905761|P2|Injection Phase|Lost to Follow-up|1
271673|NCT02076178|905762|P1|Injection Phase|Lost to Follow-up|0
271674|NCT02076178|905761|P2|Injection Phase|Physician Decision|3
271675|NCT02076178|905762|P1|Injection Phase|Physician Decision|0
271676|NCT02076178|905761|P2|Injection Phase|Withdrawal by Subject|3
271677|NCT02076178|905762|P1|Injection Phase|Withdrawal by Subject|0
271678|NCT02076178|905761|P2|Injection Phase|Protocol defined stopping criteria|0
271679|NCT02076178|905762|P1|Injection Phase|Protocol defined stopping criteria|1
271680|NCT02076178|905761|P2|Oral Phase|Physician Decision|1
271681|NCT02076178|905762|P1|Oral Phase|Physician Decision|0
271682|NCT02076178|905761|P2|Oral Phase|Withdrawal by Subject|4
271683|NCT02076178|905762|P1|Oral Phase|Withdrawal by Subject|0
271684|NCT02076178|905761|P2|Oral Phase|Adverse Event|7
271685|NCT02076178|905762|P1|Oral Phase|Adverse Event|0
271686|NCT02076009|905796|P2|Overall Study|Subjects randomized but not treated|3
271687|NCT02076009|905797|P1|Overall Study|Subjects randomized but not treated|2
271688|NCT02076009|905796|P2|Overall Study|Ongoing|249
271689|NCT02076009|905797|P1|Overall Study|Ongoing|226
271690|NCT02076009|905796|P2|Overall Study|Progressive disease|0
271691|NCT02076009|905797|P1|Overall Study|Progressive disease|1
271692|NCT02076009|905796|P2|Overall Study|Lost to Follow-up|1
271693|NCT02076009|905797|P1|Overall Study|Lost to Follow-up|1
271694|NCT02076009|905796|P2|Overall Study|Withdrawal by Subject|3
271695|NCT02076009|905797|P1|Overall Study|Withdrawal by Subject|9
271696|NCT02076009|905796|P2|Overall Study|Death|30
271697|NCT02076009|905797|P1|Overall Study|Death|44
271698|NCT02075840|905819|P2|Overall Study|Ongoing at CCOD|82
271699|NCT02075840|905820|P1|Overall Study|Ongoing at CCOD|99
271700|NCT02075840|905819|P2|Overall Study|Physician Decision|3
271701|NCT02075840|905820|P1|Overall Study|Physician Decision|1
271702|NCT02075840|905819|P2|Overall Study|Lost to Follow-up|2
271703|NCT02075840|905820|P1|Overall Study|Lost to Follow-up|3
271704|NCT02075840|905819|P2|Overall Study|Death|40
271705|NCT02075840|905820|P1|Overall Study|Death|35
271706|NCT02075840|905819|P2|Overall Study|Adverse Event|2
271707|NCT02075840|905820|P1|Overall Study|Adverse Event|0
271708|NCT02075840|905819|P2|Overall Study|Reason not specified|0
271709|NCT02075840|905820|P1|Overall Study|Reason not specified|1
271710|NCT02075840|905819|P2|Overall Study|Withdrawal by Subject|22
271711|NCT02075840|905820|P1|Overall Study|Withdrawal by Subject|13
271712|NCT02075658|905876|P2|Overall Study|Physician Decision|2
271713|NCT02075658|905877|P1|Overall Study|Physician Decision|2
271714|NCT02075632|905887|P2|Overall Study|Withdrawal by Subject|1
271715|NCT02075632|905888|P1|Overall Study|Withdrawal by Subject|0
271716|NCT02075632|905887|P2|Overall Study|Lost to Follow-up|3
271717|NCT02075632|905888|P1|Overall Study|Lost to Follow-up|0
271718|NCT02075632|905887|P2|Overall Study|Adverse Event|1
271719|NCT02075632|905888|P1|Overall Study|Adverse Event|1
271720|NCT02075515|905901|P3|Overall Study|Lost to Follow-up|6
271721|NCT02075515|905902|P2|Overall Study|Lost to Follow-up|3
271722|NCT02075515|905903|P1|Overall Study|Lost to Follow-up|1
271723|NCT02075515|905901|P3|Overall Study|Withdrawal by Subject|1
271724|NCT02075515|905902|P2|Overall Study|Withdrawal by Subject|0
271725|NCT02075515|905903|P1|Overall Study|Withdrawal by Subject|2
271726|NCT02075515|905901|P3|Overall Study|Non-Serious Adverse Event|0
271727|NCT02075515|905902|P2|Overall Study|Non-Serious Adverse Event|1
271728|NCT02075515|905903|P1|Overall Study|Non-Serious Adverse Event|0
271729|NCT02075515|905901|P3|Overall Study|Serious Adverse Event|1
271730|NCT02075515|905902|P2|Overall Study|Serious Adverse Event|1
271731|NCT02075515|905903|P1|Overall Study|Serious Adverse Event|1
271732|NCT02075463|905938|P1|Overall Study|Withdrawal by Subject|1
271733|NCT02075463|905938|P1|Overall Study|Par. reached stopping criteria|4
271734|NCT02075463|905938|P1|Overall Study|Adverse Event|3
271735|NCT02075320|905988|P1|Overall Study|Withdrawal by Subject|2
271736|NCT02075255|905998|P3|Overall Study|Death|0
271737|NCT02075255|905999|P2|Overall Study|Death|2
271738|NCT02075255|906000|P1|Overall Study|Death|0
271739|NCT02075255|905998|P3|Overall Study|Adverse Event|1
271740|NCT02075255|905999|P2|Overall Study|Adverse Event|0
271741|NCT02075255|906000|P1|Overall Study|Adverse Event|0
271742|NCT02075255|905998|P3|Overall Study|Lost to Follow-up|1
271743|NCT02075255|905999|P2|Overall Study|Lost to Follow-up|0
271744|NCT02075255|906000|P1|Overall Study|Lost to Follow-up|0
271745|NCT02075255|905998|P3|Overall Study|Withdrawal by Subject|0
271746|NCT02075255|905999|P2|Overall Study|Withdrawal by Subject|1
271747|NCT02075255|906000|P1|Overall Study|Withdrawal by Subject|4
271748|NCT02075255|905998|P3|Overall Study|Study specific withdrawal criteria|1
271749|NCT02075255|905999|P2|Overall Study|Study specific withdrawal criteria|1
271750|NCT02075255|906000|P1|Overall Study|Study specific withdrawal criteria|0
271751|NCT02075073|906131|P3|Overall Study|Withdrawal by Subject|0
271752|NCT02075073|906132|P2|Overall Study|Withdrawal by Subject|1
271753|NCT02075073|906133|P1|Overall Study|Withdrawal by Subject|0
271754|NCT02075008|906155|P1|Overall Study|Study terminated by Sponsor|159
271755|NCT02075008|906155|P1|Overall Study|Withdrawal by Subject|6
271756|NCT02075008|906155|P1|Overall Study|Adverse Event|5
271757|NCT02075008|906155|P1|Overall Study|Death|1
271758|NCT02075008|906155|P1|Overall Study|Lack of Efficacy|1
271759|NCT02075008|906155|P1|Overall Study|Lost to Follow-up|1
271760|NCT02075008|906155|P1|Overall Study|Physician Decision|1
271761|NCT02075008|906155|P1|Overall Study|Pregnancy|1
271762|NCT02075008|906155|P1|Overall Study|Technical problems|1
271763|NCT02074982|906178|P2|Overall Study|Death|2
271764|NCT02074982|906179|P1|Overall Study|Death|0
271765|NCT02074982|906178|P2|Overall Study|Subject/guardian decision|24
271766|NCT02074982|906179|P1|Overall Study|Subject/guardian decision|15
271767|NCT02074982|906178|P2|Overall Study|Technical problems|2
271768|NCT02074982|906179|P1|Overall Study|Technical problems|0
271769|NCT02074982|906178|P2|Overall Study|Protocol deviation|3
271770|NCT02074982|906179|P1|Overall Study|Protocol deviation|4
271771|NCT02074982|906178|P2|Overall Study|Pregnancy|2
271772|NCT02074982|906179|P1|Overall Study|Pregnancy|1
271773|NCT02074982|906178|P2|Overall Study|Physician Decision|1
271774|NCT02074982|906179|P1|Overall Study|Physician Decision|1
271775|NCT02074982|906178|P2|Overall Study|Non-compliance with study treatment|2
271776|NCT02074982|906179|P1|Overall Study|Non-compliance with study treatment|0
271777|NCT02074982|906178|P2|Overall Study|Lost to Follow-up|10
271778|NCT02074982|906179|P1|Overall Study|Lost to Follow-up|9
271779|NCT02074982|906178|P2|Overall Study|Lack of Efficacy|1
271780|NCT02074982|906179|P1|Overall Study|Lack of Efficacy|6
271781|NCT02074982|906178|P2|Overall Study|Adverse Event|7
271782|NCT02074982|906179|P1|Overall Study|Adverse Event|15
271783|NCT02074553|906217|P8|Washout Period 3|Physician Decision|1
271784|NCT02074553|906218|P7|Washout Period 3|Physician Decision|0
271785|NCT02074553|906219|P6|Washout Period 3|Physician Decision|0
271786|NCT02074553|906220|P5|Washout Period 3|Physician Decision|0
271787|NCT02074553|906221|P4|Washout Period 3|Physician Decision|0
271788|NCT02074553|906222|P3|Washout Period 3|Physician Decision|0
271789|NCT02074553|906223|P2|Washout Period 3|Physician Decision|0
271790|NCT02074553|906224|P1|Washout Period 3|Physician Decision|0
271791|NCT02074553|906217|P8|Washout Period 2|Lost to Follow-up|0
271792|NCT02074553|906218|P7|Washout Period 2|Lost to Follow-up|0
271793|NCT02074553|906219|P6|Washout Period 2|Lost to Follow-up|0
271794|NCT02074553|906220|P5|Washout Period 2|Lost to Follow-up|0
271795|NCT02074553|906221|P4|Washout Period 2|Lost to Follow-up|0
271796|NCT02074553|906222|P3|Washout Period 2|Lost to Follow-up|1
271797|NCT02074553|906223|P2|Washout Period 2|Lost to Follow-up|0
271798|NCT02074553|906224|P1|Washout Period 2|Lost to Follow-up|0
271799|NCT02074553|906217|P8|Washout Period 2|Physician Decision|0
271800|NCT02074553|906218|P7|Washout Period 2|Physician Decision|0
271801|NCT02074553|906219|P6|Washout Period 2|Physician Decision|1
271802|NCT02074553|906220|P5|Washout Period 2|Physician Decision|0
271803|NCT02074553|906221|P4|Washout Period 2|Physician Decision|0
271804|NCT02074553|906222|P3|Washout Period 2|Physician Decision|0
271805|NCT02074553|906223|P2|Washout Period 2|Physician Decision|0
271806|NCT02074553|906224|P1|Washout Period 2|Physician Decision|0
271807|NCT02074553|906217|P8|Washout Period 2|Adverse Event|0
271808|NCT02074553|906218|P7|Washout Period 2|Adverse Event|1
271809|NCT02074553|906219|P6|Washout Period 2|Adverse Event|0
271810|NCT02074553|906220|P5|Washout Period 2|Adverse Event|0
271811|NCT02074553|906221|P4|Washout Period 2|Adverse Event|0
271812|NCT02074553|906222|P3|Washout Period 2|Adverse Event|0
271813|NCT02074553|906223|P2|Washout Period 2|Adverse Event|0
271814|NCT02074553|906224|P1|Washout Period 2|Adverse Event|0
271815|NCT02074553|906217|P8|Washout Period 1|Other|0
271816|NCT02074553|906218|P7|Washout Period 1|Other|0
271817|NCT02074553|906219|P6|Washout Period 1|Other|1
271818|NCT02074553|906220|P5|Washout Period 1|Other|0
271819|NCT02074553|906221|P4|Washout Period 1|Other|0
271820|NCT02074553|906222|P3|Washout Period 1|Other|0
271821|NCT02074553|906223|P2|Washout Period 1|Other|0
271822|NCT02074553|906224|P1|Washout Period 1|Other|0
271823|NCT02074553|906217|P8|Washout Period 1|Physician Decision|0
271824|NCT02074553|906218|P7|Washout Period 1|Physician Decision|0
271825|NCT02074553|906219|P6|Washout Period 1|Physician Decision|0
271826|NCT02074553|906220|P5|Washout Period 1|Physician Decision|0
271827|NCT02074553|906221|P4|Washout Period 1|Physician Decision|1
271828|NCT02074553|906222|P3|Washout Period 1|Physician Decision|0
271829|NCT02074553|906223|P2|Washout Period 1|Physician Decision|0
271830|NCT02074553|906224|P1|Washout Period 1|Physician Decision|0
271831|NCT02074553|906217|P8|Washout Period 1|Adverse Event|0
271832|NCT02074553|906218|P7|Washout Period 1|Adverse Event|0
271833|NCT02074553|906219|P6|Washout Period 1|Adverse Event|0
271834|NCT02074553|906220|P5|Washout Period 1|Adverse Event|0
271835|NCT02074553|906221|P4|Washout Period 1|Adverse Event|0
271836|NCT02074553|906222|P3|Washout Period 1|Adverse Event|0
271837|NCT02074553|906223|P2|Washout Period 1|Adverse Event|0
271838|NCT02074553|906224|P1|Washout Period 1|Adverse Event|1
271839|NCT02074553|906217|P8|Intervention Period 1|Family Emergency|0
271840|NCT02074553|906218|P7|Intervention Period 1|Family Emergency|0
271841|NCT02074553|906219|P6|Intervention Period 1|Family Emergency|0
271842|NCT02074553|906220|P5|Intervention Period 1|Family Emergency|0
271843|NCT02074553|906221|P4|Intervention Period 1|Family Emergency|1
271844|NCT02074553|906222|P3|Intervention Period 1|Family Emergency|0
271845|NCT02074553|906223|P2|Intervention Period 1|Family Emergency|0
271846|NCT02074553|906224|P1|Intervention Period 1|Family Emergency|0
271847|NCT02074514|906406|P2|Overall Study|Withdrew Consent|1
271848|NCT02074514|906407|P1|Overall Study|Withdrew Consent|0
271849|NCT02074514|906406|P2|Overall Study|Lost to Follow-up|1
271850|NCT02074514|906407|P1|Overall Study|Lost to Follow-up|0
271851|NCT02074514|906406|P2|Overall Study|Lack of Efficacy|2
271852|NCT02074514|906407|P1|Overall Study|Lack of Efficacy|3
271853|NCT02074059|906548|P6|Overall Study|Death|1
271854|NCT02074059|906549|P5|Overall Study|Death|1
271855|NCT02074059|906550|P4|Overall Study|Death|0
271856|NCT02074059|906551|P3|Overall Study|Death|0
271857|NCT02074059|906552|P2|Overall Study|Death|0
271858|NCT02074059|906553|P1|Overall Study|Death|0
271859|NCT02073656|906600|P1|Primary Study|Withdrew Consent|1
271860|NCT02073656|906600|P1|Primary Study|Death|1
271861|NCT02073656|906600|P1|Primary Study|Lost to Follow-up|6
271862|NCT02072980|906678|P2|Period 2, Second Wear|Adverse Event|1
271863|NCT02072980|906679|P1|Period 2, Second Wear|Adverse Event|0
271864|NCT02072096|906705|P2|Overall Study|Lost to Follow-up|0
271865|NCT02072096|906706|P1|Overall Study|Lost to Follow-up|1
271866|NCT02072096|906705|P2|Overall Study|Study Terminated by Sponsor|30
271867|NCT02072096|906706|P1|Overall Study|Study Terminated by Sponsor|43
271868|NCT02072096|906705|P2|Overall Study|Physician Decision|1
271869|NCT02072096|906706|P1|Overall Study|Physician Decision|0
271870|NCT02072096|906705|P2|Overall Study|Death|0
271871|NCT02072096|906706|P1|Overall Study|Death|2
271872|NCT02072096|906705|P2|Overall Study|No Reason Provided|2
271873|NCT02072096|906706|P1|Overall Study|No Reason Provided|4
271874|NCT02072096|906705|P2|Overall Study|Adverse Event|2
271875|NCT02072096|906706|P1|Overall Study|Adverse Event|5
271876|NCT02072096|906705|P2|Overall Study|Withdrawal by Subject|7
271877|NCT02072096|906706|P1|Overall Study|Withdrawal by Subject|5
271878|NCT02072096|906705|P2|Overall Study|Protocol Violation|7
271879|NCT02072096|906706|P1|Overall Study|Protocol Violation|7
271880|NCT02072096|906705|P2|Overall Study|Lack of Efficacy|29
271881|NCT02072096|906706|P1|Overall Study|Lack of Efficacy|18
271882|NCT02071849|906728|P1|2-year Extended Follow-up|Adverse Event|1
271883|NCT02071849|906728|P1|6-month Primary Endpoint|Adverse Event|1
271884|NCT02071849|906728|P1|6-month Primary Endpoint|Did not receive device|4
271885|NCT02071771|906794|P2|Period 1: First 10 Days|Unavailable lens power|0
271886|NCT02071771|906795|P1|Period 1: First 10 Days|Unavailable lens power|1
271887|NCT02071771|906794|P2|Period 1: First 10 Days|Unacceptable lens fit|0
271888|NCT02071771|906795|P1|Period 1: First 10 Days|Unacceptable lens fit|1
271889|NCT02071082|906850|P2|Overall Study|Lost to Follow-up|1
271890|NCT02071082|906851|P1|Overall Study|Lost to Follow-up|1
271891|NCT02071082|906850|P2|Overall Study|Withdrew Consent|4
271892|NCT02071082|906851|P1|Overall Study|Withdrew Consent|0
271893|NCT02071082|906850|P2|Overall Study|Adverse Event|1
271894|NCT02071082|906851|P1|Overall Study|Adverse Event|0
271895|NCT02071082|906850|P2|Overall Study|Enrolled and Never Treated|1
271896|NCT02071082|906851|P1|Overall Study|Enrolled and Never Treated|1
271897|NCT02070965|906882|P3|Overall Study|Subject moved|0
271898|NCT02070965|906883|P2|Overall Study|Subject moved|0
271899|NCT02070965|906884|P1|Overall Study|Subject moved|1
271900|NCT02070965|906882|P3|Overall Study|Withdrawal by Subject|1
271901|NCT02070965|906883|P2|Overall Study|Withdrawal by Subject|1
271902|NCT02070965|906884|P1|Overall Study|Withdrawal by Subject|1
271903|NCT02070965|906882|P3|Overall Study|Lost to Follow-up|0
271904|NCT02070965|906883|P2|Overall Study|Lost to Follow-up|1
271905|NCT02070965|906884|P1|Overall Study|Lost to Follow-up|0
271906|NCT02070744|906896|P5|OLE Phase (48 Weeks)|Other|1
271907|NCT02070744|906897|P4|OLE Phase (48 Weeks)|Other|0
271908|NCT02070744|906898|P3|OLE Phase (48 Weeks)|Other|0
271909|NCT02070744|906899|P2|OLE Phase (48 Weeks)|Other|0
271910|NCT02070744|906900|P1|OLE Phase (48 Weeks)|Other|0
271911|NCT02070744|906896|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
271912|NCT02070744|906897|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
271913|NCT02070744|906898|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
271914|NCT02070744|906899|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
271915|NCT02070744|906900|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
271916|NCT02070744|906896|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
271917|NCT02070744|906897|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
271918|NCT02070744|906898|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
271919|NCT02070744|906899|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
271920|NCT02070744|906900|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
271921|NCT02070588|906983|P3|Overall Study|Adverse Event|0
271922|NCT02070588|906984|P2|Overall Study|Adverse Event|0
271923|NCT02070588|906985|P1|Overall Study|Adverse Event|1
271924|NCT02070588|906983|P3|Overall Study|Writhdrawal due to early termination|0
271925|NCT02070588|906984|P2|Overall Study|Writhdrawal due to early termination|0
271926|NCT02070588|906985|P1|Overall Study|Writhdrawal due to early termination|9
271927|NCT02070588|906983|P3|Overall Study|Withdrawal by Subject|0
271928|NCT02070588|906984|P2|Overall Study|Withdrawal by Subject|1
271929|NCT02070588|906985|P1|Overall Study|Withdrawal by Subject|29
271930|NCT02070380|907003|P4|Second Injection|Protocol Violation|5
271931|NCT02070380|907004|P3|Second Injection|Protocol Violation|1
271932|NCT02070380|907005|P2|Second Injection|Protocol Violation|1
271933|NCT02070380|907006|P1|Second Injection|Protocol Violation|0
271934|NCT02070380|907003|P4|Second Injection|Image sets missing or technically inadeq|0
271935|NCT02070380|907004|P3|Second Injection|Image sets missing or technically inadeq|0
271936|NCT02070380|907005|P2|Second Injection|Image sets missing or technically inadeq|1
271937|NCT02070380|907006|P1|Second Injection|Image sets missing or technically inadeq|0
271938|NCT02070380|907003|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
271939|NCT02070380|907004|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
271940|NCT02070380|907005|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
271941|NCT02070380|907006|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
271942|NCT02069093|907084|P1|Overall Study|Adverse Event|10
271943|NCT02069093|907084|P1|Overall Study|Abnormal laboratory values|1
271944|NCT02069093|907084|P1|Overall Study|Withdrawal by Subject|2
271945|NCT02069093|907084|P1|Overall Study|Administrative problems|1
271946|NCT02069093|907084|P1|Overall Study|Death|1
271947|NCT02069093|907084|P1|Overall Study|New cancer therapy|1
271948|NCT02069093|907084|P1|Overall Study|Disease progression|14
271949|NCT02068547|907095|P2|Overall Study|Physician Decision|0
271950|NCT02068547|907096|P1|Overall Study|Physician Decision|1
271951|NCT02068547|907095|P2|Overall Study|Lost to Follow-up|3
271952|NCT02068547|907096|P1|Overall Study|Lost to Follow-up|3
271953|NCT02068443|907109|P3|Overall Study|Other Reason Not Specified|0
271954|NCT02068443|907110|P2|Overall Study|Other Reason Not Specified|0
271955|NCT02068443|907111|P1|Overall Study|Other Reason Not Specified|1
271956|NCT02068443|907109|P3|Overall Study|Lack of Efficacy|0
271957|NCT02068443|907110|P2|Overall Study|Lack of Efficacy|1
271958|NCT02068443|907111|P1|Overall Study|Lack of Efficacy|2
271959|NCT02068443|907109|P3|Overall Study|Voluntary Withdrawal|1
271960|NCT02068443|907110|P2|Overall Study|Voluntary Withdrawal|0
271961|NCT02068443|907111|P1|Overall Study|Voluntary Withdrawal|4
271962|NCT02068443|907109|P3|Overall Study|Pretreatment Event/Adverse Event|2
271963|NCT02068443|907110|P2|Overall Study|Pretreatment Event/Adverse Event|5
271964|NCT02068443|907111|P1|Overall Study|Pretreatment Event/Adverse Event|0
271965|NCT02068222|907146|P1|Overall Study|Lost to Follow-up|1
271966|NCT02067728|907171|P2|6 Month Measurements|Unable to attend|97
271967|NCT02067728|907172|P1|6 Month Measurements|Unable to attend|114
271968|NCT02067728|907171|P2|6 Month Follow up Survey|Lost to Follow-up|60
271969|NCT02067728|907172|P1|6 Month Follow up Survey|Lost to Follow-up|48
271970|NCT02067728|907171|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
271971|NCT02067728|907172|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
271972|NCT02067676|907206|P6|Overall Study|Withdrawal by Subject|0
271973|NCT02067676|907207|P5|Overall Study|Withdrawal by Subject|0
271974|NCT02067676|907208|P4|Overall Study|Withdrawal by Subject|0
271975|NCT02067676|907209|P3|Overall Study|Withdrawal by Subject|0
271976|NCT02067676|907210|P2|Overall Study|Withdrawal by Subject|0
271977|NCT02067676|907211|P1|Overall Study|Withdrawal by Subject|1
271978|NCT02067533|907328|P2|Overall Study|Lost to Follow-up|2
271979|NCT02067533|907329|P1|Overall Study|Lost to Follow-up|4
271980|NCT02066922|907344|P1|Overall Study|Adverse Event|1
271981|NCT02066415|907399|P3|Overall Study|Lost to Follow-up|2
271982|NCT02066415|907400|P2|Overall Study|Lost to Follow-up|2
271983|NCT02066415|907401|P1|Overall Study|Lost to Follow-up|7
271984|NCT02066415|907399|P3|Overall Study|Withdrawal by Subject|4
271985|NCT02066415|907400|P2|Overall Study|Withdrawal by Subject|1
271986|NCT02066415|907401|P1|Overall Study|Withdrawal by Subject|9
271987|NCT02066415|907399|P3|Overall Study|Decision by Sponsor|2
271988|NCT02066415|907400|P2|Overall Study|Decision by Sponsor|4
271989|NCT02066415|907401|P1|Overall Study|Decision by Sponsor|5
271990|NCT02066402|907426|P2|Overall Study|Protocol driven decision point|1
271991|NCT02066402|907427|P1|Overall Study|Protocol driven decision point|0
271992|NCT02066402|907426|P2|Overall Study|Progressive disease-clinical progression|1
271993|NCT02066402|907427|P1|Overall Study|Progressive disease-clinical progression|0
271994|NCT02066402|907426|P2|Overall Study|Withdrawal by Subject|11
271995|NCT02066402|907427|P1|Overall Study|Withdrawal by Subject|14
271996|NCT02066402|907426|P2|Overall Study|Lost to Follow-up|8
271997|NCT02066402|907427|P1|Overall Study|Lost to Follow-up|11
271998|NCT02066402|907426|P2|Overall Study|Adverse Event|2
271999|NCT02066402|907427|P1|Overall Study|Adverse Event|1
272000|NCT02066233|907455|P2|EG Scan II (Day 1)|difficulty intubating subject|6
272001|NCT02066233|907456|P1|EG Scan II (Day 1)|difficulty intubating subject|6
272002|NCT02066051|907464|P1|Overall Study|Subject developed active GVHD|1
272003|NCT02065895|907469|P6|Overall Study|Scheduling conflicts|0
272004|NCT02065895|907470|P5|Overall Study|Scheduling conflicts|0
272005|NCT02065895|907471|P4|Overall Study|Scheduling conflicts|0
272006|NCT02065895|907472|P3|Overall Study|Scheduling conflicts|0
272007|NCT02065895|907473|P2|Overall Study|Scheduling conflicts|1
272008|NCT02065895|907474|P1|Overall Study|Scheduling conflicts|0
272009|NCT02065895|907469|P6|Overall Study|Protocol Violation|0
272010|NCT02065895|907470|P5|Overall Study|Protocol Violation|0
272011|NCT02065895|907471|P4|Overall Study|Protocol Violation|1
272012|NCT02065895|907472|P3|Overall Study|Protocol Violation|0
272013|NCT02065895|907473|P2|Overall Study|Protocol Violation|0
272014|NCT02065895|907474|P1|Overall Study|Protocol Violation|1
272015|NCT02064920|907667|P2|Overall Study|Withdrawal by Subject|3
272016|NCT02064920|907668|P1|Overall Study|Withdrawal by Subject|1
272017|NCT02064920|907667|P2|Overall Study|Technical Problems|1
272018|NCT02064920|907668|P1|Overall Study|Technical Problems|0
272019|NCT02064920|907667|P2|Overall Study|Physician Decision|1
272020|NCT02064920|907668|P1|Overall Study|Physician Decision|0
272021|NCT02064920|907667|P2|Overall Study|Adverse Event|4
272022|NCT02064920|907668|P1|Overall Study|Adverse Event|0
272023|NCT02064894|907698|P3|Overall Study|Withdrawal by Subject|115
272024|NCT02064894|907699|P2|Overall Study|Withdrawal by Subject|102
272025|NCT02064894|907700|P1|Overall Study|Withdrawal by Subject|43
272026|NCT02064439|907714|P3|Overall Study|Other|7
272027|NCT02064439|907715|P2|Overall Study|Other|2
272028|NCT02064439|907716|P1|Overall Study|Other|2
272029|NCT02064439|907714|P3|Overall Study|Safety outcome reached|10
272030|NCT02064439|907715|P2|Overall Study|Safety outcome reached|20
272031|NCT02064439|907716|P1|Overall Study|Safety outcome reached|12
272032|NCT02064439|907714|P3|Overall Study|Efficacy outcome reached|57
272033|NCT02064439|907715|P2|Overall Study|Efficacy outcome reached|16
272034|NCT02064439|907716|P1|Overall Study|Efficacy outcome reached|18
272035|NCT02064439|907714|P3|Overall Study|Logistical difficulties|2
272036|NCT02064439|907715|P2|Overall Study|Logistical difficulties|5
272037|NCT02064439|907716|P1|Overall Study|Logistical difficulties|6
272038|NCT02064439|907714|P3|Overall Study|Physician Decision|1
272039|NCT02064439|907715|P2|Overall Study|Physician Decision|1
272040|NCT02064439|907716|P1|Overall Study|Physician Decision|0
272041|NCT02064439|907714|P3|Overall Study|Non-compliance with study medication|23
272042|NCT02064439|907715|P2|Overall Study|Non-compliance with study medication|19
272043|NCT02064439|907716|P1|Overall Study|Non-compliance with study medication|21
272044|NCT02064439|907714|P3|Overall Study|Lost to Follow-up|4
272045|NCT02064439|907715|P2|Overall Study|Lost to Follow-up|3
272046|NCT02064439|907716|P1|Overall Study|Lost to Follow-up|1
272047|NCT02064439|907714|P3|Overall Study|Protocol Violation|3
272048|NCT02064439|907715|P2|Overall Study|Protocol Violation|5
272049|NCT02064439|907716|P1|Overall Study|Protocol Violation|3
272050|NCT02064439|907714|P3|Overall Study|Withdrawal by Subject|26
272051|NCT02064439|907715|P2|Overall Study|Withdrawal by Subject|18
272052|NCT02064439|907716|P1|Overall Study|Withdrawal by Subject|29
272053|NCT02064439|907714|P3|Overall Study|Death|3
272054|NCT02064439|907715|P2|Overall Study|Death|2
272055|NCT02064439|907716|P1|Overall Study|Death|0
272056|NCT02064439|907714|P3|Overall Study|Adverse Event|46
272057|NCT02064439|907715|P2|Overall Study|Adverse Event|47
272058|NCT02064439|907716|P1|Overall Study|Adverse Event|51
272059|NCT02064231|907751|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
272060|NCT02064231|907752|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
272061|NCT02064231|907753|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
272062|NCT02064231|907754|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
272063|NCT02064231|907751|P4|First Test Period (Test A or Test C)|Adverse Event|0
272064|NCT02064231|907752|P3|First Test Period (Test A or Test C)|Adverse Event|1
272065|NCT02064231|907753|P2|First Test Period (Test A or Test C)|Adverse Event|0
272066|NCT02064231|907754|P1|First Test Period (Test A or Test C)|Adverse Event|1
272067|NCT02064231|907751|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
272068|NCT02064231|907752|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
272069|NCT02064231|907753|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
272070|NCT02064231|907754|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
272071|NCT02064231|907751|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
272072|NCT02064231|907752|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
272073|NCT02064231|907753|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
272074|NCT02064231|907754|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
272075|NCT02064205|907766|P1|Overall Study|Withdrawal by Subject|1
272076|NCT02063880|907784|P2|Overall Study|Ineligible|2
272077|NCT02063880|907785|P1|Overall Study|Ineligible|0
272078|NCT02063880|907784|P2|Overall Study|Lost to Follow-up|7
272079|NCT02063880|907785|P1|Overall Study|Lost to Follow-up|7
272080|NCT02063880|907784|P2|Overall Study|Death|18
272081|NCT02063880|907785|P1|Overall Study|Death|21
272082|NCT02063854|907802|P7|Overall Study|Did Not Receive Study Drug|0
272083|NCT02063854|907803|P6|Overall Study|Did Not Receive Study Drug|1
272084|NCT02063854|907804|P5|Overall Study|Did Not Receive Study Drug|0
272085|NCT02063854|907805|P4|Overall Study|Did Not Receive Study Drug|0
272086|NCT02063854|907806|P3|Overall Study|Did Not Receive Study Drug|0
272087|NCT02063854|907807|P2|Overall Study|Did Not Receive Study Drug|0
272088|NCT02063854|907808|P1|Overall Study|Did Not Receive Study Drug|0
272089|NCT02063854|907802|P7|Overall Study|Reason Not Specified|0
272090|NCT02063854|907803|P6|Overall Study|Reason Not Specified|0
272091|NCT02063854|907804|P5|Overall Study|Reason Not Specified|0
272092|NCT02063854|907805|P4|Overall Study|Reason Not Specified|0
272093|NCT02063854|907806|P3|Overall Study|Reason Not Specified|0
272094|NCT02063854|907807|P2|Overall Study|Reason Not Specified|0
272095|NCT02063854|907808|P1|Overall Study|Reason Not Specified|1
272096|NCT02063854|907802|P7|Overall Study|Surgical Dental Work Performed/Planned|1
272097|NCT02063854|907803|P6|Overall Study|Surgical Dental Work Performed/Planned|6
272098|NCT02063854|907804|P5|Overall Study|Surgical Dental Work Performed/Planned|1
272099|NCT02063854|907805|P4|Overall Study|Surgical Dental Work Performed/Planned|1
272100|NCT02063854|907806|P3|Overall Study|Surgical Dental Work Performed/Planned|6
272101|NCT02063854|907807|P2|Overall Study|Surgical Dental Work Performed/Planned|2
272102|NCT02063854|907808|P1|Overall Study|Surgical Dental Work Performed/Planned|5
272103|NCT02063854|907802|P7|Overall Study|Voluntary Withdrawal|1
272104|NCT02063854|907803|P6|Overall Study|Voluntary Withdrawal|6
272105|NCT02063854|907804|P5|Overall Study|Voluntary Withdrawal|3
272106|NCT02063854|907805|P4|Overall Study|Voluntary Withdrawal|1
272107|NCT02063854|907806|P3|Overall Study|Voluntary Withdrawal|8
272108|NCT02063854|907807|P2|Overall Study|Voluntary Withdrawal|0
272109|NCT02063854|907808|P1|Overall Study|Voluntary Withdrawal|2
272110|NCT02063854|907802|P7|Overall Study|Major Protocol Deviation|0
272111|NCT02063854|907803|P6|Overall Study|Major Protocol Deviation|0
272112|NCT02063854|907804|P5|Overall Study|Major Protocol Deviation|0
272113|NCT02063854|907805|P4|Overall Study|Major Protocol Deviation|0
272114|NCT02063854|907806|P3|Overall Study|Major Protocol Deviation|3
272115|NCT02063854|907807|P2|Overall Study|Major Protocol Deviation|0
272116|NCT02063854|907808|P1|Overall Study|Major Protocol Deviation|0
272117|NCT02063854|907802|P7|Overall Study|Pretreatment Event/Adverse Event|4
272118|NCT02063854|907803|P6|Overall Study|Pretreatment Event/Adverse Event|18
272119|NCT02063854|907804|P5|Overall Study|Pretreatment Event/Adverse Event|7
272120|NCT02063854|907805|P4|Overall Study|Pretreatment Event/Adverse Event|8
272121|NCT02063854|907806|P3|Overall Study|Pretreatment Event/Adverse Event|13
272122|NCT02063854|907807|P2|Overall Study|Pretreatment Event/Adverse Event|10
272123|NCT02063854|907808|P1|Overall Study|Pretreatment Event/Adverse Event|13
272124|NCT02063737|907892|P2|Overall Study|Lost to Follow-up|4
272125|NCT02063737|907893|P1|Overall Study|Lost to Follow-up|11
272126|NCT02063672|907927|P2|Overall Study|Withdrawal by Subject|2
272127|NCT02063672|907928|P1|Overall Study|Withdrawal by Subject|2
272128|NCT02063672|907927|P2|Overall Study|Lost to Follow-up|3
272129|NCT02063672|907928|P1|Overall Study|Lost to Follow-up|1
272130|NCT02063672|907927|P2|Overall Study|Death|3
272131|NCT02063672|907928|P1|Overall Study|Death|5
272132|NCT02063672|907927|P2|Overall Study|Ongoing Follow-up|14
272133|NCT02063672|907928|P1|Overall Study|Ongoing Follow-up|27
272134|NCT02063659|907975|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
272135|NCT02063659|907976|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
272136|NCT02063659|907977|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
272137|NCT02063659|907978|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
272138|NCT02063659|907975|P4|Open-Label Extension Period (OLE)|Adverse Event|7
272139|NCT02063659|907976|P3|Open-Label Extension Period (OLE)|Adverse Event|0
272140|NCT02063659|907977|P2|Open-Label Extension Period (OLE)|Adverse Event|0
272141|NCT02063659|907978|P1|Open-Label Extension Period (OLE)|Adverse Event|0
272142|NCT02063659|907975|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
272143|NCT02063659|907976|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
272144|NCT02063659|907977|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
272145|NCT02063659|907978|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
272146|NCT02063659|907975|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
272147|NCT02063659|907976|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
272148|NCT02063659|907977|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
272149|NCT02063659|907978|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
272150|NCT02063659|907975|P4|Open-Label Extension Period (OLE)|Physician Decision|1
272151|NCT02063659|907976|P3|Open-Label Extension Period (OLE)|Physician Decision|0
272152|NCT02063659|907977|P2|Open-Label Extension Period (OLE)|Physician Decision|0
272153|NCT02063659|907978|P1|Open-Label Extension Period (OLE)|Physician Decision|0
272154|NCT02063659|907975|P4|Double-Blind Treatment Period|Withdrawal of consent|0
272155|NCT02063659|907976|P3|Double-Blind Treatment Period|Withdrawal of consent|3
272156|NCT02063659|907977|P2|Double-Blind Treatment Period|Withdrawal of consent|1
272157|NCT02063659|907978|P1|Double-Blind Treatment Period|Withdrawal of consent|0
272158|NCT02063659|907975|P4|Double-Blind Treatment Period|Physician Decision|0
272159|NCT02063659|907976|P3|Double-Blind Treatment Period|Physician Decision|0
272160|NCT02063659|907977|P2|Double-Blind Treatment Period|Physician Decision|0
272161|NCT02063659|907978|P1|Double-Blind Treatment Period|Physician Decision|1
272162|NCT02063659|907975|P4|Double-Blind Treatment Period|Adverse Event|0
272163|NCT02063659|907976|P3|Double-Blind Treatment Period|Adverse Event|0
272164|NCT02063659|907977|P2|Double-Blind Treatment Period|Adverse Event|2
272165|NCT02063659|907978|P1|Double-Blind Treatment Period|Adverse Event|1
272166|NCT02063217|908061|P3|Overall Study|Withdrawal by Subject|0
272167|NCT02063217|908062|P2|Overall Study|Withdrawal by Subject|0
272168|NCT02063217|908063|P1|Overall Study|Withdrawal by Subject|1
272169|NCT02062879|908099|P2|Overall Study|Withdrawal by Subject|1
272170|NCT02062879|908100|P1|Overall Study|Withdrawal by Subject|4
272171|NCT02062658|908136|P1|Overall Study|Lack of Efficacy|1
272172|NCT02062658|908136|P1|Overall Study|Withdrawal by Subject|1
272173|NCT02062645|908140|P1|Overall Study|Lost to Follow-up|5
272174|NCT02062645|908140|P1|Overall Study|Protocol Violation|8
272175|NCT02062645|908140|P1|Overall Study|Adverse Event|2
272176|NCT02062450|908182|P1|Overall Study|No follow-up visit|124
272177|NCT02062437|908196|P1|Overall Study|Pt. couldn't come due to med. condition|1
272178|NCT02062437|908196|P1|Overall Study|Death|2
272179|NCT02062437|908196|P1|Overall Study|Patient not available for the 2y visit|18
272180|NCT02062437|908196|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
272181|NCT02062385|908209|P4|Overall Study|Lost to Follow-up|0
272182|NCT02062385|908210|P3|Overall Study|Lost to Follow-up|1
272183|NCT02062385|908211|P2|Overall Study|Lost to Follow-up|0
272184|NCT02062385|908212|P1|Overall Study|Lost to Follow-up|0
272185|NCT02062385|908209|P4|Overall Study|Death|1
272186|NCT02062385|908210|P3|Overall Study|Death|0
272187|NCT02062385|908211|P2|Overall Study|Death|0
272188|NCT02062385|908212|P1|Overall Study|Death|0
272189|NCT02062385|908209|P4|Overall Study|Withdrawn by parent/guardian|8
272190|NCT02062385|908210|P3|Overall Study|Withdrawn by parent/guardian|9
272191|NCT02062385|908211|P2|Overall Study|Withdrawn by parent/guardian|41
272192|NCT02062385|908212|P1|Overall Study|Withdrawn by parent/guardian|46
272193|NCT02062385|908209|P4|Overall Study|Moved|0
272194|NCT02062385|908210|P3|Overall Study|Moved|1
272195|NCT02062385|908211|P2|Overall Study|Moved|11
272196|NCT02062385|908212|P1|Overall Study|Moved|10
272197|NCT02062385|908209|P4|Overall Study|Incomplete EPI by database lock|0
272198|NCT02062385|908210|P3|Overall Study|Incomplete EPI by database lock|0
272199|NCT02062385|908211|P2|Overall Study|Incomplete EPI by database lock|0
272200|NCT02062385|908212|P1|Overall Study|Incomplete EPI by database lock|2
272201|NCT02062385|908209|P4|Overall Study|Protocol Violation|0
272202|NCT02062385|908210|P3|Overall Study|Protocol Violation|0
272203|NCT02062385|908211|P2|Overall Study|Protocol Violation|0
272204|NCT02062385|908212|P1|Overall Study|Protocol Violation|1
272205|NCT02062385|908209|P4|Overall Study|Adverse Event|0
272206|NCT02062385|908210|P3|Overall Study|Adverse Event|1
272207|NCT02062385|908211|P2|Overall Study|Adverse Event|13
272208|NCT02062385|908212|P1|Overall Study|Adverse Event|19
272209|NCT02061592|908365|P2|Period 2|Lost to Follow-up|1
272210|NCT02061592|908366|P1|Period 2|Lost to Follow-up|0
272211|NCT02061592|908365|P2|Period 1|Protocol Violation|0
272212|NCT02061592|908366|P1|Period 1|Protocol Violation|1
272213|NCT02061592|908365|P2|Period 1|Withdrawal by Subject|0
272214|NCT02061592|908366|P1|Period 1|Withdrawal by Subject|1
272215|NCT02061540|908378|P1|Overall Study|Withdrawal by Subject|2
272216|NCT02061540|908378|P1|Overall Study|Adverse Event|2
272217|NCT02061280|908546|P2|Overall Study|Lost to Follow-up|1
272218|NCT02061280|908547|P1|Overall Study|Lost to Follow-up|5
272219|NCT02061280|908546|P2|Overall Study|Withdrawal by Subject|2
272220|NCT02061280|908547|P1|Overall Study|Withdrawal by Subject|1
272221|NCT02061280|908546|P2|Overall Study|moved out of state|1
272222|NCT02061280|908547|P1|Overall Study|moved out of state|0
272223|NCT02061280|908546|P2|Overall Study|Protocol Violation|8
272224|NCT02061280|908547|P1|Overall Study|Protocol Violation|12
272225|NCT02059395|908723|P2|Overall Study|Lost to Follow-up|4
272226|NCT02059395|908724|P1|Overall Study|Lost to Follow-up|2
272227|NCT02059291|908739|P25|Epoch 4|Lack of Efficacy|0
272228|NCT02059291|908740|P24|Epoch 4|Lack of Efficacy|1
272229|NCT02059291|908741|P23|Epoch 4|Lack of Efficacy|0
272230|NCT02059291|908742|P22|Epoch 4|Lack of Efficacy|0
272231|NCT02059291|908743|P21|Epoch 4|Lack of Efficacy|0
272232|NCT02059291|908744|P20|Epoch 4|Lack of Efficacy|0
272233|NCT02059291|908745|P19|Epoch 4|Lack of Efficacy|0
272234|NCT02059291|908746|P18|Epoch 4|Lack of Efficacy|0
272235|NCT02059291|908747|P17|Epoch 4|Lack of Efficacy|0
272236|NCT02059291|908748|P16|Epoch 4|Lack of Efficacy|0
272237|NCT02059291|908749|P15|Epoch 4|Lack of Efficacy|0
272238|NCT02059291|908750|P14|Epoch 4|Lack of Efficacy|0
272239|NCT02059291|908751|P13|Epoch 4|Lack of Efficacy|0
272240|NCT02059291|908752|P12|Epoch 4|Lack of Efficacy|0
272241|NCT02059291|908753|P11|Epoch 4|Lack of Efficacy|0
272242|NCT02059291|908754|P10|Epoch 4|Lack of Efficacy|0
272243|NCT02059291|908755|P9|Epoch 4|Lack of Efficacy|0
272244|NCT02059291|908756|P8|Epoch 4|Lack of Efficacy|0
272245|NCT02059291|908757|P7|Epoch 4|Lack of Efficacy|0
272246|NCT02059291|908758|P6|Epoch 4|Lack of Efficacy|0
272247|NCT02059291|908759|P5|Epoch 4|Lack of Efficacy|0
272248|NCT02059291|908760|P4|Epoch 4|Lack of Efficacy|0
272249|NCT02059291|908761|P3|Epoch 4|Lack of Efficacy|0
272250|NCT02059291|908762|P2|Epoch 4|Lack of Efficacy|0
272251|NCT02059291|908763|P1|Epoch 4|Lack of Efficacy|0
272252|NCT02059291|908739|P25|Epoch 4|Withdrawal by Subject|0
272253|NCT02059291|908740|P24|Epoch 4|Withdrawal by Subject|0
272254|NCT02059291|908741|P23|Epoch 4|Withdrawal by Subject|0
272255|NCT02059291|908742|P22|Epoch 4|Withdrawal by Subject|0
272256|NCT02059291|908743|P21|Epoch 4|Withdrawal by Subject|1
272257|NCT02059291|908744|P20|Epoch 4|Withdrawal by Subject|0
272258|NCT02059291|908745|P19|Epoch 4|Withdrawal by Subject|0
272259|NCT02059291|908746|P18|Epoch 4|Withdrawal by Subject|0
272260|NCT02059291|908747|P17|Epoch 4|Withdrawal by Subject|0
272261|NCT02059291|908748|P16|Epoch 4|Withdrawal by Subject|0
272262|NCT02059291|908749|P15|Epoch 4|Withdrawal by Subject|0
272263|NCT02059291|908750|P14|Epoch 4|Withdrawal by Subject|0
272264|NCT02059291|908751|P13|Epoch 4|Withdrawal by Subject|0
272265|NCT02059291|908752|P12|Epoch 4|Withdrawal by Subject|0
272266|NCT02059291|908753|P11|Epoch 4|Withdrawal by Subject|0
272267|NCT02059291|908754|P10|Epoch 4|Withdrawal by Subject|0
272268|NCT02059291|908755|P9|Epoch 4|Withdrawal by Subject|0
272269|NCT02059291|908756|P8|Epoch 4|Withdrawal by Subject|0
272270|NCT02059291|908757|P7|Epoch 4|Withdrawal by Subject|0
272271|NCT02059291|908758|P6|Epoch 4|Withdrawal by Subject|0
272272|NCT02059291|908759|P5|Epoch 4|Withdrawal by Subject|0
272273|NCT02059291|908760|P4|Epoch 4|Withdrawal by Subject|0
272274|NCT02059291|908761|P3|Epoch 4|Withdrawal by Subject|0
272275|NCT02059291|908762|P2|Epoch 4|Withdrawal by Subject|0
272276|NCT02059291|908763|P1|Epoch 4|Withdrawal by Subject|0
272277|NCT02059291|908739|P25|Epoch 4|Pregnancy|0
272278|NCT02059291|908740|P24|Epoch 4|Pregnancy|0
272279|NCT02059291|908741|P23|Epoch 4|Pregnancy|0
272280|NCT02059291|908742|P22|Epoch 4|Pregnancy|0
272281|NCT02059291|908743|P21|Epoch 4|Pregnancy|0
272282|NCT02059291|908744|P20|Epoch 4|Pregnancy|0
272283|NCT02059291|908745|P19|Epoch 4|Pregnancy|0
272284|NCT02059291|908746|P18|Epoch 4|Pregnancy|0
272285|NCT02059291|908747|P17|Epoch 4|Pregnancy|1
272286|NCT02059291|908748|P16|Epoch 4|Pregnancy|0
272287|NCT02059291|908749|P15|Epoch 4|Pregnancy|0
272288|NCT02059291|908750|P14|Epoch 4|Pregnancy|0
272289|NCT02059291|908751|P13|Epoch 4|Pregnancy|0
272290|NCT02059291|908752|P12|Epoch 4|Pregnancy|0
272291|NCT02059291|908753|P11|Epoch 4|Pregnancy|0
272292|NCT02059291|908754|P10|Epoch 4|Pregnancy|0
272293|NCT02059291|908755|P9|Epoch 4|Pregnancy|0
272294|NCT02059291|908756|P8|Epoch 4|Pregnancy|0
272295|NCT02059291|908757|P7|Epoch 4|Pregnancy|0
272296|NCT02059291|908758|P6|Epoch 4|Pregnancy|0
272297|NCT02059291|908759|P5|Epoch 4|Pregnancy|0
272298|NCT02059291|908760|P4|Epoch 4|Pregnancy|0
272299|NCT02059291|908761|P3|Epoch 4|Pregnancy|0
272300|NCT02059291|908762|P2|Epoch 4|Pregnancy|0
272301|NCT02059291|908763|P1|Epoch 4|Pregnancy|0
272302|NCT02059291|908739|P25|Epoch 4|Adverse Event|0
272303|NCT02059291|908740|P24|Epoch 4|Adverse Event|0
272304|NCT02059291|908741|P23|Epoch 4|Adverse Event|1
272305|NCT02059291|908742|P22|Epoch 4|Adverse Event|0
272306|NCT02059291|908743|P21|Epoch 4|Adverse Event|0
272307|NCT02059291|908744|P20|Epoch 4|Adverse Event|0
272308|NCT02059291|908745|P19|Epoch 4|Adverse Event|0
272309|NCT02059291|908746|P18|Epoch 4|Adverse Event|0
272310|NCT02059291|908747|P17|Epoch 4|Adverse Event|1
272311|NCT02059291|908748|P16|Epoch 4|Adverse Event|0
272312|NCT02059291|908749|P15|Epoch 4|Adverse Event|0
272313|NCT02059291|908750|P14|Epoch 4|Adverse Event|0
272314|NCT02059291|908751|P13|Epoch 4|Adverse Event|0
272315|NCT02059291|908752|P12|Epoch 4|Adverse Event|0
272316|NCT02059291|908753|P11|Epoch 4|Adverse Event|0
272317|NCT02059291|908754|P10|Epoch 4|Adverse Event|0
272318|NCT02059291|908755|P9|Epoch 4|Adverse Event|0
272319|NCT02059291|908756|P8|Epoch 4|Adverse Event|0
272320|NCT02059291|908757|P7|Epoch 4|Adverse Event|0
272321|NCT02059291|908758|P6|Epoch 4|Adverse Event|0
272322|NCT02059291|908759|P5|Epoch 4|Adverse Event|0
272323|NCT02059291|908760|P4|Epoch 4|Adverse Event|0
272324|NCT02059291|908761|P3|Epoch 4|Adverse Event|0
272325|NCT02059291|908762|P2|Epoch 4|Adverse Event|0
272326|NCT02059291|908763|P1|Epoch 4|Adverse Event|0
272327|NCT02059291|908739|P25|Epoch 3|Withdrawal by Subject|0
272328|NCT02059291|908740|P24|Epoch 3|Withdrawal by Subject|0
272329|NCT02059291|908741|P23|Epoch 3|Withdrawal by Subject|0
272330|NCT02059291|908742|P22|Epoch 3|Withdrawal by Subject|0
272331|NCT02059291|908743|P21|Epoch 3|Withdrawal by Subject|0
272332|NCT02059291|908744|P20|Epoch 3|Withdrawal by Subject|0
272333|NCT02059291|908745|P19|Epoch 3|Withdrawal by Subject|0
272334|NCT02059291|908746|P18|Epoch 3|Withdrawal by Subject|0
272335|NCT02059291|908747|P17|Epoch 3|Withdrawal by Subject|0
272336|NCT02059291|908748|P16|Epoch 3|Withdrawal by Subject|1
272337|NCT02059291|908749|P15|Epoch 3|Withdrawal by Subject|0
272338|NCT02059291|908750|P14|Epoch 3|Withdrawal by Subject|0
272339|NCT02059291|908751|P13|Epoch 3|Withdrawal by Subject|0
272340|NCT02059291|908752|P12|Epoch 3|Withdrawal by Subject|0
272341|NCT02059291|908753|P11|Epoch 3|Withdrawal by Subject|0
272342|NCT02059291|908754|P10|Epoch 3|Withdrawal by Subject|0
272343|NCT02059291|908755|P9|Epoch 3|Withdrawal by Subject|0
272344|NCT02059291|908756|P8|Epoch 3|Withdrawal by Subject|0
272345|NCT02059291|908757|P7|Epoch 3|Withdrawal by Subject|0
272346|NCT02059291|908758|P6|Epoch 3|Withdrawal by Subject|0
272347|NCT02059291|908759|P5|Epoch 3|Withdrawal by Subject|0
272348|NCT02059291|908760|P4|Epoch 3|Withdrawal by Subject|0
272349|NCT02059291|908761|P3|Epoch 3|Withdrawal by Subject|0
272350|NCT02059291|908762|P2|Epoch 3|Withdrawal by Subject|0
272351|NCT02059291|908763|P1|Epoch 3|Withdrawal by Subject|0
272352|NCT02059291|908739|P25|Epoch 3|Lack of Efficacy|0
272353|NCT02059291|908740|P24|Epoch 3|Lack of Efficacy|0
272354|NCT02059291|908741|P23|Epoch 3|Lack of Efficacy|0
272355|NCT02059291|908742|P22|Epoch 3|Lack of Efficacy|0
272356|NCT02059291|908743|P21|Epoch 3|Lack of Efficacy|0
272357|NCT02059291|908744|P20|Epoch 3|Lack of Efficacy|0
272358|NCT02059291|908745|P19|Epoch 3|Lack of Efficacy|0
272359|NCT02059291|908746|P18|Epoch 3|Lack of Efficacy|0
272360|NCT02059291|908747|P17|Epoch 3|Lack of Efficacy|0
272361|NCT02059291|908748|P16|Epoch 3|Lack of Efficacy|3
272362|NCT02059291|908749|P15|Epoch 3|Lack of Efficacy|0
272363|NCT02059291|908750|P14|Epoch 3|Lack of Efficacy|0
272364|NCT02059291|908751|P13|Epoch 3|Lack of Efficacy|0
272365|NCT02059291|908752|P12|Epoch 3|Lack of Efficacy|0
272366|NCT02059291|908753|P11|Epoch 3|Lack of Efficacy|0
272367|NCT02059291|908754|P10|Epoch 3|Lack of Efficacy|0
272368|NCT02059291|908755|P9|Epoch 3|Lack of Efficacy|0
272369|NCT02059291|908756|P8|Epoch 3|Lack of Efficacy|0
272370|NCT02059291|908757|P7|Epoch 3|Lack of Efficacy|0
272371|NCT02059291|908758|P6|Epoch 3|Lack of Efficacy|0
272372|NCT02059291|908759|P5|Epoch 3|Lack of Efficacy|0
272373|NCT02059291|908760|P4|Epoch 3|Lack of Efficacy|0
272374|NCT02059291|908761|P3|Epoch 3|Lack of Efficacy|0
272375|NCT02059291|908762|P2|Epoch 3|Lack of Efficacy|0
272376|NCT02059291|908763|P1|Epoch 3|Lack of Efficacy|0
272377|NCT02059291|908739|P25|Epoch 3|Adverse Event|0
272378|NCT02059291|908740|P24|Epoch 3|Adverse Event|0
272379|NCT02059291|908741|P23|Epoch 3|Adverse Event|0
272380|NCT02059291|908742|P22|Epoch 3|Adverse Event|0
272381|NCT02059291|908743|P21|Epoch 3|Adverse Event|0
272382|NCT02059291|908744|P20|Epoch 3|Adverse Event|0
272383|NCT02059291|908745|P19|Epoch 3|Adverse Event|0
272384|NCT02059291|908746|P18|Epoch 3|Adverse Event|0
272385|NCT02059291|908747|P17|Epoch 3|Adverse Event|0
272386|NCT02059291|908748|P16|Epoch 3|Adverse Event|1
272387|NCT02059291|908749|P15|Epoch 3|Adverse Event|0
272388|NCT02059291|908750|P14|Epoch 3|Adverse Event|0
272389|NCT02059291|908751|P13|Epoch 3|Adverse Event|0
272390|NCT02059291|908752|P12|Epoch 3|Adverse Event|0
272391|NCT02059291|908753|P11|Epoch 3|Adverse Event|0
272392|NCT02059291|908754|P10|Epoch 3|Adverse Event|0
272393|NCT02059291|908755|P9|Epoch 3|Adverse Event|0
272394|NCT02059291|908756|P8|Epoch 3|Adverse Event|0
272395|NCT02059291|908757|P7|Epoch 3|Adverse Event|0
272396|NCT02059291|908758|P6|Epoch 3|Adverse Event|0
272397|NCT02059291|908759|P5|Epoch 3|Adverse Event|0
272398|NCT02059291|908760|P4|Epoch 3|Adverse Event|0
272399|NCT02059291|908761|P3|Epoch 3|Adverse Event|0
272400|NCT02059291|908762|P2|Epoch 3|Adverse Event|0
272401|NCT02059291|908763|P1|Epoch 3|Adverse Event|0
272402|NCT02059291|908739|P25|Epoch 3|Physician Decision|0
272403|NCT02059291|908740|P24|Epoch 3|Physician Decision|0
272404|NCT02059291|908741|P23|Epoch 3|Physician Decision|0
272405|NCT02059291|908742|P22|Epoch 3|Physician Decision|0
272406|NCT02059291|908743|P21|Epoch 3|Physician Decision|0
272407|NCT02059291|908744|P20|Epoch 3|Physician Decision|0
272408|NCT02059291|908745|P19|Epoch 3|Physician Decision|0
272409|NCT02059291|908746|P18|Epoch 3|Physician Decision|0
272410|NCT02059291|908747|P17|Epoch 3|Physician Decision|0
272411|NCT02059291|908748|P16|Epoch 3|Physician Decision|1
272412|NCT02059291|908749|P15|Epoch 3|Physician Decision|0
272413|NCT02059291|908750|P14|Epoch 3|Physician Decision|1
272414|NCT02059291|908751|P13|Epoch 3|Physician Decision|0
272415|NCT02059291|908752|P12|Epoch 3|Physician Decision|0
272416|NCT02059291|908753|P11|Epoch 3|Physician Decision|0
272417|NCT02059291|908754|P10|Epoch 3|Physician Decision|0
272418|NCT02059291|908755|P9|Epoch 3|Physician Decision|0
272419|NCT02059291|908756|P8|Epoch 3|Physician Decision|0
272420|NCT02059291|908757|P7|Epoch 3|Physician Decision|0
272421|NCT02059291|908758|P6|Epoch 3|Physician Decision|0
272422|NCT02059291|908759|P5|Epoch 3|Physician Decision|0
272423|NCT02059291|908760|P4|Epoch 3|Physician Decision|0
272424|NCT02059291|908761|P3|Epoch 3|Physician Decision|0
272425|NCT02059291|908762|P2|Epoch 3|Physician Decision|0
272426|NCT02059291|908763|P1|Epoch 3|Physician Decision|0
272427|NCT02059291|908739|P25|Epoch 2|Withdrawal by Subject|0
272428|NCT02059291|908740|P24|Epoch 2|Withdrawal by Subject|0
272429|NCT02059291|908741|P23|Epoch 2|Withdrawal by Subject|0
272430|NCT02059291|908742|P22|Epoch 2|Withdrawal by Subject|0
272431|NCT02059291|908743|P21|Epoch 2|Withdrawal by Subject|0
272432|NCT02059291|908744|P20|Epoch 2|Withdrawal by Subject|0
272433|NCT02059291|908745|P19|Epoch 2|Withdrawal by Subject|0
272434|NCT02059291|908746|P18|Epoch 2|Withdrawal by Subject|0
272435|NCT02059291|908747|P17|Epoch 2|Withdrawal by Subject|0
272436|NCT02059291|908748|P16|Epoch 2|Withdrawal by Subject|0
272437|NCT02059291|908749|P15|Epoch 2|Withdrawal by Subject|0
272438|NCT02059291|908750|P14|Epoch 2|Withdrawal by Subject|0
272439|NCT02059291|908751|P13|Epoch 2|Withdrawal by Subject|0
272440|NCT02059291|908752|P12|Epoch 2|Withdrawal by Subject|0
272441|NCT02059291|908753|P11|Epoch 2|Withdrawal by Subject|0
272442|NCT02059291|908754|P10|Epoch 2|Withdrawal by Subject|0
272443|NCT02059291|908755|P9|Epoch 2|Withdrawal by Subject|1
272444|NCT02059291|908756|P8|Epoch 2|Withdrawal by Subject|0
272445|NCT02059291|908757|P7|Epoch 2|Withdrawal by Subject|0
272446|NCT02059291|908758|P6|Epoch 2|Withdrawal by Subject|1
272447|NCT02059291|908759|P5|Epoch 2|Withdrawal by Subject|0
272448|NCT02059291|908760|P4|Epoch 2|Withdrawal by Subject|0
272449|NCT02059291|908761|P3|Epoch 2|Withdrawal by Subject|0
272450|NCT02059291|908762|P2|Epoch 2|Withdrawal by Subject|1
272451|NCT02059291|908763|P1|Epoch 2|Withdrawal by Subject|0
272452|NCT02059291|908739|P25|Epoch 2|Adverse Event|0
272453|NCT02059291|908740|P24|Epoch 2|Adverse Event|0
272454|NCT02059291|908741|P23|Epoch 2|Adverse Event|0
272455|NCT02059291|908742|P22|Epoch 2|Adverse Event|0
272456|NCT02059291|908743|P21|Epoch 2|Adverse Event|0
272457|NCT02059291|908744|P20|Epoch 2|Adverse Event|0
272458|NCT02059291|908745|P19|Epoch 2|Adverse Event|0
272459|NCT02059291|908746|P18|Epoch 2|Adverse Event|0
272460|NCT02059291|908747|P17|Epoch 2|Adverse Event|0
272461|NCT02059291|908748|P16|Epoch 2|Adverse Event|0
272462|NCT02059291|908749|P15|Epoch 2|Adverse Event|0
272463|NCT02059291|908750|P14|Epoch 2|Adverse Event|0
272464|NCT02059291|908751|P13|Epoch 2|Adverse Event|0
272465|NCT02059291|908752|P12|Epoch 2|Adverse Event|0
272466|NCT02059291|908753|P11|Epoch 2|Adverse Event|0
272467|NCT02059291|908754|P10|Epoch 2|Adverse Event|0
272468|NCT02059291|908755|P9|Epoch 2|Adverse Event|1
272469|NCT02059291|908756|P8|Epoch 2|Adverse Event|1
272470|NCT02059291|908757|P7|Epoch 2|Adverse Event|0
272471|NCT02059291|908758|P6|Epoch 2|Adverse Event|0
272472|NCT02059291|908759|P5|Epoch 2|Adverse Event|0
272473|NCT02059291|908760|P4|Epoch 2|Adverse Event|1
272474|NCT02059291|908761|P3|Epoch 2|Adverse Event|1
272475|NCT02059291|908762|P2|Epoch 2|Adverse Event|0
272476|NCT02059291|908763|P1|Epoch 2|Adverse Event|0
272477|NCT02059291|908739|P25|Epoch 2|Lack of Efficacy|0
272478|NCT02059291|908740|P24|Epoch 2|Lack of Efficacy|0
272479|NCT02059291|908741|P23|Epoch 2|Lack of Efficacy|0
272480|NCT02059291|908742|P22|Epoch 2|Lack of Efficacy|0
272481|NCT02059291|908743|P21|Epoch 2|Lack of Efficacy|0
272482|NCT02059291|908744|P20|Epoch 2|Lack of Efficacy|0
272483|NCT02059291|908745|P19|Epoch 2|Lack of Efficacy|0
272484|NCT02059291|908746|P18|Epoch 2|Lack of Efficacy|0
272485|NCT02059291|908747|P17|Epoch 2|Lack of Efficacy|0
272486|NCT02059291|908748|P16|Epoch 2|Lack of Efficacy|0
272487|NCT02059291|908749|P15|Epoch 2|Lack of Efficacy|0
272488|NCT02059291|908750|P14|Epoch 2|Lack of Efficacy|0
272489|NCT02059291|908751|P13|Epoch 2|Lack of Efficacy|0
272490|NCT02059291|908752|P12|Epoch 2|Lack of Efficacy|0
272491|NCT02059291|908753|P11|Epoch 2|Lack of Efficacy|0
272492|NCT02059291|908754|P10|Epoch 2|Lack of Efficacy|0
272493|NCT02059291|908755|P9|Epoch 2|Lack of Efficacy|0
272494|NCT02059291|908756|P8|Epoch 2|Lack of Efficacy|0
272495|NCT02059291|908757|P7|Epoch 2|Lack of Efficacy|0
272496|NCT02059291|908758|P6|Epoch 2|Lack of Efficacy|1
272497|NCT02059291|908759|P5|Epoch 2|Lack of Efficacy|0
272498|NCT02059291|908760|P4|Epoch 2|Lack of Efficacy|1
272499|NCT02059291|908761|P3|Epoch 2|Lack of Efficacy|0
272500|NCT02059291|908762|P2|Epoch 2|Lack of Efficacy|0
272501|NCT02059291|908763|P1|Epoch 2|Lack of Efficacy|0
272502|NCT02059187|908817|P2|Overall Study|Withdrawal by Subject|8
272503|NCT02059187|908818|P1|Overall Study|Withdrawal by Subject|12
272504|NCT02059187|908817|P2|Overall Study|Protocol Violation|0
272505|NCT02059187|908818|P1|Overall Study|Protocol Violation|1
272506|NCT02059187|908817|P2|Overall Study|Physician Decision|2
272507|NCT02059187|908818|P1|Overall Study|Physician Decision|1
272508|NCT02059187|908817|P2|Overall Study|Non-compliance with study drug|0
272509|NCT02059187|908818|P1|Overall Study|Non-compliance with study drug|1
272510|NCT02059187|908817|P2|Overall Study|Lost to Follow-up|8
272511|NCT02059187|908818|P1|Overall Study|Lost to Follow-up|9
272512|NCT02059187|908817|P2|Overall Study|Death|1
272513|NCT02059187|908818|P1|Overall Study|Death|1
272514|NCT02059187|908817|P2|Overall Study|Adverse Event|3
272515|NCT02059187|908818|P1|Overall Study|Adverse Event|0
272516|NCT02059174|908844|P2|Period 3|Physician Decision|0
272517|NCT02059174|908845|P1|Period 3|Physician Decision|1
272518|NCT02059174|908844|P2|Period 2|Protocol Violation|0
272519|NCT02059174|908845|P1|Period 2|Protocol Violation|1
272520|NCT02059174|908844|P2|Period 2|Withdrawal by Subject|2
272521|NCT02059174|908845|P1|Period 2|Withdrawal by Subject|0
272522|NCT02059174|908844|P2|Period 1|Withdrawal by Subject|2
272523|NCT02059174|908845|P1|Period 1|Withdrawal by Subject|0
272524|NCT02059161|908869|P2|Overall Study|Non-compliance with study drug|2
272525|NCT02059161|908870|P1|Overall Study|Non-compliance with study drug|6
272526|NCT02059161|908869|P2|Overall Study|Randomized in error, no study drug|1
272527|NCT02059161|908870|P1|Overall Study|Randomized in error, no study drug|0
272528|NCT02059161|908869|P2|Overall Study|Withdrawal by Subject|13
272529|NCT02059161|908870|P1|Overall Study|Withdrawal by Subject|16
272530|NCT02059161|908869|P2|Overall Study|Protocol Violation|1
272531|NCT02059161|908870|P1|Overall Study|Protocol Violation|1
272532|NCT02059161|908869|P2|Overall Study|Physician Decision|4
272533|NCT02059161|908870|P1|Overall Study|Physician Decision|4
272534|NCT02059161|908869|P2|Overall Study|Lost to Follow-up|12
272535|NCT02059161|908870|P1|Overall Study|Lost to Follow-up|20
272536|NCT02059161|908869|P2|Overall Study|Adverse Event|6
272537|NCT02059161|908870|P1|Overall Study|Adverse Event|2
272538|NCT02059161|908869|P2|Overall Study|Pregnancy|2
272539|NCT02059161|908870|P1|Overall Study|Pregnancy|0
272540|NCT02059135|908932|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
272541|NCT02059135|908933|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
272542|NCT02059135|908932|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
272543|NCT02059135|908933|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
272544|NCT02059135|908932|P2|Neonatal Follow-up (Safety Population)|Death|2
272545|NCT02059135|908933|P1|Neonatal Follow-up (Safety Population)|Death|3
272546|NCT02059135|908932|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
272547|NCT02059135|908933|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
272548|NCT02059135|908932|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
272549|NCT02059135|908933|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
272550|NCT02059135|908932|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
272551|NCT02059135|908933|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
272552|NCT02059135|908932|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
272553|NCT02059135|908933|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
272554|NCT02059135|908932|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
272555|NCT02059135|908933|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
272556|NCT02058992|908960|P1|Overall Study|CRF Uncollected|20
272557|NCT02058992|908960|P1|Overall Study|Protocol Violation|92
272558|NCT02058992|908960|P1|Overall Study|Lost to Follow-up|4
272559|NCT02058836|908971|P2|Overall Study|Withdrawal by Subject|1
272560|NCT02058836|908972|P1|Overall Study|Withdrawal by Subject|1
272561|NCT02058628|909002|P2|Overall Study|Non compliance|0
272562|NCT02058628|909003|P1|Overall Study|Non compliance|1
272563|NCT02058628|909002|P2|Overall Study|A lot of time for study for participant|0
272564|NCT02058628|909003|P1|Overall Study|A lot of time for study for participant|1
272565|NCT02058628|909002|P2|Overall Study|The visit date was not in timeline|1
272566|NCT02058628|909003|P1|Overall Study|The visit date was not in timeline|0
272567|NCT02058628|909002|P2|Overall Study|Not in time schedule|1
272568|NCT02058628|909003|P1|Overall Study|Not in time schedule|0
272569|NCT02058628|909002|P2|Overall Study|Lost to Follow-up|4
272570|NCT02058628|909003|P1|Overall Study|Lost to Follow-up|2
272571|NCT02058628|909002|P2|Overall Study|Withdrawal by Subject|2
272572|NCT02058628|909003|P1|Overall Study|Withdrawal by Subject|2
272573|NCT02058628|909002|P2|Overall Study|Adverse Event|0
272574|NCT02058628|909003|P1|Overall Study|Adverse Event|1
272575|NCT02058563|909035|P2|Overall Study|Other (patient incarcerated)|1
272576|NCT02058563|909036|P1|Overall Study|Other (patient incarcerated)|0
272577|NCT02058563|909035|P2|Overall Study|Consent Withdrawal|1
272578|NCT02058563|909036|P1|Overall Study|Consent Withdrawal|1
272579|NCT02058563|909035|P2|Overall Study|Other (vaccinated later as new subject)|0
272580|NCT02058563|909036|P1|Overall Study|Other (vaccinated later as new subject)|1
272581|NCT02058563|909035|P2|Overall Study|Lost to Follow-up|22
272582|NCT02058563|909036|P1|Overall Study|Lost to Follow-up|26
272583|NCT02058537|909072|P1|Overall Study|Withdrawal by Subject|1
272584|NCT02058498|909078|P1|Overall Study|Withdrawal by Subject|4
272585|NCT02058290|909086|P2|Overall Study|Withdrawal by Subject|1
272586|NCT02058290|909087|P1|Overall Study|Withdrawal by Subject|0
272587|NCT02058290|909086|P2|Overall Study|Didn't meet intraoperative criteria|7
272588|NCT02058290|909087|P1|Overall Study|Didn't meet intraoperative criteria|8
272589|NCT02058290|909086|P2|Overall Study|Physician Decision|0
272590|NCT02058290|909087|P1|Overall Study|Physician Decision|1
272591|NCT02058290|909086|P2|Overall Study|Protocol Violation|1
272592|NCT02058290|909087|P1|Overall Study|Protocol Violation|2
272593|NCT02058160|909103|P2|Overall Study|Other than specified above|6
272594|NCT02058160|909104|P1|Overall Study|Other than specified above|12
272595|NCT02058160|909103|P2|Overall Study|Lost to Follow-up|0
272596|NCT02058160|909104|P1|Overall Study|Lost to Follow-up|1
272597|NCT02058160|909103|P2|Overall Study|Adverse Event|3
272598|NCT02058160|909104|P1|Overall Study|Adverse Event|12
272599|NCT02058160|909103|P2|Overall Study|Poor compliance to protocol|1
272600|NCT02058160|909104|P1|Overall Study|Poor compliance to protocol|4
272601|NCT02058160|909103|P2|Overall Study|Randomized but not treated|4
272602|NCT02058160|909104|P1|Overall Study|Randomized but not treated|2
272603|NCT02058147|909141|P3|Overall Study|Other than specified|0
272604|NCT02058147|909142|P2|Overall Study|Other than specified|9
272605|NCT02058147|909143|P1|Overall Study|Other than specified|8
272606|NCT02058147|909141|P3|Overall Study|Poor compliance to protocol|4
272607|NCT02058147|909142|P2|Overall Study|Poor compliance to protocol|9
272608|NCT02058147|909143|P1|Overall Study|Poor compliance to protocol|8
272609|NCT02058147|909141|P3|Overall Study|Lack of Efficacy|3
272610|NCT02058147|909142|P2|Overall Study|Lack of Efficacy|0
272611|NCT02058147|909143|P1|Overall Study|Lack of Efficacy|1
272612|NCT02058147|909141|P3|Overall Study|Adverse Event|21
272613|NCT02058147|909142|P2|Overall Study|Adverse Event|9
272614|NCT02058147|909143|P1|Overall Study|Adverse Event|12
272615|NCT02058147|909141|P3|Overall Study|Randomized but not treated|1
272616|NCT02058147|909142|P2|Overall Study|Randomized but not treated|0
272617|NCT02058147|909143|P1|Overall Study|Randomized but not treated|0
272618|NCT02058069|909192|P1|Overall Study|Withdrawal by Subject|6
272619|NCT02058069|909192|P1|Overall Study|Exclusion due to implant size|5
272620|NCT02057835|909251|P10|Overall Study|Withdrawal by Subject|0
272621|NCT02057835|909252|P9|Overall Study|Withdrawal by Subject|0
272622|NCT02057835|909253|P8|Overall Study|Withdrawal by Subject|0
272623|NCT02057835|909254|P7|Overall Study|Withdrawal by Subject|0
272624|NCT02057835|909255|P6|Overall Study|Withdrawal by Subject|0
272625|NCT02057835|909256|P5|Overall Study|Withdrawal by Subject|0
272626|NCT02057835|909257|P4|Overall Study|Withdrawal by Subject|0
272627|NCT02057835|909258|P3|Overall Study|Withdrawal by Subject|0
272628|NCT02057835|909259|P2|Overall Study|Withdrawal by Subject|2
272629|NCT02057835|909260|P1|Overall Study|Withdrawal by Subject|0
272630|NCT02057692|909341|P4|Overall Study|Lost to Follow-up|1
272631|NCT02057692|909342|P3|Overall Study|Lost to Follow-up|0
272632|NCT02057692|909343|P2|Overall Study|Lost to Follow-up|0
272633|NCT02057692|909344|P1|Overall Study|Lost to Follow-up|0
272634|NCT02057692|909341|P4|Overall Study|Adverse Event|0
272635|NCT02057692|909342|P3|Overall Study|Adverse Event|0
272636|NCT02057692|909343|P2|Overall Study|Adverse Event|0
272637|NCT02057692|909344|P1|Overall Study|Adverse Event|1
272638|NCT02057549|909370|P2|Overall Study|Withdrawal by Subject|0
272639|NCT02057549|909371|P1|Overall Study|Withdrawal by Subject|1
272640|NCT02057549|909370|P2|Overall Study|Physician Decision|0
272641|NCT02057549|909371|P1|Overall Study|Physician Decision|1
272642|NCT02057549|909370|P2|Overall Study|Lost to Follow-up|0
272643|NCT02057549|909371|P1|Overall Study|Lost to Follow-up|1
272644|NCT02057406|909394|P3|Overall Study|Patient transportation issues|1
272645|NCT02057406|909395|P2|Overall Study|Patient transportation issues|0
272646|NCT02057406|909396|P1|Overall Study|Patient transportation issues|0
272647|NCT02057406|909394|P3|Overall Study|Protocol Violation|0
272648|NCT02057406|909395|P2|Overall Study|Protocol Violation|1
272649|NCT02057406|909396|P1|Overall Study|Protocol Violation|0
272650|NCT02057406|909394|P3|Overall Study|Death|0
272651|NCT02057406|909395|P2|Overall Study|Death|0
272652|NCT02057406|909396|P1|Overall Study|Death|1
272653|NCT02057406|909394|P3|Overall Study|Lost to Follow-up|1
272654|NCT02057406|909395|P2|Overall Study|Lost to Follow-up|0
272655|NCT02057406|909396|P1|Overall Study|Lost to Follow-up|0
272656|NCT02057406|909394|P3|Overall Study|Withdrawal by Subject|0
272657|NCT02057406|909395|P2|Overall Study|Withdrawal by Subject|2
272658|NCT02057406|909396|P1|Overall Study|Withdrawal by Subject|0
272659|NCT02057406|909394|P3|Overall Study|Physician Decision|2
272660|NCT02057406|909395|P2|Overall Study|Physician Decision|0
272661|NCT02057406|909396|P1|Overall Study|Physician Decision|0
272662|NCT02057393|909407|P1|Overall Study|Patient did not meet criteria|1
272663|NCT02057393|909407|P1|Overall Study|Withdrawal by Subject|1
272664|NCT02057250|909428|P5|Extension Phase|Other than specified above|7
272665|NCT02057250|909429|P4|Extension Phase|Other than specified above|0
272666|NCT02057250|909430|P3|Extension Phase|Other than specified above|0
272667|NCT02057250|909431|P2|Extension Phase|Other than specified above|0
272668|NCT02057250|909432|P1|Extension Phase|Other than specified above|0
272669|NCT02057250|909428|P5|Extension Phase|Entered in this period but not treated|4
272670|NCT02057250|909429|P4|Extension Phase|Entered in this period but not treated|0
272671|NCT02057250|909430|P3|Extension Phase|Entered in this period but not treated|0
272672|NCT02057250|909431|P2|Extension Phase|Entered in this period but not treated|0
272673|NCT02057250|909432|P1|Extension Phase|Entered in this period but not treated|0
272674|NCT02057250|909428|P5|Extension Phase|Lack of Efficacy|10
272675|NCT02057250|909429|P4|Extension Phase|Lack of Efficacy|0
272676|NCT02057250|909430|P3|Extension Phase|Lack of Efficacy|0
272677|NCT02057250|909431|P2|Extension Phase|Lack of Efficacy|0
272678|NCT02057250|909432|P1|Extension Phase|Lack of Efficacy|0
272679|NCT02057250|909428|P5|Extension Phase|Adverse Event|15
272680|NCT02057250|909429|P4|Extension Phase|Adverse Event|0
272681|NCT02057250|909430|P3|Extension Phase|Adverse Event|0
272682|NCT02057250|909431|P2|Extension Phase|Adverse Event|0
272683|NCT02057250|909432|P1|Extension Phase|Adverse Event|0
272684|NCT02057250|909428|P5|AID Assessment Phase|Other than specified above|0
272685|NCT02057250|909429|P4|AID Assessment Phase|Other than specified above|1
272686|NCT02057250|909430|P3|AID Assessment Phase|Other than specified above|1
272687|NCT02057250|909431|P2|AID Assessment Phase|Other than specified above|1
272688|NCT02057250|909432|P1|AID Assessment Phase|Other than specified above|1
272689|NCT02057250|909428|P5|AID Assessment Phase|Adverse Event|0
272690|NCT02057250|909429|P4|AID Assessment Phase|Adverse Event|1
272691|NCT02057250|909430|P3|AID Assessment Phase|Adverse Event|6
272692|NCT02057250|909431|P2|AID Assessment Phase|Adverse Event|2
272693|NCT02057250|909432|P1|AID Assessment Phase|Adverse Event|3
272694|NCT02057068|909452|P2|Overall Study|Lost to Follow-up|2
272695|NCT02057068|909453|P1|Overall Study|Lost to Follow-up|2
272696|NCT02057068|909452|P2|Overall Study|Carepartner (CP) Health|2
272697|NCT02057068|909453|P1|Overall Study|Carepartner (CP) Health|4
272698|NCT02057068|909452|P2|Overall Study|Caregiver (CG) Health|2
272699|NCT02057068|909453|P1|Overall Study|Caregiver (CG) Health|0
272700|NCT02057068|909452|P2|Overall Study|Withdrawal by Subject|2
272701|NCT02057068|909453|P1|Overall Study|Withdrawal by Subject|2
272702|NCT02056834|909463|P1|Overall Study|Lost to Follow-up|7
272703|NCT02056652|909484|P2|Overall Study|Lost to Follow-up|3
272704|NCT02056652|909485|P1|Overall Study|Lost to Follow-up|0
272705|NCT02056652|909484|P2|Overall Study|Withdrawal by Subject|0
272706|NCT02056652|909485|P1|Overall Study|Withdrawal by Subject|1
272707|NCT02056392|909535|P6|Overall Study|Withdrawal by Subject|0
272708|NCT02056392|909536|P5|Overall Study|Withdrawal by Subject|1
272709|NCT02056392|909537|P4|Overall Study|Withdrawal by Subject|0
272710|NCT02056392|909538|P3|Overall Study|Withdrawal by Subject|0
272711|NCT02056392|909539|P2|Overall Study|Withdrawal by Subject|0
272712|NCT02056392|909540|P1|Overall Study|Withdrawal by Subject|1
272713|NCT02056392|909535|P6|Overall Study|Protocol Violation|0
272714|NCT02056392|909536|P5|Overall Study|Protocol Violation|0
272715|NCT02056392|909537|P4|Overall Study|Protocol Violation|0
272716|NCT02056392|909538|P3|Overall Study|Protocol Violation|1
272717|NCT02056392|909539|P2|Overall Study|Protocol Violation|0
272718|NCT02056392|909540|P1|Overall Study|Protocol Violation|1
272719|NCT02056392|909535|P6|Overall Study|Lost to Follow-up|0
272720|NCT02056392|909536|P5|Overall Study|Lost to Follow-up|0
272721|NCT02056392|909537|P4|Overall Study|Lost to Follow-up|0
272722|NCT02056392|909538|P3|Overall Study|Lost to Follow-up|2
272723|NCT02056392|909539|P2|Overall Study|Lost to Follow-up|1
272724|NCT02056392|909540|P1|Overall Study|Lost to Follow-up|0
272725|NCT02055365|909610|P1|Overall Study|Prematurely Withdrawn|1
272726|NCT02055352|909623|P2|Overall Study|Reason unknown|5
272727|NCT02055352|909624|P1|Overall Study|Reason unknown|1
272728|NCT02055352|909623|P2|Overall Study|Withdrawal of informed consent|0
272729|NCT02055352|909624|P1|Overall Study|Withdrawal of informed consent|1
272730|NCT02055352|909623|P2|Overall Study|AE, study drug would be detrimental|3
272731|NCT02055352|909624|P1|Overall Study|AE, study drug would be detrimental|1
272732|NCT02055352|909623|P2|Overall Study|Use of prohibited treatment|3
272733|NCT02055352|909624|P1|Overall Study|Use of prohibited treatment|0
272734|NCT02055352|909623|P2|Overall Study|Patient decision|1
272735|NCT02055352|909624|P1|Overall Study|Patient decision|1
272736|NCT02055352|909623|P2|Overall Study|Death|2
272737|NCT02055352|909624|P1|Overall Study|Death|1
272738|NCT02055352|909623|P2|Overall Study|Poor compliance|1
272739|NCT02055352|909624|P1|Overall Study|Poor compliance|1
272740|NCT02055352|909623|P2|Overall Study|Non-eligible|1
272741|NCT02055352|909624|P1|Overall Study|Non-eligible|0
272742|NCT02055352|909623|P2|Overall Study|Adverse Event|1
272743|NCT02055352|909624|P1|Overall Study|Adverse Event|0
272744|NCT02054910|909640|P2|Overall Study|Lost to Follow-up|1
272745|NCT02054910|909641|P1|Overall Study|Lost to Follow-up|4
272746|NCT02054897|909660|P3|Overall Study|Randomized but not exposed|0
272747|NCT02054897|909661|P2|Overall Study|Randomized but not exposed|0
272748|NCT02054897|909662|P1|Overall Study|Randomized but not exposed|1
272749|NCT02054897|909660|P3|Overall Study|Lost to Follow-up|7
272750|NCT02054897|909661|P2|Overall Study|Lost to Follow-up|2
272751|NCT02054897|909662|P1|Overall Study|Lost to Follow-up|4
272752|NCT02054897|909660|P3|Overall Study|Missing follow-up information|3
272753|NCT02054897|909661|P2|Overall Study|Missing follow-up information|5
272754|NCT02054897|909662|P1|Overall Study|Missing follow-up information|3
272755|NCT02054897|909660|P3|Overall Study|Withdrawal by Subject|2
272756|NCT02054897|909661|P2|Overall Study|Withdrawal by Subject|0
272757|NCT02054897|909662|P1|Overall Study|Withdrawal by Subject|2
272758|NCT02054715|909709|P2|Follow-up 2|Treatment Change or Delay|0
272759|NCT02054715|909710|P1|Follow-up 2|Treatment Change or Delay|1
272760|NCT02054715|909709|P2|Follow-up 2|No Reason|0
272761|NCT02054715|909710|P1|Follow-up 2|No Reason|2
272762|NCT02054715|909709|P2|Follow-up 2|Changed Mind|1
272763|NCT02054715|909710|P1|Follow-up 2|Changed Mind|0
272764|NCT02054715|909709|P2|Follow-up 2|Changed MD/Facility|1
272765|NCT02054715|909710|P1|Follow-up 2|Changed MD/Facility|0
272766|NCT02054715|909709|P2|Follow-up 2|Hospitalization|2
272767|NCT02054715|909710|P1|Follow-up 2|Hospitalization|0
272768|NCT02054715|909709|P2|Follow-up 2|Death|3
272769|NCT02054715|909710|P1|Follow-up 2|Death|3
272770|NCT02054715|909709|P2|Follow-up 2|Ineligible|5
272771|NCT02054715|909710|P1|Follow-up 2|Ineligible|4
272772|NCT02054715|909709|P2|Follow-up 2|Followup Not Completed|4
272773|NCT02054715|909710|P1|Follow-up 2|Followup Not Completed|3
272774|NCT02054715|909709|P2|Follow-up 2|Refused|2
272775|NCT02054715|909710|P1|Follow-up 2|Refused|3
272776|NCT02054715|909709|P2|Follow-up 2|Lost to Followup|1
272777|NCT02054715|909710|P1|Follow-up 2|Lost to Followup|3
272778|NCT02054715|909709|P2|Baseline/Follow-up 1|Changed Mind|0
272779|NCT02054715|909710|P1|Baseline/Follow-up 1|Changed Mind|1
272780|NCT02054715|909709|P2|Baseline/Follow-up 1|Hospitalization|0
272781|NCT02054715|909710|P1|Baseline/Follow-up 1|Hospitalization|1
272782|NCT02054715|909709|P2|Baseline/Follow-up 1|Ineligible|0
272783|NCT02054715|909710|P1|Baseline/Follow-up 1|Ineligible|3
272784|NCT02054715|909709|P2|Baseline/Follow-up 1|Overwhelmed|0
272785|NCT02054715|909710|P1|Baseline/Follow-up 1|Overwhelmed|2
272786|NCT02054715|909709|P2|Baseline/Follow-up 1|No Reason|1
272787|NCT02054715|909710|P1|Baseline/Follow-up 1|No Reason|0
272788|NCT02054715|909709|P2|Baseline/Follow-up 1|Disliked Procedure|1
272789|NCT02054715|909710|P1|Baseline/Follow-up 1|Disliked Procedure|0
272790|NCT02054715|909709|P2|Baseline/Follow-up 1|Changed MD/Facility|1
272791|NCT02054715|909710|P1|Baseline/Follow-up 1|Changed MD/Facility|0
272792|NCT02054715|909709|P2|Baseline/Follow-up 1|Medical|1
272793|NCT02054715|909710|P1|Baseline/Follow-up 1|Medical|0
272794|NCT02054715|909709|P2|Baseline/Follow-up 1|Refused|3
272795|NCT02054715|909710|P1|Baseline/Follow-up 1|Refused|1
272796|NCT02054702|909724|P2|Overall Study|Withdrawal by Subject|4
272797|NCT02054702|909725|P1|Overall Study|Withdrawal by Subject|14
272798|NCT02054702|909724|P2|Overall Study|Physician Decision|1
272799|NCT02054702|909725|P1|Overall Study|Physician Decision|0
272800|NCT02054702|909724|P2|Overall Study|Met Withdrawal Criteria|1
272801|NCT02054702|909725|P1|Overall Study|Met Withdrawal Criteria|4
272802|NCT02054702|909724|P2|Overall Study|Adverse Event|1
272803|NCT02054702|909725|P1|Overall Study|Adverse Event|3
272804|NCT02054702|909724|P2|Overall Study|Lost to Follow-up|5
272805|NCT02054702|909725|P1|Overall Study|Lost to Follow-up|3
272806|NCT02054481|909780|P4|Overall Study|Other reason|0
272807|NCT02054481|909781|P3|Overall Study|Other reason|2
272808|NCT02054481|909782|P2|Overall Study|Other reason|1
272809|NCT02054481|909783|P1|Overall Study|Other reason|2
272810|NCT02054481|909780|P4|Overall Study|Lost to Follow-up|0
272811|NCT02054481|909781|P3|Overall Study|Lost to Follow-up|0
272812|NCT02054481|909782|P2|Overall Study|Lost to Follow-up|0
272813|NCT02054481|909783|P1|Overall Study|Lost to Follow-up|1
272814|NCT02054481|909780|P4|Overall Study|Adverse Event|1
272815|NCT02054481|909781|P3|Overall Study|Adverse Event|0
272816|NCT02054481|909782|P2|Overall Study|Adverse Event|1
272817|NCT02054481|909783|P1|Overall Study|Adverse Event|1
272818|NCT02054325|909831|P2|Overall Study|Lost to Follow-up|5
272819|NCT02054325|909832|P1|Overall Study|Lost to Follow-up|8
272820|NCT02053753|909842|P2|Overall Study|Lost to Follow-up|3
272821|NCT02053753|909843|P1|Overall Study|Lost to Follow-up|4
272822|NCT02053753|909842|P2|Overall Study|Decision by Sponsor|1
272823|NCT02053753|909843|P1|Overall Study|Decision by Sponsor|1
272824|NCT02053753|909842|P2|Overall Study|Withdrawal by Subject|4
272825|NCT02053753|909843|P1|Overall Study|Withdrawal by Subject|2
272826|NCT02053610|909867|P2|Overall Study|Failure to Return|3
272827|NCT02053610|909868|P1|Overall Study|Failure to Return|4
272828|NCT02053610|909867|P2|Overall Study|Did not Receive Treatment|2
272829|NCT02053610|909868|P1|Overall Study|Did not Receive Treatment|0
272830|NCT02053610|909867|P2|Overall Study|Refused treatment/Did not cooperate|0
272831|NCT02053610|909868|P1|Overall Study|Refused treatment/Did not cooperate|3
272832|NCT02053610|909867|P2|Overall Study|Disease Progression|94
272833|NCT02053610|909868|P1|Overall Study|Disease Progression|148
272834|NCT02053610|909867|P2|Overall Study|Administrative/Other|27
272835|NCT02053610|909868|P1|Overall Study|Administrative/Other|34
272836|NCT02053610|909867|P2|Overall Study|Death|25
272837|NCT02053610|909868|P1|Overall Study|Death|31
272838|NCT02053610|909867|P2|Overall Study|Withdrew Consent|14
272839|NCT02053610|909868|P1|Overall Study|Withdrew Consent|12
272840|NCT02053610|909867|P2|Overall Study|Adverse Event/Intercurrent Illness|9
272841|NCT02053610|909868|P1|Overall Study|Adverse Event/Intercurrent Illness|3
272842|NCT02053493|909900|P2|Overall Study|Withdrawal by Subject|1
272843|NCT02053493|909901|P1|Overall Study|Withdrawal by Subject|1
272844|NCT02053168|909939|P1|Overall Study|Lost to Follow-up|1
272845|NCT02053168|909939|P1|Overall Study|Physician Decision|1
272846|NCT02053168|909939|P1|Overall Study|Withdrawal by Subject|1
272847|NCT02052596|910018|P2|Safety Phase|Lost due to Crohn`s disease|1
272848|NCT02052596|910019|P1|Safety Phase|Lost due to Crohn`s disease|0
272849|NCT02052596|910018|P2|Safety Phase|Enrolled in error|0
272850|NCT02052596|910019|P1|Safety Phase|Enrolled in error|1
272851|NCT02052596|910018|P2|Safety Phase|Withdrawal by Subject|11
272852|NCT02052596|910019|P1|Safety Phase|Withdrawal by Subject|8
272853|NCT02052596|910018|P2|Safety Phase|Protocol Violation|2
272854|NCT02052596|910019|P1|Safety Phase|Protocol Violation|1
272855|NCT02052596|910018|P2|Safety Phase|Lost to Follow-up|18
272856|NCT02052596|910019|P1|Safety Phase|Lost to Follow-up|11
272857|NCT02052596|910018|P2|Safety Phase|Adverse Event|3
272858|NCT02052596|910019|P1|Safety Phase|Adverse Event|6
272859|NCT02052596|910018|P2|Active Phase|Lost due to Crohn`s disease|1
272860|NCT02052596|910019|P1|Active Phase|Lost due to Crohn`s disease|0
272861|NCT02052596|910018|P2|Active Phase|Enrolled in error|0
272862|NCT02052596|910019|P1|Active Phase|Enrolled in error|1
272863|NCT02052596|910018|P2|Active Phase|Withdrawal by Subject|4
272864|NCT02052596|910019|P1|Active Phase|Withdrawal by Subject|3
272865|NCT02052596|910018|P2|Active Phase|Protocol Violation|2
272866|NCT02052596|910019|P1|Active Phase|Protocol Violation|1
272867|NCT02052596|910018|P2|Active Phase|Lost to Follow-up|11
272868|NCT02052596|910019|P1|Active Phase|Lost to Follow-up|8
272869|NCT02052596|910018|P2|Active Phase|Adverse Event|2
272870|NCT02052596|910019|P1|Active Phase|Adverse Event|3
272871|NCT02052466|910049|P1|Overall Study|Acromial fracture|1
272872|NCT02052466|910049|P1|Overall Study|Withdrawal by Subject|1
272873|NCT02052440|910066|P2|Overall Study|Withdrawal by Subject|1
272874|NCT02052440|910067|P1|Overall Study|Withdrawal by Subject|0
272875|NCT02052414|910079|P1|Overall Study|Withdrawal by Subject|3
272876|NCT02052414|910079|P1|Overall Study|Lack of Efficacy|2
272877|NCT02052414|910079|P1|Overall Study|Adverse Event|12
272878|NCT02052011|910089|P2|Overall Study|Withdrawal by Subject|2
272879|NCT02052011|910090|P1|Overall Study|Withdrawal by Subject|1
272880|NCT02052011|910089|P2|Overall Study|Lost to Follow-up|0
272881|NCT02052011|910090|P1|Overall Study|Lost to Follow-up|3
272882|NCT02051296|910232|P2|Overall Study|withdraw prior to treatment|7
272883|NCT02051296|910233|P1|Overall Study|withdraw prior to treatment|7
272884|NCT02051296|910232|P2|Overall Study|Lost to Follow-up|2
272885|NCT02051296|910233|P1|Overall Study|Lost to Follow-up|1
272886|NCT02050321|910250|P1|Overall Study|Adverse Event|1
272887|NCT02050321|910250|P1|Overall Study|Withdrawal by Subject|1
272888|NCT02050048|910257|P2|Overall Study|Ineligible after ERCP|1
272889|NCT02050048|910258|P1|Overall Study|Ineligible after ERCP|4
272890|NCT02050048|910257|P2|Overall Study|Death|0
272891|NCT02050048|910258|P1|Overall Study|Death|1
272892|NCT02050048|910257|P2|Overall Study|Lost to Follow-up|1
272893|NCT02050048|910258|P1|Overall Study|Lost to Follow-up|0
272894|NCT02049450|910277|P1|Overall Study|Patients/guardian decision|1
272895|NCT02049450|910277|P1|Overall Study|Withdrawal by Subject|1
272896|NCT02049450|910277|P1|Overall Study|Adverse Event|2
272897|NCT02048904|910315|P1|Overall Study|Physician Decision|70
272898|NCT02048904|910315|P1|Overall Study|Withdrawal by Subject|7
272899|NCT02048241|910330|P2|Overall Study|Withdrawal by Subject|1
272900|NCT02048241|910331|P1|Overall Study|Withdrawal by Subject|0
272901|NCT02048072|910337|P1|Overall Study|Lost to Follow-up|1
272902|NCT02048072|910337|P1|Overall Study|Adverse Event|3
272903|NCT02047227|910352|P2|Overall Study|Other|9
272904|NCT02047227|910353|P1|Overall Study|Other|10
272905|NCT02047227|910352|P2|Overall Study|All embryos discarded|11
272906|NCT02047227|910353|P1|Overall Study|All embryos discarded|12
272907|NCT02047227|910352|P2|Overall Study|Intention to freeze all embryos|0
272908|NCT02047227|910353|P1|Overall Study|Intention to freeze all embryos|1
272909|NCT02047227|910352|P2|Overall Study|No fertilization|51
272910|NCT02047227|910353|P1|Overall Study|No fertilization|61
272911|NCT02047227|910352|P2|Overall Study|No oocytes retrieved|20
272912|NCT02047227|910353|P1|Overall Study|No oocytes retrieved|21
272913|NCT02047227|910352|P2|Overall Study|Lack of ovarian response to stimulation|32
272914|NCT02047227|910353|P1|Overall Study|Lack of ovarian response to stimulation|35
272915|NCT02047227|910352|P2|Overall Study|Spontaneous pregnancy|0
272916|NCT02047227|910353|P1|Overall Study|Spontaneous pregnancy|1
272917|NCT02047227|910352|P2|Overall Study|Protocol Violation|0
272918|NCT02047227|910353|P1|Overall Study|Protocol Violation|1
272919|NCT02047227|910352|P2|Overall Study|Lost to Follow-up|3
272920|NCT02047227|910353|P1|Overall Study|Lost to Follow-up|0
272921|NCT02047227|910352|P2|Overall Study|Adverse Event|4
272922|NCT02047227|910353|P1|Overall Study|Adverse Event|2
272923|NCT02046993|910371|P2|Overall Study|Lost to Follow-up|1
272924|NCT02046993|910372|P1|Overall Study|Lost to Follow-up|1
272925|NCT02046993|910371|P2|Overall Study|Withdrawal by Subject|10
272926|NCT02046993|910372|P1|Overall Study|Withdrawal by Subject|2
272927|NCT02046616|910422|P1|8-Week FU Period|Lost to Follow-up|1
272928|NCT02046616|910422|P1|24-Week Treatment Period|Not Specified|1
272929|NCT02046616|910422|P1|24-Week Treatment Period|Physician Decision|3
272930|NCT02046616|910422|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
272931|NCT02046616|910422|P1|24-Week Treatment Period|Any Other Adverse Event|13
272932|NCT02046616|910422|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
272933|NCT02046564|910444|P2|Overall Study|Subject met withdrawal criteria|5
272934|NCT02046564|910445|P1|Overall Study|Subject met withdrawal criteria|2
272935|NCT02046564|910444|P2|Overall Study|Withdrawal by Subject|10
272936|NCT02046564|910445|P1|Overall Study|Withdrawal by Subject|4
272937|NCT02046564|910444|P2|Overall Study|Protocol Violation|1
272938|NCT02046564|910445|P1|Overall Study|Protocol Violation|3
272939|NCT02046564|910444|P2|Overall Study|Physician Decision|1
272940|NCT02046564|910445|P1|Overall Study|Physician Decision|0
272941|NCT02046564|910444|P2|Overall Study|Adverse Event|3
272942|NCT02046564|910445|P1|Overall Study|Adverse Event|6
272943|NCT02046369|910484|P2|Overall Study|non compliance|0
272944|NCT02046369|910485|P1|Overall Study|non compliance|1
272945|NCT02046369|910484|P2|Overall Study|never received study drug|1
272946|NCT02046369|910485|P1|Overall Study|never received study drug|0
272947|NCT02046369|910484|P2|Overall Study|Withdrawal by Subject|6
272948|NCT02046369|910485|P1|Overall Study|Withdrawal by Subject|3
272949|NCT02046369|910484|P2|Overall Study|Protocol Violation|2
272950|NCT02046369|910485|P1|Overall Study|Protocol Violation|1
272951|NCT02046369|910484|P2|Overall Study|Lost to Follow-up|3
272952|NCT02046369|910485|P1|Overall Study|Lost to Follow-up|3
272953|NCT02046369|910484|P2|Overall Study|Lack of Efficacy|3
272954|NCT02046369|910485|P1|Overall Study|Lack of Efficacy|3
272955|NCT02046369|910484|P2|Overall Study|Adverse Event|3
272956|NCT02046369|910485|P1|Overall Study|Adverse Event|3
272957|NCT02046226|910518|P1|Overall Study|Lost to Follow-up|7
272958|NCT02046148|910566|P2|Overall Study|Withdrawal by Subject|2
272959|NCT02046148|910567|P1|Overall Study|Withdrawal by Subject|0
272960|NCT02046148|910566|P2|Overall Study|Lost to Follow-up|1
272961|NCT02046148|910567|P1|Overall Study|Lost to Follow-up|1
272962|NCT02045979|910627|P3|Overall Study|not specified above|0
272963|NCT02045979|910628|P2|Overall Study|not specified above|1
272964|NCT02045979|910629|P1|Overall Study|not specified above|0
272965|NCT02045979|910627|P3|Overall Study|Informed Consent Withdrawn|1
272966|NCT02045979|910628|P2|Overall Study|Informed Consent Withdrawn|0
272967|NCT02045979|910629|P1|Overall Study|Informed Consent Withdrawn|2
272968|NCT02045875|910666|P2|Overall Study|Withdrawal by Subject|3
272969|NCT02045875|910667|P1|Overall Study|Withdrawal by Subject|4
272970|NCT02045875|910666|P2|Overall Study|Lost to Follow-up|0
272971|NCT02045875|910667|P1|Overall Study|Lost to Follow-up|3
272972|NCT02045862|910678|P3|Overall Study|Lost to Follow-up|6
272973|NCT02045862|910679|P2|Overall Study|Lost to Follow-up|2
272974|NCT02045862|910680|P1|Overall Study|Lost to Follow-up|1
272975|NCT02045862|910678|P3|Overall Study|Adverse Event|27
272976|NCT02045862|910679|P2|Overall Study|Adverse Event|5
272977|NCT02045862|910680|P1|Overall Study|Adverse Event|7
272978|NCT02045862|910678|P3|Overall Study|Randomized but not Received Study Drug|8
272979|NCT02045862|910679|P2|Overall Study|Randomized but not Received Study Drug|2
272980|NCT02045862|910680|P1|Overall Study|Randomized but not Received Study Drug|0
272981|NCT02045862|910678|P3|Overall Study|Lack of Efficacy|13
272982|NCT02045862|910679|P2|Overall Study|Lack of Efficacy|4
272983|NCT02045862|910680|P1|Overall Study|Lack of Efficacy|8
272984|NCT02045862|910678|P3|Overall Study|Protocol Violation|6
272985|NCT02045862|910679|P2|Overall Study|Protocol Violation|0
272986|NCT02045862|910680|P1|Overall Study|Protocol Violation|0
272987|NCT02045862|910678|P3|Overall Study|Withdrawal by Patient|57
272988|NCT02045862|910679|P2|Overall Study|Withdrawal by Patient|27
272989|NCT02045862|910680|P1|Overall Study|Withdrawal by Patient|18
272990|NCT02045862|910678|P3|Overall Study|Miscellaneous|8
272991|NCT02045862|910679|P2|Overall Study|Miscellaneous|0
272992|NCT02045862|910680|P1|Overall Study|Miscellaneous|5
272993|NCT02045862|910678|P3|Overall Study|Death|1
272994|NCT02045862|910679|P2|Overall Study|Death|0
272995|NCT02045862|910680|P1|Overall Study|Death|0
272996|NCT02045836|910861|P2|Overall Study|Migrated from study area|2
272997|NCT02045836|910862|P1|Overall Study|Migrated from study area|0
272998|NCT02045836|910861|P2|Overall Study|Lost to Follow-up|7
272999|NCT02045836|910862|P1|Overall Study|Lost to Follow-up|4
273000|NCT02045836|910861|P2|Overall Study|Withdrawal by Subject|1
273001|NCT02045836|910862|P1|Overall Study|Withdrawal by Subject|1
273002|NCT02045836|910861|P2|Overall Study|Adverse Event|4
273003|NCT02045836|910862|P1|Overall Study|Adverse Event|4
273004|NCT02045797|910894|P3|Overall Study|Withdrawal by Subject|0
273005|NCT02045797|910895|P2|Overall Study|Withdrawal by Subject|2
273006|NCT02045797|910896|P1|Overall Study|Withdrawal by Subject|1
273007|NCT02045797|910894|P3|Overall Study|Physician Decision|0
273008|NCT02045797|910895|P2|Overall Study|Physician Decision|1
273009|NCT02045797|910896|P1|Overall Study|Physician Decision|0
273010|NCT02045797|910894|P3|Overall Study|Lost to Follow-up|1
273011|NCT02045797|910895|P2|Overall Study|Lost to Follow-up|3
273012|NCT02045797|910896|P1|Overall Study|Lost to Follow-up|2
273013|NCT02045797|910894|P3|Overall Study|Lack of Efficacy|0
273014|NCT02045797|910895|P2|Overall Study|Lack of Efficacy|0
273015|NCT02045797|910896|P1|Overall Study|Lack of Efficacy|1
273016|NCT02045797|910894|P3|Overall Study|Adverse Event|0
273017|NCT02045797|910895|P2|Overall Study|Adverse Event|1
273018|NCT02045797|910896|P1|Overall Study|Adverse Event|3
273019|NCT02045732|911041|P2|Overall Study|At the discretion of the investigator|1
273020|NCT02045732|911042|P1|Overall Study|At the discretion of the investigator|1
273021|NCT02044848|911173|P2|Overall Study|Administrative Problems|3
273022|NCT02044848|911174|P1|Overall Study|Administrative Problems|2
273023|NCT02044822|911180|P1|Overall Study|Lost to Follow-up|1
273024|NCT02044822|911180|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
273025|NCT02044822|911180|P1|Overall Study|Withdrew Consent|3
273026|NCT02044822|911180|P1|Overall Study|Investigator's Discretion|10
273027|NCT02044822|911180|P1|Overall Study|Study Terminated by Sponsor|77
273028|NCT02044458|911192|P2|Overall Study|Protocol Violation|8
273029|NCT02044458|911193|P1|Overall Study|Protocol Violation|3
273030|NCT02044302|911279|P2|Overall Study|study terminated|0
273031|NCT02044302|911280|P1|Overall Study|study terminated|2
273032|NCT02044094|911286|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
273033|NCT02044094|911286|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
273034|NCT02044094|911286|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
273035|NCT02044094|911286|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
273036|NCT02044094|911286|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
273037|NCT02044094|911286|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
273038|NCT02044094|911286|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
273039|NCT02044094|911286|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
273040|NCT02043938|911343|P1|Overall Study|Investigator decision|1
273041|NCT02043938|911343|P1|Overall Study|No show by subject|1
273042|NCT02043938|911343|P1|Overall Study|Unable to place EEG sensors on patient|1
273043|NCT02043938|911343|P1|Overall Study|Withdrawal by Subject|7
273044|NCT02043782|911394|P6|Period 1|Adverse Event|0
273045|NCT02043782|911395|P5|Period 1|Adverse Event|0
273046|NCT02043782|911396|P4|Period 1|Adverse Event|0
273047|NCT02043782|911397|P3|Period 1|Adverse Event|1
273048|NCT02043782|911398|P2|Period 1|Adverse Event|0
273049|NCT02043782|911399|P1|Period 1|Adverse Event|0
273050|NCT02043366|911510|P6|Overall Study|Lost to Follow-up|2
273051|NCT02043366|911511|P5|Overall Study|Lost to Follow-up|2
273052|NCT02043366|911512|P4|Overall Study|Lost to Follow-up|2
273053|NCT02043366|911513|P3|Overall Study|Lost to Follow-up|2
273054|NCT02043366|911514|P2|Overall Study|Lost to Follow-up|2
273055|NCT02043366|911515|P1|Overall Study|Lost to Follow-up|2
273056|NCT02043132|911553|P2|Overall Study|screen failures|8
273057|NCT02043132|911554|P1|Overall Study|screen failures|4
273058|NCT02043132|911553|P2|Overall Study|Lost to Follow-up|1
273059|NCT02043132|911554|P1|Overall Study|Lost to Follow-up|1
273060|NCT02043015|911574|P1|Overall Study|Incarceration|1
273061|NCT02043015|911574|P1|Overall Study|Participant moved away from study city|4
273062|NCT02043015|911574|P1|Overall Study|Removed once target enrollment reached|15
273063|NCT02043015|911574|P1|Overall Study|Withdrawal by Subject|4
273064|NCT02043015|911574|P1|Overall Study|Lost to Follow-up|4
273065|NCT02042924|911587|P1|Overall Study|Early Death|1
273066|NCT02042443|911635|P2|Overall Study|Not eligible/not analyzable|6
273067|NCT02042443|911636|P1|Overall Study|Not eligible/not analyzable|3
273068|NCT02042443|911635|P2|Overall Study|not protocol specified|1
273069|NCT02042443|911636|P1|Overall Study|not protocol specified|1
273070|NCT02042443|911635|P2|Overall Study|Progression|17
273071|NCT02042443|911636|P1|Overall Study|Progression|21
273072|NCT02042443|911635|P2|Overall Study|Withdrawal by Subject|1
273073|NCT02042443|911636|P1|Overall Study|Withdrawal by Subject|0
273074|NCT02042443|911635|P2|Overall Study|Adverse Event|1
273075|NCT02042443|911636|P1|Overall Study|Adverse Event|2
273076|NCT02042404|911648|P2|Overall Study|Inability to meet time requirements|0
273077|NCT02042404|911649|P1|Overall Study|Inability to meet time requirements|1
273078|NCT02042404|911648|P2|Overall Study|Unrelated Adverse Event|0
273079|NCT02042404|911649|P1|Overall Study|Unrelated Adverse Event|3
273080|NCT02042404|911648|P2|Overall Study|Death|0
273081|NCT02042404|911649|P1|Overall Study|Death|1
273082|NCT02041533|911689|P2|Overall Study|Randomized, not treated|7
273083|NCT02041533|911690|P1|Overall Study|Randomized, not treated|4
273084|NCT02041533|911689|P2|Overall Study|Completed max number of chemo cycles|29
273085|NCT02041533|911690|P1|Overall Study|Completed max number of chemo cycles|0
273086|NCT02041533|911689|P2|Overall Study|Other reasons|1
273087|NCT02041533|911690|P1|Overall Study|Other reasons|0
273088|NCT02041533|911689|P2|Overall Study|Poor/non-compliance|0
273089|NCT02041533|911690|P1|Overall Study|Poor/non-compliance|1
273090|NCT02041533|911689|P2|Overall Study|Maximum clinical benefit|18
273091|NCT02041533|911690|P1|Overall Study|Maximum clinical benefit|0
273092|NCT02041533|911689|P2|Overall Study|Withdrawal by Subject|1
273093|NCT02041533|911690|P1|Overall Study|Withdrawal by Subject|2
273094|NCT02041533|911689|P2|Overall Study|Subject request to discontinue treatment|9
273095|NCT02041533|911690|P1|Overall Study|Subject request to discontinue treatment|5
273096|NCT02041533|911689|P2|Overall Study|Adverse Event unrelated to study drug|21
273097|NCT02041533|911690|P1|Overall Study|Adverse Event unrelated to study drug|20
273098|NCT02041533|911689|P2|Overall Study|Death|0
273099|NCT02041533|911690|P1|Overall Study|Death|1
273100|NCT02041533|911689|P2|Overall Study|Study drug toxicity|30
273101|NCT02041533|911690|P1|Overall Study|Study drug toxicity|27
273102|NCT02041533|911689|P2|Overall Study|Disease Progression|142
273103|NCT02041533|911690|P1|Overall Study|Disease Progression|168
273104|NCT02041520|911712|P2|Overall Study|Hypothiroidism identified during follow-|1
273105|NCT02041520|911713|P1|Overall Study|Hypothiroidism identified during follow-|0
273106|NCT02041520|911712|P2|Overall Study|Lost to Follow-up|1
273107|NCT02041520|911713|P1|Overall Study|Lost to Follow-up|0
273108|NCT02041520|911712|P2|Overall Study|Protocol Violation|0
273109|NCT02041520|911713|P1|Overall Study|Protocol Violation|1
273110|NCT02041520|911712|P2|Overall Study|Withdrawal by Subject|4
273111|NCT02041520|911713|P1|Overall Study|Withdrawal by Subject|3
273112|NCT02041520|911712|P2|Overall Study|Adverse Event|1
273113|NCT02041520|911713|P1|Overall Study|Adverse Event|2
273114|NCT02041286|911756|P1|Overall Study|Adverse Event|1
273115|NCT02041091|911791|P2|Optional Safety Extension Period|Lost to Follow-up|3
273116|NCT02041091|911792|P1|Optional Safety Extension Period|Lost to Follow-up|2
273117|NCT02041091|911791|P2|Optional Safety Extension Period|Sponsor Decision|74
273118|NCT02041091|911792|P1|Optional Safety Extension Period|Sponsor Decision|70
273119|NCT02041091|911791|P2|Optional Safety Extension Period|Physician Decision|1
273120|NCT02041091|911792|P1|Optional Safety Extension Period|Physician Decision|2
273121|NCT02041091|911791|P2|Optional Safety Extension Period|Protocol Violation|0
273122|NCT02041091|911792|P1|Optional Safety Extension Period|Protocol Violation|2
273123|NCT02041091|911791|P2|Optional Safety Extension Period|Withdrawal by Subject|2
273124|NCT02041091|911792|P1|Optional Safety Extension Period|Withdrawal by Subject|5
273125|NCT02041091|911791|P2|Optional Safety Extension Period|Adverse Event|2
273126|NCT02041091|911792|P1|Optional Safety Extension Period|Adverse Event|4
273127|NCT02041091|911791|P2|Treatment|Lost to Follow-up|0
273128|NCT02041091|911792|P1|Treatment|Lost to Follow-up|1
273129|NCT02041091|911791|P2|Treatment|Sponsor Decision|16
273130|NCT02041091|911792|P1|Treatment|Sponsor Decision|15
273131|NCT02041091|911791|P2|Treatment|Physician Decision|0
273132|NCT02041091|911792|P1|Treatment|Physician Decision|1
273133|NCT02041091|911791|P2|Treatment|Withdrawal by Subject|4
273134|NCT02041091|911792|P1|Treatment|Withdrawal by Subject|2
273135|NCT02041091|911791|P2|Treatment|Adverse Event|3
273136|NCT02041091|911792|P1|Treatment|Adverse Event|3
273137|NCT02040844|911817|P3|Overall Study|Concomitant medication|1
273138|NCT02040844|911818|P2|Overall Study|Concomitant medication|3
273139|NCT02040844|911819|P1|Overall Study|Concomitant medication|1
273140|NCT02040844|911817|P3|Overall Study|Non-specified|5
273141|NCT02040844|911818|P2|Overall Study|Non-specified|2
273142|NCT02040844|911819|P1|Overall Study|Non-specified|8
273143|NCT02040844|911817|P3|Overall Study|Missing|2
273144|NCT02040844|911818|P2|Overall Study|Missing|3
273145|NCT02040844|911819|P1|Overall Study|Missing|13
273146|NCT02040844|911817|P3|Overall Study|Lost to Follow-up|13
273147|NCT02040844|911818|P2|Overall Study|Lost to Follow-up|9
273148|NCT02040844|911819|P1|Overall Study|Lost to Follow-up|12
273149|NCT02040844|911817|P3|Overall Study|Withdrawal by Subject|25
273150|NCT02040844|911818|P2|Overall Study|Withdrawal by Subject|22
273151|NCT02040844|911819|P1|Overall Study|Withdrawal by Subject|16
273152|NCT02040844|911817|P3|Overall Study|Adverse Event|1
273153|NCT02040844|911818|P2|Overall Study|Adverse Event|0
273154|NCT02040844|911819|P1|Overall Study|Adverse Event|0
273155|NCT02040779|911866|P3|Overall Study|Lack of Efficacy|0
273156|NCT02040779|911867|P2|Overall Study|Lack of Efficacy|2
273157|NCT02040779|911868|P1|Overall Study|Lack of Efficacy|4
273158|NCT02040779|911866|P3|Overall Study|Lost to Follow-up|1
273159|NCT02040779|911867|P2|Overall Study|Lost to Follow-up|2
273160|NCT02040779|911868|P1|Overall Study|Lost to Follow-up|1
273161|NCT02040779|911866|P3|Overall Study|Protocol Violation|0
273162|NCT02040779|911867|P2|Overall Study|Protocol Violation|1
273163|NCT02040779|911868|P1|Overall Study|Protocol Violation|2
273164|NCT02040779|911866|P3|Overall Study|Non-compliance|0
273165|NCT02040779|911867|P2|Overall Study|Non-compliance|1
273166|NCT02040779|911868|P1|Overall Study|Non-compliance|0
273167|NCT02040779|911866|P3|Overall Study|Withdrawal by Subject|3
273168|NCT02040779|911867|P2|Overall Study|Withdrawal by Subject|1
273169|NCT02040779|911868|P1|Overall Study|Withdrawal by Subject|4
273170|NCT02040779|911866|P3|Overall Study|Adverse Event|0
273171|NCT02040779|911867|P2|Overall Study|Adverse Event|0
273172|NCT02040779|911868|P1|Overall Study|Adverse Event|1
273173|NCT02040766|911908|P5|Overall Study|Lack of Efficacy|5
273174|NCT02040766|911909|P4|Overall Study|Lack of Efficacy|6
273175|NCT02040766|911910|P3|Overall Study|Lack of Efficacy|4
273176|NCT02040766|911911|P2|Overall Study|Lack of Efficacy|3
273177|NCT02040766|911912|P1|Overall Study|Lack of Efficacy|6
273178|NCT02040766|911908|P5|Overall Study|Not reported|0
273179|NCT02040766|911909|P4|Overall Study|Not reported|0
273180|NCT02040766|911910|P3|Overall Study|Not reported|0
273181|NCT02040766|911911|P2|Overall Study|Not reported|0
273182|NCT02040766|911912|P1|Overall Study|Not reported|1
273183|NCT02040766|911908|P5|Overall Study|Lost to Follow-up|4
273184|NCT02040766|911909|P4|Overall Study|Lost to Follow-up|1
273185|NCT02040766|911910|P3|Overall Study|Lost to Follow-up|3
273186|NCT02040766|911911|P2|Overall Study|Lost to Follow-up|1
273187|NCT02040766|911912|P1|Overall Study|Lost to Follow-up|4
273188|NCT02040766|911908|P5|Overall Study|Protocol Violation|0
273189|NCT02040766|911909|P4|Overall Study|Protocol Violation|3
273190|NCT02040766|911910|P3|Overall Study|Protocol Violation|2
273191|NCT02040766|911911|P2|Overall Study|Protocol Violation|1
273192|NCT02040766|911912|P1|Overall Study|Protocol Violation|2
273193|NCT02040766|911908|P5|Overall Study|Non-compliance|0
273194|NCT02040766|911909|P4|Overall Study|Non-compliance|0
273195|NCT02040766|911910|P3|Overall Study|Non-compliance|0
273196|NCT02040766|911911|P2|Overall Study|Non-compliance|1
273197|NCT02040766|911912|P1|Overall Study|Non-compliance|0
273198|NCT02040766|911908|P5|Overall Study|Withdrawal by Subject|2
273199|NCT02040766|911909|P4|Overall Study|Withdrawal by Subject|3
273200|NCT02040766|911910|P3|Overall Study|Withdrawal by Subject|2
273201|NCT02040766|911911|P2|Overall Study|Withdrawal by Subject|3
273202|NCT02040766|911912|P1|Overall Study|Withdrawal by Subject|4
273203|NCT02040766|911908|P5|Overall Study|Adverse Event|2
273204|NCT02040766|911909|P4|Overall Study|Adverse Event|0
273205|NCT02040766|911910|P3|Overall Study|Adverse Event|1
273206|NCT02040766|911911|P2|Overall Study|Adverse Event|1
273207|NCT02040766|911912|P1|Overall Study|Adverse Event|1
273208|NCT02040532|911963|P1|Overall Study|Withdrawal by Subject|3
273209|NCT02040532|911963|P1|Overall Study|Adverse Event|4
273210|NCT02040532|911963|P1|Overall Study|Physician Decision|4
273211|NCT02040532|911963|P1|Overall Study|Lost to Follow-up|1
273212|NCT02040428|911976|P2|Overall Study|Withdrawal by Subject|1
273213|NCT02040428|911977|P1|Overall Study|Withdrawal by Subject|1
273214|NCT02040428|911976|P2|Overall Study|Death|3
273215|NCT02040428|911977|P1|Overall Study|Death|4
273216|NCT02039778|912025|P1|Overall Study|Never started the protocol treatment|1
273217|NCT02039778|912025|P1|Overall Study|Withdrawal by Subject|1
273218|NCT02039778|912025|P1|Overall Study|Death|2
273219|NCT02039687|912037|P4|Overall Study|treatment assignment could not be confir|0
273220|NCT02039687|912038|P3|Overall Study|treatment assignment could not be confir|2
273221|NCT02039687|912039|P2|Overall Study|treatment assignment could not be confir|0
273222|NCT02039687|912040|P1|Overall Study|treatment assignment could not be confir|0
273223|NCT02039687|912037|P4|Overall Study|Withdrawal by Subject|0
273224|NCT02039687|912038|P3|Overall Study|Withdrawal by Subject|0
273225|NCT02039687|912039|P2|Overall Study|Withdrawal by Subject|1
273226|NCT02039687|912040|P1|Overall Study|Withdrawal by Subject|0
273227|NCT02039687|912037|P4|Overall Study|Adverse Event|0
273228|NCT02039687|912038|P3|Overall Study|Adverse Event|1
273229|NCT02039687|912039|P2|Overall Study|Adverse Event|0
273230|NCT02039687|912040|P1|Overall Study|Adverse Event|0
273231|NCT02039674|912075|P9|Overall Study|Ongoing in Study|4
273232|NCT02039674|912076|P8|Overall Study|Ongoing in Study|33
273233|NCT02039674|912077|P7|Overall Study|Ongoing in Study|34
273234|NCT02039674|912078|P6|Overall Study|Ongoing in Study|1
273235|NCT02039674|912079|P5|Overall Study|Ongoing in Study|6
273236|NCT02039674|912080|P4|Overall Study|Ongoing in Study|2
273237|NCT02039674|912081|P3|Overall Study|Ongoing in Study|5
273238|NCT02039674|912082|P2|Overall Study|Ongoing in Study|5
273239|NCT02039674|912083|P1|Overall Study|Ongoing in Study|7
273240|NCT02039674|912075|P9|Overall Study|Withdrawal by Subject|2
273241|NCT02039674|912076|P8|Overall Study|Withdrawal by Subject|5
273242|NCT02039674|912077|P7|Overall Study|Withdrawal by Subject|3
273243|NCT02039674|912078|P6|Overall Study|Withdrawal by Subject|1
273244|NCT02039674|912079|P5|Overall Study|Withdrawal by Subject|2
273245|NCT02039674|912080|P4|Overall Study|Withdrawal by Subject|0
273246|NCT02039674|912081|P3|Overall Study|Withdrawal by Subject|1
273247|NCT02039674|912082|P2|Overall Study|Withdrawal by Subject|1
273248|NCT02039674|912083|P1|Overall Study|Withdrawal by Subject|2
273249|NCT02039674|912075|P9|Overall Study|Progressive Disease|23
273250|NCT02039674|912076|P8|Overall Study|Progressive Disease|18
273251|NCT02039674|912077|P7|Overall Study|Progressive Disease|17
273252|NCT02039674|912078|P6|Overall Study|Progressive Disease|0
273253|NCT02039674|912079|P5|Overall Study|Progressive Disease|2
273254|NCT02039674|912080|P4|Overall Study|Progressive Disease|4
273255|NCT02039674|912081|P3|Overall Study|Progressive Disease|15
273256|NCT02039674|912082|P2|Overall Study|Progressive Disease|13
273257|NCT02039674|912083|P1|Overall Study|Progressive Disease|13
273258|NCT02039674|912075|P9|Overall Study|Physician Decision|0
273259|NCT02039674|912076|P8|Overall Study|Physician Decision|0
273260|NCT02039674|912077|P7|Overall Study|Physician Decision|1
273261|NCT02039674|912078|P6|Overall Study|Physician Decision|0
273262|NCT02039674|912079|P5|Overall Study|Physician Decision|0
273263|NCT02039674|912080|P4|Overall Study|Physician Decision|0
273264|NCT02039674|912081|P3|Overall Study|Physician Decision|0
273265|NCT02039674|912082|P2|Overall Study|Physician Decision|0
273266|NCT02039674|912083|P1|Overall Study|Physician Decision|0
273267|NCT02039674|912075|P9|Overall Study|Lost to Follow-up|0
273268|NCT02039674|912076|P8|Overall Study|Lost to Follow-up|1
273269|NCT02039674|912077|P7|Overall Study|Lost to Follow-up|0
273270|NCT02039674|912078|P6|Overall Study|Lost to Follow-up|0
273271|NCT02039674|912079|P5|Overall Study|Lost to Follow-up|0
273272|NCT02039674|912080|P4|Overall Study|Lost to Follow-up|0
273273|NCT02039674|912081|P3|Overall Study|Lost to Follow-up|0
273274|NCT02039674|912082|P2|Overall Study|Lost to Follow-up|0
273275|NCT02039674|912083|P1|Overall Study|Lost to Follow-up|0
273276|NCT02039674|912075|P9|Overall Study|Excluded Medication|5
273277|NCT02039674|912076|P8|Overall Study|Excluded Medication|4
273278|NCT02039674|912077|P7|Overall Study|Excluded Medication|2
273279|NCT02039674|912078|P6|Overall Study|Excluded Medication|4
273280|NCT02039674|912079|P5|Overall Study|Excluded Medication|2
273281|NCT02039674|912080|P4|Overall Study|Excluded Medication|0
273282|NCT02039674|912081|P3|Overall Study|Excluded Medication|2
273283|NCT02039674|912082|P2|Overall Study|Excluded Medication|1
273284|NCT02039674|912083|P1|Overall Study|Excluded Medication|2
273285|NCT02039674|912075|P9|Overall Study|Death|8
273286|NCT02039674|912076|P8|Overall Study|Death|0
273287|NCT02039674|912077|P7|Overall Study|Death|1
273288|NCT02039674|912078|P6|Overall Study|Death|1
273289|NCT02039674|912079|P5|Overall Study|Death|0
273290|NCT02039674|912080|P4|Overall Study|Death|0
273291|NCT02039674|912081|P3|Overall Study|Death|0
273292|NCT02039674|912082|P2|Overall Study|Death|3
273293|NCT02039674|912083|P1|Overall Study|Death|0
273294|NCT02039674|912075|P9|Overall Study|Adverse Event|3
273295|NCT02039674|912076|P8|Overall Study|Adverse Event|2
273296|NCT02039674|912077|P7|Overall Study|Adverse Event|2
273297|NCT02039674|912078|P6|Overall Study|Adverse Event|0
273298|NCT02039674|912079|P5|Overall Study|Adverse Event|0
273299|NCT02039674|912080|P4|Overall Study|Adverse Event|0
273300|NCT02039674|912081|P3|Overall Study|Adverse Event|1
273301|NCT02039674|912082|P2|Overall Study|Adverse Event|2
273302|NCT02039674|912083|P1|Overall Study|Adverse Event|0
273303|NCT02039427|912119|P4|Overall Study|Steroid Use|0
273304|NCT02039427|912120|P3|Overall Study|Steroid Use|0
273305|NCT02039427|912121|P2|Overall Study|Steroid Use|0
273306|NCT02039427|912122|P1|Overall Study|Steroid Use|1
273307|NCT02039427|912119|P4|Overall Study|Loss of follow - up|4
273308|NCT02039427|912120|P3|Overall Study|Loss of follow - up|2
273309|NCT02039427|912121|P2|Overall Study|Loss of follow - up|0
273310|NCT02039427|912122|P1|Overall Study|Loss of follow - up|1
273311|NCT02039427|912119|P4|Overall Study|Cancellation of surgery|0
273312|NCT02039427|912120|P3|Overall Study|Cancellation of surgery|1
273313|NCT02039427|912121|P2|Overall Study|Cancellation of surgery|0
273314|NCT02039427|912122|P1|Overall Study|Cancellation of surgery|0
273315|NCT02039427|912119|P4|Overall Study|Withdrawal on concent|1
273316|NCT02039427|912120|P3|Overall Study|Withdrawal on concent|0
273317|NCT02039427|912121|P2|Overall Study|Withdrawal on concent|0
273318|NCT02039427|912122|P1|Overall Study|Withdrawal on concent|0
273319|NCT02039427|912119|P4|Overall Study|Duration of surgery > 3h|0
273320|NCT02039427|912120|P3|Overall Study|Duration of surgery > 3h|0
273321|NCT02039427|912121|P2|Overall Study|Duration of surgery > 3h|1
273322|NCT02039427|912122|P1|Overall Study|Duration of surgery > 3h|1
273323|NCT02039414|912142|P2|Overall Study|Protocol Violation|1
273324|NCT02039414|912143|P1|Overall Study|Protocol Violation|3
273325|NCT02039414|912142|P2|Overall Study|Lost to Follow-up|0
273326|NCT02039414|912143|P1|Overall Study|Lost to Follow-up|2
273327|NCT02039414|912142|P2|Overall Study|Delivered|1
273328|NCT02039414|912143|P1|Overall Study|Delivered|1
273329|NCT02038959|912166|P2|Overall Study|Withdrawal by Subject|8
273330|NCT02038959|912167|P1|Overall Study|Withdrawal by Subject|6
273331|NCT02038946|912193|P1|Overall Study|Other reasons|1
273332|NCT02038946|912193|P1|Overall Study|Lost to Follow-up|2
273333|NCT02038946|912193|P1|Overall Study|Withdrawal by Subject|3
273334|NCT02038946|912193|P1|Overall Study|Death|5
273335|NCT02038933|912204|P1|Follow-up|Disease Progression|2
273336|NCT02038933|912204|P1|Follow-up|Withdrawal by Subject|1
273337|NCT02038933|912204|P1|Follow-up|Lost to Follow-up|1
273338|NCT02038933|912204|P1|Follow-up|Adverse event unrelated to study drug|4
273339|NCT02038933|912204|P1|Follow-up|Death|11
273340|NCT02038933|912204|P1|Treatment|Withdrawal by Subject|1
273341|NCT02038933|912204|P1|Treatment|Disease Progression|101
273342|NCT02038933|912204|P1|Treatment|Study Drug Toxicity|4
273343|NCT02038933|912204|P1|Treatment|Adverse Event Unrelated to Study Drug|6
273344|NCT02038933|912204|P1|Treatment|Lost to Follow-up|1
273345|NCT02038933|912204|P1|Treatment|No longer meets study criteria|1
273346|NCT02038907|912237|P14|Overall Study|Withdrawal by Subject|0
273347|NCT02038907|912238|P13|Overall Study|Withdrawal by Subject|0
273348|NCT02038907|912239|P12|Overall Study|Withdrawal by Subject|0
273349|NCT02038907|912240|P11|Overall Study|Withdrawal by Subject|1
273350|NCT02038907|912241|P10|Overall Study|Withdrawal by Subject|0
273351|NCT02038907|912242|P9|Overall Study|Withdrawal by Subject|0
273352|NCT02038907|912243|P8|Overall Study|Withdrawal by Subject|0
273353|NCT02038907|912244|P7|Overall Study|Withdrawal by Subject|0
273354|NCT02038907|912245|P6|Overall Study|Withdrawal by Subject|0
273355|NCT02038907|912246|P5|Overall Study|Withdrawal by Subject|0
273356|NCT02038907|912247|P4|Overall Study|Withdrawal by Subject|0
273357|NCT02038907|912248|P3|Overall Study|Withdrawal by Subject|0
273358|NCT02038907|912249|P2|Overall Study|Withdrawal by Subject|0
273359|NCT02038907|912250|P1|Overall Study|Withdrawal by Subject|0
273360|NCT02038907|912237|P14|Overall Study|Protocol Violation|0
273361|NCT02038907|912238|P13|Overall Study|Protocol Violation|0
273362|NCT02038907|912239|P12|Overall Study|Protocol Violation|0
273363|NCT02038907|912240|P11|Overall Study|Protocol Violation|1
273364|NCT02038907|912241|P10|Overall Study|Protocol Violation|0
273365|NCT02038907|912242|P9|Overall Study|Protocol Violation|0
273366|NCT02038907|912243|P8|Overall Study|Protocol Violation|0
273367|NCT02038907|912244|P7|Overall Study|Protocol Violation|0
273368|NCT02038907|912245|P6|Overall Study|Protocol Violation|0
273369|NCT02038907|912246|P5|Overall Study|Protocol Violation|0
273370|NCT02038907|912247|P4|Overall Study|Protocol Violation|0
273371|NCT02038907|912248|P3|Overall Study|Protocol Violation|0
273372|NCT02038907|912249|P2|Overall Study|Protocol Violation|0
273373|NCT02038907|912250|P1|Overall Study|Protocol Violation|0
273374|NCT02038829|912778|P12|Treatment Period 6|Adverse Event|0
273375|NCT02038829|912779|P11|Treatment Period 6|Adverse Event|0
273376|NCT02038829|912780|P10|Treatment Period 6|Adverse Event|0
273377|NCT02038829|912781|P9|Treatment Period 6|Adverse Event|0
273378|NCT02038829|912782|P8|Treatment Period 6|Adverse Event|0
273379|NCT02038829|912783|P7|Treatment Period 6|Adverse Event|0
273380|NCT02038829|912784|P6|Treatment Period 6|Adverse Event|0
273381|NCT02038829|912785|P5|Treatment Period 6|Adverse Event|0
273382|NCT02038829|912786|P4|Treatment Period 6|Adverse Event|0
273383|NCT02038829|912787|P3|Treatment Period 6|Adverse Event|1
273384|NCT02038829|912788|P2|Treatment Period 6|Adverse Event|0
273385|NCT02038829|912789|P1|Treatment Period 6|Adverse Event|0
273386|NCT02038829|912778|P12|Washout Period 4|Adverse Event|0
273387|NCT02038829|912779|P11|Washout Period 4|Adverse Event|0
273388|NCT02038829|912780|P10|Washout Period 4|Adverse Event|0
273389|NCT02038829|912781|P9|Washout Period 4|Adverse Event|0
273390|NCT02038829|912782|P8|Washout Period 4|Adverse Event|0
273391|NCT02038829|912783|P7|Washout Period 4|Adverse Event|1
273392|NCT02038829|912784|P6|Washout Period 4|Adverse Event|0
273393|NCT02038829|912785|P5|Washout Period 4|Adverse Event|0
273394|NCT02038829|912786|P4|Washout Period 4|Adverse Event|0
273395|NCT02038829|912787|P3|Washout Period 4|Adverse Event|0
273396|NCT02038829|912788|P2|Washout Period 4|Adverse Event|0
273397|NCT02038829|912789|P1|Washout Period 4|Adverse Event|0
273398|NCT02038829|912778|P12|Treatment Period 4|Adverse Event|0
273399|NCT02038829|912779|P11|Treatment Period 4|Adverse Event|0
273400|NCT02038829|912780|P10|Treatment Period 4|Adverse Event|0
273401|NCT02038829|912781|P9|Treatment Period 4|Adverse Event|0
273402|NCT02038829|912782|P8|Treatment Period 4|Adverse Event|0
273403|NCT02038829|912783|P7|Treatment Period 4|Adverse Event|0
273404|NCT02038829|912784|P6|Treatment Period 4|Adverse Event|0
273405|NCT02038829|912785|P5|Treatment Period 4|Adverse Event|0
273406|NCT02038829|912786|P4|Treatment Period 4|Adverse Event|0
273407|NCT02038829|912787|P3|Treatment Period 4|Adverse Event|0
273408|NCT02038829|912788|P2|Treatment Period 4|Adverse Event|1
273409|NCT02038829|912789|P1|Treatment Period 4|Adverse Event|0
273410|NCT02038829|912778|P12|Washout Period 2|Withdrawal by Subject|0
273411|NCT02038829|912779|P11|Washout Period 2|Withdrawal by Subject|0
273412|NCT02038829|912780|P10|Washout Period 2|Withdrawal by Subject|0
273413|NCT02038829|912781|P9|Washout Period 2|Withdrawal by Subject|0
273414|NCT02038829|912782|P8|Washout Period 2|Withdrawal by Subject|0
273415|NCT02038829|912783|P7|Washout Period 2|Withdrawal by Subject|0
273416|NCT02038829|912784|P6|Washout Period 2|Withdrawal by Subject|1
273417|NCT02038829|912785|P5|Washout Period 2|Withdrawal by Subject|0
273418|NCT02038829|912786|P4|Washout Period 2|Withdrawal by Subject|0
273419|NCT02038829|912787|P3|Washout Period 2|Withdrawal by Subject|0
273420|NCT02038829|912788|P2|Washout Period 2|Withdrawal by Subject|0
273421|NCT02038829|912789|P1|Washout Period 2|Withdrawal by Subject|0
273422|NCT02038829|912778|P12|Washout Period 2|Adverse Event|0
273423|NCT02038829|912779|P11|Washout Period 2|Adverse Event|0
273424|NCT02038829|912780|P10|Washout Period 2|Adverse Event|0
273425|NCT02038829|912781|P9|Washout Period 2|Adverse Event|1
273426|NCT02038829|912782|P8|Washout Period 2|Adverse Event|0
273427|NCT02038829|912783|P7|Washout Period 2|Adverse Event|0
273428|NCT02038829|912784|P6|Washout Period 2|Adverse Event|0
273429|NCT02038829|912785|P5|Washout Period 2|Adverse Event|0
273430|NCT02038829|912786|P4|Washout Period 2|Adverse Event|0
273431|NCT02038829|912787|P3|Washout Period 2|Adverse Event|0
273432|NCT02038829|912788|P2|Washout Period 2|Adverse Event|0
273433|NCT02038829|912789|P1|Washout Period 2|Adverse Event|0
273434|NCT02038829|912778|P12|Treatment Period 2|Withdrawal by Subject|0
273435|NCT02038829|912779|P11|Treatment Period 2|Withdrawal by Subject|0
273436|NCT02038829|912780|P10|Treatment Period 2|Withdrawal by Subject|0
273437|NCT02038829|912781|P9|Treatment Period 2|Withdrawal by Subject|0
273438|NCT02038829|912782|P8|Treatment Period 2|Withdrawal by Subject|0
273439|NCT02038829|912783|P7|Treatment Period 2|Withdrawal by Subject|0
273440|NCT02038829|912784|P6|Treatment Period 2|Withdrawal by Subject|0
273441|NCT02038829|912785|P5|Treatment Period 2|Withdrawal by Subject|0
273442|NCT02038829|912786|P4|Treatment Period 2|Withdrawal by Subject|0
273443|NCT02038829|912787|P3|Treatment Period 2|Withdrawal by Subject|0
273444|NCT02038829|912788|P2|Treatment Period 2|Withdrawal by Subject|0
273445|NCT02038829|912789|P1|Treatment Period 2|Withdrawal by Subject|1
273446|NCT02038829|912778|P12|Treatment Period 2|Adverse Event|0
273447|NCT02038829|912779|P11|Treatment Period 2|Adverse Event|1
273448|NCT02038829|912780|P10|Treatment Period 2|Adverse Event|0
273449|NCT02038829|912781|P9|Treatment Period 2|Adverse Event|0
273450|NCT02038829|912782|P8|Treatment Period 2|Adverse Event|0
273451|NCT02038829|912783|P7|Treatment Period 2|Adverse Event|0
273452|NCT02038829|912784|P6|Treatment Period 2|Adverse Event|0
273453|NCT02038829|912785|P5|Treatment Period 2|Adverse Event|0
273454|NCT02038829|912786|P4|Treatment Period 2|Adverse Event|0
273455|NCT02038829|912787|P3|Treatment Period 2|Adverse Event|0
273456|NCT02038829|912788|P2|Treatment Period 2|Adverse Event|0
273457|NCT02038829|912789|P1|Treatment Period 2|Adverse Event|0
273458|NCT02038829|912778|P12|Washout Period 1|Death|0
273459|NCT02038829|912779|P11|Washout Period 1|Death|0
273460|NCT02038829|912780|P10|Washout Period 1|Death|0
273461|NCT02038829|912781|P9|Washout Period 1|Death|0
273462|NCT02038829|912782|P8|Washout Period 1|Death|0
273463|NCT02038829|912783|P7|Washout Period 1|Death|0
273464|NCT02038829|912784|P6|Washout Period 1|Death|0
273465|NCT02038829|912785|P5|Washout Period 1|Death|1
273466|NCT02038829|912786|P4|Washout Period 1|Death|0
273467|NCT02038829|912787|P3|Washout Period 1|Death|0
273468|NCT02038829|912788|P2|Washout Period 1|Death|0
273469|NCT02038829|912789|P1|Washout Period 1|Death|0
273470|NCT02038790|912823|P2|Day 0 - First Treatment|Withdrawal by Subject|1
273471|NCT02038790|912824|P1|Day 0 - First Treatment|Withdrawal by Subject|1
273472|NCT02038543|912859|P4|Overall Study|Withdrawal by Subject|1
273473|NCT02038543|912860|P3|Overall Study|Withdrawal by Subject|0
273474|NCT02038543|912861|P2|Overall Study|Withdrawal by Subject|0
273475|NCT02038543|912862|P1|Overall Study|Withdrawal by Subject|0
273476|NCT02038543|912859|P4|Overall Study|Screen Failure|1
273477|NCT02038543|912860|P3|Overall Study|Screen Failure|0
273478|NCT02038543|912861|P2|Overall Study|Screen Failure|0
273479|NCT02038543|912862|P1|Overall Study|Screen Failure|0
273480|NCT02038075|912878|P2|Overall Study|Withdrawal by Subject|0
273481|NCT02038075|912879|P1|Overall Study|Withdrawal by Subject|3
273482|NCT02037568|912917|P2|Overall Study|Patient did not receive transplant|1
273483|NCT02037568|912918|P1|Overall Study|Patient did not receive transplant|0
273484|NCT02037568|912917|P2|Overall Study|Screen Failure|1
273485|NCT02037568|912918|P1|Overall Study|Screen Failure|3
273486|NCT02037568|912917|P2|Overall Study|Lost to Follow-up|13
273487|NCT02037568|912918|P1|Overall Study|Lost to Follow-up|16
273488|NCT02037568|912917|P2|Overall Study|Withdrawal by Subject|24
273489|NCT02037568|912918|P1|Overall Study|Withdrawal by Subject|17
273490|NCT02037477|912944|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
273491|NCT02037477|912945|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
273492|NCT02037477|912946|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
273493|NCT02037477|912947|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
273494|NCT02036775|913025|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
273495|NCT02036775|913026|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
273496|NCT02036775|913027|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
273497|NCT02036775|913028|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
273498|NCT02036775|913029|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
273499|NCT02036775|913030|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
273500|NCT02036580|913071|P3|Overall Study|Adverse Event|0
273501|NCT02036580|913072|P2|Overall Study|Adverse Event|0
273502|NCT02036580|913073|P1|Overall Study|Adverse Event|1
273503|NCT02036580|913071|P3|Overall Study|Withdrawal by Subject|0
273504|NCT02036580|913072|P2|Overall Study|Withdrawal by Subject|1
273505|NCT02036580|913073|P1|Overall Study|Withdrawal by Subject|0
273506|NCT02036515|913094|P3|Overall Study|Hyperglycemia|1
273507|NCT02036515|913095|P2|Overall Study|Hyperglycemia|0
273508|NCT02036515|913096|P1|Overall Study|Hyperglycemia|0
273509|NCT02036515|913094|P3|Overall Study|Withdrawal by Subject|9
273510|NCT02036515|913095|P2|Overall Study|Withdrawal by Subject|7
273511|NCT02036515|913096|P1|Overall Study|Withdrawal by Subject|4
273512|NCT02036515|913094|P3|Overall Study|Screen failure|0
273513|NCT02036515|913095|P2|Overall Study|Screen failure|2
273514|NCT02036515|913096|P1|Overall Study|Screen failure|0
273515|NCT02036515|913094|P3|Overall Study|Non-compliance with study drug|2
273516|NCT02036515|913095|P2|Overall Study|Non-compliance with study drug|0
273517|NCT02036515|913096|P1|Overall Study|Non-compliance with study drug|0
273518|NCT02036515|913094|P3|Overall Study|Lost to Follow-up|0
273519|NCT02036515|913095|P2|Overall Study|Lost to Follow-up|2
273520|NCT02036515|913096|P1|Overall Study|Lost to Follow-up|0
273521|NCT02036515|913094|P3|Overall Study|Adverse Event|2
273522|NCT02036515|913095|P2|Overall Study|Adverse Event|1
273523|NCT02036515|913096|P1|Overall Study|Adverse Event|1
273524|NCT02035748|913195|P1|Overall Study|Progressive Disease|1
273525|NCT02035748|913195|P1|Overall Study|Withdrawal by Subject|6
273526|NCT02035748|913195|P1|Overall Study|Physician Decision|3
273527|NCT02035748|913195|P1|Overall Study|Lost to Follow-up|2
273528|NCT02035748|913195|P1|Overall Study|Death|3
273529|NCT02035748|913195|P1|Overall Study|Adverse Event|5
273530|NCT02035696|913209|P4|Overall Study|Withdrawal by Subject|1
273531|NCT02035696|913210|P3|Overall Study|Withdrawal by Subject|2
273532|NCT02035696|913211|P2|Overall Study|Withdrawal by Subject|0
273533|NCT02035696|913212|P1|Overall Study|Withdrawal by Subject|3
273534|NCT02035696|913209|P4|Overall Study|Lost to Follow-up|2
273535|NCT02035696|913210|P3|Overall Study|Lost to Follow-up|1
273536|NCT02035696|913211|P2|Overall Study|Lost to Follow-up|3
273537|NCT02035696|913212|P1|Overall Study|Lost to Follow-up|0
273538|NCT02035553|913268|P2|Overall Study|Other Reason|4
273539|NCT02035553|913269|P1|Overall Study|Other Reason|0
273540|NCT02035553|913268|P2|Overall Study|Lost to Follow-up|1
273541|NCT02035553|913269|P1|Overall Study|Lost to Follow-up|0
273542|NCT02035553|913268|P2|Overall Study|Non-compliance with Study Drug|1
273543|NCT02035553|913269|P1|Overall Study|Non-compliance with Study Drug|0
273544|NCT02035553|913268|P2|Overall Study|Withdrawal by Subject|7
273545|NCT02035553|913269|P1|Overall Study|Withdrawal by Subject|4
273546|NCT02035553|913268|P2|Overall Study|Lack of Efficacy|1
273547|NCT02035553|913269|P1|Overall Study|Lack of Efficacy|1
273548|NCT02035553|913268|P2|Overall Study|Physician Decision|2
273549|NCT02035553|913269|P1|Overall Study|Physician Decision|3
273550|NCT02035553|913268|P2|Overall Study|Adverse Event|6
273551|NCT02035553|913269|P1|Overall Study|Adverse Event|10
273552|NCT02035553|913268|P2|Overall Study|Death (See All-Cause Mortality Table)|1
273553|NCT02035553|913269|P1|Overall Study|Death (See All-Cause Mortality Table)|0
273554|NCT02035475|913275|P1|Overall Study|Equipment Error|1
273555|NCT02035475|913275|P1|Overall Study|Physician Decision|1
273556|NCT02035475|913275|P1|Overall Study|Withdrawal by Subject|4
273557|NCT02035332|913286|P1|Overall Study|Procedure Aborted due to Uterine Width|1
273558|NCT02034916|913294|P2|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|20
273559|NCT02034916|913295|P1|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|15
273560|NCT02034916|913294|P2|Overall Study|Lost to Follow-up|1
273561|NCT02034916|913295|P1|Overall Study|Lost to Follow-up|1
273562|NCT02034916|913294|P2|Overall Study|Withdrawal by Subject|1
273563|NCT02034916|913295|P1|Overall Study|Withdrawal by Subject|1
273564|NCT02034916|913294|P2|Overall Study|Death|13
273565|NCT02034916|913295|P1|Overall Study|Death|32
273566|NCT02034877|913330|P2|Overall Study|No Longer Willing to Participate|3
273567|NCT02034877|913331|P1|Overall Study|No Longer Willing to Participate|0
273568|NCT02034877|913330|P2|Overall Study|Lost to Follow-up|3
273569|NCT02034877|913331|P1|Overall Study|Lost to Follow-up|0
273570|NCT02034799|913349|P2|Overall Study|Death|1
273571|NCT02034799|913350|P1|Overall Study|Death|2
273572|NCT02034799|913349|P2|Overall Study|Lost to Follow-up|1
273573|NCT02034799|913350|P1|Overall Study|Lost to Follow-up|0
273574|NCT02034799|913349|P2|Overall Study|Withdrawal by Subject|2
273575|NCT02034799|913350|P1|Overall Study|Withdrawal by Subject|0
273576|NCT02034708|913364|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
273577|NCT02034708|913365|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
273578|NCT02034708|913364|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
273579|NCT02034708|913365|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
273580|NCT02034708|913364|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
273581|NCT02034708|913365|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
273582|NCT02034708|913364|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
273583|NCT02034708|913365|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
273584|NCT02034591|913376|P6|Overall Study|Withdrawal by Subject|0
273585|NCT02034591|913377|P5|Overall Study|Withdrawal by Subject|1
273586|NCT02034591|913378|P4|Overall Study|Withdrawal by Subject|0
273587|NCT02034591|913379|P3|Overall Study|Withdrawal by Subject|0
273588|NCT02034591|913380|P2|Overall Study|Withdrawal by Subject|0
273589|NCT02034591|913381|P1|Overall Study|Withdrawal by Subject|0
273590|NCT02034565|913436|P2|Overall Study|Adverse Event|0
273591|NCT02034565|913437|P1|Overall Study|Adverse Event|1
273592|NCT02034552|913454|P3|Overall Study|Non-compliance with study drug|1
273593|NCT02034552|913455|P2|Overall Study|Non-compliance with study drug|0
273594|NCT02034552|913456|P1|Overall Study|Non-compliance with study drug|0
273595|NCT02034552|913454|P3|Overall Study|Withdrawal by Subject|1
273596|NCT02034552|913455|P2|Overall Study|Withdrawal by Subject|0
273597|NCT02034552|913456|P1|Overall Study|Withdrawal by Subject|2
273598|NCT02034552|913454|P3|Overall Study|AE associated with disease progression|0
273599|NCT02034552|913455|P2|Overall Study|AE associated with disease progression|1
273600|NCT02034552|913456|P1|Overall Study|AE associated with disease progression|0
273601|NCT02034552|913454|P3|Overall Study|AE not assoc. with disease progression|2
273602|NCT02034552|913455|P2|Overall Study|AE not assoc. with disease progression|3
273603|NCT02034552|913456|P1|Overall Study|AE not assoc. with disease progression|1
273604|NCT02034552|913454|P3|Overall Study|Ongoing with treatment|11
273605|NCT02034552|913455|P2|Overall Study|Ongoing with treatment|11
273606|NCT02034552|913456|P1|Overall Study|Ongoing with treatment|0
273607|NCT02034552|913454|P3|Overall Study|Never treated|0
273608|NCT02034552|913455|P2|Overall Study|Never treated|2
273609|NCT02034552|913456|P1|Overall Study|Never treated|3
273610|NCT02034513|913481|P2|Overall Study|Unclassified|1
273611|NCT02034513|913482|P1|Overall Study|Unclassified|0
273612|NCT02034513|913481|P2|Overall Study|Withdrawal by Subject|25
273613|NCT02034513|913482|P1|Overall Study|Withdrawal by Subject|25
273614|NCT02034513|913481|P2|Overall Study|Protocol Violation|10
273615|NCT02034513|913482|P1|Overall Study|Protocol Violation|7
273616|NCT02034513|913481|P2|Overall Study|Pregnancy|3
273617|NCT02034513|913482|P1|Overall Study|Pregnancy|0
273618|NCT02034513|913481|P2|Overall Study|Lost to Follow-up|7
273619|NCT02034513|913482|P1|Overall Study|Lost to Follow-up|6
273620|NCT02034513|913481|P2|Overall Study|Lack of Efficacy|1
273621|NCT02034513|913482|P1|Overall Study|Lack of Efficacy|0
273622|NCT02034513|913481|P2|Overall Study|Adverse Event|10
273623|NCT02034513|913482|P1|Overall Study|Adverse Event|11
273624|NCT02034162|913500|P3|Double-blind|Withdrawal by Subject|0
273625|NCT02034162|913501|P2|Double-blind|Withdrawal by Subject|7
273626|NCT02034162|913502|P1|Double-blind|Withdrawal by Subject|5
273627|NCT02034162|913500|P3|Double-blind|Protocol Violation|0
273628|NCT02034162|913501|P2|Double-blind|Protocol Violation|1
273629|NCT02034162|913502|P1|Double-blind|Protocol Violation|0
273630|NCT02034162|913500|P3|Double-blind|Physician Decision|0
273631|NCT02034162|913501|P2|Double-blind|Physician Decision|0
273632|NCT02034162|913502|P1|Double-blind|Physician Decision|1
273633|NCT02034162|913500|P3|Double-blind|Lost to Follow-up|0
273634|NCT02034162|913501|P2|Double-blind|Lost to Follow-up|0
273635|NCT02034162|913502|P1|Double-blind|Lost to Follow-up|3
273636|NCT02033369|913575|P2|Overall Study|Protocol Violation|0
273637|NCT02033369|913576|P1|Overall Study|Protocol Violation|2
273638|NCT02033369|913575|P2|Overall Study|Lost to Follow-up|0
273639|NCT02033369|913576|P1|Overall Study|Lost to Follow-up|1
273640|NCT02033369|913575|P2|Overall Study|Withdrawal by Subject|1
273641|NCT02033369|913576|P1|Overall Study|Withdrawal by Subject|1
273642|NCT02033369|913575|P2|Overall Study|Not a good demographic match|2
273643|NCT02033369|913576|P1|Overall Study|Not a good demographic match|0
273644|NCT02033369|913575|P2|Overall Study|Physician Decision|2
273645|NCT02033369|913576|P1|Overall Study|Physician Decision|1
273646|NCT02032901|913642|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
273647|NCT02032901|913643|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
273648|NCT02032901|913642|P2|Treatment Period (12 Weeks)|Pregnancy|0
273649|NCT02032901|913643|P1|Treatment Period (12 Weeks)|Pregnancy|1
273650|NCT02032888|913667|P3|Follow-up Period|Not specified|0
273651|NCT02032888|913668|P2|Follow-up Period|Not specified|0
273652|NCT02032888|913669|P1|Follow-up Period|Not specified|1
273653|NCT02032888|913667|P3|Follow-up Period|Death|0
273654|NCT02032888|913668|P2|Follow-up Period|Death|1
273655|NCT02032888|913669|P1|Follow-up Period|Death|1
273656|NCT02032888|913667|P3|Follow-up Period|Lost to Follow-up|0
273657|NCT02032888|913668|P2|Follow-up Period|Lost to Follow-up|1
273658|NCT02032888|913669|P1|Follow-up Period|Lost to Follow-up|1
273659|NCT02032888|913667|P3|Treatment Period|Not specified|0
273660|NCT02032888|913668|P2|Treatment Period|Not specified|1
273661|NCT02032888|913669|P1|Treatment Period|Not specified|1
273662|NCT02032888|913667|P3|Treatment Period|Poor compliance/noncompliance|0
273663|NCT02032888|913668|P2|Treatment Period|Poor compliance/noncompliance|1
273664|NCT02032888|913669|P1|Treatment Period|Poor compliance/noncompliance|1
273665|NCT02032875|913700|P2|Follow-up Period|Virologic Relapse|10
273666|NCT02032875|913701|P1|Follow-up Period|Virologic Relapse|3
273667|NCT02032875|913700|P2|Follow-up Period|Death|1
273668|NCT02032875|913701|P1|Follow-up Period|Death|0
273669|NCT02032875|913700|P2|Treatment Period|Liver transplant, Treatment extension|3
273670|NCT02032875|913701|P1|Treatment Period|Liver transplant, Treatment extension|0
273671|NCT02032875|913700|P2|Treatment Period|Liver transplant, No extension needed|1
273672|NCT02032875|913701|P1|Treatment Period|Liver transplant, No extension needed|0
273673|NCT02032875|913700|P2|Treatment Period|Adverse Event|0
273674|NCT02032875|913701|P1|Treatment Period|Adverse Event|1
273675|NCT02032706|913730|P1|Overall Study|Protocol Violation|1
273676|NCT02032706|913730|P1|Overall Study|Did not qualify|5
273677|NCT02032407|913787|P1|Overall Study|Other Miscellaneous Reasons|2
273678|NCT02032407|913787|P1|Overall Study|Pregnancy|1
273679|NCT02032407|913787|P1|Overall Study|Lost to Follow-up|2
273680|NCT02032238|913800|P2|Overall Study|Lost to Follow-up|0
273681|NCT02032238|913801|P1|Overall Study|Lost to Follow-up|2
273682|NCT02031679|913842|P2|Overall Study|Lack of Efficacy|1
273683|NCT02031679|913843|P1|Overall Study|Lack of Efficacy|0
273684|NCT02031679|913842|P2|Overall Study|Protocol Violation|1
273685|NCT02031679|913843|P1|Overall Study|Protocol Violation|0
273686|NCT02031640|913858|P6|Double-blind Treatment Period|Lost to Follow-up|0
273687|NCT02031640|913859|P5|Double-blind Treatment Period|Lost to Follow-up|1
273688|NCT02031640|913860|P4|Double-blind Treatment Period|Lost to Follow-up|0
273689|NCT02031640|913861|P3|Double-blind Treatment Period|Lost to Follow-up|0
273690|NCT02031640|913862|P2|Double-blind Treatment Period|Lost to Follow-up|3
273691|NCT02031640|913863|P1|Double-blind Treatment Period|Lost to Follow-up|0
273692|NCT02031640|913858|P6|Double-blind Treatment Period|Withdrawal by Subject|1
273693|NCT02031640|913859|P5|Double-blind Treatment Period|Withdrawal by Subject|1
273694|NCT02031640|913860|P4|Double-blind Treatment Period|Withdrawal by Subject|1
273695|NCT02031640|913861|P3|Double-blind Treatment Period|Withdrawal by Subject|3
273696|NCT02031640|913862|P2|Double-blind Treatment Period|Withdrawal by Subject|2
273697|NCT02031640|913863|P1|Double-blind Treatment Period|Withdrawal by Subject|0
273698|NCT02031640|913858|P6|Double-blind Treatment Period|Adverse Event|0
273699|NCT02031640|913859|P5|Double-blind Treatment Period|Adverse Event|0
273700|NCT02031640|913860|P4|Double-blind Treatment Period|Adverse Event|2
273701|NCT02031640|913861|P3|Double-blind Treatment Period|Adverse Event|0
273702|NCT02031640|913862|P2|Double-blind Treatment Period|Adverse Event|0
273703|NCT02031640|913863|P1|Double-blind Treatment Period|Adverse Event|0
273704|NCT02031640|913858|P6|Double-blind Treatment Period|Non-compliance|0
273705|NCT02031640|913859|P5|Double-blind Treatment Period|Non-compliance|1
273706|NCT02031640|913860|P4|Double-blind Treatment Period|Non-compliance|1
273707|NCT02031640|913861|P3|Double-blind Treatment Period|Non-compliance|0
273708|NCT02031640|913862|P2|Double-blind Treatment Period|Non-compliance|1
273709|NCT02031640|913863|P1|Double-blind Treatment Period|Non-compliance|0
273710|NCT02031640|913858|P6|Double-blind Treatment Period|Lack of Efficacy|1
273711|NCT02031640|913859|P5|Double-blind Treatment Period|Lack of Efficacy|5
273712|NCT02031640|913860|P4|Double-blind Treatment Period|Lack of Efficacy|2
273713|NCT02031640|913861|P3|Double-blind Treatment Period|Lack of Efficacy|3
273714|NCT02031640|913862|P2|Double-blind Treatment Period|Lack of Efficacy|14
273715|NCT02031640|913863|P1|Double-blind Treatment Period|Lack of Efficacy|0
273716|NCT02031640|913858|P6|Double-blind Treatment Period|Protocol deviation|1
273717|NCT02031640|913859|P5|Double-blind Treatment Period|Protocol deviation|3
273718|NCT02031640|913860|P4|Double-blind Treatment Period|Protocol deviation|1
273719|NCT02031640|913861|P3|Double-blind Treatment Period|Protocol deviation|0
273720|NCT02031640|913862|P2|Double-blind Treatment Period|Protocol deviation|2
273721|NCT02031640|913863|P1|Double-blind Treatment Period|Protocol deviation|0
273722|NCT02031640|913858|P6|Run-In Period|Various administrative reasons|0
273723|NCT02031640|913859|P5|Run-In Period|Various administrative reasons|0
273724|NCT02031640|913860|P4|Run-In Period|Various administrative reasons|0
273725|NCT02031640|913861|P3|Run-In Period|Various administrative reasons|0
273726|NCT02031640|913862|P2|Run-In Period|Various administrative reasons|0
273727|NCT02031640|913863|P1|Run-In Period|Various administrative reasons|17
273728|NCT02031640|913858|P6|Run-In Period|Randomization criteria not met|0
273729|NCT02031640|913859|P5|Run-In Period|Randomization criteria not met|0
273730|NCT02031640|913860|P4|Run-In Period|Randomization criteria not met|0
273731|NCT02031640|913861|P3|Run-In Period|Randomization criteria not met|0
273732|NCT02031640|913862|P2|Run-In Period|Randomization criteria not met|0
273733|NCT02031640|913863|P1|Run-In Period|Randomization criteria not met|85
273734|NCT02031640|913858|P6|Run-In Period|Exclusion criteria met|0
273735|NCT02031640|913859|P5|Run-In Period|Exclusion criteria met|0
273736|NCT02031640|913860|P4|Run-In Period|Exclusion criteria met|0
273737|NCT02031640|913861|P3|Run-In Period|Exclusion criteria met|0
273738|NCT02031640|913862|P2|Run-In Period|Exclusion criteria met|0
273739|NCT02031640|913863|P1|Run-In Period|Exclusion criteria met|8
273740|NCT02031640|913858|P6|Run-In Period|Inclusion criteria not met|0
273741|NCT02031640|913859|P5|Run-In Period|Inclusion criteria not met|0
273742|NCT02031640|913860|P4|Run-In Period|Inclusion criteria not met|0
273743|NCT02031640|913861|P3|Run-In Period|Inclusion criteria not met|0
273744|NCT02031640|913862|P2|Run-In Period|Inclusion criteria not met|0
273745|NCT02031640|913863|P1|Run-In Period|Inclusion criteria not met|38
273746|NCT02031640|913858|P6|Run-In Period|Withdrawal by Subject|0
273747|NCT02031640|913859|P5|Run-In Period|Withdrawal by Subject|0
273748|NCT02031640|913860|P4|Run-In Period|Withdrawal by Subject|0
273749|NCT02031640|913861|P3|Run-In Period|Withdrawal by Subject|0
273750|NCT02031640|913862|P2|Run-In Period|Withdrawal by Subject|0
273751|NCT02031640|913863|P1|Run-In Period|Withdrawal by Subject|17
273752|NCT02031640|913858|P6|Run-In Period|Adverse Event|0
273753|NCT02031640|913859|P5|Run-In Period|Adverse Event|0
273754|NCT02031640|913860|P4|Run-In Period|Adverse Event|0
273755|NCT02031640|913861|P3|Run-In Period|Adverse Event|0
273756|NCT02031640|913862|P2|Run-In Period|Adverse Event|0
273757|NCT02031640|913863|P1|Run-In Period|Adverse Event|4
273758|NCT02031640|913858|P6|Screening Period|Enrollment closed|0
273759|NCT02031640|913859|P5|Screening Period|Enrollment closed|0
273760|NCT02031640|913860|P4|Screening Period|Enrollment closed|0
273761|NCT02031640|913861|P3|Screening Period|Enrollment closed|0
273762|NCT02031640|913862|P2|Screening Period|Enrollment closed|0
273763|NCT02031640|913863|P1|Screening Period|Enrollment closed|26
273764|NCT02031640|913858|P6|Screening Period|Lost to Follow-up|0
273765|NCT02031640|913859|P5|Screening Period|Lost to Follow-up|0
273766|NCT02031640|913860|P4|Screening Period|Lost to Follow-up|0
273767|NCT02031640|913861|P3|Screening Period|Lost to Follow-up|0
273768|NCT02031640|913862|P2|Screening Period|Lost to Follow-up|0
273769|NCT02031640|913863|P1|Screening Period|Lost to Follow-up|14
273770|NCT02031640|913858|P6|Screening Period|Exclusion criteria met|0
273771|NCT02031640|913859|P5|Screening Period|Exclusion criteria met|0
273772|NCT02031640|913860|P4|Screening Period|Exclusion criteria met|0
273773|NCT02031640|913861|P3|Screening Period|Exclusion criteria met|0
273774|NCT02031640|913862|P2|Screening Period|Exclusion criteria met|0
273775|NCT02031640|913863|P1|Screening Period|Exclusion criteria met|30
273776|NCT02031640|913858|P6|Screening Period|Inclusion criteria not met|0
273777|NCT02031640|913859|P5|Screening Period|Inclusion criteria not met|0
273778|NCT02031640|913860|P4|Screening Period|Inclusion criteria not met|0
273779|NCT02031640|913861|P3|Screening Period|Inclusion criteria not met|0
273780|NCT02031640|913862|P2|Screening Period|Inclusion criteria not met|0
273781|NCT02031640|913863|P1|Screening Period|Inclusion criteria not met|312
273782|NCT02031640|913858|P6|Screening Period|Withdrawal by Subject|0
273783|NCT02031640|913859|P5|Screening Period|Withdrawal by Subject|0
273784|NCT02031640|913860|P4|Screening Period|Withdrawal by Subject|0
273785|NCT02031640|913861|P3|Screening Period|Withdrawal by Subject|0
273786|NCT02031640|913862|P2|Screening Period|Withdrawal by Subject|0
273787|NCT02031640|913863|P1|Screening Period|Withdrawal by Subject|29
273788|NCT02031640|913858|P6|Screening Period|Adverse Event|0
273789|NCT02031640|913859|P5|Screening Period|Adverse Event|0
273790|NCT02031640|913860|P4|Screening Period|Adverse Event|0
273791|NCT02031640|913861|P3|Screening Period|Adverse Event|0
273792|NCT02031640|913862|P2|Screening Period|Adverse Event|0
273793|NCT02031640|913863|P1|Screening Period|Adverse Event|1
273794|NCT02031471|913906|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
273795|NCT02031471|913906|P1|Long Term Extension (LTE) Period|Adverse Event|1
273796|NCT02031471|913906|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
273797|NCT02031471|913906|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
273798|NCT02031471|913906|P1|24 Week Treatment Period|Protocol Violation|1
273799|NCT02031471|913906|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
273800|NCT02031471|913906|P1|24 Week Treatment Period|Adverse Event|6
273801|NCT02031458|913939|P3|Overall Study|Lost to Follow-up|2
273802|NCT02031458|913940|P2|Overall Study|Lost to Follow-up|1
273803|NCT02031458|913941|P1|Overall Study|Lost to Follow-up|1
273804|NCT02031458|913939|P3|Overall Study|On Treatment|73
273805|NCT02031458|913940|P2|Overall Study|On Treatment|81
273806|NCT02031458|913941|P1|Overall Study|On Treatment|43
273807|NCT02031458|913939|P3|Overall Study|On Survival Follow-Up|73
273808|NCT02031458|913940|P2|Overall Study|On Survival Follow-Up|83
273809|NCT02031458|913941|P1|Overall Study|On Survival Follow-Up|46
273810|NCT02031458|913939|P3|Overall Study|Withdrawal by Subject|3
273811|NCT02031458|913940|P2|Overall Study|Withdrawal by Subject|9
273812|NCT02031458|913941|P1|Overall Study|Withdrawal by Subject|6
273813|NCT02031458|913939|P3|Overall Study|Unknown Reason|2
273814|NCT02031458|913940|P2|Overall Study|Unknown Reason|1
273815|NCT02031458|913941|P1|Overall Study|Unknown Reason|0
273816|NCT02031458|913939|P3|Overall Study|Physician Decision|0
273817|NCT02031458|913940|P2|Overall Study|Physician Decision|1
273818|NCT02031458|913941|P1|Overall Study|Physician Decision|0
273819|NCT02031458|913939|P3|Overall Study|Protocol Violation|0
273820|NCT02031458|913940|P2|Overall Study|Protocol Violation|4
273821|NCT02031458|913941|P1|Overall Study|Protocol Violation|7
273822|NCT02031458|913939|P3|Overall Study|Death|100
273823|NCT02031458|913940|P2|Overall Study|Death|87
273824|NCT02031458|913941|P1|Overall Study|Death|36
273825|NCT02030600|914037|P2|Treatment Period 2|Unclassified|0
273826|NCT02030600|914038|P1|Treatment Period 2|Unclassified|1
273827|NCT02030600|914037|P2|Treatment Period 2|Withdrawal by Subject|9
273828|NCT02030600|914038|P1|Treatment Period 2|Withdrawal by Subject|13
273829|NCT02030600|914037|P2|Treatment Period 2|Protocol Violation|2
273830|NCT02030600|914038|P1|Treatment Period 2|Protocol Violation|1
273831|NCT02030600|914037|P2|Treatment Period 2|Lost to Follow-up|2
273832|NCT02030600|914038|P1|Treatment Period 2|Lost to Follow-up|4
273833|NCT02030600|914037|P2|Treatment Period 2|Lack of Efficacy|1
273834|NCT02030600|914038|P1|Treatment Period 2|Lack of Efficacy|2
273835|NCT02030600|914037|P2|Treatment Period 2|Adverse Event|4
273836|NCT02030600|914038|P1|Treatment Period 2|Adverse Event|4
273837|NCT02030600|914037|P2|Treatment Period 1|Unclassified|0
273838|NCT02030600|914038|P1|Treatment Period 1|Unclassified|1
273839|NCT02030600|914037|P2|Treatment Period 1|Casebook Unsigned|0
273840|NCT02030600|914038|P1|Treatment Period 1|Casebook Unsigned|1
273841|NCT02030600|914037|P2|Treatment Period 1|Withdrawal by Subject|17
273842|NCT02030600|914038|P1|Treatment Period 1|Withdrawal by Subject|13
273843|NCT02030600|914037|P2|Treatment Period 1|Protocol Violation|17
273844|NCT02030600|914038|P1|Treatment Period 1|Protocol Violation|22
273845|NCT02030600|914037|P2|Treatment Period 1|Lost to Follow-up|3
273846|NCT02030600|914038|P1|Treatment Period 1|Lost to Follow-up|11
273847|NCT02030600|914037|P2|Treatment Period 1|Lack of Efficacy|1
273848|NCT02030600|914038|P1|Treatment Period 1|Lack of Efficacy|0
273849|NCT02030600|914037|P2|Treatment Period 1|Adverse Event|7
273850|NCT02030600|914038|P1|Treatment Period 1|Adverse Event|5
273851|NCT02030535|914059|P1|Washout Period 1 (21 Days)|Adverse Event|1
273852|NCT02030405|914127|P1|Overall Study|Lost to Follow-up|1
273853|NCT02030405|914127|P1|Overall Study|Withdrawal by Subject|1
273854|NCT02030119|914136|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
273855|NCT02030119|914137|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
273856|NCT02030119|914138|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
273857|NCT02030119|914139|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
273858|NCT02030119|914136|P4|Overall Study|Withdrawal by Subject|3
273859|NCT02030119|914137|P3|Overall Study|Withdrawal by Subject|5
273860|NCT02030119|914138|P2|Overall Study|Withdrawal by Subject|1
273861|NCT02030119|914139|P1|Overall Study|Withdrawal by Subject|3
273862|NCT02030041|914177|P3|Overall Study|Withdrawal by Subject|1
273863|NCT02030041|914178|P2|Overall Study|Withdrawal by Subject|2
273864|NCT02030041|914179|P1|Overall Study|Withdrawal by Subject|2
273865|NCT02029989|914192|P2|Overall Study|Protocol Violation|0
273866|NCT02029989|914193|P1|Overall Study|Protocol Violation|1
273867|NCT02029989|914192|P2|Overall Study|Death|1
273868|NCT02029989|914193|P1|Overall Study|Death|0
273869|NCT02029989|914192|P2|Overall Study|Lost to Follow-up|7
273870|NCT02029989|914193|P1|Overall Study|Lost to Follow-up|9
273871|NCT02029989|914192|P2|Overall Study|Physician Decision|0
273872|NCT02029989|914193|P1|Overall Study|Physician Decision|2
273873|NCT02029989|914192|P2|Overall Study|Change of location|3
273874|NCT02029989|914193|P1|Overall Study|Change of location|2
273875|NCT02029989|914192|P2|Overall Study|Withdrawal: Fear of needles|0
273876|NCT02029989|914193|P1|Overall Study|Withdrawal: Fear of needles|1
273877|NCT02029989|914192|P2|Overall Study|Withdrawal by Subject|0
273878|NCT02029989|914193|P1|Overall Study|Withdrawal by Subject|1
273879|NCT02029846|914216|P2|Overall Study|n=1 each arm|1
273880|NCT02029846|914217|P1|Overall Study|n=1 each arm|1
273881|NCT02029521|914254|P2|Overall Study|Withdrawal by Subject|1
273882|NCT02029521|914255|P1|Overall Study|Withdrawal by Subject|1
273883|NCT02029521|914254|P2|Overall Study|Protocol Violation|0
273884|NCT02029521|914255|P1|Overall Study|Protocol Violation|1
273885|NCT02029417|914353|P1|Overall Study|Adverse Event|1
273886|NCT02029417|914353|P1|Overall Study|Death|1
273887|NCT02028767|914457|P2|Treatment Period 2|Reason other than those specified above|0
273888|NCT02028767|914458|P1|Treatment Period 2|Reason other than those specified above|1
273889|NCT02028767|914457|P2|Treatment Period 2|Non compliant with protocol|0
273890|NCT02028767|914458|P1|Treatment Period 2|Non compliant with protocol|1
273891|NCT02028169|914683|P1|Overall Study|Concomitant Medication Usage|1
273892|NCT02028169|914683|P1|Overall Study|Cessation of Drug|1
273893|NCT02028169|914683|P1|Overall Study|Adverse Event|1
273894|NCT02028169|914683|P1|Overall Study|Withdrawal by Subject|2
273895|NCT02028169|914683|P1|Overall Study|Lack of Efficacy|2
273896|NCT02028169|914683|P1|Overall Study|Lost to Follow-up|21
273897|NCT02028065|914709|P3|Treatment Through Study Completion|Adverse Event|5
273898|NCT02028065|914710|P2|Treatment Through Study Completion|Adverse Event|3
273899|NCT02028065|914711|P1|Treatment Through Study Completion|Adverse Event|3
273900|NCT02028065|914709|P3|Treatment Through Study Completion|Withdrawal by Subject|3
273901|NCT02028065|914710|P2|Treatment Through Study Completion|Withdrawal by Subject|4
273902|NCT02028065|914711|P1|Treatment Through Study Completion|Withdrawal by Subject|5
273903|NCT02028065|914709|P3|Treatment Through Study Completion|Protocol Violation|0
273904|NCT02028065|914710|P2|Treatment Through Study Completion|Protocol Violation|4
273905|NCT02028065|914711|P1|Treatment Through Study Completion|Protocol Violation|1
273906|NCT02028065|914709|P3|Treatment Through Study Completion|Physician Decision|0
273907|NCT02028065|914710|P2|Treatment Through Study Completion|Physician Decision|0
273908|NCT02028065|914711|P1|Treatment Through Study Completion|Physician Decision|1
273909|NCT02028065|914709|P3|Treatment Through Study Completion|Lost to Follow-up|6
273910|NCT02028065|914710|P2|Treatment Through Study Completion|Lost to Follow-up|4
273911|NCT02028065|914711|P1|Treatment Through Study Completion|Lost to Follow-up|2
273912|NCT02028065|914709|P3|Randomization Through Start Treatment|Not treated|3
273913|NCT02028065|914710|P2|Randomization Through Start Treatment|Not treated|3
273914|NCT02028065|914711|P1|Randomization Through Start Treatment|Not treated|1
273915|NCT02027844|914738|P3|Overall Study|Incomlete data|0
273916|NCT02027844|914739|P2|Overall Study|Incomlete data|0
273917|NCT02027844|914740|P1|Overall Study|Incomlete data|2
273918|NCT02027844|914738|P3|Overall Study|Protocol Violation|0
273919|NCT02027844|914739|P2|Overall Study|Protocol Violation|2
273920|NCT02027844|914740|P1|Overall Study|Protocol Violation|0
273921|NCT02027844|914738|P3|Overall Study|Lost to Follow-up|1
273922|NCT02027844|914739|P2|Overall Study|Lost to Follow-up|2
273923|NCT02027844|914740|P1|Overall Study|Lost to Follow-up|0
273924|NCT02027844|914738|P3|Overall Study|Withdrawal by Subject|1
273925|NCT02027844|914739|P2|Overall Study|Withdrawal by Subject|2
273926|NCT02027844|914740|P1|Overall Study|Withdrawal by Subject|3
273927|NCT02027402|914759|P2|Overall Study|Withdrawal by Subject|1
273928|NCT02027402|914760|P1|Overall Study|Withdrawal by Subject|4
273929|NCT02027311|914774|P2|Overall Study|Protocol Violation|2
273930|NCT02027311|914775|P1|Overall Study|Protocol Violation|3
273931|NCT02026258|914810|P2|Recieved Allocated Intervention|Lost to Follow-up|1
273932|NCT02026258|914811|P1|Recieved Allocated Intervention|Lost to Follow-up|0
273933|NCT02026258|914810|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
273934|NCT02026258|914811|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
273935|NCT02026258|914810|P2|Randomized|Presence of periodontal disease|1
273936|NCT02026258|914811|P1|Randomized|Presence of periodontal disease|1
273937|NCT02026258|914810|P2|Randomized|Change in treatment plan|0
273938|NCT02026258|914811|P1|Randomized|Change in treatment plan|1
273939|NCT02026258|914810|P2|Randomized|Did not start treatment|1
273940|NCT02026258|914811|P1|Randomized|Did not start treatment|2
273941|NCT02026141|914845|P2|Overall Study|Protocol Violation|1
273942|NCT02026141|914846|P1|Overall Study|Protocol Violation|0
273943|NCT02025907|914854|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
273944|NCT02025907|914855|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
273945|NCT02025907|914854|P2|Overall Study|Adverse Event|1
273946|NCT02025907|914855|P1|Overall Study|Adverse Event|3
273947|NCT02025907|914854|P2|Overall Study|Lost to Follow-up|2
273948|NCT02025907|914855|P1|Overall Study|Lost to Follow-up|2
273949|NCT02025907|914854|P2|Overall Study|Physician Decision|0
273950|NCT02025907|914855|P1|Overall Study|Physician Decision|2
273951|NCT02025907|914854|P2|Overall Study|Protocol Violation|0
273952|NCT02025907|914855|P1|Overall Study|Protocol Violation|2
273953|NCT02025907|914854|P2|Overall Study|Withdrawal by Subject|8
273954|NCT02025907|914855|P1|Overall Study|Withdrawal by Subject|15
273955|NCT02025907|914854|P2|Overall Study|Lack of Efficacy|0
273956|NCT02025907|914855|P1|Overall Study|Lack of Efficacy|1
273957|NCT02025621|914912|P2|Overall Study|Surgery initiated before infusion|3
273958|NCT02025621|914913|P1|Overall Study|Surgery initiated before infusion|3
273959|NCT02025621|914912|P2|Overall Study|No longer eligible|15
273960|NCT02025621|914913|P1|Overall Study|No longer eligible|10
273961|NCT02025621|914912|P2|Overall Study|Death|1
273962|NCT02025621|914913|P1|Overall Study|Death|0
273963|NCT02025621|914912|P2|Overall Study|Withdrawal by Subject|0
273964|NCT02025621|914913|P1|Overall Study|Withdrawal by Subject|1
273965|NCT02024971|914958|P1|Overall Study|Lost to Follow-up|6
273966|NCT02024971|914958|P1|Overall Study|Data Not Available|30
273967|NCT02024932|914971|P6|Overall Study|Abnormal laboratory value|0
273968|NCT02024932|914972|P5|Overall Study|Abnormal laboratory value|0
273969|NCT02024932|914973|P4|Overall Study|Abnormal laboratory value|2
273970|NCT02024932|914974|P3|Overall Study|Abnormal laboratory value|0
273971|NCT02024932|914975|P2|Overall Study|Abnormal laboratory value|0
273972|NCT02024932|914976|P1|Overall Study|Abnormal laboratory value|0
273973|NCT02024932|914971|P6|Overall Study|Adverse Event|0
273974|NCT02024932|914972|P5|Overall Study|Adverse Event|2
273975|NCT02024932|914973|P4|Overall Study|Adverse Event|0
273976|NCT02024932|914974|P3|Overall Study|Adverse Event|0
273977|NCT02024932|914975|P2|Overall Study|Adverse Event|3
273978|NCT02024932|914976|P1|Overall Study|Adverse Event|2
273979|NCT02024867|915035|P2|Overall Study|Lost to Follow-up|4
273980|NCT02024867|915036|P1|Overall Study|Lost to Follow-up|6
273981|NCT02024867|915035|P2|Overall Study|Protocol Violation|3
273982|NCT02024867|915036|P1|Overall Study|Protocol Violation|3
273983|NCT02024698|915061|P2|First Intervention (7 Days)|Withdrawal by Subject|1
273984|NCT02024698|915062|P1|First Intervention (7 Days)|Withdrawal by Subject|0
273985|NCT02023879|915140|P3|Overall Study|Other than specified above|1
273986|NCT02023879|915141|P2|Overall Study|Other than specified above|3
273987|NCT02023879|915142|P1|Overall Study|Other than specified above|1
273988|NCT02023879|915140|P3|Overall Study|Randomized but not treated|1
273989|NCT02023879|915141|P2|Overall Study|Randomized but not treated|1
273990|NCT02023879|915142|P1|Overall Study|Randomized but not treated|0
273991|NCT02023879|915140|P3|Overall Study|Consent withdrawn by participant|1
273992|NCT02023879|915141|P2|Overall Study|Consent withdrawn by participant|0
273993|NCT02023879|915142|P1|Overall Study|Consent withdrawn by participant|1
273994|NCT02023879|915140|P3|Overall Study|Physician Decision|0
273995|NCT02023879|915141|P2|Overall Study|Physician Decision|1
273996|NCT02023879|915142|P1|Overall Study|Physician Decision|0
273997|NCT02023879|915140|P3|Overall Study|Poor compliance to protocol|1
273998|NCT02023879|915141|P2|Overall Study|Poor compliance to protocol|2
273999|NCT02023879|915142|P1|Overall Study|Poor compliance to protocol|0
274000|NCT02023879|915140|P3|Overall Study|Adverse Event|5
274001|NCT02023879|915141|P2|Overall Study|Adverse Event|2
274002|NCT02023879|915142|P1|Overall Study|Adverse Event|2
274003|NCT02023866|915225|P1|Overall Study|Withdrawal by Subject|1
274004|NCT02023866|915225|P1|Overall Study|Adverse Event|3
274005|NCT02023866|915225|P1|Overall Study|Non-compliance|2
274006|NCT02023268|915257|P2|Overall Study|Withdrawal by Subject|1
274007|NCT02023268|915258|P1|Overall Study|Withdrawal by Subject|0
274008|NCT02023268|915257|P2|Overall Study|Adverse Event|2
274009|NCT02023268|915258|P1|Overall Study|Adverse Event|0
274010|NCT02023268|915257|P2|Overall Study|Lack of Efficacy|1
274011|NCT02023268|915258|P1|Overall Study|Lack of Efficacy|0
274012|NCT02023151|915264|P1|Overall Study|Lost to Follow-up|4
274013|NCT02023112|915334|P2|Overall Study|Withdrawal by Subject|1
274014|NCT02023112|915335|P1|Overall Study|Withdrawal by Subject|2
274015|NCT02023099|915356|P3|Overall Study|Non-treatment-emergent Fatal AE|1
274016|NCT02023099|915357|P2|Overall Study|Non-treatment-emergent Fatal AE|0
274017|NCT02023099|915358|P1|Overall Study|Non-treatment-emergent Fatal AE|0
274018|NCT02023099|915356|P3|Overall Study|Withdrawn Consent|1
274019|NCT02023099|915357|P2|Overall Study|Withdrawn Consent|0
274020|NCT02023099|915358|P1|Overall Study|Withdrawn Consent|3
274021|NCT02023099|915356|P3|Overall Study|Non-fatal Adverse Event (AE)|1
274022|NCT02023099|915357|P2|Overall Study|Non-fatal Adverse Event (AE)|0
274023|NCT02023099|915358|P1|Overall Study|Non-fatal Adverse Event (AE)|0
274024|NCT02022748|915381|P3|Overall Study|Withdrawal by Subject|0
274025|NCT02022748|915382|P2|Overall Study|Withdrawal by Subject|1
274026|NCT02022748|915383|P1|Overall Study|Withdrawal by Subject|0
274027|NCT02022748|915381|P3|Overall Study|Adverse Event|0
274028|NCT02022748|915382|P2|Overall Study|Adverse Event|1
274029|NCT02022748|915383|P1|Overall Study|Adverse Event|1
274030|NCT02022670|915409|P3|Overall Study|Adverse Event|1
274031|NCT02022670|915410|P2|Overall Study|Adverse Event|0
274032|NCT02022670|915411|P1|Overall Study|Adverse Event|1
274033|NCT02022007|915455|P3|Overall Study|Noncompliant|1
274034|NCT02022007|915456|P2|Overall Study|Noncompliant|0
274035|NCT02022007|915457|P1|Overall Study|Noncompliant|0
274036|NCT02022007|915455|P3|Overall Study|Withdrawal by Subject|1
274037|NCT02022007|915456|P2|Overall Study|Withdrawal by Subject|1
274038|NCT02022007|915457|P1|Overall Study|Withdrawal by Subject|1
274039|NCT02021643|915522|P4|Overall Study|Withdrew Consent|0
274040|NCT02021643|915523|P3|Overall Study|Withdrew Consent|0
274041|NCT02021643|915524|P2|Overall Study|Withdrew Consent|1
274042|NCT02021643|915525|P1|Overall Study|Withdrew Consent|0
274043|NCT02021643|915522|P4|Overall Study|Lost to Follow-up|0
274044|NCT02021643|915523|P3|Overall Study|Lost to Follow-up|0
274045|NCT02021643|915524|P2|Overall Study|Lost to Follow-up|1
274046|NCT02021643|915525|P1|Overall Study|Lost to Follow-up|0
274047|NCT02021643|915522|P4|Overall Study|Lack of Efficacy|12
274048|NCT02021643|915523|P3|Overall Study|Lack of Efficacy|0
274049|NCT02021643|915524|P2|Overall Study|Lack of Efficacy|6
274050|NCT02021643|915525|P1|Overall Study|Lack of Efficacy|7
274051|NCT02021643|915522|P4|Overall Study|Investigator's Discretion|0
274052|NCT02021643|915523|P3|Overall Study|Investigator's Discretion|0
274053|NCT02021643|915524|P2|Overall Study|Investigator's Discretion|0
274054|NCT02021643|915525|P1|Overall Study|Investigator's Discretion|1
274055|NCT02021643|915522|P4|Overall Study|Death|0
274056|NCT02021643|915523|P3|Overall Study|Death|0
274057|NCT02021643|915524|P2|Overall Study|Death|1
274058|NCT02021643|915525|P1|Overall Study|Death|0
274059|NCT02021643|915522|P4|Overall Study|Adverse Event|0
274060|NCT02021643|915523|P3|Overall Study|Adverse Event|0
274061|NCT02021643|915524|P2|Overall Study|Adverse Event|1
274062|NCT02021643|915525|P1|Overall Study|Adverse Event|0
274063|NCT02021643|915522|P4|Overall Study|Enrolled but Never Treated|0
274064|NCT02021643|915523|P3|Overall Study|Enrolled but Never Treated|0
274065|NCT02021643|915524|P2|Overall Study|Enrolled but Never Treated|0
274066|NCT02021643|915525|P1|Overall Study|Enrolled but Never Treated|1
274067|NCT02021565|915567|P2|3-month Follow-up|Protocol Violation|2
274068|NCT02021565|915568|P1|3-month Follow-up|Protocol Violation|3
274069|NCT02021565|915567|P2|3-month Follow-up|Withdrawal by Subject|0
274070|NCT02021565|915568|P1|3-month Follow-up|Withdrawal by Subject|4
274071|NCT02021565|915567|P2|3-month Follow-up|Death|0
274072|NCT02021565|915568|P1|3-month Follow-up|Death|3
274073|NCT02021565|915567|P2|Baseline Through Intervention|Lost to Follow-up|2
274074|NCT02021565|915568|P1|Baseline Through Intervention|Lost to Follow-up|4
274075|NCT02021565|915567|P2|Baseline Through Intervention|Protocol Violation|7
274076|NCT02021565|915568|P1|Baseline Through Intervention|Protocol Violation|0
274077|NCT02021565|915567|P2|Baseline Through Intervention|Withdrawal by Subject|8
274078|NCT02021565|915568|P1|Baseline Through Intervention|Withdrawal by Subject|8
274079|NCT02021565|915567|P2|Baseline Through Intervention|Death|1
274080|NCT02021565|915568|P1|Baseline Through Intervention|Death|0
274081|NCT02021331|915588|P2|Overall Study|Adverse Event|2
274082|NCT02021331|915589|P1|Overall Study|Adverse Event|0
274083|NCT02021292|915601|P2|Overall Study|Death|1
274084|NCT02021292|915602|P1|Overall Study|Death|0
274085|NCT02021292|915601|P2|Overall Study|Lost to Follow-up|1
274086|NCT02021292|915602|P1|Overall Study|Lost to Follow-up|0
274087|NCT02021292|915601|P2|Overall Study|Physician Decision|1
274088|NCT02021292|915602|P1|Overall Study|Physician Decision|0
274089|NCT02020941|915624|P1|Overall Study|Disease Progression|4
274090|NCT02020941|915624|P1|Overall Study|Withdrawal by Subject|1
274091|NCT02020941|915624|P1|Overall Study|Physician Decision|2
274092|NCT02020941|915624|P1|Overall Study|Adverse Event|1
274093|NCT02020889|915635|P2|Overall Study|Withdrawal by Subject|2
274094|NCT02020889|915636|P1|Overall Study|Withdrawal by Subject|3
274095|NCT02020889|915635|P2|Overall Study|Physician Decision|0
274096|NCT02020889|915636|P1|Overall Study|Physician Decision|2
274097|NCT02020889|915635|P2|Overall Study|Lost to Follow-up|0
274098|NCT02020889|915636|P1|Overall Study|Lost to Follow-up|1
274099|NCT02020889|915635|P2|Overall Study|Lack of Efficacy|0
274100|NCT02020889|915636|P1|Overall Study|Lack of Efficacy|1
274101|NCT02020889|915635|P2|Overall Study|Adverse Event|1
274102|NCT02020889|915636|P1|Overall Study|Adverse Event|0
274103|NCT02020863|915690|P1|Overall Study|Team chose not to place an a line|1
274104|NCT02020863|915690|P1|Overall Study|Discovery of Metastatic disease|4
274105|NCT02020616|915705|P7|Overall Study|Lack of Efficacy|0
274106|NCT02020616|915706|P6|Overall Study|Lack of Efficacy|0
274107|NCT02020616|915707|P5|Overall Study|Lack of Efficacy|1
274108|NCT02020616|915708|P4|Overall Study|Lack of Efficacy|0
274109|NCT02020616|915709|P3|Overall Study|Lack of Efficacy|0
274110|NCT02020616|915710|P2|Overall Study|Lack of Efficacy|0
274111|NCT02020616|915711|P1|Overall Study|Lack of Efficacy|0
274112|NCT02020616|915705|P7|Overall Study|Randomized in Error|0
274113|NCT02020616|915706|P6|Overall Study|Randomized in Error|0
274114|NCT02020616|915707|P5|Overall Study|Randomized in Error|0
274115|NCT02020616|915708|P4|Overall Study|Randomized in Error|1
274116|NCT02020616|915709|P3|Overall Study|Randomized in Error|0
274117|NCT02020616|915710|P2|Overall Study|Randomized in Error|0
274118|NCT02020616|915711|P1|Overall Study|Randomized in Error|0
274119|NCT02020616|915705|P7|Overall Study|Early Termination Criteria Met|0
274120|NCT02020616|915706|P6|Overall Study|Early Termination Criteria Met|1
274121|NCT02020616|915707|P5|Overall Study|Early Termination Criteria Met|0
274122|NCT02020616|915708|P4|Overall Study|Early Termination Criteria Met|0
274123|NCT02020616|915709|P3|Overall Study|Early Termination Criteria Met|1
274124|NCT02020616|915710|P2|Overall Study|Early Termination Criteria Met|0
274125|NCT02020616|915711|P1|Overall Study|Early Termination Criteria Met|0
274126|NCT02020616|915705|P7|Overall Study|Lost to Follow-up|0
274127|NCT02020616|915706|P6|Overall Study|Lost to Follow-up|1
274128|NCT02020616|915707|P5|Overall Study|Lost to Follow-up|1
274129|NCT02020616|915708|P4|Overall Study|Lost to Follow-up|1
274130|NCT02020616|915709|P3|Overall Study|Lost to Follow-up|0
274131|NCT02020616|915710|P2|Overall Study|Lost to Follow-up|1
274132|NCT02020616|915711|P1|Overall Study|Lost to Follow-up|0
274133|NCT02020616|915705|P7|Overall Study|Withdrawal by Subject|1
274134|NCT02020616|915706|P6|Overall Study|Withdrawal by Subject|1
274135|NCT02020616|915707|P5|Overall Study|Withdrawal by Subject|0
274136|NCT02020616|915708|P4|Overall Study|Withdrawal by Subject|0
274137|NCT02020616|915709|P3|Overall Study|Withdrawal by Subject|1
274138|NCT02020616|915710|P2|Overall Study|Withdrawal by Subject|0
274139|NCT02020616|915711|P1|Overall Study|Withdrawal by Subject|0
274140|NCT02020616|915705|P7|Overall Study|Physician Decision|2
274141|NCT02020616|915706|P6|Overall Study|Physician Decision|1
274142|NCT02020616|915707|P5|Overall Study|Physician Decision|0
274143|NCT02020616|915708|P4|Overall Study|Physician Decision|0
274144|NCT02020616|915709|P3|Overall Study|Physician Decision|0
274145|NCT02020616|915710|P2|Overall Study|Physician Decision|0
274146|NCT02020616|915711|P1|Overall Study|Physician Decision|0
274147|NCT02020616|915705|P7|Overall Study|Adverse Event|1
274148|NCT02020616|915706|P6|Overall Study|Adverse Event|1
274149|NCT02020616|915707|P5|Overall Study|Adverse Event|0
274150|NCT02020616|915708|P4|Overall Study|Adverse Event|0
274151|NCT02020616|915709|P3|Overall Study|Adverse Event|0
274152|NCT02020616|915710|P2|Overall Study|Adverse Event|0
274153|NCT02020616|915711|P1|Overall Study|Adverse Event|0
274154|NCT02020577|915804|P2|Overall Study|Other than stated above|1
274155|NCT02020577|915805|P1|Overall Study|Other than stated above|0
274156|NCT02020577|915804|P2|Overall Study|Withdrawal by Subject|1
274157|NCT02020577|915805|P1|Overall Study|Withdrawal by Subject|0
274158|NCT02020577|915804|P2|Overall Study|Other AE or clinical progression|15
274159|NCT02020577|915805|P1|Overall Study|Other AE or clinical progression|0
274160|NCT02020577|915804|P2|Overall Study|Progressive disease|38
274161|NCT02020577|915805|P1|Overall Study|Progressive disease|3
274162|NCT02020512|915832|P1|Overall Study|Protocol Violation|4
274163|NCT02020512|915832|P1|Overall Study|Lost to Follow-up|3
274164|NCT02020512|915832|P1|Overall Study|Adverse Event|1
274165|NCT02020031|915884|P2|Overall Study|Physician Decision|1
274166|NCT02020031|915885|P1|Overall Study|Physician Decision|1
274167|NCT02019979|915893|P1|Overall Study|study terminated|14
274168|NCT02019719|915904|P5|Overall Study|Physician Decision|0
274169|NCT02019719|915905|P4|Overall Study|Physician Decision|0
274170|NCT02019719|915906|P3|Overall Study|Physician Decision|0
274171|NCT02019719|915907|P2|Overall Study|Physician Decision|0
274172|NCT02019719|915908|P1|Overall Study|Physician Decision|2
274173|NCT02019719|915904|P5|Overall Study|Protocol defined stopping criteria|1
274174|NCT02019719|915905|P4|Overall Study|Protocol defined stopping criteria|1
274175|NCT02019719|915906|P3|Overall Study|Protocol defined stopping criteria|0
274176|NCT02019719|915907|P2|Overall Study|Protocol defined stopping criteria|0
274177|NCT02019719|915908|P1|Overall Study|Protocol defined stopping criteria|2
274178|NCT02019719|915904|P5|Overall Study|Protocol Violation|0
274179|NCT02019719|915905|P4|Overall Study|Protocol Violation|0
274180|NCT02019719|915906|P3|Overall Study|Protocol Violation|0
274181|NCT02019719|915907|P2|Overall Study|Protocol Violation|1
274182|NCT02019719|915908|P1|Overall Study|Protocol Violation|1
274183|NCT02019719|915904|P5|Overall Study|Adverse Event|1
274184|NCT02019719|915905|P4|Overall Study|Adverse Event|1
274185|NCT02019719|915906|P3|Overall Study|Adverse Event|0
274186|NCT02019719|915907|P2|Overall Study|Adverse Event|0
274187|NCT02019719|915908|P1|Overall Study|Adverse Event|1
274188|NCT02019550|916024|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
274189|NCT02019550|916025|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
274190|NCT02019472|916066|P3|Overall Study|Other|6
274191|NCT02019472|916067|P2|Overall Study|Other|8
274192|NCT02019472|916068|P1|Overall Study|Other|3
274193|NCT02019472|916066|P3|Overall Study|Withdrawal by Subject|11
274194|NCT02019472|916067|P2|Overall Study|Withdrawal by Subject|10
274195|NCT02019472|916068|P1|Overall Study|Withdrawal by Subject|11
274196|NCT02019472|916066|P3|Overall Study|Pregnancy|2
274197|NCT02019472|916067|P2|Overall Study|Pregnancy|2
274198|NCT02019472|916068|P1|Overall Study|Pregnancy|1
274199|NCT02019472|916066|P3|Overall Study|Physician Decision|0
274200|NCT02019472|916067|P2|Overall Study|Physician Decision|2
274201|NCT02019472|916068|P1|Overall Study|Physician Decision|1
274202|NCT02019472|916066|P3|Overall Study|Lost to Follow-up|1
274203|NCT02019472|916067|P2|Overall Study|Lost to Follow-up|2
274204|NCT02019472|916068|P1|Overall Study|Lost to Follow-up|0
274205|NCT02019472|916066|P3|Overall Study|Lack of Efficacy|4
274206|NCT02019472|916067|P2|Overall Study|Lack of Efficacy|4
274207|NCT02019472|916068|P1|Overall Study|Lack of Efficacy|7
274208|NCT02019472|916066|P3|Overall Study|Death|1
274209|NCT02019472|916067|P2|Overall Study|Death|1
274210|NCT02019472|916068|P1|Overall Study|Death|0
274211|NCT02019472|916066|P3|Overall Study|Adverse Event|17
274212|NCT02019472|916067|P2|Overall Study|Adverse Event|23
274213|NCT02019472|916068|P1|Overall Study|Adverse Event|14
274214|NCT02018562|916112|P2|Overall Study|Discharged prior to study completion|0
274215|NCT02018562|916113|P1|Overall Study|Discharged prior to study completion|1
274216|NCT02018562|916112|P2|Overall Study|Withdrawal by Subject|0
274217|NCT02018562|916113|P1|Overall Study|Withdrawal by Subject|2
274218|NCT02017015|916153|P1|Overall Study|Physician Decision|2
274219|NCT02017015|916153|P1|Overall Study|Non-compliance with study drug|2
274220|NCT02017015|916153|P1|Overall Study|Progressive Disease|31
274221|NCT02017015|916153|P1|Overall Study|Death|4
274222|NCT02017015|916153|P1|Overall Study|Withdrawal by Subject|21
274223|NCT02017015|916153|P1|Overall Study|Adverse Event|9
274224|NCT02016898|916178|P2|Overall Study|Lost to Follow-up|4
274225|NCT02016898|916179|P1|Overall Study|Lost to Follow-up|4
274226|NCT02016898|916178|P2|Overall Study|Death|1
274227|NCT02016898|916179|P1|Overall Study|Death|1
274228|NCT02016690|916187|P1|Overall Study|Hospitalized for RSV at study start|3
274229|NCT02016690|916187|P1|Overall Study|Did not meet inclusion criteria|13
274230|NCT02016690|916187|P1|Overall Study|Excluded from SAS: Ineligible for study|2
274231|NCT02016690|916187|P1|Overall Study|Excluded from SAS: Early treatment|2
274232|NCT02016690|916187|P1|Overall Study|Excluded from SAS: Duplication|2
274233|NCT02016690|916187|P1|Overall Study|Excluded from SAS: Enrollment violation|2
274234|NCT02016625|916200|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
274235|NCT02016625|916201|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
274236|NCT02016625|916200|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
274237|NCT02016625|916201|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
274238|NCT02016625|916200|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
274239|NCT02016625|916201|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
274240|NCT02016482|916256|P2|Period B|Required Alternative/Prohibited Therapy|2
274241|NCT02016482|916257|P1|Period B|Required Alternative/Prohibited Therapy|0
274242|NCT02016482|916256|P2|Period B|Not Specified|0
274243|NCT02016482|916257|P1|Period B|Not Specified|4
274244|NCT02016482|916256|P2|Period B|Lack of Efficacy|4
274245|NCT02016482|916257|P1|Period B|Lack of Efficacy|6
274246|NCT02016482|916256|P2|Period B|Lost to Follow-up|0
274247|NCT02016482|916257|P1|Period B|Lost to Follow-up|2
274248|NCT02016482|916256|P2|Period B|Withdrawal by Subject|1
274249|NCT02016482|916257|P1|Period B|Withdrawal by Subject|1
274250|NCT02016482|916256|P2|Period A|Required Alternative/Prohibited Therapy|1
274251|NCT02016482|916257|P1|Period A|Required Alternative/Prohibited Therapy|0
274252|NCT02016482|916256|P2|Period A|Protocol Violation|1
274253|NCT02016482|916257|P1|Period A|Protocol Violation|0
274254|NCT02016482|916256|P2|Period A|Not Specified|0
274255|NCT02016482|916257|P1|Period A|Not Specified|3
274256|NCT02016482|916256|P2|Period A|Lack of Efficacy|1
274257|NCT02016482|916257|P1|Period A|Lack of Efficacy|2
274258|NCT02016482|916256|P2|Period A|Lost to Follow-up|3
274259|NCT02016482|916257|P1|Period A|Lost to Follow-up|3
274260|NCT02016482|916256|P2|Period A|Withdrawal by Subject|4
274261|NCT02016482|916257|P1|Period A|Withdrawal by Subject|3
274262|NCT02016482|916256|P2|Period A|Adverse Event|5
274263|NCT02016482|916257|P1|Period A|Adverse Event|3
274264|NCT02016170|916348|P3|Overall Study|Protocol Violation|0
274265|NCT02016170|916349|P2|Overall Study|Protocol Violation|0
274266|NCT02016170|916350|P1|Overall Study|Protocol Violation|1
274267|NCT02016170|916348|P3|Overall Study|Adverse Event|0
274268|NCT02016170|916349|P2|Overall Study|Adverse Event|1
274269|NCT02016170|916350|P1|Overall Study|Adverse Event|1
274270|NCT02016105|916361|P6|EXTENSION PERIOD|Lost to Follow-up|2
274271|NCT02016105|916362|P5|EXTENSION PERIOD|Lost to Follow-up|0
274272|NCT02016105|916363|P4|EXTENSION PERIOD|Lost to Follow-up|0
274273|NCT02016105|916364|P3|EXTENSION PERIOD|Lost to Follow-up|0
274274|NCT02016105|916365|P2|EXTENSION PERIOD|Lost to Follow-up|0
274275|NCT02016105|916366|P1|EXTENSION PERIOD|Lost to Follow-up|0
274276|NCT02016105|916361|P6|EXTENSION PERIOD|Non-compliance with study indication|0
274277|NCT02016105|916362|P5|EXTENSION PERIOD|Non-compliance with study indication|1
274278|NCT02016105|916363|P4|EXTENSION PERIOD|Non-compliance with study indication|0
274279|NCT02016105|916364|P3|EXTENSION PERIOD|Non-compliance with study indication|0
274280|NCT02016105|916365|P2|EXTENSION PERIOD|Non-compliance with study indication|0
274281|NCT02016105|916366|P1|EXTENSION PERIOD|Non-compliance with study indication|0
274282|NCT02016105|916361|P6|EXTENSION PERIOD|Withdrawal by Subject|2
274283|NCT02016105|916362|P5|EXTENSION PERIOD|Withdrawal by Subject|2
274284|NCT02016105|916363|P4|EXTENSION PERIOD|Withdrawal by Subject|2
274285|NCT02016105|916364|P3|EXTENSION PERIOD|Withdrawal by Subject|2
274286|NCT02016105|916365|P2|EXTENSION PERIOD|Withdrawal by Subject|0
274287|NCT02016105|916366|P1|EXTENSION PERIOD|Withdrawal by Subject|0
274288|NCT02016105|916361|P6|EXTENSION PERIOD|Adverse Event|0
274289|NCT02016105|916362|P5|EXTENSION PERIOD|Adverse Event|1
274290|NCT02016105|916363|P4|EXTENSION PERIOD|Adverse Event|0
274291|NCT02016105|916364|P3|EXTENSION PERIOD|Adverse Event|2
274292|NCT02016105|916365|P2|EXTENSION PERIOD|Adverse Event|0
274293|NCT02016105|916366|P1|EXTENSION PERIOD|Adverse Event|0
274294|NCT02016105|916361|P6|EXTENSION PERIOD|Lack of Efficacy|1
274295|NCT02016105|916362|P5|EXTENSION PERIOD|Lack of Efficacy|1
274296|NCT02016105|916363|P4|EXTENSION PERIOD|Lack of Efficacy|3
274297|NCT02016105|916364|P3|EXTENSION PERIOD|Lack of Efficacy|1
274298|NCT02016105|916365|P2|EXTENSION PERIOD|Lack of Efficacy|0
274299|NCT02016105|916366|P1|EXTENSION PERIOD|Lack of Efficacy|0
274300|NCT02016105|916361|P6|EXTENSION PERIOD|New therapy for study indication|1
274301|NCT02016105|916362|P5|EXTENSION PERIOD|New therapy for study indication|1
274302|NCT02016105|916363|P4|EXTENSION PERIOD|New therapy for study indication|0
274303|NCT02016105|916364|P3|EXTENSION PERIOD|New therapy for study indication|0
274304|NCT02016105|916365|P2|EXTENSION PERIOD|New therapy for study indication|0
274305|NCT02016105|916366|P1|EXTENSION PERIOD|New therapy for study indication|0
274306|NCT02016105|916361|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
274307|NCT02016105|916362|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
274308|NCT02016105|916363|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
274309|NCT02016105|916364|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
274310|NCT02016105|916365|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
274311|NCT02016105|916366|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
274312|NCT02016105|916361|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
274313|NCT02016105|916362|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
274314|NCT02016105|916363|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
274315|NCT02016105|916364|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
274316|NCT02016105|916365|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
274317|NCT02016105|916366|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
274318|NCT02016105|916361|P6|TREATMENT PERIOD 2|Adverse Event|1
274319|NCT02016105|916362|P5|TREATMENT PERIOD 2|Adverse Event|0
274320|NCT02016105|916363|P4|TREATMENT PERIOD 2|Adverse Event|4
274321|NCT02016105|916364|P3|TREATMENT PERIOD 2|Adverse Event|0
274322|NCT02016105|916365|P2|TREATMENT PERIOD 2|Adverse Event|0
274323|NCT02016105|916366|P1|TREATMENT PERIOD 2|Adverse Event|0
274324|NCT02016105|916361|P6|TREATMENT PERIOD 2|Death|1
274325|NCT02016105|916362|P5|TREATMENT PERIOD 2|Death|0
274326|NCT02016105|916363|P4|TREATMENT PERIOD 2|Death|0
274327|NCT02016105|916364|P3|TREATMENT PERIOD 2|Death|0
274328|NCT02016105|916365|P2|TREATMENT PERIOD 2|Death|0
274329|NCT02016105|916366|P1|TREATMENT PERIOD 2|Death|0
274330|NCT02016105|916361|P6|TREATMENT PERIOD 2|Pregnancy|1
274331|NCT02016105|916362|P5|TREATMENT PERIOD 2|Pregnancy|0
274332|NCT02016105|916363|P4|TREATMENT PERIOD 2|Pregnancy|0
274333|NCT02016105|916364|P3|TREATMENT PERIOD 2|Pregnancy|0
274334|NCT02016105|916365|P2|TREATMENT PERIOD 2|Pregnancy|0
274335|NCT02016105|916366|P1|TREATMENT PERIOD 2|Pregnancy|0
274336|NCT02016105|916361|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
274337|NCT02016105|916362|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
274338|NCT02016105|916363|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
274339|NCT02016105|916364|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
274340|NCT02016105|916365|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
274341|NCT02016105|916366|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
274342|NCT02016105|916361|P6|TREATMENT PERIOD 2|Non compliance study medication|1
274343|NCT02016105|916362|P5|TREATMENT PERIOD 2|Non compliance study medication|0
274344|NCT02016105|916363|P4|TREATMENT PERIOD 2|Non compliance study medication|0
274345|NCT02016105|916364|P3|TREATMENT PERIOD 2|Non compliance study medication|0
274346|NCT02016105|916365|P2|TREATMENT PERIOD 2|Non compliance study medication|0
274347|NCT02016105|916366|P1|TREATMENT PERIOD 2|Non compliance study medication|0
274348|NCT02016105|916361|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
274349|NCT02016105|916362|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
274350|NCT02016105|916363|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
274351|NCT02016105|916364|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
274352|NCT02016105|916365|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
274353|NCT02016105|916366|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
274354|NCT02016105|916361|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
274355|NCT02016105|916362|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
274356|NCT02016105|916363|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
274357|NCT02016105|916364|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
274358|NCT02016105|916365|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
274359|NCT02016105|916366|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
274360|NCT02016105|916361|P6|TREATMENT PERIOD 1|Adverse Event|0
274361|NCT02016105|916362|P5|TREATMENT PERIOD 1|Adverse Event|0
274362|NCT02016105|916363|P4|TREATMENT PERIOD 1|Adverse Event|0
274363|NCT02016105|916364|P3|TREATMENT PERIOD 1|Adverse Event|0
274364|NCT02016105|916365|P2|TREATMENT PERIOD 1|Adverse Event|5
274365|NCT02016105|916366|P1|TREATMENT PERIOD 1|Adverse Event|3
274366|NCT02016105|916361|P6|TREATMENT PERIOD 1|Pregnancy|0
274367|NCT02016105|916362|P5|TREATMENT PERIOD 1|Pregnancy|0
274368|NCT02016105|916363|P4|TREATMENT PERIOD 1|Pregnancy|0
274369|NCT02016105|916364|P3|TREATMENT PERIOD 1|Pregnancy|0
274370|NCT02016105|916365|P2|TREATMENT PERIOD 1|Pregnancy|1
274371|NCT02016105|916366|P1|TREATMENT PERIOD 1|Pregnancy|0
274372|NCT02016105|916361|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
274373|NCT02016105|916362|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
274374|NCT02016105|916363|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
274375|NCT02016105|916364|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
274376|NCT02016105|916365|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
274377|NCT02016105|916366|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
274378|NCT02016105|916361|P6|TREATMENT PERIOD 1|Physician Decision|0
274379|NCT02016105|916362|P5|TREATMENT PERIOD 1|Physician Decision|0
274380|NCT02016105|916363|P4|TREATMENT PERIOD 1|Physician Decision|0
274381|NCT02016105|916364|P3|TREATMENT PERIOD 1|Physician Decision|0
274382|NCT02016105|916365|P2|TREATMENT PERIOD 1|Physician Decision|2
274383|NCT02016105|916366|P1|TREATMENT PERIOD 1|Physician Decision|0
274384|NCT02016105|916361|P6|TREATMENT PERIOD 1|Protocol Violation|0
274385|NCT02016105|916362|P5|TREATMENT PERIOD 1|Protocol Violation|0
274386|NCT02016105|916363|P4|TREATMENT PERIOD 1|Protocol Violation|0
274387|NCT02016105|916364|P3|TREATMENT PERIOD 1|Protocol Violation|0
274388|NCT02016105|916365|P2|TREATMENT PERIOD 1|Protocol Violation|8
274389|NCT02016105|916366|P1|TREATMENT PERIOD 1|Protocol Violation|2
274390|NCT02015793|916425|P2|Overall Study|Withdrawal by Subject|1
274391|NCT02015793|916426|P1|Overall Study|Withdrawal by Subject|1
274392|NCT02015793|916425|P2|Overall Study|Adverse Event|3
274393|NCT02015793|916426|P1|Overall Study|Adverse Event|3
274394|NCT02015754|916456|P1|Overall Study|Lost to Follow-up|1
274395|NCT02015754|916456|P1|Overall Study|Change in treatment modality|5
274396|NCT02015754|916456|P1|Overall Study|Disease progression|5
274397|NCT02015676|916476|P3|Overall Study|Disease progression|1
274398|NCT02015676|916477|P2|Overall Study|Disease progression|1
274399|NCT02015676|916478|P1|Overall Study|Disease progression|3
274400|NCT02015676|916476|P3|Overall Study|Death|0
274401|NCT02015676|916477|P2|Overall Study|Death|1
274402|NCT02015676|916478|P1|Overall Study|Death|0
274403|NCT02015676|916476|P3|Overall Study|Administrative reasons|1
274404|NCT02015676|916477|P2|Overall Study|Administrative reasons|3
274405|NCT02015676|916478|P1|Overall Study|Administrative reasons|0
274406|NCT02015676|916476|P3|Overall Study|Withdrawal by Subject|1
274407|NCT02015676|916477|P2|Overall Study|Withdrawal by Subject|7
274408|NCT02015676|916478|P1|Overall Study|Withdrawal by Subject|1
274409|NCT02015676|916476|P3|Overall Study|Protocol Violation|0
274410|NCT02015676|916477|P2|Overall Study|Protocol Violation|0
274411|NCT02015676|916478|P1|Overall Study|Protocol Violation|1
274412|NCT02015676|916476|P3|Overall Study|Lack of Efficacy|0
274413|NCT02015676|916477|P2|Overall Study|Lack of Efficacy|4
274414|NCT02015676|916478|P1|Overall Study|Lack of Efficacy|2
274415|NCT02015676|916476|P3|Overall Study|Adverse Event|0
274416|NCT02015676|916477|P2|Overall Study|Adverse Event|18
274417|NCT02015676|916478|P1|Overall Study|Adverse Event|2
274418|NCT02015663|916494|P2|Overall Study|Administrative problems|11
274419|NCT02015663|916495|P1|Overall Study|Administrative problems|10
274420|NCT02015663|916494|P2|Overall Study|Adverse Event|0
274421|NCT02015663|916495|P1|Overall Study|Adverse Event|3
274422|NCT02015663|916494|P2|Overall Study|Protocol Violation|1
274423|NCT02015663|916495|P1|Overall Study|Protocol Violation|0
274424|NCT02015663|916494|P2|Overall Study|Withdrawal by Subject|0
274425|NCT02015663|916495|P1|Overall Study|Withdrawal by Subject|1
274426|NCT02015663|916494|P2|Overall Study|unsatisfactory therapeutic effect|0
274427|NCT02015663|916495|P1|Overall Study|unsatisfactory therapeutic effect|1
274428|NCT02015637|916526|P2|Overall Study|Did not take study drug|0
274429|NCT02015637|916527|P1|Overall Study|Did not take study drug|2
274430|NCT02015637|916526|P2|Overall Study|Adverse Event|0
274431|NCT02015637|916527|P1|Overall Study|Adverse Event|3
274432|NCT02015637|916526|P2|Overall Study|Lost to Follow-up|5
274433|NCT02015637|916527|P1|Overall Study|Lost to Follow-up|3
274434|NCT02015546|916538|P3|Overall Study|Screem Failure|3
274435|NCT02015546|916539|P2|Overall Study|Screem Failure|1
274436|NCT02015546|916540|P1|Overall Study|Screem Failure|2
274437|NCT02015546|916538|P3|Overall Study|Withdrawal by Subject|1
274438|NCT02015546|916539|P2|Overall Study|Withdrawal by Subject|1
274439|NCT02015546|916540|P1|Overall Study|Withdrawal by Subject|1
274440|NCT02015481|916572|P1|Overall Study|Death|1
274441|NCT02015221|916596|P2|Overall Study|Lost to Follow-up|0
274442|NCT02015221|916597|P1|Overall Study|Lost to Follow-up|1
274443|NCT02015221|916596|P2|Overall Study|Withdrawal by Subject|6
274444|NCT02015221|916597|P1|Overall Study|Withdrawal by Subject|8
274445|NCT02015195|916610|P7|Overall Study|Adverse Event|0
274446|NCT02015195|916611|P6|Overall Study|Adverse Event|0
274447|NCT02015195|916612|P5|Overall Study|Adverse Event|0
274448|NCT02015195|916613|P4|Overall Study|Adverse Event|1
274449|NCT02015195|916614|P3|Overall Study|Adverse Event|0
274450|NCT02015195|916615|P2|Overall Study|Adverse Event|0
274451|NCT02015195|916616|P1|Overall Study|Adverse Event|0
274452|NCT02015039|916639|P2|Overall Study|Not eligible|1
274453|NCT02015039|916640|P1|Overall Study|Not eligible|0
274454|NCT02014740|916660|P2|Overall Study|Withdrawal by Subject|1
274455|NCT02014740|916661|P1|Overall Study|Withdrawal by Subject|2
274456|NCT02014740|916660|P2|Overall Study|Lost to Follow-up|4
274457|NCT02014740|916661|P1|Overall Study|Lost to Follow-up|4
274458|NCT02014584|916669|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
274459|NCT02014584|916670|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
274460|NCT02014584|916671|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
274461|NCT02014584|916672|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
274462|NCT02014584|916673|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
274463|NCT02014584|916674|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
274464|NCT02014584|916669|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
274465|NCT02014584|916670|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
274466|NCT02014584|916671|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
274467|NCT02014584|916672|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
274468|NCT02014584|916673|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
274469|NCT02014584|916674|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
274470|NCT02014584|916669|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
274471|NCT02014584|916670|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
274472|NCT02014584|916671|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
274473|NCT02014584|916672|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
274474|NCT02014584|916673|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
274475|NCT02014584|916674|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
274476|NCT02014584|916669|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
274477|NCT02014584|916670|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
274478|NCT02014584|916671|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
274479|NCT02014584|916672|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
274480|NCT02014584|916673|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
274481|NCT02014584|916674|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
274482|NCT02014584|916669|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
274483|NCT02014584|916670|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
274484|NCT02014584|916671|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
274485|NCT02014584|916672|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
274486|NCT02014584|916673|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
274487|NCT02014584|916674|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
274488|NCT02014480|916791|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
274489|NCT02014480|916792|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
274490|NCT02014480|916793|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
274491|NCT02014480|916794|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
274492|NCT02014480|916795|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
274493|NCT02014480|916796|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
274494|NCT02014480|916791|P6|Treatment Period 3 (14 Days)|Adverse Event|1
274495|NCT02014480|916792|P5|Treatment Period 3 (14 Days)|Adverse Event|0
274496|NCT02014480|916793|P4|Treatment Period 3 (14 Days)|Adverse Event|0
274497|NCT02014480|916794|P3|Treatment Period 3 (14 Days)|Adverse Event|1
274498|NCT02014480|916795|P2|Treatment Period 3 (14 Days)|Adverse Event|0
274499|NCT02014480|916796|P1|Treatment Period 3 (14 Days)|Adverse Event|0
274500|NCT02014480|916791|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
274501|NCT02014480|916792|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
274502|NCT02014480|916793|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
274503|NCT02014480|916794|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
274504|NCT02014480|916795|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
274505|NCT02014480|916796|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
274506|NCT02014480|916791|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
274507|NCT02014480|916792|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
274508|NCT02014480|916793|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
274509|NCT02014480|916794|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
274510|NCT02014480|916795|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
274511|NCT02014480|916796|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
274512|NCT02014480|916791|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
274513|NCT02014480|916792|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
274514|NCT02014480|916793|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
274515|NCT02014480|916794|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
274516|NCT02014480|916795|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
274517|NCT02014480|916796|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
274518|NCT02014480|916791|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
274519|NCT02014480|916792|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
274520|NCT02014480|916793|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
274521|NCT02014480|916794|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
274522|NCT02014480|916795|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
274523|NCT02014480|916796|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
274524|NCT02014480|916791|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
274525|NCT02014480|916792|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
274526|NCT02014480|916793|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
274527|NCT02014480|916794|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
274528|NCT02014480|916795|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
274529|NCT02014480|916796|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
274530|NCT02014467|916815|P2|Overall Study|Withdrawal by Subject|4
274531|NCT02014467|916816|P1|Overall Study|Withdrawal by Subject|16
274532|NCT02014467|916815|P2|Overall Study|Physician Decision|3
274533|NCT02014467|916816|P1|Overall Study|Physician Decision|2
274534|NCT02014467|916815|P2|Overall Study|Protocol Violation|0
274535|NCT02014467|916816|P1|Overall Study|Protocol Violation|3
274536|NCT02014467|916815|P2|Overall Study|Adverse Event|0
274537|NCT02014467|916816|P1|Overall Study|Adverse Event|4
274538|NCT02014441|916876|P1|Overall Study|Continuing in Study|21
274539|NCT02014441|916876|P1|Overall Study|Withdrawal by Subject|9
274540|NCT02014402|916972|P4|Overall Study|Lost to Follow-up|2
274541|NCT02014402|916973|P3|Overall Study|Lost to Follow-up|1
274542|NCT02014402|916974|P2|Overall Study|Lost to Follow-up|0
274543|NCT02014402|916975|P1|Overall Study|Lost to Follow-up|0
274544|NCT02014402|916972|P4|Overall Study|Subject did not have transportation|0
274545|NCT02014402|916973|P3|Overall Study|Subject did not have transportation|0
274546|NCT02014402|916974|P2|Overall Study|Subject did not have transportation|1
274547|NCT02014402|916975|P1|Overall Study|Subject did not have transportation|0
274548|NCT02014402|916972|P4|Overall Study|Withdrawal by Subject|1
274549|NCT02014402|916973|P3|Overall Study|Withdrawal by Subject|2
274550|NCT02014402|916974|P2|Overall Study|Withdrawal by Subject|2
274551|NCT02014402|916975|P1|Overall Study|Withdrawal by Subject|1
274552|NCT02014402|916972|P4|Overall Study|Adverse Event|0
274553|NCT02014402|916973|P3|Overall Study|Adverse Event|0
274554|NCT02014402|916974|P2|Overall Study|Adverse Event|0
274555|NCT02014402|916975|P1|Overall Study|Adverse Event|1
274556|NCT02014272|917015|P2|Intervention Period 1|Adverse Event|1
274557|NCT02014272|917016|P1|Intervention Period 1|Adverse Event|0
274558|NCT02014272|917015|P2|Intervention Period 1|Withdrawal by Subject|0
274559|NCT02014272|917016|P1|Intervention Period 1|Withdrawal by Subject|1
274560|NCT02013830|917048|P1|Overall Study|Refused treatment|1
274561|NCT02013830|917048|P1|Overall Study|Insufficient therapeutic response|25
274562|NCT02013830|917048|P1|Overall Study|Death|1
274563|NCT02013830|917048|P1|Overall Study|Adverse Event|3
274564|NCT02013817|917059|P1|Overall Study|Not specified|9
274565|NCT02013817|917059|P1|Overall Study|Death|2
274566|NCT02013817|917059|P1|Overall Study|Withdrawal by Subject|4
274567|NCT02013817|917059|P1|Overall Study|Adverse Event|12
274568|NCT02013791|917077|P9|Period 1|Other Miscellaneous Reasons|0
274569|NCT02013791|917078|P8|Period 1|Other Miscellaneous Reasons|0
274570|NCT02013791|917079|P7|Period 1|Other Miscellaneous Reasons|0
274571|NCT02013791|917080|P6|Period 1|Other Miscellaneous Reasons|0
274572|NCT02013791|917081|P5|Period 1|Other Miscellaneous Reasons|0
274573|NCT02013791|917082|P4|Period 1|Other Miscellaneous Reasons|0
274574|NCT02013791|917083|P3|Period 1|Other Miscellaneous Reasons|0
274575|NCT02013791|917084|P2|Period 1|Other Miscellaneous Reasons|2
274576|NCT02013791|917085|P1|Period 1|Other Miscellaneous Reasons|0
274577|NCT02013791|917077|P9|Period 1|Lost to Follow-up|0
274578|NCT02013791|917078|P8|Period 1|Lost to Follow-up|1
274579|NCT02013791|917079|P7|Period 1|Lost to Follow-up|1
274580|NCT02013791|917080|P6|Period 1|Lost to Follow-up|0
274581|NCT02013791|917081|P5|Period 1|Lost to Follow-up|0
274582|NCT02013791|917082|P4|Period 1|Lost to Follow-up|1
274583|NCT02013791|917083|P3|Period 1|Lost to Follow-up|0
274584|NCT02013791|917084|P2|Period 1|Lost to Follow-up|0
274585|NCT02013791|917085|P1|Period 1|Lost to Follow-up|0
274586|NCT02013765|917106|P1|Overall Study|Trial was terminated by sponsor|1
274587|NCT02013687|917120|P4|Overall Study|Missed visits due to patient travel|0
274588|NCT02013687|917121|P3|Overall Study|Missed visits due to patient travel|1
274589|NCT02013687|917122|P2|Overall Study|Missed visits due to patient travel|0
274590|NCT02013687|917123|P1|Overall Study|Missed visits due to patient travel|0
274591|NCT02013687|917120|P4|Overall Study|Withdrawal by Subject|1
274592|NCT02013687|917121|P3|Overall Study|Withdrawal by Subject|0
274593|NCT02013687|917122|P2|Overall Study|Withdrawal by Subject|0
274594|NCT02013687|917123|P1|Overall Study|Withdrawal by Subject|0
274595|NCT02013687|917120|P4|Overall Study|Protocol Violation|1
274596|NCT02013687|917121|P3|Overall Study|Protocol Violation|0
274597|NCT02013687|917122|P2|Overall Study|Protocol Violation|0
274598|NCT02013687|917123|P1|Overall Study|Protocol Violation|0
274599|NCT02013687|917120|P4|Overall Study|Lost to Follow-up|0
274600|NCT02013687|917121|P3|Overall Study|Lost to Follow-up|1
274601|NCT02013687|917122|P2|Overall Study|Lost to Follow-up|0
274602|NCT02013687|917123|P1|Overall Study|Lost to Follow-up|0
274603|NCT02013622|917153|P1|Overall Study|Lack of Efficacy|1
274604|NCT02013622|917153|P1|Overall Study|Protocol Deviation|1
274605|NCT02013622|917153|P1|Overall Study|Withdrawal by Subject|6
274606|NCT02013622|917153|P1|Overall Study|Met Withdrawal Criteria|3
274607|NCT02013622|917153|P1|Overall Study|Adverse Event|3
274608|NCT02013622|917153|P1|Overall Study|Lost to Follow-up|10
274609|NCT02013609|917173|P1|Overall Study|Met Withdrawal Criteria|3
274610|NCT02013609|917173|P1|Overall Study|Adverse Event|3
274611|NCT02013609|917173|P1|Overall Study|Lost to Follow-up|3
274612|NCT02013609|917173|P1|Overall Study|Withdrawal by Subject|9
274613|NCT02013544|917198|P2|Overall Study|Entry criteria not met/non-compliance|3
274614|NCT02013544|917199|P1|Overall Study|Entry criteria not met/non-compliance|2
274615|NCT02013544|917198|P2|Overall Study|Physician Decision|1
274616|NCT02013544|917199|P1|Overall Study|Physician Decision|0
274617|NCT02013544|917198|P2|Overall Study|Withdrawal by Subject|8
274618|NCT02013544|917199|P1|Overall Study|Withdrawal by Subject|2
274619|NCT02013544|917198|P2|Overall Study|Lost to Follow-up|3
274620|NCT02013544|917199|P1|Overall Study|Lost to Follow-up|2
274621|NCT02013544|917198|P2|Overall Study|Adverse Event|5
274622|NCT02013544|917199|P1|Overall Study|Adverse Event|5
274623|NCT02013531|917221|P1|Overall Study|Withdrawal by Subject|1
274624|NCT02013531|917221|P1|Overall Study|Met Withdrawal Criteria|1
274625|NCT02013531|917221|P1|Overall Study|Lost to Follow-up|3
274626|NCT02013388|917251|P8|Overall Study|work emergency|0
274627|NCT02013388|917252|P7|Overall Study|work emergency|0
274628|NCT02013388|917253|P6|Overall Study|work emergency|0
274629|NCT02013388|917254|P5|Overall Study|work emergency|1
274630|NCT02013388|917255|P4|Overall Study|work emergency|0
274631|NCT02013388|917256|P3|Overall Study|work emergency|0
274632|NCT02013388|917257|P2|Overall Study|work emergency|0
274633|NCT02013388|917258|P1|Overall Study|work emergency|1
274634|NCT02013206|917315|P2|Overall Study|Other reasons off treatment|2
274635|NCT02013206|917316|P1|Overall Study|Other reasons off treatment|5
274636|NCT02013206|917315|P2|Overall Study|Death|2
274637|NCT02013206|917316|P1|Overall Study|Death|1
274638|NCT02013206|917315|P2|Overall Study|Patient non-compliance|0
274639|NCT02013206|917316|P1|Overall Study|Patient non-compliance|1
274640|NCT02013206|917315|P2|Overall Study|Patient refusal|0
274641|NCT02013206|917316|P1|Overall Study|Patient refusal|2
274642|NCT02013206|917315|P2|Overall Study|Adverse Event|0
274643|NCT02013206|917316|P1|Overall Study|Adverse Event|1
274644|NCT02013206|917315|P2|Overall Study|Symptomatic deterioration|1
274645|NCT02013206|917316|P1|Overall Study|Symptomatic deterioration|3
274646|NCT02013206|917315|P2|Overall Study|Progressive disease (PD)|17
274647|NCT02013206|917316|P1|Overall Study|Progressive disease (PD)|14
274648|NCT02013167|917338|P2|Overall Study|Death|160
274649|NCT02013167|917339|P1|Overall Study|Death|85
274650|NCT02013167|917338|P2|Overall Study|Lost to Follow-up|1
274651|NCT02013167|917339|P1|Overall Study|Lost to Follow-up|0
274652|NCT02013167|917338|P2|Overall Study|Sponsor Decision|3
274653|NCT02013167|917339|P1|Overall Study|Sponsor Decision|1
274654|NCT02013167|917338|P2|Overall Study|Withdrawal by Subject|14
274655|NCT02013167|917339|P1|Overall Study|Withdrawal by Subject|15
274656|NCT02012686|917417|P2|Overall Study|electrocardiography monitoring noise|1
274657|NCT02012686|917418|P1|Overall Study|electrocardiography monitoring noise|0
274658|NCT02012686|917417|P2|Overall Study|muscle contraction|1
274659|NCT02012686|917418|P1|Overall Study|muscle contraction|0
274660|NCT02012452|917465|P2|Overall Study|Withdrawal by Subject|0
274661|NCT02012452|917466|P1|Overall Study|Withdrawal by Subject|4
274662|NCT02012452|917465|P2|Overall Study|Lost to Follow-up|1
274663|NCT02012452|917466|P1|Overall Study|Lost to Follow-up|2
274664|NCT02012218|917479|P5|Overall Study|Protocol Deviation|0
274665|NCT02012218|917480|P4|Overall Study|Protocol Deviation|0
274666|NCT02012218|917481|P3|Overall Study|Protocol Deviation|0
274667|NCT02012218|917482|P2|Overall Study|Protocol Deviation|0
274668|NCT02012218|917483|P1|Overall Study|Protocol Deviation|1
274669|NCT02012218|917479|P5|Overall Study|Protocol Specified|0
274670|NCT02012218|917480|P4|Overall Study|Protocol Specified|0
274671|NCT02012218|917481|P3|Overall Study|Protocol Specified|0
274672|NCT02012218|917482|P2|Overall Study|Protocol Specified|0
274673|NCT02012218|917483|P1|Overall Study|Protocol Specified|1
274674|NCT02012218|917479|P5|Overall Study|Lost to Follow-up|0
274675|NCT02012218|917480|P4|Overall Study|Lost to Follow-up|0
274676|NCT02012218|917481|P3|Overall Study|Lost to Follow-up|1
274677|NCT02012218|917482|P2|Overall Study|Lost to Follow-up|1
274678|NCT02012218|917483|P1|Overall Study|Lost to Follow-up|0
274679|NCT02012218|917479|P5|Overall Study|Adverse Event|0
274680|NCT02012218|917480|P4|Overall Study|Adverse Event|1
274681|NCT02012218|917481|P3|Overall Study|Adverse Event|0
274682|NCT02012218|917482|P2|Overall Study|Adverse Event|0
274683|NCT02012218|917483|P1|Overall Study|Adverse Event|1
274684|NCT02012218|917479|P5|Overall Study|Withdrawal by Subject|1
274685|NCT02012218|917480|P4|Overall Study|Withdrawal by Subject|1
274686|NCT02012218|917481|P3|Overall Study|Withdrawal by Subject|1
274687|NCT02012218|917482|P2|Overall Study|Withdrawal by Subject|0
274688|NCT02012218|917483|P1|Overall Study|Withdrawal by Subject|1
274689|NCT02011893|917495|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
274690|NCT02011893|917496|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
274691|NCT02011893|917497|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
274692|NCT02011893|917495|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
274693|NCT02011893|917496|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
274694|NCT02011893|917497|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
274695|NCT02011893|917495|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
274696|NCT02011893|917496|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
274697|NCT02011893|917497|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
274698|NCT02011893|917495|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
274699|NCT02011893|917496|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
274700|NCT02011893|917497|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
274701|NCT02011893|917495|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
274702|NCT02011893|917496|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
274703|NCT02011893|917497|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
274704|NCT02011893|917495|P3|Enrollment to Randomization|Screening Failure|0
274705|NCT02011893|917496|P2|Enrollment to Randomization|Screening Failure|0
274706|NCT02011893|917497|P1|Enrollment to Randomization|Screening Failure|29
274707|NCT02011893|917495|P3|Enrollment to Randomization|Withdrawal by Subject|0
274708|NCT02011893|917496|P2|Enrollment to Randomization|Withdrawal by Subject|0
274709|NCT02011893|917497|P1|Enrollment to Randomization|Withdrawal by Subject|21
274710|NCT02011893|917495|P3|Enrollment to Randomization|Physician Decision|0
274711|NCT02011893|917496|P2|Enrollment to Randomization|Physician Decision|0
274712|NCT02011893|917497|P1|Enrollment to Randomization|Physician Decision|10
274713|NCT02011893|917495|P3|Enrollment to Randomization|Adverse Event|0
274714|NCT02011893|917496|P2|Enrollment to Randomization|Adverse Event|0
274715|NCT02011893|917497|P1|Enrollment to Randomization|Adverse Event|2
274716|NCT02011542|917508|P1|Overall Study|Physician Decision|1
274717|NCT02011113|917639|P1|Overall Study|Study terminated by sponsor|11
274718|NCT02011113|917639|P1|Overall Study|Investigator's judgement- DP|3
274719|NCT02011113|917639|P1|Overall Study|Insufficient effect of Pomalidomide|1
274720|NCT02011113|917639|P1|Overall Study|Death|1
274721|NCT02011113|917639|P1|Overall Study|Disease Progression (DP)|16
274722|NCT02011113|917639|P1|Overall Study|Adverse Event|4
274723|NCT02010684|917668|P2|Overall Study|Withdrawal by Subject|5
274724|NCT02010684|917669|P1|Overall Study|Withdrawal by Subject|4
274725|NCT02010684|917668|P2|Overall Study|Lost to Follow-up|18
274726|NCT02010684|917669|P1|Overall Study|Lost to Follow-up|8
274727|NCT02010632|917687|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
274728|NCT02010632|917688|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
274729|NCT02010567|917699|P5|Overall Study|Adverse Event|1
274730|NCT02010567|917700|P4|Overall Study|Adverse Event|0
274731|NCT02010567|917701|P3|Overall Study|Adverse Event|1
274732|NCT02010567|917702|P2|Overall Study|Adverse Event|0
274733|NCT02010567|917703|P1|Overall Study|Adverse Event|0
274734|NCT02010255|917728|P14|Overall Study|Randomized but Not Treated|1
274735|NCT02010255|917729|P13|Overall Study|Randomized but Not Treated|0
274736|NCT02010255|917730|P12|Overall Study|Randomized but Not Treated|0
274737|NCT02010255|917731|P11|Overall Study|Randomized but Not Treated|0
274738|NCT02010255|917732|P10|Overall Study|Randomized but Not Treated|0
274739|NCT02010255|917733|P9|Overall Study|Randomized but Not Treated|0
274740|NCT02010255|917734|P8|Overall Study|Randomized but Not Treated|0
274741|NCT02010255|917735|P7|Overall Study|Randomized but Not Treated|0
274742|NCT02010255|917736|P6|Overall Study|Randomized but Not Treated|0
274743|NCT02010255|917737|P5|Overall Study|Randomized but Not Treated|0
274744|NCT02010255|917738|P4|Overall Study|Randomized but Not Treated|0
274745|NCT02010255|917739|P3|Overall Study|Randomized but Not Treated|0
274746|NCT02010255|917740|P2|Overall Study|Randomized but Not Treated|0
274747|NCT02010255|917741|P1|Overall Study|Randomized but Not Treated|0
274748|NCT02010255|917728|P14|Overall Study|Lost to Follow-up|0
274749|NCT02010255|917729|P13|Overall Study|Lost to Follow-up|0
274750|NCT02010255|917730|P12|Overall Study|Lost to Follow-up|0
274751|NCT02010255|917731|P11|Overall Study|Lost to Follow-up|0
274752|NCT02010255|917732|P10|Overall Study|Lost to Follow-up|0
274753|NCT02010255|917733|P9|Overall Study|Lost to Follow-up|0
274754|NCT02010255|917734|P8|Overall Study|Lost to Follow-up|0
274755|NCT02010255|917735|P7|Overall Study|Lost to Follow-up|0
274756|NCT02010255|917736|P6|Overall Study|Lost to Follow-up|0
274757|NCT02010255|917737|P5|Overall Study|Lost to Follow-up|1
274758|NCT02010255|917738|P4|Overall Study|Lost to Follow-up|0
274759|NCT02010255|917739|P3|Overall Study|Lost to Follow-up|1
274760|NCT02010255|917740|P2|Overall Study|Lost to Follow-up|0
274761|NCT02010255|917741|P1|Overall Study|Lost to Follow-up|0
274762|NCT02010255|917728|P14|Overall Study|Adverse Event|0
274763|NCT02010255|917729|P13|Overall Study|Adverse Event|0
274764|NCT02010255|917730|P12|Overall Study|Adverse Event|0
274765|NCT02010255|917731|P11|Overall Study|Adverse Event|0
274766|NCT02010255|917732|P10|Overall Study|Adverse Event|0
274767|NCT02010255|917733|P9|Overall Study|Adverse Event|0
274768|NCT02010255|917734|P8|Overall Study|Adverse Event|0
274769|NCT02010255|917735|P7|Overall Study|Adverse Event|0
274770|NCT02010255|917736|P6|Overall Study|Adverse Event|0
274771|NCT02010255|917737|P5|Overall Study|Adverse Event|0
274772|NCT02010255|917738|P4|Overall Study|Adverse Event|0
274773|NCT02010255|917739|P3|Overall Study|Adverse Event|0
274774|NCT02010255|917740|P2|Overall Study|Adverse Event|0
274775|NCT02010255|917741|P1|Overall Study|Adverse Event|1
274776|NCT02010255|917728|P14|Overall Study|Withdrew Consent|0
274777|NCT02010255|917729|P13|Overall Study|Withdrew Consent|0
274778|NCT02010255|917730|P12|Overall Study|Withdrew Consent|0
274779|NCT02010255|917731|P11|Overall Study|Withdrew Consent|0
274780|NCT02010255|917732|P10|Overall Study|Withdrew Consent|0
274781|NCT02010255|917733|P9|Overall Study|Withdrew Consent|0
274782|NCT02010255|917734|P8|Overall Study|Withdrew Consent|0
274783|NCT02010255|917735|P7|Overall Study|Withdrew Consent|0
274784|NCT02010255|917736|P6|Overall Study|Withdrew Consent|0
274785|NCT02010255|917737|P5|Overall Study|Withdrew Consent|0
274786|NCT02010255|917738|P4|Overall Study|Withdrew Consent|1
274787|NCT02010255|917739|P3|Overall Study|Withdrew Consent|0
274788|NCT02010255|917740|P2|Overall Study|Withdrew Consent|0
274789|NCT02010255|917741|P1|Overall Study|Withdrew Consent|1
274790|NCT02010255|917728|P14|Overall Study|Lack of Efficacy|0
274791|NCT02010255|917729|P13|Overall Study|Lack of Efficacy|0
274792|NCT02010255|917730|P12|Overall Study|Lack of Efficacy|0
274793|NCT02010255|917731|P11|Overall Study|Lack of Efficacy|1
274794|NCT02010255|917732|P10|Overall Study|Lack of Efficacy|0
274795|NCT02010255|917733|P9|Overall Study|Lack of Efficacy|0
274796|NCT02010255|917734|P8|Overall Study|Lack of Efficacy|0
274797|NCT02010255|917735|P7|Overall Study|Lack of Efficacy|0
274798|NCT02010255|917736|P6|Overall Study|Lack of Efficacy|0
274799|NCT02010255|917737|P5|Overall Study|Lack of Efficacy|1
274800|NCT02010255|917738|P4|Overall Study|Lack of Efficacy|1
274801|NCT02010255|917739|P3|Overall Study|Lack of Efficacy|2
274802|NCT02010255|917740|P2|Overall Study|Lack of Efficacy|1
274803|NCT02010255|917741|P1|Overall Study|Lack of Efficacy|4
274804|NCT02010255|917728|P14|Overall Study|Death|0
274805|NCT02010255|917729|P13|Overall Study|Death|0
274806|NCT02010255|917730|P12|Overall Study|Death|1
274807|NCT02010255|917731|P11|Overall Study|Death|1
274808|NCT02010255|917732|P10|Overall Study|Death|0
274809|NCT02010255|917733|P9|Overall Study|Death|1
274810|NCT02010255|917734|P8|Overall Study|Death|1
274811|NCT02010255|917735|P7|Overall Study|Death|1
274812|NCT02010255|917736|P6|Overall Study|Death|0
274813|NCT02010255|917737|P5|Overall Study|Death|2
274814|NCT02010255|917738|P4|Overall Study|Death|4
274815|NCT02010255|917739|P3|Overall Study|Death|4
274816|NCT02010255|917740|P2|Overall Study|Death|1
274817|NCT02010255|917741|P1|Overall Study|Death|0
274818|NCT02009878|918085|P3|Overall Study|Participant Met Withdrawal Criteria|0
274819|NCT02009878|918086|P2|Overall Study|Participant Met Withdrawal Criteria|1
274820|NCT02009878|918087|P1|Overall Study|Participant Met Withdrawal Criteria|0
274821|NCT02009865|918121|P2|Overall Study|Withdrawal by Subject|1
274822|NCT02009865|918122|P1|Overall Study|Withdrawal by Subject|1
274823|NCT02009865|918121|P2|Overall Study|Protocol Violation|2
274824|NCT02009865|918122|P1|Overall Study|Protocol Violation|0
274825|NCT02009865|918121|P2|Overall Study|Adverse Event|2
274826|NCT02009865|918122|P1|Overall Study|Adverse Event|0
274827|NCT02009722|918138|P2|Overall Study|Did not receive intervention|1
274828|NCT02009722|918139|P1|Overall Study|Did not receive intervention|0
274829|NCT02009722|918138|P2|Overall Study|Protocol Violation|2
274830|NCT02009722|918139|P1|Overall Study|Protocol Violation|1
274831|NCT02009696|918163|P1|Overall Study|Withdrawal by Subject|2
274832|NCT02009163|918171|P3|Randomized-withdrawal Period|Not specified|5
274833|NCT02009163|918172|P2|Randomized-withdrawal Period|Not specified|9
274834|NCT02009163|918173|P1|Randomized-withdrawal Period|Not specified|0
274835|NCT02009163|918171|P3|Randomized-withdrawal Period|Pregnancy|2
274836|NCT02009163|918172|P2|Randomized-withdrawal Period|Pregnancy|0
274837|NCT02009163|918173|P1|Randomized-withdrawal Period|Pregnancy|0
274838|NCT02009163|918171|P3|Randomized-withdrawal Period|Protocol Violation|2
274839|NCT02009163|918172|P2|Randomized-withdrawal Period|Protocol Violation|1
274840|NCT02009163|918173|P1|Randomized-withdrawal Period|Protocol Violation|0
274841|NCT02009163|918171|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
274842|NCT02009163|918172|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
274843|NCT02009163|918173|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
274844|NCT02009163|918171|P3|Randomized-withdrawal Period|Adverse Event|6
274845|NCT02009163|918172|P2|Randomized-withdrawal Period|Adverse Event|0
274846|NCT02009163|918173|P1|Randomized-withdrawal Period|Adverse Event|0
274847|NCT02009163|918171|P3|Randomized-withdrawal Period|Lost to Follow-up|6
274848|NCT02009163|918172|P2|Randomized-withdrawal Period|Lost to Follow-up|13
274849|NCT02009163|918173|P1|Randomized-withdrawal Period|Lost to Follow-up|0
274850|NCT02009163|918171|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
274851|NCT02009163|918172|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
274852|NCT02009163|918173|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
274853|NCT02009163|918171|P3|Open-label Period (Non-randomized)|Not specified|0
274854|NCT02009163|918172|P2|Open-label Period (Non-randomized)|Not specified|0
274855|NCT02009163|918173|P1|Open-label Period (Non-randomized)|Not specified|13
274856|NCT02009163|918171|P3|Open-label Period (Non-randomized)|Pregnancy|0
274857|NCT02009163|918172|P2|Open-label Period (Non-randomized)|Pregnancy|0
274858|NCT02009163|918173|P1|Open-label Period (Non-randomized)|Pregnancy|1
274859|NCT02009163|918171|P3|Open-label Period (Non-randomized)|Protocol Violation|0
274860|NCT02009163|918172|P2|Open-label Period (Non-randomized)|Protocol Violation|0
274861|NCT02009163|918173|P1|Open-label Period (Non-randomized)|Protocol Violation|10
274862|NCT02009163|918171|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
274863|NCT02009163|918172|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
274864|NCT02009163|918173|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
274865|NCT02009163|918171|P3|Open-label Period (Non-randomized)|Adverse Event|0
274866|NCT02009163|918172|P2|Open-label Period (Non-randomized)|Adverse Event|0
274867|NCT02009163|918173|P1|Open-label Period (Non-randomized)|Adverse Event|22
274868|NCT02009163|918171|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
274869|NCT02009163|918172|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
274870|NCT02009163|918173|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
274871|NCT02009163|918171|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
274872|NCT02009163|918172|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
274873|NCT02009163|918173|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
274874|NCT02008526|918250|P3|Overall Study|Lost to Follow-up|6
274875|NCT02008526|918251|P2|Overall Study|Lost to Follow-up|9
274876|NCT02008526|918252|P1|Overall Study|Lost to Follow-up|5
274877|NCT02008526|918250|P3|Overall Study|Withdrawal by Subject|2
274878|NCT02008526|918251|P2|Overall Study|Withdrawal by Subject|3
274879|NCT02008526|918252|P1|Overall Study|Withdrawal by Subject|3
274880|NCT02008526|918250|P3|Overall Study|Death|1
274881|NCT02008526|918251|P2|Overall Study|Death|2
274882|NCT02008526|918252|P1|Overall Study|Death|0
274883|NCT02008227|918265|P2|Overall Study|Ongoing Survival Follow-up|106
274884|NCT02008227|918266|P1|Overall Study|Ongoing Survival Follow-up|135
274885|NCT02008227|918265|P2|Overall Study|Ongoing on Study Treatment|85
274886|NCT02008227|918266|P1|Overall Study|Ongoing on Study Treatment|4
274887|NCT02008227|918265|P2|Overall Study|Withdrawal by Subject|34
274888|NCT02008227|918266|P1|Overall Study|Withdrawal by Subject|63
274889|NCT02008227|918265|P2|Overall Study|Death|383
274890|NCT02008227|918266|P1|Overall Study|Death|407
274891|NCT02008227|918265|P2|Overall Study|Lost to Follow-up|5
274892|NCT02008227|918266|P1|Overall Study|Lost to Follow-up|3
274893|NCT02007954|918327|P1|Overall Study|Death|1
274894|NCT02007954|918327|P1|Overall Study|Disease progression and unrelated AE|1
274895|NCT02007954|918327|P1|Overall Study|Switch in treatment modality|2
274896|NCT02007954|918327|P1|Overall Study|Received liver transplant|3
274897|NCT02007577|918346|P2|Overall Study|Withdrawal by Subject|1
274898|NCT02007577|918347|P1|Overall Study|Withdrawal by Subject|0
274899|NCT02007577|918346|P2|Overall Study|Adverse Event|0
274900|NCT02007577|918347|P1|Overall Study|Adverse Event|1
274901|NCT02007512|918359|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
274902|NCT02007512|918360|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
274903|NCT02007512|918361|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
274904|NCT02007512|918362|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
274905|NCT02007512|918359|P4|Open Label Treatment Period|Disease progression|11
274906|NCT02007512|918360|P3|Open Label Treatment Period|Disease progression|0
274907|NCT02007512|918361|P2|Open Label Treatment Period|Disease progression|17
274908|NCT02007512|918362|P1|Open Label Treatment Period|Disease progression|0
274909|NCT02007512|918359|P4|Open Label Treatment Period|Other|1
274910|NCT02007512|918360|P3|Open Label Treatment Period|Other|0
274911|NCT02007512|918361|P2|Open Label Treatment Period|Other|0
274912|NCT02007512|918362|P1|Open Label Treatment Period|Other|0
274913|NCT02007512|918359|P4|Open Label Treatment Period|Adverse Event|0
274914|NCT02007512|918360|P3|Open Label Treatment Period|Adverse Event|0
274915|NCT02007512|918361|P2|Open Label Treatment Period|Adverse Event|1
274916|NCT02007512|918362|P1|Open Label Treatment Period|Adverse Event|0
274917|NCT02007512|918359|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
274918|NCT02007512|918360|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
274919|NCT02007512|918361|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
274920|NCT02007512|918362|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
274921|NCT02007512|918359|P4|Double Blind Treatment Period|Other|2
274922|NCT02007512|918360|P3|Double Blind Treatment Period|Other|1
274923|NCT02007512|918361|P2|Double Blind Treatment Period|Other|0
274924|NCT02007512|918362|P1|Double Blind Treatment Period|Other|0
274925|NCT02007512|918359|P4|Double Blind Treatment Period|Protocol Violation|1
274926|NCT02007512|918360|P3|Double Blind Treatment Period|Protocol Violation|0
274927|NCT02007512|918361|P2|Double Blind Treatment Period|Protocol Violation|0
274928|NCT02007512|918362|P1|Double Blind Treatment Period|Protocol Violation|0
274929|NCT02007512|918359|P4|Double Blind Treatment Period|Withdrawal by Subject|3
274930|NCT02007512|918360|P3|Double Blind Treatment Period|Withdrawal by Subject|3
274931|NCT02007512|918361|P2|Double Blind Treatment Period|Withdrawal by Subject|2
274932|NCT02007512|918362|P1|Double Blind Treatment Period|Withdrawal by Subject|4
274933|NCT02007512|918359|P4|Double Blind Treatment Period|Disease progression|51
274934|NCT02007512|918360|P3|Double Blind Treatment Period|Disease progression|45
274935|NCT02007512|918361|P2|Double Blind Treatment Period|Disease progression|49
274936|NCT02007512|918362|P1|Double Blind Treatment Period|Disease progression|44
274937|NCT02007512|918359|P4|Double Blind Treatment Period|Death|0
274938|NCT02007512|918360|P3|Double Blind Treatment Period|Death|0
274939|NCT02007512|918361|P2|Double Blind Treatment Period|Death|0
274940|NCT02007512|918362|P1|Double Blind Treatment Period|Death|1
274941|NCT02007512|918359|P4|Double Blind Treatment Period|Adverse Event|2
274942|NCT02007512|918360|P3|Double Blind Treatment Period|Adverse Event|6
274943|NCT02007512|918361|P2|Double Blind Treatment Period|Adverse Event|2
274944|NCT02007512|918362|P1|Double Blind Treatment Period|Adverse Event|4
274945|NCT02007434|918432|P8|Overall Study|Non-compliance|0
274946|NCT02007434|918433|P7|Overall Study|Non-compliance|0
274947|NCT02007434|918434|P6|Overall Study|Non-compliance|0
274948|NCT02007434|918435|P5|Overall Study|Non-compliance|0
274949|NCT02007434|918436|P4|Overall Study|Non-compliance|0
274950|NCT02007434|918437|P3|Overall Study|Non-compliance|1
274951|NCT02007434|918438|P2|Overall Study|Non-compliance|0
274952|NCT02007434|918439|P1|Overall Study|Non-compliance|1
274953|NCT02007434|918432|P8|Overall Study|Lost to Follow-up|0
274954|NCT02007434|918433|P7|Overall Study|Lost to Follow-up|0
274955|NCT02007434|918434|P6|Overall Study|Lost to Follow-up|0
274956|NCT02007434|918435|P5|Overall Study|Lost to Follow-up|0
274957|NCT02007434|918436|P4|Overall Study|Lost to Follow-up|0
274958|NCT02007434|918437|P3|Overall Study|Lost to Follow-up|0
274959|NCT02007434|918438|P2|Overall Study|Lost to Follow-up|1
274960|NCT02007434|918439|P1|Overall Study|Lost to Follow-up|0
274961|NCT02007278|918570|P2|Overall Study|Mis-randomization|1
274962|NCT02007278|918571|P1|Overall Study|Mis-randomization|1
274963|NCT02007278|918570|P2|Overall Study|Incorrect medication administration|0
274964|NCT02007278|918571|P1|Overall Study|Incorrect medication administration|1
274965|NCT02007278|918570|P2|Overall Study|Ingestion of drugs not allowed in study|1
274966|NCT02007278|918571|P1|Overall Study|Ingestion of drugs not allowed in study|0
274967|NCT02007278|918570|P2|Overall Study|Failure to comply with an eligibility|1
274968|NCT02007278|918571|P1|Overall Study|Failure to comply with an eligibility|0
274969|NCT02007252|918593|P2|Overall Study|Adverse Event|4
274970|NCT02007252|918594|P1|Overall Study|Adverse Event|7
274971|NCT02007252|918593|P2|Overall Study|Abnormal laboratory value(s)|0
274972|NCT02007252|918594|P1|Overall Study|Abnormal laboratory value(s)|1
274973|NCT02007252|918593|P2|Overall Study|Administrative problems|7
274974|NCT02007252|918594|P1|Overall Study|Administrative problems|3
274975|NCT02007096|918609|P2|Overall Study|no mesh placed|1
274976|NCT02007096|918610|P1|Overall Study|no mesh placed|0
274977|NCT02007096|918609|P2|Overall Study|converted to open surgery|1
274978|NCT02007096|918610|P1|Overall Study|converted to open surgery|1
274979|NCT02007096|918609|P2|Overall Study|did not follow postoperative protocol|11
274980|NCT02007096|918610|P1|Overall Study|did not follow postoperative protocol|8
274981|NCT02007096|918609|P2|Overall Study|did not inject saline|3
274982|NCT02007096|918610|P1|Overall Study|did not inject saline|0
274983|NCT02007096|918609|P2|Overall Study|medication not available|0
274984|NCT02007096|918610|P1|Overall Study|medication not available|2
274985|NCT02007070|918622|P1|Overall Study|Progressive Disease|21
274986|NCT02007070|918622|P1|Overall Study|Physician Decision|1
274987|NCT02007070|918622|P1|Overall Study|Protocol Violation|2
274988|NCT02007070|918622|P1|Overall Study|Death|1
274989|NCT02007070|918622|P1|Overall Study|Clinical Progression|4
274990|NCT02007070|918622|P1|Overall Study|Adverse Event|4
274991|NCT02006732|918679|P4|Overall Study|Withdrawal by Subject|1
274992|NCT02006732|918680|P3|Overall Study|Withdrawal by Subject|4
274993|NCT02006732|918681|P2|Overall Study|Withdrawal by Subject|0
274994|NCT02006732|918682|P1|Overall Study|Withdrawal by Subject|3
274995|NCT02006732|918679|P4|Overall Study|Lost to Follow-up|0
274996|NCT02006732|918680|P3|Overall Study|Lost to Follow-up|0
274997|NCT02006732|918681|P2|Overall Study|Lost to Follow-up|1
274998|NCT02006732|918682|P1|Overall Study|Lost to Follow-up|0
274999|NCT02006732|918679|P4|Overall Study|Protocol Violation|0
275000|NCT02006732|918680|P3|Overall Study|Protocol Violation|0
275001|NCT02006732|918681|P2|Overall Study|Protocol Violation|1
275002|NCT02006732|918682|P1|Overall Study|Protocol Violation|1
275003|NCT02006732|918679|P4|Overall Study|Lack of Efficacy|1
275004|NCT02006732|918680|P3|Overall Study|Lack of Efficacy|1
275005|NCT02006732|918681|P2|Overall Study|Lack of Efficacy|3
275006|NCT02006732|918682|P1|Overall Study|Lack of Efficacy|6
275007|NCT02006732|918679|P4|Overall Study|Adverse Event|2
275008|NCT02006732|918680|P3|Overall Study|Adverse Event|4
275009|NCT02006732|918681|P2|Overall Study|Adverse Event|7
275010|NCT02006732|918682|P1|Overall Study|Adverse Event|10
275011|NCT02006719|918722|P2|Overall Study|Other/Unknown|1
275012|NCT02006719|918723|P1|Overall Study|Other/Unknown|0
275013|NCT02006719|918722|P2|Overall Study|Adverse Event|1
275014|NCT02006719|918723|P1|Overall Study|Adverse Event|1
275015|NCT02006719|918722|P2|Overall Study|Protocol Violation|0
275016|NCT02006719|918723|P1|Overall Study|Protocol Violation|2
275017|NCT02006719|918722|P2|Overall Study|Lost to Follow-up|1
275018|NCT02006719|918723|P1|Overall Study|Lost to Follow-up|5
275019|NCT02006719|918722|P2|Overall Study|Withdrawal by Subject|2
275020|NCT02006719|918723|P1|Overall Study|Withdrawal by Subject|10
275021|NCT02006706|918753|P1|Overall Study|Lost to Follow-up|1
275022|NCT02006667|918758|P1|Overall Study|Withdrawal by Subject|1
275023|NCT02006667|918758|P1|Overall Study|Death|2
275024|NCT02006667|918758|P1|Overall Study|Adverse Event|3
275025|NCT02006654|918770|P2|Overall Study|moving out of state|1
275026|NCT02006654|918771|P1|Overall Study|moving out of state|0
275027|NCT02006654|918770|P2|Overall Study|disallowed medication|0
275028|NCT02006654|918771|P1|Overall Study|disallowed medication|1
275029|NCT02006654|918770|P2|Overall Study|mood disorder|1
275030|NCT02006654|918771|P1|Overall Study|mood disorder|0
275031|NCT02006654|918770|P2|Overall Study|faecal incontinence|1
275032|NCT02006654|918771|P1|Overall Study|faecal incontinence|0
275033|NCT02006654|918770|P2|Overall Study|worsening cognitive condition|1
275034|NCT02006654|918771|P1|Overall Study|worsening cognitive condition|0
275035|NCT02006654|918770|P2|Overall Study|insufficient compliance|0
275036|NCT02006654|918771|P1|Overall Study|insufficient compliance|1
275037|NCT02006654|918770|P2|Overall Study|patient's will|1
275038|NCT02006654|918771|P1|Overall Study|patient's will|2
275039|NCT02006654|918770|P2|Overall Study|Lost to Follow-up|0
275040|NCT02006654|918771|P1|Overall Study|Lost to Follow-up|1
275041|NCT02006654|918770|P2|Overall Study|Protocol Violation|8
275042|NCT02006654|918771|P1|Overall Study|Protocol Violation|5
275043|NCT02006654|918770|P2|Overall Study|Withdrawal by Subject|12
275044|NCT02006654|918771|P1|Overall Study|Withdrawal by Subject|14
275045|NCT02006654|918770|P2|Overall Study|Death|0
275046|NCT02006654|918771|P1|Overall Study|Death|1
275047|NCT02006654|918770|P2|Overall Study|Adverse Event|17
275048|NCT02006654|918771|P1|Overall Study|Adverse Event|16
275049|NCT02006654|918770|P2|Overall Study|Withdrawal before treatment|2
275050|NCT02006654|918771|P1|Overall Study|Withdrawal before treatment|4
275051|NCT02006641|918800|P3|Overall Study|Other reason: protocol non-compliance|1
275052|NCT02006641|918801|P2|Overall Study|Other reason: protocol non-compliance|0
275053|NCT02006641|918802|P1|Overall Study|Other reason: protocol non-compliance|0
275054|NCT02006641|918800|P3|Overall Study|Other reason: caregiver impossibility|1
275055|NCT02006641|918801|P2|Overall Study|Other reason: caregiver impossibility|0
275056|NCT02006641|918802|P1|Overall Study|Other reason: caregiver impossibility|0
275057|NCT02006641|918800|P3|Overall Study|Other reason: hospitalisation|0
275058|NCT02006641|918801|P2|Overall Study|Other reason: hospitalisation|1
275059|NCT02006641|918802|P1|Overall Study|Other reason: hospitalisation|0
275060|NCT02006641|918800|P3|Overall Study|Other reason: patient's wife has died|1
275061|NCT02006641|918801|P2|Overall Study|Other reason: patient's wife has died|0
275062|NCT02006641|918802|P1|Overall Study|Other reason: patient's wife has died|0
275063|NCT02006641|918800|P3|Overall Study|Other reason: caregiver in hospital|0
275064|NCT02006641|918801|P2|Overall Study|Other reason: caregiver in hospital|1
275065|NCT02006641|918802|P1|Overall Study|Other reason: caregiver in hospital|0
275066|NCT02006641|918800|P3|Overall Study|Other reason: patient has moved|1
275067|NCT02006641|918801|P2|Overall Study|Other reason: patient has moved|0
275068|NCT02006641|918802|P1|Overall Study|Other reason: patient has moved|1
275069|NCT02006641|918800|P3|Overall Study|Other reason:patient didn't want to come|1
275070|NCT02006641|918801|P2|Overall Study|Other reason:patient didn't want to come|0
275071|NCT02006641|918802|P1|Overall Study|Other reason:patient didn't want to come|0
275072|NCT02006641|918800|P3|Overall Study|Other reason: patient didn't show up|0
275073|NCT02006641|918801|P2|Overall Study|Other reason: patient didn't show up|0
275074|NCT02006641|918802|P1|Overall Study|Other reason: patient didn't show up|1
275075|NCT02006641|918800|P3|Overall Study|Withdrawal by Subject|11
275076|NCT02006641|918801|P2|Overall Study|Withdrawal by Subject|12
275077|NCT02006641|918802|P1|Overall Study|Withdrawal by Subject|7
275078|NCT02006641|918800|P3|Overall Study|Lost to Follow-up|0
275079|NCT02006641|918801|P2|Overall Study|Lost to Follow-up|1
275080|NCT02006641|918802|P1|Overall Study|Lost to Follow-up|0
275081|NCT02006641|918800|P3|Overall Study|Protocol Violation|2
275082|NCT02006641|918801|P2|Overall Study|Protocol Violation|2
275083|NCT02006641|918802|P1|Overall Study|Protocol Violation|0
275084|NCT02006641|918800|P3|Overall Study|Adverse Event|15
275085|NCT02006641|918801|P2|Overall Study|Adverse Event|11
275086|NCT02006641|918802|P1|Overall Study|Adverse Event|15
275087|NCT02006641|918800|P3|Overall Study|Withdrawal before treatment|3
275088|NCT02006641|918801|P2|Overall Study|Withdrawal before treatment|5
275089|NCT02006641|918802|P1|Overall Study|Withdrawal before treatment|2
275090|NCT02005692|918868|P1|Overall Study|Discharged earlier than anticipated|5
275091|NCT02005692|918868|P1|Overall Study|Withdrawal by Subject|1
275092|NCT02005692|918868|P1|Overall Study|Protocol Violation|1
275093|NCT02005562|918888|P2|Overall Study|Physician Decision|1
275094|NCT02005562|918889|P1|Overall Study|Physician Decision|0
275095|NCT02005562|918888|P2|Overall Study|No transplant|4
275096|NCT02005562|918889|P1|Overall Study|No transplant|1
275097|NCT02005562|918888|P2|Overall Study|Withdrawal by Subject|2
275098|NCT02005562|918889|P1|Overall Study|Withdrawal by Subject|2
275099|NCT02005562|918888|P2|Overall Study|Graft loss|6
275100|NCT02005562|918889|P1|Overall Study|Graft loss|7
275101|NCT02005562|918888|P2|Overall Study|Death|2
275102|NCT02005562|918889|P1|Overall Study|Death|2
275103|NCT02005484|918931|P1|Overall Study|Sponsor decision|1
275104|NCT02005484|918931|P1|Overall Study|Changed to a Different Study|1
275105|NCT02005484|918931|P1|Overall Study|Disease progression|1
275106|NCT02005484|918931|P1|Overall Study|Death|1
275107|NCT02005211|918952|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
275108|NCT02005211|918953|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
275109|NCT02005211|918954|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
275110|NCT02005211|918955|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
275111|NCT02005211|918956|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
275112|NCT02005211|918957|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
275113|NCT02005211|918958|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
275114|NCT02005029|918993|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
275115|NCT02005029|918994|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
275116|NCT02004886|919046|P4|Overall Study|Unable to attend future visits|0
275117|NCT02004886|919047|P3|Overall Study|Unable to attend future visits|0
275118|NCT02004886|919048|P2|Overall Study|Unable to attend future visits|0
275119|NCT02004886|919049|P1|Overall Study|Unable to attend future visits|1
275120|NCT02004886|919046|P4|Overall Study|Adverse Event|0
275121|NCT02004886|919047|P3|Overall Study|Adverse Event|0
275122|NCT02004886|919048|P2|Overall Study|Adverse Event|1
275123|NCT02004886|919049|P1|Overall Study|Adverse Event|0
275124|NCT02004873|919099|P1|Overall Study|Withdrawal by Subject|1
275125|NCT02004873|919099|P1|Overall Study|Death|23
275126|NCT02004873|919099|P1|Overall Study|Missed 6-month visit|4
275127|NCT02004873|919099|P1|Overall Study|Awaiting 6-month visit|390
275128|NCT02004873|919099|P1|Overall Study|Implant unsuccessful|6
275129|NCT02004847|919108|P2|Overall Study|Protocol Violation|1
275130|NCT02004847|919109|P1|Overall Study|Protocol Violation|1
275131|NCT02004262|919159|P6|Overall Study|Study Terminated by Sponsor|5
275132|NCT02004262|919160|P5|Overall Study|Study Terminated by Sponsor|1
275133|NCT02004262|919161|P4|Overall Study|Study Terminated by Sponsor|1
275134|NCT02004262|919162|P3|Overall Study|Study Terminated by Sponsor|2
275135|NCT02004262|919163|P2|Overall Study|Study Terminated by Sponsor|3
275136|NCT02004262|919164|P1|Overall Study|Study Terminated by Sponsor|4
275137|NCT02004262|919159|P6|Overall Study|Lost to Follow-up|0
275138|NCT02004262|919160|P5|Overall Study|Lost to Follow-up|0
275139|NCT02004262|919161|P4|Overall Study|Lost to Follow-up|0
275140|NCT02004262|919162|P3|Overall Study|Lost to Follow-up|0
275141|NCT02004262|919163|P2|Overall Study|Lost to Follow-up|1
275142|NCT02004262|919164|P1|Overall Study|Lost to Follow-up|1
275143|NCT02004262|919159|P6|Overall Study|Withdrawal by Subject|3
275144|NCT02004262|919160|P5|Overall Study|Withdrawal by Subject|1
275145|NCT02004262|919161|P4|Overall Study|Withdrawal by Subject|0
275146|NCT02004262|919162|P3|Overall Study|Withdrawal by Subject|4
275147|NCT02004262|919163|P2|Overall Study|Withdrawal by Subject|0
275148|NCT02004262|919164|P1|Overall Study|Withdrawal by Subject|1
275149|NCT02004262|919159|P6|Overall Study|Death|22
275150|NCT02004262|919160|P5|Overall Study|Death|29
275151|NCT02004262|919161|P4|Overall Study|Death|28
275152|NCT02004262|919162|P3|Overall Study|Death|66
275153|NCT02004262|919163|P2|Overall Study|Death|64
275154|NCT02004262|919164|P1|Overall Study|Death|67
275155|NCT02004236|919184|P3|Overall Study|Lack of Efficacy|16
275156|NCT02004236|919185|P2|Overall Study|Lack of Efficacy|0
275157|NCT02004236|919186|P1|Overall Study|Lack of Efficacy|0
275158|NCT02004093|919246|P2|Overall Study|Not specified|1
275159|NCT02004093|919247|P1|Overall Study|Not specified|3
275160|NCT02004093|919246|P2|Overall Study|Withdrawal by Subject|7
275161|NCT02004093|919247|P1|Overall Study|Withdrawal by Subject|3
275162|NCT02004093|919246|P2|Overall Study|Lost to Follow-up|1
275163|NCT02004093|919247|P1|Overall Study|Lost to Follow-up|0
275164|NCT02004093|919246|P2|Overall Study|Protocol Violation|1
275165|NCT02004093|919247|P1|Overall Study|Protocol Violation|0
275166|NCT02004093|919246|P2|Overall Study|Lack of Efficacy|62
275167|NCT02004093|919247|P1|Overall Study|Lack of Efficacy|66
275168|NCT02004093|919246|P2|Overall Study|Death|1
275169|NCT02004093|919247|P1|Overall Study|Death|2
275170|NCT02003963|919279|P2|Overall Study|Lost to Follow-up|1
275171|NCT02003963|919280|P1|Overall Study|Lost to Follow-up|2
275172|NCT02003638|919302|P2|Overall Study|Withdrawal by Subject|0
275173|NCT02003638|919303|P1|Overall Study|Withdrawal by Subject|1
275174|NCT02003534|919309|P1|Overall Study|Lost to Follow-up|47
275175|NCT02003391|919321|P2|Overall Study|Adverse Event|0
275176|NCT02003391|919322|P1|Overall Study|Adverse Event|1
275177|NCT02003391|919321|P2|Overall Study|Protocol Violation|1
275178|NCT02003391|919322|P1|Overall Study|Protocol Violation|0
275179|NCT02003391|919321|P2|Overall Study|Withdrawal by Subject|1
275180|NCT02003391|919322|P1|Overall Study|Withdrawal by Subject|2
275181|NCT02003365|919335|P3|Overall Study|Lost to Follow-up|1
275182|NCT02003365|919336|P2|Overall Study|Lost to Follow-up|0
275183|NCT02003365|919337|P1|Overall Study|Lost to Follow-up|0
275184|NCT02003014|919361|P1|Overall Study|Investigator's transfer|4
275185|NCT02003014|919361|P1|Overall Study|Patient did not visit the study site|5
275186|NCT02003014|919361|P1|Overall Study|Treatment started after contract period|1
275187|NCT02003014|919361|P1|Overall Study|Case report forms uncollected|9
275188|NCT02002689|919443|P1|Overall Study|Adverse Event|3
275189|NCT02002689|919443|P1|Overall Study|Disease Progression|7
275190|NCT02002533|919462|P2|Overall Study|Lost to Follow-up|1
275191|NCT02002533|919463|P1|Overall Study|Lost to Follow-up|0
275192|NCT02002533|919462|P2|Overall Study|Adverse Event|3
275193|NCT02002533|919463|P1|Overall Study|Adverse Event|0
275194|NCT02002533|919462|P2|Overall Study|Protocol Violation|1
275195|NCT02002533|919463|P1|Overall Study|Protocol Violation|0
275196|NCT02002533|919462|P2|Overall Study|Withdrawal by Subject|13
275197|NCT02002533|919463|P1|Overall Study|Withdrawal by Subject|6
275198|NCT02002221|919488|P2|Overall Study|Patient withdrew consent|1
275199|NCT02002221|919489|P1|Overall Study|Patient withdrew consent|0
275200|NCT02002221|919488|P2|Overall Study|Unsatisfactory therapeutic effect|1
275201|NCT02002221|919489|P1|Overall Study|Unsatisfactory therapeutic effect|0
275202|NCT02002221|919488|P2|Overall Study|Adverse Event|1
275203|NCT02002221|919489|P1|Overall Study|Adverse Event|2
275204|NCT02001181|919525|P2|Overall Study|Withdrawal by Subject|1
275205|NCT02001181|919526|P1|Overall Study|Withdrawal by Subject|0
275206|NCT02001181|919525|P2|Overall Study|Lost to Follow-up|0
275207|NCT02001181|919526|P1|Overall Study|Lost to Follow-up|1
275208|NCT02001181|919525|P2|Overall Study|Adverse Event|2
275209|NCT02001181|919526|P1|Overall Study|Adverse Event|0
275210|NCT02001051|919542|P2|Overall Study|Deemed not eligible following enrollment|1
275211|NCT02001051|919543|P1|Overall Study|Deemed not eligible following enrollment|0
275212|NCT02000921|919595|P3|Overall Study|Physician Decision|0
275213|NCT02000921|919596|P2|Overall Study|Physician Decision|2
275214|NCT02000921|919597|P1|Overall Study|Physician Decision|0
275215|NCT02000921|919595|P3|Overall Study|Lost to Follow-up|5
275216|NCT02000921|919596|P2|Overall Study|Lost to Follow-up|4
275217|NCT02000921|919597|P1|Overall Study|Lost to Follow-up|2
275218|NCT02000921|919595|P3|Overall Study|Withdrawal by Subject|5
275219|NCT02000921|919596|P2|Overall Study|Withdrawal by Subject|10
275220|NCT02000921|919597|P1|Overall Study|Withdrawal by Subject|3
275221|NCT02000752|919616|P2|Overall Study|Shift Changes|5
275222|NCT02000752|919617|P1|Overall Study|Shift Changes|12
275223|NCT02000752|919616|P2|Overall Study|Dystocic delivery|8
275224|NCT02000752|919617|P1|Overall Study|Dystocic delivery|19
275225|NCT02000622|919631|P2|Overall Study|Withdrawal by Subject|7
275226|NCT02000622|919632|P1|Overall Study|Withdrawal by Subject|5
275227|NCT02000622|919631|P2|Overall Study|Death|46
275228|NCT02000622|919632|P1|Overall Study|Death|94
275229|NCT02000622|919631|P2|Overall Study|Lost to Follow-up|0
275230|NCT02000622|919632|P1|Overall Study|Lost to Follow-up|1
275231|NCT02000622|919631|P2|Overall Study|Withdrawn due to site closure|0
275232|NCT02000622|919632|P1|Overall Study|Withdrawn due to site closure|1
275233|NCT02000531|919654|P2|Overall Study|Discontinued due to data cut-off|8
275234|NCT02000531|919655|P1|Overall Study|Discontinued due to data cut-off|3
275235|NCT02000531|919654|P2|Overall Study|Lost to Follow-up|0
275236|NCT02000531|919655|P1|Overall Study|Lost to Follow-up|1
275237|NCT02000440|919663|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
275238|NCT02000440|919663|P1|Overall Study|Adverse Event|3
275239|NCT02000427|919683|P1|Overall Study|Death|22
275240|NCT01999894|919740|P1|Overall Study|Inclusion/exclusion criteria not met|1
275241|NCT01999894|919740|P1|Overall Study|Other Reason|3
275242|NCT01999894|919740|P1|Overall Study|Lost to Follow-up|10
275243|NCT01999894|919740|P1|Overall Study|Withdrawal by Subject|7
275244|NCT01999894|919740|P1|Overall Study|Protocol Violation|1
275245|NCT01999894|919740|P1|Overall Study|Lack of Efficacy|5
275246|NCT01999894|919740|P1|Overall Study|Adverse Event|9
275247|NCT01999322|919782|P2|Overall Study|Adverse Event|0
275248|NCT01999322|919783|P1|Overall Study|Adverse Event|1
275249|NCT01999218|919835|P3|Overall Study|Treated but excluded at 1 trial site|2
275250|NCT01999218|919836|P2|Overall Study|Treated but excluded at 1 trial site|5
275251|NCT01999218|919837|P1|Overall Study|Treated but excluded at 1 trial site|3
275252|NCT01999218|919835|P3|Overall Study|Adverse Event|7
275253|NCT01999218|919836|P2|Overall Study|Adverse Event|7
275254|NCT01999218|919837|P1|Overall Study|Adverse Event|9
275255|NCT01999218|919835|P3|Overall Study|Excluded Medication|2
275256|NCT01999218|919836|P2|Overall Study|Excluded Medication|1
275257|NCT01999218|919837|P1|Overall Study|Excluded Medication|1
275258|NCT01999218|919835|P3|Overall Study|Death|2
275259|NCT01999218|919836|P2|Overall Study|Death|1
275260|NCT01999218|919837|P1|Overall Study|Death|7
275261|NCT01999218|919835|P3|Overall Study|Creatinine/eGFR|1
275262|NCT01999218|919836|P2|Overall Study|Creatinine/eGFR|0
275263|NCT01999218|919837|P1|Overall Study|Creatinine/eGFR|0
275264|NCT01999218|919835|P3|Overall Study|Withdrawal by Subject|34
275265|NCT01999218|919836|P2|Overall Study|Withdrawal by Subject|29
275266|NCT01999218|919837|P1|Overall Study|Withdrawal by Subject|28
275267|NCT01999218|919835|P3|Overall Study|Participant moves|3
275268|NCT01999218|919836|P2|Overall Study|Participant moves|5
275269|NCT01999218|919837|P1|Overall Study|Participant moves|2
275270|NCT01999218|919835|P3|Overall Study|Study Terminated By Sponsor|12
275271|NCT01999218|919836|P2|Overall Study|Study Terminated By Sponsor|5
275272|NCT01999218|919837|P1|Overall Study|Study Terminated By Sponsor|7
275273|NCT01999218|919835|P3|Overall Study|Screen failure|0
275274|NCT01999218|919836|P2|Overall Study|Screen failure|1
275275|NCT01999218|919837|P1|Overall Study|Screen failure|0
275276|NCT01999218|919835|P3|Overall Study|Protocol Violation|4
275277|NCT01999218|919836|P2|Overall Study|Protocol Violation|5
275278|NCT01999218|919837|P1|Overall Study|Protocol Violation|4
275279|NCT01999218|919835|P3|Overall Study|Physician Decision|6
275280|NCT01999218|919836|P2|Overall Study|Physician Decision|4
275281|NCT01999218|919837|P1|Overall Study|Physician Decision|1
275282|NCT01999218|919835|P3|Overall Study|Non-Compliance With Study Drug|1
275283|NCT01999218|919836|P2|Overall Study|Non-Compliance With Study Drug|4
275284|NCT01999218|919837|P1|Overall Study|Non-Compliance With Study Drug|6
275285|NCT01999218|919835|P3|Overall Study|Lost to Follow-up|18
275286|NCT01999218|919836|P2|Overall Study|Lost to Follow-up|17
275287|NCT01999218|919837|P1|Overall Study|Lost to Follow-up|22
275288|NCT01999218|919835|P3|Overall Study|Lack of Efficacy|1
275289|NCT01999218|919836|P2|Overall Study|Lack of Efficacy|0
275290|NCT01999218|919837|P1|Overall Study|Lack of Efficacy|1
275291|NCT01999218|919835|P3|Overall Study|Hyperglycemia|17
275292|NCT01999218|919836|P2|Overall Study|Hyperglycemia|17
275293|NCT01999218|919837|P1|Overall Study|Hyperglycemia|18
275294|NCT01998919|919879|P2|Overall Study|Not specified|2
275295|NCT01998919|919880|P1|Overall Study|Not specified|5
275296|NCT01998919|919879|P2|Overall Study|Lost to Follow-up|0
275297|NCT01998919|919880|P1|Overall Study|Lost to Follow-up|2
275298|NCT01998919|919879|P2|Overall Study|Withdrawal by Subject|4
275299|NCT01998919|919880|P1|Overall Study|Withdrawal by Subject|2
275300|NCT01998919|919879|P2|Overall Study|Disease progression|22
275301|NCT01998919|919880|P1|Overall Study|Disease progression|31
275302|NCT01998919|919879|P2|Overall Study|Adverse Event|5
275303|NCT01998919|919880|P1|Overall Study|Adverse Event|0
275304|NCT01998919|919879|P2|Overall Study|Death|2
275305|NCT01998919|919880|P1|Overall Study|Death|2
275306|NCT01998906|919901|P3|Overall Study|Not specified|4
275307|NCT01998906|919902|P2|Overall Study|Not specified|8
275308|NCT01998906|919903|P1|Overall Study|Not specified|3
275309|NCT01998906|919901|P3|Overall Study|Administrative/Other|3
275310|NCT01998906|919902|P2|Overall Study|Administrative/Other|1
275311|NCT01998906|919903|P1|Overall Study|Administrative/Other|2
275312|NCT01998906|919901|P3|Overall Study|Withdrawal by Subject|3
275313|NCT01998906|919902|P2|Overall Study|Withdrawal by Subject|4
275314|NCT01998906|919903|P1|Overall Study|Withdrawal by Subject|1
275315|NCT01998906|919901|P3|Overall Study|Violation of Selection Criteria|1
275316|NCT01998906|919902|P2|Overall Study|Violation of Selection Criteria|0
275317|NCT01998906|919903|P1|Overall Study|Violation of Selection Criteria|0
275318|NCT01998906|919901|P3|Overall Study|Failure to return|4
275319|NCT01998906|919902|P2|Overall Study|Failure to return|2
275320|NCT01998906|919903|P1|Overall Study|Failure to return|0
275321|NCT01998906|919901|P3|Overall Study|Lack of Efficacy|8
275322|NCT01998906|919902|P2|Overall Study|Lack of Efficacy|9
275323|NCT01998906|919903|P1|Overall Study|Lack of Efficacy|10
275324|NCT01998906|919901|P3|Overall Study|Death|17
275325|NCT01998906|919902|P2|Overall Study|Death|30
275326|NCT01998906|919903|P1|Overall Study|Death|21
275327|NCT01998906|919901|P3|Overall Study|Participants ongoing in follow−up|58
275328|NCT01998906|919902|P2|Overall Study|Participants ongoing in follow−up|60
275329|NCT01998906|919903|P1|Overall Study|Participants ongoing in follow−up|77
275330|NCT01998893|919947|P1|Overall Study|Transformation to high-grade lymphoma|1
275331|NCT01998893|919947|P1|Overall Study|Withdrawal by Subject|1
275332|NCT01998893|919947|P1|Overall Study|Protocol Violation|2
275333|NCT01998893|919947|P1|Overall Study|Physician Decision|2
275334|NCT01998893|919947|P1|Overall Study|Lost to Follow-up|8
275335|NCT01998893|919947|P1|Overall Study|Death|1
275336|NCT01998893|919947|P1|Overall Study|Adverse Event|2
275337|NCT01998880|919959|P2|Overall Study|Violation of Selection Criteria at Entry|1
275338|NCT01998880|919960|P1|Overall Study|Violation of Selection Criteria at Entry|1
275339|NCT01998880|919959|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
275340|NCT01998880|919960|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
275341|NCT01998880|919959|P2|Overall Study|Other Protocol Violation|1
275342|NCT01998880|919960|P1|Overall Study|Other Protocol Violation|0
275343|NCT01998880|919959|P2|Overall Study|Administrative/Other|1
275344|NCT01998880|919960|P1|Overall Study|Administrative/Other|3
275345|NCT01998880|919959|P2|Overall Study|Insufficient Therapeutic Response|5
275346|NCT01998880|919960|P1|Overall Study|Insufficient Therapeutic Response|1
275347|NCT01998880|919959|P2|Overall Study|Death|6
275348|NCT01998880|919960|P1|Overall Study|Death|3
275349|NCT01998880|919959|P2|Overall Study|Withdrew Consent|2
275350|NCT01998880|919960|P1|Overall Study|Withdrew Consent|2
275351|NCT01998880|919959|P2|Overall Study|Progression of Disease|8
275352|NCT01998880|919960|P1|Overall Study|Progression of Disease|2
275353|NCT01998880|919959|P2|Overall Study|Adverse Events or Intercurrent Illness|16
275354|NCT01998880|919960|P1|Overall Study|Adverse Events or Intercurrent Illness|16
275355|NCT01998737|919978|P2|Overall Study|Corrupted database|0
275356|NCT01998737|919979|P1|Overall Study|Corrupted database|23
275357|NCT01998633|919991|P1|Overall Study|Death|1
275358|NCT01998581|920009|P2|Overall Study|Randomized but withdrew before treatment|0
275359|NCT01998581|920010|P1|Overall Study|Randomized but withdrew before treatment|1
275360|NCT01998581|920009|P2|Overall Study|Other reasons|2
275361|NCT01998581|920010|P1|Overall Study|Other reasons|3
275362|NCT01998581|920009|P2|Overall Study|Adverse Event|1
275363|NCT01998581|920010|P1|Overall Study|Adverse Event|1
275364|NCT01998581|920009|P2|Overall Study|Lost to Follow-up|4
275365|NCT01998581|920010|P1|Overall Study|Lost to Follow-up|12
275366|NCT01998581|920009|P2|Overall Study|Withdrawal by Subject|1
275367|NCT01998581|920010|P1|Overall Study|Withdrawal by Subject|8
275368|NCT01998581|920009|P2|Overall Study|Protocol Violation|0
275369|NCT01998581|920010|P1|Overall Study|Protocol Violation|1
275370|NCT01998581|920009|P2|Overall Study|Refused repeat treatment|4
275371|NCT01998581|920010|P1|Overall Study|Refused repeat treatment|20
275372|NCT01998477|920022|P2|Overall Study|Withdrawal by Subject|0
275373|NCT01998477|920023|P1|Overall Study|Withdrawal by Subject|6
275374|NCT01998477|920022|P2|Overall Study|Lost to Follow-up|5
275375|NCT01998477|920023|P1|Overall Study|Lost to Follow-up|4
275376|NCT01998399|920069|P2|Overall Study|Withdrawal by Subject|1
275377|NCT01998399|920070|P1|Overall Study|Withdrawal by Subject|0
275378|NCT01998399|920069|P2|Overall Study|Study stopped before dosing completed|3
275379|NCT01998399|920070|P1|Overall Study|Study stopped before dosing completed|3
275380|NCT01998399|920069|P2|Overall Study|Death|2
275381|NCT01998399|920070|P1|Overall Study|Death|4
275382|NCT01998399|920069|P2|Overall Study|Lost to Follow-up|3
275383|NCT01998399|920070|P1|Overall Study|Lost to Follow-up|1
275384|NCT01997892|920132|P1|Overall Study|Study completion data not recorded|35
275385|NCT01997892|920132|P1|Overall Study|Other|3
275386|NCT01997892|920132|P1|Overall Study|Renal transplant|8
275387|NCT01997892|920132|P1|Overall Study|Death|14
275388|NCT01997892|920132|P1|Overall Study|Lost to Follow-up|6
275389|NCT01997892|920132|P1|Overall Study|Physician Decision|2
275390|NCT01996904|920299|P2|Overall Study|Lost to Follow-up|27
275391|NCT01996904|920300|P1|Overall Study|Lost to Follow-up|38
275392|NCT01996748|920319|P2|Overall Study|Lost to Follow-up|1
275393|NCT01996748|920320|P1|Overall Study|Lost to Follow-up|4
275394|NCT01996748|920319|P2|Overall Study|Withdrawal by Subject|1
275395|NCT01996748|920320|P1|Overall Study|Withdrawal by Subject|0
275396|NCT01996748|920319|P2|Overall Study|Adverse Event|4
275397|NCT01996748|920320|P1|Overall Study|Adverse Event|1
275398|NCT01996748|920319|P2|Overall Study|Physician Decision|0
275399|NCT01996748|920320|P1|Overall Study|Physician Decision|2
275400|NCT01996748|920319|P2|Overall Study|Personal reason|0
275401|NCT01996748|920320|P1|Overall Study|Personal reason|1
275402|NCT01996709|920334|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
275403|NCT01996709|920335|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
275404|NCT01996709|920334|P2|Overall Study|Subject Non-Compliant|0
275405|NCT01996709|920335|P1|Overall Study|Subject Non-Compliant|1
275406|NCT01996709|920334|P2|Overall Study|Lost to Follow-up|0
275407|NCT01996709|920335|P1|Overall Study|Lost to Follow-up|3
275408|NCT01996709|920334|P2|Overall Study|Withdrawal by Subject|0
275409|NCT01996709|920335|P1|Overall Study|Withdrawal by Subject|1
275410|NCT01996332|920409|P1|Overall Study|Lost to Follow-up|34
275411|NCT01996332|920409|P1|Overall Study|Physician Decision|17
275412|NCT01996332|920409|P1|Overall Study|Clinical Deterioration|28
275413|NCT01996332|920409|P1|Overall Study|Other|20
275414|NCT01996332|920409|P1|Overall Study|Withdrawal by Subject|71
275415|NCT01996332|920409|P1|Overall Study|Protocol Violation|9
275416|NCT01996332|920409|P1|Overall Study|Death|264
275417|NCT01996332|920409|P1|Overall Study|Lack of Efficacy|1245
275418|NCT01996332|920409|P1|Overall Study|Adverse Event|117
275419|NCT01996319|920417|P2|Overall Study|Adverse Event|2
275420|NCT01996319|920418|P1|Overall Study|Adverse Event|2
275421|NCT01996319|920417|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
275422|NCT01996319|920418|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
275423|NCT01996319|920417|P2|Overall Study|Protocol Violation|0
275424|NCT01996319|920418|P1|Overall Study|Protocol Violation|1
275425|NCT01995513|920438|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
275426|NCT01995513|920439|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
275427|NCT01995513|920440|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
275428|NCT01995513|920438|P3|Double Blind Treatment Period|Disease Progression|93
275429|NCT01995513|920439|P2|Double Blind Treatment Period|Disease Progression|82
275430|NCT01995513|920440|P1|Double Blind Treatment Period|Disease Progression|0
275431|NCT01995513|920438|P3|Double Blind Treatment Period|Death|1
275432|NCT01995513|920439|P2|Double Blind Treatment Period|Death|0
275433|NCT01995513|920440|P1|Double Blind Treatment Period|Death|0
275434|NCT01995513|920438|P3|Double Blind Treatment Period|Withdrawal by Subject|6
275435|NCT01995513|920439|P2|Double Blind Treatment Period|Withdrawal by Subject|4
275436|NCT01995513|920440|P1|Double Blind Treatment Period|Withdrawal by Subject|0
275437|NCT01995513|920438|P3|Double Blind Treatment Period|Other|2
275438|NCT01995513|920439|P2|Double Blind Treatment Period|Other|1
275439|NCT01995513|920440|P1|Double Blind Treatment Period|Other|0
275440|NCT01995513|920438|P3|Double Blind Treatment Period|Adverse Event|5
275441|NCT01995513|920439|P2|Double Blind Treatment Period|Adverse Event|12
275442|NCT01995513|920440|P1|Double Blind Treatment Period|Adverse Event|0
275443|NCT01995513|920438|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
275444|NCT01995513|920439|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
275445|NCT01995513|920440|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
275446|NCT01995513|920438|P3|Open Label Treatment Period|Death|0
275447|NCT01995513|920439|P2|Open Label Treatment Period|Death|0
275448|NCT01995513|920440|P1|Open Label Treatment Period|Death|8
275449|NCT01995513|920438|P3|Open Label Treatment Period|Adverse Event|0
275450|NCT01995513|920439|P2|Open Label Treatment Period|Adverse Event|0
275451|NCT01995513|920440|P1|Open Label Treatment Period|Adverse Event|35
275452|NCT01995513|920438|P3|Open Label Treatment Period|No PSA response at week 13|0
275453|NCT01995513|920439|P2|Open Label Treatment Period|No PSA response at week 13|0
275454|NCT01995513|920440|P1|Open Label Treatment Period|No PSA response at week 13|43
275455|NCT01995513|920438|P3|Open Label Treatment Period|Disease Progression|0
275456|NCT01995513|920439|P2|Open Label Treatment Period|Disease Progression|0
275457|NCT01995513|920440|P1|Open Label Treatment Period|Disease Progression|64
275458|NCT01995513|920438|P3|Open Label Treatment Period|Protocol Violation|0
275459|NCT01995513|920439|P2|Open Label Treatment Period|Protocol Violation|0
275460|NCT01995513|920440|P1|Open Label Treatment Period|Protocol Violation|1
275461|NCT01995513|920438|P3|Open Label Treatment Period|Withdrawal by Subject|0
275462|NCT01995513|920439|P2|Open Label Treatment Period|Withdrawal by Subject|0
275463|NCT01995513|920440|P1|Open Label Treatment Period|Withdrawal by Subject|14
275464|NCT01995513|920438|P3|Open Label Treatment Period|Other|0
275465|NCT01995513|920439|P2|Open Label Treatment Period|Other|0
275466|NCT01995513|920440|P1|Open Label Treatment Period|Other|9
275467|NCT01995461|920483|P1|Overall Study|Withdrawal by Subject|2
275468|NCT01995461|920483|P1|Overall Study|Lost to Follow-up|2
275469|NCT01995461|920483|P1|Overall Study|Death|1
275470|NCT01995357|920489|P6|Period 5|Adverse Event|0
275471|NCT01995357|920490|P5|Period 5|Adverse Event|0
275472|NCT01995357|920491|P4|Period 5|Adverse Event|0
275473|NCT01995357|920492|P3|Period 5|Adverse Event|1
275474|NCT01995357|920493|P2|Period 5|Adverse Event|0
275475|NCT01995357|920494|P1|Period 5|Adverse Event|1
275476|NCT01995357|920489|P6|Period 5|Lack of Efficacy|0
275477|NCT01995357|920490|P5|Period 5|Lack of Efficacy|0
275478|NCT01995357|920491|P4|Period 5|Lack of Efficacy|0
275479|NCT01995357|920492|P3|Period 5|Lack of Efficacy|0
275480|NCT01995357|920493|P2|Period 5|Lack of Efficacy|0
275481|NCT01995357|920494|P1|Period 5|Lack of Efficacy|1
275482|NCT01995201|920512|P7|From Week 24 Until Week 48|Protocol Violation|0
275483|NCT01995201|920513|P6|From Week 24 Until Week 48|Protocol Violation|0
275484|NCT01995201|920514|P5|From Week 24 Until Week 48|Protocol Violation|2
275485|NCT01995201|920515|P4|From Week 24 Until Week 48|Protocol Violation|0
275486|NCT01995201|920516|P3|From Week 24 Until Week 48|Protocol Violation|1
275487|NCT01995201|920517|P2|From Week 24 Until Week 48|Protocol Violation|0
275488|NCT01995201|920518|P1|From Week 24 Until Week 48|Protocol Violation|0
275489|NCT01995201|920512|P7|From Week 24 Until Week 48|Physician Decision|0
275490|NCT01995201|920513|P6|From Week 24 Until Week 48|Physician Decision|0
275491|NCT01995201|920514|P5|From Week 24 Until Week 48|Physician Decision|1
275492|NCT01995201|920515|P4|From Week 24 Until Week 48|Physician Decision|0
275493|NCT01995201|920516|P3|From Week 24 Until Week 48|Physician Decision|0
275494|NCT01995201|920517|P2|From Week 24 Until Week 48|Physician Decision|0
275495|NCT01995201|920518|P1|From Week 24 Until Week 48|Physician Decision|0
275496|NCT01995201|920512|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
275497|NCT01995201|920513|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
275498|NCT01995201|920514|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
275499|NCT01995201|920515|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
275500|NCT01995201|920516|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
275501|NCT01995201|920517|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
275502|NCT01995201|920518|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
275503|NCT01995201|920512|P7|From Week 24 Until Week 48|Lost to Follow-up|0
275504|NCT01995201|920513|P6|From Week 24 Until Week 48|Lost to Follow-up|1
275505|NCT01995201|920514|P5|From Week 24 Until Week 48|Lost to Follow-up|1
275506|NCT01995201|920515|P4|From Week 24 Until Week 48|Lost to Follow-up|0
275507|NCT01995201|920516|P3|From Week 24 Until Week 48|Lost to Follow-up|0
275508|NCT01995201|920517|P2|From Week 24 Until Week 48|Lost to Follow-up|0
275509|NCT01995201|920518|P1|From Week 24 Until Week 48|Lost to Follow-up|0
275510|NCT01995201|920512|P7|From Week 24 Until Week 48|Lack of Efficacy|1
275511|NCT01995201|920513|P6|From Week 24 Until Week 48|Lack of Efficacy|2
275512|NCT01995201|920514|P5|From Week 24 Until Week 48|Lack of Efficacy|0
275513|NCT01995201|920515|P4|From Week 24 Until Week 48|Lack of Efficacy|0
275514|NCT01995201|920516|P3|From Week 24 Until Week 48|Lack of Efficacy|1
275515|NCT01995201|920517|P2|From Week 24 Until Week 48|Lack of Efficacy|0
275516|NCT01995201|920518|P1|From Week 24 Until Week 48|Lack of Efficacy|0
275517|NCT01995201|920512|P7|From Week 24 Until Week 48|Death|0
275518|NCT01995201|920513|P6|From Week 24 Until Week 48|Death|2
275519|NCT01995201|920514|P5|From Week 24 Until Week 48|Death|0
275520|NCT01995201|920515|P4|From Week 24 Until Week 48|Death|0
275521|NCT01995201|920516|P3|From Week 24 Until Week 48|Death|0
275522|NCT01995201|920517|P2|From Week 24 Until Week 48|Death|0
275523|NCT01995201|920518|P1|From Week 24 Until Week 48|Death|0
275524|NCT01995201|920512|P7|From Week 24 Until Week 48|Adverse Event|1
275525|NCT01995201|920513|P6|From Week 24 Until Week 48|Adverse Event|3
275526|NCT01995201|920514|P5|From Week 24 Until Week 48|Adverse Event|1
275527|NCT01995201|920515|P4|From Week 24 Until Week 48|Adverse Event|1
275528|NCT01995201|920516|P3|From Week 24 Until Week 48|Adverse Event|2
275529|NCT01995201|920517|P2|From Week 24 Until Week 48|Adverse Event|0
275530|NCT01995201|920518|P1|From Week 24 Until Week 48|Adverse Event|0
275531|NCT01995201|920512|P7|From Baseline Until Week 24|Protocol Violation|0
275532|NCT01995201|920513|P6|From Baseline Until Week 24|Protocol Violation|0
275533|NCT01995201|920514|P5|From Baseline Until Week 24|Protocol Violation|0
275534|NCT01995201|920515|P4|From Baseline Until Week 24|Protocol Violation|0
275535|NCT01995201|920516|P3|From Baseline Until Week 24|Protocol Violation|0
275536|NCT01995201|920517|P2|From Baseline Until Week 24|Protocol Violation|9
275537|NCT01995201|920518|P1|From Baseline Until Week 24|Protocol Violation|0
275538|NCT01995201|920512|P7|From Baseline Until Week 24|Physician Decision|0
275539|NCT01995201|920513|P6|From Baseline Until Week 24|Physician Decision|0
275540|NCT01995201|920514|P5|From Baseline Until Week 24|Physician Decision|0
275541|NCT01995201|920515|P4|From Baseline Until Week 24|Physician Decision|0
275542|NCT01995201|920516|P3|From Baseline Until Week 24|Physician Decision|0
275543|NCT01995201|920517|P2|From Baseline Until Week 24|Physician Decision|2
275544|NCT01995201|920518|P1|From Baseline Until Week 24|Physician Decision|0
275545|NCT01995201|920512|P7|From Baseline Until Week 24|Withdrawal by Subject|0
275546|NCT01995201|920513|P6|From Baseline Until Week 24|Withdrawal by Subject|0
275547|NCT01995201|920514|P5|From Baseline Until Week 24|Withdrawal by Subject|0
275548|NCT01995201|920515|P4|From Baseline Until Week 24|Withdrawal by Subject|0
275549|NCT01995201|920516|P3|From Baseline Until Week 24|Withdrawal by Subject|0
275550|NCT01995201|920517|P2|From Baseline Until Week 24|Withdrawal by Subject|8
275551|NCT01995201|920518|P1|From Baseline Until Week 24|Withdrawal by Subject|2
275552|NCT01995201|920512|P7|From Baseline Until Week 24|Lost to Follow-up|0
275553|NCT01995201|920513|P6|From Baseline Until Week 24|Lost to Follow-up|0
275554|NCT01995201|920514|P5|From Baseline Until Week 24|Lost to Follow-up|0
275555|NCT01995201|920515|P4|From Baseline Until Week 24|Lost to Follow-up|0
275556|NCT01995201|920516|P3|From Baseline Until Week 24|Lost to Follow-up|0
275557|NCT01995201|920517|P2|From Baseline Until Week 24|Lost to Follow-up|3
275558|NCT01995201|920518|P1|From Baseline Until Week 24|Lost to Follow-up|2
275559|NCT01995201|920512|P7|From Baseline Until Week 24|Lack of Efficacy|0
275560|NCT01995201|920513|P6|From Baseline Until Week 24|Lack of Efficacy|0
275561|NCT01995201|920514|P5|From Baseline Until Week 24|Lack of Efficacy|0
275562|NCT01995201|920515|P4|From Baseline Until Week 24|Lack of Efficacy|0
275563|NCT01995201|920516|P3|From Baseline Until Week 24|Lack of Efficacy|0
275564|NCT01995201|920517|P2|From Baseline Until Week 24|Lack of Efficacy|5
275565|NCT01995201|920518|P1|From Baseline Until Week 24|Lack of Efficacy|2
275566|NCT01995201|920512|P7|From Baseline Until Week 24|Death|0
275567|NCT01995201|920513|P6|From Baseline Until Week 24|Death|0
275568|NCT01995201|920514|P5|From Baseline Until Week 24|Death|0
275569|NCT01995201|920515|P4|From Baseline Until Week 24|Death|0
275570|NCT01995201|920516|P3|From Baseline Until Week 24|Death|0
275571|NCT01995201|920517|P2|From Baseline Until Week 24|Death|1
275572|NCT01995201|920518|P1|From Baseline Until Week 24|Death|0
275573|NCT01995201|920512|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
275574|NCT01995201|920513|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
275575|NCT01995201|920514|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
275576|NCT01995201|920515|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
275577|NCT01995201|920516|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
275578|NCT01995201|920517|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
275579|NCT01995201|920518|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
275580|NCT01995201|920512|P7|From Baseline Until Week 24|Adverse Event|0
275581|NCT01995201|920513|P6|From Baseline Until Week 24|Adverse Event|0
275582|NCT01995201|920514|P5|From Baseline Until Week 24|Adverse Event|0
275583|NCT01995201|920515|P4|From Baseline Until Week 24|Adverse Event|0
275584|NCT01995201|920516|P3|From Baseline Until Week 24|Adverse Event|0
275585|NCT01995201|920517|P2|From Baseline Until Week 24|Adverse Event|15
275586|NCT01995201|920518|P1|From Baseline Until Week 24|Adverse Event|4
275587|NCT01995136|920627|P1|Overall Study|Change in residence|1
275588|NCT01995071|920643|P12|Overall Study|Incarcerated|0
275589|NCT01995071|920644|P11|Overall Study|Incarcerated|0
275590|NCT01995071|920645|P10|Overall Study|Incarcerated|0
275591|NCT01995071|920646|P9|Overall Study|Incarcerated|0
275592|NCT01995071|920647|P8|Overall Study|Incarcerated|1
275593|NCT01995071|920648|P7|Overall Study|Incarcerated|0
275594|NCT01995071|920649|P6|Overall Study|Incarcerated|0
275595|NCT01995071|920650|P5|Overall Study|Incarcerated|0
275596|NCT01995071|920651|P4|Overall Study|Incarcerated|0
275597|NCT01995071|920652|P3|Overall Study|Incarcerated|0
275598|NCT01995071|920653|P2|Overall Study|Incarcerated|0
275599|NCT01995071|920654|P1|Overall Study|Incarcerated|0
275600|NCT01995071|920643|P12|Overall Study|Lost to Follow-up|0
275601|NCT01995071|920644|P11|Overall Study|Lost to Follow-up|0
275602|NCT01995071|920645|P10|Overall Study|Lost to Follow-up|0
275603|NCT01995071|920646|P9|Overall Study|Lost to Follow-up|1
275604|NCT01995071|920647|P8|Overall Study|Lost to Follow-up|1
275605|NCT01995071|920648|P7|Overall Study|Lost to Follow-up|0
275606|NCT01995071|920649|P6|Overall Study|Lost to Follow-up|0
275607|NCT01995071|920650|P5|Overall Study|Lost to Follow-up|0
275608|NCT01995071|920651|P4|Overall Study|Lost to Follow-up|0
275609|NCT01995071|920652|P3|Overall Study|Lost to Follow-up|0
275610|NCT01995071|920653|P2|Overall Study|Lost to Follow-up|0
275611|NCT01995071|920654|P1|Overall Study|Lost to Follow-up|1
275612|NCT01995071|920643|P12|Overall Study|Moved|0
275613|NCT01995071|920644|P11|Overall Study|Moved|1
275614|NCT01995071|920645|P10|Overall Study|Moved|0
275615|NCT01995071|920646|P9|Overall Study|Moved|0
275616|NCT01995071|920647|P8|Overall Study|Moved|0
275617|NCT01995071|920648|P7|Overall Study|Moved|0
275618|NCT01995071|920649|P6|Overall Study|Moved|0
275619|NCT01995071|920650|P5|Overall Study|Moved|1
275620|NCT01995071|920651|P4|Overall Study|Moved|0
275621|NCT01995071|920652|P3|Overall Study|Moved|1
275622|NCT01995071|920653|P2|Overall Study|Moved|0
275623|NCT01995071|920654|P1|Overall Study|Moved|0
275624|NCT01995071|920643|P12|Overall Study|Adverse Event|0
275625|NCT01995071|920644|P11|Overall Study|Adverse Event|0
275626|NCT01995071|920645|P10|Overall Study|Adverse Event|0
275627|NCT01995071|920646|P9|Overall Study|Adverse Event|0
275628|NCT01995071|920647|P8|Overall Study|Adverse Event|0
275629|NCT01995071|920648|P7|Overall Study|Adverse Event|1
275630|NCT01995071|920649|P6|Overall Study|Adverse Event|0
275631|NCT01995071|920650|P5|Overall Study|Adverse Event|0
275632|NCT01995071|920651|P4|Overall Study|Adverse Event|0
275633|NCT01995071|920652|P3|Overall Study|Adverse Event|0
275634|NCT01995071|920653|P2|Overall Study|Adverse Event|0
275635|NCT01995071|920654|P1|Overall Study|Adverse Event|0
275636|NCT01994902|920789|P2|Test Period 2|Other|3
275637|NCT01994902|920790|P1|Test Period 2|Other|0
275638|NCT01994902|920789|P2|Test Period 2|Lack of Efficacy|1
275639|NCT01994902|920790|P1|Test Period 2|Lack of Efficacy|0
275640|NCT01994902|920789|P2|Test Period 2|Withdrawal by Subject|2
275641|NCT01994902|920790|P1|Test Period 2|Withdrawal by Subject|0
275642|NCT01994902|920789|P2|Test Period 1|bag too small|0
275643|NCT01994902|920790|P1|Test Period 1|bag too small|1
275644|NCT01994902|920789|P2|Test Period 1|Lack of Efficacy|1
275645|NCT01994902|920790|P1|Test Period 1|Lack of Efficacy|0
275646|NCT01994902|920789|P2|Test Period 1|Adverse Event|1
275647|NCT01994902|920790|P1|Test Period 1|Adverse Event|2
275648|NCT01994902|920789|P2|Test Period 1|device deficiency with adverse event|1
275649|NCT01994902|920790|P1|Test Period 1|device deficiency with adverse event|0
275650|NCT01994902|920789|P2|Test Period 1|Withdrawal by Subject|0
275651|NCT01994902|920790|P1|Test Period 1|Withdrawal by Subject|3
275652|NCT01994876|920796|P2|Test Period 2|Protocol Violation|1
275653|NCT01994876|920797|P1|Test Period 2|Protocol Violation|0
275654|NCT01994876|920796|P2|Test Period 2|Adverse Event|0
275655|NCT01994876|920797|P1|Test Period 2|Adverse Event|1
275656|NCT01994876|920796|P2|Test Period 1|Adverse Event|1
275657|NCT01994876|920797|P1|Test Period 1|Adverse Event|0
275658|NCT01994876|920796|P2|Test Period 1|Withdrawal by Subject|1
275659|NCT01994876|920797|P1|Test Period 1|Withdrawal by Subject|0
275660|NCT01994863|920805|P2|Period 2|Withdrawal by Subject|1
275661|NCT01994863|920806|P1|Period 2|Withdrawal by Subject|1
275662|NCT01994863|920805|P2|Period 2|Lack of Efficacy|2
275663|NCT01994863|920806|P1|Period 2|Lack of Efficacy|0
275664|NCT01994863|920805|P2|Period 2|Adverse Event|1
275665|NCT01994863|920806|P1|Period 2|Adverse Event|0
275666|NCT01994863|920805|P2|Period 1|Lack of Efficacy|0
275667|NCT01994863|920806|P1|Period 1|Lack of Efficacy|1
275668|NCT01994863|920805|P2|Period 1|Trial stopped by sponsor|3
275669|NCT01994863|920806|P1|Period 1|Trial stopped by sponsor|1
275670|NCT01994863|920805|P2|Period 1|Withdrawal by Subject|0
275671|NCT01994863|920806|P1|Period 1|Withdrawal by Subject|1
275672|NCT01994863|920805|P2|Period 1|Adverse Event|0
275673|NCT01994863|920806|P1|Period 1|Adverse Event|4
275674|NCT01994837|920812|P1|Overall Study|Removed from study due to no response|1
275675|NCT01994837|920812|P1|Overall Study|Proceeded to transplant|1
275676|NCT01994837|920812|P1|Overall Study|Chose palliative care|1
275677|NCT01994837|920812|P1|Overall Study|Adverse event not related to progression|1
275678|NCT01994837|920812|P1|Overall Study|Fatal progressive disease|2
275679|NCT01994837|920812|P1|Overall Study|Adv event related to progressive disease|3
275680|NCT01994837|920812|P1|Overall Study|Progressive disease per protocol|23
275681|NCT01994720|920851|P2|Overall Study|Withdrawal by Subject|56
275682|NCT01994720|920852|P1|Overall Study|Withdrawal by Subject|46
275683|NCT01994629|920894|P2|Overall Study|Lost to Follow-up|3
275684|NCT01994629|920895|P1|Overall Study|Lost to Follow-up|0
275685|NCT01994629|920894|P2|Overall Study|Withdrawal by Subject|0
275686|NCT01994629|920895|P1|Overall Study|Withdrawal by Subject|1
275687|NCT01994395|920930|P2|Overall Study|Withdrawal by Subject|2
275688|NCT01994395|920931|P1|Overall Study|Withdrawal by Subject|1
275689|NCT01994291|920956|P3|Overall Study|Other|0
275690|NCT01994291|920957|P2|Overall Study|Other|2
275691|NCT01994291|920958|P1|Overall Study|Other|1
275692|NCT01994291|920956|P3|Overall Study|Withdrawal by Subject|5
275693|NCT01994291|920957|P2|Overall Study|Withdrawal by Subject|3
275694|NCT01994291|920958|P1|Overall Study|Withdrawal by Subject|6
275695|NCT01994291|920956|P3|Overall Study|Protocol Violation|0
275696|NCT01994291|920957|P2|Overall Study|Protocol Violation|0
275697|NCT01994291|920958|P1|Overall Study|Protocol Violation|1
275698|NCT01994291|920956|P3|Overall Study|Medication error without associated AE|1
275699|NCT01994291|920957|P2|Overall Study|Medication error without associated AE|0
275700|NCT01994291|920958|P1|Overall Study|Medication error without associated AE|1
275701|NCT01994291|920956|P3|Overall Study|Does not meet entrance criteria|0
275702|NCT01994291|920957|P2|Overall Study|Does not meet entrance criteria|0
275703|NCT01994291|920958|P1|Overall Study|Does not meet entrance criteria|1
275704|NCT01994291|920956|P3|Overall Study|Lost to Follow-up|0
275705|NCT01994291|920957|P2|Overall Study|Lost to Follow-up|1
275706|NCT01994291|920958|P1|Overall Study|Lost to Follow-up|1
275707|NCT01994291|920956|P3|Overall Study|Adverse Event|3
275708|NCT01994291|920957|P2|Overall Study|Adverse Event|1
275709|NCT01994291|920958|P1|Overall Study|Adverse Event|4
275710|NCT01994226|921014|P2|Overall Study|Early Cessation of treatment|11
275711|NCT01994226|921015|P1|Overall Study|Early Cessation of treatment|6
275712|NCT01994226|921014|P2|Overall Study|Protocol Violation|10
275713|NCT01994226|921015|P1|Overall Study|Protocol Violation|13
275714|NCT01993940|921023|P2|Overall Study|Other - Miscellaneous|1
275715|NCT01993940|921024|P1|Overall Study|Other - Miscellaneous|1
275716|NCT01993940|921023|P2|Overall Study|Death|0
275717|NCT01993940|921024|P1|Overall Study|Death|1
275718|NCT01993940|921023|P2|Overall Study|Protocol Violation|8
275719|NCT01993940|921024|P1|Overall Study|Protocol Violation|5
275720|NCT01993940|921023|P2|Overall Study|Lost to Follow-up|5
275721|NCT01993940|921024|P1|Overall Study|Lost to Follow-up|2
275722|NCT01993940|921023|P2|Overall Study|Withdrawal by Subject|19
275723|NCT01993940|921024|P1|Overall Study|Withdrawal by Subject|15
275724|NCT01993940|921023|P2|Overall Study|Adverse Event|11
275725|NCT01993940|921024|P1|Overall Study|Adverse Event|16
275726|NCT01993888|921040|P2|Overall Study|Withdrawal by Subject|1
275727|NCT01993888|921041|P1|Overall Study|Withdrawal by Subject|0
275728|NCT01993888|921040|P2|Overall Study|Lost to Follow-up|1
275729|NCT01993888|921041|P1|Overall Study|Lost to Follow-up|1
275730|NCT01993888|921040|P2|Overall Study|Death|1
275731|NCT01993888|921041|P1|Overall Study|Death|1
275732|NCT01993823|921059|P2|Overall Study|Lost to Follow-up|4
275733|NCT01993823|921060|P1|Overall Study|Lost to Follow-up|1
275734|NCT01993823|921059|P2|Overall Study|Protocol Violation|1
275735|NCT01993823|921060|P1|Overall Study|Protocol Violation|0
275736|NCT01993823|921059|P2|Overall Study|Requested by the patient|11
275737|NCT01993823|921060|P1|Overall Study|Requested by the patient|6
275738|NCT01993030|921107|P2|Overall Study|Adverse Event|4
275739|NCT01993030|921108|P1|Overall Study|Adverse Event|0
275740|NCT01992536|921162|P10|Overall Study|Withdrawal by Subject|0
275741|NCT01992536|921163|P9|Overall Study|Withdrawal by Subject|0
275742|NCT01992536|921164|P8|Overall Study|Withdrawal by Subject|0
275743|NCT01992536|921165|P7|Overall Study|Withdrawal by Subject|0
275744|NCT01992536|921166|P6|Overall Study|Withdrawal by Subject|0
275745|NCT01992536|921167|P5|Overall Study|Withdrawal by Subject|0
275746|NCT01992536|921168|P4|Overall Study|Withdrawal by Subject|2
275747|NCT01992536|921169|P3|Overall Study|Withdrawal by Subject|0
275748|NCT01992536|921170|P2|Overall Study|Withdrawal by Subject|1
275749|NCT01992536|921171|P1|Overall Study|Withdrawal by Subject|0
275750|NCT01992536|921162|P10|Overall Study|Lost to Follow-up|1
275751|NCT01992536|921163|P9|Overall Study|Lost to Follow-up|1
275752|NCT01992536|921164|P8|Overall Study|Lost to Follow-up|0
275753|NCT01992536|921165|P7|Overall Study|Lost to Follow-up|0
275754|NCT01992536|921166|P6|Overall Study|Lost to Follow-up|1
275755|NCT01992536|921167|P5|Overall Study|Lost to Follow-up|0
275756|NCT01992536|921168|P4|Overall Study|Lost to Follow-up|0
275757|NCT01992536|921169|P3|Overall Study|Lost to Follow-up|1
275758|NCT01992536|921170|P2|Overall Study|Lost to Follow-up|2
275759|NCT01992536|921171|P1|Overall Study|Lost to Follow-up|4
275760|NCT01992536|921162|P10|Overall Study|Administrative Reason|0
275761|NCT01992536|921163|P9|Overall Study|Administrative Reason|0
275762|NCT01992536|921164|P8|Overall Study|Administrative Reason|0
275763|NCT01992536|921165|P7|Overall Study|Administrative Reason|7
275764|NCT01992536|921166|P6|Overall Study|Administrative Reason|0
275765|NCT01992536|921167|P5|Overall Study|Administrative Reason|0
275766|NCT01992536|921168|P4|Overall Study|Administrative Reason|0
275767|NCT01992536|921169|P3|Overall Study|Administrative Reason|0
275768|NCT01992536|921170|P2|Overall Study|Administrative Reason|0
275769|NCT01992536|921171|P1|Overall Study|Administrative Reason|0
275770|NCT01992107|921422|P3|Overall Study|Withdrawal by Subject|8
275771|NCT01992107|921423|P2|Overall Study|Withdrawal by Subject|7
275772|NCT01992107|921424|P1|Overall Study|Withdrawal by Subject|13
275773|NCT01992107|921422|P3|Overall Study|noncompliance and were unavailable|2
275774|NCT01992107|921423|P2|Overall Study|noncompliance and were unavailable|3
275775|NCT01992107|921424|P1|Overall Study|noncompliance and were unavailable|7
275776|NCT01992107|921422|P3|Overall Study|Lost to Follow-up|26
275777|NCT01992107|921423|P2|Overall Study|Lost to Follow-up|22
275778|NCT01992107|921424|P1|Overall Study|Lost to Follow-up|46
275779|NCT01992107|921422|P3|Overall Study|Adverse Event|0
275780|NCT01992107|921423|P2|Overall Study|Adverse Event|1
275781|NCT01992107|921424|P1|Overall Study|Adverse Event|0
275782|NCT01992107|921422|P3|Overall Study|Administrative reasons|0
275783|NCT01992107|921423|P2|Overall Study|Administrative reasons|0
275784|NCT01992107|921424|P1|Overall Study|Administrative reasons|2
275785|NCT01992094|921480|P3|Overall Study|Withdrawal by Subject|4
275786|NCT01992094|921481|P2|Overall Study|Withdrawal by Subject|3
275787|NCT01992094|921482|P1|Overall Study|Withdrawal by Subject|7
275788|NCT01992094|921480|P3|Overall Study|Protocol Violation|1
275789|NCT01992094|921481|P2|Overall Study|Protocol Violation|0
275790|NCT01992094|921482|P1|Overall Study|Protocol Violation|1
275791|NCT01992094|921480|P3|Overall Study|OTHER|0
275792|NCT01992094|921481|P2|Overall Study|OTHER|0
275793|NCT01992094|921482|P1|Overall Study|OTHER|4
275794|NCT01992094|921480|P3|Overall Study|Lost to Follow-up|13
275795|NCT01992094|921481|P2|Overall Study|Lost to Follow-up|9
275796|NCT01992094|921482|P1|Overall Study|Lost to Follow-up|26
275797|NCT01992094|921480|P3|Overall Study|Death|2
275798|NCT01992094|921481|P2|Overall Study|Death|5
275799|NCT01992094|921482|P1|Overall Study|Death|5
275800|NCT01992094|921480|P3|Overall Study|Adverse Event|0
275801|NCT01992094|921481|P2|Overall Study|Adverse Event|0
275802|NCT01992094|921482|P1|Overall Study|Adverse Event|1
275803|NCT01992094|921480|P3|Overall Study|ADMINISTRATIVE REASON|1
275804|NCT01992094|921481|P2|Overall Study|ADMINISTRATIVE REASON|7
275805|NCT01992094|921482|P1|Overall Study|ADMINISTRATIVE REASON|6
275806|NCT01991314|921596|P2|Overall Study|Lost to Follow-up|10
275807|NCT01991314|921597|P1|Overall Study|Lost to Follow-up|6
275808|NCT01991314|921596|P2|Overall Study|Adverse Event|1
275809|NCT01991314|921597|P1|Overall Study|Adverse Event|5
275810|NCT01990859|921619|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
275811|NCT01990859|921619|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
275812|NCT01990664|921768|P2|Overall Study|Unsatisfactory Visual Response|1
275813|NCT01990664|921769|P1|Overall Study|Unsatisfactory Visual Response|0
275814|NCT01990664|921768|P2|Overall Study|Lens Handling Difficulties|0
275815|NCT01990664|921769|P1|Overall Study|Lens Handling Difficulties|1
275816|NCT01990664|921768|P2|Overall Study|Lens Discomfort|1
275817|NCT01990664|921769|P1|Overall Study|Lens Discomfort|1
275818|NCT01990664|921768|P2|Overall Study|Protocol Violation|0
275819|NCT01990664|921769|P1|Overall Study|Protocol Violation|1
275820|NCT01990664|921768|P2|Overall Study|Withdrawal by Subject|3
275821|NCT01990664|921769|P1|Overall Study|Withdrawal by Subject|2
275822|NCT01990664|921768|P2|Overall Study|Lost to Follow-up|6
275823|NCT01990664|921769|P1|Overall Study|Lost to Follow-up|2
275824|NCT01990560|921775|P1|Overall Study|Withdrawal by Subject|1
275825|NCT01990534|921789|P1|Overall Study|Overall Survival Follow-up|25
275826|NCT01990534|921789|P1|Overall Study|Progression Free Survival Follow-up|11
275827|NCT01990534|921789|P1|Overall Study|Reason Not Specified|2
275828|NCT01990534|921789|P1|Overall Study|Withdrawal by Subject|3
275829|NCT01990534|921789|P1|Overall Study|Symptomatic Deterioration|1
275830|NCT01990534|921789|P1|Overall Study|Withdrawal of Informed Consent|2
275831|NCT01990534|921789|P1|Overall Study|Protocol Violation|1
275832|NCT01990534|921789|P1|Overall Study|Progressive disease|3
275833|NCT01990534|921789|P1|Overall Study|Death|12
275834|NCT01990339|921805|P1|Overall Study|Lost to Follow-up|861
275835|NCT01990339|921805|P1|Overall Study|Voluntary Withdrawal|1402
275836|NCT01990339|921805|P1|Overall Study|Data Not Available|49
275837|NCT01990313|921810|P1|Overall Study|Lost to Follow-up|1
275838|NCT01990261|921815|P1|Overall Study|Lost to Follow-up|2
275839|NCT01990261|921815|P1|Overall Study|Dossier not Approved|1
275840|NCT01990261|921815|P1|Overall Study|PD Before Treatment Start|1
275841|NCT01990261|921815|P1|Overall Study|Disease Progression (PD)|8
275842|NCT01990261|921815|P1|Overall Study|Death From other Causes|1
275843|NCT01990261|921815|P1|Overall Study|Death due to Disease Progression (PD)|10
275844|NCT01990261|921815|P1|Overall Study|Death Before Treatment Start|2
275845|NCT01989689|921852|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
275846|NCT01989689|921853|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
275847|NCT01989689|921852|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
275848|NCT01989689|921853|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
275849|NCT01989676|921865|P2|Overall Study|Discontinued|68
275850|NCT01989676|921866|P1|Overall Study|Discontinued|59
275851|NCT01989676|921865|P2|Overall Study|Ongoing at data cutoff|279
275852|NCT01989676|921866|P1|Overall Study|Ongoing at data cutoff|279
275853|NCT01989572|921892|P6|Overall Study|alternative therapy|3
275854|NCT01989572|921893|P5|Overall Study|alternative therapy|1
275855|NCT01989572|921894|P4|Overall Study|alternative therapy|0
275856|NCT01989572|921895|P3|Overall Study|alternative therapy|0
275857|NCT01989572|921896|P2|Overall Study|alternative therapy|0
275858|NCT01989572|921897|P1|Overall Study|alternative therapy|3
275859|NCT01989572|921892|P6|Overall Study|not start protocol therapy|18
275860|NCT01989572|921893|P5|Overall Study|not start protocol therapy|4
275861|NCT01989572|921894|P4|Overall Study|not start protocol therapy|3
275862|NCT01989572|921895|P3|Overall Study|not start protocol therapy|2
275863|NCT01989572|921896|P2|Overall Study|not start protocol therapy|1
275864|NCT01989572|921897|P1|Overall Study|not start protocol therapy|5
275865|NCT01989572|921892|P6|Overall Study|unknown/not specify|5
275866|NCT01989572|921893|P5|Overall Study|unknown/not specify|3
275867|NCT01989572|921894|P4|Overall Study|unknown/not specify|3
275868|NCT01989572|921895|P3|Overall Study|unknown/not specify|1
275869|NCT01989572|921896|P2|Overall Study|unknown/not specify|4
275870|NCT01989572|921897|P1|Overall Study|unknown/not specify|3
275871|NCT01989572|921892|P6|Overall Study|maximum dose reached|0
275872|NCT01989572|921893|P5|Overall Study|maximum dose reached|1
275873|NCT01989572|921894|P4|Overall Study|maximum dose reached|0
275874|NCT01989572|921895|P3|Overall Study|maximum dose reached|0
275875|NCT01989572|921896|P2|Overall Study|maximum dose reached|1
275876|NCT01989572|921897|P1|Overall Study|maximum dose reached|0
275877|NCT01989572|921892|P6|Overall Study|error|1
275878|NCT01989572|921893|P5|Overall Study|error|1
275879|NCT01989572|921894|P4|Overall Study|error|1
275880|NCT01989572|921895|P3|Overall Study|error|1
275881|NCT01989572|921896|P2|Overall Study|error|1
275882|NCT01989572|921897|P1|Overall Study|error|2
275883|NCT01989572|921892|P6|Overall Study|complicating disease|0
275884|NCT01989572|921893|P5|Overall Study|complicating disease|1
275885|NCT01989572|921894|P4|Overall Study|complicating disease|0
275886|NCT01989572|921895|P3|Overall Study|complicating disease|2
275887|NCT01989572|921896|P2|Overall Study|complicating disease|1
275888|NCT01989572|921897|P1|Overall Study|complicating disease|1
275889|NCT01989572|921892|P6|Overall Study|Withdrawal by Subject|4
275890|NCT01989572|921893|P5|Overall Study|Withdrawal by Subject|12
275891|NCT01989572|921894|P4|Overall Study|Withdrawal by Subject|1
275892|NCT01989572|921895|P3|Overall Study|Withdrawal by Subject|5
275893|NCT01989572|921896|P2|Overall Study|Withdrawal by Subject|1
275894|NCT01989572|921897|P1|Overall Study|Withdrawal by Subject|4
275895|NCT01989572|921892|P6|Overall Study|Death|0
275896|NCT01989572|921893|P5|Overall Study|Death|1
275897|NCT01989572|921894|P4|Overall Study|Death|0
275898|NCT01989572|921895|P3|Overall Study|Death|0
275899|NCT01989572|921896|P2|Overall Study|Death|0
275900|NCT01989572|921897|P1|Overall Study|Death|0
275901|NCT01989572|921892|P6|Overall Study|Adverse Event|0
275902|NCT01989572|921893|P5|Overall Study|Adverse Event|3
275903|NCT01989572|921894|P4|Overall Study|Adverse Event|0
275904|NCT01989572|921895|P3|Overall Study|Adverse Event|3
275905|NCT01989572|921896|P2|Overall Study|Adverse Event|1
275906|NCT01989572|921897|P1|Overall Study|Adverse Event|2
275907|NCT01989572|921892|P6|Overall Study|Lack of Efficacy|79
275908|NCT01989572|921893|P5|Overall Study|Lack of Efficacy|71
275909|NCT01989572|921894|P4|Overall Study|Lack of Efficacy|43
275910|NCT01989572|921895|P3|Overall Study|Lack of Efficacy|48
275911|NCT01989572|921896|P2|Overall Study|Lack of Efficacy|48
275912|NCT01989572|921897|P1|Overall Study|Lack of Efficacy|35
275913|NCT01989455|921930|P5|Overall Study|Technical problems with infusion|1
275914|NCT01989455|921931|P4|Overall Study|Technical problems with infusion|0
275915|NCT01989455|921932|P3|Overall Study|Technical problems with infusion|1
275916|NCT01989455|921933|P2|Overall Study|Technical problems with infusion|0
275917|NCT01989455|921934|P1|Overall Study|Technical problems with infusion|0
275918|NCT01989455|921930|P5|Overall Study|Withdrawal by Subject|0
275919|NCT01989455|921931|P4|Overall Study|Withdrawal by Subject|0
275920|NCT01989455|921932|P3|Overall Study|Withdrawal by Subject|0
275921|NCT01989455|921933|P2|Overall Study|Withdrawal by Subject|1
275922|NCT01989455|921934|P1|Overall Study|Withdrawal by Subject|0
275923|NCT01989455|921930|P5|Overall Study|Adverse Event|0
275924|NCT01989455|921931|P4|Overall Study|Adverse Event|0
275925|NCT01989455|921932|P3|Overall Study|Adverse Event|0
275926|NCT01989455|921933|P2|Overall Study|Adverse Event|1
275927|NCT01989455|921934|P1|Overall Study|Adverse Event|0
275928|NCT01989169|921978|P2|Period 2|Adverse Event|1
275929|NCT01989169|921979|P1|Period 2|Adverse Event|0
275930|NCT01989156|921992|P3|End of Study (Population at Day 90)|Employment Conflict|0
275931|NCT01989156|921993|P2|End of Study (Population at Day 90)|Employment Conflict|1
275932|NCT01989156|921994|P1|End of Study (Population at Day 90)|Employment Conflict|0
275933|NCT01989156|921992|P3|End of Study (Population at Day 90)|Moved out of state|0
275934|NCT01989156|921993|P2|End of Study (Population at Day 90)|Moved out of state|0
275935|NCT01989156|921994|P1|End of Study (Population at Day 90)|Moved out of state|1
275936|NCT01989156|921992|P3|End of Study (Population at Day 90)|Physician Decision|1
275937|NCT01989156|921993|P2|End of Study (Population at Day 90)|Physician Decision|0
275938|NCT01989156|921994|P1|End of Study (Population at Day 90)|Physician Decision|1
275939|NCT01989156|921992|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
275940|NCT01989156|921993|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
275941|NCT01989156|921994|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
275942|NCT01989156|921992|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
275943|NCT01989156|921993|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
275944|NCT01989156|921994|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
275945|NCT01989156|921992|P3|Confinement Period (Population at Day 5)|Adverse Event|1
275946|NCT01989156|921993|P2|Confinement Period (Population at Day 5)|Adverse Event|0
275947|NCT01989156|921994|P1|Confinement Period (Population at Day 5)|Adverse Event|0
275948|NCT01989156|921992|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
275949|NCT01989156|921993|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
275950|NCT01989156|921994|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
275951|NCT01989156|921992|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
275952|NCT01989156|921993|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
275953|NCT01989156|921994|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
275954|NCT01988662|922054|P2|Overall Study|Adverse Event|1
275955|NCT01988662|922055|P1|Overall Study|Adverse Event|3
275956|NCT01988662|922054|P2|Overall Study|Subject/guardian decision|1
275957|NCT01988662|922055|P1|Overall Study|Subject/guardian decision|1
275958|NCT01988402|922082|P2|Overall Study|Withdrawal by Subject|0
275959|NCT01988402|922083|P1|Overall Study|Withdrawal by Subject|1
275960|NCT01988402|922082|P2|Overall Study|Adverse Event|2
275961|NCT01988402|922083|P1|Overall Study|Adverse Event|1
275962|NCT01988012|922125|P1|Overall Study|Protocol Violation|1
275963|NCT01988012|922125|P1|Overall Study|Physician Decision|1
275964|NCT01988012|922125|P1|Overall Study|Lost to Follow-up|1
275965|NCT01988012|922125|P1|Overall Study|Patient Withdrawal of Consent|4
275966|NCT01988012|922125|P1|Overall Study|Insufficient Therapeutic Response|3
275967|NCT01988012|922125|P1|Overall Study|Adverse Event|5
275968|NCT01987986|922151|P4|Overall Study|Adverse Event|0
275969|NCT01987986|922152|P3|Overall Study|Adverse Event|2
275970|NCT01987986|922153|P2|Overall Study|Adverse Event|0
275971|NCT01987986|922154|P1|Overall Study|Adverse Event|1
275972|NCT01987986|922151|P4|Overall Study|Lost to Follow-up|0
275973|NCT01987986|922152|P3|Overall Study|Lost to Follow-up|0
275974|NCT01987986|922153|P2|Overall Study|Lost to Follow-up|0
275975|NCT01987986|922154|P1|Overall Study|Lost to Follow-up|1
275976|NCT01987960|922194|P4|Period 3|Administrative or other reason|43
275977|NCT01987960|922195|P3|Period 3|Administrative or other reason|0
275978|NCT01987960|922196|P2|Period 3|Administrative or other reason|0
275979|NCT01987960|922197|P1|Period 3|Administrative or other reason|0
275980|NCT01987960|922194|P4|Period 3|Lost to Follow-up|5
275981|NCT01987960|922195|P3|Period 3|Lost to Follow-up|0
275982|NCT01987960|922196|P2|Period 3|Lost to Follow-up|0
275983|NCT01987960|922197|P1|Period 3|Lost to Follow-up|0
275984|NCT01987960|922194|P4|Period 3|Withdrawal by Subject|9
275985|NCT01987960|922195|P3|Period 3|Withdrawal by Subject|0
275986|NCT01987960|922196|P2|Period 3|Withdrawal by Subject|0
275987|NCT01987960|922197|P1|Period 3|Withdrawal by Subject|0
275988|NCT01987960|922194|P4|Period 3|Protocol Violation|6
275989|NCT01987960|922195|P3|Period 3|Protocol Violation|0
275990|NCT01987960|922196|P2|Period 3|Protocol Violation|0
275991|NCT01987960|922197|P1|Period 3|Protocol Violation|0
275992|NCT01987960|922194|P4|Period 3|Non-compliance with IMP|1
275993|NCT01987960|922195|P3|Period 3|Non-compliance with IMP|0
275994|NCT01987960|922196|P2|Period 3|Non-compliance with IMP|0
275995|NCT01987960|922197|P1|Period 3|Non-compliance with IMP|0
275996|NCT01987960|922194|P4|Period 3|Adverse Event|7
275997|NCT01987960|922195|P3|Period 3|Adverse Event|0
275998|NCT01987960|922196|P2|Period 3|Adverse Event|0
275999|NCT01987960|922197|P1|Period 3|Adverse Event|0
276000|NCT01987960|922194|P4|Period 2|Administrative or other reason|0
276001|NCT01987960|922195|P3|Period 2|Administrative or other reason|7
276002|NCT01987960|922196|P2|Period 2|Administrative or other reason|5
276003|NCT01987960|922197|P1|Period 2|Administrative or other reason|0
276004|NCT01987960|922194|P4|Period 2|Withdrawal by Subject|0
276005|NCT01987960|922195|P3|Period 2|Withdrawal by Subject|1
276006|NCT01987960|922196|P2|Period 2|Withdrawal by Subject|0
276007|NCT01987960|922197|P1|Period 2|Withdrawal by Subject|0
276008|NCT01987960|922194|P4|Period 2|Adverse Event|0
276009|NCT01987960|922195|P3|Period 2|Adverse Event|1
276010|NCT01987960|922196|P2|Period 2|Adverse Event|0
276011|NCT01987960|922197|P1|Period 2|Adverse Event|0
276012|NCT01987960|922194|P4|Period 1|Withdrawal of consent before treatment|0
276013|NCT01987960|922195|P3|Period 1|Withdrawal of consent before treatment|0
276014|NCT01987960|922196|P2|Period 1|Withdrawal of consent before treatment|0
276015|NCT01987960|922197|P1|Period 1|Withdrawal of consent before treatment|4
276016|NCT01987960|922194|P4|Period 1|administrative or other reason|0
276017|NCT01987960|922195|P3|Period 1|administrative or other reason|0
276018|NCT01987960|922196|P2|Period 1|administrative or other reason|0
276019|NCT01987960|922197|P1|Period 1|administrative or other reason|75
276020|NCT01987960|922194|P4|Period 1|Lost to Follow-up|0
276021|NCT01987960|922195|P3|Period 1|Lost to Follow-up|0
276022|NCT01987960|922196|P2|Period 1|Lost to Follow-up|0
276023|NCT01987960|922197|P1|Period 1|Lost to Follow-up|40
276024|NCT01987960|922194|P4|Period 1|Withdrawal by Subject|0
276025|NCT01987960|922195|P3|Period 1|Withdrawal by Subject|0
276026|NCT01987960|922196|P2|Period 1|Withdrawal by Subject|0
276027|NCT01987960|922197|P1|Period 1|Withdrawal by Subject|21
276028|NCT01987960|922194|P4|Period 1|Protocol Violation|0
276029|NCT01987960|922195|P3|Period 1|Protocol Violation|0
276030|NCT01987960|922196|P2|Period 1|Protocol Violation|0
276031|NCT01987960|922197|P1|Period 1|Protocol Violation|12
276032|NCT01987960|922194|P4|Period 1|Non-compliance with IMP|0
276033|NCT01987960|922195|P3|Period 1|Non-compliance with IMP|0
276034|NCT01987960|922196|P2|Period 1|Non-compliance with IMP|0
276035|NCT01987960|922197|P1|Period 1|Non-compliance with IMP|6
276036|NCT01987960|922194|P4|Period 1|Lack of Efficacy|0
276037|NCT01987960|922195|P3|Period 1|Lack of Efficacy|0
276038|NCT01987960|922196|P2|Period 1|Lack of Efficacy|0
276039|NCT01987960|922197|P1|Period 1|Lack of Efficacy|4
276040|NCT01987960|922194|P4|Period 1|Adverse Event|0
276041|NCT01987960|922195|P3|Period 1|Adverse Event|0
276042|NCT01987960|922196|P2|Period 1|Adverse Event|0
276043|NCT01987960|922197|P1|Period 1|Adverse Event|24
276044|NCT01987908|922209|P3|Post-Treatment Observation Period|Other: Bad Veins|0
276045|NCT01987908|922210|P2|Post-Treatment Observation Period|Other: Bad Veins|1
276046|NCT01987908|922211|P1|Post-Treatment Observation Period|Other: Bad Veins|0
276047|NCT01987908|922209|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
276048|NCT01987908|922210|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
276049|NCT01987908|922211|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
276050|NCT01987908|922209|P3|Treatment Period|Adverse Event|1
276051|NCT01987908|922210|P2|Treatment Period|Adverse Event|1
276052|NCT01987908|922211|P1|Treatment Period|Adverse Event|0
276053|NCT01987908|922209|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
276054|NCT01987908|922210|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
276055|NCT01987908|922211|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
276056|NCT01987908|922209|P3|Placebo Lead-in Period|Withdrawal by Subject|0
276057|NCT01987908|922210|P2|Placebo Lead-in Period|Withdrawal by Subject|0
276058|NCT01987908|922211|P1|Placebo Lead-in Period|Withdrawal by Subject|1
276059|NCT01987908|922209|P3|Placebo Lead-in Period|Physician Decision|0
276060|NCT01987908|922210|P2|Placebo Lead-in Period|Physician Decision|0
276061|NCT01987908|922211|P1|Placebo Lead-in Period|Physician Decision|2
276062|NCT01987908|922209|P3|Placebo Lead-in Period|Adverse Event|0
276063|NCT01987908|922210|P2|Placebo Lead-in Period|Adverse Event|0
276064|NCT01987908|922211|P1|Placebo Lead-in Period|Adverse Event|2
276065|NCT01987895|922294|P2|Overall Study|randomized before giving IC|1
276066|NCT01987895|922295|P1|Overall Study|randomized before giving IC|0
276067|NCT01987895|922294|P2|Overall Study|Lost to Follow-up|5
276068|NCT01987895|922295|P1|Overall Study|Lost to Follow-up|3
276069|NCT01987895|922294|P2|Overall Study|Death|7
276070|NCT01987895|922295|P1|Overall Study|Death|7
276071|NCT01987895|922294|P2|Overall Study|Physician Decision|10
276072|NCT01987895|922295|P1|Overall Study|Physician Decision|8
276073|NCT01987895|922294|P2|Overall Study|Withdrawal by Subject|7
276074|NCT01987895|922295|P1|Overall Study|Withdrawal by Subject|12
276075|NCT01987765|922319|P1|Overall Study|Lost to Follow-up|37
276076|NCT01987765|922319|P1|Overall Study|Protocol Violation|65
276077|NCT01987557|922343|P3|Overall Study|Adverse Event|0
276078|NCT01987557|922344|P2|Overall Study|Adverse Event|2
276079|NCT01987557|922345|P1|Overall Study|Adverse Event|0
276080|NCT01987557|922343|P3|Overall Study|Withdrawal by Subject|2
276081|NCT01987557|922344|P2|Overall Study|Withdrawal by Subject|1
276082|NCT01987557|922345|P1|Overall Study|Withdrawal by Subject|2
276083|NCT01987557|922343|P3|Overall Study|Protocol Violation|1
276084|NCT01987557|922344|P2|Overall Study|Protocol Violation|0
276085|NCT01987557|922345|P1|Overall Study|Protocol Violation|1
276086|NCT01987479|922353|P1|Overall Study|Adverse Event|7
276087|NCT01987479|922353|P1|Overall Study|Lost to Follow-up|1
276088|NCT01987479|922353|P1|Overall Study|Other|5
276089|NCT01987479|922353|P1|Overall Study|Participant/legal guardian decision|1
276090|NCT01987479|922353|P1|Overall Study|Physician Decision|2
276091|NCT01987479|922353|P1|Overall Study|Protocol Violation|1
276092|NCT01987453|922381|P3|Overall Study|Lack of Efficacy|0
276093|NCT01987453|922382|P2|Overall Study|Lack of Efficacy|12
276094|NCT01987453|922383|P1|Overall Study|Lack of Efficacy|1
276095|NCT01987453|922381|P3|Overall Study|Death|1
276096|NCT01987453|922382|P2|Overall Study|Death|0
276097|NCT01987453|922383|P1|Overall Study|Death|0
276098|NCT01987232|922452|P5|Overall Study|Ongoing in Study|0
276099|NCT01987232|922453|P4|Overall Study|Ongoing in Study|1
276100|NCT01987232|922454|P3|Overall Study|Ongoing in Study|0
276101|NCT01987232|922455|P2|Overall Study|Ongoing in Study|0
276102|NCT01987232|922456|P1|Overall Study|Ongoing in Study|0
276103|NCT01986985|922543|P1|Overall Study|Scan not completed due to malfunction|3
276104|NCT01986985|922543|P1|Overall Study|Withdrawal by Subject|4
276105|NCT01986855|922583|P3|Overall Study|Withdrawal by Subject|5
276106|NCT01986855|922584|P2|Overall Study|Withdrawal by Subject|8
276107|NCT01986855|922585|P1|Overall Study|Withdrawal by Subject|7
276108|NCT01986855|922583|P3|Overall Study|Participant Moved|2
276109|NCT01986855|922584|P2|Overall Study|Participant Moved|0
276110|NCT01986855|922585|P1|Overall Study|Participant Moved|0
276111|NCT01986855|922583|P3|Overall Study|Screen Failure|0
276112|NCT01986855|922584|P2|Overall Study|Screen Failure|1
276113|NCT01986855|922585|P1|Overall Study|Screen Failure|0
276114|NCT01986855|922583|P3|Overall Study|Lost to Follow-up|0
276115|NCT01986855|922584|P2|Overall Study|Lost to Follow-up|1
276116|NCT01986855|922585|P1|Overall Study|Lost to Follow-up|2
276117|NCT01986855|922583|P3|Overall Study|Death|4
276118|NCT01986855|922584|P2|Overall Study|Death|4
276119|NCT01986855|922585|P1|Overall Study|Death|3
276120|NCT01986855|922583|P3|Overall Study|Adverse Event|0
276121|NCT01986855|922584|P2|Overall Study|Adverse Event|0
276122|NCT01986855|922585|P1|Overall Study|Adverse Event|1
276123|NCT01986751|922635|P2|Overall Study|improperly consented|2
276124|NCT01986751|922636|P1|Overall Study|improperly consented|10
276125|NCT01986231|922690|P1|Overall Study|Adverse Event|1
276126|NCT01986062|922697|P2|Overall Study|Lost to Follow-up|1
276127|NCT01986062|922698|P1|Overall Study|Lost to Follow-up|1
276128|NCT01985321|922771|P2|Overall Study|Subject treated wrong type of sore|0
276129|NCT01985321|922772|P1|Overall Study|Subject treated wrong type of sore|1
276130|NCT01985321|922771|P2|Overall Study|Lost to Follow-up|2
276131|NCT01985321|922772|P1|Overall Study|Lost to Follow-up|5
276132|NCT01985321|922771|P2|Overall Study|Withdrawal by Subject|0
276133|NCT01985321|922772|P1|Overall Study|Withdrawal by Subject|1
276134|NCT01985321|922771|P2|Overall Study|Protocol Violation|3
276135|NCT01985321|922772|P1|Overall Study|Protocol Violation|4
276136|NCT01985126|922782|P2|Overall Study|Withdrawal by Subject|7
276137|NCT01985126|922783|P1|Overall Study|Withdrawal by Subject|2
276138|NCT01985126|922782|P2|Overall Study|Study Terminated By Sponsor|22
276139|NCT01985126|922783|P1|Overall Study|Study Terminated By Sponsor|1
276140|NCT01985126|922782|P2|Overall Study|Lost to Follow-up|8
276141|NCT01985126|922783|P1|Overall Study|Lost to Follow-up|0
276142|NCT01985126|922782|P2|Overall Study|Death|69
276143|NCT01985126|922783|P1|Overall Study|Death|15
276144|NCT01984892|922801|P1|Overall Study|Progressive disease|7
276145|NCT01984697|922812|P5|Overall Study|Follow-up continues|308
276146|NCT01984697|922813|P4|Overall Study|Follow-up continues|290
276147|NCT01984697|922814|P3|Overall Study|Follow-up continues|292
276148|NCT01984697|922815|P2|Overall Study|Follow-up continues|294
276149|NCT01984697|922816|P1|Overall Study|Follow-up continues|290
276150|NCT01984697|922812|P5|Overall Study|Withdrawal by Subject|2
276151|NCT01984697|922813|P4|Overall Study|Withdrawal by Subject|7
276152|NCT01984697|922814|P3|Overall Study|Withdrawal by Subject|4
276153|NCT01984697|922815|P2|Overall Study|Withdrawal by Subject|5
276154|NCT01984697|922816|P1|Overall Study|Withdrawal by Subject|3
276155|NCT01984697|922812|P5|Overall Study|Protocol Violation|0
276156|NCT01984697|922813|P4|Overall Study|Protocol Violation|1
276157|NCT01984697|922814|P3|Overall Study|Protocol Violation|0
276158|NCT01984697|922815|P2|Overall Study|Protocol Violation|0
276159|NCT01984697|922816|P1|Overall Study|Protocol Violation|0
276160|NCT01984697|922812|P5|Overall Study|Physician Decision|0
276161|NCT01984697|922813|P4|Overall Study|Physician Decision|0
276162|NCT01984697|922814|P3|Overall Study|Physician Decision|0
276163|NCT01984697|922815|P2|Overall Study|Physician Decision|0
276164|NCT01984697|922816|P1|Overall Study|Physician Decision|1
276165|NCT01984697|922812|P5|Overall Study|Lost to Follow-up|4
276166|NCT01984697|922813|P4|Overall Study|Lost to Follow-up|3
276167|NCT01984697|922814|P3|Overall Study|Lost to Follow-up|4
276168|NCT01984697|922815|P2|Overall Study|Lost to Follow-up|2
276169|NCT01984697|922816|P1|Overall Study|Lost to Follow-up|7
276170|NCT01984697|922812|P5|Overall Study|Adverse Event|0
276171|NCT01984697|922813|P4|Overall Study|Adverse Event|0
276172|NCT01984697|922814|P3|Overall Study|Adverse Event|1
276173|NCT01984697|922815|P2|Overall Study|Adverse Event|0
276174|NCT01984697|922816|P1|Overall Study|Adverse Event|0
276175|NCT01984684|922915|P2|Overall Study|Subject had inadequate IV access|1
276176|NCT01984684|922916|P1|Overall Study|Subject had inadequate IV access|0
276177|NCT01984684|922915|P2|Overall Study|Study drug not available at site|1
276178|NCT01984684|922916|P1|Overall Study|Study drug not available at site|1
276179|NCT01984684|922915|P2|Overall Study|Subject incarcerated|0
276180|NCT01984684|922916|P1|Overall Study|Subject incarcerated|1
276181|NCT01984684|922915|P2|Overall Study|Noncompliance with study drug|1
276182|NCT01984684|922916|P1|Overall Study|Noncompliance with study drug|2
276183|NCT01984684|922915|P2|Overall Study|Death|1
276184|NCT01984684|922916|P1|Overall Study|Death|0
276185|NCT01984684|922915|P2|Overall Study|Protocol Violation|2
276186|NCT01984684|922916|P1|Overall Study|Protocol Violation|4
276187|NCT01984684|922915|P2|Overall Study|Physician Decision|2
276188|NCT01984684|922916|P1|Overall Study|Physician Decision|4
276189|NCT01984684|922915|P2|Overall Study|Lack of Efficacy|6
276190|NCT01984684|922916|P1|Overall Study|Lack of Efficacy|3
276191|NCT01984684|922915|P2|Overall Study|Withdrawal by Subject|9
276192|NCT01984684|922916|P1|Overall Study|Withdrawal by Subject|9
276193|NCT01984684|922915|P2|Overall Study|Adverse Event|12
276194|NCT01984684|922916|P1|Overall Study|Adverse Event|8
276195|NCT01984684|922915|P2|Overall Study|Lost to Follow-up|24
276196|NCT01984684|922916|P1|Overall Study|Lost to Follow-up|25
276197|NCT01984424|922934|P2|Overall Study|Lost to Follow-up|1
276198|NCT01984424|922935|P1|Overall Study|Lost to Follow-up|0
276199|NCT01984424|922934|P2|Overall Study|Sponsor Decision|1
276200|NCT01984424|922935|P1|Overall Study|Sponsor Decision|0
276201|NCT01984424|922934|P2|Overall Study|Withdrawal by Subject|5
276202|NCT01984424|922935|P1|Overall Study|Withdrawal by Subject|3
276203|NCT01984294|922990|P3|Overall Study|Adverse Event|0
276204|NCT01984294|922991|P2|Overall Study|Adverse Event|1
276205|NCT01984294|922992|P1|Overall Study|Adverse Event|0
276206|NCT01984294|922990|P3|Overall Study|Lack of Efficacy|6
276207|NCT01984294|922991|P2|Overall Study|Lack of Efficacy|2
276208|NCT01984294|922992|P1|Overall Study|Lack of Efficacy|4
276209|NCT01984294|922990|P3|Overall Study|Randomized but Never Treated|1
276210|NCT01984294|922991|P2|Overall Study|Randomized but Never Treated|0
276211|NCT01984294|922992|P1|Overall Study|Randomized but Never Treated|0
276212|NCT01984242|923015|P3|Overall Study|Ongoing in Study|61
276213|NCT01984242|923016|P2|Overall Study|Ongoing in Study|65
276214|NCT01984242|923017|P1|Overall Study|Ongoing in Study|60
276215|NCT01984242|923015|P3|Overall Study|Randomized, but not treated|1
276216|NCT01984242|923016|P2|Overall Study|Randomized, but not treated|0
276217|NCT01984242|923017|P1|Overall Study|Randomized, but not treated|0
276218|NCT01984242|923015|P3|Overall Study|Other|1
276219|NCT01984242|923016|P2|Overall Study|Other|0
276220|NCT01984242|923017|P1|Overall Study|Other|1
276221|NCT01984242|923015|P3|Overall Study|Lost to Follow-up|1
276222|NCT01984242|923016|P2|Overall Study|Lost to Follow-up|0
276223|NCT01984242|923017|P1|Overall Study|Lost to Follow-up|0
276224|NCT01984242|923015|P3|Overall Study|Physician Decision|2
276225|NCT01984242|923016|P2|Overall Study|Physician Decision|0
276226|NCT01984242|923017|P1|Overall Study|Physician Decision|1
276227|NCT01984242|923015|P3|Overall Study|Withdrawal by Subject|5
276228|NCT01984242|923016|P2|Overall Study|Withdrawal by Subject|2
276229|NCT01984242|923017|P1|Overall Study|Withdrawal by Subject|2
276230|NCT01984242|923015|P3|Overall Study|Death|30
276231|NCT01984242|923016|P2|Overall Study|Death|36
276232|NCT01984242|923017|P1|Overall Study|Death|37
276233|NCT01984229|923167|P2|Safety Follow-up Period|Lost to Follow-up|0
276234|NCT01984229|923168|P1|Safety Follow-up Period|Lost to Follow-up|1
276235|NCT01984229|923167|P2|Safety Follow-up Period|Adverse Event|1
276236|NCT01984229|923168|P1|Safety Follow-up Period|Adverse Event|1
276237|NCT01983683|923259|P2|Overall Study|Sponsor Decision|1
276238|NCT01983683|923260|P1|Overall Study|Sponsor Decision|1
276239|NCT01983683|923259|P2|Overall Study|Lost to Follow-up|8
276240|NCT01983683|923260|P1|Overall Study|Lost to Follow-up|4
276241|NCT01983683|923259|P2|Overall Study|Physician Decision|9
276242|NCT01983683|923260|P1|Overall Study|Physician Decision|8
276243|NCT01983683|923259|P2|Overall Study|Death|15
276244|NCT01983683|923260|P1|Overall Study|Death|11
276245|NCT01983683|923259|P2|Overall Study|Withdrawal by Subject|18
276246|NCT01983683|923260|P1|Overall Study|Withdrawal by Subject|14
276247|NCT01983254|923312|P2|Overall Study|too ill|8
276248|NCT01983254|923313|P1|Overall Study|too ill|11
276249|NCT01983254|923312|P2|Overall Study|Lost to Follow-up|16
276250|NCT01983254|923313|P1|Overall Study|Lost to Follow-up|17
276251|NCT01983254|923312|P2|Overall Study|Death|6
276252|NCT01983254|923313|P1|Overall Study|Death|6
276253|NCT01983111|923325|P2|Overall Study|Protocol Violation|1
276254|NCT01983111|923326|P1|Overall Study|Protocol Violation|0
276255|NCT01983111|923325|P2|Overall Study|Adverse Event|0
276256|NCT01983111|923326|P1|Overall Study|Adverse Event|4
276257|NCT01983111|923325|P2|Overall Study|Withdrawal by Subject|6
276258|NCT01983111|923326|P1|Overall Study|Withdrawal by Subject|8
276259|NCT01982812|923361|P2|Overall Study|Adverse Event|5
276260|NCT01982812|923362|P1|Overall Study|Adverse Event|0
276261|NCT01982812|923361|P2|Overall Study|Death|5
276262|NCT01982812|923362|P1|Overall Study|Death|1
276263|NCT01982773|923376|P2|Overall Study|Lost to Follow-up|1
276264|NCT01982773|923377|P1|Overall Study|Lost to Follow-up|7
276265|NCT01982773|923376|P2|Overall Study|Withdrawal by Subject|3
276266|NCT01982773|923377|P1|Overall Study|Withdrawal by Subject|1
276267|NCT01982682|923398|P1|Overall Study|Physician Decision|1
276268|NCT01982435|923412|P2|Overall Study|Adverse Event|0
276269|NCT01982435|923413|P1|Overall Study|Adverse Event|1
276270|NCT01982292|923452|P2|Overall Study|Technical Problems|0
276271|NCT01982292|923453|P1|Overall Study|Technical Problems|2
276272|NCT01982292|923452|P2|Overall Study|Patient/Guardian Decision|1
276273|NCT01982292|923453|P1|Overall Study|Patient/Guardian Decision|3
276274|NCT01982292|923452|P2|Overall Study|Protocol Deviation|0
276275|NCT01982292|923453|P1|Overall Study|Protocol Deviation|1
276276|NCT01982292|923452|P2|Overall Study|Non-Compliance With Study Treatment|0
276277|NCT01982292|923453|P1|Overall Study|Non-Compliance With Study Treatment|1
276278|NCT01982292|923452|P2|Overall Study|Lost to Follow-up|0
276279|NCT01982292|923453|P1|Overall Study|Lost to Follow-up|2
276280|NCT01982292|923452|P2|Overall Study|Death|0
276281|NCT01982292|923453|P1|Overall Study|Death|1
276282|NCT01982292|923452|P2|Overall Study|Adverse Event|0
276283|NCT01982292|923453|P1|Overall Study|Adverse Event|2
276284|NCT01982253|923474|P3|Overall Study|Study terminated by sponsor|4
276285|NCT01982253|923475|P2|Overall Study|Study terminated by sponsor|4
276286|NCT01982253|923476|P1|Overall Study|Study terminated by sponsor|1
276287|NCT01982253|923474|P3|Overall Study|Withdrawal by Subject|0
276288|NCT01982253|923475|P2|Overall Study|Withdrawal by Subject|0
276289|NCT01982253|923476|P1|Overall Study|Withdrawal by Subject|1
276290|NCT01981954|923500|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
276291|NCT01981954|923500|P1|Titration Period|Protocol Deviation|1
276292|NCT01981616|923560|P2|Overall Study|Protocol Violation|0
276293|NCT01981616|923561|P1|Overall Study|Protocol Violation|1
276294|NCT01981616|923560|P2|Overall Study|Adverse Event|1
276295|NCT01981616|923561|P1|Overall Study|Adverse Event|0
276296|NCT01981473|923587|P3|Overall Study|Received treatment for >24 months|6
276297|NCT01981473|923588|P2|Overall Study|Received treatment for >24 months|0
276298|NCT01981473|923589|P1|Overall Study|Received treatment for >24 months|2
276299|NCT01981473|923587|P3|Overall Study|Received treatment for < 6 months|1
276300|NCT01981473|923588|P2|Overall Study|Received treatment for < 6 months|0
276301|NCT01981473|923589|P1|Overall Study|Received treatment for < 6 months|0
276302|NCT01981473|923587|P3|Overall Study|Incorrect diagnosis of RA|1
276303|NCT01981473|923588|P2|Overall Study|Incorrect diagnosis of RA|0
276304|NCT01981473|923589|P1|Overall Study|Incorrect diagnosis of RA|0
276305|NCT01981356|923630|P2|Overall Study|Protocol Violation|0
276306|NCT01981356|923631|P1|Overall Study|Protocol Violation|2
276307|NCT01981356|923630|P2|Overall Study|Withdrawal by Subject|1
276308|NCT01981356|923631|P1|Overall Study|Withdrawal by Subject|1
276309|NCT01981356|923630|P2|Overall Study|Lost to Follow-up|1
276310|NCT01981356|923631|P1|Overall Study|Lost to Follow-up|4
276311|NCT01980992|923667|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
276312|NCT01980992|923668|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
276313|NCT01980992|923667|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
276314|NCT01980992|923668|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
276315|NCT01980992|923667|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
276316|NCT01980992|923668|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
276317|NCT01980992|923667|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
276318|NCT01980992|923668|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
276319|NCT01980992|923667|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
276320|NCT01980992|923668|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
276321|NCT01980992|923667|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
276322|NCT01980992|923668|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
276323|NCT01980940|923693|P8|Overall Study|Protocol Violation|0
276324|NCT01980940|923694|P7|Overall Study|Protocol Violation|0
276325|NCT01980940|923695|P6|Overall Study|Protocol Violation|2
276326|NCT01980940|923696|P5|Overall Study|Protocol Violation|0
276327|NCT01980940|923697|P4|Overall Study|Protocol Violation|0
276328|NCT01980940|923698|P3|Overall Study|Protocol Violation|0
276329|NCT01980940|923699|P2|Overall Study|Protocol Violation|0
276330|NCT01980940|923700|P1|Overall Study|Protocol Violation|0
276331|NCT01980888|923754|P2|Overall Study|Non-Compliance with Study Drug|2
276332|NCT01980888|923755|P1|Overall Study|Non-Compliance with Study Drug|3
276333|NCT01980888|923754|P2|Overall Study|Investigator's Discretion|3
276334|NCT01980888|923755|P1|Overall Study|Investigator's Discretion|8
276335|NCT01980888|923754|P2|Overall Study|Withdrew Consent|6
276336|NCT01980888|923755|P1|Overall Study|Withdrew Consent|17
276337|NCT01980888|923754|P2|Overall Study|Study Terminated by Sponsor|122
276338|NCT01980888|923755|P1|Overall Study|Study Terminated by Sponsor|116
276339|NCT01980875|923774|P3|Overall Study|Lost to Follow-up|1
276340|NCT01980875|923775|P2|Overall Study|Lost to Follow-up|0
276341|NCT01980875|923776|P1|Overall Study|Lost to Follow-up|0
276342|NCT01980875|923774|P3|Overall Study|Study Terminated by Sponsor|22
276343|NCT01980875|923775|P2|Overall Study|Study Terminated by Sponsor|24
276344|NCT01980875|923776|P1|Overall Study|Study Terminated by Sponsor|7
276345|NCT01980875|923774|P3|Overall Study|Withdrew Consent|1
276346|NCT01980875|923775|P2|Overall Study|Withdrew Consent|1
276347|NCT01980875|923776|P1|Overall Study|Withdrew Consent|1
276348|NCT01980095|923847|P2|Overall Study|Study drug discontinued|0
276349|NCT01980095|923848|P1|Overall Study|Study drug discontinued|1
276350|NCT01980095|923847|P2|Overall Study|Safety issue|1
276351|NCT01980095|923848|P1|Overall Study|Safety issue|0
276352|NCT01980095|923847|P2|Overall Study|Poor compliance|0
276353|NCT01980095|923848|P1|Overall Study|Poor compliance|5
276354|NCT01980095|923847|P2|Overall Study|Withdrawal by Subject|3
276355|NCT01980095|923848|P1|Overall Study|Withdrawal by Subject|2
276356|NCT01980095|923847|P2|Overall Study|Lost to Follow-up|7
276357|NCT01980095|923848|P1|Overall Study|Lost to Follow-up|6
276358|NCT01979952|923858|P2|Overall Study|Other than specified above|0
276359|NCT01979952|923859|P1|Overall Study|Other than specified above|1
276360|NCT01979952|923858|P2|Overall Study|Withdrawal by Subject|1
276361|NCT01979952|923859|P1|Overall Study|Withdrawal by Subject|2
276362|NCT01979952|923858|P2|Overall Study|Protocol Violation|0
276363|NCT01979952|923859|P1|Overall Study|Protocol Violation|1
276364|NCT01979952|923858|P2|Overall Study|Adverse Event|5
276365|NCT01979952|923859|P1|Overall Study|Adverse Event|4
276366|NCT01979185|923926|P2|Period 2|Not specified|1
276367|NCT01979185|923927|P1|Period 2|Not specified|0
276368|NCT01978145|924092|P2|Treatment Period 2|Par. reached defined stopping criteria|5
276369|NCT01978145|924093|P1|Treatment Period 2|Par. reached defined stopping criteria|8
276370|NCT01978145|924092|P2|Treatment Period 2|Withdrawal by Subject|4
276371|NCT01978145|924093|P1|Treatment Period 2|Withdrawal by Subject|7
276372|NCT01978145|924092|P2|Treatment Period 2|Lost to Follow-up|1
276373|NCT01978145|924093|P1|Treatment Period 2|Lost to Follow-up|1
276374|NCT01978145|924092|P2|Treatment Period 2|Protocol Violation|1
276375|NCT01978145|924093|P1|Treatment Period 2|Protocol Violation|0
276376|NCT01978145|924092|P2|Treatment Period 2|Adverse Event|3
276377|NCT01978145|924093|P1|Treatment Period 2|Adverse Event|3
276378|NCT01978145|924092|P2|Washout Period 1|Par. reached defined stopping criteria|1
276379|NCT01978145|924093|P1|Washout Period 1|Par. reached defined stopping criteria|0
276380|NCT01978145|924092|P2|Washout Period 1|Withdrawal by Subject|1
276381|NCT01978145|924093|P1|Washout Period 1|Withdrawal by Subject|1
276382|NCT01978145|924092|P2|Washout Period 1|Adverse Event|1
276383|NCT01978145|924093|P1|Washout Period 1|Adverse Event|0
276384|NCT01978145|924092|P2|Treatment Period 1|Par. reached defined stopping criteria|3
276385|NCT01978145|924093|P1|Treatment Period 1|Par. reached defined stopping criteria|2
276386|NCT01978145|924092|P2|Treatment Period 1|Withdrawal by Subject|4
276387|NCT01978145|924093|P1|Treatment Period 1|Withdrawal by Subject|5
276388|NCT01978145|924092|P2|Treatment Period 1|Physician Decision|0
276389|NCT01978145|924093|P1|Treatment Period 1|Physician Decision|1
276390|NCT01978145|924092|P2|Treatment Period 1|Adverse Event|9
276391|NCT01978145|924093|P1|Treatment Period 1|Adverse Event|1
276392|NCT01978119|924109|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
276393|NCT01978119|924110|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
276394|NCT01978119|924109|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
276395|NCT01978119|924110|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
276396|NCT01978119|924109|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
276397|NCT01978119|924110|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
276398|NCT01978093|924136|P2|Overall Study|N/A for vaccine administration|1
276399|NCT01978093|924137|P1|Overall Study|N/A for vaccine administration|0
276400|NCT01978093|924136|P2|Overall Study|Child was in care of grandmother|1
276401|NCT01978093|924137|P1|Overall Study|Child was in care of grandmother|0
276402|NCT01978093|924136|P2|Overall Study|Mother lost custody of child|1
276403|NCT01978093|924137|P1|Overall Study|Mother lost custody of child|0
276404|NCT01978093|924136|P2|Overall Study|Lost kaiser health plan unable to contac|0
276405|NCT01978093|924137|P1|Overall Study|Lost kaiser health plan unable to contac|1
276406|NCT01978093|924136|P2|Overall Study|Loss of kaiser coverage|10
276407|NCT01978093|924137|P1|Overall Study|Loss of kaiser coverage|4
276408|NCT01978093|924136|P2|Overall Study|Migrated/moved from study area|13
276409|NCT01978093|924137|P1|Overall Study|Migrated/moved from study area|11
276410|NCT01978093|924136|P2|Overall Study|Lost to Follow-up|15
276411|NCT01978093|924137|P1|Overall Study|Lost to Follow-up|11
276412|NCT01978093|924136|P2|Overall Study|Withdrawal by Subject|25
276413|NCT01978093|924137|P1|Overall Study|Withdrawal by Subject|29
276414|NCT01978093|924136|P2|Overall Study|Protocol Violation|2
276415|NCT01978093|924137|P1|Overall Study|Protocol Violation|8
276416|NCT01978093|924136|P2|Overall Study|Adverse Event|5
276417|NCT01978093|924137|P1|Overall Study|Adverse Event|0
276418|NCT01978093|924136|P2|Overall Study|Death|0
276419|NCT01978093|924137|P1|Overall Study|Death|1
276420|NCT01977820|924181|P2|Overall Study|Sponsor terminated the study|1
276421|NCT01977820|924182|P1|Overall Study|Sponsor terminated the study|1
276422|NCT01977794|924190|P2|Overall Study|Other|1
276423|NCT01977794|924191|P1|Overall Study|Other|0
276424|NCT01977794|924190|P2|Overall Study|Withdrew consent|1
276425|NCT01977794|924191|P1|Overall Study|Withdrew consent|2
276426|NCT01977794|924190|P2|Overall Study|Death|1
276427|NCT01977794|924191|P1|Overall Study|Death|1
276428|NCT01977794|924190|P2|Overall Study|Protocol Violation|0
276429|NCT01977794|924191|P1|Overall Study|Protocol Violation|1
276430|NCT01977794|924190|P2|Overall Study|Lost to Follow-up|1
276431|NCT01977794|924191|P1|Overall Study|Lost to Follow-up|2
276432|NCT01977794|924190|P2|Overall Study|Adverse Event|2
276433|NCT01977794|924191|P1|Overall Study|Adverse Event|2
276434|NCT01977729|924226|P1|Overall Study|Study terminated|1
276435|NCT01977690|924238|P2|Overall Study|Withdrawal by Subject|4
276436|NCT01977690|924239|P1|Overall Study|Withdrawal by Subject|0
276437|NCT01977625|924245|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
276438|NCT01977625|924246|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
276439|NCT01977625|924245|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
276440|NCT01977625|924246|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
276441|NCT01977612|924256|P2|Overall Study|Lost to Follow-up|1
276442|NCT01977612|924257|P1|Overall Study|Lost to Follow-up|1
276443|NCT01977573|924279|P4|Overall Study|Withdrawal by Subject|1
276444|NCT01977573|924280|P3|Overall Study|Withdrawal by Subject|1
276445|NCT01977573|924281|P2|Overall Study|Withdrawal by Subject|1
276446|NCT01977573|924282|P1|Overall Study|Withdrawal by Subject|6
276447|NCT01977573|924279|P4|Overall Study|Reached Defined Stopping Criteria|0
276448|NCT01977573|924280|P3|Overall Study|Reached Defined Stopping Criteria|1
276449|NCT01977573|924281|P2|Overall Study|Reached Defined Stopping Criteria|1
276450|NCT01977573|924282|P1|Overall Study|Reached Defined Stopping Criteria|2
276451|NCT01977573|924279|P4|Overall Study|Protocol Violation|0
276452|NCT01977573|924280|P3|Overall Study|Protocol Violation|0
276453|NCT01977573|924281|P2|Overall Study|Protocol Violation|1
276454|NCT01977573|924282|P1|Overall Study|Protocol Violation|3
276455|NCT01977573|924279|P4|Overall Study|Physician Decision|0
276456|NCT01977573|924280|P3|Overall Study|Physician Decision|0
276457|NCT01977573|924281|P2|Overall Study|Physician Decision|0
276458|NCT01977573|924282|P1|Overall Study|Physician Decision|1
276459|NCT01977573|924279|P4|Overall Study|Lost to Follow-up|1
276460|NCT01977573|924280|P3|Overall Study|Lost to Follow-up|0
276461|NCT01977573|924281|P2|Overall Study|Lost to Follow-up|0
276462|NCT01977573|924282|P1|Overall Study|Lost to Follow-up|1
276463|NCT01977573|924279|P4|Overall Study|Adverse Event|1
276464|NCT01977573|924280|P3|Overall Study|Adverse Event|2
276465|NCT01977573|924281|P2|Overall Study|Adverse Event|0
276466|NCT01977573|924282|P1|Overall Study|Adverse Event|7
276467|NCT01977482|924396|P6|Overall Study|Withdrawal by Subject|5
276468|NCT01977482|924397|P5|Overall Study|Withdrawal by Subject|1
276469|NCT01977482|924398|P4|Overall Study|Withdrawal by Subject|3
276470|NCT01977482|924399|P3|Overall Study|Withdrawal by Subject|1
276471|NCT01977482|924400|P2|Overall Study|Withdrawal by Subject|4
276472|NCT01977482|924401|P1|Overall Study|Withdrawal by Subject|2
276473|NCT01977482|924396|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
276474|NCT01977482|924397|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
276475|NCT01977482|924398|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
276476|NCT01977482|924399|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
276477|NCT01977482|924400|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
276478|NCT01977482|924401|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
276479|NCT01977482|924396|P6|Overall Study|Protocol Violation|0
276480|NCT01977482|924397|P5|Overall Study|Protocol Violation|0
276481|NCT01977482|924398|P4|Overall Study|Protocol Violation|0
276482|NCT01977482|924399|P3|Overall Study|Protocol Violation|1
276483|NCT01977482|924400|P2|Overall Study|Protocol Violation|0
276484|NCT01977482|924401|P1|Overall Study|Protocol Violation|0
276485|NCT01977482|924396|P6|Overall Study|Physician Decision|0
276486|NCT01977482|924397|P5|Overall Study|Physician Decision|0
276487|NCT01977482|924398|P4|Overall Study|Physician Decision|0
276488|NCT01977482|924399|P3|Overall Study|Physician Decision|0
276489|NCT01977482|924400|P2|Overall Study|Physician Decision|1
276490|NCT01977482|924401|P1|Overall Study|Physician Decision|0
276491|NCT01977482|924396|P6|Overall Study|Lost to Follow-up|0
276492|NCT01977482|924397|P5|Overall Study|Lost to Follow-up|0
276493|NCT01977482|924398|P4|Overall Study|Lost to Follow-up|0
276494|NCT01977482|924399|P3|Overall Study|Lost to Follow-up|0
276495|NCT01977482|924400|P2|Overall Study|Lost to Follow-up|0
276496|NCT01977482|924401|P1|Overall Study|Lost to Follow-up|1
276497|NCT01977482|924396|P6|Overall Study|Adverse Event|0
276498|NCT01977482|924397|P5|Overall Study|Adverse Event|2
276499|NCT01977482|924398|P4|Overall Study|Adverse Event|0
276500|NCT01977482|924399|P3|Overall Study|Adverse Event|1
276501|NCT01977482|924400|P2|Overall Study|Adverse Event|1
276502|NCT01977482|924401|P1|Overall Study|Adverse Event|0
276503|NCT01977456|924516|P1|Overall Study|Death|5
276504|NCT01977352|924525|P2|Overall Study|Lost to Follow-up|2
276505|NCT01977352|924526|P1|Overall Study|Lost to Follow-up|1
276506|NCT01977222|924544|P1|Overall Study|Withdrawal by Subject|1
276507|NCT01976845|924586|P3|Overall Study|Physician Decision|3
276508|NCT01976845|924587|P2|Overall Study|Physician Decision|8
276509|NCT01976845|924588|P1|Overall Study|Physician Decision|8
276510|NCT01976806|924613|P2|Overall Study|Withdrawal by Subject|1
276511|NCT01976806|924614|P1|Overall Study|Withdrawal by Subject|1
276512|NCT01976806|924613|P2|Overall Study|Adverse Event|1
276513|NCT01976806|924614|P1|Overall Study|Adverse Event|1
276514|NCT01976806|924613|P2|Overall Study|Lost to Follow-up|4
276515|NCT01976806|924614|P1|Overall Study|Lost to Follow-up|1
276516|NCT01976663|924642|P1|Overall Study|Lost to Follow-up|3
276517|NCT01976663|924642|P1|Overall Study|Adverse Event|2
276518|NCT01976663|924642|P1|Overall Study|Screen Failure|3
276519|NCT01976663|924642|P1|Overall Study|Withdrawal by Subject|4
276520|NCT01976663|924642|P1|Overall Study|Personal Reasons|6
276521|NCT01976663|924642|P1|Overall Study|Completed 18 mos but no repeat treatment|24
276522|NCT01976624|924661|P1|Overall Study|Participants age less than 19 years|12
276523|NCT01976624|924661|P1|Overall Study|Participants contraindicated|2
276524|NCT01976507|924689|P1|Overall Study|ablation not done, drug not given|1
276525|NCT01976507|924689|P1|Overall Study|Adverse Event|6
276526|NCT01976338|924713|P2|Overall Study|Adverse Event|1
276527|NCT01976338|924714|P1|Overall Study|Adverse Event|5
276528|NCT01976338|924713|P2|Overall Study|Withdrawal by Subject|2
276529|NCT01976338|924714|P1|Overall Study|Withdrawal by Subject|5
276530|NCT01976338|924713|P2|Overall Study|Lost to Follow-up|0
276531|NCT01976338|924714|P1|Overall Study|Lost to Follow-up|3
276532|NCT01976338|924713|P2|Overall Study|Physician Decision|1
276533|NCT01976338|924714|P1|Overall Study|Physician Decision|0
276534|NCT01976312|924741|P2|Overall Study|Protocol Violation|0
276535|NCT01976312|924742|P1|Overall Study|Protocol Violation|2
276536|NCT01976312|924741|P2|Overall Study|Adverse Event|6
276537|NCT01976312|924742|P1|Overall Study|Adverse Event|6
276538|NCT01976312|924741|P2|Overall Study|Withdrawal by Subject|2
276539|NCT01976312|924742|P1|Overall Study|Withdrawal by Subject|7
276540|NCT01976312|924741|P2|Overall Study|Lost to Follow-up|0
276541|NCT01976312|924742|P1|Overall Study|Lost to Follow-up|2
276542|NCT01976312|924741|P2|Overall Study|Pregnancy|1
276543|NCT01976312|924742|P1|Overall Study|Pregnancy|0
276544|NCT01976299|924763|P2|Overall Study|See clarification above in comments|2
276545|NCT01976299|924764|P1|Overall Study|See clarification above in comments|9
276546|NCT01976299|924763|P2|Overall Study|Lost to Follow-up|1
276547|NCT01976299|924764|P1|Overall Study|Lost to Follow-up|7
276548|NCT01976299|924763|P2|Overall Study|Death|2
276549|NCT01976299|924764|P1|Overall Study|Death|4
276550|NCT01976299|924763|P2|Overall Study|Withdrawal by Subject|1
276551|NCT01976299|924764|P1|Overall Study|Withdrawal by Subject|3
276552|NCT01976104|924791|P4|Overall Study|Other|0
276553|NCT01976104|924792|P3|Overall Study|Other|0
276554|NCT01976104|924793|P2|Overall Study|Other|1
276555|NCT01976104|924794|P1|Overall Study|Other|0
276556|NCT01976104|924791|P4|Overall Study|Withdrawal by Subject|1
276557|NCT01976104|924792|P3|Overall Study|Withdrawal by Subject|0
276558|NCT01976104|924793|P2|Overall Study|Withdrawal by Subject|0
276559|NCT01976104|924794|P1|Overall Study|Withdrawal by Subject|3
276560|NCT01976104|924791|P4|Overall Study|Subject Choice|1
276561|NCT01976104|924792|P3|Overall Study|Subject Choice|0
276562|NCT01976104|924793|P2|Overall Study|Subject Choice|1
276563|NCT01976104|924794|P1|Overall Study|Subject Choice|0
276564|NCT01976104|924791|P4|Overall Study|Lost to Follow-up|1
276565|NCT01976104|924792|P3|Overall Study|Lost to Follow-up|1
276566|NCT01976104|924793|P2|Overall Study|Lost to Follow-up|0
276567|NCT01976104|924794|P1|Overall Study|Lost to Follow-up|3
276568|NCT01976104|924791|P4|Overall Study|Adverse Event|0
276569|NCT01976104|924792|P3|Overall Study|Adverse Event|1
276570|NCT01976104|924793|P2|Overall Study|Adverse Event|0
276571|NCT01976104|924794|P1|Overall Study|Adverse Event|0
276572|NCT01975948|924828|P4|Overall Study|Withdrawal by Subject|6
276573|NCT01975948|924829|P3|Overall Study|Withdrawal by Subject|7
276574|NCT01975948|924830|P2|Overall Study|Withdrawal by Subject|21
276575|NCT01975948|924831|P1|Overall Study|Withdrawal by Subject|17
276576|NCT01975675|924902|P4|Overall Study|Death|0
276577|NCT01975675|924903|P3|Overall Study|Death|0
276578|NCT01975675|924904|P2|Overall Study|Death|1
276579|NCT01975675|924905|P1|Overall Study|Death|0
276580|NCT01975389|924938|P2|Overall Study|Randomized, not treated|5
276581|NCT01975389|924939|P1|Overall Study|Randomized, not treated|4
276582|NCT01975389|924938|P2|Overall Study|Other|9
276583|NCT01975389|924939|P1|Overall Study|Other|6
276584|NCT01975389|924938|P2|Overall Study|Withdrawal by Subject|76
276585|NCT01975389|924939|P1|Overall Study|Withdrawal by Subject|90
276586|NCT01975389|924938|P2|Overall Study|Lost to Follow-up|86
276587|NCT01975389|924939|P1|Overall Study|Lost to Follow-up|81
276588|NCT01975389|924938|P2|Overall Study|Death|54
276589|NCT01975389|924939|P1|Overall Study|Death|61
276590|NCT01975389|924938|P2|Overall Study|Adverse Event|6
276591|NCT01975389|924939|P1|Overall Study|Adverse Event|10
276592|NCT01975376|924999|P2|Overall Study|Randomized, Not Treated|8
276593|NCT01975376|925000|P1|Overall Study|Randomized, Not Treated|16
276594|NCT01975376|924999|P2|Overall Study|Other|4
276595|NCT01975376|925000|P1|Overall Study|Other|2
276596|NCT01975376|924999|P2|Overall Study|Withdrew consent|62
276597|NCT01975376|925000|P1|Overall Study|Withdrew consent|68
276598|NCT01975376|924999|P2|Overall Study|Lost to Follow-up|66
276599|NCT01975376|925000|P1|Overall Study|Lost to Follow-up|70
276600|NCT01975376|924999|P2|Overall Study|Death|72
276601|NCT01975376|925000|P1|Overall Study|Death|65
276602|NCT01975376|924999|P2|Overall Study|Adverse Event|5
276603|NCT01975376|925000|P1|Overall Study|Adverse Event|5
276604|NCT01975285|925060|P2|Overall Study|Failed Block and follow up|2
276605|NCT01975285|925061|P1|Overall Study|Failed Block and follow up|2
276606|NCT01975246|925077|P2|Overall Study|Other than stated|1
276607|NCT01975246|925078|P1|Overall Study|Other than stated|0
276608|NCT01975246|925077|P2|Overall Study|Protocol Violation|0
276609|NCT01975246|925078|P1|Overall Study|Protocol Violation|1
276610|NCT01975246|925077|P2|Overall Study|Lack of Efficacy|0
276611|NCT01975246|925078|P1|Overall Study|Lack of Efficacy|1
276612|NCT01975246|925077|P2|Overall Study|Adverse Event|1
276613|NCT01975246|925078|P1|Overall Study|Adverse Event|2
276614|NCT01975220|925091|P6|Test Period 1|Not treated|0
276615|NCT01975220|925092|P5|Test Period 1|Not treated|0
276616|NCT01975220|925093|P4|Test Period 1|Not treated|0
276617|NCT01975220|925094|P3|Test Period 1|Not treated|0
276618|NCT01975220|925095|P2|Test Period 1|Not treated|1
276619|NCT01975220|925096|P1|Test Period 1|Not treated|0
276620|NCT01974895|925152|P2|Overall Study|Other (Reason unknown)|8
276621|NCT01974895|925153|P1|Overall Study|Other (Reason unknown)|9
276622|NCT01974895|925152|P2|Overall Study|Other (Missed Visit)|0
276623|NCT01974895|925153|P1|Overall Study|Other (Missed Visit)|1
276624|NCT01974895|925152|P2|Overall Study|Withdrawal by Subject|1
276625|NCT01974895|925153|P1|Overall Study|Withdrawal by Subject|0
276626|NCT01974895|925152|P2|Overall Study|Lost to Follow-up|6
276627|NCT01974895|925153|P1|Overall Study|Lost to Follow-up|4
276628|NCT01974895|925152|P2|Overall Study|Protocol Violation|0
276629|NCT01974895|925153|P1|Overall Study|Protocol Violation|1
276630|NCT01974817|925183|P1|Overall Study|Protocol Violation|2
276631|NCT01974817|925183|P1|Overall Study|Lost to Follow-up|2
276632|NCT01974817|925183|P1|Overall Study|Death|4
276633|NCT01974752|925189|P2|Overall Study|Other Eligibility Criteria|1
276634|NCT01974752|925190|P1|Overall Study|Other Eligibility Criteria|0
276635|NCT01974752|925189|P2|Overall Study|Withdrawal by Subject|3
276636|NCT01974752|925190|P1|Overall Study|Withdrawal by Subject|2
276637|NCT01974752|925189|P2|Overall Study|Lost to Follow-up|0
276638|NCT01974752|925190|P1|Overall Study|Lost to Follow-up|2
276639|NCT01974752|925189|P2|Overall Study|Death|11
276640|NCT01974752|925190|P1|Overall Study|Death|33
276641|NCT01974323|925217|P2|Overall Study|Adverse Event|2
276642|NCT01974323|925218|P1|Overall Study|Adverse Event|2
276643|NCT01974323|925217|P2|Overall Study|Lack of Efficacy|1
276644|NCT01974323|925218|P1|Overall Study|Lack of Efficacy|1
276645|NCT01974323|925217|P2|Overall Study|Pregnancy|1
276646|NCT01974323|925218|P1|Overall Study|Pregnancy|2
276647|NCT01974323|925217|P2|Overall Study|Lost to Follow-up|40
276648|NCT01974323|925218|P1|Overall Study|Lost to Follow-up|45
276649|NCT01974323|925217|P2|Overall Study|Personal Reasons|19
276650|NCT01974323|925218|P1|Overall Study|Personal Reasons|15
276651|NCT01974323|925217|P2|Overall Study|Protocol Violation|2
276652|NCT01974323|925218|P1|Overall Study|Protocol Violation|2
276653|NCT01974323|925217|P2|Overall Study|Other Reasons|28
276654|NCT01974323|925218|P1|Overall Study|Other Reasons|25
276655|NCT01974141|925251|P2|Overall Study|Adverse Event|5
276656|NCT01974141|925252|P1|Overall Study|Adverse Event|4
276657|NCT01974141|925251|P2|Overall Study|Lack of Efficacy|1
276658|NCT01974141|925252|P1|Overall Study|Lack of Efficacy|0
276659|NCT01974141|925251|P2|Overall Study|Pregnancy|3
276660|NCT01974141|925252|P1|Overall Study|Pregnancy|3
276661|NCT01974141|925251|P2|Overall Study|Lost to Follow-up|29
276662|NCT01974141|925252|P1|Overall Study|Lost to Follow-up|38
276663|NCT01974141|925251|P2|Overall Study|Personal Reasons|20
276664|NCT01974141|925252|P1|Overall Study|Personal Reasons|21
276665|NCT01974141|925251|P2|Overall Study|Protocol Violation|6
276666|NCT01974141|925252|P1|Overall Study|Protocol Violation|2
276667|NCT01974141|925251|P2|Overall Study|Other Reasons|18
276668|NCT01974141|925252|P1|Overall Study|Other Reasons|28
276669|NCT01973595|925316|P4|Washout|Withdrawal by Subject|0
276670|NCT01973595|925317|P3|Washout|Withdrawal by Subject|1
276671|NCT01973595|925318|P2|Washout|Withdrawal by Subject|0
276672|NCT01973595|925319|P1|Washout|Withdrawal by Subject|1
276673|NCT01973491|925333|P1|Treatment Period (16 Weeks)|Adverse Event|1
276674|NCT01973491|925333|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
276675|NCT01973491|925333|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
276676|NCT01973439|925349|P1|Overall Study|PK curve incomplete|2
276677|NCT01973439|925349|P1|Overall Study|Vomiting after commencing once daily|1
276678|NCT01973439|925349|P1|Overall Study|Lost samples from one PK Day|2
276679|NCT01973387|925371|P2|Overall Study|Did not receive study drug|2
276680|NCT01973387|925372|P1|Overall Study|Did not receive study drug|2
276681|NCT01973387|925371|P2|Overall Study|Ongoing|0
276682|NCT01973387|925372|P1|Overall Study|Ongoing|72
276683|NCT01973387|925371|P2|Overall Study|Adverse Event|4
276684|NCT01973387|925372|P1|Overall Study|Adverse Event|13
276685|NCT01973387|925371|P2|Overall Study|Progressive disease or relapse|5
276686|NCT01973387|925372|P1|Overall Study|Progressive disease or relapse|10
276687|NCT01973387|925371|P2|Overall Study|Death|3
276688|NCT01973387|925372|P1|Overall Study|Death|3
276689|NCT01973387|925371|P2|Overall Study|Withdrawal by Subject|4
276690|NCT01973387|925372|P1|Overall Study|Withdrawal by Subject|6
276691|NCT01973231|925409|P2|Overall Study|Withdrawal by Subject|9
276692|NCT01973231|925410|P1|Overall Study|Withdrawal by Subject|7
276693|NCT01973231|925409|P2|Overall Study|unclassified|1
276694|NCT01973231|925410|P1|Overall Study|unclassified|2
276695|NCT01973231|925409|P2|Overall Study|Lost to Follow-up|1
276696|NCT01973231|925410|P1|Overall Study|Lost to Follow-up|1
276697|NCT01973231|925409|P2|Overall Study|Protocol Violation|1
276698|NCT01973231|925410|P1|Overall Study|Protocol Violation|1
276699|NCT01973218|925430|P2|Overall Study|Withdrawal by Subject|0
276700|NCT01973218|925431|P1|Overall Study|Withdrawal by Subject|1
276701|NCT01973218|925430|P2|Overall Study|Adverse Event|0
276702|NCT01973218|925431|P1|Overall Study|Adverse Event|1
276703|NCT01972841|925473|P6|Overall Study|Did not have end of treatment page|0
276704|NCT01972841|925474|P5|Overall Study|Did not have end of treatment page|1
276705|NCT01972841|925475|P4|Overall Study|Did not have end of treatment page|0
276706|NCT01972841|925476|P3|Overall Study|Did not have end of treatment page|0
276707|NCT01972841|925477|P2|Overall Study|Did not have end of treatment page|0
276708|NCT01972841|925478|P1|Overall Study|Did not have end of treatment page|0
276709|NCT01972841|925473|P6|Overall Study|Miscellaneous|4
276710|NCT01972841|925474|P5|Overall Study|Miscellaneous|0
276711|NCT01972841|925475|P4|Overall Study|Miscellaneous|1
276712|NCT01972841|925476|P3|Overall Study|Miscellaneous|4
276713|NCT01972841|925477|P2|Overall Study|Miscellaneous|0
276714|NCT01972841|925478|P1|Overall Study|Miscellaneous|0
276715|NCT01972841|925473|P6|Overall Study|Withdrawal by participants|34
276716|NCT01972841|925474|P5|Overall Study|Withdrawal by participants|33
276717|NCT01972841|925475|P4|Overall Study|Withdrawal by participants|16
276718|NCT01972841|925476|P3|Overall Study|Withdrawal by participants|23
276719|NCT01972841|925477|P2|Overall Study|Withdrawal by participants|27
276720|NCT01972841|925478|P1|Overall Study|Withdrawal by participants|21
276721|NCT01972841|925473|P6|Overall Study|Protocol Violation|4
276722|NCT01972841|925474|P5|Overall Study|Protocol Violation|9
276723|NCT01972841|925475|P4|Overall Study|Protocol Violation|5
276724|NCT01972841|925476|P3|Overall Study|Protocol Violation|3
276725|NCT01972841|925477|P2|Overall Study|Protocol Violation|2
276726|NCT01972841|925478|P1|Overall Study|Protocol Violation|2
276727|NCT01972841|925473|P6|Overall Study|Lost to Follow-up|3
276728|NCT01972841|925474|P5|Overall Study|Lost to Follow-up|9
276729|NCT01972841|925475|P4|Overall Study|Lost to Follow-up|2
276730|NCT01972841|925476|P3|Overall Study|Lost to Follow-up|4
276731|NCT01972841|925477|P2|Overall Study|Lost to Follow-up|2
276732|NCT01972841|925478|P1|Overall Study|Lost to Follow-up|4
276733|NCT01972841|925473|P6|Overall Study|Lack of Efficacy|1
276734|NCT01972841|925474|P5|Overall Study|Lack of Efficacy|4
276735|NCT01972841|925475|P4|Overall Study|Lack of Efficacy|2
276736|NCT01972841|925476|P3|Overall Study|Lack of Efficacy|0
276737|NCT01972841|925477|P2|Overall Study|Lack of Efficacy|0
276738|NCT01972841|925478|P1|Overall Study|Lack of Efficacy|1
276739|NCT01972841|925473|P6|Overall Study|Adverse Event|26
276740|NCT01972841|925474|P5|Overall Study|Adverse Event|21
276741|NCT01972841|925475|P4|Overall Study|Adverse Event|9
276742|NCT01972841|925476|P3|Overall Study|Adverse Event|12
276743|NCT01972841|925477|P2|Overall Study|Adverse Event|8
276744|NCT01972841|925478|P1|Overall Study|Adverse Event|13
276745|NCT01972841|925473|P6|Overall Study|Randomized but Never Received Treatment|13
276746|NCT01972841|925474|P5|Overall Study|Randomized but Never Received Treatment|6
276747|NCT01972841|925475|P4|Overall Study|Randomized but Never Received Treatment|2
276748|NCT01972841|925476|P3|Overall Study|Randomized but Never Received Treatment|4
276749|NCT01972841|925477|P2|Overall Study|Randomized but Never Received Treatment|5
276750|NCT01972841|925478|P1|Overall Study|Randomized but Never Received Treatment|2
276751|NCT01972776|925912|P6|Part 2|Administrative problems|7
276752|NCT01972776|925913|P5|Part 2|Administrative problems|10
276753|NCT01972776|925914|P4|Part 2|Administrative problems|0
276754|NCT01972776|925915|P3|Part 2|Administrative problems|0
276755|NCT01972776|925916|P2|Part 2|Administrative problems|0
276756|NCT01972776|925917|P1|Part 2|Administrative problems|0
276757|NCT01972776|925912|P6|Part 2|Adverse Event|0
276758|NCT01972776|925913|P5|Part 2|Adverse Event|3
276759|NCT01972776|925914|P4|Part 2|Adverse Event|0
276760|NCT01972776|925915|P3|Part 2|Adverse Event|0
276761|NCT01972776|925916|P2|Part 2|Adverse Event|0
276762|NCT01972776|925917|P1|Part 2|Adverse Event|0
276763|NCT01972776|925912|P6|Part 1|Adverse Event|0
276764|NCT01972776|925913|P5|Part 1|Adverse Event|0
276765|NCT01972776|925914|P4|Part 1|Adverse Event|1
276766|NCT01972776|925915|P3|Part 1|Adverse Event|1
276767|NCT01972776|925916|P2|Part 1|Adverse Event|0
276768|NCT01972776|925917|P1|Part 1|Adverse Event|0
276769|NCT01972776|925912|P6|Part 1|Withdrawal by Subject|0
276770|NCT01972776|925913|P5|Part 1|Withdrawal by Subject|0
276771|NCT01972776|925914|P4|Part 1|Withdrawal by Subject|0
276772|NCT01972776|925915|P3|Part 1|Withdrawal by Subject|1
276773|NCT01972776|925916|P2|Part 1|Withdrawal by Subject|0
276774|NCT01972776|925917|P1|Part 1|Withdrawal by Subject|0
276775|NCT01972659|925987|P2|Overall Study|problems realted to acceleromyograph|1
276776|NCT01972659|925988|P1|Overall Study|problems realted to acceleromyograph|2
276777|NCT01972659|925987|P2|Overall Study|Protocol Violation|2
276778|NCT01972659|925988|P1|Overall Study|Protocol Violation|2
276779|NCT01972568|925997|P3|Overall Study|Adverse Event|5
276780|NCT01972568|925998|P2|Overall Study|Adverse Event|6
276781|NCT01972568|925999|P1|Overall Study|Adverse Event|5
276782|NCT01972568|925997|P3|Overall Study|Lost to Follow-up|0
276783|NCT01972568|925998|P2|Overall Study|Lost to Follow-up|0
276784|NCT01972568|925999|P1|Overall Study|Lost to Follow-up|1
276785|NCT01972568|925997|P3|Overall Study|Withdrawal by Subject|7
276786|NCT01972568|925998|P2|Overall Study|Withdrawal by Subject|3
276787|NCT01972568|925999|P1|Overall Study|Withdrawal by Subject|6
276788|NCT01972568|925997|P3|Overall Study|Protocol Violation|2
276789|NCT01972568|925998|P2|Overall Study|Protocol Violation|2
276790|NCT01972568|925999|P1|Overall Study|Protocol Violation|1
276791|NCT01972568|925997|P3|Overall Study|Lack of Efficacy|2
276792|NCT01972568|925998|P2|Overall Study|Lack of Efficacy|1
276793|NCT01972568|925999|P1|Overall Study|Lack of Efficacy|0
276794|NCT01972568|925997|P3|Overall Study|Other events|0
276795|NCT01972568|925998|P2|Overall Study|Other events|0
276796|NCT01972568|925999|P1|Overall Study|Other events|3
276797|NCT01972529|926038|P4|Overall Study|Not treated|1
276798|NCT01972529|926039|P3|Overall Study|Not treated|2
276799|NCT01972529|926040|P2|Overall Study|Not treated|1
276800|NCT01972529|926041|P1|Overall Study|Not treated|0
276801|NCT01972529|926038|P4|Overall Study|Not Specified|2
276802|NCT01972529|926039|P3|Overall Study|Not Specified|0
276803|NCT01972529|926040|P2|Overall Study|Not Specified|0
276804|NCT01972529|926041|P1|Overall Study|Not Specified|0
276805|NCT01972529|926038|P4|Overall Study|Withdrawl of Consent|1
276806|NCT01972529|926039|P3|Overall Study|Withdrawl of Consent|0
276807|NCT01972529|926040|P2|Overall Study|Withdrawl of Consent|2
276808|NCT01972529|926041|P1|Overall Study|Withdrawl of Consent|1
276809|NCT01972529|926038|P4|Overall Study|Participant Choice|0
276810|NCT01972529|926039|P3|Overall Study|Participant Choice|0
276811|NCT01972529|926040|P2|Overall Study|Participant Choice|1
276812|NCT01972529|926041|P1|Overall Study|Participant Choice|0
276813|NCT01972529|926038|P4|Overall Study|Lost to Follow-up|0
276814|NCT01972529|926039|P3|Overall Study|Lost to Follow-up|0
276815|NCT01972529|926040|P2|Overall Study|Lost to Follow-up|0
276816|NCT01972529|926041|P1|Overall Study|Lost to Follow-up|1
276817|NCT01972529|926038|P4|Overall Study|Adverse Event|0
276818|NCT01972529|926039|P3|Overall Study|Adverse Event|0
276819|NCT01972529|926040|P2|Overall Study|Adverse Event|1
276820|NCT01972529|926041|P1|Overall Study|Adverse Event|0
276821|NCT01972464|926086|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
276822|NCT01972464|926087|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
276823|NCT01972464|926086|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
276824|NCT01972464|926087|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
276825|NCT01972464|926086|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
276826|NCT01972464|926087|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
276827|NCT01972464|926086|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
276828|NCT01972464|926087|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
276829|NCT01972438|926103|P2|Post Month 12 Study Period|Early Study Closure|4
276830|NCT01972438|926104|P1|Post Month 12 Study Period|Early Study Closure|3
276831|NCT01972438|926103|P2|Months 6-12 Study Period|Early Study Closure|2
276832|NCT01972438|926104|P1|Months 6-12 Study Period|Early Study Closure|2
276833|NCT01972438|926103|P2|Months 6-12 Study Period|Death|0
276834|NCT01972438|926104|P1|Months 6-12 Study Period|Death|1
276835|NCT01972438|926103|P2|Months 3-6 Crossover Period|Early Study Closure|1
276836|NCT01972438|926104|P1|Months 3-6 Crossover Period|Early Study Closure|0
276837|NCT01972438|926103|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
276838|NCT01972438|926104|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
276839|NCT01972438|926103|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
276840|NCT01972438|926104|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
276841|NCT01972438|926103|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
276842|NCT01972438|926104|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
276843|NCT01972438|926103|P2|Baseline-Month 3 Crossover Period|Death|0
276844|NCT01972438|926104|P1|Baseline-Month 3 Crossover Period|Death|1
276845|NCT01972152|926156|P6|Second Treatment Visit|Protocol Violation|0
276846|NCT01972152|926157|P5|Second Treatment Visit|Protocol Violation|0
276847|NCT01972152|926158|P4|Second Treatment Visit|Protocol Violation|0
276848|NCT01972152|926159|P3|Second Treatment Visit|Protocol Violation|0
276849|NCT01972152|926160|P2|Second Treatment Visit|Protocol Violation|1
276850|NCT01972152|926161|P1|Second Treatment Visit|Protocol Violation|0
276851|NCT01972152|926156|P6|First Treatment Visit|Lost to Follow-up|0
276852|NCT01972152|926157|P5|First Treatment Visit|Lost to Follow-up|0
276853|NCT01972152|926158|P4|First Treatment Visit|Lost to Follow-up|0
276854|NCT01972152|926159|P3|First Treatment Visit|Lost to Follow-up|0
276855|NCT01972152|926160|P2|First Treatment Visit|Lost to Follow-up|1
276856|NCT01972152|926161|P1|First Treatment Visit|Lost to Follow-up|0
276857|NCT01971723|926198|P2|Overall Study|Protocol Violation|2
276858|NCT01971723|926199|P1|Overall Study|Protocol Violation|1
276859|NCT01971723|926198|P2|Overall Study|Withdrawal by Subject|1
276860|NCT01971723|926199|P1|Overall Study|Withdrawal by Subject|1
276861|NCT01971645|926232|P3|Overall Study|Protocol Violation|1
276862|NCT01971645|926233|P2|Overall Study|Protocol Violation|0
276863|NCT01971645|926234|P1|Overall Study|Protocol Violation|0
276864|NCT01971645|926232|P3|Overall Study|Lost to Follow-up|1
276865|NCT01971645|926233|P2|Overall Study|Lost to Follow-up|0
276866|NCT01971645|926234|P1|Overall Study|Lost to Follow-up|1
276867|NCT01971645|926232|P3|Overall Study|Adverse Event|0
276868|NCT01971645|926233|P2|Overall Study|Adverse Event|0
276869|NCT01971645|926234|P1|Overall Study|Adverse Event|1
276870|NCT01971567|926268|P2|Overall Study|Lost to Follow-up|0
276871|NCT01971567|926269|P1|Overall Study|Lost to Follow-up|1
276872|NCT01971567|926268|P2|Overall Study|Withdrawal by Subject|2
276873|NCT01971567|926269|P1|Overall Study|Withdrawal by Subject|3
276874|NCT01971554|926295|P4|Overall Study|Lost to Follow-up|0
276875|NCT01971554|926296|P3|Overall Study|Lost to Follow-up|0
276876|NCT01971554|926297|P2|Overall Study|Lost to Follow-up|0
276877|NCT01971554|926298|P1|Overall Study|Lost to Follow-up|1
276878|NCT01971203|926365|P2|Overall Study|Adverse Event|0
276879|NCT01971203|926366|P1|Overall Study|Adverse Event|1
276880|NCT01971203|926365|P2|Overall Study|Withdrawal by Subject|6
276881|NCT01971203|926366|P1|Overall Study|Withdrawal by Subject|5
276882|NCT01971203|926365|P2|Overall Study|Protocol Violation|2
276883|NCT01971203|926366|P1|Overall Study|Protocol Violation|3
276884|NCT01970995|926393|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
276885|NCT01970995|926394|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
276886|NCT01970995|926395|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
276887|NCT01970995|926393|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
276888|NCT01970995|926394|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
276889|NCT01970995|926395|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
276890|NCT01970982|926418|P3|Overall Study|Withdrawal by Subject|2
276891|NCT01970982|926419|P2|Overall Study|Withdrawal by Subject|0
276892|NCT01970982|926420|P1|Overall Study|Withdrawal by Subject|0
276893|NCT01970878|926442|P4|Overall Study|No Completion Status|0
276894|NCT01970878|926443|P3|Overall Study|No Completion Status|0
276895|NCT01970878|926444|P2|Overall Study|No Completion Status|1
276896|NCT01970878|926445|P1|Overall Study|No Completion Status|0
276897|NCT01970878|926442|P4|Overall Study|Physician Decision|0
276898|NCT01970878|926443|P3|Overall Study|Physician Decision|1
276899|NCT01970878|926444|P2|Overall Study|Physician Decision|1
276900|NCT01970878|926445|P1|Overall Study|Physician Decision|0
276901|NCT01970878|926442|P4|Overall Study|Protocol Specified Criteria|6
276902|NCT01970878|926443|P3|Overall Study|Protocol Specified Criteria|3
276903|NCT01970878|926444|P2|Overall Study|Protocol Specified Criteria|4
276904|NCT01970878|926445|P1|Overall Study|Protocol Specified Criteria|10
276905|NCT01970878|926442|P4|Overall Study|Adverse Event|3
276906|NCT01970878|926443|P3|Overall Study|Adverse Event|4
276907|NCT01970878|926444|P2|Overall Study|Adverse Event|7
276908|NCT01970878|926445|P1|Overall Study|Adverse Event|12
276909|NCT01970878|926442|P4|Overall Study|Lack of Efficacy|0
276910|NCT01970878|926443|P3|Overall Study|Lack of Efficacy|2
276911|NCT01970878|926444|P2|Overall Study|Lack of Efficacy|1
276912|NCT01970878|926445|P1|Overall Study|Lack of Efficacy|2
276913|NCT01970878|926442|P4|Overall Study|Administrative Reasons|4
276914|NCT01970878|926443|P3|Overall Study|Administrative Reasons|0
276915|NCT01970878|926444|P2|Overall Study|Administrative Reasons|0
276916|NCT01970878|926445|P1|Overall Study|Administrative Reasons|1
276917|NCT01970878|926442|P4|Overall Study|Lost to Follow-up|4
276918|NCT01970878|926443|P3|Overall Study|Lost to Follow-up|2
276919|NCT01970878|926444|P2|Overall Study|Lost to Follow-up|3
276920|NCT01970878|926445|P1|Overall Study|Lost to Follow-up|1
276921|NCT01970878|926442|P4|Overall Study|Withdrawal by Subject|7
276922|NCT01970878|926443|P3|Overall Study|Withdrawal by Subject|14
276923|NCT01970878|926444|P2|Overall Study|Withdrawal by Subject|10
276924|NCT01970878|926445|P1|Overall Study|Withdrawal by Subject|11
276925|NCT01970865|926488|P17|Overall Study|Study ongoing|2
276926|NCT01970865|926489|P16|Overall Study|Study ongoing|29
276927|NCT01970865|926490|P15|Overall Study|Study ongoing|29
276928|NCT01970865|926491|P14|Overall Study|Study ongoing|41
276929|NCT01970865|926492|P13|Overall Study|Study ongoing|43
276930|NCT01970865|926493|P12|Overall Study|Study ongoing|22
276931|NCT01970865|926494|P11|Overall Study|Study ongoing|29
276932|NCT01970865|926495|P10|Overall Study|Study ongoing|3
276933|NCT01970865|926496|P9|Overall Study|Study ongoing|1
276934|NCT01970865|926497|P8|Overall Study|Study ongoing|0
276935|NCT01970865|926498|P7|Overall Study|Study ongoing|2
276936|NCT01970865|926499|P6|Overall Study|Study ongoing|0
276937|NCT01970865|926500|P5|Overall Study|Study ongoing|8
276938|NCT01970865|926501|P4|Overall Study|Study ongoing|6
276939|NCT01970865|926502|P3|Overall Study|Study ongoing|0
276940|NCT01970865|926503|P2|Overall Study|Study ongoing|2
276941|NCT01970865|926504|P1|Overall Study|Study ongoing|0
276942|NCT01970865|926488|P17|Overall Study|Other|0
276943|NCT01970865|926489|P16|Overall Study|Other|1
276944|NCT01970865|926490|P15|Overall Study|Other|0
276945|NCT01970865|926491|P14|Overall Study|Other|1
276946|NCT01970865|926492|P13|Overall Study|Other|0
276947|NCT01970865|926493|P12|Overall Study|Other|0
276948|NCT01970865|926494|P11|Overall Study|Other|0
276949|NCT01970865|926495|P10|Overall Study|Other|0
276950|NCT01970865|926496|P9|Overall Study|Other|0
276951|NCT01970865|926497|P8|Overall Study|Other|0
276952|NCT01970865|926498|P7|Overall Study|Other|0
276953|NCT01970865|926499|P6|Overall Study|Other|0
276954|NCT01970865|926500|P5|Overall Study|Other|0
276955|NCT01970865|926501|P4|Overall Study|Other|1
276956|NCT01970865|926502|P3|Overall Study|Other|0
276957|NCT01970865|926503|P2|Overall Study|Other|0
276958|NCT01970865|926504|P1|Overall Study|Other|0
276959|NCT01970865|926488|P17|Overall Study|Withdrawal by Subject|0
276960|NCT01970865|926489|P16|Overall Study|Withdrawal by Subject|7
276961|NCT01970865|926490|P15|Overall Study|Withdrawal by Subject|2
276962|NCT01970865|926491|P14|Overall Study|Withdrawal by Subject|5
276963|NCT01970865|926492|P13|Overall Study|Withdrawal by Subject|2
276964|NCT01970865|926493|P12|Overall Study|Withdrawal by Subject|1
276965|NCT01970865|926494|P11|Overall Study|Withdrawal by Subject|0
276966|NCT01970865|926495|P10|Overall Study|Withdrawal by Subject|0
276967|NCT01970865|926496|P9|Overall Study|Withdrawal by Subject|0
276968|NCT01970865|926497|P8|Overall Study|Withdrawal by Subject|0
276969|NCT01970865|926498|P7|Overall Study|Withdrawal by Subject|0
276970|NCT01970865|926499|P6|Overall Study|Withdrawal by Subject|0
276971|NCT01970865|926500|P5|Overall Study|Withdrawal by Subject|2
276972|NCT01970865|926501|P4|Overall Study|Withdrawal by Subject|1
276973|NCT01970865|926502|P3|Overall Study|Withdrawal by Subject|0
276974|NCT01970865|926503|P2|Overall Study|Withdrawal by Subject|0
276975|NCT01970865|926504|P1|Overall Study|Withdrawal by Subject|0
276976|NCT01970865|926488|P17|Overall Study|Lost to Follow-up|0
276977|NCT01970865|926489|P16|Overall Study|Lost to Follow-up|0
276978|NCT01970865|926490|P15|Overall Study|Lost to Follow-up|0
276979|NCT01970865|926491|P14|Overall Study|Lost to Follow-up|0
276980|NCT01970865|926492|P13|Overall Study|Lost to Follow-up|1
276981|NCT01970865|926493|P12|Overall Study|Lost to Follow-up|0
276982|NCT01970865|926494|P11|Overall Study|Lost to Follow-up|0
276983|NCT01970865|926495|P10|Overall Study|Lost to Follow-up|0
276984|NCT01970865|926496|P9|Overall Study|Lost to Follow-up|0
276985|NCT01970865|926497|P8|Overall Study|Lost to Follow-up|0
276986|NCT01970865|926498|P7|Overall Study|Lost to Follow-up|0
276987|NCT01970865|926499|P6|Overall Study|Lost to Follow-up|0
276988|NCT01970865|926500|P5|Overall Study|Lost to Follow-up|1
276989|NCT01970865|926501|P4|Overall Study|Lost to Follow-up|1
276990|NCT01970865|926502|P3|Overall Study|Lost to Follow-up|0
276991|NCT01970865|926503|P2|Overall Study|Lost to Follow-up|0
276992|NCT01970865|926504|P1|Overall Study|Lost to Follow-up|0
276993|NCT01970865|926488|P17|Overall Study|Death|1
276994|NCT01970865|926489|P16|Overall Study|Death|10
276995|NCT01970865|926490|P15|Overall Study|Death|15
276996|NCT01970865|926491|P14|Overall Study|Death|19
276997|NCT01970865|926492|P13|Overall Study|Death|14
276998|NCT01970865|926493|P12|Overall Study|Death|4
276999|NCT01970865|926494|P11|Overall Study|Death|1
277000|NCT01970865|926495|P10|Overall Study|Death|1
277001|NCT01970865|926496|P9|Overall Study|Death|2
277002|NCT01970865|926497|P8|Overall Study|Death|3
277003|NCT01970865|926498|P7|Overall Study|Death|1
277004|NCT01970865|926499|P6|Overall Study|Death|3
277005|NCT01970865|926500|P5|Overall Study|Death|6
277006|NCT01970865|926501|P4|Overall Study|Death|4
277007|NCT01970865|926502|P3|Overall Study|Death|3
277008|NCT01970865|926503|P2|Overall Study|Death|1
277009|NCT01970865|926504|P1|Overall Study|Death|3
277010|NCT01970488|926938|P5|Part 2: Post Week 16|Lost to Follow-up|2
277011|NCT01970488|926939|P4|Part 2: Post Week 16|Lost to Follow-up|1
277012|NCT01970488|926940|P3|Part 2: Post Week 16|Lost to Follow-up|1
277013|NCT01970488|926941|P2|Part 2: Post Week 16|Lost to Follow-up|0
277014|NCT01970488|926942|P1|Part 2: Post Week 16|Lost to Follow-up|0
277015|NCT01970488|926938|P5|Part 2: Post Week 16|Withdrawal by Subject|3
277016|NCT01970488|926939|P4|Part 2: Post Week 16|Withdrawal by Subject|3
277017|NCT01970488|926940|P3|Part 2: Post Week 16|Withdrawal by Subject|8
277018|NCT01970488|926941|P2|Part 2: Post Week 16|Withdrawal by Subject|0
277019|NCT01970488|926942|P1|Part 2: Post Week 16|Withdrawal by Subject|0
277020|NCT01970488|926938|P5|Part 2: Post Week 16|Adverse Event|1
277021|NCT01970488|926939|P4|Part 2: Post Week 16|Adverse Event|1
277022|NCT01970488|926940|P3|Part 2: Post Week 16|Adverse Event|5
277023|NCT01970488|926941|P2|Part 2: Post Week 16|Adverse Event|0
277024|NCT01970488|926942|P1|Part 2: Post Week 16|Adverse Event|0
277025|NCT01970488|926938|P5|Part 2: Post Week 16|Lack of Efficacy|1
277026|NCT01970488|926939|P4|Part 2: Post Week 16|Lack of Efficacy|3
277027|NCT01970488|926940|P3|Part 2: Post Week 16|Lack of Efficacy|2
277028|NCT01970488|926941|P2|Part 2: Post Week 16|Lack of Efficacy|0
277029|NCT01970488|926942|P1|Part 2: Post Week 16|Lack of Efficacy|0
277030|NCT01970488|926938|P5|Part 2: Post Week 16|Non-compliance|0
277031|NCT01970488|926939|P4|Part 2: Post Week 16|Non-compliance|0
277032|NCT01970488|926940|P3|Part 2: Post Week 16|Non-compliance|1
277033|NCT01970488|926941|P2|Part 2: Post Week 16|Non-compliance|0
277034|NCT01970488|926942|P1|Part 2: Post Week 16|Non-compliance|0
277035|NCT01970488|926938|P5|Part 2: Post Week 16|Physician Decision|1
277036|NCT01970488|926939|P4|Part 2: Post Week 16|Physician Decision|0
277037|NCT01970488|926940|P3|Part 2: Post Week 16|Physician Decision|0
277038|NCT01970488|926941|P2|Part 2: Post Week 16|Physician Decision|0
277039|NCT01970488|926942|P1|Part 2: Post Week 16|Physician Decision|0
277040|NCT01970488|926938|P5|Part 1: Through Week 16|Lost to Follow-up|0
277041|NCT01970488|926939|P4|Part 1: Through Week 16|Lost to Follow-up|0
277042|NCT01970488|926940|P3|Part 1: Through Week 16|Lost to Follow-up|0
277043|NCT01970488|926941|P2|Part 1: Through Week 16|Lost to Follow-up|2
277044|NCT01970488|926942|P1|Part 1: Through Week 16|Lost to Follow-up|0
277045|NCT01970488|926938|P5|Part 1: Through Week 16|Withdrawal by Subject|0
277046|NCT01970488|926939|P4|Part 1: Through Week 16|Withdrawal by Subject|0
277047|NCT01970488|926940|P3|Part 1: Through Week 16|Withdrawal by Subject|0
277048|NCT01970488|926941|P2|Part 1: Through Week 16|Withdrawal by Subject|2
277049|NCT01970488|926942|P1|Part 1: Through Week 16|Withdrawal by Subject|3
277050|NCT01970488|926938|P5|Part 1: Through Week 16|Adverse Event|0
277051|NCT01970488|926939|P4|Part 1: Through Week 16|Adverse Event|0
277052|NCT01970488|926940|P3|Part 1: Through Week 16|Adverse Event|0
277053|NCT01970488|926941|P2|Part 1: Through Week 16|Adverse Event|5
277054|NCT01970488|926942|P1|Part 1: Through Week 16|Adverse Event|6
277055|NCT01970488|926938|P5|Part 1: Through Week 16|Protocol Violation|0
277056|NCT01970488|926939|P4|Part 1: Through Week 16|Protocol Violation|0
277057|NCT01970488|926940|P3|Part 1: Through Week 16|Protocol Violation|0
277058|NCT01970488|926941|P2|Part 1: Through Week 16|Protocol Violation|2
277059|NCT01970488|926942|P1|Part 1: Through Week 16|Protocol Violation|1
277060|NCT01970488|926938|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
277061|NCT01970488|926939|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
277062|NCT01970488|926940|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
277063|NCT01970488|926941|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
277064|NCT01970488|926942|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
277065|NCT01970475|927009|P2|Overall Study|Protocol Violation|0
277066|NCT01970475|927010|P1|Overall Study|Protocol Violation|1
277067|NCT01970475|927009|P2|Overall Study|Lost to Follow-up|2
277068|NCT01970475|927010|P1|Overall Study|Lost to Follow-up|2
277069|NCT01970475|927009|P2|Overall Study|Adverse Event|3
277070|NCT01970475|927010|P1|Overall Study|Adverse Event|7
277071|NCT01970475|927009|P2|Overall Study|Withdrawal by Subject|6
277072|NCT01970475|927010|P1|Overall Study|Withdrawal by Subject|11
277073|NCT01970462|927030|P2|Overall Study|Lost to Follow-up|2
277074|NCT01970462|927031|P1|Overall Study|Lost to Follow-up|0
277075|NCT01970397|927045|P2|Overall Study|Protocol Violation|1
277076|NCT01970397|927046|P1|Overall Study|Protocol Violation|1
277077|NCT01970397|927045|P2|Overall Study|Personal Reasons|2
277078|NCT01970397|927046|P1|Overall Study|Personal Reasons|1
277079|NCT01970397|927045|P2|Overall Study|Lost to Follow-up|1
277080|NCT01970397|927046|P1|Overall Study|Lost to Follow-up|0
277081|NCT01970397|927045|P2|Overall Study|Adverse Event|1
277082|NCT01970397|927046|P1|Overall Study|Adverse Event|0
277083|NCT01969799|927058|P2|Overall Study|Physician Decision|0
277084|NCT01969799|927059|P1|Overall Study|Physician Decision|1
277085|NCT01969799|927058|P2|Overall Study|Lost to Follow-up|2
277086|NCT01969799|927059|P1|Overall Study|Lost to Follow-up|0
277087|NCT01969799|927058|P2|Overall Study|Death|11
277088|NCT01969799|927059|P1|Overall Study|Death|16
277089|NCT01969799|927058|P2|Overall Study|Adverse Event|1
277090|NCT01969799|927059|P1|Overall Study|Adverse Event|0
277091|NCT01969721|927096|P4|Overall Study|Discontinued during washout periods.|2
277092|NCT01969721|927097|P3|Overall Study|Discontinued during washout periods.|1
277093|NCT01969721|927098|P2|Overall Study|Discontinued during washout periods.|1
277094|NCT01969721|927099|P1|Overall Study|Discontinued during washout periods.|0
277095|NCT01969721|927096|P4|Overall Study|Other not defined above|0
277096|NCT01969721|927097|P3|Overall Study|Other not defined above|0
277097|NCT01969721|927098|P2|Overall Study|Other not defined above|2
277098|NCT01969721|927099|P1|Overall Study|Other not defined above|0
277099|NCT01969721|927096|P4|Overall Study|Non compliant with protocol|2
277100|NCT01969721|927097|P3|Overall Study|Non compliant with protocol|0
277101|NCT01969721|927098|P2|Overall Study|Non compliant with protocol|1
277102|NCT01969721|927099|P1|Overall Study|Non compliant with protocol|1
277103|NCT01969721|927096|P4|Overall Study|Lack of Efficacy|0
277104|NCT01969721|927097|P3|Overall Study|Lack of Efficacy|1
277105|NCT01969721|927098|P2|Overall Study|Lack of Efficacy|0
277106|NCT01969721|927099|P1|Overall Study|Lack of Efficacy|0
277107|NCT01969721|927096|P4|Overall Study|Adverse Event|2
277108|NCT01969721|927097|P3|Overall Study|Adverse Event|3
277109|NCT01969721|927098|P2|Overall Study|Adverse Event|8
277110|NCT01969721|927099|P1|Overall Study|Adverse Event|3
277111|NCT01969565|927125|P1|Overall Study|Withdrawal by Subject|1
277112|NCT01969084|927185|P2|Overall Study|Adverse Event|1
277113|NCT01969084|927186|P1|Overall Study|Adverse Event|0
277114|NCT01969058|927202|P2|Overall Study|Adverse Event|0
277115|NCT01969058|927203|P1|Overall Study|Adverse Event|1
277116|NCT01969058|927202|P2|Overall Study|Withdrawal by Subject|0
277117|NCT01969058|927203|P1|Overall Study|Withdrawal by Subject|2
277118|NCT01968980|927239|P2|Overall Study|Other unspecified|2
277119|NCT01968980|927240|P1|Overall Study|Other unspecified|1
277120|NCT01968980|927239|P2|Overall Study|Withdrawal by Subject|5
277121|NCT01968980|927240|P1|Overall Study|Withdrawal by Subject|13
277122|NCT01968980|927239|P2|Overall Study|Does not meet entry criteria|3
277123|NCT01968980|927240|P1|Overall Study|Does not meet entry criteria|1
277124|NCT01968980|927239|P2|Overall Study|Adverse Event|3
277125|NCT01968980|927240|P1|Overall Study|Adverse Event|1
277126|NCT01968980|927239|P2|Overall Study|Death|1
277127|NCT01968980|927240|P1|Overall Study|Death|0
277128|NCT01968967|927302|P2|Overall Study|Randomized Not Treated|5
277129|NCT01968967|927303|P1|Overall Study|Randomized Not Treated|6
277130|NCT01968967|927302|P2|Overall Study|Death|2
277131|NCT01968967|927303|P1|Overall Study|Death|9
277132|NCT01968967|927302|P2|Overall Study|Adverse Event|8
277133|NCT01968967|927303|P1|Overall Study|Adverse Event|9
277134|NCT01968967|927302|P2|Overall Study|Protocol Violation|2
277135|NCT01968967|927303|P1|Overall Study|Protocol Violation|1
277136|NCT01968967|927302|P2|Overall Study|Lost to Follow-up|31
277137|NCT01968967|927303|P1|Overall Study|Lost to Follow-up|26
277138|NCT01968967|927302|P2|Overall Study|Did Not Meet Entrance Criteria|3
277139|NCT01968967|927303|P1|Overall Study|Did Not Meet Entrance Criteria|2
277140|NCT01968967|927302|P2|Overall Study|Withdrawal by Subject|61
277141|NCT01968967|927303|P1|Overall Study|Withdrawal by Subject|71
277142|NCT01968967|927302|P2|Overall Study|Other|22
277143|NCT01968967|927303|P1|Overall Study|Other|22
277144|NCT01968954|927364|P2|Overall Study|Did not met inclusion criteria|2
277145|NCT01968954|927365|P1|Overall Study|Did not met inclusion criteria|0
277146|NCT01968954|927364|P2|Overall Study|Protocol Violation|1
277147|NCT01968954|927365|P1|Overall Study|Protocol Violation|0
277148|NCT01968954|927364|P2|Overall Study|Other|8
277149|NCT01968954|927365|P1|Overall Study|Other|7
277150|NCT01968954|927364|P2|Overall Study|Withdrawal by Subject|23
277151|NCT01968954|927365|P1|Overall Study|Withdrawal by Subject|20
277152|NCT01968954|927364|P2|Overall Study|Lost to Follow-up|4
277153|NCT01968954|927365|P1|Overall Study|Lost to Follow-up|6
277154|NCT01968954|927364|P2|Overall Study|Death|2
277155|NCT01968954|927365|P1|Overall Study|Death|1
277156|NCT01968954|927364|P2|Overall Study|Adverse Event|3
277157|NCT01968954|927365|P1|Overall Study|Adverse Event|6
277158|NCT01968811|927429|P1|Overall Study|post op.ref. of subject to other hospita|1
277159|NCT01968811|927429|P1|Overall Study|Protocol Violation|4
277160|NCT01968694|927436|P2|Washout (1 Month)|Lost to Follow-up|1
277161|NCT01968694|927437|P1|Washout (1 Month)|Lost to Follow-up|0
277162|NCT01968551|927454|P3|Extension Phase|Lost to Follow-up|1
277163|NCT01968551|927455|P2|Extension Phase|Lost to Follow-up|0
277164|NCT01968551|927456|P1|Extension Phase|Lost to Follow-up|1
277165|NCT01968551|927454|P3|Extension Phase|Withdrew Consent|1
277166|NCT01968551|927455|P2|Extension Phase|Withdrew Consent|0
277167|NCT01968551|927456|P1|Extension Phase|Withdrew Consent|0
277168|NCT01968551|927454|P3|Extension Phase|Death|0
277169|NCT01968551|927455|P2|Extension Phase|Death|1
277170|NCT01968551|927456|P1|Extension Phase|Death|0
277171|NCT01968551|927454|P3|Extension Phase|Adverse Event|2
277172|NCT01968551|927455|P2|Extension Phase|Adverse Event|0
277173|NCT01968551|927456|P1|Extension Phase|Adverse Event|0
277174|NCT01968551|927454|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
277175|NCT01968551|927455|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
277176|NCT01968551|927456|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
277177|NCT01968551|927454|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
277178|NCT01968551|927455|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
277179|NCT01968551|927456|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
277180|NCT01968551|927454|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
277181|NCT01968551|927455|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
277182|NCT01968551|927456|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
277183|NCT01968551|927454|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
277184|NCT01968551|927455|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
277185|NCT01968551|927456|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
277186|NCT01968434|927472|P2|Overall Study|Lost to Follow-up|6
277187|NCT01968434|927473|P1|Overall Study|Lost to Follow-up|3
277188|NCT01968226|927483|P1|Overall Study|[F-18] RDG-K5 was not available|2
277189|NCT01967940|927515|P3|Part 2|Still on Study|14
277190|NCT01967940|927516|P2|Part 2|Still on Study|16
277191|NCT01967940|927517|P1|Part 2|Still on Study|8
277192|NCT01967732|927544|P4|First Intervention (Day 1)|Poor venous access|0
277193|NCT01967732|927545|P3|First Intervention (Day 1)|Poor venous access|0
277194|NCT01967732|927546|P2|First Intervention (Day 1)|Poor venous access|1
277195|NCT01967732|927547|P1|First Intervention (Day 1)|Poor venous access|0
277196|NCT01967732|927544|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
277197|NCT01967732|927545|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
277198|NCT01967732|927546|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
277199|NCT01967732|927547|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
277200|NCT01967719|927561|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
277201|NCT01967719|927562|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
277202|NCT01967719|927563|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
277203|NCT01967719|927564|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
277204|NCT01967719|927561|P4|First Intervention (Day 1)|Withdrawal by Subject|1
277205|NCT01967719|927562|P3|First Intervention (Day 1)|Withdrawal by Subject|0
277206|NCT01967719|927563|P2|First Intervention (Day 1)|Withdrawal by Subject|1
277207|NCT01967719|927564|P1|First Intervention (Day 1)|Withdrawal by Subject|0
277208|NCT01967706|927579|P4|First Intervention (Day 1)|Withdrawal by Subject|0
277209|NCT01967706|927580|P3|First Intervention (Day 1)|Withdrawal by Subject|0
277210|NCT01967706|927581|P2|First Intervention (Day 1)|Withdrawal by Subject|0
277211|NCT01967706|927582|P1|First Intervention (Day 1)|Withdrawal by Subject|1
277212|NCT01967628|927603|P2|Overall Study|Low protein concentration in sample|25
277213|NCT01967628|927604|P1|Overall Study|Low protein concentration in sample|20
277214|NCT01967628|927603|P2|Overall Study|Lost to Follow-up|0
277215|NCT01967628|927604|P1|Overall Study|Lost to Follow-up|1
277216|NCT01967628|927603|P2|Overall Study|Unable to complete bronchoscopy|6
277217|NCT01967628|927604|P1|Overall Study|Unable to complete bronchoscopy|4
277218|NCT01967628|927603|P2|Overall Study|Withdrawal by Subject|0
277219|NCT01967628|927604|P1|Overall Study|Withdrawal by Subject|2
277220|NCT01967550|927612|P2|Overall Study|Non Compliance|1
277221|NCT01967550|927613|P1|Overall Study|Non Compliance|0
277222|NCT01967550|927612|P2|Overall Study|Protocol Violation|1
277223|NCT01967550|927613|P1|Overall Study|Protocol Violation|2
277224|NCT01967550|927612|P2|Overall Study|Adverse Event|0
277225|NCT01967550|927613|P1|Overall Study|Adverse Event|2
277226|NCT01967550|927612|P2|Overall Study|Withdrawal by Subject|0
277227|NCT01967550|927613|P1|Overall Study|Withdrawal by Subject|1
277228|NCT01967277|927643|P2|Overall Study|Unrelated illness|1
277229|NCT01967277|927644|P1|Overall Study|Unrelated illness|0
277230|NCT01967277|927643|P2|Overall Study|Lost to Follow-up|2
277231|NCT01967277|927644|P1|Overall Study|Lost to Follow-up|1
277232|NCT01967147|927654|P2|Overall Study|Other|5
277233|NCT01967147|927655|P1|Overall Study|Other|4
277234|NCT01967147|927654|P2|Overall Study|Non-compliance with Study Drug|3
277235|NCT01967147|927655|P1|Overall Study|Non-compliance with Study Drug|0
277236|NCT01967147|927654|P2|Overall Study|Withdrawal by Subject|4
277237|NCT01967147|927655|P1|Overall Study|Withdrawal by Subject|2
277238|NCT01967147|927654|P2|Overall Study|Lost to Follow-up|2
277239|NCT01967147|927655|P1|Overall Study|Lost to Follow-up|1
277240|NCT01967147|927654|P2|Overall Study|Lack of Efficacy|4
277241|NCT01967147|927655|P1|Overall Study|Lack of Efficacy|1
277242|NCT01967147|927654|P2|Overall Study|Adverse Event|2
277243|NCT01967147|927655|P1|Overall Study|Adverse Event|5
277244|NCT01967069|927685|P2|Overall Study|Lack of Efficacy|1
277245|NCT01967069|927686|P1|Overall Study|Lack of Efficacy|0
277246|NCT01967069|927685|P2|Overall Study|Withdrawal by Subject|3
277247|NCT01967069|927686|P1|Overall Study|Withdrawal by Subject|1
277248|NCT01967069|927685|P2|Overall Study|Lost to Follow-up|2
277249|NCT01967069|927686|P1|Overall Study|Lost to Follow-up|5
277250|NCT01967069|927685|P2|Overall Study|Adverse Event|2
277251|NCT01967069|927686|P1|Overall Study|Adverse Event|2
277252|NCT01966432|927843|P3|Overall Study|SBIRT program ended|20
277253|NCT01966432|927844|P2|Overall Study|SBIRT program ended|8
277254|NCT01966432|927845|P1|Overall Study|SBIRT program ended|1
277255|NCT01966432|927843|P3|Overall Study|Subject Incarcerated|1
277256|NCT01966432|927844|P2|Overall Study|Subject Incarcerated|0
277257|NCT01966432|927845|P1|Overall Study|Subject Incarcerated|0
277258|NCT01966432|927843|P3|Overall Study|Withdrawal by Subject|0
277259|NCT01966432|927844|P2|Overall Study|Withdrawal by Subject|3
277260|NCT01966432|927845|P1|Overall Study|Withdrawal by Subject|1
277261|NCT01966432|927843|P3|Overall Study|Lost to Follow-up|5
277262|NCT01966432|927844|P2|Overall Study|Lost to Follow-up|2
277263|NCT01966432|927845|P1|Overall Study|Lost to Follow-up|3
277264|NCT01966120|927915|P2|Overall Study|Lost to Follow-up|1
277265|NCT01966120|927916|P1|Overall Study|Lost to Follow-up|1
277266|NCT01966120|927915|P2|Overall Study|Withdrawal by Subject|5
277267|NCT01966120|927916|P1|Overall Study|Withdrawal by Subject|0
277268|NCT01966068|927940|P1|Overall Study|Lost to Follow-up|81
277269|NCT01966068|927940|P1|Overall Study|Withdrawal by Subject|57
277270|NCT01966042|927945|P1|Overall Study|Death|2
277271|NCT01966003|927954|P2|Overall Study|Other|1
277272|NCT01966003|927955|P1|Overall Study|Other|1
277273|NCT01966003|927954|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
277274|NCT01966003|927955|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
277275|NCT01966003|927954|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
277276|NCT01966003|927955|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
277277|NCT01966003|927954|P2|Overall Study|Withdrawal by Subject|19
277278|NCT01966003|927955|P1|Overall Study|Withdrawal by Subject|29
277279|NCT01966003|927954|P2|Overall Study|Physician Decision|13
277280|NCT01966003|927955|P1|Overall Study|Physician Decision|12
277281|NCT01966003|927954|P2|Overall Study|Lost to Follow-up|3
277282|NCT01966003|927955|P1|Overall Study|Lost to Follow-up|4
277283|NCT01966003|927954|P2|Overall Study|Protocol Violation|4
277284|NCT01966003|927955|P1|Overall Study|Protocol Violation|6
277285|NCT01966003|927954|P2|Overall Study|Death|36
277286|NCT01966003|927955|P1|Overall Study|Death|43
277287|NCT01965938|927973|P2|Overall Study|Withdrawal by Subject|0
277288|NCT01965938|927974|P1|Overall Study|Withdrawal by Subject|1
277289|NCT01965834|928005|P1|Overall Study|Lack of Efficacy|4
277290|NCT01965652|928036|P2|Overall Study|Pregnancy|1
277291|NCT01965652|928037|P1|Overall Study|Pregnancy|0
277292|NCT01965652|928036|P2|Overall Study|Other - Miscellaneous|21
277293|NCT01965652|928037|P1|Overall Study|Other - Miscellaneous|18
277294|NCT01965652|928036|P2|Overall Study|Death|4
277295|NCT01965652|928037|P1|Overall Study|Death|3
277296|NCT01965652|928036|P2|Overall Study|Protocol Violation|38
277297|NCT01965652|928037|P1|Overall Study|Protocol Violation|34
277298|NCT01965652|928036|P2|Overall Study|Lost to Follow-up|40
277299|NCT01965652|928037|P1|Overall Study|Lost to Follow-up|53
277300|NCT01965652|928036|P2|Overall Study|Withdrawal by Subject|69
277301|NCT01965652|928037|P1|Overall Study|Withdrawal by Subject|62
277302|NCT01965652|928036|P2|Overall Study|Adverse Event|37
277303|NCT01965652|928037|P1|Overall Study|Adverse Event|40
277304|NCT01965600|928067|P4|Second Intervention|Study terminated by Sponsor|2
277305|NCT01965600|928068|P3|Second Intervention|Study terminated by Sponsor|2
277306|NCT01965600|928069|P2|Second Intervention|Study terminated by Sponsor|0
277307|NCT01965600|928070|P1|Second Intervention|Study terminated by Sponsor|0
277308|NCT01965600|928067|P4|Washout Period of Approximately 15 Days|Adverse Event|1
277309|NCT01965600|928068|P3|Washout Period of Approximately 15 Days|Adverse Event|0
277310|NCT01965600|928069|P2|Washout Period of Approximately 15 Days|Adverse Event|0
277311|NCT01965600|928070|P1|Washout Period of Approximately 15 Days|Adverse Event|0
277312|NCT01965600|928067|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
277313|NCT01965600|928068|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
277314|NCT01965600|928069|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
277315|NCT01965600|928070|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
277316|NCT01965600|928067|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
277317|NCT01965600|928068|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
277318|NCT01965600|928069|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
277319|NCT01965600|928070|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
277320|NCT01965600|928067|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
277321|NCT01965600|928068|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
277322|NCT01965600|928069|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
277323|NCT01965600|928070|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
277324|NCT01965535|928127|P2|Overall Study|Lack of Efficacy|1
277325|NCT01965535|928128|P1|Overall Study|Lack of Efficacy|2
277326|NCT01965431|928142|P6|Overall Study|Other than stated above|6
277327|NCT01965431|928143|P5|Overall Study|Other than stated above|6
277328|NCT01965431|928144|P4|Overall Study|Other than stated above|6
277329|NCT01965431|928145|P3|Overall Study|Other than stated above|6
277330|NCT01965431|928146|P2|Overall Study|Other than stated above|5
277331|NCT01965431|928147|P1|Overall Study|Other than stated above|6
277332|NCT01965431|928142|P6|Overall Study|Adverse Event|0
277333|NCT01965431|928143|P5|Overall Study|Adverse Event|0
277334|NCT01965431|928144|P4|Overall Study|Adverse Event|0
277335|NCT01965431|928145|P3|Overall Study|Adverse Event|0
277336|NCT01965431|928146|P2|Overall Study|Adverse Event|1
277337|NCT01965431|928147|P1|Overall Study|Adverse Event|0
277338|NCT01965327|928160|P1|Overall Study|Physician Decision|2
277339|NCT01965262|928374|P2|Second Intervention (7 Days)|Poor visual acuity|0
277340|NCT01965262|928375|P1|Second Intervention (7 Days)|Poor visual acuity|1
277341|NCT01965262|928374|P2|Second Intervention (7 Days)|Poor lens fit|9
277342|NCT01965262|928375|P1|Second Intervention (7 Days)|Poor lens fit|0
277343|NCT01965262|928374|P2|Second Intervention (7 Days)|Discontinued|1
277344|NCT01965262|928375|P1|Second Intervention (7 Days)|Discontinued|0
277345|NCT01965158|928439|P2|Overall Study|Other - Miscellaneous|0
277346|NCT01965158|928440|P1|Overall Study|Other - Miscellaneous|3
277347|NCT01965158|928439|P2|Overall Study|Protocol Violation|1
277348|NCT01965158|928440|P1|Overall Study|Protocol Violation|1
277349|NCT01965158|928439|P2|Overall Study|Lost to Follow-up|5
277350|NCT01965158|928440|P1|Overall Study|Lost to Follow-up|7
277351|NCT01965158|928439|P2|Overall Study|Withdrawal by Subject|24
277352|NCT01965158|928440|P1|Overall Study|Withdrawal by Subject|16
277353|NCT01965158|928439|P2|Overall Study|Adverse Event|5
277354|NCT01965158|928440|P1|Overall Study|Adverse Event|14
277355|NCT01964976|928481|P1|Overall Study|Protocol Violation|31
277356|NCT01964950|928495|P1|Overall Study|Protocol Violation|25
277357|NCT01964898|928509|P2|Overall Study|Withdrawal by Subject|0
277358|NCT01964898|928510|P1|Overall Study|Withdrawal by Subject|1
277359|NCT01964898|928509|P2|Overall Study|Lost to Follow-up|5
277360|NCT01964898|928510|P1|Overall Study|Lost to Follow-up|3
277361|NCT01964898|928509|P2|Overall Study|did not receive the allocated interventi|1
277362|NCT01964898|928510|P1|Overall Study|did not receive the allocated interventi|2
277363|NCT01964898|928509|P2|Overall Study|ineligible post-randomization|1
277364|NCT01964898|928510|P1|Overall Study|ineligible post-randomization|1
277365|NCT01964716|928532|P2|Overall Study|Death|0
277366|NCT01964716|928533|P1|Overall Study|Death|1
277367|NCT01964716|928532|P2|Overall Study|No longer met eligibility criteria|1
277368|NCT01964716|928533|P1|Overall Study|No longer met eligibility criteria|1
277369|NCT01964716|928532|P2|Overall Study|Lost to Follow-up|2
277370|NCT01964716|928533|P1|Overall Study|Lost to Follow-up|1
277371|NCT01964716|928532|P2|Overall Study|Withdrawal by Subject|3
277372|NCT01964716|928533|P1|Overall Study|Withdrawal by Subject|2
277373|NCT01964547|928571|P2|Overall Study|Withdrawal by Investigator|1
277374|NCT01964547|928572|P1|Overall Study|Withdrawal by Investigator|0
277375|NCT01964547|928571|P2|Overall Study|Lost to Follow-up|1
277376|NCT01964547|928572|P1|Overall Study|Lost to Follow-up|0
277377|NCT01964547|928571|P2|Overall Study|Withdrawal by Subject|7
277378|NCT01964547|928572|P1|Overall Study|Withdrawal by Subject|4
277379|NCT01964547|928571|P2|Overall Study|Adverse Event|2
277380|NCT01964547|928572|P1|Overall Study|Adverse Event|8
277381|NCT01964352|928600|P4|Overall Study|Other than stated above|2
277382|NCT01964352|928601|P3|Overall Study|Other than stated above|1
277383|NCT01964352|928602|P2|Overall Study|Other than stated above|2
277384|NCT01964352|928603|P1|Overall Study|Other than stated above|0
277385|NCT01964352|928600|P4|Overall Study|Withdrawal by Subject|0
277386|NCT01964352|928601|P3|Overall Study|Withdrawal by Subject|1
277387|NCT01964352|928602|P2|Overall Study|Withdrawal by Subject|2
277388|NCT01964352|928603|P1|Overall Study|Withdrawal by Subject|4
277389|NCT01964352|928600|P4|Overall Study|Lost to Follow-up|1
277390|NCT01964352|928601|P3|Overall Study|Lost to Follow-up|0
277391|NCT01964352|928602|P2|Overall Study|Lost to Follow-up|0
277392|NCT01964352|928603|P1|Overall Study|Lost to Follow-up|1
277393|NCT01964352|928600|P4|Overall Study|Protocol Violation|2
277394|NCT01964352|928601|P3|Overall Study|Protocol Violation|0
277395|NCT01964352|928602|P2|Overall Study|Protocol Violation|4
277396|NCT01964352|928603|P1|Overall Study|Protocol Violation|2
277397|NCT01964352|928600|P4|Overall Study|Lack of Efficacy|0
277398|NCT01964352|928601|P3|Overall Study|Lack of Efficacy|0
277399|NCT01964352|928602|P2|Overall Study|Lack of Efficacy|0
277400|NCT01964352|928603|P1|Overall Study|Lack of Efficacy|6
277401|NCT01964352|928600|P4|Overall Study|Adverse Event|3
277402|NCT01964352|928601|P3|Overall Study|Adverse Event|4
277403|NCT01964352|928602|P2|Overall Study|Adverse Event|3
277404|NCT01964352|928603|P1|Overall Study|Adverse Event|13
277405|NCT01964326|928633|P1|Overall Study|Did not meet eligibility criteria|1
277406|NCT01964326|928633|P1|Overall Study|Other|9
277407|NCT01964326|928633|P1|Overall Study|Investigator Discretion|1
277408|NCT01964326|928633|P1|Overall Study|Physician Decision|55
277409|NCT01964326|928633|P1|Overall Study|No Longer Meets Eligibility Criteria|1
277410|NCT01964326|928633|P1|Overall Study|Pregnancy|1
277411|NCT01964326|928633|P1|Overall Study|Withdrawal by Subject|87
277412|NCT01964326|928633|P1|Overall Study|Lost to Follow-up|88
277413|NCT01964326|928633|P1|Overall Study|Protocol Violation|4
277414|NCT01964326|928633|P1|Overall Study|Death|2
277415|NCT01964326|928633|P1|Overall Study|Adverse Event|48
277416|NCT01964222|928642|P2|Overall Study|Screening Failure|0
277417|NCT01964222|928643|P1|Overall Study|Screening Failure|2
277418|NCT01964222|928642|P2|Overall Study|Withdrawal by Subject|6
277419|NCT01964222|928643|P1|Overall Study|Withdrawal by Subject|6
277420|NCT01964222|928642|P2|Overall Study|Lost to Follow-up|5
277421|NCT01964222|928643|P1|Overall Study|Lost to Follow-up|7
277422|NCT01964105|928660|P3|Overall Study|Lost to Follow-up|0
277423|NCT01964105|928661|P2|Overall Study|Lost to Follow-up|13
277424|NCT01964105|928662|P1|Overall Study|Lost to Follow-up|2
277425|NCT01963767|928689|P2|Overall Study|Adverse Event|0
277426|NCT01963767|928690|P1|Overall Study|Adverse Event|2
277427|NCT01963767|928689|P2|Overall Study|Withdrawal by Subject|2
277428|NCT01963767|928690|P1|Overall Study|Withdrawal by Subject|4
277429|NCT01963676|928700|P2|Overall Study|Withdrawal by Subject|0
277430|NCT01963676|928701|P1|Overall Study|Withdrawal by Subject|1
277431|NCT01963611|928714|P5|Overall Study|Other|45
277432|NCT01963611|928715|P4|Overall Study|Other|45
277433|NCT01963611|928716|P3|Overall Study|Other|48
277434|NCT01963611|928717|P2|Overall Study|Other|46
277435|NCT01963611|928718|P1|Overall Study|Other|47
277436|NCT01963611|928714|P5|Overall Study|Withdrawal by Subject|3
277437|NCT01963611|928715|P4|Overall Study|Withdrawal by Subject|1
277438|NCT01963611|928716|P3|Overall Study|Withdrawal by Subject|1
277439|NCT01963611|928717|P2|Overall Study|Withdrawal by Subject|2
277440|NCT01963611|928718|P1|Overall Study|Withdrawal by Subject|3
277441|NCT01963611|928714|P5|Overall Study|Lack of Efficacy|0
277442|NCT01963611|928715|P4|Overall Study|Lack of Efficacy|1
277443|NCT01963611|928716|P3|Overall Study|Lack of Efficacy|0
277444|NCT01963611|928717|P2|Overall Study|Lack of Efficacy|0
277445|NCT01963611|928718|P1|Overall Study|Lack of Efficacy|0
277446|NCT01963611|928714|P5|Overall Study|Protocol Violation|0
277447|NCT01963611|928715|P4|Overall Study|Protocol Violation|1
277448|NCT01963611|928716|P3|Overall Study|Protocol Violation|0
277449|NCT01963611|928717|P2|Overall Study|Protocol Violation|0
277450|NCT01963611|928718|P1|Overall Study|Protocol Violation|0
277451|NCT01963611|928714|P5|Overall Study|Adverse Event|3
277452|NCT01963611|928715|P4|Overall Study|Adverse Event|4
277453|NCT01963611|928716|P3|Overall Study|Adverse Event|3
277454|NCT01963611|928717|P2|Overall Study|Adverse Event|1
277455|NCT01963611|928718|P1|Overall Study|Adverse Event|1
277456|NCT01963403|928777|P2|Overall Study|Implant removal|1
277457|NCT01963403|928778|P1|Overall Study|Implant removal|0
277458|NCT01963403|928777|P2|Overall Study|Lost to Follow-up|3
277459|NCT01963403|928778|P1|Overall Study|Lost to Follow-up|2
277460|NCT01963260|928800|P10|Overall Study|Withdrawal by Subject|0
277461|NCT01963260|928801|P9|Overall Study|Withdrawal by Subject|0
277462|NCT01963260|928802|P8|Overall Study|Withdrawal by Subject|0
277463|NCT01963260|928803|P7|Overall Study|Withdrawal by Subject|0
277464|NCT01963260|928804|P6|Overall Study|Withdrawal by Subject|0
277465|NCT01963260|928805|P5|Overall Study|Withdrawal by Subject|2
277466|NCT01963260|928806|P4|Overall Study|Withdrawal by Subject|1
277467|NCT01963260|928807|P3|Overall Study|Withdrawal by Subject|0
277468|NCT01963260|928808|P2|Overall Study|Withdrawal by Subject|0
277469|NCT01963260|928809|P1|Overall Study|Withdrawal by Subject|2
277470|NCT01962974|928889|P1|Overall Study|Study termination|7
277471|NCT01962922|928916|P2|Extendion Portion (up to Month 6)|Physician Decision|0
277472|NCT01962922|928917|P1|Extendion Portion (up to Month 6)|Physician Decision|1
277473|NCT01962922|928916|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
277474|NCT01962922|928917|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
277475|NCT01962922|928916|P2|PK Portion Day 7|non-compliance|0
277476|NCT01962922|928917|P1|PK Portion Day 7|non-compliance|1
277477|NCT01962922|928916|P2|PK Portion Day 7|Withdrawal by Subject|0
277478|NCT01962922|928917|P1|PK Portion Day 7|Withdrawal by Subject|3
277479|NCT01962493|928994|P2|Overall Study|Withdrawal by Subject|2
277480|NCT01962493|928995|P1|Overall Study|Withdrawal by Subject|4
277481|NCT01962493|928994|P2|Overall Study|Protocol Violation|1
277482|NCT01962493|928995|P1|Overall Study|Protocol Violation|0
277483|NCT01962493|928994|P2|Overall Study|Adverse Event|2
277484|NCT01962493|928995|P1|Overall Study|Adverse Event|1
277485|NCT01962441|929018|P3|Retreatment Substudy|Lost to Follow-up|0
277486|NCT01962441|929019|P2|Retreatment Substudy|Lost to Follow-up|0
277487|NCT01962441|929020|P1|Retreatment Substudy|Lost to Follow-up|1
277488|NCT01962441|929018|P3|Retreatment Substudy|Lack of Efficacy|0
277489|NCT01962441|929019|P2|Retreatment Substudy|Lack of Efficacy|0
277490|NCT01962441|929020|P1|Retreatment Substudy|Lack of Efficacy|1
277491|NCT01962441|929018|P3|Randomized Period|Protocol Violation|0
277492|NCT01962441|929019|P2|Randomized Period|Protocol Violation|1
277493|NCT01962441|929020|P1|Randomized Period|Protocol Violation|0
277494|NCT01962441|929018|P3|Randomized Period|Death|2
277495|NCT01962441|929019|P2|Randomized Period|Death|0
277496|NCT01962441|929020|P1|Randomized Period|Death|0
277497|NCT01962441|929018|P3|Randomized Period|Adverse Event|0
277498|NCT01962441|929019|P2|Randomized Period|Adverse Event|1
277499|NCT01962441|929020|P1|Randomized Period|Adverse Event|1
277500|NCT01962441|929018|P3|Randomized Period|Withdrew Consent|2
277501|NCT01962441|929019|P2|Randomized Period|Withdrew Consent|3
277502|NCT01962441|929020|P1|Randomized Period|Withdrew Consent|3
277503|NCT01962441|929018|P3|Randomized Period|Lost to Follow-up|4
277504|NCT01962441|929019|P2|Randomized Period|Lost to Follow-up|4
277505|NCT01962441|929020|P1|Randomized Period|Lost to Follow-up|2
277506|NCT01962441|929018|P3|Randomized Period|Randomized but Never Treated|3
277507|NCT01962441|929019|P2|Randomized Period|Randomized but Never Treated|2
277508|NCT01962441|929020|P1|Randomized Period|Randomized but Never Treated|4
277509|NCT01961544|929059|P1|Overall Study|Aggravation of Steral Pain|1
277510|NCT01961544|929059|P1|Overall Study|Poor Tolerance|1
277511|NCT01961544|929059|P1|Overall Study|Physician Decision|2
277512|NCT01961544|929059|P1|Overall Study|Adverse Event|1
277513|NCT01961544|929059|P1|Overall Study|Withdrawal by Subject|7
277514|NCT01961544|929059|P1|Overall Study|Protocol Violation|1
277515|NCT01961349|929067|P3|Overall Study|registration error, personal reason etc|1
277516|NCT01961349|929068|P2|Overall Study|registration error, personal reason etc|2
277517|NCT01961349|929069|P1|Overall Study|registration error, personal reason etc|2
277518|NCT01961349|929067|P3|Overall Study|Adverse Event|1
277519|NCT01961349|929068|P2|Overall Study|Adverse Event|0
277520|NCT01961349|929069|P1|Overall Study|Adverse Event|0
277521|NCT01961349|929067|P3|Overall Study|Withdrawal by Subject|0
277522|NCT01961349|929068|P2|Overall Study|Withdrawal by Subject|4
277523|NCT01961349|929069|P1|Overall Study|Withdrawal by Subject|1
277524|NCT01961323|929080|P1|Overall Study|screen failure|34
277525|NCT01961323|929080|P1|Overall Study|Lost to Follow-up|8
277526|NCT01961323|929080|P1|Overall Study|Withdrawal by Subject|7
277527|NCT01961297|929088|P2|Overall Study|unconfirmed diagnosis of SD|1
277528|NCT01961297|929089|P1|Overall Study|unconfirmed diagnosis of SD|2
277529|NCT01961115|929115|P3|Overall Study|Adverse Event|1
277530|NCT01961115|929116|P2|Overall Study|Adverse Event|0
277531|NCT01961115|929117|P1|Overall Study|Adverse Event|1
277532|NCT01961115|929115|P3|Overall Study|Disease Progression|3
277533|NCT01961115|929116|P2|Overall Study|Disease Progression|0
277534|NCT01961115|929117|P1|Overall Study|Disease Progression|1
277535|NCT01960907|929160|P2|Overall Study|Withdrawal by Subject|42
277536|NCT01960907|929161|P1|Overall Study|Withdrawal by Subject|32
277537|NCT01960907|929160|P2|Overall Study|Death|3
277538|NCT01960907|929161|P1|Overall Study|Death|4
277539|NCT01960855|929176|P5|Overall Study|Lost to Follow-up|2
277540|NCT01960855|929177|P4|Overall Study|Lost to Follow-up|0
277541|NCT01960855|929178|P3|Overall Study|Lost to Follow-up|0
277542|NCT01960855|929179|P2|Overall Study|Lost to Follow-up|1
277543|NCT01960855|929180|P1|Overall Study|Lost to Follow-up|2
277544|NCT01960855|929176|P5|Overall Study|Consent withdrawn by subject|1
277545|NCT01960855|929177|P4|Overall Study|Consent withdrawn by subject|1
277546|NCT01960855|929178|P3|Overall Study|Consent withdrawn by subject|2
277547|NCT01960855|929179|P2|Overall Study|Consent withdrawn by subject|1
277548|NCT01960855|929180|P1|Overall Study|Consent withdrawn by subject|3
277549|NCT01960855|929176|P5|Overall Study|Not specified|0
277550|NCT01960855|929177|P4|Overall Study|Not specified|1
277551|NCT01960855|929178|P3|Overall Study|Not specified|1
277552|NCT01960855|929179|P2|Overall Study|Not specified|1
277553|NCT01960855|929180|P1|Overall Study|Not specified|2
277554|NCT01960855|929176|P5|Overall Study|Lack of Efficacy|0
277555|NCT01960855|929177|P4|Overall Study|Lack of Efficacy|0
277556|NCT01960855|929178|P3|Overall Study|Lack of Efficacy|0
277557|NCT01960855|929179|P2|Overall Study|Lack of Efficacy|1
277558|NCT01960855|929180|P1|Overall Study|Lack of Efficacy|1
277559|NCT01960855|929176|P5|Overall Study|Adverse Event|2
277560|NCT01960855|929177|P4|Overall Study|Adverse Event|2
277561|NCT01960855|929178|P3|Overall Study|Adverse Event|6
277562|NCT01960855|929179|P2|Overall Study|Adverse Event|0
277563|NCT01960855|929180|P1|Overall Study|Adverse Event|2
277564|NCT01960855|929176|P5|Overall Study|Subject noncompliant|0
277565|NCT01960855|929177|P4|Overall Study|Subject noncompliant|0
277566|NCT01960855|929178|P3|Overall Study|Subject noncompliant|0
277567|NCT01960855|929179|P2|Overall Study|Subject noncompliant|0
277568|NCT01960855|929180|P1|Overall Study|Subject noncompliant|1
277569|NCT01960842|929212|P1|Overall Study|Withdrawal by Subject|2
277570|NCT01960842|929212|P1|Overall Study|Adverse Event|1
277571|NCT01960816|929235|P1|Overall Study|Lost to Follow-up|1
277572|NCT01960725|929243|P2|Overall Study|unable to obtain blood sample|2
277573|NCT01960725|929244|P1|Overall Study|unable to obtain blood sample|1
277574|NCT01960725|929243|P2|Overall Study|Withdrawal by Subject|0
277575|NCT01960725|929244|P1|Overall Study|Withdrawal by Subject|1
277576|NCT01960725|929243|P2|Overall Study|Lost to Follow-up|3
277577|NCT01960725|929244|P1|Overall Study|Lost to Follow-up|4
277578|NCT01960296|929323|P2|Overall Study|Received different procedure|3
277579|NCT01960296|929324|P1|Overall Study|Received different procedure|1
277580|NCT01960296|929323|P2|Overall Study|Postponed surgery|0
277581|NCT01960296|929324|P1|Overall Study|Postponed surgery|1
277582|NCT01960140|929344|P1|Period 2 (Days 3-18)|Adverse Event|2
277583|NCT01960114|929355|P2|Overall Study|Could not swallow study medication|1
277584|NCT01960114|929356|P1|Overall Study|Could not swallow study medication|0
277585|NCT01960114|929355|P2|Overall Study|Adverse Event|0
277586|NCT01960114|929356|P1|Overall Study|Adverse Event|1
277587|NCT01959932|929402|P3|Overall Study|Withdrawal by Subject|0
277588|NCT01959932|929403|P2|Overall Study|Withdrawal by Subject|0
277589|NCT01959932|929404|P1|Overall Study|Withdrawal by Subject|1
277590|NCT01959880|929426|P4|Overall Study|Study completed early-FDA approved|152
277591|NCT01959880|929427|P3|Overall Study|Study completed early-FDA approved|179
277592|NCT01959880|929428|P2|Overall Study|Study completed early-FDA approved|311
277593|NCT01959880|929429|P1|Overall Study|Study completed early-FDA approved|1003
277594|NCT01959880|929426|P4|Overall Study|Explantation w/o study device reimplant.|12
277595|NCT01959880|929427|P3|Overall Study|Explantation w/o study device reimplant.|5
277596|NCT01959880|929428|P2|Overall Study|Explantation w/o study device reimplant.|17
277597|NCT01959880|929429|P1|Overall Study|Explantation w/o study device reimplant.|22
277598|NCT01959880|929426|P4|Overall Study|Lost to Follow-up|8
277599|NCT01959880|929427|P3|Overall Study|Lost to Follow-up|15
277600|NCT01959880|929428|P2|Overall Study|Lost to Follow-up|18
277601|NCT01959880|929429|P1|Overall Study|Lost to Follow-up|95
277602|NCT01959880|929426|P4|Overall Study|Death|2
277603|NCT01959880|929427|P3|Overall Study|Death|1
277604|NCT01959880|929428|P2|Overall Study|Death|10
277605|NCT01959880|929429|P1|Overall Study|Death|1
277606|NCT01959880|929426|P4|Overall Study|Withdrawal by Subject|7
277607|NCT01959880|929427|P3|Overall Study|Withdrawal by Subject|8
277608|NCT01959880|929428|P2|Overall Study|Withdrawal by Subject|13
277609|NCT01959880|929429|P1|Overall Study|Withdrawal by Subject|11
277610|NCT01959607|929458|P4|First Intervention (Day 1)|Withdrawal by Subject|0
277611|NCT01959607|929459|P3|First Intervention (Day 1)|Withdrawal by Subject|0
277612|NCT01959607|929460|P2|First Intervention (Day 1)|Withdrawal by Subject|1
277613|NCT01959607|929461|P1|First Intervention (Day 1)|Withdrawal by Subject|1
277614|NCT01959581|929474|P1|Overall Study|Lost to Follow-up|5
277615|NCT01959529|929480|P2|Overall Study|Lack of glycaemic control|1
277616|NCT01959529|929481|P1|Overall Study|Lack of glycaemic control|1
277617|NCT01959529|929480|P2|Overall Study|Hypoglycaemia|1
277618|NCT01959529|929481|P1|Overall Study|Hypoglycaemia|1
277619|NCT01959529|929480|P2|Overall Study|Other|68
277620|NCT01959529|929481|P1|Overall Study|Other|70
277621|NCT01959529|929480|P2|Overall Study|Lost to Follow-up|1
277622|NCT01959529|929481|P1|Overall Study|Lost to Follow-up|4
277623|NCT01959529|929480|P2|Overall Study|Adverse event (not hypoglycaemia)|1
277624|NCT01959529|929481|P1|Overall Study|Adverse event (not hypoglycaemia)|0
277625|NCT01959516|929493|P2|Epoch 2|Moderate or severe COPD exacerbation|1
277626|NCT01959516|929494|P1|Epoch 2|Moderate or severe COPD exacerbation|0
277627|NCT01959516|929493|P2|Epoch 2|Subject withdrew consent|0
277628|NCT01959516|929494|P1|Epoch 2|Subject withdrew consent|1
277629|NCT01959516|929493|P2|Epoch 2|unsatisfactory therapeutic effect|0
277630|NCT01959516|929494|P1|Epoch 2|unsatisfactory therapeutic effect|1
277631|NCT01959516|929493|P2|Epoch 1|Protocol deviation|1
277632|NCT01959516|929494|P1|Epoch 1|Protocol deviation|0
277633|NCT01959516|929493|P2|Epoch 1|Moderate or severe COPD exacerbation|1
277634|NCT01959516|929494|P1|Epoch 1|Moderate or severe COPD exacerbation|0
277635|NCT01959516|929493|P2|Epoch 1|Use of prohibited treatment|0
277636|NCT01959516|929494|P1|Epoch 1|Use of prohibited treatment|1
277637|NCT01959516|929493|P2|Epoch 1|Administrative problems|0
277638|NCT01959516|929494|P1|Epoch 1|Administrative problems|1
277639|NCT01959516|929493|P2|Epoch 1|Subject withdrew consent|2
277640|NCT01959516|929494|P1|Epoch 1|Subject withdrew consent|3
277641|NCT01959516|929493|P2|Epoch 1|unsatisfactory therapeutic effect|0
277642|NCT01959516|929494|P1|Epoch 1|unsatisfactory therapeutic effect|1
277643|NCT01959516|929493|P2|Epoch 1|Adverse Event|1
277644|NCT01959516|929494|P1|Epoch 1|Adverse Event|4
277645|NCT01959503|929504|P2|Overall Study|Randomized but not treated|1
277646|NCT01959503|929505|P1|Overall Study|Randomized but not treated|1
277647|NCT01959503|929504|P2|Overall Study|Death|1
277648|NCT01959503|929505|P1|Overall Study|Death|2
277649|NCT01959412|929525|P6|Overall Study|Adverse Event|0
277650|NCT01959412|929526|P5|Overall Study|Adverse Event|0
277651|NCT01959412|929527|P4|Overall Study|Adverse Event|1
277652|NCT01959412|929528|P3|Overall Study|Adverse Event|0
277653|NCT01959412|929529|P2|Overall Study|Adverse Event|0
277654|NCT01959412|929530|P1|Overall Study|Adverse Event|0
277655|NCT01959412|929525|P6|Overall Study|Protocol deviation|0
277656|NCT01959412|929526|P5|Overall Study|Protocol deviation|3
277657|NCT01959412|929527|P4|Overall Study|Protocol deviation|1
277658|NCT01959412|929528|P3|Overall Study|Protocol deviation|0
277659|NCT01959412|929529|P2|Overall Study|Protocol deviation|1
277660|NCT01959412|929530|P1|Overall Study|Protocol deviation|1
277661|NCT01959035|929568|P1|Overall Study|Other (no primary reason given)|1
277662|NCT01959035|929568|P1|Overall Study|Lost to Follow-up|1
277663|NCT01959035|929568|P1|Overall Study|Withdrawal by Subject|4
277664|NCT01959035|929568|P1|Overall Study|Adverse Event|5
277665|NCT01958827|929594|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
277666|NCT01958827|929594|P1|Overall Study|Lack of Efficacy|6
277667|NCT01958827|929594|P1|Overall Study|Adverse Event|3
277668|NCT01958671|929625|P3|Overall Study|Withdrawal by Subject|13
277669|NCT01958671|929626|P2|Overall Study|Withdrawal by Subject|10
277670|NCT01958671|929627|P1|Overall Study|Withdrawal by Subject|8
277671|NCT01958671|929625|P3|Overall Study|Participant moved|1
277672|NCT01958671|929626|P2|Overall Study|Participant moved|0
277673|NCT01958671|929627|P1|Overall Study|Participant moved|0
277674|NCT01958671|929625|P3|Overall Study|Study site terminated by sponsor|1
277675|NCT01958671|929626|P2|Overall Study|Study site terminated by sponsor|0
277676|NCT01958671|929627|P1|Overall Study|Study site terminated by sponsor|1
277677|NCT01958671|929625|P3|Overall Study|Protocol Violation|0
277678|NCT01958671|929626|P2|Overall Study|Protocol Violation|1
277679|NCT01958671|929627|P1|Overall Study|Protocol Violation|0
277680|NCT01958671|929625|P3|Overall Study|Pregnancy|1
277681|NCT01958671|929626|P2|Overall Study|Pregnancy|0
277682|NCT01958671|929627|P1|Overall Study|Pregnancy|0
277683|NCT01958671|929625|P3|Overall Study|Non-compliance with study drug|1
277684|NCT01958671|929626|P2|Overall Study|Non-compliance with study drug|1
277685|NCT01958671|929627|P1|Overall Study|Non-compliance with study drug|1
277686|NCT01958671|929625|P3|Overall Study|Lost to Follow-up|7
277687|NCT01958671|929626|P2|Overall Study|Lost to Follow-up|11
277688|NCT01958671|929627|P1|Overall Study|Lost to Follow-up|7
277689|NCT01958671|929625|P3|Overall Study|Hyperglycemia|2
277690|NCT01958671|929626|P2|Overall Study|Hyperglycemia|0
277691|NCT01958671|929627|P1|Overall Study|Hyperglycemia|0
277692|NCT01958671|929625|P3|Overall Study|Excluded medication|1
277693|NCT01958671|929626|P2|Overall Study|Excluded medication|0
277694|NCT01958671|929627|P1|Overall Study|Excluded medication|0
277695|NCT01958671|929625|P3|Overall Study|Death|0
277696|NCT01958671|929626|P2|Overall Study|Death|0
277697|NCT01958671|929627|P1|Overall Study|Death|1
277698|NCT01958671|929625|P3|Overall Study|Adverse Event|5
277699|NCT01958671|929626|P2|Overall Study|Adverse Event|1
277700|NCT01958671|929627|P1|Overall Study|Adverse Event|1
277701|NCT01958619|929701|P4|Overall Study|Protocol Violation|0
277702|NCT01958619|929702|P3|Overall Study|Protocol Violation|1
277703|NCT01958619|929703|P2|Overall Study|Protocol Violation|0
277704|NCT01958619|929704|P1|Overall Study|Protocol Violation|2
277705|NCT01958164|929778|P2|Overall Study|Lost to Follow-up|3
277706|NCT01958164|929779|P1|Overall Study|Lost to Follow-up|2
277707|NCT01958164|929778|P2|Overall Study|Adverse Event|2
277708|NCT01958164|929779|P1|Overall Study|Adverse Event|0
277709|NCT01958060|929798|P6|Overall Study|Not treated|0
277710|NCT01958060|929799|P5|Overall Study|Not treated|1
277711|NCT01958060|929800|P4|Overall Study|Not treated|0
277712|NCT01958060|929801|P3|Overall Study|Not treated|0
277713|NCT01958060|929802|P2|Overall Study|Not treated|0
277714|NCT01958060|929803|P1|Overall Study|Not treated|2
277715|NCT01958021|929828|P2|Overall Study|Death|0
277716|NCT01958021|929829|P1|Overall Study|Death|2
277717|NCT01958021|929828|P2|Overall Study|Protocol Violation|1
277718|NCT01958021|929829|P1|Overall Study|Protocol Violation|3
277719|NCT01958021|929828|P2|Overall Study|Physician Decision|13
277720|NCT01958021|929829|P1|Overall Study|Physician Decision|10
277721|NCT01958021|929828|P2|Overall Study|Subject/guardian decision|13
277722|NCT01958021|929829|P1|Overall Study|Subject/guardian decision|12
277723|NCT01958021|929828|P2|Overall Study|Adverse Event|7
277724|NCT01958021|929829|P1|Overall Study|Adverse Event|25
277725|NCT01958021|929828|P2|Overall Study|Progressive disease|146
277726|NCT01958021|929829|P1|Overall Study|Progressive disease|87
277727|NCT01958008|929841|P4|Overall Study|Other adverse event|0
277728|NCT01958008|929842|P3|Overall Study|Other adverse event|0
277729|NCT01958008|929843|P2|Overall Study|Other adverse event|0
277730|NCT01958008|929844|P1|Overall Study|Other adverse event|1
277731|NCT01958008|929841|P4|Overall Study|Worsening of disease under study|0
277732|NCT01958008|929842|P3|Overall Study|Worsening of disease under study|1
277733|NCT01958008|929843|P2|Overall Study|Worsening of disease under study|0
277734|NCT01958008|929844|P1|Overall Study|Worsening of disease under study|0
277735|NCT01957865|929884|P3|Overall Study|Lost to Follow-up|2
277736|NCT01957865|929885|P2|Overall Study|Lost to Follow-up|2
277737|NCT01957865|929886|P1|Overall Study|Lost to Follow-up|0
277738|NCT01957865|929884|P3|Overall Study|Found HIV negative|1
277739|NCT01957865|929885|P2|Overall Study|Found HIV negative|0
277740|NCT01957865|929886|P1|Overall Study|Found HIV negative|0
277741|NCT01957579|929919|P4|Overall Study|Death|0
277742|NCT01957579|929920|P3|Overall Study|Death|2
277743|NCT01957579|929921|P2|Overall Study|Death|0
277744|NCT01957579|929922|P1|Overall Study|Death|0
277745|NCT01957579|929919|P4|Overall Study|Withdrawal of concent|0
277746|NCT01957579|929920|P3|Overall Study|Withdrawal of concent|0
277747|NCT01957579|929921|P2|Overall Study|Withdrawal of concent|1
277748|NCT01957579|929922|P1|Overall Study|Withdrawal of concent|0
277749|NCT01957553|929989|P2|Test Period 2 (21 +- 1 Days)|Other|0
277750|NCT01957553|929990|P1|Test Period 2 (21 +- 1 Days)|Other|1
277751|NCT01957553|929989|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
277752|NCT01957553|929990|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
277753|NCT01957553|929989|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
277754|NCT01957553|929990|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
277755|NCT01957553|929989|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
277756|NCT01957553|929990|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
277757|NCT01957553|929989|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
277758|NCT01957553|929990|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
277759|NCT01957553|929989|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
277760|NCT01957553|929990|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
277761|NCT01957553|929989|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
277762|NCT01957553|929990|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
277763|NCT01957553|929989|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
277764|NCT01957553|929990|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
277765|NCT01957553|929989|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
277766|NCT01957553|929990|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
277767|NCT01957488|929996|P6|Test Period 3|Lack of Efficacy|0
277768|NCT01957488|929997|P5|Test Period 3|Lack of Efficacy|0
277769|NCT01957488|929998|P4|Test Period 3|Lack of Efficacy|0
277770|NCT01957488|929999|P3|Test Period 3|Lack of Efficacy|0
277771|NCT01957488|930000|P2|Test Period 3|Lack of Efficacy|1
277772|NCT01957488|930001|P1|Test Period 3|Lack of Efficacy|0
277773|NCT01957488|929996|P6|Test Period 3|Withdrawal by Subject|0
277774|NCT01957488|929997|P5|Test Period 3|Withdrawal by Subject|0
277775|NCT01957488|929998|P4|Test Period 3|Withdrawal by Subject|0
277776|NCT01957488|929999|P3|Test Period 3|Withdrawal by Subject|0
277777|NCT01957488|930000|P2|Test Period 3|Withdrawal by Subject|0
277778|NCT01957488|930001|P1|Test Period 3|Withdrawal by Subject|1
277779|NCT01957488|929996|P6|Test Period 2|Discontinue due to personal problems|1
277780|NCT01957488|929997|P5|Test Period 2|Discontinue due to personal problems|0
277781|NCT01957488|929998|P4|Test Period 2|Discontinue due to personal problems|0
277782|NCT01957488|929999|P3|Test Period 2|Discontinue due to personal problems|0
277783|NCT01957488|930000|P2|Test Period 2|Discontinue due to personal problems|0
277784|NCT01957488|930001|P1|Test Period 2|Discontinue due to personal problems|0
277785|NCT01957488|929996|P6|Test Period 2|Adverse Event|0
277786|NCT01957488|929997|P5|Test Period 2|Adverse Event|2
277787|NCT01957488|929998|P4|Test Period 2|Adverse Event|0
277788|NCT01957488|929999|P3|Test Period 2|Adverse Event|0
277789|NCT01957488|930000|P2|Test Period 2|Adverse Event|0
277790|NCT01957488|930001|P1|Test Period 2|Adverse Event|0
277791|NCT01957488|929996|P6|Test Period 2|Withdrawal by Subject|0
277792|NCT01957488|929997|P5|Test Period 2|Withdrawal by Subject|0
277793|NCT01957488|929998|P4|Test Period 2|Withdrawal by Subject|0
277794|NCT01957488|929999|P3|Test Period 2|Withdrawal by Subject|0
277795|NCT01957488|930000|P2|Test Period 2|Withdrawal by Subject|1
277796|NCT01957488|930001|P1|Test Period 2|Withdrawal by Subject|0
277797|NCT01957488|929996|P6|Test Period 2|Other|0
277798|NCT01957488|929997|P5|Test Period 2|Other|0
277799|NCT01957488|929998|P4|Test Period 2|Other|0
277800|NCT01957488|929999|P3|Test Period 2|Other|0
277801|NCT01957488|930000|P2|Test Period 2|Other|0
277802|NCT01957488|930001|P1|Test Period 2|Other|1
277803|NCT01957488|929996|P6|Test Period 2|Protocol Violation|0
277804|NCT01957488|929997|P5|Test Period 2|Protocol Violation|0
277805|NCT01957488|929998|P4|Test Period 2|Protocol Violation|1
277806|NCT01957488|929999|P3|Test Period 2|Protocol Violation|1
277807|NCT01957488|930000|P2|Test Period 2|Protocol Violation|0
277808|NCT01957488|930001|P1|Test Period 2|Protocol Violation|2
277809|NCT01957488|929996|P6|Test Period 1|screen failure|1
277810|NCT01957488|929997|P5|Test Period 1|screen failure|0
277811|NCT01957488|929998|P4|Test Period 1|screen failure|0
277812|NCT01957488|929999|P3|Test Period 1|screen failure|0
277813|NCT01957488|930000|P2|Test Period 1|screen failure|0
277814|NCT01957488|930001|P1|Test Period 1|screen failure|0
277815|NCT01957488|929996|P6|Test Period 1|subject did not want to wait for cut bag|0
277816|NCT01957488|929997|P5|Test Period 1|subject did not want to wait for cut bag|1
277817|NCT01957488|929998|P4|Test Period 1|subject did not want to wait for cut bag|0
277818|NCT01957488|929999|P3|Test Period 1|subject did not want to wait for cut bag|0
277819|NCT01957488|930000|P2|Test Period 1|subject did not want to wait for cut bag|0
277820|NCT01957488|930001|P1|Test Period 1|subject did not want to wait for cut bag|0
277821|NCT01957488|929996|P6|Test Period 1|Withdrawal by Subject|2
277822|NCT01957488|929997|P5|Test Period 1|Withdrawal by Subject|1
277823|NCT01957488|929998|P4|Test Period 1|Withdrawal by Subject|1
277824|NCT01957488|929999|P3|Test Period 1|Withdrawal by Subject|0
277825|NCT01957488|930000|P2|Test Period 1|Withdrawal by Subject|0
277826|NCT01957488|930001|P1|Test Period 1|Withdrawal by Subject|0
277827|NCT01957488|929996|P6|Test Period 1|Adverse Event|0
277828|NCT01957488|929997|P5|Test Period 1|Adverse Event|1
277829|NCT01957488|929998|P4|Test Period 1|Adverse Event|0
277830|NCT01957488|929999|P3|Test Period 1|Adverse Event|1
277831|NCT01957488|930000|P2|Test Period 1|Adverse Event|1
277832|NCT01957488|930001|P1|Test Period 1|Adverse Event|0
277833|NCT01957488|929996|P6|Test Period 1|Protocol Violation|3
277834|NCT01957488|929997|P5|Test Period 1|Protocol Violation|0
277835|NCT01957488|929998|P4|Test Period 1|Protocol Violation|1
277836|NCT01957488|929999|P3|Test Period 1|Protocol Violation|2
277837|NCT01957488|930000|P2|Test Period 1|Protocol Violation|2
277838|NCT01957488|930001|P1|Test Period 1|Protocol Violation|1
277839|NCT01957488|929996|P6|Test Period 1|Lost to Follow-up|0
277840|NCT01957488|929997|P5|Test Period 1|Lost to Follow-up|0
277841|NCT01957488|929998|P4|Test Period 1|Lost to Follow-up|1
277842|NCT01957488|929999|P3|Test Period 1|Lost to Follow-up|1
277843|NCT01957488|930000|P2|Test Period 1|Lost to Follow-up|0
277844|NCT01957488|930001|P1|Test Period 1|Lost to Follow-up|2
277845|NCT01957475|930009|P2|Test Period 2|Adverse Event|0
277846|NCT01957475|930010|P1|Test Period 2|Adverse Event|1
277847|NCT01957475|930009|P2|Test Period 1|Lack of Efficacy|1
277848|NCT01957475|930010|P1|Test Period 1|Lack of Efficacy|0
277849|NCT01957475|930009|P2|Test Period 1|Other|0
277850|NCT01957475|930010|P1|Test Period 1|Other|1
277851|NCT01957475|930009|P2|Test Period 1|Withdrawal by Subject|0
277852|NCT01957475|930010|P1|Test Period 1|Withdrawal by Subject|1
277853|NCT01957462|930016|P2|Test Period 1|Adverse Event|0
277854|NCT01957462|930017|P1|Test Period 1|Adverse Event|1
277855|NCT01957462|930016|P2|Test Period 1|Withdrawal by Subject|0
277856|NCT01957462|930017|P1|Test Period 1|Withdrawal by Subject|1
277857|NCT01957397|930028|P2|Test Period 3|the adhesive did not work|0
277858|NCT01957397|930029|P1|Test Period 3|the adhesive did not work|1
277859|NCT01957397|930028|P2|Test Period 3|Adverse Event|2
277860|NCT01957397|930029|P1|Test Period 3|Adverse Event|1
277861|NCT01957397|930028|P2|Test Period 2|Adverse Event|1
277862|NCT01957397|930029|P1|Test Period 2|Adverse Event|0
277863|NCT01957397|930028|P2|Test Period 1|Withdrawal by Subject|0
277864|NCT01957397|930029|P1|Test Period 1|Withdrawal by Subject|1
277865|NCT01957397|930028|P2|Test Period 1|sudden leakage/small bag|1
277866|NCT01957397|930029|P1|Test Period 1|sudden leakage/small bag|1
277867|NCT01957215|930054|P2|Overall Study|Withdrawal by Subject|5
277868|NCT01957215|930055|P1|Overall Study|Withdrawal by Subject|7
277869|NCT01957215|930054|P2|Overall Study|Protocol Violation|2
277870|NCT01957215|930055|P1|Overall Study|Protocol Violation|1
277871|NCT01957215|930054|P2|Overall Study|Lost to Follow-up|3
277872|NCT01957215|930055|P1|Overall Study|Lost to Follow-up|3
277873|NCT01957215|930054|P2|Overall Study|Adverse Event|2
277874|NCT01957215|930055|P1|Overall Study|Adverse Event|2
277875|NCT01957202|930083|P18|Treatment Period 3 (8 Days)|Adverse Event|0
277876|NCT01957202|930084|P17|Treatment Period 3 (8 Days)|Adverse Event|1
277877|NCT01957202|930085|P16|Treatment Period 3 (8 Days)|Adverse Event|0
277878|NCT01957202|930086|P15|Treatment Period 3 (8 Days)|Adverse Event|0
277879|NCT01957202|930087|P14|Treatment Period 3 (8 Days)|Adverse Event|0
277880|NCT01957202|930088|P13|Treatment Period 3 (8 Days)|Adverse Event|0
277881|NCT01957202|930089|P12|Treatment Period 3 (8 Days)|Adverse Event|0
277882|NCT01957202|930090|P11|Treatment Period 3 (8 Days)|Adverse Event|0
277883|NCT01957202|930091|P10|Treatment Period 3 (8 Days)|Adverse Event|0
277884|NCT01957202|930092|P9|Treatment Period 3 (8 Days)|Adverse Event|0
277885|NCT01957202|930093|P8|Treatment Period 3 (8 Days)|Adverse Event|0
277886|NCT01957202|930094|P7|Treatment Period 3 (8 Days)|Adverse Event|0
277887|NCT01957202|930095|P6|Treatment Period 3 (8 Days)|Adverse Event|0
277888|NCT01957202|930096|P5|Treatment Period 3 (8 Days)|Adverse Event|0
277889|NCT01957202|930097|P4|Treatment Period 3 (8 Days)|Adverse Event|0
277890|NCT01957202|930098|P3|Treatment Period 3 (8 Days)|Adverse Event|0
277891|NCT01957202|930099|P2|Treatment Period 3 (8 Days)|Adverse Event|0
277892|NCT01957202|930100|P1|Treatment Period 3 (8 Days)|Adverse Event|0
277893|NCT01957202|930083|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277894|NCT01957202|930084|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
277895|NCT01957202|930085|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277896|NCT01957202|930086|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277897|NCT01957202|930087|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277898|NCT01957202|930088|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277899|NCT01957202|930089|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277900|NCT01957202|930090|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277901|NCT01957202|930091|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277902|NCT01957202|930092|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277903|NCT01957202|930093|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277904|NCT01957202|930094|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277905|NCT01957202|930095|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277906|NCT01957202|930096|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277907|NCT01957202|930097|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277908|NCT01957202|930098|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277909|NCT01957202|930099|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
277910|NCT01957202|930100|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
277911|NCT01957163|930125|P3|Overall Study|Withdrawal by Subject|4
277912|NCT01957163|930126|P2|Overall Study|Withdrawal by Subject|2
277913|NCT01957163|930127|P1|Overall Study|Withdrawal by Subject|4
277914|NCT01957163|930125|P3|Overall Study|Lost to Follow-up|0
277915|NCT01957163|930126|P2|Overall Study|Lost to Follow-up|1
277916|NCT01957163|930127|P1|Overall Study|Lost to Follow-up|0
277917|NCT01957163|930125|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
277918|NCT01957163|930126|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
277919|NCT01957163|930127|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
277920|NCT01957163|930125|P3|Overall Study|Protocol Violation|0
277921|NCT01957163|930126|P2|Overall Study|Protocol Violation|2
277922|NCT01957163|930127|P1|Overall Study|Protocol Violation|1
277923|NCT01957163|930125|P3|Overall Study|Lack of Efficacy|9
277924|NCT01957163|930126|P2|Overall Study|Lack of Efficacy|4
277925|NCT01957163|930127|P1|Overall Study|Lack of Efficacy|5
277926|NCT01957163|930125|P3|Overall Study|Adverse Event|4
277927|NCT01957163|930126|P2|Overall Study|Adverse Event|2
277928|NCT01957163|930127|P1|Overall Study|Adverse Event|5
277929|NCT01957137|930138|P1|Randomized Portion|Withdrawal by Subject|1
277930|NCT01957137|930138|P1|Randomized Portion|Adverse Event|1
277931|NCT01957111|930168|P2|Overall Study|Withdrawal by Subject|1
277932|NCT01957111|930169|P1|Overall Study|Withdrawal by Subject|1
277933|NCT01956240|930187|P2|Overall Study|Adverse Event|4
277934|NCT01956240|930188|P1|Overall Study|Adverse Event|17
277935|NCT01956240|930187|P2|Overall Study|Lost to Follow-up|20
277936|NCT01956240|930188|P1|Overall Study|Lost to Follow-up|6
277937|NCT01955733|930277|P3|Period 2|Other not defined above|2
277938|NCT01955733|930278|P2|Period 2|Other not defined above|2
277939|NCT01955733|930279|P1|Period 2|Other not defined above|0
277940|NCT01955733|930277|P3|Period 2|Lost to Follow-up|0
277941|NCT01955733|930278|P2|Period 2|Lost to Follow-up|0
277942|NCT01955733|930279|P1|Period 2|Lost to Follow-up|2
277943|NCT01955733|930277|P3|Period 2|Study terminated by sponsor|16
277944|NCT01955733|930278|P2|Period 2|Study terminated by sponsor|14
277945|NCT01955733|930279|P1|Period 2|Study terminated by sponsor|8
277946|NCT01955733|930277|P3|Period 2|Withdrawal by Subject|2
277947|NCT01955733|930278|P2|Period 2|Withdrawal by Subject|3
277948|NCT01955733|930279|P1|Period 2|Withdrawal by Subject|1
277949|NCT01955733|930277|P3|Period 2|Physician Decision|1
277950|NCT01955733|930278|P2|Period 2|Physician Decision|0
277951|NCT01955733|930279|P1|Period 2|Physician Decision|0
277952|NCT01955733|930277|P3|Period 2|Adverse Event|0
277953|NCT01955733|930278|P2|Period 2|Adverse Event|0
277954|NCT01955733|930279|P1|Period 2|Adverse Event|1
277955|NCT01955733|930277|P3|Period 1|Lost to Follow-up|0
277956|NCT01955733|930278|P2|Period 1|Lost to Follow-up|0
277957|NCT01955733|930279|P1|Period 1|Lost to Follow-up|1
277958|NCT01955707|930372|P2|Overall Study|Not Specified|2
277959|NCT01955707|930373|P1|Overall Study|Not Specified|4
277960|NCT01955707|930372|P2|Overall Study|Death|14
277961|NCT01955707|930373|P1|Overall Study|Death|13
277962|NCT01955707|930372|P2|Overall Study|Withdrawal by Subject|3
277963|NCT01955707|930373|P1|Overall Study|Withdrawal by Subject|0
277964|NCT01955707|930372|P2|Overall Study|Lost to Follow-up|1
277965|NCT01955707|930373|P1|Overall Study|Lost to Follow-up|2
277966|NCT01955707|930372|P2|Overall Study|Adverse Event|2
277967|NCT01955707|930373|P1|Overall Study|Adverse Event|1
277968|NCT01955161|930641|P3|Overall Study|Other reason: patient's will|1
277969|NCT01955161|930642|P2|Overall Study|Other reason: patient's will|0
277970|NCT01955161|930643|P1|Overall Study|Other reason: patient's will|0
277971|NCT01955161|930641|P3|Overall Study|Other reason: primary biliary cirrhosis|0
277972|NCT01955161|930642|P2|Overall Study|Other reason: primary biliary cirrhosis|0
277973|NCT01955161|930643|P1|Overall Study|Other reason: primary biliary cirrhosis|1
277974|NCT01955161|930641|P3|Overall Study|Other reason: insufficient compliance|1
277975|NCT01955161|930642|P2|Overall Study|Other reason: insufficient compliance|0
277976|NCT01955161|930643|P1|Overall Study|Other reason: insufficient compliance|0
277977|NCT01955161|930641|P3|Overall Study|Other reason: moved to nursing home|0
277978|NCT01955161|930642|P2|Overall Study|Other reason: moved to nursing home|1
277979|NCT01955161|930643|P1|Overall Study|Other reason: moved to nursing home|0
277980|NCT01955161|930641|P3|Overall Study|Other reason: caregiver unavailable|0
277981|NCT01955161|930642|P2|Overall Study|Other reason: caregiver unavailable|0
277982|NCT01955161|930643|P1|Overall Study|Other reason: caregiver unavailable|1
277983|NCT01955161|930641|P3|Overall Study|Other reason: disallowed medication|1
277984|NCT01955161|930642|P2|Overall Study|Other reason: disallowed medication|0
277985|NCT01955161|930643|P1|Overall Study|Other reason: disallowed medication|1
277986|NCT01955161|930641|P3|Overall Study|Other reason: physician decision|1
277987|NCT01955161|930642|P2|Overall Study|Other reason: physician decision|1
277988|NCT01955161|930643|P1|Overall Study|Other reason: physician decision|0
277989|NCT01955161|930641|P3|Overall Study|Protocol Violation|0
277990|NCT01955161|930642|P2|Overall Study|Protocol Violation|0
277991|NCT01955161|930643|P1|Overall Study|Protocol Violation|2
277992|NCT01955161|930641|P3|Overall Study|Withdrawal by Subject|12
277993|NCT01955161|930642|P2|Overall Study|Withdrawal by Subject|8
277994|NCT01955161|930643|P1|Overall Study|Withdrawal by Subject|9
277995|NCT01955161|930641|P3|Overall Study|Death|3
277996|NCT01955161|930642|P2|Overall Study|Death|1
277997|NCT01955161|930643|P1|Overall Study|Death|1
277998|NCT01955161|930641|P3|Overall Study|Adverse Event|15
277999|NCT01955161|930642|P2|Overall Study|Adverse Event|14
278000|NCT01955161|930643|P1|Overall Study|Adverse Event|10
278001|NCT01955161|930641|P3|Overall Study|Withdrawal before treatment|1
278002|NCT01955161|930642|P2|Overall Study|Withdrawal before treatment|0
278003|NCT01955161|930643|P1|Overall Study|Withdrawal before treatment|2
278004|NCT01955122|930683|P2|Overall Study|Physician Decision|5
278005|NCT01955122|930684|P1|Overall Study|Physician Decision|5
278006|NCT01955083|930704|P2|Overall Study|Lost to Follow-up|1
278007|NCT01955083|930705|P1|Overall Study|Lost to Follow-up|1
278008|NCT01955044|930738|P3|Overall Study|Death|0
278009|NCT01955044|930739|P2|Overall Study|Death|1
278010|NCT01955044|930740|P1|Overall Study|Death|1
278011|NCT01955005|930753|P2|Overall Study|Withdrawal by Subject|5
278012|NCT01955005|930754|P1|Overall Study|Withdrawal by Subject|3
278013|NCT01954771|930767|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
278014|NCT01954771|930768|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
278015|NCT01954771|930769|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
278016|NCT01954771|930767|P3|Overall Study|Missing CGMS of end-point|0
278017|NCT01954771|930768|P2|Overall Study|Missing CGMS of end-point|1
278018|NCT01954771|930769|P1|Overall Study|Missing CGMS of end-point|1
278019|NCT01954771|930767|P3|Overall Study|Missing HbA1c of end-point|0
278020|NCT01954771|930768|P2|Overall Study|Missing HbA1c of end-point|1
278021|NCT01954771|930769|P1|Overall Study|Missing HbA1c of end-point|1
278022|NCT01954745|930786|P1|Overall Study|Death|1
278023|NCT01954745|930786|P1|Overall Study|Adverse Event|2
278024|NCT01954745|930786|P1|Overall Study|Clinical Progression|5
278025|NCT01954745|930786|P1|Overall Study|Radiological Progression|11
278026|NCT01954251|930817|P2|Overall Study|Withdrawal by Subject|6
278027|NCT01954251|930818|P1|Overall Study|Withdrawal by Subject|2
278028|NCT01954251|930817|P2|Overall Study|Lost to Follow-up|6
278029|NCT01954251|930818|P1|Overall Study|Lost to Follow-up|6
278030|NCT01954251|930817|P2|Overall Study|Adverse Event|7
278031|NCT01954251|930818|P1|Overall Study|Adverse Event|5
278032|NCT01954121|930915|P2|Overall Study|Subject did not follow instructions|2
278033|NCT01954121|930916|P1|Overall Study|Subject did not follow instructions|0
278034|NCT01954121|930915|P2|Overall Study|Non-compliant patient|1
278035|NCT01954121|930916|P1|Overall Study|Non-compliant patient|1
278036|NCT01954121|930915|P2|Overall Study|Non-compliant with study procedures|0
278037|NCT01954121|930916|P1|Overall Study|Non-compliant with study procedures|1
278038|NCT01954121|930915|P2|Overall Study|SAE, non-fatal|4
278039|NCT01954121|930916|P1|Overall Study|SAE, non-fatal|1
278040|NCT01954121|930915|P2|Overall Study|AE, non-serious non-fatal|22
278041|NCT01954121|930916|P1|Overall Study|AE, non-serious non-fatal|5
278042|NCT01954121|930915|P2|Overall Study|AE, serious fatal|0
278043|NCT01954121|930916|P1|Overall Study|AE, serious fatal|1
278044|NCT01954121|930915|P2|Overall Study|Pregnancy|1
278045|NCT01954121|930916|P1|Overall Study|Pregnancy|1
278046|NCT01954121|930915|P2|Overall Study|Withdrawal by Subject|12
278047|NCT01954121|930916|P1|Overall Study|Withdrawal by Subject|18
278048|NCT01954121|930915|P2|Overall Study|Lost to Follow-up|6
278049|NCT01954121|930916|P1|Overall Study|Lost to Follow-up|5
278050|NCT01954121|930915|P2|Overall Study|Protocol Violation|2
278051|NCT01954121|930916|P1|Overall Study|Protocol Violation|0
278052|NCT01954121|930915|P2|Overall Study|Lack of Efficacy|41
278053|NCT01954121|930916|P1|Overall Study|Lack of Efficacy|94
278054|NCT01953354|930978|P2|Overall Study|Disease Exacerbation|0
278055|NCT01953354|930979|P1|Overall Study|Disease Exacerbation|1
278056|NCT01953354|930978|P2|Overall Study|Decision of Sponsor|1
278057|NCT01953354|930979|P1|Overall Study|Decision of Sponsor|0
278058|NCT01953354|930978|P2|Overall Study|Withdrawal by Subject|1
278059|NCT01953354|930979|P1|Overall Study|Withdrawal by Subject|0
278060|NCT01953328|931007|P8|Overall Study|Lost to Follow-up|0
278061|NCT01953328|931008|P7|Overall Study|Lost to Follow-up|0
278062|NCT01953328|931009|P6|Overall Study|Lost to Follow-up|0
278063|NCT01953328|931010|P5|Overall Study|Lost to Follow-up|1
278064|NCT01953328|931011|P4|Overall Study|Lost to Follow-up|0
278065|NCT01953328|931012|P3|Overall Study|Lost to Follow-up|0
278066|NCT01953328|931013|P2|Overall Study|Lost to Follow-up|0
278067|NCT01953328|931014|P1|Overall Study|Lost to Follow-up|0
278068|NCT01953328|931007|P8|Overall Study|Withdrawal by Subject|0
278069|NCT01953328|931008|P7|Overall Study|Withdrawal by Subject|0
278070|NCT01953328|931009|P6|Overall Study|Withdrawal by Subject|0
278071|NCT01953328|931010|P5|Overall Study|Withdrawal by Subject|1
278072|NCT01953328|931011|P4|Overall Study|Withdrawal by Subject|0
278073|NCT01953328|931012|P3|Overall Study|Withdrawal by Subject|0
278074|NCT01953328|931013|P2|Overall Study|Withdrawal by Subject|0
278075|NCT01953328|931014|P1|Overall Study|Withdrawal by Subject|0
278076|NCT01952834|931244|P1|Overall Study|Adverse Event|1
278077|NCT01952691|931251|P1|Overall Study|Lost to Follow-up|2
278078|NCT01952665|931259|P2|Overall Study|Protocol Violation|1
278079|NCT01952665|931260|P1|Overall Study|Protocol Violation|0
278080|NCT01952665|931259|P2|Overall Study|Adverse Event|1
278081|NCT01952665|931260|P1|Overall Study|Adverse Event|2
278082|NCT01952665|931259|P2|Overall Study|Lost to Follow-up|2
278083|NCT01952665|931260|P1|Overall Study|Lost to Follow-up|1
278084|NCT01952665|931259|P2|Overall Study|Physician Decision|2
278085|NCT01952665|931260|P1|Overall Study|Physician Decision|3
278086|NCT01952366|931426|P1|Overall Study|Withdrawal by Subject|9
278087|NCT01952366|931426|P1|Overall Study|Death|22
278088|NCT01952145|931441|P2|Overall Study|Unclassified|1
278089|NCT01952145|931442|P1|Overall Study|Unclassified|1
278090|NCT01952145|931441|P2|Overall Study|Withdrawal Criteria|11
278091|NCT01952145|931442|P1|Overall Study|Withdrawal Criteria|16
278092|NCT01952145|931441|P2|Overall Study|Adverse Event|0
278093|NCT01952145|931442|P1|Overall Study|Adverse Event|9
278094|NCT01952145|931441|P2|Overall Study|Death|1
278095|NCT01952145|931442|P1|Overall Study|Death|0
278096|NCT01952145|931441|P2|Overall Study|Protocol Violation|1
278097|NCT01952145|931442|P1|Overall Study|Protocol Violation|2
278098|NCT01952080|931456|P4|Overall Study|Protocol Non-compliance|0
278099|NCT01952080|931457|P3|Overall Study|Protocol Non-compliance|0
278100|NCT01952080|931458|P2|Overall Study|Protocol Non-compliance|1
278101|NCT01952080|931459|P1|Overall Study|Protocol Non-compliance|0
278102|NCT01952080|931456|P4|Overall Study|Withdrawal by Subject|1
278103|NCT01952080|931457|P3|Overall Study|Withdrawal by Subject|0
278104|NCT01952080|931458|P2|Overall Study|Withdrawal by Subject|0
278105|NCT01952080|931459|P1|Overall Study|Withdrawal by Subject|0
278106|NCT01951703|931538|P2|Second Intervention|Unsatisfactory Lens fitting|1
278107|NCT01951703|931539|P1|Second Intervention|Unsatisfactory Lens fitting|0
278108|NCT01951703|931538|P2|Second Intervention|Protocol Violation|1
278109|NCT01951703|931539|P1|Second Intervention|Protocol Violation|0
278110|NCT01951703|931538|P2|First Intervention|Physician Decision|0
278111|NCT01951703|931539|P1|First Intervention|Physician Decision|1
278112|NCT01951703|931538|P2|First Intervention|Subject was not compliant|1
278113|NCT01951703|931539|P1|First Intervention|Subject was not compliant|1
278114|NCT01951703|931538|P2|First Intervention|Withdrawal by Subject|0
278115|NCT01951703|931539|P1|First Intervention|Withdrawal by Subject|1
278116|NCT01951586|931564|P2|Overall Study|Withdrawal by Subject|13
278117|NCT01951586|931565|P1|Overall Study|Withdrawal by Subject|7
278118|NCT01951586|931564|P2|Overall Study|Death|100
278119|NCT01951586|931565|P1|Overall Study|Death|52
278120|NCT01951573|931589|P2|Washout Period|Adverse Event|1
278121|NCT01951573|931590|P1|Washout Period|Adverse Event|0
278122|NCT01951417|931600|P1|Overall Study|Lost to Follow-up|6
278123|NCT01951417|931600|P1|Overall Study|Protocol Violation|2
278124|NCT01951417|931600|P1|Overall Study|Withdrawal by Subject|1
278125|NCT01951170|931623|P1|Overall Study|Investigator decision|1
278126|NCT01951092|931646|P1|Overall Study|Transfer of Care|1
278127|NCT01951092|931646|P1|Overall Study|Incarceration|1
278128|NCT01951092|931646|P1|Overall Study|Lost to Follow-up|10
278129|NCT01950741|931657|P1|Overall Study|Withdrawal by Subject|1
278130|NCT01950741|931657|P1|Overall Study|Death|1
278131|NCT01950741|931657|P1|Overall Study|Lost to Follow-up|1
278132|NCT01950364|931672|P2|Overall Study|Protocol Violation|1
278133|NCT01950364|931673|P1|Overall Study|Protocol Violation|0
278134|NCT01950364|931672|P2|Overall Study|Withdrawal by Subject|1
278135|NCT01950364|931673|P1|Overall Study|Withdrawal by Subject|0
278136|NCT01950364|931672|P2|Overall Study|Disease Progression|2
278137|NCT01950364|931673|P1|Overall Study|Disease Progression|5
278138|NCT01950364|931672|P2|Overall Study|Stem Cell Transplant|6
278139|NCT01950364|931673|P1|Overall Study|Stem Cell Transplant|2
278140|NCT01950364|931672|P2|Overall Study|Adverse Event|0
278141|NCT01950364|931673|P1|Overall Study|Adverse Event|3
278142|NCT01949870|931782|P1|Overall Study|Eligibility requirements not fulfilled|2
278143|NCT01949870|931782|P1|Overall Study|Study termination|1
278144|NCT01949870|931782|P1|Overall Study|Adverse Event|1
278145|NCT01949870|931782|P1|Overall Study|Lack of Efficacy|2
278146|NCT01949532|931945|P2|Overall Study|On-study at the Data Cut-off Date|3
278147|NCT01949532|931946|P1|Overall Study|On-study at the Data Cut-off Date|3
278148|NCT01949155|932021|P2|Overall Study|Protocol Violation|0
278149|NCT01949155|932022|P1|Overall Study|Protocol Violation|1
278150|NCT01949155|932021|P2|Overall Study|Lost to Follow-up|0
278151|NCT01949155|932022|P1|Overall Study|Lost to Follow-up|1
278152|NCT01949142|932034|P2|Overall Study|Parent changed their mind|0
278153|NCT01949142|932035|P1|Overall Study|Parent changed their mind|1
278154|NCT01949142|932034|P2|Overall Study|Lost to Follow-up|1
278155|NCT01949142|932035|P1|Overall Study|Lost to Follow-up|1
278156|NCT01949142|932034|P2|Overall Study|Withdrawal of consent|0
278157|NCT01949142|932035|P1|Overall Study|Withdrawal of consent|1
278158|NCT01949116|932047|P2|Overall Study|Withdrawal by Subject|3
278159|NCT01949116|932048|P1|Overall Study|Withdrawal by Subject|5
278160|NCT01949116|932047|P2|Overall Study|Lost to Follow-up|3
278161|NCT01949116|932048|P1|Overall Study|Lost to Follow-up|1
278162|NCT01949116|932047|P2|Overall Study|Death|0
278163|NCT01949116|932048|P1|Overall Study|Death|2
278164|NCT01949090|932085|P5|Overall Study|Lost to Follow-up|1
278165|NCT01949090|932086|P4|Overall Study|Lost to Follow-up|1
278166|NCT01949090|932087|P3|Overall Study|Lost to Follow-up|0
278167|NCT01949090|932088|P2|Overall Study|Lost to Follow-up|1
278168|NCT01949090|932089|P1|Overall Study|Lost to Follow-up|2
278169|NCT01949090|932085|P5|Overall Study|Protocol non-compliance|1
278170|NCT01949090|932086|P4|Overall Study|Protocol non-compliance|0
278171|NCT01949090|932087|P3|Overall Study|Protocol non-compliance|0
278172|NCT01949090|932088|P2|Overall Study|Protocol non-compliance|0
278173|NCT01949090|932089|P1|Overall Study|Protocol non-compliance|0
278174|NCT01949090|932085|P5|Overall Study|Withdrawal by Subject|1
278175|NCT01949090|932086|P4|Overall Study|Withdrawal by Subject|0
278176|NCT01949090|932087|P3|Overall Study|Withdrawal by Subject|0
278177|NCT01949090|932088|P2|Overall Study|Withdrawal by Subject|0
278178|NCT01949090|932089|P1|Overall Study|Withdrawal by Subject|2
278179|NCT01949090|932085|P5|Overall Study|Serious Adverse Event|1
278180|NCT01949090|932086|P4|Overall Study|Serious Adverse Event|0
278181|NCT01949090|932087|P3|Overall Study|Serious Adverse Event|2
278182|NCT01949090|932088|P2|Overall Study|Serious Adverse Event|1
278183|NCT01949090|932089|P1|Overall Study|Serious Adverse Event|0
278184|NCT01949051|932266|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
278185|NCT01949051|932267|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
278186|NCT01949051|932268|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
278187|NCT01949051|932269|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
278188|NCT01949051|932270|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
278189|NCT01949051|932271|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
278190|NCT01949051|932266|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
278191|NCT01949051|932267|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
278192|NCT01949051|932268|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
278193|NCT01949051|932269|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
278194|NCT01949051|932270|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
278195|NCT01949051|932271|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
278196|NCT01949051|932266|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
278197|NCT01949051|932267|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
278198|NCT01949051|932268|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
278199|NCT01949051|932269|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
278200|NCT01949051|932270|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
278201|NCT01949051|932271|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
278202|NCT01949051|932266|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
278203|NCT01949051|932267|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
278204|NCT01949051|932268|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
278205|NCT01949051|932269|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
278206|NCT01949051|932270|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
278207|NCT01949051|932271|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
278208|NCT01949051|932266|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
278209|NCT01949051|932267|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
278210|NCT01949051|932268|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
278211|NCT01949051|932269|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
278212|NCT01949051|932270|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
278213|NCT01949051|932271|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
278214|NCT01948908|932300|P3|Overall Study|Protocol Violation|2
278215|NCT01948908|932301|P2|Overall Study|Protocol Violation|0
278216|NCT01948908|932302|P1|Overall Study|Protocol Violation|1
278217|NCT01948830|932318|P2|Overall Study|Death|4
278218|NCT01948830|932319|P1|Overall Study|Death|3
278219|NCT01948830|932318|P2|Overall Study|Adverse Event|2
278220|NCT01948830|932319|P1|Overall Study|Adverse Event|9
278221|NCT01948830|932318|P2|Overall Study|Withdrawal by Subject|17
278222|NCT01948830|932319|P1|Overall Study|Withdrawal by Subject|14
278223|NCT01948830|932318|P2|Overall Study|Lost to Follow-up|4
278224|NCT01948830|932319|P1|Overall Study|Lost to Follow-up|5
278225|NCT01948830|932318|P2|Overall Study|Protocol deviation|2
278226|NCT01948830|932319|P1|Overall Study|Protocol deviation|1
278227|NCT01948830|932318|P2|Overall Study|Physician Decision|3
278228|NCT01948830|932319|P1|Overall Study|Physician Decision|1
278229|NCT01948791|932351|P1|Overall Study|Screening failure|35
278230|NCT01948791|932351|P1|Overall Study|Others|7
278231|NCT01948791|932351|P1|Overall Study|Management issues|1
278232|NCT01948791|932351|P1|Overall Study|Lost to Follow-up|6
278233|NCT01948791|932351|P1|Overall Study|Withdrawal by Subject|5
278234|NCT01948791|932351|P1|Overall Study|Protocol Violation|2
278235|NCT01948791|932351|P1|Overall Study|Lack of Efficacy|3
278236|NCT01948791|932351|P1|Overall Study|Adverse Event|12
278237|NCT01948193|932394|P1|Overall Study|Lost to Follow-up|7
278238|NCT01948193|932394|P1|Overall Study|Serious event|2
278239|NCT01948076|932416|P2|Overall Study|Withdrawal by Subject|1
278240|NCT01948076|932417|P1|Overall Study|Withdrawal by Subject|0
278241|NCT01948063|932427|P2|Overall Study|Blood samples were accidentally thawed|0
278242|NCT01948063|932428|P1|Overall Study|Blood samples were accidentally thawed|1
278243|NCT01948063|932427|P2|Overall Study|Discovered an enrollment in other study|1
278244|NCT01948063|932428|P1|Overall Study|Discovered an enrollment in other study|0
278245|NCT01948063|932427|P2|Overall Study|Boston MCI halted research protocol|1
278246|NCT01948063|932428|P1|Overall Study|Boston MCI halted research protocol|0
278247|NCT01948050|932436|P2|Overall Study|Withdrawal by Subject|1
278248|NCT01948050|932437|P1|Overall Study|Withdrawal by Subject|0
278249|NCT01947855|932505|P3|Overall Study|Withdrawal by Subject|0
278250|NCT01947855|932506|P2|Overall Study|Withdrawal by Subject|0
278251|NCT01947855|932507|P1|Overall Study|Withdrawal by Subject|1
278252|NCT01947582|932515|P1|Overall Study|Withdrawal by Subject|1
278253|NCT01947517|932524|P2|Overall Study|Withdrawal by Subject|1
278254|NCT01947517|932525|P1|Overall Study|Withdrawal by Subject|1
278255|NCT01947491|932543|P4|Overall Study|Adverse Event|2
278256|NCT01947491|932544|P3|Overall Study|Adverse Event|0
278257|NCT01947491|932545|P2|Overall Study|Adverse Event|1
278258|NCT01947491|932546|P1|Overall Study|Adverse Event|0
278259|NCT01947491|932543|P4|Overall Study|Worsening of condition|0
278260|NCT01947491|932544|P3|Overall Study|Worsening of condition|0
278261|NCT01947491|932545|P2|Overall Study|Worsening of condition|1
278262|NCT01947491|932546|P1|Overall Study|Worsening of condition|0
278263|NCT01947491|932543|P4|Overall Study|Withdrawal by Subject|0
278264|NCT01947491|932544|P3|Overall Study|Withdrawal by Subject|1
278265|NCT01947491|932545|P2|Overall Study|Withdrawal by Subject|1
278266|NCT01947491|932546|P1|Overall Study|Withdrawal by Subject|1
278267|NCT01947491|932543|P4|Overall Study|Protocol Violation|0
278268|NCT01947491|932544|P3|Overall Study|Protocol Violation|0
278269|NCT01947491|932545|P2|Overall Study|Protocol Violation|0
278270|NCT01947491|932546|P1|Overall Study|Protocol Violation|1
278271|NCT01947491|932543|P4|Overall Study|Lack of Efficacy|1
278272|NCT01947491|932544|P3|Overall Study|Lack of Efficacy|0
278273|NCT01947491|932545|P2|Overall Study|Lack of Efficacy|0
278274|NCT01947491|932546|P1|Overall Study|Lack of Efficacy|1
278275|NCT01947491|932543|P4|Overall Study|Lost to Follow-up|2
278276|NCT01947491|932544|P3|Overall Study|Lost to Follow-up|1
278277|NCT01947491|932545|P2|Overall Study|Lost to Follow-up|3
278278|NCT01947491|932546|P1|Overall Study|Lost to Follow-up|5
278279|NCT01947127|932590|P2|Overall Study|Data loss|4
278280|NCT01947127|932591|P1|Overall Study|Data loss|4
278281|NCT01947127|932590|P2|Overall Study|Withdrawal by Subject|1
278282|NCT01947127|932591|P1|Overall Study|Withdrawal by Subject|1
278283|NCT01947127|932590|P2|Overall Study|Protocol Violation|38
278284|NCT01947127|932591|P1|Overall Study|Protocol Violation|18
278285|NCT01946529|932615|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
278286|NCT01946529|932616|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
278287|NCT01946529|932617|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
278288|NCT01946529|932615|P3|End of Window Therapy (2 Courses)|Physician Decision|0
278289|NCT01946529|932616|P2|End of Window Therapy (2 Courses)|Physician Decision|1
278290|NCT01946529|932617|P1|End of Window Therapy (2 Courses)|Physician Decision|0
278291|NCT01946438|932628|P4|Overall Study|Withdrawal by Subject|0
278292|NCT01946438|932629|P3|Overall Study|Withdrawal by Subject|0
278293|NCT01946438|932630|P2|Overall Study|Withdrawal by Subject|0
278294|NCT01946438|932631|P1|Overall Study|Withdrawal by Subject|1
278295|NCT01946438|932628|P4|Overall Study|Protocol Violation|0
278296|NCT01946438|932629|P3|Overall Study|Protocol Violation|1
278297|NCT01946438|932630|P2|Overall Study|Protocol Violation|0
278298|NCT01946438|932631|P1|Overall Study|Protocol Violation|0
278299|NCT01946438|932628|P4|Overall Study|Serious Adverse event|0
278300|NCT01946438|932629|P3|Overall Study|Serious Adverse event|0
278301|NCT01946438|932630|P2|Overall Study|Serious Adverse event|0
278302|NCT01946438|932631|P1|Overall Study|Serious Adverse event|1
278303|NCT01946438|932628|P4|Overall Study|Adverse Event|1
278304|NCT01946438|932629|P3|Overall Study|Adverse Event|0
278305|NCT01946438|932630|P2|Overall Study|Adverse Event|0
278306|NCT01946438|932631|P1|Overall Study|Adverse Event|0
278307|NCT01946425|932659|P2|Overall Study|Withdrawal by Subject|0
278308|NCT01946425|932660|P1|Overall Study|Withdrawal by Subject|1
278309|NCT01946425|932659|P2|Overall Study|Protocol Violation|0
278310|NCT01946425|932660|P1|Overall Study|Protocol Violation|1
278311|NCT01946412|932674|P1|Overall Study|Difficulty in swallowing|1
278312|NCT01946412|932674|P1|Overall Study|Continued with commercial Kalydeco|2
278313|NCT01946412|932674|P1|Overall Study|Non-Compliance|1
278314|NCT01946412|932674|P1|Overall Study|Adverse Event|1
278315|NCT01946204|932719|P2|Overall Study|Other|3
278316|NCT01946204|932720|P1|Overall Study|Other|7
278317|NCT01946204|932719|P2|Overall Study|Ongoing|687
278318|NCT01946204|932720|P1|Overall Study|Ongoing|316
278319|NCT01946204|932719|P2|Overall Study|Lost to Follow-up|7
278320|NCT01946204|932720|P1|Overall Study|Lost to Follow-up|3
278321|NCT01946204|932719|P2|Overall Study|Withdrawal by Subject|50
278322|NCT01946204|932720|P1|Overall Study|Withdrawal by Subject|37
278323|NCT01946204|932719|P2|Overall Study|Death|59
278324|NCT01946204|932720|P1|Overall Study|Death|38
278325|NCT01946178|932736|P1|Overall Study|Lost to Follow-up|1
278326|NCT01946178|932736|P1|Overall Study|Pregnancy|1
278327|NCT01945944|932805|P2|Overall Study|Withdrawal by Subject|1
278328|NCT01945944|932806|P1|Overall Study|Withdrawal by Subject|0
278329|NCT01945944|932805|P2|Overall Study|Physician Decision|0
278330|NCT01945944|932806|P1|Overall Study|Physician Decision|1
278331|NCT01945944|932805|P2|Overall Study|Adverse Event|2
278332|NCT01945944|932806|P1|Overall Study|Adverse Event|0
278333|NCT01945489|932830|P2|Cycle 2|Lost to Follow-up|1
278334|NCT01945489|932831|P1|Cycle 2|Lost to Follow-up|0
278335|NCT01945489|932830|P2|Cycle 2|Adverse Event|0
278336|NCT01945489|932831|P1|Cycle 2|Adverse Event|1
278337|NCT01945489|932830|P2|Cycle 1|Other Miscellaneous Reasons|1
278338|NCT01945489|932831|P1|Cycle 1|Other Miscellaneous Reasons|3
278339|NCT01945489|932830|P2|Cycle 1|Protocol Violation|1
278340|NCT01945489|932831|P1|Cycle 1|Protocol Violation|0
278341|NCT01945489|932830|P2|Cycle 1|Personal Reasons|2
278342|NCT01945489|932831|P1|Cycle 1|Personal Reasons|4
278343|NCT01945489|932830|P2|Cycle 1|Lost to Follow-up|0
278344|NCT01945489|932831|P1|Cycle 1|Lost to Follow-up|4
278345|NCT01945489|932830|P2|Cycle 1|Adverse Event|0
278346|NCT01945489|932831|P1|Cycle 1|Adverse Event|2
278347|NCT01945242|932885|P2|Overall Study|Physician Decision|3
278348|NCT01945242|932886|P1|Overall Study|Physician Decision|3
278349|NCT01945086|932944|P3|Overall Study|Adverse Event|1
278350|NCT01945086|932945|P2|Overall Study|Adverse Event|0
278351|NCT01945086|932946|P1|Overall Study|Adverse Event|0
278352|NCT01945086|932944|P3|Overall Study|Withdrawal by Subject|1
278353|NCT01945086|932945|P2|Overall Study|Withdrawal by Subject|0
278354|NCT01945086|932946|P1|Overall Study|Withdrawal by Subject|1
278355|NCT01945034|932990|P3|Overall Study|Protocol Violation|1
278356|NCT01945034|932991|P2|Overall Study|Protocol Violation|0
278357|NCT01945034|932992|P1|Overall Study|Protocol Violation|1
278358|NCT01945034|932990|P3|Overall Study|Lost to Follow-up|2
278359|NCT01945034|932991|P2|Overall Study|Lost to Follow-up|0
278360|NCT01945034|932992|P1|Overall Study|Lost to Follow-up|0
278361|NCT01945034|932990|P3|Overall Study|Other|3
278362|NCT01945034|932991|P2|Overall Study|Other|1
278363|NCT01945034|932992|P1|Overall Study|Other|0
278364|NCT01945034|932990|P3|Overall Study|Withdrawal by Subject|1
278365|NCT01945034|932991|P2|Overall Study|Withdrawal by Subject|3
278366|NCT01945034|932992|P1|Overall Study|Withdrawal by Subject|0
278367|NCT01945034|932990|P3|Overall Study|Medication Error|0
278368|NCT01945034|932991|P2|Overall Study|Medication Error|1
278369|NCT01945034|932992|P1|Overall Study|Medication Error|0
278370|NCT01945021|933042|P1|Overall Study|Non-RECIST disease progression|1
278371|NCT01945021|933042|P1|Overall Study|Withdrawal of consent|3
278372|NCT01945021|933042|P1|Overall Study|Withdrawal by Subject|2
278373|NCT01945021|933042|P1|Overall Study|Global deterioration of health-related s|1
278374|NCT01945021|933042|P1|Overall Study|Disease progression by RECIST v1.1|30
278375|NCT01945021|933042|P1|Overall Study|Pregnancy|1
278376|NCT01945021|933042|P1|Overall Study|Death|1
278377|NCT01945021|933042|P1|Overall Study|Adverse Event|8
278378|NCT01944969|933056|P1|Overall Study|Administrative or other reasons|23
278379|NCT01944969|933056|P1|Overall Study|Non-compliance with IMP|1
278380|NCT01944969|933056|P1|Overall Study|Lack of Efficacy|1
278381|NCT01944969|933056|P1|Overall Study|Adverse Event|1
278382|NCT01944774|933081|P3|Overall Study|Lost to Follow-up|0
278383|NCT01944774|933082|P2|Overall Study|Lost to Follow-up|1
278384|NCT01944774|933083|P1|Overall Study|Lost to Follow-up|0
278385|NCT01944774|933081|P3|Overall Study|Lack of Efficacy|2
278386|NCT01944774|933082|P2|Overall Study|Lack of Efficacy|2
278387|NCT01944774|933083|P1|Overall Study|Lack of Efficacy|1
278388|NCT01944774|933081|P3|Overall Study|Adverse Event|3
278389|NCT01944774|933082|P2|Overall Study|Adverse Event|2
278390|NCT01944774|933083|P1|Overall Study|Adverse Event|3
278391|NCT01944774|933081|P3|Overall Study|Withdrawal by Subject|3
278392|NCT01944774|933082|P2|Overall Study|Withdrawal by Subject|3
278393|NCT01944774|933083|P1|Overall Study|Withdrawal by Subject|2
278394|NCT01944722|933126|P1|Overall Study|>ASCUS Cytology|1122
278395|NCT01944722|933126|P1|Overall Study|Unsatisfactory Cytology Result|63
278396|NCT01944722|933126|P1|Overall Study|NILM Subjects <30 years old|8106
278397|NCT01944722|933126|P1|Overall Study|Withdrawal by Subject|8
278398|NCT01944722|933126|P1|Overall Study|Specimens Mislabeled|2
278399|NCT01944722|933126|P1|Overall Study|Missing Specimens|3
278400|NCT01944722|933126|P1|Overall Study|Insufficient Volume for Test|1
278401|NCT01944722|933126|P1|Overall Study|Improper Storage/Transport|5
278402|NCT01944722|933126|P1|Overall Study|Specimen Shipping Issues|34
278403|NCT01944722|933126|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
278404|NCT01944670|933160|P1|Overall Study|Lost to Follow-up|2
278405|NCT01944631|933167|P2|Overall Study|Withdrawal by Subject|1
278406|NCT01944631|933168|P1|Overall Study|Withdrawal by Subject|0
278407|NCT01944631|933167|P2|Overall Study|Lost to Follow-up|1
278408|NCT01944631|933168|P1|Overall Study|Lost to Follow-up|3
278409|NCT01944631|933167|P2|Overall Study|Adverse Event|0
278410|NCT01944631|933168|P1|Overall Study|Adverse Event|1
278411|NCT01944462|933184|P1|PPPP Educational Program|Lost to Follow-up|60
278412|NCT01944098|933214|P2|Overall Study|Physician Decision|0
278413|NCT01944098|933215|P1|Overall Study|Physician Decision|1
278414|NCT01944059|933227|P1|Overall Study|Adverse Event|2
278415|NCT01944059|933227|P1|Overall Study|Withdrawal by Subject|1
278416|NCT01944059|933227|P1|Overall Study|Physician Decision|3
278417|NCT01944059|933227|P1|Overall Study|Lost to Follow-up|1
278418|NCT01943552|933300|P2|Overall Study|Other Reasons|17
278419|NCT01943552|933301|P1|Overall Study|Other Reasons|16
278420|NCT01943552|933300|P2|Overall Study|Withdrawal by Subject|6
278421|NCT01943552|933301|P1|Overall Study|Withdrawal by Subject|6
278422|NCT01943552|933300|P2|Overall Study|Adverse Event|2
278423|NCT01943552|933301|P1|Overall Study|Adverse Event|3
278424|NCT01943539|933317|P2|Overall Study|Non-compliance with at-home intervention|0
278425|NCT01943539|933318|P1|Overall Study|Non-compliance with at-home intervention|4
278426|NCT01943435|933354|P3|6 Month Follow up|Lost to Follow-up|15
278427|NCT01943435|933355|P2|6 Month Follow up|Lost to Follow-up|7
278428|NCT01943435|933356|P1|6 Month Follow up|Lost to Follow-up|12
278429|NCT01943435|933354|P3|2 Month Follow up|Lost to Follow-up|0
278430|NCT01943435|933355|P2|2 Month Follow up|Lost to Follow-up|3
278431|NCT01943435|933356|P1|2 Month Follow up|Lost to Follow-up|2
278432|NCT01943435|933354|P3|Intervention Period|Withdrawal by Subject|4
278433|NCT01943435|933355|P2|Intervention Period|Withdrawal by Subject|3
278434|NCT01943435|933356|P1|Intervention Period|Withdrawal by Subject|3
278435|NCT01943435|933354|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
278436|NCT01943435|933355|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
278437|NCT01943435|933356|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
278438|NCT01943292|933377|P3|Overall Study|Withdrawal by Subject|0
278439|NCT01943292|933378|P2|Overall Study|Withdrawal by Subject|0
278440|NCT01943292|933379|P1|Overall Study|Withdrawal by Subject|1
278441|NCT01942785|933406|P1|Overall Study|Protocol Violation|1
278442|NCT01942785|933406|P1|Overall Study|Withdrawal by Subject|1
278443|NCT01942785|933406|P1|Overall Study|Adverse Event|2
278444|NCT01942733|933435|P1|Overall Study|Administrative|1
278445|NCT01942733|933435|P1|Overall Study|Non-compliance with IMP|1
278446|NCT01942733|933435|P1|Overall Study|Lost to Follow-up|1
278447|NCT01942590|933487|P2|Overall Study|Adverse Event|0
278448|NCT01942590|933488|P1|Overall Study|Adverse Event|1
278449|NCT01942590|933487|P2|Overall Study|Withdrawal by Subject|1
278450|NCT01942590|933488|P1|Overall Study|Withdrawal by Subject|0
278451|NCT01942161|933521|P3|Overall Study|Withdrawal by Subject|1
278452|NCT01942161|933522|P2|Overall Study|Withdrawal by Subject|3
278453|NCT01942161|933523|P1|Overall Study|Withdrawal by Subject|3
278454|NCT01942161|933521|P3|Overall Study|Protocol Violation|0
278455|NCT01942161|933522|P2|Overall Study|Protocol Violation|0
278456|NCT01942161|933523|P1|Overall Study|Protocol Violation|1
278457|NCT01942161|933521|P3|Overall Study|Physician Decision|0
278458|NCT01942161|933522|P2|Overall Study|Physician Decision|1
278459|NCT01942161|933523|P1|Overall Study|Physician Decision|3
278460|NCT01942161|933521|P3|Overall Study|Adverse Event|5
278461|NCT01942161|933522|P2|Overall Study|Adverse Event|2
278462|NCT01942161|933523|P1|Overall Study|Adverse Event|1
278463|NCT01942148|933543|P1|Overall Study|Use of the prohibition medicine|1
278464|NCT01942148|933543|P1|Overall Study|Withdrawal by Subject|8
278465|NCT01942148|933543|P1|Overall Study|Protocol Violation|1
278466|NCT01942148|933543|P1|Overall Study|Physician Decision|11
278467|NCT01942148|933543|P1|Overall Study|Lack of Efficacy|2
278468|NCT01942148|933543|P1|Overall Study|Adverse Event|4
278469|NCT01942135|933551|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
278470|NCT01942135|933552|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
278471|NCT01942135|933551|P2|Overall Study|Withdrawal by Subject|2
278472|NCT01942135|933552|P1|Overall Study|Withdrawal by Subject|4
278473|NCT01942135|933551|P2|Overall Study|Participant Refused toContinue Treatment|1
278474|NCT01942135|933552|P1|Overall Study|Participant Refused toContinue Treatment|1
278475|NCT01942135|933551|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
278476|NCT01942135|933552|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
278477|NCT01942135|933551|P2|Overall Study|Death|1
278478|NCT01942135|933552|P1|Overall Study|Death|0
278479|NCT01942135|933551|P2|Overall Study|Randomized Not Treated|2
278480|NCT01942135|933552|P1|Overall Study|Randomized Not Treated|2
278481|NCT01942135|933551|P2|Overall Study|Global deterioration of health status|3
278482|NCT01942135|933552|P1|Overall Study|Global deterioration of health status|8
278483|NCT01942135|933551|P2|Overall Study|Adverse Event|3
278484|NCT01942135|933552|P1|Overall Study|Adverse Event|9
278485|NCT01941940|933589|P1|Overall Study|Other|1
278486|NCT01941940|933589|P1|Overall Study|Other|1
278487|NCT01941940|933589|P1|Overall Study|Death|1
278488|NCT01941940|933589|P1|Overall Study|Withdrawal by Subject|15
278489|NCT01941940|933589|P1|Overall Study|Physician Decision|2
278490|NCT01941940|933589|P1|Overall Study|Lost to Follow-up|2
278491|NCT01941940|933589|P1|Overall Study|Adverse Event|11
278492|NCT01941498|933638|P1|Overall Study|Relocated out of state|1
278493|NCT01941186|933756|P2|Follow-up|Lost to Follow-up|0
278494|NCT01941186|933757|P1|Follow-up|Lost to Follow-up|1
278495|NCT01940497|933827|P2|Overall Study|Ongoing at data cut-off|117
278496|NCT01940497|933828|P1|Overall Study|Ongoing at data cut-off|116
278497|NCT01940497|933827|P2|Overall Study|Withdrawal by Subject|0
278498|NCT01940497|933828|P1|Overall Study|Withdrawal by Subject|2
278499|NCT01940497|933827|P2|Overall Study|Protocol Violation|0
278500|NCT01940497|933828|P1|Overall Study|Protocol Violation|1
278501|NCT01940497|933827|P2|Overall Study|Failure to return|1
278502|NCT01940497|933828|P1|Overall Study|Failure to return|0
278503|NCT01940497|933827|P2|Overall Study|Adverse event/Intercurrent illness|0
278504|NCT01940497|933828|P1|Overall Study|Adverse event/Intercurrent illness|1
278505|NCT01940484|933867|P1|Overall Study|Adverse Event|1
278506|NCT01940484|933867|P1|Overall Study|Death|2
278507|NCT01940484|933867|P1|Overall Study|Underwent transplantation|4
278508|NCT01940484|933867|P1|Overall Study|Withdrawal by Subject|3
278509|NCT01940471|933887|P2|Open-Label Extension|Still on Open-Label Treatment|8
278510|NCT01940471|933888|P1|Open-Label Extension|Still on Open-Label Treatment|14
278511|NCT01940471|933887|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
278512|NCT01940471|933888|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
278513|NCT01940471|933887|P2|Double-Blind Phase|HBsAg Seroconversion|0
278514|NCT01940471|933888|P1|Double-Blind Phase|HBsAg Seroconversion|1
278515|NCT01940471|933887|P2|Double-Blind Phase|Protocol Violation|1
278516|NCT01940471|933888|P1|Double-Blind Phase|Protocol Violation|0
278517|NCT01940471|933887|P2|Double-Blind Phase|Lack of Efficacy|0
278518|NCT01940471|933888|P1|Double-Blind Phase|Lack of Efficacy|1
278519|NCT01940471|933887|P2|Double-Blind Phase|Death|0
278520|NCT01940471|933888|P1|Double-Blind Phase|Death|1
278521|NCT01940471|933887|P2|Double-Blind Phase|Protocol-Specified Criteria|0
278522|NCT01940471|933888|P1|Double-Blind Phase|Protocol-Specified Criteria|2
278523|NCT01940471|933887|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
278524|NCT01940471|933888|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
278525|NCT01940471|933887|P2|Double-Blind Phase|Investigator's Discretion|1
278526|NCT01940471|933888|P1|Double-Blind Phase|Investigator's Discretion|2
278527|NCT01940471|933887|P2|Double-Blind Phase|Pregnancy|1
278528|NCT01940471|933888|P1|Double-Blind Phase|Pregnancy|2
278529|NCT01940471|933887|P2|Double-Blind Phase|Lost to Follow-up|2
278530|NCT01940471|933888|P1|Double-Blind Phase|Lost to Follow-up|2
278531|NCT01940471|933887|P2|Double-Blind Phase|Adverse Event|3
278532|NCT01940471|933888|P1|Double-Blind Phase|Adverse Event|6
278533|NCT01940471|933887|P2|Double-Blind Phase|Withdrew Consent|5
278534|NCT01940471|933888|P1|Double-Blind Phase|Withdrew Consent|11
278535|NCT01940471|933887|P2|Double-Blind Phase|Randomized but Never Treated|1
278536|NCT01940471|933888|P1|Double-Blind Phase|Randomized but Never Treated|1
278537|NCT01940354|933906|P2|Overall Study|Withdrawal by Subject|2
278538|NCT01940354|933907|P1|Overall Study|Withdrawal by Subject|4
278539|NCT01940341|933919|P2|Open-label Extension Phase|Still on Study|1
278540|NCT01940341|933920|P1|Open-label Extension Phase|Still on Study|4
278541|NCT01940341|933919|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
278542|NCT01940341|933920|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
278543|NCT01940341|933919|P2|Double-Blind Phase|Protocol Specified Criteria|0
278544|NCT01940341|933920|P1|Double-Blind Phase|Protocol Specified Criteria|1
278545|NCT01940341|933919|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
278546|NCT01940341|933920|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
278547|NCT01940341|933919|P2|Double-Blind Phase|Investigator's Discretion|0
278548|NCT01940341|933920|P1|Double-Blind Phase|Investigator's Discretion|1
278549|NCT01940341|933919|P2|Double-Blind Phase|Pregnancy|1
278550|NCT01940341|933920|P1|Double-Blind Phase|Pregnancy|0
278551|NCT01940341|933919|P2|Double-Blind Phase|Lost to Follow-up|1
278552|NCT01940341|933920|P1|Double-Blind Phase|Lost to Follow-up|4
278553|NCT01940341|933919|P2|Double-Blind Phase|Withdrew Consent|2
278554|NCT01940341|933920|P1|Double-Blind Phase|Withdrew Consent|3
278555|NCT01940341|933919|P2|Double-Blind Phase|Adverse Event|2
278556|NCT01940341|933920|P1|Double-Blind Phase|Adverse Event|3
278557|NCT01940341|933919|P2|Double-Blind Phase|Randomized but Never Treated|1
278558|NCT01940341|933920|P1|Double-Blind Phase|Randomized but Never Treated|0
278559|NCT01940120|933951|P1|Overall Study|Withdrawal by Subject|8
278560|NCT01940120|933951|P1|Overall Study|Death|40
278561|NCT01939548|934113|P3|Overall Study|Did not complete follow-up|0
278562|NCT01939548|934114|P2|Overall Study|Did not complete follow-up|1
278563|NCT01939548|934115|P1|Overall Study|Did not complete follow-up|0
278564|NCT01939548|934113|P3|Overall Study|Participant withdrew consent|0
278565|NCT01939548|934114|P2|Overall Study|Participant withdrew consent|2
278566|NCT01939548|934115|P1|Overall Study|Participant withdrew consent|0
278567|NCT01939548|934113|P3|Overall Study|Participant unwilling to continue|0
278568|NCT01939548|934114|P2|Overall Study|Participant unwilling to continue|1
278569|NCT01939548|934115|P1|Overall Study|Participant unwilling to continue|0
278570|NCT01939548|934113|P3|Overall Study|Participant dropped|1
278571|NCT01939548|934114|P2|Overall Study|Participant dropped|0
278572|NCT01939548|934115|P1|Overall Study|Participant dropped|0
278573|NCT01939548|934113|P3|Overall Study|Death|1
278574|NCT01939548|934114|P2|Overall Study|Death|0
278575|NCT01939548|934115|P1|Overall Study|Death|0
278576|NCT01939548|934113|P3|Overall Study|Adverse Event|7
278577|NCT01939548|934114|P2|Overall Study|Adverse Event|9
278578|NCT01939548|934115|P1|Overall Study|Adverse Event|2
278579|NCT01939548|934113|P3|Overall Study|Lost to Follow-up|3
278580|NCT01939548|934114|P2|Overall Study|Lost to Follow-up|5
278581|NCT01939548|934115|P1|Overall Study|Lost to Follow-up|5
278582|NCT01939548|934113|P3|Overall Study|Protocol Violation|5
278583|NCT01939548|934114|P2|Overall Study|Protocol Violation|6
278584|NCT01939548|934115|P1|Overall Study|Protocol Violation|7
278585|NCT01939548|934113|P3|Overall Study|Withdrawal by Subject|1
278586|NCT01939548|934114|P2|Overall Study|Withdrawal by Subject|4
278587|NCT01939548|934115|P1|Overall Study|Withdrawal by Subject|4
278588|NCT01939548|934113|P3|Overall Study|Did Not Meet Entrance Criteria|0
278589|NCT01939548|934114|P2|Overall Study|Did Not Meet Entrance Criteria|0
278590|NCT01939548|934115|P1|Overall Study|Did Not Meet Entrance Criteria|1
278591|NCT01939548|934113|P3|Overall Study|Insufficient Clinical Response|0
278592|NCT01939548|934114|P2|Overall Study|Insufficient Clinical Response|0
278593|NCT01939548|934115|P1|Overall Study|Insufficient Clinical Response|1
278594|NCT01939548|934113|P3|Overall Study|Study Terminated by Sponsor|12
278595|NCT01939548|934114|P2|Overall Study|Study Terminated by Sponsor|19
278596|NCT01939548|934115|P1|Overall Study|Study Terminated by Sponsor|17
278597|NCT01939548|934113|P3|Overall Study|Non compliance|0
278598|NCT01939548|934114|P2|Overall Study|Non compliance|2
278599|NCT01939548|934115|P1|Overall Study|Non compliance|0
278600|NCT01939496|934189|P3|Overall Study|Other|1
278601|NCT01939496|934190|P2|Overall Study|Other|0
278602|NCT01939496|934191|P1|Overall Study|Other|2
278603|NCT01939496|934189|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
278604|NCT01939496|934190|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
278605|NCT01939496|934191|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
278606|NCT01939496|934189|P3|Overall Study|Withdrawal by Subject|1
278607|NCT01939496|934190|P2|Overall Study|Withdrawal by Subject|1
278608|NCT01939496|934191|P1|Overall Study|Withdrawal by Subject|0
278609|NCT01939496|934189|P3|Overall Study|Protocol Violation|0
278610|NCT01939496|934190|P2|Overall Study|Protocol Violation|0
278611|NCT01939496|934191|P1|Overall Study|Protocol Violation|3
278612|NCT01939496|934189|P3|Overall Study|Physician Decision|0
278613|NCT01939496|934190|P2|Overall Study|Physician Decision|0
278614|NCT01939496|934191|P1|Overall Study|Physician Decision|1
278615|NCT01939496|934189|P3|Overall Study|Lost to Follow-up|0
278616|NCT01939496|934190|P2|Overall Study|Lost to Follow-up|1
278617|NCT01939496|934191|P1|Overall Study|Lost to Follow-up|1
278618|NCT01939496|934189|P3|Overall Study|Adverse Event|0
278619|NCT01939496|934190|P2|Overall Study|Adverse Event|0
278620|NCT01939496|934191|P1|Overall Study|Adverse Event|2
278621|NCT01939314|934258|P2|Overall Study|Lost to Follow-up|6
278622|NCT01939314|934259|P1|Overall Study|Lost to Follow-up|5
278623|NCT01939314|934258|P2|Overall Study|Pregnancy|1
278624|NCT01939314|934259|P1|Overall Study|Pregnancy|0
278625|NCT01939314|934258|P2|Overall Study|Protocol Violation|0
278626|NCT01939314|934259|P1|Overall Study|Protocol Violation|1
278627|NCT01939314|934258|P2|Overall Study|Withdrawal by Subject|1
278628|NCT01939314|934259|P1|Overall Study|Withdrawal by Subject|3
278629|NCT01939223|934280|P2|Overall Study|Withdrawal by Subject|0
278630|NCT01939223|934281|P1|Overall Study|Withdrawal by Subject|6
278631|NCT01939223|934280|P2|Overall Study|Study stopped by Sponsor|7
278632|NCT01939223|934281|P1|Overall Study|Study stopped by Sponsor|5
278633|NCT01939223|934280|P2|Overall Study|Disease recurrence (radiological)|3
278634|NCT01939223|934281|P1|Overall Study|Disease recurrence (radiological)|1
278635|NCT01939223|934280|P2|Overall Study|AE not assoc. with disease recurrence|1
278636|NCT01939223|934281|P1|Overall Study|AE not assoc. with disease recurrence|1
278637|NCT01939197|934296|P7|Overall Study|Lost to Follow-up|2
278638|NCT01939197|934297|P6|Overall Study|Lost to Follow-up|1
278639|NCT01939197|934298|P5|Overall Study|Lost to Follow-up|3
278640|NCT01939197|934299|P4|Overall Study|Lost to Follow-up|1
278641|NCT01939197|934300|P3|Overall Study|Lost to Follow-up|0
278642|NCT01939197|934301|P2|Overall Study|Lost to Follow-up|1
278643|NCT01939197|934302|P1|Overall Study|Lost to Follow-up|0
278644|NCT01939197|934296|P7|Overall Study|Withdrawal by Subject|0
278645|NCT01939197|934297|P6|Overall Study|Withdrawal by Subject|0
278646|NCT01939197|934298|P5|Overall Study|Withdrawal by Subject|1
278647|NCT01939197|934299|P4|Overall Study|Withdrawal by Subject|0
278648|NCT01939197|934300|P3|Overall Study|Withdrawal by Subject|0
278649|NCT01939197|934301|P2|Overall Study|Withdrawal by Subject|0
278650|NCT01939197|934302|P1|Overall Study|Withdrawal by Subject|1
278651|NCT01939002|934373|P2|Overall Study|Not Specified|2
278652|NCT01939002|934374|P1|Overall Study|Not Specified|1
278653|NCT01939002|934373|P2|Overall Study|Withdrawal by Subject|3
278654|NCT01939002|934374|P1|Overall Study|Withdrawal by Subject|5
278655|NCT01939002|934373|P2|Overall Study|Adverse Event|13
278656|NCT01939002|934374|P1|Overall Study|Adverse Event|13
278657|NCT01938573|934455|P2|Overall Study|Operation at other hospital|0
278658|NCT01938573|934456|P1|Overall Study|Operation at other hospital|1
278659|NCT01938573|934455|P2|Overall Study|Lack of Efficacy|0
278660|NCT01938573|934456|P1|Overall Study|Lack of Efficacy|1
278661|NCT01938430|934476|P14|Overall Study|Withdrew Consent|0
278662|NCT01938430|934477|P13|Overall Study|Withdrew Consent|0
278663|NCT01938430|934478|P12|Overall Study|Withdrew Consent|0
278664|NCT01938430|934479|P11|Overall Study|Withdrew Consent|0
278665|NCT01938430|934480|P10|Overall Study|Withdrew Consent|0
278666|NCT01938430|934481|P9|Overall Study|Withdrew Consent|1
278667|NCT01938430|934482|P8|Overall Study|Withdrew Consent|0
278668|NCT01938430|934483|P7|Overall Study|Withdrew Consent|0
278669|NCT01938430|934484|P6|Overall Study|Withdrew Consent|0
278670|NCT01938430|934485|P5|Overall Study|Withdrew Consent|0
278671|NCT01938430|934486|P4|Overall Study|Withdrew Consent|0
278672|NCT01938430|934487|P3|Overall Study|Withdrew Consent|0
278673|NCT01938430|934488|P2|Overall Study|Withdrew Consent|0
278674|NCT01938430|934489|P1|Overall Study|Withdrew Consent|0
278675|NCT01938430|934476|P14|Overall Study|Lost to Follow-up|0
278676|NCT01938430|934477|P13|Overall Study|Lost to Follow-up|0
278677|NCT01938430|934478|P12|Overall Study|Lost to Follow-up|0
278678|NCT01938430|934479|P11|Overall Study|Lost to Follow-up|0
278679|NCT01938430|934480|P10|Overall Study|Lost to Follow-up|0
278680|NCT01938430|934481|P9|Overall Study|Lost to Follow-up|0
278681|NCT01938430|934482|P8|Overall Study|Lost to Follow-up|0
278682|NCT01938430|934483|P7|Overall Study|Lost to Follow-up|0
278683|NCT01938430|934484|P6|Overall Study|Lost to Follow-up|1
278684|NCT01938430|934485|P5|Overall Study|Lost to Follow-up|0
278685|NCT01938430|934486|P4|Overall Study|Lost to Follow-up|0
278686|NCT01938430|934487|P3|Overall Study|Lost to Follow-up|1
278687|NCT01938430|934488|P2|Overall Study|Lost to Follow-up|0
278688|NCT01938430|934489|P1|Overall Study|Lost to Follow-up|0
278689|NCT01938430|934476|P14|Overall Study|Lack of Efficacy|0
278690|NCT01938430|934477|P13|Overall Study|Lack of Efficacy|0
278691|NCT01938430|934478|P12|Overall Study|Lack of Efficacy|1
278692|NCT01938430|934479|P11|Overall Study|Lack of Efficacy|2
278693|NCT01938430|934480|P10|Overall Study|Lack of Efficacy|0
278694|NCT01938430|934481|P9|Overall Study|Lack of Efficacy|1
278695|NCT01938430|934482|P8|Overall Study|Lack of Efficacy|0
278696|NCT01938430|934483|P7|Overall Study|Lack of Efficacy|0
278697|NCT01938430|934484|P6|Overall Study|Lack of Efficacy|0
278698|NCT01938430|934485|P5|Overall Study|Lack of Efficacy|0
278699|NCT01938430|934486|P4|Overall Study|Lack of Efficacy|1
278700|NCT01938430|934487|P3|Overall Study|Lack of Efficacy|1
278701|NCT01938430|934488|P2|Overall Study|Lack of Efficacy|1
278702|NCT01938430|934489|P1|Overall Study|Lack of Efficacy|3
278703|NCT01938430|934476|P14|Overall Study|Investigator's Discretion|0
278704|NCT01938430|934477|P13|Overall Study|Investigator's Discretion|0
278705|NCT01938430|934478|P12|Overall Study|Investigator's Discretion|0
278706|NCT01938430|934479|P11|Overall Study|Investigator's Discretion|0
278707|NCT01938430|934480|P10|Overall Study|Investigator's Discretion|0
278708|NCT01938430|934481|P9|Overall Study|Investigator's Discretion|0
278709|NCT01938430|934482|P8|Overall Study|Investigator's Discretion|0
278710|NCT01938430|934483|P7|Overall Study|Investigator's Discretion|0
278711|NCT01938430|934484|P6|Overall Study|Investigator's Discretion|0
278712|NCT01938430|934485|P5|Overall Study|Investigator's Discretion|0
278713|NCT01938430|934486|P4|Overall Study|Investigator's Discretion|0
278714|NCT01938430|934487|P3|Overall Study|Investigator's Discretion|1
278715|NCT01938430|934488|P2|Overall Study|Investigator's Discretion|0
278716|NCT01938430|934489|P1|Overall Study|Investigator's Discretion|0
278717|NCT01938430|934476|P14|Overall Study|Death|0
278718|NCT01938430|934477|P13|Overall Study|Death|0
278719|NCT01938430|934478|P12|Overall Study|Death|0
278720|NCT01938430|934479|P11|Overall Study|Death|0
278721|NCT01938430|934480|P10|Overall Study|Death|3
278722|NCT01938430|934481|P9|Overall Study|Death|2
278723|NCT01938430|934482|P8|Overall Study|Death|1
278724|NCT01938430|934483|P7|Overall Study|Death|1
278725|NCT01938430|934484|P6|Overall Study|Death|0
278726|NCT01938430|934485|P5|Overall Study|Death|0
278727|NCT01938430|934486|P4|Overall Study|Death|1
278728|NCT01938430|934487|P3|Overall Study|Death|2
278729|NCT01938430|934488|P2|Overall Study|Death|2
278730|NCT01938430|934489|P1|Overall Study|Death|1
278731|NCT01938430|934476|P14|Overall Study|Adverse Event|0
278732|NCT01938430|934477|P13|Overall Study|Adverse Event|0
278733|NCT01938430|934478|P12|Overall Study|Adverse Event|0
278734|NCT01938430|934479|P11|Overall Study|Adverse Event|0
278735|NCT01938430|934480|P10|Overall Study|Adverse Event|0
278736|NCT01938430|934481|P9|Overall Study|Adverse Event|0
278737|NCT01938430|934482|P8|Overall Study|Adverse Event|0
278738|NCT01938430|934483|P7|Overall Study|Adverse Event|1
278739|NCT01938430|934484|P6|Overall Study|Adverse Event|0
278740|NCT01938430|934485|P5|Overall Study|Adverse Event|0
278741|NCT01938430|934486|P4|Overall Study|Adverse Event|0
278742|NCT01938430|934487|P3|Overall Study|Adverse Event|0
278743|NCT01938430|934488|P2|Overall Study|Adverse Event|0
278744|NCT01938430|934489|P1|Overall Study|Adverse Event|0
278745|NCT01938430|934476|P14|Overall Study|Randomized but Not Treated|1
278746|NCT01938430|934477|P13|Overall Study|Randomized but Not Treated|0
278747|NCT01938430|934478|P12|Overall Study|Randomized but Not Treated|0
278748|NCT01938430|934479|P11|Overall Study|Randomized but Not Treated|1
278749|NCT01938430|934480|P10|Overall Study|Randomized but Not Treated|0
278750|NCT01938430|934481|P9|Overall Study|Randomized but Not Treated|0
278751|NCT01938430|934482|P8|Overall Study|Randomized but Not Treated|0
278752|NCT01938430|934483|P7|Overall Study|Randomized but Not Treated|0
278753|NCT01938430|934484|P6|Overall Study|Randomized but Not Treated|0
278754|NCT01938430|934485|P5|Overall Study|Randomized but Not Treated|0
278755|NCT01938430|934486|P4|Overall Study|Randomized but Not Treated|0
278756|NCT01938430|934487|P3|Overall Study|Randomized but Not Treated|0
278757|NCT01938430|934488|P2|Overall Study|Randomized but Not Treated|0
278758|NCT01938430|934489|P1|Overall Study|Randomized but Not Treated|0
278759|NCT01938391|934814|P1|12 Month Follow up|Withdrawal by Subject|1
278760|NCT01938391|934814|P1|12 Month Follow up|Physician Decision|1
278761|NCT01938391|934814|P1|6 Month Follow up|Withdrawal by Subject|1
278762|NCT01937871|934933|P3|Overall Study|Entry Criteria Not Met|1
278763|NCT01937871|934934|P2|Overall Study|Entry Criteria Not Met|2
278764|NCT01937871|934935|P1|Overall Study|Entry Criteria Not Met|1
278765|NCT01937871|934933|P3|Overall Study|Physician Decision|0
278766|NCT01937871|934934|P2|Overall Study|Physician Decision|1
278767|NCT01937871|934935|P1|Overall Study|Physician Decision|0
278768|NCT01937871|934933|P3|Overall Study|Withdrawal by Subject|4
278769|NCT01937871|934934|P2|Overall Study|Withdrawal by Subject|6
278770|NCT01937871|934935|P1|Overall Study|Withdrawal by Subject|9
278771|NCT01937871|934933|P3|Overall Study|Lost to Follow-up|4
278772|NCT01937871|934934|P2|Overall Study|Lost to Follow-up|2
278773|NCT01937871|934935|P1|Overall Study|Lost to Follow-up|8
278774|NCT01937871|934933|P3|Overall Study|Adverse Event|2
278775|NCT01937871|934934|P2|Overall Study|Adverse Event|6
278776|NCT01937871|934935|P1|Overall Study|Adverse Event|6
278777|NCT01937715|935011|P5|Overall Study|Other|0
278778|NCT01937715|935012|P4|Overall Study|Other|3
278779|NCT01937715|935013|P3|Overall Study|Other|0
278780|NCT01937715|935014|P2|Overall Study|Other|0
278781|NCT01937715|935015|P1|Overall Study|Other|0
278782|NCT01937715|935011|P5|Overall Study|Withdrawal by Subject|2
278783|NCT01937715|935012|P4|Overall Study|Withdrawal by Subject|0
278784|NCT01937715|935013|P3|Overall Study|Withdrawal by Subject|0
278785|NCT01937715|935014|P2|Overall Study|Withdrawal by Subject|1
278786|NCT01937715|935015|P1|Overall Study|Withdrawal by Subject|0
278787|NCT01937715|935011|P5|Overall Study|Death|0
278788|NCT01937715|935012|P4|Overall Study|Death|1
278789|NCT01937715|935013|P3|Overall Study|Death|0
278790|NCT01937715|935014|P2|Overall Study|Death|0
278791|NCT01937715|935015|P1|Overall Study|Death|0
278792|NCT01937364|935208|P2|Overall Study|Adverse Event|1
278793|NCT01937364|935209|P1|Overall Study|Adverse Event|2
278794|NCT01937351|935221|P2|Overall Study|Not treated w device, per protocol fail|0
278795|NCT01937351|935222|P1|Overall Study|Not treated w device, per protocol fail|4
278796|NCT01937351|935221|P2|Overall Study|Death|0
278797|NCT01937351|935222|P1|Overall Study|Death|1
278798|NCT01937351|935221|P2|Overall Study|Withdrawal by Subject|2
278799|NCT01937351|935222|P1|Overall Study|Withdrawal by Subject|4
278800|NCT01937312|935230|P2|Overall Study|Withdrawal of subject prior to treatment|1
278801|NCT01937312|935231|P1|Overall Study|Withdrawal of subject prior to treatment|1
278802|NCT01937312|935230|P2|Overall Study|Lack of Efficacy|1
278803|NCT01937312|935231|P1|Overall Study|Lack of Efficacy|0
278804|NCT01937312|935230|P2|Overall Study|Adverse Event|1
278805|NCT01937312|935231|P1|Overall Study|Adverse Event|10
278806|NCT01937299|935246|P2|Overall Study|Withdrawal by Subject|0
278807|NCT01937299|935247|P1|Overall Study|Withdrawal by Subject|1
278808|NCT01937299|935246|P2|Overall Study|Lack of Efficacy|4
278809|NCT01937299|935247|P1|Overall Study|Lack of Efficacy|0
278810|NCT01937299|935246|P2|Overall Study|Adverse Event|0
278811|NCT01937299|935247|P1|Overall Study|Adverse Event|13
278812|NCT01937130|935282|P4|Overall Study|Patient lost to FU due to death|0
278813|NCT01937130|935283|P3|Overall Study|Patient lost to FU due to death|0
278814|NCT01937130|935284|P2|Overall Study|Patient lost to FU due to death|0
278815|NCT01937130|935285|P1|Overall Study|Patient lost to FU due to death|2
278816|NCT01937130|935282|P4|Overall Study|Patients unable to swallow|0
278817|NCT01937130|935283|P3|Overall Study|Patients unable to swallow|0
278818|NCT01937130|935284|P2|Overall Study|Patients unable to swallow|1
278819|NCT01937130|935285|P1|Overall Study|Patients unable to swallow|0
278820|NCT01937130|935282|P4|Overall Study|Physician Decision|0
278821|NCT01937130|935283|P3|Overall Study|Physician Decision|0
278822|NCT01937130|935284|P2|Overall Study|Physician Decision|1
278823|NCT01937130|935285|P1|Overall Study|Physician Decision|0
278824|NCT01937130|935282|P4|Overall Study|Lost to Follow-up|0
278825|NCT01937130|935283|P3|Overall Study|Lost to Follow-up|2
278826|NCT01937130|935284|P2|Overall Study|Lost to Follow-up|0
278827|NCT01937130|935285|P1|Overall Study|Lost to Follow-up|2
278828|NCT01937130|935282|P4|Overall Study|Death|0
278829|NCT01937130|935283|P3|Overall Study|Death|1
278830|NCT01937130|935284|P2|Overall Study|Death|1
278831|NCT01937130|935285|P1|Overall Study|Death|1
278832|NCT01937130|935282|P4|Overall Study|Adverse Event|1
278833|NCT01937130|935283|P3|Overall Study|Adverse Event|0
278834|NCT01937130|935284|P2|Overall Study|Adverse Event|1
278835|NCT01937130|935285|P1|Overall Study|Adverse Event|0
278836|NCT01937130|935282|P4|Overall Study|Withdrawal by Subject|1
278837|NCT01937130|935283|P3|Overall Study|Withdrawal by Subject|0
278838|NCT01937130|935284|P2|Overall Study|Withdrawal by Subject|0
278839|NCT01937130|935285|P1|Overall Study|Withdrawal by Subject|0
278840|NCT01936974|935323|P2|Overall Study|Physician Decision|5
278841|NCT01936974|935324|P1|Overall Study|Physician Decision|2
278842|NCT01936870|935354|P1|Overall Study|No Drug Administration|1
278843|NCT01936870|935354|P1|Overall Study|Protocol Violation|12
278844|NCT01936870|935354|P1|Overall Study|No Visit After Treatment|176
278845|NCT01936649|935391|P1|Overall Study|Other than specified above|5
278846|NCT01936649|935391|P1|Overall Study|Protocol Violation|2
278847|NCT01936649|935391|P1|Overall Study|Physician Decision|2
278848|NCT01936649|935391|P1|Overall Study|Withdrawal by Subject|4
278849|NCT01936623|935398|P2|Overall Study|Lost to Follow-up|5
278850|NCT01936623|935399|P1|Overall Study|Lost to Follow-up|0
278851|NCT01936363|935443|P2|Overall Study|Ongoing|5
278852|NCT01936363|935444|P1|Overall Study|Ongoing|7
278853|NCT01936181|935470|P4|Transition-extension|Withdrawal by Subject|1
278854|NCT01936181|935471|P3|Transition-extension|Withdrawal by Subject|2
278855|NCT01936181|935472|P2|Transition-extension|Withdrawal by Subject|0
278856|NCT01936181|935473|P1|Transition-extension|Withdrawal by Subject|7
278857|NCT01936181|935470|P4|Transition-extension|Physician Decision|1
278858|NCT01936181|935471|P3|Transition-extension|Physician Decision|0
278859|NCT01936181|935472|P2|Transition-extension|Physician Decision|0
278860|NCT01936181|935473|P1|Transition-extension|Physician Decision|2
278861|NCT01936181|935470|P4|Transition-extension|Lost to Follow-up|2
278862|NCT01936181|935471|P3|Transition-extension|Lost to Follow-up|1
278863|NCT01936181|935472|P2|Transition-extension|Lost to Follow-up|0
278864|NCT01936181|935473|P1|Transition-extension|Lost to Follow-up|3
278865|NCT01936181|935470|P4|Transition-extension|Adverse Event|1
278866|NCT01936181|935471|P3|Transition-extension|Adverse Event|3
278867|NCT01936181|935472|P2|Transition-extension|Adverse Event|0
278868|NCT01936181|935473|P1|Transition-extension|Adverse Event|3
278869|NCT01936181|935470|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
278870|NCT01936181|935471|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
278871|NCT01936181|935472|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
278872|NCT01936181|935473|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
278873|NCT01936181|935470|P4|Randomised, Double-blind|Withdrawal by Subject|0
278874|NCT01936181|935471|P3|Randomised, Double-blind|Withdrawal by Subject|0
278875|NCT01936181|935472|P2|Randomised, Double-blind|Withdrawal by Subject|26
278876|NCT01936181|935473|P1|Randomised, Double-blind|Withdrawal by Subject|23
278877|NCT01936181|935470|P4|Randomised, Double-blind|Physician Decision|0
278878|NCT01936181|935471|P3|Randomised, Double-blind|Physician Decision|0
278879|NCT01936181|935472|P2|Randomised, Double-blind|Physician Decision|4
278880|NCT01936181|935473|P1|Randomised, Double-blind|Physician Decision|4
278881|NCT01936181|935470|P4|Randomised, Double-blind|Pregnancy|0
278882|NCT01936181|935471|P3|Randomised, Double-blind|Pregnancy|0
278883|NCT01936181|935472|P2|Randomised, Double-blind|Pregnancy|1
278884|NCT01936181|935473|P1|Randomised, Double-blind|Pregnancy|0
278885|NCT01936181|935470|P4|Randomised, Double-blind|Lost to Follow-up|0
278886|NCT01936181|935471|P3|Randomised, Double-blind|Lost to Follow-up|0
278887|NCT01936181|935472|P2|Randomised, Double-blind|Lost to Follow-up|1
278888|NCT01936181|935473|P1|Randomised, Double-blind|Lost to Follow-up|0
278889|NCT01936181|935470|P4|Randomised, Double-blind|Lack of Efficacy|0
278890|NCT01936181|935471|P3|Randomised, Double-blind|Lack of Efficacy|0
278891|NCT01936181|935472|P2|Randomised, Double-blind|Lack of Efficacy|6
278892|NCT01936181|935473|P1|Randomised, Double-blind|Lack of Efficacy|5
278893|NCT01936181|935470|P4|Randomised, Double-blind|Protocol Violation|0
278894|NCT01936181|935471|P3|Randomised, Double-blind|Protocol Violation|0
278895|NCT01936181|935472|P2|Randomised, Double-blind|Protocol Violation|5
278896|NCT01936181|935473|P1|Randomised, Double-blind|Protocol Violation|1
278897|NCT01936181|935470|P4|Randomised, Double-blind|Adverse Event|0
278898|NCT01936181|935471|P3|Randomised, Double-blind|Adverse Event|0
278899|NCT01936181|935472|P2|Randomised, Double-blind|Adverse Event|21
278900|NCT01936181|935473|P1|Randomised, Double-blind|Adverse Event|27
278901|NCT01934894|935520|P2|Overall Study|Progressive Disease|2
278902|NCT01934894|935521|P1|Overall Study|Progressive Disease|3
278903|NCT01934894|935520|P2|Overall Study|Withdrawal by Subject|1
278904|NCT01934894|935521|P1|Overall Study|Withdrawal by Subject|0
278905|NCT01934894|935520|P2|Overall Study|Death|0
278906|NCT01934894|935521|P1|Overall Study|Death|2
278907|NCT01934894|935520|P2|Overall Study|Adverse Event|2
278908|NCT01934894|935521|P1|Overall Study|Adverse Event|1
278909|NCT01934790|935536|P1|Active Follow up|Other reason|1
278910|NCT01934790|935536|P1|Active Follow up|Progressive disease|1
278911|NCT01934790|935536|P1|Active Follow up|Physician Decision|2
278912|NCT01934790|935536|P1|Active Follow up|Death|20
278913|NCT01934790|935536|P1|Treatment|Study drug never administered|1
278914|NCT01934790|935536|P1|Treatment|Withdrawal by Subject|2
278915|NCT01934790|935536|P1|Treatment|Radiological progression|4
278916|NCT01934790|935536|P1|Treatment|Clinical progression|6
278917|NCT01934790|935536|P1|Treatment|Adverse Event|3
278918|NCT01934504|935590|P4|Overall Study|Study Terminated by Sponsor|5
278919|NCT01934504|935591|P3|Overall Study|Study Terminated by Sponsor|5
278920|NCT01934504|935592|P2|Overall Study|Study Terminated by Sponsor|0
278921|NCT01934504|935593|P1|Overall Study|Study Terminated by Sponsor|1
278922|NCT01934504|935590|P4|Overall Study|Protocol Deviation|2
278923|NCT01934504|935591|P3|Overall Study|Protocol Deviation|0
278924|NCT01934504|935592|P2|Overall Study|Protocol Deviation|0
278925|NCT01934504|935593|P1|Overall Study|Protocol Deviation|0
278926|NCT01934218|935626|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
278927|NCT01934218|935627|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
278928|NCT01934218|935626|P2|Open-Label Phase|Noncompliance with Study Protocol|2
278929|NCT01934218|935627|P1|Open-Label Phase|Noncompliance with Study Protocol|4
278930|NCT01934218|935626|P2|Open-Label Phase|Withdrawal by Subject|11
278931|NCT01934218|935627|P1|Open-Label Phase|Withdrawal by Subject|13
278932|NCT01934218|935626|P2|Open-Label Phase|Protocol Violation|0
278933|NCT01934218|935627|P1|Open-Label Phase|Protocol Violation|1
278934|NCT01934218|935626|P2|Open-Label Phase|Physician Decision|0
278935|NCT01934218|935627|P1|Open-Label Phase|Physician Decision|1
278936|NCT01934218|935626|P2|Open-Label Phase|Lost to Follow-up|2
278937|NCT01934218|935627|P1|Open-Label Phase|Lost to Follow-up|4
278938|NCT01934218|935626|P2|Open-Label Phase|Lack of Efficacy|4
278939|NCT01934218|935627|P1|Open-Label Phase|Lack of Efficacy|1
278940|NCT01934218|935626|P2|Open-Label Phase|Adverse Event|4
278941|NCT01934218|935627|P1|Open-Label Phase|Adverse Event|2
278942|NCT01934218|935626|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
278943|NCT01934218|935627|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
278944|NCT01934218|935626|P2|Double-blind Phase|Noncompliance with Study Protocol|8
278945|NCT01934218|935627|P1|Double-blind Phase|Noncompliance with Study Protocol|5
278946|NCT01934218|935626|P2|Double-blind Phase|Withdrawal by Subject|13
278947|NCT01934218|935627|P1|Double-blind Phase|Withdrawal by Subject|16
278948|NCT01934218|935626|P2|Double-blind Phase|Protocol Violation|0
278949|NCT01934218|935627|P1|Double-blind Phase|Protocol Violation|4
278950|NCT01934218|935626|P2|Double-blind Phase|Physician Decision|2
278951|NCT01934218|935627|P1|Double-blind Phase|Physician Decision|1
278952|NCT01934218|935626|P2|Double-blind Phase|Lost to Follow-up|14
278953|NCT01934218|935627|P1|Double-blind Phase|Lost to Follow-up|7
278954|NCT01934218|935626|P2|Double-blind Phase|Lack of Efficacy|7
278955|NCT01934218|935627|P1|Double-blind Phase|Lack of Efficacy|6
278956|NCT01934218|935626|P2|Double-blind Phase|Adverse Event|8
278957|NCT01934218|935627|P1|Double-blind Phase|Adverse Event|8
278958|NCT01934192|935638|P4|Overall Study|Physician Decision|0
278959|NCT01934192|935639|P3|Overall Study|Physician Decision|0
278960|NCT01934192|935640|P2|Overall Study|Physician Decision|2
278961|NCT01934192|935641|P1|Overall Study|Physician Decision|3
278962|NCT01934192|935638|P4|Overall Study|Other: reached stopping criteria|0
278963|NCT01934192|935639|P3|Overall Study|Other: reached stopping criteria|1
278964|NCT01934192|935640|P2|Overall Study|Other: reached stopping criteria|5
278965|NCT01934192|935641|P1|Overall Study|Other: reached stopping criteria|6
278966|NCT01934192|935638|P4|Overall Study|Protocol Violation|1
278967|NCT01934192|935639|P3|Overall Study|Protocol Violation|0
278968|NCT01934192|935640|P2|Overall Study|Protocol Violation|0
278969|NCT01934192|935641|P1|Overall Study|Protocol Violation|0
278970|NCT01934010|935778|P3|Overall Study|Lost to Follow-up|0
278971|NCT01934010|935779|P2|Overall Study|Lost to Follow-up|4
278972|NCT01934010|935780|P1|Overall Study|Lost to Follow-up|7
278973|NCT01934010|935778|P3|Overall Study|Withdrawal by Subject|2
278974|NCT01934010|935779|P2|Overall Study|Withdrawal by Subject|6
278975|NCT01934010|935780|P1|Overall Study|Withdrawal by Subject|15
278976|NCT01934010|935778|P3|Overall Study|Adverse Event|0
278977|NCT01934010|935779|P2|Overall Study|Adverse Event|1
278978|NCT01934010|935780|P1|Overall Study|Adverse Event|1
278979|NCT01933932|935799|P2|Overall Study|Eligibility criteria not fulfilled|1
278980|NCT01933932|935800|P1|Overall Study|Eligibility criteria not fulfilled|0
278981|NCT01933932|935799|P2|Overall Study|Withdrawal by Subject|14
278982|NCT01933932|935800|P1|Overall Study|Withdrawal by Subject|11
278983|NCT01933932|935799|P2|Overall Study|Death|163
278984|NCT01933932|935800|P1|Overall Study|Death|173
278985|NCT01933919|935818|P2|Open-label Long-term Phase|Other|2
278986|NCT01933919|935819|P1|Open-label Long-term Phase|Other|1
278987|NCT01933919|935818|P2|Open-label Long-term Phase|Lost to Follow-up|0
278988|NCT01933919|935819|P1|Open-label Long-term Phase|Lost to Follow-up|1
278989|NCT01933919|935818|P2|Open-label Long-term Phase|Withdrawal by Subject|4
278990|NCT01933919|935819|P1|Open-label Long-term Phase|Withdrawal by Subject|3
278991|NCT01933919|935818|P2|Open-label Long-term Phase|Adverse Event|0
278992|NCT01933919|935819|P1|Open-label Long-term Phase|Adverse Event|2
278993|NCT01933919|935818|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
278994|NCT01933919|935819|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
278995|NCT01933919|935818|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
278996|NCT01933919|935819|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
278997|NCT01933919|935818|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
278998|NCT01933919|935819|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
278999|NCT01933880|935855|P2|Overall Study|Protocol Violation|0
279000|NCT01933880|935856|P1|Overall Study|Protocol Violation|1
279001|NCT01933880|935855|P2|Overall Study|Other|0
279002|NCT01933880|935856|P1|Overall Study|Other|4
279003|NCT01933880|935855|P2|Overall Study|Followup exceeded 4 days to visit window|0
279004|NCT01933880|935856|P1|Overall Study|Followup exceeded 4 days to visit window|19
279005|NCT01933880|935855|P2|Overall Study|Concomitant medication Interference|1
279006|NCT01933880|935856|P1|Overall Study|Concomitant medication Interference|0
279007|NCT01933880|935855|P2|Overall Study|Lack of Efficacy|0
279008|NCT01933880|935856|P1|Overall Study|Lack of Efficacy|1
279009|NCT01933880|935855|P2|Overall Study|Withdrawal by Subject|0
279010|NCT01933880|935856|P1|Overall Study|Withdrawal by Subject|5
279011|NCT01933672|935932|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
279012|NCT01933672|935933|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
279013|NCT01933672|935934|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
279014|NCT01933672|935935|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
279015|NCT01933672|935936|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
279016|NCT01933672|935937|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
279017|NCT01933672|935938|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
279018|NCT01933672|935932|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
279019|NCT01933672|935933|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
279020|NCT01933672|935934|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
279021|NCT01933672|935935|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
279022|NCT01933672|935936|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
279023|NCT01933672|935937|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
279024|NCT01933672|935938|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
279025|NCT01933672|935932|P7|Second Intervention Period (12-16 Days)|Other|0
279026|NCT01933672|935933|P6|Second Intervention Period (12-16 Days)|Other|0
279027|NCT01933672|935934|P5|Second Intervention Period (12-16 Days)|Other|0
279028|NCT01933672|935935|P4|Second Intervention Period (12-16 Days)|Other|0
279029|NCT01933672|935936|P3|Second Intervention Period (12-16 Days)|Other|1
279030|NCT01933672|935937|P2|Second Intervention Period (12-16 Days)|Other|1
279031|NCT01933672|935938|P1|Second Intervention Period (12-16 Days)|Other|0
279032|NCT01933672|935932|P7|First Intervention Period (12-16 Days)|Other|0
279033|NCT01933672|935933|P6|First Intervention Period (12-16 Days)|Other|1
279034|NCT01933672|935934|P5|First Intervention Period (12-16 Days)|Other|0
279035|NCT01933672|935935|P4|First Intervention Period (12-16 Days)|Other|0
279036|NCT01933672|935936|P3|First Intervention Period (12-16 Days)|Other|1
279037|NCT01933672|935937|P2|First Intervention Period (12-16 Days)|Other|0
279038|NCT01933672|935938|P1|First Intervention Period (12-16 Days)|Other|0
279039|NCT01933672|935932|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
279040|NCT01933672|935933|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
279041|NCT01933672|935934|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
279042|NCT01933672|935935|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
279043|NCT01933672|935936|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
279044|NCT01933672|935937|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
279045|NCT01933672|935938|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
279046|NCT01933672|935932|P7|Metformin Run-in Period|Other|0
279047|NCT01933672|935933|P6|Metformin Run-in Period|Other|0
279048|NCT01933672|935934|P5|Metformin Run-in Period|Other|0
279049|NCT01933672|935935|P4|Metformin Run-in Period|Other|0
279050|NCT01933672|935936|P3|Metformin Run-in Period|Other|0
279051|NCT01933672|935937|P2|Metformin Run-in Period|Other|0
279052|NCT01933672|935938|P1|Metformin Run-in Period|Other|5
279053|NCT01933672|935932|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
279054|NCT01933672|935933|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
279055|NCT01933672|935934|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
279056|NCT01933672|935935|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
279057|NCT01933672|935936|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
279058|NCT01933672|935937|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
279059|NCT01933672|935938|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
279060|NCT01933672|935932|P7|Metformin Run-in Period|Adverse Event|0
279061|NCT01933672|935933|P6|Metformin Run-in Period|Adverse Event|0
279062|NCT01933672|935934|P5|Metformin Run-in Period|Adverse Event|0
279063|NCT01933672|935935|P4|Metformin Run-in Period|Adverse Event|0
279064|NCT01933672|935936|P3|Metformin Run-in Period|Adverse Event|0
279065|NCT01933672|935937|P2|Metformin Run-in Period|Adverse Event|0
279066|NCT01933672|935938|P1|Metformin Run-in Period|Adverse Event|1
279067|NCT01933334|936013|P2|Overall Study|Withdrawal by Subject|1
279068|NCT01933334|936014|P1|Overall Study|Withdrawal by Subject|0
279069|NCT01933334|936013|P2|Overall Study|Adverse Event|1
279070|NCT01933334|936014|P1|Overall Study|Adverse Event|5
279071|NCT01933048|936043|P2|Overall Study|unknown reasons|1
279072|NCT01933048|936044|P1|Overall Study|unknown reasons|1
279073|NCT01933048|936043|P2|Overall Study|Physician Decision|0
279074|NCT01933048|936044|P1|Overall Study|Physician Decision|1
279075|NCT01933048|936043|P2|Overall Study|Protocol Violation|8
279076|NCT01933048|936044|P1|Overall Study|Protocol Violation|7
279077|NCT01933048|936043|P2|Overall Study|personal reasons|1
279078|NCT01933048|936044|P1|Overall Study|personal reasons|1
279079|NCT01933048|936043|P2|Overall Study|Lost to Follow-up|18
279080|NCT01933048|936044|P1|Overall Study|Lost to Follow-up|15
279081|NCT01932970|936057|P1|Overall Study|Protocol Specified Criteria|10
279082|NCT01932970|936057|P1|Overall Study|Lost to Follow-up|2
279083|NCT01932970|936057|P1|Overall Study|Death|1
279084|NCT01932970|936057|P1|Overall Study|Withdrawal by Subject|5
279085|NCT01932762|936069|P4|Overall Study|Physician Decision|0
279086|NCT01932762|936070|P3|Overall Study|Physician Decision|0
279087|NCT01932762|936071|P2|Overall Study|Physician Decision|0
279088|NCT01932762|936072|P1|Overall Study|Physician Decision|1
279089|NCT01932762|936069|P4|Overall Study|Lost to Follow-up|1
279090|NCT01932762|936070|P3|Overall Study|Lost to Follow-up|0
279091|NCT01932762|936071|P2|Overall Study|Lost to Follow-up|0
279092|NCT01932762|936072|P1|Overall Study|Lost to Follow-up|4
279093|NCT01932762|936069|P4|Overall Study|Withdrawal by Subject|0
279094|NCT01932762|936070|P3|Overall Study|Withdrawal by Subject|0
279095|NCT01932762|936071|P2|Overall Study|Withdrawal by Subject|2
279096|NCT01932762|936072|P1|Overall Study|Withdrawal by Subject|1
279097|NCT01931865|936319|P1|Overall Study|Withdrawal by Subject|2
279098|NCT01931865|936319|P1|Overall Study|Lost to Follow-up|2
279099|NCT01931839|936332|P7|Overall Study|Other|0
279100|NCT01931839|936333|P6|Overall Study|Other|0
279101|NCT01931839|936334|P5|Overall Study|Other|0
279102|NCT01931839|936335|P4|Overall Study|Other|0
279103|NCT01931839|936336|P3|Overall Study|Other|6
279104|NCT01931839|936337|P2|Overall Study|Other|2
279105|NCT01931839|936338|P1|Overall Study|Other|4
279106|NCT01931839|936332|P7|Overall Study|Lost to Follow-up|0
279107|NCT01931839|936333|P6|Overall Study|Lost to Follow-up|0
279108|NCT01931839|936334|P5|Overall Study|Lost to Follow-up|0
279109|NCT01931839|936335|P4|Overall Study|Lost to Follow-up|5
279110|NCT01931839|936336|P3|Overall Study|Lost to Follow-up|4
279111|NCT01931839|936337|P2|Overall Study|Lost to Follow-up|2
279112|NCT01931839|936338|P1|Overall Study|Lost to Follow-up|1
279113|NCT01931839|936332|P7|Overall Study|Other non-compliance|0
279114|NCT01931839|936333|P6|Overall Study|Other non-compliance|3
279115|NCT01931839|936334|P5|Overall Study|Other non-compliance|0
279116|NCT01931839|936335|P4|Overall Study|Other non-compliance|3
279117|NCT01931839|936336|P3|Overall Study|Other non-compliance|12
279118|NCT01931839|936337|P2|Overall Study|Other non-compliance|9
279119|NCT01931839|936338|P1|Overall Study|Other non-compliance|15
279120|NCT01931839|936332|P7|Overall Study|Withdrawal of consent (not due to AE)|2
279121|NCT01931839|936333|P6|Overall Study|Withdrawal of consent (not due to AE)|2
279122|NCT01931839|936334|P5|Overall Study|Withdrawal of consent (not due to AE)|0
279123|NCT01931839|936335|P4|Overall Study|Withdrawal of consent (not due to AE)|3
279124|NCT01931839|936336|P3|Overall Study|Withdrawal of consent (not due to AE)|13
279125|NCT01931839|936337|P2|Overall Study|Withdrawal of consent (not due to AE)|8
279126|NCT01931839|936338|P1|Overall Study|Withdrawal of consent (not due to AE)|11
279127|NCT01931839|936332|P7|Overall Study|Adverse Event|1
279128|NCT01931839|936333|P6|Overall Study|Adverse Event|0
279129|NCT01931839|936334|P5|Overall Study|Adverse Event|0
279130|NCT01931839|936335|P4|Overall Study|Adverse Event|3
279131|NCT01931839|936336|P3|Overall Study|Adverse Event|1
279132|NCT01931839|936337|P2|Overall Study|Adverse Event|4
279133|NCT01931839|936338|P1|Overall Study|Adverse Event|9
279134|NCT01931839|936332|P7|Overall Study|Withdrawal of consent|0
279135|NCT01931839|936333|P6|Overall Study|Withdrawal of consent|0
279136|NCT01931839|936334|P5|Overall Study|Withdrawal of consent|1
279137|NCT01931839|936335|P4|Overall Study|Withdrawal of consent|0
279138|NCT01931839|936336|P3|Overall Study|Withdrawal of consent|0
279139|NCT01931839|936337|P2|Overall Study|Withdrawal of consent|0
279140|NCT01931839|936338|P1|Overall Study|Withdrawal of consent|0
279141|NCT01931839|936332|P7|Overall Study|Physician Decision|1
279142|NCT01931839|936333|P6|Overall Study|Physician Decision|0
279143|NCT01931839|936334|P5|Overall Study|Physician Decision|0
279144|NCT01931839|936335|P4|Overall Study|Physician Decision|0
279145|NCT01931839|936336|P3|Overall Study|Physician Decision|1
279146|NCT01931839|936337|P2|Overall Study|Physician Decision|0
279147|NCT01931839|936338|P1|Overall Study|Physician Decision|1
279148|NCT01931839|936332|P7|Overall Study|Death|0
279149|NCT01931839|936333|P6|Overall Study|Death|0
279150|NCT01931839|936334|P5|Overall Study|Death|0
279151|NCT01931839|936335|P4|Overall Study|Death|0
279152|NCT01931839|936336|P3|Overall Study|Death|2
279153|NCT01931839|936337|P2|Overall Study|Death|1
279154|NCT01931839|936338|P1|Overall Study|Death|0
279155|NCT01931475|936429|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
279156|NCT01931475|936430|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
279157|NCT01931475|936429|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
279158|NCT01931475|936430|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
279159|NCT01931475|936429|P2|Period 2: Extension Treatment Phase|Physician Decision|1
279160|NCT01931475|936430|P1|Period 2: Extension Treatment Phase|Physician Decision|1
279161|NCT01931475|936429|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
279162|NCT01931475|936430|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
279163|NCT01931475|936429|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
279164|NCT01931475|936430|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
279165|NCT01931475|936429|P2|Period 2: Extension Treatment Phase|Adverse Event|8
279166|NCT01931475|936430|P1|Period 2: Extension Treatment Phase|Adverse Event|0
279167|NCT01931475|936429|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
279168|NCT01931475|936430|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
279169|NCT01931475|936429|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
279170|NCT01931475|936430|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
279171|NCT01931475|936429|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
279172|NCT01931475|936430|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
279173|NCT01931475|936429|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
279174|NCT01931475|936430|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
279175|NCT01931475|936429|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
279176|NCT01931475|936430|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
279177|NCT01931462|936457|P1|Overall Study|Withdrawal by Subject|1
279178|NCT01931397|936468|P1|Overall Study|moved out of state|1
279179|NCT01931397|936468|P1|Overall Study|Withdrawal by Subject|8
279180|NCT01931397|936468|P1|Overall Study|Physician Decision|2
279181|NCT01931150|936479|P2|Overall Study|Withdrawal by Subject|2
279182|NCT01931150|936480|P1|Overall Study|Withdrawal by Subject|1
279183|NCT01931059|936488|P2|Day3|Lost to Follow-up|0
279184|NCT01931059|936489|P1|Day3|Lost to Follow-up|1
279185|NCT01931059|936488|P2|Day 1|Pregnancy|1
279186|NCT01931059|936489|P1|Day 1|Pregnancy|0
279187|NCT01930890|936505|P4|Overall Study|Adverse Event|0
279188|NCT01930890|936506|P3|Overall Study|Adverse Event|0
279189|NCT01930890|936507|P2|Overall Study|Adverse Event|1
279190|NCT01930890|936508|P1|Overall Study|Adverse Event|0
279191|NCT01930890|936505|P4|Overall Study|Consent Withdrawn|1
279192|NCT01930890|936506|P3|Overall Study|Consent Withdrawn|0
279193|NCT01930890|936507|P2|Overall Study|Consent Withdrawn|3
279194|NCT01930890|936508|P1|Overall Study|Consent Withdrawn|0
279195|NCT01930890|936505|P4|Overall Study|Investigator Decision|0
279196|NCT01930890|936506|P3|Overall Study|Investigator Decision|0
279197|NCT01930890|936507|P2|Overall Study|Investigator Decision|1
279198|NCT01930890|936508|P1|Overall Study|Investigator Decision|0
279199|NCT01930890|936505|P4|Overall Study|Death|1
279200|NCT01930890|936506|P3|Overall Study|Death|0
279201|NCT01930890|936507|P2|Overall Study|Death|0
279202|NCT01930890|936508|P1|Overall Study|Death|0
279203|NCT01930890|936505|P4|Overall Study|Study Termination|25
279204|NCT01930890|936506|P3|Overall Study|Study Termination|13
279205|NCT01930890|936507|P2|Overall Study|Study Termination|28
279206|NCT01930890|936508|P1|Overall Study|Study Termination|14
279207|NCT01930799|936522|P1|Overall Study|Lost to Follow-up|5
279208|NCT01930799|936522|P1|Overall Study|Withdrawal by Subject|3
279209|NCT01930162|936630|P1|Overall Study|Death|1
279210|NCT01930162|936630|P1|Overall Study|Abnormal test procedure result(s)|4
279211|NCT01930045|936666|P6|Pause (up to 37 Days)|Protocol Violation|1
279212|NCT01930045|936667|P5|Pause (up to 37 Days)|Protocol Violation|0
279213|NCT01930045|936668|P4|Pause (up to 37 Days)|Protocol Violation|0
279214|NCT01930045|936669|P3|Pause (up to 37 Days)|Protocol Violation|0
279215|NCT01930045|936670|P2|Pause (up to 37 Days)|Protocol Violation|0
279216|NCT01930045|936671|P1|Pause (up to 37 Days)|Protocol Violation|0
279217|NCT01930045|936666|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
279218|NCT01930045|936667|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
279219|NCT01930045|936668|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
279220|NCT01930045|936669|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
279221|NCT01930045|936670|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
279222|NCT01930045|936671|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
279223|NCT01929993|936698|P2|Overall Study|Absent CIN, invasion present or artifact|22
279224|NCT01929993|936699|P1|Overall Study|Absent CIN, invasion present or artifact|26
279225|NCT01929993|936698|P2|Overall Study|Protocol Violation|6
279226|NCT01929993|936699|P1|Overall Study|Protocol Violation|4
279227|NCT01929980|936705|P1|Overall Study|Physician Decision|1
279228|NCT01929876|936713|P1|Period 2|Non-Compliance|1
279229|NCT01929863|936726|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
279230|NCT01929863|936727|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
279231|NCT01929863|936726|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
279232|NCT01929863|936727|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
279233|NCT01929863|936726|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
279234|NCT01929863|936727|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
279235|NCT01929681|936784|P2|Overall Study|Physician Decision|1
279236|NCT01929681|936785|P1|Overall Study|Physician Decision|1
279237|NCT01929681|936784|P2|Overall Study|Withdrawal by Subject|0
279238|NCT01929681|936785|P1|Overall Study|Withdrawal by Subject|1
279239|NCT01929317|936830|P2|Long-term Phase|Study Closed/Terminated|3
279240|NCT01929317|936831|P1|Long-term Phase|Study Closed/Terminated|5
279241|NCT01929317|936830|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
279242|NCT01929317|936831|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
279243|NCT01929317|936830|P2|Long-term Phase|Protocol Violation|0
279244|NCT01929317|936831|P1|Long-term Phase|Protocol Violation|1
279245|NCT01929317|936830|P2|Long-term Phase|Withdrawal by Subject|0
279246|NCT01929317|936831|P1|Long-term Phase|Withdrawal by Subject|4
279247|NCT01929317|936830|P2|Long-term Phase|Physician Decision|0
279248|NCT01929317|936831|P1|Long-term Phase|Physician Decision|3
279249|NCT01929317|936830|P2|Long-term Phase|Adverse Event|1
279250|NCT01929317|936831|P1|Long-term Phase|Adverse Event|5
279251|NCT01929317|936830|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
279252|NCT01929317|936831|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
279253|NCT01929317|936830|P2|Dose Increase Effect Verification Phase|Physician Decision|0
279254|NCT01929317|936831|P1|Dose Increase Effect Verification Phase|Physician Decision|1
279255|NCT01929317|936830|P2|Dose Increase Effect Verification Phase|Adverse Event|1
279256|NCT01929317|936831|P1|Dose Increase Effect Verification Phase|Adverse Event|5
279257|NCT01929135|936900|P2|Overall Study|Lost to Follow-up|1
279258|NCT01929135|936901|P1|Overall Study|Lost to Follow-up|1
279259|NCT01929083|936915|P2|Intervention 2|Adverse Event|1
279260|NCT01929083|936916|P1|Intervention 2|Adverse Event|0
279261|NCT01929083|936915|P2|Intervention 1|Nonadherent to study medications|0
279262|NCT01929083|936916|P1|Intervention 1|Nonadherent to study medications|1
279263|NCT01929083|936915|P2|Intervention 1|Lost to Follow-up|0
279264|NCT01929083|936916|P1|Intervention 1|Lost to Follow-up|2
279265|NCT01929044|936942|P2|Overall Study|Not Treated|3
279266|NCT01929044|936943|P1|Overall Study|Not Treated|1
279267|NCT01929044|936942|P2|Overall Study|Protocol Violation|14
279268|NCT01929044|936943|P1|Overall Study|Protocol Violation|9
279269|NCT01929044|936942|P2|Overall Study|Adverse Event|0
279270|NCT01929044|936943|P1|Overall Study|Adverse Event|1
279271|NCT01929031|936965|P6|Overall Study|Reason other than specified above|0
279272|NCT01929031|936966|P5|Overall Study|Reason other than specified above|1
279273|NCT01929031|936967|P4|Overall Study|Reason other than specified above|0
279274|NCT01929031|936968|P3|Overall Study|Reason other than specified above|0
279275|NCT01929031|936969|P2|Overall Study|Reason other than specified above|1
279276|NCT01929031|936970|P1|Overall Study|Reason other than specified above|0
279277|NCT01929031|936965|P6|Overall Study|Protocol Violation|1
279278|NCT01929031|936966|P5|Overall Study|Protocol Violation|0
279279|NCT01929031|936967|P4|Overall Study|Protocol Violation|0
279280|NCT01929031|936968|P3|Overall Study|Protocol Violation|0
279281|NCT01929031|936969|P2|Overall Study|Protocol Violation|0
279282|NCT01929031|936970|P1|Overall Study|Protocol Violation|1
279283|NCT01929031|936965|P6|Overall Study|Adverse Event|0
279284|NCT01929031|936966|P5|Overall Study|Adverse Event|0
279285|NCT01929031|936967|P4|Overall Study|Adverse Event|0
279286|NCT01929031|936968|P3|Overall Study|Adverse Event|1
279287|NCT01929031|936969|P2|Overall Study|Adverse Event|1
279288|NCT01929031|936970|P1|Overall Study|Adverse Event|3
279289|NCT01928940|936994|P2|Overall Study|Adverse Event|1
279290|NCT01928940|936995|P1|Overall Study|Adverse Event|0
279291|NCT01928927|937038|P2|Overall Study|Withdrawal by Subject|1
279292|NCT01928927|937039|P1|Overall Study|Withdrawal by Subject|1
279293|NCT01928927|937038|P2|Overall Study|Lost to Follow-up|0
279294|NCT01928927|937039|P1|Overall Study|Lost to Follow-up|1
279295|NCT01928862|937166|P5|Overall Study|Lost to Follow-up|1
279296|NCT01928862|937167|P4|Overall Study|Lost to Follow-up|0
279297|NCT01928862|937168|P3|Overall Study|Lost to Follow-up|0
279298|NCT01928862|937169|P2|Overall Study|Lost to Follow-up|0
279299|NCT01928862|937170|P1|Overall Study|Lost to Follow-up|1
279300|NCT01928771|937223|P3|Overall Study|Severe Non-Compliance to Protocol|2
279301|NCT01928771|937224|P2|Overall Study|Severe Non-Compliance to Protocol|2
279302|NCT01928771|937225|P1|Overall Study|Severe Non-Compliance to Protocol|4
279303|NCT01928771|937223|P3|Overall Study|Other Reasons|14
279304|NCT01928771|937224|P2|Overall Study|Other Reasons|9
279305|NCT01928771|937225|P1|Overall Study|Other Reasons|9
279306|NCT01928771|937223|P3|Overall Study|Study-Specific Withdrawal Criteria|1
279307|NCT01928771|937224|P2|Overall Study|Study-Specific Withdrawal Criteria|1
279308|NCT01928771|937225|P1|Overall Study|Study-Specific Withdrawal Criteria|0
279309|NCT01928771|937223|P3|Overall Study|Withdrawal by Subject|17
279310|NCT01928771|937224|P2|Overall Study|Withdrawal by Subject|15
279311|NCT01928771|937225|P1|Overall Study|Withdrawal by Subject|20
279312|NCT01928771|937223|P3|Overall Study|Lost to Follow-up|3
279313|NCT01928771|937224|P2|Overall Study|Lost to Follow-up|6
279314|NCT01928771|937225|P1|Overall Study|Lost to Follow-up|5
279315|NCT01928771|937223|P3|Overall Study|Death|2
279316|NCT01928771|937224|P2|Overall Study|Death|2
279317|NCT01928771|937225|P1|Overall Study|Death|2
279318|NCT01928771|937223|P3|Overall Study|Adverse Event|1
279319|NCT01928771|937224|P2|Overall Study|Adverse Event|5
279320|NCT01928771|937225|P1|Overall Study|Adverse Event|6
279321|NCT01928615|937337|P1|Overall Study|Study Terminated by Sponsor|2
279322|NCT01928472|937356|P4|Overall Study|Unclassified|0
279323|NCT01928472|937357|P3|Overall Study|Unclassified|1
279324|NCT01928472|937358|P2|Overall Study|Unclassified|0
279325|NCT01928472|937359|P1|Overall Study|Unclassified|0
279326|NCT01928472|937356|P4|Overall Study|Administrative Reason|0
279327|NCT01928472|937357|P3|Overall Study|Administrative Reason|0
279328|NCT01928472|937358|P2|Overall Study|Administrative Reason|1
279329|NCT01928472|937359|P1|Overall Study|Administrative Reason|2
279330|NCT01928472|937356|P4|Overall Study|Lost to Follow-up|0
279331|NCT01928472|937357|P3|Overall Study|Lost to Follow-up|4
279332|NCT01928472|937358|P2|Overall Study|Lost to Follow-up|3
279333|NCT01928472|937359|P1|Overall Study|Lost to Follow-up|2
279334|NCT01928472|937356|P4|Overall Study|Withdrawal by Subject|2
279335|NCT01928472|937357|P3|Overall Study|Withdrawal by Subject|1
279336|NCT01928472|937358|P2|Overall Study|Withdrawal by Subject|4
279337|NCT01928472|937359|P1|Overall Study|Withdrawal by Subject|4
279338|NCT01928472|937356|P4|Overall Study|Death|0
279339|NCT01928472|937357|P3|Overall Study|Death|1
279340|NCT01928472|937358|P2|Overall Study|Death|0
279341|NCT01928472|937359|P1|Overall Study|Death|0
279342|NCT01928433|937429|P3|Overall Study|Other reasons|4
279343|NCT01928433|937430|P2|Overall Study|Other reasons|3
279344|NCT01928433|937431|P1|Overall Study|Other reasons|3
279345|NCT01928433|937429|P3|Overall Study|Lost to Follow-up|3
279346|NCT01928433|937430|P2|Overall Study|Lost to Follow-up|2
279347|NCT01928433|937431|P1|Overall Study|Lost to Follow-up|0
279348|NCT01928433|937429|P3|Overall Study|Negative screening urine culture|10
279349|NCT01928433|937430|P2|Overall Study|Negative screening urine culture|6
279350|NCT01928433|937431|P1|Overall Study|Negative screening urine culture|7
279351|NCT01928433|937429|P3|Overall Study|Withdrawal by Subject|0
279352|NCT01928433|937430|P2|Overall Study|Withdrawal by Subject|4
279353|NCT01928433|937431|P1|Overall Study|Withdrawal by Subject|0
279354|NCT01928433|937429|P3|Overall Study|Lack of Efficacy|4
279355|NCT01928433|937430|P2|Overall Study|Lack of Efficacy|4
279356|NCT01928433|937431|P1|Overall Study|Lack of Efficacy|5
279357|NCT01928433|937429|P3|Overall Study|Protocol Violation|2
279358|NCT01928433|937430|P2|Overall Study|Protocol Violation|0
279359|NCT01928433|937431|P1|Overall Study|Protocol Violation|0
279360|NCT01928433|937429|P3|Overall Study|Adverse Event|5
279361|NCT01928433|937430|P2|Overall Study|Adverse Event|2
279362|NCT01928433|937431|P1|Overall Study|Adverse Event|5
279363|NCT01928381|937454|P7|Part 2 - Post Third Intervention|Protocol Violation|0
279364|NCT01928381|937455|P6|Part 2 - Post Third Intervention|Protocol Violation|0
279365|NCT01928381|937456|P5|Part 2 - Post Third Intervention|Protocol Violation|0
279366|NCT01928381|937457|P4|Part 2 - Post Third Intervention|Protocol Violation|0
279367|NCT01928381|937458|P3|Part 2 - Post Third Intervention|Protocol Violation|1
279368|NCT01928381|937459|P2|Part 2 - Post Third Intervention|Protocol Violation|0
279369|NCT01928381|937460|P1|Part 2 - Post Third Intervention|Protocol Violation|0
279370|NCT01928381|937454|P7|Part 2 - Second Intervention|Lost to Follow-up|0
279371|NCT01928381|937455|P6|Part 2 - Second Intervention|Lost to Follow-up|0
279372|NCT01928381|937456|P5|Part 2 - Second Intervention|Lost to Follow-up|0
279373|NCT01928381|937457|P4|Part 2 - Second Intervention|Lost to Follow-up|1
279374|NCT01928381|937458|P3|Part 2 - Second Intervention|Lost to Follow-up|0
279375|NCT01928381|937459|P2|Part 2 - Second Intervention|Lost to Follow-up|1
279376|NCT01928381|937460|P1|Part 2 - Second Intervention|Lost to Follow-up|0
279377|NCT01928381|937454|P7|Washout First Intervention|Protocol Violation|0
279378|NCT01928381|937455|P6|Washout First Intervention|Protocol Violation|0
279379|NCT01928381|937456|P5|Washout First Intervention|Protocol Violation|1
279380|NCT01928381|937457|P4|Washout First Intervention|Protocol Violation|0
279381|NCT01928381|937458|P3|Washout First Intervention|Protocol Violation|0
279382|NCT01928381|937459|P2|Washout First Intervention|Protocol Violation|0
279383|NCT01928381|937460|P1|Washout First Intervention|Protocol Violation|0
279457|NCT01928381|937457|P4|Part 1 - Pain Training|Withdrawal by Subject|0
279384|NCT01928381|937454|P7|Part 2 - First Intervention|Lost to Follow-up|0
279385|NCT01928381|937455|P6|Part 2 - First Intervention|Lost to Follow-up|0
279386|NCT01928381|937456|P5|Part 2 - First Intervention|Lost to Follow-up|0
279387|NCT01928381|937457|P4|Part 2 - First Intervention|Lost to Follow-up|1
279388|NCT01928381|937458|P3|Part 2 - First Intervention|Lost to Follow-up|0
279389|NCT01928381|937459|P2|Part 2 - First Intervention|Lost to Follow-up|0
279390|NCT01928381|937460|P1|Part 2 - First Intervention|Lost to Follow-up|0
279391|NCT01928381|937454|P7|Part 2 - First Intervention|Eligibility criterion not met|1
279392|NCT01928381|937455|P6|Part 2 - First Intervention|Eligibility criterion not met|1
279393|NCT01928381|937456|P5|Part 2 - First Intervention|Eligibility criterion not met|0
279394|NCT01928381|937457|P4|Part 2 - First Intervention|Eligibility criterion not met|0
279395|NCT01928381|937458|P3|Part 2 - First Intervention|Eligibility criterion not met|0
279396|NCT01928381|937459|P2|Part 2 - First Intervention|Eligibility criterion not met|0
279397|NCT01928381|937460|P1|Part 2 - First Intervention|Eligibility criterion not met|0
279398|NCT01928381|937454|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
279399|NCT01928381|937455|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
279400|NCT01928381|937456|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
279401|NCT01928381|937457|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
279402|NCT01928381|937458|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
279403|NCT01928381|937459|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
279404|NCT01928381|937460|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
279405|NCT01928381|937454|P7|Part 2 - First Intervention|Withdrawal by Subject|0
279406|NCT01928381|937455|P6|Part 2 - First Intervention|Withdrawal by Subject|0
279407|NCT01928381|937456|P5|Part 2 - First Intervention|Withdrawal by Subject|0
279408|NCT01928381|937457|P4|Part 2 - First Intervention|Withdrawal by Subject|0
279409|NCT01928381|937458|P3|Part 2 - First Intervention|Withdrawal by Subject|1
279410|NCT01928381|937459|P2|Part 2 - First Intervention|Withdrawal by Subject|0
279411|NCT01928381|937460|P1|Part 2 - First Intervention|Withdrawal by Subject|0
279412|NCT01928381|937454|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
279413|NCT01928381|937455|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
279414|NCT01928381|937456|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
279415|NCT01928381|937457|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
279416|NCT01928381|937458|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
279417|NCT01928381|937459|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
279418|NCT01928381|937460|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
279419|NCT01928381|937454|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
279420|NCT01928381|937455|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
279421|NCT01928381|937456|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
279422|NCT01928381|937457|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
279423|NCT01928381|937458|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
279424|NCT01928381|937459|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
279425|NCT01928381|937460|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
279426|NCT01928381|937454|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
279427|NCT01928381|937455|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
279428|NCT01928381|937456|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
279429|NCT01928381|937457|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
279430|NCT01928381|937458|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
279431|NCT01928381|937459|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
279432|NCT01928381|937460|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
279433|NCT01928381|937454|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
279434|NCT01928381|937455|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
279435|NCT01928381|937456|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
279436|NCT01928381|937457|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
279437|NCT01928381|937458|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
279438|NCT01928381|937459|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
279439|NCT01928381|937460|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
279440|NCT01928381|937454|P7|Part 1 - Pain Training|Protocol Violation|0
279441|NCT01928381|937455|P6|Part 1 - Pain Training|Protocol Violation|0
279442|NCT01928381|937456|P5|Part 1 - Pain Training|Protocol Violation|0
279443|NCT01928381|937457|P4|Part 1 - Pain Training|Protocol Violation|0
279444|NCT01928381|937458|P3|Part 1 - Pain Training|Protocol Violation|0
279445|NCT01928381|937459|P2|Part 1 - Pain Training|Protocol Violation|0
279446|NCT01928381|937460|P1|Part 1 - Pain Training|Protocol Violation|1
279447|NCT01928381|937454|P7|Part 1 - Pain Training|Lost to Follow-up|0
279448|NCT01928381|937455|P6|Part 1 - Pain Training|Lost to Follow-up|0
279449|NCT01928381|937456|P5|Part 1 - Pain Training|Lost to Follow-up|0
279450|NCT01928381|937457|P4|Part 1 - Pain Training|Lost to Follow-up|0
279451|NCT01928381|937458|P3|Part 1 - Pain Training|Lost to Follow-up|0
279452|NCT01928381|937459|P2|Part 1 - Pain Training|Lost to Follow-up|0
279453|NCT01928381|937460|P1|Part 1 - Pain Training|Lost to Follow-up|4
279454|NCT01928381|937454|P7|Part 1 - Pain Training|Withdrawal by Subject|0
279455|NCT01928381|937455|P6|Part 1 - Pain Training|Withdrawal by Subject|0
279456|NCT01928381|937456|P5|Part 1 - Pain Training|Withdrawal by Subject|0
279458|NCT01928381|937458|P3|Part 1 - Pain Training|Withdrawal by Subject|0
279459|NCT01928381|937459|P2|Part 1 - Pain Training|Withdrawal by Subject|0
279460|NCT01928381|937460|P1|Part 1 - Pain Training|Withdrawal by Subject|1
279461|NCT01928381|937454|P7|Part 1 - Pain Training|Pain training criteria not met|0
279462|NCT01928381|937455|P6|Part 1 - Pain Training|Pain training criteria not met|0
279463|NCT01928381|937456|P5|Part 1 - Pain Training|Pain training criteria not met|0
279464|NCT01928381|937457|P4|Part 1 - Pain Training|Pain training criteria not met|0
279465|NCT01928381|937458|P3|Part 1 - Pain Training|Pain training criteria not met|0
279466|NCT01928381|937459|P2|Part 1 - Pain Training|Pain training criteria not met|0
279467|NCT01928381|937460|P1|Part 1 - Pain Training|Pain training criteria not met|29
279468|NCT01928381|937454|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
279469|NCT01928381|937455|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
279470|NCT01928381|937456|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
279471|NCT01928381|937457|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
279472|NCT01928381|937458|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
279473|NCT01928381|937459|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
279474|NCT01928381|937460|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
279475|NCT01928082|937487|P1|Overall Study|Study terminated.|1
279476|NCT01927757|937505|P1|Overall Study|Ethical Reasons|4
279477|NCT01927757|937505|P1|Overall Study|Other|1
279478|NCT01927757|937505|P1|Overall Study|Decision by Sponsor|2
279479|NCT01927757|937505|P1|Overall Study|Lost to Follow-up|2
279480|NCT01927757|937505|P1|Overall Study|Withdrawal by Subject|14
279481|NCT01927419|937533|P2|Overall Study|Not reported|0
279482|NCT01927419|937534|P1|Overall Study|Not reported|1
279483|NCT01927419|937533|P2|Overall Study|Not specified|1
279484|NCT01927419|937534|P1|Overall Study|Not specified|2
279485|NCT01927419|937533|P2|Overall Study|Withdrawal by Subject|1
279486|NCT01927419|937534|P1|Overall Study|Withdrawal by Subject|3
279487|NCT01927419|937533|P2|Overall Study|Adverse event unrelated to study drug|1
279488|NCT01927419|937534|P1|Overall Study|Adverse event unrelated to study drug|6
279489|NCT01927419|937533|P2|Overall Study|Death|1
279490|NCT01927419|937534|P1|Overall Study|Death|0
279491|NCT01927419|937533|P2|Overall Study|Study drug toxicity|7
279492|NCT01927419|937534|P1|Overall Study|Study drug toxicity|43
279493|NCT01927419|937533|P2|Overall Study|Disease progression|17
279494|NCT01927419|937534|P1|Overall Study|Disease progression|15
279495|NCT01927055|937568|P3|Double-Blind|Extended Vacation|0
279496|NCT01927055|937569|P2|Double-Blind|Extended Vacation|1
279497|NCT01927055|937570|P1|Double-Blind|Extended Vacation|0
279498|NCT01927055|937568|P3|Double-Blind|Supine Hypertension|1
279499|NCT01927055|937569|P2|Double-Blind|Supine Hypertension|0
279500|NCT01927055|937570|P1|Double-Blind|Supine Hypertension|0
279501|NCT01927055|937568|P3|Double-Blind|Study Stopped|7
279502|NCT01927055|937569|P2|Double-Blind|Study Stopped|7
279503|NCT01927055|937570|P1|Double-Blind|Study Stopped|0
279504|NCT01927055|937568|P3|Double-Blind|Withdrawal by Subject|3
279505|NCT01927055|937569|P2|Double-Blind|Withdrawal by Subject|2
279506|NCT01927055|937570|P1|Double-Blind|Withdrawal by Subject|0
279507|NCT01927055|937568|P3|Double-Blind|Protocol Violation|1
279508|NCT01927055|937569|P2|Double-Blind|Protocol Violation|0
279509|NCT01927055|937570|P1|Double-Blind|Protocol Violation|0
279510|NCT01927055|937568|P3|Double-Blind|Adverse Event|1
279511|NCT01927055|937569|P2|Double-Blind|Adverse Event|1
279512|NCT01927055|937570|P1|Double-Blind|Adverse Event|0
279513|NCT01927055|937568|P3|Open-label|Difficulty attending study visits|0
279514|NCT01927055|937569|P2|Open-label|Difficulty attending study visits|0
279515|NCT01927055|937570|P1|Open-label|Difficulty attending study visits|1
279516|NCT01927055|937568|P3|Open-label|Supine Hypertension|0
279517|NCT01927055|937569|P2|Open-label|Supine Hypertension|0
279518|NCT01927055|937570|P1|Open-label|Supine Hypertension|4
279519|NCT01927055|937568|P3|Open-label|Study Stopped|0
279520|NCT01927055|937569|P2|Open-label|Study Stopped|0
279521|NCT01927055|937570|P1|Open-label|Study Stopped|4
279522|NCT01927055|937568|P3|Open-label|Withdrawal by Subject|0
279523|NCT01927055|937569|P2|Open-label|Withdrawal by Subject|0
279524|NCT01927055|937570|P1|Open-label|Withdrawal by Subject|1
279525|NCT01927055|937568|P3|Open-label|Adverse Event|0
279526|NCT01927055|937569|P2|Open-label|Adverse Event|0
279527|NCT01927055|937570|P1|Open-label|Adverse Event|6
279528|NCT01926782|937594|P6|Overall Study|Related to study drug administration|2
279529|NCT01926782|937595|P5|Overall Study|Related to study drug administration|0
279530|NCT01926782|937596|P4|Overall Study|Related to study drug administration|0
279531|NCT01926782|937597|P3|Overall Study|Related to study drug administration|0
279532|NCT01926782|937598|P2|Overall Study|Related to study drug administration|0
279533|NCT01926782|937599|P1|Overall Study|Related to study drug administration|0
279534|NCT01926782|937594|P6|Overall Study|Withdrawal by Subject|5
279535|NCT01926782|937595|P5|Overall Study|Withdrawal by Subject|0
279536|NCT01926782|937596|P4|Overall Study|Withdrawal by Subject|1
279537|NCT01926782|937597|P3|Overall Study|Withdrawal by Subject|8
279538|NCT01926782|937598|P2|Overall Study|Withdrawal by Subject|1
279539|NCT01926782|937599|P1|Overall Study|Withdrawal by Subject|6
279540|NCT01926782|937594|P6|Overall Study|Randomized and not treated|0
279541|NCT01926782|937595|P5|Overall Study|Randomized and not treated|0
279542|NCT01926782|937596|P4|Overall Study|Randomized and not treated|1
279543|NCT01926782|937597|P3|Overall Study|Randomized and not treated|0
279544|NCT01926782|937598|P2|Overall Study|Randomized and not treated|0
279545|NCT01926782|937599|P1|Overall Study|Randomized and not treated|0
279546|NCT01926782|937594|P6|Overall Study|Poor compliance to protocol|6
279547|NCT01926782|937595|P5|Overall Study|Poor compliance to protocol|1
279548|NCT01926782|937596|P4|Overall Study|Poor compliance to protocol|0
279549|NCT01926782|937597|P3|Overall Study|Poor compliance to protocol|8
279550|NCT01926782|937598|P2|Overall Study|Poor compliance to protocol|3
279551|NCT01926782|937599|P1|Overall Study|Poor compliance to protocol|5
279552|NCT01926782|937594|P6|Overall Study|Adverse Event|14
279553|NCT01926782|937595|P5|Overall Study|Adverse Event|3
279554|NCT01926782|937596|P4|Overall Study|Adverse Event|4
279555|NCT01926782|937597|P3|Overall Study|Adverse Event|17
279556|NCT01926782|937598|P2|Overall Study|Adverse Event|4
279557|NCT01926782|937599|P1|Overall Study|Adverse Event|13
279558|NCT01926782|937594|P6|Overall Study|Other than specified|11
279559|NCT01926782|937595|P5|Overall Study|Other than specified|4
279560|NCT01926782|937596|P4|Overall Study|Other than specified|12
279561|NCT01926782|937597|P3|Overall Study|Other than specified|5
279562|NCT01926782|937598|P2|Overall Study|Other than specified|3
279563|NCT01926782|937599|P1|Overall Study|Other than specified|2
279564|NCT01926782|937594|P6|Overall Study|Physician Decision|0
279565|NCT01926782|937595|P5|Overall Study|Physician Decision|0
279566|NCT01926782|937596|P4|Overall Study|Physician Decision|1
279567|NCT01926782|937597|P3|Overall Study|Physician Decision|1
279568|NCT01926782|937598|P2|Overall Study|Physician Decision|2
279569|NCT01926782|937599|P1|Overall Study|Physician Decision|0
279570|NCT01926782|937594|P6|Overall Study|Participant moved|3
279571|NCT01926782|937595|P5|Overall Study|Participant moved|0
279572|NCT01926782|937596|P4|Overall Study|Participant moved|1
279573|NCT01926782|937597|P3|Overall Study|Participant moved|1
279574|NCT01926782|937598|P2|Overall Study|Participant moved|0
279575|NCT01926782|937599|P1|Overall Study|Participant moved|2
279576|NCT01926626|937748|P1|Overall Study|Lost to Follow-up|7
279577|NCT01926626|937748|P1|Overall Study|Withdrawal by Subject|15
279578|NCT01926119|937758|P1|Overall Study|Withdrawal by Subject|1
279579|NCT01926028|937771|P3|Overall Study|Non compliance or other reasons|0
279580|NCT01926028|937772|P2|Overall Study|Non compliance or other reasons|2
279581|NCT01926028|937773|P1|Overall Study|Non compliance or other reasons|4
279582|NCT01926028|937771|P3|Overall Study|Withdrawal by Subject|2
279583|NCT01926028|937772|P2|Overall Study|Withdrawal by Subject|9
279584|NCT01926028|937773|P1|Overall Study|Withdrawal by Subject|9
279585|NCT01926028|937771|P3|Overall Study|Physician Decision|0
279586|NCT01926028|937772|P2|Overall Study|Physician Decision|5
279587|NCT01926028|937773|P1|Overall Study|Physician Decision|1
279588|NCT01926028|937771|P3|Overall Study|Lost to Follow-up|0
279589|NCT01926028|937772|P2|Overall Study|Lost to Follow-up|6
279590|NCT01926028|937773|P1|Overall Study|Lost to Follow-up|7
279591|NCT01926015|937809|P2|Overall Study|Randomized not treated|0
279592|NCT01926015|937810|P1|Overall Study|Randomized not treated|2
279593|NCT01926015|937809|P2|Overall Study|Withdrawal by parent/guardian|1
279594|NCT01926015|937810|P1|Overall Study|Withdrawal by parent/guardian|0
279595|NCT01925768|937853|P2|Overall Study|Non-compliance with study drug|1
279596|NCT01925768|937854|P1|Overall Study|Non-compliance with study drug|0
279597|NCT01925768|937853|P2|Overall Study|Withdrawal by Subject|4
279598|NCT01925768|937854|P1|Overall Study|Withdrawal by Subject|1
279599|NCT01925768|937853|P2|Overall Study|Lack of Efficacy|6
279600|NCT01925768|937854|P1|Overall Study|Lack of Efficacy|3
279601|NCT01925768|937853|P2|Overall Study|Adverse Event|10
279602|NCT01925768|937854|P1|Overall Study|Adverse Event|5
279603|NCT01925768|937853|P2|Overall Study|Protocol Violation|2
279604|NCT01925768|937854|P1|Overall Study|Protocol Violation|1
279605|NCT01925768|937853|P2|Overall Study|Lost to Follow-up|0
279606|NCT01925768|937854|P1|Overall Study|Lost to Follow-up|1
279607|NCT01925703|937862|P1|Overall Study|Discharge prior to full iron repletion|1
279608|NCT01925703|937862|P1|Overall Study|Lost to Follow-up|2
279609|NCT01925703|937862|P1|Overall Study|Physician Decision|1
279610|NCT01925612|937873|P5|Overall Study|Adverse Event|2
279611|NCT01925612|937874|P4|Overall Study|Adverse Event|1
279612|NCT01925612|937875|P3|Overall Study|Adverse Event|0
279613|NCT01925612|937876|P2|Overall Study|Adverse Event|3
279614|NCT01925612|937877|P1|Overall Study|Adverse Event|3
279615|NCT01925612|937873|P5|Overall Study|Progressive Disease|0
279616|NCT01925612|937874|P4|Overall Study|Progressive Disease|0
279617|NCT01925612|937875|P3|Overall Study|Progressive Disease|1
279618|NCT01925612|937876|P2|Overall Study|Progressive Disease|1
279619|NCT01925612|937877|P1|Overall Study|Progressive Disease|1
279620|NCT01925417|937927|P1|Overall Study|Death|1
279621|NCT01925417|937927|P1|Overall Study|Withdrawal by Subject|2
279622|NCT01925274|937958|P3|Overall Study|Protocol amendment|6
279623|NCT01925274|937959|P2|Overall Study|Protocol amendment|3
279624|NCT01925274|937960|P1|Overall Study|Protocol amendment|1
279625|NCT01925274|937958|P3|Overall Study|Study terminated by sponsor|0
279626|NCT01925274|937959|P2|Overall Study|Study terminated by sponsor|0
279627|NCT01925274|937960|P1|Overall Study|Study terminated by sponsor|4
279628|NCT01925274|937958|P3|Overall Study|Withdrawal by Subject|0
279629|NCT01925274|937959|P2|Overall Study|Withdrawal by Subject|2
279630|NCT01925274|937960|P1|Overall Study|Withdrawal by Subject|1
279631|NCT01925274|937958|P3|Overall Study|Lost to Follow-up|0
279632|NCT01925274|937959|P2|Overall Study|Lost to Follow-up|1
279633|NCT01925274|937960|P1|Overall Study|Lost to Follow-up|0
279634|NCT01925274|937958|P3|Overall Study|Death|0
279635|NCT01925274|937959|P2|Overall Study|Death|0
279636|NCT01925274|937960|P1|Overall Study|Death|1
279637|NCT01925209|938041|P4|Follow-up|Withdrawal by Subject|2
279638|NCT01925209|938042|P3|Follow-up|Withdrawal by Subject|0
279639|NCT01925209|938043|P2|Follow-up|Withdrawal by Subject|2
279640|NCT01925209|938044|P1|Follow-up|Withdrawal by Subject|0
279641|NCT01925209|938041|P4|Follow-up|Non-compliance with study treatment|1
279642|NCT01925209|938042|P3|Follow-up|Non-compliance with study treatment|0
279643|NCT01925209|938043|P2|Follow-up|Non-compliance with study treatment|0
279644|NCT01925209|938044|P1|Follow-up|Non-compliance with study treatment|0
279645|NCT01925209|938041|P4|Follow-up|Physician Decision|0
279646|NCT01925209|938042|P3|Follow-up|Physician Decision|1
279647|NCT01925209|938043|P2|Follow-up|Physician Decision|0
279648|NCT01925209|938044|P1|Follow-up|Physician Decision|0
279649|NCT01925209|938041|P4|Follow-up|Adverse Event|1
279650|NCT01925209|938042|P3|Follow-up|Adverse Event|0
279651|NCT01925209|938043|P2|Follow-up|Adverse Event|4
279652|NCT01925209|938044|P1|Follow-up|Adverse Event|1
279653|NCT01925209|938041|P4|Maintenance Treatment Epoch|Adverse Event|0
279654|NCT01925209|938042|P3|Maintenance Treatment Epoch|Adverse Event|1
279655|NCT01925209|938043|P2|Maintenance Treatment Epoch|Adverse Event|0
279656|NCT01925209|938044|P1|Maintenance Treatment Epoch|Adverse Event|0
279657|NCT01925209|938041|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
279658|NCT01925209|938042|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
279659|NCT01925209|938043|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
279660|NCT01925209|938044|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
279661|NCT01925209|938041|P4|Treatment Epoch|Adverse Event|1
279662|NCT01925209|938042|P3|Treatment Epoch|Adverse Event|3
279663|NCT01925209|938043|P2|Treatment Epoch|Adverse Event|5
279664|NCT01925209|938044|P1|Treatment Epoch|Adverse Event|3
279665|NCT01925209|938041|P4|Treatment Epoch|Withdrawal by Subject|2
279666|NCT01925209|938042|P3|Treatment Epoch|Withdrawal by Subject|3
279667|NCT01925209|938043|P2|Treatment Epoch|Withdrawal by Subject|3
279668|NCT01925209|938044|P1|Treatment Epoch|Withdrawal by Subject|4
279669|NCT01925209|938041|P4|Treatment Epoch|Protocol deviation|1
279670|NCT01925209|938042|P3|Treatment Epoch|Protocol deviation|1
279671|NCT01925209|938043|P2|Treatment Epoch|Protocol deviation|0
279672|NCT01925209|938044|P1|Treatment Epoch|Protocol deviation|0
279673|NCT01925209|938041|P4|Treatment Epoch|Death|0
279674|NCT01925209|938042|P3|Treatment Epoch|Death|0
279675|NCT01925209|938043|P2|Treatment Epoch|Death|0
279676|NCT01925209|938044|P1|Treatment Epoch|Death|1
279677|NCT01925209|938041|P4|Treatment Epoch|Non-compliance with study treatment|1
279678|NCT01925209|938042|P3|Treatment Epoch|Non-compliance with study treatment|0
279679|NCT01925209|938043|P2|Treatment Epoch|Non-compliance with study treatment|0
279680|NCT01925209|938044|P1|Treatment Epoch|Non-compliance with study treatment|0
279681|NCT01925209|938041|P4|Treatment Epoch|Physician Decision|0
279682|NCT01925209|938042|P3|Treatment Epoch|Physician Decision|0
279683|NCT01925209|938043|P2|Treatment Epoch|Physician Decision|0
279684|NCT01925209|938044|P1|Treatment Epoch|Physician Decision|1
279685|NCT01925183|938076|P2|Overall Study|Adverse Event|0
279686|NCT01925183|938077|P1|Overall Study|Adverse Event|1
279687|NCT01925170|938085|P1|Overall Study|Unverified cancer status|53
279688|NCT01924845|938145|P1|Overall Study|Protocol Violation|1
279689|NCT01924845|938145|P1|Overall Study|Withdrawal by Subject|2
279690|NCT01924845|938145|P1|Overall Study|Adverse Event|3
279691|NCT01924767|938158|P5|Overall Study|Adverse Event|0
279692|NCT01924767|938159|P4|Overall Study|Adverse Event|0
279693|NCT01924767|938160|P3|Overall Study|Adverse Event|1
279694|NCT01924767|938161|P2|Overall Study|Adverse Event|0
279695|NCT01924767|938162|P1|Overall Study|Adverse Event|1
279696|NCT01924429|938278|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
279697|NCT01924429|938279|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
279698|NCT01924364|938322|P1|Overall Study|Physician Decision|3
279699|NCT01924299|938339|P2|Period 2|Adverse Event|1
279700|NCT01924299|938340|P1|Period 2|Adverse Event|0
279701|NCT01924299|938339|P2|Period 2|Withdrawal by Subject|0
279702|NCT01924299|938340|P1|Period 2|Withdrawal by Subject|1
279703|NCT01924182|938362|P2|Overall Study|Withdrawal by Subject|0
279704|NCT01924182|938363|P1|Overall Study|Withdrawal by Subject|1
279705|NCT01923896|938382|P2|Overall Study|Adverse Event|0
279706|NCT01923896|938383|P1|Overall Study|Adverse Event|1
279707|NCT01923740|938406|P2|3 Year Clinical Follow-up|Death|0
279708|NCT01923740|938407|P1|3 Year Clinical Follow-up|Death|1
279709|NCT01923740|938406|P2|2 Year Clinical Follow-up|ICF withdrawal|0
279710|NCT01923740|938407|P1|2 Year Clinical Follow-up|ICF withdrawal|1
279711|NCT01923740|938406|P2|2 Year Clinical Follow-up|Lost to Follow-up|2
279712|NCT01923740|938407|P1|2 Year Clinical Follow-up|Lost to Follow-up|0
279713|NCT01923740|938406|P2|2 Year Clinical Follow-up|Death|1
279714|NCT01923740|938407|P1|2 Year Clinical Follow-up|Death|1
279715|NCT01923740|938406|P2|1 Year Clinical Follow-up|Lost to Follow-up|0
279716|NCT01923740|938407|P1|1 Year Clinical Follow-up|Lost to Follow-up|1
279717|NCT01923740|938406|P2|270-day Clinical Follow-up|Death|4
279718|NCT01923740|938407|P1|270-day Clinical Follow-up|Death|0
279719|NCT01923467|938828|P1|Overall Study|Subject non-interest|479
279720|NCT01923467|938828|P1|Overall Study|Lost to Follow-up|62
279721|NCT01923389|938834|P2|Overall Study|Protocol Violation|0
279722|NCT01923389|938835|P1|Overall Study|Protocol Violation|1
279723|NCT01922934|938872|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
279724|NCT01922934|938873|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
279725|NCT01922934|938872|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
279726|NCT01922934|938873|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
279727|NCT01922934|938872|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
279728|NCT01922934|938873|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
279729|NCT01922934|938872|P2|Eligible Patients|Did not meet inclusion criteria|81
279730|NCT01922934|938873|P1|Eligible Patients|Did not meet inclusion criteria|36
279731|NCT01922934|938872|P2|Eligible Patients|Physician Decision|0
279732|NCT01922934|938873|P1|Eligible Patients|Physician Decision|17
279733|NCT01922934|938872|P2|Eligible Patients|Death|7
279734|NCT01922934|938873|P1|Eligible Patients|Death|0
279735|NCT01922739|938885|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
279736|NCT01922739|938885|P1|Open-label Treatment Period|Physician Decision|1
279737|NCT01922739|938885|P1|Open-label Treatment Period|Lost to Follow-up|2
279738|NCT01922739|938885|P1|Open-label Treatment Period|Noncompliance to study procedures|1
279739|NCT01922739|938885|P1|Open-label Treatment Period|Pregnancy|1
279740|NCT01922739|938885|P1|Open-label Treatment Period|Protocol Violation|5
279741|NCT01922739|938885|P1|Open-label Treatment Period|Noncompliance to study medication|3
279742|NCT01922739|938885|P1|Open-label Treatment Period|Withdrawal by Subject|14
279743|NCT01922739|938885|P1|Open-label Treatment Period|Adverse Event|6
279744|NCT01922739|938885|P1|Titration/Adjustment Period|Lack of Efficacy|3
279745|NCT01922739|938885|P1|Titration/Adjustment Period|Lost to Follow-up|1
279746|NCT01922739|938885|P1|Titration/Adjustment Period|Withdrawal by Subject|5
279747|NCT01922739|938885|P1|Titration/Adjustment Period|Adverse Event|3
279748|NCT01922349|938914|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
279749|NCT01922349|938915|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
279750|NCT01922349|938916|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
279751|NCT01922349|938917|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
279752|NCT01922271|939024|P2|WASHOUT Period|Withdrawal by Subject|0
279753|NCT01922271|939025|P1|WASHOUT Period|Withdrawal by Subject|1
279754|NCT01922089|939066|P2|Overall Study|Lost to Follow-up|1
279755|NCT01922089|939067|P1|Overall Study|Lost to Follow-up|0
279756|NCT01922089|939066|P2|Overall Study|Death|1
279757|NCT01922089|939067|P1|Overall Study|Death|2
279758|NCT01922089|939066|P2|Overall Study|Physician Decision|3
279759|NCT01922089|939067|P1|Overall Study|Physician Decision|2
279760|NCT01922089|939066|P2|Overall Study|administrative problems|1
279761|NCT01922089|939067|P1|Overall Study|administrative problems|4
279762|NCT01922089|939066|P2|Overall Study|Withdrawal by Subject|4
279763|NCT01922089|939067|P1|Overall Study|Withdrawal by Subject|3
279764|NCT01922089|939066|P2|Overall Study|Protocol Deviation|7
279765|NCT01922089|939067|P1|Overall Study|Protocol Deviation|10
279766|NCT01922089|939066|P2|Overall Study|Adverse Event|13
279767|NCT01922089|939067|P1|Overall Study|Adverse Event|18
279768|NCT01922037|939079|P2|Overall Study|Other unspecified|66
279769|NCT01922037|939080|P1|Overall Study|Other unspecified|2
279770|NCT01922037|939079|P2|Overall Study|Investigator/Sponsor decision|4
279771|NCT01922037|939080|P1|Overall Study|Investigator/Sponsor decision|1
279772|NCT01922037|939079|P2|Overall Study|Participant non-compliance|46
279773|NCT01922037|939080|P1|Overall Study|Participant non-compliance|4
279774|NCT01922037|939079|P2|Overall Study|Pregnancy|2
279775|NCT01922037|939080|P1|Overall Study|Pregnancy|0
279776|NCT01922037|939079|P2|Overall Study|Death|5
279777|NCT01922037|939080|P1|Overall Study|Death|0
279778|NCT01922037|939079|P2|Overall Study|Adverse Event|7
279779|NCT01922037|939080|P1|Overall Study|Adverse Event|1
279780|NCT01922037|939079|P2|Overall Study|Withdrawal by Subject|44
279781|NCT01922037|939080|P1|Overall Study|Withdrawal by Subject|2
279782|NCT01922011|939174|P2|Overall Study|Randomized in error|0
279783|NCT01922011|939175|P1|Overall Study|Randomized in error|1
279784|NCT01922011|939174|P2|Overall Study|Lack of willing home health agency|0
279785|NCT01922011|939175|P1|Overall Study|Lack of willing home health agency|1
279786|NCT01922011|939174|P2|Overall Study|Not Treated|0
279787|NCT01922011|939175|P1|Overall Study|Not Treated|1
279788|NCT01922011|939174|P2|Overall Study|Missed Test-of-Cure Visit|2
279789|NCT01922011|939175|P1|Overall Study|Missed Test-of-Cure Visit|0
279790|NCT01922011|939174|P2|Overall Study|Lost to Follow-up|1
279791|NCT01922011|939175|P1|Overall Study|Lost to Follow-up|0
279792|NCT01922011|939174|P2|Overall Study|Parent/Guardian Decision|0
279793|NCT01922011|939175|P1|Overall Study|Parent/Guardian Decision|3
279794|NCT01922011|939174|P2|Overall Study|Physician Decision|1
279795|NCT01922011|939175|P1|Overall Study|Physician Decision|0
279796|NCT01922011|939174|P2|Overall Study|Protocol Violation|1
279797|NCT01922011|939175|P1|Overall Study|Protocol Violation|0
279798|NCT01921829|939242|P2|Overall Study|Withdrawal by Subject|1
279799|NCT01921829|939243|P1|Overall Study|Withdrawal by Subject|0
279800|NCT01921348|939319|P2|Overall Study|Lost to Follow-up|2
279801|NCT01921348|939320|P1|Overall Study|Lost to Follow-up|0
279802|NCT01921348|939319|P2|Overall Study|Withdrawal by Subject|0
279803|NCT01921348|939320|P1|Overall Study|Withdrawal by Subject|1
279804|NCT01921270|939349|P1|Overall Study|Withdrawal by Subject|1
279805|NCT01921257|939365|P1|Overall Study|Withdrawal by Subject|1
279806|NCT01921257|939365|P1|Overall Study|Protocol Violation|1
279807|NCT01921257|939365|P1|Overall Study|Adverse Event|1
279808|NCT01921205|939372|P2|Overall Study|Non Compliance Of Child|1
279809|NCT01921205|939373|P1|Overall Study|Non Compliance Of Child|0
279810|NCT01921205|939372|P2|Overall Study|Non Compliance Of The Parent|1
279811|NCT01921205|939373|P1|Overall Study|Non Compliance Of The Parent|0
279812|NCT01921205|939372|P2|Overall Study|The Excessive Use Of Rescue Medication|1
279813|NCT01921205|939373|P1|Overall Study|The Excessive Use Of Rescue Medication|0
279814|NCT01921205|939372|P2|Overall Study|Use Of Prohibited Medication|1
279815|NCT01921205|939373|P1|Overall Study|Use Of Prohibited Medication|0
279816|NCT01921205|939372|P2|Overall Study|Withdrawal by Subject|5
279817|NCT01921205|939373|P1|Overall Study|Withdrawal by Subject|6
279818|NCT01921205|939372|P2|Overall Study|Lost to Follow-up|1
279819|NCT01921205|939373|P1|Overall Study|Lost to Follow-up|1
279820|NCT01921205|939372|P2|Overall Study|Protocol Violation|3
279821|NCT01921205|939373|P1|Overall Study|Protocol Violation|1
279822|NCT01921205|939372|P2|Overall Study|Lack of Efficacy|0
279823|NCT01921205|939373|P1|Overall Study|Lack of Efficacy|1
279824|NCT01921205|939372|P2|Overall Study|Adverse Event|7
279825|NCT01921205|939373|P1|Overall Study|Adverse Event|12
279826|NCT01921101|939414|P2|Overall Study|Death|6
279827|NCT01921101|939415|P1|Overall Study|Death|16
279828|NCT01920958|939423|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
279829|NCT01920893|939441|P2|Overall Study|Lack of Efficacy|0
279830|NCT01920893|939442|P1|Overall Study|Lack of Efficacy|2
279831|NCT01920893|939441|P2|Overall Study|Adverse Event|2
279832|NCT01920893|939442|P1|Overall Study|Adverse Event|5
279833|NCT01920854|939475|P7|Overall Study|Withdrawal by Subject|1
279834|NCT01920854|939476|P6|Overall Study|Withdrawal by Subject|0
279835|NCT01920854|939477|P5|Overall Study|Withdrawal by Subject|1
279836|NCT01920854|939478|P4|Overall Study|Withdrawal by Subject|0
279837|NCT01920854|939479|P3|Overall Study|Withdrawal by Subject|0
279838|NCT01920854|939480|P2|Overall Study|Withdrawal by Subject|0
279839|NCT01920854|939481|P1|Overall Study|Withdrawal by Subject|1
279840|NCT01920594|939641|P2|Overall Study|Investigator discretion|1
279841|NCT01920594|939642|P1|Overall Study|Investigator discretion|0
279842|NCT01920594|939641|P2|Overall Study|Recovery|0
279843|NCT01920594|939642|P1|Overall Study|Recovery|2
279844|NCT01920594|939641|P2|Overall Study|Lost to Follow-up|0
279845|NCT01920594|939642|P1|Overall Study|Lost to Follow-up|1
279846|NCT01920594|939641|P2|Overall Study|Adverse Event|2
279847|NCT01920594|939642|P1|Overall Study|Adverse Event|4
279848|NCT01920568|939692|P2|Overall Study|Death due to disease progression|12
279849|NCT01920568|939693|P1|Overall Study|Death due to disease progression|25
279850|NCT01920568|939692|P2|Overall Study|Withdrawal by Subject|55
279851|NCT01920568|939693|P1|Overall Study|Withdrawal by Subject|79
279852|NCT01920568|939692|P2|Overall Study|Physician Decision|4
279853|NCT01920568|939693|P1|Overall Study|Physician Decision|13
279854|NCT01920568|939692|P2|Overall Study|Lost to Follow-up|2
279855|NCT01920568|939693|P1|Overall Study|Lost to Follow-up|2
279856|NCT01920568|939692|P2|Overall Study|Protocol Violation|3
279857|NCT01920568|939693|P1|Overall Study|Protocol Violation|5
279858|NCT01920568|939692|P2|Overall Study|Adverse Event|8
279859|NCT01920568|939693|P1|Overall Study|Adverse Event|27
279860|NCT01920555|939719|P5|Overall Study|Lost to Follow-up|0
279861|NCT01920555|939720|P4|Overall Study|Lost to Follow-up|1
279862|NCT01920555|939721|P3|Overall Study|Lost to Follow-up|0
279863|NCT01920555|939722|P2|Overall Study|Lost to Follow-up|1
279864|NCT01920555|939723|P1|Overall Study|Lost to Follow-up|0
279865|NCT01920555|939719|P5|Overall Study|Travel Difficulties|1
279866|NCT01920555|939720|P4|Overall Study|Travel Difficulties|0
279867|NCT01920555|939721|P3|Overall Study|Travel Difficulties|0
279868|NCT01920555|939722|P2|Overall Study|Travel Difficulties|1
279869|NCT01920555|939723|P1|Overall Study|Travel Difficulties|1
279870|NCT01920555|939719|P5|Overall Study|Lack of Efficacy|0
279871|NCT01920555|939720|P4|Overall Study|Lack of Efficacy|0
279872|NCT01920555|939721|P3|Overall Study|Lack of Efficacy|0
279873|NCT01920555|939722|P2|Overall Study|Lack of Efficacy|0
279874|NCT01920555|939723|P1|Overall Study|Lack of Efficacy|2
279875|NCT01920555|939719|P5|Overall Study|Physician Decision|0
279876|NCT01920555|939720|P4|Overall Study|Physician Decision|2
279877|NCT01920555|939721|P3|Overall Study|Physician Decision|1
279878|NCT01920555|939722|P2|Overall Study|Physician Decision|2
279879|NCT01920555|939723|P1|Overall Study|Physician Decision|1
279880|NCT01920178|939798|P2|Overall Study|Lost to Follow-up|1
279881|NCT01920178|939799|P1|Overall Study|Lost to Follow-up|2
279882|NCT01919801|939817|P2|Overall Study|Other|1
279883|NCT01919801|939818|P1|Overall Study|Other|0
279884|NCT01919801|939817|P2|Overall Study|Lost to Follow-up|1
279885|NCT01919801|939818|P1|Overall Study|Lost to Follow-up|0
279886|NCT01919801|939817|P2|Overall Study|Physician Decision|1
279887|NCT01919801|939818|P1|Overall Study|Physician Decision|0
279888|NCT01919801|939817|P2|Overall Study|Withdrawal by Subject|0
279889|NCT01919801|939818|P1|Overall Study|Withdrawal by Subject|1
279890|NCT01919723|939843|P2|Overall Study|Blood Samples Hemolyzed|2
279891|NCT01919723|939844|P1|Overall Study|Blood Samples Hemolyzed|2
279892|NCT01919307|939884|P1|Overall Study|Withdrawal by Subject|9
279893|NCT01919229|939894|P3|Overall Study|Subject/guardian decision|1
279894|NCT01919229|939895|P2|Overall Study|Subject/guardian decision|0
279895|NCT01919229|939896|P1|Overall Study|Subject/guardian decision|0
279896|NCT01918371|939961|P2|Overall Study|Missing Data|1
279897|NCT01918371|939962|P1|Overall Study|Missing Data|1
279898|NCT01918332|940040|P4|Overall Study|lipid result by central lab did not meet|0
279899|NCT01918332|940041|P3|Overall Study|lipid result by central lab did not meet|1
279900|NCT01918332|940042|P2|Overall Study|lipid result by central lab did not meet|0
279901|NCT01918332|940043|P1|Overall Study|lipid result by central lab did not meet|0
279902|NCT01918332|940040|P4|Overall Study|Protocol Violation|3
279903|NCT01918332|940041|P3|Overall Study|Protocol Violation|6
279904|NCT01918332|940042|P2|Overall Study|Protocol Violation|2
279905|NCT01918332|940043|P1|Overall Study|Protocol Violation|6
279906|NCT01918332|940040|P4|Overall Study|Withdrawal by Subject|3
279907|NCT01918332|940041|P3|Overall Study|Withdrawal by Subject|2
279908|NCT01918332|940042|P2|Overall Study|Withdrawal by Subject|3
279909|NCT01918332|940043|P1|Overall Study|Withdrawal by Subject|2
279910|NCT01918332|940040|P4|Overall Study|Adverse Event|1
279911|NCT01918332|940041|P3|Overall Study|Adverse Event|0
279912|NCT01918332|940042|P2|Overall Study|Adverse Event|0
279913|NCT01918332|940043|P1|Overall Study|Adverse Event|0
279914|NCT01918306|940055|P4|Overall Study|progress disease, crossover|0
279915|NCT01918306|940056|P3|Overall Study|progress disease, crossover|1
279916|NCT01918306|940057|P2|Overall Study|progress disease, crossover|0
279917|NCT01918306|940058|P1|Overall Study|progress disease, crossover|0
279918|NCT01918306|940055|P4|Overall Study|Lack of Efficacy|0
279919|NCT01918306|940056|P3|Overall Study|Lack of Efficacy|0
279920|NCT01918306|940057|P2|Overall Study|Lack of Efficacy|0
279921|NCT01918306|940058|P1|Overall Study|Lack of Efficacy|1
279922|NCT01918306|940055|P4|Overall Study|neutropenia|0
279923|NCT01918306|940056|P3|Overall Study|neutropenia|0
279924|NCT01918306|940057|P2|Overall Study|neutropenia|0
279925|NCT01918306|940058|P1|Overall Study|neutropenia|1
279926|NCT01918306|940055|P4|Overall Study|Withdrawal by Subject|2
279927|NCT01918306|940056|P3|Overall Study|Withdrawal by Subject|0
279928|NCT01918306|940057|P2|Overall Study|Withdrawal by Subject|0
279929|NCT01918306|940058|P1|Overall Study|Withdrawal by Subject|0
279930|NCT01918306|940055|P4|Overall Study|progresive disease|1
279931|NCT01918306|940056|P3|Overall Study|progresive disease|1
279932|NCT01918306|940057|P2|Overall Study|progresive disease|0
279933|NCT01918306|940058|P1|Overall Study|progresive disease|4
279934|NCT01918085|940080|P2|Test Period 1: Strata Strip|Adverse Event|1
279935|NCT01918085|940081|P1|Test Period 1: Strata Strip|Adverse Event|0
279936|NCT01918033|940092|P3|Overall Study|Withdrawal by Subject|0
279937|NCT01918033|940093|P2|Overall Study|Withdrawal by Subject|1
279938|NCT01918033|940094|P1|Overall Study|Withdrawal by Subject|2
279939|NCT01918033|940092|P3|Overall Study|Protocol Violation|1
279940|NCT01918033|940093|P2|Overall Study|Protocol Violation|0
279941|NCT01918033|940094|P1|Overall Study|Protocol Violation|2
279942|NCT01918033|940092|P3|Overall Study|Lost to Follow-up|0
279943|NCT01918033|940093|P2|Overall Study|Lost to Follow-up|1
279944|NCT01918033|940094|P1|Overall Study|Lost to Follow-up|0
279945|NCT01918033|940092|P3|Overall Study|Adverse Event|2
279946|NCT01918033|940093|P2|Overall Study|Adverse Event|0
279947|NCT01918033|940094|P1|Overall Study|Adverse Event|1
279948|NCT01917656|940165|P2|Overall Study|Lost to Follow-up|4
279949|NCT01917656|940166|P1|Overall Study|Lost to Follow-up|3
279950|NCT01917656|940165|P2|Overall Study|Withdrawal by Subject|3
279951|NCT01917656|940166|P1|Overall Study|Withdrawal by Subject|4
279952|NCT01917656|940165|P2|Overall Study|Unclassified|3
279953|NCT01917656|940166|P1|Overall Study|Unclassified|0
279954|NCT01917656|940165|P2|Overall Study|Withdrawal criteria|14
279955|NCT01917656|940166|P1|Overall Study|Withdrawal criteria|8
279956|NCT01917656|940165|P2|Overall Study|Adverse Event|0
279957|NCT01917656|940166|P1|Overall Study|Adverse Event|11
279958|NCT01917526|940192|P2|Overall Study|Protocol Violation|1
279959|NCT01917526|940193|P1|Overall Study|Protocol Violation|1
279960|NCT01917344|940210|P1|Overall Study|Withdrawal by Subject|1
279961|NCT01916980|940225|P2|Overall Study|Withdrawal by Subject|0
279962|NCT01916980|940226|P1|Overall Study|Withdrawal by Subject|1
279963|NCT01916980|940225|P2|Overall Study|Lack of Efficacy|2
279964|NCT01916980|940226|P1|Overall Study|Lack of Efficacy|2
279965|NCT01916980|940225|P2|Overall Study|Adverse Event|2
279966|NCT01916980|940226|P1|Overall Study|Adverse Event|4
279967|NCT01916967|940245|P3|Overall Study|Protocol Violation|0
279968|NCT01916967|940246|P2|Overall Study|Protocol Violation|1
279969|NCT01916967|940247|P1|Overall Study|Protocol Violation|0
279970|NCT01916967|940245|P3|Overall Study|Physician Decision|1
279971|NCT01916967|940246|P2|Overall Study|Physician Decision|0
279972|NCT01916967|940247|P1|Overall Study|Physician Decision|0
279973|NCT01916967|940245|P3|Overall Study|Lack of Efficacy|6
279974|NCT01916967|940246|P2|Overall Study|Lack of Efficacy|0
279975|NCT01916967|940247|P1|Overall Study|Lack of Efficacy|0
279976|NCT01916967|940245|P3|Overall Study|Adverse Event|2
279977|NCT01916967|940246|P2|Overall Study|Adverse Event|0
279978|NCT01916967|940247|P1|Overall Study|Adverse Event|0
279979|NCT01916824|940303|P2|Overall Study|Withdrawal by Subject|3
279980|NCT01916824|940304|P1|Overall Study|Withdrawal by Subject|2
279981|NCT01916824|940303|P2|Overall Study|Physician Decision|0
279982|NCT01916824|940304|P1|Overall Study|Physician Decision|2
279983|NCT01916824|940303|P2|Overall Study|Lost to Follow-up|6
279984|NCT01916824|940304|P1|Overall Study|Lost to Follow-up|3
279985|NCT01916304|940373|P1|Overall Study|Screening failure|17
279986|NCT01916226|940385|P4|Overall Study|Physician Decision|1
279987|NCT01916226|940386|P3|Overall Study|Physician Decision|0
279988|NCT01916226|940387|P2|Overall Study|Physician Decision|0
279989|NCT01916226|940388|P1|Overall Study|Physician Decision|0
279990|NCT01916226|940385|P4|Overall Study|Protocol Violation|1
279991|NCT01916226|940386|P3|Overall Study|Protocol Violation|0
279992|NCT01916226|940387|P2|Overall Study|Protocol Violation|1
279993|NCT01916226|940388|P1|Overall Study|Protocol Violation|0
279994|NCT01916226|940385|P4|Overall Study|Lack of Efficacy|1
279995|NCT01916226|940386|P3|Overall Study|Lack of Efficacy|2
279996|NCT01916226|940387|P2|Overall Study|Lack of Efficacy|0
279997|NCT01916226|940388|P1|Overall Study|Lack of Efficacy|0
279998|NCT01916226|940385|P4|Overall Study|Adverse Event|1
279999|NCT01916226|940386|P3|Overall Study|Adverse Event|1
280000|NCT01916226|940387|P2|Overall Study|Adverse Event|0
280001|NCT01916226|940388|P1|Overall Study|Adverse Event|1
280002|NCT01916109|940422|P1|Overall Study|Withdrawal by Subject|1
280003|NCT01915940|940428|P3|Treatment Period|Other Miscellaneous Reasons|0
280004|NCT01915940|940429|P2|Treatment Period|Other Miscellaneous Reasons|1
280005|NCT01915940|940430|P1|Treatment Period|Other Miscellaneous Reasons|0
280006|NCT01915940|940428|P3|Treatment Period|Adverse Event|1
280007|NCT01915940|940429|P2|Treatment Period|Adverse Event|9
280008|NCT01915940|940430|P1|Treatment Period|Adverse Event|0
280009|NCT01915940|940428|P3|Treatment Period|Decision of Participant|3
280010|NCT01915940|940429|P2|Treatment Period|Decision of Participant|1
280011|NCT01915940|940430|P1|Treatment Period|Decision of Participant|0
280012|NCT01915940|940428|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
280013|NCT01915940|940429|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
280014|NCT01915940|940430|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
280015|NCT01915914|940446|P4|Follow-up Phase|Physician Decision|1
280016|NCT01915914|940447|P3|Follow-up Phase|Physician Decision|0
280017|NCT01915914|940448|P2|Follow-up Phase|Physician Decision|0
280018|NCT01915914|940449|P1|Follow-up Phase|Physician Decision|0
280019|NCT01915914|940446|P4|Follow-up Phase|Withdrawal by Subject|1
280020|NCT01915914|940447|P3|Follow-up Phase|Withdrawal by Subject|0
280021|NCT01915914|940448|P2|Follow-up Phase|Withdrawal by Subject|0
280022|NCT01915914|940449|P1|Follow-up Phase|Withdrawal by Subject|0
280023|NCT01915914|940446|P4|Maintenance Phase|Missing|0
280024|NCT01915914|940447|P3|Maintenance Phase|Missing|0
280025|NCT01915914|940448|P2|Maintenance Phase|Missing|1
280026|NCT01915914|940449|P1|Maintenance Phase|Missing|0
280027|NCT01915914|940446|P4|Maintenance Phase|Lost to Follow-up|0
280028|NCT01915914|940447|P3|Maintenance Phase|Lost to Follow-up|1
280029|NCT01915914|940448|P2|Maintenance Phase|Lost to Follow-up|4
280030|NCT01915914|940449|P1|Maintenance Phase|Lost to Follow-up|0
280031|NCT01915914|940446|P4|Maintenance Phase|Withdrawal by Subject|0
280032|NCT01915914|940447|P3|Maintenance Phase|Withdrawal by Subject|1
280033|NCT01915914|940448|P2|Maintenance Phase|Withdrawal by Subject|1
280034|NCT01915914|940449|P1|Maintenance Phase|Withdrawal by Subject|0
280035|NCT01915914|940446|P4|Acute Phase|Missing|0
280036|NCT01915914|940447|P3|Acute Phase|Missing|0
280037|NCT01915914|940448|P2|Acute Phase|Missing|0
280038|NCT01915914|940449|P1|Acute Phase|Missing|1
280039|NCT01915914|940446|P4|Acute Phase|"Not Achieved treatment success"|0
280040|NCT01915914|940447|P3|Acute Phase|"Not Achieved treatment success"|0
280041|NCT01915914|940448|P2|Acute Phase|"Not Achieved treatment success"|0
280042|NCT01915914|940449|P1|Acute Phase|"Not Achieved treatment success"|1
280043|NCT01915914|940446|P4|Acute Phase|Accepted Other Topic Therapies|0
280044|NCT01915914|940447|P3|Acute Phase|Accepted Other Topic Therapies|0
280045|NCT01915914|940448|P2|Acute Phase|Accepted Other Topic Therapies|0
280046|NCT01915914|940449|P1|Acute Phase|Accepted Other Topic Therapies|1
280047|NCT01915914|940446|P4|Acute Phase|Physician Decision|0
280048|NCT01915914|940447|P3|Acute Phase|Physician Decision|0
280049|NCT01915914|940448|P2|Acute Phase|Physician Decision|0
280050|NCT01915914|940449|P1|Acute Phase|Physician Decision|1
280051|NCT01915914|940446|P4|Acute Phase|Lost to Follow-up|0
280052|NCT01915914|940447|P3|Acute Phase|Lost to Follow-up|0
280053|NCT01915914|940448|P2|Acute Phase|Lost to Follow-up|0
280054|NCT01915914|940449|P1|Acute Phase|Lost to Follow-up|4
280055|NCT01915914|940446|P4|Acute Phase|Withdrawal by Subject|0
280056|NCT01915914|940447|P3|Acute Phase|Withdrawal by Subject|0
280057|NCT01915914|940448|P2|Acute Phase|Withdrawal by Subject|0
280058|NCT01915914|940449|P1|Acute Phase|Withdrawal by Subject|4
280059|NCT01915849|940481|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
280060|NCT01915849|940482|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
280146|NCT01914666|940673|P1|Treatment Period|Lack of Efficacy|0
280061|NCT01915849|940483|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
280062|NCT01915849|940484|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
280063|NCT01915849|940481|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
280064|NCT01915849|940482|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
280065|NCT01915849|940483|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
280066|NCT01915849|940484|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
280067|NCT01915732|940509|P2|Overall Study|Poor Conscious Effect|1
280068|NCT01915732|940510|P1|Overall Study|Poor Conscious Effect|0
280069|NCT01915732|940509|P2|Overall Study|Improper Facial Procedure|1
280070|NCT01915732|940510|P1|Overall Study|Improper Facial Procedure|0
280071|NCT01915732|940509|P2|Overall Study|Job Transfer|1
280072|NCT01915732|940510|P1|Overall Study|Job Transfer|0
280073|NCT01915732|940509|P2|Overall Study|Par. Refused to Hospital Visits|1
280074|NCT01915732|940510|P1|Overall Study|Par. Refused to Hospital Visits|0
280075|NCT01915732|940509|P2|Overall Study|Par. not Willing to Continue Treatment|1
280076|NCT01915732|940510|P1|Overall Study|Par. not Willing to Continue Treatment|0
280077|NCT01915732|940509|P2|Overall Study|Got Well|1
280078|NCT01915732|940510|P1|Overall Study|Got Well|0
280079|NCT01915732|940509|P2|Overall Study|Par. Unable to Come to the Hospital|1
280080|NCT01915732|940510|P1|Overall Study|Par. Unable to Come to the Hospital|0
280081|NCT01915732|940509|P2|Overall Study|Poor Perceived Efficacy|0
280082|NCT01915732|940510|P1|Overall Study|Poor Perceived Efficacy|1
280083|NCT01915732|940509|P2|Overall Study|Pregnancy|0
280084|NCT01915732|940510|P1|Overall Study|Pregnancy|1
280085|NCT01915732|940509|P2|Overall Study|Recovered|0
280086|NCT01915732|940510|P1|Overall Study|Recovered|1
280087|NCT01915732|940509|P2|Overall Study|Drug Release Error|0
280088|NCT01915732|940510|P1|Overall Study|Drug Release Error|1
280089|NCT01915732|940509|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
280090|NCT01915732|940510|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
280091|NCT01915732|940509|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
280092|NCT01915732|940510|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
280093|NCT01915732|940509|P2|Overall Study|Lost to Follow-up|26
280094|NCT01915732|940510|P1|Overall Study|Lost to Follow-up|22
280095|NCT01915732|940509|P2|Overall Study|Lack of Efficacy|11
280096|NCT01915732|940510|P1|Overall Study|Lack of Efficacy|6
280097|NCT01915732|940509|P2|Overall Study|Protocol Violation|5
280098|NCT01915732|940510|P1|Overall Study|Protocol Violation|5
280099|NCT01915732|940509|P2|Overall Study|Adverse Event|4
280100|NCT01915732|940510|P1|Overall Study|Adverse Event|12
280101|NCT01915732|940509|P2|Overall Study|Failure to Meet Randomization Criteria|0
280102|NCT01915732|940510|P1|Overall Study|Failure to Meet Randomization Criteria|1
280103|NCT01915732|940509|P2|Overall Study|Withdrawal by Subject|18
280104|NCT01915732|940510|P1|Overall Study|Withdrawal by Subject|18
280105|NCT01914926|940578|P2|Overall Study|uncooperative, agitated and removed|1
280106|NCT01914926|940579|P1|Overall Study|uncooperative, agitated and removed|0
280107|NCT01914926|940578|P2|Overall Study|Adverse Event|0
280108|NCT01914926|940579|P1|Overall Study|Adverse Event|1
280109|NCT01914757|940588|P3|Overall Study|Other reasons|4
280110|NCT01914757|940589|P2|Overall Study|Other reasons|9
280111|NCT01914757|940590|P1|Overall Study|Other reasons|5
280112|NCT01914757|940588|P3|Overall Study|Eligibility criteria not fulfilled|2
280113|NCT01914757|940589|P2|Overall Study|Eligibility criteria not fulfilled|0
280114|NCT01914757|940590|P1|Overall Study|Eligibility criteria not fulfilled|2
280115|NCT01914757|940588|P3|Overall Study|Study specific withdrawal criteria|0
280116|NCT01914757|940589|P2|Overall Study|Study specific withdrawal criteria|1
280117|NCT01914757|940590|P1|Overall Study|Study specific withdrawal criteria|0
280118|NCT01914757|940588|P3|Overall Study|Adverse Event|4
280119|NCT01914757|940589|P2|Overall Study|Adverse Event|3
280120|NCT01914757|940590|P1|Overall Study|Adverse Event|4
280121|NCT01914757|940588|P3|Overall Study|Death|1
280122|NCT01914757|940589|P2|Overall Study|Death|2
280123|NCT01914757|940590|P1|Overall Study|Death|2
280124|NCT01914757|940588|P3|Overall Study|Withdrawal by Subject|19
280125|NCT01914757|940589|P2|Overall Study|Withdrawal by Subject|27
280126|NCT01914757|940590|P1|Overall Study|Withdrawal by Subject|15
280127|NCT01914757|940588|P3|Overall Study|Lost to Follow-up|6
280128|NCT01914757|940589|P2|Overall Study|Lost to Follow-up|8
280129|NCT01914757|940590|P1|Overall Study|Lost to Follow-up|5
280130|NCT01914757|940588|P3|Overall Study|Severe non-compliance to protocol|2
280131|NCT01914757|940589|P2|Overall Study|Severe non-compliance to protocol|1
280132|NCT01914757|940590|P1|Overall Study|Severe non-compliance to protocol|3
280133|NCT01914679|940664|P1|Overall Study|Sponsor terminated study|4
280134|NCT01914679|940664|P1|Overall Study|Lack of Efficacy|1
280135|NCT01914666|940671|P3|Treatment Period|Physician Decision|2
280136|NCT01914666|940672|P2|Treatment Period|Physician Decision|0
280137|NCT01914666|940673|P1|Treatment Period|Physician Decision|0
280138|NCT01914666|940671|P3|Treatment Period|Withdrawal by Subject|2
280139|NCT01914666|940672|P2|Treatment Period|Withdrawal by Subject|2
280140|NCT01914666|940673|P1|Treatment Period|Withdrawal by Subject|3
280141|NCT01914666|940671|P3|Treatment Period|Adverse Event|2
280142|NCT01914666|940672|P2|Treatment Period|Adverse Event|4
280143|NCT01914666|940673|P1|Treatment Period|Adverse Event|10
280144|NCT01914666|940671|P3|Treatment Period|Lack of Efficacy|2
280145|NCT01914666|940672|P2|Treatment Period|Lack of Efficacy|0
280147|NCT01913483|940799|P2|Overall Study|Death|17
280148|NCT01913483|940800|P1|Overall Study|Death|14
280149|NCT01913483|940799|P2|Overall Study|Lost to Follow-up|3
280150|NCT01913483|940800|P1|Overall Study|Lost to Follow-up|6
280151|NCT01913483|940799|P2|Overall Study|Withdrawal by Subject|2
280152|NCT01913483|940800|P1|Overall Study|Withdrawal by Subject|1
280153|NCT01913470|940812|P2|Overall Study|Withdrawal by Subject|1
280154|NCT01913470|940813|P1|Overall Study|Withdrawal by Subject|0
280155|NCT01913470|940812|P2|Overall Study|Physician Decision|1
280156|NCT01913470|940813|P1|Overall Study|Physician Decision|0
280157|NCT01913470|940812|P2|Overall Study|Lost to Follow-up|1
280158|NCT01913470|940813|P1|Overall Study|Lost to Follow-up|0
280159|NCT01913405|940831|P1|Overall Study|Adverse Event|1
280160|NCT01913405|940831|P1|Overall Study|Withdrawal by Subject|1
280161|NCT01913041|940885|P1|Overall Study|Physician Decision|1
280162|NCT01913041|940885|P1|Overall Study|Withdrawal by Subject|3
280163|NCT01913041|940885|P1|Overall Study|Protocol Violation|35
280164|NCT01912781|940891|P2|Overall Study|Withdrawal by Subject|0
280165|NCT01912781|940892|P1|Overall Study|Withdrawal by Subject|2
280166|NCT01912768|940923|P2|Overall Study|Randomized in error|0
280167|NCT01912768|940924|P1|Overall Study|Randomized in error|1
280168|NCT01912768|940923|P2|Overall Study|Withdrawal by Subject|3
280169|NCT01912768|940924|P1|Overall Study|Withdrawal by Subject|5
280170|NCT01912768|940923|P2|Overall Study|Lost to Follow-up|1
280171|NCT01912768|940924|P1|Overall Study|Lost to Follow-up|2
280172|NCT01912768|940923|P2|Overall Study|Adverse Event|0
280173|NCT01912768|940924|P1|Overall Study|Adverse Event|2
280174|NCT01912599|940955|P2|Overall Study|Withdrawal by Subject|1
280175|NCT01912599|940956|P1|Overall Study|Withdrawal by Subject|0
280176|NCT01912404|940981|P2|Overall Study|Due to personal reasons|0
280177|NCT01912404|940982|P1|Overall Study|Due to personal reasons|1
280178|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
280179|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
280180|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
280181|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
280182|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
280183|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
280184|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
280185|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
280186|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
280187|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
280188|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
280189|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
280190|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
280191|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
280192|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
280193|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
280194|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
280195|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
280196|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
280197|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
280198|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
280199|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
280200|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
280201|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
280202|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
280203|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
280204|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
280205|NCT01912339|940995|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
280206|NCT01912339|940996|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
280207|NCT01912339|940997|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
280208|NCT01912339|940995|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
280209|NCT01912339|940996|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
280210|NCT01912339|940997|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
280211|NCT01912339|940995|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
280212|NCT01912339|940996|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
280213|NCT01912339|940997|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
280214|NCT01912339|940995|P3|Blinded (0 to 3 Months)|Declined to participate|0
280215|NCT01912339|940996|P2|Blinded (0 to 3 Months)|Declined to participate|0
280216|NCT01912339|940997|P1|Blinded (0 to 3 Months)|Declined to participate|1
280217|NCT01912222|941014|P3|Part B: Treatment Period|Withdrawal by Subject|2
280218|NCT01912222|941015|P2|Part B: Treatment Period|Withdrawal by Subject|1
280219|NCT01912222|941016|P1|Part B: Treatment Period|Withdrawal by Subject|2
280220|NCT01912222|941014|P3|Part B: Treatment Period|Adverse Event|3
280221|NCT01912222|941015|P2|Part B: Treatment Period|Adverse Event|2
280222|NCT01912222|941016|P1|Part B: Treatment Period|Adverse Event|1
280223|NCT01912222|941014|P3|Part B: Treatment Period|Progressive disease|15
280224|NCT01912222|941015|P2|Part B: Treatment Period|Progressive disease|12
280225|NCT01912222|941016|P1|Part B: Treatment Period|Progressive disease|10
280226|NCT01912222|941014|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
280227|NCT01912222|941015|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
280228|NCT01912222|941016|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
280229|NCT01911845|941039|P1|Overall Study|Other (not specified)|3
280230|NCT01911845|941039|P1|Overall Study|Lost to Follow-up|1
280231|NCT01911845|941039|P1|Overall Study|Adverse Event|2
280232|NCT01911819|941056|P3|Overall Study|Withdrawal by Subject|0
280233|NCT01911819|941057|P2|Overall Study|Withdrawal by Subject|1
280234|NCT01911819|941058|P1|Overall Study|Withdrawal by Subject|1
280235|NCT01911819|941056|P3|Overall Study|Adverse Event|0
280236|NCT01911819|941057|P2|Overall Study|Adverse Event|1
280237|NCT01911819|941058|P1|Overall Study|Adverse Event|0
280238|NCT01911793|941071|P2|Overall Study|Physician Decision|5
280239|NCT01911793|941072|P1|Overall Study|Physician Decision|1
280240|NCT01911780|941096|P2|Extension Period (52 Weeks)|Personal reason|1
280241|NCT01911780|941097|P1|Extension Period (52 Weeks)|Personal reason|1
280242|NCT01911780|941096|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
280243|NCT01911780|941097|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
280244|NCT01911780|941096|P2|Extension Period (52 Weeks)|Adverse Event|0
280245|NCT01911780|941097|P1|Extension Period (52 Weeks)|Adverse Event|3
280246|NCT01911780|941096|P2|Double-blind Period (8 Weeks)|Personal reason|0
280247|NCT01911780|941097|P1|Double-blind Period (8 Weeks)|Personal reason|1
280248|NCT01911780|941096|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
280249|NCT01911780|941097|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
280250|NCT01911780|941096|P2|Double-blind Period (8 Weeks)|Adverse Event|2
280251|NCT01911780|941097|P1|Double-blind Period (8 Weeks)|Adverse Event|1
280252|NCT01911546|941131|P1|Overall Study|Everolimus was discontinued|5
280253|NCT01911546|941131|P1|Overall Study|Lost to Follow-up|1
280254|NCT01911442|941141|P3|Overall Study|Mother's Work Schedule|0
280255|NCT01911442|941142|P2|Overall Study|Mother's Work Schedule|1
280256|NCT01911442|941143|P1|Overall Study|Mother's Work Schedule|0
280257|NCT01911442|941141|P3|Overall Study|Withdrawal by Subject|6
280258|NCT01911442|941142|P2|Overall Study|Withdrawal by Subject|0
280259|NCT01911442|941143|P1|Overall Study|Withdrawal by Subject|1
280260|NCT01911442|941141|P3|Overall Study|Lost to Follow-up|1
280261|NCT01911442|941142|P2|Overall Study|Lost to Follow-up|0
280262|NCT01911442|941143|P1|Overall Study|Lost to Follow-up|2
280263|NCT01911442|941141|P3|Overall Study|Lack of Efficacy|1
280264|NCT01911442|941142|P2|Overall Study|Lack of Efficacy|1
280265|NCT01911442|941143|P1|Overall Study|Lack of Efficacy|1
280266|NCT01911442|941141|P3|Overall Study|Adverse Event|4
280267|NCT01911442|941142|P2|Overall Study|Adverse Event|2
280268|NCT01911442|941143|P1|Overall Study|Adverse Event|2
280269|NCT01911429|941172|P3|Overall Study|subject left study|0
280270|NCT01911429|941173|P2|Overall Study|subject left study|0
280271|NCT01911429|941174|P1|Overall Study|subject left study|1
280272|NCT01911429|941172|P3|Overall Study|Accidental randomization|1
280273|NCT01911429|941173|P2|Overall Study|Accidental randomization|0
280274|NCT01911429|941174|P1|Overall Study|Accidental randomization|0
280275|NCT01911429|941172|P3|Overall Study|Withdrawal by Subject|4
280276|NCT01911429|941173|P2|Overall Study|Withdrawal by Subject|5
280277|NCT01911429|941174|P1|Overall Study|Withdrawal by Subject|5
280278|NCT01911429|941172|P3|Overall Study|Protocol Violation|1
280279|NCT01911429|941173|P2|Overall Study|Protocol Violation|0
280280|NCT01911429|941174|P1|Overall Study|Protocol Violation|0
280281|NCT01911429|941172|P3|Overall Study|Lost to Follow-up|1
280282|NCT01911429|941173|P2|Overall Study|Lost to Follow-up|0
280283|NCT01911429|941174|P1|Overall Study|Lost to Follow-up|0
280284|NCT01911429|941172|P3|Overall Study|Lack of Efficacy|4
280285|NCT01911429|941173|P2|Overall Study|Lack of Efficacy|2
280286|NCT01911429|941174|P1|Overall Study|Lack of Efficacy|1
280287|NCT01911429|941172|P3|Overall Study|Adverse Event|9
280288|NCT01911429|941173|P2|Overall Study|Adverse Event|3
280289|NCT01911429|941174|P1|Overall Study|Adverse Event|5
280290|NCT01911273|941266|P2|Overall Study|Withdrawal by Subject|2
280291|NCT01911273|941267|P1|Overall Study|Withdrawal by Subject|0
280292|NCT01911273|941266|P2|Overall Study|Progression of Disease|0
280293|NCT01911273|941267|P1|Overall Study|Progression of Disease|1
280294|NCT01911260|941301|P4|Follow-up Period|transference or evasion of school|12
280295|NCT01911260|941302|P3|Follow-up Period|transference or evasion of school|15
280296|NCT01911260|941303|P2|Follow-up Period|transference or evasion of school|20
280297|NCT01911260|941304|P1|Follow-up Period|transference or evasion of school|13
280298|NCT01911260|941301|P4|Supplementation Period|less than 12 weeks supplementation|2
280299|NCT01911260|941302|P3|Supplementation Period|less than 12 weeks supplementation|1
280300|NCT01911260|941303|P2|Supplementation Period|less than 12 weeks supplementation|3
280301|NCT01911260|941304|P1|Supplementation Period|less than 12 weeks supplementation|0
280302|NCT01911260|941301|P4|Supplementation Period|refused to receive supplement|0
280303|NCT01911260|941302|P3|Supplementation Period|refused to receive supplement|1
280304|NCT01911260|941303|P2|Supplementation Period|refused to receive supplement|0
280305|NCT01911260|941304|P1|Supplementation Period|refused to receive supplement|1
280306|NCT01911260|941301|P4|Supplementation Period|Adverse Event|0
280307|NCT01911260|941302|P3|Supplementation Period|Adverse Event|1
280308|NCT01911260|941303|P2|Supplementation Period|Adverse Event|0
280309|NCT01911260|941304|P1|Supplementation Period|Adverse Event|2
280310|NCT01911260|941301|P4|Supplementation Period|transference or evasion of school|6
280311|NCT01911260|941302|P3|Supplementation Period|transference or evasion of school|7
280312|NCT01911260|941303|P2|Supplementation Period|transference or evasion of school|9
280313|NCT01911260|941304|P1|Supplementation Period|transference or evasion of school|7
280314|NCT01910441|941390|P2|Overall Study|Physician Decision|1
280315|NCT01910441|941391|P1|Overall Study|Physician Decision|0
280316|NCT01910441|941390|P2|Overall Study|Adverse Event|0
280317|NCT01910441|941391|P1|Overall Study|Adverse Event|1
280318|NCT01910441|941390|P2|Overall Study|Non-compliance|1
280319|NCT01910441|941391|P1|Overall Study|Non-compliance|0
280320|NCT01910441|941390|P2|Overall Study|Withdrawal by Subject|1
280321|NCT01910441|941391|P1|Overall Study|Withdrawal by Subject|0
280322|NCT01910441|941390|P2|Overall Study|Lost to Follow-up|5
280323|NCT01910441|941391|P1|Overall Study|Lost to Follow-up|6
280324|NCT01910441|941390|P2|Overall Study|Sponsor decision|2
280325|NCT01910441|941391|P1|Overall Study|Sponsor decision|0
280326|NCT01910402|941399|P2|Continuation Phase|Withdrawal by Subject|0
280327|NCT01910402|941400|P1|Continuation Phase|Withdrawal by Subject|2
280328|NCT01910402|941399|P2|Continuation Phase|Protocol Violation|0
280329|NCT01910402|941400|P1|Continuation Phase|Protocol Violation|3
280330|NCT01910402|941399|P2|Continuation Phase|Adverse Event|0
280331|NCT01910402|941400|P1|Continuation Phase|Adverse Event|1
280332|NCT01910402|941399|P2|Continuation Phase|Ongoing|0
280333|NCT01910402|941400|P1|Continuation Phase|Ongoing|84
280334|NCT01910402|941399|P2|Randomized Phase|Withdrawal by Subject|7
280335|NCT01910402|941400|P1|Randomized Phase|Withdrawal by Subject|5
280336|NCT01910402|941399|P2|Randomized Phase|Protocol Violation|13
280337|NCT01910402|941400|P1|Randomized Phase|Protocol Violation|10
280338|NCT01910402|941399|P2|Randomized Phase|Lost to Follow-up|13
280339|NCT01910402|941400|P1|Randomized Phase|Lost to Follow-up|11
280340|NCT01910402|941399|P2|Randomized Phase|Lack of Efficacy|4
280341|NCT01910402|941400|P1|Randomized Phase|Lack of Efficacy|5
280342|NCT01910402|941399|P2|Randomized Phase|Physician Decision|0
280343|NCT01910402|941400|P1|Randomized Phase|Physician Decision|1
280344|NCT01910402|941399|P2|Randomized Phase|Adverse Event|18
280345|NCT01910402|941400|P1|Randomized Phase|Adverse Event|10
280346|NCT01910389|941470|P2|Overall Study|Study Closed|8
280347|NCT01910389|941471|P1|Overall Study|Study Closed|13
280348|NCT01910389|941470|P2|Overall Study|Withdrawal by Subject|0
280349|NCT01910389|941471|P1|Overall Study|Withdrawal by Subject|2
280353|NCT01910116|941539|P2|Overall Study|incomplete data|1
280354|NCT01910116|941540|P1|Overall Study|incomplete data|0
280355|NCT01910116|941539|P2|Overall Study|uncertain allocation|3
280356|NCT01910116|941540|P1|Overall Study|uncertain allocation|1
280357|NCT01910116|941539|P2|Overall Study|Withdrawal by Subject|3
280358|NCT01910116|941540|P1|Overall Study|Withdrawal by Subject|8
280359|NCT01910116|941539|P2|Overall Study|Protocol Violation|2
280360|NCT01910116|941540|P1|Overall Study|Protocol Violation|1
280361|NCT01910116|941539|P2|Overall Study|Lost to Follow-up|0
280362|NCT01910116|941540|P1|Overall Study|Lost to Follow-up|1
280363|NCT01910116|941539|P2|Overall Study|Lack of Efficacy|4
280364|NCT01910116|941540|P1|Overall Study|Lack of Efficacy|3
280365|NCT01910116|941539|P2|Overall Study|Adverse Event|3
280366|NCT01910116|941540|P1|Overall Study|Adverse Event|0
280367|NCT01909804|941637|P12|Overall Study|Protocol Violation|1
280368|NCT01909804|941638|P11|Overall Study|Protocol Violation|0
280369|NCT01909804|941639|P10|Overall Study|Protocol Violation|0
280370|NCT01909804|941640|P9|Overall Study|Protocol Violation|0
280371|NCT01909804|941641|P8|Overall Study|Protocol Violation|0
280372|NCT01909804|941642|P7|Overall Study|Protocol Violation|0
280373|NCT01909804|941643|P6|Overall Study|Protocol Violation|0
280374|NCT01909804|941644|P5|Overall Study|Protocol Violation|0
280375|NCT01909804|941645|P4|Overall Study|Protocol Violation|0
280376|NCT01909804|941646|P3|Overall Study|Protocol Violation|0
280377|NCT01909804|941647|P2|Overall Study|Protocol Violation|0
280378|NCT01909804|941648|P1|Overall Study|Protocol Violation|0
280379|NCT01909804|941637|P12|Overall Study|Withdrew Consent|0
280380|NCT01909804|941638|P11|Overall Study|Withdrew Consent|0
280381|NCT01909804|941639|P10|Overall Study|Withdrew Consent|0
280382|NCT01909804|941640|P9|Overall Study|Withdrew Consent|0
280383|NCT01909804|941641|P8|Overall Study|Withdrew Consent|0
280384|NCT01909804|941642|P7|Overall Study|Withdrew Consent|0
280385|NCT01909804|941643|P6|Overall Study|Withdrew Consent|1
280386|NCT01909804|941644|P5|Overall Study|Withdrew Consent|1
280387|NCT01909804|941645|P4|Overall Study|Withdrew Consent|0
280388|NCT01909804|941646|P3|Overall Study|Withdrew Consent|0
280389|NCT01909804|941647|P2|Overall Study|Withdrew Consent|0
280390|NCT01909804|941648|P1|Overall Study|Withdrew Consent|0
280391|NCT01909804|941637|P12|Overall Study|Lack of Efficacy|1
280392|NCT01909804|941638|P11|Overall Study|Lack of Efficacy|0
280393|NCT01909804|941639|P10|Overall Study|Lack of Efficacy|1
280394|NCT01909804|941640|P9|Overall Study|Lack of Efficacy|0
280395|NCT01909804|941641|P8|Overall Study|Lack of Efficacy|1
280396|NCT01909804|941642|P7|Overall Study|Lack of Efficacy|1
280397|NCT01909804|941643|P6|Overall Study|Lack of Efficacy|3
280398|NCT01909804|941644|P5|Overall Study|Lack of Efficacy|7
280399|NCT01909804|941645|P4|Overall Study|Lack of Efficacy|0
280400|NCT01909804|941646|P3|Overall Study|Lack of Efficacy|0
280401|NCT01909804|941647|P2|Overall Study|Lack of Efficacy|1
280402|NCT01909804|941648|P1|Overall Study|Lack of Efficacy|4
280403|NCT01909804|941637|P12|Overall Study|Death|0
280404|NCT01909804|941638|P11|Overall Study|Death|1
280405|NCT01909804|941639|P10|Overall Study|Death|0
280406|NCT01909804|941640|P9|Overall Study|Death|0
280407|NCT01909804|941641|P8|Overall Study|Death|0
280408|NCT01909804|941642|P7|Overall Study|Death|0
280409|NCT01909804|941643|P6|Overall Study|Death|0
280410|NCT01909804|941644|P5|Overall Study|Death|0
280411|NCT01909804|941645|P4|Overall Study|Death|0
280412|NCT01909804|941646|P3|Overall Study|Death|0
280413|NCT01909804|941647|P2|Overall Study|Death|0
280414|NCT01909804|941648|P1|Overall Study|Death|0
280415|NCT01909804|941637|P12|Overall Study|Randomized but Never Treated|1
280416|NCT01909804|941638|P11|Overall Study|Randomized but Never Treated|0
280417|NCT01909804|941639|P10|Overall Study|Randomized but Never Treated|0
280418|NCT01909804|941640|P9|Overall Study|Randomized but Never Treated|0
280419|NCT01909804|941641|P8|Overall Study|Randomized but Never Treated|0
280420|NCT01909804|941642|P7|Overall Study|Randomized but Never Treated|1
280421|NCT01909804|941643|P6|Overall Study|Randomized but Never Treated|0
280422|NCT01909804|941644|P5|Overall Study|Randomized but Never Treated|0
280423|NCT01909804|941645|P4|Overall Study|Randomized but Never Treated|0
280424|NCT01909804|941646|P3|Overall Study|Randomized but Never Treated|0
280425|NCT01909804|941647|P2|Overall Study|Randomized but Never Treated|0
280426|NCT01909804|941648|P1|Overall Study|Randomized but Never Treated|0
280427|NCT01909778|941694|P1|Overall Study|failed screening|1
280428|NCT01909674|941773|P2|Overall Study|Withdrawal by Subject|2
280429|NCT01909674|941774|P1|Overall Study|Withdrawal by Subject|5
280430|NCT01909466|941793|P2|Overall Study|Lack of Efficacy|0
280431|NCT01909466|941794|P1|Overall Study|Lack of Efficacy|1
280432|NCT01909466|941793|P2|Overall Study|Withdrawal by Subject|9
280433|NCT01909466|941794|P1|Overall Study|Withdrawal by Subject|11
280434|NCT01909466|941793|P2|Overall Study|Physician Decision|0
280435|NCT01909466|941794|P1|Overall Study|Physician Decision|2
280436|NCT01909466|941793|P2|Overall Study|Met Withdrawal Criteria|3
280437|NCT01909466|941794|P1|Overall Study|Met Withdrawal Criteria|0
280438|NCT01909466|941793|P2|Overall Study|Adverse Event|4
280439|NCT01909466|941794|P1|Overall Study|Adverse Event|3
280440|NCT01909466|941793|P2|Overall Study|Lost to Follow-up|7
280441|NCT01909466|941794|P1|Overall Study|Lost to Follow-up|5
280442|NCT01909336|941817|P3|Overall Study|Physician Decision|1
280443|NCT01909336|941818|P2|Overall Study|Physician Decision|1
280444|NCT01909336|941819|P1|Overall Study|Physician Decision|0
280445|NCT01909336|941817|P3|Overall Study|Lost to Follow-up|2
280446|NCT01909336|941818|P2|Overall Study|Lost to Follow-up|2
280447|NCT01909336|941819|P1|Overall Study|Lost to Follow-up|4
280448|NCT01908907|941871|P2|Overall Study|Protocol Violation|0
280449|NCT01908907|941872|P1|Overall Study|Protocol Violation|1
280450|NCT01908907|941871|P2|Overall Study|Physician Decision|0
280451|NCT01908907|941872|P1|Overall Study|Physician Decision|1
280452|NCT01908829|941916|P3|Overall Study|Withdrawal by Subject|22
280453|NCT01908829|941917|P2|Overall Study|Withdrawal by Subject|29
280454|NCT01908829|941918|P1|Overall Study|Withdrawal by Subject|26
280455|NCT01908829|941916|P3|Overall Study|Lack of Efficacy|2
280456|NCT01908829|941917|P2|Overall Study|Lack of Efficacy|3
280457|NCT01908829|941918|P1|Overall Study|Lack of Efficacy|1
280458|NCT01908829|941916|P3|Overall Study|Protocol Violation|0
280459|NCT01908829|941917|P2|Overall Study|Protocol Violation|2
280460|NCT01908829|941918|P1|Overall Study|Protocol Violation|2
280461|NCT01908829|941916|P3|Overall Study|Miscellaneous|0
280462|NCT01908829|941917|P2|Overall Study|Miscellaneous|2
280463|NCT01908829|941918|P1|Overall Study|Miscellaneous|0
280464|NCT01908829|941916|P3|Overall Study|Discontinued (no EoT page)|0
280465|NCT01908829|941917|P2|Overall Study|Discontinued (no EoT page)|0
280466|NCT01908829|941918|P1|Overall Study|Discontinued (no EoT page)|2
280467|NCT01908829|941916|P3|Overall Study|Randomized no double-blind drug received|1
280468|NCT01908829|941917|P2|Overall Study|Randomized no double-blind drug received|0
280469|NCT01908829|941918|P1|Overall Study|Randomized no double-blind drug received|1
280470|NCT01908829|941916|P3|Overall Study|Lost to Follow-up|1
280471|NCT01908829|941917|P2|Overall Study|Lost to Follow-up|2
280472|NCT01908829|941918|P1|Overall Study|Lost to Follow-up|4
280473|NCT01908829|941916|P3|Overall Study|Adverse Event|13
280474|NCT01908829|941917|P2|Overall Study|Adverse Event|11
280475|NCT01908829|941918|P1|Overall Study|Adverse Event|13
280476|NCT01908803|942033|P2|Overall Study|Adverse Event (pre-treatment)|0
280477|NCT01908803|942034|P1|Overall Study|Adverse Event (pre-treatment)|1
280478|NCT01908803|942033|P2|Overall Study|Randomization Error|0
280479|NCT01908803|942034|P1|Overall Study|Randomization Error|1
280480|NCT01908803|942033|P2|Overall Study|Withdrawal by Subject|0
280481|NCT01908803|942034|P1|Overall Study|Withdrawal by Subject|1
280482|NCT01908803|942033|P2|Overall Study|Physician Decision|1
280483|NCT01908803|942034|P1|Overall Study|Physician Decision|0
280484|NCT01908803|942033|P2|Overall Study|Adverse Event|0
280485|NCT01908803|942034|P1|Overall Study|Adverse Event|1
280486|NCT01908140|942047|P2|Overall Study|Adverse Event|23
280487|NCT01908140|942048|P1|Overall Study|Adverse Event|22
280488|NCT01908140|942047|P2|Overall Study|Protocol Violation|9
280489|NCT01908140|942048|P1|Overall Study|Protocol Violation|8
280490|NCT01908140|942047|P2|Overall Study|Lost to Follow-up|6
280491|NCT01908140|942048|P1|Overall Study|Lost to Follow-up|1
280492|NCT01908140|942047|P2|Overall Study|Withdrawal by Subject|24
280493|NCT01908140|942048|P1|Overall Study|Withdrawal by Subject|23
280494|NCT01908140|942047|P2|Overall Study|Lack of Efficacy|5
280495|NCT01908140|942048|P1|Overall Study|Lack of Efficacy|7
280496|NCT01908140|942047|P2|Overall Study|Other or Progressive Disease|12
280497|NCT01908140|942048|P1|Overall Study|Other or Progressive Disease|5
280498|NCT01907906|942069|P2|Overall Study|Physician Decision|1
280499|NCT01907906|942070|P1|Overall Study|Physician Decision|3
280500|NCT01907906|942069|P2|Overall Study|Withdrawal by Subject|0
280501|NCT01907906|942070|P1|Overall Study|Withdrawal by Subject|1
280502|NCT01907854|942150|P2|Overall Study|Unclassified|3
280503|NCT01907854|942151|P1|Overall Study|Unclassified|4
280504|NCT01907854|942150|P2|Overall Study|Lost to Follow-up|2
280505|NCT01907854|942151|P1|Overall Study|Lost to Follow-up|2
280506|NCT01907854|942150|P2|Overall Study|Withdrawal by Subject|7
280507|NCT01907854|942151|P1|Overall Study|Withdrawal by Subject|9
280508|NCT01907854|942150|P2|Overall Study|Protocol Violation|1
280509|NCT01907854|942151|P1|Overall Study|Protocol Violation|1
280510|NCT01907815|942171|P2|Overall Study|Withdrawal by Subject|0
280511|NCT01907815|942172|P1|Overall Study|Withdrawal by Subject|1
280512|NCT01907516|942188|P2|First Intervention (3 Weeks)|Developed DKA during study|0
280513|NCT01907516|942189|P1|First Intervention (3 Weeks)|Developed DKA during study|1
280514|NCT01907516|942188|P2|First Intervention (3 Weeks)|Delivered before second arm|4
280515|NCT01907516|942189|P1|First Intervention (3 Weeks)|Delivered before second arm|3
280516|NCT01907516|942188|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
280517|NCT01907516|942189|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
280518|NCT01907516|942188|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
280519|NCT01907516|942189|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
280520|NCT01907087|942324|P1|Overall Study|Withdrawal by Subject|1
280521|NCT01906372|942373|P1|Overall Study|Withdrawal by Subject|2
280522|NCT01905683|942403|P1|Overall Study|Lost to Follow-up|4
280523|NCT01905683|942403|P1|Overall Study|Adverse Event|4
280524|NCT01905683|942403|P1|Overall Study|Withdrawal by Subject|20
280525|NCT01905683|942403|P1|Overall Study|Lack of Efficacy|8
280526|NCT01905683|942403|P1|Overall Study|Physician Decision|1
280527|NCT01905683|942403|P1|Overall Study|Re-injection criteria not met; others|13
280528|NCT01905683|942403|P1|Overall Study|Protocol Violation|1
280529|NCT01905657|942419|P3|Overall Study|Excluded from Efficacy Analysis|0
280530|NCT01905657|942420|P2|Overall Study|Excluded from Efficacy Analysis|0
280531|NCT01905657|942421|P1|Overall Study|Excluded from Efficacy Analysis|1
280532|NCT01905657|942419|P3|Overall Study|Continuing in Study|11
280533|NCT01905657|942420|P2|Overall Study|Continuing in Study|74
280534|NCT01905657|942421|P1|Overall Study|Continuing in Study|74
280535|NCT01905657|942419|P3|Overall Study|Withdrawal by Subject|45
280536|NCT01905657|942420|P2|Overall Study|Withdrawal by Subject|10
280537|NCT01905657|942421|P1|Overall Study|Withdrawal by Subject|5
280538|NCT01905657|942419|P3|Overall Study|Protocol Violation|1
280539|NCT01905657|942420|P2|Overall Study|Protocol Violation|1
280540|NCT01905657|942421|P1|Overall Study|Protocol Violation|2
280541|NCT01905657|942419|P3|Overall Study|Progressive Disease|89
280542|NCT01905657|942420|P2|Overall Study|Progressive Disease|126
280543|NCT01905657|942421|P1|Overall Study|Progressive Disease|124
280544|NCT01905657|942419|P3|Overall Study|Physician Decision|113
280545|NCT01905657|942420|P2|Overall Study|Physician Decision|74
280546|NCT01905657|942421|P1|Overall Study|Physician Decision|82
280547|NCT01905657|942419|P3|Overall Study|Other|1
280548|NCT01905657|942420|P2|Overall Study|Other|7
280549|NCT01905657|942421|P1|Overall Study|Other|3
280550|NCT01905657|942419|P3|Overall Study|Death|21
280551|NCT01905657|942420|P2|Overall Study|Death|21
280552|NCT01905657|942421|P1|Overall Study|Death|21
280553|NCT01905657|942419|P3|Overall Study|Adverse Event|47
280554|NCT01905657|942420|P2|Overall Study|Adverse Event|32
280555|NCT01905657|942421|P1|Overall Study|Adverse Event|33
280556|NCT01905657|942419|P3|Overall Study|Not Treated|0
280557|NCT01905657|942420|P2|Overall Study|Not Treated|1
280558|NCT01905657|942421|P1|Overall Study|Not Treated|0
280559|NCT01905553|942446|P2|Period 2|Adverse Event|0
280560|NCT01905553|942447|P1|Period 2|Adverse Event|1
280561|NCT01905540|942461|P4|Period 3|Not specified|1
280562|NCT01905540|942462|P3|Period 3|Not specified|1
280563|NCT01905540|942463|P2|Period 3|Not specified|0
280564|NCT01905540|942464|P1|Period 3|Not specified|1
280565|NCT01904773|942510|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280566|NCT01904773|942511|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280567|NCT01904773|942512|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280568|NCT01904773|942513|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280569|NCT01904773|942514|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280570|NCT01904773|942515|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280571|NCT01904773|942516|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280572|NCT01904773|942517|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
280573|NCT01904773|942518|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
280574|NCT01904773|942510|P9|Fifth Intervention|Adverse Event|0
280575|NCT01904773|942511|P8|Fifth Intervention|Adverse Event|1
280576|NCT01904773|942512|P7|Fifth Intervention|Adverse Event|0
280577|NCT01904773|942513|P6|Fifth Intervention|Adverse Event|0
280578|NCT01904773|942514|P5|Fifth Intervention|Adverse Event|0
280579|NCT01904773|942515|P4|Fifth Intervention|Adverse Event|0
280580|NCT01904773|942516|P3|Fifth Intervention|Adverse Event|0
280581|NCT01904773|942517|P2|Fifth Intervention|Adverse Event|0
280582|NCT01904773|942518|P1|Fifth Intervention|Adverse Event|0
280583|NCT01904773|942510|P9|Placebo Washout First Intervention|Condition worsened|0
280584|NCT01904773|942511|P8|Placebo Washout First Intervention|Condition worsened|0
280585|NCT01904773|942512|P7|Placebo Washout First Intervention|Condition worsened|0
280586|NCT01904773|942513|P6|Placebo Washout First Intervention|Condition worsened|0
280587|NCT01904773|942514|P5|Placebo Washout First Intervention|Condition worsened|0
280588|NCT01904773|942515|P4|Placebo Washout First Intervention|Condition worsened|0
280589|NCT01904773|942516|P3|Placebo Washout First Intervention|Condition worsened|0
280590|NCT01904773|942517|P2|Placebo Washout First Intervention|Condition worsened|1
280591|NCT01904773|942518|P1|Placebo Washout First Intervention|Condition worsened|0
280592|NCT01904773|942510|P9|First Intervention|Adverse Event|0
280593|NCT01904773|942511|P8|First Intervention|Adverse Event|0
280594|NCT01904773|942512|P7|First Intervention|Adverse Event|1
280595|NCT01904773|942513|P6|First Intervention|Adverse Event|0
280596|NCT01904773|942514|P5|First Intervention|Adverse Event|0
280597|NCT01904773|942515|P4|First Intervention|Adverse Event|0
280598|NCT01904773|942516|P3|First Intervention|Adverse Event|0
280599|NCT01904773|942517|P2|First Intervention|Adverse Event|0
280600|NCT01904773|942518|P1|First Intervention|Adverse Event|0
280601|NCT01904773|942510|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280602|NCT01904773|942511|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280603|NCT01904773|942512|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280604|NCT01904773|942513|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280605|NCT01904773|942514|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280606|NCT01904773|942515|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280607|NCT01904773|942516|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280608|NCT01904773|942517|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
280609|NCT01904773|942518|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
280610|NCT01904773|942510|P9|Screen|Withdrawal by Subject|0
280611|NCT01904773|942511|P8|Screen|Withdrawal by Subject|0
280612|NCT01904773|942512|P7|Screen|Withdrawal by Subject|0
280613|NCT01904773|942513|P6|Screen|Withdrawal by Subject|0
280614|NCT01904773|942514|P5|Screen|Withdrawal by Subject|0
280615|NCT01904773|942515|P4|Screen|Withdrawal by Subject|0
280616|NCT01904773|942516|P3|Screen|Withdrawal by Subject|0
280617|NCT01904773|942517|P2|Screen|Withdrawal by Subject|0
280618|NCT01904773|942518|P1|Screen|Withdrawal by Subject|1
280619|NCT01904773|942510|P9|Screen|Screen failure|0
280620|NCT01904773|942511|P8|Screen|Screen failure|0
280621|NCT01904773|942512|P7|Screen|Screen failure|0
280622|NCT01904773|942513|P6|Screen|Screen failure|0
280623|NCT01904773|942514|P5|Screen|Screen failure|0
280624|NCT01904773|942515|P4|Screen|Screen failure|0
280625|NCT01904773|942516|P3|Screen|Screen failure|0
280626|NCT01904773|942517|P2|Screen|Screen failure|0
280627|NCT01904773|942518|P1|Screen|Screen failure|3
280628|NCT01904760|942535|P2|Overall Study|Protocol Violation|0
280629|NCT01904760|942536|P1|Overall Study|Protocol Violation|1
280630|NCT01904721|942551|P7|Overall Study|Adverse Event|0
280631|NCT01904721|942552|P6|Overall Study|Adverse Event|1
280632|NCT01904721|942553|P5|Overall Study|Adverse Event|3
280633|NCT01904721|942554|P4|Overall Study|Adverse Event|0
280634|NCT01904721|942555|P3|Overall Study|Adverse Event|0
280635|NCT01904721|942556|P2|Overall Study|Adverse Event|0
280636|NCT01904721|942557|P1|Overall Study|Adverse Event|0
280637|NCT01904721|942551|P7|Overall Study|Lack of Efficacy|1
280638|NCT01904721|942552|P6|Overall Study|Lack of Efficacy|0
280639|NCT01904721|942553|P5|Overall Study|Lack of Efficacy|0
280640|NCT01904721|942554|P4|Overall Study|Lack of Efficacy|0
280641|NCT01904721|942555|P3|Overall Study|Lack of Efficacy|0
280642|NCT01904721|942556|P2|Overall Study|Lack of Efficacy|0
280643|NCT01904721|942557|P1|Overall Study|Lack of Efficacy|0
280644|NCT01904721|942551|P7|Overall Study|Lost to Follow-up|1
280645|NCT01904721|942552|P6|Overall Study|Lost to Follow-up|3
280646|NCT01904721|942553|P5|Overall Study|Lost to Follow-up|1
280647|NCT01904721|942554|P4|Overall Study|Lost to Follow-up|0
280648|NCT01904721|942555|P3|Overall Study|Lost to Follow-up|0
280649|NCT01904721|942556|P2|Overall Study|Lost to Follow-up|0
280650|NCT01904721|942557|P1|Overall Study|Lost to Follow-up|0
280651|NCT01904721|942551|P7|Overall Study|Personal Reasons|3
280652|NCT01904721|942552|P6|Overall Study|Personal Reasons|3
280653|NCT01904721|942553|P5|Overall Study|Personal Reasons|2
280654|NCT01904721|942554|P4|Overall Study|Personal Reasons|0
280655|NCT01904721|942555|P3|Overall Study|Personal Reasons|0
280656|NCT01904721|942556|P2|Overall Study|Personal Reasons|0
280657|NCT01904721|942557|P1|Overall Study|Personal Reasons|0
280658|NCT01904721|942551|P7|Overall Study|Other Reasons|2
280659|NCT01904721|942552|P6|Overall Study|Other Reasons|2
280660|NCT01904721|942553|P5|Overall Study|Other Reasons|2
280661|NCT01904721|942554|P4|Overall Study|Other Reasons|1
280662|NCT01904721|942555|P3|Overall Study|Other Reasons|1
280663|NCT01904721|942556|P2|Overall Study|Other Reasons|0
280664|NCT01904721|942557|P1|Overall Study|Other Reasons|0
280665|NCT01904604|942587|P3|Overall Study|Unrelated illness|0
280666|NCT01904604|942588|P2|Overall Study|Unrelated illness|1
280667|NCT01904604|942589|P1|Overall Study|Unrelated illness|0
280668|NCT01904604|942587|P3|Overall Study|Increased syncope|0
280669|NCT01904604|942588|P2|Overall Study|Increased syncope|1
280670|NCT01904604|942589|P1|Overall Study|Increased syncope|0
280671|NCT01904604|942587|P3|Overall Study|Patch site reactions|0
280672|NCT01904604|942588|P2|Overall Study|Patch site reactions|1
280673|NCT01904604|942589|P1|Overall Study|Patch site reactions|0
280674|NCT01904604|942587|P3|Overall Study|Anxiety about OFC/Refused OFC|0
280675|NCT01904604|942588|P2|Overall Study|Anxiety about OFC/Refused OFC|0
280676|NCT01904604|942589|P1|Overall Study|Anxiety about OFC/Refused OFC|2
280677|NCT01904604|942587|P3|Overall Study|Non-compliance|0
280678|NCT01904604|942588|P2|Overall Study|Non-compliance|0
280679|NCT01904604|942589|P1|Overall Study|Non-compliance|1
280680|NCT01904604|942587|P3|Overall Study|Withdrew before receiving dosing|0
280681|NCT01904604|942588|P2|Overall Study|Withdrew before receiving dosing|1
280682|NCT01904604|942589|P1|Overall Study|Withdrew before receiving dosing|0
280683|NCT01904279|942643|P2|Overall Study|Withdrawal by Subject|0
280684|NCT01904279|942644|P1|Overall Study|Withdrawal by Subject|1
280685|NCT01904279|942643|P2|Overall Study|Lack of Efficacy|3
280686|NCT01904279|942644|P1|Overall Study|Lack of Efficacy|2
280687|NCT01904149|942670|P6|Overall Study|non compliance with study drug|0
280688|NCT01904149|942671|P5|Overall Study|non compliance with study drug|0
280689|NCT01904149|942672|P4|Overall Study|non compliance with study drug|0
280690|NCT01904149|942673|P3|Overall Study|non compliance with study drug|0
280691|NCT01904149|942674|P2|Overall Study|non compliance with study drug|0
280692|NCT01904149|942675|P1|Overall Study|non compliance with study drug|1
280693|NCT01904149|942670|P6|Overall Study|Protocol Violation|0
280694|NCT01904149|942671|P5|Overall Study|Protocol Violation|0
280695|NCT01904149|942672|P4|Overall Study|Protocol Violation|0
280696|NCT01904149|942673|P3|Overall Study|Protocol Violation|0
280697|NCT01904149|942674|P2|Overall Study|Protocol Violation|1
280698|NCT01904149|942675|P1|Overall Study|Protocol Violation|0
280699|NCT01904149|942670|P6|Overall Study|Withdrawal by Subject|0
280700|NCT01904149|942671|P5|Overall Study|Withdrawal by Subject|1
280701|NCT01904149|942672|P4|Overall Study|Withdrawal by Subject|0
280702|NCT01904149|942673|P3|Overall Study|Withdrawal by Subject|1
280703|NCT01904149|942674|P2|Overall Study|Withdrawal by Subject|3
280704|NCT01904149|942675|P1|Overall Study|Withdrawal by Subject|1
280705|NCT01904149|942670|P6|Overall Study|Lack of Efficacy|1
280706|NCT01904149|942671|P5|Overall Study|Lack of Efficacy|3
280707|NCT01904149|942672|P4|Overall Study|Lack of Efficacy|3
280708|NCT01904149|942673|P3|Overall Study|Lack of Efficacy|1
280709|NCT01904149|942674|P2|Overall Study|Lack of Efficacy|3
280710|NCT01904149|942675|P1|Overall Study|Lack of Efficacy|0
280711|NCT01904149|942670|P6|Overall Study|Adverse Event|2
280712|NCT01904149|942671|P5|Overall Study|Adverse Event|1
280713|NCT01904149|942672|P4|Overall Study|Adverse Event|1
280714|NCT01904149|942673|P3|Overall Study|Adverse Event|0
280715|NCT01904149|942674|P2|Overall Study|Adverse Event|4
280716|NCT01904149|942675|P1|Overall Study|Adverse Event|3
280717|NCT01904058|942726|P4|Overall Study|Pregnancy|1
280718|NCT01904058|942727|P3|Overall Study|Pregnancy|0
280719|NCT01904058|942728|P2|Overall Study|Pregnancy|0
280720|NCT01904058|942729|P1|Overall Study|Pregnancy|0
280721|NCT01904058|942726|P4|Overall Study|Withdrawal by Subject|0
280722|NCT01904058|942727|P3|Overall Study|Withdrawal by Subject|1
280723|NCT01904058|942728|P2|Overall Study|Withdrawal by Subject|0
280724|NCT01904058|942729|P1|Overall Study|Withdrawal by Subject|1
280725|NCT01904058|942726|P4|Overall Study|Adverse Event|0
280726|NCT01904058|942727|P3|Overall Study|Adverse Event|0
280727|NCT01904058|942728|P2|Overall Study|Adverse Event|0
280728|NCT01904058|942729|P1|Overall Study|Adverse Event|2
280729|NCT01903993|942769|P2|Overall Study|Lost to Follow-up|1
280730|NCT01903993|942770|P1|Overall Study|Lost to Follow-up|2
280731|NCT01903993|942769|P2|Overall Study|Withdrawal by Subject|5
280732|NCT01903993|942770|P1|Overall Study|Withdrawal by Subject|13
280733|NCT01903993|942769|P2|Overall Study|Death|89
280734|NCT01903993|942770|P1|Overall Study|Death|108
280735|NCT01903876|942787|P2|Six-Month Follow-up Period|Lost to Follow-up|145
280736|NCT01903876|942788|P1|Six-Month Follow-up Period|Lost to Follow-up|91
280737|NCT01903876|942787|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
280738|NCT01903876|942788|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
280739|NCT01903863|942798|P2|Overall Study|Physician Decision|0
280740|NCT01903863|942799|P1|Overall Study|Physician Decision|2
280741|NCT01903720|942819|P1|Overall Study|Treatment with alternative drug|1
280742|NCT01903720|942819|P1|Overall Study|Lost to Follow-up|2
280743|NCT01903720|942819|P1|Overall Study|Rescinding of informed consent|2
280744|NCT01903720|942819|P1|Overall Study|Adverse Event|1
280745|NCT01903720|942819|P1|Overall Study|Inclusion / exclusion criteria not met|6
280746|NCT01903460|942857|P4|Overall Study|Adverse Event|1
280747|NCT01903460|942858|P3|Overall Study|Adverse Event|0
280748|NCT01903460|942859|P2|Overall Study|Adverse Event|0
280749|NCT01903460|942860|P1|Overall Study|Adverse Event|0
280750|NCT01903031|942930|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
280751|NCT01903031|942931|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
280752|NCT01903031|942932|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
280753|NCT01903031|942930|P3|Overall Study|Lost to Follow-up|1
280754|NCT01903031|942931|P2|Overall Study|Lost to Follow-up|0
280755|NCT01903031|942932|P1|Overall Study|Lost to Follow-up|0
280756|NCT01903031|942930|P3|Overall Study|Protocol Violation|2
280757|NCT01903031|942931|P2|Overall Study|Protocol Violation|0
280758|NCT01903031|942932|P1|Overall Study|Protocol Violation|0
280759|NCT01903031|942930|P3|Overall Study|Withdrawal by Subject|1
280760|NCT01903031|942931|P2|Overall Study|Withdrawal by Subject|1
280761|NCT01903031|942932|P1|Overall Study|Withdrawal by Subject|0
280762|NCT01903031|942930|P3|Overall Study|Adverse Event|0
280763|NCT01903031|942931|P2|Overall Study|Adverse Event|1
280764|NCT01903031|942932|P1|Overall Study|Adverse Event|0
280765|NCT01903031|942930|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
280766|NCT01903031|942931|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
280767|NCT01903031|942932|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
280768|NCT01903031|942930|P3|Overall Study|Not Able to Attend Clinic|0
280769|NCT01903031|942931|P2|Overall Study|Not Able to Attend Clinic|1
280770|NCT01903031|942932|P1|Overall Study|Not Able to Attend Clinic|1
280771|NCT01902888|942988|P1|Overall Study|Study Terminated|3
280772|NCT01902303|943023|P2|Overall Study|Did not develop a cold sore|19
280773|NCT01902303|943024|P1|Overall Study|Did not develop a cold sore|21
280774|NCT01902303|943023|P2|Overall Study|subject lost investigational product|1
280775|NCT01902303|943024|P1|Overall Study|subject lost investigational product|0
280776|NCT01902303|943023|P2|Overall Study|Protocol Violation|2
280777|NCT01902303|943024|P1|Overall Study|Protocol Violation|2
280778|NCT01902303|943023|P2|Overall Study|Lost to Follow-up|1
280779|NCT01902303|943024|P1|Overall Study|Lost to Follow-up|0
280780|NCT01902303|943023|P2|Overall Study|Adverse Event|1
280781|NCT01902303|943024|P1|Overall Study|Adverse Event|0
280782|NCT01902134|943038|P6|Overall Study|not specified|0
280783|NCT01902134|943039|P5|Overall Study|not specified|1
280784|NCT01902134|943040|P4|Overall Study|not specified|0
280785|NCT01902134|943041|P3|Overall Study|not specified|2
280786|NCT01902134|943042|P2|Overall Study|not specified|1
280787|NCT01902134|943043|P1|Overall Study|not specified|0
280788|NCT01902134|943038|P6|Overall Study|no compliance|0
280789|NCT01902134|943039|P5|Overall Study|no compliance|0
280790|NCT01902134|943040|P4|Overall Study|no compliance|0
280791|NCT01902134|943041|P3|Overall Study|no compliance|0
280792|NCT01902134|943042|P2|Overall Study|no compliance|0
280793|NCT01902134|943043|P1|Overall Study|no compliance|1
280794|NCT01902134|943038|P6|Overall Study|Withdrawal by Subject|4
280795|NCT01902134|943039|P5|Overall Study|Withdrawal by Subject|5
280796|NCT01902134|943040|P4|Overall Study|Withdrawal by Subject|1
280797|NCT01902134|943041|P3|Overall Study|Withdrawal by Subject|9
280798|NCT01902134|943042|P2|Overall Study|Withdrawal by Subject|8
280799|NCT01902134|943043|P1|Overall Study|Withdrawal by Subject|4
280800|NCT01902134|943038|P6|Overall Study|Protocol Violation|1
280801|NCT01902134|943039|P5|Overall Study|Protocol Violation|0
280802|NCT01902134|943040|P4|Overall Study|Protocol Violation|0
280803|NCT01902134|943041|P3|Overall Study|Protocol Violation|0
280804|NCT01902134|943042|P2|Overall Study|Protocol Violation|0
280805|NCT01902134|943043|P1|Overall Study|Protocol Violation|0
280806|NCT01902134|943038|P6|Overall Study|Physician Decision|0
280807|NCT01902134|943039|P5|Overall Study|Physician Decision|0
280808|NCT01902134|943040|P4|Overall Study|Physician Decision|0
280809|NCT01902134|943041|P3|Overall Study|Physician Decision|0
280810|NCT01902134|943042|P2|Overall Study|Physician Decision|1
280811|NCT01902134|943043|P1|Overall Study|Physician Decision|0
280812|NCT01902134|943038|P6|Overall Study|Lack of Efficacy|1
280813|NCT01902134|943039|P5|Overall Study|Lack of Efficacy|0
280814|NCT01902134|943040|P4|Overall Study|Lack of Efficacy|0
280815|NCT01902134|943041|P3|Overall Study|Lack of Efficacy|2
280816|NCT01902134|943042|P2|Overall Study|Lack of Efficacy|0
280817|NCT01902134|943043|P1|Overall Study|Lack of Efficacy|0
280818|NCT01902134|943038|P6|Overall Study|Adverse Event|3
280819|NCT01902134|943039|P5|Overall Study|Adverse Event|1
280820|NCT01902134|943040|P4|Overall Study|Adverse Event|1
280821|NCT01902134|943041|P3|Overall Study|Adverse Event|2
280822|NCT01902134|943042|P2|Overall Study|Adverse Event|1
280823|NCT01902134|943043|P1|Overall Study|Adverse Event|3
280824|NCT01901393|943112|P2|Overall Study|Adverse Event|0
280825|NCT01901393|943113|P1|Overall Study|Adverse Event|1
280826|NCT01901341|943131|P2|Overall Study|Withdrawal by Subject|1
280827|NCT01901341|943132|P1|Overall Study|Withdrawal by Subject|1
280828|NCT01901341|943131|P2|Overall Study|Study Terminated by Sponsor|15
280829|NCT01901341|943132|P1|Overall Study|Study Terminated by Sponsor|13
280830|NCT01901341|943131|P2|Overall Study|Protocol Violation|0
280831|NCT01901341|943132|P1|Overall Study|Protocol Violation|2
280832|NCT01901341|943131|P2|Overall Study|Lost to Follow-up|1
280833|NCT01901341|943132|P1|Overall Study|Lost to Follow-up|0
280834|NCT01901341|943131|P2|Overall Study|Lack of Efficacy|2
280835|NCT01901341|943132|P1|Overall Study|Lack of Efficacy|0
280836|NCT01901341|943131|P2|Overall Study|Adverse Event|2
280837|NCT01901341|943132|P1|Overall Study|Adverse Event|4
280838|NCT01901328|943146|P2|Overall Study|Lack of Efficacy|1
280839|NCT01901328|943147|P1|Overall Study|Lack of Efficacy|0
280840|NCT01901328|943146|P2|Overall Study|Withdrawal by Subject|2
280841|NCT01901328|943147|P1|Overall Study|Withdrawal by Subject|1
280842|NCT01901328|943146|P2|Overall Study|Study Terminated by Sponsor|16
280843|NCT01901328|943147|P1|Overall Study|Study Terminated by Sponsor|19
280844|NCT01901328|943146|P2|Overall Study|Protocol Violation|1
280845|NCT01901328|943147|P1|Overall Study|Protocol Violation|1
280846|NCT01901328|943146|P2|Overall Study|Physician Decision|1
280847|NCT01901328|943147|P1|Overall Study|Physician Decision|0
280848|NCT01901328|943146|P2|Overall Study|Lost to Follow-up|0
280849|NCT01901328|943147|P1|Overall Study|Lost to Follow-up|1
280850|NCT01901302|943161|P2|Overall Study|Withdrawal by Subject|0
280851|NCT01901302|943162|P1|Overall Study|Withdrawal by Subject|2
280852|NCT01901302|943161|P2|Overall Study|Study Terminated by Sponsor|20
280853|NCT01901302|943162|P1|Overall Study|Study Terminated by Sponsor|23
280854|NCT01901302|943161|P2|Overall Study|Lack of Efficacy|2
280855|NCT01901302|943162|P1|Overall Study|Lack of Efficacy|0
280856|NCT01901302|943161|P2|Overall Study|Adverse Event|1
280857|NCT01901302|943162|P1|Overall Study|Adverse Event|2
280858|NCT01901185|943209|P1|Overall Study|Withdrawal by Subject|2
280859|NCT01900665|943218|P2|Open Label Period|Withdrawal by Subject|28
280860|NCT01900665|943219|P1|Open Label Period|Withdrawal by Subject|20
280861|NCT01900665|943218|P2|Open Label Period|Sponsor Decision|765
280862|NCT01900665|943219|P1|Open Label Period|Sponsor Decision|802
280863|NCT01900665|943218|P2|Open Label Period|Protocol Violation|1
280864|NCT01900665|943219|P1|Open Label Period|Protocol Violation|0
280865|NCT01900665|943218|P2|Open Label Period|Physician Decision|4
280866|NCT01900665|943219|P1|Open Label Period|Physician Decision|4
280867|NCT01900665|943218|P2|Open Label Period|Parent/Caregiver Decision|34
280868|NCT01900665|943219|P1|Open Label Period|Parent/Caregiver Decision|33
280869|NCT01900665|943218|P2|Open Label Period|Lost to Follow-up|1
280870|NCT01900665|943219|P1|Open Label Period|Lost to Follow-up|1
280871|NCT01900665|943218|P2|Open Label Period|Death|6
280872|NCT01900665|943219|P1|Open Label Period|Death|5
280873|NCT01900665|943218|P2|Open Label Period|Adverse Event|20
280874|NCT01900665|943219|P1|Open Label Period|Adverse Event|16
280875|NCT01900665|943218|P2|Placebo Controlled Period|Entry Criteria Not Met|9
280876|NCT01900665|943219|P1|Placebo Controlled Period|Entry Criteria Not Met|5
280877|NCT01900665|943218|P2|Placebo Controlled Period|Caregiver Decision|41
280878|NCT01900665|943219|P1|Placebo Controlled Period|Caregiver Decision|33
280879|NCT01900665|943218|P2|Placebo Controlled Period|Lost to Follow-up|0
280880|NCT01900665|943219|P1|Placebo Controlled Period|Lost to Follow-up|3
280881|NCT01900665|943218|P2|Placebo Controlled Period|Physician Decision|7
280882|NCT01900665|943219|P1|Placebo Controlled Period|Physician Decision|11
280883|NCT01900665|943218|P2|Placebo Controlled Period|Withdrawal by Subject|45
280884|NCT01900665|943219|P1|Placebo Controlled Period|Withdrawal by Subject|33
280885|NCT01900665|943218|P2|Placebo Controlled Period|Protocol Violation|7
280886|NCT01900665|943219|P1|Placebo Controlled Period|Protocol Violation|1
280887|NCT01900665|943218|P2|Placebo Controlled Period|Adverse Event|39
280888|NCT01900665|943219|P1|Placebo Controlled Period|Adverse Event|48
280889|NCT01900665|943218|P2|Placebo Controlled Period|Death|16
280890|NCT01900665|943219|P1|Placebo Controlled Period|Death|9
280891|NCT01900652|943262|P2|Overall Study|Physician Decision|1
280892|NCT01900652|943263|P1|Overall Study|Physician Decision|1
280893|NCT01900652|943262|P2|Overall Study|Adverse Event|1
280894|NCT01900652|943263|P1|Overall Study|Adverse Event|2
280895|NCT01900652|943262|P2|Overall Study|Death|0
280896|NCT01900652|943263|P1|Overall Study|Death|3
280897|NCT01900652|943262|P2|Overall Study|Consent withdrawn by subject|1
280898|NCT01900652|943263|P1|Overall Study|Consent withdrawn by subject|1
280899|NCT01900652|943262|P2|Overall Study|Progressive Disease|0
280900|NCT01900652|943263|P1|Overall Study|Progressive Disease|1
280901|NCT01900444|943297|P1|Overall Study|Lost to Follow-up|1
280902|NCT01900444|943297|P1|Overall Study|Protocol Violation|2
280903|NCT01900431|943310|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
280904|NCT01900431|943311|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
280905|NCT01900431|943312|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
280906|NCT01900431|943310|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
280907|NCT01900431|943311|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
280908|NCT01900431|943312|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
280909|NCT01900431|943310|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
280910|NCT01900431|943311|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
280911|NCT01900431|943312|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
280912|NCT01900431|943310|P3|Extended Treatment Period (Part B)|Other than specified above|0
280913|NCT01900431|943311|P2|Extended Treatment Period (Part B)|Other than specified above|1
280914|NCT01900431|943312|P1|Extended Treatment Period (Part B)|Other than specified above|0
280915|NCT01900431|943310|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
280916|NCT01900431|943311|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
280917|NCT01900431|943312|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
280918|NCT01900431|943310|P3|Extended Treatment Period (Part B)|Adverse Event|0
280919|NCT01900431|943311|P2|Extended Treatment Period (Part B)|Adverse Event|2
280920|NCT01900431|943312|P1|Extended Treatment Period (Part B)|Adverse Event|0
280921|NCT01900431|943310|P3|Principal Treatment Period (Part A)|Other than specified above|0
280922|NCT01900431|943311|P2|Principal Treatment Period (Part A)|Other than specified above|1
280923|NCT01900431|943312|P1|Principal Treatment Period (Part A)|Other than specified above|0
280924|NCT01900431|943310|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
280925|NCT01900431|943311|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
280926|NCT01900431|943312|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
280927|NCT01900431|943310|P3|Principal Treatment Period (Part A)|Adverse Event|0
280928|NCT01900431|943311|P2|Principal Treatment Period (Part A)|Adverse Event|3
280929|NCT01900431|943312|P1|Principal Treatment Period (Part A)|Adverse Event|1
280930|NCT01900314|943338|P2|Overall Study|Withdrawal by Subject|3
280931|NCT01900314|943339|P1|Overall Study|Withdrawal by Subject|3
280932|NCT01900314|943338|P2|Overall Study|Protocol Violation|1
280933|NCT01900314|943339|P1|Overall Study|Protocol Violation|0
280934|NCT01900314|943338|P2|Overall Study|Lost to Follow-up|0
280935|NCT01900314|943339|P1|Overall Study|Lost to Follow-up|1
280936|NCT01900054|943369|P1|Overall Study|Withdrawal by Subject|1
280937|NCT01900054|943369|P1|Overall Study|Physician Decision|1
280938|NCT01899768|943378|P1|Part B|Withdrawal by Subject|1
280939|NCT01899768|943378|P1|Part B|Adverse Event|1
280940|NCT01899768|943378|P1|Part A|Withdrawal by Subject|1
280941|NCT01899768|943378|P1|Part A|Adverse Event|2
280942|NCT01899742|943452|P2|Overall Study|Withdrawal by Subject|5
280943|NCT01899742|943453|P1|Overall Study|Withdrawal by Subject|9
280944|NCT01899742|943452|P2|Overall Study|Protocol Violation|2
280945|NCT01899742|943453|P1|Overall Study|Protocol Violation|2
280946|NCT01899742|943452|P2|Overall Study|Lack of Efficacy|5
280947|NCT01899742|943453|P1|Overall Study|Lack of Efficacy|1
280948|NCT01899742|943452|P2|Overall Study|Adverse Event|4
280949|NCT01899742|943453|P1|Overall Study|Adverse Event|5
280950|NCT01899144|943492|P1|Treatment Period 5|Not specified|1
280951|NCT01899144|943492|P1|Treatment Period 3|Not specified|2
280952|NCT01899144|943492|P1|Treatment Period 2|Not specified|1
280953|NCT01898884|943519|P9|Multiple Dose Period|Randomized Not Treated|1
280954|NCT01898884|943520|P8|Multiple Dose Period|Randomized Not Treated|0
280955|NCT01898884|943521|P7|Multiple Dose Period|Randomized Not Treated|0
280956|NCT01898884|943522|P6|Multiple Dose Period|Randomized Not Treated|0
280957|NCT01898884|943523|P5|Multiple Dose Period|Randomized Not Treated|0
280958|NCT01898884|943524|P4|Multiple Dose Period|Randomized Not Treated|0
280959|NCT01898884|943525|P3|Multiple Dose Period|Randomized Not Treated|0
280960|NCT01898884|943526|P2|Multiple Dose Period|Randomized Not Treated|0
280961|NCT01898884|943527|P1|Multiple Dose Period|Randomized Not Treated|0
280962|NCT01898884|943519|P9|Multiple Dose Period|Adverse Event|0
280963|NCT01898884|943520|P8|Multiple Dose Period|Adverse Event|0
280964|NCT01898884|943521|P7|Multiple Dose Period|Adverse Event|1
280965|NCT01898884|943522|P6|Multiple Dose Period|Adverse Event|0
280966|NCT01898884|943523|P5|Multiple Dose Period|Adverse Event|0
280967|NCT01898884|943524|P4|Multiple Dose Period|Adverse Event|0
280968|NCT01898884|943525|P3|Multiple Dose Period|Adverse Event|0
280969|NCT01898884|943526|P2|Multiple Dose Period|Adverse Event|0
280970|NCT01898884|943527|P1|Multiple Dose Period|Adverse Event|0
280971|NCT01898598|943679|P2|Overall Study|Other|1
280972|NCT01898598|943680|P1|Overall Study|Other|0
280973|NCT01898598|943679|P2|Overall Study|Lost to Follow-up|1
280974|NCT01898598|943680|P1|Overall Study|Lost to Follow-up|0
280975|NCT01898598|943679|P2|Overall Study|Withdrawal by Subject|0
280976|NCT01898598|943680|P1|Overall Study|Withdrawal by Subject|3
280977|NCT01898598|943679|P2|Overall Study|Adverse Event|0
280978|NCT01898598|943680|P1|Overall Study|Adverse Event|1
280979|NCT01898442|943699|P3|Overall Study|Patient vomited pills|1
280980|NCT01898442|943700|P2|Overall Study|Patient vomited pills|0
280981|NCT01898442|943701|P1|Overall Study|Patient vomited pills|0
280982|NCT01898442|943699|P3|Overall Study|Hemolysis/technical problems|2
280983|NCT01898442|943700|P2|Overall Study|Hemolysis/technical problems|2
280984|NCT01898442|943701|P1|Overall Study|Hemolysis/technical problems|1
280985|NCT01898286|943730|P1|Overall Study|Lost to Follow-up|1
280986|NCT01898286|943730|P1|Overall Study|Protocol Violation|1
280987|NCT01898286|943730|P1|Overall Study|Withdrawal by Subject|1
280988|NCT01898208|943740|P3|Overall Study|Lost to Follow-up|1
280989|NCT01898208|943741|P2|Overall Study|Lost to Follow-up|1
280990|NCT01898208|943742|P1|Overall Study|Lost to Follow-up|3
280991|NCT01898208|943740|P3|Overall Study|System/Technical Error|3
280992|NCT01898208|943741|P2|Overall Study|System/Technical Error|2
280993|NCT01898208|943742|P1|Overall Study|System/Technical Error|1
280994|NCT01898208|943740|P3|Overall Study|Non-Blood Specimens in Bottles|4
280995|NCT01898208|943741|P2|Overall Study|Non-Blood Specimens in Bottles|5
280996|NCT01898208|943742|P1|Overall Study|Non-Blood Specimens in Bottles|3
280997|NCT01898208|943740|P3|Overall Study|Negative Gram Stain|6
280998|NCT01898208|943741|P2|Overall Study|Negative Gram Stain|9
280999|NCT01898208|943742|P1|Overall Study|Negative Gram Stain|6
281000|NCT01898208|943740|P3|Overall Study|Death/comfort care within 24 hours|8
281001|NCT01898208|943741|P2|Overall Study|Death/comfort care within 24 hours|9
281002|NCT01898208|943742|P1|Overall Study|Death/comfort care within 24 hours|10
281003|NCT01898208|943740|P3|Overall Study|Positive blood culture|15
281004|NCT01898208|943741|P2|Overall Study|Positive blood culture|23
281005|NCT01898208|943742|P1|Overall Study|Positive blood culture|17
281006|NCT01898195|943789|P3|Smoking Abstinence|Did not have good measurements|36
281007|NCT01898195|943790|P2|Smoking Abstinence|Did not have good measurements|38
281008|NCT01898195|943791|P1|Smoking Abstinence|Did not have good measurements|35
281009|NCT01898091|943804|P2|Overall Study|Withdrawal by Subject|5
281010|NCT01898091|943805|P1|Overall Study|Withdrawal by Subject|1
281011|NCT01898091|943804|P2|Overall Study|Lost to Follow-up|1
281012|NCT01898091|943805|P1|Overall Study|Lost to Follow-up|1
281013|NCT01897727|943840|P2|Overall Study|Exclusion: central sleep apnea|1
281014|NCT01897727|943841|P1|Overall Study|Exclusion: central sleep apnea|0
281015|NCT01897233|943870|P1|Part B (24 Weeks)|Physician Decision|1
281016|NCT01897233|943870|P1|Part B (24 Weeks)|Withdrawal by Subject|2
281017|NCT01897233|943870|P1|Part B (24 Weeks)|Adverse Event|1
281018|NCT01896986|943903|P2|Overall Study|samples lost|23
281019|NCT01896986|943904|P1|Overall Study|samples lost|14
281020|NCT01896934|943910|P1|Overall Study|Withdrawal by Subject|1
281021|NCT01896934|943910|P1|Overall Study|Adverse Event|1
281022|NCT01896895|943919|P4|Double-blind MP|Lost to Follow-up|0
281023|NCT01896895|943920|P3|Double-blind MP|Lost to Follow-up|1
281024|NCT01896895|943921|P2|Double-blind MP|Lost to Follow-up|0
281025|NCT01896895|943922|P1|Double-blind MP|Lost to Follow-up|1
281026|NCT01896895|943919|P4|Double-blind MP|Withdrawal by Subject|0
281027|NCT01896895|943920|P3|Double-blind MP|Withdrawal by Subject|1
281028|NCT01896895|943921|P2|Double-blind MP|Withdrawal by Subject|2
281029|NCT01896895|943922|P1|Double-blind MP|Withdrawal by Subject|0
281030|NCT01896895|943919|P4|Double-blind MP|Physician Decision|0
281031|NCT01896895|943920|P3|Double-blind MP|Physician Decision|1
281032|NCT01896895|943921|P2|Double-blind MP|Physician Decision|0
281033|NCT01896895|943922|P1|Double-blind MP|Physician Decision|0
281034|NCT01896726|943937|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
281035|NCT01896726|943937|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
281036|NCT01896700|943952|P2|Overall Study|Withdrawal by Subject|1
281037|NCT01896700|943953|P1|Overall Study|Withdrawal by Subject|0
281038|NCT01896700|943952|P2|Overall Study|Adverse Event|5
281039|NCT01896700|943953|P1|Overall Study|Adverse Event|4
281040|NCT01896557|943984|P2|Clopidogrel + GI Protector|Reading error|3
281041|NCT01896557|943985|P1|Clopidogrel + GI Protector|Reading error|1
281042|NCT01896557|943984|P2|Clopidogrel + GI Protector|low adherence|1
281043|NCT01896557|943985|P1|Clopidogrel + GI Protector|low adherence|1
281044|NCT01896557|943984|P2|Clopidogrel Alone|Adverse Event|0
281045|NCT01896557|943985|P1|Clopidogrel Alone|Adverse Event|1
281046|NCT01896297|944018|P1|Overall Study|Died in post treatment phase|1
281047|NCT01896232|944025|P2|Overall Study|Lost to Follow-up|12
281048|NCT01896232|944026|P1|Overall Study|Lost to Follow-up|9
281049|NCT01896232|944025|P2|Overall Study|Sponsor Decision|0
281050|NCT01896232|944026|P1|Overall Study|Sponsor Decision|2
281051|NCT01896232|944025|P2|Overall Study|Withdrawal by Subject|31
281052|NCT01896232|944026|P1|Overall Study|Withdrawal by Subject|32
281053|NCT01896232|944025|P2|Overall Study|Death|10
281054|NCT01896232|944026|P1|Overall Study|Death|6
281055|NCT01896193|944054|P2|Overall Study|Withdrew Consent|0
281056|NCT01896193|944055|P1|Overall Study|Withdrew Consent|1
281057|NCT01896193|944054|P2|Overall Study|Protocol Violation|1
281058|NCT01896193|944055|P1|Overall Study|Protocol Violation|0
281059|NCT01896193|944054|P2|Overall Study|Lack of Efficacy|11
281060|NCT01896193|944055|P1|Overall Study|Lack of Efficacy|20
281061|NCT01896050|944107|P2|Overall Study|Death|0
281062|NCT01896050|944108|P1|Overall Study|Death|1
281063|NCT01896050|944107|P2|Overall Study|Adverse Event|2
281064|NCT01896050|944108|P1|Overall Study|Adverse Event|37
281065|NCT01895608|944156|P4|Overall Study|Withdrawal by Subject|0
281066|NCT01895608|944157|P3|Overall Study|Withdrawal by Subject|2
281067|NCT01895608|944158|P2|Overall Study|Withdrawal by Subject|0
281068|NCT01895608|944159|P1|Overall Study|Withdrawal by Subject|0
281069|NCT01895608|944156|P4|Overall Study|change in health status|0
281070|NCT01895608|944157|P3|Overall Study|change in health status|1
281071|NCT01895608|944158|P2|Overall Study|change in health status|1
281072|NCT01895608|944159|P1|Overall Study|change in health status|0
281073|NCT01895543|944189|P1|Overall Study|Other (Not fulfilling above criteria)|24
281074|NCT01895543|944189|P1|Overall Study|Physician Decision|2
281075|NCT01895543|944189|P1|Overall Study|Protocol Violation|1
281076|NCT01895543|944189|P1|Overall Study|Subject's substantial non-compliance|6
281077|NCT01895543|944189|P1|Overall Study|Adverse Event|28
281078|NCT01895543|944189|P1|Overall Study|Lost to Follow-up|25
281079|NCT01895543|944189|P1|Overall Study|Withdrawal by Subject|43
281080|NCT01895452|944205|P2|Overall Study|Noncompliance with study drug|1
281081|NCT01895452|944206|P1|Overall Study|Noncompliance with study drug|0
281082|NCT01895452|944205|P2|Overall Study|Underlying disease|3
281083|NCT01895452|944206|P1|Overall Study|Underlying disease|0
281084|NCT01895452|944205|P2|Overall Study|Withdrawal by Subject|14
281085|NCT01895452|944206|P1|Overall Study|Withdrawal by Subject|2
281086|NCT01895452|944205|P2|Overall Study|Pregnancy|1
281087|NCT01895452|944206|P1|Overall Study|Pregnancy|0
281088|NCT01895452|944205|P2|Overall Study|Lost to Follow-up|5
281089|NCT01895452|944206|P1|Overall Study|Lost to Follow-up|1
281090|NCT01895452|944205|P2|Overall Study|Adverse Event|4
281091|NCT01895452|944206|P1|Overall Study|Adverse Event|1
281092|NCT01895335|944216|P1|Overall Study|Other than Specified Above|44
281093|NCT01895335|944216|P1|Overall Study|Included But Not treated|1
281094|NCT01895335|944216|P1|Overall Study|Poor Compliance to Protocol|11
281095|NCT01895335|944216|P1|Overall Study|Lack of Efficacy|53
281096|NCT01895335|944216|P1|Overall Study|Adverse Event|106
281097|NCT01895322|944233|P1|Overall Study|Protocol Violation|10
281098|NCT01895322|944233|P1|Overall Study|Withdrawal by Subject|2
281099|NCT01895322|944233|P1|Overall Study|Adverse Event|1
281100|NCT01895309|944242|P2|Overall Study|Withdrawal by Subject|18
281101|NCT01895309|944243|P1|Overall Study|Withdrawal by Subject|9
281102|NCT01895309|944242|P2|Overall Study|Physician Decision|10
281103|NCT01895309|944243|P1|Overall Study|Physician Decision|15
281104|NCT01895309|944242|P2|Overall Study|Lost to Follow-up|3
281105|NCT01895309|944243|P1|Overall Study|Lost to Follow-up|1
281106|NCT01895309|944242|P2|Overall Study|Lack of Efficacy|3
281107|NCT01895309|944243|P1|Overall Study|Lack of Efficacy|1
281108|NCT01895309|944242|P2|Overall Study|Protocol Violation|0
281109|NCT01895309|944243|P1|Overall Study|Protocol Violation|1
281110|NCT01895309|944242|P2|Overall Study|Adverse Event|17
281111|NCT01895309|944243|P1|Overall Study|Adverse Event|13
281112|NCT01895270|944257|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
281113|NCT01895270|944258|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
281114|NCT01895270|944257|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
281115|NCT01895270|944258|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
281116|NCT01895270|944257|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
281117|NCT01895270|944258|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
281118|NCT01895270|944257|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
281119|NCT01895270|944258|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
281120|NCT01895270|944257|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
281121|NCT01895270|944258|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
281122|NCT01895270|944257|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
281123|NCT01895270|944258|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
281124|NCT01895270|944257|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
281125|NCT01895270|944258|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
281126|NCT01895101|944277|P3|Overall Study|coagulation disorder|0
281127|NCT01895101|944278|P2|Overall Study|coagulation disorder|1
281128|NCT01895101|944279|P1|Overall Study|coagulation disorder|0
281129|NCT01895101|944277|P3|Overall Study|Death|0
281130|NCT01895101|944278|P2|Overall Study|Death|1
281131|NCT01895101|944279|P1|Overall Study|Death|0
281132|NCT01895101|944277|P3|Overall Study|another study, enrolled in other study|0
281133|NCT01895101|944278|P2|Overall Study|another study, enrolled in other study|1
281134|NCT01895101|944279|P1|Overall Study|another study, enrolled in other study|0
281135|NCT01895101|944277|P3|Overall Study|Withdrawal by Subject|2
281136|NCT01895101|944278|P2|Overall Study|Withdrawal by Subject|1
281137|NCT01895101|944279|P1|Overall Study|Withdrawal by Subject|0
281138|NCT01895101|944277|P3|Overall Study|OPCAB procedure|3
281139|NCT01895101|944278|P2|Overall Study|OPCAB procedure|1
281140|NCT01895101|944279|P1|Overall Study|OPCAB procedure|1
281141|NCT01894984|944314|P2|Overall Study|Other|175
281142|NCT01894984|944315|P1|Overall Study|Other|314
281143|NCT01894620|944372|P2|Overall Study|Withdrawal by Subject|1
281144|NCT01894620|944373|P1|Overall Study|Withdrawal by Subject|0
281145|NCT01894607|944381|P1|Overall Study|Ineligible|1
281146|NCT01894581|944388|P2|Overall Study|Screen Failure|4
281147|NCT01894581|944389|P1|Overall Study|Screen Failure|3
281148|NCT01894581|944388|P2|Overall Study|Withdrawal by Subject|3
281149|NCT01894581|944389|P1|Overall Study|Withdrawal by Subject|2
281150|NCT01894477|944406|P2|Overall Study|protocol changed due SC changed to cord|1
281151|NCT01894477|944407|P1|Overall Study|protocol changed due SC changed to cord|0
281152|NCT01894477|944406|P2|Overall Study|Protocol Violation|1
281153|NCT01894477|944407|P1|Overall Study|Protocol Violation|0
281154|NCT01894256|944418|P3|Part B|Lack of Efficacy|13
281155|NCT01894256|944419|P2|Part B|Lack of Efficacy|12
281156|NCT01894256|944420|P1|Part B|Lack of Efficacy|15
281157|NCT01894256|944418|P3|Part B|Withdrawal by Subject|0
281158|NCT01894256|944419|P2|Part B|Withdrawal by Subject|1
281159|NCT01894256|944420|P1|Part B|Withdrawal by Subject|0
281160|NCT01894256|944418|P3|Part B|Death|1
281161|NCT01894256|944419|P2|Part B|Death|1
281162|NCT01894256|944420|P1|Part B|Death|0
281163|NCT01894256|944418|P3|Part A|Adverse Event|0
281164|NCT01894256|944419|P2|Part A|Adverse Event|1
281165|NCT01894256|944420|P1|Part A|Adverse Event|0
281166|NCT01894230|944466|P2|Overall Study|Death|0
281167|NCT01894230|944467|P1|Overall Study|Death|1
281168|NCT01894230|944466|P2|Overall Study|Non-adherent|1
281169|NCT01894230|944467|P1|Overall Study|Non-adherent|0
281170|NCT01894230|944466|P2|Overall Study|Withdrawal by Subject|4
281171|NCT01894230|944467|P1|Overall Study|Withdrawal by Subject|4
281172|NCT01894230|944466|P2|Overall Study|Lost to Follow-up|2
281173|NCT01894230|944467|P1|Overall Study|Lost to Follow-up|2
281174|NCT01894100|944493|P2|Overall Study|Withdrawal by Subject|0
281175|NCT01894100|944494|P1|Overall Study|Withdrawal by Subject|3
281176|NCT01894100|944493|P2|Overall Study|Lost to Follow-up|1
281177|NCT01894100|944494|P1|Overall Study|Lost to Follow-up|0
281178|NCT01894022|944519|P2|Overall Study|Study Closed/terminated|10
281179|NCT01894022|944520|P1|Overall Study|Study Closed/terminated|7
281180|NCT01894022|944519|P2|Overall Study|Adverse Event, non-fatal|0
281181|NCT01894022|944520|P1|Overall Study|Adverse Event, non-fatal|1
281182|NCT01894022|944519|P2|Overall Study|Death|0
281183|NCT01894022|944520|P1|Overall Study|Death|1
281184|NCT01893905|944574|P2|Overall Study|Other reason|3
281185|NCT01893905|944575|P1|Overall Study|Other reason|1
281186|NCT01893905|944574|P2|Overall Study|Lack of adherence to treatment|0
281187|NCT01893905|944575|P1|Overall Study|Lack of adherence to treatment|2
281188|NCT01893905|944574|P2|Overall Study|Protocol Violation|1
281189|NCT01893905|944575|P1|Overall Study|Protocol Violation|6
281190|NCT01893905|944574|P2|Overall Study|Lost to Follow-up|0
281191|NCT01893905|944575|P1|Overall Study|Lost to Follow-up|1
281192|NCT01893905|944574|P2|Overall Study|Lack of Efficacy|7
281193|NCT01893905|944575|P1|Overall Study|Lack of Efficacy|5
281194|NCT01893905|944574|P2|Overall Study|Adverse Event|3
281195|NCT01893905|944575|P1|Overall Study|Adverse Event|9
281196|NCT01893905|944574|P2|Overall Study|Withdrawal by Subject|0
281197|NCT01893905|944575|P1|Overall Study|Withdrawal by Subject|1
281198|NCT01893411|944597|P3|Overall Study|Lost to Follow-up|1
281199|NCT01893411|944598|P2|Overall Study|Lost to Follow-up|0
281200|NCT01893411|944599|P1|Overall Study|Lost to Follow-up|2
281201|NCT01893411|944597|P3|Overall Study|Withdrawal by Subject|3
281202|NCT01893411|944598|P2|Overall Study|Withdrawal by Subject|4
281203|NCT01893411|944599|P1|Overall Study|Withdrawal by Subject|7
281204|NCT01893411|944597|P3|Overall Study|Adverse Event|0
281205|NCT01893411|944598|P2|Overall Study|Adverse Event|0
281206|NCT01893411|944599|P1|Overall Study|Adverse Event|1
281207|NCT01893411|944597|P3|Overall Study|Not Specified|3
281208|NCT01893411|944598|P2|Overall Study|Not Specified|1
281209|NCT01893411|944599|P1|Overall Study|Not Specified|3
281210|NCT01893411|944597|P3|Overall Study|Lack of Efficacy|0
281211|NCT01893411|944598|P2|Overall Study|Lack of Efficacy|1
281212|NCT01893411|944599|P1|Overall Study|Lack of Efficacy|2
281213|NCT01893411|944597|P3|Overall Study|Physician Decision|2
281214|NCT01893411|944598|P2|Overall Study|Physician Decision|1
281215|NCT01893411|944599|P1|Overall Study|Physician Decision|1
281216|NCT01893411|944597|P3|Overall Study|Protocol Violation|0
281217|NCT01893411|944598|P2|Overall Study|Protocol Violation|0
281218|NCT01893411|944599|P1|Overall Study|Protocol Violation|1
281219|NCT01893346|944681|P4|Overall Study|Withdrawal by Subject|0
281220|NCT01893346|944682|P3|Overall Study|Withdrawal by Subject|0
281221|NCT01893346|944683|P2|Overall Study|Withdrawal by Subject|0
281222|NCT01893346|944684|P1|Overall Study|Withdrawal by Subject|2
281223|NCT01893346|944681|P4|Overall Study|Protocol Violation|0
281224|NCT01893346|944682|P3|Overall Study|Protocol Violation|0
281225|NCT01893346|944683|P2|Overall Study|Protocol Violation|0
281226|NCT01893346|944684|P1|Overall Study|Protocol Violation|1
281227|NCT01893346|944681|P4|Overall Study|Lost to Follow-up|0
281228|NCT01893346|944682|P3|Overall Study|Lost to Follow-up|0
281229|NCT01893346|944683|P2|Overall Study|Lost to Follow-up|1
281230|NCT01893346|944684|P1|Overall Study|Lost to Follow-up|0
281231|NCT01893281|944698|P1|Overall Study|Withdrawal by Subject|1
281232|NCT01893281|944698|P1|Overall Study|Protocol Violation|1
281233|NCT01893281|944698|P1|Overall Study|Adverse Event|1
281234|NCT01893203|944705|P1|Overall Study|Withdrawal by Subject|1
281235|NCT01892657|944737|P1|Overall Study|Protocol Violation|12
281236|NCT01892657|944737|P1|Overall Study|Withdrawal by Subject|6
281237|NCT01892189|944814|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281238|NCT01892189|944815|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281239|NCT01892189|944816|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281240|NCT01892189|944817|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
281241|NCT01892189|944818|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281242|NCT01892189|944819|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281243|NCT01892189|944820|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281244|NCT01892189|944821|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281245|NCT01892189|944822|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
281246|NCT01892189|944814|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
281247|NCT01892189|944815|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
281248|NCT01892189|944816|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
281249|NCT01892189|944817|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
281250|NCT01892189|944818|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
281251|NCT01892189|944819|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
281252|NCT01892189|944820|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
281253|NCT01892189|944821|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
281254|NCT01892189|944822|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
281255|NCT01892189|944814|P9|Washout Period 1 (7 Days)|Adverse Event|1
281256|NCT01892189|944815|P8|Washout Period 1 (7 Days)|Adverse Event|0
281257|NCT01892189|944816|P7|Washout Period 1 (7 Days)|Adverse Event|0
281258|NCT01892189|944817|P6|Washout Period 1 (7 Days)|Adverse Event|0
281259|NCT01892189|944818|P5|Washout Period 1 (7 Days)|Adverse Event|0
281260|NCT01892189|944819|P4|Washout Period 1 (7 Days)|Adverse Event|0
281261|NCT01892189|944820|P3|Washout Period 1 (7 Days)|Adverse Event|0
281262|NCT01892189|944821|P2|Washout Period 1 (7 Days)|Adverse Event|0
281263|NCT01892189|944822|P1|Washout Period 1 (7 Days)|Adverse Event|0
281264|NCT01892163|944864|P2|Overall Study|Lost to Follow-up|0
281265|NCT01892163|944865|P1|Overall Study|Lost to Follow-up|1
281266|NCT01892163|944864|P2|Overall Study|Death|1
281267|NCT01892163|944865|P1|Overall Study|Death|1
281268|NCT01892020|944877|P2|Period 2|Protocol Violation|0
281269|NCT01892020|944878|P1|Period 2|Protocol Violation|1
281270|NCT01892020|944877|P2|Period 1|Unclassified|1
281271|NCT01892020|944878|P1|Period 1|Unclassified|0
281272|NCT01892020|944877|P2|Period 1|Protocol Violation|4
281273|NCT01892020|944878|P1|Period 1|Protocol Violation|2
281274|NCT01892020|944877|P2|Period 1|Adverse Event|1
281275|NCT01892020|944878|P1|Period 1|Adverse Event|1
281276|NCT01891890|944903|P3|Overall Study|Study ended before endpoint reached|6
281277|NCT01891890|944904|P2|Overall Study|Study ended before endpoint reached|3
281278|NCT01891890|944905|P1|Overall Study|Study ended before endpoint reached|7
281279|NCT01891890|944903|P3|Overall Study|Lost to Follow-up|1
281280|NCT01891890|944904|P2|Overall Study|Lost to Follow-up|0
281281|NCT01891890|944905|P1|Overall Study|Lost to Follow-up|0
281282|NCT01891864|944948|P6|Extension Period|Lost to Follow-up|0
281283|NCT01891864|944949|P5|Extension Period|Lost to Follow-up|0
281284|NCT01891864|944950|P4|Extension Period|Lost to Follow-up|0
281285|NCT01891864|944951|P3|Extension Period|Lost to Follow-up|2
281286|NCT01891864|944952|P2|Extension Period|Lost to Follow-up|0
281287|NCT01891864|944953|P1|Extension Period|Lost to Follow-up|0
281288|NCT01891864|944948|P6|Extension Period|Withdrawal by Subject|0
281289|NCT01891864|944949|P5|Extension Period|Withdrawal by Subject|4
281290|NCT01891864|944950|P4|Extension Period|Withdrawal by Subject|2
281291|NCT01891864|944951|P3|Extension Period|Withdrawal by Subject|1
281292|NCT01891864|944952|P2|Extension Period|Withdrawal by Subject|0
281293|NCT01891864|944953|P1|Extension Period|Withdrawal by Subject|0
281294|NCT01891864|944948|P6|Extension Period|Adverse Event|0
281295|NCT01891864|944949|P5|Extension Period|Adverse Event|2
281296|NCT01891864|944950|P4|Extension Period|Adverse Event|2
281297|NCT01891864|944951|P3|Extension Period|Adverse Event|4
281298|NCT01891864|944952|P2|Extension Period|Adverse Event|0
281299|NCT01891864|944953|P1|Extension Period|Adverse Event|0
281300|NCT01891864|944948|P6|Extension Period|Pregnancy|0
281301|NCT01891864|944949|P5|Extension Period|Pregnancy|0
281302|NCT01891864|944950|P4|Extension Period|Pregnancy|0
281303|NCT01891864|944951|P3|Extension Period|Pregnancy|1
281304|NCT01891864|944952|P2|Extension Period|Pregnancy|0
281305|NCT01891864|944953|P1|Extension Period|Pregnancy|0
281306|NCT01891864|944948|P6|Extension Period|Lack of Efficacy|0
281307|NCT01891864|944949|P5|Extension Period|Lack of Efficacy|1
281308|NCT01891864|944950|P4|Extension Period|Lack of Efficacy|1
281309|NCT01891864|944951|P3|Extension Period|Lack of Efficacy|0
281310|NCT01891864|944952|P2|Extension Period|Lack of Efficacy|0
281311|NCT01891864|944953|P1|Extension Period|Lack of Efficacy|0
281312|NCT01891864|944948|P6|Treatment Period 2|Withdrawal by Subject|1
281313|NCT01891864|944949|P5|Treatment Period 2|Withdrawal by Subject|1
281314|NCT01891864|944950|P4|Treatment Period 2|Withdrawal by Subject|4
281315|NCT01891864|944951|P3|Treatment Period 2|Withdrawal by Subject|3
281316|NCT01891864|944952|P2|Treatment Period 2|Withdrawal by Subject|0
281317|NCT01891864|944953|P1|Treatment Period 2|Withdrawal by Subject|0
281318|NCT01891864|944948|P6|Treatment Period 2|Termination of Site|0
281319|NCT01891864|944949|P5|Treatment Period 2|Termination of Site|2
281320|NCT01891864|944950|P4|Treatment Period 2|Termination of Site|0
281321|NCT01891864|944951|P3|Treatment Period 2|Termination of Site|0
281322|NCT01891864|944952|P2|Treatment Period 2|Termination of Site|0
281323|NCT01891864|944953|P1|Treatment Period 2|Termination of Site|0
281324|NCT01891864|944948|P6|Treatment Period 2|Adverse Event|4
281325|NCT01891864|944949|P5|Treatment Period 2|Adverse Event|0
281326|NCT01891864|944950|P4|Treatment Period 2|Adverse Event|2
281327|NCT01891864|944951|P3|Treatment Period 2|Adverse Event|1
281328|NCT01891864|944952|P2|Treatment Period 2|Adverse Event|0
281329|NCT01891864|944953|P1|Treatment Period 2|Adverse Event|0
281330|NCT01891864|944948|P6|Treatment Period 2|Lack of Efficacy|0
281331|NCT01891864|944949|P5|Treatment Period 2|Lack of Efficacy|1
281332|NCT01891864|944950|P4|Treatment Period 2|Lack of Efficacy|0
281333|NCT01891864|944951|P3|Treatment Period 2|Lack of Efficacy|1
281334|NCT01891864|944952|P2|Treatment Period 2|Lack of Efficacy|0
281335|NCT01891864|944953|P1|Treatment Period 2|Lack of Efficacy|0
281336|NCT01891864|944948|P6|Treatment Period 2|Site Termination|0
281337|NCT01891864|944949|P5|Treatment Period 2|Site Termination|0
281338|NCT01891864|944950|P4|Treatment Period 2|Site Termination|2
281339|NCT01891864|944951|P3|Treatment Period 2|Site Termination|1
281340|NCT01891864|944952|P2|Treatment Period 2|Site Termination|0
281341|NCT01891864|944953|P1|Treatment Period 2|Site Termination|0
281342|NCT01891864|944948|P6|Treatment Period 2|Physician Decision|0
281343|NCT01891864|944949|P5|Treatment Period 2|Physician Decision|0
281344|NCT01891864|944950|P4|Treatment Period 2|Physician Decision|0
281345|NCT01891864|944951|P3|Treatment Period 2|Physician Decision|1
281346|NCT01891864|944952|P2|Treatment Period 2|Physician Decision|0
281347|NCT01891864|944953|P1|Treatment Period 2|Physician Decision|0
281348|NCT01891864|944948|P6|Treatment Period 2|Protocol Violation|0
281349|NCT01891864|944949|P5|Treatment Period 2|Protocol Violation|0
281350|NCT01891864|944950|P4|Treatment Period 2|Protocol Violation|1
281351|NCT01891864|944951|P3|Treatment Period 2|Protocol Violation|0
281352|NCT01891864|944952|P2|Treatment Period 2|Protocol Violation|0
281353|NCT01891864|944953|P1|Treatment Period 2|Protocol Violation|0
281354|NCT01891864|944948|P6|Treatment Period 1|Lost to Follow-up|0
281355|NCT01891864|944949|P5|Treatment Period 1|Lost to Follow-up|0
281356|NCT01891864|944950|P4|Treatment Period 1|Lost to Follow-up|0
281357|NCT01891864|944951|P3|Treatment Period 1|Lost to Follow-up|0
281358|NCT01891864|944952|P2|Treatment Period 1|Lost to Follow-up|0
281359|NCT01891864|944953|P1|Treatment Period 1|Lost to Follow-up|1
281360|NCT01891864|944948|P6|Treatment Period 1|Withdrawal by Subject|0
281361|NCT01891864|944949|P5|Treatment Period 1|Withdrawal by Subject|0
281362|NCT01891864|944950|P4|Treatment Period 1|Withdrawal by Subject|0
281363|NCT01891864|944951|P3|Treatment Period 1|Withdrawal by Subject|0
281364|NCT01891864|944952|P2|Treatment Period 1|Withdrawal by Subject|5
281365|NCT01891864|944953|P1|Treatment Period 1|Withdrawal by Subject|2
281366|NCT01891864|944948|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
281367|NCT01891864|944949|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
281368|NCT01891864|944950|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
281369|NCT01891864|944951|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
281370|NCT01891864|944952|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
281371|NCT01891864|944953|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
281372|NCT01891864|944948|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
281373|NCT01891864|944949|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
281374|NCT01891864|944950|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
281375|NCT01891864|944951|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
281376|NCT01891864|944952|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
281377|NCT01891864|944953|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
281378|NCT01891864|944948|P6|Treatment Period 1|Physician Decision|0
281379|NCT01891864|944949|P5|Treatment Period 1|Physician Decision|0
281380|NCT01891864|944950|P4|Treatment Period 1|Physician Decision|0
281381|NCT01891864|944951|P3|Treatment Period 1|Physician Decision|0
281382|NCT01891864|944952|P2|Treatment Period 1|Physician Decision|1
281383|NCT01891864|944953|P1|Treatment Period 1|Physician Decision|0
281384|NCT01891864|944948|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
281385|NCT01891864|944949|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
281386|NCT01891864|944950|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
281387|NCT01891864|944951|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
281388|NCT01891864|944952|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
281389|NCT01891864|944953|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
281390|NCT01891669|944996|P10|Overall Study|Other|0
281391|NCT01891669|944997|P9|Overall Study|Other|0
281392|NCT01891669|944998|P8|Overall Study|Other|1
281393|NCT01891669|944999|P7|Overall Study|Other|0
281394|NCT01891669|945000|P6|Overall Study|Other|0
281395|NCT01891669|945001|P5|Overall Study|Other|0
281396|NCT01891669|945002|P4|Overall Study|Other|0
281397|NCT01891669|945003|P3|Overall Study|Other|0
281398|NCT01891669|945004|P2|Overall Study|Other|0
281399|NCT01891669|945005|P1|Overall Study|Other|1
281400|NCT01891669|944996|P10|Overall Study|Withdrawal by Subject|1
281401|NCT01891669|944997|P9|Overall Study|Withdrawal by Subject|1
281402|NCT01891669|944998|P8|Overall Study|Withdrawal by Subject|2
281403|NCT01891669|944999|P7|Overall Study|Withdrawal by Subject|1
281404|NCT01891669|945000|P6|Overall Study|Withdrawal by Subject|0
281405|NCT01891669|945001|P5|Overall Study|Withdrawal by Subject|0
281406|NCT01891669|945002|P4|Overall Study|Withdrawal by Subject|0
281407|NCT01891669|945003|P3|Overall Study|Withdrawal by Subject|0
281408|NCT01891669|945004|P2|Overall Study|Withdrawal by Subject|1
281409|NCT01891669|945005|P1|Overall Study|Withdrawal by Subject|1
281410|NCT01891669|944996|P10|Overall Study|Death|1
281411|NCT01891669|944997|P9|Overall Study|Death|0
281412|NCT01891669|944998|P8|Overall Study|Death|1
281413|NCT01891669|944999|P7|Overall Study|Death|0
281414|NCT01891669|945000|P6|Overall Study|Death|0
281415|NCT01891669|945001|P5|Overall Study|Death|0
281416|NCT01891669|945002|P4|Overall Study|Death|0
281417|NCT01891669|945003|P3|Overall Study|Death|0
281418|NCT01891669|945004|P2|Overall Study|Death|0
281419|NCT01891669|945005|P1|Overall Study|Death|0
281420|NCT01890967|945162|P6|Overall Study|Withdrawal by Subject|1
281421|NCT01890967|945163|P5|Overall Study|Withdrawal by Subject|3
281422|NCT01890967|945164|P4|Overall Study|Withdrawal by Subject|3
281423|NCT01890967|945165|P3|Overall Study|Withdrawal by Subject|2
281424|NCT01890967|945166|P2|Overall Study|Withdrawal by Subject|4
281425|NCT01890967|945167|P1|Overall Study|Withdrawal by Subject|3
281426|NCT01890967|945162|P6|Overall Study|Sponsor Decision|3
281427|NCT01890967|945163|P5|Overall Study|Sponsor Decision|2
281428|NCT01890967|945164|P4|Overall Study|Sponsor Decision|3
281429|NCT01890967|945165|P3|Overall Study|Sponsor Decision|1
281430|NCT01890967|945166|P2|Overall Study|Sponsor Decision|0
281431|NCT01890967|945167|P1|Overall Study|Sponsor Decision|2
281432|NCT01890967|945162|P6|Overall Study|Protocol Violation|1
281433|NCT01890967|945163|P5|Overall Study|Protocol Violation|4
281434|NCT01890967|945164|P4|Overall Study|Protocol Violation|2
281435|NCT01890967|945165|P3|Overall Study|Protocol Violation|3
281436|NCT01890967|945166|P2|Overall Study|Protocol Violation|3
281437|NCT01890967|945167|P1|Overall Study|Protocol Violation|0
281438|NCT01890967|945162|P6|Overall Study|Lost to Follow-up|1
281439|NCT01890967|945163|P5|Overall Study|Lost to Follow-up|0
281440|NCT01890967|945164|P4|Overall Study|Lost to Follow-up|1
281441|NCT01890967|945165|P3|Overall Study|Lost to Follow-up|1
281442|NCT01890967|945166|P2|Overall Study|Lost to Follow-up|1
281443|NCT01890967|945167|P1|Overall Study|Lost to Follow-up|1
281444|NCT01890967|945162|P6|Overall Study|Death|0
281445|NCT01890967|945163|P5|Overall Study|Death|0
281446|NCT01890967|945164|P4|Overall Study|Death|0
281447|NCT01890967|945165|P3|Overall Study|Death|0
281448|NCT01890967|945166|P2|Overall Study|Death|0
281449|NCT01890967|945167|P1|Overall Study|Death|1
281450|NCT01890967|945162|P6|Overall Study|Adverse Event|7
281451|NCT01890967|945163|P5|Overall Study|Adverse Event|1
281452|NCT01890967|945164|P4|Overall Study|Adverse Event|2
281453|NCT01890967|945165|P3|Overall Study|Adverse Event|3
281454|NCT01890967|945166|P2|Overall Study|Adverse Event|3
281455|NCT01890967|945167|P1|Overall Study|Adverse Event|3
281456|NCT01890915|945245|P2|Overall Study|Equipment Malfunction|1
281457|NCT01890915|945246|P1|Overall Study|Equipment Malfunction|0
281458|NCT01890915|945245|P2|Overall Study|Protocol Violation|0
281459|NCT01890915|945246|P1|Overall Study|Protocol Violation|2
281460|NCT01890915|945245|P2|Overall Study|Adverse Event|0
281461|NCT01890915|945246|P1|Overall Study|Adverse Event|1
281462|NCT01890785|945262|P6|Third Intervention|Withdrawal by Subject|0
281463|NCT01890785|945263|P5|Third Intervention|Withdrawal by Subject|0
281464|NCT01890785|945264|P4|Third Intervention|Withdrawal by Subject|0
281465|NCT01890785|945265|P3|Third Intervention|Withdrawal by Subject|0
281466|NCT01890785|945266|P2|Third Intervention|Withdrawal by Subject|1
281467|NCT01890785|945267|P1|Third Intervention|Withdrawal by Subject|0
281468|NCT01890759|945286|P2|Overall Study|Withdrawal by Subject|8
281469|NCT01890759|945287|P1|Overall Study|Withdrawal by Subject|2
281470|NCT01890759|945286|P2|Overall Study|Lost to Follow-up|2
281471|NCT01890759|945287|P1|Overall Study|Lost to Follow-up|0
281472|NCT01890759|945286|P2|Overall Study|Protocol Violation|2
281473|NCT01890759|945287|P1|Overall Study|Protocol Violation|0
281474|NCT01890746|945321|P2|Overall Study|Ongoing|50
281475|NCT01890746|945322|P1|Overall Study|Ongoing|44
281476|NCT01890746|945321|P2|Overall Study|Death|14
281477|NCT01890746|945322|P1|Overall Study|Death|23
281478|NCT01890746|945321|P2|Overall Study|Withdrawal by Subject|8
281479|NCT01890746|945322|P1|Overall Study|Withdrawal by Subject|4
281480|NCT01890746|945321|P2|Overall Study|Physician Decision|2
281481|NCT01890746|945322|P1|Overall Study|Physician Decision|2
281482|NCT01890746|945321|P2|Overall Study|Adverse Event|0
281483|NCT01890746|945322|P1|Overall Study|Adverse Event|1
281484|NCT01890512|945419|P1|Overall Study|Protocol Violation|1
281485|NCT01890512|945419|P1|Overall Study|Withdrawal by Subject|1
281486|NCT01890512|945419|P1|Overall Study|Physician Decision|1
281487|NCT01890473|945425|P2|Overall Study|Poor/non-compliance|0
281488|NCT01890473|945426|P1|Overall Study|Poor/non-compliance|1
281489|NCT01890473|945425|P2|Overall Study|Lost to Follow-up|0
281490|NCT01890473|945426|P1|Overall Study|Lost to Follow-up|1
281491|NCT01890434|945452|P1|Overall Study|Withdrawal by PI for ICA not performed|2
281492|NCT01890434|945452|P1|Overall Study|Unable to contact|1
281493|NCT01890434|945452|P1|Overall Study|Moved out of position|1
281494|NCT01890434|945452|P1|Overall Study|Uncontactable by phone|1
281495|NCT01890434|945452|P1|Overall Study|Participant didn't complete MRI|1
281496|NCT01890434|945452|P1|Overall Study|GSPECT at rest was not done|1
281497|NCT01890434|945452|P1|Overall Study|Decline to return for GSPECT|1
281498|NCT01890434|945452|P1|Overall Study|Could not get whole set of images|1
281499|NCT01890434|945452|P1|Overall Study|CRC didn't contact participant for FU|1
281500|NCT01890434|945452|P1|Overall Study|Assessment discrepancy|1
281501|NCT01890434|945452|P1|Overall Study|PCI at external hospital|1
281502|NCT01890434|945452|P1|Overall Study|Adverse Event|8
281503|NCT01890421|945482|P1|Overall Study|Other reason|10
281504|NCT01890421|945482|P1|Overall Study|Adverse Event|1
281505|NCT01890148|945521|P1|Overall Study|Adverse Event|1
281506|NCT01890122|945541|P4|Overall Study|Randomized but not Treated|0
281507|NCT01890122|945542|P3|Overall Study|Randomized but not Treated|0
281508|NCT01890122|945543|P2|Overall Study|Randomized but not Treated|1
281509|NCT01890122|945544|P1|Overall Study|Randomized but not Treated|1
281510|NCT01890122|945541|P4|Overall Study|Reason not Specified|2
281511|NCT01890122|945542|P3|Overall Study|Reason not Specified|1
281512|NCT01890122|945543|P2|Overall Study|Reason not Specified|1
281513|NCT01890122|945544|P1|Overall Study|Reason not Specified|0
281514|NCT01890122|945541|P4|Overall Study|Lack of Efficacy|41
281515|NCT01890122|945542|P3|Overall Study|Lack of Efficacy|7
281516|NCT01890122|945543|P2|Overall Study|Lack of Efficacy|24
281517|NCT01890122|945544|P1|Overall Study|Lack of Efficacy|14
281518|NCT01890122|945541|P4|Overall Study|Voluntary Withdrawal|11
281519|NCT01890122|945542|P3|Overall Study|Voluntary Withdrawal|2
281520|NCT01890122|945543|P2|Overall Study|Voluntary Withdrawal|8
281521|NCT01890122|945544|P1|Overall Study|Voluntary Withdrawal|8
281522|NCT01890122|945541|P4|Overall Study|Lost to Follow-up|2
281523|NCT01890122|945542|P3|Overall Study|Lost to Follow-up|2
281524|NCT01890122|945543|P2|Overall Study|Lost to Follow-up|1
281525|NCT01890122|945544|P1|Overall Study|Lost to Follow-up|0
281526|NCT01890122|945541|P4|Overall Study|Major Protocol Deviation|1
281527|NCT01890122|945542|P3|Overall Study|Major Protocol Deviation|0
281528|NCT01890122|945543|P2|Overall Study|Major Protocol Deviation|1
281529|NCT01890122|945544|P1|Overall Study|Major Protocol Deviation|3
281530|NCT01890122|945541|P4|Overall Study|Adverse Event|2
281531|NCT01890122|945542|P3|Overall Study|Adverse Event|1
281532|NCT01890122|945543|P2|Overall Study|Adverse Event|1
281533|NCT01890122|945544|P1|Overall Study|Adverse Event|1
281534|NCT01889251|945691|P2|Overall Study|Adverse Event|0
281535|NCT01889251|945692|P1|Overall Study|Adverse Event|1
281536|NCT01888965|945698|P1|Overall Study|Lack of Efficacy|4
281537|NCT01888965|945698|P1|Overall Study|Adverse Event|5
281538|NCT01888900|945710|P2|Overall Study|failed treatment|2
281539|NCT01888900|945711|P1|Overall Study|failed treatment|0
281540|NCT01888367|945734|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
281541|NCT01888367|945735|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
281542|NCT01888367|945736|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
281543|NCT01888367|945734|P3|Overall Study|Protocol Violation|1
281544|NCT01888367|945735|P2|Overall Study|Protocol Violation|0
281545|NCT01888367|945736|P1|Overall Study|Protocol Violation|0
281546|NCT01888367|945734|P3|Overall Study|Lost to Follow-up|0
281547|NCT01888367|945735|P2|Overall Study|Lost to Follow-up|1
281548|NCT01888367|945736|P1|Overall Study|Lost to Follow-up|1
281549|NCT01888367|945734|P3|Overall Study|Withdrawal by Subject|1
281550|NCT01888367|945735|P2|Overall Study|Withdrawal by Subject|0
281551|NCT01888367|945736|P1|Overall Study|Withdrawal by Subject|1
281552|NCT01888367|945734|P3|Overall Study|Death|1
281553|NCT01888367|945735|P2|Overall Study|Death|0
281554|NCT01888367|945736|P1|Overall Study|Death|2
281555|NCT01888367|945734|P3|Overall Study|Physician Decision|2
281556|NCT01888367|945735|P2|Overall Study|Physician Decision|4
281557|NCT01888367|945736|P1|Overall Study|Physician Decision|3
281558|NCT01888003|945756|P3|Overall Study|Study Terminated|40
281559|NCT01888003|945757|P2|Overall Study|Study Terminated|6
281560|NCT01888003|945758|P1|Overall Study|Study Terminated|5
281561|NCT01887678|945798|P2|Overall Study|Specified|2
281562|NCT01887678|945799|P1|Overall Study|Specified|1
281563|NCT01887678|945798|P2|Overall Study|Non-compliance|3
281564|NCT01887678|945799|P1|Overall Study|Non-compliance|0
281565|NCT01887678|945798|P2|Overall Study|Lack of Efficacy|2
281566|NCT01887678|945799|P1|Overall Study|Lack of Efficacy|1
281567|NCT01887678|945798|P2|Overall Study|Deterioration of clinical condition|4
281568|NCT01887678|945799|P1|Overall Study|Deterioration of clinical condition|0
281569|NCT01887678|945798|P2|Overall Study|Lost to Follow-up|2
281570|NCT01887678|945799|P1|Overall Study|Lost to Follow-up|4
281571|NCT01887678|945798|P2|Overall Study|Withdrawal of consent|4
281572|NCT01887678|945799|P1|Overall Study|Withdrawal of consent|3
281573|NCT01887678|945798|P2|Overall Study|Exceeded rescue medication dosage|5
281574|NCT01887678|945799|P1|Overall Study|Exceeded rescue medication dosage|4
281575|NCT01887678|945798|P2|Overall Study|Adverse Event|6
281576|NCT01887678|945799|P1|Overall Study|Adverse Event|4
281577|NCT01887418|945867|P3|Overall Study|Travelling difficulties|1
281578|NCT01887418|945868|P2|Overall Study|Travelling difficulties|0
281579|NCT01887418|945869|P1|Overall Study|Travelling difficulties|0
281580|NCT01887353|945888|P2|Overall Study|Study stopped early|3
281581|NCT01887353|945889|P1|Overall Study|Study stopped early|4
281582|NCT01887288|945895|P1|Overall Study|The study was terminated and the PI has|16
281583|NCT01886781|945947|P2|Overall Study|Worsening of symptoms|1
281584|NCT01886781|945948|P1|Overall Study|Worsening of symptoms|1
281585|NCT01886781|945947|P2|Overall Study|Withdrawal by Subject|1
281586|NCT01886781|945948|P1|Overall Study|Withdrawal by Subject|2
281587|NCT01886781|945947|P2|Overall Study|Lost to Follow-up|0
281588|NCT01886781|945948|P1|Overall Study|Lost to Follow-up|5
281589|NCT01886781|945947|P2|Overall Study|Adverse Event|0
281590|NCT01886781|945948|P1|Overall Study|Adverse Event|1
281591|NCT01886781|945947|P2|Overall Study|Protocol Violation|0
281592|NCT01886781|945948|P1|Overall Study|Protocol Violation|5
281593|NCT01886716|945958|P4|Week 3|Lost to Follow-up|1
281594|NCT01886716|945959|P3|Week 3|Lost to Follow-up|0
281595|NCT01886716|945960|P2|Week 3|Lost to Follow-up|1
281596|NCT01886716|945961|P1|Week 3|Lost to Follow-up|1
281597|NCT01886716|945958|P4|Week 2|Lost to Follow-up|3
281598|NCT01886716|945959|P3|Week 2|Lost to Follow-up|1
281599|NCT01886716|945960|P2|Week 2|Lost to Follow-up|2
281600|NCT01886716|945961|P1|Week 2|Lost to Follow-up|3
281601|NCT01886716|945958|P4|Week 1|Lost to Follow-up|2
281602|NCT01886716|945959|P3|Week 1|Lost to Follow-up|2
281603|NCT01886716|945960|P2|Week 1|Lost to Follow-up|0
281604|NCT01886716|945961|P1|Week 1|Lost to Follow-up|0
281605|NCT01886690|945977|P2|Overall Study|Personal Reasons|1
281606|NCT01886690|945978|P1|Overall Study|Personal Reasons|0
281607|NCT01886690|945977|P2|Overall Study|Protocol Violation|1
281608|NCT01886690|945978|P1|Overall Study|Protocol Violation|0
281609|NCT01886313|945994|P2|Overall Study|Adverse Event|1
281610|NCT01886313|945995|P1|Overall Study|Adverse Event|1
281611|NCT01886300|946001|P1|Overall Study|Trial terminated by sponsor|16
281612|NCT01886287|946012|P1|Overall Study|Clinical progression due to disease|1
281613|NCT01886287|946012|P1|Overall Study|Radiographic disease progression|1
281614|NCT01885936|946030|P2|Overall Study|Withdrawal by Subject|0
281615|NCT01885936|946031|P1|Overall Study|Withdrawal by Subject|1
281616|NCT01885559|946065|P2|Overall Study|Protocol Violation|1
281617|NCT01885559|946066|P1|Overall Study|Protocol Violation|0
281618|NCT01885559|946065|P2|Overall Study|Less than full participation|19
281619|NCT01885559|946066|P1|Overall Study|Less than full participation|9
281620|NCT01885559|946065|P2|Overall Study|Lost to Follow-up|16
281621|NCT01885559|946066|P1|Overall Study|Lost to Follow-up|15
281622|NCT01885208|946088|P2|Overall Study|Unclassified|38
281623|NCT01885208|946089|P1|Overall Study|Unclassified|32
281624|NCT01885104|946130|P2|Overall Study|Physician Decision|0
281625|NCT01885104|946131|P1|Overall Study|Physician Decision|1
281626|NCT01885104|946130|P2|Overall Study|Lost to Follow-up|1
281627|NCT01885104|946131|P1|Overall Study|Lost to Follow-up|0
281628|NCT01885104|946130|P2|Overall Study|Withdrawal of Consent|0
281629|NCT01885104|946131|P1|Overall Study|Withdrawal of Consent|1
281630|NCT01885000|946141|P2|Overall Study|Protocol Violation|1
281631|NCT01885000|946142|P1|Overall Study|Protocol Violation|0
281632|NCT01885000|946141|P2|Overall Study|Withdrawal by Subject|1
281633|NCT01885000|946142|P1|Overall Study|Withdrawal by Subject|1
281634|NCT01885000|946141|P2|Overall Study|Adverse Event|0
281635|NCT01885000|946142|P1|Overall Study|Adverse Event|1
281636|NCT01884688|946163|P1|Overall Study|Screen Failure|2
281637|NCT01884675|946169|P2|Overall Study|Study closed/terminated|2
281638|NCT01884675|946170|P1|Overall Study|Study closed/terminated|3
281639|NCT01884597|946213|P3|Overall Study|Death|0
281640|NCT01884597|946214|P2|Overall Study|Death|1
281641|NCT01884597|946215|P1|Overall Study|Death|0
281642|NCT01884597|946213|P3|Overall Study|Lack of Efficacy|0
281643|NCT01884597|946214|P2|Overall Study|Lack of Efficacy|0
281644|NCT01884597|946215|P1|Overall Study|Lack of Efficacy|1
281645|NCT01884597|946213|P3|Overall Study|Adverse Event|1
281646|NCT01884597|946214|P2|Overall Study|Adverse Event|0
281647|NCT01884597|946215|P1|Overall Study|Adverse Event|0
281648|NCT01884571|946244|P1|Overall Study|Disease progression|3
281649|NCT01884571|946244|P1|Overall Study|Withdrawal by Subject|2
281650|NCT01884571|946244|P1|Overall Study|Death|2
281651|NCT01884571|946244|P1|Overall Study|Adverse Event|1
281652|NCT01884545|946259|P4|Overall Study|Non-adherence|0
281653|NCT01884545|946260|P3|Overall Study|Non-adherence|0
281654|NCT01884545|946261|P2|Overall Study|Non-adherence|2
281655|NCT01884545|946262|P1|Overall Study|Non-adherence|0
281656|NCT01884545|946259|P4|Overall Study|Patient withdrawn|5
281657|NCT01884545|946260|P3|Overall Study|Patient withdrawn|5
281658|NCT01884545|946261|P2|Overall Study|Patient withdrawn|12
281659|NCT01884545|946262|P1|Overall Study|Patient withdrawn|7
281660|NCT01884545|946259|P4|Overall Study|Lost to Follow-up|4
281661|NCT01884545|946260|P3|Overall Study|Lost to Follow-up|9
281662|NCT01884545|946261|P2|Overall Study|Lost to Follow-up|4
281663|NCT01884545|946262|P1|Overall Study|Lost to Follow-up|6
281664|NCT01883895|946454|P1|Overall Study|Lost to Follow-up|2
281665|NCT01883635|946468|P2|Overall Study|Withdrawal by Subject|0
281666|NCT01883635|946469|P1|Overall Study|Withdrawal by Subject|4
281667|NCT01883453|946483|P2|Overall Study|No episode of common cold|23
281668|NCT01883453|946484|P1|Overall Study|No episode of common cold|25
281669|NCT01882985|946510|P1|Overall Study|Withdrawal by Subject|1
281670|NCT01882985|946510|P1|Overall Study|Lost to Follow-up|1
281671|NCT01882907|946519|P2|Overall Study|Withdrawal by Subject|6
281672|NCT01882907|946520|P1|Overall Study|Withdrawal by Subject|0
281673|NCT01882907|946519|P2|Overall Study|Protocol Violation|14
281674|NCT01882907|946520|P1|Overall Study|Protocol Violation|10
281675|NCT01882907|946519|P2|Overall Study|Lost to Follow-up|4
281676|NCT01882907|946520|P1|Overall Study|Lost to Follow-up|1
281677|NCT01882907|946519|P2|Overall Study|Lack of Efficacy|3
281678|NCT01882907|946520|P1|Overall Study|Lack of Efficacy|0
281679|NCT01882907|946519|P2|Overall Study|Adverse Event|1
281680|NCT01882907|946520|P1|Overall Study|Adverse Event|3
281681|NCT01882829|946556|P1|Overall Study|Withdrawal by Subject|1
281682|NCT01882829|946556|P1|Overall Study|Protocol Violation|1
281683|NCT01882829|946556|P1|Overall Study|Adverse Event|4
281684|NCT01882647|946577|P2|Overall Study|Withdrawal by Subject|4
281685|NCT01882647|946578|P1|Overall Study|Withdrawal by Subject|0
281686|NCT01882647|946577|P2|Overall Study|Lost to Follow-up|2
281687|NCT01882647|946578|P1|Overall Study|Lost to Follow-up|2
281688|NCT01882465|946618|P7|Period 2|Protocol Violation|0
281689|NCT01882465|946619|P6|Period 2|Protocol Violation|0
281690|NCT01882465|946620|P5|Period 2|Protocol Violation|1
281691|NCT01882465|946621|P4|Period 2|Protocol Violation|0
281692|NCT01882465|946622|P3|Period 2|Protocol Violation|0
281693|NCT01882465|946623|P2|Period 2|Protocol Violation|0
281694|NCT01882465|946624|P1|Period 2|Protocol Violation|0
281695|NCT01882465|946618|P7|Period 1|Withdrawal by Subject|1
281696|NCT01882465|946619|P6|Period 1|Withdrawal by Subject|0
281697|NCT01882465|946620|P5|Period 1|Withdrawal by Subject|0
281698|NCT01882465|946621|P4|Period 1|Withdrawal by Subject|0
281699|NCT01882465|946622|P3|Period 1|Withdrawal by Subject|0
281700|NCT01882465|946623|P2|Period 1|Withdrawal by Subject|0
281701|NCT01882465|946624|P1|Period 1|Withdrawal by Subject|0
281702|NCT01882465|946618|P7|Period 1|Lens Discomfort|0
281703|NCT01882465|946619|P6|Period 1|Lens Discomfort|0
281704|NCT01882465|946620|P5|Period 1|Lens Discomfort|0
281705|NCT01882465|946621|P4|Period 1|Lens Discomfort|1
281706|NCT01882465|946622|P3|Period 1|Lens Discomfort|0
281707|NCT01882465|946623|P2|Period 1|Lens Discomfort|0
281708|NCT01882465|946624|P1|Period 1|Lens Discomfort|0
281709|NCT01882439|946636|P4|Overall Study|Adverse event unrelated to study drug|1
281710|NCT01882439|946637|P3|Overall Study|Adverse event unrelated to study drug|1
281711|NCT01882439|946638|P2|Overall Study|Adverse event unrelated to study drug|2
281712|NCT01882439|946639|P1|Overall Study|Adverse event unrelated to study drug|2
281713|NCT01882439|946636|P4|Overall Study|Insufficient clinical response|2
281714|NCT01882439|946637|P3|Overall Study|Insufficient clinical response|4
281715|NCT01882439|946638|P2|Overall Study|Insufficient clinical response|4
281716|NCT01882439|946639|P1|Overall Study|Insufficient clinical response|1
281717|NCT01882439|946636|P4|Overall Study|Medication error with no associated AE|0
281718|NCT01882439|946637|P3|Overall Study|Medication error with no associated AE|2
281719|NCT01882439|946638|P2|Overall Study|Medication error with no associated AE|0
281720|NCT01882439|946639|P1|Overall Study|Medication error with no associated AE|0
281721|NCT01882439|946636|P4|Overall Study|No longer willing to participate|3
281722|NCT01882439|946637|P3|Overall Study|No longer willing to participate|2
281723|NCT01882439|946638|P2|Overall Study|No longer willing to participate|4
281724|NCT01882439|946639|P1|Overall Study|No longer willing to participate|1
281725|NCT01882439|946636|P4|Overall Study|Protocol Violation|1
281726|NCT01882439|946637|P3|Overall Study|Protocol Violation|0
281727|NCT01882439|946638|P2|Overall Study|Protocol Violation|2
281728|NCT01882439|946639|P1|Overall Study|Protocol Violation|2
281729|NCT01882439|946636|P4|Overall Study|Pregnancy|0
281730|NCT01882439|946637|P3|Overall Study|Pregnancy|0
281731|NCT01882439|946638|P2|Overall Study|Pregnancy|1
281732|NCT01882439|946639|P1|Overall Study|Pregnancy|0
281733|NCT01882439|946636|P4|Overall Study|Adverse event related to study drug|2
281734|NCT01882439|946637|P3|Overall Study|Adverse event related to study drug|1
281735|NCT01882439|946638|P2|Overall Study|Adverse event related to study drug|8
281736|NCT01882439|946639|P1|Overall Study|Adverse event related to study drug|3
281737|NCT01882257|946836|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
281738|NCT01882257|946837|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
281739|NCT01882257|946838|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
281740|NCT01882257|946836|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
281741|NCT01882257|946837|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
281742|NCT01882257|946838|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
281743|NCT01881776|946870|P3|Overall Study|Protocol Violation|1
281744|NCT01881776|946871|P2|Overall Study|Protocol Violation|2
281745|NCT01881776|946872|P1|Overall Study|Protocol Violation|0
281746|NCT01881776|946870|P3|Overall Study|Lost to Follow-up|1
281747|NCT01881776|946871|P2|Overall Study|Lost to Follow-up|2
281748|NCT01881776|946872|P1|Overall Study|Lost to Follow-up|1
281749|NCT01881737|946898|P1|Overall Study|Worsening of baseline behavior|1
281750|NCT01881737|946898|P1|Overall Study|Withdrawal by Subject|1
281751|NCT01881737|946898|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
281752|NCT01881230|946910|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
281753|NCT01881230|946911|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
281754|NCT01881230|946912|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
281755|NCT01881230|946910|P3|Overall Study|Untreated: Death|1
281756|NCT01881230|946911|P2|Overall Study|Untreated: Death|0
281757|NCT01881230|946912|P1|Overall Study|Untreated: Death|0
281758|NCT01881230|946910|P3|Overall Study|Untreated: Other|1
281759|NCT01881230|946911|P2|Overall Study|Untreated: Other|0
281760|NCT01881230|946912|P1|Overall Study|Untreated: Other|0
281761|NCT01881230|946910|P3|Overall Study|Miscellaneous|0
281762|NCT01881230|946911|P2|Overall Study|Miscellaneous|3
281763|NCT01881230|946912|P1|Overall Study|Miscellaneous|3
281764|NCT01881230|946910|P3|Overall Study|Protocol Violation|0
281765|NCT01881230|946911|P2|Overall Study|Protocol Violation|1
281766|NCT01881230|946912|P1|Overall Study|Protocol Violation|1
281767|NCT01881230|946910|P3|Overall Study|Given Commercially Available Drug|2
281768|NCT01881230|946911|P2|Overall Study|Given Commercially Available Drug|0
281769|NCT01881230|946912|P1|Overall Study|Given Commercially Available Drug|0
281770|NCT01881230|946910|P3|Overall Study|Non-Compliance with Study Drug|0
281771|NCT01881230|946911|P2|Overall Study|Non-Compliance with Study Drug|2
281772|NCT01881230|946912|P1|Overall Study|Non-Compliance with Study Drug|1
281773|NCT01881230|946910|P3|Overall Study|Physician Decision|6
281774|NCT01881230|946911|P2|Overall Study|Physician Decision|3
281775|NCT01881230|946912|P1|Overall Study|Physician Decision|4
281776|NCT01881230|946910|P3|Overall Study|Withdrawal by Subject|6
281777|NCT01881230|946911|P2|Overall Study|Withdrawal by Subject|4
281778|NCT01881230|946912|P1|Overall Study|Withdrawal by Subject|6
281779|NCT01881230|946910|P3|Overall Study|Symptomatic Deterioration|1
281780|NCT01881230|946911|P2|Overall Study|Symptomatic Deterioration|3
281781|NCT01881230|946912|P1|Overall Study|Symptomatic Deterioration|3
281782|NCT01881230|946910|P3|Overall Study|Progressive Disease|36
281783|NCT01881230|946911|P2|Overall Study|Progressive Disease|35
281784|NCT01881230|946912|P1|Overall Study|Progressive Disease|31
281785|NCT01881230|946910|P3|Overall Study|Adverse Event|12
281786|NCT01881230|946911|P2|Overall Study|Adverse Event|13
281787|NCT01881230|946912|P1|Overall Study|Adverse Event|9
281788|NCT01881230|946910|P3|Overall Study|Death|1
281789|NCT01881230|946911|P2|Overall Study|Death|0
281790|NCT01881230|946912|P1|Overall Study|Death|2
281791|NCT01881126|946940|P2|Overall Study|Adverse Event|1
281792|NCT01881126|946941|P1|Overall Study|Adverse Event|0
281793|NCT01881126|946940|P2|Overall Study|Non-compliance|1
281794|NCT01881126|946941|P1|Overall Study|Non-compliance|1
281795|NCT01880736|947033|P4|Overall Study|Withdrawal Criteria|5
281796|NCT01880736|947034|P3|Overall Study|Withdrawal Criteria|1
281797|NCT01880736|947035|P2|Overall Study|Withdrawal Criteria|2
281798|NCT01880736|947036|P1|Overall Study|Withdrawal Criteria|1
281799|NCT01880736|947033|P4|Overall Study|Adverse Event|1
281800|NCT01880736|947034|P3|Overall Study|Adverse Event|0
281801|NCT01880736|947035|P2|Overall Study|Adverse Event|0
281802|NCT01880736|947036|P1|Overall Study|Adverse Event|0
281803|NCT01880515|947120|P2|Overall Study|Disease Progression|7
281804|NCT01880515|947121|P1|Overall Study|Disease Progression|5
281805|NCT01880515|947120|P2|Overall Study|Lost to Follow-up|2
281806|NCT01880515|947121|P1|Overall Study|Lost to Follow-up|3
281807|NCT01880437|947132|P3|Overall Study|Study terminated by Sponsor|2
281808|NCT01880437|947133|P2|Overall Study|Study terminated by Sponsor|0
281809|NCT01880437|947134|P1|Overall Study|Study terminated by Sponsor|3
281810|NCT01880437|947132|P3|Overall Study|Death|17
281811|NCT01880437|947133|P2|Overall Study|Death|4
281812|NCT01880437|947134|P1|Overall Study|Death|12
281813|NCT01880424|947160|P2|Overall Study|Not specified|0
281814|NCT01880424|947161|P1|Overall Study|Not specified|1
281815|NCT01880424|947160|P2|Overall Study|Withdrawal by Subject|30
281816|NCT01880424|947161|P1|Overall Study|Withdrawal by Subject|10
281817|NCT01880424|947160|P2|Overall Study|Protocol Violation|13
281818|NCT01880424|947161|P1|Overall Study|Protocol Violation|11
281819|NCT01880424|947160|P2|Overall Study|Lost to Follow-up|2
281820|NCT01880424|947161|P1|Overall Study|Lost to Follow-up|3
281821|NCT01880424|947160|P2|Overall Study|Lack of Efficacy|4
281822|NCT01880424|947161|P1|Overall Study|Lack of Efficacy|1
281823|NCT01880424|947160|P2|Overall Study|Adverse Event|6
281824|NCT01880424|947161|P1|Overall Study|Adverse Event|7
281825|NCT01880086|947217|P2|Overall Study|Lost to Follow-up|1
281826|NCT01880086|947218|P1|Overall Study|Lost to Follow-up|1
281827|NCT01879852|947238|P2|Overall Study|Withdrawal by Subject|0
281828|NCT01879852|947239|P1|Overall Study|Withdrawal by Subject|2
281829|NCT01879722|947283|P10|Overall Study|Voluntary Withdrawal|0
281830|NCT01879722|947284|P9|Overall Study|Voluntary Withdrawal|1
281831|NCT01879722|947285|P8|Overall Study|Voluntary Withdrawal|0
281832|NCT01879722|947286|P7|Overall Study|Voluntary Withdrawal|0
281833|NCT01879722|947287|P6|Overall Study|Voluntary Withdrawal|0
281834|NCT01879722|947288|P5|Overall Study|Voluntary Withdrawal|0
281835|NCT01879722|947289|P4|Overall Study|Voluntary Withdrawal|0
281836|NCT01879722|947290|P3|Overall Study|Voluntary Withdrawal|0
281837|NCT01879722|947291|P2|Overall Study|Voluntary Withdrawal|0
281838|NCT01879722|947292|P1|Overall Study|Voluntary Withdrawal|0
281839|NCT01879722|947283|P10|Overall Study|Pretreatment Event/Adverse Event|0
281840|NCT01879722|947284|P9|Overall Study|Pretreatment Event/Adverse Event|1
281841|NCT01879722|947285|P8|Overall Study|Pretreatment Event/Adverse Event|1
281842|NCT01879722|947286|P7|Overall Study|Pretreatment Event/Adverse Event|0
281843|NCT01879722|947287|P6|Overall Study|Pretreatment Event/Adverse Event|0
281844|NCT01879722|947288|P5|Overall Study|Pretreatment Event/Adverse Event|1
281845|NCT01879722|947289|P4|Overall Study|Pretreatment Event/Adverse Event|1
281846|NCT01879722|947290|P3|Overall Study|Pretreatment Event/Adverse Event|0
281847|NCT01879722|947291|P2|Overall Study|Pretreatment Event/Adverse Event|1
281848|NCT01879722|947292|P1|Overall Study|Pretreatment Event/Adverse Event|0
281849|NCT01879683|947440|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
281850|NCT01879618|947447|P1|Overall Study|Adverse Event|5
281851|NCT01879618|947447|P1|Overall Study|Protocol Violation|6
281852|NCT01879618|947447|P1|Overall Study|Surgery;changed schedule; not available|8
281853|NCT01879618|947447|P1|Overall Study|Withdrawal by Subject|1
281854|NCT01879618|947447|P1|Overall Study|Does not meet entrance criteria|1
281855|NCT01879579|947454|P2|Overall Study|Discontinued insulin - possible allergy|1
281856|NCT01879579|947455|P1|Overall Study|Discontinued insulin - possible allergy|0
281857|NCT01879579|947454|P2|Overall Study|Phenotypic type 1 diabetes|1
281858|NCT01879579|947455|P1|Overall Study|Phenotypic type 1 diabetes|0
281859|NCT01879579|947454|P2|Overall Study|Did not initiate insulin treatment|0
281860|NCT01879579|947455|P1|Overall Study|Did not initiate insulin treatment|1
281861|NCT01879579|947454|P2|Overall Study|Did not enroll in texting platform|0
281862|NCT01879579|947455|P1|Overall Study|Did not enroll in texting platform|1
281863|NCT01879579|947454|P2|Overall Study|Phone incompatible with texting platform|0
281864|NCT01879579|947455|P1|Overall Study|Phone incompatible with texting platform|3
281865|NCT01879553|947485|P2|Overall Study|Withdrawal by Subject|0
281866|NCT01879553|947486|P1|Overall Study|Withdrawal by Subject|1
281867|NCT01879410|947520|P2|Overall Study|Randomised in Error|2
281868|NCT01879410|947521|P1|Overall Study|Randomised in Error|1
281869|NCT01879410|947520|P2|Overall Study|Withdrawal by Subject|8
281870|NCT01879410|947521|P1|Overall Study|Withdrawal by Subject|7
281871|NCT01879410|947520|P2|Overall Study|Lost to Follow-up|1
281872|NCT01879410|947521|P1|Overall Study|Lost to Follow-up|2
281873|NCT01879410|947520|P2|Overall Study|Protocol Violation|7
281874|NCT01879410|947521|P1|Overall Study|Protocol Violation|1
281875|NCT01879410|947520|P2|Overall Study|Lack of Efficacy|6
281876|NCT01879410|947521|P1|Overall Study|Lack of Efficacy|4
281877|NCT01879410|947520|P2|Overall Study|Adverse Event|14
281878|NCT01879410|947521|P1|Overall Study|Adverse Event|9
281879|NCT01879319|947588|P2|Overall Study|Lost to Follow-up|5
281880|NCT01879319|947589|P1|Overall Study|Lost to Follow-up|1
281881|NCT01879319|947588|P2|Overall Study|Withdrawal by Subject|0
281882|NCT01879319|947589|P1|Overall Study|Withdrawal by Subject|1
281883|NCT01879072|947606|P1|Overall Study|Withdrawal by Subject|48
281884|NCT01878214|947731|P2|Overall Study|Lost to Follow-up|36
281885|NCT01878214|947732|P1|Overall Study|Lost to Follow-up|35
281886|NCT01878214|947731|P2|Overall Study|Death|1
281887|NCT01878214|947732|P1|Overall Study|Death|0
281888|NCT01878214|947731|P2|Overall Study|Withdrawal by Subject|7
281889|NCT01878214|947732|P1|Overall Study|Withdrawal by Subject|18
281890|NCT01878175|947746|P1|Overall Study|Developed contraindicated health problem|2
281891|NCT01878149|947765|P2|Overall Study|Did Not Meet Eligibility Criteria|2
281892|NCT01878149|947766|P1|Overall Study|Did Not Meet Eligibility Criteria|2
281893|NCT01878097|947774|P2|Implementation Year 4|Surveys not fully completed|3007
281894|NCT01878097|947775|P1|Implementation Year 4|Surveys not fully completed|3604
281895|NCT01878097|947774|P2|Implementation Year 3|Surveys not fully completed|2980
281896|NCT01878097|947775|P1|Implementation Year 3|Surveys not fully completed|3494
281897|NCT01878097|947774|P2|Implementation Year 2|Surveys not fully completed|2841
281898|NCT01878097|947775|P1|Implementation Year 2|Surveys not fully completed|3281
281899|NCT01878097|947774|P2|Implementation Year 1|Surveys not fully completed|2549
281900|NCT01878097|947775|P1|Implementation Year 1|Surveys not fully completed|3202
281901|NCT01878097|947774|P2|Baseline|Surveys not fully completed|1800
281902|NCT01878097|947775|P1|Baseline|Surveys not fully completed|2497
281903|NCT01877720|947791|P2|Overall Study|Adverse Event|0
281904|NCT01877720|947792|P1|Overall Study|Adverse Event|1
281905|NCT01877668|947821|P5|Overall Study|Adverse event unrelated to study drug|1
281906|NCT01877668|947822|P4|Overall Study|Adverse event unrelated to study drug|0
281907|NCT01877668|947823|P3|Overall Study|Adverse event unrelated to study drug|2
281908|NCT01877668|947824|P2|Overall Study|Adverse event unrelated to study drug|1
281909|NCT01877668|947825|P1|Overall Study|Adverse event unrelated to study drug|4
281910|NCT01877668|947821|P5|Overall Study|Adverse event related to study drug|1
281911|NCT01877668|947822|P4|Overall Study|Adverse event related to study drug|2
281912|NCT01877668|947823|P3|Overall Study|Adverse event related to study drug|2
281913|NCT01877668|947824|P2|Overall Study|Adverse event related to study drug|2
281914|NCT01877668|947825|P1|Overall Study|Adverse event related to study drug|2
281915|NCT01877668|947821|P5|Overall Study|Protocol Violation|3
281916|NCT01877668|947822|P4|Overall Study|Protocol Violation|0
281917|NCT01877668|947823|P3|Overall Study|Protocol Violation|0
281918|NCT01877668|947824|P2|Overall Study|Protocol Violation|1
281919|NCT01877668|947825|P1|Overall Study|Protocol Violation|1
281920|NCT01877668|947821|P5|Overall Study|Not specified|3
281921|NCT01877668|947822|P4|Overall Study|Not specified|1
281922|NCT01877668|947823|P3|Overall Study|Not specified|1
281923|NCT01877668|947824|P2|Overall Study|Not specified|1
281924|NCT01877668|947825|P1|Overall Study|Not specified|1
281925|NCT01877668|947821|P5|Overall Study|Withdrawal by Subject|2
281926|NCT01877668|947822|P4|Overall Study|Withdrawal by Subject|2
281927|NCT01877668|947823|P3|Overall Study|Withdrawal by Subject|3
281928|NCT01877668|947824|P2|Overall Study|Withdrawal by Subject|0
281929|NCT01877668|947825|P1|Overall Study|Withdrawal by Subject|2
281930|NCT01877668|947821|P5|Overall Study|Lost to Follow-up|0
281931|NCT01877668|947822|P4|Overall Study|Lost to Follow-up|0
281932|NCT01877668|947823|P3|Overall Study|Lost to Follow-up|1
281933|NCT01877668|947824|P2|Overall Study|Lost to Follow-up|2
281934|NCT01877668|947825|P1|Overall Study|Lost to Follow-up|0
281935|NCT01877668|947821|P5|Overall Study|Insufficient clinical response|0
281936|NCT01877668|947822|P4|Overall Study|Insufficient clinical response|2
281937|NCT01877668|947823|P3|Overall Study|Insufficient clinical response|2
281938|NCT01877668|947824|P2|Overall Study|Insufficient clinical response|1
281939|NCT01877668|947825|P1|Overall Study|Insufficient clinical response|0
281940|NCT01877668|947821|P5|Overall Study|No longer met study criteria|0
281941|NCT01877668|947822|P4|Overall Study|No longer met study criteria|0
281942|NCT01877668|947823|P3|Overall Study|No longer met study criteria|1
281943|NCT01877668|947824|P2|Overall Study|No longer met study criteria|0
281944|NCT01877668|947825|P1|Overall Study|No longer met study criteria|1
281945|NCT01877668|947821|P5|Overall Study|Death|0
281946|NCT01877668|947822|P4|Overall Study|Death|1
281947|NCT01877668|947823|P3|Overall Study|Death|0
281948|NCT01877668|947824|P2|Overall Study|Death|0
281949|NCT01877668|947825|P1|Overall Study|Death|0
281950|NCT01877421|948129|P18|Phase 2|Protocol Violation|0
281951|NCT01877421|948130|P17|Phase 2|Protocol Violation|0
281952|NCT01877421|948131|P16|Phase 2|Protocol Violation|0
281953|NCT01877421|948132|P15|Phase 2|Protocol Violation|0
281954|NCT01877421|948133|P14|Phase 2|Protocol Violation|0
281955|NCT01877421|948134|P13|Phase 2|Protocol Violation|0
281956|NCT01877421|948135|P12|Phase 2|Protocol Violation|0
281957|NCT01877421|948136|P11|Phase 2|Protocol Violation|1
281958|NCT01877421|948137|P10|Phase 2|Protocol Violation|0
281959|NCT01877421|948138|P9|Phase 2|Protocol Violation|0
281960|NCT01877421|948139|P8|Phase 2|Protocol Violation|0
281961|NCT01877421|948140|P7|Phase 2|Protocol Violation|0
281962|NCT01877421|948141|P6|Phase 2|Protocol Violation|0
281963|NCT01877421|948142|P5|Phase 2|Protocol Violation|0
281964|NCT01877421|948143|P4|Phase 2|Protocol Violation|0
281965|NCT01877421|948144|P3|Phase 2|Protocol Violation|0
281966|NCT01877421|948145|P2|Phase 2|Protocol Violation|0
281967|NCT01877421|948146|P1|Phase 2|Protocol Violation|0
281968|NCT01877421|948129|P18|Phase 2|Withdrawal by Subject|0
281969|NCT01877421|948130|P17|Phase 2|Withdrawal by Subject|0
281970|NCT01877421|948131|P16|Phase 2|Withdrawal by Subject|1
281971|NCT01877421|948132|P15|Phase 2|Withdrawal by Subject|0
281972|NCT01877421|948133|P14|Phase 2|Withdrawal by Subject|0
281973|NCT01877421|948134|P13|Phase 2|Withdrawal by Subject|1
281974|NCT01877421|948135|P12|Phase 2|Withdrawal by Subject|0
281975|NCT01877421|948136|P11|Phase 2|Withdrawal by Subject|1
281976|NCT01877421|948137|P10|Phase 2|Withdrawal by Subject|0
281977|NCT01877421|948138|P9|Phase 2|Withdrawal by Subject|1
281978|NCT01877421|948139|P8|Phase 2|Withdrawal by Subject|0
281979|NCT01877421|948140|P7|Phase 2|Withdrawal by Subject|0
281980|NCT01877421|948141|P6|Phase 2|Withdrawal by Subject|0
281981|NCT01877421|948142|P5|Phase 2|Withdrawal by Subject|0
281982|NCT01877421|948143|P4|Phase 2|Withdrawal by Subject|0
281983|NCT01877421|948144|P3|Phase 2|Withdrawal by Subject|0
281984|NCT01877421|948145|P2|Phase 2|Withdrawal by Subject|0
281985|NCT01877421|948146|P1|Phase 2|Withdrawal by Subject|0
281986|NCT01877421|948129|P18|Phase 2|Lost to Follow-up|0
281987|NCT01877421|948130|P17|Phase 2|Lost to Follow-up|0
281988|NCT01877421|948131|P16|Phase 2|Lost to Follow-up|0
281989|NCT01877421|948132|P15|Phase 2|Lost to Follow-up|0
281990|NCT01877421|948133|P14|Phase 2|Lost to Follow-up|0
281991|NCT01877421|948134|P13|Phase 2|Lost to Follow-up|0
281992|NCT01877421|948135|P12|Phase 2|Lost to Follow-up|0
281993|NCT01877421|948136|P11|Phase 2|Lost to Follow-up|0
281994|NCT01877421|948137|P10|Phase 2|Lost to Follow-up|0
281995|NCT01877421|948138|P9|Phase 2|Lost to Follow-up|0
281996|NCT01877421|948139|P8|Phase 2|Lost to Follow-up|0
281997|NCT01877421|948140|P7|Phase 2|Lost to Follow-up|1
281998|NCT01877421|948141|P6|Phase 2|Lost to Follow-up|0
281999|NCT01877421|948142|P5|Phase 2|Lost to Follow-up|0
282000|NCT01877421|948143|P4|Phase 2|Lost to Follow-up|0
282001|NCT01877421|948144|P3|Phase 2|Lost to Follow-up|0
282002|NCT01877421|948145|P2|Phase 2|Lost to Follow-up|0
282003|NCT01877421|948146|P1|Phase 2|Lost to Follow-up|0
282004|NCT01877408|948256|P2|Overall Study|Lost to Follow-up|2
282005|NCT01877408|948257|P1|Overall Study|Lost to Follow-up|0
282006|NCT01877278|948290|P2|Overall Study|Lost to Follow-up|3
282007|NCT01877278|948291|P1|Overall Study|Lost to Follow-up|3
282008|NCT01876979|948339|P2|Overall Study|Physician Decision|3
282009|NCT01876979|948340|P1|Overall Study|Physician Decision|2
282010|NCT01876823|948346|P1|Overall Study|Patients moved|2
282011|NCT01876823|948346|P1|Overall Study|Physician Decision|2
282012|NCT01876823|948346|P1|Overall Study|Withdrawal by Subject|5
282013|NCT01876810|948359|P2|Overall Study|Physician Decision|1
282014|NCT01876810|948360|P1|Overall Study|Physician Decision|0
282015|NCT01876784|948372|P2|Overall Study|Ongoing|40
282016|NCT01876784|948373|P1|Overall Study|Ongoing|41
282017|NCT01876784|948372|P2|Overall Study|Other than specified above|6
282018|NCT01876784|948373|P1|Overall Study|Other than specified above|5
282019|NCT01876784|948372|P2|Overall Study|Randomized but not treated|1
282020|NCT01876784|948373|P1|Overall Study|Randomized but not treated|2
282021|NCT01876784|948372|P2|Overall Study|Death|0
282022|NCT01876784|948373|P1|Overall Study|Death|1
282023|NCT01876784|948372|P2|Overall Study|Lost to Follow-up|1
282024|NCT01876784|948373|P1|Overall Study|Lost to Follow-up|0
282025|NCT01876784|948372|P2|Overall Study|Disease progression|67
282026|NCT01876784|948373|P1|Overall Study|Disease progression|37
282027|NCT01876784|948372|P2|Overall Study|Protocol Violation|0
282028|NCT01876784|948373|P1|Overall Study|Protocol Violation|1
282029|NCT01876784|948372|P2|Overall Study|Adverse Event|2
282030|NCT01876784|948373|P1|Overall Study|Adverse Event|15
282031|NCT01876784|948372|P2|Overall Study|Withdrawal by Subject|2
282032|NCT01876784|948373|P1|Overall Study|Withdrawal by Subject|17
282033|NCT01876732|948379|P1|Overall Study|MMA was not over 800mg/dL|75
282034|NCT01876706|948384|P1|Overall Study|Lost to Follow-up|2
282035|NCT01876706|948384|P1|Overall Study|BPH Intervention|2
282036|NCT01876368|948403|P2|Overall Study|Subject/guardian decision|1
282037|NCT01876368|948404|P1|Overall Study|Subject/guardian decision|3
282038|NCT01876368|948403|P2|Overall Study|Protocol deviation|3
282039|NCT01876368|948404|P1|Overall Study|Protocol deviation|3
282040|NCT01876368|948403|P2|Overall Study|Physician Decision|2
282041|NCT01876368|948404|P1|Overall Study|Physician Decision|0
282042|NCT01876368|948403|P2|Overall Study|Non-compliance with study treatment|1
282043|NCT01876368|948404|P1|Overall Study|Non-compliance with study treatment|0
282044|NCT01876368|948403|P2|Overall Study|Lost to Follow-up|1
282045|NCT01876368|948404|P1|Overall Study|Lost to Follow-up|0
282046|NCT01876368|948403|P2|Overall Study|Lack of Efficacy|0
282047|NCT01876368|948404|P1|Overall Study|Lack of Efficacy|1
282048|NCT01876368|948403|P2|Overall Study|Adverse Event|5
282049|NCT01876368|948404|P1|Overall Study|Adverse Event|2
282050|NCT01875991|948448|P2|Overall Study|Sponsor Decision|0
282051|NCT01875991|948449|P1|Overall Study|Sponsor Decision|1
282052|NCT01875991|948448|P2|Overall Study|Withdrawal by Subject|6
282053|NCT01875991|948449|P1|Overall Study|Withdrawal by Subject|6
282054|NCT01875848|948487|P2|Overall Study|Withdrawal by Subject|0
282055|NCT01875848|948488|P1|Overall Study|Withdrawal by Subject|2
282056|NCT01875731|948505|P2|Overall Study|Fail to obtain lab sample|0
282057|NCT01875731|948506|P1|Overall Study|Fail to obtain lab sample|1
282058|NCT01875471|948525|P2|Overall Study|Unsatisfactory Lens Fitting|0
282059|NCT01875471|948526|P1|Overall Study|Unsatisfactory Lens Fitting|1
282060|NCT01875471|948525|P2|Overall Study|Adverse Event|1
282061|NCT01875471|948526|P1|Overall Study|Adverse Event|0
282062|NCT01875445|948534|P2|Overall Study|Withdrawal by Subject|0
282063|NCT01875445|948535|P1|Overall Study|Withdrawal by Subject|2
282064|NCT01875445|948534|P2|Overall Study|Lost to Follow-up|0
282065|NCT01875445|948535|P1|Overall Study|Lost to Follow-up|5
282066|NCT01875185|948545|P2|Overall Study|study was terminated|48
282067|NCT01875185|948546|P1|Overall Study|study was terminated|52
282068|NCT01874665|948594|P2|Overall Study|Other|0
282069|NCT01874665|948595|P1|Overall Study|Other|2
282070|NCT01874665|948594|P2|Overall Study|Documented Progressive Disease|7
282071|NCT01874665|948595|P1|Overall Study|Documented Progressive Disease|11
282072|NCT01874665|948594|P2|Overall Study|Study Terminated by Sponsor|2
282073|NCT01874665|948595|P1|Overall Study|Study Terminated by Sponsor|0
282074|NCT01874665|948594|P2|Overall Study|Clinical Progressive Disease|3
282075|NCT01874665|948595|P1|Overall Study|Clinical Progressive Disease|4
282076|NCT01874665|948594|P2|Overall Study|Physician Decision|0
282077|NCT01874665|948595|P1|Overall Study|Physician Decision|3
282078|NCT01874665|948594|P2|Overall Study|Withdrawal by Subject|1
282079|NCT01874665|948595|P1|Overall Study|Withdrawal by Subject|4
282080|NCT01874665|948594|P2|Overall Study|Adverse Event|2
282081|NCT01874665|948595|P1|Overall Study|Adverse Event|6
282082|NCT01874353|948623|P2|Overall Study|Withdrawal by Subject|9
282083|NCT01874353|948624|P1|Overall Study|Withdrawal by Subject|7
282084|NCT01874353|948623|P2|Overall Study|Death|27
282085|NCT01874353|948624|P1|Overall Study|Death|45
282086|NCT01874353|948623|P2|Overall Study|Lost to Follow-up|1
282087|NCT01874353|948624|P1|Overall Study|Lost to Follow-up|1
282088|NCT01874353|948623|P2|Overall Study|Other|0
282089|NCT01874353|948624|P1|Overall Study|Other|2
282090|NCT01874340|948651|P4|Overall Study|Withdrawal by Subject|1
282091|NCT01874340|948652|P3|Overall Study|Withdrawal by Subject|0
282092|NCT01874340|948653|P2|Overall Study|Withdrawal by Subject|0
282093|NCT01874340|948654|P1|Overall Study|Withdrawal by Subject|0
282094|NCT01874340|948651|P4|Overall Study|Study terminated by Sponsor|4
282095|NCT01874340|948652|P3|Overall Study|Study terminated by Sponsor|8
282096|NCT01874340|948653|P2|Overall Study|Study terminated by Sponsor|8
282097|NCT01874340|948654|P1|Overall Study|Study terminated by Sponsor|6
282098|NCT01874275|948682|P2|Overall Study|Lost to Follow-up|0
282099|NCT01874275|948683|P1|Overall Study|Lost to Follow-up|1
282100|NCT01874145|948706|P2|Extension Period|Lost to Follow-up|1
282101|NCT01874145|948707|P1|Extension Period|Lost to Follow-up|1
282102|NCT01874145|948706|P2|Extension Period|Withdrawal by Subject|1
282103|NCT01874145|948707|P1|Extension Period|Withdrawal by Subject|2
282104|NCT01874145|948706|P2|Extension Period|Adverse Event|2
282105|NCT01874145|948707|P1|Extension Period|Adverse Event|3
282106|NCT01874145|948706|P2|Core Period|Withdrawal by Subject|4
282107|NCT01874145|948707|P1|Core Period|Withdrawal by Subject|0
282108|NCT01874145|948706|P2|Core Period|Adverse Event|1
282109|NCT01874145|948707|P1|Core Period|Adverse Event|0
282110|NCT01874145|948706|P2|Core Period|Physician Decision|1
282111|NCT01874145|948707|P1|Core Period|Physician Decision|1
282112|NCT01874145|948706|P2|Core Period|Protocol Violation|1
282113|NCT01874145|948707|P1|Core Period|Protocol Violation|1
282114|NCT01874145|948706|P2|Core Period|Non-compliance|0
282115|NCT01874145|948707|P1|Core Period|Non-compliance|1
282116|NCT01874054|948766|P1|Follow-up Period|Continuing in Follow-up|48
282117|NCT01874054|948766|P1|Follow-up Period|Withdrawal by Subject|1
282118|NCT01874054|948766|P1|Treatment Period|Non-AE related|2
282119|NCT01874054|948766|P1|Treatment Period|Withdrawal by Subject|6
282120|NCT01874054|948766|P1|Treatment Period|Physician Decision|3
282121|NCT01874054|948766|P1|Treatment Period|Adverse Event|20
282122|NCT01874054|948766|P1|Treatment Period|Progressive Disease|7
282123|NCT01873950|948788|P5|Period 5|Withdrawal by Subject|0
282124|NCT01873950|948789|P4|Period 5|Withdrawal by Subject|1
282125|NCT01873950|948790|P3|Period 5|Withdrawal by Subject|0
282126|NCT01873950|948791|P2|Period 5|Withdrawal by Subject|0
282127|NCT01873950|948792|P1|Period 5|Withdrawal by Subject|0
282128|NCT01873859|948829|P2|Overall Study|Withdrawal by Subject|4
282129|NCT01873859|948830|P1|Overall Study|Withdrawal by Subject|0
282130|NCT01873729|948838|P1|Overall Study|Withdrawal by Subject|1
282131|NCT01873417|948843|P1|Overall Study|Physician Decision|3
282132|NCT01873417|948843|P1|Overall Study|Withdrawal by Subject|2
282133|NCT01873417|948843|P1|Overall Study|Lost to Follow-up|2
282134|NCT01873417|948843|P1|Overall Study|Adverse Event|24
282135|NCT01873417|948843|P1|Overall Study|Did Not Receive Any Study Drug|4
282136|NCT01872910|948860|P6|Overall Study|Lost to Follow-up|0
282137|NCT01872910|948861|P5|Overall Study|Lost to Follow-up|0
282138|NCT01872910|948862|P4|Overall Study|Lost to Follow-up|0
282139|NCT01872910|948863|P3|Overall Study|Lost to Follow-up|2
282140|NCT01872910|948864|P2|Overall Study|Lost to Follow-up|0
282141|NCT01872910|948865|P1|Overall Study|Lost to Follow-up|2
282142|NCT01872715|948910|P1|Overall Study|Withdrawal by Subject|2
282143|NCT01872715|948910|P1|Overall Study|Protocol Violation|1
282144|NCT01872715|948910|P1|Overall Study|Adverse Event|1
282145|NCT01872611|948927|P2|Overall Study|Reason not provided|6
282146|NCT01872611|948928|P1|Overall Study|Reason not provided|6
282147|NCT01872611|948927|P2|Overall Study|Withdrawal by Subject|1
282148|NCT01872611|948928|P1|Overall Study|Withdrawal by Subject|6
282149|NCT01872611|948927|P2|Overall Study|Physician Decision|0
282150|NCT01872611|948928|P1|Overall Study|Physician Decision|1
282151|NCT01872611|948927|P2|Overall Study|Lost to Follow-up|1
282152|NCT01872611|948928|P1|Overall Study|Lost to Follow-up|8
282153|NCT01872611|948927|P2|Overall Study|Death, prior to treatment|1
282154|NCT01872611|948928|P1|Overall Study|Death, prior to treatment|0
282155|NCT01872611|948927|P2|Overall Study|Death|1
282156|NCT01872611|948928|P1|Overall Study|Death|0
282157|NCT01872611|948927|P2|Overall Study|Adverse Event, prior to treatment|1
282158|NCT01872611|948928|P1|Overall Study|Adverse Event, prior to treatment|0
282159|NCT01872611|948927|P2|Overall Study|Adverse Event|1
282160|NCT01872611|948928|P1|Overall Study|Adverse Event|3
282161|NCT01872078|948950|P4|Overall Study|Patient met exclusion criterion 16.|1
282162|NCT01872078|948951|P3|Overall Study|Patient met exclusion criterion 16.|0
282163|NCT01872078|948952|P2|Overall Study|Patient met exclusion criterion 16.|0
282164|NCT01872078|948953|P1|Overall Study|Patient met exclusion criterion 16.|0
282165|NCT01872078|948950|P4|Overall Study|Withdrawal by Subject|0
282166|NCT01872078|948951|P3|Overall Study|Withdrawal by Subject|1
282167|NCT01872078|948952|P2|Overall Study|Withdrawal by Subject|0
282168|NCT01872078|948953|P1|Overall Study|Withdrawal by Subject|0
282169|NCT01872078|948950|P4|Overall Study|Protocol Violation|0
282170|NCT01872078|948951|P3|Overall Study|Protocol Violation|1
282171|NCT01872078|948952|P2|Overall Study|Protocol Violation|0
282172|NCT01872078|948953|P1|Overall Study|Protocol Violation|0
282173|NCT01872078|948950|P4|Overall Study|Dose administration non-compliance|1
282174|NCT01872078|948951|P3|Overall Study|Dose administration non-compliance|0
282175|NCT01872078|948952|P2|Overall Study|Dose administration non-compliance|0
282176|NCT01872078|948953|P1|Overall Study|Dose administration non-compliance|0
282177|NCT01872078|948950|P4|Overall Study|Adverse Event|0
282178|NCT01872078|948951|P3|Overall Study|Adverse Event|1
282179|NCT01872078|948952|P2|Overall Study|Adverse Event|0
282180|NCT01872078|948953|P1|Overall Study|Adverse Event|0
282181|NCT01871870|948963|P1|Overall Study|hyperglycemia|2
282182|NCT01871870|948963|P1|Overall Study|Hardware issues|7
282183|NCT01871805|948974|P6|Phase II|Lost to Follow-up|2
282184|NCT01871805|948975|P5|Phase II|Lost to Follow-up|0
282185|NCT01871805|948976|P4|Phase II|Lost to Follow-up|0
282186|NCT01871805|948977|P3|Phase II|Lost to Follow-up|0
282187|NCT01871805|948978|P2|Phase II|Lost to Follow-up|0
282188|NCT01871805|948979|P1|Phase II|Lost to Follow-up|0
282189|NCT01871805|948974|P6|Phase II|Alive in Survival Follow-up|17
282190|NCT01871805|948975|P5|Phase II|Alive in Survival Follow-up|0
282191|NCT01871805|948976|P4|Phase II|Alive in Survival Follow-up|0
282192|NCT01871805|948977|P3|Phase II|Alive in Survival Follow-up|0
282193|NCT01871805|948978|P2|Phase II|Alive in Survival Follow-up|0
282194|NCT01871805|948979|P1|Phase II|Alive in Survival Follow-up|0
282195|NCT01871805|948974|P6|Phase II|Alive on Treatment|56
282196|NCT01871805|948975|P5|Phase II|Alive on Treatment|0
282197|NCT01871805|948976|P4|Phase II|Alive on Treatment|0
282198|NCT01871805|948977|P3|Phase II|Alive on Treatment|0
282199|NCT01871805|948978|P2|Phase II|Alive on Treatment|0
282200|NCT01871805|948979|P1|Phase II|Alive on Treatment|0
282201|NCT01871805|948974|P6|Phase II|Death|12
282202|NCT01871805|948975|P5|Phase II|Death|0
282203|NCT01871805|948976|P4|Phase II|Death|0
282204|NCT01871805|948977|P3|Phase II|Death|0
282205|NCT01871805|948978|P2|Phase II|Death|0
282206|NCT01871805|948979|P1|Phase II|Death|0
282207|NCT01871805|948974|P6|Phase I|Lost to Follow-up|0
282208|NCT01871805|948975|P5|Phase I|Lost to Follow-up|0
282209|NCT01871805|948976|P4|Phase I|Lost to Follow-up|0
282210|NCT01871805|948977|P3|Phase I|Lost to Follow-up|0
282211|NCT01871805|948978|P2|Phase I|Lost to Follow-up|1
282212|NCT01871805|948979|P1|Phase I|Lost to Follow-up|0
282213|NCT01871805|948974|P6|Phase I|Alive in Survival Follow-up|0
282214|NCT01871805|948975|P5|Phase I|Alive in Survival Follow-up|4
282215|NCT01871805|948976|P4|Phase I|Alive in Survival Follow-up|1
282216|NCT01871805|948977|P3|Phase I|Alive in Survival Follow-up|3
282217|NCT01871805|948978|P2|Phase I|Alive in Survival Follow-up|0
282218|NCT01871805|948979|P1|Phase I|Alive in Survival Follow-up|1
282219|NCT01871805|948974|P6|Phase I|Alive on Treatment|0
282220|NCT01871805|948975|P5|Phase I|Alive on Treatment|3
282221|NCT01871805|948976|P4|Phase I|Alive on Treatment|4
282222|NCT01871805|948977|P3|Phase I|Alive on Treatment|5
282223|NCT01871805|948978|P2|Phase I|Alive on Treatment|3
282224|NCT01871805|948979|P1|Phase I|Alive on Treatment|0
282225|NCT01871805|948974|P6|Phase I|Death|0
282226|NCT01871805|948975|P5|Phase I|Death|6
282227|NCT01871805|948976|P4|Phase I|Death|2
282228|NCT01871805|948977|P3|Phase I|Death|5
282229|NCT01871805|948978|P2|Phase I|Death|3
282230|NCT01871805|948979|P1|Phase I|Death|6
282231|NCT01871558|949047|P2|Overall Study|Withdrawal by Subject|0
282232|NCT01871558|949048|P1|Overall Study|Withdrawal by Subject|2
282233|NCT01871558|949047|P2|Overall Study|antidiabetic drug prematurely stopped|1
282234|NCT01871558|949048|P1|Overall Study|antidiabetic drug prematurely stopped|1
282235|NCT01871558|949047|P2|Overall Study|Other reason|1
282236|NCT01871558|949048|P1|Overall Study|Other reason|0
282237|NCT01871532|949068|P2|Overall Study|Withdrawal by Subject|2
282238|NCT01871532|949069|P1|Overall Study|Withdrawal by Subject|1
282239|NCT01871519|949103|P1|Overall Study|Withdrawal by Subject|49
282240|NCT01871519|949103|P1|Overall Study|Lost to Follow-up|15
282241|NCT01871519|949103|P1|Overall Study|Death|26
282242|NCT01871402|949133|P2|Overall Study|Non-compliance|1
282243|NCT01871402|949134|P1|Overall Study|Non-compliance|0
282244|NCT01871402|949133|P2|Overall Study|Withdrawal by Subject|2
282245|NCT01871402|949134|P1|Overall Study|Withdrawal by Subject|0
282246|NCT01871402|949133|P2|Overall Study|Lost to Follow-up|0
282247|NCT01871402|949134|P1|Overall Study|Lost to Follow-up|1
282248|NCT01871285|949152|P4|First Intervention (1 Day)|Lost to Follow-up|0
282249|NCT01871285|949153|P3|First Intervention (1 Day)|Lost to Follow-up|1
282250|NCT01871285|949154|P2|First Intervention (1 Day)|Lost to Follow-up|1
282251|NCT01871285|949155|P1|First Intervention (1 Day)|Lost to Follow-up|0
282252|NCT01871285|949152|P4|First Intervention (1 Day)|Adverse Event|0
282253|NCT01871285|949153|P3|First Intervention (1 Day)|Adverse Event|0
282254|NCT01871285|949154|P2|First Intervention (1 Day)|Adverse Event|0
282255|NCT01871285|949155|P1|First Intervention (1 Day)|Adverse Event|1
282256|NCT01871142|949181|P1|Overall Study|Adverse Event|1
282257|NCT01871090|949197|P2|Overall Study|Subject Non-Compliance|1
282258|NCT01871090|949198|P1|Overall Study|Subject Non-Compliance|0
282259|NCT01871090|949197|P2|Overall Study|Interrogation not completed correctly|0
282260|NCT01871090|949198|P1|Overall Study|Interrogation not completed correctly|1
282261|NCT01871090|949197|P2|Overall Study|Interrogation not done in Emergency Room|22
282262|NCT01871090|949198|P1|Overall Study|Interrogation not done in Emergency Room|1
282263|NCT01870999|949211|P3|Overall Study|Protocol Violation|1
282264|NCT01870999|949212|P2|Overall Study|Protocol Violation|0
282265|NCT01870999|949213|P1|Overall Study|Protocol Violation|0
282266|NCT01870999|949211|P3|Overall Study|Withdrawal by Subject|5
282267|NCT01870999|949212|P2|Overall Study|Withdrawal by Subject|2
282268|NCT01870999|949213|P1|Overall Study|Withdrawal by Subject|0
282269|NCT01870999|949211|P3|Overall Study|Subject withdrawn by Investigator|0
282270|NCT01870999|949212|P2|Overall Study|Subject withdrawn by Investigator|0
282271|NCT01870999|949213|P1|Overall Study|Subject withdrawn by Investigator|1
282272|NCT01870999|949211|P3|Overall Study|Subject met withdrawal criteria|0
282273|NCT01870999|949212|P2|Overall Study|Subject met withdrawal criteria|2
282274|NCT01870999|949213|P1|Overall Study|Subject met withdrawal criteria|3
282275|NCT01870999|949211|P3|Overall Study|Adverse Event|1
282276|NCT01870999|949212|P2|Overall Study|Adverse Event|4
282277|NCT01870999|949213|P1|Overall Study|Adverse Event|0
282278|NCT01870973|949271|P2|Overall Study|Lost to Follow-up|3
282279|NCT01870973|949272|P1|Overall Study|Lost to Follow-up|10
282280|NCT01870921|949278|P1|Overall Study|Other|1
282281|NCT01870921|949278|P1|Overall Study|Subject Lost to Follow up|2
282282|NCT01870921|949278|P1|Overall Study|Severe non-compliance to protocol|7
282283|NCT01870921|949278|P1|Overall Study|Subject decision|80
282284|NCT01870843|949297|P1|Overall Study|Withdrawal by Subject|18
282285|NCT01870843|949297|P1|Overall Study|Death|1
282286|NCT01870843|949297|P1|Overall Study|Lost to Follow-up|24
282287|NCT01870843|949297|P1|Overall Study|Adverse Event|10
282288|NCT01870778|949312|P2|Overall Study|Lost to Follow-up|2
282289|NCT01870778|949313|P1|Overall Study|Lost to Follow-up|0
282290|NCT01870778|949312|P2|Overall Study|Withdrawal by Subject|7
282291|NCT01870778|949313|P1|Overall Study|Withdrawal by Subject|8
282292|NCT01870739|949339|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
282293|NCT01870739|949340|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
282294|NCT01870739|949339|P2|Add-on Period (40 Weeks)|Protocol deviation|1
282295|NCT01870739|949340|P1|Add-on Period (40 Weeks)|Protocol deviation|1
282296|NCT01870739|949339|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
282297|NCT01870739|949340|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
282298|NCT01870739|949339|P2|Add-on Period (40 Weeks)|Adverse Event|1
282299|NCT01870739|949340|P1|Add-on Period (40 Weeks)|Adverse Event|0
282300|NCT01870739|949339|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
282301|NCT01870739|949340|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
282302|NCT01870739|949339|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
282303|NCT01870739|949340|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
282304|NCT01870739|949339|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
282305|NCT01870739|949340|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
282306|NCT01870726|949379|P7|Overall Study|Progressive disease|10
282307|NCT01870726|949380|P6|Overall Study|Progressive disease|4
282308|NCT01870726|949381|P5|Overall Study|Progressive disease|6
282309|NCT01870726|949382|P4|Overall Study|Progressive disease|5
282310|NCT01870726|949383|P3|Overall Study|Progressive disease|4
282311|NCT01870726|949384|P2|Overall Study|Progressive disease|5
282312|NCT01870726|949385|P1|Overall Study|Progressive disease|5
282313|NCT01870726|949379|P7|Overall Study|Adverse Event|0
282314|NCT01870726|949380|P6|Overall Study|Adverse Event|1
282315|NCT01870726|949381|P5|Overall Study|Adverse Event|1
282316|NCT01870726|949382|P4|Overall Study|Adverse Event|0
282317|NCT01870726|949383|P3|Overall Study|Adverse Event|0
282318|NCT01870726|949384|P2|Overall Study|Adverse Event|0
282319|NCT01870726|949385|P1|Overall Study|Adverse Event|0
282320|NCT01870726|949379|P7|Overall Study|Withdrawal by Subject|0
282321|NCT01870726|949380|P6|Overall Study|Withdrawal by Subject|0
282322|NCT01870726|949381|P5|Overall Study|Withdrawal by Subject|0
282323|NCT01870726|949382|P4|Overall Study|Withdrawal by Subject|0
282324|NCT01870726|949383|P3|Overall Study|Withdrawal by Subject|0
282325|NCT01870726|949384|P2|Overall Study|Withdrawal by Subject|1
282326|NCT01870726|949385|P1|Overall Study|Withdrawal by Subject|0
282327|NCT01870726|949379|P7|Overall Study|Withdrawal of informed consent|0
282328|NCT01870726|949380|P6|Overall Study|Withdrawal of informed consent|0
282329|NCT01870726|949381|P5|Overall Study|Withdrawal of informed consent|0
282330|NCT01870726|949382|P4|Overall Study|Withdrawal of informed consent|1
282331|NCT01870726|949383|P3|Overall Study|Withdrawal of informed consent|0
282332|NCT01870726|949384|P2|Overall Study|Withdrawal of informed consent|0
282333|NCT01870726|949385|P1|Overall Study|Withdrawal of informed consent|0
282334|NCT01870583|949480|P3|Overall Study|Lost to Follow-up|5
282335|NCT01870583|949481|P2|Overall Study|Lost to Follow-up|13
282336|NCT01870583|949482|P1|Overall Study|Lost to Follow-up|11
282337|NCT01870583|949480|P3|Overall Study|Protocol Violation|3
282338|NCT01870583|949481|P2|Overall Study|Protocol Violation|5
282339|NCT01870583|949482|P1|Overall Study|Protocol Violation|0
282340|NCT01870076|949505|P4|Overall Study|Withdrawal by Subject|0
282341|NCT01870076|949506|P3|Overall Study|Withdrawal by Subject|1
282342|NCT01870076|949507|P2|Overall Study|Withdrawal by Subject|0
282343|NCT01870076|949508|P1|Overall Study|Withdrawal by Subject|1
282344|NCT01869959|949526|P5|Treatment Period|Withdrawal by Subject|0
282345|NCT01869959|949527|P4|Treatment Period|Withdrawal by Subject|0
282346|NCT01869959|949528|P3|Treatment Period|Withdrawal by Subject|0
282347|NCT01869959|949529|P2|Treatment Period|Withdrawal by Subject|1
282348|NCT01869959|949530|P1|Treatment Period|Withdrawal by Subject|0
282349|NCT01869959|949526|P5|Treatment Period|Sponsor decision|0
282350|NCT01869959|949527|P4|Treatment Period|Sponsor decision|1
282351|NCT01869959|949528|P3|Treatment Period|Sponsor decision|0
282352|NCT01869959|949529|P2|Treatment Period|Sponsor decision|1
282353|NCT01869959|949530|P1|Treatment Period|Sponsor decision|0
282354|NCT01869959|949526|P5|Treatment Period|Adverse Event|0
282355|NCT01869959|949527|P4|Treatment Period|Adverse Event|1
282356|NCT01869959|949528|P3|Treatment Period|Adverse Event|3
282357|NCT01869959|949529|P2|Treatment Period|Adverse Event|0
282358|NCT01869959|949530|P1|Treatment Period|Adverse Event|1
282359|NCT01869959|949526|P5|Randomization Period|Physician Decision|1
282360|NCT01869959|949527|P4|Randomization Period|Physician Decision|0
282361|NCT01869959|949528|P3|Randomization Period|Physician Decision|0
282362|NCT01869959|949529|P2|Randomization Period|Physician Decision|0
282363|NCT01869959|949530|P1|Randomization Period|Physician Decision|0
282364|NCT01869699|949600|P2|Overall Study|Withdrawal by Subject|0
282365|NCT01869699|949601|P1|Overall Study|Withdrawal by Subject|1
282366|NCT01869348|949664|P2|Overall Study|Withdrawal by Subject|1
282367|NCT01869348|949665|P1|Overall Study|Withdrawal by Subject|1
282368|NCT01868997|949698|P2|Overall Study|Not Specified|1
282369|NCT01868997|949699|P1|Overall Study|Not Specified|3
282370|NCT01868997|949698|P2|Overall Study|Lack of Efficacy|0
282371|NCT01868997|949699|P1|Overall Study|Lack of Efficacy|2
282372|NCT01868997|949698|P2|Overall Study|Adverse Event|5
282373|NCT01868997|949699|P1|Overall Study|Adverse Event|2
282374|NCT01868893|949715|P1|Overall Study|Neutropenia|1
282375|NCT01868893|949715|P1|Overall Study|Commercial availability of study drug|17
282376|NCT01868893|949715|P1|Overall Study|Adverse Event|2
282377|NCT01868542|949761|P2|Overall Study|Unclassified|1
282378|NCT01868542|949762|P1|Overall Study|Unclassified|0
282379|NCT01868542|949761|P2|Overall Study|Protocol Violation|1
282380|NCT01868542|949762|P1|Overall Study|Protocol Violation|0
282381|NCT01868503|949780|P1|Overall Study|Protocol Violation|1
282382|NCT01868503|949780|P1|Overall Study|Withdrawal by Subject|1
282383|NCT01868243|949835|P2|Overall Study|Death|1
282384|NCT01868243|949836|P1|Overall Study|Death|0
282385|NCT01868074|949846|P2|Overall Study|Withdrawal by Subject|2
282386|NCT01868074|949847|P1|Overall Study|Withdrawal by Subject|4
282387|NCT01868074|949846|P2|Overall Study|Lost to Follow-up|2
282388|NCT01868074|949847|P1|Overall Study|Lost to Follow-up|3
282389|NCT01868035|949857|P1|Overall Study|Non-compliance|1
282390|NCT01868035|949857|P1|Overall Study|Progressive Disease|2
282391|NCT01868035|949857|P1|Overall Study|Withdrawal by Subject|1
282392|NCT01868035|949857|P1|Overall Study|Lost to Follow-up|3
282393|NCT01868009|949873|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
282394|NCT01868009|949874|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
282395|NCT01868009|949873|P2|Period 2 (5-9 Days)|Adverse Event|0
282396|NCT01868009|949874|P1|Period 2 (5-9 Days)|Adverse Event|1
282397|NCT01868009|949873|P2|Period 1 (5-9 Days)|Adverse Event|2
282398|NCT01868009|949874|P1|Period 1 (5-9 Days)|Adverse Event|0
282399|NCT01867710|949888|P4|Overall Study|Other|0
282400|NCT01867710|949889|P3|Overall Study|Other|0
282401|NCT01867710|949890|P2|Overall Study|Other|1
282402|NCT01867710|949891|P1|Overall Study|Other|0
282403|NCT01867710|949888|P4|Overall Study|Eligible Criteria Not Met|0
282404|NCT01867710|949889|P3|Overall Study|Eligible Criteria Not Met|1
282405|NCT01867710|949890|P2|Overall Study|Eligible Criteria Not Met|0
282406|NCT01867710|949891|P1|Overall Study|Eligible Criteria Not Met|0
282407|NCT01867710|949888|P4|Overall Study|Withdrawal by Subject|0
282408|NCT01867710|949889|P3|Overall Study|Withdrawal by Subject|0
282409|NCT01867710|949890|P2|Overall Study|Withdrawal by Subject|1
282410|NCT01867710|949891|P1|Overall Study|Withdrawal by Subject|0
282411|NCT01867710|949888|P4|Overall Study|Protocol Violation|1
282412|NCT01867710|949889|P3|Overall Study|Protocol Violation|0
282413|NCT01867710|949890|P2|Overall Study|Protocol Violation|0
282414|NCT01867710|949891|P1|Overall Study|Protocol Violation|1
282415|NCT01867710|949888|P4|Overall Study|Physician Decision|0
282416|NCT01867710|949889|P3|Overall Study|Physician Decision|1
282417|NCT01867710|949890|P2|Overall Study|Physician Decision|0
282418|NCT01867710|949891|P1|Overall Study|Physician Decision|0
282419|NCT01867710|949888|P4|Overall Study|Death|0
282420|NCT01867710|949889|P3|Overall Study|Death|1
282421|NCT01867710|949890|P2|Overall Study|Death|1
282422|NCT01867710|949891|P1|Overall Study|Death|0
282423|NCT01867710|949888|P4|Overall Study|Other Adverse Events|3
282424|NCT01867710|949889|P3|Overall Study|Other Adverse Events|1
282425|NCT01867710|949890|P2|Overall Study|Other Adverse Events|0
282426|NCT01867710|949891|P1|Overall Study|Other Adverse Events|1
282427|NCT01867710|949888|P4|Overall Study|Palliative Radiation Required|1
282428|NCT01867710|949889|P3|Overall Study|Palliative Radiation Required|1
282429|NCT01867710|949890|P2|Overall Study|Palliative Radiation Required|0
282430|NCT01867710|949891|P1|Overall Study|Palliative Radiation Required|0
282431|NCT01867710|949888|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
282432|NCT01867710|949889|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
282433|NCT01867710|949890|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
282434|NCT01867710|949891|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
282435|NCT01867710|949888|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
282436|NCT01867710|949889|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
282437|NCT01867710|949890|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
282438|NCT01867710|949891|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
282439|NCT01867710|949888|P4|Overall Study|Disease Progression|2
282440|NCT01867710|949889|P3|Overall Study|Disease Progression|4
282441|NCT01867710|949890|P2|Overall Study|Disease Progression|2
282442|NCT01867710|949891|P1|Overall Study|Disease Progression|5
282443|NCT01867658|949905|P1|Overall Study|Subject could not be contacted|1
282444|NCT01867658|949905|P1|Overall Study|Death|2
282445|NCT01867658|949905|P1|Overall Study|Withdrawal by Subject|6
282446|NCT01867580|949929|P2|Overall Study|Wound recurrence|1
282447|NCT01867580|949930|P1|Overall Study|Wound recurrence|0
282448|NCT01867580|949929|P2|Overall Study|Continuation of therapy|1
282449|NCT01867580|949930|P1|Overall Study|Continuation of therapy|0
282450|NCT01867580|949929|P2|Overall Study|Osteomyelitis|1
282451|NCT01867580|949930|P1|Overall Study|Osteomyelitis|0
282452|NCT01867580|949929|P2|Overall Study|Interruption to therapy|0
282453|NCT01867580|949930|P1|Overall Study|Interruption to therapy|3
282454|NCT01867580|949929|P2|Overall Study|Missed follow-up assessment|1
282455|NCT01867580|949930|P1|Overall Study|Missed follow-up assessment|2
282456|NCT01867580|949929|P2|Overall Study|Sponsor terminated study|0
282457|NCT01867580|949930|P1|Overall Study|Sponsor terminated study|1
282458|NCT01867580|949929|P2|Overall Study|Lost to Follow-up|5
282459|NCT01867580|949930|P1|Overall Study|Lost to Follow-up|3
282460|NCT01867580|949929|P2|Overall Study|Physician Decision|12
282461|NCT01867580|949930|P1|Overall Study|Physician Decision|17
282462|NCT01867580|949929|P2|Overall Study|Withdrawal by Subject|3
282463|NCT01867580|949930|P1|Overall Study|Withdrawal by Subject|2
282464|NCT01867424|949955|P2|Overall Study|Patient noncompliance|1
282465|NCT01867424|949956|P1|Overall Study|Patient noncompliance|2
282466|NCT01867307|949970|P2|Overall Study|Other Adverse Event|3
282467|NCT01867307|949971|P1|Overall Study|Other Adverse Event|1
282468|NCT01867307|949970|P2|Overall Study|Protocol Violation|0
282469|NCT01867307|949971|P1|Overall Study|Protocol Violation|2
282470|NCT01867086|949994|P1|Overall Study|Disease Progression|1
282471|NCT01867047|950003|P2|Overall Study|surgery not indicated in protocol|2
282472|NCT01867047|950004|P1|Overall Study|surgery not indicated in protocol|1
282473|NCT01867047|950003|P2|Overall Study|Physician Decision|0
282474|NCT01867047|950004|P1|Overall Study|Physician Decision|2
282475|NCT01867047|950003|P2|Overall Study|Withdrawal by Subject|0
282476|NCT01867047|950004|P1|Overall Study|Withdrawal by Subject|2
282477|NCT01867047|950003|P2|Overall Study|Lost to Follow-up|3
282478|NCT01867047|950004|P1|Overall Study|Lost to Follow-up|3
282479|NCT01867021|950024|P2|Overall Study|Withdrawal by Subject|6
282480|NCT01867021|950025|P1|Overall Study|Withdrawal by Subject|1
282481|NCT01867021|950024|P2|Overall Study|Lost to Follow-up|2
282482|NCT01867021|950025|P1|Overall Study|Lost to Follow-up|0
282483|NCT01867021|950024|P2|Overall Study|Death|0
282484|NCT01867021|950025|P1|Overall Study|Death|1
282485|NCT01867021|950024|P2|Overall Study|Not Eligible|1
282486|NCT01867021|950025|P1|Overall Study|Not Eligible|0
282487|NCT01867021|950024|P2|Overall Study|Adverse Event|1
282488|NCT01867021|950025|P1|Overall Study|Adverse Event|0
282489|NCT01866709|950056|P2|Overall Study|Adverse Event|0
282490|NCT01866709|950057|P1|Overall Study|Adverse Event|1
282491|NCT01866423|950098|P1|Overall Study|Sponsor Decision|1
282492|NCT01866423|950098|P1|Overall Study|Lack of Efficacy|3
282493|NCT01866319|950111|P3|Overall Study|Remain on study|176
282494|NCT01866319|950112|P2|Overall Study|Remain on study|190
282495|NCT01866319|950113|P1|Overall Study|Remain on study|131
282496|NCT01866319|950111|P3|Overall Study|Withdrawal by Subject|6
282497|NCT01866319|950112|P2|Overall Study|Withdrawal by Subject|9
282498|NCT01866319|950113|P1|Overall Study|Withdrawal by Subject|31
282499|NCT01866319|950111|P3|Overall Study|Physician Decision|0
282500|NCT01866319|950112|P2|Overall Study|Physician Decision|0
282501|NCT01866319|950113|P1|Overall Study|Physician Decision|1
282502|NCT01866319|950111|P3|Overall Study|Lost to Follow-up|6
282503|NCT01866319|950112|P2|Overall Study|Lost to Follow-up|0
282504|NCT01866319|950113|P1|Overall Study|Lost to Follow-up|3
282505|NCT01866319|950111|P3|Overall Study|Death|77
282506|NCT01866319|950112|P2|Overall Study|Death|74
282507|NCT01866319|950113|P1|Overall Study|Death|97
282508|NCT01866319|950111|P3|Overall Study|Clinical progression|0
282509|NCT01866319|950112|P2|Overall Study|Clinical progression|0
282510|NCT01866319|950113|P1|Overall Study|Clinical progression|1
282511|NCT01866319|950111|P3|Overall Study|Adverse Event|12
282512|NCT01866319|950112|P2|Overall Study|Adverse Event|6
282513|NCT01866319|950113|P1|Overall Study|Adverse Event|13
282514|NCT01866293|950212|P1|Overall Study|Adverse Event|2
282515|NCT01865812|950254|P1|Overall Study|Adverse Event|2
282516|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Other|1
282517|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Other|0
282518|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
282519|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
282520|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
282521|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
282522|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Physician Decision|2
282523|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Physician Decision|4
282524|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
282525|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
282526|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
282527|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
282528|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
282529|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
282530|NCT01865747|950262|P2|Primary Intent to Treat (PITT)|Adverse Event|20
282531|NCT01865747|950263|P1|Primary Intent to Treat (PITT)|Adverse Event|21
282532|NCT01865747|950262|P2|Overall Study (ITT)|Reason Not Provided|1
282533|NCT01865747|950263|P1|Overall Study (ITT)|Reason Not Provided|0
282534|NCT01865747|950262|P2|Overall Study (ITT)|Progressive Disease|158
282535|NCT01865747|950263|P1|Overall Study (ITT)|Progressive Disease|122
282536|NCT01865747|950262|P2|Overall Study (ITT)|Sponsor Decision|1
282537|NCT01865747|950263|P1|Overall Study (ITT)|Sponsor Decision|0
282538|NCT01865747|950262|P2|Overall Study (ITT)|Withdrawal by Subject|11
282539|NCT01865747|950263|P1|Overall Study (ITT)|Withdrawal by Subject|6
282540|NCT01865747|950262|P2|Overall Study (ITT)|Physician Decision|2
282541|NCT01865747|950263|P1|Overall Study (ITT)|Physician Decision|5
282542|NCT01865747|950262|P2|Overall Study (ITT)|Protocol Violation|1
282543|NCT01865747|950263|P1|Overall Study (ITT)|Protocol Violation|1
282544|NCT01865747|950262|P2|Overall Study (ITT)|Lack of Efficacy|0
282545|NCT01865747|950263|P1|Overall Study (ITT)|Lack of Efficacy|3
282546|NCT01865747|950262|P2|Overall Study (ITT)|Clinical Deterioration|50
282547|NCT01865747|950263|P1|Overall Study (ITT)|Clinical Deterioration|29
282548|NCT01865747|950262|P2|Overall Study (ITT)|Adverse Event|31
282549|NCT01865747|950263|P1|Overall Study (ITT)|Adverse Event|32
282550|NCT01865084|950281|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
282551|NCT01865084|950282|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
282552|NCT01865084|950283|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
282553|NCT01865084|950281|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
282554|NCT01865084|950282|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
282555|NCT01865084|950283|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
282556|NCT01865084|950281|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
282557|NCT01865084|950282|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
282558|NCT01865084|950283|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
282559|NCT01865084|950281|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
282560|NCT01865084|950282|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
282561|NCT01865084|950283|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
282562|NCT01865084|950281|P3|Open Label Extension (OLE) Period|Adverse Event|1
282563|NCT01865084|950282|P2|Open Label Extension (OLE) Period|Adverse Event|0
282564|NCT01865084|950283|P1|Open Label Extension (OLE) Period|Adverse Event|0
282565|NCT01865084|950281|P3|Double Blind Period (DB)|Withdrawal by Subject|0
282566|NCT01865084|950282|P2|Double Blind Period (DB)|Withdrawal by Subject|0
282567|NCT01865084|950283|P1|Double Blind Period (DB)|Withdrawal by Subject|1
282568|NCT01865084|950281|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
282569|NCT01865084|950282|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
282570|NCT01865084|950283|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
282571|NCT01865084|950281|P3|Double Blind Period (DB)|Protocol Violation|1
282572|NCT01865084|950282|P2|Double Blind Period (DB)|Protocol Violation|0
282573|NCT01865084|950283|P1|Double Blind Period (DB)|Protocol Violation|0
282574|NCT01865084|950281|P3|Double Blind Period (DB)|Adverse Event|1
282575|NCT01865084|950282|P2|Double Blind Period (DB)|Adverse Event|2
282576|NCT01865084|950283|P1|Double Blind Period (DB)|Adverse Event|2
282577|NCT01864200|950328|P2|Overall Study|Protocol Violation|0
282578|NCT01864200|950329|P1|Overall Study|Protocol Violation|1
282579|NCT01864200|950328|P2|Overall Study|Lost to Follow-up|3
282580|NCT01864200|950329|P1|Overall Study|Lost to Follow-up|1
282581|NCT01864174|950337|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
282582|NCT01864174|950338|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
282583|NCT01864174|950337|P2|Off Treatment Follow-Up|Other|0
282584|NCT01864174|950338|P1|Off Treatment Follow-Up|Other|2
282585|NCT01864174|950337|P2|Double Blind - Compliant Randomized|Other|10
282586|NCT01864174|950338|P1|Double Blind - Compliant Randomized|Other|6
282587|NCT01864174|950337|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
282588|NCT01864174|950338|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
282589|NCT01864174|950337|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
282590|NCT01864174|950338|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
282591|NCT01864174|950337|P2|Double Blind - Compliant Randomized|Death|0
282592|NCT01864174|950338|P1|Double Blind - Compliant Randomized|Death|1
282593|NCT01864174|950337|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
282594|NCT01864174|950338|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
282595|NCT01864174|950337|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
282596|NCT01864174|950338|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
282597|NCT01864174|950337|P2|Double Blind - Compliant Randomized|Adverse Event|1
282598|NCT01864174|950338|P1|Double Blind - Compliant Randomized|Adverse Event|6
282599|NCT01864174|950337|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
282600|NCT01864174|950338|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
282601|NCT01864148|950357|P5|Overall Study|Not Dosed|0
282602|NCT01864148|950358|P4|Overall Study|Not Dosed|1
282603|NCT01864148|950359|P3|Overall Study|Not Dosed|0
282604|NCT01864148|950360|P2|Overall Study|Not Dosed|0
282605|NCT01864148|950361|P1|Overall Study|Not Dosed|0
282606|NCT01864148|950357|P5|Overall Study|Adverse Event|7
282607|NCT01864148|950358|P4|Overall Study|Adverse Event|7
282608|NCT01864148|950359|P3|Overall Study|Adverse Event|4
282609|NCT01864148|950360|P2|Overall Study|Adverse Event|2
282610|NCT01864148|950361|P1|Overall Study|Adverse Event|4
282611|NCT01864148|950357|P5|Overall Study|Lost to Follow-up|1
282612|NCT01864148|950358|P4|Overall Study|Lost to Follow-up|2
282613|NCT01864148|950359|P3|Overall Study|Lost to Follow-up|0
282614|NCT01864148|950360|P2|Overall Study|Lost to Follow-up|0
282615|NCT01864148|950361|P1|Overall Study|Lost to Follow-up|0
282616|NCT01864148|950357|P5|Overall Study|Withdrawal by Subject|8
282617|NCT01864148|950358|P4|Overall Study|Withdrawal by Subject|8
282618|NCT01864148|950359|P3|Overall Study|Withdrawal by Subject|6
282619|NCT01864148|950360|P2|Overall Study|Withdrawal by Subject|2
282620|NCT01864148|950361|P1|Overall Study|Withdrawal by Subject|9
282621|NCT01864148|950357|P5|Overall Study|Investigator Decision|6
282622|NCT01864148|950358|P4|Overall Study|Investigator Decision|4
282623|NCT01864148|950359|P3|Overall Study|Investigator Decision|0
282624|NCT01864148|950360|P2|Overall Study|Investigator Decision|0
282625|NCT01864148|950361|P1|Overall Study|Investigator Decision|5
282626|NCT01864148|950357|P5|Overall Study|Death|0
282627|NCT01864148|950358|P4|Overall Study|Death|1
282628|NCT01864148|950359|P3|Overall Study|Death|0
282629|NCT01864148|950360|P2|Overall Study|Death|0
282630|NCT01864148|950361|P1|Overall Study|Death|0
282631|NCT01864148|950357|P5|Overall Study|Not Specified|1
282632|NCT01864148|950358|P4|Overall Study|Not Specified|3
282633|NCT01864148|950359|P3|Overall Study|Not Specified|1
282634|NCT01864148|950360|P2|Overall Study|Not Specified|1
282635|NCT01864148|950361|P1|Overall Study|Not Specified|2
282636|NCT01864005|950390|P2|Overall Study|Need GP IIb/IIIa|3
282637|NCT01864005|950391|P1|Overall Study|Need GP IIb/IIIa|1
282638|NCT01864005|950390|P2|Overall Study|Disease need|1
282639|NCT01864005|950391|P1|Overall Study|Disease need|1
282640|NCT01864005|950390|P2|Overall Study|Incorrect enrolment|0
282641|NCT01864005|950391|P1|Overall Study|Incorrect enrolment|1
282642|NCT01864005|950390|P2|Overall Study|Withdrawal by Subject|1
282643|NCT01864005|950391|P1|Overall Study|Withdrawal by Subject|0
282644|NCT01864005|950390|P2|Overall Study|Protocol Violation|1
282645|NCT01864005|950391|P1|Overall Study|Protocol Violation|0
282646|NCT01863953|950408|P3|Overall Study|Adverse Event|1
282647|NCT01863953|950409|P2|Overall Study|Adverse Event|0
282648|NCT01863953|950410|P1|Overall Study|Adverse Event|0
282649|NCT01863771|950424|P4|Maintenance Phase|Withdrawal by Subject|3
282650|NCT01863771|950425|P3|Maintenance Phase|Withdrawal by Subject|2
282651|NCT01863771|950426|P2|Maintenance Phase|Withdrawal by Subject|1
282652|NCT01863771|950427|P1|Maintenance Phase|Withdrawal by Subject|0
282653|NCT01863771|950424|P4|Maintenance Phase|Pregnancy|0
282654|NCT01863771|950425|P3|Maintenance Phase|Pregnancy|0
282655|NCT01863771|950426|P2|Maintenance Phase|Pregnancy|1
282656|NCT01863771|950427|P1|Maintenance Phase|Pregnancy|0
282657|NCT01863771|950424|P4|Maintenance Phase|Physician Decision|1
282658|NCT01863771|950425|P3|Maintenance Phase|Physician Decision|2
282659|NCT01863771|950426|P2|Maintenance Phase|Physician Decision|0
282660|NCT01863771|950427|P1|Maintenance Phase|Physician Decision|0
282661|NCT01863771|950424|P4|Maintenance Phase|Lack of Efficacy|38
282662|NCT01863771|950425|P3|Maintenance Phase|Lack of Efficacy|7
282663|NCT01863771|950426|P2|Maintenance Phase|Lack of Efficacy|3
282664|NCT01863771|950427|P1|Maintenance Phase|Lack of Efficacy|0
282665|NCT01863771|950424|P4|Maintenance Phase|Adverse Event|1
282666|NCT01863771|950425|P3|Maintenance Phase|Adverse Event|1
282667|NCT01863771|950426|P2|Maintenance Phase|Adverse Event|0
282668|NCT01863771|950427|P1|Maintenance Phase|Adverse Event|0
282669|NCT01863771|950424|P4|Induction Phase|Withdrawal by Subject|0
282670|NCT01863771|950425|P3|Induction Phase|Withdrawal by Subject|0
282671|NCT01863771|950426|P2|Induction Phase|Withdrawal by Subject|0
282672|NCT01863771|950427|P1|Induction Phase|Withdrawal by Subject|2
282673|NCT01863771|950424|P4|Induction Phase|Lack of Efficacy|0
282674|NCT01863771|950425|P3|Induction Phase|Lack of Efficacy|0
282675|NCT01863771|950426|P2|Induction Phase|Lack of Efficacy|0
282676|NCT01863771|950427|P1|Induction Phase|Lack of Efficacy|10
282677|NCT01863771|950424|P4|Induction Phase|Adverse Event|0
282678|NCT01863771|950425|P3|Induction Phase|Adverse Event|0
282679|NCT01863771|950426|P2|Induction Phase|Adverse Event|0
282680|NCT01863771|950427|P1|Induction Phase|Adverse Event|9
282681|NCT01863758|950439|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
282682|NCT01863758|950439|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
282683|NCT01863680|950447|P1|Overall Study|Other|6
282684|NCT01863680|950447|P1|Overall Study|Did not undergo IVF/ET|14
282685|NCT01863680|950447|P1|Overall Study|Withdrawal by Subject|1
282686|NCT01863680|950447|P1|Overall Study|Spontaneous pregnancy|2
282687|NCT01863680|950447|P1|Overall Study|Risk of OHSS|17
282688|NCT01863680|950447|P1|Overall Study|Adverse Event|17
282689|NCT01863667|950455|P2|Overall Study|Withdrawal by Subject|2
282690|NCT01863667|950456|P1|Overall Study|Withdrawal by Subject|2
282691|NCT01863667|950455|P2|Overall Study|Study terminated by Sponsor|30
282692|NCT01863667|950456|P1|Overall Study|Study terminated by Sponsor|30
282693|NCT01863667|950455|P2|Overall Study|Adverse Event|0
282694|NCT01863667|950456|P1|Overall Study|Adverse Event|1
282695|NCT01863433|950480|P1|Overall Study|Protocol Violation|1
282696|NCT01863368|950490|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
282697|NCT01863368|950491|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
282698|NCT01863368|950490|P2|Phase II, Day 35 to Day 90|Adverse Event|0
282699|NCT01863368|950491|P1|Phase II, Day 35 to Day 90|Adverse Event|1
282700|NCT01863368|950490|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
282701|NCT01863368|950491|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
282702|NCT01863368|950490|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
282703|NCT01863368|950491|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
282704|NCT01863368|950490|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
282705|NCT01863368|950491|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
282706|NCT01863368|950490|P2|Phase I, Day 0 to Day 35|Adverse Event|4
282707|NCT01863368|950491|P1|Phase I, Day 0 to Day 35|Adverse Event|2
282708|NCT01862991|950516|P3|Overall Study|Protocol Violation|0
282709|NCT01862991|950517|P2|Overall Study|Protocol Violation|0
282710|NCT01862991|950518|P1|Overall Study|Protocol Violation|1
282711|NCT01862991|950516|P3|Overall Study|Lost to Follow-up|1
282712|NCT01862991|950517|P2|Overall Study|Lost to Follow-up|1
282713|NCT01862991|950518|P1|Overall Study|Lost to Follow-up|2
282714|NCT01862484|950531|P2|Overall Study|Withdrawal by Subject|3
282715|NCT01862484|950532|P1|Overall Study|Withdrawal by Subject|0
282716|NCT01862484|950531|P2|Overall Study|Protocol Violation|2
282717|NCT01862484|950532|P1|Overall Study|Protocol Violation|0
282718|NCT01862484|950531|P2|Overall Study|Lost to Follow-up|2
282719|NCT01862484|950532|P1|Overall Study|Lost to Follow-up|1
282720|NCT01862484|950531|P2|Overall Study|Lack of Efficacy|1
282721|NCT01862484|950532|P1|Overall Study|Lack of Efficacy|1
282722|NCT01862250|950551|P1|Overall Study|Adverse Event|4
282723|NCT01861522|950627|P2|Overall Study|Withdrawal by Subject|0
282724|NCT01861522|950628|P1|Overall Study|Withdrawal by Subject|2
282725|NCT01861522|950627|P2|Overall Study|Adverse Event|0
282726|NCT01861522|950628|P1|Overall Study|Adverse Event|1
282727|NCT01860989|950652|P1|Overall Study|Unsatisfactory therapeutic|5
282728|NCT01860976|950658|P2|Long Term Extension|Ongoing treatment at time of analysis|100
282729|NCT01860976|950659|P1|Long Term Extension|Ongoing treatment at time of analysis|106
282730|NCT01860976|950658|P2|Long Term Extension|Withdrawal by Subject|0
282731|NCT01860976|950659|P1|Long Term Extension|Withdrawal by Subject|1
282732|NCT01860976|950658|P2|Long Term Extension|Subject request to discontinue treatment|0
282733|NCT01860976|950659|P1|Long Term Extension|Subject request to discontinue treatment|2
282734|NCT01860976|950658|P2|Long Term Extension|Lack of Efficacy|7
282735|NCT01860976|950659|P1|Long Term Extension|Lack of Efficacy|3
282736|NCT01860976|950658|P2|Long Term Extension|Adverse Event|0
282737|NCT01860976|950659|P1|Long Term Extension|Adverse Event|1
282738|NCT01860976|950658|P2|Open-Label|Ongoing OL treatment at time of analysis|45
282739|NCT01860976|950659|P1|Open-Label|Ongoing OL treatment at time of analysis|46
282740|NCT01860976|950658|P2|Open-Label|Other Reasons|1
282741|NCT01860976|950659|P1|Open-Label|Other Reasons|1
282742|NCT01860976|950658|P2|Open-Label|Withdrawal by Subject|1
282743|NCT01860976|950659|P1|Open-Label|Withdrawal by Subject|4
282744|NCT01860976|950658|P2|Open-Label|Subject request discontinue treatment|3
282745|NCT01860976|950659|P1|Open-Label|Subject request discontinue treatment|4
282746|NCT01860976|950658|P2|Open-Label|Lost to Follow-up|2
282747|NCT01860976|950659|P1|Open-Label|Lost to Follow-up|1
282748|NCT01860976|950658|P2|Open-Label|Lack of Efficacy|8
282749|NCT01860976|950659|P1|Open-Label|Lack of Efficacy|16
282750|NCT01860976|950658|P2|Open-Label|Adverse Event|4
282751|NCT01860976|950659|P1|Open-Label|Adverse Event|2
282752|NCT01860976|950658|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
282753|NCT01860976|950659|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
282754|NCT01860976|950658|P2|Blinded Treatment|Entered Open-Label in error|1
282755|NCT01860976|950659|P1|Blinded Treatment|Entered Open-Label in error|0
282756|NCT01860976|950658|P2|Blinded Treatment|Subject no longer met criteria|0
282757|NCT01860976|950659|P1|Blinded Treatment|Subject no longer met criteria|1
282758|NCT01860976|950658|P2|Blinded Treatment|Withdrawal by Subject|5
282759|NCT01860976|950659|P1|Blinded Treatment|Withdrawal by Subject|3
282760|NCT01860976|950658|P2|Blinded Treatment|Subject request to discontinue treatment|3
282761|NCT01860976|950659|P1|Blinded Treatment|Subject request to discontinue treatment|2
282762|NCT01860976|950658|P2|Blinded Treatment|Lack of Efficacy|12
282763|NCT01860976|950659|P1|Blinded Treatment|Lack of Efficacy|5
282764|NCT01860976|950658|P2|Blinded Treatment|Adverse Event|3
282765|NCT01860976|950659|P1|Blinded Treatment|Adverse Event|1
282766|NCT01860846|950681|P1|Overall Study|Lost to Follow-up|33
282767|NCT01860703|950692|P4|Overall Study|Personal reason|0
282768|NCT01860703|950693|P3|Overall Study|Personal reason|1
282769|NCT01860703|950694|P2|Overall Study|Personal reason|0
282770|NCT01860703|950695|P1|Overall Study|Personal reason|1
282771|NCT01860703|950692|P4|Overall Study|Withdrawal by Subject|0
282772|NCT01860703|950693|P3|Overall Study|Withdrawal by Subject|0
282773|NCT01860703|950694|P2|Overall Study|Withdrawal by Subject|1
282774|NCT01860703|950695|P1|Overall Study|Withdrawal by Subject|0
282775|NCT01860703|950692|P4|Overall Study|Adverse Event|2
282776|NCT01860703|950693|P3|Overall Study|Adverse Event|0
282777|NCT01860703|950694|P2|Overall Study|Adverse Event|4
282778|NCT01860703|950695|P1|Overall Study|Adverse Event|1
282779|NCT01860677|950727|P2|Second Intervention (1 Day)|Lost to Follow-up|0
282780|NCT01860677|950728|P1|Second Intervention (1 Day)|Lost to Follow-up|7
282781|NCT01860534|950766|P2|ROP #2|discharged prior to ROP #2|0
282782|NCT01860534|950767|P1|ROP #2|discharged prior to ROP #2|1
282783|NCT01860534|950766|P2|ROP #1|Needed treatment for ROP|1
282784|NCT01860534|950767|P1|ROP #1|Needed treatment for ROP|0
282785|NCT01860079|950815|P2|Overall Study|Physician Decision|22
282786|NCT01860079|950816|P1|Overall Study|Physician Decision|14
282787|NCT01860040|950824|P2|Overall Study|Withdrawal by Subject|0
282788|NCT01860040|950825|P1|Overall Study|Withdrawal by Subject|1
282789|NCT01859988|950836|P6|Overall Study|Other than specified above|3
282790|NCT01859988|950837|P5|Overall Study|Other than specified above|5
282791|NCT01859988|950838|P4|Overall Study|Other than specified above|3
282792|NCT01859988|950839|P3|Overall Study|Other than specified above|11
282793|NCT01859988|950840|P2|Overall Study|Other than specified above|2
282794|NCT01859988|950841|P1|Overall Study|Other than specified above|0
282795|NCT01859988|950836|P6|Overall Study|Protocol Violation|0
282796|NCT01859988|950837|P5|Overall Study|Protocol Violation|0
282797|NCT01859988|950838|P4|Overall Study|Protocol Violation|0
282798|NCT01859988|950839|P3|Overall Study|Protocol Violation|1
282799|NCT01859988|950840|P2|Overall Study|Protocol Violation|0
282800|NCT01859988|950841|P1|Overall Study|Protocol Violation|0
282801|NCT01859988|950836|P6|Overall Study|Lost to Follow-up|2
282802|NCT01859988|950837|P5|Overall Study|Lost to Follow-up|3
282803|NCT01859988|950838|P4|Overall Study|Lost to Follow-up|0
282804|NCT01859988|950839|P3|Overall Study|Lost to Follow-up|3
282805|NCT01859988|950840|P2|Overall Study|Lost to Follow-up|2
282806|NCT01859988|950841|P1|Overall Study|Lost to Follow-up|1
282807|NCT01859988|950836|P6|Overall Study|Adverse Event|2
282808|NCT01859988|950837|P5|Overall Study|Adverse Event|2
282809|NCT01859988|950838|P4|Overall Study|Adverse Event|1
282810|NCT01859988|950839|P3|Overall Study|Adverse Event|3
282811|NCT01859988|950840|P2|Overall Study|Adverse Event|1
282812|NCT01859988|950841|P1|Overall Study|Adverse Event|2
282813|NCT01859988|950836|P6|Overall Study|Physician Decision|1
282814|NCT01859988|950837|P5|Overall Study|Physician Decision|4
282815|NCT01859988|950838|P4|Overall Study|Physician Decision|3
282816|NCT01859988|950839|P3|Overall Study|Physician Decision|1
282817|NCT01859988|950840|P2|Overall Study|Physician Decision|3
282818|NCT01859988|950841|P1|Overall Study|Physician Decision|1
282819|NCT01859988|950836|P6|Overall Study|Lack of Efficacy|9
282820|NCT01859988|950837|P5|Overall Study|Lack of Efficacy|7
282821|NCT01859988|950838|P4|Overall Study|Lack of Efficacy|0
282822|NCT01859988|950839|P3|Overall Study|Lack of Efficacy|5
282823|NCT01859988|950840|P2|Overall Study|Lack of Efficacy|1
282824|NCT01859988|950841|P1|Overall Study|Lack of Efficacy|1
282825|NCT01859988|950836|P6|Overall Study|Withdrawal by Subject|2
282826|NCT01859988|950837|P5|Overall Study|Withdrawal by Subject|2
282827|NCT01859988|950838|P4|Overall Study|Withdrawal by Subject|3
282828|NCT01859988|950839|P3|Overall Study|Withdrawal by Subject|4
282829|NCT01859988|950840|P2|Overall Study|Withdrawal by Subject|3
282830|NCT01859988|950841|P1|Overall Study|Withdrawal by Subject|6
282831|NCT01859949|950935|P2|Overall Study|Adverse Event|1
282832|NCT01859949|950936|P1|Overall Study|Adverse Event|0
282833|NCT01859949|950935|P2|Overall Study|Protocol Violation|1
282834|NCT01859949|950936|P1|Overall Study|Protocol Violation|1
282835|NCT01859949|950935|P2|Overall Study|Withdrawal by Subject|10
282836|NCT01859949|950936|P1|Overall Study|Withdrawal by Subject|11
282837|NCT01859949|950935|P2|Overall Study|Physician Decision|4
282838|NCT01859949|950936|P1|Overall Study|Physician Decision|2
282839|NCT01859949|950935|P2|Overall Study|Family Matters|1
282840|NCT01859949|950936|P1|Overall Study|Family Matters|0
282841|NCT01859793|950954|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
282842|NCT01859793|950955|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
282843|NCT01859793|950954|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
282844|NCT01859793|950955|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
282845|NCT01859793|950954|P2|First Intervention (8 Weeks)|Adverse Event|0
282846|NCT01859793|950955|P1|First Intervention (8 Weeks)|Adverse Event|1
282847|NCT01859793|950954|P2|First Intervention (8 Weeks)|Protocol Violation|0
282848|NCT01859793|950955|P1|First Intervention (8 Weeks)|Protocol Violation|2
282849|NCT01859715|950968|P3|Overall Study|No 2nd VAS|23
282850|NCT01859715|950969|P2|Overall Study|No 2nd VAS|8
282851|NCT01859715|950970|P1|Overall Study|No 2nd VAS|16
282852|NCT01859702|950981|P1|Overall Study|Adverse Event|2
282853|NCT01859702|950981|P1|Overall Study|Protocol deviation|3
282854|NCT01859598|950995|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
282855|NCT01859507|951003|P1|Overall Study|left the country|4
282856|NCT01859494|951008|P1|Overall Study|Adverse Event|1
282857|NCT01859390|951019|P2|Overall Study|Shipment Error|1
282858|NCT01859390|951020|P1|Overall Study|Shipment Error|0
282859|NCT01859390|951019|P2|Overall Study|Tube Cracked|2
282860|NCT01859390|951020|P1|Overall Study|Tube Cracked|0
282861|NCT01859390|951019|P2|Overall Study|Sample Missing Collection Date|1
282862|NCT01859390|951020|P1|Overall Study|Sample Missing Collection Date|0
282863|NCT01859390|951019|P2|Overall Study|Insufficient Sputum Collected|3
282864|NCT01859390|951020|P1|Overall Study|Insufficient Sputum Collected|1
282865|NCT01859143|951154|P2|Overall Study|Lost to Follow-up|0
282866|NCT01859143|951155|P1|Overall Study|Lost to Follow-up|2
282867|NCT01858766|951211|P19|Overall Study|Withdrew Consent|0
282868|NCT01858766|951212|P18|Overall Study|Withdrew Consent|0
282869|NCT01858766|951213|P17|Overall Study|Withdrew Consent|0
282870|NCT01858766|951214|P16|Overall Study|Withdrew Consent|0
282871|NCT01858766|951215|P15|Overall Study|Withdrew Consent|0
282872|NCT01858766|951216|P14|Overall Study|Withdrew Consent|0
282873|NCT01858766|951217|P13|Overall Study|Withdrew Consent|0
282874|NCT01858766|951218|P12|Overall Study|Withdrew Consent|1
282875|NCT01858766|951219|P11|Overall Study|Withdrew Consent|0
282876|NCT01858766|951220|P10|Overall Study|Withdrew Consent|0
282877|NCT01858766|951221|P9|Overall Study|Withdrew Consent|0
282878|NCT01858766|951222|P8|Overall Study|Withdrew Consent|0
282879|NCT01858766|951223|P7|Overall Study|Withdrew Consent|0
282880|NCT01858766|951224|P6|Overall Study|Withdrew Consent|0
282881|NCT01858766|951225|P5|Overall Study|Withdrew Consent|0
282882|NCT01858766|951226|P4|Overall Study|Withdrew Consent|0
282883|NCT01858766|951227|P3|Overall Study|Withdrew Consent|0
282884|NCT01858766|951228|P2|Overall Study|Withdrew Consent|0
282885|NCT01858766|951229|P1|Overall Study|Withdrew Consent|0
282886|NCT01858766|951211|P19|Overall Study|Lost to Follow-up|1
282887|NCT01858766|951212|P18|Overall Study|Lost to Follow-up|0
282888|NCT01858766|951213|P17|Overall Study|Lost to Follow-up|1
282889|NCT01858766|951214|P16|Overall Study|Lost to Follow-up|1
282890|NCT01858766|951215|P15|Overall Study|Lost to Follow-up|3
282891|NCT01858766|951216|P14|Overall Study|Lost to Follow-up|0
282892|NCT01858766|951217|P13|Overall Study|Lost to Follow-up|0
282893|NCT01858766|951218|P12|Overall Study|Lost to Follow-up|1
282894|NCT01858766|951219|P11|Overall Study|Lost to Follow-up|0
282895|NCT01858766|951220|P10|Overall Study|Lost to Follow-up|0
282896|NCT01858766|951221|P9|Overall Study|Lost to Follow-up|0
282897|NCT01858766|951222|P8|Overall Study|Lost to Follow-up|2
282898|NCT01858766|951223|P7|Overall Study|Lost to Follow-up|0
282899|NCT01858766|951224|P6|Overall Study|Lost to Follow-up|1
282900|NCT01858766|951225|P5|Overall Study|Lost to Follow-up|0
282901|NCT01858766|951226|P4|Overall Study|Lost to Follow-up|0
282902|NCT01858766|951227|P3|Overall Study|Lost to Follow-up|0
282903|NCT01858766|951228|P2|Overall Study|Lost to Follow-up|0
282904|NCT01858766|951229|P1|Overall Study|Lost to Follow-up|0
282905|NCT01858766|951211|P19|Overall Study|Lack of Efficacy|3
282906|NCT01858766|951212|P18|Overall Study|Lack of Efficacy|3
282907|NCT01858766|951213|P17|Overall Study|Lack of Efficacy|2
282908|NCT01858766|951214|P16|Overall Study|Lack of Efficacy|5
282909|NCT01858766|951215|P15|Overall Study|Lack of Efficacy|5
282910|NCT01858766|951216|P14|Overall Study|Lack of Efficacy|3
282911|NCT01858766|951217|P13|Overall Study|Lack of Efficacy|5
282912|NCT01858766|951218|P12|Overall Study|Lack of Efficacy|3
282913|NCT01858766|951219|P11|Overall Study|Lack of Efficacy|0
282914|NCT01858766|951220|P10|Overall Study|Lack of Efficacy|0
282915|NCT01858766|951221|P9|Overall Study|Lack of Efficacy|0
282916|NCT01858766|951222|P8|Overall Study|Lack of Efficacy|0
282917|NCT01858766|951223|P7|Overall Study|Lack of Efficacy|0
282918|NCT01858766|951224|P6|Overall Study|Lack of Efficacy|2
282919|NCT01858766|951225|P5|Overall Study|Lack of Efficacy|1
282920|NCT01858766|951226|P4|Overall Study|Lack of Efficacy|0
282921|NCT01858766|951227|P3|Overall Study|Lack of Efficacy|0
282922|NCT01858766|951228|P2|Overall Study|Lack of Efficacy|0
282923|NCT01858766|951229|P1|Overall Study|Lack of Efficacy|1
282924|NCT01858766|951211|P19|Overall Study|Death|0
282925|NCT01858766|951212|P18|Overall Study|Death|0
282926|NCT01858766|951213|P17|Overall Study|Death|0
282927|NCT01858766|951214|P16|Overall Study|Death|0
282928|NCT01858766|951215|P15|Overall Study|Death|0
282929|NCT01858766|951216|P14|Overall Study|Death|0
282930|NCT01858766|951217|P13|Overall Study|Death|0
282931|NCT01858766|951218|P12|Overall Study|Death|0
282932|NCT01858766|951219|P11|Overall Study|Death|0
282933|NCT01858766|951220|P10|Overall Study|Death|0
282934|NCT01858766|951221|P9|Overall Study|Death|0
282935|NCT01858766|951222|P8|Overall Study|Death|0
282936|NCT01858766|951223|P7|Overall Study|Death|0
282937|NCT01858766|951224|P6|Overall Study|Death|0
282938|NCT01858766|951225|P5|Overall Study|Death|0
282939|NCT01858766|951226|P4|Overall Study|Death|0
282940|NCT01858766|951227|P3|Overall Study|Death|1
282941|NCT01858766|951228|P2|Overall Study|Death|0
282942|NCT01858766|951229|P1|Overall Study|Death|0
282943|NCT01858766|951211|P19|Overall Study|Randomized but Never Treated|0
282944|NCT01858766|951212|P18|Overall Study|Randomized but Never Treated|1
282945|NCT01858766|951213|P17|Overall Study|Randomized but Never Treated|0
282946|NCT01858766|951214|P16|Overall Study|Randomized but Never Treated|0
282947|NCT01858766|951215|P15|Overall Study|Randomized but Never Treated|0
282948|NCT01858766|951216|P14|Overall Study|Randomized but Never Treated|0
282949|NCT01858766|951217|P13|Overall Study|Randomized but Never Treated|0
282950|NCT01858766|951218|P12|Overall Study|Randomized but Never Treated|0
282951|NCT01858766|951219|P11|Overall Study|Randomized but Never Treated|0
282952|NCT01858766|951220|P10|Overall Study|Randomized but Never Treated|0
282953|NCT01858766|951221|P9|Overall Study|Randomized but Never Treated|0
282954|NCT01858766|951222|P8|Overall Study|Randomized but Never Treated|0
282955|NCT01858766|951223|P7|Overall Study|Randomized but Never Treated|0
282956|NCT01858766|951224|P6|Overall Study|Randomized but Never Treated|1
282957|NCT01858766|951225|P5|Overall Study|Randomized but Never Treated|0
282958|NCT01858766|951226|P4|Overall Study|Randomized but Never Treated|0
282959|NCT01858766|951227|P3|Overall Study|Randomized but Never Treated|0
282960|NCT01858766|951228|P2|Overall Study|Randomized but Never Treated|0
282961|NCT01858766|951229|P1|Overall Study|Randomized but Never Treated|0
282962|NCT01858701|951300|P2|Period 2, Second 30 Days of Wear|Comfort|1
282963|NCT01858701|951301|P1|Period 2, Second 30 Days of Wear|Comfort|0
282964|NCT01858701|951300|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
282965|NCT01858701|951301|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
282966|NCT01858701|951300|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
282967|NCT01858701|951301|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
282968|NCT01858701|951300|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
282969|NCT01858701|951301|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
282970|NCT01858636|951307|P1|Overall Study|Withdrawal by Subject|1
282971|NCT01858636|951307|P1|Overall Study|Lost to Follow-up|1
282972|NCT01858636|951307|P1|Overall Study|Death|1
282973|NCT01858636|951307|P1|Overall Study|Physician Decision|1
282974|NCT01858636|951307|P1|Overall Study|No Device Deployment Attempted|24
282975|NCT01858389|951360|P2|Overall Study|Did not receive treatment|3
282976|NCT01858389|951361|P1|Overall Study|Did not receive treatment|0
282977|NCT01858389|951360|P2|Overall Study|Adverse Event|1
282978|NCT01858389|951361|P1|Overall Study|Adverse Event|3
282979|NCT01858389|951360|P2|Overall Study|Not specified|4
282980|NCT01858389|951361|P1|Overall Study|Not specified|2
282981|NCT01858389|951360|P2|Overall Study|Progressive disease|11
282982|NCT01858389|951361|P1|Overall Study|Progressive disease|10
282983|NCT01858389|951360|P2|Overall Study|Withdrawal by Subject|1
282984|NCT01858389|951361|P1|Overall Study|Withdrawal by Subject|0
282985|NCT01858389|951360|P2|Overall Study|Study terminated by sponsor|2
282986|NCT01858389|951361|P1|Overall Study|Study terminated by sponsor|0
282987|NCT01858389|951360|P2|Overall Study|Death|3
282988|NCT01858389|951361|P1|Overall Study|Death|1
282989|NCT01858376|951376|P1|Overall Study|Dropped d/t lab work not fitting criter|4
282990|NCT01857622|951414|P3|Overall Study|Withdrawal by Subject|0
282991|NCT01857622|951415|P2|Overall Study|Withdrawal by Subject|0
282992|NCT01857622|951416|P1|Overall Study|Withdrawal by Subject|1
282993|NCT01857622|951414|P3|Overall Study|Protocol Violation|0
282994|NCT01857622|951415|P2|Overall Study|Protocol Violation|1
282995|NCT01857622|951416|P1|Overall Study|Protocol Violation|4
282996|NCT01857622|951414|P3|Overall Study|Physician Decision|0
282997|NCT01857622|951415|P2|Overall Study|Physician Decision|0
282998|NCT01857622|951416|P1|Overall Study|Physician Decision|1
282999|NCT01857622|951414|P3|Overall Study|Adverse Event|2
283000|NCT01857622|951415|P2|Overall Study|Adverse Event|0
283001|NCT01857622|951416|P1|Overall Study|Adverse Event|5
283002|NCT01857583|951428|P4|Overall Study|Withdrawal by Subject|2
283003|NCT01857583|951429|P3|Overall Study|Withdrawal by Subject|1
283004|NCT01857583|951430|P2|Overall Study|Withdrawal by Subject|0
283005|NCT01857583|951431|P1|Overall Study|Withdrawal by Subject|1
283006|NCT01857583|951428|P4|Overall Study|Physician Decision|1
283007|NCT01857583|951429|P3|Overall Study|Physician Decision|0
283008|NCT01857583|951430|P2|Overall Study|Physician Decision|0
283009|NCT01857583|951431|P1|Overall Study|Physician Decision|0
283010|NCT01857583|951428|P4|Overall Study|Death|0
283011|NCT01857583|951429|P3|Overall Study|Death|1
283012|NCT01857583|951430|P2|Overall Study|Death|1
283013|NCT01857583|951431|P1|Overall Study|Death|0
283014|NCT01857583|951428|P4|Overall Study|Adverse Event|1
283015|NCT01857583|951429|P3|Overall Study|Adverse Event|1
283016|NCT01857583|951430|P2|Overall Study|Adverse Event|0
283017|NCT01857583|951431|P1|Overall Study|Adverse Event|0
283018|NCT01857531|951441|P1|Overall Study|Withdrawal by Subject|4
283019|NCT01857323|951459|P1|Overall Study|Did not complete 180 doses|48
283020|NCT01857323|951459|P1|Overall Study|Not specified|4
283021|NCT01857323|951459|P1|Overall Study|Lost to Follow-up|1
283022|NCT01857323|951459|P1|Overall Study|Protocol Violation|6
283023|NCT01857323|951459|P1|Overall Study|Non-compliance|1
283024|NCT01857323|951459|P1|Overall Study|Withdrawal by Subject|3
283025|NCT01857323|951459|P1|Overall Study|Adverse Event|1
283026|NCT01857206|951508|P2|Overall Study|Withdrawal by Subject|0
283027|NCT01857206|951509|P1|Overall Study|Withdrawal by Subject|1
283028|NCT01857206|951508|P2|Overall Study|Unclassified|3
283029|NCT01857206|951509|P1|Overall Study|Unclassified|3
283030|NCT01857206|951508|P2|Overall Study|Lost to Follow-up|6
283031|NCT01857206|951509|P1|Overall Study|Lost to Follow-up|9
283032|NCT01857206|951508|P2|Overall Study|ADMINISTRATIVE REASON|1
283033|NCT01857206|951509|P1|Overall Study|ADMINISTRATIVE REASON|0
283034|NCT01857102|951527|P2|Period 2|Unsatisfactory Lens Fit|0
283035|NCT01857102|951528|P1|Period 2|Unsatisfactory Lens Fit|1
283036|NCT01857102|951527|P2|Period 2|Lens Discomfort|0
283037|NCT01857102|951528|P1|Period 2|Lens Discomfort|1
283038|NCT01857102|951527|P2|Period 1|Physician Decision|0
283039|NCT01857102|951528|P1|Period 1|Physician Decision|1
283040|NCT01857102|951527|P2|Period 1|Unsatisfactory Visual Response|0
283041|NCT01857102|951528|P1|Period 1|Unsatisfactory Visual Response|1
283042|NCT01857102|951527|P2|Period 1|Unsatisfactory Lens Fit|0
283043|NCT01857102|951528|P1|Period 1|Unsatisfactory Lens Fit|1
283044|NCT01857102|951527|P2|Period 1|Lost to Follow-up|3
283045|NCT01857102|951528|P1|Period 1|Lost to Follow-up|0
283046|NCT01857102|951527|P2|Period 1|No longer meets Eligibility Criteria|2
283047|NCT01857102|951528|P1|Period 1|No longer meets Eligibility Criteria|0
283048|NCT01857063|951538|P2|Period 2 (7 Days)|Withdrawal by Subject|0
283049|NCT01857063|951539|P1|Period 2 (7 Days)|Withdrawal by Subject|1
283050|NCT01857063|951538|P2|Period 2 (7 Days)|Physician Decision|1
283051|NCT01857063|951539|P1|Period 2 (7 Days)|Physician Decision|1
283052|NCT01857063|951538|P2|Period 2 (7 Days)|Adverse Event|1
283053|NCT01857063|951539|P1|Period 2 (7 Days)|Adverse Event|2
283054|NCT01857063|951538|P2|Period 1 (7 Days)|Withdrawal by Subject|3
283055|NCT01857063|951539|P1|Period 1 (7 Days)|Withdrawal by Subject|1
283056|NCT01857063|951538|P2|Period 1 (7 Days)|Physician Decision|0
283057|NCT01857063|951539|P1|Period 1 (7 Days)|Physician Decision|1
283058|NCT01857063|951538|P2|Period 1 (7 Days)|Adverse Event|1
283059|NCT01857063|951539|P1|Period 1 (7 Days)|Adverse Event|0
283060|NCT01856907|951572|P3|Overall Study|Withdrawal by Subject|0
283061|NCT01856907|951573|P2|Overall Study|Withdrawal by Subject|1
283062|NCT01856907|951574|P1|Overall Study|Withdrawal by Subject|0
283063|NCT01856907|951572|P3|Overall Study|Pregnancy|0
283064|NCT01856907|951573|P2|Overall Study|Pregnancy|1
283065|NCT01856907|951574|P1|Overall Study|Pregnancy|0
283066|NCT01856907|951572|P3|Overall Study|Pregnancy|0
283067|NCT01856907|951573|P2|Overall Study|Pregnancy|1
283068|NCT01856907|951574|P1|Overall Study|Pregnancy|0
283069|NCT01856686|951627|P2|Overall Study|Lost to Follow-up|11
283070|NCT01856686|951628|P1|Overall Study|Lost to Follow-up|5
283071|NCT01856673|951671|P3|Overall Study|Protocol Violation|1
283072|NCT01856673|951672|P2|Overall Study|Protocol Violation|0
283073|NCT01856673|951673|P1|Overall Study|Protocol Violation|1
283074|NCT01856673|951671|P3|Overall Study|Death|0
283075|NCT01856673|951672|P2|Overall Study|Death|1
283076|NCT01856673|951673|P1|Overall Study|Death|2
283077|NCT01856673|951671|P3|Overall Study|Paperwork errors|0
283078|NCT01856673|951672|P2|Overall Study|Paperwork errors|0
283079|NCT01856673|951673|P1|Overall Study|Paperwork errors|4
283080|NCT01856673|951671|P3|Overall Study|Psychologist decision|0
283081|NCT01856673|951672|P2|Overall Study|Psychologist decision|0
283082|NCT01856673|951673|P1|Overall Study|Psychologist decision|3
283083|NCT01856673|951671|P3|Overall Study|Unknown reasons|0
283084|NCT01856673|951672|P2|Overall Study|Unknown reasons|0
283085|NCT01856673|951673|P1|Overall Study|Unknown reasons|20
283086|NCT01856673|951671|P3|Overall Study|Lost to Follow-up|0
283087|NCT01856673|951672|P2|Overall Study|Lost to Follow-up|34
283088|NCT01856673|951673|P1|Overall Study|Lost to Follow-up|22
283089|NCT01856673|951671|P3|Overall Study|Withdrawal by Subject|33
283090|NCT01856673|951672|P2|Overall Study|Withdrawal by Subject|50
283091|NCT01856673|951673|P1|Overall Study|Withdrawal by Subject|46
283092|NCT01856569|951684|P1|Overall Study|Did not met inclusion criteria|8
283093|NCT01856569|951684|P1|Overall Study|Lost to Follow-up|3
283094|NCT01856569|951684|P1|Overall Study|Changed Site/Structure|1
283095|NCT01856569|951684|P1|Overall Study|Other|1
283096|NCT01856322|951739|P3|Overall Study|off study due to lack of accrual|3
283097|NCT01856322|951740|P2|Overall Study|off study due to lack of accrual|0
283098|NCT01856322|951741|P1|Overall Study|off study due to lack of accrual|0
283099|NCT01856257|951774|P4|Overall Study|Donor complication|1
283100|NCT01856257|951775|P3|Overall Study|Donor complication|0
283101|NCT01856257|951776|P2|Overall Study|Donor complication|0
283102|NCT01856257|951777|P1|Overall Study|Donor complication|0
283103|NCT01856257|951774|P4|Overall Study|Withdrawal by Subject|0
283104|NCT01856257|951775|P3|Overall Study|Withdrawal by Subject|0
283105|NCT01856257|951776|P2|Overall Study|Withdrawal by Subject|1
283106|NCT01856257|951777|P1|Overall Study|Withdrawal by Subject|1
283107|NCT01856257|951774|P4|Overall Study|Physician Decision|1
283108|NCT01856257|951775|P3|Overall Study|Physician Decision|0
283109|NCT01856257|951776|P2|Overall Study|Physician Decision|0
283110|NCT01856257|951777|P1|Overall Study|Physician Decision|0
283111|NCT01856257|951774|P4|Overall Study|Death|0
283112|NCT01856257|951775|P3|Overall Study|Death|0
283113|NCT01856257|951776|P2|Overall Study|Death|0
283114|NCT01856257|951777|P1|Overall Study|Death|2
283115|NCT01855958|951945|P2|Overall Study|Withdrawal by Subject|0
283116|NCT01855958|951946|P1|Overall Study|Withdrawal by Subject|1
283117|NCT01855945|951976|P12|Overall Study|Withdrawal by Subject|1
283118|NCT01855945|951977|P11|Overall Study|Withdrawal by Subject|4
283119|NCT01855945|951978|P10|Overall Study|Withdrawal by Subject|2
283120|NCT01855945|951979|P9|Overall Study|Withdrawal by Subject|0
283121|NCT01855945|951980|P8|Overall Study|Withdrawal by Subject|0
283122|NCT01855945|951981|P7|Overall Study|Withdrawal by Subject|1
283123|NCT01855945|951982|P6|Overall Study|Withdrawal by Subject|0
283124|NCT01855945|951983|P5|Overall Study|Withdrawal by Subject|1
283125|NCT01855945|951984|P4|Overall Study|Withdrawal by Subject|1
283126|NCT01855945|951985|P3|Overall Study|Withdrawal by Subject|4
283127|NCT01855945|951986|P2|Overall Study|Withdrawal by Subject|0
283128|NCT01855945|951987|P1|Overall Study|Withdrawal by Subject|4
283129|NCT01855945|951976|P12|Overall Study|Other - Unclassified|0
283130|NCT01855945|951977|P11|Overall Study|Other - Unclassified|1
283131|NCT01855945|951978|P10|Overall Study|Other - Unclassified|0
283132|NCT01855945|951979|P9|Overall Study|Other - Unclassified|0
283133|NCT01855945|951980|P8|Overall Study|Other - Unclassified|1
283134|NCT01855945|951981|P7|Overall Study|Other - Unclassified|2
283135|NCT01855945|951982|P6|Overall Study|Other - Unclassified|0
283136|NCT01855945|951983|P5|Overall Study|Other - Unclassified|0
283137|NCT01855945|951984|P4|Overall Study|Other - Unclassified|0
283138|NCT01855945|951985|P3|Overall Study|Other - Unclassified|1
283139|NCT01855945|951986|P2|Overall Study|Other - Unclassified|1
283140|NCT01855945|951987|P1|Overall Study|Other - Unclassified|1
283141|NCT01855945|951976|P12|Overall Study|Lost to Follow-up|2
283142|NCT01855945|951977|P11|Overall Study|Lost to Follow-up|0
283143|NCT01855945|951978|P10|Overall Study|Lost to Follow-up|0
283144|NCT01855945|951979|P9|Overall Study|Lost to Follow-up|2
283145|NCT01855945|951980|P8|Overall Study|Lost to Follow-up|7
283146|NCT01855945|951981|P7|Overall Study|Lost to Follow-up|4
283147|NCT01855945|951982|P6|Overall Study|Lost to Follow-up|3
283148|NCT01855945|951983|P5|Overall Study|Lost to Follow-up|0
283149|NCT01855945|951984|P4|Overall Study|Lost to Follow-up|3
283150|NCT01855945|951985|P3|Overall Study|Lost to Follow-up|7
283151|NCT01855945|951986|P2|Overall Study|Lost to Follow-up|10
283152|NCT01855945|951987|P1|Overall Study|Lost to Follow-up|11
283153|NCT01855945|951976|P12|Overall Study|Death|0
283154|NCT01855945|951977|P11|Overall Study|Death|0
283155|NCT01855945|951978|P10|Overall Study|Death|0
283156|NCT01855945|951979|P9|Overall Study|Death|0
283157|NCT01855945|951980|P8|Overall Study|Death|0
283158|NCT01855945|951981|P7|Overall Study|Death|2
283159|NCT01855945|951982|P6|Overall Study|Death|0
283160|NCT01855945|951983|P5|Overall Study|Death|0
283161|NCT01855945|951984|P4|Overall Study|Death|0
283162|NCT01855945|951985|P3|Overall Study|Death|0
283163|NCT01855945|951986|P2|Overall Study|Death|0
283164|NCT01855945|951987|P1|Overall Study|Death|0
283165|NCT01855945|951976|P12|Overall Study|Adverse Event|0
283166|NCT01855945|951977|P11|Overall Study|Adverse Event|0
283167|NCT01855945|951978|P10|Overall Study|Adverse Event|0
283168|NCT01855945|951979|P9|Overall Study|Adverse Event|0
283169|NCT01855945|951980|P8|Overall Study|Adverse Event|0
283170|NCT01855945|951981|P7|Overall Study|Adverse Event|1
283171|NCT01855945|951982|P6|Overall Study|Adverse Event|0
283172|NCT01855945|951983|P5|Overall Study|Adverse Event|0
283173|NCT01855945|951984|P4|Overall Study|Adverse Event|0
283174|NCT01855945|951985|P3|Overall Study|Adverse Event|0
283175|NCT01855945|951986|P2|Overall Study|Adverse Event|0
283176|NCT01855945|951987|P1|Overall Study|Adverse Event|0
283177|NCT01855919|952123|P2|Overall Study|Protocol Violation|4
283178|NCT01855919|952124|P1|Overall Study|Protocol Violation|1
283179|NCT01855919|952123|P2|Overall Study|Entry Criteria Not Met|1
283180|NCT01855919|952124|P1|Overall Study|Entry Criteria Not Met|1
283181|NCT01855919|952123|P2|Overall Study|Withdrawal by Subject|10
283182|NCT01855919|952124|P1|Overall Study|Withdrawal by Subject|4
283183|NCT01855919|952123|P2|Overall Study|Lack of Efficacy|3
283184|NCT01855919|952124|P1|Overall Study|Lack of Efficacy|1
283185|NCT01855919|952123|P2|Overall Study|Adverse Event|8
283186|NCT01855919|952124|P1|Overall Study|Adverse Event|16
283187|NCT01855789|952156|P4|2) Week 24 up to End of Study|Other|1
283188|NCT01855789|952157|P3|2) Week 24 up to End of Study|Other|0
283189|NCT01855789|952158|P2|2) Week 24 up to End of Study|Other|0
283190|NCT01855789|952159|P1|2) Week 24 up to End of Study|Other|0
283191|NCT01855789|952156|P4|2) Week 24 up to End of Study|Sponsor Decision|1
283192|NCT01855789|952157|P3|2) Week 24 up to End of Study|Sponsor Decision|0
283193|NCT01855789|952158|P2|2) Week 24 up to End of Study|Sponsor Decision|0
283194|NCT01855789|952159|P1|2) Week 24 up to End of Study|Sponsor Decision|0
283195|NCT01855789|952156|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
283196|NCT01855789|952157|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
283197|NCT01855789|952158|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
283198|NCT01855789|952159|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
283199|NCT01855789|952156|P4|2) Week 24 up to End of Study|Physician Decision|4
283200|NCT01855789|952157|P3|2) Week 24 up to End of Study|Physician Decision|2
283201|NCT01855789|952158|P2|2) Week 24 up to End of Study|Physician Decision|0
283202|NCT01855789|952159|P1|2) Week 24 up to End of Study|Physician Decision|0
283203|NCT01855789|952156|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
283204|NCT01855789|952157|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
283205|NCT01855789|952158|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
283206|NCT01855789|952159|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
283207|NCT01855789|952156|P4|2) Week 24 up to End of Study|Protocol Violation|1
283208|NCT01855789|952157|P3|2) Week 24 up to End of Study|Protocol Violation|0
283209|NCT01855789|952158|P2|2) Week 24 up to End of Study|Protocol Violation|0
283210|NCT01855789|952159|P1|2) Week 24 up to End of Study|Protocol Violation|0
283211|NCT01855789|952156|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
283212|NCT01855789|952157|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
283213|NCT01855789|952158|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
283214|NCT01855789|952159|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
283215|NCT01855789|952156|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
283216|NCT01855789|952157|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
283217|NCT01855789|952158|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
283218|NCT01855789|952159|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
283219|NCT01855789|952156|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
283220|NCT01855789|952157|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
283221|NCT01855789|952158|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
283222|NCT01855789|952159|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
283223|NCT01855789|952156|P4|2) Week 24 up to End of Study|Adverse Event|21
283224|NCT01855789|952157|P3|2) Week 24 up to End of Study|Adverse Event|5
283225|NCT01855789|952158|P2|2) Week 24 up to End of Study|Adverse Event|4
283226|NCT01855789|952159|P1|2) Week 24 up to End of Study|Adverse Event|0
283227|NCT01855789|952156|P4|1) Baseline up to Week 24|Other|0
283228|NCT01855789|952157|P3|1) Baseline up to Week 24|Other|0
283229|NCT01855789|952158|P2|1) Baseline up to Week 24|Other|0
283230|NCT01855789|952159|P1|1) Baseline up to Week 24|Other|4
283231|NCT01855789|952156|P4|1) Baseline up to Week 24|Sponsor Decision|0
283232|NCT01855789|952157|P3|1) Baseline up to Week 24|Sponsor Decision|0
283233|NCT01855789|952158|P2|1) Baseline up to Week 24|Sponsor Decision|0
283234|NCT01855789|952159|P1|1) Baseline up to Week 24|Sponsor Decision|3
283235|NCT01855789|952156|P4|1) Baseline up to Week 24|Participant Non-compliance|0
283236|NCT01855789|952157|P3|1) Baseline up to Week 24|Participant Non-compliance|0
283237|NCT01855789|952158|P2|1) Baseline up to Week 24|Participant Non-compliance|0
283238|NCT01855789|952159|P1|1) Baseline up to Week 24|Participant Non-compliance|3
283239|NCT01855789|952156|P4|1) Baseline up to Week 24|Pregnancy|0
283240|NCT01855789|952157|P3|1) Baseline up to Week 24|Pregnancy|0
283241|NCT01855789|952158|P2|1) Baseline up to Week 24|Pregnancy|0
283242|NCT01855789|952159|P1|1) Baseline up to Week 24|Pregnancy|1
283243|NCT01855789|952156|P4|1) Baseline up to Week 24|Physician Decision|0
283244|NCT01855789|952157|P3|1) Baseline up to Week 24|Physician Decision|0
283245|NCT01855789|952158|P2|1) Baseline up to Week 24|Physician Decision|0
283246|NCT01855789|952159|P1|1) Baseline up to Week 24|Physician Decision|4
283247|NCT01855789|952156|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
283248|NCT01855789|952157|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
283249|NCT01855789|952158|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
283250|NCT01855789|952159|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
283251|NCT01855789|952156|P4|1) Baseline up to Week 24|Protocol Violation|0
283252|NCT01855789|952157|P3|1) Baseline up to Week 24|Protocol Violation|0
283253|NCT01855789|952158|P2|1) Baseline up to Week 24|Protocol Violation|0
283254|NCT01855789|952159|P1|1) Baseline up to Week 24|Protocol Violation|4
283255|NCT01855789|952156|P4|1) Baseline up to Week 24|Lost to Follow-up|0
283256|NCT01855789|952157|P3|1) Baseline up to Week 24|Lost to Follow-up|0
283257|NCT01855789|952158|P2|1) Baseline up to Week 24|Lost to Follow-up|0
283258|NCT01855789|952159|P1|1) Baseline up to Week 24|Lost to Follow-up|11
283259|NCT01855789|952156|P4|1) Baseline up to Week 24|Lack of Efficacy|0
283260|NCT01855789|952157|P3|1) Baseline up to Week 24|Lack of Efficacy|0
283261|NCT01855789|952158|P2|1) Baseline up to Week 24|Lack of Efficacy|0
283262|NCT01855789|952159|P1|1) Baseline up to Week 24|Lack of Efficacy|16
283263|NCT01855789|952156|P4|1) Baseline up to Week 24|Death|0
283264|NCT01855789|952157|P3|1) Baseline up to Week 24|Death|0
283265|NCT01855789|952158|P2|1) Baseline up to Week 24|Death|0
283266|NCT01855789|952159|P1|1) Baseline up to Week 24|Death|2
283267|NCT01855789|952156|P4|1) Baseline up to Week 24|Adverse Event|0
283268|NCT01855789|952157|P3|1) Baseline up to Week 24|Adverse Event|0
283269|NCT01855789|952158|P2|1) Baseline up to Week 24|Adverse Event|0
283270|NCT01855789|952159|P1|1) Baseline up to Week 24|Adverse Event|37
283271|NCT01855074|952181|P1|Overall Study|Started but not treated|1
283272|NCT01855074|952181|P1|Overall Study|Withdrawal by Subject|8
283273|NCT01855074|952181|P1|Overall Study|Lost to Follow-up|4
283274|NCT01855074|952181|P1|Overall Study|Adverse Event|1
283275|NCT01854944|952193|P3|Overall Study|Withdrawal by Subject|1
283276|NCT01854944|952194|P2|Overall Study|Withdrawal by Subject|0
283277|NCT01854944|952195|P1|Overall Study|Withdrawal by Subject|0
283278|NCT01854827|952249|P1|Overall Study|Death|1
283279|NCT01854710|952261|P6|Overall Study|CRI procedural error|2
283280|NCT01854710|952262|P5|Overall Study|CRI procedural error|2
283281|NCT01854710|952263|P4|Overall Study|CRI procedural error|2
283282|NCT01854710|952264|P3|Overall Study|CRI procedural error|2
283283|NCT01854710|952265|P2|Overall Study|CRI procedural error|2
283284|NCT01854710|952266|P1|Overall Study|CRI procedural error|2
283285|NCT01854710|952261|P6|Overall Study|Withdrawal by Subject|0
283286|NCT01854710|952262|P5|Overall Study|Withdrawal by Subject|0
283287|NCT01854710|952263|P4|Overall Study|Withdrawal by Subject|0
283288|NCT01854710|952264|P3|Overall Study|Withdrawal by Subject|0
283289|NCT01854710|952265|P2|Overall Study|Withdrawal by Subject|1
283290|NCT01854710|952266|P1|Overall Study|Withdrawal by Subject|2
283291|NCT01854697|952287|P5|Overall Study|Not Specified|0
283292|NCT01854697|952288|P4|Overall Study|Not Specified|0
283293|NCT01854697|952289|P3|Overall Study|Not Specified|1
283294|NCT01854697|952290|P2|Overall Study|Not Specified|1
283295|NCT01854697|952291|P1|Overall Study|Not Specified|0
283296|NCT01854697|952287|P5|Overall Study|Withdrew Consent|0
283297|NCT01854697|952288|P4|Overall Study|Withdrew Consent|1
283298|NCT01854697|952289|P3|Overall Study|Withdrew Consent|0
283299|NCT01854697|952290|P2|Overall Study|Withdrew Consent|1
283300|NCT01854697|952291|P1|Overall Study|Withdrew Consent|0
283301|NCT01854697|952287|P5|Overall Study|To enter another AbbVie study|1
283302|NCT01854697|952288|P4|Overall Study|To enter another AbbVie study|0
283303|NCT01854697|952289|P3|Overall Study|To enter another AbbVie study|0
283304|NCT01854697|952290|P2|Overall Study|To enter another AbbVie study|0
283305|NCT01854697|952291|P1|Overall Study|To enter another AbbVie study|1
283306|NCT01854697|952287|P5|Overall Study|Lost to Follow-up|0
283307|NCT01854697|952288|P4|Overall Study|Lost to Follow-up|2
283308|NCT01854697|952289|P3|Overall Study|Lost to Follow-up|1
283309|NCT01854697|952290|P2|Overall Study|Lost to Follow-up|1
283310|NCT01854697|952291|P1|Overall Study|Lost to Follow-up|4
283311|NCT01854697|952287|P5|Overall Study|Adverse Event|1
283312|NCT01854697|952288|P4|Overall Study|Adverse Event|0
283313|NCT01854697|952289|P3|Overall Study|Adverse Event|0
283314|NCT01854697|952290|P2|Overall Study|Adverse Event|0
283315|NCT01854697|952291|P1|Overall Study|Adverse Event|1
283316|NCT01854658|952335|P4|Overall Study|Administrative reasons|2
283317|NCT01854658|952336|P3|Overall Study|Administrative reasons|2
283318|NCT01854658|952337|P2|Overall Study|Administrative reasons|1
283319|NCT01854658|952338|P1|Overall Study|Administrative reasons|5
283320|NCT01854658|952335|P4|Overall Study|Adverse Event|19
283321|NCT01854658|952336|P3|Overall Study|Adverse Event|23
283322|NCT01854658|952337|P2|Overall Study|Adverse Event|14
283323|NCT01854658|952338|P1|Overall Study|Adverse Event|21
283324|NCT01854658|952335|P4|Overall Study|Lack of Efficacy|7
283325|NCT01854658|952336|P3|Overall Study|Lack of Efficacy|4
283326|NCT01854658|952337|P2|Overall Study|Lack of Efficacy|8
283327|NCT01854658|952338|P1|Overall Study|Lack of Efficacy|3
283328|NCT01854658|952335|P4|Overall Study|Protocol-specified criteria|7
283329|NCT01854658|952336|P3|Overall Study|Protocol-specified criteria|10
283330|NCT01854658|952337|P2|Overall Study|Protocol-specified criteria|15
283331|NCT01854658|952338|P1|Overall Study|Protocol-specified criteria|15
283332|NCT01854658|952335|P4|Overall Study|Withdrawal by Subject|15
283333|NCT01854658|952336|P3|Overall Study|Withdrawal by Subject|29
283334|NCT01854658|952337|P2|Overall Study|Withdrawal by Subject|21
283335|NCT01854658|952338|P1|Overall Study|Withdrawal by Subject|28
283336|NCT01854658|952335|P4|Overall Study|Lost to Follow-up|4
283337|NCT01854658|952336|P3|Overall Study|Lost to Follow-up|8
283338|NCT01854658|952337|P2|Overall Study|Lost to Follow-up|9
283339|NCT01854658|952338|P1|Overall Study|Lost to Follow-up|8
283340|NCT01854658|952335|P4|Overall Study|Physician Decision|4
283341|NCT01854658|952336|P3|Overall Study|Physician Decision|2
283342|NCT01854658|952337|P2|Overall Study|Physician Decision|5
283343|NCT01854658|952338|P1|Overall Study|Physician Decision|7
283344|NCT01854658|952335|P4|Overall Study|Protocol Violation|1
283345|NCT01854658|952336|P3|Overall Study|Protocol Violation|2
283346|NCT01854658|952337|P2|Overall Study|Protocol Violation|2
283347|NCT01854658|952338|P1|Overall Study|Protocol Violation|6
283348|NCT01854645|952373|P5|Overall Study|Adverse Event|11
283349|NCT01854645|952374|P4|Overall Study|Adverse Event|20
283350|NCT01854645|952375|P3|Overall Study|Adverse Event|19
283351|NCT01854645|952376|P2|Overall Study|Adverse Event|31
283352|NCT01854645|952377|P1|Overall Study|Adverse Event|33
283353|NCT01854645|952373|P5|Overall Study|Lack of Efficacy|9
283354|NCT01854645|952374|P4|Overall Study|Lack of Efficacy|3
283355|NCT01854645|952375|P3|Overall Study|Lack of Efficacy|9
283356|NCT01854645|952376|P2|Overall Study|Lack of Efficacy|12
283357|NCT01854645|952377|P1|Overall Study|Lack of Efficacy|7
283358|NCT01854645|952373|P5|Overall Study|Withdrawal by Subject|24
283359|NCT01854645|952374|P4|Overall Study|Withdrawal by Subject|21
283360|NCT01854645|952375|P3|Overall Study|Withdrawal by Subject|30
283361|NCT01854645|952376|P2|Overall Study|Withdrawal by Subject|41
283362|NCT01854645|952377|P1|Overall Study|Withdrawal by Subject|31
283363|NCT01854645|952373|P5|Overall Study|Physician Decision|7
283364|NCT01854645|952374|P4|Overall Study|Physician Decision|3
283365|NCT01854645|952375|P3|Overall Study|Physician Decision|3
283366|NCT01854645|952376|P2|Overall Study|Physician Decision|5
283367|NCT01854645|952377|P1|Overall Study|Physician Decision|1
283368|NCT01854645|952373|P5|Overall Study|Lost to Follow-up|0
283369|NCT01854645|952374|P4|Overall Study|Lost to Follow-up|5
283370|NCT01854645|952375|P3|Overall Study|Lost to Follow-up|8
283371|NCT01854645|952376|P2|Overall Study|Lost to Follow-up|7
283372|NCT01854645|952377|P1|Overall Study|Lost to Follow-up|10
283373|NCT01854645|952373|P5|Overall Study|Protocol Violation|1
283374|NCT01854645|952374|P4|Overall Study|Protocol Violation|4
283375|NCT01854645|952375|P3|Overall Study|Protocol Violation|5
283376|NCT01854645|952376|P2|Overall Study|Protocol Violation|0
283377|NCT01854645|952377|P1|Overall Study|Protocol Violation|3
283378|NCT01854645|952373|P5|Overall Study|Administrative Reasons / Missing|1
283379|NCT01854645|952374|P4|Overall Study|Administrative Reasons / Missing|1
283380|NCT01854645|952375|P3|Overall Study|Administrative Reasons / Missing|0
283381|NCT01854645|952376|P2|Overall Study|Administrative Reasons / Missing|0
283382|NCT01854645|952377|P1|Overall Study|Administrative Reasons / Missing|0
283383|NCT01854645|952373|P5|Overall Study|Protocol-Specified Criteria|7
283384|NCT01854645|952374|P4|Overall Study|Protocol-Specified Criteria|5
283385|NCT01854645|952375|P3|Overall Study|Protocol-Specified Criteria|8
283386|NCT01854645|952376|P2|Overall Study|Protocol-Specified Criteria|10
283387|NCT01854645|952377|P1|Overall Study|Protocol-Specified Criteria|13
283388|NCT01854528|952458|P2|Overall Study|Virologic Failure|9
283389|NCT01854528|952459|P1|Overall Study|Virologic Failure|0
283390|NCT01854528|952458|P2|Overall Study|Withdrawal by Subject|2
283391|NCT01854528|952459|P1|Overall Study|Withdrawal by Subject|0
283392|NCT01854528|952458|P2|Overall Study|Adverse Event|4
283393|NCT01854528|952459|P1|Overall Study|Adverse Event|0
283394|NCT01854047|952507|P5|Overall Study|Other than specified above|8
283395|NCT01854047|952508|P4|Overall Study|Other than specified above|5
283396|NCT01854047|952509|P3|Overall Study|Other than specified above|3
283397|NCT01854047|952510|P2|Overall Study|Other than specified above|3
283398|NCT01854047|952511|P1|Overall Study|Other than specified above|3
283399|NCT01854047|952507|P5|Overall Study|Randomized but not treated|4
283400|NCT01854047|952508|P4|Overall Study|Randomized but not treated|0
283401|NCT01854047|952509|P3|Overall Study|Randomized but not treated|2
283402|NCT01854047|952510|P2|Overall Study|Randomized but not treated|1
283403|NCT01854047|952511|P1|Overall Study|Randomized but not treated|0
283404|NCT01854047|952507|P5|Overall Study|Adverse Event|7
283405|NCT01854047|952508|P4|Overall Study|Adverse Event|10
283406|NCT01854047|952509|P3|Overall Study|Adverse Event|6
283407|NCT01854047|952510|P2|Overall Study|Adverse Event|4
283408|NCT01854047|952511|P1|Overall Study|Adverse Event|5
283409|NCT01854047|952507|P5|Overall Study|Poor compliance to protocol|0
283410|NCT01854047|952508|P4|Overall Study|Poor compliance to protocol|0
283411|NCT01854047|952509|P3|Overall Study|Poor compliance to protocol|2
283412|NCT01854047|952510|P2|Overall Study|Poor compliance to protocol|0
283413|NCT01854047|952511|P1|Overall Study|Poor compliance to protocol|3
283414|NCT01854047|952507|P5|Overall Study|Lack of Efficacy|0
283415|NCT01854047|952508|P4|Overall Study|Lack of Efficacy|0
283416|NCT01854047|952509|P3|Overall Study|Lack of Efficacy|0
283417|NCT01854047|952510|P2|Overall Study|Lack of Efficacy|0
283418|NCT01854047|952511|P1|Overall Study|Lack of Efficacy|1
283419|NCT01853982|952642|P2|Overall Study|Lost to Follow-up|1
283420|NCT01853982|952643|P1|Overall Study|Lost to Follow-up|0
283421|NCT01853982|952642|P2|Overall Study|Death|0
283422|NCT01853982|952643|P1|Overall Study|Death|1
283423|NCT01853982|952642|P2|Overall Study|Withdrawal by Subject|0
283424|NCT01853982|952643|P1|Overall Study|Withdrawal by Subject|1
283425|NCT01853839|952649|P1|Overall Study|Lost to follow-up or no valid BP measure|336
283426|NCT01853839|952649|P1|Overall Study|End of treatment visit too early|33
283427|NCT01853839|952649|P1|Overall Study|Not meet ITT population definition|58
283428|NCT01853839|952649|P1|Overall Study|Violated inclusion criteria|2
283429|NCT01853696|952671|P2|Overall Study|Lost to Follow-up|4
283430|NCT01853696|952672|P1|Overall Study|Lost to Follow-up|5
283431|NCT01853696|952671|P2|Overall Study|Withdrawal by Subject|1
283432|NCT01853696|952672|P1|Overall Study|Withdrawal by Subject|1
283433|NCT01853475|952708|P3|Overall Study|Withdrawal by Subject|0
283434|NCT01853475|952709|P2|Overall Study|Withdrawal by Subject|1
283435|NCT01853475|952710|P1|Overall Study|Withdrawal by Subject|0
283436|NCT01853397|952731|P4|Overall Study|Subject Noncompliance|1
283437|NCT01853397|952732|P3|Overall Study|Subject Noncompliance|0
283438|NCT01853397|952733|P2|Overall Study|Subject Noncompliance|0
283439|NCT01853397|952734|P1|Overall Study|Subject Noncompliance|0
283440|NCT01853397|952731|P4|Overall Study|Withdrawal by Subject|1
283441|NCT01853397|952732|P3|Overall Study|Withdrawal by Subject|0
283442|NCT01853397|952733|P2|Overall Study|Withdrawal by Subject|0
283443|NCT01853397|952734|P1|Overall Study|Withdrawal by Subject|0
283444|NCT01853384|952762|P2|Completed Follow up Visit 2|Lost to Follow-up|1
283445|NCT01853384|952763|P1|Completed Follow up Visit 2|Lost to Follow-up|0
283446|NCT01853384|952762|P2|Completed Follow up Visit 2|Death|0
283447|NCT01853384|952763|P1|Completed Follow up Visit 2|Death|1
283448|NCT01853384|952762|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
283449|NCT01853384|952763|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
283450|NCT01853384|952762|P2|Completed Follow up Visit 2|Adverse Event|0
283451|NCT01853384|952763|P1|Completed Follow up Visit 2|Adverse Event|1
283452|NCT01853384|952762|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
283453|NCT01853384|952763|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
283454|NCT01853384|952762|P2|Completed Follow up Visit 1|Early Termination|9
283455|NCT01853384|952763|P1|Completed Follow up Visit 1|Early Termination|13
283456|NCT01853384|952762|P2|Randomized|Other|3
283457|NCT01853384|952763|P1|Randomized|Other|3
283458|NCT01853384|952762|P2|Randomized|Sponsor Decision|34
283459|NCT01853384|952763|P1|Randomized|Sponsor Decision|47
283460|NCT01853384|952762|P2|Randomized|Withdrawal by Subject|3
283461|NCT01853384|952763|P1|Randomized|Withdrawal by Subject|5
283462|NCT01853384|952762|P2|Randomized|Lost to Follow-up|1
283463|NCT01853384|952763|P1|Randomized|Lost to Follow-up|1
283464|NCT01853384|952762|P2|Randomized|Death|2
283465|NCT01853384|952763|P1|Randomized|Death|1
283466|NCT01853384|952762|P2|Randomized|Adverse Event|3
283467|NCT01853384|952763|P1|Randomized|Adverse Event|5
283468|NCT01853280|952803|P2|Overall Study|Ineligible|1
283469|NCT01853280|952804|P1|Overall Study|Ineligible|0
283470|NCT01853280|952803|P2|Overall Study|Withdrawal by Subject|1
283471|NCT01853280|952804|P1|Overall Study|Withdrawal by Subject|0
283472|NCT01853280|952803|P2|Overall Study|Physician Decision|1
283473|NCT01853280|952804|P1|Overall Study|Physician Decision|0
283474|NCT01853280|952803|P2|Overall Study|Lost to Follow-up|1
283475|NCT01853280|952804|P1|Overall Study|Lost to Follow-up|0
283476|NCT01853280|952803|P2|Overall Study|Lack of Efficacy|2
283477|NCT01853280|952804|P1|Overall Study|Lack of Efficacy|2
283478|NCT01853254|952810|P1|Overall Study|Administrative/Other|16
283479|NCT01853254|952810|P1|Overall Study|Withdrawal of Consent|16
283480|NCT01853254|952810|P1|Overall Study|Other Protocol Violation|1
283481|NCT01853254|952810|P1|Overall Study|Refusal of Treatment|1
283482|NCT01853254|952810|P1|Overall Study|Insufficient Therapeutic Response|22
283483|NCT01853254|952810|P1|Overall Study|Failure to Return|43
283484|NCT01853254|952810|P1|Overall Study|Death|1
283485|NCT01853254|952810|P1|Overall Study|Adverse Event/Intercurrent Illness|3
283486|NCT01853254|952810|P1|Overall Study|Abnormal Laboratory Test|1
283487|NCT01853176|952827|P2|Overall Study|Study terminated|0
283488|NCT01853176|952828|P1|Overall Study|Study terminated|4
283489|NCT01853072|952847|P2|Overall Study|Reason not specified|6
283490|NCT01853072|952848|P1|Overall Study|Reason not specified|9
283491|NCT01853072|952847|P2|Overall Study|Withdrawal by Subject|2
283492|NCT01853072|952848|P1|Overall Study|Withdrawal by Subject|1
283493|NCT01853072|952847|P2|Overall Study|Physician Decision|1
283494|NCT01853072|952848|P1|Overall Study|Physician Decision|1
283495|NCT01853072|952847|P2|Overall Study|Non-compliance with study drug|1
283496|NCT01853072|952848|P1|Overall Study|Non-compliance with study drug|0
283497|NCT01853072|952847|P2|Overall Study|Lost to Follow-up|3
283498|NCT01853072|952848|P1|Overall Study|Lost to Follow-up|0
283499|NCT01853072|952847|P2|Overall Study|Death|4
283500|NCT01853072|952848|P1|Overall Study|Death|1
283501|NCT01853072|952847|P2|Overall Study|Adverse Event|3
283502|NCT01853072|952848|P1|Overall Study|Adverse Event|0
283503|NCT01853072|952847|P2|Overall Study|Adverse event prior to treatment|1
283504|NCT01853072|952848|P1|Overall Study|Adverse event prior to treatment|0
283505|NCT01853046|952868|P2|Overall Study|Disease progression|3
283506|NCT01853046|952869|P1|Overall Study|Disease progression|13
283507|NCT01853046|952868|P2|Overall Study|Adverse Event|2
283508|NCT01853046|952869|P1|Overall Study|Adverse Event|4
283509|NCT01853046|952868|P2|Overall Study|Withdrawal by Subject|1
283510|NCT01853046|952869|P1|Overall Study|Withdrawal by Subject|1
283511|NCT01852825|952937|P3|Overall Study|Withdrawal by Subject|0
283512|NCT01852825|952938|P2|Overall Study|Withdrawal by Subject|0
283513|NCT01852825|952939|P1|Overall Study|Withdrawal by Subject|2
283514|NCT01852812|952965|P3|Overall Study|Non-compliance With Study Drug|0
283515|NCT01852812|952966|P2|Overall Study|Non-compliance With Study Drug|1
283516|NCT01852812|952967|P1|Overall Study|Non-compliance With Study Drug|0
283517|NCT01852812|952965|P3|Overall Study|Adverse Event|1
283518|NCT01852812|952966|P2|Overall Study|Adverse Event|0
283519|NCT01852812|952967|P1|Overall Study|Adverse Event|0
283520|NCT01852591|952996|P1|Overall Study|Not Evaluable at Time of Analysis|1
283521|NCT01852591|952996|P1|Overall Study|Withdrawal by Subject|2
283522|NCT01852292|953037|P2|Overall Study|Progressive disease|52
283523|NCT01852292|953038|P1|Overall Study|Progressive disease|42
283524|NCT01852292|953037|P2|Overall Study|Study terminated by Sponsor|1
283525|NCT01852292|953038|P1|Overall Study|Study terminated by Sponsor|0
283526|NCT01852292|953037|P2|Overall Study|Non-compliance with study treatment|0
283527|NCT01852292|953038|P1|Overall Study|Non-compliance with study treatment|1
283528|NCT01852292|953037|P2|Overall Study|Protocol Violation|0
283529|NCT01852292|953038|P1|Overall Study|Protocol Violation|2
283530|NCT01852292|953037|P2|Overall Study|Physician Decision|2
283531|NCT01852292|953038|P1|Overall Study|Physician Decision|6
283532|NCT01852292|953037|P2|Overall Study|Adverse Event|11
283533|NCT01852292|953038|P1|Overall Study|Adverse Event|8
283534|NCT01852292|953037|P2|Overall Study|Patient/guardian decision|4
283535|NCT01852292|953038|P1|Overall Study|Patient/guardian decision|8
283536|NCT01852292|953037|P2|Overall Study|Death|8
283537|NCT01852292|953038|P1|Overall Study|Death|9
283538|NCT01852292|953037|P2|Overall Study|Untreated - did not receive study drug|1
283539|NCT01852292|953038|P1|Overall Study|Untreated - did not receive study drug|3
283540|NCT01852214|953062|P2|Washout Period|Withdrawal by Subject|1
283541|NCT01852214|953063|P1|Washout Period|Withdrawal by Subject|0
283542|NCT01852214|953062|P2|Period 1|Withdrawal by Subject|1
283543|NCT01852214|953063|P1|Period 1|Withdrawal by Subject|0
283544|NCT01852214|953062|P2|Period 1|Adverse Event|2
283545|NCT01852214|953063|P1|Period 1|Adverse Event|1
283546|NCT01852162|953090|P2|Overall Study|Withdrawal by Subject|1
283547|NCT01852162|953091|P1|Overall Study|Withdrawal by Subject|3
283548|NCT01852162|953090|P2|Overall Study|Adverse Event|0
283549|NCT01852162|953091|P1|Overall Study|Adverse Event|1
283550|NCT01852110|953107|P6|Overall Study|Withdrawal by Subject|0
283551|NCT01852110|953108|P5|Overall Study|Withdrawal by Subject|0
283552|NCT01852110|953109|P4|Overall Study|Withdrawal by Subject|0
283553|NCT01852110|953110|P3|Overall Study|Withdrawal by Subject|0
283554|NCT01852110|953111|P2|Overall Study|Withdrawal by Subject|4
283555|NCT01852110|953112|P1|Overall Study|Withdrawal by Subject|4
283556|NCT01852110|953107|P6|Overall Study|Study Terminated by Sponsor|0
283557|NCT01852110|953108|P5|Overall Study|Study Terminated by Sponsor|0
283558|NCT01852110|953109|P4|Overall Study|Study Terminated by Sponsor|0
283559|NCT01852110|953110|P3|Overall Study|Study Terminated by Sponsor|0
283560|NCT01852110|953111|P2|Overall Study|Study Terminated by Sponsor|32
283561|NCT01852110|953112|P1|Overall Study|Study Terminated by Sponsor|30
283562|NCT01852110|953107|P6|Overall Study|Protocol Violation|0
283563|NCT01852110|953108|P5|Overall Study|Protocol Violation|0
283564|NCT01852110|953109|P4|Overall Study|Protocol Violation|0
283565|NCT01852110|953110|P3|Overall Study|Protocol Violation|0
283566|NCT01852110|953111|P2|Overall Study|Protocol Violation|1
283567|NCT01852110|953112|P1|Overall Study|Protocol Violation|0
283568|NCT01852110|953107|P6|Overall Study|Physician Decision|0
283569|NCT01852110|953108|P5|Overall Study|Physician Decision|0
283570|NCT01852110|953109|P4|Overall Study|Physician Decision|0
283571|NCT01852110|953110|P3|Overall Study|Physician Decision|0
283572|NCT01852110|953111|P2|Overall Study|Physician Decision|0
283573|NCT01852110|953112|P1|Overall Study|Physician Decision|1
283574|NCT01852110|953107|P6|Overall Study|Non-compliance with Study Drug|0
283575|NCT01852110|953108|P5|Overall Study|Non-compliance with Study Drug|0
283576|NCT01852110|953109|P4|Overall Study|Non-compliance with Study Drug|0
283577|NCT01852110|953110|P3|Overall Study|Non-compliance with Study Drug|0
283578|NCT01852110|953111|P2|Overall Study|Non-compliance with Study Drug|1
283579|NCT01852110|953112|P1|Overall Study|Non-compliance with Study Drug|2
283580|NCT01852110|953107|P6|Overall Study|Lost to Follow-up|0
283581|NCT01852110|953108|P5|Overall Study|Lost to Follow-up|0
283582|NCT01852110|953109|P4|Overall Study|Lost to Follow-up|0
283583|NCT01852110|953110|P3|Overall Study|Lost to Follow-up|0
283584|NCT01852110|953111|P2|Overall Study|Lost to Follow-up|3
283585|NCT01852110|953112|P1|Overall Study|Lost to Follow-up|1
283586|NCT01852110|953107|P6|Overall Study|Adverse Event|0
283587|NCT01852110|953108|P5|Overall Study|Adverse Event|0
283588|NCT01852110|953109|P4|Overall Study|Adverse Event|0
283589|NCT01852110|953110|P3|Overall Study|Adverse Event|0
283590|NCT01852110|953111|P2|Overall Study|Adverse Event|5
283591|NCT01852110|953112|P1|Overall Study|Adverse Event|12
283592|NCT01851863|953186|P4|Overall Study|Lost to Follow-up|3
283593|NCT01851863|953187|P3|Overall Study|Lost to Follow-up|2
283594|NCT01851863|953188|P2|Overall Study|Lost to Follow-up|4
283595|NCT01851863|953189|P1|Overall Study|Lost to Follow-up|3
283596|NCT01851863|953186|P4|Overall Study|Did not receive study medication|0
283597|NCT01851863|953187|P3|Overall Study|Did not receive study medication|3
283598|NCT01851863|953188|P2|Overall Study|Did not receive study medication|5
283599|NCT01851863|953189|P1|Overall Study|Did not receive study medication|2
283600|NCT01851720|953218|P2|Overall Study|Lost to Follow-up|1
283601|NCT01851720|953219|P1|Overall Study|Lost to Follow-up|0
283602|NCT01851590|953249|P3|Overall Study|Lack of Efficacy|0
283603|NCT01851590|953250|P2|Overall Study|Lack of Efficacy|1
283604|NCT01851590|953251|P1|Overall Study|Lack of Efficacy|0
283605|NCT01851590|953249|P3|Overall Study|Adverse Event|2
283606|NCT01851590|953250|P2|Overall Study|Adverse Event|0
283607|NCT01851590|953251|P1|Overall Study|Adverse Event|0
283608|NCT01851590|953249|P3|Overall Study|Withdrawal by Subject|1
283609|NCT01851590|953250|P2|Overall Study|Withdrawal by Subject|0
283610|NCT01851590|953251|P1|Overall Study|Withdrawal by Subject|0
283611|NCT01851330|953274|P3|Overall Study|Investigator’s Discretion|1
283612|NCT01851330|953275|P2|Overall Study|Investigator’s Discretion|0
283613|NCT01851330|953276|P1|Overall Study|Investigator’s Discretion|0
283614|NCT01851330|953274|P3|Overall Study|Withdrew Consent|0
283615|NCT01851330|953275|P2|Overall Study|Withdrew Consent|1
283616|NCT01851330|953276|P1|Overall Study|Withdrew Consent|2
283617|NCT01851330|953274|P3|Overall Study|Lost to Follow-up|9
283618|NCT01851330|953275|P2|Overall Study|Lost to Follow-up|6
283619|NCT01851330|953276|P1|Overall Study|Lost to Follow-up|1
283620|NCT01851330|953274|P3|Overall Study|Lack of Efficacy|2
283621|NCT01851330|953275|P2|Overall Study|Lack of Efficacy|9
283622|NCT01851330|953276|P1|Overall Study|Lack of Efficacy|10
283623|NCT01850615|953318|P2|Overall Study|Unclassified|1
283624|NCT01850615|953319|P1|Overall Study|Unclassified|0
283625|NCT01850615|953318|P2|Overall Study|Lost to Follow-up|1
283626|NCT01850615|953319|P1|Overall Study|Lost to Follow-up|0
283627|NCT01850615|953318|P2|Overall Study|Withdrawal by Subject|1
283628|NCT01850615|953319|P1|Overall Study|Withdrawal by Subject|3
283629|NCT01850615|953318|P2|Overall Study|Adverse Event|1
283630|NCT01850615|953319|P1|Overall Study|Adverse Event|2
283631|NCT01850615|953318|P2|Overall Study|Protocol Violation|1
283632|NCT01850615|953319|P1|Overall Study|Protocol Violation|4
283633|NCT01850589|953337|P2|Overall Study|Withdrawal by Subject|0
283634|NCT01850589|953338|P1|Overall Study|Withdrawal by Subject|8
283635|NCT01850030|953403|P2|Overall Study|pregnancy not confirmed at visit 4|249
283636|NCT01850030|953404|P1|Overall Study|pregnancy not confirmed at visit 4|248
283637|NCT01850030|953403|P2|Overall Study|Protocol Violation|28
283638|NCT01850030|953404|P1|Overall Study|Protocol Violation|24
283639|NCT01850030|953403|P2|Overall Study|Withdrawal by Subject|4
283640|NCT01850030|953404|P1|Overall Study|Withdrawal by Subject|3
283641|NCT01850030|953403|P2|Overall Study|Lost to Follow-up|5
283642|NCT01850030|953404|P1|Overall Study|Lost to Follow-up|5
283643|NCT01850030|953403|P2|Overall Study|Lack of Efficacy|1
283644|NCT01850030|953404|P1|Overall Study|Lack of Efficacy|3
283645|NCT01850030|953403|P2|Overall Study|Adverse Event|82
283646|NCT01850030|953404|P1|Overall Study|Adverse Event|64
283647|NCT01849848|953416|P1|Overall Study|Progression of the primary disease|3
283648|NCT01849848|953416|P1|Overall Study|Physician Decision|1
283649|NCT01849588|953514|P1|Overall Study|Lack of Efficacy|3
283650|NCT01849562|953524|P3|Overall Study|Non-compliance with Study Drug|0
283651|NCT01849562|953525|P2|Overall Study|Non-compliance with Study Drug|0
283652|NCT01849562|953526|P1|Overall Study|Non-compliance with Study Drug|1
283653|NCT01849562|953524|P3|Overall Study|Lost to Follow-up|0
283654|NCT01849562|953525|P2|Overall Study|Lost to Follow-up|0
283655|NCT01849562|953526|P1|Overall Study|Lost to Follow-up|1
283656|NCT01849497|953539|P2|Overall Study|Lost to Follow-up|1
283657|NCT01849497|953540|P1|Overall Study|Lost to Follow-up|0
283658|NCT01849497|953539|P2|Overall Study|Sponsor Decision|1
283659|NCT01849497|953540|P1|Overall Study|Sponsor Decision|0
283660|NCT01849497|953539|P2|Overall Study|Withdrawal by Subject|2
283661|NCT01849497|953540|P1|Overall Study|Withdrawal by Subject|1
283662|NCT01849458|953548|P1|Overall Study|Lost to Follow-up|4
283663|NCT01849289|953587|P2|Overall Study|Unclassified|18
283664|NCT01849289|953588|P1|Overall Study|Unclassified|25
283665|NCT01849289|953587|P2|Overall Study|Withdrawal criteria|0
283666|NCT01849289|953588|P1|Overall Study|Withdrawal criteria|1
283667|NCT01849289|953587|P2|Overall Study|Protocol Violation|3
283668|NCT01849289|953588|P1|Overall Study|Protocol Violation|3
283669|NCT01849289|953587|P2|Overall Study|Adverse Event|3
283670|NCT01849289|953588|P1|Overall Study|Adverse Event|3
283671|NCT01848990|953632|P3|Overall Study|Death|0
283672|NCT01848990|953633|P2|Overall Study|Death|0
283673|NCT01848990|953634|P1|Overall Study|Death|1
283674|NCT01848990|953632|P3|Overall Study|Non Compliance|0
283675|NCT01848990|953633|P2|Overall Study|Non Compliance|0
283676|NCT01848990|953634|P1|Overall Study|Non Compliance|1
283677|NCT01848990|953632|P3|Overall Study|Physician Decision|0
283678|NCT01848990|953633|P2|Overall Study|Physician Decision|0
283679|NCT01848990|953634|P1|Overall Study|Physician Decision|1
283680|NCT01848990|953632|P3|Overall Study|Withdrawal by Subject|9
283681|NCT01848990|953633|P2|Overall Study|Withdrawal by Subject|6
283682|NCT01848990|953634|P1|Overall Study|Withdrawal by Subject|20
283683|NCT01848990|953632|P3|Overall Study|Protocol Violation|0
283684|NCT01848990|953633|P2|Overall Study|Protocol Violation|1
283685|NCT01848990|953634|P1|Overall Study|Protocol Violation|0
283686|NCT01848990|953632|P3|Overall Study|Lost to Follow-up|2
283687|NCT01848990|953633|P2|Overall Study|Lost to Follow-up|1
283688|NCT01848990|953634|P1|Overall Study|Lost to Follow-up|6
283689|NCT01848990|953632|P3|Overall Study|Adverse Event|0
283690|NCT01848990|953633|P2|Overall Study|Adverse Event|1
283691|NCT01848990|953634|P1|Overall Study|Adverse Event|4
283692|NCT01848938|953660|P2|Overall Study|Lost to Follow-up|1
283693|NCT01848938|953661|P1|Overall Study|Lost to Follow-up|1
283694|NCT01848834|953710|P5|Overall Study|Not Treated|0
283695|NCT01848834|953711|P4|Overall Study|Not Treated|0
283696|NCT01848834|953712|P3|Overall Study|Not Treated|0
283697|NCT01848834|953713|P2|Overall Study|Not Treated|1
283698|NCT01848834|953714|P1|Overall Study|Not Treated|0
283699|NCT01848834|953710|P5|Overall Study|Withdrawal by Subject|7
283700|NCT01848834|953711|P4|Overall Study|Withdrawal by Subject|0
283701|NCT01848834|953712|P3|Overall Study|Withdrawal by Subject|3
283702|NCT01848834|953713|P2|Overall Study|Withdrawal by Subject|2
283703|NCT01848834|953714|P1|Overall Study|Withdrawal by Subject|0
283704|NCT01848834|953710|P5|Overall Study|Protocol Violation|2
283705|NCT01848834|953711|P4|Overall Study|Protocol Violation|0
283706|NCT01848834|953712|P3|Overall Study|Protocol Violation|1
283707|NCT01848834|953713|P2|Overall Study|Protocol Violation|0
283708|NCT01848834|953714|P1|Overall Study|Protocol Violation|0
283709|NCT01848834|953710|P5|Overall Study|Progressive Disease|78
283710|NCT01848834|953711|P4|Overall Study|Progressive Disease|36
283711|NCT01848834|953712|P3|Overall Study|Progressive Disease|21
283712|NCT01848834|953713|P2|Overall Study|Progressive Disease|41
283713|NCT01848834|953714|P1|Overall Study|Progressive Disease|27
283714|NCT01848834|953710|P5|Overall Study|Death|3
283715|NCT01848834|953711|P4|Overall Study|Death|0
283716|NCT01848834|953712|P3|Overall Study|Death|0
283717|NCT01848834|953713|P2|Overall Study|Death|1
283718|NCT01848834|953714|P1|Overall Study|Death|0
283719|NCT01848834|953710|P5|Overall Study|Complete Response|0
283720|NCT01848834|953711|P4|Overall Study|Complete Response|0
283721|NCT01848834|953712|P3|Overall Study|Complete Response|0
283722|NCT01848834|953713|P2|Overall Study|Complete Response|1
283723|NCT01848834|953714|P1|Overall Study|Complete Response|0
283724|NCT01848834|953710|P5|Overall Study|Adverse Event|15
283725|NCT01848834|953711|P4|Overall Study|Adverse Event|1
283726|NCT01848834|953712|P3|Overall Study|Adverse Event|6
283727|NCT01848834|953713|P2|Overall Study|Adverse Event|8
283728|NCT01848834|953714|P1|Overall Study|Adverse Event|3
283729|NCT01848834|953710|P5|Overall Study|Physician Decision|1
283730|NCT01848834|953711|P4|Overall Study|Physician Decision|0
283731|NCT01848834|953712|P3|Overall Study|Physician Decision|0
283732|NCT01848834|953713|P2|Overall Study|Physician Decision|0
283733|NCT01848834|953714|P1|Overall Study|Physician Decision|0
283734|NCT01848834|953710|P5|Overall Study|Ongoing in Study|26
283735|NCT01848834|953711|P4|Overall Study|Ongoing in Study|0
283736|NCT01848834|953712|P3|Overall Study|Ongoing in Study|1
283737|NCT01848834|953713|P2|Overall Study|Ongoing in Study|6
283738|NCT01848834|953714|P1|Overall Study|Ongoing in Study|0
283739|NCT01848756|953749|P1|Overall Study|Enrolled in Error|1
283740|NCT01848756|953749|P1|Overall Study|Withdrawal by Subject|1
283741|NCT01848756|953749|P1|Overall Study|Adverse Event|1
283742|NCT01848288|953763|P1|Overall Study|Withdrawal by Subject|1
283743|NCT01848288|953763|P1|Overall Study|Protocol Violation|1
283744|NCT01848288|953763|P1|Overall Study|Death|1
283745|NCT01848210|953774|P2|Overall Study|Administrative|0
283746|NCT01848210|953775|P1|Overall Study|Administrative|1
283747|NCT01848210|953774|P2|Overall Study|Chronic Venous Insufficiency Course|2
283748|NCT01848210|953775|P1|Overall Study|Chronic Venous Insufficiency Course|1
283749|NCT01848210|953774|P2|Overall Study|Hepatic Function Alteration|0
283750|NCT01848210|953775|P1|Overall Study|Hepatic Function Alteration|4
283751|NCT01848210|953774|P2|Overall Study|Hypesensitivity|0
283752|NCT01848210|953775|P1|Overall Study|Hypesensitivity|1
283753|NCT01848210|953774|P2|Overall Study|Discontinuation Criterion|7
283754|NCT01848210|953775|P1|Overall Study|Discontinuation Criterion|5
283755|NCT01848210|953774|P2|Overall Study|Adverse Event|9
283756|NCT01848210|953775|P1|Overall Study|Adverse Event|7
283757|NCT01848210|953774|P2|Overall Study|Impedition Condition|9
283758|NCT01848210|953775|P1|Overall Study|Impedition Condition|5
283759|NCT01848210|953774|P2|Overall Study|Use of Forbidden Drugs|10
283760|NCT01848210|953775|P1|Overall Study|Use of Forbidden Drugs|9
283761|NCT01848210|953774|P2|Overall Study|Protocol Violation|5
283762|NCT01848210|953775|P1|Overall Study|Protocol Violation|3
283763|NCT01848210|953774|P2|Overall Study|Lost to Follow-up|12
283764|NCT01848210|953775|P1|Overall Study|Lost to Follow-up|24
283765|NCT01848210|953774|P2|Overall Study|Informed Consent Form Withdrawal|24
283766|NCT01848210|953775|P1|Overall Study|Informed Consent Form Withdrawal|28
283767|NCT01848145|953787|P1|Subsequent Infusions: Weeks 3-8|Death|1
283768|NCT01848145|953787|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
283769|NCT01848145|953787|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
283770|NCT01848145|953787|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
283771|NCT01848145|953787|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
283772|NCT01848145|953787|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
283773|NCT01848145|953787|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
283774|NCT01847885|953827|P3|Randomization|Screen Failure|0
283775|NCT01847885|953828|P2|Randomization|Screen Failure|3
283776|NCT01847885|953829|P1|Randomization|Screen Failure|0
283777|NCT01847885|953827|P3|Randomization|Withdrawal by Subject|2
283778|NCT01847885|953828|P2|Randomization|Withdrawal by Subject|0
283779|NCT01847885|953829|P1|Randomization|Withdrawal by Subject|0
283780|NCT01847885|953827|P3|Randomization|Protocol Violation|0
283781|NCT01847885|953828|P2|Randomization|Protocol Violation|1
283782|NCT01847885|953829|P1|Randomization|Protocol Violation|0
283783|NCT01847885|953827|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
283784|NCT01847885|953828|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
283785|NCT01847885|953829|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
283786|NCT01847885|953827|P3|Initial Enrollment (Consented)|Screen failure|0
283787|NCT01847885|953828|P2|Initial Enrollment (Consented)|Screen failure|0
283788|NCT01847885|953829|P1|Initial Enrollment (Consented)|Screen failure|39
283789|NCT01847885|953827|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
283790|NCT01847885|953828|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
283791|NCT01847885|953829|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
283792|NCT01847885|953827|P3|Initial Enrollment (Consented)|Protocol Violation|0
283793|NCT01847885|953828|P2|Initial Enrollment (Consented)|Protocol Violation|0
283794|NCT01847885|953829|P1|Initial Enrollment (Consented)|Protocol Violation|1
283795|NCT01847443|953906|P4|Washout Period Before Study Period 4|Positive alcohol test|0
283796|NCT01847443|953907|P3|Washout Period Before Study Period 4|Positive alcohol test|0
283797|NCT01847443|953908|P2|Washout Period Before Study Period 4|Positive alcohol test|0
283798|NCT01847443|953909|P1|Washout Period Before Study Period 4|Positive alcohol test|1
283799|NCT01847443|953906|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
283800|NCT01847443|953907|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
283801|NCT01847443|953908|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
283802|NCT01847443|953909|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
283803|NCT01847443|953906|P4|Washout Period Before Study Period 3|Other reason|0
283804|NCT01847443|953907|P3|Washout Period Before Study Period 3|Other reason|0
283805|NCT01847443|953908|P2|Washout Period Before Study Period 3|Other reason|0
283806|NCT01847443|953909|P1|Washout Period Before Study Period 3|Other reason|1
283807|NCT01847443|953906|P4|Washout Period Before Study Period 2|Other reason|0
283808|NCT01847443|953907|P3|Washout Period Before Study Period 2|Other reason|0
283809|NCT01847443|953908|P2|Washout Period Before Study Period 2|Other reason|0
283810|NCT01847443|953909|P1|Washout Period Before Study Period 2|Other reason|1
283811|NCT01847443|953906|P4|Washout Period Before Study Period 2|Adverse Event|0
283812|NCT01847443|953907|P3|Washout Period Before Study Period 2|Adverse Event|0
283813|NCT01847443|953908|P2|Washout Period Before Study Period 2|Adverse Event|1
283814|NCT01847443|953909|P1|Washout Period Before Study Period 2|Adverse Event|1
283815|NCT01847443|953906|P4|Study Period 1|Withdrawal by Subject|0
283816|NCT01847443|953907|P3|Study Period 1|Withdrawal by Subject|0
283817|NCT01847443|953908|P2|Study Period 1|Withdrawal by Subject|1
283818|NCT01847443|953909|P1|Study Period 1|Withdrawal by Subject|0
283819|NCT01846741|953966|P1|Baseline Visit|Subject did not meet entry criteria|2
283820|NCT01846442|954092|P4|Overall Study|Left the city/Lost medication|1
283821|NCT01846442|954093|P3|Overall Study|Left the city/Lost medication|1
283822|NCT01846442|954094|P2|Overall Study|Left the city/Lost medication|0
283823|NCT01846442|954095|P1|Overall Study|Left the city/Lost medication|1
283824|NCT01846442|954092|P4|Overall Study|Withdrawal by Subject|1
283825|NCT01846442|954093|P3|Overall Study|Withdrawal by Subject|0
283826|NCT01846442|954094|P2|Overall Study|Withdrawal by Subject|2
283827|NCT01846442|954095|P1|Overall Study|Withdrawal by Subject|3
283828|NCT01846442|954092|P4|Overall Study|Lost to Follow-up|0
283829|NCT01846442|954093|P3|Overall Study|Lost to Follow-up|1
283830|NCT01846442|954094|P2|Overall Study|Lost to Follow-up|0
283831|NCT01846442|954095|P1|Overall Study|Lost to Follow-up|0
283832|NCT01846442|954092|P4|Overall Study|Adverse Event|1
283833|NCT01846442|954093|P3|Overall Study|Adverse Event|2
283834|NCT01846442|954094|P2|Overall Study|Adverse Event|4
283835|NCT01846442|954095|P1|Overall Study|Adverse Event|2
283836|NCT01846416|954136|P3|Overall Study|Lost to Follow-up|1
283837|NCT01846416|954137|P2|Overall Study|Lost to Follow-up|2
283838|NCT01846416|954138|P1|Overall Study|Lost to Follow-up|0
283839|NCT01846416|954136|P3|Overall Study|Ongoing as of 7 January 2015|3
283840|NCT01846416|954137|P2|Overall Study|Ongoing as of 7 January 2015|41
283841|NCT01846416|954138|P1|Overall Study|Ongoing as of 7 January 2015|21
283842|NCT01846416|954136|P3|Overall Study|Other|0
283843|NCT01846416|954137|P2|Overall Study|Other|0
283844|NCT01846416|954138|P1|Overall Study|Other|1
283845|NCT01846416|954136|P3|Overall Study|Withdrawal by Subject|0
283846|NCT01846416|954137|P2|Overall Study|Withdrawal by Subject|7
283847|NCT01846416|954138|P1|Overall Study|Withdrawal by Subject|1
283848|NCT01846416|954136|P3|Overall Study|Death|9
283849|NCT01846416|954137|P2|Overall Study|Death|43
283850|NCT01846416|954138|P1|Overall Study|Death|8
283851|NCT01846299|954183|P2|Overall Study|Adverse Event|0
283852|NCT01846299|954184|P1|Overall Study|Adverse Event|2
283853|NCT01846299|954183|P2|Overall Study|Withdrawal by Subject|6
283854|NCT01846299|954184|P1|Overall Study|Withdrawal by Subject|1
283855|NCT01846299|954183|P2|Overall Study|Lost to Follow-up|0
283856|NCT01846299|954184|P1|Overall Study|Lost to Follow-up|3
283857|NCT01846299|954183|P2|Overall Study|Death|2
283858|NCT01846299|954184|P1|Overall Study|Death|1
283859|NCT01846299|954183|P2|Overall Study|Protocol deviation|0
283860|NCT01846299|954184|P1|Overall Study|Protocol deviation|1
283861|NCT01846299|954183|P2|Overall Study|Physician Decision|2
283862|NCT01846299|954184|P1|Overall Study|Physician Decision|4
283863|NCT01846221|954222|P2|Overall Study|Age Exclusion|0
283864|NCT01846221|954223|P1|Overall Study|Age Exclusion|1
283865|NCT01846221|954222|P2|Overall Study|Catheter Failure|0
283866|NCT01846221|954223|P1|Overall Study|Catheter Failure|2
283867|NCT01846104|954237|P1|Overall Study|Withdrawal by Subject|1
283868|NCT01846039|954243|P1|Overall Study|Subject Withdrew Consent|1
283869|NCT01846039|954243|P1|Overall Study|Protocol Violation|1
283870|NCT01845974|954255|P2|Overall Study|screen failure|0
283871|NCT01845974|954256|P1|Overall Study|screen failure|1
283872|NCT01845831|954264|P5|Inpatient Phase|Withdrawal by Subject|0
283873|NCT01845831|954265|P4|Inpatient Phase|Withdrawal by Subject|0
283874|NCT01845831|954266|P3|Inpatient Phase|Withdrawal by Subject|0
283875|NCT01845831|954267|P2|Inpatient Phase|Withdrawal by Subject|1
283876|NCT01845831|954268|P1|Inpatient Phase|Withdrawal by Subject|1
283877|NCT01845077|954340|P6|Washout Period|Protocol Violation|0
283878|NCT01845077|954341|P5|Washout Period|Protocol Violation|1
283879|NCT01845077|954342|P4|Washout Period|Protocol Violation|1
283880|NCT01845077|954343|P3|Washout Period|Protocol Violation|0
283881|NCT01845077|954344|P2|Washout Period|Protocol Violation|0
283882|NCT01845077|954345|P1|Washout Period|Protocol Violation|0
283883|NCT01845077|954340|P6|Washout Period|elevated lab values (not clinic. sign.)|0
283884|NCT01845077|954341|P5|Washout Period|elevated lab values (not clinic. sign.)|0
283885|NCT01845077|954342|P4|Washout Period|elevated lab values (not clinic. sign.)|0
283886|NCT01845077|954343|P3|Washout Period|elevated lab values (not clinic. sign.)|1
283887|NCT01845077|954344|P2|Washout Period|elevated lab values (not clinic. sign.)|0
283888|NCT01845077|954345|P1|Washout Period|elevated lab values (not clinic. sign.)|0
283889|NCT01845077|954340|P6|Washout Period|Adverse Event|0
283890|NCT01845077|954341|P5|Washout Period|Adverse Event|0
283891|NCT01845077|954342|P4|Washout Period|Adverse Event|0
283892|NCT01845077|954343|P3|Washout Period|Adverse Event|0
283893|NCT01845077|954344|P2|Washout Period|Adverse Event|0
283894|NCT01845077|954345|P1|Washout Period|Adverse Event|1
283895|NCT01845077|954340|P6|Washout Period|Lost to Follow-up|1
283896|NCT01845077|954341|P5|Washout Period|Lost to Follow-up|0
283897|NCT01845077|954342|P4|Washout Period|Lost to Follow-up|1
283898|NCT01845077|954343|P3|Washout Period|Lost to Follow-up|0
283899|NCT01845077|954344|P2|Washout Period|Lost to Follow-up|1
283900|NCT01845077|954345|P1|Washout Period|Lost to Follow-up|0
283901|NCT01845025|954391|P2|Overall Study|Missing|1
283902|NCT01845025|954392|P1|Overall Study|Missing|1
283903|NCT01845025|954391|P2|Overall Study|Protocol deviation|6
283904|NCT01845025|954392|P1|Overall Study|Protocol deviation|3
283905|NCT01845025|954391|P2|Overall Study|Death|0
283906|NCT01845025|954392|P1|Overall Study|Death|2
283907|NCT01845025|954391|P2|Overall Study|Administrative problems|8
283908|NCT01845025|954392|P1|Overall Study|Administrative problems|8
283909|NCT01845025|954391|P2|Overall Study|Lost to Follow-up|13
283910|NCT01845025|954392|P1|Overall Study|Lost to Follow-up|13
283911|NCT01845025|954391|P2|Overall Study|Withdrawal by Subject|44
283912|NCT01845025|954392|P1|Overall Study|Withdrawal by Subject|48
283913|NCT01845025|954391|P2|Overall Study|Unsatisfactory therapeutic effect|2
283914|NCT01845025|954392|P1|Overall Study|Unsatisfactory therapeutic effect|4
283915|NCT01845025|954391|P2|Overall Study|Adverse Event|3
283916|NCT01845025|954392|P1|Overall Study|Adverse Event|6
283917|NCT01844895|954414|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
283918|NCT01844895|954414|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
283919|NCT01844895|954414|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
283920|NCT01844895|954414|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
283921|NCT01844895|954414|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
283922|NCT01844895|954414|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
283923|NCT01844895|954414|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
283924|NCT01844856|954432|P2|Overall Study|Randomized but was a Screen Failure|1
283925|NCT01844856|954433|P1|Overall Study|Randomized but was a Screen Failure|0
283926|NCT01844856|954432|P2|Overall Study|Inadvertently Not Scheduled|0
283927|NCT01844856|954433|P1|Overall Study|Inadvertently Not Scheduled|1
283928|NCT01844856|954432|P2|Overall Study|Enterococcus Resistant|1
283929|NCT01844856|954433|P1|Overall Study|Enterococcus Resistant|0
283930|NCT01844856|954432|P2|Overall Study|Noncompliance|3
283931|NCT01844856|954433|P1|Overall Study|Noncompliance|2
283932|NCT01844856|954432|P2|Overall Study|Withdrawal by Subject|2
283933|NCT01844856|954433|P1|Overall Study|Withdrawal by Subject|3
283934|NCT01844856|954432|P2|Overall Study|Adverse Event|6
283935|NCT01844856|954433|P1|Overall Study|Adverse Event|3
283936|NCT01844856|954432|P2|Overall Study|Lost to Follow-up|3
283937|NCT01844856|954433|P1|Overall Study|Lost to Follow-up|15
283938|NCT01844830|954445|P2|Overall Study|Withdrawal by Subject|0
283939|NCT01844830|954446|P1|Overall Study|Withdrawal by Subject|1
283940|NCT01844817|954476|P2|Treatment|Other|3
283941|NCT01844817|954477|P1|Treatment|Other|0
283942|NCT01844817|954476|P2|Treatment|Lost to Follow-up|1
283943|NCT01844817|954477|P1|Treatment|Lost to Follow-up|0
283944|NCT01844817|954476|P2|Treatment|Death|8
283945|NCT01844817|954477|P1|Treatment|Death|10
283946|NCT01844817|954476|P2|Treatment|Withdrawal by Subject|6
283947|NCT01844817|954477|P1|Treatment|Withdrawal by Subject|10
283948|NCT01844817|954476|P2|Treatment|Adverse Event|9
283949|NCT01844817|954477|P1|Treatment|Adverse Event|17
283950|NCT01844817|954476|P2|Treatment|Progressive Disease|36
283951|NCT01844817|954477|P1|Treatment|Progressive Disease|27
283952|NCT01844817|954476|P2|Enrolled and Randomized|Withdrawal by Subject|3
283953|NCT01844817|954477|P1|Enrolled and Randomized|Withdrawal by Subject|2
283954|NCT01844778|954490|P3|Overall Study|Adverse Event|2
283955|NCT01844778|954491|P2|Overall Study|Adverse Event|2
283956|NCT01844778|954492|P1|Overall Study|Adverse Event|0
283957|NCT01844778|954490|P3|Overall Study|Withdrawal by Subject|0
283958|NCT01844778|954491|P2|Overall Study|Withdrawal by Subject|0
283959|NCT01844778|954492|P1|Overall Study|Withdrawal by Subject|2
283960|NCT01844778|954490|P3|Overall Study|Protocol deviation|2
283961|NCT01844778|954491|P2|Overall Study|Protocol deviation|1
283962|NCT01844778|954492|P1|Overall Study|Protocol deviation|0
283963|NCT01844765|954518|P2|Overall Study|Untreated|0
283964|NCT01844765|954519|P1|Overall Study|Untreated|1
283965|NCT01844765|954518|P2|Overall Study|Protocol Violation|0
283966|NCT01844765|954519|P1|Overall Study|Protocol Violation|1
283967|NCT01844765|954518|P2|Overall Study|Disease progression|0
283968|NCT01844765|954519|P1|Overall Study|Disease progression|1
283969|NCT01844765|954518|P2|Overall Study|Administrative problems|1
283970|NCT01844765|954519|P1|Overall Study|Administrative problems|1
283971|NCT01844765|954518|P2|Overall Study|Withdrawal by Subject|1
283972|NCT01844765|954519|P1|Overall Study|Withdrawal by Subject|0
283973|NCT01844765|954518|P2|Overall Study|Adverse Event|4
283974|NCT01844765|954519|P1|Overall Study|Adverse Event|5
283975|NCT01844700|954539|P2|Overall Study|stopped taking meds|1
283976|NCT01844700|954540|P1|Overall Study|stopped taking meds|0
283977|NCT01844700|954539|P2|Overall Study|Withdrawal by Subject|0
283978|NCT01844700|954540|P1|Overall Study|Withdrawal by Subject|1
283979|NCT01844700|954539|P2|Overall Study|refused medication switch|0
283980|NCT01844700|954540|P1|Overall Study|refused medication switch|1
283981|NCT01844700|954539|P2|Overall Study|Lack of Efficacy|0
283982|NCT01844700|954540|P1|Overall Study|Lack of Efficacy|1
283983|NCT01844687|954552|P1|Visit 4|Withdrawal by Subject|2
283984|NCT01844687|954552|P1|Visit 4|Lost to Follow-up|1
283985|NCT01844687|954552|P1|Visit 4|Pregnancy|1
283986|NCT01844687|954552|P1|Visit 3|child care problems|1
283987|NCT01844687|954552|P1|Visit 3|Withdrawal by Subject|3
283988|NCT01844687|954552|P1|Visit 3|Lost to Follow-up|1
283989|NCT01844687|954552|P1|Visit 2|Protocol Violation|1
283990|NCT01844687|954552|P1|Visit 2|Withdrawal by Subject|1
283991|NCT01844687|954552|P1|Visit 1|Lost to Follow-up|5
283992|NCT01844687|954552|P1|Visit 1|Protocol Violation|3
283993|NCT01844531|954615|P4|Overall Study|Withdrawal by Subject|0
283994|NCT01844531|954616|P3|Overall Study|Withdrawal by Subject|0
283995|NCT01844531|954617|P2|Overall Study|Withdrawal by Subject|1
283996|NCT01844531|954618|P1|Overall Study|Withdrawal by Subject|0
283997|NCT01844518|954648|P1|Long-Term Extension|Still in On-Going Study|149
283998|NCT01844518|954648|P1|Long-Term Extension|No Longer Met Study Criteria|1
283999|NCT01844518|954648|P1|Long-Term Extension|Adverse Event|1
284000|NCT01844518|954648|P1|Long-Term Extension|Lack of Efficacy|6
284001|NCT01844518|954648|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
284002|NCT01844518|954648|P1|Short-Term (ST) Period|Withdrawal of Consent|2
284003|NCT01844518|954648|P1|Short-Term (ST) Period|Lack of Efficacy|3
284004|NCT01844518|954648|P1|Short-Term (ST) Period|Adverse Event|3
284005|NCT01844505|954665|P3|Overall Study|Not Reported|1
284006|NCT01844505|954666|P2|Overall Study|Not Reported|0
284007|NCT01844505|954667|P1|Overall Study|Not Reported|0
284008|NCT01844505|954665|P3|Overall Study|Other Reasons|2
284009|NCT01844505|954666|P2|Overall Study|Other Reasons|2
284010|NCT01844505|954667|P1|Overall Study|Other Reasons|4
284011|NCT01844505|954665|P3|Overall Study|Subject no longer meets criteria|0
284012|NCT01844505|954666|P2|Overall Study|Subject no longer meets criteria|1
284013|NCT01844505|954667|P1|Overall Study|Subject no longer meets criteria|0
284014|NCT01844505|954665|P3|Overall Study|Poor/non-compliance|1
284015|NCT01844505|954666|P2|Overall Study|Poor/non-compliance|1
284016|NCT01844505|954667|P1|Overall Study|Poor/non-compliance|1
284017|NCT01844505|954665|P3|Overall Study|Maximum clinical benefit|2
284018|NCT01844505|954666|P2|Overall Study|Maximum clinical benefit|11
284019|NCT01844505|954667|P1|Overall Study|Maximum clinical benefit|8
284020|NCT01844505|954665|P3|Overall Study|Lost to Follow-up|0
284021|NCT01844505|954666|P2|Overall Study|Lost to Follow-up|0
284022|NCT01844505|954667|P1|Overall Study|Lost to Follow-up|1
284023|NCT01844505|954665|P3|Overall Study|Withdrawal by Subject|0
284024|NCT01844505|954666|P2|Overall Study|Withdrawal by Subject|3
284025|NCT01844505|954667|P1|Overall Study|Withdrawal by Subject|0
284026|NCT01844505|954665|P3|Overall Study|Subject request discontinue treatment|8
284027|NCT01844505|954666|P2|Overall Study|Subject request discontinue treatment|14
284028|NCT01844505|954667|P1|Overall Study|Subject request discontinue treatment|17
284029|NCT01844505|954665|P3|Overall Study|Adverse event unrelated to study drug|6
284030|NCT01844505|954666|P2|Overall Study|Adverse event unrelated to study drug|15
284031|NCT01844505|954667|P1|Overall Study|Adverse event unrelated to study drug|7
284032|NCT01844505|954665|P3|Overall Study|Death|1
284033|NCT01844505|954666|P2|Overall Study|Death|3
284034|NCT01844505|954667|P1|Overall Study|Death|1
284035|NCT01844505|954665|P3|Overall Study|Study drug toxicity|50
284036|NCT01844505|954666|P2|Overall Study|Study drug toxicity|131
284037|NCT01844505|954667|P1|Overall Study|Study drug toxicity|40
284038|NCT01844505|954665|P3|Overall Study|Disease progression|224
284039|NCT01844505|954666|P2|Overall Study|Disease progression|88
284040|NCT01844505|954667|P1|Overall Study|Disease progression|170
284041|NCT01843972|954778|P10|Overall Study|Withdrawal by Subject|0
284042|NCT01843972|954779|P9|Overall Study|Withdrawal by Subject|0
284043|NCT01843972|954780|P8|Overall Study|Withdrawal by Subject|0
284044|NCT01843972|954781|P7|Overall Study|Withdrawal by Subject|0
284045|NCT01843972|954782|P6|Overall Study|Withdrawal by Subject|0
284046|NCT01843972|954783|P5|Overall Study|Withdrawal by Subject|1
284047|NCT01843972|954784|P4|Overall Study|Withdrawal by Subject|0
284048|NCT01843972|954785|P3|Overall Study|Withdrawal by Subject|0
284049|NCT01843972|954786|P2|Overall Study|Withdrawal by Subject|0
284050|NCT01843972|954787|P1|Overall Study|Withdrawal by Subject|0
284051|NCT01843933|954857|P2|Overall Study|Data lost|4
284052|NCT01843933|954858|P1|Overall Study|Data lost|6
284053|NCT01843777|954877|P2|Overall Study|Withdrawal by Subject|0
284054|NCT01843777|954878|P1|Overall Study|Withdrawal by Subject|1
284055|NCT01843673|954886|P1|Overall Study|Withdrawal by Subject|4
284056|NCT01843673|954886|P1|Overall Study|Lack of Efficacy|2
284057|NCT01843660|954898|P1|Overall Study|Other|30
284058|NCT01843374|954922|P2|Overall Study|Withdrawal by Subject|19
284059|NCT01843374|954923|P1|Overall Study|Withdrawal by Subject|14
284060|NCT01843374|954922|P2|Overall Study|Death|302
284061|NCT01843374|954923|P1|Overall Study|Death|150
284062|NCT01843348|954950|P3|Overall Study|Various reasons|6
284063|NCT01843348|954951|P2|Overall Study|Various reasons|9
284064|NCT01843348|954952|P1|Overall Study|Various reasons|4
284065|NCT01843348|954950|P3|Overall Study|Graft loss/retransplantation|11
284066|NCT01843348|954951|P2|Overall Study|Graft loss/retransplantation|8
284067|NCT01843348|954952|P1|Overall Study|Graft loss/retransplantation|5
284068|NCT01843348|954950|P3|Overall Study|Death|4
284069|NCT01843348|954951|P2|Overall Study|Death|3
284070|NCT01843348|954952|P1|Overall Study|Death|5
284071|NCT01843348|954950|P3|Overall Study|Lost to Follow-up|2
284072|NCT01843348|954951|P2|Overall Study|Lost to Follow-up|4
284073|NCT01843348|954952|P1|Overall Study|Lost to Follow-up|5
284074|NCT01843348|954950|P3|Overall Study|Withdrawal by Subject|18
284075|NCT01843348|954951|P2|Overall Study|Withdrawal by Subject|16
284076|NCT01843348|954952|P1|Overall Study|Withdrawal by Subject|4
284077|NCT01843205|954992|P2|First Treatment (11 Days)|Withdrawal by Subject|0
284078|NCT01843205|954993|P1|First Treatment (11 Days)|Withdrawal by Subject|1
284079|NCT01843192|955054|P3|Overall Study|Intra-operative exclusions per protocol|2
284080|NCT01843192|955055|P2|Overall Study|Intra-operative exclusions per protocol|6
284081|NCT01843192|955056|P1|Overall Study|Intra-operative exclusions per protocol|2
284082|NCT01842958|955087|P2|Overall Study|Lost to Follow-up|1
284083|NCT01842958|955088|P1|Overall Study|Lost to Follow-up|1
284084|NCT01842633|955161|P3|Overall Study|Technical issues|0
284085|NCT01842633|955162|P2|Overall Study|Technical issues|0
284086|NCT01842633|955163|P1|Overall Study|Technical issues|1
284087|NCT01842633|955161|P3|Overall Study|Withdrawal by Subject|0
284088|NCT01842633|955162|P2|Overall Study|Withdrawal by Subject|1
284089|NCT01842633|955163|P1|Overall Study|Withdrawal by Subject|0
284090|NCT01842633|955161|P3|Overall Study|Adverse Event|0
284091|NCT01842633|955162|P2|Overall Study|Adverse Event|1
284092|NCT01842633|955163|P1|Overall Study|Adverse Event|1
284093|NCT01842633|955161|P3|Overall Study|Screen Failure|0
284094|NCT01842633|955162|P2|Overall Study|Screen Failure|0
284095|NCT01842633|955163|P1|Overall Study|Screen Failure|1
284096|NCT01842620|955210|P2|Period 1|Withdrawal by Subject|0
284097|NCT01842620|955211|P1|Period 1|Withdrawal by Subject|1
284098|NCT01842607|955227|P1|Overall Study|Withdrawal by Subject|14
284099|NCT01842607|955227|P1|Overall Study|Physician Decision|9
284100|NCT01842607|955227|P1|Overall Study|Lost to Follow-up|3
284101|NCT01842607|955227|P1|Overall Study|Protocol defined stopping criteria|2
284102|NCT01842607|955227|P1|Overall Study|Protocol Violation|8
284103|NCT01842607|955227|P1|Overall Study|Lack of Efficacy|19
284104|NCT01842607|955227|P1|Overall Study|Adverse Event|11
284105|NCT01842438|955259|P2|T2: 6month Follow-up|Death|1
284106|NCT01842438|955260|P1|T2: 6month Follow-up|Death|0
284107|NCT01842438|955259|P2|T2: 6month Follow-up|Withdrawal by Subject|3
284108|NCT01842438|955260|P1|T2: 6month Follow-up|Withdrawal by Subject|4
284109|NCT01842438|955259|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
284110|NCT01842438|955260|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
284111|NCT01841970|955272|P1|Overall Study|Lost to Follow-up|8
284112|NCT01841970|955272|P1|Overall Study|Physician Decision|2
284113|NCT01841970|955272|P1|Overall Study|Withdrawal by Subject|1
284114|NCT01841697|955298|P2|Overall Study|Withdrawal by Subject|16
284115|NCT01841697|955299|P1|Overall Study|Withdrawal by Subject|16
284116|NCT01841697|955298|P2|Overall Study|Lost to Follow-up|1
284117|NCT01841697|955299|P1|Overall Study|Lost to Follow-up|4
284118|NCT01841697|955298|P2|Overall Study|Death|1
284119|NCT01841697|955299|P1|Overall Study|Death|0
284120|NCT01841593|955334|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
284121|NCT01841593|955335|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
284122|NCT01841593|955334|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
284123|NCT01841593|955335|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
284124|NCT01841567|955351|P1|Overall Study|Adverse Event|3
284125|NCT01840943|955379|P2|Overall Study|Lost to Follow-up|4
284126|NCT01840943|955380|P1|Overall Study|Lost to Follow-up|4
284127|NCT01840943|955379|P2|Overall Study|Physician Decision|2
284128|NCT01840943|955380|P1|Overall Study|Physician Decision|4
284129|NCT01840943|955379|P2|Overall Study|Withdrawal by Subject|6
284130|NCT01840943|955380|P1|Overall Study|Withdrawal by Subject|5
284131|NCT01840605|955416|P2|Overall Study|Physician Decision|1
284132|NCT01840605|955417|P1|Overall Study|Physician Decision|2
284133|NCT01840605|955416|P2|Overall Study|Adverse Event|1
284134|NCT01840605|955417|P1|Overall Study|Adverse Event|0
284135|NCT01840410|955431|P2|Overall Study|Adverse Event|1
284136|NCT01840410|955432|P1|Overall Study|Adverse Event|1
284137|NCT01840410|955431|P2|Overall Study|Withdrawal by Subject|1
284138|NCT01840410|955432|P1|Overall Study|Withdrawal by Subject|2
284139|NCT01840410|955431|P2|Overall Study|Lost to Follow-up|0
284140|NCT01840410|955432|P1|Overall Study|Lost to Follow-up|1
284141|NCT01840410|955431|P2|Overall Study|Protocol deviation|0
284142|NCT01840410|955432|P1|Overall Study|Protocol deviation|1
284143|NCT01840410|955431|P2|Overall Study|Pregnancy|0
284144|NCT01840410|955432|P1|Overall Study|Pregnancy|1
284145|NCT01840410|955431|P2|Overall Study|Physician Decision|2
284146|NCT01840410|955432|P1|Overall Study|Physician Decision|1
284147|NCT01839279|955599|P3|Overall Study|Classified as 'Other'|0
284148|NCT01839279|955600|P2|Overall Study|Classified as 'Other'|0
284149|NCT01839279|955601|P1|Overall Study|Classified as 'Other'|5
284150|NCT01839279|955599|P3|Overall Study|Withdrawal by Subject|1
284151|NCT01839279|955600|P2|Overall Study|Withdrawal by Subject|1
284152|NCT01839279|955601|P1|Overall Study|Withdrawal by Subject|4
284153|NCT01839279|955599|P3|Overall Study|Adverse Event|1
284154|NCT01839279|955600|P2|Overall Study|Adverse Event|1
284155|NCT01839279|955601|P1|Overall Study|Adverse Event|4
284156|NCT01838941|955633|P1|Overall Study|Withdrawal by Subject|1
284157|NCT01838941|955633|P1|Overall Study|Adverse Event|1
284158|NCT01838694|955645|P2|Overall Study|Adverse Event|1
284159|NCT01838694|955646|P1|Overall Study|Adverse Event|0
284160|NCT01838681|955655|P4|Period B/A+|Administrative or other reasons|28
284161|NCT01838681|955656|P3|Period B/A+|Administrative or other reasons|10
284162|NCT01838681|955657|P2|Period B/A+|Administrative or other reasons|6
284163|NCT01838681|955658|P1|Period B/A+|Administrative or other reasons|0
284164|NCT01838681|955655|P4|Period B/A+|Withdrawal before treatment|0
284165|NCT01838681|955656|P3|Period B/A+|Withdrawal before treatment|0
284166|NCT01838681|955657|P2|Period B/A+|Withdrawal before treatment|1
284167|NCT01838681|955658|P1|Period B/A+|Withdrawal before treatment|0
284168|NCT01838681|955655|P4|Period B/A+|Lost to Follow-up|11
284169|NCT01838681|955656|P3|Period B/A+|Lost to Follow-up|5
284170|NCT01838681|955657|P2|Period B/A+|Lost to Follow-up|2
284171|NCT01838681|955658|P1|Period B/A+|Lost to Follow-up|0
284172|NCT01838681|955655|P4|Period B/A+|Non-compliance with IMP|3
284173|NCT01838681|955656|P3|Period B/A+|Non-compliance with IMP|3
284174|NCT01838681|955657|P2|Period B/A+|Non-compliance with IMP|2
284175|NCT01838681|955658|P1|Period B/A+|Non-compliance with IMP|0
284176|NCT01838681|955655|P4|Period B/A+|Protocol Violation|6
284177|NCT01838681|955656|P3|Period B/A+|Protocol Violation|4
284178|NCT01838681|955657|P2|Period B/A+|Protocol Violation|1
284179|NCT01838681|955658|P1|Period B/A+|Protocol Violation|0
284180|NCT01838681|955655|P4|Period B/A+|Withdrawal by Subject|47
284181|NCT01838681|955656|P3|Period B/A+|Withdrawal by Subject|35
284182|NCT01838681|955657|P2|Period B/A+|Withdrawal by Subject|28
284183|NCT01838681|955658|P1|Period B/A+|Withdrawal by Subject|0
284184|NCT01838681|955655|P4|Period B/A+|Lack of Efficacy|6
284185|NCT01838681|955656|P3|Period B/A+|Lack of Efficacy|11
284186|NCT01838681|955657|P2|Period B/A+|Lack of Efficacy|9
284187|NCT01838681|955658|P1|Period B/A+|Lack of Efficacy|0
284188|NCT01838681|955655|P4|Period B/A+|Adverse Event|16
284189|NCT01838681|955656|P3|Period B/A+|Adverse Event|27
284190|NCT01838681|955657|P2|Period B/A+|Adverse Event|13
284191|NCT01838681|955658|P1|Period B/A+|Adverse Event|0
284192|NCT01838681|955655|P4|Period A|Administrative or other reasons|0
284193|NCT01838681|955656|P3|Period A|Administrative or other reasons|0
284194|NCT01838681|955657|P2|Period A|Administrative or other reasons|0
284195|NCT01838681|955658|P1|Period A|Administrative or other reasons|17
284196|NCT01838681|955655|P4|Period A|Withdrawal before treatment|0
284197|NCT01838681|955656|P3|Period A|Withdrawal before treatment|0
284198|NCT01838681|955657|P2|Period A|Withdrawal before treatment|0
284199|NCT01838681|955658|P1|Period A|Withdrawal before treatment|4
284200|NCT01838681|955655|P4|Period A|Lost to Follow-up|0
284201|NCT01838681|955656|P3|Period A|Lost to Follow-up|0
284202|NCT01838681|955657|P2|Period A|Lost to Follow-up|0
284203|NCT01838681|955658|P1|Period A|Lost to Follow-up|4
284204|NCT01838681|955655|P4|Period A|Non-compliance with IMP|0
284205|NCT01838681|955656|P3|Period A|Non-compliance with IMP|0
284206|NCT01838681|955657|P2|Period A|Non-compliance with IMP|0
284207|NCT01838681|955658|P1|Period A|Non-compliance with IMP|6
284208|NCT01838681|955655|P4|Period A|Protocol Violation|0
284209|NCT01838681|955656|P3|Period A|Protocol Violation|0
284210|NCT01838681|955657|P2|Period A|Protocol Violation|0
284211|NCT01838681|955658|P1|Period A|Protocol Violation|16
284212|NCT01838681|955655|P4|Period A|Withdrawal by Subject|0
284213|NCT01838681|955656|P3|Period A|Withdrawal by Subject|0
284214|NCT01838681|955657|P2|Period A|Withdrawal by Subject|0
284215|NCT01838681|955658|P1|Period A|Withdrawal by Subject|70
284216|NCT01838681|955655|P4|Period A|Early response|0
284217|NCT01838681|955656|P3|Period A|Early response|0
284218|NCT01838681|955657|P2|Period A|Early response|0
284219|NCT01838681|955658|P1|Period A|Early response|148
284220|NCT01838681|955655|P4|Period A|Lack of Efficacy|0
284221|NCT01838681|955656|P3|Period A|Lack of Efficacy|0
284222|NCT01838681|955657|P2|Period A|Lack of Efficacy|0
284223|NCT01838681|955658|P1|Period A|Lack of Efficacy|21
284224|NCT01838681|955655|P4|Period A|Adverse Event|0
284225|NCT01838681|955656|P3|Period A|Adverse Event|0
284226|NCT01838681|955657|P2|Period A|Adverse Event|0
284227|NCT01838681|955658|P1|Period A|Adverse Event|39
284228|NCT01838642|955766|P1|Overall Study|Died on study|1
284229|NCT01838616|955779|P2|Pick-up Arm|Technical problems|0
284230|NCT01838616|955780|P1|Pick-up Arm|Technical problems|1
284231|NCT01838616|955779|P2|Pick-up Arm|Withdrawal by Subject|0
284232|NCT01838616|955780|P1|Pick-up Arm|Withdrawal by Subject|1
284233|NCT01838616|955779|P2|Pick-up Arm|Adverse Event|0
284234|NCT01838616|955780|P1|Pick-up Arm|Adverse Event|9
284235|NCT01838616|955779|P2|Pick-up Arm|Lack of Efficacy|0
284236|NCT01838616|955780|P1|Pick-up Arm|Lack of Efficacy|4
284237|NCT01838616|955779|P2|Continuation Period|Technical problems|1
284238|NCT01838616|955780|P1|Continuation Period|Technical problems|0
284239|NCT01838616|955779|P2|Continuation Period|Withdrawal by Subject|4
284240|NCT01838616|955780|P1|Continuation Period|Withdrawal by Subject|0
284241|NCT01838616|955779|P2|Continuation Period|Lost to Follow-up|0
284242|NCT01838616|955780|P1|Continuation Period|Lost to Follow-up|1
284243|NCT01838616|955779|P2|Continuation Period|Protocol Violation|0
284244|NCT01838616|955780|P1|Continuation Period|Protocol Violation|2
284245|NCT01838616|955779|P2|Continuation Period|Adverse Event|4
284246|NCT01838616|955780|P1|Continuation Period|Adverse Event|8
284247|NCT01838616|955779|P2|Continuation Period|Lack of Efficacy|5
284248|NCT01838616|955780|P1|Continuation Period|Lack of Efficacy|3
284249|NCT01838616|955779|P2|Titration Period|Protocol Violation|1
284250|NCT01838616|955780|P1|Titration Period|Protocol Violation|0
284251|NCT01838616|955779|P2|Titration Period|Not specified|0
284252|NCT01838616|955780|P1|Titration Period|Not specified|1
284253|NCT01838616|955779|P2|Titration Period|Technical problems|0
284254|NCT01838616|955780|P1|Titration Period|Technical problems|1
284255|NCT01838616|955779|P2|Titration Period|Withdrawal by Subject|5
284256|NCT01838616|955780|P1|Titration Period|Withdrawal by Subject|5
284257|NCT01838616|955779|P2|Titration Period|Lack of Efficacy|12
284258|NCT01838616|955780|P1|Titration Period|Lack of Efficacy|5
284259|NCT01838616|955779|P2|Titration Period|Adverse Event|48
284260|NCT01838616|955780|P1|Titration Period|Adverse Event|18
284261|NCT01838590|955851|P2|Overall Study|Lost to Follow-up|1
284262|NCT01838590|955852|P1|Overall Study|Lost to Follow-up|0
284263|NCT01838590|955851|P2|Overall Study|Lack of Efficacy|4
284264|NCT01838590|955852|P1|Overall Study|Lack of Efficacy|12
284265|NCT01838499|955876|P2|Overall Study|Withdrawal by Subject|9
284266|NCT01838499|955877|P1|Overall Study|Withdrawal by Subject|19
284267|NCT01838499|955876|P2|Overall Study|Adverse Event|1
284268|NCT01838499|955877|P1|Overall Study|Adverse Event|2
284269|NCT01838499|955876|P2|Overall Study|Lack of Efficacy|2
284270|NCT01838499|955877|P1|Overall Study|Lack of Efficacy|1
284271|NCT01838499|955876|P2|Overall Study|Lost to Follow-up|4
284272|NCT01838499|955877|P1|Overall Study|Lost to Follow-up|2
284273|NCT01838499|955876|P2|Overall Study|Protocol Violation|1
284274|NCT01838499|955877|P1|Overall Study|Protocol Violation|0
284275|NCT01838213|955904|P2|Overall Study|Ineligible|191
284276|NCT01838213|955905|P1|Overall Study|Ineligible|166
284277|NCT01838044|955913|P2|Overall Study|Lost to Follow-up|2
284278|NCT01838044|955914|P1|Overall Study|Lost to Follow-up|0
284279|NCT01838044|955913|P2|Overall Study|Medication error without associated AE|1
284280|NCT01838044|955914|P1|Overall Study|Medication error without associated AE|0
284281|NCT01838044|955913|P2|Overall Study|Insufficient clinical response|2
284282|NCT01838044|955914|P1|Overall Study|Insufficient clinical response|1
284283|NCT01838044|955913|P2|Overall Study|Withdrawal by Subject|2
284284|NCT01838044|955914|P1|Overall Study|Withdrawal by Subject|0
284285|NCT01838044|955913|P2|Overall Study|Protocol Violation|3
284286|NCT01838044|955914|P1|Overall Study|Protocol Violation|3
284287|NCT01838044|955913|P2|Overall Study|Adverse Event|6
284288|NCT01838044|955914|P1|Overall Study|Adverse Event|4
284289|NCT01837966|955947|P2|Overall Study|Withdrawal by Subject|1
284290|NCT01837966|955948|P1|Overall Study|Withdrawal by Subject|2
284291|NCT01837823|955954|P1|Overall Study|Lost to Follow-up|6
284292|NCT01837797|955985|P5|Period 3|Other|2
284293|NCT01837797|955986|P4|Period 3|Other|0
284294|NCT01837797|955987|P3|Period 3|Other|0
284295|NCT01837797|955988|P2|Period 3|Other|0
284296|NCT01837797|955989|P1|Period 3|Other|0
284297|NCT01837797|955985|P5|Period 3|Administrative reasons|20
284298|NCT01837797|955986|P4|Period 3|Administrative reasons|0
284299|NCT01837797|955987|P3|Period 3|Administrative reasons|0
284300|NCT01837797|955988|P2|Period 3|Administrative reasons|0
284301|NCT01837797|955989|P1|Period 3|Administrative reasons|0
284302|NCT01837797|955985|P5|Period 3|Adverse Event|1
284303|NCT01837797|955986|P4|Period 3|Adverse Event|0
284304|NCT01837797|955987|P3|Period 3|Adverse Event|0
284305|NCT01837797|955988|P2|Period 3|Adverse Event|0
284306|NCT01837797|955989|P1|Period 3|Adverse Event|0
284307|NCT01837797|955985|P5|Period 2|Adverse Event|0
284308|NCT01837797|955986|P4|Period 2|Adverse Event|1
284309|NCT01837797|955987|P3|Period 2|Adverse Event|0
284310|NCT01837797|955988|P2|Period 2|Adverse Event|0
284311|NCT01837797|955989|P1|Period 2|Adverse Event|0
284312|NCT01837797|955985|P5|Period 2|Administrative or other reasons|0
284313|NCT01837797|955986|P4|Period 2|Administrative or other reasons|4
284314|NCT01837797|955987|P3|Period 2|Administrative or other reasons|2
284315|NCT01837797|955988|P2|Period 2|Administrative or other reasons|5
284316|NCT01837797|955989|P1|Period 2|Administrative or other reasons|0
284317|NCT01837797|955985|P5|Period 1|Other|0
284318|NCT01837797|955986|P4|Period 1|Other|0
284319|NCT01837797|955987|P3|Period 1|Other|0
284320|NCT01837797|955988|P2|Period 1|Other|0
284321|NCT01837797|955989|P1|Period 1|Other|10
284322|NCT01837797|955985|P5|Period 1|Withdrawal of consent before treatment|0
284323|NCT01837797|955986|P4|Period 1|Withdrawal of consent before treatment|0
284324|NCT01837797|955987|P3|Period 1|Withdrawal of consent before treatment|0
284325|NCT01837797|955988|P2|Period 1|Withdrawal of consent before treatment|0
284326|NCT01837797|955989|P1|Period 1|Withdrawal of consent before treatment|1
284327|NCT01837797|955985|P5|Period 1|Administrative reasons|0
284328|NCT01837797|955986|P4|Period 1|Administrative reasons|0
284329|NCT01837797|955987|P3|Period 1|Administrative reasons|0
284330|NCT01837797|955988|P2|Period 1|Administrative reasons|0
284331|NCT01837797|955989|P1|Period 1|Administrative reasons|76
284332|NCT01837797|955985|P5|Period 1|Withdrawal by Subject|0
284333|NCT01837797|955986|P4|Period 1|Withdrawal by Subject|0
284334|NCT01837797|955987|P3|Period 1|Withdrawal by Subject|0
284335|NCT01837797|955988|P2|Period 1|Withdrawal by Subject|0
284336|NCT01837797|955989|P1|Period 1|Withdrawal by Subject|6
284337|NCT01837797|955985|P5|Period 1|Adverse Event|0
284338|NCT01837797|955986|P4|Period 1|Adverse Event|0
284339|NCT01837797|955987|P3|Period 1|Adverse Event|0
284340|NCT01837797|955988|P2|Period 1|Adverse Event|0
284341|NCT01837797|955989|P1|Period 1|Adverse Event|9
284342|NCT01837719|956024|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
284343|NCT01837719|956024|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
284344|NCT01837680|956093|P2|Overall Study|switched to oral hypoglycemic or diet|4
284345|NCT01837680|956094|P1|Overall Study|switched to oral hypoglycemic or diet|2
284346|NCT01837680|956093|P2|Overall Study|allergic reaction|0
284347|NCT01837680|956094|P1|Overall Study|allergic reaction|6
284348|NCT01837680|956093|P2|Overall Study|lack of insurance|2
284349|NCT01837680|956094|P1|Overall Study|lack of insurance|0
284350|NCT01837680|956093|P2|Overall Study|Lost to Follow-up|2
284351|NCT01837680|956094|P1|Overall Study|Lost to Follow-up|2
284352|NCT01836523|956200|P4|Overall Study|Unclassified|29
284353|NCT01836523|956201|P3|Overall Study|Unclassified|19
284354|NCT01836523|956202|P2|Overall Study|Unclassified|28
284355|NCT01836523|956203|P1|Overall Study|Unclassified|17
284356|NCT01836523|956200|P4|Overall Study|Met Withdrawal Criteria|27
284357|NCT01836523|956201|P3|Overall Study|Met Withdrawal Criteria|21
284358|NCT01836523|956202|P2|Overall Study|Met Withdrawal Criteria|13
284359|NCT01836523|956203|P1|Overall Study|Met Withdrawal Criteria|13
284360|NCT01836523|956200|P4|Overall Study|Protocol Violation|4
284361|NCT01836523|956201|P3|Overall Study|Protocol Violation|2
284362|NCT01836523|956202|P2|Overall Study|Protocol Violation|3
284363|NCT01836523|956203|P1|Overall Study|Protocol Violation|6
284364|NCT01836523|956200|P4|Overall Study|Adverse Event|14
284365|NCT01836523|956201|P3|Overall Study|Adverse Event|49
284366|NCT01836523|956202|P2|Overall Study|Adverse Event|41
284367|NCT01836523|956203|P1|Overall Study|Adverse Event|15
284368|NCT01836471|956230|P5|Overall Study|Non compliance with tx|0
284369|NCT01836471|956231|P4|Overall Study|Non compliance with tx|0
284370|NCT01836471|956232|P3|Overall Study|Non compliance with tx|0
284371|NCT01836471|956233|P2|Overall Study|Non compliance with tx|1
284372|NCT01836471|956234|P1|Overall Study|Non compliance with tx|1
284373|NCT01836471|956230|P5|Overall Study|Adverse Event|2
284374|NCT01836471|956231|P4|Overall Study|Adverse Event|1
284375|NCT01836471|956232|P3|Overall Study|Adverse Event|1
284376|NCT01836471|956233|P2|Overall Study|Adverse Event|3
284377|NCT01836471|956234|P1|Overall Study|Adverse Event|6
284378|NCT01836471|956230|P5|Overall Study|Lost to Follow-up|1
284379|NCT01836471|956231|P4|Overall Study|Lost to Follow-up|1
284380|NCT01836471|956232|P3|Overall Study|Lost to Follow-up|0
284381|NCT01836471|956233|P2|Overall Study|Lost to Follow-up|0
284382|NCT01836471|956234|P1|Overall Study|Lost to Follow-up|0
284383|NCT01836471|956230|P5|Overall Study|Physician Decision|0
284384|NCT01836471|956231|P4|Overall Study|Physician Decision|0
284385|NCT01836471|956232|P3|Overall Study|Physician Decision|0
284386|NCT01836471|956233|P2|Overall Study|Physician Decision|1
284387|NCT01836471|956234|P1|Overall Study|Physician Decision|0
284388|NCT01836471|956230|P5|Overall Study|Withdrawal by Subject|2
284389|NCT01836471|956231|P4|Overall Study|Withdrawal by Subject|0
284390|NCT01836471|956232|P3|Overall Study|Withdrawal by Subject|1
284391|NCT01836471|956233|P2|Overall Study|Withdrawal by Subject|4
284392|NCT01836471|956234|P1|Overall Study|Withdrawal by Subject|3
284393|NCT01836471|956230|P5|Overall Study|Pregnancy|0
284394|NCT01836471|956231|P4|Overall Study|Pregnancy|0
284395|NCT01836471|956232|P3|Overall Study|Pregnancy|0
284396|NCT01836471|956233|P2|Overall Study|Pregnancy|0
284397|NCT01836471|956234|P1|Overall Study|Pregnancy|1
284398|NCT01836458|956263|P4|Overall Study|Unsatisfactory therapeutic effect|6
284399|NCT01836458|956264|P3|Overall Study|Unsatisfactory therapeutic effect|5
284400|NCT01836458|956265|P2|Overall Study|Unsatisfactory therapeutic effect|2
284401|NCT01836458|956266|P1|Overall Study|Unsatisfactory therapeutic effect|3
284402|NCT01835899|956328|P3|Overall Study|Other than stated above|0
284403|NCT01835899|956329|P2|Overall Study|Other than stated above|1
284404|NCT01835899|956330|P1|Overall Study|Other than stated above|0
284405|NCT01835899|956328|P3|Overall Study|Adverse Event|1
284406|NCT01835899|956329|P2|Overall Study|Adverse Event|0
284407|NCT01835899|956330|P1|Overall Study|Adverse Event|0
284408|NCT01835548|956374|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
284409|NCT01835548|956375|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
284410|NCT01835548|956376|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
284411|NCT01835548|956374|P3|Double-Blind Treatment Period|Adverse Event|0
284412|NCT01835548|956375|P2|Double-Blind Treatment Period|Adverse Event|1
284413|NCT01835548|956376|P1|Double-Blind Treatment Period|Adverse Event|0
284414|NCT01835548|956374|P3|Dose Optimization Period|Withdrawal by Subject|1
284415|NCT01835548|956375|P2|Dose Optimization Period|Withdrawal by Subject|0
284416|NCT01835548|956376|P1|Dose Optimization Period|Withdrawal by Subject|0
284417|NCT01835548|956374|P3|Dose Optimization Period|Adverse Event|1
284418|NCT01835548|956375|P2|Dose Optimization Period|Adverse Event|0
284419|NCT01835548|956376|P1|Dose Optimization Period|Adverse Event|0
284420|NCT01835470|956405|P1|Long Term Treatment Period|Lack of Efficacy|1
284421|NCT01835470|956405|P1|Long Term Treatment Period|Subject Request to Discontinue|1
284422|NCT01835431|956417|P2|Overall Study|Protocol Violation|0
284423|NCT01835431|956418|P1|Overall Study|Protocol Violation|1
284424|NCT01835431|956417|P2|Overall Study|Withdrawal by Subject|10
284425|NCT01835431|956418|P1|Overall Study|Withdrawal by Subject|6
284426|NCT01835431|956417|P2|Overall Study|other|2
284427|NCT01835431|956418|P1|Overall Study|other|0
284428|NCT01835431|956417|P2|Overall Study|Adverse Event|0
284429|NCT01835431|956418|P1|Overall Study|Adverse Event|1
284430|NCT01835132|956456|P1|Initial Phase|Insufficient Therapeutic Response|2
284431|NCT01835015|956501|P5|Overall Study|Adverse Event|0
284432|NCT01835015|956502|P4|Overall Study|Adverse Event|0
284433|NCT01835015|956503|P3|Overall Study|Adverse Event|1
284434|NCT01835015|956504|P2|Overall Study|Adverse Event|0
284435|NCT01835015|956505|P1|Overall Study|Adverse Event|0
284436|NCT01834586|956588|P1|Overall Study|Adverse Event|1
284437|NCT01834274|956628|P2|Overall Study|Other|1
284438|NCT01834274|956629|P1|Overall Study|Other|2
284439|NCT01834274|956628|P2|Overall Study|Lost to Follow-up|1
284440|NCT01834274|956629|P1|Overall Study|Lost to Follow-up|3
284441|NCT01834274|956628|P2|Overall Study|Withdrawal by Subject|1
284442|NCT01834274|956629|P1|Overall Study|Withdrawal by Subject|1
284443|NCT01834274|956628|P2|Overall Study|Study Termination|38
284444|NCT01834274|956629|P1|Overall Study|Study Termination|41
284445|NCT01834222|956652|P1|Overall Study|Not meet inclusion/exclusion criteria|1
284446|NCT01833897|956738|P1|Overall Study|Lack of Efficacy|1
284447|NCT01833533|956765|P2|Overall Study|Not Specified|7
284448|NCT01833533|956766|P1|Overall Study|Not Specified|2
284449|NCT01833533|956765|P2|Overall Study|To Enter an Extension Study|4
284450|NCT01833533|956766|P1|Overall Study|To Enter an Extension Study|0
284451|NCT01833533|956765|P2|Overall Study|Lost to Follow-up|9
284452|NCT01833533|956766|P1|Overall Study|Lost to Follow-up|4
284453|NCT01833533|956765|P2|Overall Study|Adverse Event|1
284454|NCT01833533|956766|P1|Overall Study|Adverse Event|0
284455|NCT01833169|956810|P1|Overall Study|Physician Decision|2
284456|NCT01833169|956810|P1|Overall Study|Death|3
284457|NCT01833169|956810|P1|Overall Study|Withdrawal by Subject|9
284458|NCT01833169|956810|P1|Overall Study|Adverse Event|33
284459|NCT01833169|956810|P1|Overall Study|Disease Progression|99
284460|NCT01833065|956879|P5|Overall Study|Others|4
284461|NCT01833065|956880|P4|Overall Study|Others|1
284462|NCT01833065|956881|P3|Overall Study|Others|1
284463|NCT01833065|956882|P2|Overall Study|Others|1
284464|NCT01833065|956883|P1|Overall Study|Others|2
284465|NCT01833065|956879|P5|Overall Study|Trial terminated by sponsor|13
284466|NCT01833065|956880|P4|Overall Study|Trial terminated by sponsor|3
284467|NCT01833065|956881|P3|Overall Study|Trial terminated by sponsor|7
284468|NCT01833065|956882|P2|Overall Study|Trial terminated by sponsor|8
284469|NCT01833065|956883|P1|Overall Study|Trial terminated by sponsor|8
284470|NCT01833065|956879|P5|Overall Study|Subject's substantial non-compliance|0
284471|NCT01833065|956880|P4|Overall Study|Subject's substantial non-compliance|0
284472|NCT01833065|956881|P3|Overall Study|Subject's substantial non-compliance|0
284473|NCT01833065|956882|P2|Overall Study|Subject's substantial non-compliance|1
284474|NCT01833065|956883|P1|Overall Study|Subject's substantial non-compliance|0
284475|NCT01833065|956879|P5|Overall Study|Withdrawal by Subject|11
284476|NCT01833065|956880|P4|Overall Study|Withdrawal by Subject|3
284477|NCT01833065|956881|P3|Overall Study|Withdrawal by Subject|4
284478|NCT01833065|956882|P2|Overall Study|Withdrawal by Subject|2
284479|NCT01833065|956883|P1|Overall Study|Withdrawal by Subject|6
284480|NCT01833065|956879|P5|Overall Study|Lost to Follow-up|3
284481|NCT01833065|956880|P4|Overall Study|Lost to Follow-up|0
284482|NCT01833065|956881|P3|Overall Study|Lost to Follow-up|0
284483|NCT01833065|956882|P2|Overall Study|Lost to Follow-up|0
284484|NCT01833065|956883|P1|Overall Study|Lost to Follow-up|1
284485|NCT01833065|956879|P5|Overall Study|Protocol Violation|2
284486|NCT01833065|956880|P4|Overall Study|Protocol Violation|0
284487|NCT01833065|956881|P3|Overall Study|Protocol Violation|0
284488|NCT01833065|956882|P2|Overall Study|Protocol Violation|0
284489|NCT01833065|956883|P1|Overall Study|Protocol Violation|1
284490|NCT01833065|956879|P5|Overall Study|Adverse Event|3
284491|NCT01833065|956880|P4|Overall Study|Adverse Event|2
284492|NCT01833065|956881|P3|Overall Study|Adverse Event|0
284493|NCT01833065|956882|P2|Overall Study|Adverse Event|1
284494|NCT01833065|956883|P1|Overall Study|Adverse Event|6
284495|NCT01832766|956914|P2|Washout|Lost to Follow-up|1
284496|NCT01832766|956915|P1|Washout|Lost to Follow-up|0
284497|NCT01832493|956981|P1|Overall Study|Unable to place LV lead|2
284498|NCT01832493|956981|P1|Overall Study|Protocol Violation|4
284499|NCT01832493|956981|P1|Overall Study|Physician Decision|2
284500|NCT01832155|956999|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
284501|NCT01832155|957000|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
284502|NCT01832155|956999|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
284503|NCT01832155|957000|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
284504|NCT01831817|957080|P4|Overall Study|Withdrawl of Consent|0
284505|NCT01831817|957081|P3|Overall Study|Withdrawl of Consent|0
284506|NCT01831817|957082|P2|Overall Study|Withdrawl of Consent|0
284507|NCT01831817|957083|P1|Overall Study|Withdrawl of Consent|3
284508|NCT01831817|957080|P4|Overall Study|Lost to Follow-up|0
284509|NCT01831817|957081|P3|Overall Study|Lost to Follow-up|0
284510|NCT01831817|957082|P2|Overall Study|Lost to Follow-up|0
284511|NCT01831817|957083|P1|Overall Study|Lost to Follow-up|1
284512|NCT01831791|957121|P1|Overall Study|Withdrawal by Subject|10
284513|NCT01831765|957150|P3|Overall Study|Lost to Follow-up|3
284514|NCT01831765|957151|P2|Overall Study|Lost to Follow-up|3
284515|NCT01831765|957152|P1|Overall Study|Lost to Follow-up|2
284516|NCT01831765|957150|P3|Overall Study|Withdrawal criteria|16
284517|NCT01831765|957151|P2|Overall Study|Withdrawal criteria|10
284518|NCT01831765|957152|P1|Overall Study|Withdrawal criteria|12
284519|NCT01831765|957150|P3|Overall Study|Withdrawal by Subject|17
284520|NCT01831765|957151|P2|Overall Study|Withdrawal by Subject|7
284521|NCT01831765|957152|P1|Overall Study|Withdrawal by Subject|22
284522|NCT01831765|957150|P3|Overall Study|Adverse Event|3
284523|NCT01831765|957151|P2|Overall Study|Adverse Event|3
284524|NCT01831765|957152|P1|Overall Study|Adverse Event|5
284525|NCT01831765|957150|P3|Overall Study|Other, site closed|0
284526|NCT01831765|957151|P2|Overall Study|Other, site closed|1
284527|NCT01831765|957152|P1|Overall Study|Other, site closed|1
284528|NCT01831765|957150|P3|Overall Study|Death|1
284529|NCT01831765|957151|P2|Overall Study|Death|1
284530|NCT01831765|957152|P1|Overall Study|Death|0
284531|NCT01831765|957150|P3|Overall Study|Pregnancy|2
284532|NCT01831765|957151|P2|Overall Study|Pregnancy|1
284533|NCT01831765|957152|P1|Overall Study|Pregnancy|1
284534|NCT01831765|957150|P3|Overall Study|Other, sponsor withdrew subject|0
284535|NCT01831765|957151|P2|Overall Study|Other, sponsor withdrew subject|1
284536|NCT01831765|957152|P1|Overall Study|Other, sponsor withdrew subject|0
284537|NCT01831765|957150|P3|Overall Study|Lack of Efficacy|0
284538|NCT01831765|957151|P2|Overall Study|Lack of Efficacy|0
284539|NCT01831765|957152|P1|Overall Study|Lack of Efficacy|1
284540|NCT01831726|957178|P1|Overall Study|Subject/guardian decision|7
284541|NCT01831726|957178|P1|Overall Study|Physician Decision|1
284542|NCT01831726|957178|P1|Overall Study|Disease Progression|49
284543|NCT01831726|957178|P1|Overall Study|Death|7
284544|NCT01831726|957178|P1|Overall Study|Adverse Event|16
284545|NCT01831466|957197|P12|Overall Study|Adverse Event|2
284546|NCT01831466|957198|P11|Overall Study|Adverse Event|0
284547|NCT01831466|957199|P10|Overall Study|Adverse Event|1
284548|NCT01831466|957200|P9|Overall Study|Adverse Event|1
284549|NCT01831466|957201|P8|Overall Study|Adverse Event|1
284550|NCT01831466|957202|P7|Overall Study|Adverse Event|0
284551|NCT01831466|957203|P6|Overall Study|Adverse Event|7
284552|NCT01831466|957204|P5|Overall Study|Adverse Event|3
284553|NCT01831466|957205|P4|Overall Study|Adverse Event|6
284554|NCT01831466|957206|P3|Overall Study|Adverse Event|4
284555|NCT01831466|957207|P2|Overall Study|Adverse Event|0
284556|NCT01831466|957208|P1|Overall Study|Adverse Event|0
284557|NCT01831466|957197|P12|Overall Study|Lack of Efficacy|0
284558|NCT01831466|957198|P11|Overall Study|Lack of Efficacy|2
284559|NCT01831466|957199|P10|Overall Study|Lack of Efficacy|2
284560|NCT01831466|957200|P9|Overall Study|Lack of Efficacy|2
284561|NCT01831466|957201|P8|Overall Study|Lack of Efficacy|1
284562|NCT01831466|957202|P7|Overall Study|Lack of Efficacy|1
284563|NCT01831466|957203|P6|Overall Study|Lack of Efficacy|8
284564|NCT01831466|957204|P5|Overall Study|Lack of Efficacy|9
284565|NCT01831466|957205|P4|Overall Study|Lack of Efficacy|6
284566|NCT01831466|957206|P3|Overall Study|Lack of Efficacy|7
284567|NCT01831466|957207|P2|Overall Study|Lack of Efficacy|8
284568|NCT01831466|957208|P1|Overall Study|Lack of Efficacy|5
284569|NCT01831466|957197|P12|Overall Study|Lost to Follow-up|1
284570|NCT01831466|957198|P11|Overall Study|Lost to Follow-up|0
284571|NCT01831466|957199|P10|Overall Study|Lost to Follow-up|1
284572|NCT01831466|957200|P9|Overall Study|Lost to Follow-up|0
284573|NCT01831466|957201|P8|Overall Study|Lost to Follow-up|0
284574|NCT01831466|957202|P7|Overall Study|Lost to Follow-up|0
284575|NCT01831466|957203|P6|Overall Study|Lost to Follow-up|3
284576|NCT01831466|957204|P5|Overall Study|Lost to Follow-up|0
284577|NCT01831466|957205|P4|Overall Study|Lost to Follow-up|2
284578|NCT01831466|957206|P3|Overall Study|Lost to Follow-up|4
284579|NCT01831466|957207|P2|Overall Study|Lost to Follow-up|1
284580|NCT01831466|957208|P1|Overall Study|Lost to Follow-up|0
284581|NCT01831466|957197|P12|Overall Study|Withdrawal by Subject|1
284582|NCT01831466|957198|P11|Overall Study|Withdrawal by Subject|0
284583|NCT01831466|957199|P10|Overall Study|Withdrawal by Subject|1
284584|NCT01831466|957200|P9|Overall Study|Withdrawal by Subject|0
284585|NCT01831466|957201|P8|Overall Study|Withdrawal by Subject|0
284586|NCT01831466|957202|P7|Overall Study|Withdrawal by Subject|0
284587|NCT01831466|957203|P6|Overall Study|Withdrawal by Subject|5
284588|NCT01831466|957204|P5|Overall Study|Withdrawal by Subject|3
284589|NCT01831466|957205|P4|Overall Study|Withdrawal by Subject|3
284590|NCT01831466|957206|P3|Overall Study|Withdrawal by Subject|3
284591|NCT01831466|957207|P2|Overall Study|Withdrawal by Subject|3
284592|NCT01831466|957208|P1|Overall Study|Withdrawal by Subject|6
284593|NCT01831466|957197|P12|Overall Study|Death|0
284594|NCT01831466|957198|P11|Overall Study|Death|0
284595|NCT01831466|957199|P10|Overall Study|Death|0
284596|NCT01831466|957200|P9|Overall Study|Death|0
284597|NCT01831466|957201|P8|Overall Study|Death|0
284598|NCT01831466|957202|P7|Overall Study|Death|0
284599|NCT01831466|957203|P6|Overall Study|Death|0
284600|NCT01831466|957204|P5|Overall Study|Death|0
284601|NCT01831466|957205|P4|Overall Study|Death|0
284602|NCT01831466|957206|P3|Overall Study|Death|0
284603|NCT01831466|957207|P2|Overall Study|Death|1
284604|NCT01831466|957208|P1|Overall Study|Death|0
284605|NCT01831466|957197|P12|Overall Study|Non-compliance with study treatment|0
284606|NCT01831466|957198|P11|Overall Study|Non-compliance with study treatment|0
284607|NCT01831466|957199|P10|Overall Study|Non-compliance with study treatment|0
284608|NCT01831466|957200|P9|Overall Study|Non-compliance with study treatment|0
284609|NCT01831466|957201|P8|Overall Study|Non-compliance with study treatment|0
284610|NCT01831466|957202|P7|Overall Study|Non-compliance with study treatment|0
284611|NCT01831466|957203|P6|Overall Study|Non-compliance with study treatment|1
284612|NCT01831466|957204|P5|Overall Study|Non-compliance with study treatment|0
284613|NCT01831466|957205|P4|Overall Study|Non-compliance with study treatment|0
284614|NCT01831466|957206|P3|Overall Study|Non-compliance with study treatment|1
284615|NCT01831466|957207|P2|Overall Study|Non-compliance with study treatment|1
284616|NCT01831466|957208|P1|Overall Study|Non-compliance with study treatment|2
284617|NCT01831466|957197|P12|Overall Study|Not specified|0
284618|NCT01831466|957198|P11|Overall Study|Not specified|0
284619|NCT01831466|957199|P10|Overall Study|Not specified|0
284620|NCT01831466|957200|P9|Overall Study|Not specified|0
284621|NCT01831466|957201|P8|Overall Study|Not specified|0
284622|NCT01831466|957202|P7|Overall Study|Not specified|0
284623|NCT01831466|957203|P6|Overall Study|Not specified|1
284624|NCT01831466|957204|P5|Overall Study|Not specified|2
284625|NCT01831466|957205|P4|Overall Study|Not specified|2
284626|NCT01831466|957206|P3|Overall Study|Not specified|2
284627|NCT01831466|957207|P2|Overall Study|Not specified|3
284628|NCT01831466|957208|P1|Overall Study|Not specified|2
284629|NCT01831466|957197|P12|Overall Study|Protocol Violation|0
284630|NCT01831466|957198|P11|Overall Study|Protocol Violation|0
284631|NCT01831466|957199|P10|Overall Study|Protocol Violation|0
284632|NCT01831466|957200|P9|Overall Study|Protocol Violation|0
284633|NCT01831466|957201|P8|Overall Study|Protocol Violation|0
284634|NCT01831466|957202|P7|Overall Study|Protocol Violation|0
284635|NCT01831466|957203|P6|Overall Study|Protocol Violation|1
284636|NCT01831466|957204|P5|Overall Study|Protocol Violation|0
284637|NCT01831466|957205|P4|Overall Study|Protocol Violation|0
284638|NCT01831466|957206|P3|Overall Study|Protocol Violation|2
284639|NCT01831466|957207|P2|Overall Study|Protocol Violation|1
284640|NCT01831466|957208|P1|Overall Study|Protocol Violation|1
284641|NCT01831258|957330|P2|Overall Study|Lost to Follow-up|2
284642|NCT01831258|957331|P1|Overall Study|Lost to Follow-up|3
284643|NCT01831258|957330|P2|Overall Study|Withdrawal by Subject|1
284644|NCT01831258|957331|P1|Overall Study|Withdrawal by Subject|2
284645|NCT01830972|957417|P2|Part IV|Non-Compliance|0
284646|NCT01830972|957418|P1|Part IV|Non-Compliance|1
284647|NCT01830972|957417|P2|Part IV|Withdrawal by Subject|1
284648|NCT01830972|957418|P1|Part IV|Withdrawal by Subject|2
284649|NCT01830972|957417|P2|Part III|Noncompliance|0
284650|NCT01830972|957418|P1|Part III|Noncompliance|1
284651|NCT01830972|957417|P2|Part III|Withdrawal by Subject|0
284652|NCT01830972|957418|P1|Part III|Withdrawal by Subject|1
284653|NCT01830972|957417|P2|Part II|Withdrawal by Subject|2
284654|NCT01830972|957418|P1|Part II|Withdrawal by Subject|2
284655|NCT01830920|957462|P5|Overall Study|Not specified|3
284656|NCT01830920|957463|P4|Overall Study|Not specified|5
284657|NCT01830920|957464|P3|Overall Study|Not specified|1
284658|NCT01830920|957465|P2|Overall Study|Not specified|1
284659|NCT01830920|957466|P1|Overall Study|Not specified|15
284660|NCT01830920|957462|P5|Overall Study|Death|4
284661|NCT01830920|957463|P4|Overall Study|Death|4
284662|NCT01830920|957464|P3|Overall Study|Death|5
284663|NCT01830920|957465|P2|Overall Study|Death|3
284664|NCT01830920|957466|P1|Overall Study|Death|3
284665|NCT01830920|957462|P5|Overall Study|Withdrawal by Subject|1
284666|NCT01830920|957463|P4|Overall Study|Withdrawal by Subject|7
284667|NCT01830920|957464|P3|Overall Study|Withdrawal by Subject|1
284668|NCT01830920|957465|P2|Overall Study|Withdrawal by Subject|2
284669|NCT01830920|957466|P1|Overall Study|Withdrawal by Subject|2
284670|NCT01830920|957462|P5|Overall Study|Adverse Event|0
284671|NCT01830920|957463|P4|Overall Study|Adverse Event|0
284672|NCT01830920|957464|P3|Overall Study|Adverse Event|1
284673|NCT01830920|957465|P2|Overall Study|Adverse Event|0
284674|NCT01830920|957466|P1|Overall Study|Adverse Event|1
284675|NCT01830881|957505|P2|Overall Study|Changed decision to have an abortion|1
284676|NCT01830881|957506|P1|Overall Study|Changed decision to have an abortion|0
284677|NCT01830855|957554|P4|Overall Study|Lost to Follow-up|33
284678|NCT01830855|957555|P3|Overall Study|Lost to Follow-up|23
284679|NCT01830855|957556|P2|Overall Study|Lost to Follow-up|20
284680|NCT01830855|957557|P1|Overall Study|Lost to Follow-up|47
284681|NCT01830855|957554|P4|Overall Study|No longer willing to participate|17
284682|NCT01830855|957555|P3|Overall Study|No longer willing to participate|12
284683|NCT01830855|957556|P2|Overall Study|No longer willing to participate|13
284684|NCT01830855|957557|P1|Overall Study|No longer willing to participate|32
284685|NCT01830855|957554|P4|Overall Study|Withdrawal by Subject|12
284686|NCT01830855|957555|P3|Overall Study|Withdrawal by Subject|10
284687|NCT01830855|957556|P2|Overall Study|Withdrawal by Subject|14
284688|NCT01830855|957557|P1|Overall Study|Withdrawal by Subject|33
284689|NCT01830855|957554|P4|Overall Study|Protocol deviation|6
284690|NCT01830855|957555|P3|Overall Study|Protocol deviation|6
284691|NCT01830855|957556|P2|Overall Study|Protocol deviation|5
284692|NCT01830855|957557|P1|Overall Study|Protocol deviation|10
284693|NCT01830855|957554|P4|Overall Study|Adverse Event|3
284694|NCT01830855|957555|P3|Overall Study|Adverse Event|6
284695|NCT01830855|957556|P2|Overall Study|Adverse Event|5
284696|NCT01830855|957557|P1|Overall Study|Adverse Event|11
284697|NCT01830855|957554|P4|Overall Study|No longer meets eligibility criteria|5
284698|NCT01830855|957555|P3|Overall Study|No longer meets eligibility criteria|3
284699|NCT01830855|957556|P2|Overall Study|No longer meets eligibility criteria|2
284700|NCT01830855|957557|P1|Overall Study|No longer meets eligibility criteria|11
284701|NCT01830855|957554|P4|Overall Study|Pregnancy|1
284702|NCT01830855|957555|P3|Overall Study|Pregnancy|2
284703|NCT01830855|957556|P2|Overall Study|Pregnancy|1
284704|NCT01830855|957557|P1|Overall Study|Pregnancy|3
284705|NCT01830855|957554|P4|Overall Study|Medication error without associated AE|1
284706|NCT01830855|957555|P3|Overall Study|Medication error without associated AE|0
284707|NCT01830855|957556|P2|Overall Study|Medication error without associated AE|0
284708|NCT01830855|957557|P1|Overall Study|Medication error without associated AE|1
284709|NCT01830855|957554|P4|Overall Study|Other|4
284710|NCT01830855|957555|P3|Overall Study|Other|4
284711|NCT01830855|957556|P2|Overall Study|Other|1
284712|NCT01830855|957557|P1|Overall Study|Other|7
284713|NCT01830543|957697|P3|Overall Study|Other|37
284714|NCT01830543|957698|P2|Overall Study|Other|17
284715|NCT01830543|957699|P1|Overall Study|Other|12
284716|NCT01830543|957697|P3|Overall Study|Withdrawal by consent|3
284717|NCT01830543|957698|P2|Overall Study|Withdrawal by consent|3
284718|NCT01830543|957699|P1|Overall Study|Withdrawal by consent|3
284719|NCT01830543|957697|P3|Overall Study|Physician Decision|12
284720|NCT01830543|957698|P2|Overall Study|Physician Decision|5
284721|NCT01830543|957699|P1|Overall Study|Physician Decision|11
284722|NCT01830543|957697|P3|Overall Study|Protocol Violation|7
284723|NCT01830543|957698|P2|Overall Study|Protocol Violation|7
284724|NCT01830543|957699|P1|Overall Study|Protocol Violation|3
284725|NCT01830543|957697|P3|Overall Study|Death|22
284726|NCT01830543|957698|P2|Overall Study|Death|22
284727|NCT01830543|957699|P1|Overall Study|Death|20
284728|NCT01830543|957697|P3|Overall Study|Adverse Event|76
284729|NCT01830543|957698|P2|Overall Study|Adverse Event|77
284730|NCT01830543|957699|P1|Overall Study|Adverse Event|91
284731|NCT01830543|957697|P3|Overall Study|Subject Decision|57
284732|NCT01830543|957698|P2|Overall Study|Subject Decision|21
284733|NCT01830543|957699|P1|Overall Study|Subject Decision|19
284734|NCT01830127|957831|P2|Overall Study|Other reason not defined above|2
284735|NCT01830127|957832|P1|Overall Study|Other reason not defined above|0
284736|NCT01830127|957831|P2|Overall Study|Withdrawal by Subject|1
284737|NCT01830127|957832|P1|Overall Study|Withdrawal by Subject|1
284738|NCT01830127|957831|P2|Overall Study|Lack of Efficacy|0
284739|NCT01830127|957832|P1|Overall Study|Lack of Efficacy|3
284740|NCT01830127|957831|P2|Overall Study|Adverse Event|6
284741|NCT01830127|957832|P1|Overall Study|Adverse Event|1
284742|NCT01829477|957881|P2|Overall Study|Withdrawal by Subject|0
284743|NCT01829477|957882|P1|Overall Study|Withdrawal by Subject|1
284744|NCT01829477|957881|P2|Overall Study|Study Terminated by Sponsor|15
284745|NCT01829477|957882|P1|Overall Study|Study Terminated by Sponsor|15
284746|NCT01829464|957895|P3|Overall Study|Lack of Efficacy|0
284747|NCT01829464|957896|P2|Overall Study|Lack of Efficacy|1
284748|NCT01829464|957897|P1|Overall Study|Lack of Efficacy|0
284749|NCT01829464|957895|P3|Overall Study|Study terminated by sponsor|25
284750|NCT01829464|957896|P2|Overall Study|Study terminated by sponsor|28
284751|NCT01829464|957897|P1|Overall Study|Study terminated by sponsor|25
284752|NCT01829464|957895|P3|Overall Study|Withdrawal by Subject|0
284753|NCT01829464|957896|P2|Overall Study|Withdrawal by Subject|0
284754|NCT01829464|957897|P1|Overall Study|Withdrawal by Subject|2
284755|NCT01829464|957895|P3|Overall Study|Lost to Follow-up|1
284756|NCT01829464|957896|P2|Overall Study|Lost to Follow-up|0
284757|NCT01829464|957897|P1|Overall Study|Lost to Follow-up|0
284758|NCT01829464|957895|P3|Overall Study|Adverse Event|0
284759|NCT01829464|957896|P2|Overall Study|Adverse Event|0
284760|NCT01829464|957897|P1|Overall Study|Adverse Event|1
284761|NCT01829243|957922|P2|First Intervention|Screen Failure|2
284762|NCT01829243|957923|P1|First Intervention|Screen Failure|4
284763|NCT01829230|957937|P2|Overall Study|Lost to Follow-up|1
284764|NCT01829230|957938|P1|Overall Study|Lost to Follow-up|1
284765|NCT01829230|957937|P2|Overall Study|Withdrawal by Subject|1
284766|NCT01829230|957938|P1|Overall Study|Withdrawal by Subject|0
284767|NCT01829230|957937|P2|Overall Study|Protocol Violation|2
284768|NCT01829230|957938|P1|Overall Study|Protocol Violation|0
284769|NCT01829191|957948|P2|Overall Study|Subject was fit for ortho - k|1
284770|NCT01829191|957949|P1|Overall Study|Subject was fit for ortho - k|0
284771|NCT01829191|957948|P2|Overall Study|Lost to Follow-up|1
284772|NCT01829191|957949|P1|Overall Study|Lost to Follow-up|0
284773|NCT01829191|957948|P2|Overall Study|Withdrawal by Subject|3
284774|NCT01829191|957949|P1|Overall Study|Withdrawal by Subject|2
284775|NCT01829191|957948|P2|Overall Study|Protocol Violation|1
284776|NCT01829191|957949|P1|Overall Study|Protocol Violation|4
284777|NCT01829191|957948|P2|Overall Study|Lens handling difficulty|4
284778|NCT01829191|957949|P1|Overall Study|Lens handling difficulty|1
284779|NCT01829191|957948|P2|Overall Study|Lens discomfort|3
284780|NCT01829191|957949|P1|Overall Study|Lens discomfort|0
284781|NCT01829191|957948|P2|Overall Study|Relocation|1
284782|NCT01829191|957949|P1|Overall Study|Relocation|0
284783|NCT01829165|957958|P2|Overall Study|Did not complete intervention|0
284784|NCT01829165|957959|P1|Overall Study|Did not complete intervention|2
284785|NCT01829113|957967|P2|Overall Study|Physician Decision|1
284786|NCT01829113|957968|P1|Overall Study|Physician Decision|1
284787|NCT01829113|957967|P2|Overall Study|No Study Treatment Received|2
284788|NCT01829113|957968|P1|Overall Study|No Study Treatment Received|3
284789|NCT01829113|957967|P2|Overall Study|Sponsor Decision|1
284790|NCT01829113|957968|P1|Overall Study|Sponsor Decision|1
284791|NCT01829113|957967|P2|Overall Study|Death|6
284792|NCT01829113|957968|P1|Overall Study|Death|4
284793|NCT01829113|957967|P2|Overall Study|Withdrawal by Subject|10
284794|NCT01829113|957968|P1|Overall Study|Withdrawal by Subject|17
284795|NCT01829113|957967|P2|Overall Study|Adverse Event|10
284796|NCT01829113|957968|P1|Overall Study|Adverse Event|14
284797|NCT01829113|957967|P2|Overall Study|Disease Progression|48
284798|NCT01829113|957968|P1|Overall Study|Disease Progression|37
284799|NCT01828281|958044|P2|Overall Study|Withdrawal by Subject|0
284800|NCT01828281|958045|P1|Overall Study|Withdrawal by Subject|1
284801|NCT01828112|958078|P2|Overall Study|Subject/guardian decision|8
284802|NCT01828112|958079|P1|Overall Study|Subject/guardian decision|6
284803|NCT01828112|958078|P2|Overall Study|Progressive disease|82
284804|NCT01828112|958079|P1|Overall Study|Progressive disease|56
284805|NCT01828112|958078|P2|Overall Study|Physician Decision|5
284806|NCT01828112|958079|P1|Overall Study|Physician Decision|5
284807|NCT01828112|958078|P2|Overall Study|Death|5
284808|NCT01828112|958079|P1|Overall Study|Death|9
284809|NCT01828112|958078|P2|Overall Study|Adverse Event|8
284810|NCT01828112|958079|P1|Overall Study|Adverse Event|6
284811|NCT01828099|958087|P2|Overall Study|Subject/guardian decision|23
284812|NCT01828099|958088|P1|Overall Study|Subject/guardian decision|7
284813|NCT01828099|958087|P2|Overall Study|Protocol Violation|0
284814|NCT01828099|958088|P1|Overall Study|Protocol Violation|1
284815|NCT01828099|958087|P2|Overall Study|Progressive disease|94
284816|NCT01828099|958088|P1|Overall Study|Progressive disease|51
284817|NCT01828099|958087|P2|Overall Study|Physician Decision|11
284818|NCT01828099|958088|P1|Overall Study|Physician Decision|7
284819|NCT01828099|958087|P2|Overall Study|Non-compliance with study treatment|0
284820|NCT01828099|958088|P1|Overall Study|Non-compliance with study treatment|2
284821|NCT01828099|958087|P2|Overall Study|Lost to Follow-up|0
284822|NCT01828099|958088|P1|Overall Study|Lost to Follow-up|2
284823|NCT01828099|958087|P2|Overall Study|Death|11
284824|NCT01828099|958088|P1|Overall Study|Death|9
284825|NCT01828099|958087|P2|Overall Study|Adverse Event|18
284826|NCT01828099|958088|P1|Overall Study|Adverse Event|15
284827|NCT01827839|958094|P1|Overall Study|Consent Withdrawal|2
284828|NCT01827839|958094|P1|Overall Study|Adverse Event|1
284829|NCT01827670|958118|P2|Overall Study|Lost to Follow-up|1
284830|NCT01827670|958119|P1|Overall Study|Lost to Follow-up|0
284831|NCT01827670|958118|P2|Overall Study|Withdrawal of Consent|2
284832|NCT01827670|958119|P1|Overall Study|Withdrawal of Consent|3
284833|NCT01827592|958138|P3|Overall Study|Others|3
284834|NCT01827592|958139|P2|Overall Study|Others|1
284835|NCT01827592|958140|P1|Overall Study|Others|0
284836|NCT01827592|958138|P3|Overall Study|Trial terminated by Sponsor|51
284837|NCT01827592|958139|P2|Overall Study|Trial terminated by Sponsor|53
284838|NCT01827592|958140|P1|Overall Study|Trial terminated by Sponsor|47
284839|NCT01827592|958138|P3|Overall Study|Patient's substantial non-compliance|6
284840|NCT01827592|958139|P2|Overall Study|Patient's substantial non-compliance|1
284841|NCT01827592|958140|P1|Overall Study|Patient's substantial non-compliance|1
284842|NCT01827592|958138|P3|Overall Study|Withdrawal by Subject|11
284843|NCT01827592|958139|P2|Overall Study|Withdrawal by Subject|11
284844|NCT01827592|958140|P1|Overall Study|Withdrawal by Subject|12
284845|NCT01827592|958138|P3|Overall Study|Lost to Follow-up|2
284846|NCT01827592|958139|P2|Overall Study|Lost to Follow-up|2
284847|NCT01827592|958140|P1|Overall Study|Lost to Follow-up|1
284848|NCT01827592|958138|P3|Overall Study|Protocol Violation|0
284849|NCT01827592|958139|P2|Overall Study|Protocol Violation|1
284850|NCT01827592|958140|P1|Overall Study|Protocol Violation|2
284851|NCT01827592|958138|P3|Overall Study|Physician Decision|1
284852|NCT01827592|958139|P2|Overall Study|Physician Decision|2
284853|NCT01827592|958140|P1|Overall Study|Physician Decision|0
284854|NCT01827592|958138|P3|Overall Study|Adverse Event|2
284855|NCT01827592|958139|P2|Overall Study|Adverse Event|9
284856|NCT01827592|958140|P1|Overall Study|Adverse Event|11
284857|NCT01827371|958205|P4|Overall Study|Temporary study halt to vaccinations|13
284858|NCT01827371|958206|P3|Overall Study|Temporary study halt to vaccinations|5
284859|NCT01827371|958207|P2|Overall Study|Temporary study halt to vaccinations|2
284860|NCT01827371|958208|P1|Overall Study|Temporary study halt to vaccinations|11
284861|NCT01827371|958205|P4|Overall Study|Physician Decision|1
284862|NCT01827371|958206|P3|Overall Study|Physician Decision|0
284863|NCT01827371|958207|P2|Overall Study|Physician Decision|1
284864|NCT01827371|958208|P1|Overall Study|Physician Decision|0
284865|NCT01827371|958205|P4|Overall Study|Withdrawal by Subject|3
284866|NCT01827371|958206|P3|Overall Study|Withdrawal by Subject|2
284867|NCT01827371|958207|P2|Overall Study|Withdrawal by Subject|2
284868|NCT01827371|958208|P1|Overall Study|Withdrawal by Subject|1
284869|NCT01827371|958205|P4|Overall Study|Protocol Violation|0
284870|NCT01827371|958206|P3|Overall Study|Protocol Violation|0
284871|NCT01827371|958207|P2|Overall Study|Protocol Violation|0
284872|NCT01827371|958208|P1|Overall Study|Protocol Violation|1
284873|NCT01827371|958205|P4|Overall Study|Lost to Follow-up|4
284874|NCT01827371|958206|P3|Overall Study|Lost to Follow-up|0
284875|NCT01827371|958207|P2|Overall Study|Lost to Follow-up|2
284876|NCT01827371|958208|P1|Overall Study|Lost to Follow-up|0
284877|NCT01827371|958205|P4|Overall Study|Adverse Event|2
284878|NCT01827371|958206|P3|Overall Study|Adverse Event|4
284879|NCT01827371|958207|P2|Overall Study|Adverse Event|0
284880|NCT01827371|958208|P1|Overall Study|Adverse Event|0
284881|NCT01827332|958267|P2|Overall Study|Lost to Follow-up|1
284882|NCT01827332|958268|P1|Overall Study|Lost to Follow-up|2
284883|NCT01827319|958276|P1|Overall Study|Lost to Follow-up|3
284884|NCT01827267|958299|P2|Overall Study|Still on study|2
284885|NCT01827267|958300|P1|Overall Study|Still on study|0
284886|NCT01827267|958299|P2|Overall Study|Sponsor Discontinued Study|8
284887|NCT01827267|958300|P1|Overall Study|Sponsor Discontinued Study|2
284888|NCT01827267|958299|P2|Overall Study|Disease Progression|1
284889|NCT01827267|958300|P1|Overall Study|Disease Progression|1
284890|NCT01827267|958299|P2|Overall Study|Physician Decision|0
284891|NCT01827267|958300|P1|Overall Study|Physician Decision|1
284892|NCT01827267|958299|P2|Overall Study|Did not receive study drug|1
284893|NCT01827267|958300|P1|Overall Study|Did not receive study drug|1
284894|NCT01827254|958315|P1|Overall Study|Intolerance to treatment|4
284895|NCT01827254|958315|P1|Overall Study|Disease progression|36
284896|NCT01827254|958315|P1|Overall Study|Did not complete re-challenge|1
284897|NCT01827254|958315|P1|Overall Study|Discontinued prior initiation: sunitinib|1
284898|NCT01827254|958315|P1|Overall Study|Invalidated centre|3
284899|NCT01827254|958315|P1|Overall Study|Case report form not completed|4
284900|NCT01827254|958315|P1|Overall Study|Death|10
284901|NCT01826981|958340|P15|Overall Study|Enrolled/Randomized but Not Treated|0
284902|NCT01826981|958341|P14|Overall Study|Enrolled/Randomized but Not Treated|0
284903|NCT01826981|958342|P13|Overall Study|Enrolled/Randomized but Not Treated|0
284904|NCT01826981|958343|P12|Overall Study|Enrolled/Randomized but Not Treated|0
284905|NCT01826981|958344|P11|Overall Study|Enrolled/Randomized but Not Treated|0
284906|NCT01826981|958345|P10|Overall Study|Enrolled/Randomized but Not Treated|0
284907|NCT01826981|958346|P9|Overall Study|Enrolled/Randomized but Not Treated|0
284908|NCT01826981|958347|P8|Overall Study|Enrolled/Randomized but Not Treated|1
284909|NCT01826981|958348|P7|Overall Study|Enrolled/Randomized but Not Treated|0
284910|NCT01826981|958349|P6|Overall Study|Enrolled/Randomized but Not Treated|0
284911|NCT01826981|958350|P5|Overall Study|Enrolled/Randomized but Not Treated|0
284912|NCT01826981|958351|P4|Overall Study|Enrolled/Randomized but Not Treated|0
284913|NCT01826981|958352|P3|Overall Study|Enrolled/Randomized but Not Treated|0
284914|NCT01826981|958353|P2|Overall Study|Enrolled/Randomized but Not Treated|0
284915|NCT01826981|958354|P1|Overall Study|Enrolled/Randomized but Not Treated|0
284916|NCT01826981|958340|P15|Overall Study|Upper G-I Haemorrhage|0
284917|NCT01826981|958341|P14|Overall Study|Upper G-I Haemorrhage|1
284918|NCT01826981|958342|P13|Overall Study|Upper G-I Haemorrhage|0
284919|NCT01826981|958343|P12|Overall Study|Upper G-I Haemorrhage|0
284920|NCT01826981|958344|P11|Overall Study|Upper G-I Haemorrhage|0
284921|NCT01826981|958345|P10|Overall Study|Upper G-I Haemorrhage|0
284922|NCT01826981|958346|P9|Overall Study|Upper G-I Haemorrhage|0
284923|NCT01826981|958347|P8|Overall Study|Upper G-I Haemorrhage|0
284924|NCT01826981|958348|P7|Overall Study|Upper G-I Haemorrhage|0
284925|NCT01826981|958349|P6|Overall Study|Upper G-I Haemorrhage|0
284926|NCT01826981|958350|P5|Overall Study|Upper G-I Haemorrhage|0
284927|NCT01826981|958351|P4|Overall Study|Upper G-I Haemorrhage|0
284928|NCT01826981|958352|P3|Overall Study|Upper G-I Haemorrhage|0
284929|NCT01826981|958353|P2|Overall Study|Upper G-I Haemorrhage|0
284930|NCT01826981|958354|P1|Overall Study|Upper G-I Haemorrhage|0
284931|NCT01826981|958340|P15|Overall Study|Adverse Event|0
284932|NCT01826981|958341|P14|Overall Study|Adverse Event|0
284933|NCT01826981|958342|P13|Overall Study|Adverse Event|0
284934|NCT01826981|958343|P12|Overall Study|Adverse Event|0
284935|NCT01826981|958344|P11|Overall Study|Adverse Event|0
284936|NCT01826981|958345|P10|Overall Study|Adverse Event|0
284937|NCT01826981|958346|P9|Overall Study|Adverse Event|0
284938|NCT01826981|958347|P8|Overall Study|Adverse Event|0
284939|NCT01826981|958348|P7|Overall Study|Adverse Event|0
284940|NCT01826981|958349|P6|Overall Study|Adverse Event|0
284941|NCT01826981|958350|P5|Overall Study|Adverse Event|1
284942|NCT01826981|958351|P4|Overall Study|Adverse Event|0
284943|NCT01826981|958352|P3|Overall Study|Adverse Event|0
284944|NCT01826981|958353|P2|Overall Study|Adverse Event|0
284945|NCT01826981|958354|P1|Overall Study|Adverse Event|0
284946|NCT01826981|958340|P15|Overall Study|Withdrew Consent|0
284947|NCT01826981|958341|P14|Overall Study|Withdrew Consent|1
284948|NCT01826981|958342|P13|Overall Study|Withdrew Consent|0
284949|NCT01826981|958343|P12|Overall Study|Withdrew Consent|1
284950|NCT01826981|958344|P11|Overall Study|Withdrew Consent|0
284951|NCT01826981|958345|P10|Overall Study|Withdrew Consent|0
284952|NCT01826981|958346|P9|Overall Study|Withdrew Consent|0
284953|NCT01826981|958347|P8|Overall Study|Withdrew Consent|1
284954|NCT01826981|958348|P7|Overall Study|Withdrew Consent|1
284955|NCT01826981|958349|P6|Overall Study|Withdrew Consent|0
284956|NCT01826981|958350|P5|Overall Study|Withdrew Consent|0
284957|NCT01826981|958351|P4|Overall Study|Withdrew Consent|0
284958|NCT01826981|958352|P3|Overall Study|Withdrew Consent|0
284959|NCT01826981|958353|P2|Overall Study|Withdrew Consent|0
284960|NCT01826981|958354|P1|Overall Study|Withdrew Consent|0
284961|NCT01826981|958340|P15|Overall Study|Lost to Follow-up|0
284962|NCT01826981|958341|P14|Overall Study|Lost to Follow-up|0
284963|NCT01826981|958342|P13|Overall Study|Lost to Follow-up|1
284964|NCT01826981|958343|P12|Overall Study|Lost to Follow-up|1
284965|NCT01826981|958344|P11|Overall Study|Lost to Follow-up|1
284966|NCT01826981|958345|P10|Overall Study|Lost to Follow-up|1
284967|NCT01826981|958346|P9|Overall Study|Lost to Follow-up|0
284968|NCT01826981|958347|P8|Overall Study|Lost to Follow-up|1
284969|NCT01826981|958348|P7|Overall Study|Lost to Follow-up|0
284970|NCT01826981|958349|P6|Overall Study|Lost to Follow-up|1
284971|NCT01826981|958350|P5|Overall Study|Lost to Follow-up|1
284972|NCT01826981|958351|P4|Overall Study|Lost to Follow-up|0
284973|NCT01826981|958352|P3|Overall Study|Lost to Follow-up|0
284974|NCT01826981|958353|P2|Overall Study|Lost to Follow-up|0
284975|NCT01826981|958354|P1|Overall Study|Lost to Follow-up|0
284976|NCT01826981|958340|P15|Overall Study|Lack of Efficacy|0
284977|NCT01826981|958341|P14|Overall Study|Lack of Efficacy|3
284978|NCT01826981|958342|P13|Overall Study|Lack of Efficacy|0
284979|NCT01826981|958343|P12|Overall Study|Lack of Efficacy|0
284980|NCT01826981|958344|P11|Overall Study|Lack of Efficacy|1
284981|NCT01826981|958345|P10|Overall Study|Lack of Efficacy|0
284982|NCT01826981|958346|P9|Overall Study|Lack of Efficacy|7
284983|NCT01826981|958347|P8|Overall Study|Lack of Efficacy|8
284984|NCT01826981|958348|P7|Overall Study|Lack of Efficacy|0
284985|NCT01826981|958349|P6|Overall Study|Lack of Efficacy|0
284986|NCT01826981|958350|P5|Overall Study|Lack of Efficacy|5
284987|NCT01826981|958351|P4|Overall Study|Lack of Efficacy|0
284988|NCT01826981|958352|P3|Overall Study|Lack of Efficacy|0
284989|NCT01826981|958353|P2|Overall Study|Lack of Efficacy|1
284990|NCT01826981|958354|P1|Overall Study|Lack of Efficacy|0
284991|NCT01826604|958519|P2|Overall Study|Lost to Follow-up|9
284992|NCT01826604|958520|P1|Overall Study|Lost to Follow-up|8
284993|NCT01826422|958564|P2|Overall Study|Withdrawal by Subject|3
284994|NCT01826422|958565|P1|Overall Study|Withdrawal by Subject|1
284995|NCT01826370|958609|P1|Overall Study|Other reason not defined above|2
284996|NCT01826370|958609|P1|Overall Study|Lost to Follow-up|12
284997|NCT01826370|958609|P1|Overall Study|Protocol Violation|6
284998|NCT01826214|958621|P2|Overall Study|Subject/guardian decision|3
284999|NCT01826214|958622|P1|Overall Study|Subject/guardian decision|2
285000|NCT01826214|958621|P2|Overall Study|Study terminated by Sponsor|1
285001|NCT01826214|958622|P1|Overall Study|Study terminated by Sponsor|0
285002|NCT01826214|958621|P2|Overall Study|Progressive disease|21
285003|NCT01826214|958622|P1|Overall Study|Progressive disease|22
285004|NCT01826214|958621|P2|Overall Study|Physician Decision|2
285005|NCT01826214|958622|P1|Overall Study|Physician Decision|0
285006|NCT01826214|958621|P2|Overall Study|Lost to Follow-up|0
285007|NCT01826214|958622|P1|Overall Study|Lost to Follow-up|1
285008|NCT01826214|958621|P2|Overall Study|Death|1
285009|NCT01826214|958622|P1|Overall Study|Death|3
285010|NCT01826214|958621|P2|Overall Study|Adverse Event|6
285011|NCT01826214|958622|P1|Overall Study|Adverse Event|7
285012|NCT01826201|958640|P1|Overall Study|Non compliance with protocol|4
285013|NCT01825941|958648|P2|Overall Study|Lost to Follow-up|1
285014|NCT01825941|958649|P1|Overall Study|Lost to Follow-up|4
285015|NCT01825837|958659|P4|PART II|reason unspecified|0
285016|NCT01825837|958660|P3|PART II|reason unspecified|2
285017|NCT01825837|958661|P2|PART II|reason unspecified|2
285018|NCT01825837|958662|P1|PART II|reason unspecified|2
285019|NCT01825837|958659|P4|PART II|Treatment failure|0
285020|NCT01825837|958660|P3|PART II|Treatment failure|5
285021|NCT01825837|958661|P2|PART II|Treatment failure|4
285022|NCT01825837|958662|P1|PART II|Treatment failure|6
285023|NCT01825837|958659|P4|PART II|Adverse Event|0
285024|NCT01825837|958660|P3|PART II|Adverse Event|1
285025|NCT01825837|958661|P2|PART II|Adverse Event|3
285026|NCT01825837|958662|P1|PART II|Adverse Event|3
285027|NCT01825837|958659|P4|PART II|Patient non-compliance|0
285028|NCT01825837|958660|P3|PART II|Patient non-compliance|4
285029|NCT01825837|958661|P2|PART II|Patient non-compliance|2
285030|NCT01825837|958662|P1|PART II|Patient non-compliance|5
285031|NCT01825837|958659|P4|PART II|Withdrawal by Subject|0
285032|NCT01825837|958660|P3|PART II|Withdrawal by Subject|7
285033|NCT01825837|958661|P2|PART II|Withdrawal by Subject|3
285034|NCT01825837|958662|P1|PART II|Withdrawal by Subject|3
285035|NCT01825837|958659|P4|PART I|reason unspecified|3
285036|NCT01825837|958660|P3|PART I|reason unspecified|0
285037|NCT01825837|958661|P2|PART I|reason unspecified|0
285038|NCT01825837|958662|P1|PART I|reason unspecified|0
285039|NCT01825837|958659|P4|PART I|Treatment failure|7
285040|NCT01825837|958660|P3|PART I|Treatment failure|0
285041|NCT01825837|958661|P2|PART I|Treatment failure|0
285042|NCT01825837|958662|P1|PART I|Treatment failure|0
285043|NCT01825837|958659|P4|PART I|Patient non-compliance|1
285044|NCT01825837|958660|P3|PART I|Patient non-compliance|0
285045|NCT01825837|958661|P2|PART I|Patient non-compliance|0
285046|NCT01825837|958662|P1|PART I|Patient non-compliance|0
285047|NCT01825837|958659|P4|PART I|Withdrawal by Subject|6
285048|NCT01825837|958660|P3|PART I|Withdrawal by Subject|0
285049|NCT01825837|958661|P2|PART I|Withdrawal by Subject|0
285050|NCT01825837|958662|P1|PART I|Withdrawal by Subject|0
285051|NCT01825798|958672|P2|Overall Study|Lost to Follow-up|0
285052|NCT01825798|958673|P1|Overall Study|Lost to Follow-up|1
285053|NCT01825798|958672|P2|Overall Study|Adverse Event|5
285054|NCT01825798|958673|P1|Overall Study|Adverse Event|1
285055|NCT01825577|958701|P1|Overall Study|Lack of Efficacy|3
285056|NCT01825577|958701|P1|Overall Study|Withdrawn by family members|2
285057|NCT01825577|958701|P1|Overall Study|Withdrawal by Subject|1
285058|NCT01825577|958701|P1|Overall Study|Physician Decision|2
285059|NCT01825200|958725|P2|Overall Study|Withdrawal by Subject|1
285060|NCT01825200|958726|P1|Overall Study|Withdrawal by Subject|0
285061|NCT01825200|958725|P2|Overall Study|Lost to Follow-up|6
285062|NCT01825200|958726|P1|Overall Study|Lost to Follow-up|5
285063|NCT01824979|958749|P2|Overall Study|Protocol Violation|13
285064|NCT01824979|958750|P1|Overall Study|Protocol Violation|6
285065|NCT01824979|958749|P2|Overall Study|Physician Decision|0
285066|NCT01824979|958750|P1|Overall Study|Physician Decision|2
285067|NCT01824979|958749|P2|Overall Study|Withdrawal by Subject|0
285068|NCT01824979|958750|P1|Overall Study|Withdrawal by Subject|5
285069|NCT01824823|958767|P2|Overall Study|Off-treatment reason not submitted|0
285070|NCT01824823|958768|P1|Overall Study|Off-treatment reason not submitted|1
285071|NCT01824823|958767|P2|Overall Study|Lack of Efficacy|1
285072|NCT01824823|958768|P1|Overall Study|Lack of Efficacy|1
285073|NCT01824602|958778|P4|Overall Study|Treatment failure|1
285074|NCT01824602|958779|P3|Overall Study|Treatment failure|0
285075|NCT01824602|958780|P2|Overall Study|Treatment failure|0
285076|NCT01824602|958781|P1|Overall Study|Treatment failure|0
285077|NCT01824602|958778|P4|Overall Study|Adverse Event|2
285078|NCT01824602|958779|P3|Overall Study|Adverse Event|2
285079|NCT01824602|958780|P2|Overall Study|Adverse Event|0
285080|NCT01824602|958781|P1|Overall Study|Adverse Event|1
285081|NCT01824602|958778|P4|Overall Study|Patient non-compliance|0
285082|NCT01824602|958779|P3|Overall Study|Patient non-compliance|1
285083|NCT01824602|958780|P2|Overall Study|Patient non-compliance|0
285084|NCT01824602|958781|P1|Overall Study|Patient non-compliance|0
285085|NCT01824602|958778|P4|Overall Study|Withdrawal by Subject|2
285086|NCT01824602|958779|P3|Overall Study|Withdrawal by Subject|1
285087|NCT01824602|958780|P2|Overall Study|Withdrawal by Subject|0
285088|NCT01824602|958781|P1|Overall Study|Withdrawal by Subject|0
285089|NCT01824576|958820|P1|Overall Study|Device deficiency|2
285090|NCT01824498|958838|P6|Washout (8 Weeks)|Withdrawal by Subject|0
285091|NCT01824498|958839|P5|Washout (8 Weeks)|Withdrawal by Subject|1
285092|NCT01824498|958840|P4|Washout (8 Weeks)|Withdrawal by Subject|1
285093|NCT01824498|958841|P3|Washout (8 Weeks)|Withdrawal by Subject|2
285094|NCT01824498|958842|P2|Washout (8 Weeks)|Withdrawal by Subject|0
285095|NCT01824498|958843|P1|Washout (8 Weeks)|Withdrawal by Subject|2
285096|NCT01824355|958874|P1|Overall Study|unevaluable reference method results per|1
285097|NCT01824355|958874|P1|Overall Study|Adverse Event|2
285098|NCT01824342|958885|P2|Overall Study|Death|0
285099|NCT01824342|958886|P1|Overall Study|Death|2
285100|NCT01824342|958885|P2|Overall Study|Physician Decision|0
285101|NCT01824342|958886|P1|Overall Study|Physician Decision|5
285102|NCT01824342|958885|P2|Overall Study|Disease Progression|1
285103|NCT01824342|958886|P1|Overall Study|Disease Progression|1
285104|NCT01824342|958885|P2|Overall Study|Adverse Event|1
285105|NCT01824342|958886|P1|Overall Study|Adverse Event|1
285106|NCT01824342|958885|P2|Overall Study|Withdrawal by Subject|3
285107|NCT01824342|958886|P1|Overall Study|Withdrawal by Subject|0
285108|NCT01824303|958900|P2|Randomized Study|Other Miscellaneous Reasons|0
285109|NCT01824303|958901|P1|Randomized Study|Other Miscellaneous Reasons|1
285110|NCT01824303|958900|P2|Randomized Study|Withdrawal by Subject|1
285111|NCT01824303|958901|P1|Randomized Study|Withdrawal by Subject|1
285112|NCT01823679|958929|P1|Overall Study|Death|1
285113|NCT01823536|958982|P6|Overall Study|Subject moved out of the state|0
285114|NCT01823536|958983|P5|Overall Study|Subject moved out of the state|1
285115|NCT01823536|958984|P4|Overall Study|Subject moved out of the state|0
285116|NCT01823536|958985|P3|Overall Study|Subject moved out of the state|0
285117|NCT01823536|958986|P2|Overall Study|Subject moved out of the state|0
285118|NCT01823536|958987|P1|Overall Study|Subject moved out of the state|0
285119|NCT01823536|958982|P6|Overall Study|Met exclusion criterion No 6|0
285120|NCT01823536|958983|P5|Overall Study|Met exclusion criterion No 6|0
285121|NCT01823536|958984|P4|Overall Study|Met exclusion criterion No 6|1
285122|NCT01823536|958985|P3|Overall Study|Met exclusion criterion No 6|0
285123|NCT01823536|958986|P2|Overall Study|Met exclusion criterion No 6|0
285124|NCT01823536|958987|P1|Overall Study|Met exclusion criterion No 6|0
285125|NCT01823536|958982|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
285126|NCT01823536|958983|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
285127|NCT01823536|958984|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
285128|NCT01823536|958985|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
285129|NCT01823536|958986|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
285130|NCT01823536|958987|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
285131|NCT01823536|958982|P6|Overall Study|Withdrawal by Subject|0
285132|NCT01823536|958983|P5|Overall Study|Withdrawal by Subject|0
285133|NCT01823536|958984|P4|Overall Study|Withdrawal by Subject|0
285134|NCT01823536|958985|P3|Overall Study|Withdrawal by Subject|0
285135|NCT01823536|958986|P2|Overall Study|Withdrawal by Subject|1
285136|NCT01823536|958987|P1|Overall Study|Withdrawal by Subject|1
285137|NCT01823536|958982|P6|Overall Study|Protocol Violation|0
285138|NCT01823536|958983|P5|Overall Study|Protocol Violation|0
285139|NCT01823536|958984|P4|Overall Study|Protocol Violation|0
285140|NCT01823536|958985|P3|Overall Study|Protocol Violation|0
285141|NCT01823536|958986|P2|Overall Study|Protocol Violation|1
285142|NCT01823536|958987|P1|Overall Study|Protocol Violation|0
285143|NCT01823536|958982|P6|Overall Study|Lost to Follow-up|0
285144|NCT01823536|958983|P5|Overall Study|Lost to Follow-up|1
285145|NCT01823536|958984|P4|Overall Study|Lost to Follow-up|1
285146|NCT01823536|958985|P3|Overall Study|Lost to Follow-up|0
285147|NCT01823536|958986|P2|Overall Study|Lost to Follow-up|0
285148|NCT01823536|958987|P1|Overall Study|Lost to Follow-up|1
285149|NCT01823341|959038|P1|Overall Study|Adverse Event|1
285150|NCT01823341|959038|P1|Overall Study|Withdrawal by Subject|7
285151|NCT01823341|959038|P1|Overall Study|Failed run-in|7
285152|NCT01823289|959081|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
285153|NCT01823289|959081|P1|Overall Study|Drug affected efficacy and safety|1
285154|NCT01823289|959081|P1|Overall Study|Transaminase increased more than 3 times|1
285155|NCT01823289|959081|P1|Overall Study|Administered contraindicated medicine|1
285156|NCT01823289|959081|P1|Overall Study|Physician Decision|9
285157|NCT01823289|959081|P1|Overall Study|Lack of Efficacy|1
285158|NCT01823289|959081|P1|Overall Study|Adverse Event|5
285159|NCT01823289|959081|P1|Overall Study|Lost to Follow-up|5
285160|NCT01823224|959089|P2|Overall Study|Withdrawal by Subject|1
285161|NCT01823224|959090|P1|Overall Study|Withdrawal by Subject|0
285162|NCT01823224|959089|P2|Overall Study|missed med dose|1
285163|NCT01823224|959090|P1|Overall Study|missed med dose|0
285164|NCT01823224|959089|P2|Overall Study|pharmacy error|1
285165|NCT01823224|959090|P1|Overall Study|pharmacy error|0
285166|NCT01823224|959089|P2|Overall Study|didn't qualify|2
285167|NCT01823224|959090|P1|Overall Study|didn't qualify|1
285168|NCT01823224|959089|P2|Overall Study|Lost to Follow-up|6
285169|NCT01823224|959090|P1|Overall Study|Lost to Follow-up|5
285170|NCT01823146|959100|P2|Overall Study|Lost to Follow-up|1
285171|NCT01823146|959101|P1|Overall Study|Lost to Follow-up|2
285172|NCT01823146|959100|P2|Overall Study|Withdrawal by Subject|1
285173|NCT01823146|959101|P1|Overall Study|Withdrawal by Subject|0
285174|NCT01822899|959113|P2|Overall Study|Withdrawal by Subject|7
285175|NCT01822899|959114|P1|Overall Study|Withdrawal by Subject|5
285176|NCT01822899|959113|P2|Overall Study|Lost to Follow-up|0
285177|NCT01822899|959114|P1|Overall Study|Lost to Follow-up|1
285178|NCT01822899|959113|P2|Overall Study|Protocol Violation|3
285179|NCT01822899|959114|P1|Overall Study|Protocol Violation|6
285180|NCT01822899|959113|P2|Overall Study|Lack of Efficacy|3
285181|NCT01822899|959114|P1|Overall Study|Lack of Efficacy|6
285182|NCT01822899|959113|P2|Overall Study|Adverse Event|5
285183|NCT01822899|959114|P1|Overall Study|Adverse Event|6
285184|NCT01822821|959124|P2|Overall Study|Other reasons|0
285185|NCT01822821|959125|P1|Overall Study|Other reasons|1
285186|NCT01822821|959124|P2|Overall Study|Eligible surgery cancelled|1
285187|NCT01822821|959125|P1|Overall Study|Eligible surgery cancelled|1
285188|NCT01822756|959154|P5|Overall Study|disease progression & patient preference|0
285189|NCT01822756|959155|P4|Overall Study|disease progression & patient preference|0
285190|NCT01822756|959156|P3|Overall Study|disease progression & patient preference|1
285191|NCT01822756|959157|P2|Overall Study|disease progression & patient preference|0
285192|NCT01822756|959158|P1|Overall Study|disease progression & patient preference|2
285193|NCT01822756|959154|P5|Overall Study|Physician Decision|0
285194|NCT01822756|959155|P4|Overall Study|Physician Decision|0
285195|NCT01822756|959156|P3|Overall Study|Physician Decision|0
285196|NCT01822756|959157|P2|Overall Study|Physician Decision|1
285197|NCT01822756|959158|P1|Overall Study|Physician Decision|0
285198|NCT01822756|959154|P5|Overall Study|Lost to Follow-up|1
285199|NCT01822756|959155|P4|Overall Study|Lost to Follow-up|0
285200|NCT01822756|959156|P3|Overall Study|Lost to Follow-up|1
285201|NCT01822756|959157|P2|Overall Study|Lost to Follow-up|0
285202|NCT01822756|959158|P1|Overall Study|Lost to Follow-up|1
285203|NCT01822756|959154|P5|Overall Study|Death|0
285204|NCT01822756|959155|P4|Overall Study|Death|0
285205|NCT01822756|959156|P3|Overall Study|Death|1
285206|NCT01822756|959157|P2|Overall Study|Death|2
285207|NCT01822756|959158|P1|Overall Study|Death|2
285208|NCT01822756|959154|P5|Overall Study|Disease progression|6
285209|NCT01822756|959155|P4|Overall Study|Disease progression|2
285210|NCT01822756|959156|P3|Overall Study|Disease progression|7
285211|NCT01822756|959157|P2|Overall Study|Disease progression|1
285212|NCT01822756|959158|P1|Overall Study|Disease progression|11
285213|NCT01822756|959154|P5|Overall Study|Adverse Event|0
285214|NCT01822756|959155|P4|Overall Study|Adverse Event|2
285215|NCT01822756|959156|P3|Overall Study|Adverse Event|0
285216|NCT01822756|959157|P2|Overall Study|Adverse Event|0
285217|NCT01822756|959158|P1|Overall Study|Adverse Event|0
285218|NCT01822691|959200|P1|Overall Study|Withdrawal by Subject|2
285219|NCT01822678|959211|P3|Overall Study|Lost to Follow-up|1
285220|NCT01822678|959212|P2|Overall Study|Lost to Follow-up|2
285221|NCT01822678|959213|P1|Overall Study|Lost to Follow-up|0
285222|NCT01822678|959211|P3|Overall Study|Lack of Efficacy|5
285223|NCT01822678|959212|P2|Overall Study|Lack of Efficacy|6
285224|NCT01822678|959213|P1|Overall Study|Lack of Efficacy|3
285225|NCT01822678|959211|P3|Overall Study|Adverse Event|1
285226|NCT01822678|959212|P2|Overall Study|Adverse Event|3
285227|NCT01822678|959213|P1|Overall Study|Adverse Event|4
285228|NCT01822678|959211|P3|Overall Study|Withdrawal by Subject|4
285229|NCT01822678|959212|P2|Overall Study|Withdrawal by Subject|4
285230|NCT01822678|959213|P1|Overall Study|Withdrawal by Subject|5
285231|NCT01822665|959221|P1|Overall Study|Other Reason|5
285232|NCT01822665|959221|P1|Overall Study|Adverse Event|3
285233|NCT01822561|959264|P1|Overall Study|Withdrawal by Subject|2
285234|NCT01822535|959285|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
285235|NCT01822535|959286|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
285236|NCT01822535|959285|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
285237|NCT01822535|959286|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
285238|NCT01822535|959285|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
285239|NCT01822535|959286|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
285240|NCT01822223|959310|P2|Overall Study|Death|1
285241|NCT01822223|959311|P1|Overall Study|Death|0
285242|NCT01821963|959356|P1|Overall Study|Adverse Event|1
285243|NCT01821937|959362|P2|Overall Study|Adverse Event|3
285244|NCT01821937|959363|P1|Overall Study|Adverse Event|0
285245|NCT01821807|959387|P2|Overall Study|Lost to Follow-up|1
285246|NCT01821807|959388|P1|Overall Study|Lost to Follow-up|3
285247|NCT01821118|959476|P2|Overall Study|Death|1
285248|NCT01821118|959477|P1|Overall Study|Death|0
285249|NCT01820585|959528|P4|Overall Study|Pregnancy|0
285250|NCT01820585|959529|P3|Overall Study|Pregnancy|0
285251|NCT01820585|959530|P2|Overall Study|Pregnancy|1
285252|NCT01820585|959531|P1|Overall Study|Pregnancy|0
285253|NCT01820585|959528|P4|Overall Study|at sponsor request|0
285254|NCT01820585|959529|P3|Overall Study|at sponsor request|1
285255|NCT01820585|959530|P2|Overall Study|at sponsor request|0
285256|NCT01820585|959531|P1|Overall Study|at sponsor request|0
285257|NCT01820585|959528|P4|Overall Study|Subject non-compliance|2
285258|NCT01820585|959529|P3|Overall Study|Subject non-compliance|1
285259|NCT01820585|959530|P2|Overall Study|Subject non-compliance|0
285260|NCT01820585|959531|P1|Overall Study|Subject non-compliance|0
285261|NCT01820585|959528|P4|Overall Study|Protocol Violation|1
285262|NCT01820585|959529|P3|Overall Study|Protocol Violation|1
285263|NCT01820585|959530|P2|Overall Study|Protocol Violation|1
285264|NCT01820585|959531|P1|Overall Study|Protocol Violation|3
285265|NCT01820585|959528|P4|Overall Study|Lost to Follow-up|3
285266|NCT01820585|959529|P3|Overall Study|Lost to Follow-up|0
285267|NCT01820585|959530|P2|Overall Study|Lost to Follow-up|3
285268|NCT01820585|959531|P1|Overall Study|Lost to Follow-up|3
285269|NCT01820585|959528|P4|Overall Study|Withdrawal by Subject|8
285270|NCT01820585|959529|P3|Overall Study|Withdrawal by Subject|3
285271|NCT01820585|959530|P2|Overall Study|Withdrawal by Subject|7
285272|NCT01820585|959531|P1|Overall Study|Withdrawal by Subject|3
285273|NCT01820585|959528|P4|Overall Study|Lack of Efficacy|1
285274|NCT01820585|959529|P3|Overall Study|Lack of Efficacy|5
285275|NCT01820585|959530|P2|Overall Study|Lack of Efficacy|7
285276|NCT01820585|959531|P1|Overall Study|Lack of Efficacy|9
285277|NCT01820585|959528|P4|Overall Study|Adverse Event|34
285278|NCT01820585|959529|P3|Overall Study|Adverse Event|23
285279|NCT01820585|959530|P2|Overall Study|Adverse Event|13
285280|NCT01820585|959531|P1|Overall Study|Adverse Event|9
285281|NCT01820559|959544|P3|Overall Study|Lack of Efficacy|3
285282|NCT01820559|959545|P2|Overall Study|Lack of Efficacy|2
285283|NCT01820559|959546|P1|Overall Study|Lack of Efficacy|3
285284|NCT01820559|959544|P3|Overall Study|At sponsor request|1
285285|NCT01820559|959545|P2|Overall Study|At sponsor request|0
285286|NCT01820559|959546|P1|Overall Study|At sponsor request|0
285287|NCT01820559|959544|P3|Overall Study|Lost to Follow-up|2
285288|NCT01820559|959545|P2|Overall Study|Lost to Follow-up|2
285289|NCT01820559|959546|P1|Overall Study|Lost to Follow-up|3
285290|NCT01820559|959544|P3|Overall Study|Subject's non-compliance|2
285291|NCT01820559|959545|P2|Overall Study|Subject's non-compliance|0
285292|NCT01820559|959546|P1|Overall Study|Subject's non-compliance|1
285293|NCT01820559|959544|P3|Overall Study|Protocol Violation|3
285294|NCT01820559|959545|P2|Overall Study|Protocol Violation|1
285295|NCT01820559|959546|P1|Overall Study|Protocol Violation|2
285296|NCT01820559|959544|P3|Overall Study|Withdrawal by Subject|5
285297|NCT01820559|959545|P2|Overall Study|Withdrawal by Subject|2
285298|NCT01820559|959546|P1|Overall Study|Withdrawal by Subject|1
285299|NCT01820559|959544|P3|Overall Study|Adverse Event|13
285300|NCT01820559|959545|P2|Overall Study|Adverse Event|6
285301|NCT01820559|959546|P1|Overall Study|Adverse Event|4
285302|NCT01820364|959567|P2|Part II: LGX818 + MEK162|Study Termination|1
285303|NCT01820364|959568|P1|Part II: LGX818 + MEK162|Study Termination|0
285304|NCT01820364|959567|P2|Part I: LGX818|Disease Progression|0
285305|NCT01820364|959568|P1|Part I: LGX818|Disease Progression|4
285306|NCT01820364|959567|P2|Part I: LGX818|Adverse Event|0
285307|NCT01820364|959568|P1|Part I: LGX818|Adverse Event|6
285308|NCT01820364|959567|P2|Part I: LGX818|Administrative Problems|0
285309|NCT01820364|959568|P1|Part I: LGX818|Administrative Problems|3
285310|NCT01820364|959567|P2|Part I: LGX818|Death|0
285311|NCT01820364|959568|P1|Part I: LGX818|Death|1
285312|NCT01819272|959752|P6|Overall Study|Loss of Glucose Control|0
285313|NCT01819272|959753|P5|Overall Study|Loss of Glucose Control|2
285314|NCT01819272|959754|P4|Overall Study|Loss of Glucose Control|1
285315|NCT01819272|959755|P3|Overall Study|Loss of Glucose Control|0
285316|NCT01819272|959756|P2|Overall Study|Loss of Glucose Control|1
285317|NCT01819272|959757|P1|Overall Study|Loss of Glucose Control|2
285318|NCT01819272|959752|P6|Overall Study|Withdrawal of Consent|1
285319|NCT01819272|959753|P5|Overall Study|Withdrawal of Consent|0
285320|NCT01819272|959754|P4|Overall Study|Withdrawal of Consent|1
285321|NCT01819272|959755|P3|Overall Study|Withdrawal of Consent|2
285322|NCT01819272|959756|P2|Overall Study|Withdrawal of Consent|1
285323|NCT01819272|959757|P1|Overall Study|Withdrawal of Consent|0
285324|NCT01819272|959752|P6|Overall Study|Physician Decision|0
285325|NCT01819272|959753|P5|Overall Study|Physician Decision|0
285326|NCT01819272|959754|P4|Overall Study|Physician Decision|0
285327|NCT01819272|959755|P3|Overall Study|Physician Decision|0
285328|NCT01819272|959756|P2|Overall Study|Physician Decision|1
285329|NCT01819272|959757|P1|Overall Study|Physician Decision|0
285330|NCT01819272|959752|P6|Overall Study|Protocol Violation|3
285331|NCT01819272|959753|P5|Overall Study|Protocol Violation|2
285332|NCT01819272|959754|P4|Overall Study|Protocol Violation|1
285333|NCT01819272|959755|P3|Overall Study|Protocol Violation|0
285334|NCT01819272|959756|P2|Overall Study|Protocol Violation|0
285335|NCT01819272|959757|P1|Overall Study|Protocol Violation|0
285336|NCT01819272|959752|P6|Overall Study|Lost to Follow-up|3
285337|NCT01819272|959753|P5|Overall Study|Lost to Follow-up|0
285338|NCT01819272|959754|P4|Overall Study|Lost to Follow-up|0
285339|NCT01819272|959755|P3|Overall Study|Lost to Follow-up|1
285340|NCT01819272|959756|P2|Overall Study|Lost to Follow-up|0
285341|NCT01819272|959757|P1|Overall Study|Lost to Follow-up|3
285342|NCT01819272|959752|P6|Overall Study|Adverse Event|0
285343|NCT01819272|959753|P5|Overall Study|Adverse Event|0
285344|NCT01819272|959754|P4|Overall Study|Adverse Event|2
285345|NCT01819272|959755|P3|Overall Study|Adverse Event|0
285346|NCT01819272|959756|P2|Overall Study|Adverse Event|0
285347|NCT01819272|959757|P1|Overall Study|Adverse Event|1
285348|NCT01819194|959783|P1|Overall Study|Loss of study articles|2
285349|NCT01819129|959790|P2|Overall Study|Withdrawal Criteria|15
285350|NCT01819129|959791|P1|Overall Study|Withdrawal Criteria|20
285351|NCT01819129|959790|P2|Overall Study|Death|1
285352|NCT01819129|959791|P1|Overall Study|Death|1
285353|NCT01819129|959790|P2|Overall Study|Adverse Event|4
285354|NCT01819129|959791|P1|Overall Study|Adverse Event|1
285355|NCT01819129|959790|P2|Overall Study|Lack of Efficacy|1
285356|NCT01819129|959791|P1|Overall Study|Lack of Efficacy|0
285357|NCT01819129|959790|P2|Overall Study|Lost to Follow-up|2
285358|NCT01819129|959791|P1|Overall Study|Lost to Follow-up|5
285359|NCT01819129|959790|P2|Overall Study|Withdrawal by Subject|15
285360|NCT01819129|959791|P1|Overall Study|Withdrawal by Subject|15
285361|NCT01819129|959790|P2|Overall Study|Other, Subject moved out of the country|1
285362|NCT01819129|959791|P1|Overall Study|Other, Subject moved out of the country|0
285363|NCT01819129|959790|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
285364|NCT01819129|959791|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
285365|NCT01819129|959790|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
285366|NCT01819129|959791|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
285367|NCT01818752|959805|P2|Overall Study|Randomized but not Dosed|4
285368|NCT01818752|959806|P1|Overall Study|Randomized but not Dosed|7
285369|NCT01818752|959805|P2|Overall Study|Continuing Treatment|4
285370|NCT01818752|959806|P1|Overall Study|Continuing Treatment|1
285371|NCT01818752|959805|P2|Overall Study|Other|8
285372|NCT01818752|959806|P1|Overall Study|Other|7
285373|NCT01818752|959805|P2|Overall Study|Disease Progression|48
285374|NCT01818752|959806|P1|Overall Study|Disease Progression|54
285375|NCT01818752|959805|P2|Overall Study|Physician Decision|8
285376|NCT01818752|959806|P1|Overall Study|Physician Decision|9
285377|NCT01818752|959805|P2|Overall Study|Withdrawal by Subject|14
285378|NCT01818752|959806|P1|Overall Study|Withdrawal by Subject|15
285379|NCT01818752|959805|P2|Overall Study|Non-compliance|20
285380|NCT01818752|959806|P1|Overall Study|Non-compliance|16
285381|NCT01818752|959805|P2|Overall Study|Death|18
285382|NCT01818752|959806|P1|Overall Study|Death|14
285383|NCT01818752|959805|P2|Overall Study|Adverse Event|74
285384|NCT01818752|959806|P1|Overall Study|Adverse Event|64
285385|NCT01818700|959824|P1|Overall Study|Other|1
285386|NCT01818700|959824|P1|Overall Study|Protocol Violation|2
285387|NCT01818700|959824|P1|Overall Study|Withdrawal by Subject|27
285388|NCT01818700|959824|P1|Overall Study|Lost to Follow-up|5
285389|NCT01818700|959824|P1|Overall Study|Lack of Efficacy|2
285390|NCT01818700|959824|P1|Overall Study|Adverse Event|67
285391|NCT01818596|959835|P2|Overall Study|Still on Study|6
285392|NCT01818596|959836|P1|Overall Study|Still on Study|232
285393|NCT01818596|959835|P2|Overall Study|Lost to Follow-up|0
285394|NCT01818596|959836|P1|Overall Study|Lost to Follow-up|2
285395|NCT01818596|959835|P2|Overall Study|Protocol Violation|0
285396|NCT01818596|959836|P1|Overall Study|Protocol Violation|1
285397|NCT01818596|959835|P2|Overall Study|Withdrew Consent|0
285398|NCT01818596|959836|P1|Overall Study|Withdrew Consent|3
285399|NCT01818596|959835|P2|Overall Study|Adverse Event|0
285400|NCT01818596|959836|P1|Overall Study|Adverse Event|4
285401|NCT01818596|959835|P2|Overall Study|Enrolled but Not Treated|0
285402|NCT01818596|959836|P1|Overall Study|Enrolled but Not Treated|4
285403|NCT01818336|959884|P2|Overall Study|Lost to Follow-up|1
285404|NCT01818336|959885|P1|Overall Study|Lost to Follow-up|0
285405|NCT01818336|959884|P2|Overall Study|Declined retest visit|11
285406|NCT01818336|959885|P1|Overall Study|Declined retest visit|0
285407|NCT01818297|959893|P2|Open Label Phase (3-12 Months)|Early study closure|10
285408|NCT01818297|959894|P1|Open Label Phase (3-12 Months)|Early study closure|17
285409|NCT01818297|959893|P2|Open Label Phase (3-12 Months)|Physician Decision|0
285410|NCT01818297|959894|P1|Open Label Phase (3-12 Months)|Physician Decision|1
285411|NCT01818297|959893|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
285412|NCT01818297|959894|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
285413|NCT01818141|959912|P2|Overall Study|Lost to Follow-up|2
285414|NCT01818141|959913|P1|Overall Study|Lost to Follow-up|0
285415|NCT01818141|959912|P2|Overall Study|No baseline C.diff colonies|1
285416|NCT01818141|959913|P1|Overall Study|No baseline C.diff colonies|1
285417|NCT01818141|959912|P2|Overall Study|Withdrawal by Subject|0
285418|NCT01818141|959913|P1|Overall Study|Withdrawal by Subject|2
285419|NCT01817790|959978|P2|Overall Study|Other: Could not attend appointment|1
285420|NCT01817790|959979|P1|Overall Study|Other: Could not attend appointment|1
285421|NCT01817790|959978|P2|Overall Study|Withdrawal by Subject|3
285422|NCT01817790|959979|P1|Overall Study|Withdrawal by Subject|1
285423|NCT01817790|959978|P2|Overall Study|Protocol Violation|1
285424|NCT01817790|959979|P1|Overall Study|Protocol Violation|2
285425|NCT01817790|959978|P2|Overall Study|Lost to Follow-up|1
285426|NCT01817790|959979|P1|Overall Study|Lost to Follow-up|0
285427|NCT01817790|959978|P2|Overall Study|Adverse Event|2
285428|NCT01817790|959979|P1|Overall Study|Adverse Event|0
285429|NCT01817777|960023|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
285430|NCT01817777|960024|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
285431|NCT01817777|960025|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
285432|NCT01817777|960023|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
285433|NCT01817777|960024|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
285434|NCT01817777|960025|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
285435|NCT01817777|960023|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
285436|NCT01817777|960024|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
285437|NCT01817777|960025|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
285438|NCT01817777|960023|P3|Observational Phase (8 Weeks)|Early Study Termination|0
285439|NCT01817777|960024|P2|Observational Phase (8 Weeks)|Early Study Termination|0
285440|NCT01817777|960025|P1|Observational Phase (8 Weeks)|Early Study Termination|2
285441|NCT01817777|960023|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
285442|NCT01817777|960024|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
285443|NCT01817777|960025|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
285444|NCT01817764|960049|P2|Overall Study|Withdrawal by Subject|12
285445|NCT01817764|960050|P1|Overall Study|Withdrawal by Subject|10
285446|NCT01817764|960049|P2|Overall Study|Lost to Follow-up|4
285447|NCT01817764|960050|P1|Overall Study|Lost to Follow-up|1
285448|NCT01817764|960049|P2|Overall Study|Protocol Violation|5
285449|NCT01817764|960050|P1|Overall Study|Protocol Violation|7
285450|NCT01817764|960049|P2|Overall Study|Lack of Efficacy|7
285451|NCT01817764|960050|P1|Overall Study|Lack of Efficacy|9
285452|NCT01817764|960049|P2|Overall Study|Adverse Event|10
285453|NCT01817764|960050|P1|Overall Study|Adverse Event|7
285454|NCT01817725|960058|P1|Overall Study|Withdrawal by Subject|1
285455|NCT01816893|960126|P2|Washout Period|Withdrawal by Subject|0
285456|NCT01816893|960127|P1|Washout Period|Withdrawal by Subject|2
285457|NCT01816685|960162|P2|Overall Study|Surgery Cancelled|2
285458|NCT01816685|960163|P1|Overall Study|Surgery Cancelled|3
285459|NCT01816685|960162|P2|Overall Study|Lost to Follow-up|9
285460|NCT01816685|960163|P1|Overall Study|Lost to Follow-up|7
285461|NCT01816477|960173|P2|Overall Study|Unable to tolerate catheter placement|0
285462|NCT01816477|960174|P1|Overall Study|Unable to tolerate catheter placement|3
285463|NCT01816477|960173|P2|Overall Study|Withdrawal by Subject|1
285464|NCT01816477|960174|P1|Overall Study|Withdrawal by Subject|13
285465|NCT01816295|960228|P2|OLE Phase|Lack of Efficacy|7
285466|NCT01816295|960229|P1|OLE Phase|Lack of Efficacy|3
285467|NCT01816295|960228|P2|OLE Phase|Withdrawal by Subject|10
285468|NCT01816295|960229|P1|OLE Phase|Withdrawal by Subject|10
285469|NCT01816295|960228|P2|OLE Phase|Sponsor Decision|9
285470|NCT01816295|960229|P1|OLE Phase|Sponsor Decision|7
285471|NCT01816295|960228|P2|OLE Phase|Protocol Violation|4
285472|NCT01816295|960229|P1|OLE Phase|Protocol Violation|4
285473|NCT01816295|960228|P2|OLE Phase|Physician Decision|1
285474|NCT01816295|960229|P1|OLE Phase|Physician Decision|3
285475|NCT01816295|960228|P2|OLE Phase|Lost to Follow-up|5
285476|NCT01816295|960229|P1|OLE Phase|Lost to Follow-up|5
285477|NCT01816295|960228|P2|OLE Phase|Entry Criteria Not Met|5
285478|NCT01816295|960229|P1|OLE Phase|Entry Criteria Not Met|3
285479|NCT01816295|960228|P2|OLE Phase|Death|0
285480|NCT01816295|960229|P1|OLE Phase|Death|1
285481|NCT01816295|960228|P2|OLE Phase|Adverse Event|15
285482|NCT01816295|960229|P1|OLE Phase|Adverse Event|17
285483|NCT01816295|960228|P2|Double Blind Phase|Withdrawal by Subject|20
285484|NCT01816295|960229|P1|Double Blind Phase|Withdrawal by Subject|22
285485|NCT01816295|960228|P2|Double Blind Phase|Sponsor Decision|8
285486|NCT01816295|960229|P1|Double Blind Phase|Sponsor Decision|8
285487|NCT01816295|960228|P2|Double Blind Phase|Protocol Violation|11
285488|NCT01816295|960229|P1|Double Blind Phase|Protocol Violation|17
285489|NCT01816295|960228|P2|Double Blind Phase|Physician Decision|2
285490|NCT01816295|960229|P1|Double Blind Phase|Physician Decision|2
285491|NCT01816295|960228|P2|Double Blind Phase|Lost to Follow-up|5
285492|NCT01816295|960229|P1|Double Blind Phase|Lost to Follow-up|3
285493|NCT01816295|960228|P2|Double Blind Phase|Entry Criteria Not Met|2
285494|NCT01816295|960229|P1|Double Blind Phase|Entry Criteria Not Met|0
285495|NCT01816295|960228|P2|Double Blind Phase|Adverse Event|8
285496|NCT01816295|960229|P1|Double Blind Phase|Adverse Event|11
285497|NCT01816243|960244|P1|Overall Study|Amputation|3
285498|NCT01816243|960244|P1|Overall Study|Not eligible for the study|1
285499|NCT01816243|960244|P1|Overall Study|Lack of Efficacy|1
285500|NCT01816243|960244|P1|Overall Study|Lost to Follow-up|1
285501|NCT01816243|960244|P1|Overall Study|Adverse Event|6
285502|NCT01816074|960255|P4|Phase 2|Withdrawal by Subject|0
285503|NCT01816074|960256|P3|Phase 2|Withdrawal by Subject|0
285504|NCT01816074|960257|P2|Phase 2|Withdrawal by Subject|0
285505|NCT01816074|960258|P1|Phase 2|Withdrawal by Subject|1
285506|NCT01816074|960255|P4|Phase 2|Physician Decision|1
285507|NCT01816074|960256|P3|Phase 2|Physician Decision|0
285508|NCT01816074|960257|P2|Phase 2|Physician Decision|0
285509|NCT01816074|960258|P1|Phase 2|Physician Decision|0
285510|NCT01816074|960255|P4|Phase 2|Unsatisfied with Randomization assignmen|0
285511|NCT01816074|960256|P3|Phase 2|Unsatisfied with Randomization assignmen|0
285512|NCT01816074|960257|P2|Phase 2|Unsatisfied with Randomization assignmen|0
285513|NCT01816074|960258|P1|Phase 2|Unsatisfied with Randomization assignmen|1
285514|NCT01816074|960255|P4|Phase 2|Time commitment Issues|0
285515|NCT01816074|960256|P3|Phase 2|Time commitment Issues|0
285516|NCT01816074|960257|P2|Phase 2|Time commitment Issues|2
285517|NCT01816074|960258|P1|Phase 2|Time commitment Issues|0
285518|NCT01816074|960255|P4|Phase 1|Time commitment issues|0
285519|NCT01816074|960256|P3|Phase 1|Time commitment issues|1
285520|NCT01816074|960257|P2|Phase 1|Time commitment issues|0
285521|NCT01816074|960258|P1|Phase 1|Time commitment issues|0
285522|NCT01816048|960286|P1|Overall Study|Disease Progression|3
285523|NCT01816048|960286|P1|Overall Study|Withdrawal by Subject|1
285524|NCT01816048|960286|P1|Overall Study|Death|1
285525|NCT01816048|960286|P1|Overall Study|Adverse Event|1
285526|NCT01815918|960301|P2|Overall Study|Lack of Efficacy|15
285527|NCT01815918|960302|P1|Overall Study|Lack of Efficacy|15
285528|NCT01815918|960301|P2|Overall Study|Patient samples not analyzable|4
285529|NCT01815918|960302|P1|Overall Study|Patient samples not analyzable|3
285530|NCT01815840|960318|P2|Overall Study|Sponsor Termination Treatment|0
285531|NCT01815840|960319|P1|Overall Study|Sponsor Termination Treatment|1
285532|NCT01815840|960318|P2|Overall Study|Refused Treatment|1
285533|NCT01815840|960319|P1|Overall Study|Refused Treatment|5
285534|NCT01815840|960318|P2|Overall Study|Lost to Follow-up|6
285535|NCT01815840|960319|P1|Overall Study|Lost to Follow-up|3
285536|NCT01815840|960318|P2|Overall Study|Investigators Decision|3
285537|NCT01815840|960319|P1|Overall Study|Investigators Decision|2
285538|NCT01815840|960318|P2|Overall Study|Disease progression|2
285539|NCT01815840|960319|P1|Overall Study|Disease progression|3
285540|NCT01815840|960318|P2|Overall Study|Death|2
285541|NCT01815840|960319|P1|Overall Study|Death|2
285542|NCT01815840|960318|P2|Overall Study|Adverse Event|16
285543|NCT01815840|960319|P1|Overall Study|Adverse Event|10
285544|NCT01815840|960318|P2|Overall Study|Administrative/Other|3
285545|NCT01815840|960319|P1|Overall Study|Administrative/Other|1
285546|NCT01815840|960318|P2|Overall Study|Withdrew Consent|30
285547|NCT01815840|960319|P1|Overall Study|Withdrew Consent|31
285548|NCT01815840|960318|P2|Overall Study|Missing|0
285549|NCT01815840|960319|P1|Overall Study|Missing|1
285550|NCT01815736|960349|P2|Overall Study|Still on Study|449
285551|NCT01815736|960350|P1|Overall Study|Still on Study|929
285552|NCT01815736|960349|P2|Overall Study|Lost to Follow-up|7
285553|NCT01815736|960350|P1|Overall Study|Lost to Follow-up|6
285554|NCT01815736|960349|P2|Overall Study|Withdrew Consent|15
285555|NCT01815736|960350|P1|Overall Study|Withdrew Consent|7
285556|NCT01815736|960349|P2|Overall Study|Investigator's Discretion|0
285557|NCT01815736|960350|P1|Overall Study|Investigator's Discretion|4
285558|NCT01815736|960349|P2|Overall Study|Death|0
285559|NCT01815736|960350|P1|Overall Study|Death|4
285560|NCT01815736|960349|P2|Overall Study|Adverse Event|4
285561|NCT01815736|960350|P1|Overall Study|Adverse Event|7
285562|NCT01815736|960349|P2|Overall Study|Randomized but Not Treated|3
285563|NCT01815736|960350|P1|Overall Study|Randomized but Not Treated|4
285564|NCT01815138|960398|P2|Overall Study|Physician Decision|5
285565|NCT01815138|960399|P1|Overall Study|Physician Decision|8
285566|NCT01815138|960398|P2|Overall Study|Withdrawal by Subject|1
285567|NCT01815138|960399|P1|Overall Study|Withdrawal by Subject|0
285568|NCT01815099|960411|P1|Overall Study|unable to attend study visits|1
285569|NCT01815099|960411|P1|Overall Study|Lack of Efficacy|1
285570|NCT01814878|960425|P2|Overall Study|Other|0
285571|NCT01814878|960426|P1|Overall Study|Other|2
285572|NCT01814878|960425|P2|Overall Study|Screening failure (drop-out)|3
285573|NCT01814878|960426|P1|Overall Study|Screening failure (drop-out)|0
285574|NCT01814878|960425|P2|Overall Study|Physician Decision|1
285575|NCT01814878|960426|P1|Overall Study|Physician Decision|3
285576|NCT01814878|960425|P2|Overall Study|Protocol Violation|5
285577|NCT01814878|960426|P1|Overall Study|Protocol Violation|5
285578|NCT01814878|960425|P2|Overall Study|Withdrawal by Subject|16
285579|NCT01814878|960426|P1|Overall Study|Withdrawal by Subject|20
285580|NCT01814878|960425|P2|Overall Study|Adverse Event|5
285581|NCT01814878|960426|P1|Overall Study|Adverse Event|16
285582|NCT01814800|960446|P1|Overall Study|Subject relocation|1
285583|NCT01814800|960446|P1|Overall Study|Sponsor decision|1
285584|NCT01814800|960446|P1|Overall Study|Pregnancy|1
285585|NCT01814800|960446|P1|Overall Study|Adverse Event|2
285586|NCT01814761|960506|P2|Overall Study|Lost to Follow-up|5
285587|NCT01814761|960507|P1|Overall Study|Lost to Follow-up|1
285588|NCT01814761|960506|P2|Overall Study|Ocular Adverse Event|15
285589|NCT01814761|960507|P1|Overall Study|Ocular Adverse Event|6
285590|NCT01814761|960506|P2|Overall Study|Other Reasons|10
285591|NCT01814761|960507|P1|Overall Study|Other Reasons|1
285592|NCT01814748|960521|P2|Overall Study|Withdrawal by Subject|4
285593|NCT01814748|960522|P1|Overall Study|Withdrawal by Subject|6
285594|NCT01814748|960521|P2|Overall Study|Study site terminated by sponsor|1
285595|NCT01814748|960522|P1|Overall Study|Study site terminated by sponsor|1
285596|NCT01814748|960521|P2|Overall Study|Lost to Follow-up|2
285597|NCT01814748|960522|P1|Overall Study|Lost to Follow-up|1
285598|NCT01814696|960566|P2|Overall Study|Randomized to wrong group|0
285599|NCT01814696|960567|P1|Overall Study|Randomized to wrong group|1
285600|NCT01814696|960566|P2|Overall Study|Withdrawal by Subject|0
285601|NCT01814696|960567|P1|Overall Study|Withdrawal by Subject|1
285602|NCT01814670|960585|P1|Overall Study|Protocol Violation|12
285603|NCT01814553|960595|P2|Overall Study|Other than stated|8
285604|NCT01814553|960596|P1|Overall Study|Other than stated|7
285605|NCT01814553|960595|P2|Overall Study|Withdrawal by Subject|1
285606|NCT01814553|960596|P1|Overall Study|Withdrawal by Subject|1
285607|NCT01814553|960595|P2|Overall Study|Other Adverse Event|5
285608|NCT01814553|960596|P1|Overall Study|Other Adverse Event|4
285609|NCT01814553|960595|P2|Overall Study|PD per clinical progression|8
285610|NCT01814553|960596|P1|Overall Study|PD per clinical progression|6
285611|NCT01814397|960610|P1|Overall Study|Withdrawal by Subject|7
285612|NCT01814397|960610|P1|Overall Study|Adverse Event|7
285613|NCT01814332|960619|P2|Overall Study|Lost to Follow-up|1
285614|NCT01814332|960620|P1|Overall Study|Lost to Follow-up|5
285615|NCT01814332|960619|P2|Overall Study|Protocol Violation|4
285616|NCT01814332|960620|P1|Overall Study|Protocol Violation|0
285617|NCT01814332|960619|P2|Overall Study|Withdrawal by Subject|8
285618|NCT01814332|960620|P1|Overall Study|Withdrawal by Subject|3
285619|NCT01814332|960619|P2|Overall Study|Adverse Event|3
285620|NCT01814332|960620|P1|Overall Study|Adverse Event|8
285621|NCT01814137|960642|P2|Overall Study|Unclassified|1
285622|NCT01814137|960643|P1|Overall Study|Unclassified|2
285623|NCT01814137|960642|P2|Overall Study|Physician Decision|1
285624|NCT01814137|960643|P1|Overall Study|Physician Decision|1
285625|NCT01814137|960642|P2|Overall Study|Withdrawal by Subject|2
285626|NCT01814137|960643|P1|Overall Study|Withdrawal by Subject|2
285627|NCT01814137|960642|P2|Overall Study|Adverse Event|1
285628|NCT01814137|960643|P1|Overall Study|Adverse Event|0
285629|NCT01814046|960659|P3|Drug Administration|Death due to complications of RSV|0
285630|NCT01814046|960660|P2|Drug Administration|Death due to complications of RSV|0
285631|NCT01814046|960661|P1|Drug Administration|Death due to complications of RSV|1
285632|NCT01813890|960675|P3|Overall Study|Lack of Efficacy|2
285633|NCT01813890|960676|P2|Overall Study|Lack of Efficacy|1
285634|NCT01813890|960677|P1|Overall Study|Lack of Efficacy|9
285635|NCT01813890|960675|P3|Overall Study|Adverse Event|4
285636|NCT01813890|960676|P2|Overall Study|Adverse Event|3
285637|NCT01813890|960677|P1|Overall Study|Adverse Event|0
285638|NCT01813721|960706|P1|Overall Study|Withdrawal by Subject|1
285639|NCT01813721|960706|P1|Overall Study|Ineligibility determined|63
285640|NCT01813474|960761|P3|Overall Study|Death|1
285641|NCT01813474|960762|P2|Overall Study|Death|0
285642|NCT01813474|960763|P1|Overall Study|Death|0
285643|NCT01813474|960761|P3|Overall Study|Lack of Efficacy|9
285644|NCT01813474|960762|P2|Overall Study|Lack of Efficacy|6
285645|NCT01813474|960763|P1|Overall Study|Lack of Efficacy|2
285646|NCT01813474|960761|P3|Overall Study|Adverse Event|0
285647|NCT01813474|960762|P2|Overall Study|Adverse Event|1
285648|NCT01813474|960763|P1|Overall Study|Adverse Event|1
285649|NCT01813474|960761|P3|Overall Study|Withdrawal by Subject|1
285650|NCT01813474|960762|P2|Overall Study|Withdrawal by Subject|0
285651|NCT01813474|960763|P1|Overall Study|Withdrawal by Subject|0
285652|NCT01813422|960787|P2|Overall Study|Lost to Follow-up|4
285653|NCT01813422|960788|P1|Overall Study|Lost to Follow-up|2
285654|NCT01813422|960787|P2|Overall Study|Sponsor Decision|1
285655|NCT01813422|960788|P1|Overall Study|Sponsor Decision|2
285656|NCT01813422|960787|P2|Overall Study|Death|3
285657|NCT01813422|960788|P1|Overall Study|Death|2
285658|NCT01813422|960787|P2|Overall Study|Withdrawal by Subject|8
285659|NCT01813422|960788|P1|Overall Study|Withdrawal by Subject|14
285660|NCT01813019|960813|P2|Overall Study|Protocol Deviation|1
285661|NCT01813019|960814|P1|Overall Study|Protocol Deviation|2
285662|NCT01813019|960813|P2|Overall Study|administrative problems|0
285663|NCT01813019|960814|P1|Overall Study|administrative problems|2
285664|NCT01813019|960813|P2|Overall Study|Withdrawal by Subject|2
285665|NCT01813019|960814|P1|Overall Study|Withdrawal by Subject|3
285666|NCT01813019|960813|P2|Overall Study|Adverse Event|3
285667|NCT01813019|960814|P1|Overall Study|Adverse Event|0
285668|NCT01812837|960825|P3|Overall Study|Protocol Violation|0
285669|NCT01812837|960826|P2|Overall Study|Protocol Violation|0
285670|NCT01812837|960827|P1|Overall Study|Protocol Violation|1
285671|NCT01812837|960825|P3|Overall Study|Lost to Follow-up|0
285672|NCT01812837|960826|P2|Overall Study|Lost to Follow-up|1
285673|NCT01812837|960827|P1|Overall Study|Lost to Follow-up|1
285674|NCT01812707|960839|P4|Overall Study|Consent withdrawn by participant|0
285675|NCT01812707|960840|P3|Overall Study|Consent withdrawn by participant|0
285676|NCT01812707|960841|P2|Overall Study|Consent withdrawn by participant|0
285677|NCT01812707|960842|P1|Overall Study|Consent withdrawn by participant|1
285678|NCT01812707|960839|P4|Overall Study|Poor compliance to protocol|0
285679|NCT01812707|960840|P3|Overall Study|Poor compliance to protocol|0
285680|NCT01812707|960841|P2|Overall Study|Poor compliance to protocol|0
285681|NCT01812707|960842|P1|Overall Study|Poor compliance to protocol|1
285682|NCT01812707|960839|P4|Overall Study|Adverse Event|2
285683|NCT01812707|960840|P3|Overall Study|Adverse Event|0
285684|NCT01812707|960841|P2|Overall Study|Adverse Event|0
285685|NCT01812707|960842|P1|Overall Study|Adverse Event|0
285686|NCT01812655|960890|P3|Overall Study|Protocol Violation|0
285687|NCT01812655|960891|P2|Overall Study|Protocol Violation|1
285688|NCT01812655|960892|P1|Overall Study|Protocol Violation|1
285689|NCT01812057|960917|P2|Overall Study|Physician Decision|0
285690|NCT01812057|960918|P1|Overall Study|Physician Decision|1
285691|NCT01812057|960917|P2|Overall Study|Protocol Violation|0
285692|NCT01812057|960918|P1|Overall Study|Protocol Violation|1
285693|NCT01811953|961021|P6|Overall Study|Protocol Violation|0
285694|NCT01811953|961022|P5|Overall Study|Protocol Violation|1
285695|NCT01811953|961023|P4|Overall Study|Protocol Violation|0
285696|NCT01811953|961024|P3|Overall Study|Protocol Violation|0
285697|NCT01811953|961025|P2|Overall Study|Protocol Violation|0
285698|NCT01811953|961026|P1|Overall Study|Protocol Violation|0
285699|NCT01811953|961021|P6|Overall Study|Adverse Event|1
285700|NCT01811953|961022|P5|Overall Study|Adverse Event|0
285701|NCT01811953|961023|P4|Overall Study|Adverse Event|1
285702|NCT01811953|961024|P3|Overall Study|Adverse Event|0
285703|NCT01811953|961025|P2|Overall Study|Adverse Event|0
285704|NCT01811953|961026|P1|Overall Study|Adverse Event|0
285705|NCT01811732|961072|P2|Overall Study|Correct study drug not available on site|0
285706|NCT01811732|961073|P1|Overall Study|Correct study drug not available on site|1
285707|NCT01811732|961072|P2|Overall Study|Admitted to another facility|0
285708|NCT01811732|961073|P1|Overall Study|Admitted to another facility|1
285709|NCT01811732|961072|P2|Overall Study|Subject incarcerated|2
285710|NCT01811732|961073|P1|Overall Study|Subject incarcerated|1
285711|NCT01811732|961072|P2|Overall Study|Protocol Violation|1
285712|NCT01811732|961073|P1|Overall Study|Protocol Violation|0
285713|NCT01811732|961072|P2|Overall Study|Insufficient venous access|1
285714|NCT01811732|961073|P1|Overall Study|Insufficient venous access|0
285715|NCT01811732|961072|P2|Overall Study|Death|1
285716|NCT01811732|961073|P1|Overall Study|Death|1
285717|NCT01811732|961072|P2|Overall Study|Physician Decision|0
285718|NCT01811732|961073|P1|Overall Study|Physician Decision|2
285719|NCT01811732|961072|P2|Overall Study|Non-compliance with study drug/procedure|3
285720|NCT01811732|961073|P1|Overall Study|Non-compliance with study drug/procedure|3
285721|NCT01811732|961072|P2|Overall Study|Lack of Efficacy|1
285722|NCT01811732|961073|P1|Overall Study|Lack of Efficacy|3
285723|NCT01811732|961072|P2|Overall Study|Adverse Event|9
285724|NCT01811732|961073|P1|Overall Study|Adverse Event|3
285725|NCT01811732|961072|P2|Overall Study|Withdrawal by Subject|10
285726|NCT01811732|961073|P1|Overall Study|Withdrawal by Subject|16
285727|NCT01811732|961072|P2|Overall Study|Lost to Follow-up|30
285728|NCT01811732|961073|P1|Overall Study|Lost to Follow-up|24
285729|NCT01811706|961083|P2|First Intervention ( 4 Weeks)|Adverse Event|0
285730|NCT01811706|961084|P1|First Intervention ( 4 Weeks)|Adverse Event|1
285731|NCT01811563|961101|P2|Overall Study|Incorrect Randomization procedure|1
285732|NCT01811563|961102|P1|Overall Study|Incorrect Randomization procedure|0
285733|NCT01811563|961101|P2|Overall Study|Lost to Follow-up|2
285734|NCT01811563|961102|P1|Overall Study|Lost to Follow-up|5
285735|NCT01811485|961131|P3|Overall Study|Protocol Deviation|0
285736|NCT01811485|961132|P2|Overall Study|Protocol Deviation|1
285737|NCT01811485|961133|P1|Overall Study|Protocol Deviation|0
285738|NCT01811485|961131|P3|Overall Study|Administrative problems|0
285739|NCT01811485|961132|P2|Overall Study|Administrative problems|0
285740|NCT01811485|961133|P1|Overall Study|Administrative problems|1
285741|NCT01811485|961131|P3|Overall Study|Unsatisfactory therapeutic effect|3
285742|NCT01811485|961132|P2|Overall Study|Unsatisfactory therapeutic effect|0
285743|NCT01811485|961133|P1|Overall Study|Unsatisfactory therapeutic effect|0
285744|NCT01811485|961131|P3|Overall Study|Adverse Event|2
285745|NCT01811485|961132|P2|Overall Study|Adverse Event|3
285746|NCT01811485|961133|P1|Overall Study|Adverse Event|1
285747|NCT01811472|961153|P3|Overall Study|Subject/guardian decision|0
285748|NCT01811472|961154|P2|Overall Study|Subject/guardian decision|0
285749|NCT01811472|961155|P1|Overall Study|Subject/guardian decision|1
285750|NCT01811472|961153|P3|Overall Study|Lost to Follow-up|1
285751|NCT01811472|961154|P2|Overall Study|Lost to Follow-up|0
285752|NCT01811472|961155|P1|Overall Study|Lost to Follow-up|0
285753|NCT01811472|961153|P3|Overall Study|Adverse Event|4
285754|NCT01811472|961154|P2|Overall Study|Adverse Event|0
285755|NCT01811472|961155|P1|Overall Study|Adverse Event|1
285756|NCT01811238|961242|P1|Overall Study|subject refused study medication|6
285757|NCT01811238|961242|P1|Overall Study|Lack of Efficacy|4
285758|NCT01811238|961242|P1|Overall Study|Protocol Violation|4
285759|NCT01811238|961242|P1|Overall Study|Adverse Event|25
285760|NCT01811238|961242|P1|Overall Study|Withdrawal by Subject|42
285761|NCT01811186|961266|P2|Overall Study|Lost to Follow-up|2
285762|NCT01811186|961267|P1|Overall Study|Lost to Follow-up|4
285763|NCT01811186|961266|P2|Overall Study|Lack of Efficacy|6
285764|NCT01811186|961267|P1|Overall Study|Lack of Efficacy|3
285765|NCT01811186|961266|P2|Overall Study|Withdrawal by Subject|10
285766|NCT01811186|961267|P1|Overall Study|Withdrawal by Subject|5
285767|NCT01811186|961266|P2|Overall Study|Protocol Violation|6
285768|NCT01811186|961267|P1|Overall Study|Protocol Violation|5
285769|NCT01811186|961266|P2|Overall Study|Adverse Event|38
285770|NCT01811186|961267|P1|Overall Study|Adverse Event|54
285771|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
285772|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
285773|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
285774|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
285775|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
285776|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
285777|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
285778|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
285779|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
285780|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
285781|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
285782|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
285783|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
285784|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
285785|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
285786|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
285787|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
285788|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
285789|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Death|1
285790|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Death|0
285791|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Death|0
285792|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
285793|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
285794|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
285795|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
285796|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
285797|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
285798|NCT01810939|961300|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
285799|NCT01810939|961301|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
285800|NCT01810939|961302|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
285801|NCT01810939|961300|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
285802|NCT01810939|961301|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
285803|NCT01810939|961302|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
285804|NCT01810939|961300|P3|Part A Treatment Period|Protocol-specified (High K+)|0
285805|NCT01810939|961301|P2|Part A Treatment Period|Protocol-specified (High K+)|0
285806|NCT01810939|961302|P1|Part A Treatment Period|Protocol-specified (High K+)|3
285807|NCT01810939|961300|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
285808|NCT01810939|961301|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
285809|NCT01810939|961302|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
285810|NCT01810939|961300|P3|Part A Treatment Period|Withdrawal by Subject|0
285811|NCT01810939|961301|P2|Part A Treatment Period|Withdrawal by Subject|0
285812|NCT01810939|961302|P1|Part A Treatment Period|Withdrawal by Subject|5
285813|NCT01810939|961300|P3|Part A Treatment Period|Adverse Event|0
285814|NCT01810939|961301|P2|Part A Treatment Period|Adverse Event|0
285815|NCT01810939|961302|P1|Part A Treatment Period|Adverse Event|10
285816|NCT01810939|961300|P3|Part A Treatment Period|Protocol Violation|0
285817|NCT01810939|961301|P2|Part A Treatment Period|Protocol Violation|0
285818|NCT01810939|961302|P1|Part A Treatment Period|Protocol Violation|2
285819|NCT01810939|961300|P3|Part A Treatment Period|Non-compliance with Study Drug|0
285820|NCT01810939|961301|P2|Part A Treatment Period|Non-compliance with Study Drug|0
285821|NCT01810939|961302|P1|Part A Treatment Period|Non-compliance with Study Drug|1
285822|NCT01810783|961315|P1|Overall Study|Enrolled, not treated|1
285823|NCT01810783|961315|P1|Overall Study|Adminstrative or other reason(s)|23
285824|NCT01810783|961315|P1|Overall Study|Non-compliance with IMP|4
285825|NCT01810783|961315|P1|Overall Study|Protocol Violation|5
285826|NCT01810783|961315|P1|Overall Study|Lost to Follow-up|10
285827|NCT01810783|961315|P1|Overall Study|Lack of Efficacy|12
285828|NCT01810783|961315|P1|Overall Study|Withdrawal by Subject|22
285829|NCT01810783|961315|P1|Overall Study|Adverse Event|32
285830|NCT01810380|961343|P3|Overall Study|Administrative or other reasons|9
285831|NCT01810380|961344|P2|Overall Study|Administrative or other reasons|13
285832|NCT01810380|961345|P1|Overall Study|Administrative or other reasons|11
285833|NCT01810380|961343|P3|Overall Study|Withdrawal by Subject|6
285834|NCT01810380|961344|P2|Overall Study|Withdrawal by Subject|0
285835|NCT01810380|961345|P1|Overall Study|Withdrawal by Subject|6
285836|NCT01810380|961343|P3|Overall Study|Protocol Violation|1
285837|NCT01810380|961344|P2|Overall Study|Protocol Violation|0
285838|NCT01810380|961345|P1|Overall Study|Protocol Violation|1
285839|NCT01810380|961343|P3|Overall Study|Lack of Efficacy|11
285840|NCT01810380|961344|P2|Overall Study|Lack of Efficacy|10
285841|NCT01810380|961345|P1|Overall Study|Lack of Efficacy|24
285842|NCT01810380|961343|P3|Overall Study|Adverse Event|4
285843|NCT01810380|961344|P2|Overall Study|Adverse Event|14
285844|NCT01810380|961345|P1|Overall Study|Adverse Event|11
285845|NCT01810380|961343|P3|Overall Study|Randomised not treated|1
285846|NCT01810380|961344|P2|Overall Study|Randomised not treated|1
285847|NCT01810380|961345|P1|Overall Study|Randomised not treated|2
285848|NCT01810302|961406|P2|Overall Study|Physician Decision|1
285849|NCT01810302|961407|P1|Overall Study|Physician Decision|0
285850|NCT01810302|961406|P2|Overall Study|Death|0
285851|NCT01810302|961407|P1|Overall Study|Death|1
285852|NCT01810263|961426|P2|Overall Study|Lost to Follow-up|7
285853|NCT01810263|961427|P1|Overall Study|Lost to Follow-up|8
285854|NCT01810042|961433|P1|Overall Study|Lost to Follow-up|10
285855|NCT01809327|961499|P5|Overall Study|Other|9
285856|NCT01809327|961500|P4|Overall Study|Other|4
285857|NCT01809327|961501|P3|Overall Study|Other|7
285858|NCT01809327|961502|P2|Overall Study|Other|15
285859|NCT01809327|961503|P1|Overall Study|Other|14
285860|NCT01809327|961499|P5|Overall Study|Pregnancy|0
285861|NCT01809327|961500|P4|Overall Study|Pregnancy|0
285862|NCT01809327|961501|P3|Overall Study|Pregnancy|0
285863|NCT01809327|961502|P2|Overall Study|Pregnancy|0
285864|NCT01809327|961503|P1|Overall Study|Pregnancy|1
285865|NCT01809327|961499|P5|Overall Study|Physician Decision|0
285866|NCT01809327|961500|P4|Overall Study|Physician Decision|0
285867|NCT01809327|961501|P3|Overall Study|Physician Decision|0
285868|NCT01809327|961502|P2|Overall Study|Physician Decision|1
285869|NCT01809327|961503|P1|Overall Study|Physician Decision|1
285870|NCT01809327|961499|P5|Overall Study|Protocol Violation|0
285871|NCT01809327|961500|P4|Overall Study|Protocol Violation|0
285872|NCT01809327|961501|P3|Overall Study|Protocol Violation|0
285873|NCT01809327|961502|P2|Overall Study|Protocol Violation|1
285874|NCT01809327|961503|P1|Overall Study|Protocol Violation|0
285875|NCT01809327|961499|P5|Overall Study|Death|0
285876|NCT01809327|961500|P4|Overall Study|Death|0
285877|NCT01809327|961501|P3|Overall Study|Death|0
285878|NCT01809327|961502|P2|Overall Study|Death|0
285879|NCT01809327|961503|P1|Overall Study|Death|1
285880|NCT01809327|961499|P5|Overall Study|Adverse Event|8
285881|NCT01809327|961500|P4|Overall Study|Adverse Event|4
285882|NCT01809327|961501|P3|Overall Study|Adverse Event|7
285883|NCT01809327|961502|P2|Overall Study|Adverse Event|3
285884|NCT01809327|961503|P1|Overall Study|Adverse Event|4
285885|NCT01809327|961499|P5|Overall Study|Withdrawal by Subject|5
285886|NCT01809327|961500|P4|Overall Study|Withdrawal by Subject|2
285887|NCT01809327|961501|P3|Overall Study|Withdrawal by Subject|4
285888|NCT01809327|961502|P2|Overall Study|Withdrawal by Subject|4
285889|NCT01809327|961503|P1|Overall Study|Withdrawal by Subject|6
285890|NCT01809327|961499|P5|Overall Study|Lost to Follow-up|3
285891|NCT01809327|961500|P4|Overall Study|Lost to Follow-up|2
285892|NCT01809327|961501|P3|Overall Study|Lost to Follow-up|4
285893|NCT01809327|961502|P2|Overall Study|Lost to Follow-up|2
285894|NCT01809327|961503|P1|Overall Study|Lost to Follow-up|5
285895|NCT01809314|961545|P1|Overall Study|Lost to Follow-up|724
285896|NCT01809314|961545|P1|Overall Study|Insufficient Therapeutic Response|14
285897|NCT01809314|961545|P1|Overall Study|Adverse Event|6
285898|NCT01809314|961545|P1|Overall Study|Withdrawal Prior to Treatment|1
285899|NCT01809262|961551|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
285900|NCT01809262|961552|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
285901|NCT01809262|961553|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
285902|NCT01809262|961554|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
285903|NCT01809262|961555|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
285904|NCT01809262|961556|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
285905|NCT01809262|961557|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
285906|NCT01809262|961558|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
285907|NCT01809262|961559|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
285908|NCT01809262|961560|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
285909|NCT01809262|961551|P10|Period 1 (First Dose + Washout)|Adverse Event|0
285910|NCT01809262|961552|P9|Period 1 (First Dose + Washout)|Adverse Event|0
285911|NCT01809262|961553|P8|Period 1 (First Dose + Washout)|Adverse Event|0
285912|NCT01809262|961554|P7|Period 1 (First Dose + Washout)|Adverse Event|0
285913|NCT01809262|961555|P6|Period 1 (First Dose + Washout)|Adverse Event|0
285914|NCT01809262|961556|P5|Period 1 (First Dose + Washout)|Adverse Event|1
285915|NCT01809262|961557|P4|Period 1 (First Dose + Washout)|Adverse Event|0
285916|NCT01809262|961558|P3|Period 1 (First Dose + Washout)|Adverse Event|0
285917|NCT01809262|961559|P2|Period 1 (First Dose + Washout)|Adverse Event|0
285918|NCT01809262|961560|P1|Period 1 (First Dose + Washout)|Adverse Event|0
285919|NCT01809210|961634|P7|Overall Study|Death|1
285920|NCT01809210|961635|P6|Overall Study|Death|3
285921|NCT01809210|961636|P5|Overall Study|Death|1
285922|NCT01809210|961637|P4|Overall Study|Death|0
285923|NCT01809210|961638|P3|Overall Study|Death|2
285924|NCT01809210|961639|P2|Overall Study|Death|1
285925|NCT01809210|961640|P1|Overall Study|Death|1
285926|NCT01809210|961634|P7|Overall Study|Withdrawal by Subject|4
285927|NCT01809210|961635|P6|Overall Study|Withdrawal by Subject|0
285928|NCT01809210|961636|P5|Overall Study|Withdrawal by Subject|1
285929|NCT01809210|961637|P4|Overall Study|Withdrawal by Subject|1
285930|NCT01809210|961638|P3|Overall Study|Withdrawal by Subject|1
285931|NCT01809210|961639|P2|Overall Study|Withdrawal by Subject|0
285932|NCT01809210|961640|P1|Overall Study|Withdrawal by Subject|0
285933|NCT01809197|961714|P2|Overall Study|Product not available|1
285934|NCT01809197|961715|P1|Overall Study|Product not available|0
285935|NCT01809197|961714|P2|Overall Study|Withdrawal by Subject|1
285936|NCT01809197|961715|P1|Overall Study|Withdrawal by Subject|1
285937|NCT01809197|961714|P2|Overall Study|Decision Unrelated to an Adverse Event|0
285938|NCT01809197|961715|P1|Overall Study|Decision Unrelated to an Adverse Event|1
285939|NCT01809197|961714|P2|Overall Study|Non-Compliance|1
285940|NCT01809197|961715|P1|Overall Study|Non-Compliance|1
285941|NCT01809197|961714|P2|Overall Study|Failed slit lamp exam|0
285942|NCT01809197|961715|P1|Overall Study|Failed slit lamp exam|1
285943|NCT01809197|961714|P2|Overall Study|Adverse Event|3
285944|NCT01809197|961715|P1|Overall Study|Adverse Event|2
285945|NCT01809197|961714|P2|Overall Study|Lost to Follow-up|2
285946|NCT01809197|961715|P1|Overall Study|Lost to Follow-up|4
285947|NCT01808651|961786|P3|Study Period 1|Participant Decision|3
285948|NCT01808651|961787|P2|Study Period 1|Participant Decision|7
285949|NCT01808651|961788|P1|Study Period 1|Participant Decision|9
285950|NCT01808651|961786|P3|Study Period 1|Adverse Event|1
285951|NCT01808651|961787|P2|Study Period 1|Adverse Event|4
285952|NCT01808651|961788|P1|Study Period 1|Adverse Event|10
285953|NCT01808651|961786|P3|Study Period 1|Lack of Efficacy|0
285954|NCT01808651|961787|P2|Study Period 1|Lack of Efficacy|1
285955|NCT01808651|961788|P1|Study Period 1|Lack of Efficacy|2
285956|NCT01808651|961786|P3|Study Period 1|Physician Decision|0
285957|NCT01808651|961787|P2|Study Period 1|Physician Decision|2
285958|NCT01808651|961788|P1|Study Period 1|Physician Decision|3
285959|NCT01808651|961786|P3|Study Period 1|Protocol Violation|1
285960|NCT01808651|961787|P2|Study Period 1|Protocol Violation|0
285961|NCT01808651|961788|P1|Study Period 1|Protocol Violation|1
285962|NCT01808651|961786|P3|Study Period 1|Lost to Follow-up|0
285963|NCT01808651|961787|P2|Study Period 1|Lost to Follow-up|3
285964|NCT01808651|961788|P1|Study Period 1|Lost to Follow-up|1
285965|NCT01808612|961823|P3|Discontinuation Period|Lost to Follow-up|0
285966|NCT01808612|961824|P2|Discontinuation Period|Lost to Follow-up|1
285967|NCT01808612|961825|P1|Discontinuation Period|Lost to Follow-up|0
285968|NCT01808612|961823|P3|Discontinuation Period|Physician Decision|0
285969|NCT01808612|961824|P2|Discontinuation Period|Physician Decision|0
285970|NCT01808612|961825|P1|Discontinuation Period|Physician Decision|1
285971|NCT01808612|961823|P3|Discontinuation Period|Adverse Event|0
285972|NCT01808612|961824|P2|Discontinuation Period|Adverse Event|0
285973|NCT01808612|961825|P1|Discontinuation Period|Adverse Event|1
285974|NCT01808612|961823|P3|Treatment Period|Lack of Efficacy|2
285975|NCT01808612|961824|P2|Treatment Period|Lack of Efficacy|1
285976|NCT01808612|961825|P1|Treatment Period|Lack of Efficacy|1
285977|NCT01808612|961823|P3|Treatment Period|Sponsor Decision|0
285978|NCT01808612|961824|P2|Treatment Period|Sponsor Decision|0
285979|NCT01808612|961825|P1|Treatment Period|Sponsor Decision|1
285980|NCT01808612|961823|P3|Treatment Period|Physician Decision|4
285981|NCT01808612|961824|P2|Treatment Period|Physician Decision|0
285982|NCT01808612|961825|P1|Treatment Period|Physician Decision|1
285983|NCT01808612|961823|P3|Treatment Period|Withdrawal by Subject|4
285984|NCT01808612|961824|P2|Treatment Period|Withdrawal by Subject|0
285985|NCT01808612|961825|P1|Treatment Period|Withdrawal by Subject|1
285986|NCT01808612|961823|P3|Treatment Period|Protocol Violation|0
285987|NCT01808612|961824|P2|Treatment Period|Protocol Violation|0
285988|NCT01808612|961825|P1|Treatment Period|Protocol Violation|1
285989|NCT01808612|961823|P3|Treatment Period|Lost to Follow-up|1
285990|NCT01808612|961824|P2|Treatment Period|Lost to Follow-up|2
285991|NCT01808612|961825|P1|Treatment Period|Lost to Follow-up|2
285992|NCT01808612|961823|P3|Treatment Period|Adverse Event|3
285993|NCT01808612|961824|P2|Treatment Period|Adverse Event|4
285994|NCT01808612|961825|P1|Treatment Period|Adverse Event|8
285995|NCT01808534|961891|P1|Overall Study|Physician Decision|1
285996|NCT01808534|961891|P1|Overall Study|Disease progression|3
285997|NCT01808508|961902|P3|Overall Study|Lost to Follow-up|0
285998|NCT01808508|961903|P2|Overall Study|Lost to Follow-up|0
285999|NCT01808508|961904|P1|Overall Study|Lost to Follow-up|1
286000|NCT01808339|961921|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
286001|NCT01808339|961922|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
286002|NCT01808339|961923|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
286003|NCT01808339|961924|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
286004|NCT01808339|961925|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
286005|NCT01808339|961926|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
286006|NCT01808339|961921|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
286007|NCT01808339|961922|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
286008|NCT01808339|961923|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
286009|NCT01808339|961924|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
286010|NCT01808339|961925|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
286011|NCT01808339|961926|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
286012|NCT01808339|961921|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
286013|NCT01808339|961922|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
286014|NCT01808339|961923|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
286015|NCT01808339|961924|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
286016|NCT01808339|961925|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
286017|NCT01808339|961926|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
286018|NCT01808313|961970|P1|Overall Study|Physician Decision|1
286019|NCT01808313|961970|P1|Overall Study|Lost to Follow-up|1
286020|NCT01808313|961970|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
286021|NCT01808313|961970|P1|Overall Study|Protocol Violation|2
286022|NCT01808313|961970|P1|Overall Study|Adverse Event|5
286023|NCT01808261|962000|P2|Overall Study|Lost to Follow-up|1
286024|NCT01808261|962001|P1|Overall Study|Lost to Follow-up|3
286025|NCT01808261|962000|P2|Overall Study|Consent withdrawn by subject|7
286026|NCT01808261|962001|P1|Overall Study|Consent withdrawn by subject|6
286027|NCT01808261|962000|P2|Overall Study|Adverse event, non-fatal|0
286028|NCT01808261|962001|P1|Overall Study|Adverse event, non-fatal|2
286029|NCT01808261|962000|P2|Overall Study|Study Closed/Terminated|23
286030|NCT01808261|962001|P1|Overall Study|Study Closed/Terminated|25
286031|NCT01808261|962000|P2|Overall Study|Physician Decision|2
286032|NCT01808261|962001|P1|Overall Study|Physician Decision|0
286033|NCT01808248|962057|P1|Overall Study|Lost to Follow-up|1
286034|NCT01808248|962057|P1|Overall Study|Withdrawal by Subject|1
286035|NCT01808248|962057|P1|Overall Study|Lack of Efficacy|3
286036|NCT01808209|962071|P2|Overall Study|Lost to Follow-up|1
286037|NCT01808209|962072|P1|Overall Study|Lost to Follow-up|0
286038|NCT01808144|962116|P2|Overall Study|Adverse Event|15
286039|NCT01808144|962117|P1|Overall Study|Adverse Event|11
286040|NCT01808144|962116|P2|Overall Study|Gout flare|1
286041|NCT01808144|962117|P1|Overall Study|Gout flare|0
286042|NCT01808144|962116|P2|Overall Study|Protocol Violation|6
286043|NCT01808144|962117|P1|Overall Study|Protocol Violation|6
286044|NCT01808144|962116|P2|Overall Study|Lost to Follow-up|3
286045|NCT01808144|962117|P1|Overall Study|Lost to Follow-up|6
286046|NCT01808144|962116|P2|Overall Study|Withdrawal by Subject|23
286047|NCT01808144|962117|P1|Overall Study|Withdrawal by Subject|16
286048|NCT01808144|962116|P2|Overall Study|Death|0
286049|NCT01808144|962117|P1|Overall Study|Death|1
286050|NCT01808118|962125|P3|Period 2|Switched to other therapy|0
286051|NCT01808118|962126|P2|Period 2|Switched to other therapy|1
286052|NCT01808118|962127|P1|Period 2|Switched to other therapy|0
286053|NCT01808118|962125|P3|Period 2|Investigator no longer conducting trials|0
286054|NCT01808118|962126|P2|Period 2|Investigator no longer conducting trials|1
286055|NCT01808118|962127|P1|Period 2|Investigator no longer conducting trials|0
286056|NCT01808118|962125|P3|Period 2|Lost to Follow-up|2
286057|NCT01808118|962126|P2|Period 2|Lost to Follow-up|0
286058|NCT01808118|962127|P1|Period 2|Lost to Follow-up|0
286059|NCT01808118|962125|P3|Period 2|Withdrew consent|6
286060|NCT01808118|962126|P2|Period 2|Withdrew consent|7
286061|NCT01808118|962127|P1|Period 2|Withdrew consent|0
286062|NCT01808118|962125|P3|Period 2|Adverse Event|0
286063|NCT01808118|962126|P2|Period 2|Adverse Event|4
286064|NCT01808118|962127|P1|Period 2|Adverse Event|0
286065|NCT01808118|962125|P3|Period 1|Lack of Efficacy|0
286066|NCT01808118|962126|P2|Period 1|Lack of Efficacy|0
286067|NCT01808118|962127|P1|Period 1|Lack of Efficacy|1
286068|NCT01808118|962125|P3|Period 1|Non-compliance per sponsor|0
286069|NCT01808118|962126|P2|Period 1|Non-compliance per sponsor|0
286070|NCT01808118|962127|P1|Period 1|Non-compliance per sponsor|1
286071|NCT01808118|962125|P3|Period 1|Investigator decision: site closure|0
286072|NCT01808118|962126|P2|Period 1|Investigator decision: site closure|0
286073|NCT01808118|962127|P1|Period 1|Investigator decision: site closure|2
286074|NCT01808118|962125|P3|Period 1|Non-conformance with inclusion criteria|0
286075|NCT01808118|962126|P2|Period 1|Non-conformance with inclusion criteria|0
286076|NCT01808118|962127|P1|Period 1|Non-conformance with inclusion criteria|3
286077|NCT01808118|962125|P3|Period 1|Did not meet inclusion criteria|0
286078|NCT01808118|962126|P2|Period 1|Did not meet inclusion criteria|0
286079|NCT01808118|962127|P1|Period 1|Did not meet inclusion criteria|3
286080|NCT01808118|962125|P3|Period 1|Enrolled in error|0
286081|NCT01808118|962126|P2|Period 1|Enrolled in error|0
286082|NCT01808118|962127|P1|Period 1|Enrolled in error|7
286083|NCT01808118|962125|P3|Period 1|Did not meet criteria for remission|0
286084|NCT01808118|962126|P2|Period 1|Did not meet criteria for remission|0
286085|NCT01808118|962127|P1|Period 1|Did not meet criteria for remission|303
286086|NCT01808118|962125|P3|Period 1|Lost to Follow-up|0
286087|NCT01808118|962126|P2|Period 1|Lost to Follow-up|0
286088|NCT01808118|962127|P1|Period 1|Lost to Follow-up|9
286089|NCT01808118|962125|P3|Period 1|Withdrew consent|0
286090|NCT01808118|962126|P2|Period 1|Withdrew consent|0
286091|NCT01808118|962127|P1|Period 1|Withdrew consent|24
286092|NCT01808118|962125|P3|Period 1|Adverse Event|0
286093|NCT01808118|962126|P2|Period 1|Adverse Event|0
286094|NCT01808118|962127|P1|Period 1|Adverse Event|15
286095|NCT01808092|962190|P2|Overall Study|Other Eligibility criteria|5
286096|NCT01808092|962191|P1|Overall Study|Other Eligibility criteria|3
286097|NCT01808092|962190|P2|Overall Study|Withdrawal by Subject|4
286098|NCT01808092|962191|P1|Overall Study|Withdrawal by Subject|9
286099|NCT01808092|962190|P2|Overall Study|Lost to Follow-up|7
286100|NCT01808092|962191|P1|Overall Study|Lost to Follow-up|3
286101|NCT01808092|962190|P2|Overall Study|Death|29
286102|NCT01808092|962191|P1|Overall Study|Death|39
286103|NCT01808066|962293|P1|Overall Study|Withdrawal by Subject|15
286104|NCT01807949|962300|P3|Overall Study|Randomized But Not Treated|2
286105|NCT01807949|962301|P2|Overall Study|Randomized But Not Treated|2
286106|NCT01807949|962302|P1|Overall Study|Randomized But Not Treated|0
286107|NCT01807949|962300|P3|Overall Study|Undefined|2
286108|NCT01807949|962301|P2|Overall Study|Undefined|1
286109|NCT01807949|962302|P1|Overall Study|Undefined|0
286110|NCT01807949|962300|P3|Overall Study|Non-Compliance|1
286111|NCT01807949|962301|P2|Overall Study|Non-Compliance|0
286112|NCT01807949|962302|P1|Overall Study|Non-Compliance|0
286113|NCT01807949|962300|P3|Overall Study|Withdrawal by Subject|2
286114|NCT01807949|962301|P2|Overall Study|Withdrawal by Subject|2
286115|NCT01807949|962302|P1|Overall Study|Withdrawal by Subject|1
286116|NCT01807949|962300|P3|Overall Study|Adverse Event|2
286117|NCT01807949|962301|P2|Overall Study|Adverse Event|2
286118|NCT01807949|962302|P1|Overall Study|Adverse Event|1
286119|NCT01807923|962354|P3|Overall Study|Randomized But Not Treated|5
286120|NCT01807923|962355|P2|Overall Study|Randomized But Not Treated|2
286121|NCT01807923|962356|P1|Overall Study|Randomized But Not Treated|3
286122|NCT01807923|962354|P3|Overall Study|Not Eligible (Genotype)|1
286123|NCT01807923|962355|P2|Overall Study|Not Eligible (Genotype)|0
286124|NCT01807923|962356|P1|Overall Study|Not Eligible (Genotype)|0
286125|NCT01807923|962354|P3|Overall Study|Physician Decision|1
286126|NCT01807923|962355|P2|Overall Study|Physician Decision|0
286127|NCT01807923|962356|P1|Overall Study|Physician Decision|0
286128|NCT01807923|962354|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
286129|NCT01807923|962355|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
286130|NCT01807923|962356|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
286131|NCT01807923|962354|P3|Overall Study|Adverse Event|2
286132|NCT01807923|962355|P2|Overall Study|Adverse Event|1
286133|NCT01807923|962356|P1|Overall Study|Adverse Event|2
286134|NCT01807520|962455|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
286135|NCT01807520|962456|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
286136|NCT01807520|962457|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
286137|NCT01807520|962458|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
286138|NCT01807520|962459|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
286139|NCT01807520|962460|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
286140|NCT01807520|962461|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
286141|NCT01807520|962455|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
286142|NCT01807520|962456|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
286143|NCT01807520|962457|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
286144|NCT01807520|962458|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
286145|NCT01807520|962459|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
286146|NCT01807520|962460|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
286147|NCT01807520|962461|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
286148|NCT01807520|962455|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
286149|NCT01807520|962456|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
286150|NCT01807520|962457|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
286151|NCT01807520|962458|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
286152|NCT01807520|962459|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
286153|NCT01807520|962460|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
286154|NCT01807520|962461|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
286155|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
286156|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
286157|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
286158|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
286159|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
286160|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
286161|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
286162|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
286163|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
286164|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
286165|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
286166|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
286167|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
286168|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
286169|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
286170|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
286171|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
286172|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
286173|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
286174|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
286175|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
286176|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
286177|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
286178|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
286179|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
286180|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
286181|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
286182|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
286183|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
286184|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
286185|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
286186|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
286187|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
286188|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
286189|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
286190|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
286191|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
286192|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
286193|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
286194|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
286195|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
286196|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
286197|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
286198|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
286199|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
286200|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
286201|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
286202|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
286203|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
286204|NCT01807520|962455|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
286205|NCT01807520|962456|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
286206|NCT01807520|962457|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
286207|NCT01807520|962458|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
286208|NCT01807520|962459|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
286209|NCT01807520|962460|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
286210|NCT01807520|962461|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
286211|NCT01807520|962455|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
286212|NCT01807520|962456|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
286213|NCT01807520|962457|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
286214|NCT01807520|962458|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
286215|NCT01807520|962459|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
286216|NCT01807520|962460|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
286217|NCT01807520|962461|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
286218|NCT01807520|962455|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
286219|NCT01807520|962456|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
286220|NCT01807520|962457|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
286221|NCT01807520|962458|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
286222|NCT01807520|962459|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
286223|NCT01807520|962460|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
286224|NCT01807520|962461|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
286225|NCT01807520|962455|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
286226|NCT01807520|962456|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
286227|NCT01807520|962457|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
286228|NCT01807520|962458|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
286229|NCT01807520|962459|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
286230|NCT01807520|962460|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
286231|NCT01807520|962461|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
286232|NCT01807520|962455|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
286233|NCT01807520|962456|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
286234|NCT01807520|962457|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
286235|NCT01807520|962458|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
286236|NCT01807520|962459|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
286237|NCT01807520|962460|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
286238|NCT01807520|962461|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
286239|NCT01807520|962455|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
286240|NCT01807520|962456|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
286241|NCT01807520|962457|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
286242|NCT01807520|962458|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
286243|NCT01807520|962459|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
286244|NCT01807520|962460|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
286245|NCT01807520|962461|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
286246|NCT01807520|962455|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
286247|NCT01807520|962456|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
286248|NCT01807520|962457|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
286249|NCT01807520|962458|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
286250|NCT01807520|962459|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
286251|NCT01807520|962460|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
286252|NCT01807520|962461|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
286253|NCT01807234|962494|P6|Overall Study|Lack of Efficacy|1
286254|NCT01807234|962495|P5|Overall Study|Lack of Efficacy|1
286255|NCT01807234|962496|P4|Overall Study|Lack of Efficacy|0
286256|NCT01807234|962497|P3|Overall Study|Lack of Efficacy|0
286257|NCT01807234|962498|P2|Overall Study|Lack of Efficacy|0
286258|NCT01807234|962499|P1|Overall Study|Lack of Efficacy|0
286259|NCT01807234|962494|P6|Overall Study|Withdrawal by Subject|1
286260|NCT01807234|962495|P5|Overall Study|Withdrawal by Subject|2
286261|NCT01807234|962496|P4|Overall Study|Withdrawal by Subject|1
286262|NCT01807234|962497|P3|Overall Study|Withdrawal by Subject|1
286263|NCT01807234|962498|P2|Overall Study|Withdrawal by Subject|1
286264|NCT01807234|962499|P1|Overall Study|Withdrawal by Subject|3
286265|NCT01807234|962494|P6|Overall Study|Lost to Follow-up|2
286266|NCT01807234|962495|P5|Overall Study|Lost to Follow-up|1
286267|NCT01807234|962496|P4|Overall Study|Lost to Follow-up|1
286268|NCT01807234|962497|P3|Overall Study|Lost to Follow-up|1
286269|NCT01807234|962498|P2|Overall Study|Lost to Follow-up|5
286270|NCT01807234|962499|P1|Overall Study|Lost to Follow-up|2
286271|NCT01807156|962534|P1|Overall Study|Physician Decision|1
286272|NCT01806961|962558|P1|Overall Study|sponsor decision|16
286273|NCT01806896|962564|P2|Overall Study|Other|0
286274|NCT01806896|962565|P1|Overall Study|Other|1
286275|NCT01806896|962564|P2|Overall Study|Adverse Event|0
286276|NCT01806896|962565|P1|Overall Study|Adverse Event|2
286277|NCT01806779|962632|P3|Overall Study|Withdrawal by Subject|22
286278|NCT01806779|962633|P2|Overall Study|Withdrawal by Subject|23
286279|NCT01806779|962634|P1|Overall Study|Withdrawal by Subject|20
286280|NCT01806779|962632|P3|Overall Study|Lost to Follow-up|0
286281|NCT01806779|962633|P2|Overall Study|Lost to Follow-up|20
286282|NCT01806779|962634|P1|Overall Study|Lost to Follow-up|19
286283|NCT01806779|962632|P3|Overall Study|Lack of Efficacy|0
286284|NCT01806779|962633|P2|Overall Study|Lack of Efficacy|1
286285|NCT01806779|962634|P1|Overall Study|Lack of Efficacy|1
286286|NCT01806779|962632|P3|Overall Study|Physician Decision|1
286287|NCT01806779|962633|P2|Overall Study|Physician Decision|0
286288|NCT01806779|962634|P1|Overall Study|Physician Decision|2
286289|NCT01806714|962649|P2|Overall Study|No functioning phone number|170
286290|NCT01806714|962650|P1|Overall Study|No functioning phone number|200
286291|NCT01806662|962660|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
286292|NCT01806662|962661|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
286293|NCT01806662|962660|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
286294|NCT01806662|962661|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
286295|NCT01806662|962660|P2|First Intervention (Weeks 0-16)|Adverse Event|1
286296|NCT01806662|962661|P1|First Intervention (Weeks 0-16)|Adverse Event|0
286297|NCT01806662|962660|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
286298|NCT01806662|962661|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
286299|NCT01806623|962667|P1|Overall Study|Did not meet the inclusion criteria|56
286300|NCT01806623|962667|P1|Overall Study|Adverse Event|1
286301|NCT01806623|962667|P1|Overall Study|Withdrawal by Subject|1
286302|NCT01806597|962687|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
286303|NCT01806597|962688|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
286304|NCT01806597|962689|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
286305|NCT01806597|962690|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
286306|NCT01806597|962691|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
286307|NCT01806597|962692|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
286308|NCT01806597|962687|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
286309|NCT01806597|962688|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
286310|NCT01806597|962689|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
286311|NCT01806597|962690|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
286312|NCT01806597|962691|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
286313|NCT01806597|962692|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
286314|NCT01806597|962687|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
286315|NCT01806597|962688|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
286316|NCT01806597|962689|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
286317|NCT01806597|962690|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
286318|NCT01806597|962691|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
286319|NCT01806597|962692|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
286320|NCT01806597|962687|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
286321|NCT01806597|962688|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
286322|NCT01806597|962689|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
286323|NCT01806597|962690|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
286324|NCT01806597|962691|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
286325|NCT01806597|962692|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
286326|NCT01806597|962687|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
286327|NCT01806597|962688|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
286328|NCT01806597|962689|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
286329|NCT01806597|962690|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
286330|NCT01806597|962691|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
286331|NCT01806597|962692|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
286332|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
286333|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
286334|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
286335|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
286336|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
286337|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
286338|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
286339|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
286340|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
286341|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
286342|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
286343|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
286344|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
286345|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
286346|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
286347|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
286348|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
286349|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
286350|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
286351|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
286352|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
286353|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
286354|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
286355|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
286356|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
286357|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
286358|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
286359|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
286360|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
286361|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
286362|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
286363|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
286364|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
286365|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
286366|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
286367|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
286368|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
286369|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
286370|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
286371|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
286372|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
286373|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
286374|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
286375|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
286376|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
286377|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
286378|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
286379|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
286380|NCT01806597|962687|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
286381|NCT01806597|962688|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
286382|NCT01806597|962689|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
286383|NCT01806597|962690|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
286384|NCT01806597|962691|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
286385|NCT01806597|962692|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
286386|NCT01806597|962687|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
286387|NCT01806597|962688|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
286388|NCT01806597|962689|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
286389|NCT01806597|962690|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
286390|NCT01806597|962691|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
286391|NCT01806597|962692|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
286392|NCT01806597|962687|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
286393|NCT01806597|962688|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
286394|NCT01806597|962689|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
286395|NCT01806597|962690|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
286396|NCT01806597|962691|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
286397|NCT01806597|962692|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
286398|NCT01806597|962687|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
286399|NCT01806597|962688|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
286400|NCT01806597|962689|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
286401|NCT01806597|962690|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
286402|NCT01806597|962691|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
286403|NCT01806597|962692|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
286404|NCT01806597|962687|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
286405|NCT01806597|962688|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
286406|NCT01806597|962689|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
286407|NCT01806597|962690|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
286408|NCT01806597|962691|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
286409|NCT01806597|962692|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
286410|NCT01806597|962687|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
286411|NCT01806597|962688|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
286412|NCT01806597|962689|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
286413|NCT01806597|962690|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
286414|NCT01806597|962691|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
286415|NCT01806597|962692|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
286416|NCT01806584|962728|P2|Overall Study|Other unspecified|0
286417|NCT01806584|962729|P1|Overall Study|Other unspecified|1
286418|NCT01806584|962728|P2|Overall Study|Withdrawal by Subject|1
286419|NCT01806584|962729|P1|Overall Study|Withdrawal by Subject|1
286420|NCT01806584|962728|P2|Overall Study|Study terminated by sponsor|14
286421|NCT01806584|962729|P1|Overall Study|Study terminated by sponsor|9
286422|NCT01806584|962728|P2|Overall Study|Lost to Follow-up|2
286423|NCT01806584|962729|P1|Overall Study|Lost to Follow-up|0
286424|NCT01806584|962728|P2|Overall Study|Death|0
286425|NCT01806584|962729|P1|Overall Study|Death|1
286426|NCT01806584|962728|P2|Overall Study|Adverse Event|1
286427|NCT01806584|962729|P1|Overall Study|Adverse Event|2
286428|NCT01806545|962743|P2|Overall Study|Withdrawal by Subject|2
286429|NCT01806545|962744|P1|Overall Study|Withdrawal by Subject|3
286430|NCT01806545|962743|P2|Overall Study|Lost to Follow-up|0
286431|NCT01806545|962744|P1|Overall Study|Lost to Follow-up|1
286432|NCT01806545|962743|P2|Overall Study|Adverse Event|3
286433|NCT01806545|962744|P1|Overall Study|Adverse Event|2
286434|NCT01806389|962766|P1|Overall Study|Withdrawal by Subject|4
286435|NCT01806298|962780|P1|Overall Study|Other|5
286436|NCT01806298|962780|P1|Overall Study|Withdrawal by Subject|1
286437|NCT01806298|962780|P1|Overall Study|Protocol Non-compliance|1
286438|NCT01806298|962780|P1|Overall Study|Adverse Event|3
286439|NCT01806051|962790|P1|Overall Study|Withdrawal by Subject|6
286440|NCT01805180|962888|P3|Lead-in Donor Phase|screen failure|0
286441|NCT01805180|962889|P2|Lead-in Donor Phase|screen failure|0
286442|NCT01805180|962890|P1|Lead-in Donor Phase|screen failure|1
286443|NCT01804946|962928|P2|Overall Study|Do not meet inclusion criteria|2
286444|NCT01804946|962929|P1|Overall Study|Do not meet inclusion criteria|1
286445|NCT01804946|962928|P2|Overall Study|Insufficient data available|1
286446|NCT01804946|962929|P1|Overall Study|Insufficient data available|0
286447|NCT01804946|962928|P2|Overall Study|Adverse Event|1
286448|NCT01804946|962929|P1|Overall Study|Adverse Event|0
286449|NCT01804946|962928|P2|Overall Study|Protocol Violation|0
286450|NCT01804946|962929|P1|Overall Study|Protocol Violation|1
286451|NCT01804842|962967|P3|Overall Study|Personal Reason|1
286452|NCT01804842|962968|P2|Overall Study|Personal Reason|0
286453|NCT01804842|962969|P1|Overall Study|Personal Reason|0
286454|NCT01804842|962967|P3|Overall Study|Non-Compliance|0
286455|NCT01804842|962968|P2|Overall Study|Non-Compliance|1
286456|NCT01804842|962969|P1|Overall Study|Non-Compliance|1
286457|NCT01804842|962967|P3|Overall Study|Lost to Follow-up|0
286458|NCT01804842|962968|P2|Overall Study|Lost to Follow-up|0
286459|NCT01804842|962969|P1|Overall Study|Lost to Follow-up|1
286460|NCT01804842|962967|P3|Overall Study|Adverse Event|0
286461|NCT01804842|962968|P2|Overall Study|Adverse Event|1
286462|NCT01804842|962969|P1|Overall Study|Adverse Event|1
286463|NCT01804673|962986|P1|Overall Study|Other|4
286464|NCT01804673|962986|P1|Overall Study|Use of Prohibited Medication|1
286465|NCT01804673|962986|P1|Overall Study|No Further Therapy Required|84
286466|NCT01804673|962986|P1|Overall Study|Change to Oral Therapy|37
286467|NCT01804673|962986|P1|Overall Study|Lack of Efficacy|9
286468|NCT01804673|962986|P1|Overall Study|Withdrawal by Subject|1
286469|NCT01804673|962986|P1|Overall Study|Adverse Event|4
286470|NCT01804140|963006|P1|Overall Study|No sampling or biopsy procedures done|114
286471|NCT01803737|963075|P2|Overall Study|Lost to Follow-up|2
286472|NCT01803737|963076|P1|Overall Study|Lost to Follow-up|0
286473|NCT01803737|963075|P2|Overall Study|Medical Reason|1
286474|NCT01803737|963076|P1|Overall Study|Medical Reason|0
286475|NCT01803737|963075|P2|Overall Study|Lack of Time|0
286476|NCT01803737|963076|P1|Overall Study|Lack of Time|1
286477|NCT01803711|963100|P2|Overall Study|Adverse Event|1
286478|NCT01803711|963101|P1|Overall Study|Adverse Event|1
286479|NCT01803646|963119|P2|Overall Study|Lost to Follow-up|1
286480|NCT01803646|963120|P1|Overall Study|Lost to Follow-up|5
286481|NCT01803646|963119|P2|Overall Study|Randomization error|2
286482|NCT01803646|963120|P1|Overall Study|Randomization error|1
286483|NCT01803646|963119|P2|Overall Study|Withdrawal by Subject|6
286484|NCT01803646|963120|P1|Overall Study|Withdrawal by Subject|9
286485|NCT01803646|963119|P2|Overall Study|Adverse Event|1
286486|NCT01803646|963120|P1|Overall Study|Adverse Event|1
286487|NCT01803646|963119|P2|Overall Study|Protocol Violation|0
286488|NCT01803646|963120|P1|Overall Study|Protocol Violation|1
286489|NCT01803607|963132|P2|Overall Study|Withdrawal by Subject|5
286490|NCT01803607|963133|P1|Overall Study|Withdrawal by Subject|6
286491|NCT01803607|963132|P2|Overall Study|Study terminated by sponsor|56
286492|NCT01803607|963133|P1|Overall Study|Study terminated by sponsor|54
286493|NCT01803607|963132|P2|Overall Study|Protocol Violation|2
286494|NCT01803607|963133|P1|Overall Study|Protocol Violation|3
286495|NCT01803607|963132|P2|Overall Study|Lack of Efficacy|1
286496|NCT01803607|963133|P1|Overall Study|Lack of Efficacy|0
286497|NCT01803607|963132|P2|Overall Study|Adverse Event|3
286498|NCT01803607|963133|P1|Overall Study|Adverse Event|5
286499|NCT01803464|963157|P4|Overall Study|Withdrawal by Subject|0
286500|NCT01803464|963158|P3|Overall Study|Withdrawal by Subject|0
286501|NCT01803464|963159|P2|Overall Study|Withdrawal by Subject|0
286502|NCT01803464|963160|P1|Overall Study|Withdrawal by Subject|1
286503|NCT01803464|963157|P4|Overall Study|Incomplete data|0
286504|NCT01803464|963158|P3|Overall Study|Incomplete data|4
286505|NCT01803464|963159|P2|Overall Study|Incomplete data|0
286506|NCT01803464|963160|P1|Overall Study|Incomplete data|0
286507|NCT01802775|963180|P2|Overall Study|Lost to Follow-up|2
286508|NCT01802775|963181|P1|Overall Study|Lost to Follow-up|1
286509|NCT01802775|963180|P2|Overall Study|Withdrawal by Subject|5
286510|NCT01802775|963181|P1|Overall Study|Withdrawal by Subject|3
286511|NCT01802775|963180|P2|Overall Study|Adverse Event|1
286512|NCT01802775|963181|P1|Overall Study|Adverse Event|1
286513|NCT01802775|963180|P2|Overall Study|Physician Decision|0
286514|NCT01802775|963181|P1|Overall Study|Physician Decision|1
286515|NCT01802775|963180|P2|Overall Study|Reason not provided|1
286516|NCT01802775|963181|P1|Overall Study|Reason not provided|0
286517|NCT01802775|963180|P2|Overall Study|Death|3
286518|NCT01802775|963181|P1|Overall Study|Death|0
286519|NCT01802632|963203|P6|Overall Study|Other (not specified)|1
286520|NCT01802632|963204|P5|Overall Study|Other (not specified)|0
286521|NCT01802632|963205|P4|Overall Study|Other (not specified)|1
286522|NCT01802632|963206|P3|Overall Study|Other (not specified)|7
286523|NCT01802632|963207|P2|Overall Study|Other (not specified)|0
286524|NCT01802632|963208|P1|Overall Study|Other (not specified)|0
286525|NCT01802632|963203|P6|Overall Study|Ongoing Study at Data Cut-off|22
286526|NCT01802632|963204|P5|Overall Study|Ongoing Study at Data Cut-off|6
286527|NCT01802632|963205|P4|Overall Study|Ongoing Study at Data Cut-off|50
286528|NCT01802632|963206|P3|Overall Study|Ongoing Study at Data Cut-off|115
286529|NCT01802632|963207|P2|Overall Study|Ongoing Study at Data Cut-off|16
286530|NCT01802632|963208|P1|Overall Study|Ongoing Study at Data Cut-off|168
286531|NCT01802632|963203|P6|Overall Study|Objective Disease Progression|4
286532|NCT01802632|963204|P5|Overall Study|Objective Disease Progression|4
286533|NCT01802632|963205|P4|Overall Study|Objective Disease Progression|6
286534|NCT01802632|963206|P3|Overall Study|Objective Disease Progression|104
286535|NCT01802632|963207|P2|Overall Study|Objective Disease Progression|12
286536|NCT01802632|963208|P1|Overall Study|Objective Disease Progression|1
286537|NCT01802632|963203|P6|Overall Study|Withdrawal by Subject|1
286538|NCT01802632|963204|P5|Overall Study|Withdrawal by Subject|0
286539|NCT01802632|963205|P4|Overall Study|Withdrawal by Subject|3
286540|NCT01802632|963206|P3|Overall Study|Withdrawal by Subject|7
286541|NCT01802632|963207|P2|Overall Study|Withdrawal by Subject|2
286542|NCT01802632|963208|P1|Overall Study|Withdrawal by Subject|4
286543|NCT01802632|963203|P6|Overall Study|Death|0
286544|NCT01802632|963204|P5|Overall Study|Death|2
286545|NCT01802632|963205|P4|Overall Study|Death|0
286546|NCT01802632|963206|P3|Overall Study|Death|38
286547|NCT01802632|963207|P2|Overall Study|Death|1
286548|NCT01802632|963208|P1|Overall Study|Death|28
286549|NCT01802515|963242|P3|Overall Study|Withdrawal by Subject|0
286550|NCT01802515|963243|P2|Overall Study|Withdrawal by Subject|0
286551|NCT01802515|963244|P1|Overall Study|Withdrawal by Subject|3
286552|NCT01802320|963255|P1|Overall Study|Withdrawal by Subject|1
286553|NCT01802320|963255|P1|Overall Study|Death|1
286554|NCT01801982|963329|P1|Overall Study|Lost to Follow-up|1
286555|NCT01801917|963343|P4|Period 1 - Randomized|Adverse Event|0
286556|NCT01801917|963344|P3|Period 1 - Randomized|Adverse Event|1
286557|NCT01801917|963345|P2|Period 1 - Randomized|Adverse Event|0
286558|NCT01801917|963346|P1|Period 1 - Randomized|Adverse Event|1
286559|NCT01801735|963366|P1|Overall Study|Other, including site closure|19
286560|NCT01801735|963366|P1|Overall Study|Death|1
286561|NCT01801735|963366|P1|Overall Study|Physician Decision|3
286562|NCT01801735|963366|P1|Overall Study|Non-compliance with Trial Drug|13
286563|NCT01801735|963366|P1|Overall Study|Lost to Follow-up|15
286564|NCT01801735|963366|P1|Overall Study|Protocol Violation|25
286565|NCT01801735|963366|P1|Overall Study|Withdrawal by Subject|27
286566|NCT01801735|963366|P1|Overall Study|Lack of Efficacy|28
286567|NCT01801735|963366|P1|Overall Study|Adverse Event|79
286568|NCT01801475|963373|P5|Overall Study|Withdrawal by Subject|1
286569|NCT01801475|963374|P4|Overall Study|Withdrawal by Subject|0
286570|NCT01801475|963375|P3|Overall Study|Withdrawal by Subject|0
286571|NCT01801475|963376|P2|Overall Study|Withdrawal by Subject|0
286572|NCT01801475|963377|P1|Overall Study|Withdrawal by Subject|0
286573|NCT01801436|963402|P1|Overall Study|Progressive disease|4
286574|NCT01801436|963402|P1|Overall Study|Adverse Event|2
286575|NCT01801436|963402|P1|Overall Study|Withdrawal by Subject|3
286576|NCT01801358|963440|P6|Overall Study|Withdrawal by Subject|2
286577|NCT01801358|963441|P5|Overall Study|Withdrawal by Subject|0
286578|NCT01801358|963442|P4|Overall Study|Withdrawal by Subject|1
286579|NCT01801358|963443|P3|Overall Study|Withdrawal by Subject|0
286580|NCT01801358|963444|P2|Overall Study|Withdrawal by Subject|0
286581|NCT01801358|963445|P1|Overall Study|Withdrawal by Subject|0
286582|NCT01801358|963440|P6|Overall Study|Progressive Disease|5
286583|NCT01801358|963441|P5|Overall Study|Progressive Disease|6
286584|NCT01801358|963442|P4|Overall Study|Progressive Disease|5
286585|NCT01801358|963443|P3|Overall Study|Progressive Disease|4
286586|NCT01801358|963444|P2|Overall Study|Progressive Disease|4
286587|NCT01801358|963445|P1|Overall Study|Progressive Disease|6
286588|NCT01801358|963440|P6|Overall Study|Physician Decision|0
286589|NCT01801358|963441|P5|Overall Study|Physician Decision|0
286590|NCT01801358|963442|P4|Overall Study|Physician Decision|0
286591|NCT01801358|963443|P3|Overall Study|Physician Decision|1
286592|NCT01801358|963444|P2|Overall Study|Physician Decision|0
286593|NCT01801358|963445|P1|Overall Study|Physician Decision|0
286594|NCT01801358|963440|P6|Overall Study|Adverse Event|1
286595|NCT01801358|963441|P5|Overall Study|Adverse Event|0
286596|NCT01801358|963442|P4|Overall Study|Adverse Event|0
286597|NCT01801358|963443|P3|Overall Study|Adverse Event|1
286598|NCT01801358|963444|P2|Overall Study|Adverse Event|2
286599|NCT01801358|963445|P1|Overall Study|Adverse Event|0
286600|NCT01801280|963567|P4|Period 4|Protocol Violation|0
286601|NCT01801280|963568|P3|Period 4|Protocol Violation|1
286602|NCT01801280|963569|P2|Period 4|Protocol Violation|0
286603|NCT01801280|963570|P1|Period 4|Protocol Violation|0
286604|NCT01801280|963567|P4|Period 2|Withdrawal by Subject|0
286605|NCT01801280|963568|P3|Period 2|Withdrawal by Subject|0
286606|NCT01801280|963569|P2|Period 2|Withdrawal by Subject|0
286607|NCT01801280|963570|P1|Period 2|Withdrawal by Subject|1
286608|NCT01801280|963567|P4|Period 1|Withdrawal by Subject|0
286609|NCT01801280|963568|P3|Period 1|Withdrawal by Subject|0
286610|NCT01801280|963569|P2|Period 1|Withdrawal by Subject|1
286611|NCT01801280|963570|P1|Period 1|Withdrawal by Subject|0
286612|NCT01801111|963585|P1|Overall Study|On-going Survival Follow up|25
286613|NCT01801111|963585|P1|Overall Study|Death|24
286614|NCT01801111|963585|P1|Overall Study|Treatment On-going|89
286615|NCT01800968|963610|P2|Overall Study|Physician Decision|0
286616|NCT01800968|963611|P1|Overall Study|Physician Decision|1
286617|NCT01800968|963610|P2|Overall Study|Withdrawal by Subject|9
286618|NCT01800968|963611|P1|Overall Study|Withdrawal by Subject|7
286619|NCT01800968|963610|P2|Overall Study|Lost to Follow-up|7
286620|NCT01800968|963611|P1|Overall Study|Lost to Follow-up|5
286621|NCT01800968|963610|P2|Overall Study|Death|16
286622|NCT01800968|963611|P1|Overall Study|Death|23
286623|NCT01800916|963653|P9|Test Period 1 (1 Week)|Adverse Event|0
286624|NCT01800916|963654|P8|Test Period 1 (1 Week)|Adverse Event|0
286625|NCT01800916|963655|P7|Test Period 1 (1 Week)|Adverse Event|0
286626|NCT01800916|963656|P6|Test Period 1 (1 Week)|Adverse Event|0
286627|NCT01800916|963657|P5|Test Period 1 (1 Week)|Adverse Event|1
286628|NCT01800916|963658|P4|Test Period 1 (1 Week)|Adverse Event|0
286629|NCT01800916|963659|P3|Test Period 1 (1 Week)|Adverse Event|0
286630|NCT01800916|963660|P2|Test Period 1 (1 Week)|Adverse Event|0
286631|NCT01800916|963661|P1|Test Period 1 (1 Week)|Adverse Event|0
286632|NCT01800916|963653|P9|Test Period 1 (1 Week)|Convex product user|0
286633|NCT01800916|963654|P8|Test Period 1 (1 Week)|Convex product user|0
286634|NCT01800916|963655|P7|Test Period 1 (1 Week)|Convex product user|0
286635|NCT01800916|963656|P6|Test Period 1 (1 Week)|Convex product user|0
286636|NCT01800916|963657|P5|Test Period 1 (1 Week)|Convex product user|0
286637|NCT01800916|963658|P4|Test Period 1 (1 Week)|Convex product user|1
286638|NCT01800916|963659|P3|Test Period 1 (1 Week)|Convex product user|0
286639|NCT01800916|963660|P2|Test Period 1 (1 Week)|Convex product user|0
286640|NCT01800916|963661|P1|Test Period 1 (1 Week)|Convex product user|0
286641|NCT01800903|963671|P6|Second Test Period|unable to catheterise|0
286642|NCT01800903|963672|P5|Second Test Period|unable to catheterise|0
286643|NCT01800903|963673|P4|Second Test Period|unable to catheterise|0
286644|NCT01800903|963674|P3|Second Test Period|unable to catheterise|0
286645|NCT01800903|963675|P2|Second Test Period|unable to catheterise|0
286646|NCT01800903|963676|P1|Second Test Period|unable to catheterise|1
286647|NCT01799993|963773|P2|Overall Study|Subject didn't return for follow-up|1
286648|NCT01799993|963774|P1|Overall Study|Subject didn't return for follow-up|0
286649|NCT01799993|963773|P2|Overall Study|Other|0
286650|NCT01799993|963774|P1|Overall Study|Other|1
286651|NCT01799993|963773|P2|Overall Study|Withdrawal by parent/guardian|1
286652|NCT01799993|963774|P1|Overall Study|Withdrawal by parent/guardian|0
286653|NCT01799993|963773|P2|Overall Study|Non-compliance with medical device|0
286654|NCT01799993|963774|P1|Overall Study|Non-compliance with medical device|1
286655|NCT01799993|963773|P2|Overall Study|Protocol deviation|0
286656|NCT01799993|963774|P1|Overall Study|Protocol deviation|1
286657|NCT01799993|963773|P2|Overall Study|Logistical difficulties|0
286658|NCT01799993|963774|P1|Overall Study|Logistical difficulties|1
286659|NCT01799993|963773|P2|Overall Study|Recovery|1
286660|NCT01799993|963774|P1|Overall Study|Recovery|0
286661|NCT01799993|963773|P2|Overall Study|Lack of Efficacy|0
286662|NCT01799993|963774|P1|Overall Study|Lack of Efficacy|1
286663|NCT01799993|963773|P2|Overall Study|Adverse Event|0
286664|NCT01799993|963774|P1|Overall Study|Adverse Event|1
286665|NCT01799993|963773|P2|Overall Study|Screen failure|1
286666|NCT01799993|963774|P1|Overall Study|Screen failure|0
286667|NCT01799993|963773|P2|Overall Study|Deterioration of general conditions|0
286668|NCT01799993|963774|P1|Overall Study|Deterioration of general conditions|2
286669|NCT01799993|963773|P2|Overall Study|Protocol Violation|1
286670|NCT01799993|963774|P1|Overall Study|Protocol Violation|1
286671|NCT01799993|963773|P2|Overall Study|Protocol driven decision point|3
286672|NCT01799993|963774|P1|Overall Study|Protocol driven decision point|0
286673|NCT01799993|963773|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
286674|NCT01799993|963774|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
286675|NCT01799993|963773|P2|Overall Study|Lost to Follow-up|8
286676|NCT01799993|963774|P1|Overall Study|Lost to Follow-up|5
286677|NCT01799993|963773|P2|Overall Study|Withdrawal by Subject|24
286678|NCT01799993|963774|P1|Overall Study|Withdrawal by Subject|23
286679|NCT01799993|963773|P2|Overall Study|Death|45
286680|NCT01799993|963774|P1|Overall Study|Death|61
286681|NCT01799993|963773|P2|Overall Study|"Didn't complete CRF page End of FU"|40
286682|NCT01799993|963774|P1|Overall Study|"Didn't complete CRF page End of FU"|30
286683|NCT01799941|963806|P1|Overall Study|Not Specified|15
286684|NCT01799941|963806|P1|Overall Study|Lost to Follow-up|17
286685|NCT01799941|963806|P1|Overall Study|Lack of Efficacy|3
286686|NCT01799941|963806|P1|Overall Study|Investigator Decision|4
286687|NCT01799941|963806|P1|Overall Study|Death|2
286688|NCT01799941|963806|P1|Overall Study|Withdrawal by Subject|21
286689|NCT01799941|963806|P1|Overall Study|Adverse Event|34
286690|NCT01799720|963863|P3|Overall Study|Pregnancy|1
286691|NCT01799720|963864|P2|Overall Study|Pregnancy|0
286692|NCT01799720|963865|P1|Overall Study|Pregnancy|0
286693|NCT01799720|963863|P3|Overall Study|Protocol Violation|0
286694|NCT01799720|963864|P2|Overall Study|Protocol Violation|1
286695|NCT01799720|963865|P1|Overall Study|Protocol Violation|0
286696|NCT01799720|963863|P3|Overall Study|Withdrawal by Subject|0
286697|NCT01799720|963864|P2|Overall Study|Withdrawal by Subject|0
286698|NCT01799720|963865|P1|Overall Study|Withdrawal by Subject|3
286699|NCT01799590|963903|P3|Overall Study|Other|1
286700|NCT01799590|963904|P2|Overall Study|Other|0
286701|NCT01799590|963905|P1|Overall Study|Other|3
286702|NCT01799590|963903|P3|Overall Study|Use of prohibited concomitant drugs|0
286703|NCT01799590|963904|P2|Overall Study|Use of prohibited concomitant drugs|0
286704|NCT01799590|963905|P1|Overall Study|Use of prohibited concomitant drugs|1
286705|NCT01799590|963903|P3|Overall Study|Using drugs with restricted days of use|2
286706|NCT01799590|963904|P2|Overall Study|Using drugs with restricted days of use|3
286707|NCT01799590|963905|P1|Overall Study|Using drugs with restricted days of use|0
286708|NCT01799590|963903|P3|Overall Study|Aggravation of complications|1
286709|NCT01799590|963904|P2|Overall Study|Aggravation of complications|1
286710|NCT01799590|963905|P1|Overall Study|Aggravation of complications|0
286711|NCT01799590|963903|P3|Overall Study|Participants convenience|2
286712|NCT01799590|963904|P2|Overall Study|Participants convenience|4
286713|NCT01799590|963905|P1|Overall Study|Participants convenience|4
286714|NCT01799590|963903|P3|Overall Study|Lack of Efficacy|3
286715|NCT01799590|963904|P2|Overall Study|Lack of Efficacy|1
286716|NCT01799590|963905|P1|Overall Study|Lack of Efficacy|3
286717|NCT01799590|963903|P3|Overall Study|Pregnancy|0
286718|NCT01799590|963904|P2|Overall Study|Pregnancy|0
286719|NCT01799590|963905|P1|Overall Study|Pregnancy|2
286720|NCT01799590|963903|P3|Overall Study|Adverse Event|5
286721|NCT01799590|963904|P2|Overall Study|Adverse Event|7
286722|NCT01799590|963905|P1|Overall Study|Adverse Event|13
286723|NCT01799239|963948|P2|Period 2 (7 Days)|Protocol Violation|0
286724|NCT01799239|963949|P1|Period 2 (7 Days)|Protocol Violation|1
286725|NCT01799239|963948|P2|Period 2 (7 Days)|Withdrawal by Subject|1
286726|NCT01799239|963949|P1|Period 2 (7 Days)|Withdrawal by Subject|1
286727|NCT01799239|963948|P2|Period 1 (7 Days)|Protocol Violation|1
286728|NCT01799239|963949|P1|Period 1 (7 Days)|Protocol Violation|0
286729|NCT01799239|963948|P2|Period 1 (7 Days)|Withdrawal by Subject|0
286730|NCT01799239|963949|P1|Period 1 (7 Days)|Withdrawal by Subject|2
286731|NCT01799239|963948|P2|Period 1 (7 Days)|Lack of Efficacy|0
286732|NCT01799239|963949|P1|Period 1 (7 Days)|Lack of Efficacy|1
286733|NCT01799226|963957|P2|Overall Study|Disqualified at Day 14|0
286734|NCT01799226|963958|P1|Overall Study|Disqualified at Day 14|1
286735|NCT01799226|963957|P2|Overall Study|Withdrawal by Subject|0
286736|NCT01799226|963958|P1|Overall Study|Withdrawal by Subject|1
286737|NCT01798992|963970|P4|Overall Study|Insufficient biopsy tissue|0
286738|NCT01798992|963971|P3|Overall Study|Insufficient biopsy tissue|1
286739|NCT01798992|963972|P2|Overall Study|Insufficient biopsy tissue|0
286740|NCT01798992|963973|P1|Overall Study|Insufficient biopsy tissue|0
286741|NCT01798992|963970|P4|Overall Study|Lost to Follow-up|0
286742|NCT01798992|963971|P3|Overall Study|Lost to Follow-up|1
286743|NCT01798992|963972|P2|Overall Study|Lost to Follow-up|1
286744|NCT01798992|963973|P1|Overall Study|Lost to Follow-up|0
286745|NCT01798992|963970|P4|Overall Study|Administrative withdrawal|1
286746|NCT01798992|963971|P3|Overall Study|Administrative withdrawal|0
286747|NCT01798992|963972|P2|Overall Study|Administrative withdrawal|1
286748|NCT01798992|963973|P1|Overall Study|Administrative withdrawal|0
286749|NCT01798927|963993|P1|Overall Study|Withdrawal by Subject|1
286750|NCT01798706|964001|P2|Overall Study|Other than specified above|9
286751|NCT01798706|964002|P1|Overall Study|Other than specified above|5
286752|NCT01798706|964001|P2|Overall Study|Poor compliance to protocol|0
286753|NCT01798706|964002|P1|Overall Study|Poor compliance to protocol|1
286754|NCT01798706|964001|P2|Overall Study|Lack of Efficacy|2
286755|NCT01798706|964002|P1|Overall Study|Lack of Efficacy|0
286756|NCT01798706|964001|P2|Overall Study|Adverse Event|10
286757|NCT01798706|964002|P1|Overall Study|Adverse Event|15
286758|NCT01798485|964047|P2|Overall Study|Clinical Progression|24
286759|NCT01798485|964048|P1|Overall Study|Clinical Progression|35
286760|NCT01798485|964047|P2|Overall Study|Sponsor Decision|54
286761|NCT01798485|964048|P1|Overall Study|Sponsor Decision|61
286762|NCT01798485|964047|P2|Overall Study|Death|22
286763|NCT01798485|964048|P1|Overall Study|Death|25
286764|NCT01798485|964047|P2|Overall Study|Objective Disease Progression|106
286765|NCT01798485|964048|P1|Overall Study|Objective Disease Progression|152
286766|NCT01798485|964047|P2|Overall Study|Physician Decision|10
286767|NCT01798485|964048|P1|Overall Study|Physician Decision|14
286768|NCT01798485|964047|P2|Overall Study|Lost to Follow-up|3
286769|NCT01798485|964048|P1|Overall Study|Lost to Follow-up|0
286770|NCT01798485|964047|P2|Overall Study|Withdrawal by Subject|31
286771|NCT01798485|964048|P1|Overall Study|Withdrawal by Subject|27
286772|NCT01798485|964047|P2|Overall Study|Adverse Event|40
286773|NCT01798485|964048|P1|Overall Study|Adverse Event|32
286774|NCT01798134|964174|P1|Overall Study|Liver transplant/surgery|4
286775|NCT01798134|964174|P1|Overall Study|Physician Decision|3
286776|NCT01798134|964174|P1|Overall Study|Adverse Event|3
286777|NCT01798134|964174|P1|Overall Study|Death|2
286778|NCT01798134|964174|P1|Overall Study|Withdrawal by Subject|3
286779|NCT01798134|964174|P1|Overall Study|Lost to Follow-up|1
286780|NCT01798004|964181|P1|Overall Study|Enrollment another COG therapeutic trial|32
286781|NCT01798004|964181|P1|Overall Study|Initiation of other non-protocol therapy|5
286782|NCT01798004|964181|P1|Overall Study|Patient/parent refusal|7
286783|NCT01798004|964181|P1|Overall Study|Ineligible|4
286784|NCT01798004|964181|P1|Overall Study|Withdrawal by Subject|4
286785|NCT01798004|964181|P1|Overall Study|Physician Decision|25
286786|NCT01798004|964181|P1|Overall Study|Lack of Efficacy|8
286787|NCT01798004|964181|P1|Overall Study|Death|2
286788|NCT01797783|964187|P2|Overall Study|Withdrawal by Subject|0
286789|NCT01797783|964188|P1|Overall Study|Withdrawal by Subject|1
286790|NCT01797783|964187|P2|Overall Study|Adverse Event|1
286791|NCT01797783|964188|P1|Overall Study|Adverse Event|1
286792|NCT01797731|964212|P2|Overall Study|Didn't have proper radiographs required|3
286793|NCT01797731|964213|P1|Overall Study|Didn't have proper radiographs required|3
286794|NCT01797705|964221|P1|Overall Study|Withdrawal by Subject|1
286795|NCT01797705|964221|P1|Overall Study|Equipment anomalies during sleep studies|4
286796|NCT01797536|964286|P4|Overall Study|Adverse Event|0
286797|NCT01797536|964287|P3|Overall Study|Adverse Event|0
286798|NCT01797536|964288|P2|Overall Study|Adverse Event|1
286799|NCT01797536|964289|P1|Overall Study|Adverse Event|0
286800|NCT01797445|964361|P2|Overall Study|Still on Study|383
286801|NCT01797445|964362|P1|Overall Study|Still on Study|381
286802|NCT01797445|964361|P2|Overall Study|Lost to Follow-up|15
286803|NCT01797445|964362|P1|Overall Study|Lost to Follow-up|22
286804|NCT01797445|964361|P2|Overall Study|Withdrew Consent|19
286805|NCT01797445|964362|P1|Overall Study|Withdrew Consent|12
286806|NCT01797445|964361|P2|Overall Study|Protocol Violation|1
286807|NCT01797445|964362|P1|Overall Study|Protocol Violation|0
286808|NCT01797445|964361|P2|Overall Study|Noncompliance with Study Drug|1
286809|NCT01797445|964362|P1|Overall Study|Noncompliance with Study Drug|3
286810|NCT01797445|964361|P2|Overall Study|Investigator's Discretion|12
286811|NCT01797445|964362|P1|Overall Study|Investigator's Discretion|8
286812|NCT01797445|964361|P2|Overall Study|Lack of Efficacy|2
286813|NCT01797445|964362|P1|Overall Study|Lack of Efficacy|1
286814|NCT01797445|964361|P2|Overall Study|Death|2
286815|NCT01797445|964362|P1|Overall Study|Death|1
286816|NCT01797445|964361|P2|Overall Study|Adverse Event|0
286817|NCT01797445|964362|P1|Overall Study|Adverse Event|3
286818|NCT01797445|964361|P2|Overall Study|Randomized but Not Treated|2
286819|NCT01797445|964362|P1|Overall Study|Randomized but Not Treated|4
286820|NCT01797120|964420|P2|Overall Study|never start protocol therapy|0
286821|NCT01797120|964421|P1|Overall Study|never start protocol therapy|2
286822|NCT01797120|964420|P2|Overall Study|still on treatment|4
286823|NCT01797120|964421|P1|Overall Study|still on treatment|2
286824|NCT01797120|964420|P2|Overall Study|Physician Decision|0
286825|NCT01797120|964421|P1|Overall Study|Physician Decision|3
286826|NCT01797120|964420|P2|Overall Study|Non-compliance|0
286827|NCT01797120|964421|P1|Overall Study|Non-compliance|1
286828|NCT01797120|964420|P2|Overall Study|Symptomatic progression|1
286829|NCT01797120|964421|P1|Overall Study|Symptomatic progression|2
286830|NCT01797120|964420|P2|Overall Study|Withdrawal by Subject|6
286831|NCT01797120|964421|P1|Overall Study|Withdrawal by Subject|6
286832|NCT01797120|964420|P2|Overall Study|Adverse Event|5
286833|NCT01797120|964421|P1|Overall Study|Adverse Event|13
286834|NCT01797120|964420|P2|Overall Study|Disesae progression|49
286835|NCT01797120|964421|P1|Overall Study|Disesae progression|37
286836|NCT01797094|964435|P2|Overall Study|Other Miscellaneous Reasons|0
286837|NCT01797094|964436|P1|Overall Study|Other Miscellaneous Reasons|1
286838|NCT01797094|964435|P2|Overall Study|Protocol Violation|1
286839|NCT01797094|964436|P1|Overall Study|Protocol Violation|0
286840|NCT01797094|964435|P2|Overall Study|Personal Reasons|0
286841|NCT01797094|964436|P1|Overall Study|Personal Reasons|4
286842|NCT01797094|964435|P2|Overall Study|Adverse Event|1
286843|NCT01797094|964436|P1|Overall Study|Adverse Event|1
286844|NCT01797081|964458|P4|Overall Study|Protocol Violation|1
286845|NCT01797081|964459|P3|Overall Study|Protocol Violation|0
286846|NCT01797081|964460|P2|Overall Study|Protocol Violation|0
286847|NCT01797081|964461|P1|Overall Study|Protocol Violation|0
286848|NCT01797081|964458|P4|Overall Study|Personal Reasons|8
286849|NCT01797081|964459|P3|Overall Study|Personal Reasons|4
286850|NCT01797081|964460|P2|Overall Study|Personal Reasons|4
286851|NCT01797081|964461|P1|Overall Study|Personal Reasons|12
286852|NCT01797081|964458|P4|Overall Study|Pregnancy|0
286853|NCT01797081|964459|P3|Overall Study|Pregnancy|0
286854|NCT01797081|964460|P2|Overall Study|Pregnancy|0
286855|NCT01797081|964461|P1|Overall Study|Pregnancy|1
286856|NCT01797081|964458|P4|Overall Study|Adverse Event|0
286857|NCT01797081|964459|P3|Overall Study|Adverse Event|1
286858|NCT01797081|964460|P2|Overall Study|Adverse Event|0
286859|NCT01797081|964461|P1|Overall Study|Adverse Event|1
286860|NCT01796964|964502|P2|Overall Study|Withdrawal by Subject|1
286861|NCT01796964|964503|P1|Overall Study|Withdrawal by Subject|1
286862|NCT01796964|964502|P2|Overall Study|Protocol Violation|1
286863|NCT01796964|964503|P1|Overall Study|Protocol Violation|0
286864|NCT01796964|964502|P2|Overall Study|Death|0
286865|NCT01796964|964503|P1|Overall Study|Death|1
286866|NCT01796964|964502|P2|Overall Study|Adverse Event|1
286867|NCT01796964|964503|P1|Overall Study|Adverse Event|1
286868|NCT01796860|964525|P1|Overall Study|Withdrawal by Subject|3
286869|NCT01796548|964531|P1|Overall Study|Other|2
286870|NCT01796548|964531|P1|Overall Study|Lost to Follow-up|1
286871|NCT01795937|964565|P3|Overall Study|Physician Decision|0
286872|NCT01795937|964566|P2|Overall Study|Physician Decision|1
286873|NCT01795937|964567|P1|Overall Study|Physician Decision|0
286874|NCT01795937|964565|P3|Overall Study|Withdrawal by Subject|0
286875|NCT01795937|964566|P2|Overall Study|Withdrawal by Subject|0
286876|NCT01795937|964567|P1|Overall Study|Withdrawal by Subject|1
286877|NCT01795898|964596|P1|Overall Study|Physician Decision|1
286878|NCT01795898|964596|P1|Overall Study|Withdrew consent & had adverse events|3
286879|NCT01795898|964596|P1|Overall Study|Death|1
286880|NCT01795898|964596|P1|Overall Study|No pain|1
286881|NCT01795898|964596|P1|Overall Study|Diagnosed with metastasis|1
286882|NCT01795898|964596|P1|Overall Study|Withdrawal of consent|6
286883|NCT01795898|964596|P1|Overall Study|Lost to Follow-up|20
286884|NCT01795898|964596|P1|Overall Study|Adverse Event|27
286885|NCT01795547|964632|P2|Overall Study|Not stated|1
286886|NCT01795547|964633|P1|Overall Study|Not stated|0
286887|NCT01795547|964632|P2|Overall Study|Others|1
286888|NCT01795547|964633|P1|Overall Study|Others|4
286889|NCT01795547|964632|P2|Overall Study|Non-compliance with IMP|1
286890|NCT01795547|964633|P1|Overall Study|Non-compliance with IMP|1
286891|NCT01795547|964632|P2|Overall Study|Not Treated|10
286892|NCT01795547|964633|P1|Overall Study|Not Treated|4
286893|NCT01795547|964632|P2|Overall Study|Withdrawal of consent|12
286894|NCT01795547|964633|P1|Overall Study|Withdrawal of consent|7
286895|NCT01795547|964632|P2|Overall Study|Lost to Follow-up|5
286896|NCT01795547|964633|P1|Overall Study|Lost to Follow-up|2
286897|NCT01795547|964632|P2|Overall Study|Protocol Violation|4
286898|NCT01795547|964633|P1|Overall Study|Protocol Violation|6
286899|NCT01795547|964632|P2|Overall Study|Lack of Efficacy|3
286900|NCT01795547|964633|P1|Overall Study|Lack of Efficacy|8
286901|NCT01795547|964632|P2|Overall Study|Adverse Event|27
286902|NCT01795547|964633|P1|Overall Study|Adverse Event|16
286903|NCT01795495|964665|P3|Overall Study|Physician Decision|1
286904|NCT01795495|964666|P2|Overall Study|Physician Decision|0
286905|NCT01795495|964667|P1|Overall Study|Physician Decision|0
286906|NCT01795495|964665|P3|Overall Study|Protocol Violation|1
286907|NCT01795495|964666|P2|Overall Study|Protocol Violation|0
286908|NCT01795495|964667|P1|Overall Study|Protocol Violation|1
286909|NCT01794949|964680|P2|Overall Study|Lost to Follow-up|0
286910|NCT01794949|964681|P1|Overall Study|Lost to Follow-up|1
286911|NCT01794845|964692|P1|Overall Study|Withdrawal by Subject|1
286912|NCT01794000|964742|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
286913|NCT01794000|964743|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
286914|NCT01794000|964742|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
286915|NCT01794000|964743|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
286916|NCT01794000|964742|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
286917|NCT01794000|964743|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
286918|NCT01794000|964742|P2|Double-Blind Phase (DBP)|Physician Decision|0
286919|NCT01794000|964743|P1|Double-Blind Phase (DBP)|Physician Decision|2
286920|NCT01794000|964742|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
286921|NCT01794000|964743|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
286922|NCT01794000|964742|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
286923|NCT01794000|964743|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
286924|NCT01794000|964742|P2|Double-Blind Phase (DBP)|Death|2
286925|NCT01794000|964743|P1|Double-Blind Phase (DBP)|Death|1
286926|NCT01794000|964742|P2|Double-Blind Phase (DBP)|Adverse Event|2
286927|NCT01794000|964743|P1|Double-Blind Phase (DBP)|Adverse Event|5
286928|NCT01793935|964776|P2|Overall Study|Lost to Follow-up|1
286929|NCT01793935|964777|P1|Overall Study|Lost to Follow-up|0
286930|NCT01793935|964776|P2|Overall Study|Patient did not take study medication|1
286931|NCT01793935|964777|P1|Overall Study|Patient did not take study medication|1
286932|NCT01793935|964776|P2|Overall Study|Adverse Event|0
286933|NCT01793935|964777|P1|Overall Study|Adverse Event|2
286934|NCT01793935|964776|P2|Overall Study|Protocol Violation|1
286935|NCT01793935|964777|P1|Overall Study|Protocol Violation|2
286936|NCT01793935|964776|P2|Overall Study|Pregnancy|0
286937|NCT01793935|964777|P1|Overall Study|Pregnancy|1
286938|NCT01793883|964814|P3|Overall Study|Respiratory distress during spirometry|1
286939|NCT01793883|964815|P2|Overall Study|Respiratory distress during spirometry|0
286940|NCT01793883|964816|P1|Overall Study|Respiratory distress during spirometry|0
286941|NCT01793883|964814|P3|Overall Study|Dosing error|0
286942|NCT01793883|964815|P2|Overall Study|Dosing error|1
286943|NCT01793883|964816|P1|Overall Study|Dosing error|0
286944|NCT01793883|964814|P3|Overall Study|Met exclusion criteria|0
286945|NCT01793883|964815|P2|Overall Study|Met exclusion criteria|0
286946|NCT01793883|964816|P1|Overall Study|Met exclusion criteria|1
286947|NCT01793883|964814|P3|Overall Study|Unable to complete measurements|0
286948|NCT01793883|964815|P2|Overall Study|Unable to complete measurements|0
286949|NCT01793883|964816|P1|Overall Study|Unable to complete measurements|1
286950|NCT01793883|964814|P3|Overall Study|Unable to complete spriometry|0
286951|NCT01793883|964815|P2|Overall Study|Unable to complete spriometry|0
286952|NCT01793883|964816|P1|Overall Study|Unable to complete spriometry|1
286953|NCT01793883|964814|P3|Overall Study|Randomized in error|0
286954|NCT01793883|964815|P2|Overall Study|Randomized in error|0
286955|NCT01793883|964816|P1|Overall Study|Randomized in error|1
286956|NCT01793883|964814|P3|Overall Study|Lost to Follow-up|3
286957|NCT01793883|964815|P2|Overall Study|Lost to Follow-up|1
286958|NCT01793883|964816|P1|Overall Study|Lost to Follow-up|5
286959|NCT01793883|964814|P3|Overall Study|Subject noncompliance|1
286960|NCT01793883|964815|P2|Overall Study|Subject noncompliance|1
286961|NCT01793883|964816|P1|Overall Study|Subject noncompliance|0
286962|NCT01793883|964814|P3|Overall Study|Withdrawal by Subject|3
286963|NCT01793883|964815|P2|Overall Study|Withdrawal by Subject|7
286964|NCT01793883|964816|P1|Overall Study|Withdrawal by Subject|3
286965|NCT01793688|964824|P1|Overall Study|Protocol Violation|2
286966|NCT01792830|964866|P7|Overall Study|Adverse Event|0
286967|NCT01792830|964867|P6|Overall Study|Adverse Event|0
286968|NCT01792830|964868|P5|Overall Study|Adverse Event|1
286969|NCT01792830|964869|P4|Overall Study|Adverse Event|0
286970|NCT01792830|964870|P3|Overall Study|Adverse Event|0
286971|NCT01792830|964871|P2|Overall Study|Adverse Event|0
286972|NCT01792830|964872|P1|Overall Study|Adverse Event|0
286973|NCT01792830|964866|P7|Overall Study|Death|1
286974|NCT01792830|964867|P6|Overall Study|Death|0
286975|NCT01792830|964868|P5|Overall Study|Death|2
286976|NCT01792830|964869|P4|Overall Study|Death|1
286977|NCT01792830|964870|P3|Overall Study|Death|0
286978|NCT01792830|964871|P2|Overall Study|Death|0
286979|NCT01792830|964872|P1|Overall Study|Death|3
286980|NCT01792830|964866|P7|Overall Study|Withdrawal by Subject|2
286981|NCT01792830|964867|P6|Overall Study|Withdrawal by Subject|0
286982|NCT01792830|964868|P5|Overall Study|Withdrawal by Subject|9
286983|NCT01792830|964869|P4|Overall Study|Withdrawal by Subject|4
286984|NCT01792830|964870|P3|Overall Study|Withdrawal by Subject|0
286985|NCT01792830|964871|P2|Overall Study|Withdrawal by Subject|0
286986|NCT01792830|964872|P1|Overall Study|Withdrawal by Subject|22
286987|NCT01792635|964920|P3|Part B|Study terminated|3
286988|NCT01792635|964921|P2|Part B|Study terminated|4
286989|NCT01792635|964922|P1|Part B|Study terminated|0
286990|NCT01792635|964920|P3|Part B|Adverse Event|1
286991|NCT01792635|964921|P2|Part B|Adverse Event|0
286992|NCT01792635|964922|P1|Part B|Adverse Event|0
286993|NCT01792518|964950|P2|Overall Study|Other Reason|1
286994|NCT01792518|964951|P1|Overall Study|Other Reason|0
286995|NCT01792518|964950|P2|Overall Study|Withdrawal by Subject|0
286996|NCT01792518|964951|P1|Overall Study|Withdrawal by Subject|2
286997|NCT01792518|964950|P2|Overall Study|Lost to Follow-up|1
286998|NCT01792518|964951|P1|Overall Study|Lost to Follow-up|3
286999|NCT01792518|964950|P2|Overall Study|Protocol Violation|1
287000|NCT01792518|964951|P1|Overall Study|Protocol Violation|0
287001|NCT01792518|964950|P2|Overall Study|Adverse Event|4
287002|NCT01792518|964951|P1|Overall Study|Adverse Event|3
287003|NCT01792284|964961|P3|Randomization Period 2|Withdrawal by Subject|0
287004|NCT01792284|964962|P2|Randomization Period 2|Withdrawal by Subject|2
287005|NCT01792284|964963|P1|Randomization Period 2|Withdrawal by Subject|0
287006|NCT01792284|964961|P3|Randomization Period 2|Protocol Violation|0
287007|NCT01792284|964962|P2|Randomization Period 2|Protocol Violation|1
287008|NCT01792284|964963|P1|Randomization Period 2|Protocol Violation|0
287009|NCT01792284|964961|P3|Randomization Period 1|Lost to Follow-up|1
287010|NCT01792284|964962|P2|Randomization Period 1|Lost to Follow-up|0
287011|NCT01792284|964963|P1|Randomization Period 1|Lost to Follow-up|0
287012|NCT01792284|964961|P3|Randomization Period 1|Adverse Event|2
287013|NCT01792284|964962|P2|Randomization Period 1|Adverse Event|0
287014|NCT01792284|964963|P1|Randomization Period 1|Adverse Event|0
287015|NCT01792284|964961|P3|Randomization Period 1|Physician Decision|1
287016|NCT01792284|964962|P2|Randomization Period 1|Physician Decision|1
287017|NCT01792284|964963|P1|Randomization Period 1|Physician Decision|0
287018|NCT01792284|964961|P3|Randomization Period 1|Withdrawal by Subject|1
287019|NCT01792284|964962|P2|Randomization Period 1|Withdrawal by Subject|1
287020|NCT01792284|964963|P1|Randomization Period 1|Withdrawal by Subject|0
287021|NCT01792284|964961|P3|Lead-in Period|Protocol Required Discontinuation|0
287022|NCT01792284|964962|P2|Lead-in Period|Protocol Required Discontinuation|0
287023|NCT01792284|964963|P1|Lead-in Period|Protocol Required Discontinuation|1
287024|NCT01792284|964961|P3|Lead-in Period|Physician Decision|0
287025|NCT01792284|964962|P2|Lead-in Period|Physician Decision|0
287026|NCT01792284|964963|P1|Lead-in Period|Physician Decision|1
287027|NCT01792284|964961|P3|Lead-in Period|Withdrawal by Subject|0
287028|NCT01792284|964962|P2|Lead-in Period|Withdrawal by Subject|0
287029|NCT01792284|964963|P1|Lead-in Period|Withdrawal by Subject|10
287030|NCT01792284|964961|P3|Lead-in Period|Protocol Violation|0
287031|NCT01792284|964962|P2|Lead-in Period|Protocol Violation|0
287032|NCT01792284|964963|P1|Lead-in Period|Protocol Violation|1
287033|NCT01792284|964961|P3|Lead-in Period|Lost to Follow-up|0
287034|NCT01792284|964962|P2|Lead-in Period|Lost to Follow-up|0
287035|NCT01792284|964963|P1|Lead-in Period|Lost to Follow-up|2
287036|NCT01792284|964961|P3|Lead-in Period|Adverse Event|0
287037|NCT01792284|964962|P2|Lead-in Period|Adverse Event|0
287038|NCT01792284|964963|P1|Lead-in Period|Adverse Event|15
287039|NCT01791894|965022|P1|Overall Study|Adverse Event|1
287040|NCT01791803|965033|P4|Overall Study|Death|2
287041|NCT01791803|965034|P3|Overall Study|Death|2
287042|NCT01791803|965035|P2|Overall Study|Death|0
287043|NCT01791803|965036|P1|Overall Study|Death|0
287044|NCT01791803|965033|P4|Overall Study|Physician Decision|1
287045|NCT01791803|965034|P3|Overall Study|Physician Decision|0
287046|NCT01791803|965035|P2|Overall Study|Physician Decision|2
287047|NCT01791803|965036|P1|Overall Study|Physician Decision|0
287048|NCT01791803|965033|P4|Overall Study|Withdrawal by Subject|2
287049|NCT01791803|965034|P3|Overall Study|Withdrawal by Subject|0
287050|NCT01791803|965035|P2|Overall Study|Withdrawal by Subject|0
287051|NCT01791803|965036|P1|Overall Study|Withdrawal by Subject|0
287052|NCT01791725|965054|P3|Overall Study|Withdrawal by Subject|0
287053|NCT01791725|965055|P2|Overall Study|Withdrawal by Subject|1
287054|NCT01791725|965056|P1|Overall Study|Withdrawal by Subject|0
287055|NCT01791517|965079|P12|Phase II|Pre-Existing Ocular Issue|1
287056|NCT01791517|965080|P11|Phase II|Pre-Existing Ocular Issue|0
287057|NCT01791517|965081|P10|Phase II|Pre-Existing Ocular Issue|0
287058|NCT01791517|965082|P9|Phase II|Pre-Existing Ocular Issue|0
287059|NCT01791517|965083|P8|Phase II|Pre-Existing Ocular Issue|0
287060|NCT01791517|965084|P7|Phase II|Pre-Existing Ocular Issue|0
287061|NCT01791517|965085|P6|Phase II|Pre-Existing Ocular Issue|0
287062|NCT01791517|965086|P5|Phase II|Pre-Existing Ocular Issue|0
287063|NCT01791517|965087|P4|Phase II|Pre-Existing Ocular Issue|0
287064|NCT01791517|965088|P3|Phase II|Pre-Existing Ocular Issue|0
287065|NCT01791517|965089|P2|Phase II|Pre-Existing Ocular Issue|0
287066|NCT01791517|965090|P1|Phase II|Pre-Existing Ocular Issue|0
287067|NCT01791517|965079|P12|Phase II|Unsatisfactory Lens Fitting|0
287068|NCT01791517|965080|P11|Phase II|Unsatisfactory Lens Fitting|0
287069|NCT01791517|965081|P10|Phase II|Unsatisfactory Lens Fitting|1
287070|NCT01791517|965082|P9|Phase II|Unsatisfactory Lens Fitting|0
287071|NCT01791517|965083|P8|Phase II|Unsatisfactory Lens Fitting|0
287072|NCT01791517|965084|P7|Phase II|Unsatisfactory Lens Fitting|0
287073|NCT01791517|965085|P6|Phase II|Unsatisfactory Lens Fitting|0
287074|NCT01791517|965086|P5|Phase II|Unsatisfactory Lens Fitting|0
287075|NCT01791517|965087|P4|Phase II|Unsatisfactory Lens Fitting|0
287076|NCT01791517|965088|P3|Phase II|Unsatisfactory Lens Fitting|0
287077|NCT01791517|965089|P2|Phase II|Unsatisfactory Lens Fitting|0
287078|NCT01791517|965090|P1|Phase II|Unsatisfactory Lens Fitting|0
287079|NCT01791517|965079|P12|Phase II|Lens Handling Difficulties|0
287080|NCT01791517|965080|P11|Phase II|Lens Handling Difficulties|0
287081|NCT01791517|965081|P10|Phase II|Lens Handling Difficulties|0
287082|NCT01791517|965082|P9|Phase II|Lens Handling Difficulties|1
287083|NCT01791517|965083|P8|Phase II|Lens Handling Difficulties|0
287084|NCT01791517|965084|P7|Phase II|Lens Handling Difficulties|0
287085|NCT01791517|965085|P6|Phase II|Lens Handling Difficulties|0
287086|NCT01791517|965086|P5|Phase II|Lens Handling Difficulties|0
287087|NCT01791517|965087|P4|Phase II|Lens Handling Difficulties|0
287088|NCT01791517|965088|P3|Phase II|Lens Handling Difficulties|0
287089|NCT01791517|965089|P2|Phase II|Lens Handling Difficulties|0
287090|NCT01791517|965090|P1|Phase II|Lens Handling Difficulties|0
287091|NCT01791517|965079|P12|Phase II|Adverse Event|0
287092|NCT01791517|965080|P11|Phase II|Adverse Event|0
287093|NCT01791517|965081|P10|Phase II|Adverse Event|1
287094|NCT01791517|965082|P9|Phase II|Adverse Event|0
287095|NCT01791517|965083|P8|Phase II|Adverse Event|1
287096|NCT01791517|965084|P7|Phase II|Adverse Event|2
287097|NCT01791517|965085|P6|Phase II|Adverse Event|0
287098|NCT01791517|965086|P5|Phase II|Adverse Event|0
287099|NCT01791517|965087|P4|Phase II|Adverse Event|0
287100|NCT01791517|965088|P3|Phase II|Adverse Event|0
287101|NCT01791517|965089|P2|Phase II|Adverse Event|0
287102|NCT01791517|965090|P1|Phase II|Adverse Event|0
287103|NCT01791517|965079|P12|Phase II|Lack of Efficacy|0
287104|NCT01791517|965080|P11|Phase II|Lack of Efficacy|0
287105|NCT01791517|965081|P10|Phase II|Lack of Efficacy|0
287106|NCT01791517|965082|P9|Phase II|Lack of Efficacy|0
287107|NCT01791517|965083|P8|Phase II|Lack of Efficacy|0
287108|NCT01791517|965084|P7|Phase II|Lack of Efficacy|0
287109|NCT01791517|965085|P6|Phase II|Lack of Efficacy|0
287110|NCT01791517|965086|P5|Phase II|Lack of Efficacy|1
287111|NCT01791517|965087|P4|Phase II|Lack of Efficacy|0
287112|NCT01791517|965088|P3|Phase II|Lack of Efficacy|0
287113|NCT01791517|965089|P2|Phase II|Lack of Efficacy|0
287114|NCT01791517|965090|P1|Phase II|Lack of Efficacy|0
287115|NCT01791517|965079|P12|Phase II|Withdrawal by Subject|0
287116|NCT01791517|965080|P11|Phase II|Withdrawal by Subject|1
287117|NCT01791517|965081|P10|Phase II|Withdrawal by Subject|0
287118|NCT01791517|965082|P9|Phase II|Withdrawal by Subject|0
287119|NCT01791517|965083|P8|Phase II|Withdrawal by Subject|1
287120|NCT01791517|965084|P7|Phase II|Withdrawal by Subject|0
287121|NCT01791517|965085|P6|Phase II|Withdrawal by Subject|2
287122|NCT01791517|965086|P5|Phase II|Withdrawal by Subject|0
287123|NCT01791517|965087|P4|Phase II|Withdrawal by Subject|0
287124|NCT01791517|965088|P3|Phase II|Withdrawal by Subject|0
287125|NCT01791517|965089|P2|Phase II|Withdrawal by Subject|0
287126|NCT01791517|965090|P1|Phase II|Withdrawal by Subject|1
287127|NCT01791517|965079|P12|Phase II|Lost to Follow-up|0
287128|NCT01791517|965080|P11|Phase II|Lost to Follow-up|0
287129|NCT01791517|965081|P10|Phase II|Lost to Follow-up|1
287130|NCT01791517|965082|P9|Phase II|Lost to Follow-up|1
287131|NCT01791517|965083|P8|Phase II|Lost to Follow-up|1
287132|NCT01791517|965084|P7|Phase II|Lost to Follow-up|0
287133|NCT01791517|965085|P6|Phase II|Lost to Follow-up|2
287134|NCT01791517|965086|P5|Phase II|Lost to Follow-up|1
287135|NCT01791517|965087|P4|Phase II|Lost to Follow-up|0
287136|NCT01791517|965088|P3|Phase II|Lost to Follow-up|1
287137|NCT01791517|965089|P2|Phase II|Lost to Follow-up|0
287138|NCT01791517|965090|P1|Phase II|Lost to Follow-up|1
287139|NCT01791517|965079|P12|Phase I: Period 3|Adverse Event|0
287140|NCT01791517|965080|P11|Phase I: Period 3|Adverse Event|0
287141|NCT01791517|965081|P10|Phase I: Period 3|Adverse Event|0
287142|NCT01791517|965082|P9|Phase I: Period 3|Adverse Event|0
287143|NCT01791517|965083|P8|Phase I: Period 3|Adverse Event|0
287144|NCT01791517|965084|P7|Phase I: Period 3|Adverse Event|0
287145|NCT01791517|965085|P6|Phase I: Period 3|Adverse Event|0
287146|NCT01791517|965086|P5|Phase I: Period 3|Adverse Event|0
287147|NCT01791517|965087|P4|Phase I: Period 3|Adverse Event|1
287148|NCT01791517|965088|P3|Phase I: Period 3|Adverse Event|0
287149|NCT01791517|965089|P2|Phase I: Period 3|Adverse Event|0
287150|NCT01791517|965090|P1|Phase I: Period 3|Adverse Event|0
287151|NCT01791517|965079|P12|Phase I: Period 3|Lost to Follow-up|0
287152|NCT01791517|965080|P11|Phase I: Period 3|Lost to Follow-up|0
287153|NCT01791517|965081|P10|Phase I: Period 3|Lost to Follow-up|0
287154|NCT01791517|965082|P9|Phase I: Period 3|Lost to Follow-up|0
287155|NCT01791517|965083|P8|Phase I: Period 3|Lost to Follow-up|0
287156|NCT01791517|965084|P7|Phase I: Period 3|Lost to Follow-up|0
287157|NCT01791517|965085|P6|Phase I: Period 3|Lost to Follow-up|0
287158|NCT01791517|965086|P5|Phase I: Period 3|Lost to Follow-up|1
287159|NCT01791517|965087|P4|Phase I: Period 3|Lost to Follow-up|0
287160|NCT01791517|965088|P3|Phase I: Period 3|Lost to Follow-up|0
287161|NCT01791517|965089|P2|Phase I: Period 3|Lost to Follow-up|1
287162|NCT01791517|965090|P1|Phase I: Period 3|Lost to Follow-up|0
287163|NCT01791517|965079|P12|Phase I: Period 3|Lens Discomfort|1
287164|NCT01791517|965080|P11|Phase I: Period 3|Lens Discomfort|0
287165|NCT01791517|965081|P10|Phase I: Period 3|Lens Discomfort|0
287166|NCT01791517|965082|P9|Phase I: Period 3|Lens Discomfort|0
287167|NCT01791517|965083|P8|Phase I: Period 3|Lens Discomfort|0
287168|NCT01791517|965084|P7|Phase I: Period 3|Lens Discomfort|0
287169|NCT01791517|965085|P6|Phase I: Period 3|Lens Discomfort|0
287170|NCT01791517|965086|P5|Phase I: Period 3|Lens Discomfort|0
287171|NCT01791517|965087|P4|Phase I: Period 3|Lens Discomfort|0
287172|NCT01791517|965088|P3|Phase I: Period 3|Lens Discomfort|0
287173|NCT01791517|965089|P2|Phase I: Period 3|Lens Discomfort|0
287174|NCT01791517|965090|P1|Phase I: Period 3|Lens Discomfort|0
287175|NCT01791517|965079|P12|Phase I: Period 2|Lost to Follow-up|0
287176|NCT01791517|965080|P11|Phase I: Period 2|Lost to Follow-up|0
287177|NCT01791517|965081|P10|Phase I: Period 2|Lost to Follow-up|0
287178|NCT01791517|965082|P9|Phase I: Period 2|Lost to Follow-up|0
287179|NCT01791517|965083|P8|Phase I: Period 2|Lost to Follow-up|0
287180|NCT01791517|965084|P7|Phase I: Period 2|Lost to Follow-up|0
287181|NCT01791517|965085|P6|Phase I: Period 2|Lost to Follow-up|0
287182|NCT01791517|965086|P5|Phase I: Period 2|Lost to Follow-up|0
287183|NCT01791517|965087|P4|Phase I: Period 2|Lost to Follow-up|0
287184|NCT01791517|965088|P3|Phase I: Period 2|Lost to Follow-up|2
287185|NCT01791517|965089|P2|Phase I: Period 2|Lost to Follow-up|3
287186|NCT01791517|965090|P1|Phase I: Period 2|Lost to Follow-up|0
287187|NCT01791517|965079|P12|Phase I: Period 2|Lens Discomfort|0
287188|NCT01791517|965080|P11|Phase I: Period 2|Lens Discomfort|0
287189|NCT01791517|965081|P10|Phase I: Period 2|Lens Discomfort|0
287190|NCT01791517|965082|P9|Phase I: Period 2|Lens Discomfort|0
287191|NCT01791517|965083|P8|Phase I: Period 2|Lens Discomfort|0
287192|NCT01791517|965084|P7|Phase I: Period 2|Lens Discomfort|0
287193|NCT01791517|965085|P6|Phase I: Period 2|Lens Discomfort|1
287194|NCT01791517|965086|P5|Phase I: Period 2|Lens Discomfort|0
287195|NCT01791517|965087|P4|Phase I: Period 2|Lens Discomfort|0
287196|NCT01791517|965088|P3|Phase I: Period 2|Lens Discomfort|0
287197|NCT01791517|965089|P2|Phase I: Period 2|Lens Discomfort|0
287198|NCT01791517|965090|P1|Phase I: Period 2|Lens Discomfort|0
287199|NCT01791517|965079|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
287200|NCT01791517|965080|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
287201|NCT01791517|965081|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
287202|NCT01791517|965082|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
287203|NCT01791517|965083|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
287204|NCT01791517|965084|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
287205|NCT01791517|965085|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
287206|NCT01791517|965086|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
287207|NCT01791517|965087|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
287208|NCT01791517|965088|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
287209|NCT01791517|965089|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
287210|NCT01791517|965090|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
287211|NCT01791517|965079|P12|Phase I: Period 2|Withdrawal by Subject|0
287212|NCT01791517|965080|P11|Phase I: Period 2|Withdrawal by Subject|1
287213|NCT01791517|965081|P10|Phase I: Period 2|Withdrawal by Subject|1
287214|NCT01791517|965082|P9|Phase I: Period 2|Withdrawal by Subject|0
287215|NCT01791517|965083|P8|Phase I: Period 2|Withdrawal by Subject|0
287216|NCT01791517|965084|P7|Phase I: Period 2|Withdrawal by Subject|0
287217|NCT01791517|965085|P6|Phase I: Period 2|Withdrawal by Subject|0
287218|NCT01791517|965086|P5|Phase I: Period 2|Withdrawal by Subject|0
287219|NCT01791517|965087|P4|Phase I: Period 2|Withdrawal by Subject|0
287220|NCT01791517|965088|P3|Phase I: Period 2|Withdrawal by Subject|0
287221|NCT01791517|965089|P2|Phase I: Period 2|Withdrawal by Subject|0
287222|NCT01791517|965090|P1|Phase I: Period 2|Withdrawal by Subject|0
287223|NCT01791517|965079|P12|Phase I: Period 2|Protocol Violation|0
287224|NCT01791517|965080|P11|Phase I: Period 2|Protocol Violation|0
287225|NCT01791517|965081|P10|Phase I: Period 2|Protocol Violation|0
287226|NCT01791517|965082|P9|Phase I: Period 2|Protocol Violation|0
287227|NCT01791517|965083|P8|Phase I: Period 2|Protocol Violation|0
287228|NCT01791517|965084|P7|Phase I: Period 2|Protocol Violation|0
287229|NCT01791517|965085|P6|Phase I: Period 2|Protocol Violation|0
287230|NCT01791517|965086|P5|Phase I: Period 2|Protocol Violation|0
287231|NCT01791517|965087|P4|Phase I: Period 2|Protocol Violation|1
287232|NCT01791517|965088|P3|Phase I: Period 2|Protocol Violation|0
287233|NCT01791517|965089|P2|Phase I: Period 2|Protocol Violation|0
287234|NCT01791517|965090|P1|Phase I: Period 2|Protocol Violation|0
287235|NCT01791517|965079|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
287236|NCT01791517|965080|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
287237|NCT01791517|965081|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
287238|NCT01791517|965082|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
287239|NCT01791517|965083|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
287240|NCT01791517|965084|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
287241|NCT01791517|965085|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
287242|NCT01791517|965086|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
287243|NCT01791517|965087|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
287244|NCT01791517|965088|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
287245|NCT01791517|965089|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
287246|NCT01791517|965090|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
287247|NCT01791517|965079|P12|Phase I: Period 1|Lens Handling DIfficulties|1
287248|NCT01791517|965080|P11|Phase I: Period 1|Lens Handling DIfficulties|0
287249|NCT01791517|965081|P10|Phase I: Period 1|Lens Handling DIfficulties|0
287250|NCT01791517|965082|P9|Phase I: Period 1|Lens Handling DIfficulties|0
287251|NCT01791517|965083|P8|Phase I: Period 1|Lens Handling DIfficulties|0
287252|NCT01791517|965084|P7|Phase I: Period 1|Lens Handling DIfficulties|0
287253|NCT01791517|965085|P6|Phase I: Period 1|Lens Handling DIfficulties|0
287254|NCT01791517|965086|P5|Phase I: Period 1|Lens Handling DIfficulties|0
287255|NCT01791517|965087|P4|Phase I: Period 1|Lens Handling DIfficulties|0
287256|NCT01791517|965088|P3|Phase I: Period 1|Lens Handling DIfficulties|0
287257|NCT01791517|965089|P2|Phase I: Period 1|Lens Handling DIfficulties|0
287258|NCT01791517|965090|P1|Phase I: Period 1|Lens Handling DIfficulties|0
287259|NCT01791517|965079|P12|Phase I: Period 1|Lost to Follow-up|0
287260|NCT01791517|965080|P11|Phase I: Period 1|Lost to Follow-up|0
287261|NCT01791517|965081|P10|Phase I: Period 1|Lost to Follow-up|1
287262|NCT01791517|965082|P9|Phase I: Period 1|Lost to Follow-up|1
287263|NCT01791517|965083|P8|Phase I: Period 1|Lost to Follow-up|0
287264|NCT01791517|965084|P7|Phase I: Period 1|Lost to Follow-up|1
287265|NCT01791517|965085|P6|Phase I: Period 1|Lost to Follow-up|0
287266|NCT01791517|965086|P5|Phase I: Period 1|Lost to Follow-up|0
287267|NCT01791517|965087|P4|Phase I: Period 1|Lost to Follow-up|1
287268|NCT01791517|965088|P3|Phase I: Period 1|Lost to Follow-up|0
287269|NCT01791517|965089|P2|Phase I: Period 1|Lost to Follow-up|0
287270|NCT01791517|965090|P1|Phase I: Period 1|Lost to Follow-up|0
287271|NCT01791517|965079|P12|Phase I: Period 1|Protocol Violation|0
287272|NCT01791517|965080|P11|Phase I: Period 1|Protocol Violation|0
287273|NCT01791517|965081|P10|Phase I: Period 1|Protocol Violation|0
287274|NCT01791517|965082|P9|Phase I: Period 1|Protocol Violation|0
287275|NCT01791517|965083|P8|Phase I: Period 1|Protocol Violation|0
287276|NCT01791517|965084|P7|Phase I: Period 1|Protocol Violation|0
287277|NCT01791517|965085|P6|Phase I: Period 1|Protocol Violation|0
287278|NCT01791517|965086|P5|Phase I: Period 1|Protocol Violation|0
287279|NCT01791517|965087|P4|Phase I: Period 1|Protocol Violation|0
287280|NCT01791517|965088|P3|Phase I: Period 1|Protocol Violation|0
287281|NCT01791517|965089|P2|Phase I: Period 1|Protocol Violation|1
287282|NCT01791517|965090|P1|Phase I: Period 1|Protocol Violation|0
287283|NCT01791517|965079|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287284|NCT01791517|965080|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287285|NCT01791517|965081|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287286|NCT01791517|965082|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287287|NCT01791517|965083|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287288|NCT01791517|965084|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287289|NCT01791517|965085|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287290|NCT01791517|965086|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287291|NCT01791517|965087|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287292|NCT01791517|965088|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287293|NCT01791517|965089|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
287294|NCT01791517|965090|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
287295|NCT01791517|965079|P12|Phase I: Period 1|Adverse Event|0
287296|NCT01791517|965080|P11|Phase I: Period 1|Adverse Event|0
287297|NCT01791517|965081|P10|Phase I: Period 1|Adverse Event|0
287298|NCT01791517|965082|P9|Phase I: Period 1|Adverse Event|0
287299|NCT01791517|965083|P8|Phase I: Period 1|Adverse Event|0
287300|NCT01791517|965084|P7|Phase I: Period 1|Adverse Event|0
287301|NCT01791517|965085|P6|Phase I: Period 1|Adverse Event|0
287302|NCT01791517|965086|P5|Phase I: Period 1|Adverse Event|0
287303|NCT01791517|965087|P4|Phase I: Period 1|Adverse Event|1
287304|NCT01791517|965088|P3|Phase I: Period 1|Adverse Event|1
287305|NCT01791517|965089|P2|Phase I: Period 1|Adverse Event|0
287306|NCT01791517|965090|P1|Phase I: Period 1|Adverse Event|0
287307|NCT01791517|965079|P12|Phase I: Period 1|Withdrawal by Subject|0
287308|NCT01791517|965080|P11|Phase I: Period 1|Withdrawal by Subject|0
287309|NCT01791517|965081|P10|Phase I: Period 1|Withdrawal by Subject|0
287310|NCT01791517|965082|P9|Phase I: Period 1|Withdrawal by Subject|0
287311|NCT01791517|965083|P8|Phase I: Period 1|Withdrawal by Subject|0
287312|NCT01791517|965084|P7|Phase I: Period 1|Withdrawal by Subject|0
287313|NCT01791517|965085|P6|Phase I: Period 1|Withdrawal by Subject|1
287314|NCT01791517|965086|P5|Phase I: Period 1|Withdrawal by Subject|1
287315|NCT01791517|965087|P4|Phase I: Period 1|Withdrawal by Subject|0
287316|NCT01791517|965088|P3|Phase I: Period 1|Withdrawal by Subject|1
287317|NCT01791517|965089|P2|Phase I: Period 1|Withdrawal by Subject|1
287318|NCT01791517|965090|P1|Phase I: Period 1|Withdrawal by Subject|0
287319|NCT01791413|965154|P2|Overall Study|Lost to Follow-up|1
287320|NCT01791413|965155|P1|Overall Study|Lost to Follow-up|5
287321|NCT01791244|965164|P2|Overall Study|Laboratory Abnormality|1
287322|NCT01791244|965165|P1|Overall Study|Laboratory Abnormality|0
287323|NCT01791244|965164|P2|Overall Study|Insufficient clinical response|10
287324|NCT01791244|965165|P1|Overall Study|Insufficient clinical response|10
287325|NCT01791244|965164|P2|Overall Study|Adverse Event|7
287326|NCT01791244|965165|P1|Overall Study|Adverse Event|5
287327|NCT01791205|965201|P2|Phase II|Physician’s decision|0
287328|NCT01791205|965202|P1|Phase II|Physician’s decision|1
287329|NCT01791205|965201|P2|Phase II|Remission of disease|0
287330|NCT01791205|965202|P1|Phase II|Remission of disease|1
287331|NCT01791205|965201|P2|Phase II|Lost to Follow-up|0
287332|NCT01791205|965202|P1|Phase II|Lost to Follow-up|1
287333|NCT01791205|965201|P2|Phase II|Safety|0
287334|NCT01791205|965202|P1|Phase II|Safety|1
287335|NCT01791205|965201|P2|Phase II|Adverse Event|0
287336|NCT01791205|965202|P1|Phase II|Adverse Event|2
287337|NCT01791205|965201|P2|Phase II|Lack of Efficacy|0
287338|NCT01791205|965202|P1|Phase II|Lack of Efficacy|6
287339|NCT01791153|965286|P4|Overall Study|Withdrawal by Subject|1
287340|NCT01791153|965287|P3|Overall Study|Withdrawal by Subject|2
287341|NCT01791153|965288|P2|Overall Study|Withdrawal by Subject|2
287342|NCT01791153|965289|P1|Overall Study|Withdrawal by Subject|6
287343|NCT01791153|965286|P4|Overall Study|Protocol Violation|1
287344|NCT01791153|965287|P3|Overall Study|Protocol Violation|0
287345|NCT01791153|965288|P2|Overall Study|Protocol Violation|0
287346|NCT01791153|965289|P1|Overall Study|Protocol Violation|0
287347|NCT01791153|965286|P4|Overall Study|Physician Decision|1
287348|NCT01791153|965287|P3|Overall Study|Physician Decision|0
287349|NCT01791153|965288|P2|Overall Study|Physician Decision|0
287350|NCT01791153|965289|P1|Overall Study|Physician Decision|0
287351|NCT01791153|965286|P4|Overall Study|Non-Compliance|0
287352|NCT01791153|965287|P3|Overall Study|Non-Compliance|0
287353|NCT01791153|965288|P2|Overall Study|Non-Compliance|0
287354|NCT01791153|965289|P1|Overall Study|Non-Compliance|1
287355|NCT01791153|965286|P4|Overall Study|Lack of Efficacy|2
287356|NCT01791153|965287|P3|Overall Study|Lack of Efficacy|2
287357|NCT01791153|965288|P2|Overall Study|Lack of Efficacy|3
287358|NCT01791153|965289|P1|Overall Study|Lack of Efficacy|1
287359|NCT01791153|965286|P4|Overall Study|Adverse Event|0
287360|NCT01791153|965287|P3|Overall Study|Adverse Event|2
287361|NCT01791153|965288|P2|Overall Study|Adverse Event|3
287362|NCT01791153|965289|P1|Overall Study|Adverse Event|7
287363|NCT01790828|965345|P1|Overall Study|Not specified|34
287364|NCT01790633|965403|P2|Overall Study|RT failure and no follow-up ELISA|3
287365|NCT01790633|965404|P1|Overall Study|RT failure and no follow-up ELISA|0
287366|NCT01790633|965403|P2|Overall Study|Did not have serology performed|0
287367|NCT01790633|965404|P1|Overall Study|Did not have serology performed|47
287368|NCT01790633|965403|P2|Overall Study|Protocol Violation|2
287369|NCT01790633|965404|P1|Overall Study|Protocol Violation|1
287370|NCT01790594|965417|P3|Overall Study|Terminated prior to week 76|0
287371|NCT01790594|965418|P2|Overall Study|Terminated prior to week 76|2
287372|NCT01790594|965419|P1|Overall Study|Terminated prior to week 76|0
287373|NCT01790594|965417|P3|Overall Study|Transplant was not done|3
287374|NCT01790594|965418|P2|Overall Study|Transplant was not done|0
287375|NCT01790594|965419|P1|Overall Study|Transplant was not done|0
287376|NCT01790594|965417|P3|Overall Study|Withdrawal by Subject|0
287377|NCT01790594|965418|P2|Overall Study|Withdrawal by Subject|0
287378|NCT01790594|965419|P1|Overall Study|Withdrawal by Subject|2
287379|NCT01790594|965417|P3|Overall Study|Physician Decision|0
287380|NCT01790594|965418|P2|Overall Study|Physician Decision|1
287381|NCT01790594|965419|P1|Overall Study|Physician Decision|2
287382|NCT01790594|965417|P3|Overall Study|Death|0
287383|NCT01790594|965418|P2|Overall Study|Death|0
287384|NCT01790594|965419|P1|Overall Study|Death|1
287385|NCT01790568|965496|P2|Overall Study|Progression prior to transplant|1
287386|NCT01790568|965497|P1|Overall Study|Progression prior to transplant|0
287387|NCT01790516|965505|P2|Overall Study|Physician Decision|0
287388|NCT01790516|965506|P1|Overall Study|Physician Decision|1
287389|NCT01790438|965530|P2|Overall Study|Protocol Required Discontinuation|1
287390|NCT01790438|965531|P1|Overall Study|Protocol Required Discontinuation|7
287391|NCT01790438|965530|P2|Overall Study|Sponsor Decision|3
287392|NCT01790438|965531|P1|Overall Study|Sponsor Decision|0
287393|NCT01790438|965530|P2|Overall Study|Physician Decision|1
287394|NCT01790438|965531|P1|Overall Study|Physician Decision|3
287395|NCT01790438|965530|P2|Overall Study|Withdrawal by Subject|2
287396|NCT01790438|965531|P1|Overall Study|Withdrawal by Subject|13
287397|NCT01790438|965530|P2|Overall Study|Lost to Follow-up|2
287398|NCT01790438|965531|P1|Overall Study|Lost to Follow-up|5
287399|NCT01790438|965530|P2|Overall Study|Death|0
287400|NCT01790438|965531|P1|Overall Study|Death|4
287401|NCT01790438|965530|P2|Overall Study|Adverse Event|2
287402|NCT01790438|965531|P1|Overall Study|Adverse Event|3
287403|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
287404|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
287405|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
287406|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
287407|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
287408|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
287409|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
287410|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
287411|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
287412|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
287413|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
287414|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
287415|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
287416|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
287417|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
287418|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
287419|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
287420|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
287421|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
287422|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
287423|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
287424|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
287425|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
287426|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
287427|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
287428|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
287429|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
287430|NCT01789970|965600|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
287431|NCT01789970|965601|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
287432|NCT01789970|965602|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
287433|NCT01789970|965600|P3|Open-label Titration Period|Dropped out prior to dosing|0
287434|NCT01789970|965601|P2|Open-label Titration Period|Dropped out prior to dosing|0
287435|NCT01789970|965602|P1|Open-label Titration Period|Dropped out prior to dosing|2
287436|NCT01789970|965600|P3|Open-label Titration Period|Not specified|0
287437|NCT01789970|965601|P2|Open-label Titration Period|Not specified|0
287438|NCT01789970|965602|P1|Open-label Titration Period|Not specified|76
287439|NCT01789970|965600|P3|Open-label Titration Period|Pregnancy|0
287440|NCT01789970|965601|P2|Open-label Titration Period|Pregnancy|0
287441|NCT01789970|965602|P1|Open-label Titration Period|Pregnancy|2
287442|NCT01789970|965600|P3|Open-label Titration Period|Noncompliance with study procedures|0
287443|NCT01789970|965601|P2|Open-label Titration Period|Noncompliance with study procedures|0
287444|NCT01789970|965602|P1|Open-label Titration Period|Noncompliance with study procedures|8
287445|NCT01789970|965600|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
287446|NCT01789970|965601|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
287447|NCT01789970|965602|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
287448|NCT01789970|965600|P3|Open-label Titration Period|Noncompliance to study drug admin|0
287449|NCT01789970|965601|P2|Open-label Titration Period|Noncompliance to study drug admin|0
287450|NCT01789970|965602|P1|Open-label Titration Period|Noncompliance to study drug admin|11
287451|NCT01789970|965600|P3|Open-label Titration Period|Lost to Follow-up|0
287452|NCT01789970|965601|P2|Open-label Titration Period|Lost to Follow-up|0
287453|NCT01789970|965602|P1|Open-label Titration Period|Lost to Follow-up|5
287454|NCT01789970|965600|P3|Open-label Titration Period|Protocol Violation|0
287455|NCT01789970|965601|P2|Open-label Titration Period|Protocol Violation|0
287456|NCT01789970|965602|P1|Open-label Titration Period|Protocol Violation|18
287457|NCT01789970|965600|P3|Open-label Titration Period|Withdrawal by Subject|0
287458|NCT01789970|965601|P2|Open-label Titration Period|Withdrawal by Subject|0
287459|NCT01789970|965602|P1|Open-label Titration Period|Withdrawal by Subject|31
287460|NCT01789970|965600|P3|Open-label Titration Period|Lack of Efficacy|0
287461|NCT01789970|965601|P2|Open-label Titration Period|Lack of Efficacy|0
287462|NCT01789970|965602|P1|Open-label Titration Period|Lack of Efficacy|31
287463|NCT01789970|965600|P3|Open-label Titration Period|Adverse Event|0
287464|NCT01789970|965601|P2|Open-label Titration Period|Adverse Event|0
287465|NCT01789970|965602|P1|Open-label Titration Period|Adverse Event|68
287466|NCT01789606|965654|P2|Overall Study|Ineligible or not Willing to Continue|348
287467|NCT01789606|965655|P1|Overall Study|Ineligible or not Willing to Continue|0
287468|NCT01789606|965654|P2|Overall Study|Lost to Follow-up|14
287469|NCT01789606|965655|P1|Overall Study|Lost to Follow-up|0
287470|NCT01789606|965654|P2|Overall Study|Adverse Event|3
287471|NCT01789606|965655|P1|Overall Study|Adverse Event|0
287472|NCT01789606|965654|P2|Overall Study|Protocol Violation|55
287473|NCT01789606|965655|P1|Overall Study|Protocol Violation|0
287474|NCT01789606|965654|P2|Overall Study|No Study Medication Taken|1
287475|NCT01789606|965655|P1|Overall Study|No Study Medication Taken|0
287476|NCT01789606|965654|P2|Overall Study|Administrative Reasons|6
287477|NCT01789606|965655|P1|Overall Study|Administrative Reasons|17
287478|NCT01789606|965654|P2|Overall Study|Ineligible|2
287479|NCT01789606|965655|P1|Overall Study|Ineligible|6
287480|NCT01789606|965654|P2|Overall Study|Withdrawal by Subject|1
287481|NCT01789606|965655|P1|Overall Study|Withdrawal by Subject|0
287482|NCT01789606|965654|P2|Overall Study|Participant not Purchased the Product|20
287483|NCT01789606|965655|P1|Overall Study|Participant not Purchased the Product|0
287484|NCT01789476|965675|P2|Overall Study|Unable to get IV access|0
287485|NCT01789476|965676|P1|Overall Study|Unable to get IV access|1
287486|NCT01789476|965675|P2|Overall Study|Adverse Event|0
287487|NCT01789476|965676|P1|Overall Study|Adverse Event|1
287488|NCT01789476|965675|P2|Overall Study|Lack of Efficacy|2
287489|NCT01789476|965676|P1|Overall Study|Lack of Efficacy|6
287490|NCT01788943|965704|P2|Overall Study|Withdrawal by Subject|0
287491|NCT01788943|965705|P1|Overall Study|Withdrawal by Subject|1
287492|NCT01788566|965734|P1|Overall Study|Clinical Progressive Disease|3
287493|NCT01788566|965734|P1|Overall Study|Adverse Event|1
287494|NCT01788566|965734|P1|Overall Study|Death|4
287495|NCT01788358|965744|P1|Overall Study|Adverse Event|51
287496|NCT01788358|965744|P1|Overall Study|Lack of Efficacy|1
287497|NCT01788358|965744|P1|Overall Study|Withdrawal by Subject|26
287498|NCT01788358|965744|P1|Overall Study|Protocol Violation|3
287499|NCT01788358|965744|P1|Overall Study|Lost to Follow-up|5
287500|NCT01788358|965744|P1|Overall Study|Logistical difficulties|1
287501|NCT01788358|965744|P1|Overall Study|Other|11
287502|NCT01788228|965758|P2|Overall Study|Migrated/moved from study area|0
287503|NCT01788228|965759|P1|Overall Study|Migrated/moved from study area|1
287504|NCT01788215|965778|P2|Overall Study|Lost to Follow-up|0
287505|NCT01788215|965779|P1|Overall Study|Lost to Follow-up|2
287506|NCT01788215|965778|P2|Overall Study|Withdrawal by Subject|1
287507|NCT01788215|965779|P1|Overall Study|Withdrawal by Subject|0
287508|NCT01788163|965808|P9|Overall Study|Withdrawal by Subject|1
287509|NCT01788163|965809|P8|Overall Study|Withdrawal by Subject|0
287510|NCT01788163|965810|P7|Overall Study|Withdrawal by Subject|0
287511|NCT01788163|965811|P6|Overall Study|Withdrawal by Subject|0
287512|NCT01788163|965812|P5|Overall Study|Withdrawal by Subject|0
287513|NCT01788163|965813|P4|Overall Study|Withdrawal by Subject|0
287514|NCT01788163|965814|P3|Overall Study|Withdrawal by Subject|0
287515|NCT01788163|965815|P2|Overall Study|Withdrawal by Subject|0
287516|NCT01788163|965816|P1|Overall Study|Withdrawal by Subject|2
287517|NCT01788163|965808|P9|Overall Study|Other|15
287518|NCT01788163|965809|P8|Overall Study|Other|48
287519|NCT01788163|965810|P7|Overall Study|Other|1
287520|NCT01788163|965811|P6|Overall Study|Other|7
287521|NCT01788163|965812|P5|Overall Study|Other|0
287522|NCT01788163|965813|P4|Overall Study|Other|0
287523|NCT01788163|965814|P3|Overall Study|Other|0
287524|NCT01788163|965815|P2|Overall Study|Other|0
287525|NCT01788163|965816|P1|Overall Study|Other|53
287526|NCT01788046|965979|P2|Overall Study|Protocol Specified Criteria|1
287527|NCT01788046|965980|P1|Overall Study|Protocol Specified Criteria|25
287528|NCT01788046|965979|P2|Overall Study|Death|5
287529|NCT01788046|965980|P1|Overall Study|Death|7
287530|NCT01788046|965979|P2|Overall Study|Lost to Follow-up|19
287531|NCT01788046|965980|P1|Overall Study|Lost to Follow-up|12
287532|NCT01788046|965979|P2|Overall Study|Withdrawal by Subject|12
287533|NCT01788046|965980|P1|Overall Study|Withdrawal by Subject|12
287534|NCT01787838|966003|P1|Overall Study|refused|1413
287535|NCT01787825|966007|P2|Overall Study|Data Not Analyzable|1
287536|NCT01787825|966008|P1|Overall Study|Data Not Analyzable|5
287537|NCT01787825|966007|P2|Overall Study|Subject Did Not Ingest Capsules|0
287538|NCT01787825|966008|P1|Overall Study|Subject Did Not Ingest Capsules|1
287539|NCT01787760|966026|P3|Overall Study|Near vision blur|0
287540|NCT01787760|966027|P2|Overall Study|Near vision blur|0
287541|NCT01787760|966028|P1|Overall Study|Near vision blur|1
287542|NCT01787760|966026|P3|Overall Study|Unsatisfactory visual response|0
287543|NCT01787760|966027|P2|Overall Study|Unsatisfactory visual response|1
287544|NCT01787760|966028|P1|Overall Study|Unsatisfactory visual response|1
287545|NCT01787760|966026|P3|Overall Study|Unsatisfactory physiological response|0
287546|NCT01787760|966027|P2|Overall Study|Unsatisfactory physiological response|4
287547|NCT01787760|966028|P1|Overall Study|Unsatisfactory physiological response|2
287548|NCT01787760|966026|P3|Overall Study|Unsatisfactory lens fitting performance|0
287549|NCT01787760|966027|P2|Overall Study|Unsatisfactory lens fitting performance|6
287550|NCT01787760|966028|P1|Overall Study|Unsatisfactory lens fitting performance|3
287551|NCT01787760|966026|P3|Overall Study|Stroke|0
287552|NCT01787760|966027|P2|Overall Study|Stroke|0
287553|NCT01787760|966028|P1|Overall Study|Stroke|1
287554|NCT01787760|966026|P3|Overall Study|Lost to Follow-up|1
287555|NCT01787760|966027|P2|Overall Study|Lost to Follow-up|0
287556|NCT01787760|966028|P1|Overall Study|Lost to Follow-up|1
287557|NCT01787760|966026|P3|Overall Study|Withdrawal by Subject|2
287558|NCT01787760|966027|P2|Overall Study|Withdrawal by Subject|1
287559|NCT01787760|966028|P1|Overall Study|Withdrawal by Subject|5
287560|NCT01787760|966026|P3|Overall Study|Protocol Violation|1
287561|NCT01787760|966027|P2|Overall Study|Protocol Violation|0
287562|NCT01787760|966028|P1|Overall Study|Protocol Violation|6
287563|NCT01787760|966026|P3|Overall Study|Lens handling difficulty|0
287564|NCT01787760|966027|P2|Overall Study|Lens handling difficulty|2
287565|NCT01787760|966028|P1|Overall Study|Lens handling difficulty|1
287566|NCT01787760|966026|P3|Overall Study|Lens discomfort|0
287567|NCT01787760|966027|P2|Overall Study|Lens discomfort|0
287568|NCT01787760|966028|P1|Overall Study|Lens discomfort|3
287569|NCT01787760|966026|P3|Overall Study|Relocation|0
287570|NCT01787760|966027|P2|Overall Study|Relocation|1
287571|NCT01787760|966028|P1|Overall Study|Relocation|1
287572|NCT01787760|966026|P3|Overall Study|Dryness|0
287573|NCT01787760|966027|P2|Overall Study|Dryness|1
287574|NCT01787760|966028|P1|Overall Study|Dryness|0
287575|NCT01787760|966026|P3|Overall Study|Decompensated on left exotropia|1
287576|NCT01787760|966027|P2|Overall Study|Decompensated on left exotropia|0
287577|NCT01787760|966028|P1|Overall Study|Decompensated on left exotropia|0
287578|NCT01787760|966026|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
287579|NCT01787760|966027|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
287580|NCT01787760|966028|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
287581|NCT01787591|966042|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
287582|NCT01787591|966043|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
287583|NCT01787591|966044|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
287584|NCT01787591|966045|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
287585|NCT01787461|966073|P2|Overall Study|Protocol Violation|0
287586|NCT01787461|966074|P1|Overall Study|Protocol Violation|3
287587|NCT01787461|966073|P2|Overall Study|Withdrawal by Subject|4
287588|NCT01787461|966074|P1|Overall Study|Withdrawal by Subject|3
287589|NCT01787461|966073|P2|Overall Study|No longer met eligibility criteria|0
287590|NCT01787461|966074|P1|Overall Study|No longer met eligibility criteria|1
287591|NCT01787461|966073|P2|Overall Study|Lost to Follow-up|2
287592|NCT01787461|966074|P1|Overall Study|Lost to Follow-up|3
287593|NCT01787461|966073|P2|Overall Study|Adverse Event|3
287594|NCT01787461|966074|P1|Overall Study|Adverse Event|4
287595|NCT01787279|966123|P1|Overall Study|Lack of Efficacy|1
287596|NCT01787279|966123|P1|Overall Study|Lost to Follow-up|2
287597|NCT01787188|966149|P3|Overall Study|Other, including patient moved|0
287598|NCT01787188|966150|P2|Overall Study|Other, including patient moved|3
287599|NCT01787188|966151|P1|Overall Study|Other, including patient moved|0
287600|NCT01787188|966149|P3|Overall Study|Lost to Follow-up|2
287601|NCT01787188|966150|P2|Overall Study|Lost to Follow-up|2
287602|NCT01787188|966151|P1|Overall Study|Lost to Follow-up|1
287603|NCT01787188|966149|P3|Overall Study|Protocol Violation|3
287604|NCT01787188|966150|P2|Overall Study|Protocol Violation|2
287605|NCT01787188|966151|P1|Overall Study|Protocol Violation|3
287606|NCT01787188|966149|P3|Overall Study|Withdrawal by Subject|2
287607|NCT01787188|966150|P2|Overall Study|Withdrawal by Subject|3
287608|NCT01787188|966151|P1|Overall Study|Withdrawal by Subject|4
287609|NCT01787188|966149|P3|Overall Study|Non-compliance with Study Drug|0
287610|NCT01787188|966150|P2|Overall Study|Non-compliance with Study Drug|1
287611|NCT01787188|966151|P1|Overall Study|Non-compliance with Study Drug|0
287612|NCT01787188|966149|P3|Overall Study|Lack of Efficacy|5
287613|NCT01787188|966150|P2|Overall Study|Lack of Efficacy|3
287614|NCT01787188|966151|P1|Overall Study|Lack of Efficacy|7
287615|NCT01787188|966149|P3|Overall Study|Adverse Event|6
287616|NCT01787188|966150|P2|Overall Study|Adverse Event|4
287617|NCT01787188|966151|P1|Overall Study|Adverse Event|2
287618|NCT01787032|966223|P6|Overall Study|Protocol Violation|1
287619|NCT01787032|966224|P5|Overall Study|Protocol Violation|1
287620|NCT01787032|966225|P4|Overall Study|Protocol Violation|0
287621|NCT01787032|966226|P3|Overall Study|Protocol Violation|0
287622|NCT01787032|966227|P2|Overall Study|Protocol Violation|0
287623|NCT01787032|966228|P1|Overall Study|Protocol Violation|0
287624|NCT01786993|966252|P2|Overall Study|Hospice Admission|0
287625|NCT01786993|966253|P1|Overall Study|Hospice Admission|1
287626|NCT01786993|966252|P2|Overall Study|System Explant|0
287627|NCT01786993|966253|P1|Overall Study|System Explant|1
287628|NCT01786993|966252|P2|Overall Study|Subject Non-Compliance|0
287629|NCT01786993|966253|P1|Overall Study|Subject Non-Compliance|1
287630|NCT01786993|966252|P2|Overall Study|Lost to Follow-up|1
287631|NCT01786993|966253|P1|Overall Study|Lost to Follow-up|0
287632|NCT01786993|966252|P2|Overall Study|Withdrawal by Subject|2
287633|NCT01786993|966253|P1|Overall Study|Withdrawal by Subject|3
287634|NCT01786993|966252|P2|Overall Study|Death|7
287635|NCT01786993|966253|P1|Overall Study|Death|6
287636|NCT01786707|966303|P2|Overall Study|Lost to Follow-up|1
287637|NCT01786707|966304|P1|Overall Study|Lost to Follow-up|1
287638|NCT01786668|966316|P4|Overall Study|Lost to Follow-up|0
287639|NCT01786668|966317|P3|Overall Study|Lost to Follow-up|1
287640|NCT01786668|966318|P2|Overall Study|Lost to Follow-up|0
287641|NCT01786668|966319|P1|Overall Study|Lost to Follow-up|1
287642|NCT01786668|966316|P4|Overall Study|Pregnancy|1
287643|NCT01786668|966317|P3|Overall Study|Pregnancy|0
287644|NCT01786668|966318|P2|Overall Study|Pregnancy|0
287645|NCT01786668|966319|P1|Overall Study|Pregnancy|0
287646|NCT01786668|966316|P4|Overall Study|Withdrawal by Subject|1
287647|NCT01786668|966317|P3|Overall Study|Withdrawal by Subject|3
287648|NCT01786668|966318|P2|Overall Study|Withdrawal by Subject|0
287649|NCT01786668|966319|P1|Overall Study|Withdrawal by Subject|0
287650|NCT01786668|966316|P4|Overall Study|Adverse Event|2
287651|NCT01786668|966317|P3|Overall Study|Adverse Event|1
287652|NCT01786668|966318|P2|Overall Study|Adverse Event|1
287653|NCT01786668|966319|P1|Overall Study|Adverse Event|0
287654|NCT01786629|966419|P2|Overall Study|Adverse Event|1
287655|NCT01786629|966420|P1|Overall Study|Adverse Event|0
287656|NCT01786629|966419|P2|Overall Study|Lack of Efficacy|4
287657|NCT01786629|966420|P1|Overall Study|Lack of Efficacy|0
287658|NCT01786551|966426|P1|Overall Study|Participant withdrew consent|2
287659|NCT01786330|966434|P2|Overall Study|Protocol Violation|0
287660|NCT01786330|966435|P1|Overall Study|Protocol Violation|1
287661|NCT01786330|966434|P2|Overall Study|Excluded intraoperatively|1
287662|NCT01786330|966435|P1|Overall Study|Excluded intraoperatively|0
287663|NCT01786330|966434|P2|Overall Study|Lost to Follow-up|1
287664|NCT01786330|966435|P1|Overall Study|Lost to Follow-up|0
287665|NCT01786330|966434|P2|Overall Study|Withdrawal by Subject|1
287666|NCT01786330|966435|P1|Overall Study|Withdrawal by Subject|0
287667|NCT01786174|966473|P2|Overall Study|Discontinued Study Drug|0
287668|NCT01786174|966474|P1|Overall Study|Discontinued Study Drug|2
287669|NCT01786109|966504|P3|Overall Study|adverse effects colon preparation|1
287670|NCT01786109|966505|P2|Overall Study|adverse effects colon preparation|0
287671|NCT01786109|966506|P1|Overall Study|adverse effects colon preparation|0
287672|NCT01786109|966504|P3|Overall Study|unrelated illness|1
287673|NCT01786109|966505|P2|Overall Study|unrelated illness|0
287674|NCT01786109|966506|P1|Overall Study|unrelated illness|0
287675|NCT01786109|966504|P3|Overall Study|fail manometry barostat tube placement|0
287676|NCT01786109|966505|P2|Overall Study|fail manometry barostat tube placement|0
287677|NCT01786109|966506|P1|Overall Study|fail manometry barostat tube placement|1
287678|NCT01785875|966535|P3|Overall Study|Missing|3
287679|NCT01785875|966536|P2|Overall Study|Missing|1
287680|NCT01785875|966537|P1|Overall Study|Missing|0
287681|NCT01785875|966535|P3|Overall Study|Protocol Specified Criteria|55
287682|NCT01785875|966536|P2|Overall Study|Protocol Specified Criteria|214
287683|NCT01785875|966537|P1|Overall Study|Protocol Specified Criteria|207
287684|NCT01785875|966535|P3|Overall Study|Sponsor Decision|0
287685|NCT01785875|966536|P2|Overall Study|Sponsor Decision|2
287686|NCT01785875|966537|P1|Overall Study|Sponsor Decision|0
287687|NCT01785875|966535|P3|Overall Study|Death|7
287688|NCT01785875|966536|P2|Overall Study|Death|16
287689|NCT01785875|966537|P1|Overall Study|Death|27
287690|NCT01785875|966535|P3|Overall Study|Lost to Follow-up|6
287691|NCT01785875|966536|P2|Overall Study|Lost to Follow-up|22
287692|NCT01785875|966537|P1|Overall Study|Lost to Follow-up|19
287693|NCT01785875|966535|P3|Overall Study|Withdrawal by Subject|36
287694|NCT01785875|966536|P2|Overall Study|Withdrawal by Subject|34
287695|NCT01785875|966537|P1|Overall Study|Withdrawal by Subject|41
287696|NCT01785849|966606|P2|Overall Study|Lost to Follow-up|11
287697|NCT01785849|966607|P1|Overall Study|Lost to Follow-up|10
287698|NCT01785849|966606|P2|Overall Study|Sponsor Decision|1
287699|NCT01785849|966607|P1|Overall Study|Sponsor Decision|0
287700|NCT01785849|966606|P2|Overall Study|Withdrawal by Subject|12
287701|NCT01785849|966607|P1|Overall Study|Withdrawal by Subject|15
287702|NCT01785849|966606|P2|Overall Study|Protocol Specified Criteria|1
287703|NCT01785849|966607|P1|Overall Study|Protocol Specified Criteria|29
287704|NCT01785849|966606|P2|Overall Study|Death|9
287705|NCT01785849|966607|P1|Overall Study|Death|7
287706|NCT01785628|966625|P2|Overall Study|Lost to Follow-up|3
287707|NCT01785628|966626|P1|Overall Study|Lost to Follow-up|2
287708|NCT01785615|966649|P4|Dietary Phase|Lost to Follow-up|24
287709|NCT01785615|966650|P3|Dietary Phase|Lost to Follow-up|0
287710|NCT01785615|966651|P2|Dietary Phase|Lost to Follow-up|0
287711|NCT01785615|966652|P1|Dietary Phase|Lost to Follow-up|0
287712|NCT01785602|966724|P2|Overall Study|Administrative problems|3
287713|NCT01785602|966725|P1|Overall Study|Administrative problems|7
287714|NCT01785602|966724|P2|Overall Study|Adverse Event|5
287715|NCT01785602|966725|P1|Overall Study|Adverse Event|3
287716|NCT01785602|966724|P2|Overall Study|Lost to Follow-up|1
287717|NCT01785602|966725|P1|Overall Study|Lost to Follow-up|1
287718|NCT01785602|966724|P2|Overall Study|Withdrawal by Subject|0
287719|NCT01785602|966725|P1|Overall Study|Withdrawal by Subject|2
287720|NCT01785524|966735|P2|Overall Study|Withdrawal by Subject|2
287721|NCT01785524|966736|P1|Overall Study|Withdrawal by Subject|2
287722|NCT01785472|966755|P3|Overall Study|Technical problems|1
287723|NCT01785472|966756|P2|Overall Study|Technical problems|0
287724|NCT01785472|966757|P1|Overall Study|Technical problems|0
287725|NCT01785472|966755|P3|Overall Study|Subject/guardian decision|11
287726|NCT01785472|966756|P2|Overall Study|Subject/guardian decision|10
287727|NCT01785472|966757|P1|Overall Study|Subject/guardian decision|15
287728|NCT01785472|966755|P3|Overall Study|Protocol deviation|2
287729|NCT01785472|966756|P2|Overall Study|Protocol deviation|2
287730|NCT01785472|966757|P1|Overall Study|Protocol deviation|0
287731|NCT01785472|966755|P3|Overall Study|Physician Decision|1
287732|NCT01785472|966756|P2|Overall Study|Physician Decision|1
287733|NCT01785472|966757|P1|Overall Study|Physician Decision|1
287734|NCT01785472|966755|P3|Overall Study|Lost to Follow-up|0
287735|NCT01785472|966756|P2|Overall Study|Lost to Follow-up|2
287736|NCT01785472|966757|P1|Overall Study|Lost to Follow-up|1
287737|NCT01785472|966755|P3|Overall Study|Lack of Efficacy|1
287738|NCT01785472|966756|P2|Overall Study|Lack of Efficacy|0
287739|NCT01785472|966757|P1|Overall Study|Lack of Efficacy|2
287740|NCT01785472|966755|P3|Overall Study|Adverse Event|6
287741|NCT01785472|966756|P2|Overall Study|Adverse Event|4
287742|NCT01785472|966757|P1|Overall Study|Adverse Event|5
287743|NCT01785160|966830|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
287744|NCT01785160|966830|P1|Treatment Period 1: Raltegravir|Not treated|1
287745|NCT01784965|966865|P2|Overall Study|Adverse Event|8
287746|NCT01784965|966866|P1|Overall Study|Adverse Event|0
287747|NCT01784965|966865|P2|Overall Study|Withdrawal by Subject|3
287748|NCT01784965|966866|P1|Overall Study|Withdrawal by Subject|6
287749|NCT01783938|966941|P2|Overall Study|Not Specified|0
287750|NCT01783938|966942|P1|Overall Study|Not Specified|1
287751|NCT01783938|966941|P2|Overall Study|Withdrew Consent|0
287752|NCT01783938|966942|P1|Overall Study|Withdrew Consent|3
287753|NCT01783938|966941|P2|Overall Study|Request to Discontinue Study Treatment|2
287754|NCT01783938|966942|P1|Overall Study|Request to Discontinue Study Treatment|1
287755|NCT01783938|966941|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
287756|NCT01783938|966942|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
287757|NCT01783938|966941|P2|Overall Study|Study Drug Toxicity|10
287758|NCT01783938|966942|P1|Overall Study|Study Drug Toxicity|22
287759|NCT01783938|966941|P2|Overall Study|Disease Progression|39
287760|NCT01783938|966942|P1|Overall Study|Disease Progression|18
287761|NCT01783886|966970|P3|Overall Study|Adverse Event|4
287762|NCT01783886|966971|P2|Overall Study|Adverse Event|5
287763|NCT01783886|966972|P1|Overall Study|Adverse Event|4
287764|NCT01783886|966970|P3|Overall Study|Withdrawal of consent by participant|4
287765|NCT01783886|966971|P2|Overall Study|Withdrawal of consent by participant|3
287766|NCT01783886|966972|P1|Overall Study|Withdrawal of consent by participant|1
287767|NCT01783886|966970|P3|Overall Study|Protocol deviation|2
287768|NCT01783886|966971|P2|Overall Study|Protocol deviation|0
287769|NCT01783886|966972|P1|Overall Study|Protocol deviation|0
287770|NCT01783886|966970|P3|Overall Study|Lost to Follow-up|0
287771|NCT01783886|966971|P2|Overall Study|Lost to Follow-up|3
287772|NCT01783886|966972|P1|Overall Study|Lost to Follow-up|0
287773|NCT01783821|967019|P2|Overall Study|Screen Failure|1
287774|NCT01783821|967020|P1|Overall Study|Screen Failure|1
287775|NCT01783743|967038|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
287776|NCT01783743|967039|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
287777|NCT01783743|967038|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
287778|NCT01783743|967039|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
287779|NCT01783743|967038|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
287780|NCT01783743|967039|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
287781|NCT01783730|967053|P1|Overall Study|Failed to meet inclusion criteria|6
287782|NCT01783678|967078|P6|Overall Study|Withdrew Consent|0
287783|NCT01783678|967079|P5|Overall Study|Withdrew Consent|0
287784|NCT01783678|967080|P4|Overall Study|Withdrew Consent|2
287785|NCT01783678|967081|P3|Overall Study|Withdrew Consent|0
287786|NCT01783678|967082|P2|Overall Study|Withdrew Consent|1
287787|NCT01783678|967083|P1|Overall Study|Withdrew Consent|1
287788|NCT01783678|967078|P6|Overall Study|Lost to Follow-up|0
287789|NCT01783678|967079|P5|Overall Study|Lost to Follow-up|1
287790|NCT01783678|967080|P4|Overall Study|Lost to Follow-up|2
287791|NCT01783678|967081|P3|Overall Study|Lost to Follow-up|0
287792|NCT01783678|967082|P2|Overall Study|Lost to Follow-up|4
287793|NCT01783678|967083|P1|Overall Study|Lost to Follow-up|0
287794|NCT01783678|967078|P6|Overall Study|Lack of Efficacy|5
287795|NCT01783678|967079|P5|Overall Study|Lack of Efficacy|6
287796|NCT01783678|967080|P4|Overall Study|Lack of Efficacy|3
287797|NCT01783678|967081|P3|Overall Study|Lack of Efficacy|1
287798|NCT01783678|967082|P2|Overall Study|Lack of Efficacy|13
287799|NCT01783678|967083|P1|Overall Study|Lack of Efficacy|1
287800|NCT01783678|967078|P6|Overall Study|Randomized but Not Treated|0
287801|NCT01783678|967079|P5|Overall Study|Randomized but Not Treated|0
287802|NCT01783678|967080|P4|Overall Study|Randomized but Not Treated|1
287803|NCT01783678|967081|P3|Overall Study|Randomized but Not Treated|0
287804|NCT01783678|967082|P2|Overall Study|Randomized but Not Treated|0
287805|NCT01783678|967083|P1|Overall Study|Randomized but Not Treated|0
287806|NCT01783548|967185|P2|Overall Study|Lack of Efficacy|1
287807|NCT01783548|967186|P1|Overall Study|Lack of Efficacy|1
287808|NCT01783548|967185|P2|Overall Study|Lost to Follow-up|3
287809|NCT01783548|967186|P1|Overall Study|Lost to Follow-up|8
287810|NCT01783548|967185|P2|Overall Study|Protocol Violation|2
287811|NCT01783548|967186|P1|Overall Study|Protocol Violation|2
287812|NCT01783548|967185|P2|Overall Study|Non-compliance|0
287813|NCT01783548|967186|P1|Overall Study|Non-compliance|4
287814|NCT01783548|967185|P2|Overall Study|Withdrawal by Subject|8
287815|NCT01783548|967186|P1|Overall Study|Withdrawal by Subject|11
287816|NCT01783548|967185|P2|Overall Study|Adverse Event|4
287817|NCT01783548|967186|P1|Overall Study|Adverse Event|8
287818|NCT01783496|967204|P6|Overall Study|Withdrawal by Subject|0
287819|NCT01783496|967205|P5|Overall Study|Withdrawal by Subject|0
287820|NCT01783496|967206|P4|Overall Study|Withdrawal by Subject|0
287821|NCT01783496|967207|P3|Overall Study|Withdrawal by Subject|0
287822|NCT01783496|967208|P2|Overall Study|Withdrawal by Subject|0
287823|NCT01783496|967209|P1|Overall Study|Withdrawal by Subject|1
287824|NCT01783496|967204|P6|Overall Study|Lost to Follow-up|1
287825|NCT01783496|967205|P5|Overall Study|Lost to Follow-up|0
287826|NCT01783496|967206|P4|Overall Study|Lost to Follow-up|2
287827|NCT01783496|967207|P3|Overall Study|Lost to Follow-up|0
287828|NCT01783496|967208|P2|Overall Study|Lost to Follow-up|0
287829|NCT01783496|967209|P1|Overall Study|Lost to Follow-up|0
287830|NCT01783483|967237|P2|Overall Study|Physician Decision|1
287831|NCT01783483|967238|P1|Overall Study|Physician Decision|1
287832|NCT01783483|967237|P2|Overall Study|Withdrawal by Subject|1
287833|NCT01783483|967238|P1|Overall Study|Withdrawal by Subject|2
287834|NCT01783483|967237|P2|Overall Study|Lost to Follow-up|10
287835|NCT01783483|967238|P1|Overall Study|Lost to Follow-up|14
287836|NCT01783483|967237|P2|Overall Study|Death|3
287837|NCT01783483|967238|P1|Overall Study|Death|3
287838|NCT01783418|967276|P2|Overall Study|Withdrawal by Subject|0
287839|NCT01783418|967277|P1|Overall Study|Withdrawal by Subject|1
287840|NCT01783015|967330|P3|Open Label Treatment|Study Terminated by Sponsor|6
287841|NCT01783015|967331|P2|Open Label Treatment|Study Terminated by Sponsor|0
287842|NCT01783015|967332|P1|Open Label Treatment|Study Terminated by Sponsor|0
287843|NCT01783015|967330|P3|Blinded Treatment|Study Terminated by Sponsor|0
287844|NCT01783015|967331|P2|Blinded Treatment|Study Terminated by Sponsor|0
287845|NCT01783015|967332|P1|Blinded Treatment|Study Terminated by Sponsor|2
287846|NCT01783015|967330|P3|Blinded Treatment|Withdrawal by Subject|0
287847|NCT01783015|967331|P2|Blinded Treatment|Withdrawal by Subject|1
287848|NCT01783015|967332|P1|Blinded Treatment|Withdrawal by Subject|0
287849|NCT01783015|967330|P3|Blinded Treatment|Protocol Violation|0
287850|NCT01783015|967331|P2|Blinded Treatment|Protocol Violation|1
287851|NCT01783015|967332|P1|Blinded Treatment|Protocol Violation|0
287852|NCT01783015|967330|P3|Blinded Treatment|Adverse Event|0
287853|NCT01783015|967331|P2|Blinded Treatment|Adverse Event|1
287854|NCT01783015|967332|P1|Blinded Treatment|Adverse Event|0
287855|NCT01782885|967441|P2|Overall Study|Lost to Follow-up|6
287856|NCT01782885|967442|P1|Overall Study|Lost to Follow-up|4
287857|NCT01782872|967468|P4|Overall Study|Withdrawal by Subject|0
287858|NCT01782872|967469|P3|Overall Study|Withdrawal by Subject|0
287859|NCT01782872|967470|P2|Overall Study|Withdrawal by Subject|1
287860|NCT01782872|967471|P1|Overall Study|Withdrawal by Subject|0
287861|NCT01782872|967468|P4|Overall Study|Protocol Violation|1
287862|NCT01782872|967469|P3|Overall Study|Protocol Violation|0
287863|NCT01782872|967470|P2|Overall Study|Protocol Violation|0
287864|NCT01782872|967471|P1|Overall Study|Protocol Violation|0
287865|NCT01782859|967495|P2|Overall Study|Withdrawal by Subject|1
287866|NCT01782859|967496|P1|Overall Study|Withdrawal by Subject|0
287867|NCT01782859|967495|P2|Overall Study|Protocol Violation|6
287868|NCT01782859|967496|P1|Overall Study|Protocol Violation|6
287869|NCT01782742|967512|P2|Double-blind Treatment Phase|Adverse Event|0
287870|NCT01782742|967513|P1|Double-blind Treatment Phase|Adverse Event|1
287871|NCT01782664|967552|P6|Overall Study|Withdrawal by Subject|0
287872|NCT01782664|967553|P5|Overall Study|Withdrawal by Subject|0
287873|NCT01782664|967554|P4|Overall Study|Withdrawal by Subject|0
287874|NCT01782664|967555|P3|Overall Study|Withdrawal by Subject|0
287875|NCT01782664|967556|P2|Overall Study|Withdrawal by Subject|2
287876|NCT01782664|967557|P1|Overall Study|Withdrawal by Subject|2
287877|NCT01782664|967552|P6|Overall Study|Protocol Violation|0
287878|NCT01782664|967553|P5|Overall Study|Protocol Violation|0
287879|NCT01782664|967554|P4|Overall Study|Protocol Violation|1
287880|NCT01782664|967555|P3|Overall Study|Protocol Violation|0
287881|NCT01782664|967556|P2|Overall Study|Protocol Violation|1
287882|NCT01782664|967557|P1|Overall Study|Protocol Violation|0
287883|NCT01782664|967552|P6|Overall Study|Lack of Efficacy|0
287884|NCT01782664|967553|P5|Overall Study|Lack of Efficacy|0
287885|NCT01782664|967554|P4|Overall Study|Lack of Efficacy|2
287886|NCT01782664|967555|P3|Overall Study|Lack of Efficacy|2
287887|NCT01782664|967556|P2|Overall Study|Lack of Efficacy|0
287888|NCT01782664|967557|P1|Overall Study|Lack of Efficacy|2
287889|NCT01782664|967552|P6|Overall Study|Adverse Event|0
287890|NCT01782664|967553|P5|Overall Study|Adverse Event|0
287891|NCT01782664|967554|P4|Overall Study|Adverse Event|2
287892|NCT01782664|967555|P3|Overall Study|Adverse Event|2
287893|NCT01782664|967556|P2|Overall Study|Adverse Event|2
287894|NCT01782664|967557|P1|Overall Study|Adverse Event|2
287895|NCT01782495|967714|P11|Overall Study|Withdrew Consent|0
287896|NCT01782495|967715|P10|Overall Study|Withdrew Consent|0
287897|NCT01782495|967716|P9|Overall Study|Withdrew Consent|0
287898|NCT01782495|967717|P8|Overall Study|Withdrew Consent|1
287899|NCT01782495|967718|P7|Overall Study|Withdrew Consent|0
287900|NCT01782495|967719|P6|Overall Study|Withdrew Consent|0
287901|NCT01782495|967720|P5|Overall Study|Withdrew Consent|0
287902|NCT01782495|967721|P4|Overall Study|Withdrew Consent|0
287903|NCT01782495|967722|P3|Overall Study|Withdrew Consent|0
287904|NCT01782495|967723|P2|Overall Study|Withdrew Consent|1
287905|NCT01782495|967724|P1|Overall Study|Withdrew Consent|0
287906|NCT01782495|967714|P11|Overall Study|Adverse Event|0
287907|NCT01782495|967715|P10|Overall Study|Adverse Event|0
287908|NCT01782495|967716|P9|Overall Study|Adverse Event|0
287909|NCT01782495|967717|P8|Overall Study|Adverse Event|2
287910|NCT01782495|967718|P7|Overall Study|Adverse Event|0
287911|NCT01782495|967719|P6|Overall Study|Adverse Event|0
287912|NCT01782495|967720|P5|Overall Study|Adverse Event|0
287913|NCT01782495|967721|P4|Overall Study|Adverse Event|0
287914|NCT01782495|967722|P3|Overall Study|Adverse Event|0
287915|NCT01782495|967723|P2|Overall Study|Adverse Event|0
287916|NCT01782495|967724|P1|Overall Study|Adverse Event|0
287917|NCT01782482|967783|P2|Overall Study|Habitually wearing toric lens OS|1
287918|NCT01782482|967784|P1|Overall Study|Habitually wearing toric lens OS|0
287919|NCT01782482|967783|P2|Overall Study|Randomized in Error|2
287920|NCT01782482|967784|P1|Overall Study|Randomized in Error|2
287921|NCT01782482|967783|P2|Overall Study|Withdrawal by Subject|3
287922|NCT01782482|967784|P1|Overall Study|Withdrawal by Subject|2
287923|NCT01782482|967783|P2|Overall Study|Protocol Violation|0
287924|NCT01782482|967784|P1|Overall Study|Protocol Violation|1
287925|NCT01782482|967783|P2|Overall Study|Physician Decision|0
287926|NCT01782482|967784|P1|Overall Study|Physician Decision|1
287927|NCT01782482|967783|P2|Overall Study|Lost to Follow-up|3
287928|NCT01782482|967784|P1|Overall Study|Lost to Follow-up|2
287929|NCT01782482|967783|P2|Overall Study|Adverse Event|1
287930|NCT01782482|967784|P1|Overall Study|Adverse Event|2
287931|NCT01782469|967792|P1|Overall Study|Lost to Follow-up|1
287932|NCT01782326|967802|P2|Double-blind Treatment|Technical problems|5
287933|NCT01782326|967803|P1|Double-blind Treatment|Technical problems|0
287934|NCT01782326|967802|P2|Double-blind Treatment|Protocol deviation|7
287935|NCT01782326|967803|P1|Double-blind Treatment|Protocol deviation|8
287936|NCT01782326|967802|P2|Double-blind Treatment|Physician Decision|16
287937|NCT01782326|967803|P1|Double-blind Treatment|Physician Decision|13
287938|NCT01782326|967802|P2|Double-blind Treatment|Lack of Efficacy|22
287939|NCT01782326|967803|P1|Double-blind Treatment|Lack of Efficacy|17
287940|NCT01782326|967802|P2|Double-blind Treatment|Subject/guardian decision|125
287941|NCT01782326|967803|P1|Double-blind Treatment|Subject/guardian decision|111
287942|NCT01782326|967802|P2|Double-blind Treatment|Adverse Event|145
287943|NCT01782326|967803|P1|Double-blind Treatment|Adverse Event|129
287944|NCT01782326|967802|P2|Planned Treatment Epoch|Technical problems|4
287945|NCT01782326|967803|P1|Planned Treatment Epoch|Technical problems|0
287946|NCT01782326|967802|P2|Planned Treatment Epoch|Lost to Follow-up|4
287947|NCT01782326|967803|P1|Planned Treatment Epoch|Lost to Follow-up|4
287948|NCT01782326|967802|P2|Planned Treatment Epoch|Protocol deviation|3
287949|NCT01782326|967803|P1|Planned Treatment Epoch|Protocol deviation|2
287950|NCT01782326|967802|P2|Planned Treatment Epoch|Physician Decision|16
287951|NCT01782326|967803|P1|Planned Treatment Epoch|Physician Decision|18
287952|NCT01782326|967802|P2|Planned Treatment Epoch|Death|30
287953|NCT01782326|967803|P1|Planned Treatment Epoch|Death|29
287954|NCT01782326|967802|P2|Planned Treatment Epoch|Subject/guardian decision|151
287955|NCT01782326|967803|P1|Planned Treatment Epoch|Subject/guardian decision|149
287956|NCT01782222|967866|P3|Overall Study|Moved to other state|0
287957|NCT01782222|967867|P2|Overall Study|Moved to other state|1
287958|NCT01782222|967868|P1|Overall Study|Moved to other state|0
287959|NCT01782222|967866|P3|Overall Study|Withdrawal by Subject|1
287960|NCT01782222|967867|P2|Overall Study|Withdrawal by Subject|4
287961|NCT01782222|967868|P1|Overall Study|Withdrawal by Subject|1
287962|NCT01782222|967866|P3|Overall Study|Protocol Violation|0
287963|NCT01782222|967867|P2|Overall Study|Protocol Violation|0
287964|NCT01782222|967868|P1|Overall Study|Protocol Violation|1
287965|NCT01782222|967866|P3|Overall Study|Lack of Efficacy|0
287966|NCT01782222|967867|P2|Overall Study|Lack of Efficacy|1
287967|NCT01782222|967868|P1|Overall Study|Lack of Efficacy|2
287968|NCT01782222|967866|P3|Overall Study|Adverse Event|3
287969|NCT01782222|967867|P2|Overall Study|Adverse Event|5
287970|NCT01782222|967868|P1|Overall Study|Adverse Event|4
287971|NCT01781962|967900|P1|Overall Study|Other Miscellaneous Reasons|5
287972|NCT01781832|967906|P1|Overall Study|Withdrawal by Subject|1
287973|NCT01781637|967926|P2|Overall Study|Withdrawal by Subject|0
287974|NCT01781637|967927|P1|Overall Study|Withdrawal by Subject|1
287975|NCT01781637|967926|P2|Overall Study|Lack of Efficacy|6
287976|NCT01781637|967927|P1|Overall Study|Lack of Efficacy|2
287977|NCT01781637|967926|P2|Overall Study|Adverse Event|0
287978|NCT01781637|967927|P1|Overall Study|Adverse Event|1
287979|NCT01781299|968014|P2|Overall Study|Withdrawal by Subject|1
287980|NCT01781299|968015|P1|Overall Study|Withdrawal by Subject|0
287981|NCT01781026|968051|P1|Overall Study|Lack of Efficacy|2
287982|NCT01780987|968057|P2|Overall Study|Not Receiving any Study Medication|1
287983|NCT01780987|968058|P1|Overall Study|Not Receiving any Study Medication|0
287984|NCT01780987|968057|P2|Overall Study|Changing Residence|0
287985|NCT01780987|968058|P1|Overall Study|Changing Residence|1
287986|NCT01780987|968057|P2|Overall Study|Request of Changing Hospital|1
287987|NCT01780987|968058|P1|Overall Study|Request of Changing Hospital|0
287988|NCT01780987|968057|P2|Overall Study|Withdrawal by Subject|0
287989|NCT01780987|968058|P1|Overall Study|Withdrawal by Subject|2
287990|NCT01780987|968057|P2|Overall Study|Adverse Event|4
287991|NCT01780987|968058|P1|Overall Study|Adverse Event|0
287992|NCT01780974|968076|P2|Overall Study|Adverse Event|3
287993|NCT01780974|968077|P1|Overall Study|Adverse Event|1
287994|NCT01780974|968076|P2|Overall Study|Death|0
287995|NCT01780974|968077|P1|Overall Study|Death|1
287996|NCT01780935|968087|P2|Overall Study|Patient withdrew consent|9
287997|NCT01780935|968088|P1|Overall Study|Patient withdrew consent|8
287998|NCT01780935|968087|P2|Overall Study|Protocol deviation|1
287999|NCT01780935|968088|P1|Overall Study|Protocol deviation|0
288000|NCT01780935|968087|P2|Overall Study|Physician Decision|1
288001|NCT01780935|968088|P1|Overall Study|Physician Decision|1
288002|NCT01780935|968087|P2|Overall Study|Lost to Follow-up|6
288003|NCT01780935|968088|P1|Overall Study|Lost to Follow-up|2
288004|NCT01780935|968087|P2|Overall Study|Death|6
288005|NCT01780935|968088|P1|Overall Study|Death|1
288006|NCT01780935|968087|P2|Overall Study|Adverse Event|4
288007|NCT01780935|968088|P1|Overall Study|Adverse Event|2
288008|NCT01780935|968087|P2|Overall Study|Admin problems due to early termination|309
288009|NCT01780935|968088|P1|Overall Study|Admin problems due to early termination|321
288010|NCT01780584|968192|P3|Overall Study|Protocol Violation|1
288011|NCT01780584|968193|P2|Overall Study|Protocol Violation|0
288012|NCT01780584|968194|P1|Overall Study|Protocol Violation|0
288013|NCT01780584|968192|P3|Overall Study|Adverse Event|0
288014|NCT01780584|968193|P2|Overall Study|Adverse Event|1
288015|NCT01780584|968194|P1|Overall Study|Adverse Event|0
288016|NCT01780584|968192|P3|Overall Study|Death|1
288017|NCT01780584|968193|P2|Overall Study|Death|0
288018|NCT01780584|968194|P1|Overall Study|Death|1
288019|NCT01780545|968216|P2|Overall Study|Lost to Follow-up|1
288020|NCT01780545|968217|P1|Overall Study|Lost to Follow-up|1
288021|NCT01780545|968216|P2|Overall Study|Withdrawal by Subject|1
288022|NCT01780545|968217|P1|Overall Study|Withdrawal by Subject|3
288023|NCT01780506|968235|P2|Overall Study|Still on Study|388
288024|NCT01780506|968236|P1|Overall Study|Still on Study|401
288025|NCT01780506|968235|P2|Overall Study|Lost to Follow-up|14
288026|NCT01780506|968236|P1|Overall Study|Lost to Follow-up|10
288027|NCT01780506|968235|P2|Overall Study|Withdrew Consent|15
288028|NCT01780506|968236|P1|Overall Study|Withdrew Consent|13
288029|NCT01780506|968235|P2|Overall Study|Protocol Violation|3
288030|NCT01780506|968236|P1|Overall Study|Protocol Violation|3
288031|NCT01780506|968235|P2|Overall Study|Non-Compliance with Study Drug|1
288032|NCT01780506|968236|P1|Overall Study|Non-Compliance with Study Drug|1
288033|NCT01780506|968235|P2|Overall Study|Investigator's Discretion|1
288034|NCT01780506|968236|P1|Overall Study|Investigator's Discretion|2
288035|NCT01780506|968235|P2|Overall Study|Lack of Efficacy|1
288036|NCT01780506|968236|P1|Overall Study|Lack of Efficacy|1
288037|NCT01780506|968235|P2|Overall Study|Pregnancy|0
288038|NCT01780506|968236|P1|Overall Study|Pregnancy|1
288039|NCT01780506|968235|P2|Overall Study|Death|1
288040|NCT01780506|968236|P1|Overall Study|Death|0
288041|NCT01780506|968235|P2|Overall Study|Adverse Event|8
288042|NCT01780506|968236|P1|Overall Study|Adverse Event|3
288043|NCT01780506|968235|P2|Overall Study|Randomized but not Treated|2
288044|NCT01780506|968236|P1|Overall Study|Randomized but not Treated|3
288045|NCT01780389|968274|P1|Overall Study|Adverse Event|1
288046|NCT01779869|968312|P1|Overall Study|Physician Decision|2
288047|NCT01779648|968318|P2|Overall Study|Protocol Violation|0
288048|NCT01779648|968319|P1|Overall Study|Protocol Violation|1
288049|NCT01779440|968349|P2|Overall Study|Withdrawal by Subject|5
288050|NCT01779440|968350|P1|Overall Study|Withdrawal by Subject|3
288051|NCT01778985|968380|P2|Overall Study|Protocol Violation|1
288052|NCT01778985|968381|P1|Overall Study|Protocol Violation|4
288053|NCT01778985|968380|P2|Overall Study|Physician Decision|2
288054|NCT01778985|968381|P1|Overall Study|Physician Decision|2
288055|NCT01778985|968380|P2|Overall Study|Lost to Follow-up|0
288056|NCT01778985|968381|P1|Overall Study|Lost to Follow-up|1
288057|NCT01778855|968427|P2|Overall Study|Death|1
288058|NCT01778855|968428|P1|Overall Study|Death|0
288059|NCT01778751|968436|P2|Overall Study|Transfered care|0
288060|NCT01778751|968437|P1|Overall Study|Transfered care|1
288061|NCT01778751|968436|P2|Overall Study|Withdrawal by Subject|2
288062|NCT01778751|968437|P1|Overall Study|Withdrawal by Subject|0
288063|NCT01778751|968436|P2|Overall Study|Lost to Follow-up|0
288064|NCT01778751|968437|P1|Overall Study|Lost to Follow-up|1
288065|NCT01778530|968488|P1|Overall Study|Adverse event/side effect|1
288066|NCT01778530|968488|P1|Overall Study|Progression on study|1
288067|NCT01778127|968500|P3|Overall Study|Withdrawal by Subject|4
288068|NCT01778127|968501|P2|Overall Study|Withdrawal by Subject|1
288069|NCT01778127|968502|P1|Overall Study|Withdrawal by Subject|3
288070|NCT01778127|968500|P3|Overall Study|Lost to Follow-up|2
288071|NCT01778127|968501|P2|Overall Study|Lost to Follow-up|1
288072|NCT01778127|968502|P1|Overall Study|Lost to Follow-up|5
288073|NCT01778062|968545|P2|Overall Study|major protocol deviation|3
288074|NCT01778062|968546|P1|Overall Study|major protocol deviation|4
288075|NCT01778062|968545|P2|Overall Study|Consent Withdrawal|5
288076|NCT01778062|968546|P1|Overall Study|Consent Withdrawal|1
288077|NCT01778062|968545|P2|Overall Study|Adverse Event|3
288078|NCT01778062|968546|P1|Overall Study|Adverse Event|1
288079|NCT01778049|968560|P6|Double Blind Treatment Period|Other reason not defined above|1
288080|NCT01778049|968561|P5|Double Blind Treatment Period|Other reason not defined above|2
288081|NCT01778049|968562|P4|Double Blind Treatment Period|Other reason not defined above|2
288082|NCT01778049|968563|P3|Double Blind Treatment Period|Other reason not defined above|4
288083|NCT01778049|968564|P2|Double Blind Treatment Period|Other reason not defined above|0
288084|NCT01778049|968565|P1|Double Blind Treatment Period|Other reason not defined above|0
288085|NCT01778049|968560|P6|Double Blind Treatment Period|Not treated|0
288086|NCT01778049|968561|P5|Double Blind Treatment Period|Not treated|2
288087|NCT01778049|968562|P4|Double Blind Treatment Period|Not treated|2
288088|NCT01778049|968563|P3|Double Blind Treatment Period|Not treated|0
288089|NCT01778049|968564|P2|Double Blind Treatment Period|Not treated|0
288090|NCT01778049|968565|P1|Double Blind Treatment Period|Not treated|0
288091|NCT01778049|968560|P6|Double Blind Treatment Period|Withdrawal by Subject|1
288092|NCT01778049|968561|P5|Double Blind Treatment Period|Withdrawal by Subject|0
288093|NCT01778049|968562|P4|Double Blind Treatment Period|Withdrawal by Subject|2
288094|NCT01778049|968563|P3|Double Blind Treatment Period|Withdrawal by Subject|1
288095|NCT01778049|968564|P2|Double Blind Treatment Period|Withdrawal by Subject|0
288096|NCT01778049|968565|P1|Double Blind Treatment Period|Withdrawal by Subject|0
288097|NCT01778049|968560|P6|Double Blind Treatment Period|Lost to Follow-up|2
288098|NCT01778049|968561|P5|Double Blind Treatment Period|Lost to Follow-up|5
288099|NCT01778049|968562|P4|Double Blind Treatment Period|Lost to Follow-up|1
288100|NCT01778049|968563|P3|Double Blind Treatment Period|Lost to Follow-up|4
288101|NCT01778049|968564|P2|Double Blind Treatment Period|Lost to Follow-up|0
288102|NCT01778049|968565|P1|Double Blind Treatment Period|Lost to Follow-up|0
288103|NCT01778049|968560|P6|Double Blind Treatment Period|Protocol Violation|0
288104|NCT01778049|968561|P5|Double Blind Treatment Period|Protocol Violation|0
288105|NCT01778049|968562|P4|Double Blind Treatment Period|Protocol Violation|0
288106|NCT01778049|968563|P3|Double Blind Treatment Period|Protocol Violation|2
288107|NCT01778049|968564|P2|Double Blind Treatment Period|Protocol Violation|0
288108|NCT01778049|968565|P1|Double Blind Treatment Period|Protocol Violation|0
288109|NCT01778049|968560|P6|Double Blind Treatment Period|Lack of Efficacy|1
288110|NCT01778049|968561|P5|Double Blind Treatment Period|Lack of Efficacy|0
288111|NCT01778049|968562|P4|Double Blind Treatment Period|Lack of Efficacy|0
288112|NCT01778049|968563|P3|Double Blind Treatment Period|Lack of Efficacy|0
288113|NCT01778049|968564|P2|Double Blind Treatment Period|Lack of Efficacy|0
288114|NCT01778049|968565|P1|Double Blind Treatment Period|Lack of Efficacy|0
288115|NCT01778049|968560|P6|Double Blind Treatment Period|Adverse Event|2
288116|NCT01778049|968561|P5|Double Blind Treatment Period|Adverse Event|3
288117|NCT01778049|968562|P4|Double Blind Treatment Period|Adverse Event|5
288118|NCT01778049|968563|P3|Double Blind Treatment Period|Adverse Event|4
288119|NCT01778049|968564|P2|Double Blind Treatment Period|Adverse Event|0
288120|NCT01778049|968565|P1|Double Blind Treatment Period|Adverse Event|0
288121|NCT01778049|968560|P6|Open Label Treatment Period|Other reason not defined above|0
288122|NCT01778049|968561|P5|Open Label Treatment Period|Other reason not defined above|0
288123|NCT01778049|968562|P4|Open Label Treatment Period|Other reason not defined above|0
288124|NCT01778049|968563|P3|Open Label Treatment Period|Other reason not defined above|0
288125|NCT01778049|968564|P2|Open Label Treatment Period|Other reason not defined above|94
288126|NCT01778049|968565|P1|Open Label Treatment Period|Other reason not defined above|77
288127|NCT01778049|968560|P6|Open Label Treatment Period|Not treated|0
288128|NCT01778049|968561|P5|Open Label Treatment Period|Not treated|0
288129|NCT01778049|968562|P4|Open Label Treatment Period|Not treated|0
288130|NCT01778049|968563|P3|Open Label Treatment Period|Not treated|0
288131|NCT01778049|968564|P2|Open Label Treatment Period|Not treated|1
288132|NCT01778049|968565|P1|Open Label Treatment Period|Not treated|2
288133|NCT01778049|968560|P6|Open Label Treatment Period|Withdrawal by Subject|0
288134|NCT01778049|968561|P5|Open Label Treatment Period|Withdrawal by Subject|0
288135|NCT01778049|968562|P4|Open Label Treatment Period|Withdrawal by Subject|0
288136|NCT01778049|968563|P3|Open Label Treatment Period|Withdrawal by Subject|0
288137|NCT01778049|968564|P2|Open Label Treatment Period|Withdrawal by Subject|10
288138|NCT01778049|968565|P1|Open Label Treatment Period|Withdrawal by Subject|4
288139|NCT01778049|968560|P6|Open Label Treatment Period|Lost to Follow-up|0
288140|NCT01778049|968561|P5|Open Label Treatment Period|Lost to Follow-up|0
288141|NCT01778049|968562|P4|Open Label Treatment Period|Lost to Follow-up|0
288142|NCT01778049|968563|P3|Open Label Treatment Period|Lost to Follow-up|0
288143|NCT01778049|968564|P2|Open Label Treatment Period|Lost to Follow-up|3
288144|NCT01778049|968565|P1|Open Label Treatment Period|Lost to Follow-up|4
288145|NCT01778049|968560|P6|Open Label Treatment Period|Protocol Violation|0
288146|NCT01778049|968561|P5|Open Label Treatment Period|Protocol Violation|0
288147|NCT01778049|968562|P4|Open Label Treatment Period|Protocol Violation|0
288148|NCT01778049|968563|P3|Open Label Treatment Period|Protocol Violation|0
288149|NCT01778049|968564|P2|Open Label Treatment Period|Protocol Violation|5
288150|NCT01778049|968565|P1|Open Label Treatment Period|Protocol Violation|5
288151|NCT01778049|968560|P6|Open Label Treatment Period|Lack of Efficacy|0
288152|NCT01778049|968561|P5|Open Label Treatment Period|Lack of Efficacy|0
288153|NCT01778049|968562|P4|Open Label Treatment Period|Lack of Efficacy|0
288154|NCT01778049|968563|P3|Open Label Treatment Period|Lack of Efficacy|0
288155|NCT01778049|968564|P2|Open Label Treatment Period|Lack of Efficacy|1
288156|NCT01778049|968565|P1|Open Label Treatment Period|Lack of Efficacy|1
288157|NCT01778049|968560|P6|Open Label Treatment Period|Adverse Event|0
288158|NCT01778049|968561|P5|Open Label Treatment Period|Adverse Event|0
288159|NCT01778049|968562|P4|Open Label Treatment Period|Adverse Event|0
288160|NCT01778049|968563|P3|Open Label Treatment Period|Adverse Event|0
288161|NCT01778049|968564|P2|Open Label Treatment Period|Adverse Event|15
288162|NCT01778049|968565|P1|Open Label Treatment Period|Adverse Event|5
288163|NCT01778023|968583|P2|Overall Study|Withdrawal by Subject|3
288164|NCT01778023|968584|P1|Overall Study|Withdrawal by Subject|0
288165|NCT01778010|968601|P1|Overall Study|rash while on placebo|1
288166|NCT01778010|968601|P1|Overall Study|Arrested|1
288167|NCT01778010|968601|P1|Overall Study|abnormal ECG before meds|1
288168|NCT01778010|968601|P1|Overall Study|Withdrawal by Subject|2
288169|NCT01777997|968642|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
288170|NCT01777997|968642|P1|Weeks 48 to 72/96 on ART|Death|1
288171|NCT01777997|968642|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
288172|NCT01777997|968642|P1|12 Week lead-in of no ART|Severe debilitation|2
288173|NCT01777932|968664|P1|Overall Study|Patient refused further treatment|10
288174|NCT01777932|968664|P1|Overall Study|Reimbursement limit|9
288175|NCT01777932|968664|P1|Overall Study|Investigator decision|10
288176|NCT01777932|968664|P1|Overall Study|Lost to Follow-up|3
288177|NCT01777932|968664|P1|Overall Study|Adverse Event|34
288178|NCT01777932|968664|P1|Overall Study|Death|3
288179|NCT01777932|968664|P1|Overall Study|Disease progression|136
288180|NCT01777776|968682|P4|Overall Study|Withdrawal by Subject|1
288181|NCT01777776|968683|P3|Overall Study|Withdrawal by Subject|0
288182|NCT01777776|968684|P2|Overall Study|Withdrawal by Subject|0
288183|NCT01777776|968685|P1|Overall Study|Withdrawal by Subject|0
288184|NCT01777776|968682|P4|Overall Study|Disease Progression|3
288185|NCT01777776|968683|P3|Overall Study|Disease Progression|6
288186|NCT01777776|968684|P2|Overall Study|Disease Progression|8
288187|NCT01777776|968685|P1|Overall Study|Disease Progression|4
288188|NCT01777776|968682|P4|Overall Study|Adverse Event|0
288189|NCT01777776|968683|P3|Overall Study|Adverse Event|0
288190|NCT01777776|968684|P2|Overall Study|Adverse Event|4
288191|NCT01777776|968685|P1|Overall Study|Adverse Event|2
288192|NCT01777763|968744|P2|Overall Study|Treatment Failure|6
288193|NCT01777763|968745|P1|Overall Study|Treatment Failure|1
288194|NCT01777763|968744|P2|Overall Study|Withdrawal by Subject|2
288195|NCT01777763|968745|P1|Overall Study|Withdrawal by Subject|0
288196|NCT01777763|968744|P2|Overall Study|Protocol Violation|7
288197|NCT01777763|968745|P1|Overall Study|Protocol Violation|1
288198|NCT01777763|968744|P2|Overall Study|Adverse Event|32
288199|NCT01777763|968745|P1|Overall Study|Adverse Event|2
288200|NCT01777620|968769|P2|Overall Study|Subject Withdrawal|0
288201|NCT01777620|968770|P1|Overall Study|Subject Withdrawal|1
288202|NCT01777581|968796|P2|Overall Study|Lack of Efficacy|1
288203|NCT01777581|968797|P1|Overall Study|Lack of Efficacy|0
288204|NCT01777581|968796|P2|Overall Study|Adverse Event|0
288205|NCT01777581|968797|P1|Overall Study|Adverse Event|2
288206|NCT01777581|968796|P2|Overall Study|Lost to Follow-up|1
288207|NCT01777581|968797|P1|Overall Study|Lost to Follow-up|1
288208|NCT01777542|968815|P2|Second Intervention (20 Weeks)|Adverse Event|1
288209|NCT01777542|968816|P1|Second Intervention (20 Weeks)|Adverse Event|0
288210|NCT01777334|968884|P2|Overall Study|Withdrawal by Subject|11
288211|NCT01777334|968885|P1|Overall Study|Withdrawal by Subject|14
288212|NCT01777334|968884|P2|Overall Study|Lost to Follow-up|2
288213|NCT01777334|968885|P1|Overall Study|Lost to Follow-up|3
288214|NCT01777334|968884|P2|Overall Study|Protocol Violation|7
288215|NCT01777334|968885|P1|Overall Study|Protocol Violation|3
288216|NCT01777334|968884|P2|Overall Study|Lack of Efficacy|29
288217|NCT01777334|968885|P1|Overall Study|Lack of Efficacy|15
288218|NCT01777334|968884|P2|Overall Study|Adverse Event|14
288219|NCT01777334|968885|P1|Overall Study|Adverse Event|18
288220|NCT01777321|968895|P2|Overall Study|Withdrawal by Subject|1
288221|NCT01777321|968896|P1|Overall Study|Withdrawal by Subject|0
288222|NCT01777282|968937|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
288223|NCT01777282|968938|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
288224|NCT01777282|968939|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
288225|NCT01777282|968940|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
288226|NCT01777282|968941|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
288227|NCT01777282|968937|P5|Overall Study|Protocol Violation|2
288228|NCT01777282|968938|P4|Overall Study|Protocol Violation|0
288229|NCT01777282|968939|P3|Overall Study|Protocol Violation|1
288230|NCT01777282|968940|P2|Overall Study|Protocol Violation|0
288231|NCT01777282|968941|P1|Overall Study|Protocol Violation|2
288232|NCT01777282|968937|P5|Overall Study|Withdrawal by Subject|2
288233|NCT01777282|968938|P4|Overall Study|Withdrawal by Subject|1
288234|NCT01777282|968939|P3|Overall Study|Withdrawal by Subject|0
288235|NCT01777282|968940|P2|Overall Study|Withdrawal by Subject|0
288236|NCT01777282|968941|P1|Overall Study|Withdrawal by Subject|4
288237|NCT01777282|968937|P5|Overall Study|Adverse Event|3
288238|NCT01777282|968938|P4|Overall Study|Adverse Event|1
288239|NCT01777282|968939|P3|Overall Study|Adverse Event|2
288240|NCT01777282|968940|P2|Overall Study|Adverse Event|4
288241|NCT01777282|968941|P1|Overall Study|Adverse Event|4
288242|NCT01777282|968937|P5|Overall Study|New Antidiabetic Medication|0
288243|NCT01777282|968938|P4|Overall Study|New Antidiabetic Medication|0
288244|NCT01777282|968939|P3|Overall Study|New Antidiabetic Medication|1
288245|NCT01777282|968940|P2|Overall Study|New Antidiabetic Medication|0
288246|NCT01777282|968941|P1|Overall Study|New Antidiabetic Medication|0
288247|NCT01777282|968937|P5|Overall Study|Persistent Hyperglycemia|0
288248|NCT01777282|968938|P4|Overall Study|Persistent Hyperglycemia|0
288249|NCT01777282|968939|P3|Overall Study|Persistent Hyperglycemia|1
288250|NCT01777282|968940|P2|Overall Study|Persistent Hyperglycemia|0
288251|NCT01777282|968941|P1|Overall Study|Persistent Hyperglycemia|0
288252|NCT01777269|968985|P2|Overall Study|Withdrawal by Subject|9
288253|NCT01777269|968986|P1|Overall Study|Withdrawal by Subject|9
288254|NCT01777269|968985|P2|Overall Study|Physician Decision|2
288255|NCT01777269|968986|P1|Overall Study|Physician Decision|5
288256|NCT01777269|968985|P2|Overall Study|Lost to Follow-up|0
288257|NCT01777269|968986|P1|Overall Study|Lost to Follow-up|4
288258|NCT01777269|968985|P2|Overall Study|Participants reached stopping criteria|1
288259|NCT01777269|968986|P1|Overall Study|Participants reached stopping criteria|1
288260|NCT01777269|968985|P2|Overall Study|Protocol Violation|4
288261|NCT01777269|968986|P1|Overall Study|Protocol Violation|4
288262|NCT01777269|968985|P2|Overall Study|Lack of Efficacy|10
288263|NCT01777269|968986|P1|Overall Study|Lack of Efficacy|8
288264|NCT01777269|968985|P2|Overall Study|Adverse Event|33
288265|NCT01777269|968986|P1|Overall Study|Adverse Event|24
288266|NCT01777191|969023|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
288267|NCT01777191|969024|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
288268|NCT01777191|969023|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
288269|NCT01777191|969024|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
288270|NCT01777191|969023|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
288271|NCT01777191|969024|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
288272|NCT01777191|969023|P2|Safety Extension Per (Week 12-Week 48)|Death|1
288273|NCT01777191|969024|P1|Safety Extension Per (Week 12-Week 48)|Death|0
288274|NCT01777191|969023|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
288275|NCT01777191|969024|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
288276|NCT01777191|969023|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
288277|NCT01777191|969024|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
288278|NCT01777191|969023|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
288279|NCT01777191|969024|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
288280|NCT01777191|969023|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
288281|NCT01777191|969024|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
288282|NCT01777191|969023|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
288283|NCT01777191|969024|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
288284|NCT01777191|969023|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
288285|NCT01777191|969024|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
288286|NCT01777191|969023|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
288287|NCT01777191|969024|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
288288|NCT01776554|969087|P2|Overall Study|Unclassified|1
288289|NCT01776554|969088|P1|Overall Study|Unclassified|4
288290|NCT01776554|969087|P2|Overall Study|Protocol Violation|0
288291|NCT01776554|969088|P1|Overall Study|Protocol Violation|1
288292|NCT01776554|969087|P2|Overall Study|Administrative Reason|5
288293|NCT01776554|969088|P1|Overall Study|Administrative Reason|2
288294|NCT01776554|969087|P2|Overall Study|Lost to Follow-up|9
288295|NCT01776554|969088|P1|Overall Study|Lost to Follow-up|6
288296|NCT01776554|969087|P2|Overall Study|Withdrawal by Subject|8
288297|NCT01776554|969088|P1|Overall Study|Withdrawal by Subject|3
288298|NCT01776554|969087|P2|Overall Study|Adverse Event|0
288299|NCT01776554|969088|P1|Overall Study|Adverse Event|1
288300|NCT01776541|969131|P2|Overall Study|Withdrawal by Subject|20
288301|NCT01776541|969132|P1|Overall Study|Withdrawal by Subject|12
288302|NCT01776541|969131|P2|Overall Study|Protocol Violation|1
288303|NCT01776541|969132|P1|Overall Study|Protocol Violation|2
288304|NCT01776541|969131|P2|Overall Study|Unclassified|4
288305|NCT01776541|969132|P1|Overall Study|Unclassified|5
288306|NCT01776541|969131|P2|Overall Study|Lost to Follow-up|48
288307|NCT01776541|969132|P1|Overall Study|Lost to Follow-up|27
288308|NCT01776541|969131|P2|Overall Study|Death|0
288309|NCT01776541|969132|P1|Overall Study|Death|4
288310|NCT01776541|969131|P2|Overall Study|Administrative Reason|2
288311|NCT01776541|969132|P1|Overall Study|Administrative Reason|6
288312|NCT01776008|969162|P1|Overall Study|ineligible|2
288313|NCT01775995|969176|P2|Overall Study|Lost to Follow-up|1
288314|NCT01775995|969177|P1|Overall Study|Lost to Follow-up|1
288315|NCT01775787|969271|P2|Second 7-10 Days|concerns with using IV|1
288316|NCT01775787|969272|P1|Second 7-10 Days|concerns with using IV|0
288317|NCT01775787|969271|P2|Second 7-10 Days|time commitment|1
288318|NCT01775787|969272|P1|Second 7-10 Days|time commitment|0
288319|NCT01775787|969271|P2|First 7-10 Days|concerns with using IV|2
288320|NCT01775787|969272|P1|First 7-10 Days|concerns with using IV|1
288321|NCT01775787|969271|P2|First 7-10 Days|time commitment|2
288322|NCT01775787|969272|P1|First 7-10 Days|time commitment|0
288323|NCT01775787|969271|P2|First 7-10 Days|family emergency|1
288324|NCT01775787|969272|P1|First 7-10 Days|family emergency|0
288325|NCT01775787|969271|P2|First 7-10 Days|Adverse Event|1
288326|NCT01775787|969272|P1|First 7-10 Days|Adverse Event|0
288327|NCT01775670|969319|P2|Overall Study|Lost to Follow-up|1
288328|NCT01775670|969320|P1|Overall Study|Lost to Follow-up|1
288329|NCT01775553|969346|P1|Overall Study|Disease Progression|12
288330|NCT01775553|969346|P1|Overall Study|Adverse Event|1
288331|NCT01775189|969354|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
288332|NCT01775189|969355|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
288333|NCT01775189|969356|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
288334|NCT01775189|969357|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
288335|NCT01775189|969358|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
288336|NCT01775189|969359|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
288337|NCT01775189|969360|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
288338|NCT01775189|969354|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
288339|NCT01775189|969355|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
288340|NCT01775189|969356|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
288341|NCT01775189|969357|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
288342|NCT01775189|969358|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
288343|NCT01775189|969359|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
288344|NCT01775189|969360|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
288345|NCT01775189|969354|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
288346|NCT01775189|969355|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
288347|NCT01775189|969356|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
288348|NCT01775189|969357|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
288349|NCT01775189|969358|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
288350|NCT01775189|969359|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
288351|NCT01775189|969360|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
288352|NCT01775189|969354|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
288353|NCT01775189|969355|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
288354|NCT01775189|969356|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
288355|NCT01775189|969357|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
288356|NCT01775189|969358|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
288357|NCT01775189|969359|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
288358|NCT01775189|969360|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
288359|NCT01775189|969354|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
288360|NCT01775189|969355|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
288361|NCT01775189|969356|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
288362|NCT01775189|969357|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
288363|NCT01775189|969358|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
288364|NCT01775189|969359|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
288365|NCT01775189|969360|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
288366|NCT01775189|969354|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
288367|NCT01775189|969355|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
288368|NCT01775189|969356|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
288369|NCT01775189|969357|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
288370|NCT01775189|969358|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
288371|NCT01775189|969359|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
288372|NCT01775189|969360|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
288373|NCT01775137|969579|P1|Overall Study|Withdrawal by participants|5
288374|NCT01775137|969579|P1|Overall Study|Adverse Event|1
288375|NCT01775137|969579|P1|Overall Study|Unsatisfactory therapeutic effect|2
288376|NCT01775137|969579|P1|Overall Study|Protocol deviation|2
288377|NCT01775137|969579|P1|Overall Study|Death|1
288378|NCT01775124|969606|P2|Extension Period|Withdrawal by Subject|12
288379|NCT01775124|969607|P1|Extension Period|Withdrawal by Subject|9
288380|NCT01775124|969606|P2|Extension Period|Lost to Follow-up|1
288381|NCT01775124|969607|P1|Extension Period|Lost to Follow-up|0
288382|NCT01775124|969606|P2|Extension Period|Administrative problems|1
288383|NCT01775124|969607|P1|Extension Period|Administrative problems|0
288384|NCT01775124|969606|P2|Extension Period|Physician Decision|2
288385|NCT01775124|969607|P1|Extension Period|Physician Decision|0
288386|NCT01775124|969606|P2|Extension Period|Adverse Event|2
288387|NCT01775124|969607|P1|Extension Period|Adverse Event|3
288388|NCT01775124|969606|P2|Core Period|Adverse Event|5
288389|NCT01775124|969607|P1|Core Period|Adverse Event|5
288390|NCT01775124|969606|P2|Core Period|Withdrawal by Subject|2
288391|NCT01775124|969607|P1|Core Period|Withdrawal by Subject|4
288392|NCT01775124|969606|P2|Core Period|Administrative problems|0
288393|NCT01775124|969607|P1|Core Period|Administrative problems|1
288394|NCT01775124|969606|P2|Core Period|Death|1
288395|NCT01775124|969607|P1|Core Period|Death|0
288396|NCT01775124|969606|P2|Core Period|Physician Decision|1
288397|NCT01775124|969607|P1|Core Period|Physician Decision|1
288398|NCT01775124|969606|P2|Core Period|Disease Progression|1
288399|NCT01775124|969607|P1|Core Period|Disease Progression|0
288400|NCT01774981|969642|P8|Overall Study|Death|0
288401|NCT01774981|969643|P7|Overall Study|Death|0
288402|NCT01774981|969644|P6|Overall Study|Death|0
288403|NCT01774981|969645|P5|Overall Study|Death|1
288404|NCT01774981|969646|P4|Overall Study|Death|0
288405|NCT01774981|969647|P3|Overall Study|Death|0
288406|NCT01774981|969648|P2|Overall Study|Death|0
288407|NCT01774981|969649|P1|Overall Study|Death|0
288408|NCT01774981|969642|P8|Overall Study|Withdrawal by Subject|1
288409|NCT01774981|969643|P7|Overall Study|Withdrawal by Subject|0
288410|NCT01774981|969644|P6|Overall Study|Withdrawal by Subject|0
288411|NCT01774981|969645|P5|Overall Study|Withdrawal by Subject|0
288412|NCT01774981|969646|P4|Overall Study|Withdrawal by Subject|0
288413|NCT01774981|969647|P3|Overall Study|Withdrawal by Subject|0
288414|NCT01774981|969648|P2|Overall Study|Withdrawal by Subject|0
288415|NCT01774981|969649|P1|Overall Study|Withdrawal by Subject|0
288416|NCT01774981|969642|P8|Overall Study|Adverse Event|0
288417|NCT01774981|969643|P7|Overall Study|Adverse Event|0
288418|NCT01774981|969644|P6|Overall Study|Adverse Event|1
288419|NCT01774981|969645|P5|Overall Study|Adverse Event|0
288420|NCT01774981|969646|P4|Overall Study|Adverse Event|0
288421|NCT01774981|969647|P3|Overall Study|Adverse Event|0
288422|NCT01774981|969648|P2|Overall Study|Adverse Event|0
288423|NCT01774981|969649|P1|Overall Study|Adverse Event|0
288424|NCT01774968|969681|P2|Overall Study|Withdrawal by Subject|11
288425|NCT01774968|969682|P1|Overall Study|Withdrawal by Subject|6
288426|NCT01774968|969681|P2|Overall Study|Sponsor Decision|2
288427|NCT01774968|969682|P1|Overall Study|Sponsor Decision|0
288428|NCT01774968|969681|P2|Overall Study|Protocol Violation|13
288429|NCT01774968|969682|P1|Overall Study|Protocol Violation|14
288430|NCT01774968|969681|P2|Overall Study|Physician Decision|1
288431|NCT01774968|969682|P1|Overall Study|Physician Decision|5
288432|NCT01774968|969681|P2|Overall Study|Lost to Follow-up|3
288433|NCT01774968|969682|P1|Overall Study|Lost to Follow-up|1
288434|NCT01774968|969681|P2|Overall Study|Death|1
288435|NCT01774968|969682|P1|Overall Study|Death|0
288436|NCT01774968|969681|P2|Overall Study|Adverse Event|4
288437|NCT01774968|969682|P1|Overall Study|Adverse Event|4
288438|NCT01774929|969716|P1|Overall Study|Adverse Event|3
288439|NCT01774903|969722|P1|Overall Study|Ineligible to continue the trial|1
288440|NCT01774903|969722|P1|Overall Study|Lack of Efficacy|1
288441|NCT01774903|969722|P1|Overall Study|Withdrawal by Subject|2
288442|NCT01774903|969722|P1|Overall Study|Adverse Event|7
288443|NCT01774786|969740|P2|Overall Study|Ineligible for Study|3
288444|NCT01774786|969741|P1|Overall Study|Ineligible for Study|1
288445|NCT01774786|969740|P2|Overall Study|Physician Decision|0
288446|NCT01774786|969741|P1|Overall Study|Physician Decision|1
288447|NCT01774786|969740|P2|Overall Study|Withdrawal by Subject|12
288448|NCT01774786|969741|P1|Overall Study|Withdrawal by Subject|15
288449|NCT01774786|969740|P2|Overall Study|Lost to Follow-up|4
288450|NCT01774786|969741|P1|Overall Study|Lost to Follow-up|3
288451|NCT01774786|969740|P2|Overall Study|Death|262
288452|NCT01774786|969741|P1|Overall Study|Death|242
288453|NCT01774786|969740|P2|Overall Study|In Follow-up|62
288454|NCT01774786|969741|P1|Overall Study|In Follow-up|65
288455|NCT01774786|969740|P2|Overall Study|Between Treatment and Follow-up|2
288456|NCT01774786|969741|P1|Overall Study|Between Treatment and Follow-up|6
288457|NCT01774786|969740|P2|Overall Study|On Treatment|47
288458|NCT01774786|969741|P1|Overall Study|On Treatment|55
288459|NCT01774591|969792|P2|Overall Study|Adverse Event|2
288460|NCT01774591|969793|P1|Overall Study|Adverse Event|0
288461|NCT01774591|969792|P2|Overall Study|Withdrawal by Subject|1
288462|NCT01774591|969793|P1|Overall Study|Withdrawal by Subject|0
288463|NCT01774591|969792|P2|Overall Study|Physician Decision|1
288464|NCT01774591|969793|P1|Overall Study|Physician Decision|1
288465|NCT01774344|969805|P2|Overall Study|Non-compliance with study drug|2
288466|NCT01774344|969806|P1|Overall Study|Non-compliance with study drug|0
288467|NCT01774344|969805|P2|Overall Study|Physician Decision|1
288468|NCT01774344|969806|P1|Overall Study|Physician Decision|0
288469|NCT01774344|969805|P2|Overall Study|Adverse event (AE)|1
288470|NCT01774344|969806|P1|Overall Study|Adverse event (AE)|0
288471|NCT01774344|969805|P2|Overall Study|AE not related to disease progression|47
288472|NCT01774344|969806|P1|Overall Study|AE not related to disease progression|12
288473|NCT01774344|969805|P2|Overall Study|Ongoing with treatment|65
288474|NCT01774344|969806|P1|Overall Study|Ongoing with treatment|10
288475|NCT01774344|969805|P2|Overall Study|Other|0
288476|NCT01774344|969806|P1|Overall Study|Other|1
288477|NCT01774344|969805|P2|Overall Study|Study drug never administered|5
288478|NCT01774344|969806|P1|Overall Study|Study drug never administered|1
288479|NCT01774344|969805|P2|Overall Study|Withdrawal by Subject|26
288480|NCT01774344|969806|P1|Overall Study|Withdrawal by Subject|5
288481|NCT01774344|969805|P2|Overall Study|Protocol Violation|1
288482|NCT01774344|969806|P1|Overall Study|Protocol Violation|3
288483|NCT01774305|969822|P2|Overall Study|Physician Decision|0
288484|NCT01774305|969823|P1|Overall Study|Physician Decision|1
288485|NCT01774253|969831|P1|Overall Study|Death|1
288486|NCT01774253|969831|P1|Overall Study|Withdrawal by Subject|2
288487|NCT01774253|969831|P1|Overall Study|Physician Decision|2
288488|NCT01774253|969831|P1|Overall Study|Lack of Efficacy|4
288489|NCT01774110|969850|P1|Overall Study|Lost to Follow-up|7
288490|NCT01774097|969858|P2|Overall Study|Adverse Event|1
288491|NCT01774097|969859|P1|Overall Study|Adverse Event|1
288492|NCT01774097|969858|P2|Overall Study|Withdrawal by Subject|1
288493|NCT01774097|969859|P1|Overall Study|Withdrawal by Subject|1
288494|NCT01774084|969889|P2|Overall Study|Personal reasons|0
288495|NCT01774084|969890|P1|Overall Study|Personal reasons|1
288496|NCT01773889|969920|P1|Overall Study|lack of funding|2
288497|NCT01773473|969926|P2|Overall Study|Lost to Follow-up|0
288498|NCT01773473|969927|P1|Overall Study|Lost to Follow-up|2
288499|NCT01773473|969926|P2|Overall Study|Withdrawal by Subject|3
288500|NCT01773473|969927|P1|Overall Study|Withdrawal by Subject|5
288501|NCT01773473|969926|P2|Overall Study|Non-Compliance with study drug|4
288502|NCT01773473|969927|P1|Overall Study|Non-Compliance with study drug|1
288503|NCT01773473|969926|P2|Overall Study|Lack of Efficacy|1
288504|NCT01773473|969927|P1|Overall Study|Lack of Efficacy|0
288505|NCT01773473|969926|P2|Overall Study|Sponsor Decision|0
288506|NCT01773473|969927|P1|Overall Study|Sponsor Decision|2
288507|NCT01773473|969926|P2|Overall Study|Physician Decision|5
288508|NCT01773473|969927|P1|Overall Study|Physician Decision|3
288509|NCT01773473|969926|P2|Overall Study|Protocol Violation|4
288510|NCT01773473|969927|P1|Overall Study|Protocol Violation|0
288511|NCT01773473|969926|P2|Overall Study|Adverse Event|2
288512|NCT01773473|969927|P1|Overall Study|Adverse Event|3
288513|NCT01773291|969948|P3|Overall Study|Withdrawal by Subject|1
288514|NCT01773291|969949|P2|Overall Study|Withdrawal by Subject|0
288515|NCT01773291|969950|P1|Overall Study|Withdrawal by Subject|0
288516|NCT01773291|969948|P3|Overall Study|Protocol Violation|0
288517|NCT01773291|969949|P2|Overall Study|Protocol Violation|0
288518|NCT01773291|969950|P1|Overall Study|Protocol Violation|1
288519|NCT01773226|969961|P1|Overall Study|Withdrawal by Subject|1
288520|NCT01773122|969980|P4|Overall Study|Due to amended age eligibility criteria|1
288521|NCT01773122|969981|P3|Overall Study|Due to amended age eligibility criteria|0
288522|NCT01773122|969982|P2|Overall Study|Due to amended age eligibility criteria|1
288523|NCT01773122|969983|P1|Overall Study|Due to amended age eligibility criteria|3
288524|NCT01773070|969997|P1|Overall Study|Death (unrelated to study procedures)|3
288525|NCT01773070|969997|P1|Overall Study|Other|15
288526|NCT01773070|969997|P1|Overall Study|Lost to Follow-up|39
288527|NCT01773070|969997|P1|Overall Study|Withdrawal by Subject|24
288528|NCT01772823|970007|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
288529|NCT01772823|970008|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
288530|NCT01772823|970007|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
288531|NCT01772823|970008|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
288532|NCT01772823|970007|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
288533|NCT01772823|970008|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
288534|NCT01772823|970007|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
288535|NCT01772823|970008|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
288536|NCT01772823|970007|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
288537|NCT01772823|970008|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
288538|NCT01772823|970007|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
288539|NCT01772823|970008|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
288540|NCT01772823|970007|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
288541|NCT01772823|970008|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
288542|NCT01772823|970007|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
288543|NCT01772823|970008|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
288544|NCT01772823|970007|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
288545|NCT01772823|970008|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
288546|NCT01772823|970007|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
288547|NCT01772823|970008|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
288548|NCT01772823|970007|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
288549|NCT01772823|970008|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
288550|NCT01772823|970007|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
288551|NCT01772823|970008|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
288552|NCT01772823|970007|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
288553|NCT01772823|970008|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
288554|NCT01772823|970007|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
288555|NCT01772823|970008|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
288556|NCT01772823|970007|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
288557|NCT01772823|970008|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
288558|NCT01772823|970007|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
288559|NCT01772823|970008|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
288560|NCT01772576|970130|P1|Overall Study|Withdrawal by Subject|6
288561|NCT01772576|970130|P1|Overall Study|Adverse Event|6
288562|NCT01772576|970130|P1|Overall Study|Study device not used|3
288563|NCT01772576|970130|P1|Overall Study|Lost to Follow-up|3
288564|NCT01772576|970130|P1|Overall Study|Protocol Violation|1
288565|NCT01772576|970130|P1|Overall Study|Death|15
288566|NCT01772550|970142|P3|Overall Study|Adverse Event|1
288567|NCT01772550|970143|P2|Overall Study|Adverse Event|0
288568|NCT01772550|970144|P1|Overall Study|Adverse Event|0
288569|NCT01772550|970142|P3|Overall Study|Unable to insert IV in antecubital vein|5
288570|NCT01772550|970143|P2|Overall Study|Unable to insert IV in antecubital vein|1
288571|NCT01772550|970144|P1|Overall Study|Unable to insert IV in antecubital vein|1
288572|NCT01772537|970185|P3|Overall Study|unsuccessful lumbar drain placement|0
288573|NCT01772537|970186|P2|Overall Study|unsuccessful lumbar drain placement|0
288574|NCT01772537|970187|P1|Overall Study|unsuccessful lumbar drain placement|1
288575|NCT01772368|970201|P1|Overall Study|Not specified|1
288576|NCT01772368|970201|P1|Overall Study|Protocol Violation|2
288577|NCT01772368|970201|P1|Overall Study|Withdrawal by Subject|3
288578|NCT01772368|970201|P1|Overall Study|Adverse Event|1
288579|NCT01772316|970247|P1|Overall Study|Withdrawn by sponsor decision|5
288580|NCT01772316|970247|P1|Overall Study|Inform consent withdrawn|1
288581|NCT01772316|970247|P1|Overall Study|Serious adverse event|1
288582|NCT01772147|970268|P3|Overall Study|Lack of Efficacy|6
288583|NCT01772147|970269|P2|Overall Study|Lack of Efficacy|6
288584|NCT01772147|970270|P1|Overall Study|Lack of Efficacy|8
288585|NCT01772147|970268|P3|Overall Study|Protocol Deviation|1
288586|NCT01772147|970269|P2|Overall Study|Protocol Deviation|1
288587|NCT01772147|970270|P1|Overall Study|Protocol Deviation|2
288588|NCT01772147|970268|P3|Overall Study|Lost to Follow-up|1
288589|NCT01772147|970269|P2|Overall Study|Lost to Follow-up|0
288590|NCT01772147|970270|P1|Overall Study|Lost to Follow-up|1
288591|NCT01772147|970268|P3|Overall Study|Withdrew Consent|4
288592|NCT01772147|970269|P2|Overall Study|Withdrew Consent|8
288593|NCT01772147|970270|P1|Overall Study|Withdrew Consent|7
288594|NCT01772147|970268|P3|Overall Study|Adverse Event|6
288595|NCT01772147|970269|P2|Overall Study|Adverse Event|10
288596|NCT01772147|970270|P1|Overall Study|Adverse Event|13
288597|NCT01772134|970290|P3|Overall Study|Randomized Study Medication Not Received|1
288598|NCT01772134|970291|P2|Overall Study|Randomized Study Medication Not Received|0
288599|NCT01772134|970292|P1|Overall Study|Randomized Study Medication Not Received|2
288600|NCT01772134|970290|P3|Overall Study|Protocol-defined Stopping Criteria|0
288601|NCT01772134|970291|P2|Overall Study|Protocol-defined Stopping Criteria|0
288602|NCT01772134|970292|P1|Overall Study|Protocol-defined Stopping Criteria|1
288603|NCT01772134|970290|P3|Overall Study|Lack of Efficacy|3
288604|NCT01772134|970291|P2|Overall Study|Lack of Efficacy|5
288605|NCT01772134|970292|P1|Overall Study|Lack of Efficacy|11
288606|NCT01772134|970290|P3|Overall Study|Protocol Deviation|3
288607|NCT01772134|970291|P2|Overall Study|Protocol Deviation|3
288608|NCT01772134|970292|P1|Overall Study|Protocol Deviation|4
288609|NCT01772134|970290|P3|Overall Study|Lost to Follow-up|0
288610|NCT01772134|970291|P2|Overall Study|Lost to Follow-up|0
288611|NCT01772134|970292|P1|Overall Study|Lost to Follow-up|2
288612|NCT01772134|970290|P3|Overall Study|Withdrew Consent|5
288613|NCT01772134|970291|P2|Overall Study|Withdrew Consent|1
288614|NCT01772134|970292|P1|Overall Study|Withdrew Consent|3
288615|NCT01772134|970290|P3|Overall Study|Adverse Event|10
288616|NCT01772134|970291|P2|Overall Study|Adverse Event|5
288617|NCT01772134|970292|P1|Overall Study|Adverse Event|6
288618|NCT01771913|970329|P2|Overall Study|Withdrawal by Subject|0
288619|NCT01771913|970330|P1|Overall Study|Withdrawal by Subject|1
288620|NCT01770860|970349|P1|Overall Study|Administrative decision made by the PI|1
288621|NCT01770860|970349|P1|Overall Study|Lost to Follow-up|1
288622|NCT01770860|970349|P1|Overall Study|Withdrawal by Subject|4
288623|NCT01770743|970397|P5|Overall Study|Moving Out of State|0
288624|NCT01770743|970398|P4|Overall Study|Moving Out of State|0
288625|NCT01770743|970399|P3|Overall Study|Moving Out of State|0
288626|NCT01770743|970400|P2|Overall Study|Moving Out of State|1
288627|NCT01770743|970401|P1|Overall Study|Moving Out of State|0
288628|NCT01770743|970397|P5|Overall Study|Sponsor Terminated Subject|0
288629|NCT01770743|970398|P4|Overall Study|Sponsor Terminated Subject|1
288630|NCT01770743|970399|P3|Overall Study|Sponsor Terminated Subject|0
288631|NCT01770743|970400|P2|Overall Study|Sponsor Terminated Subject|0
288632|NCT01770743|970401|P1|Overall Study|Sponsor Terminated Subject|1
288633|NCT01770743|970397|P5|Overall Study|Lost to Follow-up|1
288634|NCT01770743|970398|P4|Overall Study|Lost to Follow-up|0
288635|NCT01770743|970399|P3|Overall Study|Lost to Follow-up|0
288636|NCT01770743|970400|P2|Overall Study|Lost to Follow-up|2
288637|NCT01770743|970401|P1|Overall Study|Lost to Follow-up|0
288638|NCT01770743|970397|P5|Overall Study|Withdrawal by Subject|1
288639|NCT01770743|970398|P4|Overall Study|Withdrawal by Subject|1
288640|NCT01770743|970399|P3|Overall Study|Withdrawal by Subject|1
288641|NCT01770743|970400|P2|Overall Study|Withdrawal by Subject|0
288642|NCT01770743|970401|P1|Overall Study|Withdrawal by Subject|0
288643|NCT01770743|970397|P5|Overall Study|Adverse Event|0
288644|NCT01770743|970398|P4|Overall Study|Adverse Event|0
288645|NCT01770743|970399|P3|Overall Study|Adverse Event|0
288646|NCT01770743|970400|P2|Overall Study|Adverse Event|0
288647|NCT01770743|970401|P1|Overall Study|Adverse Event|1
288648|NCT01770509|970503|P2|Overall Study|Lost to Follow-up|2
288649|NCT01770509|970504|P1|Overall Study|Lost to Follow-up|1
288650|NCT01770509|970503|P2|Overall Study|Injury|1
288651|NCT01770509|970504|P1|Overall Study|Injury|0
288652|NCT01770392|970540|P1|Washout Period of at Least 14 Days|Adverse Event|1
288653|NCT01770379|970555|P3|Overall Study|Adverse Event|2
288654|NCT01770379|970556|P2|Overall Study|Adverse Event|3
288655|NCT01770379|970557|P1|Overall Study|Adverse Event|1
288656|NCT01770379|970555|P3|Overall Study|Lack of Efficacy|6
288657|NCT01770379|970556|P2|Overall Study|Lack of Efficacy|6
288658|NCT01770379|970557|P1|Overall Study|Lack of Efficacy|8
288659|NCT01770379|970555|P3|Overall Study|Lost to Follow-up|2
288660|NCT01770379|970556|P2|Overall Study|Lost to Follow-up|0
288661|NCT01770379|970557|P1|Overall Study|Lost to Follow-up|0
288662|NCT01770379|970555|P3|Overall Study|Physician Decision|2
288663|NCT01770379|970556|P2|Overall Study|Physician Decision|1
288664|NCT01770379|970557|P1|Overall Study|Physician Decision|0
288665|NCT01770379|970555|P3|Overall Study|Protocol Violation|1
288666|NCT01770379|970556|P2|Overall Study|Protocol Violation|1
288667|NCT01770379|970557|P1|Overall Study|Protocol Violation|0
288668|NCT01770379|970555|P3|Overall Study|study terminated by sponsor|22
288669|NCT01770379|970556|P2|Overall Study|study terminated by sponsor|23
288670|NCT01770379|970557|P1|Overall Study|study terminated by sponsor|22
288671|NCT01770379|970555|P3|Overall Study|Withdrawal by Subject|7
288672|NCT01770379|970556|P2|Overall Study|Withdrawal by Subject|10
288673|NCT01770379|970557|P1|Overall Study|Withdrawal by Subject|7
288674|NCT01770379|970555|P3|Overall Study|Technical issues|0
288675|NCT01770379|970556|P2|Overall Study|Technical issues|0
288676|NCT01770379|970557|P1|Overall Study|Technical issues|1
288677|NCT01770145|970594|P1|Treatment|Withdrawal by Subject|1
288678|NCT01770145|970594|P1|Treatment|Adverse Event|3
288679|NCT01770145|970594|P1|Baseline|Unable to define optimal dose|4
288680|NCT01770145|970594|P1|Baseline|Lost to Follow-up|1
288681|NCT01770145|970594|P1|Baseline|Withdrawal by Subject|1
288682|NCT01770145|970594|P1|Baseline|Adverse Event|20
288683|NCT01769508|970614|P1|Overall Study|Lost to Follow-up|1
288684|NCT01769508|970614|P1|Overall Study|Adverse Event|1
288685|NCT01769508|970614|P1|Overall Study|Withdrawal by Subject|1
288686|NCT01769508|970614|P1|Overall Study|Death|3
288687|NCT01769456|970623|P1|Overall Study|Parental request to youth to withdraw|1
288688|NCT01769456|970623|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
288689|NCT01769456|970623|P1|Overall Study|Moved out of the area|3
288690|NCT01769456|970623|P1|Overall Study|Did not receive PCC intervention|6
288691|NCT01769456|970623|P1|Overall Study|Withdrawal by Subject|3
288692|NCT01769456|970623|P1|Overall Study|Lost to Follow-up|19
288693|NCT01769443|970644|P2|Overall Study|Study closure|0
288694|NCT01769443|970645|P1|Overall Study|Study closure|1
288695|NCT01769391|970689|P2|Overall Study|On Treatment at Study Conclusion|0
288696|NCT01769391|970690|P1|Overall Study|On Treatment at Study Conclusion|3
288697|NCT01769391|970689|P2|Overall Study|Investigator Decision|0
288698|NCT01769391|970690|P1|Overall Study|Investigator Decision|2
288699|NCT01769391|970689|P2|Overall Study|Withdrawal by Subject|3
288700|NCT01769391|970690|P1|Overall Study|Withdrawal by Subject|4
288701|NCT01769391|970689|P2|Overall Study|Progressive Disease|2
288702|NCT01769391|970690|P1|Overall Study|Progressive Disease|1
288703|NCT01769391|970689|P2|Overall Study|Adverse Event|3
288704|NCT01769391|970690|P1|Overall Study|Adverse Event|0
288705|NCT01769391|970689|P2|Overall Study|Death|1
288706|NCT01769391|970690|P1|Overall Study|Death|10
288707|NCT01769378|970709|P2|Overall Study|Lost to Follow-up|0
288708|NCT01769378|970710|P1|Overall Study|Lost to Follow-up|2
288709|NCT01769378|970709|P2|Overall Study|Sponsor Decision|0
288710|NCT01769378|970710|P1|Overall Study|Sponsor Decision|1
288711|NCT01769378|970709|P2|Overall Study|Withdrawal by Subject|3
288712|NCT01769378|970710|P1|Overall Study|Withdrawal by Subject|10
288713|NCT01769378|970709|P2|Overall Study|Protocol Violation|1
288714|NCT01769378|970710|P1|Overall Study|Protocol Violation|1
288715|NCT01769378|970709|P2|Overall Study|Entry criteria not met|0
288716|NCT01769378|970710|P1|Overall Study|Entry criteria not met|1
288717|NCT01769378|970709|P2|Overall Study|Adverse Event|0
288718|NCT01769378|970710|P1|Overall Study|Adverse Event|10
288719|NCT01769339|970790|P1|Overall Study|Adverse Event|1
288720|NCT01769339|970790|P1|Overall Study|Lost to Follow-up|42
288721|NCT01769326|970801|P4|Overall Study|Got sick and could not complete study|0
288722|NCT01769326|970802|P3|Overall Study|Got sick and could not complete study|1
288723|NCT01769326|970803|P2|Overall Study|Got sick and could not complete study|0
288724|NCT01769326|970804|P1|Overall Study|Got sick and could not complete study|0
288725|NCT01769326|970801|P4|Overall Study|got a job|0
288726|NCT01769326|970802|P3|Overall Study|got a job|0
288727|NCT01769326|970803|P2|Overall Study|got a job|1
288728|NCT01769326|970804|P1|Overall Study|got a job|0
288729|NCT01769326|970801|P4|Overall Study|unrelated injry|0
288730|NCT01769326|970802|P3|Overall Study|unrelated injry|0
288731|NCT01769326|970803|P2|Overall Study|unrelated injry|1
288732|NCT01769326|970804|P1|Overall Study|unrelated injry|1
288733|NCT01769326|970801|P4|Overall Study|Lost to Follow-up|0
288734|NCT01769326|970802|P3|Overall Study|Lost to Follow-up|0
288735|NCT01769326|970803|P2|Overall Study|Lost to Follow-up|2
288736|NCT01769326|970804|P1|Overall Study|Lost to Follow-up|1
288737|NCT01769196|970846|P2|Overall Study|Withdrew consent|40
288738|NCT01769196|970847|P1|Overall Study|Withdrew consent|36
288739|NCT01769196|970846|P2|Overall Study|Participant never dosed with study drug|0
288740|NCT01769196|970847|P1|Overall Study|Participant never dosed with study drug|1
288741|NCT01769196|970846|P2|Overall Study|Study terminated by sponsor|161
288742|NCT01769196|970847|P1|Overall Study|Study terminated by sponsor|160
288743|NCT01769196|970846|P2|Overall Study|Protocol Violation|3
288744|NCT01769196|970847|P1|Overall Study|Protocol Violation|0
288745|NCT01769196|970846|P2|Overall Study|Protocol defined criteria for withdrawal|11
288746|NCT01769196|970847|P1|Overall Study|Protocol defined criteria for withdrawal|9
288747|NCT01769196|970846|P2|Overall Study|Progressive disease|6
288748|NCT01769196|970847|P1|Overall Study|Progressive disease|11
288749|NCT01769196|970846|P2|Overall Study|Lack of Efficacy|2
288750|NCT01769196|970847|P1|Overall Study|Lack of Efficacy|3
288751|NCT01769196|970846|P2|Overall Study|Investigator Discretion|3
288752|NCT01769196|970847|P1|Overall Study|Investigator Discretion|7
288753|NCT01769196|970846|P2|Overall Study|Death|26
288754|NCT01769196|970847|P1|Overall Study|Death|21
288755|NCT01769196|970846|P2|Overall Study|Adverse Event|20
288756|NCT01769196|970847|P1|Overall Study|Adverse Event|24
288757|NCT01769105|970877|P2|Cross-over|Lost to Follow-up|0
288758|NCT01769105|970878|P1|Cross-over|Lost to Follow-up|5
288759|NCT01769105|970877|P2|First Intervention|Protocol Violation|2
288760|NCT01769105|970878|P1|First Intervention|Protocol Violation|2
288761|NCT01768676|970899|P2|Overall Study|Withdrawal by Subject|10
288762|NCT01768676|970900|P1|Overall Study|Withdrawal by Subject|3
288763|NCT01768676|970899|P2|Overall Study|Physician Decision|1
288764|NCT01768676|970900|P1|Overall Study|Physician Decision|4
288765|NCT01768676|970899|P2|Overall Study|Protocol Violation|1
288766|NCT01768676|970900|P1|Overall Study|Protocol Violation|1
288767|NCT01768676|970899|P2|Overall Study|Lost to Follow-up|16
288768|NCT01768676|970900|P1|Overall Study|Lost to Follow-up|13
288769|NCT01768676|970899|P2|Overall Study|Adverse Event|3
288770|NCT01768676|970900|P1|Overall Study|Adverse Event|3
288771|NCT01768572|970917|P3|Overall Study|Other, Not due to an adverse event|1
288772|NCT01768572|970918|P2|Overall Study|Other, Not due to an adverse event|1
288773|NCT01768572|970919|P1|Overall Study|Other, Not due to an adverse event|1
288774|NCT01768572|970917|P3|Overall Study|Lack of Efficacy|1
288775|NCT01768572|970918|P2|Overall Study|Lack of Efficacy|3
288776|NCT01768572|970919|P1|Overall Study|Lack of Efficacy|1
288777|NCT01768572|970917|P3|Overall Study|Adverse Event|4
288778|NCT01768572|970918|P2|Overall Study|Adverse Event|8
288779|NCT01768572|970919|P1|Overall Study|Adverse Event|7
288780|NCT01768559|970930|P3|Overall Study|Other than specified|5
288781|NCT01768559|970931|P2|Overall Study|Other than specified|8
288782|NCT01768559|970932|P1|Overall Study|Other than specified|9
288783|NCT01768559|970930|P3|Overall Study|Poor compliance to protocol|2
288784|NCT01768559|970931|P2|Overall Study|Poor compliance to protocol|3
288785|NCT01768559|970932|P1|Overall Study|Poor compliance to protocol|0
288786|NCT01768559|970930|P3|Overall Study|Lack of Efficacy|0
288787|NCT01768559|970931|P2|Overall Study|Lack of Efficacy|4
288788|NCT01768559|970932|P1|Overall Study|Lack of Efficacy|6
288789|NCT01768559|970930|P3|Overall Study|Adverse Event|5
288790|NCT01768559|970931|P2|Overall Study|Adverse Event|2
288791|NCT01768559|970932|P1|Overall Study|Adverse Event|15
288792|NCT01768559|970930|P3|Overall Study|Randomized but not treated|1
288793|NCT01768559|970931|P2|Overall Study|Randomized but not treated|0
288794|NCT01768559|970932|P1|Overall Study|Randomized but not treated|0
288795|NCT01768286|970997|P4|Overall Study|Withdrew Consent|0
288796|NCT01768286|970998|P3|Overall Study|Withdrew Consent|1
288797|NCT01768286|970999|P2|Overall Study|Withdrew Consent|0
288798|NCT01768286|971000|P1|Overall Study|Withdrew Consent|0
288799|NCT01768286|970997|P4|Overall Study|Lack of Efficacy|1
288800|NCT01768286|970998|P3|Overall Study|Lack of Efficacy|0
288801|NCT01768286|970999|P2|Overall Study|Lack of Efficacy|4
288802|NCT01768286|971000|P1|Overall Study|Lack of Efficacy|7
288803|NCT01768286|970997|P4|Overall Study|Randomized But Not Treated|0
288804|NCT01768286|970998|P3|Overall Study|Randomized But Not Treated|1
288805|NCT01768286|970999|P2|Overall Study|Randomized But Not Treated|0
288806|NCT01768286|971000|P1|Overall Study|Randomized But Not Treated|0
288807|NCT01768117|971062|P1|Overall Study|Protocol Violation|3
288808|NCT01768117|971062|P1|Overall Study|Withdrawal by Subject|2
288809|NCT01768117|971062|P1|Overall Study|Lost to Follow-up|1
288810|NCT01767987|971126|P2|Overall Study|Physician Decision|1
288811|NCT01767987|971127|P1|Overall Study|Physician Decision|4
288812|NCT01767597|971193|P2|Overall Study|Withdrawal by Subject|0
288813|NCT01767597|971194|P1|Overall Study|Withdrawal by Subject|1
288814|NCT01767597|971193|P2|Overall Study|Incomplete intervention|1
288815|NCT01767597|971194|P1|Overall Study|Incomplete intervention|3
288816|NCT01767519|971203|P3|Overall Study|Adverse Event|1
288817|NCT01767519|971204|P2|Overall Study|Adverse Event|5
288818|NCT01767519|971205|P1|Overall Study|Adverse Event|5
288819|NCT01767519|971203|P3|Overall Study|Lack of Efficacy|0
288820|NCT01767519|971204|P2|Overall Study|Lack of Efficacy|0
288821|NCT01767519|971205|P1|Overall Study|Lack of Efficacy|1
288822|NCT01767519|971203|P3|Overall Study|Lost to Follow-up|2
288823|NCT01767519|971204|P2|Overall Study|Lost to Follow-up|1
288824|NCT01767519|971205|P1|Overall Study|Lost to Follow-up|3
288825|NCT01767519|971203|P3|Overall Study|Personal Reasons|0
288826|NCT01767519|971204|P2|Overall Study|Personal Reasons|0
288827|NCT01767519|971205|P1|Overall Study|Personal Reasons|1
288828|NCT01767519|971203|P3|Overall Study|Protocol Violation|0
288829|NCT01767519|971204|P2|Overall Study|Protocol Violation|3
288830|NCT01767519|971205|P1|Overall Study|Protocol Violation|0
288831|NCT01767519|971203|P3|Overall Study|Other Reasons|2
288832|NCT01767519|971204|P2|Overall Study|Other Reasons|4
288833|NCT01767519|971205|P1|Overall Study|Other Reasons|4
288834|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
288835|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
288836|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Physician Decision|0
288837|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Physician Decision|1
288838|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
288839|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
288840|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
288841|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
288842|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
288843|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
288844|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
288845|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
288846|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
288847|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
288848|NCT01767467|971246|P2|End of Study Phase (up to Month 13)|Adverse Event|39
288849|NCT01767467|971247|P1|End of Study Phase (up to Month 13)|Adverse Event|29
288850|NCT01767467|971246|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
288851|NCT01767467|971247|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
288852|NCT01767467|971246|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
288853|NCT01767467|971247|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
288854|NCT01767467|971246|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
288855|NCT01767467|971247|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
288856|NCT01767467|971246|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
288857|NCT01767467|971247|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
288858|NCT01767467|971246|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
288859|NCT01767467|971247|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
288860|NCT01767467|971246|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
288861|NCT01767467|971247|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
288862|NCT01767376|971298|P3|Overall Study|Withdrawal by Subject|0
288863|NCT01767376|971299|P2|Overall Study|Withdrawal by Subject|1
288864|NCT01767376|971300|P1|Overall Study|Withdrawal by Subject|1
288865|NCT01767376|971298|P3|Overall Study|Lost to Follow-up|0
288866|NCT01767376|971299|P2|Overall Study|Lost to Follow-up|2
288867|NCT01767376|971300|P1|Overall Study|Lost to Follow-up|3
288868|NCT01767116|971366|P2|Overall Study|Lost to Follow-up|2
288869|NCT01767116|971367|P1|Overall Study|Lost to Follow-up|2
288870|NCT01766921|971425|P2|Overall Study|Withdrawal by Subject|5
288871|NCT01766921|971426|P1|Overall Study|Withdrawal by Subject|14
288872|NCT01766921|971425|P2|Overall Study|Protocol Violation|1
288873|NCT01766921|971426|P1|Overall Study|Protocol Violation|1
288874|NCT01766921|971425|P2|Overall Study|Unclassified|2
288875|NCT01766921|971426|P1|Overall Study|Unclassified|2
288876|NCT01766921|971425|P2|Overall Study|Lost to Follow-up|3
288877|NCT01766921|971426|P1|Overall Study|Lost to Follow-up|1
288878|NCT01766921|971425|P2|Overall Study|Death|1
288879|NCT01766921|971426|P1|Overall Study|Death|1
288880|NCT01766921|971425|P2|Overall Study|Administrative Reason|5
288881|NCT01766921|971426|P1|Overall Study|Administrative Reason|5
288882|NCT01766778|971447|P2|Overall Study|Withdrawal by Subject|0
288883|NCT01766778|971448|P1|Overall Study|Withdrawal by Subject|1
288884|NCT01766778|971447|P2|Overall Study|Adverse Event|4
288885|NCT01766778|971448|P1|Overall Study|Adverse Event|4
288886|NCT01766336|971502|P2|Overall Study|Withdrawal by Subject|15
288887|NCT01766336|971503|P1|Overall Study|Withdrawal by Subject|18
288888|NCT01766336|971502|P2|Overall Study|Sponsor Decision|43
288889|NCT01766336|971503|P1|Overall Study|Sponsor Decision|52
288890|NCT01766336|971502|P2|Overall Study|Protocol Violation|1
288891|NCT01766336|971503|P1|Overall Study|Protocol Violation|0
288892|NCT01766336|971502|P2|Overall Study|Physician Decision|2
288893|NCT01766336|971503|P1|Overall Study|Physician Decision|4
288894|NCT01766336|971502|P2|Overall Study|Lost to Follow-up|3
288895|NCT01766336|971503|P1|Overall Study|Lost to Follow-up|1
288896|NCT01766336|971502|P2|Overall Study|Death|3
288897|NCT01766336|971503|P1|Overall Study|Death|4
288898|NCT01766336|971502|P2|Overall Study|Adverse Event|8
288899|NCT01766336|971503|P1|Overall Study|Adverse Event|11
288900|NCT01766310|971511|P2|Overall Study|Lost to Follow-up|3
288901|NCT01766310|971512|P1|Overall Study|Lost to Follow-up|1
288902|NCT01766050|971540|P1|Overall Study|Withdrawal by Subject|2
288903|NCT01766050|971540|P1|Overall Study|Lost to Follow-up|1
288904|NCT01766050|971540|P1|Overall Study|Adverse Event|1
288905|NCT01766037|971675|P2|Overall Study|nausea / discomfort|0
288906|NCT01766037|971676|P1|Overall Study|nausea / discomfort|3
288907|NCT01766037|971675|P2|Overall Study|medical - unrelated|2
288908|NCT01766037|971676|P1|Overall Study|medical - unrelated|1
288909|NCT01766037|971675|P2|Overall Study|Moved from area|0
288910|NCT01766037|971676|P1|Overall Study|Moved from area|5
288911|NCT01766037|971675|P2|Overall Study|Withdrawal by Subject|16
288912|NCT01766037|971676|P1|Overall Study|Withdrawal by Subject|18
288913|NCT01766037|971675|P2|Overall Study|Physician Decision|1
288914|NCT01766037|971676|P1|Overall Study|Physician Decision|0
288915|NCT01766037|971675|P2|Overall Study|Lost to Follow-up|10
288916|NCT01766037|971676|P1|Overall Study|Lost to Follow-up|0
288917|NCT01766037|971675|P2|Overall Study|Lack of Efficacy|0
288918|NCT01766037|971676|P1|Overall Study|Lack of Efficacy|1
288919|NCT01766037|971675|P2|Overall Study|Adverse Event|0
288920|NCT01766037|971676|P1|Overall Study|Adverse Event|1
288921|NCT01765764|971745|P3|Treatment Period|Other Miscellaneous Reasons|2
288922|NCT01765764|971746|P2|Treatment Period|Other Miscellaneous Reasons|2
288923|NCT01765764|971747|P1|Treatment Period|Other Miscellaneous Reasons|1
288924|NCT01765764|971745|P3|Treatment Period|Personal Reasons|1
288925|NCT01765764|971746|P2|Treatment Period|Personal Reasons|2
288926|NCT01765764|971747|P1|Treatment Period|Personal Reasons|1
288927|NCT01765764|971745|P3|Treatment Period|Lost to Follow-up|2
288928|NCT01765764|971746|P2|Treatment Period|Lost to Follow-up|3
288929|NCT01765764|971747|P1|Treatment Period|Lost to Follow-up|0
288930|NCT01765764|971745|P3|Treatment Period|Adverse Event|1
288931|NCT01765764|971746|P2|Treatment Period|Adverse Event|2
288932|NCT01765764|971747|P1|Treatment Period|Adverse Event|1
288933|NCT01765751|971767|P3|Overall Study|Lost to Follow-up|1
288934|NCT01765751|971768|P2|Overall Study|Lost to Follow-up|2
288935|NCT01765751|971769|P1|Overall Study|Lost to Follow-up|0
288936|NCT01765673|971801|P1|Overall Study|No transportation for 2nd/3rd visits|1
288937|NCT01765582|971827|P3|Overall Study|Withdrawal of Consent|10
288938|NCT01765582|971828|P2|Overall Study|Withdrawal of Consent|6
288939|NCT01765582|971829|P1|Overall Study|Withdrawal of Consent|11
288940|NCT01765582|971827|P3|Overall Study|Sponsor Decision|42
288941|NCT01765582|971828|P2|Overall Study|Sponsor Decision|42
288942|NCT01765582|971829|P1|Overall Study|Sponsor Decision|46
288943|NCT01765582|971827|P3|Overall Study|Death|33
288944|NCT01765582|971828|P2|Overall Study|Death|36
288945|NCT01765582|971829|P1|Overall Study|Death|31
288946|NCT01765582|971827|P3|Overall Study|Lost to Follow-up|1
288947|NCT01765582|971828|P2|Overall Study|Lost to Follow-up|2
288948|NCT01765582|971829|P1|Overall Study|Lost to Follow-up|2
288949|NCT01765582|971827|P3|Overall Study|Other|9
288950|NCT01765582|971828|P2|Overall Study|Other|6
288951|NCT01765582|971829|P1|Overall Study|Other|3
288952|NCT01765569|971862|P1|Period C|Death|1
288953|NCT01765569|971862|P1|Period B|Withdrawal by Subject|1
288954|NCT01765543|971883|P1|Overall Study|Withdrawal by Subject|2
288955|NCT01765543|971883|P1|Overall Study|Death|1
288956|NCT01765426|971935|P4|Overall Study|Lost to Follow-up|0
288957|NCT01765426|971936|P3|Overall Study|Lost to Follow-up|0
288958|NCT01765426|971937|P2|Overall Study|Lost to Follow-up|1
288959|NCT01765426|971938|P1|Overall Study|Lost to Follow-up|0
288960|NCT01765270|971994|P2|Overall Study|Withdrawal by Subject|1
288961|NCT01765270|971995|P1|Overall Study|Withdrawal by Subject|0
288962|NCT01765270|971994|P2|Overall Study|Physician Decision|0
288963|NCT01765270|971995|P1|Overall Study|Physician Decision|1
288964|NCT01765192|972017|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
288965|NCT01765192|972018|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
288966|NCT01765192|972017|P2|Treatment Period 2|Reason not specified|2
288967|NCT01765192|972018|P1|Treatment Period 2|Reason not specified|0
288968|NCT01765192|972017|P2|Washout Period|Reason not specified|0
288969|NCT01765192|972018|P1|Washout Period|Reason not specified|1
288970|NCT01765192|972017|P2|Washout Period|Voluntary Withdrawal|1
288971|NCT01765192|972018|P1|Washout Period|Voluntary Withdrawal|1
288972|NCT01765192|972017|P2|Treatment Period 1|Adverse Event|1
288973|NCT01765192|972018|P1|Treatment Period 1|Adverse Event|0
288974|NCT01765179|972036|P1|Overall Study|Ca elevated 10.6|1
288975|NCT01765179|972036|P1|Overall Study|work conflict|1
288976|NCT01765179|972036|P1|Overall Study|lack of venous access|1
288977|NCT01765179|972036|P1|Overall Study|Out of country unable to finish study|1
288978|NCT01765179|972036|P1|Overall Study|prohibited med|1
288979|NCT01765179|972036|P1|Overall Study|Hematocrit >54%|3
288980|NCT01765179|972036|P1|Overall Study|Withdrawal by Subject|8
288981|NCT01765179|972036|P1|Overall Study|Protocol Violation|1
288982|NCT01765179|972036|P1|Overall Study|Non-compliance with study drug|2
288983|NCT01765179|972036|P1|Overall Study|Lost to Follow-up|5
288984|NCT01765179|972036|P1|Overall Study|Adverse Event|3
288985|NCT01765153|972043|P2|Rest Phase 2|Lost to Follow-up|1
288986|NCT01765153|972044|P1|Rest Phase 2|Lost to Follow-up|2
288987|NCT01765153|972043|P2|Training Phase 2|Withdrawal by Subject|1
288988|NCT01765153|972044|P1|Training Phase 2|Withdrawal by Subject|0
288989|NCT01765153|972043|P2|Rest Phase 1|Withdrawal by Subject|1
288990|NCT01765153|972044|P1|Rest Phase 1|Withdrawal by Subject|0
288991|NCT01765153|972043|P2|Training Phase 1|Poor participation in intervention|1
288992|NCT01765153|972044|P1|Training Phase 1|Poor participation in intervention|0
288993|NCT01765153|972043|P2|Training Phase 1|Format of intervention differed|0
288994|NCT01765153|972044|P1|Training Phase 1|Format of intervention differed|1
288995|NCT01764997|972151|P5|Study Drug Treatment Period|Other than specified above|10
288996|NCT01764997|972152|P4|Study Drug Treatment Period|Other than specified above|0
288997|NCT01764997|972153|P3|Study Drug Treatment Period|Other than specified above|0
288998|NCT01764997|972154|P2|Study Drug Treatment Period|Other than specified above|0
288999|NCT01764997|972155|P1|Study Drug Treatment Period|Other than specified above|0
289000|NCT01764997|972151|P5|Study Drug Treatment Period|Lack of Efficacy|2
289001|NCT01764997|972152|P4|Study Drug Treatment Period|Lack of Efficacy|0
289002|NCT01764997|972153|P3|Study Drug Treatment Period|Lack of Efficacy|0
289003|NCT01764997|972154|P2|Study Drug Treatment Period|Lack of Efficacy|0
289004|NCT01764997|972155|P1|Study Drug Treatment Period|Lack of Efficacy|0
289005|NCT01764997|972151|P5|Study Drug Treatment Period|Adverse Event|24
289006|NCT01764997|972152|P4|Study Drug Treatment Period|Adverse Event|0
289007|NCT01764997|972153|P3|Study Drug Treatment Period|Adverse Event|0
289008|NCT01764997|972154|P2|Study Drug Treatment Period|Adverse Event|1
289009|NCT01764997|972155|P1|Study Drug Treatment Period|Adverse Event|0
289010|NCT01764997|972151|P5|Run-in Period|Other than specified above|0
289011|NCT01764997|972152|P4|Run-in Period|Other than specified above|0
289012|NCT01764997|972153|P3|Run-in Period|Other than specified above|0
289013|NCT01764997|972154|P2|Run-in Period|Other than specified above|0
289014|NCT01764997|972155|P1|Run-in Period|Other than specified above|17
289015|NCT01764997|972151|P5|Run-in Period|Poor compliance to protocol|0
289016|NCT01764997|972152|P4|Run-in Period|Poor compliance to protocol|0
289017|NCT01764997|972153|P3|Run-in Period|Poor compliance to protocol|0
289018|NCT01764997|972154|P2|Run-in Period|Poor compliance to protocol|0
289019|NCT01764997|972155|P1|Run-in Period|Poor compliance to protocol|1
289020|NCT01764997|972151|P5|Run-in Period|Lack of Efficacy|0
289021|NCT01764997|972152|P4|Run-in Period|Lack of Efficacy|0
289022|NCT01764997|972153|P3|Run-in Period|Lack of Efficacy|0
289023|NCT01764997|972154|P2|Run-in Period|Lack of Efficacy|0
289024|NCT01764997|972155|P1|Run-in Period|Lack of Efficacy|5
289025|NCT01764997|972151|P5|Run-in Period|Adverse Event|0
289026|NCT01764997|972152|P4|Run-in Period|Adverse Event|0
289027|NCT01764997|972153|P3|Run-in Period|Adverse Event|0
289028|NCT01764997|972154|P2|Run-in Period|Adverse Event|0
289029|NCT01764997|972155|P1|Run-in Period|Adverse Event|15
289030|NCT01764945|972182|P8|Overall Study|Adverse Event|0
289031|NCT01764945|972183|P7|Overall Study|Adverse Event|1
289032|NCT01764945|972184|P6|Overall Study|Adverse Event|0
289033|NCT01764945|972185|P5|Overall Study|Adverse Event|0
289034|NCT01764945|972186|P4|Overall Study|Adverse Event|0
289035|NCT01764945|972187|P3|Overall Study|Adverse Event|0
289036|NCT01764945|972188|P2|Overall Study|Adverse Event|1
289037|NCT01764945|972189|P1|Overall Study|Adverse Event|0
289038|NCT01764841|972235|P4|Overall Study|Lost to Follow-up|0
289039|NCT01764841|972236|P3|Overall Study|Lost to Follow-up|1
289040|NCT01764841|972237|P2|Overall Study|Lost to Follow-up|0
289041|NCT01764841|972238|P1|Overall Study|Lost to Follow-up|3
289042|NCT01764841|972235|P4|Overall Study|Withdrawal by Subject|15
289043|NCT01764841|972236|P3|Overall Study|Withdrawal by Subject|11
289044|NCT01764841|972237|P2|Overall Study|Withdrawal by Subject|24
289045|NCT01764841|972238|P1|Overall Study|Withdrawal by Subject|16
289046|NCT01764841|972235|P4|Overall Study|Protocol Violation|0
289047|NCT01764841|972236|P3|Overall Study|Protocol Violation|0
289048|NCT01764841|972237|P2|Overall Study|Protocol Violation|1
289049|NCT01764841|972238|P1|Overall Study|Protocol Violation|0
289050|NCT01764841|972235|P4|Overall Study|No Follow Up|0
289051|NCT01764841|972236|P3|Overall Study|No Follow Up|1
289052|NCT01764841|972237|P2|Overall Study|No Follow Up|0
289053|NCT01764841|972238|P1|Overall Study|No Follow Up|1
289054|NCT01764841|972235|P4|Overall Study|Death|4
289055|NCT01764841|972236|P3|Overall Study|Death|1
289056|NCT01764841|972237|P2|Overall Study|Death|0
289057|NCT01764841|972238|P1|Overall Study|Death|3
289058|NCT01764841|972235|P4|Overall Study|Logistical Difficulties|0
289059|NCT01764841|972236|P3|Overall Study|Logistical Difficulties|0
289060|NCT01764841|972237|P2|Overall Study|Logistical Difficulties|1
289061|NCT01764841|972238|P1|Overall Study|Logistical Difficulties|0
289062|NCT01764633|972281|P2|Overall Study|Lost to Follow-up|5
289063|NCT01764633|972282|P1|Overall Study|Lost to Follow-up|13
289064|NCT01764633|972281|P2|Overall Study|Withdrawal by Subject|88
289065|NCT01764633|972282|P1|Overall Study|Withdrawal by Subject|105
289066|NCT01764386|972311|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
289067|NCT01764386|972312|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
289068|NCT01764386|972311|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
289069|NCT01764386|972312|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
289070|NCT01764386|972311|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
289071|NCT01764386|972312|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
289072|NCT01764386|972311|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
289073|NCT01764386|972312|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
289074|NCT01764386|972311|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
289075|NCT01764386|972312|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
289076|NCT01764386|972311|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
289077|NCT01764386|972312|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
289078|NCT01764386|972311|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
289079|NCT01764386|972312|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
289080|NCT01764386|972311|P2|Controlled Treatment Period (CTP)|Adverse Event|0
289081|NCT01764386|972312|P1|Controlled Treatment Period (CTP)|Adverse Event|35
289082|NCT01764022|972355|P2|Overall Study|Protocol Violation|0
289083|NCT01764022|972356|P1|Overall Study|Protocol Violation|1
289084|NCT01764022|972355|P2|Overall Study|Physician Decision|2
289085|NCT01764022|972356|P1|Overall Study|Physician Decision|2
289086|NCT01764022|972355|P2|Overall Study|Lack of Efficacy|5
289087|NCT01764022|972356|P1|Overall Study|Lack of Efficacy|10
289088|NCT01764022|972355|P2|Overall Study|Withdrawal by Subject|4
289089|NCT01764022|972356|P1|Overall Study|Withdrawal by Subject|5
289090|NCT01764022|972355|P2|Overall Study|Death|1
289091|NCT01764022|972356|P1|Overall Study|Death|3
289092|NCT01763996|972384|P2|Treatment Period 2|Adverse Event|1
289093|NCT01763996|972385|P1|Treatment Period 2|Adverse Event|0
289094|NCT01763918|972415|P4|Overall Study|Sponsor Decision|0
289095|NCT01763918|972416|P3|Overall Study|Sponsor Decision|9
289096|NCT01763918|972417|P2|Overall Study|Sponsor Decision|0
289097|NCT01763918|972418|P1|Overall Study|Sponsor Decision|4
289098|NCT01763918|972415|P4|Overall Study|Withdrawal by Subject|2
289099|NCT01763918|972416|P3|Overall Study|Withdrawal by Subject|1
289100|NCT01763918|972417|P2|Overall Study|Withdrawal by Subject|1
289101|NCT01763918|972418|P1|Overall Study|Withdrawal by Subject|2
289102|NCT01763905|972516|P4|Overall Study|Lost to Follow-up|0
289103|NCT01763905|972517|P3|Overall Study|Lost to Follow-up|1
289104|NCT01763905|972518|P2|Overall Study|Lost to Follow-up|0
289105|NCT01763905|972519|P1|Overall Study|Lost to Follow-up|0
289106|NCT01763905|972516|P4|Overall Study|Decision by sponsor|0
289107|NCT01763905|972517|P3|Overall Study|Decision by sponsor|8
289108|NCT01763905|972518|P2|Overall Study|Decision by sponsor|0
289109|NCT01763905|972519|P1|Overall Study|Decision by sponsor|5
289110|NCT01763905|972516|P4|Overall Study|Withdrawal by Subject|1
289111|NCT01763905|972517|P3|Overall Study|Withdrawal by Subject|0
289112|NCT01763905|972518|P2|Overall Study|Withdrawal by Subject|1
289113|NCT01763905|972519|P1|Overall Study|Withdrawal by Subject|1
289114|NCT01763866|972637|P24|Overall Study|Death|0
289115|NCT01763866|972638|P23|Overall Study|Death|0
289116|NCT01763866|972639|P22|Overall Study|Death|0
289117|NCT01763866|972640|P21|Overall Study|Death|0
289118|NCT01763866|972641|P20|Overall Study|Death|0
289119|NCT01763866|972642|P19|Overall Study|Death|0
289120|NCT01763866|972643|P18|Overall Study|Death|0
289121|NCT01763866|972644|P17|Overall Study|Death|1
289122|NCT01763866|972645|P16|Overall Study|Death|0
289123|NCT01763866|972646|P15|Overall Study|Death|0
289124|NCT01763866|972647|P14|Overall Study|Death|0
289125|NCT01763866|972648|P13|Overall Study|Death|0
289126|NCT01763866|972649|P12|Overall Study|Death|0
289127|NCT01763866|972650|P11|Overall Study|Death|0
289128|NCT01763866|972651|P10|Overall Study|Death|0
289129|NCT01763866|972652|P9|Overall Study|Death|0
289130|NCT01763866|972653|P8|Overall Study|Death|0
289131|NCT01763866|972654|P7|Overall Study|Death|0
289132|NCT01763866|972655|P6|Overall Study|Death|0
289133|NCT01763866|972656|P5|Overall Study|Death|0
289134|NCT01763866|972657|P4|Overall Study|Death|0
289135|NCT01763866|972658|P3|Overall Study|Death|0
289136|NCT01763866|972659|P2|Overall Study|Death|0
289137|NCT01763866|972660|P1|Overall Study|Death|0
289138|NCT01763866|972637|P24|Overall Study|Lost to Follow-up|1
289139|NCT01763866|972638|P23|Overall Study|Lost to Follow-up|0
289140|NCT01763866|972639|P22|Overall Study|Lost to Follow-up|0
289141|NCT01763866|972640|P21|Overall Study|Lost to Follow-up|0
289142|NCT01763866|972641|P20|Overall Study|Lost to Follow-up|1
289143|NCT01763866|972642|P19|Overall Study|Lost to Follow-up|1
289144|NCT01763866|972643|P18|Overall Study|Lost to Follow-up|0
289145|NCT01763866|972644|P17|Overall Study|Lost to Follow-up|0
289146|NCT01763866|972645|P16|Overall Study|Lost to Follow-up|0
289147|NCT01763866|972646|P15|Overall Study|Lost to Follow-up|1
289148|NCT01763866|972647|P14|Overall Study|Lost to Follow-up|0
289149|NCT01763866|972648|P13|Overall Study|Lost to Follow-up|1
289150|NCT01763866|972649|P12|Overall Study|Lost to Follow-up|0
289151|NCT01763866|972650|P11|Overall Study|Lost to Follow-up|0
289152|NCT01763866|972651|P10|Overall Study|Lost to Follow-up|0
289153|NCT01763866|972652|P9|Overall Study|Lost to Follow-up|0
289154|NCT01763866|972653|P8|Overall Study|Lost to Follow-up|0
289155|NCT01763866|972654|P7|Overall Study|Lost to Follow-up|1
289156|NCT01763866|972655|P6|Overall Study|Lost to Follow-up|0
289157|NCT01763866|972656|P5|Overall Study|Lost to Follow-up|0
289158|NCT01763866|972657|P4|Overall Study|Lost to Follow-up|0
289159|NCT01763866|972658|P3|Overall Study|Lost to Follow-up|0
289160|NCT01763866|972659|P2|Overall Study|Lost to Follow-up|0
289161|NCT01763866|972660|P1|Overall Study|Lost to Follow-up|0
289162|NCT01763866|972637|P24|Overall Study|Decision by sponsor|0
289163|NCT01763866|972638|P23|Overall Study|Decision by sponsor|1
289164|NCT01763866|972639|P22|Overall Study|Decision by sponsor|0
289165|NCT01763866|972640|P21|Overall Study|Decision by sponsor|2
289166|NCT01763866|972641|P20|Overall Study|Decision by sponsor|0
289167|NCT01763866|972642|P19|Overall Study|Decision by sponsor|4
289168|NCT01763866|972643|P18|Overall Study|Decision by sponsor|0
289169|NCT01763866|972644|P17|Overall Study|Decision by sponsor|0
289170|NCT01763866|972645|P16|Overall Study|Decision by sponsor|0
289171|NCT01763866|972646|P15|Overall Study|Decision by sponsor|5
289172|NCT01763866|972647|P14|Overall Study|Decision by sponsor|0
289173|NCT01763866|972648|P13|Overall Study|Decision by sponsor|1
289174|NCT01763866|972649|P12|Overall Study|Decision by sponsor|0
289175|NCT01763866|972650|P11|Overall Study|Decision by sponsor|6
289176|NCT01763866|972651|P10|Overall Study|Decision by sponsor|0
289177|NCT01763866|972652|P9|Overall Study|Decision by sponsor|2
289178|NCT01763866|972653|P8|Overall Study|Decision by sponsor|0
289179|NCT01763866|972654|P7|Overall Study|Decision by sponsor|2
289180|NCT01763866|972655|P6|Overall Study|Decision by sponsor|0
289181|NCT01763866|972656|P5|Overall Study|Decision by sponsor|2
289182|NCT01763866|972657|P4|Overall Study|Decision by sponsor|0
289183|NCT01763866|972658|P3|Overall Study|Decision by sponsor|1
289184|NCT01763866|972659|P2|Overall Study|Decision by sponsor|0
289185|NCT01763866|972660|P1|Overall Study|Decision by sponsor|0
289186|NCT01763866|972637|P24|Overall Study|Withdrawal by Subject|1
289187|NCT01763866|972638|P23|Overall Study|Withdrawal by Subject|2
289188|NCT01763866|972639|P22|Overall Study|Withdrawal by Subject|1
289189|NCT01763866|972640|P21|Overall Study|Withdrawal by Subject|2
289190|NCT01763866|972641|P20|Overall Study|Withdrawal by Subject|1
289191|NCT01763866|972642|P19|Overall Study|Withdrawal by Subject|1
289192|NCT01763866|972643|P18|Overall Study|Withdrawal by Subject|1
289193|NCT01763866|972644|P17|Overall Study|Withdrawal by Subject|0
289194|NCT01763866|972645|P16|Overall Study|Withdrawal by Subject|3
289195|NCT01763866|972646|P15|Overall Study|Withdrawal by Subject|6
289196|NCT01763866|972647|P14|Overall Study|Withdrawal by Subject|0
289197|NCT01763866|972648|P13|Overall Study|Withdrawal by Subject|2
289198|NCT01763866|972649|P12|Overall Study|Withdrawal by Subject|2
289199|NCT01763866|972650|P11|Overall Study|Withdrawal by Subject|2
289200|NCT01763866|972651|P10|Overall Study|Withdrawal by Subject|1
289201|NCT01763866|972652|P9|Overall Study|Withdrawal by Subject|1
289202|NCT01763866|972653|P8|Overall Study|Withdrawal by Subject|0
289203|NCT01763866|972654|P7|Overall Study|Withdrawal by Subject|4
289204|NCT01763866|972655|P6|Overall Study|Withdrawal by Subject|3
289205|NCT01763866|972656|P5|Overall Study|Withdrawal by Subject|0
289206|NCT01763866|972657|P4|Overall Study|Withdrawal by Subject|0
289207|NCT01763866|972658|P3|Overall Study|Withdrawal by Subject|4
289208|NCT01763866|972659|P2|Overall Study|Withdrawal by Subject|1
289209|NCT01763866|972660|P1|Overall Study|Withdrawal by Subject|2
289210|NCT01763827|973220|P6|Overall Study|Lost to Follow-up|1
289211|NCT01763827|973221|P5|Overall Study|Lost to Follow-up|2
289212|NCT01763827|973222|P4|Overall Study|Lost to Follow-up|1
289213|NCT01763827|973223|P3|Overall Study|Lost to Follow-up|1
289214|NCT01763827|973224|P2|Overall Study|Lost to Follow-up|1
289215|NCT01763827|973225|P1|Overall Study|Lost to Follow-up|0
289216|NCT01763827|973220|P6|Overall Study|Decision by sponsor|1
289217|NCT01763827|973221|P5|Overall Study|Decision by sponsor|2
289218|NCT01763827|973222|P4|Overall Study|Decision by sponsor|0
289219|NCT01763827|973223|P3|Overall Study|Decision by sponsor|3
289220|NCT01763827|973224|P2|Overall Study|Decision by sponsor|0
289221|NCT01763827|973225|P1|Overall Study|Decision by sponsor|2
289222|NCT01763827|973220|P6|Overall Study|Withdrawal by Subject|0
289223|NCT01763827|973221|P5|Overall Study|Withdrawal by Subject|2
289224|NCT01763827|973222|P4|Overall Study|Withdrawal by Subject|0
289225|NCT01763827|973223|P3|Overall Study|Withdrawal by Subject|0
289226|NCT01763827|973224|P2|Overall Study|Withdrawal by Subject|0
289227|NCT01763827|973225|P1|Overall Study|Withdrawal by Subject|1
289228|NCT01763047|973396|P2|Period 2|Unsatisfactory lens Fitting|1
289229|NCT01763047|973397|P1|Period 2|Unsatisfactory lens Fitting|0
289230|NCT01763047|973396|P2|Period 2|Protocol Violation|2
289231|NCT01763047|973397|P1|Period 2|Protocol Violation|0
289232|NCT01763047|973396|P2|Period 2|Unsatisfactory Visual Response|1
289233|NCT01763047|973397|P1|Period 2|Unsatisfactory Visual Response|1
289234|NCT01763047|973396|P2|Period 2|Study Site office Closed|1
289235|NCT01763047|973397|P1|Period 2|Study Site office Closed|1
289236|NCT01763047|973396|P2|Period 2|No longer meets Eligibility Criteria|0
289237|NCT01763047|973397|P1|Period 2|No longer meets Eligibility Criteria|1
289238|NCT01763047|973396|P2|Period 2|Lens Discomfort|0
289239|NCT01763047|973397|P1|Period 2|Lens Discomfort|1
289240|NCT01763047|973396|P2|Period 1|Study Site office Closed|1
289241|NCT01763047|973397|P1|Period 1|Study Site office Closed|0
289242|NCT01763047|973396|P2|Period 1|Lens Power Not Available|1
289243|NCT01763047|973397|P1|Period 1|Lens Power Not Available|0
289244|NCT01763047|973396|P2|Period 1|Unsatisfactory Visual Response|3
289245|NCT01763047|973397|P1|Period 1|Unsatisfactory Visual Response|0
289246|NCT01763047|973396|P2|Period 1|Adverse Event|1
289247|NCT01763047|973397|P1|Period 1|Adverse Event|0
289248|NCT01763047|973396|P2|Period 1|No Longer Meets Eligibility criteria|0
289249|NCT01763047|973397|P1|Period 1|No Longer Meets Eligibility criteria|1
289250|NCT01763047|973396|P2|Period 1|Protocol Violation|4
289251|NCT01763047|973397|P1|Period 1|Protocol Violation|4
289252|NCT01763047|973396|P2|Period 1|Test Article Not Available|1
289253|NCT01763047|973397|P1|Period 1|Test Article Not Available|4
289254|NCT01762943|973436|P2|Overall Study|Withdrawal by Subject|1
289255|NCT01762943|973437|P1|Overall Study|Withdrawal by Subject|2
289256|NCT01762943|973436|P2|Overall Study|Protocol Violation|0
289257|NCT01762943|973437|P1|Overall Study|Protocol Violation|1
289258|NCT01762943|973436|P2|Overall Study|Physician Decision|1
289259|NCT01762943|973437|P1|Overall Study|Physician Decision|1
289260|NCT01762800|973454|P2|Overall Study|Withdrawal by Subject|4
289261|NCT01762800|973455|P1|Overall Study|Withdrawal by Subject|7
289262|NCT01762800|973454|P2|Overall Study|Physician Decision|1
289263|NCT01762800|973455|P1|Overall Study|Physician Decision|1
289264|NCT01762800|973454|P2|Overall Study|Study Closed/Terminated|1
289265|NCT01762800|973455|P1|Overall Study|Study Closed/Terminated|0
289266|NCT01762800|973454|P2|Overall Study|Lack of Efficacy|2
289267|NCT01762800|973455|P1|Overall Study|Lack of Efficacy|3
289268|NCT01762800|973454|P2|Overall Study|Adverse Event|13
289269|NCT01762800|973455|P1|Overall Study|Adverse Event|8
289270|NCT01762761|973529|P2|Overall Study|Physician Decision|1
289271|NCT01762761|973530|P1|Overall Study|Physician Decision|0
289272|NCT01762761|973529|P2|Overall Study|Protocol Violation|1
289273|NCT01762761|973530|P1|Overall Study|Protocol Violation|0
289274|NCT01762761|973529|P2|Overall Study|Lack of Efficacy|0
289275|NCT01762761|973530|P1|Overall Study|Lack of Efficacy|1
289276|NCT01762761|973529|P2|Overall Study|Adverse Event|2
289277|NCT01762761|973530|P1|Overall Study|Adverse Event|1
289278|NCT01762345|973608|P1|Overall Study|Protocol Violation|2
289279|NCT01762345|973608|P1|Overall Study|Adverse Event|5
289280|NCT01761565|973656|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
289281|NCT01761162|973709|P1|Overall Study|Withdrawal by Subject|3
289282|NCT01760876|973801|P1|Overall Study|Very poor baseline OCT quality|2
289283|NCT01760876|973801|P1|Overall Study|Major depression|1
289284|NCT01760876|973801|P1|Overall Study|Impaired renal function|1
289285|NCT01760876|973801|P1|Overall Study|Carcinoma of prostate|1
289286|NCT01760876|973801|P1|Overall Study|Non-cardiac death (head injury)|1
289287|NCT01759511|973856|P1|Overall Study|Withdrawal by Subject|3
289288|NCT01759511|973856|P1|Overall Study|Study Terminated by Sponsor|13
289289|NCT01759511|973856|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
289290|NCT01759511|973856|P1|Overall Study|Progressive Disease|5
289291|NCT01759511|973856|P1|Overall Study|Physician Decision|1
289292|NCT01759511|973856|P1|Overall Study|Lack of Efficacy|2
289293|NCT01759511|973856|P1|Overall Study|Death|2
289294|NCT01759511|973856|P1|Overall Study|Adverse Event|4
289295|NCT01759420|973864|P1|Overall Study|Inaccurate EKG machine readings|1
289296|NCT01759420|973864|P1|Overall Study|Screen failure|5
289297|NCT01759407|973871|P2|Overall Study|Protocol Violation|2
289298|NCT01759407|973872|P1|Overall Study|Protocol Violation|0
289299|NCT01759381|973884|P2|Overall Study|Death|0
289300|NCT01759381|973885|P1|Overall Study|Death|1
289301|NCT01759368|973893|P2|Overall Study|Lost to Follow-up|0
289302|NCT01759368|973894|P1|Overall Study|Lost to Follow-up|1
289303|NCT01759290|973912|P1|Overall Study|Unknown reason|4
289304|NCT01759290|973912|P1|Overall Study|Lost to Follow-up|53
289305|NCT01759290|973912|P1|Overall Study|Death|17
289306|NCT01759290|973912|P1|Overall Study|Physician Decision|2
289307|NCT01759290|973912|P1|Overall Study|Subjects withdrawn consent|5
289308|NCT01759264|973972|P1|Overall Study|Discontinued Humira Due to Business Trip|1
289309|NCT01759264|973972|P1|Overall Study|Withdrawal by Subject|3
289310|NCT01759264|973972|P1|Overall Study|Lost to Follow-up|2
289311|NCT01759264|973972|P1|Overall Study|Not Specified|2
289312|NCT01759264|973972|P1|Overall Study|Adverse Event|1
289313|NCT01759264|973972|P1|Overall Study|Serious Adverse Events (SAEs)|1
289314|NCT01758900|974000|P2|Overall Study|difficulty for further intubation|8
289315|NCT01758900|974001|P1|Overall Study|difficulty for further intubation|7
289316|NCT01758289|974019|P1|Overall Study|Adverse Event|9
289317|NCT01758289|974019|P1|Overall Study|Premature Study Termination|44
289318|NCT01757847|974045|P2|Overall Study|Withdrawal by Subject|4
289319|NCT01757847|974046|P1|Overall Study|Withdrawal by Subject|3
289320|NCT01757821|974054|P1|Overall Study|Adverse Event|1
289321|NCT01757704|974069|P2|Overall Study|Protocol Violation|3
289322|NCT01757704|974070|P1|Overall Study|Protocol Violation|1
289323|NCT01757691|974088|P2|Overall Study|Administrative problems|0
289324|NCT01757691|974089|P1|Overall Study|Administrative problems|2
289325|NCT01757405|974137|P2|Overall Study|Withdrawal by Subject|1
289326|NCT01757405|974138|P1|Overall Study|Withdrawal by Subject|0
289327|NCT01757405|974137|P2|Overall Study|Lost to Follow-up|1
289328|NCT01757405|974138|P1|Overall Study|Lost to Follow-up|1
289329|NCT01757275|974156|P2|Overall Study|Not treated|4
289330|NCT01757275|974157|P1|Overall Study|Not treated|3
289331|NCT01757275|974156|P2|Overall Study|Withdrawal by Subject|4
289332|NCT01757275|974157|P1|Overall Study|Withdrawal by Subject|2
289333|NCT01757275|974156|P2|Overall Study|Adverse Event|3
289334|NCT01757275|974157|P1|Overall Study|Adverse Event|3
289335|NCT01757275|974156|P2|Overall Study|Lost to Follow-up|2
289336|NCT01757275|974157|P1|Overall Study|Lost to Follow-up|1
289337|NCT01757197|974179|P1|Overall Study|Death|2
289338|NCT01757184|974188|P2|Double-Blind Period|Adverse Event|0
289339|NCT01757184|974189|P1|Double-Blind Period|Adverse Event|1
289340|NCT01757171|974213|P2|Overall Study|ECOG decline|0
289341|NCT01757171|974214|P1|Overall Study|ECOG decline|1
289342|NCT01757171|974213|P2|Overall Study|Hospitalization|0
289343|NCT01757171|974214|P1|Overall Study|Hospitalization|1
289344|NCT01757171|974213|P2|Overall Study|Disease Progression|0
289345|NCT01757171|974214|P1|Overall Study|Disease Progression|1
289346|NCT01757171|974213|P2|Overall Study|Adverse Event|1
289347|NCT01757171|974214|P1|Overall Study|Adverse Event|5
289348|NCT01756300|974248|P1|Overall Study|Withdrawal by Subject|1
289349|NCT01756300|974248|P1|Overall Study|Death|1
289350|NCT01756274|974270|P1|Overall Study|Laboratory error|1
289351|NCT01756274|974270|P1|Overall Study|Protocol Violation|2
289352|NCT01756235|974277|P1|Overall Study|Adalimumab Treatment was not Documented|2
289353|NCT01756157|974298|P2|First Intervention Period|Lost to Follow-up|2
289354|NCT01756157|974299|P1|First Intervention Period|Lost to Follow-up|0
289355|NCT01756157|974298|P2|First Intervention Period|Withdrawal by Subject|0
289356|NCT01756157|974299|P1|First Intervention Period|Withdrawal by Subject|1
289357|NCT01756079|974313|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
289358|NCT01756079|974313|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
289359|NCT01756079|974313|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
289360|NCT01756079|974313|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
289361|NCT01756079|974313|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
289362|NCT01756053|974319|P2|Period 2 (10 Days)|Protocol Violation|2
289363|NCT01756053|974320|P1|Period 2 (10 Days)|Protocol Violation|0
289364|NCT01756053|974319|P2|Period 1 (10 Days)|Protocol Violation|1
289365|NCT01756053|974320|P1|Period 1 (10 Days)|Protocol Violation|1
289366|NCT01755702|974340|P1|Washout Period II|Other Reason|5
289367|NCT01755702|974340|P1|Wash Out Period I|Other Reason|3
289368|NCT01755637|974382|P2|Period 1|Adverse Event|1
289369|NCT01755637|974383|P1|Period 1|Adverse Event|0
289370|NCT01755234|974416|P2|Overall Study|unblinded|0
289371|NCT01755234|974417|P1|Overall Study|unblinded|1
289372|NCT01755234|974416|P2|Overall Study|Withdrawal by Subject|1
289373|NCT01755234|974417|P1|Overall Study|Withdrawal by Subject|0
289374|NCT01755234|974416|P2|Overall Study|case cancelled|0
289375|NCT01755234|974417|P1|Overall Study|case cancelled|1
289376|NCT01755234|974416|P2|Overall Study|Change in surgical case|1
289377|NCT01755234|974417|P1|Overall Study|Change in surgical case|2
289378|NCT01755234|974416|P2|Overall Study|Lost to Follow-up|6
289379|NCT01755234|974417|P1|Overall Study|Lost to Follow-up|11
289380|NCT01755156|974448|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
289381|NCT01755156|974449|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
289382|NCT01755156|974448|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
289383|NCT01755156|974449|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
289384|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
289385|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
289386|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
289387|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
289388|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
289389|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
289390|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Protocol Violation|1
289391|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Protocol Violation|1
289392|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Physician Decision|1
289393|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Physician Decision|0
289394|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
289395|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
289396|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
289397|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
289398|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
289399|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
289400|NCT01755156|974448|P2|Phase A (Weeks 0-24)|Adverse Event|3
289401|NCT01755156|974449|P1|Phase A (Weeks 0-24)|Adverse Event|2
289402|NCT01755091|974513|P3|Overall Study|Physician Decision|2
289403|NCT01755091|974514|P2|Overall Study|Physician Decision|1
289404|NCT01755091|974515|P1|Overall Study|Physician Decision|1
289405|NCT01755091|974513|P3|Overall Study|Lost to Follow-up|1
289406|NCT01755091|974514|P2|Overall Study|Lost to Follow-up|0
289407|NCT01755091|974515|P1|Overall Study|Lost to Follow-up|1
289408|NCT01755091|974513|P3|Overall Study|Adverse Event|1
289409|NCT01755091|974514|P2|Overall Study|Adverse Event|1
289410|NCT01755091|974515|P1|Overall Study|Adverse Event|1
289411|NCT01755091|974513|P3|Overall Study|Withdrawal by Subject|3
289412|NCT01755091|974514|P2|Overall Study|Withdrawal by Subject|1
289413|NCT01755091|974515|P1|Overall Study|Withdrawal by Subject|6
289414|NCT01755026|974540|P2|Overall Study|Withdrawal by Subject|1
289415|NCT01755026|974541|P1|Overall Study|Withdrawal by Subject|1
289416|NCT01755026|974540|P2|Overall Study|Adverse Event|0
289417|NCT01755026|974541|P1|Overall Study|Adverse Event|1
289418|NCT01754922|974549|P2|Overall Study|Adverse Event|1
289419|NCT01754922|974550|P1|Overall Study|Adverse Event|0
289420|NCT01754766|974563|P3|Overall Study|Personal reasons|0
289421|NCT01754766|974564|P2|Overall Study|Personal reasons|1
289422|NCT01754766|974565|P1|Overall Study|Personal reasons|1
289423|NCT01754727|974579|P1|Overall Study|Adalimumab Treatment was not Documented|2
289424|NCT01754493|974706|P1|Overall Study|Scheduling conflict|1
289425|NCT01754493|974706|P1|Overall Study|Moved out of town|1
289426|NCT01754493|974706|P1|Overall Study|Withdrawal by Subject|1
289427|NCT01754493|974706|P1|Overall Study|Lost to Follow-up|3
289428|NCT01754493|974706|P1|Overall Study|Adverse Event|1
289429|NCT01754467|974731|P1|Overall Study|Lost to Follow-up|1
289430|NCT01754402|974741|P3|Overall Study|Lack of Efficacy|1
289431|NCT01754402|974742|P2|Overall Study|Lack of Efficacy|0
289432|NCT01754402|974743|P1|Overall Study|Lack of Efficacy|0
289433|NCT01754402|974741|P3|Overall Study|Withdrawal by Subject|1
289434|NCT01754402|974742|P2|Overall Study|Withdrawal by Subject|0
289435|NCT01754402|974743|P1|Overall Study|Withdrawal by Subject|0
289436|NCT01754402|974741|P3|Overall Study|Adverse Event|1
289437|NCT01754402|974742|P2|Overall Study|Adverse Event|2
289438|NCT01754402|974743|P1|Overall Study|Adverse Event|2
289439|NCT01754402|974741|P3|Overall Study|Death|1
289440|NCT01754402|974742|P2|Overall Study|Death|0
289441|NCT01754402|974743|P1|Overall Study|Death|0
289442|NCT01754376|974777|P1|Overall Study|Lack of Efficacy|2
289443|NCT01754376|974777|P1|Overall Study|Adverse Event|1
289444|NCT01754259|974788|P2|Overall Study|Lost to Follow-up|1
289445|NCT01754259|974789|P1|Overall Study|Lost to Follow-up|0
289446|NCT01754259|974788|P2|Overall Study|Adverse Event|1
289447|NCT01754259|974789|P1|Overall Study|Adverse Event|3
289448|NCT01754259|974788|P2|Overall Study|Withdrawal by Subject|4
289449|NCT01754259|974789|P1|Overall Study|Withdrawal by Subject|2
289450|NCT01754194|974799|P2|Overall Study|Not Specified|8
289451|NCT01754194|974800|P1|Overall Study|Not Specified|9
289452|NCT01754194|974799|P2|Overall Study|Withdrawal by Subject|5
289453|NCT01754194|974800|P1|Overall Study|Withdrawal by Subject|4
289454|NCT01754194|974799|P2|Overall Study|Lost to Follow-up|14
289455|NCT01754194|974800|P1|Overall Study|Lost to Follow-up|39
289456|NCT01753856|974822|P2|Overall Study|Sponsor Decision|0
289457|NCT01753856|974823|P1|Overall Study|Sponsor Decision|2
289458|NCT01753856|974822|P2|Overall Study|Withdrawal by Subject|2
289459|NCT01753856|974823|P1|Overall Study|Withdrawal by Subject|0
289460|NCT01753856|974822|P2|Overall Study|Adverse Event|0
289461|NCT01753856|974823|P1|Overall Study|Adverse Event|1
289462|NCT01753518|974913|P2|Postpartum Follow-up|Lost to Follow-up|15
289463|NCT01753518|974914|P1|Postpartum Follow-up|Lost to Follow-up|22
289464|NCT01753518|974913|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
289465|NCT01753518|974914|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
289466|NCT01753518|974913|P2|Intention-to-Treat Analysis|Multifetal gestation|3
289467|NCT01753518|974914|P1|Intention-to-Treat Analysis|Multifetal gestation|2
289468|NCT01753518|974913|P2|Intention-to-Treat Analysis|Missing consent form|3
289469|NCT01753518|974914|P1|Intention-to-Treat Analysis|Missing consent form|5
289470|NCT01753336|974936|P1|Overall Study|Withdrawal by Subject|1
289471|NCT01753336|974936|P1|Overall Study|Sponsor's decision|2
289472|NCT01753336|974936|P1|Overall Study|Physician Decision|2
289473|NCT01753336|974936|P1|Overall Study|Lost to Follow-up|3
289474|NCT01753336|974936|P1|Overall Study|Patient decision|12
289475|NCT01753323|974948|P3|Overall Study|Adverse Event|1
289476|NCT01753323|974949|P2|Overall Study|Adverse Event|0
289477|NCT01753323|974950|P1|Overall Study|Adverse Event|0
289478|NCT01753323|974948|P3|Overall Study|Protocol deviation|0
289479|NCT01753323|974949|P2|Overall Study|Protocol deviation|0
289480|NCT01753323|974950|P1|Overall Study|Protocol deviation|1
289481|NCT01753323|974948|P3|Overall Study|Lack of Efficacy|8
289482|NCT01753323|974949|P2|Overall Study|Lack of Efficacy|0
289483|NCT01753323|974950|P1|Overall Study|Lack of Efficacy|0
289484|NCT01753310|974988|P2|Overall Study|Withdrawal by Subject|0
289485|NCT01753310|974989|P1|Overall Study|Withdrawal by Subject|1
289486|NCT01753310|974988|P2|Overall Study|Sponsor decision|0
289487|NCT01753310|974989|P1|Overall Study|Sponsor decision|1
289488|NCT01753310|974988|P2|Overall Study|Subject decision|2
289489|NCT01753310|974989|P1|Overall Study|Subject decision|2
289490|NCT01753310|974988|P2|Overall Study|Lost to Follow-up|0
289491|NCT01753310|974989|P1|Overall Study|Lost to Follow-up|2
289492|NCT01753310|974988|P2|Overall Study|Adverse Event|0
289493|NCT01753310|974989|P1|Overall Study|Adverse Event|1
289494|NCT01753310|974988|P2|Overall Study|Entered into open label extension study|22
289495|NCT01753310|974989|P1|Overall Study|Entered into open label extension study|25
289496|NCT01753115|975012|P3|Overall Study|Used excluded drug|0
289497|NCT01753115|975013|P2|Overall Study|Used excluded drug|1
289498|NCT01753115|975014|P1|Overall Study|Used excluded drug|0
289499|NCT01753115|975012|P3|Overall Study|Subject non-compliant|0
289500|NCT01753115|975013|P2|Overall Study|Subject non-compliant|3
289501|NCT01753115|975014|P1|Overall Study|Subject non-compliant|3
289502|NCT01753115|975012|P3|Overall Study|Withdrawal by Subject|6
289503|NCT01753115|975013|P2|Overall Study|Withdrawal by Subject|5
289504|NCT01753115|975014|P1|Overall Study|Withdrawal by Subject|6
289505|NCT01753115|975012|P3|Overall Study|Lost to Follow-up|8
289506|NCT01753115|975013|P2|Overall Study|Lost to Follow-up|6
289507|NCT01753115|975014|P1|Overall Study|Lost to Follow-up|3
289508|NCT01753076|975024|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
289509|NCT01753076|975025|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
289510|NCT01753076|975024|P2|Overall Study|Withdrawal by Subject|24
289511|NCT01753076|975025|P1|Overall Study|Withdrawal by Subject|14
289512|NCT01753076|975024|P2|Overall Study|Physician Decision|2
289513|NCT01753076|975025|P1|Overall Study|Physician Decision|4
289514|NCT01753076|975024|P2|Overall Study|Lost to Follow-up|1
289515|NCT01753076|975025|P1|Overall Study|Lost to Follow-up|2
289516|NCT01753076|975024|P2|Overall Study|Lack of Efficacy|1
289517|NCT01753076|975025|P1|Overall Study|Lack of Efficacy|3
289518|NCT01753076|975024|P2|Overall Study|Adverse Event|18
289519|NCT01753076|975025|P1|Overall Study|Adverse Event|17
289520|NCT01752907|975051|P2|Overall Study|Decision by Sponsor|9
289521|NCT01752907|975052|P1|Overall Study|Decision by Sponsor|6
289522|NCT01752907|975051|P2|Overall Study|Lost to Follow-up|1
289523|NCT01752907|975052|P1|Overall Study|Lost to Follow-up|2
289524|NCT01752907|975051|P2|Overall Study|Withdrawal by Subject|10
289525|NCT01752907|975052|P1|Overall Study|Withdrawal by Subject|4
289526|NCT01752855|975072|P2|Overall Study|Lack of Efficacy|2
289527|NCT01752855|975073|P1|Overall Study|Lack of Efficacy|0
289528|NCT01752855|975072|P2|Overall Study|Withdrew Consent|2
289529|NCT01752855|975073|P1|Overall Study|Withdrew Consent|0
289530|NCT01752855|975072|P2|Overall Study|Adverse Event|0
289531|NCT01752855|975073|P1|Overall Study|Adverse Event|1
289532|NCT01752023|975119|P2|Overall Study|Physician Decision|1
289533|NCT01752023|975120|P1|Overall Study|Physician Decision|2
289534|NCT01751867|975307|P2|Overall Study|Randomized but not treated.|1
289535|NCT01751867|975308|P1|Overall Study|Randomized but not treated.|2
289536|NCT01751867|975307|P2|Overall Study|Other|37
289537|NCT01751867|975308|P1|Overall Study|Other|11
289538|NCT01751867|975307|P2|Overall Study|Death|5
289539|NCT01751867|975308|P1|Overall Study|Death|0
289540|NCT01751867|975307|P2|Overall Study|Protocol Violation|2
289541|NCT01751867|975308|P1|Overall Study|Protocol Violation|0
289542|NCT01751867|975307|P2|Overall Study|Physician Decision|7
289543|NCT01751867|975308|P1|Overall Study|Physician Decision|4
289544|NCT01751867|975307|P2|Overall Study|Withdrawal by Subject|1
289545|NCT01751867|975308|P1|Overall Study|Withdrawal by Subject|3
289546|NCT01751867|975307|P2|Overall Study|Poor Compliance|5
289547|NCT01751867|975308|P1|Overall Study|Poor Compliance|0
289548|NCT01751867|975307|P2|Overall Study|Adverse Event|15
289549|NCT01751867|975308|P1|Overall Study|Adverse Event|8
289550|NCT01751867|975307|P2|Overall Study|Diease Progression|18
289551|NCT01751867|975308|P1|Overall Study|Diease Progression|4
289552|NCT01751867|975307|P2|Overall Study|Completed treatment,dropped in follow-up|8
289553|NCT01751867|975308|P1|Overall Study|Completed treatment,dropped in follow-up|4
289554|NCT01751802|975328|P2|Overall Study|Adverse Event|2
289555|NCT01751802|975329|P1|Overall Study|Adverse Event|4
289556|NCT01751724|975343|P2|Overall Study|withdrawn by parent|2
289557|NCT01751724|975344|P1|Overall Study|withdrawn by parent|0
289558|NCT01751724|975343|P2|Overall Study|extubated bef.start assigned treatment|0
289559|NCT01751724|975344|P1|Overall Study|extubated bef.start assigned treatment|1
289560|NCT01751412|975370|P1|Overall Study|Disease Progression Before Treatment|1
289561|NCT01751178|975438|P3|Overall Study|Other Reason (unknown)|2
289562|NCT01751178|975439|P2|Overall Study|Other Reason (unknown)|0
289563|NCT01751178|975440|P1|Overall Study|Other Reason (unknown)|1
289564|NCT01751178|975438|P3|Overall Study|Adverse Event|0
289565|NCT01751178|975439|P2|Overall Study|Adverse Event|0
289566|NCT01751178|975440|P1|Overall Study|Adverse Event|2
289567|NCT01751165|975460|P3|Overall Study|Lost to Follow-up|1
289568|NCT01751165|975461|P2|Overall Study|Lost to Follow-up|1
289569|NCT01751165|975462|P1|Overall Study|Lost to Follow-up|1
289570|NCT01751165|975460|P3|Overall Study|Serious adverse event|0
289571|NCT01751165|975461|P2|Overall Study|Serious adverse event|2
289572|NCT01751165|975462|P1|Overall Study|Serious adverse event|0
289573|NCT01751165|975460|P3|Overall Study|Withdrawal by Subject|1
289574|NCT01751165|975461|P2|Overall Study|Withdrawal by Subject|0
289575|NCT01751165|975462|P1|Overall Study|Withdrawal by Subject|0
289576|NCT01751165|975460|P3|Overall Study|Adverse event, serious fatal|1
289577|NCT01751165|975461|P2|Overall Study|Adverse event, serious fatal|0
289578|NCT01751165|975462|P1|Overall Study|Adverse event, serious fatal|1
289579|NCT01751113|975502|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
289580|NCT01751113|975503|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
289581|NCT01751113|975504|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
289582|NCT01751113|975505|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
289583|NCT01751113|975506|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
289584|NCT01751113|975507|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
289585|NCT01751113|975502|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
289586|NCT01751113|975503|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
289587|NCT01751113|975504|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
289588|NCT01751113|975505|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
289589|NCT01751113|975506|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
289590|NCT01751113|975507|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
289591|NCT01751087|975548|P3|Overall Study|Physician Decision|1
289592|NCT01751087|975549|P2|Overall Study|Physician Decision|0
289593|NCT01751087|975550|P1|Overall Study|Physician Decision|0
289594|NCT01751087|975548|P3|Overall Study|Withdrawal by Subject|0
289595|NCT01751087|975549|P2|Overall Study|Withdrawal by Subject|0
289596|NCT01751087|975550|P1|Overall Study|Withdrawal by Subject|1
289597|NCT01750840|975638|P1|Overall Study|Lost to Follow-up|4
289598|NCT01750684|975645|P2|Overall Study|Protocol Violation|0
289599|NCT01750684|975646|P1|Overall Study|Protocol Violation|1
289600|NCT01750684|975645|P2|Overall Study|Withdrawn by Sponsor|1
289601|NCT01750684|975646|P1|Overall Study|Withdrawn by Sponsor|0
289602|NCT01750684|975645|P2|Overall Study|Non-compliance with Study Drug|1
289603|NCT01750684|975646|P1|Overall Study|Non-compliance with Study Drug|0
289604|NCT01750684|975645|P2|Overall Study|Death|0
289605|NCT01750684|975646|P1|Overall Study|Death|1
289606|NCT01750346|975681|P3|Overall Study|Adverse Event|0
289607|NCT01750346|975682|P2|Overall Study|Adverse Event|0
289608|NCT01750346|975683|P1|Overall Study|Adverse Event|1
289609|NCT01750294|975709|P1|Overall Study|Safety Endpoint|1
289610|NCT01750294|975709|P1|Overall Study|Withdrawal by Subject|1
289611|NCT01750281|975716|P3|Overall Study|Did not receive treatment|0
289612|NCT01750281|975717|P2|Overall Study|Did not receive treatment|1
289613|NCT01750281|975718|P1|Overall Study|Did not receive treatment|0
289614|NCT01750281|975716|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
289615|NCT01750281|975717|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
289616|NCT01750281|975718|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
289617|NCT01750281|975716|P3|Overall Study|Discontinued Selumetinib/Placebo|75
289618|NCT01750281|975717|P2|Overall Study|Discontinued Selumetinib/Placebo|77
289619|NCT01750281|975718|P1|Overall Study|Discontinued Selumetinib/Placebo|37
289620|NCT01750242|975748|P1|Overall Study|Unreadable Images|3
289621|NCT01750229|975753|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
289622|NCT01750229|975753|P1|Long-term Follow-up Phase|Adverse Event|2
289623|NCT01750229|975753|P1|Randomized Crossover Phase|Withdrawal by Subject|1
289624|NCT01750229|975753|P1|Randomized Crossover Phase|Adverse Event|1
289625|NCT01749982|975776|P4|Overall Study|Withdrawal by Subject|1
289626|NCT01749982|975777|P3|Overall Study|Withdrawal by Subject|0
289627|NCT01749982|975778|P2|Overall Study|Withdrawal by Subject|0
289628|NCT01749982|975779|P1|Overall Study|Withdrawal by Subject|0
289629|NCT01749982|975776|P4|Overall Study|Lost to Follow-up|1
289630|NCT01749982|975777|P3|Overall Study|Lost to Follow-up|0
289631|NCT01749982|975778|P2|Overall Study|Lost to Follow-up|0
289632|NCT01749982|975779|P1|Overall Study|Lost to Follow-up|0
289633|NCT01749982|975776|P4|Overall Study|Physician Decision|1
289634|NCT01749982|975777|P3|Overall Study|Physician Decision|0
289635|NCT01749982|975778|P2|Overall Study|Physician Decision|0
289636|NCT01749982|975779|P1|Overall Study|Physician Decision|0
289637|NCT01749800|975810|P3|Overall Study|Withdrawal by Subject|0
289638|NCT01749800|975811|P2|Overall Study|Withdrawal by Subject|1
289639|NCT01749800|975812|P1|Overall Study|Withdrawal by Subject|0
289640|NCT01749800|975810|P3|Overall Study|not meeting inclusion criteria|0
289641|NCT01749800|975811|P2|Overall Study|not meeting inclusion criteria|0
289642|NCT01749800|975812|P1|Overall Study|not meeting inclusion criteria|3
289643|NCT01749735|975822|P2|Overall Study|Withdrawal by Subject|0
289644|NCT01749735|975823|P1|Overall Study|Withdrawal by Subject|1
289645|NCT01748890|975912|P1|Overall Study|Insufficient recruitment for analysis|4
289646|NCT01748760|975967|P2|Overall Study|Lost to Follow-up|1
289647|NCT01748760|975968|P1|Overall Study|Lost to Follow-up|5
289648|NCT01748760|975967|P2|Overall Study|Withdrawal by Subject|1
289649|NCT01748760|975968|P1|Overall Study|Withdrawal by Subject|1
289650|NCT01748292|976004|P2|Overall Study|Withdrawal by Subject|2
289651|NCT01748292|976005|P1|Overall Study|Withdrawal by Subject|0
289652|NCT01748292|976004|P2|Overall Study|Death|3
289653|NCT01748292|976005|P1|Overall Study|Death|0
289654|NCT01748292|976004|P2|Overall Study|Lost to Follow-up|3
289655|NCT01748292|976005|P1|Overall Study|Lost to Follow-up|0
289656|NCT01748292|976004|P2|Overall Study|Adverse Event|4
289657|NCT01748292|976005|P1|Overall Study|Adverse Event|2
289658|NCT01748162|976031|P2|Overall Study|reasons not available|2
289659|NCT01748162|976032|P1|Overall Study|reasons not available|3
289660|NCT01748162|976031|P2|Overall Study|participant consented but did not begin|1
289661|NCT01748162|976032|P1|Overall Study|participant consented but did not begin|0
289662|NCT01748162|976031|P2|Overall Study|no additional croup episodes to evaluate|2
289663|NCT01748162|976032|P1|Overall Study|no additional croup episodes to evaluate|2
289664|NCT01748071|976043|P3|Overall Study|Adverse Event|0
289665|NCT01748071|976044|P2|Overall Study|Adverse Event|2
289666|NCT01748071|976045|P1|Overall Study|Adverse Event|2
289667|NCT01747811|976332|P2|Overall Study|Lack of Efficacy|4
289668|NCT01747811|976333|P1|Overall Study|Lack of Efficacy|2
289669|NCT01747772|976349|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
289670|NCT01747655|976357|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
289671|NCT01747655|976358|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
289672|NCT01747655|976357|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
289673|NCT01747655|976358|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
289674|NCT01747655|976357|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
289675|NCT01747655|976358|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
289676|NCT01747629|976388|P2|Overall Study|Not specified|1
289677|NCT01747629|976389|P1|Overall Study|Not specified|2
289678|NCT01747629|976388|P2|Overall Study|Not treated|0
289679|NCT01747629|976389|P1|Overall Study|Not treated|1
289680|NCT01747629|976388|P2|Overall Study|Inclusion criteria not met|0
289681|NCT01747629|976389|P1|Overall Study|Inclusion criteria not met|1
289682|NCT01747629|976388|P2|Overall Study|Noncompliance|1
289683|NCT01747629|976389|P1|Overall Study|Noncompliance|1
289684|NCT01747629|976388|P2|Overall Study|Withdrawal by Subject|2
289685|NCT01747629|976389|P1|Overall Study|Withdrawal by Subject|2
289686|NCT01747629|976388|P2|Overall Study|Adverse Event|2
289687|NCT01747629|976389|P1|Overall Study|Adverse Event|1
289688|NCT01747551|976423|P2|Overall Study|Other|0
289689|NCT01747551|976424|P1|Overall Study|Other|2
289690|NCT01747551|976423|P2|Overall Study|Physician Decision|1
289691|NCT01747551|976424|P1|Overall Study|Physician Decision|2
289692|NCT01747551|976423|P2|Overall Study|Withdrawal by Subject|1
289693|NCT01747551|976424|P1|Overall Study|Withdrawal by Subject|3
289694|NCT01747551|976423|P2|Overall Study|Prolonged Treatment Delay|0
289695|NCT01747551|976424|P1|Overall Study|Prolonged Treatment Delay|2
289696|NCT01747551|976423|P2|Overall Study|Adverse Event|1
289697|NCT01747551|976424|P1|Overall Study|Adverse Event|7
289698|NCT01747551|976423|P2|Overall Study|Death|1
289699|NCT01747551|976424|P1|Overall Study|Death|3
289700|NCT01747551|976423|P2|Overall Study|Progressive Disease|17
289701|NCT01747551|976424|P1|Overall Study|Progressive Disease|24
289702|NCT01746862|976482|P2|Overall Study|Entered puberty during the study|0
289703|NCT01746862|976483|P1|Overall Study|Entered puberty during the study|1
289704|NCT01746862|976482|P2|Overall Study|Consent withdrawal by parent’s guardian|2
289705|NCT01746862|976483|P1|Overall Study|Consent withdrawal by parent’s guardian|5
289706|NCT01746862|976482|P2|Overall Study|Protocol Violation|0
289707|NCT01746862|976483|P1|Overall Study|Protocol Violation|1
289708|NCT01746862|976482|P2|Overall Study|Withdrawal by Subject|1
289709|NCT01746862|976483|P1|Overall Study|Withdrawal by Subject|1
289710|NCT01746368|976553|P2|Overall Study|Withdrawal by Subject|1
289711|NCT01746368|976554|P1|Overall Study|Withdrawal by Subject|0
289712|NCT01746368|976553|P2|Overall Study|Lost to Follow-up|0
289713|NCT01746368|976554|P1|Overall Study|Lost to Follow-up|2
289714|NCT01746173|976581|P1|Overall Study|Disease Progression|2
289715|NCT01746108|976589|P3|Overall Study|Lost to Follow-up|0
289716|NCT01746108|976590|P2|Overall Study|Lost to Follow-up|1
289717|NCT01746108|976591|P1|Overall Study|Lost to Follow-up|0
289718|NCT01746108|976589|P3|Overall Study|Withdrawal by Subject|0
289719|NCT01746108|976590|P2|Overall Study|Withdrawal by Subject|1
289720|NCT01746108|976591|P1|Overall Study|Withdrawal by Subject|0
289721|NCT01746108|976589|P3|Overall Study|Adverse event, non-fatal|0
289722|NCT01746108|976590|P2|Overall Study|Adverse event, non-fatal|1
289723|NCT01746108|976591|P1|Overall Study|Adverse event, non-fatal|0
289724|NCT01746108|976589|P3|Overall Study|Migrated /moved from study area|0
289725|NCT01746108|976590|P2|Overall Study|Migrated /moved from study area|1
289726|NCT01746108|976591|P1|Overall Study|Migrated /moved from study area|0
289727|NCT01745848|976689|P1|Overall Study|Adverse Event|6
289728|NCT01745380|976696|P2|Overall Study|Lack of Efficacy|1
289729|NCT01745380|976697|P1|Overall Study|Lack of Efficacy|0
289730|NCT01745380|976696|P2|Overall Study|Lost to Follow-up|0
289731|NCT01745380|976697|P1|Overall Study|Lost to Follow-up|1
289732|NCT01745094|976750|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
289733|NCT01745094|976751|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
289734|NCT01745094|976752|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
289735|NCT01745094|976753|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
289736|NCT01745094|976750|P4|Overall Study|Show no Stable Solifenacin Intake|0
289737|NCT01745094|976751|P3|Overall Study|Show no Stable Solifenacin Intake|1
289738|NCT01745094|976752|P2|Overall Study|Show no Stable Solifenacin Intake|0
289739|NCT01745094|976753|P1|Overall Study|Show no Stable Solifenacin Intake|0
289740|NCT01745094|976750|P4|Overall Study|Need Further Examinations Due to Biopsy|0
289741|NCT01745094|976751|P3|Overall Study|Need Further Examinations Due to Biopsy|1
289742|NCT01745094|976752|P2|Overall Study|Need Further Examinations Due to Biopsy|0
289743|NCT01745094|976753|P1|Overall Study|Need Further Examinations Due to Biopsy|0
289744|NCT01745094|976750|P4|Overall Study|Protocol Violation|1
289745|NCT01745094|976751|P3|Overall Study|Protocol Violation|3
289746|NCT01745094|976752|P2|Overall Study|Protocol Violation|0
289747|NCT01745094|976753|P1|Overall Study|Protocol Violation|1
289748|NCT01745094|976750|P4|Overall Study|Withdrawal by Subject|2
289749|NCT01745094|976751|P3|Overall Study|Withdrawal by Subject|1
289750|NCT01745094|976752|P2|Overall Study|Withdrawal by Subject|0
289751|NCT01745094|976753|P1|Overall Study|Withdrawal by Subject|2
289752|NCT01745094|976750|P4|Overall Study|Adverse Event|0
289753|NCT01745094|976751|P3|Overall Study|Adverse Event|3
289754|NCT01745094|976752|P2|Overall Study|Adverse Event|0
289755|NCT01745094|976753|P1|Overall Study|Adverse Event|0
289756|NCT01745094|976750|P4|Overall Study|Not Meeting the Eligibility Criteria|0
289757|NCT01745094|976751|P3|Overall Study|Not Meeting the Eligibility Criteria|3
289758|NCT01745094|976752|P2|Overall Study|Not Meeting the Eligibility Criteria|0
289759|NCT01745094|976753|P1|Overall Study|Not Meeting the Eligibility Criteria|1
289760|NCT01744977|976854|P2|Overall Study|No longer meets inclusion|0
289761|NCT01744977|976855|P1|Overall Study|No longer meets inclusion|6
289762|NCT01744977|976854|P2|Overall Study|Lost to Follow-up|0
289763|NCT01744977|976855|P1|Overall Study|Lost to Follow-up|2
289764|NCT01744977|976854|P2|Overall Study|Death|3
289765|NCT01744977|976855|P1|Overall Study|Death|2
289766|NCT01744977|976854|P2|Overall Study|Withdrawal by Subject|2
289767|NCT01744977|976855|P1|Overall Study|Withdrawal by Subject|1
289768|NCT01744782|976926|P1|Overall Study|Death|1
289769|NCT01744691|976986|P1|Overall Study|Physician Decision|4
289770|NCT01744691|976986|P1|Overall Study|Withdrawal of consent for treatment|3
289771|NCT01744691|976986|P1|Overall Study|Unacceptable toxicity, AE or death|18
289772|NCT01744691|976986|P1|Overall Study|Progressive Disease|18
289773|NCT01744496|976993|P2|Maintenance Period|Subject left town|0
289774|NCT01744496|976994|P1|Maintenance Period|Subject left town|1
289775|NCT01744496|976993|P2|Maintenance Period|Withdrawal by Subject|1
289776|NCT01744496|976994|P1|Maintenance Period|Withdrawal by Subject|1
289777|NCT01744496|976993|P2|Maintenance Period|Protocol Violation|0
289778|NCT01744496|976994|P1|Maintenance Period|Protocol Violation|1
289779|NCT01744496|976993|P2|Maintenance Period|Adverse Event|3
289780|NCT01744496|976994|P1|Maintenance Period|Adverse Event|1
289781|NCT01744496|976993|P2|Titration Period|Personal reasons|1
289782|NCT01744496|976994|P1|Titration Period|Personal reasons|0
289783|NCT01744496|976993|P2|Titration Period|Adverse Event|1
289784|NCT01744496|976994|P1|Titration Period|Adverse Event|2
289785|NCT01744483|977015|P3|Overall Study|Routed to OSH|1
289786|NCT01744483|977016|P2|Overall Study|Routed to OSH|0
289787|NCT01744483|977017|P1|Overall Study|Routed to OSH|2
289788|NCT01744483|977015|P3|Overall Study|No ICU Admit|2
289789|NCT01744483|977016|P2|Overall Study|No ICU Admit|1
289790|NCT01744483|977017|P1|Overall Study|No ICU Admit|5
289791|NCT01744483|977015|P3|Overall Study|Withdrawal by Subject|2
289792|NCT01744483|977016|P2|Overall Study|Withdrawal by Subject|6
289793|NCT01744483|977017|P1|Overall Study|Withdrawal by Subject|4
289794|NCT01744483|977015|P3|Overall Study|Protocol Violation|1
289795|NCT01744483|977016|P2|Overall Study|Protocol Violation|2
289796|NCT01744483|977017|P1|Overall Study|Protocol Violation|1
289797|NCT01744483|977015|P3|Overall Study|Lost to Follow-up|11
289798|NCT01744483|977016|P2|Overall Study|Lost to Follow-up|9
289799|NCT01744483|977017|P1|Overall Study|Lost to Follow-up|8
289800|NCT01744483|977015|P3|Overall Study|Death|11
289801|NCT01744483|977016|P2|Overall Study|Death|4
289802|NCT01744483|977017|P1|Overall Study|Death|9
289803|NCT01744392|977025|P1|Overall Study|Physician Decision|1
289804|NCT01744197|977065|P2|Overall Study|No patch received|2
289805|NCT01744197|977066|P1|Overall Study|No patch received|2
289806|NCT01744197|977065|P2|Overall Study|Received 1 patch|1
289807|NCT01744197|977066|P1|Overall Study|Received 1 patch|2
289808|NCT01743469|977157|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
289809|NCT01743469|977158|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
289810|NCT01743469|977159|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
289811|NCT01743469|977160|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
289812|NCT01743469|977157|P4|Follow-up Period - Post-Treatment|Death|16
289813|NCT01743469|977158|P3|Follow-up Period - Post-Treatment|Death|22
289814|NCT01743469|977159|P2|Follow-up Period - Post-Treatment|Death|47
289815|NCT01743469|977160|P1|Follow-up Period - Post-Treatment|Death|43
289816|NCT01743469|977157|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
289817|NCT01743469|977158|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
289818|NCT01743469|977159|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
289819|NCT01743469|977160|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
289820|NCT01743469|977157|P4|Active Treatment Phase|Missing|0
289821|NCT01743469|977158|P3|Active Treatment Phase|Missing|0
289822|NCT01743469|977159|P2|Active Treatment Phase|Missing|0
289823|NCT01743469|977160|P1|Active Treatment Phase|Missing|1
289824|NCT01743469|977157|P4|Active Treatment Phase|Withdrawal by Subject|0
289825|NCT01743469|977158|P3|Active Treatment Phase|Withdrawal by Subject|0
289826|NCT01743469|977159|P2|Active Treatment Phase|Withdrawal by Subject|3
289827|NCT01743469|977160|P1|Active Treatment Phase|Withdrawal by Subject|2
289828|NCT01743469|977157|P4|Active Treatment Phase|Disease Progression|20
289829|NCT01743469|977158|P3|Active Treatment Phase|Disease Progression|30
289830|NCT01743469|977159|P2|Active Treatment Phase|Disease Progression|47
289831|NCT01743469|977160|P1|Active Treatment Phase|Disease Progression|40
289832|NCT01743469|977157|P4|Active Treatment Phase|Adverse Event|1
289833|NCT01743469|977158|P3|Active Treatment Phase|Adverse Event|8
289834|NCT01743469|977159|P2|Active Treatment Phase|Adverse Event|5
289835|NCT01743469|977160|P1|Active Treatment Phase|Adverse Event|10
289836|NCT01743092|977200|P2|Overall Study|Lost to Follow-up|15
289837|NCT01743092|977201|P1|Overall Study|Lost to Follow-up|14
289838|NCT01743027|977213|P4|Overall Study|Withdrawal by Subject|1
289839|NCT01743027|977214|P3|Overall Study|Withdrawal by Subject|3
289840|NCT01743027|977215|P2|Overall Study|Withdrawal by Subject|0
289841|NCT01743027|977216|P1|Overall Study|Withdrawal by Subject|1
289842|NCT01743027|977213|P4|Overall Study|Protocol Violation|0
289843|NCT01743027|977214|P3|Overall Study|Protocol Violation|1
289844|NCT01743027|977215|P2|Overall Study|Protocol Violation|1
289845|NCT01743027|977216|P1|Overall Study|Protocol Violation|1
289846|NCT01743027|977213|P4|Overall Study|Progressive Disease|0
289847|NCT01743027|977214|P3|Overall Study|Progressive Disease|3
289848|NCT01743027|977215|P2|Overall Study|Progressive Disease|4
289849|NCT01743027|977216|P1|Overall Study|Progressive Disease|1
289850|NCT01743027|977213|P4|Overall Study|Lost to Follow-up|0
289851|NCT01743027|977214|P3|Overall Study|Lost to Follow-up|2
289852|NCT01743027|977215|P2|Overall Study|Lost to Follow-up|0
289853|NCT01743027|977216|P1|Overall Study|Lost to Follow-up|0
289854|NCT01743027|977213|P4|Overall Study|Adverse Event|0
289855|NCT01743027|977214|P3|Overall Study|Adverse Event|0
289856|NCT01743027|977215|P2|Overall Study|Adverse Event|0
289857|NCT01743027|977216|P1|Overall Study|Adverse Event|2
289858|NCT01743001|977256|P2|Overall Study|Death|0
289859|NCT01743001|977257|P1|Overall Study|Death|1
289860|NCT01743001|977256|P2|Overall Study|Pregnancy|0
289861|NCT01743001|977257|P1|Overall Study|Pregnancy|1
289862|NCT01743001|977256|P2|Overall Study|Physician Decision|0
289863|NCT01743001|977257|P1|Overall Study|Physician Decision|1
289864|NCT01742897|977280|P1|Overall Study|Other|1
289865|NCT01742897|977280|P1|Overall Study|Withdrawal by Subject|1
289866|NCT01742897|977280|P1|Overall Study|Adverse Event|3
289867|NCT01741792|977329|P3|Overall Study|Death|12
289868|NCT01741792|977330|P2|Overall Study|Death|1
289869|NCT01741792|977331|P1|Overall Study|Death|6
289870|NCT01741701|977398|P2|Overall Study|Withdrawal by Subject|1
289871|NCT01741701|977399|P1|Overall Study|Withdrawal by Subject|0
289872|NCT01741701|977398|P2|Overall Study|Adverse Event|1
289873|NCT01741701|977399|P1|Overall Study|Adverse Event|5
289874|NCT01741688|977415|P1|Overall Study|Withdrawal by Subject|1
289875|NCT01741688|977415|P1|Overall Study|Lack of insurance coverage|2
289876|NCT01741259|977588|P2|Overall Study|Withdrawal by Subject|2
289877|NCT01741259|977589|P1|Overall Study|Withdrawal by Subject|0
289878|NCT01741259|977588|P2|Overall Study|Protocol Violation|4
289879|NCT01741259|977589|P1|Overall Study|Protocol Violation|6
289880|NCT01740440|977708|P1|Overall Study|Lost to Follow-up|3
289881|NCT01740427|977716|P2|Overall Study|Study terminated by Sponsor|0
289882|NCT01740427|977717|P1|Overall Study|Study terminated by Sponsor|1
289883|NCT01740427|977716|P2|Overall Study|Lost to Follow-up|0
289884|NCT01740427|977717|P1|Overall Study|Lost to Follow-up|1
289885|NCT01740427|977716|P2|Overall Study|Protocol Violation|3
289886|NCT01740427|977717|P1|Overall Study|Protocol Violation|5
289887|NCT01740427|977716|P2|Overall Study|Death|2
289888|NCT01740427|977717|P1|Overall Study|Death|6
289889|NCT01740427|977716|P2|Overall Study|Unspecified reasons|4
289890|NCT01740427|977717|P1|Overall Study|Unspecified reasons|6
289891|NCT01740427|977716|P2|Overall Study|Subject refused continued treatment|9
289892|NCT01740427|977717|P1|Overall Study|Subject refused continued treatment|12
289893|NCT01740427|977716|P2|Overall Study|Global deterioration of health status|9
289894|NCT01740427|977717|P1|Overall Study|Global deterioration of health status|16
289895|NCT01740427|977716|P2|Overall Study|Adverse Event|9
289896|NCT01740427|977717|P1|Overall Study|Adverse Event|20
289897|NCT01740427|977716|P2|Overall Study|Objective progression or relapse|125
289898|NCT01740427|977717|P1|Overall Study|Objective progression or relapse|172
289899|NCT01740427|977716|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
289900|NCT01740427|977717|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
289901|NCT01740401|977769|P1|Overall Study|Did not reach primary endpoint|2
289902|NCT01740401|977769|P1|Overall Study|Adverse Event|2
289903|NCT01740401|977769|P1|Overall Study|Progression of disease|6
289904|NCT01740388|977778|P2|Overall Study|Subjects missing data, completed|36
289905|NCT01740388|977779|P1|Overall Study|Subjects missing data, completed|41
289906|NCT01740388|977778|P2|Overall Study|Physician Decision|6
289907|NCT01740388|977779|P1|Overall Study|Physician Decision|2
289908|NCT01740388|977778|P2|Overall Study|Lost to Follow-up|0
289909|NCT01740388|977779|P1|Overall Study|Lost to Follow-up|2
289910|NCT01740388|977778|P2|Overall Study|Withdrawal by Subject|2
289911|NCT01740388|977779|P1|Overall Study|Withdrawal by Subject|1
289912|NCT01740297|977831|P3|Overall Study|Sponsor Decision|0
289913|NCT01740297|977832|P2|Overall Study|Sponsor Decision|1
289914|NCT01740297|977833|P1|Overall Study|Sponsor Decision|0
289915|NCT01740297|977831|P3|Overall Study|Death|19
289916|NCT01740297|977832|P2|Overall Study|Death|23
289917|NCT01740297|977833|P1|Overall Study|Death|8
289918|NCT01740297|977831|P3|Overall Study|Withdrawal by Subject|11
289919|NCT01740297|977832|P2|Overall Study|Withdrawal by Subject|9
289920|NCT01740297|977833|P1|Overall Study|Withdrawal by Subject|1
289921|NCT01740297|977831|P3|Overall Study|Continuing Study|68
289922|NCT01740297|977832|P2|Overall Study|Continuing Study|67
289923|NCT01740297|977833|P1|Overall Study|Continuing Study|10
289924|NCT01740128|977884|P2|Overall Study|Insufficient protocol compliance|2
289925|NCT01740128|977885|P1|Overall Study|Insufficient protocol compliance|2
289926|NCT01740128|977884|P2|Overall Study|Withdrawal by Subject|0
289927|NCT01740128|977885|P1|Overall Study|Withdrawal by Subject|1
289928|NCT01740128|977884|P2|Overall Study|Lost to Follow-up|2
289929|NCT01740128|977885|P1|Overall Study|Lost to Follow-up|2
289930|NCT01740128|977884|P2|Overall Study|Protocol Violation|2
289931|NCT01740128|977885|P1|Overall Study|Protocol Violation|1
289932|NCT01740128|977884|P2|Overall Study|Pregnancy|1
289933|NCT01740128|977885|P1|Overall Study|Pregnancy|0
289934|NCT01740089|977914|P3|After 12 Weeks|Withdrawal by Subject|1
289935|NCT01740089|977915|P2|After 12 Weeks|Withdrawal by Subject|1
289936|NCT01740089|977916|P1|After 12 Weeks|Withdrawal by Subject|1
289937|NCT01740089|977914|P3|After 12 Weeks|Protocol Violation|1
289938|NCT01740089|977915|P2|After 12 Weeks|Protocol Violation|1
289939|NCT01740089|977916|P1|After 12 Weeks|Protocol Violation|1
289940|NCT01740089|977914|P3|After 12 Weeks|Adverse Event|5
289941|NCT01740089|977915|P2|After 12 Weeks|Adverse Event|0
289942|NCT01740089|977916|P1|After 12 Weeks|Adverse Event|2
289943|NCT01740089|977914|P3|After 12 Weeks|Lack of Efficacy|4
289944|NCT01740089|977915|P2|After 12 Weeks|Lack of Efficacy|1
289945|NCT01740089|977916|P1|After 12 Weeks|Lack of Efficacy|3
289946|NCT01740089|977914|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
289947|NCT01740089|977915|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
289948|NCT01740089|977916|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
289949|NCT01740089|977914|P3|First 12 Weeks of Treatment|Adverse Event|2
289950|NCT01740089|977915|P2|First 12 Weeks of Treatment|Adverse Event|1
289951|NCT01740089|977916|P1|First 12 Weeks of Treatment|Adverse Event|0
289952|NCT01739803|977934|P2|Overall Study|Lost to Follow-up|6
289953|NCT01739803|977935|P1|Overall Study|Lost to Follow-up|9
289954|NCT01739790|977947|P2|Overall Study|Early Trial Termination|4
289955|NCT01739790|977948|P1|Overall Study|Early Trial Termination|2
289956|NCT01739595|977957|P3|Overall Study|Drug discrepancy|0
289957|NCT01739595|977958|P2|Overall Study|Drug discrepancy|0
289958|NCT01739595|977959|P1|Overall Study|Drug discrepancy|1
289959|NCT01739595|977957|P3|Overall Study|Lab assessment|0
289960|NCT01739595|977958|P2|Overall Study|Lab assessment|0
289961|NCT01739595|977959|P1|Overall Study|Lab assessment|1
289962|NCT01739595|977957|P3|Overall Study|Protocol Violation|0
289963|NCT01739595|977958|P2|Overall Study|Protocol Violation|0
289964|NCT01739595|977959|P1|Overall Study|Protocol Violation|1
289965|NCT01739595|977957|P3|Overall Study|Eligibility issue|0
289966|NCT01739595|977958|P2|Overall Study|Eligibility issue|0
289967|NCT01739595|977959|P1|Overall Study|Eligibility issue|3
289968|NCT01739595|977957|P3|Overall Study|Withdrawal by Subject|2
289969|NCT01739595|977958|P2|Overall Study|Withdrawal by Subject|1
289970|NCT01739595|977959|P1|Overall Study|Withdrawal by Subject|2
289971|NCT01739595|977957|P3|Overall Study|Lost to Follow-up|0
289972|NCT01739595|977958|P2|Overall Study|Lost to Follow-up|0
289973|NCT01739595|977959|P1|Overall Study|Lost to Follow-up|2
289974|NCT01739595|977957|P3|Overall Study|Adverse Event|0
289975|NCT01739595|977958|P2|Overall Study|Adverse Event|0
289976|NCT01739595|977959|P1|Overall Study|Adverse Event|3
289977|NCT01739348|977984|P4|Part II (Extension Study)|Withdrawal by Subject|7
289978|NCT01739348|977985|P3|Part II (Extension Study)|Withdrawal by Subject|4
289979|NCT01739348|977986|P2|Part II (Extension Study)|Withdrawal by Subject|2
289980|NCT01739348|977987|P1|Part II (Extension Study)|Withdrawal by Subject|5
290059|NCT01739348|977986|P2|Part I (Base Study)|Lack of Efficacy|8
289981|NCT01739348|977984|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
289982|NCT01739348|977985|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
289983|NCT01739348|977986|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
289984|NCT01739348|977987|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
289985|NCT01739348|977984|P4|Part II (Extension Study)|Participant Moved|3
289986|NCT01739348|977985|P3|Part II (Extension Study)|Participant Moved|0
289987|NCT01739348|977986|P2|Part II (Extension Study)|Participant Moved|3
289988|NCT01739348|977987|P1|Part II (Extension Study)|Participant Moved|3
289989|NCT01739348|977984|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
289990|NCT01739348|977985|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
289991|NCT01739348|977986|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
289992|NCT01739348|977987|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
289993|NCT01739348|977984|P4|Part II (Extension Study)|Physician Decision|12
289994|NCT01739348|977985|P3|Part II (Extension Study)|Physician Decision|6
289995|NCT01739348|977986|P2|Part II (Extension Study)|Physician Decision|11
289996|NCT01739348|977987|P1|Part II (Extension Study)|Physician Decision|7
289997|NCT01739348|977984|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
289998|NCT01739348|977985|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
289999|NCT01739348|977986|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
290000|NCT01739348|977987|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
290001|NCT01739348|977984|P4|Part II (Extension Study)|Lost to Follow-up|1
290002|NCT01739348|977985|P3|Part II (Extension Study)|Lost to Follow-up|0
290003|NCT01739348|977986|P2|Part II (Extension Study)|Lost to Follow-up|4
290004|NCT01739348|977987|P1|Part II (Extension Study)|Lost to Follow-up|3
290005|NCT01739348|977984|P4|Part II (Extension Study)|Lack of Efficacy|1
290006|NCT01739348|977985|P3|Part II (Extension Study)|Lack of Efficacy|0
290007|NCT01739348|977986|P2|Part II (Extension Study)|Lack of Efficacy|5
290008|NCT01739348|977987|P1|Part II (Extension Study)|Lack of Efficacy|1
290009|NCT01739348|977984|P4|Part II (Extension Study)|Death|6
290010|NCT01739348|977985|P3|Part II (Extension Study)|Death|2
290011|NCT01739348|977986|P2|Part II (Extension Study)|Death|3
290012|NCT01739348|977987|P1|Part II (Extension Study)|Death|3
290013|NCT01739348|977984|P4|Part II (Extension Study)|Adverse Event|26
290014|NCT01739348|977985|P3|Part II (Extension Study)|Adverse Event|7
290015|NCT01739348|977986|P2|Part II (Extension Study)|Adverse Event|11
290016|NCT01739348|977987|P1|Part II (Extension Study)|Adverse Event|10
290017|NCT01739348|977984|P4|Part I (Base Study)|Withdrawal by Subject|20
290018|NCT01739348|977985|P3|Part I (Base Study)|Withdrawal by Subject|7
290019|NCT01739348|977986|P2|Part I (Base Study)|Withdrawal by Subject|21
290020|NCT01739348|977987|P1|Part I (Base Study)|Withdrawal by Subject|23
290021|NCT01739348|977984|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
290022|NCT01739348|977985|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
290023|NCT01739348|977986|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
290024|NCT01739348|977987|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
290025|NCT01739348|977984|P4|Part I (Base Study)|Participant Moved|7
290026|NCT01739348|977985|P3|Part I (Base Study)|Participant Moved|1
290027|NCT01739348|977986|P2|Part I (Base Study)|Participant Moved|3
290028|NCT01739348|977987|P1|Part I (Base Study)|Participant Moved|4
290029|NCT01739348|977984|P4|Part I (Base Study)|Study Terminated by Sponsor|86
290030|NCT01739348|977985|P3|Part I (Base Study)|Study Terminated by Sponsor|0
290031|NCT01739348|977986|P2|Part I (Base Study)|Study Terminated by Sponsor|73
290032|NCT01739348|977987|P1|Part I (Base Study)|Study Terminated by Sponsor|72
290033|NCT01739348|977984|P4|Part I (Base Study)|Site Discontinued Study Participation|0
290034|NCT01739348|977985|P3|Part I (Base Study)|Site Discontinued Study Participation|0
290035|NCT01739348|977986|P2|Part I (Base Study)|Site Discontinued Study Participation|3
290036|NCT01739348|977987|P1|Part I (Base Study)|Site Discontinued Study Participation|1
290037|NCT01739348|977984|P4|Part I (Base Study)|Screen Failure|0
290038|NCT01739348|977985|P3|Part I (Base Study)|Screen Failure|0
290039|NCT01739348|977986|P2|Part I (Base Study)|Screen Failure|0
290040|NCT01739348|977987|P1|Part I (Base Study)|Screen Failure|2
290041|NCT01739348|977984|P4|Part I (Base Study)|Protocol Violation|2
290042|NCT01739348|977985|P3|Part I (Base Study)|Protocol Violation|1
290043|NCT01739348|977986|P2|Part I (Base Study)|Protocol Violation|0
290044|NCT01739348|977987|P1|Part I (Base Study)|Protocol Violation|2
290045|NCT01739348|977984|P4|Part I (Base Study)|Physician Decision|4
290046|NCT01739348|977985|P3|Part I (Base Study)|Physician Decision|1
290047|NCT01739348|977986|P2|Part I (Base Study)|Physician Decision|7
290048|NCT01739348|977987|P1|Part I (Base Study)|Physician Decision|10
290049|NCT01739348|977984|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
290050|NCT01739348|977985|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
290051|NCT01739348|977986|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
290052|NCT01739348|977987|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
290053|NCT01739348|977984|P4|Part I (Base Study)|Lost to Follow-up|4
290054|NCT01739348|977985|P3|Part I (Base Study)|Lost to Follow-up|4
290055|NCT01739348|977986|P2|Part I (Base Study)|Lost to Follow-up|2
290056|NCT01739348|977987|P1|Part I (Base Study)|Lost to Follow-up|4
290057|NCT01739348|977984|P4|Part I (Base Study)|Lack of Efficacy|7
290058|NCT01739348|977985|P3|Part I (Base Study)|Lack of Efficacy|0
290060|NCT01739348|977987|P1|Part I (Base Study)|Lack of Efficacy|3
290061|NCT01739348|977984|P4|Part I (Base Study)|Death|8
290062|NCT01739348|977985|P3|Part I (Base Study)|Death|2
290063|NCT01739348|977986|P2|Part I (Base Study)|Death|7
290064|NCT01739348|977987|P1|Part I (Base Study)|Death|10
290065|NCT01739348|977984|P4|Part I (Base Study)|Adverse Event|33
290066|NCT01739348|977985|P3|Part I (Base Study)|Adverse Event|8
290067|NCT01739348|977986|P2|Part I (Base Study)|Adverse Event|52
290068|NCT01739348|977987|P1|Part I (Base Study)|Adverse Event|41
290069|NCT01739335|978059|P2|Overall Study|Ineligible patient randomized|1
290070|NCT01739335|978060|P1|Overall Study|Ineligible patient randomized|0
290071|NCT01739335|978059|P2|Overall Study|Lost to Follow-up|4
290072|NCT01739335|978060|P1|Overall Study|Lost to Follow-up|7
290073|NCT01738984|978094|P2|Overall Study|Lost to Follow-up|39
290074|NCT01738984|978095|P1|Overall Study|Lost to Follow-up|59
290075|NCT01738984|978094|P2|Overall Study|Withdrawal by Subject|0
290076|NCT01738984|978095|P1|Overall Study|Withdrawal by Subject|1
290077|NCT01738984|978094|P2|Overall Study|Pregnancy|0
290078|NCT01738984|978095|P1|Overall Study|Pregnancy|4
290079|NCT01738971|978108|P3|Overall Study|Lost to Follow-up|17
290080|NCT01738971|978109|P2|Overall Study|Lost to Follow-up|30
290081|NCT01738971|978110|P1|Overall Study|Lost to Follow-up|19
290082|NCT01738919|978126|P2|Overall Study|Not treated in accordance to guidelines|1
290083|NCT01738919|978127|P1|Overall Study|Not treated in accordance to guidelines|0
290084|NCT01738919|978126|P2|Overall Study|Withdrawal by Subject|1
290085|NCT01738919|978127|P1|Overall Study|Withdrawal by Subject|0
290086|NCT01738919|978126|P2|Overall Study|Immigrated|1
290087|NCT01738919|978127|P1|Overall Study|Immigrated|0
290088|NCT01738919|978126|P2|Overall Study|Lost to Follow-up|0
290089|NCT01738919|978127|P1|Overall Study|Lost to Follow-up|1
290090|NCT01738646|978277|P1|Overall Study|Still Receiving Treatment|2
290091|NCT01738581|978287|P2|Overall Study|Lost to Follow-up|0
290092|NCT01738581|978288|P1|Overall Study|Lost to Follow-up|1
290093|NCT01738503|978312|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
290094|NCT01738503|978313|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
290095|NCT01738503|978314|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
290096|NCT01738503|978315|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
290097|NCT01738503|978316|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
290098|NCT01738503|978317|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
290099|NCT01738503|978318|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
290100|NCT01738503|978312|P7|PET Imaging Sub-study|Adverse Event|0
290101|NCT01738503|978313|P6|PET Imaging Sub-study|Adverse Event|1
290102|NCT01738503|978314|P5|PET Imaging Sub-study|Adverse Event|0
290103|NCT01738503|978315|P4|PET Imaging Sub-study|Adverse Event|0
290104|NCT01738503|978316|P3|PET Imaging Sub-study|Adverse Event|0
290105|NCT01738503|978317|P2|PET Imaging Sub-study|Adverse Event|0
290106|NCT01738503|978318|P1|PET Imaging Sub-study|Adverse Event|0
290107|NCT01738503|978312|P7|Treatment Period|Not specified|0
290108|NCT01738503|978313|P6|Treatment Period|Not specified|0
290109|NCT01738503|978314|P5|Treatment Period|Not specified|0
290110|NCT01738503|978315|P4|Treatment Period|Not specified|0
290111|NCT01738503|978316|P3|Treatment Period|Not specified|1
290112|NCT01738503|978317|P2|Treatment Period|Not specified|0
290113|NCT01738503|978318|P1|Treatment Period|Not specified|0
290114|NCT01738503|978312|P7|Treatment Period|Protocol Violation|0
290115|NCT01738503|978313|P6|Treatment Period|Protocol Violation|2
290116|NCT01738503|978314|P5|Treatment Period|Protocol Violation|4
290117|NCT01738503|978315|P4|Treatment Period|Protocol Violation|0
290118|NCT01738503|978316|P3|Treatment Period|Protocol Violation|1
290119|NCT01738503|978317|P2|Treatment Period|Protocol Violation|3
290120|NCT01738503|978318|P1|Treatment Period|Protocol Violation|0
290121|NCT01738503|978312|P7|Treatment Period|Withdrawal by Subject|1
290122|NCT01738503|978313|P6|Treatment Period|Withdrawal by Subject|1
290123|NCT01738503|978314|P5|Treatment Period|Withdrawal by Subject|1
290124|NCT01738503|978315|P4|Treatment Period|Withdrawal by Subject|1
290125|NCT01738503|978316|P3|Treatment Period|Withdrawal by Subject|0
290126|NCT01738503|978317|P2|Treatment Period|Withdrawal by Subject|1
290127|NCT01738503|978318|P1|Treatment Period|Withdrawal by Subject|0
290128|NCT01738503|978312|P7|Treatment Period|Lost to Follow-up|5
290129|NCT01738503|978313|P6|Treatment Period|Lost to Follow-up|1
290130|NCT01738503|978314|P5|Treatment Period|Lost to Follow-up|1
290131|NCT01738503|978315|P4|Treatment Period|Lost to Follow-up|4
290132|NCT01738503|978316|P3|Treatment Period|Lost to Follow-up|3
290133|NCT01738503|978317|P2|Treatment Period|Lost to Follow-up|0
290134|NCT01738503|978318|P1|Treatment Period|Lost to Follow-up|0
290135|NCT01738503|978312|P7|Treatment Period|Adverse Event|2
290136|NCT01738503|978313|P6|Treatment Period|Adverse Event|2
290137|NCT01738503|978314|P5|Treatment Period|Adverse Event|2
290138|NCT01738503|978315|P4|Treatment Period|Adverse Event|1
290139|NCT01738503|978316|P3|Treatment Period|Adverse Event|0
290140|NCT01738503|978317|P2|Treatment Period|Adverse Event|1
290141|NCT01738503|978318|P1|Treatment Period|Adverse Event|0
290142|NCT01738503|978312|P7|Induction/Stabilization (Days -14 to -1)|Not specified|0
290143|NCT01738503|978313|P6|Induction/Stabilization (Days -14 to -1)|Not specified|0
290230|NCT01736475|979336|P1|Overall Study|Other - Surgical procedure|1
290144|NCT01738503|978314|P5|Induction/Stabilization (Days -14 to -1)|Not specified|0
290145|NCT01738503|978315|P4|Induction/Stabilization (Days -14 to -1)|Not specified|0
290146|NCT01738503|978316|P3|Induction/Stabilization (Days -14 to -1)|Not specified|0
290147|NCT01738503|978317|P2|Induction/Stabilization (Days -14 to -1)|Not specified|0
290148|NCT01738503|978318|P1|Induction/Stabilization (Days -14 to -1)|Not specified|35
290149|NCT01738477|978516|P2|Overall Study|Lost to Follow-up|4
290150|NCT01738477|978517|P1|Overall Study|Lost to Follow-up|1
290151|NCT01738438|978545|P1|Overall Study|Adverse Event|3
290152|NCT01738438|978545|P1|Overall Study|Disease Progression|32
290153|NCT01737996|978563|P3|Overall Study|Withdrawal by Subject|1
290154|NCT01737996|978564|P2|Overall Study|Withdrawal by Subject|0
290155|NCT01737996|978565|P1|Overall Study|Withdrawal by Subject|0
290156|NCT01737996|978563|P3|Overall Study|Adverse Event|1
290157|NCT01737996|978564|P2|Overall Study|Adverse Event|1
290158|NCT01737996|978565|P1|Overall Study|Adverse Event|0
290159|NCT01737931|978627|P3|Overall Study|Physician Decision|0
290160|NCT01737931|978628|P2|Overall Study|Physician Decision|1
290161|NCT01737931|978629|P1|Overall Study|Physician Decision|0
290162|NCT01737931|978627|P3|Overall Study|Withdrawal by Subject|1
290163|NCT01737931|978628|P2|Overall Study|Withdrawal by Subject|1
290164|NCT01737931|978629|P1|Overall Study|Withdrawal by Subject|0
290165|NCT01737879|978644|P1|Overall Study|Sponsor decision|40
290166|NCT01737879|978644|P1|Overall Study|Death|1
290167|NCT01737840|978653|P2|Overall Study|Diagnosed with an other pathology|2
290168|NCT01737840|978654|P1|Overall Study|Diagnosed with an other pathology|2
290169|NCT01737762|978664|P2|Overall Study|Trial termination|9
290170|NCT01737762|978665|P1|Overall Study|Trial termination|11
290171|NCT01737762|978664|P2|Overall Study|Moved from area|1
290172|NCT01737762|978665|P1|Overall Study|Moved from area|2
290173|NCT01737762|978664|P2|Overall Study|Physician Decision|1
290174|NCT01737762|978665|P1|Overall Study|Physician Decision|1
290175|NCT01737762|978664|P2|Overall Study|Progressive disease|2
290176|NCT01737762|978665|P1|Overall Study|Progressive disease|1
290177|NCT01737762|978664|P2|Overall Study|Withdrawal by Subject|2
290178|NCT01737762|978665|P1|Overall Study|Withdrawal by Subject|2
290179|NCT01737762|978664|P2|Overall Study|Lost to Follow-up|0
290180|NCT01737762|978665|P1|Overall Study|Lost to Follow-up|1
290181|NCT01737762|978664|P2|Overall Study|Adverse Event|2
290182|NCT01737762|978665|P1|Overall Study|Adverse Event|2
290183|NCT01737710|978678|P5|Overall Study|Vaccinated in Error/Ineligible|0
290184|NCT01737710|978679|P4|Overall Study|Vaccinated in Error/Ineligible|0
290185|NCT01737710|978680|P3|Overall Study|Vaccinated in Error/Ineligible|0
290186|NCT01737710|978681|P2|Overall Study|Vaccinated in Error/Ineligible|1
290187|NCT01737710|978682|P1|Overall Study|Vaccinated in Error/Ineligible|1
290188|NCT01737710|978678|P5|Overall Study|Withdrawal by Subject|0
290189|NCT01737710|978679|P4|Overall Study|Withdrawal by Subject|0
290190|NCT01737710|978680|P3|Overall Study|Withdrawal by Subject|1
290191|NCT01737710|978681|P2|Overall Study|Withdrawal by Subject|1
290192|NCT01737710|978682|P1|Overall Study|Withdrawal by Subject|1
290193|NCT01737710|978678|P5|Overall Study|Lost to Follow-up|0
290194|NCT01737710|978679|P4|Overall Study|Lost to Follow-up|0
290195|NCT01737710|978680|P3|Overall Study|Lost to Follow-up|2
290196|NCT01737710|978681|P2|Overall Study|Lost to Follow-up|2
290197|NCT01737710|978682|P1|Overall Study|Lost to Follow-up|0
290198|NCT01737268|978773|P1|Overall Study|In consideration of the patient’s safety|1
290199|NCT01737268|978773|P1|Overall Study|Worsening of Target Disease|2
290200|NCT01737268|978773|P1|Overall Study|Adverse Event|6
290201|NCT01737021|978787|P2|Overall Study|Lost to Follow-up|3
290202|NCT01737021|978788|P1|Overall Study|Lost to Follow-up|5
290203|NCT01736917|978834|P1|Overall Study|Protocol Violation|10
290204|NCT01736917|978834|P1|Overall Study|Adverse Event|1
290205|NCT01736696|978848|P7|Overall Study|Withdrawal by Subject|0
290206|NCT01736696|978849|P6|Overall Study|Withdrawal by Subject|0
290207|NCT01736696|978850|P5|Overall Study|Withdrawal by Subject|0
290208|NCT01736696|978851|P4|Overall Study|Withdrawal by Subject|0
290209|NCT01736696|978852|P3|Overall Study|Withdrawal by Subject|1
290210|NCT01736696|978853|P2|Overall Study|Withdrawal by Subject|0
290211|NCT01736696|978854|P1|Overall Study|Withdrawal by Subject|0
290212|NCT01736657|979171|P1|Overall Study|insufficient vascular access|1
290213|NCT01736579|979180|P2|Overall Study|Termination of Study by Sponsor|2
290214|NCT01736579|979181|P1|Overall Study|Termination of Study by Sponsor|2
290215|NCT01736553|979217|P2|Overall Study|Lost to Follow-up|2
290216|NCT01736553|979218|P1|Overall Study|Lost to Follow-up|2
290217|NCT01736553|979217|P2|Overall Study|Withdrawal by Subject|2
290218|NCT01736553|979218|P1|Overall Study|Withdrawal by Subject|5
290219|NCT01736553|979217|P2|Overall Study|Death|0
290220|NCT01736553|979218|P1|Overall Study|Death|12
290221|NCT01736540|979269|P1|Overall Study|Unable to make MRI appointment|3
290222|NCT01736540|979269|P1|Overall Study|No show for MRI appointment|1
290223|NCT01736540|979269|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
290224|NCT01736540|979269|P1|Overall Study|Protocol Violation|1
290225|NCT01736540|979269|P1|Overall Study|Withdrawal by Subject|5
290226|NCT01736540|979269|P1|Overall Study|Abnormal test procedure|1
290227|NCT01736540|979269|P1|Overall Study|Death|1
290228|NCT01736540|979269|P1|Overall Study|Did not complete scan within 45 days|2
290229|NCT01736475|979335|P2|Overall Study|Other - Surgical procedure|0
290231|NCT01736475|979335|P2|Overall Study|Other - Screen failure|0
290232|NCT01736475|979336|P1|Overall Study|Other - Screen failure|1
290233|NCT01736475|979335|P2|Overall Study|Protocol Violation|0
290234|NCT01736475|979336|P1|Overall Study|Protocol Violation|4
290235|NCT01736475|979335|P2|Overall Study|Withdrawal by Subject|0
290236|NCT01736475|979336|P1|Overall Study|Withdrawal by Subject|2
290237|NCT01736475|979335|P2|Overall Study|Adverse Event|0
290238|NCT01736475|979336|P1|Overall Study|Adverse Event|4
290239|NCT01736397|979391|P2|Overall Study|Not stated|4
290240|NCT01736397|979392|P1|Overall Study|Not stated|1
290241|NCT01736397|979391|P2|Overall Study|Adverse Event|3
290242|NCT01736397|979392|P1|Overall Study|Adverse Event|6
290243|NCT01736397|979391|P2|Overall Study|Lost to Follow-up|1
290244|NCT01736397|979392|P1|Overall Study|Lost to Follow-up|0
290245|NCT01736397|979391|P2|Overall Study|Withdrawal by Subject|5
290246|NCT01736397|979392|P1|Overall Study|Withdrawal by Subject|6
290247|NCT01736397|979391|P2|Overall Study|Lack of Efficacy|11
290248|NCT01736397|979392|P1|Overall Study|Lack of Efficacy|1
290249|NCT01736215|979404|P1|Overall Study|Insufficient data to perform analysis|8
290250|NCT01736215|979404|P1|Overall Study|Progressive disease stop chemotherapy|1
290251|NCT01736215|979404|P1|Overall Study|Adverse Event|4
290252|NCT01736215|979404|P1|Overall Study|Early termination of erythropoietin use|1
290253|NCT01736176|979416|P1|Overall Study|Unable to Complete PEG Placement|1
290254|NCT01736176|979416|P1|Overall Study|Lack of Efficacy|3
290255|NCT01736176|979416|P1|Overall Study|Withdrawal by Subject|4
290256|NCT01736176|979416|P1|Overall Study|Adverse Event|3
290257|NCT01735916|979463|P3|Overall Study|Withdrawal by Subject|0
290258|NCT01735916|979464|P2|Overall Study|Withdrawal by Subject|0
290259|NCT01735916|979465|P1|Overall Study|Withdrawal by Subject|3
290260|NCT01735916|979463|P3|Overall Study|Early termination of study by sponsor|7
290261|NCT01735916|979464|P2|Overall Study|Early termination of study by sponsor|19
290262|NCT01735916|979465|P1|Overall Study|Early termination of study by sponsor|4
290263|NCT01735916|979463|P3|Overall Study|Subject not eligible to be randomized|0
290264|NCT01735916|979464|P2|Overall Study|Subject not eligible to be randomized|0
290265|NCT01735916|979465|P1|Overall Study|Subject not eligible to be randomized|11
290266|NCT01735630|979503|P2|Overall Study|Withdrawal by Subject|9
290267|NCT01735630|979504|P1|Overall Study|Withdrawal by Subject|7
290268|NCT01735630|979503|P2|Overall Study|Sponsor Decision|1
290269|NCT01735630|979504|P1|Overall Study|Sponsor Decision|2
290270|NCT01735630|979503|P2|Overall Study|Physician Decision|1
290271|NCT01735630|979504|P1|Overall Study|Physician Decision|0
290272|NCT01735630|979503|P2|Overall Study|Lost to Follow-up|0
290273|NCT01735630|979504|P1|Overall Study|Lost to Follow-up|1
290274|NCT01735630|979503|P2|Overall Study|Adverse Event|7
290275|NCT01735630|979504|P1|Overall Study|Adverse Event|8
290276|NCT01735396|979531|P1|Overall Study|not evaluable|1
290277|NCT01735201|979560|P8|Overall Study|Other Miscellaneous Reasons|1
290278|NCT01735201|979561|P7|Overall Study|Other Miscellaneous Reasons|1
290279|NCT01735201|979562|P6|Overall Study|Other Miscellaneous Reasons|2
290280|NCT01735201|979563|P5|Overall Study|Other Miscellaneous Reasons|0
290281|NCT01735201|979564|P4|Overall Study|Other Miscellaneous Reasons|1
290282|NCT01735201|979565|P3|Overall Study|Other Miscellaneous Reasons|0
290283|NCT01735201|979566|P2|Overall Study|Other Miscellaneous Reasons|0
290284|NCT01735201|979567|P1|Overall Study|Other Miscellaneous Reasons|0
290285|NCT01735201|979560|P8|Overall Study|Protocol Violation|0
290286|NCT01735201|979561|P7|Overall Study|Protocol Violation|0
290287|NCT01735201|979562|P6|Overall Study|Protocol Violation|0
290288|NCT01735201|979563|P5|Overall Study|Protocol Violation|0
290289|NCT01735201|979564|P4|Overall Study|Protocol Violation|0
290290|NCT01735201|979565|P3|Overall Study|Protocol Violation|0
290291|NCT01735201|979566|P2|Overall Study|Protocol Violation|0
290292|NCT01735201|979567|P1|Overall Study|Protocol Violation|1
290293|NCT01735201|979560|P8|Overall Study|Personal Reasons|0
290294|NCT01735201|979561|P7|Overall Study|Personal Reasons|0
290295|NCT01735201|979562|P6|Overall Study|Personal Reasons|0
290296|NCT01735201|979563|P5|Overall Study|Personal Reasons|0
290297|NCT01735201|979564|P4|Overall Study|Personal Reasons|0
290298|NCT01735201|979565|P3|Overall Study|Personal Reasons|0
290299|NCT01735201|979566|P2|Overall Study|Personal Reasons|0
290300|NCT01735201|979567|P1|Overall Study|Personal Reasons|1
290301|NCT01735201|979560|P8|Overall Study|Adverse Event|1
290302|NCT01735201|979561|P7|Overall Study|Adverse Event|2
290303|NCT01735201|979562|P6|Overall Study|Adverse Event|3
290304|NCT01735201|979563|P5|Overall Study|Adverse Event|1
290305|NCT01735201|979564|P4|Overall Study|Adverse Event|1
290306|NCT01735201|979565|P3|Overall Study|Adverse Event|0
290307|NCT01735201|979566|P2|Overall Study|Adverse Event|1
290308|NCT01735201|979567|P1|Overall Study|Adverse Event|1
290309|NCT01735175|979603|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
290310|NCT01735175|979604|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
290311|NCT01735175|979603|P2|Overall Study|Death|2
290312|NCT01735175|979604|P1|Overall Study|Death|3
290313|NCT01735175|979603|P2|Overall Study|Lost to Follow-up|2
290314|NCT01735175|979604|P1|Overall Study|Lost to Follow-up|4
290315|NCT01735175|979603|P2|Overall Study|Withdrawal by Subject|2
290316|NCT01735175|979604|P1|Overall Study|Withdrawal by Subject|9
290317|NCT01734993|979624|P1|Overall Study|Lack of Efficacy|1
290318|NCT01734993|979624|P1|Overall Study|Adverse Event|1
290319|NCT01734785|979661|P4|Double−Blind Period|Not treated|0
290320|NCT01734785|979662|P3|Double−Blind Period|Not treated|0
290321|NCT01734785|979663|P2|Double−Blind Period|Not treated|0
290322|NCT01734785|979664|P1|Double−Blind Period|Not treated|1
290323|NCT01734785|979661|P4|Double−Blind Period|Withdrawal by Subject|0
290324|NCT01734785|979662|P3|Double−Blind Period|Withdrawal by Subject|0
290325|NCT01734785|979663|P2|Double−Blind Period|Withdrawal by Subject|0
290326|NCT01734785|979664|P1|Double−Blind Period|Withdrawal by Subject|2
290327|NCT01734785|979661|P4|Double−Blind Period|Lost to Follow-up|0
290328|NCT01734785|979662|P3|Double−Blind Period|Lost to Follow-up|2
290329|NCT01734785|979663|P2|Double−Blind Period|Lost to Follow-up|4
290330|NCT01734785|979664|P1|Double−Blind Period|Lost to Follow-up|2
290331|NCT01734785|979661|P4|Double−Blind Period|Protocol Violation|0
290332|NCT01734785|979662|P3|Double−Blind Period|Protocol Violation|1
290333|NCT01734785|979663|P2|Double−Blind Period|Protocol Violation|1
290334|NCT01734785|979664|P1|Double−Blind Period|Protocol Violation|0
290335|NCT01734785|979661|P4|Double−Blind Period|Lack of Efficacy|0
290336|NCT01734785|979662|P3|Double−Blind Period|Lack of Efficacy|0
290337|NCT01734785|979663|P2|Double−Blind Period|Lack of Efficacy|1
290338|NCT01734785|979664|P1|Double−Blind Period|Lack of Efficacy|0
290339|NCT01734785|979661|P4|Double−Blind Period|Adverse Event|0
290340|NCT01734785|979662|P3|Double−Blind Period|Adverse Event|2
290341|NCT01734785|979663|P2|Double−Blind Period|Adverse Event|3
290342|NCT01734785|979664|P1|Double−Blind Period|Adverse Event|0
290343|NCT01734785|979661|P4|Open−Label Period|Other Reasons|224
290344|NCT01734785|979662|P3|Open−Label Period|Other Reasons|0
290345|NCT01734785|979663|P2|Open−Label Period|Other Reasons|0
290346|NCT01734785|979664|P1|Open−Label Period|Other Reasons|0
290347|NCT01734785|979661|P4|Open−Label Period|Withdrawal by Subject|12
290348|NCT01734785|979662|P3|Open−Label Period|Withdrawal by Subject|0
290349|NCT01734785|979663|P2|Open−Label Period|Withdrawal by Subject|0
290350|NCT01734785|979664|P1|Open−Label Period|Withdrawal by Subject|0
290351|NCT01734785|979661|P4|Open−Label Period|Lost to Follow-up|14
290352|NCT01734785|979662|P3|Open−Label Period|Lost to Follow-up|0
290353|NCT01734785|979663|P2|Open−Label Period|Lost to Follow-up|0
290354|NCT01734785|979664|P1|Open−Label Period|Lost to Follow-up|0
290355|NCT01734785|979661|P4|Open−Label Period|Protocol Violation|13
290356|NCT01734785|979662|P3|Open−Label Period|Protocol Violation|0
290357|NCT01734785|979663|P2|Open−Label Period|Protocol Violation|0
290358|NCT01734785|979664|P1|Open−Label Period|Protocol Violation|0
290359|NCT01734785|979661|P4|Open−Label Period|Lack of Efficacy|1
290360|NCT01734785|979662|P3|Open−Label Period|Lack of Efficacy|0
290361|NCT01734785|979663|P2|Open−Label Period|Lack of Efficacy|0
290362|NCT01734785|979664|P1|Open−Label Period|Lack of Efficacy|0
290363|NCT01734785|979661|P4|Open−Label Period|Adverse Event|9
290364|NCT01734785|979662|P3|Open−Label Period|Adverse Event|0
290365|NCT01734785|979663|P2|Open−Label Period|Adverse Event|0
290366|NCT01734785|979664|P1|Open−Label Period|Adverse Event|0
290367|NCT01734772|979681|P2|Overall Study|Withdrawal by Subject|1
290368|NCT01734772|979682|P1|Overall Study|Withdrawal by Subject|0
290369|NCT01734772|979681|P2|Overall Study|Adverse Event|2
290370|NCT01734772|979682|P1|Overall Study|Adverse Event|1
290371|NCT01734395|979723|P1|Overall Study|Missing the reasons for not completed|3
290372|NCT01734395|979723|P1|Overall Study|Withdrawal by Subject|10
290373|NCT01734395|979723|P1|Overall Study|Adverse Event|40
290374|NCT01734395|979723|P1|Overall Study|Lack of Efficacy|5
290375|NCT01734395|979723|P1|Overall Study|Lost to Follow-up|287
290376|NCT01734395|979723|P1|Overall Study|Not specified|65
290377|NCT01733758|979781|P4|Overall Study|Inv Decision, HbA1c not controlled|1
290378|NCT01733758|979782|P3|Overall Study|Inv Decision, HbA1c not controlled|0
290379|NCT01733758|979783|P2|Overall Study|Inv Decision, HbA1c not controlled|1
290380|NCT01733758|979784|P1|Overall Study|Inv Decision, HbA1c not controlled|1
290381|NCT01733758|979781|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
290382|NCT01733758|979782|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
290383|NCT01733758|979783|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
290384|NCT01733758|979784|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
290385|NCT01733758|979781|P4|Overall Study|Non-compliance|0
290386|NCT01733758|979782|P3|Overall Study|Non-compliance|0
290387|NCT01733758|979783|P2|Overall Study|Non-compliance|0
290388|NCT01733758|979784|P1|Overall Study|Non-compliance|1
290389|NCT01733758|979781|P4|Overall Study|Protocol Violation|2
290390|NCT01733758|979782|P3|Overall Study|Protocol Violation|2
290391|NCT01733758|979783|P2|Overall Study|Protocol Violation|1
290392|NCT01733758|979784|P1|Overall Study|Protocol Violation|0
290393|NCT01733758|979781|P4|Overall Study|Persistent Hyperglycemia|0
290394|NCT01733758|979782|P3|Overall Study|Persistent Hyperglycemia|0
290395|NCT01733758|979783|P2|Overall Study|Persistent Hyperglycemia|2
290396|NCT01733758|979784|P1|Overall Study|Persistent Hyperglycemia|3
290397|NCT01733758|979781|P4|Overall Study|Withdrawal by Subject|3
290398|NCT01733758|979782|P3|Overall Study|Withdrawal by Subject|5
290399|NCT01733758|979783|P2|Overall Study|Withdrawal by Subject|1
290400|NCT01733758|979784|P1|Overall Study|Withdrawal by Subject|1
290401|NCT01733758|979781|P4|Overall Study|Adverse Event|1
290402|NCT01733758|979782|P3|Overall Study|Adverse Event|8
290403|NCT01733758|979783|P2|Overall Study|Adverse Event|7
290404|NCT01733758|979784|P1|Overall Study|Adverse Event|5
290409|NCT01733329|979895|P2|Overall Study|Uterine artery injury|0
290410|NCT01733329|979896|P1|Overall Study|Uterine artery injury|1
290411|NCT01733329|979895|P2|Overall Study|Protocol Violation|1
290412|NCT01733329|979896|P1|Overall Study|Protocol Violation|1
290413|NCT01733316|979908|P1|Overall Study|Withdrawal by Subject|1
290414|NCT01733316|979908|P1|Overall Study|Noncompliance|1
290415|NCT01733121|979954|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
290416|NCT01733121|979955|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
290417|NCT01733121|979954|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
290418|NCT01733121|979955|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
290419|NCT01733121|979954|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
290420|NCT01733121|979955|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
290421|NCT01733121|979954|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
290422|NCT01733121|979955|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
290423|NCT01732926|979997|P2|Overall Study|Blind Broken by Subject or Study Site|1
290424|NCT01732926|979998|P1|Overall Study|Blind Broken by Subject or Study Site|1
290425|NCT01732926|979997|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
290426|NCT01732926|979998|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
290427|NCT01732926|979997|P2|Overall Study|Other Reason|4
290428|NCT01732926|979998|P1|Overall Study|Other Reason|21
290429|NCT01732926|979997|P2|Overall Study|Physician Decision|11
290430|NCT01732926|979998|P1|Overall Study|Physician Decision|24
290431|NCT01732926|979997|P2|Overall Study|Withdrawal by Subject|8
290432|NCT01732926|979998|P1|Overall Study|Withdrawal by Subject|46
290433|NCT01732926|979997|P2|Overall Study|Study Terminated by Sponsor|80
290434|NCT01732926|979998|P1|Overall Study|Study Terminated by Sponsor|168
290435|NCT01732913|980014|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
290436|NCT01732913|980015|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
290437|NCT01732913|980014|P2|Overall Study|Other|1
290438|NCT01732913|980015|P1|Overall Study|Other|7
290439|NCT01732913|980014|P2|Overall Study|Physician Decision|7
290440|NCT01732913|980015|P1|Overall Study|Physician Decision|14
290441|NCT01732913|980014|P2|Overall Study|Withdrawal by Subject|4
290442|NCT01732913|980015|P1|Overall Study|Withdrawal by Subject|27
290443|NCT01732913|980014|P2|Overall Study|Study Terminated by Sponsor|55
290444|NCT01732913|980015|P1|Overall Study|Study Terminated by Sponsor|105
290445|NCT01732835|980029|P1|2-year Extended Follow-up|Death|1
290446|NCT01732835|980029|P1|2-year Extended Follow-up|Adverse Event|3
290447|NCT01732835|980029|P1|2-year Extended Follow-up|Withdrawal by Subject|1
290448|NCT01732835|980029|P1|6-month Primary Endpoint|Adverse Event|3
290449|NCT01732835|980029|P1|6-month Primary Endpoint|Withdrawal by Subject|2
290450|NCT01732835|980029|P1|6-month Primary Endpoint|Did not receive device|19
290451|NCT01732822|980062|P2|Overall Study|Withdrawal by Subject|113
290452|NCT01732822|980063|P1|Overall Study|Withdrawal by Subject|123
290453|NCT01732796|980136|P3|Overall Study|Other reason not defined above|2
290454|NCT01732796|980137|P2|Overall Study|Other reason not defined above|0
290455|NCT01732796|980138|P1|Overall Study|Other reason not defined above|1
290456|NCT01732796|980136|P3|Overall Study|Withdrawal by Subject|2
290457|NCT01732796|980137|P2|Overall Study|Withdrawal by Subject|8
290458|NCT01732796|980138|P1|Overall Study|Withdrawal by Subject|6
290459|NCT01732796|980136|P3|Overall Study|Lost to Follow-up|0
290460|NCT01732796|980137|P2|Overall Study|Lost to Follow-up|0
290461|NCT01732796|980138|P1|Overall Study|Lost to Follow-up|2
290462|NCT01732796|980136|P3|Overall Study|Lack of Efficacy|5
290463|NCT01732796|980137|P2|Overall Study|Lack of Efficacy|18
290464|NCT01732796|980138|P1|Overall Study|Lack of Efficacy|21
290465|NCT01732796|980136|P3|Overall Study|Adverse Event|4
290466|NCT01732796|980137|P2|Overall Study|Adverse Event|16
290467|NCT01732796|980138|P1|Overall Study|Adverse Event|16
290468|NCT01732770|980156|P2|Overall Study|Death|0
290469|NCT01732770|980157|P1|Overall Study|Death|1
290470|NCT01732770|980156|P2|Overall Study|Decision by Sponsor|2
290471|NCT01732770|980157|P1|Overall Study|Decision by Sponsor|2
290472|NCT01732770|980156|P2|Overall Study|Withdrawal by Subject|3
290473|NCT01732770|980157|P1|Overall Study|Withdrawal by Subject|5
290474|NCT01732770|980156|P2|Overall Study|Lost to Follow-up|3
290475|NCT01732770|980157|P1|Overall Study|Lost to Follow-up|2
290476|NCT01732757|980172|P3|Overall Study|Lost to Follow-up|0
290477|NCT01732757|980173|P2|Overall Study|Lost to Follow-up|0
290478|NCT01732757|980174|P1|Overall Study|Lost to Follow-up|1
290479|NCT01732692|980214|P2|Overall Study|Adverse Event|1
290480|NCT01732692|980215|P1|Overall Study|Adverse Event|0
290481|NCT01732588|980232|P3|First Intervention (7 Days)|Adverse Event|0
290482|NCT01732588|980233|P2|First Intervention (7 Days)|Adverse Event|1
290483|NCT01732588|980234|P1|First Intervention (7 Days)|Adverse Event|0
290484|NCT01732549|980250|P2|Overall Study|Not Specified|14
290485|NCT01732549|980251|P1|Overall Study|Not Specified|8
290486|NCT01732549|980250|P2|Overall Study|Disease progression|50
290487|NCT01732549|980251|P1|Overall Study|Disease progression|37
290488|NCT01732549|980250|P2|Overall Study|Consent withdrawn|6
290758|NCT01729754|981058|P8|Part 3|Death|0
290489|NCT01732549|980251|P1|Overall Study|Consent withdrawn|13
290490|NCT01732549|980250|P2|Overall Study|Adverse Event|3
290491|NCT01732549|980251|P1|Overall Study|Adverse Event|13
290492|NCT01732510|980278|P7|Overall Study|Study Terminated By Sponsor|6
290493|NCT01732510|980279|P6|Overall Study|Study Terminated By Sponsor|12
290494|NCT01732510|980280|P5|Overall Study|Study Terminated By Sponsor|0
290495|NCT01732510|980281|P4|Overall Study|Study Terminated By Sponsor|1
290496|NCT01732510|980282|P3|Overall Study|Study Terminated By Sponsor|0
290497|NCT01732510|980283|P2|Overall Study|Study Terminated By Sponsor|0
290498|NCT01732510|980284|P1|Overall Study|Study Terminated By Sponsor|0
290499|NCT01732510|980278|P7|Overall Study|Pregnancy|0
290500|NCT01732510|980279|P6|Overall Study|Pregnancy|0
290501|NCT01732510|980280|P5|Overall Study|Pregnancy|0
290502|NCT01732510|980281|P4|Overall Study|Pregnancy|1
290503|NCT01732510|980282|P3|Overall Study|Pregnancy|0
290504|NCT01732510|980283|P2|Overall Study|Pregnancy|0
290505|NCT01732510|980284|P1|Overall Study|Pregnancy|0
290506|NCT01732510|980278|P7|Overall Study|Physician Decision|0
290507|NCT01732510|980279|P6|Overall Study|Physician Decision|0
290508|NCT01732510|980280|P5|Overall Study|Physician Decision|0
290509|NCT01732510|980281|P4|Overall Study|Physician Decision|0
290510|NCT01732510|980282|P3|Overall Study|Physician Decision|0
290511|NCT01732510|980283|P2|Overall Study|Physician Decision|1
290512|NCT01732510|980284|P1|Overall Study|Physician Decision|0
290513|NCT01732510|980278|P7|Overall Study|Lost to Follow-up|0
290514|NCT01732510|980279|P6|Overall Study|Lost to Follow-up|1
290515|NCT01732510|980280|P5|Overall Study|Lost to Follow-up|0
290516|NCT01732510|980281|P4|Overall Study|Lost to Follow-up|1
290517|NCT01732510|980282|P3|Overall Study|Lost to Follow-up|1
290518|NCT01732510|980283|P2|Overall Study|Lost to Follow-up|0
290519|NCT01732510|980284|P1|Overall Study|Lost to Follow-up|0
290520|NCT01732510|980278|P7|Overall Study|Withdrawal by Subject|1
290521|NCT01732510|980279|P6|Overall Study|Withdrawal by Subject|0
290522|NCT01732510|980280|P5|Overall Study|Withdrawal by Subject|5
290523|NCT01732510|980281|P4|Overall Study|Withdrawal by Subject|1
290524|NCT01732510|980282|P3|Overall Study|Withdrawal by Subject|2
290525|NCT01732510|980283|P2|Overall Study|Withdrawal by Subject|3
290526|NCT01732510|980284|P1|Overall Study|Withdrawal by Subject|1
290527|NCT01732510|980278|P7|Overall Study|Protocol Violation|0
290528|NCT01732510|980279|P6|Overall Study|Protocol Violation|0
290529|NCT01732510|980280|P5|Overall Study|Protocol Violation|0
290530|NCT01732510|980281|P4|Overall Study|Protocol Violation|1
290531|NCT01732510|980282|P3|Overall Study|Protocol Violation|0
290532|NCT01732510|980283|P2|Overall Study|Protocol Violation|0
290533|NCT01732510|980284|P1|Overall Study|Protocol Violation|0
290534|NCT01732510|980278|P7|Overall Study|Adverse Event|1
290535|NCT01732510|980279|P6|Overall Study|Adverse Event|0
290536|NCT01732510|980280|P5|Overall Study|Adverse Event|0
290537|NCT01732510|980281|P4|Overall Study|Adverse Event|0
290538|NCT01732510|980282|P3|Overall Study|Adverse Event|1
290539|NCT01732510|980283|P2|Overall Study|Adverse Event|1
290540|NCT01732510|980284|P1|Overall Study|Adverse Event|0
290541|NCT01732484|980363|P1|Overall Study|chronical illness|5
290542|NCT01732484|980363|P1|Overall Study|Lost to Follow-up|14
290543|NCT01732484|980363|P1|Overall Study|Death|7
290544|NCT01732471|980371|P1|Overall Study|Withdrawal by Subject|1
290545|NCT01732458|980382|P4|Overall Study|Screen Failure|0
290546|NCT01732458|980383|P3|Overall Study|Screen Failure|0
290547|NCT01732458|980384|P2|Overall Study|Screen Failure|1
290548|NCT01732458|980385|P1|Overall Study|Screen Failure|0
290549|NCT01732458|980382|P4|Overall Study|Protocol Violation|2
290550|NCT01732458|980383|P3|Overall Study|Protocol Violation|0
290551|NCT01732458|980384|P2|Overall Study|Protocol Violation|0
290552|NCT01732458|980385|P1|Overall Study|Protocol Violation|2
290553|NCT01732458|980382|P4|Overall Study|Physician Decision|0
290554|NCT01732458|980383|P3|Overall Study|Physician Decision|2
290555|NCT01732458|980384|P2|Overall Study|Physician Decision|2
290556|NCT01732458|980385|P1|Overall Study|Physician Decision|1
290557|NCT01732458|980382|P4|Overall Study|Non-Compliance With Study Drug|0
290558|NCT01732458|980383|P3|Overall Study|Non-Compliance With Study Drug|1
290559|NCT01732458|980384|P2|Overall Study|Non-Compliance With Study Drug|0
290560|NCT01732458|980385|P1|Overall Study|Non-Compliance With Study Drug|0
290561|NCT01732458|980382|P4|Overall Study|Lost to Follow-up|0
290562|NCT01732458|980383|P3|Overall Study|Lost to Follow-up|0
290563|NCT01732458|980384|P2|Overall Study|Lost to Follow-up|2
290564|NCT01732458|980385|P1|Overall Study|Lost to Follow-up|0
290565|NCT01731990|980499|P2|Overall Study|Death|0
290566|NCT01731990|980500|P1|Overall Study|Death|1
290567|NCT01731990|980499|P2|Overall Study|Protocol deviation|2
290568|NCT01731990|980500|P1|Overall Study|Protocol deviation|1
290569|NCT01731990|980499|P2|Overall Study|Withdrawal by Subject|1
290570|NCT01731990|980500|P1|Overall Study|Withdrawal by Subject|1
290571|NCT01731990|980499|P2|Overall Study|Adverse Event|5
290572|NCT01731990|980500|P1|Overall Study|Adverse Event|1
290573|NCT01731938|980516|P2|Primary Part II|Missed Week 6 visit|3
290574|NCT01731938|980517|P1|Primary Part II|Missed Week 6 visit|2
290575|NCT01731938|980516|P2|Primary Part II|Death|1
290576|NCT01731938|980517|P1|Primary Part II|Death|2
290577|NCT01731938|980516|P2|Primary Part II|Lost to Follow-up|5
290578|NCT01731938|980517|P1|Primary Part II|Lost to Follow-up|4
290579|NCT01731938|980516|P2|Primary Part II|Withdrawal by Subject|4
290580|NCT01731938|980517|P1|Primary Part II|Withdrawal by Subject|5
290581|NCT01731938|980516|P2|Preliminary Part I|Missed Week 6 visit|3
290582|NCT01731938|980517|P1|Preliminary Part I|Missed Week 6 visit|0
290583|NCT01731938|980516|P2|Preliminary Part I|Lost to Follow-up|3
290584|NCT01731938|980517|P1|Preliminary Part I|Lost to Follow-up|0
290585|NCT01731938|980516|P2|Preliminary Part I|Physician Decision|0
290586|NCT01731938|980517|P1|Preliminary Part I|Physician Decision|1
290587|NCT01731938|980516|P2|Preliminary Part I|Withdrawal by Subject|2
290588|NCT01731938|980517|P1|Preliminary Part I|Withdrawal by Subject|2
290589|NCT01731470|980529|P1|Overall Study|Did not meet study criteria|1
290590|NCT01731470|980529|P1|Overall Study|Withdrawal by Subject|1
290591|NCT01731002|980556|P3|Overall Study|Inappropriate use of study medications|1
290592|NCT01731002|980557|P2|Overall Study|Inappropriate use of study medications|0
290593|NCT01731002|980558|P1|Overall Study|Inappropriate use of study medications|0
290594|NCT01731002|980556|P3|Overall Study|Elevated IOP|0
290595|NCT01731002|980557|P2|Overall Study|Elevated IOP|0
290596|NCT01731002|980558|P1|Overall Study|Elevated IOP|1
290597|NCT01731002|980556|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
290598|NCT01731002|980557|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
290599|NCT01731002|980558|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
290600|NCT01731002|980556|P3|Overall Study|Test Agent Discontinuation|0
290601|NCT01731002|980557|P2|Overall Study|Test Agent Discontinuation|1
290602|NCT01731002|980558|P1|Overall Study|Test Agent Discontinuation|0
290603|NCT01731002|980556|P3|Overall Study|Lost to Follow-up|0
290604|NCT01731002|980557|P2|Overall Study|Lost to Follow-up|0
290605|NCT01731002|980558|P1|Overall Study|Lost to Follow-up|1
290606|NCT01731002|980556|P3|Overall Study|Non-Compliant|0
290607|NCT01731002|980557|P2|Overall Study|Non-Compliant|1
290608|NCT01731002|980558|P1|Overall Study|Non-Compliant|0
290609|NCT01731002|980556|P3|Overall Study|Adverse Event|2
290610|NCT01731002|980557|P2|Overall Study|Adverse Event|2
290611|NCT01731002|980558|P1|Overall Study|Adverse Event|0
290612|NCT01730378|980587|P2|Overall Study|Lost to Follow-up|0
290613|NCT01730378|980588|P1|Overall Study|Lost to Follow-up|1
290614|NCT01730339|980619|P2|Overall Study|Un-specified|0
290615|NCT01730339|980620|P1|Overall Study|Un-specified|1
290616|NCT01730339|980619|P2|Overall Study|Lost to Follow-up|1
290617|NCT01730339|980620|P1|Overall Study|Lost to Follow-up|1
290618|NCT01730339|980619|P2|Overall Study|Withdrawal by Subject|2
290619|NCT01730339|980620|P1|Overall Study|Withdrawal by Subject|3
290620|NCT01730053|980660|P6|Overall Study|Other than specified|9
290621|NCT01730053|980661|P5|Overall Study|Other than specified|7
290622|NCT01730053|980662|P4|Overall Study|Other than specified|4
290623|NCT01730053|980663|P3|Overall Study|Other than specified|5
290624|NCT01730053|980664|P2|Overall Study|Other than specified|6
290625|NCT01730053|980665|P1|Overall Study|Other than specified|2
290626|NCT01730053|980660|P6|Overall Study|Poor compliance to protocol|2
290627|NCT01730053|980661|P5|Overall Study|Poor compliance to protocol|0
290628|NCT01730053|980662|P4|Overall Study|Poor compliance to protocol|0
290629|NCT01730053|980663|P3|Overall Study|Poor compliance to protocol|2
290630|NCT01730053|980664|P2|Overall Study|Poor compliance to protocol|2
290631|NCT01730053|980665|P1|Overall Study|Poor compliance to protocol|1
290632|NCT01730053|980660|P6|Overall Study|Adverse Event|2
290633|NCT01730053|980661|P5|Overall Study|Adverse Event|2
290634|NCT01730053|980662|P4|Overall Study|Adverse Event|3
290635|NCT01730053|980663|P3|Overall Study|Adverse Event|3
290636|NCT01730053|980664|P2|Overall Study|Adverse Event|6
290637|NCT01730053|980665|P1|Overall Study|Adverse Event|2
290638|NCT01730053|980660|P6|Overall Study|Physician Decision|0
290639|NCT01730053|980661|P5|Overall Study|Physician Decision|0
290640|NCT01730053|980662|P4|Overall Study|Physician Decision|1
290641|NCT01730053|980663|P3|Overall Study|Physician Decision|0
290642|NCT01730053|980664|P2|Overall Study|Physician Decision|0
290643|NCT01730053|980665|P1|Overall Study|Physician Decision|0
290644|NCT01730053|980660|P6|Overall Study|Participant moved|0
290645|NCT01730053|980661|P5|Overall Study|Participant moved|0
290646|NCT01730053|980662|P4|Overall Study|Participant moved|0
290647|NCT01730053|980663|P3|Overall Study|Participant moved|1
290648|NCT01730053|980664|P2|Overall Study|Participant moved|0
290649|NCT01730053|980665|P1|Overall Study|Participant moved|0
290650|NCT01730040|980824|P7|Overall Study|Poor compliance to protocol|1
290651|NCT01730040|980825|P6|Overall Study|Poor compliance to protocol|0
290652|NCT01730040|980826|P5|Overall Study|Poor compliance to protocol|0
290653|NCT01730040|980827|P4|Overall Study|Poor compliance to protocol|0
290654|NCT01730040|980828|P3|Overall Study|Poor compliance to protocol|0
290655|NCT01730040|980829|P2|Overall Study|Poor compliance to protocol|4
290656|NCT01730040|980830|P1|Overall Study|Poor compliance to protocol|2
290657|NCT01730040|980824|P7|Overall Study|Adverse Event|2
290658|NCT01730040|980825|P6|Overall Study|Adverse Event|1
290659|NCT01730040|980826|P5|Overall Study|Adverse Event|1
290660|NCT01730040|980827|P4|Overall Study|Adverse Event|3
290661|NCT01730040|980828|P3|Overall Study|Adverse Event|5
290662|NCT01730040|980829|P2|Overall Study|Adverse Event|3
290663|NCT01730040|980830|P1|Overall Study|Adverse Event|4
290664|NCT01730040|980824|P7|Overall Study|Other than specified|4
290665|NCT01730040|980825|P6|Overall Study|Other than specified|4
290666|NCT01730040|980826|P5|Overall Study|Other than specified|5
290667|NCT01730040|980827|P4|Overall Study|Other than specified|5
290668|NCT01730040|980828|P3|Overall Study|Other than specified|5
290669|NCT01730040|980829|P2|Overall Study|Other than specified|8
290670|NCT01730040|980830|P1|Overall Study|Other than specified|7
290671|NCT01730040|980824|P7|Overall Study|Physician Decision|1
290672|NCT01730040|980825|P6|Overall Study|Physician Decision|1
290673|NCT01730040|980826|P5|Overall Study|Physician Decision|0
290674|NCT01730040|980827|P4|Overall Study|Physician Decision|0
290675|NCT01730040|980828|P3|Overall Study|Physician Decision|0
290676|NCT01730040|980829|P2|Overall Study|Physician Decision|0
290677|NCT01730040|980830|P1|Overall Study|Physician Decision|0
290678|NCT01730040|980824|P7|Overall Study|Subject moved|1
290679|NCT01730040|980825|P6|Overall Study|Subject moved|0
290680|NCT01730040|980826|P5|Overall Study|Subject moved|0
290681|NCT01730040|980827|P4|Overall Study|Subject moved|0
290682|NCT01730040|980828|P3|Overall Study|Subject moved|1
290683|NCT01730040|980829|P2|Overall Study|Subject moved|0
290684|NCT01730040|980830|P1|Overall Study|Subject moved|0
290685|NCT01730040|980824|P7|Overall Study|Randomized but not treated|0
290686|NCT01730040|980825|P6|Overall Study|Randomized but not treated|1
290687|NCT01730040|980826|P5|Overall Study|Randomized but not treated|0
290688|NCT01730040|980827|P4|Overall Study|Randomized but not treated|0
290689|NCT01730040|980828|P3|Overall Study|Randomized but not treated|0
290690|NCT01730040|980829|P2|Overall Study|Randomized but not treated|0
290691|NCT01730040|980830|P1|Overall Study|Randomized but not treated|0
290692|NCT01729871|981019|P2|Overall Study|Other|9
290693|NCT01729871|981020|P1|Overall Study|Other|4
290694|NCT01729871|981019|P2|Overall Study|Withdrawal by Subject|3
290695|NCT01729871|981020|P1|Overall Study|Withdrawal by Subject|0
290696|NCT01729871|981019|P2|Overall Study|Protocol Violation|0
290697|NCT01729871|981020|P1|Overall Study|Protocol Violation|1
290698|NCT01729871|981019|P2|Overall Study|Physician Decision|2
290699|NCT01729871|981020|P1|Overall Study|Physician Decision|0
290700|NCT01729871|981019|P2|Overall Study|Lack of Efficacy|1
290701|NCT01729871|981020|P1|Overall Study|Lack of Efficacy|0
290702|NCT01729871|981019|P2|Overall Study|Death|1
290703|NCT01729871|981020|P1|Overall Study|Death|0
290704|NCT01729871|981019|P2|Overall Study|Adverse Event|7
290705|NCT01729871|981020|P1|Overall Study|Adverse Event|7
290706|NCT01729754|981056|P10|Part 3|Other Protocol Specified Criteria|0
290707|NCT01729754|981057|P9|Part 3|Other Protocol Specified Criteria|0
290708|NCT01729754|981058|P8|Part 3|Other Protocol Specified Criteria|1
290709|NCT01729754|981059|P7|Part 3|Other Protocol Specified Criteria|0
290710|NCT01729754|981060|P6|Part 3|Other Protocol Specified Criteria|2
290711|NCT01729754|981061|P5|Part 3|Other Protocol Specified Criteria|0
290712|NCT01729754|981062|P4|Part 3|Other Protocol Specified Criteria|0
290713|NCT01729754|981063|P3|Part 3|Other Protocol Specified Criteria|0
290714|NCT01729754|981064|P2|Part 3|Other Protocol Specified Criteria|0
290715|NCT01729754|981065|P1|Part 3|Other Protocol Specified Criteria|0
290716|NCT01729754|981056|P10|Part 3|Withdrawal by Subject|0
290717|NCT01729754|981057|P9|Part 3|Withdrawal by Subject|0
290718|NCT01729754|981058|P8|Part 3|Withdrawal by Subject|2
290719|NCT01729754|981059|P7|Part 3|Withdrawal by Subject|0
290720|NCT01729754|981060|P6|Part 3|Withdrawal by Subject|1
290721|NCT01729754|981061|P5|Part 3|Withdrawal by Subject|2
290722|NCT01729754|981062|P4|Part 3|Withdrawal by Subject|0
290723|NCT01729754|981063|P3|Part 3|Withdrawal by Subject|1
290724|NCT01729754|981064|P2|Part 3|Withdrawal by Subject|4
290725|NCT01729754|981065|P1|Part 3|Withdrawal by Subject|0
290726|NCT01729754|981056|P10|Part 3|Physician Decision|0
290727|NCT01729754|981057|P9|Part 3|Physician Decision|0
290728|NCT01729754|981058|P8|Part 3|Physician Decision|0
290729|NCT01729754|981059|P7|Part 3|Physician Decision|0
290730|NCT01729754|981060|P6|Part 3|Physician Decision|0
290731|NCT01729754|981061|P5|Part 3|Physician Decision|0
290732|NCT01729754|981062|P4|Part 3|Physician Decision|0
290733|NCT01729754|981063|P3|Part 3|Physician Decision|1
290734|NCT01729754|981064|P2|Part 3|Physician Decision|0
290735|NCT01729754|981065|P1|Part 3|Physician Decision|0
290736|NCT01729754|981056|P10|Part 3|Lost to Follow-up|0
290737|NCT01729754|981057|P9|Part 3|Lost to Follow-up|1
290738|NCT01729754|981058|P8|Part 3|Lost to Follow-up|0
290739|NCT01729754|981059|P7|Part 3|Lost to Follow-up|0
290740|NCT01729754|981060|P6|Part 3|Lost to Follow-up|3
290741|NCT01729754|981061|P5|Part 3|Lost to Follow-up|0
290742|NCT01729754|981062|P4|Part 3|Lost to Follow-up|0
290743|NCT01729754|981063|P3|Part 3|Lost to Follow-up|2
290744|NCT01729754|981064|P2|Part 3|Lost to Follow-up|1
290745|NCT01729754|981065|P1|Part 3|Lost to Follow-up|0
290746|NCT01729754|981056|P10|Part 3|Lack of Efficacy|4
290747|NCT01729754|981057|P9|Part 3|Lack of Efficacy|0
290748|NCT01729754|981058|P8|Part 3|Lack of Efficacy|0
290749|NCT01729754|981059|P7|Part 3|Lack of Efficacy|0
290750|NCT01729754|981060|P6|Part 3|Lack of Efficacy|0
290751|NCT01729754|981061|P5|Part 3|Lack of Efficacy|2
290752|NCT01729754|981062|P4|Part 3|Lack of Efficacy|0
290753|NCT01729754|981063|P3|Part 3|Lack of Efficacy|0
290754|NCT01729754|981064|P2|Part 3|Lack of Efficacy|0
290755|NCT01729754|981065|P1|Part 3|Lack of Efficacy|0
290756|NCT01729754|981056|P10|Part 3|Death|0
290757|NCT01729754|981057|P9|Part 3|Death|0
290766|NCT01729754|981056|P10|Part 3|Adverse Event|3
290767|NCT01729754|981057|P9|Part 3|Adverse Event|0
290768|NCT01729754|981058|P8|Part 3|Adverse Event|0
290769|NCT01729754|981059|P7|Part 3|Adverse Event|0
290770|NCT01729754|981060|P6|Part 3|Adverse Event|5
290771|NCT01729754|981061|P5|Part 3|Adverse Event|0
290772|NCT01729754|981062|P4|Part 3|Adverse Event|0
290773|NCT01729754|981063|P3|Part 3|Adverse Event|1
290774|NCT01729754|981064|P2|Part 3|Adverse Event|0
290775|NCT01729754|981065|P1|Part 3|Adverse Event|0
290776|NCT01729754|981056|P10|Part 2|Other Protocol Specified Criteria|0
290777|NCT01729754|981057|P9|Part 2|Other Protocol Specified Criteria|0
290778|NCT01729754|981058|P8|Part 2|Other Protocol Specified Criteria|1
290779|NCT01729754|981059|P7|Part 2|Other Protocol Specified Criteria|0
290780|NCT01729754|981060|P6|Part 2|Other Protocol Specified Criteria|0
290781|NCT01729754|981061|P5|Part 2|Other Protocol Specified Criteria|0
290782|NCT01729754|981062|P4|Part 2|Other Protocol Specified Criteria|0
290783|NCT01729754|981063|P3|Part 2|Other Protocol Specified Criteria|0
290784|NCT01729754|981064|P2|Part 2|Other Protocol Specified Criteria|0
290785|NCT01729754|981065|P1|Part 2|Other Protocol Specified Criteria|1
290786|NCT01729754|981056|P10|Part 2|Withdrawal by Subject|4
290787|NCT01729754|981057|P9|Part 2|Withdrawal by Subject|1
290788|NCT01729754|981058|P8|Part 2|Withdrawal by Subject|1
290789|NCT01729754|981059|P7|Part 2|Withdrawal by Subject|0
290790|NCT01729754|981060|P6|Part 2|Withdrawal by Subject|0
290791|NCT01729754|981061|P5|Part 2|Withdrawal by Subject|0
290792|NCT01729754|981062|P4|Part 2|Withdrawal by Subject|2
290793|NCT01729754|981063|P3|Part 2|Withdrawal by Subject|0
290794|NCT01729754|981064|P2|Part 2|Withdrawal by Subject|0
290795|NCT01729754|981065|P1|Part 2|Withdrawal by Subject|3
290796|NCT01729754|981056|P10|Part 2|Pregnancy|1
290797|NCT01729754|981057|P9|Part 2|Pregnancy|0
290798|NCT01729754|981058|P8|Part 2|Pregnancy|0
290799|NCT01729754|981059|P7|Part 2|Pregnancy|0
290800|NCT01729754|981060|P6|Part 2|Pregnancy|0
290801|NCT01729754|981061|P5|Part 2|Pregnancy|0
290802|NCT01729754|981062|P4|Part 2|Pregnancy|1
290803|NCT01729754|981063|P3|Part 2|Pregnancy|0
290804|NCT01729754|981064|P2|Part 2|Pregnancy|0
290805|NCT01729754|981065|P1|Part 2|Pregnancy|0
290806|NCT01729754|981056|P10|Part 2|Non-Compliance with Study Drug|1
290807|NCT01729754|981057|P9|Part 2|Non-Compliance with Study Drug|0
290808|NCT01729754|981058|P8|Part 2|Non-Compliance with Study Drug|0
290809|NCT01729754|981059|P7|Part 2|Non-Compliance with Study Drug|0
290810|NCT01729754|981060|P6|Part 2|Non-Compliance with Study Drug|0
290811|NCT01729754|981061|P5|Part 2|Non-Compliance with Study Drug|0
290812|NCT01729754|981062|P4|Part 2|Non-Compliance with Study Drug|0
290813|NCT01729754|981063|P3|Part 2|Non-Compliance with Study Drug|0
290814|NCT01729754|981064|P2|Part 2|Non-Compliance with Study Drug|0
290815|NCT01729754|981065|P1|Part 2|Non-Compliance with Study Drug|0
290816|NCT01729754|981056|P10|Part 2|Lost to Follow-up|2
290817|NCT01729754|981057|P9|Part 2|Lost to Follow-up|0
290818|NCT01729754|981058|P8|Part 2|Lost to Follow-up|1
290819|NCT01729754|981059|P7|Part 2|Lost to Follow-up|0
290820|NCT01729754|981060|P6|Part 2|Lost to Follow-up|0
290821|NCT01729754|981061|P5|Part 2|Lost to Follow-up|0
290822|NCT01729754|981062|P4|Part 2|Lost to Follow-up|2
290823|NCT01729754|981063|P3|Part 2|Lost to Follow-up|0
290824|NCT01729754|981064|P2|Part 2|Lost to Follow-up|0
290825|NCT01729754|981065|P1|Part 2|Lost to Follow-up|0
290826|NCT01729754|981056|P10|Part 2|Lack of Efficacy|2
290827|NCT01729754|981057|P9|Part 2|Lack of Efficacy|2
290828|NCT01729754|981058|P8|Part 2|Lack of Efficacy|0
290829|NCT01729754|981059|P7|Part 2|Lack of Efficacy|0
290830|NCT01729754|981060|P6|Part 2|Lack of Efficacy|0
290831|NCT01729754|981061|P5|Part 2|Lack of Efficacy|0
290832|NCT01729754|981062|P4|Part 2|Lack of Efficacy|0
290833|NCT01729754|981063|P3|Part 2|Lack of Efficacy|0
290834|NCT01729754|981064|P2|Part 2|Lack of Efficacy|0
290835|NCT01729754|981065|P1|Part 2|Lack of Efficacy|0
290836|NCT01729754|981056|P10|Part 2|Adverse Event|2
290837|NCT01729754|981057|P9|Part 2|Adverse Event|1
290838|NCT01729754|981058|P8|Part 2|Adverse Event|0
290839|NCT01729754|981059|P7|Part 2|Adverse Event|0
290840|NCT01729754|981060|P6|Part 2|Adverse Event|0
290841|NCT01729754|981061|P5|Part 2|Adverse Event|0
290842|NCT01729754|981062|P4|Part 2|Adverse Event|0
290843|NCT01729754|981063|P3|Part 2|Adverse Event|0
290844|NCT01729754|981064|P2|Part 2|Adverse Event|0
290845|NCT01729754|981065|P1|Part 2|Adverse Event|2
290846|NCT01729754|981056|P10|Part 1|Other Protocol Specified Criteria|4
290847|NCT01729754|981057|P9|Part 1|Other Protocol Specified Criteria|0
290848|NCT01729754|981058|P8|Part 1|Other Protocol Specified Criteria|0
290849|NCT01729754|981059|P7|Part 1|Other Protocol Specified Criteria|1
290850|NCT01729754|981060|P6|Part 1|Other Protocol Specified Criteria|0
290851|NCT01729754|981061|P5|Part 1|Other Protocol Specified Criteria|0
290852|NCT01729754|981062|P4|Part 1|Other Protocol Specified Criteria|0
290853|NCT01729754|981063|P3|Part 1|Other Protocol Specified Criteria|0
290854|NCT01729754|981064|P2|Part 1|Other Protocol Specified Criteria|0
290855|NCT01729754|981065|P1|Part 1|Other Protocol Specified Criteria|2
290856|NCT01729754|981056|P10|Part 1|Withdrawal by Subject|6
290857|NCT01729754|981057|P9|Part 1|Withdrawal by Subject|0
290858|NCT01729754|981058|P8|Part 1|Withdrawal by Subject|0
290859|NCT01729754|981059|P7|Part 1|Withdrawal by Subject|5
290860|NCT01729754|981060|P6|Part 1|Withdrawal by Subject|0
290861|NCT01729754|981061|P5|Part 1|Withdrawal by Subject|0
290862|NCT01729754|981062|P4|Part 1|Withdrawal by Subject|7
290863|NCT01729754|981063|P3|Part 1|Withdrawal by Subject|0
290864|NCT01729754|981064|P2|Part 1|Withdrawal by Subject|0
290865|NCT01729754|981065|P1|Part 1|Withdrawal by Subject|5
290866|NCT01729754|981056|P10|Part 1|Protocol Violation|0
290867|NCT01729754|981057|P9|Part 1|Protocol Violation|0
290868|NCT01729754|981058|P8|Part 1|Protocol Violation|0
290869|NCT01729754|981059|P7|Part 1|Protocol Violation|1
290870|NCT01729754|981060|P6|Part 1|Protocol Violation|0
290871|NCT01729754|981061|P5|Part 1|Protocol Violation|0
290872|NCT01729754|981062|P4|Part 1|Protocol Violation|1
290873|NCT01729754|981063|P3|Part 1|Protocol Violation|0
290874|NCT01729754|981064|P2|Part 1|Protocol Violation|0
290875|NCT01729754|981065|P1|Part 1|Protocol Violation|2
290876|NCT01729754|981056|P10|Part 1|Progressive Disease|1
290877|NCT01729754|981057|P9|Part 1|Progressive Disease|0
290878|NCT01729754|981058|P8|Part 1|Progressive Disease|0
290879|NCT01729754|981059|P7|Part 1|Progressive Disease|0
290880|NCT01729754|981060|P6|Part 1|Progressive Disease|0
290881|NCT01729754|981061|P5|Part 1|Progressive Disease|0
290882|NCT01729754|981062|P4|Part 1|Progressive Disease|0
290883|NCT01729754|981063|P3|Part 1|Progressive Disease|0
290884|NCT01729754|981064|P2|Part 1|Progressive Disease|0
290885|NCT01729754|981065|P1|Part 1|Progressive Disease|0
290886|NCT01729754|981056|P10|Part 1|Pregnancy|1
290887|NCT01729754|981057|P9|Part 1|Pregnancy|0
290888|NCT01729754|981058|P8|Part 1|Pregnancy|0
290889|NCT01729754|981059|P7|Part 1|Pregnancy|0
290890|NCT01729754|981060|P6|Part 1|Pregnancy|0
290891|NCT01729754|981061|P5|Part 1|Pregnancy|0
290892|NCT01729754|981062|P4|Part 1|Pregnancy|1
290893|NCT01729754|981063|P3|Part 1|Pregnancy|0
290894|NCT01729754|981064|P2|Part 1|Pregnancy|0
290895|NCT01729754|981065|P1|Part 1|Pregnancy|0
290896|NCT01729754|981056|P10|Part 1|Physician Decision|4
290897|NCT01729754|981057|P9|Part 1|Physician Decision|0
290898|NCT01729754|981058|P8|Part 1|Physician Decision|0
290899|NCT01729754|981059|P7|Part 1|Physician Decision|0
290900|NCT01729754|981060|P6|Part 1|Physician Decision|0
290901|NCT01729754|981061|P5|Part 1|Physician Decision|0
290902|NCT01729754|981062|P4|Part 1|Physician Decision|0
290903|NCT01729754|981063|P3|Part 1|Physician Decision|0
290904|NCT01729754|981064|P2|Part 1|Physician Decision|0
290905|NCT01729754|981065|P1|Part 1|Physician Decision|0
290906|NCT01729754|981056|P10|Part 1|Non-compliance with Study Drug|0
290907|NCT01729754|981057|P9|Part 1|Non-compliance with Study Drug|0
290908|NCT01729754|981058|P8|Part 1|Non-compliance with Study Drug|0
290909|NCT01729754|981059|P7|Part 1|Non-compliance with Study Drug|0
290910|NCT01729754|981060|P6|Part 1|Non-compliance with Study Drug|0
290911|NCT01729754|981061|P5|Part 1|Non-compliance with Study Drug|0
290912|NCT01729754|981062|P4|Part 1|Non-compliance with Study Drug|0
290913|NCT01729754|981063|P3|Part 1|Non-compliance with Study Drug|0
290914|NCT01729754|981064|P2|Part 1|Non-compliance with Study Drug|0
290915|NCT01729754|981065|P1|Part 1|Non-compliance with Study Drug|1
290916|NCT01729754|981056|P10|Part 1|Lost to Follow-up|3
290917|NCT01729754|981057|P9|Part 1|Lost to Follow-up|0
290918|NCT01729754|981058|P8|Part 1|Lost to Follow-up|0
290919|NCT01729754|981059|P7|Part 1|Lost to Follow-up|3
290920|NCT01729754|981060|P6|Part 1|Lost to Follow-up|0
290921|NCT01729754|981061|P5|Part 1|Lost to Follow-up|0
290922|NCT01729754|981062|P4|Part 1|Lost to Follow-up|2
290923|NCT01729754|981063|P3|Part 1|Lost to Follow-up|0
290924|NCT01729754|981064|P2|Part 1|Lost to Follow-up|0
290925|NCT01729754|981065|P1|Part 1|Lost to Follow-up|1
290926|NCT01729754|981056|P10|Part 1|Lack of Efficacy|0
290927|NCT01729754|981057|P9|Part 1|Lack of Efficacy|0
290928|NCT01729754|981058|P8|Part 1|Lack of Efficacy|0
290929|NCT01729754|981059|P7|Part 1|Lack of Efficacy|2
290930|NCT01729754|981060|P6|Part 1|Lack of Efficacy|0
290931|NCT01729754|981061|P5|Part 1|Lack of Efficacy|0
290932|NCT01729754|981062|P4|Part 1|Lack of Efficacy|0
290933|NCT01729754|981063|P3|Part 1|Lack of Efficacy|0
290934|NCT01729754|981064|P2|Part 1|Lack of Efficacy|0
290935|NCT01729754|981065|P1|Part 1|Lack of Efficacy|1
290936|NCT01729754|981056|P10|Part 1|Adverse Event|5
290937|NCT01729754|981057|P9|Part 1|Adverse Event|0
290938|NCT01729754|981058|P8|Part 1|Adverse Event|0
290939|NCT01729754|981059|P7|Part 1|Adverse Event|2
290940|NCT01729754|981060|P6|Part 1|Adverse Event|0
290941|NCT01729754|981061|P5|Part 1|Adverse Event|0
290942|NCT01729754|981062|P4|Part 1|Adverse Event|1
290943|NCT01729754|981063|P3|Part 1|Adverse Event|0
290944|NCT01729754|981064|P2|Part 1|Adverse Event|0
290945|NCT01729754|981065|P1|Part 1|Adverse Event|2
290946|NCT01729728|981272|P3|Overall Study|Protocol Violation|1
290947|NCT01729728|981273|P2|Overall Study|Protocol Violation|0
290948|NCT01729728|981274|P1|Overall Study|Protocol Violation|1
290949|NCT01729728|981272|P3|Overall Study|Adverse Event|0
290950|NCT01729728|981273|P2|Overall Study|Adverse Event|6
290951|NCT01729728|981274|P1|Overall Study|Adverse Event|0
290952|NCT01729559|981407|P2|Overall Study|Protocol Violation|28
290953|NCT01729559|981408|P1|Overall Study|Protocol Violation|31
290954|NCT01729026|981451|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
291125|NCT01727700|981843|P2|Overall Study|Particpant withdrew consent|3
290955|NCT01729026|981452|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
290956|NCT01729026|981451|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
290957|NCT01729026|981452|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
290958|NCT01728792|981463|P5|Overall Study|Lost to Follow-up|0
290959|NCT01728792|981464|P4|Overall Study|Lost to Follow-up|2
290960|NCT01728792|981465|P3|Overall Study|Lost to Follow-up|4
290961|NCT01728792|981466|P2|Overall Study|Lost to Follow-up|1
290962|NCT01728792|981467|P1|Overall Study|Lost to Follow-up|2
290963|NCT01728792|981463|P5|Overall Study|Withdrawal of Consent|0
290964|NCT01728792|981464|P4|Overall Study|Withdrawal of Consent|1
290965|NCT01728792|981465|P3|Overall Study|Withdrawal of Consent|0
290966|NCT01728792|981466|P2|Overall Study|Withdrawal of Consent|1
290967|NCT01728792|981467|P1|Overall Study|Withdrawal of Consent|1
290968|NCT01728584|981518|P4|Overall Study|Other reason (not specified)|1
290969|NCT01728584|981519|P3|Overall Study|Other reason (not specified)|0
290970|NCT01728584|981520|P2|Overall Study|Other reason (not specified)|0
290971|NCT01728584|981521|P1|Overall Study|Other reason (not specified)|1
290972|NCT01728584|981518|P4|Overall Study|Screen failure|0
290973|NCT01728584|981519|P3|Overall Study|Screen failure|0
290974|NCT01728584|981520|P2|Overall Study|Screen failure|0
290975|NCT01728584|981521|P1|Overall Study|Screen failure|1
290976|NCT01728584|981518|P4|Overall Study|Withdrawal by Subject|0
290977|NCT01728584|981519|P3|Overall Study|Withdrawal by Subject|0
290978|NCT01728584|981520|P2|Overall Study|Withdrawal by Subject|0
290979|NCT01728584|981521|P1|Overall Study|Withdrawal by Subject|1
290980|NCT01728584|981518|P4|Overall Study|Physician Decision|0
290981|NCT01728584|981519|P3|Overall Study|Physician Decision|1
290982|NCT01728584|981520|P2|Overall Study|Physician Decision|0
290983|NCT01728584|981521|P1|Overall Study|Physician Decision|4
290984|NCT01728584|981518|P4|Overall Study|Adverse Event|0
290985|NCT01728584|981519|P3|Overall Study|Adverse Event|0
290986|NCT01728584|981520|P2|Overall Study|Adverse Event|0
290987|NCT01728584|981521|P1|Overall Study|Adverse Event|1
290988|NCT01728376|981579|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
290989|NCT01728376|981580|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
290990|NCT01728376|981581|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
290991|NCT01728376|981582|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
290992|NCT01728376|981583|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
290993|NCT01728376|981584|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
290994|NCT01728376|981579|P6|Overall Study|Did not receive treatment|0
290995|NCT01728376|981580|P5|Overall Study|Did not receive treatment|0
290996|NCT01728376|981581|P4|Overall Study|Did not receive treatment|0
290997|NCT01728376|981582|P3|Overall Study|Did not receive treatment|0
290998|NCT01728376|981583|P2|Overall Study|Did not receive treatment|1
290999|NCT01728376|981584|P1|Overall Study|Did not receive treatment|0
291000|NCT01728376|981579|P6|Overall Study|No relevant bacteria|1
291001|NCT01728376|981580|P5|Overall Study|No relevant bacteria|1
291002|NCT01728376|981581|P4|Overall Study|No relevant bacteria|0
291003|NCT01728376|981582|P3|Overall Study|No relevant bacteria|0
291004|NCT01728376|981583|P2|Overall Study|No relevant bacteria|0
291005|NCT01728376|981584|P1|Overall Study|No relevant bacteria|2
291006|NCT01728376|981579|P6|Overall Study|Persistent Positive Blood Cultures|0
291007|NCT01728376|981580|P5|Overall Study|Persistent Positive Blood Cultures|0
291008|NCT01728376|981581|P4|Overall Study|Persistent Positive Blood Cultures|0
291009|NCT01728376|981582|P3|Overall Study|Persistent Positive Blood Cultures|1
291010|NCT01728376|981583|P2|Overall Study|Persistent Positive Blood Cultures|0
291011|NCT01728376|981584|P1|Overall Study|Persistent Positive Blood Cultures|1
291012|NCT01728376|981579|P6|Overall Study|Adverse Event|0
291013|NCT01728376|981580|P5|Overall Study|Adverse Event|1
291014|NCT01728376|981581|P4|Overall Study|Adverse Event|1
291015|NCT01728376|981582|P3|Overall Study|Adverse Event|1
291016|NCT01728376|981583|P2|Overall Study|Adverse Event|1
291017|NCT01728376|981584|P1|Overall Study|Adverse Event|1
291018|NCT01728324|981657|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
291019|NCT01728324|981658|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
291020|NCT01728324|981659|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
291021|NCT01728324|981657|P3|Termination of RBV|Adverse Event (Placebo Period)|0
291022|NCT01728324|981658|P2|Termination of RBV|Adverse Event (Placebo Period)|1
291023|NCT01728324|981659|P1|Termination of RBV|Adverse Event (Placebo Period)|0
291024|NCT01728324|981657|P3|Termination of RBV|Other than stated|1
291025|NCT01728324|981658|P2|Termination of RBV|Other than stated|3
291026|NCT01728324|981659|P1|Termination of RBV|Other than stated|1
291027|NCT01728324|981657|P3|Termination of RBV|Withdrawal by Subject|2
291028|NCT01728324|981658|P2|Termination of RBV|Withdrawal by Subject|5
291029|NCT01728324|981659|P1|Termination of RBV|Withdrawal by Subject|9
291030|NCT01728324|981657|P3|Termination of RBV|Lack of Efficacy|7
291031|NCT01728324|981658|P2|Termination of RBV|Lack of Efficacy|11
291032|NCT01728324|981659|P1|Termination of RBV|Lack of Efficacy|14
291033|NCT01728324|981657|P3|Termination of RBV|Adverse Event|5
291034|NCT01728324|981658|P2|Termination of RBV|Adverse Event|16
291035|NCT01728324|981659|P1|Termination of RBV|Adverse Event|15
291036|NCT01728324|981657|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
291037|NCT01728324|981658|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
291038|NCT01728324|981659|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
291039|NCT01728324|981657|P3|Termination of FDV|Adverse Event (Placebo Period)|0
291040|NCT01728324|981658|P2|Termination of FDV|Adverse Event (Placebo Period)|1
291041|NCT01728324|981659|P1|Termination of FDV|Adverse Event (Placebo Period)|0
291042|NCT01728324|981657|P3|Termination of FDV|Other than stated|0
291043|NCT01728324|981658|P2|Termination of FDV|Other than stated|3
291044|NCT01728324|981659|P1|Termination of FDV|Other than stated|1
291045|NCT01728324|981657|P3|Termination of FDV|Withdrawal by Subject|2
291046|NCT01728324|981658|P2|Termination of FDV|Withdrawal by Subject|6
291047|NCT01728324|981659|P1|Termination of FDV|Withdrawal by Subject|9
291048|NCT01728324|981657|P3|Termination of FDV|Lack of Efficacy|8
291049|NCT01728324|981658|P2|Termination of FDV|Lack of Efficacy|12
291050|NCT01728324|981659|P1|Termination of FDV|Lack of Efficacy|14
291051|NCT01728324|981657|P3|Termination of FDV|Adverse Event|4
291052|NCT01728324|981658|P2|Termination of FDV|Adverse Event|13
291053|NCT01728324|981659|P1|Termination of FDV|Adverse Event|14
291054|NCT01728324|981657|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
291055|NCT01728324|981658|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
291056|NCT01728324|981659|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
291057|NCT01728324|981657|P3|Termination of DBV|Adverse Event (Placebo Period)|0
291058|NCT01728324|981658|P2|Termination of DBV|Adverse Event (Placebo Period)|1
291059|NCT01728324|981659|P1|Termination of DBV|Adverse Event (Placebo Period)|0
291060|NCT01728324|981657|P3|Termination of DBV|Other than stated|0
291061|NCT01728324|981658|P2|Termination of DBV|Other than stated|3
291062|NCT01728324|981659|P1|Termination of DBV|Other than stated|1
291063|NCT01728324|981657|P3|Termination of DBV|Withdrawal by Subject|2
291064|NCT01728324|981658|P2|Termination of DBV|Withdrawal by Subject|6
291065|NCT01728324|981659|P1|Termination of DBV|Withdrawal by Subject|9
291066|NCT01728324|981657|P3|Termination of DBV|Lack of Efficacy|8
291067|NCT01728324|981658|P2|Termination of DBV|Lack of Efficacy|12
291068|NCT01728324|981659|P1|Termination of DBV|Lack of Efficacy|14
291069|NCT01728324|981657|P3|Termination of DBV|Adverse Event|4
291070|NCT01728324|981658|P2|Termination of DBV|Adverse Event|13
291071|NCT01728324|981659|P1|Termination of DBV|Adverse Event|14
291072|NCT01728246|981680|P2|Overall Study|Adverse Event|5
291073|NCT01728246|981681|P1|Overall Study|Adverse Event|8
291074|NCT01728246|981680|P2|Overall Study|Lack of Efficacy|1
291075|NCT01728246|981681|P1|Overall Study|Lack of Efficacy|1
291076|NCT01728246|981680|P2|Overall Study|Lost to Follow-up|22
291077|NCT01728246|981681|P1|Overall Study|Lost to Follow-up|23
291078|NCT01728246|981680|P2|Overall Study|Withdrawal by Subject|3
291079|NCT01728246|981681|P1|Overall Study|Withdrawal by Subject|2
291080|NCT01728246|981680|P2|Overall Study|Protocol Violation|0
291081|NCT01728246|981681|P1|Overall Study|Protocol Violation|1
291082|NCT01728246|981680|P2|Overall Study|Participant needed rescue medication|5
291083|NCT01728246|981681|P1|Overall Study|Participant needed rescue medication|1
291084|NCT01728116|981699|P2|Overall Study|various not noted previously|0
291085|NCT01728116|981700|P1|Overall Study|various not noted previously|5
291086|NCT01728116|981699|P2|Overall Study|Incorrectly enrolled in Study|1
291087|NCT01728116|981700|P1|Overall Study|Incorrectly enrolled in Study|0
291088|NCT01728116|981699|P2|Overall Study|Inter-current finding at procedure|0
291089|NCT01728116|981700|P1|Overall Study|Inter-current finding at procedure|1
291090|NCT01728116|981699|P2|Overall Study|Subject Non-Compliance|0
291091|NCT01728116|981700|P1|Overall Study|Subject Non-Compliance|2
291092|NCT01728116|981699|P2|Overall Study|Physician Decision|0
291093|NCT01728116|981700|P1|Overall Study|Physician Decision|2
291094|NCT01728116|981699|P2|Overall Study|Lost to Follow-up|2
291095|NCT01728116|981700|P1|Overall Study|Lost to Follow-up|9
291096|NCT01728116|981699|P2|Overall Study|Procedure/device failure|0
291097|NCT01728116|981700|P1|Overall Study|Procedure/device failure|7
291098|NCT01728116|981699|P2|Overall Study|Adverse Event|0
291099|NCT01728116|981700|P1|Overall Study|Adverse Event|13
291100|NCT01728116|981699|P2|Overall Study|Withdrawal by Subject|9
291101|NCT01728116|981700|P1|Overall Study|Withdrawal by Subject|16
291102|NCT01728116|981699|P2|Overall Study|Sponsor Terminated Study|35
291103|NCT01728116|981700|P1|Overall Study|Sponsor Terminated Study|106
291104|NCT01728077|981725|P2|Overall Study|Non compliance|0
291105|NCT01728077|981726|P1|Overall Study|Non compliance|1
291106|NCT01728077|981725|P2|Overall Study|Patient moving|0
291107|NCT01728077|981726|P1|Overall Study|Patient moving|1
291108|NCT01728077|981725|P2|Overall Study|Death|1
291109|NCT01728077|981726|P1|Overall Study|Death|0
291110|NCT01728077|981725|P2|Overall Study|Subject choice|3
291111|NCT01728077|981726|P1|Overall Study|Subject choice|2
291112|NCT01728077|981725|P2|Overall Study|Lost to Follow-up|0
291113|NCT01728077|981726|P1|Overall Study|Lost to Follow-up|1
291114|NCT01728077|981725|P2|Overall Study|Lack of Efficacy|1
291115|NCT01728077|981726|P1|Overall Study|Lack of Efficacy|3
291116|NCT01727713|981815|P1|Overall Study|Protocol Deviation|2
291117|NCT01727713|981815|P1|Overall Study|Withdrawal by Subject|13
291118|NCT01727713|981815|P1|Overall Study|Participant Met Withdrawal Criteria|5
291119|NCT01727713|981815|P1|Overall Study|Adverse Event|10
291120|NCT01727713|981815|P1|Overall Study|Lost to Follow-up|5
291121|NCT01727700|981842|P3|Overall Study|Protocol Violation|0
291122|NCT01727700|981843|P2|Overall Study|Protocol Violation|0
291123|NCT01727700|981844|P1|Overall Study|Protocol Violation|2
291124|NCT01727700|981842|P3|Overall Study|Particpant withdrew consent|1
291126|NCT01727700|981844|P1|Overall Study|Particpant withdrew consent|0
291127|NCT01727700|981842|P3|Overall Study|Adverse Event|1
291128|NCT01727700|981843|P2|Overall Study|Adverse Event|7
291129|NCT01727700|981844|P1|Overall Study|Adverse Event|0
291130|NCT01727505|981867|P2|Second 24 Hours|Missing data|1
291131|NCT01727505|981868|P1|Second 24 Hours|Missing data|0
291132|NCT01727505|981867|P2|First 24 Hours|Adverse Event|1
291133|NCT01727505|981868|P1|First 24 Hours|Adverse Event|0
291134|NCT01727297|981893|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
291135|NCT01727297|981894|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
291136|NCT01727297|981893|P2|Overall Study|Physician Decision|5
291137|NCT01727297|981894|P1|Overall Study|Physician Decision|19
291138|NCT01727297|981893|P2|Overall Study|Withdrawal by Subject|27
291139|NCT01727297|981894|P1|Overall Study|Withdrawal by Subject|26
291140|NCT01727297|981893|P2|Overall Study|Lost to Follow-up|0
291141|NCT01727297|981894|P1|Overall Study|Lost to Follow-up|11
291142|NCT01727297|981893|P2|Overall Study|Adverse Event|1
291143|NCT01727297|981894|P1|Overall Study|Adverse Event|3
291144|NCT01727297|981893|P2|Overall Study|Protocol Violation|10
291145|NCT01727297|981894|P1|Overall Study|Protocol Violation|1
291146|NCT01727297|981893|P2|Overall Study|Death|0
291147|NCT01727297|981894|P1|Overall Study|Death|13
291148|NCT01727258|981910|P3|Overall Study|Lost to Follow-up|0
291149|NCT01727258|981911|P2|Overall Study|Lost to Follow-up|0
291150|NCT01727258|981912|P1|Overall Study|Lost to Follow-up|1
291151|NCT01727258|981910|P3|Overall Study|Withdrawal by Subject|0
291152|NCT01727258|981911|P2|Overall Study|Withdrawal by Subject|1
291153|NCT01727258|981912|P1|Overall Study|Withdrawal by Subject|1
291154|NCT01727258|981910|P3|Overall Study|Noncompliance with Study Drug|1
291155|NCT01727258|981911|P2|Overall Study|Noncompliance with Study Drug|0
291156|NCT01727258|981912|P1|Overall Study|Noncompliance with Study Drug|0
291157|NCT01727258|981910|P3|Overall Study|Adverse Event|0
291158|NCT01727258|981911|P2|Overall Study|Adverse Event|2
291159|NCT01727258|981912|P1|Overall Study|Adverse Event|0
291160|NCT01727141|981954|P4|Overall Study|Withdrawal by Subject|11
291161|NCT01727141|981955|P3|Overall Study|Withdrawal by Subject|2
291162|NCT01727141|981956|P2|Overall Study|Withdrawal by Subject|4
291163|NCT01727141|981957|P1|Overall Study|Withdrawal by Subject|4
291164|NCT01727141|981954|P4|Overall Study|Protocol deviation|1
291165|NCT01727141|981955|P3|Overall Study|Protocol deviation|0
291166|NCT01727141|981956|P2|Overall Study|Protocol deviation|1
291167|NCT01727141|981957|P1|Overall Study|Protocol deviation|1
291168|NCT01727141|981954|P4|Overall Study|Death|1
291169|NCT01727141|981955|P3|Overall Study|Death|1
291170|NCT01727141|981956|P2|Overall Study|Death|1
291171|NCT01727141|981957|P1|Overall Study|Death|0
291172|NCT01727141|981954|P4|Overall Study|Lost to Follow-up|0
291173|NCT01727141|981955|P3|Overall Study|Lost to Follow-up|0
291174|NCT01727141|981956|P2|Overall Study|Lost to Follow-up|2
291175|NCT01727141|981957|P1|Overall Study|Lost to Follow-up|0
291176|NCT01727141|981954|P4|Overall Study|Physician Decision|2
291177|NCT01727141|981955|P3|Overall Study|Physician Decision|0
291178|NCT01727141|981956|P2|Overall Study|Physician Decision|1
291179|NCT01727141|981957|P1|Overall Study|Physician Decision|0
291180|NCT01727024|982022|P2|Period 1|Withdrawal by Subject|3
291181|NCT01727024|982023|P1|Period 1|Withdrawal by Subject|2
291182|NCT01727024|982022|P2|Period 1|Lost to Follow-up|1
291183|NCT01727024|982023|P1|Period 1|Lost to Follow-up|1
291184|NCT01726517|982045|P5|Overall Study|Withdrawal by Subject|0
291185|NCT01726517|982046|P4|Overall Study|Withdrawal by Subject|0
291186|NCT01726517|982047|P3|Overall Study|Withdrawal by Subject|1
291187|NCT01726517|982048|P2|Overall Study|Withdrawal by Subject|0
291188|NCT01726517|982049|P1|Overall Study|Withdrawal by Subject|0
291189|NCT01726335|982105|P1|Overall Study|Exacerbation of psychotic symptoms|1
291190|NCT01726335|982105|P1|Overall Study|Lost to Follow-up|2
291191|NCT01726335|982105|P1|Overall Study|Adverse Event|4
291192|NCT01726335|982105|P1|Overall Study|Withdrawal by Subject|15
291193|NCT01726335|982105|P1|Overall Study|Lost to Follow-up|2
291194|NCT01726049|982123|P2|Overall Study|refused second HC|2
291195|NCT01726049|982124|P1|Overall Study|refused second HC|0
291196|NCT01726049|982123|P2|Overall Study|Adverse Event|1
291197|NCT01726049|982124|P1|Overall Study|Adverse Event|4
291198|NCT01726049|982123|P2|Overall Study|Death|1
291199|NCT01726049|982124|P1|Overall Study|Death|1
291200|NCT01726023|982138|P2|Overall Study|Withdrawal by Subject|8
291201|NCT01726023|982139|P1|Overall Study|Withdrawal by Subject|16
291202|NCT01726023|982138|P2|Overall Study|Other Eligibility criteria|7
291203|NCT01726023|982139|P1|Overall Study|Other Eligibility criteria|7
291204|NCT01726023|982138|P2|Overall Study|Lost to Follow-up|10
291205|NCT01726023|982139|P1|Overall Study|Lost to Follow-up|5
291206|NCT01726023|982138|P2|Overall Study|Death|1
291207|NCT01726023|982139|P1|Overall Study|Death|1
291208|NCT01725529|982259|P3|Overall Study|Withdrawal by Subject|8
291209|NCT01725529|982260|P2|Overall Study|Withdrawal by Subject|14
291210|NCT01725529|982261|P1|Overall Study|Withdrawal by Subject|12
291211|NCT01725529|982259|P3|Overall Study|Protocol Violation|1
291212|NCT01725529|982260|P2|Overall Study|Protocol Violation|1
291213|NCT01725529|982261|P1|Overall Study|Protocol Violation|0
291214|NCT01725529|982259|P3|Overall Study|Lost to Follow-up|1
291215|NCT01725529|982260|P2|Overall Study|Lost to Follow-up|1
291216|NCT01725529|982261|P1|Overall Study|Lost to Follow-up|2
291217|NCT01725529|982259|P3|Overall Study|Adverse Event|0
291218|NCT01725529|982260|P2|Overall Study|Adverse Event|0
291219|NCT01725529|982261|P1|Overall Study|Adverse Event|1
291220|NCT01725451|982287|P4|Period 4|Adverse Event|0
291221|NCT01725451|982288|P3|Period 4|Adverse Event|1
291222|NCT01725451|982289|P2|Period 4|Adverse Event|0
291223|NCT01725451|982290|P1|Period 4|Adverse Event|0
291224|NCT01725451|982287|P4|Washout From Period 3|Adverse Event|0
291225|NCT01725451|982288|P3|Washout From Period 3|Adverse Event|0
291226|NCT01725451|982289|P2|Washout From Period 3|Adverse Event|1
291227|NCT01725451|982290|P1|Washout From Period 3|Adverse Event|0
291228|NCT01725451|982287|P4|Washout From Period 3|Protocol Violation|0
291229|NCT01725451|982288|P3|Washout From Period 3|Protocol Violation|1
291230|NCT01725451|982289|P2|Washout From Period 3|Protocol Violation|0
291231|NCT01725451|982290|P1|Washout From Period 3|Protocol Violation|0
291232|NCT01725451|982287|P4|Period 1|Withdrawal by Subject|0
291233|NCT01725451|982288|P3|Period 1|Withdrawal by Subject|0
291234|NCT01725451|982289|P2|Period 1|Withdrawal by Subject|0
291235|NCT01725451|982290|P1|Period 1|Withdrawal by Subject|1
291236|NCT01725386|982312|P2|Overall Study|Withdrawal by Subject|0
291237|NCT01725386|982313|P1|Overall Study|Withdrawal by Subject|10
291238|NCT01725386|982312|P2|Overall Study|Lost to Follow-up|6
291239|NCT01725386|982313|P1|Overall Study|Lost to Follow-up|81
291240|NCT01725386|982312|P2|Overall Study|Death|40
291241|NCT01725386|982313|P1|Overall Study|Death|84
291242|NCT01725308|982332|P3|Treatment Period II|Miscellaneous|7
291243|NCT01725308|982333|P2|Treatment Period II|Miscellaneous|3
291244|NCT01725308|982334|P1|Treatment Period II|Miscellaneous|5
291245|NCT01725308|982332|P3|Treatment Period II|Protocol Deviations|1
291246|NCT01725308|982333|P2|Treatment Period II|Protocol Deviations|0
291247|NCT01725308|982334|P1|Treatment Period II|Protocol Deviations|0
291248|NCT01725308|982332|P3|Treatment Period II|Lost to Follow-up|3
291249|NCT01725308|982333|P2|Treatment Period II|Lost to Follow-up|5
291250|NCT01725308|982334|P1|Treatment Period II|Lost to Follow-up|1
291251|NCT01725308|982332|P3|Treatment Period II|Withdrawal of Consent|16
291252|NCT01725308|982333|P2|Treatment Period II|Withdrawal of Consent|2
291253|NCT01725308|982334|P1|Treatment Period II|Withdrawal of Consent|28
291254|NCT01725308|982332|P3|Treatment Period II|Changes in the Episodes|5
291255|NCT01725308|982333|P2|Treatment Period II|Changes in the Episodes|0
291256|NCT01725308|982334|P1|Treatment Period II|Changes in the Episodes|1
291257|NCT01725308|982332|P3|Treatment Period II|Worsening of the Target Disease|2
291258|NCT01725308|982333|P2|Treatment Period II|Worsening of the Target Disease|4
291259|NCT01725308|982334|P1|Treatment Period II|Worsening of the Target Disease|1
291260|NCT01725308|982332|P3|Treatment Period II|Insufficient Response|6
291261|NCT01725308|982333|P2|Treatment Period II|Insufficient Response|4
291262|NCT01725308|982334|P1|Treatment Period II|Insufficient Response|2
291263|NCT01725308|982332|P3|Treatment Period II|Adverse Event|20
291264|NCT01725308|982333|P2|Treatment Period II|Adverse Event|8
291265|NCT01725308|982334|P1|Treatment Period II|Adverse Event|13
291266|NCT01725308|982332|P3|Treatment Period II|Did Not Receive Drug|0
291267|NCT01725308|982333|P2|Treatment Period II|Did Not Receive Drug|0
291268|NCT01725308|982334|P1|Treatment Period II|Did Not Receive Drug|4
291269|NCT01725308|982332|P3|Treatment Period II|Did Not Meet Transition Criteria|4
291270|NCT01725308|982333|P2|Treatment Period II|Did Not Meet Transition Criteria|3
291271|NCT01725308|982334|P1|Treatment Period II|Did Not Meet Transition Criteria|0
291272|NCT01725308|982332|P3|Treatment Period I|Miscellaneous|3
291273|NCT01725308|982333|P2|Treatment Period I|Miscellaneous|0
291274|NCT01725308|982334|P1|Treatment Period I|Miscellaneous|2
291275|NCT01725308|982332|P3|Treatment Period I|Protocol Deviations|1
291276|NCT01725308|982333|P2|Treatment Period I|Protocol Deviations|1
291277|NCT01725308|982334|P1|Treatment Period I|Protocol Deviations|3
291278|NCT01725308|982332|P3|Treatment Period I|Lost to Follow-up|2
291279|NCT01725308|982333|P2|Treatment Period I|Lost to Follow-up|2
291280|NCT01725308|982334|P1|Treatment Period I|Lost to Follow-up|3
291281|NCT01725308|982332|P3|Treatment Period I|Withdrawal of Consent|5
291282|NCT01725308|982333|P2|Treatment Period I|Withdrawal of Consent|7
291283|NCT01725308|982334|P1|Treatment Period I|Withdrawal of Consent|12
291284|NCT01725308|982332|P3|Treatment Period I|Changes in the Episodes|2
291285|NCT01725308|982333|P2|Treatment Period I|Changes in the Episodes|0
291286|NCT01725308|982334|P1|Treatment Period I|Changes in the Episodes|3
291287|NCT01725308|982332|P3|Treatment Period I|Worsening of the Target Disease|2
291288|NCT01725308|982333|P2|Treatment Period I|Worsening of the Target Disease|0
291289|NCT01725308|982334|P1|Treatment Period I|Worsening of the Target Disease|8
291290|NCT01725308|982332|P3|Treatment Period I|Insufficient Response|5
291291|NCT01725308|982333|P2|Treatment Period I|Insufficient Response|0
291292|NCT01725308|982334|P1|Treatment Period I|Insufficient Response|7
291293|NCT01725308|982332|P3|Treatment Period I|Adverse Event|21
291294|NCT01725308|982333|P2|Treatment Period I|Adverse Event|4
291295|NCT01725308|982334|P1|Treatment Period I|Adverse Event|5
291296|NCT01725308|982332|P3|Treatment Period I|Did Not Receive Drug|0
291297|NCT01725308|982333|P2|Treatment Period I|Did Not Receive Drug|0
291298|NCT01725308|982334|P1|Treatment Period I|Did Not Receive Drug|1
291299|NCT01725282|982481|P4|Overall Study|Lack of Efficacy|1
291300|NCT01725282|982482|P3|Overall Study|Lack of Efficacy|0
291301|NCT01725282|982483|P2|Overall Study|Lack of Efficacy|1
291302|NCT01725282|982484|P1|Overall Study|Lack of Efficacy|0
291303|NCT01725282|982481|P4|Overall Study|Withdrawal by Subject|1
291304|NCT01725282|982482|P3|Overall Study|Withdrawal by Subject|1
291305|NCT01725282|982483|P2|Overall Study|Withdrawal by Subject|0
291306|NCT01725282|982484|P1|Overall Study|Withdrawal by Subject|0
291307|NCT01725282|982481|P4|Overall Study|Study Site Withdrawal|0
291308|NCT01725282|982482|P3|Overall Study|Study Site Withdrawal|0
291309|NCT01725282|982483|P2|Overall Study|Study Site Withdrawal|1
291310|NCT01725282|982484|P1|Overall Study|Study Site Withdrawal|0
291311|NCT01725282|982481|P4|Overall Study|Met Exclusion Criteria|0
291312|NCT01725282|982482|P3|Overall Study|Met Exclusion Criteria|1
291313|NCT01725282|982483|P2|Overall Study|Met Exclusion Criteria|0
291314|NCT01725282|982484|P1|Overall Study|Met Exclusion Criteria|0
291315|NCT01725282|982481|P4|Overall Study|Exacerbation of Target Disease|1
291316|NCT01725282|982482|P3|Overall Study|Exacerbation of Target Disease|0
291317|NCT01725282|982483|P2|Overall Study|Exacerbation of Target Disease|0
291318|NCT01725282|982484|P1|Overall Study|Exacerbation of Target Disease|1
291319|NCT01725282|982481|P4|Overall Study|Adverse Event|4
291320|NCT01725282|982482|P3|Overall Study|Adverse Event|6
291321|NCT01725282|982483|P2|Overall Study|Adverse Event|3
291322|NCT01725282|982484|P1|Overall Study|Adverse Event|1
291323|NCT01725217|982517|P3|Overall Study|Withdrawal by Subject|0
291324|NCT01725217|982518|P2|Overall Study|Withdrawal by Subject|0
291325|NCT01725217|982519|P1|Overall Study|Withdrawal by Subject|1
291326|NCT01725126|982553|P6|Overall Study|Withdrawal by Subject|0
291327|NCT01725126|982554|P5|Overall Study|Withdrawal by Subject|0
291328|NCT01725126|982555|P4|Overall Study|Withdrawal by Subject|1
291329|NCT01725126|982556|P3|Overall Study|Withdrawal by Subject|0
291330|NCT01725126|982557|P2|Overall Study|Withdrawal by Subject|0
291331|NCT01725126|982558|P1|Overall Study|Withdrawal by Subject|0
291332|NCT01725126|982553|P6|Overall Study|Protocol Violation|0
291333|NCT01725126|982554|P5|Overall Study|Protocol Violation|0
291334|NCT01725126|982555|P4|Overall Study|Protocol Violation|0
291335|NCT01725126|982556|P3|Overall Study|Protocol Violation|0
291336|NCT01725126|982557|P2|Overall Study|Protocol Violation|1
291337|NCT01725126|982558|P1|Overall Study|Protocol Violation|0
291338|NCT01724528|982756|P2|Overall Study|Patient refused to attend last visit|0
291339|NCT01724528|982757|P1|Overall Study|Patient refused to attend last visit|1
291340|NCT01724528|982756|P2|Overall Study|Protocol Violation|1
291341|NCT01724528|982757|P1|Overall Study|Protocol Violation|0
291342|NCT01724528|982756|P2|Overall Study|Withdrawal by Subject|2
291343|NCT01724528|982757|P1|Overall Study|Withdrawal by Subject|0
291344|NCT01724528|982756|P2|Overall Study|Death|0
291345|NCT01724528|982757|P1|Overall Study|Death|3
291346|NCT01724359|982771|P1|Overall Study|Not specified|20
291347|NCT01724359|982771|P1|Overall Study|Death|1
291348|NCT01724359|982771|P1|Overall Study|Adverse Event|10
291349|NCT01724216|982784|P1|Overall Study|Scan was not completed|1
291350|NCT01724177|982788|P1|Overall Study|Serious Adverse Event Related|1
291351|NCT01724177|982788|P1|Overall Study|Nervous participant|1
291352|NCT01724177|982788|P1|Overall Study|Progressive disease or Relapsed Disease|16
291353|NCT01724177|982788|P1|Overall Study|Adverse Event|8
291354|NCT01724021|982801|P2|Overall Study|Missing|1
291355|NCT01724021|982802|P1|Overall Study|Missing|1
291356|NCT01724021|982801|P2|Overall Study|Reason Not Specified|39
291357|NCT01724021|982802|P1|Overall Study|Reason Not Specified|36
291358|NCT01724021|982801|P2|Overall Study|Lost to Follow-up|15
291359|NCT01724021|982802|P1|Overall Study|Lost to Follow-up|15
291360|NCT01724021|982801|P2|Overall Study|Participant request/ Withdrew consent|14
291361|NCT01724021|982802|P1|Overall Study|Participant request/ Withdrew consent|18
291362|NCT01724021|982801|P2|Overall Study|Death|58
291363|NCT01724021|982802|P1|Overall Study|Death|46
291364|NCT01724021|982801|P2|Overall Study|Adverse Event|6
291365|NCT01724021|982802|P1|Overall Study|Adverse Event|11
291366|NCT01723904|982834|P1|Overall Study|Unable to follow protocol/ judged by inv|3
291367|NCT01723904|982834|P1|Overall Study|Adverse Event|5
291368|NCT01723904|982834|P1|Overall Study|Noncompliant|3
291369|NCT01723397|982855|P2|Study Period 2|Protocol Violation|1
291370|NCT01723397|982856|P1|Study Period 2|Protocol Violation|0
291371|NCT01723397|982855|P2|Study Period 1|Protocol Violation|1
291372|NCT01723397|982856|P1|Study Period 1|Protocol Violation|0
291373|NCT01723254|982870|P8|Overall Study|Withdrawal by Subject|2
291374|NCT01723254|982871|P7|Overall Study|Withdrawal by Subject|1
291375|NCT01723254|982872|P6|Overall Study|Withdrawal by Subject|1
291376|NCT01723254|982873|P5|Overall Study|Withdrawal by Subject|1
291377|NCT01723254|982874|P4|Overall Study|Withdrawal by Subject|0
291378|NCT01723254|982875|P3|Overall Study|Withdrawal by Subject|1
291379|NCT01723254|982876|P2|Overall Study|Withdrawal by Subject|2
291380|NCT01723254|982877|P1|Overall Study|Withdrawal by Subject|1
291381|NCT01723254|982870|P8|Overall Study|Protocol Violation|0
291382|NCT01723254|982871|P7|Overall Study|Protocol Violation|0
291383|NCT01723254|982872|P6|Overall Study|Protocol Violation|0
291384|NCT01723254|982873|P5|Overall Study|Protocol Violation|0
291385|NCT01723254|982874|P4|Overall Study|Protocol Violation|0
291386|NCT01723254|982875|P3|Overall Study|Protocol Violation|0
291387|NCT01723254|982876|P2|Overall Study|Protocol Violation|1
291388|NCT01723254|982877|P1|Overall Study|Protocol Violation|0
291389|NCT01723254|982870|P8|Overall Study|Move/Left to another country/city|0
291390|NCT01723254|982871|P7|Overall Study|Move/Left to another country/city|0
291391|NCT01723254|982872|P6|Overall Study|Move/Left to another country/city|0
291392|NCT01723254|982873|P5|Overall Study|Move/Left to another country/city|1
291393|NCT01723254|982874|P4|Overall Study|Move/Left to another country/city|1
291394|NCT01723254|982875|P3|Overall Study|Move/Left to another country/city|2
291395|NCT01723254|982876|P2|Overall Study|Move/Left to another country/city|0
291396|NCT01723254|982877|P1|Overall Study|Move/Left to another country/city|0
291397|NCT01723254|982870|P8|Overall Study|No longer have time to participate|0
291398|NCT01723254|982871|P7|Overall Study|No longer have time to participate|0
291399|NCT01723254|982872|P6|Overall Study|No longer have time to participate|0
291400|NCT01723254|982873|P5|Overall Study|No longer have time to participate|0
291401|NCT01723254|982874|P4|Overall Study|No longer have time to participate|1
291402|NCT01723254|982875|P3|Overall Study|No longer have time to participate|0
291403|NCT01723254|982876|P2|Overall Study|No longer have time to participate|0
291404|NCT01723254|982877|P1|Overall Study|No longer have time to participate|0
291405|NCT01723254|982870|P8|Overall Study|Personal issues|0
291406|NCT01723254|982871|P7|Overall Study|Personal issues|0
291407|NCT01723254|982872|P6|Overall Study|Personal issues|1
291408|NCT01723254|982873|P5|Overall Study|Personal issues|0
291409|NCT01723254|982874|P4|Overall Study|Personal issues|0
291410|NCT01723254|982875|P3|Overall Study|Personal issues|0
291411|NCT01723254|982876|P2|Overall Study|Personal issues|0
291412|NCT01723254|982877|P1|Overall Study|Personal issues|0
291413|NCT01723254|982870|P8|Overall Study|Conflict with work schedule|1
291414|NCT01723254|982871|P7|Overall Study|Conflict with work schedule|0
291415|NCT01723254|982872|P6|Overall Study|Conflict with work schedule|0
291416|NCT01723254|982873|P5|Overall Study|Conflict with work schedule|0
291417|NCT01723254|982874|P4|Overall Study|Conflict with work schedule|0
291418|NCT01723254|982875|P3|Overall Study|Conflict with work schedule|0
291419|NCT01723254|982876|P2|Overall Study|Conflict with work schedule|0
291420|NCT01723254|982877|P1|Overall Study|Conflict with work schedule|0
291421|NCT01723228|982929|P2|Overall Study|Not Specified|1
291422|NCT01723228|982930|P1|Overall Study|Not Specified|2
291423|NCT01723228|982929|P2|Overall Study|Lost to Follow-up|1
291424|NCT01723228|982930|P1|Overall Study|Lost to Follow-up|2
291425|NCT01723228|982929|P2|Overall Study|Protocol Violation|2
291426|NCT01723228|982930|P1|Overall Study|Protocol Violation|0
291427|NCT01723228|982929|P2|Overall Study|Withdrawal by Subject|1
291428|NCT01723228|982930|P1|Overall Study|Withdrawal by Subject|2
291429|NCT01723228|982929|P2|Overall Study|Adverse Event|6
291430|NCT01723228|982930|P1|Overall Study|Adverse Event|2
291431|NCT01722994|982948|P2|Overall Study|Missing data|17
291432|NCT01722994|982949|P1|Overall Study|Missing data|25
291433|NCT01722877|982968|P1|Overall Study|Lost to Follow-up|1
291434|NCT01722877|982968|P1|Overall Study|Death|1
291435|NCT01722331|983039|P7|Part 3|Other Protocol Specified Criteria|0
291436|NCT01722331|983040|P6|Part 3|Other Protocol Specified Criteria|0
291437|NCT01722331|983041|P5|Part 3|Other Protocol Specified Criteria|0
291438|NCT01722331|983042|P4|Part 3|Other Protocol Specified Criteria|0
291439|NCT01722331|983043|P3|Part 3|Other Protocol Specified Criteria|0
291440|NCT01722331|983044|P2|Part 3|Other Protocol Specified Criteria|1
291441|NCT01722331|983045|P1|Part 3|Other Protocol Specified Criteria|1
291442|NCT01722331|983039|P7|Part 3|Withdrawal by Subject|1
291443|NCT01722331|983040|P6|Part 3|Withdrawal by Subject|2
291444|NCT01722331|983041|P5|Part 3|Withdrawal by Subject|0
291445|NCT01722331|983042|P4|Part 3|Withdrawal by Subject|0
291446|NCT01722331|983043|P3|Part 3|Withdrawal by Subject|0
291447|NCT01722331|983044|P2|Part 3|Withdrawal by Subject|7
291448|NCT01722331|983045|P1|Part 3|Withdrawal by Subject|4
291449|NCT01722331|983039|P7|Part 3|Protocol Violation|0
291450|NCT01722331|983040|P6|Part 3|Protocol Violation|0
291451|NCT01722331|983041|P5|Part 3|Protocol Violation|0
291452|NCT01722331|983042|P4|Part 3|Protocol Violation|0
291453|NCT01722331|983043|P3|Part 3|Protocol Violation|0
291454|NCT01722331|983044|P2|Part 3|Protocol Violation|1
291455|NCT01722331|983045|P1|Part 3|Protocol Violation|2
291456|NCT01722331|983039|P7|Part 3|Physician Decision|1
291457|NCT01722331|983040|P6|Part 3|Physician Decision|0
291458|NCT01722331|983041|P5|Part 3|Physician Decision|0
291459|NCT01722331|983042|P4|Part 3|Physician Decision|0
291460|NCT01722331|983043|P3|Part 3|Physician Decision|0
291461|NCT01722331|983044|P2|Part 3|Physician Decision|1
291462|NCT01722331|983045|P1|Part 3|Physician Decision|1
291463|NCT01722331|983039|P7|Part 3|Non-Compliance with Study Drug|0
291464|NCT01722331|983040|P6|Part 3|Non-Compliance with Study Drug|0
291465|NCT01722331|983041|P5|Part 3|Non-Compliance with Study Drug|0
291466|NCT01722331|983042|P4|Part 3|Non-Compliance with Study Drug|0
291467|NCT01722331|983043|P3|Part 3|Non-Compliance with Study Drug|0
291468|NCT01722331|983044|P2|Part 3|Non-Compliance with Study Drug|1
291469|NCT01722331|983045|P1|Part 3|Non-Compliance with Study Drug|0
291470|NCT01722331|983039|P7|Part 3|Lost to Follow-up|0
291471|NCT01722331|983040|P6|Part 3|Lost to Follow-up|1
291472|NCT01722331|983041|P5|Part 3|Lost to Follow-up|0
291473|NCT01722331|983042|P4|Part 3|Lost to Follow-up|0
291474|NCT01722331|983043|P3|Part 3|Lost to Follow-up|0
291475|NCT01722331|983044|P2|Part 3|Lost to Follow-up|4
291476|NCT01722331|983045|P1|Part 3|Lost to Follow-up|3
291477|NCT01722331|983039|P7|Part 3|Lack of Efficacy|0
291478|NCT01722331|983040|P6|Part 3|Lack of Efficacy|0
291479|NCT01722331|983041|P5|Part 3|Lack of Efficacy|0
291480|NCT01722331|983042|P4|Part 3|Lack of Efficacy|0
291481|NCT01722331|983043|P3|Part 3|Lack of Efficacy|0
291482|NCT01722331|983044|P2|Part 3|Lack of Efficacy|0
291483|NCT01722331|983045|P1|Part 3|Lack of Efficacy|1
291484|NCT01722331|983039|P7|Part 3|Death|0
291485|NCT01722331|983040|P6|Part 3|Death|0
291486|NCT01722331|983041|P5|Part 3|Death|0
291487|NCT01722331|983042|P4|Part 3|Death|0
291488|NCT01722331|983043|P3|Part 3|Death|0
291489|NCT01722331|983044|P2|Part 3|Death|0
291490|NCT01722331|983045|P1|Part 3|Death|1
291491|NCT01722331|983039|P7|Part 3|Adverse Event|0
291492|NCT01722331|983040|P6|Part 3|Adverse Event|0
291493|NCT01722331|983041|P5|Part 3|Adverse Event|0
291494|NCT01722331|983042|P4|Part 3|Adverse Event|1
291495|NCT01722331|983043|P3|Part 3|Adverse Event|0
291496|NCT01722331|983044|P2|Part 3|Adverse Event|2
291497|NCT01722331|983045|P1|Part 3|Adverse Event|2
291498|NCT01722331|983039|P7|Part 2|Other Protocol Specified Criteria|1
291499|NCT01722331|983040|P6|Part 2|Other Protocol Specified Criteria|2
291500|NCT01722331|983041|P5|Part 2|Other Protocol Specified Criteria|0
291501|NCT01722331|983042|P4|Part 2|Other Protocol Specified Criteria|0
291502|NCT01722331|983043|P3|Part 2|Other Protocol Specified Criteria|10
291503|NCT01722331|983044|P2|Part 2|Other Protocol Specified Criteria|0
291504|NCT01722331|983045|P1|Part 2|Other Protocol Specified Criteria|6
291505|NCT01722331|983039|P7|Part 2|Withdrawal by Subject|2
291506|NCT01722331|983040|P6|Part 2|Withdrawal by Subject|2
291507|NCT01722331|983041|P5|Part 2|Withdrawal by Subject|0
291508|NCT01722331|983042|P4|Part 2|Withdrawal by Subject|0
291509|NCT01722331|983043|P3|Part 2|Withdrawal by Subject|3
291510|NCT01722331|983044|P2|Part 2|Withdrawal by Subject|0
291511|NCT01722331|983045|P1|Part 2|Withdrawal by Subject|5
291512|NCT01722331|983039|P7|Part 2|Protocol Violation|0
291513|NCT01722331|983040|P6|Part 2|Protocol Violation|0
291514|NCT01722331|983041|P5|Part 2|Protocol Violation|0
291515|NCT01722331|983042|P4|Part 2|Protocol Violation|0
291516|NCT01722331|983043|P3|Part 2|Protocol Violation|0
291517|NCT01722331|983044|P2|Part 2|Protocol Violation|0
291518|NCT01722331|983045|P1|Part 2|Protocol Violation|1
291519|NCT01722331|983039|P7|Part 2|Progressive Disease|0
291520|NCT01722331|983040|P6|Part 2|Progressive Disease|0
291521|NCT01722331|983041|P5|Part 2|Progressive Disease|0
291522|NCT01722331|983042|P4|Part 2|Progressive Disease|0
291523|NCT01722331|983043|P3|Part 2|Progressive Disease|1
291524|NCT01722331|983044|P2|Part 2|Progressive Disease|0
291525|NCT01722331|983045|P1|Part 2|Progressive Disease|0
291526|NCT01722331|983039|P7|Part 2|Pregnancy|0
291527|NCT01722331|983040|P6|Part 2|Pregnancy|1
291528|NCT01722331|983041|P5|Part 2|Pregnancy|0
291529|NCT01722331|983042|P4|Part 2|Pregnancy|0
291530|NCT01722331|983043|P3|Part 2|Pregnancy|0
291531|NCT01722331|983044|P2|Part 2|Pregnancy|0
291532|NCT01722331|983045|P1|Part 2|Pregnancy|0
291533|NCT01722331|983039|P7|Part 2|Physician Decision|0
291534|NCT01722331|983040|P6|Part 2|Physician Decision|0
291535|NCT01722331|983041|P5|Part 2|Physician Decision|0
291536|NCT01722331|983042|P4|Part 2|Physician Decision|0
291537|NCT01722331|983043|P3|Part 2|Physician Decision|2
291538|NCT01722331|983044|P2|Part 2|Physician Decision|0
291539|NCT01722331|983045|P1|Part 2|Physician Decision|0
291540|NCT01722331|983039|P7|Part 2|Non-Compliance with Study Drug|0
291541|NCT01722331|983040|P6|Part 2|Non-Compliance with Study Drug|0
291542|NCT01722331|983041|P5|Part 2|Non-Compliance with Study Drug|0
291543|NCT01722331|983042|P4|Part 2|Non-Compliance with Study Drug|0
291544|NCT01722331|983043|P3|Part 2|Non-Compliance with Study Drug|1
291545|NCT01722331|983044|P2|Part 2|Non-Compliance with Study Drug|0
291546|NCT01722331|983045|P1|Part 2|Non-Compliance with Study Drug|1
291547|NCT01722331|983039|P7|Part 2|Lost to Follow-up|1
291548|NCT01722331|983040|P6|Part 2|Lost to Follow-up|1
291549|NCT01722331|983041|P5|Part 2|Lost to Follow-up|0
291550|NCT01722331|983042|P4|Part 2|Lost to Follow-up|0
291551|NCT01722331|983043|P3|Part 2|Lost to Follow-up|3
291552|NCT01722331|983044|P2|Part 2|Lost to Follow-up|0
291553|NCT01722331|983045|P1|Part 2|Lost to Follow-up|0
291554|NCT01722331|983039|P7|Part 2|Lack of Efficacy|3
291555|NCT01722331|983040|P6|Part 2|Lack of Efficacy|3
291556|NCT01722331|983041|P5|Part 2|Lack of Efficacy|0
291557|NCT01722331|983042|P4|Part 2|Lack of Efficacy|0
291558|NCT01722331|983043|P3|Part 2|Lack of Efficacy|11
291559|NCT01722331|983044|P2|Part 2|Lack of Efficacy|0
291560|NCT01722331|983045|P1|Part 2|Lack of Efficacy|3
291561|NCT01722331|983039|P7|Part 2|Adverse Event|0
291562|NCT01722331|983040|P6|Part 2|Adverse Event|1
291563|NCT01722331|983041|P5|Part 2|Adverse Event|0
291564|NCT01722331|983042|P4|Part 2|Adverse Event|0
291565|NCT01722331|983043|P3|Part 2|Adverse Event|0
291566|NCT01722331|983044|P2|Part 2|Adverse Event|0
291567|NCT01722331|983045|P1|Part 2|Adverse Event|3
291568|NCT01722331|983039|P7|Part 1|Withdrawal by Subject|0
291569|NCT01722331|983040|P6|Part 1|Withdrawal by Subject|0
291570|NCT01722331|983041|P5|Part 1|Withdrawal by Subject|3
291571|NCT01722331|983042|P4|Part 1|Withdrawal by Subject|0
291572|NCT01722331|983043|P3|Part 1|Withdrawal by Subject|3
291573|NCT01722331|983044|P2|Part 1|Withdrawal by Subject|0
291574|NCT01722331|983045|P1|Part 1|Withdrawal by Subject|2
291575|NCT01722331|983039|P7|Part 1|Protocol Violation|0
291576|NCT01722331|983040|P6|Part 1|Protocol Violation|0
291577|NCT01722331|983041|P5|Part 1|Protocol Violation|1
291578|NCT01722331|983042|P4|Part 1|Protocol Violation|0
291579|NCT01722331|983043|P3|Part 1|Protocol Violation|0
291580|NCT01722331|983044|P2|Part 1|Protocol Violation|0
291581|NCT01722331|983045|P1|Part 1|Protocol Violation|1
291582|NCT01722331|983039|P7|Part 1|Progressive Disease|0
291583|NCT01722331|983040|P6|Part 1|Progressive Disease|0
291584|NCT01722331|983041|P5|Part 1|Progressive Disease|1
291585|NCT01722331|983042|P4|Part 1|Progressive Disease|0
291586|NCT01722331|983043|P3|Part 1|Progressive Disease|0
291587|NCT01722331|983044|P2|Part 1|Progressive Disease|0
291588|NCT01722331|983045|P1|Part 1|Progressive Disease|0
291589|NCT01722331|983039|P7|Part 1|Pregnancy|0
291590|NCT01722331|983040|P6|Part 1|Pregnancy|0
291591|NCT01722331|983041|P5|Part 1|Pregnancy|0
291592|NCT01722331|983042|P4|Part 1|Pregnancy|0
291593|NCT01722331|983043|P3|Part 1|Pregnancy|0
291594|NCT01722331|983044|P2|Part 1|Pregnancy|0
291595|NCT01722331|983045|P1|Part 1|Pregnancy|1
291596|NCT01722331|983039|P7|Part 1|Physician Decision|0
291597|NCT01722331|983040|P6|Part 1|Physician Decision|0
291598|NCT01722331|983041|P5|Part 1|Physician Decision|1
291599|NCT01722331|983042|P4|Part 1|Physician Decision|0
291600|NCT01722331|983043|P3|Part 1|Physician Decision|3
291601|NCT01722331|983044|P2|Part 1|Physician Decision|0
291602|NCT01722331|983045|P1|Part 1|Physician Decision|0
291603|NCT01722331|983039|P7|Part 1|Lost to Follow-up|0
291604|NCT01722331|983040|P6|Part 1|Lost to Follow-up|0
291605|NCT01722331|983041|P5|Part 1|Lost to Follow-up|1
291606|NCT01722331|983042|P4|Part 1|Lost to Follow-up|0
291607|NCT01722331|983043|P3|Part 1|Lost to Follow-up|2
291608|NCT01722331|983044|P2|Part 1|Lost to Follow-up|0
291609|NCT01722331|983045|P1|Part 1|Lost to Follow-up|1
291610|NCT01722331|983039|P7|Part 1|Lack of Efficacy|0
291611|NCT01722331|983040|P6|Part 1|Lack of Efficacy|0
291612|NCT01722331|983041|P5|Part 1|Lack of Efficacy|2
291613|NCT01722331|983042|P4|Part 1|Lack of Efficacy|0
291614|NCT01722331|983043|P3|Part 1|Lack of Efficacy|1
291615|NCT01722331|983044|P2|Part 1|Lack of Efficacy|0
291616|NCT01722331|983045|P1|Part 1|Lack of Efficacy|0
291617|NCT01722331|983039|P7|Part 1|Adverse Event|0
291618|NCT01722331|983040|P6|Part 1|Adverse Event|0
291619|NCT01722331|983041|P5|Part 1|Adverse Event|0
291620|NCT01722331|983042|P4|Part 1|Adverse Event|0
291621|NCT01722331|983043|P3|Part 1|Adverse Event|0
291622|NCT01722331|983044|P2|Part 1|Adverse Event|0
291623|NCT01722331|983045|P1|Part 1|Adverse Event|5
291624|NCT01722266|983088|P4|Overall Study|Dropped out due to Nausea|0
291625|NCT01722266|983089|P3|Overall Study|Dropped out due to Nausea|2
291626|NCT01722266|983090|P2|Overall Study|Dropped out due to Nausea|0
291627|NCT01722266|983091|P1|Overall Study|Dropped out due to Nausea|0
291628|NCT01722266|983088|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
291629|NCT01722266|983089|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
291630|NCT01722266|983090|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
291631|NCT01722266|983091|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
291632|NCT01722266|983088|P4|Overall Study|Withdrawal by Subject|0
291633|NCT01722266|983089|P3|Overall Study|Withdrawal by Subject|0
291634|NCT01722266|983090|P2|Overall Study|Withdrawal by Subject|2
291635|NCT01722266|983091|P1|Overall Study|Withdrawal by Subject|1
291636|NCT01722162|983119|P2|Overall Study|Noncompliance|1
291637|NCT01722162|983120|P1|Overall Study|Noncompliance|0
291638|NCT01722162|983119|P2|Overall Study|Insurance denial post enrollment|1
291639|NCT01722162|983120|P1|Overall Study|Insurance denial post enrollment|0
291640|NCT01722162|983119|P2|Overall Study|Adverse Event|1
291641|NCT01722162|983120|P1|Overall Study|Adverse Event|1
291642|NCT01722162|983119|P2|Overall Study|Unrelated to study adverse event|2
291643|NCT01722162|983120|P1|Overall Study|Unrelated to study adverse event|2
291644|NCT01722162|983119|P2|Overall Study|Found ineligible|0
291645|NCT01722162|983120|P1|Overall Study|Found ineligible|1
291646|NCT01722162|983119|P2|Overall Study|Withdrawal by Subject|1
291647|NCT01722162|983120|P1|Overall Study|Withdrawal by Subject|1
291648|NCT01722097|983130|P2|Overall Study|Patient sheets not returned|5
291649|NCT01722097|983131|P1|Overall Study|Patient sheets not returned|6
291650|NCT01722071|983139|P2|Overall Study|Protocol Violation|0
291651|NCT01722071|983140|P1|Overall Study|Protocol Violation|1
291652|NCT01722045|983146|P1|Overall Study|Relocation (did not wish to transfer)|1
291653|NCT01722045|983146|P1|Overall Study|Physician Decision|3
291654|NCT01722045|983146|P1|Overall Study|Protocol Deviation|1
291655|NCT01722045|983146|P1|Overall Study|Lost to Follow-up|4
291656|NCT01722045|983146|P1|Overall Study|Withdrawal by Subject|8
291657|NCT01722045|983146|P1|Overall Study|Death|3
291658|NCT01722045|983146|P1|Overall Study|Adverse Event|8
291659|NCT01721772|983171|P2|Overall Study|Not specified|1
291660|NCT01721772|983172|P1|Overall Study|Not specified|0
291661|NCT01721772|983171|P2|Overall Study|Maximum clinical benefit|1
291662|NCT01721772|983172|P1|Overall Study|Maximum clinical benefit|1
291663|NCT01721772|983171|P2|Overall Study|Withdrawal by Subject|5
291664|NCT01721772|983172|P1|Overall Study|Withdrawal by Subject|7
291665|NCT01721772|983171|P2|Overall Study|Unrelated adverse event|3
291666|NCT01721772|983172|P1|Overall Study|Unrelated adverse event|2
291667|NCT01721772|983171|P2|Overall Study|Study drug toxicity|7
291668|NCT01721772|983172|P1|Overall Study|Study drug toxicity|5
291669|NCT01721772|983171|P2|Overall Study|Disease progression|175
291670|NCT01721772|983172|P1|Overall Study|Disease progression|96
291671|NCT01721759|983192|P1|Overall Study|Withdrawal by Subject|1
291672|NCT01721759|983192|P1|Overall Study|Adverse event unrelated to study drug|9
291673|NCT01721759|983192|P1|Overall Study|Study drug toxicity|14
291674|NCT01721759|983192|P1|Overall Study|Disease progression|78
291675|NCT01721746|983200|P3|Treatment Period|Other|1
291676|NCT01721746|983201|P2|Treatment Period|Other|1
291677|NCT01721746|983202|P1|Treatment Period|Other|2
291678|NCT01721746|983200|P3|Treatment Period|Subject No Longer Met Study Criteria|0
291679|NCT01721746|983201|P2|Treatment Period|Subject No Longer Met Study Criteria|0
291680|NCT01721746|983202|P1|Treatment Period|Subject No Longer Met Study Criteria|4
291681|NCT01721746|983200|P3|Treatment Period|Poor/Non-compliance|0
291682|NCT01721746|983201|P2|Treatment Period|Poor/Non-compliance|0
291683|NCT01721746|983202|P1|Treatment Period|Poor/Non-compliance|1
291684|NCT01721746|983200|P3|Treatment Period|Maximum Clinical Benefit|3
291685|NCT01721746|983201|P2|Treatment Period|Maximum Clinical Benefit|0
291686|NCT01721746|983202|P1|Treatment Period|Maximum Clinical Benefit|1
291687|NCT01721746|983200|P3|Treatment Period|Subject Withdrew Consent|2
291688|NCT01721746|983201|P2|Treatment Period|Subject Withdrew Consent|0
291689|NCT01721746|983202|P1|Treatment Period|Subject Withdrew Consent|3
291690|NCT01721746|983200|P3|Treatment Period|Subject Request to Discontinue Treatment|6
291691|NCT01721746|983201|P2|Treatment Period|Subject Request to Discontinue Treatment|1
291692|NCT01721746|983202|P1|Treatment Period|Subject Request to Discontinue Treatment|19
291693|NCT01721746|983200|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
291694|NCT01721746|983201|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
291695|NCT01721746|983202|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
291696|NCT01721746|983200|P3|Treatment Period|Study Drug Toxicity|9
291697|NCT01721746|983201|P2|Treatment Period|Study Drug Toxicity|2
291698|NCT01721746|983202|P1|Treatment Period|Study Drug Toxicity|15
291699|NCT01721746|983200|P3|Treatment Period|Disease Progression|34
291700|NCT01721746|983201|P2|Treatment Period|Disease Progression|40
291701|NCT01721746|983202|P1|Treatment Period|Disease Progression|182
291702|NCT01721486|983242|P2|Overall Study|Physician Decision|1
291703|NCT01721486|983243|P1|Overall Study|Physician Decision|0
291704|NCT01721486|983242|P2|Overall Study|Protocol Violation|0
291705|NCT01721486|983243|P1|Overall Study|Protocol Violation|1
291706|NCT01721408|983264|P2|Overall Study|Does not meet entrance criteria|0
291707|NCT01721408|983265|P1|Overall Study|Does not meet entrance criteria|1
291708|NCT01721408|983264|P2|Overall Study|Lost to Follow-up|2
291709|NCT01721408|983265|P1|Overall Study|Lost to Follow-up|1
291710|NCT01721408|983264|P2|Overall Study|Other|3
291711|NCT01721408|983265|P1|Overall Study|Other|3
291712|NCT01721408|983264|P2|Overall Study|Protocol Violation|2
291713|NCT01721408|983265|P1|Overall Study|Protocol Violation|0
291714|NCT01721408|983264|P2|Overall Study|No longer willing to participate study|10
291715|NCT01721408|983265|P1|Overall Study|No longer willing to participate study|9
291716|NCT01721408|983264|P2|Overall Study|Insufficient clinical response|6
291717|NCT01721408|983265|P1|Overall Study|Insufficient clinical response|15
291718|NCT01721408|983264|P2|Overall Study|Death|0
291719|NCT01721408|983265|P1|Overall Study|Death|1
291720|NCT01721408|983264|P2|Overall Study|Adverse Event|1
291721|NCT01721408|983265|P1|Overall Study|Adverse Event|6
291722|NCT01721330|983281|P2|Overall Study|Withdrawal by Subject|1
291723|NCT01721330|983282|P1|Overall Study|Withdrawal by Subject|0
291724|NCT01721317|983290|P2|Overall Study|Withdrawal by Subject|1
291725|NCT01721317|983291|P1|Overall Study|Withdrawal by Subject|0
291726|NCT01721317|983290|P2|Overall Study|Physician Decision|1
291727|NCT01721317|983291|P1|Overall Study|Physician Decision|0
291728|NCT01721317|983290|P2|Overall Study|Study Closed / Terminated|2
291729|NCT01721317|983291|P1|Overall Study|Study Closed / Terminated|2
291730|NCT01721200|983370|P2|Overall Study|Lost to Follow-up|5
291731|NCT01721200|983371|P1|Overall Study|Lost to Follow-up|3
291732|NCT01721161|983396|P2|Overall Study|Not Specified|1
291733|NCT01721161|983397|P1|Overall Study|Not Specified|0
291734|NCT01721161|983396|P2|Overall Study|Withdrawal by Subject|1
291735|NCT01721161|983397|P1|Overall Study|Withdrawal by Subject|1
291736|NCT01721161|983396|P2|Overall Study|Lost to Follow-up|2
291737|NCT01721161|983397|P1|Overall Study|Lost to Follow-up|1
291738|NCT01721161|983396|P2|Overall Study|Adverse Event|3
291739|NCT01721161|983397|P1|Overall Study|Adverse Event|2
291740|NCT01721109|983420|P1|Extension Phase|Still on Study|35
291741|NCT01721109|983420|P1|Extension Phase|Non-Compliance with Study Drug|2
291742|NCT01721109|983420|P1|Main Phase|Non-Compliance with Study Drug|1
291743|NCT01721096|983435|P2|Overall Study|Other|0
291744|NCT01721096|983436|P1|Overall Study|Other|1
291745|NCT01721096|983435|P2|Overall Study|Lost to Follow-up|2
291746|NCT01721096|983436|P1|Overall Study|Lost to Follow-up|12
291747|NCT01721096|983435|P2|Overall Study|Physician Decision|0
291748|NCT01721096|983436|P1|Overall Study|Physician Decision|1
291749|NCT01721096|983435|P2|Overall Study|Withdrawal by Subject|0
291750|NCT01721096|983436|P1|Overall Study|Withdrawal by Subject|1
291751|NCT01721096|983435|P2|Overall Study|Death|8
291752|NCT01721096|983436|P1|Overall Study|Death|12
291753|NCT01721070|983585|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
291754|NCT01721057|983596|P7|Rescue Period|Lack of Efficacy|0
291755|NCT01721057|983597|P6|Rescue Period|Lack of Efficacy|0
291756|NCT01721057|983598|P5|Rescue Period|Lack of Efficacy|0
291757|NCT01721057|983599|P4|Rescue Period|Lack of Efficacy|2
291758|NCT01721057|983600|P3|Rescue Period|Lack of Efficacy|0
291759|NCT01721057|983601|P2|Rescue Period|Lack of Efficacy|0
291760|NCT01721057|983602|P1|Rescue Period|Lack of Efficacy|0
291761|NCT01721057|983596|P7|Rescue Period|Adverse Event|0
291762|NCT01721057|983597|P6|Rescue Period|Adverse Event|0
291763|NCT01721057|983598|P5|Rescue Period|Adverse Event|0
291764|NCT01721057|983599|P4|Rescue Period|Adverse Event|1
291765|NCT01721057|983600|P3|Rescue Period|Adverse Event|0
291766|NCT01721057|983601|P2|Rescue Period|Adverse Event|0
291767|NCT01721057|983602|P1|Rescue Period|Adverse Event|0
291768|NCT01721057|983596|P7|Treatment Period|Death|0
291769|NCT01721057|983597|P6|Treatment Period|Death|0
291770|NCT01721057|983598|P5|Treatment Period|Death|0
291771|NCT01721057|983599|P4|Treatment Period|Death|0
291772|NCT01721057|983600|P3|Treatment Period|Death|0
291773|NCT01721057|983601|P2|Treatment Period|Death|0
291774|NCT01721057|983602|P1|Treatment Period|Death|2
291775|NCT01721057|983596|P7|Treatment Period|Physician Decision|0
291776|NCT01721057|983597|P6|Treatment Period|Physician Decision|0
291777|NCT01721057|983598|P5|Treatment Period|Physician Decision|0
291778|NCT01721057|983599|P4|Treatment Period|Physician Decision|0
291779|NCT01721057|983600|P3|Treatment Period|Physician Decision|3
291780|NCT01721057|983601|P2|Treatment Period|Physician Decision|1
291781|NCT01721057|983602|P1|Treatment Period|Physician Decision|0
291782|NCT01721057|983596|P7|Treatment Period|Lost to Follow-up|0
291783|NCT01721057|983597|P6|Treatment Period|Lost to Follow-up|0
291784|NCT01721057|983598|P5|Treatment Period|Lost to Follow-up|0
291785|NCT01721057|983599|P4|Treatment Period|Lost to Follow-up|0
291786|NCT01721057|983600|P3|Treatment Period|Lost to Follow-up|0
291787|NCT01721057|983601|P2|Treatment Period|Lost to Follow-up|0
291788|NCT01721057|983602|P1|Treatment Period|Lost to Follow-up|1
291789|NCT01721057|983596|P7|Treatment Period|Lack of Efficacy|0
291790|NCT01721057|983597|P6|Treatment Period|Lack of Efficacy|0
291791|NCT01721057|983598|P5|Treatment Period|Lack of Efficacy|0
291792|NCT01721057|983599|P4|Treatment Period|Lack of Efficacy|0
291793|NCT01721057|983600|P3|Treatment Period|Lack of Efficacy|0
291794|NCT01721057|983601|P2|Treatment Period|Lack of Efficacy|3
291795|NCT01721057|983602|P1|Treatment Period|Lack of Efficacy|7
291796|NCT01721057|983596|P7|Treatment Period|Adverse Event|0
291797|NCT01721057|983597|P6|Treatment Period|Adverse Event|0
291798|NCT01721057|983598|P5|Treatment Period|Adverse Event|0
291799|NCT01721057|983599|P4|Treatment Period|Adverse Event|0
291800|NCT01721057|983600|P3|Treatment Period|Adverse Event|12
291801|NCT01721057|983601|P2|Treatment Period|Adverse Event|10
291802|NCT01721057|983602|P1|Treatment Period|Adverse Event|7
291803|NCT01721057|983596|P7|Treatment Period|Withdrawal by Subject|0
291804|NCT01721057|983597|P6|Treatment Period|Withdrawal by Subject|0
291805|NCT01721057|983598|P5|Treatment Period|Withdrawal by Subject|0
291806|NCT01721057|983599|P4|Treatment Period|Withdrawal by Subject|0
291807|NCT01721057|983600|P3|Treatment Period|Withdrawal by Subject|8
291808|NCT01721057|983601|P2|Treatment Period|Withdrawal by Subject|5
291809|NCT01721057|983602|P1|Treatment Period|Withdrawal by Subject|11
291810|NCT01721044|983675|P3|Treatment Period|Withdrawal by Subject|1
291811|NCT01721044|983676|P2|Treatment Period|Withdrawal by Subject|6
291812|NCT01721044|983677|P1|Treatment Period|Withdrawal by Subject|7
291813|NCT01721044|983675|P3|Treatment Period|Protocol Violation|0
291814|NCT01721044|983676|P2|Treatment Period|Protocol Violation|0
291815|NCT01721044|983677|P1|Treatment Period|Protocol Violation|1
291816|NCT01721044|983675|P3|Treatment Period|Physician Decision|2
291817|NCT01721044|983676|P2|Treatment Period|Physician Decision|0
291818|NCT01721044|983677|P1|Treatment Period|Physician Decision|1
291819|NCT01721044|983675|P3|Treatment Period|Lost to Follow-up|1
291820|NCT01721044|983676|P2|Treatment Period|Lost to Follow-up|0
291821|NCT01721044|983677|P1|Treatment Period|Lost to Follow-up|0
291822|NCT01721044|983675|P3|Treatment Period|Lack of Efficacy|4
291823|NCT01721044|983676|P2|Treatment Period|Lack of Efficacy|4
291824|NCT01721044|983677|P1|Treatment Period|Lack of Efficacy|16
291825|NCT01721044|983675|P3|Treatment Period|Death|1
291826|NCT01721044|983676|P2|Treatment Period|Death|0
291827|NCT01721044|983677|P1|Treatment Period|Death|0
291828|NCT01721044|983675|P3|Treatment Period|Adverse Event|10
291829|NCT01721044|983676|P2|Treatment Period|Adverse Event|7
291830|NCT01721044|983677|P1|Treatment Period|Adverse Event|7
291831|NCT01720797|983750|P2|Overall Study|Withdrawal by Subject|0
291832|NCT01720797|983751|P1|Overall Study|Withdrawal by Subject|3
291833|NCT01720602|983757|P1|Overall Study|Progressive disease on therapy|2
291834|NCT01720602|983757|P1|Overall Study|Adverse Event|3
291835|NCT01720446|983767|P4|Overall Study|Withdrawal by Subject|4
291836|NCT01720446|983768|P3|Overall Study|Withdrawal by Subject|4
291837|NCT01720446|983769|P2|Overall Study|Withdrawal by Subject|5
291838|NCT01720446|983770|P1|Overall Study|Withdrawal by Subject|2
291839|NCT01720446|983767|P4|Overall Study|Lost to Follow-up|16
291840|NCT01720446|983768|P3|Overall Study|Lost to Follow-up|16
291841|NCT01720446|983769|P2|Overall Study|Lost to Follow-up|6
291842|NCT01720446|983770|P1|Overall Study|Lost to Follow-up|12
291843|NCT01720043|983912|P1|Overall Study|Withdrawal by Subject|1
291844|NCT01719861|983916|P1|Cycle 2|Death|1
291845|NCT01719861|983916|P1|Cycle 1|Death|4
291846|NCT01719757|983924|P1|Overall Study|well controlled pain|27
291847|NCT01719757|983924|P1|Overall Study|Protocol Violation|1
291848|NCT01719757|983924|P1|Overall Study|Lost to Follow-up|20
291849|NCT01719757|983924|P1|Overall Study|Withdrawal by Subject|15
291850|NCT01719757|983924|P1|Overall Study|Adverse Event|38
291851|NCT01719224|983969|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
291852|NCT01719224|983970|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
291853|NCT01719172|983979|P1|Overall Study|Death|1
291854|NCT01719172|983979|P1|Overall Study|Lost to Follow-up|1
291855|NCT01719003|983993|P9|Overall Study|Lack of Efficacy|0
291856|NCT01719003|983994|P8|Overall Study|Lack of Efficacy|0
291857|NCT01719003|983995|P7|Overall Study|Lack of Efficacy|1
291858|NCT01719003|983996|P6|Overall Study|Lack of Efficacy|0
291859|NCT01719003|983997|P5|Overall Study|Lack of Efficacy|0
291860|NCT01719003|983998|P4|Overall Study|Lack of Efficacy|0
291861|NCT01719003|983999|P3|Overall Study|Lack of Efficacy|0
291862|NCT01719003|984000|P2|Overall Study|Lack of Efficacy|0
291863|NCT01719003|984001|P1|Overall Study|Lack of Efficacy|0
291864|NCT01719003|983993|P9|Overall Study|Reason other than those specified|1
291865|NCT01719003|983994|P8|Overall Study|Reason other than those specified|3
291866|NCT01719003|983995|P7|Overall Study|Reason other than those specified|0
291867|NCT01719003|983996|P6|Overall Study|Reason other than those specified|1
291868|NCT01719003|983997|P5|Overall Study|Reason other than those specified|4
291869|NCT01719003|983998|P4|Overall Study|Reason other than those specified|3
291870|NCT01719003|983999|P3|Overall Study|Reason other than those specified|2
291871|NCT01719003|984000|P2|Overall Study|Reason other than those specified|0
291872|NCT01719003|984001|P1|Overall Study|Reason other than those specified|0
291873|NCT01719003|983993|P9|Overall Study|Refusal to continue, not due to AE|1
291874|NCT01719003|983994|P8|Overall Study|Refusal to continue, not due to AE|7
291875|NCT01719003|983995|P7|Overall Study|Refusal to continue, not due to AE|8
291876|NCT01719003|983996|P6|Overall Study|Refusal to continue, not due to AE|3
291877|NCT01719003|983997|P5|Overall Study|Refusal to continue, not due to AE|4
291878|NCT01719003|983998|P4|Overall Study|Refusal to continue, not due to AE|4
291879|NCT01719003|983999|P3|Overall Study|Refusal to continue, not due to AE|4
291880|NCT01719003|984000|P2|Overall Study|Refusal to continue, not due to AE|5
291881|NCT01719003|984001|P1|Overall Study|Refusal to continue, not due to AE|2
291882|NCT01719003|983993|P9|Overall Study|Lost to Follow-up|2
291883|NCT01719003|983994|P8|Overall Study|Lost to Follow-up|2
291884|NCT01719003|983995|P7|Overall Study|Lost to Follow-up|3
291885|NCT01719003|983996|P6|Overall Study|Lost to Follow-up|4
291886|NCT01719003|983997|P5|Overall Study|Lost to Follow-up|3
291887|NCT01719003|983998|P4|Overall Study|Lost to Follow-up|2
291888|NCT01719003|983999|P3|Overall Study|Lost to Follow-up|7
291889|NCT01719003|984000|P2|Overall Study|Lost to Follow-up|6
291890|NCT01719003|984001|P1|Overall Study|Lost to Follow-up|0
291891|NCT01719003|983993|P9|Overall Study|Adverse Event|0
291892|NCT01719003|983994|P8|Overall Study|Adverse Event|5
291893|NCT01719003|983995|P7|Overall Study|Adverse Event|6
291894|NCT01719003|983996|P6|Overall Study|Adverse Event|3
291895|NCT01719003|983997|P5|Overall Study|Adverse Event|4
291896|NCT01719003|983998|P4|Overall Study|Adverse Event|3
291897|NCT01719003|983999|P3|Overall Study|Adverse Event|4
291898|NCT01719003|984000|P2|Overall Study|Adverse Event|5
291899|NCT01719003|984001|P1|Overall Study|Adverse Event|6
291900|NCT01719003|983993|P9|Overall Study|Non compliant with protocol|0
291901|NCT01719003|983994|P8|Overall Study|Non compliant with protocol|3
291902|NCT01719003|983995|P7|Overall Study|Non compliant with protocol|2
291903|NCT01719003|983996|P6|Overall Study|Non compliant with protocol|1
291904|NCT01719003|983997|P5|Overall Study|Non compliant with protocol|2
291905|NCT01719003|983998|P4|Overall Study|Non compliant with protocol|1
291906|NCT01719003|983999|P3|Overall Study|Non compliant with protocol|0
291907|NCT01719003|984000|P2|Overall Study|Non compliant with protocol|1
291908|NCT01719003|984001|P1|Overall Study|Non compliant with protocol|1
291909|NCT01718535|984082|P10|Overall Study|Bidirectional Sequencing not possible|0
291910|NCT01718535|984083|P9|Overall Study|Bidirectional Sequencing not possible|0
291911|NCT01718535|984084|P8|Overall Study|Bidirectional Sequencing not possible|0
291912|NCT01718535|984085|P7|Overall Study|Bidirectional Sequencing not possible|0
291913|NCT01718535|984086|P6|Overall Study|Bidirectional Sequencing not possible|0
291914|NCT01718535|984087|P5|Overall Study|Bidirectional Sequencing not possible|0
291915|NCT01718535|984088|P4|Overall Study|Bidirectional Sequencing not possible|1
291916|NCT01718535|984089|P3|Overall Study|Bidirectional Sequencing not possible|0
291917|NCT01718535|984090|P2|Overall Study|Bidirectional Sequencing not possible|0
291918|NCT01718535|984091|P1|Overall Study|Bidirectional Sequencing not possible|1
291919|NCT01718509|984115|P2|Overall Study|Lack of Efficacy|0
291920|NCT01718509|984116|P1|Overall Study|Lack of Efficacy|1
291921|NCT01718509|984115|P2|Overall Study|Protocol Violation|2
291922|NCT01718509|984116|P1|Overall Study|Protocol Violation|4
291923|NCT01718509|984115|P2|Overall Study|Not specified|11
291924|NCT01718509|984116|P1|Overall Study|Not specified|13
291925|NCT01718509|984115|P2|Overall Study|Adverse Event|7
291926|NCT01718509|984116|P1|Overall Study|Adverse Event|5
291927|NCT01718509|984115|P2|Overall Study|Withdrawal by Subject|13
291928|NCT01718509|984116|P1|Overall Study|Withdrawal by Subject|7
291929|NCT01718509|984115|P2|Overall Study|Lost to Follow-up|15
291930|NCT01718509|984116|P1|Overall Study|Lost to Follow-up|18
291931|NCT01718483|984162|P2|Overall Study|Lack of Efficacy|0
291932|NCT01718483|984163|P1|Overall Study|Lack of Efficacy|1
291933|NCT01718483|984162|P2|Overall Study|Pregnancy|1
291934|NCT01718483|984163|P1|Overall Study|Pregnancy|1
291935|NCT01718483|984162|P2|Overall Study|Not specified|4
291936|NCT01718483|984163|P1|Overall Study|Not specified|1
291937|NCT01718483|984162|P2|Overall Study|Protocol Violation|2
291938|NCT01718483|984163|P1|Overall Study|Protocol Violation|4
291939|NCT01718483|984162|P2|Overall Study|Lost to Follow-up|3
291940|NCT01718483|984163|P1|Overall Study|Lost to Follow-up|8
291941|NCT01718483|984162|P2|Overall Study|Adverse Event|12
291942|NCT01718483|984163|P1|Overall Study|Adverse Event|5
291943|NCT01718483|984162|P2|Overall Study|Withdrawal by Subject|12
291944|NCT01718483|984163|P1|Overall Study|Withdrawal by Subject|14
291945|NCT01718353|984209|P2|Overall Study|Randomized but not treated|0
291946|NCT01718353|984210|P1|Overall Study|Randomized but not treated|2
291947|NCT01718353|984209|P2|Overall Study|Principal Investigator's Decision|4
291948|NCT01718353|984210|P1|Overall Study|Principal Investigator's Decision|10
291949|NCT01718353|984209|P2|Overall Study|Lost to Follow-up|1
291950|NCT01718353|984210|P1|Overall Study|Lost to Follow-up|0
291951|NCT01717989|984241|P1|Overall Study|Other|40
291952|NCT01717989|984241|P1|Overall Study|Protocol-specified criteria|551
291953|NCT01717989|984241|P1|Overall Study|Death|439
291954|NCT01717989|984241|P1|Overall Study|Lost to Follow-up|11
291955|NCT01717989|984241|P1|Overall Study|Physician Decision|2
291956|NCT01717989|984241|P1|Overall Study|Withdrawal by Subject|11
291957|NCT01717989|984241|P1|Overall Study|Protocol deviation|6
291958|NCT01717989|984241|P1|Overall Study|Ineligibility determined|6
291959|NCT01717976|984309|P2|Overall Study|Protocol Violation|1
291960|NCT01717976|984310|P1|Overall Study|Protocol Violation|0
291961|NCT01717768|984375|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291962|NCT01717768|984376|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291963|NCT01717768|984377|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
291964|NCT01717768|984378|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291965|NCT01717768|984379|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291966|NCT01717768|984380|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291967|NCT01717768|984381|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291968|NCT01717768|984382|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291969|NCT01717768|984383|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291970|NCT01717768|984384|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291971|NCT01717768|984385|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291972|NCT01717768|984386|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
291973|NCT01717768|984375|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291974|NCT01717768|984376|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291975|NCT01717768|984377|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291976|NCT01717768|984378|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291977|NCT01717768|984379|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
291978|NCT01717768|984380|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291979|NCT01717768|984381|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291980|NCT01717768|984382|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291981|NCT01717768|984383|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291982|NCT01717768|984384|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291983|NCT01717768|984385|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291984|NCT01717768|984386|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
291985|NCT01717768|984375|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
291986|NCT01717768|984376|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291987|NCT01717768|984377|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291988|NCT01717768|984378|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291989|NCT01717768|984379|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291990|NCT01717768|984380|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291991|NCT01717768|984381|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291992|NCT01717768|984382|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291993|NCT01717768|984383|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291994|NCT01717768|984384|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291995|NCT01717768|984385|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291996|NCT01717768|984386|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
291997|NCT01717768|984375|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
291998|NCT01717768|984376|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
291999|NCT01717768|984377|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292000|NCT01717768|984378|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292088|NCT01717326|984702|P9|Overall Study|Protocol Violation|0
292001|NCT01717768|984379|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292002|NCT01717768|984380|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292003|NCT01717768|984381|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292004|NCT01717768|984382|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292005|NCT01717768|984383|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292006|NCT01717768|984384|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292007|NCT01717768|984385|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
292008|NCT01717768|984386|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
292009|NCT01717638|984437|P13|Overall Study|Withdrawal by Subject|18
292010|NCT01717638|984438|P12|Overall Study|Withdrawal by Subject|0
292011|NCT01717638|984439|P11|Overall Study|Withdrawal by Subject|0
292012|NCT01717638|984440|P10|Overall Study|Withdrawal by Subject|1
292013|NCT01717638|984441|P9|Overall Study|Withdrawal by Subject|2
292014|NCT01717638|984442|P8|Overall Study|Withdrawal by Subject|1
292015|NCT01717638|984443|P7|Overall Study|Withdrawal by Subject|2
292016|NCT01717638|984444|P6|Overall Study|Withdrawal by Subject|0
292017|NCT01717638|984445|P5|Overall Study|Withdrawal by Subject|1
292018|NCT01717638|984446|P4|Overall Study|Withdrawal by Subject|0
292019|NCT01717638|984447|P3|Overall Study|Withdrawal by Subject|1
292020|NCT01717638|984448|P2|Overall Study|Withdrawal by Subject|1
292021|NCT01717638|984449|P1|Overall Study|Withdrawal by Subject|0
292022|NCT01717638|984437|P13|Overall Study|Father in hospital|1
292023|NCT01717638|984438|P12|Overall Study|Father in hospital|0
292024|NCT01717638|984439|P11|Overall Study|Father in hospital|0
292025|NCT01717638|984440|P10|Overall Study|Father in hospital|0
292026|NCT01717638|984441|P9|Overall Study|Father in hospital|0
292027|NCT01717638|984442|P8|Overall Study|Father in hospital|0
292028|NCT01717638|984443|P7|Overall Study|Father in hospital|0
292029|NCT01717638|984444|P6|Overall Study|Father in hospital|0
292030|NCT01717638|984445|P5|Overall Study|Father in hospital|0
292031|NCT01717638|984446|P4|Overall Study|Father in hospital|0
292032|NCT01717638|984447|P3|Overall Study|Father in hospital|0
292033|NCT01717638|984448|P2|Overall Study|Father in hospital|0
292034|NCT01717638|984449|P1|Overall Study|Father in hospital|0
292035|NCT01717638|984437|P13|Overall Study|Lost to Follow-up|0
292036|NCT01717638|984438|P12|Overall Study|Lost to Follow-up|0
292037|NCT01717638|984439|P11|Overall Study|Lost to Follow-up|0
292038|NCT01717638|984440|P10|Overall Study|Lost to Follow-up|0
292039|NCT01717638|984441|P9|Overall Study|Lost to Follow-up|0
292040|NCT01717638|984442|P8|Overall Study|Lost to Follow-up|0
292041|NCT01717638|984443|P7|Overall Study|Lost to Follow-up|0
292042|NCT01717638|984444|P6|Overall Study|Lost to Follow-up|1
292043|NCT01717638|984445|P5|Overall Study|Lost to Follow-up|0
292044|NCT01717638|984446|P4|Overall Study|Lost to Follow-up|0
292045|NCT01717638|984447|P3|Overall Study|Lost to Follow-up|0
292046|NCT01717638|984448|P2|Overall Study|Lost to Follow-up|0
292047|NCT01717638|984449|P1|Overall Study|Lost to Follow-up|0
292048|NCT01717456|984593|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
292049|NCT01717456|984594|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
292050|NCT01717456|984593|P2|End of Treatment|Lost to Follow-up|1
292051|NCT01717456|984594|P1|End of Treatment|Lost to Follow-up|0
292052|NCT01717456|984593|P2|End of Treatment|Physician Decision|1
292053|NCT01717456|984594|P1|End of Treatment|Physician Decision|0
292054|NCT01717391|984662|P1|Overall Study|FLT technical failure|3
292055|NCT01717391|984662|P1|Overall Study|Physician Decision|1
292056|NCT01717391|984662|P1|Overall Study|Withdrawal by Subject|5
292057|NCT01717326|984691|P20|Overall Study|Withdrawal by Subject|3
292058|NCT01717326|984692|P19|Overall Study|Withdrawal by Subject|2
292059|NCT01717326|984693|P18|Overall Study|Withdrawal by Subject|0
292060|NCT01717326|984694|P17|Overall Study|Withdrawal by Subject|0
292061|NCT01717326|984695|P16|Overall Study|Withdrawal by Subject|1
292062|NCT01717326|984696|P15|Overall Study|Withdrawal by Subject|0
292063|NCT01717326|984697|P14|Overall Study|Withdrawal by Subject|0
292064|NCT01717326|984698|P13|Overall Study|Withdrawal by Subject|1
292065|NCT01717326|984699|P12|Overall Study|Withdrawal by Subject|0
292066|NCT01717326|984700|P11|Overall Study|Withdrawal by Subject|0
292067|NCT01717326|984701|P10|Overall Study|Withdrawal by Subject|1
292068|NCT01717326|984702|P9|Overall Study|Withdrawal by Subject|0
292069|NCT01717326|984703|P8|Overall Study|Withdrawal by Subject|0
292070|NCT01717326|984704|P7|Overall Study|Withdrawal by Subject|0
292071|NCT01717326|984705|P6|Overall Study|Withdrawal by Subject|0
292072|NCT01717326|984706|P5|Overall Study|Withdrawal by Subject|0
292073|NCT01717326|984707|P4|Overall Study|Withdrawal by Subject|0
292074|NCT01717326|984708|P3|Overall Study|Withdrawal by Subject|0
292075|NCT01717326|984709|P2|Overall Study|Withdrawal by Subject|1
292076|NCT01717326|984710|P1|Overall Study|Withdrawal by Subject|0
292077|NCT01717326|984691|P20|Overall Study|Protocol Violation|0
292078|NCT01717326|984692|P19|Overall Study|Protocol Violation|0
292079|NCT01717326|984693|P18|Overall Study|Protocol Violation|0
292080|NCT01717326|984694|P17|Overall Study|Protocol Violation|0
292081|NCT01717326|984695|P16|Overall Study|Protocol Violation|0
292082|NCT01717326|984696|P15|Overall Study|Protocol Violation|0
292083|NCT01717326|984697|P14|Overall Study|Protocol Violation|0
292084|NCT01717326|984698|P13|Overall Study|Protocol Violation|0
292085|NCT01717326|984699|P12|Overall Study|Protocol Violation|0
292086|NCT01717326|984700|P11|Overall Study|Protocol Violation|0
292087|NCT01717326|984701|P10|Overall Study|Protocol Violation|0
292089|NCT01717326|984703|P8|Overall Study|Protocol Violation|0
292090|NCT01717326|984704|P7|Overall Study|Protocol Violation|0
292091|NCT01717326|984705|P6|Overall Study|Protocol Violation|0
292092|NCT01717326|984706|P5|Overall Study|Protocol Violation|1
292093|NCT01717326|984707|P4|Overall Study|Protocol Violation|0
292094|NCT01717326|984708|P3|Overall Study|Protocol Violation|0
292095|NCT01717326|984709|P2|Overall Study|Protocol Violation|0
292096|NCT01717326|984710|P1|Overall Study|Protocol Violation|0
292097|NCT01717326|984691|P20|Overall Study|Physician Decision|0
292098|NCT01717326|984692|P19|Overall Study|Physician Decision|0
292099|NCT01717326|984693|P18|Overall Study|Physician Decision|0
292100|NCT01717326|984694|P17|Overall Study|Physician Decision|0
292101|NCT01717326|984695|P16|Overall Study|Physician Decision|0
292102|NCT01717326|984696|P15|Overall Study|Physician Decision|0
292103|NCT01717326|984697|P14|Overall Study|Physician Decision|0
292104|NCT01717326|984698|P13|Overall Study|Physician Decision|0
292105|NCT01717326|984699|P12|Overall Study|Physician Decision|0
292106|NCT01717326|984700|P11|Overall Study|Physician Decision|0
292107|NCT01717326|984701|P10|Overall Study|Physician Decision|1
292108|NCT01717326|984702|P9|Overall Study|Physician Decision|0
292109|NCT01717326|984703|P8|Overall Study|Physician Decision|0
292110|NCT01717326|984704|P7|Overall Study|Physician Decision|0
292111|NCT01717326|984705|P6|Overall Study|Physician Decision|0
292112|NCT01717326|984706|P5|Overall Study|Physician Decision|0
292113|NCT01717326|984707|P4|Overall Study|Physician Decision|0
292114|NCT01717326|984708|P3|Overall Study|Physician Decision|0
292115|NCT01717326|984709|P2|Overall Study|Physician Decision|0
292116|NCT01717326|984710|P1|Overall Study|Physician Decision|0
292117|NCT01717326|984691|P20|Overall Study|Lost to Follow-up|3
292118|NCT01717326|984692|P19|Overall Study|Lost to Follow-up|2
292119|NCT01717326|984693|P18|Overall Study|Lost to Follow-up|0
292120|NCT01717326|984694|P17|Overall Study|Lost to Follow-up|1
292121|NCT01717326|984695|P16|Overall Study|Lost to Follow-up|2
292122|NCT01717326|984696|P15|Overall Study|Lost to Follow-up|0
292123|NCT01717326|984697|P14|Overall Study|Lost to Follow-up|0
292124|NCT01717326|984698|P13|Overall Study|Lost to Follow-up|0
292125|NCT01717326|984699|P12|Overall Study|Lost to Follow-up|0
292126|NCT01717326|984700|P11|Overall Study|Lost to Follow-up|1
292127|NCT01717326|984701|P10|Overall Study|Lost to Follow-up|0
292128|NCT01717326|984702|P9|Overall Study|Lost to Follow-up|0
292129|NCT01717326|984703|P8|Overall Study|Lost to Follow-up|0
292130|NCT01717326|984704|P7|Overall Study|Lost to Follow-up|1
292131|NCT01717326|984705|P6|Overall Study|Lost to Follow-up|0
292132|NCT01717326|984706|P5|Overall Study|Lost to Follow-up|1
292133|NCT01717326|984707|P4|Overall Study|Lost to Follow-up|2
292134|NCT01717326|984708|P3|Overall Study|Lost to Follow-up|0
292135|NCT01717326|984709|P2|Overall Study|Lost to Follow-up|0
292136|NCT01717326|984710|P1|Overall Study|Lost to Follow-up|3
292137|NCT01717326|984691|P20|Overall Study|Death|0
292138|NCT01717326|984692|P19|Overall Study|Death|0
292139|NCT01717326|984693|P18|Overall Study|Death|0
292140|NCT01717326|984694|P17|Overall Study|Death|0
292141|NCT01717326|984695|P16|Overall Study|Death|0
292142|NCT01717326|984696|P15|Overall Study|Death|0
292143|NCT01717326|984697|P14|Overall Study|Death|0
292144|NCT01717326|984698|P13|Overall Study|Death|0
292145|NCT01717326|984699|P12|Overall Study|Death|0
292146|NCT01717326|984700|P11|Overall Study|Death|1
292147|NCT01717326|984701|P10|Overall Study|Death|0
292148|NCT01717326|984702|P9|Overall Study|Death|0
292149|NCT01717326|984703|P8|Overall Study|Death|0
292150|NCT01717326|984704|P7|Overall Study|Death|0
292151|NCT01717326|984705|P6|Overall Study|Death|0
292152|NCT01717326|984706|P5|Overall Study|Death|0
292153|NCT01717326|984707|P4|Overall Study|Death|0
292154|NCT01717326|984708|P3|Overall Study|Death|0
292155|NCT01717326|984709|P2|Overall Study|Death|0
292156|NCT01717326|984710|P1|Overall Study|Death|0
292157|NCT01717313|984974|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
292158|NCT01717313|984975|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
292159|NCT01717313|984974|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
292160|NCT01717313|984975|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
292161|NCT01717313|984974|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
292162|NCT01717313|984975|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
292163|NCT01717313|984974|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
292164|NCT01717313|984975|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
292165|NCT01717313|984974|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
292166|NCT01717313|984975|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
292167|NCT01717313|984974|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
292168|NCT01717313|984975|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
292169|NCT01717313|984974|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
292170|NCT01717313|984975|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
292171|NCT01717313|984974|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
292172|NCT01717313|984975|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
292173|NCT01717313|984974|P2|Phase A (Weeks 0 to 24)|Death|1
292174|NCT01717313|984975|P1|Phase A (Weeks 0 to 24)|Death|0
292175|NCT01717287|985013|P2|Overall Study|Protocol Violation|1
292176|NCT01717287|985014|P1|Overall Study|Protocol Violation|0
292177|NCT01717287|985013|P2|Overall Study|Lost to Follow-up|2
292178|NCT01717287|985014|P1|Overall Study|Lost to Follow-up|0
292179|NCT01717040|985047|P2|Overall Study|New Substance Use Disorder|0
292180|NCT01717040|985048|P1|Overall Study|New Substance Use Disorder|1
292181|NCT01717040|985047|P2|Overall Study|Required Medication Change|1
292182|NCT01717040|985048|P1|Overall Study|Required Medication Change|0
292183|NCT01717040|985047|P2|Overall Study|Adverse Event|0
292184|NCT01717040|985048|P1|Overall Study|Adverse Event|1
292185|NCT01717040|985047|P2|Overall Study|Lack of Efficacy|1
292186|NCT01717040|985048|P1|Overall Study|Lack of Efficacy|1
292187|NCT01717040|985047|P2|Overall Study|Lost to Follow-up|3
292188|NCT01717040|985048|P1|Overall Study|Lost to Follow-up|2
292189|NCT01716754|985066|P4|Overall Study|Withdrawal by Subject|3
292190|NCT01716754|985067|P3|Overall Study|Withdrawal by Subject|4
292191|NCT01716754|985068|P2|Overall Study|Withdrawal by Subject|0
292192|NCT01716754|985069|P1|Overall Study|Withdrawal by Subject|5
292193|NCT01716754|985066|P4|Overall Study|Adverse Event|1
292194|NCT01716754|985067|P3|Overall Study|Adverse Event|2
292195|NCT01716754|985068|P2|Overall Study|Adverse Event|2
292196|NCT01716754|985069|P1|Overall Study|Adverse Event|4
292197|NCT01716754|985066|P4|Overall Study|Lost to Follow-up|1
292198|NCT01716754|985067|P3|Overall Study|Lost to Follow-up|0
292199|NCT01716754|985068|P2|Overall Study|Lost to Follow-up|0
292200|NCT01716754|985069|P1|Overall Study|Lost to Follow-up|1
292201|NCT01716754|985066|P4|Overall Study|Physician Decision|0
292202|NCT01716754|985067|P3|Overall Study|Physician Decision|0
292203|NCT01716754|985068|P2|Overall Study|Physician Decision|0
292204|NCT01716754|985069|P1|Overall Study|Physician Decision|1
292205|NCT01716754|985066|P4|Overall Study|Non-compliance with study treatment|0
292206|NCT01716754|985067|P3|Overall Study|Non-compliance with study treatment|1
292207|NCT01716754|985068|P2|Overall Study|Non-compliance with study treatment|0
292208|NCT01716754|985069|P1|Overall Study|Non-compliance with study treatment|0
292209|NCT01716754|985066|P4|Overall Study|Protocol deviation|2
292210|NCT01716754|985067|P3|Overall Study|Protocol deviation|7
292211|NCT01716754|985068|P2|Overall Study|Protocol deviation|2
292212|NCT01716754|985069|P1|Overall Study|Protocol deviation|0
292213|NCT01716754|985066|P4|Overall Study|Death|1
292214|NCT01716754|985067|P3|Overall Study|Death|0
292215|NCT01716754|985068|P2|Overall Study|Death|0
292216|NCT01716754|985069|P1|Overall Study|Death|0
292217|NCT01716663|985090|P1|Overall Study|Treated with non-study catheter|2
292218|NCT01716663|985090|P1|Overall Study|Withdrawn prior to procedure|4
292219|NCT01716585|985100|P2|Open-label Treatment|Withdrawal by Subject|3
292220|NCT01716585|985101|P1|Open-label Treatment|Withdrawal by Subject|0
292221|NCT01716585|985100|P2|Open-label Treatment|Virologic Failure|2
292222|NCT01716585|985101|P1|Open-label Treatment|Virologic Failure|0
292223|NCT01716585|985100|P2|Open-label Treatment|Adverse Event|2
292224|NCT01716585|985101|P1|Open-label Treatment|Adverse Event|0
292225|NCT01716585|985100|P2|Double-blind Treatment|Not Specified|0
292226|NCT01716585|985101|P1|Double-blind Treatment|Not Specified|1
292227|NCT01716585|985100|P2|Double-blind Treatment|Subject Noncompliant|0
292228|NCT01716585|985101|P1|Double-blind Treatment|Subject Noncompliant|1
292229|NCT01716585|985100|P2|Double-blind Treatment|Lost to Follow-up|0
292230|NCT01716585|985101|P1|Double-blind Treatment|Lost to Follow-up|2
292231|NCT01716585|985100|P2|Double-blind Treatment|Withdrawal by Subject|0
292232|NCT01716585|985101|P1|Double-blind Treatment|Withdrawal by Subject|3
292233|NCT01716585|985100|P2|Double-blind Treatment|Adverse Event|1
292234|NCT01716585|985101|P1|Double-blind Treatment|Adverse Event|2
292235|NCT01716585|985100|P2|Double-blind Treatment|Did Not Receive Study Drug|1
292236|NCT01716585|985101|P1|Double-blind Treatment|Did Not Receive Study Drug|4
292237|NCT01716559|985113|P1|Overall Study|Other withdrawal reason|75
292238|NCT01716559|985113|P1|Overall Study|Withdrawal by Subject|4
292239|NCT01716559|985113|P1|Overall Study|Death|21
292240|NCT01716559|985113|P1|Overall Study|Adverse Event|11
292241|NCT01716520|985121|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
292242|NCT01716520|985122|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
292243|NCT01716520|985123|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
292244|NCT01716520|985124|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
292245|NCT01716520|985125|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
292246|NCT01716520|985126|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
292247|NCT01716520|985121|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
292248|NCT01716520|985122|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
292249|NCT01716520|985123|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
292250|NCT01716520|985124|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
292251|NCT01716520|985125|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
292252|NCT01716520|985126|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
292253|NCT01716520|985121|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
292254|NCT01716520|985122|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
292255|NCT01716520|985123|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
292256|NCT01716520|985124|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
292257|NCT01716520|985125|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
292258|NCT01716520|985126|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
292259|NCT01716520|985121|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
292260|NCT01716520|985122|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
292261|NCT01716520|985123|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
292262|NCT01716520|985124|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
292263|NCT01716520|985125|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
292264|NCT01716520|985126|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
292265|NCT01716520|985121|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
292266|NCT01716520|985122|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
292267|NCT01716520|985123|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
292268|NCT01716520|985124|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
292269|NCT01716520|985125|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
292270|NCT01716520|985126|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
292271|NCT01716520|985121|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
292272|NCT01716520|985122|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
292273|NCT01716520|985123|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
292274|NCT01716520|985124|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
292275|NCT01716520|985125|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
292276|NCT01716520|985126|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
292277|NCT01716520|985121|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
292278|NCT01716520|985122|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
292279|NCT01716520|985123|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
292280|NCT01716520|985124|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
292281|NCT01716520|985125|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
292282|NCT01716520|985126|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
292283|NCT01716520|985121|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
292284|NCT01716520|985122|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
292285|NCT01716520|985123|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
292286|NCT01716520|985124|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
292287|NCT01716520|985125|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
292288|NCT01716520|985126|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
292289|NCT01716520|985121|P6|Treatment Period 2 (14 Days)|Adverse Event|0
292290|NCT01716520|985122|P5|Treatment Period 2 (14 Days)|Adverse Event|1
292291|NCT01716520|985123|P4|Treatment Period 2 (14 Days)|Adverse Event|0
292292|NCT01716520|985124|P3|Treatment Period 2 (14 Days)|Adverse Event|0
292293|NCT01716520|985125|P2|Treatment Period 2 (14 Days)|Adverse Event|0
292294|NCT01716520|985126|P1|Treatment Period 2 (14 Days)|Adverse Event|0
292295|NCT01716520|985121|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
292296|NCT01716520|985122|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
292297|NCT01716520|985123|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
292298|NCT01716520|985124|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
292299|NCT01716520|985125|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
292300|NCT01716520|985126|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
292301|NCT01716520|985121|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
292302|NCT01716520|985122|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
292303|NCT01716520|985123|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
292304|NCT01716520|985124|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
292305|NCT01716520|985125|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
292306|NCT01716520|985126|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
292307|NCT01716520|985121|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
292308|NCT01716520|985122|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
292309|NCT01716520|985123|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
292310|NCT01716520|985124|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
292311|NCT01716520|985125|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
292312|NCT01716520|985126|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
292313|NCT01716520|985121|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
292314|NCT01716520|985122|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
292315|NCT01716520|985123|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
292316|NCT01716520|985124|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
292317|NCT01716520|985125|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
292318|NCT01716520|985126|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
292319|NCT01716520|985121|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
292320|NCT01716520|985122|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
292321|NCT01716520|985123|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
292322|NCT01716520|985124|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
292323|NCT01716520|985125|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
292324|NCT01716520|985126|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
292325|NCT01716520|985121|P6|Treatment Period 1 (14 Days)|Adverse Event|0
292326|NCT01716520|985122|P5|Treatment Period 1 (14 Days)|Adverse Event|0
292327|NCT01716520|985123|P4|Treatment Period 1 (14 Days)|Adverse Event|0
292328|NCT01716520|985124|P3|Treatment Period 1 (14 Days)|Adverse Event|0
292329|NCT01716520|985125|P2|Treatment Period 1 (14 Days)|Adverse Event|0
292330|NCT01716520|985126|P1|Treatment Period 1 (14 Days)|Adverse Event|1
292331|NCT01716234|985181|P7|Overall Study|Withdrawal by Subject|0
292332|NCT01716234|985182|P6|Overall Study|Withdrawal by Subject|3
292333|NCT01716234|985183|P5|Overall Study|Withdrawal by Subject|1
292334|NCT01716234|985184|P4|Overall Study|Withdrawal by Subject|2
292335|NCT01716234|985185|P3|Overall Study|Withdrawal by Subject|2
292336|NCT01716234|985186|P2|Overall Study|Withdrawal by Subject|0
292337|NCT01716234|985187|P1|Overall Study|Withdrawal by Subject|3
292338|NCT01716234|985181|P7|Overall Study|Adverse Event|0
292339|NCT01716234|985182|P6|Overall Study|Adverse Event|6
292340|NCT01716234|985183|P5|Overall Study|Adverse Event|3
292341|NCT01716234|985184|P4|Overall Study|Adverse Event|8
292342|NCT01716234|985185|P3|Overall Study|Adverse Event|2
292343|NCT01716234|985186|P2|Overall Study|Adverse Event|10
292344|NCT01716234|985187|P1|Overall Study|Adverse Event|7
292345|NCT01716234|985181|P7|Overall Study|Did not meet protocol eligibility|0
292346|NCT01716234|985182|P6|Overall Study|Did not meet protocol eligibility|4
292347|NCT01716234|985183|P5|Overall Study|Did not meet protocol eligibility|0
292348|NCT01716234|985184|P4|Overall Study|Did not meet protocol eligibility|0
292349|NCT01716234|985185|P3|Overall Study|Did not meet protocol eligibility|1
292350|NCT01716234|985186|P2|Overall Study|Did not meet protocol eligibility|0
292351|NCT01716234|985187|P1|Overall Study|Did not meet protocol eligibility|0
292352|NCT01716234|985181|P7|Overall Study|Lack of Efficacy|0
292353|NCT01716234|985182|P6|Overall Study|Lack of Efficacy|0
292354|NCT01716234|985183|P5|Overall Study|Lack of Efficacy|0
292355|NCT01716234|985184|P4|Overall Study|Lack of Efficacy|1
292356|NCT01716234|985185|P3|Overall Study|Lack of Efficacy|0
292357|NCT01716234|985186|P2|Overall Study|Lack of Efficacy|0
292358|NCT01716234|985187|P1|Overall Study|Lack of Efficacy|0
292359|NCT01716234|985181|P7|Overall Study|Protocol Violation|0
292360|NCT01716234|985182|P6|Overall Study|Protocol Violation|1
292361|NCT01716234|985183|P5|Overall Study|Protocol Violation|1
292362|NCT01716234|985184|P4|Overall Study|Protocol Violation|1
292363|NCT01716234|985185|P3|Overall Study|Protocol Violation|0
292364|NCT01716234|985186|P2|Overall Study|Protocol Violation|0
292365|NCT01716234|985187|P1|Overall Study|Protocol Violation|0
292366|NCT01716169|985250|P1|Overall Study|inconsistent dressing application|1
292367|NCT01716169|985250|P1|Overall Study|Withdrawal by Subject|1
292368|NCT01716169|985250|P1|Overall Study|Lost to Follow-up|1
292369|NCT01716169|985250|P1|Overall Study|Adverse Event|1
292370|NCT01716156|985259|P3|Overall Study|Lost to Follow-up|0
292371|NCT01716156|985260|P2|Overall Study|Lost to Follow-up|0
292372|NCT01716156|985261|P1|Overall Study|Lost to Follow-up|1
292373|NCT01716156|985259|P3|Overall Study|Withdrawal by Subject|2
292374|NCT01716156|985260|P2|Overall Study|Withdrawal by Subject|1
292375|NCT01716156|985261|P1|Overall Study|Withdrawal by Subject|0
292376|NCT01716156|985259|P3|Overall Study|Protocol Violation|0
292377|NCT01716156|985260|P2|Overall Study|Protocol Violation|0
292378|NCT01716156|985261|P1|Overall Study|Protocol Violation|1
292379|NCT01716052|985287|P2|Overall Study|Withdrawal of funding|1
292380|NCT01716052|985288|P1|Overall Study|Withdrawal of funding|1
292381|NCT01715896|985330|P2|Overall Study|Other|5
292382|NCT01715896|985331|P1|Overall Study|Other|2
292383|NCT01715896|985330|P2|Overall Study|Withdrawal by Subject|4
292384|NCT01715896|985331|P1|Overall Study|Withdrawal by Subject|1
292385|NCT01715896|985330|P2|Overall Study|Lost to Follow-up|2
292386|NCT01715896|985331|P1|Overall Study|Lost to Follow-up|0
292387|NCT01715857|985394|P1|Overall Study|Did Not Meet Eligibility Criteria|96
292388|NCT01715831|985404|P1|Overall Study|Adverse Event|1
292389|NCT01715415|985422|P2|Open-label Treatment|Subject Noncompliant|1
292390|NCT01715415|985423|P1|Open-label Treatment|Subject Noncompliant|0
292391|NCT01715415|985422|P2|Open-label Treatment|Adverse Event|1
292392|NCT01715415|985423|P1|Open-label Treatment|Adverse Event|0
292393|NCT01715415|985422|P2|Double-blind Treatment|Not Specified|0
292394|NCT01715415|985423|P1|Double-blind Treatment|Not Specified|1
292395|NCT01715415|985422|P2|Double-blind Treatment|Withdrawal by Subject|1
292396|NCT01715415|985423|P1|Double-blind Treatment|Withdrawal by Subject|1
292397|NCT01715415|985422|P2|Double-blind Treatment|Adverse Event|0
292398|NCT01715415|985423|P1|Double-blind Treatment|Adverse Event|3
292399|NCT01715415|985422|P2|Double-blind Treatment|Did Not Receive Study Drug|1
292400|NCT01715415|985423|P1|Double-blind Treatment|Did Not Receive Study Drug|0
292401|NCT01715298|985437|P2|Overall Study|Patient/guardian decision|9
292402|NCT01715298|985438|P1|Overall Study|Patient/guardian decision|7
292403|NCT01715298|985437|P2|Overall Study|Lost to Follow-up|2
292404|NCT01715298|985438|P1|Overall Study|Lost to Follow-up|0
292405|NCT01715129|985485|P1|Overall Study|Other|1
292406|NCT01715129|985485|P1|Overall Study|Lost to Follow-up|1
292407|NCT01715129|985485|P1|Overall Study|Consent Withdrawn|2
292408|NCT01715129|985485|P1|Overall Study|Protocol Violation|1
292409|NCT01715129|985485|P1|Overall Study|Lack of Efficacy|3
292410|NCT01715129|985485|P1|Overall Study|Adverse Event, fatal|1
292411|NCT01714817|985513|P2|Overall Study|Hypersensitivity to the medication|1
292412|NCT01714817|985514|P1|Overall Study|Hypersensitivity to the medication|0
292413|NCT01714817|985513|P2|Overall Study|Antiproteinuric changed/dose increased|1
292414|NCT01714817|985514|P1|Overall Study|Antiproteinuric changed/dose increased|0
292415|NCT01714817|985513|P2|Overall Study|Need of use of Prohibited Medications|0
292416|NCT01714817|985514|P1|Overall Study|Need of use of Prohibited Medications|1
292417|NCT01714817|985513|P2|Overall Study|Change in Concomitant Medication|1
292418|NCT01714817|985514|P1|Overall Study|Change in Concomitant Medication|0
292419|NCT01714817|985513|P2|Overall Study|Not treated- received ACE inhibition|0
292507|NCT01712516|985998|P1|Overall Study|Withdrawal by Subject|3
292420|NCT01714817|985514|P1|Overall Study|Not treated- received ACE inhibition|1
292421|NCT01714817|985513|P2|Overall Study|Participant no longer meets criteria|2
292422|NCT01714817|985514|P1|Overall Study|Participant no longer meets criteria|6
292423|NCT01714817|985513|P2|Overall Study|Pregnancy|0
292424|NCT01714817|985514|P1|Overall Study|Pregnancy|2
292425|NCT01714817|985513|P2|Overall Study|Poor / non-compliance|1
292426|NCT01714817|985514|P1|Overall Study|Poor / non-compliance|0
292427|NCT01714817|985513|P2|Overall Study|Lost to Follow-up|2
292428|NCT01714817|985514|P1|Overall Study|Lost to Follow-up|0
292429|NCT01714817|985513|P2|Overall Study|Death|1
292430|NCT01714817|985514|P1|Overall Study|Death|1
292431|NCT01714817|985513|P2|Overall Study|Withdrawal by Subject|7
292432|NCT01714817|985514|P1|Overall Study|Withdrawal by Subject|6
292433|NCT01714817|985513|P2|Overall Study|Adverse Event|17
292434|NCT01714817|985514|P1|Overall Study|Adverse Event|20
292435|NCT01714817|985513|P2|Overall Study|Lack of Efficacy|9
292436|NCT01714817|985514|P1|Overall Study|Lack of Efficacy|11
292437|NCT01714635|985547|P3|Overall Study|Missed 6-month exam|0
292438|NCT01714635|985548|P2|Overall Study|Missed 6-month exam|0
292439|NCT01714635|985549|P1|Overall Study|Missed 6-month exam|1
292440|NCT01714635|985547|P3|Overall Study|Discontinued|2
292441|NCT01714635|985548|P2|Overall Study|Discontinued|0
292442|NCT01714635|985549|P1|Overall Study|Discontinued|1
292443|NCT01714609|985565|P2|Overall Study|Protocol Violation|0
292444|NCT01714609|985566|P1|Overall Study|Protocol Violation|1
292445|NCT01714544|985572|P1|Overall Study|Withdrawal by Subject|1
292446|NCT01714544|985572|P1|Overall Study|Physician Decision|1
292447|NCT01714544|985572|P1|Overall Study|Lost to Follow-up|1
292448|NCT01714310|985643|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
292449|NCT01714310|985644|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
292450|NCT01714310|985645|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
292451|NCT01714310|985643|P3|Double Blind Adjunctive Treatment|Adverse Event|0
292452|NCT01714310|985644|P2|Double Blind Adjunctive Treatment|Adverse Event|1
292453|NCT01714310|985645|P1|Double Blind Adjunctive Treatment|Adverse Event|1
292454|NCT01714310|985643|P3|Open Lisdexamfetamine Titration|Adverse Event|3
292455|NCT01714310|985644|P2|Open Lisdexamfetamine Titration|Adverse Event|0
292456|NCT01714310|985645|P1|Open Lisdexamfetamine Titration|Adverse Event|0
292457|NCT01714310|985643|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
292458|NCT01714310|985644|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
292459|NCT01714310|985645|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
292460|NCT01713998|985723|P3|Overall Study|Withdrawal by Subject|0
292461|NCT01713998|985724|P2|Overall Study|Withdrawal by Subject|0
292462|NCT01713998|985725|P1|Overall Study|Withdrawal by Subject|1
292463|NCT01713998|985723|P3|Overall Study|Lost to Follow-up|2
292464|NCT01713998|985724|P2|Overall Study|Lost to Follow-up|0
292465|NCT01713998|985725|P1|Overall Study|Lost to Follow-up|2
292466|NCT01713933|985743|P1|Overall Study|Excluded from analysis as a BMI outlier|1
292467|NCT01713933|985743|P1|Overall Study|Withdrawal by Subject|3
292468|NCT01713933|985743|P1|Overall Study|Lost to Follow-up|2
292469|NCT01713686|985755|P1|Overall Study|Withdrawal by Subject|6
292470|NCT01713686|985755|P1|Overall Study|Lost to Follow-up|9
292471|NCT01713530|985806|P2|Overall Study|Unclassified|2
292472|NCT01713530|985807|P1|Overall Study|Unclassified|4
292473|NCT01713530|985806|P2|Overall Study|Withdrawal criteria|12
292474|NCT01713530|985807|P1|Overall Study|Withdrawal criteria|21
292475|NCT01713530|985806|P2|Overall Study|Adverse Event|5
292476|NCT01713530|985807|P1|Overall Study|Adverse Event|0
292477|NCT01713348|985838|P4|Overall Study|Lost to Follow-up|0
292478|NCT01713348|985839|P3|Overall Study|Lost to Follow-up|0
292479|NCT01713348|985840|P2|Overall Study|Lost to Follow-up|0
292480|NCT01713348|985841|P1|Overall Study|Lost to Follow-up|1
292481|NCT01713348|985838|P4|Overall Study|Withdrawal by Subject|0
292482|NCT01713348|985839|P3|Overall Study|Withdrawal by Subject|2
292483|NCT01713348|985840|P2|Overall Study|Withdrawal by Subject|2
292484|NCT01713348|985841|P1|Overall Study|Withdrawal by Subject|3
292485|NCT01713283|985871|P2|Overall Study|Lost to Follow-up|1
292486|NCT01713283|985872|P1|Overall Study|Lost to Follow-up|1
292487|NCT01713283|985871|P2|Overall Study|Lack of Efficacy|2
292488|NCT01713283|985872|P1|Overall Study|Lack of Efficacy|10
292489|NCT01713036|985894|P1|Overall Study|Death|1
292490|NCT01712984|985934|P3|Overall Study|Withdrawal by Subject|7
292491|NCT01712984|985935|P2|Overall Study|Withdrawal by Subject|6
292492|NCT01712984|985936|P1|Overall Study|Withdrawal by Subject|6
292493|NCT01712984|985934|P3|Overall Study|Lost to Follow-up|1
292494|NCT01712984|985935|P2|Overall Study|Lost to Follow-up|10
292495|NCT01712984|985936|P1|Overall Study|Lost to Follow-up|8
292496|NCT01712984|985934|P3|Overall Study|Protocol Violation|1
292497|NCT01712984|985935|P2|Overall Study|Protocol Violation|0
292498|NCT01712984|985936|P1|Overall Study|Protocol Violation|2
292499|NCT01712984|985934|P3|Overall Study|Adverse Event|1
292500|NCT01712984|985935|P2|Overall Study|Adverse Event|0
292501|NCT01712984|985936|P1|Overall Study|Adverse Event|0
292502|NCT01712854|985956|P1|Overall Study|Physician Decision|1
292503|NCT01712685|985979|P1|Overall Study|pt declined to participate before trmt|1
292504|NCT01712516|985995|P4|Overall Study|Withdrawal by Subject|9
292505|NCT01712516|985996|P3|Overall Study|Withdrawal by Subject|3
292506|NCT01712516|985997|P2|Overall Study|Withdrawal by Subject|9
292508|NCT01712516|985995|P4|Overall Study|Physician Decision|1
292509|NCT01712516|985996|P3|Overall Study|Physician Decision|0
292510|NCT01712516|985997|P2|Overall Study|Physician Decision|0
292511|NCT01712516|985998|P1|Overall Study|Physician Decision|2
292512|NCT01712516|985995|P4|Overall Study|Protocol deviation|0
292513|NCT01712516|985996|P3|Overall Study|Protocol deviation|1
292514|NCT01712516|985997|P2|Overall Study|Protocol deviation|0
292515|NCT01712516|985998|P1|Overall Study|Protocol deviation|1
292516|NCT01712516|985995|P4|Overall Study|Death|0
292517|NCT01712516|985996|P3|Overall Study|Death|0
292518|NCT01712516|985997|P2|Overall Study|Death|1
292519|NCT01712516|985998|P1|Overall Study|Death|0
292520|NCT01712516|985995|P4|Overall Study|Lost to Follow-up|1
292521|NCT01712516|985996|P3|Overall Study|Lost to Follow-up|2
292522|NCT01712516|985997|P2|Overall Study|Lost to Follow-up|0
292523|NCT01712516|985998|P1|Overall Study|Lost to Follow-up|0
292524|NCT01712516|985995|P4|Overall Study|Technical problems|2
292525|NCT01712516|985996|P3|Overall Study|Technical problems|0
292526|NCT01712516|985997|P2|Overall Study|Technical problems|0
292527|NCT01712516|985998|P1|Overall Study|Technical problems|0
292528|NCT01712399|986048|P1|Overall Study|Study closure|345
292529|NCT01712399|986048|P1|Overall Study|Adverse Event|11
292530|NCT01712399|986048|P1|Overall Study|Death|1
292531|NCT01712399|986048|P1|Overall Study|Withdrawal by Subject|39
292532|NCT01712399|986048|P1|Overall Study|Lost to Follow-up|1
292533|NCT01712334|986094|P2|Treatment Period 1|Randomized in Error|2
292534|NCT01712334|986095|P1|Treatment Period 1|Randomized in Error|0
292535|NCT01712256|986103|P1|Overall Study|Lost to Follow-up|1
292536|NCT01712204|986114|P2|Overall Study|Protocol Violation|1
292537|NCT01712204|986115|P1|Overall Study|Protocol Violation|1
292538|NCT01712204|986114|P2|Overall Study|Lost to Follow-up|0
292539|NCT01712204|986115|P1|Overall Study|Lost to Follow-up|1
292540|NCT01712204|986114|P2|Overall Study|Withdrawal by Subject|3
292541|NCT01712204|986115|P1|Overall Study|Withdrawal by Subject|3
292542|NCT01712204|986114|P2|Overall Study|Adverse Event|1
292543|NCT01712204|986115|P1|Overall Study|Adverse Event|3
292544|NCT01712178|986123|P2|Overall Study|Lost to Follow-up|1
292545|NCT01712178|986124|P1|Overall Study|Lost to Follow-up|0
292546|NCT01712178|986123|P2|Overall Study|Serious adverse event/withdrew consent|1
292547|NCT01712178|986124|P1|Overall Study|Serious adverse event/withdrew consent|0
292548|NCT01712178|986123|P2|Overall Study|Withdrew consent due to an adverse event|1
292549|NCT01712178|986124|P1|Overall Study|Withdrew consent due to an adverse event|1
292550|NCT01712074|986149|P3|Double Blind Period|No longer met eligibility criteria|0
292551|NCT01712074|986150|P2|Double Blind Period|No longer met eligibility criteria|3
292552|NCT01712074|986151|P1|Double Blind Period|No longer met eligibility criteria|0
292553|NCT01712074|986149|P3|Double Blind Period|Protocol Violation|1
292554|NCT01712074|986150|P2|Double Blind Period|Protocol Violation|0
292555|NCT01712074|986151|P1|Double Blind Period|Protocol Violation|0
292556|NCT01712074|986149|P3|Double Blind Period|Other|1
292557|NCT01712074|986150|P2|Double Blind Period|Other|4
292558|NCT01712074|986151|P1|Double Blind Period|Other|0
292559|NCT01712074|986149|P3|Double Blind Period|Lost to Follow-up|1
292560|NCT01712074|986150|P2|Double Blind Period|Lost to Follow-up|2
292561|NCT01712074|986151|P1|Double Blind Period|Lost to Follow-up|0
292562|NCT01712074|986149|P3|Double Blind Period|Death|0
292563|NCT01712074|986150|P2|Double Blind Period|Death|1
292564|NCT01712074|986151|P1|Double Blind Period|Death|0
292565|NCT01712074|986149|P3|Double Blind Period|No longer willing to participate|4
292566|NCT01712074|986150|P2|Double Blind Period|No longer willing to participate|2
292567|NCT01712074|986151|P1|Double Blind Period|No longer willing to participate|0
292568|NCT01712074|986149|P3|Double Blind Period|Adverse Event|1
292569|NCT01712074|986150|P2|Double Blind Period|Adverse Event|2
292570|NCT01712074|986151|P1|Double Blind Period|Adverse Event|0
292571|NCT01712074|986149|P3|Placebo Run-in Period|No longer willing to participate|0
292572|NCT01712074|986150|P2|Placebo Run-in Period|No longer willing to participate|0
292573|NCT01712074|986151|P1|Placebo Run-in Period|No longer willing to participate|1
292574|NCT01712074|986149|P3|Placebo Run-in Period|Other|0
292575|NCT01712074|986150|P2|Placebo Run-in Period|Other|0
292576|NCT01712074|986151|P1|Placebo Run-in Period|Other|1
292577|NCT01712074|986149|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
292578|NCT01712074|986150|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
292579|NCT01712074|986151|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
292580|NCT01712074|986149|P3|Placebo Run-in Period|Lost to Follow-up|0
292581|NCT01712074|986150|P2|Placebo Run-in Period|Lost to Follow-up|0
292582|NCT01712074|986151|P1|Placebo Run-in Period|Lost to Follow-up|1
292583|NCT01712074|986149|P3|Placebo Run-in Period|Adverse Event|0
292584|NCT01712074|986150|P2|Placebo Run-in Period|Adverse Event|0
292585|NCT01712074|986151|P1|Placebo Run-in Period|Adverse Event|2
292586|NCT01712061|986207|P3|Overall Study|Other|0
292587|NCT01712061|986208|P2|Overall Study|Other|3
292588|NCT01712061|986209|P1|Overall Study|Other|0
292589|NCT01712061|986207|P3|Overall Study|Withdrawal by Subject|1
292590|NCT01712061|986208|P2|Overall Study|Withdrawal by Subject|7
292591|NCT01712061|986209|P1|Overall Study|Withdrawal by Subject|1
292592|NCT01712061|986207|P3|Overall Study|Medication Error Without Associated AE|0
292593|NCT01712061|986208|P2|Overall Study|Medication Error Without Associated AE|1
292594|NCT01712061|986209|P1|Overall Study|Medication Error Without Associated AE|0
292595|NCT01712061|986207|P3|Overall Study|Did Not Meet Entrance Criteria|3
292596|NCT01712061|986208|P2|Overall Study|Did Not Meet Entrance Criteria|6
292597|NCT01712061|986209|P1|Overall Study|Did Not Meet Entrance Criteria|4
292598|NCT01712061|986207|P3|Overall Study|Lost to Follow-up|1
292599|NCT01712061|986208|P2|Overall Study|Lost to Follow-up|0
292600|NCT01712061|986209|P1|Overall Study|Lost to Follow-up|1
292601|NCT01712061|986207|P3|Overall Study|Death|1
292602|NCT01712061|986208|P2|Overall Study|Death|0
292603|NCT01712061|986209|P1|Overall Study|Death|0
292604|NCT01712061|986207|P3|Overall Study|Adverse Event|5
292605|NCT01712061|986208|P2|Overall Study|Adverse Event|9
292606|NCT01712061|986209|P1|Overall Study|Adverse Event|4
292607|NCT01712009|986249|P3|Overall Study|Decision by Sponsor|12
292608|NCT01712009|986250|P2|Overall Study|Decision by Sponsor|14
292609|NCT01712009|986251|P1|Overall Study|Decision by Sponsor|12
292610|NCT01712009|986249|P3|Overall Study|Lost to Follow-up|1
292611|NCT01712009|986250|P2|Overall Study|Lost to Follow-up|0
292612|NCT01712009|986251|P1|Overall Study|Lost to Follow-up|2
292613|NCT01712009|986249|P3|Overall Study|Withdrawal by Subject|8
292614|NCT01712009|986250|P2|Overall Study|Withdrawal by Subject|15
292615|NCT01712009|986251|P1|Overall Study|Withdrawal by Subject|24
292616|NCT01711866|986285|P1|Overall Study|Adverse Event|2
292617|NCT01711866|986285|P1|Overall Study|Withdrawal by Subject|3
292618|NCT01711866|986285|P1|Overall Study|Noncompliant|3
292619|NCT01711853|986290|P1|Overall Study|Not treated|3
292620|NCT01711736|986297|P2|Overall Study|Migrated/moved from study area|1
292621|NCT01711736|986298|P1|Overall Study|Migrated/moved from study area|2
292622|NCT01711736|986297|P2|Overall Study|Withdrawal by Subject|6
292623|NCT01711736|986298|P1|Overall Study|Withdrawal by Subject|6
292624|NCT01711736|986297|P2|Overall Study|Lost to Follow-up|1
292625|NCT01711736|986298|P1|Overall Study|Lost to Follow-up|4
292626|NCT01711645|986326|P1|Overall Study|Physician Decision|5
292627|NCT01711645|986326|P1|Overall Study|Lost to Follow-up|6
292628|NCT01711645|986326|P1|Overall Study|Withdrawal by Subject|8
292629|NCT01711359|986371|P3|Treatment Period|Randomized, Not Treated|0
292630|NCT01711359|986372|P2|Treatment Period|Randomized, Not Treated|1
292631|NCT01711359|986373|P1|Treatment Period|Randomized, Not Treated|3
292632|NCT01711359|986371|P3|Treatment Period|Lost to Follow-up|1
292633|NCT01711359|986372|P2|Treatment Period|Lost to Follow-up|1
292634|NCT01711359|986373|P1|Treatment Period|Lost to Follow-up|1
292635|NCT01711359|986371|P3|Treatment Period|Sponsor Decision|0
292636|NCT01711359|986372|P2|Treatment Period|Sponsor Decision|0
292637|NCT01711359|986373|P1|Treatment Period|Sponsor Decision|1
292638|NCT01711359|986371|P3|Treatment Period|Entry Criteria Not Met|0
292639|NCT01711359|986372|P2|Treatment Period|Entry Criteria Not Met|0
292640|NCT01711359|986373|P1|Treatment Period|Entry Criteria Not Met|1
292641|NCT01711359|986371|P3|Treatment Period|Death|0
292642|NCT01711359|986372|P2|Treatment Period|Death|0
292643|NCT01711359|986373|P1|Treatment Period|Death|3
292644|NCT01711359|986371|P3|Treatment Period|Physician Decision|2
292645|NCT01711359|986372|P2|Treatment Period|Physician Decision|3
292646|NCT01711359|986373|P1|Treatment Period|Physician Decision|4
292647|NCT01711359|986371|P3|Treatment Period|Adverse Event|24
292648|NCT01711359|986372|P2|Treatment Period|Adverse Event|10
292649|NCT01711359|986373|P1|Treatment Period|Adverse Event|8
292650|NCT01711359|986371|P3|Treatment Period|Lack of Efficacy|2
292651|NCT01711359|986372|P2|Treatment Period|Lack of Efficacy|2
292652|NCT01711359|986373|P1|Treatment Period|Lack of Efficacy|13
292653|NCT01711359|986371|P3|Treatment Period|Withdrawal by Subject|13
292654|NCT01711359|986372|P2|Treatment Period|Withdrawal by Subject|7
292655|NCT01711359|986373|P1|Treatment Period|Withdrawal by Subject|18
292656|NCT01711216|986444|P1|Overall Study|no reason specified|22
292657|NCT01711216|986444|P1|Overall Study|variety of other minor reasons|83
292658|NCT01711216|986444|P1|Overall Study|Lost to Follow-up|46
292659|NCT01711216|986444|P1|Overall Study|Withdrawal by Subject|6
292660|NCT01711216|986444|P1|Overall Study|Pregnancy|56
292661|NCT01711216|986444|P1|Overall Study|Adverse Event|4
292662|NCT01710800|986503|P1|Overall Study|Protocol Violation|1
292663|NCT01710800|986503|P1|Overall Study|Withdrawal by Subject|21
292664|NCT01710657|986570|P3|Overall Study|Lack of Efficacy|1
292665|NCT01710657|986571|P2|Overall Study|Lack of Efficacy|1
292666|NCT01710657|986572|P1|Overall Study|Lack of Efficacy|0
292667|NCT01710657|986570|P3|Overall Study|Withdrawal by Subject|2
292668|NCT01710657|986571|P2|Overall Study|Withdrawal by Subject|1
292669|NCT01710657|986572|P1|Overall Study|Withdrawal by Subject|0
292670|NCT01710657|986570|P3|Overall Study|Adverse Event|28
292671|NCT01710657|986571|P2|Overall Study|Adverse Event|8
292672|NCT01710657|986572|P1|Overall Study|Adverse Event|14
292673|NCT01710657|986570|P3|Overall Study|Protocol Violation|0
292674|NCT01710657|986571|P2|Overall Study|Protocol Violation|2
292675|NCT01710657|986572|P1|Overall Study|Protocol Violation|2
292676|NCT01710657|986570|P3|Overall Study|Lost to Follow-up|1
292677|NCT01710657|986571|P2|Overall Study|Lost to Follow-up|0
292678|NCT01710657|986572|P1|Overall Study|Lost to Follow-up|2
292679|NCT01710527|986589|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
292680|NCT01710527|986590|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
292681|NCT01710514|986616|P2|Overall Study|Withdrawal by Subject|0
292682|NCT01710514|986617|P1|Overall Study|Withdrawal by Subject|1
292683|NCT01710514|986616|P2|Overall Study|Adverse Event|7
292684|NCT01710514|986617|P1|Overall Study|Adverse Event|6
292685|NCT01710501|986638|P3|Overall Study|Lost to Follow-up|0
292686|NCT01710501|986639|P2|Overall Study|Lost to Follow-up|0
292687|NCT01710501|986640|P1|Overall Study|Lost to Follow-up|2
292688|NCT01710358|986672|P3|Rescue Period|Withdrawal by Subject|0
292689|NCT01710358|986673|P2|Rescue Period|Withdrawal by Subject|8
292690|NCT01710358|986674|P1|Rescue Period|Withdrawal by Subject|0
292691|NCT01710358|986672|P3|Rescue Period|Lack of Efficacy|0
292692|NCT01710358|986673|P2|Rescue Period|Lack of Efficacy|7
292693|NCT01710358|986674|P1|Rescue Period|Lack of Efficacy|0
292694|NCT01710358|986672|P3|Rescue Period|Death|0
292695|NCT01710358|986673|P2|Rescue Period|Death|1
292696|NCT01710358|986674|P1|Rescue Period|Death|0
292697|NCT01710358|986672|P3|Rescue Period|Adverse Event|0
292698|NCT01710358|986673|P2|Rescue Period|Adverse Event|15
292699|NCT01710358|986674|P1|Rescue Period|Adverse Event|0
292700|NCT01710358|986672|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
292701|NCT01710358|986673|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
292702|NCT01710358|986674|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
292703|NCT01710358|986672|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
292704|NCT01710358|986673|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
292705|NCT01710358|986674|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
292706|NCT01710358|986672|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
292707|NCT01710358|986673|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
292708|NCT01710358|986674|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
292709|NCT01710358|986672|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
292710|NCT01710358|986673|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
292711|NCT01710358|986674|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
292712|NCT01710358|986672|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
292713|NCT01710358|986673|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
292714|NCT01710358|986674|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
292715|NCT01710358|986672|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
292716|NCT01710358|986673|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
292717|NCT01710358|986674|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
292718|NCT01710358|986672|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
292719|NCT01710358|986673|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
292720|NCT01710358|986674|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
292721|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
292722|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
292723|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
292724|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
292725|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
292726|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
292727|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
292728|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
292729|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
292730|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
292731|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
292732|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
292733|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
292734|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
292735|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
292736|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
292737|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
292738|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
292739|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
292740|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
292741|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
292742|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
292743|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
292744|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
292745|NCT01710358|986672|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
292746|NCT01710358|986673|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
292747|NCT01710358|986674|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
292748|NCT01710345|986745|P3|Overall Study|Drug Dosing Error|0
292749|NCT01710345|986746|P2|Overall Study|Drug Dosing Error|0
292750|NCT01710345|986747|P1|Overall Study|Drug Dosing Error|1
292751|NCT01710345|986745|P3|Overall Study|Lack of Efficacy|1
292752|NCT01710345|986746|P2|Overall Study|Lack of Efficacy|3
292753|NCT01710345|986747|P1|Overall Study|Lack of Efficacy|2
292754|NCT01710345|986745|P3|Overall Study|Adverse Event|0
292755|NCT01710345|986746|P2|Overall Study|Adverse Event|2
292756|NCT01710345|986747|P1|Overall Study|Adverse Event|0
292757|NCT01710046|986774|P2|Overall Study|Lost to Follow-up|0
292758|NCT01710046|986775|P1|Overall Study|Lost to Follow-up|1
292759|NCT01710033|986815|P5|Stage 2|Adverse Event|1
292760|NCT01710033|986816|P4|Stage 2|Adverse Event|0
292761|NCT01710033|986817|P3|Stage 2|Adverse Event|0
292762|NCT01710033|986818|P2|Stage 2|Adverse Event|0
292763|NCT01710033|986819|P1|Stage 2|Adverse Event|0
292764|NCT01710020|986900|P1|Period 1|Protocol Violation|1
292765|NCT01709903|986919|P2|Overall Study|Adverse Event|18
292766|NCT01709903|986920|P1|Overall Study|Adverse Event|11
292767|NCT01709903|986919|P2|Overall Study|Withdrawal by Subject|6
292768|NCT01709903|986920|P1|Overall Study|Withdrawal by Subject|6
292769|NCT01709903|986919|P2|Overall Study|Lack of Efficacy|3
292770|NCT01709903|986920|P1|Overall Study|Lack of Efficacy|3
292771|NCT01709903|986919|P2|Overall Study|Protocol Violation|2
292772|NCT01709903|986920|P1|Overall Study|Protocol Violation|3
292773|NCT01709903|986919|P2|Overall Study|Death|0
292774|NCT01709903|986920|P1|Overall Study|Death|2
292775|NCT01709903|986919|P2|Overall Study|Lost to Follow-up|2
292776|NCT01709903|986920|P1|Overall Study|Lost to Follow-up|0
292777|NCT01709903|986919|P2|Overall Study|no longer needed study drug|1
292778|NCT01709903|986920|P1|Overall Study|no longer needed study drug|0
292779|NCT01709903|986919|P2|Overall Study|In ability to use device|1
292780|NCT01709903|986920|P1|Overall Study|In ability to use device|1
292781|NCT01709903|986919|P2|Overall Study|Abnormal test procedure results|0
292782|NCT01709903|986920|P1|Overall Study|Abnormal test procedure results|1
292783|NCT01709903|986919|P2|Overall Study|administrative problems|6
292784|NCT01709903|986920|P1|Overall Study|administrative problems|2
292785|NCT01709864|986944|P2|Overall Study|Death|1
292786|NCT01709864|986945|P1|Overall Study|Death|0
292787|NCT01709864|986944|P2|Overall Study|Adverse Event|2
292788|NCT01709864|986945|P1|Overall Study|Adverse Event|0
292789|NCT01709864|986944|P2|Overall Study|non-compliance with study treatment|1
292790|NCT01709864|986945|P1|Overall Study|non-compliance with study treatment|1
292791|NCT01709864|986944|P2|Overall Study|Lost to Follow-up|0
292792|NCT01709864|986945|P1|Overall Study|Lost to Follow-up|1
292793|NCT01709864|986944|P2|Overall Study|subject/guardian decision|6
292794|NCT01709864|986945|P1|Overall Study|subject/guardian decision|5
292795|NCT01709864|986944|P2|Overall Study|Physician Decision|1
292796|NCT01709864|986945|P1|Overall Study|Physician Decision|0
292797|NCT01709708|987016|P2|Overall Study|Protocol Violation|2
292798|NCT01709708|987017|P1|Overall Study|Protocol Violation|1
292799|NCT01709695|987041|P2|Overall Study|Withdrawal by Subject|1
292800|NCT01709695|987042|P1|Overall Study|Withdrawal by Subject|1
292801|NCT01709578|987067|P3|Overall Study|Other, not related to safety or efficacy|5
292802|NCT01709578|987068|P2|Overall Study|Other, not related to safety or efficacy|7
292803|NCT01709578|987069|P1|Overall Study|Other, not related to safety or efficacy|2
292804|NCT01709578|987067|P3|Overall Study|Poor compliance to protocol|1
292805|NCT01709578|987068|P2|Overall Study|Poor compliance to protocol|2
292806|NCT01709578|987069|P1|Overall Study|Poor compliance to protocol|1
292807|NCT01709578|987067|P3|Overall Study|Lack of Efficacy|2
292808|NCT01709578|987068|P2|Overall Study|Lack of Efficacy|4
292809|NCT01709578|987069|P1|Overall Study|Lack of Efficacy|5
292810|NCT01709578|987067|P3|Overall Study|Adverse Event|17
292811|NCT01709578|987068|P2|Overall Study|Adverse Event|18
292812|NCT01709578|987069|P1|Overall Study|Adverse Event|9
292813|NCT01709578|987067|P3|Overall Study|Rescued and entered in long term safety|26
292814|NCT01709578|987068|P2|Overall Study|Rescued and entered in long term safety|25
292815|NCT01709578|987069|P1|Overall Study|Rescued and entered in long term safety|63
292816|NCT01709513|987200|P3|Overall Study|Other|7
292817|NCT01709513|987201|P2|Overall Study|Other|11
292818|NCT01709513|987202|P1|Overall Study|Other|3
292819|NCT01709513|987200|P3|Overall Study|Poor compliance to protocol|0
292820|NCT01709513|987201|P2|Overall Study|Poor compliance to protocol|0
292821|NCT01709513|987202|P1|Overall Study|Poor compliance to protocol|2
292822|NCT01709513|987200|P3|Overall Study|Adverse Event|23
292823|NCT01709513|987201|P2|Overall Study|Adverse Event|31
292824|NCT01709513|987202|P1|Overall Study|Adverse Event|16
292825|NCT01709513|987200|P3|Overall Study|Randomized but not treated|0
292826|NCT01709513|987201|P2|Overall Study|Randomized but not treated|1
292827|NCT01709513|987202|P1|Overall Study|Randomized but not treated|0
292828|NCT01709500|987263|P2|Overall Study|Treatment ongoing|78
292829|NCT01709500|987264|P1|Overall Study|Treatment ongoing|156
292830|NCT01709500|987263|P2|Overall Study|Related to IMP administration|0
292831|NCT01709500|987264|P1|Overall Study|Related to IMP administration|1
292832|NCT01709500|987263|P2|Overall Study|Other|1
292833|NCT01709500|987264|P1|Overall Study|Other|3
292834|NCT01709500|987263|P2|Overall Study|Poor compliance to protocol|1
292835|NCT01709500|987264|P1|Overall Study|Poor compliance to protocol|2
292836|NCT01709500|987263|P2|Overall Study|Adverse Event|1
292837|NCT01709500|987264|P1|Overall Study|Adverse Event|5
292838|NCT01709500|987263|P2|Overall Study|Randomized but not treated|1
292839|NCT01709500|987264|P1|Overall Study|Randomized but not treated|0
292840|NCT01709409|987342|P2|Overall Study|Protocol Violation|0
292841|NCT01709409|987343|P1|Overall Study|Protocol Violation|1
292842|NCT01709383|987351|P2|Overall Study|Lost to Follow-up|0
292843|NCT01709383|987352|P1|Overall Study|Lost to Follow-up|1
292844|NCT01709331|987370|P1|Overall Study|Adverse Event|1
292845|NCT01709305|987376|P5|Phase 2|Withdrawal by Subject|12
292846|NCT01709305|987377|P4|Phase 2|Withdrawal by Subject|15
292847|NCT01709305|987378|P3|Phase 2|Withdrawal by Subject|6
292848|NCT01709305|987379|P2|Phase 2|Withdrawal by Subject|8
292849|NCT01709305|987380|P1|Phase 2|Withdrawal by Subject|0
292850|NCT01709305|987376|P5|Phase 2|Protocol Violation|9
292851|NCT01709305|987377|P4|Phase 2|Protocol Violation|13
292852|NCT01709305|987378|P3|Phase 2|Protocol Violation|19
292853|NCT01709305|987379|P2|Phase 2|Protocol Violation|19
292854|NCT01709305|987380|P1|Phase 2|Protocol Violation|0
292855|NCT01709305|987376|P5|Phase 2|Physician Decision|2
292856|NCT01709305|987377|P4|Phase 2|Physician Decision|1
292857|NCT01709305|987378|P3|Phase 2|Physician Decision|0
292858|NCT01709305|987379|P2|Phase 2|Physician Decision|2
292859|NCT01709305|987380|P1|Phase 2|Physician Decision|0
292860|NCT01709305|987376|P5|Phase 2|Travel, moving, etc.|5
292861|NCT01709305|987377|P4|Phase 2|Travel, moving, etc.|3
292862|NCT01709305|987378|P3|Phase 2|Travel, moving, etc.|3
292863|NCT01709305|987379|P2|Phase 2|Travel, moving, etc.|2
292864|NCT01709305|987380|P1|Phase 2|Travel, moving, etc.|0
292865|NCT01709305|987376|P5|Phase 2|Lost to Follow-up|5
292866|NCT01709305|987377|P4|Phase 2|Lost to Follow-up|9
292867|NCT01709305|987378|P3|Phase 2|Lost to Follow-up|6
292868|NCT01709305|987379|P2|Phase 2|Lost to Follow-up|10
292869|NCT01709305|987380|P1|Phase 2|Lost to Follow-up|0
292870|NCT01709305|987376|P5|Phase 2|Laboratory Adverse Event|1
292871|NCT01709305|987377|P4|Phase 2|Laboratory Adverse Event|1
292872|NCT01709305|987378|P3|Phase 2|Laboratory Adverse Event|0
292873|NCT01709305|987379|P2|Phase 2|Laboratory Adverse Event|1
292874|NCT01709305|987380|P1|Phase 2|Laboratory Adverse Event|0
292875|NCT01709305|987376|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
292876|NCT01709305|987377|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
292877|NCT01709305|987378|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
292878|NCT01709305|987379|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
292879|NCT01709305|987380|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
292880|NCT01709305|987376|P5|Phase 2|Death|0
292881|NCT01709305|987377|P4|Phase 2|Death|0
292882|NCT01709305|987378|P3|Phase 2|Death|1
292883|NCT01709305|987379|P2|Phase 2|Death|0
292884|NCT01709305|987380|P1|Phase 2|Death|0
292885|NCT01709305|987376|P5|Phase 2|Clinical Adverse Event|11
292886|NCT01709305|987377|P4|Phase 2|Clinical Adverse Event|6
292887|NCT01709305|987378|P3|Phase 2|Clinical Adverse Event|10
292888|NCT01709305|987379|P2|Phase 2|Clinical Adverse Event|10
292889|NCT01709305|987380|P1|Phase 2|Clinical Adverse Event|0
292890|NCT01709305|987376|P5|Phase 1|Withdrawal by Subject|0
292891|NCT01709305|987377|P4|Phase 1|Withdrawal by Subject|0
292892|NCT01709305|987378|P3|Phase 1|Withdrawal by Subject|0
292893|NCT01709305|987379|P2|Phase 1|Withdrawal by Subject|0
292894|NCT01709305|987380|P1|Phase 1|Withdrawal by Subject|218
292895|NCT01709305|987376|P5|Phase 1|Protocol Violation|0
292896|NCT01709305|987377|P4|Phase 1|Protocol Violation|0
292897|NCT01709305|987378|P3|Phase 1|Protocol Violation|0
292898|NCT01709305|987379|P2|Phase 1|Protocol Violation|0
292899|NCT01709305|987380|P1|Phase 1|Protocol Violation|118
292900|NCT01709305|987376|P5|Phase 1|Physician Decision|0
292901|NCT01709305|987377|P4|Phase 1|Physician Decision|0
292902|NCT01709305|987378|P3|Phase 1|Physician Decision|0
292903|NCT01709305|987379|P2|Phase 1|Physician Decision|0
292904|NCT01709305|987380|P1|Phase 1|Physician Decision|13
292905|NCT01709305|987376|P5|Phase 1|Travel, moving, etc.|0
292906|NCT01709305|987377|P4|Phase 1|Travel, moving, etc.|0
292907|NCT01709305|987378|P3|Phase 1|Travel, moving, etc.|0
292908|NCT01709305|987379|P2|Phase 1|Travel, moving, etc.|0
292909|NCT01709305|987380|P1|Phase 1|Travel, moving, etc.|30
292910|NCT01709305|987376|P5|Phase 1|Lost to Follow-up|0
292911|NCT01709305|987377|P4|Phase 1|Lost to Follow-up|0
292912|NCT01709305|987378|P3|Phase 1|Lost to Follow-up|0
292913|NCT01709305|987379|P2|Phase 1|Lost to Follow-up|0
292914|NCT01709305|987380|P1|Phase 1|Lost to Follow-up|147
292915|NCT01709305|987376|P5|Phase 1|Laboratory Adverse Event|0
292916|NCT01709305|987377|P4|Phase 1|Laboratory Adverse Event|0
292917|NCT01709305|987378|P3|Phase 1|Laboratory Adverse Event|0
292918|NCT01709305|987379|P2|Phase 1|Laboratory Adverse Event|0
292919|NCT01709305|987380|P1|Phase 1|Laboratory Adverse Event|16
292920|NCT01709305|987376|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
292921|NCT01709305|987377|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
292922|NCT01709305|987378|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
292923|NCT01709305|987379|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
292924|NCT01709305|987380|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
292925|NCT01709305|987376|P5|Phase 1|Death|0
292926|NCT01709305|987377|P4|Phase 1|Death|0
292927|NCT01709305|987378|P3|Phase 1|Death|0
292928|NCT01709305|987379|P2|Phase 1|Death|0
292929|NCT01709305|987380|P1|Phase 1|Death|2
292930|NCT01709305|987376|P5|Phase 1|Clinical Adverse Event|0
292931|NCT01709305|987377|P4|Phase 1|Clinical Adverse Event|0
292932|NCT01709305|987378|P3|Phase 1|Clinical Adverse Event|0
292933|NCT01709305|987379|P2|Phase 1|Clinical Adverse Event|0
292934|NCT01709305|987380|P1|Phase 1|Clinical Adverse Event|80
292935|NCT01709227|987417|P2|Overall Study|Pleural Peritoneal communication|9
292936|NCT01709227|987418|P1|Overall Study|Pleural Peritoneal communication|0
292937|NCT01709227|987417|P2|Overall Study|Physician Decision|0
292938|NCT01709227|987418|P1|Overall Study|Physician Decision|1
292939|NCT01709162|987444|P2|Overall Study|Withdrawal by Subject|1
292940|NCT01709162|987445|P1|Overall Study|Withdrawal by Subject|0
292941|NCT01709162|987444|P2|Overall Study|Not specified|0
292942|NCT01709162|987445|P1|Overall Study|Not specified|1
292943|NCT01709162|987444|P2|Overall Study|Administrative reason by sponsor|1
292944|NCT01709162|987445|P1|Overall Study|Administrative reason by sponsor|0
292945|NCT01709162|987444|P2|Overall Study|Study drug toxicity|0
292946|NCT01709162|987445|P1|Overall Study|Study drug toxicity|2
292947|NCT01709162|987444|P2|Overall Study|Disease progression|3
292948|NCT01709162|987445|P1|Overall Study|Disease progression|3
292949|NCT01709110|987466|P2|Overall Study|Caregiver Decision|1
292950|NCT01709110|987467|P1|Overall Study|Caregiver Decision|1
292951|NCT01709110|987466|P2|Overall Study|Lack of Efficacy|1
292952|NCT01709110|987467|P1|Overall Study|Lack of Efficacy|1
292953|NCT01709110|987466|P2|Overall Study|Sponsor Decision|2
292954|NCT01709110|987467|P1|Overall Study|Sponsor Decision|2
292955|NCT01709110|987466|P2|Overall Study|Physician Decision|10
292956|NCT01709110|987467|P1|Overall Study|Physician Decision|4
292957|NCT01709110|987466|P2|Overall Study|Withdrawal by Subject|89
292958|NCT01709110|987467|P1|Overall Study|Withdrawal by Subject|96
292959|NCT01709110|987466|P2|Overall Study|Protocol Violation|6
292960|NCT01709110|987467|P1|Overall Study|Protocol Violation|4
292961|NCT01709110|987466|P2|Overall Study|Lost to Follow-up|5
292962|NCT01709110|987467|P1|Overall Study|Lost to Follow-up|7
292963|NCT01709110|987466|P2|Overall Study|Death|6
292964|NCT01709110|987467|P1|Overall Study|Death|14
292965|NCT01709110|987466|P2|Overall Study|Adverse Event|48
292966|NCT01709110|987467|P1|Overall Study|Adverse Event|56
292967|NCT01709084|987497|P2|Overall Study|Not Treated|2
292968|NCT01709084|987498|P1|Overall Study|Not Treated|0
292969|NCT01709084|987497|P2|Overall Study|Participant Reached a Virologic Endpoint|1
292970|NCT01709084|987498|P1|Overall Study|Participant Reached a Virologic Endpoint|0
292971|NCT01709084|987497|P2|Overall Study|Other|3
292972|NCT01709084|987498|P1|Overall Study|Other|5
292973|NCT01709084|987497|P2|Overall Study|Adverse Event|0
292974|NCT01709084|987498|P1|Overall Study|Adverse Event|5
292975|NCT01709084|987497|P2|Overall Study|Withdrawal by Subject|2
292976|NCT01709084|987498|P1|Overall Study|Withdrawal by Subject|2
292977|NCT01709084|987497|P2|Overall Study|Lost to Follow-up|7
292978|NCT01709084|987498|P1|Overall Study|Lost to Follow-up|4
292979|NCT01708954|987526|P3|Step 2|Withdrawal by Subject|0
292980|NCT01708954|987527|P2|Step 2|Withdrawal by Subject|1
292981|NCT01708954|987528|P1|Step 2|Withdrawal by Subject|1
292982|NCT01708954|987526|P3|Step 2|Adverse Event|0
292983|NCT01708954|987527|P2|Step 2|Adverse Event|2
292984|NCT01708954|987528|P1|Step 2|Adverse Event|3
292985|NCT01708954|987526|P3|Step 2|Disease progression|0
292986|NCT01708954|987527|P2|Step 2|Disease progression|4
292987|NCT01708954|987528|P1|Step 2|Disease progression|9
292988|NCT01708954|987526|P3|Step 1|Ineligible or never received treatment|8
292989|NCT01708954|987527|P2|Step 1|Ineligible or never received treatment|2
292990|NCT01708954|987528|P1|Step 1|Ineligible or never received treatment|4
292991|NCT01708954|987526|P3|Step 1|Off-treatment reason not submitted|1
292992|NCT01708954|987527|P2|Step 1|Off-treatment reason not submitted|1
292993|NCT01708954|987528|P1|Step 1|Off-treatment reason not submitted|1
292994|NCT01708954|987526|P3|Step 1|Symptomatic deterioration|1
292995|NCT01708954|987527|P2|Step 1|Symptomatic deterioration|0
292996|NCT01708954|987528|P1|Step 1|Symptomatic deterioration|1
292997|NCT01708954|987526|P3|Step 1|Crossed over to Step 2|0
292998|NCT01708954|987527|P2|Step 1|Crossed over to Step 2|0
292999|NCT01708954|987528|P1|Step 1|Crossed over to Step 2|2
293000|NCT01708954|987526|P3|Step 1|Other complicating disease|0
293001|NCT01708954|987527|P2|Step 1|Other complicating disease|2
293002|NCT01708954|987528|P1|Step 1|Other complicating disease|0
293003|NCT01708954|987526|P3|Step 1|Withdrawal by Subject|3
293004|NCT01708954|987527|P2|Step 1|Withdrawal by Subject|5
293005|NCT01708954|987528|P1|Step 1|Withdrawal by Subject|2
293006|NCT01708954|987526|P3|Step 1|Death|3
293007|NCT01708954|987527|P2|Step 1|Death|2
293008|NCT01708954|987528|P1|Step 1|Death|3
293009|NCT01708954|987526|P3|Step 1|Adverse Event|13
293010|NCT01708954|987527|P2|Step 1|Adverse Event|11
293011|NCT01708954|987528|P1|Step 1|Adverse Event|3
293012|NCT01708954|987526|P3|Step 1|Disease progression|14
293013|NCT01708954|987527|P2|Step 1|Disease progression|17
293014|NCT01708954|987528|P1|Step 1|Disease progression|26
293015|NCT01708915|987553|P4|Overall Study|Other reasons than stated above|2
293016|NCT01708915|987554|P3|Overall Study|Other reasons than stated above|0
293017|NCT01708915|987555|P2|Overall Study|Other reasons than stated above|1
293018|NCT01708915|987556|P1|Overall Study|Other reasons than stated above|1
293019|NCT01708915|987553|P4|Overall Study|Withdrawal by Subject|2
293020|NCT01708915|987554|P3|Overall Study|Withdrawal by Subject|2
293021|NCT01708915|987555|P2|Overall Study|Withdrawal by Subject|1
293022|NCT01708915|987556|P1|Overall Study|Withdrawal by Subject|0
293023|NCT01708915|987553|P4|Overall Study|Protocol Violation|1
293024|NCT01708915|987554|P3|Overall Study|Protocol Violation|0
293025|NCT01708915|987555|P2|Overall Study|Protocol Violation|0
293026|NCT01708915|987556|P1|Overall Study|Protocol Violation|0
293027|NCT01708915|987553|P4|Overall Study|Lack of Efficacy|15
293028|NCT01708915|987554|P3|Overall Study|Lack of Efficacy|35
293029|NCT01708915|987555|P2|Overall Study|Lack of Efficacy|60
293030|NCT01708915|987556|P1|Overall Study|Lack of Efficacy|84
293031|NCT01708915|987553|P4|Overall Study|Adverse Event|13
293032|NCT01708915|987554|P3|Overall Study|Adverse Event|9
293033|NCT01708915|987555|P2|Overall Study|Adverse Event|0
293034|NCT01708915|987556|P1|Overall Study|Adverse Event|1
293035|NCT01708902|987585|P7|Overall Study|Other Reason|0
293036|NCT01708902|987586|P6|Overall Study|Other Reason|2
293037|NCT01708902|987587|P5|Overall Study|Other Reason|1
293038|NCT01708902|987588|P4|Overall Study|Other Reason|1
293039|NCT01708902|987589|P3|Overall Study|Other Reason|1
293040|NCT01708902|987590|P2|Overall Study|Other Reason|0
293041|NCT01708902|987591|P1|Overall Study|Other Reason|1
293042|NCT01708902|987585|P7|Overall Study|Refused to continue trial medication|1
293043|NCT01708902|987586|P6|Overall Study|Refused to continue trial medication|1
293044|NCT01708902|987587|P5|Overall Study|Refused to continue trial medication|8
293045|NCT01708902|987588|P4|Overall Study|Refused to continue trial medication|2
293046|NCT01708902|987589|P3|Overall Study|Refused to continue trial medication|4
293047|NCT01708902|987590|P2|Overall Study|Refused to continue trial medication|0
293048|NCT01708902|987591|P1|Overall Study|Refused to continue trial medication|8
293049|NCT01708902|987585|P7|Overall Study|Lost to Follow-up|1
293050|NCT01708902|987586|P6|Overall Study|Lost to Follow-up|0
293051|NCT01708902|987587|P5|Overall Study|Lost to Follow-up|0
293052|NCT01708902|987588|P4|Overall Study|Lost to Follow-up|2
293053|NCT01708902|987589|P3|Overall Study|Lost to Follow-up|2
293054|NCT01708902|987590|P2|Overall Study|Lost to Follow-up|1
293055|NCT01708902|987591|P1|Overall Study|Lost to Follow-up|2
293056|NCT01708902|987585|P7|Overall Study|Non compliance with protocol|0
293057|NCT01708902|987586|P6|Overall Study|Non compliance with protocol|0
293058|NCT01708902|987587|P5|Overall Study|Non compliance with protocol|0
293059|NCT01708902|987588|P4|Overall Study|Non compliance with protocol|3
293060|NCT01708902|987589|P3|Overall Study|Non compliance with protocol|1
293061|NCT01708902|987590|P2|Overall Study|Non compliance with protocol|2
293062|NCT01708902|987591|P1|Overall Study|Non compliance with protocol|0
293063|NCT01708902|987585|P7|Overall Study|Lack of Efficacy|0
293064|NCT01708902|987586|P6|Overall Study|Lack of Efficacy|1
293065|NCT01708902|987587|P5|Overall Study|Lack of Efficacy|0
293066|NCT01708902|987588|P4|Overall Study|Lack of Efficacy|0
293067|NCT01708902|987589|P3|Overall Study|Lack of Efficacy|0
293068|NCT01708902|987590|P2|Overall Study|Lack of Efficacy|1
293069|NCT01708902|987591|P1|Overall Study|Lack of Efficacy|3
293070|NCT01708902|987585|P7|Overall Study|Adverse Event|5
293071|NCT01708902|987586|P6|Overall Study|Adverse Event|3
293072|NCT01708902|987587|P5|Overall Study|Adverse Event|7
293073|NCT01708902|987588|P4|Overall Study|Adverse Event|2
293074|NCT01708902|987589|P3|Overall Study|Adverse Event|9
293075|NCT01708902|987590|P2|Overall Study|Adverse Event|4
293076|NCT01708902|987591|P1|Overall Study|Adverse Event|3
293077|NCT01708291|987664|P2|Overall Study|fighting|1
293078|NCT01708291|987665|P1|Overall Study|fighting|2
293079|NCT01708187|987704|P2|Overall Study|Lost to Follow-up|1
293080|NCT01708187|987705|P1|Overall Study|Lost to Follow-up|0
293081|NCT01708174|987714|P3|Treatment Period|Adverse Event|0
293082|NCT01708174|987715|P2|Treatment Period|Adverse Event|1
293083|NCT01708174|987716|P1|Treatment Period|Adverse Event|0
293084|NCT01708174|987714|P3|Treatment Period|Death|1
293085|NCT01708174|987715|P2|Treatment Period|Death|0
293086|NCT01708174|987716|P1|Treatment Period|Death|0
293087|NCT01708174|987714|P3|Treatment Period|Progressive disease|0
293088|NCT01708174|987715|P2|Treatment Period|Progressive disease|1
293089|NCT01708174|987716|P1|Treatment Period|Progressive disease|0
293090|NCT01708174|987714|P3|Treatment Period|Withdrawal by Subject|0
293091|NCT01708174|987715|P2|Treatment Period|Withdrawal by Subject|0
293092|NCT01708174|987716|P1|Treatment Period|Withdrawal by Subject|1
293093|NCT01708161|987748|P6|Overall Study|Disease progression|0
293094|NCT01708161|987749|P5|Overall Study|Disease progression|3
293095|NCT01708161|987750|P4|Overall Study|Disease progression|13
293096|NCT01708161|987751|P3|Overall Study|Disease progression|5
293097|NCT01708161|987752|P2|Overall Study|Disease progression|5
293098|NCT01708161|987753|P1|Overall Study|Disease progression|3
293099|NCT01708161|987748|P6|Overall Study|Administrative problems|0
293100|NCT01708161|987749|P5|Overall Study|Administrative problems|0
293101|NCT01708161|987750|P4|Overall Study|Administrative problems|0
293102|NCT01708161|987751|P3|Overall Study|Administrative problems|0
293103|NCT01708161|987752|P2|Overall Study|Administrative problems|1
293104|NCT01708161|987753|P1|Overall Study|Administrative problems|0
293105|NCT01708161|987748|P6|Overall Study|Withdrawal by Subject|0
293106|NCT01708161|987749|P5|Overall Study|Withdrawal by Subject|0
293107|NCT01708161|987750|P4|Overall Study|Withdrawal by Subject|0
293108|NCT01708161|987751|P3|Overall Study|Withdrawal by Subject|1
293109|NCT01708161|987752|P2|Overall Study|Withdrawal by Subject|1
293110|NCT01708161|987753|P1|Overall Study|Withdrawal by Subject|0
293111|NCT01708161|987748|P6|Overall Study|Death|1
293112|NCT01708161|987749|P5|Overall Study|Death|0
293113|NCT01708161|987750|P4|Overall Study|Death|1
293114|NCT01708161|987751|P3|Overall Study|Death|0
293115|NCT01708161|987752|P2|Overall Study|Death|0
293116|NCT01708161|987753|P1|Overall Study|Death|0
293117|NCT01708161|987748|P6|Overall Study|Adverse Event|0
293118|NCT01708161|987749|P5|Overall Study|Adverse Event|3
293119|NCT01708161|987750|P4|Overall Study|Adverse Event|2
293120|NCT01708161|987751|P3|Overall Study|Adverse Event|4
293121|NCT01708161|987752|P2|Overall Study|Adverse Event|3
293122|NCT01708161|987753|P1|Overall Study|Adverse Event|1
293123|NCT01708057|987804|P3|Overall Study|Withdrawal due to study termination.|1
293124|NCT01708057|987805|P2|Overall Study|Withdrawal due to study termination.|1
293125|NCT01708057|987806|P1|Overall Study|Withdrawal due to study termination.|1
293126|NCT01707667|987864|P2|Period 1|expulsion of colonic sensor catheter|0
293127|NCT01707667|987865|P1|Period 1|expulsion of colonic sensor catheter|1
293128|NCT01707290|987889|P2|Overall Study|Other unspecified|0
293129|NCT01707290|987890|P1|Overall Study|Other unspecified|17
293130|NCT01707290|987889|P2|Overall Study|Commercial drug available|1
293131|NCT01707290|987890|P1|Overall Study|Commercial drug available|60
293132|NCT01707290|987889|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
293133|NCT01707290|987890|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
293134|NCT01707290|987889|P2|Overall Study|Lost to Follow-up|0
293135|NCT01707290|987890|P1|Overall Study|Lost to Follow-up|3
293136|NCT01707290|987889|P2|Overall Study|Physician Decision|0
293137|NCT01707290|987890|P1|Overall Study|Physician Decision|1
293138|NCT01707290|987889|P2|Overall Study|Adverse event (AE)|0
293139|NCT01707290|987890|P1|Overall Study|Adverse event (AE)|1
293140|NCT01706926|987984|P4|Overall Study|Other|3
293141|NCT01706926|987985|P3|Overall Study|Other|4
293142|NCT01706926|987986|P2|Overall Study|Other|4
293143|NCT01706926|987987|P1|Overall Study|Other|4
293144|NCT01706926|987984|P4|Overall Study|Withdrawal by Subject|2
293145|NCT01706926|987985|P3|Overall Study|Withdrawal by Subject|1
293146|NCT01706926|987986|P2|Overall Study|Withdrawal by Subject|0
293147|NCT01706926|987987|P1|Overall Study|Withdrawal by Subject|2
293148|NCT01706926|987984|P4|Overall Study|Lost to Follow-up|0
293149|NCT01706926|987985|P3|Overall Study|Lost to Follow-up|1
293150|NCT01706926|987986|P2|Overall Study|Lost to Follow-up|0
293151|NCT01706926|987987|P1|Overall Study|Lost to Follow-up|0
293152|NCT01706770|988106|P2|Overall Study|Physician Decision|0
293153|NCT01706770|988107|P1|Overall Study|Physician Decision|1
293154|NCT01706770|988106|P2|Overall Study|Lost to Follow-up|0
293155|NCT01706770|988107|P1|Overall Study|Lost to Follow-up|1
293156|NCT01706575|988155|P1|Overall Study|Started but not Treated|6
293157|NCT01706575|988155|P1|Overall Study|Lost to Follow-up|2
293158|NCT01706575|988155|P1|Overall Study|Participant Withdrew Consent|4
293159|NCT01706536|988176|P5|Overall Study|non compliance|0
293160|NCT01706536|988177|P4|Overall Study|non compliance|0
293161|NCT01706536|988178|P3|Overall Study|non compliance|0
293162|NCT01706536|988179|P2|Overall Study|non compliance|1
293163|NCT01706536|988180|P1|Overall Study|non compliance|0
293164|NCT01706536|988176|P5|Overall Study|Lack of Efficacy|0
293165|NCT01706536|988177|P4|Overall Study|Lack of Efficacy|1
293166|NCT01706536|988178|P3|Overall Study|Lack of Efficacy|0
293167|NCT01706536|988179|P2|Overall Study|Lack of Efficacy|0
293168|NCT01706536|988180|P1|Overall Study|Lack of Efficacy|1
293169|NCT01706536|988176|P5|Overall Study|Adverse Event|2
293170|NCT01706536|988177|P4|Overall Study|Adverse Event|3
293171|NCT01706536|988178|P3|Overall Study|Adverse Event|4
293172|NCT01706536|988179|P2|Overall Study|Adverse Event|3
293173|NCT01706536|988180|P1|Overall Study|Adverse Event|2
293174|NCT01706536|988176|P5|Overall Study|Withdrawal by Subject|0
293175|NCT01706536|988177|P4|Overall Study|Withdrawal by Subject|0
293176|NCT01706536|988178|P3|Overall Study|Withdrawal by Subject|1
293177|NCT01706536|988179|P2|Overall Study|Withdrawal by Subject|0
293178|NCT01706536|988180|P1|Overall Study|Withdrawal by Subject|1
293179|NCT01706328|988239|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
293180|NCT01706328|988240|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
293181|NCT01706328|988241|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
293182|NCT01706328|988239|P3|12-week Double-blind Treatment Period|Physician Decision|2
293183|NCT01706328|988240|P2|12-week Double-blind Treatment Period|Physician Decision|2
293184|NCT01706328|988241|P1|12-week Double-blind Treatment Period|Physician Decision|0
293185|NCT01706328|988239|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
293186|NCT01706328|988240|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
293187|NCT01706328|988241|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
293188|NCT01706328|988239|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
293189|NCT01706328|988240|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
293190|NCT01706328|988241|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
293191|NCT01706328|988239|P3|12-week Double-blind Treatment Period|Protocol Violation|2
293192|NCT01706328|988240|P2|12-week Double-blind Treatment Period|Protocol Violation|4
293193|NCT01706328|988241|P1|12-week Double-blind Treatment Period|Protocol Violation|0
293194|NCT01706328|988239|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
293195|NCT01706328|988240|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
293196|NCT01706328|988241|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
293197|NCT01706328|988239|P3|12-week Double-blind Treatment Period|Adverse Event|16
293198|NCT01706328|988240|P2|12-week Double-blind Treatment Period|Adverse Event|14
293199|NCT01706328|988241|P1|12-week Double-blind Treatment Period|Adverse Event|0
293200|NCT01706328|988239|P3|2-week Run-in Period|Lost to Follow-up|0
293201|NCT01706328|988240|P2|2-week Run-in Period|Lost to Follow-up|0
293202|NCT01706328|988241|P1|2-week Run-in Period|Lost to Follow-up|2
293203|NCT01706328|988239|P3|2-week Run-in Period|Adverse Event|0
293204|NCT01706328|988240|P2|2-week Run-in Period|Adverse Event|0
293205|NCT01706328|988241|P1|2-week Run-in Period|Adverse Event|4
293206|NCT01706328|988239|P3|2-week Run-in Period|Physician Decision|0
293207|NCT01706328|988240|P2|2-week Run-in Period|Physician Decision|0
293208|NCT01706328|988241|P1|2-week Run-in Period|Physician Decision|4
293209|NCT01706328|988239|P3|2-week Run-in Period|Withdrawal by Subject|0
293210|NCT01706328|988240|P2|2-week Run-in Period|Withdrawal by Subject|0
293211|NCT01706328|988241|P1|2-week Run-in Period|Withdrawal by Subject|15
293212|NCT01706328|988239|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
293213|NCT01706328|988240|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
293214|NCT01706328|988241|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
293215|NCT01706250|988260|P1|Overall Study|Lost to Follow-up|2
293216|NCT01706159|988291|P2|Overall Study|Unclassified|1
293217|NCT01706159|988292|P1|Overall Study|Unclassified|6
293218|NCT01706159|988291|P2|Overall Study|Withdrawal Criteria|1
293219|NCT01706159|988292|P1|Overall Study|Withdrawal Criteria|2
293220|NCT01706146|988306|P1|Overall Study|Developed AF and need for antiplatelets|2
293221|NCT01706146|988306|P1|Overall Study|Adverse Event|3
293222|NCT01706146|988306|P1|Overall Study|Withdrawal by Subject|1
293223|NCT01705717|988313|P2|Overall Study|Not Specified|2
293224|NCT01705717|988314|P1|Overall Study|Not Specified|0
293225|NCT01705717|988313|P2|Overall Study|Lack of Efficacy|1
293226|NCT01705717|988314|P1|Overall Study|Lack of Efficacy|0
293227|NCT01705717|988313|P2|Overall Study|Adverse Event|2
293228|NCT01705717|988314|P1|Overall Study|Adverse Event|2
293229|NCT01705652|988331|P2|Overall Study|non-compliance|1
293230|NCT01705652|988332|P1|Overall Study|non-compliance|1
293231|NCT01705652|988331|P2|Overall Study|Withdrawal by Subject|2
293232|NCT01705652|988332|P1|Overall Study|Withdrawal by Subject|1
293233|NCT01705652|988331|P2|Overall Study|Adverse Event|0
293234|NCT01705652|988332|P1|Overall Study|Adverse Event|1
293235|NCT01705587|988340|P2|Overall Study|Withdrawal by Subject|1
293236|NCT01705587|988341|P1|Overall Study|Withdrawal by Subject|0
293237|NCT01705574|988359|P2|Overall Study|Still on Study|125
293238|NCT01705574|988360|P1|Overall Study|Still on Study|135
293239|NCT01705574|988359|P2|Overall Study|Lost to Follow-up|15
293240|NCT01705574|988360|P1|Overall Study|Lost to Follow-up|11
293241|NCT01705574|988359|P2|Overall Study|Withdrew Consent|5
293242|NCT01705574|988360|P1|Overall Study|Withdrew Consent|8
293243|NCT01705574|988359|P2|Overall Study|Protocol Violation|0
293244|NCT01705574|988360|P1|Overall Study|Protocol Violation|1
293245|NCT01705574|988359|P2|Overall Study|Non-Compliance with Study Drug|4
293246|NCT01705574|988360|P1|Overall Study|Non-Compliance with Study Drug|4
293247|NCT01705574|988359|P2|Overall Study|Pregnancy|1
293248|NCT01705574|988360|P1|Overall Study|Pregnancy|1
293249|NCT01705574|988359|P2|Overall Study|Adverse Event|9
293250|NCT01705574|988360|P1|Overall Study|Adverse Event|3
293251|NCT01705574|988359|P2|Overall Study|Randomized but Not Treated|4
293252|NCT01705574|988360|P1|Overall Study|Randomized but Not Treated|4
293253|NCT01705145|988378|P1|Part B|Adverse Event|1
293254|NCT01704846|988433|P2|Treatment Period 2|Withdrawal by Subject|1
293255|NCT01704846|988434|P1|Treatment Period 2|Withdrawal by Subject|0
293256|NCT01704755|988489|P2|Overall Study|Withdrew consent and personal issues|0
293257|NCT01704755|988490|P1|Overall Study|Withdrew consent and personal issues|1
293258|NCT01704755|988489|P2|Overall Study|Other (not specified)|1
293259|NCT01704755|988490|P1|Overall Study|Other (not specified)|3
293260|NCT01704755|988489|P2|Overall Study|Withdrew consent|1
293261|NCT01704755|988490|P1|Overall Study|Withdrew consent|1
293262|NCT01704755|988489|P2|Overall Study|Lost to Follow-up|4
293263|NCT01704755|988490|P1|Overall Study|Lost to Follow-up|3
293264|NCT01704755|988489|P2|Overall Study|Adverse Event|1
293265|NCT01704755|988490|P1|Overall Study|Adverse Event|4
293266|NCT01704651|988504|P2|Overall Study|Post-op did not have laparotomy|1
293267|NCT01704651|988505|P1|Overall Study|Post-op did not have laparotomy|2
293268|NCT01704651|988504|P2|Overall Study|Nasogastric tube placement in surgery|1
293269|NCT01704651|988505|P1|Overall Study|Nasogastric tube placement in surgery|1
293270|NCT01704651|988504|P2|Overall Study|Pre-op change in treatment plan|4
293271|NCT01704651|988505|P1|Overall Study|Pre-op change in treatment plan|1
293272|NCT01704651|988504|P2|Overall Study|Pre-op withdrawal by subject|1
293273|NCT01704651|988505|P1|Overall Study|Pre-op withdrawal by subject|1
293274|NCT01704599|988513|P1|Overall Study|Adverse Event|1
293275|NCT01704495|988553|P4|Optional Safety Extension|Withdrawal by Subject|2
293276|NCT01704495|988554|P3|Optional Safety Extension|Withdrawal by Subject|1
293277|NCT01704495|988555|P2|Optional Safety Extension|Withdrawal by Subject|0
293278|NCT01704495|988556|P1|Optional Safety Extension|Withdrawal by Subject|2
293279|NCT01704495|988553|P4|Optional Safety Extension|Other reason|28
293280|NCT01704495|988554|P3|Optional Safety Extension|Other reason|30
293281|NCT01704495|988555|P2|Optional Safety Extension|Other reason|29
293282|NCT01704495|988556|P1|Optional Safety Extension|Other reason|27
293283|NCT01704495|988553|P4|Optional Safety Extension|Adverse Event|1
293284|NCT01704495|988554|P3|Optional Safety Extension|Adverse Event|0
293285|NCT01704495|988555|P2|Optional Safety Extension|Adverse Event|4
293286|NCT01704495|988556|P1|Optional Safety Extension|Adverse Event|0
293287|NCT01704495|988553|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
293288|NCT01704495|988554|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
293289|NCT01704495|988555|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
293290|NCT01704495|988556|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
293291|NCT01704495|988553|P4|Subjects Randomized|Protocol Violation|0
293292|NCT01704495|988554|P3|Subjects Randomized|Protocol Violation|2
293293|NCT01704495|988555|P2|Subjects Randomized|Protocol Violation|1
293294|NCT01704495|988556|P1|Subjects Randomized|Protocol Violation|1
293295|NCT01704495|988553|P4|Subjects Randomized|Withdrawal by Subject|5
293296|NCT01704495|988554|P3|Subjects Randomized|Withdrawal by Subject|5
293297|NCT01704495|988555|P2|Subjects Randomized|Withdrawal by Subject|5
293298|NCT01704495|988556|P1|Subjects Randomized|Withdrawal by Subject|5
293299|NCT01704495|988553|P4|Subjects Randomized|Adverse Event|7
293300|NCT01704495|988554|P3|Subjects Randomized|Adverse Event|0
293301|NCT01704495|988555|P2|Subjects Randomized|Adverse Event|2
293302|NCT01704495|988556|P1|Subjects Randomized|Adverse Event|8
293303|NCT01704495|988553|P4|Subjects Randomized|Discontinuation criteria met|0
293304|NCT01704495|988554|P3|Subjects Randomized|Discontinuation criteria met|2
293305|NCT01704495|988555|P2|Subjects Randomized|Discontinuation criteria met|2
293306|NCT01704495|988556|P1|Subjects Randomized|Discontinuation criteria met|4
293307|NCT01704495|988553|P4|Subjects Randomized|Other Reason|2
293308|NCT01704495|988554|P3|Subjects Randomized|Other Reason|3
293309|NCT01704495|988555|P2|Subjects Randomized|Other Reason|2
293310|NCT01704495|988556|P1|Subjects Randomized|Other Reason|3
293311|NCT01704287|988772|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
293312|NCT01704287|988773|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
293313|NCT01704287|988774|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
293314|NCT01704287|988775|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
293315|NCT01704287|988776|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
293316|NCT01704287|988772|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
293317|NCT01704287|988773|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
293318|NCT01704287|988774|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
293319|NCT01704287|988775|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
293320|NCT01704287|988776|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
293321|NCT01704287|988772|P5|Switch to Pembrolizumab Treatment Period|Death|28
293322|NCT01704287|988773|P4|Switch to Pembrolizumab Treatment Period|Death|29
293323|NCT01704287|988774|P3|Switch to Pembrolizumab Treatment Period|Death|0
293324|NCT01704287|988775|P2|Switch to Pembrolizumab Treatment Period|Death|0
293325|NCT01704287|988776|P1|Switch to Pembrolizumab Treatment Period|Death|0
293326|NCT01704287|988772|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
293327|NCT01704287|988773|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
293328|NCT01704287|988774|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
293329|NCT01704287|988775|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
293330|NCT01704287|988776|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
293331|NCT01704287|988772|P5|Initial Treatment Period|Switched to Pembrolizumab|0
293332|NCT01704287|988773|P4|Initial Treatment Period|Switched to Pembrolizumab|0
293333|NCT01704287|988774|P3|Initial Treatment Period|Switched to Pembrolizumab|98
293334|NCT01704287|988775|P2|Initial Treatment Period|Switched to Pembrolizumab|0
293335|NCT01704287|988776|P1|Initial Treatment Period|Switched to Pembrolizumab|0
293336|NCT01704287|988772|P5|Initial Treatment Period|Lost to Follow-up|0
293337|NCT01704287|988773|P4|Initial Treatment Period|Lost to Follow-up|0
293338|NCT01704287|988774|P3|Initial Treatment Period|Lost to Follow-up|3
293339|NCT01704287|988775|P2|Initial Treatment Period|Lost to Follow-up|1
293340|NCT01704287|988776|P1|Initial Treatment Period|Lost to Follow-up|3
293341|NCT01704287|988772|P5|Initial Treatment Period|Ongoing in Study|0
293342|NCT01704287|988773|P4|Initial Treatment Period|Ongoing in Study|0
293343|NCT01704287|988774|P3|Initial Treatment Period|Ongoing in Study|44
293344|NCT01704287|988775|P2|Initial Treatment Period|Ongoing in Study|62
293345|NCT01704287|988776|P1|Initial Treatment Period|Ongoing in Study|52
293346|NCT01704287|988772|P5|Initial Treatment Period|Other|0
293347|NCT01704287|988773|P4|Initial Treatment Period|Other|0
293348|NCT01704287|988774|P3|Initial Treatment Period|Other|0
293349|NCT01704287|988775|P2|Initial Treatment Period|Other|0
293350|NCT01704287|988776|P1|Initial Treatment Period|Other|1
293351|NCT01704287|988772|P5|Initial Treatment Period|Withdrawal by Subject|0
293352|NCT01704287|988773|P4|Initial Treatment Period|Withdrawal by Subject|0
293353|NCT01704287|988774|P3|Initial Treatment Period|Withdrawal by Subject|4
293354|NCT01704287|988775|P2|Initial Treatment Period|Withdrawal by Subject|1
293355|NCT01704287|988776|P1|Initial Treatment Period|Withdrawal by Subject|1
293356|NCT01704287|988772|P5|Initial Treatment Period|Death|0
293357|NCT01704287|988773|P4|Initial Treatment Period|Death|0
293358|NCT01704287|988774|P3|Initial Treatment Period|Death|30
293359|NCT01704287|988775|P2|Initial Treatment Period|Death|117
293360|NCT01704287|988776|P1|Initial Treatment Period|Death|123
293361|NCT01704261|988811|P2|Overall Study|Lost to Follow-up|0
293362|NCT01704261|988812|P1|Overall Study|Lost to Follow-up|1
293363|NCT01704261|988811|P2|Overall Study|Withdrawal by Subject|15
293364|NCT01704261|988812|P1|Overall Study|Withdrawal by Subject|12
293365|NCT01704079|988839|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
293366|NCT01704079|988840|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
293367|NCT01704079|988839|P2|Overall Study|Subject noncompliance|3
293368|NCT01704079|988840|P1|Overall Study|Subject noncompliance|2
293369|NCT01704079|988839|P2|Overall Study|Protocol Violation|0
293370|NCT01704079|988840|P1|Overall Study|Protocol Violation|1
293371|NCT01704079|988839|P2|Overall Study|Adverse Event|7
293372|NCT01704079|988840|P1|Overall Study|Adverse Event|4
293373|NCT01704079|988839|P2|Overall Study|Lost to Follow-up|5
293374|NCT01704079|988840|P1|Overall Study|Lost to Follow-up|2
293375|NCT01704079|988839|P2|Overall Study|Withdrawal by Subject|7
293376|NCT01704079|988840|P1|Overall Study|Withdrawal by Subject|5
293377|NCT01703988|988856|P4|Overall Study|Investigator Judgment|1
293378|NCT01703988|988857|P3|Overall Study|Investigator Judgment|0
293379|NCT01703988|988858|P2|Overall Study|Investigator Judgment|0
293380|NCT01703988|988859|P1|Overall Study|Investigator Judgment|0
293381|NCT01703858|988889|P3|Overall Study|Withdrawal by Subject|0
293382|NCT01703858|988890|P2|Overall Study|Withdrawal by Subject|1
293383|NCT01703858|988891|P1|Overall Study|Withdrawal by Subject|0
293384|NCT01703845|988916|P2|Overall Study|other than stated above|0
293385|NCT01703845|988917|P1|Overall Study|other than stated above|1
293386|NCT01703845|988916|P2|Overall Study|Protocol Violation|0
293387|NCT01703845|988917|P1|Overall Study|Protocol Violation|1
293388|NCT01703845|988916|P2|Overall Study|Adverse Event|0
293389|NCT01703845|988917|P1|Overall Study|Adverse Event|1
293390|NCT01703832|988954|P2|Overall Study|Withdrawal by Subject|0
293391|NCT01703832|988955|P1|Overall Study|Withdrawal by Subject|1
293392|NCT01703819|988987|P2|Overall Study|Withdrawal by Subject|1
293393|NCT01703819|988988|P1|Overall Study|Withdrawal by Subject|0
293394|NCT01703819|988987|P2|Overall Study|Adverse Event|1
293395|NCT01703819|988988|P1|Overall Study|Adverse Event|0
293396|NCT01703741|989018|P1|Overall Study|Subject started testosterone injections|1
293397|NCT01703741|989018|P1|Overall Study|Subject cannot comply with study visits|1
293398|NCT01703741|989018|P1|Overall Study|Subject did not want to continue|2
293399|NCT01703741|989018|P1|Overall Study|Lost to Follow-up|3
293400|NCT01703741|989018|P1|Overall Study|Protocol Violation|1
293401|NCT01703741|989018|P1|Overall Study|Physician Decision|2
293402|NCT01703741|989018|P1|Overall Study|Adverse Event|2
293403|NCT01703741|989018|P1|Overall Study|Withdrawal by Subject|6
293404|NCT01703286|989061|P6|Period 2 Including Washout|Adverse Event|0
293405|NCT01703286|989062|P5|Period 2 Including Washout|Adverse Event|0
293406|NCT01703286|989063|P4|Period 2 Including Washout|Adverse Event|1
293407|NCT01703286|989064|P3|Period 2 Including Washout|Adverse Event|0
293408|NCT01703286|989065|P2|Period 2 Including Washout|Adverse Event|0
293409|NCT01703286|989066|P1|Period 2 Including Washout|Adverse Event|0
293410|NCT01703286|989061|P6|Period 1 Including Washout|Withdrawal by Subject|1
293411|NCT01703286|989062|P5|Period 1 Including Washout|Withdrawal by Subject|0
293412|NCT01703286|989063|P4|Period 1 Including Washout|Withdrawal by Subject|1
293413|NCT01703286|989064|P3|Period 1 Including Washout|Withdrawal by Subject|0
293414|NCT01703286|989065|P2|Period 1 Including Washout|Withdrawal by Subject|0
293415|NCT01703286|989066|P1|Period 1 Including Washout|Withdrawal by Subject|0
293416|NCT01703260|989089|P3|Overall Study|Study Termination|0
293417|NCT01703260|989090|P2|Overall Study|Study Termination|2
293418|NCT01703260|989091|P1|Overall Study|Study Termination|1
293419|NCT01703260|989089|P3|Overall Study|Withdrawal by Subject|1
293420|NCT01703260|989090|P2|Overall Study|Withdrawal by Subject|0
293421|NCT01703260|989091|P1|Overall Study|Withdrawal by Subject|0
293422|NCT01703260|989089|P3|Overall Study|Lost to Follow-up|0
293423|NCT01703260|989090|P2|Overall Study|Lost to Follow-up|0
293424|NCT01703260|989091|P1|Overall Study|Lost to Follow-up|1
293425|NCT01703260|989089|P3|Overall Study|Adverse Event|2
293426|NCT01703260|989090|P2|Overall Study|Adverse Event|2
293427|NCT01703260|989091|P1|Overall Study|Adverse Event|1
293428|NCT01703221|989117|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
293429|NCT01703221|989118|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
293430|NCT01703221|989119|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
293431|NCT01703221|989117|P3|Phase B - (Week 25 to 52)|Adverse Event|2
293432|NCT01703221|989118|P2|Phase B - (Week 25 to 52)|Adverse Event|3
293433|NCT01703221|989119|P1|Phase B - (Week 25 to 52)|Adverse Event|2
293434|NCT01703221|989117|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
293435|NCT01703221|989118|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
293436|NCT01703221|989119|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
293437|NCT01703221|989117|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
293438|NCT01703221|989118|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
293439|NCT01703221|989119|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
293440|NCT01703221|989117|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
293441|NCT01703221|989118|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
293442|NCT01703221|989119|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
293443|NCT01703221|989117|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
293444|NCT01703221|989118|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
293445|NCT01703221|989119|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
293446|NCT01703221|989117|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
293447|NCT01703221|989118|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
293448|NCT01703221|989119|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
293449|NCT01703221|989117|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
293450|NCT01703221|989118|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
293451|NCT01703221|989119|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
293452|NCT01703208|989150|P2|Overall Study|Protocol Deviation|0
293453|NCT01703208|989151|P1|Overall Study|Protocol Deviation|2
293454|NCT01703208|989150|P2|Overall Study|Technical Problems|1
293455|NCT01703208|989151|P1|Overall Study|Technical Problems|0
293456|NCT01703208|989150|P2|Overall Study|Adverse Event|19
293457|NCT01703208|989151|P1|Overall Study|Adverse Event|14
293458|NCT01703208|989150|P2|Overall Study|Withdrawal by Subject|209
293459|NCT01703208|989151|P1|Overall Study|Withdrawal by Subject|205
293460|NCT01703208|989150|P2|Overall Study|Study Terminated by Sponsor|1716
293461|NCT01703208|989151|P1|Overall Study|Study Terminated by Sponsor|1710
293462|NCT01703208|989150|P2|Overall Study|Protocol Violation|1
293463|NCT01703208|989151|P1|Overall Study|Protocol Violation|1
293464|NCT01703208|989150|P2|Overall Study|Progressive disease|2
293465|NCT01703208|989151|P1|Overall Study|Progressive disease|2
293466|NCT01703208|989150|P2|Overall Study|Physician Decision|13
293467|NCT01703208|989151|P1|Overall Study|Physician Decision|11
293468|NCT01703208|989150|P2|Overall Study|Site Discontinued Study Participation|27
293469|NCT01703208|989151|P1|Overall Study|Site Discontinued Study Participation|23
293470|NCT01703208|989150|P2|Overall Study|Excluded Medication|2
293471|NCT01703208|989151|P1|Overall Study|Excluded Medication|1
293472|NCT01703208|989150|P2|Overall Study|Non-Compliance with Study Drug|0
293473|NCT01703208|989151|P1|Overall Study|Non-Compliance with Study Drug|1
293474|NCT01703208|989150|P2|Overall Study|Lost to Follow-up|62
293475|NCT01703208|989151|P1|Overall Study|Lost to Follow-up|68
293476|NCT01703208|989150|P2|Overall Study|Lack of Efficacy|2
293477|NCT01703208|989151|P1|Overall Study|Lack of Efficacy|1
293478|NCT01703208|989150|P2|Overall Study|Death|48
293479|NCT01703208|989151|P1|Overall Study|Death|61
293480|NCT01703091|989215|P2|Overall Study|Sponsor Decision|0
293481|NCT01703091|989216|P1|Overall Study|Sponsor Decision|1
293482|NCT01703091|989215|P2|Overall Study|Withdrawal by Subject|0
293483|NCT01703091|989216|P1|Overall Study|Withdrawal by Subject|1
293484|NCT01703091|989215|P2|Overall Study|Physician Decision|1
293485|NCT01703091|989216|P1|Overall Study|Physician Decision|2
293486|NCT01703091|989215|P2|Overall Study|Adverse Event|3
293487|NCT01703091|989216|P1|Overall Study|Adverse Event|5
293488|NCT01703000|989232|P1|Overall Study|Death|1
293489|NCT01702987|989265|P2|Overall Study|Withdrawal by Subject|0
293490|NCT01702987|989266|P1|Overall Study|Withdrawal by Subject|1
293497|NCT01702532|989292|P2|Overall Study|Adverse Event|1
293498|NCT01702532|989293|P1|Overall Study|Adverse Event|0
293499|NCT01702519|989303|P2|Washout Period|Withdrawal by Subject|2
293500|NCT01702519|989304|P1|Washout Period|Withdrawal by Subject|0
293501|NCT01702519|989303|P2|Washout Period|Lost to Follow-up|0
293502|NCT01702519|989304|P1|Washout Period|Lost to Follow-up|1
293503|NCT01702454|989322|P2|Overall Study|Lost to Follow-up|6
293504|NCT01702454|989323|P1|Overall Study|Lost to Follow-up|3
293505|NCT01702454|989322|P2|Overall Study|Migrated/moved from study area|1
293506|NCT01702454|989323|P1|Overall Study|Migrated/moved from study area|0
293507|NCT01702454|989322|P2|Overall Study|Consent withdrawal|1
293508|NCT01702454|989323|P1|Overall Study|Consent withdrawal|0
293509|NCT01702428|989405|P4|Overall Study|Withdrawal by Subject|10
293510|NCT01702428|989406|P3|Overall Study|Withdrawal by Subject|14
293511|NCT01702428|989407|P2|Overall Study|Withdrawal by Subject|23
293512|NCT01702428|989408|P1|Overall Study|Withdrawal by Subject|21
293513|NCT01702428|989405|P4|Overall Study|Protocol Violation|0
293514|NCT01702428|989406|P3|Overall Study|Protocol Violation|1
293515|NCT01702428|989407|P2|Overall Study|Protocol Violation|0
293516|NCT01702428|989408|P1|Overall Study|Protocol Violation|3
293517|NCT01702428|989405|P4|Overall Study|Parents too busy|0
293518|NCT01702428|989406|P3|Overall Study|Parents too busy|0
293519|NCT01702428|989407|P2|Overall Study|Parents too busy|0
293520|NCT01702428|989408|P1|Overall Study|Parents too busy|1
293521|NCT01702428|989405|P4|Overall Study|Mother transferred care|0
293522|NCT01702428|989406|P3|Overall Study|Mother transferred care|0
293523|NCT01702428|989407|P2|Overall Study|Mother transferred care|1
293524|NCT01702428|989408|P1|Overall Study|Mother transferred care|0
293525|NCT01702428|989405|P4|Overall Study|Lost Health Plan|2
293526|NCT01702428|989406|P3|Overall Study|Lost Health Plan|0
293527|NCT01702428|989407|P2|Overall Study|Lost Health Plan|5
293528|NCT01702428|989408|P1|Overall Study|Lost Health Plan|3
293529|NCT01702428|989405|P4|Overall Study|Lost Coverage|1
293530|NCT01702428|989406|P3|Overall Study|Lost Coverage|0
293531|NCT01702428|989407|P2|Overall Study|Lost Coverage|0
293532|NCT01702428|989408|P1|Overall Study|Lost Coverage|0
293533|NCT01702428|989405|P4|Overall Study|Parents cannot assist to site|0
293534|NCT01702428|989406|P3|Overall Study|Parents cannot assist to site|1
293535|NCT01702428|989407|P2|Overall Study|Parents cannot assist to site|0
293536|NCT01702428|989408|P1|Overall Study|Parents cannot assist to site|1
293537|NCT01702428|989405|P4|Overall Study|Lost to Follow-up|44
293538|NCT01702428|989406|P3|Overall Study|Lost to Follow-up|37
293539|NCT01702428|989407|P2|Overall Study|Lost to Follow-up|41
293540|NCT01702428|989408|P1|Overall Study|Lost to Follow-up|33
293541|NCT01702428|989405|P4|Overall Study|Adverse Event|0
293542|NCT01702428|989406|P3|Overall Study|Adverse Event|0
293543|NCT01702428|989407|P2|Overall Study|Adverse Event|0
293544|NCT01702428|989408|P1|Overall Study|Adverse Event|2
293545|NCT01702363|989495|P1|Overall Study|Withdrawal by Subject|2
293546|NCT01702363|989495|P1|Overall Study|Lack of Efficacy|4
293547|NCT01702363|989495|P1|Overall Study|Adverse Event|14
293548|NCT01702311|989512|P2|Overall Study|Physician Decision|4
293549|NCT01702311|989513|P1|Overall Study|Physician Decision|3
293550|NCT01702311|989512|P2|Overall Study|Discharge less than 24 hours|7
293551|NCT01702311|989513|P1|Overall Study|Discharge less than 24 hours|10
293552|NCT01702311|989512|P2|Overall Study|Withdrawal by Subject|2
293553|NCT01702311|989513|P1|Overall Study|Withdrawal by Subject|3
293554|NCT01702298|989543|P1|Overall Study|Withdrawal by Subject|1
293555|NCT01702246|989571|P1|Overall Study|Physician Decision|1
293556|NCT01702246|989571|P1|Overall Study|Withdrawal by Subject|2
293557|NCT01702246|989571|P1|Overall Study|Lost to Follow-up|2
293558|NCT01702025|989625|P4|Overall Study|Adverse Event|0
293559|NCT01702025|989626|P3|Overall Study|Adverse Event|1
293560|NCT01702025|989627|P2|Overall Study|Adverse Event|1
293561|NCT01702025|989628|P1|Overall Study|Adverse Event|1
293562|NCT01702025|989625|P4|Overall Study|Equipment failure|0
293563|NCT01702025|989626|P3|Overall Study|Equipment failure|0
293564|NCT01702025|989627|P2|Overall Study|Equipment failure|0
293565|NCT01702025|989628|P1|Overall Study|Equipment failure|1
293566|NCT01701973|989657|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
293567|NCT01701973|989658|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
293568|NCT01701973|989659|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
293569|NCT01701973|989660|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
293570|NCT01701973|989661|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
293571|NCT01701973|989662|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
293572|NCT01701973|989663|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
293573|NCT01701973|989664|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
293574|NCT01701674|989711|P1|Overall Study|Unable to safely complete treatment|1
293575|NCT01701401|989797|P4|Overall Study|Protocol Violation|0
293576|NCT01701401|989798|P3|Overall Study|Protocol Violation|1
293577|NCT01701401|989799|P2|Overall Study|Protocol Violation|0
293578|NCT01701401|989800|P1|Overall Study|Protocol Violation|0
293579|NCT01701401|989797|P4|Overall Study|Adverse Event|0
293580|NCT01701401|989798|P3|Overall Study|Adverse Event|0
293581|NCT01701401|989799|P2|Overall Study|Adverse Event|0
293582|NCT01701401|989800|P1|Overall Study|Adverse Event|1
293583|NCT01701401|989797|P4|Overall Study|Lack of Efficacy|0
293584|NCT01701401|989798|P3|Overall Study|Lack of Efficacy|2
293585|NCT01701401|989799|P2|Overall Study|Lack of Efficacy|0
293586|NCT01701401|989800|P1|Overall Study|Lack of Efficacy|1
293587|NCT01701401|989797|P4|Overall Study|Withdrew Consent|2
293588|NCT01701401|989798|P3|Overall Study|Withdrew Consent|1
293589|NCT01701401|989799|P2|Overall Study|Withdrew Consent|3
293590|NCT01701401|989800|P1|Overall Study|Withdrew Consent|0
293591|NCT01701401|989797|P4|Overall Study|Lost to Follow-up|3
293592|NCT01701401|989798|P3|Overall Study|Lost to Follow-up|1
293593|NCT01701401|989799|P2|Overall Study|Lost to Follow-up|5
293594|NCT01701401|989800|P1|Overall Study|Lost to Follow-up|5
293595|NCT01701401|989797|P4|Overall Study|Randomized But Not Treated|1
293596|NCT01701401|989798|P3|Overall Study|Randomized But Not Treated|0
293597|NCT01701401|989799|P2|Overall Study|Randomized But Not Treated|1
293598|NCT01701401|989800|P1|Overall Study|Randomized But Not Treated|3
293599|NCT01701362|989852|P2|Overall Study|Reasons other than those mentioned above|5
293600|NCT01701362|989853|P1|Overall Study|Reasons other than those mentioned above|3
293601|NCT01701362|989852|P2|Overall Study|Randomized but not treated|2
293602|NCT01701362|989853|P1|Overall Study|Randomized but not treated|1
293603|NCT01701362|989852|P2|Overall Study|Death|1
293604|NCT01701362|989853|P1|Overall Study|Death|0
293605|NCT01701362|989852|P2|Overall Study|Insufficient clinical response|6
293606|NCT01701362|989853|P1|Overall Study|Insufficient clinical response|6
293607|NCT01701362|989852|P2|Overall Study|Lost to Follow-up|9
293608|NCT01701362|989853|P1|Overall Study|Lost to Follow-up|6
293609|NCT01701362|989852|P2|Overall Study|No longer willing to participate|14
293610|NCT01701362|989853|P1|Overall Study|No longer willing to participate|8
293611|NCT01701362|989852|P2|Overall Study|Protocol Violation|3
293612|NCT01701362|989853|P1|Overall Study|Protocol Violation|5
293613|NCT01701362|989852|P2|Overall Study|Adverse events related to study drug|10
293614|NCT01701362|989853|P1|Overall Study|Adverse events related to study drug|12
293615|NCT01701362|989852|P2|Overall Study|Adverse events not related to study drug|6
293616|NCT01701362|989853|P1|Overall Study|Adverse events not related to study drug|1
293617|NCT01701258|989891|P13|Assessment and Scheduling|Investigator Terminated|0
293618|NCT01701258|989892|P12|Assessment and Scheduling|Investigator Terminated|0
293619|NCT01701258|989893|P11|Assessment and Scheduling|Investigator Terminated|0
293620|NCT01701258|989894|P10|Assessment and Scheduling|Investigator Terminated|0
293621|NCT01701258|989895|P9|Assessment and Scheduling|Investigator Terminated|0
293622|NCT01701258|989896|P8|Assessment and Scheduling|Investigator Terminated|0
293623|NCT01701258|989897|P7|Assessment and Scheduling|Investigator Terminated|0
293624|NCT01701258|989898|P6|Assessment and Scheduling|Investigator Terminated|0
293625|NCT01701258|989899|P5|Assessment and Scheduling|Investigator Terminated|0
293626|NCT01701258|989900|P4|Assessment and Scheduling|Investigator Terminated|0
293627|NCT01701258|989901|P3|Assessment and Scheduling|Investigator Terminated|0
293628|NCT01701258|989902|P2|Assessment and Scheduling|Investigator Terminated|0
293629|NCT01701258|989903|P1|Assessment and Scheduling|Investigator Terminated|2
293630|NCT01701258|989891|P13|Assessment and Scheduling|Withdrawal by Subject|0
293631|NCT01701258|989892|P12|Assessment and Scheduling|Withdrawal by Subject|0
293632|NCT01701258|989893|P11|Assessment and Scheduling|Withdrawal by Subject|0
293633|NCT01701258|989894|P10|Assessment and Scheduling|Withdrawal by Subject|0
293634|NCT01701258|989895|P9|Assessment and Scheduling|Withdrawal by Subject|0
293635|NCT01701258|989896|P8|Assessment and Scheduling|Withdrawal by Subject|0
293636|NCT01701258|989897|P7|Assessment and Scheduling|Withdrawal by Subject|0
293637|NCT01701258|989898|P6|Assessment and Scheduling|Withdrawal by Subject|0
293638|NCT01701258|989899|P5|Assessment and Scheduling|Withdrawal by Subject|0
293639|NCT01701258|989900|P4|Assessment and Scheduling|Withdrawal by Subject|0
293640|NCT01701258|989901|P3|Assessment and Scheduling|Withdrawal by Subject|0
293641|NCT01701258|989902|P2|Assessment and Scheduling|Withdrawal by Subject|0
293642|NCT01701258|989903|P1|Assessment and Scheduling|Withdrawal by Subject|14
293643|NCT01701258|989891|P13|Assessment and Scheduling|Lost to Follow-up|0
293644|NCT01701258|989892|P12|Assessment and Scheduling|Lost to Follow-up|0
293645|NCT01701258|989893|P11|Assessment and Scheduling|Lost to Follow-up|0
293646|NCT01701258|989894|P10|Assessment and Scheduling|Lost to Follow-up|0
293647|NCT01701258|989895|P9|Assessment and Scheduling|Lost to Follow-up|0
293648|NCT01701258|989896|P8|Assessment and Scheduling|Lost to Follow-up|0
293649|NCT01701258|989897|P7|Assessment and Scheduling|Lost to Follow-up|0
293650|NCT01701258|989898|P6|Assessment and Scheduling|Lost to Follow-up|0
293651|NCT01701258|989899|P5|Assessment and Scheduling|Lost to Follow-up|0
293652|NCT01701258|989900|P4|Assessment and Scheduling|Lost to Follow-up|0
293653|NCT01701258|989901|P3|Assessment and Scheduling|Lost to Follow-up|0
293654|NCT01701258|989902|P2|Assessment and Scheduling|Lost to Follow-up|0
293655|NCT01701258|989903|P1|Assessment and Scheduling|Lost to Follow-up|10
293656|NCT01701258|989891|P13|Assessment and Scheduling|Found to be Ineligible|0
293657|NCT01701258|989892|P12|Assessment and Scheduling|Found to be Ineligible|0
293658|NCT01701258|989893|P11|Assessment and Scheduling|Found to be Ineligible|0
293659|NCT01701258|989894|P10|Assessment and Scheduling|Found to be Ineligible|0
293660|NCT01701258|989895|P9|Assessment and Scheduling|Found to be Ineligible|0
293661|NCT01701258|989896|P8|Assessment and Scheduling|Found to be Ineligible|0
293662|NCT01701258|989897|P7|Assessment and Scheduling|Found to be Ineligible|0
293663|NCT01701258|989898|P6|Assessment and Scheduling|Found to be Ineligible|0
293664|NCT01701258|989899|P5|Assessment and Scheduling|Found to be Ineligible|0
293665|NCT01701258|989900|P4|Assessment and Scheduling|Found to be Ineligible|0
293666|NCT01701258|989901|P3|Assessment and Scheduling|Found to be Ineligible|0
293667|NCT01701258|989902|P2|Assessment and Scheduling|Found to be Ineligible|0
293668|NCT01701258|989903|P1|Assessment and Scheduling|Found to be Ineligible|57
293669|NCT01701245|989957|P2|Overall Study|Did not complete the open label period|12
293670|NCT01701245|989958|P1|Overall Study|Did not complete the open label period|11
293671|NCT01701245|989957|P2|Overall Study|Protocol Violation|3
293672|NCT01701245|989958|P1|Overall Study|Protocol Violation|1
293673|NCT01701063|990005|P3|Overall Study|Other|1
293674|NCT01701063|990006|P2|Overall Study|Other|0
293675|NCT01701063|990007|P1|Overall Study|Other|0
293676|NCT01701063|990005|P3|Overall Study|Withdrawal by Subject|1
293677|NCT01701063|990006|P2|Overall Study|Withdrawal by Subject|0
293678|NCT01701063|990007|P1|Overall Study|Withdrawal by Subject|0
293679|NCT01701063|990005|P3|Overall Study|Lost to Follow-up|0
293680|NCT01701063|990006|P2|Overall Study|Lost to Follow-up|1
293681|NCT01701063|990007|P1|Overall Study|Lost to Follow-up|0
293682|NCT01700959|990095|P6|Overall Study|Side effects|1
293683|NCT01700959|990096|P5|Overall Study|Side effects|4
293684|NCT01700959|990097|P4|Overall Study|Side effects|4
293685|NCT01700959|990098|P3|Overall Study|Side effects|8
293686|NCT01700959|990099|P2|Overall Study|Side effects|4
293687|NCT01700959|990100|P1|Overall Study|Side effects|1
293688|NCT01700959|990095|P6|Overall Study|Noncompliant|9
293689|NCT01700959|990096|P5|Overall Study|Noncompliant|15
293690|NCT01700959|990097|P4|Overall Study|Noncompliant|18
293691|NCT01700959|990098|P3|Overall Study|Noncompliant|17
293692|NCT01700959|990099|P2|Overall Study|Noncompliant|9
293693|NCT01700959|990100|P1|Overall Study|Noncompliant|9
293694|NCT01700959|990095|P6|Overall Study|Ineligible|1
293695|NCT01700959|990096|P5|Overall Study|Ineligible|0
293696|NCT01700959|990097|P4|Overall Study|Ineligible|0
293697|NCT01700959|990098|P3|Overall Study|Ineligible|2
293698|NCT01700959|990099|P2|Overall Study|Ineligible|1
293699|NCT01700959|990100|P1|Overall Study|Ineligible|2
293700|NCT01700959|990095|P6|Overall Study|Withdrawal by Subject|12
293701|NCT01700959|990096|P5|Overall Study|Withdrawal by Subject|8
293702|NCT01700959|990097|P4|Overall Study|Withdrawal by Subject|11
293703|NCT01700959|990098|P3|Overall Study|Withdrawal by Subject|12
293704|NCT01700959|990099|P2|Overall Study|Withdrawal by Subject|9
293705|NCT01700959|990100|P1|Overall Study|Withdrawal by Subject|15
293706|NCT01700959|990095|P6|Overall Study|Adverse Event|2
293707|NCT01700959|990096|P5|Overall Study|Adverse Event|0
293708|NCT01700959|990097|P4|Overall Study|Adverse Event|2
293709|NCT01700959|990098|P3|Overall Study|Adverse Event|1
293710|NCT01700959|990099|P2|Overall Study|Adverse Event|1
293711|NCT01700959|990100|P1|Overall Study|Adverse Event|0
293712|NCT01700530|990171|P3|Overall Study|Withdrawal by Subject|1
293713|NCT01700530|990172|P2|Overall Study|Withdrawal by Subject|3
293714|NCT01700530|990173|P1|Overall Study|Withdrawal by Subject|0
293715|NCT01700387|990222|P2|Overall Study|Lost to Follow-up|1
293716|NCT01700387|990223|P1|Overall Study|Lost to Follow-up|2
293717|NCT01700387|990222|P2|Overall Study|Adverse Event|1
293718|NCT01700387|990223|P1|Overall Study|Adverse Event|1
293719|NCT01700387|990222|P2|Overall Study|Withdrawal by Subject|2
293720|NCT01700387|990223|P1|Overall Study|Withdrawal by Subject|1
293721|NCT01700348|990233|P1|Overall Study|Lost to Follow-up|1
293722|NCT01700348|990233|P1|Overall Study|Withdrawal by Subject|22
293723|NCT01700192|990251|P2|Overall Study|Never received study drug|0
293724|NCT01700192|990252|P1|Overall Study|Never received study drug|1
293725|NCT01700192|990251|P2|Overall Study|Withdrawal by Subject|64
293726|NCT01700192|990252|P1|Overall Study|Withdrawal by Subject|56
293727|NCT01700192|990251|P2|Overall Study|Technical problems|1
293728|NCT01700192|990252|P1|Overall Study|Technical problems|0
293729|NCT01700192|990251|P2|Overall Study|Protocol Violation|4
293730|NCT01700192|990252|P1|Overall Study|Protocol Violation|3
293731|NCT01700192|990251|P2|Overall Study|Progressive disease|0
293732|NCT01700192|990252|P1|Overall Study|Progressive disease|1
293733|NCT01700192|990251|P2|Overall Study|Pregnancy|4
293734|NCT01700192|990252|P1|Overall Study|Pregnancy|1
293735|NCT01700192|990251|P2|Overall Study|Physician Decision|3
293736|NCT01700192|990252|P1|Overall Study|Physician Decision|2
293737|NCT01700192|990251|P2|Overall Study|Noncompliance with study drug|5
293738|NCT01700192|990252|P1|Overall Study|Noncompliance with study drug|0
293739|NCT01700192|990251|P2|Overall Study|Lost to Follow-up|29
293740|NCT01700192|990252|P1|Overall Study|Lost to Follow-up|42
293741|NCT01700192|990251|P2|Overall Study|Lack of Efficacy|0
293742|NCT01700192|990252|P1|Overall Study|Lack of Efficacy|1
293743|NCT01700192|990251|P2|Overall Study|Adverse Event|18
293744|NCT01700192|990252|P1|Overall Study|Adverse Event|73
293745|NCT01700179|990270|P1|Overall Study|Physician Decision|2
293746|NCT01700140|990277|P3|Overall Study|Inclusion/exclusion criteria deviation|0
293747|NCT01700140|990278|P2|Overall Study|Inclusion/exclusion criteria deviation|4
293748|NCT01700140|990279|P1|Overall Study|Inclusion/exclusion criteria deviation|1
293749|NCT01700140|990277|P3|Overall Study|Adverse Event|0
293750|NCT01700140|990278|P2|Overall Study|Adverse Event|1
293751|NCT01700140|990279|P1|Overall Study|Adverse Event|0
293752|NCT01700140|990277|P3|Overall Study|Aggravation of symptoms|0
293753|NCT01700140|990278|P2|Overall Study|Aggravation of symptoms|0
293754|NCT01700140|990279|P1|Overall Study|Aggravation of symptoms|1
293755|NCT01700140|990277|P3|Overall Study|Use of chemotherapy or surgical therapy|0
293756|NCT01700140|990278|P2|Overall Study|Use of chemotherapy or surgical therapy|1
293757|NCT01700140|990279|P1|Overall Study|Use of chemotherapy or surgical therapy|0
293758|NCT01700140|990277|P3|Overall Study|Discontinuation of radiotherapy|0
293759|NCT01700140|990278|P2|Overall Study|Discontinuation of radiotherapy|0
293760|NCT01700140|990279|P1|Overall Study|Discontinuation of radiotherapy|1
293761|NCT01700140|990277|P3|Overall Study|Use of rescue drugs|1
293762|NCT01700140|990278|P2|Overall Study|Use of rescue drugs|3
293763|NCT01700140|990279|P1|Overall Study|Use of rescue drugs|3
293764|NCT01699867|990320|P1|Overall Study|Screening Failure|3
293765|NCT01699815|990327|P2|Overall Study|Adverse Event|1
293766|NCT01699815|990328|P1|Overall Study|Adverse Event|0
293767|NCT01699815|990327|P2|Overall Study|record could not be located|0
293768|NCT01699815|990328|P1|Overall Study|record could not be located|1
293769|NCT01699815|990327|P2|Overall Study|Protocol Violation|7
293770|NCT01699815|990328|P1|Overall Study|Protocol Violation|4
293771|NCT01699789|990340|P2|Overall Study|Lost to Follow-up|101
293772|NCT01699789|990341|P1|Overall Study|Lost to Follow-up|83
293773|NCT01699789|990340|P2|Overall Study|Death|2
293774|NCT01699789|990341|P1|Overall Study|Death|1
293775|NCT01699789|990340|P2|Overall Study|Withdrawal by Subject|23
293776|NCT01699789|990341|P1|Overall Study|Withdrawal by Subject|18
293777|NCT01699750|990411|P2|Overall Study|Other|2
293778|NCT01699750|990412|P1|Overall Study|Other|0
293779|NCT01699750|990411|P2|Overall Study|Withdrew Consent|1
293780|NCT01699750|990412|P1|Overall Study|Withdrew Consent|0
293781|NCT01699685|990447|P2|Period 2|Lost to Follow-up|0
293782|NCT01699685|990448|P1|Period 2|Lost to Follow-up|1
293783|NCT01699685|990447|P2|Period 1|Patient request|1
293784|NCT01699685|990448|P1|Period 1|Patient request|0
293785|NCT01699685|990447|P2|Period 1|Other|1
293786|NCT01699685|990448|P1|Period 1|Other|0
293787|NCT01699685|990447|P2|Period 1|Medical or ethical, noncompliance|0
293788|NCT01699685|990448|P1|Period 1|Medical or ethical, noncompliance|2
293789|NCT01699685|990447|P2|Period 1|Adverse Event|1
293790|NCT01699685|990448|P1|Period 1|Adverse Event|1
293794|NCT01699022|990495|P1|Overall Study|Early discontinuation from the study|3
293795|NCT01698814|990510|P2|Overall Study|Randomized in error|0
293796|NCT01698814|990511|P1|Overall Study|Randomized in error|1
293797|NCT01698814|990510|P2|Overall Study|Pregnancy|0
293798|NCT01698814|990511|P1|Overall Study|Pregnancy|1
293799|NCT01698814|990510|P2|Overall Study|Lost to Follow-up|1
293800|NCT01698814|990511|P1|Overall Study|Lost to Follow-up|0
293801|NCT01698814|990510|P2|Overall Study|Adverse Event|2
293802|NCT01698814|990511|P1|Overall Study|Adverse Event|0
293803|NCT01698801|990517|P1|Follow Up Phase|Death|4
293804|NCT01698801|990517|P1|Follow Up Phase|Withdrawal by Subject|1
293805|NCT01698801|990517|P1|Treatment Phase|Disease progression|1
293806|NCT01698801|990517|P1|Treatment Phase|Withdrawal by Subject|1
293807|NCT01698801|990517|P1|Treatment Phase|Not specified|4
293808|NCT01698801|990517|P1|Treatment Phase|Protocol Violation|1
293809|NCT01698801|990517|P1|Treatment Phase|Adverse Event|4
293810|NCT01698775|990528|P2|Phase B|Withdrawal by Subject|2
293811|NCT01698775|990529|P1|Phase B|Withdrawal by Subject|6
293812|NCT01698775|990528|P2|Phase B|Protocol Violation|1
293813|NCT01698775|990529|P1|Phase B|Protocol Violation|1
293814|NCT01698775|990528|P2|Phase B|Physician Decision|1
293815|NCT01698775|990529|P1|Phase B|Physician Decision|1
293816|NCT01698775|990528|P2|Phase B|Lost to Follow-up|1
293817|NCT01698775|990529|P1|Phase B|Lost to Follow-up|0
293818|NCT01698775|990528|P2|Phase B|Lack of Efficacy|1
293819|NCT01698775|990529|P1|Phase B|Lack of Efficacy|0
293820|NCT01698775|990528|P2|Phase B|Death|1
293821|NCT01698775|990529|P1|Phase B|Death|0
293822|NCT01698775|990528|P2|Phase B|Adverse Event|3
293823|NCT01698775|990529|P1|Phase B|Adverse Event|6
293824|NCT01698775|990528|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
293825|NCT01698775|990529|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
293826|NCT01698775|990528|P2|Phase A|Kidney [transplant]|1
293827|NCT01698775|990529|P1|Phase A|Kidney [transplant]|0
293828|NCT01698775|990528|P2|Phase A|Withdrawal by Subject|4
293829|NCT01698775|990529|P1|Phase A|Withdrawal by Subject|3
293830|NCT01698775|990528|P2|Phase A|Protocol Violation|0
293831|NCT01698775|990529|P1|Phase A|Protocol Violation|1
293832|NCT01698775|990528|P2|Phase A|Lost to Follow-up|2
293833|NCT01698775|990529|P1|Phase A|Lost to Follow-up|1
293834|NCT01698775|990528|P2|Phase A|Lack of Efficacy|0
293835|NCT01698775|990529|P1|Phase A|Lack of Efficacy|1
293836|NCT01698775|990528|P2|Phase A|Death|1
293837|NCT01698775|990529|P1|Phase A|Death|1
293838|NCT01698775|990528|P2|Phase A|Adverse Event|1
293839|NCT01698775|990529|P1|Phase A|Adverse Event|2
293840|NCT01698554|990578|P4|Overall Study|Other Miscellaneous Reasons|0
293841|NCT01698554|990579|P3|Overall Study|Other Miscellaneous Reasons|0
293842|NCT01698554|990580|P2|Overall Study|Other Miscellaneous Reasons|0
293843|NCT01698554|990581|P1|Overall Study|Other Miscellaneous Reasons|1
293844|NCT01698554|990578|P4|Overall Study|Protocol Violation|0
293845|NCT01698554|990579|P3|Overall Study|Protocol Violation|1
293846|NCT01698554|990580|P2|Overall Study|Protocol Violation|0
293847|NCT01698554|990581|P1|Overall Study|Protocol Violation|2
293848|NCT01698554|990578|P4|Overall Study|Personal Reasons|1
293849|NCT01698554|990579|P3|Overall Study|Personal Reasons|1
293850|NCT01698554|990580|P2|Overall Study|Personal Reasons|5
293851|NCT01698554|990581|P1|Overall Study|Personal Reasons|0
293852|NCT01698554|990578|P4|Overall Study|Lost to Follow-up|0
293853|NCT01698554|990579|P3|Overall Study|Lost to Follow-up|0
293854|NCT01698554|990580|P2|Overall Study|Lost to Follow-up|0
293855|NCT01698554|990581|P1|Overall Study|Lost to Follow-up|1
293856|NCT01698554|990578|P4|Overall Study|Adverse Event|1
293857|NCT01698554|990579|P3|Overall Study|Adverse Event|0
293858|NCT01698554|990580|P2|Overall Study|Adverse Event|5
293859|NCT01698554|990581|P1|Overall Study|Adverse Event|2
293860|NCT01698320|990637|P3|40-Week Open-Label Period|Lost to Follow-up|0
293861|NCT01698320|990638|P2|40-Week Open-Label Period|Lost to Follow-up|2
293862|NCT01698320|990639|P1|40-Week Open-Label Period|Lost to Follow-up|0
293863|NCT01698320|990637|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
293864|NCT01698320|990638|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
293865|NCT01698320|990639|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
293866|NCT01698320|990637|P3|40-Week Open-Label Period|Pregnancy|1
293867|NCT01698320|990638|P2|40-Week Open-Label Period|Pregnancy|2
293868|NCT01698320|990639|P1|40-Week Open-Label Period|Pregnancy|0
293869|NCT01698320|990637|P3|40-Week Open-Label Period|Withdrawal by Subject|7
293870|NCT01698320|990638|P2|40-Week Open-Label Period|Withdrawal by Subject|11
293871|NCT01698320|990639|P1|40-Week Open-Label Period|Withdrawal by Subject|0
293872|NCT01698320|990637|P3|40-Week Open-Label Period|Adverse Event|2
293873|NCT01698320|990638|P2|40-Week Open-Label Period|Adverse Event|3
293874|NCT01698320|990639|P1|40-Week Open-Label Period|Adverse Event|0
293875|NCT01698320|990637|P3|12-Week Double-Blind Period|Lost to Follow-up|4
293876|NCT01698320|990638|P2|12-Week Double-Blind Period|Lost to Follow-up|0
293877|NCT01698320|990639|P1|12-Week Double-Blind Period|Lost to Follow-up|0
293878|NCT01698320|990637|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
293879|NCT01698320|990638|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
293880|NCT01698320|990639|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
293881|NCT01698320|990637|P3|12-Week Double-Blind Period|Pregnancy|1
293882|NCT01698320|990638|P2|12-Week Double-Blind Period|Pregnancy|1
293883|NCT01698320|990639|P1|12-Week Double-Blind Period|Pregnancy|0
293884|NCT01698320|990637|P3|12-Week Double-Blind Period|Protocol Violation|2
293885|NCT01698320|990638|P2|12-Week Double-Blind Period|Protocol Violation|0
293886|NCT01698320|990639|P1|12-Week Double-Blind Period|Protocol Violation|0
293887|NCT01698320|990637|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
293888|NCT01698320|990638|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
293889|NCT01698320|990639|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
293890|NCT01698320|990637|P3|12-Week Double-Blind Period|Adverse Event|1
293891|NCT01698320|990638|P2|12-Week Double-Blind Period|Adverse Event|1
293892|NCT01698320|990639|P1|12-Week Double-Blind Period|Adverse Event|0
293893|NCT01698320|990637|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
293894|NCT01698320|990638|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
293895|NCT01698320|990639|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
293896|NCT01698320|990637|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
293897|NCT01698320|990638|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
293898|NCT01698320|990639|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
293899|NCT01698320|990637|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
293900|NCT01698320|990638|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
293901|NCT01698320|990639|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
293902|NCT01698320|990637|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
293903|NCT01698320|990638|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
293904|NCT01698320|990639|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
293905|NCT01698268|990659|P2|Overall Study|Physician Decision|1
293906|NCT01698268|990660|P1|Overall Study|Physician Decision|2
293907|NCT01697969|990666|P1|Overall Study|Did not meet inc/exc criteria|3
293908|NCT01697956|990673|P2|Overall Study|Protocol Violation|1
293909|NCT01697956|990674|P1|Overall Study|Protocol Violation|1
293910|NCT01697696|990704|P2|Overall Study|Subject/guardian decision|35
293911|NCT01697696|990705|P1|Overall Study|Subject/guardian decision|31
293912|NCT01697696|990704|P2|Overall Study|Lost to Follow-up|7
293913|NCT01697696|990705|P1|Overall Study|Lost to Follow-up|10
293914|NCT01697696|990704|P2|Overall Study|Death|2
293915|NCT01697696|990705|P1|Overall Study|Death|4
293916|NCT01697696|990704|P2|Overall Study|Physician Decision|0
293917|NCT01697696|990705|P1|Overall Study|Physician Decision|1
293918|NCT01697696|990704|P2|Overall Study|Protocol deviation|0
293919|NCT01697696|990705|P1|Overall Study|Protocol deviation|1
293920|NCT01697696|990704|P2|Overall Study|Study terminated by sponsor|3
293921|NCT01697696|990705|P1|Overall Study|Study terminated by sponsor|0
293922|NCT01697592|990737|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
293923|NCT01697592|990738|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
293924|NCT01697592|990739|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
293925|NCT01697592|990740|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
293926|NCT01697592|990741|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
293927|NCT01697592|990742|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
293928|NCT01697592|990743|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
293929|NCT01697592|990744|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
293930|NCT01697592|990745|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
293931|NCT01697592|990746|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
293932|NCT01697592|990737|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
293933|NCT01697592|990738|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
293934|NCT01697592|990739|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
293935|NCT01697592|990740|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
293936|NCT01697592|990741|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
293937|NCT01697592|990742|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
293938|NCT01697592|990743|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
293939|NCT01697592|990744|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
293940|NCT01697592|990745|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
293941|NCT01697592|990746|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
293942|NCT01697592|990737|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
293943|NCT01697592|990738|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
293944|NCT01697592|990739|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
293945|NCT01697592|990740|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
293946|NCT01697592|990741|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
293947|NCT01697592|990742|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
293948|NCT01697592|990743|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
293949|NCT01697592|990744|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
293950|NCT01697592|990745|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
293951|NCT01697592|990746|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
293952|NCT01697592|990737|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
293953|NCT01697592|990738|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
293954|NCT01697592|990739|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
293955|NCT01697592|990740|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
293956|NCT01697592|990741|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
293957|NCT01697592|990742|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
293958|NCT01697592|990743|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
293959|NCT01697592|990744|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
293960|NCT01697592|990745|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
293961|NCT01697592|990746|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
293962|NCT01697592|990737|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
293963|NCT01697592|990738|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
293964|NCT01697592|990739|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
293965|NCT01697592|990740|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
293966|NCT01697592|990741|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
293967|NCT01697592|990742|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
293968|NCT01697592|990743|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
293969|NCT01697592|990744|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
293970|NCT01697592|990745|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
293971|NCT01697592|990746|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
293972|NCT01697592|990737|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
293973|NCT01697592|990738|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
293974|NCT01697592|990739|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
293975|NCT01697592|990740|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
293976|NCT01697592|990741|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
293977|NCT01697592|990742|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
293978|NCT01697592|990743|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
293979|NCT01697592|990744|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
293980|NCT01697592|990745|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
293981|NCT01697592|990746|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
293982|NCT01697592|990737|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
293983|NCT01697592|990738|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
293984|NCT01697592|990739|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
293985|NCT01697592|990740|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
293986|NCT01697592|990741|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
293987|NCT01697592|990742|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
293988|NCT01697592|990743|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
293989|NCT01697592|990744|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
293990|NCT01697592|990745|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
293991|NCT01697592|990746|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
293992|NCT01697592|990737|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
293993|NCT01697592|990738|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
293994|NCT01697592|990739|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
293995|NCT01697592|990740|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
293996|NCT01697592|990741|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
293997|NCT01697592|990742|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
293998|NCT01697592|990743|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
293999|NCT01697592|990744|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
294000|NCT01697592|990745|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
294001|NCT01697592|990746|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
294002|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
294003|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
294004|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
294005|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
294006|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
294007|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
294008|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
294009|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
294010|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
294011|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
294012|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
294013|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
294014|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
294015|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
294016|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Participant Moved|2
294017|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Participant Moved|0
294018|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Participant Moved|0
294019|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Participant Moved|0
294020|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Participant Moved|0
294021|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Participant Moved|0
294022|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Participant Moved|0
294023|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Technical Problems|1
294024|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Technical Problems|0
294025|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Technical Problems|0
294026|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Technical Problems|0
294027|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Technical Problems|0
294028|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Technical Problems|0
294029|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Technical Problems|0
294030|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
294031|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
294032|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
294033|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
294034|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
294035|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
294036|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
294037|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
294038|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
294039|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
294040|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
294041|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
294042|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
294043|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
294044|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
294045|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
294046|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
294047|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
294048|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
294049|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
294050|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
294051|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
294052|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
294053|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
294054|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
294055|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
294056|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
294057|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
294058|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
294059|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
294060|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
294061|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
294062|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
294063|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
294064|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
294065|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
294066|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
294067|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
294068|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
294069|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
294070|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
294071|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
294072|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Physician Decision|11
294073|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Physician Decision|7
294074|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Physician Decision|0
294075|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Physician Decision|0
294076|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Physician Decision|0
294077|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Physician Decision|0
294078|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Physician Decision|0
294079|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
294080|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
294081|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
294082|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
294083|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
294084|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
294085|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
294086|NCT01697579|990815|P7|Optional Extension-Cycles 2-6|Death|2
294087|NCT01697579|990816|P6|Optional Extension-Cycles 2-6|Death|0
294088|NCT01697579|990817|P5|Optional Extension-Cycles 2-6|Death|0
294089|NCT01697579|990818|P4|Optional Extension-Cycles 2-6|Death|0
294090|NCT01697579|990819|P3|Optional Extension-Cycles 2-6|Death|0
294091|NCT01697579|990820|P2|Optional Extension-Cycles 2-6|Death|0
294092|NCT01697579|990821|P1|Optional Extension-Cycles 2-6|Death|0
294093|NCT01697579|990815|P7|Base Study-Cycle 1|Technical Problems|0
294094|NCT01697579|990816|P6|Base Study-Cycle 1|Technical Problems|0
294095|NCT01697579|990817|P5|Base Study-Cycle 1|Technical Problems|0
294096|NCT01697579|990818|P4|Base Study-Cycle 1|Technical Problems|1
294097|NCT01697579|990819|P3|Base Study-Cycle 1|Technical Problems|1
294098|NCT01697579|990820|P2|Base Study-Cycle 1|Technical Problems|0
294099|NCT01697579|990821|P1|Base Study-Cycle 1|Technical Problems|0
294100|NCT01697579|990815|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
294101|NCT01697579|990816|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
294102|NCT01697579|990817|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
294103|NCT01697579|990818|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
294104|NCT01697579|990819|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
294105|NCT01697579|990820|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
294106|NCT01697579|990821|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
294107|NCT01697579|990815|P7|Base Study-Cycle 1|Protocol Violation|0
294108|NCT01697579|990816|P6|Base Study-Cycle 1|Protocol Violation|0
294109|NCT01697579|990817|P5|Base Study-Cycle 1|Protocol Violation|3
294110|NCT01697579|990818|P4|Base Study-Cycle 1|Protocol Violation|0
294111|NCT01697579|990819|P3|Base Study-Cycle 1|Protocol Violation|0
294112|NCT01697579|990820|P2|Base Study-Cycle 1|Protocol Violation|0
294113|NCT01697579|990821|P1|Base Study-Cycle 1|Protocol Violation|0
294114|NCT01697579|990815|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
294115|NCT01697579|990816|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
294116|NCT01697579|990817|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
294117|NCT01697579|990818|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
294118|NCT01697579|990819|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
294119|NCT01697579|990820|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
294120|NCT01697579|990821|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
294121|NCT01697579|990815|P7|Base Study-Cycle 1|Adverse Event|0
294122|NCT01697579|990816|P6|Base Study-Cycle 1|Adverse Event|0
294123|NCT01697579|990817|P5|Base Study-Cycle 1|Adverse Event|0
294124|NCT01697579|990818|P4|Base Study-Cycle 1|Adverse Event|0
294125|NCT01697579|990819|P3|Base Study-Cycle 1|Adverse Event|0
294126|NCT01697579|990820|P2|Base Study-Cycle 1|Adverse Event|0
294127|NCT01697579|990821|P1|Base Study-Cycle 1|Adverse Event|1
294128|NCT01697501|990933|P1|Overall Study|Protocol Violation|2
294129|NCT01697462|990976|P1|Overall Study|Missing|5
294130|NCT01697462|990976|P1|Overall Study|Other|10
294131|NCT01697462|990976|P1|Overall Study|Death|1
294132|NCT01697462|990976|P1|Overall Study|Investigator Decision|21
294133|NCT01697462|990976|P1|Overall Study|Withdrawal by Subject|12
294134|NCT01697462|990976|P1|Overall Study|Lost to Follow-up|21
294135|NCT01697462|990976|P1|Overall Study|Adverse Event|6
294136|NCT01697462|990976|P1|Overall Study|Disease Progression|1
294137|NCT01697449|990983|P1|Overall Study|Missing|25
294138|NCT01697449|990983|P1|Overall Study|Other|1
294139|NCT01697449|990983|P1|Overall Study|Death|2
294140|NCT01697449|990983|P1|Overall Study|Physician Decision|1
294141|NCT01697449|990983|P1|Overall Study|Withdrawal by Subject|2
294142|NCT01697449|990983|P1|Overall Study|Lost to Follow-up|5
294143|NCT01697449|990983|P1|Overall Study|Adverse Event|7
294144|NCT01697449|990983|P1|Overall Study|Disease progression|47
294145|NCT01697358|990994|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
294146|NCT01697358|990995|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
294147|NCT01697358|990994|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
294148|NCT01697358|990995|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
294149|NCT01697358|990994|P2|Period II: 6-24M Long-term Follow-up|Death|1
294150|NCT01697358|990995|P1|Period II: 6-24M Long-term Follow-up|Death|1
294151|NCT01697358|990994|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
294152|NCT01697358|990995|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
294153|NCT01697358|990994|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
294154|NCT01697358|990995|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
294155|NCT01697358|990994|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
294156|NCT01697358|990995|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
294157|NCT01697358|990994|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
294158|NCT01697358|990995|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
294159|NCT01697358|990994|P2|Period I: Randomization to 6 Months|Adverse Event|1
294160|NCT01697358|990995|P1|Period I: Randomization to 6 Months|Adverse Event|1
294161|NCT01697358|990994|P2|Period I: Randomization to 6 Months|Physician Decision|0
294162|NCT01697358|990995|P1|Period I: Randomization to 6 Months|Physician Decision|4
294163|NCT01697358|990994|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
294164|NCT01697358|990995|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
294165|NCT01697345|991011|P1|Overall Study|Withdrawal by Subject|1
294166|NCT01697319|991036|P1|Extension Phase|Terminated by Sponsor|15
294167|NCT01697319|991036|P1|Primary Phase|Withdrawal by Subject|1
294168|NCT01696994|991045|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
294169|NCT01696994|991046|P1|Overall Study|Refused Screen (Ovarian Screening)|0
294170|NCT01696994|991045|P2|Overall Study|Refused ASU (Control)|0
294171|NCT01696994|991046|P1|Overall Study|Refused ASU (Control)|311
294172|NCT01696994|991045|P2|Overall Study|No Ovaries at Baseline|4851
294173|NCT01696994|991046|P1|Overall Study|No Ovaries at Baseline|4807
294174|NCT01696994|991045|P2|Overall Study|Died Before ASU (Control)|0
294175|NCT01696994|991046|P1|Overall Study|Died Before ASU (Control)|73
294176|NCT01696994|991045|P2|Overall Study|Died Before Randomization|2
294177|NCT01696994|991046|P1|Overall Study|Died Before Randomization|1
294178|NCT01696994|991045|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
294179|NCT01696994|991046|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
294180|NCT01696981|991074|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
294181|NCT01696981|991075|P1|Overall Study|Refused Screen (Colorectal Screening)|0
294182|NCT01696981|991074|P2|Overall Study|Refused ASU (Control)|0
294183|NCT01696981|991075|P1|Overall Study|Refused ASU (Control)|920
294184|NCT01696981|991074|P2|Overall Study|Died Before ASU (Control)|0
294185|NCT01696981|991075|P1|Overall Study|Died Before ASU (Control)|278
294186|NCT01696981|991074|P2|Overall Study|Died Before Randomization|8
294187|NCT01696981|991075|P1|Overall Study|Died Before Randomization|3
294188|NCT01696981|991074|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
294189|NCT01696981|991075|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
294190|NCT01696968|991095|P2|Overall Study|Refused Screen (Lung Screening)|6796
294191|NCT01696968|991096|P1|Overall Study|Refused Screen (Lung Screening)|0
294192|NCT01696968|991095|P2|Overall Study|Refused ASU (Control)|0
294193|NCT01696968|991096|P1|Overall Study|Refused ASU (Control)|920
294194|NCT01696968|991095|P2|Overall Study|Died Before ASU (Control)|0
294195|NCT01696968|991096|P1|Overall Study|Died Before ASU (Control)|278
294196|NCT01696968|991095|P2|Overall Study|Died Before Randomization|8
294197|NCT01696968|991096|P1|Overall Study|Died Before Randomization|3
294198|NCT01696968|991095|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
294199|NCT01696968|991096|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
294200|NCT01696942|991118|P2|Overall Study|screen failure|1
294201|NCT01696942|991119|P1|Overall Study|screen failure|0
294202|NCT01696942|991118|P2|Overall Study|Protocol Violation|2
294203|NCT01696942|991119|P1|Overall Study|Protocol Violation|1
294204|NCT01696942|991118|P2|Overall Study|Withdrawal by Subject|0
294205|NCT01696942|991119|P1|Overall Study|Withdrawal by Subject|1
294206|NCT01696929|991127|P1|Overall Study|Physician Decision|1
294207|NCT01696773|991134|P2|Days 15-27, Washout|Adverse Event|0
294208|NCT01696773|991135|P1|Days 15-27, Washout|Adverse Event|1
294209|NCT01696695|991162|P1|Overall Study|Major Protocol Violation|192
294210|NCT01696695|991162|P1|Overall Study|Other|74
294211|NCT01696695|991162|P1|Overall Study|Lost to Follow-up|48
294212|NCT01696695|991162|P1|Overall Study|Withdrawal by Subject|92
294213|NCT01696695|991162|P1|Overall Study|Adverse Event|74
294214|NCT01696695|991162|P1|Overall Study|Death|29
294215|NCT01696695|991162|P1|Overall Study|Disease progression|373
294216|NCT01696643|991174|P2|Overall Study|Participant Did Not Receive Study Drug|2
294217|NCT01696643|991175|P1|Overall Study|Participant Did Not Receive Study Drug|2
294218|NCT01696643|991174|P2|Overall Study|Medical Monitor Decision|2
294219|NCT01696643|991175|P1|Overall Study|Medical Monitor Decision|0
294220|NCT01696643|991174|P2|Overall Study|Participant Incarcerated|1
294221|NCT01696643|991175|P1|Overall Study|Participant Incarcerated|0
294222|NCT01696643|991174|P2|Overall Study|Site Error|1
294223|NCT01696643|991175|P1|Overall Study|Site Error|2
294224|NCT01696643|991174|P2|Overall Study|Participant on Restricted Bed Rest|0
294225|NCT01696643|991175|P1|Overall Study|Participant on Restricted Bed Rest|1
294226|NCT01696643|991174|P2|Overall Study|Withdrawal by Subject|149
294227|NCT01696643|991175|P1|Overall Study|Withdrawal by Subject|142
294228|NCT01696643|991174|P2|Overall Study|Study Terminated by Sponsor|294
294229|NCT01696643|991175|P1|Overall Study|Study Terminated by Sponsor|286
294230|NCT01696643|991174|P2|Overall Study|Protocol Violation|7
294231|NCT01696643|991175|P1|Overall Study|Protocol Violation|7
294232|NCT01696643|991174|P2|Overall Study|Pregnancy|1
294233|NCT01696643|991175|P1|Overall Study|Pregnancy|0
294234|NCT01696643|991174|P2|Overall Study|Physician Decision|2
294235|NCT01696643|991175|P1|Overall Study|Physician Decision|3
294236|NCT01696643|991174|P2|Overall Study|Lost to Follow-up|67
294237|NCT01696643|991175|P1|Overall Study|Lost to Follow-up|67
294238|NCT01696643|991174|P2|Overall Study|Lack of Efficacy|0
294239|NCT01696643|991175|P1|Overall Study|Lack of Efficacy|3
294240|NCT01696643|991174|P2|Overall Study|Death|2
294241|NCT01696643|991175|P1|Overall Study|Death|1
294242|NCT01696643|991174|P2|Overall Study|Adverse Event|7
294243|NCT01696643|991175|P1|Overall Study|Adverse Event|15
294244|NCT01696214|991203|P4|Overall Study|Lost to Follow-up|0
294245|NCT01696214|991204|P3|Overall Study|Lost to Follow-up|0
294246|NCT01696214|991205|P2|Overall Study|Lost to Follow-up|1
294247|NCT01696214|991206|P1|Overall Study|Lost to Follow-up|0
294248|NCT01696188|991218|P2|Overall Study|Protocol Violation|1
294249|NCT01696188|991219|P1|Overall Study|Protocol Violation|1
294250|NCT01696071|991250|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
294251|NCT01696071|991251|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
294252|NCT01696058|991279|P2|Overall Study|Other reason prematurely discontinued|3
294253|NCT01696058|991280|P1|Overall Study|Other reason prematurely discontinued|5
294254|NCT01696058|991279|P2|Overall Study|Withdrawal by Subject|6
294255|NCT01696058|991280|P1|Overall Study|Withdrawal by Subject|4
294256|NCT01696058|991279|P2|Overall Study|Lost to Follow-up|5
294257|NCT01696058|991280|P1|Overall Study|Lost to Follow-up|2
294258|NCT01696058|991279|P2|Overall Study|Protocol Violation|3
294259|NCT01696058|991280|P1|Overall Study|Protocol Violation|9
294260|NCT01696058|991279|P2|Overall Study|Lack of Efficacy|3
294261|NCT01696058|991280|P1|Overall Study|Lack of Efficacy|2
294262|NCT01696058|991279|P2|Overall Study|Adverse Event|11
294263|NCT01696058|991280|P1|Overall Study|Adverse Event|21
294264|NCT01696045|991308|P2|Overall Study|Disease progression|2
294265|NCT01696045|991309|P1|Overall Study|Disease progression|2
294266|NCT01696045|991308|P2|Overall Study|Study drug toxicity|5
294267|NCT01696045|991309|P1|Overall Study|Study drug toxicity|1
294268|NCT01695993|991328|P3|Overall Study|Changed Medical Facility|1
294269|NCT01695993|991329|P2|Overall Study|Changed Medical Facility|0
294270|NCT01695993|991330|P1|Overall Study|Changed Medical Facility|0
294271|NCT01695993|991328|P3|Overall Study|To ill to continue|0
294272|NCT01695993|991329|P2|Overall Study|To ill to continue|2
294273|NCT01695993|991330|P1|Overall Study|To ill to continue|1
294274|NCT01695993|991328|P3|Overall Study|Withdrawal by Subject|2
294275|NCT01695993|991329|P2|Overall Study|Withdrawal by Subject|2
294276|NCT01695993|991330|P1|Overall Study|Withdrawal by Subject|2
294277|NCT01695993|991328|P3|Overall Study|Lost to Follow-up|3
294278|NCT01695993|991329|P2|Overall Study|Lost to Follow-up|1
294279|NCT01695993|991330|P1|Overall Study|Lost to Follow-up|2
294280|NCT01695772|991338|P1|Overall Study|Unspecified Reason|1
294281|NCT01695772|991338|P1|Overall Study|Protocol Violation|2
294282|NCT01695772|991338|P1|Overall Study|Lost to Follow-up|4
294283|NCT01695772|991338|P1|Overall Study|Investigator Decision|5
294284|NCT01695772|991338|P1|Overall Study|Progressive Disease|8
294285|NCT01695772|991338|P1|Overall Study|Withdrawal by Subject|18
294286|NCT01695746|991350|P1|Overall Study|Participant not willing to participate|3
294287|NCT01695746|991350|P1|Overall Study|Protocol Violation|5
294288|NCT01695746|991350|P1|Overall Study|Non-compliance by the participant|3
294289|NCT01695746|991350|P1|Overall Study|Adverse Event|1
294290|NCT01695239|991399|P4|Overall Study|Protocol Violation|0
294291|NCT01695239|991400|P3|Overall Study|Protocol Violation|0
294292|NCT01695239|991401|P2|Overall Study|Protocol Violation|0
294293|NCT01695239|991402|P1|Overall Study|Protocol Violation|1
294294|NCT01695239|991399|P4|Overall Study|Lost to Follow-up|0
294295|NCT01695239|991400|P3|Overall Study|Lost to Follow-up|0
294296|NCT01695239|991401|P2|Overall Study|Lost to Follow-up|0
294297|NCT01695239|991402|P1|Overall Study|Lost to Follow-up|1
294298|NCT01695239|991399|P4|Overall Study|Sponsor Decision|0
294299|NCT01695239|991400|P3|Overall Study|Sponsor Decision|1
294300|NCT01695239|991401|P2|Overall Study|Sponsor Decision|0
294301|NCT01695239|991402|P1|Overall Study|Sponsor Decision|3
294302|NCT01695239|991399|P4|Overall Study|Withdrawal by Subject|0
294303|NCT01695239|991400|P3|Overall Study|Withdrawal by Subject|1
294304|NCT01695239|991401|P2|Overall Study|Withdrawal by Subject|1
294305|NCT01695239|991402|P1|Overall Study|Withdrawal by Subject|3
294306|NCT01695239|991399|P4|Overall Study|Lack of Efficacy|0
294307|NCT01695239|991400|P3|Overall Study|Lack of Efficacy|2
294308|NCT01695239|991401|P2|Overall Study|Lack of Efficacy|0
294309|NCT01695239|991402|P1|Overall Study|Lack of Efficacy|4
294310|NCT01695239|991399|P4|Overall Study|Adverse Event|3
294311|NCT01695239|991400|P3|Overall Study|Adverse Event|2
294312|NCT01695239|991401|P2|Overall Study|Adverse Event|2
294313|NCT01695239|991402|P1|Overall Study|Adverse Event|2
294314|NCT01695239|991399|P4|Overall Study|Entry Criteria Not Met|3
294315|NCT01695239|991400|P3|Overall Study|Entry Criteria Not Met|3
294316|NCT01695239|991401|P2|Overall Study|Entry Criteria Not Met|1
294317|NCT01695239|991402|P1|Overall Study|Entry Criteria Not Met|1
294318|NCT01695239|991399|P4|Overall Study|On Study Treatment|0
294319|NCT01695239|991400|P3|Overall Study|On Study Treatment|1
294320|NCT01695239|991401|P2|Overall Study|On Study Treatment|0
294321|NCT01695239|991402|P1|Overall Study|On Study Treatment|0
294322|NCT01694771|991518|P2|Overall Study|Other reasons|6
294323|NCT01694771|991519|P1|Overall Study|Other reasons|5
294324|NCT01694771|991518|P2|Overall Study|Consent withdrawn|9
294325|NCT01694771|991519|P1|Overall Study|Consent withdrawn|7
294326|NCT01694771|991518|P2|Overall Study|Lost to Follow-up|3
294327|NCT01694771|991519|P1|Overall Study|Lost to Follow-up|2
294328|NCT01694771|991518|P2|Overall Study|Non compliance protocol|6
294329|NCT01694771|991519|P1|Overall Study|Non compliance protocol|7
294330|NCT01694771|991518|P2|Overall Study|Lack of Efficacy|0
294331|NCT01694771|991519|P1|Overall Study|Lack of Efficacy|1
294332|NCT01694771|991518|P2|Overall Study|Adverse Event|16
294333|NCT01694771|991519|P1|Overall Study|Adverse Event|18
294334|NCT01694706|991543|P3|Overall Study|other reason not defined above|0
294335|NCT01694706|991544|P2|Overall Study|other reason not defined above|0
294336|NCT01694706|991545|P1|Overall Study|other reason not defined above|1
294337|NCT01694706|991543|P3|Overall Study|Adverse Event|0
294338|NCT01694706|991544|P2|Overall Study|Adverse Event|1
294339|NCT01694706|991545|P1|Overall Study|Adverse Event|0
294340|NCT01694420|991590|P1|Overall Study|Lost to Follow-up|3
294341|NCT01693367|991721|P2|Overall Study|Physician Decision|1
294342|NCT01693367|991722|P1|Overall Study|Physician Decision|0
294343|NCT01693367|991721|P2|Overall Study|Withdrawal by Subject|1
294344|NCT01693367|991722|P1|Overall Study|Withdrawal by Subject|1
294345|NCT01693185|991740|P2|Overall Study|diagnostic procedure after colonoscopy|6
294346|NCT01693185|991741|P1|Overall Study|diagnostic procedure after colonoscopy|0
294347|NCT01693120|991757|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
294348|NCT01693120|991757|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
294349|NCT01693120|991757|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
294350|NCT01693120|991757|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
294351|NCT01693120|991757|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
294352|NCT01693120|991757|P1|Enrollment|Not specified|1
294353|NCT01693120|991757|P1|Enrollment|Study closed|8
294354|NCT01693120|991757|P1|Enrollment|Adverse Event|1
294355|NCT01693120|991757|P1|Enrollment|Physician Decision|3
294356|NCT01693120|991757|P1|Enrollment|Protocol Violation|46
294357|NCT01693120|991757|P1|Enrollment|Withdrawal by Subject|10
294358|NCT01693120|991757|P1|Enrollment|Lost to Follow-up|1
294359|NCT01693068|991766|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
294360|NCT01693068|991767|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
294361|NCT01693068|991768|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
294362|NCT01693068|991766|P3|Randomization Period|On-study|0
294363|NCT01693068|991767|P2|Randomization Period|On-study|5
294364|NCT01693068|991768|P1|Randomization Period|On-study|2
294365|NCT01693029|991800|P2|Overall Study|Non-compliance|1
294366|NCT01693029|991801|P1|Overall Study|Non-compliance|2
294367|NCT01693029|991800|P2|Overall Study|Death|8
294368|NCT01693029|991801|P1|Overall Study|Death|5
294369|NCT01693029|991800|P2|Overall Study|Adverse Event|6
294370|NCT01693029|991801|P1|Overall Study|Adverse Event|1
294371|NCT01693029|991800|P2|Overall Study|Lost to Follow-up|1
294372|NCT01693029|991801|P1|Overall Study|Lost to Follow-up|0
294373|NCT01693029|991800|P2|Overall Study|Physician Decision|2
294374|NCT01693029|991801|P1|Overall Study|Physician Decision|0
294375|NCT01693029|991800|P2|Overall Study|Change in dialysis modality|1
294376|NCT01693029|991801|P1|Overall Study|Change in dialysis modality|2
294377|NCT01693029|991800|P2|Overall Study|Protocol Violation|7
294378|NCT01693029|991801|P1|Overall Study|Protocol Violation|6
294379|NCT01693029|991800|P2|Overall Study|Bindinging anti-EPO antibodies|2
294380|NCT01693029|991801|P1|Overall Study|Bindinging anti-EPO antibodies|6
294381|NCT01693029|991800|P2|Overall Study|Kidney transplantation|7
294382|NCT01693029|991801|P1|Overall Study|Kidney transplantation|7
294383|NCT01693029|991800|P2|Overall Study|Withdrawal by Subject|22
294384|NCT01693029|991801|P1|Overall Study|Withdrawal by Subject|15
294385|NCT01692938|991832|P2|Overall Study|Study completed prior to site completion|3
294386|NCT01692938|991833|P1|Overall Study|Study completed prior to site completion|3
294387|NCT01692938|991832|P2|Overall Study|Protocol Deviation|1
294388|NCT01692938|991833|P1|Overall Study|Protocol Deviation|1
294389|NCT01692782|991844|P3|Overall Study|Withdrawal by Subject|3
294390|NCT01692782|991845|P2|Overall Study|Withdrawal by Subject|10
294391|NCT01692782|991846|P1|Overall Study|Withdrawal by Subject|3
294392|NCT01692782|991844|P3|Overall Study|SAE not related to study drug|0
294393|NCT01692782|991845|P2|Overall Study|SAE not related to study drug|1
294394|NCT01692782|991846|P1|Overall Study|SAE not related to study drug|0
294395|NCT01692782|991844|P3|Overall Study|Non-compliant with study visits|1
294396|NCT01692782|991845|P2|Overall Study|Non-compliant with study visits|0
294397|NCT01692782|991846|P1|Overall Study|Non-compliant with study visits|0
294398|NCT01692782|991844|P3|Overall Study|Non-complance with study drug|1
294399|NCT01692782|991845|P2|Overall Study|Non-complance with study drug|4
294400|NCT01692782|991846|P1|Overall Study|Non-complance with study drug|0
294401|NCT01692782|991844|P3|Overall Study|Protocol Violation|2
294402|NCT01692782|991845|P2|Overall Study|Protocol Violation|0
294403|NCT01692782|991846|P1|Overall Study|Protocol Violation|1
294404|NCT01692782|991844|P3|Overall Study|Pregnancy|0
294405|NCT01692782|991845|P2|Overall Study|Pregnancy|0
294406|NCT01692782|991846|P1|Overall Study|Pregnancy|1
294407|NCT01692782|991844|P3|Overall Study|Lost to Follow-up|1
294408|NCT01692782|991845|P2|Overall Study|Lost to Follow-up|7
294409|NCT01692782|991846|P1|Overall Study|Lost to Follow-up|2
294410|NCT01692782|991844|P3|Overall Study|Lack of Efficacy|0
294411|NCT01692782|991845|P2|Overall Study|Lack of Efficacy|2
294412|NCT01692782|991846|P1|Overall Study|Lack of Efficacy|1
294413|NCT01692782|991844|P3|Overall Study|Adverse Event|2
294414|NCT01692782|991845|P2|Overall Study|Adverse Event|32
294415|NCT01692782|991846|P1|Overall Study|Adverse Event|12
294416|NCT01692730|991871|P2|Overall Study|Lost to Follow-up|227
294417|NCT01692730|991872|P1|Overall Study|Lost to Follow-up|225
294418|NCT01692626|991886|P2|Overall Study|Withdrawal by Subject|0
294419|NCT01692626|991887|P1|Overall Study|Withdrawal by Subject|1
294420|NCT01692626|991886|P2|Overall Study|Protocol Violation|2
294421|NCT01692626|991887|P1|Overall Study|Protocol Violation|1
294422|NCT01692626|991886|P2|Overall Study|Adverse Event|3
294423|NCT01692626|991887|P1|Overall Study|Adverse Event|2
294424|NCT01692626|991886|P2|Overall Study|Death|1
294425|NCT01692626|991887|P1|Overall Study|Death|0
294426|NCT01692301|991914|P2|Overall Study|Lost to Follow-up|1
294427|NCT01692301|991915|P1|Overall Study|Lost to Follow-up|1
294428|NCT01692301|991914|P2|Overall Study|Physician Decision|2
294429|NCT01692301|991915|P1|Overall Study|Physician Decision|2
294430|NCT01692301|991914|P2|Overall Study|Technical problems|1
294431|NCT01692301|991915|P1|Overall Study|Technical problems|0
294432|NCT01692301|991914|P2|Overall Study|Patient/guardian decision|15
294433|NCT01692301|991915|P1|Overall Study|Patient/guardian decision|16
294434|NCT01692301|991914|P2|Overall Study|Protocol deviation|2
294435|NCT01692301|991915|P1|Overall Study|Protocol deviation|9
294436|NCT01692301|991914|P2|Overall Study|Non-compliance with study treatment|2
294437|NCT01692301|991915|P1|Overall Study|Non-compliance with study treatment|1
294438|NCT01692301|991914|P2|Overall Study|Lack of Efficacy|5
294439|NCT01692301|991915|P1|Overall Study|Lack of Efficacy|0
294440|NCT01692301|991914|P2|Overall Study|Death|2
294441|NCT01692301|991915|P1|Overall Study|Death|1
294442|NCT01692301|991914|P2|Overall Study|Adverse Event|12
294443|NCT01692301|991915|P1|Overall Study|Adverse Event|15
294444|NCT01691898|991947|P6|Overall Study|Other|1
294445|NCT01691898|991948|P5|Overall Study|Other|0
294446|NCT01691898|991949|P4|Overall Study|Other|0
294447|NCT01691898|991950|P3|Overall Study|Other|1
294448|NCT01691898|991951|P2|Overall Study|Other|2
294449|NCT01691898|991952|P1|Overall Study|Other|0
294450|NCT01691898|991947|P6|Overall Study|Withdrawal by Subject|3
294451|NCT01691898|991948|P5|Overall Study|Withdrawal by Subject|2
294452|NCT01691898|991949|P4|Overall Study|Withdrawal by Subject|1
294453|NCT01691898|991950|P3|Overall Study|Withdrawal by Subject|1
294454|NCT01691898|991951|P2|Overall Study|Withdrawal by Subject|5
294455|NCT01691898|991952|P1|Overall Study|Withdrawal by Subject|8
294456|NCT01691898|991947|P6|Overall Study|Lost to Follow-up|0
294457|NCT01691898|991948|P5|Overall Study|Lost to Follow-up|0
294458|NCT01691898|991949|P4|Overall Study|Lost to Follow-up|0
294459|NCT01691898|991950|P3|Overall Study|Lost to Follow-up|0
294460|NCT01691898|991951|P2|Overall Study|Lost to Follow-up|0
294461|NCT01691898|991952|P1|Overall Study|Lost to Follow-up|1
294462|NCT01691898|991947|P6|Overall Study|Progression of Disease|2
294463|NCT01691898|991948|P5|Overall Study|Progression of Disease|1
294464|NCT01691898|991949|P4|Overall Study|Progression of Disease|0
294465|NCT01691898|991950|P3|Overall Study|Progression of Disease|1
294466|NCT01691898|991951|P2|Overall Study|Progression of Disease|3
294467|NCT01691898|991952|P1|Overall Study|Progression of Disease|2
294468|NCT01691898|991947|P6|Overall Study|Adverse Event|0
294469|NCT01691898|991948|P5|Overall Study|Adverse Event|0
294470|NCT01691898|991949|P4|Overall Study|Adverse Event|1
294471|NCT01691898|991950|P3|Overall Study|Adverse Event|0
294472|NCT01691898|991951|P2|Overall Study|Adverse Event|1
294473|NCT01691898|991952|P1|Overall Study|Adverse Event|0
294474|NCT01691898|991947|P6|Overall Study|Death|20
294475|NCT01691898|991948|P5|Overall Study|Death|5
294476|NCT01691898|991949|P4|Overall Study|Death|2
294477|NCT01691898|991950|P3|Overall Study|Death|4
294478|NCT01691898|991951|P2|Overall Study|Death|28
294479|NCT01691898|991952|P1|Overall Study|Death|31
294480|NCT01691898|991947|P6|Overall Study|Ongoing in Study|14
294481|NCT01691898|991948|P5|Overall Study|Ongoing in Study|31
294482|NCT01691898|991949|P4|Overall Study|Ongoing in Study|5
294483|NCT01691898|991950|P3|Overall Study|Ongoing in Study|11
294484|NCT01691898|991951|P2|Overall Study|Ongoing in Study|19
294485|NCT01691898|991952|P1|Overall Study|Ongoing in Study|18
294486|NCT01691885|992098|P2|Washout Period (7-9 Days)|Adverse Event|1
294487|NCT01691885|992099|P1|Washout Period (7-9 Days)|Adverse Event|0
294488|NCT01691885|992098|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
294489|NCT01691885|992099|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
294490|NCT01691859|992105|P1|Overall Study|Withdrawal by Subject|31
294491|NCT01691859|992105|P1|Overall Study|Physician Decision|6
294492|NCT01691859|992105|P1|Overall Study|Lost to Follow-up|5
294493|NCT01691859|992105|P1|Overall Study|Study closed/terminated|50
294494|NCT01691859|992105|P1|Overall Study|Product commercially available|221
294495|NCT01691859|992105|P1|Overall Study|Protocol Violation|4
294496|NCT01691859|992105|P1|Overall Study|Lack of Efficacy|11
294497|NCT01691859|992105|P1|Overall Study|Adverse Event|19
294498|NCT01691794|992127|P3|Overall Study|Did not complete first 24 weeks of study|3
294499|NCT01691794|992128|P2|Overall Study|Did not complete first 24 weeks of study|3
294500|NCT01691794|992129|P1|Overall Study|Did not complete first 24 weeks of study|0
294501|NCT01691794|992127|P3|Overall Study|Completed Only first 24 weeks of study|3
294502|NCT01691794|992128|P2|Overall Study|Completed Only first 24 weeks of study|2
294503|NCT01691794|992129|P1|Overall Study|Completed Only first 24 weeks of study|0
294504|NCT01691794|992127|P3|Overall Study|Adverse Event|1
294505|NCT01691794|992128|P2|Overall Study|Adverse Event|1
294506|NCT01691794|992129|P1|Overall Study|Adverse Event|0
294507|NCT01691794|992127|P3|Overall Study|Participant request to discontinue|0
294508|NCT01691794|992128|P2|Overall Study|Participant request to discontinue|1
294509|NCT01691794|992129|P1|Overall Study|Participant request to discontinue|0
294510|NCT01691794|992127|P3|Overall Study|Lack of Efficacy|1
294511|NCT01691794|992128|P2|Overall Study|Lack of Efficacy|7
294512|NCT01691794|992129|P1|Overall Study|Lack of Efficacy|0
294513|NCT01691794|992127|P3|Overall Study|Death|1
294514|NCT01691794|992128|P2|Overall Study|Death|0
294515|NCT01691794|992129|P1|Overall Study|Death|0
294516|NCT01691794|992127|P3|Overall Study|Poor/Non-Compliance|1
294517|NCT01691794|992128|P2|Overall Study|Poor/Non-Compliance|4
294518|NCT01691794|992129|P1|Overall Study|Poor/Non-Compliance|1
294519|NCT01691781|992145|P2|Overall Study|Adverse Event|1
294520|NCT01691781|992146|P1|Overall Study|Adverse Event|0
294521|NCT01691781|992145|P2|Overall Study|Protocol Violation|2
294522|NCT01691781|992146|P1|Overall Study|Protocol Violation|2
294523|NCT01691781|992145|P2|Overall Study|Physician Decision|1
294524|NCT01691781|992146|P1|Overall Study|Physician Decision|1
294525|NCT01691781|992145|P2|Overall Study|Withdrawal by Subject|3
294526|NCT01691781|992146|P1|Overall Study|Withdrawal by Subject|4
294527|NCT01691612|992169|P1|Overall Study|Adverse Event|1
294528|NCT01691612|992169|P1|Overall Study|deemed ineligible after 1st visit|6
294529|NCT01691521|992280|P3|Overall Study|Withdrawal by Subject|4
294530|NCT01691521|992281|P2|Overall Study|Withdrawal by Subject|9
294531|NCT01691521|992282|P1|Overall Study|Withdrawal by Subject|5
294532|NCT01691521|992280|P3|Overall Study|Physician Decision|0
294533|NCT01691521|992281|P2|Overall Study|Physician Decision|1
294534|NCT01691521|992282|P1|Overall Study|Physician Decision|2
294535|NCT01691521|992280|P3|Overall Study|Lost to Follow-up|2
294536|NCT01691521|992281|P2|Overall Study|Lost to Follow-up|2
294537|NCT01691521|992282|P1|Overall Study|Lost to Follow-up|0
294538|NCT01691521|992280|P3|Overall Study|Protocol Violation|0
294539|NCT01691521|992281|P2|Overall Study|Protocol Violation|3
294540|NCT01691521|992282|P1|Overall Study|Protocol Violation|0
294541|NCT01691521|992280|P3|Overall Study|Lack of Efficacy|2
294542|NCT01691521|992281|P2|Overall Study|Lack of Efficacy|1
294543|NCT01691521|992282|P1|Overall Study|Lack of Efficacy|1
294544|NCT01691521|992280|P3|Overall Study|Adverse Event|1
294545|NCT01691521|992281|P2|Overall Study|Adverse Event|0
294546|NCT01691521|992282|P1|Overall Study|Adverse Event|4
294547|NCT01691508|992304|P2|Overall Study|Withdrawal by Subject|0
294548|NCT01691508|992305|P1|Overall Study|Withdrawal by Subject|1
294549|NCT01691508|992304|P2|Overall Study|Adverse Event|3
294550|NCT01691508|992305|P1|Overall Study|Adverse Event|3
294551|NCT01691482|992319|P2|Treatment Period 2|Protocol Violation|1
294552|NCT01691482|992320|P1|Treatment Period 2|Protocol Violation|1
294553|NCT01691482|992319|P2|Treatment Period 2|Adverse Event|1
294554|NCT01691482|992320|P1|Treatment Period 2|Adverse Event|0
294555|NCT01691430|992338|P2|Overall Study|Lost to Follow-up|3
294556|NCT01691430|992339|P1|Overall Study|Lost to Follow-up|0
294557|NCT01691430|992338|P2|Overall Study|Withdrawal by Subject|1
294558|NCT01691430|992339|P1|Overall Study|Withdrawal by Subject|5
294559|NCT01691430|992338|P2|Overall Study|Death|16
294560|NCT01691430|992339|P1|Overall Study|Death|17
294561|NCT01691248|992436|P2|Overall Study|Not Treated|7
294562|NCT01691248|992437|P1|Overall Study|Not Treated|4
294563|NCT01691248|992436|P2|Overall Study|Reason not provided|4
294564|NCT01691248|992437|P1|Overall Study|Reason not provided|4
294565|NCT01691248|992436|P2|Overall Study|Lost to Follow-up|5
294566|NCT01691248|992437|P1|Overall Study|Lost to Follow-up|2
294567|NCT01691248|992436|P2|Overall Study|Confirmed CDAD|31
294568|NCT01691248|992437|P1|Overall Study|Confirmed CDAD|14
294569|NCT01691248|992436|P2|Overall Study|Withdrawal by Subject|18
294570|NCT01691248|992437|P1|Overall Study|Withdrawal by Subject|20
294571|NCT01691248|992436|P2|Overall Study|Adverse Event|22
294572|NCT01691248|992437|P1|Overall Study|Adverse Event|24
294573|NCT01691248|992436|P2|Overall Study|Protocol Violation|27
294574|NCT01691248|992437|P1|Overall Study|Protocol Violation|43
294575|NCT01691092|992447|P1|Overall Study|screen fail|19
294576|NCT01691092|992447|P1|Overall Study|used for different study|2
294577|NCT01691092|992447|P1|Overall Study|non-compliance|3
294578|NCT01691092|992447|P1|Overall Study|Withdrawal by Subject|3
294579|NCT01691092|992447|P1|Overall Study|Physician Decision|4
294580|NCT01691092|992447|P1|Overall Study|Lost to Follow-up|10
294581|NCT01691014|992460|P4|Overall Study|Lack of Efficacy|0
294582|NCT01691014|992461|P3|Overall Study|Lack of Efficacy|7
294583|NCT01691014|992462|P2|Overall Study|Lack of Efficacy|3
294584|NCT01691014|992463|P1|Overall Study|Lack of Efficacy|2
294585|NCT01691014|992460|P4|Overall Study|Adverse Event|1
294586|NCT01691014|992461|P3|Overall Study|Adverse Event|1
294587|NCT01691014|992462|P2|Overall Study|Adverse Event|5
294588|NCT01691014|992463|P1|Overall Study|Adverse Event|0
294589|NCT01691014|992460|P4|Overall Study|Withdrawal by Subject|1
294590|NCT01691014|992461|P3|Overall Study|Withdrawal by Subject|1
294591|NCT01691014|992462|P2|Overall Study|Withdrawal by Subject|1
294592|NCT01691014|992463|P1|Overall Study|Withdrawal by Subject|0
294593|NCT01691014|992460|P4|Overall Study|Other|0
294594|NCT01691014|992461|P3|Overall Study|Other|2
294595|NCT01691014|992462|P2|Overall Study|Other|0
294596|NCT01691014|992463|P1|Overall Study|Other|0
294597|NCT01691014|992460|P4|Overall Study|Premature Termination|3
294598|NCT01691014|992461|P3|Overall Study|Premature Termination|0
294599|NCT01691014|992462|P2|Overall Study|Premature Termination|6
294600|NCT01691014|992463|P1|Overall Study|Premature Termination|1
294601|NCT01690988|992508|P3|Overall Study|Sedated|2
294602|NCT01690988|992509|P2|Overall Study|Sedated|1
294603|NCT01690988|992510|P1|Overall Study|Sedated|1
294604|NCT01690988|992508|P3|Overall Study|Death|1
294605|NCT01690988|992509|P2|Overall Study|Death|1
294606|NCT01690988|992510|P1|Overall Study|Death|1
294607|NCT01690988|992508|P3|Overall Study|Determined ineligible|0
294608|NCT01690988|992509|P2|Overall Study|Determined ineligible|0
294609|NCT01690988|992510|P1|Overall Study|Determined ineligible|1
294610|NCT01690988|992508|P3|Overall Study|Operation Cancelled|0
294611|NCT01690988|992509|P2|Overall Study|Operation Cancelled|1
294612|NCT01690988|992510|P1|Overall Study|Operation Cancelled|1
294613|NCT01690988|992508|P3|Overall Study|Physician Decision|1
294614|NCT01690988|992509|P2|Overall Study|Physician Decision|0
294615|NCT01690988|992510|P1|Overall Study|Physician Decision|0
294616|NCT01690988|992508|P3|Overall Study|Withdrawal by Subject|3
294617|NCT01690988|992509|P2|Overall Study|Withdrawal by Subject|2
294618|NCT01690988|992510|P1|Overall Study|Withdrawal by Subject|2
294619|NCT01690299|992578|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
294620|NCT01690299|992579|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
294621|NCT01690299|992580|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
294622|NCT01690299|992581|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
294623|NCT01690299|992582|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
294624|NCT01690299|992583|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
294625|NCT01690299|992578|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
294626|NCT01690299|992579|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
294627|NCT01690299|992580|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
294628|NCT01690299|992581|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
294629|NCT01690299|992582|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
294630|NCT01690299|992583|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
294631|NCT01690299|992578|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
294632|NCT01690299|992579|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
294633|NCT01690299|992580|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
294634|NCT01690299|992581|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
294635|NCT01690299|992582|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
294636|NCT01690299|992583|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
294637|NCT01690299|992578|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
294638|NCT01690299|992579|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
294639|NCT01690299|992580|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
294640|NCT01690299|992581|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
294641|NCT01690299|992582|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
294642|NCT01690299|992583|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
294643|NCT01690299|992578|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
294644|NCT01690299|992579|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
294645|NCT01690299|992580|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
294646|NCT01690299|992581|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
294647|NCT01690299|992582|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
294648|NCT01690299|992583|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
294649|NCT01690299|992578|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
294650|NCT01690299|992579|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
294651|NCT01690299|992580|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
294652|NCT01690299|992581|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
294653|NCT01690299|992582|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
294654|NCT01690299|992583|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
294655|NCT01690299|992578|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
294656|NCT01690299|992579|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
294657|NCT01690299|992580|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
294658|NCT01690299|992581|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
294659|NCT01690299|992582|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
294660|NCT01690299|992583|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
294661|NCT01690299|992578|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
294662|NCT01690299|992579|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
294663|NCT01690299|992580|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
294664|NCT01690299|992581|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
294665|NCT01690299|992582|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
294666|NCT01690299|992583|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
294667|NCT01690299|992578|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
294668|NCT01690299|992579|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
294669|NCT01690299|992580|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
294670|NCT01690299|992581|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
294671|NCT01690299|992582|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
294672|NCT01690299|992583|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
294673|NCT01690299|992578|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
294674|NCT01690299|992579|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
294675|NCT01690299|992580|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
294676|NCT01690299|992581|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
294677|NCT01690299|992582|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
294678|NCT01690299|992583|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
294679|NCT01690052|992719|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
294680|NCT01690052|992720|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
294681|NCT01689974|992737|P2|Overall Study|Termination of Study|5
294682|NCT01689974|992738|P1|Overall Study|Termination of Study|5
294683|NCT01689857|992767|P2|Overall Study|Lost to Follow-up|2
294684|NCT01689857|992768|P1|Overall Study|Lost to Follow-up|5
294685|NCT01689649|992793|P1|Overall Study|Lost to Follow-up|5
294686|NCT01689649|992793|P1|Overall Study|Protocol Violation|3
294687|NCT01689649|992793|P1|Overall Study|Non-compliance|11
294688|NCT01689649|992793|P1|Overall Study|Lack of Efficacy|3
294689|NCT01689532|992805|P2|Overall Study|Physician Decision|0
294690|NCT01689532|992806|P1|Overall Study|Physician Decision|2
294691|NCT01689532|992805|P2|Overall Study|Withdrawal by Subject|2
294692|NCT01689532|992806|P1|Overall Study|Withdrawal by Subject|1
294693|NCT01689532|992805|P2|Overall Study|Lack of Efficacy|2
294694|NCT01689532|992806|P1|Overall Study|Lack of Efficacy|2
294695|NCT01689532|992805|P2|Overall Study|Adverse Event|5
294696|NCT01689532|992806|P1|Overall Study|Adverse Event|9
294697|NCT01689519|992870|P2|Overall Study|Physician Decision|3
294698|NCT01689519|992871|P1|Overall Study|Physician Decision|0
294699|NCT01689519|992870|P2|Overall Study|Withdrawal by Subject|17
294700|NCT01689519|992871|P1|Overall Study|Withdrawal by Subject|17
294701|NCT01689519|992870|P2|Overall Study|Lost to Follow-up|2
294702|NCT01689519|992871|P1|Overall Study|Lost to Follow-up|6
294703|NCT01689519|992870|P2|Overall Study|Death|116
294704|NCT01689519|992871|P1|Overall Study|Death|143
294705|NCT01689363|992898|P8|Overall Study|Protocol Violation|0
294706|NCT01689363|992899|P7|Overall Study|Protocol Violation|0
294707|NCT01689363|992900|P6|Overall Study|Protocol Violation|0
294708|NCT01689363|992901|P5|Overall Study|Protocol Violation|0
294709|NCT01689363|992902|P4|Overall Study|Protocol Violation|0
294710|NCT01689363|992903|P3|Overall Study|Protocol Violation|0
294711|NCT01689363|992904|P2|Overall Study|Protocol Violation|1
294712|NCT01689363|992905|P1|Overall Study|Protocol Violation|0
294713|NCT01689337|992960|P1|Overall Study|Study Discontinuation|1
294714|NCT01689207|992999|P11|Overall Study|Adverse Event|0
294715|NCT01689207|993000|P10|Overall Study|Adverse Event|0
294716|NCT01689207|993001|P9|Overall Study|Adverse Event|1
294717|NCT01689207|993002|P8|Overall Study|Adverse Event|0
294718|NCT01689207|993003|P7|Overall Study|Adverse Event|0
294719|NCT01689207|993004|P6|Overall Study|Adverse Event|1
294720|NCT01689207|993005|P5|Overall Study|Adverse Event|2
294721|NCT01689207|993006|P4|Overall Study|Adverse Event|0
294722|NCT01689207|993007|P3|Overall Study|Adverse Event|0
294723|NCT01689207|993008|P2|Overall Study|Adverse Event|1
294724|NCT01689207|993009|P1|Overall Study|Adverse Event|0
294725|NCT01688921|993116|P2|Overall Study|informed consent|0
294726|NCT01688921|993117|P1|Overall Study|informed consent|3
294727|NCT01688921|993116|P2|Overall Study|Protocol Violation|1
294728|NCT01688921|993117|P1|Overall Study|Protocol Violation|0
294729|NCT01688921|993116|P2|Overall Study|Physician Decision|1
294730|NCT01688921|993117|P1|Overall Study|Physician Decision|6
294731|NCT01688921|993116|P2|Overall Study|Lost to Follow-up|13
294732|NCT01688921|993117|P1|Overall Study|Lost to Follow-up|7
294733|NCT01688882|993142|P2|Overall Study|Administrative problems|0
294734|NCT01688882|993143|P1|Overall Study|Administrative problems|1
294735|NCT01688882|993142|P2|Overall Study|Unsatisfactory therapeutic effect|1
294736|NCT01688882|993143|P1|Overall Study|Unsatisfactory therapeutic effect|1
294737|NCT01688882|993142|P2|Overall Study|Adverse Event|0
294738|NCT01688882|993143|P1|Overall Study|Adverse Event|1
294739|NCT01688830|993188|P21|Overall Study|Lost to Follow-up|0
294740|NCT01688830|993189|P20|Overall Study|Lost to Follow-up|0
294741|NCT01688830|993190|P19|Overall Study|Lost to Follow-up|0
294742|NCT01688830|993191|P18|Overall Study|Lost to Follow-up|0
294743|NCT01688830|993192|P17|Overall Study|Lost to Follow-up|0
294744|NCT01688830|993193|P16|Overall Study|Lost to Follow-up|0
294745|NCT01688830|993194|P15|Overall Study|Lost to Follow-up|0
294746|NCT01688830|993195|P14|Overall Study|Lost to Follow-up|0
294747|NCT01688830|993196|P13|Overall Study|Lost to Follow-up|0
294748|NCT01688830|993197|P12|Overall Study|Lost to Follow-up|0
294749|NCT01688830|993198|P11|Overall Study|Lost to Follow-up|1
294750|NCT01688830|993199|P10|Overall Study|Lost to Follow-up|0
294751|NCT01688830|993200|P9|Overall Study|Lost to Follow-up|0
294752|NCT01688830|993201|P8|Overall Study|Lost to Follow-up|0
294753|NCT01688830|993202|P7|Overall Study|Lost to Follow-up|0
294754|NCT01688830|993203|P6|Overall Study|Lost to Follow-up|0
294755|NCT01688830|993204|P5|Overall Study|Lost to Follow-up|0
294756|NCT01688830|993205|P4|Overall Study|Lost to Follow-up|0
294757|NCT01688830|993206|P3|Overall Study|Lost to Follow-up|0
294758|NCT01688830|993207|P2|Overall Study|Lost to Follow-up|0
294759|NCT01688830|993208|P1|Overall Study|Lost to Follow-up|0
294764|NCT01688635|993367|P2|Washout 3|Withdrawal by Subject|0
294765|NCT01688635|993368|P1|Washout 3|Withdrawal by Subject|1
294766|NCT01688635|993367|P2|Washout 2|Sponsor Decision|2
294767|NCT01688635|993368|P1|Washout 2|Sponsor Decision|1
294768|NCT01688635|993367|P2|Washout 2|Withdrawal by Subject|0
294769|NCT01688635|993368|P1|Washout 2|Withdrawal by Subject|1
294770|NCT01688635|993367|P2|Washout 2|Physician Decision|0
294771|NCT01688635|993368|P1|Washout 2|Physician Decision|1
294772|NCT01688635|993367|P2|Washout 1|Physician Decision|1
294773|NCT01688635|993368|P1|Washout 1|Physician Decision|0
294774|NCT01688635|993367|P2|Washout 1|Adverse Event|1
294775|NCT01688635|993368|P1|Washout 1|Adverse Event|0
294776|NCT01688635|993367|P2|Washout 1|Withdrawal by Subject|0
294777|NCT01688635|993368|P1|Washout 1|Withdrawal by Subject|1
294778|NCT01688466|993390|P2|Overall Study|Not evaluable|1
294779|NCT01688466|993391|P1|Overall Study|Not evaluable|0
294780|NCT01688466|993390|P2|Overall Study|Adverse Event|4
294781|NCT01688466|993391|P1|Overall Study|Adverse Event|0
294782|NCT01688466|993390|P2|Overall Study|Death|1
294783|NCT01688466|993391|P1|Overall Study|Death|0
294784|NCT01688466|993390|P2|Overall Study|Withdrawal by Subject|1
294785|NCT01688466|993391|P1|Overall Study|Withdrawal by Subject|2
294786|NCT01688050|993461|P1|Overall Study|Still be eligible for follow-up|37
294787|NCT01688050|993461|P1|Overall Study|Withdrawal by Subject|2
294788|NCT01688050|993461|P1|Overall Study|Lost to Follow-up|5
294789|NCT01688050|993461|P1|Overall Study|Conversion to open repair|1
294790|NCT01688050|993461|P1|Overall Study|Death|5
294791|NCT01688037|993470|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
294792|NCT01688037|993471|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
294793|NCT01688037|993472|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
294794|NCT01688037|993470|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
294795|NCT01688037|993471|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
294796|NCT01688037|993472|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
294797|NCT01688037|993470|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
294798|NCT01688037|993471|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
294799|NCT01688037|993472|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
294800|NCT01688037|993470|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
294801|NCT01688037|993471|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
294802|NCT01688037|993472|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
294803|NCT01688037|993470|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
294804|NCT01688037|993471|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
294805|NCT01688037|993472|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
294806|NCT01688037|993470|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
294807|NCT01688037|993471|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
294808|NCT01688037|993472|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
294809|NCT01688037|993470|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
294810|NCT01688037|993471|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
294811|NCT01688037|993472|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
294812|NCT01688037|993470|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
294813|NCT01688037|993471|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
294814|NCT01688037|993472|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
294815|NCT01688037|993470|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
294816|NCT01688037|993471|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
294817|NCT01688037|993472|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
294818|NCT01688037|993470|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
294819|NCT01688037|993471|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
294820|NCT01688037|993472|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
294821|NCT01687998|993488|P2|Overall Study|Lost to Follow-up|7
294822|NCT01687998|993489|P1|Overall Study|Lost to Follow-up|9
294823|NCT01687998|993488|P2|Overall Study|Known to be Alive at Study End|62
294824|NCT01687998|993489|P1|Overall Study|Known to be Alive at Study End|54
294825|NCT01687998|993488|P2|Overall Study|Withdrawal by Subject|51
294826|NCT01687998|993489|P1|Overall Study|Withdrawal by Subject|49
294827|NCT01687712|993525|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
294828|NCT01687712|993526|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
294829|NCT01687712|993525|P2|Cycle 3|Ectopic Pregnancy|0
294830|NCT01687712|993526|P1|Cycle 3|Ectopic Pregnancy|1
294831|NCT01687712|993525|P2|Cycle 3|Early Pregnancy Loss|2
294832|NCT01687712|993526|P1|Cycle 3|Early Pregnancy Loss|1
294833|NCT01687712|993525|P2|Cycle 3|Not Biochemically Pregnant|22
294834|NCT01687712|993526|P1|Cycle 3|Not Biochemically Pregnant|21
294835|NCT01687712|993525|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
294836|NCT01687712|993526|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
294837|NCT01687712|993525|P2|Cycle 2|Still Birth|0
294838|NCT01687712|993526|P1|Cycle 2|Still Birth|1
294839|NCT01687712|993525|P2|Cycle 2|Ectopic Pregnancy|1
294840|NCT01687712|993526|P1|Cycle 2|Ectopic Pregnancy|0
294841|NCT01687712|993525|P2|Cycle 2|Early Pregnancy Loss|16
294842|NCT01687712|993526|P1|Cycle 2|Early Pregnancy Loss|18
294843|NCT01687712|993525|P2|Cycle 2|Not Biochemically Pregnant|77
294844|NCT01687712|993526|P1|Cycle 2|Not Biochemically Pregnant|74
294845|NCT01687712|993525|P2|Cycle 1|Lost to Follow-up|1
294846|NCT01687712|993526|P1|Cycle 1|Lost to Follow-up|1
294847|NCT01687712|993525|P2|Cycle 1|Intrauterine Fetal Death|1
294848|NCT01687712|993526|P1|Cycle 1|Intrauterine Fetal Death|0
294849|NCT01687712|993525|P2|Cycle 1|Abortion|0
294850|NCT01687712|993526|P1|Cycle 1|Abortion|3
294851|NCT01687712|993525|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
294852|NCT01687712|993526|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
294853|NCT01687712|993525|P2|Cycle 1|Heterotropic Pregnancy|0
294854|NCT01687712|993526|P1|Cycle 1|Heterotropic Pregnancy|1
294855|NCT01687712|993525|P2|Cycle 1|Ectopic Pregnancy|5
294856|NCT01687712|993526|P1|Cycle 1|Ectopic Pregnancy|5
294857|NCT01687712|993525|P2|Cycle 1|Early Pregnancy Loss|60
294858|NCT01687712|993526|P1|Cycle 1|Early Pregnancy Loss|43
294859|NCT01687712|993525|P2|Cycle 1|Not Biochemically Pregnant|348
294860|NCT01687712|993526|P1|Cycle 1|Not Biochemically Pregnant|386
294861|NCT01687478|993566|P2|Overall Study|Entry Criteria Not Met|2
294862|NCT01687478|993567|P1|Overall Study|Entry Criteria Not Met|6
294863|NCT01687478|993566|P2|Overall Study|Physician Decision|3
294864|NCT01687478|993567|P1|Overall Study|Physician Decision|1
294865|NCT01687478|993566|P2|Overall Study|Withdrawal by Subject|19
294866|NCT01687478|993567|P1|Overall Study|Withdrawal by Subject|21
294867|NCT01687478|993566|P2|Overall Study|Protocol Violation|2
294868|NCT01687478|993567|P1|Overall Study|Protocol Violation|0
294869|NCT01687478|993566|P2|Overall Study|Lost to Follow-up|3
294870|NCT01687478|993567|P1|Overall Study|Lost to Follow-up|1
294871|NCT01687478|993566|P2|Overall Study|Adverse Event|10
294872|NCT01687478|993567|P1|Overall Study|Adverse Event|3
294873|NCT01687296|993591|P2|Overall Study|Withdrawal by Subject|3
294874|NCT01687296|993592|P1|Overall Study|Withdrawal by Subject|6
294875|NCT01687296|993591|P2|Overall Study|Protocol Violation|1
294876|NCT01687296|993592|P1|Overall Study|Protocol Violation|0
294877|NCT01687296|993591|P2|Overall Study|Lack of Efficacy|1
294878|NCT01687296|993592|P1|Overall Study|Lack of Efficacy|1
294879|NCT01687283|993614|P2|Overall Study|Withdrawal by Subject|8
294880|NCT01687283|993615|P1|Overall Study|Withdrawal by Subject|9
294881|NCT01687283|993614|P2|Overall Study|Investigator discretion|0
294882|NCT01687283|993615|P1|Overall Study|Investigator discretion|2
294883|NCT01687283|993614|P2|Overall Study|Lost to Follow-up|1
294884|NCT01687283|993615|P1|Overall Study|Lost to Follow-up|1
294885|NCT01687283|993614|P2|Overall Study|protocol defined stopping criteria|10
294886|NCT01687283|993615|P1|Overall Study|protocol defined stopping criteria|8
294887|NCT01687283|993614|P2|Overall Study|Protocol Violation|3
294888|NCT01687283|993615|P1|Overall Study|Protocol Violation|1
294889|NCT01687283|993614|P2|Overall Study|Lack of Efficacy|1
294890|NCT01687283|993615|P1|Overall Study|Lack of Efficacy|3
294891|NCT01687283|993614|P2|Overall Study|Adverse Event|4
294892|NCT01687283|993615|P1|Overall Study|Adverse Event|11
294893|NCT01687270|993638|P1|Overall Study|Lost to Follow-up|1
294894|NCT01687270|993638|P1|Overall Study|Lack of Efficacy|11
294895|NCT01687257|993649|P3|Overall Study|Investigator's Discretion|0
294896|NCT01687257|993650|P2|Overall Study|Investigator's Discretion|3
294897|NCT01687257|993651|P1|Overall Study|Investigator's Discretion|0
294898|NCT01687257|993649|P3|Overall Study|Adverse Event|0
294899|NCT01687257|993650|P2|Overall Study|Adverse Event|0
294900|NCT01687257|993651|P1|Overall Study|Adverse Event|1
294901|NCT01687257|993649|P3|Overall Study|Subject Withdrew Consent|1
294902|NCT01687257|993650|P2|Overall Study|Subject Withdrew Consent|1
294903|NCT01687257|993651|P1|Overall Study|Subject Withdrew Consent|1
294904|NCT01687257|993649|P3|Overall Study|Efficacy Failure|5
294905|NCT01687257|993650|P2|Overall Study|Efficacy Failure|0
294906|NCT01687257|993651|P1|Overall Study|Efficacy Failure|6
294907|NCT01687218|993716|P6|Overall Study|Relocated, no follow-up planned|0
294908|NCT01687218|993717|P5|Overall Study|Relocated, no follow-up planned|0
294909|NCT01687218|993718|P4|Overall Study|Relocated, no follow-up planned|1
294910|NCT01687218|993719|P3|Overall Study|Relocated, no follow-up planned|1
294911|NCT01687218|993720|P2|Overall Study|Relocated, no follow-up planned|0
294912|NCT01687218|993721|P1|Overall Study|Relocated, no follow-up planned|1
294913|NCT01687218|993716|P6|Overall Study|Withdrawal by Subject|0
294914|NCT01687218|993717|P5|Overall Study|Withdrawal by Subject|1
294915|NCT01687218|993718|P4|Overall Study|Withdrawal by Subject|1
294916|NCT01687218|993719|P3|Overall Study|Withdrawal by Subject|0
294917|NCT01687218|993720|P2|Overall Study|Withdrawal by Subject|3
294918|NCT01687218|993721|P1|Overall Study|Withdrawal by Subject|2
294919|NCT01687166|993745|P4|Overall Study|Insurance|1
294920|NCT01687166|993746|P3|Overall Study|Insurance|1
294921|NCT01687166|993747|P2|Overall Study|Insurance|0
294922|NCT01687166|993748|P1|Overall Study|Insurance|0
294923|NCT01687166|993745|P4|Overall Study|Physician choice to use different device|0
294924|NCT01687166|993746|P3|Overall Study|Physician choice to use different device|4
294925|NCT01687166|993747|P2|Overall Study|Physician choice to use different device|2
294926|NCT01687166|993748|P1|Overall Study|Physician choice to use different device|1
294927|NCT01687166|993745|P4|Overall Study|Patient unable to be compliant|0
294928|NCT01687166|993746|P3|Overall Study|Patient unable to be compliant|0
294929|NCT01687166|993747|P2|Overall Study|Patient unable to be compliant|0
294930|NCT01687166|993748|P1|Overall Study|Patient unable to be compliant|1
294931|NCT01687166|993745|P4|Overall Study|Subject moved out of state|0
294932|NCT01687166|993746|P3|Overall Study|Subject moved out of state|0
294933|NCT01687166|993747|P2|Overall Study|Subject moved out of state|1
294934|NCT01687166|993748|P1|Overall Study|Subject moved out of state|0
294935|NCT01687166|993745|P4|Overall Study|Protocol Violation|0
294936|NCT01687166|993746|P3|Overall Study|Protocol Violation|1
294937|NCT01687166|993747|P2|Overall Study|Protocol Violation|1
294938|NCT01687166|993748|P1|Overall Study|Protocol Violation|1
294939|NCT01687166|993745|P4|Overall Study|Death|0
294940|NCT01687166|993746|P3|Overall Study|Death|0
294941|NCT01687166|993747|P2|Overall Study|Death|1
294942|NCT01687166|993748|P1|Overall Study|Death|1
294943|NCT01687166|993745|P4|Overall Study|Equipment/Device Availability|0
294944|NCT01687166|993746|P3|Overall Study|Equipment/Device Availability|0
294945|NCT01687166|993747|P2|Overall Study|Equipment/Device Availability|1
294946|NCT01687166|993748|P1|Overall Study|Equipment/Device Availability|0
294947|NCT01687166|993745|P4|Overall Study|Lost to Follow-up|0
294948|NCT01687166|993746|P3|Overall Study|Lost to Follow-up|1
294949|NCT01687166|993747|P2|Overall Study|Lost to Follow-up|5
294950|NCT01687166|993748|P1|Overall Study|Lost to Follow-up|2
294951|NCT01687166|993745|P4|Overall Study|Withdrawal by Subject|0
294952|NCT01687166|993746|P3|Overall Study|Withdrawal by Subject|3
294953|NCT01687166|993747|P2|Overall Study|Withdrawal by Subject|4
294954|NCT01687166|993748|P1|Overall Study|Withdrawal by Subject|11
294955|NCT01687166|993745|P4|Overall Study|Physician Decision|0
294956|NCT01687166|993746|P3|Overall Study|Physician Decision|1
294957|NCT01687166|993747|P2|Overall Study|Physician Decision|2
294958|NCT01687166|993748|P1|Overall Study|Physician Decision|3
294959|NCT01687166|993745|P4|Overall Study|Adverse Event|0
294960|NCT01687166|993746|P3|Overall Study|Adverse Event|0
294961|NCT01687166|993747|P2|Overall Study|Adverse Event|1
294962|NCT01687166|993748|P1|Overall Study|Adverse Event|2
294963|NCT01687166|993745|P4|Overall Study|Did not meet eligibility criteria|1
294964|NCT01687166|993746|P3|Overall Study|Did not meet eligibility criteria|1
294965|NCT01687166|993747|P2|Overall Study|Did not meet eligibility criteria|6
294966|NCT01687166|993748|P1|Overall Study|Did not meet eligibility criteria|4
294967|NCT01687166|993745|P4|Overall Study|Attempt subject|0
294968|NCT01687166|993746|P3|Overall Study|Attempt subject|2
294969|NCT01687166|993747|P2|Overall Study|Attempt subject|3
294970|NCT01687166|993748|P1|Overall Study|Attempt subject|2
294971|NCT01687101|993764|P1|Overall Study|Lost to Follow-up|7
294972|NCT01686932|993791|P2|Period 1|Adverse Event|1
294973|NCT01686932|993792|P1|Period 1|Adverse Event|1
294974|NCT01686828|993822|P4|Overall Study|Weight Loss|0
294975|NCT01686828|993823|P3|Overall Study|Weight Loss|1
294976|NCT01686828|993824|P2|Overall Study|Weight Loss|0
294977|NCT01686828|993825|P1|Overall Study|Weight Loss|0
294978|NCT01686828|993822|P4|Overall Study|New Job|0
294979|NCT01686828|993823|P3|Overall Study|New Job|0
294980|NCT01686828|993824|P2|Overall Study|New Job|1
294981|NCT01686828|993825|P1|Overall Study|New Job|0
294982|NCT01686828|993822|P4|Overall Study|Physician Decision|0
294983|NCT01686828|993823|P3|Overall Study|Physician Decision|0
294984|NCT01686828|993824|P2|Overall Study|Physician Decision|0
294985|NCT01686828|993825|P1|Overall Study|Physician Decision|1
294986|NCT01686633|993899|P3|Overall Study|Lost to Follow-up|1
294987|NCT01686633|993900|P2|Overall Study|Lost to Follow-up|1
294988|NCT01686633|993901|P1|Overall Study|Lost to Follow-up|0
294989|NCT01686633|993899|P3|Overall Study|Protocol-defined Stopping Criteria|1
294990|NCT01686633|993900|P2|Overall Study|Protocol-defined Stopping Criteria|0
294991|NCT01686633|993901|P1|Overall Study|Protocol-defined Stopping Criteria|1
294992|NCT01686633|993899|P3|Overall Study|Protocol Violation|0
294993|NCT01686633|993900|P2|Overall Study|Protocol Violation|3
294994|NCT01686633|993901|P1|Overall Study|Protocol Violation|2
294995|NCT01686633|993899|P3|Overall Study|Adverse Event|3
294996|NCT01686633|993900|P2|Overall Study|Adverse Event|3
294997|NCT01686633|993901|P1|Overall Study|Adverse Event|4
294998|NCT01686633|993899|P3|Overall Study|Physician Decision|4
294999|NCT01686633|993900|P2|Overall Study|Physician Decision|4
295000|NCT01686633|993901|P1|Overall Study|Physician Decision|3
295001|NCT01686633|993899|P3|Overall Study|Withdrawal by Subject|5
295002|NCT01686633|993900|P2|Overall Study|Withdrawal by Subject|8
295003|NCT01686633|993901|P1|Overall Study|Withdrawal by Subject|8
295004|NCT01686633|993899|P3|Overall Study|Lack of Efficacy|11
295005|NCT01686633|993900|P2|Overall Study|Lack of Efficacy|13
295006|NCT01686633|993901|P1|Overall Study|Lack of Efficacy|33
295007|NCT01686568|993926|P2|Sub-Study|Not consented for sub-study|2
295008|NCT01686568|993927|P1|Sub-Study|Not consented for sub-study|2
295009|NCT01686568|993926|P2|Main Study|Liver enzymes above range of exclusion|0
295010|NCT01686568|993927|P1|Main Study|Liver enzymes above range of exclusion|1
295011|NCT01686568|993926|P2|Main Study|Noncompliance with protocol|1
295012|NCT01686568|993927|P1|Main Study|Noncompliance with protocol|0
295013|NCT01686568|993926|P2|Main Study|Withdrawal by Subject|3
295014|NCT01686568|993927|P1|Main Study|Withdrawal by Subject|1
295015|NCT01685983|994012|P1|Overall Study|Other|7
295016|NCT01685983|994012|P1|Overall Study|Noncompliance with Study Drug|1
295017|NCT01685983|994012|P1|Overall Study|Physician Decision|13
295018|NCT01685983|994012|P1|Overall Study|Progressive Disease|32
295019|NCT01685983|994012|P1|Overall Study|Protocol Violation|2
295020|NCT01685983|994012|P1|Overall Study|Withdrawal by Subject|19
295021|NCT01685983|994012|P1|Overall Study|Death|1
295022|NCT01685983|994012|P1|Overall Study|Adverse Event|7
295023|NCT01685840|994024|P2|Overall Study|Had VAD, Dialysis or Transplant|17
295024|NCT01685840|994025|P1|Overall Study|Had VAD, Dialysis or Transplant|11
295025|NCT01685840|994024|P2|Overall Study|Futility|200
295026|NCT01685840|994025|P1|Overall Study|Futility|197
295027|NCT01685840|994024|P2|Overall Study|Withdrawal by Subject|17
295028|NCT01685840|994025|P1|Overall Study|Withdrawal by Subject|14
295029|NCT01685840|994024|P2|Overall Study|Physician Decision|7
295030|NCT01685840|994025|P1|Overall Study|Physician Decision|3
295031|NCT01685840|994024|P2|Overall Study|Lost to Follow-up|25
295032|NCT01685840|994025|P1|Overall Study|Lost to Follow-up|27
295033|NCT01685840|994024|P2|Overall Study|Death|66
295034|NCT01685840|994025|P1|Overall Study|Death|77
295035|NCT01685801|994069|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
295036|NCT01685801|994070|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
295037|NCT01685801|994071|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
295038|NCT01685801|994072|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
295039|NCT01685801|994069|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
295040|NCT01685801|994070|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
295041|NCT01685801|994071|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
295042|NCT01685801|994072|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
295043|NCT01685606|994120|P1|Overall Study|Withdrawal by Subject|1
295044|NCT01685437|994133|P1|Overall Study|Unable to make visits due to work|1
295045|NCT01685437|994133|P1|Overall Study|Protocol Violation|4
295046|NCT01685437|994133|P1|Overall Study|Adverse Event|1
295047|NCT01685437|994133|P1|Overall Study|Lost to Follow-up|3
295048|NCT01685437|994133|P1|Overall Study|Withdrawal by Subject|22
295049|NCT01685372|994147|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
295050|NCT01685372|994148|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
295051|NCT01685216|994236|P1|Overall Study|Did not receive study drug|1
295052|NCT01685203|994253|P7|Overall Study|Patient's decision|0
295053|NCT01685203|994254|P6|Overall Study|Patient's decision|1
295054|NCT01685203|994255|P5|Overall Study|Patient's decision|0
295055|NCT01685203|994256|P4|Overall Study|Patient's decision|0
295056|NCT01685203|994257|P3|Overall Study|Patient's decision|0
295057|NCT01685203|994258|P2|Overall Study|Patient's decision|0
295058|NCT01685203|994259|P1|Overall Study|Patient's decision|0
295059|NCT01685203|994253|P7|Overall Study|Adverse event and withdrew consent|0
295060|NCT01685203|994254|P6|Overall Study|Adverse event and withdrew consent|0
295061|NCT01685203|994255|P5|Overall Study|Adverse event and withdrew consent|0
295062|NCT01685203|994256|P4|Overall Study|Adverse event and withdrew consent|0
295063|NCT01685203|994257|P3|Overall Study|Adverse event and withdrew consent|0
295064|NCT01685203|994258|P2|Overall Study|Adverse event and withdrew consent|0
295065|NCT01685203|994259|P1|Overall Study|Adverse event and withdrew consent|1
295066|NCT01685203|994253|P7|Overall Study|Adverse Event|0
295067|NCT01685203|994254|P6|Overall Study|Adverse Event|2
295068|NCT01685203|994255|P5|Overall Study|Adverse Event|0
295069|NCT01685203|994256|P4|Overall Study|Adverse Event|0
295070|NCT01685203|994257|P3|Overall Study|Adverse Event|0
295071|NCT01685203|994258|P2|Overall Study|Adverse Event|0
295072|NCT01685203|994259|P1|Overall Study|Adverse Event|0
295073|NCT01685203|994253|P7|Overall Study|Lost to Follow-up|0
295074|NCT01685203|994254|P6|Overall Study|Lost to Follow-up|0
295075|NCT01685203|994255|P5|Overall Study|Lost to Follow-up|0
295076|NCT01685203|994256|P4|Overall Study|Lost to Follow-up|1
295077|NCT01685203|994257|P3|Overall Study|Lost to Follow-up|0
295078|NCT01685203|994258|P2|Overall Study|Lost to Follow-up|3
295079|NCT01685203|994259|P1|Overall Study|Lost to Follow-up|3
295080|NCT01685060|994303|P1|Overall Study|Death|8
295081|NCT01685060|994303|P1|Overall Study|Lost to Follow-up|1
295082|NCT01685060|994303|P1|Overall Study|Subject/guardian decision|20
295083|NCT01685060|994303|P1|Overall Study|Physician Decision|14
295084|NCT01685060|994303|P1|Overall Study|Progressive disease|69
295085|NCT01685060|994303|P1|Overall Study|Adverse Event|12
295086|NCT01685060|994303|P1|Overall Study|Rollover patients|16
295087|NCT01684930|994329|P2|Overall Study|Withdrawal by Subject|1
295088|NCT01684930|994330|P1|Overall Study|Withdrawal by Subject|3
295089|NCT01684878|994350|P4|Part 2: Randomized Phase|Participant noncompliance|1
295090|NCT01684878|994351|P3|Part 2: Randomized Phase|Participant noncompliance|0
295091|NCT01684878|994352|P2|Part 2: Randomized Phase|Participant noncompliance|0
295092|NCT01684878|994353|P1|Part 2: Randomized Phase|Participant noncompliance|0
295093|NCT01684878|994350|P4|Part 2: Randomized Phase|Alive at data-cut|7
295094|NCT01684878|994351|P3|Part 2: Randomized Phase|Alive at data-cut|13
295095|NCT01684878|994352|P2|Part 2: Randomized Phase|Alive at data-cut|0
295096|NCT01684878|994353|P1|Part 2: Randomized Phase|Alive at data-cut|0
295097|NCT01684878|994350|P4|Part 2: Randomized Phase|Death|68
295098|NCT01684878|994351|P3|Part 2: Randomized Phase|Death|62
295099|NCT01684878|994352|P2|Part 2: Randomized Phase|Death|0
295100|NCT01684878|994353|P1|Part 2: Randomized Phase|Death|0
295101|NCT01684878|994350|P4|Part 2: Randomized Phase|Lost to Follow-up|0
295102|NCT01684878|994351|P3|Part 2: Randomized Phase|Lost to Follow-up|2
295103|NCT01684878|994352|P2|Part 2: Randomized Phase|Lost to Follow-up|0
295104|NCT01684878|994353|P1|Part 2: Randomized Phase|Lost to Follow-up|0
295105|NCT01684878|994350|P4|Part 2: Randomized Phase|Participant withdrew consent|2
295106|NCT01684878|994351|P3|Part 2: Randomized Phase|Participant withdrew consent|1
295107|NCT01684878|994352|P2|Part 2: Randomized Phase|Participant withdrew consent|0
295108|NCT01684878|994353|P1|Part 2: Randomized Phase|Participant withdrew consent|0
295109|NCT01684878|994350|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
295110|NCT01684878|994351|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
295111|NCT01684878|994352|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
295112|NCT01684878|994353|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
295113|NCT01684878|994350|P4|Part 1: Safety Run in Phase|Death|0
295114|NCT01684878|994351|P3|Part 1: Safety Run in Phase|Death|0
295115|NCT01684878|994352|P2|Part 1: Safety Run in Phase|Death|20
295116|NCT01684878|994353|P1|Part 1: Safety Run in Phase|Death|15
295117|NCT01684878|994350|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
295118|NCT01684878|994351|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
295119|NCT01684878|994352|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
295120|NCT01684878|994353|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
295121|NCT01684423|994457|P5|Overall Study|Withdrawal by Subject|0
295122|NCT01684423|994458|P4|Overall Study|Withdrawal by Subject|0
295123|NCT01684423|994459|P3|Overall Study|Withdrawal by Subject|1
295124|NCT01684423|994460|P2|Overall Study|Withdrawal by Subject|0
295125|NCT01684423|994461|P1|Overall Study|Withdrawal by Subject|0
295126|NCT01684215|994518|P4|Overall Study|Ongoing at date of cut-off|38
295127|NCT01684215|994519|P3|Overall Study|Ongoing at date of cut-off|4
295128|NCT01684215|994520|P2|Overall Study|Ongoing at date of cut-off|0
295129|NCT01684215|994521|P1|Overall Study|Ongoing at date of cut-off|0
295130|NCT01684215|994518|P4|Overall Study|Death|1
295131|NCT01684215|994519|P3|Overall Study|Death|0
295132|NCT01684215|994520|P2|Overall Study|Death|0
295133|NCT01684215|994521|P1|Overall Study|Death|0
295134|NCT01684215|994518|P4|Overall Study|Other|0
295135|NCT01684215|994519|P3|Overall Study|Other|1
295136|NCT01684215|994520|P2|Overall Study|Other|0
295137|NCT01684215|994521|P1|Overall Study|Other|0
295138|NCT01684215|994518|P4|Overall Study|Objective progression or relapse|0
295139|NCT01684215|994519|P3|Overall Study|Objective progression or relapse|0
295140|NCT01684215|994520|P2|Overall Study|Objective progression or relapse|6
295141|NCT01684215|994521|P1|Overall Study|Objective progression or relapse|5
295142|NCT01684215|994518|P4|Overall Study|Adverse Event|4
295143|NCT01684215|994519|P3|Overall Study|Adverse Event|1
295144|NCT01684215|994520|P2|Overall Study|Adverse Event|0
295145|NCT01684215|994521|P1|Overall Study|Adverse Event|1
295146|NCT01684046|994595|P2|Period 1, First 30 Days|Adverse Event|2
295147|NCT01684046|994596|P1|Period 1, First 30 Days|Adverse Event|0
295148|NCT01684033|994602|P2|Period 2, Second 30 Days|Adverse Event|0
295149|NCT01684033|994603|P1|Period 2, Second 30 Days|Adverse Event|1
295150|NCT01684033|994602|P2|Period 1, First 30 Days|Lost to Follow-up|0
295151|NCT01684033|994603|P1|Period 1, First 30 Days|Lost to Follow-up|1
295152|NCT01684033|994602|P2|Period 1, First 30 Days|Withdrawal by Subject|0
295153|NCT01684033|994603|P1|Period 1, First 30 Days|Withdrawal by Subject|1
295154|NCT01684033|994602|P2|Period 1, First 30 Days|Noncompliance|0
295155|NCT01684033|994603|P1|Period 1, First 30 Days|Noncompliance|1
295156|NCT01684033|994602|P2|Period 1, First 30 Days|Adverse Event|1
295157|NCT01684033|994603|P1|Period 1, First 30 Days|Adverse Event|1
295158|NCT01683838|994637|P2|Overall Study|not specified|3
295159|NCT01683838|994638|P1|Overall Study|not specified|4
295160|NCT01683838|994637|P2|Overall Study|Lost to Follow-up|1
295161|NCT01683838|994638|P1|Overall Study|Lost to Follow-up|1
295162|NCT01683838|994637|P2|Overall Study|Withdrawal by Subject|5
295163|NCT01683838|994638|P1|Overall Study|Withdrawal by Subject|6
295164|NCT01683838|994637|P2|Overall Study|Protocol Violation|1
295165|NCT01683838|994638|P1|Overall Study|Protocol Violation|3
295166|NCT01683838|994637|P2|Overall Study|Adverse Event|2
295167|NCT01683838|994638|P1|Overall Study|Adverse Event|12
295168|NCT01683604|994678|P1|Overall Study|Other|2
295169|NCT01683604|994678|P1|Overall Study|Lack of Efficacy|1
295170|NCT01683604|994678|P1|Overall Study|Adverse Event|2
295171|NCT01683409|994863|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
295172|NCT01683409|994864|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
295173|NCT01683409|994865|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
295174|NCT01683409|994866|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
295175|NCT01683409|994867|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
295176|NCT01683409|994863|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
295177|NCT01683409|994864|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
295178|NCT01683409|994865|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
295179|NCT01683409|994866|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
295180|NCT01683409|994867|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
295181|NCT01683409|994863|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
295182|NCT01683409|994864|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
295183|NCT01683409|994865|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
295184|NCT01683409|994866|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
295185|NCT01683409|994867|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
295186|NCT01683409|994863|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
295187|NCT01683409|994864|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
295188|NCT01683409|994865|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
295189|NCT01683409|994866|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
295190|NCT01683409|994867|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
295191|NCT01683409|994863|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
295192|NCT01683409|994864|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
295193|NCT01683409|994865|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
295194|NCT01683409|994866|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
295195|NCT01683409|994867|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
295196|NCT01683409|994863|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
295197|NCT01683409|994864|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
295198|NCT01683409|994865|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
295199|NCT01683409|994866|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
295200|NCT01683409|994867|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
295201|NCT01683409|994863|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
295202|NCT01683409|994864|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
295203|NCT01683409|994865|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
295204|NCT01683409|994866|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
295205|NCT01683409|994867|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
295206|NCT01683409|994863|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
295207|NCT01683409|994864|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
295208|NCT01683409|994865|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
295209|NCT01683409|994866|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
295210|NCT01683409|994867|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
295211|NCT01683409|994863|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
295212|NCT01683409|994864|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
295213|NCT01683409|994865|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
295214|NCT01683409|994866|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
295215|NCT01683409|994867|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
295216|NCT01683409|994863|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
295217|NCT01683409|994864|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
295218|NCT01683409|994865|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
295219|NCT01683409|994866|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
295220|NCT01683409|994867|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
295221|NCT01683409|994863|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
295222|NCT01683409|994864|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
295223|NCT01683409|994865|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
295224|NCT01683409|994866|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
295225|NCT01683409|994867|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
295226|NCT01683383|994910|P2|Overall Study|Infant was not transported|0
295227|NCT01683383|994911|P1|Overall Study|Infant was not transported|1
295228|NCT01683266|994927|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
295229|NCT01683266|994928|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
295230|NCT01683266|994927|P2|Overall Study|Possibly Hypoglycemia|0
295231|NCT01683266|994928|P1|Overall Study|Possibly Hypoglycemia|1
295232|NCT01683266|994927|P2|Overall Study|Perceived Lack of Efficacy|1
295233|NCT01683266|994928|P1|Overall Study|Perceived Lack of Efficacy|1
295234|NCT01683266|994927|P2|Overall Study|Nonserious Hypoglycemia|3
295235|NCT01683266|994928|P1|Overall Study|Nonserious Hypoglycemia|0
295236|NCT01683266|994927|P2|Overall Study|Site Closure / Site Withdrawal|3
295237|NCT01683266|994928|P1|Overall Study|Site Closure / Site Withdrawal|1
295238|NCT01683266|994927|P2|Overall Study|Lost to Follow-up|0
295239|NCT01683266|994928|P1|Overall Study|Lost to Follow-up|5
295240|NCT01683266|994927|P2|Overall Study|Selection Criterion / Protocol Violation|5
295241|NCT01683266|994928|P1|Overall Study|Selection Criterion / Protocol Violation|7
295242|NCT01683266|994927|P2|Overall Study|Personal Reason|25
295243|NCT01683266|994928|P1|Overall Study|Personal Reason|17
295244|NCT01683266|994927|P2|Overall Study|Protocol Violation|6
295245|NCT01683266|994928|P1|Overall Study|Protocol Violation|13
295246|NCT01683266|994927|P2|Overall Study|Lack of Efficacy|2
295247|NCT01683266|994928|P1|Overall Study|Lack of Efficacy|5
295248|NCT01683266|994927|P2|Overall Study|Adverse Event|4
295249|NCT01683266|994928|P1|Overall Study|Adverse Event|5
295250|NCT01683058|994956|P1|Overall Study|Lack of Efficacy|2
295251|NCT01683058|994956|P1|Overall Study|Withdrawal by Subject|7
295252|NCT01683058|994956|P1|Overall Study|Subject Met Withdrawal Criteria|5
295253|NCT01683058|994956|P1|Overall Study|Adverse Event|6
295254|NCT01683058|994956|P1|Overall Study|Lost to Follow-up|9
295255|NCT01683019|994987|P3|Overall Study|Withdrawal by Subject|4
295256|NCT01683019|994988|P2|Overall Study|Withdrawal by Subject|1
295257|NCT01683019|994989|P1|Overall Study|Withdrawal by Subject|2
295258|NCT01682876|995012|P4|Overall Study|Other|1
295259|NCT01682876|995013|P3|Overall Study|Other|1
295260|NCT01682876|995014|P2|Overall Study|Other|0
295261|NCT01682876|995015|P1|Overall Study|Other|1
295262|NCT01682876|995012|P4|Overall Study|Withdrawal by Subject|2
295263|NCT01682876|995013|P3|Overall Study|Withdrawal by Subject|0
295264|NCT01682876|995014|P2|Overall Study|Withdrawal by Subject|0
295265|NCT01682876|995015|P1|Overall Study|Withdrawal by Subject|4
295266|NCT01682876|995012|P4|Overall Study|Protocol Violation|1
295267|NCT01682876|995013|P3|Overall Study|Protocol Violation|1
295268|NCT01682876|995014|P2|Overall Study|Protocol Violation|1
295269|NCT01682876|995015|P1|Overall Study|Protocol Violation|1
295270|NCT01682876|995012|P4|Overall Study|Lost to Follow-up|11
295271|NCT01682876|995013|P3|Overall Study|Lost to Follow-up|9
295272|NCT01682876|995014|P2|Overall Study|Lost to Follow-up|15
295273|NCT01682876|995015|P1|Overall Study|Lost to Follow-up|11
295274|NCT01682876|995012|P4|Overall Study|Adverse Event|1
295275|NCT01682876|995013|P3|Overall Study|Adverse Event|0
295276|NCT01682876|995014|P2|Overall Study|Adverse Event|0
295277|NCT01682876|995015|P1|Overall Study|Adverse Event|0
295278|NCT01682876|995012|P4|Overall Study|Administrative reason|3
295279|NCT01682876|995013|P3|Overall Study|Administrative reason|0
295280|NCT01682876|995014|P2|Overall Study|Administrative reason|4
295281|NCT01682876|995015|P1|Overall Study|Administrative reason|4
295282|NCT01682863|995061|P3|Overall Study|Physician Decision|1
295283|NCT01682863|995062|P2|Overall Study|Physician Decision|0
295284|NCT01682863|995063|P1|Overall Study|Physician Decision|0
295285|NCT01682863|995061|P3|Overall Study|Adverse Event|2
295286|NCT01682863|995062|P2|Overall Study|Adverse Event|1
295287|NCT01682863|995063|P1|Overall Study|Adverse Event|0
295288|NCT01682863|995061|P3|Overall Study|Technical problems|0
295289|NCT01682863|995062|P2|Overall Study|Technical problems|0
295290|NCT01682863|995063|P1|Overall Study|Technical problems|1
295291|NCT01682863|995061|P3|Overall Study|Protocol deviation|1
295292|NCT01682863|995062|P2|Overall Study|Protocol deviation|0
295293|NCT01682863|995063|P1|Overall Study|Protocol deviation|1
295294|NCT01682863|995061|P3|Overall Study|Death|4
295295|NCT01682863|995062|P2|Overall Study|Death|3
295296|NCT01682863|995063|P1|Overall Study|Death|1
295297|NCT01682863|995061|P3|Overall Study|Lost to Follow-up|6
295298|NCT01682863|995062|P2|Overall Study|Lost to Follow-up|1
295299|NCT01682863|995063|P1|Overall Study|Lost to Follow-up|5
295300|NCT01682863|995061|P3|Overall Study|Subject/guardian decision|10
295301|NCT01682863|995062|P2|Overall Study|Subject/guardian decision|12
295302|NCT01682863|995063|P1|Overall Study|Subject/guardian decision|19
295303|NCT01682837|995092|P1|Baseline|Withdrawal by Subject|5
295304|NCT01682759|995136|P2|Overall Study|Withdrawal by Subject|55
295305|NCT01682759|995137|P1|Overall Study|Withdrawal by Subject|56
295306|NCT01682759|995136|P2|Overall Study|Physician Decision|1
295307|NCT01682759|995137|P1|Overall Study|Physician Decision|1
295308|NCT01682759|995136|P2|Overall Study|Lost to Follow-up|13
295309|NCT01682759|995137|P1|Overall Study|Lost to Follow-up|10
295310|NCT01682759|995136|P2|Overall Study|Death|1
295311|NCT01682759|995137|P1|Overall Study|Death|2
295312|NCT01682720|995161|P4|Overall Study|Adverse Event|1
295313|NCT01682720|995162|P3|Overall Study|Adverse Event|1
295314|NCT01682720|995163|P2|Overall Study|Adverse Event|0
295315|NCT01682720|995164|P1|Overall Study|Adverse Event|1
295316|NCT01682720|995161|P4|Overall Study|Subject Withdrew Consent|2
295317|NCT01682720|995162|P3|Overall Study|Subject Withdrew Consent|2
295318|NCT01682720|995163|P2|Overall Study|Subject Withdrew Consent|0
295319|NCT01682720|995164|P1|Overall Study|Subject Withdrew Consent|0
295320|NCT01682720|995161|P4|Overall Study|Lost to Follow-up|6
295321|NCT01682720|995162|P3|Overall Study|Lost to Follow-up|0
295322|NCT01682720|995163|P2|Overall Study|Lost to Follow-up|1
295323|NCT01682720|995164|P1|Overall Study|Lost to Follow-up|1
295324|NCT01682720|995161|P4|Overall Study|Efficacy Failure|30
295325|NCT01682720|995162|P3|Overall Study|Efficacy Failure|3
295326|NCT01682720|995163|P2|Overall Study|Efficacy Failure|3
295327|NCT01682720|995164|P1|Overall Study|Efficacy Failure|0
295328|NCT01682720|995161|P4|Overall Study|Terminated by Sponsor|0
295329|NCT01682720|995162|P3|Overall Study|Terminated by Sponsor|0
295330|NCT01682720|995163|P2|Overall Study|Terminated by Sponsor|0
295331|NCT01682720|995164|P1|Overall Study|Terminated by Sponsor|83
295332|NCT01682720|995161|P4|Overall Study|Randomized but Not Treated|0
295333|NCT01682720|995162|P3|Overall Study|Randomized but Not Treated|1
295334|NCT01682720|995163|P2|Overall Study|Randomized but Not Treated|1
295335|NCT01682720|995164|P1|Overall Study|Randomized but Not Treated|0
295336|NCT01682681|995181|P1|Overall Study|Low compliance|13
295337|NCT01682681|995181|P1|Overall Study|Other|21
295338|NCT01682681|995181|P1|Overall Study|tapering of topiramate|5
295339|NCT01682681|995181|P1|Overall Study|Adverse Event|46
295340|NCT01682681|995181|P1|Overall Study|Lost to Follow-up|174
295341|NCT01682681|995181|P1|Overall Study|Moved to other hospital|10
295342|NCT01682681|995181|P1|Overall Study|Withdrawal by Subject|1
295343|NCT01682681|995181|P1|Overall Study|Lack of Efficacy|62
295344|NCT01682603|995210|P1|Overall Study|Lost to Follow-up|3
295345|NCT01682512|995255|P3|Overall Study|Other than stated above|2
295346|NCT01682512|995256|P2|Overall Study|Other than stated above|4
295347|NCT01682512|995257|P1|Overall Study|Other than stated above|2
295348|NCT01682512|995255|P3|Overall Study|Secondary lack of efficacy|0
295349|NCT01682512|995256|P2|Overall Study|Secondary lack of efficacy|1
295350|NCT01682512|995257|P1|Overall Study|Secondary lack of efficacy|1
295351|NCT01682512|995255|P3|Overall Study|Primary lack of efficacy|7
295352|NCT01682512|995256|P2|Overall Study|Primary lack of efficacy|7
295353|NCT01682512|995257|P1|Overall Study|Primary lack of efficacy|10
295354|NCT01682512|995255|P3|Overall Study|Protocol Violation|2
295355|NCT01682512|995256|P2|Overall Study|Protocol Violation|3
295356|NCT01682512|995257|P1|Overall Study|Protocol Violation|2
295357|NCT01682512|995255|P3|Overall Study|Lost to Follow-up|2
295358|NCT01682512|995256|P2|Overall Study|Lost to Follow-up|0
295359|NCT01682512|995257|P1|Overall Study|Lost to Follow-up|3
295360|NCT01682512|995255|P3|Overall Study|Study terminated by sponsor|0
295361|NCT01682512|995256|P2|Overall Study|Study terminated by sponsor|43
295362|NCT01682512|995257|P1|Overall Study|Study terminated by sponsor|46
295363|NCT01682512|995255|P3|Overall Study|Physician Decision|0
295364|NCT01682512|995256|P2|Overall Study|Physician Decision|2
295365|NCT01682512|995257|P1|Overall Study|Physician Decision|0
295366|NCT01682512|995255|P3|Overall Study|Withdrawal by Subject|3
295367|NCT01682512|995256|P2|Overall Study|Withdrawal by Subject|6
295368|NCT01682512|995257|P1|Overall Study|Withdrawal by Subject|2
295369|NCT01682512|995255|P3|Overall Study|Adverse Event|2
295370|NCT01682512|995256|P2|Overall Study|Adverse Event|5
295371|NCT01682512|995257|P1|Overall Study|Adverse Event|6
295372|NCT01682460|995282|P1|Overall Study|Did not meet inclusion criteria|2
295373|NCT01682460|995282|P1|Overall Study|Withdrawal by Subject|2
295374|NCT01682044|995334|P1|Overall Study|Progression|3
295375|NCT01682044|995334|P1|Overall Study|Death|1
295376|NCT01682031|995346|P2|Overall Study|Patient stopped selenium on his own|1
295377|NCT01682031|995347|P1|Overall Study|Patient stopped selenium on his own|0
295378|NCT01682031|995346|P2|Overall Study|Patient could not swallow tablets|0
295379|NCT01682031|995347|P1|Overall Study|Patient could not swallow tablets|1
295380|NCT01682031|995346|P2|Overall Study|MRI results indicate increased nodul|1
295381|NCT01682031|995347|P1|Overall Study|MRI results indicate increased nodul|0
295382|NCT01682031|995346|P2|Overall Study|Adverse Event|2
295383|NCT01682031|995347|P1|Overall Study|Adverse Event|0
295384|NCT01682031|995346|P2|Overall Study|Withdrawal by Subject|1
295385|NCT01682031|995347|P1|Overall Study|Withdrawal by Subject|0
295386|NCT01681849|995370|P3|Overall Study|Lost to Follow-up|6
295387|NCT01681849|995371|P2|Overall Study|Lost to Follow-up|2
295388|NCT01681849|995372|P1|Overall Study|Lost to Follow-up|3
295389|NCT01681849|995370|P3|Overall Study|Withdrawal by Subject|33
295390|NCT01681849|995371|P2|Overall Study|Withdrawal by Subject|5
295391|NCT01681849|995372|P1|Overall Study|Withdrawal by Subject|3
295392|NCT01681849|995370|P3|Overall Study|Protocol Violation|0
295393|NCT01681849|995371|P2|Overall Study|Protocol Violation|0
295394|NCT01681849|995372|P1|Overall Study|Protocol Violation|2
295395|NCT01681628|995383|P2|19 Months Follow-up|Lost to Follow-up|43
295396|NCT01681628|995384|P1|19 Months Follow-up|Lost to Follow-up|61
295397|NCT01681628|995383|P2|19 Months Follow-up|Death|0
295398|NCT01681628|995384|P1|19 Months Follow-up|Death|1
295399|NCT01681628|995383|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
295400|NCT01681628|995384|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
295401|NCT01681628|995383|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
295402|NCT01681628|995384|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
295403|NCT01681576|995397|P2|Period 2|Non-compliance with study treatment|0
295404|NCT01681576|995398|P1|Period 2|Non-compliance with study treatment|1
295405|NCT01681576|995397|P2|Period 2|subject/guardian decision|1
295406|NCT01681576|995398|P1|Period 2|subject/guardian decision|3
295407|NCT01681576|995397|P2|Period 1|Protocol Deviation|0
295408|NCT01681576|995398|P1|Period 1|Protocol Deviation|1
295409|NCT01681576|995397|P2|Period 1|Adverse Event|0
295410|NCT01681576|995398|P1|Period 1|Adverse Event|1
295411|NCT01681511|995414|P2|Overall Study|No post-catheter sample collected|4
295412|NCT01681511|995415|P1|Overall Study|No post-catheter sample collected|11
295413|NCT01681511|995414|P2|Overall Study|No Daily Urine Sample Collected|1
295414|NCT01681511|995415|P1|Overall Study|No Daily Urine Sample Collected|0
295415|NCT01681511|995414|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
295416|NCT01681511|995415|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
295417|NCT01681511|995414|P2|Overall Study|Failed Inclusion/Exclusion|0
295418|NCT01681511|995415|P1|Overall Study|Failed Inclusion/Exclusion|3
295419|NCT01681511|995414|P2|Overall Study|No Treatment Received|3
295420|NCT01681511|995415|P1|Overall Study|No Treatment Received|1
295421|NCT01681472|995433|P4|Overall Study|Adverse Event|0
295422|NCT01681472|995434|P3|Overall Study|Adverse Event|0
295423|NCT01681472|995435|P2|Overall Study|Adverse Event|1
295424|NCT01681472|995436|P1|Overall Study|Adverse Event|0
295425|NCT01681368|995446|P1|Overall Study|Refused further follow up|1
295426|NCT01681368|995446|P1|Overall Study|Refused further treatment|1
295427|NCT01681277|995463|P5|Overall Study|Adverse Event|0
295428|NCT01681277|995464|P4|Overall Study|Adverse Event|0
295429|NCT01681277|995465|P3|Overall Study|Adverse Event|0
295430|NCT01681277|995466|P2|Overall Study|Adverse Event|0
295431|NCT01681277|995467|P1|Overall Study|Adverse Event|1
295432|NCT01681212|995508|P1|Overall Study|Administrative reason by sponsor|1
295433|NCT01681212|995508|P1|Overall Study|No longer met study criteria|5
295434|NCT01681069|995566|P2|Overall Study|Adverse Event|1
295435|NCT01681069|995567|P1|Overall Study|Adverse Event|0
295436|NCT01681069|995566|P2|Overall Study|Protocol Violation|1
295437|NCT01681069|995567|P1|Overall Study|Protocol Violation|1
295438|NCT01681069|995566|P2|Overall Study|Withdrawal by Subject|5
295439|NCT01681069|995567|P1|Overall Study|Withdrawal by Subject|4
295440|NCT01681004|995604|P2|Study Completion|Death|1
295441|NCT01681004|995605|P1|Study Completion|Death|1
295442|NCT01681004|995604|P2|Study Completion|Site Termination|1
295443|NCT01681004|995605|P1|Study Completion|Site Termination|2
295444|NCT01681004|995604|P2|Study Completion|Physician Decision|3
295445|NCT01681004|995605|P1|Study Completion|Physician Decision|1
295446|NCT01681004|995604|P2|Study Completion|Lost to Follow-up|3
295447|NCT01681004|995605|P1|Study Completion|Lost to Follow-up|8
295448|NCT01681004|995604|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
295449|NCT01681004|995605|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
295450|NCT01680991|995662|P3|Overall Study|PD confirmed in other hospital|0
295451|NCT01680991|995663|P2|Overall Study|PD confirmed in other hospital|0
295452|NCT01680991|995664|P1|Overall Study|PD confirmed in other hospital|1
295453|NCT01680991|995662|P3|Overall Study|Bad physical condition|1
295454|NCT01680991|995663|P2|Overall Study|Bad physical condition|0
295455|NCT01680991|995664|P1|Overall Study|Bad physical condition|0
295456|NCT01680991|995662|P3|Overall Study|Physician Decision|2
295457|NCT01680991|995663|P2|Overall Study|Physician Decision|7
295458|NCT01680991|995664|P1|Overall Study|Physician Decision|0
295459|NCT01680991|995662|P3|Overall Study|Progressive disease (PD)|0
295460|NCT01680991|995663|P2|Overall Study|Progressive disease (PD)|10
295461|NCT01680991|995664|P1|Overall Study|Progressive disease (PD)|0
295462|NCT01680991|995662|P3|Overall Study|Withdrawal by Subject|0
295463|NCT01680991|995663|P2|Overall Study|Withdrawal by Subject|1
295464|NCT01680991|995664|P1|Overall Study|Withdrawal by Subject|5
295465|NCT01680991|995662|P3|Overall Study|Protocol Violation|0
295466|NCT01680991|995663|P2|Overall Study|Protocol Violation|1
295467|NCT01680991|995664|P1|Overall Study|Protocol Violation|0
295468|NCT01680991|995662|P3|Overall Study|Death|1
295469|NCT01680991|995663|P2|Overall Study|Death|0
295470|NCT01680991|995664|P1|Overall Study|Death|1
295471|NCT01680991|995662|P3|Overall Study|Adverse Event|0
295472|NCT01680991|995663|P2|Overall Study|Adverse Event|0
295473|NCT01680991|995664|P1|Overall Study|Adverse Event|1
295474|NCT01680861|995744|P2|Early Post-transplant Period|Protocol Violation|1
295475|NCT01680861|995745|P1|Early Post-transplant Period|Protocol Violation|1
295476|NCT01680497|995818|P1|Overall Study|Lost to Follow-up|2
295477|NCT01680458|995828|P1|Overall Study|Protocol Violation|3
295478|NCT01680341|995839|P2|Overall Study|Unclassified|15
295479|NCT01680341|995840|P1|Overall Study|Unclassified|18
295480|NCT01680341|995839|P2|Overall Study|Adverse Event|2
295481|NCT01680341|995840|P1|Overall Study|Adverse Event|3
295482|NCT01680159|995911|P1|Increased Dose Period|Withdrawal by Subject|2
295483|NCT01680159|995911|P1|Increased Dose Period|Adverse Event|6
295484|NCT01680159|995911|P1|Screening Period|Not meet criteria for dose-up period|7
295485|NCT01680016|995938|P4|Overall Study|Withdrawal by Subject|1
295486|NCT01680016|995939|P3|Overall Study|Withdrawal by Subject|1
295487|NCT01680016|995940|P2|Overall Study|Withdrawal by Subject|7
295488|NCT01680016|995941|P1|Overall Study|Withdrawal by Subject|5
295489|NCT01680016|995938|P4|Overall Study|Protocol Violation|0
295490|NCT01680016|995939|P3|Overall Study|Protocol Violation|0
295491|NCT01680016|995940|P2|Overall Study|Protocol Violation|1
295492|NCT01680016|995941|P1|Overall Study|Protocol Violation|0
295493|NCT01680016|995938|P4|Overall Study|The Subject went out of The Trial|0
295494|NCT01680016|995939|P3|Overall Study|The Subject went out of The Trial|3
295495|NCT01680016|995940|P2|Overall Study|The Subject went out of The Trial|0
295496|NCT01680016|995941|P1|Overall Study|The Subject went out of The Trial|1
295497|NCT01680016|995938|P4|Overall Study|Adverse Event|4
295498|NCT01680016|995939|P3|Overall Study|Adverse Event|1
295499|NCT01680016|995940|P2|Overall Study|Adverse Event|0
295500|NCT01680016|995941|P1|Overall Study|Adverse Event|0
295501|NCT01679613|996003|P4|Overall Study|other than stated above|2
295502|NCT01679613|996004|P3|Overall Study|other than stated above|2
295503|NCT01679613|996005|P2|Overall Study|other than stated above|1
295504|NCT01679613|996006|P1|Overall Study|other than stated above|0
295505|NCT01679236|996049|P2|Overall Study|Lost to Follow-up|15
295506|NCT01679236|996050|P1|Overall Study|Lost to Follow-up|15
295507|NCT01679002|996097|P3|Overall Study|Adverse Event|0
295508|NCT01679002|996098|P2|Overall Study|Adverse Event|1
295509|NCT01679002|996099|P1|Overall Study|Adverse Event|1
295510|NCT01678911|996126|P2|Second Intervention|Lost to Follow-up|0
295511|NCT01678911|996127|P1|Second Intervention|Lost to Follow-up|2
295512|NCT01678820|996173|P3|Overall Study|Not treated with double-blind study drug|2
295513|NCT01678820|996174|P2|Overall Study|Not treated with double-blind study drug|2
295514|NCT01678820|996175|P1|Overall Study|Not treated with double-blind study drug|0
295515|NCT01678820|996173|P3|Overall Study|Protocol Violation|4
295516|NCT01678820|996174|P2|Overall Study|Protocol Violation|5
295517|NCT01678820|996175|P1|Overall Study|Protocol Violation|4
295518|NCT01678820|996173|P3|Overall Study|Physician Decision|1
295519|NCT01678820|996174|P2|Overall Study|Physician Decision|0
295520|NCT01678820|996175|P1|Overall Study|Physician Decision|0
295521|NCT01678820|996173|P3|Overall Study|Non-compliance with study drug|0
295522|NCT01678820|996174|P2|Overall Study|Non-compliance with study drug|1
295523|NCT01678820|996175|P1|Overall Study|Non-compliance with study drug|0
295524|NCT01678820|996173|P3|Overall Study|Lost to Follow-up|2
295525|NCT01678820|996174|P2|Overall Study|Lost to Follow-up|2
295526|NCT01678820|996175|P1|Overall Study|Lost to Follow-up|7
295527|NCT01678820|996173|P3|Overall Study|Adverse Event|2
295528|NCT01678820|996174|P2|Overall Study|Adverse Event|2
295529|NCT01678820|996175|P1|Overall Study|Adverse Event|2
295530|NCT01678820|996173|P3|Overall Study|Protocol Specified Criteria|1
295531|NCT01678820|996174|P2|Overall Study|Protocol Specified Criteria|3
295532|NCT01678820|996175|P1|Overall Study|Protocol Specified Criteria|2
295533|NCT01678820|996173|P3|Overall Study|Withdrawal by Subject|2
295534|NCT01678820|996174|P2|Overall Study|Withdrawal by Subject|5
295535|NCT01678820|996175|P1|Overall Study|Withdrawal by Subject|2
295536|NCT01678820|996173|P3|Overall Study|Study Terminated by Sponsor|43
295537|NCT01678820|996174|P2|Overall Study|Study Terminated by Sponsor|43
295538|NCT01678820|996175|P1|Overall Study|Study Terminated by Sponsor|45
295539|NCT01678807|996220|P3|Overall Study|Withdrawn by Parent/Guardian|0
295540|NCT01678807|996221|P2|Overall Study|Withdrawn by Parent/Guardian|1
295541|NCT01678807|996222|P1|Overall Study|Withdrawn by Parent/Guardian|0
295542|NCT01678807|996220|P3|Overall Study|Adverse Event|0
295543|NCT01678807|996221|P2|Overall Study|Adverse Event|4
295544|NCT01678807|996222|P1|Overall Study|Adverse Event|4
295545|NCT01678313|996240|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
295546|NCT01678313|996241|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
295547|NCT01678313|996240|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
295548|NCT01678313|996241|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
295549|NCT01678313|996240|P2|Completed the 3-month Therapy|Physician Decision|4
295550|NCT01678313|996241|P1|Completed the 3-month Therapy|Physician Decision|3
295551|NCT01678313|996240|P2|Completed the 3-month Therapy|Lost to Follow-up|8
295552|NCT01678313|996241|P1|Completed the 3-month Therapy|Lost to Follow-up|3
295553|NCT01678131|996275|P3|Overall Study|Withdrawal by Subject|2
295554|NCT01678131|996276|P2|Overall Study|Withdrawal by Subject|0
295555|NCT01678131|996277|P1|Overall Study|Withdrawal by Subject|0
295556|NCT01678131|996275|P3|Overall Study|Adverse Event|0
295557|NCT01678131|996276|P2|Overall Study|Adverse Event|1
295558|NCT01678131|996277|P1|Overall Study|Adverse Event|0
295559|NCT01677988|996285|P1|Overall Study|Lack of Efficacy|2
295560|NCT01677936|996298|P2|Overall Study|Protocol Violation|4
295561|NCT01677936|996299|P1|Overall Study|Protocol Violation|0
295562|NCT01677936|996298|P2|Overall Study|Lost to Follow-up|0
295563|NCT01677936|996299|P1|Overall Study|Lost to Follow-up|1
295564|NCT01677936|996298|P2|Overall Study|Adverse Event|0
295565|NCT01677936|996299|P1|Overall Study|Adverse Event|1
295566|NCT01677936|996298|P2|Overall Study|Protocol Violation|0
295567|NCT01677936|996299|P1|Overall Study|Protocol Violation|3
295568|NCT01677936|996298|P2|Overall Study|Lost to Follow-up|1
295569|NCT01677936|996299|P1|Overall Study|Lost to Follow-up|4
295570|NCT01677910|996310|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
295571|NCT01677910|996311|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
295572|NCT01677910|996312|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
295573|NCT01677910|996313|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
295574|NCT01677910|996310|P4|Open-Label Extension Period (OLE)|Adverse Event|15
295575|NCT01677910|996311|P3|Open-Label Extension Period (OLE)|Adverse Event|0
295576|NCT01677910|996312|P2|Open-Label Extension Period (OLE)|Adverse Event|0
295577|NCT01677910|996313|P1|Open-Label Extension Period (OLE)|Adverse Event|0
295578|NCT01677910|996310|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
295579|NCT01677910|996311|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
295580|NCT01677910|996312|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
295581|NCT01677910|996313|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
295582|NCT01677910|996310|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
295583|NCT01677910|996311|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
295584|NCT01677910|996312|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
295585|NCT01677910|996313|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
295586|NCT01677910|996310|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
295587|NCT01677910|996311|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
295588|NCT01677910|996312|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
295589|NCT01677910|996313|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
295590|NCT01677910|996310|P4|Open-Label Extension Period (OLE)|Physician Decision|4
295591|NCT01677910|996311|P3|Open-Label Extension Period (OLE)|Physician Decision|0
295592|NCT01677910|996312|P2|Open-Label Extension Period (OLE)|Physician Decision|0
295593|NCT01677910|996313|P1|Open-Label Extension Period (OLE)|Physician Decision|0
295594|NCT01677910|996310|P4|Double-Blind Treatment Period|Reason Not Specified|0
295595|NCT01677910|996311|P3|Double-Blind Treatment Period|Reason Not Specified|0
295596|NCT01677910|996312|P2|Double-Blind Treatment Period|Reason Not Specified|1
295597|NCT01677910|996313|P1|Double-Blind Treatment Period|Reason Not Specified|0
295598|NCT01677910|996310|P4|Double-Blind Treatment Period|Withdrawal of consent|0
295599|NCT01677910|996311|P3|Double-Blind Treatment Period|Withdrawal of consent|3
295600|NCT01677910|996312|P2|Double-Blind Treatment Period|Withdrawal of consent|0
295601|NCT01677910|996313|P1|Double-Blind Treatment Period|Withdrawal of consent|1
295602|NCT01677910|996310|P4|Double-Blind Treatment Period|Physician Decision|0
295603|NCT01677910|996311|P3|Double-Blind Treatment Period|Physician Decision|1
295604|NCT01677910|996312|P2|Double-Blind Treatment Period|Physician Decision|0
295605|NCT01677910|996313|P1|Double-Blind Treatment Period|Physician Decision|0
295606|NCT01677910|996310|P4|Double-Blind Treatment Period|Adverse Event|0
295607|NCT01677910|996311|P3|Double-Blind Treatment Period|Adverse Event|3
295608|NCT01677910|996312|P2|Double-Blind Treatment Period|Adverse Event|2
295609|NCT01677910|996313|P1|Double-Blind Treatment Period|Adverse Event|6
295610|NCT01677858|996340|P5|Overall Study|Lost to Follow-up|1
295611|NCT01677858|996341|P4|Overall Study|Lost to Follow-up|0
295612|NCT01677858|996342|P3|Overall Study|Lost to Follow-up|0
295613|NCT01677858|996343|P2|Overall Study|Lost to Follow-up|0
295614|NCT01677858|996344|P1|Overall Study|Lost to Follow-up|0
295615|NCT01677858|996340|P5|Overall Study|Withdrawal by Subject|15
295616|NCT01677858|996341|P4|Overall Study|Withdrawal by Subject|0
295617|NCT01677858|996342|P3|Overall Study|Withdrawal by Subject|1
295618|NCT01677858|996343|P2|Overall Study|Withdrawal by Subject|1
295619|NCT01677858|996344|P1|Overall Study|Withdrawal by Subject|0
295620|NCT01677858|996340|P5|Overall Study|Progressive Disease|43
295621|NCT01677858|996341|P4|Overall Study|Progressive Disease|3
295622|NCT01677858|996342|P3|Overall Study|Progressive Disease|9
295623|NCT01677858|996343|P2|Overall Study|Progressive Disease|1
295624|NCT01677858|996344|P1|Overall Study|Progressive Disease|2
295625|NCT01677858|996340|P5|Overall Study|Physician Decision|12
295626|NCT01677858|996341|P4|Overall Study|Physician Decision|0
295627|NCT01677858|996342|P3|Overall Study|Physician Decision|2
295628|NCT01677858|996343|P2|Overall Study|Physician Decision|0
295629|NCT01677858|996344|P1|Overall Study|Physician Decision|1
295630|NCT01677858|996340|P5|Overall Study|Death|1
295631|NCT01677858|996341|P4|Overall Study|Death|0
295632|NCT01677858|996342|P3|Overall Study|Death|0
295633|NCT01677858|996343|P2|Overall Study|Death|0
295634|NCT01677858|996344|P1|Overall Study|Death|0
295635|NCT01677858|996340|P5|Overall Study|Adverse Event|13
295636|NCT01677858|996341|P4|Overall Study|Adverse Event|3
295637|NCT01677858|996342|P3|Overall Study|Adverse Event|2
295638|NCT01677858|996343|P2|Overall Study|Adverse Event|0
295639|NCT01677858|996344|P1|Overall Study|Adverse Event|0
295640|NCT01677767|996417|P1|Overall Study|Non-compliance by the participants|3
295641|NCT01677767|996417|P1|Overall Study|Withdrawal by Subject|10
295642|NCT01677767|996417|P1|Overall Study|Protocol Violation|4
295643|NCT01677767|996417|P1|Overall Study|Death|4
295644|NCT01677767|996417|P1|Overall Study|Adverse Event|1
295645|NCT01677624|996431|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
295646|NCT01677507|996436|P2|Second Assigment|Adverse Event|3
295647|NCT01677507|996437|P1|Second Assigment|Adverse Event|1
295648|NCT01677507|996436|P2|Second Assigment|Withdrawal by Subject|2
295649|NCT01677507|996437|P1|Second Assigment|Withdrawal by Subject|2
295650|NCT01677507|996436|P2|Initial Assignment|Protocol Violation|1
295651|NCT01677507|996437|P1|Initial Assignment|Protocol Violation|0
295652|NCT01677507|996436|P2|Initial Assignment|Adverse Event|1
295653|NCT01677507|996437|P1|Initial Assignment|Adverse Event|0
295654|NCT01677299|996451|P4|Overall Study|Withdrawal by Subject|1
295655|NCT01677299|996452|P3|Overall Study|Withdrawal by Subject|0
295656|NCT01677299|996453|P2|Overall Study|Withdrawal by Subject|1
295657|NCT01677299|996454|P1|Overall Study|Withdrawal by Subject|0
295658|NCT01677299|996451|P4|Overall Study|Adverse Event|0
295659|NCT01677299|996452|P3|Overall Study|Adverse Event|1
295660|NCT01677299|996453|P2|Overall Study|Adverse Event|2
295661|NCT01677299|996454|P1|Overall Study|Adverse Event|0
295662|NCT01677195|996486|P3|Overall Study|Protocol Violation|4
295663|NCT01677195|996487|P2|Overall Study|Protocol Violation|3
295664|NCT01677195|996488|P1|Overall Study|Protocol Violation|7
295665|NCT01677195|996486|P3|Overall Study|Pregnancy|0
295666|NCT01677195|996487|P2|Overall Study|Pregnancy|1
295667|NCT01677195|996488|P1|Overall Study|Pregnancy|0
295668|NCT01677195|996486|P3|Overall Study|Physician Decision|2
295669|NCT01677195|996487|P2|Overall Study|Physician Decision|2
295670|NCT01677195|996488|P1|Overall Study|Physician Decision|1
295671|NCT01677195|996486|P3|Overall Study|Adverse Event|1
295672|NCT01677195|996487|P2|Overall Study|Adverse Event|4
295673|NCT01677195|996488|P1|Overall Study|Adverse Event|6
295674|NCT01677195|996486|P3|Overall Study|Withdrawal by Subject|1
295675|NCT01677195|996487|P2|Overall Study|Withdrawal by Subject|0
295676|NCT01677195|996488|P1|Overall Study|Withdrawal by Subject|1
295677|NCT01677195|996486|P3|Overall Study|Lost to Follow-up|22
295678|NCT01677195|996487|P2|Overall Study|Lost to Follow-up|22
295679|NCT01677195|996488|P1|Overall Study|Lost to Follow-up|14
295680|NCT01677182|996499|P3|Overall Study|Other reasons|2
295681|NCT01677182|996500|P2|Overall Study|Other reasons|5
295682|NCT01677182|996501|P1|Overall Study|Other reasons|1
295683|NCT01677182|996499|P3|Overall Study|Lack of Efficacy|1
295684|NCT01677182|996500|P2|Overall Study|Lack of Efficacy|0
295685|NCT01677182|996501|P1|Overall Study|Lack of Efficacy|3
295686|NCT01677182|996499|P3|Overall Study|Study termination|11
295687|NCT01677182|996500|P2|Overall Study|Study termination|9
295688|NCT01677182|996501|P1|Overall Study|Study termination|12
295689|NCT01677182|996499|P3|Overall Study|Withdrawal by Subject|10
295690|NCT01677182|996500|P2|Overall Study|Withdrawal by Subject|12
295691|NCT01677182|996501|P1|Overall Study|Withdrawal by Subject|7
295692|NCT01677182|996499|P3|Overall Study|Lost to Follow-up|3
295693|NCT01677182|996500|P2|Overall Study|Lost to Follow-up|0
295694|NCT01677182|996501|P1|Overall Study|Lost to Follow-up|4
295695|NCT01677182|996499|P3|Overall Study|Protocol Violation|4
295696|NCT01677182|996500|P2|Overall Study|Protocol Violation|1
295697|NCT01677182|996501|P1|Overall Study|Protocol Violation|5
295698|NCT01677182|996499|P3|Overall Study|Adverse Event|8
295699|NCT01677182|996500|P2|Overall Study|Adverse Event|1
295700|NCT01677182|996501|P1|Overall Study|Adverse Event|2
295701|NCT01676961|996533|P1|Overall Study|Withdrawal by Subject|1
295702|NCT01676961|996533|P1|Overall Study|Lost to Follow-up|1
295703|NCT01676961|996533|P1|Overall Study|Death|3
295704|NCT01676896|996541|P3|Overall Study|Withdrawal by Subject|19
295705|NCT01676896|996542|P2|Overall Study|Withdrawal by Subject|7
295706|NCT01676896|996543|P1|Overall Study|Withdrawal by Subject|12
295707|NCT01676701|996647|P2|Overall Study|Sponsor Decision|4
295708|NCT01676701|996648|P1|Overall Study|Sponsor Decision|3
295709|NCT01676701|996647|P2|Overall Study|Protocol Violation|0
295710|NCT01676701|996648|P1|Overall Study|Protocol Violation|1
295711|NCT01676220|996733|P2|Overall Study|No More Need of Insulin|0
295712|NCT01676220|996734|P1|Overall Study|No More Need of Insulin|1
295713|NCT01676220|996733|P2|Overall Study|Non Serious Hypoglycemia|0
295714|NCT01676220|996734|P1|Overall Study|Non Serious Hypoglycemia|2
295715|NCT01676220|996733|P2|Overall Study|Perceived Lack of Efficacy|1
295716|NCT01676220|996734|P1|Overall Study|Perceived Lack of Efficacy|3
295717|NCT01676220|996733|P2|Overall Study|Site Closure/Site Withdrawal|4
295718|NCT01676220|996734|P1|Overall Study|Site Closure/Site Withdrawal|1
295719|NCT01676220|996733|P2|Overall Study|Selection Criterion/Protocol Violation|9
295720|NCT01676220|996734|P1|Overall Study|Selection Criterion/Protocol Violation|9
295721|NCT01676220|996733|P2|Overall Study|Lost to Follow-up|18
295722|NCT01676220|996734|P1|Overall Study|Lost to Follow-up|11
295723|NCT01676220|996733|P2|Overall Study|Personal Reason|45
295724|NCT01676220|996734|P1|Overall Study|Personal Reason|34
295725|NCT01676220|996733|P2|Overall Study|Received Rescue Therapy|22
295726|NCT01676220|996734|P1|Overall Study|Received Rescue Therapy|14
295727|NCT01676220|996733|P2|Overall Study|Protocol Violation|12
295728|NCT01676220|996734|P1|Overall Study|Protocol Violation|11
295729|NCT01676220|996733|P2|Overall Study|Lack of Efficacy|5
295730|NCT01676220|996734|P1|Overall Study|Lack of Efficacy|2
295731|NCT01676220|996733|P2|Overall Study|Adverse Event|8
295732|NCT01676220|996734|P1|Overall Study|Adverse Event|10
295733|NCT01676220|996733|P2|Overall Study|Randomized But Not Treated|1
295734|NCT01676220|996734|P1|Overall Study|Randomized But Not Treated|4
295735|NCT01676012|996764|P1|Overall Study|incomplete set of videos|1
295736|NCT01676012|996764|P1|Overall Study|Adverse Event|2
295737|NCT01675661|996775|P2|Overall Study|Other reason|2
295738|NCT01675661|996776|P1|Overall Study|Other reason|1
295739|NCT01675661|996775|P2|Overall Study|Death|1
295740|NCT01675661|996776|P1|Overall Study|Death|0
295741|NCT01675661|996775|P2|Overall Study|Physician Decision|2
295742|NCT01675661|996776|P1|Overall Study|Physician Decision|0
295743|NCT01675661|996775|P2|Overall Study|Withdrawal by Subject|7
295744|NCT01675661|996776|P1|Overall Study|Withdrawal by Subject|3
295745|NCT01675661|996775|P2|Overall Study|Moved away|6
295746|NCT01675661|996776|P1|Overall Study|Moved away|5
295747|NCT01675661|996775|P2|Overall Study|Practical problems|5
295748|NCT01675661|996776|P1|Overall Study|Practical problems|9
295749|NCT01675661|996775|P2|Overall Study|Lost to Follow-up|23
295750|NCT01675661|996776|P1|Overall Study|Lost to Follow-up|22
295751|NCT01675622|996805|P2|Overall Study|not specified|4
295752|NCT01675622|996806|P1|Overall Study|not specified|5
295753|NCT01675622|996805|P2|Overall Study|Lost to Follow-up|3
295754|NCT01675622|996806|P1|Overall Study|Lost to Follow-up|1
295755|NCT01675622|996805|P2|Overall Study|Lack of Efficacy|4
295756|NCT01675622|996806|P1|Overall Study|Lack of Efficacy|2
295757|NCT01675622|996805|P2|Overall Study|Protocol Violation|1
295758|NCT01675622|996806|P1|Overall Study|Protocol Violation|4
295759|NCT01675622|996805|P2|Overall Study|Adverse Event|10
295760|NCT01675622|996806|P1|Overall Study|Adverse Event|12
295761|NCT01675622|996805|P2|Overall Study|Withdrawal by Subject|2
295762|NCT01675622|996806|P1|Overall Study|Withdrawal by Subject|2
295763|NCT01675544|996830|P1|Overall Study|Withdrawal by Subject|2
295764|NCT01675531|996835|P1|Overall Study|Protocol Violation|8
295765|NCT01675531|996835|P1|Overall Study|Lack of Efficacy|1
295766|NCT01675531|996835|P1|Overall Study|Withdrawal by Subject|7
295767|NCT01675531|996835|P1|Overall Study|Adverse Event|9
295768|NCT01675492|996842|P1|Overall Study|study completed early - product approval|42
295769|NCT01675479|996847|P1|Overall Study|Lost to Follow-up|11
295770|NCT01675427|996861|P1|Overall Study|Not Specified|2
295771|NCT01675427|996861|P1|Overall Study|Lost to Follow-up|5
295772|NCT01675427|996861|P1|Overall Study|Sample not Collected by Mistake|2
295773|NCT01675427|996861|P1|Overall Study|Participant Refused Sample Collection|18
295774|NCT01675427|996861|P1|Overall Study|Withdrawal by Subject|7
295775|NCT01675167|997148|P3|Double-blind Treatment Phase|Not specified|5
295776|NCT01675167|997149|P2|Double-blind Treatment Phase|Not specified|7
295777|NCT01675167|997150|P1|Double-blind Treatment Phase|Not specified|0
295778|NCT01675167|997148|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
295779|NCT01675167|997149|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
295780|NCT01675167|997150|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
295781|NCT01675167|997148|P3|Double-blind Treatment Phase|Lost to Follow-up|5
295782|NCT01675167|997149|P2|Double-blind Treatment Phase|Lost to Follow-up|1
295783|NCT01675167|997150|P1|Double-blind Treatment Phase|Lost to Follow-up|0
295784|NCT01675167|997148|P3|Double-blind Treatment Phase|Protocol Violation|11
295785|NCT01675167|997149|P2|Double-blind Treatment Phase|Protocol Violation|4
295786|NCT01675167|997150|P1|Double-blind Treatment Phase|Protocol Violation|0
295787|NCT01675167|997148|P3|Double-blind Treatment Phase|Adverse Event|13
295788|NCT01675167|997149|P2|Double-blind Treatment Phase|Adverse Event|5
295789|NCT01675167|997150|P1|Double-blind Treatment Phase|Adverse Event|0
295790|NCT01675167|997148|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
295791|NCT01675167|997149|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
295792|NCT01675167|997150|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
295793|NCT01675167|997148|P3|Double-blind Treatment Phase|Lack of Efficacy|61
295794|NCT01675167|997149|P2|Double-blind Treatment Phase|Lack of Efficacy|19
295795|NCT01675167|997150|P1|Double-blind Treatment Phase|Lack of Efficacy|0
295796|NCT01675167|997148|P3|Open-label Titration Phase|Not specified|0
295797|NCT01675167|997149|P2|Open-label Titration Phase|Not specified|0
295798|NCT01675167|997150|P1|Open-label Titration Phase|Not specified|55
295799|NCT01675167|997148|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
295800|NCT01675167|997149|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
295801|NCT01675167|997150|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
295802|NCT01675167|997148|P3|Open-label Titration Phase|Lost to Follow-up|0
295803|NCT01675167|997149|P2|Open-label Titration Phase|Lost to Follow-up|0
295804|NCT01675167|997150|P1|Open-label Titration Phase|Lost to Follow-up|15
295805|NCT01675167|997148|P3|Open-label Titration Phase|Protocol Violation|0
295806|NCT01675167|997149|P2|Open-label Titration Phase|Protocol Violation|0
295807|NCT01675167|997150|P1|Open-label Titration Phase|Protocol Violation|43
295808|NCT01675167|997148|P3|Open-label Titration Phase|Withdrawal by Subject|0
295809|NCT01675167|997149|P2|Open-label Titration Phase|Withdrawal by Subject|0
295810|NCT01675167|997150|P1|Open-label Titration Phase|Withdrawal by Subject|46
295811|NCT01675167|997148|P3|Open-label Titration Phase|Lack of Efficacy|0
295812|NCT01675167|997149|P2|Open-label Titration Phase|Lack of Efficacy|0
295813|NCT01675167|997150|P1|Open-label Titration Phase|Lack of Efficacy|63
295814|NCT01675167|997148|P3|Open-label Titration Phase|Adverse Event|0
295815|NCT01675167|997149|P2|Open-label Titration Phase|Adverse Event|0
295816|NCT01675167|997150|P1|Open-label Titration Phase|Adverse Event|81
295817|NCT01675141|997172|P1|Overall Study|No treatment, per protocol|1
295818|NCT01675141|997172|P1|Overall Study|Physician Decision|4
295819|NCT01675141|997172|P1|Overall Study|Withdrawal by Subject|3
295820|NCT01675141|997172|P1|Overall Study|Lenalidomide outside NIH|3
295821|NCT01675128|997185|P3|Overall Study|Pulmonary complication; off study|0
295822|NCT01675128|997186|P2|Overall Study|Pulmonary complication; off study|1
295823|NCT01675128|997187|P1|Overall Study|Pulmonary complication; off study|0
295824|NCT01675128|997185|P3|Overall Study|Refused further treatment|0
295825|NCT01675128|997186|P2|Overall Study|Refused further treatment|0
295826|NCT01675128|997187|P1|Overall Study|Refused further treatment|1
295827|NCT01675128|997185|P3|Overall Study|Disease progression on study|1
295828|NCT01675128|997186|P2|Overall Study|Disease progression on study|1
295829|NCT01675128|997187|P1|Overall Study|Disease progression on study|1
295830|NCT01675050|997215|P2|Period One Treatment|Withdrawal by Subject|0
295831|NCT01675050|997216|P1|Period One Treatment|Withdrawal by Subject|1
295832|NCT01675011|997226|P2|Overall Study|Trial terminated by Sponsor|1
295833|NCT01675011|997227|P1|Overall Study|Trial terminated by Sponsor|3
295834|NCT01674725|997235|P2|Overall Study|Lost to Follow-up|1
295835|NCT01674725|997236|P1|Overall Study|Lost to Follow-up|0
295836|NCT01674725|997235|P2|Overall Study|Withdrawal by Subject|0
295837|NCT01674725|997236|P1|Overall Study|Withdrawal by Subject|1
295838|NCT01674725|997235|P2|Overall Study|Did not receive study drug|0
295839|NCT01674725|997236|P1|Overall Study|Did not receive study drug|1
295840|NCT01674725|997235|P2|Overall Study|Adverse Event|0
295841|NCT01674725|997236|P1|Overall Study|Adverse Event|1
295842|NCT01674712|997255|P5|Overall Study|Lack of Efficacy|1
295843|NCT01674712|997256|P4|Overall Study|Lack of Efficacy|0
295844|NCT01674712|997257|P3|Overall Study|Lack of Efficacy|1
295845|NCT01674712|997258|P2|Overall Study|Lack of Efficacy|0
295846|NCT01674712|997259|P1|Overall Study|Lack of Efficacy|0
295847|NCT01674712|997255|P5|Overall Study|Administrative|1
295848|NCT01674712|997256|P4|Overall Study|Administrative|0
295849|NCT01674712|997257|P3|Overall Study|Administrative|0
295850|NCT01674712|997258|P2|Overall Study|Administrative|1
295851|NCT01674712|997259|P1|Overall Study|Administrative|0
295852|NCT01674712|997255|P5|Overall Study|Withdrawal by Subject|3
295853|NCT01674712|997256|P4|Overall Study|Withdrawal by Subject|4
295854|NCT01674712|997257|P3|Overall Study|Withdrawal by Subject|5
295855|NCT01674712|997258|P2|Overall Study|Withdrawal by Subject|2
295856|NCT01674712|997259|P1|Overall Study|Withdrawal by Subject|2
295857|NCT01674712|997255|P5|Overall Study|Protocol Violation|0
295858|NCT01674712|997256|P4|Overall Study|Protocol Violation|0
295859|NCT01674712|997257|P3|Overall Study|Protocol Violation|0
295860|NCT01674712|997258|P2|Overall Study|Protocol Violation|0
295861|NCT01674712|997259|P1|Overall Study|Protocol Violation|2
295862|NCT01674712|997255|P5|Overall Study|Lost to Follow-up|0
295863|NCT01674712|997256|P4|Overall Study|Lost to Follow-up|0
295864|NCT01674712|997257|P3|Overall Study|Lost to Follow-up|0
295865|NCT01674712|997258|P2|Overall Study|Lost to Follow-up|0
295866|NCT01674712|997259|P1|Overall Study|Lost to Follow-up|1
295867|NCT01674712|997255|P5|Overall Study|Adverse Event|6
295868|NCT01674712|997256|P4|Overall Study|Adverse Event|4
295869|NCT01674712|997257|P3|Overall Study|Adverse Event|3
295870|NCT01674712|997258|P2|Overall Study|Adverse Event|6
295871|NCT01674712|997259|P1|Overall Study|Adverse Event|5
295872|NCT01674647|997283|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
295873|NCT01674647|997284|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
295874|NCT01674647|997283|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
295875|NCT01674647|997284|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
295876|NCT01674647|997283|P2|30-day Safety Follow-up Period|Logistical difficulties|3
295877|NCT01674647|997284|P1|30-day Safety Follow-up Period|Logistical difficulties|1
295878|NCT01674647|997283|P2|30-day Safety Follow-up Period|Protocol Violation|22
295879|NCT01674647|997284|P1|30-day Safety Follow-up Period|Protocol Violation|39
295880|NCT01674647|997283|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
295881|NCT01674647|997284|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
295882|NCT01674647|997283|P2|30-day Safety Follow-up Period|Death|2
295883|NCT01674647|997284|P1|30-day Safety Follow-up Period|Death|3
295884|NCT01674647|997283|P2|Treatment Period|Protocol Violation|36
295885|NCT01674647|997284|P1|Treatment Period|Protocol Violation|56
295886|NCT01674647|997283|P2|Treatment Period|Treatment failure|14
295887|NCT01674647|997284|P1|Treatment Period|Treatment failure|0
295888|NCT01674647|997283|P2|Treatment Period|Logistical difficulties|8
295889|NCT01674647|997284|P1|Treatment Period|Logistical difficulties|5
295890|NCT01674647|997283|P2|Treatment Period|Switching to other therapy|2
295891|NCT01674647|997284|P1|Treatment Period|Switching to other therapy|5
295892|NCT01674647|997283|P2|Treatment Period|Withdrawal by Subject|16
295893|NCT01674647|997284|P1|Treatment Period|Withdrawal by Subject|19
295894|NCT01674647|997283|P2|Treatment Period|Lost to Follow-up|1
295895|NCT01674647|997284|P1|Treatment Period|Lost to Follow-up|1
295896|NCT01674647|997283|P2|Treatment Period|Non-compliance with study drug|0
295897|NCT01674647|997284|P1|Treatment Period|Non-compliance with study drug|3
295898|NCT01674647|997283|P2|Treatment Period|Adverse Event|22
295899|NCT01674647|997284|P1|Treatment Period|Adverse Event|60
295900|NCT01674647|997283|P2|Treatment Period|Physician Decision|1
295901|NCT01674647|997284|P1|Treatment Period|Physician Decision|3
295902|NCT01674647|997283|P2|Treatment Period|Efficacy outcome reached|1
295903|NCT01674647|997284|P1|Treatment Period|Efficacy outcome reached|0
295904|NCT01674647|997283|P2|Treatment Period|Death|1
295905|NCT01674647|997284|P1|Treatment Period|Death|4
295906|NCT01674634|997310|P1|Overall Study|Lost to Follow-up|3
295907|NCT01674634|997310|P1|Overall Study|Withdrawal by Subject|3
295908|NCT01674569|997356|P1|Overall Study|Withdrawal by Subject|1
295909|NCT01674569|997356|P1|Overall Study|Protocol Violation|3
295910|NCT01674569|997356|P1|Overall Study|Adverse Event|6
295911|NCT01674062|997362|P2|Overall Study|Programming Error|0
295912|NCT01674062|997363|P1|Overall Study|Programming Error|1
295913|NCT01674062|997362|P2|Overall Study|Death|1
295914|NCT01674062|997363|P1|Overall Study|Death|0
295915|NCT01674062|997362|P2|Overall Study|Adverse Event|1
295916|NCT01674062|997363|P1|Overall Study|Adverse Event|1
295917|NCT01674062|997362|P2|Overall Study|Not Specified|1
295918|NCT01674062|997363|P1|Overall Study|Not Specified|8
295919|NCT01674062|997362|P2|Overall Study|Insufficient Therapeutic Response|26
295920|NCT01674062|997363|P1|Overall Study|Insufficient Therapeutic Response|56
295921|NCT01674010|997378|P3|Randomization Phase 2|Withdrawal by Subject|7
295922|NCT01674010|997379|P2|Randomization Phase 2|Withdrawal by Subject|8
295923|NCT01674010|997380|P1|Randomization Phase 2|Withdrawal by Subject|0
295924|NCT01674010|997378|P3|Randomization Phase 2|Sponsor Decision|45
295925|NCT01674010|997379|P2|Randomization Phase 2|Sponsor Decision|42
295926|NCT01674010|997380|P1|Randomization Phase 2|Sponsor Decision|0
295927|NCT01674010|997378|P3|Randomization Phase 2|Protocol Violation|1
295928|NCT01674010|997379|P2|Randomization Phase 2|Protocol Violation|1
295929|NCT01674010|997380|P1|Randomization Phase 2|Protocol Violation|0
295930|NCT01674010|997378|P3|Randomization Phase 2|Pregnancy|1
295931|NCT01674010|997379|P2|Randomization Phase 2|Pregnancy|1
295932|NCT01674010|997380|P1|Randomization Phase 2|Pregnancy|0
295933|NCT01674010|997378|P3|Randomization Phase 2|Physician Decision|2
295934|NCT01674010|997379|P2|Randomization Phase 2|Physician Decision|0
295935|NCT01674010|997380|P1|Randomization Phase 2|Physician Decision|0
295936|NCT01674010|997378|P3|Randomization Phase 2|Mood episode recurrence|2
295937|NCT01674010|997379|P2|Randomization Phase 2|Mood episode recurrence|8
295938|NCT01674010|997380|P1|Randomization Phase 2|Mood episode recurrence|0
295939|NCT01674010|997378|P3|Randomization Phase 2|Lost to Follow-up|2
295940|NCT01674010|997379|P2|Randomization Phase 2|Lost to Follow-up|1
295941|NCT01674010|997380|P1|Randomization Phase 2|Lost to Follow-up|0
295942|NCT01674010|997378|P3|Randomization Phase 2|Adverse Event|1
295943|NCT01674010|997379|P2|Randomization Phase 2|Adverse Event|1
295944|NCT01674010|997380|P1|Randomization Phase 2|Adverse Event|0
295945|NCT01674010|997378|P3|Open Treatment Phase 1|Withdrawal by Subject|0
295946|NCT01674010|997379|P2|Open Treatment Phase 1|Withdrawal by Subject|0
295947|NCT01674010|997380|P1|Open Treatment Phase 1|Withdrawal by Subject|25
295948|NCT01674010|997378|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
295949|NCT01674010|997379|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
295950|NCT01674010|997380|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
295951|NCT01674010|997378|P3|Open Treatment Phase 1|Sponsor Decision|0
295952|NCT01674010|997379|P2|Open Treatment Phase 1|Sponsor Decision|0
295953|NCT01674010|997380|P1|Open Treatment Phase 1|Sponsor Decision|79
295954|NCT01674010|997378|P3|Open Treatment Phase 1|Protocol Violation|0
295955|NCT01674010|997379|P2|Open Treatment Phase 1|Protocol Violation|0
295956|NCT01674010|997380|P1|Open Treatment Phase 1|Protocol Violation|7
295957|NCT01674010|997378|P3|Open Treatment Phase 1|Physician Decision|0
295958|NCT01674010|997379|P2|Open Treatment Phase 1|Physician Decision|0
295959|NCT01674010|997380|P1|Open Treatment Phase 1|Physician Decision|9
295960|NCT01674010|997378|P3|Open Treatment Phase 1|Lost to Follow-up|0
295961|NCT01674010|997379|P2|Open Treatment Phase 1|Lost to Follow-up|0
295962|NCT01674010|997380|P1|Open Treatment Phase 1|Lost to Follow-up|19
295963|NCT01674010|997378|P3|Open Treatment Phase 1|Death|0
295964|NCT01674010|997379|P2|Open Treatment Phase 1|Death|0
295965|NCT01674010|997380|P1|Open Treatment Phase 1|Death|1
295966|NCT01674010|997378|P3|Open Treatment Phase 1|Adverse Event|0
295967|NCT01674010|997379|P2|Open Treatment Phase 1|Adverse Event|0
295968|NCT01674010|997380|P1|Open Treatment Phase 1|Adverse Event|10
295969|NCT01673984|997399|P2|Overall Study|Study termination|6
295970|NCT01673984|997400|P1|Overall Study|Study termination|9
295971|NCT01673984|997399|P2|Overall Study|Adverse Event|0
295972|NCT01673984|997400|P1|Overall Study|Adverse Event|1
295973|NCT01673867|997442|P2|Treatment|Physician Decision|1
295974|NCT01673867|997443|P1|Treatment|Physician Decision|0
295975|NCT01673867|997442|P2|Treatment|Symptomatic deterioration|1
295976|NCT01673867|997443|P1|Treatment|Symptomatic deterioration|0
295977|NCT01673867|997442|P2|Treatment|Required prolonged hospitalization|1
295978|NCT01673867|997443|P1|Treatment|Required prolonged hospitalization|0
295979|NCT01673867|997442|P2|Treatment|Health status not improved|0
295980|NCT01673867|997443|P1|Treatment|Health status not improved|1
295981|NCT01673867|997442|P2|Treatment|Required steroid therapy|0
295982|NCT01673867|997443|P1|Treatment|Required steroid therapy|1
295983|NCT01673867|997442|P2|Treatment|No longer meets criteria|0
295984|NCT01673867|997443|P1|Treatment|No longer meets criteria|2
295985|NCT01673867|997442|P2|Treatment|Maximum clinical benefit|10
295986|NCT01673867|997443|P1|Treatment|Maximum clinical benefit|0
295987|NCT01673867|997442|P2|Treatment|Withdrawal by Subject|6
295988|NCT01673867|997443|P1|Treatment|Withdrawal by Subject|4
295989|NCT01673867|997442|P2|Treatment|Requested treatment discontinuation|16
295990|NCT01673867|997443|P1|Treatment|Requested treatment discontinuation|5
295991|NCT01673867|997442|P2|Treatment|AE unrelated to study drug|11
295992|NCT01673867|997443|P1|Treatment|AE unrelated to study drug|19
295993|NCT01673867|997442|P2|Treatment|Death|1
295994|NCT01673867|997443|P1|Treatment|Death|1
295995|NCT01673867|997442|P2|Treatment|Study Drug Toxicity|42
295996|NCT01673867|997443|P1|Treatment|Study Drug Toxicity|17
295997|NCT01673867|997442|P2|Treatment|Disease Progression|179
295998|NCT01673867|997443|P1|Treatment|Disease Progression|194
295999|NCT01673867|997442|P2|Randomization|No longer meets criteria|5
296000|NCT01673867|997443|P1|Randomization|No longer meets criteria|4
296001|NCT01673867|997442|P2|Randomization|Lost to Follow-up|1
296002|NCT01673867|997443|P1|Randomization|Lost to Follow-up|0
296003|NCT01673867|997442|P2|Randomization|Withdrawal by Subject|12
296004|NCT01673867|997443|P1|Randomization|Withdrawal by Subject|0
296005|NCT01673867|997442|P2|Randomization|Requested treatment discontinuation|4
296006|NCT01673867|997443|P1|Randomization|Requested treatment discontinuation|0
296007|NCT01673867|997442|P2|Randomization|AE unrelated to study drug|0
296008|NCT01673867|997443|P1|Randomization|AE unrelated to study drug|1
296009|NCT01673854|997469|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
296010|NCT01673854|997469|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
296011|NCT01673854|997469|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
296012|NCT01673854|997469|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
296013|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
296014|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
296015|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
296016|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
296017|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
296018|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
296019|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
296020|NCT01673854|997469|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
296021|NCT01673698|997492|P2|Overall Study|Lost to Follow-up|13
296022|NCT01673698|997493|P1|Overall Study|Lost to Follow-up|51
296023|NCT01673620|997503|P2|Overall Study|Adverse Event|0
296024|NCT01673620|997504|P1|Overall Study|Adverse Event|1
296025|NCT01673594|997514|P2|Overall Study|Withdrawal by Subject|1
296026|NCT01673594|997515|P1|Overall Study|Withdrawal by Subject|0
296027|NCT01673594|997514|P2|Overall Study|Physician Decision|4
296028|NCT01673594|997515|P1|Overall Study|Physician Decision|2
296029|NCT01673594|997514|P2|Overall Study|Lost to Follow-up|0
296030|NCT01673594|997515|P1|Overall Study|Lost to Follow-up|1
296031|NCT01673594|997514|P2|Overall Study|Adverse Event|1
296032|NCT01673594|997515|P1|Overall Study|Adverse Event|3
296033|NCT01673490|997534|P1|Overall Study|Withdrawal by Subject|3
296034|NCT01673490|997534|P1|Overall Study|Adverse Event|3
296035|NCT01673490|997534|P1|Overall Study|Lost to Follow-up|1
296036|NCT01673347|997551|P1|Overall Study|failure of allograft|7
296037|NCT01673282|997560|P2|Overall Study|Other|6
296038|NCT01673282|997561|P1|Overall Study|Other|1
296039|NCT01673282|997560|P2|Overall Study|Withdrawal by Subject|3
296040|NCT01673282|997561|P1|Overall Study|Withdrawal by Subject|3
296041|NCT01673282|997560|P2|Overall Study|Lost to Follow-up|10
296042|NCT01673282|997561|P1|Overall Study|Lost to Follow-up|11
296043|NCT01673282|997560|P2|Overall Study|Lack of Efficacy|2
296044|NCT01673282|997561|P1|Overall Study|Lack of Efficacy|9
296045|NCT01673282|997560|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
296046|NCT01673282|997561|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
296047|NCT01673178|997597|P5|Overall Study|Other|0
296048|NCT01673178|997598|P4|Overall Study|Other|1
296049|NCT01673178|997599|P3|Overall Study|Other|2
296050|NCT01673178|997600|P2|Overall Study|Other|0
296051|NCT01673178|997601|P1|Overall Study|Other|1
296052|NCT01673178|997597|P5|Overall Study|Adverse Event|0
296053|NCT01673178|997598|P4|Overall Study|Adverse Event|2
296054|NCT01673178|997599|P3|Overall Study|Adverse Event|0
296055|NCT01673178|997600|P2|Overall Study|Adverse Event|0
296056|NCT01673178|997601|P1|Overall Study|Adverse Event|1
296057|NCT01673178|997597|P5|Overall Study|Protocol Violation|0
296058|NCT01673178|997598|P4|Overall Study|Protocol Violation|1
296059|NCT01673178|997599|P3|Overall Study|Protocol Violation|0
296060|NCT01673178|997600|P2|Overall Study|Protocol Violation|1
296061|NCT01673178|997601|P1|Overall Study|Protocol Violation|1
296062|NCT01673178|997597|P5|Overall Study|Withdrawal by Subject|2
296063|NCT01673178|997598|P4|Overall Study|Withdrawal by Subject|4
296064|NCT01673178|997599|P3|Overall Study|Withdrawal by Subject|1
296065|NCT01673178|997600|P2|Overall Study|Withdrawal by Subject|0
296066|NCT01673178|997601|P1|Overall Study|Withdrawal by Subject|0
296067|NCT01673178|997597|P5|Overall Study|Lost to Follow-up|0
296068|NCT01673178|997598|P4|Overall Study|Lost to Follow-up|0
296069|NCT01673178|997599|P3|Overall Study|Lost to Follow-up|0
296070|NCT01673178|997600|P2|Overall Study|Lost to Follow-up|1
296071|NCT01673178|997601|P1|Overall Study|Lost to Follow-up|0
296072|NCT01673126|997840|P2|Overall Study|change of diagnosis|3
296073|NCT01673126|997841|P1|Overall Study|change of diagnosis|4
296074|NCT01673009|997857|P1|Overall Study|Withdrawal by Subject|8
296075|NCT01673009|997857|P1|Overall Study|Physician Decision|5
296076|NCT01672970|997942|P1|Overall Study|Enrolled but not treated|1
296077|NCT01672970|997942|P1|Overall Study|Other|9
296078|NCT01672970|997942|P1|Overall Study|Lost to Follow-up|5
296079|NCT01672970|997942|P1|Overall Study|Withdrawal by Subject|2
296080|NCT01672970|997942|P1|Overall Study|Adverse Event|18
296081|NCT01672970|997942|P1|Overall Study|Lack of Efficacy|12
296082|NCT01672957|997978|P1|Overall Study|ICF Signed After Transplantation|5
296083|NCT01672957|997978|P1|Overall Study|Death|2
296084|NCT01672957|997978|P1|Overall Study|Protocol Violation|48
296085|NCT01672892|997993|P2|Overall Study|Protocol Violation|3
296086|NCT01672892|997994|P1|Overall Study|Protocol Violation|8
296087|NCT01672788|998014|P4|Washout Period 2 (7 Days)|Adverse Event|1
296088|NCT01672788|998015|P3|Washout Period 2 (7 Days)|Adverse Event|0
296089|NCT01672788|998016|P2|Washout Period 2 (7 Days)|Adverse Event|0
296090|NCT01672788|998017|P1|Washout Period 2 (7 Days)|Adverse Event|0
296091|NCT01672723|998047|P2|First Intervention|Adverse Event|0
296092|NCT01672723|998048|P1|First Intervention|Adverse Event|3
296093|NCT01672294|998085|P4|Overall Study|Lost to Follow-up|9
296094|NCT01672294|998086|P3|Overall Study|Lost to Follow-up|7
296095|NCT01672294|998087|P2|Overall Study|Lost to Follow-up|16
296096|NCT01672294|998088|P1|Overall Study|Lost to Follow-up|1
296097|NCT01672294|998085|P4|Overall Study|Excluded by study|0
296098|NCT01672294|998086|P3|Overall Study|Excluded by study|0
296099|NCT01672294|998087|P2|Overall Study|Excluded by study|1
296100|NCT01672294|998088|P1|Overall Study|Excluded by study|1
296101|NCT01672294|998085|P4|Overall Study|Withdrawal by Subject|4
296102|NCT01672294|998086|P3|Overall Study|Withdrawal by Subject|4
296103|NCT01672294|998087|P2|Overall Study|Withdrawal by Subject|4
296104|NCT01672294|998088|P1|Overall Study|Withdrawal by Subject|4
296105|NCT01671748|998128|P2|4 Week run-in Phase|Not eligible|0
296106|NCT01671748|998129|P1|4 Week run-in Phase|Not eligible|9
296107|NCT01671748|998128|P2|4 Week run-in Phase|Adverse Event|0
296108|NCT01671748|998129|P1|4 Week run-in Phase|Adverse Event|1
296109|NCT01671748|998128|P2|4 Week run-in Phase|Withdrawal by Subject|0
296110|NCT01671748|998129|P1|4 Week run-in Phase|Withdrawal by Subject|1
296111|NCT01671488|998156|P1|Overall Study|Withdrawal by Subject|1
296112|NCT01671319|998162|P1|Overall Study|Withdrawal by Subject|1
296113|NCT01671280|998177|P1|Overall Study|Withdrawal by Subject|2
296114|NCT01671111|998188|P1|Overall Study|Other|24
296115|NCT01671111|998188|P1|Overall Study|Physician Decision|1
296116|NCT01671111|998188|P1|Overall Study|Withdrawal by Subject|2
296117|NCT01671111|998188|P1|Overall Study|Lack of Efficacy|1
296118|NCT01671111|998188|P1|Overall Study|Adverse Event|2
296119|NCT01671059|998198|P1|Overall Study|Lack of Efficacy|1
296120|NCT01671059|998198|P1|Overall Study|Adverse Event|4
296121|NCT01670721|998290|P1|Overall Study|Other than specified above|38
296122|NCT01670721|998290|P1|Overall Study|Participant's decision|15
296123|NCT01670656|998302|P5|Overall Study|Subject moved|0
296124|NCT01670656|998303|P4|Overall Study|Subject moved|1
296125|NCT01670656|998304|P3|Overall Study|Subject moved|0
296126|NCT01670656|998305|P2|Overall Study|Subject moved|0
296127|NCT01670656|998306|P1|Overall Study|Subject moved|0
296128|NCT01670656|998302|P5|Overall Study|Lost to Follow-up|3
296129|NCT01670656|998303|P4|Overall Study|Lost to Follow-up|0
296130|NCT01670656|998304|P3|Overall Study|Lost to Follow-up|0
296131|NCT01670656|998305|P2|Overall Study|Lost to Follow-up|0
296132|NCT01670656|998306|P1|Overall Study|Lost to Follow-up|0
296133|NCT01670656|998302|P5|Overall Study|Subject withdrew consent|1
296134|NCT01670656|998303|P4|Overall Study|Subject withdrew consent|1
296135|NCT01670656|998304|P3|Overall Study|Subject withdrew consent|2
296136|NCT01670656|998305|P2|Overall Study|Subject withdrew consent|1
296137|NCT01670656|998306|P1|Overall Study|Subject withdrew consent|0
296138|NCT01670656|998302|P5|Overall Study|Adverse Event|3
296139|NCT01670656|998303|P4|Overall Study|Adverse Event|3
296140|NCT01670656|998304|P3|Overall Study|Adverse Event|2
296141|NCT01670656|998305|P2|Overall Study|Adverse Event|2
296142|NCT01670656|998306|P1|Overall Study|Adverse Event|2
296143|NCT01670656|998302|P5|Overall Study|Non-compliance with protocol|2
296144|NCT01670656|998303|P4|Overall Study|Non-compliance with protocol|1
296145|NCT01670656|998304|P3|Overall Study|Non-compliance with protocol|1
296146|NCT01670656|998305|P2|Overall Study|Non-compliance with protocol|3
296147|NCT01670656|998306|P1|Overall Study|Non-compliance with protocol|0
296148|NCT01670656|998302|P5|Overall Study|Withdrawal by Subject|0
296149|NCT01670656|998303|P4|Overall Study|Withdrawal by Subject|0
296150|NCT01670656|998304|P3|Overall Study|Withdrawal by Subject|0
296151|NCT01670656|998305|P2|Overall Study|Withdrawal by Subject|1
296152|NCT01670656|998306|P1|Overall Study|Withdrawal by Subject|1
296153|NCT01670656|998302|P5|Overall Study|Pregnancy|1
296154|NCT01670656|998303|P4|Overall Study|Pregnancy|0
296155|NCT01670656|998304|P3|Overall Study|Pregnancy|0
296156|NCT01670656|998305|P2|Overall Study|Pregnancy|0
296157|NCT01670656|998306|P1|Overall Study|Pregnancy|0
296158|NCT01670656|998302|P5|Overall Study|Non-compliance with study drug|1
296159|NCT01670656|998303|P4|Overall Study|Non-compliance with study drug|0
296160|NCT01670656|998304|P3|Overall Study|Non-compliance with study drug|3
296161|NCT01670656|998305|P2|Overall Study|Non-compliance with study drug|0
296162|NCT01670656|998306|P1|Overall Study|Non-compliance with study drug|0
296163|NCT01670526|998335|P2|Overall Study|Lost to Follow-up|5
296164|NCT01670526|998336|P1|Overall Study|Lost to Follow-up|9
296165|NCT01670526|998335|P2|Overall Study|Withdrawal by Subject|1
296166|NCT01670526|998336|P1|Overall Study|Withdrawal by Subject|3
296167|NCT01670292|998357|P1|Overall Study|Lost to Follow-up|14
296168|NCT01670279|998398|P4|Overall Study|Participant met withdrawal criteria|1
296169|NCT01670279|998399|P3|Overall Study|Participant met withdrawal criteria|0
296170|NCT01670279|998400|P2|Overall Study|Participant met withdrawal criteria|0
296171|NCT01670279|998401|P1|Overall Study|Participant met withdrawal criteria|0
296172|NCT01670279|998398|P4|Overall Study|Physician Decision|0
296173|NCT01670279|998399|P3|Overall Study|Physician Decision|0
296174|NCT01670279|998400|P2|Overall Study|Physician Decision|1
296175|NCT01670279|998401|P1|Overall Study|Physician Decision|0
296176|NCT01670279|998398|P4|Overall Study|Adverse Event|0
296177|NCT01670279|998399|P3|Overall Study|Adverse Event|0
296178|NCT01670279|998400|P2|Overall Study|Adverse Event|1
296179|NCT01670279|998401|P1|Overall Study|Adverse Event|0
296180|NCT01670188|998443|P2|Overall Study|Death|1
296181|NCT01670188|998444|P1|Overall Study|Death|0
296182|NCT01670045|998450|P1|Overall Study|Lost to Follow-up|11
296183|NCT01670045|998450|P1|Overall Study|Death|1
296184|NCT01670045|998450|P1|Overall Study|Adverse Event|1
296185|NCT01670045|998450|P1|Overall Study|Withdrawal by Subject|3
296186|NCT01670019|998468|P2|Overall Study|Withdrawal by Subject|0
296187|NCT01670019|998469|P1|Overall Study|Withdrawal by Subject|6
296188|NCT01670019|998468|P2|Overall Study|Adverse Event|0
296189|NCT01670019|998469|P1|Overall Study|Adverse Event|3
296190|NCT01669902|998483|P1|Overall Study|Other|8
296191|NCT01669902|998483|P1|Overall Study|Lack of Efficacy|10
296192|NCT01669902|998483|P1|Overall Study|Adverse Event|11
296193|NCT01669811|998518|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
296194|NCT01669811|998519|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
296195|NCT01669811|998518|P2|Overall Study|Adverse Event|6
296196|NCT01669811|998519|P1|Overall Study|Adverse Event|2
296197|NCT01669811|998518|P2|Overall Study|Withdrawal by Subject|2
296198|NCT01669811|998519|P1|Overall Study|Withdrawal by Subject|1
296199|NCT01669811|998518|P2|Overall Study|Investigator decision|1
296200|NCT01669811|998519|P1|Overall Study|Investigator decision|0
296201|NCT01669629|998630|P2|Period 1|protocol deviation|2
296202|NCT01669629|998631|P1|Period 1|protocol deviation|1
296203|NCT01669577|998654|P1|Overall Study|Physician Decision|34
296204|NCT01669577|998654|P1|Overall Study|Lost to Follow-up|78
296205|NCT01669577|998654|P1|Overall Study|Death|22
296206|NCT01669174|998679|P2|Overall Study|Administrative problems|2
296207|NCT01669174|998680|P1|Overall Study|Administrative problems|1
296208|NCT01669174|998679|P2|Overall Study|Adverse Event|2
296209|NCT01669174|998680|P1|Overall Study|Adverse Event|2
296210|NCT01669174|998679|P2|Overall Study|Lost to Follow-up|0
296211|NCT01669174|998680|P1|Overall Study|Lost to Follow-up|1
296212|NCT01669174|998679|P2|Overall Study|Subject withdrew consent|2
296213|NCT01669174|998680|P1|Overall Study|Subject withdrew consent|2
296214|NCT01669122|998696|P1|Washout Period II|Protocol Violation|2
296215|NCT01669122|998696|P1|Period I|Lost to Follow-up|1
296216|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
296217|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
296218|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
296219|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
296220|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
296221|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
296222|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
296223|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
296224|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
296225|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
296226|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
296227|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
296228|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
296229|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
296230|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
296231|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
296232|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
296233|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
296234|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
296235|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
296236|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
296237|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
296238|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
296239|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
296240|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
296241|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
296242|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
296243|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
296244|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
296245|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
296246|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
296247|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
296248|NCT01668797|998789|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
296249|NCT01668797|998790|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
296250|NCT01668797|998791|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
296251|NCT01668797|998792|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
296252|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
296253|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
296254|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
296255|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
296256|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
296257|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
296258|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
296259|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
296260|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
296261|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
296262|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
296263|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
296264|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Protocol Violation|0
296265|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Protocol Violation|0
296266|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Protocol Violation|3
296267|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Protocol Violation|0
296268|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
296269|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
296270|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
296271|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
296272|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Physician Decision|0
296273|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Physician Decision|0
296274|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Physician Decision|11
296275|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Physician Decision|0
296276|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
296277|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
296278|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
296279|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
296280|NCT01668797|998789|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
296281|NCT01668797|998790|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
296282|NCT01668797|998791|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
296283|NCT01668797|998792|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
296284|NCT01668797|998789|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
296285|NCT01668797|998790|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
296286|NCT01668797|998791|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
296287|NCT01668797|998792|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
296288|NCT01668797|998789|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
296289|NCT01668797|998790|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
296290|NCT01668797|998791|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
296291|NCT01668797|998792|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
296292|NCT01668797|998789|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
296293|NCT01668797|998790|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
296294|NCT01668797|998791|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
296295|NCT01668797|998792|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
296296|NCT01668797|998789|P4|Phase A (Conversion Phase)|Protocol Violation|0
296297|NCT01668797|998790|P3|Phase A (Conversion Phase)|Protocol Violation|0
296298|NCT01668797|998791|P2|Phase A (Conversion Phase)|Protocol Violation|0
296299|NCT01668797|998792|P1|Phase A (Conversion Phase)|Protocol Violation|2
296300|NCT01668797|998789|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
296301|NCT01668797|998790|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
296302|NCT01668797|998791|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
296303|NCT01668797|998792|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
296304|NCT01668797|998789|P4|Phase A (Conversion Phase)|Physician Decision|0
296305|NCT01668797|998790|P3|Phase A (Conversion Phase)|Physician Decision|0
296306|NCT01668797|998791|P2|Phase A (Conversion Phase)|Physician Decision|0
296307|NCT01668797|998792|P1|Phase A (Conversion Phase)|Physician Decision|2
296308|NCT01668797|998789|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
296309|NCT01668797|998790|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
296310|NCT01668797|998791|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
296311|NCT01668797|998792|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
296312|NCT01668797|998789|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
296313|NCT01668797|998790|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
296314|NCT01668797|998791|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
296315|NCT01668797|998792|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
296316|NCT01668784|998857|P2|Treated (Overall)|Not Specified|4
296317|NCT01668784|998858|P1|Treated (Overall)|Not Specified|0
296318|NCT01668784|998857|P2|Treated (Overall)|Maximal Clinical Benefit|3
296319|NCT01668784|998858|P1|Treated (Overall)|Maximal Clinical Benefit|2
296320|NCT01668784|998857|P2|Treated (Overall)|Withdrawal by Subject|3
296321|NCT01668784|998858|P1|Treated (Overall)|Withdrawal by Subject|2
296322|NCT01668784|998857|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
296323|NCT01668784|998858|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
296324|NCT01668784|998857|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
296325|NCT01668784|998858|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
296326|NCT01668784|998857|P2|Treated (Overall)|Death|1
296327|NCT01668784|998858|P1|Treated (Overall)|Death|1
296328|NCT01668784|998857|P2|Treated (Overall)|Study Drug Toxicity|53
296329|NCT01668784|998858|P1|Treated (Overall)|Study Drug Toxicity|35
296330|NCT01668784|998857|P2|Treated (Overall)|Disease Progression|273
296331|NCT01668784|998858|P1|Treated (Overall)|Disease Progression|285
296332|NCT01668784|998857|P2|Randomized (Pre-treatment)|Not Specified|1
296333|NCT01668784|998858|P1|Randomized (Pre-treatment)|Not Specified|0
296334|NCT01668784|998857|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
296335|NCT01668784|998858|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
296336|NCT01668784|998857|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
296337|NCT01668784|998858|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
296338|NCT01668784|998857|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
296339|NCT01668784|998858|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
296340|NCT01668784|998857|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
296341|NCT01668784|998858|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
296342|NCT01668784|998857|P2|Randomized (Pre-treatment)|Disease Progression|1
296343|NCT01668784|998858|P1|Randomized (Pre-treatment)|Disease Progression|0
296344|NCT01668667|998886|P4|Overall Study|Withdrawal by Subject|5
296345|NCT01668667|998887|P3|Overall Study|Withdrawal by Subject|5
296346|NCT01668667|998888|P2|Overall Study|Withdrawal by Subject|4
296347|NCT01668667|998889|P1|Overall Study|Withdrawal by Subject|7
296348|NCT01668667|998886|P4|Overall Study|Physician Decision|0
296349|NCT01668667|998887|P3|Overall Study|Physician Decision|1
296350|NCT01668667|998888|P2|Overall Study|Physician Decision|0
296351|NCT01668667|998889|P1|Overall Study|Physician Decision|3
296352|NCT01668667|998886|P4|Overall Study|Lost to Follow-up|6
296353|NCT01668667|998887|P3|Overall Study|Lost to Follow-up|7
296354|NCT01668667|998888|P2|Overall Study|Lost to Follow-up|4
296355|NCT01668667|998889|P1|Overall Study|Lost to Follow-up|9
296356|NCT01668667|998886|P4|Overall Study|Protocol Violation|5
296357|NCT01668667|998887|P3|Overall Study|Protocol Violation|12
296358|NCT01668667|998888|P2|Overall Study|Protocol Violation|10
296359|NCT01668667|998889|P1|Overall Study|Protocol Violation|6
296360|NCT01668667|998886|P4|Overall Study|Lack of Efficacy|3
296361|NCT01668667|998887|P3|Overall Study|Lack of Efficacy|2
296362|NCT01668667|998888|P2|Overall Study|Lack of Efficacy|2
296363|NCT01668667|998889|P1|Overall Study|Lack of Efficacy|3
296364|NCT01668667|998886|P4|Overall Study|Adverse Event|4
296365|NCT01668667|998887|P3|Overall Study|Adverse Event|4
296366|NCT01668667|998888|P2|Overall Study|Adverse Event|6
296367|NCT01668667|998889|P1|Overall Study|Adverse Event|3
296368|NCT01668654|998911|P1|Overall Study|Withdrawal by Subject|1
296369|NCT01668654|998911|P1|Overall Study|Study Closed/Terminated|3
296370|NCT01668589|998972|P4|Overall Study|Other|15
296371|NCT01668589|998973|P3|Overall Study|Other|7
296372|NCT01668589|998974|P2|Overall Study|Other|10
296373|NCT01668589|998975|P1|Overall Study|Other|44
296374|NCT01668589|998972|P4|Overall Study|Death|11
296375|NCT01668589|998973|P3|Overall Study|Death|2
296376|NCT01668589|998974|P2|Overall Study|Death|3
296377|NCT01668589|998975|P1|Overall Study|Death|12
296378|NCT01668589|998972|P4|Overall Study|Full Consent/Agreement Withdrawn|4
296379|NCT01668589|998973|P3|Overall Study|Full Consent/Agreement Withdrawn|11
296380|NCT01668589|998974|P2|Overall Study|Full Consent/Agreement Withdrawn|8
296381|NCT01668589|998975|P1|Overall Study|Full Consent/Agreement Withdrawn|54
296382|NCT01668589|998972|P4|Overall Study|Lost to Follow-up|5
296383|NCT01668589|998973|P3|Overall Study|Lost to Follow-up|15
296384|NCT01668589|998974|P2|Overall Study|Lost to Follow-up|37
296385|NCT01668589|998975|P1|Overall Study|Lost to Follow-up|29
296386|NCT01668173|999013|P1|Overall Study|Trial suspension|4
296387|NCT01668173|999013|P1|Overall Study|Adverse Event|3
296388|NCT01668004|999139|P1|Overall Study|Non-compliance with treatment|2
296389|NCT01668004|999139|P1|Overall Study|Lack of Efficacy|9
296390|NCT01668004|999139|P1|Overall Study|Lost to Follow-up|5
296391|NCT01668004|999139|P1|Overall Study|Withdrawal by Subject|2
296392|NCT01668004|999139|P1|Overall Study|Adverse Event|7
296393|NCT01667926|999161|P3|Overall Study|Side effects|0
296394|NCT01667926|999162|P2|Overall Study|Side effects|0
296395|NCT01667926|999163|P1|Overall Study|Side effects|3
296396|NCT01667926|999161|P3|Overall Study|Lost to Follow-up|1
296397|NCT01667926|999162|P2|Overall Study|Lost to Follow-up|2
296398|NCT01667926|999163|P1|Overall Study|Lost to Follow-up|1
296399|NCT01667926|999161|P3|Overall Study|Inclusion/Exclusion Criteria|5
296400|NCT01667926|999162|P2|Overall Study|Inclusion/Exclusion Criteria|0
296401|NCT01667926|999163|P1|Overall Study|Inclusion/Exclusion Criteria|0
296402|NCT01667926|999161|P3|Overall Study|Time committment|2
296403|NCT01667926|999162|P2|Overall Study|Time committment|0
296404|NCT01667926|999163|P1|Overall Study|Time committment|0
296405|NCT01667926|999161|P3|Overall Study|Physician Decision|1
296406|NCT01667926|999162|P2|Overall Study|Physician Decision|0
296407|NCT01667926|999163|P1|Overall Study|Physician Decision|0
296408|NCT01667926|999161|P3|Overall Study|Withdrawal by Subject|2
296409|NCT01667926|999162|P2|Overall Study|Withdrawal by Subject|2
296410|NCT01667926|999163|P1|Overall Study|Withdrawal by Subject|1
296411|NCT01667900|999176|P20|Part B|Death|0
296412|NCT01667900|999177|P19|Part B|Death|0
296413|NCT01667900|999178|P18|Part B|Death|0
296414|NCT01667900|999179|P17|Part B|Death|1
296415|NCT01667900|999180|P16|Part B|Death|0
296416|NCT01667900|999181|P15|Part B|Death|0
296417|NCT01667900|999182|P14|Part B|Death|0
296418|NCT01667900|999183|P13|Part B|Death|0
296419|NCT01667900|999184|P12|Part B|Death|0
296420|NCT01667900|999185|P11|Part B|Death|0
296421|NCT01667900|999186|P10|Part B|Death|0
296422|NCT01667900|999187|P9|Part B|Death|0
296423|NCT01667900|999188|P8|Part B|Death|0
296424|NCT01667900|999189|P7|Part B|Death|0
296425|NCT01667900|999190|P6|Part B|Death|0
296426|NCT01667900|999191|P5|Part B|Death|0
296427|NCT01667900|999192|P4|Part B|Death|0
296428|NCT01667900|999193|P3|Part B|Death|0
296429|NCT01667900|999194|P2|Part B|Death|0
296430|NCT01667900|999195|P1|Part B|Death|0
296431|NCT01667731|999258|P5|Overall Study|Death|0
296432|NCT01667731|999259|P4|Overall Study|Death|0
296433|NCT01667731|999260|P3|Overall Study|Death|0
296434|NCT01667731|999261|P2|Overall Study|Death|1
296435|NCT01667731|999262|P1|Overall Study|Death|0
296436|NCT01667731|999258|P5|Overall Study|Subject Withdrew Consent|1
296437|NCT01667731|999259|P4|Overall Study|Subject Withdrew Consent|0
296438|NCT01667731|999260|P3|Overall Study|Subject Withdrew Consent|1
296439|NCT01667731|999261|P2|Overall Study|Subject Withdrew Consent|0
296440|NCT01667731|999262|P1|Overall Study|Subject Withdrew Consent|2
296441|NCT01667731|999258|P5|Overall Study|Lost to Follow-up|2
296442|NCT01667731|999259|P4|Overall Study|Lost to Follow-up|1
296443|NCT01667731|999260|P3|Overall Study|Lost to Follow-up|1
296444|NCT01667731|999261|P2|Overall Study|Lost to Follow-up|3
296445|NCT01667731|999262|P1|Overall Study|Lost to Follow-up|2
296446|NCT01667731|999258|P5|Overall Study|Efficacy Failure|24
296447|NCT01667731|999259|P4|Overall Study|Efficacy Failure|1
296448|NCT01667731|999260|P3|Overall Study|Efficacy Failure|0
296449|NCT01667731|999261|P2|Overall Study|Efficacy Failure|12
296450|NCT01667731|999262|P1|Overall Study|Efficacy Failure|1
296451|NCT01667731|999258|P5|Overall Study|Enrolled but not treated|1
296452|NCT01667731|999259|P4|Overall Study|Enrolled but not treated|0
296453|NCT01667731|999260|P3|Overall Study|Enrolled but not treated|0
296454|NCT01667731|999261|P2|Overall Study|Enrolled but not treated|0
296455|NCT01667731|999262|P1|Overall Study|Enrolled but not treated|0
296456|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
296457|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
296458|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
296459|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
296460|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
296461|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
296462|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
296463|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
296464|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
296465|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
296466|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
296467|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
296468|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
296469|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
296470|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
296471|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
296472|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
296473|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
296474|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
296475|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
296476|NCT01667679|999317|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
296477|NCT01667679|999318|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
296478|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
296479|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
296480|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
296481|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
296482|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
296483|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
296484|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
296485|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
296486|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
296487|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
296488|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
296489|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
296490|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
296491|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
296492|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
296493|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
296494|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
296495|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
296496|NCT01667679|999317|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
296497|NCT01667679|999318|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
296498|NCT01667432|999403|P1|Overall Study|Missing Information|4
296499|NCT01667432|999403|P1|Overall Study|Reason Not Specified|2
296500|NCT01667432|999403|P1|Overall Study|Principal Investigator Decision|1
296501|NCT01667432|999403|P1|Overall Study|Protocol Deviation|2
296502|NCT01667432|999403|P1|Overall Study|Adverse Event|1
296503|NCT01667432|999403|P1|Overall Study|Insufficient Therapeutic Response|4
296504|NCT01667432|999403|P1|Overall Study|Refused Treatment/Withdrew Consent|1
296505|NCT01667432|999403|P1|Overall Study|Lost to Follow-up|3
296506|NCT01667432|999403|P1|Overall Study|Moved to Another Center|3
296507|NCT01667432|999403|P1|Overall Study|Failure to Return|10
296508|NCT01667432|999403|P1|Overall Study|Premature Study Termination|26
296509|NCT01667224|999428|P2|Overall Study|Protocol Violation|1
296510|NCT01667224|999429|P1|Overall Study|Protocol Violation|1
296511|NCT01667224|999428|P2|Overall Study|Withdrawal by Subject|1
296512|NCT01667224|999429|P1|Overall Study|Withdrawal by Subject|3
296513|NCT01667107|999443|P2|Overall Study|Lack of Efficacy|1
296514|NCT01667107|999444|P1|Overall Study|Lack of Efficacy|0
296515|NCT01667107|999443|P2|Overall Study|Protocol Violation|1
296516|NCT01667107|999444|P1|Overall Study|Protocol Violation|0
296517|NCT01667107|999443|P2|Overall Study|Tolerability issues|2
296518|NCT01667107|999444|P1|Overall Study|Tolerability issues|0
296519|NCT01667107|999443|P2|Overall Study|Adverse Event|3
296520|NCT01667107|999444|P1|Overall Study|Adverse Event|4
296521|NCT01666951|999462|P2|Overall Study|Not dosed|1
296522|NCT01666951|999463|P1|Overall Study|Not dosed|1
296523|NCT01666782|999514|P2|Overall Study|Enrolled both years; year 1 data used|0
296524|NCT01666782|999515|P1|Overall Study|Enrolled both years; year 1 data used|4
296525|NCT01666782|999514|P2|Overall Study|Received 2 doses of vaccine|1
296526|NCT01666782|999515|P1|Overall Study|Received 2 doses of vaccine|0
296527|NCT01666314|999539|P4|Overall Study|Reason not Specified|5
296528|NCT01666314|999540|P3|Overall Study|Reason not Specified|5
296529|NCT01666314|999541|P2|Overall Study|Reason not Specified|7
296530|NCT01666314|999542|P1|Overall Study|Reason not Specified|10
296531|NCT01666314|999539|P4|Overall Study|Withdrawal by Subject|3
296532|NCT01666314|999540|P3|Overall Study|Withdrawal by Subject|2
296533|NCT01666314|999541|P2|Overall Study|Withdrawal by Subject|1
296534|NCT01666314|999542|P1|Overall Study|Withdrawal by Subject|1
296535|NCT01666314|999539|P4|Overall Study|Unsatisfactory Therapeutic Response|1
296536|NCT01666314|999540|P3|Overall Study|Unsatisfactory Therapeutic Response|1
296537|NCT01666314|999541|P2|Overall Study|Unsatisfactory Therapeutic Response|2
296538|NCT01666314|999542|P1|Overall Study|Unsatisfactory Therapeutic Response|7
296539|NCT01666314|999539|P4|Overall Study|Symptomatic Deterioration|0
296540|NCT01666314|999540|P3|Overall Study|Symptomatic Deterioration|2
296541|NCT01666314|999541|P2|Overall Study|Symptomatic Deterioration|0
296542|NCT01666314|999542|P1|Overall Study|Symptomatic Deterioration|1
296543|NCT01666314|999539|P4|Overall Study|Progressive Disease|20
296544|NCT01666314|999540|P3|Overall Study|Progressive Disease|19
296545|NCT01666314|999541|P2|Overall Study|Progressive Disease|9
296546|NCT01666314|999542|P1|Overall Study|Progressive Disease|11
296547|NCT01666314|999539|P4|Overall Study|Adverse Event|7
296548|NCT01666314|999540|P3|Overall Study|Adverse Event|7
296549|NCT01666314|999541|P2|Overall Study|Adverse Event|13
296550|NCT01666314|999542|P1|Overall Study|Adverse Event|3
296551|NCT01666119|999673|P1|Overall Study|Subject experiencing withdrawal symptoms|5
296552|NCT01666119|999673|P1|Overall Study|non compliance with study medication, pa|18
296553|NCT01666119|999673|P1|Overall Study|Lost to Follow-up|7
296554|NCT01666119|999673|P1|Overall Study|Withdrawal by Subject|16
296555|NCT01666119|999673|P1|Overall Study|Adverse Event|6
296556|NCT01666002|999680|P2|Overall Study|Lost to Follow-up|0
296557|NCT01666002|999681|P1|Overall Study|Lost to Follow-up|5
296558|NCT01665911|999702|P1|Overall Study|Adverse Event|1
296559|NCT01665911|999702|P1|Overall Study|Withdrawal by Subject|1
296560|NCT01665911|999702|P1|Overall Study|Protocol Violation|4
296561|NCT01665807|999711|P3|Overall Study|Withdrawal by Subject|1
296562|NCT01665807|999712|P2|Overall Study|Withdrawal by Subject|0
296563|NCT01665807|999713|P1|Overall Study|Withdrawal by Subject|2
296564|NCT01665599|999724|P1|Overall Study|Could Not Continue Due to Time Constrain|1
296565|NCT01665599|999724|P1|Overall Study|Participant Left for More Than 3 Months|1
296566|NCT01665599|999724|P1|Overall Study|Lost to Follow-up|2
296567|NCT01665599|999724|P1|Overall Study|Death|1
296568|NCT01665599|999724|P1|Overall Study|Investigator/Sponsor decision|1
296569|NCT01665599|999724|P1|Overall Study|Consent Withdrawn|1
296570|NCT01665599|999724|P1|Overall Study|Adverse Event|1
296571|NCT01665430|999760|P1|Overall Study|Other Unspecified|2
296572|NCT01665430|999760|P1|Overall Study|Withdrawal by Subject|6
296573|NCT01665430|999760|P1|Overall Study|Adverse Event|1
296574|NCT01664949|999908|P2|Overall Study|Other Miscellaneous Reasons|1
296575|NCT01664949|999909|P1|Overall Study|Other Miscellaneous Reasons|3
296576|NCT01664949|999908|P2|Overall Study|Protocol Violation|5
296577|NCT01664949|999909|P1|Overall Study|Protocol Violation|5
296578|NCT01664949|999908|P2|Overall Study|Personal Reasons|4
296579|NCT01664949|999909|P1|Overall Study|Personal Reasons|3
296580|NCT01664949|999908|P2|Overall Study|Lost to Follow-up|2
296581|NCT01664949|999909|P1|Overall Study|Lost to Follow-up|1
296582|NCT01664949|999908|P2|Overall Study|Lack of Efficacy|1
296583|NCT01664949|999909|P1|Overall Study|Lack of Efficacy|1
296584|NCT01664949|999908|P2|Overall Study|Adverse Event|12
296585|NCT01664949|999909|P1|Overall Study|Adverse Event|11
296600|NCT01664624|999970|P4|Overall Study|Adverse Event|0
296601|NCT01664624|999971|P3|Overall Study|Adverse Event|0
296602|NCT01664624|999972|P2|Overall Study|Adverse Event|1
296603|NCT01664624|999973|P1|Overall Study|Adverse Event|0
296604|NCT01664533|1000020|P1|Overall Study|Protocol Violation|3
296605|NCT01664533|1000020|P1|Overall Study|Study termination|9
296606|NCT01664533|1000020|P1|Overall Study|Lost to Follow-up|3
296607|NCT01664533|1000020|P1|Overall Study|Death|42
296608|NCT01664494|1000028|P1|Overall Study|Lost to Follow-up|99
296609|NCT01664494|1000028|P1|Overall Study|Not specified|49
296610|NCT01664494|1000028|P1|Overall Study|Death|18
296611|NCT01664494|1000028|P1|Overall Study|Withdrawal by Subject|27
296612|NCT01664247|1000035|P2|Overall Study|Unclassified|29
296613|NCT01664247|1000036|P1|Overall Study|Unclassified|5
296614|NCT01664247|1000035|P2|Overall Study|Withdrawal Criteria|4
296615|NCT01664247|1000036|P1|Overall Study|Withdrawal Criteria|1
296616|NCT01664247|1000035|P2|Overall Study|Protocol Violation|5
296617|NCT01664247|1000036|P1|Overall Study|Protocol Violation|3
296618|NCT01664247|1000035|P2|Overall Study|Adverse Event|3
296619|NCT01664247|1000036|P1|Overall Study|Adverse Event|5
296620|NCT01664104|1000113|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
296621|NCT01664104|1000113|P1|Overall Study|Other|1
296622|NCT01664104|1000113|P1|Overall Study|Lost to Follow-up|4
296623|NCT01664104|1000113|P1|Overall Study|Withdrawal by Subject|1
296624|NCT01664104|1000113|P1|Overall Study|Lack of Efficacy|2
296625|NCT01664104|1000113|P1|Overall Study|Adverse Event|6
296626|NCT01664052|1000182|P2|Phase 2|No device placement|4
296627|NCT01664052|1000183|P1|Phase 2|No device placement|0
296628|NCT01664052|1000182|P2|Phase 1|No HSG 1 hr post placement|0
296629|NCT01664052|1000183|P1|Phase 1|No HSG 1 hr post placement|1
296630|NCT01664052|1000182|P2|Phase 1|No device placement|0
296631|NCT01664052|1000183|P1|Phase 1|No device placement|6
296632|NCT01664039|1000201|P2|Overall Study|Noncompliance|1
296633|NCT01664039|1000202|P1|Overall Study|Noncompliance|1
296634|NCT01664039|1000201|P2|Overall Study|Withdrawal by Subject|3
296635|NCT01664039|1000202|P1|Overall Study|Withdrawal by Subject|1
296636|NCT01664039|1000201|P2|Overall Study|Lost to Follow-up|1
296637|NCT01664039|1000202|P1|Overall Study|Lost to Follow-up|1
296638|NCT01664039|1000201|P2|Overall Study|Adverse Event|4
296639|NCT01664039|1000202|P1|Overall Study|Adverse Event|3
296640|NCT01663987|1000224|P2|Overall Study|Other reason not defined above|0
296641|NCT01663987|1000225|P1|Overall Study|Other reason not defined above|3
296642|NCT01663987|1000224|P2|Overall Study|Withdrawal by Subject|3
296643|NCT01663987|1000225|P1|Overall Study|Withdrawal by Subject|2
296644|NCT01663987|1000224|P2|Overall Study|Lost to Follow-up|1
296645|NCT01663987|1000225|P1|Overall Study|Lost to Follow-up|1
296646|NCT01663987|1000224|P2|Overall Study|Adverse Event|2
296647|NCT01663987|1000225|P1|Overall Study|Adverse Event|7
296648|NCT01663727|1000268|P2|Overall Study|Lost to Follow-up|3
296649|NCT01663727|1000269|P1|Overall Study|Lost to Follow-up|8
296650|NCT01663727|1000268|P2|Overall Study|Alive in Follow-Up|132
296651|NCT01663727|1000269|P1|Overall Study|Alive in Follow-Up|143
296652|NCT01663727|1000268|P2|Overall Study|Alive on Treatment|39
296653|NCT01663727|1000269|P1|Overall Study|Alive on Treatment|31
296654|NCT01663727|1000268|P2|Overall Study|Death|65
296655|NCT01663727|1000269|P1|Overall Study|Death|60
296656|NCT01663714|1000297|P1|Long-Term Follow-Up|Non-compliance|1
296657|NCT01663714|1000297|P1|Long-Term Follow-Up|Death|4
296658|NCT01663714|1000297|P1|Long-Term Follow-Up|Lost to Follow-up|1
296659|NCT01663714|1000297|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
296660|NCT01663714|1000297|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
296661|NCT01663714|1000297|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
296662|NCT01663623|1000326|P2|Overall Study|Withdrawal by Subject|1
296663|NCT01663623|1000327|P1|Overall Study|Withdrawal by Subject|2
296664|NCT01663623|1000326|P2|Overall Study|Physician Decision|4
296665|NCT01663623|1000327|P1|Overall Study|Physician Decision|1
296666|NCT01663623|1000326|P2|Overall Study|Other-Study closed/terminated|1
296667|NCT01663623|1000327|P1|Overall Study|Other-Study closed/terminated|1
296668|NCT01663623|1000326|P2|Overall Study|Protocol Violation|1
296669|NCT01663623|1000327|P1|Overall Study|Protocol Violation|0
296670|NCT01663623|1000326|P2|Overall Study|Lack of Efficacy|6
296671|NCT01663623|1000327|P1|Overall Study|Lack of Efficacy|5
296672|NCT01663623|1000326|P2|Overall Study|Adverse Event|7
296673|NCT01663623|1000327|P1|Overall Study|Adverse Event|3
296674|NCT01663532|1000337|P2|Overall Study|Lack of Efficacy|60
296675|NCT01663532|1000338|P1|Overall Study|Lack of Efficacy|15
296676|NCT01663532|1000337|P2|Overall Study|Withdrawal by Subject|17
296677|NCT01663532|1000338|P1|Overall Study|Withdrawal by Subject|35
296678|NCT01663532|1000337|P2|Overall Study|Physician Decision|1
296679|NCT01663532|1000338|P1|Overall Study|Physician Decision|1
296680|NCT01663532|1000337|P2|Overall Study|Met Withdrawal Criteria|6
296681|NCT01663532|1000338|P1|Overall Study|Met Withdrawal Criteria|7
296682|NCT01663532|1000337|P2|Overall Study|Adverse Event|13
296683|NCT01663532|1000338|P1|Overall Study|Adverse Event|7
296684|NCT01663532|1000337|P2|Overall Study|Lost to Follow-up|10
296685|NCT01663532|1000338|P1|Overall Study|Lost to Follow-up|9
296686|NCT01663506|1000356|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
296687|NCT01663506|1000356|P1|Overall Study|Adverse Event|1
296688|NCT01663506|1000356|P1|Overall Study|Lost to Follow-up|1
296689|NCT01663506|1000356|P1|Overall Study|Consent Withdrawal by Subject|1
296690|NCT01663506|1000356|P1|Overall Study|Lack of Efficacy|3
296691|NCT01663233|1000398|P2|Overall Study|Lost to Follow-up|1
296692|NCT01663233|1000399|P1|Overall Study|Lost to Follow-up|0
296693|NCT01663233|1000398|P2|Overall Study|Protocol Deviation|4
296694|NCT01663233|1000399|P1|Overall Study|Protocol Deviation|1
296695|NCT01663233|1000398|P2|Overall Study|Withdrawal by Subject|2
296696|NCT01663233|1000399|P1|Overall Study|Withdrawal by Subject|3
296697|NCT01663103|1000423|P2|Overall Study|dog bite|0
296698|NCT01663103|1000424|P1|Overall Study|dog bite|1
296699|NCT01663103|1000423|P2|Overall Study|Adverse Event|0
296700|NCT01663103|1000424|P1|Overall Study|Adverse Event|1
296701|NCT01663103|1000423|P2|Overall Study|Withdrawal by Subject|2
296702|NCT01663103|1000424|P1|Overall Study|Withdrawal by Subject|1
296703|NCT01662999|1000452|P6|Period 3|Withdrawal by Subject|0
296704|NCT01662999|1000453|P5|Period 3|Withdrawal by Subject|0
296705|NCT01662999|1000454|P4|Period 3|Withdrawal by Subject|0
296706|NCT01662999|1000455|P3|Period 3|Withdrawal by Subject|0
296707|NCT01662999|1000456|P2|Period 3|Withdrawal by Subject|1
296708|NCT01662999|1000457|P1|Period 3|Withdrawal by Subject|0
296709|NCT01662986|1000528|P2|Overall Study|Other than stated above|0
296710|NCT01662986|1000529|P1|Overall Study|Other than stated above|3
296711|NCT01662986|1000528|P2|Overall Study|Not Treated|0
296712|NCT01662986|1000529|P1|Overall Study|Not Treated|1
296713|NCT01662986|1000528|P2|Overall Study|Withdrawal by Subject|2
296714|NCT01662986|1000529|P1|Overall Study|Withdrawal by Subject|2
296715|NCT01662986|1000528|P2|Overall Study|Lost to Follow-up|4
296716|NCT01662986|1000529|P1|Overall Study|Lost to Follow-up|5
296717|NCT01662986|1000528|P2|Overall Study|Protocol Violation|3
296718|NCT01662986|1000529|P1|Overall Study|Protocol Violation|2
296719|NCT01662986|1000528|P2|Overall Study|Adverse Event|4
296720|NCT01662986|1000529|P1|Overall Study|Adverse Event|5
296721|NCT01662648|1000649|P2|Overall Study|LOE and Participant non-compliant|1
296722|NCT01662648|1000650|P1|Overall Study|LOE and Participant non-compliant|0
296723|NCT01662648|1000649|P2|Overall Study|LOE and other reason unspecified|0
296724|NCT01662648|1000650|P1|Overall Study|LOE and other reason unspecified|1
296725|NCT01662648|1000649|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
296726|NCT01662648|1000650|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
296727|NCT01662648|1000649|P2|Overall Study|Other|11
296728|NCT01662648|1000650|P1|Overall Study|Other|8
296729|NCT01662648|1000649|P2|Overall Study|Participant non-compliant|20
296730|NCT01662648|1000650|P1|Overall Study|Participant non-compliant|16
296731|NCT01662648|1000649|P2|Overall Study|Withdrawal by Subject|53
296732|NCT01662648|1000650|P1|Overall Study|Withdrawal by Subject|36
296733|NCT01662648|1000649|P2|Overall Study|Lost to Follow-up|36
296734|NCT01662648|1000650|P1|Overall Study|Lost to Follow-up|24
296735|NCT01662648|1000649|P2|Overall Study|Participant ineligible to continue trial|1
296736|NCT01662648|1000650|P1|Overall Study|Participant ineligible to continue trial|1
296737|NCT01662648|1000649|P2|Overall Study|Lack of Efficacy|16
296738|NCT01662648|1000650|P1|Overall Study|Lack of Efficacy|17
296739|NCT01662648|1000649|P2|Overall Study|Adverse Event|37
296740|NCT01662648|1000650|P1|Overall Study|Adverse Event|40
296741|NCT01662648|1000649|P2|Overall Study|Death|3
296742|NCT01662648|1000650|P1|Overall Study|Death|1
296743|NCT01662635|1000672|P1|Overall Study|scarce samples for evaluation|30
296744|NCT01662492|1000723|P3|Overall Study|Lack of Efficacy|2
296745|NCT01662492|1000724|P2|Overall Study|Lack of Efficacy|1
296746|NCT01662492|1000725|P1|Overall Study|Lack of Efficacy|1
296747|NCT01662492|1000723|P3|Overall Study|Lost to Follow-up|2
296748|NCT01662492|1000724|P2|Overall Study|Lost to Follow-up|0
296749|NCT01662492|1000725|P1|Overall Study|Lost to Follow-up|0
296750|NCT01662492|1000723|P3|Overall Study|Protocol Violation|0
296751|NCT01662492|1000724|P2|Overall Study|Protocol Violation|0
296752|NCT01662492|1000725|P1|Overall Study|Protocol Violation|1
296753|NCT01662492|1000723|P3|Overall Study|Withdrawal by Subject|1
296754|NCT01662492|1000724|P2|Overall Study|Withdrawal by Subject|0
296755|NCT01662492|1000725|P1|Overall Study|Withdrawal by Subject|0
296756|NCT01662492|1000723|P3|Overall Study|Other miscellaneous reasons.|1
296757|NCT01662492|1000724|P2|Overall Study|Other miscellaneous reasons.|0
296758|NCT01662492|1000725|P1|Overall Study|Other miscellaneous reasons.|1
296759|NCT01662440|1000749|P4|Overall Study|Withdrawal by Subject|2
296760|NCT01662440|1000750|P3|Overall Study|Withdrawal by Subject|2
296761|NCT01662440|1000751|P2|Overall Study|Withdrawal by Subject|2
296762|NCT01662440|1000752|P1|Overall Study|Withdrawal by Subject|5
296763|NCT01662440|1000749|P4|Overall Study|Protocol Violation|0
296764|NCT01662440|1000750|P3|Overall Study|Protocol Violation|0
296765|NCT01662440|1000751|P2|Overall Study|Protocol Violation|0
296766|NCT01662440|1000752|P1|Overall Study|Protocol Violation|1
296767|NCT01662440|1000749|P4|Overall Study|Subject moved to another country.|0
296768|NCT01662440|1000750|P3|Overall Study|Subject moved to another country.|0
296769|NCT01662440|1000751|P2|Overall Study|Subject moved to another country.|1
296770|NCT01662440|1000752|P1|Overall Study|Subject moved to another country.|0
296771|NCT01662440|1000749|P4|Overall Study|Lost to Follow-up|1
296772|NCT01662440|1000750|P3|Overall Study|Lost to Follow-up|4
296773|NCT01662440|1000751|P2|Overall Study|Lost to Follow-up|2
296774|NCT01662440|1000752|P1|Overall Study|Lost to Follow-up|2
296775|NCT01662440|1000749|P4|Overall Study|Death|0
296776|NCT01662440|1000750|P3|Overall Study|Death|0
296777|NCT01662440|1000751|P2|Overall Study|Death|1
296778|NCT01662440|1000752|P1|Overall Study|Death|0
296779|NCT01662440|1000749|P4|Overall Study|Adverse Event|1
296780|NCT01662440|1000750|P3|Overall Study|Adverse Event|0
296781|NCT01662440|1000751|P2|Overall Study|Adverse Event|0
296782|NCT01662440|1000752|P1|Overall Study|Adverse Event|1
296783|NCT01662362|1000800|P1|Overall Study|Lost to Follow-up|38
296784|NCT01662336|1000805|P1|Overall Study|Withdrawal by Subject|6
296785|NCT01662336|1000805|P1|Overall Study|Other|29
296786|NCT01662336|1000805|P1|Overall Study|No longer on LPV/r|30
296787|NCT01662336|1000805|P1|Overall Study|Adverse Event|1
296788|NCT01662310|1000831|P5|Open-Label Extension Phase|Withdrawal by Subject|7
296789|NCT01662310|1000832|P4|Open-Label Extension Phase|Withdrawal by Subject|2
296790|NCT01662310|1000833|P3|Open-Label Extension Phase|Withdrawal by Subject|0
296791|NCT01662310|1000834|P2|Open-Label Extension Phase|Withdrawal by Subject|0
296792|NCT01662310|1000835|P1|Open-Label Extension Phase|Withdrawal by Subject|0
296793|NCT01662310|1000831|P5|Open-Label Extension Phase|Pregnancy|0
296794|NCT01662310|1000832|P4|Open-Label Extension Phase|Pregnancy|1
296795|NCT01662310|1000833|P3|Open-Label Extension Phase|Pregnancy|0
296796|NCT01662310|1000834|P2|Open-Label Extension Phase|Pregnancy|0
296797|NCT01662310|1000835|P1|Open-Label Extension Phase|Pregnancy|0
296798|NCT01662310|1000831|P5|Open-Label Extension Phase|Lost to Follow-up|1
296799|NCT01662310|1000832|P4|Open-Label Extension Phase|Lost to Follow-up|2
296800|NCT01662310|1000833|P3|Open-Label Extension Phase|Lost to Follow-up|0
296801|NCT01662310|1000834|P2|Open-Label Extension Phase|Lost to Follow-up|0
296802|NCT01662310|1000835|P1|Open-Label Extension Phase|Lost to Follow-up|0
296803|NCT01662310|1000831|P5|Open-Label Extension Phase|Lack of Efficacy|2
296804|NCT01662310|1000832|P4|Open-Label Extension Phase|Lack of Efficacy|2
296805|NCT01662310|1000833|P3|Open-Label Extension Phase|Lack of Efficacy|0
296806|NCT01662310|1000834|P2|Open-Label Extension Phase|Lack of Efficacy|0
296807|NCT01662310|1000835|P1|Open-Label Extension Phase|Lack of Efficacy|0
296808|NCT01662310|1000831|P5|Open-Label Extension Phase|Death|0
296809|NCT01662310|1000832|P4|Open-Label Extension Phase|Death|1
296810|NCT01662310|1000833|P3|Open-Label Extension Phase|Death|0
296811|NCT01662310|1000834|P2|Open-Label Extension Phase|Death|0
296812|NCT01662310|1000835|P1|Open-Label Extension Phase|Death|0
296813|NCT01662310|1000831|P5|Open-Label Extension Phase|Adverse Event|0
296814|NCT01662310|1000832|P4|Open-Label Extension Phase|Adverse Event|3
296815|NCT01662310|1000833|P3|Open-Label Extension Phase|Adverse Event|0
296816|NCT01662310|1000834|P2|Open-Label Extension Phase|Adverse Event|0
296817|NCT01662310|1000835|P1|Open-Label Extension Phase|Adverse Event|0
296818|NCT01662310|1000831|P5|Double-Blind Phase|Randomized but not treated|0
296819|NCT01662310|1000832|P4|Double-Blind Phase|Randomized but not treated|0
296820|NCT01662310|1000833|P3|Double-Blind Phase|Randomized but not treated|0
296821|NCT01662310|1000834|P2|Double-Blind Phase|Randomized but not treated|1
296822|NCT01662310|1000835|P1|Double-Blind Phase|Randomized but not treated|0
296823|NCT01662310|1000831|P5|Double-Blind Phase|Other|0
296824|NCT01662310|1000832|P4|Double-Blind Phase|Other|0
296825|NCT01662310|1000833|P3|Double-Blind Phase|Other|1
296826|NCT01662310|1000834|P2|Double-Blind Phase|Other|0
296827|NCT01662310|1000835|P1|Double-Blind Phase|Other|0
296828|NCT01662310|1000831|P5|Double-Blind Phase|Withdrawal by Subject|0
296829|NCT01662310|1000832|P4|Double-Blind Phase|Withdrawal by Subject|0
296830|NCT01662310|1000833|P3|Double-Blind Phase|Withdrawal by Subject|3
296831|NCT01662310|1000834|P2|Double-Blind Phase|Withdrawal by Subject|9
296832|NCT01662310|1000835|P1|Double-Blind Phase|Withdrawal by Subject|0
296833|NCT01662310|1000831|P5|Double-Blind Phase|Pregnancy|0
296834|NCT01662310|1000832|P4|Double-Blind Phase|Pregnancy|0
296835|NCT01662310|1000833|P3|Double-Blind Phase|Pregnancy|0
296836|NCT01662310|1000834|P2|Double-Blind Phase|Pregnancy|2
296837|NCT01662310|1000835|P1|Double-Blind Phase|Pregnancy|0
296838|NCT01662310|1000831|P5|Double-Blind Phase|Lost to Follow-up|0
296839|NCT01662310|1000832|P4|Double-Blind Phase|Lost to Follow-up|0
296840|NCT01662310|1000833|P3|Double-Blind Phase|Lost to Follow-up|0
296841|NCT01662310|1000834|P2|Double-Blind Phase|Lost to Follow-up|3
296842|NCT01662310|1000835|P1|Double-Blind Phase|Lost to Follow-up|0
296843|NCT01662310|1000831|P5|Double-Blind Phase|Adverse Event|0
296844|NCT01662310|1000832|P4|Double-Blind Phase|Adverse Event|0
296845|NCT01662310|1000833|P3|Double-Blind Phase|Adverse Event|1
296846|NCT01662310|1000834|P2|Double-Blind Phase|Adverse Event|0
296847|NCT01662310|1000835|P1|Double-Blind Phase|Adverse Event|0
296848|NCT01662310|1000831|P5|Run-In or Stabilization Phase|Other|0
296849|NCT01662310|1000832|P4|Run-In or Stabilization Phase|Other|0
296850|NCT01662310|1000833|P3|Run-In or Stabilization Phase|Other|0
296851|NCT01662310|1000834|P2|Run-In or Stabilization Phase|Other|0
296852|NCT01662310|1000835|P1|Run-In or Stabilization Phase|Other|1
296853|NCT01662310|1000831|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
296854|NCT01662310|1000832|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
296855|NCT01662310|1000833|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
296856|NCT01662310|1000834|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
296857|NCT01662310|1000835|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
296858|NCT01662310|1000831|P5|Run-In or Stabilization Phase|Protocol Violation|0
296859|NCT01662310|1000832|P4|Run-In or Stabilization Phase|Protocol Violation|0
296860|NCT01662310|1000833|P3|Run-In or Stabilization Phase|Protocol Violation|0
296861|NCT01662310|1000834|P2|Run-In or Stabilization Phase|Protocol Violation|0
296862|NCT01662310|1000835|P1|Run-In or Stabilization Phase|Protocol Violation|15
296863|NCT01662310|1000831|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
296864|NCT01662310|1000832|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
296865|NCT01662310|1000833|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
296866|NCT01662310|1000834|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
296867|NCT01662310|1000835|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
296868|NCT01662310|1000831|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
296869|NCT01662310|1000832|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
296870|NCT01662310|1000833|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
296871|NCT01662310|1000834|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
296872|NCT01662310|1000835|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
296873|NCT01662310|1000831|P5|Run-In or Stabilization Phase|Adverse Event|0
296874|NCT01662310|1000832|P4|Run-In or Stabilization Phase|Adverse Event|0
296875|NCT01662310|1000833|P3|Run-In or Stabilization Phase|Adverse Event|0
296876|NCT01662310|1000834|P2|Run-In or Stabilization Phase|Adverse Event|0
296877|NCT01662310|1000835|P1|Run-In or Stabilization Phase|Adverse Event|11
296878|NCT01662102|1000891|P2|Overall Study|Sponsor's decision|0
296879|NCT01662102|1000892|P1|Overall Study|Sponsor's decision|1
296880|NCT01662063|1000900|P3|Overall Study|Not Specified|0
296881|NCT01662063|1000901|P2|Overall Study|Not Specified|1
296882|NCT01662063|1000902|P1|Overall Study|Not Specified|0
296883|NCT01662063|1000900|P3|Overall Study|Physician Decision|0
296884|NCT01662063|1000901|P2|Overall Study|Physician Decision|2
296885|NCT01662063|1000902|P1|Overall Study|Physician Decision|0
296886|NCT01662063|1000900|P3|Overall Study|Withdrawal by Subject|1
296887|NCT01662063|1000901|P2|Overall Study|Withdrawal by Subject|4
296888|NCT01662063|1000902|P1|Overall Study|Withdrawal by Subject|2
296889|NCT01662063|1000900|P3|Overall Study|Protocol Violation|0
296890|NCT01662063|1000901|P2|Overall Study|Protocol Violation|0
296891|NCT01662063|1000902|P1|Overall Study|Protocol Violation|1
296892|NCT01662063|1000900|P3|Overall Study|Lost to Follow-up|0
296893|NCT01662063|1000901|P2|Overall Study|Lost to Follow-up|4
296894|NCT01662063|1000902|P1|Overall Study|Lost to Follow-up|0
296895|NCT01662063|1000900|P3|Overall Study|Lack of Efficacy|0
296896|NCT01662063|1000901|P2|Overall Study|Lack of Efficacy|6
296897|NCT01662063|1000902|P1|Overall Study|Lack of Efficacy|1
296898|NCT01662063|1000900|P3|Overall Study|Adverse Event or Intercurrent Illness|0
296899|NCT01662063|1000901|P2|Overall Study|Adverse Event or Intercurrent Illness|12
296900|NCT01662063|1000902|P1|Overall Study|Adverse Event or Intercurrent Illness|1
296901|NCT01662024|1000981|P1|Overall Study|Withdrawal by Subject|3
296902|NCT01662024|1000981|P1|Overall Study|Pregnancy|2
296903|NCT01661972|1000993|P2|Overall Study|Withdrawal by Subject|1
296904|NCT01661972|1000994|P1|Overall Study|Withdrawal by Subject|0
296905|NCT01661972|1000993|P2|Overall Study|Death during Treatment period|1
296906|NCT01661972|1000994|P1|Overall Study|Death during Treatment period|1
296907|NCT01661972|1000993|P2|Overall Study|Adverse Event|2
296908|NCT01661972|1000994|P1|Overall Study|Adverse Event|1
296909|NCT01661933|1001004|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
296910|NCT01661933|1001004|P1|Low-dose Gluten Challenge|Physician Decision|2
296911|NCT01661790|1001019|P2|Overall Study|Lost to Follow-up|2
296912|NCT01661790|1001020|P1|Overall Study|Lost to Follow-up|0
296913|NCT01661205|1001136|P1|Overall Study|Physician Decision|2
296914|NCT01661179|1001147|P1|Overall Study|Other Eligibility criteria|4
296915|NCT01661179|1001147|P1|Overall Study|Withdrawal by Subject|1
296916|NCT01661179|1001147|P1|Overall Study|Death|1
296917|NCT01661140|1001151|P3|Double-Blind Period|Administrative/Other|6
296918|NCT01661140|1001152|P2|Double-Blind Period|Administrative/Other|7
296919|NCT01661140|1001153|P1|Double-Blind Period|Administrative/Other|0
296920|NCT01661140|1001151|P3|Double-Blind Period|Sponsor Termination|17
296921|NCT01661140|1001152|P2|Double-Blind Period|Sponsor Termination|14
296922|NCT01661140|1001153|P1|Double-Blind Period|Sponsor Termination|0
296923|NCT01661140|1001151|P3|Double-Blind Period|Investigator's Decision|2
296924|NCT01661140|1001152|P2|Double-Blind Period|Investigator's Decision|1
296925|NCT01661140|1001153|P1|Double-Blind Period|Investigator's Decision|0
296926|NCT01661140|1001151|P3|Double-Blind Period|Withdrawal by Subject|3
296927|NCT01661140|1001152|P2|Double-Blind Period|Withdrawal by Subject|1
296928|NCT01661140|1001153|P1|Double-Blind Period|Withdrawal by Subject|0
296929|NCT01661140|1001151|P3|Double-Blind Period|Protocol Violation|3
296930|NCT01661140|1001152|P2|Double-Blind Period|Protocol Violation|2
296931|NCT01661140|1001153|P1|Double-Blind Period|Protocol Violation|0
296932|NCT01661140|1001151|P3|Double-Blind Period|Adverse Event|18
296933|NCT01661140|1001152|P2|Double-Blind Period|Adverse Event|16
296934|NCT01661140|1001153|P1|Double-Blind Period|Adverse Event|0
296935|NCT01661140|1001151|P3|Double-Blind Period|Refused Treatment|1
296936|NCT01661140|1001152|P2|Double-Blind Period|Refused Treatment|0
296937|NCT01661140|1001153|P1|Double-Blind Period|Refused Treatment|0
296938|NCT01661140|1001151|P3|Open-Label Period|Lost to Follow-up|0
296939|NCT01661140|1001152|P2|Open-Label Period|Lost to Follow-up|0
296940|NCT01661140|1001153|P1|Open-Label Period|Lost to Follow-up|2
296941|NCT01661140|1001151|P3|Open-Label Period|Did not meet EULAR criteria|0
296942|NCT01661140|1001152|P2|Open-Label Period|Did not meet EULAR criteria|0
296943|NCT01661140|1001153|P1|Open-Label Period|Did not meet EULAR criteria|1
296944|NCT01661140|1001151|P3|Open-Label Period|Sponsor termination|0
296945|NCT01661140|1001152|P2|Open-Label Period|Sponsor termination|0
296946|NCT01661140|1001153|P1|Open-Label Period|Sponsor termination|16
296947|NCT01661140|1001151|P3|Open-Label Period|Administrative/Other|0
296948|NCT01661140|1001152|P2|Open-Label Period|Administrative/Other|0
296949|NCT01661140|1001153|P1|Open-Label Period|Administrative/Other|1
296950|NCT01661140|1001151|P3|Open-Label Period|Death|0
296951|NCT01661140|1001152|P2|Open-Label Period|Death|0
296952|NCT01661140|1001153|P1|Open-Label Period|Death|1
296953|NCT01661140|1001151|P3|Open-Label Period|Investigator Decision|0
296954|NCT01661140|1001152|P2|Open-Label Period|Investigator Decision|0
296955|NCT01661140|1001153|P1|Open-Label Period|Investigator Decision|3
296956|NCT01661140|1001151|P3|Open-Label Period|Withdrawal by Subject|0
296957|NCT01661140|1001152|P2|Open-Label Period|Withdrawal by Subject|0
296958|NCT01661140|1001153|P1|Open-Label Period|Withdrawal by Subject|5
296959|NCT01661140|1001151|P3|Open-Label Period|Protocol Violation|0
296960|NCT01661140|1001152|P2|Open-Label Period|Protocol Violation|0
296961|NCT01661140|1001153|P1|Open-Label Period|Protocol Violation|3
296962|NCT01661140|1001151|P3|Open-Label Period|Adverse Event|0
296963|NCT01661140|1001152|P2|Open-Label Period|Adverse Event|0
296964|NCT01661140|1001153|P1|Open-Label Period|Adverse Event|44
296965|NCT01661062|1001199|P1|Overall Study|Withdrawal by Subject|2
296966|NCT01661062|1001199|P1|Overall Study|Completed Treatment Off Study|3
296967|NCT01660906|1001204|P1|Overall Study|Discontinued due to study drug toxicity|3
296968|NCT01660763|1001287|P2|Overall Study|Patient ready for early discharge|4
296969|NCT01660763|1001288|P1|Overall Study|Patient ready for early discharge|28
296970|NCT01660763|1001287|P2|Overall Study|Withdrawal by Subject|0
296971|NCT01660763|1001288|P1|Overall Study|Withdrawal by Subject|4
296972|NCT01660763|1001287|P2|Overall Study|Protocol Violation|0
296973|NCT01660763|1001288|P1|Overall Study|Protocol Violation|1
296974|NCT01660763|1001287|P2|Overall Study|Adverse Event|7
296975|NCT01660763|1001288|P1|Overall Study|Adverse Event|22
296976|NCT01660763|1001287|P2|Overall Study|Lack of Efficacy|50
296977|NCT01660763|1001288|P1|Overall Study|Lack of Efficacy|45
296978|NCT01660451|1001336|P3|Overall Study|Ongoing with treatment|46
296979|NCT01660451|1001337|P2|Overall Study|Ongoing with treatment|3
296980|NCT01660451|1001338|P1|Overall Study|Ongoing with treatment|3
296981|NCT01660451|1001336|P3|Overall Study|Withdrawal by Subject|16
296982|NCT01660451|1001337|P2|Overall Study|Withdrawal by Subject|0
296983|NCT01660451|1001338|P1|Overall Study|Withdrawal by Subject|1
296984|NCT01660451|1001336|P3|Overall Study|Physician Decision|5
296985|NCT01660451|1001337|P2|Overall Study|Physician Decision|2
296986|NCT01660451|1001338|P1|Overall Study|Physician Decision|1
296987|NCT01660451|1001336|P3|Overall Study|Protocol Deviation|1
296988|NCT01660451|1001337|P2|Overall Study|Protocol Deviation|0
296989|NCT01660451|1001338|P1|Overall Study|Protocol Deviation|0
296990|NCT01660451|1001336|P3|Overall Study|Sponsor Decision|1
296991|NCT01660451|1001337|P2|Overall Study|Sponsor Decision|0
296992|NCT01660451|1001338|P1|Overall Study|Sponsor Decision|0
296993|NCT01660451|1001336|P3|Overall Study|AE with Clinical PD|9
296994|NCT01660451|1001337|P2|Overall Study|AE with Clinical PD|3
296995|NCT01660451|1001338|P1|Overall Study|AE with Clinical PD|1
296996|NCT01660451|1001336|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
296997|NCT01660451|1001337|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
296998|NCT01660451|1001338|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
296999|NCT01660451|1001336|P3|Overall Study|Protocol Violation|1
297000|NCT01660451|1001337|P2|Overall Study|Protocol Violation|1
297001|NCT01660451|1001338|P1|Overall Study|Protocol Violation|0
297002|NCT01660412|1001366|P2|Overall Study|Protocol Violation|3
297003|NCT01660412|1001367|P1|Overall Study|Protocol Violation|0
297004|NCT01660334|1001373|P1|Overall Study|Lost to Follow-up|1
297005|NCT01660022|1001616|P6|First Sequence (7 Days)|Protocol Violation|1
297006|NCT01660022|1001617|P5|First Sequence (7 Days)|Protocol Violation|0
297007|NCT01660022|1001618|P4|First Sequence (7 Days)|Protocol Violation|0
297008|NCT01660022|1001619|P3|First Sequence (7 Days)|Protocol Violation|0
297009|NCT01660022|1001620|P2|First Sequence (7 Days)|Protocol Violation|0
297010|NCT01660022|1001621|P1|First Sequence (7 Days)|Protocol Violation|0
297011|NCT01660022|1001616|P6|First Sequence (7 Days)|Adverse Event|3
297012|NCT01660022|1001617|P5|First Sequence (7 Days)|Adverse Event|1
297013|NCT01660022|1001618|P4|First Sequence (7 Days)|Adverse Event|0
297014|NCT01660022|1001619|P3|First Sequence (7 Days)|Adverse Event|0
297015|NCT01660022|1001620|P2|First Sequence (7 Days)|Adverse Event|0
297016|NCT01660022|1001621|P1|First Sequence (7 Days)|Adverse Event|0
297017|NCT01660022|1001616|P6|First Sequence (7 Days)|Withdrawal by Subject|0
297018|NCT01660022|1001617|P5|First Sequence (7 Days)|Withdrawal by Subject|0
297019|NCT01660022|1001618|P4|First Sequence (7 Days)|Withdrawal by Subject|1
297020|NCT01660022|1001619|P3|First Sequence (7 Days)|Withdrawal by Subject|0
297021|NCT01660022|1001620|P2|First Sequence (7 Days)|Withdrawal by Subject|1
297022|NCT01660022|1001621|P1|First Sequence (7 Days)|Withdrawal by Subject|0
297023|NCT01659996|1001680|P3|Overall Study|Withdrawal by Subject|5
297024|NCT01659996|1001681|P2|Overall Study|Withdrawal by Subject|1
297025|NCT01659996|1001682|P1|Overall Study|Withdrawal by Subject|4
297026|NCT01659996|1001680|P3|Overall Study|Adverse Event|1
297027|NCT01659996|1001681|P2|Overall Study|Adverse Event|0
297028|NCT01659996|1001682|P1|Overall Study|Adverse Event|0
297029|NCT01659996|1001680|P3|Overall Study|Lost to Follow-up|2
297030|NCT01659996|1001681|P2|Overall Study|Lost to Follow-up|3
297031|NCT01659996|1001682|P1|Overall Study|Lost to Follow-up|1
297032|NCT01659996|1001680|P3|Overall Study|Protocol Violation|3
297033|NCT01659996|1001681|P2|Overall Study|Protocol Violation|3
297034|NCT01659996|1001682|P1|Overall Study|Protocol Violation|3
297035|NCT01659853|1001714|P2|Washout , 3 to 7 Days|Protocol Violation|0
297036|NCT01659853|1001715|P1|Washout , 3 to 7 Days|Protocol Violation|1
297037|NCT01659853|1001714|P2|Washout , 3 to 7 Days|Adverse Event|0
297038|NCT01659853|1001715|P1|Washout , 3 to 7 Days|Adverse Event|1
297039|NCT01659736|1001725|P2|3-month Follow-up|Lost to Follow-up|1
297040|NCT01659736|1001726|P1|3-month Follow-up|Lost to Follow-up|0
297041|NCT01659736|1001725|P2|Treatment Period|Withdrawal by Subject|0
297042|NCT01659736|1001726|P1|Treatment Period|Withdrawal by Subject|1
297043|NCT01659736|1001725|P2|Treatment Period|Protocol Violation|1
297044|NCT01659736|1001726|P1|Treatment Period|Protocol Violation|3
297045|NCT01659736|1001725|P2|Treatment Period|Adverse Event|1
297046|NCT01659736|1001726|P1|Treatment Period|Adverse Event|1
297047|NCT01659567|1001740|P1|Overall Study|Other|13
297048|NCT01659567|1001740|P1|Overall Study|Progression of the main disease|1
297049|NCT01659567|1001740|P1|Overall Study|Withdrawal by Subject|64
297050|NCT01659567|1001740|P1|Overall Study|Good result at early stage of treatment|5
297051|NCT01659567|1001740|P1|Overall Study|Adverse Event|12
297052|NCT01659567|1001740|P1|Overall Study|Switched to Pegferon|6
297053|NCT01659567|1001740|P1|Overall Study|Lack of Efficacy|22
297054|NCT01659554|1001757|P1|Overall Study|Study Termination|4
297055|NCT01659320|1001764|P1|Overall Study|Physician Decision|1
297056|NCT01659320|1001764|P1|Overall Study|Withdrawal by Subject|2
297057|NCT01659125|1001783|P1|Overall Study|Failed to Start Treatment|2
297058|NCT01659125|1001783|P1|Overall Study|Time Constraints|2
297059|NCT01659125|1001783|P1|Overall Study|Technical Problem|1
297060|NCT01659125|1001783|P1|Overall Study|Lost to Follow-up|7
297061|NCT01659125|1001783|P1|Overall Study|Withdrawal by Subject|2
297062|NCT01659021|1001790|P2|Overall Study|Still on Study|1
297063|NCT01659021|1001791|P1|Overall Study|Still on Study|34
297064|NCT01659021|1001790|P2|Overall Study|Withdrawal by Subject|16
297065|NCT01659021|1001791|P1|Overall Study|Withdrawal by Subject|18
297066|NCT01659021|1001790|P2|Overall Study|Physician Decision|16
297067|NCT01659021|1001791|P1|Overall Study|Physician Decision|32
297068|NCT01659021|1001790|P2|Overall Study|Other?|1
297069|NCT01659021|1001791|P1|Overall Study|Other?|1
297070|NCT01659021|1001790|P2|Overall Study|Lost to Follow-up|0
297071|NCT01659021|1001791|P1|Overall Study|Lost to Follow-up|1
297072|NCT01659021|1001790|P2|Overall Study|Adverse Event|3
297073|NCT01659021|1001791|P1|Overall Study|Adverse Event|2
297074|NCT01658943|1001809|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
297075|NCT01658943|1001810|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
297076|NCT01658943|1001809|P2|Overall Study|Not eligible|9
297077|NCT01658943|1001810|P1|Overall Study|Not eligible|7
297078|NCT01658943|1001809|P2|Overall Study|not protocol specified|1
297079|NCT01658943|1001810|P1|Overall Study|not protocol specified|4
297080|NCT01658943|1001809|P2|Overall Study|Death|2
297081|NCT01658943|1001810|P1|Overall Study|Death|4
297082|NCT01658943|1001809|P2|Overall Study|Progression/Relapse|40
297083|NCT01658943|1001810|P1|Overall Study|Progression/Relapse|39
297084|NCT01658943|1001809|P2|Overall Study|Withdrawal by Subject|2
297085|NCT01658943|1001810|P1|Overall Study|Withdrawal by Subject|9
297086|NCT01658943|1001809|P2|Overall Study|Adverse Event|13
297087|NCT01658943|1001810|P1|Overall Study|Adverse Event|6
297088|NCT01658904|1001825|P3|Overall Study|Principal Investigator discretion|0
297089|NCT01658904|1001826|P2|Overall Study|Principal Investigator discretion|0
297090|NCT01658904|1001827|P1|Overall Study|Principal Investigator discretion|2
297091|NCT01658813|1001853|P1|Overall Study|Disease progression|3
297092|NCT01658735|1001864|P3|Overall Study|Withdrawal by Subject|3
297093|NCT01658735|1001865|P2|Overall Study|Withdrawal by Subject|5
297094|NCT01658735|1001866|P1|Overall Study|Withdrawal by Subject|3
297095|NCT01658735|1001864|P3|Overall Study|Protocol Violation|0
297096|NCT01658735|1001865|P2|Overall Study|Protocol Violation|1
297097|NCT01658735|1001866|P1|Overall Study|Protocol Violation|0
297098|NCT01658735|1001864|P3|Overall Study|Lost to Follow-up|0
297099|NCT01658735|1001865|P2|Overall Study|Lost to Follow-up|1
297100|NCT01658735|1001866|P1|Overall Study|Lost to Follow-up|1
297101|NCT01658735|1001864|P3|Overall Study|Lack of Efficacy|1
297102|NCT01658735|1001865|P2|Overall Study|Lack of Efficacy|0
297103|NCT01658735|1001866|P1|Overall Study|Lack of Efficacy|1
297104|NCT01658579|1001908|P4|Treatment Period B|Other|1
297105|NCT01658579|1001909|P3|Treatment Period B|Other|0
297106|NCT01658579|1001910|P2|Treatment Period B|Other|0
297107|NCT01658579|1001911|P1|Treatment Period B|Other|0
297108|NCT01658579|1001908|P4|Treatment Period A|Adverse Event|0
297109|NCT01658579|1001909|P3|Treatment Period A|Adverse Event|0
297110|NCT01658579|1001910|P2|Treatment Period A|Adverse Event|0
297111|NCT01658579|1001911|P1|Treatment Period A|Adverse Event|1
297112|NCT01658579|1001908|P4|Treatment Period A|Other|1
297113|NCT01658579|1001909|P3|Treatment Period A|Other|1
297114|NCT01658579|1001910|P2|Treatment Period A|Other|0
297115|NCT01658579|1001911|P1|Treatment Period A|Other|0
297116|NCT01658514|1001939|P3|Overall Study|Protocol Violation|2
297117|NCT01658514|1001940|P2|Overall Study|Protocol Violation|0
297118|NCT01658514|1001941|P1|Overall Study|Protocol Violation|1
297119|NCT01658436|1001952|P2|Overall Study|Death|0
297120|NCT01658436|1001953|P1|Overall Study|Death|1
297121|NCT01658436|1001952|P2|Overall Study|Subject/guardian decision|1
297122|NCT01658436|1001953|P1|Overall Study|Subject/guardian decision|0
297123|NCT01658436|1001952|P2|Overall Study|Study terminated by sponsor|1
297124|NCT01658436|1001953|P1|Overall Study|Study terminated by sponsor|0
297125|NCT01658436|1001952|P2|Overall Study|Progressive disease|4
297126|NCT01658436|1001953|P1|Overall Study|Progressive disease|12
297127|NCT01658436|1001952|P2|Overall Study|Physician Decision|0
297128|NCT01658436|1001953|P1|Overall Study|Physician Decision|1
297129|NCT01658436|1001952|P2|Overall Study|Adverse Event|5
297130|NCT01658436|1001953|P1|Overall Study|Adverse Event|6
297131|NCT01658072|1001975|P2|Overall Study|Protocol Violation|2
297132|NCT01658072|1001976|P1|Overall Study|Protocol Violation|4
297133|NCT01658020|1001984|P2|Overall Study|Protocol Violation|1
297134|NCT01658020|1001985|P1|Overall Study|Protocol Violation|0
297135|NCT01658020|1001984|P2|Overall Study|Withdrawal by Subject|5
297136|NCT01658020|1001985|P1|Overall Study|Withdrawal by Subject|4
297137|NCT01658020|1001984|P2|Overall Study|Lost to Follow-up|0
297138|NCT01658020|1001985|P1|Overall Study|Lost to Follow-up|1
297139|NCT01658020|1001984|P2|Overall Study|Adverse Event|3
297140|NCT01658020|1001985|P1|Overall Study|Adverse Event|3
297141|NCT01657903|1002001|P1|Overall Study|Withdrawal by Subject|1
297142|NCT01657903|1002001|P1|Overall Study|Lost to Follow-up|1
297143|NCT01657877|1002023|P1|Overall Study|Other Reason|2
297144|NCT01657877|1002023|P1|Overall Study|Adverse Event|2
297145|NCT01657877|1002023|P1|Overall Study|Protocol Violation|6
297146|NCT01657877|1002023|P1|Overall Study|Withdrawal by Subject|4
297147|NCT01657799|1002043|P3|Overall Study|Other|49
297148|NCT01657799|1002044|P2|Overall Study|Other|62
297149|NCT01657799|1002045|P1|Overall Study|Other|52
297150|NCT01657799|1002043|P3|Overall Study|Radiographic & Clinical Progression|15
297151|NCT01657799|1002044|P2|Overall Study|Radiographic & Clinical Progression|11
297152|NCT01657799|1002045|P1|Overall Study|Radiographic & Clinical Progression|16
297153|NCT01657799|1002043|P3|Overall Study|Progressive Disease Clinical|7
297154|NCT01657799|1002044|P2|Overall Study|Progressive Disease Clinical|4
297155|NCT01657799|1002045|P1|Overall Study|Progressive Disease Clinical|7
297156|NCT01657799|1002043|P3|Overall Study|Disease Progression|4
297157|NCT01657799|1002044|P2|Overall Study|Disease Progression|4
297158|NCT01657799|1002045|P1|Overall Study|Disease Progression|2
297159|NCT01657799|1002043|P3|Overall Study|Lost to Follow-up|1
297160|NCT01657799|1002044|P2|Overall Study|Lost to Follow-up|0
297161|NCT01657799|1002045|P1|Overall Study|Lost to Follow-up|1
297162|NCT01657799|1002043|P3|Overall Study|Withdrawal by Subject|10
297163|NCT01657799|1002044|P2|Overall Study|Withdrawal by Subject|10
297164|NCT01657799|1002045|P1|Overall Study|Withdrawal by Subject|13
297165|NCT01657799|1002043|P3|Overall Study|Adverse Event Not Related to Progression|4
297166|NCT01657799|1002044|P2|Overall Study|Adverse Event Not Related to Progression|4
297339|NCT01655069|1002800|P4|Overall Study|Lack of Efficacy|0
297167|NCT01657799|1002045|P1|Overall Study|Adverse Event Not Related to Progression|5
297168|NCT01657799|1002043|P3|Overall Study|Adverse Event Related to progression|12
297169|NCT01657799|1002044|P2|Overall Study|Adverse Event Related to progression|8
297170|NCT01657799|1002045|P1|Overall Study|Adverse Event Related to progression|6
297171|NCT01657461|1002064|P2|Overall Study|Withdrawal by Subject|3
297172|NCT01657461|1002065|P1|Overall Study|Withdrawal by Subject|1
297173|NCT01657461|1002064|P2|Overall Study|Physician Decision|2
297174|NCT01657461|1002065|P1|Overall Study|Physician Decision|0
297175|NCT01657461|1002064|P2|Overall Study|Lost to Follow-up|3
297176|NCT01657461|1002065|P1|Overall Study|Lost to Follow-up|0
297177|NCT01657461|1002064|P2|Overall Study|Death|12
297178|NCT01657461|1002065|P1|Overall Study|Death|9
297179|NCT01657370|1002095|P6|Overall Study|Lost to Follow-up|1
297180|NCT01657370|1002096|P5|Overall Study|Lost to Follow-up|0
297181|NCT01657370|1002097|P4|Overall Study|Lost to Follow-up|0
297182|NCT01657370|1002098|P3|Overall Study|Lost to Follow-up|1
297183|NCT01657370|1002099|P2|Overall Study|Lost to Follow-up|0
297184|NCT01657370|1002100|P1|Overall Study|Lost to Follow-up|2
297185|NCT01657370|1002095|P6|Overall Study|Protocol Violation|0
297186|NCT01657370|1002096|P5|Overall Study|Protocol Violation|0
297187|NCT01657370|1002097|P4|Overall Study|Protocol Violation|1
297188|NCT01657370|1002098|P3|Overall Study|Protocol Violation|1
297189|NCT01657370|1002099|P2|Overall Study|Protocol Violation|1
297190|NCT01657370|1002100|P1|Overall Study|Protocol Violation|1
297191|NCT01657370|1002095|P6|Overall Study|Adverse Event|0
297192|NCT01657370|1002096|P5|Overall Study|Adverse Event|1
297193|NCT01657370|1002097|P4|Overall Study|Adverse Event|0
297194|NCT01657370|1002098|P3|Overall Study|Adverse Event|0
297195|NCT01657370|1002099|P2|Overall Study|Adverse Event|0
297196|NCT01657370|1002100|P1|Overall Study|Adverse Event|0
297197|NCT01657370|1002095|P6|Overall Study|Lack of Qualifying Event|2
297198|NCT01657370|1002096|P5|Overall Study|Lack of Qualifying Event|1
297199|NCT01657370|1002097|P4|Overall Study|Lack of Qualifying Event|2
297200|NCT01657370|1002098|P3|Overall Study|Lack of Qualifying Event|3
297201|NCT01657370|1002099|P2|Overall Study|Lack of Qualifying Event|0
297202|NCT01657370|1002100|P1|Overall Study|Lack of Qualifying Event|1
297203|NCT01657370|1002095|P6|Overall Study|Physician Decision|0
297204|NCT01657370|1002096|P5|Overall Study|Physician Decision|5
297205|NCT01657370|1002097|P4|Overall Study|Physician Decision|2
297206|NCT01657370|1002098|P3|Overall Study|Physician Decision|1
297207|NCT01657370|1002099|P2|Overall Study|Physician Decision|3
297208|NCT01657370|1002100|P1|Overall Study|Physician Decision|2
297209|NCT01657370|1002095|P6|Overall Study|Withdrawal by Subject|1
297210|NCT01657370|1002096|P5|Overall Study|Withdrawal by Subject|0
297211|NCT01657370|1002097|P4|Overall Study|Withdrawal by Subject|0
297212|NCT01657370|1002098|P3|Overall Study|Withdrawal by Subject|1
297213|NCT01657370|1002099|P2|Overall Study|Withdrawal by Subject|0
297214|NCT01657370|1002100|P1|Overall Study|Withdrawal by Subject|0
297215|NCT01657305|1002182|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
297216|NCT01657305|1002182|P1|Overall Study|Lost to Follow-up|1
297217|NCT01657305|1002182|P1|Overall Study|Adverse Event|1
297218|NCT01657305|1002182|P1|Overall Study|Withdrawal by Subject|4
297219|NCT01657305|1002182|P1|Overall Study|Lack of Wound Closure at Day 28|15
297220|NCT01657292|1002232|P1|Overall Study|Change of therapy|1
297221|NCT01657292|1002232|P1|Overall Study|Violation of eligibility criteria|1
297222|NCT01657292|1002232|P1|Overall Study|Withdrawal by Subject|2
297223|NCT01657292|1002232|P1|Overall Study|Adverse Event|6
297224|NCT01657253|1002241|P2|Overall Study|Adverse Event|1
297225|NCT01657253|1002242|P1|Overall Study|Adverse Event|0
297226|NCT01657253|1002241|P2|Overall Study|Withdrawal by Subject|12
297227|NCT01657253|1002242|P1|Overall Study|Withdrawal by Subject|11
297228|NCT01657253|1002241|P2|Overall Study|Lost to Follow-up|5
297229|NCT01657253|1002242|P1|Overall Study|Lost to Follow-up|6
297230|NCT01657032|1002254|P2|Overall Study|Lost to Follow-up|7
297231|NCT01657032|1002255|P1|Overall Study|Lost to Follow-up|0
297232|NCT01657019|1002281|P1|Overall Study|Not Specified|58
297233|NCT01657019|1002281|P1|Overall Study|Lack of Efficacy|3
297234|NCT01657019|1002281|P1|Overall Study|Protocol Violation|6
297235|NCT01657019|1002281|P1|Overall Study|Lost to Follow-up|48
297236|NCT01657019|1002281|P1|Overall Study|Adverse Event|55
297237|NCT01657019|1002281|P1|Overall Study|Withdrawal by Subject|65
297238|NCT01656967|1002295|P2|Overall Study|unsuccessful ETT insertion|2
297239|NCT01656967|1002296|P1|Overall Study|unsuccessful ETT insertion|3
297240|NCT01656967|1002295|P2|Overall Study|faulty monitor|0
297241|NCT01656967|1002296|P1|Overall Study|faulty monitor|1
297242|NCT01656889|1002318|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
297243|NCT01656889|1002319|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
297244|NCT01656889|1002318|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
297245|NCT01656889|1002319|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
297246|NCT01656889|1002318|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
297247|NCT01656889|1002319|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
297248|NCT01656889|1002318|P2|Post Treatment Follow-Up, 3 Months|Death|5
297249|NCT01656889|1002319|P1|Post Treatment Follow-Up, 3 Months|Death|1
297250|NCT01656889|1002318|P2|Treatment Period, 12 Weeks|Moved out of the area|2
297251|NCT01656889|1002319|P1|Treatment Period, 12 Weeks|Moved out of the area|0
297252|NCT01656889|1002318|P2|Treatment Period, 12 Weeks|Protocol Violation|1
297253|NCT01656889|1002319|P1|Treatment Period, 12 Weeks|Protocol Violation|0
297254|NCT01656889|1002318|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
297255|NCT01656889|1002319|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
297256|NCT01656889|1002318|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
297257|NCT01656889|1002319|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
297258|NCT01656889|1002318|P2|Treatment Period, 12 Weeks|Death|1
297259|NCT01656889|1002319|P1|Treatment Period, 12 Weeks|Death|0
297260|NCT01656889|1002318|P2|Treatment Period, 12 Weeks|Adverse Event|4
297261|NCT01656889|1002319|P1|Treatment Period, 12 Weeks|Adverse Event|10
297262|NCT01656850|1002339|P2|First Intervention (3 Months)|Withdrawal by Subject|4
297263|NCT01656850|1002340|P1|First Intervention (3 Months)|Withdrawal by Subject|3
297264|NCT01656759|1002431|P2|Overall Study|Protocol Violation|3
297265|NCT01656759|1002432|P1|Overall Study|Protocol Violation|2
297266|NCT01656434|1002463|P2|Overall Study|Withdrawal by Subject|7
297267|NCT01656434|1002464|P1|Overall Study|Withdrawal by Subject|64
297268|NCT01656434|1002463|P2|Overall Study|Participant withdrew consent|9
297269|NCT01656434|1002464|P1|Overall Study|Participant withdrew consent|28
297270|NCT01656434|1002463|P2|Overall Study|Participant moved|12
297271|NCT01656434|1002464|P1|Overall Study|Participant moved|40
297272|NCT01656434|1002463|P2|Overall Study|Non-compliance with protocol|15
297273|NCT01656434|1002464|P1|Overall Study|Non-compliance with protocol|39
297274|NCT01656434|1002463|P2|Overall Study|Part. discontinued; unrelated to drug|10
297275|NCT01656434|1002464|P1|Overall Study|Part. discontinued; unrelated to drug|55
297276|NCT01656434|1002463|P2|Overall Study|Participant discontinued; drug related|4
297277|NCT01656434|1002464|P1|Overall Study|Participant discontinued; drug related|13
297278|NCT01656434|1002463|P2|Overall Study|Study terminated by sponsor|348
297279|NCT01656434|1002464|P1|Overall Study|Study terminated by sponsor|1501
297280|NCT01656434|1002463|P2|Overall Study|Non-compliance with study drug|9
297281|NCT01656434|1002464|P1|Overall Study|Non-compliance with study drug|48
297282|NCT01656434|1002463|P2|Overall Study|Physician Decision|2
297283|NCT01656434|1002464|P1|Overall Study|Physician Decision|7
297284|NCT01656434|1002463|P2|Overall Study|Pregnancy|10
297285|NCT01656434|1002464|P1|Overall Study|Pregnancy|45
297286|NCT01656434|1002463|P2|Overall Study|Pregnancy wish|6
297287|NCT01656434|1002464|P1|Overall Study|Pregnancy wish|18
297288|NCT01656434|1002463|P2|Overall Study|Protocol Violation|0
297289|NCT01656434|1002464|P1|Overall Study|Protocol Violation|7
297290|NCT01656434|1002463|P2|Overall Study|Screen failure|0
297291|NCT01656434|1002464|P1|Overall Study|Screen failure|2
297292|NCT01656434|1002463|P2|Overall Study|Site discontinued study participation|9
297293|NCT01656434|1002464|P1|Overall Study|Site discontinued study participation|24
297294|NCT01656434|1002463|P2|Overall Study|Lost to Follow-up|76
297295|NCT01656434|1002464|P1|Overall Study|Lost to Follow-up|309
297296|NCT01656434|1002463|P2|Overall Study|Enrollment terminated at trial site|0
297297|NCT01656434|1002464|P1|Overall Study|Enrollment terminated at trial site|2
297298|NCT01656434|1002463|P2|Overall Study|Adverse Event|63
297299|NCT01656434|1002464|P1|Overall Study|Adverse Event|199
297300|NCT01656408|1002490|P10|Overall Study|Physician Decision|3
297301|NCT01656408|1002491|P9|Overall Study|Physician Decision|1
297302|NCT01656408|1002492|P8|Overall Study|Physician Decision|1
297303|NCT01656408|1002493|P7|Overall Study|Physician Decision|0
297304|NCT01656408|1002494|P6|Overall Study|Physician Decision|1
297305|NCT01656408|1002495|P5|Overall Study|Physician Decision|1
297306|NCT01656408|1002496|P4|Overall Study|Physician Decision|0
297307|NCT01656408|1002497|P3|Overall Study|Physician Decision|1
297308|NCT01656408|1002498|P2|Overall Study|Physician Decision|0
297309|NCT01656408|1002499|P1|Overall Study|Physician Decision|1
297310|NCT01656408|1002490|P10|Overall Study|Adverse Event|0
297311|NCT01656408|1002491|P9|Overall Study|Adverse Event|1
297312|NCT01656408|1002492|P8|Overall Study|Adverse Event|0
297313|NCT01656408|1002493|P7|Overall Study|Adverse Event|1
297314|NCT01656408|1002494|P6|Overall Study|Adverse Event|1
297315|NCT01656408|1002495|P5|Overall Study|Adverse Event|0
297316|NCT01656408|1002496|P4|Overall Study|Adverse Event|0
297317|NCT01656408|1002497|P3|Overall Study|Adverse Event|1
297318|NCT01656408|1002498|P2|Overall Study|Adverse Event|0
297319|NCT01656408|1002499|P1|Overall Study|Adverse Event|0
297320|NCT01656304|1002688|P1|Overall Study|Ineligible, uncontrolled hypertension|1
297321|NCT01656161|1002729|P1|Overall Study|Withdrawal by Subject|1
297322|NCT01656161|1002729|P1|Overall Study|Protocol Violation|1
297323|NCT01656161|1002729|P1|Overall Study|Adverse Event|2
297324|NCT01656161|1002729|P1|Overall Study|Death|3
297325|NCT01655498|1002753|P1|Overall Study|Withdrawal by Subject|1
297326|NCT01655498|1002753|P1|Overall Study|Protocol Violation|2
297327|NCT01655498|1002753|P1|Overall Study|Unrelated health issue|2
297328|NCT01655381|1002760|P1|Overall Study|Insufficient Treatment Response|1
297329|NCT01655381|1002760|P1|Overall Study|Moved to Another City|1
297330|NCT01655381|1002760|P1|Overall Study|Investigator Decision|1
297331|NCT01655069|1002800|P4|Overall Study|Withdrawal by Subject|0
297332|NCT01655069|1002801|P3|Overall Study|Withdrawal by Subject|0
297333|NCT01655069|1002802|P2|Overall Study|Withdrawal by Subject|3
297334|NCT01655069|1002803|P1|Overall Study|Withdrawal by Subject|2
297335|NCT01655069|1002800|P4|Overall Study|No Treatment Needed|0
297336|NCT01655069|1002801|P3|Overall Study|No Treatment Needed|0
297337|NCT01655069|1002802|P2|Overall Study|No Treatment Needed|1
297338|NCT01655069|1002803|P1|Overall Study|No Treatment Needed|0
297340|NCT01655069|1002801|P3|Overall Study|Lack of Efficacy|0
297341|NCT01655069|1002802|P2|Overall Study|Lack of Efficacy|1
297342|NCT01655069|1002803|P1|Overall Study|Lack of Efficacy|0
297343|NCT01655069|1002800|P4|Overall Study|Adverse Event|3
297344|NCT01655069|1002801|P3|Overall Study|Adverse Event|2
297345|NCT01655069|1002802|P2|Overall Study|Adverse Event|7
297346|NCT01655069|1002803|P1|Overall Study|Adverse Event|6
297347|NCT01655069|1002800|P4|Overall Study|Physician Decision|1
297348|NCT01655069|1002801|P3|Overall Study|Physician Decision|0
297349|NCT01655069|1002802|P2|Overall Study|Physician Decision|0
297350|NCT01655069|1002803|P1|Overall Study|Physician Decision|0
297351|NCT01654666|1002863|P3|Overall Study|Withdrawal by Subject|1
297352|NCT01654666|1002864|P2|Overall Study|Withdrawal by Subject|4
297353|NCT01654666|1002865|P1|Overall Study|Withdrawal by Subject|4
297354|NCT01654666|1002863|P3|Overall Study|Lost to Follow-up|5
297355|NCT01654666|1002864|P2|Overall Study|Lost to Follow-up|5
297356|NCT01654666|1002865|P1|Overall Study|Lost to Follow-up|4
297357|NCT01654666|1002863|P3|Overall Study|Protocol Violation|8
297358|NCT01654666|1002864|P2|Overall Study|Protocol Violation|4
297359|NCT01654666|1002865|P1|Overall Study|Protocol Violation|7
297360|NCT01654601|1002890|P2|2nd Administration|Protocol Violation|1
297361|NCT01654601|1002891|P1|2nd Administration|Protocol Violation|0
297362|NCT01654601|1002890|P2|2nd Administration|Adverse Event|0
297363|NCT01654601|1002891|P1|2nd Administration|Adverse Event|1
297364|NCT01654601|1002890|P2|1st Administration|Protocol Violation|2
297365|NCT01654601|1002891|P1|1st Administration|Protocol Violation|0
297366|NCT01654601|1002890|P2|1st Administration|Withdrawal by Subject|0
297367|NCT01654601|1002891|P1|1st Administration|Withdrawal by Subject|2
297368|NCT01654549|1002905|P2|Overall Study|H.pylori eradication not successful|1
297369|NCT01654549|1002906|P1|Overall Study|H.pylori eradication not successful|0
297370|NCT01654536|1002918|P2|Overall Study|Withdrawal by Subject|25
297371|NCT01654536|1002919|P1|Overall Study|Withdrawal by Subject|27
297372|NCT01654536|1002918|P2|Overall Study|Physician Decision|8
297373|NCT01654536|1002919|P1|Overall Study|Physician Decision|12
297374|NCT01654536|1002918|P2|Overall Study|Lost to Follow-up|5
297375|NCT01654536|1002919|P1|Overall Study|Lost to Follow-up|5
297376|NCT01654523|1002955|P1|Overall Study|Withdrawal by Subject|1
297377|NCT01654302|1002961|P2|Second Intervention (Day 7)|Lost to Follow-up|1
297378|NCT01654302|1002962|P1|Second Intervention (Day 7)|Lost to Follow-up|1
297379|NCT01654276|1002968|P1|Overall Study|Withdrawal by Subject|1
297380|NCT01654276|1002968|P1|Overall Study|Lost to Follow-up|4
297381|NCT01654276|1002968|P1|Overall Study|Lack of Efficacy|1
297382|NCT01654250|1003022|P2|Overall Study|Lost to Follow-up|0
297383|NCT01654250|1003023|P1|Overall Study|Lost to Follow-up|1
297384|NCT01654224|1003040|P2|Overall Study|Insufficient blood sample|2
297385|NCT01654224|1003041|P1|Overall Study|Insufficient blood sample|3
297386|NCT01654224|1003040|P2|Overall Study|Did not receive allocation|8
297387|NCT01654224|1003041|P1|Overall Study|Did not receive allocation|1
297388|NCT01654224|1003040|P2|Overall Study|Lost to Follow-up|2
297389|NCT01654224|1003041|P1|Overall Study|Lost to Follow-up|2
297390|NCT01653912|1003066|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
297391|NCT01653912|1003067|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
297392|NCT01653912|1003068|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
297393|NCT01653912|1003069|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
297394|NCT01653912|1003070|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
297395|NCT01653912|1003071|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
297396|NCT01653912|1003066|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
297397|NCT01653912|1003067|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
297398|NCT01653912|1003068|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
297399|NCT01653912|1003069|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
297400|NCT01653912|1003070|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
297401|NCT01653912|1003071|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
297402|NCT01653912|1003066|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
297403|NCT01653912|1003067|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
297404|NCT01653912|1003068|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
297405|NCT01653912|1003069|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
297406|NCT01653912|1003070|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
297407|NCT01653912|1003071|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
297408|NCT01653912|1003066|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
297409|NCT01653912|1003067|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
297410|NCT01653912|1003068|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
297411|NCT01653912|1003069|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
297412|NCT01653912|1003070|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
297413|NCT01653912|1003071|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
297414|NCT01653912|1003066|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
297415|NCT01653912|1003067|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
297416|NCT01653912|1003068|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
297417|NCT01653912|1003069|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
297418|NCT01653912|1003070|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
297419|NCT01653912|1003071|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
297420|NCT01653912|1003066|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
297421|NCT01653912|1003067|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
297422|NCT01653912|1003068|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
297423|NCT01653912|1003069|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
297424|NCT01653912|1003070|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
297425|NCT01653912|1003071|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
297426|NCT01653912|1003066|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
297427|NCT01653912|1003067|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
297428|NCT01653912|1003068|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
297429|NCT01653912|1003069|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
297430|NCT01653912|1003070|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
297431|NCT01653912|1003071|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
297432|NCT01653782|1003089|P3|Overall Study|Lost to Follow-up|2
297433|NCT01653782|1003090|P2|Overall Study|Lost to Follow-up|3
297434|NCT01653782|1003091|P1|Overall Study|Lost to Follow-up|7
297435|NCT01653782|1003089|P3|Overall Study|Withdrawal by Subject|4
297436|NCT01653782|1003090|P2|Overall Study|Withdrawal by Subject|15
297437|NCT01653782|1003091|P1|Overall Study|Withdrawal by Subject|9
297438|NCT01653743|1003101|P2|Overall Study|Investigator discretion|0
297439|NCT01653743|1003102|P1|Overall Study|Investigator discretion|3
297440|NCT01653743|1003101|P2|Overall Study|Withdrawal by Subject|0
297441|NCT01653743|1003102|P1|Overall Study|Withdrawal by Subject|1
297442|NCT01653262|1003149|P1|Overall Study|AE, non-serious non-fatal|1
297443|NCT01653262|1003149|P1|Overall Study|SAE, non-fatal|1
297444|NCT01653262|1003149|P1|Overall Study|Lack of Efficacy|1
297445|NCT01653158|1003162|P8|Overall Study|Withdrawal by Subject|0
297446|NCT01653158|1003163|P7|Overall Study|Withdrawal by Subject|0
297447|NCT01653158|1003164|P6|Overall Study|Withdrawal by Subject|0
297448|NCT01653158|1003165|P5|Overall Study|Withdrawal by Subject|0
297449|NCT01653158|1003166|P4|Overall Study|Withdrawal by Subject|0
297450|NCT01653158|1003167|P3|Overall Study|Withdrawal by Subject|0
297451|NCT01653158|1003168|P2|Overall Study|Withdrawal by Subject|0
297452|NCT01653158|1003169|P1|Overall Study|Withdrawal by Subject|1
297453|NCT01653158|1003162|P8|Overall Study|Progressive disease|9
297454|NCT01653158|1003163|P7|Overall Study|Progressive disease|2
297455|NCT01653158|1003164|P6|Overall Study|Progressive disease|1
297456|NCT01653158|1003165|P5|Overall Study|Progressive disease|1
297457|NCT01653158|1003166|P4|Overall Study|Progressive disease|0
297458|NCT01653158|1003167|P3|Overall Study|Progressive disease|0
297459|NCT01653158|1003168|P2|Overall Study|Progressive disease|0
297460|NCT01653158|1003169|P1|Overall Study|Progressive disease|0
297461|NCT01653158|1003162|P8|Overall Study|Other|1
297462|NCT01653158|1003163|P7|Overall Study|Other|0
297463|NCT01653158|1003164|P6|Overall Study|Other|0
297464|NCT01653158|1003165|P5|Overall Study|Other|0
297465|NCT01653158|1003166|P4|Overall Study|Other|0
297466|NCT01653158|1003167|P3|Overall Study|Other|0
297467|NCT01653158|1003168|P2|Overall Study|Other|0
297468|NCT01653158|1003169|P1|Overall Study|Other|0
297469|NCT01653158|1003162|P8|Overall Study|Adverse Event|3
297470|NCT01653158|1003163|P7|Overall Study|Adverse Event|0
297471|NCT01653158|1003164|P6|Overall Study|Adverse Event|0
297472|NCT01653158|1003165|P5|Overall Study|Adverse Event|0
297473|NCT01653158|1003166|P4|Overall Study|Adverse Event|1
297474|NCT01653158|1003167|P3|Overall Study|Adverse Event|0
297475|NCT01653158|1003168|P2|Overall Study|Adverse Event|0
297476|NCT01653158|1003169|P1|Overall Study|Adverse Event|0
297477|NCT01653158|1003162|P8|Overall Study|Death|2
297478|NCT01653158|1003163|P7|Overall Study|Death|0
297479|NCT01653158|1003164|P6|Overall Study|Death|0
297480|NCT01653158|1003165|P5|Overall Study|Death|0
297481|NCT01653158|1003166|P4|Overall Study|Death|1
297482|NCT01653158|1003167|P3|Overall Study|Death|0
297483|NCT01653158|1003168|P2|Overall Study|Death|0
297484|NCT01653158|1003169|P1|Overall Study|Death|0
297485|NCT01653132|1003441|P2|First Intervention|Protocol Violation|0
297486|NCT01653132|1003442|P1|First Intervention|Protocol Violation|1
297487|NCT01652885|1003492|P1|Overall Study|Adverse Event|1
297488|NCT01652729|1003520|P3|Overall Study|Administrative|0
297489|NCT01652729|1003521|P2|Overall Study|Administrative|0
297490|NCT01652729|1003522|P1|Overall Study|Administrative|1
297491|NCT01652729|1003520|P3|Overall Study|Lost to Follow-up|3
297492|NCT01652729|1003521|P2|Overall Study|Lost to Follow-up|6
297493|NCT01652729|1003522|P1|Overall Study|Lost to Follow-up|6
297494|NCT01652729|1003520|P3|Overall Study|Protocol Violation|0
297495|NCT01652729|1003521|P2|Overall Study|Protocol Violation|0
297496|NCT01652729|1003522|P1|Overall Study|Protocol Violation|1
297497|NCT01652729|1003520|P3|Overall Study|Physician Decision|1
297498|NCT01652729|1003521|P2|Overall Study|Physician Decision|0
297499|NCT01652729|1003522|P1|Overall Study|Physician Decision|1
297500|NCT01652729|1003520|P3|Overall Study|Adverse Event|3
297501|NCT01652729|1003521|P2|Overall Study|Adverse Event|0
297502|NCT01652729|1003522|P1|Overall Study|Adverse Event|4
297503|NCT01652729|1003520|P3|Overall Study|Withdrawal by Subject|7
297504|NCT01652729|1003521|P2|Overall Study|Withdrawal by Subject|7
297505|NCT01652729|1003522|P1|Overall Study|Withdrawal by Subject|14
297506|NCT01652716|1003544|P2|Overall Study|Withdrawal by Subject|18
297507|NCT01652716|1003545|P1|Overall Study|Withdrawal by Subject|33
297508|NCT01652716|1003544|P2|Overall Study|Adverse Event|10
297509|NCT01652716|1003545|P1|Overall Study|Adverse Event|7
297510|NCT01652716|1003544|P2|Overall Study|Protocol Violation|1
297511|NCT01652716|1003545|P1|Overall Study|Protocol Violation|2
297512|NCT01652716|1003544|P2|Overall Study|Lost to Follow-up|11
297513|NCT01652716|1003545|P1|Overall Study|Lost to Follow-up|12
297514|NCT01652716|1003544|P2|Overall Study|Investigator decision|4
297515|NCT01652716|1003545|P1|Overall Study|Investigator decision|1
297516|NCT01652716|1003544|P2|Overall Study|Administrative|2
297517|NCT01652716|1003545|P1|Overall Study|Administrative|0
297518|NCT01652716|1003544|P2|Overall Study|Loss of glucose control|0
297519|NCT01652716|1003545|P1|Overall Study|Loss of glucose control|1
297520|NCT01652703|1003565|P6|Overall Study|Other|1
297521|NCT01652703|1003566|P5|Overall Study|Other|1
297522|NCT01652703|1003567|P4|Overall Study|Other|1
297523|NCT01652703|1003568|P3|Overall Study|Other|0
297524|NCT01652703|1003569|P2|Overall Study|Other|0
297525|NCT01652703|1003570|P1|Overall Study|Other|0
297526|NCT01652703|1003565|P6|Overall Study|Withdrawal by Subject|1
297527|NCT01652703|1003566|P5|Overall Study|Withdrawal by Subject|0
297528|NCT01652703|1003567|P4|Overall Study|Withdrawal by Subject|1
297529|NCT01652703|1003568|P3|Overall Study|Withdrawal by Subject|3
297530|NCT01652703|1003569|P2|Overall Study|Withdrawal by Subject|1
297531|NCT01652703|1003570|P1|Overall Study|Withdrawal by Subject|0
297532|NCT01652690|1003628|P2|Overall Study|Death|2
297533|NCT01652690|1003629|P1|Overall Study|Death|5
297534|NCT01652690|1003628|P2|Overall Study|Lost to Follow-up|6
297535|NCT01652690|1003629|P1|Overall Study|Lost to Follow-up|6
297536|NCT01652690|1003628|P2|Overall Study|Other|9
297537|NCT01652690|1003629|P1|Overall Study|Other|8
297538|NCT01652690|1003628|P2|Overall Study|Withdrawal by Subject|4
297539|NCT01652690|1003629|P1|Overall Study|Withdrawal by Subject|16
297540|NCT01652664|1003663|P2|Overall Study|Inadequate IOP control|0
297541|NCT01652664|1003664|P1|Overall Study|Inadequate IOP control|1
297542|NCT01652664|1003663|P2|Overall Study|Treatment Failure|1
297543|NCT01652664|1003664|P1|Overall Study|Treatment Failure|5
297544|NCT01652573|1003673|P2|Overall Study|Adverse Event|1
297545|NCT01652573|1003674|P1|Overall Study|Adverse Event|0
297546|NCT01652287|1003729|P2|Overall Study|Withdrawal by Subject|0
297547|NCT01652287|1003730|P1|Overall Study|Withdrawal by Subject|2
297548|NCT01651949|1003761|P3|Overall Study|Withdrawal by Subject|9
297549|NCT01651949|1003762|P2|Overall Study|Withdrawal by Subject|18
297550|NCT01651949|1003763|P1|Overall Study|Withdrawal by Subject|17
297551|NCT01651949|1003761|P3|Overall Study|Screen failure|0
297552|NCT01651949|1003762|P2|Overall Study|Screen failure|2
297553|NCT01651949|1003763|P1|Overall Study|Screen failure|2
297554|NCT01651949|1003761|P3|Overall Study|Adverse Event|1
297555|NCT01651949|1003762|P2|Overall Study|Adverse Event|2
297556|NCT01651949|1003763|P1|Overall Study|Adverse Event|0
297557|NCT01651949|1003761|P3|Overall Study|Physician Decision|0
297558|NCT01651949|1003762|P2|Overall Study|Physician Decision|2
297559|NCT01651949|1003763|P1|Overall Study|Physician Decision|0
297560|NCT01651949|1003761|P3|Overall Study|Protocol Violation|1
297561|NCT01651949|1003762|P2|Overall Study|Protocol Violation|2
297562|NCT01651949|1003763|P1|Overall Study|Protocol Violation|0
297563|NCT01651949|1003761|P3|Overall Study|Lost to Follow-up|20
297564|NCT01651949|1003762|P2|Overall Study|Lost to Follow-up|56
297565|NCT01651949|1003763|P1|Overall Study|Lost to Follow-up|30
297566|NCT01651949|1003761|P3|Overall Study|Unknown status|0
297567|NCT01651949|1003762|P2|Overall Study|Unknown status|4
297568|NCT01651949|1003763|P1|Overall Study|Unknown status|4
297569|NCT01651936|1003783|P3|Extension Study|Study terminated by sponsor|13
297570|NCT01651936|1003784|P2|Extension Study|Study terminated by sponsor|0
297571|NCT01651936|1003785|P1|Extension Study|Study terminated by sponsor|0
297572|NCT01651936|1003783|P3|Extension Study|Lack of Efficacy|1
297573|NCT01651936|1003784|P2|Extension Study|Lack of Efficacy|0
297574|NCT01651936|1003785|P1|Extension Study|Lack of Efficacy|0
297575|NCT01651936|1003783|P3|Base Study|Study terminated by sponsor|0
297576|NCT01651936|1003784|P2|Base Study|Study terminated by sponsor|16
297577|NCT01651936|1003785|P1|Base Study|Study terminated by sponsor|21
297578|NCT01651936|1003783|P3|Base Study|Early Escape|0
297579|NCT01651936|1003784|P2|Base Study|Early Escape|8
297580|NCT01651936|1003785|P1|Base Study|Early Escape|2
297581|NCT01651936|1003783|P3|Base Study|Withdrawal by Subject|0
297582|NCT01651936|1003784|P2|Base Study|Withdrawal by Subject|1
297583|NCT01651936|1003785|P1|Base Study|Withdrawal by Subject|1
297584|NCT01651936|1003783|P3|Base Study|Adverse Event|0
297585|NCT01651936|1003784|P2|Base Study|Adverse Event|0
297586|NCT01651936|1003785|P1|Base Study|Adverse Event|3
297587|NCT01651780|1003855|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
297588|NCT01651780|1003856|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
297589|NCT01651780|1003855|P2|Overall Study|Lost to Follow-up|2
297590|NCT01651780|1003856|P1|Overall Study|Lost to Follow-up|1
297591|NCT01651780|1003855|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
297592|NCT01651780|1003856|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
297593|NCT01651780|1003855|P2|Overall Study|Withdrawal by Subject|0
297594|NCT01651780|1003856|P1|Overall Study|Withdrawal by Subject|2
297595|NCT01651780|1003855|P2|Overall Study|Reason Not Specified: No 30-day visit|2
297596|NCT01651780|1003856|P1|Overall Study|Reason Not Specified: No 30-day visit|2
297597|NCT01651780|1003855|P2|Overall Study|Physician decision: No 30-day visit|1
297598|NCT01651780|1003856|P1|Overall Study|Physician decision: No 30-day visit|2
297599|NCT01651260|1003906|P1|Overall Study|unable to apply product|3
297600|NCT01651208|1003913|P2|Overall Study|Lost to Follow-up|16
297601|NCT01651208|1003914|P1|Overall Study|Lost to Follow-up|14
297602|NCT01651039|1003929|P1|Overall Study|Progressive Disease|22
297603|NCT01651039|1003929|P1|Overall Study|Withdrawal by Subject|1
297604|NCT01651039|1003929|P1|Overall Study|Physician Decision|2
297605|NCT01651039|1003929|P1|Overall Study|Non-evaluables|5
297606|NCT01651000|1003942|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
297607|NCT01651000|1003943|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
297608|NCT01651000|1003942|P2|Overall Study|Administrative reason|0
297609|NCT01651000|1003943|P1|Overall Study|Administrative reason|1
297610|NCT01651000|1003942|P2|Overall Study|Physician Decision|0
297611|NCT01651000|1003943|P1|Overall Study|Physician Decision|1
297612|NCT01651000|1003942|P2|Overall Study|Lack of Efficacy|1
297613|NCT01651000|1003943|P1|Overall Study|Lack of Efficacy|1
297614|NCT01651000|1003942|P2|Overall Study|Subject noncompliance|3
297615|NCT01651000|1003943|P1|Overall Study|Subject noncompliance|0
297616|NCT01651000|1003942|P2|Overall Study|Withdrawal by Subject|10
297617|NCT01651000|1003943|P1|Overall Study|Withdrawal by Subject|2
297618|NCT01651000|1003942|P2|Overall Study|Protocol Violation|3
297619|NCT01651000|1003943|P1|Overall Study|Protocol Violation|0
297620|NCT01651000|1003942|P2|Overall Study|Lost to Follow-up|2
297621|NCT01651000|1003943|P1|Overall Study|Lost to Follow-up|3
297622|NCT01651000|1003942|P2|Overall Study|Adverse Event|8
297623|NCT01651000|1003943|P1|Overall Study|Adverse Event|2
297624|NCT01650831|1003964|P1|Overall Study|Screen failure|1
297625|NCT01650805|1003974|P2|Overall Study|Withdrawal by Subject|0
297626|NCT01650805|1003975|P1|Overall Study|Withdrawal by Subject|1
297627|NCT01650779|1003985|P1|Overall Study|Withdrawal by Subject|1
297628|NCT01650519|1004007|P2|Overall Study|Withdrawal by Subject|0
297629|NCT01650519|1004008|P1|Overall Study|Withdrawal by Subject|1
297630|NCT01650285|1004069|P1|Overall Study|Adverse Event|1
297631|NCT01650246|1004074|P1|Overall Study|Lack of Efficacy|30
297632|NCT01650246|1004074|P1|Overall Study|Death|1
297633|NCT01650246|1004074|P1|Overall Study|Withdrawal by Subject|26
297634|NCT01650246|1004074|P1|Overall Study|Lost to Follow-up|5
297635|NCT01650246|1004074|P1|Overall Study|Sponsor terminated study|53
297636|NCT01650246|1004074|P1|Overall Study|Protocol Violation|5
297637|NCT01650246|1004074|P1|Overall Study|Adverse Event|23
297638|NCT01649856|1004081|P2|Overall Study|Not Specified|5
297639|NCT01649856|1004082|P1|Overall Study|Not Specified|20
297640|NCT01649856|1004081|P2|Overall Study|Lack of Compliance|1
297641|NCT01649856|1004082|P1|Overall Study|Lack of Compliance|6
297642|NCT01649856|1004081|P2|Overall Study|Lost to Follow-up|16
297643|NCT01649856|1004082|P1|Overall Study|Lost to Follow-up|20
297644|NCT01649856|1004081|P2|Overall Study|Stable or Progressed Disease|3
297645|NCT01649856|1004082|P1|Overall Study|Stable or Progressed Disease|5
297646|NCT01649856|1004081|P2|Overall Study|Death|34
297647|NCT01649856|1004082|P1|Overall Study|Death|69
297648|NCT01649856|1004081|P2|Overall Study|Treatment Failure|1
297649|NCT01649856|1004082|P1|Overall Study|Treatment Failure|1
297650|NCT01649856|1004081|P2|Overall Study|Protocol Violation|4
297651|NCT01649856|1004082|P1|Overall Study|Protocol Violation|4
297652|NCT01649856|1004081|P2|Overall Study|Withdrawal by Subject|14
297653|NCT01649856|1004082|P1|Overall Study|Withdrawal by Subject|14
297654|NCT01649804|1004114|P1|Overall Study|Administrative/Other|8
297655|NCT01649791|1004126|P1|Overall Study|Adverse Event|1
297656|NCT01649791|1004126|P1|Overall Study|Disease Progression|2
297657|NCT01649557|1004158|P3|Overall Study|Lack of Efficacy|0
297658|NCT01649557|1004159|P2|Overall Study|Lack of Efficacy|0
297659|NCT01649557|1004160|P1|Overall Study|Lack of Efficacy|5
297660|NCT01649557|1004158|P3|Overall Study|Protocol deviation|0
297661|NCT01649557|1004159|P2|Overall Study|Protocol deviation|2
297662|NCT01649557|1004160|P1|Overall Study|Protocol deviation|0
297663|NCT01649557|1004158|P3|Overall Study|Withdrawal by Subject|4
297664|NCT01649557|1004159|P2|Overall Study|Withdrawal by Subject|5
297665|NCT01649557|1004160|P1|Overall Study|Withdrawal by Subject|15
297666|NCT01649557|1004158|P3|Overall Study|Physician Decision|1
297667|NCT01649557|1004159|P2|Overall Study|Physician Decision|2
297668|NCT01649557|1004160|P1|Overall Study|Physician Decision|8
297669|NCT01649557|1004158|P3|Overall Study|Met withdrawal criteria|0
297670|NCT01649557|1004159|P2|Overall Study|Met withdrawal criteria|0
297671|NCT01649557|1004160|P1|Overall Study|Met withdrawal criteria|4
297672|NCT01649557|1004158|P3|Overall Study|Adverse Event|1
297673|NCT01649557|1004159|P2|Overall Study|Adverse Event|5
297674|NCT01649557|1004160|P1|Overall Study|Adverse Event|7
297675|NCT01649557|1004158|P3|Overall Study|Lost to Follow-up|3
297676|NCT01649557|1004159|P2|Overall Study|Lost to Follow-up|0
297677|NCT01649557|1004160|P1|Overall Study|Lost to Follow-up|5
297678|NCT01649297|1004222|P5|Overall Study|For other reason|0
297679|NCT01649297|1004223|P4|Overall Study|For other reason|0
297680|NCT01649297|1004224|P3|Overall Study|For other reason|2
297681|NCT01649297|1004225|P2|Overall Study|For other reason|1
297682|NCT01649297|1004226|P1|Overall Study|For other reason|4
297683|NCT01649297|1004222|P5|Overall Study|Patient withdrawal (not due to AE)|1
297684|NCT01649297|1004223|P4|Overall Study|Patient withdrawal (not due to AE)|1
297685|NCT01649297|1004224|P3|Overall Study|Patient withdrawal (not due to AE)|4
297686|NCT01649297|1004225|P2|Overall Study|Patient withdrawal (not due to AE)|6
297687|NCT01649297|1004226|P1|Overall Study|Patient withdrawal (not due to AE)|3
297688|NCT01649297|1004222|P5|Overall Study|Lost to Follow-up|0
297689|NCT01649297|1004223|P4|Overall Study|Lost to Follow-up|3
297690|NCT01649297|1004224|P3|Overall Study|Lost to Follow-up|4
297691|NCT01649297|1004225|P2|Overall Study|Lost to Follow-up|1
297692|NCT01649297|1004226|P1|Overall Study|Lost to Follow-up|1
297693|NCT01649297|1004222|P5|Overall Study|Non compliant with Protocol|1
297694|NCT01649297|1004223|P4|Overall Study|Non compliant with Protocol|2
297695|NCT01649297|1004224|P3|Overall Study|Non compliant with Protocol|3
297696|NCT01649297|1004225|P2|Overall Study|Non compliant with Protocol|0
297697|NCT01649297|1004226|P1|Overall Study|Non compliant with Protocol|1
297698|NCT01649297|1004222|P5|Overall Study|Lack of Efficacy|1
297699|NCT01649297|1004223|P4|Overall Study|Lack of Efficacy|0
297700|NCT01649297|1004224|P3|Overall Study|Lack of Efficacy|0
297701|NCT01649297|1004225|P2|Overall Study|Lack of Efficacy|0
297702|NCT01649297|1004226|P1|Overall Study|Lack of Efficacy|0
297703|NCT01649297|1004222|P5|Overall Study|Adverse Event|1
297704|NCT01649297|1004223|P4|Overall Study|Adverse Event|13
297705|NCT01649297|1004224|P3|Overall Study|Adverse Event|4
297706|NCT01649297|1004225|P2|Overall Study|Adverse Event|5
297707|NCT01649297|1004226|P1|Overall Study|Adverse Event|5
297708|NCT01649271|1004245|P2|Overall Study|Other than stated above|0
297709|NCT01649271|1004246|P1|Overall Study|Other than stated above|1
297710|NCT01649271|1004245|P2|Overall Study|Withdrawal by Subject|0
297711|NCT01649271|1004246|P1|Overall Study|Withdrawal by Subject|1
297712|NCT01649271|1004245|P2|Overall Study|Other Adverse Event|2
297713|NCT01649271|1004246|P1|Overall Study|Other Adverse Event|0
297714|NCT01649271|1004245|P2|Overall Study|Progressive disease|5
297715|NCT01649271|1004246|P1|Overall Study|Progressive disease|4
297716|NCT01649232|1004261|P2|Overall Study|Physician Decision|0
297717|NCT01649232|1004262|P1|Overall Study|Physician Decision|2
297718|NCT01648790|1004314|P5|Treatment 3|Withdrawal by Subject|0
297719|NCT01648790|1004315|P4|Treatment 3|Withdrawal by Subject|1
297720|NCT01648790|1004316|P3|Treatment 3|Withdrawal by Subject|0
297721|NCT01648790|1004317|P2|Treatment 3|Withdrawal by Subject|0
297722|NCT01648790|1004318|P1|Treatment 3|Withdrawal by Subject|0
297723|NCT01648699|1004339|P1|Overall Study|Unspecified/unable to complete 4 visits|2
297724|NCT01648699|1004339|P1|Overall Study|Lost to Follow-up|2
297725|NCT01648699|1004339|P1|Overall Study|Death|1
297726|NCT01648582|1004368|P3|Overall Study|Sponsor Decision|1
297727|NCT01648582|1004369|P2|Overall Study|Sponsor Decision|1
297728|NCT01648582|1004370|P1|Overall Study|Sponsor Decision|0
297729|NCT01648582|1004368|P3|Overall Study|Death|0
297730|NCT01648582|1004369|P2|Overall Study|Death|0
297731|NCT01648582|1004370|P1|Overall Study|Death|1
297732|NCT01648582|1004368|P3|Overall Study|Physician Decision|3
297733|NCT01648582|1004369|P2|Overall Study|Physician Decision|1
297734|NCT01648582|1004370|P1|Overall Study|Physician Decision|0
297735|NCT01648582|1004368|P3|Overall Study|Withdrawal by Subject|17
297736|NCT01648582|1004369|P2|Overall Study|Withdrawal by Subject|17
297737|NCT01648582|1004370|P1|Overall Study|Withdrawal by Subject|15
297738|NCT01648582|1004368|P3|Overall Study|Protocol Violation|1
297739|NCT01648582|1004369|P2|Overall Study|Protocol Violation|2
297740|NCT01648582|1004370|P1|Overall Study|Protocol Violation|1
297741|NCT01648582|1004368|P3|Overall Study|Lost to Follow-up|8
297742|NCT01648582|1004369|P2|Overall Study|Lost to Follow-up|6
297743|NCT01648582|1004370|P1|Overall Study|Lost to Follow-up|9
297744|NCT01648582|1004368|P3|Overall Study|Adverse Event|2
297745|NCT01648582|1004369|P2|Overall Study|Adverse Event|11
297746|NCT01648582|1004370|P1|Overall Study|Adverse Event|6
297747|NCT01648348|1004473|P6|Overall Study|Replaced for MTD analysis|0
297748|NCT01648348|1004474|P5|Overall Study|Replaced for MTD analysis|0
297749|NCT01648348|1004475|P4|Overall Study|Replaced for MTD analysis|0
297750|NCT01648348|1004476|P3|Overall Study|Replaced for MTD analysis|1
297751|NCT01648348|1004477|P2|Overall Study|Replaced for MTD analysis|0
297752|NCT01648348|1004478|P1|Overall Study|Replaced for MTD analysis|1
297753|NCT01648348|1004473|P6|Overall Study|Cancel|6
297754|NCT01648348|1004474|P5|Overall Study|Cancel|3
297755|NCT01648348|1004475|P4|Overall Study|Cancel|0
297756|NCT01648348|1004476|P3|Overall Study|Cancel|0
297757|NCT01648348|1004477|P2|Overall Study|Cancel|0
297758|NCT01648348|1004478|P1|Overall Study|Cancel|1
297759|NCT01648283|1004523|P1|Overall Study|Withdrawal by Subject|14
297760|NCT01648140|1004533|P4|Overall Study|Lost to Follow-up|0
297761|NCT01648140|1004534|P3|Overall Study|Lost to Follow-up|2
297762|NCT01648140|1004535|P2|Overall Study|Lost to Follow-up|1
297763|NCT01648140|1004536|P1|Overall Study|Lost to Follow-up|2
297764|NCT01648140|1004533|P4|Overall Study|Withdrawal by Subject|2
297765|NCT01648140|1004534|P3|Overall Study|Withdrawal by Subject|3
297766|NCT01648140|1004535|P2|Overall Study|Withdrawal by Subject|3
297767|NCT01648140|1004536|P1|Overall Study|Withdrawal by Subject|2
297768|NCT01648140|1004533|P4|Overall Study|Adverse Event|0
297769|NCT01648140|1004534|P3|Overall Study|Adverse Event|2
297770|NCT01648140|1004535|P2|Overall Study|Adverse Event|1
297771|NCT01648140|1004536|P1|Overall Study|Adverse Event|3
297772|NCT01648140|1004533|P4|Overall Study|Lack of Efficacy|0
297773|NCT01648140|1004534|P3|Overall Study|Lack of Efficacy|1
297774|NCT01648140|1004535|P2|Overall Study|Lack of Efficacy|7
297775|NCT01648140|1004536|P1|Overall Study|Lack of Efficacy|4
297776|NCT01648140|1004533|P4|Overall Study|Physician Decision|0
297777|NCT01648140|1004534|P3|Overall Study|Physician Decision|0
297778|NCT01648140|1004535|P2|Overall Study|Physician Decision|0
297779|NCT01648140|1004536|P1|Overall Study|Physician Decision|1
297780|NCT01648101|1004701|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
297781|NCT01648101|1004702|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
297782|NCT01648101|1004703|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
297783|NCT01648101|1004701|P3|Transition Phase (4 Weeks)|Study Terminated|0
297784|NCT01648101|1004702|P2|Transition Phase (4 Weeks)|Study Terminated|0
297785|NCT01648101|1004703|P1|Transition Phase (4 Weeks)|Study Terminated|1
297786|NCT01648101|1004701|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
297787|NCT01648101|1004702|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
297788|NCT01648101|1004703|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
297789|NCT01648101|1004701|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
297790|NCT01648101|1004702|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
297791|NCT01648101|1004703|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
297792|NCT01648101|1004701|P3|Transition Phase (4 Weeks)|Adverse Event|2
297793|NCT01648101|1004702|P2|Transition Phase (4 Weeks)|Adverse Event|3
297794|NCT01648101|1004703|P1|Transition Phase (4 Weeks)|Adverse Event|4
297795|NCT01648101|1004701|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
297796|NCT01648101|1004702|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
297797|NCT01648101|1004703|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
297798|NCT01648101|1004701|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
297799|NCT01648101|1004702|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
297800|NCT01648101|1004703|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
297801|NCT01648101|1004701|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
297802|NCT01648101|1004702|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
297803|NCT01648101|1004703|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
297804|NCT01648101|1004701|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
297805|NCT01648101|1004702|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
297806|NCT01648101|1004703|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
297807|NCT01648101|1004701|P3|Titration Phase (4 Weeks)|Adverse Event|3
297808|NCT01648101|1004702|P2|Titration Phase (4 Weeks)|Adverse Event|2
297809|NCT01648101|1004703|P1|Titration Phase (4 Weeks)|Adverse Event|0
297810|NCT01648101|1004701|P3|Titration Phase (4 Weeks)|Protocol Violation|2
297811|NCT01648101|1004702|P2|Titration Phase (4 Weeks)|Protocol Violation|1
297812|NCT01648101|1004703|P1|Titration Phase (4 Weeks)|Protocol Violation|2
297813|NCT01647711|1004790|P5|Overall Study|Other reason not defined|0
297814|NCT01647711|1004791|P4|Overall Study|Other reason not defined|1
297815|NCT01647711|1004792|P3|Overall Study|Other reason not defined|1
297816|NCT01647711|1004793|P2|Overall Study|Other reason not defined|1
297817|NCT01647711|1004794|P1|Overall Study|Other reason not defined|0
297818|NCT01647711|1004790|P5|Overall Study|Refused to continue taking medication|1
297819|NCT01647711|1004791|P4|Overall Study|Refused to continue taking medication|2
297820|NCT01647711|1004792|P3|Overall Study|Refused to continue taking medication|0
297821|NCT01647711|1004793|P2|Overall Study|Refused to continue taking medication|0
297822|NCT01647711|1004794|P1|Overall Study|Refused to continue taking medication|0
297823|NCT01647711|1004790|P5|Overall Study|Protocol Violation|1
297824|NCT01647711|1004791|P4|Overall Study|Protocol Violation|0
297825|NCT01647711|1004792|P3|Overall Study|Protocol Violation|0
297826|NCT01647711|1004793|P2|Overall Study|Protocol Violation|0
297827|NCT01647711|1004794|P1|Overall Study|Protocol Violation|0
297828|NCT01647711|1004790|P5|Overall Study|Other adverse event|2
297829|NCT01647711|1004791|P4|Overall Study|Other adverse event|0
297830|NCT01647711|1004792|P3|Overall Study|Other adverse event|2
297831|NCT01647711|1004793|P2|Overall Study|Other adverse event|0
297832|NCT01647711|1004794|P1|Overall Study|Other adverse event|0
297833|NCT01647711|1004790|P5|Overall Study|Progressive disease|2
297834|NCT01647711|1004791|P4|Overall Study|Progressive disease|8
297835|NCT01647711|1004792|P3|Overall Study|Progressive disease|6
297836|NCT01647711|1004793|P2|Overall Study|Progressive disease|2
297837|NCT01647711|1004794|P1|Overall Study|Progressive disease|6
297838|NCT01647542|1004822|P3|Overall Study|Death|1
297839|NCT01647542|1004823|P2|Overall Study|Death|0
297840|NCT01647542|1004824|P1|Overall Study|Death|0
297841|NCT01647542|1004822|P3|Overall Study|Lack of Efficacy|0
297842|NCT01647542|1004823|P2|Overall Study|Lack of Efficacy|1
297843|NCT01647542|1004824|P1|Overall Study|Lack of Efficacy|1
297844|NCT01647542|1004822|P3|Overall Study|Study Termination|65
297845|NCT01647542|1004823|P2|Overall Study|Study Termination|61
297846|NCT01647542|1004824|P1|Overall Study|Study Termination|64
297847|NCT01647542|1004822|P3|Overall Study|Withdrawal by Subject|0
297848|NCT01647542|1004823|P2|Overall Study|Withdrawal by Subject|4
297849|NCT01647542|1004824|P1|Overall Study|Withdrawal by Subject|6
297850|NCT01647542|1004822|P3|Overall Study|Lost to Follow-up|2
297851|NCT01647542|1004823|P2|Overall Study|Lost to Follow-up|2
297852|NCT01647542|1004824|P1|Overall Study|Lost to Follow-up|0
297853|NCT01647542|1004822|P3|Overall Study|Adverse Event|4
297854|NCT01647542|1004823|P2|Overall Study|Adverse Event|5
297855|NCT01647542|1004824|P1|Overall Study|Adverse Event|4
297856|NCT01647542|1004822|P3|Overall Study|Major Protocol Deviation|0
297857|NCT01647542|1004823|P2|Overall Study|Major Protocol Deviation|0
297858|NCT01647542|1004824|P1|Overall Study|Major Protocol Deviation|1
297859|NCT01647282|1004858|P2|Overall Study|Physician Decision|5
297860|NCT01647282|1004859|P1|Overall Study|Physician Decision|7
297861|NCT01646827|1004880|P2|Overall Study|Withdrawal by Subject|0
297862|NCT01646827|1004881|P1|Overall Study|Withdrawal by Subject|1
297863|NCT01646827|1004880|P2|Overall Study|Physician Decision|2
297864|NCT01646827|1004881|P1|Overall Study|Physician Decision|1
297865|NCT01646827|1004880|P2|Overall Study|Lost to Follow-up|3
297866|NCT01646827|1004881|P1|Overall Study|Lost to Follow-up|0
297867|NCT01646398|1004968|P2|Overall Study|Withdrawal by Subject|0
297868|NCT01646398|1004969|P1|Overall Study|Withdrawal by Subject|1
297869|NCT01646385|1004985|P2|Overall Study|Switched to alternate biologic|649
297870|NCT01646385|1004986|P1|Overall Study|Switched to alternate biologic|636
297871|NCT01646385|1004985|P2|Overall Study|Death|222
297872|NCT01646385|1004986|P1|Overall Study|Death|202
297873|NCT01646320|1005019|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
297874|NCT01646320|1005020|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
297875|NCT01646320|1005019|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
297876|NCT01646320|1005020|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
297877|NCT01646320|1005019|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
297878|NCT01646320|1005020|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
297879|NCT01646320|1005019|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
297880|NCT01646320|1005020|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
297881|NCT01646320|1005019|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
297882|NCT01646320|1005020|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
297883|NCT01646320|1005019|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
297884|NCT01646320|1005020|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
297885|NCT01646320|1005019|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
297886|NCT01646320|1005020|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
297887|NCT01646320|1005019|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
297888|NCT01646320|1005020|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
297889|NCT01646320|1005019|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
297890|NCT01646320|1005020|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
297891|NCT01646320|1005019|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
297892|NCT01646320|1005020|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
297893|NCT01646320|1005019|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
297894|NCT01646320|1005020|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
297895|NCT01646268|1005036|P2|Overall Study|Other|0
297896|NCT01646268|1005037|P1|Overall Study|Other|2
297897|NCT01646268|1005036|P2|Overall Study|Withdrawal by Subject|5
297898|NCT01646268|1005037|P1|Overall Study|Withdrawal by Subject|2
297899|NCT01646268|1005036|P2|Overall Study|Protocol Violation|1
297900|NCT01646268|1005037|P1|Overall Study|Protocol Violation|0
297901|NCT01646268|1005036|P2|Overall Study|Lack of Efficacy|3
297902|NCT01646268|1005037|P1|Overall Study|Lack of Efficacy|1
297903|NCT01646268|1005036|P2|Overall Study|Adverse Event|7
297904|NCT01646268|1005037|P1|Overall Study|Adverse Event|6
297905|NCT01646255|1005051|P2|Overall Study|Inclusion Criteria Deviation|0
297906|NCT01646255|1005052|P1|Overall Study|Inclusion Criteria Deviation|1
297907|NCT01646255|1005051|P2|Overall Study|Compliance is not well|0
297908|NCT01646255|1005052|P1|Overall Study|Compliance is not well|1
297909|NCT01646255|1005051|P2|Overall Study|Withdrawal by Subject|6
297910|NCT01646255|1005052|P1|Overall Study|Withdrawal by Subject|10
297911|NCT01646255|1005051|P2|Overall Study|Lack of Efficacy|0
297912|NCT01646255|1005052|P1|Overall Study|Lack of Efficacy|2
297913|NCT01646255|1005051|P2|Overall Study|Adverse Event|8
297914|NCT01646255|1005052|P1|Overall Study|Adverse Event|7
297915|NCT01646216|1005084|P2|Overall Study|Investigator decision|1
297916|NCT01646216|1005085|P1|Overall Study|Investigator decision|1
297917|NCT01646216|1005084|P2|Overall Study|Did not complete training|2
297918|NCT01646216|1005085|P1|Overall Study|Did not complete training|0
297919|NCT01646216|1005084|P2|Overall Study|Baseline step length difference (<5cm)|10
297920|NCT01646216|1005085|P1|Overall Study|Baseline step length difference (<5cm)|10
297921|NCT01646177|1005108|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
297922|NCT01646177|1005109|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
297923|NCT01646177|1005110|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
297924|NCT01646177|1005111|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
297925|NCT01646177|1005108|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
297926|NCT01646177|1005109|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
297927|NCT01646177|1005110|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
297928|NCT01646177|1005111|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
297929|NCT01646177|1005108|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
297930|NCT01646177|1005109|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
297931|NCT01646177|1005110|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
297932|NCT01646177|1005111|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
297933|NCT01646177|1005108|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
297934|NCT01646177|1005109|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
297935|NCT01646177|1005110|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
297936|NCT01646177|1005111|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
297937|NCT01646177|1005108|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
297938|NCT01646177|1005109|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
297939|NCT01646177|1005110|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
297940|NCT01646177|1005111|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
297941|NCT01646177|1005108|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
297942|NCT01646177|1005109|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
297943|NCT01646177|1005110|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
297944|NCT01646177|1005111|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
297945|NCT01646138|1005205|P5|Overall Study|Lost to Follow-up|2
297946|NCT01646138|1005206|P4|Overall Study|Lost to Follow-up|0
297947|NCT01646138|1005207|P3|Overall Study|Lost to Follow-up|0
297948|NCT01646138|1005208|P2|Overall Study|Lost to Follow-up|0
297949|NCT01646138|1005209|P1|Overall Study|Lost to Follow-up|0
297950|NCT01646125|1005223|P2|Overall Study|Subject/Guardian decision|1
297951|NCT01646125|1005224|P1|Overall Study|Subject/Guardian decision|1
297952|NCT01646125|1005223|P2|Overall Study|Study terminated by sponsor|1
297953|NCT01646125|1005224|P1|Overall Study|Study terminated by sponsor|2
297954|NCT01646125|1005223|P2|Overall Study|Progressive disease|16
297955|NCT01646125|1005224|P1|Overall Study|Progressive disease|22
297956|NCT01646125|1005223|P2|Overall Study|Physician Decision|3
297957|NCT01646125|1005224|P1|Overall Study|Physician Decision|1
297958|NCT01646125|1005223|P2|Overall Study|Death|1
297959|NCT01646125|1005224|P1|Overall Study|Death|1
297960|NCT01646125|1005223|P2|Overall Study|Adverse Event|1
297961|NCT01646125|1005224|P1|Overall Study|Adverse Event|2
297962|NCT01646125|1005223|P2|Overall Study|Untreated|5
297963|NCT01646125|1005224|P1|Overall Study|Untreated|2
297964|NCT01646073|1005249|P2|Period B (12 Weeks)|Lost to Follow-up|1
297965|NCT01646073|1005250|P1|Period B (12 Weeks)|Lost to Follow-up|0
297966|NCT01646073|1005249|P2|Period B (12 Weeks)|Withdrawal by Subject|5
297967|NCT01646073|1005250|P1|Period B (12 Weeks)|Withdrawal by Subject|1
297968|NCT01646073|1005249|P2|Period B (12 Weeks)|Adverse Event|7
297969|NCT01646073|1005250|P1|Period B (12 Weeks)|Adverse Event|0
297970|NCT01646073|1005249|P2|Period A (12 Weeks)|Not Specified|1
297971|NCT01646073|1005250|P1|Period A (12 Weeks)|Not Specified|0
297972|NCT01646073|1005249|P2|Period A (12 Weeks)|Protocol Violation|1
297973|NCT01646073|1005250|P1|Period A (12 Weeks)|Protocol Violation|0
297974|NCT01646073|1005249|P2|Period A (12 Weeks)|Lack of Efficacy|0
297975|NCT01646073|1005250|P1|Period A (12 Weeks)|Lack of Efficacy|1
297976|NCT01646073|1005249|P2|Period A (12 Weeks)|Withdrawal by Subject|1
297977|NCT01646073|1005250|P1|Period A (12 Weeks)|Withdrawal by Subject|1
297978|NCT01646073|1005249|P2|Period A (12 Weeks)|Adverse Event|2
297979|NCT01646073|1005250|P1|Period A (12 Weeks)|Adverse Event|0
297980|NCT01646021|1005291|P2|Overall Study|Withdrawal by Subject|15
297981|NCT01646021|1005292|P1|Overall Study|Withdrawal by Subject|10
297982|NCT01646021|1005291|P2|Overall Study|Lost to Follow-up|2
297983|NCT01646021|1005292|P1|Overall Study|Lost to Follow-up|2
297984|NCT01646021|1005291|P2|Overall Study|Study Terminated by Sponsor|41
297985|NCT01646021|1005292|P1|Overall Study|Study Terminated by Sponsor|50
297986|NCT01646021|1005291|P2|Overall Study|Death|83
297987|NCT01646021|1005292|P1|Overall Study|Death|77
297988|NCT01645735|1005331|P2|Overall Study|Adverse Event|1
297989|NCT01645735|1005332|P1|Overall Study|Adverse Event|0
297990|NCT01645735|1005331|P2|Overall Study|Protocol Violation|0
297991|NCT01645735|1005332|P1|Overall Study|Protocol Violation|1
297992|NCT01645735|1005331|P2|Overall Study|Withdrawal by Subject|0
297993|NCT01645735|1005332|P1|Overall Study|Withdrawal by Subject|1
297994|NCT01645735|1005331|P2|Overall Study|Physician Decision|0
297995|NCT01645735|1005332|P1|Overall Study|Physician Decision|2
297996|NCT01645280|1005374|P5|Overall Study|Treatment not completed/Completed f/u|2
297997|NCT01645280|1005375|P4|Overall Study|Treatment not completed/Completed f/u|0
297998|NCT01645280|1005376|P3|Overall Study|Treatment not completed/Completed f/u|2
297999|NCT01645280|1005377|P2|Overall Study|Treatment not completed/Completed f/u|1
298000|NCT01645280|1005378|P1|Overall Study|Treatment not completed/Completed f/u|1
298001|NCT01645280|1005374|P5|Overall Study|Other|0
298002|NCT01645280|1005375|P4|Overall Study|Other|0
298003|NCT01645280|1005376|P3|Overall Study|Other|2
298004|NCT01645280|1005377|P2|Overall Study|Other|1
298005|NCT01645280|1005378|P1|Overall Study|Other|1
298006|NCT01645280|1005374|P5|Overall Study|Lost to Follow-up|1
298007|NCT01645280|1005375|P4|Overall Study|Lost to Follow-up|2
298008|NCT01645280|1005376|P3|Overall Study|Lost to Follow-up|0
298009|NCT01645280|1005377|P2|Overall Study|Lost to Follow-up|0
298010|NCT01645280|1005378|P1|Overall Study|Lost to Follow-up|0
298011|NCT01645280|1005374|P5|Overall Study|Withdrawal by Subject|5
298012|NCT01645280|1005375|P4|Overall Study|Withdrawal by Subject|4
298013|NCT01645280|1005376|P3|Overall Study|Withdrawal by Subject|2
298014|NCT01645280|1005377|P2|Overall Study|Withdrawal by Subject|0
298015|NCT01645280|1005378|P1|Overall Study|Withdrawal by Subject|4
298016|NCT01645280|1005374|P5|Overall Study|Death|0
298017|NCT01645280|1005375|P4|Overall Study|Death|0
298018|NCT01645280|1005376|P3|Overall Study|Death|0
298019|NCT01645280|1005377|P2|Overall Study|Death|1
298020|NCT01645280|1005378|P1|Overall Study|Death|0
298021|NCT01645176|1005406|P1|Overall Study|did not complete final MRI|1
298022|NCT01645176|1005406|P1|Overall Study|Lack of Efficacy|4
298023|NCT01645111|1005410|P1|Overall Study|Did not require Clevidipine|15
298024|NCT01644734|1005449|P1|Overall Study|Missing documentation|238
298025|NCT01644734|1005449|P1|Overall Study|Reasons other than stated above|7
298026|NCT01644734|1005449|P1|Overall Study|Lost to Follow-up|17
298027|NCT01644734|1005449|P1|Overall Study|Adverse Event|4
298028|NCT01644643|1005463|P4|Overall Study|Other Eligibility criteria|2
298029|NCT01644643|1005464|P3|Overall Study|Other Eligibility criteria|0
298030|NCT01644643|1005465|P2|Overall Study|Other Eligibility criteria|0
298031|NCT01644643|1005466|P1|Overall Study|Other Eligibility criteria|0
298032|NCT01644643|1005463|P4|Overall Study|Withdrawal by Subject|1
298033|NCT01644643|1005464|P3|Overall Study|Withdrawal by Subject|2
298034|NCT01644643|1005465|P2|Overall Study|Withdrawal by Subject|0
298035|NCT01644643|1005466|P1|Overall Study|Withdrawal by Subject|1
298036|NCT01644643|1005463|P4|Overall Study|Lost to Follow-up|4
298037|NCT01644643|1005464|P3|Overall Study|Lost to Follow-up|0
298038|NCT01644643|1005465|P2|Overall Study|Lost to Follow-up|0
298039|NCT01644643|1005466|P1|Overall Study|Lost to Follow-up|0
298040|NCT01644643|1005463|P4|Overall Study|Death|3
298041|NCT01644643|1005464|P3|Overall Study|Death|3
298042|NCT01644643|1005465|P2|Overall Study|Death|0
298043|NCT01644643|1005466|P1|Overall Study|Death|1
298044|NCT01644617|1005631|P3|Overall Study|Adverse Event|6
298045|NCT01644617|1005632|P2|Overall Study|Adverse Event|0
298046|NCT01644617|1005633|P1|Overall Study|Adverse Event|3
298047|NCT01644617|1005631|P3|Overall Study|Lost to Follow-up|0
298048|NCT01644617|1005632|P2|Overall Study|Lost to Follow-up|1
298049|NCT01644617|1005633|P1|Overall Study|Lost to Follow-up|0
298050|NCT01644617|1005631|P3|Overall Study|Withdrawal by Subject|1
298051|NCT01644617|1005632|P2|Overall Study|Withdrawal by Subject|4
298052|NCT01644617|1005633|P1|Overall Study|Withdrawal by Subject|3
298053|NCT01644500|1005686|P3|Overall Study|Physician Decision|1
298054|NCT01644500|1005687|P2|Overall Study|Physician Decision|1
298055|NCT01644500|1005688|P1|Overall Study|Physician Decision|1
298056|NCT01644500|1005686|P3|Overall Study|Withdrawal by Subject|12
298057|NCT01644500|1005687|P2|Overall Study|Withdrawal by Subject|12
298058|NCT01644500|1005688|P1|Overall Study|Withdrawal by Subject|11
298059|NCT01644500|1005686|P3|Overall Study|Protocol Violation|0
298060|NCT01644500|1005687|P2|Overall Study|Protocol Violation|1
298061|NCT01644500|1005688|P1|Overall Study|Protocol Violation|1
298062|NCT01644500|1005686|P3|Overall Study|Lost to Follow-up|0
298063|NCT01644500|1005687|P2|Overall Study|Lost to Follow-up|8
298064|NCT01644500|1005688|P1|Overall Study|Lost to Follow-up|3
298065|NCT01644500|1005686|P3|Overall Study|Death|0
298066|NCT01644500|1005687|P2|Overall Study|Death|1
298067|NCT01644500|1005688|P1|Overall Study|Death|0
298068|NCT01644500|1005686|P3|Overall Study|Adverse Event|2
298069|NCT01644500|1005687|P2|Overall Study|Adverse Event|1
298070|NCT01644500|1005688|P1|Overall Study|Adverse Event|6
298071|NCT01644474|1005758|P2|Overall Study|Protocol Violation|0
298072|NCT01644474|1005759|P1|Overall Study|Protocol Violation|1
298073|NCT01644474|1005758|P2|Overall Study|Site scheduling error|1
298074|NCT01644474|1005759|P1|Overall Study|Site scheduling error|1
298075|NCT01644474|1005758|P2|Overall Study|Adverse Event|5
298076|NCT01644474|1005759|P1|Overall Study|Adverse Event|4
298077|NCT01644474|1005758|P2|Overall Study|Participant moved|1
298078|NCT01644474|1005759|P1|Overall Study|Participant moved|0
298079|NCT01644474|1005758|P2|Overall Study|Consent withdrawn by participant|1
298080|NCT01644474|1005759|P1|Overall Study|Consent withdrawn by participant|0
298081|NCT01644474|1005758|P2|Overall Study|Poor compliance to protocol|0
298082|NCT01644474|1005759|P1|Overall Study|Poor compliance to protocol|1
298083|NCT01644188|1005943|P2|Overall Study|Other than specified above|7
298084|NCT01644188|1005944|P1|Overall Study|Other than specified above|6
298085|NCT01644188|1005943|P2|Overall Study|Site closure|1
298086|NCT01644188|1005944|P1|Overall Study|Site closure|1
298087|NCT01644188|1005943|P2|Overall Study|Last visit outside protocol visit window|16
298088|NCT01644188|1005944|P1|Overall Study|Last visit outside protocol visit window|14
298089|NCT01644188|1005943|P2|Overall Study|Death|3
298090|NCT01644188|1005944|P1|Overall Study|Death|4
298091|NCT01644188|1005943|P2|Overall Study|Lost to Follow-up|0
298092|NCT01644188|1005944|P1|Overall Study|Lost to Follow-up|1
298093|NCT01644188|1005943|P2|Overall Study|Selection criteria finally not met|0
298094|NCT01644188|1005944|P1|Overall Study|Selection criteria finally not met|2
298095|NCT01644188|1005943|P2|Overall Study|Consent withdrawn by participant|7
298096|NCT01644188|1005944|P1|Overall Study|Consent withdrawn by participant|14
298097|NCT01644188|1005943|P2|Overall Study|Related to auto-injector administration|2
298098|NCT01644188|1005944|P1|Overall Study|Related to auto-injector administration|2
298099|NCT01644188|1005943|P2|Overall Study|Participant moved|2
298100|NCT01644188|1005944|P1|Overall Study|Participant moved|7
298101|NCT01644188|1005943|P2|Overall Study|Physician Decision|3
298102|NCT01644188|1005944|P1|Overall Study|Physician Decision|1
298103|NCT01644188|1005943|P2|Overall Study|Poor compliance to protocol|14
298104|NCT01644188|1005944|P1|Overall Study|Poor compliance to protocol|26
298105|NCT01644188|1005943|P2|Overall Study|Adverse Event|20
298106|NCT01644188|1005944|P1|Overall Study|Adverse Event|44
298107|NCT01644175|1006002|P2|Overall Study|Other than specified above|3
298108|NCT01644175|1006003|P1|Overall Study|Other than specified above|0
298109|NCT01644175|1006002|P2|Overall Study|Lost to Follow-up|0
298110|NCT01644175|1006003|P1|Overall Study|Lost to Follow-up|1
298111|NCT01644175|1006002|P2|Overall Study|Site closure|2
298112|NCT01644175|1006003|P1|Overall Study|Site closure|2
298113|NCT01644175|1006002|P2|Overall Study|Selection criteria finally not met|1
298114|NCT01644175|1006003|P1|Overall Study|Selection criteria finally not met|0
298115|NCT01644175|1006002|P2|Overall Study|Last visit outside protocol visit window|11
298116|NCT01644175|1006003|P1|Overall Study|Last visit outside protocol visit window|4
298117|NCT01644175|1006002|P2|Overall Study|Related to Autoinjector Administration|1
298118|NCT01644175|1006003|P1|Overall Study|Related to Autoinjector Administration|2
298119|NCT01644175|1006002|P2|Overall Study|Consent withdrawn by participant|4
298120|NCT01644175|1006003|P1|Overall Study|Consent withdrawn by participant|3
298121|NCT01644175|1006002|P2|Overall Study|Participant Moved|2
298122|NCT01644175|1006003|P1|Overall Study|Participant Moved|1
298123|NCT01644175|1006002|P2|Overall Study|Physician Decision|2
298124|NCT01644175|1006003|P1|Overall Study|Physician Decision|1
298125|NCT01644175|1006002|P2|Overall Study|Poor compliance to protocol|10
298126|NCT01644175|1006003|P1|Overall Study|Poor compliance to protocol|9
298127|NCT01644175|1006002|P2|Overall Study|Death|2
298128|NCT01644175|1006003|P1|Overall Study|Death|1
298129|NCT01644175|1006002|P2|Overall Study|Adverse Event|13
298130|NCT01644175|1006003|P1|Overall Study|Adverse Event|8
298131|NCT01644175|1006002|P2|Overall Study|Randomized But Not Treated|2
298132|NCT01644175|1006003|P1|Overall Study|Randomized But Not Treated|0
298133|NCT01643928|1006063|P5|Overall Study|Adverse Event|2
298134|NCT01643928|1006064|P4|Overall Study|Adverse Event|1
298135|NCT01643928|1006065|P3|Overall Study|Adverse Event|0
298136|NCT01643928|1006066|P2|Overall Study|Adverse Event|1
298137|NCT01643928|1006067|P1|Overall Study|Adverse Event|2
298138|NCT01643928|1006063|P5|Overall Study|Other|0
298139|NCT01643928|1006064|P4|Overall Study|Other|0
298140|NCT01643928|1006065|P3|Overall Study|Other|1
298141|NCT01643928|1006066|P2|Overall Study|Other|1
298142|NCT01643928|1006067|P1|Overall Study|Other|5
298143|NCT01643928|1006063|P5|Overall Study|Pregnancy|0
298144|NCT01643928|1006064|P4|Overall Study|Pregnancy|1
298145|NCT01643928|1006065|P3|Overall Study|Pregnancy|0
298146|NCT01643928|1006066|P2|Overall Study|Pregnancy|0
298147|NCT01643928|1006067|P1|Overall Study|Pregnancy|0
298148|NCT01643928|1006063|P5|Overall Study|Withdrawal by Subject|0
298149|NCT01643928|1006064|P4|Overall Study|Withdrawal by Subject|1
298150|NCT01643928|1006065|P3|Overall Study|Withdrawal by Subject|0
298151|NCT01643928|1006066|P2|Overall Study|Withdrawal by Subject|0
298152|NCT01643928|1006067|P1|Overall Study|Withdrawal by Subject|2
298153|NCT01643928|1006063|P5|Overall Study|Lost to Follow-up|0
298154|NCT01643928|1006064|P4|Overall Study|Lost to Follow-up|0
298155|NCT01643928|1006065|P3|Overall Study|Lost to Follow-up|2
298156|NCT01643928|1006066|P2|Overall Study|Lost to Follow-up|0
298157|NCT01643928|1006067|P1|Overall Study|Lost to Follow-up|1
298158|NCT01643798|1006362|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
298159|NCT01643798|1006363|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
298160|NCT01643668|1006374|P1|Overall Study|Death|1
298161|NCT01643044|1006414|P2|Overall Study|Delivered outside of hospital|2
298162|NCT01643044|1006415|P1|Overall Study|Delivered outside of hospital|1
298163|NCT01643044|1006414|P2|Overall Study|Miscarried baby|2
298164|NCT01643044|1006415|P1|Overall Study|Miscarried baby|2
298165|NCT01643044|1006414|P2|Overall Study|Lost to Follow-up|1
298166|NCT01643044|1006415|P1|Overall Study|Lost to Follow-up|1
298167|NCT01642914|1006424|P3|Overall Study|Other Reason|0
298168|NCT01642914|1006425|P2|Overall Study|Other Reason|0
298169|NCT01642914|1006426|P1|Overall Study|Other Reason|1
298170|NCT01642914|1006424|P3|Overall Study|Lost to Follow-up|7
298171|NCT01642914|1006425|P2|Overall Study|Lost to Follow-up|3
298172|NCT01642914|1006426|P1|Overall Study|Lost to Follow-up|5
298173|NCT01642914|1006424|P3|Overall Study|Withdrawal by Subject|10
298174|NCT01642914|1006425|P2|Overall Study|Withdrawal by Subject|5
298175|NCT01642914|1006426|P1|Overall Study|Withdrawal by Subject|5
298176|NCT01642914|1006424|P3|Overall Study|Protocol Violation|6
298177|NCT01642914|1006425|P2|Overall Study|Protocol Violation|13
298178|NCT01642914|1006426|P1|Overall Study|Protocol Violation|15
298179|NCT01642914|1006424|P3|Overall Study|Lack of Efficacy|2
298180|NCT01642914|1006425|P2|Overall Study|Lack of Efficacy|4
298181|NCT01642914|1006426|P1|Overall Study|Lack of Efficacy|9
298182|NCT01642914|1006424|P3|Overall Study|Adverse Event|15
298183|NCT01642914|1006425|P2|Overall Study|Adverse Event|7
298184|NCT01642914|1006426|P1|Overall Study|Adverse Event|11
298185|NCT01642732|1006501|P1|Overall Study|Withdrawal by Subject|1
298186|NCT01642615|1006506|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
298187|NCT01642615|1006507|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
298188|NCT01642615|1006508|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
298189|NCT01642615|1006506|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
298190|NCT01642615|1006507|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
298191|NCT01642615|1006508|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
298192|NCT01642615|1006506|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
298193|NCT01642615|1006507|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
298194|NCT01642615|1006508|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
298195|NCT01642615|1006506|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
298196|NCT01642615|1006507|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
298197|NCT01642615|1006508|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
298198|NCT01642615|1006506|P3|Open Label Maintenance Phase|Did not receive treatment|0
298199|NCT01642615|1006507|P2|Open Label Maintenance Phase|Did not receive treatment|0
298200|NCT01642615|1006508|P1|Open Label Maintenance Phase|Did not receive treatment|1
298201|NCT01642615|1006506|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
298202|NCT01642615|1006507|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
298203|NCT01642615|1006508|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
298204|NCT01642615|1006506|P3|Open Label Maintenance Phase|Lost to Follow-up|0
298205|NCT01642615|1006507|P2|Open Label Maintenance Phase|Lost to Follow-up|0
298206|NCT01642615|1006508|P1|Open Label Maintenance Phase|Lost to Follow-up|1
298207|NCT01642615|1006506|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
298208|NCT01642615|1006507|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
298209|NCT01642615|1006508|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
298210|NCT01642615|1006506|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
298211|NCT01642615|1006507|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
298212|NCT01642615|1006508|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
298213|NCT01642602|1006522|P1|Overall Study|Adverse Event|2
298214|NCT01642589|1006529|P2|Overall Study|Withdrawal by Subject|1
298215|NCT01642589|1006530|P1|Overall Study|Withdrawal by Subject|1
298217|NCT01642277|1006613|P2|Overall Study|Withdrawal by Subject|0
298218|NCT01642277|1006614|P1|Overall Study|Withdrawal by Subject|11
298219|NCT01642277|1006613|P2|Overall Study|Protocol Violation|0
298220|NCT01642277|1006614|P1|Overall Study|Protocol Violation|1
298221|NCT01642277|1006613|P2|Overall Study|Physician Decision|0
298222|NCT01642277|1006614|P1|Overall Study|Physician Decision|2
298223|NCT01642277|1006613|P2|Overall Study|Adverse Event|0
298224|NCT01642277|1006614|P1|Overall Study|Adverse Event|10
298225|NCT01642212|1006646|P5|Open-label Extension|Not Specified|1
298226|NCT01642212|1006647|P4|Open-label Extension|Not Specified|0
298227|NCT01642212|1006648|P3|Open-label Extension|Not Specified|0
298228|NCT01642212|1006649|P2|Open-label Extension|Not Specified|0
298229|NCT01642212|1006650|P1|Open-label Extension|Not Specified|0
298230|NCT01642212|1006646|P5|Open-label Extension|Lost to Follow-up|1
298231|NCT01642212|1006647|P4|Open-label Extension|Lost to Follow-up|0
298232|NCT01642212|1006648|P3|Open-label Extension|Lost to Follow-up|0
298233|NCT01642212|1006649|P2|Open-label Extension|Lost to Follow-up|0
298234|NCT01642212|1006650|P1|Open-label Extension|Lost to Follow-up|0
298235|NCT01642212|1006646|P5|Open-label Extension|Consent Withdrawn|2
298236|NCT01642212|1006647|P4|Open-label Extension|Consent Withdrawn|0
298237|NCT01642212|1006648|P3|Open-label Extension|Consent Withdrawn|0
298238|NCT01642212|1006649|P2|Open-label Extension|Consent Withdrawn|0
298239|NCT01642212|1006650|P1|Open-label Extension|Consent Withdrawn|0
298240|NCT01642212|1006646|P5|Open-label Extension|Sponsor Decision|4
298241|NCT01642212|1006647|P4|Open-label Extension|Sponsor Decision|7
298242|NCT01642212|1006648|P3|Open-label Extension|Sponsor Decision|0
298243|NCT01642212|1006649|P2|Open-label Extension|Sponsor Decision|0
298244|NCT01642212|1006650|P1|Open-label Extension|Sponsor Decision|0
298245|NCT01642212|1006646|P5|Open-label Extension|Adverse Event|0
298246|NCT01642212|1006647|P4|Open-label Extension|Adverse Event|3
298247|NCT01642212|1006648|P3|Open-label Extension|Adverse Event|0
298248|NCT01642212|1006649|P2|Open-label Extension|Adverse Event|0
298249|NCT01642212|1006650|P1|Open-label Extension|Adverse Event|0
298250|NCT01642212|1006646|P5|Double-blind Treatment|Adverse Event|0
298251|NCT01642212|1006647|P4|Double-blind Treatment|Adverse Event|0
298252|NCT01642212|1006648|P3|Double-blind Treatment|Adverse Event|1
298253|NCT01642212|1006649|P2|Double-blind Treatment|Adverse Event|0
298254|NCT01642212|1006650|P1|Double-blind Treatment|Adverse Event|0
298255|NCT01642212|1006646|P5|Double-blind Treatment|Non-compliance|0
298256|NCT01642212|1006647|P4|Double-blind Treatment|Non-compliance|0
298257|NCT01642212|1006648|P3|Double-blind Treatment|Non-compliance|0
298258|NCT01642212|1006649|P2|Double-blind Treatment|Non-compliance|1
298259|NCT01642212|1006650|P1|Double-blind Treatment|Non-compliance|0
298260|NCT01642212|1006646|P5|Double-blind Treatment|Not Specified|0
298261|NCT01642212|1006647|P4|Double-blind Treatment|Not Specified|0
298262|NCT01642212|1006648|P3|Double-blind Treatment|Not Specified|1
298263|NCT01642212|1006649|P2|Double-blind Treatment|Not Specified|2
298264|NCT01642212|1006650|P1|Double-blind Treatment|Not Specified|0
298265|NCT01642212|1006646|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
298266|NCT01642212|1006647|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
298267|NCT01642212|1006648|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
298268|NCT01642212|1006649|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
298269|NCT01642212|1006650|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
298270|NCT01642004|1006745|P2|Treatment|Missing from data|1
298271|NCT01642004|1006746|P1|Treatment|Missing from data|0
298272|NCT01642004|1006745|P2|Treatment|Other|2
298273|NCT01642004|1006746|P1|Treatment|Other|1
298274|NCT01642004|1006745|P2|Treatment|No longer meets study criteria|2
298275|NCT01642004|1006746|P1|Treatment|No longer meets study criteria|1
298276|NCT01642004|1006745|P2|Treatment|Poor/non-compliance|0
298277|NCT01642004|1006746|P1|Treatment|Poor/non-compliance|1
298278|NCT01642004|1006745|P2|Treatment|Maximum clinical benefit|7
298279|NCT01642004|1006746|P1|Treatment|Maximum clinical benefit|2
298280|NCT01642004|1006745|P2|Treatment|Withdrawal by Subject|9
298281|NCT01642004|1006746|P1|Treatment|Withdrawal by Subject|5
298526|NCT01641692|1007019|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
298282|NCT01642004|1006745|P2|Treatment|Adverse event unrelated to study drug|13
298283|NCT01642004|1006746|P1|Treatment|Adverse event unrelated to study drug|6
298284|NCT01642004|1006745|P2|Treatment|Death|0
298285|NCT01642004|1006746|P1|Treatment|Death|1
298286|NCT01642004|1006745|P2|Treatment|Study drug toxicity|13
298287|NCT01642004|1006746|P1|Treatment|Study drug toxicity|5
298288|NCT01642004|1006745|P2|Treatment|Disease progression|80
298289|NCT01642004|1006746|P1|Treatment|Disease progression|88
298290|NCT01642004|1006745|P2|Randomization|No longer meets study criteria|2
298291|NCT01642004|1006746|P1|Randomization|No longer meets study criteria|2
298292|NCT01642004|1006745|P2|Randomization|Withdrawal by Subject|6
298293|NCT01642004|1006746|P1|Randomization|Withdrawal by Subject|1
298294|NCT01642004|1006745|P2|Randomization|Adverse Event unrelated to study drug|0
298295|NCT01642004|1006746|P1|Randomization|Adverse Event unrelated to study drug|1
298296|NCT01641991|1006780|P4|Overall Study|no longer eligible|4
298297|NCT01641991|1006781|P3|Overall Study|no longer eligible|0
298298|NCT01641991|1006782|P2|Overall Study|no longer eligible|1
298299|NCT01641991|1006783|P1|Overall Study|no longer eligible|2
298300|NCT01641991|1006780|P4|Overall Study|Pregnancy|0
298301|NCT01641991|1006781|P3|Overall Study|Pregnancy|1
298302|NCT01641991|1006782|P2|Overall Study|Pregnancy|0
298303|NCT01641991|1006783|P1|Overall Study|Pregnancy|0
298304|NCT01641991|1006780|P4|Overall Study|Protocol Violation|0
298305|NCT01641991|1006781|P3|Overall Study|Protocol Violation|3
298306|NCT01641991|1006782|P2|Overall Study|Protocol Violation|1
298307|NCT01641991|1006783|P1|Overall Study|Protocol Violation|1
298308|NCT01641991|1006780|P4|Overall Study|Lost to Follow-up|1
298309|NCT01641991|1006781|P3|Overall Study|Lost to Follow-up|3
298310|NCT01641991|1006782|P2|Overall Study|Lost to Follow-up|2
298311|NCT01641991|1006783|P1|Overall Study|Lost to Follow-up|0
298312|NCT01641991|1006780|P4|Overall Study|Adverse Event|1
298313|NCT01641991|1006781|P3|Overall Study|Adverse Event|2
298314|NCT01641991|1006782|P2|Overall Study|Adverse Event|1
298315|NCT01641991|1006783|P1|Overall Study|Adverse Event|2
298316|NCT01641991|1006780|P4|Overall Study|Withdrawal by Subject|5
298317|NCT01641991|1006781|P3|Overall Study|Withdrawal by Subject|1
298318|NCT01641991|1006782|P2|Overall Study|Withdrawal by Subject|2
298319|NCT01641991|1006783|P1|Overall Study|Withdrawal by Subject|4
298320|NCT01641991|1006780|P4|Overall Study|Physician Decision|5
298321|NCT01641991|1006781|P3|Overall Study|Physician Decision|7
298322|NCT01641991|1006782|P2|Overall Study|Physician Decision|1
298323|NCT01641991|1006783|P1|Overall Study|Physician Decision|0
298324|NCT01641952|1006867|P1|Overall Study|Adverse Event|6
298325|NCT01641952|1006867|P1|Overall Study|Lost to Follow-up|28
298326|NCT01641939|1006883|P3|Overall Study|Study Terminated by Sponsor|3
298327|NCT01641939|1006884|P2|Overall Study|Study Terminated by Sponsor|28
298328|NCT01641939|1006885|P1|Overall Study|Study Terminated by Sponsor|10
298329|NCT01641939|1006883|P3|Overall Study|Withdrawal by Subject|5
298330|NCT01641939|1006884|P2|Overall Study|Withdrawal by Subject|11
298331|NCT01641939|1006885|P1|Overall Study|Withdrawal by Subject|14
298332|NCT01641939|1006883|P3|Overall Study|Lost to Follow-up|1
298333|NCT01641939|1006884|P2|Overall Study|Lost to Follow-up|2
298334|NCT01641939|1006885|P1|Overall Study|Lost to Follow-up|3
298335|NCT01641939|1006883|P3|Overall Study|Death|61
298336|NCT01641939|1006884|P2|Overall Study|Death|187
298337|NCT01641939|1006885|P1|Overall Study|Death|90
298338|NCT01641926|1006928|P4|Overall Study|Not Treated|0
298339|NCT01641926|1006929|P3|Overall Study|Not Treated|1
298340|NCT01641926|1006930|P2|Overall Study|Not Treated|1
298341|NCT01641926|1006931|P1|Overall Study|Not Treated|1
298342|NCT01641926|1006928|P4|Overall Study|Withdrawal by Subject|1
298343|NCT01641926|1006929|P3|Overall Study|Withdrawal by Subject|6
298344|NCT01641926|1006930|P2|Overall Study|Withdrawal by Subject|5
298345|NCT01641926|1006931|P1|Overall Study|Withdrawal by Subject|13
298346|NCT01641926|1006928|P4|Overall Study|Protocol Violation|1
298347|NCT01641926|1006929|P3|Overall Study|Protocol Violation|0
298348|NCT01641926|1006930|P2|Overall Study|Protocol Violation|0
298349|NCT01641926|1006931|P1|Overall Study|Protocol Violation|1
298350|NCT01641926|1006928|P4|Overall Study|Physician Decision|1
298351|NCT01641926|1006929|P3|Overall Study|Physician Decision|0
298352|NCT01641926|1006930|P2|Overall Study|Physician Decision|5
298353|NCT01641926|1006931|P1|Overall Study|Physician Decision|6
298354|NCT01641926|1006928|P4|Overall Study|Lost to Follow-up|0
298355|NCT01641926|1006929|P3|Overall Study|Lost to Follow-up|1
298356|NCT01641926|1006930|P2|Overall Study|Lost to Follow-up|2
298357|NCT01641926|1006931|P1|Overall Study|Lost to Follow-up|2
298358|NCT01641926|1006928|P4|Overall Study|Adverse Event|1
298359|NCT01641926|1006929|P3|Overall Study|Adverse Event|3
298360|NCT01641926|1006930|P2|Overall Study|Adverse Event|2
298361|NCT01641926|1006931|P1|Overall Study|Adverse Event|5
298362|NCT01641900|1006959|P2|Overall Study|Withdrawal by Subject|2
298363|NCT01641900|1006960|P1|Overall Study|Withdrawal by Subject|2
298364|NCT01641861|1006972|P2|Overall Study|Died due to drowning|1
298365|NCT01641861|1006973|P1|Overall Study|Died due to drowning|0
298366|NCT01641861|1006972|P2|Overall Study|Lost the tooth due to normal exfoliation|8
298367|NCT01641861|1006973|P1|Overall Study|Lost the tooth due to normal exfoliation|14
298368|NCT01641861|1006972|P2|Overall Study|Lost to Follow-up|16
298369|NCT01641861|1006973|P1|Overall Study|Lost to Follow-up|21
298370|NCT01641822|1006994|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
298371|NCT01641822|1006995|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
298372|NCT01641822|1006996|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
298373|NCT01641822|1006994|P3|Comparative Phase|Withdrew consent|7
298374|NCT01641822|1006995|P2|Comparative Phase|Withdrew consent|3
298375|NCT01641822|1006996|P1|Comparative Phase|Withdrew consent|0
298376|NCT01641822|1006994|P3|Comparative Phase|Adverse event, serious fatal|0
298377|NCT01641822|1006995|P2|Comparative Phase|Adverse event, serious fatal|1
298378|NCT01641822|1006996|P1|Comparative Phase|Adverse event, serious fatal|0
298379|NCT01641822|1006994|P3|Comparative Phase|Pregnancy|1
298380|NCT01641822|1006995|P2|Comparative Phase|Pregnancy|0
298381|NCT01641822|1006996|P1|Comparative Phase|Pregnancy|0
298382|NCT01641822|1006994|P3|Comparative Phase|Investigator's discretion|1
298383|NCT01641822|1006995|P2|Comparative Phase|Investigator's discretion|0
298384|NCT01641822|1006996|P1|Comparative Phase|Investigator's discretion|0
298385|NCT01641822|1006994|P3|Comparative Phase|Noncompliance with study drug|0
298386|NCT01641822|1006995|P2|Comparative Phase|Noncompliance with study drug|1
298387|NCT01641822|1006996|P1|Comparative Phase|Noncompliance with study drug|0
298388|NCT01641822|1006994|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
298389|NCT01641822|1006995|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
298390|NCT01641822|1006996|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
298391|NCT01641822|1006994|P3|Run-in Phase|Withdrew consent|0
298392|NCT01641822|1006995|P2|Run-in Phase|Withdrew consent|0
298393|NCT01641822|1006996|P1|Run-in Phase|Withdrew consent|1
298394|NCT01641822|1006994|P3|Run-in Phase|Adverse Event|0
298395|NCT01641822|1006995|P2|Run-in Phase|Adverse Event|0
298396|NCT01641822|1006996|P1|Run-in Phase|Adverse Event|3
298397|NCT01641822|1006994|P3|Run-in Phase|Noncompliance with study drug|0
298398|NCT01641822|1006995|P2|Run-in Phase|Noncompliance with study drug|0
298399|NCT01641822|1006996|P1|Run-in Phase|Noncompliance with study drug|1
298400|NCT01641692|1007013|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
298401|NCT01641692|1007014|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
298402|NCT01641692|1007015|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
298403|NCT01641692|1007016|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
298404|NCT01641692|1007017|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
298405|NCT01641692|1007018|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
298406|NCT01641692|1007019|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
298407|NCT01641692|1007020|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
298408|NCT01641692|1007013|P8|Washout Period 3 or Follow-up|Protocol Violation|0
298409|NCT01641692|1007014|P7|Washout Period 3 or Follow-up|Protocol Violation|0
298410|NCT01641692|1007015|P6|Washout Period 3 or Follow-up|Protocol Violation|1
298411|NCT01641692|1007016|P5|Washout Period 3 or Follow-up|Protocol Violation|0
298412|NCT01641692|1007017|P4|Washout Period 3 or Follow-up|Protocol Violation|0
298413|NCT01641692|1007018|P3|Washout Period 3 or Follow-up|Protocol Violation|0
298414|NCT01641692|1007019|P2|Washout Period 3 or Follow-up|Protocol Violation|0
298415|NCT01641692|1007020|P1|Washout Period 3 or Follow-up|Protocol Violation|0
298416|NCT01641692|1007013|P8|Treatment Period 3|Lost to Follow-up|0
298417|NCT01641692|1007014|P7|Treatment Period 3|Lost to Follow-up|0
298418|NCT01641692|1007015|P6|Treatment Period 3|Lost to Follow-up|0
298419|NCT01641692|1007016|P5|Treatment Period 3|Lost to Follow-up|0
298420|NCT01641692|1007017|P4|Treatment Period 3|Lost to Follow-up|0
298421|NCT01641692|1007018|P3|Treatment Period 3|Lost to Follow-up|0
298422|NCT01641692|1007019|P2|Treatment Period 3|Lost to Follow-up|1
298423|NCT01641692|1007020|P1|Treatment Period 3|Lost to Follow-up|0
298424|NCT01641692|1007013|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
298425|NCT01641692|1007014|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
298426|NCT01641692|1007015|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
298427|NCT01641692|1007016|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
298428|NCT01641692|1007017|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
298429|NCT01641692|1007018|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
298430|NCT01641692|1007019|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
298431|NCT01641692|1007020|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
298432|NCT01641692|1007013|P8|Treatment Period 3|Protocol Violation|0
298433|NCT01641692|1007014|P7|Treatment Period 3|Protocol Violation|0
298434|NCT01641692|1007015|P6|Treatment Period 3|Protocol Violation|0
298435|NCT01641692|1007016|P5|Treatment Period 3|Protocol Violation|0
298436|NCT01641692|1007017|P4|Treatment Period 3|Protocol Violation|0
298437|NCT01641692|1007018|P3|Treatment Period 3|Protocol Violation|1
298438|NCT01641692|1007019|P2|Treatment Period 3|Protocol Violation|0
298439|NCT01641692|1007020|P1|Treatment Period 3|Protocol Violation|0
298440|NCT01641692|1007013|P8|Treatment Period 3|Adverse Event|0
298441|NCT01641692|1007014|P7|Treatment Period 3|Adverse Event|1
298442|NCT01641692|1007015|P6|Treatment Period 3|Adverse Event|0
298443|NCT01641692|1007016|P5|Treatment Period 3|Adverse Event|0
298444|NCT01641692|1007017|P4|Treatment Period 3|Adverse Event|0
298445|NCT01641692|1007018|P3|Treatment Period 3|Adverse Event|0
298446|NCT01641692|1007019|P2|Treatment Period 3|Adverse Event|0
298447|NCT01641692|1007020|P1|Treatment Period 3|Adverse Event|0
298448|NCT01641692|1007013|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
298449|NCT01641692|1007014|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
298450|NCT01641692|1007015|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
298451|NCT01641692|1007016|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
298452|NCT01641692|1007017|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
298453|NCT01641692|1007018|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
298454|NCT01641692|1007019|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
298455|NCT01641692|1007020|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
298456|NCT01641692|1007013|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
298457|NCT01641692|1007014|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
298458|NCT01641692|1007015|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
298459|NCT01641692|1007016|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
298460|NCT01641692|1007017|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
298461|NCT01641692|1007018|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
298462|NCT01641692|1007019|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
298463|NCT01641692|1007020|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
298464|NCT01641692|1007013|P8|Treatment Period 2|Withdrawal by Subject|1
298465|NCT01641692|1007014|P7|Treatment Period 2|Withdrawal by Subject|0
298466|NCT01641692|1007015|P6|Treatment Period 2|Withdrawal by Subject|1
298467|NCT01641692|1007016|P5|Treatment Period 2|Withdrawal by Subject|0
298468|NCT01641692|1007017|P4|Treatment Period 2|Withdrawal by Subject|0
298469|NCT01641692|1007018|P3|Treatment Period 2|Withdrawal by Subject|0
298470|NCT01641692|1007019|P2|Treatment Period 2|Withdrawal by Subject|0
298471|NCT01641692|1007020|P1|Treatment Period 2|Withdrawal by Subject|1
298472|NCT01641692|1007013|P8|Treatment Period 2|Lost to Follow-up|0
298473|NCT01641692|1007014|P7|Treatment Period 2|Lost to Follow-up|0
298474|NCT01641692|1007015|P6|Treatment Period 2|Lost to Follow-up|1
298475|NCT01641692|1007016|P5|Treatment Period 2|Lost to Follow-up|0
298476|NCT01641692|1007017|P4|Treatment Period 2|Lost to Follow-up|0
298477|NCT01641692|1007018|P3|Treatment Period 2|Lost to Follow-up|0
298478|NCT01641692|1007019|P2|Treatment Period 2|Lost to Follow-up|0
298479|NCT01641692|1007020|P1|Treatment Period 2|Lost to Follow-up|0
298480|NCT01641692|1007013|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
298481|NCT01641692|1007014|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
298482|NCT01641692|1007015|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
298483|NCT01641692|1007016|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
298484|NCT01641692|1007017|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
298485|NCT01641692|1007018|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
298486|NCT01641692|1007019|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
298487|NCT01641692|1007020|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
298488|NCT01641692|1007013|P8|Treatment Period 2|Lack of Efficacy|0
298489|NCT01641692|1007014|P7|Treatment Period 2|Lack of Efficacy|0
298490|NCT01641692|1007015|P6|Treatment Period 2|Lack of Efficacy|0
298491|NCT01641692|1007016|P5|Treatment Period 2|Lack of Efficacy|0
298492|NCT01641692|1007017|P4|Treatment Period 2|Lack of Efficacy|0
298493|NCT01641692|1007018|P3|Treatment Period 2|Lack of Efficacy|0
298494|NCT01641692|1007019|P2|Treatment Period 2|Lack of Efficacy|0
298495|NCT01641692|1007020|P1|Treatment Period 2|Lack of Efficacy|1
298496|NCT01641692|1007013|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
298497|NCT01641692|1007014|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
298498|NCT01641692|1007015|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
298499|NCT01641692|1007016|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
298500|NCT01641692|1007017|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
298501|NCT01641692|1007018|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
298502|NCT01641692|1007019|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
298503|NCT01641692|1007020|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
298504|NCT01641692|1007013|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
298505|NCT01641692|1007014|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
298506|NCT01641692|1007015|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
298507|NCT01641692|1007016|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
298508|NCT01641692|1007017|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
298509|NCT01641692|1007018|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
298510|NCT01641692|1007019|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
298511|NCT01641692|1007020|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
298512|NCT01641692|1007013|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
298513|NCT01641692|1007014|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
298514|NCT01641692|1007015|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
298515|NCT01641692|1007016|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
298516|NCT01641692|1007017|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
298517|NCT01641692|1007018|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
298518|NCT01641692|1007019|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
298519|NCT01641692|1007020|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
298520|NCT01641692|1007013|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
298521|NCT01641692|1007014|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
298522|NCT01641692|1007015|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
298523|NCT01641692|1007016|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
298524|NCT01641692|1007017|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
298525|NCT01641692|1007018|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
298527|NCT01641692|1007020|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
298528|NCT01641692|1007013|P8|Treatment Period 1|Withdrawal by Subject|1
298529|NCT01641692|1007014|P7|Treatment Period 1|Withdrawal by Subject|0
298530|NCT01641692|1007015|P6|Treatment Period 1|Withdrawal by Subject|2
298531|NCT01641692|1007016|P5|Treatment Period 1|Withdrawal by Subject|0
298532|NCT01641692|1007017|P4|Treatment Period 1|Withdrawal by Subject|0
298533|NCT01641692|1007018|P3|Treatment Period 1|Withdrawal by Subject|0
298534|NCT01641692|1007019|P2|Treatment Period 1|Withdrawal by Subject|0
298535|NCT01641692|1007020|P1|Treatment Period 1|Withdrawal by Subject|0
298536|NCT01641692|1007013|P8|Treatment Period 1|Physician Decision|0
298537|NCT01641692|1007014|P7|Treatment Period 1|Physician Decision|0
298538|NCT01641692|1007015|P6|Treatment Period 1|Physician Decision|0
298539|NCT01641692|1007016|P5|Treatment Period 1|Physician Decision|1
298540|NCT01641692|1007017|P4|Treatment Period 1|Physician Decision|0
298541|NCT01641692|1007018|P3|Treatment Period 1|Physician Decision|0
298542|NCT01641692|1007019|P2|Treatment Period 1|Physician Decision|0
298543|NCT01641692|1007020|P1|Treatment Period 1|Physician Decision|0
298544|NCT01641692|1007013|P8|Treatment Period 1|Lost to Follow-up|0
298545|NCT01641692|1007014|P7|Treatment Period 1|Lost to Follow-up|0
298546|NCT01641692|1007015|P6|Treatment Period 1|Lost to Follow-up|0
298547|NCT01641692|1007016|P5|Treatment Period 1|Lost to Follow-up|0
298548|NCT01641692|1007017|P4|Treatment Period 1|Lost to Follow-up|0
298549|NCT01641692|1007018|P3|Treatment Period 1|Lost to Follow-up|1
298550|NCT01641692|1007019|P2|Treatment Period 1|Lost to Follow-up|0
298551|NCT01641692|1007020|P1|Treatment Period 1|Lost to Follow-up|0
298552|NCT01641692|1007013|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
298553|NCT01641692|1007014|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
298554|NCT01641692|1007015|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
298555|NCT01641692|1007016|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
298556|NCT01641692|1007017|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
298557|NCT01641692|1007018|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
298558|NCT01641692|1007019|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
298559|NCT01641692|1007020|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
298560|NCT01641692|1007013|P8|Treatment Period 1|Protocol Violation|0
298561|NCT01641692|1007014|P7|Treatment Period 1|Protocol Violation|0
298562|NCT01641692|1007015|P6|Treatment Period 1|Protocol Violation|0
298563|NCT01641692|1007016|P5|Treatment Period 1|Protocol Violation|2
298564|NCT01641692|1007017|P4|Treatment Period 1|Protocol Violation|0
298565|NCT01641692|1007018|P3|Treatment Period 1|Protocol Violation|0
298566|NCT01641692|1007019|P2|Treatment Period 1|Protocol Violation|0
298567|NCT01641692|1007020|P1|Treatment Period 1|Protocol Violation|1
298568|NCT01641692|1007013|P8|Treatment Period 1|Lack of Efficacy|1
298569|NCT01641692|1007014|P7|Treatment Period 1|Lack of Efficacy|0
298570|NCT01641692|1007015|P6|Treatment Period 1|Lack of Efficacy|0
298571|NCT01641692|1007016|P5|Treatment Period 1|Lack of Efficacy|0
298572|NCT01641692|1007017|P4|Treatment Period 1|Lack of Efficacy|0
298573|NCT01641692|1007018|P3|Treatment Period 1|Lack of Efficacy|0
298574|NCT01641692|1007019|P2|Treatment Period 1|Lack of Efficacy|0
298575|NCT01641692|1007020|P1|Treatment Period 1|Lack of Efficacy|0
298576|NCT01641692|1007013|P8|Treatment Period 1|Adverse Event|0
298577|NCT01641692|1007014|P7|Treatment Period 1|Adverse Event|0
298578|NCT01641692|1007015|P6|Treatment Period 1|Adverse Event|0
298579|NCT01641692|1007016|P5|Treatment Period 1|Adverse Event|0
298580|NCT01641692|1007017|P4|Treatment Period 1|Adverse Event|0
298581|NCT01641692|1007018|P3|Treatment Period 1|Adverse Event|0
298582|NCT01641692|1007019|P2|Treatment Period 1|Adverse Event|0
298583|NCT01641692|1007020|P1|Treatment Period 1|Adverse Event|1
298584|NCT01641640|1007220|P1|Overall Study|Adverse Event|1
298585|NCT01641640|1007220|P1|Overall Study|Withdrawal by Subject|2
298586|NCT01641640|1007220|P1|Overall Study|Lost to Follow-up|3
298587|NCT01641640|1007220|P1|Overall Study|Efficacy failure|29
298588|NCT01641640|1007220|P1|Overall Study|Enrolled but not treated|1
298589|NCT01641471|1007231|P2|Overall Study|Protocol Violation|4
298590|NCT01641471|1007232|P1|Overall Study|Protocol Violation|2
298591|NCT01641471|1007231|P2|Overall Study|Lost to Follow-up|4
298592|NCT01641471|1007232|P1|Overall Study|Lost to Follow-up|2
298593|NCT01641471|1007231|P2|Overall Study|Withdrawal by Subject|19
298594|NCT01641471|1007232|P1|Overall Study|Withdrawal by Subject|19
298595|NCT01641367|1007250|P6|Overall Study|Lost to Follow-up|0
298596|NCT01641367|1007251|P5|Overall Study|Lost to Follow-up|2
298597|NCT01641367|1007252|P4|Overall Study|Lost to Follow-up|0
298598|NCT01641367|1007253|P3|Overall Study|Lost to Follow-up|2
298599|NCT01641367|1007254|P2|Overall Study|Lost to Follow-up|0
298600|NCT01641367|1007255|P1|Overall Study|Lost to Follow-up|16
298601|NCT01641367|1007250|P6|Overall Study|Death|1
298602|NCT01641367|1007251|P5|Overall Study|Death|1
298603|NCT01641367|1007252|P4|Overall Study|Death|0
298604|NCT01641367|1007253|P3|Overall Study|Death|2
298605|NCT01641367|1007254|P2|Overall Study|Death|1
298606|NCT01641367|1007255|P1|Overall Study|Death|18
298607|NCT01641237|1007270|P4|Period III|Lost to Follow-up|0
298608|NCT01641237|1007271|P3|Period III|Lost to Follow-up|0
298609|NCT01641237|1007272|P2|Period III|Lost to Follow-up|0
298610|NCT01641237|1007273|P1|Period III|Lost to Follow-up|1
298611|NCT01641237|1007270|P4|Period II|Withdrawal by Subject|0
298612|NCT01641237|1007271|P3|Period II|Withdrawal by Subject|0
298613|NCT01641237|1007272|P2|Period II|Withdrawal by Subject|0
298614|NCT01641237|1007273|P1|Period II|Withdrawal by Subject|1
298615|NCT01641159|1007297|P2|Overall Study|Withdrawal by Subject|1
298616|NCT01641159|1007298|P1|Overall Study|Withdrawal by Subject|0
298617|NCT01641159|1007297|P2|Overall Study|Lost to Follow-up|1
298618|NCT01641159|1007298|P1|Overall Study|Lost to Follow-up|2
298619|NCT01641133|1007309|P3|Overall Study|Lost to Follow-up|2
298620|NCT01641133|1007310|P2|Overall Study|Lost to Follow-up|2
298621|NCT01641133|1007311|P1|Overall Study|Lost to Follow-up|0
298622|NCT01641133|1007309|P3|Overall Study|Withdrawal by Subject|3
298623|NCT01641133|1007310|P2|Overall Study|Withdrawal by Subject|3
298624|NCT01641133|1007311|P1|Overall Study|Withdrawal by Subject|5
298625|NCT01641133|1007309|P3|Overall Study|Adverse Event|1
298626|NCT01641133|1007310|P2|Overall Study|Adverse Event|0
298627|NCT01641133|1007311|P1|Overall Study|Adverse Event|0
298628|NCT01641133|1007309|P3|Overall Study|Migrated/moved from study area|1
298629|NCT01641133|1007310|P2|Overall Study|Migrated/moved from study area|3
298630|NCT01641133|1007311|P1|Overall Study|Migrated/moved from study area|5
298631|NCT01641133|1007309|P3|Overall Study|Protocol Violation|1
298632|NCT01641133|1007310|P2|Overall Study|Protocol Violation|1
298633|NCT01641133|1007311|P1|Overall Study|Protocol Violation|0
298634|NCT01641081|1007361|P10|Period 5|Adverse Event|0
298635|NCT01641081|1007362|P9|Period 5|Adverse Event|0
298636|NCT01641081|1007363|P8|Period 5|Adverse Event|0
298637|NCT01641081|1007364|P7|Period 5|Adverse Event|0
298638|NCT01641081|1007365|P6|Period 5|Adverse Event|0
298639|NCT01641081|1007366|P5|Period 5|Adverse Event|0
298640|NCT01641081|1007367|P4|Period 5|Adverse Event|0
298641|NCT01641081|1007368|P3|Period 5|Adverse Event|2
298642|NCT01641081|1007369|P2|Period 5|Adverse Event|0
298643|NCT01641081|1007370|P1|Period 5|Adverse Event|0
298644|NCT01641081|1007361|P10|Period 4|Adverse Event|0
298645|NCT01641081|1007362|P9|Period 4|Adverse Event|0
298646|NCT01641081|1007363|P8|Period 4|Adverse Event|0
298647|NCT01641081|1007364|P7|Period 4|Adverse Event|0
298648|NCT01641081|1007365|P6|Period 4|Adverse Event|0
298649|NCT01641081|1007366|P5|Period 4|Adverse Event|0
298650|NCT01641081|1007367|P4|Period 4|Adverse Event|1
298651|NCT01641081|1007368|P3|Period 4|Adverse Event|0
298652|NCT01641081|1007369|P2|Period 4|Adverse Event|1
298653|NCT01641081|1007370|P1|Period 4|Adverse Event|0
298654|NCT01641081|1007361|P10|Period 3|Withdrawal by Subject|0
298655|NCT01641081|1007362|P9|Period 3|Withdrawal by Subject|1
298656|NCT01641081|1007363|P8|Period 3|Withdrawal by Subject|0
298657|NCT01641081|1007364|P7|Period 3|Withdrawal by Subject|0
298658|NCT01641081|1007365|P6|Period 3|Withdrawal by Subject|0
298659|NCT01641081|1007366|P5|Period 3|Withdrawal by Subject|0
298660|NCT01641081|1007367|P4|Period 3|Withdrawal by Subject|0
298661|NCT01641081|1007368|P3|Period 3|Withdrawal by Subject|0
298662|NCT01641081|1007369|P2|Period 3|Withdrawal by Subject|0
298663|NCT01641081|1007370|P1|Period 3|Withdrawal by Subject|0
298664|NCT01641081|1007361|P10|Period 3|Adverse Event|0
298665|NCT01641081|1007362|P9|Period 3|Adverse Event|0
298666|NCT01641081|1007363|P8|Period 3|Adverse Event|0
298667|NCT01641081|1007364|P7|Period 3|Adverse Event|0
298668|NCT01641081|1007365|P6|Period 3|Adverse Event|0
298669|NCT01641081|1007366|P5|Period 3|Adverse Event|0
298670|NCT01641081|1007367|P4|Period 3|Adverse Event|0
298671|NCT01641081|1007368|P3|Period 3|Adverse Event|1
298672|NCT01641081|1007369|P2|Period 3|Adverse Event|0
298673|NCT01641081|1007370|P1|Period 3|Adverse Event|0
298674|NCT01641081|1007361|P10|Period 2|Protocol Violation|0
298675|NCT01641081|1007362|P9|Period 2|Protocol Violation|0
298676|NCT01641081|1007363|P8|Period 2|Protocol Violation|0
298677|NCT01641081|1007364|P7|Period 2|Protocol Violation|0
298678|NCT01641081|1007365|P6|Period 2|Protocol Violation|0
298679|NCT01641081|1007366|P5|Period 2|Protocol Violation|0
298680|NCT01641081|1007367|P4|Period 2|Protocol Violation|0
298681|NCT01641081|1007368|P3|Period 2|Protocol Violation|0
298682|NCT01641081|1007369|P2|Period 2|Protocol Violation|0
298683|NCT01641081|1007370|P1|Period 2|Protocol Violation|1
298684|NCT01641081|1007361|P10|Period 2|Withdrawal by Subject|0
298685|NCT01641081|1007362|P9|Period 2|Withdrawal by Subject|0
298686|NCT01641081|1007363|P8|Period 2|Withdrawal by Subject|0
298687|NCT01641081|1007364|P7|Period 2|Withdrawal by Subject|2
298688|NCT01641081|1007365|P6|Period 2|Withdrawal by Subject|0
298689|NCT01641081|1007366|P5|Period 2|Withdrawal by Subject|0
298690|NCT01641081|1007367|P4|Period 2|Withdrawal by Subject|1
298691|NCT01641081|1007368|P3|Period 2|Withdrawal by Subject|0
298692|NCT01641081|1007369|P2|Period 2|Withdrawal by Subject|0
298693|NCT01641081|1007370|P1|Period 2|Withdrawal by Subject|0
298694|NCT01641081|1007361|P10|Period 2|Adverse Event|0
298695|NCT01641081|1007362|P9|Period 2|Adverse Event|0
298696|NCT01641081|1007363|P8|Period 2|Adverse Event|0
298697|NCT01641081|1007364|P7|Period 2|Adverse Event|0
298698|NCT01641081|1007365|P6|Period 2|Adverse Event|1
298699|NCT01641081|1007366|P5|Period 2|Adverse Event|0
298700|NCT01641081|1007367|P4|Period 2|Adverse Event|0
298701|NCT01641081|1007368|P3|Period 2|Adverse Event|0
298702|NCT01641081|1007369|P2|Period 2|Adverse Event|0
298703|NCT01641081|1007370|P1|Period 2|Adverse Event|0
298704|NCT01641081|1007361|P10|Period 1|Adverse Event|0
298705|NCT01641081|1007362|P9|Period 1|Adverse Event|0
298706|NCT01641081|1007363|P8|Period 1|Adverse Event|2
298707|NCT01641081|1007364|P7|Period 1|Adverse Event|0
298708|NCT01641081|1007365|P6|Period 1|Adverse Event|0
298709|NCT01641081|1007366|P5|Period 1|Adverse Event|0
298710|NCT01641081|1007367|P4|Period 1|Adverse Event|0
298711|NCT01641081|1007368|P3|Period 1|Adverse Event|0
298712|NCT01641081|1007369|P2|Period 1|Adverse Event|0
298713|NCT01641081|1007370|P1|Period 1|Adverse Event|1
298714|NCT01641081|1007361|P10|Period 1|Protocol Violation|0
298715|NCT01641081|1007362|P9|Period 1|Protocol Violation|0
298716|NCT01641081|1007363|P8|Period 1|Protocol Violation|1
298717|NCT01641081|1007364|P7|Period 1|Protocol Violation|0
298718|NCT01641081|1007365|P6|Period 1|Protocol Violation|0
298719|NCT01641081|1007366|P5|Period 1|Protocol Violation|1
298720|NCT01641081|1007367|P4|Period 1|Protocol Violation|0
298721|NCT01641081|1007368|P3|Period 1|Protocol Violation|0
298722|NCT01641081|1007369|P2|Period 1|Protocol Violation|0
298723|NCT01641081|1007370|P1|Period 1|Protocol Violation|0
298724|NCT01641081|1007361|P10|Period 1|Sponsor request (potential unblinding)|0
298725|NCT01641081|1007362|P9|Period 1|Sponsor request (potential unblinding)|0
298726|NCT01641081|1007363|P8|Period 1|Sponsor request (potential unblinding)|0
298727|NCT01641081|1007364|P7|Period 1|Sponsor request (potential unblinding)|1
298728|NCT01641081|1007365|P6|Period 1|Sponsor request (potential unblinding)|0
298729|NCT01641081|1007366|P5|Period 1|Sponsor request (potential unblinding)|0
298730|NCT01641081|1007367|P4|Period 1|Sponsor request (potential unblinding)|0
298731|NCT01641081|1007368|P3|Period 1|Sponsor request (potential unblinding)|0
298732|NCT01641081|1007369|P2|Period 1|Sponsor request (potential unblinding)|0
298733|NCT01641081|1007370|P1|Period 1|Sponsor request (potential unblinding)|0
298734|NCT01640964|1007439|P3|Overall Study|Protocol Deviation|2
298735|NCT01640964|1007440|P2|Overall Study|Protocol Deviation|1
298736|NCT01640964|1007441|P1|Overall Study|Protocol Deviation|1
298737|NCT01640964|1007439|P3|Overall Study|Lost to Follow-up|1
298738|NCT01640964|1007440|P2|Overall Study|Lost to Follow-up|0
298739|NCT01640964|1007441|P1|Overall Study|Lost to Follow-up|0
298740|NCT01640951|1007464|P8|Overall Study|Death|2
298741|NCT01640951|1007465|P7|Overall Study|Death|0
298742|NCT01640951|1007466|P6|Overall Study|Death|0
298743|NCT01640951|1007467|P5|Overall Study|Death|0
298744|NCT01640951|1007468|P4|Overall Study|Death|0
298745|NCT01640951|1007469|P3|Overall Study|Death|1
298746|NCT01640951|1007470|P2|Overall Study|Death|1
298747|NCT01640951|1007471|P1|Overall Study|Death|0
298748|NCT01640951|1007464|P8|Overall Study|Subject/Guardian decision|4
298749|NCT01640951|1007465|P7|Overall Study|Subject/Guardian decision|5
298750|NCT01640951|1007466|P6|Overall Study|Subject/Guardian decision|19
298751|NCT01640951|1007467|P5|Overall Study|Subject/Guardian decision|7
298752|NCT01640951|1007468|P4|Overall Study|Subject/Guardian decision|15
298753|NCT01640951|1007469|P3|Overall Study|Subject/Guardian decision|13
298754|NCT01640951|1007470|P2|Overall Study|Subject/Guardian decision|4
298755|NCT01640951|1007471|P1|Overall Study|Subject/Guardian decision|12
298756|NCT01640951|1007464|P8|Overall Study|Protocol Deviation|0
298757|NCT01640951|1007465|P7|Overall Study|Protocol Deviation|0
298758|NCT01640951|1007466|P6|Overall Study|Protocol Deviation|1
298759|NCT01640951|1007467|P5|Overall Study|Protocol Deviation|0
298760|NCT01640951|1007468|P4|Overall Study|Protocol Deviation|1
298761|NCT01640951|1007469|P3|Overall Study|Protocol Deviation|2
298762|NCT01640951|1007470|P2|Overall Study|Protocol Deviation|1
298763|NCT01640951|1007471|P1|Overall Study|Protocol Deviation|0
298764|NCT01640951|1007464|P8|Overall Study|Pregnancy|0
298765|NCT01640951|1007465|P7|Overall Study|Pregnancy|2
298766|NCT01640951|1007466|P6|Overall Study|Pregnancy|0
298767|NCT01640951|1007467|P5|Overall Study|Pregnancy|0
298768|NCT01640951|1007468|P4|Overall Study|Pregnancy|4
298769|NCT01640951|1007469|P3|Overall Study|Pregnancy|0
298770|NCT01640951|1007470|P2|Overall Study|Pregnancy|0
298771|NCT01640951|1007471|P1|Overall Study|Pregnancy|3
298772|NCT01640951|1007464|P8|Overall Study|Physician Decision|0
298773|NCT01640951|1007465|P7|Overall Study|Physician Decision|3
298774|NCT01640951|1007466|P6|Overall Study|Physician Decision|3
298775|NCT01640951|1007467|P5|Overall Study|Physician Decision|2
298776|NCT01640951|1007468|P4|Overall Study|Physician Decision|2
298777|NCT01640951|1007469|P3|Overall Study|Physician Decision|2
298778|NCT01640951|1007470|P2|Overall Study|Physician Decision|5
298779|NCT01640951|1007471|P1|Overall Study|Physician Decision|2
298780|NCT01640951|1007464|P8|Overall Study|Non-compliance with study treatment|0
298781|NCT01640951|1007465|P7|Overall Study|Non-compliance with study treatment|1
298782|NCT01640951|1007466|P6|Overall Study|Non-compliance with study treatment|4
298783|NCT01640951|1007467|P5|Overall Study|Non-compliance with study treatment|1
298784|NCT01640951|1007468|P4|Overall Study|Non-compliance with study treatment|1
298785|NCT01640951|1007469|P3|Overall Study|Non-compliance with study treatment|1
298786|NCT01640951|1007470|P2|Overall Study|Non-compliance with study treatment|0
298787|NCT01640951|1007471|P1|Overall Study|Non-compliance with study treatment|0
298788|NCT01640951|1007464|P8|Overall Study|Lost to Follow-up|1
298789|NCT01640951|1007465|P7|Overall Study|Lost to Follow-up|1
298790|NCT01640951|1007466|P6|Overall Study|Lost to Follow-up|3
298791|NCT01640951|1007467|P5|Overall Study|Lost to Follow-up|2
298792|NCT01640951|1007468|P4|Overall Study|Lost to Follow-up|2
298793|NCT01640951|1007469|P3|Overall Study|Lost to Follow-up|6
298794|NCT01640951|1007470|P2|Overall Study|Lost to Follow-up|0
298795|NCT01640951|1007471|P1|Overall Study|Lost to Follow-up|1
298796|NCT01640951|1007464|P8|Overall Study|Lack of Efficacy|6
298797|NCT01640951|1007465|P7|Overall Study|Lack of Efficacy|5
298798|NCT01640951|1007466|P6|Overall Study|Lack of Efficacy|6
298799|NCT01640951|1007467|P5|Overall Study|Lack of Efficacy|0
298800|NCT01640951|1007468|P4|Overall Study|Lack of Efficacy|14
298801|NCT01640951|1007469|P3|Overall Study|Lack of Efficacy|7
298802|NCT01640951|1007470|P2|Overall Study|Lack of Efficacy|1
298803|NCT01640951|1007471|P1|Overall Study|Lack of Efficacy|20
298804|NCT01640951|1007464|P8|Overall Study|Adverse Event|3
298805|NCT01640951|1007465|P7|Overall Study|Adverse Event|1
298806|NCT01640951|1007466|P6|Overall Study|Adverse Event|11
298807|NCT01640951|1007467|P5|Overall Study|Adverse Event|1
298808|NCT01640951|1007468|P4|Overall Study|Adverse Event|6
298809|NCT01640951|1007469|P3|Overall Study|Adverse Event|10
298810|NCT01640951|1007470|P2|Overall Study|Adverse Event|3
298811|NCT01640951|1007471|P1|Overall Study|Adverse Event|8
298812|NCT01640925|1007573|P2|Overall Study|Previously enrolled in this trial|11
298813|NCT01640925|1007574|P1|Overall Study|Previously enrolled in this trial|13
298814|NCT01640925|1007573|P2|Overall Study|Withdrawal by Subject|0
298815|NCT01640925|1007574|P1|Overall Study|Withdrawal by Subject|1
298816|NCT01640353|1007611|P1|Overall Study|Physician Decision|1
298817|NCT01640353|1007611|P1|Overall Study|Lost to Follow-up|12
298818|NCT01640353|1007611|P1|Overall Study|Early site termination|3
298819|NCT01640353|1007611|P1|Overall Study|Death|2
298820|NCT01640353|1007611|P1|Overall Study|Withdrawal by Subject|5
298821|NCT01640353|1007611|P1|Overall Study|Withdrawn from analysis at term site|12
298822|NCT01640353|1007611|P1|Overall Study|Withdrew prior to treatment|10
298823|NCT01640314|1007659|P2|Overall Study|Protocol Violation|1
298824|NCT01640314|1007660|P1|Overall Study|Protocol Violation|0
298825|NCT01640184|1007698|P3|Overall Study|Protocol Violation|1
298826|NCT01640184|1007699|P2|Overall Study|Protocol Violation|0
298827|NCT01640184|1007700|P1|Overall Study|Protocol Violation|0
298828|NCT01640184|1007698|P3|Overall Study|Withdrawal by Subject|1
298829|NCT01640184|1007699|P2|Overall Study|Withdrawal by Subject|1
298830|NCT01640184|1007700|P1|Overall Study|Withdrawal by Subject|0
298831|NCT01640184|1007698|P3|Overall Study|Physician Decision|0
298832|NCT01640184|1007699|P2|Overall Study|Physician Decision|0
298833|NCT01640184|1007700|P1|Overall Study|Physician Decision|3
298834|NCT01640184|1007698|P3|Overall Study|Lost to Follow-up|0
298835|NCT01640184|1007699|P2|Overall Study|Lost to Follow-up|1
298836|NCT01640184|1007700|P1|Overall Study|Lost to Follow-up|4
298837|NCT01640184|1007698|P3|Overall Study|Death|0
298838|NCT01640184|1007699|P2|Overall Study|Death|0
298839|NCT01640184|1007700|P1|Overall Study|Death|1
298840|NCT01640054|1007729|P1|Overall Study|Adverse Event|2
298841|NCT01640054|1007729|P1|Overall Study|Lack of Efficacy|3
298842|NCT01640054|1007729|P1|Overall Study|Study-specific disc criteria|1
298843|NCT01639833|1007739|P2|Overall Study|Withdrawal by Subject|2
298844|NCT01639833|1007740|P1|Overall Study|Withdrawal by Subject|2
298845|NCT01639833|1007739|P2|Overall Study|Death|2
298846|NCT01639833|1007740|P1|Overall Study|Death|4
298847|NCT01639755|1007748|P1|Overall Study|Patient had device explantation|4
298848|NCT01639755|1007748|P1|Overall Study|Study Ongoing|15
298849|NCT01639742|1007756|P1|Overall Study|Lost to Follow-up|1
298850|NCT01639742|1007756|P1|Overall Study|Study Ongoing|17
298851|NCT01639729|1007764|P6|Overall Study|Withdrawal by Subject|0
298852|NCT01639729|1007765|P5|Overall Study|Withdrawal by Subject|0
298853|NCT01639729|1007766|P4|Overall Study|Withdrawal by Subject|1
298854|NCT01639729|1007767|P3|Overall Study|Withdrawal by Subject|1
298855|NCT01639729|1007768|P2|Overall Study|Withdrawal by Subject|0
298856|NCT01639729|1007769|P1|Overall Study|Withdrawal by Subject|1
298857|NCT01639703|1007791|P1|Overall Study|Other reason|7
298858|NCT01639703|1007791|P1|Overall Study|Withdrawal by Subject|5
298859|NCT01639560|1007834|P2|Overall Study|Adverse Event|2
298860|NCT01639560|1007835|P1|Overall Study|Adverse Event|0
298861|NCT01639560|1007834|P2|Overall Study|Lost to Follow-up|11
298862|NCT01639560|1007835|P1|Overall Study|Lost to Follow-up|9
298863|NCT01639560|1007834|P2|Overall Study|Lack of Efficacy|2
298864|NCT01639560|1007835|P1|Overall Study|Lack of Efficacy|1
298865|NCT01639560|1007834|P2|Overall Study|Withdrawal by Subject|14
298866|NCT01639560|1007835|P1|Overall Study|Withdrawal by Subject|9
298867|NCT01639495|1007847|P1|Overall Study|No radiofrequency energy applied|2
298868|NCT01639495|1007847|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
298869|NCT01639495|1007847|P1|Overall Study|Consented but didn’t have study catheter|4
298870|NCT01639495|1007847|P1|Overall Study|Lost to Follow-up|6
298871|NCT01639469|1007857|P2|Overall Study|Lost to Follow-up|1
298872|NCT01639469|1007858|P1|Overall Study|Lost to Follow-up|1
298873|NCT01639469|1007857|P2|Overall Study|Death|2
298874|NCT01639469|1007858|P1|Overall Study|Death|4
298875|NCT01639144|1007963|P2|Overall Study|Met postoperative exclusion criteria|3
298876|NCT01639144|1007964|P1|Overall Study|Met postoperative exclusion criteria|4
298877|NCT01639144|1007963|P2|Overall Study|Physician Decision|0
298878|NCT01639144|1007964|P1|Overall Study|Physician Decision|2
298879|NCT01639144|1007963|P2|Overall Study|Withdrawal by Subject|2
298880|NCT01639144|1007964|P1|Overall Study|Withdrawal by Subject|4
298881|NCT01639040|1007972|P2|Overall Study|Adverse Event|0
298882|NCT01639040|1007973|P1|Overall Study|Adverse Event|1
298883|NCT01639001|1007991|P2|Overall Study|Death|35
298884|NCT01639001|1007992|P1|Overall Study|Death|35
298885|NCT01639001|1007991|P2|Overall Study|Lost to Follow-up|0
298886|NCT01639001|1007992|P1|Overall Study|Lost to Follow-up|1
298887|NCT01639001|1007991|P2|Overall Study|Refused further follow-up|6
298888|NCT01639001|1007992|P1|Overall Study|Refused further follow-up|3
298889|NCT01639001|1007991|P2|Overall Study|Ongoing at date of cutoff|60
298890|NCT01639001|1007992|P1|Overall Study|Ongoing at date of cutoff|65
298891|NCT01639001|1007991|P2|Overall Study|Randomized but not treated|2
298892|NCT01639001|1007992|P1|Overall Study|Randomized but not treated|0
298893|NCT01638546|1008042|P2|Overall Study|Adverse Event|3
298894|NCT01638546|1008043|P1|Overall Study|Adverse Event|1
298895|NCT01638000|1008089|P2|Overall Study|Miscellaneous|2
298896|NCT01638000|1008090|P1|Overall Study|Miscellaneous|2
298897|NCT01638000|1008089|P2|Overall Study|Withdrawal by Subject|24
298898|NCT01638000|1008090|P1|Overall Study|Withdrawal by Subject|21
298899|NCT01638000|1008089|P2|Overall Study|Protocol Violation|13
298900|NCT01638000|1008090|P1|Overall Study|Protocol Violation|11
298901|NCT01638000|1008089|P2|Overall Study|Lack of Efficacy|6
298902|NCT01638000|1008090|P1|Overall Study|Lack of Efficacy|5
298903|NCT01638000|1008089|P2|Overall Study|Adverse Event|16
298904|NCT01638000|1008090|P1|Overall Study|Adverse Event|14
298905|NCT01638000|1008089|P2|Overall Study|Randomized but Never Received Drug|10
298906|NCT01638000|1008090|P1|Overall Study|Randomized but Never Received Drug|7
298907|NCT01637961|1008188|P1|Overall Study|Ineligible: inadequate pathology|1
298908|NCT01637961|1008188|P1|Overall Study|Ineligible: wrong primary|1
298909|NCT01637922|1008220|P2|Overall Study|Lost to Follow-up|0
298910|NCT01637922|1008221|P1|Overall Study|Lost to Follow-up|2
298911|NCT01637922|1008220|P2|Overall Study|Withdrawal by Subject|3
298912|NCT01637922|1008221|P1|Overall Study|Withdrawal by Subject|0
298913|NCT01637922|1008220|P2|Overall Study|Protocol Violation|1
298914|NCT01637922|1008221|P1|Overall Study|Protocol Violation|0
298915|NCT01637922|1008220|P2|Overall Study|Adverse Event|1
298916|NCT01637922|1008221|P1|Overall Study|Adverse Event|0
298917|NCT01637584|1008250|P2|Overall Study|Withdrawal by Subject|3
298918|NCT01637584|1008251|P1|Overall Study|Withdrawal by Subject|1
298919|NCT01637272|1008258|P1|Overall Study|Protocol Violation|2
298920|NCT01637272|1008258|P1|Overall Study|Administrative problems|1
298921|NCT01637272|1008258|P1|Overall Study|completed core, did not enter ext. phase|4
298922|NCT01637272|1008258|P1|Overall Study|Lost to Follow-up|2
298923|NCT01637272|1008258|P1|Overall Study|Withdrawal by Subject|3
298924|NCT01637272|1008258|P1|Overall Study|Unsatisfactory therapeutic effect|2
298925|NCT01637272|1008258|P1|Overall Study|Adverse Event|6
298926|NCT01637077|1008338|P2|Overall Study|No cycle 1 questionnaire data|0
298927|NCT01637077|1008339|P1|Overall Study|No cycle 1 questionnaire data|2
298928|NCT01637077|1008338|P2|Overall Study|Withdrawal by Subject|0
298929|NCT01637077|1008339|P1|Overall Study|Withdrawal by Subject|1
298930|NCT01637077|1008338|P2|Overall Study|Cancel|1
298931|NCT01637077|1008339|P1|Overall Study|Cancel|1
298932|NCT01636986|1008367|P2|Overall Study|Corneal Staining|1
298933|NCT01636986|1008368|P1|Overall Study|Corneal Staining|0
298934|NCT01636986|1008367|P2|Overall Study|Withdrawal by Subject|1
298935|NCT01636986|1008368|P1|Overall Study|Withdrawal by Subject|0
298936|NCT01636960|1008374|P1|Maintenance Phase|Progressive disease|1
298937|NCT01636960|1008374|P1|Maintenance Phase|Adverse Event|3
298938|NCT01636960|1008374|P1|Maintenance Phase|Continued drug after regulatory approval|3
298939|NCT01636960|1008374|P1|Induction Phase|Adverse Event|2
298940|NCT01636947|1008382|P2|Overall Study|Did Not Meet Eligibility Criteria|4
298941|NCT01636947|1008383|P1|Overall Study|Did Not Meet Eligibility Criteria|1
298942|NCT01636947|1008382|P2|Overall Study|Adverse Event|1
298943|NCT01636947|1008383|P1|Overall Study|Adverse Event|1
298944|NCT01636947|1008382|P2|Overall Study|Withdrawal by Subject|3
298945|NCT01636947|1008383|P1|Overall Study|Withdrawal by Subject|3
298946|NCT01636947|1008382|P2|Overall Study|Protocol Violation|1
298947|NCT01636947|1008383|P1|Overall Study|Protocol Violation|1
298948|NCT01636947|1008382|P2|Overall Study|Lost to Follow-up|0
298949|NCT01636947|1008383|P1|Overall Study|Lost to Follow-up|4
298950|NCT01636947|1008382|P2|Overall Study|Not Treated|2
298951|NCT01636947|1008383|P1|Overall Study|Not Treated|2
298952|NCT01636778|1008407|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
298953|NCT01636778|1008408|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
298954|NCT01636778|1008409|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
298955|NCT01636778|1008407|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
298956|NCT01636778|1008408|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
298957|NCT01636778|1008409|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
298958|NCT01636778|1008407|P3|Follow-up Period After Part 2|Other|1
298959|NCT01636778|1008408|P2|Follow-up Period After Part 2|Other|0
298960|NCT01636778|1008409|P1|Follow-up Period After Part 2|Other|0
298961|NCT01636778|1008407|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
298962|NCT01636778|1008408|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
298963|NCT01636778|1008409|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
298964|NCT01636778|1008407|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
298965|NCT01636778|1008408|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
298966|NCT01636778|1008409|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
298967|NCT01636778|1008407|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
298968|NCT01636778|1008408|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
298969|NCT01636778|1008409|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
298970|NCT01636778|1008407|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
298971|NCT01636778|1008408|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
298972|NCT01636778|1008409|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
298973|NCT01636778|1008407|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
298974|NCT01636778|1008408|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
298975|NCT01636778|1008409|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
298976|NCT01636713|1008480|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
298977|NCT01636713|1008481|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
298978|NCT01636713|1008482|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
298979|NCT01636713|1008480|P3|Overall Study|Withdrawal by Subject|8
298980|NCT01636713|1008481|P2|Overall Study|Withdrawal by Subject|4
298981|NCT01636713|1008482|P1|Overall Study|Withdrawal by Subject|5
298982|NCT01636713|1008480|P3|Overall Study|Lost to Follow-up|1
298983|NCT01636713|1008481|P2|Overall Study|Lost to Follow-up|0
298984|NCT01636713|1008482|P1|Overall Study|Lost to Follow-up|0
298985|NCT01636713|1008480|P3|Overall Study|Protocol Violation|1
298986|NCT01636713|1008481|P2|Overall Study|Protocol Violation|0
298987|NCT01636713|1008482|P1|Overall Study|Protocol Violation|3
298988|NCT01636713|1008480|P3|Overall Study|Lack of Efficacy|2
298989|NCT01636713|1008481|P2|Overall Study|Lack of Efficacy|6
298990|NCT01636713|1008482|P1|Overall Study|Lack of Efficacy|6
298991|NCT01636713|1008480|P3|Overall Study|Adverse Event|7
298992|NCT01636713|1008481|P2|Overall Study|Adverse Event|16
298993|NCT01636713|1008482|P1|Overall Study|Adverse Event|16
298994|NCT01636362|1008534|P1|Overall Study|Withdrawal by Subject|1
298995|NCT01636362|1008534|P1|Overall Study|Subject healed, not returning|1
298996|NCT01636362|1008534|P1|Overall Study|Physician Decision|6
298997|NCT01636258|1008542|P2|Overall Study|Lost to Follow-up|0
298998|NCT01636258|1008543|P1|Overall Study|Lost to Follow-up|1
298999|NCT01636076|1008583|P2|Overall Study|Withdrawal by Subject|10
299000|NCT01636076|1008584|P1|Overall Study|Withdrawal by Subject|7
299001|NCT01636076|1008583|P2|Overall Study|Adverse Event|11
299002|NCT01636076|1008584|P1|Overall Study|Adverse Event|6
299003|NCT01636076|1008583|P2|Overall Study|Non-compliance with study treatment|1
299004|NCT01636076|1008584|P1|Overall Study|Non-compliance with study treatment|1
299005|NCT01636076|1008583|P2|Overall Study|Physician Decision|1
299006|NCT01636076|1008584|P1|Overall Study|Physician Decision|1
299007|NCT01636076|1008583|P2|Overall Study|Lost to Follow-up|0
299008|NCT01636076|1008584|P1|Overall Study|Lost to Follow-up|1
299009|NCT01636076|1008583|P2|Overall Study|Lack of Efficacy|1
299010|NCT01636076|1008584|P1|Overall Study|Lack of Efficacy|0
299011|NCT01636076|1008583|P2|Overall Study|Terminated by sponsor|1
299012|NCT01636076|1008584|P1|Overall Study|Terminated by sponsor|1
299013|NCT01635933|1008655|P2|Overall Study|No longer had transportation|1
299014|NCT01635933|1008656|P1|Overall Study|No longer had transportation|0
299015|NCT01635933|1008655|P2|Overall Study|Noncompliance|1
299016|NCT01635933|1008656|P1|Overall Study|Noncompliance|0
299017|NCT01635933|1008655|P2|Overall Study|Subject decision|1
299018|NCT01635933|1008656|P1|Overall Study|Subject decision|1
299019|NCT01635933|1008655|P2|Overall Study|Lost to Follow-up|5
299020|NCT01635933|1008656|P1|Overall Study|Lost to Follow-up|0
299021|NCT01635933|1008655|P2|Overall Study|Adverse Event|0
299022|NCT01635933|1008656|P1|Overall Study|Adverse Event|1
299023|NCT01635920|1008668|P2|Overall Study|Subject decision|0
299024|NCT01635920|1008669|P1|Overall Study|Subject decision|2
299025|NCT01635920|1008668|P2|Overall Study|Lost to Follow-up|1
299026|NCT01635920|1008669|P1|Overall Study|Lost to Follow-up|0
299027|NCT01635920|1008668|P2|Overall Study|Adverse Event|0
299028|NCT01635920|1008669|P1|Overall Study|Adverse Event|1
299029|NCT01635855|1008682|P1|Overall Study|Withdrawal by Subject|4
299030|NCT01635764|1008691|P1|Overall Study|Not Specified|28
299031|NCT01635764|1008691|P1|Overall Study|Lost to Follow-up|53
299032|NCT01635764|1008691|P1|Overall Study|Withdrew Consent|67
299033|NCT01635764|1008691|P1|Overall Study|Protocol Deviation|1
299034|NCT01635764|1008691|P1|Overall Study|Exceed Protocol-specified Interventions|2
299035|NCT01635764|1008691|P1|Overall Study|Lack of Efficacy|76
299036|NCT01635764|1008691|P1|Overall Study|Adverse Event|46
299037|NCT01635218|1008757|P3|Overall Study|Lost to Follow-up|6
299038|NCT01635218|1008758|P2|Overall Study|Lost to Follow-up|7
299039|NCT01635218|1008759|P1|Overall Study|Lost to Follow-up|3
299040|NCT01634854|1008794|P2|Overall Study|Cesarean delivery|7
299041|NCT01634854|1008795|P1|Overall Study|Cesarean delivery|2
299042|NCT01634659|1008815|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
299043|NCT01634659|1008816|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
299044|NCT01634659|1008815|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
299045|NCT01634659|1008816|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
299046|NCT01634555|1008846|P1|Overall Study|Ongoing receiving treatment|13
299047|NCT01634555|1008846|P1|Overall Study|Physician Decision|1
299048|NCT01634555|1008846|P1|Overall Study|Adverse Event|3
299049|NCT01634360|1008856|P2|Overall Study|Study termination by sponsor|44
299050|NCT01634360|1008857|P1|Overall Study|Study termination by sponsor|18
299051|NCT01634360|1008856|P2|Overall Study|Not specified|20
299052|NCT01634360|1008857|P1|Overall Study|Not specified|3
299053|NCT01634360|1008856|P2|Overall Study|Lack of Efficacy|14
299054|NCT01634360|1008857|P1|Overall Study|Lack of Efficacy|4
299055|NCT01634360|1008856|P2|Overall Study|Protocol Violation|1
299056|NCT01634360|1008857|P1|Overall Study|Protocol Violation|1
299057|NCT01634360|1008856|P2|Overall Study|subject withdrew consent|23
299058|NCT01634360|1008857|P1|Overall Study|subject withdrew consent|13
299059|NCT01634360|1008856|P2|Overall Study|Adverse Event|34
299060|NCT01634360|1008857|P1|Overall Study|Adverse Event|10
299061|NCT01634243|1008886|P2|Overall Study|Lack of Efficacy|0
299062|NCT01634243|1008887|P1|Overall Study|Lack of Efficacy|1
299063|NCT01634243|1008886|P2|Overall Study|Adverse Event|5
299064|NCT01634243|1008887|P1|Overall Study|Adverse Event|5
299065|NCT01634165|1008913|P4|Period 2|Adverse Event|0
299066|NCT01634165|1008914|P3|Period 2|Adverse Event|0
299067|NCT01634165|1008915|P2|Period 2|Adverse Event|1
299068|NCT01634165|1008916|P1|Period 2|Adverse Event|0
299069|NCT01634152|1008949|P3|Overall Study|Other reason not defined above|1
299070|NCT01634152|1008950|P2|Overall Study|Other reason not defined above|0
299071|NCT01634152|1008951|P1|Overall Study|Other reason not defined above|1
299072|NCT01634152|1008949|P3|Overall Study|Not treated|0
299073|NCT01634152|1008950|P2|Overall Study|Not treated|1
299074|NCT01634152|1008951|P1|Overall Study|Not treated|0
299075|NCT01634152|1008949|P3|Overall Study|Consent withdrawn not due to AE|1
299076|NCT01634152|1008950|P2|Overall Study|Consent withdrawn not due to AE|0
299077|NCT01634152|1008951|P1|Overall Study|Consent withdrawn not due to AE|1
299078|NCT01634152|1008949|P3|Overall Study|Adverse Event|2
299079|NCT01634152|1008950|P2|Overall Study|Adverse Event|0
299080|NCT01634152|1008951|P1|Overall Study|Adverse Event|2
299081|NCT01634139|1009034|P3|Overall Study|Not treated|0
299082|NCT01634139|1009035|P2|Overall Study|Not treated|1
299083|NCT01634139|1009036|P1|Overall Study|Not treated|1
299084|NCT01634139|1009034|P3|Overall Study|Lost to Follow-up|0
299085|NCT01634139|1009035|P2|Overall Study|Lost to Follow-up|2
299086|NCT01634139|1009036|P1|Overall Study|Lost to Follow-up|0
299087|NCT01634139|1009034|P3|Overall Study|Other|3
299088|NCT01634139|1009035|P2|Overall Study|Other|0
299089|NCT01634139|1009036|P1|Overall Study|Other|4
299090|NCT01634139|1009034|P3|Overall Study|Consent withdrawn not due to AE|2
299091|NCT01634139|1009035|P2|Overall Study|Consent withdrawn not due to AE|3
299092|NCT01634139|1009036|P1|Overall Study|Consent withdrawn not due to AE|4
299093|NCT01634139|1009034|P3|Overall Study|Non compliant with protocol|0
299094|NCT01634139|1009035|P2|Overall Study|Non compliant with protocol|0
299095|NCT01634139|1009036|P1|Overall Study|Non compliant with protocol|1
299096|NCT01634113|1009137|P3|Overall Study|Not treated|1
299097|NCT01634113|1009138|P2|Overall Study|Not treated|0
299098|NCT01634113|1009139|P1|Overall Study|Not treated|0
299099|NCT01634100|1009183|P6|Overall Study|Withdrawal by Subject|0
299100|NCT01634100|1009184|P5|Overall Study|Withdrawal by Subject|0
299101|NCT01634100|1009185|P4|Overall Study|Withdrawal by Subject|0
299102|NCT01634100|1009186|P3|Overall Study|Withdrawal by Subject|1
299103|NCT01634100|1009187|P2|Overall Study|Withdrawal by Subject|0
299104|NCT01634100|1009188|P1|Overall Study|Withdrawal by Subject|1
299105|NCT01633944|1009204|P3|Double-blind Treatment Phase|Not specified|0
299106|NCT01633944|1009205|P2|Double-blind Treatment Phase|Not specified|7
299107|NCT01633944|1009206|P1|Double-blind Treatment Phase|Not specified|0
299108|NCT01633944|1009204|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
299109|NCT01633944|1009205|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
299110|NCT01633944|1009206|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
299111|NCT01633944|1009204|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
299112|NCT01633944|1009205|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
299113|NCT01633944|1009206|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
299114|NCT01633944|1009204|P3|Double-blind Treatment Phase|Lost to Follow-up|9
299115|NCT01633944|1009205|P2|Double-blind Treatment Phase|Lost to Follow-up|4
299116|NCT01633944|1009206|P1|Double-blind Treatment Phase|Lost to Follow-up|0
299117|NCT01633944|1009204|P3|Double-blind Treatment Phase|Protocol Violation|10
299118|NCT01633944|1009205|P2|Double-blind Treatment Phase|Protocol Violation|7
299119|NCT01633944|1009206|P1|Double-blind Treatment Phase|Protocol Violation|0
299120|NCT01633944|1009204|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
299121|NCT01633944|1009205|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
299122|NCT01633944|1009206|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
299123|NCT01633944|1009204|P3|Double-blind Treatment Phase|Lack of Efficacy|23
299124|NCT01633944|1009205|P2|Double-blind Treatment Phase|Lack of Efficacy|8
299125|NCT01633944|1009206|P1|Double-blind Treatment Phase|Lack of Efficacy|0
299126|NCT01633944|1009204|P3|Double-blind Treatment Phase|Adverse Event|7
299127|NCT01633944|1009205|P2|Double-blind Treatment Phase|Adverse Event|13
299128|NCT01633944|1009206|P1|Double-blind Treatment Phase|Adverse Event|0
299129|NCT01633944|1009204|P3|Open-label Titration Phase|Not specified|0
299130|NCT01633944|1009205|P2|Open-label Titration Phase|Not specified|0
299131|NCT01633944|1009206|P1|Open-label Titration Phase|Not specified|68
299132|NCT01633944|1009204|P3|Open-label Titration Phase|Lost to Follow-up|0
299133|NCT01633944|1009205|P2|Open-label Titration Phase|Lost to Follow-up|0
299134|NCT01633944|1009206|P1|Open-label Titration Phase|Lost to Follow-up|22
299135|NCT01633944|1009204|P3|Open-label Titration Phase|Protocol Violation|0
299136|NCT01633944|1009205|P2|Open-label Titration Phase|Protocol Violation|0
299137|NCT01633944|1009206|P1|Open-label Titration Phase|Protocol Violation|24
299138|NCT01633944|1009204|P3|Open-label Titration Phase|Withdrawal by Subject|0
299139|NCT01633944|1009205|P2|Open-label Titration Phase|Withdrawal by Subject|0
299140|NCT01633944|1009206|P1|Open-label Titration Phase|Withdrawal by Subject|34
299141|NCT01633944|1009204|P3|Open-label Titration Phase|Lack of Efficacy|0
299142|NCT01633944|1009205|P2|Open-label Titration Phase|Lack of Efficacy|0
299143|NCT01633944|1009206|P1|Open-label Titration Phase|Lack of Efficacy|33
299144|NCT01633944|1009204|P3|Open-label Titration Phase|Adverse Event|0
299145|NCT01633944|1009205|P2|Open-label Titration Phase|Adverse Event|0
299146|NCT01633944|1009206|P1|Open-label Titration Phase|Adverse Event|109
299147|NCT01633788|1009274|P4|Overall Study|Other Reasons|7
299148|NCT01633788|1009275|P3|Overall Study|Other Reasons|3
299149|NCT01633788|1009276|P2|Overall Study|Other Reasons|2
299150|NCT01633788|1009277|P1|Overall Study|Other Reasons|0
299151|NCT01633788|1009274|P4|Overall Study|Protocol Violation|0
299152|NCT01633788|1009275|P3|Overall Study|Protocol Violation|1
299153|NCT01633788|1009276|P2|Overall Study|Protocol Violation|0
299154|NCT01633788|1009277|P1|Overall Study|Protocol Violation|1
299155|NCT01633788|1009274|P4|Overall Study|Personal Reasons|3
299156|NCT01633788|1009275|P3|Overall Study|Personal Reasons|1
299157|NCT01633788|1009276|P2|Overall Study|Personal Reasons|1
299158|NCT01633788|1009277|P1|Overall Study|Personal Reasons|3
299159|NCT01633788|1009274|P4|Overall Study|Lost to Follow-up|0
299160|NCT01633788|1009275|P3|Overall Study|Lost to Follow-up|2
299161|NCT01633788|1009276|P2|Overall Study|Lost to Follow-up|2
299162|NCT01633788|1009277|P1|Overall Study|Lost to Follow-up|2
299163|NCT01633788|1009274|P4|Overall Study|Adverse Event|3
299164|NCT01633788|1009275|P3|Overall Study|Adverse Event|3
299165|NCT01633788|1009276|P2|Overall Study|Adverse Event|3
299166|NCT01633788|1009277|P1|Overall Study|Adverse Event|1
299167|NCT01632904|1009321|P2|Overall Study|Reason for discontinuation not available|1
299168|NCT01632904|1009322|P1|Overall Study|Reason for discontinuation not available|0
299169|NCT01632904|1009321|P2|Overall Study|Disease Progression|1
299170|NCT01632904|1009322|P1|Overall Study|Disease Progression|0
299171|NCT01632904|1009321|P2|Overall Study|Subject decision|2
299172|NCT01632904|1009322|P1|Overall Study|Subject decision|3
299173|NCT01632904|1009321|P2|Overall Study|Physician Decision|1
299174|NCT01632904|1009322|P1|Overall Study|Physician Decision|0
299175|NCT01632904|1009321|P2|Overall Study|Adverse Event|1
299176|NCT01632904|1009322|P1|Overall Study|Adverse Event|4
299177|NCT01632878|1009333|P1|Treatment|no information on study completion|43
299178|NCT01632878|1009333|P1|Treatment|missing information|4
299179|NCT01632878|1009333|P1|Treatment|Physician Decision|34
299180|NCT01632878|1009333|P1|Treatment|Withdrawal by Subject|36
299181|NCT01632878|1009333|P1|Treatment|Lost to Follow-up|41
299182|NCT01632878|1009333|P1|Screening|Physician Decision|268
299183|NCT01632800|1009337|P1|Overall Study|Subject did not fit in apparatus|1
299184|NCT01632345|1009417|P7|Treatment: Part II|Withdrawal by Subject|2
299185|NCT01632345|1009418|P6|Treatment: Part II|Withdrawal by Subject|2
299186|NCT01632345|1009419|P5|Treatment: Part II|Withdrawal by Subject|0
299187|NCT01632345|1009420|P4|Treatment: Part II|Withdrawal by Subject|0
299188|NCT01632345|1009421|P3|Treatment: Part II|Withdrawal by Subject|0
299189|NCT01632345|1009422|P2|Treatment: Part II|Withdrawal by Subject|0
299190|NCT01632345|1009423|P1|Treatment: Part II|Withdrawal by Subject|0
299191|NCT01632345|1009417|P7|Treatment: Part II|Non-Compliance with Study Drug|0
299192|NCT01632345|1009418|P6|Treatment: Part II|Non-Compliance with Study Drug|3
299193|NCT01632345|1009419|P5|Treatment: Part II|Non-Compliance with Study Drug|0
299194|NCT01632345|1009420|P4|Treatment: Part II|Non-Compliance with Study Drug|0
299195|NCT01632345|1009421|P3|Treatment: Part II|Non-Compliance with Study Drug|0
299196|NCT01632345|1009422|P2|Treatment: Part II|Non-Compliance with Study Drug|0
299197|NCT01632345|1009423|P1|Treatment: Part II|Non-Compliance with Study Drug|0
299198|NCT01632345|1009417|P7|Treatment: Part II|Lost to Follow-up|1
299199|NCT01632345|1009418|P6|Treatment: Part II|Lost to Follow-up|3
299200|NCT01632345|1009419|P5|Treatment: Part II|Lost to Follow-up|0
299201|NCT01632345|1009420|P4|Treatment: Part II|Lost to Follow-up|0
299202|NCT01632345|1009421|P3|Treatment: Part II|Lost to Follow-up|0
299203|NCT01632345|1009422|P2|Treatment: Part II|Lost to Follow-up|0
299204|NCT01632345|1009423|P1|Treatment: Part II|Lost to Follow-up|0
299205|NCT01632345|1009417|P7|Treatment: Part II|Adverse Event|8
299206|NCT01632345|1009418|P6|Treatment: Part II|Adverse Event|3
299207|NCT01632345|1009419|P5|Treatment: Part II|Adverse Event|0
299208|NCT01632345|1009420|P4|Treatment: Part II|Adverse Event|0
299209|NCT01632345|1009421|P3|Treatment: Part II|Adverse Event|0
299210|NCT01632345|1009422|P2|Treatment: Part II|Adverse Event|0
299211|NCT01632345|1009423|P1|Treatment: Part II|Adverse Event|0
299212|NCT01632345|1009417|P7|Treatment: Part I|Withdrawal by Subject|0
299213|NCT01632345|1009418|P6|Treatment: Part I|Withdrawal by Subject|0
299214|NCT01632345|1009419|P5|Treatment: Part I|Withdrawal by Subject|4
299215|NCT01632345|1009420|P4|Treatment: Part I|Withdrawal by Subject|1
299216|NCT01632345|1009421|P3|Treatment: Part I|Withdrawal by Subject|4
299217|NCT01632345|1009422|P2|Treatment: Part I|Withdrawal by Subject|4
299218|NCT01632345|1009423|P1|Treatment: Part I|Withdrawal by Subject|3
299219|NCT01632345|1009417|P7|Treatment: Part I|Protocol Deviation|0
299220|NCT01632345|1009418|P6|Treatment: Part I|Protocol Deviation|0
299221|NCT01632345|1009419|P5|Treatment: Part I|Protocol Deviation|0
299222|NCT01632345|1009420|P4|Treatment: Part I|Protocol Deviation|1
299223|NCT01632345|1009421|P3|Treatment: Part I|Protocol Deviation|1
299224|NCT01632345|1009422|P2|Treatment: Part I|Protocol Deviation|0
299225|NCT01632345|1009423|P1|Treatment: Part I|Protocol Deviation|0
299226|NCT01632345|1009417|P7|Treatment: Part I|Pregnancy|0
299227|NCT01632345|1009418|P6|Treatment: Part I|Pregnancy|0
299228|NCT01632345|1009419|P5|Treatment: Part I|Pregnancy|0
299229|NCT01632345|1009420|P4|Treatment: Part I|Pregnancy|0
299230|NCT01632345|1009421|P3|Treatment: Part I|Pregnancy|0
299231|NCT01632345|1009422|P2|Treatment: Part I|Pregnancy|1
299232|NCT01632345|1009423|P1|Treatment: Part I|Pregnancy|0
299233|NCT01632345|1009417|P7|Treatment: Part I|Physician Decision|0
299234|NCT01632345|1009418|P6|Treatment: Part I|Physician Decision|0
299235|NCT01632345|1009419|P5|Treatment: Part I|Physician Decision|1
299236|NCT01632345|1009420|P4|Treatment: Part I|Physician Decision|0
299237|NCT01632345|1009421|P3|Treatment: Part I|Physician Decision|0
299238|NCT01632345|1009422|P2|Treatment: Part I|Physician Decision|1
299239|NCT01632345|1009423|P1|Treatment: Part I|Physician Decision|2
299240|NCT01632345|1009417|P7|Treatment: Part I|Non-Compliance with Study Drug|0
299241|NCT01632345|1009418|P6|Treatment: Part I|Non-Compliance with Study Drug|0
299242|NCT01632345|1009419|P5|Treatment: Part I|Non-Compliance with Study Drug|0
299243|NCT01632345|1009420|P4|Treatment: Part I|Non-Compliance with Study Drug|1
299244|NCT01632345|1009421|P3|Treatment: Part I|Non-Compliance with Study Drug|2
299245|NCT01632345|1009422|P2|Treatment: Part I|Non-Compliance with Study Drug|2
299246|NCT01632345|1009423|P1|Treatment: Part I|Non-Compliance with Study Drug|3
299247|NCT01632345|1009417|P7|Treatment: Part I|Lost to Follow-up|0
299248|NCT01632345|1009418|P6|Treatment: Part I|Lost to Follow-up|0
299249|NCT01632345|1009419|P5|Treatment: Part I|Lost to Follow-up|4
299250|NCT01632345|1009420|P4|Treatment: Part I|Lost to Follow-up|3
299251|NCT01632345|1009421|P3|Treatment: Part I|Lost to Follow-up|1
299252|NCT01632345|1009422|P2|Treatment: Part I|Lost to Follow-up|2
299253|NCT01632345|1009423|P1|Treatment: Part I|Lost to Follow-up|3
299254|NCT01632345|1009417|P7|Treatment: Part I|Lack of Efficacy|0
299255|NCT01632345|1009418|P6|Treatment: Part I|Lack of Efficacy|0
299256|NCT01632345|1009419|P5|Treatment: Part I|Lack of Efficacy|1
299257|NCT01632345|1009420|P4|Treatment: Part I|Lack of Efficacy|1
299258|NCT01632345|1009421|P3|Treatment: Part I|Lack of Efficacy|0
299259|NCT01632345|1009422|P2|Treatment: Part I|Lack of Efficacy|1
299260|NCT01632345|1009423|P1|Treatment: Part I|Lack of Efficacy|0
299261|NCT01632345|1009417|P7|Treatment: Part I|Adverse Event|0
299262|NCT01632345|1009418|P6|Treatment: Part I|Adverse Event|0
299263|NCT01632345|1009419|P5|Treatment: Part I|Adverse Event|3
299264|NCT01632345|1009420|P4|Treatment: Part I|Adverse Event|1
299265|NCT01632345|1009421|P3|Treatment: Part I|Adverse Event|2
299266|NCT01632345|1009422|P2|Treatment: Part I|Adverse Event|4
299267|NCT01632345|1009423|P1|Treatment: Part I|Adverse Event|1
299268|NCT01632280|1009485|P2|Overall Study|Withdrawal by Subject|0
299269|NCT01632280|1009486|P1|Overall Study|Withdrawal by Subject|1
299270|NCT01632150|1009509|P1|Overall Study|Moved to compassionate program|2
299271|NCT01632150|1009509|P1|Overall Study|Patient underwent autologous transplant|1
299272|NCT01632150|1009509|P1|Overall Study|Withdrawal by Subject|2
299273|NCT01632150|1009509|P1|Overall Study|Unrelated adverse event|7
299274|NCT01632150|1009509|P1|Overall Study|Study drug toxicity|1
299275|NCT01632150|1009509|P1|Overall Study|Disease progression|27
299276|NCT01632020|1009518|P2|Overall Study|Adverse Event|0
299277|NCT01632020|1009519|P1|Overall Study|Adverse Event|1
299278|NCT01632020|1009518|P2|Overall Study|Withdrawal by Subject|0
299279|NCT01632020|1009519|P1|Overall Study|Withdrawal by Subject|1
299280|NCT01631864|1009538|P2|Overall Study|Adverse Event|3
299281|NCT01631864|1009539|P1|Overall Study|Adverse Event|2
299282|NCT01631864|1009538|P2|Overall Study|Withdrawal by Subject|1
299283|NCT01631864|1009539|P1|Overall Study|Withdrawal by Subject|0
299284|NCT01631825|1009551|P1|Overall Study|Physician Decision|2
299285|NCT01631825|1009551|P1|Overall Study|Discontinuation criteria|1
299286|NCT01631825|1009551|P1|Overall Study|Protocol Violation|4
299287|NCT01631825|1009551|P1|Overall Study|Withdrawal by Subject|9
299288|NCT01631825|1009551|P1|Overall Study|Lack of Efficacy|7
299289|NCT01631825|1009551|P1|Overall Study|Adverse Event|42
299290|NCT01631812|1009571|P1|Overall Study|Physician Decision|3
299291|NCT01631812|1009571|P1|Overall Study|Withdrawal by Subject|4
299292|NCT01631812|1009571|P1|Overall Study|Lack of Efficacy|5
299293|NCT01631812|1009571|P1|Overall Study|Adverse Event|25
299294|NCT01631435|1009718|P1|Overall Study|incomplete study procedure|5
299295|NCT01631435|1009718|P1|Overall Study|Withdrawal by Subject|2
299296|NCT01631435|1009718|P1|Overall Study|Adverse Event|2
299297|NCT01631227|1009732|P2|Overall Study|administrative|1
299298|NCT01631227|1009733|P1|Overall Study|administrative|2
299299|NCT01631227|1009732|P2|Overall Study|Adverse Event|0
299300|NCT01631227|1009733|P1|Overall Study|Adverse Event|1
299301|NCT01631227|1009732|P2|Overall Study|withdrawn consent|21
299302|NCT01631227|1009733|P1|Overall Study|withdrawn consent|27
299303|NCT01630811|1009786|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
299304|NCT01630811|1009787|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
299305|NCT01630616|1009814|P6|Overall Study|Withdrawal by Subject|0
299306|NCT01630616|1009815|P5|Overall Study|Withdrawal by Subject|0
299307|NCT01630616|1009816|P4|Overall Study|Withdrawal by Subject|2
299308|NCT01630616|1009817|P3|Overall Study|Withdrawal by Subject|0
299309|NCT01630616|1009818|P2|Overall Study|Withdrawal by Subject|0
299310|NCT01630616|1009819|P1|Overall Study|Withdrawal by Subject|0
299311|NCT01630616|1009814|P6|Overall Study|Adverse Event|0
299312|NCT01630616|1009815|P5|Overall Study|Adverse Event|0
299313|NCT01630616|1009816|P4|Overall Study|Adverse Event|1
299314|NCT01630616|1009817|P3|Overall Study|Adverse Event|0
299315|NCT01630616|1009818|P2|Overall Study|Adverse Event|0
299316|NCT01630616|1009819|P1|Overall Study|Adverse Event|0
299317|NCT01630135|1009894|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
299318|NCT01630135|1009895|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
299319|NCT01629953|1009958|P2|Overall Study|Lost to Follow-up|14
299320|NCT01629953|1009959|P1|Overall Study|Lost to Follow-up|10
299321|NCT01629953|1009958|P2|Overall Study|Death|1
299322|NCT01629953|1009959|P1|Overall Study|Death|3
299323|NCT01629823|1009979|P3|Washout Period|Protocol Violation|0
299324|NCT01629823|1009980|P2|Washout Period|Protocol Violation|1
299325|NCT01629823|1009981|P1|Washout Period|Protocol Violation|0
299326|NCT01629823|1009979|P3|Washout Period|Pregnancy|0
299327|NCT01629823|1009980|P2|Washout Period|Pregnancy|0
299328|NCT01629823|1009981|P1|Washout Period|Pregnancy|1
299329|NCT01629823|1009979|P3|Washout Period|Safety|0
299330|NCT01629823|1009980|P2|Washout Period|Safety|5
299331|NCT01629823|1009981|P1|Washout Period|Safety|2
299332|NCT01629823|1009979|P3|Trial Period|Failed to hold medication|1
299333|NCT01629823|1009980|P2|Trial Period|Failed to hold medication|0
299334|NCT01629823|1009981|P1|Trial Period|Failed to hold medication|0
299335|NCT01629823|1009979|P3|Trial Period|Out-of-window visit|0
299336|NCT01629823|1009980|P2|Trial Period|Out-of-window visit|2
299337|NCT01629823|1009981|P1|Trial Period|Out-of-window visit|0
299338|NCT01629823|1009979|P3|Trial Period|Adverse Event|0
299339|NCT01629823|1009980|P2|Trial Period|Adverse Event|1
299340|NCT01629823|1009981|P1|Trial Period|Adverse Event|0
299341|NCT01629823|1009979|P3|Trial Period|Pregnancy|0
299342|NCT01629823|1009980|P2|Trial Period|Pregnancy|0
299343|NCT01629823|1009981|P1|Trial Period|Pregnancy|1
299344|NCT01629823|1009979|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
299345|NCT01629823|1009980|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
299346|NCT01629823|1009981|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
299347|NCT01629823|1009979|P3|Trial Period|Missed visit|8
299348|NCT01629823|1009980|P2|Trial Period|Missed visit|9
299349|NCT01629823|1009981|P1|Trial Period|Missed visit|11
299350|NCT01629706|1010016|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
299351|NCT01629706|1010016|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
299352|NCT01629706|1010016|P1|Phase 2 Habitual|Relocation prior to Dispense|1
299353|NCT01629706|1010016|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
299354|NCT01629706|1010016|P1|Phase 2 Habitual|Screen Failure|6
299355|NCT01629706|1010016|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
299356|NCT01629706|1010016|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
299357|NCT01629706|1010016|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
299358|NCT01629706|1010016|P1|Phase 1 PureVision|Screen Failure|4
299359|NCT01629693|1010044|P2|Overall Study|Subject decision unrelated to AE|1
299360|NCT01629693|1010045|P1|Overall Study|Subject decision unrelated to AE|0
299361|NCT01629693|1010044|P2|Overall Study|Poor comfort of study lenses|2
299362|NCT01629693|1010045|P1|Overall Study|Poor comfort of study lenses|0
299363|NCT01629693|1010044|P2|Overall Study|Investigator decision|1
299364|NCT01629693|1010045|P1|Overall Study|Investigator decision|0
299365|NCT01629693|1010044|P2|Overall Study|Adverse Event|0
299366|NCT01629693|1010045|P1|Overall Study|Adverse Event|1
299367|NCT01629693|1010044|P2|Overall Study|Withdrawal by Subject|2
299368|NCT01629693|1010045|P1|Overall Study|Withdrawal by Subject|2
299369|NCT01629693|1010044|P2|Overall Study|Lost to Follow-up|4
299370|NCT01629693|1010045|P1|Overall Study|Lost to Follow-up|2
299371|NCT01629667|1010054|P3|Overall Study|Code break|0
299372|NCT01629667|1010055|P2|Overall Study|Code break|0
299373|NCT01629667|1010056|P1|Overall Study|Code break|1
299374|NCT01629667|1010054|P3|Overall Study|Enrolled in another clinical study|0
299375|NCT01629667|1010055|P2|Overall Study|Enrolled in another clinical study|1
299376|NCT01629667|1010056|P1|Overall Study|Enrolled in another clinical study|0
299377|NCT01629667|1010054|P3|Overall Study|Site error in safety follow-up|1
299378|NCT01629667|1010055|P2|Overall Study|Site error in safety follow-up|0
299379|NCT01629667|1010056|P1|Overall Study|Site error in safety follow-up|0
299380|NCT01629667|1010054|P3|Overall Study|Started other medicine|1
299381|NCT01629667|1010055|P2|Overall Study|Started other medicine|0
299382|NCT01629667|1010056|P1|Overall Study|Started other medicine|1
299383|NCT01629667|1010054|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
299384|NCT01629667|1010055|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
299385|NCT01629667|1010056|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
299386|NCT01629667|1010054|P3|Overall Study|Requiring lung transplant|3
299387|NCT01629667|1010055|P2|Overall Study|Requiring lung transplant|1
299388|NCT01629667|1010056|P1|Overall Study|Requiring lung transplant|2
299389|NCT01629667|1010054|P3|Overall Study|Ongoing AE worsening right heart failure|0
299390|NCT01629667|1010055|P2|Overall Study|Ongoing AE worsening right heart failure|1
299391|NCT01629667|1010056|P1|Overall Study|Ongoing AE worsening right heart failure|0
299392|NCT01629667|1010054|P3|Overall Study|Randomized, not treated|0
299393|NCT01629667|1010055|P2|Overall Study|Randomized, not treated|1
299394|NCT01629667|1010056|P1|Overall Study|Randomized, not treated|2
299395|NCT01629667|1010054|P3|Overall Study|Death|3
299396|NCT01629667|1010055|P2|Overall Study|Death|5
299397|NCT01629667|1010056|P1|Overall Study|Death|1
299398|NCT01629667|1010054|P3|Overall Study|Withdrawal by Subject|28
299399|NCT01629667|1010055|P2|Overall Study|Withdrawal by Subject|20
299400|NCT01629667|1010056|P1|Overall Study|Withdrawal by Subject|31
299401|NCT01629667|1010054|P3|Overall Study|Lost to Follow-up|1
299402|NCT01629667|1010055|P2|Overall Study|Lost to Follow-up|1
299403|NCT01629667|1010056|P1|Overall Study|Lost to Follow-up|0
299404|NCT01629589|1010140|P2|Overall Study|Did not receive study vaccine|1
299405|NCT01629589|1010141|P1|Overall Study|Did not receive study vaccine|0
299406|NCT01629589|1010140|P2|Overall Study|Withdrawal by Subject|3
299407|NCT01629589|1010141|P1|Overall Study|Withdrawal by Subject|2
299408|NCT01629589|1010140|P2|Overall Study|Lost to Follow-up|1
299409|NCT01629589|1010141|P1|Overall Study|Lost to Follow-up|2
299410|NCT01629589|1010140|P2|Overall Study|Protocol Violation|2
299411|NCT01629589|1010141|P1|Overall Study|Protocol Violation|4
299412|NCT01628965|1010180|P1|Overall Study|Discontinuation criteria|8
299413|NCT01628965|1010180|P1|Overall Study|Lost to Follow-up|1
299414|NCT01628965|1010180|P1|Overall Study|Withdrawal by Subject|3
299415|NCT01628965|1010180|P1|Overall Study|Lack of Efficacy|7
299416|NCT01628965|1010180|P1|Overall Study|Adverse Event|30
299417|NCT01628926|1010189|P3|Overall Study|Physician Decision|1
299418|NCT01628926|1010190|P2|Overall Study|Physician Decision|2
299419|NCT01628926|1010191|P1|Overall Study|Physician Decision|2
299420|NCT01628926|1010189|P3|Overall Study|Discontinuation criteria|0
299421|NCT01628926|1010190|P2|Overall Study|Discontinuation criteria|4
299422|NCT01628926|1010191|P1|Overall Study|Discontinuation criteria|3
299423|NCT01628926|1010189|P3|Overall Study|Protocol Violation|0
299424|NCT01628926|1010190|P2|Overall Study|Protocol Violation|1
299425|NCT01628926|1010191|P1|Overall Study|Protocol Violation|0
299426|NCT01628926|1010189|P3|Overall Study|Withdrawal by Subject|2
299427|NCT01628926|1010190|P2|Overall Study|Withdrawal by Subject|4
299428|NCT01628926|1010191|P1|Overall Study|Withdrawal by Subject|6
299429|NCT01628926|1010189|P3|Overall Study|Lack of Efficacy|5
299430|NCT01628926|1010190|P2|Overall Study|Lack of Efficacy|1
299431|NCT01628926|1010191|P1|Overall Study|Lack of Efficacy|2
299432|NCT01628926|1010189|P3|Overall Study|Adverse Event|9
299433|NCT01628926|1010190|P2|Overall Study|Adverse Event|11
299434|NCT01628926|1010191|P1|Overall Study|Adverse Event|13
299435|NCT01628913|1010240|P2|Overall Study|Physician Decision|3
299436|NCT01628913|1010241|P1|Overall Study|Physician Decision|1
299437|NCT01628913|1010240|P2|Overall Study|Withdrawal by Subject|0
299438|NCT01628913|1010241|P1|Overall Study|Withdrawal by Subject|1
299439|NCT01628913|1010240|P2|Overall Study|study terminated by Sponsor|9
299440|NCT01628913|1010241|P1|Overall Study|study terminated by Sponsor|4
299441|NCT01628913|1010240|P2|Overall Study|Death|0
299442|NCT01628913|1010241|P1|Overall Study|Death|1
299443|NCT01628913|1010240|P2|Overall Study|Protocol Violation|0
299444|NCT01628913|1010241|P1|Overall Study|Protocol Violation|1
299445|NCT01628913|1010240|P2|Overall Study|Disease Progression|14
299446|NCT01628913|1010241|P1|Overall Study|Disease Progression|11
299447|NCT01628913|1010240|P2|Overall Study|Adverse Event|5
299448|NCT01628913|1010241|P1|Overall Study|Adverse Event|12
299449|NCT01628848|1010255|P2|Overall Study|Physician Decision|1
299450|NCT01628848|1010256|P1|Overall Study|Physician Decision|3
299451|NCT01628848|1010255|P2|Overall Study|Withdrawal by Subject|2
299452|NCT01628848|1010256|P1|Overall Study|Withdrawal by Subject|0
299453|NCT01628848|1010255|P2|Overall Study|Lack of Efficacy|4
299454|NCT01628848|1010256|P1|Overall Study|Lack of Efficacy|0
299455|NCT01628848|1010255|P2|Overall Study|Adverse Event|7
299456|NCT01628848|1010256|P1|Overall Study|Adverse Event|9
299457|NCT01628692|1010290|P6|Overall Study|Completed 12 Week only|1
299458|NCT01628692|1010291|P5|Overall Study|Completed 12 Week only|0
299459|NCT01628692|1010292|P4|Overall Study|Completed 12 Week only|0
299460|NCT01628692|1010293|P3|Overall Study|Completed 12 Week only|0
299461|NCT01628692|1010294|P2|Overall Study|Completed 12 Week only|0
299462|NCT01628692|1010295|P1|Overall Study|Completed 12 Week only|0
299463|NCT01628692|1010290|P6|Overall Study|Administrative reason by sponsor|1
299464|NCT01628692|1010291|P5|Overall Study|Administrative reason by sponsor|0
299465|NCT01628692|1010292|P4|Overall Study|Administrative reason by sponsor|0
299466|NCT01628692|1010293|P3|Overall Study|Administrative reason by sponsor|0
299467|NCT01628692|1010294|P2|Overall Study|Administrative reason by sponsor|0
299468|NCT01628692|1010295|P1|Overall Study|Administrative reason by sponsor|0
299469|NCT01628692|1010290|P6|Overall Study|Poor compliance/noncompliance|0
299470|NCT01628692|1010291|P5|Overall Study|Poor compliance/noncompliance|0
299471|NCT01628692|1010292|P4|Overall Study|Poor compliance/noncompliance|0
299472|NCT01628692|1010293|P3|Overall Study|Poor compliance/noncompliance|0
299473|NCT01628692|1010294|P2|Overall Study|Poor compliance/noncompliance|0
299474|NCT01628692|1010295|P1|Overall Study|Poor compliance/noncompliance|1
299475|NCT01628692|1010290|P6|Overall Study|Death|0
299476|NCT01628692|1010291|P5|Overall Study|Death|0
299477|NCT01628692|1010292|P4|Overall Study|Death|0
299478|NCT01628692|1010293|P3|Overall Study|Death|0
299479|NCT01628692|1010294|P2|Overall Study|Death|1
299480|NCT01628692|1010295|P1|Overall Study|Death|0
299481|NCT01628692|1010290|P6|Overall Study|Withdrawal by Subject|0
299482|NCT01628692|1010291|P5|Overall Study|Withdrawal by Subject|0
299483|NCT01628692|1010292|P4|Overall Study|Withdrawal by Subject|0
299484|NCT01628692|1010293|P3|Overall Study|Withdrawal by Subject|1
299485|NCT01628692|1010294|P2|Overall Study|Withdrawal by Subject|1
299486|NCT01628692|1010295|P1|Overall Study|Withdrawal by Subject|0
299487|NCT01628692|1010290|P6|Overall Study|Adverse Event|0
299488|NCT01628692|1010291|P5|Overall Study|Adverse Event|0
299489|NCT01628692|1010292|P4|Overall Study|Adverse Event|0
299490|NCT01628692|1010293|P3|Overall Study|Adverse Event|2
299491|NCT01628692|1010294|P2|Overall Study|Adverse Event|0
299492|NCT01628692|1010295|P1|Overall Study|Adverse Event|2
299493|NCT01628692|1010290|P6|Overall Study|Lack of Efficacy|7
299494|NCT01628692|1010291|P5|Overall Study|Lack of Efficacy|4
299495|NCT01628692|1010292|P4|Overall Study|Lack of Efficacy|1
299496|NCT01628692|1010293|P3|Overall Study|Lack of Efficacy|5
299497|NCT01628692|1010294|P2|Overall Study|Lack of Efficacy|4
299498|NCT01628692|1010295|P1|Overall Study|Lack of Efficacy|4
299499|NCT01628510|1010363|P2|Overall Study|Death|1
299500|NCT01628510|1010364|P1|Overall Study|Death|3
299501|NCT01628510|1010363|P2|Overall Study|Withdrawal by Subject|4
299502|NCT01628510|1010364|P1|Overall Study|Withdrawal by Subject|0
299503|NCT01628367|1010374|P2|Overall Study|Adverse Event|0
299504|NCT01628367|1010375|P1|Overall Study|Adverse Event|1
299505|NCT01628198|1010394|P1|Overall Study|Screen failure|1
299506|NCT01628198|1010394|P1|Overall Study|Withdrawal by Subject|10
299507|NCT01628198|1010394|P1|Overall Study|Lost to Follow-up|7
299508|NCT01627860|1010434|P2|Overall Study|Protocol Violation|0
299509|NCT01627860|1010435|P1|Overall Study|Protocol Violation|1
299510|NCT01627860|1010434|P2|Overall Study|Seizure frequency doubled|1
299511|NCT01627860|1010435|P1|Overall Study|Seizure frequency doubled|0
299512|NCT01627860|1010434|P2|Overall Study|Withdrawal by Subject|1
299513|NCT01627860|1010435|P1|Overall Study|Withdrawal by Subject|2
299514|NCT01627860|1010434|P2|Overall Study|Adverse Event|4
299515|NCT01627860|1010435|P1|Overall Study|Adverse Event|9
299516|NCT01627782|1010449|P4|Overall Study|Randomized But Not Treated|0
299517|NCT01627782|1010450|P3|Overall Study|Randomized But Not Treated|0
299518|NCT01627782|1010451|P2|Overall Study|Randomized But Not Treated|0
299519|NCT01627782|1010452|P1|Overall Study|Randomized But Not Treated|1
299520|NCT01627782|1010449|P4|Overall Study|Other|3
299521|NCT01627782|1010450|P3|Overall Study|Other|0
299522|NCT01627782|1010451|P2|Overall Study|Other|2
299523|NCT01627782|1010452|P1|Overall Study|Other|0
299524|NCT01627782|1010449|P4|Overall Study|Withdrawal by Subject|0
299525|NCT01627782|1010450|P3|Overall Study|Withdrawal by Subject|0
299526|NCT01627782|1010451|P2|Overall Study|Withdrawal by Subject|1
299527|NCT01627782|1010452|P1|Overall Study|Withdrawal by Subject|2
299528|NCT01627782|1010449|P4|Overall Study|Protocol Violation|0
299529|NCT01627782|1010450|P3|Overall Study|Protocol Violation|0
299530|NCT01627782|1010451|P2|Overall Study|Protocol Violation|0
299531|NCT01627782|1010452|P1|Overall Study|Protocol Violation|1
299532|NCT01627782|1010449|P4|Overall Study|Lack of Efficacy|2
299533|NCT01627782|1010450|P3|Overall Study|Lack of Efficacy|15
299534|NCT01627782|1010451|P2|Overall Study|Lack of Efficacy|1
299535|NCT01627782|1010452|P1|Overall Study|Lack of Efficacy|11
299536|NCT01627782|1010449|P4|Overall Study|Adverse Event|1
299537|NCT01627782|1010450|P3|Overall Study|Adverse Event|0
299538|NCT01627782|1010451|P2|Overall Study|Adverse Event|2
299539|NCT01627782|1010452|P1|Overall Study|Adverse Event|1
299540|NCT01627561|1010510|P2|Overall Study|Withdrawal by Subject|2
299541|NCT01627561|1010511|P1|Overall Study|Withdrawal by Subject|0
299542|NCT01627561|1010510|P2|Overall Study|Migrated/moved from study area|1
299543|NCT01627561|1010511|P1|Overall Study|Migrated/moved from study area|0
299544|NCT01627340|1010559|P2|Overall Study|Withdrawal by Subject|0
299545|NCT01627340|1010560|P1|Overall Study|Withdrawal by Subject|2
299546|NCT01627340|1010559|P2|Overall Study|Pregnancy|0
299547|NCT01627340|1010560|P1|Overall Study|Pregnancy|1
299548|NCT01627340|1010559|P2|Overall Study|Lost to Follow-up|4
299549|NCT01627340|1010560|P1|Overall Study|Lost to Follow-up|8
299550|NCT01627340|1010559|P2|Overall Study|Adverse Event|0
299551|NCT01627340|1010560|P1|Overall Study|Adverse Event|1
299552|NCT01627327|1010578|P2|Overall Study|Withdrawal by Subject|3
299553|NCT01627327|1010579|P1|Overall Study|Withdrawal by Subject|3
299554|NCT01627327|1010578|P2|Overall Study|Physician Decision|0
299555|NCT01627327|1010579|P1|Overall Study|Physician Decision|1
299556|NCT01627327|1010578|P2|Overall Study|Lost to Follow-up|3
299557|NCT01627327|1010579|P1|Overall Study|Lost to Follow-up|1
299558|NCT01627327|1010578|P2|Overall Study|Protocol Violation|10
299559|NCT01627327|1010579|P1|Overall Study|Protocol Violation|4
299560|NCT01627327|1010578|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
299561|NCT01627327|1010579|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
299562|NCT01627327|1010578|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
299563|NCT01627327|1010579|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
299564|NCT01627327|1010578|P2|Overall Study|Adverse Event|12
299565|NCT01627327|1010579|P1|Overall Study|Adverse Event|6
299566|NCT01627249|1010592|P3|Overall Study|Missed Visit|0
299567|NCT01627249|1010593|P2|Overall Study|Missed Visit|1
299568|NCT01627249|1010594|P1|Overall Study|Missed Visit|1
299569|NCT01627249|1010592|P3|Overall Study|Withdrawal by Subject|9
299570|NCT01627249|1010593|P2|Overall Study|Withdrawal by Subject|6
299571|NCT01627249|1010594|P1|Overall Study|Withdrawal by Subject|12
299572|NCT01627249|1010592|P3|Overall Study|Death|3
299573|NCT01627249|1010593|P2|Overall Study|Death|5
299574|NCT01627249|1010594|P1|Overall Study|Death|3
299575|NCT01626690|1010715|P2|Overall Study|Adverse Event|0
299576|NCT01626690|1010716|P1|Overall Study|Adverse Event|1
299577|NCT01626690|1010715|P2|Overall Study|Protocol Violation|0
299578|NCT01626690|1010716|P1|Overall Study|Protocol Violation|1
299579|NCT01626456|1010753|P2|Overall Study|Incarceration|2
299580|NCT01626456|1010754|P1|Overall Study|Incarceration|0
299581|NCT01626456|1010753|P2|Overall Study|Site Closure|3
299582|NCT01626456|1010754|P1|Overall Study|Site Closure|2
299583|NCT01626456|1010753|P2|Overall Study|Protocol Violation|1
299584|NCT01626456|1010754|P1|Overall Study|Protocol Violation|1
299585|NCT01626456|1010753|P2|Overall Study|Physician Decision|4
299586|NCT01626456|1010754|P1|Overall Study|Physician Decision|1
299587|NCT01626456|1010753|P2|Overall Study|Lack of Efficacy|7
299588|NCT01626456|1010754|P1|Overall Study|Lack of Efficacy|6
299589|NCT01626456|1010753|P2|Overall Study|Lost to Follow-up|27
299590|NCT01626456|1010754|P1|Overall Study|Lost to Follow-up|2
299591|NCT01626456|1010753|P2|Overall Study|Adverse Event|27
299592|NCT01626456|1010754|P1|Overall Study|Adverse Event|2
299593|NCT01626456|1010753|P2|Overall Study|Withdrawal by Subject|46
299594|NCT01626456|1010754|P1|Overall Study|Withdrawal by Subject|21
299595|NCT01626391|1010784|P2|Overall Study|Withdrawal by Subject|0
299596|NCT01626391|1010785|P1|Overall Study|Withdrawal by Subject|1
299597|NCT01626391|1010784|P2|Overall Study|Physician Decision|0
299598|NCT01626391|1010785|P1|Overall Study|Physician Decision|1
299599|NCT01626352|1010791|P1|Overall Study|Never Treated|1
299600|NCT01626352|1010791|P1|Overall Study|Non-Compliance|1
299601|NCT01626352|1010791|P1|Overall Study|Withdrawal by Subject|1
299602|NCT01626352|1010791|P1|Overall Study|Death|2
299603|NCT01626352|1010791|P1|Overall Study|Intercurrent Illness|2
299604|NCT01626352|1010791|P1|Overall Study|Disease Progression|3
299605|NCT01626118|1010805|P4|Overall Study|Investigator Decision|0
299606|NCT01626118|1010806|P3|Overall Study|Investigator Decision|0
299607|NCT01626118|1010807|P2|Overall Study|Investigator Decision|1
299608|NCT01626118|1010808|P1|Overall Study|Investigator Decision|0
299609|NCT01626118|1010805|P4|Overall Study|Adverse Event|0
299610|NCT01626118|1010806|P3|Overall Study|Adverse Event|1
299611|NCT01626118|1010807|P2|Overall Study|Adverse Event|1
299612|NCT01626118|1010808|P1|Overall Study|Adverse Event|0
299613|NCT01626118|1010805|P4|Overall Study|Lost to Follow-up|0
299614|NCT01626118|1010806|P3|Overall Study|Lost to Follow-up|0
299615|NCT01626118|1010807|P2|Overall Study|Lost to Follow-up|0
299616|NCT01626118|1010808|P1|Overall Study|Lost to Follow-up|1
299617|NCT01626118|1010805|P4|Overall Study|Lack of Efficacy|3
299618|NCT01626118|1010806|P3|Overall Study|Lack of Efficacy|1
299619|NCT01626118|1010807|P2|Overall Study|Lack of Efficacy|0
299620|NCT01626118|1010808|P1|Overall Study|Lack of Efficacy|1
299621|NCT01625910|1010854|P2|Overall Study|Lost to Follow-up|4
299622|NCT01625910|1010855|P1|Overall Study|Lost to Follow-up|3
299623|NCT01625845|1010865|P2|Overall Study|Withdrawal by Subject|0
299624|NCT01625845|1010866|P1|Overall Study|Withdrawal by Subject|2
299625|NCT01625845|1010865|P2|Overall Study|Lost to Follow-up|1
299626|NCT01625845|1010866|P1|Overall Study|Lost to Follow-up|2
299627|NCT01625845|1010865|P2|Overall Study|Adverse Event|2
299628|NCT01625845|1010866|P1|Overall Study|Adverse Event|1
299629|NCT01625689|1010886|P2|Overall Study|Migration|1
299630|NCT01625689|1010887|P1|Overall Study|Migration|2
299631|NCT01625377|1010942|P2|Overall Study|Abnormal laboratory values|0
299632|NCT01625377|1010943|P1|Overall Study|Abnormal laboratory values|1
299633|NCT01625377|1010942|P2|Overall Study|Unsatisfactory therapeutic effect|1
299634|NCT01625377|1010943|P1|Overall Study|Unsatisfactory therapeutic effect|0
299635|NCT01625377|1010942|P2|Overall Study|Graft loss|0
299636|NCT01625377|1010943|P1|Overall Study|Graft loss|1
299637|NCT01625377|1010942|P2|Overall Study|Adverse Event|16
299638|NCT01625377|1010943|P1|Overall Study|Adverse Event|3
299639|NCT01625377|1010942|P2|Overall Study|Protocol Violation|3
299640|NCT01625377|1010943|P1|Overall Study|Protocol Violation|0
299641|NCT01625377|1010942|P2|Overall Study|Administrative Problem|1
299642|NCT01625377|1010943|P1|Overall Study|Administrative Problem|1
299643|NCT01625377|1010942|P2|Overall Study|Death|1
299644|NCT01625377|1010943|P1|Overall Study|Death|1
299645|NCT01625338|1010976|P3|Overall Study|Study Discontinued by Sponsor|1
299646|NCT01625338|1010977|P2|Overall Study|Study Discontinued by Sponsor|0
299647|NCT01625338|1010978|P1|Overall Study|Study Discontinued by Sponsor|0
299648|NCT01625338|1010976|P3|Overall Study|Adverse Event|1
299649|NCT01625338|1010977|P2|Overall Study|Adverse Event|0
299650|NCT01625338|1010978|P1|Overall Study|Adverse Event|1
299651|NCT01625338|1010976|P3|Overall Study|Subject Withdrew Consent|2
299652|NCT01625338|1010977|P2|Overall Study|Subject Withdrew Consent|0
299653|NCT01625338|1010978|P1|Overall Study|Subject Withdrew Consent|1
299654|NCT01625338|1010976|P3|Overall Study|Investigator Decision|1
299655|NCT01625338|1010977|P2|Overall Study|Investigator Decision|2
299656|NCT01625338|1010978|P1|Overall Study|Investigator Decision|0
299657|NCT01625338|1010976|P3|Overall Study|Lost to Follow-up|2
299658|NCT01625338|1010977|P2|Overall Study|Lost to Follow-up|3
299659|NCT01625338|1010978|P1|Overall Study|Lost to Follow-up|3
299660|NCT01625338|1010976|P3|Overall Study|Efficacy Failure|31
299661|NCT01625338|1010977|P2|Overall Study|Efficacy Failure|39
299662|NCT01625338|1010978|P1|Overall Study|Efficacy Failure|27
299663|NCT01625338|1010976|P3|Overall Study|Enrolled but not Treated|1
299664|NCT01625338|1010977|P2|Overall Study|Enrolled but not Treated|0
299665|NCT01625338|1010978|P1|Overall Study|Enrolled but not Treated|0
299666|NCT01625182|1011005|P2|Overall Study|Lack of Efficacy|8
299667|NCT01625182|1011006|P1|Overall Study|Lack of Efficacy|12
299668|NCT01625182|1011005|P2|Overall Study|Withdrawal by Subject|1
299669|NCT01625182|1011006|P1|Overall Study|Withdrawal by Subject|5
299670|NCT01625182|1011005|P2|Overall Study|Adverse Event|0
299671|NCT01625182|1011006|P1|Overall Study|Adverse Event|2
299672|NCT01625182|1011005|P2|Overall Study|Protocol deviation|2
299673|NCT01625182|1011006|P1|Overall Study|Protocol deviation|0
299674|NCT01625182|1011005|P2|Overall Study|Administrative problems|0
299675|NCT01625182|1011006|P1|Overall Study|Administrative problems|1
299676|NCT01625091|1011043|P2|Post-intervention|Study termination|1
299677|NCT01625091|1011044|P1|Post-intervention|Study termination|2
299678|NCT01625091|1011043|P2|Post-intervention|Lost to Follow-up|0
299679|NCT01625091|1011044|P1|Post-intervention|Lost to Follow-up|2
299680|NCT01625091|1011043|P2|Post-intervention|Death|1
299681|NCT01625091|1011044|P1|Post-intervention|Death|0
299682|NCT01625091|1011043|P2|Intervention|Study termination|3
299683|NCT01625091|1011044|P1|Intervention|Study termination|2
299684|NCT01625091|1011043|P2|Intervention|Lost to Follow-up|4
299685|NCT01625091|1011044|P1|Intervention|Lost to Follow-up|4
299686|NCT01625091|1011043|P2|Intervention|Adverse Event|2
299687|NCT01625091|1011044|P1|Intervention|Adverse Event|0
299688|NCT01625091|1011043|P2|Intervention|Withdrawal by Subject|1
299689|NCT01625091|1011044|P1|Intervention|Withdrawal by Subject|4
299690|NCT01625091|1011043|P2|Intervention|Death|1
299691|NCT01625091|1011044|P1|Intervention|Death|1
299692|NCT01624467|1011085|P1|Overall Study|Subject Withdrew from Treatment|1
299693|NCT01624467|1011085|P1|Overall Study|Per Sponsor Requirement|1
299694|NCT01624467|1011085|P1|Overall Study|Progressive Disease|19
299695|NCT01624467|1011085|P1|Overall Study|Adverse Event|7
299696|NCT01624467|1011085|P1|Overall Study|Lost to Follow-up|1
299697|NCT01624467|1011085|P1|Overall Study|Withdrawal by Subject|2
299698|NCT01624259|1011124|P2|Overall Study|Abnormal laboratory measure|0
299699|NCT01624259|1011125|P1|Overall Study|Abnormal laboratory measure|3
299700|NCT01624259|1011124|P2|Overall Study|Lost to Follow-up|3
299701|NCT01624259|1011125|P1|Overall Study|Lost to Follow-up|2
299702|NCT01624259|1011124|P2|Overall Study|Physician Decision|1
299703|NCT01624259|1011125|P1|Overall Study|Physician Decision|1
299704|NCT01624259|1011124|P2|Overall Study|Withdrawal by Subject|7
299705|NCT01624259|1011125|P1|Overall Study|Withdrawal by Subject|5
299706|NCT01624259|1011124|P2|Overall Study|Protocol Violation|2
299707|NCT01624259|1011125|P1|Overall Study|Protocol Violation|1
299708|NCT01624259|1011124|P2|Overall Study|Adverse Event|18
299709|NCT01624259|1011125|P1|Overall Study|Adverse Event|18
299710|NCT01624233|1011174|P1|Period 3 - Maintenance|Withdrawal by Subject|2
299711|NCT01624233|1011174|P1|Period 3 - Maintenance|Physician Decision|2
299712|NCT01624233|1011174|P1|Period 3 - Maintenance|Lack of Efficacy|1
299713|NCT01624233|1011174|P1|Period 3 - Maintenance|Adverse Event|2
299714|NCT01624233|1011174|P1|Period 2 - Induction|Adverse Event|1
299715|NCT01624194|1011193|P2|Overall Study|Withdrawal by Subject|0
299716|NCT01624194|1011194|P1|Overall Study|Withdrawal by Subject|1
299717|NCT01624194|1011193|P2|Overall Study|Lost to Follow-up|0
299718|NCT01624194|1011194|P1|Overall Study|Lost to Follow-up|1
299719|NCT01623830|1011268|P2|Overall Study|Exclusion from Study|2
299720|NCT01623830|1011269|P1|Overall Study|Exclusion from Study|1
299721|NCT01623830|1011268|P2|Overall Study|Withdrawal by Subject|7
299722|NCT01623830|1011269|P1|Overall Study|Withdrawal by Subject|6
299723|NCT01623596|1011294|P2|Overall Study|Lack of Efficacy|3
299724|NCT01623596|1011295|P1|Overall Study|Lack of Efficacy|5
299725|NCT01623596|1011294|P2|Overall Study|Protocol Violation|6
299726|NCT01623596|1011295|P1|Overall Study|Protocol Violation|0
299727|NCT01623596|1011294|P2|Overall Study|Patient no longer requires study drug|0
299728|NCT01623596|1011295|P1|Overall Study|Patient no longer requires study drug|1
299729|NCT01623596|1011294|P2|Overall Study|Withdrawal by Subject|31
299730|NCT01623596|1011295|P1|Overall Study|Withdrawal by Subject|13
299731|NCT01623596|1011294|P2|Overall Study|Lost to Follow-up|16
299732|NCT01623596|1011295|P1|Overall Study|Lost to Follow-up|12
299733|NCT01623596|1011294|P2|Overall Study|Death|2
299734|NCT01623596|1011295|P1|Overall Study|Death|0
299735|NCT01623596|1011294|P2|Overall Study|Adverse Event|29
299736|NCT01623596|1011295|P1|Overall Study|Adverse Event|20
299737|NCT01623596|1011294|P2|Overall Study|Administrative problems|13
299738|NCT01623596|1011295|P1|Overall Study|Administrative problems|9
299739|NCT01623596|1011294|P2|Overall Study|Abnormal laboratory values|0
299740|NCT01623596|1011295|P1|Overall Study|Abnormal laboratory values|2
299741|NCT01623310|1011338|P1|Overall Study|Investigators Discretion-Noncompliant|1
299742|NCT01623310|1011338|P1|Overall Study|Diagnoses of bilateral cateracts|1
299743|NCT01623310|1011338|P1|Overall Study|Became potentially child-bearing|1
299744|NCT01623310|1011338|P1|Overall Study|Withdrawal by Subject|25
299745|NCT01623310|1011338|P1|Overall Study|Protocol Violation|6
299746|NCT01623310|1011338|P1|Overall Study|Lack of Efficacy|6
299747|NCT01623310|1011338|P1|Overall Study|Lost to Follow-up|18
299748|NCT01623310|1011338|P1|Overall Study|Adverse Event|21
299749|NCT01623271|1011347|P1|Overall Study|Withdrawal by Subject|2
299750|NCT01623154|1011351|P1|Overall Study|Did not drink Pranactin Citric|4
299751|NCT01623115|1011359|P2|Overall Study|Other than specified above|3
299752|NCT01623115|1011360|P1|Overall Study|Other than specified above|0
299753|NCT01623115|1011359|P2|Overall Study|Death|4
299754|NCT01623115|1011360|P1|Overall Study|Death|0
299755|NCT01623115|1011359|P2|Overall Study|Site closure|7
299756|NCT01623115|1011360|P1|Overall Study|Site closure|1
299757|NCT01623115|1011359|P2|Overall Study|Last visit outside protocol visit window|26
299758|NCT01623115|1011360|P1|Overall Study|Last visit outside protocol visit window|14
299759|NCT01623115|1011359|P2|Overall Study|Related to study drug administration|2
299760|NCT01623115|1011360|P1|Overall Study|Related to study drug administration|0
299761|NCT01623115|1011359|P2|Overall Study|Consent withdrawn by participant|6
299762|NCT01623115|1011360|P1|Overall Study|Consent withdrawn by participant|2
299763|NCT01623115|1011359|P2|Overall Study|Poor compliance to protocol|10
299764|NCT01623115|1011360|P1|Overall Study|Poor compliance to protocol|4
299765|NCT01623115|1011359|P2|Overall Study|Adverse Event|13
299766|NCT01623115|1011360|P1|Overall Study|Adverse Event|10
299767|NCT01623115|1011359|P2|Overall Study|Participants moved|5
299768|NCT01623115|1011360|P1|Overall Study|Participants moved|1
299769|NCT01623115|1011359|P2|Overall Study|Physician Decision|0
299770|NCT01623115|1011360|P1|Overall Study|Physician Decision|1
299771|NCT01623115|1011359|P2|Overall Study|Randomized but not treated|1
299772|NCT01623115|1011360|P1|Overall Study|Randomized but not treated|0
299773|NCT01623050|1011420|P1|Overall Study|Lost to Follow-up|9
299774|NCT01622673|1011434|P6|Treatment Period 3|Protocol Violation|0
299775|NCT01622673|1011435|P5|Treatment Period 3|Protocol Violation|0
299776|NCT01622673|1011436|P4|Treatment Period 3|Protocol Violation|0
299777|NCT01622673|1011437|P3|Treatment Period 3|Protocol Violation|0
299778|NCT01622673|1011438|P2|Treatment Period 3|Protocol Violation|1
299779|NCT01622673|1011439|P1|Treatment Period 3|Protocol Violation|0
299780|NCT01622673|1011434|P6|Treatment Period 2|Withdrawal by Subject|0
299781|NCT01622673|1011435|P5|Treatment Period 2|Withdrawal by Subject|0
299782|NCT01622673|1011436|P4|Treatment Period 2|Withdrawal by Subject|1
299783|NCT01622673|1011437|P3|Treatment Period 2|Withdrawal by Subject|0
299784|NCT01622673|1011438|P2|Treatment Period 2|Withdrawal by Subject|0
299785|NCT01622673|1011439|P1|Treatment Period 2|Withdrawal by Subject|0
299786|NCT01622673|1011434|P6|Treatment Period 1|Protocol Violation|0
299787|NCT01622673|1011435|P5|Treatment Period 1|Protocol Violation|0
299788|NCT01622673|1011436|P4|Treatment Period 1|Protocol Violation|0
299789|NCT01622673|1011437|P3|Treatment Period 1|Protocol Violation|0
299790|NCT01622673|1011438|P2|Treatment Period 1|Protocol Violation|1
299791|NCT01622673|1011439|P1|Treatment Period 1|Protocol Violation|0
299792|NCT01622673|1011434|P6|Treatment Period 1|Withdrawal by Subject|0
299793|NCT01622673|1011435|P5|Treatment Period 1|Withdrawal by Subject|0
299794|NCT01622673|1011436|P4|Treatment Period 1|Withdrawal by Subject|1
299795|NCT01622673|1011437|P3|Treatment Period 1|Withdrawal by Subject|0
299796|NCT01622673|1011438|P2|Treatment Period 1|Withdrawal by Subject|0
299797|NCT01622673|1011439|P1|Treatment Period 1|Withdrawal by Subject|0
299798|NCT01622660|1011474|P1|Overall Study|Adverse Event|1
299799|NCT01622348|1011481|P3|Overall Study|Withdrawal by Subject|1
299800|NCT01622348|1011482|P2|Overall Study|Withdrawal by Subject|0
299801|NCT01622348|1011483|P1|Overall Study|Withdrawal by Subject|1
299802|NCT01622231|1011522|P1|Overall Study|Withdrawal by Subject|1
299803|NCT01622231|1011522|P1|Overall Study|Physician Decision|1
299804|NCT01621802|1011556|P6|Overall Study|Lost to Follow-up|11
299805|NCT01621802|1011557|P5|Overall Study|Lost to Follow-up|31
299806|NCT01621802|1011558|P4|Overall Study|Lost to Follow-up|7
299807|NCT01621802|1011559|P3|Overall Study|Lost to Follow-up|24
299808|NCT01621802|1011560|P2|Overall Study|Lost to Follow-up|16
299809|NCT01621802|1011561|P1|Overall Study|Lost to Follow-up|36
299810|NCT01621802|1011556|P6|Overall Study|Others|0
299811|NCT01621802|1011557|P5|Overall Study|Others|1
299812|NCT01621802|1011558|P4|Overall Study|Others|2
299813|NCT01621802|1011559|P3|Overall Study|Others|3
299814|NCT01621802|1011560|P2|Overall Study|Others|3
299815|NCT01621802|1011561|P1|Overall Study|Others|3
299816|NCT01621802|1011556|P6|Overall Study|Migrated/moved from study area|0
299817|NCT01621802|1011557|P5|Overall Study|Migrated/moved from study area|1
299818|NCT01621802|1011558|P4|Overall Study|Migrated/moved from study area|0
299819|NCT01621802|1011559|P3|Overall Study|Migrated/moved from study area|2
299820|NCT01621802|1011560|P2|Overall Study|Migrated/moved from study area|0
299821|NCT01621802|1011561|P1|Overall Study|Migrated/moved from study area|0
299822|NCT01621802|1011556|P6|Overall Study|Withdrawal by Subject|0
299823|NCT01621802|1011557|P5|Overall Study|Withdrawal by Subject|2
299824|NCT01621802|1011558|P4|Overall Study|Withdrawal by Subject|2
299825|NCT01621802|1011559|P3|Overall Study|Withdrawal by Subject|4
299826|NCT01621802|1011560|P2|Overall Study|Withdrawal by Subject|4
299827|NCT01621802|1011561|P1|Overall Study|Withdrawal by Subject|8
299828|NCT01621802|1011556|P6|Overall Study|Protocol Violation|1
299829|NCT01621802|1011557|P5|Overall Study|Protocol Violation|0
299830|NCT01621802|1011558|P4|Overall Study|Protocol Violation|0
299831|NCT01621802|1011559|P3|Overall Study|Protocol Violation|0
299832|NCT01621802|1011560|P2|Overall Study|Protocol Violation|0
299833|NCT01621802|1011561|P1|Overall Study|Protocol Violation|0
299834|NCT01621191|1011732|P1|Overall Study|Site Removed From Study|1
299835|NCT01621191|1011732|P1|Overall Study|Lost to Follow-up|1
299836|NCT01621191|1011732|P1|Overall Study|Lack of Efficacy|6
299837|NCT01621191|1011732|P1|Overall Study|Withdrawal by Subject|8
299838|NCT01621191|1011732|P1|Overall Study|Adverse Event|9
299839|NCT01621178|1011746|P3|Overall Study|Physician Decision|7
299840|NCT01621178|1011747|P2|Overall Study|Physician Decision|2
299841|NCT01621178|1011748|P1|Overall Study|Physician Decision|5
299842|NCT01621178|1011746|P3|Overall Study|Withdrawal by Subject|18
299843|NCT01621178|1011747|P2|Overall Study|Withdrawal by Subject|17
299844|NCT01621178|1011748|P1|Overall Study|Withdrawal by Subject|14
299845|NCT01621178|1011746|P3|Overall Study|Lost to Follow-up|1
299846|NCT01621178|1011747|P2|Overall Study|Lost to Follow-up|2
299847|NCT01621178|1011748|P1|Overall Study|Lost to Follow-up|1
299848|NCT01621178|1011746|P3|Overall Study|Death|2
299849|NCT01621178|1011747|P2|Overall Study|Death|7
299850|NCT01621178|1011748|P1|Overall Study|Death|6
299851|NCT01621178|1011746|P3|Overall Study|Adverse Event|8
299852|NCT01621178|1011747|P2|Overall Study|Adverse Event|2
299853|NCT01621178|1011748|P1|Overall Study|Adverse Event|5
299854|NCT01621126|1011840|P1|Overall Study|Physician Decision|6
299855|NCT01620762|1011862|P3|Overall Study|Use of prohibted therapies|1
299856|NCT01620762|1011863|P2|Overall Study|Use of prohibted therapies|1
299857|NCT01620762|1011864|P1|Overall Study|Use of prohibted therapies|0
299858|NCT01620762|1011862|P3|Overall Study|Non-specified|5
299859|NCT01620762|1011863|P2|Overall Study|Non-specified|6
299860|NCT01620762|1011864|P1|Overall Study|Non-specified|3
299861|NCT01620762|1011862|P3|Overall Study|Subject deterioration|1
299862|NCT01620762|1011863|P2|Overall Study|Subject deterioration|1
299863|NCT01620762|1011864|P1|Overall Study|Subject deterioration|0
299864|NCT01620762|1011862|P3|Overall Study|Protocol deviation|6
299865|NCT01620762|1011863|P2|Overall Study|Protocol deviation|1
299866|NCT01620762|1011864|P1|Overall Study|Protocol deviation|1
299867|NCT01620762|1011862|P3|Overall Study|Lost to Follow-up|10
299868|NCT01620762|1011863|P2|Overall Study|Lost to Follow-up|17
299869|NCT01620762|1011864|P1|Overall Study|Lost to Follow-up|11
299870|NCT01620762|1011862|P3|Overall Study|Withdrawal by Subject|27
299871|NCT01620762|1011863|P2|Overall Study|Withdrawal by Subject|26
299872|NCT01620762|1011864|P1|Overall Study|Withdrawal by Subject|23
299873|NCT01620762|1011862|P3|Overall Study|Adverse Event|2
299874|NCT01620762|1011863|P2|Overall Study|Adverse Event|5
299875|NCT01620762|1011864|P1|Overall Study|Adverse Event|9
299876|NCT01620762|1011862|P3|Overall Study|Protocol Violation|1
299877|NCT01620762|1011863|P2|Overall Study|Protocol Violation|1
299878|NCT01620762|1011864|P1|Overall Study|Protocol Violation|1
299879|NCT01620489|1011909|P2|Overall Study|Unclassified|2
299880|NCT01620489|1011910|P1|Overall Study|Unclassified|1
299881|NCT01620489|1011909|P2|Overall Study|Withdrawal Criteria|25
299882|NCT01620489|1011910|P1|Overall Study|Withdrawal Criteria|17
299883|NCT01620489|1011909|P2|Overall Study|Protocol Violation|3
299884|NCT01620489|1011910|P1|Overall Study|Protocol Violation|0
299885|NCT01620489|1011909|P2|Overall Study|Adverse Event|4
299886|NCT01620489|1011910|P1|Overall Study|Adverse Event|17
299887|NCT01620255|1011931|P5|Overall Study|Withdrawn at discretion of investigator|1
299888|NCT01620255|1011932|P4|Overall Study|Withdrawn at discretion of investigator|0
299889|NCT01620255|1011933|P3|Overall Study|Withdrawn at discretion of investigator|0
299890|NCT01620255|1011934|P2|Overall Study|Withdrawn at discretion of investigator|0
299891|NCT01620255|1011935|P1|Overall Study|Withdrawn at discretion of investigator|0
299892|NCT01620255|1011931|P5|Overall Study|Adverse Event|1
299893|NCT01620255|1011932|P4|Overall Study|Adverse Event|1
299894|NCT01620255|1011933|P3|Overall Study|Adverse Event|0
299895|NCT01620255|1011934|P2|Overall Study|Adverse Event|4
299896|NCT01620255|1011935|P1|Overall Study|Adverse Event|0
299897|NCT01620255|1011931|P5|Overall Study|Non-compliance|0
299898|NCT01620255|1011932|P4|Overall Study|Non-compliance|0
299899|NCT01620255|1011933|P3|Overall Study|Non-compliance|0
299900|NCT01620255|1011934|P2|Overall Study|Non-compliance|1
299901|NCT01620255|1011935|P1|Overall Study|Non-compliance|0
299902|NCT01620255|1011931|P5|Overall Study|Participant underwent fecal transplant|0
299903|NCT01620255|1011932|P4|Overall Study|Participant underwent fecal transplant|0
299904|NCT01620255|1011933|P3|Overall Study|Participant underwent fecal transplant|1
299905|NCT01620255|1011934|P2|Overall Study|Participant underwent fecal transplant|0
299906|NCT01620255|1011935|P1|Overall Study|Participant underwent fecal transplant|0
299907|NCT01620255|1011931|P5|Overall Study|Withdrawal by Subject|4
299908|NCT01620255|1011932|P4|Overall Study|Withdrawal by Subject|2
299909|NCT01620255|1011933|P3|Overall Study|Withdrawal by Subject|1
299910|NCT01620255|1011934|P2|Overall Study|Withdrawal by Subject|1
299911|NCT01620255|1011935|P1|Overall Study|Withdrawal by Subject|4
299912|NCT01620177|1012012|P1|Overall Study|Randomized, Not Active due to Scheduling|1
299913|NCT01620177|1012012|P1|Overall Study|Physician Decision|2
299914|NCT01620177|1012012|P1|Overall Study|Lost to Follow-up|7
299915|NCT01620177|1012012|P1|Overall Study|Withdrawal by Subject|26
299916|NCT01620177|1012012|P1|Overall Study|Failure at Screening Visit|43
299917|NCT01620138|1012037|P2|Overall Study|Adverse Event|0
299918|NCT01620138|1012038|P1|Overall Study|Adverse Event|2
299919|NCT01620138|1012037|P2|Overall Study|Lack of Efficacy|0
299920|NCT01620138|1012038|P1|Overall Study|Lack of Efficacy|1
299921|NCT01620138|1012037|P2|Overall Study|Withdrawal by Subject|0
299922|NCT01620138|1012038|P1|Overall Study|Withdrawal by Subject|3
299923|NCT01620086|1012046|P3|Overall Study|Physician Decision|0
299924|NCT01620086|1012047|P2|Overall Study|Physician Decision|0
299925|NCT01620086|1012048|P1|Overall Study|Physician Decision|1
299926|NCT01620086|1012046|P3|Overall Study|failed study criteria|0
299927|NCT01620086|1012047|P2|Overall Study|failed study criteria|4
299928|NCT01620086|1012048|P1|Overall Study|failed study criteria|1
299929|NCT01620086|1012046|P3|Overall Study|Withdrawal by Subject|0
299930|NCT01620086|1012047|P2|Overall Study|Withdrawal by Subject|3
299931|NCT01620086|1012048|P1|Overall Study|Withdrawal by Subject|3
299932|NCT01620060|1012067|P1|Overall Study|Per Sponsor Decision|2
299933|NCT01620060|1012067|P1|Overall Study|Family emergency|1
299934|NCT01620060|1012067|P1|Overall Study|Did not comply with Study Produre|1
299935|NCT01620060|1012067|P1|Overall Study|Withdrawal by Subject|1
299936|NCT01620060|1012067|P1|Overall Study|Protocol Violation|1
299937|NCT01620060|1012067|P1|Overall Study|Adverse Event|9
299938|NCT01619878|1012105|P1|Follow-up at 12 Months of Age|Death|2
299939|NCT01619878|1012105|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
299940|NCT01619878|1012105|P1|6 Week Follow-up Phase|Adverse Event|1
299941|NCT01619800|1012119|P2|Overall Study|study terminated|0
299942|NCT01619800|1012120|P1|Overall Study|study terminated|2
299943|NCT01619787|1012128|P1|Overall Study|Lost to Follow-up|5
299944|NCT01619579|1012145|P2|Overall Study|Withdrawal by Subject|3
299945|NCT01619579|1012146|P1|Overall Study|Withdrawal by Subject|0
299946|NCT01619059|1012158|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
299947|NCT01619059|1012159|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
299948|NCT01619059|1012158|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
299949|NCT01619059|1012159|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
299950|NCT01619059|1012158|P2|Long-Term (LT) Treatment Period|Death|0
299951|NCT01619059|1012159|P1|Long-Term (LT) Treatment Period|Death|1
299952|NCT01619059|1012158|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
299953|NCT01619059|1012159|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
299954|NCT01619059|1012158|P2|Long-Term (LT) Treatment Period|Adverse Event|3
299955|NCT01619059|1012159|P1|Long-Term (LT) Treatment Period|Adverse Event|2
299956|NCT01619059|1012158|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
299957|NCT01619059|1012159|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
299958|NCT01619059|1012158|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
299959|NCT01619059|1012159|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
299960|NCT01619059|1012158|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
299961|NCT01619059|1012159|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
299962|NCT01619059|1012158|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
299963|NCT01619059|1012159|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
299964|NCT01619059|1012158|P2|Short-Term (ST) Treatment Period|Adverse Event|0
299965|NCT01619059|1012159|P1|Short-Term (ST) Treatment Period|Adverse Event|1
299966|NCT01618968|1012175|P4|Overall Study|Death|1
299967|NCT01618968|1012176|P3|Overall Study|Death|0
299968|NCT01618968|1012177|P2|Overall Study|Death|0
299969|NCT01618968|1012178|P1|Overall Study|Death|0
299970|NCT01618968|1012175|P4|Overall Study|Adverse Event|0
299971|NCT01618968|1012176|P3|Overall Study|Adverse Event|0
299972|NCT01618968|1012177|P2|Overall Study|Adverse Event|0
299973|NCT01618968|1012178|P1|Overall Study|Adverse Event|1
299974|NCT01618864|1012245|P1|Overall Study|Lost to Follow-up|2
299975|NCT01618864|1012245|P1|Overall Study|Withdrawal by Subject|2
299976|NCT01618838|1012254|P1|Overall Study|slow accrual, trial closed prematurely.|4
299977|NCT01618708|1012260|P2|Overall Study|Randomized but not treated|2
299978|NCT01618708|1012261|P1|Overall Study|Randomized but not treated|3
299979|NCT01618708|1012260|P2|Overall Study|Other than specified above|1
299980|NCT01618708|1012261|P1|Overall Study|Other than specified above|1
299981|NCT01618708|1012260|P2|Overall Study|Technical problems|0
299982|NCT01618708|1012261|P1|Overall Study|Technical problems|2
299983|NCT01618708|1012260|P2|Overall Study|Lack of Efficacy|8
299984|NCT01618708|1012261|P1|Overall Study|Lack of Efficacy|8
299985|NCT01618708|1012260|P2|Overall Study|Withdrawal by Subject|22
299986|NCT01618708|1012261|P1|Overall Study|Withdrawal by Subject|17
299987|NCT01618708|1012260|P2|Overall Study|Lost to Follow-up|3
299988|NCT01618708|1012261|P1|Overall Study|Lost to Follow-up|3
299989|NCT01618708|1012260|P2|Overall Study|Adverse Event|10
299990|NCT01618708|1012261|P1|Overall Study|Adverse Event|10
299991|NCT01618669|1012275|P2|Overall Study|Miscellaneous Reason|1
299992|NCT01618669|1012276|P1|Overall Study|Miscellaneous Reason|0
299993|NCT01618669|1012275|P2|Overall Study|Withdrawal by Subject|9
299994|NCT01618669|1012276|P1|Overall Study|Withdrawal by Subject|9
299995|NCT01618669|1012275|P2|Overall Study|Protocol Violation|3
299996|NCT01618669|1012276|P1|Overall Study|Protocol Violation|5
299997|NCT01618669|1012275|P2|Overall Study|Adverse Event|7
299998|NCT01618669|1012276|P1|Overall Study|Adverse Event|16
299999|NCT01618669|1012275|P2|Overall Study|Randomized but Never Received Study Drug|2
300000|NCT01618669|1012276|P1|Overall Study|Randomized but Never Received Study Drug|3
300001|NCT01618669|1012275|P2|Overall Study|Lost to Follow-up|1
300002|NCT01618669|1012276|P1|Overall Study|Lost to Follow-up|1
300003|NCT01618266|1012333|P1|Overall Study|Protocol Violation|43
300004|NCT01618266|1012333|P1|Overall Study|Lack of Efficacy|23
300005|NCT01618266|1012333|P1|Overall Study|Other reasons|11
300006|NCT01618266|1012333|P1|Overall Study|Treatment satisfaction|10
300007|NCT01618266|1012333|P1|Overall Study|Lost to Follow-up|9
300008|NCT01618214|1012370|P2|Overall Study|Unclassified|5
300009|NCT01618214|1012371|P1|Overall Study|Unclassified|4
300010|NCT01618214|1012370|P2|Overall Study|Withdrawal Criteria|2
300011|NCT01618214|1012371|P1|Overall Study|Withdrawal Criteria|1
300012|NCT01618214|1012370|P2|Overall Study|Protocol Violation|4
300013|NCT01618214|1012371|P1|Overall Study|Protocol Violation|1
300014|NCT01618214|1012370|P2|Overall Study|Lack of Efficacy|1
300015|NCT01618214|1012371|P1|Overall Study|Lack of Efficacy|1
300016|NCT01618214|1012370|P2|Overall Study|Adverse Event|1
300017|NCT01618214|1012371|P1|Overall Study|Adverse Event|3
300018|NCT01618162|1012387|P2|Overall Study|Unclassified|13
300019|NCT01618162|1012388|P1|Overall Study|Unclassified|14
300020|NCT01618162|1012387|P2|Overall Study|Withdrawal Criteria|10
300021|NCT01618162|1012388|P1|Overall Study|Withdrawal Criteria|2
300022|NCT01618162|1012387|P2|Overall Study|Adverse Event|2
300023|NCT01618162|1012388|P1|Overall Study|Adverse Event|9
300024|NCT01618162|1012387|P2|Overall Study|Protocol Violation|10
300025|NCT01618162|1012388|P1|Overall Study|Protocol Violation|13
300026|NCT01618019|1012408|P2|Overall Study|Withdrawal by Subject|14
300027|NCT01618019|1012409|P1|Overall Study|Withdrawal by Subject|14
300028|NCT01617681|1012433|P5|Period 2 Open Label|Withdrawal by Subject|3
300029|NCT01617681|1012434|P4|Period 2 Open Label|Withdrawal by Subject|0
300030|NCT01617681|1012435|P3|Period 2 Open Label|Withdrawal by Subject|0
300031|NCT01617681|1012436|P2|Period 2 Open Label|Withdrawal by Subject|0
300032|NCT01617681|1012437|P1|Period 2 Open Label|Withdrawal by Subject|0
300033|NCT01617681|1012433|P5|Period 2 Open Label|Adverse Event|3
300034|NCT01617681|1012434|P4|Period 2 Open Label|Adverse Event|0
300035|NCT01617681|1012435|P3|Period 2 Open Label|Adverse Event|0
300036|NCT01617681|1012436|P2|Period 2 Open Label|Adverse Event|0
300037|NCT01617681|1012437|P1|Period 2 Open Label|Adverse Event|0
300038|NCT01617681|1012433|P5|Period 1 Double Blind|Withdrawal by Subject|0
300039|NCT01617681|1012434|P4|Period 1 Double Blind|Withdrawal by Subject|0
300040|NCT01617681|1012435|P3|Period 1 Double Blind|Withdrawal by Subject|1
300041|NCT01617681|1012436|P2|Period 1 Double Blind|Withdrawal by Subject|1
300042|NCT01617681|1012437|P1|Period 1 Double Blind|Withdrawal by Subject|1
300043|NCT01617681|1012433|P5|Period 1 Double Blind|Adverse Event|0
300044|NCT01617681|1012434|P4|Period 1 Double Blind|Adverse Event|2
300045|NCT01617681|1012435|P3|Period 1 Double Blind|Adverse Event|0
300046|NCT01617681|1012436|P2|Period 1 Double Blind|Adverse Event|0
300047|NCT01617681|1012437|P1|Period 1 Double Blind|Adverse Event|2
300048|NCT01617668|1012458|P4|Overall Study|Subject/guardian decision|1
300049|NCT01617668|1012459|P3|Overall Study|Subject/guardian decision|2
300050|NCT01617668|1012460|P2|Overall Study|Subject/guardian decision|3
300051|NCT01617668|1012461|P1|Overall Study|Subject/guardian decision|1
300052|NCT01617668|1012458|P4|Overall Study|Progressive Disease|9
300053|NCT01617668|1012459|P3|Overall Study|Progressive Disease|6
300054|NCT01617668|1012460|P2|Overall Study|Progressive Disease|4
300055|NCT01617668|1012461|P1|Overall Study|Progressive Disease|4
300056|NCT01617668|1012458|P4|Overall Study|Physician Decision|0
300057|NCT01617668|1012459|P3|Overall Study|Physician Decision|3
300058|NCT01617668|1012460|P2|Overall Study|Physician Decision|2
300059|NCT01617668|1012461|P1|Overall Study|Physician Decision|1
300060|NCT01617668|1012458|P4|Overall Study|Adverse Event|5
300061|NCT01617668|1012459|P3|Overall Study|Adverse Event|12
300062|NCT01617668|1012460|P2|Overall Study|Adverse Event|0
300063|NCT01617668|1012461|P1|Overall Study|Adverse Event|7
300064|NCT01617655|1012502|P2|Overall Study|Other than specified above|2
300065|NCT01617655|1012503|P1|Overall Study|Other than specified above|1
300066|NCT01617655|1012502|P2|Overall Study|Site closure|5
300067|NCT01617655|1012503|P1|Overall Study|Site closure|3
300068|NCT01617655|1012502|P2|Overall Study|Last visit outside protocol visit window|10
300069|NCT01617655|1012503|P1|Overall Study|Last visit outside protocol visit window|1
300070|NCT01617655|1012502|P2|Overall Study|Consent withdrawn by participant|1
300071|NCT01617655|1012503|P1|Overall Study|Consent withdrawn by participant|1
300072|NCT01617655|1012502|P2|Overall Study|Participants moved|4
300073|NCT01617655|1012503|P1|Overall Study|Participants moved|0
300074|NCT01617655|1012502|P2|Overall Study|Poor compliance to protocol|4
300075|NCT01617655|1012503|P1|Overall Study|Poor compliance to protocol|1
300076|NCT01617655|1012502|P2|Overall Study|Adverse Event|3
300077|NCT01617655|1012503|P1|Overall Study|Adverse Event|2
300078|NCT01617629|1012563|P1|Overall Study|Participant Withdrew Consent|2
300079|NCT01617629|1012563|P1|Overall Study|Reason Not Specified|1
300080|NCT01617629|1012563|P1|Overall Study|Investigator's Clinical Judgement|1
300081|NCT01617629|1012563|P1|Overall Study|Death|2
300082|NCT01617460|1012591|P1|Overall Study|Withdrawal by Subject|9
300083|NCT01617460|1012591|P1|Overall Study|Protocol Violation|5
300084|NCT01617460|1012591|P1|Overall Study|Physician Decision|16
300085|NCT01617460|1012591|P1|Overall Study|Adverse Event|10
300086|NCT01617447|1012597|P2|Overall Study|Physician Decision|2
300087|NCT01617447|1012598|P1|Overall Study|Physician Decision|0
300088|NCT01617447|1012597|P2|Overall Study|Adverse Event|1
300089|NCT01617447|1012598|P1|Overall Study|Adverse Event|0
300090|NCT01617434|1012606|P2|Overall Study|Unclassified|4
300091|NCT01617434|1012607|P1|Overall Study|Unclassified|3
300092|NCT01617434|1012606|P2|Overall Study|Withdrawal Criteria|37
300093|NCT01617434|1012607|P1|Overall Study|Withdrawal Criteria|12
300094|NCT01617434|1012606|P2|Overall Study|Protocol Violation|7
300095|NCT01617434|1012607|P1|Overall Study|Protocol Violation|8
300096|NCT01617434|1012606|P2|Overall Study|Adverse Event|3
300097|NCT01617434|1012607|P1|Overall Study|Adverse Event|12
300098|NCT01617187|1012639|P4|Treatment Through Study Completion|Protocol Violation|1
300099|NCT01617187|1012640|P3|Treatment Through Study Completion|Protocol Violation|0
300100|NCT01617187|1012641|P2|Treatment Through Study Completion|Protocol Violation|0
300101|NCT01617187|1012642|P1|Treatment Through Study Completion|Protocol Violation|1
300102|NCT01617187|1012639|P4|Treatment Through Study Completion|Withdrawal by Subject|6
300103|NCT01617187|1012640|P3|Treatment Through Study Completion|Withdrawal by Subject|3
300104|NCT01617187|1012641|P2|Treatment Through Study Completion|Withdrawal by Subject|8
300105|NCT01617187|1012642|P1|Treatment Through Study Completion|Withdrawal by Subject|5
300106|NCT01617187|1012639|P4|Treatment Through Study Completion|Lost to Follow-up|2
300107|NCT01617187|1012640|P3|Treatment Through Study Completion|Lost to Follow-up|2
300108|NCT01617187|1012641|P2|Treatment Through Study Completion|Lost to Follow-up|2
300109|NCT01617187|1012642|P1|Treatment Through Study Completion|Lost to Follow-up|4
300110|NCT01617187|1012639|P4|Treatment Through Study Completion|Adverse Event|1
300111|NCT01617187|1012640|P3|Treatment Through Study Completion|Adverse Event|0
300112|NCT01617187|1012641|P2|Treatment Through Study Completion|Adverse Event|1
300113|NCT01617187|1012642|P1|Treatment Through Study Completion|Adverse Event|1
300114|NCT01617187|1012639|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
300115|NCT01617187|1012640|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
300116|NCT01617187|1012641|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
300117|NCT01617187|1012642|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
300118|NCT01617187|1012639|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
300119|NCT01617187|1012640|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
300120|NCT01617187|1012641|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
300121|NCT01617187|1012642|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
300122|NCT01617187|1012639|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
300123|NCT01617187|1012640|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
300124|NCT01617187|1012641|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
300125|NCT01617187|1012642|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
300126|NCT01617070|1012728|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
300127|NCT01617005|1012746|P1|Overall Study|Lack of motivation for treatment|1
300128|NCT01617005|1012746|P1|Overall Study|Pregnancy|1
300129|NCT01616953|1012755|P2|Overall Study|lack of bone and soft tissue|0
300130|NCT01616953|1012756|P1|Overall Study|lack of bone and soft tissue|1
300131|NCT01616953|1012755|P2|Overall Study|Lost to Follow-up|0
300132|NCT01616953|1012756|P1|Overall Study|Lost to Follow-up|1
300133|NCT01616771|1012764|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
300134|NCT01616459|1012789|P4|Overall Study|Other reason|0
300135|NCT01616459|1012790|P3|Overall Study|Other reason|1
300136|NCT01616459|1012791|P2|Overall Study|Other reason|1
300137|NCT01616459|1012792|P1|Overall Study|Other reason|0
300138|NCT01616459|1012789|P4|Overall Study|Withdrawal by Subject|4
300139|NCT01616459|1012790|P3|Overall Study|Withdrawal by Subject|4
300140|NCT01616459|1012791|P2|Overall Study|Withdrawal by Subject|4
300141|NCT01616459|1012792|P1|Overall Study|Withdrawal by Subject|2
300142|NCT01616459|1012789|P4|Overall Study|Protocol Violation|2
300143|NCT01616459|1012790|P3|Overall Study|Protocol Violation|0
300144|NCT01616459|1012791|P2|Overall Study|Protocol Violation|0
300145|NCT01616459|1012792|P1|Overall Study|Protocol Violation|0
300146|NCT01616459|1012789|P4|Overall Study|Lost to Follow-up|2
300147|NCT01616459|1012790|P3|Overall Study|Lost to Follow-up|3
300148|NCT01616459|1012791|P2|Overall Study|Lost to Follow-up|11
300149|NCT01616459|1012792|P1|Overall Study|Lost to Follow-up|1
300150|NCT01616459|1012789|P4|Overall Study|Adverse Event|0
300151|NCT01616459|1012790|P3|Overall Study|Adverse Event|2
300152|NCT01616459|1012791|P2|Overall Study|Adverse Event|1
300153|NCT01616459|1012792|P1|Overall Study|Adverse Event|1
300154|NCT01616173|1012881|P3|Overall Study|Lost to Follow-up|0
300155|NCT01616173|1012882|P2|Overall Study|Lost to Follow-up|2
300156|NCT01616173|1012883|P1|Overall Study|Lost to Follow-up|0
300157|NCT01615939|1012916|P2|Overall Study|Lost to Follow-up|0
300158|NCT01615939|1012917|P1|Overall Study|Lost to Follow-up|5
300159|NCT01615822|1012930|P3|Period 2|Lost to Follow-up|2
300160|NCT01615822|1012931|P2|Period 2|Lost to Follow-up|1
300161|NCT01615822|1012932|P1|Period 2|Lost to Follow-up|0
300162|NCT01615822|1012930|P3|Period 1|Adverse Event|0
300163|NCT01615822|1012931|P2|Period 1|Adverse Event|1
300164|NCT01615822|1012932|P1|Period 1|Adverse Event|1
300165|NCT01615822|1012930|P3|Period 1|Withdrawal by Subject|0
300166|NCT01615822|1012931|P2|Period 1|Withdrawal by Subject|1
300167|NCT01615822|1012932|P1|Period 1|Withdrawal by Subject|0
300168|NCT01615328|1013020|P2|Overall Study|Lost to Follow-up|5
300169|NCT01615328|1013021|P1|Overall Study|Lost to Follow-up|3
300170|NCT01615263|1013033|P2|Overall Study|Post-randomization exclusion|2
300171|NCT01615263|1013034|P1|Overall Study|Post-randomization exclusion|0
300172|NCT01615198|1013048|P2|Overall Study|Adverse Event|5
300173|NCT01615198|1013049|P1|Overall Study|Adverse Event|11
300174|NCT01615198|1013048|P2|Overall Study|Lack of Efficacy|6
300175|NCT01615198|1013049|P1|Overall Study|Lack of Efficacy|1
300176|NCT01615198|1013048|P2|Overall Study|Lost to Follow-up|1
300177|NCT01615198|1013049|P1|Overall Study|Lost to Follow-up|1
300178|NCT01615198|1013048|P2|Overall Study|Physician Decision|1
300179|NCT01615198|1013049|P1|Overall Study|Physician Decision|5
300180|NCT01615198|1013048|P2|Overall Study|Protocol deviation|1
300181|NCT01615198|1013049|P1|Overall Study|Protocol deviation|1
300182|NCT01615198|1013048|P2|Overall Study|Withdrawal by Subject|5
300183|NCT01615198|1013049|P1|Overall Study|Withdrawal by Subject|5
300184|NCT01615029|1013082|P5|Overall Study|Ongoing|23
300185|NCT01615029|1013083|P4|Overall Study|Ongoing|2
300186|NCT01615029|1013084|P3|Overall Study|Ongoing|3
300187|NCT01615029|1013085|P2|Overall Study|Ongoing|2
300188|NCT01615029|1013086|P1|Overall Study|Ongoing|1
300189|NCT01615029|1013082|P5|Overall Study|Physician Decision|1
300190|NCT01615029|1013083|P4|Overall Study|Physician Decision|0
300191|NCT01615029|1013084|P3|Overall Study|Physician Decision|0
300192|NCT01615029|1013085|P2|Overall Study|Physician Decision|0
300193|NCT01615029|1013086|P1|Overall Study|Physician Decision|0
300194|NCT01615029|1013082|P5|Overall Study|Progressive disease|5
300195|NCT01615029|1013083|P4|Overall Study|Progressive disease|1
300196|NCT01615029|1013084|P3|Overall Study|Progressive disease|1
300197|NCT01615029|1013085|P2|Overall Study|Progressive disease|1
300198|NCT01615029|1013086|P1|Overall Study|Progressive disease|2
300199|NCT01615029|1013082|P5|Overall Study|Lost to Follow-up|1
300200|NCT01615029|1013083|P4|Overall Study|Lost to Follow-up|0
300201|NCT01615029|1013084|P3|Overall Study|Lost to Follow-up|0
300202|NCT01615029|1013085|P2|Overall Study|Lost to Follow-up|0
300203|NCT01615029|1013086|P1|Overall Study|Lost to Follow-up|0
300204|NCT01615029|1013082|P5|Overall Study|Death|1
300205|NCT01615029|1013083|P4|Overall Study|Death|0
300206|NCT01615029|1013084|P3|Overall Study|Death|0
300207|NCT01615029|1013085|P2|Overall Study|Death|0
300208|NCT01615029|1013086|P1|Overall Study|Death|0
300209|NCT01615029|1013082|P5|Overall Study|Adverse Event|1
300210|NCT01615029|1013083|P4|Overall Study|Adverse Event|0
300211|NCT01615029|1013084|P3|Overall Study|Adverse Event|0
300212|NCT01615029|1013085|P2|Overall Study|Adverse Event|0
300213|NCT01615029|1013086|P1|Overall Study|Adverse Event|0
300214|NCT01614886|1013109|P2|Overall Study|Protocol deviation|2
300215|NCT01614886|1013110|P1|Overall Study|Protocol deviation|0
300216|NCT01614886|1013109|P2|Overall Study|Death|0
300217|NCT01614886|1013110|P1|Overall Study|Death|1
300218|NCT01614886|1013109|P2|Overall Study|Withdrawal by Subject|4
300219|NCT01614886|1013110|P1|Overall Study|Withdrawal by Subject|4
300220|NCT01614886|1013109|P2|Overall Study|Adverse Event|20
300221|NCT01614886|1013110|P1|Overall Study|Adverse Event|15
300222|NCT01614795|1013128|P4|Overall Study|Ineligible|0
300223|NCT01614795|1013129|P3|Overall Study|Ineligible|0
300224|NCT01614795|1013130|P2|Overall Study|Ineligible|1
300225|NCT01614795|1013131|P1|Overall Study|Ineligible|0
300226|NCT01614795|1013128|P4|Overall Study|Withdrawal by Subject|2
300227|NCT01614795|1013129|P3|Overall Study|Withdrawal by Subject|0
300228|NCT01614795|1013130|P2|Overall Study|Withdrawal by Subject|1
300229|NCT01614795|1013131|P1|Overall Study|Withdrawal by Subject|0
300230|NCT01614795|1013128|P4|Overall Study|Physician Decision|1
300231|NCT01614795|1013129|P3|Overall Study|Physician Decision|1
300232|NCT01614795|1013130|P2|Overall Study|Physician Decision|0
300233|NCT01614795|1013131|P1|Overall Study|Physician Decision|1
300234|NCT01614795|1013128|P4|Overall Study|Lack of Efficacy|8
300235|NCT01614795|1013129|P3|Overall Study|Lack of Efficacy|9
300236|NCT01614795|1013130|P2|Overall Study|Lack of Efficacy|10
300237|NCT01614795|1013131|P1|Overall Study|Lack of Efficacy|10
300238|NCT01614795|1013128|P4|Overall Study|Adverse Event|1
300239|NCT01614795|1013129|P3|Overall Study|Adverse Event|1
300240|NCT01614795|1013130|P2|Overall Study|Adverse Event|0
300241|NCT01614795|1013131|P1|Overall Study|Adverse Event|0
300242|NCT01614769|1013141|P6|Period 3|Withdrawal by Subject|0
300243|NCT01614769|1013142|P5|Period 3|Withdrawal by Subject|0
300244|NCT01614769|1013143|P4|Period 3|Withdrawal by Subject|0
300245|NCT01614769|1013144|P3|Period 3|Withdrawal by Subject|1
300246|NCT01614769|1013145|P2|Period 3|Withdrawal by Subject|0
300247|NCT01614769|1013146|P1|Period 3|Withdrawal by Subject|0
300248|NCT01614769|1013141|P6|Period 1|Withdrawal by Subject|0
300249|NCT01614769|1013142|P5|Period 1|Withdrawal by Subject|0
300250|NCT01614769|1013143|P4|Period 1|Withdrawal by Subject|0
300251|NCT01614769|1013144|P3|Period 1|Withdrawal by Subject|0
300252|NCT01614769|1013145|P2|Period 1|Withdrawal by Subject|0
300253|NCT01614769|1013146|P1|Period 1|Withdrawal by Subject|1
300254|NCT01614769|1013141|P6|Period 1|Protocol Violation|0
300255|NCT01614769|1013142|P5|Period 1|Protocol Violation|0
300256|NCT01614769|1013143|P4|Period 1|Protocol Violation|1
300257|NCT01614769|1013144|P3|Period 1|Protocol Violation|0
300258|NCT01614769|1013145|P2|Period 1|Protocol Violation|0
300259|NCT01614769|1013146|P1|Period 1|Protocol Violation|0
300260|NCT01614769|1013141|P6|Period 1|Discontinued due to Hypoglycemia|1
300261|NCT01614769|1013142|P5|Period 1|Discontinued due to Hypoglycemia|0
300262|NCT01614769|1013143|P4|Period 1|Discontinued due to Hypoglycemia|1
300263|NCT01614769|1013144|P3|Period 1|Discontinued due to Hypoglycemia|0
300264|NCT01614769|1013145|P2|Period 1|Discontinued due to Hypoglycemia|0
300265|NCT01614769|1013146|P1|Period 1|Discontinued due to Hypoglycemia|0
300266|NCT01614600|1013168|P1|Overall Study|Protocol deviation|1
300267|NCT01614600|1013168|P1|Overall Study|Unable to remove lens at the end of day|1
300268|NCT01614600|1013168|P1|Overall Study|Discomfort|1
300269|NCT01614600|1013168|P1|Overall Study|Unacceptable fit|1
300270|NCT01614470|1013199|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
300271|NCT01614470|1013200|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
300272|NCT01614470|1013201|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
300273|NCT01614470|1013199|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
300274|NCT01614470|1013200|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
300275|NCT01614470|1013201|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
300276|NCT01614457|1013223|P2|Overall Study|Pregnancy (Self or Partner)|0
300277|NCT01614457|1013224|P1|Overall Study|Pregnancy (Self or Partner)|1
300278|NCT01614457|1013223|P2|Overall Study|Non-Compliance|0
300279|NCT01614457|1013224|P1|Overall Study|Non-Compliance|1
300280|NCT01614249|1013242|P2|Overall Study|Lost to Follow-up|23
300281|NCT01614249|1013243|P1|Overall Study|Lost to Follow-up|11
300282|NCT01614093|1013255|P1|Overall Study|Withdrawal by Subject|1
300283|NCT01613716|1013260|P1|Overall Study|Lost to Follow-up|4
300284|NCT01613716|1013260|P1|Overall Study|screen failures|3
300285|NCT01613599|1013265|P1|Overall Study|Ongoing|81
300286|NCT01613599|1013265|P1|Overall Study|Reason not specified|2
300287|NCT01613599|1013265|P1|Overall Study|Withdrawal by Subject|6
300288|NCT01613599|1013265|P1|Overall Study|Lost to Follow-up|2
300289|NCT01613599|1013265|P1|Overall Study|Death|6
300290|NCT01613417|1013280|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
300291|NCT01613417|1013281|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
300292|NCT01613378|1013318|P1|Overall Study|Other Reason|4
300293|NCT01613378|1013318|P1|Overall Study|Lost to Follow-up|1
300294|NCT01613378|1013318|P1|Overall Study|Death|2
300295|NCT01613378|1013318|P1|Overall Study|Withdrawal by Subject|8
300296|NCT01613378|1013318|P1|Overall Study|Adverse Event|11
300297|NCT01613378|1013318|P1|Overall Study|Lack of Efficacy|13
300298|NCT01613326|1013348|P2|Overall Study|Protocol Violation|1
300299|NCT01613326|1013349|P1|Overall Study|Protocol Violation|0
300300|NCT01613326|1013348|P2|Overall Study|Administrative|2
300301|NCT01613326|1013349|P1|Overall Study|Administrative|0
300302|NCT01613326|1013348|P2|Overall Study|Lost to Follow-up|1
300303|NCT01613326|1013349|P1|Overall Study|Lost to Follow-up|0
300304|NCT01613326|1013348|P2|Overall Study|Lack of Efficacy|1
300305|NCT01613326|1013349|P1|Overall Study|Lack of Efficacy|0
300306|NCT01613326|1013348|P2|Overall Study|inability to use device|0
300307|NCT01613326|1013349|P1|Overall Study|inability to use device|1
300308|NCT01613326|1013348|P2|Overall Study|Abnormal test procedure result(s)|0
300309|NCT01613326|1013349|P1|Overall Study|Abnormal test procedure result(s)|2
300310|NCT01613326|1013348|P2|Overall Study|Withdrawal by Subject|4
300311|NCT01613326|1013349|P1|Overall Study|Withdrawal by Subject|3
300312|NCT01613326|1013348|P2|Overall Study|Adverse Event|5
300313|NCT01613326|1013349|P1|Overall Study|Adverse Event|7
300314|NCT01613248|1013406|P6|Overall Study|Pregnancy|0
300315|NCT01613248|1013407|P5|Overall Study|Pregnancy|0
300316|NCT01613248|1013408|P4|Overall Study|Pregnancy|1
300317|NCT01613248|1013409|P3|Overall Study|Pregnancy|0
300318|NCT01613248|1013410|P2|Overall Study|Pregnancy|0
300319|NCT01613248|1013411|P1|Overall Study|Pregnancy|0
300320|NCT01613248|1013406|P6|Overall Study|Lack of Qualifying Event|18
300321|NCT01613248|1013407|P5|Overall Study|Lack of Qualifying Event|15
300322|NCT01613248|1013408|P4|Overall Study|Lack of Qualifying Event|11
300323|NCT01613248|1013409|P3|Overall Study|Lack of Qualifying Event|10
300324|NCT01613248|1013410|P2|Overall Study|Lack of Qualifying Event|11
300325|NCT01613248|1013411|P1|Overall Study|Lack of Qualifying Event|9
300326|NCT01613248|1013406|P6|Overall Study|Physician Decision|6
300327|NCT01613248|1013407|P5|Overall Study|Physician Decision|7
300328|NCT01613248|1013408|P4|Overall Study|Physician Decision|4
300329|NCT01613248|1013409|P3|Overall Study|Physician Decision|9
300330|NCT01613248|1013410|P2|Overall Study|Physician Decision|8
300331|NCT01613248|1013411|P1|Overall Study|Physician Decision|8
300332|NCT01613248|1013406|P6|Overall Study|Study Terminated by Sponsor|11
300333|NCT01613248|1013407|P5|Overall Study|Study Terminated by Sponsor|9
300334|NCT01613248|1013408|P4|Overall Study|Study Terminated by Sponsor|8
300335|NCT01613248|1013409|P3|Overall Study|Study Terminated by Sponsor|8
300336|NCT01613248|1013410|P2|Overall Study|Study Terminated by Sponsor|6
300337|NCT01613248|1013411|P1|Overall Study|Study Terminated by Sponsor|4
300338|NCT01613248|1013406|P6|Overall Study|Lost to Follow-up|2
300339|NCT01613248|1013407|P5|Overall Study|Lost to Follow-up|4
300340|NCT01613248|1013408|P4|Overall Study|Lost to Follow-up|8
300341|NCT01613248|1013409|P3|Overall Study|Lost to Follow-up|4
300342|NCT01613248|1013410|P2|Overall Study|Lost to Follow-up|7
300343|NCT01613248|1013411|P1|Overall Study|Lost to Follow-up|5
300344|NCT01613248|1013406|P6|Overall Study|Withdrawal by Subject|1
300345|NCT01613248|1013407|P5|Overall Study|Withdrawal by Subject|0
300346|NCT01613248|1013408|P4|Overall Study|Withdrawal by Subject|5
300347|NCT01613248|1013409|P3|Overall Study|Withdrawal by Subject|2
300348|NCT01613248|1013410|P2|Overall Study|Withdrawal by Subject|2
300349|NCT01613248|1013411|P1|Overall Study|Withdrawal by Subject|3
300350|NCT01613248|1013406|P6|Overall Study|Adverse Event|0
300351|NCT01613248|1013407|P5|Overall Study|Adverse Event|0
300352|NCT01613248|1013408|P4|Overall Study|Adverse Event|1
300353|NCT01613248|1013409|P3|Overall Study|Adverse Event|0
300354|NCT01613248|1013410|P2|Overall Study|Adverse Event|0
300355|NCT01613248|1013411|P1|Overall Study|Adverse Event|0
300356|NCT01613131|1013511|P2|Overall Study|Withdrawal by Subject|5
300357|NCT01613131|1013512|P1|Overall Study|Withdrawal by Subject|3
300358|NCT01613027|1013540|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
300359|NCT01613027|1013540|P1|Overall Study|Lack of Efficacy|1
300360|NCT01613027|1013540|P1|Overall Study|Switched Physician|1
300361|NCT01613027|1013540|P1|Overall Study|Lost to Follow-up|5
300362|NCT01612858|1013583|P2|Overall Study|Withdrawal by Subject|1
300363|NCT01612858|1013584|P1|Overall Study|Withdrawal by Subject|5
300364|NCT01612702|1013621|P2|Overall Study|Protocol Violation|11
300365|NCT01612702|1013622|P1|Overall Study|Protocol Violation|11
300366|NCT01612676|1013636|P4|Overall Study|Protocol Violation|0
300367|NCT01612676|1013637|P3|Overall Study|Protocol Violation|0
300368|NCT01612676|1013638|P2|Overall Study|Protocol Violation|1
300369|NCT01612676|1013639|P1|Overall Study|Protocol Violation|0
300370|NCT01612676|1013636|P4|Overall Study|Adverse Event|3
300371|NCT01612676|1013637|P3|Overall Study|Adverse Event|1
300372|NCT01612676|1013638|P2|Overall Study|Adverse Event|3
300373|NCT01612676|1013639|P1|Overall Study|Adverse Event|2
300374|NCT01612156|1013737|P2|Overall Study|Protocol Violation|0
300375|NCT01612156|1013738|P1|Overall Study|Protocol Violation|2
300376|NCT01612000|1013750|P4|Overall Study|Withdrawal by Subject|2
300377|NCT01612000|1013751|P3|Overall Study|Withdrawal by Subject|2
300378|NCT01612000|1013752|P2|Overall Study|Withdrawal by Subject|1
300379|NCT01612000|1013753|P1|Overall Study|Withdrawal by Subject|3
300380|NCT01612000|1013750|P4|Overall Study|Physician Decision|0
300381|NCT01612000|1013751|P3|Overall Study|Physician Decision|1
300382|NCT01612000|1013752|P2|Overall Study|Physician Decision|0
300383|NCT01612000|1013753|P1|Overall Study|Physician Decision|0
300384|NCT01612000|1013750|P4|Overall Study|Lost to Follow-up|8
300385|NCT01612000|1013751|P3|Overall Study|Lost to Follow-up|4
300386|NCT01612000|1013752|P2|Overall Study|Lost to Follow-up|4
300387|NCT01612000|1013753|P1|Overall Study|Lost to Follow-up|6
300388|NCT01611974|1013778|P3|Overall Study|Withdrawal by Subject|4
300389|NCT01611974|1013779|P2|Overall Study|Withdrawal by Subject|1
300390|NCT01611974|1013780|P1|Overall Study|Withdrawal by Subject|0
300391|NCT01611974|1013778|P3|Overall Study|Physician Decision|2
300392|NCT01611974|1013779|P2|Overall Study|Physician Decision|1
300393|NCT01611974|1013780|P1|Overall Study|Physician Decision|5
300394|NCT01611974|1013778|P3|Overall Study|Lost to Follow-up|0
300395|NCT01611974|1013779|P2|Overall Study|Lost to Follow-up|1
300396|NCT01611974|1013780|P1|Overall Study|Lost to Follow-up|0
300397|NCT01611974|1013778|P3|Overall Study|Death|10
300398|NCT01611974|1013779|P2|Overall Study|Death|12
300399|NCT01611974|1013780|P1|Overall Study|Death|10
300400|NCT01611883|1013826|P2|Overall Study|Adverse Event|1
300401|NCT01611883|1013827|P1|Overall Study|Adverse Event|1
300402|NCT01611857|1013853|P2|Overall Study|Withdrawal by Subject|2
300403|NCT01611857|1013854|P1|Overall Study|Withdrawal by Subject|0
300404|NCT01611792|1013866|P2|Followup: at 6 Months|Lost to Follow-up|13
300405|NCT01611792|1013867|P1|Followup: at 6 Months|Lost to Follow-up|6
300406|NCT01611792|1013866|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
300407|NCT01611792|1013867|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
300408|NCT01611558|1013921|P1|Maintenance Phase|Study drug toxicity|1
300409|NCT01611558|1013921|P1|Maintenance Phase|Withdrawal by Subject|1
300410|NCT01611558|1013921|P1|Induction Phase|Death|1
300411|NCT01611558|1013921|P1|Induction Phase|Adverse event unrelated to study drug|1
300412|NCT01611558|1013921|P1|Induction Phase|Not reported|5
300413|NCT01611558|1013921|P1|Induction Phase|Disease progression|14
300414|NCT01611558|1013921|P1|Induction Phase|Study drug toxicity|17
300415|NCT01611259|1013927|P1|Overall Study|Withdrawal by Subject|7
300416|NCT01611259|1013927|P1|Overall Study|Adverse Event|4
300417|NCT01611259|1013927|P1|Overall Study|Lack of Efficacy|2
300418|NCT01611259|1013927|P1|Overall Study|Physician Decision|1
300419|NCT01610791|1013931|P1|Overall Study|Not determined|5
300420|NCT01610791|1013931|P1|Overall Study|Death|1
300421|NCT01610791|1013931|P1|Overall Study|Adverse event and Investigator decision|1
300422|NCT01610791|1013931|P1|Overall Study|Physician Decision|1
300423|NCT01610791|1013931|P1|Overall Study|Adverse Event|6
300424|NCT01610791|1013931|P1|Overall Study|Lost to Follow-up|7
300425|NCT01610713|1013954|P2|Overall Study|Lost to Follow-up|1
300426|NCT01610713|1013955|P1|Overall Study|Lost to Follow-up|0
300427|NCT01610713|1013954|P2|Overall Study|adv. to use original dose/amitriptyline|0
300428|NCT01610713|1013955|P1|Overall Study|adv. to use original dose/amitriptyline|1
300429|NCT01610713|1013954|P2|Overall Study|low mood and poor motivation|0
300430|NCT01610713|1013955|P1|Overall Study|low mood and poor motivation|1
300431|NCT01610713|1013954|P2|Overall Study|Lack of Efficacy|0
300432|NCT01610713|1013955|P1|Overall Study|Lack of Efficacy|1
300433|NCT01610713|1013954|P2|Overall Study|Adverse Event|0
300434|NCT01610713|1013955|P1|Overall Study|Adverse Event|3
300435|NCT01610700|1014013|P2|Overall Study|subject took one dose of street cannabis|1
300436|NCT01610700|1014014|P1|Overall Study|subject took one dose of street cannabis|0
300437|NCT01610700|1014013|P2|Overall Study|Withdrawal by Subject|1
300438|NCT01610700|1014014|P1|Overall Study|Withdrawal by Subject|0
300439|NCT01610700|1014013|P2|Overall Study|Adverse Event|1
300440|NCT01610700|1014014|P1|Overall Study|Adverse Event|3
300441|NCT01610687|1014068|P1|Overall Study|Felt more alter without study medication|1
300442|NCT01610687|1014068|P1|Overall Study|Cannabis affecting job|1
300443|NCT01610687|1014068|P1|Overall Study|Death|1
300444|NCT01610687|1014068|P1|Overall Study|Unable to make journey|1
300445|NCT01610687|1014068|P1|Overall Study|Symptom control without study medication|2
300446|NCT01610687|1014068|P1|Overall Study|Lost to Follow-up|4
300447|NCT01610687|1014068|P1|Overall Study|Withdrawal by Subject|7
300448|NCT01610687|1014068|P1|Overall Study|Moved out of area|6
300449|NCT01610687|1014068|P1|Overall Study|Adverse Event|18
300450|NCT01610687|1014068|P1|Overall Study|Lack of Efficacy|26
300451|NCT01610596|1014081|P2|Overall Study|Lost to Follow-up|1
300452|NCT01610596|1014082|P1|Overall Study|Lost to Follow-up|0
300453|NCT01610557|1014140|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
300454|NCT01610557|1014141|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
300455|NCT01610557|1014142|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
300456|NCT01610557|1014143|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
300457|NCT01610557|1014144|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
300458|NCT01610557|1014140|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
300459|NCT01610557|1014141|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
300460|NCT01610557|1014142|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
300461|NCT01610557|1014143|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
300462|NCT01610557|1014144|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
300463|NCT01610492|1014157|P1|Overall Study|Other:Treatment stopped due to remission|1
300464|NCT01610492|1014157|P1|Overall Study|Other: Reached stopping criteria|1
300465|NCT01610492|1014157|P1|Overall Study|Lack of Efficacy|3
300466|NCT01610492|1014157|P1|Overall Study|Adverse Event|1
300467|NCT01610414|1014208|P2|After Month 25|Study end not reached|53
300468|NCT01610414|1014209|P1|After Month 25|Study end not reached|48
300469|NCT01610414|1014208|P2|Month 13 - Month 25|Other reasons for withdrawal|7
300470|NCT01610414|1014209|P1|Month 13 - Month 25|Other reasons for withdrawal|6
300471|NCT01610414|1014208|P2|Month 13 - Month 25|Lost to Follow-up|9
300472|NCT01610414|1014209|P1|Month 13 - Month 25|Lost to Follow-up|5
300473|NCT01610414|1014208|P2|Month 13 - Month 25|Protocol Violation|2
300474|NCT01610414|1014209|P1|Month 13 - Month 25|Protocol Violation|0
300475|NCT01610414|1014208|P2|Month 13 - Month 25|Migrated/moved from study area|2
300476|NCT01610414|1014209|P1|Month 13 - Month 25|Migrated/moved from study area|4
300477|NCT01610414|1014208|P2|Month 13 - Month 25|Withdrawal by Subject|8
300478|NCT01610414|1014209|P1|Month 13 - Month 25|Withdrawal by Subject|7
300479|NCT01610414|1014208|P2|Month 13 - Month 25|Adverse Event|4
300480|NCT01610414|1014209|P1|Month 13 - Month 25|Adverse Event|8
300481|NCT01610414|1014208|P2|Month 13 - Month 25|Serious Adverse Event|38
300482|NCT01610414|1014209|P1|Month 13 - Month 25|Serious Adverse Event|35
300483|NCT01610414|1014208|P2|Study Start - Month 13|Other reasons for withdrawal|4
300484|NCT01610414|1014209|P1|Study Start - Month 13|Other reasons for withdrawal|3
300485|NCT01610414|1014208|P2|Study Start - Month 13|Suspected HZ episode|3
300486|NCT01610414|1014209|P1|Study Start - Month 13|Suspected HZ episode|1
300487|NCT01610414|1014208|P2|Study Start - Month 13|Lost to Follow-up|6
300488|NCT01610414|1014209|P1|Study Start - Month 13|Lost to Follow-up|4
300489|NCT01610414|1014208|P2|Study Start - Month 13|Migrated/moved from study area|4
300490|NCT01610414|1014209|P1|Study Start - Month 13|Migrated/moved from study area|2
300491|NCT01610414|1014208|P2|Study Start - Month 13|Withdrawal by Subject|30
300492|NCT01610414|1014209|P1|Study Start - Month 13|Withdrawal by Subject|23
300493|NCT01610414|1014208|P2|Study Start - Month 13|Protocol Violation|1
300494|NCT01610414|1014209|P1|Study Start - Month 13|Protocol Violation|3
300495|NCT01610414|1014208|P2|Study Start - Month 13|Adverse Event|14
300496|NCT01610414|1014209|P1|Study Start - Month 13|Adverse Event|14
300497|NCT01610414|1014208|P2|Study Start - Month 13|Serious Adverse Event|67
300498|NCT01610414|1014209|P1|Study Start - Month 13|Serious Adverse Event|65
300499|NCT01610297|1014238|P1|Overall Study|Lost to Follow-up|1
300500|NCT01610167|1014249|P3|Overall Study|Scheduling conflict.|2
300501|NCT01610167|1014250|P2|Overall Study|Scheduling conflict.|0
300502|NCT01610167|1014251|P1|Overall Study|Scheduling conflict.|0
300503|NCT01610076|1014288|P2|Overall Study|Lost to Follow-up|4
300504|NCT01610076|1014289|P1|Overall Study|Lost to Follow-up|3
300505|NCT01610076|1014288|P2|Overall Study|Technical issue with video|1
300506|NCT01610076|1014289|P1|Overall Study|Technical issue with video|0
300507|NCT01610063|1014300|P2|Overall Study|Lost to Follow-up|20
300508|NCT01610063|1014301|P1|Overall Study|Lost to Follow-up|42
300509|NCT01610037|1014324|P3|Treatment and Follow up Period|Lost to Follow-up|4
300510|NCT01610037|1014325|P2|Treatment and Follow up Period|Lost to Follow-up|6
300511|NCT01610037|1014326|P1|Treatment and Follow up Period|Lost to Follow-up|1
300512|NCT01610037|1014324|P3|Treatment and Follow up Period|Administrative problems|2
300513|NCT01610037|1014325|P2|Treatment and Follow up Period|Administrative problems|3
300514|NCT01610037|1014326|P1|Treatment and Follow up Period|Administrative problems|1
300515|NCT01610037|1014324|P3|Treatment and Follow up Period|Death|4
300516|NCT01610037|1014325|P2|Treatment and Follow up Period|Death|5
300517|NCT01610037|1014326|P1|Treatment and Follow up Period|Death|10
300518|NCT01610037|1014324|P3|Treatment and Follow up Period|Subject withdrew consent|16
300519|NCT01610037|1014325|P2|Treatment and Follow up Period|Subject withdrew consent|14
300520|NCT01610037|1014326|P1|Treatment and Follow up Period|Subject withdrew consent|13
300521|NCT01610037|1014324|P3|All Patients|Abnormal test procedure result(s)|3
300522|NCT01610037|1014325|P2|All Patients|Abnormal test procedure result(s)|1
300523|NCT01610037|1014326|P1|All Patients|Abnormal test procedure result(s)|0
300524|NCT01610037|1014324|P3|All Patients|Lost to Follow-up|0
300525|NCT01610037|1014325|P2|All Patients|Lost to Follow-up|0
300526|NCT01610037|1014326|P1|All Patients|Lost to Follow-up|1
300527|NCT01610037|1014324|P3|All Patients|Administrative problems|4
300528|NCT01610037|1014325|P2|All Patients|Administrative problems|4
300529|NCT01610037|1014326|P1|All Patients|Administrative problems|1
300530|NCT01610037|1014324|P3|All Patients|Abnormal laboratory value|0
300531|NCT01610037|1014325|P2|All Patients|Abnormal laboratory value|1
300532|NCT01610037|1014326|P1|All Patients|Abnormal laboratory value|1
300533|NCT01610037|1014324|P3|All Patients|Protocol deviation|3
300534|NCT01610037|1014325|P2|All Patients|Protocol deviation|3
300535|NCT01610037|1014326|P1|All Patients|Protocol deviation|4
300536|NCT01610037|1014324|P3|All Patients|Death|1
300537|NCT01610037|1014325|P2|All Patients|Death|2
300538|NCT01610037|1014326|P1|All Patients|Death|4
300539|NCT01610037|1014324|P3|All Patients|Unsatisfactory therapeutic effect|27
300540|NCT01610037|1014325|P2|All Patients|Unsatisfactory therapeutic effect|8
300541|NCT01610037|1014326|P1|All Patients|Unsatisfactory therapeutic effect|9
300542|NCT01610037|1014324|P3|All Patients|Withdrawal by Subject|20
300543|NCT01610037|1014325|P2|All Patients|Withdrawal by Subject|10
300544|NCT01610037|1014326|P1|All Patients|Withdrawal by Subject|12
300545|NCT01610037|1014324|P3|All Patients|Adverse Event|26
300546|NCT01610037|1014325|P2|All Patients|Adverse Event|22
300547|NCT01610037|1014326|P1|All Patients|Adverse Event|27
300548|NCT01609933|1014376|P1|Overall Study|Withdrawal by Subject|3
300549|NCT01609933|1014376|P1|Overall Study|Adverse Event|1
300550|NCT01609790|1014386|P3|Overall Study|Protocol Violation|8
300551|NCT01609790|1014387|P2|Overall Study|Protocol Violation|7
300552|NCT01609790|1014388|P1|Overall Study|Protocol Violation|1
300553|NCT01609582|1014407|P2|Overall Study|Randomized, but not treated|3
300554|NCT01609582|1014408|P1|Overall Study|Randomized, but not treated|0
300555|NCT01609582|1014407|P2|Overall Study|Other|10
300556|NCT01609582|1014408|P1|Overall Study|Other|9
300557|NCT01609582|1014407|P2|Overall Study|Study Terminated by Sponsor|1548
300558|NCT01609582|1014408|P1|Overall Study|Study Terminated by Sponsor|1543
300559|NCT01609582|1014407|P2|Overall Study|Withdrawal by Subject|15
300560|NCT01609582|1014408|P1|Overall Study|Withdrawal by Subject|21
300561|NCT01609582|1014407|P2|Overall Study|Lost to Follow-up|10
300562|NCT01609582|1014408|P1|Overall Study|Lost to Follow-up|10
300563|NCT01609582|1014407|P2|Overall Study|Adverse Event|18
300564|NCT01609582|1014408|P1|Overall Study|Adverse Event|20
300565|NCT01609543|1014416|P1|Overall Study|Death|7
300566|NCT01609543|1014416|P1|Overall Study|Protocol Violation|1
300567|NCT01609543|1014416|P1|Overall Study|Withdrawal by Subject|1
300568|NCT01609543|1014416|P1|Overall Study|Adverse Event|5
300569|NCT01609543|1014416|P1|Overall Study|Disease Progression|28
300570|NCT01609478|1014425|P3|Overall Study|Withdrawal by Subject|2
300571|NCT01609478|1014426|P2|Overall Study|Withdrawal by Subject|0
300572|NCT01609478|1014427|P1|Overall Study|Withdrawal by Subject|2
300573|NCT01609478|1014425|P3|Overall Study|Physician Decision|1
300574|NCT01609478|1014426|P2|Overall Study|Physician Decision|0
300575|NCT01609478|1014427|P1|Overall Study|Physician Decision|1
300576|NCT01609478|1014425|P3|Overall Study|Non-Compliance with study treatment|0
300577|NCT01609478|1014426|P2|Overall Study|Non-Compliance with study treatment|0
300578|NCT01609478|1014427|P1|Overall Study|Non-Compliance with study treatment|1
300579|NCT01609478|1014425|P3|Overall Study|Protocol Deviation|1
300580|NCT01609478|1014426|P2|Overall Study|Protocol Deviation|1
300581|NCT01609478|1014427|P1|Overall Study|Protocol Deviation|0
300582|NCT01609478|1014425|P3|Overall Study|Adverse Event|5
300583|NCT01609478|1014426|P2|Overall Study|Adverse Event|1
300584|NCT01609478|1014427|P1|Overall Study|Adverse Event|3
300585|NCT01609257|1014502|P2|Overall Study|Non-compliance/Protocol deviation|6
300586|NCT01609257|1014503|P1|Overall Study|Non-compliance/Protocol deviation|4
300587|NCT01609257|1014502|P2|Overall Study|Voluntary Withdrawal by Subject|1
300588|NCT01609257|1014503|P1|Overall Study|Voluntary Withdrawal by Subject|0
300589|NCT01609257|1014502|P2|Overall Study|Lost to Follow-up|1
300590|NCT01609257|1014503|P1|Overall Study|Lost to Follow-up|2
300591|NCT01609062|1014575|P2|Extension Phase|Anticipated surgery & transition to EAP|1
300592|NCT01609062|1014576|P1|Extension Phase|Anticipated surgery & transition to EAP|0
300593|NCT01609062|1014575|P2|Extension Phase|Discontinued drug and then was pregnant|0
300594|NCT01609062|1014576|P1|Extension Phase|Discontinued drug and then was pregnant|1
300595|NCT01609062|1014575|P2|Extension Phase|Terminated by Sponsor|9
300596|NCT01609062|1014576|P1|Extension Phase|Terminated by Sponsor|14
300597|NCT01609023|1014619|P1|Overall Study|Personal reasons|1
300598|NCT01609023|1014619|P1|Overall Study|Death|2
300599|NCT01609023|1014619|P1|Overall Study|Physician Decision|2
300600|NCT01609023|1014619|P1|Overall Study|Disease progression|10
300601|NCT01609023|1014619|P1|Overall Study|Toxicity|3
300602|NCT01609023|1014619|P1|Overall Study|Lost to Follow-up|8
300603|NCT01609023|1014619|P1|Overall Study|Withdrawal by Subject|4
300604|NCT01609023|1014619|P1|Overall Study|Lack of Efficacy|3
300605|NCT01609010|1014631|P2|Overall Study|Lost to Follow-up|1
300606|NCT01609010|1014632|P1|Overall Study|Lost to Follow-up|1
300607|NCT01609010|1014631|P2|Overall Study|New cancer|0
300608|NCT01609010|1014632|P1|Overall Study|New cancer|1
300609|NCT01609010|1014631|P2|Overall Study|Protocol Violation|1
300610|NCT01609010|1014632|P1|Overall Study|Protocol Violation|1
300611|NCT01609010|1014631|P2|Overall Study|Pathology review|1
300612|NCT01609010|1014632|P1|Overall Study|Pathology review|2
300613|NCT01609010|1014631|P2|Overall Study|Other malignancy|0
300614|NCT01609010|1014632|P1|Overall Study|Other malignancy|1
300615|NCT01609010|1014631|P2|Overall Study|Not specified|0
300616|NCT01609010|1014632|P1|Overall Study|Not specified|2
300617|NCT01609010|1014631|P2|Overall Study|Withdrawal by Subject|2
300618|NCT01609010|1014632|P1|Overall Study|Withdrawal by Subject|2
300619|NCT01609010|1014631|P2|Overall Study|Adverse Event|6
300620|NCT01609010|1014632|P1|Overall Study|Adverse Event|3
300621|NCT01609010|1014631|P2|Overall Study|Progressive disease (PD)|10
300622|NCT01609010|1014632|P1|Overall Study|Progressive disease (PD)|8
300623|NCT01609010|1014631|P2|Overall Study|Stable disease (SD)|16
300624|NCT01609010|1014632|P1|Overall Study|Stable disease (SD)|22
300625|NCT01608724|1014693|P1|Overall Study|Safety reasons|1
300626|NCT01608724|1014693|P1|Overall Study|bood sugar too high, etc.|3
300627|NCT01608724|1014693|P1|Overall Study|Protocol Violation|6
300628|NCT01608724|1014693|P1|Overall Study|Adverse Event|29
300629|NCT01608724|1014693|P1|Overall Study|Study-specific discontinuation criteria|32
300630|NCT01608724|1014693|P1|Overall Study|Lost to Follow-up|41
300631|NCT01608724|1014693|P1|Overall Study|Withdrawal by Subject|131
300632|NCT01608321|1014725|P2|Overall Study|Withdrawal by Subject|0
300633|NCT01608321|1014726|P1|Overall Study|Withdrawal by Subject|1
300634|NCT01608308|1014734|P2|Overall Study|pretreatment medical and billing reasons|2
300635|NCT01608308|1014735|P1|Overall Study|pretreatment medical and billing reasons|0
300636|NCT01607593|1014935|P1|Overall Study|Other|4
300637|NCT01607593|1014935|P1|Overall Study|Continuation|33
300638|NCT01607593|1014935|P1|Overall Study|Lost to Follow-up|25
300639|NCT01607593|1014935|P1|Overall Study|Lack of Efficacy|16
300640|NCT01607593|1014935|P1|Overall Study|Adverse Event|15
300641|NCT01607554|1014941|P1|Overall Study|Disease progression|2
300642|NCT01607476|1014954|P3|Overall Study|Lost to Follow-up|2
300643|NCT01607476|1014955|P2|Overall Study|Lost to Follow-up|0
300644|NCT01607476|1014956|P1|Overall Study|Lost to Follow-up|0
300645|NCT01607476|1014954|P3|Overall Study|Withdrawal by Subject|1
300646|NCT01607476|1014955|P2|Overall Study|Withdrawal by Subject|0
300647|NCT01607476|1014956|P1|Overall Study|Withdrawal by Subject|1
300648|NCT01607398|1015050|P2|Overall Study|Severe COPD|0
300649|NCT01607398|1015051|P1|Overall Study|Severe COPD|2
300650|NCT01607398|1015050|P2|Overall Study|Adverse Event|2
300651|NCT01607398|1015051|P1|Overall Study|Adverse Event|0
300652|NCT01607346|1015095|P1|Overall Study|Adverse Event|3
300653|NCT01606800|1015179|P2|Overall Study|Missing completion status|0
300654|NCT01606800|1015180|P1|Overall Study|Missing completion status|2
300655|NCT01606800|1015179|P2|Overall Study|Participant withdrew consent|1
300656|NCT01606800|1015180|P1|Overall Study|Participant withdrew consent|0
300657|NCT01606800|1015179|P2|Overall Study|Adverse Event|1
300658|NCT01606800|1015180|P1|Overall Study|Adverse Event|3
300659|NCT01606787|1015188|P2|Overall Study|Surgery canceled|2
300660|NCT01606787|1015189|P1|Overall Study|Surgery canceled|0
300661|NCT01606787|1015188|P2|Overall Study|Withdrawal by Subject|5
300662|NCT01606787|1015189|P1|Overall Study|Withdrawal by Subject|4
300663|NCT01606761|1015200|P5|Safety Follow-up Period (Week 52-68)|Other|3
300664|NCT01606761|1015201|P4|Safety Follow-up Period (Week 52-68)|Other|1
300665|NCT01606761|1015202|P3|Safety Follow-up Period (Week 52-68)|Other|9
300666|NCT01606761|1015203|P2|Safety Follow-up Period (Week 52-68)|Other|3
300667|NCT01606761|1015204|P1|Safety Follow-up Period (Week 52-68)|Other|0
300668|NCT01606761|1015200|P5|Safety Follow-up Period (Week 52-68)|Death|1
300669|NCT01606761|1015201|P4|Safety Follow-up Period (Week 52-68)|Death|0
300670|NCT01606761|1015202|P3|Safety Follow-up Period (Week 52-68)|Death|0
300671|NCT01606761|1015203|P2|Safety Follow-up Period (Week 52-68)|Death|0
300672|NCT01606761|1015204|P1|Safety Follow-up Period (Week 52-68)|Death|0
300673|NCT01606761|1015200|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
300674|NCT01606761|1015201|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
300675|NCT01606761|1015202|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
300676|NCT01606761|1015203|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
300677|NCT01606761|1015204|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
300678|NCT01606761|1015200|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
300679|NCT01606761|1015201|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
300680|NCT01606761|1015202|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
300681|NCT01606761|1015203|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
300682|NCT01606761|1015204|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
300683|NCT01606761|1015200|P5|Week 24 to Week 52|Other|2
300684|NCT01606761|1015201|P4|Week 24 to Week 52|Other|2
300685|NCT01606761|1015202|P3|Week 24 to Week 52|Other|5
300686|NCT01606761|1015203|P2|Week 24 to Week 52|Other|1
300687|NCT01606761|1015204|P1|Week 24 to Week 52|Other|0
300688|NCT01606761|1015200|P5|Week 24 to Week 52|Physician Decision|0
300689|NCT01606761|1015201|P4|Week 24 to Week 52|Physician Decision|0
300690|NCT01606761|1015202|P3|Week 24 to Week 52|Physician Decision|1
300691|NCT01606761|1015203|P2|Week 24 to Week 52|Physician Decision|1
300692|NCT01606761|1015204|P1|Week 24 to Week 52|Physician Decision|0
300693|NCT01606761|1015200|P5|Week 24 to Week 52|Lack of Efficacy|3
300694|NCT01606761|1015201|P4|Week 24 to Week 52|Lack of Efficacy|10
300695|NCT01606761|1015202|P3|Week 24 to Week 52|Lack of Efficacy|7
300696|NCT01606761|1015203|P2|Week 24 to Week 52|Lack of Efficacy|13
300697|NCT01606761|1015204|P1|Week 24 to Week 52|Lack of Efficacy|0
300698|NCT01606761|1015200|P5|Week 24 to Week 52|Death|0
300699|NCT01606761|1015201|P4|Week 24 to Week 52|Death|1
300700|NCT01606761|1015202|P3|Week 24 to Week 52|Death|2
300701|NCT01606761|1015203|P2|Week 24 to Week 52|Death|0
300702|NCT01606761|1015204|P1|Week 24 to Week 52|Death|0
300703|NCT01606761|1015200|P5|Week 24 to Week 52|Adverse Event|15
300704|NCT01606761|1015201|P4|Week 24 to Week 52|Adverse Event|3
300705|NCT01606761|1015202|P3|Week 24 to Week 52|Adverse Event|14
300706|NCT01606761|1015203|P2|Week 24 to Week 52|Adverse Event|11
300707|NCT01606761|1015204|P1|Week 24 to Week 52|Adverse Event|0
300708|NCT01606761|1015200|P5|Week 24 to Week 52|Withdrawal by Subject|0
300709|NCT01606761|1015201|P4|Week 24 to Week 52|Withdrawal by Subject|0
300710|NCT01606761|1015202|P3|Week 24 to Week 52|Withdrawal by Subject|3
300711|NCT01606761|1015203|P2|Week 24 to Week 52|Withdrawal by Subject|6
300712|NCT01606761|1015204|P1|Week 24 to Week 52|Withdrawal by Subject|0
300713|NCT01606761|1015200|P5|Week 24 to Week 52|Lost to Follow-up|0
300714|NCT01606761|1015201|P4|Week 24 to Week 52|Lost to Follow-up|1
300715|NCT01606761|1015202|P3|Week 24 to Week 52|Lost to Follow-up|1
300716|NCT01606761|1015203|P2|Week 24 to Week 52|Lost to Follow-up|1
300717|NCT01606761|1015204|P1|Week 24 to Week 52|Lost to Follow-up|0
300718|NCT01606761|1015200|P5|Prior to Week 24|Other|0
300719|NCT01606761|1015201|P4|Prior to Week 24|Other|0
300720|NCT01606761|1015202|P3|Prior to Week 24|Other|5
300721|NCT01606761|1015203|P2|Prior to Week 24|Other|7
300722|NCT01606761|1015204|P1|Prior to Week 24|Other|4
300723|NCT01606761|1015200|P5|Prior to Week 24|Physician Decision|0
300724|NCT01606761|1015201|P4|Prior to Week 24|Physician Decision|0
300725|NCT01606761|1015202|P3|Prior to Week 24|Physician Decision|1
300726|NCT01606761|1015203|P2|Prior to Week 24|Physician Decision|3
300727|NCT01606761|1015204|P1|Prior to Week 24|Physician Decision|0
300728|NCT01606761|1015200|P5|Prior to Week 24|Lack of Efficacy|0
300729|NCT01606761|1015201|P4|Prior to Week 24|Lack of Efficacy|0
300730|NCT01606761|1015202|P3|Prior to Week 24|Lack of Efficacy|8
300731|NCT01606761|1015203|P2|Prior to Week 24|Lack of Efficacy|14
300732|NCT01606761|1015204|P1|Prior to Week 24|Lack of Efficacy|15
300733|NCT01606761|1015200|P5|Prior to Week 24|Adverse Event|0
300734|NCT01606761|1015201|P4|Prior to Week 24|Adverse Event|0
300735|NCT01606761|1015202|P3|Prior to Week 24|Adverse Event|22
300736|NCT01606761|1015203|P2|Prior to Week 24|Adverse Event|18
300737|NCT01606761|1015204|P1|Prior to Week 24|Adverse Event|11
300738|NCT01606761|1015200|P5|Prior to Week 24|Withdrawal by Subject|0
300739|NCT01606761|1015201|P4|Prior to Week 24|Withdrawal by Subject|0
300740|NCT01606761|1015202|P3|Prior to Week 24|Withdrawal by Subject|9
300741|NCT01606761|1015203|P2|Prior to Week 24|Withdrawal by Subject|10
300742|NCT01606761|1015204|P1|Prior to Week 24|Withdrawal by Subject|12
300743|NCT01606761|1015200|P5|Prior to Week 24|Lost to Follow-up|0
300744|NCT01606761|1015201|P4|Prior to Week 24|Lost to Follow-up|0
300745|NCT01606761|1015202|P3|Prior to Week 24|Lost to Follow-up|2
300746|NCT01606761|1015203|P2|Prior to Week 24|Lost to Follow-up|3
300747|NCT01606761|1015204|P1|Prior to Week 24|Lost to Follow-up|0
300748|NCT01606748|1015230|P2|Overall Study|Withdrawal by Subject|0
300749|NCT01606748|1015231|P1|Overall Study|Withdrawal by Subject|1
300750|NCT01606748|1015230|P2|Overall Study|Progressive Disease|0
300751|NCT01606748|1015231|P1|Overall Study|Progressive Disease|1
300752|NCT01606748|1015230|P2|Overall Study|Adverse Event|0
300753|NCT01606748|1015231|P1|Overall Study|Adverse Event|1
300754|NCT01606670|1015272|P1|Overall Study|Other Reason|2
300755|NCT01606670|1015272|P1|Overall Study|Withdrawal by Subject|3
300756|NCT01606670|1015272|P1|Overall Study|Lost to Follow-up|3
300757|NCT01606670|1015272|P1|Overall Study|Lack of Efficacy|2
300758|NCT01606670|1015272|P1|Overall Study|Adverse Event|6
300759|NCT01606319|1015282|P2|Overall Study|Adverse Event|4
300760|NCT01606319|1015283|P1|Overall Study|Adverse Event|1
300761|NCT01606319|1015282|P2|Overall Study|Lack of Efficacy|8
300762|NCT01606319|1015283|P1|Overall Study|Lack of Efficacy|6
300763|NCT01606319|1015282|P2|Overall Study|Physician Decision|2
300764|NCT01606319|1015283|P1|Overall Study|Physician Decision|1
300765|NCT01606319|1015282|P2|Overall Study|Withdrawal by Subject|12
300766|NCT01606319|1015283|P1|Overall Study|Withdrawal by Subject|9
300767|NCT01606319|1015282|P2|Overall Study|Lost to Follow-up|14
300768|NCT01606319|1015283|P1|Overall Study|Lost to Follow-up|17
300769|NCT01606306|1015301|P6|Overall Study|Physician Decision|0
300770|NCT01606306|1015302|P5|Overall Study|Physician Decision|0
300771|NCT01606306|1015303|P4|Overall Study|Physician Decision|0
300772|NCT01606306|1015304|P3|Overall Study|Physician Decision|0
300773|NCT01606306|1015305|P2|Overall Study|Physician Decision|2
300774|NCT01606306|1015306|P1|Overall Study|Physician Decision|1
300775|NCT01606306|1015301|P6|Overall Study|Withdrawal by Subject|4
300776|NCT01606306|1015302|P5|Overall Study|Withdrawal by Subject|5
300777|NCT01606306|1015303|P4|Overall Study|Withdrawal by Subject|4
300778|NCT01606306|1015304|P3|Overall Study|Withdrawal by Subject|4
300779|NCT01606306|1015305|P2|Overall Study|Withdrawal by Subject|3
300780|NCT01606306|1015306|P1|Overall Study|Withdrawal by Subject|4
300781|NCT01606306|1015301|P6|Overall Study|Lost to Follow-up|5
300782|NCT01606306|1015302|P5|Overall Study|Lost to Follow-up|3
300783|NCT01606306|1015303|P4|Overall Study|Lost to Follow-up|4
300784|NCT01606306|1015304|P3|Overall Study|Lost to Follow-up|5
300785|NCT01606306|1015305|P2|Overall Study|Lost to Follow-up|4
300786|NCT01606306|1015306|P1|Overall Study|Lost to Follow-up|7
300787|NCT01606306|1015301|P6|Overall Study|Adverse Event|0
300788|NCT01606306|1015302|P5|Overall Study|Adverse Event|2
300789|NCT01606306|1015303|P4|Overall Study|Adverse Event|1
300790|NCT01606306|1015304|P3|Overall Study|Adverse Event|1
300791|NCT01606306|1015305|P2|Overall Study|Adverse Event|0
300792|NCT01606306|1015306|P1|Overall Study|Adverse Event|1
300793|NCT01606306|1015301|P6|Overall Study|Lack of Efficacy|2
300794|NCT01606306|1015302|P5|Overall Study|Lack of Efficacy|1
300795|NCT01606306|1015303|P4|Overall Study|Lack of Efficacy|4
300796|NCT01606306|1015304|P3|Overall Study|Lack of Efficacy|4
300797|NCT01606306|1015305|P2|Overall Study|Lack of Efficacy|1
300798|NCT01606306|1015306|P1|Overall Study|Lack of Efficacy|2
300799|NCT01606254|1015316|P4|Overall Study|Adverse Event|1
300800|NCT01606254|1015317|P3|Overall Study|Adverse Event|0
300801|NCT01606254|1015318|P2|Overall Study|Adverse Event|1
300802|NCT01606254|1015319|P1|Overall Study|Adverse Event|1
300803|NCT01606254|1015316|P4|Overall Study|Withdrawal by Subject|2
300804|NCT01606254|1015317|P3|Overall Study|Withdrawal by Subject|0
300805|NCT01606254|1015318|P2|Overall Study|Withdrawal by Subject|3
300806|NCT01606254|1015319|P1|Overall Study|Withdrawal by Subject|1
300807|NCT01606228|1015401|P1|Overall Study|Adverse Event|1
300808|NCT01606228|1015401|P1|Overall Study|Lack of Efficacy|2
300809|NCT01606228|1015401|P1|Overall Study|Non-compliant|3
300810|NCT01606228|1015401|P1|Overall Study|Withdrawal by Subject|3
300811|NCT01606228|1015401|P1|Overall Study|Lost to Follow-up|20
300812|NCT01606202|1015418|P2|Overall Study|Problems with administration|1
300813|NCT01606202|1015419|P1|Overall Study|Problems with administration|0
300814|NCT01606202|1015418|P2|Overall Study|Personal problems|1
300815|NCT01606202|1015419|P1|Overall Study|Personal problems|0
300816|NCT01606202|1015418|P2|Overall Study|Withdrawal by Subject|1
300817|NCT01606202|1015419|P1|Overall Study|Withdrawal by Subject|2
300818|NCT01606202|1015418|P2|Overall Study|Adverse Event|0
300819|NCT01606202|1015419|P1|Overall Study|Adverse Event|5
300820|NCT01606189|1015451|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
300821|NCT01606189|1015452|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
300822|NCT01606189|1015453|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
300823|NCT01606189|1015454|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
300824|NCT01606189|1015455|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
300825|NCT01606189|1015456|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
300826|NCT01606189|1015451|P6|Second Intenvention (14-20 Days)|Adverse Event|1
300827|NCT01606189|1015452|P5|Second Intenvention (14-20 Days)|Adverse Event|0
300828|NCT01606189|1015453|P4|Second Intenvention (14-20 Days)|Adverse Event|0
300829|NCT01606189|1015454|P3|Second Intenvention (14-20 Days)|Adverse Event|0
300830|NCT01606189|1015455|P2|Second Intenvention (14-20 Days)|Adverse Event|0
300831|NCT01606189|1015456|P1|Second Intenvention (14-20 Days)|Adverse Event|0
300832|NCT01606176|1015490|P2|Overall Study|Withdrawal by Subject|0
300833|NCT01606176|1015491|P1|Overall Study|Withdrawal by Subject|1
300834|NCT01606176|1015490|P2|Overall Study|Disease progression|0
300835|NCT01606176|1015491|P1|Overall Study|Disease progression|1
300836|NCT01606176|1015490|P2|Overall Study|Adverse Event|3
300837|NCT01606176|1015491|P1|Overall Study|Adverse Event|2
300838|NCT01606137|1015536|P1|Overall Study|Unable to collect consistent data|1
300839|NCT01606137|1015536|P1|Overall Study|Patient moving|1
300840|NCT01606137|1015536|P1|Overall Study|Unable to tolerate study med. taste|1
300841|NCT01606137|1015536|P1|Overall Study|Personal reasons|1
300842|NCT01606137|1015536|P1|Overall Study|Patient leaving country|1
300843|NCT01606137|1015536|P1|Overall Study|Wanted to try another treatment|1
300844|NCT01606137|1015536|P1|Overall Study|Not enough improvement|4
300845|NCT01606137|1015536|P1|Overall Study|Spray causes nausea|1
300846|NCT01606137|1015536|P1|Overall Study|Increased bilirubin|1
300847|NCT01606137|1015536|P1|Overall Study|multiple sclerosis less stable|1
300848|NCT01606137|1015536|P1|Overall Study|Issues with driving|4
300849|NCT01606137|1015536|P1|Overall Study|Decreased/no pain|4
300850|NCT01606137|1015536|P1|Overall Study|Death|1
300851|NCT01606137|1015536|P1|Overall Study|Patient non-compliance|9
300852|NCT01606137|1015536|P1|Overall Study|Protocol Violation|1
300853|NCT01606137|1015536|P1|Overall Study|Lost to Follow-up|15
300854|NCT01606137|1015536|P1|Overall Study|Lack of Efficacy|56
300855|NCT01606137|1015536|P1|Overall Study|Withdrawal by Subject|74
300856|NCT01606137|1015536|P1|Overall Study|Adverse Event|85
300857|NCT01606007|1015570|P3|Overall Study|Poor/Non-compliance|0
300858|NCT01606007|1015571|P2|Overall Study|Poor/Non-compliance|0
300859|NCT01606007|1015572|P1|Overall Study|Poor/Non-compliance|1
300860|NCT01606007|1015570|P3|Overall Study|Lost to Follow-up|5
300861|NCT01606007|1015571|P2|Overall Study|Lost to Follow-up|8
300862|NCT01606007|1015572|P1|Overall Study|Lost to Follow-up|6
300863|NCT01606007|1015570|P3|Overall Study|discontinue study treatment|1
300864|NCT01606007|1015571|P2|Overall Study|discontinue study treatment|2
300865|NCT01606007|1015572|P1|Overall Study|discontinue study treatment|0
300866|NCT01606007|1015570|P3|Overall Study|Adverse Event|1
300867|NCT01606007|1015571|P2|Overall Study|Adverse Event|1
300868|NCT01606007|1015572|P1|Overall Study|Adverse Event|0
300869|NCT01606007|1015570|P3|Overall Study|Withdrawal by Subject|1
300870|NCT01606007|1015571|P2|Overall Study|Withdrawal by Subject|6
300871|NCT01606007|1015572|P1|Overall Study|Withdrawal by Subject|8
300872|NCT01606007|1015570|P3|Overall Study|Pregnancy|1
300873|NCT01606007|1015571|P2|Overall Study|Pregnancy|1
300874|NCT01606007|1015572|P1|Overall Study|Pregnancy|0
300875|NCT01606007|1015570|P3|Overall Study|Reason 'Other' in the protocol|1
300876|NCT01606007|1015571|P2|Overall Study|Reason 'Other' in the protocol|1
300877|NCT01606007|1015572|P1|Overall Study|Reason 'Other' in the protocol|0
300878|NCT01605916|1015607|P5|Overall Study|Withdrawal by Subject|2
300879|NCT01605916|1015608|P4|Overall Study|Withdrawal by Subject|0
300880|NCT01605916|1015609|P3|Overall Study|Withdrawal by Subject|0
300881|NCT01605916|1015610|P2|Overall Study|Withdrawal by Subject|1
300882|NCT01605916|1015611|P1|Overall Study|Withdrawal by Subject|1
300883|NCT01605916|1015607|P5|Overall Study|Lack of Efficacy|4
300884|NCT01605916|1015608|P4|Overall Study|Lack of Efficacy|5
300885|NCT01605916|1015609|P3|Overall Study|Lack of Efficacy|3
300886|NCT01605916|1015610|P2|Overall Study|Lack of Efficacy|3
300887|NCT01605916|1015611|P1|Overall Study|Lack of Efficacy|2
300888|NCT01605916|1015607|P5|Overall Study|Adverse Event|0
300889|NCT01605916|1015608|P4|Overall Study|Adverse Event|1
300890|NCT01605916|1015609|P3|Overall Study|Adverse Event|0
300891|NCT01605916|1015610|P2|Overall Study|Adverse Event|0
300892|NCT01605916|1015611|P1|Overall Study|Adverse Event|1
300893|NCT01605877|1015693|P1|Overall Study|Withdrawal by Subject|1
300894|NCT01605825|1015757|P2|Overall Study|Non-Compliance with Protocol|0
300895|NCT01605825|1015758|P1|Overall Study|Non-Compliance with Protocol|3
300896|NCT01605825|1015757|P2|Overall Study|Non-Compliance -Investigational Drug|0
300897|NCT01605825|1015758|P1|Overall Study|Non-Compliance -Investigational Drug|3
300898|NCT01605825|1015757|P2|Overall Study|Withdrawal by Subject|1
300899|NCT01605825|1015758|P1|Overall Study|Withdrawal by Subject|0
300900|NCT01605825|1015757|P2|Overall Study|Adverse Event|2
300901|NCT01605825|1015758|P1|Overall Study|Adverse Event|4
300902|NCT01605799|1015766|P2|Overall Study|Withdrawal by Subject|1
300903|NCT01605799|1015767|P1|Overall Study|Withdrawal by Subject|2
300904|NCT01605617|1015782|P2|Washout Period of 4 Weeks|Study Terminated|1
300905|NCT01605617|1015783|P1|Washout Period of 4 Weeks|Study Terminated|2
300906|NCT01605617|1015782|P2|First Intervention|Adverse Event|1
300907|NCT01605617|1015783|P1|First Intervention|Adverse Event|0
300908|NCT01605461|1015842|P1|Overall Study|Withdrawal by Subject|1
300909|NCT01605461|1015842|P1|Overall Study|Lost to Follow-up|3
300910|NCT01605370|1015853|P2|Overall Study|Adverse Event|0
300911|NCT01605370|1015854|P1|Overall Study|Adverse Event|1
300912|NCT01605227|1015889|P2|Overall Study|Dose Held >6 weeks|1
300913|NCT01605227|1015890|P1|Overall Study|Dose Held >6 weeks|0
300914|NCT01605227|1015889|P2|Overall Study|Subject Decision|1
300915|NCT01605227|1015890|P1|Overall Study|Subject Decision|0
300916|NCT01605227|1015889|P2|Overall Study|Started New Therapy|0
300917|NCT01605227|1015890|P1|Overall Study|Started New Therapy|1
300918|NCT01605227|1015889|P2|Overall Study|Sponsor Decision|0
300919|NCT01605227|1015890|P1|Overall Study|Sponsor Decision|2
300920|NCT01605227|1015889|P2|Overall Study|Withdrawal by Subject|14
300921|NCT01605227|1015890|P1|Overall Study|Withdrawal by Subject|18
300922|NCT01605227|1015889|P2|Overall Study|Physician Decision|7
300923|NCT01605227|1015890|P1|Overall Study|Physician Decision|9
300924|NCT01605227|1015889|P2|Overall Study|Protocol Violation|0
300925|NCT01605227|1015890|P1|Overall Study|Protocol Violation|1
300926|NCT01605227|1015889|P2|Overall Study|Lost to Follow-up|0
300927|NCT01605227|1015890|P1|Overall Study|Lost to Follow-up|1
300928|NCT01605227|1015889|P2|Overall Study|Clinical Deterioration|133
300929|NCT01605227|1015890|P1|Overall Study|Clinical Deterioration|227
300930|NCT01605227|1015889|P2|Overall Study|Progressive Disease|128
300931|NCT01605227|1015890|P1|Overall Study|Progressive Disease|132
300932|NCT01605227|1015889|P2|Overall Study|Adverse Event|42
300933|NCT01605227|1015890|P1|Overall Study|Adverse Event|228
300934|NCT01605227|1015889|P2|Overall Study|Did not receive study treatment|3
300935|NCT01605227|1015890|P1|Overall Study|Did not receive study treatment|2
300936|NCT01604941|1015902|P6|Overall Study|Early Study Termination|0
300937|NCT01604941|1015903|P5|Overall Study|Early Study Termination|0
300938|NCT01604941|1015904|P4|Overall Study|Early Study Termination|3
300939|NCT01604941|1015905|P3|Overall Study|Early Study Termination|3
300940|NCT01604941|1015906|P2|Overall Study|Early Study Termination|2
300941|NCT01604941|1015907|P1|Overall Study|Early Study Termination|9
300942|NCT01604941|1015902|P6|Overall Study|Participant Decision|2
300943|NCT01604941|1015903|P5|Overall Study|Participant Decision|0
300944|NCT01604941|1015904|P4|Overall Study|Participant Decision|0
300945|NCT01604941|1015905|P3|Overall Study|Participant Decision|0
300946|NCT01604941|1015906|P2|Overall Study|Participant Decision|0
300947|NCT01604941|1015907|P1|Overall Study|Participant Decision|0
300948|NCT01604941|1015902|P6|Overall Study|Non-compliance|0
300949|NCT01604941|1015903|P5|Overall Study|Non-compliance|0
300950|NCT01604941|1015904|P4|Overall Study|Non-compliance|0
300951|NCT01604941|1015905|P3|Overall Study|Non-compliance|0
300952|NCT01604941|1015906|P2|Overall Study|Non-compliance|0
300953|NCT01604941|1015907|P1|Overall Study|Non-compliance|1
300954|NCT01604941|1015902|P6|Overall Study|Adverse Event|5
300955|NCT01604941|1015903|P5|Overall Study|Adverse Event|1
300956|NCT01604941|1015904|P4|Overall Study|Adverse Event|0
300957|NCT01604941|1015905|P3|Overall Study|Adverse Event|0
300958|NCT01604941|1015906|P2|Overall Study|Adverse Event|2
300959|NCT01604941|1015907|P1|Overall Study|Adverse Event|1
300960|NCT01604850|1015935|P2|Overall Study|Subject withdrew consent|0
300961|NCT01604850|1015936|P1|Overall Study|Subject withdrew consent|1
300962|NCT01604850|1015935|P2|Overall Study|Lost to Follow-up|0
300963|NCT01604850|1015936|P1|Overall Study|Lost to Follow-up|1
300964|NCT01604850|1015935|P2|Overall Study|Efficacy Failure|29
300965|NCT01604850|1015936|P1|Overall Study|Efficacy Failure|50
300966|NCT01604850|1015935|P2|Overall Study|Enrolled but never treated|1
300967|NCT01604850|1015936|P1|Overall Study|Enrolled but never treated|0
300968|NCT01604408|1015960|P2|Observation Period|Withdrawal by Subject|2
300969|NCT01604408|1015961|P1|Observation Period|Withdrawal by Subject|0
300970|NCT01604408|1015960|P2|Observation Period|Adverse Event|1
300971|NCT01604408|1015961|P1|Observation Period|Adverse Event|1
300972|NCT01604408|1015960|P2|Treatment Period 6|Sponsor decision|1
300973|NCT01604408|1015961|P1|Treatment Period 6|Sponsor decision|0
300974|NCT01604408|1015960|P2|Treatment Period 6|Adverse Event|0
300975|NCT01604408|1015961|P1|Treatment Period 6|Adverse Event|2
300976|NCT01604408|1015960|P2|Treatment Period 6|Lost to Follow-up|1
300977|NCT01604408|1015961|P1|Treatment Period 6|Lost to Follow-up|0
300978|NCT01604408|1015960|P2|Treatment Period 5|Adverse Event|0
300979|NCT01604408|1015961|P1|Treatment Period 5|Adverse Event|4
300980|NCT01604408|1015960|P2|Treatment Period 4|Adverse Event|1
300981|NCT01604408|1015961|P1|Treatment Period 4|Adverse Event|0
300982|NCT01604408|1015960|P2|Treatment Period 4|Withdrawal by Subject|1
300983|NCT01604408|1015961|P1|Treatment Period 4|Withdrawal by Subject|2
300984|NCT01604408|1015960|P2|Treatment Period 4|Death|0
300985|NCT01604408|1015961|P1|Treatment Period 4|Death|1
300986|NCT01604408|1015960|P2|Treatment Period 3|Sponsor Decision|0
300987|NCT01604408|1015961|P1|Treatment Period 3|Sponsor Decision|1
300988|NCT01604408|1015960|P2|Treatment Period 3|Withdrawal by Subject|1
300989|NCT01604408|1015961|P1|Treatment Period 3|Withdrawal by Subject|3
300990|NCT01604408|1015960|P2|Treatment Period 3|Adverse Event|3
300991|NCT01604408|1015961|P1|Treatment Period 3|Adverse Event|0
300992|NCT01604408|1015960|P2|Treatment Period 3|Protocol Violation|1
300993|NCT01604408|1015961|P1|Treatment Period 3|Protocol Violation|1
300994|NCT01604408|1015960|P2|Treatment Period 2|Adverse Event|1
300995|NCT01604408|1015961|P1|Treatment Period 2|Adverse Event|0
300996|NCT01604408|1015960|P2|Treatment Period 2|Protocol Violation|0
300997|NCT01604408|1015961|P1|Treatment Period 2|Protocol Violation|1
300998|NCT01604408|1015960|P2|Treatment Period 2|Withdrawal by Subject|1
300999|NCT01604408|1015961|P1|Treatment Period 2|Withdrawal by Subject|1
301000|NCT01604408|1015960|P2|Treatment Period 1|Protocol Violation|1
301001|NCT01604408|1015961|P1|Treatment Period 1|Protocol Violation|0
301002|NCT01604343|1015976|P5|Safety Follow-up Period (Week 104-120)|Other|14
301003|NCT01604343|1015977|P4|Safety Follow-up Period (Week 104-120)|Other|6
301004|NCT01604343|1015978|P3|Safety Follow-up Period (Week 104-120)|Other|20
301005|NCT01604343|1015979|P2|Safety Follow-up Period (Week 104-120)|Other|2
301006|NCT01604343|1015980|P1|Safety Follow-up Period (Week 104-120)|Other|15
301007|NCT01604343|1015976|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
301008|NCT01604343|1015977|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
301009|NCT01604343|1015978|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
301010|NCT01604343|1015979|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
301011|NCT01604343|1015980|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
301012|NCT01604343|1015976|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
301013|NCT01604343|1015977|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
301014|NCT01604343|1015978|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
301015|NCT01604343|1015979|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
301016|NCT01604343|1015980|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
301017|NCT01604343|1015976|P5|Week 52 to Week 104|Other|3
301018|NCT01604343|1015977|P4|Week 52 to Week 104|Other|6
301019|NCT01604343|1015978|P3|Week 52 to Week 104|Other|11
301020|NCT01604343|1015979|P2|Week 52 to Week 104|Other|11
301021|NCT01604343|1015980|P1|Week 52 to Week 104|Other|0
301022|NCT01604343|1015976|P5|Week 52 to Week 104|Pregnancy|1
301023|NCT01604343|1015977|P4|Week 52 to Week 104|Pregnancy|2
301024|NCT01604343|1015978|P3|Week 52 to Week 104|Pregnancy|1
301025|NCT01604343|1015979|P2|Week 52 to Week 104|Pregnancy|0
301026|NCT01604343|1015980|P1|Week 52 to Week 104|Pregnancy|0
301027|NCT01604343|1015976|P5|Week 52 to Week 104|Physician Decision|2
301028|NCT01604343|1015977|P4|Week 52 to Week 104|Physician Decision|0
301029|NCT01604343|1015978|P3|Week 52 to Week 104|Physician Decision|0
301030|NCT01604343|1015979|P2|Week 52 to Week 104|Physician Decision|1
301031|NCT01604343|1015980|P1|Week 52 to Week 104|Physician Decision|0
301032|NCT01604343|1015976|P5|Week 52 to Week 104|Lack of Efficacy|3
301033|NCT01604343|1015977|P4|Week 52 to Week 104|Lack of Efficacy|2
301034|NCT01604343|1015978|P3|Week 52 to Week 104|Lack of Efficacy|11
301035|NCT01604343|1015979|P2|Week 52 to Week 104|Lack of Efficacy|6
301036|NCT01604343|1015980|P1|Week 52 to Week 104|Lack of Efficacy|0
301037|NCT01604343|1015976|P5|Week 52 to Week 104|Death|0
301038|NCT01604343|1015977|P4|Week 52 to Week 104|Death|5
301039|NCT01604343|1015978|P3|Week 52 to Week 104|Death|2
301040|NCT01604343|1015979|P2|Week 52 to Week 104|Death|4
301041|NCT01604343|1015980|P1|Week 52 to Week 104|Death|0
301042|NCT01604343|1015976|P5|Week 52 to Week 104|Adverse Event|27
301043|NCT01604343|1015977|P4|Week 52 to Week 104|Adverse Event|21
301044|NCT01604343|1015978|P3|Week 52 to Week 104|Adverse Event|26
301045|NCT01604343|1015979|P2|Week 52 to Week 104|Adverse Event|12
301046|NCT01604343|1015980|P1|Week 52 to Week 104|Adverse Event|0
301047|NCT01604343|1015976|P5|Week 52 to Week 104|Withdrawal by Subject|4
301048|NCT01604343|1015977|P4|Week 52 to Week 104|Withdrawal by Subject|8
301049|NCT01604343|1015978|P3|Week 52 to Week 104|Withdrawal by Subject|12
301050|NCT01604343|1015979|P2|Week 52 to Week 104|Withdrawal by Subject|7
301051|NCT01604343|1015980|P1|Week 52 to Week 104|Withdrawal by Subject|0
301052|NCT01604343|1015976|P5|Week 52 to Week 104|Lost to Follow-up|1
301053|NCT01604343|1015977|P4|Week 52 to Week 104|Lost to Follow-up|2
301054|NCT01604343|1015978|P3|Week 52 to Week 104|Lost to Follow-up|4
301055|NCT01604343|1015979|P2|Week 52 to Week 104|Lost to Follow-up|2
301056|NCT01604343|1015980|P1|Week 52 to Week 104|Lost to Follow-up|0
301057|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Other|6
301058|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Other|0
301059|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Other|10
301060|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Other|0
301061|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Other|15
301062|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
301063|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
301064|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
301065|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
301066|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
301067|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
301068|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
301069|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
301070|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
301071|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
301072|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
301073|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
301074|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
301075|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
301076|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
301077|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Death|4
301078|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Death|0
301079|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Death|2
301080|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Death|0
301081|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Death|5
301082|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
301083|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
301084|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
301085|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
301086|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
301087|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
301088|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
301089|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
301090|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
301091|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
301092|NCT01604343|1015976|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
301093|NCT01604343|1015977|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
301094|NCT01604343|1015978|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
301095|NCT01604343|1015979|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
301096|NCT01604343|1015980|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
301097|NCT01604278|1016091|P2|Overall Study|Protocol Deviation|3
301098|NCT01604278|1016092|P1|Overall Study|Protocol Deviation|5
301099|NCT01604278|1016091|P2|Overall Study|Adverse Event|5
301100|NCT01604278|1016092|P1|Overall Study|Adverse Event|3
301101|NCT01604278|1016091|P2|Overall Study|Withdrawal by Subject|3
301102|NCT01604278|1016092|P1|Overall Study|Withdrawal by Subject|3
301103|NCT01604278|1016091|P2|Overall Study|Administrative problems|1
301104|NCT01604278|1016092|P1|Overall Study|Administrative problems|2
301105|NCT01604278|1016091|P2|Overall Study|Lost to Follow-up|0
301106|NCT01604278|1016092|P1|Overall Study|Lost to Follow-up|1
301107|NCT01604278|1016091|P2|Overall Study|Lack of Efficacy|1
301108|NCT01604278|1016092|P1|Overall Study|Lack of Efficacy|0
301109|NCT01604265|1016118|P2|Overall Study|Withdrawal by Subject|0
301110|NCT01604265|1016119|P1|Overall Study|Withdrawal by Subject|1
301111|NCT01604265|1016118|P2|Overall Study|Adverse Event|0
301112|NCT01604265|1016119|P1|Overall Study|Adverse Event|1
301113|NCT01603875|1016230|P3|Overall Study|Protocol Violation|0
301114|NCT01603875|1016231|P2|Overall Study|Protocol Violation|1
301115|NCT01603875|1016232|P1|Overall Study|Protocol Violation|0
301116|NCT01603875|1016230|P3|Overall Study|Lost to Follow-up|6
301117|NCT01603875|1016231|P2|Overall Study|Lost to Follow-up|3
301118|NCT01603875|1016232|P1|Overall Study|Lost to Follow-up|4
301119|NCT01603875|1016230|P3|Overall Study|Preexisting rabies antibody|3
301120|NCT01603875|1016231|P2|Overall Study|Preexisting rabies antibody|4
301121|NCT01603875|1016232|P1|Overall Study|Preexisting rabies antibody|3
301122|NCT01603459|1016252|P1|Overall Study|Administrative reason|1
301123|NCT01603459|1016252|P1|Overall Study|Non-compliance|1
301124|NCT01603459|1016252|P1|Overall Study|Predefined discontinuation criteria|3
301125|NCT01603459|1016252|P1|Overall Study|Lost to Follow-up|3
301126|NCT01603459|1016252|P1|Overall Study|Withdrawal by Subject|5
301127|NCT01603459|1016252|P1|Overall Study|Adverse Event|5
301128|NCT01603394|1016403|P1|Overall Study|Adverse Event|1
301129|NCT01603277|1016420|P2|Overall Study|Non-Compliance|1
301130|NCT01603277|1016421|P1|Overall Study|Non-Compliance|2
301131|NCT01603277|1016420|P2|Overall Study|Withdrawal by Subject|4
301132|NCT01603277|1016421|P1|Overall Study|Withdrawal by Subject|5
301133|NCT01603277|1016420|P2|Overall Study|Protocol Violation|10
301134|NCT01603277|1016421|P1|Overall Study|Protocol Violation|6
301135|NCT01603277|1016420|P2|Overall Study|Physician Decision|1
301136|NCT01603277|1016421|P1|Overall Study|Physician Decision|0
301137|NCT01603277|1016420|P2|Overall Study|Adverse Event|2
301138|NCT01603277|1016421|P1|Overall Study|Adverse Event|1
301139|NCT01603121|1016427|P2|Second Intervention, 10 Hours|Adverse Event|0
301140|NCT01603121|1016428|P1|Second Intervention, 10 Hours|Adverse Event|1
301141|NCT01603082|1016440|P2|Overall Study|Failed inclusion criterion after dosed|0
301142|NCT01603082|1016441|P1|Overall Study|Failed inclusion criterion after dosed|1
301143|NCT01603082|1016440|P2|Overall Study|Withdrawal by Subject|0
301144|NCT01603082|1016441|P1|Overall Study|Withdrawal by Subject|1
301145|NCT01603082|1016440|P2|Overall Study|Adverse Event|1
301146|NCT01603082|1016441|P1|Overall Study|Adverse Event|0
301147|NCT01603043|1016482|P2|Overall Study|Study Futility|3
301148|NCT01603043|1016483|P1|Overall Study|Study Futility|7
301149|NCT01602965|1016495|P2|Overall Study|Lost to Follow-up|2
301150|NCT01602965|1016496|P1|Overall Study|Lost to Follow-up|4
301151|NCT01602744|1016504|P2|Overall Study|Lost to Follow-up|8
301152|NCT01602744|1016505|P1|Overall Study|Lost to Follow-up|13
301153|NCT01602744|1016504|P2|Overall Study|Death|15
301154|NCT01602744|1016505|P1|Overall Study|Death|17
301155|NCT01602562|1016529|P2|Overall Study|Withdrawal by Subject|1
301156|NCT01602562|1016530|P1|Overall Study|Withdrawal by Subject|1
301157|NCT01602562|1016529|P2|Overall Study|Physician Decision|1
301158|NCT01602562|1016530|P1|Overall Study|Physician Decision|1
301159|NCT01602562|1016529|P2|Overall Study|Adverse Event|1
301160|NCT01602562|1016530|P1|Overall Study|Adverse Event|3
301161|NCT01602549|1016566|P2|Overall Study|Withdrawal by Subject|0
301162|NCT01602549|1016567|P1|Overall Study|Withdrawal by Subject|1
301163|NCT01602549|1016566|P2|Overall Study|Protocol Violation|1
301164|NCT01602549|1016567|P1|Overall Study|Protocol Violation|0
301165|NCT01602510|1016646|P3|Randomized Phase|Withdrawal by Subject|7
301166|NCT01602510|1016647|P2|Randomized Phase|Withdrawal by Subject|6
301167|NCT01602510|1016648|P1|Randomized Phase|Withdrawal by Subject|0
301168|NCT01602510|1016646|P3|Randomized Phase|Physician Decision|2
301169|NCT01602510|1016647|P2|Randomized Phase|Physician Decision|0
301170|NCT01602510|1016648|P1|Randomized Phase|Physician Decision|0
301171|NCT01602510|1016646|P3|Randomized Phase|Lost to Follow-up|3
301172|NCT01602510|1016647|P2|Randomized Phase|Lost to Follow-up|1
301173|NCT01602510|1016648|P1|Randomized Phase|Lost to Follow-up|0
301174|NCT01602510|1016646|P3|Randomized Phase|Met protocol-defined stopping criteria|48
301175|NCT01602510|1016647|P2|Randomized Phase|Met protocol-defined stopping criteria|58
301176|NCT01602510|1016648|P1|Randomized Phase|Met protocol-defined stopping criteria|0
301177|NCT01602510|1016646|P3|Randomized Phase|Protocol Violation|3
301178|NCT01602510|1016647|P2|Randomized Phase|Protocol Violation|3
301179|NCT01602510|1016648|P1|Randomized Phase|Protocol Violation|0
301180|NCT01602510|1016646|P3|Randomized Phase|Lack of Efficacy|4
301181|NCT01602510|1016647|P2|Randomized Phase|Lack of Efficacy|4
301182|NCT01602510|1016648|P1|Randomized Phase|Lack of Efficacy|0
301183|NCT01602510|1016646|P3|Randomized Phase|Adverse Event|6
301184|NCT01602510|1016647|P2|Randomized Phase|Adverse Event|2
301185|NCT01602510|1016648|P1|Randomized Phase|Adverse Event|0
301186|NCT01602510|1016646|P3|Open Label Phase|Withdrawal by Subject|0
301187|NCT01602510|1016647|P2|Open Label Phase|Withdrawal by Subject|0
301188|NCT01602510|1016648|P1|Open Label Phase|Withdrawal by Subject|57
301189|NCT01602510|1016646|P3|Open Label Phase|Physician Decision|0
301190|NCT01602510|1016647|P2|Open Label Phase|Physician Decision|0
301191|NCT01602510|1016648|P1|Open Label Phase|Physician Decision|19
301192|NCT01602510|1016646|P3|Open Label Phase|Lost to Follow-up|0
301193|NCT01602510|1016647|P2|Open Label Phase|Lost to Follow-up|0
301194|NCT01602510|1016648|P1|Open Label Phase|Lost to Follow-up|22
301195|NCT01602510|1016646|P3|Open Label Phase|Met protocol-defined stopping criteria|0
301196|NCT01602510|1016647|P2|Open Label Phase|Met protocol-defined stopping criteria|0
301197|NCT01602510|1016648|P1|Open Label Phase|Met protocol-defined stopping criteria|122
301198|NCT01602510|1016646|P3|Open Label Phase|Protocol Violation|0
301199|NCT01602510|1016647|P2|Open Label Phase|Protocol Violation|0
301200|NCT01602510|1016648|P1|Open Label Phase|Protocol Violation|15
301201|NCT01602510|1016646|P3|Open Label Phase|Lack of Efficacy|0
301202|NCT01602510|1016647|P2|Open Label Phase|Lack of Efficacy|0
301203|NCT01602510|1016648|P1|Open Label Phase|Lack of Efficacy|22
301204|NCT01602510|1016646|P3|Open Label Phase|Adverse Event|0
301205|NCT01602510|1016647|P2|Open Label Phase|Adverse Event|0
301206|NCT01602510|1016648|P1|Open Label Phase|Adverse Event|46
301207|NCT01602484|1016674|P2|Overall Study|Airway issues unrelated to study|1
301208|NCT01602484|1016675|P1|Overall Study|Airway issues unrelated to study|0
301209|NCT01602380|1016693|P2|Overall Study|Eligibility criteria not fulfilled|3
301210|NCT01602380|1016694|P1|Overall Study|Eligibility criteria not fulfilled|2
301211|NCT01602380|1016693|P2|Overall Study|Lost to Follow-up|1
301212|NCT01602380|1016694|P1|Overall Study|Lost to Follow-up|6
301213|NCT01602380|1016693|P2|Overall Study|Withdrawal by Subject|29
301214|NCT01602380|1016694|P1|Overall Study|Withdrawal by Subject|22
301215|NCT01602380|1016693|P2|Overall Study|Death|68
301216|NCT01602380|1016694|P1|Overall Study|Death|63
301217|NCT01602341|1016718|P2|Overall Study|Adverse Event|1
301218|NCT01602341|1016719|P1|Overall Study|Adverse Event|0
301219|NCT01602315|1016760|P7|Overall Study|Cross-over patients to combo treatment|0
301220|NCT01602315|1016761|P6|Overall Study|Cross-over patients to combo treatment|16
301221|NCT01602315|1016762|P5|Overall Study|Cross-over patients to combo treatment|0
301222|NCT01602315|1016763|P4|Overall Study|Cross-over patients to combo treatment|0
301223|NCT01602315|1016764|P3|Overall Study|Cross-over patients to combo treatment|0
301224|NCT01602315|1016765|P2|Overall Study|Cross-over patients to combo treatment|0
301225|NCT01602315|1016766|P1|Overall Study|Cross-over patients to combo treatment|0
301226|NCT01602315|1016760|P7|Overall Study|Subject/guardian decision|1
301227|NCT01602315|1016761|P6|Overall Study|Subject/guardian decision|0
301228|NCT01602315|1016762|P5|Overall Study|Subject/guardian decision|0
301229|NCT01602315|1016763|P4|Overall Study|Subject/guardian decision|0
301230|NCT01602315|1016764|P3|Overall Study|Subject/guardian decision|0
301231|NCT01602315|1016765|P2|Overall Study|Subject/guardian decision|0
301232|NCT01602315|1016766|P1|Overall Study|Subject/guardian decision|0
301233|NCT01602315|1016760|P7|Overall Study|Adverse Event|9
301234|NCT01602315|1016761|P6|Overall Study|Adverse Event|3
301235|NCT01602315|1016762|P5|Overall Study|Adverse Event|15
301236|NCT01602315|1016763|P4|Overall Study|Adverse Event|4
301237|NCT01602315|1016764|P3|Overall Study|Adverse Event|5
301238|NCT01602315|1016765|P2|Overall Study|Adverse Event|1
301239|NCT01602315|1016766|P1|Overall Study|Adverse Event|5
301240|NCT01602315|1016760|P7|Overall Study|Withdrawal by Subject|1
301241|NCT01602315|1016761|P6|Overall Study|Withdrawal by Subject|0
301242|NCT01602315|1016762|P5|Overall Study|Withdrawal by Subject|6
301243|NCT01602315|1016763|P4|Overall Study|Withdrawal by Subject|0
301244|NCT01602315|1016764|P3|Overall Study|Withdrawal by Subject|2
301245|NCT01602315|1016765|P2|Overall Study|Withdrawal by Subject|0
301246|NCT01602315|1016766|P1|Overall Study|Withdrawal by Subject|2
301247|NCT01602315|1016760|P7|Overall Study|Death|2
301248|NCT01602315|1016761|P6|Overall Study|Death|2
301249|NCT01602315|1016762|P5|Overall Study|Death|7
301250|NCT01602315|1016763|P4|Overall Study|Death|1
301251|NCT01602315|1016764|P3|Overall Study|Death|1
301252|NCT01602315|1016765|P2|Overall Study|Death|1
301253|NCT01602315|1016766|P1|Overall Study|Death|1
301254|NCT01602315|1016760|P7|Overall Study|Disease progression|15
301255|NCT01602315|1016761|P6|Overall Study|Disease progression|12
301256|NCT01602315|1016762|P5|Overall Study|Disease progression|41
301257|NCT01602315|1016763|P4|Overall Study|Disease progression|1
301258|NCT01602315|1016764|P3|Overall Study|Disease progression|10
301259|NCT01602315|1016765|P2|Overall Study|Disease progression|3
301260|NCT01602315|1016766|P1|Overall Study|Disease progression|6
301261|NCT01602315|1016760|P7|Overall Study|Physician Decision|1
301262|NCT01602315|1016761|P6|Overall Study|Physician Decision|1
301263|NCT01602315|1016762|P5|Overall Study|Physician Decision|2
301264|NCT01602315|1016763|P4|Overall Study|Physician Decision|0
301265|NCT01602315|1016764|P3|Overall Study|Physician Decision|0
301266|NCT01602315|1016765|P2|Overall Study|Physician Decision|0
301267|NCT01602315|1016766|P1|Overall Study|Physician Decision|2
301268|NCT01602315|1016760|P7|Overall Study|Protocol Violation|0
301269|NCT01602315|1016761|P6|Overall Study|Protocol Violation|1
301270|NCT01602315|1016762|P5|Overall Study|Protocol Violation|0
301271|NCT01602315|1016763|P4|Overall Study|Protocol Violation|0
301272|NCT01602315|1016764|P3|Overall Study|Protocol Violation|0
301273|NCT01602315|1016765|P2|Overall Study|Protocol Violation|0
301274|NCT01602315|1016766|P1|Overall Study|Protocol Violation|0
301275|NCT01601847|1016897|P2|Overall Study|Lost to Follow-up|3
301276|NCT01601847|1016898|P1|Overall Study|Lost to Follow-up|1
301277|NCT01601847|1016897|P2|Overall Study|Withdrawal by Subject|7
301278|NCT01601847|1016898|P1|Overall Study|Withdrawal by Subject|11
301279|NCT01601847|1016897|P2|Overall Study|Death|0
301280|NCT01601847|1016898|P1|Overall Study|Death|1
301281|NCT01601821|1016910|P2|Overall Study|Other|1
301282|NCT01601821|1016911|P1|Overall Study|Other|5
301283|NCT01601821|1016910|P2|Overall Study|Study Events|1
301284|NCT01601821|1016911|P1|Overall Study|Study Events|7
301285|NCT01601821|1016910|P2|Overall Study|Graft Loss|6
301286|NCT01601821|1016911|P1|Overall Study|Graft Loss|6
301287|NCT01601821|1016910|P2|Overall Study|Withdrawal by Subject|0
301288|NCT01601821|1016911|P1|Overall Study|Withdrawal by Subject|1
301289|NCT01601821|1016910|P2|Overall Study|Lost to Follow-up|14
301290|NCT01601821|1016911|P1|Overall Study|Lost to Follow-up|6
301291|NCT01601821|1016910|P2|Overall Study|Protocol Violation|2
301292|NCT01601821|1016911|P1|Overall Study|Protocol Violation|2
301293|NCT01601821|1016910|P2|Overall Study|Death|5
301294|NCT01601821|1016911|P1|Overall Study|Death|2
301295|NCT01601704|1016947|P2|Overall Study|Randomized but not dispensed study med|4
301296|NCT01601704|1016948|P1|Overall Study|Randomized but not dispensed study med|1
301297|NCT01601626|1016969|P3|Overall Study|Not Willing to Adhere to Requirements|0
301298|NCT01601626|1016970|P2|Overall Study|Not Willing to Adhere to Requirements|0
301299|NCT01601626|1016971|P1|Overall Study|Not Willing to Adhere to Requirements|1
301300|NCT01601626|1016969|P3|Overall Study|Withdrawal by Subject|1
301301|NCT01601626|1016970|P2|Overall Study|Withdrawal by Subject|1
301302|NCT01601626|1016971|P1|Overall Study|Withdrawal by Subject|0
301303|NCT01601626|1016969|P3|Overall Study|Unable to Get to Clinic|0
301304|NCT01601626|1016970|P2|Overall Study|Unable to Get to Clinic|1
301305|NCT01601626|1016971|P1|Overall Study|Unable to Get to Clinic|0
301306|NCT01601626|1016969|P3|Overall Study|Lost to Follow-up|0
301307|NCT01601626|1016970|P2|Overall Study|Lost to Follow-up|2
301308|NCT01601626|1016971|P1|Overall Study|Lost to Follow-up|1
301309|NCT01601626|1016969|P3|Overall Study|Death|1
301310|NCT01601626|1016970|P2|Overall Study|Death|1
301311|NCT01601626|1016971|P1|Overall Study|Death|1
301312|NCT01601470|1017054|P1|Period 2 - LCZ696|Physician Decision|1
301313|NCT01601132|1017125|P1|Overall Study|Protocol deviation|1
301314|NCT01601132|1017125|P1|Overall Study|Patient withdrew consent|1
301315|NCT01600885|1017159|P2|First Period|moved out of area|0
301316|NCT01600885|1017160|P1|First Period|moved out of area|1
301317|NCT01600885|1017159|P2|First Period|Adverse Event|1
301318|NCT01600885|1017160|P1|First Period|Adverse Event|1
301319|NCT01600716|1017177|P2|Overall Study|Adverse Event|1
301320|NCT01600716|1017178|P1|Overall Study|Adverse Event|1
301321|NCT01600716|1017177|P2|Overall Study|Lack of Efficacy|1
301322|NCT01600716|1017178|P1|Overall Study|Lack of Efficacy|2
301323|NCT01600716|1017177|P2|Overall Study|Pregnancy|0
301324|NCT01600716|1017178|P1|Overall Study|Pregnancy|1
301325|NCT01600716|1017177|P2|Overall Study|Lost to Follow-up|2
301326|NCT01600716|1017178|P1|Overall Study|Lost to Follow-up|0
301327|NCT01600716|1017177|P2|Overall Study|Personal Reasons|2
301328|NCT01600716|1017178|P1|Overall Study|Personal Reasons|0
301329|NCT01600716|1017177|P2|Overall Study|Other Reasons|1
301330|NCT01600716|1017178|P1|Overall Study|Other Reasons|3
301331|NCT01600586|1017218|P2|Overall Study|Physician Decision|3
301332|NCT01600586|1017219|P1|Overall Study|Physician Decision|3
301333|NCT01600326|1017271|P2|Overall Study|Lost to Follow-up|1
301334|NCT01600326|1017272|P1|Overall Study|Lost to Follow-up|1
301335|NCT01600092|1017348|P2|Overall Study|Randomized but not vaccinated|3
301336|NCT01600092|1017349|P1|Overall Study|Randomized but not vaccinated|3
301337|NCT01600092|1017348|P2|Overall Study|Physician Decision|1
301338|NCT01600092|1017349|P1|Overall Study|Physician Decision|1
301339|NCT01600092|1017348|P2|Overall Study|Withdrawal by parent/guardian|6
301340|NCT01600092|1017349|P1|Overall Study|Withdrawal by parent/guardian|8
301341|NCT01600092|1017348|P2|Overall Study|Lost to Follow-up|6
301342|NCT01600092|1017349|P1|Overall Study|Lost to Follow-up|4
301343|NCT01600092|1017348|P2|Overall Study|Adverse Event|0
301344|NCT01600092|1017349|P1|Overall Study|Adverse Event|2
301345|NCT01600053|1017363|P1|Overall Study|trial will not meet the interim endpoint|9
301346|NCT01600053|1017363|P1|Overall Study|Adverse Event|2
301347|NCT01600014|1017368|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
301348|NCT01600014|1017369|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
301349|NCT01600014|1017368|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
301350|NCT01600014|1017369|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
301351|NCT01600014|1017368|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
301352|NCT01600014|1017369|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
301353|NCT01600014|1017368|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
301354|NCT01600014|1017369|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
301355|NCT01600014|1017368|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
301356|NCT01600014|1017369|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
301357|NCT01600014|1017368|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
301358|NCT01600014|1017369|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
301359|NCT01600014|1017368|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
301360|NCT01600014|1017369|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
301361|NCT01600014|1017368|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
301362|NCT01600014|1017369|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
301363|NCT01600014|1017368|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
301364|NCT01600014|1017369|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
301365|NCT01600014|1017368|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
301366|NCT01600014|1017369|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
301367|NCT01600014|1017368|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
301368|NCT01600014|1017369|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
301369|NCT01600014|1017368|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
301370|NCT01600014|1017369|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
301371|NCT01600014|1017368|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
301372|NCT01600014|1017369|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
301373|NCT01600014|1017368|P2|1. Cycle & Observation Period D1 to W52|Other|0
301374|NCT01600014|1017369|P1|1. Cycle & Observation Period D1 to W52|Other|27
301375|NCT01600014|1017368|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
301376|NCT01600014|1017369|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
301377|NCT01600014|1017368|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
301378|NCT01600014|1017369|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
301379|NCT01600014|1017368|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
301380|NCT01600014|1017369|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
301381|NCT01599806|1017397|P2|Overall Study|Other Eligibility criteria|9
301382|NCT01599806|1017398|P1|Overall Study|Other Eligibility criteria|11
301383|NCT01599806|1017397|P2|Overall Study|Withdrawal by Subject|12
301384|NCT01599806|1017398|P1|Overall Study|Withdrawal by Subject|12
301385|NCT01599806|1017397|P2|Overall Study|Lost to Follow-up|20
301386|NCT01599806|1017398|P1|Overall Study|Lost to Follow-up|20
301387|NCT01599650|1017531|P3|Overall Study|Adverse Event|4
301388|NCT01599650|1017532|P2|Overall Study|Adverse Event|8
301389|NCT01599650|1017533|P1|Overall Study|Adverse Event|3
301390|NCT01599650|1017531|P3|Overall Study|Withdrawal by Subject|10
301391|NCT01599650|1017532|P2|Overall Study|Withdrawal by Subject|11
301392|NCT01599650|1017533|P1|Overall Study|Withdrawal by Subject|11
301393|NCT01599650|1017531|P3|Overall Study|Lost to Follow-up|3
301394|NCT01599650|1017532|P2|Overall Study|Lost to Follow-up|3
301395|NCT01599650|1017533|P1|Overall Study|Lost to Follow-up|3
301396|NCT01599650|1017531|P3|Overall Study|Death|2
301397|NCT01599650|1017532|P2|Overall Study|Death|1
301398|NCT01599650|1017533|P1|Overall Study|Death|2
301399|NCT01599650|1017531|P3|Overall Study|Protocol Violation|0
301400|NCT01599650|1017532|P2|Overall Study|Protocol Violation|3
301401|NCT01599650|1017533|P1|Overall Study|Protocol Violation|0
301402|NCT01599650|1017531|P3|Overall Study|Physician Decision|7
301403|NCT01599650|1017532|P2|Overall Study|Physician Decision|0
301404|NCT01599650|1017533|P1|Overall Study|Physician Decision|2
301405|NCT01599650|1017531|P3|Overall Study|Administrative issue|1
301406|NCT01599650|1017532|P2|Overall Study|Administrative issue|0
301407|NCT01599650|1017533|P1|Overall Study|Administrative issue|1
301408|NCT01599637|1017572|P3|Overall Study|Adverse Event|0
301409|NCT01599637|1017573|P2|Overall Study|Adverse Event|0
301410|NCT01599637|1017574|P1|Overall Study|Adverse Event|1
301411|NCT01599637|1017572|P3|Overall Study|administrative problems|0
301412|NCT01599637|1017573|P2|Overall Study|administrative problems|2
301413|NCT01599637|1017574|P1|Overall Study|administrative problems|0
301414|NCT01599585|1017621|P2|Overall Study|randomized did not start treatment|3
301415|NCT01599585|1017622|P1|Overall Study|randomized did not start treatment|3
301416|NCT01599585|1017621|P2|Overall Study|Lost to Follow-up|5
301417|NCT01599585|1017622|P1|Overall Study|Lost to Follow-up|3
301418|NCT01599585|1017621|P2|Overall Study|Withdrawal by Subject|9
301419|NCT01599585|1017622|P1|Overall Study|Withdrawal by Subject|16
301420|NCT01599325|1017660|P1|Overall Study|Other|2
301421|NCT01599325|1017660|P1|Overall Study|Lack of Therapeutic Effect|9
301422|NCT01599325|1017660|P1|Overall Study|Protocol Violation|1
301423|NCT01599325|1017660|P1|Overall Study|Death|13
301424|NCT01599325|1017660|P1|Overall Study|Withdrawal by Subject|20
301425|NCT01599325|1017660|P1|Overall Study|Disease Progression|7
301426|NCT01599325|1017660|P1|Overall Study|Adverse Event|5
301427|NCT01599234|1017682|P2|Overall Study|Pregnancy|1
301428|NCT01599234|1017683|P1|Overall Study|Pregnancy|0
301429|NCT01599234|1017682|P2|Overall Study|Contra-indication discovered|1
301430|NCT01599234|1017683|P1|Overall Study|Contra-indication discovered|0
301431|NCT01599234|1017682|P2|Overall Study|Patient would not stop driving|0
301432|NCT01599234|1017683|P1|Overall Study|Patient would not stop driving|1
301433|NCT01599234|1017682|P2|Overall Study|Death|0
301434|NCT01599234|1017683|P1|Overall Study|Death|1
301435|NCT01599234|1017682|P2|Overall Study|Sponsor request as creatinine levels <50|1
301436|NCT01599234|1017683|P1|Overall Study|Sponsor request as creatinine levels <50|0
301437|NCT01599234|1017682|P2|Overall Study|Unable to operate spray|0
301438|NCT01599234|1017683|P1|Overall Study|Unable to operate spray|1
301439|NCT01599234|1017682|P2|Overall Study|Lack of Efficacy|4
301440|NCT01599234|1017683|P1|Overall Study|Lack of Efficacy|2
301441|NCT01599234|1017682|P2|Overall Study|Lost to Follow-up|2
301442|NCT01599234|1017683|P1|Overall Study|Lost to Follow-up|1
301443|NCT01599234|1017682|P2|Overall Study|Withdrawal by Subject|1
301444|NCT01599234|1017683|P1|Overall Study|Withdrawal by Subject|2
301445|NCT01599234|1017682|P2|Overall Study|Adverse Event|5
301446|NCT01599234|1017683|P1|Overall Study|Adverse Event|9
301447|NCT01599104|1017708|P3|Overall Study|Adverse Event|12
301448|NCT01599104|1017709|P2|Overall Study|Adverse Event|6
301449|NCT01599104|1017710|P1|Overall Study|Adverse Event|7
301450|NCT01599104|1017708|P3|Overall Study|Lack of Efficacy|10
301451|NCT01599104|1017709|P2|Overall Study|Lack of Efficacy|4
301452|NCT01599104|1017710|P1|Overall Study|Lack of Efficacy|4
301453|NCT01599104|1017708|P3|Overall Study|Non-compliance with study treatment|0
301454|NCT01599104|1017709|P2|Overall Study|Non-compliance with study treatment|1
301455|NCT01599104|1017710|P1|Overall Study|Non-compliance with study treatment|0
301456|NCT01599104|1017708|P3|Overall Study|Physician Decision|2
301457|NCT01599104|1017709|P2|Overall Study|Physician Decision|2
301458|NCT01599104|1017710|P1|Overall Study|Physician Decision|3
301459|NCT01599104|1017708|P3|Overall Study|Technical Problems|0
301460|NCT01599104|1017709|P2|Overall Study|Technical Problems|0
301461|NCT01599104|1017710|P1|Overall Study|Technical Problems|1
301462|NCT01599104|1017708|P3|Overall Study|Withdrawal by Subject|2
301463|NCT01599104|1017709|P2|Overall Study|Withdrawal by Subject|1
301464|NCT01599104|1017710|P1|Overall Study|Withdrawal by Subject|1
301465|NCT01598987|1017748|P1|Baseline to 24 Month|Lost to Follow-up|1
301466|NCT01598987|1017748|P1|Baseline to 24 Month|Administrative problems|2
301467|NCT01598987|1017748|P1|Baseline to 24 Month|Withdrawal by Subject|5
301468|NCT01598987|1017748|P1|Baseline to Month 12|Withdrawal by Subject|4
301469|NCT01598987|1017748|P1|Baseline to Month 12|Administrative problems|2
301470|NCT01598610|1017814|P1|Overall Study|Adverse Event|1
301471|NCT01598532|1017831|P1|Overall Study|Did not meet inclusion criteria|8
301472|NCT01598532|1017831|P1|Overall Study|Lost to Follow-up|3
301473|NCT01598506|1017840|P1|Overall Study|Withdrawal by Subject|2
301474|NCT01598311|1017860|P2|Overall Study|Assigned to CB but received vancomycin|0
301475|NCT01598311|1017861|P1|Overall Study|Assigned to CB but received vancomycin|1
301476|NCT01598311|1017860|P2|Overall Study|Treated but no confirmed CDAD|8
301477|NCT01598311|1017861|P1|Overall Study|Treated but no confirmed CDAD|9
301478|NCT01598311|1017860|P2|Overall Study|Randomized but never treated|5
301479|NCT01598311|1017861|P1|Overall Study|Randomized but never treated|8
301480|NCT01598311|1017860|P2|Overall Study|No reason provided.|5
301481|NCT01598311|1017861|P1|Overall Study|No reason provided.|0
301482|NCT01598311|1017860|P2|Overall Study|Withdrawal by Subject|13
301483|NCT01598311|1017861|P1|Overall Study|Withdrawal by Subject|9
301484|NCT01598311|1017860|P2|Overall Study|Lost to Follow-up|12
301485|NCT01598311|1017861|P1|Overall Study|Lost to Follow-up|7
301486|NCT01598311|1017860|P2|Overall Study|Adverse Event|13
301487|NCT01598311|1017861|P1|Overall Study|Adverse Event|9
301488|NCT01598311|1017860|P2|Overall Study|Physician Decision|5
301489|NCT01598311|1017861|P1|Overall Study|Physician Decision|4
301490|NCT01598298|1017877|P2|Overall Study|Other reason (not protocol specified)|0
301491|NCT01598298|1017878|P1|Overall Study|Other reason (not protocol specified)|4
301492|NCT01598298|1017877|P2|Overall Study|Withdrawal by Subject|15
301493|NCT01598298|1017878|P1|Overall Study|Withdrawal by Subject|10
301494|NCT01598298|1017877|P2|Overall Study|Progression/relapse|2
301495|NCT01598298|1017878|P1|Overall Study|Progression/relapse|0
301496|NCT01598298|1017877|P2|Overall Study|Adverse Event|19
301497|NCT01598298|1017878|P1|Overall Study|Adverse Event|21
301498|NCT01598298|1017877|P2|Overall Study|Not eligible|5
301499|NCT01598298|1017878|P1|Overall Study|Not eligible|5
301500|NCT01598129|1017909|P1|Overall Study|Withdrawal by Subject|1
301501|NCT01598129|1017909|P1|Overall Study|Deterioration of WHO status to WHO 4|2
301502|NCT01598129|1017909|P1|Overall Study|Disease progression|6
301503|NCT01597908|1017942|P2|Overall Study|Ongoing|202
301504|NCT01597908|1017943|P1|Overall Study|Ongoing|236
301505|NCT01597908|1017942|P2|Overall Study|Withdrawal by Subject|18
301506|NCT01597908|1017943|P1|Overall Study|Withdrawal by Subject|10
301507|NCT01597908|1017942|P2|Overall Study|Physician Decision|1
301508|NCT01597908|1017943|P1|Overall Study|Physician Decision|2
301509|NCT01597908|1017942|P2|Overall Study|Lost to Follow-up|9
301510|NCT01597908|1017943|P1|Overall Study|Lost to Follow-up|4
301511|NCT01597908|1017942|P2|Overall Study|Death|122
301512|NCT01597908|1017943|P1|Overall Study|Death|100
301513|NCT01597791|1017970|P2|Overall Study|Protocol Violation|1
301514|NCT01597791|1017971|P1|Overall Study|Protocol Violation|0
301515|NCT01597791|1017970|P2|Overall Study|Subject withdrawal|1
301516|NCT01597791|1017971|P1|Overall Study|Subject withdrawal|0
301517|NCT01597791|1017970|P2|Overall Study|Cesarean Section|7
301518|NCT01597791|1017971|P1|Overall Study|Cesarean Section|6
301519|NCT01597791|1017970|P2|Overall Study|Physician Decision|1
301520|NCT01597791|1017971|P1|Overall Study|Physician Decision|2
301521|NCT01597635|1017980|P3|Part B|Withdrawal by Subject|0
301522|NCT01597635|1017981|P2|Part B|Withdrawal by Subject|1
301523|NCT01597635|1017982|P1|Part B|Withdrawal by Subject|0
301524|NCT01597635|1017980|P3|Part B|Protocol-defined stopping criteria|3
301525|NCT01597635|1017981|P2|Part B|Protocol-defined stopping criteria|4
301526|NCT01597635|1017982|P1|Part B|Protocol-defined stopping criteria|0
301527|NCT01597635|1017980|P3|Part B|Protocol Violation|0
301528|NCT01597635|1017981|P2|Part B|Protocol Violation|1
301529|NCT01597635|1017982|P1|Part B|Protocol Violation|0
301530|NCT01597635|1017980|P3|Part B|Adverse Event|1
301531|NCT01597635|1017981|P2|Part B|Adverse Event|0
301532|NCT01597635|1017982|P1|Part B|Adverse Event|0
301533|NCT01597635|1017980|P3|Part A|Adverse Event|0
301534|NCT01597635|1017981|P2|Part A|Adverse Event|0
301535|NCT01597635|1017982|P1|Part A|Adverse Event|3
301536|NCT01597596|1018047|P2|Overall Study|Physician Decision|1
301537|NCT01597596|1018048|P1|Overall Study|Physician Decision|0
301538|NCT01597596|1018047|P2|Overall Study|Study terminated by sponsor|0
301539|NCT01597596|1018048|P1|Overall Study|Study terminated by sponsor|1
301540|NCT01597505|1018062|P2|Overall Study|Missing|0
301541|NCT01597505|1018063|P1|Overall Study|Missing|1
301542|NCT01597505|1018062|P2|Overall Study|Other|6
301543|NCT01597505|1018063|P1|Overall Study|Other|5
301544|NCT01597505|1018062|P2|Overall Study|Withdrawal by Subject|18
301545|NCT01597505|1018063|P1|Overall Study|Withdrawal by Subject|10
301546|NCT01597505|1018062|P2|Overall Study|Lost to Follow-up|2
301547|NCT01597505|1018063|P1|Overall Study|Lost to Follow-up|4
301548|NCT01597505|1018062|P2|Overall Study|Adverse Event|7
301549|NCT01597505|1018063|P1|Overall Study|Adverse Event|19
301550|NCT01597505|1018062|P2|Overall Study|Physician Decision|0
301551|NCT01597505|1018063|P1|Overall Study|Physician Decision|5
301552|NCT01597492|1018097|P2|Overall Study|Other Reason|0
301553|NCT01597492|1018098|P1|Overall Study|Other Reason|2
301554|NCT01597492|1018097|P2|Overall Study|Lost to Follow-up|2
301555|NCT01597492|1018098|P1|Overall Study|Lost to Follow-up|0
301556|NCT01597492|1018097|P2|Overall Study|Adverse Event|0
301557|NCT01597492|1018098|P1|Overall Study|Adverse Event|3
301558|NCT01597492|1018097|P2|Overall Study|Withdrawal by Subject|2
301559|NCT01597492|1018098|P1|Overall Study|Withdrawal by Subject|1
301560|NCT01597479|1018106|P2|Overall Study|Lost to Follow-up|0
301561|NCT01597479|1018107|P1|Overall Study|Lost to Follow-up|1
301562|NCT01597479|1018106|P2|Overall Study|Protocol Violation|0
301563|NCT01597479|1018107|P1|Overall Study|Protocol Violation|1
301564|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301565|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301566|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
301567|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301568|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301569|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301570|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301571|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301572|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301573|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301574|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301575|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301576|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
301577|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301578|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
301579|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
301580|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
301581|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
301582|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301583|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
301584|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301585|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301586|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301587|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301588|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301589|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
301590|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
301591|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
301592|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
301593|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
301594|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
301595|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
301596|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
301597|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
301598|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
301599|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
301600|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
301601|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
301602|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
301603|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
301604|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301605|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
301606|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
301607|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
301608|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301609|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301610|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301611|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
301612|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301613|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301614|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301615|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
301616|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
301617|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
301618|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
301619|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
301620|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
301621|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
301622|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
301623|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
301624|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
301625|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
301626|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
301627|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
301628|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
301629|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
301630|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
301631|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
301632|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
301633|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
301634|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
301635|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
301636|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
301637|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
301638|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
301639|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
301640|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
301641|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
301642|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
301643|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
301644|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
301645|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301646|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
301647|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301648|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
301649|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301650|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301651|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301652|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301653|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301654|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
301655|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301656|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301657|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301658|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
301659|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301660|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
301661|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
301662|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
301663|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
301664|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301665|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301666|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301667|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
301668|NCT01597245|1018129|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301669|NCT01597245|1018130|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301670|NCT01597245|1018131|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301671|NCT01597245|1018132|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301672|NCT01597245|1018133|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301673|NCT01597245|1018134|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301674|NCT01597245|1018135|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
301675|NCT01597245|1018136|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
301676|NCT01597245|1018137|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301677|NCT01597245|1018138|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301678|NCT01597245|1018139|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301679|NCT01597245|1018140|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301680|NCT01597245|1018141|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
301681|NCT01597245|1018129|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301682|NCT01597245|1018130|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301683|NCT01597245|1018131|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301684|NCT01597245|1018132|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301685|NCT01597245|1018133|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301686|NCT01597245|1018134|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301687|NCT01597245|1018135|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301688|NCT01597245|1018136|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301689|NCT01597245|1018137|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301690|NCT01597245|1018138|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
301691|NCT01597245|1018139|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
301692|NCT01597245|1018140|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
301693|NCT01597245|1018141|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
301694|NCT01597245|1018129|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
301695|NCT01597245|1018130|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
301696|NCT01597245|1018131|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
301697|NCT01597245|1018132|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
301698|NCT01597245|1018133|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
301699|NCT01597245|1018134|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
301700|NCT01597245|1018135|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
301701|NCT01597245|1018136|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
301702|NCT01597245|1018137|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
301703|NCT01597245|1018138|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
301704|NCT01597245|1018139|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
301705|NCT01597245|1018140|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
301706|NCT01597245|1018141|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
301707|NCT01597245|1018129|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301708|NCT01597245|1018130|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301709|NCT01597245|1018131|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301710|NCT01597245|1018132|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301711|NCT01597245|1018133|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301712|NCT01597245|1018134|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301713|NCT01597245|1018135|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301714|NCT01597245|1018136|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301715|NCT01597245|1018137|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301716|NCT01597245|1018138|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
301717|NCT01597245|1018139|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
301718|NCT01597245|1018140|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
301719|NCT01597245|1018141|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
301720|NCT01597245|1018129|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301721|NCT01597245|1018130|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301722|NCT01597245|1018131|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301723|NCT01597245|1018132|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301724|NCT01597245|1018133|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301725|NCT01597245|1018134|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301726|NCT01597245|1018135|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301727|NCT01597245|1018136|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301728|NCT01597245|1018137|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
301729|NCT01597245|1018138|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
301730|NCT01597245|1018139|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
301731|NCT01597245|1018140|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
301732|NCT01597245|1018141|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
301733|NCT01597245|1018129|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301734|NCT01597245|1018130|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301735|NCT01597245|1018131|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301736|NCT01597245|1018132|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301737|NCT01597245|1018133|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301738|NCT01597245|1018134|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301739|NCT01597245|1018135|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301740|NCT01597245|1018136|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301741|NCT01597245|1018137|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
301742|NCT01597245|1018138|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
301743|NCT01597245|1018139|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
301744|NCT01597245|1018140|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
301745|NCT01597245|1018141|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
301746|NCT01597245|1018129|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
301747|NCT01597245|1018130|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
301748|NCT01597245|1018131|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
301749|NCT01597245|1018132|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
301750|NCT01597245|1018133|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
301751|NCT01597245|1018134|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
301752|NCT01597245|1018135|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
301753|NCT01597245|1018136|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
301754|NCT01597245|1018137|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
301755|NCT01597245|1018138|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
301756|NCT01597245|1018139|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
301757|NCT01597245|1018140|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
301758|NCT01597245|1018141|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
301759|NCT01597050|1018264|P2|Overall Study|Withdrawal by Subject|0
301760|NCT01597050|1018265|P1|Overall Study|Withdrawal by Subject|1
301761|NCT01596972|1018273|P2|Overall Study|Withdrawal by Subject|1
301762|NCT01596972|1018274|P1|Overall Study|Withdrawal by Subject|0
301763|NCT01596972|1018273|P2|Overall Study|Lost to Follow-up|4
301764|NCT01596972|1018274|P1|Overall Study|Lost to Follow-up|0
301765|NCT01596972|1018273|P2|Overall Study|Physician Decision|9
301766|NCT01596972|1018274|P1|Overall Study|Physician Decision|1
301767|NCT01596582|1018297|P2|Overall Study|Missing all outcome data|1
301768|NCT01596582|1018298|P1|Overall Study|Missing all outcome data|1
301769|NCT01596582|1018297|P2|Overall Study|Deemed ineligible after study visit|6
301770|NCT01596582|1018298|P1|Overall Study|Deemed ineligible after study visit|3
301771|NCT01596504|1018325|P3|Overall Study|Withdrawal by Subject|0
301772|NCT01596504|1018326|P2|Overall Study|Withdrawal by Subject|0
301773|NCT01596504|1018327|P1|Overall Study|Withdrawal by Subject|1
301774|NCT01596504|1018325|P3|Overall Study|Adverse Event|1
301775|NCT01596504|1018326|P2|Overall Study|Adverse Event|2
301776|NCT01596504|1018327|P1|Overall Study|Adverse Event|1
301777|NCT01596504|1018325|P3|Overall Study|Participant's Private Reason|0
301778|NCT01596504|1018326|P2|Overall Study|Participant's Private Reason|1
301779|NCT01596504|1018327|P1|Overall Study|Participant's Private Reason|0
301780|NCT01596127|1018409|P1|Overall Study|Patient Ineligible|1
301781|NCT01596062|1018421|P3|Overall Study|Lack of Efficacy|1
301782|NCT01596062|1018422|P2|Overall Study|Lack of Efficacy|0
301783|NCT01596062|1018423|P1|Overall Study|Lack of Efficacy|0
301784|NCT01596062|1018421|P3|Overall Study|Adverse Event|2
301785|NCT01596062|1018422|P2|Overall Study|Adverse Event|0
301786|NCT01596062|1018423|P1|Overall Study|Adverse Event|1
301787|NCT01595646|1018487|P3|Overall Study|Withdrawal by Subject|0
301788|NCT01595646|1018488|P2|Overall Study|Withdrawal by Subject|0
301789|NCT01595646|1018489|P1|Overall Study|Withdrawal by Subject|1
301790|NCT01595438|1018511|P2|Overall Study|Other Eligibility criteria|9
301791|NCT01595438|1018512|P1|Overall Study|Other Eligibility criteria|11
301792|NCT01595438|1018511|P2|Overall Study|Withdrawal by Subject|12
301793|NCT01595438|1018512|P1|Overall Study|Withdrawal by Subject|12
301794|NCT01595438|1018511|P2|Overall Study|Lost to Follow-up|20
301795|NCT01595438|1018512|P1|Overall Study|Lost to Follow-up|20
301796|NCT01594970|1018681|P3|Overall Study|Lost to Follow-up|37
301797|NCT01594970|1018682|P2|Overall Study|Lost to Follow-up|54
301798|NCT01594970|1018683|P1|Overall Study|Lost to Follow-up|54
301799|NCT01594970|1018681|P3|Overall Study|Adverse Event|23
301800|NCT01594970|1018682|P2|Overall Study|Adverse Event|23
301801|NCT01594970|1018683|P1|Overall Study|Adverse Event|17
301802|NCT01594970|1018681|P3|Overall Study|Non-Adverse Event Related|6
301803|NCT01594970|1018682|P2|Overall Study|Non-Adverse Event Related|5
301804|NCT01594970|1018683|P1|Overall Study|Non-Adverse Event Related|4
301805|NCT01594762|1018702|P2|Overall Study|Lost to Follow-up|10
301806|NCT01594762|1018703|P1|Overall Study|Lost to Follow-up|10
301807|NCT01594762|1018702|P2|Overall Study|Withdrawal by Subject|0
301808|NCT01594762|1018703|P1|Overall Study|Withdrawal by Subject|1
301809|NCT01594749|1018715|P2|Overall Study|Lost Source Documentation|0
301810|NCT01594749|1018716|P1|Overall Study|Lost Source Documentation|1
301811|NCT01594749|1018715|P2|Overall Study|Not Treated|10
301812|NCT01594749|1018716|P1|Overall Study|Not Treated|4
301813|NCT01594749|1018715|P2|Overall Study|Death|3
301814|NCT01594749|1018716|P1|Overall Study|Death|9
301815|NCT01594749|1018715|P2|Overall Study|Lost to Follow-up|0
301816|NCT01594749|1018716|P1|Overall Study|Lost to Follow-up|1
301817|NCT01594749|1018715|P2|Overall Study|Non-compliance with Protocol|1
301818|NCT01594749|1018716|P1|Overall Study|Non-compliance with Protocol|0
301819|NCT01594749|1018715|P2|Overall Study|Physician Decision|1
301820|NCT01594749|1018716|P1|Overall Study|Physician Decision|1
301821|NCT01594749|1018715|P2|Overall Study|Protocol Violation|0
301822|NCT01594749|1018716|P1|Overall Study|Protocol Violation|2
301823|NCT01594749|1018715|P2|Overall Study|Withdrawal by Subject|2
301824|NCT01594749|1018716|P1|Overall Study|Withdrawal by Subject|2
301825|NCT01594749|1018715|P2|Overall Study|Adverse Event|1
301826|NCT01594749|1018716|P1|Overall Study|Adverse Event|2
301827|NCT01594411|1018845|P1|Overall Study|Lost to Follow-up|2
301828|NCT01594125|1018899|P5|Overall Study|Progressive Disease|7
301829|NCT01594125|1018900|P4|Overall Study|Progressive Disease|3
301830|NCT01594125|1018901|P3|Overall Study|Progressive Disease|3
301831|NCT01594125|1018902|P2|Overall Study|Progressive Disease|12
301832|NCT01594125|1018903|P1|Overall Study|Progressive Disease|3
301833|NCT01594125|1018899|P5|Overall Study|Withdrawal by Subject|0
301834|NCT01594125|1018900|P4|Overall Study|Withdrawal by Subject|1
301835|NCT01594125|1018901|P3|Overall Study|Withdrawal by Subject|0
301836|NCT01594125|1018902|P2|Overall Study|Withdrawal by Subject|0
301837|NCT01594125|1018903|P1|Overall Study|Withdrawal by Subject|1
301838|NCT01593787|1018963|P3|Overall Study|Adverse Event|0
301839|NCT01593787|1018964|P2|Overall Study|Adverse Event|0
301840|NCT01593787|1018965|P1|Overall Study|Adverse Event|1
301841|NCT01592864|1019052|P2|Overall Study|Withdrawal by Subject|1
301842|NCT01592864|1019053|P1|Overall Study|Withdrawal by Subject|0
301843|NCT01592786|1019084|P1|Overall Study|Other|3
301844|NCT01592786|1019084|P1|Overall Study|Lost to Follow-up|19
301845|NCT01592786|1019084|P1|Overall Study|Withdrawal by Subject|23
301846|NCT01592786|1019084|P1|Overall Study|Protocol Violation|14
301847|NCT01592786|1019084|P1|Overall Study|Lack of Efficacy|19
301848|NCT01592786|1019084|P1|Overall Study|Adverse Event|60
301849|NCT01592773|1019088|P1|Overall Study|Other Reason|1
301850|NCT01592773|1019088|P1|Overall Study|Inclusion/exclusion not meet|1
301851|NCT01592773|1019088|P1|Overall Study|Protocol Violation|2
301852|NCT01592773|1019088|P1|Overall Study|Lack of Efficacy|9
301853|NCT01592773|1019088|P1|Overall Study|Adverse Event|17
301854|NCT01592773|1019088|P1|Overall Study|Lost to Follow-up|19
301855|NCT01592773|1019088|P1|Overall Study|Withdrawal by Subject|35
301856|NCT01592773|1019088|P1|Overall Study|Study Terminated by Sponsor|582
301857|NCT01592760|1019095|P3|24-hour Follow-Up|Lost to Follow-up|2
301858|NCT01592760|1019096|P2|24-hour Follow-Up|Lost to Follow-up|3
301859|NCT01592760|1019097|P1|24-hour Follow-Up|Lost to Follow-up|4
301860|NCT01592708|1019140|P2|Overall Study|Protocol Violation|0
301861|NCT01592708|1019141|P1|Overall Study|Protocol Violation|3
301862|NCT01592695|1019157|P2|Overall Study|Lost to Follow-up|4
301863|NCT01592695|1019158|P1|Overall Study|Lost to Follow-up|8
301864|NCT01592344|1019202|P2|Overall Study|not available at primary outcome visit|4
301865|NCT01592344|1019203|P1|Overall Study|not available at primary outcome visit|2
301866|NCT01592344|1019202|P2|Overall Study|Lack of Efficacy|0
301867|NCT01592344|1019203|P1|Overall Study|Lack of Efficacy|1
301868|NCT01592344|1019202|P2|Overall Study|Adverse Event|1
301869|NCT01592344|1019203|P1|Overall Study|Adverse Event|1
301870|NCT01592292|1019217|P4|Overall Study|Not specified|1
301871|NCT01592292|1019218|P3|Overall Study|Not specified|2
301872|NCT01592292|1019219|P2|Overall Study|Not specified|1
301873|NCT01592292|1019220|P1|Overall Study|Not specified|1
301874|NCT01592292|1019217|P4|Overall Study|Withdrew consent|0
301875|NCT01592292|1019218|P3|Overall Study|Withdrew consent|0
301876|NCT01592292|1019219|P2|Overall Study|Withdrew consent|1
301877|NCT01592292|1019220|P1|Overall Study|Withdrew consent|2
301878|NCT01592292|1019217|P4|Overall Study|Follow-up loss|0
301879|NCT01592292|1019218|P3|Overall Study|Follow-up loss|1
301880|NCT01592292|1019219|P2|Overall Study|Follow-up loss|3
301881|NCT01592292|1019220|P1|Overall Study|Follow-up loss|3
301882|NCT01592240|1019259|P7|Overall Study|Did Not Meet Entrance Criteria|0
301883|NCT01592240|1019260|P6|Overall Study|Did Not Meet Entrance Criteria|0
301884|NCT01592240|1019261|P5|Overall Study|Did Not Meet Entrance Criteria|0
301885|NCT01592240|1019262|P4|Overall Study|Did Not Meet Entrance Criteria|0
301886|NCT01592240|1019263|P3|Overall Study|Did Not Meet Entrance Criteria|1
301887|NCT01592240|1019264|P2|Overall Study|Did Not Meet Entrance Criteria|0
301888|NCT01592240|1019265|P1|Overall Study|Did Not Meet Entrance Criteria|1
301889|NCT01592240|1019259|P7|Overall Study|Other|1
301890|NCT01592240|1019260|P6|Overall Study|Other|0
301891|NCT01592240|1019261|P5|Overall Study|Other|0
301892|NCT01592240|1019262|P4|Overall Study|Other|1
301893|NCT01592240|1019263|P3|Overall Study|Other|1
301894|NCT01592240|1019264|P2|Overall Study|Other|3
301895|NCT01592240|1019265|P1|Overall Study|Other|0
301896|NCT01592240|1019259|P7|Overall Study|Withdrawal by Subject|2
301897|NCT01592240|1019260|P6|Overall Study|Withdrawal by Subject|0
301898|NCT01592240|1019261|P5|Overall Study|Withdrawal by Subject|3
301899|NCT01592240|1019262|P4|Overall Study|Withdrawal by Subject|1
301900|NCT01592240|1019263|P3|Overall Study|Withdrawal by Subject|4
301901|NCT01592240|1019264|P2|Overall Study|Withdrawal by Subject|4
301902|NCT01592240|1019265|P1|Overall Study|Withdrawal by Subject|0
301903|NCT01592240|1019259|P7|Overall Study|Protocol Violation|0
301904|NCT01592240|1019260|P6|Overall Study|Protocol Violation|1
301905|NCT01592240|1019261|P5|Overall Study|Protocol Violation|0
301906|NCT01592240|1019262|P4|Overall Study|Protocol Violation|0
301907|NCT01592240|1019263|P3|Overall Study|Protocol Violation|0
301908|NCT01592240|1019264|P2|Overall Study|Protocol Violation|0
301909|NCT01592240|1019265|P1|Overall Study|Protocol Violation|0
301910|NCT01592240|1019259|P7|Overall Study|Lost to Follow-up|0
301911|NCT01592240|1019260|P6|Overall Study|Lost to Follow-up|2
301912|NCT01592240|1019261|P5|Overall Study|Lost to Follow-up|3
301913|NCT01592240|1019262|P4|Overall Study|Lost to Follow-up|0
301914|NCT01592240|1019263|P3|Overall Study|Lost to Follow-up|1
301915|NCT01592240|1019264|P2|Overall Study|Lost to Follow-up|3
301916|NCT01592240|1019265|P1|Overall Study|Lost to Follow-up|1
301917|NCT01592240|1019259|P7|Overall Study|Death|0
301918|NCT01592240|1019260|P6|Overall Study|Death|0
301919|NCT01592240|1019261|P5|Overall Study|Death|0
301920|NCT01592240|1019262|P4|Overall Study|Death|0
301921|NCT01592240|1019263|P3|Overall Study|Death|0
301922|NCT01592240|1019264|P2|Overall Study|Death|1
301923|NCT01592240|1019265|P1|Overall Study|Death|0
301924|NCT01592240|1019259|P7|Overall Study|Adverse Event|0
301925|NCT01592240|1019260|P6|Overall Study|Adverse Event|0
301926|NCT01592240|1019261|P5|Overall Study|Adverse Event|1
301927|NCT01592240|1019262|P4|Overall Study|Adverse Event|1
301928|NCT01592240|1019263|P3|Overall Study|Adverse Event|0
301929|NCT01592240|1019264|P2|Overall Study|Adverse Event|0
301930|NCT01592240|1019265|P1|Overall Study|Adverse Event|1
301931|NCT01592045|1019458|P2|Overall Study|Moved out of country|0
301932|NCT01592045|1019459|P1|Overall Study|Moved out of country|2
301933|NCT01592045|1019458|P2|Overall Study|Withdrawal by Subject|0
301934|NCT01592045|1019459|P1|Overall Study|Withdrawal by Subject|1
301935|NCT01592045|1019458|P2|Overall Study|Adverse Event|1
301936|NCT01592045|1019459|P1|Overall Study|Adverse Event|1
301937|NCT01592045|1019458|P2|Overall Study|Disease Progression|1
301938|NCT01592045|1019459|P1|Overall Study|Disease Progression|1
301939|NCT01591863|1019477|P1|Overall Study|Lack of Efficacy|1
301940|NCT01591863|1019477|P1|Overall Study|recurrence|9
301941|NCT01591863|1019477|P1|Overall Study|Withdrawal by Subject|1
301942|NCT01591863|1019477|P1|Overall Study|Adverse Event|3
301943|NCT01591681|1019515|P1|Overall Study|Failed to use system during run-in|1
301944|NCT01591681|1019515|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
301945|NCT01591616|1019541|P1|Overall Study|Withdrawal by Subject|1
301946|NCT01591499|1019682|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
301947|NCT01591499|1019683|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
301948|NCT01591499|1019684|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
301949|NCT01591499|1019685|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
301950|NCT01591499|1019682|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
301951|NCT01591499|1019683|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
301952|NCT01591499|1019684|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
301953|NCT01591499|1019685|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
301954|NCT01591499|1019682|P4|Baseline Visit|Withdrawal by Subject|2
301955|NCT01591499|1019683|P3|Baseline Visit|Withdrawal by Subject|0
301956|NCT01591499|1019684|P2|Baseline Visit|Withdrawal by Subject|2
301957|NCT01591499|1019685|P1|Baseline Visit|Withdrawal by Subject|0
301958|NCT01591460|1019751|P1|Overall Study|Protocol Violation|1
301959|NCT01591460|1019751|P1|Overall Study|Withdrawal by Subject|1
301960|NCT01591460|1019751|P1|Overall Study|Participant Refusal|3
301961|NCT01591460|1019751|P1|Overall Study|Noncompliance|1
301962|NCT01591460|1019751|P1|Overall Study|Lost to Follow-up|1
301963|NCT01591460|1019751|P1|Overall Study|Treatment Discontinued by Error|1
301964|NCT01591460|1019751|P1|Overall Study|Rebound or Breakthrough|3
301965|NCT01591460|1019751|P1|Overall Study|Futility Rule (Week 24)|3
301966|NCT01591460|1019751|P1|Overall Study|Futility Rule (Week 12)|7
301967|NCT01591460|1019751|P1|Overall Study|Adverse Event or Intercurrent Illness|5
301968|NCT01591382|1019842|P2|Overall Study|Participant Opted for Morphine PCA|1
301969|NCT01591382|1019843|P1|Overall Study|Participant Opted for Morphine PCA|1
301970|NCT01591382|1019842|P2|Overall Study|Discharged Prior to Study Completion|1
301971|NCT01591382|1019843|P1|Overall Study|Discharged Prior to Study Completion|2
301972|NCT01591096|1019888|P1|Overall Study|Adverse Event|1
301973|NCT01590888|1019973|P3|Overall Study|Lost to Follow-up|0
301974|NCT01590888|1019974|P2|Overall Study|Lost to Follow-up|0
301975|NCT01590888|1019975|P1|Overall Study|Lost to Follow-up|1
301976|NCT01590888|1019973|P3|Overall Study|Adverse Event|1
301977|NCT01590888|1019974|P2|Overall Study|Adverse Event|0
301978|NCT01590888|1019975|P1|Overall Study|Adverse Event|3
301979|NCT01590810|1020035|P5|Overall Study|Physician Decision|0
301980|NCT01590810|1020036|P4|Overall Study|Physician Decision|0
301981|NCT01590810|1020037|P3|Overall Study|Physician Decision|1
301982|NCT01590810|1020038|P2|Overall Study|Physician Decision|1
301983|NCT01590810|1020039|P1|Overall Study|Physician Decision|0
301984|NCT01590797|1020184|P2|Overall Study|Other Protocol Specified Criteria|4
301985|NCT01590797|1020185|P1|Overall Study|Other Protocol Specified Criteria|2
301986|NCT01590797|1020184|P2|Overall Study|Withdrawal by Subject|5
301987|NCT01590797|1020185|P1|Overall Study|Withdrawal by Subject|7
301988|NCT01590797|1020184|P2|Overall Study|Protocol Violation|1
301989|NCT01590797|1020185|P1|Overall Study|Protocol Violation|4
301990|NCT01590797|1020184|P2|Overall Study|Lost to Follow-up|1
301991|NCT01590797|1020185|P1|Overall Study|Lost to Follow-up|0
301992|NCT01590797|1020184|P2|Overall Study|Lack of Efficacy|2
301993|NCT01590797|1020185|P1|Overall Study|Lack of Efficacy|0
301994|NCT01590797|1020184|P2|Overall Study|Adverse Event|3
301995|NCT01590797|1020185|P1|Overall Study|Adverse Event|4
301996|NCT01590771|1020201|P2|Overall Study|Adverse Event|7
301997|NCT01590771|1020202|P1|Overall Study|Adverse Event|3
301998|NCT01590771|1020201|P2|Overall Study|Lack of Efficacy|0
301999|NCT01590771|1020202|P1|Overall Study|Lack of Efficacy|1
302000|NCT01590771|1020201|P2|Overall Study|Lost to Follow-up|1
302001|NCT01590771|1020202|P1|Overall Study|Lost to Follow-up|1
302002|NCT01590771|1020201|P2|Overall Study|Protocol Violation|2
302003|NCT01590771|1020202|P1|Overall Study|Protocol Violation|1
302004|NCT01590771|1020201|P2|Overall Study|Withdrawal by Subject|15
302005|NCT01590771|1020202|P1|Overall Study|Withdrawal by Subject|8
302006|NCT01590771|1020201|P2|Overall Study|Other Protocol Specified Criteria|14
302007|NCT01590771|1020202|P1|Overall Study|Other Protocol Specified Criteria|5
302008|NCT01590758|1020230|P2|Overall Study|Lost to Follow-up|2
302009|NCT01590758|1020231|P1|Overall Study|Lost to Follow-up|4
302010|NCT01590758|1020230|P2|Overall Study|Physician Decision|2
302011|NCT01590758|1020231|P1|Overall Study|Physician Decision|1
302012|NCT01590758|1020230|P2|Overall Study|Withdrawal by Subject|3
302013|NCT01590758|1020231|P1|Overall Study|Withdrawal by Subject|0
302014|NCT01590563|1020241|P1|Overall Study|simple uterine hyperplasia - not related|1
302015|NCT01590212|1020269|P3|Overall Study|Lost to Follow-up|3
302016|NCT01590212|1020270|P2|Overall Study|Lost to Follow-up|2
302017|NCT01590212|1020271|P1|Overall Study|Lost to Follow-up|1
302018|NCT01590212|1020269|P3|Overall Study|Withdrawal by Subject|2
302019|NCT01590212|1020270|P2|Overall Study|Withdrawal by Subject|2
302020|NCT01590212|1020271|P1|Overall Study|Withdrawal by Subject|2
302021|NCT01589822|1020315|P3|Overall Study|Missed 90 day visit|1
302022|NCT01589822|1020316|P2|Overall Study|Missed 90 day visit|1
302023|NCT01589822|1020317|P1|Overall Study|Missed 90 day visit|2
302024|NCT01589822|1020315|P3|Overall Study|Death|0
302025|NCT01589822|1020316|P2|Overall Study|Death|0
302026|NCT01589822|1020317|P1|Overall Study|Death|1
302027|NCT01589822|1020315|P3|Overall Study|Withdrawal by Subject|0
302028|NCT01589822|1020316|P2|Overall Study|Withdrawal by Subject|2
302029|NCT01589822|1020317|P1|Overall Study|Withdrawal by Subject|1
302030|NCT01589653|1020336|P2|Overall Study|Unclassified|3
302031|NCT01589653|1020337|P1|Overall Study|Unclassified|0
302032|NCT01589653|1020336|P2|Overall Study|Withdrawal criteria|7
302033|NCT01589653|1020337|P1|Overall Study|Withdrawal criteria|4
302034|NCT01589653|1020336|P2|Overall Study|Protocol Violation|1
302035|NCT01589653|1020337|P1|Overall Study|Protocol Violation|3
302036|NCT01589497|1020385|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
302037|NCT01589497|1020386|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
302038|NCT01589497|1020387|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
302039|NCT01589497|1020388|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
302040|NCT01589497|1020385|P4|Overall Study|Death|0
302041|NCT01589497|1020386|P3|Overall Study|Death|0
302042|NCT01589497|1020387|P2|Overall Study|Death|0
302043|NCT01589497|1020388|P1|Overall Study|Death|1
302044|NCT01589497|1020385|P4|Overall Study|Withdrawal by Subject|1
302045|NCT01589497|1020386|P3|Overall Study|Withdrawal by Subject|0
302046|NCT01589497|1020387|P2|Overall Study|Withdrawal by Subject|1
302047|NCT01589497|1020388|P1|Overall Study|Withdrawal by Subject|0
302048|NCT01589445|1020494|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
302049|NCT01589445|1020494|P1|002 (Metformin)-3 Months|Adverse Event|2
302050|NCT01589445|1020494|P1|002 (Metformin)-3 Months|Protocol Violation|2
302051|NCT01589445|1020494|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
302052|NCT01589445|1020494|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
302053|NCT01589445|1020494|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
302054|NCT01589445|1020494|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
302055|NCT01589445|1020494|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
302056|NCT01589445|1020494|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
302057|NCT01589445|1020494|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
302058|NCT01589237|1020514|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
302059|NCT01589237|1020515|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
302060|NCT01589237|1020516|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
302061|NCT01589237|1020517|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
302062|NCT01589237|1020514|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
302063|NCT01589237|1020515|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
302064|NCT01589237|1020516|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
302065|NCT01589237|1020517|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
302066|NCT01589237|1020514|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
302067|NCT01589237|1020515|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
302068|NCT01589237|1020516|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
302069|NCT01589237|1020517|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
302070|NCT01589237|1020514|P4|Part A (52 Weeks)|Subject/guardian decision|0
302071|NCT01589237|1020515|P3|Part A (52 Weeks)|Subject/guardian decision|2
302072|NCT01589237|1020516|P2|Part A (52 Weeks)|Subject/guardian decision|3
302073|NCT01589237|1020517|P1|Part A (52 Weeks)|Subject/guardian decision|2
302074|NCT01588951|1020566|P3|Overall Study|Ineligible in retrospect|1
302075|NCT01588951|1020567|P2|Overall Study|Ineligible in retrospect|0
302076|NCT01588951|1020568|P1|Overall Study|Ineligible in retrospect|0
302077|NCT01588548|1020599|P6|Overall Study|Condition Under Investigation Worsened|3
302078|NCT01588548|1020600|P5|Overall Study|Condition Under Investigation Worsened|3
302079|NCT01588548|1020601|P4|Overall Study|Condition Under Investigation Worsened|4
302080|NCT01588548|1020602|P3|Overall Study|Condition Under Investigation Worsened|4
302081|NCT01588548|1020603|P2|Overall Study|Condition Under Investigation Worsened|6
302082|NCT01588548|1020604|P1|Overall Study|Condition Under Investigation Worsened|3
302083|NCT01588548|1020599|P6|Overall Study|Adverse Event|0
302084|NCT01588548|1020600|P5|Overall Study|Adverse Event|1
302085|NCT01588548|1020601|P4|Overall Study|Adverse Event|2
302086|NCT01588548|1020602|P3|Overall Study|Adverse Event|1
302087|NCT01588548|1020603|P2|Overall Study|Adverse Event|0
302088|NCT01588548|1020604|P1|Overall Study|Adverse Event|0
302089|NCT01588548|1020599|P6|Overall Study|Withdrawal by Subject|3
302090|NCT01588548|1020600|P5|Overall Study|Withdrawal by Subject|2
302091|NCT01588548|1020601|P4|Overall Study|Withdrawal by Subject|1
302092|NCT01588548|1020602|P3|Overall Study|Withdrawal by Subject|1
302093|NCT01588548|1020603|P2|Overall Study|Withdrawal by Subject|1
302094|NCT01588548|1020604|P1|Overall Study|Withdrawal by Subject|0
302095|NCT01588496|1020621|P3|Overall Study|Withdrawal by Subject|0
302096|NCT01588496|1020622|P2|Overall Study|Withdrawal by Subject|1
302097|NCT01588496|1020623|P1|Overall Study|Withdrawal by Subject|0
302098|NCT01588405|1020673|P1|Overall Study|Clinical Worsening|1
302099|NCT01588405|1020673|P1|Overall Study|Adverse Event|1
302100|NCT01588353|1020700|P3|Step3|Adverse Event|2
302101|NCT01588353|1020701|P2|Step3|Adverse Event|0
302102|NCT01588353|1020702|P1|Step3|Adverse Event|0
302103|NCT01588353|1020700|P3|Step2|Withdrawal by Subject|0
302104|NCT01588353|1020701|P2|Step2|Withdrawal by Subject|1
302105|NCT01588353|1020702|P1|Step2|Withdrawal by Subject|0
302106|NCT01588106|1020745|P2|Overall Study|Withdrawal by Subject|4
302107|NCT01588106|1020746|P1|Overall Study|Withdrawal by Subject|5
302108|NCT01587989|1020754|P3|Randomized Study Treatment|Physician Decision|1
302109|NCT01587989|1020755|P2|Randomized Study Treatment|Physician Decision|0
302110|NCT01587989|1020756|P1|Randomized Study Treatment|Physician Decision|0
302111|NCT01587989|1020754|P3|Randomized Study Treatment|Screening failure|0
302112|NCT01587989|1020755|P2|Randomized Study Treatment|Screening failure|1
302113|NCT01587989|1020756|P1|Randomized Study Treatment|Screening failure|0
302114|NCT01587989|1020754|P3|Randomized Study Treatment|Withdrawal by Subject|0
302115|NCT01587989|1020755|P2|Randomized Study Treatment|Withdrawal by Subject|1
302116|NCT01587989|1020756|P1|Randomized Study Treatment|Withdrawal by Subject|0
302117|NCT01587989|1020754|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
302118|NCT01587989|1020755|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
302119|NCT01587989|1020756|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
302120|NCT01587989|1020754|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
302121|NCT01587989|1020755|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
302122|NCT01587989|1020756|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
302123|NCT01587989|1020754|P3|12-Week Open-Label Run-In Period|Physician Decision|0
302124|NCT01587989|1020755|P2|12-Week Open-Label Run-In Period|Physician Decision|0
302125|NCT01587989|1020756|P1|12-Week Open-Label Run-In Period|Physician Decision|7
302126|NCT01587924|1020821|P4|Overall Study|Withdrawal by Subject|0
302127|NCT01587924|1020822|P3|Overall Study|Withdrawal by Subject|1
302128|NCT01587924|1020823|P2|Overall Study|Withdrawal by Subject|1
302129|NCT01587924|1020824|P1|Overall Study|Withdrawal by Subject|0
302130|NCT01587924|1020821|P4|Overall Study|Met Hemoglobin stopping criteria|0
302131|NCT01587924|1020822|P3|Overall Study|Met Hemoglobin stopping criteria|1
302132|NCT01587924|1020823|P2|Overall Study|Met Hemoglobin stopping criteria|0
302133|NCT01587924|1020824|P1|Overall Study|Met Hemoglobin stopping criteria|2
302134|NCT01587924|1020821|P4|Overall Study|Protocol Violation|1
302135|NCT01587924|1020822|P3|Overall Study|Protocol Violation|2
302136|NCT01587924|1020823|P2|Overall Study|Protocol Violation|1
302137|NCT01587924|1020824|P1|Overall Study|Protocol Violation|2
302138|NCT01587924|1020821|P4|Overall Study|Adverse Event|0
302139|NCT01587924|1020822|P3|Overall Study|Adverse Event|0
302140|NCT01587924|1020823|P2|Overall Study|Adverse Event|2
302141|NCT01587924|1020824|P1|Overall Study|Adverse Event|0
302142|NCT01587898|1020925|P4|Overall Study|Met haemoglobin stopping criteria|0
302143|NCT01587898|1020926|P3|Overall Study|Met haemoglobin stopping criteria|1
302144|NCT01587898|1020927|P2|Overall Study|Met haemoglobin stopping criteria|1
302145|NCT01587898|1020928|P1|Overall Study|Met haemoglobin stopping criteria|1
302146|NCT01587898|1020925|P4|Overall Study|Withdrawal by Subject|0
302147|NCT01587898|1020926|P3|Overall Study|Withdrawal by Subject|0
302148|NCT01587898|1020927|P2|Overall Study|Withdrawal by Subject|1
302149|NCT01587898|1020928|P1|Overall Study|Withdrawal by Subject|2
302150|NCT01587898|1020925|P4|Overall Study|Lost to Follow-up|1
302151|NCT01587898|1020926|P3|Overall Study|Lost to Follow-up|0
302152|NCT01587898|1020927|P2|Overall Study|Lost to Follow-up|0
302153|NCT01587898|1020928|P1|Overall Study|Lost to Follow-up|0
302154|NCT01587898|1020925|P4|Overall Study|Protocol Violation|1
302155|NCT01587898|1020926|P3|Overall Study|Protocol Violation|1
302156|NCT01587898|1020927|P2|Overall Study|Protocol Violation|2
302157|NCT01587898|1020928|P1|Overall Study|Protocol Violation|0
302158|NCT01587898|1020925|P4|Overall Study|Adverse Event|0
302159|NCT01587898|1020926|P3|Overall Study|Adverse Event|0
302160|NCT01587898|1020927|P2|Overall Study|Adverse Event|1
302161|NCT01587898|1020928|P1|Overall Study|Adverse Event|1
302162|NCT01587885|1021104|P2|Treatment Period 1|Protocol Violation|2
302163|NCT01587885|1021105|P1|Treatment Period 1|Protocol Violation|0
302164|NCT01587885|1021104|P2|Treatment Period 1|Failure to Return|1
302165|NCT01587885|1021105|P1|Treatment Period 1|Failure to Return|0
302166|NCT01587651|1021121|P3|Overall Study|Withdrawal by Subject|0
302167|NCT01587651|1021122|P2|Overall Study|Withdrawal by Subject|1
302168|NCT01587651|1021123|P1|Overall Study|Withdrawal by Subject|0
302169|NCT01587651|1021121|P3|Overall Study|Protocol Violation|1
302170|NCT01587651|1021122|P2|Overall Study|Protocol Violation|1
302171|NCT01587651|1021123|P1|Overall Study|Protocol Violation|0
302172|NCT01587651|1021121|P3|Overall Study|Adverse Event|0
302173|NCT01587651|1021122|P2|Overall Study|Adverse Event|1
302174|NCT01587651|1021123|P1|Overall Study|Adverse Event|0
302175|NCT01587118|1021150|P1|Overall Study|nonresponse|1
302176|NCT01587118|1021150|P1|Overall Study|Relocation|1
302177|NCT01587118|1021150|P1|Overall Study|Lost to Follow-up|2
302178|NCT01587118|1021150|P1|Overall Study|Adverse Event|3
302179|NCT01587079|1021174|P1|Overall Study|Adverse Event|14
302180|NCT01587079|1021174|P1|Overall Study|Withdrawal by Subject|7
302181|NCT01587079|1021174|P1|Overall Study|Physician Decision|2
302182|NCT01587079|1021174|P1|Overall Study|Lost to Follow-up|2
302183|NCT01587079|1021174|P1|Overall Study|Protocol Violation|5
302184|NCT01587079|1021174|P1|Overall Study|Protocol-specified criteria|9
302185|NCT01587014|1021305|P1|Overall Study|Death|2
302186|NCT01587001|1021312|P2|Overall Study|Insufficient samples to complete testing|1
302187|NCT01587001|1021313|P1|Overall Study|Insufficient samples to complete testing|4
302188|NCT01587001|1021312|P2|Overall Study|Lost to Follow-up|0
302189|NCT01587001|1021313|P1|Overall Study|Lost to Follow-up|2
302190|NCT01586819|1021361|P2|Overall Study|Withdrawal by Subject|0
302191|NCT01586819|1021362|P1|Overall Study|Withdrawal by Subject|1
302192|NCT01586806|1021373|P3|Overall Study|Lost to Follow-up|2
302193|NCT01586806|1021374|P2|Overall Study|Lost to Follow-up|3
302194|NCT01586806|1021375|P1|Overall Study|Lost to Follow-up|2
302195|NCT01586806|1021373|P3|Overall Study|Withdrawal by Subject|0
302196|NCT01586806|1021374|P2|Overall Study|Withdrawal by Subject|0
302197|NCT01586806|1021375|P1|Overall Study|Withdrawal by Subject|1
302198|NCT01586806|1021373|P3|Overall Study|Protocol Violation|0
302199|NCT01586806|1021374|P2|Overall Study|Protocol Violation|1
302200|NCT01586806|1021375|P1|Overall Study|Protocol Violation|0
302201|NCT01586364|1021395|P1|Overall Study|Other-Not specified|1
302202|NCT01586364|1021395|P1|Overall Study|Other-PI discretion, site closing|2
302203|NCT01586364|1021395|P1|Overall Study|Other-Site closure due to PI illness|1
302204|NCT01586364|1021395|P1|Overall Study|Other-Subject wasn't getting much relief|1
302205|NCT01586364|1021395|P1|Overall Study|Other-Did not feel better post-treatment|1
302206|NCT01586364|1021395|P1|Overall Study|Lack of Efficacy|1
302207|NCT01586364|1021395|P1|Overall Study|Protocol Violation|16
302208|NCT01586364|1021395|P1|Overall Study|Lost to Follow-up|17
302209|NCT01586364|1021395|P1|Overall Study|Adverse Event|37
302210|NCT01586364|1021395|P1|Overall Study|Withdrawal by Subject|40
302211|NCT01586338|1021448|P1|Overall Study|Other|1
302212|NCT01586338|1021448|P1|Overall Study|Withdrawal by participant|3
302213|NCT01586338|1021448|P1|Overall Study|Lost to Follow-up|1
302214|NCT01586338|1021448|P1|Overall Study|Adverse Event|3
302215|NCT01586195|1021471|P1|Overall Study|Reason not specified|9
302216|NCT01586195|1021471|P1|Overall Study|Started new anti-melanoma therapy|1
302217|NCT01586195|1021471|P1|Overall Study|Withdrawal of Consent|5
302218|NCT01586195|1021471|P1|Overall Study|Death|11
302219|NCT01586156|1021485|P3|Overall Study|Pregnancy|0
302220|NCT01586156|1021486|P2|Overall Study|Pregnancy|1
302221|NCT01586156|1021487|P1|Overall Study|Pregnancy|0
302222|NCT01585987|1021525|P2|Treated|Poor/Non-Compliance|1
302223|NCT01585987|1021526|P1|Treated|Poor/Non-Compliance|0
302224|NCT01585987|1021525|P2|Treated|Subject Request|1
302225|NCT01585987|1021526|P1|Treated|Subject Request|0
302226|NCT01585987|1021525|P2|Treated|Non-Specified|2
302227|NCT01585987|1021526|P1|Treated|Non-Specified|1
302228|NCT01585987|1021525|P2|Treated|Maximum Clinical Benefit|1
302229|NCT01585987|1021526|P1|Treated|Maximum Clinical Benefit|0
302230|NCT01585987|1021525|P2|Treated|Lost to Follow-up|1
302231|NCT01585987|1021526|P1|Treated|Lost to Follow-up|0
302232|NCT01585987|1021525|P2|Treated|Death|0
302233|NCT01585987|1021526|P1|Treated|Death|1
302234|NCT01585987|1021525|P2|Treated|Withdrawal by Subject|2
302235|NCT01585987|1021526|P1|Treated|Withdrawal by Subject|1
302236|NCT01585987|1021525|P2|Treated|Adverse Event|0
302237|NCT01585987|1021526|P1|Treated|Adverse Event|3
302238|NCT01585987|1021525|P2|Treated|Study Drug Toxicity|5
302239|NCT01585987|1021526|P1|Treated|Study Drug Toxicity|9
302240|NCT01585987|1021525|P2|Treated|Disease Progression|36
302241|NCT01585987|1021526|P1|Treated|Disease Progression|39
302242|NCT01585987|1021525|P2|Randomized|No longer met criteria|2
302243|NCT01585987|1021526|P1|Randomized|No longer met criteria|0
302244|NCT01585987|1021525|P2|Randomized|Withdrawal by Subject|4
302245|NCT01585987|1021526|P1|Randomized|Withdrawal by Subject|0
302246|NCT01585961|1021541|P1|Overall Study|Ablation cancelled for slow-heal wound|1
302247|NCT01585961|1021541|P1|Overall Study|Lost to Follow-up|23
302248|NCT01585961|1021541|P1|Overall Study|Withdrawal by Subject|1
302249|NCT01585961|1021541|P1|Overall Study|Decision to use non-study catheter|1
302250|NCT01585961|1021541|P1|Overall Study|Physician Decision|1
302251|NCT01585961|1021541|P1|Overall Study|Death|6
302252|NCT01585584|1021618|P1|Overall Study|Physician Decision|2
302253|NCT01585584|1021618|P1|Overall Study|Withdrawal by Subject|1
302254|NCT01585584|1021618|P1|Overall Study|Lack of Efficacy|1
302255|NCT01585558|1021625|P3|Overall Study|Lack of Efficacy|1
302256|NCT01585558|1021626|P2|Overall Study|Lack of Efficacy|0
302257|NCT01585558|1021627|P1|Overall Study|Lack of Efficacy|0
302258|NCT01585558|1021625|P3|Overall Study|Protocol Violation|2
302259|NCT01585558|1021626|P2|Overall Study|Protocol Violation|3
302260|NCT01585558|1021627|P1|Overall Study|Protocol Violation|4
302261|NCT01585558|1021625|P3|Overall Study|Adverse Event|1
302262|NCT01585558|1021626|P2|Overall Study|Adverse Event|4
302263|NCT01585558|1021627|P1|Overall Study|Adverse Event|3
302264|NCT01585558|1021625|P3|Overall Study|Lost to Follow-up|3
302265|NCT01585558|1021626|P2|Overall Study|Lost to Follow-up|0
302266|NCT01585558|1021627|P1|Overall Study|Lost to Follow-up|2
302267|NCT01585558|1021625|P3|Overall Study|Withdrawal by Subject|8
302268|NCT01585558|1021626|P2|Overall Study|Withdrawal by Subject|5
302269|NCT01585558|1021627|P1|Overall Study|Withdrawal by Subject|4
302270|NCT01585428|1021861|P2|Overall Study|Death during treatment|0
302271|NCT01585428|1021862|P1|Overall Study|Death during treatment|1
302272|NCT01585272|1021886|P1|Overall Study|Withdrawal by Subject|10
302273|NCT01585272|1021886|P1|Overall Study|Protocol Violation|7
302274|NCT01585272|1021886|P1|Overall Study|Adverse Event|22
302275|NCT01585246|1021899|P5|Overall Study|Other|0
302276|NCT01585246|1021900|P4|Overall Study|Other|1
302277|NCT01585246|1021901|P3|Overall Study|Other|1
302278|NCT01585246|1021902|P2|Overall Study|Other|1
302279|NCT01585246|1021903|P1|Overall Study|Other|0
302280|NCT01585246|1021899|P5|Overall Study|Withdrawal by Subject|1
302281|NCT01585246|1021900|P4|Overall Study|Withdrawal by Subject|2
302282|NCT01585246|1021901|P3|Overall Study|Withdrawal by Subject|1
302283|NCT01585246|1021902|P2|Overall Study|Withdrawal by Subject|0
302284|NCT01585246|1021903|P1|Overall Study|Withdrawal by Subject|0
302285|NCT01585246|1021899|P5|Overall Study|Protocol Violation|1
302286|NCT01585246|1021900|P4|Overall Study|Protocol Violation|0
302287|NCT01585246|1021901|P3|Overall Study|Protocol Violation|0
302288|NCT01585246|1021902|P2|Overall Study|Protocol Violation|0
302289|NCT01585246|1021903|P1|Overall Study|Protocol Violation|0
302290|NCT01585246|1021899|P5|Overall Study|Lost to Follow-up|0
302291|NCT01585246|1021900|P4|Overall Study|Lost to Follow-up|1
302292|NCT01585246|1021901|P3|Overall Study|Lost to Follow-up|2
302293|NCT01585246|1021902|P2|Overall Study|Lost to Follow-up|0
302294|NCT01585246|1021903|P1|Overall Study|Lost to Follow-up|0
302295|NCT01585168|1021924|P4|Overall Study|Lost to Follow-up|1
302296|NCT01585168|1021925|P3|Overall Study|Lost to Follow-up|1
302297|NCT01585168|1021926|P2|Overall Study|Lost to Follow-up|1
302298|NCT01585168|1021927|P1|Overall Study|Lost to Follow-up|3
302299|NCT01585038|1021962|P2|Overall Study|Adverse Event|2
302300|NCT01585038|1021963|P1|Overall Study|Adverse Event|2
302301|NCT01584843|1021979|P6|Second Treatment Period|Withdrawal by Subject|1
302302|NCT01584843|1021980|P5|Second Treatment Period|Withdrawal by Subject|0
302303|NCT01584843|1021981|P4|Second Treatment Period|Withdrawal by Subject|0
302304|NCT01584843|1021982|P3|Second Treatment Period|Withdrawal by Subject|0
302305|NCT01584843|1021983|P2|Second Treatment Period|Withdrawal by Subject|0
302306|NCT01584843|1021984|P1|Second Treatment Period|Withdrawal by Subject|0
302307|NCT01584843|1021979|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
302308|NCT01584843|1021980|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
302309|NCT01584843|1021981|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
302310|NCT01584843|1021982|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
302311|NCT01584843|1021983|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
302312|NCT01584843|1021984|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
302313|NCT01584843|1021979|P6|First Treatment Period|Protocol Violation|1
302314|NCT01584843|1021980|P5|First Treatment Period|Protocol Violation|0
302315|NCT01584843|1021981|P4|First Treatment Period|Protocol Violation|0
302316|NCT01584843|1021982|P3|First Treatment Period|Protocol Violation|0
302317|NCT01584843|1021983|P2|First Treatment Period|Protocol Violation|0
302318|NCT01584843|1021984|P1|First Treatment Period|Protocol Violation|0
302319|NCT01584843|1021979|P6|First Treatment Period|Adverse Event|0
302320|NCT01584843|1021980|P5|First Treatment Period|Adverse Event|0
302321|NCT01584843|1021981|P4|First Treatment Period|Adverse Event|0
302322|NCT01584843|1021982|P3|First Treatment Period|Adverse Event|1
302323|NCT01584843|1021983|P2|First Treatment Period|Adverse Event|0
302324|NCT01584843|1021984|P1|First Treatment Period|Adverse Event|0
302325|NCT01584648|1022095|P2|Overall Study|Ongoing|147
302326|NCT01584648|1022096|P1|Overall Study|Ongoing|154
302327|NCT01584648|1022095|P2|Overall Study|Death|55
302328|NCT01584648|1022096|P1|Overall Study|Death|40
302329|NCT01584648|1022095|P2|Overall Study|Withdrawal by Subject|5
302330|NCT01584648|1022096|P1|Overall Study|Withdrawal by Subject|11
302331|NCT01584648|1022095|P2|Overall Study|Physician Decision|2
302332|NCT01584648|1022096|P1|Overall Study|Physician Decision|2
302333|NCT01584648|1022095|P2|Overall Study|Lost to Follow-up|3
302334|NCT01584648|1022096|P1|Overall Study|Lost to Follow-up|4
302335|NCT01584232|1022201|P2|Overall Study|Lost to Follow-up|0
302336|NCT01584232|1022202|P1|Overall Study|Lost to Follow-up|1
302337|NCT01584232|1022201|P2|Overall Study|Physician Decision|1
302338|NCT01584232|1022202|P1|Overall Study|Physician Decision|2
302339|NCT01584232|1022201|P2|Overall Study|Withdrawal by Subject|1
302340|NCT01584232|1022202|P1|Overall Study|Withdrawal by Subject|2
302341|NCT01584232|1022201|P2|Overall Study|Adverse Event|1
302342|NCT01584232|1022202|P1|Overall Study|Adverse Event|3
302343|NCT01583530|1022248|P6|Overall Study|Lack of compliance|0
302344|NCT01583530|1022249|P5|Overall Study|Lack of compliance|1
302345|NCT01583530|1022250|P4|Overall Study|Lack of compliance|0
302346|NCT01583530|1022251|P3|Overall Study|Lack of compliance|0
302347|NCT01583530|1022252|P2|Overall Study|Lack of compliance|0
302348|NCT01583530|1022253|P1|Overall Study|Lack of compliance|0
302349|NCT01583530|1022248|P6|Overall Study|Lost to Follow-up|0
302350|NCT01583530|1022249|P5|Overall Study|Lost to Follow-up|3
302351|NCT01583530|1022250|P4|Overall Study|Lost to Follow-up|0
302352|NCT01583530|1022251|P3|Overall Study|Lost to Follow-up|0
302353|NCT01583530|1022252|P2|Overall Study|Lost to Follow-up|0
302354|NCT01583530|1022253|P1|Overall Study|Lost to Follow-up|0
302355|NCT01583530|1022248|P6|Overall Study|Withdrawal by Subject|2
302356|NCT01583530|1022249|P5|Overall Study|Withdrawal by Subject|1
302357|NCT01583530|1022250|P4|Overall Study|Withdrawal by Subject|1
302358|NCT01583530|1022251|P3|Overall Study|Withdrawal by Subject|0
302359|NCT01583530|1022252|P2|Overall Study|Withdrawal by Subject|3
302360|NCT01583530|1022253|P1|Overall Study|Withdrawal by Subject|0
302361|NCT01583530|1022248|P6|Overall Study|Adverse Event|1
302362|NCT01583530|1022249|P5|Overall Study|Adverse Event|0
302363|NCT01583530|1022250|P4|Overall Study|Adverse Event|0
302364|NCT01583530|1022251|P3|Overall Study|Adverse Event|0
302365|NCT01583530|1022252|P2|Overall Study|Adverse Event|0
302366|NCT01583530|1022253|P1|Overall Study|Adverse Event|0
302367|NCT01583374|1022315|P3|Overall Study|Other|0
302368|NCT01583374|1022316|P2|Overall Study|Other|1
302369|NCT01583374|1022317|P1|Overall Study|Other|0
302370|NCT01583374|1022315|P3|Overall Study|Protocol Violation|3
302371|NCT01583374|1022316|P2|Overall Study|Protocol Violation|0
302372|NCT01583374|1022317|P1|Overall Study|Protocol Violation|0
302373|NCT01583374|1022315|P3|Overall Study|Lost to Follow-up|0
302374|NCT01583374|1022316|P2|Overall Study|Lost to Follow-up|2
302375|NCT01583374|1022317|P1|Overall Study|Lost to Follow-up|1
302376|NCT01583374|1022315|P3|Overall Study|Withdrawal by Subject|5
302377|NCT01583374|1022316|P2|Overall Study|Withdrawal by Subject|3
302378|NCT01583374|1022317|P1|Overall Study|Withdrawal by Subject|8
302379|NCT01583374|1022315|P3|Overall Study|Non-compliance with study drug|0
302380|NCT01583374|1022316|P2|Overall Study|Non-compliance with study drug|1
302381|NCT01583374|1022317|P1|Overall Study|Non-compliance with study drug|1
302382|NCT01583374|1022315|P3|Overall Study|Lack of Efficacy|5
302383|NCT01583374|1022316|P2|Overall Study|Lack of Efficacy|2
302384|NCT01583374|1022317|P1|Overall Study|Lack of Efficacy|3
302385|NCT01583374|1022315|P3|Overall Study|Adverse Event|12
302386|NCT01583374|1022316|P2|Overall Study|Adverse Event|7
302387|NCT01583374|1022317|P1|Overall Study|Adverse Event|6
302388|NCT01583218|1022329|P2|Overall Study|Withdraw of consent on day of random|0
302389|NCT01583218|1022330|P1|Overall Study|Withdraw of consent on day of random|1
302390|NCT01583218|1022329|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
302391|NCT01583218|1022330|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
302392|NCT01583218|1022329|P2|Overall Study|Patient was randomized due to mistake|0
302393|NCT01583218|1022330|P1|Overall Study|Patient was randomized due to mistake|1
302394|NCT01583218|1022329|P2|Overall Study|Patient was early terminated from study|1
302395|NCT01583218|1022330|P1|Overall Study|Patient was early terminated from study|0
302396|NCT01583218|1022329|P2|Overall Study|Patient deemed ineligible after random|0
302397|NCT01583218|1022330|P1|Overall Study|Patient deemed ineligible after random|2
302398|NCT01583218|1022329|P2|Overall Study|Patient was assessed via phone in person|0
302399|NCT01583218|1022330|P1|Overall Study|Patient was assessed via phone in person|1
302400|NCT01583218|1022329|P2|Overall Study|Patient randomized but not dosed|16
302401|NCT01583218|1022330|P1|Overall Study|Patient randomized but not dosed|17
302402|NCT01583218|1022329|P2|Overall Study|Patient did not wish to attend visits|1
302403|NCT01583218|1022330|P1|Overall Study|Patient did not wish to attend visits|0
302404|NCT01583218|1022329|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
302405|NCT01583218|1022330|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
302406|NCT01583218|1022329|P2|Overall Study|Cannot contact patient directly|2
302407|NCT01583218|1022330|P1|Overall Study|Cannot contact patient directly|1
302408|NCT01583218|1022329|P2|Overall Study|Patient /Family decision|0
302409|NCT01583218|1022330|P1|Overall Study|Patient /Family decision|3
302410|NCT01583218|1022329|P2|Overall Study|Adverse event or serious adverse event|3
302411|NCT01583218|1022330|P1|Overall Study|Adverse event or serious adverse event|3
302412|NCT01583218|1022329|P2|Overall Study|Lost to Follow-up|17
302413|NCT01583218|1022330|P1|Overall Study|Lost to Follow-up|11
302414|NCT01583218|1022329|P2|Overall Study|Death|211
302415|NCT01583218|1022330|P1|Overall Study|Death|206
302416|NCT01583218|1022329|P2|Overall Study|Withdrawal by Subject|29
302417|NCT01583218|1022330|P1|Overall Study|Withdrawal by Subject|43
302418|NCT01582971|1022359|P2|Overall Study|Other|13
302419|NCT01582971|1022360|P1|Overall Study|Other|15
302420|NCT01582971|1022359|P2|Overall Study|Withdrawal by Subject|2
302421|NCT01582971|1022360|P1|Overall Study|Withdrawal by Subject|4
302422|NCT01582971|1022359|P2|Overall Study|Lost to Follow-up|21
302423|NCT01582971|1022360|P1|Overall Study|Lost to Follow-up|18
302424|NCT01582971|1022359|P2|Overall Study|Death|1
302425|NCT01582971|1022360|P1|Overall Study|Death|2
302426|NCT01582945|1022378|P1|Overall Study|Scheduling conflicts|1
302427|NCT01582945|1022378|P1|Overall Study|Intolerable side-effects|1
302428|NCT01582854|1022392|P2|Overall Study|Other Miscellaneous Reason|0
302429|NCT01582854|1022393|P1|Overall Study|Other Miscellaneous Reason|1
302430|NCT01582854|1022392|P2|Overall Study|General Anaesthesia|1
302431|NCT01582854|1022393|P1|Overall Study|General Anaesthesia|0
302432|NCT01582854|1022392|P2|Overall Study|Carotid or Neurosurgery|1
302433|NCT01582854|1022393|P1|Overall Study|Carotid or Neurosurgery|0
302434|NCT01582854|1022392|P2|Overall Study|Disallowed Concomitant Medication|2
302435|NCT01582854|1022393|P1|Overall Study|Disallowed Concomitant Medication|3
302436|NCT01582854|1022392|P2|Overall Study|Recurrent Stroke|8
302437|NCT01582854|1022393|P1|Overall Study|Recurrent Stroke|13
302438|NCT01582854|1022392|P2|Overall Study|Physician Decision|1
302439|NCT01582854|1022393|P1|Overall Study|Physician Decision|0
302440|NCT01582854|1022392|P2|Overall Study|Lost to Follow-up|2
302441|NCT01582854|1022393|P1|Overall Study|Lost to Follow-up|1
302442|NCT01582854|1022392|P2|Overall Study|Withdrawal by Participant|11
302443|NCT01582854|1022393|P1|Overall Study|Withdrawal by Participant|8
302444|NCT01582854|1022392|P2|Overall Study|Adverse Event|3
302445|NCT01582854|1022393|P1|Overall Study|Adverse Event|2
302446|NCT01582854|1022392|P2|Overall Study|Death|5
302447|NCT01582854|1022393|P1|Overall Study|Death|8
302448|NCT01582789|1022421|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
302449|NCT01582789|1022422|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
302450|NCT01582451|1022482|P2|Overall Study|Sponsor Decision|0
302451|NCT01582451|1022483|P1|Overall Study|Sponsor Decision|1
302452|NCT01582451|1022482|P2|Overall Study|Physician Decision|0
302453|NCT01582451|1022483|P1|Overall Study|Physician Decision|3
302454|NCT01582451|1022482|P2|Overall Study|Withdrawal by Subject|9
302455|NCT01582451|1022483|P1|Overall Study|Withdrawal by Subject|13
302456|NCT01582451|1022482|P2|Overall Study|Protocol Violation|3
302457|NCT01582451|1022483|P1|Overall Study|Protocol Violation|11
302458|NCT01582451|1022482|P2|Overall Study|Lost to Follow-up|2
302459|NCT01582451|1022483|P1|Overall Study|Lost to Follow-up|0
302460|NCT01582451|1022482|P2|Overall Study|Death|3
302461|NCT01582451|1022483|P1|Overall Study|Death|3
302462|NCT01582451|1022482|P2|Overall Study|Adverse Event|3
302463|NCT01582451|1022483|P1|Overall Study|Adverse Event|1
302464|NCT01582308|1022525|P10|Period 4|Physician Decision|1
302465|NCT01582308|1022526|P9|Period 4|Physician Decision|0
302466|NCT01582308|1022527|P8|Period 4|Physician Decision|0
302467|NCT01582308|1022528|P7|Period 4|Physician Decision|0
302468|NCT01582308|1022529|P6|Period 4|Physician Decision|1
302469|NCT01582308|1022530|P5|Period 4|Physician Decision|0
302470|NCT01582308|1022531|P4|Period 4|Physician Decision|0
302471|NCT01582308|1022532|P3|Period 4|Physician Decision|0
302472|NCT01582308|1022533|P2|Period 4|Physician Decision|0
302473|NCT01582308|1022534|P1|Period 4|Physician Decision|1
302474|NCT01582308|1022525|P10|10-day Washout Following Period 1|Physician Decision|0
302475|NCT01582308|1022526|P9|10-day Washout Following Period 1|Physician Decision|0
302476|NCT01582308|1022527|P8|10-day Washout Following Period 1|Physician Decision|0
302477|NCT01582308|1022528|P7|10-day Washout Following Period 1|Physician Decision|0
302478|NCT01582308|1022529|P6|10-day Washout Following Period 1|Physician Decision|0
302479|NCT01582308|1022530|P5|10-day Washout Following Period 1|Physician Decision|1
302480|NCT01582308|1022531|P4|10-day Washout Following Period 1|Physician Decision|0
302481|NCT01582308|1022532|P3|10-day Washout Following Period 1|Physician Decision|0
302482|NCT01582308|1022533|P2|10-day Washout Following Period 1|Physician Decision|0
302483|NCT01582308|1022534|P1|10-day Washout Following Period 1|Physician Decision|0
302484|NCT01582308|1022525|P10|Period 1|Withdrawal by Subject|0
302485|NCT01582308|1022526|P9|Period 1|Withdrawal by Subject|0
302486|NCT01582308|1022527|P8|Period 1|Withdrawal by Subject|0
302487|NCT01582308|1022528|P7|Period 1|Withdrawal by Subject|1
302488|NCT01582308|1022529|P6|Period 1|Withdrawal by Subject|0
302489|NCT01582308|1022530|P5|Period 1|Withdrawal by Subject|0
302490|NCT01582308|1022531|P4|Period 1|Withdrawal by Subject|0
302491|NCT01582308|1022532|P3|Period 1|Withdrawal by Subject|0
302492|NCT01582308|1022533|P2|Period 1|Withdrawal by Subject|0
302493|NCT01582308|1022534|P1|Period 1|Withdrawal by Subject|0
302494|NCT01582282|1022562|P3|Overall Study|fasting blood glucose outside Protocol|0
302495|NCT01582282|1022563|P2|Overall Study|fasting blood glucose outside Protocol|1
302496|NCT01582282|1022564|P1|Overall Study|fasting blood glucose outside Protocol|0
302497|NCT01582282|1022562|P3|Overall Study|Lost to Follow-up|0
302498|NCT01582282|1022563|P2|Overall Study|Lost to Follow-up|0
302499|NCT01582282|1022564|P1|Overall Study|Lost to Follow-up|1
302500|NCT01582282|1022562|P3|Overall Study|Adverse Event|0
302501|NCT01582282|1022563|P2|Overall Study|Adverse Event|1
302502|NCT01582282|1022564|P1|Overall Study|Adverse Event|1
302503|NCT01582243|1022587|P1|Overall Study|Lost to Follow-up|1
302504|NCT01582243|1022587|P1|Overall Study|Adverse Event|1
302505|NCT01582243|1022587|P1|Overall Study|Withdrawal by Subject|1
302506|NCT01582178|1022598|P2|Overall Study|Physician Decision|5
302507|NCT01582178|1022599|P1|Overall Study|Physician Decision|6
302508|NCT01582100|1022620|P1|Overall Study|Withdrawal by Subject|1
302509|NCT01582100|1022620|P1|Overall Study|Adverse Event|1
302510|NCT01582061|1022626|P2|Overall Study|Lost to Follow-up|0
302511|NCT01582061|1022627|P1|Overall Study|Lost to Follow-up|1
302512|NCT01582061|1022626|P2|Overall Study|condition no longer requires study drug|0
302513|NCT01582061|1022627|P1|Overall Study|condition no longer requires study drug|1
302514|NCT01582061|1022626|P2|Overall Study|Death|1
302515|NCT01582061|1022627|P1|Overall Study|Death|0
302516|NCT01582061|1022626|P2|Overall Study|Abnormal laboratory value(s)|0
302517|NCT01582061|1022627|P1|Overall Study|Abnormal laboratory value(s)|1
302518|NCT01582061|1022626|P2|Overall Study|Withdrawal by Subject|4
302519|NCT01582061|1022627|P1|Overall Study|Withdrawal by Subject|10
302520|NCT01582061|1022626|P2|Overall Study|Adverse Event|8
302521|NCT01582061|1022627|P1|Overall Study|Adverse Event|12
302522|NCT01582061|1022626|P2|Overall Study|Lack of Efficacy|23
302523|NCT01582061|1022627|P1|Overall Study|Lack of Efficacy|3
302524|NCT01582009|1022677|P1|Overall Study|Physician Decision|1
302525|NCT01582009|1022677|P1|Overall Study|Withdrawal by Subject|1
302526|NCT01581931|1022685|P2|Washout|Adverse Event|1
302527|NCT01581931|1022686|P1|Washout|Adverse Event|0
302528|NCT01581684|1022739|P10|Overall Study|Other reason not defined|0
302529|NCT01581684|1022740|P9|Overall Study|Other reason not defined|1
302530|NCT01581684|1022741|P8|Overall Study|Other reason not defined|0
302531|NCT01581684|1022742|P7|Overall Study|Other reason not defined|0
302532|NCT01581684|1022743|P6|Overall Study|Other reason not defined|0
302533|NCT01581684|1022744|P5|Overall Study|Other reason not defined|0
302534|NCT01581684|1022745|P4|Overall Study|Other reason not defined|0
302535|NCT01581684|1022746|P3|Overall Study|Other reason not defined|0
302536|NCT01581684|1022747|P2|Overall Study|Other reason not defined|0
302537|NCT01581684|1022748|P1|Overall Study|Other reason not defined|0
302538|NCT01581619|1022844|P1|Overall Study|Lost to Follow-up|1
302539|NCT01581619|1022844|P1|Overall Study|Withdrawal by Subject|1
302540|NCT01581307|1022997|P1|Overall Study|Withdrawal by Subject|1
302541|NCT01581281|1023006|P3|Overall Study|Early Study Closure|12
302542|NCT01581281|1023007|P2|Overall Study|Early Study Closure|6
302543|NCT01581281|1023008|P1|Overall Study|Early Study Closure|15
302544|NCT01581021|1023030|P2|Overall Study|Lack of Efficacy|1
302545|NCT01581021|1023031|P1|Overall Study|Lack of Efficacy|0
302546|NCT01581021|1023030|P2|Overall Study|Lenke 6 Classification|1
302547|NCT01581021|1023031|P1|Overall Study|Lenke 6 Classification|0
302548|NCT01581021|1023030|P2|Overall Study|Not Randomized|2
302549|NCT01581021|1023031|P1|Overall Study|Not Randomized|1
302550|NCT01581021|1023030|P2|Overall Study|Neuromuscular|1
302551|NCT01581021|1023031|P1|Overall Study|Neuromuscular|2
302552|NCT01581021|1023030|P2|Overall Study|More than 2 hooks in thoracic|0
302553|NCT01581021|1023031|P1|Overall Study|More than 2 hooks in thoracic|3
302554|NCT01581021|1023030|P2|Overall Study|Lost to Follow-up|6
302555|NCT01581021|1023031|P1|Overall Study|Lost to Follow-up|4
302556|NCT01580995|1023057|P2|Overall Study|Lost to Follow-up|2
302557|NCT01580995|1023058|P1|Overall Study|Lost to Follow-up|2
302558|NCT01580488|1023111|P1|Overall Study|Withdrawal by Subject|1
302559|NCT01580020|1023267|P4|Overall Study|Lost to Follow-up|0
302560|NCT01580020|1023268|P3|Overall Study|Lost to Follow-up|1
302561|NCT01580020|1023269|P2|Overall Study|Lost to Follow-up|0
302562|NCT01580020|1023270|P1|Overall Study|Lost to Follow-up|0
302563|NCT01580020|1023267|P4|Overall Study|Administrative Problems|0
302564|NCT01580020|1023268|P3|Overall Study|Administrative Problems|1
302565|NCT01580020|1023269|P2|Overall Study|Administrative Problems|0
302566|NCT01580020|1023270|P1|Overall Study|Administrative Problems|0
302567|NCT01580020|1023267|P4|Overall Study|Adverse Event|1
302568|NCT01580020|1023268|P3|Overall Study|Adverse Event|1
302569|NCT01580020|1023269|P2|Overall Study|Adverse Event|1
302570|NCT01580020|1023270|P1|Overall Study|Adverse Event|1
302571|NCT01580020|1023267|P4|Overall Study|Withdrawal by Subject|0
302572|NCT01580020|1023268|P3|Overall Study|Withdrawal by Subject|1
302573|NCT01580020|1023269|P2|Overall Study|Withdrawal by Subject|1
302574|NCT01580020|1023270|P1|Overall Study|Withdrawal by Subject|0
302575|NCT01580020|1023267|P4|Overall Study|Lack of Efficacy|1
302576|NCT01580020|1023268|P3|Overall Study|Lack of Efficacy|0
302577|NCT01580020|1023269|P2|Overall Study|Lack of Efficacy|5
302578|NCT01580020|1023270|P1|Overall Study|Lack of Efficacy|0
302579|NCT01579916|1023314|P2|Overall Study|Death|0
302580|NCT01579916|1023315|P1|Overall Study|Death|1
302581|NCT01579916|1023314|P2|Overall Study|Withdrawal by Subject|1
302582|NCT01579916|1023315|P1|Overall Study|Withdrawal by Subject|1
302583|NCT01579916|1023314|P2|Overall Study|Lost to Follow-up|1
302584|NCT01579916|1023315|P1|Overall Study|Lost to Follow-up|6
302585|NCT01579812|1023341|P1|Overall Study|Withdrawal by Subject|6
302586|NCT01579812|1023341|P1|Overall Study|Noncompliance|3
302587|NCT01579812|1023341|P1|Overall Study|Patient choice|3
302588|NCT01579812|1023341|P1|Overall Study|Ineligible after treatment start|40
302589|NCT01579578|1023375|P2|Overall Study|Ongoing|0
302590|NCT01579578|1023376|P1|Overall Study|Ongoing|3
302591|NCT01579578|1023375|P2|Overall Study|Eligibility criteria|9
302592|NCT01579578|1023376|P1|Overall Study|Eligibility criteria|3
302593|NCT01579578|1023375|P2|Overall Study|Withdrawal by Subject|1
302594|NCT01579578|1023376|P1|Overall Study|Withdrawal by Subject|2
302595|NCT01579578|1023375|P2|Overall Study|Lost to Follow-up|1
302596|NCT01579578|1023376|P1|Overall Study|Lost to Follow-up|1
302597|NCT01579578|1023375|P2|Overall Study|Death|1
302598|NCT01579578|1023376|P1|Overall Study|Death|4
302599|NCT01579565|1023388|P2|Treated|declined to return for final visit|1
302600|NCT01579565|1023389|P1|Treated|declined to return for final visit|0
302601|NCT01579565|1023388|P2|Treated|Lost to Follow-up|1
302602|NCT01579565|1023389|P1|Treated|Lost to Follow-up|2
302603|NCT01579565|1023388|P2|Treated|Physician Decision|1
302604|NCT01579565|1023389|P1|Treated|Physician Decision|0
302605|NCT01579565|1023388|P2|Randomized|prohibited preoperative medication|1
302606|NCT01579565|1023389|P1|Randomized|prohibited preoperative medication|0
302607|NCT01579565|1023388|P2|Randomized|prohibited preoperative eating|0
302608|NCT01579565|1023389|P1|Randomized|prohibited preoperative eating|1
302609|NCT01579565|1023388|P2|Randomized|inadequate preoperative pupil dilation|1
302610|NCT01579565|1023389|P1|Randomized|inadequate preoperative pupil dilation|0
302611|NCT01579565|1023388|P2|Randomized|Withdrawal by Subject|0
302612|NCT01579565|1023389|P1|Randomized|Withdrawal by Subject|3
302613|NCT01579565|1023388|P2|Randomized|Adverse Event|3
302614|NCT01579565|1023389|P1|Randomized|Adverse Event|1
302615|NCT01579474|1023423|P6|Overall Study|Withdrawal by Subject|0
302616|NCT01579474|1023424|P5|Overall Study|Withdrawal by Subject|0
302617|NCT01579474|1023425|P4|Overall Study|Withdrawal by Subject|0
302618|NCT01579474|1023426|P3|Overall Study|Withdrawal by Subject|0
302619|NCT01579474|1023427|P2|Overall Study|Withdrawal by Subject|0
302620|NCT01579474|1023428|P1|Overall Study|Withdrawal by Subject|1
302621|NCT01579474|1023423|P6|Overall Study|Lack of Efficacy|0
302622|NCT01579474|1023424|P5|Overall Study|Lack of Efficacy|1
302623|NCT01579474|1023425|P4|Overall Study|Lack of Efficacy|0
302624|NCT01579474|1023426|P3|Overall Study|Lack of Efficacy|0
302625|NCT01579474|1023427|P2|Overall Study|Lack of Efficacy|0
302626|NCT01579474|1023428|P1|Overall Study|Lack of Efficacy|1
302627|NCT01579474|1023423|P6|Overall Study|Adverse Event|1
302628|NCT01579474|1023424|P5|Overall Study|Adverse Event|0
302629|NCT01579474|1023425|P4|Overall Study|Adverse Event|0
302630|NCT01579474|1023426|P3|Overall Study|Adverse Event|2
302631|NCT01579474|1023427|P2|Overall Study|Adverse Event|13
302632|NCT01579474|1023428|P1|Overall Study|Adverse Event|1
302633|NCT01579318|1023502|P1|Overall Study|Disease Progression|1
302634|NCT01579006|1023597|P1|Overall Study|Scheduled surgery|1
302635|NCT01579006|1023597|P1|Overall Study|Due to participant's health fund|1
302636|NCT01579006|1023597|P1|Overall Study|Non-compliance|3
302637|NCT01579006|1023597|P1|Overall Study|Withdrawal by Subject|5
302638|NCT01579006|1023597|P1|Overall Study|Adverse Event|13
302639|NCT01579006|1023597|P1|Overall Study|Lack of Efficacy|10
302640|NCT01578850|1023656|P3|Period 2|Unspecified Reasons|0
302641|NCT01578850|1023657|P2|Period 2|Unspecified Reasons|1
302642|NCT01578850|1023658|P1|Period 2|Unspecified Reasons|0
302643|NCT01578850|1023656|P3|Period 2|Study Terminated by Sponsor|4
302644|NCT01578850|1023657|P2|Period 2|Study Terminated by Sponsor|5
302645|NCT01578850|1023658|P1|Period 2|Study Terminated by Sponsor|0
302646|NCT01578850|1023656|P3|Period 2|Withdrawal by Subject|2
302647|NCT01578850|1023657|P2|Period 2|Withdrawal by Subject|2
302648|NCT01578850|1023658|P1|Period 2|Withdrawal by Subject|0
302649|NCT01578850|1023656|P3|Period 2|Lost to Follow-up|2
302650|NCT01578850|1023657|P2|Period 2|Lost to Follow-up|1
302651|NCT01578850|1023658|P1|Period 2|Lost to Follow-up|0
302652|NCT01578850|1023656|P3|Period 2|Adverse Event|6
302653|NCT01578850|1023657|P2|Period 2|Adverse Event|3
302654|NCT01578850|1023658|P1|Period 2|Adverse Event|0
302655|NCT01578850|1023656|P3|Period 2|Insufficient Clinical Response|0
302656|NCT01578850|1023657|P2|Period 2|Insufficient Clinical Response|1
302657|NCT01578850|1023658|P1|Period 2|Insufficient Clinical Response|0
302658|NCT01578850|1023656|P3|Period 1|Study Terminated by Sponsor|0
302659|NCT01578850|1023657|P2|Period 1|Study Terminated by Sponsor|0
302660|NCT01578850|1023658|P1|Period 1|Study Terminated by Sponsor|3
302661|NCT01578850|1023656|P3|Period 1|Withdrawal by Subject|0
302662|NCT01578850|1023657|P2|Period 1|Withdrawal by Subject|0
302663|NCT01578850|1023658|P1|Period 1|Withdrawal by Subject|9
302664|NCT01578850|1023656|P3|Period 1|Does Not Meet Entrance Criteria|0
302665|NCT01578850|1023657|P2|Period 1|Does Not Meet Entrance Criteria|0
302666|NCT01578850|1023658|P1|Period 1|Does Not Meet Entrance Criteria|12
302667|NCT01578850|1023656|P3|Period 1|Death|0
302668|NCT01578850|1023657|P2|Period 1|Death|0
302669|NCT01578850|1023658|P1|Period 1|Death|1
302670|NCT01578850|1023656|P3|Period 1|Adverse Event|0
302671|NCT01578850|1023657|P2|Period 1|Adverse Event|0
302672|NCT01578850|1023658|P1|Period 1|Adverse Event|11
302673|NCT01578850|1023656|P3|Period 1|Insufficient Clinical Response|0
302674|NCT01578850|1023657|P2|Period 1|Insufficient Clinical Response|0
302675|NCT01578850|1023658|P1|Period 1|Insufficient Clinical Response|1
302676|NCT01578785|1023710|P2|Overall Study|Study terminated by sponsor|118
302677|NCT01578785|1023711|P1|Overall Study|Study terminated by sponsor|59
302678|NCT01578785|1023710|P2|Overall Study|Withdrawal by Subject|1
302679|NCT01578785|1023711|P1|Overall Study|Withdrawal by Subject|0
302680|NCT01578499|1023743|P2|Overall Study|Participants on Study Treatment|0
302681|NCT01578499|1023744|P1|Overall Study|Participants on Study Treatment|3
302682|NCT01578499|1023743|P2|Overall Study|Participants in Follow-up|39
302683|NCT01578499|1023744|P1|Overall Study|Participants in Follow-up|42
302684|NCT01578499|1023743|P2|Overall Study|Reason not Specified|1
302685|NCT01578499|1023744|P1|Overall Study|Reason not Specified|0
302686|NCT01578499|1023743|P2|Overall Study|Lost to Follow-up|1
302687|NCT01578499|1023744|P1|Overall Study|Lost to Follow-up|2
302688|NCT01578499|1023743|P2|Overall Study|Withdrawal by Participant|10
302689|NCT01578499|1023744|P1|Overall Study|Withdrawal by Participant|8
302690|NCT01578499|1023743|P2|Overall Study|Death|14
302691|NCT01578499|1023744|P1|Overall Study|Death|11
302692|NCT01578486|1023778|P1|Overall Study|Withdrawal by Subject|2
302693|NCT01578486|1023778|P1|Overall Study|Physician Decision|3
302694|NCT01578330|1023789|P1|Overall Study|Protocol Violation|5
302695|NCT01578330|1023789|P1|Overall Study|Adverse Event|2
302696|NCT01578187|1023805|P1|Usability Phase|Withdrawal by Subject|1
302697|NCT01577758|1023839|P8|mCRC Expansion Phase|Progression Disease|19
302698|NCT01577758|1023840|P7|mCRC Expansion Phase|Progression Disease|0
302699|NCT01577758|1023841|P6|mCRC Expansion Phase|Progression Disease|0
302700|NCT01577758|1023842|P5|mCRC Expansion Phase|Progression Disease|0
302701|NCT01577758|1023843|P4|mCRC Expansion Phase|Progression Disease|0
302702|NCT01577758|1023844|P3|mCRC Expansion Phase|Progression Disease|0
302703|NCT01577758|1023845|P2|mCRC Expansion Phase|Progression Disease|0
302704|NCT01577758|1023846|P1|mCRC Expansion Phase|Progression Disease|0
302705|NCT01577758|1023839|P8|mCRC Expansion Phase|Withdrawal by Subject|2
302706|NCT01577758|1023840|P7|mCRC Expansion Phase|Withdrawal by Subject|0
302707|NCT01577758|1023841|P6|mCRC Expansion Phase|Withdrawal by Subject|0
302708|NCT01577758|1023842|P5|mCRC Expansion Phase|Withdrawal by Subject|0
302709|NCT01577758|1023843|P4|mCRC Expansion Phase|Withdrawal by Subject|0
302710|NCT01577758|1023844|P3|mCRC Expansion Phase|Withdrawal by Subject|0
302711|NCT01577758|1023845|P2|mCRC Expansion Phase|Withdrawal by Subject|0
302712|NCT01577758|1023846|P1|mCRC Expansion Phase|Withdrawal by Subject|0
302713|NCT01577758|1023839|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
302714|NCT01577758|1023840|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
302715|NCT01577758|1023841|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
302716|NCT01577758|1023842|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
302717|NCT01577758|1023843|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
302718|NCT01577758|1023844|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
302719|NCT01577758|1023845|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
302720|NCT01577758|1023846|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
302721|NCT01577758|1023839|P8|Dose Escalation Phase|Progression Disease|0
302722|NCT01577758|1023840|P7|Dose Escalation Phase|Progression Disease|0
302723|NCT01577758|1023841|P6|Dose Escalation Phase|Progression Disease|0
302724|NCT01577758|1023842|P5|Dose Escalation Phase|Progression Disease|5
302725|NCT01577758|1023843|P4|Dose Escalation Phase|Progression Disease|2
302726|NCT01577758|1023844|P3|Dose Escalation Phase|Progression Disease|1
302727|NCT01577758|1023845|P2|Dose Escalation Phase|Progression Disease|2
302728|NCT01577758|1023846|P1|Dose Escalation Phase|Progression Disease|2
302729|NCT01577758|1023839|P8|Dose Escalation Phase|Withdrawal by Subject|0
302730|NCT01577758|1023840|P7|Dose Escalation Phase|Withdrawal by Subject|0
302731|NCT01577758|1023841|P6|Dose Escalation Phase|Withdrawal by Subject|1
302732|NCT01577758|1023842|P5|Dose Escalation Phase|Withdrawal by Subject|0
302733|NCT01577758|1023843|P4|Dose Escalation Phase|Withdrawal by Subject|0
302734|NCT01577758|1023844|P3|Dose Escalation Phase|Withdrawal by Subject|0
302735|NCT01577758|1023845|P2|Dose Escalation Phase|Withdrawal by Subject|0
302736|NCT01577758|1023846|P1|Dose Escalation Phase|Withdrawal by Subject|0
302737|NCT01577758|1023839|P8|Dose Escalation Phase|Symptomatic Deterioration|0
302738|NCT01577758|1023840|P7|Dose Escalation Phase|Symptomatic Deterioration|0
302739|NCT01577758|1023841|P6|Dose Escalation Phase|Symptomatic Deterioration|1
302740|NCT01577758|1023842|P5|Dose Escalation Phase|Symptomatic Deterioration|1
302741|NCT01577758|1023843|P4|Dose Escalation Phase|Symptomatic Deterioration|0
302742|NCT01577758|1023844|P3|Dose Escalation Phase|Symptomatic Deterioration|1
302743|NCT01577758|1023845|P2|Dose Escalation Phase|Symptomatic Deterioration|0
302744|NCT01577758|1023846|P1|Dose Escalation Phase|Symptomatic Deterioration|0
302745|NCT01577758|1023839|P8|Dose Escalation Phase|Adverse Event|0
302746|NCT01577758|1023840|P7|Dose Escalation Phase|Adverse Event|1
302747|NCT01577758|1023841|P6|Dose Escalation Phase|Adverse Event|2
302748|NCT01577758|1023842|P5|Dose Escalation Phase|Adverse Event|0
302749|NCT01577758|1023843|P4|Dose Escalation Phase|Adverse Event|0
302750|NCT01577758|1023844|P3|Dose Escalation Phase|Adverse Event|0
302751|NCT01577758|1023845|P2|Dose Escalation Phase|Adverse Event|0
302752|NCT01577758|1023846|P1|Dose Escalation Phase|Adverse Event|0
302753|NCT01577745|1023885|P6|Overall Study|Alternative Therapy|0
302754|NCT01577745|1023886|P5|Overall Study|Alternative Therapy|1
302755|NCT01577745|1023887|P4|Overall Study|Alternative Therapy|1
302756|NCT01577745|1023888|P3|Overall Study|Alternative Therapy|0
302757|NCT01577745|1023889|P2|Overall Study|Alternative Therapy|0
302758|NCT01577745|1023890|P1|Overall Study|Alternative Therapy|0
302759|NCT01577745|1023885|P6|Overall Study|Lost to Follow-up|1
302760|NCT01577745|1023886|P5|Overall Study|Lost to Follow-up|0
302761|NCT01577745|1023887|P4|Overall Study|Lost to Follow-up|0
302762|NCT01577745|1023888|P3|Overall Study|Lost to Follow-up|0
302763|NCT01577745|1023889|P2|Overall Study|Lost to Follow-up|0
302764|NCT01577745|1023890|P1|Overall Study|Lost to Follow-up|0
302765|NCT01577745|1023885|P6|Overall Study|Physician Decision|0
302766|NCT01577745|1023886|P5|Overall Study|Physician Decision|1
302767|NCT01577745|1023887|P4|Overall Study|Physician Decision|1
302768|NCT01577745|1023888|P3|Overall Study|Physician Decision|0
302769|NCT01577745|1023889|P2|Overall Study|Physician Decision|0
302770|NCT01577745|1023890|P1|Overall Study|Physician Decision|0
302771|NCT01577745|1023885|P6|Overall Study|Death|3
302772|NCT01577745|1023886|P5|Overall Study|Death|1
302773|NCT01577745|1023887|P4|Overall Study|Death|1
302774|NCT01577745|1023888|P3|Overall Study|Death|2
302775|NCT01577745|1023889|P2|Overall Study|Death|2
302776|NCT01577745|1023890|P1|Overall Study|Death|3
302777|NCT01577745|1023885|P6|Overall Study|Withdrawal by Subject|0
302778|NCT01577745|1023886|P5|Overall Study|Withdrawal by Subject|2
302779|NCT01577745|1023887|P4|Overall Study|Withdrawal by Subject|3
302780|NCT01577745|1023888|P3|Overall Study|Withdrawal by Subject|0
302781|NCT01577745|1023889|P2|Overall Study|Withdrawal by Subject|1
302782|NCT01577745|1023890|P1|Overall Study|Withdrawal by Subject|0
302783|NCT01577381|1024074|P4|Overall Study|Ongoing at Date of Cut-Off|0
302784|NCT01577381|1024075|P3|Overall Study|Ongoing at Date of Cut-Off|1
302785|NCT01577381|1024076|P2|Overall Study|Ongoing at Date of Cut-Off|2
302786|NCT01577381|1024077|P1|Overall Study|Ongoing at Date of Cut-Off|0
302787|NCT01577381|1024074|P4|Overall Study|Discontinued|2
302788|NCT01577381|1024075|P3|Overall Study|Discontinued|2
302789|NCT01577381|1024076|P2|Overall Study|Discontinued|1
302790|NCT01577381|1024077|P1|Overall Study|Discontinued|2
302791|NCT01577186|1024215|P1|Overall Study|Other|2
302792|NCT01577186|1024215|P1|Overall Study|Non-Compliant|8
302793|NCT01577186|1024215|P1|Overall Study|Ineligible to Continue|15
302794|NCT01577186|1024215|P1|Overall Study|Insufficient Response|18
302795|NCT01577186|1024215|P1|Overall Study|Withdrawal by Subject|35
302796|NCT01577186|1024215|P1|Overall Study|Lost to Follow-up|28
302797|NCT01577186|1024215|P1|Overall Study|Death|1
302798|NCT01577186|1024215|P1|Overall Study|Adverse Event|23
302799|NCT01577160|1024223|P1|Overall Study|Other|9
302800|NCT01577160|1024223|P1|Overall Study|Subject Uncooperative|7
302801|NCT01577160|1024223|P1|Overall Study|Withdrawal by Subject|18
302802|NCT01577160|1024223|P1|Overall Study|Lost to Follow-up|40
302803|NCT01577160|1024223|P1|Overall Study|Lack of Efficacy|15
302804|NCT01577160|1024223|P1|Overall Study|Adverse Event|9
302805|NCT01576718|1024269|P7|Treatment Period|Noncompliance to study medication|1
302806|NCT01576718|1024270|P6|Treatment Period|Noncompliance to study medication|1
302807|NCT01576718|1024271|P5|Treatment Period|Noncompliance to study medication|0
302808|NCT01576718|1024272|P4|Treatment Period|Noncompliance to study medication|0
302809|NCT01576718|1024273|P3|Treatment Period|Noncompliance to study medication|0
302810|NCT01576718|1024274|P2|Treatment Period|Noncompliance to study medication|0
302811|NCT01576718|1024275|P1|Treatment Period|Noncompliance to study medication|0
302812|NCT01576718|1024269|P7|Treatment Period|Lost to Follow-up|0
302813|NCT01576718|1024270|P6|Treatment Period|Lost to Follow-up|0
302814|NCT01576718|1024271|P5|Treatment Period|Lost to Follow-up|1
302815|NCT01576718|1024272|P4|Treatment Period|Lost to Follow-up|0
302816|NCT01576718|1024273|P3|Treatment Period|Lost to Follow-up|0
302817|NCT01576718|1024274|P2|Treatment Period|Lost to Follow-up|0
302818|NCT01576718|1024275|P1|Treatment Period|Lost to Follow-up|0
302819|NCT01576718|1024269|P7|Treatment Period|Met stopping criteria|15
302820|NCT01576718|1024270|P6|Treatment Period|Met stopping criteria|33
302821|NCT01576718|1024271|P5|Treatment Period|Met stopping criteria|16
302822|NCT01576718|1024272|P4|Treatment Period|Met stopping criteria|19
302823|NCT01576718|1024273|P3|Treatment Period|Met stopping criteria|13
302824|NCT01576718|1024274|P2|Treatment Period|Met stopping criteria|16
302825|NCT01576718|1024275|P1|Treatment Period|Met stopping criteria|0
302826|NCT01576718|1024269|P7|Treatment Period|Sponsor request|0
302827|NCT01576718|1024270|P6|Treatment Period|Sponsor request|1
302828|NCT01576718|1024271|P5|Treatment Period|Sponsor request|0
302829|NCT01576718|1024272|P4|Treatment Period|Sponsor request|0
302830|NCT01576718|1024273|P3|Treatment Period|Sponsor request|0
302831|NCT01576718|1024274|P2|Treatment Period|Sponsor request|1
302832|NCT01576718|1024275|P1|Treatment Period|Sponsor request|0
302833|NCT01576718|1024269|P7|Treatment Period|Protocol Violation|12
302834|NCT01576718|1024270|P6|Treatment Period|Protocol Violation|8
302835|NCT01576718|1024271|P5|Treatment Period|Protocol Violation|6
302836|NCT01576718|1024272|P4|Treatment Period|Protocol Violation|10
302837|NCT01576718|1024273|P3|Treatment Period|Protocol Violation|4
302838|NCT01576718|1024274|P2|Treatment Period|Protocol Violation|5
302839|NCT01576718|1024275|P1|Treatment Period|Protocol Violation|0
302840|NCT01576718|1024269|P7|Treatment Period|Physician Decision|0
302841|NCT01576718|1024270|P6|Treatment Period|Physician Decision|0
302842|NCT01576718|1024271|P5|Treatment Period|Physician Decision|1
302843|NCT01576718|1024272|P4|Treatment Period|Physician Decision|1
302844|NCT01576718|1024273|P3|Treatment Period|Physician Decision|1
302845|NCT01576718|1024274|P2|Treatment Period|Physician Decision|1
302846|NCT01576718|1024275|P1|Treatment Period|Physician Decision|0
302847|NCT01576718|1024269|P7|Treatment Period|Withdrawal by Subject|2
302848|NCT01576718|1024270|P6|Treatment Period|Withdrawal by Subject|4
302849|NCT01576718|1024271|P5|Treatment Period|Withdrawal by Subject|2
302850|NCT01576718|1024272|P4|Treatment Period|Withdrawal by Subject|0
302851|NCT01576718|1024273|P3|Treatment Period|Withdrawal by Subject|1
302852|NCT01576718|1024274|P2|Treatment Period|Withdrawal by Subject|1
302853|NCT01576718|1024275|P1|Treatment Period|Withdrawal by Subject|0
302854|NCT01576718|1024269|P7|Treatment Period|Adverse Event|0
302855|NCT01576718|1024270|P6|Treatment Period|Adverse Event|1
302856|NCT01576718|1024271|P5|Treatment Period|Adverse Event|1
302857|NCT01576718|1024272|P4|Treatment Period|Adverse Event|1
302858|NCT01576718|1024273|P3|Treatment Period|Adverse Event|1
302859|NCT01576718|1024274|P2|Treatment Period|Adverse Event|1
302860|NCT01576718|1024275|P1|Treatment Period|Adverse Event|0
302861|NCT01576718|1024269|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
302862|NCT01576718|1024270|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
302863|NCT01576718|1024271|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
302864|NCT01576718|1024272|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
302865|NCT01576718|1024273|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
302866|NCT01576718|1024274|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
302867|NCT01576718|1024275|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
302868|NCT01576718|1024269|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
302869|NCT01576718|1024270|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
302870|NCT01576718|1024271|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
302871|NCT01576718|1024272|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
302872|NCT01576718|1024273|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
302873|NCT01576718|1024274|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
302874|NCT01576718|1024275|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
302875|NCT01576718|1024269|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
302876|NCT01576718|1024270|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
302877|NCT01576718|1024271|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
302878|NCT01576718|1024272|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
302879|NCT01576718|1024273|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
302880|NCT01576718|1024274|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
302881|NCT01576718|1024275|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
302882|NCT01576718|1024269|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
302883|NCT01576718|1024270|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
302884|NCT01576718|1024271|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
302885|NCT01576718|1024272|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
302886|NCT01576718|1024273|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
302887|NCT01576718|1024274|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
302888|NCT01576718|1024275|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
302889|NCT01576718|1024269|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
302890|NCT01576718|1024270|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
302891|NCT01576718|1024271|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
302892|NCT01576718|1024272|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
302893|NCT01576718|1024273|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
302894|NCT01576718|1024274|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
302895|NCT01576718|1024275|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
302896|NCT01576549|1024367|P1|Overall Study|Sponsor Decision|2
302897|NCT01576367|1024384|P1|Overall Study|Moved to commercial use after 6 months|1
302898|NCT01576367|1024384|P1|Overall Study|Unsatisfactory therapeutic effect|2
302899|NCT01576341|1024392|P1|Overall Study|Other|12
302900|NCT01576341|1024392|P1|Overall Study|Protocol Violation|12
302901|NCT01576341|1024392|P1|Overall Study|Kidney transplantation|10
302902|NCT01576341|1024392|P1|Overall Study|Lost to Follow-up|2
302903|NCT01576341|1024392|P1|Overall Study|Physician Decision|2
302904|NCT01576341|1024392|P1|Overall Study|Death|21
302905|NCT01576341|1024392|P1|Overall Study|Adverse Event|10
302906|NCT01576341|1024392|P1|Overall Study|Withdrawal by Subject|24
302907|NCT01576159|1024413|P4|Overall Study|Protocol Violation|0
302908|NCT01576159|1024414|P3|Overall Study|Protocol Violation|0
302909|NCT01576159|1024415|P2|Overall Study|Protocol Violation|0
302910|NCT01576159|1024416|P1|Overall Study|Protocol Violation|1
302911|NCT01576159|1024413|P4|Overall Study|Lost to Follow-up|1
302912|NCT01576159|1024414|P3|Overall Study|Lost to Follow-up|0
302913|NCT01576159|1024415|P2|Overall Study|Lost to Follow-up|0
302914|NCT01576159|1024416|P1|Overall Study|Lost to Follow-up|0
302915|NCT01576159|1024413|P4|Overall Study|Physician Decision|0
302916|NCT01576159|1024414|P3|Overall Study|Physician Decision|1
302917|NCT01576159|1024415|P2|Overall Study|Physician Decision|0
302918|NCT01576159|1024416|P1|Overall Study|Physician Decision|0
302919|NCT01576159|1024413|P4|Overall Study|Withdrawal by Subject|0
302920|NCT01576159|1024414|P3|Overall Study|Withdrawal by Subject|0
302921|NCT01576159|1024415|P2|Overall Study|Withdrawal by Subject|1
302922|NCT01576159|1024416|P1|Overall Study|Withdrawal by Subject|0
302923|NCT01576146|1024434|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
302924|NCT01576146|1024434|P1|Extension Period 2|Renal Transplant|1
302925|NCT01576146|1024434|P1|Extension Period 2|Adverse Event|1
302926|NCT01576146|1024434|P1|Extension Period 2|Death|1
302927|NCT01576146|1024434|P1|Extension Period 2|Sponsor Decision|13
302928|NCT01576146|1024434|P1|Extension Period 1|Renal Transplant|1
302929|NCT01576146|1024434|P1|Extension Period 1|Parathyroidectomy|1
302930|NCT01576146|1024434|P1|Extension Period 1|Lost to Follow-up|1
302931|NCT01576146|1024434|P1|Extension Period 1|Withdrawal by Subject|1
302932|NCT01576146|1024434|P1|Extension Period 1|Physician Decision|2
302933|NCT01576146|1024434|P1|Extension Period 1|Death|2
302934|NCT01576146|1024434|P1|Extension Period 1|Adverse Event|2
302935|NCT01576042|1024467|P2|Overall Study|Physician Decision|0
302936|NCT01576042|1024468|P1|Overall Study|Physician Decision|2
302937|NCT01575899|1024504|P3|Overall Study|Protocol Violation|0
302938|NCT01575899|1024505|P2|Overall Study|Protocol Violation|1
302939|NCT01575899|1024506|P1|Overall Study|Protocol Violation|2
302940|NCT01575899|1024504|P3|Overall Study|Lost to Follow-up|2
302941|NCT01575899|1024505|P2|Overall Study|Lost to Follow-up|4
302942|NCT01575899|1024506|P1|Overall Study|Lost to Follow-up|3
302943|NCT01575808|1024518|P2|Overall Study|Withdrawal by Subject|0
302944|NCT01575808|1024519|P1|Overall Study|Withdrawal by Subject|1
302945|NCT01575808|1024518|P2|Overall Study|Death|0
302946|NCT01575808|1024519|P1|Overall Study|Death|2
302947|NCT01575769|1024566|P1|Overall Study|Study terminated by sponsor|40
302948|NCT01575769|1024566|P1|Overall Study|Adverse Event|1
302949|NCT01575561|1024624|P1|Overall Study|administration|1
302950|NCT01575561|1024624|P1|Overall Study|Withdrawal by Subject|11
302951|NCT01575561|1024624|P1|Overall Study|Protocol Violation|4
302952|NCT01575561|1024624|P1|Overall Study|Lost to Follow-up|6
302953|NCT01575561|1024624|P1|Overall Study|Lack of Efficacy|8
302954|NCT01575561|1024624|P1|Overall Study|Adverse Event|9
302955|NCT01575197|1024647|P3|Overall Study|Protocol Violation|1
302956|NCT01575197|1024648|P2|Overall Study|Protocol Violation|1
302957|NCT01575197|1024649|P1|Overall Study|Protocol Violation|2
302958|NCT01575197|1024647|P3|Overall Study|Withdrawal by Subject|1
302959|NCT01575197|1024648|P2|Overall Study|Withdrawal by Subject|1
302960|NCT01575197|1024649|P1|Overall Study|Withdrawal by Subject|0
302961|NCT01575197|1024647|P3|Overall Study|Lost to Follow-up|0
302962|NCT01575197|1024648|P2|Overall Study|Lost to Follow-up|1
302963|NCT01575197|1024649|P1|Overall Study|Lost to Follow-up|0
302964|NCT01575197|1024647|P3|Overall Study|SAE|0
302965|NCT01575197|1024648|P2|Overall Study|SAE|1
302966|NCT01575197|1024649|P1|Overall Study|SAE|0
302967|NCT01575197|1024647|P3|Overall Study|Migration out of study area|4
302968|NCT01575197|1024648|P2|Overall Study|Migration out of study area|5
302969|NCT01575197|1024649|P1|Overall Study|Migration out of study area|1
302970|NCT01575054|1024677|P2|Overall Study|Adverse Event|8
302971|NCT01575054|1024678|P1|Overall Study|Adverse Event|9
302972|NCT01575054|1024677|P2|Overall Study|Lost to Follow-up|3
302973|NCT01575054|1024678|P1|Overall Study|Lost to Follow-up|3
302974|NCT01575054|1024677|P2|Overall Study|Personal Reasons|11
302975|NCT01575054|1024678|P1|Overall Study|Personal Reasons|10
302976|NCT01575054|1024677|P2|Overall Study|Protocol Violation|1
302977|NCT01575054|1024678|P1|Overall Study|Protocol Violation|2
302978|NCT01575054|1024677|P2|Overall Study|Other Reasons|3
302979|NCT01575054|1024678|P1|Overall Study|Other Reasons|5
302980|NCT01575028|1024694|P2|Overall Study|Physician Decision|1
302981|NCT01575028|1024695|P1|Overall Study|Physician Decision|0
302982|NCT01574703|1024705|P4|Overall Study|Death|0
302983|NCT01574703|1024706|P3|Overall Study|Death|1
302984|NCT01574703|1024707|P2|Overall Study|Death|1
302985|NCT01574703|1024708|P1|Overall Study|Death|2
302986|NCT01574703|1024705|P4|Overall Study|Lost to Follow-up|35
302987|NCT01574703|1024706|P3|Overall Study|Lost to Follow-up|46
302988|NCT01574703|1024707|P2|Overall Study|Lost to Follow-up|41
302989|NCT01574703|1024708|P1|Overall Study|Lost to Follow-up|43
302990|NCT01574703|1024705|P4|Overall Study|Met Withdrawal Criteria|0
302991|NCT01574703|1024706|P3|Overall Study|Met Withdrawal Criteria|1
302992|NCT01574703|1024707|P2|Overall Study|Met Withdrawal Criteria|1
302993|NCT01574703|1024708|P1|Overall Study|Met Withdrawal Criteria|0
302994|NCT01574703|1024705|P4|Overall Study|Withdrawal by Subject|61
302995|NCT01574703|1024706|P3|Overall Study|Withdrawal by Subject|36
302996|NCT01574703|1024707|P2|Overall Study|Withdrawal by Subject|52
302997|NCT01574703|1024708|P1|Overall Study|Withdrawal by Subject|53
302998|NCT01574703|1024705|P4|Overall Study|Unspecified Reason|16
302999|NCT01574703|1024706|P3|Overall Study|Unspecified Reason|20
303000|NCT01574703|1024707|P2|Overall Study|Unspecified Reason|15
303001|NCT01574703|1024708|P1|Overall Study|Unspecified Reason|27
303002|NCT01574703|1024705|P4|Overall Study|Protocol Violation|1
303003|NCT01574703|1024706|P3|Overall Study|Protocol Violation|0
303004|NCT01574703|1024707|P2|Overall Study|Protocol Violation|0
303005|NCT01574703|1024708|P1|Overall Study|Protocol Violation|0
303006|NCT01574703|1024705|P4|Overall Study|Adverse Event|1
303007|NCT01574703|1024706|P3|Overall Study|Adverse Event|1
303008|NCT01574703|1024707|P2|Overall Study|Adverse Event|2
303009|NCT01574703|1024708|P1|Overall Study|Adverse Event|0
303010|NCT01574651|1024752|P2|Overall Study|Withdrawal by Subject|10
303011|NCT01574651|1024753|P1|Overall Study|Withdrawal by Subject|9
303012|NCT01574651|1024752|P2|Overall Study|Protocol Violation|5
303013|NCT01574651|1024753|P1|Overall Study|Protocol Violation|3
303014|NCT01574651|1024752|P2|Overall Study|Unsatisfactory therapeutic effect|0
303015|NCT01574651|1024753|P1|Overall Study|Unsatisfactory therapeutic effect|6
303016|NCT01574651|1024752|P2|Overall Study|Abnormal test procedure result(s)|1
303017|NCT01574651|1024753|P1|Overall Study|Abnormal test procedure result(s)|1
303018|NCT01574651|1024752|P2|Overall Study|Abnormal laboratory value(s)|0
303019|NCT01574651|1024753|P1|Overall Study|Abnormal laboratory value(s)|1
303020|NCT01574651|1024752|P2|Overall Study|Adverse Event|27
303021|NCT01574651|1024753|P1|Overall Study|Adverse Event|36
303022|NCT01574651|1024752|P2|Overall Study|Patient's inability to use the device|1
303023|NCT01574651|1024753|P1|Overall Study|Patient's inability to use the device|0
303024|NCT01574651|1024752|P2|Overall Study|Death|3
303025|NCT01574651|1024753|P1|Overall Study|Death|3
303026|NCT01574651|1024752|P2|Overall Study|Administrative problems|1
303027|NCT01574651|1024753|P1|Overall Study|Administrative problems|0
303028|NCT01574651|1024752|P2|Overall Study|Lost to Follow-up|4
303029|NCT01574651|1024753|P1|Overall Study|Lost to Follow-up|2
303030|NCT01574612|1024775|P1|Overall Study|Lost to Follow-up|2
303031|NCT01574612|1024775|P1|Overall Study|Withdrawal by Subject|1
303032|NCT01574612|1024775|P1|Overall Study|non compliant with drug|2
303033|NCT01574612|1024775|P1|Overall Study|Adverse Event|3
303034|NCT01574326|1024781|P2|Overall Study|Other: Mainly kidney transplant|8
303035|NCT01574326|1024782|P1|Overall Study|Other: Mainly kidney transplant|8
303036|NCT01574326|1024781|P2|Overall Study|Adverse Event|3
303037|NCT01574326|1024782|P1|Overall Study|Adverse Event|1
303038|NCT01574326|1024781|P2|Overall Study|Physician Decision|3
303039|NCT01574326|1024782|P1|Overall Study|Physician Decision|5
303040|NCT01574326|1024781|P2|Overall Study|Withdrawal by Participant|4
303041|NCT01574326|1024782|P1|Overall Study|Withdrawal by Participant|2
303042|NCT01574326|1024781|P2|Overall Study|Randomized but not treated|1
303043|NCT01574326|1024782|P1|Overall Study|Randomized but not treated|0
303044|NCT01574248|1024795|P2|Overall Study|Missing primary endpoint data|0
303045|NCT01574248|1024796|P1|Overall Study|Missing primary endpoint data|1
303046|NCT01574248|1024795|P2|Overall Study|Withdrawal by Subject|0
303047|NCT01574248|1024796|P1|Overall Study|Withdrawal by Subject|2
303048|NCT01574079|1024840|P2|Overall Study|Lost to Follow-up|0
303049|NCT01574079|1024841|P1|Overall Study|Lost to Follow-up|1
303050|NCT01574079|1024840|P2|Overall Study|Physician Decision|2
303051|NCT01574079|1024841|P1|Overall Study|Physician Decision|0
303052|NCT01573910|1024853|P2|Overall Study|Patient decision unrelated to Advs Event|11
303053|NCT01573910|1024854|P1|Overall Study|Patient decision unrelated to Advs Event|11
303054|NCT01573910|1024853|P2|Overall Study|Protocol Violation|0
303055|NCT01573910|1024854|P1|Overall Study|Protocol Violation|3
303056|NCT01573910|1024853|P2|Overall Study|Withdrawal by Subject|1
303057|NCT01573910|1024854|P1|Overall Study|Withdrawal by Subject|0
303058|NCT01573910|1024853|P2|Overall Study|Lost to Follow-up|1
303059|NCT01573910|1024854|P1|Overall Study|Lost to Follow-up|2
303060|NCT01573910|1024853|P2|Overall Study|Adverse Event|4
303061|NCT01573910|1024854|P1|Overall Study|Adverse Event|4
303062|NCT01573767|1024866|P4|Overall Study|Withdrawal by Subject|0
303063|NCT01573767|1024867|P3|Overall Study|Withdrawal by Subject|0
303064|NCT01573767|1024868|P2|Overall Study|Withdrawal by Subject|1
303065|NCT01573767|1024869|P1|Overall Study|Withdrawal by Subject|0
303066|NCT01573767|1024866|P4|Overall Study|Physician Decision|2
303067|NCT01573767|1024867|P3|Overall Study|Physician Decision|0
303068|NCT01573767|1024868|P2|Overall Study|Physician Decision|2
303069|NCT01573767|1024869|P1|Overall Study|Physician Decision|1
303070|NCT01573767|1024866|P4|Overall Study|Lost to Follow-up|1
303071|NCT01573767|1024867|P3|Overall Study|Lost to Follow-up|1
303072|NCT01573767|1024868|P2|Overall Study|Lost to Follow-up|1
303073|NCT01573767|1024869|P1|Overall Study|Lost to Follow-up|0
303074|NCT01573767|1024866|P4|Overall Study|Protocol Violation|3
303075|NCT01573767|1024867|P3|Overall Study|Protocol Violation|1
303076|NCT01573767|1024868|P2|Overall Study|Protocol Violation|1
303077|NCT01573767|1024869|P1|Overall Study|Protocol Violation|3
303078|NCT01573767|1024866|P4|Overall Study|Lack of Efficacy|17
303079|NCT01573767|1024867|P3|Overall Study|Lack of Efficacy|12
303080|NCT01573767|1024868|P2|Overall Study|Lack of Efficacy|15
303081|NCT01573767|1024869|P1|Overall Study|Lack of Efficacy|18
303082|NCT01573767|1024866|P4|Overall Study|Adverse Event|1
303083|NCT01573767|1024867|P3|Overall Study|Adverse Event|0
303084|NCT01573767|1024868|P2|Overall Study|Adverse Event|1
303085|NCT01573767|1024869|P1|Overall Study|Adverse Event|0
303086|NCT01573624|1024903|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
303087|NCT01573624|1024904|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
303088|NCT01573624|1024905|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
303089|NCT01573624|1024906|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
303090|NCT01573624|1024907|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
303091|NCT01573624|1024908|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
303092|NCT01573624|1024909|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
303093|NCT01573624|1024903|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
303094|NCT01573624|1024904|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
303095|NCT01573624|1024905|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
303096|NCT01573624|1024906|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
303097|NCT01573624|1024907|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
303098|NCT01573624|1024908|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
303099|NCT01573624|1024909|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
303100|NCT01573624|1024903|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
303101|NCT01573624|1024904|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
303102|NCT01573624|1024905|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
303103|NCT01573624|1024906|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
303104|NCT01573624|1024907|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
303105|NCT01573624|1024908|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
303106|NCT01573624|1024909|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
303107|NCT01573624|1024903|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
303108|NCT01573624|1024904|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
303109|NCT01573624|1024905|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
303110|NCT01573624|1024906|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
303111|NCT01573624|1024907|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
303112|NCT01573624|1024908|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
303113|NCT01573624|1024909|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
303114|NCT01573624|1024903|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
303115|NCT01573624|1024904|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
303116|NCT01573624|1024905|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
303117|NCT01573624|1024906|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
303118|NCT01573624|1024907|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
303119|NCT01573624|1024908|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
303120|NCT01573624|1024909|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
303121|NCT01573624|1024903|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
303122|NCT01573624|1024904|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
303123|NCT01573624|1024905|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
303124|NCT01573624|1024906|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
303125|NCT01573624|1024907|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
303126|NCT01573624|1024908|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
303127|NCT01573624|1024909|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
303128|NCT01573624|1024903|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
303129|NCT01573624|1024904|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
303130|NCT01573624|1024905|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
303131|NCT01573624|1024906|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
303132|NCT01573624|1024907|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
303133|NCT01573624|1024908|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
303134|NCT01573624|1024909|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
303353|NCT01572792|1025133|P3|Lead-in Study|Withdrawal by Subject|12
303135|NCT01573624|1024903|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
303136|NCT01573624|1024904|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
303137|NCT01573624|1024905|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
303138|NCT01573624|1024906|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
303139|NCT01573624|1024907|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
303140|NCT01573624|1024908|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
303141|NCT01573624|1024909|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
303142|NCT01573624|1024903|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
303143|NCT01573624|1024904|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
303144|NCT01573624|1024905|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
303145|NCT01573624|1024906|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
303146|NCT01573624|1024907|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
303147|NCT01573624|1024908|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
303148|NCT01573624|1024909|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
303149|NCT01573624|1024903|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
303150|NCT01573624|1024904|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
303151|NCT01573624|1024905|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
303152|NCT01573624|1024906|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
303153|NCT01573624|1024907|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
303154|NCT01573624|1024908|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
303155|NCT01573624|1024909|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
303156|NCT01573624|1024903|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
303157|NCT01573624|1024904|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
303158|NCT01573624|1024905|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
303159|NCT01573624|1024906|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
303160|NCT01573624|1024907|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
303161|NCT01573624|1024908|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
303162|NCT01573624|1024909|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
303163|NCT01573624|1024903|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
303164|NCT01573624|1024904|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
303165|NCT01573624|1024905|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
303166|NCT01573624|1024906|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
303167|NCT01573624|1024907|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
303168|NCT01573624|1024908|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
303169|NCT01573624|1024909|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
303170|NCT01573624|1024903|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
303171|NCT01573624|1024904|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
303172|NCT01573624|1024905|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
303173|NCT01573624|1024906|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
303174|NCT01573624|1024907|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
303175|NCT01573624|1024908|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
303176|NCT01573624|1024909|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
303177|NCT01573624|1024903|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
303178|NCT01573624|1024904|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
303179|NCT01573624|1024905|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
303180|NCT01573624|1024906|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
303181|NCT01573624|1024907|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
303182|NCT01573624|1024908|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
303183|NCT01573624|1024909|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
303184|NCT01573624|1024903|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
303185|NCT01573624|1024904|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
303186|NCT01573624|1024905|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
303187|NCT01573624|1024906|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
303188|NCT01573624|1024907|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
303189|NCT01573624|1024908|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
303190|NCT01573624|1024909|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
303191|NCT01573624|1024903|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
303192|NCT01573624|1024904|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
303193|NCT01573624|1024905|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
303194|NCT01573624|1024906|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
303195|NCT01573624|1024907|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
303196|NCT01573624|1024908|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
303197|NCT01573624|1024909|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
303198|NCT01573624|1024903|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
303199|NCT01573624|1024904|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
303200|NCT01573624|1024905|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
303201|NCT01573624|1024906|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
303202|NCT01573624|1024907|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
303203|NCT01573624|1024908|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
303204|NCT01573624|1024909|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
303205|NCT01573624|1024903|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
303206|NCT01573624|1024904|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
303207|NCT01573624|1024905|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
303208|NCT01573624|1024906|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
303209|NCT01573624|1024907|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
303210|NCT01573624|1024908|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
303211|NCT01573624|1024909|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
303212|NCT01573624|1024903|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
303213|NCT01573624|1024904|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
303214|NCT01573624|1024905|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
303215|NCT01573624|1024906|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
303216|NCT01573624|1024907|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
303217|NCT01573624|1024908|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
303218|NCT01573624|1024909|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
303219|NCT01573624|1024903|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
303220|NCT01573624|1024904|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
303221|NCT01573624|1024905|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
303222|NCT01573624|1024906|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
303223|NCT01573624|1024907|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
303224|NCT01573624|1024908|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
303225|NCT01573624|1024909|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
303226|NCT01573624|1024903|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
303227|NCT01573624|1024904|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
303228|NCT01573624|1024905|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
303229|NCT01573624|1024906|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
303230|NCT01573624|1024907|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
303231|NCT01573624|1024908|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
303232|NCT01573624|1024909|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
303233|NCT01573624|1024903|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
303234|NCT01573624|1024904|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
303235|NCT01573624|1024905|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
303236|NCT01573624|1024906|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
303237|NCT01573624|1024907|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
303238|NCT01573624|1024908|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
303239|NCT01573624|1024909|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
303240|NCT01573624|1024903|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
303241|NCT01573624|1024904|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
303242|NCT01573624|1024905|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
303243|NCT01573624|1024906|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
303244|NCT01573624|1024907|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
303245|NCT01573624|1024908|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
303246|NCT01573624|1024909|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
303247|NCT01573624|1024903|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
303248|NCT01573624|1024904|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
303249|NCT01573624|1024905|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
303250|NCT01573624|1024906|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
303251|NCT01573624|1024907|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
303252|NCT01573624|1024908|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
303253|NCT01573624|1024909|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
303254|NCT01573624|1024903|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
303255|NCT01573624|1024904|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
303256|NCT01573624|1024905|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
303257|NCT01573624|1024906|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
303258|NCT01573624|1024907|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
303259|NCT01573624|1024908|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
303260|NCT01573624|1024909|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
303261|NCT01573624|1024903|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
303262|NCT01573624|1024904|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
303263|NCT01573624|1024905|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
303264|NCT01573624|1024906|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
303265|NCT01573624|1024907|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
303266|NCT01573624|1024908|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
303267|NCT01573624|1024909|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
303268|NCT01573624|1024903|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
303269|NCT01573624|1024904|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
303270|NCT01573624|1024905|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
303271|NCT01573624|1024906|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
303272|NCT01573624|1024907|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
303273|NCT01573624|1024908|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
303274|NCT01573624|1024909|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
303275|NCT01573000|1024998|P2|Long-Term Follow-Up|Lost to Follow-up|1
303276|NCT01573000|1024999|P1|Long-Term Follow-Up|Lost to Follow-up|0
303277|NCT01573000|1024998|P2|Long-Term Follow-Up|Death|0
303278|NCT01573000|1024999|P1|Long-Term Follow-Up|Death|3
303279|NCT01573000|1024998|P2|Crossover Phase|Death|3
303280|NCT01573000|1024999|P1|Crossover Phase|Death|0
303281|NCT01573000|1024998|P2|Crossover Phase|Lost to Follow-up|2
303282|NCT01573000|1024999|P1|Crossover Phase|Lost to Follow-up|0
303283|NCT01573000|1024998|P2|Crossover Phase|Lack of Efficacy|13
303284|NCT01573000|1024999|P1|Crossover Phase|Lack of Efficacy|0
303285|NCT01573000|1024998|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
303286|NCT01573000|1024999|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
303287|NCT01573000|1024998|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
303288|NCT01573000|1024999|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
303289|NCT01573000|1024998|P2|Dosimetric and Therapeutic Treatment|Death|1
303290|NCT01573000|1024999|P1|Dosimetric and Therapeutic Treatment|Death|0
303291|NCT01573000|1024998|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
303292|NCT01573000|1024999|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
303293|NCT01573000|1024998|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
303294|NCT01573000|1024999|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
303295|NCT01572948|1025095|P2|Overall Study|unable to contact|1
303296|NCT01572948|1025096|P1|Overall Study|unable to contact|0
303297|NCT01572948|1025095|P2|Overall Study|Lost to Follow-up|0
303298|NCT01572948|1025096|P1|Overall Study|Lost to Follow-up|1
303299|NCT01572844|1025112|P2|Overall Study|Physician Decision|1
303300|NCT01572844|1025113|P1|Overall Study|Physician Decision|1
303301|NCT01572792|1025131|P5|Extension Study|Site termination/COPD exacerbation/other|6
303302|NCT01572792|1025132|P4|Extension Study|Site termination/COPD exacerbation/other|6
303303|NCT01572792|1025133|P3|Extension Study|Site termination/COPD exacerbation/other|4
303304|NCT01572792|1025134|P2|Extension Study|Site termination/COPD exacerbation/other|8
303305|NCT01572792|1025135|P1|Extension Study|Site termination/COPD exacerbation/other|3
303306|NCT01572792|1025131|P5|Extension Study|Adverse Event|4
303307|NCT01572792|1025132|P4|Extension Study|Adverse Event|6
303308|NCT01572792|1025133|P3|Extension Study|Adverse Event|5
303309|NCT01572792|1025134|P2|Extension Study|Adverse Event|6
303310|NCT01572792|1025135|P1|Extension Study|Adverse Event|7
303311|NCT01572792|1025131|P5|Extension Study|Lack of Efficacy|2
303312|NCT01572792|1025132|P4|Extension Study|Lack of Efficacy|2
303313|NCT01572792|1025133|P3|Extension Study|Lack of Efficacy|3
303314|NCT01572792|1025134|P2|Extension Study|Lack of Efficacy|3
303315|NCT01572792|1025135|P1|Extension Study|Lack of Efficacy|2
303316|NCT01572792|1025131|P5|Extension Study|Protocol Violation|3
303317|NCT01572792|1025132|P4|Extension Study|Protocol Violation|4
303318|NCT01572792|1025133|P3|Extension Study|Protocol Violation|3
303319|NCT01572792|1025134|P2|Extension Study|Protocol Violation|4
303320|NCT01572792|1025135|P1|Extension Study|Protocol Violation|0
303321|NCT01572792|1025131|P5|Extension Study|Withdrawal by Subject|14
303322|NCT01572792|1025132|P4|Extension Study|Withdrawal by Subject|8
303323|NCT01572792|1025133|P3|Extension Study|Withdrawal by Subject|11
303324|NCT01572792|1025134|P2|Extension Study|Withdrawal by Subject|6
303325|NCT01572792|1025135|P1|Extension Study|Withdrawal by Subject|7
303326|NCT01572792|1025131|P5|Extension Study|Lost to Follow-up|3
303327|NCT01572792|1025132|P4|Extension Study|Lost to Follow-up|3
303328|NCT01572792|1025133|P3|Extension Study|Lost to Follow-up|0
303329|NCT01572792|1025134|P2|Extension Study|Lost to Follow-up|2
303330|NCT01572792|1025135|P1|Extension Study|Lost to Follow-up|6
303331|NCT01572792|1025131|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
303332|NCT01572792|1025132|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
303333|NCT01572792|1025133|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
303334|NCT01572792|1025134|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
303335|NCT01572792|1025135|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
303336|NCT01572792|1025131|P5|Lead-in Study|Adverse Event|14
303337|NCT01572792|1025132|P4|Lead-in Study|Adverse Event|16
303338|NCT01572792|1025133|P3|Lead-in Study|Adverse Event|22
303339|NCT01572792|1025134|P2|Lead-in Study|Adverse Event|21
303340|NCT01572792|1025135|P1|Lead-in Study|Adverse Event|21
303341|NCT01572792|1025131|P5|Lead-in Study|Lack of Efficacy|10
303342|NCT01572792|1025132|P4|Lead-in Study|Lack of Efficacy|8
303343|NCT01572792|1025133|P3|Lead-in Study|Lack of Efficacy|4
303344|NCT01572792|1025134|P2|Lead-in Study|Lack of Efficacy|5
303345|NCT01572792|1025135|P1|Lead-in Study|Lack of Efficacy|20
303346|NCT01572792|1025131|P5|Lead-in Study|Protocol Violation|21
303347|NCT01572792|1025132|P4|Lead-in Study|Protocol Violation|13
303348|NCT01572792|1025133|P3|Lead-in Study|Protocol Violation|12
303349|NCT01572792|1025134|P2|Lead-in Study|Protocol Violation|10
303350|NCT01572792|1025135|P1|Lead-in Study|Protocol Violation|19
303351|NCT01572792|1025131|P5|Lead-in Study|Withdrawal by Subject|11
303352|NCT01572792|1025132|P4|Lead-in Study|Withdrawal by Subject|24
303354|NCT01572792|1025134|P2|Lead-in Study|Withdrawal by Subject|11
303355|NCT01572792|1025135|P1|Lead-in Study|Withdrawal by Subject|22
303356|NCT01572792|1025131|P5|Lead-in Study|Lost to Follow-up|4
303357|NCT01572792|1025132|P4|Lead-in Study|Lost to Follow-up|2
303358|NCT01572792|1025133|P3|Lead-in Study|Lost to Follow-up|4
303359|NCT01572792|1025134|P2|Lead-in Study|Lost to Follow-up|9
303360|NCT01572792|1025135|P1|Lead-in Study|Lost to Follow-up|5
303361|NCT01572740|1025184|P2|Overall Study|unclassified|3
303362|NCT01572740|1025185|P1|Overall Study|unclassified|4
303363|NCT01572740|1025184|P2|Overall Study|Withdrawal by Subject|1
303364|NCT01572740|1025185|P1|Overall Study|Withdrawal by Subject|1
303365|NCT01572740|1025184|P2|Overall Study|Adverse Event|1
303366|NCT01572740|1025185|P1|Overall Study|Adverse Event|1
303367|NCT01572727|1025215|P2|Overall Study|Untreated|7
303368|NCT01572727|1025216|P1|Overall Study|Untreated|4
303369|NCT01572727|1025215|P2|Overall Study|Death|2
303370|NCT01572727|1025216|P1|Overall Study|Death|2
303371|NCT01572727|1025215|P2|Overall Study|Parent/guardian decision|9
303372|NCT01572727|1025216|P1|Overall Study|Parent/guardian decision|14
303373|NCT01572727|1025215|P2|Overall Study|Study terminated by sponsor|83
303374|NCT01572727|1025216|P1|Overall Study|Study terminated by sponsor|61
303375|NCT01572727|1025215|P2|Overall Study|Protocol Violation|1
303376|NCT01572727|1025216|P1|Overall Study|Protocol Violation|0
303377|NCT01572727|1025215|P2|Overall Study|Progressive disease|82
303378|NCT01572727|1025216|P1|Overall Study|Progressive disease|59
303379|NCT01572727|1025215|P2|Overall Study|Physician Decision|9
303380|NCT01572727|1025216|P1|Overall Study|Physician Decision|23
303381|NCT01572727|1025215|P2|Overall Study|Lost to Follow-up|1
303382|NCT01572727|1025216|P1|Overall Study|Lost to Follow-up|1
303383|NCT01572727|1025215|P2|Overall Study|Adverse Event|15
303384|NCT01572727|1025216|P1|Overall Study|Adverse Event|43
303385|NCT01572675|1025238|P2|Overall Study|Lost to Follow-up|27
303386|NCT01572675|1025239|P1|Overall Study|Lost to Follow-up|22
303387|NCT01572675|1025238|P2|Overall Study|Missing data|4
303388|NCT01572675|1025239|P1|Overall Study|Missing data|1
303389|NCT01572675|1025238|P2|Overall Study|Rheumatologist new evaluation|1
303390|NCT01572675|1025239|P1|Overall Study|Rheumatologist new evaluation|0
303391|NCT01572675|1025238|P2|Overall Study|Unknown reason|1
303392|NCT01572675|1025239|P1|Overall Study|Unknown reason|1
303393|NCT01572675|1025238|P2|Overall Study|Other disease detected|1
303394|NCT01572675|1025239|P1|Overall Study|Other disease detected|1
303395|NCT01572675|1025238|P2|Overall Study|Death unrelated to coxibs|1
303396|NCT01572675|1025239|P1|Overall Study|Death unrelated to coxibs|1
303397|NCT01572675|1025238|P2|Overall Study|Physician Decision|2
303398|NCT01572675|1025239|P1|Overall Study|Physician Decision|2
303399|NCT01572675|1025238|P2|Overall Study|Withdrawal by Subject|1
303400|NCT01572675|1025239|P1|Overall Study|Withdrawal by Subject|5
303401|NCT01572675|1025238|P2|Overall Study|Surgical intervention|6
303402|NCT01572675|1025239|P1|Overall Study|Surgical intervention|3
303403|NCT01572675|1025238|P2|Overall Study|Improved symptoms|2
303404|NCT01572675|1025239|P1|Overall Study|Improved symptoms|8
303405|NCT01572675|1025238|P2|Overall Study|Intolerance|5
303406|NCT01572675|1025239|P1|Overall Study|Intolerance|6
303407|NCT01572675|1025238|P2|Overall Study|Lack of Efficacy|31
303408|NCT01572675|1025239|P1|Overall Study|Lack of Efficacy|31
303409|NCT01572675|1025238|P2|Overall Study|Recovery|23
303410|NCT01572675|1025239|P1|Overall Study|Recovery|16
303411|NCT01572675|1025238|P2|Overall Study|End of prescribed treatment|118
303412|NCT01572675|1025239|P1|Overall Study|End of prescribed treatment|140
303413|NCT01572389|1025338|P2|Overall Study|Only A1C or Assessment was Collected|2
303414|NCT01572389|1025339|P1|Overall Study|Only A1C or Assessment was Collected|6
303415|NCT01572389|1025338|P2|Overall Study|Lost to Follow-up|14
303416|NCT01572389|1025339|P1|Overall Study|Lost to Follow-up|25
303417|NCT01572389|1025338|P2|Overall Study|Withdrawal by Subject|2
303418|NCT01572389|1025339|P1|Overall Study|Withdrawal by Subject|14
303419|NCT01572389|1025338|P2|Overall Study|Death|3
303420|NCT01572389|1025339|P1|Overall Study|Death|1
303421|NCT01571453|1025380|P2|Overall Study|Administrative or other reason(s)|3
303422|NCT01571453|1025381|P1|Overall Study|Administrative or other reason(s)|4
303423|NCT01571453|1025380|P2|Overall Study|Lost to Follow-up|2
303424|NCT01571453|1025381|P1|Overall Study|Lost to Follow-up|4
303425|NCT01571453|1025380|P2|Overall Study|Withdrawal of consent|13
303426|NCT01571453|1025381|P1|Overall Study|Withdrawal of consent|5
303427|NCT01571453|1025380|P2|Overall Study|Protocol Violation|5
303428|NCT01571453|1025381|P1|Overall Study|Protocol Violation|1
303429|NCT01571453|1025380|P2|Overall Study|Non-compliance|4
303430|NCT01571453|1025381|P1|Overall Study|Non-compliance|2
303431|NCT01571453|1025380|P2|Overall Study|Lack of Efficacy|3
303432|NCT01571453|1025381|P1|Overall Study|Lack of Efficacy|8
303433|NCT01571453|1025380|P2|Overall Study|Adverse Event|32
303434|NCT01571453|1025381|P1|Overall Study|Adverse Event|14
303435|NCT01571362|1025397|P3|Double-Blind Treatment Period|Other - unspecified|1
303436|NCT01571362|1025398|P2|Double-Blind Treatment Period|Other - unspecified|6
303437|NCT01571362|1025399|P1|Double-Blind Treatment Period|Other - unspecified|0
303438|NCT01571362|1025397|P3|Double-Blind Treatment Period|Insufficient clinical response|4
303439|NCT01571362|1025398|P2|Double-Blind Treatment Period|Insufficient clinical response|16
303440|NCT01571362|1025399|P1|Double-Blind Treatment Period|Insufficient clinical response|0
303441|NCT01571362|1025397|P3|Double-Blind Treatment Period|Lost to Follow-up|6
303442|NCT01571362|1025398|P2|Double-Blind Treatment Period|Lost to Follow-up|3
303443|NCT01571362|1025399|P1|Double-Blind Treatment Period|Lost to Follow-up|0
303444|NCT01571362|1025397|P3|Double-Blind Treatment Period|Adverse Event|14
303445|NCT01571362|1025398|P2|Double-Blind Treatment Period|Adverse Event|9
303446|NCT01571362|1025399|P1|Double-Blind Treatment Period|Adverse Event|0
303447|NCT01571362|1025397|P3|Double-Blind Treatment Period|Protocol Violation|9
303448|NCT01571362|1025398|P2|Double-Blind Treatment Period|Protocol Violation|8
303449|NCT01571362|1025399|P1|Double-Blind Treatment Period|Protocol Violation|0
303450|NCT01571362|1025397|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
303451|NCT01571362|1025398|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
303452|NCT01571362|1025399|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
303453|NCT01571362|1025397|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
303454|NCT01571362|1025398|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
303455|NCT01571362|1025399|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
303456|NCT01571362|1025397|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
303457|NCT01571362|1025398|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
303458|NCT01571362|1025399|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
303459|NCT01571362|1025397|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
303460|NCT01571362|1025398|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
303461|NCT01571362|1025399|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
303462|NCT01571362|1025397|P3|Open-Label Conversion + Titration Period|Adverse Event|0
303463|NCT01571362|1025398|P2|Open-Label Conversion + Titration Period|Adverse Event|0
303464|NCT01571362|1025399|P1|Open-Label Conversion + Titration Period|Adverse Event|57
303465|NCT01571362|1025397|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
303466|NCT01571362|1025398|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
303467|NCT01571362|1025399|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
303468|NCT01571362|1025397|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
303469|NCT01571362|1025398|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
303470|NCT01571362|1025399|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
303471|NCT01571284|1025569|P1|Overall Study|Other than specified above|80
303472|NCT01571284|1025569|P1|Overall Study|Enrolled but not treated|2
303473|NCT01571284|1025569|P1|Overall Study|Lost to Follow-up|3
303474|NCT01571284|1025569|P1|Overall Study|Participant's decision|84
303475|NCT01571232|1025592|P2|Overall Study|Withdrawal by Subject|0
303476|NCT01571232|1025593|P1|Overall Study|Withdrawal by Subject|1
303477|NCT01571232|1025592|P2|Overall Study|Lost to Follow-up|1
303478|NCT01571232|1025593|P1|Overall Study|Lost to Follow-up|0
303479|NCT01570751|1025605|P2|Period B (16 Weeks)|Protocol Violation|1
303480|NCT01570751|1025606|P1|Period B (16 Weeks)|Protocol Violation|0
303481|NCT01570751|1025605|P2|Period B (16 Weeks)|Adverse Event|0
303482|NCT01570751|1025606|P1|Period B (16 Weeks)|Adverse Event|1
303483|NCT01570751|1025605|P2|Period A (16 Weeks)|Unclassified|3
303484|NCT01570751|1025606|P1|Period A (16 Weeks)|Unclassified|2
303485|NCT01570751|1025605|P2|Period A (16 Weeks)|Withdrawal criteria|1
303486|NCT01570751|1025606|P1|Period A (16 Weeks)|Withdrawal criteria|0
303487|NCT01570751|1025605|P2|Period A (16 Weeks)|Protocol Violation|1
303488|NCT01570751|1025606|P1|Period A (16 Weeks)|Protocol Violation|1
303489|NCT01570686|1025624|P2|Overall Study|Unsatisfactory therapeutic effect|1
303490|NCT01570686|1025625|P1|Overall Study|Unsatisfactory therapeutic effect|2
303491|NCT01570686|1025624|P2|Overall Study|Withdrawal by Subject|4
303492|NCT01570686|1025625|P1|Overall Study|Withdrawal by Subject|4
303493|NCT01570686|1025624|P2|Overall Study|Protocol Deviation|0
303494|NCT01570686|1025625|P1|Overall Study|Protocol Deviation|3
303495|NCT01570686|1025624|P2|Overall Study|Lost to Follow-up|3
303496|NCT01570686|1025625|P1|Overall Study|Lost to Follow-up|4
303497|NCT01570686|1025624|P2|Overall Study|Adverse Event|6
303498|NCT01570686|1025625|P1|Overall Study|Adverse Event|8
303499|NCT01570686|1025624|P2|Overall Study|Administrative problems|1
303500|NCT01570686|1025625|P1|Overall Study|Administrative problems|0
303501|NCT01570686|1025624|P2|Overall Study|Abnormal test procedure result(s)|1
303502|NCT01570686|1025625|P1|Overall Study|Abnormal test procedure result(s)|1
303503|NCT01570309|1025661|P2|Overall Study|Withdrawal by Subject|3
303504|NCT01570309|1025662|P1|Overall Study|Withdrawal by Subject|3
303505|NCT01570244|1025676|P1|Microgynon+Faldaprevir|Adverse Event|1
303506|NCT01570192|1025698|P2|Overall Study|Physician Decision|1
303507|NCT01570192|1025699|P1|Overall Study|Physician Decision|0
303508|NCT01570192|1025698|P2|Overall Study|changed to palliative care|0
303509|NCT01570192|1025699|P1|Overall Study|changed to palliative care|1
303510|NCT01570192|1025698|P2|Overall Study|no qualifying organism|12
303511|NCT01570192|1025699|P1|Overall Study|no qualifying organism|6
303512|NCT01569841|1025737|P2|Period A (6 Weeks)|Withdrawal by Subject|1
303513|NCT01569841|1025738|P1|Period A (6 Weeks)|Withdrawal by Subject|0
303514|NCT01569763|1025827|P2|Overall Study|Adverse Event|0
303515|NCT01569763|1025828|P1|Overall Study|Adverse Event|1
303516|NCT01569763|1025827|P2|Overall Study|Lack of Efficacy|7
303517|NCT01569763|1025828|P1|Overall Study|Lack of Efficacy|2
303518|NCT01569568|1025865|P2|Overall Study|Physician Decision|2
303519|NCT01569568|1025866|P1|Overall Study|Physician Decision|0
303520|NCT01569464|1025889|P2|Overall Study|Other|1
303521|NCT01569464|1025890|P1|Overall Study|Other|1
303522|NCT01569464|1025889|P2|Overall Study|Withdrawal by Subject|1
303523|NCT01569464|1025890|P1|Overall Study|Withdrawal by Subject|1
303524|NCT01569464|1025889|P2|Overall Study|Lost to Follow-up|3
303525|NCT01569464|1025890|P1|Overall Study|Lost to Follow-up|2
303526|NCT01569464|1025889|P2|Overall Study|Protocol Violation|0
303527|NCT01569464|1025890|P1|Overall Study|Protocol Violation|1
303528|NCT01569464|1025889|P2|Overall Study|Lack of Efficacy|0
303529|NCT01569464|1025890|P1|Overall Study|Lack of Efficacy|1
303530|NCT01569464|1025889|P2|Overall Study|Adverse Event|0
303531|NCT01569464|1025890|P1|Overall Study|Adverse Event|4
303532|NCT01569438|1025957|P2|Overall Study|Protocol Violation|0
303533|NCT01569438|1025958|P1|Overall Study|Protocol Violation|1
303534|NCT01569438|1025957|P2|Overall Study|Withdrawal by Subject|1
303535|NCT01569438|1025958|P1|Overall Study|Withdrawal by Subject|0
303536|NCT01569438|1025957|P2|Overall Study|Lack of Efficacy|1
303537|NCT01569438|1025958|P1|Overall Study|Lack of Efficacy|1
303538|NCT01569438|1025957|P2|Overall Study|Adverse Event|7
303539|NCT01569438|1025958|P1|Overall Study|Adverse Event|0
303540|NCT01569295|1025972|P2|Overall Study|Lost to Follow-up|0
303541|NCT01569295|1025973|P1|Overall Study|Lost to Follow-up|1
303542|NCT01569295|1025972|P2|Overall Study|Other Anticancer/Experimental Therapy|1
303543|NCT01569295|1025973|P1|Overall Study|Other Anticancer/Experimental Therapy|2
303544|NCT01569295|1025972|P2|Overall Study|Noncompliance with Study Drug|0
303545|NCT01569295|1025973|P1|Overall Study|Noncompliance with Study Drug|3
303546|NCT01569295|1025972|P2|Overall Study|Other|3
303547|NCT01569295|1025973|P1|Overall Study|Other|4
303548|NCT01569295|1025972|P2|Overall Study|Physician Decision|19
303549|NCT01569295|1025973|P1|Overall Study|Physician Decision|7
303550|NCT01569295|1025972|P2|Overall Study|Withdrawal by Subject|8
303551|NCT01569295|1025973|P1|Overall Study|Withdrawal by Subject|20
303552|NCT01569295|1025972|P2|Overall Study|Adverse Event|13
303553|NCT01569295|1025973|P1|Overall Study|Adverse Event|27
303554|NCT01569295|1025972|P2|Overall Study|Ongoing in Study|23
303555|NCT01569295|1025973|P1|Overall Study|Ongoing in Study|70
303556|NCT01569152|1026010|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
303557|NCT01569152|1026011|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
303558|NCT01569152|1026012|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
303559|NCT01569152|1026010|P3|Safety Extension, Period 3|Physician Decision|2
303560|NCT01569152|1026011|P2|Safety Extension, Period 3|Physician Decision|0
303561|NCT01569152|1026012|P1|Safety Extension, Period 3|Physician Decision|0
303562|NCT01569152|1026010|P3|Safety Extension, Period 3|Withdrawal by Subject|2
303563|NCT01569152|1026011|P2|Safety Extension, Period 3|Withdrawal by Subject|0
303564|NCT01569152|1026012|P1|Safety Extension, Period 3|Withdrawal by Subject|0
303565|NCT01569152|1026010|P3|Safety Extension, Period 3|Adverse Event|4
303566|NCT01569152|1026011|P2|Safety Extension, Period 3|Adverse Event|0
303567|NCT01569152|1026012|P1|Safety Extension, Period 3|Adverse Event|0
303568|NCT01569152|1026010|P3|Phase IIa, Period 1|Withdrawal by Subject|0
303569|NCT01569152|1026011|P2|Phase IIa, Period 1|Withdrawal by Subject|1
303570|NCT01569152|1026012|P1|Phase IIa, Period 1|Withdrawal by Subject|2
303571|NCT01569152|1026010|P3|Phase IIa, Period 1|Protocol Violation|0
303572|NCT01569152|1026011|P2|Phase IIa, Period 1|Protocol Violation|1
303573|NCT01569152|1026012|P1|Phase IIa, Period 1|Protocol Violation|0
303574|NCT01569152|1026010|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
303575|NCT01569152|1026011|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
303576|NCT01569152|1026012|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
303577|NCT01569152|1026010|P3|Phase IIa, Period 1|Lost to Follow-up|0
303578|NCT01569152|1026011|P2|Phase IIa, Period 1|Lost to Follow-up|0
303579|NCT01569152|1026012|P1|Phase IIa, Period 1|Lost to Follow-up|1
303580|NCT01569152|1026010|P3|Phase IIa, Period 1|Adverse Event|0
303581|NCT01569152|1026011|P2|Phase IIa, Period 1|Adverse Event|0
303582|NCT01569152|1026012|P1|Phase IIa, Period 1|Adverse Event|4
303583|NCT01569152|1026010|P3|Phase IIa, Period 1|Early Escape|0
303584|NCT01569152|1026011|P2|Phase IIa, Period 1|Early Escape|22
303585|NCT01569152|1026012|P1|Phase IIa, Period 1|Early Escape|5
303586|NCT01569074|1026148|P5|Overall Study|Adverse Event|0
303587|NCT01569074|1026149|P4|Overall Study|Adverse Event|0
303588|NCT01569074|1026150|P3|Overall Study|Adverse Event|3
303589|NCT01569074|1026151|P2|Overall Study|Adverse Event|0
303590|NCT01569074|1026152|P1|Overall Study|Adverse Event|1
303591|NCT01569074|1026148|P5|Overall Study|eg change in circumstances|1
303592|NCT01569074|1026149|P4|Overall Study|eg change in circumstances|1
303593|NCT01569074|1026150|P3|Overall Study|eg change in circumstances|0
303594|NCT01569074|1026151|P2|Overall Study|eg change in circumstances|2
303595|NCT01569074|1026152|P1|Overall Study|eg change in circumstances|0
303596|NCT01569074|1026148|P5|Overall Study|Severe non-compliance to protocol|0
303597|NCT01569074|1026149|P4|Overall Study|Severe non-compliance to protocol|0
303598|NCT01569074|1026150|P3|Overall Study|Severe non-compliance to protocol|1
303599|NCT01569074|1026151|P2|Overall Study|Severe non-compliance to protocol|0
303600|NCT01569074|1026152|P1|Overall Study|Severe non-compliance to protocol|0
303601|NCT01569074|1026148|P5|Overall Study|Study-specific discontinuation criteria|0
303602|NCT01569074|1026149|P4|Overall Study|Study-specific discontinuation criteria|0
303603|NCT01569074|1026150|P3|Overall Study|Study-specific discontinuation criteria|0
303604|NCT01569074|1026151|P2|Overall Study|Study-specific discontinuation criteria|1
303605|NCT01569074|1026152|P1|Overall Study|Study-specific discontinuation criteria|0
303606|NCT01569074|1026148|P5|Overall Study|Study stopped|7
303607|NCT01569074|1026149|P4|Overall Study|Study stopped|7
303608|NCT01569074|1026150|P3|Overall Study|Study stopped|8
303609|NCT01569074|1026151|P2|Overall Study|Study stopped|6
303610|NCT01569074|1026152|P1|Overall Study|Study stopped|6
303611|NCT01569022|1026208|P2|Second Intervention|Lost to Follow-up|2
303612|NCT01569022|1026209|P1|Second Intervention|Lost to Follow-up|2
303613|NCT01569022|1026208|P2|First Intervention|Lost to Follow-up|1
303614|NCT01569022|1026209|P1|First Intervention|Lost to Follow-up|2
303615|NCT01568892|1026245|P2|Open-label Phase|Lost to Follow-up|1
303616|NCT01568892|1026246|P1|Open-label Phase|Lost to Follow-up|0
303617|NCT01568892|1026245|P2|Open-label Phase|Lack of Efficacy|2
303618|NCT01568892|1026246|P1|Open-label Phase|Lack of Efficacy|4
303619|NCT01568892|1026245|P2|Open-label Phase|Adverse Event|0
303620|NCT01568892|1026246|P1|Open-label Phase|Adverse Event|2
303621|NCT01568866|1026316|P2|Overall Study|Randomized but Not Dosed|1
303622|NCT01568866|1026317|P1|Overall Study|Randomized but Not Dosed|9
303623|NCT01568866|1026316|P2|Overall Study|Lost to Follow-up|0
303624|NCT01568866|1026317|P1|Overall Study|Lost to Follow-up|1
303625|NCT01568866|1026316|P2|Overall Study|Protocol Non-compliance|4
303626|NCT01568866|1026317|P1|Overall Study|Protocol Non-compliance|2
303627|NCT01568866|1026316|P2|Overall Study|Death|18
303628|NCT01568866|1026317|P1|Overall Study|Death|10
303629|NCT01568866|1026316|P2|Overall Study|Withdrawal by Subject|11
303630|NCT01568866|1026317|P1|Overall Study|Withdrawal by Subject|19
303631|NCT01568866|1026316|P2|Overall Study|Physician Decision|32
303632|NCT01568866|1026317|P1|Overall Study|Physician Decision|40
303633|NCT01568866|1026316|P2|Overall Study|Patient Request|71
303634|NCT01568866|1026317|P1|Overall Study|Patient Request|55
303635|NCT01568866|1026316|P2|Overall Study|Adverse Event|96
303636|NCT01568866|1026317|P1|Overall Study|Adverse Event|94
303637|NCT01568866|1026316|P2|Overall Study|Disease Progression|183
303638|NCT01568866|1026317|P1|Overall Study|Disease Progression|208
303639|NCT01568593|1026348|P2|Overall Study|Adverse Event|2
303640|NCT01568593|1026349|P1|Overall Study|Adverse Event|3
303641|NCT01568593|1026348|P2|Overall Study|Lack of Efficacy|1
303642|NCT01568593|1026349|P1|Overall Study|Lack of Efficacy|4
303643|NCT01568112|1026369|P4|Overall Study|Withdrawal by Physician|1
303644|NCT01568112|1026370|P3|Overall Study|Withdrawal by Physician|1
303645|NCT01568112|1026371|P2|Overall Study|Withdrawal by Physician|0
303646|NCT01568112|1026372|P1|Overall Study|Withdrawal by Physician|1
303647|NCT01568112|1026369|P4|Overall Study|Withdrawal by Subject|7
303648|NCT01568112|1026370|P3|Overall Study|Withdrawal by Subject|0
303649|NCT01568112|1026371|P2|Overall Study|Withdrawal by Subject|3
303650|NCT01568112|1026372|P1|Overall Study|Withdrawal by Subject|2
303651|NCT01568112|1026369|P4|Overall Study|Lost to Follow-up|1
303652|NCT01568112|1026370|P3|Overall Study|Lost to Follow-up|0
303653|NCT01568112|1026371|P2|Overall Study|Lost to Follow-up|0
303654|NCT01568112|1026372|P1|Overall Study|Lost to Follow-up|0
303655|NCT01568112|1026369|P4|Overall Study|Withdrew due to Adverse Event|3
303656|NCT01568112|1026370|P3|Overall Study|Withdrew due to Adverse Event|6
303657|NCT01568112|1026371|P2|Overall Study|Withdrew due to Adverse Event|4
303658|NCT01568112|1026372|P1|Overall Study|Withdrew due to Adverse Event|2
303659|NCT01568112|1026369|P4|Overall Study|Randomized But Not Treated|0
303660|NCT01568112|1026370|P3|Overall Study|Randomized But Not Treated|0
303661|NCT01568112|1026371|P2|Overall Study|Randomized But Not Treated|1
303662|NCT01568112|1026372|P1|Overall Study|Randomized But Not Treated|0
303663|NCT01568047|1026530|P4|Overall Study|Adverse Event|1
303664|NCT01568047|1026531|P3|Overall Study|Adverse Event|1
303665|NCT01568047|1026532|P2|Overall Study|Adverse Event|0
303666|NCT01568047|1026533|P1|Overall Study|Adverse Event|0
303667|NCT01568047|1026530|P4|Overall Study|Withdrawal by Subject|0
303668|NCT01568047|1026531|P3|Overall Study|Withdrawal by Subject|0
303669|NCT01568047|1026532|P2|Overall Study|Withdrawal by Subject|1
303670|NCT01568047|1026533|P1|Overall Study|Withdrawal by Subject|0
303671|NCT01568047|1026530|P4|Overall Study|Ineligibility|0
303672|NCT01568047|1026531|P3|Overall Study|Ineligibility|0
303673|NCT01568047|1026532|P2|Overall Study|Ineligibility|0
303674|NCT01568047|1026533|P1|Overall Study|Ineligibility|1
303675|NCT01568034|1026551|P4|Overall Study|Withdrawal by Subject|0
303676|NCT01568034|1026552|P3|Overall Study|Withdrawal by Subject|0
303677|NCT01568034|1026553|P2|Overall Study|Withdrawal by Subject|0
303678|NCT01568034|1026554|P1|Overall Study|Withdrawal by Subject|1
303679|NCT01567852|1026601|P2|Overall Study|ECT discontinued|1
303680|NCT01567852|1026602|P1|Overall Study|ECT discontinued|1
303681|NCT01567852|1026601|P2|Overall Study|Withdrawal by Subject|6
303682|NCT01567852|1026602|P1|Overall Study|Withdrawal by Subject|3
303683|NCT01567826|1026620|P2|Overall Study|Lost to Follow-up|2
303684|NCT01567826|1026621|P1|Overall Study|Lost to Follow-up|3
303685|NCT01567462|1026647|P2|Overall Study|Withdrawal by Subject|7
303686|NCT01567462|1026648|P1|Overall Study|Withdrawal by Subject|4
303687|NCT01567163|1026665|P1|Overall Study|Lost to Follow-up|2
303688|NCT01567163|1026665|P1|Overall Study|Progressive Disease|2
303689|NCT01566981|1026705|P2|Overall Study|Lost to Follow-up|8
303690|NCT01566981|1026706|P1|Overall Study|Lost to Follow-up|5
303691|NCT01566773|1026735|P1|Overall Study|Physician Decision|2
303692|NCT01566773|1026735|P1|Overall Study|Adverse Event|10
303693|NCT01566773|1026735|P1|Overall Study|Administrative reason|1
303694|NCT01566773|1026735|P1|Overall Study|Withdrawal by Subject|9
303695|NCT01566773|1026735|P1|Overall Study|Protocol Violation|4
303696|NCT01566773|1026735|P1|Overall Study|Protocol specified criteria|4
303697|NCT01566721|1026944|P2|Overall Study|Withdrew Prior to Treatment|1
303698|NCT01566721|1026945|P1|Overall Study|Withdrew Prior to Treatment|3
303699|NCT01566721|1026944|P2|Overall Study|Not Specified|4
303700|NCT01566721|1026945|P1|Overall Study|Not Specified|10
303701|NCT01566721|1026944|P2|Overall Study|Death|3
303702|NCT01566721|1026945|P1|Overall Study|Death|6
303703|NCT01566721|1026944|P2|Overall Study|Lost to Follow-up|0
303704|NCT01566721|1026945|P1|Overall Study|Lost to Follow-up|18
303705|NCT01566721|1026944|P2|Overall Study|Disease Progression/Recurrence|28
303706|NCT01566721|1026945|P1|Overall Study|Disease Progression/Recurrence|123
303707|NCT01566721|1026944|P2|Overall Study|Withdrawal by Subject|15
303708|NCT01566721|1026945|P1|Overall Study|Withdrawal by Subject|58
303709|NCT01566721|1026944|P2|Overall Study|Ongoing Study|659
303710|NCT01566721|1026945|P1|Overall Study|Ongoing Study|1649
303711|NCT01566604|1027027|P2|Overall Study|Withdrawal by Subject|6
303712|NCT01566604|1027028|P1|Overall Study|Withdrawal by Subject|9
303713|NCT01566604|1027027|P2|Overall Study|Adverse Event|2
303714|NCT01566604|1027028|P1|Overall Study|Adverse Event|4
303715|NCT01566604|1027027|P2|Overall Study|Death|1
303716|NCT01566604|1027028|P1|Overall Study|Death|4
303717|NCT01566604|1027027|P2|Overall Study|Abnormal laboratory value|0
303718|NCT01566604|1027028|P1|Overall Study|Abnormal laboratory value|2
303719|NCT01566604|1027027|P2|Overall Study|Protocol deviation|0
303720|NCT01566604|1027028|P1|Overall Study|Protocol deviation|2
303721|NCT01566604|1027027|P2|Overall Study|Lack of Efficacy|2
303722|NCT01566604|1027028|P1|Overall Study|Lack of Efficacy|1
303723|NCT01566604|1027027|P2|Overall Study|Administrative problems|0
303724|NCT01566604|1027028|P1|Overall Study|Administrative problems|1
303725|NCT01566604|1027027|P2|Overall Study|Patient's inability to use the device|0
303726|NCT01566604|1027028|P1|Overall Study|Patient's inability to use the device|1
303727|NCT01566435|1027184|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
303728|NCT01566149|1027257|P2|Overall Study|Withdrawal by Subject|0
303729|NCT01566149|1027258|P1|Overall Study|Withdrawal by Subject|1
303730|NCT01566149|1027257|P2|Overall Study|Protocol Violation|1
303731|NCT01566149|1027258|P1|Overall Study|Protocol Violation|0
303732|NCT01566149|1027257|P2|Overall Study|Non-compliance with study medication|0
303733|NCT01566149|1027258|P1|Overall Study|Non-compliance with study medication|2
303734|NCT01566149|1027257|P2|Overall Study|Adverse Event|1
303735|NCT01566149|1027258|P1|Overall Study|Adverse Event|0
303736|NCT01565993|1027291|P2|Overall Study|Physician Decision|3
303737|NCT01565993|1027292|P1|Overall Study|Physician Decision|0
303738|NCT01565980|1027300|P2|Overall Study|Withdrawal by Subject|3
303739|NCT01565980|1027301|P1|Overall Study|Withdrawal by Subject|0
303740|NCT01565980|1027300|P2|Overall Study|stopped medical treatment|0
303741|NCT01565980|1027301|P1|Overall Study|stopped medical treatment|1
303742|NCT01565980|1027300|P2|Overall Study|health complications|1
303743|NCT01565980|1027301|P1|Overall Study|health complications|1
303744|NCT01565980|1027300|P2|Overall Study|Lost to Follow-up|0
303745|NCT01565980|1027301|P1|Overall Study|Lost to Follow-up|1
303746|NCT01565980|1027300|P2|Overall Study|Death|0
303747|NCT01565980|1027301|P1|Overall Study|Death|1
303748|NCT01565941|1027321|P2|Overall Study|Randomized; did not receive intevention|2
303749|NCT01565941|1027322|P1|Overall Study|Randomized; did not receive intevention|8
303750|NCT01565941|1027321|P2|Overall Study|Withdrawn by parent/guardian|2
303751|NCT01565941|1027322|P1|Overall Study|Withdrawn by parent/guardian|3
303752|NCT01565889|1027401|P6|Part B|Lost to Follow-up|1
303753|NCT01565889|1027402|P5|Part B|Lost to Follow-up|0
303754|NCT01565889|1027403|P4|Part B|Lost to Follow-up|0
303755|NCT01565889|1027404|P3|Part B|Lost to Follow-up|0
303756|NCT01565889|1027405|P2|Part B|Lost to Follow-up|0
303757|NCT01565889|1027406|P1|Part B|Lost to Follow-up|0
303758|NCT01565889|1027401|P6|Part B|Lack of Efficacy|2
303759|NCT01565889|1027402|P5|Part B|Lack of Efficacy|0
303760|NCT01565889|1027403|P4|Part B|Lack of Efficacy|0
303761|NCT01565889|1027404|P3|Part B|Lack of Efficacy|0
303762|NCT01565889|1027405|P2|Part B|Lack of Efficacy|0
303763|NCT01565889|1027406|P1|Part B|Lack of Efficacy|0
303764|NCT01565889|1027401|P6|Part B|Withdrawal by Subject|1
303765|NCT01565889|1027402|P5|Part B|Withdrawal by Subject|0
303766|NCT01565889|1027403|P4|Part B|Withdrawal by Subject|0
303767|NCT01565889|1027404|P3|Part B|Withdrawal by Subject|0
303768|NCT01565889|1027405|P2|Part B|Withdrawal by Subject|0
303769|NCT01565889|1027406|P1|Part B|Withdrawal by Subject|0
303770|NCT01565889|1027401|P6|Part A|Withdrawal by Subject|0
303771|NCT01565889|1027402|P5|Part A|Withdrawal by Subject|0
303772|NCT01565889|1027403|P4|Part A|Withdrawal by Subject|0
303773|NCT01565889|1027404|P3|Part A|Withdrawal by Subject|0
303774|NCT01565889|1027405|P2|Part A|Withdrawal by Subject|0
303775|NCT01565889|1027406|P1|Part A|Withdrawal by Subject|1
303776|NCT01565850|1027437|P2|Overall Study|Withdrew Consent|2
303777|NCT01565850|1027438|P1|Overall Study|Withdrew Consent|4
303778|NCT01565850|1027437|P2|Overall Study|Participant noncompliance|0
303779|NCT01565850|1027438|P1|Overall Study|Participant noncompliance|2
303780|NCT01565850|1027437|P2|Overall Study|Investigator’s Discretion|1
303781|NCT01565850|1027438|P1|Overall Study|Investigator’s Discretion|2
303782|NCT01565850|1027437|P2|Overall Study|Lost to Follow-up|4
303783|NCT01565850|1027438|P1|Overall Study|Lost to Follow-up|12
303784|NCT01565850|1027437|P2|Overall Study|Adverse Event|1
303785|NCT01565850|1027438|P1|Overall Study|Adverse Event|0
303786|NCT01565707|1027458|P4|Overall Study|Miscellaneous|2
303787|NCT01565707|1027459|P3|Overall Study|Miscellaneous|0
303788|NCT01565707|1027460|P2|Overall Study|Miscellaneous|1
303789|NCT01565707|1027461|P1|Overall Study|Miscellaneous|1
303790|NCT01565707|1027458|P4|Overall Study|Randomized but not evaluable|0
303791|NCT01565707|1027459|P3|Overall Study|Randomized but not evaluable|0
303792|NCT01565707|1027460|P2|Overall Study|Randomized but not evaluable|0
303793|NCT01565707|1027461|P1|Overall Study|Randomized but not evaluable|2
303794|NCT01565707|1027458|P4|Overall Study|Withdrawal by Subject|1
303795|NCT01565707|1027459|P3|Overall Study|Withdrawal by Subject|1
303796|NCT01565707|1027460|P2|Overall Study|Withdrawal by Subject|1
303797|NCT01565707|1027461|P1|Overall Study|Withdrawal by Subject|3
303798|NCT01565707|1027458|P4|Overall Study|Protocol Violation|1
303799|NCT01565707|1027459|P3|Overall Study|Protocol Violation|0
303800|NCT01565707|1027460|P2|Overall Study|Protocol Violation|0
303801|NCT01565707|1027461|P1|Overall Study|Protocol Violation|1
303802|NCT01565707|1027458|P4|Overall Study|Lost to Follow-up|0
303803|NCT01565707|1027459|P3|Overall Study|Lost to Follow-up|0
303804|NCT01565707|1027460|P2|Overall Study|Lost to Follow-up|0
303805|NCT01565707|1027461|P1|Overall Study|Lost to Follow-up|1
303806|NCT01565707|1027458|P4|Overall Study|Adverse Event|1
303807|NCT01565707|1027459|P3|Overall Study|Adverse Event|2
303808|NCT01565707|1027460|P2|Overall Study|Adverse Event|6
303809|NCT01565707|1027461|P1|Overall Study|Adverse Event|1
303810|NCT01565564|1027565|P2|Overall Study|Lost to Follow-up|1
303811|NCT01565564|1027566|P1|Overall Study|Lost to Follow-up|5
303812|NCT01565343|1027616|P3|Overall Study|Administrative decision/technical issues|0
303813|NCT01565343|1027617|P2|Overall Study|Administrative decision/technical issues|0
303814|NCT01565343|1027618|P1|Overall Study|Administrative decision/technical issues|1
303815|NCT01565291|1027648|P2|Overall Study|Withdrawal by Subject|0
303816|NCT01565291|1027649|P1|Overall Study|Withdrawal by Subject|1
303817|NCT01565148|1027661|P4|Overall Study|Physician Decision|0
303818|NCT01565148|1027662|P3|Overall Study|Physician Decision|0
303819|NCT01565148|1027663|P2|Overall Study|Physician Decision|5
303820|NCT01565148|1027664|P1|Overall Study|Physician Decision|2
303821|NCT01565148|1027661|P4|Overall Study|Death|0
303822|NCT01565148|1027662|P3|Overall Study|Death|1
303823|NCT01565148|1027663|P2|Overall Study|Death|0
303824|NCT01565148|1027664|P1|Overall Study|Death|0
303825|NCT01565148|1027661|P4|Overall Study|Rescue Therapy|8
303826|NCT01565148|1027662|P3|Overall Study|Rescue Therapy|5
303827|NCT01565148|1027663|P2|Overall Study|Rescue Therapy|5
303828|NCT01565148|1027664|P1|Overall Study|Rescue Therapy|8
303829|NCT01565148|1027661|P4|Overall Study|Lost to Follow-up|3
303830|NCT01565148|1027662|P3|Overall Study|Lost to Follow-up|0
303831|NCT01565148|1027663|P2|Overall Study|Lost to Follow-up|4
303832|NCT01565148|1027664|P1|Overall Study|Lost to Follow-up|4
303833|NCT01565148|1027661|P4|Overall Study|Withdrawal by Subject|2
303834|NCT01565148|1027662|P3|Overall Study|Withdrawal by Subject|1
303835|NCT01565148|1027663|P2|Overall Study|Withdrawal by Subject|1
303836|NCT01565148|1027664|P1|Overall Study|Withdrawal by Subject|1
303837|NCT01565083|1027700|P2|Overall Study|Other|5
303838|NCT01565083|1027701|P1|Overall Study|Other|3
303839|NCT01565083|1027700|P2|Overall Study|Death|23
303840|NCT01565083|1027701|P1|Overall Study|Death|22
303841|NCT01565083|1027700|P2|Overall Study|Lost to Follow-up|7
303842|NCT01565083|1027701|P1|Overall Study|Lost to Follow-up|2
303843|NCT01565083|1027700|P2|Overall Study|Withdrawal by Subject|4
303844|NCT01565083|1027701|P1|Overall Study|Withdrawal by Subject|6
303845|NCT01564862|1027738|P3|Overall Study|Other reason(s)|0
303846|NCT01564862|1027739|P2|Overall Study|Other reason(s)|0
303847|NCT01564862|1027740|P1|Overall Study|Other reason(s)|1
303848|NCT01564862|1027738|P3|Overall Study|Lack of Efficacy|6
303849|NCT01564862|1027739|P2|Overall Study|Lack of Efficacy|5
303850|NCT01564862|1027740|P1|Overall Study|Lack of Efficacy|1
303851|NCT01564862|1027738|P3|Overall Study|Voluntary Withdrawal|8
303852|NCT01564862|1027739|P2|Overall Study|Voluntary Withdrawal|6
303853|NCT01564862|1027740|P1|Overall Study|Voluntary Withdrawal|9
303854|NCT01564862|1027738|P3|Overall Study|Lost to Follow-up|6
303855|NCT01564862|1027739|P2|Overall Study|Lost to Follow-up|8
303856|NCT01564862|1027740|P1|Overall Study|Lost to Follow-up|10
303857|NCT01564862|1027738|P3|Overall Study|Major Protocol Deviation|4
303858|NCT01564862|1027739|P2|Overall Study|Major Protocol Deviation|3
303859|NCT01564862|1027740|P1|Overall Study|Major Protocol Deviation|3
303860|NCT01564862|1027738|P3|Overall Study|Pretreatment Event or Adverse Event|6
303861|NCT01564862|1027739|P2|Overall Study|Pretreatment Event or Adverse Event|12
303862|NCT01564862|1027740|P1|Overall Study|Pretreatment Event or Adverse Event|6
303863|NCT01564784|1027791|P2|Overall Study|Death|126
303864|NCT01564784|1027792|P1|Overall Study|Death|131
303865|NCT01564784|1027791|P2|Overall Study|Lost to Follow-up|1
303866|NCT01564784|1027792|P1|Overall Study|Lost to Follow-up|1
303867|NCT01564784|1027791|P2|Overall Study|Subject refused further follow-up|6
303868|NCT01564784|1027792|P1|Overall Study|Subject refused further follow-up|1
303869|NCT01564784|1027791|P2|Overall Study|Other|0
303870|NCT01564784|1027792|P1|Overall Study|Other|1
303871|NCT01564758|1027819|P1|Overall Study|Other|3
303872|NCT01564758|1027819|P1|Overall Study|Adverse Event|3
303873|NCT01564758|1027819|P1|Overall Study|Death|8
303874|NCT01564732|1027826|P2|Overall Study|Early termination by the study sponsor|5
303875|NCT01564732|1027827|P1|Overall Study|Early termination by the study sponsor|6
303876|NCT01564537|1027862|P2|Overall Study|Other Miscellaneous Reasons|2
303877|NCT01564537|1027863|P1|Overall Study|Other Miscellaneous Reasons|1
303878|NCT01564537|1027862|P2|Overall Study|Lost to Follow-up|0
303879|NCT01564537|1027863|P1|Overall Study|Lost to Follow-up|1
303880|NCT01564537|1027862|P2|Overall Study|Withdrawal by Participant|4
303881|NCT01564537|1027863|P1|Overall Study|Withdrawal by Participant|4
303882|NCT01564459|1027886|P3|Double-blind Treatment|Adverse Event|1
303883|NCT01564459|1027887|P2|Double-blind Treatment|Adverse Event|0
303884|NCT01564459|1027888|P1|Double-blind Treatment|Adverse Event|0
303885|NCT01564459|1027886|P3|Run-In|Withdrawal by Subject|0
303886|NCT01564459|1027887|P2|Run-In|Withdrawal by Subject|0
303887|NCT01564459|1027888|P1|Run-In|Withdrawal by Subject|1
303888|NCT01564459|1027886|P3|Run-In|Protocol Violation|0
303889|NCT01564459|1027887|P2|Run-In|Protocol Violation|0
303890|NCT01564459|1027888|P1|Run-In|Protocol Violation|1
303891|NCT01564459|1027886|P3|Run-In|Non-compliance with study drug|0
303892|NCT01564459|1027887|P2|Run-In|Non-compliance with study drug|0
303893|NCT01564459|1027888|P1|Run-In|Non-compliance with study drug|2
303894|NCT01564459|1027886|P3|Run-In|Lost to Follow-up|0
303895|NCT01564459|1027887|P2|Run-In|Lost to Follow-up|0
303896|NCT01564459|1027888|P1|Run-In|Lost to Follow-up|1
303897|NCT01564459|1027886|P3|Run-In|Adverse Event|0
303898|NCT01564459|1027887|P2|Run-In|Adverse Event|0
303899|NCT01564459|1027888|P1|Run-In|Adverse Event|7
303900|NCT01564407|1027912|P5|Overall Study|funding lost, study ended|0
303901|NCT01564407|1027913|P4|Overall Study|funding lost, study ended|1
303902|NCT01564407|1027914|P3|Overall Study|funding lost, study ended|0
303903|NCT01564407|1027915|P2|Overall Study|funding lost, study ended|0
303904|NCT01564407|1027916|P1|Overall Study|funding lost, study ended|0
303905|NCT01564407|1027912|P5|Overall Study|Withdrawal by Subject|0
303906|NCT01564407|1027913|P4|Overall Study|Withdrawal by Subject|0
303907|NCT01564407|1027914|P3|Overall Study|Withdrawal by Subject|0
303908|NCT01564407|1027915|P2|Overall Study|Withdrawal by Subject|1
303909|NCT01564407|1027916|P1|Overall Study|Withdrawal by Subject|0
303910|NCT01564407|1027912|P5|Overall Study|Lost to Follow-up|0
303911|NCT01564407|1027913|P4|Overall Study|Lost to Follow-up|0
303912|NCT01564407|1027914|P3|Overall Study|Lost to Follow-up|0
303913|NCT01564407|1027915|P2|Overall Study|Lost to Follow-up|1
303914|NCT01564407|1027916|P1|Overall Study|Lost to Follow-up|0
303915|NCT01564394|1027957|P2|Overall Study|Withdrawal by Subject|10
303916|NCT01564394|1027958|P1|Overall Study|Withdrawal by Subject|6
303917|NCT01564277|1027972|P2|Overall Study|Physician Decision|0
303918|NCT01564277|1027973|P1|Overall Study|Physician Decision|1
303919|NCT01564277|1027972|P2|Overall Study|Protocol Violation|1
303920|NCT01564277|1027973|P1|Overall Study|Protocol Violation|0
303921|NCT01563978|1027991|P2|Overall Study|Adverse Event|2
303922|NCT01563978|1027992|P1|Overall Study|Adverse Event|1
303923|NCT01563978|1027991|P2|Overall Study|Dev. of study specific discont. criteria|0
303924|NCT01563978|1027992|P1|Overall Study|Dev. of study specific discont. criteria|1
303925|NCT01563978|1027991|P2|Overall Study|Lost to Follow-up|0
303926|NCT01563978|1027992|P1|Overall Study|Lost to Follow-up|1
303927|NCT01563978|1027991|P2|Overall Study|Physician Decision|0
303928|NCT01563978|1027992|P1|Overall Study|Physician Decision|1
303933|NCT01563536|1028031|P2|Overall Study|Lost to Follow-up|0
303934|NCT01563536|1028032|P1|Overall Study|Lost to Follow-up|1
303935|NCT01563536|1028031|P2|Overall Study|Withdrawal by Subject|2
303936|NCT01563536|1028032|P1|Overall Study|Withdrawal by Subject|0
303937|NCT01563185|1028091|P1|Overall Study|Non-Compliance with study drug|1
303938|NCT01563185|1028091|P1|Overall Study|Withdrawal by Subject|1
303939|NCT01563172|1028105|P1|Overall Study|Other (Not specified)|1
303940|NCT01563172|1028105|P1|Overall Study|Other (Protocol deviation)|5
303941|NCT01563172|1028105|P1|Overall Study|Lost to Follow-up|2
303942|NCT01563172|1028105|P1|Overall Study|Adverse Event|5
303943|NCT01563029|1028211|P5|Overall Study|Withdrawal by Subject|3
303944|NCT01563029|1028212|P4|Overall Study|Withdrawal by Subject|4
303945|NCT01563029|1028213|P3|Overall Study|Withdrawal by Subject|3
303946|NCT01563029|1028214|P2|Overall Study|Withdrawal by Subject|1
303947|NCT01563029|1028215|P1|Overall Study|Withdrawal by Subject|4
303948|NCT01563029|1028211|P5|Overall Study|Physician Decision|2
303949|NCT01563029|1028212|P4|Overall Study|Physician Decision|4
303950|NCT01563029|1028213|P3|Overall Study|Physician Decision|2
303951|NCT01563029|1028214|P2|Overall Study|Physician Decision|5
303952|NCT01563029|1028215|P1|Overall Study|Physician Decision|3
303953|NCT01563029|1028211|P5|Overall Study|Lost to Follow-up|1
303954|NCT01563029|1028212|P4|Overall Study|Lost to Follow-up|1
303955|NCT01563029|1028213|P3|Overall Study|Lost to Follow-up|1
303956|NCT01563029|1028214|P2|Overall Study|Lost to Follow-up|0
303957|NCT01563029|1028215|P1|Overall Study|Lost to Follow-up|1
303958|NCT01563029|1028211|P5|Overall Study|Protocol defined stopping criteria|0
303959|NCT01563029|1028212|P4|Overall Study|Protocol defined stopping criteria|0
303960|NCT01563029|1028213|P3|Overall Study|Protocol defined stopping criteria|0
303961|NCT01563029|1028214|P2|Overall Study|Protocol defined stopping criteria|0
303962|NCT01563029|1028215|P1|Overall Study|Protocol defined stopping criteria|1
303963|NCT01563029|1028211|P5|Overall Study|Protocol Violation|3
303964|NCT01563029|1028212|P4|Overall Study|Protocol Violation|1
303965|NCT01563029|1028213|P3|Overall Study|Protocol Violation|3
303966|NCT01563029|1028214|P2|Overall Study|Protocol Violation|2
303967|NCT01563029|1028215|P1|Overall Study|Protocol Violation|1
303968|NCT01563029|1028211|P5|Overall Study|Lack of Efficacy|19
303969|NCT01563029|1028212|P4|Overall Study|Lack of Efficacy|21
303970|NCT01563029|1028213|P3|Overall Study|Lack of Efficacy|23
303971|NCT01563029|1028214|P2|Overall Study|Lack of Efficacy|16
303972|NCT01563029|1028215|P1|Overall Study|Lack of Efficacy|42
303973|NCT01563029|1028211|P5|Overall Study|Adverse Event|1
303974|NCT01563029|1028212|P4|Overall Study|Adverse Event|2
303975|NCT01563029|1028213|P3|Overall Study|Adverse Event|1
303976|NCT01563029|1028214|P2|Overall Study|Adverse Event|0
303977|NCT01563029|1028215|P1|Overall Study|Adverse Event|1
303978|NCT01562873|1028281|P2|Overall Study|Clinical PD and adverse event|0
303979|NCT01562873|1028282|P1|Overall Study|Clinical PD and adverse event|1
303980|NCT01562873|1028281|P2|Overall Study|Clinical Disease Progression|0
303981|NCT01562873|1028282|P1|Overall Study|Clinical Disease Progression|9
303982|NCT01562873|1028281|P2|Overall Study|Adverse Event|0
303983|NCT01562873|1028282|P1|Overall Study|Adverse Event|1
303984|NCT01562873|1028281|P2|Overall Study|Disease Progression per RECIST|0
303985|NCT01562873|1028282|P1|Overall Study|Disease Progression per RECIST|10
303986|NCT01562743|1028294|P1|Overall Study|Physician Decision|2
303987|NCT01562743|1028294|P1|Overall Study|Lost to Follow-up|2
303988|NCT01562743|1028294|P1|Overall Study|Discontinuation criteria|2
303989|NCT01562743|1028294|P1|Overall Study|Protocol Violation|1
303990|NCT01562743|1028294|P1|Overall Study|Withdrawal by Subject|13
303991|NCT01562743|1028294|P1|Overall Study|Lack of Efficacy|3
303992|NCT01562743|1028294|P1|Overall Study|Adverse Event|29
303993|NCT01562613|1028313|P1|Overall Study|Withdrawal by Subject|2
303994|NCT01562613|1028313|P1|Overall Study|Lost to Follow-up|2
303995|NCT01562548|1028323|P4|Overall Study|Lost to Follow-up|0
303996|NCT01562548|1028324|P3|Overall Study|Lost to Follow-up|1
303997|NCT01562548|1028325|P2|Overall Study|Lost to Follow-up|0
303998|NCT01562548|1028326|P1|Overall Study|Lost to Follow-up|0
303999|NCT01562327|1028376|P1|Overall Study|Infusion not received at 6 month window|4
304000|NCT01562327|1028376|P1|Overall Study|Participant drop-out|1
304001|NCT01562327|1028376|P1|Overall Study|Lack of Efficacy|1
304002|NCT01562327|1028376|P1|Overall Study|Adverse Event|2
304003|NCT01562314|1028406|P2|Overall Study|Withdrawal by Subject|1
304004|NCT01562314|1028407|P1|Overall Study|Withdrawal by Subject|0
304005|NCT01562314|1028406|P2|Overall Study|Met Withdrawal Criteria|2
304006|NCT01562314|1028407|P1|Overall Study|Met Withdrawal Criteria|3
304007|NCT01562314|1028406|P2|Overall Study|Adverse Event|5
304008|NCT01562314|1028407|P1|Overall Study|Adverse Event|10
304009|NCT01562275|1028494|P13|Stage 2|Progression of Disease|4
304010|NCT01562275|1028495|P12|Stage 2|Progression of Disease|12
304011|NCT01562275|1028496|P11|Stage 2|Progression of Disease|0
304012|NCT01562275|1028497|P10|Stage 2|Progression of Disease|0
304013|NCT01562275|1028498|P9|Stage 2|Progression of Disease|0
304014|NCT01562275|1028499|P8|Stage 2|Progression of Disease|0
304015|NCT01562275|1028500|P7|Stage 2|Progression of Disease|0
304016|NCT01562275|1028501|P6|Stage 2|Progression of Disease|0
304017|NCT01562275|1028502|P5|Stage 2|Progression of Disease|0
304018|NCT01562275|1028503|P4|Stage 2|Progression of Disease|0
304019|NCT01562275|1028504|P3|Stage 2|Progression of Disease|0
304020|NCT01562275|1028505|P2|Stage 2|Progression of Disease|0
304021|NCT01562275|1028506|P1|Stage 2|Progression of Disease|0
304022|NCT01562275|1028494|P13|Stage 2|Death|1
304023|NCT01562275|1028495|P12|Stage 2|Death|2
304024|NCT01562275|1028496|P11|Stage 2|Death|0
304025|NCT01562275|1028497|P10|Stage 2|Death|0
304026|NCT01562275|1028498|P9|Stage 2|Death|0
304027|NCT01562275|1028499|P8|Stage 2|Death|0
304028|NCT01562275|1028500|P7|Stage 2|Death|0
304029|NCT01562275|1028501|P6|Stage 2|Death|0
304030|NCT01562275|1028502|P5|Stage 2|Death|0
304031|NCT01562275|1028503|P4|Stage 2|Death|0
304032|NCT01562275|1028504|P3|Stage 2|Death|0
304033|NCT01562275|1028505|P2|Stage 2|Death|0
304034|NCT01562275|1028506|P1|Stage 2|Death|0
304035|NCT01562275|1028494|P13|Stage 1|Withdrawal by Subject|0
304036|NCT01562275|1028495|P12|Stage 1|Withdrawal by Subject|0
304037|NCT01562275|1028496|P11|Stage 1|Withdrawal by Subject|0
304038|NCT01562275|1028497|P10|Stage 1|Withdrawal by Subject|1
304039|NCT01562275|1028498|P9|Stage 1|Withdrawal by Subject|0
304040|NCT01562275|1028499|P8|Stage 1|Withdrawal by Subject|0
304041|NCT01562275|1028500|P7|Stage 1|Withdrawal by Subject|1
304042|NCT01562275|1028501|P6|Stage 1|Withdrawal by Subject|0
304043|NCT01562275|1028502|P5|Stage 1|Withdrawal by Subject|0
304044|NCT01562275|1028503|P4|Stage 1|Withdrawal by Subject|2
304045|NCT01562275|1028504|P3|Stage 1|Withdrawal by Subject|0
304046|NCT01562275|1028505|P2|Stage 1|Withdrawal by Subject|1
304047|NCT01562275|1028506|P1|Stage 1|Withdrawal by Subject|0
304048|NCT01562275|1028494|P13|Stage 1|Progression of Disease|0
304049|NCT01562275|1028495|P12|Stage 1|Progression of Disease|0
304050|NCT01562275|1028496|P11|Stage 1|Progression of Disease|3
304051|NCT01562275|1028497|P10|Stage 1|Progression of Disease|5
304052|NCT01562275|1028498|P9|Stage 1|Progression of Disease|2
304053|NCT01562275|1028499|P8|Stage 1|Progression of Disease|7
304054|NCT01562275|1028500|P7|Stage 1|Progression of Disease|1
304055|NCT01562275|1028501|P6|Stage 1|Progression of Disease|4
304056|NCT01562275|1028502|P5|Stage 1|Progression of Disease|2
304057|NCT01562275|1028503|P4|Stage 1|Progression of Disease|1
304058|NCT01562275|1028504|P3|Stage 1|Progression of Disease|2
304059|NCT01562275|1028505|P2|Stage 1|Progression of Disease|6
304060|NCT01562275|1028506|P1|Stage 1|Progression of Disease|2
304061|NCT01562275|1028494|P13|Stage 1|Physician Decision|0
304062|NCT01562275|1028495|P12|Stage 1|Physician Decision|0
304063|NCT01562275|1028496|P11|Stage 1|Physician Decision|0
304064|NCT01562275|1028497|P10|Stage 1|Physician Decision|0
304065|NCT01562275|1028498|P9|Stage 1|Physician Decision|1
304066|NCT01562275|1028499|P8|Stage 1|Physician Decision|0
304067|NCT01562275|1028500|P7|Stage 1|Physician Decision|1
304068|NCT01562275|1028501|P6|Stage 1|Physician Decision|0
304069|NCT01562275|1028502|P5|Stage 1|Physician Decision|1
304070|NCT01562275|1028503|P4|Stage 1|Physician Decision|0
304071|NCT01562275|1028504|P3|Stage 1|Physician Decision|0
304072|NCT01562275|1028505|P2|Stage 1|Physician Decision|0
304073|NCT01562275|1028506|P1|Stage 1|Physician Decision|0
304074|NCT01562275|1028494|P13|Stage 1|Non Compliance|0
304075|NCT01562275|1028495|P12|Stage 1|Non Compliance|0
304076|NCT01562275|1028496|P11|Stage 1|Non Compliance|0
304077|NCT01562275|1028497|P10|Stage 1|Non Compliance|0
304078|NCT01562275|1028498|P9|Stage 1|Non Compliance|0
304079|NCT01562275|1028499|P8|Stage 1|Non Compliance|0
304080|NCT01562275|1028500|P7|Stage 1|Non Compliance|0
304081|NCT01562275|1028501|P6|Stage 1|Non Compliance|0
304082|NCT01562275|1028502|P5|Stage 1|Non Compliance|0
304083|NCT01562275|1028503|P4|Stage 1|Non Compliance|0
304084|NCT01562275|1028504|P3|Stage 1|Non Compliance|1
304085|NCT01562275|1028505|P2|Stage 1|Non Compliance|0
304086|NCT01562275|1028506|P1|Stage 1|Non Compliance|0
304087|NCT01562275|1028494|P13|Stage 1|Death|0
304088|NCT01562275|1028495|P12|Stage 1|Death|0
304089|NCT01562275|1028496|P11|Stage 1|Death|0
304090|NCT01562275|1028497|P10|Stage 1|Death|0
304091|NCT01562275|1028498|P9|Stage 1|Death|0
304092|NCT01562275|1028499|P8|Stage 1|Death|0
304093|NCT01562275|1028500|P7|Stage 1|Death|0
304094|NCT01562275|1028501|P6|Stage 1|Death|0
304095|NCT01562275|1028502|P5|Stage 1|Death|0
304096|NCT01562275|1028503|P4|Stage 1|Death|0
304097|NCT01562275|1028504|P3|Stage 1|Death|0
304098|NCT01562275|1028505|P2|Stage 1|Death|0
304099|NCT01562275|1028506|P1|Stage 1|Death|1
304100|NCT01562275|1028494|P13|Stage 1|Adverse Event|0
304101|NCT01562275|1028495|P12|Stage 1|Adverse Event|0
304102|NCT01562275|1028496|P11|Stage 1|Adverse Event|0
304103|NCT01562275|1028497|P10|Stage 1|Adverse Event|1
304104|NCT01562275|1028498|P9|Stage 1|Adverse Event|0
304105|NCT01562275|1028499|P8|Stage 1|Adverse Event|0
304106|NCT01562275|1028500|P7|Stage 1|Adverse Event|0
304107|NCT01562275|1028501|P6|Stage 1|Adverse Event|0
304108|NCT01562275|1028502|P5|Stage 1|Adverse Event|1
304109|NCT01562275|1028503|P4|Stage 1|Adverse Event|1
304110|NCT01562275|1028504|P3|Stage 1|Adverse Event|0
304111|NCT01562275|1028505|P2|Stage 1|Adverse Event|0
304112|NCT01562275|1028506|P1|Stage 1|Adverse Event|0
304113|NCT01561976|1028651|P6|Washout Period 2 (7 Days)|Non-compliance|0
304114|NCT01561976|1028652|P5|Washout Period 2 (7 Days)|Non-compliance|0
304115|NCT01561976|1028653|P4|Washout Period 2 (7 Days)|Non-compliance|0
304116|NCT01561976|1028654|P3|Washout Period 2 (7 Days)|Non-compliance|1
304117|NCT01561976|1028655|P2|Washout Period 2 (7 Days)|Non-compliance|0
304118|NCT01561976|1028656|P1|Washout Period 2 (7 Days)|Non-compliance|1
304119|NCT01561976|1028651|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
304120|NCT01561976|1028652|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
304121|NCT01561976|1028653|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
304122|NCT01561976|1028654|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
304123|NCT01561976|1028655|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
304124|NCT01561976|1028656|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
304125|NCT01561976|1028651|P6|Washout Period 1 (7 Days)|Adverse Event|0
304126|NCT01561976|1028652|P5|Washout Period 1 (7 Days)|Adverse Event|0
304127|NCT01561976|1028653|P4|Washout Period 1 (7 Days)|Adverse Event|1
304128|NCT01561976|1028654|P3|Washout Period 1 (7 Days)|Adverse Event|0
304129|NCT01561976|1028655|P2|Washout Period 1 (7 Days)|Adverse Event|0
304130|NCT01561976|1028656|P1|Washout Period 1 (7 Days)|Adverse Event|0
304131|NCT01561976|1028651|P6|Period 1|Adverse Event|0
304132|NCT01561976|1028652|P5|Period 1|Adverse Event|0
304133|NCT01561976|1028653|P4|Period 1|Adverse Event|0
304134|NCT01561976|1028654|P3|Period 1|Adverse Event|1
304135|NCT01561976|1028655|P2|Period 1|Adverse Event|0
304136|NCT01561976|1028656|P1|Period 1|Adverse Event|0
304137|NCT01561898|1028689|P4|Overall Study|Physician Decision|1
304138|NCT01561898|1028690|P3|Overall Study|Physician Decision|7
304139|NCT01561898|1028691|P2|Overall Study|Physician Decision|5
304140|NCT01561898|1028692|P1|Overall Study|Physician Decision|1
304141|NCT01561898|1028689|P4|Overall Study|Adverse Event|9
304142|NCT01561898|1028690|P3|Overall Study|Adverse Event|14
304143|NCT01561898|1028691|P2|Overall Study|Adverse Event|19
304144|NCT01561898|1028692|P1|Overall Study|Adverse Event|1
304145|NCT01561898|1028689|P4|Overall Study|Lost to Follow-up|0
304146|NCT01561898|1028690|P3|Overall Study|Lost to Follow-up|1
304147|NCT01561898|1028691|P2|Overall Study|Lost to Follow-up|0
304148|NCT01561898|1028692|P1|Overall Study|Lost to Follow-up|0
304149|NCT01561898|1028689|P4|Overall Study|Worsening of complications|0
304150|NCT01561898|1028690|P3|Overall Study|Worsening of complications|0
304151|NCT01561898|1028691|P2|Overall Study|Worsening of complications|1
304152|NCT01561898|1028692|P1|Overall Study|Worsening of complications|0
304153|NCT01561898|1028689|P4|Overall Study|Lack of Efficacy|5
304154|NCT01561898|1028690|P3|Overall Study|Lack of Efficacy|10
304155|NCT01561898|1028691|P2|Overall Study|Lack of Efficacy|8
304156|NCT01561898|1028692|P1|Overall Study|Lack of Efficacy|0
304157|NCT01561898|1028689|P4|Overall Study|Withdrawal by Subject|5
304158|NCT01561898|1028690|P3|Overall Study|Withdrawal by Subject|12
304159|NCT01561898|1028691|P2|Overall Study|Withdrawal by Subject|8
304160|NCT01561898|1028692|P1|Overall Study|Withdrawal by Subject|0
304161|NCT01561755|1028706|P2|Overall Study|Lost to Follow-up|1
304162|NCT01561755|1028707|P1|Overall Study|Lost to Follow-up|0
304163|NCT01561560|1028759|P2|Second Two Weeks of Wear|Adverse Event|1
304164|NCT01561560|1028760|P1|Second Two Weeks of Wear|Adverse Event|0
304165|NCT01561560|1028759|P2|First Two Weeks of Wear|Adverse Event|1
304166|NCT01561560|1028760|P1|First Two Weeks of Wear|Adverse Event|0
304167|NCT01561560|1028759|P2|First Two Weeks of Wear|Time/job conflict|1
304168|NCT01561560|1028760|P1|First Two Weeks of Wear|Time/job conflict|0
304169|NCT01561430|1028791|P4|Overall Study|Sponsor Decision|12
304170|NCT01561430|1028792|P3|Overall Study|Sponsor Decision|13
304171|NCT01561430|1028793|P2|Overall Study|Sponsor Decision|14
304172|NCT01561430|1028794|P1|Overall Study|Sponsor Decision|1
304173|NCT01561430|1028791|P4|Overall Study|Physician Decision|0
304174|NCT01561430|1028792|P3|Overall Study|Physician Decision|0
304175|NCT01561430|1028793|P2|Overall Study|Physician Decision|1
304176|NCT01561430|1028794|P1|Overall Study|Physician Decision|0
304177|NCT01561430|1028791|P4|Overall Study|Withdrawal by Subject|0
304178|NCT01561430|1028792|P3|Overall Study|Withdrawal by Subject|1
304179|NCT01561430|1028793|P2|Overall Study|Withdrawal by Subject|0
304180|NCT01561430|1028794|P1|Overall Study|Withdrawal by Subject|0
304181|NCT01561430|1028791|P4|Overall Study|Adverse Event|1
304182|NCT01561430|1028792|P3|Overall Study|Adverse Event|3
304183|NCT01561430|1028793|P2|Overall Study|Adverse Event|0
304184|NCT01561430|1028794|P1|Overall Study|Adverse Event|0
304185|NCT01561313|1028834|P2|Overall Study|Adverse event and withdrawal by subject|0
304186|NCT01561313|1028835|P1|Overall Study|Adverse event and withdrawal by subject|1
304187|NCT01561313|1028834|P2|Overall Study|Withdrawal by Subject|0
304188|NCT01561313|1028835|P1|Overall Study|Withdrawal by Subject|1
304189|NCT01561300|1028853|P2|Run in on Placebo|Adverse Event|0
304190|NCT01561300|1028854|P1|Run in on Placebo|Adverse Event|1
304191|NCT01561079|1028865|P1|Overall Study|Protocol Violation|2
304192|NCT01561079|1028865|P1|Overall Study|Withdrawal by Subject|59
304193|NCT01561079|1028865|P1|Overall Study|Physician Decision|17
304194|NCT01560988|1028908|P2|Washout (Six Weeks)|Lost to Follow-up|2
304195|NCT01560988|1028909|P1|Washout (Six Weeks)|Lost to Follow-up|2
304196|NCT01560988|1028908|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
304197|NCT01560988|1028909|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
304198|NCT01560988|1028908|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
304199|NCT01560988|1028909|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
304200|NCT01560819|1028947|P2|Overall Study|Physician Decision|0
304201|NCT01560819|1028948|P1|Overall Study|Physician Decision|1
304202|NCT01560507|1028955|P3|Overall Study|Withdrawal by Subject|0
304203|NCT01560507|1028956|P2|Overall Study|Withdrawal by Subject|1
304204|NCT01560507|1028957|P1|Overall Study|Withdrawal by Subject|1
304205|NCT01560507|1028955|P3|Overall Study|Lost to Follow-up|2
304206|NCT01560507|1028956|P2|Overall Study|Lost to Follow-up|1
304207|NCT01560507|1028957|P1|Overall Study|Lost to Follow-up|3
304208|NCT01560429|1028970|P2|Overall Study|Protocol Violation|6
304209|NCT01560429|1028971|P1|Overall Study|Protocol Violation|3
304210|NCT01560403|1028981|P2|Overall Study|Lost to Follow-up|1
304211|NCT01560403|1028982|P1|Overall Study|Lost to Follow-up|0
304212|NCT01560234|1029000|P8|Overall Study|Lost to Follow-up|2
304213|NCT01560234|1029001|P7|Overall Study|Lost to Follow-up|0
304214|NCT01560234|1029002|P6|Overall Study|Lost to Follow-up|2
304215|NCT01560234|1029003|P5|Overall Study|Lost to Follow-up|0
304216|NCT01560234|1029004|P4|Overall Study|Lost to Follow-up|0
304217|NCT01560234|1029005|P3|Overall Study|Lost to Follow-up|1
304218|NCT01560234|1029006|P2|Overall Study|Lost to Follow-up|0
304219|NCT01560234|1029007|P1|Overall Study|Lost to Follow-up|3
304220|NCT01559935|1029085|P1|Maintenance Phase|Non-compliance|2
304221|NCT01559935|1029085|P1|Maintenance Phase|Withdrawal by Subject|5
304222|NCT01559935|1029085|P1|Maintenance Phase|Lack of Efficacy|18
304223|NCT01559935|1029085|P1|Maintenance Phase|Toxicity|1
304224|NCT01559935|1029085|P1|Maintenance Phase|Remains on study|28
304225|NCT01559935|1029085|P1|BiRD Phase|Withdrawal by Subject|2
304226|NCT01559935|1029085|P1|BiRD Phase|Lack of Efficacy|1
304227|NCT01559935|1029085|P1|BiRD Phase|Toxicity|1
304228|NCT01559935|1029085|P1|Car Phase|non-compliance|1
304229|NCT01559935|1029085|P1|Car Phase|Insurance|1
304230|NCT01559935|1029085|P1|Car Phase|Per protocol|1
304231|NCT01559935|1029085|P1|Car Phase|Withdrawal by Subject|2
304232|NCT01559935|1029085|P1|Car Phase|Physician Decision|1
304233|NCT01559935|1029085|P1|Car Phase|Lost to Follow-up|1
304234|NCT01559935|1029085|P1|Car Phase|Lack of Efficacy|2
304235|NCT01559935|1029085|P1|Car Phase|Death|1
304236|NCT01559935|1029085|P1|Car Phase|Toxicity|4
304237|NCT01559844|1029121|P1|Overall Study|No Longer A Transplant Candidate|3
304238|NCT01559844|1029121|P1|Overall Study|Efficacy Failure|10
304239|NCT01559844|1029121|P1|Overall Study|Death|5
304240|NCT01559844|1029121|P1|Overall Study|Consent Withdrawn|7
304241|NCT01559675|1029134|P2|Overall Study|2nd operation on same patient excluded|12
304242|NCT01559675|1029135|P1|Overall Study|2nd operation on same patient excluded|14
304243|NCT01559675|1029134|P2|Overall Study|Protocol Violation|2
304244|NCT01559675|1029135|P1|Overall Study|Protocol Violation|1
304245|NCT01559454|1029166|P2|Overall Study|Lack of Efficacy|1
304246|NCT01559454|1029167|P1|Overall Study|Lack of Efficacy|0
304247|NCT01559454|1029166|P2|Overall Study|Protocol Violation|1
304248|NCT01559454|1029167|P1|Overall Study|Protocol Violation|0
304249|NCT01559454|1029166|P2|Overall Study|Physician Decision|1
304250|NCT01559454|1029167|P1|Overall Study|Physician Decision|0
304251|NCT01559454|1029166|P2|Overall Study|Withdrawal by Subject|1
304252|NCT01559454|1029167|P1|Overall Study|Withdrawal by Subject|0
304253|NCT01559454|1029166|P2|Overall Study|Lost to Follow-up|2
304254|NCT01559454|1029167|P1|Overall Study|Lost to Follow-up|3
304255|NCT01559311|1029186|P3|Overall Study|Adverse Event|1
304256|NCT01559311|1029187|P2|Overall Study|Adverse Event|0
304257|NCT01559311|1029188|P1|Overall Study|Adverse Event|0
304258|NCT01559311|1029186|P3|Overall Study|Lost to Follow-up|2
304259|NCT01559311|1029187|P2|Overall Study|Lost to Follow-up|3
304260|NCT01559311|1029188|P1|Overall Study|Lost to Follow-up|0
304261|NCT01559311|1029186|P3|Overall Study|Death|3
304262|NCT01559311|1029187|P2|Overall Study|Death|2
304263|NCT01559311|1029188|P1|Overall Study|Death|0
304264|NCT01559311|1029186|P3|Overall Study|Withdrawal by Subject|0
304265|NCT01559311|1029187|P2|Overall Study|Withdrawal by Subject|1
304266|NCT01559311|1029188|P1|Overall Study|Withdrawal by Subject|2
304267|NCT01559311|1029186|P3|Overall Study|Difficulty in cannulating the lateral ve|0
304268|NCT01559311|1029187|P2|Overall Study|Difficulty in cannulating the lateral ve|0
304269|NCT01559311|1029188|P1|Overall Study|Difficulty in cannulating the lateral ve|1
304270|NCT01559311|1029186|P3|Overall Study|Protocol Violation|2
304271|NCT01559311|1029187|P2|Overall Study|Protocol Violation|0
304272|NCT01559311|1029188|P1|Overall Study|Protocol Violation|0
304273|NCT01559116|1029199|P1|Overall Study|other than stated above|9
304274|NCT01559116|1029199|P1|Overall Study|Withdrawal by Subject|4
304275|NCT01559116|1029199|P1|Overall Study|Protocol Violation|1
304276|NCT01559116|1029199|P1|Overall Study|Lost to Follow-up|1
304277|NCT01559116|1029199|P1|Overall Study|Lack of Efficacy|1
304278|NCT01559116|1029199|P1|Overall Study|Adverse Event|10
304279|NCT01559012|1029282|P2|Overall Study|Withdrawal by Subject|1
304280|NCT01559012|1029283|P1|Overall Study|Withdrawal by Subject|0
304281|NCT01558739|1029319|P1|Overall Study|Protocol Violation|1
304282|NCT01558739|1029319|P1|Overall Study|Disease Progression|4
304283|NCT01558739|1029319|P1|Overall Study|Death|3
304284|NCT01558739|1029319|P1|Overall Study|Withdrawal by Subject|2
304285|NCT01558739|1029319|P1|Overall Study|Adverse Event|7
304286|NCT01558674|1029344|P2|Part 1|Withdrawal by Subject|0
304287|NCT01558674|1029345|P1|Part 1|Withdrawal by Subject|1
304288|NCT01558674|1029344|P2|Part 1|Study Terminated by Sponsor|0
304289|NCT01558674|1029345|P1|Part 1|Study Terminated by Sponsor|10
304290|NCT01558596|1029398|P2|Overall Study|Protocol Violation|0
304291|NCT01558596|1029399|P1|Overall Study|Protocol Violation|1
304292|NCT01558596|1029398|P2|Overall Study|surgery elsewhere or cancelled|1
304293|NCT01558596|1029399|P1|Overall Study|surgery elsewhere or cancelled|1
304294|NCT01558596|1029398|P2|Overall Study|Withdrawal by Subject|0
304295|NCT01558596|1029399|P1|Overall Study|Withdrawal by Subject|1
304296|NCT01558297|1029414|P3|Overall Study|Withdrawal by Subject|1
304297|NCT01558297|1029415|P2|Overall Study|Withdrawal by Subject|2
304298|NCT01558297|1029416|P1|Overall Study|Withdrawal by Subject|2
304299|NCT01558271|1029433|P3|Overall Study|Physician Decision|1
304300|NCT01558271|1029434|P2|Overall Study|Physician Decision|2
304301|NCT01558271|1029435|P1|Overall Study|Physician Decision|0
304302|NCT01558271|1029433|P3|Overall Study|Withdrawal by Subject|12
304303|NCT01558271|1029434|P2|Overall Study|Withdrawal by Subject|6
304304|NCT01558271|1029435|P1|Overall Study|Withdrawal by Subject|10
304305|NCT01558271|1029433|P3|Overall Study|Protocol Violation|0
304306|NCT01558271|1029434|P2|Overall Study|Protocol Violation|0
304307|NCT01558271|1029435|P1|Overall Study|Protocol Violation|1
304308|NCT01558271|1029433|P3|Overall Study|Lost to Follow-up|0
304309|NCT01558271|1029434|P2|Overall Study|Lost to Follow-up|0
304310|NCT01558271|1029435|P1|Overall Study|Lost to Follow-up|1
304311|NCT01558271|1029433|P3|Overall Study|Adverse Event|4
304312|NCT01558271|1029434|P2|Overall Study|Adverse Event|3
304313|NCT01558271|1029435|P1|Overall Study|Adverse Event|6
304314|NCT01558089|1029501|P1|Overall Study|Withdrawal by Subject|6
304315|NCT01558089|1029501|P1|Overall Study|Lost to Follow-up|5
304316|NCT01558089|1029501|P1|Overall Study|Lack of Efficacy|1
304317|NCT01558089|1029501|P1|Overall Study|Adverse Event|1
304318|NCT01557946|1029522|P2|Overall Study|Adverse Event|0
304319|NCT01557946|1029523|P1|Overall Study|Adverse Event|3
304320|NCT01557920|1029529|P2|Overall Study|Lack of Efficacy|0
304321|NCT01557920|1029530|P1|Overall Study|Lack of Efficacy|1
304322|NCT01557920|1029529|P2|Overall Study|Withdrawal by Subject|3
304323|NCT01557920|1029530|P1|Overall Study|Withdrawal by Subject|2
304324|NCT01557842|1029593|P2|Overall Study|Not Ablated|0
304325|NCT01557842|1029594|P1|Overall Study|Not Ablated|2
304326|NCT01557842|1029593|P2|Overall Study|Study Terminated by Sponsor|4
304327|NCT01557842|1029594|P1|Overall Study|Study Terminated by Sponsor|3
304328|NCT01557842|1029593|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
304329|NCT01557842|1029594|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
304330|NCT01557842|1029593|P2|Overall Study|Lack of Efficacy|1
304331|NCT01557842|1029594|P1|Overall Study|Lack of Efficacy|0
304332|NCT01557842|1029593|P2|Overall Study|Death|0
304333|NCT01557842|1029594|P1|Overall Study|Death|1
304334|NCT01557842|1029593|P2|Overall Study|Lost to Follow-up|1
304335|NCT01557842|1029594|P1|Overall Study|Lost to Follow-up|0
304336|NCT01557751|1029602|P1|Overall Study|Physician Decision|3
304337|NCT01557582|1029647|P1|Overall Study|Operator error|2
304338|NCT01557582|1029647|P1|Overall Study|Protocol Violation|4
304339|NCT01557569|1029655|P2|Overall Study|noncompliance with rules of residential|1
304340|NCT01557569|1029656|P1|Overall Study|noncompliance with rules of residential|0
304341|NCT01557569|1029655|P2|Overall Study|Withdrawal by Subject|5
304342|NCT01557569|1029656|P1|Overall Study|Withdrawal by Subject|3
304343|NCT01557569|1029655|P2|Overall Study|high blood pressure|1
304344|NCT01557569|1029656|P1|Overall Study|high blood pressure|0
304345|NCT01557569|1029655|P2|Overall Study|Adverse Event|0
304346|NCT01557569|1029656|P1|Overall Study|Adverse Event|2
304347|NCT01557504|1029664|P2|Overall Study|Physician Decision|0
304348|NCT01557504|1029665|P1|Overall Study|Physician Decision|1
304349|NCT01557348|1029690|P2|Overall Study|Administrative|11
304350|NCT01557348|1029691|P1|Overall Study|Administrative|18
304351|NCT01557348|1029690|P2|Overall Study|Lost to Follow-up|22
304352|NCT01557348|1029691|P1|Overall Study|Lost to Follow-up|26
304353|NCT01557348|1029690|P2|Overall Study|Withdrawal by Subject|4
304354|NCT01557348|1029691|P1|Overall Study|Withdrawal by Subject|5
304355|NCT01557348|1029690|P2|Overall Study|Insufficient Therapeutic Response|28
304356|NCT01557348|1029691|P1|Overall Study|Insufficient Therapeutic Response|13
304357|NCT01557348|1029690|P2|Overall Study|Death|4
304358|NCT01557348|1029691|P1|Overall Study|Death|7
304359|NCT01557348|1029690|P2|Overall Study|Infusion reaction event|5
304360|NCT01557348|1029691|P1|Overall Study|Infusion reaction event|5
304361|NCT01557348|1029690|P2|Overall Study|Adverse Event|16
304362|NCT01557348|1029691|P1|Overall Study|Adverse Event|6
304363|NCT01557283|1029808|P1|Overall Study|Other|6
304364|NCT01557283|1029808|P1|Overall Study|Worsening of psoriasis|1
304365|NCT01557283|1029808|P1|Overall Study|Participant’s weight too high for dose|1
304366|NCT01557283|1029808|P1|Overall Study|Withdrawal by Subject|1
304367|NCT01557283|1029808|P1|Overall Study|Non-compliance|1
304368|NCT01557283|1029808|P1|Overall Study|Lack of Efficacy|1
304369|NCT01557283|1029808|P1|Overall Study|Adverse Event|7
304370|NCT01557283|1029808|P1|Overall Study|Non-responder|19
304371|NCT01557283|1029808|P1|Overall Study|Lost to Follow-up|7
304372|NCT01557166|1029820|P2|Overall Study|Unclassified|5
304373|NCT01557166|1029821|P1|Overall Study|Unclassified|2
304374|NCT01557166|1029820|P2|Overall Study|Psychiatric disorder|0
304375|NCT01557166|1029821|P1|Overall Study|Psychiatric disorder|1
304376|NCT01557166|1029820|P2|Overall Study|Target dose not tolerated|0
304377|NCT01557166|1029821|P1|Overall Study|Target dose not tolerated|1
304378|NCT01557166|1029820|P2|Overall Study|Withdrawn consent|20
304379|NCT01557166|1029821|P1|Overall Study|Withdrawn consent|12
304380|NCT01557166|1029820|P2|Overall Study|Protocol Violation|5
304381|NCT01557166|1029821|P1|Overall Study|Protocol Violation|8
304382|NCT01557166|1029820|P2|Overall Study|Lack of Efficacy|1
304383|NCT01557166|1029821|P1|Overall Study|Lack of Efficacy|2
304384|NCT01557166|1029820|P2|Overall Study|Adverse Event|6
304385|NCT01557166|1029821|P1|Overall Study|Adverse Event|20
304386|NCT01556997|1029836|P3|Overall Study|Not specified|7
304387|NCT01556997|1029837|P2|Overall Study|Not specified|3
304388|NCT01556997|1029838|P1|Overall Study|Not specified|2
304389|NCT01556997|1029836|P3|Overall Study|Withdrawal by Subject|8
304390|NCT01556997|1029837|P2|Overall Study|Withdrawal by Subject|6
304391|NCT01556997|1029838|P1|Overall Study|Withdrawal by Subject|7
304392|NCT01556997|1029836|P3|Overall Study|Physician Decision|1
304393|NCT01556997|1029837|P2|Overall Study|Physician Decision|1
304394|NCT01556997|1029838|P1|Overall Study|Physician Decision|1
304395|NCT01556997|1029836|P3|Overall Study|Lost to Follow-up|4
304396|NCT01556997|1029837|P2|Overall Study|Lost to Follow-up|6
304397|NCT01556997|1029838|P1|Overall Study|Lost to Follow-up|6
304398|NCT01556997|1029836|P3|Overall Study|Adverse Event|12
304399|NCT01556997|1029837|P2|Overall Study|Adverse Event|12
304400|NCT01556997|1029838|P1|Overall Study|Adverse Event|10
304401|NCT01556932|1029849|P2|Time Point 60 Minutes|Withdrawal by Subject|1
304402|NCT01556932|1029850|P1|Time Point 60 Minutes|Withdrawal by Subject|1
304403|NCT01556763|1029876|P3|Overall Study|Withdrawal by Subject|0
304404|NCT01556763|1029877|P2|Overall Study|Withdrawal by Subject|1
304405|NCT01556763|1029878|P1|Overall Study|Withdrawal by Subject|0
304406|NCT01556165|1030048|P2|Overall Study|Withdrawal of Consent|1
304407|NCT01556165|1030049|P1|Overall Study|Withdrawal of Consent|7
304408|NCT01556165|1030048|P2|Overall Study|Protocol Violation|3
304409|NCT01556165|1030049|P1|Overall Study|Protocol Violation|0
304410|NCT01556165|1030048|P2|Overall Study|Adverse Event|3
304411|NCT01556165|1030049|P1|Overall Study|Adverse Event|5
304412|NCT01555983|1030079|P6|Overall Study|Withdrawal by Subject|1
304413|NCT01555983|1030080|P5|Overall Study|Withdrawal by Subject|1
304414|NCT01555983|1030081|P4|Overall Study|Withdrawal by Subject|0
304415|NCT01555983|1030082|P3|Overall Study|Withdrawal by Subject|0
304416|NCT01555983|1030083|P2|Overall Study|Withdrawal by Subject|0
304417|NCT01555983|1030084|P1|Overall Study|Withdrawal by Subject|1
304418|NCT01555931|1030094|P2|Overall Study|Lost to Follow-up|5
304419|NCT01555931|1030095|P1|Overall Study|Lost to Follow-up|2
304420|NCT01555463|1030126|P2|Follow up|Other reason|3
304421|NCT01555463|1030127|P1|Follow up|Other reason|3
304422|NCT01555463|1030126|P2|Follow up|Protocol Violation|4
304423|NCT01555463|1030127|P1|Follow up|Protocol Violation|2
304424|NCT01555463|1030126|P2|Follow up|Lost to Follow-up|10
304425|NCT01555463|1030127|P1|Follow up|Lost to Follow-up|9
304426|NCT01555463|1030126|P2|Follow up|Withdrawal by Subject|22
304427|NCT01555463|1030127|P1|Follow up|Withdrawal by Subject|22
304428|NCT01555463|1030126|P2|Follow up|Death|1
304429|NCT01555463|1030127|P1|Follow up|Death|0
304430|NCT01555463|1030126|P2|Follow up|Adverse Event|5
304431|NCT01555463|1030127|P1|Follow up|Adverse Event|2
304432|NCT01555463|1030126|P2|Treatment|Other reason|3
304433|NCT01555463|1030127|P1|Treatment|Other reason|2
304434|NCT01555463|1030126|P2|Treatment|Protocol Violation|5
304435|NCT01555463|1030127|P1|Treatment|Protocol Violation|4
304436|NCT01555463|1030126|P2|Treatment|Lost to Follow-up|23
304437|NCT01555463|1030127|P1|Treatment|Lost to Follow-up|28
304438|NCT01555463|1030126|P2|Treatment|Withdrawal by Subject|36
304439|NCT01555463|1030127|P1|Treatment|Withdrawal by Subject|24
304440|NCT01555463|1030126|P2|Treatment|Adverse Event|12
304441|NCT01555463|1030127|P1|Treatment|Adverse Event|6
304442|NCT01555164|1030169|P2|Overall Study|Subject Withdrew Consent|11
304443|NCT01555164|1030170|P1|Overall Study|Subject Withdrew Consent|6
304444|NCT01555164|1030169|P2|Overall Study|Subject Non-compliance|6
304445|NCT01555164|1030170|P1|Overall Study|Subject Non-compliance|14
304446|NCT01555164|1030169|P2|Overall Study|Protocol Violation|5
304447|NCT01555164|1030170|P1|Overall Study|Protocol Violation|9
304448|NCT01555164|1030169|P2|Overall Study|Lost to Follow-up|3
304449|NCT01555164|1030170|P1|Overall Study|Lost to Follow-up|4
304450|NCT01555164|1030169|P2|Overall Study|Investigator's Discretion|2
304451|NCT01555164|1030170|P1|Overall Study|Investigator's Discretion|2
304452|NCT01555164|1030169|P2|Overall Study|Hyperglycemia|1
304453|NCT01555164|1030170|P1|Overall Study|Hyperglycemia|0
304454|NCT01555164|1030169|P2|Overall Study|Adverse Event|7
304455|NCT01555164|1030170|P1|Overall Study|Adverse Event|5
304456|NCT01555151|1030184|P4|Overall Study|Lost to Follow-up|1
304457|NCT01555151|1030185|P3|Overall Study|Lost to Follow-up|0
304458|NCT01555151|1030186|P2|Overall Study|Lost to Follow-up|0
304459|NCT01555151|1030187|P1|Overall Study|Lost to Follow-up|0
304460|NCT01555151|1030184|P4|Overall Study|Adverse Event|2
304461|NCT01555151|1030185|P3|Overall Study|Adverse Event|1
304462|NCT01555151|1030186|P2|Overall Study|Adverse Event|2
304463|NCT01555151|1030187|P1|Overall Study|Adverse Event|1
304464|NCT01555151|1030184|P4|Overall Study|Protocol Violation|5
304465|NCT01555151|1030185|P3|Overall Study|Protocol Violation|3
304466|NCT01555151|1030186|P2|Overall Study|Protocol Violation|3
304467|NCT01555151|1030187|P1|Overall Study|Protocol Violation|3
304468|NCT01555151|1030184|P4|Overall Study|Administrative|0
304469|NCT01555151|1030185|P3|Overall Study|Administrative|2
304470|NCT01555151|1030186|P2|Overall Study|Administrative|1
304471|NCT01555151|1030187|P1|Overall Study|Administrative|3
304472|NCT01555151|1030184|P4|Overall Study|Withdrawal by Subject|2
304473|NCT01555151|1030185|P3|Overall Study|Withdrawal by Subject|0
304474|NCT01555151|1030186|P2|Overall Study|Withdrawal by Subject|2
304475|NCT01555151|1030187|P1|Overall Study|Withdrawal by Subject|6
304476|NCT01555138|1030240|P2|Overall Study|Adverse Event|14
304477|NCT01555138|1030241|P1|Overall Study|Adverse Event|14
304478|NCT01555138|1030240|P2|Overall Study|Withdrawal by Subject|15
304479|NCT01555138|1030241|P1|Overall Study|Withdrawal by Subject|16
304480|NCT01555138|1030240|P2|Overall Study|Administrative problems|0
304481|NCT01555138|1030241|P1|Overall Study|Administrative problems|8
304482|NCT01555138|1030240|P2|Overall Study|Protocol Violation|3
304483|NCT01555138|1030241|P1|Overall Study|Protocol Violation|5
304484|NCT01555138|1030240|P2|Overall Study|Lack of Efficacy|2
304485|NCT01555138|1030241|P1|Overall Study|Lack of Efficacy|2
304486|NCT01555138|1030240|P2|Overall Study|Abnormal Lab reults|3
304487|NCT01555138|1030241|P1|Overall Study|Abnormal Lab reults|1
304488|NCT01555138|1030240|P2|Overall Study|Lost to Follow-up|0
304489|NCT01555138|1030241|P1|Overall Study|Lost to Follow-up|1
304490|NCT01555138|1030240|P2|Overall Study|Death|1
304491|NCT01555138|1030241|P1|Overall Study|Death|0
304492|NCT01555073|1030271|P4|Overall Study|Lost to Follow-up|5
304493|NCT01555073|1030272|P3|Overall Study|Lost to Follow-up|0
304494|NCT01555073|1030273|P2|Overall Study|Lost to Follow-up|2
304495|NCT01555073|1030274|P1|Overall Study|Lost to Follow-up|1
304496|NCT01554904|1030301|P1|Overall Study|Had sleep apnea on Home Study 1|1
304497|NCT01554904|1030301|P1|Overall Study|Withdrawal by Subject|3
304498|NCT01554579|1030321|P2|Overall Study|Withdrawal by Subject|1
304499|NCT01554579|1030322|P1|Overall Study|Withdrawal by Subject|2
304500|NCT01554579|1030321|P2|Overall Study|Lack of Efficacy|1
304501|NCT01554579|1030322|P1|Overall Study|Lack of Efficacy|2
304502|NCT01554579|1030321|P2|Overall Study|Adverse Event|25
304503|NCT01554579|1030322|P1|Overall Study|Adverse Event|6
304504|NCT01554241|1030336|P4|Overall Study|Withdrawal by Subject|0
304505|NCT01554241|1030337|P3|Overall Study|Withdrawal by Subject|2
304506|NCT01554241|1030338|P2|Overall Study|Withdrawal by Subject|0
304507|NCT01554241|1030339|P1|Overall Study|Withdrawal by Subject|0
304508|NCT01554241|1030336|P4|Overall Study|protocol specified change in eGFR|0
304509|NCT01554241|1030337|P3|Overall Study|protocol specified change in eGFR|1
304510|NCT01554241|1030338|P2|Overall Study|protocol specified change in eGFR|0
304511|NCT01554241|1030339|P1|Overall Study|protocol specified change in eGFR|0
304512|NCT01554241|1030336|P4|Overall Study|protocol specified renal stone|1
304513|NCT01554241|1030337|P3|Overall Study|protocol specified renal stone|0
304514|NCT01554241|1030338|P2|Overall Study|protocol specified renal stone|0
304515|NCT01554241|1030339|P1|Overall Study|protocol specified renal stone|0
304516|NCT01554241|1030336|P4|Overall Study|Death|0
304517|NCT01554241|1030337|P3|Overall Study|Death|1
304518|NCT01554241|1030338|P2|Overall Study|Death|1
304519|NCT01554241|1030339|P1|Overall Study|Death|3
304520|NCT01554176|1030355|P5|Run-out Phase|Protocol Violation|0
304521|NCT01554176|1030356|P4|Run-out Phase|Protocol Violation|1
304522|NCT01554176|1030357|P3|Run-out Phase|Protocol Violation|0
304523|NCT01554176|1030358|P2|Run-out Phase|Protocol Violation|0
304524|NCT01554176|1030359|P1|Run-out Phase|Protocol Violation|0
304525|NCT01554176|1030355|P5|Treatment Phase|Lost to Follow-up|0
304526|NCT01554176|1030356|P4|Treatment Phase|Lost to Follow-up|0
304527|NCT01554176|1030357|P3|Treatment Phase|Lost to Follow-up|0
304528|NCT01554176|1030358|P2|Treatment Phase|Lost to Follow-up|0
304529|NCT01554176|1030359|P1|Treatment Phase|Lost to Follow-up|3
304530|NCT01554176|1030355|P5|Treatment Phase|Withdrawal by Subject|0
304531|NCT01554176|1030356|P4|Treatment Phase|Withdrawal by Subject|0
304532|NCT01554176|1030357|P3|Treatment Phase|Withdrawal by Subject|0
304533|NCT01554176|1030358|P2|Treatment Phase|Withdrawal by Subject|0
304534|NCT01554176|1030359|P1|Treatment Phase|Withdrawal by Subject|1
304535|NCT01554176|1030355|P5|Treatment Phase|Non-compliance with study drug|0
304536|NCT01554176|1030356|P4|Treatment Phase|Non-compliance with study drug|0
304537|NCT01554176|1030357|P3|Treatment Phase|Non-compliance with study drug|0
304538|NCT01554176|1030358|P2|Treatment Phase|Non-compliance with study drug|0
304539|NCT01554176|1030359|P1|Treatment Phase|Non-compliance with study drug|1
304540|NCT01554176|1030355|P5|Treatment Phase|Adverse event, non-fatal|0
304541|NCT01554176|1030356|P4|Treatment Phase|Adverse event, non-fatal|0
304542|NCT01554176|1030357|P3|Treatment Phase|Adverse event, non-fatal|0
304543|NCT01554176|1030358|P2|Treatment Phase|Adverse event, non-fatal|1
304544|NCT01554176|1030359|P1|Treatment Phase|Adverse event, non-fatal|1
304545|NCT01554176|1030355|P5|Treatment Phase|Lack of Efficacy|0
304546|NCT01554176|1030356|P4|Treatment Phase|Lack of Efficacy|0
304547|NCT01554176|1030357|P3|Treatment Phase|Lack of Efficacy|0
304548|NCT01554176|1030358|P2|Treatment Phase|Lack of Efficacy|1
304549|NCT01554176|1030359|P1|Treatment Phase|Lack of Efficacy|0
304550|NCT01554176|1030355|P5|Treatment Phase|Physician Decision|0
304551|NCT01554176|1030356|P4|Treatment Phase|Physician Decision|0
304552|NCT01554176|1030357|P3|Treatment Phase|Physician Decision|0
304553|NCT01554176|1030358|P2|Treatment Phase|Physician Decision|1
304554|NCT01554176|1030359|P1|Treatment Phase|Physician Decision|1
304555|NCT01554176|1030355|P5|Treatment Phase|Protocol Violation|0
304556|NCT01554176|1030356|P4|Treatment Phase|Protocol Violation|0
304557|NCT01554176|1030357|P3|Treatment Phase|Protocol Violation|0
304558|NCT01554176|1030358|P2|Treatment Phase|Protocol Violation|2
304559|NCT01554176|1030359|P1|Treatment Phase|Protocol Violation|1
304560|NCT01554163|1030386|P2|Overall Study|Not Treated|0
304561|NCT01554163|1030387|P1|Overall Study|Not Treated|1
304562|NCT01554163|1030386|P2|Overall Study|Withdrawal by Subject|5
304563|NCT01554163|1030387|P1|Overall Study|Withdrawal by Subject|1
304564|NCT01554163|1030386|P2|Overall Study|Protocol Violation|4
304565|NCT01554163|1030387|P1|Overall Study|Protocol Violation|0
304566|NCT01554163|1030386|P2|Overall Study|Non-Compliance With Study Drug|1
304567|NCT01554163|1030387|P1|Overall Study|Non-Compliance With Study Drug|1
304568|NCT01554163|1030386|P2|Overall Study|Lost to Follow-up|0
304569|NCT01554163|1030387|P1|Overall Study|Lost to Follow-up|1
304570|NCT01554163|1030386|P2|Overall Study|Lack of Efficacy|0
304571|NCT01554163|1030387|P1|Overall Study|Lack of Efficacy|1
304572|NCT01554163|1030386|P2|Overall Study|Adverse Event|0
304573|NCT01554163|1030387|P1|Overall Study|Adverse Event|3
304574|NCT01553916|1030405|P1|Overall Study|Pre-treatment MRI metastatic disease|1
304575|NCT01553916|1030405|P1|Overall Study|Withdrawal by Subject|2
304576|NCT01553851|1030418|P1|Overall Study|constipation|1
304577|NCT01553851|1030418|P1|Overall Study|Adverse Event|2
304578|NCT01553318|1030449|P2|Overall Study|Protocol Violation|2
304579|NCT01553318|1030450|P1|Overall Study|Protocol Violation|3
304580|NCT01553136|1030485|P2|Overall Study|Scheduling Difficulties|4
304581|NCT01553136|1030486|P1|Overall Study|Scheduling Difficulties|5
304582|NCT01553136|1030485|P2|Overall Study|Physician Decision|3
304583|NCT01553136|1030486|P1|Overall Study|Physician Decision|2
304584|NCT01553136|1030485|P2|Overall Study|Lost to Follow-up|10
304585|NCT01553136|1030486|P1|Overall Study|Lost to Follow-up|4
304586|NCT01553136|1030485|P2|Overall Study|Withdrawal by Subject|3
304587|NCT01553136|1030486|P1|Overall Study|Withdrawal by Subject|2
304588|NCT01553136|1030485|P2|Overall Study|Adverse Event|2
304589|NCT01553136|1030486|P1|Overall Study|Adverse Event|3
304590|NCT01552954|1030566|P2|Overall Study|diagnosed DM|0
304591|NCT01552954|1030567|P1|Overall Study|diagnosed DM|1
304592|NCT01552954|1030566|P2|Overall Study|Protocol Violation|2
304593|NCT01552954|1030567|P1|Overall Study|Protocol Violation|1
304594|NCT01552954|1030566|P2|Overall Study|Withdrawal by Subject|1
304595|NCT01552954|1030567|P1|Overall Study|Withdrawal by Subject|1
304596|NCT01552954|1030566|P2|Overall Study|Lost to Follow-up|1
304597|NCT01552954|1030567|P1|Overall Study|Lost to Follow-up|1
304598|NCT01552954|1030566|P2|Overall Study|Adverse Event|2
304599|NCT01552954|1030567|P1|Overall Study|Adverse Event|1
304600|NCT01552928|1030583|P4|Period 3|Adverse Event|0
304601|NCT01552928|1030584|P3|Period 3|Adverse Event|1
304602|NCT01552928|1030585|P2|Period 3|Adverse Event|0
304603|NCT01552928|1030586|P1|Period 3|Adverse Event|0
304604|NCT01552915|1030633|P3|Overall Study|Not specified|6
304605|NCT01552915|1030634|P2|Overall Study|Not specified|0
304606|NCT01552915|1030635|P1|Overall Study|Not specified|2
304607|NCT01552915|1030633|P3|Overall Study|Lack of Efficacy|4
304608|NCT01552915|1030634|P2|Overall Study|Lack of Efficacy|1
304609|NCT01552915|1030635|P1|Overall Study|Lack of Efficacy|8
304610|NCT01552915|1030633|P3|Overall Study|Protocol Violation|4
304611|NCT01552915|1030634|P2|Overall Study|Protocol Violation|4
304612|NCT01552915|1030635|P1|Overall Study|Protocol Violation|0
304613|NCT01552915|1030633|P3|Overall Study|Withdrawal by Subject|5
304614|NCT01552915|1030634|P2|Overall Study|Withdrawal by Subject|4
304615|NCT01552915|1030635|P1|Overall Study|Withdrawal by Subject|6
304616|NCT01552915|1030633|P3|Overall Study|Lost to Follow-up|5
304617|NCT01552915|1030634|P2|Overall Study|Lost to Follow-up|6
304618|NCT01552915|1030635|P1|Overall Study|Lost to Follow-up|4
304619|NCT01552915|1030633|P3|Overall Study|Adverse Event|3
304620|NCT01552915|1030634|P2|Overall Study|Adverse Event|14
304621|NCT01552915|1030635|P1|Overall Study|Adverse Event|3
304622|NCT01552902|1030658|P3|Overall Study|Other|3
304623|NCT01552902|1030659|P2|Overall Study|Other|4
304624|NCT01552902|1030660|P1|Overall Study|Other|3
304625|NCT01552902|1030658|P3|Overall Study|Lost to Follow-up|6
304626|NCT01552902|1030659|P2|Overall Study|Lost to Follow-up|3
304627|NCT01552902|1030660|P1|Overall Study|Lost to Follow-up|1
304628|NCT01552902|1030658|P3|Overall Study|Withdrawal by Subject|6
304629|NCT01552902|1030659|P2|Overall Study|Withdrawal by Subject|9
304630|NCT01552902|1030660|P1|Overall Study|Withdrawal by Subject|1
304631|NCT01552902|1030658|P3|Overall Study|Lack of Efficacy|1
304632|NCT01552902|1030659|P2|Overall Study|Lack of Efficacy|3
304633|NCT01552902|1030660|P1|Overall Study|Lack of Efficacy|4
304634|NCT01552902|1030658|P3|Overall Study|Protocol Violation|3
304635|NCT01552902|1030659|P2|Overall Study|Protocol Violation|3
304636|NCT01552902|1030660|P1|Overall Study|Protocol Violation|3
304637|NCT01552902|1030658|P3|Overall Study|Adverse Event|14
304638|NCT01552902|1030659|P2|Overall Study|Adverse Event|15
304639|NCT01552902|1030660|P1|Overall Study|Adverse Event|1
304640|NCT01552772|1030710|P1|Overall Study|Protocol Deviation|1
304641|NCT01552772|1030710|P1|Overall Study|Adverse Event|1
304642|NCT01552772|1030710|P1|Overall Study|Lost to Follow-up|2
304643|NCT01552694|1030726|P2|Overall Study|Protocol Violation|1
304644|NCT01552694|1030727|P1|Overall Study|Protocol Violation|0
304645|NCT01552694|1030726|P2|Overall Study|Lost to Follow-up|1
304646|NCT01552694|1030727|P1|Overall Study|Lost to Follow-up|0
304647|NCT01552681|1030743|P2|Overall Study|Subject moved away|1
304648|NCT01552681|1030744|P1|Overall Study|Subject moved away|0
304649|NCT01552681|1030743|P2|Overall Study|Physician Decision|0
304650|NCT01552681|1030744|P1|Overall Study|Physician Decision|1
304651|NCT01552681|1030743|P2|Overall Study|Withdrawal by Subject|0
304652|NCT01552681|1030744|P1|Overall Study|Withdrawal by Subject|4
304653|NCT01552603|1030792|P1|Overall Study|Physician Decision|1
304654|NCT01552057|1030823|P2|Overall Study|Physician Decision|0
304655|NCT01552057|1030824|P1|Overall Study|Physician Decision|1
304656|NCT01552057|1030823|P2|Overall Study|Entry Criteria Not Met|2
304657|NCT01552057|1030824|P1|Overall Study|Entry Criteria Not Met|2
304658|NCT01552057|1030823|P2|Overall Study|Withdrawal by Subject|8
304659|NCT01552057|1030824|P1|Overall Study|Withdrawal by Subject|5
304660|NCT01552057|1030823|P2|Overall Study|Lack of Efficacy|23
304661|NCT01552057|1030824|P1|Overall Study|Lack of Efficacy|8
304662|NCT01552057|1030823|P2|Overall Study|Adverse Event|15
304663|NCT01552057|1030824|P1|Overall Study|Adverse Event|14
304664|NCT01551758|1030890|P2|Overall Study|Withdrawal by Subject|17
304665|NCT01551758|1030891|P1|Overall Study|Withdrawal by Subject|14
304666|NCT01551758|1030890|P2|Overall Study|Physician Decision|3
304667|NCT01551758|1030891|P1|Overall Study|Physician Decision|9
304668|NCT01551758|1030890|P2|Overall Study|Lost to Follow-up|25
304669|NCT01551758|1030891|P1|Overall Study|Lost to Follow-up|29
304670|NCT01551758|1030890|P2|Overall Study|Met Protocol-defined stopping criteria|10
304671|NCT01551758|1030891|P1|Overall Study|Met Protocol-defined stopping criteria|8
304672|NCT01551758|1030890|P2|Overall Study|Protocol Violation|6
304673|NCT01551758|1030891|P1|Overall Study|Protocol Violation|5
304674|NCT01551758|1030890|P2|Overall Study|Lack of Efficacy|1
304675|NCT01551758|1030891|P1|Overall Study|Lack of Efficacy|0
304676|NCT01551758|1030890|P2|Overall Study|Adverse Event|43
304677|NCT01551758|1030891|P1|Overall Study|Adverse Event|29
304678|NCT01551745|1030929|P1|Overall Study|Disease Progression|2
304679|NCT01551745|1030929|P1|Overall Study|Withdrawal by Subject|1
304680|NCT01551693|1030938|P2|Overall Study|Withdrawal by Subject|1
304681|NCT01551693|1030939|P1|Overall Study|Withdrawal by Subject|0
304682|NCT01551693|1030938|P2|Overall Study|Adverse Event|1
304683|NCT01551693|1030939|P1|Overall Study|Adverse Event|0
304684|NCT01551693|1030938|P2|Overall Study|Disease Progression|0
304685|NCT01551693|1030939|P1|Overall Study|Disease Progression|1
304686|NCT01551355|1030955|P6|Overall Study|Lost to Follow-up|6
304687|NCT01551355|1030956|P5|Overall Study|Lost to Follow-up|9
304688|NCT01551355|1030957|P4|Overall Study|Lost to Follow-up|24
304689|NCT01551355|1030958|P3|Overall Study|Lost to Follow-up|34
304690|NCT01551355|1030959|P2|Overall Study|Lost to Follow-up|49
304691|NCT01551355|1030960|P1|Overall Study|Lost to Follow-up|51
304692|NCT01551303|1030974|P2|Overall Study|failed awareness check on vision test|7
304693|NCT01551303|1030975|P1|Overall Study|failed awareness check on vision test|4
304694|NCT01551173|1030989|P2|Overall Study|Not specified|3
304695|NCT01551173|1030990|P1|Overall Study|Not specified|5
304696|NCT01551173|1030989|P2|Overall Study|Lost to Follow-up|7
304697|NCT01551173|1030990|P1|Overall Study|Lost to Follow-up|5
304698|NCT01551173|1030989|P2|Overall Study|Adverse Event|6
304699|NCT01551173|1030990|P1|Overall Study|Adverse Event|7
304700|NCT01551173|1030989|P2|Overall Study|Withdrawal by Subject|16
304701|NCT01551173|1030990|P1|Overall Study|Withdrawal by Subject|11
304702|NCT01550965|1031067|P1|Overall Study|Not Specified|13
304703|NCT01550965|1031067|P1|Overall Study|Lack of Efficacy|59
304704|NCT01550965|1031067|P1|Overall Study|Lost to Follow-up|2
304705|NCT01550965|1031067|P1|Overall Study|Withdrawal by Subject|10
304706|NCT01550965|1031067|P1|Overall Study|Adverse Event|26
304707|NCT01550757|1031111|P4|Overall Study|Withdrawal by Subject|1
304708|NCT01550757|1031112|P3|Overall Study|Withdrawal by Subject|3
304709|NCT01550757|1031113|P2|Overall Study|Withdrawal by Subject|0
304710|NCT01550757|1031114|P1|Overall Study|Withdrawal by Subject|2
304711|NCT01550757|1031111|P4|Overall Study|Lost to Follow-up|53
304712|NCT01550757|1031112|P3|Overall Study|Lost to Follow-up|42
304713|NCT01550757|1031113|P2|Overall Study|Lost to Follow-up|14
304714|NCT01550757|1031114|P1|Overall Study|Lost to Follow-up|21
304715|NCT01550744|1031124|P3|Double-Blind|Other|10
304716|NCT01550744|1031125|P2|Double-Blind|Other|2
304717|NCT01550744|1031126|P1|Double-Blind|Other|0
304718|NCT01550744|1031124|P3|Double-Blind|Pregnancy|3
304719|NCT01550744|1031125|P2|Double-Blind|Pregnancy|0
304720|NCT01550744|1031126|P1|Double-Blind|Pregnancy|0
304721|NCT01550744|1031124|P3|Double-Blind|Protocol Violation|4
304722|NCT01550744|1031125|P2|Double-Blind|Protocol Violation|0
304723|NCT01550744|1031126|P1|Double-Blind|Protocol Violation|0
304724|NCT01550744|1031124|P3|Double-Blind|Lack of Efficacy|8
304725|NCT01550744|1031125|P2|Double-Blind|Lack of Efficacy|2
304726|NCT01550744|1031126|P1|Double-Blind|Lack of Efficacy|0
304727|NCT01550744|1031124|P3|Double-Blind|Death|0
304728|NCT01550744|1031125|P2|Double-Blind|Death|1
304729|NCT01550744|1031126|P1|Double-Blind|Death|0
304730|NCT01550744|1031124|P3|Double-Blind|Adverse Event|15
304731|NCT01550744|1031125|P2|Double-Blind|Adverse Event|4
304732|NCT01550744|1031126|P1|Double-Blind|Adverse Event|0
304733|NCT01550744|1031124|P3|Double-Blind|Withdrawal by Subject|15
304734|NCT01550744|1031125|P2|Double-Blind|Withdrawal by Subject|2
304735|NCT01550744|1031126|P1|Double-Blind|Withdrawal by Subject|0
304736|NCT01550744|1031124|P3|Double-Blind|Lost to Follow-up|12
304737|NCT01550744|1031125|P2|Double-Blind|Lost to Follow-up|6
304738|NCT01550744|1031126|P1|Double-Blind|Lost to Follow-up|0
304739|NCT01550744|1031124|P3|Open-Label|Other|0
304740|NCT01550744|1031125|P2|Open-Label|Other|0
304741|NCT01550744|1031126|P1|Open-Label|Other|1
304742|NCT01550744|1031124|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
304743|NCT01550744|1031125|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
304744|NCT01550744|1031126|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
304745|NCT01550744|1031124|P3|Open-Label|Not all 3 study drug injections received|0
304746|NCT01550744|1031125|P2|Open-Label|Not all 3 study drug injections received|0
304747|NCT01550744|1031126|P1|Open-Label|Not all 3 study drug injections received|2
304748|NCT01550744|1031124|P3|Open-Label|Protocol Violation|0
304749|NCT01550744|1031125|P2|Open-Label|Protocol Violation|0
304750|NCT01550744|1031126|P1|Open-Label|Protocol Violation|4
304751|NCT01550744|1031124|P3|Open-Label|Lack of Efficacy|0
304752|NCT01550744|1031125|P2|Open-Label|Lack of Efficacy|0
304753|NCT01550744|1031126|P1|Open-Label|Lack of Efficacy|4
304754|NCT01550744|1031124|P3|Open-Label|Adverse Event|0
304755|NCT01550744|1031125|P2|Open-Label|Adverse Event|0
304756|NCT01550744|1031126|P1|Open-Label|Adverse Event|11
304757|NCT01550744|1031124|P3|Open-Label|Withdrawal by Subject|0
304758|NCT01550744|1031125|P2|Open-Label|Withdrawal by Subject|0
304759|NCT01550744|1031126|P1|Open-Label|Withdrawal by Subject|13
304760|NCT01550744|1031124|P3|Open-Label|Lost to Follow-up|0
304761|NCT01550744|1031125|P2|Open-Label|Lost to Follow-up|0
304762|NCT01550744|1031126|P1|Open-Label|Lost to Follow-up|7
304763|NCT01550289|1031179|P2|Overall Study|Withdrawal by Subject|3
304764|NCT01550289|1031180|P1|Overall Study|Withdrawal by Subject|11
304765|NCT01550289|1031179|P2|Overall Study|Lost to Follow-up|1
304766|NCT01550289|1031180|P1|Overall Study|Lost to Follow-up|1
304767|NCT01550289|1031179|P2|Overall Study|Protocol Violation|0
304768|NCT01550289|1031180|P1|Overall Study|Protocol Violation|1
304769|NCT01549964|1031231|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
304770|NCT01549964|1031232|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
304771|NCT01549964|1031233|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
304772|NCT01549964|1031234|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
304773|NCT01549964|1031231|P4|80-Week Extension Period|Lost to Follow-up|1
304774|NCT01549964|1031232|P3|80-Week Extension Period|Lost to Follow-up|2
304775|NCT01549964|1031233|P2|80-Week Extension Period|Lost to Follow-up|0
304776|NCT01549964|1031234|P1|80-Week Extension Period|Lost to Follow-up|1
304777|NCT01549964|1031231|P4|80-Week Extension Period|Voluntary Withdrawal|2
304778|NCT01549964|1031232|P3|80-Week Extension Period|Voluntary Withdrawal|4
304779|NCT01549964|1031233|P2|80-Week Extension Period|Voluntary Withdrawal|1
304780|NCT01549964|1031234|P1|80-Week Extension Period|Voluntary Withdrawal|0
304781|NCT01549964|1031231|P4|80-Week Extension Period|Study Terminated by Sponsor|132
304782|NCT01549964|1031232|P3|80-Week Extension Period|Study Terminated by Sponsor|132
304783|NCT01549964|1031233|P2|80-Week Extension Period|Study Terminated by Sponsor|137
304784|NCT01549964|1031234|P1|80-Week Extension Period|Study Terminated by Sponsor|65
304785|NCT01549964|1031231|P4|80-Week Extension Period|Pregnancy|0
304786|NCT01549964|1031232|P3|80-Week Extension Period|Pregnancy|1
304787|NCT01549964|1031233|P2|80-Week Extension Period|Pregnancy|0
304788|NCT01549964|1031234|P1|80-Week Extension Period|Pregnancy|0
304789|NCT01549964|1031231|P4|24-Week Treatment Period|Completion Status Unknown|0
304790|NCT01549964|1031232|P3|24-Week Treatment Period|Completion Status Unknown|1
304791|NCT01549964|1031233|P2|24-Week Treatment Period|Completion Status Unknown|0
304792|NCT01549964|1031234|P1|24-Week Treatment Period|Completion Status Unknown|1
304793|NCT01549964|1031231|P4|24-Week Treatment Period|Randomized but Not Treated|1
304794|NCT01549964|1031232|P3|24-Week Treatment Period|Randomized but Not Treated|0
304795|NCT01549964|1031233|P2|24-Week Treatment Period|Randomized but Not Treated|0
304796|NCT01549964|1031234|P1|24-Week Treatment Period|Randomized but Not Treated|0
304797|NCT01549964|1031231|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
304798|NCT01549964|1031232|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
304799|NCT01549964|1031233|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
304800|NCT01549964|1031234|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
304801|NCT01549964|1031231|P4|24-Week Treatment Period|Other|0
304802|NCT01549964|1031232|P3|24-Week Treatment Period|Other|1
304803|NCT01549964|1031233|P2|24-Week Treatment Period|Other|0
304804|NCT01549964|1031234|P1|24-Week Treatment Period|Other|1
304805|NCT01549964|1031231|P4|24-Week Treatment Period|Lack of Efficacy|1
304806|NCT01549964|1031232|P3|24-Week Treatment Period|Lack of Efficacy|1
304807|NCT01549964|1031233|P2|24-Week Treatment Period|Lack of Efficacy|0
304808|NCT01549964|1031234|P1|24-Week Treatment Period|Lack of Efficacy|1
304809|NCT01549964|1031231|P4|24-Week Treatment Period|Lost to Follow-up|2
304810|NCT01549964|1031232|P3|24-Week Treatment Period|Lost to Follow-up|1
304811|NCT01549964|1031233|P2|24-Week Treatment Period|Lost to Follow-up|0
304812|NCT01549964|1031234|P1|24-Week Treatment Period|Lost to Follow-up|1
304813|NCT01549964|1031231|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
304814|NCT01549964|1031232|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
304815|NCT01549964|1031233|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
304816|NCT01549964|1031234|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
304817|NCT01549964|1031231|P4|24-Week Treatment Period|Voluntary Withdrawal|8
304818|NCT01549964|1031232|P3|24-Week Treatment Period|Voluntary Withdrawal|3
304819|NCT01549964|1031233|P2|24-Week Treatment Period|Voluntary Withdrawal|3
304820|NCT01549964|1031234|P1|24-Week Treatment Period|Voluntary Withdrawal|6
304821|NCT01549964|1031231|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
304822|NCT01549964|1031232|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
304823|NCT01549964|1031233|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
304824|NCT01549964|1031234|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
304825|NCT01549951|1031252|P1|Overall Study|Other|2
304826|NCT01549951|1031252|P1|Overall Study|Symptomatic deterioration|1
304827|NCT01549951|1031252|P1|Overall Study|Progressive disease|29
304828|NCT01549951|1031252|P1|Overall Study|Unsatisfactory therapeutic response|1
304829|NCT01549951|1031252|P1|Overall Study|Withdrawal by Subject|2
304830|NCT01549951|1031252|P1|Overall Study|Adverse Event|15
304831|NCT01549873|1031279|P2|Overall Study|Physician Decision|1
304832|NCT01549873|1031280|P1|Overall Study|Physician Decision|0
304833|NCT01549860|1031292|P2|Overall Study|Physician Decision|1
304834|NCT01549860|1031293|P1|Overall Study|Physician Decision|1
304835|NCT01549860|1031292|P2|Overall Study|Withdrawal by Subject|0
304836|NCT01549860|1031293|P1|Overall Study|Withdrawal by Subject|1
304837|NCT01549613|1031305|P2|Overall Study|Lost to Follow-up|11
304838|NCT01549613|1031306|P1|Overall Study|Lost to Follow-up|11
304839|NCT01549392|1031325|P2|Overall Study|Withdrawal by Subject|0
304840|NCT01549392|1031326|P1|Overall Study|Withdrawal by Subject|1
304841|NCT01549275|1031345|P2|Overall Study|Lost to Follow-up|0
304842|NCT01549275|1031346|P1|Overall Study|Lost to Follow-up|1
304843|NCT01549041|1031369|P2|Overall Study|Adverse Event|4
304844|NCT01549041|1031370|P1|Overall Study|Adverse Event|0
304845|NCT01549041|1031369|P2|Overall Study|Lack of Efficacy|4
304846|NCT01549041|1031370|P1|Overall Study|Lack of Efficacy|2
304847|NCT01549002|1031380|P2|Overall Study|Moderate sedation required|2
304848|NCT01549002|1031381|P1|Overall Study|Moderate sedation required|0
304849|NCT01549002|1031380|P2|Overall Study|Excessive pain|2
304850|NCT01549002|1031381|P1|Overall Study|Excessive pain|0
304851|NCT01548638|1031421|P1|Overall Study|Withdrawal by Subject|1
304852|NCT01548638|1031421|P1|Overall Study|Protocol Violation|3
304853|NCT01548573|1031431|P1|Overall Study|Withdrawal by Subject|2
304854|NCT01548573|1031431|P1|Overall Study|Death|3
304855|NCT01548417|1031440|P2|Overall Study|Withdrawal by Subject|2
304856|NCT01548417|1031441|P1|Overall Study|Withdrawal by Subject|0
304857|NCT01548287|1031453|P5|Randomized Period|Adverse Event|0
304858|NCT01548287|1031454|P4|Randomized Period|Adverse Event|0
304859|NCT01548287|1031455|P3|Randomized Period|Adverse Event|5
304860|NCT01548287|1031456|P2|Randomized Period|Adverse Event|2
304861|NCT01548287|1031457|P1|Randomized Period|Adverse Event|0
304862|NCT01548287|1031453|P5|Randomized Period|Did not meet inclusion criteria|0
304863|NCT01548287|1031454|P4|Randomized Period|Did not meet inclusion criteria|0
304864|NCT01548287|1031455|P3|Randomized Period|Did not meet inclusion criteria|2
304865|NCT01548287|1031456|P2|Randomized Period|Did not meet inclusion criteria|0
304866|NCT01548287|1031457|P1|Randomized Period|Did not meet inclusion criteria|0
304867|NCT01548287|1031453|P5|Screening|Did not meet eligibility criteria|74
304868|NCT01548287|1031454|P4|Screening|Did not meet eligibility criteria|0
304869|NCT01548287|1031455|P3|Screening|Did not meet eligibility criteria|0
304870|NCT01548287|1031456|P2|Screening|Did not meet eligibility criteria|0
304871|NCT01548287|1031457|P1|Screening|Did not meet eligibility criteria|0
304872|NCT01548287|1031453|P5|Screening|No reason provided|9
304873|NCT01548287|1031454|P4|Screening|No reason provided|0
304874|NCT01548287|1031455|P3|Screening|No reason provided|0
304875|NCT01548287|1031456|P2|Screening|No reason provided|0
304876|NCT01548287|1031457|P1|Screening|No reason provided|0
304877|NCT01547728|1031514|P1|Overall Study|Screen failure|39
304878|NCT01547728|1031514|P1|Overall Study|Drug not ready for subject|1
304879|NCT01547728|1031514|P1|Overall Study|Change in procedure and equipment|1
304880|NCT01547598|1031623|P2|Overall Study|Other Miscellaneous Reasons|1
304881|NCT01547598|1031624|P1|Overall Study|Other Miscellaneous Reasons|2
304882|NCT01547598|1031623|P2|Overall Study|Protocol Violation|1
304883|NCT01547598|1031624|P1|Overall Study|Protocol Violation|1
304884|NCT01547598|1031623|P2|Overall Study|Adverse Event|1
304885|NCT01547598|1031624|P1|Overall Study|Adverse Event|1
304886|NCT01547598|1031623|P2|Overall Study|Lost to Follow-up|1
304887|NCT01547598|1031624|P1|Overall Study|Lost to Follow-up|1
304888|NCT01547598|1031623|P2|Overall Study|Withdrew consent|1
304889|NCT01547598|1031624|P1|Overall Study|Withdrew consent|1
304898|NCT01547299|1031652|P2|Overall Study|Withdrawal by Subject|2
304899|NCT01547299|1031653|P1|Overall Study|Withdrawal by Subject|2
304900|NCT01547286|1031719|P1|Overall Study|Physician Decision|1
304901|NCT01547286|1031719|P1|Overall Study|Did not meet all eligibility criteria|1
304902|NCT01547130|1031739|P2|Overall Study|Lost to Follow-up|5
304903|NCT01547130|1031740|P1|Overall Study|Lost to Follow-up|9
304904|NCT01546922|1031763|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
304905|NCT01546922|1031764|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
304906|NCT01546922|1031763|P2|Second Period of 10 Weeks|Protocol Violation|1
304907|NCT01546922|1031764|P1|Second Period of 10 Weeks|Protocol Violation|3
304908|NCT01546922|1031763|P2|First Period of 10 Weeks|Investigator's judgment|0
304909|NCT01546922|1031764|P1|First Period of 10 Weeks|Investigator's judgment|1
304910|NCT01546922|1031763|P2|First Period of 10 Weeks|Withdrawal by Subject|1
304911|NCT01546922|1031764|P1|First Period of 10 Weeks|Withdrawal by Subject|1
304912|NCT01546922|1031763|P2|First Period of 10 Weeks|Protocol Violation|1
304913|NCT01546922|1031764|P1|First Period of 10 Weeks|Protocol Violation|3
304914|NCT01546883|1031770|P1|Overall Study|other unrelated illness|1
304915|NCT01546883|1031770|P1|Overall Study|early closure of study|2
304916|NCT01546883|1031770|P1|Overall Study|Lost to Follow-up|2
304917|NCT01546883|1031770|P1|Overall Study|Adverse Event|4
304918|NCT01546883|1031770|P1|Overall Study|Withdrawal by Subject|3
304919|NCT01546688|1031776|P2|Overall Study|Lack of Efficacy|0
304920|NCT01546688|1031777|P1|Overall Study|Lack of Efficacy|1
304921|NCT01546688|1031776|P2|Overall Study|Withdrawal by Subject|1
304922|NCT01546688|1031777|P1|Overall Study|Withdrawal by Subject|2
304923|NCT01546688|1031776|P2|Overall Study|Adverse Event|4
304924|NCT01546688|1031777|P1|Overall Study|Adverse Event|0
304925|NCT01546649|1031809|P2|Overall Study|Withdrawal by Subject|2
304926|NCT01546649|1031810|P1|Overall Study|Withdrawal by Subject|1
304927|NCT01546649|1031809|P2|Overall Study|Discovery of secondary cancer|1
304928|NCT01546649|1031810|P1|Overall Study|Discovery of secondary cancer|0
304929|NCT01546649|1031809|P2|Overall Study|Recurrence|1
304930|NCT01546649|1031810|P1|Overall Study|Recurrence|1
304931|NCT01546649|1031809|P2|Overall Study|Lack of Efficacy|0
304932|NCT01546649|1031810|P1|Overall Study|Lack of Efficacy|1
304933|NCT01546649|1031809|P2|Overall Study|Protocol Violation|0
304934|NCT01546649|1031810|P1|Overall Study|Protocol Violation|1
304935|NCT01546649|1031809|P2|Overall Study|Adverse Event|5
304936|NCT01546649|1031810|P1|Overall Study|Adverse Event|4
304937|NCT01546623|1031845|P2|Overall Study|Did Not Receive Study Drug|1
304938|NCT01546623|1031846|P1|Overall Study|Did Not Receive Study Drug|1
304939|NCT01546623|1031845|P2|Overall Study|High Prostate specific antigen|1
304940|NCT01546623|1031846|P1|Overall Study|High Prostate specific antigen|2
304941|NCT01546623|1031845|P2|Overall Study|Major Protocol Deviation|1
304942|NCT01546623|1031846|P1|Overall Study|Major Protocol Deviation|1
304943|NCT01546623|1031845|P2|Overall Study|Adverse Event|3
304944|NCT01546623|1031846|P1|Overall Study|Adverse Event|2
304945|NCT01546519|1031876|P4|Overall Study|Withdrawal by Subject|0
304946|NCT01546519|1031877|P3|Overall Study|Withdrawal by Subject|0
304947|NCT01546519|1031878|P2|Overall Study|Withdrawal by Subject|0
304948|NCT01546519|1031879|P1|Overall Study|Withdrawal by Subject|1
304949|NCT01546519|1031876|P4|Overall Study|Physician Decision|3
304950|NCT01546519|1031877|P3|Overall Study|Physician Decision|2
304951|NCT01546519|1031878|P2|Overall Study|Physician Decision|5
304952|NCT01546519|1031879|P1|Overall Study|Physician Decision|6
304953|NCT01546519|1031876|P4|Overall Study|related to disease progression|1
304954|NCT01546519|1031877|P3|Overall Study|related to disease progression|2
304955|NCT01546519|1031878|P2|Overall Study|related to disease progression|2
304956|NCT01546519|1031879|P1|Overall Study|related to disease progression|2
304957|NCT01546519|1031876|P4|Overall Study|Death|1
304958|NCT01546519|1031877|P3|Overall Study|Death|3
304959|NCT01546519|1031878|P2|Overall Study|Death|1
304960|NCT01546519|1031879|P1|Overall Study|Death|0
304961|NCT01546519|1031876|P4|Overall Study|Adverse Event|1
304962|NCT01546519|1031877|P3|Overall Study|Adverse Event|1
304963|NCT01546519|1031878|P2|Overall Study|Adverse Event|0
304964|NCT01546519|1031879|P1|Overall Study|Adverse Event|0
304965|NCT01546207|1031944|P1|Overall Study|Death|1
304966|NCT01546168|1031959|P2|Overall Study|ineligible after signing consent|0
304967|NCT01546168|1031960|P1|Overall Study|ineligible after signing consent|2
304968|NCT01546168|1031959|P2|Overall Study|Withdrawal by Subject|0
304969|NCT01546168|1031960|P1|Overall Study|Withdrawal by Subject|1
304970|NCT01546168|1031959|P2|Overall Study|Lost to Follow-up|0
304971|NCT01546168|1031960|P1|Overall Study|Lost to Follow-up|1
304972|NCT01546155|1031972|P1|Overall Study|could not tolerate long scan duration|3
304973|NCT01546142|1031978|P2|Overall Study|Subject Randomized but Not Treated|0
304974|NCT01546142|1031979|P1|Overall Study|Subject Randomized but Not Treated|1
304975|NCT01546142|1031978|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
304976|NCT01546142|1031979|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
304977|NCT01546142|1031978|P2|Overall Study|Lost to Follow-up|15
304978|NCT01546142|1031979|P1|Overall Study|Lost to Follow-up|20
304979|NCT01546142|1031978|P2|Overall Study|Adverse Event|3
304980|NCT01546142|1031979|P1|Overall Study|Adverse Event|6
304981|NCT01546142|1031978|P2|Overall Study|Subject Noncompliance|1
304982|NCT01546142|1031979|P1|Overall Study|Subject Noncompliance|1
304983|NCT01546142|1031978|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
304984|NCT01546142|1031979|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
304985|NCT01546038|1031997|P9|Overall Study|: Randomized, not treated|3
304986|NCT01546038|1031998|P8|Overall Study|: Randomized, not treated|4
304987|NCT01546038|1031999|P7|Overall Study|: Randomized, not treated|2
304988|NCT01546038|1032000|P6|Overall Study|: Randomized, not treated|0
304989|NCT01546038|1032001|P5|Overall Study|: Randomized, not treated|0
304990|NCT01546038|1032002|P4|Overall Study|: Randomized, not treated|0
304991|NCT01546038|1032003|P3|Overall Study|: Randomized, not treated|0
304992|NCT01546038|1032004|P2|Overall Study|: Randomized, not treated|0
304993|NCT01546038|1032005|P1|Overall Study|: Randomized, not treated|0
304994|NCT01546038|1031997|P9|Overall Study|: Study ongoing at cutoff date|1
304995|NCT01546038|1031998|P8|Overall Study|: Study ongoing at cutoff date|16
304996|NCT01546038|1031999|P7|Overall Study|: Study ongoing at cutoff date|24
304997|NCT01546038|1032000|P6|Overall Study|: Study ongoing at cutoff date|2
304998|NCT01546038|1032001|P5|Overall Study|: Study ongoing at cutoff date|8
304999|NCT01546038|1032002|P4|Overall Study|: Study ongoing at cutoff date|0
305000|NCT01546038|1032003|P3|Overall Study|: Study ongoing at cutoff date|0
305001|NCT01546038|1032004|P2|Overall Study|: Study ongoing at cutoff date|0
305002|NCT01546038|1032005|P1|Overall Study|: Study ongoing at cutoff date|1
305003|NCT01546038|1031997|P9|Overall Study|Withdrawal by Subject|0
305004|NCT01546038|1031998|P8|Overall Study|Withdrawal by Subject|3
305005|NCT01546038|1031999|P7|Overall Study|Withdrawal by Subject|3
305006|NCT01546038|1032000|P6|Overall Study|Withdrawal by Subject|1
305007|NCT01546038|1032001|P5|Overall Study|Withdrawal by Subject|0
305008|NCT01546038|1032002|P4|Overall Study|Withdrawal by Subject|1
305009|NCT01546038|1032003|P3|Overall Study|Withdrawal by Subject|0
305010|NCT01546038|1032004|P2|Overall Study|Withdrawal by Subject|0
305011|NCT01546038|1032005|P1|Overall Study|Withdrawal by Subject|1
305012|NCT01546038|1031997|P9|Overall Study|Lost to Follow-up|0
305013|NCT01546038|1031998|P8|Overall Study|Lost to Follow-up|1
305014|NCT01546038|1031999|P7|Overall Study|Lost to Follow-up|1
305015|NCT01546038|1032000|P6|Overall Study|Lost to Follow-up|0
305016|NCT01546038|1032001|P5|Overall Study|Lost to Follow-up|1
305017|NCT01546038|1032002|P4|Overall Study|Lost to Follow-up|0
305018|NCT01546038|1032003|P3|Overall Study|Lost to Follow-up|0
305019|NCT01546038|1032004|P2|Overall Study|Lost to Follow-up|0
305020|NCT01546038|1032005|P1|Overall Study|Lost to Follow-up|0
305021|NCT01546038|1031997|P9|Overall Study|Death|40
305022|NCT01546038|1031998|P8|Overall Study|Death|64
305023|NCT01546038|1031999|P7|Overall Study|Death|41
305024|NCT01546038|1032000|P6|Overall Study|Death|3
305025|NCT01546038|1032001|P5|Overall Study|Death|7
305026|NCT01546038|1032002|P4|Overall Study|Death|2
305027|NCT01546038|1032003|P3|Overall Study|Death|4
305028|NCT01546038|1032004|P2|Overall Study|Death|6
305029|NCT01546038|1032005|P1|Overall Study|Death|15
305030|NCT01545388|1032262|P3|Overall Study|Not specified|0
305031|NCT01545388|1032263|P2|Overall Study|Not specified|1
305032|NCT01545388|1032264|P1|Overall Study|Not specified|1
305033|NCT01545388|1032262|P3|Overall Study|Withdrawal by Subject|2
305034|NCT01545388|1032263|P2|Overall Study|Withdrawal by Subject|4
305035|NCT01545388|1032264|P1|Overall Study|Withdrawal by Subject|1
305036|NCT01545388|1032262|P3|Overall Study|Participant moved or relocated|0
305037|NCT01545388|1032263|P2|Overall Study|Participant moved or relocated|0
305038|NCT01545388|1032264|P1|Overall Study|Participant moved or relocated|1
305039|NCT01545388|1032262|P3|Overall Study|Lack of Efficacy|5
305040|NCT01545388|1032263|P2|Overall Study|Lack of Efficacy|2
305041|NCT01545388|1032264|P1|Overall Study|Lack of Efficacy|3
305042|NCT01545388|1032262|P3|Overall Study|Adverse Event|1
305043|NCT01545388|1032263|P2|Overall Study|Adverse Event|4
305044|NCT01545388|1032264|P1|Overall Study|Adverse Event|2
305045|NCT01545375|1032283|P2|Overall Study|Withdrawal by Subject|55
305046|NCT01545375|1032284|P1|Overall Study|Withdrawal by Subject|58
305047|NCT01545375|1032283|P2|Overall Study|Protocol Violation|3
305048|NCT01545375|1032284|P1|Overall Study|Protocol Violation|3
305049|NCT01545375|1032283|P2|Overall Study|Lost to Follow-up|31
305050|NCT01545375|1032284|P1|Overall Study|Lost to Follow-up|34
305051|NCT01545375|1032283|P2|Overall Study|Adverse Event|1
305052|NCT01545375|1032284|P1|Overall Study|Adverse Event|2
305053|NCT01544920|1032412|P2|Overall Study|Withdrawal by Subject|4
305054|NCT01544920|1032413|P1|Overall Study|Withdrawal by Subject|4
305055|NCT01544920|1032412|P2|Overall Study|Physician Decision|1
305056|NCT01544920|1032413|P1|Overall Study|Physician Decision|4
305057|NCT01544920|1032412|P2|Overall Study|Protocol Violation|2
305058|NCT01544920|1032413|P1|Overall Study|Protocol Violation|0
305059|NCT01544920|1032412|P2|Overall Study|Lost to Follow-up|12
305060|NCT01544920|1032413|P1|Overall Study|Lost to Follow-up|11
305061|NCT01544920|1032412|P2|Overall Study|Death|1
305062|NCT01544920|1032413|P1|Overall Study|Death|0
305063|NCT01544920|1032412|P2|Overall Study|Adverse Event|3
305064|NCT01544920|1032413|P1|Overall Study|Adverse Event|0
305065|NCT01544582|1032424|P4|Analysis Population|Participant in Jail|0
305066|NCT01544582|1032425|P3|Analysis Population|Participant in Jail|1
305067|NCT01544582|1032426|P2|Analysis Population|Participant in Jail|0
305068|NCT01544582|1032427|P1|Analysis Population|Participant in Jail|0
305069|NCT01544582|1032424|P4|Analysis Population|Programmed Surgery|0
305070|NCT01544582|1032425|P3|Analysis Population|Programmed Surgery|0
305071|NCT01544582|1032426|P2|Analysis Population|Programmed Surgery|1
305072|NCT01544582|1032427|P1|Analysis Population|Programmed Surgery|0
305073|NCT01544582|1032424|P4|Analysis Population|Poor Participant Compliance|0
305074|NCT01544582|1032425|P3|Analysis Population|Poor Participant Compliance|0
305075|NCT01544582|1032426|P2|Analysis Population|Poor Participant Compliance|1
305076|NCT01544582|1032427|P1|Analysis Population|Poor Participant Compliance|0
305077|NCT01544582|1032424|P4|Analysis Population|Poor Adherence|0
305078|NCT01544582|1032425|P3|Analysis Population|Poor Adherence|1
305079|NCT01544582|1032426|P2|Analysis Population|Poor Adherence|0
305080|NCT01544582|1032427|P1|Analysis Population|Poor Adherence|0
305081|NCT01544582|1032424|P4|Analysis Population|No Social Insurance|0
305082|NCT01544582|1032425|P3|Analysis Population|No Social Insurance|1
305083|NCT01544582|1032426|P2|Analysis Population|No Social Insurance|0
305084|NCT01544582|1032427|P1|Analysis Population|No Social Insurance|0
305085|NCT01544582|1032424|P4|Analysis Population|Liver Transplantation|0
305086|NCT01544582|1032425|P3|Analysis Population|Liver Transplantation|1
305087|NCT01544582|1032426|P2|Analysis Population|Liver Transplantation|0
305088|NCT01544582|1032427|P1|Analysis Population|Liver Transplantation|0
305089|NCT01544582|1032424|P4|Analysis Population|Intolerance|0
305090|NCT01544582|1032425|P3|Analysis Population|Intolerance|0
305091|NCT01544582|1032426|P2|Analysis Population|Intolerance|1
305092|NCT01544582|1032427|P1|Analysis Population|Intolerance|0
305093|NCT01544582|1032424|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
305094|NCT01544582|1032425|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
305095|NCT01544582|1032426|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
305096|NCT01544582|1032427|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
305097|NCT01544582|1032424|P4|Analysis Population|Bad Tolerance to Treatment|0
305098|NCT01544582|1032425|P3|Analysis Population|Bad Tolerance to Treatment|2
305099|NCT01544582|1032426|P2|Analysis Population|Bad Tolerance to Treatment|0
305100|NCT01544582|1032427|P1|Analysis Population|Bad Tolerance to Treatment|0
305101|NCT01544582|1032424|P4|Analysis Population|Lost to Follow-up|5
305102|NCT01544582|1032425|P3|Analysis Population|Lost to Follow-up|6
305103|NCT01544582|1032426|P2|Analysis Population|Lost to Follow-up|6
305104|NCT01544582|1032427|P1|Analysis Population|Lost to Follow-up|0
305105|NCT01544582|1032424|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
305106|NCT01544582|1032425|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
305107|NCT01544582|1032426|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
305108|NCT01544582|1032427|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
305109|NCT01544582|1032424|P4|Analysis Population|Effectiveness Reason|12
305110|NCT01544582|1032425|P3|Analysis Population|Effectiveness Reason|29
305111|NCT01544582|1032426|P2|Analysis Population|Effectiveness Reason|48
305112|NCT01544582|1032427|P1|Analysis Population|Effectiveness Reason|0
305113|NCT01544582|1032424|P4|Analysis Population|Safety Reason|8
305114|NCT01544582|1032425|P3|Analysis Population|Safety Reason|31
305115|NCT01544582|1032426|P2|Analysis Population|Safety Reason|33
305116|NCT01544582|1032427|P1|Analysis Population|Safety Reason|0
305117|NCT01544582|1032424|P4|Analysis Population|Physician Decision|9
305118|NCT01544582|1032425|P3|Analysis Population|Physician Decision|10
305119|NCT01544582|1032426|P2|Analysis Population|Physician Decision|13
305120|NCT01544582|1032427|P1|Analysis Population|Physician Decision|0
305121|NCT01544582|1032424|P4|Analysis Population|Participant Refuses to Continue Study|4
305122|NCT01544582|1032425|P3|Analysis Population|Participant Refuses to Continue Study|17
305123|NCT01544582|1032426|P2|Analysis Population|Participant Refuses to Continue Study|15
305124|NCT01544582|1032427|P1|Analysis Population|Participant Refuses to Continue Study|0
305125|NCT01544582|1032424|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
305126|NCT01544582|1032425|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
305127|NCT01544582|1032426|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
305128|NCT01544582|1032427|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
305129|NCT01544582|1032424|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
305130|NCT01544582|1032425|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
305131|NCT01544582|1032426|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
305132|NCT01544582|1032427|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
305133|NCT01544478|1032485|P1|Overall Study|Withdrawal by Subject|52
305134|NCT01544478|1032485|P1|Overall Study|Pregnancy|1
305135|NCT01544478|1032485|P1|Overall Study|Physician Decision|15
305136|NCT01544478|1032485|P1|Overall Study|Lost to Follow-up|48
305137|NCT01544478|1032485|P1|Overall Study|Death|1
305138|NCT01544478|1032485|P1|Overall Study|Adverse Event|1
305139|NCT01544348|1032528|P8|Overall Study|Physician Decision|0
305140|NCT01544348|1032529|P7|Overall Study|Physician Decision|0
305141|NCT01544348|1032530|P6|Overall Study|Physician Decision|1
305142|NCT01544348|1032531|P5|Overall Study|Physician Decision|0
305143|NCT01544348|1032532|P4|Overall Study|Physician Decision|0
305144|NCT01544348|1032533|P3|Overall Study|Physician Decision|0
305145|NCT01544348|1032534|P2|Overall Study|Physician Decision|0
305146|NCT01544348|1032535|P1|Overall Study|Physician Decision|0
305147|NCT01544348|1032528|P8|Overall Study|Withdrawal by Subject|0
305148|NCT01544348|1032529|P7|Overall Study|Withdrawal by Subject|1
305149|NCT01544348|1032530|P6|Overall Study|Withdrawal by Subject|2
305150|NCT01544348|1032531|P5|Overall Study|Withdrawal by Subject|1
305151|NCT01544348|1032532|P4|Overall Study|Withdrawal by Subject|0
305152|NCT01544348|1032533|P3|Overall Study|Withdrawal by Subject|0
305153|NCT01544348|1032534|P2|Overall Study|Withdrawal by Subject|0
305154|NCT01544348|1032535|P1|Overall Study|Withdrawal by Subject|1
305155|NCT01544348|1032528|P8|Overall Study|Lost to Follow-up|0
305156|NCT01544348|1032529|P7|Overall Study|Lost to Follow-up|1
305157|NCT01544348|1032530|P6|Overall Study|Lost to Follow-up|0
305158|NCT01544348|1032531|P5|Overall Study|Lost to Follow-up|0
305159|NCT01544348|1032532|P4|Overall Study|Lost to Follow-up|0
305160|NCT01544348|1032533|P3|Overall Study|Lost to Follow-up|0
305161|NCT01544348|1032534|P2|Overall Study|Lost to Follow-up|0
305162|NCT01544348|1032535|P1|Overall Study|Lost to Follow-up|1
305163|NCT01544309|1032577|P2|Overall Study|Administered prohibit prior medication|0
305164|NCT01544309|1032578|P1|Overall Study|Administered prohibit prior medication|1
305165|NCT01544309|1032577|P2|Overall Study|Not performed pre-dose examination|2
305166|NCT01544309|1032578|P1|Overall Study|Not performed pre-dose examination|1
305167|NCT01544309|1032577|P2|Overall Study|Physician Decision|1
305168|NCT01544309|1032578|P1|Overall Study|Physician Decision|4
305169|NCT01544309|1032577|P2|Overall Study|Protocol Violation|1
305170|NCT01544309|1032578|P1|Overall Study|Protocol Violation|2
305171|NCT01544309|1032577|P2|Overall Study|Withdrawal by Subject|7
305172|NCT01544309|1032578|P1|Overall Study|Withdrawal by Subject|12
305173|NCT01544179|1032616|P2|Overall Study|Eligibility criteria not fulfilled|0
305174|NCT01544179|1032617|P1|Overall Study|Eligibility criteria not fulfilled|1
305175|NCT01544179|1032616|P2|Overall Study|Withdrawal by Subject|7
305176|NCT01544179|1032617|P1|Overall Study|Withdrawal by Subject|12
305177|NCT01544179|1032616|P2|Overall Study|Adverse Event|1
305178|NCT01544179|1032617|P1|Overall Study|Adverse Event|0
305179|NCT01544179|1032616|P2|Overall Study|Lost to Follow-up|1
305180|NCT01544179|1032617|P1|Overall Study|Lost to Follow-up|0
305181|NCT01544179|1032616|P2|Overall Study|Death|37
305182|NCT01544179|1032617|P1|Overall Study|Death|50
305183|NCT01544153|1032710|P4|Overall Study|Non-smoker|0
305184|NCT01544153|1032711|P3|Overall Study|Non-smoker|1
305185|NCT01544153|1032712|P2|Overall Study|Non-smoker|0
305186|NCT01544153|1032713|P1|Overall Study|Non-smoker|0
305187|NCT01544153|1032710|P4|Overall Study|Under 18|0
305188|NCT01544153|1032711|P3|Overall Study|Under 18|0
305189|NCT01544153|1032712|P2|Overall Study|Under 18|1
305190|NCT01544153|1032713|P1|Overall Study|Under 18|0
305191|NCT01544114|1032730|P3|Overall Study|Protocol Violation|0
305192|NCT01544114|1032731|P2|Overall Study|Protocol Violation|1
305193|NCT01544114|1032732|P1|Overall Study|Protocol Violation|0
305194|NCT01544114|1032730|P3|Overall Study|Adverse Event|2
305195|NCT01544114|1032731|P2|Overall Study|Adverse Event|1
305196|NCT01544114|1032732|P1|Overall Study|Adverse Event|1
305197|NCT01544114|1032730|P3|Overall Study|Lost to Follow-up|0
305198|NCT01544114|1032731|P2|Overall Study|Lost to Follow-up|2
305199|NCT01544114|1032732|P1|Overall Study|Lost to Follow-up|0
305200|NCT01544114|1032730|P3|Overall Study|Withdrawal by Subject|3
305201|NCT01544114|1032731|P2|Overall Study|Withdrawal by Subject|0
305202|NCT01544114|1032732|P1|Overall Study|Withdrawal by Subject|0
305203|NCT01543958|1032815|P1|Overall Study|ART initiation|1
305204|NCT01543958|1032815|P1|Overall Study|Loss to follow-up|3
305205|NCT01543828|1032870|P2|Treatment 2|Lost to Follow-up|0
305206|NCT01543828|1032871|P1|Treatment 2|Lost to Follow-up|1
305207|NCT01543685|1032884|P5|Overall Study|Adverse Event|2
305208|NCT01543685|1032885|P4|Overall Study|Adverse Event|0
305209|NCT01543685|1032886|P3|Overall Study|Adverse Event|0
305210|NCT01543685|1032887|P2|Overall Study|Adverse Event|1
305211|NCT01543685|1032888|P1|Overall Study|Adverse Event|2
305212|NCT01543685|1032884|P5|Overall Study|Lack of Efficacy|2
305213|NCT01543685|1032885|P4|Overall Study|Lack of Efficacy|0
305214|NCT01543685|1032886|P3|Overall Study|Lack of Efficacy|2
305215|NCT01543685|1032887|P2|Overall Study|Lack of Efficacy|2
305216|NCT01543685|1032888|P1|Overall Study|Lack of Efficacy|1
305217|NCT01543503|1032960|P2|Overall Study|Screen failure|0
305218|NCT01543503|1032961|P1|Overall Study|Screen failure|1
305219|NCT01543503|1032960|P2|Overall Study|Participant went to United States|0
305220|NCT01543503|1032961|P1|Overall Study|Participant went to United States|1
305221|NCT01543503|1032960|P2|Overall Study|Participant consented to another study|2
305222|NCT01543503|1032961|P1|Overall Study|Participant consented to another study|0
305223|NCT01543503|1032960|P2|Overall Study|Moved to other rheumatologic site|1
305224|NCT01543503|1032961|P1|Overall Study|Moved to other rheumatologic site|0
305225|NCT01543503|1032960|P2|Overall Study|Participant did not attend a visit|0
305226|NCT01543503|1032961|P1|Overall Study|Participant did not attend a visit|1
305227|NCT01543503|1032960|P2|Overall Study|Site stopped participation|1
305228|NCT01543503|1032961|P1|Overall Study|Site stopped participation|5
305229|NCT01543503|1032960|P2|Overall Study|Participant recruited after closing date|1
305230|NCT01543503|1032961|P1|Overall Study|Participant recruited after closing date|0
305231|NCT01543503|1032960|P2|Overall Study|Investigator did not wish to participate|1
305232|NCT01543503|1032961|P1|Overall Study|Investigator did not wish to participate|1
305233|NCT01543503|1032960|P2|Overall Study|Participant decision to stop treatment|0
305234|NCT01543503|1032961|P1|Overall Study|Participant decision to stop treatment|1
305235|NCT01543503|1032960|P2|Overall Study|Participant moved to Scotland|0
305236|NCT01543503|1032961|P1|Overall Study|Participant moved to Scotland|1
305237|NCT01543503|1032960|P2|Overall Study|Participant transferred to another city|0
305238|NCT01543503|1032961|P1|Overall Study|Participant transferred to another city|1
305239|NCT01543503|1032960|P2|Overall Study|Participant will not return for visits|2
305240|NCT01543503|1032961|P1|Overall Study|Participant will not return for visits|0
305241|NCT01543503|1032960|P2|Overall Study|Participant moved to another city|0
305242|NCT01543503|1032961|P1|Overall Study|Participant moved to another city|2
305243|NCT01543503|1032960|P2|Overall Study|Incorrect medication received|0
305244|NCT01543503|1032961|P1|Overall Study|Incorrect medication received|1
305245|NCT01543503|1032960|P2|Overall Study|Refused to continue treatment|0
305246|NCT01543503|1032961|P1|Overall Study|Refused to continue treatment|7
305247|NCT01543503|1032960|P2|Overall Study|Participant did not complete last visit|2
305248|NCT01543503|1032961|P1|Overall Study|Participant did not complete last visit|0
305249|NCT01543503|1032960|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
305250|NCT01543503|1032961|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
305251|NCT01543503|1032960|P2|Overall Study|Intolerance to the biologic treatment|1
305252|NCT01543503|1032961|P1|Overall Study|Intolerance to the biologic treatment|0
305253|NCT01543503|1032960|P2|Overall Study|Change of jobs|1
305254|NCT01543503|1032961|P1|Overall Study|Change of jobs|0
305255|NCT01543503|1032960|P2|Overall Study|Participant withdrew informed consent|10
305256|NCT01543503|1032961|P1|Overall Study|Participant withdrew informed consent|8
305257|NCT01543503|1032960|P2|Overall Study|Lack of Efficacy|16
305258|NCT01543503|1032961|P1|Overall Study|Lack of Efficacy|4
305259|NCT01543503|1032960|P2|Overall Study|Adverse Event|13
305260|NCT01543503|1032961|P1|Overall Study|Adverse Event|9
305261|NCT01543503|1032960|P2|Overall Study|Lost to Follow-up|36
305262|NCT01543503|1032961|P1|Overall Study|Lost to Follow-up|32
305263|NCT01543204|1033005|P1|Overall Study|Lost to Follow-up|1
305264|NCT01543204|1033005|P1|Overall Study|Requirement for Alternative Therapy|1
305265|NCT01543204|1033005|P1|Overall Study|Withdrawal by Subject|4
305266|NCT01543204|1033005|P1|Overall Study|Adverse Event|1
305267|NCT01543204|1033005|P1|Overall Study|Non-compliance|1
305268|NCT01542788|1033097|P2|Overall Study|Withdrawal by Subject|0
305269|NCT01542788|1033098|P1|Overall Study|Withdrawal by Subject|1
305270|NCT01542788|1033097|P2|Overall Study|Physician Decision|0
305271|NCT01542788|1033098|P1|Overall Study|Physician Decision|1
305272|NCT01542788|1033097|P2|Overall Study|Protocol Violation|0
305273|NCT01542788|1033098|P1|Overall Study|Protocol Violation|2
305274|NCT01542788|1033097|P2|Overall Study|Death|0
305275|NCT01542788|1033098|P1|Overall Study|Death|3
305276|NCT01542788|1033097|P2|Overall Study|Lost to Follow-up|0
305277|NCT01542788|1033098|P1|Overall Study|Lost to Follow-up|5
305278|NCT01542788|1033097|P2|Overall Study|Lack of Efficacy|71
305279|NCT01542788|1033098|P1|Overall Study|Lack of Efficacy|41
305280|NCT01542788|1033097|P2|Overall Study|Randomized but Not Treated|0
305281|NCT01542788|1033098|P1|Overall Study|Randomized but Not Treated|2
305282|NCT01542632|1033137|P6|Overall Study|Sponsor/Investigator Decision|0
305283|NCT01542632|1033138|P5|Overall Study|Sponsor/Investigator Decision|1
305284|NCT01542632|1033139|P4|Overall Study|Sponsor/Investigator Decision|0
305285|NCT01542632|1033140|P3|Overall Study|Sponsor/Investigator Decision|0
305286|NCT01542632|1033141|P2|Overall Study|Sponsor/Investigator Decision|0
305287|NCT01542632|1033142|P1|Overall Study|Sponsor/Investigator Decision|0
305288|NCT01542632|1033137|P6|Overall Study|Lost to Follow-up|0
305289|NCT01542632|1033138|P5|Overall Study|Lost to Follow-up|0
305290|NCT01542632|1033139|P4|Overall Study|Lost to Follow-up|0
305291|NCT01542632|1033140|P3|Overall Study|Lost to Follow-up|0
305292|NCT01542632|1033141|P2|Overall Study|Lost to Follow-up|1
305293|NCT01542632|1033142|P1|Overall Study|Lost to Follow-up|0
305294|NCT01542632|1033137|P6|Overall Study|Adverse Event|0
305295|NCT01542632|1033138|P5|Overall Study|Adverse Event|0
305296|NCT01542632|1033139|P4|Overall Study|Adverse Event|0
305297|NCT01542632|1033140|P3|Overall Study|Adverse Event|1
305298|NCT01542632|1033141|P2|Overall Study|Adverse Event|0
305299|NCT01542632|1033142|P1|Overall Study|Adverse Event|0
305300|NCT01542632|1033137|P6|Overall Study|Withdrawal of Consent|0
305301|NCT01542632|1033138|P5|Overall Study|Withdrawal of Consent|3
305302|NCT01542632|1033139|P4|Overall Study|Withdrawal of Consent|2
305303|NCT01542632|1033140|P3|Overall Study|Withdrawal of Consent|0
305304|NCT01542632|1033141|P2|Overall Study|Withdrawal of Consent|0
305305|NCT01542632|1033142|P1|Overall Study|Withdrawal of Consent|0
305306|NCT01542528|1033199|P2|Overall Study|Withdrawal by Subject|6
305307|NCT01542528|1033200|P1|Overall Study|Withdrawal by Subject|9
305308|NCT01542528|1033199|P2|Overall Study|Physician Decision|0
305309|NCT01542528|1033200|P1|Overall Study|Physician Decision|1
305310|NCT01542528|1033199|P2|Overall Study|Lost to Follow-up|1
305311|NCT01542528|1033200|P1|Overall Study|Lost to Follow-up|2
305312|NCT01542034|1033269|P2|Overall Study|Lost to Follow-up|6
305313|NCT01542034|1033270|P1|Overall Study|Lost to Follow-up|7
305314|NCT01542034|1033269|P2|Overall Study|Adverse Event|2
305315|NCT01542034|1033270|P1|Overall Study|Adverse Event|2
305316|NCT01542034|1033269|P2|Overall Study|Subject Noncompliance|0
305317|NCT01542034|1033270|P1|Overall Study|Subject Noncompliance|1
305318|NCT01542034|1033269|P2|Overall Study|Administrative decision|3
305319|NCT01542034|1033270|P1|Overall Study|Administrative decision|0
305320|NCT01542034|1033269|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
305321|NCT01542034|1033270|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
305322|NCT01541969|1033284|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
305323|NCT01541969|1033285|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
305324|NCT01541969|1033284|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
305325|NCT01541969|1033285|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
305326|NCT01541969|1033284|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
305327|NCT01541969|1033285|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
305328|NCT01541969|1033284|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
305329|NCT01541969|1033285|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
305330|NCT01541969|1033284|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
305331|NCT01541969|1033285|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
305332|NCT01541969|1033284|P2|Double-blind (0-12 Weeks)|Adverse Event|0
305333|NCT01541969|1033285|P1|Double-blind (0-12 Weeks)|Adverse Event|2
305334|NCT01541969|1033284|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
305335|NCT01541969|1033285|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
305336|NCT01541969|1033284|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
305337|NCT01541969|1033285|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
305338|NCT01541969|1033284|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
305339|NCT01541969|1033285|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
305340|NCT01541969|1033284|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
305341|NCT01541969|1033285|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
305342|NCT01541930|1033301|P1|Overall Study|Withdrawal by Subject|1
305343|NCT01541917|1033323|P2|Overall Study|Withdrawal by Subject|7
305344|NCT01541917|1033324|P1|Overall Study|Withdrawal by Subject|13
305345|NCT01541917|1033323|P2|Overall Study|Lost to Follow-up|2
305346|NCT01541917|1033324|P1|Overall Study|Lost to Follow-up|2
305347|NCT01541865|1033340|P1|Overall Study|Protocol Violation|1
305348|NCT01541865|1033340|P1|Overall Study|Adverse Event|1
305349|NCT01541865|1033340|P1|Overall Study|Withdrawal by Subject|9
305350|NCT01541865|1033340|P1|Overall Study|Lost to Follow-up|11
305351|NCT01541826|1033358|P3|Overall Study|Withdrawal by Subject|0
305352|NCT01541826|1033359|P2|Overall Study|Withdrawal by Subject|0
305353|NCT01541826|1033360|P1|Overall Study|Withdrawal by Subject|2
305354|NCT01541826|1033358|P3|Overall Study|Lost to Follow-up|0
305355|NCT01541826|1033359|P2|Overall Study|Lost to Follow-up|3
305356|NCT01541826|1033360|P1|Overall Study|Lost to Follow-up|2
305357|NCT01541644|1033442|P1|Overall Study|Withdrawal by Subject|3
305358|NCT01541397|1033461|P2|Overall Study|Study ended prior to data collection|2
305359|NCT01541397|1033462|P1|Overall Study|Study ended prior to data collection|4
305360|NCT01541371|1033487|P1|Overall Study|Other|6
305361|NCT01541371|1033487|P1|Overall Study|Study medication non-compliance|3
305362|NCT01541371|1033487|P1|Overall Study|Protocol Violation|6
305363|NCT01541371|1033487|P1|Overall Study|Lack of Efficacy|12
305364|NCT01541371|1033487|P1|Overall Study|Adverse Event|15
305365|NCT01541371|1033487|P1|Overall Study|Lost to Follow-up|21
305366|NCT01541371|1033487|P1|Overall Study|Withdrawal by Subject|14
305367|NCT01541254|1033516|P1|Overall Study|alternate stent used|1
305368|NCT01541254|1033516|P1|Overall Study|stent not required|1
305369|NCT01541254|1033516|P1|Overall Study|GI bleed prior to procedure|1
305370|NCT01541254|1033516|P1|Overall Study|enrolled after study closed|1
305371|NCT01541254|1033516|P1|Overall Study|excluded - metal allergy|1
305372|NCT01541254|1033516|P1|Overall Study|Withdrawal by Subject|1
305373|NCT01540981|1033523|P2|Overall Study|Withdrawal by Subject|0
305374|NCT01540981|1033524|P1|Overall Study|Withdrawal by Subject|1
305375|NCT01540851|1033534|P2|Overall Study|Withdrawal by Subject|3
305376|NCT01540851|1033535|P1|Overall Study|Withdrawal by Subject|7
305377|NCT01540851|1033534|P2|Overall Study|Lost to Follow-up|15
305378|NCT01540851|1033535|P1|Overall Study|Lost to Follow-up|14
305379|NCT01540487|1033680|P2|Overall Study|Protocol Violation|0
305380|NCT01540487|1033681|P1|Overall Study|Protocol Violation|1
305381|NCT01539759|1033816|P2|Overall Study|Lost to Follow-up|8
305382|NCT01539759|1033817|P1|Overall Study|Lost to Follow-up|6
305383|NCT01539642|1033829|P2|Overall Study|Withdrawal by Subject|2
305384|NCT01539642|1033830|P1|Overall Study|Withdrawal by Subject|2
305385|NCT01539642|1033829|P2|Overall Study|Adverse Event|4
305386|NCT01539642|1033830|P1|Overall Study|Adverse Event|6
305387|NCT01539642|1033829|P2|Overall Study|Patient ready for early discharge|7
305388|NCT01539642|1033830|P1|Overall Study|Patient ready for early discharge|8
305389|NCT01539642|1033829|P2|Overall Study|Lack of Efficacy|18
305390|NCT01539642|1033830|P1|Overall Study|Lack of Efficacy|20
305391|NCT01539538|1033847|P2|Overall Study|PCA no longer required or PCA problem|7
305392|NCT01539538|1033848|P1|Overall Study|PCA no longer required or PCA problem|3
305393|NCT01539538|1033847|P2|Overall Study|Withdrawal by Subject|3
305394|NCT01539538|1033848|P1|Overall Study|Withdrawal by Subject|2
305395|NCT01539538|1033847|P2|Overall Study|Lack of Efficacy|16
305396|NCT01539538|1033848|P1|Overall Study|Lack of Efficacy|13
305397|NCT01539538|1033847|P2|Overall Study|Adverse Event|18
305398|NCT01539538|1033848|P1|Overall Study|Adverse Event|13
305399|NCT01539525|1033857|P3|Overall Study|Protocol Violation|4
305400|NCT01539525|1033858|P2|Overall Study|Protocol Violation|1
305401|NCT01539525|1033859|P1|Overall Study|Protocol Violation|1
305402|NCT01539525|1033857|P3|Overall Study|Withdrawal by Subject|2
305403|NCT01539525|1033858|P2|Overall Study|Withdrawal by Subject|3
305404|NCT01539525|1033859|P1|Overall Study|Withdrawal by Subject|0
305405|NCT01539525|1033857|P3|Overall Study|Lost to Follow-up|11
305406|NCT01539525|1033858|P2|Overall Study|Lost to Follow-up|12
305407|NCT01539525|1033859|P1|Overall Study|Lost to Follow-up|19
305408|NCT01539512|1033878|P2|Overall Study|Richter's Transformation|0
305409|NCT01539512|1033879|P1|Overall Study|Richter's Transformation|1
305410|NCT01539512|1033878|P2|Overall Study|Withdrawal by Subject|5
305411|NCT01539512|1033879|P1|Overall Study|Withdrawal by Subject|12
305412|NCT01539512|1033878|P2|Overall Study|Physician Decision|1
305413|NCT01539512|1033879|P1|Overall Study|Physician Decision|1
305414|NCT01539512|1033878|P2|Overall Study|Adverse Event|7
305415|NCT01539512|1033879|P1|Overall Study|Adverse Event|9
305416|NCT01539317|1033895|P2|Overall Study|Screening Error. Deleted from analysis.|0
305417|NCT01539317|1033896|P1|Overall Study|Screening Error. Deleted from analysis.|1
305418|NCT01539083|1033926|P3|After Randomization (TP and VTP)|Progressive Disease|2
305419|NCT01539083|1033927|P2|After Randomization (TP and VTP)|Progressive Disease|3
305420|NCT01539083|1033928|P1|After Randomization (TP and VTP)|Progressive Disease|0
305421|NCT01539083|1033926|P3|After Randomization (TP and VTP)|Death|6
305422|NCT01539083|1033927|P2|After Randomization (TP and VTP)|Death|4
305423|NCT01539083|1033928|P1|After Randomization (TP and VTP)|Death|0
305424|NCT01539083|1033926|P3|After Randomization (TP and VTP)|Adverse Event|0
305425|NCT01539083|1033927|P2|After Randomization (TP and VTP)|Adverse Event|1
305426|NCT01539083|1033928|P1|After Randomization (TP and VTP)|Adverse Event|0
305427|NCT01539083|1033926|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
305428|NCT01539083|1033927|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
305429|NCT01539083|1033928|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
305430|NCT01539083|1033926|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
305431|NCT01539083|1033927|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
305432|NCT01539083|1033928|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
305433|NCT01539083|1033926|P3|Before Randomization (VCD Induction)|Other|0
305434|NCT01539083|1033927|P2|Before Randomization (VCD Induction)|Other|0
305435|NCT01539083|1033928|P1|Before Randomization (VCD Induction)|Other|5
305436|NCT01539083|1033926|P3|Before Randomization (VCD Induction)|Progressive Disease|0
305437|NCT01539083|1033927|P2|Before Randomization (VCD Induction)|Progressive Disease|0
305438|NCT01539083|1033928|P1|Before Randomization (VCD Induction)|Progressive Disease|8
305439|NCT01539083|1033926|P3|Before Randomization (VCD Induction)|Physician Decision|0
305440|NCT01539083|1033927|P2|Before Randomization (VCD Induction)|Physician Decision|0
305441|NCT01539083|1033928|P1|Before Randomization (VCD Induction)|Physician Decision|14
305442|NCT01539083|1033926|P3|Before Randomization (VCD Induction)|Protocol Violation|0
305443|NCT01539083|1033927|P2|Before Randomization (VCD Induction)|Protocol Violation|0
305444|NCT01539083|1033928|P1|Before Randomization (VCD Induction)|Protocol Violation|2
305445|NCT01539083|1033926|P3|Before Randomization (VCD Induction)|Death|0
305446|NCT01539083|1033927|P2|Before Randomization (VCD Induction)|Death|0
305447|NCT01539083|1033928|P1|Before Randomization (VCD Induction)|Death|6
305448|NCT01539083|1033926|P3|Before Randomization (VCD Induction)|Adverse Event|0
305449|NCT01539083|1033927|P2|Before Randomization (VCD Induction)|Adverse Event|0
305450|NCT01539083|1033928|P1|Before Randomization (VCD Induction)|Adverse Event|14
305451|NCT01539083|1033926|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
305452|NCT01539083|1033927|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
305453|NCT01539083|1033928|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
305454|NCT01538719|1033972|P2|Overall Study|Lost to Follow-up|0
305455|NCT01538719|1033973|P1|Overall Study|Lost to Follow-up|2
305456|NCT01538472|1033996|P1|Overall Study|Death|1
305457|NCT01538472|1033996|P1|Overall Study|Disease Progression|3
305458|NCT01538199|1034007|P4|Overall Study|Lack of Efficacy|0
305459|NCT01538199|1034008|P3|Overall Study|Lack of Efficacy|0
305460|NCT01538199|1034009|P2|Overall Study|Lack of Efficacy|1
305461|NCT01538199|1034010|P1|Overall Study|Lack of Efficacy|0
305462|NCT01538199|1034007|P4|Overall Study|participant did not have time|2
305463|NCT01538199|1034008|P3|Overall Study|participant did not have time|0
305464|NCT01538199|1034009|P2|Overall Study|participant did not have time|0
305465|NCT01538199|1034010|P1|Overall Study|participant did not have time|1
305466|NCT01538199|1034007|P4|Overall Study|Lost to Follow-up|0
305467|NCT01538199|1034008|P3|Overall Study|Lost to Follow-up|1
305468|NCT01538199|1034009|P2|Overall Study|Lost to Follow-up|2
305469|NCT01538199|1034010|P1|Overall Study|Lost to Follow-up|1
305470|NCT01537783|1034062|P2|Overall Study|Lost to Follow-up|2
305471|NCT01537783|1034063|P1|Overall Study|Lost to Follow-up|11
305472|NCT01537549|1034114|P1|Overall Study|Withdrawal by Subject|2
305473|NCT01537549|1034114|P1|Overall Study|Lost to Follow-up|1
305474|NCT01537432|1034122|P2|Overall Study|Unsatisfactory therapeutic effect|0
305475|NCT01537432|1034123|P1|Overall Study|Unsatisfactory therapeutic effect|1
305476|NCT01537432|1034122|P2|Overall Study|Adverse Event|0
305477|NCT01537432|1034123|P1|Overall Study|Adverse Event|1
305478|NCT01537432|1034122|P2|Overall Study|Administrative problems|0
305479|NCT01537432|1034123|P1|Overall Study|Administrative problems|1
305480|NCT01537432|1034122|P2|Overall Study|Withdrawal by Subject|1
305481|NCT01537432|1034123|P1|Overall Study|Withdrawal by Subject|0
305482|NCT01537432|1034122|P2|Overall Study|Lost to Follow-up|1
305483|NCT01537432|1034123|P1|Overall Study|Lost to Follow-up|3
305484|NCT01537393|1034146|P2|Overall Study|Censored (severe event unrelated to PT)|1
305485|NCT01537393|1034147|P1|Overall Study|Censored (severe event unrelated to PT)|1
305486|NCT01537393|1034146|P2|Overall Study|Failure - Not regrafted|6
305487|NCT01537393|1034147|P1|Overall Study|Failure - Not regrafted|2
305488|NCT01537393|1034146|P2|Overall Study|Failure - Regrafted|43
305489|NCT01537393|1034147|P1|Overall Study|Failure - Regrafted|28
305490|NCT01537393|1034146|P2|Overall Study|Lost to Follow-up|48
305491|NCT01537393|1034147|P1|Overall Study|Lost to Follow-up|53
305492|NCT01537393|1034146|P2|Overall Study|Withdrawal by Subject|17
305493|NCT01537393|1034147|P1|Overall Study|Withdrawal by Subject|18
305494|NCT01537393|1034146|P2|Overall Study|Death|32
305495|NCT01537393|1034147|P1|Overall Study|Death|20
305496|NCT01537393|1034146|P2|Overall Study|Exclude prior to study|44
305497|NCT01537393|1034147|P1|Overall Study|Exclude prior to study|32
305498|NCT01537302|1034183|P1|Overall Study|Withdrawal by Subject|1
305499|NCT01537302|1034183|P1|Overall Study|Lost to Follow-up|1
305500|NCT01537198|1034190|P1|Overall Study|Not Specified|111
305501|NCT01537198|1034190|P1|Overall Study|No Further Visits to the Clinic|37
305502|NCT01537198|1034190|P1|Overall Study|Adverse Event|4
305503|NCT01537198|1034190|P1|Overall Study|RSV infection|2
305504|NCT01537133|1034219|P4|Overall Study|Lost to Follow-up|0
305505|NCT01537133|1034220|P3|Overall Study|Lost to Follow-up|0
305506|NCT01537133|1034221|P2|Overall Study|Lost to Follow-up|0
305507|NCT01537133|1034222|P1|Overall Study|Lost to Follow-up|1
305508|NCT01537133|1034219|P4|Overall Study|Withdrawal by Subject|0
305509|NCT01537133|1034220|P3|Overall Study|Withdrawal by Subject|0
305510|NCT01537133|1034221|P2|Overall Study|Withdrawal by Subject|0
305511|NCT01537133|1034222|P1|Overall Study|Withdrawal by Subject|2
305512|NCT01537120|1034238|P1|3 Weeks Placebo|Withdrawal by Subject|1
305513|NCT01537120|1034238|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
305514|NCT01537081|1034251|P3|Overall Study|Assigned but never dosed|0
305515|NCT01537081|1034252|P2|Overall Study|Assigned but never dosed|0
305516|NCT01537081|1034253|P1|Overall Study|Assigned but never dosed|1
305517|NCT01537081|1034251|P3|Overall Study|Sponsor decision|0
305518|NCT01537081|1034252|P2|Overall Study|Sponsor decision|1
305519|NCT01537081|1034253|P1|Overall Study|Sponsor decision|0
305520|NCT01537081|1034251|P3|Overall Study|Physician Decision|0
305521|NCT01537081|1034252|P2|Overall Study|Physician Decision|6
305522|NCT01537081|1034253|P1|Overall Study|Physician Decision|5
305523|NCT01537081|1034251|P3|Overall Study|Withdrawal by Subject|3
305524|NCT01537081|1034252|P2|Overall Study|Withdrawal by Subject|11
305525|NCT01537081|1034253|P1|Overall Study|Withdrawal by Subject|6
305526|NCT01537081|1034251|P3|Overall Study|Protocol Violation|2
305527|NCT01537081|1034252|P2|Overall Study|Protocol Violation|2
305528|NCT01537081|1034253|P1|Overall Study|Protocol Violation|3
305529|NCT01537081|1034251|P3|Overall Study|Lost to Follow-up|9
305530|NCT01537081|1034252|P2|Overall Study|Lost to Follow-up|15
305531|NCT01537081|1034253|P1|Overall Study|Lost to Follow-up|17
305532|NCT01537081|1034251|P3|Overall Study|Lack of Efficacy|0
305533|NCT01537081|1034252|P2|Overall Study|Lack of Efficacy|1
305534|NCT01537081|1034253|P1|Overall Study|Lack of Efficacy|2
305535|NCT01537081|1034251|P3|Overall Study|Adverse Event|2
305536|NCT01537081|1034252|P2|Overall Study|Adverse Event|2
305537|NCT01537081|1034253|P1|Overall Study|Adverse Event|5
305538|NCT01537068|1034266|P2|Overall Study|Lack of Efficacy|0
305539|NCT01537068|1034267|P1|Overall Study|Lack of Efficacy|1
305540|NCT01537068|1034266|P2|Overall Study|Withdrawal by Subject|1
305541|NCT01537068|1034267|P1|Overall Study|Withdrawal by Subject|1
305542|NCT01537068|1034266|P2|Overall Study|Adverse Event|1
305543|NCT01537068|1034267|P1|Overall Study|Adverse Event|0
305544|NCT01537068|1034266|P2|Overall Study|Lost to Follow-up|1
305545|NCT01537068|1034267|P1|Overall Study|Lost to Follow-up|2
305546|NCT01537042|1034279|P2|Overall Study|Other|1
305547|NCT01537042|1034280|P1|Overall Study|Other|0
305548|NCT01537042|1034279|P2|Overall Study|Protocol Violation|1
305549|NCT01537042|1034280|P1|Overall Study|Protocol Violation|0
305550|NCT01537042|1034279|P2|Overall Study|Lack of Efficacy|1
305551|NCT01537042|1034280|P1|Overall Study|Lack of Efficacy|0
305552|NCT01537042|1034279|P2|Overall Study|Adverse Event|2
305553|NCT01537042|1034280|P1|Overall Study|Adverse Event|0
305554|NCT01536951|1034318|P9|Second Intervention and Washout Period 2|Adverse Event|0
305555|NCT01536951|1034319|P8|Second Intervention and Washout Period 2|Adverse Event|1
305556|NCT01536951|1034320|P7|Second Intervention and Washout Period 2|Adverse Event|0
305557|NCT01536951|1034321|P6|Second Intervention and Washout Period 2|Adverse Event|0
305558|NCT01536951|1034322|P5|Second Intervention and Washout Period 2|Adverse Event|0
305559|NCT01536951|1034323|P4|Second Intervention and Washout Period 2|Adverse Event|0
305560|NCT01536951|1034324|P3|Second Intervention and Washout Period 2|Adverse Event|0
305561|NCT01536951|1034325|P2|Second Intervention and Washout Period 2|Adverse Event|0
305562|NCT01536951|1034326|P1|Second Intervention and Washout Period 2|Adverse Event|0
305563|NCT01536951|1034318|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
305564|NCT01536951|1034319|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
305565|NCT01536951|1034320|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
305566|NCT01536951|1034321|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
305567|NCT01536951|1034322|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
305568|NCT01536951|1034323|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
305569|NCT01536951|1034324|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
305570|NCT01536951|1034325|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
305571|NCT01536951|1034326|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
305572|NCT01536860|1034383|P3|Washout Period (3 Days)|Lost to Follow-up|0
305573|NCT01536860|1034384|P2|Washout Period (3 Days)|Lost to Follow-up|0
305574|NCT01536860|1034385|P1|Washout Period (3 Days)|Lost to Follow-up|1
305575|NCT01536704|1034393|P4|Washout Period 3|Adverse Event|0
305576|NCT01536704|1034394|P3|Washout Period 3|Adverse Event|1
305577|NCT01536704|1034395|P2|Washout Period 3|Adverse Event|0
305578|NCT01536704|1034396|P1|Washout Period 3|Adverse Event|0
305579|NCT01536704|1034393|P4|Period 3|Adverse Event|1
305580|NCT01536704|1034394|P3|Period 3|Adverse Event|0
305581|NCT01536704|1034395|P2|Period 3|Adverse Event|0
305582|NCT01536704|1034396|P1|Period 3|Adverse Event|0
305583|NCT01536704|1034393|P4|Washout Period 2|Withdrawal by Subject|1
305584|NCT01536704|1034394|P3|Washout Period 2|Withdrawal by Subject|0
305585|NCT01536704|1034395|P2|Washout Period 2|Withdrawal by Subject|0
305586|NCT01536704|1034396|P1|Washout Period 2|Withdrawal by Subject|0
305587|NCT01536704|1034393|P4|Washout Period 2|Adverse Event|0
305588|NCT01536704|1034394|P3|Washout Period 2|Adverse Event|0
305589|NCT01536704|1034395|P2|Washout Period 2|Adverse Event|0
305590|NCT01536704|1034396|P1|Washout Period 2|Adverse Event|1
305591|NCT01536704|1034393|P4|Washout Period 1|Withdrawal by Subject|0
305592|NCT01536704|1034394|P3|Washout Period 1|Withdrawal by Subject|0
305593|NCT01536704|1034395|P2|Washout Period 1|Withdrawal by Subject|2
305594|NCT01536704|1034396|P1|Washout Period 1|Withdrawal by Subject|1
305595|NCT01536587|1034426|P1|Overall Study|Adverse Event|2
305596|NCT01536574|1034465|P2|Overall Study|Lack of Efficacy|0
305597|NCT01536574|1034466|P1|Overall Study|Lack of Efficacy|1
305598|NCT01536574|1034465|P2|Overall Study|Withdrawal by Subject|2
305599|NCT01536574|1034466|P1|Overall Study|Withdrawal by Subject|1
305600|NCT01536574|1034465|P2|Overall Study|Adverse Event|5
305601|NCT01536574|1034466|P1|Overall Study|Adverse Event|4
305602|NCT01536561|1034484|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
305603|NCT01536561|1034484|P1|Dosimetric and Therapeutic Treatment|Death|2
305604|NCT01536561|1034484|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
305605|NCT01536561|1034484|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
305606|NCT01536561|1034484|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
305607|NCT01536561|1034484|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
305608|NCT01536418|1034561|P2|Overall Study|Withdrawal by Subject|3
305609|NCT01536418|1034562|P1|Overall Study|Withdrawal by Subject|5
305610|NCT01536418|1034561|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
305611|NCT01536418|1034562|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
305612|NCT01536418|1034561|P2|Overall Study|Adverse Event|4
305613|NCT01536418|1034562|P1|Overall Study|Adverse Event|9
305614|NCT01536418|1034561|P2|Overall Study|Lack of Efficacy|16
305615|NCT01536418|1034562|P1|Overall Study|Lack of Efficacy|10
305616|NCT01536418|1034561|P2|Overall Study|Study closed/terminated|37
305617|NCT01536418|1034562|P1|Overall Study|Study closed/terminated|41
305618|NCT01536418|1034561|P2|Overall Study|Physician Decision|3
305619|NCT01536418|1034562|P1|Overall Study|Physician Decision|1
305620|NCT01536418|1034561|P2|Overall Study|Protocol Violation|3
305621|NCT01536418|1034562|P1|Overall Study|Protocol Violation|2
305622|NCT01536405|1034582|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
305623|NCT01536405|1034583|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
305624|NCT01536405|1034582|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
305625|NCT01536405|1034583|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
305626|NCT01536405|1034582|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
305627|NCT01536405|1034583|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
305628|NCT01536405|1034582|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
305629|NCT01536405|1034583|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
305630|NCT01536405|1034582|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
305631|NCT01536405|1034583|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
305632|NCT01536405|1034582|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
305633|NCT01536405|1034583|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
305634|NCT01536405|1034582|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
305635|NCT01536405|1034583|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
305636|NCT01536405|1034582|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
305637|NCT01536405|1034583|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
305638|NCT01536405|1034582|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
305639|NCT01536405|1034583|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
305640|NCT01536405|1034582|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
305641|NCT01536405|1034583|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
305642|NCT01536405|1034582|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
305643|NCT01536405|1034583|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
305644|NCT01536405|1034582|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
305645|NCT01536405|1034583|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
305646|NCT01536405|1034582|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
305647|NCT01536405|1034583|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
305648|NCT01536379|1034621|P2|Overall Study|Withdrawal by Subject|1
305649|NCT01536379|1034622|P1|Overall Study|Withdrawal by Subject|1
305650|NCT01536379|1034621|P2|Overall Study|Adverse Event|2
305651|NCT01536379|1034622|P1|Overall Study|Adverse Event|1
305652|NCT01536262|1034714|P3|Overall Study|Other than stated above|0
305653|NCT01536262|1034715|P2|Overall Study|Other than stated above|0
305654|NCT01536262|1034716|P1|Overall Study|Other than stated above|1
305655|NCT01536262|1034714|P3|Overall Study|Withdrawal by Subject|0
305656|NCT01536262|1034715|P2|Overall Study|Withdrawal by Subject|1
305657|NCT01536262|1034716|P1|Overall Study|Withdrawal by Subject|1
305658|NCT01536262|1034714|P3|Overall Study|Adverse Event|2
305659|NCT01536262|1034715|P2|Overall Study|Adverse Event|1
305660|NCT01536262|1034716|P1|Overall Study|Adverse Event|6
305661|NCT01536171|1034758|P1|Overall Study|Withdrawal by Subject|1
305662|NCT01536145|1034763|P11|Overall Study|Adverse Event|3
305663|NCT01536145|1034764|P10|Overall Study|Adverse Event|0
305664|NCT01536145|1034765|P9|Overall Study|Adverse Event|0
305665|NCT01536145|1034766|P8|Overall Study|Adverse Event|2
305666|NCT01536145|1034767|P7|Overall Study|Adverse Event|0
305667|NCT01536145|1034768|P6|Overall Study|Adverse Event|0
305668|NCT01536145|1034769|P5|Overall Study|Adverse Event|0
305669|NCT01536145|1034770|P4|Overall Study|Adverse Event|0
305670|NCT01536145|1034771|P3|Overall Study|Adverse Event|0
305671|NCT01536145|1034772|P2|Overall Study|Adverse Event|0
305672|NCT01536145|1034773|P1|Overall Study|Adverse Event|0
305673|NCT01536145|1034763|P11|Overall Study|Death|0
305674|NCT01536145|1034764|P10|Overall Study|Death|0
305675|NCT01536145|1034765|P9|Overall Study|Death|0
305676|NCT01536145|1034766|P8|Overall Study|Death|0
305677|NCT01536145|1034767|P7|Overall Study|Death|1
305678|NCT01536145|1034768|P6|Overall Study|Death|0
305679|NCT01536145|1034769|P5|Overall Study|Death|0
305680|NCT01536145|1034770|P4|Overall Study|Death|0
305681|NCT01536145|1034771|P3|Overall Study|Death|0
305682|NCT01536145|1034772|P2|Overall Study|Death|0
305683|NCT01536145|1034773|P1|Overall Study|Death|0
305684|NCT01536145|1034763|P11|Overall Study|Other|2
305685|NCT01536145|1034764|P10|Overall Study|Other|3
305686|NCT01536145|1034765|P9|Overall Study|Other|0
305687|NCT01536145|1034766|P8|Overall Study|Other|0
305688|NCT01536145|1034767|P7|Overall Study|Other|0
305689|NCT01536145|1034768|P6|Overall Study|Other|0
305690|NCT01536145|1034769|P5|Overall Study|Other|1
305691|NCT01536145|1034770|P4|Overall Study|Other|0
305692|NCT01536145|1034771|P3|Overall Study|Other|0
305693|NCT01536145|1034772|P2|Overall Study|Other|0
305694|NCT01536145|1034773|P1|Overall Study|Other|0
305695|NCT01536145|1034763|P11|Overall Study|Withdrawal by Subject|2
305696|NCT01536145|1034764|P10|Overall Study|Withdrawal by Subject|0
305697|NCT01536145|1034765|P9|Overall Study|Withdrawal by Subject|2
305698|NCT01536145|1034766|P8|Overall Study|Withdrawal by Subject|0
305699|NCT01536145|1034767|P7|Overall Study|Withdrawal by Subject|0
305700|NCT01536145|1034768|P6|Overall Study|Withdrawal by Subject|1
305701|NCT01536145|1034769|P5|Overall Study|Withdrawal by Subject|0
305702|NCT01536145|1034770|P4|Overall Study|Withdrawal by Subject|0
305703|NCT01536145|1034771|P3|Overall Study|Withdrawal by Subject|1
305704|NCT01536145|1034772|P2|Overall Study|Withdrawal by Subject|0
305705|NCT01536145|1034773|P1|Overall Study|Withdrawal by Subject|0
305706|NCT01536145|1034763|P11|Overall Study|Progressive disease|3
305707|NCT01536145|1034764|P10|Overall Study|Progressive disease|3
305708|NCT01536145|1034765|P9|Overall Study|Progressive disease|1
305709|NCT01536145|1034766|P8|Overall Study|Progressive disease|2
305710|NCT01536145|1034767|P7|Overall Study|Progressive disease|1
305711|NCT01536145|1034768|P6|Overall Study|Progressive disease|2
305712|NCT01536145|1034769|P5|Overall Study|Progressive disease|1
305713|NCT01536145|1034770|P4|Overall Study|Progressive disease|2
305714|NCT01536145|1034771|P3|Overall Study|Progressive disease|1
305715|NCT01536145|1034772|P2|Overall Study|Progressive disease|4
305716|NCT01536145|1034773|P1|Overall Study|Progressive disease|3
305717|NCT01536119|1034880|P2|Overall Study|Lost to Follow-up|14
305718|NCT01536119|1034881|P1|Overall Study|Lost to Follow-up|17
305719|NCT01536093|1034907|P2|Overall Study|Withdrawal by Subject|1
305720|NCT01536093|1034908|P1|Overall Study|Withdrawal by Subject|0
305721|NCT01536093|1034907|P2|Overall Study|absence of maternal colostrum|0
305722|NCT01536093|1034908|P1|Overall Study|absence of maternal colostrum|2
305723|NCT01536093|1034907|P2|Overall Study|Death|2
305724|NCT01536093|1034908|P1|Overall Study|Death|1
305725|NCT01536067|1034924|P1|Overall Study|Disease Progression|1
305726|NCT01536015|1034937|P2|Overall Study|Study closure|5
305727|NCT01536015|1034938|P1|Overall Study|Study closure|5
305728|NCT01536015|1034937|P2|Overall Study|Inclusion Criterion not met|0
305729|NCT01536015|1034938|P1|Overall Study|Inclusion Criterion not met|2
305730|NCT01536015|1034937|P2|Overall Study|Lost to Follow-up|1
305731|NCT01536015|1034938|P1|Overall Study|Lost to Follow-up|0
305732|NCT01536015|1034937|P2|Overall Study|Adverse Event|4
305733|NCT01536015|1034938|P1|Overall Study|Adverse Event|1
305734|NCT01535807|1034965|P2|Overall Study|Data collection error|1
305735|NCT01535807|1034966|P1|Overall Study|Data collection error|1
305736|NCT01535807|1034965|P2|Overall Study|Withdrawal by Subject|1
305737|NCT01535807|1034966|P1|Overall Study|Withdrawal by Subject|1
305738|NCT01535729|1034972|P1|Overall Study|No participant record available|5
305739|NCT01535729|1034972|P1|Overall Study|Not treated|9
305740|NCT01535729|1034972|P1|Overall Study|Screening failure|1
305741|NCT01535729|1034972|P1|Overall Study|Protocol Violation|11
305742|NCT01535729|1034972|P1|Overall Study|NSCLC grade IV histology not confirmed|20
305743|NCT01535729|1034972|P1|Overall Study|No previous chemotherapy|33
305744|NCT01535729|1034972|P1|Overall Study|Did not sign informed consent|1
305745|NCT01535729|1034972|P1|Overall Study|Other|19
305746|NCT01535729|1034972|P1|Overall Study|Death|52
305747|NCT01535729|1034972|P1|Overall Study|Lost to Follow-up|8
305748|NCT01535729|1034972|P1|Overall Study|Discontinued treatment|25
305749|NCT01535729|1034972|P1|Overall Study|Disease progression|230
305750|NCT01535729|1034972|P1|Overall Study|Withdrawal by Subject|2
305751|NCT01535638|1035013|P6|Treatment 3 (Single Dose)|Protocol Violation|0
305752|NCT01535638|1035014|P5|Treatment 3 (Single Dose)|Protocol Violation|0
305753|NCT01535638|1035015|P4|Treatment 3 (Single Dose)|Protocol Violation|1
305754|NCT01535638|1035016|P3|Treatment 3 (Single Dose)|Protocol Violation|0
305755|NCT01535638|1035017|P2|Treatment 3 (Single Dose)|Protocol Violation|0
305756|NCT01535638|1035018|P1|Treatment 3 (Single Dose)|Protocol Violation|0
305757|NCT01535638|1035013|P6|Treatment 1 (Single Dose)|Protocol Violation|1
305758|NCT01535638|1035014|P5|Treatment 1 (Single Dose)|Protocol Violation|0
305759|NCT01535638|1035015|P4|Treatment 1 (Single Dose)|Protocol Violation|0
305760|NCT01535638|1035016|P3|Treatment 1 (Single Dose)|Protocol Violation|0
305761|NCT01535638|1035017|P2|Treatment 1 (Single Dose)|Protocol Violation|0
305762|NCT01535638|1035018|P1|Treatment 1 (Single Dose)|Protocol Violation|0
305763|NCT01535599|1035032|P2|Overall Study|Noncompliance|1
305764|NCT01535599|1035033|P1|Overall Study|Noncompliance|0
305765|NCT01535599|1035032|P2|Overall Study|Stopped medication|1
305766|NCT01535599|1035033|P1|Overall Study|Stopped medication|0
305767|NCT01535599|1035032|P2|Overall Study|Other|0
305768|NCT01535599|1035033|P1|Overall Study|Other|1
305769|NCT01535599|1035032|P2|Overall Study|Did not use product|0
305770|NCT01535599|1035033|P1|Overall Study|Did not use product|1
305771|NCT01535599|1035032|P2|Overall Study|Randomized in Error|4
305772|NCT01535599|1035033|P1|Overall Study|Randomized in Error|2
305773|NCT01535599|1035032|P2|Overall Study|BL Culture + for Yeast//Fungi|1
305774|NCT01535599|1035033|P1|Overall Study|BL Culture + for Yeast//Fungi|0
305775|NCT01535599|1035032|P2|Overall Study|BL Culture + for Group A Strep|1
305776|NCT01535599|1035033|P1|Overall Study|BL Culture + for Group A Strep|0
305777|NCT01535599|1035032|P2|Overall Study|Treatment Failure|66
305778|NCT01535599|1035033|P1|Overall Study|Treatment Failure|33
305779|NCT01535599|1035032|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
305780|NCT01535599|1035033|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
305781|NCT01535599|1035032|P2|Overall Study|Lost to Follow-up|4
305782|NCT01535599|1035033|P1|Overall Study|Lost to Follow-up|3
305783|NCT01535599|1035032|P2|Overall Study|Adverse Event|15
305784|NCT01535599|1035033|P1|Overall Study|Adverse Event|6
305785|NCT01535560|1035045|P2|Overall Study|Randomized in Error|1
305786|NCT01535560|1035046|P1|Overall Study|Randomized in Error|0
305787|NCT01535560|1035045|P2|Overall Study|Other|1
305788|NCT01535560|1035046|P1|Overall Study|Other|0
305789|NCT01535560|1035045|P2|Overall Study|Treatment Failure|83
305790|NCT01535560|1035046|P1|Overall Study|Treatment Failure|21
305791|NCT01535560|1035045|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
305792|NCT01535560|1035046|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
305793|NCT01535560|1035045|P2|Overall Study|Lost to Follow-up|3
305794|NCT01535560|1035046|P1|Overall Study|Lost to Follow-up|1
305795|NCT01535560|1035045|P2|Overall Study|Adverse Event|7
305796|NCT01535560|1035046|P1|Overall Study|Adverse Event|12
305797|NCT01535261|1035089|P1|Overall Study|Adverse Event|12
305798|NCT01535261|1035089|P1|Overall Study|Withdrawal by Subject|14
305799|NCT01535261|1035089|P1|Overall Study|Lost to Follow-up|8
305800|NCT01535261|1035089|P1|Overall Study|Death|5
305801|NCT01535261|1035089|P1|Overall Study|Protocol Violation|3
305802|NCT01535261|1035089|P1|Overall Study|Physician Decision|8
305803|NCT01535235|1035102|P2|Overall Study|Adverse Event|0
305804|NCT01535235|1035103|P1|Overall Study|Adverse Event|1
305805|NCT01535222|1035117|P6|Overall Study|Inclusion/exclusion|0
305806|NCT01535222|1035118|P5|Overall Study|Inclusion/exclusion|0
305807|NCT01535222|1035119|P4|Overall Study|Inclusion/exclusion|0
305808|NCT01535222|1035120|P3|Overall Study|Inclusion/exclusion|1
305809|NCT01535222|1035121|P2|Overall Study|Inclusion/exclusion|0
305810|NCT01535222|1035122|P1|Overall Study|Inclusion/exclusion|0
305811|NCT01535040|1035153|P2|Overall Study|Multiple Reasons|1
305812|NCT01535040|1035154|P1|Overall Study|Multiple Reasons|1
305813|NCT01535040|1035153|P2|Overall Study|Toxicity|5
305814|NCT01535040|1035154|P1|Overall Study|Toxicity|7
305815|NCT01535040|1035153|P2|Overall Study|Never Started|4
305816|NCT01535040|1035154|P1|Overall Study|Never Started|9
305817|NCT01535040|1035153|P2|Overall Study|Withdrawal by Subject|10
305818|NCT01535040|1035154|P1|Overall Study|Withdrawal by Subject|13
305819|NCT01535040|1035153|P2|Overall Study|Physician Decision|1
305820|NCT01535040|1035154|P1|Overall Study|Physician Decision|0
305821|NCT01534962|1035212|P4|Overall Study|Discontinued at AF recurrence|31
305822|NCT01534962|1035213|P3|Overall Study|Discontinued at AF recurrence|24
305823|NCT01534962|1035214|P2|Overall Study|Discontinued at AF recurrence|26
305824|NCT01534962|1035215|P1|Overall Study|Discontinued at AF recurrence|35
305825|NCT01534962|1035212|P4|Overall Study|Randomized but did not start treatment|1
305826|NCT01534962|1035213|P3|Overall Study|Randomized but did not start treatment|0
305827|NCT01534962|1035214|P2|Overall Study|Randomized but did not start treatment|0
305828|NCT01534962|1035215|P1|Overall Study|Randomized but did not start treatment|2
305829|NCT01534676|1035272|P2|Overall Study|Study closed due to poor enrollment|1
305830|NCT01534676|1035273|P1|Overall Study|Study closed due to poor enrollment|2
305831|NCT01534637|1035279|P1|Overall Study|Liver Mets before treatment|1
305832|NCT01534637|1035279|P1|Overall Study|Adverse Event|1
305833|NCT01534637|1035279|P1|Overall Study|Withdrawal by Subject|1
305834|NCT01534637|1035279|P1|Overall Study|Lack of Efficacy|3
305835|NCT01534637|1035279|P1|Overall Study|Physician Decision|3
305836|NCT01534533|1035289|P4|Overall Study|Withdrawal by Subject|1
305837|NCT01534533|1035290|P3|Overall Study|Withdrawal by Subject|4
305838|NCT01534533|1035291|P2|Overall Study|Withdrawal by Subject|3
305839|NCT01534533|1035292|P1|Overall Study|Withdrawal by Subject|5
305840|NCT01534533|1035289|P4|Overall Study|Lost to Follow-up|3
305841|NCT01534533|1035290|P3|Overall Study|Lost to Follow-up|4
305842|NCT01534533|1035291|P2|Overall Study|Lost to Follow-up|0
305843|NCT01534533|1035292|P1|Overall Study|Lost to Follow-up|3
305844|NCT01534520|1035320|P2|Overall Study|Adverse Event|1
305845|NCT01534520|1035321|P1|Overall Study|Adverse Event|0
305846|NCT01534351|1035355|P3|Overall Study|Study Terminated Early|0
305847|NCT01534351|1035356|P2|Overall Study|Study Terminated Early|0
305848|NCT01534351|1035357|P1|Overall Study|Study Terminated Early|1
305849|NCT01534208|1035376|P2|Overall Study|Needed prohibited meds|0
305850|NCT01534208|1035377|P1|Overall Study|Needed prohibited meds|1
305851|NCT01534208|1035376|P2|Overall Study|PCP decision|0
305852|NCT01534208|1035377|P1|Overall Study|PCP decision|1
305853|NCT01534208|1035376|P2|Overall Study|Eligibility error|0
305854|NCT01534208|1035377|P1|Overall Study|Eligibility error|3
305855|NCT01534208|1035376|P2|Overall Study|Lab assessment|1
305856|NCT01534208|1035377|P1|Overall Study|Lab assessment|2
305857|NCT01534208|1035376|P2|Overall Study|Subject relocation|0
305858|NCT01534208|1035377|P1|Overall Study|Subject relocation|2
305859|NCT01534208|1035376|P2|Overall Study|Sponsor decision|1
305860|NCT01534208|1035377|P1|Overall Study|Sponsor decision|4
305861|NCT01534208|1035376|P2|Overall Study|Protocol Violation|2
305862|NCT01534208|1035377|P1|Overall Study|Protocol Violation|2
305863|NCT01534208|1035376|P2|Overall Study|Lack of Efficacy|3
305864|NCT01534208|1035377|P1|Overall Study|Lack of Efficacy|0
305865|NCT01534208|1035376|P2|Overall Study|Physician Decision|0
305866|NCT01534208|1035377|P1|Overall Study|Physician Decision|2
305867|NCT01534208|1035376|P2|Overall Study|Adverse Event|8
305868|NCT01534208|1035377|P1|Overall Study|Adverse Event|15
305869|NCT01534208|1035376|P2|Overall Study|Withdrawal by Subject|20
305870|NCT01534208|1035377|P1|Overall Study|Withdrawal by Subject|6
305871|NCT01534208|1035376|P2|Overall Study|Lost to Follow-up|14
305872|NCT01534208|1035377|P1|Overall Study|Lost to Follow-up|19
305873|NCT01534182|1035395|P2|Overall Study|Adverse Event|3
305874|NCT01534182|1035396|P1|Overall Study|Adverse Event|7
305875|NCT01534182|1035395|P2|Overall Study|Withdrawal by Subject|7
305876|NCT01534182|1035396|P1|Overall Study|Withdrawal by Subject|4
305877|NCT01534182|1035395|P2|Overall Study|Administrative problems|0
305878|NCT01534182|1035396|P1|Overall Study|Administrative problems|1
305879|NCT01534078|1035427|P1|Overall Study|Withdrawal by Subject|1
305880|NCT01534078|1035427|P1|Overall Study|Death|1
305881|NCT01533935|1035455|P5|Overall Study|Other reason not defined above|1
305882|NCT01533935|1035456|P4|Overall Study|Other reason not defined above|0
305883|NCT01533935|1035457|P3|Overall Study|Other reason not defined above|1
305884|NCT01533935|1035458|P2|Overall Study|Other reason not defined above|0
305885|NCT01533935|1035459|P1|Overall Study|Other reason not defined above|1
305886|NCT01533935|1035455|P5|Overall Study|Withdrawal by Subject|4
305887|NCT01533935|1035456|P4|Overall Study|Withdrawal by Subject|2
305888|NCT01533935|1035457|P3|Overall Study|Withdrawal by Subject|5
305889|NCT01533935|1035458|P2|Overall Study|Withdrawal by Subject|4
305890|NCT01533935|1035459|P1|Overall Study|Withdrawal by Subject|0
305891|NCT01533935|1035455|P5|Overall Study|Lost to Follow-up|0
305892|NCT01533935|1035456|P4|Overall Study|Lost to Follow-up|0
305893|NCT01533935|1035457|P3|Overall Study|Lost to Follow-up|1
305894|NCT01533935|1035458|P2|Overall Study|Lost to Follow-up|0
305895|NCT01533935|1035459|P1|Overall Study|Lost to Follow-up|0
305896|NCT01533935|1035455|P5|Overall Study|Protocol Violation|0
305897|NCT01533935|1035456|P4|Overall Study|Protocol Violation|0
305898|NCT01533935|1035457|P3|Overall Study|Protocol Violation|0
305899|NCT01533935|1035458|P2|Overall Study|Protocol Violation|2
305900|NCT01533935|1035459|P1|Overall Study|Protocol Violation|0
305901|NCT01533935|1035455|P5|Overall Study|Adverse Event|3
305902|NCT01533935|1035456|P4|Overall Study|Adverse Event|5
305903|NCT01533935|1035457|P3|Overall Study|Adverse Event|1
305904|NCT01533935|1035458|P2|Overall Study|Adverse Event|7
305905|NCT01533935|1035459|P1|Overall Study|Adverse Event|5
305906|NCT01533922|1035486|P5|Overall Study|Other reason not defined above|0
305907|NCT01533922|1035487|P4|Overall Study|Other reason not defined above|0
305908|NCT01533922|1035488|P3|Overall Study|Other reason not defined above|1
305909|NCT01533922|1035489|P2|Overall Study|Other reason not defined above|0
305910|NCT01533922|1035490|P1|Overall Study|Other reason not defined above|2
305911|NCT01533922|1035486|P5|Overall Study|Withdrawal by Subject|1
305912|NCT01533922|1035487|P4|Overall Study|Withdrawal by Subject|2
305913|NCT01533922|1035488|P3|Overall Study|Withdrawal by Subject|2
305914|NCT01533922|1035489|P2|Overall Study|Withdrawal by Subject|1
305915|NCT01533922|1035490|P1|Overall Study|Withdrawal by Subject|3
305916|NCT01533922|1035486|P5|Overall Study|Protocol Violation|1
305917|NCT01533922|1035487|P4|Overall Study|Protocol Violation|0
305918|NCT01533922|1035488|P3|Overall Study|Protocol Violation|0
305919|NCT01533922|1035489|P2|Overall Study|Protocol Violation|3
305920|NCT01533922|1035490|P1|Overall Study|Protocol Violation|0
305921|NCT01533922|1035486|P5|Overall Study|Lack of Efficacy|0
305922|NCT01533922|1035487|P4|Overall Study|Lack of Efficacy|0
305923|NCT01533922|1035488|P3|Overall Study|Lack of Efficacy|1
305924|NCT01533922|1035489|P2|Overall Study|Lack of Efficacy|0
305925|NCT01533922|1035490|P1|Overall Study|Lack of Efficacy|0
305926|NCT01533922|1035486|P5|Overall Study|Adverse Event|4
305927|NCT01533922|1035487|P4|Overall Study|Adverse Event|3
305928|NCT01533922|1035488|P3|Overall Study|Adverse Event|6
305929|NCT01533922|1035489|P2|Overall Study|Adverse Event|8
305930|NCT01533922|1035490|P1|Overall Study|Adverse Event|5
305931|NCT01533493|1035553|P2|Overall Study|Lost to Follow-up|0
305932|NCT01533493|1035554|P1|Overall Study|Lost to Follow-up|2
305933|NCT01533493|1035553|P2|Overall Study|Withdrawal by Subject|2
305934|NCT01533493|1035554|P1|Overall Study|Withdrawal by Subject|1
305935|NCT01533493|1035553|P2|Overall Study|Adverse Event|1
305936|NCT01533493|1035554|P1|Overall Study|Adverse Event|2
305937|NCT01533428|1035562|P2|Overall Study|Withdrawal by Subject|6
305938|NCT01533428|1035563|P1|Overall Study|Withdrawal by Subject|7
305939|NCT01533428|1035562|P2|Overall Study|Lost to Follow-up|1
305940|NCT01533428|1035563|P1|Overall Study|Lost to Follow-up|2
305941|NCT01533428|1035562|P2|Overall Study|Adverse Event|1
305942|NCT01533428|1035563|P1|Overall Study|Adverse Event|0
305943|NCT01533246|1035609|P1|Overall Study|Withdrawal by Subject|1
305944|NCT01533246|1035609|P1|Overall Study|Adverse Event|1
305945|NCT01533181|1035620|P2|Overall Study|Patient withdrawal pre-active treatment|0
305946|NCT01533181|1035621|P1|Overall Study|Patient withdrawal pre-active treatment|1
305947|NCT01533181|1035620|P2|Overall Study|Disease progression pre-active treatment|1
305948|NCT01533181|1035621|P1|Overall Study|Disease progression pre-active treatment|0
305949|NCT01532999|1035738|P2|Overall Study|New job|2
305950|NCT01532999|1035739|P1|Overall Study|New job|0
305951|NCT01532999|1035738|P2|Overall Study|incarcerated|1
305952|NCT01532999|1035739|P1|Overall Study|incarcerated|0
305953|NCT01532999|1035738|P2|Overall Study|Adverse Event|1
305954|NCT01532999|1035739|P1|Overall Study|Adverse Event|0
305955|NCT01532999|1035738|P2|Overall Study|no show for week 9 assessments|4
305956|NCT01532999|1035739|P1|Overall Study|no show for week 9 assessments|6
305957|NCT01532999|1035738|P2|Overall Study|substantial noncompliance|0
305958|NCT01532999|1035739|P1|Overall Study|substantial noncompliance|2
305959|NCT01532999|1035738|P2|Overall Study|should not have been randomized|0
305960|NCT01532999|1035739|P1|Overall Study|should not have been randomized|1
305961|NCT01532999|1035738|P2|Overall Study|Relocated|0
305962|NCT01532999|1035739|P1|Overall Study|Relocated|2
305963|NCT01532999|1035738|P2|Overall Study|Withdrawal by Subject|0
305964|NCT01532999|1035739|P1|Overall Study|Withdrawal by Subject|5
305965|NCT01532999|1035738|P2|Overall Study|Physician Decision|2
305966|NCT01532999|1035739|P1|Overall Study|Physician Decision|1
305967|NCT01532999|1035738|P2|Overall Study|Lost to Follow-up|8
305968|NCT01532999|1035739|P1|Overall Study|Lost to Follow-up|14
305969|NCT01532934|1035821|P2|Overall Study|In controlled environment|2
305970|NCT01532934|1035822|P1|Overall Study|In controlled environment|3
305971|NCT01532934|1035821|P2|Overall Study|Lost to Follow-up|11
305972|NCT01532934|1035822|P1|Overall Study|Lost to Follow-up|11
305973|NCT01532869|1035834|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
305974|NCT01532869|1035835|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
305975|NCT01532869|1035834|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
305976|NCT01532869|1035835|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
305977|NCT01532869|1035834|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
305978|NCT01532869|1035835|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
305979|NCT01532869|1035834|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
305980|NCT01532869|1035835|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
305981|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
305982|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
305983|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
305984|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
305985|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
305986|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
305987|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
305988|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
305989|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
305990|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
305991|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
305992|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
305993|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
305994|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
305995|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
305996|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
305997|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
305998|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
305999|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
306000|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
306001|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
306002|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
306003|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
306004|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
306005|NCT01532869|1035834|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
306006|NCT01532869|1035835|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
306007|NCT01532570|1035901|P4|Overall Study|Withdrawal by Subject|0
306008|NCT01532570|1035902|P3|Overall Study|Withdrawal by Subject|0
306009|NCT01532570|1035903|P2|Overall Study|Withdrawal by Subject|1
306010|NCT01532570|1035904|P1|Overall Study|Withdrawal by Subject|0
306011|NCT01532570|1035901|P4|Overall Study|Lack of Efficacy|0
306012|NCT01532570|1035902|P3|Overall Study|Lack of Efficacy|0
306013|NCT01532570|1035903|P2|Overall Study|Lack of Efficacy|0
306014|NCT01532570|1035904|P1|Overall Study|Lack of Efficacy|1
306015|NCT01532414|1035949|P3|Overall Study|Withdrawn by sponsor|0
306016|NCT01532414|1035950|P2|Overall Study|Withdrawn by sponsor|0
306017|NCT01532414|1035951|P1|Overall Study|Withdrawn by sponsor|1
306018|NCT01532414|1035949|P3|Overall Study|Unable to complete 24 hour PK|1
306019|NCT01532414|1035950|P2|Overall Study|Unable to complete 24 hour PK|0
306020|NCT01532414|1035951|P1|Overall Study|Unable to complete 24 hour PK|0
306021|NCT01532414|1035949|P3|Overall Study|Adverse Event|1
306022|NCT01532414|1035950|P2|Overall Study|Adverse Event|1
306023|NCT01532414|1035951|P1|Overall Study|Adverse Event|0
306024|NCT01532414|1035949|P3|Overall Study|No V6 semen sample|0
306025|NCT01532414|1035950|P2|Overall Study|No V6 semen sample|1
306026|NCT01532414|1035951|P1|Overall Study|No V6 semen sample|0
306027|NCT01532414|1035949|P3|Overall Study|Withdrawal by Subject|0
306028|NCT01532414|1035950|P2|Overall Study|Withdrawal by Subject|0
306029|NCT01532414|1035951|P1|Overall Study|Withdrawal by Subject|3
306030|NCT01532414|1035949|P3|Overall Study|Lost to Follow-up|1
306031|NCT01532414|1035950|P2|Overall Study|Lost to Follow-up|0
306032|NCT01532414|1035951|P1|Overall Study|Lost to Follow-up|3
306033|NCT01531998|1036017|P1|Overall Study|Withdrawal by Subject|3
306034|NCT01531725|1036022|P1|Overall Study|Protocol Violation|5
306035|NCT01531673|1036040|P13|Overall Study|Other|0
306036|NCT01531673|1036041|P12|Overall Study|Other|0
306037|NCT01531673|1036042|P11|Overall Study|Other|0
306038|NCT01531673|1036043|P10|Overall Study|Other|1
306039|NCT01531673|1036044|P9|Overall Study|Other|0
306040|NCT01531673|1036045|P8|Overall Study|Other|0
306041|NCT01531673|1036046|P7|Overall Study|Other|0
306042|NCT01531673|1036047|P6|Overall Study|Other|0
306043|NCT01531673|1036048|P5|Overall Study|Other|0
306044|NCT01531673|1036049|P4|Overall Study|Other|1
306045|NCT01531673|1036050|P3|Overall Study|Other|0
306046|NCT01531673|1036051|P2|Overall Study|Other|0
306047|NCT01531673|1036052|P1|Overall Study|Other|0
306048|NCT01531673|1036040|P13|Overall Study|Lost to Follow-up|0
306049|NCT01531673|1036041|P12|Overall Study|Lost to Follow-up|0
306050|NCT01531673|1036042|P11|Overall Study|Lost to Follow-up|0
306051|NCT01531673|1036043|P10|Overall Study|Lost to Follow-up|0
306052|NCT01531673|1036044|P9|Overall Study|Lost to Follow-up|0
306053|NCT01531673|1036045|P8|Overall Study|Lost to Follow-up|0
306054|NCT01531673|1036046|P7|Overall Study|Lost to Follow-up|0
306055|NCT01531673|1036047|P6|Overall Study|Lost to Follow-up|0
306056|NCT01531673|1036048|P5|Overall Study|Lost to Follow-up|1
306057|NCT01531673|1036049|P4|Overall Study|Lost to Follow-up|0
306058|NCT01531673|1036050|P3|Overall Study|Lost to Follow-up|0
306059|NCT01531673|1036051|P2|Overall Study|Lost to Follow-up|0
306060|NCT01531673|1036052|P1|Overall Study|Lost to Follow-up|0
306061|NCT01531673|1036040|P13|Overall Study|Adverse Event|0
306062|NCT01531673|1036041|P12|Overall Study|Adverse Event|0
306063|NCT01531673|1036042|P11|Overall Study|Adverse Event|0
306064|NCT01531673|1036043|P10|Overall Study|Adverse Event|0
306065|NCT01531673|1036044|P9|Overall Study|Adverse Event|0
306066|NCT01531673|1036045|P8|Overall Study|Adverse Event|0
306067|NCT01531673|1036046|P7|Overall Study|Adverse Event|0
306068|NCT01531673|1036047|P6|Overall Study|Adverse Event|0
306069|NCT01531673|1036048|P5|Overall Study|Adverse Event|0
306070|NCT01531673|1036049|P4|Overall Study|Adverse Event|0
306071|NCT01531673|1036050|P3|Overall Study|Adverse Event|0
306072|NCT01531673|1036051|P2|Overall Study|Adverse Event|1
306073|NCT01531673|1036052|P1|Overall Study|Adverse Event|0
306074|NCT01531673|1036040|P13|Overall Study|Non-Compliance|0
306075|NCT01531673|1036041|P12|Overall Study|Non-Compliance|0
306076|NCT01531673|1036042|P11|Overall Study|Non-Compliance|0
306077|NCT01531673|1036043|P10|Overall Study|Non-Compliance|0
306078|NCT01531673|1036044|P9|Overall Study|Non-Compliance|0
306079|NCT01531673|1036045|P8|Overall Study|Non-Compliance|0
306080|NCT01531673|1036046|P7|Overall Study|Non-Compliance|0
306081|NCT01531673|1036047|P6|Overall Study|Non-Compliance|1
306082|NCT01531673|1036048|P5|Overall Study|Non-Compliance|0
306083|NCT01531673|1036049|P4|Overall Study|Non-Compliance|0
306084|NCT01531673|1036050|P3|Overall Study|Non-Compliance|0
306085|NCT01531673|1036051|P2|Overall Study|Non-Compliance|0
306086|NCT01531673|1036052|P1|Overall Study|Non-Compliance|0
306087|NCT01531387|1036163|P2|Overall Study|Early termination of study|11
306088|NCT01531387|1036164|P1|Overall Study|Early termination of study|11
306089|NCT01531205|1036256|P1|Overall Study|Did not proceed to surgery|1
306090|NCT01530997|1036265|P1|Overall Study|Withdrawal by Subject|1
306091|NCT01530997|1036265|P1|Overall Study|Physician Decision|1
306092|NCT01530464|1036309|P2|Washout (24h)|Withdrawal by Subject|1
306093|NCT01530464|1036310|P1|Washout (24h)|Withdrawal by Subject|0
306094|NCT01530464|1036309|P2|Washout (24h)|Withdrawal by Subject|0
306095|NCT01530464|1036310|P1|Washout (24h)|Withdrawal by Subject|1
306096|NCT01530334|1036362|P1|Overall Study|Progressive disease|47
306097|NCT01530334|1036362|P1|Overall Study|unknown reason|1
306098|NCT01530334|1036362|P1|Overall Study|Adverse Event|3
306099|NCT01530087|1036396|P1|Overall Study|Physician Decision|2
306100|NCT01529645|1036418|P10|Overall Study|Withdrawal by Subject|0
306101|NCT01529645|1036419|P9|Overall Study|Withdrawal by Subject|0
306102|NCT01529645|1036420|P8|Overall Study|Withdrawal by Subject|0
306103|NCT01529645|1036421|P7|Overall Study|Withdrawal by Subject|0
306104|NCT01529645|1036422|P6|Overall Study|Withdrawal by Subject|1
306105|NCT01529645|1036423|P5|Overall Study|Withdrawal by Subject|1
306106|NCT01529645|1036424|P4|Overall Study|Withdrawal by Subject|1
306107|NCT01529645|1036425|P3|Overall Study|Withdrawal by Subject|0
306108|NCT01529645|1036426|P2|Overall Study|Withdrawal by Subject|0
306109|NCT01529645|1036427|P1|Overall Study|Withdrawal by Subject|2
306110|NCT01529645|1036418|P10|Overall Study|SAE - Premature contractions|0
306111|NCT01529645|1036419|P9|Overall Study|SAE - Premature contractions|0
306112|NCT01529645|1036420|P8|Overall Study|SAE - Premature contractions|0
306113|NCT01529645|1036421|P7|Overall Study|SAE - Premature contractions|0
306114|NCT01529645|1036422|P6|Overall Study|SAE - Premature contractions|0
306115|NCT01529645|1036423|P5|Overall Study|SAE - Premature contractions|0
306116|NCT01529645|1036424|P4|Overall Study|SAE - Premature contractions|0
306117|NCT01529645|1036425|P3|Overall Study|SAE - Premature contractions|1
306118|NCT01529645|1036426|P2|Overall Study|SAE - Premature contractions|0
306119|NCT01529645|1036427|P1|Overall Study|SAE - Premature contractions|0
306120|NCT01529645|1036418|P10|Overall Study|Lost to Follow-up|0
306121|NCT01529645|1036419|P9|Overall Study|Lost to Follow-up|1
306122|NCT01529645|1036420|P8|Overall Study|Lost to Follow-up|0
306123|NCT01529645|1036421|P7|Overall Study|Lost to Follow-up|2
306124|NCT01529645|1036422|P6|Overall Study|Lost to Follow-up|0
306125|NCT01529645|1036423|P5|Overall Study|Lost to Follow-up|1
306126|NCT01529645|1036424|P4|Overall Study|Lost to Follow-up|1
306127|NCT01529645|1036425|P3|Overall Study|Lost to Follow-up|1
306128|NCT01529645|1036426|P2|Overall Study|Lost to Follow-up|1
306129|NCT01529645|1036427|P1|Overall Study|Lost to Follow-up|0
306130|NCT01529632|1036525|P2|Overall Study|Adverse Event|1
306131|NCT01529632|1036526|P1|Overall Study|Adverse Event|1
306132|NCT01529632|1036525|P2|Overall Study|Protocol Violation|1
306133|NCT01529632|1036526|P1|Overall Study|Protocol Violation|0
306134|NCT01529632|1036525|P2|Overall Study|Administrative problem|1
306135|NCT01529632|1036526|P1|Overall Study|Administrative problem|2
306136|NCT01529515|1036546|P4|DOUBLE BLIND PHASE|Other|2
306137|NCT01529515|1036547|P3|DOUBLE BLIND PHASE|Other|9
306138|NCT01529515|1036548|P2|DOUBLE BLIND PHASE|Other|0
306139|NCT01529515|1036549|P1|DOUBLE BLIND PHASE|Other|0
306140|NCT01529515|1036546|P4|DOUBLE BLIND PHASE|Protocol Violation|0
306141|NCT01529515|1036547|P3|DOUBLE BLIND PHASE|Protocol Violation|1
306142|NCT01529515|1036548|P2|DOUBLE BLIND PHASE|Protocol Violation|0
306143|NCT01529515|1036549|P1|DOUBLE BLIND PHASE|Protocol Violation|0
306144|NCT01529515|1036546|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
306145|NCT01529515|1036547|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
306146|NCT01529515|1036548|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
306147|NCT01529515|1036549|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
306148|NCT01529515|1036546|P4|DOUBLE BLIND PHASE|Pregnancy|0
306149|NCT01529515|1036547|P3|DOUBLE BLIND PHASE|Pregnancy|1
306150|NCT01529515|1036548|P2|DOUBLE BLIND PHASE|Pregnancy|0
306151|NCT01529515|1036549|P1|DOUBLE BLIND PHASE|Pregnancy|0
306152|NCT01529515|1036546|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
306153|NCT01529515|1036547|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
306154|NCT01529515|1036548|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
306155|NCT01529515|1036549|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
306156|NCT01529515|1036546|P4|DOUBLE BLIND PHASE|Adverse Event|0
306157|NCT01529515|1036547|P3|DOUBLE BLIND PHASE|Adverse Event|1
306158|NCT01529515|1036548|P2|DOUBLE BLIND PHASE|Adverse Event|0
306159|NCT01529515|1036549|P1|DOUBLE BLIND PHASE|Adverse Event|0
306160|NCT01529515|1036546|P4|MAINTENANCE PHASE|Other|0
306161|NCT01529515|1036547|P3|MAINTENANCE PHASE|Other|0
306162|NCT01529515|1036548|P2|MAINTENANCE PHASE|Other|10
306163|NCT01529515|1036549|P1|MAINTENANCE PHASE|Other|0
306164|NCT01529515|1036546|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
306165|NCT01529515|1036547|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
306166|NCT01529515|1036548|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
306167|NCT01529515|1036549|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
306168|NCT01529515|1036546|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
306169|NCT01529515|1036547|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
306170|NCT01529515|1036548|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
306171|NCT01529515|1036549|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
306172|NCT01529515|1036546|P4|MAINTENANCE PHASE|Protocol Violation|0
306173|NCT01529515|1036547|P3|MAINTENANCE PHASE|Protocol Violation|0
306174|NCT01529515|1036548|P2|MAINTENANCE PHASE|Protocol Violation|12
306175|NCT01529515|1036549|P1|MAINTENANCE PHASE|Protocol Violation|0
306176|NCT01529515|1036546|P4|MAINTENANCE PHASE|Lost to Follow-up|0
306177|NCT01529515|1036547|P3|MAINTENANCE PHASE|Lost to Follow-up|0
306178|NCT01529515|1036548|P2|MAINTENANCE PHASE|Lost to Follow-up|5
306179|NCT01529515|1036549|P1|MAINTENANCE PHASE|Lost to Follow-up|0
306180|NCT01529515|1036546|P4|MAINTENANCE PHASE|Lack of Efficacy|0
306181|NCT01529515|1036547|P3|MAINTENANCE PHASE|Lack of Efficacy|0
306182|NCT01529515|1036548|P2|MAINTENANCE PHASE|Lack of Efficacy|9
306183|NCT01529515|1036549|P1|MAINTENANCE PHASE|Lack of Efficacy|0
306184|NCT01529515|1036546|P4|MAINTENANCE PHASE|Adverse Event|0
306185|NCT01529515|1036547|P3|MAINTENANCE PHASE|Adverse Event|0
306186|NCT01529515|1036548|P2|MAINTENANCE PHASE|Adverse Event|10
306187|NCT01529515|1036549|P1|MAINTENANCE PHASE|Adverse Event|0
306188|NCT01529515|1036546|P4|TRANSITION PHASE|Other|0
306189|NCT01529515|1036547|P3|TRANSITION PHASE|Other|0
306190|NCT01529515|1036548|P2|TRANSITION PHASE|Other|0
306191|NCT01529515|1036549|P1|TRANSITION PHASE|Other|9
306192|NCT01529515|1036546|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
306193|NCT01529515|1036547|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
306194|NCT01529515|1036548|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
306195|NCT01529515|1036549|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
306196|NCT01529515|1036546|P4|TRANSITION PHASE|Withdrawal by Subject|0
306197|NCT01529515|1036547|P3|TRANSITION PHASE|Withdrawal by Subject|0
306198|NCT01529515|1036548|P2|TRANSITION PHASE|Withdrawal by Subject|0
306199|NCT01529515|1036549|P1|TRANSITION PHASE|Withdrawal by Subject|51
306200|NCT01529515|1036546|P4|TRANSITION PHASE|Protocol Violation|0
306201|NCT01529515|1036547|P3|TRANSITION PHASE|Protocol Violation|0
306202|NCT01529515|1036548|P2|TRANSITION PHASE|Protocol Violation|0
306203|NCT01529515|1036549|P1|TRANSITION PHASE|Protocol Violation|4
306204|NCT01529515|1036546|P4|TRANSITION PHASE|Lost to Follow-up|0
306205|NCT01529515|1036547|P3|TRANSITION PHASE|Lost to Follow-up|0
306206|NCT01529515|1036548|P2|TRANSITION PHASE|Lost to Follow-up|0
306207|NCT01529515|1036549|P1|TRANSITION PHASE|Lost to Follow-up|19
306208|NCT01529515|1036546|P4|TRANSITION PHASE|Lack of Efficacy|0
306209|NCT01529515|1036547|P3|TRANSITION PHASE|Lack of Efficacy|0
306210|NCT01529515|1036548|P2|TRANSITION PHASE|Lack of Efficacy|0
306211|NCT01529515|1036549|P1|TRANSITION PHASE|Lack of Efficacy|19
306212|NCT01529515|1036546|P4|TRANSITION PHASE|Death|0
306213|NCT01529515|1036547|P3|TRANSITION PHASE|Death|0
306214|NCT01529515|1036548|P2|TRANSITION PHASE|Death|0
306215|NCT01529515|1036549|P1|TRANSITION PHASE|Death|1
306216|NCT01529515|1036546|P4|TRANSITION PHASE|Adverse Event|0
306217|NCT01529515|1036547|P3|TRANSITION PHASE|Adverse Event|0
306218|NCT01529515|1036548|P2|TRANSITION PHASE|Adverse Event|0
306219|NCT01529515|1036549|P1|TRANSITION PHASE|Adverse Event|16
306220|NCT01529385|1036596|P2|Overall Study|Lost to Follow-up|1
306221|NCT01529385|1036597|P1|Overall Study|Lost to Follow-up|2
306222|NCT01529346|1036626|P5|Overall Study|Other|0
306223|NCT01529346|1036627|P4|Overall Study|Other|0
306224|NCT01529346|1036628|P3|Overall Study|Other|1
306225|NCT01529346|1036629|P2|Overall Study|Other|1
306226|NCT01529346|1036630|P1|Overall Study|Other|0
306227|NCT01529346|1036626|P5|Overall Study|Lost to Follow-up|0
306228|NCT01529346|1036627|P4|Overall Study|Lost to Follow-up|0
306229|NCT01529346|1036628|P3|Overall Study|Lost to Follow-up|1
306230|NCT01529346|1036629|P2|Overall Study|Lost to Follow-up|0
306231|NCT01529346|1036630|P1|Overall Study|Lost to Follow-up|2
306232|NCT01529268|1036718|P2|Overall Study|Moved|0
306233|NCT01529268|1036719|P1|Overall Study|Moved|3
306234|NCT01529268|1036718|P2|Overall Study|Lost to Follow-up|3
306235|NCT01529268|1036719|P1|Overall Study|Lost to Follow-up|9
306236|NCT01529112|1036781|P2|Overall Study|Withdrawal by Subject|3
306237|NCT01529112|1036782|P1|Overall Study|Withdrawal by Subject|7
306238|NCT01529112|1036781|P2|Overall Study|Protocol Violation|0
306239|NCT01529112|1036782|P1|Overall Study|Protocol Violation|1
306240|NCT01529112|1036781|P2|Overall Study|Death|38
306241|NCT01529112|1036782|P1|Overall Study|Death|59
306242|NCT01529112|1036781|P2|Overall Study|Adverse Event|0
306243|NCT01529112|1036782|P1|Overall Study|Adverse Event|2
306244|NCT01528969|1036809|P2|Overall Study|absent from the school at baseline|0
306245|NCT01528969|1036810|P1|Overall Study|absent from the school at baseline|2
306246|NCT01528787|1036843|P4|Overall Study|Family Emergency|0
306247|NCT01528787|1036844|P3|Overall Study|Family Emergency|1
306248|NCT01528787|1036845|P2|Overall Study|Family Emergency|0
306249|NCT01528787|1036846|P1|Overall Study|Family Emergency|0
306250|NCT01528787|1036843|P4|Overall Study|Withdrawal by Subject|1
306251|NCT01528787|1036844|P3|Overall Study|Withdrawal by Subject|0
306252|NCT01528787|1036845|P2|Overall Study|Withdrawal by Subject|0
306253|NCT01528787|1036846|P1|Overall Study|Withdrawal by Subject|0
306254|NCT01528735|1036858|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
306255|NCT01528735|1036859|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
306256|NCT01528735|1036858|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
306257|NCT01528735|1036859|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
306258|NCT01528696|1036961|P2|Overall Study|See detailed description|19
306259|NCT01528696|1036962|P1|Overall Study|See detailed description|18
306260|NCT01528605|1036978|P6|Overall Study|Death|0
306261|NCT01528605|1036979|P5|Overall Study|Death|0
306262|NCT01528605|1036980|P4|Overall Study|Death|0
306263|NCT01528605|1036981|P3|Overall Study|Death|0
306264|NCT01528605|1036982|P2|Overall Study|Death|0
306265|NCT01528605|1036983|P1|Overall Study|Death|1
306266|NCT01528605|1036978|P6|Overall Study|Lost to Follow-up|0
306267|NCT01528605|1036979|P5|Overall Study|Lost to Follow-up|0
306268|NCT01528605|1036980|P4|Overall Study|Lost to Follow-up|1
306269|NCT01528605|1036981|P3|Overall Study|Lost to Follow-up|1
306270|NCT01528605|1036982|P2|Overall Study|Lost to Follow-up|0
306271|NCT01528605|1036983|P1|Overall Study|Lost to Follow-up|1
306272|NCT01528345|1037013|P2|Overall Study|Subject/Guardian Decision|0
306273|NCT01528345|1037014|P1|Overall Study|Subject/Guardian Decision|5
306274|NCT01528345|1037013|P2|Overall Study|Study Terminated by Sponsor|8
306275|NCT01528345|1037014|P1|Overall Study|Study Terminated by Sponsor|4
306276|NCT01528345|1037013|P2|Overall Study|Progressive Disease|40
306277|NCT01528345|1037014|P1|Overall Study|Progressive Disease|26
306278|NCT01528345|1037013|P2|Overall Study|Non-compliance with study treatment|0
306279|NCT01528345|1037014|P1|Overall Study|Non-compliance with study treatment|1
306280|NCT01528345|1037013|P2|Overall Study|Death|1
306281|NCT01528345|1037014|P1|Overall Study|Death|1
306282|NCT01528345|1037013|P2|Overall Study|Adverse Event|1
306283|NCT01528345|1037014|P1|Overall Study|Adverse Event|10
306284|NCT01527487|1037104|P2|Overall Study|Death|1
306285|NCT01527487|1037105|P1|Overall Study|Death|0
306286|NCT01527487|1037104|P2|Overall Study|Adverse Event|1
306287|NCT01527487|1037105|P1|Overall Study|Adverse Event|1
306288|NCT01527487|1037104|P2|Overall Study|Disease Progression|1
306289|NCT01527487|1037105|P1|Overall Study|Disease Progression|4
306290|NCT01527487|1037104|P2|Overall Study|MD Discretion/Lack of Efficacy|4
306291|NCT01527487|1037105|P1|Overall Study|MD Discretion/Lack of Efficacy|3
306292|NCT01527370|1037117|P1|Overall Study|Death|1
306293|NCT01527370|1037117|P1|Overall Study|Physician Decision|1
306294|NCT01527370|1037117|P1|Overall Study|Withdrawal by Subject|4
306295|NCT01527110|1037134|P1|Overall Study|Adverse Event|1
306296|NCT01527006|1037181|P2|Extension Phase|Not Specified|3
306297|NCT01527006|1037182|P1|Extension Phase|Not Specified|0
306298|NCT01527006|1037181|P2|Extension Phase|Inadequate therapeutic effect|1
306299|NCT01527006|1037182|P1|Extension Phase|Inadequate therapeutic effect|1
306300|NCT01527006|1037181|P2|Extension Phase|Subject Choice|1
306301|NCT01527006|1037182|P1|Extension Phase|Subject Choice|1
306302|NCT01527006|1037181|P2|Extension Phase|Lost to Follow-up|1
306303|NCT01527006|1037182|P1|Extension Phase|Lost to Follow-up|0
306304|NCT01527006|1037181|P2|Extension Phase|Adverse Event|2
306305|NCT01527006|1037182|P1|Extension Phase|Adverse Event|4
306306|NCT01527006|1037181|P2|Core Study|Not Specified|2
306307|NCT01527006|1037182|P1|Core Study|Not Specified|0
306308|NCT01527006|1037181|P2|Core Study|Withdrawal by Subject|1
306309|NCT01527006|1037182|P1|Core Study|Withdrawal by Subject|0
306310|NCT01527006|1037181|P2|Core Study|Inadequate Therapeutic Effect|0
306311|NCT01527006|1037182|P1|Core Study|Inadequate Therapeutic Effect|1
306312|NCT01527006|1037181|P2|Core Study|Subject Choice|0
306313|NCT01527006|1037182|P1|Core Study|Subject Choice|1
306314|NCT01527006|1037181|P2|Core Study|Lost to Follow-up|1
306315|NCT01527006|1037182|P1|Core Study|Lost to Follow-up|0
306316|NCT01527006|1037181|P2|Core Study|Adverse Event|2
306317|NCT01527006|1037182|P1|Core Study|Adverse Event|0
306318|NCT01526785|1037249|P1|Overall Study|Withdrawal by Subject|2
306319|NCT01526785|1037249|P1|Overall Study|Physician Decision|1
306320|NCT01526785|1037249|P1|Overall Study|Death|2
306321|NCT01526785|1037249|P1|Overall Study|Study Terminated by Sponsor|8
306322|NCT01526733|1037259|P2|Phase 1|Withdrawal by Subject|1
306323|NCT01526733|1037260|P1|Phase 1|Withdrawal by Subject|1
306324|NCT01526733|1037259|P2|Phase 1|Protocol Violation|0
306325|NCT01526733|1037260|P1|Phase 1|Protocol Violation|1
306326|NCT01526551|1037282|P1|Overall Study|Lack of returned parental consent form|424
306327|NCT01526148|1037329|P2|Overall Study|Incarcerated|2
306328|NCT01526148|1037330|P1|Overall Study|Incarcerated|0
306329|NCT01526148|1037329|P2|Overall Study|Moved out of state|0
306330|NCT01526148|1037330|P1|Overall Study|Moved out of state|1
306331|NCT01526148|1037329|P2|Overall Study|Unable to discontinue concomitant med|0
306332|NCT01526148|1037330|P1|Overall Study|Unable to discontinue concomitant med|1
306333|NCT01526148|1037329|P2|Overall Study|Unstable Medical Condition|0
306334|NCT01526148|1037330|P1|Overall Study|Unstable Medical Condition|1
306335|NCT01526148|1037329|P2|Overall Study|Withdrawal by Subject|0
306336|NCT01526148|1037330|P1|Overall Study|Withdrawal by Subject|2
306337|NCT01526148|1037329|P2|Overall Study|Lost to Follow-up|6
306338|NCT01526148|1037330|P1|Overall Study|Lost to Follow-up|3
306339|NCT01526148|1037329|P2|Overall Study|Adverse Event|5
306340|NCT01526148|1037330|P1|Overall Study|Adverse Event|6
306341|NCT01525849|1037354|P2|Overall Study|Anatomic exclusion criteria identified|3
306342|NCT01525849|1037355|P1|Overall Study|Anatomic exclusion criteria identified|0
306343|NCT01525849|1037354|P2|Overall Study|Unrelated medical issue (not treated)|2
306344|NCT01525849|1037355|P1|Overall Study|Unrelated medical issue (not treated)|1
306345|NCT01525849|1037354|P2|Overall Study|Withdrawal by Subject|9
306346|NCT01525849|1037355|P1|Overall Study|Withdrawal by Subject|1
306347|NCT01525849|1037354|P2|Overall Study|Lost to Follow-up|2
306348|NCT01525849|1037355|P1|Overall Study|Lost to Follow-up|3
306349|NCT01525641|1037411|P1|Overall Study|Other than stated above|7
306350|NCT01525641|1037411|P1|Overall Study|Lost to follow-up (Changing hospital)|19
306351|NCT01525641|1037411|P1|Overall Study|Lost to follow-up (Unknown reason)|10
306352|NCT01525641|1037411|P1|Overall Study|Lost to follow-up (relocation)|1
306353|NCT01525641|1037411|P1|Overall Study|Improvement|5
306354|NCT01525641|1037411|P1|Overall Study|Lack of Efficacy|24
306355|NCT01525641|1037411|P1|Overall Study|Adverse Event|73
306356|NCT01525641|1037411|P1|Overall Study|No visit since the first visit|16
306357|NCT01525641|1037411|P1|Overall Study|Case report form not collected|25
306358|NCT01525628|1037425|P5|Overall Study|Other reason not defined above|0
306359|NCT01525628|1037426|P4|Overall Study|Other reason not defined above|3
306360|NCT01525628|1037427|P3|Overall Study|Other reason not defined above|0
306361|NCT01525628|1037428|P2|Overall Study|Other reason not defined above|0
306362|NCT01525628|1037429|P1|Overall Study|Other reason not defined above|0
306363|NCT01525628|1037425|P5|Overall Study|Withdrawal by Subject|0
306364|NCT01525628|1037426|P4|Overall Study|Withdrawal by Subject|0
306365|NCT01525628|1037427|P3|Overall Study|Withdrawal by Subject|0
306366|NCT01525628|1037428|P2|Overall Study|Withdrawal by Subject|1
306367|NCT01525628|1037429|P1|Overall Study|Withdrawal by Subject|0
306368|NCT01525628|1037425|P5|Overall Study|Lost to Follow-up|0
306369|NCT01525628|1037426|P4|Overall Study|Lost to Follow-up|0
306370|NCT01525628|1037427|P3|Overall Study|Lost to Follow-up|0
306371|NCT01525628|1037428|P2|Overall Study|Lost to Follow-up|1
306372|NCT01525628|1037429|P1|Overall Study|Lost to Follow-up|1
306373|NCT01525628|1037425|P5|Overall Study|Protocol Violation|0
306374|NCT01525628|1037426|P4|Overall Study|Protocol Violation|0
306375|NCT01525628|1037427|P3|Overall Study|Protocol Violation|1
306376|NCT01525628|1037428|P2|Overall Study|Protocol Violation|0
306377|NCT01525628|1037429|P1|Overall Study|Protocol Violation|0
306378|NCT01525628|1037425|P5|Overall Study|Lack of Efficacy|2
306379|NCT01525628|1037426|P4|Overall Study|Lack of Efficacy|1
306380|NCT01525628|1037427|P3|Overall Study|Lack of Efficacy|2
306381|NCT01525628|1037428|P2|Overall Study|Lack of Efficacy|2
306382|NCT01525628|1037429|P1|Overall Study|Lack of Efficacy|0
306383|NCT01525628|1037425|P5|Overall Study|Adverse Event|1
306384|NCT01525628|1037426|P4|Overall Study|Adverse Event|0
306385|NCT01525628|1037427|P3|Overall Study|Adverse Event|2
306386|NCT01525628|1037428|P2|Overall Study|Adverse Event|1
306387|NCT01525628|1037429|P1|Overall Study|Adverse Event|1
306388|NCT01525615|1037496|P3|Overall Study|Other reason not described above|1
306389|NCT01525615|1037497|P2|Overall Study|Other reason not described above|0
306390|NCT01525615|1037498|P1|Overall Study|Other reason not described above|1
306391|NCT01525615|1037496|P3|Overall Study|Withdrawal by Subject|0
306392|NCT01525615|1037497|P2|Overall Study|Withdrawal by Subject|0
306393|NCT01525615|1037498|P1|Overall Study|Withdrawal by Subject|1
306394|NCT01525615|1037496|P3|Overall Study|Lost to Follow-up|0
306395|NCT01525615|1037497|P2|Overall Study|Lost to Follow-up|0
306396|NCT01525615|1037498|P1|Overall Study|Lost to Follow-up|1
306397|NCT01525615|1037496|P3|Overall Study|Adverse Event|5
306398|NCT01525615|1037497|P2|Overall Study|Adverse Event|7
306399|NCT01525615|1037498|P1|Overall Study|Adverse Event|11
306400|NCT01525550|1037554|P2|Overall Study|Ongoing|23
306401|NCT01525550|1037555|P1|Overall Study|Ongoing|45
306402|NCT01525550|1037554|P2|Overall Study|Other Unspecified|2
306403|NCT01525550|1037555|P1|Overall Study|Other Unspecified|0
306404|NCT01525550|1037554|P2|Overall Study|Death|19
306405|NCT01525550|1037555|P1|Overall Study|Death|10
306406|NCT01525550|1037554|P2|Overall Study|Lost to Follow-up|1
306407|NCT01525550|1037555|P1|Overall Study|Lost to Follow-up|4
306408|NCT01525550|1037554|P2|Overall Study|Withdrawal by Subject|0
306409|NCT01525550|1037555|P1|Overall Study|Withdrawal by Subject|2
306410|NCT01525407|1037626|P2|Overall Study|Delay in Transplant|0
306411|NCT01525407|1037627|P1|Overall Study|Delay in Transplant|1
306412|NCT01525407|1037626|P2|Overall Study|Transplant was delayed|1
306413|NCT01525407|1037627|P1|Overall Study|Transplant was delayed|0
306414|NCT01525407|1037626|P2|Overall Study|Withdrawal by Subject|1
306415|NCT01525407|1037627|P1|Overall Study|Withdrawal by Subject|0
306416|NCT01525407|1037626|P2|Overall Study|Change in recipient treatment plan|2
306417|NCT01525407|1037627|P1|Overall Study|Change in recipient treatment plan|2
306418|NCT01525238|1037644|P3|Overall Study|Withdrawal by Subject|0
306419|NCT01525238|1037645|P2|Overall Study|Withdrawal by Subject|0
306420|NCT01525238|1037646|P1|Overall Study|Withdrawal by Subject|1
306421|NCT01525225|1037711|P1|Enrollment|Not Specified|1
306422|NCT01525225|1037711|P1|Enrollment|No longer met study criteria|1
306423|NCT01524978|1037736|P11|Overall Study|Death|17
306424|NCT01524978|1037737|P10|Overall Study|Death|6
306425|NCT01524978|1037738|P9|Overall Study|Death|5
306426|NCT01524978|1037739|P8|Overall Study|Death|9
306427|NCT01524978|1037740|P7|Overall Study|Death|1
306428|NCT01524978|1037741|P6|Overall Study|Death|4
306429|NCT01524978|1037742|P5|Overall Study|Death|4
306430|NCT01524978|1037743|P4|Overall Study|Death|24
306431|NCT01524978|1037744|P3|Overall Study|Death|5
306432|NCT01524978|1037745|P2|Overall Study|Death|2
306433|NCT01524978|1037746|P1|Overall Study|Death|34
306434|NCT01524978|1037736|P11|Overall Study|Lost to Follow-up|1
306435|NCT01524978|1037737|P10|Overall Study|Lost to Follow-up|1
306436|NCT01524978|1037738|P9|Overall Study|Lost to Follow-up|1
306437|NCT01524978|1037739|P8|Overall Study|Lost to Follow-up|0
306438|NCT01524978|1037740|P7|Overall Study|Lost to Follow-up|2
306439|NCT01524978|1037741|P6|Overall Study|Lost to Follow-up|1
306440|NCT01524978|1037742|P5|Overall Study|Lost to Follow-up|1
306441|NCT01524978|1037743|P4|Overall Study|Lost to Follow-up|0
306442|NCT01524978|1037744|P3|Overall Study|Lost to Follow-up|3
306443|NCT01524978|1037745|P2|Overall Study|Lost to Follow-up|0
306444|NCT01524978|1037746|P1|Overall Study|Lost to Follow-up|0
306445|NCT01524978|1037736|P11|Overall Study|Withdrawal by Subject|5
306446|NCT01524978|1037737|P10|Overall Study|Withdrawal by Subject|0
306447|NCT01524978|1037738|P9|Overall Study|Withdrawal by Subject|4
306448|NCT01524978|1037739|P8|Overall Study|Withdrawal by Subject|2
306449|NCT01524978|1037740|P7|Overall Study|Withdrawal by Subject|6
306450|NCT01524978|1037741|P6|Overall Study|Withdrawal by Subject|1
306451|NCT01524978|1037742|P5|Overall Study|Withdrawal by Subject|3
306452|NCT01524978|1037743|P4|Overall Study|Withdrawal by Subject|1
306453|NCT01524978|1037744|P3|Overall Study|Withdrawal by Subject|1
306454|NCT01524978|1037745|P2|Overall Study|Withdrawal by Subject|0
306455|NCT01524978|1037746|P1|Overall Study|Withdrawal by Subject|12
306456|NCT01524978|1037736|P11|Overall Study|Other|5
306457|NCT01524978|1037737|P10|Overall Study|Other|2
306458|NCT01524978|1037738|P9|Overall Study|Other|2
306459|NCT01524978|1037739|P8|Overall Study|Other|1
306460|NCT01524978|1037740|P7|Overall Study|Other|17
306461|NCT01524978|1037741|P6|Overall Study|Other|3
306462|NCT01524978|1037742|P5|Overall Study|Other|1
306463|NCT01524978|1037743|P4|Overall Study|Other|2
306464|NCT01524978|1037744|P3|Overall Study|Other|1
306465|NCT01524978|1037745|P2|Overall Study|Other|2
306466|NCT01524978|1037746|P1|Overall Study|Other|16
306467|NCT01524913|1037874|P3|Overall Study|Lost to Follow-up|0
306468|NCT01524913|1037875|P2|Overall Study|Lost to Follow-up|0
306469|NCT01524913|1037876|P1|Overall Study|Lost to Follow-up|4
306470|NCT01524900|1037898|P5|Overall Study|No reason documented|0
306471|NCT01524900|1037899|P4|Overall Study|No reason documented|1
306472|NCT01524900|1037900|P3|Overall Study|No reason documented|0
306473|NCT01524900|1037901|P2|Overall Study|No reason documented|1
306474|NCT01524900|1037902|P1|Overall Study|No reason documented|2
306475|NCT01524900|1037898|P5|Overall Study|Other reason than stated above|0
306476|NCT01524900|1037899|P4|Overall Study|Other reason than stated above|0
306477|NCT01524900|1037900|P3|Overall Study|Other reason than stated above|0
306478|NCT01524900|1037901|P2|Overall Study|Other reason than stated above|1
306479|NCT01524900|1037902|P1|Overall Study|Other reason than stated above|1
306480|NCT01524900|1037898|P5|Overall Study|Lost to Follow-up|0
306481|NCT01524900|1037899|P4|Overall Study|Lost to Follow-up|0
306482|NCT01524900|1037900|P3|Overall Study|Lost to Follow-up|1
306483|NCT01524900|1037901|P2|Overall Study|Lost to Follow-up|12
306484|NCT01524900|1037902|P1|Overall Study|Lost to Follow-up|3
306485|NCT01524887|1037947|P3|Overall Study|Use of prohibited medication|0
306486|NCT01524887|1037948|P2|Overall Study|Use of prohibited medication|0
306487|NCT01524887|1037949|P1|Overall Study|Use of prohibited medication|1
306488|NCT01524887|1037947|P3|Overall Study|Withdrawal by Caregiver|2
306489|NCT01524887|1037948|P2|Overall Study|Withdrawal by Caregiver|0
306490|NCT01524887|1037949|P1|Overall Study|Withdrawal by Caregiver|0
306491|NCT01524887|1037947|P3|Overall Study|Study termination|79
306492|NCT01524887|1037948|P2|Overall Study|Study termination|87
306493|NCT01524887|1037949|P1|Overall Study|Study termination|73
306494|NCT01524887|1037947|P3|Overall Study|Protocol Violation|1
306495|NCT01524887|1037948|P2|Overall Study|Protocol Violation|0
306496|NCT01524887|1037949|P1|Overall Study|Protocol Violation|0
306497|NCT01524887|1037947|P3|Overall Study|Adverse Event|1
306498|NCT01524887|1037948|P2|Overall Study|Adverse Event|1
306499|NCT01524887|1037949|P1|Overall Study|Adverse Event|5
306500|NCT01524887|1037947|P3|Overall Study|Withdrawal by Subject|3
306501|NCT01524887|1037948|P2|Overall Study|Withdrawal by Subject|2
306502|NCT01524887|1037949|P1|Overall Study|Withdrawal by Subject|6
306503|NCT01524796|1037993|P1|Overall Study|Adverse Event and Lack of Efficacy|1
306504|NCT01524796|1037993|P1|Overall Study|Switch to carbamazapine|1
306505|NCT01524796|1037993|P1|Overall Study|Nervous about confidentiality|1
306506|NCT01524796|1037993|P1|Overall Study|Gall stone surgery|1
306507|NCT01524796|1037993|P1|Overall Study|Deterioration of pains|1
306508|NCT01524796|1037993|P1|Overall Study|Move|1
306509|NCT01524796|1037993|P1|Overall Study|Withdrawal by Subject|4
306510|NCT01524796|1037993|P1|Overall Study|The price|1
306511|NCT01524796|1037993|P1|Overall Study|Lost to Follow-up|1
306512|NCT01524796|1037993|P1|Overall Study|Lack of Efficacy|3
306513|NCT01524796|1037993|P1|Overall Study|Adverse Event|13
306514|NCT01524783|1038008|P2|Randomized and Treated|Death|1
306515|NCT01524783|1038009|P1|Randomized and Treated|Death|4
306516|NCT01524783|1038008|P2|Randomized and Treated|Protocol Violation|1
306517|NCT01524783|1038009|P1|Randomized and Treated|Protocol Violation|1
306518|NCT01524783|1038008|P2|Randomized and Treated|Withdrawal by Subject|5
306519|NCT01524783|1038009|P1|Randomized and Treated|Withdrawal by Subject|15
306520|NCT01524783|1038008|P2|Randomized and Treated|Disease Progression|70
306521|NCT01524783|1038009|P1|Randomized and Treated|Disease Progression|76
306522|NCT01524783|1038008|P2|Randomized and Treated|Adverse Event|7
306523|NCT01524783|1038009|P1|Randomized and Treated|Adverse Event|59
306524|NCT01524783|1038008|P2|Randomized But Not Treated|Randomized, did not receive drug|0
306525|NCT01524783|1038009|P1|Randomized But Not Treated|Randomized, did not receive drug|2
306526|NCT01524770|1038031|P2|First Intervention|Protocol Violation|0
306527|NCT01524770|1038032|P1|First Intervention|Protocol Violation|1
306528|NCT01524770|1038031|P2|First Intervention|Adverse Event|1
306529|NCT01524770|1038032|P1|First Intervention|Adverse Event|1
306530|NCT01524770|1038031|P2|First Intervention|Withdrawal by Subject|0
306531|NCT01524770|1038032|P1|First Intervention|Withdrawal by Subject|1
306532|NCT01524692|1038042|P1|Overall Study|Withdrawal by Subject|3
306533|NCT01524627|1038052|P2|Overall Study|Lost to Follow-up|1
306534|NCT01524627|1038053|P1|Overall Study|Lost to Follow-up|1
306535|NCT01524627|1038052|P2|Overall Study|Physician Decision|1
306536|NCT01524627|1038053|P1|Overall Study|Physician Decision|0
306537|NCT01524198|1038080|P2|Overall Study|Withdrawal by Subject|10
306538|NCT01524198|1038081|P1|Overall Study|Withdrawal by Subject|15
306539|NCT01524198|1038080|P2|Overall Study|Protocol Violation|6
306540|NCT01524198|1038081|P1|Overall Study|Protocol Violation|8
306541|NCT01524133|1038092|P3|Overall Study 52 Weeks|Lost to Follow-up|15
306542|NCT01524133|1038093|P2|Overall Study 52 Weeks|Lost to Follow-up|15
306543|NCT01524133|1038094|P1|Overall Study 52 Weeks|Lost to Follow-up|16
306544|NCT01524133|1038092|P3|Overall Study 52 Weeks|Physician Decision|2
306545|NCT01524133|1038093|P2|Overall Study 52 Weeks|Physician Decision|0
306546|NCT01524133|1038094|P1|Overall Study 52 Weeks|Physician Decision|1
306547|NCT01524133|1038092|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
306548|NCT01524133|1038093|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
306549|NCT01524133|1038094|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
306550|NCT01524133|1038092|P3|Treatment Phase|Lost to Follow-up|2
306551|NCT01524133|1038093|P2|Treatment Phase|Lost to Follow-up|1
306552|NCT01524133|1038094|P1|Treatment Phase|Lost to Follow-up|0
306553|NCT01524133|1038092|P3|Treatment Phase|Physician Decision|3
306554|NCT01524133|1038093|P2|Treatment Phase|Physician Decision|3
306555|NCT01524133|1038094|P1|Treatment Phase|Physician Decision|6
306556|NCT01524133|1038092|P3|Treatment Phase|Withdrawal by Subject|31
306557|NCT01524133|1038093|P2|Treatment Phase|Withdrawal by Subject|28
306558|NCT01524133|1038094|P1|Treatment Phase|Withdrawal by Subject|13
306559|NCT01523886|1038137|P2|Overall Study|surgery cancelled|1
306560|NCT01523886|1038138|P1|Overall Study|surgery cancelled|0
306561|NCT01523873|1038144|P1|Overall Study|Protocol Violation|422
306562|NCT01523756|1038203|P2|Test Period 2|Withdrawal by Subject|1
306563|NCT01523756|1038204|P1|Test Period 2|Withdrawal by Subject|0
306564|NCT01523756|1038203|P2|Test Period 1|Adverse Event|0
306565|NCT01523756|1038204|P1|Test Period 1|Adverse Event|1
306566|NCT01523756|1038203|P2|Baseline Period|Adverse Event|1
306567|NCT01523756|1038204|P1|Baseline Period|Adverse Event|0
306568|NCT01523743|1038212|P2|Period 2|Adverse Event|0
306569|NCT01523743|1038213|P1|Period 2|Adverse Event|1
306570|NCT01523743|1038212|P2|Period 2|Withdrawal by Subject|2
306571|NCT01523743|1038213|P1|Period 2|Withdrawal by Subject|0
306572|NCT01523743|1038212|P2|Period 1|Felt unable to empty bladder|0
306573|NCT01523743|1038213|P1|Period 1|Felt unable to empty bladder|1
306574|NCT01523743|1038212|P2|Period 1|Lack of Efficacy|0
306575|NCT01523743|1038213|P1|Period 1|Lack of Efficacy|1
306576|NCT01523743|1038212|P2|Period 1|Lost to Follow-up|0
306577|NCT01523743|1038213|P1|Period 1|Lost to Follow-up|1
306578|NCT01523743|1038212|P2|Period 1|Withdrawal by Subject|2
306579|NCT01523743|1038213|P1|Period 1|Withdrawal by Subject|6
306580|NCT01523743|1038212|P2|Period 1|Adverse Event|0
306581|NCT01523743|1038213|P1|Period 1|Adverse Event|1
306582|NCT01523587|1038236|P2|Overall Study|Randomised but not treated|2
306583|NCT01523587|1038237|P1|Overall Study|Randomised but not treated|6
306584|NCT01523587|1038236|P2|Overall Study|no reason given|3
306585|NCT01523587|1038237|P1|Overall Study|no reason given|2
306586|NCT01523587|1038236|P2|Overall Study|Withdrawal by Subject|12
306587|NCT01523587|1038237|P1|Overall Study|Withdrawal by Subject|23
306588|NCT01523587|1038236|P2|Overall Study|Lost to Follow-up|2
306589|NCT01523587|1038237|P1|Overall Study|Lost to Follow-up|2
306590|NCT01523587|1038236|P2|Overall Study|Non Compliance with protocol|1
306591|NCT01523587|1038237|P1|Overall Study|Non Compliance with protocol|2
306592|NCT01523587|1038236|P2|Overall Study|Adverse Event|34
306593|NCT01523587|1038237|P1|Overall Study|Adverse Event|52
306594|NCT01523457|1038278|P2|Overall Study|Withdrawal by Subject|2
306595|NCT01523457|1038279|P1|Overall Study|Withdrawal by Subject|7
306596|NCT01523392|1038297|P2|Washout Period - 10 to 14 Days|Adverse Event|0
306597|NCT01523392|1038298|P1|Washout Period - 10 to 14 Days|Adverse Event|1
306598|NCT01523392|1038297|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
306599|NCT01523392|1038298|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
306600|NCT01523392|1038297|P2|Treatment Period 1|Withdrawal by Subject|0
306601|NCT01523392|1038298|P1|Treatment Period 1|Withdrawal by Subject|2
306602|NCT01523366|1038314|P2|Treatment Period 2|Not completed at least 7 days treatment|0
306603|NCT01523366|1038315|P1|Treatment Period 2|Not completed at least 7 days treatment|1
306604|NCT01523366|1038314|P2|Treatment Period 1|Withdrawal by Subject|0
306605|NCT01523366|1038315|P1|Treatment Period 1|Withdrawal by Subject|1
306606|NCT01523301|1038331|P2|Overall Study|Other Reason|2
306607|NCT01523301|1038332|P1|Overall Study|Other Reason|0
306608|NCT01523301|1038331|P2|Overall Study|Withdrawal by Subject|8
306609|NCT01523301|1038332|P1|Overall Study|Withdrawal by Subject|6
306610|NCT01523301|1038331|P2|Overall Study|Lost to Follow-up|0
306611|NCT01523301|1038332|P1|Overall Study|Lost to Follow-up|1
306612|NCT01523301|1038331|P2|Overall Study|Protocol Violation|4
306613|NCT01523301|1038332|P1|Overall Study|Protocol Violation|3
306614|NCT01523301|1038331|P2|Overall Study|Lack of Efficacy|2
306615|NCT01523301|1038332|P1|Overall Study|Lack of Efficacy|0
306616|NCT01523301|1038331|P2|Overall Study|Adverse Event|16
306617|NCT01523301|1038332|P1|Overall Study|Adverse Event|25
306618|NCT01522976|1038353|P3|Overall Study|Not protocol specified|27
306619|NCT01522976|1038354|P2|Overall Study|Not protocol specified|27
306620|NCT01522976|1038355|P1|Overall Study|Not protocol specified|22
306621|NCT01522976|1038353|P3|Overall Study|Refusal unrelated to adverse event|14
306622|NCT01522976|1038354|P2|Overall Study|Refusal unrelated to adverse event|13
306623|NCT01522976|1038355|P1|Overall Study|Refusal unrelated to adverse event|10
306624|NCT01522976|1038353|P3|Overall Study|Adverse Event|18
306625|NCT01522976|1038354|P2|Overall Study|Adverse Event|7
306626|NCT01522976|1038355|P1|Overall Study|Adverse Event|17
306627|NCT01522976|1038353|P3|Overall Study|Disease progression|25
306628|NCT01522976|1038354|P2|Overall Study|Disease progression|30
306629|NCT01522976|1038355|P1|Overall Study|Disease progression|28
306630|NCT01522976|1038353|P3|Overall Study|Still on treatment|6
306631|NCT01522976|1038354|P2|Overall Study|Still on treatment|9
306632|NCT01522976|1038355|P1|Overall Study|Still on treatment|9
306633|NCT01522976|1038353|P3|Overall Study|Death|2
306634|NCT01522976|1038354|P2|Overall Study|Death|6
306635|NCT01522976|1038355|P1|Overall Study|Death|7
306636|NCT01522976|1038353|P3|Overall Study|Ineligible|1
306637|NCT01522976|1038354|P2|Overall Study|Ineligible|0
306638|NCT01522976|1038355|P1|Overall Study|Ineligible|4
306639|NCT01522456|1038435|P1|Overall Study|Tolerability Assessment|1
306640|NCT01522456|1038435|P1|Overall Study|Pregnancy|1
306641|NCT01522456|1038435|P1|Overall Study|Withdrawal by Subject|2
306642|NCT01522456|1038435|P1|Overall Study|Lost to Follow-up|2
306643|NCT01522456|1038435|P1|Overall Study|Adverse Event|2
306644|NCT01522443|1038498|P2|Overall Study|Other|3
306645|NCT01522443|1038499|P1|Overall Study|Other|1
306646|NCT01522443|1038498|P2|Overall Study|No study treatment given|1
306647|NCT01522443|1038499|P1|Overall Study|No study treatment given|1
306648|NCT01522443|1038498|P2|Overall Study|Withdrawal by Subject|8
306649|NCT01522443|1038499|P1|Overall Study|Withdrawal by Subject|5
306650|NCT01522443|1038498|P2|Overall Study|Adverse Event|15
306651|NCT01522443|1038499|P1|Overall Study|Adverse Event|10
306652|NCT01522443|1038498|P2|Overall Study|No longer receiving clinical benefit|28
306653|NCT01522443|1038499|P1|Overall Study|No longer receiving clinical benefit|36
306654|NCT01522235|1038516|P2|Overall Study|Physician Decision|1
306655|NCT01522235|1038517|P1|Overall Study|Physician Decision|1
306656|NCT01521923|1038553|P4|Overall Study|AE, captured in Period 1|1
306657|NCT01521923|1038554|P3|Overall Study|AE, captured in Period 1|0
306658|NCT01521923|1038555|P2|Overall Study|AE, captured in Period 1|1
306659|NCT01521923|1038556|P1|Overall Study|AE, captured in Period 1|0
306660|NCT01521923|1038553|P4|Overall Study|Other|6
306661|NCT01521923|1038554|P3|Overall Study|Other|3
306662|NCT01521923|1038555|P2|Overall Study|Other|1
306663|NCT01521923|1038556|P1|Overall Study|Other|2
306664|NCT01521923|1038553|P4|Overall Study|Withdrawal by Subject|2
306665|NCT01521923|1038554|P3|Overall Study|Withdrawal by Subject|1
306666|NCT01521923|1038555|P2|Overall Study|Withdrawal by Subject|1
306667|NCT01521923|1038556|P1|Overall Study|Withdrawal by Subject|1
306668|NCT01521923|1038553|P4|Overall Study|Lost to Follow-up|1
306669|NCT01521923|1038554|P3|Overall Study|Lost to Follow-up|2
306670|NCT01521923|1038555|P2|Overall Study|Lost to Follow-up|0
306671|NCT01521923|1038556|P1|Overall Study|Lost to Follow-up|1
306672|NCT01521923|1038553|P4|Overall Study|Protocol Violation|0
306673|NCT01521923|1038554|P3|Overall Study|Protocol Violation|1
306674|NCT01521923|1038555|P2|Overall Study|Protocol Violation|0
306675|NCT01521923|1038556|P1|Overall Study|Protocol Violation|0
306676|NCT01521923|1038553|P4|Overall Study|Lack of Efficacy|0
306677|NCT01521923|1038554|P3|Overall Study|Lack of Efficacy|0
306678|NCT01521923|1038555|P2|Overall Study|Lack of Efficacy|1
306679|NCT01521923|1038556|P1|Overall Study|Lack of Efficacy|1
306680|NCT01521923|1038553|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
306681|NCT01521923|1038554|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
306682|NCT01521923|1038555|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
306683|NCT01521923|1038556|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
306684|NCT01521923|1038553|P4|Overall Study|AE, non-serious, non-fatal|2
306685|NCT01521923|1038554|P3|Overall Study|AE, non-serious, non-fatal|6
306686|NCT01521923|1038555|P2|Overall Study|AE, non-serious, non-fatal|3
306687|NCT01521923|1038556|P1|Overall Study|AE, non-serious, non-fatal|1
306688|NCT01521923|1038553|P4|Overall Study|SAE, non-fatal|0
306689|NCT01521923|1038554|P3|Overall Study|SAE, non-fatal|2
306690|NCT01521923|1038555|P2|Overall Study|SAE, non-fatal|2
306691|NCT01521923|1038556|P1|Overall Study|SAE, non-fatal|0
306692|NCT01521923|1038553|P4|Overall Study|AE, serious fatal|0
306693|NCT01521923|1038554|P3|Overall Study|AE, serious fatal|0
306694|NCT01521923|1038555|P2|Overall Study|AE, serious fatal|0
306695|NCT01521923|1038556|P1|Overall Study|AE, serious fatal|1
306696|NCT01521897|1038676|P1|Overall Study|Lost to Follow-up|5
306697|NCT01521897|1038676|P1|Overall Study|Protocol Violation|18
306698|NCT01521884|1038688|P1|Overall Study|Lost to Follow-up|4
306699|NCT01521884|1038688|P1|Overall Study|Participant non-eligible|1
306700|NCT01521884|1038688|P1|Overall Study|Protocol Violation|3
306701|NCT01521884|1038688|P1|Overall Study|Physician Decision|2
306702|NCT01521884|1038688|P1|Overall Study|Withdrawal by Subject|1
306703|NCT01521884|1038688|P1|Overall Study|Pregnancy|1
306704|NCT01521884|1038688|P1|Overall Study|Adverse Event|5
306705|NCT01521884|1038688|P1|Overall Study|Non Responders|10
306706|NCT01521559|1038785|P2|Overall Study|Other|2
306707|NCT01521559|1038786|P1|Overall Study|Other|1
306708|NCT01521559|1038785|P2|Overall Study|Protocol Violation|0
306709|NCT01521559|1038786|P1|Overall Study|Protocol Violation|1
306710|NCT01521559|1038785|P2|Overall Study|Lost to Follow-up|1
306711|NCT01521559|1038786|P1|Overall Study|Lost to Follow-up|3
306712|NCT01521559|1038785|P2|Overall Study|Withdrawal by Subject|11
306713|NCT01521559|1038786|P1|Overall Study|Withdrawal by Subject|9
306714|NCT01521559|1038785|P2|Overall Study|Death|0
306715|NCT01521559|1038786|P1|Overall Study|Death|1
306716|NCT01521559|1038785|P2|Overall Study|Adverse Event|4
306717|NCT01521559|1038786|P1|Overall Study|Adverse Event|0
306718|NCT01521507|1038809|P2|Stage 2: Observational Design|Physician Decision|0
306719|NCT01521507|1038810|P1|Stage 2: Observational Design|Physician Decision|1
306720|NCT01521507|1038809|P2|Stage 2: Observational Design|Withdrawal by Subject|1
306721|NCT01521507|1038810|P1|Stage 2: Observational Design|Withdrawal by Subject|3
306722|NCT01521507|1038809|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
306723|NCT01521507|1038810|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
306724|NCT01521507|1038809|P2|Stage 1: Randomized Design|Lost to Follow-up|2
306725|NCT01521507|1038810|P1|Stage 1: Randomized Design|Lost to Follow-up|0
306726|NCT01521507|1038809|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
306727|NCT01521507|1038810|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
306728|NCT01521507|1038809|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
306729|NCT01521507|1038810|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
306730|NCT01521364|1038827|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
306731|NCT01521364|1038827|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
306732|NCT01520987|1038903|P8|Overall Study|Withdrawal by Subject|0
306733|NCT01520987|1038904|P7|Overall Study|Withdrawal by Subject|0
306734|NCT01520987|1038905|P6|Overall Study|Withdrawal by Subject|1
306735|NCT01520987|1038906|P5|Overall Study|Withdrawal by Subject|0
306736|NCT01520987|1038907|P4|Overall Study|Withdrawal by Subject|0
306737|NCT01520987|1038908|P3|Overall Study|Withdrawal by Subject|0
306738|NCT01520987|1038909|P2|Overall Study|Withdrawal by Subject|0
306739|NCT01520987|1038910|P1|Overall Study|Withdrawal by Subject|1
306740|NCT01520922|1038970|P2|Survival Follow-up|Withdrawal by Subject|0
306741|NCT01520922|1038971|P1|Survival Follow-up|Withdrawal by Subject|1
306742|NCT01520922|1038970|P2|Follow up|Lost to Follow-up|1
306743|NCT01520922|1038971|P1|Follow up|Lost to Follow-up|0
306744|NCT01520922|1038970|P2|Treatment Phase|Adverse Event|5
306745|NCT01520922|1038971|P1|Treatment Phase|Adverse Event|3
306746|NCT01520922|1038970|P2|Treatment Phase|Progression|2
306747|NCT01520922|1038971|P1|Treatment Phase|Progression|0
306748|NCT01520922|1038970|P2|Treatment Phase|Physician Decision|1
306749|NCT01520922|1038971|P1|Treatment Phase|Physician Decision|2
306750|NCT01520909|1039033|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
306751|NCT01520909|1039034|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
306752|NCT01520909|1039035|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
306753|NCT01520909|1039033|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
306754|NCT01520909|1039034|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
306755|NCT01520909|1039035|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
306756|NCT01520909|1039033|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
306757|NCT01520909|1039034|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
306758|NCT01520909|1039035|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
306759|NCT01520909|1039033|P3|Part 1 (Randomized Period)|Adverse Event|0
306760|NCT01520909|1039034|P2|Part 1 (Randomized Period)|Adverse Event|2
306761|NCT01520909|1039035|P1|Part 1 (Randomized Period)|Adverse Event|1
306762|NCT01520714|1039152|P2|Overall Study|Lack of Efficacy|1
306763|NCT01520714|1039153|P1|Overall Study|Lack of Efficacy|0
306764|NCT01520714|1039152|P2|Overall Study|Adverse Event|2
306765|NCT01520714|1039153|P1|Overall Study|Adverse Event|0
306766|NCT01520714|1039152|P2|Overall Study|Protocol Violation|3
306767|NCT01520714|1039153|P1|Overall Study|Protocol Violation|0
306768|NCT01520506|1039178|P1|Overall Study|Withdrawal by Subject|1
306769|NCT01520506|1039178|P1|Overall Study|Lost to Follow-up|1
306770|NCT01520506|1039178|P1|Overall Study|Missed Visit|4
306771|NCT01520402|1039233|P1|Overall Study|Physician Decision|3
306772|NCT01520402|1039233|P1|Overall Study|Withdrawal by Subject|2
306773|NCT01519960|1039256|P3|Overall Study|Lost to Follow-up|0
306774|NCT01519960|1039257|P2|Overall Study|Lost to Follow-up|1
306775|NCT01519960|1039258|P1|Overall Study|Lost to Follow-up|0
306776|NCT01519960|1039256|P3|Overall Study|Withdrawal by Subject|0
306777|NCT01519960|1039257|P2|Overall Study|Withdrawal by Subject|4
306778|NCT01519960|1039258|P1|Overall Study|Withdrawal by Subject|0
306779|NCT01519960|1039256|P3|Overall Study|Adverse Event|0
306780|NCT01519960|1039257|P2|Overall Study|Adverse Event|1
306781|NCT01519960|1039258|P1|Overall Study|Adverse Event|0
306782|NCT01519960|1039256|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
306783|NCT01519960|1039257|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
306784|NCT01519960|1039258|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
306785|NCT01519960|1039256|P3|Overall Study|Ongoing in Follow-Up|10
306786|NCT01519960|1039257|P2|Overall Study|Ongoing in Follow-Up|11
306787|NCT01519960|1039258|P1|Overall Study|Ongoing in Follow-Up|101
306788|NCT01519934|1039364|P1|Overall Study|Lost to Follow-up|3
306789|NCT01519921|1039373|P2|Overall Study|High alanine aminotransferase (ALT)|1
306790|NCT01519921|1039374|P1|Overall Study|High alanine aminotransferase (ALT)|0
306791|NCT01519921|1039373|P2|Overall Study|Treatment refusal|1
306792|NCT01519921|1039374|P1|Overall Study|Treatment refusal|2
306793|NCT01519921|1039373|P2|Overall Study|Lost to Follow-up|1
306794|NCT01519921|1039374|P1|Overall Study|Lost to Follow-up|2
306795|NCT01519921|1039373|P2|Overall Study|Withdrawal by Subject|0
306796|NCT01519921|1039374|P1|Overall Study|Withdrawal by Subject|3
306797|NCT01519921|1039373|P2|Overall Study|Lack of Efficacy|3
306798|NCT01519921|1039374|P1|Overall Study|Lack of Efficacy|4
306799|NCT01519921|1039373|P2|Overall Study|Adverse Event|9
306800|NCT01519921|1039374|P1|Overall Study|Adverse Event|10
306801|NCT01519817|1039423|P4|Overall Study|Off study due to infection|1
306802|NCT01519817|1039424|P3|Overall Study|Off study due to infection|0
306803|NCT01519817|1039425|P2|Overall Study|Off study due to infection|0
306804|NCT01519817|1039426|P1|Overall Study|Off study due to infection|0
306805|NCT01519817|1039423|P4|Overall Study|Withdrawal by Subject|0
306806|NCT01519817|1039424|P3|Overall Study|Withdrawal by Subject|0
306807|NCT01519817|1039425|P2|Overall Study|Withdrawal by Subject|0
306808|NCT01519817|1039426|P1|Overall Study|Withdrawal by Subject|1
306809|NCT01519791|1039466|P2|Overall Study|Lost to Follow-up|14
306810|NCT01519791|1039467|P1|Overall Study|Lost to Follow-up|6
306811|NCT01519791|1039466|P2|Overall Study|Withdrawal by Subject|37
306812|NCT01519791|1039467|P1|Overall Study|Withdrawal by Subject|15
306813|NCT01519791|1039466|P2|Overall Study|AE, non-serious non-fatal|31
306814|NCT01519791|1039467|P1|Overall Study|AE, non-serious non-fatal|12
306815|NCT01519791|1039466|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
306816|NCT01519791|1039467|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
306817|NCT01519791|1039466|P2|Overall Study|AE, serious fatal|1
306818|NCT01519791|1039467|P1|Overall Study|AE, serious fatal|0
306819|NCT01519791|1039466|P2|Overall Study|SAE, non-fatal|22
306820|NCT01519791|1039467|P1|Overall Study|SAE, non-fatal|6
306821|NCT01519791|1039466|P2|Overall Study|Lack of Efficacy|20
306822|NCT01519791|1039467|P1|Overall Study|Lack of Efficacy|16
306823|NCT01519791|1039466|P2|Overall Study|subjects randomized in error|0
306824|NCT01519791|1039467|P1|Overall Study|subjects randomized in error|2
306825|NCT01519791|1039466|P2|Overall Study|Other Reason|222
306826|NCT01519791|1039467|P1|Overall Study|Other Reason|87
306827|NCT01519791|1039466|P2|Overall Study|Protocol Violation|19
306828|NCT01519791|1039467|P1|Overall Study|Protocol Violation|6
306829|NCT01519791|1039466|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
306830|NCT01519791|1039467|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
306831|NCT01519778|1039531|P1|Overall Study|Physician Decision|1
306832|NCT01519778|1039531|P1|Overall Study|Lost to Follow-up|10
306833|NCT01519778|1039531|P1|Overall Study|Withdrawal by Subject|3
306834|NCT01519765|1039537|P2|Overall Study|Withdrawal by Subject|1
306835|NCT01519765|1039538|P1|Overall Study|Withdrawal by Subject|0
306836|NCT01519765|1039537|P2|Overall Study|Protocol Violation|0
306837|NCT01519765|1039538|P1|Overall Study|Protocol Violation|1
306838|NCT01519765|1039537|P2|Overall Study|Lack of Efficacy|0
306839|NCT01519765|1039538|P1|Overall Study|Lack of Efficacy|2
306840|NCT01519765|1039537|P2|Overall Study|Adverse Event|1
306841|NCT01519765|1039538|P1|Overall Study|Adverse Event|0
306842|NCT01519700|1039616|P4|Overall Study|Other Reason|4
306843|NCT01519700|1039617|P3|Overall Study|Other Reason|0
306844|NCT01519700|1039618|P2|Overall Study|Other Reason|2
306845|NCT01519700|1039619|P1|Overall Study|Other Reason|2
306846|NCT01519700|1039616|P4|Overall Study|Withdrawal by Subject|2
306847|NCT01519700|1039617|P3|Overall Study|Withdrawal by Subject|3
306848|NCT01519700|1039618|P2|Overall Study|Withdrawal by Subject|3
306849|NCT01519700|1039619|P1|Overall Study|Withdrawal by Subject|5
306850|NCT01519700|1039616|P4|Overall Study|Physician Decision|0
306851|NCT01519700|1039617|P3|Overall Study|Physician Decision|3
306852|NCT01519700|1039618|P2|Overall Study|Physician Decision|1
306853|NCT01519700|1039619|P1|Overall Study|Physician Decision|1
306854|NCT01519700|1039616|P4|Overall Study|Lost to Follow-up|1
306855|NCT01519700|1039617|P3|Overall Study|Lost to Follow-up|1
306856|NCT01519700|1039618|P2|Overall Study|Lost to Follow-up|0
306857|NCT01519700|1039619|P1|Overall Study|Lost to Follow-up|0
306858|NCT01519700|1039616|P4|Overall Study|Death|0
306859|NCT01519700|1039617|P3|Overall Study|Death|0
306860|NCT01519700|1039618|P2|Overall Study|Death|0
306861|NCT01519700|1039619|P1|Overall Study|Death|1
306862|NCT01519674|1039654|P3|Overall Study|Unsclassified|3
306863|NCT01519674|1039655|P2|Overall Study|Unsclassified|4
306864|NCT01519674|1039656|P1|Overall Study|Unsclassified|10
306865|NCT01519674|1039654|P3|Overall Study|Withdrawal Criteria|7
306866|NCT01519674|1039655|P2|Overall Study|Withdrawal Criteria|2
306867|NCT01519674|1039656|P1|Overall Study|Withdrawal Criteria|7
306868|NCT01519674|1039654|P3|Overall Study|Protocol Violation|1
306869|NCT01519674|1039655|P2|Overall Study|Protocol Violation|3
306870|NCT01519674|1039656|P1|Overall Study|Protocol Violation|0
306871|NCT01519674|1039654|P3|Overall Study|Lack of Efficacy|1
306872|NCT01519674|1039655|P2|Overall Study|Lack of Efficacy|1
306873|NCT01519674|1039656|P1|Overall Study|Lack of Efficacy|1
306874|NCT01519674|1039654|P3|Overall Study|Adverse Event|0
306875|NCT01519674|1039655|P2|Overall Study|Adverse Event|3
306876|NCT01519674|1039656|P1|Overall Study|Adverse Event|3
306877|NCT01519661|1039694|P1|Overall Study|Adverse Event|29
306878|NCT01519661|1039694|P1|Overall Study|Lack of Efficacy|6
306879|NCT01519661|1039694|P1|Overall Study|Withdrawal by Subject|17
306880|NCT01519661|1039694|P1|Overall Study|Lost to Follow-up|3
306881|NCT01519661|1039694|P1|Overall Study|Protocol deviation|6
306882|NCT01519518|1039720|P2|Overall Study|Consent not available|10
306883|NCT01519518|1039721|P1|Overall Study|Consent not available|7
306884|NCT01519427|1039746|P1|Overall Study|disease progression|2
306885|NCT01519323|1039753|P2|Overall Study|Study terminated by sponsor|1
306886|NCT01519323|1039754|P1|Overall Study|Study terminated by sponsor|0
306887|NCT01519323|1039753|P2|Overall Study|Death|2
306888|NCT01519323|1039754|P1|Overall Study|Death|3
306889|NCT01519245|1039814|P2|Overall Study|Met exclusion criteria, not analysed|2
306890|NCT01519245|1039815|P1|Overall Study|Met exclusion criteria, not analysed|1
306891|NCT01519206|1039827|P1|Overall Study|Missed Visit|2
306892|NCT01519206|1039827|P1|Overall Study|Lost to Follow-up|3
306893|NCT01519167|1039841|P2|Overall Study|Physician Decision|1
306894|NCT01519167|1039842|P1|Overall Study|Physician Decision|0
306895|NCT01519167|1039841|P2|Overall Study|Medical condition changes&deep sedation|2
306896|NCT01519167|1039842|P1|Overall Study|Medical condition changes&deep sedation|0
306897|NCT01519167|1039841|P2|Overall Study|Lack of Efficacy|1
306898|NCT01519167|1039842|P1|Overall Study|Lack of Efficacy|0
306899|NCT01519167|1039841|P2|Overall Study|Adverse Event|1
306900|NCT01519167|1039842|P1|Overall Study|Adverse Event|0
306901|NCT01519167|1039841|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
306902|NCT01519167|1039842|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
306903|NCT01519089|1039868|P2|Overall Study|Not received study drug|1
306904|NCT01519089|1039869|P1|Overall Study|Not received study drug|0
306905|NCT01519089|1039868|P2|Overall Study|Other|6
306906|NCT01519089|1039869|P1|Overall Study|Other|2
306907|NCT01519089|1039868|P2|Overall Study|Withdrawal by Subject|2
306908|NCT01519089|1039869|P1|Overall Study|Withdrawal by Subject|0
306909|NCT01519089|1039868|P2|Overall Study|Lost to Follow-up|0
306910|NCT01519089|1039869|P1|Overall Study|Lost to Follow-up|1
306911|NCT01519089|1039868|P2|Overall Study|Lack of Efficacy|2
306912|NCT01519089|1039869|P1|Overall Study|Lack of Efficacy|0
306913|NCT01519089|1039868|P2|Overall Study|Adverse Event|4
306914|NCT01519089|1039869|P1|Overall Study|Adverse Event|4
306915|NCT01518946|1039990|P3|Randomized Phase (First Intervention)|Not specified|0
306916|NCT01518946|1039991|P2|Randomized Phase (First Intervention)|Not specified|1
306917|NCT01518946|1039992|P1|Randomized Phase (First Intervention)|Not specified|0
306918|NCT01518946|1039990|P3|Open-label Phase|Not specified|0
306919|NCT01518946|1039991|P2|Open-label Phase|Not specified|0
306920|NCT01518946|1039992|P1|Open-label Phase|Not specified|4
306921|NCT01518374|1040003|P1|Overall Study|Lost to Follow-up|2
306922|NCT01518374|1040003|P1|Overall Study|Protocol Violation|3
306923|NCT01518374|1040003|P1|Overall Study|Withdrawal by Subject|2
306924|NCT01518322|1040007|P1|Overall Study|FeNO measurement was missing|13
306925|NCT01518257|1040028|P2|Overall Study|Other Miscellaneous Reason|0
306926|NCT01518257|1040029|P1|Overall Study|Other Miscellaneous Reason|1
306927|NCT01518257|1040028|P2|Overall Study|Lost to Follow-up|0
306928|NCT01518257|1040029|P1|Overall Study|Lost to Follow-up|1
306929|NCT01518244|1040051|P1|Overall Study|Adverse Event|3
306930|NCT01518192|1040059|P3|Overall Study|Lost to Follow-up|35
306931|NCT01518192|1040060|P2|Overall Study|Lost to Follow-up|26
306932|NCT01518192|1040061|P1|Overall Study|Lost to Follow-up|29
306933|NCT01518153|1040082|P3|Donor Lymphocyte Infusion|Death|1
306934|NCT01518153|1040083|P2|Donor Lymphocyte Infusion|Death|2
306935|NCT01518153|1040084|P1|Donor Lymphocyte Infusion|Death|0
306936|NCT01518153|1040082|P3|Stem Cell Transplant|Adverse Event|0
306937|NCT01518153|1040083|P2|Stem Cell Transplant|Adverse Event|0
306938|NCT01518153|1040084|P1|Stem Cell Transplant|Adverse Event|1
306939|NCT01518153|1040082|P3|Stem Cell Transplant|Secondary graft failure|0
306940|NCT01518153|1040083|P2|Stem Cell Transplant|Secondary graft failure|0
306941|NCT01518153|1040084|P1|Stem Cell Transplant|Secondary graft failure|1
306942|NCT01518153|1040082|P3|Stem Cell Transplant|Death|0
306943|NCT01518153|1040083|P2|Stem Cell Transplant|Death|0
306944|NCT01518153|1040084|P1|Stem Cell Transplant|Death|2
306945|NCT01518153|1040082|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
306946|NCT01518153|1040083|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
306947|NCT01518153|1040084|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
306948|NCT01517984|1040095|P4|Overall Study|Ineligible for randomization|0
306949|NCT01517984|1040096|P3|Overall Study|Ineligible for randomization|0
306950|NCT01517984|1040097|P2|Overall Study|Ineligible for randomization|14
306951|NCT01517984|1040098|P1|Overall Study|Ineligible for randomization|0
306952|NCT01517984|1040095|P4|Overall Study|Screen Failure|0
306953|NCT01517984|1040096|P3|Overall Study|Screen Failure|0
306954|NCT01517984|1040097|P2|Overall Study|Screen Failure|0
306955|NCT01517984|1040098|P1|Overall Study|Screen Failure|4
306956|NCT01517984|1040095|P4|Overall Study|Withdrawal by Subject|1
306957|NCT01517984|1040096|P3|Overall Study|Withdrawal by Subject|4
306958|NCT01517984|1040097|P2|Overall Study|Withdrawal by Subject|8
306959|NCT01517984|1040098|P1|Overall Study|Withdrawal by Subject|1
306960|NCT01517984|1040095|P4|Overall Study|Lost to Follow-up|0
306961|NCT01517984|1040096|P3|Overall Study|Lost to Follow-up|0
306962|NCT01517984|1040097|P2|Overall Study|Lost to Follow-up|1
306963|NCT01517984|1040098|P1|Overall Study|Lost to Follow-up|0
306964|NCT01517867|1040133|P2|Overall Study|Still in treatment at study end|3
306965|NCT01517867|1040134|P1|Overall Study|Still in treatment at study end|0
306966|NCT01517867|1040133|P2|Overall Study|Withdrawal by Subject|30
306967|NCT01517867|1040134|P1|Overall Study|Withdrawal by Subject|34
306968|NCT01517867|1040133|P2|Overall Study|never started treatment|32
306969|NCT01517867|1040134|P1|Overall Study|never started treatment|29
306970|NCT01517750|1040146|P4|Overall Study|Lost to Follow-up|1
306971|NCT01517750|1040147|P3|Overall Study|Lost to Follow-up|4
306972|NCT01517750|1040148|P2|Overall Study|Lost to Follow-up|2
306973|NCT01517750|1040149|P1|Overall Study|Lost to Follow-up|1
306974|NCT01517412|1040186|P2|Overall Study|Other than specified above|5
306975|NCT01517412|1040187|P1|Overall Study|Other than specified above|8
306976|NCT01517412|1040186|P2|Overall Study|Poor compliance to protocol|3
306977|NCT01517412|1040187|P1|Overall Study|Poor compliance to protocol|8
306978|NCT01517412|1040186|P2|Overall Study|Lack of Efficacy|5
306979|NCT01517412|1040187|P1|Overall Study|Lack of Efficacy|10
306980|NCT01517412|1040186|P2|Overall Study|Adverse Event|11
306981|NCT01517412|1040187|P1|Overall Study|Adverse Event|10
306982|NCT01517373|1040216|P6|Treatment Period|Medication error without AEs|2
306983|NCT01517373|1040217|P5|Treatment Period|Medication error without AEs|0
306984|NCT01517373|1040218|P4|Treatment Period|Medication error without AEs|1
306985|NCT01517373|1040219|P3|Treatment Period|Medication error without AEs|2
306986|NCT01517373|1040220|P2|Treatment Period|Medication error without AEs|0
306987|NCT01517373|1040221|P1|Treatment Period|Medication error without AEs|0
306988|NCT01517373|1040216|P6|Treatment Period|Lack of Efficacy|0
306989|NCT01517373|1040217|P5|Treatment Period|Lack of Efficacy|2
306990|NCT01517373|1040218|P4|Treatment Period|Lack of Efficacy|3
306991|NCT01517373|1040219|P3|Treatment Period|Lack of Efficacy|1
306992|NCT01517373|1040220|P2|Treatment Period|Lack of Efficacy|1
306993|NCT01517373|1040221|P1|Treatment Period|Lack of Efficacy|0
306994|NCT01517373|1040216|P6|Treatment Period|Protocol Violation|0
306995|NCT01517373|1040217|P5|Treatment Period|Protocol Violation|1
306996|NCT01517373|1040218|P4|Treatment Period|Protocol Violation|0
306997|NCT01517373|1040219|P3|Treatment Period|Protocol Violation|0
306998|NCT01517373|1040220|P2|Treatment Period|Protocol Violation|0
306999|NCT01517373|1040221|P1|Treatment Period|Protocol Violation|0
307000|NCT01517373|1040216|P6|Treatment Period|Other|0
307001|NCT01517373|1040217|P5|Treatment Period|Other|1
307002|NCT01517373|1040218|P4|Treatment Period|Other|0
307003|NCT01517373|1040219|P3|Treatment Period|Other|0
307004|NCT01517373|1040220|P2|Treatment Period|Other|0
307005|NCT01517373|1040221|P1|Treatment Period|Other|0
307006|NCT01517373|1040216|P6|Treatment Period|Withdrawal by Subject|3
307007|NCT01517373|1040217|P5|Treatment Period|Withdrawal by Subject|2
307008|NCT01517373|1040218|P4|Treatment Period|Withdrawal by Subject|2
307009|NCT01517373|1040219|P3|Treatment Period|Withdrawal by Subject|2
307010|NCT01517373|1040220|P2|Treatment Period|Withdrawal by Subject|3
307011|NCT01517373|1040221|P1|Treatment Period|Withdrawal by Subject|0
307012|NCT01517373|1040216|P6|Treatment Period|Lost to Follow-up|0
307013|NCT01517373|1040217|P5|Treatment Period|Lost to Follow-up|0
307014|NCT01517373|1040218|P4|Treatment Period|Lost to Follow-up|1
307015|NCT01517373|1040219|P3|Treatment Period|Lost to Follow-up|1
307016|NCT01517373|1040220|P2|Treatment Period|Lost to Follow-up|0
307017|NCT01517373|1040221|P1|Treatment Period|Lost to Follow-up|0
307018|NCT01517373|1040216|P6|Treatment Period|Adverse Event|2
307019|NCT01517373|1040217|P5|Treatment Period|Adverse Event|0
307020|NCT01517373|1040218|P4|Treatment Period|Adverse Event|0
307021|NCT01517373|1040219|P3|Treatment Period|Adverse Event|0
307022|NCT01517373|1040220|P2|Treatment Period|Adverse Event|0
307023|NCT01517373|1040221|P1|Treatment Period|Adverse Event|0
307024|NCT01517373|1040216|P6|Run-in Period|Other|0
307025|NCT01517373|1040217|P5|Run-in Period|Other|0
307026|NCT01517373|1040218|P4|Run-in Period|Other|0
307027|NCT01517373|1040219|P3|Run-in Period|Other|0
307028|NCT01517373|1040220|P2|Run-in Period|Other|0
307029|NCT01517373|1040221|P1|Run-in Period|Other|1
307030|NCT01517373|1040216|P6|Run-in Period|Sponsor Decision|0
307031|NCT01517373|1040217|P5|Run-in Period|Sponsor Decision|0
307032|NCT01517373|1040218|P4|Run-in Period|Sponsor Decision|0
307033|NCT01517373|1040219|P3|Run-in Period|Sponsor Decision|0
307034|NCT01517373|1040220|P2|Run-in Period|Sponsor Decision|0
307035|NCT01517373|1040221|P1|Run-in Period|Sponsor Decision|3
307036|NCT01517373|1040216|P6|Run-in Period|Withdrawal by Subject|0
307037|NCT01517373|1040217|P5|Run-in Period|Withdrawal by Subject|0
307038|NCT01517373|1040218|P4|Run-in Period|Withdrawal by Subject|0
307039|NCT01517373|1040219|P3|Run-in Period|Withdrawal by Subject|0
307040|NCT01517373|1040220|P2|Run-in Period|Withdrawal by Subject|0
307041|NCT01517373|1040221|P1|Run-in Period|Withdrawal by Subject|12
307042|NCT01517373|1040216|P6|Run-in Period|Lost to Follow-up|0
307043|NCT01517373|1040217|P5|Run-in Period|Lost to Follow-up|0
307044|NCT01517373|1040218|P4|Run-in Period|Lost to Follow-up|0
307045|NCT01517373|1040219|P3|Run-in Period|Lost to Follow-up|0
307046|NCT01517373|1040220|P2|Run-in Period|Lost to Follow-up|0
307047|NCT01517373|1040221|P1|Run-in Period|Lost to Follow-up|1
307048|NCT01517373|1040216|P6|Run-in Period|Did not meet eligibility criteria|0
307049|NCT01517373|1040217|P5|Run-in Period|Did not meet eligibility criteria|0
307050|NCT01517373|1040218|P4|Run-in Period|Did not meet eligibility criteria|0
307051|NCT01517373|1040219|P3|Run-in Period|Did not meet eligibility criteria|0
307052|NCT01517373|1040220|P2|Run-in Period|Did not meet eligibility criteria|0
307053|NCT01517373|1040221|P1|Run-in Period|Did not meet eligibility criteria|34
307054|NCT01517373|1040216|P6|Run-in Period|Adverse Event|0
307055|NCT01517373|1040217|P5|Run-in Period|Adverse Event|0
307056|NCT01517373|1040218|P4|Run-in Period|Adverse Event|0
307057|NCT01517373|1040219|P3|Run-in Period|Adverse Event|0
307058|NCT01517373|1040220|P2|Run-in Period|Adverse Event|0
307059|NCT01517373|1040221|P1|Run-in Period|Adverse Event|5
307060|NCT01517373|1040216|P6|Run-in Period|Death|0
307061|NCT01517373|1040217|P5|Run-in Period|Death|0
307062|NCT01517373|1040218|P4|Run-in Period|Death|0
307063|NCT01517373|1040219|P3|Run-in Period|Death|0
307064|NCT01517373|1040220|P2|Run-in Period|Death|0
307065|NCT01517373|1040221|P1|Run-in Period|Death|1
307066|NCT01517295|1040291|P2|Overall Study|Physician Decision|0
307067|NCT01517295|1040292|P1|Overall Study|Physician Decision|1
307068|NCT01517282|1040306|P4|Overall Study|Physician Decision|0
307069|NCT01517282|1040307|P3|Overall Study|Physician Decision|0
307070|NCT01517282|1040308|P2|Overall Study|Physician Decision|0
307071|NCT01517282|1040309|P1|Overall Study|Physician Decision|1
307072|NCT01517282|1040306|P4|Overall Study|Consent withdrawn|1
307073|NCT01517282|1040307|P3|Overall Study|Consent withdrawn|1
307074|NCT01517282|1040308|P2|Overall Study|Consent withdrawn|1
307075|NCT01517282|1040309|P1|Overall Study|Consent withdrawn|0
307076|NCT01517178|1040343|P2|Period 2|E.g. study termination|2
307077|NCT01517178|1040344|P1|Period 2|E.g. study termination|2
307078|NCT01517178|1040343|P2|Period 2|Withdrawal by Subject|0
307079|NCT01517178|1040344|P1|Period 2|Withdrawal by Subject|3
307080|NCT01517178|1040343|P2|Period 2|Adverse Event|0
307081|NCT01517178|1040344|P1|Period 2|Adverse Event|1
307082|NCT01517178|1040343|P2|Period 1|Withdrawal by Subject|1
307083|NCT01517178|1040344|P1|Period 1|Withdrawal by Subject|0
307084|NCT01517178|1040343|P2|Period 1|E.g. study termination|1
307085|NCT01517178|1040344|P1|Period 1|E.g. study termination|3
307086|NCT01517178|1040343|P2|Period 1|Lack of Efficacy|1
307087|NCT01517178|1040344|P1|Period 1|Lack of Efficacy|0
307088|NCT01517178|1040343|P2|Period 1|Adverse Event|2
307089|NCT01517178|1040344|P1|Period 1|Adverse Event|1
307090|NCT01516970|1040363|P2|Overall Study|Other|7
307091|NCT01516970|1040364|P1|Overall Study|Other|9
307092|NCT01516970|1040363|P2|Overall Study|Withdrawal by Subject|1
307093|NCT01516970|1040364|P1|Overall Study|Withdrawal by Subject|1
307094|NCT01516970|1040363|P2|Overall Study|Adverse Event|5
307095|NCT01516970|1040364|P1|Overall Study|Adverse Event|1
307096|NCT01516970|1040363|P2|Overall Study|Lost to Follow-up|8
307097|NCT01516970|1040364|P1|Overall Study|Lost to Follow-up|7
307098|NCT01516892|1040376|P1|Overall Study|Missing|1
307099|NCT01516892|1040376|P1|Overall Study|Other Miscellaneous Reasons|43
307100|NCT01516892|1040376|P1|Overall Study|Protocol Violation|60
307101|NCT01516892|1040376|P1|Overall Study|Subject Withdrew Consent|92
307102|NCT01516892|1040376|P1|Overall Study|Lost to Follow-up|82
307103|NCT01516892|1040376|P1|Overall Study|Pregnancy|5
307104|NCT01516892|1040376|P1|Overall Study|Lack of Efficacy|35
307105|NCT01516892|1040376|P1|Overall Study|Adverse Event|25
307106|NCT01516879|1040384|P2|Overall Study|Other|10
307107|NCT01516879|1040385|P1|Overall Study|Other|5
307108|NCT01516879|1040384|P2|Overall Study|Lost to Follow-up|11
307109|NCT01516879|1040385|P1|Overall Study|Lost to Follow-up|2
307110|NCT01516879|1040384|P2|Overall Study|Death|2
307111|NCT01516879|1040385|P1|Overall Study|Death|0
307112|NCT01516879|1040384|P2|Overall Study|Withdrawal by Subject|11
307113|NCT01516879|1040385|P1|Overall Study|Withdrawal by Subject|9
307114|NCT01516749|1040419|P1|Follow-up Off Therapy|Lost to Follow-up|1
307115|NCT01516749|1040419|P1|Active Therapy|Lost to Follow-up|1
307116|NCT01516736|1040428|P2|Overall Study|Other (not specified)|1
307117|NCT01516736|1040429|P1|Overall Study|Other (not specified)|0
307118|NCT01516736|1040428|P2|Overall Study|Protocol Violation|1
307119|NCT01516736|1040429|P1|Overall Study|Protocol Violation|0
307120|NCT01516736|1040428|P2|Overall Study|Lack of Efficacy|0
307121|NCT01516736|1040429|P1|Overall Study|Lack of Efficacy|1
307122|NCT01516736|1040428|P2|Overall Study|Physician Decision|1
307123|NCT01516736|1040429|P1|Overall Study|Physician Decision|2
307124|NCT01516736|1040428|P2|Overall Study|Death|1
307125|NCT01516736|1040429|P1|Overall Study|Death|3
307126|NCT01516736|1040428|P2|Overall Study|Adverse Event|5
307127|NCT01516736|1040429|P1|Overall Study|Adverse Event|4
307128|NCT01516736|1040428|P2|Overall Study|Withdrawal by Subject|4
307129|NCT01516736|1040429|P1|Overall Study|Withdrawal by Subject|10
307130|NCT01516437|1040466|P4|Overall Study|Reason not specified|1
307131|NCT01516437|1040467|P3|Overall Study|Reason not specified|1
307132|NCT01516437|1040468|P2|Overall Study|Reason not specified|0
307133|NCT01516437|1040469|P1|Overall Study|Reason not specified|0
307134|NCT01516034|1040532|P1|Overall Study|Lack of Efficacy|7
307135|NCT01516034|1040532|P1|Overall Study|Physician Decision|1
307136|NCT01516008|1040539|P3|Overall Study|Reason not specified|1
307137|NCT01516008|1040540|P2|Overall Study|Reason not specified|0
307138|NCT01516008|1040541|P1|Overall Study|Reason not specified|0
307139|NCT01516008|1040539|P3|Overall Study|Protocol Violation|0
307140|NCT01516008|1040540|P2|Overall Study|Protocol Violation|0
307141|NCT01516008|1040541|P1|Overall Study|Protocol Violation|1
307142|NCT01516008|1040539|P3|Overall Study|Lack of Efficacy|10
307143|NCT01516008|1040540|P2|Overall Study|Lack of Efficacy|14
307144|NCT01516008|1040541|P1|Overall Study|Lack of Efficacy|44
307145|NCT01516008|1040539|P3|Overall Study|Adverse Event|7
307146|NCT01516008|1040540|P2|Overall Study|Adverse Event|2
307147|NCT01516008|1040541|P1|Overall Study|Adverse Event|0
307148|NCT01515865|1040637|P3|Part B (Open-label)|Not Specified|0
307149|NCT01515865|1040638|P2|Part B (Open-label)|Not Specified|0
307150|NCT01515865|1040639|P1|Part B (Open-label)|Not Specified|1
307151|NCT01515865|1040637|P3|Part B (Open-label)|Withdrawal by Subject|0
307152|NCT01515865|1040638|P2|Part B (Open-label)|Withdrawal by Subject|0
307153|NCT01515865|1040639|P1|Part B (Open-label)|Withdrawal by Subject|1
307154|NCT01515865|1040637|P3|Part A (Open-label)|Not Specified|0
307155|NCT01515865|1040638|P2|Part A (Open-label)|Not Specified|0
307156|NCT01515865|1040639|P1|Part A (Open-label)|Not Specified|3
307157|NCT01515423|1040707|P3|DOUBLE BLIND|Blind broken by investigator|0
307158|NCT01515423|1040708|P2|DOUBLE BLIND|Blind broken by investigator|1
307159|NCT01515423|1040709|P1|DOUBLE BLIND|Blind broken by investigator|0
307160|NCT01515423|1040707|P3|DOUBLE BLIND|Other|12
307161|NCT01515423|1040708|P2|DOUBLE BLIND|Other|6
307162|NCT01515423|1040709|P1|DOUBLE BLIND|Other|0
307163|NCT01515423|1040707|P3|DOUBLE BLIND|Withdrawal by Subject|53
307164|NCT01515423|1040708|P2|DOUBLE BLIND|Withdrawal by Subject|50
307165|NCT01515423|1040709|P1|DOUBLE BLIND|Withdrawal by Subject|0
307166|NCT01515423|1040707|P3|DOUBLE BLIND|Pregnancy|0
307167|NCT01515423|1040708|P2|DOUBLE BLIND|Pregnancy|2
307168|NCT01515423|1040709|P1|DOUBLE BLIND|Pregnancy|0
307169|NCT01515423|1040707|P3|DOUBLE BLIND|Lost to Follow-up|12
307170|NCT01515423|1040708|P2|DOUBLE BLIND|Lost to Follow-up|7
307171|NCT01515423|1040709|P1|DOUBLE BLIND|Lost to Follow-up|0
307172|NCT01515423|1040707|P3|DOUBLE BLIND|Death|2
307173|NCT01515423|1040708|P2|DOUBLE BLIND|Death|1
307174|NCT01515423|1040709|P1|DOUBLE BLIND|Death|0
307175|NCT01515423|1040707|P3|DOUBLE BLIND|Adverse Event|13
307176|NCT01515423|1040708|P2|DOUBLE BLIND|Adverse Event|15
307177|NCT01515423|1040709|P1|DOUBLE BLIND|Adverse Event|0
307178|NCT01515423|1040707|P3|Open Label Phase|Other|0
307179|NCT01515423|1040708|P2|Open Label Phase|Other|0
307180|NCT01515423|1040709|P1|Open Label Phase|Other|28
307181|NCT01515423|1040707|P3|Open Label Phase|excluded from DB Phase|0
307182|NCT01515423|1040708|P2|Open Label Phase|excluded from DB Phase|0
307183|NCT01515423|1040709|P1|Open Label Phase|excluded from DB Phase|70
307184|NCT01515423|1040707|P3|Open Label Phase|Withdrawal by Subject|0
307185|NCT01515423|1040708|P2|Open Label Phase|Withdrawal by Subject|0
307186|NCT01515423|1040709|P1|Open Label Phase|Withdrawal by Subject|118
307187|NCT01515423|1040707|P3|Open Label Phase|Lost to Follow-up|0
307188|NCT01515423|1040708|P2|Open Label Phase|Lost to Follow-up|0
307189|NCT01515423|1040709|P1|Open Label Phase|Lost to Follow-up|21
307190|NCT01515423|1040707|P3|Open Label Phase|Lack of Efficacy|0
307191|NCT01515423|1040708|P2|Open Label Phase|Lack of Efficacy|0
307192|NCT01515423|1040709|P1|Open Label Phase|Lack of Efficacy|117
307193|NCT01515423|1040707|P3|Open Label Phase|Death|0
307194|NCT01515423|1040708|P2|Open Label Phase|Death|0
307195|NCT01515423|1040709|P1|Open Label Phase|Death|2
307196|NCT01515423|1040707|P3|Open Label Phase|Adverse Event|0
307197|NCT01515423|1040708|P2|Open Label Phase|Adverse Event|0
307198|NCT01515423|1040709|P1|Open Label Phase|Adverse Event|57
307199|NCT01515306|1040750|P2|Overall Study|Ongoing receiving treatment|14
307200|NCT01515306|1040751|P1|Overall Study|Ongoing receiving treatment|9
307201|NCT01515306|1040750|P2|Overall Study|Progressive Disease|0
307202|NCT01515306|1040751|P1|Overall Study|Progressive Disease|1
307203|NCT01515306|1040750|P2|Overall Study|Adverse Event|0
307204|NCT01515306|1040751|P1|Overall Study|Adverse Event|2
307205|NCT01515189|1040764|P2|First Re-Induction Phase|Other|0
307206|NCT01515189|1040765|P1|First Re-Induction Phase|Other|1
307207|NCT01515189|1040764|P2|First Re-Induction Phase|No longer meets study criteria|0
307208|NCT01515189|1040765|P1|First Re-Induction Phase|No longer meets study criteria|1
307209|NCT01515189|1040764|P2|First Re-Induction Phase|Withdrawal by Subject|1
307210|NCT01515189|1040765|P1|First Re-Induction Phase|Withdrawal by Subject|1
307211|NCT01515189|1040764|P2|First Re-Induction Phase|Study drug toxicity|0
307212|NCT01515189|1040765|P1|First Re-Induction Phase|Study drug toxicity|5
307213|NCT01515189|1040764|P2|First Re-Induction Phase|Disease progression|14
307214|NCT01515189|1040765|P1|First Re-Induction Phase|Disease progression|6
307215|NCT01515189|1040764|P2|Induction|Other|4
307216|NCT01515189|1040765|P1|Induction|Other|0
307217|NCT01515189|1040764|P2|Induction|Lost to Follow-up|0
307218|NCT01515189|1040765|P1|Induction|Lost to Follow-up|1
307219|NCT01515189|1040764|P2|Induction|No longer meets study criteria|2
307220|NCT01515189|1040765|P1|Induction|No longer meets study criteria|0
307221|NCT01515189|1040764|P2|Induction|Withdrawal by Subject|9
307222|NCT01515189|1040765|P1|Induction|Withdrawal by Subject|3
307223|NCT01515189|1040764|P2|Induction|Adverse Event|9
307224|NCT01515189|1040765|P1|Induction|Adverse Event|14
307225|NCT01515189|1040764|P2|Induction|Death|17
307226|NCT01515189|1040765|P1|Induction|Death|24
307227|NCT01515189|1040764|P2|Induction|Study drug toxicity|36
307228|NCT01515189|1040765|P1|Induction|Study drug toxicity|86
307229|NCT01515189|1040764|P2|Induction|Disease Progression|155
307230|NCT01515189|1040765|P1|Induction|Disease Progression|109
307231|NCT01514864|1040853|P2|Overall Study|Study drug toxicity|0
307232|NCT01514864|1040854|P1|Overall Study|Study drug toxicity|2
307233|NCT01514864|1040853|P2|Overall Study|Disease progression|5
307234|NCT01514864|1040854|P1|Overall Study|Disease progression|7
307235|NCT01514760|1040879|P1|Overall Study|Lost to Follow-up|2
307236|NCT01514682|1040892|P2|Overall Study|Physician Decision|3
307237|NCT01514682|1040893|P1|Overall Study|Physician Decision|4
307238|NCT01514682|1040892|P2|Overall Study|Withdrawal by Subject|3
307239|NCT01514682|1040893|P1|Overall Study|Withdrawal by Subject|2
307240|NCT01514461|1040927|P3|Overall Study|Death|0
307241|NCT01514461|1040928|P2|Overall Study|Death|0
307242|NCT01514461|1040929|P1|Overall Study|Death|1
307243|NCT01514461|1040927|P3|Overall Study|Patient/guardian decision|1
307244|NCT01514461|1040928|P2|Overall Study|Patient/guardian decision|1
307245|NCT01514461|1040929|P1|Overall Study|Patient/guardian decision|1
307246|NCT01514461|1040927|P3|Overall Study|Physician Decision|0
307247|NCT01514461|1040928|P2|Overall Study|Physician Decision|1
307248|NCT01514461|1040929|P1|Overall Study|Physician Decision|1
307249|NCT01514461|1040927|P3|Overall Study|Adverse Event|3
307250|NCT01514461|1040928|P2|Overall Study|Adverse Event|1
307251|NCT01514461|1040929|P1|Overall Study|Adverse Event|2
307252|NCT01514448|1040968|P2|Overall Study|New Cancer Therapy|0
307253|NCT01514448|1040969|P1|Overall Study|New Cancer Therapy|1
307254|NCT01514448|1040968|P2|Overall Study|Lost to Follow-up|0
307255|NCT01514448|1040969|P1|Overall Study|Lost to Follow-up|2
307256|NCT01514448|1040968|P2|Overall Study|Withdrawal by Subject|0
307257|NCT01514448|1040969|P1|Overall Study|Withdrawal by Subject|2
307258|NCT01514448|1040968|P2|Overall Study|Death|8
307259|NCT01514448|1040969|P1|Overall Study|Death|7
307260|NCT01514422|1040984|P1|Overall Study|Lost to Follow-up|1
307261|NCT01514357|1040992|P2|Overall Study|Withdrawal by Subject|0
307262|NCT01514357|1040993|P1|Overall Study|Withdrawal by Subject|2
307263|NCT01514357|1040992|P2|Overall Study|Screen failure|0
307264|NCT01514357|1040993|P1|Overall Study|Screen failure|2
307265|NCT01514240|1041011|P2|Overall Study|Subject Decision|7
307266|NCT01514240|1041012|P1|Overall Study|Subject Decision|2
307267|NCT01514240|1041011|P2|Overall Study|Adverse Event|4
307268|NCT01514240|1041012|P1|Overall Study|Adverse Event|4
307269|NCT01514136|1041125|P8|Test Period 2; Test C*|Protocol Violation|0
307270|NCT01514136|1041126|P7|Test Period 2; Test C*|Protocol Violation|1
307271|NCT01514136|1041127|P6|Test Period 2; Test C*|Protocol Violation|0
307272|NCT01514136|1041128|P5|Test Period 2; Test C*|Protocol Violation|0
307273|NCT01514136|1041129|P4|Test Period 2; Test C*|Protocol Violation|0
307274|NCT01514136|1041130|P3|Test Period 2; Test C*|Protocol Violation|0
307275|NCT01514136|1041131|P2|Test Period 2; Test C*|Protocol Violation|0
307276|NCT01514136|1041132|P1|Test Period 2; Test C*|Protocol Violation|0
307277|NCT01514136|1041125|P8|Test Period 2; Test C*|holiday|0
307278|NCT01514136|1041126|P7|Test Period 2; Test C*|holiday|1
307279|NCT01514136|1041127|P6|Test Period 2; Test C*|holiday|0
307280|NCT01514136|1041128|P5|Test Period 2; Test C*|holiday|0
307281|NCT01514136|1041129|P4|Test Period 2; Test C*|holiday|0
307282|NCT01514136|1041130|P3|Test Period 2; Test C*|holiday|0
307283|NCT01514136|1041131|P2|Test Period 2; Test C*|holiday|0
307284|NCT01514136|1041132|P1|Test Period 2; Test C*|holiday|0
307285|NCT01514136|1041125|P8|Test Period 2; Test C*|Withdrawal by Subject|0
307286|NCT01514136|1041126|P7|Test Period 2; Test C*|Withdrawal by Subject|1
307287|NCT01514136|1041127|P6|Test Period 2; Test C*|Withdrawal by Subject|0
307288|NCT01514136|1041128|P5|Test Period 2; Test C*|Withdrawal by Subject|0
307289|NCT01514136|1041129|P4|Test Period 2; Test C*|Withdrawal by Subject|0
307290|NCT01514136|1041130|P3|Test Period 2; Test C*|Withdrawal by Subject|0
307291|NCT01514136|1041131|P2|Test Period 2; Test C*|Withdrawal by Subject|0
307292|NCT01514136|1041132|P1|Test Period 2; Test C*|Withdrawal by Subject|0
307293|NCT01514136|1041125|P8|Test Period 2; Test B*|Withdrawal by Subject|0
307294|NCT01514136|1041126|P7|Test Period 2; Test B*|Withdrawal by Subject|0
307295|NCT01514136|1041127|P6|Test Period 2; Test B*|Withdrawal by Subject|2
307296|NCT01514136|1041128|P5|Test Period 2; Test B*|Withdrawal by Subject|0
307297|NCT01514136|1041129|P4|Test Period 2; Test B*|Withdrawal by Subject|0
307298|NCT01514136|1041130|P3|Test Period 2; Test B*|Withdrawal by Subject|0
307299|NCT01514136|1041131|P2|Test Period 2; Test B*|Withdrawal by Subject|0
307300|NCT01514136|1041132|P1|Test Period 2; Test B*|Withdrawal by Subject|0
307301|NCT01514136|1041125|P8|Test Period 2; Test A*|Holiday|0
307302|NCT01514136|1041126|P7|Test Period 2; Test A*|Holiday|0
307303|NCT01514136|1041127|P6|Test Period 2; Test A*|Holiday|0
307304|NCT01514136|1041128|P5|Test Period 2; Test A*|Holiday|1
307305|NCT01514136|1041129|P4|Test Period 2; Test A*|Holiday|0
307306|NCT01514136|1041130|P3|Test Period 2; Test A*|Holiday|0
307307|NCT01514136|1041131|P2|Test Period 2; Test A*|Holiday|0
307308|NCT01514136|1041132|P1|Test Period 2; Test A*|Holiday|0
307309|NCT01514136|1041125|P8|Test Period 2; Test A*|Adverse Event|0
307310|NCT01514136|1041126|P7|Test Period 2; Test A*|Adverse Event|0
307311|NCT01514136|1041127|P6|Test Period 2; Test A*|Adverse Event|0
307312|NCT01514136|1041128|P5|Test Period 2; Test A*|Adverse Event|1
307313|NCT01514136|1041129|P4|Test Period 2; Test A*|Adverse Event|0
307314|NCT01514136|1041130|P3|Test Period 2; Test A*|Adverse Event|0
307315|NCT01514136|1041131|P2|Test Period 2; Test A*|Adverse Event|0
307316|NCT01514136|1041132|P1|Test Period 2; Test A*|Adverse Event|0
307317|NCT01514136|1041125|P8|Test Period 1; Test D|Subject took a break due to holiday|0
307318|NCT01514136|1041126|P7|Test Period 1; Test D|Subject took a break due to holiday|0
307319|NCT01514136|1041127|P6|Test Period 1; Test D|Subject took a break due to holiday|0
307320|NCT01514136|1041128|P5|Test Period 1; Test D|Subject took a break due to holiday|0
307321|NCT01514136|1041129|P4|Test Period 1; Test D|Subject took a break due to holiday|2
307322|NCT01514136|1041130|P3|Test Period 1; Test D|Subject took a break due to holiday|0
307323|NCT01514136|1041131|P2|Test Period 1; Test D|Subject took a break due to holiday|0
307324|NCT01514136|1041132|P1|Test Period 1; Test D|Subject took a break due to holiday|0
307325|NCT01514136|1041125|P8|Test Period 1; Test B|Withdrawal by Subject|0
307326|NCT01514136|1041126|P7|Test Period 1; Test B|Withdrawal by Subject|0
307327|NCT01514136|1041127|P6|Test Period 1; Test B|Withdrawal by Subject|0
307328|NCT01514136|1041128|P5|Test Period 1; Test B|Withdrawal by Subject|0
307329|NCT01514136|1041129|P4|Test Period 1; Test B|Withdrawal by Subject|0
307330|NCT01514136|1041130|P3|Test Period 1; Test B|Withdrawal by Subject|0
307331|NCT01514136|1041131|P2|Test Period 1; Test B|Withdrawal by Subject|1
307332|NCT01514136|1041132|P1|Test Period 1; Test B|Withdrawal by Subject|0
307333|NCT01514136|1041125|P8|Test Period 1; Test A|Break from study holiday|0
307334|NCT01514136|1041126|P7|Test Period 1; Test A|Break from study holiday|0
307335|NCT01514136|1041127|P6|Test Period 1; Test A|Break from study holiday|0
307336|NCT01514136|1041128|P5|Test Period 1; Test A|Break from study holiday|0
307337|NCT01514136|1041129|P4|Test Period 1; Test A|Break from study holiday|0
307338|NCT01514136|1041130|P3|Test Period 1; Test A|Break from study holiday|0
307339|NCT01514136|1041131|P2|Test Period 1; Test A|Break from study holiday|0
307340|NCT01514136|1041132|P1|Test Period 1; Test A|Break from study holiday|2
307341|NCT01514136|1041125|P8|Test Period 1; Test A|Protocol Violation|0
307342|NCT01514136|1041126|P7|Test Period 1; Test A|Protocol Violation|0
307343|NCT01514136|1041127|P6|Test Period 1; Test A|Protocol Violation|0
307344|NCT01514136|1041128|P5|Test Period 1; Test A|Protocol Violation|0
307345|NCT01514136|1041129|P4|Test Period 1; Test A|Protocol Violation|0
307346|NCT01514136|1041130|P3|Test Period 1; Test A|Protocol Violation|0
307347|NCT01514136|1041131|P2|Test Period 1; Test A|Protocol Violation|0
307348|NCT01514136|1041132|P1|Test Period 1; Test A|Protocol Violation|1
307349|NCT01513590|1041200|P2|Overall Study|Unclassified|10
307350|NCT01513590|1041201|P1|Overall Study|Unclassified|5
307351|NCT01513590|1041200|P2|Overall Study|Withdrawal Criteria|0
307352|NCT01513590|1041201|P1|Overall Study|Withdrawal Criteria|3
307353|NCT01513590|1041200|P2|Overall Study|Adverse Event|3
307354|NCT01513590|1041201|P1|Overall Study|Adverse Event|2
307355|NCT01513473|1041225|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
307356|NCT01513473|1041226|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
307357|NCT01513473|1041225|P2|Extension Trial (26 Weeks)|Adverse Event|1
307358|NCT01513473|1041226|P1|Extension Trial (26 Weeks)|Adverse Event|0
307359|NCT01513473|1041225|P2|Main Trial (26 Weeks)|Unclassified|2
307360|NCT01513473|1041226|P1|Main Trial (26 Weeks)|Unclassified|0
307361|NCT01513473|1041225|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
307362|NCT01513473|1041226|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
307363|NCT01513473|1041225|P2|Main Trial (26 Weeks)|Adverse Event|2
307364|NCT01513473|1041226|P1|Main Trial (26 Weeks)|Adverse Event|0
307365|NCT01513460|1041253|P3|Overall Study|Abnormal test procedure|0
307366|NCT01513460|1041254|P2|Overall Study|Abnormal test procedure|0
307367|NCT01513460|1041255|P1|Overall Study|Abnormal test procedure|1
307368|NCT01513460|1041253|P3|Overall Study|Adverse Event|23
307369|NCT01513460|1041254|P2|Overall Study|Adverse Event|18
307370|NCT01513460|1041255|P1|Overall Study|Adverse Event|16
307371|NCT01513460|1041253|P3|Overall Study|Withdrawal by Subject|21
307372|NCT01513460|1041254|P2|Overall Study|Withdrawal by Subject|8
307373|NCT01513460|1041255|P1|Overall Study|Withdrawal by Subject|7
307374|NCT01513460|1041253|P3|Overall Study|Protocol deviations|3
307375|NCT01513460|1041254|P2|Overall Study|Protocol deviations|4
307376|NCT01513460|1041255|P1|Overall Study|Protocol deviations|3
307377|NCT01513460|1041253|P3|Overall Study|Lack of Efficacy|5
307378|NCT01513460|1041254|P2|Overall Study|Lack of Efficacy|2
307379|NCT01513460|1041255|P1|Overall Study|Lack of Efficacy|1
307380|NCT01513460|1041253|P3|Overall Study|Abnormal laboratory value|1
307381|NCT01513460|1041254|P2|Overall Study|Abnormal laboratory value|0
307382|NCT01513460|1041255|P1|Overall Study|Abnormal laboratory value|1
307383|NCT01513460|1041253|P3|Overall Study|Lost to Follow-up|2
307384|NCT01513460|1041254|P2|Overall Study|Lost to Follow-up|0
307385|NCT01513460|1041255|P1|Overall Study|Lost to Follow-up|0
307386|NCT01513460|1041253|P3|Overall Study|Death|1
307387|NCT01513460|1041254|P2|Overall Study|Death|0
307388|NCT01513460|1041255|P1|Overall Study|Death|0
307389|NCT01513330|1041290|P2|Standard Care First,|Other|0
307390|NCT01513330|1041291|P1|Standard Care First,|Other|1
307391|NCT01513330|1041290|P2|Standard Care First,|Withdrawal by Subject|2
307392|NCT01513330|1041291|P1|Standard Care First,|Withdrawal by Subject|1
307393|NCT01513330|1041290|P2|Standard Care First,|Lack of Efficacy|2
307394|NCT01513330|1041291|P1|Standard Care First,|Lack of Efficacy|2
307395|NCT01513330|1041290|P2|SenSura Mio First,|Other|0
307396|NCT01513330|1041291|P1|SenSura Mio First,|Other|1
307397|NCT01513330|1041290|P2|SenSura Mio First,|Withdrawal by Subject|1
307398|NCT01513330|1041291|P1|SenSura Mio First,|Withdrawal by Subject|1
307399|NCT01513330|1041290|P2|SenSura Mio First,|Lack of Efficacy|1
307400|NCT01513330|1041291|P1|SenSura Mio First,|Lack of Efficacy|0
307401|NCT01513330|1041290|P2|SenSura Mio First,|Adverse Event|0
307402|NCT01513330|1041291|P1|SenSura Mio First,|Adverse Event|2
307403|NCT01513317|1041299|P2|Overall Study|Not specified|1
307404|NCT01513317|1041300|P1|Overall Study|Not specified|0
307405|NCT01513317|1041299|P2|Overall Study|Study terminated by sponsor|18
307406|NCT01513317|1041300|P1|Overall Study|Study terminated by sponsor|18
307407|NCT01513317|1041299|P2|Overall Study|Death|1
307408|NCT01513317|1041300|P1|Overall Study|Death|1
307409|NCT01513317|1041299|P2|Overall Study|Withdrawal by Subject|4
307410|NCT01513317|1041300|P1|Overall Study|Withdrawal by Subject|15
307411|NCT01513291|1041318|P5|Run-out Period|Withdrawal by Subject|0
307412|NCT01513291|1041319|P4|Run-out Period|Withdrawal by Subject|1
307413|NCT01513291|1041320|P3|Run-out Period|Withdrawal by Subject|0
307414|NCT01513291|1041321|P2|Run-out Period|Withdrawal by Subject|0
307415|NCT01513291|1041322|P1|Run-out Period|Withdrawal by Subject|0
307416|NCT01513291|1041318|P5|Run-out Period|Lost to Follow-up|0
307417|NCT01513291|1041319|P4|Run-out Period|Lost to Follow-up|1
307418|NCT01513291|1041320|P3|Run-out Period|Lost to Follow-up|0
307419|NCT01513291|1041321|P2|Run-out Period|Lost to Follow-up|0
307420|NCT01513291|1041322|P1|Run-out Period|Lost to Follow-up|0
307421|NCT01513291|1041318|P5|Treatment Period|Randomized not treated|0
307422|NCT01513291|1041319|P4|Treatment Period|Randomized not treated|0
307423|NCT01513291|1041320|P3|Treatment Period|Randomized not treated|0
307424|NCT01513291|1041321|P2|Treatment Period|Randomized not treated|2
307425|NCT01513291|1041322|P1|Treatment Period|Randomized not treated|0
307426|NCT01513291|1041318|P5|Treatment Period|Withdrawal by Subject|0
307427|NCT01513291|1041319|P4|Treatment Period|Withdrawal by Subject|0
307428|NCT01513291|1041320|P3|Treatment Period|Withdrawal by Subject|0
307429|NCT01513291|1041321|P2|Treatment Period|Withdrawal by Subject|5
307430|NCT01513291|1041322|P1|Treatment Period|Withdrawal by Subject|8
307431|NCT01513291|1041318|P5|Treatment Period|Protocol Violation|0
307432|NCT01513291|1041319|P4|Treatment Period|Protocol Violation|0
307433|NCT01513291|1041320|P3|Treatment Period|Protocol Violation|0
307434|NCT01513291|1041321|P2|Treatment Period|Protocol Violation|2
307435|NCT01513291|1041322|P1|Treatment Period|Protocol Violation|1
307436|NCT01513291|1041318|P5|Treatment Period|Physician Decision|0
307437|NCT01513291|1041319|P4|Treatment Period|Physician Decision|0
307438|NCT01513291|1041320|P3|Treatment Period|Physician Decision|0
307439|NCT01513291|1041321|P2|Treatment Period|Physician Decision|0
307440|NCT01513291|1041322|P1|Treatment Period|Physician Decision|1
307441|NCT01513291|1041318|P5|Treatment Period|Lost to Follow-up|0
307442|NCT01513291|1041319|P4|Treatment Period|Lost to Follow-up|0
307443|NCT01513291|1041320|P3|Treatment Period|Lost to Follow-up|0
307444|NCT01513291|1041321|P2|Treatment Period|Lost to Follow-up|3
307445|NCT01513291|1041322|P1|Treatment Period|Lost to Follow-up|2
307446|NCT01513291|1041318|P5|Treatment Period|Lack of Efficacy|0
307447|NCT01513291|1041319|P4|Treatment Period|Lack of Efficacy|0
307448|NCT01513291|1041320|P3|Treatment Period|Lack of Efficacy|0
307449|NCT01513291|1041321|P2|Treatment Period|Lack of Efficacy|0
307450|NCT01513291|1041322|P1|Treatment Period|Lack of Efficacy|3
307451|NCT01513291|1041318|P5|Treatment Period|Adverse Event|0
307452|NCT01513291|1041319|P4|Treatment Period|Adverse Event|0
307453|NCT01513291|1041320|P3|Treatment Period|Adverse Event|0
307454|NCT01513291|1041321|P2|Treatment Period|Adverse Event|4
307455|NCT01513291|1041322|P1|Treatment Period|Adverse Event|8
307456|NCT01513239|1041350|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
307457|NCT01513239|1041351|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
307458|NCT01513239|1041352|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
307459|NCT01513239|1041353|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
307460|NCT01513239|1041354|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
307461|NCT01513239|1041355|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
307462|NCT01513239|1041350|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
307463|NCT01513239|1041351|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
307464|NCT01513239|1041352|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
307465|NCT01513239|1041353|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
307466|NCT01513239|1041354|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
307467|NCT01513239|1041355|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
307468|NCT01513239|1041350|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
307469|NCT01513239|1041351|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
307470|NCT01513239|1041352|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
307471|NCT01513239|1041353|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
307472|NCT01513239|1041354|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
307473|NCT01513239|1041355|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
307474|NCT01513239|1041350|P6|Period 2: 9 Month Extension Phase|Death|2
307475|NCT01513239|1041351|P5|Period 2: 9 Month Extension Phase|Death|5
307476|NCT01513239|1041352|P4|Period 2: 9 Month Extension Phase|Death|2
307477|NCT01513239|1041353|P3|Period 2: 9 Month Extension Phase|Death|0
307478|NCT01513239|1041354|P2|Period 2: 9 Month Extension Phase|Death|0
307479|NCT01513239|1041355|P1|Period 2: 9 Month Extension Phase|Death|0
307480|NCT01513239|1041350|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
307481|NCT01513239|1041351|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
307482|NCT01513239|1041352|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
307483|NCT01513239|1041353|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
307484|NCT01513239|1041354|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
307485|NCT01513239|1041355|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
307486|NCT01513239|1041350|P6|Period 1: Main Phase|Withdrawal by Subject|0
307487|NCT01513239|1041351|P5|Period 1: Main Phase|Withdrawal by Subject|0
307488|NCT01513239|1041352|P4|Period 1: Main Phase|Withdrawal by Subject|0
307489|NCT01513239|1041353|P3|Period 1: Main Phase|Withdrawal by Subject|42
307490|NCT01513239|1041354|P2|Period 1: Main Phase|Withdrawal by Subject|29
307491|NCT01513239|1041355|P1|Period 1: Main Phase|Withdrawal by Subject|27
307492|NCT01513239|1041350|P6|Period 1: Main Phase|Technical Problems|0
307493|NCT01513239|1041351|P5|Period 1: Main Phase|Technical Problems|0
307494|NCT01513239|1041352|P4|Period 1: Main Phase|Technical Problems|0
307495|NCT01513239|1041353|P3|Period 1: Main Phase|Technical Problems|0
307496|NCT01513239|1041354|P2|Period 1: Main Phase|Technical Problems|2
307497|NCT01513239|1041355|P1|Period 1: Main Phase|Technical Problems|1
307498|NCT01513239|1041350|P6|Period 1: Main Phase|Protocol Violation|0
307499|NCT01513239|1041351|P5|Period 1: Main Phase|Protocol Violation|0
307500|NCT01513239|1041352|P4|Period 1: Main Phase|Protocol Violation|0
307501|NCT01513239|1041353|P3|Period 1: Main Phase|Protocol Violation|2
307502|NCT01513239|1041354|P2|Period 1: Main Phase|Protocol Violation|2
307503|NCT01513239|1041355|P1|Period 1: Main Phase|Protocol Violation|2
307504|NCT01513239|1041350|P6|Period 1: Main Phase|Physician Decision|0
307505|NCT01513239|1041351|P5|Period 1: Main Phase|Physician Decision|0
307506|NCT01513239|1041352|P4|Period 1: Main Phase|Physician Decision|0
307507|NCT01513239|1041353|P3|Period 1: Main Phase|Physician Decision|4
307508|NCT01513239|1041354|P2|Period 1: Main Phase|Physician Decision|4
307509|NCT01513239|1041355|P1|Period 1: Main Phase|Physician Decision|4
307510|NCT01513239|1041350|P6|Period 1: Main Phase|Lost to Follow-up|0
307511|NCT01513239|1041351|P5|Period 1: Main Phase|Lost to Follow-up|0
307512|NCT01513239|1041352|P4|Period 1: Main Phase|Lost to Follow-up|0
307513|NCT01513239|1041353|P3|Period 1: Main Phase|Lost to Follow-up|6
307514|NCT01513239|1041354|P2|Period 1: Main Phase|Lost to Follow-up|10
307515|NCT01513239|1041355|P1|Period 1: Main Phase|Lost to Follow-up|11
307516|NCT01513239|1041350|P6|Period 1: Main Phase|Death|0
307517|NCT01513239|1041351|P5|Period 1: Main Phase|Death|0
307518|NCT01513239|1041352|P4|Period 1: Main Phase|Death|0
307519|NCT01513239|1041353|P3|Period 1: Main Phase|Death|32
307520|NCT01513239|1041354|P2|Period 1: Main Phase|Death|22
307521|NCT01513239|1041355|P1|Period 1: Main Phase|Death|29
307522|NCT01513239|1041350|P6|Period 1: Main Phase|Adverse Event|0
307523|NCT01513239|1041351|P5|Period 1: Main Phase|Adverse Event|0
307524|NCT01513239|1041352|P4|Period 1: Main Phase|Adverse Event|0
307525|NCT01513239|1041353|P3|Period 1: Main Phase|Adverse Event|2
307526|NCT01513239|1041354|P2|Period 1: Main Phase|Adverse Event|1
307527|NCT01513239|1041355|P1|Period 1: Main Phase|Adverse Event|1
307528|NCT01513148|1041408|P2|Overall Study|Protocol Violation|2
307529|NCT01513148|1041409|P1|Overall Study|Protocol Violation|2
307530|NCT01512979|1041476|P2|Overall Study|Reason other than stated above|9
307531|NCT01512979|1041477|P1|Overall Study|Reason other than stated above|13
307532|NCT01512979|1041476|P2|Overall Study|Withdrawal by Subject|2
307533|NCT01512979|1041477|P1|Overall Study|Withdrawal by Subject|1
307534|NCT01512979|1041476|P2|Overall Study|Lost to Follow-up|5
307535|NCT01512979|1041477|P1|Overall Study|Lost to Follow-up|2
307536|NCT01512979|1041476|P2|Overall Study|Protocol Violation|4
307537|NCT01512979|1041477|P1|Overall Study|Protocol Violation|1
307538|NCT01512979|1041476|P2|Overall Study|Adverse Event|2
307539|NCT01512979|1041477|P1|Overall Study|Adverse Event|2
307540|NCT01512745|1041541|P2|Overall Study|Protocol Violation|0
307541|NCT01512745|1041542|P1|Overall Study|Protocol Violation|1
307542|NCT01512745|1041541|P2|Overall Study|Lack of Efficacy|2
307543|NCT01512745|1041542|P1|Overall Study|Lack of Efficacy|2
307544|NCT01512745|1041541|P2|Overall Study|Lost to Follow-up|0
307545|NCT01512745|1041542|P1|Overall Study|Lost to Follow-up|4
307546|NCT01512745|1041541|P2|Overall Study|Withdrawal by Subject|2
307547|NCT01512745|1041542|P1|Overall Study|Withdrawal by Subject|2
307548|NCT01512745|1041541|P2|Overall Study|Death|13
307549|NCT01512745|1041542|P1|Overall Study|Death|9
307550|NCT01512745|1041541|P2|Overall Study|Adverse Event|3
307551|NCT01512745|1041542|P1|Overall Study|Adverse Event|22
307552|NCT01512693|1041558|P2|Overall Study|Withdrawal by Subject|1
307553|NCT01512693|1041559|P1|Overall Study|Withdrawal by Subject|0
307554|NCT01512368|1041586|P1|Overall Study|Protocol Violation|3
307555|NCT01512160|1041644|P4|Overall Study|Withdrawal by Subject|1
307556|NCT01512160|1041645|P3|Overall Study|Withdrawal by Subject|0
307557|NCT01512160|1041646|P2|Overall Study|Withdrawal by Subject|0
307558|NCT01512160|1041647|P1|Overall Study|Withdrawal by Subject|1
307559|NCT01512160|1041644|P4|Overall Study|Lost to Follow-up|0
307560|NCT01512160|1041645|P3|Overall Study|Lost to Follow-up|0
307561|NCT01512160|1041646|P2|Overall Study|Lost to Follow-up|0
307562|NCT01512160|1041647|P1|Overall Study|Lost to Follow-up|1
307563|NCT01512108|1041739|P2|Overall Study|Unclassified|3
307564|NCT01512108|1041740|P1|Overall Study|Unclassified|11
307565|NCT01512108|1041739|P2|Overall Study|Withdrawal Criteria|0
307566|NCT01512108|1041740|P1|Overall Study|Withdrawal Criteria|1
307567|NCT01512108|1041739|P2|Overall Study|Protocol Violation|2
307568|NCT01512108|1041740|P1|Overall Study|Protocol Violation|1
307569|NCT01512108|1041739|P2|Overall Study|Adverse Event|4
307570|NCT01512108|1041740|P1|Overall Study|Adverse Event|9
307571|NCT01511939|1041766|P3|Overall Study|Withdrawal by Subject|0
307572|NCT01511939|1041767|P2|Overall Study|Withdrawal by Subject|1
307573|NCT01511939|1041768|P1|Overall Study|Withdrawal by Subject|2
307574|NCT01511536|1041797|P3|Phase 2|Other|9
307575|NCT01511536|1041798|P2|Phase 2|Other|0
307576|NCT01511536|1041799|P1|Phase 2|Other|0
307577|NCT01511536|1041797|P3|Phase 1|Other|0
307578|NCT01511536|1041798|P2|Phase 1|Other|1
307579|NCT01511536|1041799|P1|Phase 1|Other|0
307580|NCT01511445|1041821|P2|Overall Study|Protocol Violation|0
307581|NCT01511445|1041822|P1|Overall Study|Protocol Violation|1
307582|NCT01511445|1041821|P2|Overall Study|Protocol Violation|3
307583|NCT01511445|1041822|P1|Overall Study|Protocol Violation|1
307584|NCT01511445|1041821|P2|Overall Study|Lost to Follow-up|1
307585|NCT01511445|1041822|P1|Overall Study|Lost to Follow-up|3
307586|NCT01511250|1041850|P10|Overall Study|Protocol Violation|0
307587|NCT01511250|1041851|P9|Overall Study|Protocol Violation|0
307588|NCT01511250|1041852|P8|Overall Study|Protocol Violation|0
307589|NCT01511250|1041853|P7|Overall Study|Protocol Violation|0
307590|NCT01511250|1041854|P6|Overall Study|Protocol Violation|0
307591|NCT01511250|1041855|P5|Overall Study|Protocol Violation|0
307592|NCT01511250|1041856|P4|Overall Study|Protocol Violation|0
307593|NCT01511250|1041857|P3|Overall Study|Protocol Violation|1
307594|NCT01511250|1041858|P2|Overall Study|Protocol Violation|2
307595|NCT01511250|1041859|P1|Overall Study|Protocol Violation|0
307596|NCT01511250|1041850|P10|Overall Study|Lost to Follow-up|5
307597|NCT01511250|1041851|P9|Overall Study|Lost to Follow-up|13
307598|NCT01511250|1041852|P8|Overall Study|Lost to Follow-up|3
307599|NCT01511250|1041853|P7|Overall Study|Lost to Follow-up|2
307600|NCT01511250|1041854|P6|Overall Study|Lost to Follow-up|0
307601|NCT01511250|1041855|P5|Overall Study|Lost to Follow-up|0
307602|NCT01511250|1041856|P4|Overall Study|Lost to Follow-up|3
307603|NCT01511250|1041857|P3|Overall Study|Lost to Follow-up|3
307604|NCT01511250|1041858|P2|Overall Study|Lost to Follow-up|3
307605|NCT01511250|1041859|P1|Overall Study|Lost to Follow-up|7
307606|NCT01511250|1041850|P10|Overall Study|Sponsor/Investigator Decision|0
307607|NCT01511250|1041851|P9|Overall Study|Sponsor/Investigator Decision|0
307608|NCT01511250|1041852|P8|Overall Study|Sponsor/Investigator Decision|0
307609|NCT01511250|1041853|P7|Overall Study|Sponsor/Investigator Decision|0
307610|NCT01511250|1041854|P6|Overall Study|Sponsor/Investigator Decision|0
307611|NCT01511250|1041855|P5|Overall Study|Sponsor/Investigator Decision|0
307612|NCT01511250|1041856|P4|Overall Study|Sponsor/Investigator Decision|0
307613|NCT01511250|1041857|P3|Overall Study|Sponsor/Investigator Decision|0
307614|NCT01511250|1041858|P2|Overall Study|Sponsor/Investigator Decision|0
307615|NCT01511250|1041859|P1|Overall Study|Sponsor/Investigator Decision|1
307616|NCT01511250|1041850|P10|Overall Study|Withdrawal of Consent|0
307617|NCT01511250|1041851|P9|Overall Study|Withdrawal of Consent|1
307618|NCT01511250|1041852|P8|Overall Study|Withdrawal of Consent|1
307619|NCT01511250|1041853|P7|Overall Study|Withdrawal of Consent|0
307620|NCT01511250|1041854|P6|Overall Study|Withdrawal of Consent|0
307621|NCT01511250|1041855|P5|Overall Study|Withdrawal of Consent|0
307622|NCT01511250|1041856|P4|Overall Study|Withdrawal of Consent|0
307623|NCT01511250|1041857|P3|Overall Study|Withdrawal of Consent|0
307624|NCT01511250|1041858|P2|Overall Study|Withdrawal of Consent|0
307625|NCT01511250|1041859|P1|Overall Study|Withdrawal of Consent|1
307626|NCT01511107|1042007|P2|Overall Study|Withdrawal by Subject|20
307627|NCT01511107|1042008|P1|Overall Study|Withdrawal by Subject|9
307628|NCT01511107|1042007|P2|Overall Study|Lost to Follow-up|19
307629|NCT01511107|1042008|P1|Overall Study|Lost to Follow-up|10
307630|NCT01511107|1042007|P2|Overall Study|Ineligible|2
307631|NCT01511107|1042008|P1|Overall Study|Ineligible|3
307632|NCT01510912|1042086|P1|Overall Study|Other, including joint replacement|5
307633|NCT01510912|1042086|P1|Overall Study|Lost to Follow-up|26
307634|NCT01510912|1042086|P1|Overall Study|Protocol Violation|27
307635|NCT01510912|1042086|P1|Overall Study|Physician Decision|1
307636|NCT01510912|1042086|P1|Overall Study|Withdrawal by Subject|49
307637|NCT01510912|1042086|P1|Overall Study|Non-compliance with trial drug|23
307638|NCT01510912|1042086|P1|Overall Study|Lack of Efficacy|12
307639|NCT01510912|1042086|P1|Overall Study|Adverse Event|99
307640|NCT01510769|1042102|P3|Overall Study|Death|0
307641|NCT01510769|1042103|P2|Overall Study|Death|1
307642|NCT01510769|1042104|P1|Overall Study|Death|1
307643|NCT01510769|1042102|P3|Overall Study|Withdrawal by Subject|3
307644|NCT01510769|1042103|P2|Overall Study|Withdrawal by Subject|4
307645|NCT01510769|1042104|P1|Overall Study|Withdrawal by Subject|3
307646|NCT01510769|1042102|P3|Overall Study|Lost to Follow-up|5
307647|NCT01510769|1042103|P2|Overall Study|Lost to Follow-up|1
307648|NCT01510769|1042104|P1|Overall Study|Lost to Follow-up|5
307649|NCT01510769|1042102|P3|Overall Study|Protocol Violation|9
307650|NCT01510769|1042103|P2|Overall Study|Protocol Violation|10
307651|NCT01510769|1042104|P1|Overall Study|Protocol Violation|11
307652|NCT01510769|1042102|P3|Overall Study|Gout Flare|1
307653|NCT01510769|1042103|P2|Overall Study|Gout Flare|3
307654|NCT01510769|1042104|P1|Overall Study|Gout Flare|0
307655|NCT01510769|1042102|P3|Overall Study|Adverse Event|4
307656|NCT01510769|1042103|P2|Overall Study|Adverse Event|6
307657|NCT01510769|1042104|P1|Overall Study|Adverse Event|7
307658|NCT01510756|1042121|P1|Overall Study|Physician Decision|1
307659|NCT01510756|1042121|P1|Overall Study|Lack of Efficacy|2
307660|NCT01510756|1042121|P1|Overall Study|Death|1
307661|NCT01510717|1042129|P2|Overall Study|Withdrawal by Subject|2
307662|NCT01510717|1042130|P1|Overall Study|Withdrawal by Subject|0
307663|NCT01510717|1042129|P2|Overall Study|Lost to Follow-up|1
307664|NCT01510717|1042130|P1|Overall Study|Lost to Follow-up|0
307665|NCT01510717|1042129|P2|Overall Study|Death|0
307666|NCT01510717|1042130|P1|Overall Study|Death|1
307667|NCT01510717|1042129|P2|Overall Study|Adverse Event|2
307668|NCT01510717|1042130|P1|Overall Study|Adverse Event|1
307669|NCT01510158|1042250|P3|Overall Study|Death|0
307670|NCT01510158|1042251|P2|Overall Study|Death|0
307671|NCT01510158|1042252|P1|Overall Study|Death|1
307672|NCT01510158|1042250|P3|Overall Study|Withdrawal by Subject|10
307673|NCT01510158|1042251|P2|Overall Study|Withdrawal by Subject|13
307674|NCT01510158|1042252|P1|Overall Study|Withdrawal by Subject|10
307675|NCT01510158|1042250|P3|Overall Study|Lost to Follow-up|9
307676|NCT01510158|1042251|P2|Overall Study|Lost to Follow-up|16
307677|NCT01510158|1042252|P1|Overall Study|Lost to Follow-up|13
307678|NCT01510158|1042250|P3|Overall Study|Sponsor terminated study.|2
307679|NCT01510158|1042251|P2|Overall Study|Sponsor terminated study.|0
307680|NCT01510158|1042252|P1|Overall Study|Sponsor terminated study.|2
307681|NCT01510158|1042250|P3|Overall Study|Protocol Violation|24
307682|NCT01510158|1042251|P2|Overall Study|Protocol Violation|16
307683|NCT01510158|1042252|P1|Overall Study|Protocol Violation|17
307684|NCT01510158|1042250|P3|Overall Study|Gout flare|0
307685|NCT01510158|1042251|P2|Overall Study|Gout flare|0
307686|NCT01510158|1042252|P1|Overall Study|Gout flare|1
307687|NCT01510158|1042250|P3|Overall Study|Adverse Event|5
307688|NCT01510158|1042251|P2|Overall Study|Adverse Event|8
307689|NCT01510158|1042252|P1|Overall Study|Adverse Event|7
307690|NCT01510145|1042266|P1|Overall Study|Relative reported subject withdrew|1
307691|NCT01510145|1042266|P1|Overall Study|Withdrawal by Subject|6
307692|NCT01510145|1042266|P1|Overall Study|Lost to Follow-up|5
307693|NCT01510145|1042266|P1|Overall Study|Adverse Event|6
307694|NCT01509664|1042300|P2|Overall Study|Lost to Follow-up|21
307695|NCT01509664|1042301|P1|Overall Study|Lost to Follow-up|15
307696|NCT01509079|1042387|P2|Overall Study|started an excluded medication|1
307697|NCT01509079|1042388|P1|Overall Study|started an excluded medication|0
307698|NCT01509079|1042387|P2|Overall Study|Lack of Efficacy|2
307699|NCT01509079|1042388|P1|Overall Study|Lack of Efficacy|0
307700|NCT01509053|1042404|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
307701|NCT01509053|1042404|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
307702|NCT01509053|1042404|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
307703|NCT01509053|1042404|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
307704|NCT01509053|1042404|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
307705|NCT01509053|1042404|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
307706|NCT01508936|1042466|P2|Overall Study|Data from 2 sites deemed invalid|11
307707|NCT01508936|1042467|P1|Overall Study|Data from 2 sites deemed invalid|4
307708|NCT01508936|1042466|P2|Overall Study|Not specified|5
307709|NCT01508936|1042467|P1|Overall Study|Not specified|0
307710|NCT01508936|1042466|P2|Overall Study|Lost to Follow-up|9
307711|NCT01508936|1042467|P1|Overall Study|Lost to Follow-up|2
307712|NCT01508936|1042466|P2|Overall Study|Protocol Violation|3
307713|NCT01508936|1042467|P1|Overall Study|Protocol Violation|2
307714|NCT01508936|1042466|P2|Overall Study|Withdrawal by Subject|18
307715|NCT01508936|1042467|P1|Overall Study|Withdrawal by Subject|4
307716|NCT01508936|1042466|P2|Overall Study|Lack of Efficacy|1
307717|NCT01508936|1042467|P1|Overall Study|Lack of Efficacy|0
307718|NCT01508936|1042466|P2|Overall Study|Adverse Event|32
307719|NCT01508936|1042467|P1|Overall Study|Adverse Event|11
307720|NCT01508910|1042506|P4|Treatment|Sponsor Decision|1
307721|NCT01508910|1042507|P3|Treatment|Sponsor Decision|0
307722|NCT01508910|1042508|P2|Treatment|Sponsor Decision|0
307723|NCT01508910|1042509|P1|Treatment|Sponsor Decision|0
307724|NCT01508910|1042506|P4|Treatment|Withdrawal by Subject|1
307725|NCT01508910|1042507|P3|Treatment|Withdrawal by Subject|6
307726|NCT01508910|1042508|P2|Treatment|Withdrawal by Subject|1
307727|NCT01508910|1042509|P1|Treatment|Withdrawal by Subject|0
307728|NCT01508910|1042506|P4|Treatment|Lost to Follow-up|1
307729|NCT01508910|1042507|P3|Treatment|Lost to Follow-up|2
307730|NCT01508910|1042508|P2|Treatment|Lost to Follow-up|0
307731|NCT01508910|1042509|P1|Treatment|Lost to Follow-up|0
307732|NCT01508910|1042506|P4|Treatment|Death|0
307733|NCT01508910|1042507|P3|Treatment|Death|2
307734|NCT01508910|1042508|P2|Treatment|Death|3
307735|NCT01508910|1042509|P1|Treatment|Death|2
307736|NCT01508702|1042542|P2|Overall Study|Withdrawal by Subject|7
307737|NCT01508702|1042543|P1|Overall Study|Withdrawal by Subject|11
307738|NCT01508702|1042542|P2|Overall Study|Lost to Follow-up|2
307739|NCT01508702|1042543|P1|Overall Study|Lost to Follow-up|1
307740|NCT01508702|1042542|P2|Overall Study|Protocol Violation|1
307741|NCT01508702|1042543|P1|Overall Study|Protocol Violation|2
307742|NCT01508702|1042542|P2|Overall Study|Gout flare|0
307743|NCT01508702|1042543|P1|Overall Study|Gout flare|2
307744|NCT01508702|1042542|P2|Overall Study|Adverse Event|3
307745|NCT01508702|1042543|P1|Overall Study|Adverse Event|7
307746|NCT01508676|1042551|P2|Phase II (2 Weeks)|Medication Exclusion|0
307747|NCT01508676|1042552|P1|Phase II (2 Weeks)|Medication Exclusion|1
307748|NCT01508676|1042551|P2|Phase II (2 Weeks)|Skin Sensitivity|1
307749|NCT01508676|1042552|P1|Phase II (2 Weeks)|Skin Sensitivity|0
307750|NCT01508676|1042551|P2|Phase I (2 Weeks)|Positive Drug Screen|2
307751|NCT01508676|1042552|P1|Phase I (2 Weeks)|Positive Drug Screen|0
307752|NCT01508676|1042551|P2|Phase I (2 Weeks)|Wrong Pain Type|0
307753|NCT01508676|1042552|P1|Phase I (2 Weeks)|Wrong Pain Type|1
307754|NCT01508676|1042551|P2|Phase I (2 Weeks)|Medication Exclusion|1
307755|NCT01508676|1042552|P1|Phase I (2 Weeks)|Medication Exclusion|1
307756|NCT01508325|1042573|P2|Overall Study|Other|2
307757|NCT01508325|1042574|P1|Overall Study|Other|2
307758|NCT01508325|1042573|P2|Overall Study|Lost to Follow-up|6
307759|NCT01508325|1042574|P1|Overall Study|Lost to Follow-up|5
307760|NCT01508325|1042573|P2|Overall Study|Adverse Event|0
307761|NCT01508325|1042574|P1|Overall Study|Adverse Event|1
307762|NCT01508325|1042573|P2|Overall Study|Physician Decision|1
307763|NCT01508325|1042574|P1|Overall Study|Physician Decision|2
307764|NCT01508325|1042573|P2|Overall Study|Protocol Violation|3
307765|NCT01508325|1042574|P1|Overall Study|Protocol Violation|0
307766|NCT01508325|1042573|P2|Overall Study|Withdrawal by Subject|9
307767|NCT01508325|1042574|P1|Overall Study|Withdrawal by Subject|8
307768|NCT01508169|1042604|P2|Overall Study|Lost to Follow-up|2
307769|NCT01508169|1042605|P1|Overall Study|Lost to Follow-up|1
307770|NCT01508169|1042604|P2|Overall Study|Withdrawal by Subject|0
307771|NCT01508169|1042605|P1|Overall Study|Withdrawal by Subject|1
307772|NCT01508169|1042604|P2|Overall Study|Adverse Event|0
307773|NCT01508169|1042605|P1|Overall Study|Adverse Event|1
307774|NCT01508130|1042619|P2|Overall Study|Administrative|3
307775|NCT01508130|1042620|P1|Overall Study|Administrative|14
307776|NCT01508130|1042619|P2|Overall Study|Insufficient therapeutic response|23
307777|NCT01508130|1042620|P1|Overall Study|Insufficient therapeutic response|74
307778|NCT01508130|1042619|P2|Overall Study|Subject’s substantial non-compliance|9
307779|NCT01508130|1042620|P1|Overall Study|Subject’s substantial non-compliance|25
307780|NCT01508130|1042619|P2|Overall Study|Withdrawal by Subject|3
307781|NCT01508130|1042620|P1|Overall Study|Withdrawal by Subject|3
307782|NCT01508130|1042619|P2|Overall Study|Lost to Follow-up|2
307783|NCT01508130|1042620|P1|Overall Study|Lost to Follow-up|25
307784|NCT01508130|1042619|P2|Overall Study|Protocol Violation|0
307785|NCT01508130|1042620|P1|Overall Study|Protocol Violation|2
307786|NCT01508130|1042619|P2|Overall Study|Death|1
307787|NCT01508130|1042620|P1|Overall Study|Death|3
307788|NCT01508130|1042619|P2|Overall Study|Adverse Event|28
307789|NCT01508130|1042620|P1|Overall Study|Adverse Event|81
307790|NCT01507896|1042688|P1|Overall Study|The surgery was denied by the sponsor.|1
307791|NCT01507896|1042688|P1|Overall Study|Withdrawal by Subject|1
307792|NCT01507831|1042731|P2|Overall Study|Other|6
307793|NCT01507831|1042732|P1|Overall Study|Other|3
307794|NCT01507831|1042731|P2|Overall Study|Potential lost to follow-up|0
307795|NCT01507831|1042732|P1|Overall Study|Potential lost to follow-up|3
307796|NCT01507831|1042731|P2|Overall Study|Site closure|3
307797|NCT01507831|1042732|P1|Overall Study|Site closure|0
307798|NCT01507831|1042731|P2|Overall Study|Selection criteria finally not met|1
307799|NCT01507831|1042732|P1|Overall Study|Selection criteria finally not met|0
307800|NCT01507831|1042731|P2|Overall Study|Last visit outside protocol visit window|143
307801|NCT01507831|1042732|P1|Overall Study|Last visit outside protocol visit window|51
307802|NCT01507831|1042731|P2|Overall Study|Related to study drug administration|14
307803|NCT01507831|1042732|P1|Overall Study|Related to study drug administration|5
307804|NCT01507831|1042731|P2|Overall Study|Consent withdrawn by participant|72
307805|NCT01507831|1042732|P1|Overall Study|Consent withdrawn by participant|34
307806|NCT01507831|1042731|P2|Overall Study|Participant moved|19
307807|NCT01507831|1042732|P1|Overall Study|Participant moved|5
307808|NCT01507831|1042731|P2|Overall Study|Physician Decision|4
307809|NCT01507831|1042732|P1|Overall Study|Physician Decision|0
307810|NCT01507831|1042731|P2|Overall Study|Poor compliance to protocol|60
307811|NCT01507831|1042732|P1|Overall Study|Poor compliance to protocol|38
307812|NCT01507831|1042731|P2|Overall Study|Death|2
307813|NCT01507831|1042732|P1|Overall Study|Death|6
307814|NCT01507831|1042731|P2|Overall Study|Adverse Event|113
307815|NCT01507831|1042732|P1|Overall Study|Adverse Event|48
307816|NCT01507831|1042731|P2|Overall Study|Randomized but not treated|3
307817|NCT01507831|1042732|P1|Overall Study|Randomized but not treated|0
307826|NCT01507246|1042828|P2|Overall Study|Required different surgical procedures|1
307827|NCT01507246|1042829|P1|Overall Study|Required different surgical procedures|2
307828|NCT01507090|1042927|P1|Overall Study|incomplete dataset|18
307829|NCT01507051|1042966|P4|Overall Study|Adverse Event|0
307830|NCT01507051|1042967|P3|Overall Study|Adverse Event|0
307831|NCT01507051|1042968|P2|Overall Study|Adverse Event|0
307832|NCT01507051|1042969|P1|Overall Study|Adverse Event|1
307833|NCT01507051|1042966|P4|Overall Study|Physician Decision|1
307834|NCT01507051|1042967|P3|Overall Study|Physician Decision|0
307835|NCT01507051|1042968|P2|Overall Study|Physician Decision|0
307836|NCT01507051|1042969|P1|Overall Study|Physician Decision|0
307837|NCT01507051|1042966|P4|Overall Study|Withdrawal by Subject|6
307838|NCT01507051|1042967|P3|Overall Study|Withdrawal by Subject|1
307839|NCT01507051|1042968|P2|Overall Study|Withdrawal by Subject|3
307840|NCT01507051|1042969|P1|Overall Study|Withdrawal by Subject|1
307841|NCT01506960|1043087|P1|Overall Study|Did not meet angiographic criteria|47
307842|NCT01506947|1043093|P1|Overall Study|Did Not Meet Eligibility Criteria|3
307843|NCT01506947|1043093|P1|Overall Study|Death|1
307844|NCT01506947|1043093|P1|Overall Study|Adverse Event|5
307845|NCT01506947|1043093|P1|Overall Study|Lost to Follow-up|7
307846|NCT01506908|1043111|P2|Overall Study|Adverse Event|0
307847|NCT01506908|1043112|P1|Overall Study|Adverse Event|1
307848|NCT01506882|1043130|P2|Overall Study|Other Reason|0
307849|NCT01506882|1043131|P1|Overall Study|Other Reason|2
307850|NCT01506882|1043130|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
307851|NCT01506882|1043131|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
307852|NCT01506882|1043130|P2|Overall Study|AE, non-serious non-fatal|1
307853|NCT01506882|1043131|P1|Overall Study|AE, non-serious non-fatal|3
307854|NCT01506882|1043130|P2|Overall Study|SAE, non-fatal|0
307855|NCT01506882|1043131|P1|Overall Study|SAE, non-fatal|2
307856|NCT01506882|1043130|P2|Overall Study|Withdrawal by Subject|3
307857|NCT01506882|1043131|P1|Overall Study|Withdrawal by Subject|9
307858|NCT01506882|1043130|P2|Overall Study|Lost to Follow-up|0
307859|NCT01506882|1043131|P1|Overall Study|Lost to Follow-up|1
307860|NCT01506882|1043130|P2|Overall Study|Lack of Efficacy|3
307861|NCT01506882|1043131|P1|Overall Study|Lack of Efficacy|4
307862|NCT01506726|1043145|P2|Overall Study|Adverse Event|2
307863|NCT01506726|1043146|P1|Overall Study|Adverse Event|1
307864|NCT01506596|1043186|P1|Overall Study|ineligible pathology|1
307865|NCT01506479|1043197|P3|Overall Study|Adverse Event|0
307866|NCT01506479|1043198|P2|Overall Study|Adverse Event|1
307867|NCT01506479|1043199|P1|Overall Study|Adverse Event|0
307868|NCT01506479|1043197|P3|Overall Study|Missing assessment|0
307869|NCT01506479|1043198|P2|Overall Study|Missing assessment|0
307870|NCT01506479|1043199|P1|Overall Study|Missing assessment|1
307871|NCT01506479|1043197|P3|Overall Study|Withdrawal by Subject|1
307872|NCT01506479|1043198|P2|Overall Study|Withdrawal by Subject|2
307873|NCT01506479|1043199|P1|Overall Study|Withdrawal by Subject|1
307874|NCT01506479|1043197|P3|Overall Study|Lost to Follow-up|2
307875|NCT01506479|1043198|P2|Overall Study|Lost to Follow-up|2
307876|NCT01506479|1043199|P1|Overall Study|Lost to Follow-up|1
307877|NCT01506323|1043217|P2|Overall Study|Started another treatment|0
307878|NCT01506323|1043218|P1|Overall Study|Started another treatment|1
307879|NCT01506323|1043217|P2|Overall Study|Schedule or Transportation conflict|0
307880|NCT01506323|1043218|P1|Overall Study|Schedule or Transportation conflict|8
307881|NCT01506323|1043217|P2|Overall Study|Moved out of area|2
307882|NCT01506323|1043218|P1|Overall Study|Moved out of area|5
307883|NCT01506323|1043217|P2|Overall Study|Lack of Efficacy|3
307884|NCT01506323|1043218|P1|Overall Study|Lack of Efficacy|1
307885|NCT01506323|1043217|P2|Overall Study|Withdrawal by Subject|4
307886|NCT01506323|1043218|P1|Overall Study|Withdrawal by Subject|4
307887|NCT01506323|1043217|P2|Overall Study|Lost to Follow-up|4
307888|NCT01506323|1043218|P1|Overall Study|Lost to Follow-up|5
307889|NCT01506193|1043247|P3|Overall Study|Lost to Follow-up|3
307890|NCT01506193|1043248|P2|Overall Study|Lost to Follow-up|3
307891|NCT01506193|1043249|P1|Overall Study|Lost to Follow-up|8
307892|NCT01506193|1043247|P3|Overall Study|Withdrawal by Subject|8
307893|NCT01506193|1043248|P2|Overall Study|Withdrawal by Subject|1
307894|NCT01506193|1043249|P1|Overall Study|Withdrawal by Subject|5
307895|NCT01506193|1043247|P3|Overall Study|Adverse event, non-fatal|1
307896|NCT01506193|1043248|P2|Overall Study|Adverse event, non-fatal|0
307897|NCT01506193|1043249|P1|Overall Study|Adverse event, non-fatal|0
307898|NCT01506193|1043247|P3|Overall Study|Migrated/moved from study area|1
307899|NCT01506193|1043248|P2|Overall Study|Migrated/moved from study area|0
307900|NCT01506193|1043249|P1|Overall Study|Migrated/moved from study area|0
307901|NCT01506193|1043247|P3|Overall Study|Protocol Violation|1
307902|NCT01506193|1043248|P2|Overall Study|Protocol Violation|0
307903|NCT01506193|1043249|P1|Overall Study|Protocol Violation|1
307904|NCT01505881|1043282|P2|Overall Study|Withdrawal by Subject|0
307905|NCT01505881|1043283|P1|Overall Study|Withdrawal by Subject|2
307906|NCT01505881|1043282|P2|Overall Study|Lost to Follow-up|0
307907|NCT01505881|1043283|P1|Overall Study|Lost to Follow-up|2
307908|NCT01505881|1043282|P2|Overall Study|Adverse Event|1
307909|NCT01505881|1043283|P1|Overall Study|Adverse Event|0
307910|NCT01505647|1043389|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
307911|NCT01505647|1043390|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
307912|NCT01505647|1043389|P2|Day 43 Through Day 182 Follow-up|Death|1
307913|NCT01505647|1043390|P1|Day 43 Through Day 182 Follow-up|Death|0
307914|NCT01505647|1043389|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
307915|NCT01505647|1043390|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
307916|NCT01505647|1043389|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
307917|NCT01505647|1043390|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
307918|NCT01505647|1043389|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
307919|NCT01505647|1043390|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
307920|NCT01505608|1043406|P2|Phase II|Protocol Violation|1
307921|NCT01505608|1043407|P1|Phase II|Protocol Violation|0
307922|NCT01505608|1043406|P2|Phase II|Lack of Efficacy|1
307923|NCT01505608|1043407|P1|Phase II|Lack of Efficacy|2
307924|NCT01505608|1043406|P2|Phase I|Withdrawal by Subject|1
307925|NCT01505608|1043407|P1|Phase I|Withdrawal by Subject|0
307926|NCT01505608|1043406|P2|Phase I|Adverse Event|1
307927|NCT01505608|1043407|P1|Phase I|Adverse Event|0
307928|NCT01505608|1043406|P2|Phase I|Lack of Efficacy|4
307929|NCT01505608|1043407|P1|Phase I|Lack of Efficacy|0
307930|NCT01505530|1043426|P3|Overall Study|entry criteria not met|0
307931|NCT01505530|1043427|P2|Overall Study|entry criteria not met|1
307932|NCT01505530|1043428|P1|Overall Study|entry criteria not met|0
307933|NCT01505530|1043426|P3|Overall Study|Death|5
307934|NCT01505530|1043427|P2|Overall Study|Death|6
307935|NCT01505530|1043428|P1|Overall Study|Death|7
307936|NCT01505530|1043426|P3|Overall Study|Sponsor Decision|7
307937|NCT01505530|1043427|P2|Overall Study|Sponsor Decision|8
307938|NCT01505530|1043428|P1|Overall Study|Sponsor Decision|1
307939|NCT01505530|1043426|P3|Overall Study|Physician Decision|5
307940|NCT01505530|1043427|P2|Overall Study|Physician Decision|2
307941|NCT01505530|1043428|P1|Overall Study|Physician Decision|6
307942|NCT01505530|1043426|P3|Overall Study|Withdrawal by Subject|6
307943|NCT01505530|1043427|P2|Overall Study|Withdrawal by Subject|8
307944|NCT01505530|1043428|P1|Overall Study|Withdrawal by Subject|7
307945|NCT01505530|1043426|P3|Overall Study|Adverse Event|0
307946|NCT01505530|1043427|P2|Overall Study|Adverse Event|1
307947|NCT01505530|1043428|P1|Overall Study|Adverse Event|1
307948|NCT01505530|1043426|P3|Overall Study|Progressive Disease|18
307949|NCT01505530|1043427|P2|Overall Study|Progressive Disease|17
307950|NCT01505530|1043428|P1|Overall Study|Progressive Disease|19
307951|NCT01505387|1043488|P2|Overall Study|Withdrawal by Subject|1
307952|NCT01505387|1043489|P1|Overall Study|Withdrawal by Subject|1
307953|NCT01505387|1043488|P2|Overall Study|Protocol Violation|0
307954|NCT01505387|1043489|P1|Overall Study|Protocol Violation|1
307955|NCT01505374|1043495|P2|Overall Study|Lost to Follow-up|0
307956|NCT01505374|1043496|P1|Overall Study|Lost to Follow-up|1
307957|NCT01505114|1043531|P4|Overall Study|investigator decision|0
307958|NCT01505114|1043532|P3|Overall Study|investigator decision|1
307959|NCT01505114|1043533|P2|Overall Study|investigator decision|0
307960|NCT01505114|1043534|P1|Overall Study|investigator decision|1
307961|NCT01505114|1043531|P4|Overall Study|staff safety concerns|1
307962|NCT01505114|1043532|P3|Overall Study|staff safety concerns|0
307963|NCT01505114|1043533|P2|Overall Study|staff safety concerns|0
307964|NCT01505114|1043534|P1|Overall Study|staff safety concerns|0
307965|NCT01505114|1043531|P4|Overall Study|inadvertent enrollment due to peanut all|1
307966|NCT01505114|1043532|P3|Overall Study|inadvertent enrollment due to peanut all|0
307967|NCT01505114|1043533|P2|Overall Study|inadvertent enrollment due to peanut all|0
307968|NCT01505114|1043534|P1|Overall Study|inadvertent enrollment due to peanut all|0
307969|NCT01505114|1043531|P4|Overall Study|relocated|3
307970|NCT01505114|1043532|P3|Overall Study|relocated|2
307971|NCT01505114|1043533|P2|Overall Study|relocated|2
307972|NCT01505114|1043534|P1|Overall Study|relocated|4
307973|NCT01505114|1043531|P4|Overall Study|Lost to Follow-up|7
307974|NCT01505114|1043532|P3|Overall Study|Lost to Follow-up|8
307975|NCT01505114|1043533|P2|Overall Study|Lost to Follow-up|5
307976|NCT01505114|1043534|P1|Overall Study|Lost to Follow-up|11
307977|NCT01505114|1043531|P4|Overall Study|unable to adhere to visit schedule|3
307978|NCT01505114|1043532|P3|Overall Study|unable to adhere to visit schedule|3
307979|NCT01505114|1043533|P2|Overall Study|unable to adhere to visit schedule|2
307980|NCT01505114|1043534|P1|Overall Study|unable to adhere to visit schedule|3
307981|NCT01505114|1043531|P4|Overall Study|Death|1
307982|NCT01505114|1043532|P3|Overall Study|Death|0
307983|NCT01505114|1043533|P2|Overall Study|Death|0
307984|NCT01505114|1043534|P1|Overall Study|Death|1
307985|NCT01505114|1043531|P4|Overall Study|Withdrawal by Subject|7
307986|NCT01505114|1043532|P3|Overall Study|Withdrawal by Subject|4
307987|NCT01505114|1043533|P2|Overall Study|Withdrawal by Subject|4
307988|NCT01505114|1043534|P1|Overall Study|Withdrawal by Subject|5
307989|NCT01504971|1043548|P1|Overall Study|Physician Decision|13
307990|NCT01504867|1043577|P2|Overall Study|Consent revoked|1
307991|NCT01504867|1043578|P1|Overall Study|Consent revoked|5
307992|NCT01504867|1043577|P2|Overall Study|Inclusion criteria not met|2
307993|NCT01504867|1043578|P1|Overall Study|Inclusion criteria not met|2
307994|NCT01504204|1043615|P2|Overall Study|Lost to Follow-up|1
307995|NCT01504204|1043616|P1|Overall Study|Lost to Follow-up|1
307996|NCT01503164|1043644|P2|Overall Study|Withdrawal by Subject|1
307997|NCT01503164|1043645|P1|Overall Study|Withdrawal by Subject|2
307998|NCT01503021|1043675|P2|Overall Study|Moved, received transplant, etc.|7
307999|NCT01503021|1043676|P1|Overall Study|Moved, received transplant, etc.|5
308000|NCT01503021|1043675|P2|Overall Study|Withdrawal by Subject|8
308001|NCT01503021|1043676|P1|Overall Study|Withdrawal by Subject|9
308002|NCT01503021|1043675|P2|Overall Study|Protocol Violation|3
308003|NCT01503021|1043676|P1|Overall Study|Protocol Violation|1
308004|NCT01503021|1043675|P2|Overall Study|Physician Decision|0
308005|NCT01503021|1043676|P1|Overall Study|Physician Decision|3
308006|NCT01503021|1043675|P2|Overall Study|Lost to Follow-up|0
308007|NCT01503021|1043676|P1|Overall Study|Lost to Follow-up|2
308008|NCT01503021|1043675|P2|Overall Study|Death|2
308009|NCT01503021|1043676|P1|Overall Study|Death|0
308010|NCT01503021|1043675|P2|Overall Study|Adverse Event|6
308011|NCT01503021|1043676|P1|Overall Study|Adverse Event|7
308012|NCT01502956|1043725|P2|Overall Study|Withdrawal by Subject|10
308013|NCT01502956|1043726|P1|Overall Study|Withdrawal by Subject|8
308014|NCT01502956|1043725|P2|Overall Study|Physician Decision|3
308015|NCT01502956|1043726|P1|Overall Study|Physician Decision|2
308016|NCT01502956|1043725|P2|Overall Study|Lost to Follow-up|11
308017|NCT01502956|1043726|P1|Overall Study|Lost to Follow-up|14
308018|NCT01502956|1043725|P2|Overall Study|Death|2
308019|NCT01502956|1043726|P1|Overall Study|Death|0
308020|NCT01502709|1043784|P2|Overall Study|Lost to Follow-up|0
308021|NCT01502709|1043785|P1|Overall Study|Lost to Follow-up|4
308022|NCT01502644|1043798|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
308023|NCT01502644|1043799|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
308024|NCT01502644|1043800|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
308025|NCT01502644|1043801|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
308026|NCT01502644|1043798|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
308027|NCT01502644|1043799|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
308028|NCT01502644|1043800|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
308029|NCT01502644|1043801|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
308030|NCT01502644|1043798|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
308031|NCT01502644|1043799|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
308032|NCT01502644|1043800|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
308033|NCT01502644|1043801|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
308034|NCT01502644|1043798|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
308035|NCT01502644|1043799|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
308036|NCT01502644|1043800|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
308037|NCT01502644|1043801|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
308038|NCT01502644|1043798|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
308039|NCT01502644|1043799|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
308040|NCT01502644|1043800|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
308041|NCT01502644|1043801|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
308042|NCT01502423|1043811|P2|Overall Study|Withdrawal by Subject|1
308043|NCT01502423|1043812|P1|Overall Study|Withdrawal by Subject|0
308044|NCT01502410|1043834|P4|Overall Study|Withdrawal by Subject|0
308045|NCT01502410|1043835|P3|Overall Study|Withdrawal by Subject|0
308046|NCT01502410|1043836|P2|Overall Study|Withdrawal by Subject|0
308047|NCT01502410|1043837|P1|Overall Study|Withdrawal by Subject|2
308048|NCT01502410|1043834|P4|Overall Study|Physician Decision|0
308049|NCT01502410|1043835|P3|Overall Study|Physician Decision|0
308050|NCT01502410|1043836|P2|Overall Study|Physician Decision|1
308051|NCT01502410|1043837|P1|Overall Study|Physician Decision|0
308052|NCT01502410|1043834|P4|Overall Study|Lack of Efficacy|0
308053|NCT01502410|1043835|P3|Overall Study|Lack of Efficacy|0
308054|NCT01502410|1043836|P2|Overall Study|Lack of Efficacy|7
308055|NCT01502410|1043837|P1|Overall Study|Lack of Efficacy|7
308056|NCT01502410|1043834|P4|Overall Study|Adverse Event|0
308057|NCT01502410|1043835|P3|Overall Study|Adverse Event|0
308058|NCT01502410|1043836|P2|Overall Study|Adverse Event|2
308059|NCT01502410|1043837|P1|Overall Study|Adverse Event|1
308060|NCT01502371|1043855|P5|Overall Study|Excluded Medication|1
308061|NCT01502371|1043856|P4|Overall Study|Excluded Medication|0
308062|NCT01502371|1043857|P3|Overall Study|Excluded Medication|1
308063|NCT01502371|1043858|P2|Overall Study|Excluded Medication|1
308064|NCT01502371|1043859|P1|Overall Study|Excluded Medication|0
308065|NCT01502371|1043855|P5|Overall Study|Protocol Violation|10
308066|NCT01502371|1043856|P4|Overall Study|Protocol Violation|5
308067|NCT01502371|1043857|P3|Overall Study|Protocol Violation|6
308068|NCT01502371|1043858|P2|Overall Study|Protocol Violation|5
308069|NCT01502371|1043859|P1|Overall Study|Protocol Violation|9
308070|NCT01502371|1043855|P5|Overall Study|Technical Problems|1
308071|NCT01502371|1043856|P4|Overall Study|Technical Problems|4
308072|NCT01502371|1043857|P3|Overall Study|Technical Problems|2
308073|NCT01502371|1043858|P2|Overall Study|Technical Problems|0
308074|NCT01502371|1043859|P1|Overall Study|Technical Problems|1
308075|NCT01502371|1043855|P5|Overall Study|Noncompliance with Study Drug|1
308076|NCT01502371|1043856|P4|Overall Study|Noncompliance with Study Drug|2
308077|NCT01502371|1043857|P3|Overall Study|Noncompliance with Study Drug|1
308078|NCT01502371|1043858|P2|Overall Study|Noncompliance with Study Drug|0
308079|NCT01502371|1043859|P1|Overall Study|Noncompliance with Study Drug|0
308080|NCT01502371|1043855|P5|Overall Study|Physician Decision|1
308081|NCT01502371|1043856|P4|Overall Study|Physician Decision|0
308082|NCT01502371|1043857|P3|Overall Study|Physician Decision|0
308083|NCT01502371|1043858|P2|Overall Study|Physician Decision|0
308084|NCT01502371|1043859|P1|Overall Study|Physician Decision|3
308085|NCT01502371|1043855|P5|Overall Study|Lack of Efficacy|4
308086|NCT01502371|1043856|P4|Overall Study|Lack of Efficacy|2
308087|NCT01502371|1043857|P3|Overall Study|Lack of Efficacy|2
308088|NCT01502371|1043858|P2|Overall Study|Lack of Efficacy|3
308089|NCT01502371|1043859|P1|Overall Study|Lack of Efficacy|3
308090|NCT01502371|1043855|P5|Overall Study|Treatment Failure|30
308091|NCT01502371|1043856|P4|Overall Study|Treatment Failure|19
308092|NCT01502371|1043857|P3|Overall Study|Treatment Failure|12
308093|NCT01502371|1043858|P2|Overall Study|Treatment Failure|20
308094|NCT01502371|1043859|P1|Overall Study|Treatment Failure|22
308095|NCT01502371|1043855|P5|Overall Study|Adverse Event|3
308096|NCT01502371|1043856|P4|Overall Study|Adverse Event|4
308097|NCT01502371|1043857|P3|Overall Study|Adverse Event|0
308098|NCT01502371|1043858|P2|Overall Study|Adverse Event|1
308099|NCT01502371|1043859|P1|Overall Study|Adverse Event|2
308100|NCT01502371|1043855|P5|Overall Study|Withdrawal by Subject|1
308101|NCT01502371|1043856|P4|Overall Study|Withdrawal by Subject|1
308102|NCT01502371|1043857|P3|Overall Study|Withdrawal by Subject|1
308103|NCT01502371|1043858|P2|Overall Study|Withdrawal by Subject|2
308104|NCT01502371|1043859|P1|Overall Study|Withdrawal by Subject|1
308105|NCT01502228|1043899|P1|Overall Study|Death|1
308106|NCT01502033|1043904|P1|Overall Study|1 participant went back to school|1
308107|NCT01502033|1043904|P1|Overall Study|1 participant had worsening depression|1
308108|NCT01502033|1043904|P1|Overall Study|1 participant had scalp discomfort|1
308109|NCT01501110|1043923|P2|Overall Study|Death|1
308110|NCT01501110|1043924|P1|Overall Study|Death|0
308111|NCT01500720|1043948|P2|Overall Study|Other|8
308112|NCT01500720|1043949|P1|Overall Study|Other|4
308113|NCT01500720|1043948|P2|Overall Study|Randomized But Not Treated|1
308114|NCT01500720|1043949|P1|Overall Study|Randomized But Not Treated|1
308115|NCT01500694|1043963|P2|Overall Study|Other|3
308116|NCT01500694|1043964|P1|Overall Study|Other|9
308117|NCT01500694|1043963|P2|Overall Study|Lack of Efficacy|5
308118|NCT01500694|1043964|P1|Overall Study|Lack of Efficacy|14
308119|NCT01500694|1043963|P2|Overall Study|Lost to Follow-up|3
308120|NCT01500694|1043964|P1|Overall Study|Lost to Follow-up|2
308121|NCT01500694|1043963|P2|Overall Study|Withdrawal by Subject|14
308122|NCT01500694|1043964|P1|Overall Study|Withdrawal by Subject|23
308123|NCT01500694|1043963|P2|Overall Study|Protocol Violation|1
308124|NCT01500694|1043964|P1|Overall Study|Protocol Violation|0
308125|NCT01500694|1043963|P2|Overall Study|Adverse Event|3
308126|NCT01500694|1043964|P1|Overall Study|Adverse Event|4
308127|NCT01500629|1043990|P2|Washout Period of 14 to 30 Days|Pregnancy|0
308128|NCT01500629|1043991|P1|Washout Period of 14 to 30 Days|Pregnancy|1
308129|NCT01500434|1044075|P1|Overall Study|Missed 12-month follow-up|5
308130|NCT01500434|1044075|P1|Overall Study|Withdrawal by Subject|1
308131|NCT01500434|1044075|P1|Overall Study|Death|1
308132|NCT01500382|1044108|P4|Washout Period|Study site went out of business|0
308133|NCT01500382|1044109|P3|Washout Period|Study site went out of business|1
308134|NCT01500382|1044110|P2|Washout Period|Study site went out of business|0
308135|NCT01500382|1044111|P1|Washout Period|Study site went out of business|0
308136|NCT01500317|1044136|P3|Overall Study|Withdrawal by Subject|0
308137|NCT01500317|1044137|P2|Overall Study|Withdrawal by Subject|2
308138|NCT01500317|1044138|P1|Overall Study|Withdrawal by Subject|3
308139|NCT01500278|1044160|P2|Week 13 - Week 104|Adverse Event|54
308140|NCT01500278|1044161|P1|Week 13 - Week 104|Adverse Event|54
308141|NCT01500278|1044160|P2|Week 13 - Week 104|Death|4
308142|NCT01500278|1044161|P1|Week 13 - Week 104|Death|2
308143|NCT01500278|1044160|P2|Week 13 - Week 104|Not completed|1
308144|NCT01500278|1044161|P1|Week 13 - Week 104|Not completed|0
308145|NCT01500278|1044160|P2|Week 13 - Week 104|Personal reason|1
308146|NCT01500278|1044161|P1|Week 13 - Week 104|Personal reason|0
308147|NCT01500278|1044160|P2|Week 13 - Week 104|Medical monitor decision|2
308148|NCT01500278|1044161|P1|Week 13 - Week 104|Medical monitor decision|0
308149|NCT01500278|1044160|P2|Week 13 - Week 104|Sponsor decision|2
308150|NCT01500278|1044161|P1|Week 13 - Week 104|Sponsor decision|0
308151|NCT01500278|1044160|P2|Week 13 - Week 104|Relocation|1
308152|NCT01500278|1044161|P1|Week 13 - Week 104|Relocation|0
308153|NCT01500278|1044160|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
308154|NCT01500278|1044161|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
308155|NCT01500278|1044160|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
308156|NCT01500278|1044161|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
308157|NCT01500278|1044160|P2|Week 13 - Week 104|Principal investigator retiring|0
308158|NCT01500278|1044161|P1|Week 13 - Week 104|Principal investigator retiring|1
308159|NCT01500278|1044160|P2|Week 13 - Week 104|Protocol deviation|0
308160|NCT01500278|1044161|P1|Week 13 - Week 104|Protocol deviation|1
308161|NCT01500278|1044160|P2|Week 13 - Week 104|Exclusion criteria not met|0
308162|NCT01500278|1044161|P1|Week 13 - Week 104|Exclusion criteria not met|1
308163|NCT01500278|1044160|P2|Week 13 - Week 104|Withdrawn in error|0
308164|NCT01500278|1044161|P1|Week 13 - Week 104|Withdrawn in error|1
308165|NCT01500278|1044160|P2|Week 13 - Week 104|Sponsor request|0
308166|NCT01500278|1044161|P1|Week 13 - Week 104|Sponsor request|4
308167|NCT01500278|1044160|P2|Week 13 - Week 104|False positive test|2
308168|NCT01500278|1044161|P1|Week 13 - Week 104|False positive test|1
308169|NCT01500278|1044160|P2|Week 13 - Week 104|Recurrent infections|0
308170|NCT01500278|1044161|P1|Week 13 - Week 104|Recurrent infections|1
308171|NCT01500278|1044160|P2|Week 13 - Week 104|Non/bad compliance|5
308172|NCT01500278|1044161|P1|Week 13 - Week 104|Non/bad compliance|7
308173|NCT01500278|1044160|P2|Week 13 - Week 104|Week 24 Non-Responder|16
308174|NCT01500278|1044161|P1|Week 13 - Week 104|Week 24 Non-Responder|20
308175|NCT01500278|1044160|P2|Week 13 - Week 104|Withdrawal by Subject|13
308176|NCT01500278|1044161|P1|Week 13 - Week 104|Withdrawal by Subject|22
308177|NCT01500278|1044160|P2|Week 13 - Week 104|Lost to Follow-up|5
308178|NCT01500278|1044161|P1|Week 13 - Week 104|Lost to Follow-up|6
308179|NCT01500278|1044160|P2|Week 13 - Week 104|Protocol Violation|6
308180|NCT01500278|1044161|P1|Week 13 - Week 104|Protocol Violation|6
308181|NCT01500278|1044160|P2|Week 13 - Week 104|Lack of Efficacy|12
308182|NCT01500278|1044161|P1|Week 13 - Week 104|Lack of Efficacy|11
308183|NCT01500278|1044160|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
308184|NCT01500278|1044161|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
308185|NCT01500278|1044160|P2|Week 0 - Week 12|Other serious disease|1
308186|NCT01500278|1044161|P1|Week 0 - Week 12|Other serious disease|0
308187|NCT01500278|1044160|P2|Week 0 - Week 12|Personal reason|1
308188|NCT01500278|1044161|P1|Week 0 - Week 12|Personal reason|0
308189|NCT01500278|1044160|P2|Week 0 - Week 12|Sponsor decision|0
308190|NCT01500278|1044161|P1|Week 0 - Week 12|Sponsor decision|1
308191|NCT01500278|1044160|P2|Week 0 - Week 12|Prior history of serious disease|0
308192|NCT01500278|1044161|P1|Week 0 - Week 12|Prior history of serious disease|1
308193|NCT01500278|1044160|P2|Week 0 - Week 12|Investigator decision|0
308194|NCT01500278|1044161|P1|Week 0 - Week 12|Investigator decision|1
308195|NCT01500278|1044160|P2|Week 0 - Week 12|Exclusion criteria not met|0
308196|NCT01500278|1044161|P1|Week 0 - Week 12|Exclusion criteria not met|1
308197|NCT01500278|1044160|P2|Week 0 - Week 12|Patient decision|0
308198|NCT01500278|1044161|P1|Week 0 - Week 12|Patient decision|1
308199|NCT01500278|1044160|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
308200|NCT01500278|1044161|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
308201|NCT01500278|1044160|P2|Week 0 - Week 12|Withdrawal by Subject|2
308202|NCT01500278|1044161|P1|Week 0 - Week 12|Withdrawal by Subject|7
308203|NCT01500278|1044160|P2|Week 0 - Week 12|Lost to Follow-up|1
308204|NCT01500278|1044161|P1|Week 0 - Week 12|Lost to Follow-up|1
308205|NCT01500278|1044160|P2|Week 0 - Week 12|Protocol Violation|16
308206|NCT01500278|1044161|P1|Week 0 - Week 12|Protocol Violation|10
308207|NCT01500278|1044160|P2|Week 0 - Week 12|Lack of Efficacy|1
308208|NCT01500278|1044161|P1|Week 0 - Week 12|Lack of Efficacy|0
308209|NCT01500252|1044185|P2|Overall Study|Lost to Follow-up|4
308210|NCT01500252|1044186|P1|Overall Study|Lost to Follow-up|5
308211|NCT01500252|1044185|P2|Overall Study|Death|2
308212|NCT01500252|1044186|P1|Overall Study|Death|4
308213|NCT01500226|1044212|P2|Overall Study|Other Reasons|16
308214|NCT01500226|1044213|P1|Overall Study|Other Reasons|19
308215|NCT01500226|1044212|P2|Overall Study|Lost to Follow-up|5
308216|NCT01500226|1044213|P1|Overall Study|Lost to Follow-up|9
308217|NCT01500226|1044212|P2|Overall Study|Lack of Efficacy|30
308218|NCT01500226|1044213|P1|Overall Study|Lack of Efficacy|14
308219|NCT01500226|1044212|P2|Overall Study|Physician Decision|15
308220|NCT01500226|1044213|P1|Overall Study|Physician Decision|17
308221|NCT01500226|1044212|P2|Overall Study|Protocol Violation|39
308222|NCT01500226|1044213|P1|Overall Study|Protocol Violation|53
308223|NCT01500226|1044212|P2|Overall Study|Disease Progression|14
308224|NCT01500226|1044213|P1|Overall Study|Disease Progression|16
308225|NCT01500226|1044212|P2|Overall Study|Death|4
308226|NCT01500226|1044213|P1|Overall Study|Death|12
308227|NCT01500226|1044212|P2|Overall Study|Withdrawal by Subject|96
308228|NCT01500226|1044213|P1|Overall Study|Withdrawal by Subject|93
308229|NCT01500226|1044212|P2|Overall Study|Chemo Completed or Change in Therapy|237
308230|NCT01500226|1044213|P1|Overall Study|Chemo Completed or Change in Therapy|235
308231|NCT01500226|1044212|P2|Overall Study|Adverse Event|38
308232|NCT01500226|1044213|P1|Overall Study|Adverse Event|31
308233|NCT01500213|1044225|P2|Overall Study|Other Reasons|5
308234|NCT01500213|1044226|P1|Overall Study|Other Reasons|7
308235|NCT01500213|1044225|P2|Overall Study|Lost to Follow-up|6
308236|NCT01500213|1044226|P1|Overall Study|Lost to Follow-up|3
308237|NCT01500213|1044225|P2|Overall Study|Lack of Efficacy|7
308238|NCT01500213|1044226|P1|Overall Study|Lack of Efficacy|9
308239|NCT01500213|1044225|P2|Overall Study|Physician Decision|10
308240|NCT01500213|1044226|P1|Overall Study|Physician Decision|12
308241|NCT01500213|1044225|P2|Overall Study|Protocol Violation|19
308242|NCT01500213|1044226|P1|Overall Study|Protocol Violation|19
308243|NCT01500213|1044225|P2|Overall Study|Disease Progression|21
308244|NCT01500213|1044226|P1|Overall Study|Disease Progression|13
308245|NCT01500213|1044225|P2|Overall Study|Death|3
308246|NCT01500213|1044226|P1|Overall Study|Death|7
308247|NCT01500213|1044225|P2|Overall Study|Withdrawal by Subject|37
308248|NCT01500213|1044226|P1|Overall Study|Withdrawal by Subject|28
308249|NCT01500213|1044225|P2|Overall Study|Chemo Completed or Change in Therapy|81
308250|NCT01500213|1044226|P1|Overall Study|Chemo Completed or Change in Therapy|84
308251|NCT01500213|1044225|P2|Overall Study|Adverse Event|35
308252|NCT01500213|1044226|P1|Overall Study|Adverse Event|35
308253|NCT01500135|1044238|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
308254|NCT01500135|1044239|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
308255|NCT01500135|1044238|P2|Overall Study|Participant was a Safety Concern|0
308256|NCT01500135|1044239|P1|Overall Study|Participant was a Safety Concern|1
308257|NCT01500135|1044238|P2|Overall Study|Patient Missed Scheduled Appointments|1
308258|NCT01500135|1044239|P1|Overall Study|Patient Missed Scheduled Appointments|0
308259|NCT01500135|1044238|P2|Overall Study|Principal Investigator (PI) Discretion|0
308260|NCT01500135|1044239|P1|Overall Study|Principal Investigator (PI) Discretion|1
308261|NCT01500135|1044238|P2|Overall Study|Fatal Adverse Event (AE)|5
308262|NCT01500135|1044239|P1|Overall Study|Fatal Adverse Event (AE)|5
308263|NCT01500135|1044238|P2|Overall Study|Lost to Follow-up|4
308264|NCT01500135|1044239|P1|Overall Study|Lost to Follow-up|6
308265|NCT01500135|1044238|P2|Overall Study|Withdrawal of Consent|0
308266|NCT01500135|1044239|P1|Overall Study|Withdrawal of Consent|4
308267|NCT01500096|1044266|P4|Overall Study|Lost to Follow-up|2
308268|NCT01500096|1044267|P3|Overall Study|Lost to Follow-up|0
308269|NCT01500096|1044268|P2|Overall Study|Lost to Follow-up|0
308270|NCT01500096|1044269|P1|Overall Study|Lost to Follow-up|1
308271|NCT01500083|1044321|P2|Overall Study|Other Reasons|5
308272|NCT01500083|1044322|P1|Overall Study|Other Reasons|2
308273|NCT01500083|1044321|P2|Overall Study|Investigator Discretion|8
308274|NCT01500083|1044322|P1|Overall Study|Investigator Discretion|3
308275|NCT01500083|1044321|P2|Overall Study|Disease Progression|10
308276|NCT01500083|1044322|P1|Overall Study|Disease Progression|2
308277|NCT01500083|1044321|P2|Overall Study|Withdrawal of Consent|1
308278|NCT01500083|1044322|P1|Overall Study|Withdrawal of Consent|0
308279|NCT01500083|1044321|P2|Overall Study|Lost to Follow-up|0
308280|NCT01500083|1044322|P1|Overall Study|Lost to Follow-up|1
308281|NCT01500083|1044321|P2|Overall Study|Death|2
308282|NCT01500083|1044322|P1|Overall Study|Death|0
308283|NCT01500083|1044321|P2|Overall Study|Adverse Event|17
308284|NCT01500083|1044322|P1|Overall Study|Adverse Event|4
308285|NCT01500057|1044330|P2|Overall Study|Lost to Follow-up|4
308286|NCT01500057|1044331|P1|Overall Study|Lost to Follow-up|6
308287|NCT01500031|1044341|P1|Overall Study|Withdrawal by Subject|4
308288|NCT01500031|1044341|P1|Overall Study|Death|1
308289|NCT01499849|1044376|P2|Overall Study|Other Reasons|30
308290|NCT01499849|1044377|P1|Overall Study|Other Reasons|27
308291|NCT01499849|1044376|P2|Overall Study|Lost to Follow-up|3
308292|NCT01499849|1044377|P1|Overall Study|Lost to Follow-up|6
308293|NCT01499849|1044376|P2|Overall Study|Lack of Efficacy|4
308294|NCT01499849|1044377|P1|Overall Study|Lack of Efficacy|3
308295|NCT01499849|1044376|P2|Overall Study|Physician Decision|19
308296|NCT01499849|1044377|P1|Overall Study|Physician Decision|20
308297|NCT01499849|1044376|P2|Overall Study|Protocol Violation|11
308298|NCT01499849|1044377|P1|Overall Study|Protocol Violation|11
308299|NCT01499849|1044376|P2|Overall Study|Disease Progression|10
308300|NCT01499849|1044377|P1|Overall Study|Disease Progression|11
308301|NCT01499849|1044376|P2|Overall Study|Death|7
308302|NCT01499849|1044377|P1|Overall Study|Death|5
308303|NCT01499849|1044376|P2|Overall Study|Withdrawal by Subject|43
308304|NCT01499849|1044377|P1|Overall Study|Withdrawal by Subject|43
308305|NCT01499849|1044376|P2|Overall Study|Chemo completed or Change in Therapy|67
308306|NCT01499849|1044377|P1|Overall Study|Chemo completed or Change in Therapy|70
308307|NCT01499849|1044376|P2|Overall Study|Adverse Event|32
308308|NCT01499849|1044377|P1|Overall Study|Adverse Event|28
308309|NCT01499810|1044387|P1|Overall Study|Withdrawal by Subject|1
308310|NCT01499810|1044387|P1|Overall Study|Protocol Violation|1
308311|NCT01499810|1044387|P1|Overall Study|Lost to Follow-up|10
308312|NCT01499667|1044437|P3|Overall Study|Lack of Efficacy|0
308313|NCT01499667|1044438|P2|Overall Study|Lack of Efficacy|0
308314|NCT01499667|1044439|P1|Overall Study|Lack of Efficacy|2
308315|NCT01499667|1044437|P3|Overall Study|Withdrawal by Subject|1
308316|NCT01499667|1044438|P2|Overall Study|Withdrawal by Subject|1
308317|NCT01499667|1044439|P1|Overall Study|Withdrawal by Subject|2
308318|NCT01499667|1044437|P3|Overall Study|Adverse Event|2
308319|NCT01499667|1044438|P2|Overall Study|Adverse Event|2
308320|NCT01499667|1044439|P1|Overall Study|Adverse Event|0
308321|NCT01499667|1044437|P3|Overall Study|Protocol Violation|2
308322|NCT01499667|1044438|P2|Overall Study|Protocol Violation|3
308323|NCT01499667|1044439|P1|Overall Study|Protocol Violation|1
308324|NCT01499667|1044437|P3|Overall Study|administrative problems|5
308325|NCT01499667|1044438|P2|Overall Study|administrative problems|5
308326|NCT01499667|1044439|P1|Overall Study|administrative problems|4
308327|NCT01499576|1044487|P1|Overall Study|Withdrawal by Subject|9
308328|NCT01499576|1044487|P1|Overall Study|Physician Decision|12
308329|NCT01499355|1044501|P4|Double-Blind Period|Lost to Follow-up|0
308330|NCT01499355|1044502|P3|Double-Blind Period|Lost to Follow-up|0
308331|NCT01499355|1044503|P2|Double-Blind Period|Lost to Follow-up|1
308332|NCT01499355|1044504|P1|Double-Blind Period|Lost to Follow-up|0
308333|NCT01499355|1044501|P4|Double-Blind Period|Consent Withdrawn|2
308334|NCT01499355|1044502|P3|Double-Blind Period|Consent Withdrawn|1
308335|NCT01499355|1044503|P2|Double-Blind Period|Consent Withdrawn|0
308336|NCT01499355|1044504|P1|Double-Blind Period|Consent Withdrawn|0
308337|NCT01499355|1044501|P4|Double-Blind Period|Investigator Decision|3
308338|NCT01499355|1044502|P3|Double-Blind Period|Investigator Decision|3
308339|NCT01499355|1044503|P2|Double-Blind Period|Investigator Decision|0
308340|NCT01499355|1044504|P1|Double-Blind Period|Investigator Decision|0
308341|NCT01499355|1044501|P4|Double-Blind Period|Death|0
308342|NCT01499355|1044502|P3|Double-Blind Period|Death|0
308343|NCT01499355|1044503|P2|Double-Blind Period|Death|1
308344|NCT01499355|1044504|P1|Double-Blind Period|Death|0
308345|NCT01499355|1044501|P4|Double-Blind Period|Not Specified|2
308346|NCT01499355|1044502|P3|Double-Blind Period|Not Specified|2
308347|NCT01499355|1044503|P2|Double-Blind Period|Not Specified|1
308348|NCT01499355|1044504|P1|Double-Blind Period|Not Specified|0
308349|NCT01499355|1044501|P4|Double-Blind Period|Study Termination|14
308350|NCT01499355|1044502|P3|Double-Blind Period|Study Termination|16
308351|NCT01499355|1044503|P2|Double-Blind Period|Study Termination|18
308352|NCT01499355|1044504|P1|Double-Blind Period|Study Termination|0
308353|NCT01499355|1044501|P4|Double-Blind Period|Adverse Event|2
308354|NCT01499355|1044502|P3|Double-Blind Period|Adverse Event|3
308355|NCT01499355|1044503|P2|Double-Blind Period|Adverse Event|2
308356|NCT01499355|1044504|P1|Double-Blind Period|Adverse Event|0
308357|NCT01499355|1044501|P4|Run-In Period|Adverse Event|0
308358|NCT01499355|1044502|P3|Run-In Period|Adverse Event|0
308359|NCT01499355|1044503|P2|Run-In Period|Adverse Event|0
308360|NCT01499355|1044504|P1|Run-In Period|Adverse Event|8
308361|NCT01499355|1044501|P4|Run-In Period|Consent Withdrawn|0
308362|NCT01499355|1044502|P3|Run-In Period|Consent Withdrawn|0
308363|NCT01499355|1044503|P2|Run-In Period|Consent Withdrawn|0
308364|NCT01499355|1044504|P1|Run-In Period|Consent Withdrawn|1
308365|NCT01499355|1044501|P4|Run-In Period|Investigator Decision|0
308366|NCT01499355|1044502|P3|Run-In Period|Investigator Decision|0
308367|NCT01499355|1044503|P2|Run-In Period|Investigator Decision|0
308368|NCT01499355|1044504|P1|Run-In Period|Investigator Decision|2
308369|NCT01499355|1044501|P4|Run-In Period|Death|0
308370|NCT01499355|1044502|P3|Run-In Period|Death|0
308371|NCT01499355|1044503|P2|Run-In Period|Death|0
308372|NCT01499355|1044504|P1|Run-In Period|Death|2
308373|NCT01499355|1044501|P4|Run-In Period|Not Specified|0
308374|NCT01499355|1044502|P3|Run-In Period|Not Specified|0
308375|NCT01499355|1044503|P2|Run-In Period|Not Specified|0
308376|NCT01499355|1044504|P1|Run-In Period|Not Specified|3
308377|NCT01499355|1044501|P4|Run-In Period|Study Termination|0
308378|NCT01499355|1044502|P3|Run-In Period|Study Termination|0
308379|NCT01499355|1044503|P2|Run-In Period|Study Termination|0
308380|NCT01499355|1044504|P1|Run-In Period|Study Termination|15
308381|NCT01499303|1044537|P2|Overall Study|Other|1
308382|NCT01499303|1044538|P1|Overall Study|Other|0
308383|NCT01499303|1044537|P2|Overall Study|Adverse Event|4
308384|NCT01499303|1044538|P1|Overall Study|Adverse Event|1
308385|NCT01499303|1044537|P2|Overall Study|Withdrawal by Subject|1
308386|NCT01499303|1044538|P1|Overall Study|Withdrawal by Subject|0
308387|NCT01499303|1044537|P2|Overall Study|Ongoing|1
308388|NCT01499303|1044538|P1|Overall Study|Ongoing|2
308389|NCT01499290|1044546|P2|Overall Study|Adverse Event|7
308390|NCT01499290|1044547|P1|Overall Study|Adverse Event|14
308391|NCT01499290|1044546|P2|Overall Study|Lack of Efficacy|8
308392|NCT01499290|1044547|P1|Overall Study|Lack of Efficacy|7
308393|NCT01499290|1044546|P2|Overall Study|Condition improved/subject recovered|0
308394|NCT01499290|1044547|P1|Overall Study|Condition improved/subject recovered|1
308395|NCT01499290|1044546|P2|Overall Study|Not specified in study report|5
308396|NCT01499290|1044547|P1|Overall Study|Not specified in study report|11
308397|NCT01499290|1044546|P2|Overall Study|Withdrawal by Subject|15
308398|NCT01499290|1044547|P1|Overall Study|Withdrawal by Subject|22
308399|NCT01499277|1044597|P2|Overall Study|Lack of therapeutic response and other|7
308400|NCT01499277|1044598|P1|Overall Study|Lack of therapeutic response and other|8
308401|NCT01499277|1044597|P2|Overall Study|Withdrawal by Subject|6
308402|NCT01499277|1044598|P1|Overall Study|Withdrawal by Subject|16
308403|NCT01499277|1044597|P2|Overall Study|Protocol Violation|3
308404|NCT01499277|1044598|P1|Overall Study|Protocol Violation|2
308405|NCT01499277|1044597|P2|Overall Study|Lost to Follow-up|8
308406|NCT01499277|1044598|P1|Overall Study|Lost to Follow-up|15
308407|NCT01499277|1044597|P2|Overall Study|Death|2
308408|NCT01499277|1044598|P1|Overall Study|Death|3
308409|NCT01499277|1044597|P2|Overall Study|Adverse Event|6
308410|NCT01499277|1044598|P1|Overall Study|Adverse Event|3
308411|NCT01499199|1044620|P1|Overall Study|Lack of Efficacy|1
308412|NCT01499199|1044620|P1|Overall Study|Adverse Event|1
308413|NCT01499160|1044649|P1|Overall Study|Withdrawal by Subject|1
308414|NCT01499160|1044649|P1|Overall Study|Adverse Event|1
308415|NCT01499134|1044672|P2|Overall Study|Withdrawal by Subject|1
308416|NCT01499134|1044673|P1|Overall Study|Withdrawal by Subject|0
308417|NCT01499095|1044695|P2|Overall Study|Perceived Lack of Efficacy|1
308418|NCT01499095|1044696|P1|Overall Study|Perceived Lack of Efficacy|1
308419|NCT01499095|1044695|P2|Overall Study|Change in Injection Schedule|0
308420|NCT01499095|1044696|P1|Overall Study|Change in Injection Schedule|2
308421|NCT01499095|1044695|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
308422|NCT01499095|1044696|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
308423|NCT01499095|1044695|P2|Overall Study|Hypoglycemia|1
308424|NCT01499095|1044696|P1|Overall Study|Hypoglycemia|3
308425|NCT01499095|1044695|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
308426|NCT01499095|1044696|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
308427|NCT01499095|1044695|P2|Overall Study|Lost to Follow-up|4
308428|NCT01499095|1044696|P1|Overall Study|Lost to Follow-up|6
308429|NCT01499095|1044695|P2|Overall Study|Diverse Reasons|25
308430|NCT01499095|1044696|P1|Overall Study|Diverse Reasons|22
308431|NCT01499095|1044695|P2|Overall Study|Received Rescue Therapy|40
308432|NCT01499095|1044696|P1|Overall Study|Received Rescue Therapy|32
308433|NCT01499095|1044695|P2|Overall Study|Protocol Violation|7
308434|NCT01499095|1044696|P1|Overall Study|Protocol Violation|6
308435|NCT01499095|1044695|P2|Overall Study|Lack of Efficacy|1
308436|NCT01499095|1044696|P1|Overall Study|Lack of Efficacy|2
308437|NCT01499095|1044695|P2|Overall Study|Adverse Event|7
308438|NCT01499095|1044696|P1|Overall Study|Adverse Event|12
308439|NCT01499095|1044695|P2|Overall Study|Randomized But Not Treated|1
308440|NCT01499095|1044696|P1|Overall Study|Randomized But Not Treated|1
308441|NCT01499082|1044726|P2|Overall Study|Lost to Follow-up|3
308442|NCT01499082|1044727|P1|Overall Study|Lost to Follow-up|1
308443|NCT01499082|1044726|P2|Overall Study|Hypoglycemia|3
308444|NCT01499082|1044727|P1|Overall Study|Hypoglycemia|2
308445|NCT01499082|1044726|P2|Overall Study|Site Closure for Noncompliance|2
308446|NCT01499082|1044727|P1|Overall Study|Site Closure for Noncompliance|5
308447|NCT01499082|1044726|P2|Overall Study|Diverse Reasons|14
308448|NCT01499082|1044727|P1|Overall Study|Diverse Reasons|18
308449|NCT01499082|1044726|P2|Overall Study|Protocol Violation|8
308450|NCT01499082|1044727|P1|Overall Study|Protocol Violation|6
308451|NCT01499082|1044726|P2|Overall Study|Lack of Efficacy|1
308452|NCT01499082|1044727|P1|Overall Study|Lack of Efficacy|1
308453|NCT01499082|1044726|P2|Overall Study|Adverse Event|16
308454|NCT01499082|1044727|P1|Overall Study|Adverse Event|12
308455|NCT01499082|1044726|P2|Overall Study|Randomized but not Treated|1
308456|NCT01499082|1044727|P1|Overall Study|Randomized but not Treated|0
308457|NCT01498822|1044777|P2|Overall Study|Lost to Follow-up|3
308458|NCT01498822|1044778|P1|Overall Study|Lost to Follow-up|8
308459|NCT01498822|1044777|P2|Overall Study|Withdrawal by Subject|25
308460|NCT01498822|1044778|P1|Overall Study|Withdrawal by Subject|15
308461|NCT01498822|1044777|P2|Overall Study|Adverse Event, serious fatal|1
308462|NCT01498822|1044778|P1|Overall Study|Adverse Event, serious fatal|1
308463|NCT01498822|1044777|P2|Overall Study|SAE, non-fatal|2
308464|NCT01498822|1044778|P1|Overall Study|SAE, non-fatal|2
308465|NCT01498822|1044777|P2|Overall Study|AE, non-serious non-fatal|17
308466|NCT01498822|1044778|P1|Overall Study|AE, non-serious non-fatal|8
308467|NCT01498822|1044777|P2|Overall Study|Lack of Efficacy|2
308468|NCT01498822|1044778|P1|Overall Study|Lack of Efficacy|7
308469|NCT01498822|1044777|P2|Overall Study|Other Reason|2
308470|NCT01498822|1044778|P1|Overall Study|Other Reason|5
308471|NCT01498822|1044777|P2|Overall Study|Protocol Violation|4
308472|NCT01498822|1044778|P1|Overall Study|Protocol Violation|8
308473|NCT01498692|1044805|P1|Overall Study|Missed 12-month visit|3
308474|NCT01498692|1044805|P1|Overall Study|Withdrawal by Subject|1
308475|NCT01498692|1044805|P1|Overall Study|Death|4
308476|NCT01498679|1044836|P2|Overall Study|Withdrawal by Subject|4
308477|NCT01498679|1044837|P1|Overall Study|Withdrawal by Subject|12
308478|NCT01498679|1044836|P2|Overall Study|Physician Decision|2
308479|NCT01498679|1044837|P1|Overall Study|Physician Decision|0
308480|NCT01498679|1044836|P2|Overall Study|Protocol Violation|0
308481|NCT01498679|1044837|P1|Overall Study|Protocol Violation|4
308482|NCT01498679|1044836|P2|Overall Study|Lack of Efficacy|12
308483|NCT01498679|1044837|P1|Overall Study|Lack of Efficacy|72
308484|NCT01498679|1044836|P2|Overall Study|Adverse Event|4
308485|NCT01498679|1044837|P1|Overall Study|Adverse Event|1
308486|NCT01498653|1044853|P2|Overall Study|Withdrawal by Subject|3
308487|NCT01498653|1044854|P1|Overall Study|Withdrawal by Subject|2
308488|NCT01498653|1044853|P2|Overall Study|Physician Decision|0
308489|NCT01498653|1044854|P1|Overall Study|Physician Decision|2
308490|NCT01498653|1044853|P2|Overall Study|Lost to Follow-up|0
308491|NCT01498653|1044854|P1|Overall Study|Lost to Follow-up|1
308492|NCT01498653|1044853|P2|Overall Study|Protocol Violation|4
308493|NCT01498653|1044854|P1|Overall Study|Protocol Violation|0
308494|NCT01498653|1044853|P2|Overall Study|Lack of Efficacy|26
308495|NCT01498653|1044854|P1|Overall Study|Lack of Efficacy|12
308496|NCT01498653|1044853|P2|Overall Study|Adverse Event|2
308497|NCT01498653|1044854|P1|Overall Study|Adverse Event|2
308498|NCT01498640|1044868|P1|Overall Study|not specified|3
308499|NCT01498640|1044868|P1|Overall Study|Death|1
308500|NCT01498640|1044868|P1|Overall Study|Lost to Follow-up|1
308501|NCT01498575|1044898|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
308502|NCT01498575|1044899|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
308503|NCT01498575|1044898|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
308504|NCT01498575|1044899|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
308505|NCT01498575|1044898|P2|Overall Sample|Withdrawal by Subject|14
308506|NCT01498575|1044899|P1|Overall Sample|Withdrawal by Subject|60
308507|NCT01498458|1044916|P1|Overall Study|Physician Decision|3
308508|NCT01498458|1044916|P1|Overall Study|Adverse Event|4
308509|NCT01498185|1044971|P5|Overall Study|No longer met criteria, etc|2
308510|NCT01498185|1044972|P4|Overall Study|No longer met criteria, etc|0
308511|NCT01498185|1044973|P3|Overall Study|No longer met criteria, etc|0
308512|NCT01498185|1044974|P2|Overall Study|No longer met criteria, etc|0
308513|NCT01498185|1044975|P1|Overall Study|No longer met criteria, etc|0
308514|NCT01498185|1044971|P5|Overall Study|Withdrawal by Subject|1
308515|NCT01498185|1044972|P4|Overall Study|Withdrawal by Subject|2
308516|NCT01498185|1044973|P3|Overall Study|Withdrawal by Subject|0
308517|NCT01498185|1044974|P2|Overall Study|Withdrawal by Subject|1
308518|NCT01498185|1044975|P1|Overall Study|Withdrawal by Subject|1
308519|NCT01498185|1044971|P5|Overall Study|Adverse Event|0
308520|NCT01498185|1044972|P4|Overall Study|Adverse Event|1
308521|NCT01498185|1044973|P3|Overall Study|Adverse Event|0
308522|NCT01498185|1044974|P2|Overall Study|Adverse Event|0
308523|NCT01498185|1044975|P1|Overall Study|Adverse Event|0
308524|NCT01498120|1045015|P1|Overall Study|Other|4
308525|NCT01498120|1045015|P1|Overall Study|AE, non-serious non-fatal|3
308526|NCT01498120|1045015|P1|Overall Study|Withdrawal by Subject|5
308527|NCT01498120|1045015|P1|Overall Study|Lost to Follow-up|1
308528|NCT01498068|1045022|P2|Overall Study|Withdrawal by Subject|1
308529|NCT01498068|1045023|P1|Overall Study|Withdrawal by Subject|1
308530|NCT01497938|1045041|P2|Overall Study|Device Violation|0
308531|NCT01497938|1045042|P1|Overall Study|Device Violation|1
308532|NCT01497938|1045041|P2|Overall Study|Withdrawal by Subject|0
308533|NCT01497938|1045042|P1|Overall Study|Withdrawal by Subject|4
308534|NCT01497938|1045041|P2|Overall Study|Physician Decision|1
308535|NCT01497938|1045042|P1|Overall Study|Physician Decision|0
308536|NCT01497938|1045041|P2|Overall Study|Adverse Event|1
308537|NCT01497938|1045042|P1|Overall Study|Adverse Event|0
308538|NCT01497899|1045054|P4|Open-Label Extension Phase|Lost to Follow-up|5
308539|NCT01497899|1045055|P3|Open-Label Extension Phase|Lost to Follow-up|5
308540|NCT01497899|1045056|P2|Open-Label Extension Phase|Lost to Follow-up|3
308541|NCT01497899|1045057|P1|Open-Label Extension Phase|Lost to Follow-up|9
308542|NCT01497899|1045054|P4|Open-Label Extension Phase|Protocol Violation|0
308543|NCT01497899|1045055|P3|Open-Label Extension Phase|Protocol Violation|1
308544|NCT01497899|1045056|P2|Open-Label Extension Phase|Protocol Violation|0
308545|NCT01497899|1045057|P1|Open-Label Extension Phase|Protocol Violation|0
308546|NCT01497899|1045054|P4|Open-Label Extension Phase|Pregnancy|0
308547|NCT01497899|1045055|P3|Open-Label Extension Phase|Pregnancy|1
308548|NCT01497899|1045056|P2|Open-Label Extension Phase|Pregnancy|1
308549|NCT01497899|1045057|P1|Open-Label Extension Phase|Pregnancy|0
308550|NCT01497899|1045054|P4|Open-Label Extension Phase|Withdrew Consent|0
308551|NCT01497899|1045055|P3|Open-Label Extension Phase|Withdrew Consent|2
308552|NCT01497899|1045056|P2|Open-Label Extension Phase|Withdrew Consent|3
308553|NCT01497899|1045057|P1|Open-Label Extension Phase|Withdrew Consent|8
308554|NCT01497899|1045054|P4|Open-Label Extension Phase|Death|0
308555|NCT01497899|1045055|P3|Open-Label Extension Phase|Death|0
308556|NCT01497899|1045056|P2|Open-Label Extension Phase|Death|0
308557|NCT01497899|1045057|P1|Open-Label Extension Phase|Death|1
308558|NCT01497899|1045054|P4|Open-Label Extension Phase|Adverse Event|0
308559|NCT01497899|1045055|P3|Open-Label Extension Phase|Adverse Event|0
308560|NCT01497899|1045056|P2|Open-Label Extension Phase|Adverse Event|0
308561|NCT01497899|1045057|P1|Open-Label Extension Phase|Adverse Event|1
308562|NCT01497899|1045054|P4|Double-Blind Phase|Subject Non-Compliance|0
308563|NCT01497899|1045055|P3|Double-Blind Phase|Subject Non-Compliance|0
308564|NCT01497899|1045056|P2|Double-Blind Phase|Subject Non-Compliance|1
308565|NCT01497899|1045057|P1|Double-Blind Phase|Subject Non-Compliance|0
308566|NCT01497899|1045054|P4|Double-Blind Phase|Lost to Follow-up|0
308567|NCT01497899|1045055|P3|Double-Blind Phase|Lost to Follow-up|0
308568|NCT01497899|1045056|P2|Double-Blind Phase|Lost to Follow-up|2
308569|NCT01497899|1045057|P1|Double-Blind Phase|Lost to Follow-up|3
308570|NCT01497899|1045054|P4|Double-Blind Phase|Withdrew Consent|0
308571|NCT01497899|1045055|P3|Double-Blind Phase|Withdrew Consent|0
308572|NCT01497899|1045056|P2|Double-Blind Phase|Withdrew Consent|1
308573|NCT01497899|1045057|P1|Double-Blind Phase|Withdrew Consent|0
308574|NCT01497899|1045054|P4|Double-Blind Phase|Investigator's Discretion|0
308575|NCT01497899|1045055|P3|Double-Blind Phase|Investigator's Discretion|0
308576|NCT01497899|1045056|P2|Double-Blind Phase|Investigator's Discretion|0
308577|NCT01497899|1045057|P1|Double-Blind Phase|Investigator's Discretion|1
308578|NCT01497899|1045054|P4|Double-Blind Phase|Lack of Efficacy|0
308579|NCT01497899|1045055|P3|Double-Blind Phase|Lack of Efficacy|0
308580|NCT01497899|1045056|P2|Double-Blind Phase|Lack of Efficacy|1
308581|NCT01497899|1045057|P1|Double-Blind Phase|Lack of Efficacy|0
308582|NCT01497899|1045054|P4|Double-Blind Phase|Adverse Event|0
308583|NCT01497899|1045055|P3|Double-Blind Phase|Adverse Event|0
308584|NCT01497899|1045056|P2|Double-Blind Phase|Adverse Event|0
308585|NCT01497899|1045057|P1|Double-Blind Phase|Adverse Event|1
308586|NCT01497899|1045054|P4|Double-Blind Phase|Randomized but not Treated|0
308587|NCT01497899|1045055|P3|Double-Blind Phase|Randomized but not Treated|0
308588|NCT01497899|1045056|P2|Double-Blind Phase|Randomized but not Treated|0
308589|NCT01497899|1045057|P1|Double-Blind Phase|Randomized but not Treated|1
308590|NCT01497366|1045124|P2|Overall Study|Randomized but not treated|21
308591|NCT01497366|1045125|P1|Overall Study|Randomized but not treated|7
308592|NCT01497366|1045124|P2|Overall Study|Death|1
308593|NCT01497366|1045125|P1|Overall Study|Death|1
308594|NCT01497366|1045124|P2|Overall Study|Other|0
308595|NCT01497366|1045125|P1|Overall Study|Other|5
308596|NCT01497366|1045124|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
308597|NCT01497366|1045125|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
308598|NCT01497366|1045124|P2|Overall Study|Withdrawal by Subject|6
308599|NCT01497366|1045125|P1|Overall Study|Withdrawal by Subject|6
308600|NCT01497366|1045124|P2|Overall Study|Lost to Follow-up|10
308601|NCT01497366|1045125|P1|Overall Study|Lost to Follow-up|11
308602|NCT01497366|1045124|P2|Overall Study|Virologic failure|50
308603|NCT01497366|1045125|P1|Overall Study|Virologic failure|2
308604|NCT01497275|1045143|P1|Overall Study|Adverse Event|1
308605|NCT01497275|1045143|P1|Overall Study|Death|1
308606|NCT01497262|1045150|P1|Overall Study|Protocol Violation|1
308607|NCT01497262|1045150|P1|Overall Study|Adverse Event|2
308608|NCT01497262|1045150|P1|Overall Study|Withdrawal by Subject|2
308609|NCT01497262|1045150|P1|Overall Study|Physician Decision|1
308610|NCT01497262|1045150|P1|Overall Study|Abnormal Test Procedure Result|1
308611|NCT01497262|1045150|P1|Overall Study|Abnormal Lab Values|4
308612|NCT01497197|1045157|P2|Overall Study|Other|1
308613|NCT01497197|1045158|P1|Overall Study|Other|3
308614|NCT01497197|1045157|P2|Overall Study|All embryos discarded|3
308615|NCT01497197|1045158|P1|Overall Study|All embryos discarded|0
308616|NCT01497197|1045157|P2|Overall Study|Intention to freeze all embryos|1
308617|NCT01497197|1045158|P1|Overall Study|Intention to freeze all embryos|0
308618|NCT01497197|1045157|P2|Overall Study|No fertilisation|5
308619|NCT01497197|1045158|P1|Overall Study|No fertilisation|6
308620|NCT01497197|1045157|P2|Overall Study|No oocytes retrieved|2
308621|NCT01497197|1045158|P1|Overall Study|No oocytes retrieved|3
308622|NCT01497197|1045157|P2|Overall Study|Risk of OHSS|0
308623|NCT01497197|1045158|P1|Overall Study|Risk of OHSS|1
308624|NCT01497197|1045157|P2|Overall Study|Excessive/lack of response to treatment|0
308625|NCT01497197|1045158|P1|Overall Study|Excessive/lack of response to treatment|1
308626|NCT01497197|1045157|P2|Overall Study|Withdrawal by Subject|1
308627|NCT01497197|1045158|P1|Overall Study|Withdrawal by Subject|2
308628|NCT01497197|1045157|P2|Overall Study|Protocol Violation|2
308629|NCT01497197|1045158|P1|Overall Study|Protocol Violation|0
308630|NCT01497197|1045157|P2|Overall Study|Lost to Follow-up|0
308631|NCT01497197|1045158|P1|Overall Study|Lost to Follow-up|1
308632|NCT01496846|1045199|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
308633|NCT01496846|1045200|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
308634|NCT01496846|1045201|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
308635|NCT01496846|1045202|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
308636|NCT01496846|1045203|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
308637|NCT01496846|1045204|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
308638|NCT01496807|1045215|P1|Overall Study|Change in diagnosis|1
308639|NCT01496807|1045215|P1|Overall Study|Participant preference/toxicity|8
308640|NCT01496807|1045215|P1|Overall Study|Progressive Disease|21
308641|NCT01496469|1045227|P2|Overall Study|Other|1
308642|NCT01496469|1045228|P1|Overall Study|Other|1
308643|NCT01496469|1045227|P2|Overall Study|BP exceeds protocol limits|2
308644|NCT01496469|1045228|P1|Overall Study|BP exceeds protocol limits|1
308645|NCT01496469|1045227|P2|Overall Study|Withdrawal by Subject|4
308646|NCT01496469|1045228|P1|Overall Study|Withdrawal by Subject|4
308647|NCT01496469|1045227|P2|Overall Study|Lost to Follow-up|1
308648|NCT01496469|1045228|P1|Overall Study|Lost to Follow-up|1
308649|NCT01496469|1045227|P2|Overall Study|Protocol Violation|0
308650|NCT01496469|1045228|P1|Overall Study|Protocol Violation|2
308651|NCT01496469|1045227|P2|Overall Study|Adverse Event|0
308652|NCT01496469|1045228|P1|Overall Study|Adverse Event|1
308653|NCT01496456|1045238|P1|Overall Study|Lost to Follow-up|7
308654|NCT01496456|1045238|P1|Overall Study|Protocol Violation|1
308655|NCT01496430|1045251|P3|Overall Study|Other|0
308656|NCT01496430|1045252|P2|Overall Study|Other|0
308657|NCT01496430|1045253|P1|Overall Study|Other|2
308658|NCT01496430|1045251|P3|Overall Study|Principal Investigator Discretion|1
308659|NCT01496430|1045252|P2|Overall Study|Principal Investigator Discretion|1
308660|NCT01496430|1045253|P1|Overall Study|Principal Investigator Discretion|0
308661|NCT01496430|1045251|P3|Overall Study|Voluntary Withdrawal|6
308662|NCT01496430|1045252|P2|Overall Study|Voluntary Withdrawal|1
308663|NCT01496430|1045253|P1|Overall Study|Voluntary Withdrawal|2
308664|NCT01496430|1045251|P3|Overall Study|Lost to Follow-up|1
308665|NCT01496430|1045252|P2|Overall Study|Lost to Follow-up|3
308666|NCT01496430|1045253|P1|Overall Study|Lost to Follow-up|2
308667|NCT01496430|1045251|P3|Overall Study|Major Protocol Deviation|1
308668|NCT01496430|1045252|P2|Overall Study|Major Protocol Deviation|0
308669|NCT01496430|1045253|P1|Overall Study|Major Protocol Deviation|0
308670|NCT01496430|1045251|P3|Overall Study|Adverse Event|1
308671|NCT01496430|1045252|P2|Overall Study|Adverse Event|0
308672|NCT01496430|1045253|P1|Overall Study|Adverse Event|0
308673|NCT01496287|1045365|P1|Overall Study|Incomplete anesthesia|5
308674|NCT01496287|1045365|P1|Overall Study|Lost to Follow-up|1
308675|NCT01496274|1045375|P2|Overall Study|Lost to Follow-up|3
308676|NCT01496274|1045376|P1|Overall Study|Lost to Follow-up|0
308677|NCT01496274|1045375|P2|Overall Study|Withdrawal by Subject|0
308678|NCT01496274|1045376|P1|Overall Study|Withdrawal by Subject|2
308679|NCT01496274|1045375|P2|Overall Study|Adverse Event|1
308680|NCT01496274|1045376|P1|Overall Study|Adverse Event|1
308681|NCT01496274|1045375|P2|Overall Study|Protocol Violation|1
308682|NCT01496274|1045376|P1|Overall Study|Protocol Violation|0
308683|NCT01496183|1045421|P2|Overall Study|Withdrawal by Subject|1
308684|NCT01496183|1045422|P1|Overall Study|Withdrawal by Subject|0
308685|NCT01496183|1045421|P2|Overall Study|Physician Decision|1
308686|NCT01496183|1045422|P1|Overall Study|Physician Decision|3
308693|NCT01495975|1045528|P2|Overall Study|Lost to Follow-up|0
308694|NCT01495975|1045529|P1|Overall Study|Lost to Follow-up|1
308695|NCT01495793|1045653|P1|Overall Study|Violation of inclusion criteria|1
308696|NCT01495793|1045653|P1|Overall Study|Lost to Follow-up|1
308697|NCT01495702|1045666|P2|Randomized Phase|Protocol Violation|1
308698|NCT01495702|1045667|P1|Randomized Phase|Protocol Violation|3
308699|NCT01495702|1045666|P2|Randomized Phase|Participant Noncompliance|0
308700|NCT01495702|1045667|P1|Randomized Phase|Participant Noncompliance|1
308701|NCT01495702|1045666|P2|Randomized Phase|Lost to Follow-up|3
308702|NCT01495702|1045667|P1|Randomized Phase|Lost to Follow-up|4
308703|NCT01495702|1045666|P2|Randomized Phase|Withdrew Consent|18
308704|NCT01495702|1045667|P1|Randomized Phase|Withdrew Consent|10
308705|NCT01495702|1045666|P2|Randomized Phase|Investigators Discretion|0
308706|NCT01495702|1045667|P1|Randomized Phase|Investigators Discretion|2
308707|NCT01495702|1045666|P2|Randomized Phase|Lack of Efficacy|0
308708|NCT01495702|1045667|P1|Randomized Phase|Lack of Efficacy|2
308709|NCT01495702|1045666|P2|Randomized Phase|Death|0
308710|NCT01495702|1045667|P1|Randomized Phase|Death|1
308711|NCT01495702|1045666|P2|Randomized Phase|Adverse Event|2
308712|NCT01495702|1045667|P1|Randomized Phase|Adverse Event|2
308713|NCT01495702|1045666|P2|Randomized Phase|Randomized But Not Treated|4
308714|NCT01495702|1045667|P1|Randomized Phase|Randomized But Not Treated|1
308715|NCT01495000|1045738|P2|Overall Study|Withdrawal by Subject|10
308716|NCT01495000|1045739|P1|Overall Study|Withdrawal by Subject|10
308717|NCT01495000|1045738|P2|Overall Study|Protocol Violation|0
308718|NCT01495000|1045739|P1|Overall Study|Protocol Violation|1
308719|NCT01495000|1045738|P2|Overall Study|Lost to Follow-up|2
308720|NCT01495000|1045739|P1|Overall Study|Lost to Follow-up|2
308721|NCT01494987|1045781|P2|Overall Study|Subject Withdrew Consent|3
308722|NCT01494987|1045782|P1|Overall Study|Subject Withdrew Consent|2
308723|NCT01494987|1045781|P2|Overall Study|Subject Non-Compliance|10
308724|NCT01494987|1045782|P1|Overall Study|Subject Non-Compliance|9
308725|NCT01494987|1045781|P2|Overall Study|Protocol Violation|3
308726|NCT01494987|1045782|P1|Overall Study|Protocol Violation|3
308727|NCT01494987|1045781|P2|Overall Study|Lost to Follow-up|1
308728|NCT01494987|1045782|P1|Overall Study|Lost to Follow-up|1
308729|NCT01494987|1045781|P2|Overall Study|Investigator's Discretion|2
308730|NCT01494987|1045782|P1|Overall Study|Investigator's Discretion|1
308731|NCT01494987|1045781|P2|Overall Study|Hyperglycemia|4
308732|NCT01494987|1045782|P1|Overall Study|Hyperglycemia|6
308733|NCT01494987|1045781|P2|Overall Study|Adverse Event|5
308734|NCT01494987|1045782|P1|Overall Study|Adverse Event|6
308735|NCT01494818|1045796|P2|Overall Study|Lost to Follow-up|0
308736|NCT01494818|1045797|P1|Overall Study|Lost to Follow-up|1
308737|NCT01494818|1045796|P2|Overall Study|Relocation|2
308738|NCT01494818|1045797|P1|Overall Study|Relocation|1
308739|NCT01494649|1045828|P2|Overall Study|Lost to Follow-up|1
308740|NCT01494649|1045829|P1|Overall Study|Lost to Follow-up|0
308741|NCT01494610|1045845|P2|Period 4|Protocol Violation|0
308742|NCT01494610|1045846|P1|Period 4|Protocol Violation|1
308743|NCT01494610|1045845|P2|Period 3|Withdrawal by Subject|0
308744|NCT01494610|1045846|P1|Period 3|Withdrawal by Subject|1
308745|NCT01494610|1045845|P2|Period 3|Adverse Event|0
308746|NCT01494610|1045846|P1|Period 3|Adverse Event|1
308747|NCT01494610|1045845|P2|Period 1|Withdrawal by Subject|1
308748|NCT01494610|1045846|P1|Period 1|Withdrawal by Subject|1
308749|NCT01494584|1045914|P1|Overall Study|Study Closed/Terminated|1
308750|NCT01494532|1046046|P6|Overall Study|Withdrawal by Subject|0
308751|NCT01494532|1046047|P5|Overall Study|Withdrawal by Subject|2
308752|NCT01494532|1046048|P4|Overall Study|Withdrawal by Subject|3
308753|NCT01494532|1046049|P3|Overall Study|Withdrawal by Subject|4
308754|NCT01494532|1046050|P2|Overall Study|Withdrawal by Subject|1
308755|NCT01494532|1046051|P1|Overall Study|Withdrawal by Subject|3
308756|NCT01494532|1046046|P6|Overall Study|Physician Decision|0
308757|NCT01494532|1046047|P5|Overall Study|Physician Decision|0
308758|NCT01494532|1046048|P4|Overall Study|Physician Decision|2
308759|NCT01494532|1046049|P3|Overall Study|Physician Decision|1
308760|NCT01494532|1046050|P2|Overall Study|Physician Decision|1
308761|NCT01494532|1046051|P1|Overall Study|Physician Decision|0
308762|NCT01494532|1046046|P6|Overall Study|Lost to Follow-up|0
308763|NCT01494532|1046047|P5|Overall Study|Lost to Follow-up|0
308764|NCT01494532|1046048|P4|Overall Study|Lost to Follow-up|2
308765|NCT01494532|1046049|P3|Overall Study|Lost to Follow-up|0
308766|NCT01494532|1046050|P2|Overall Study|Lost to Follow-up|0
308767|NCT01494532|1046051|P1|Overall Study|Lost to Follow-up|1
308768|NCT01494532|1046046|P6|Overall Study|Protocol-defined stopping criteria|0
308769|NCT01494532|1046047|P5|Overall Study|Protocol-defined stopping criteria|0
308770|NCT01494532|1046048|P4|Overall Study|Protocol-defined stopping criteria|0
308771|NCT01494532|1046049|P3|Overall Study|Protocol-defined stopping criteria|1
308772|NCT01494532|1046050|P2|Overall Study|Protocol-defined stopping criteria|0
308773|NCT01494532|1046051|P1|Overall Study|Protocol-defined stopping criteria|0
308774|NCT01494532|1046046|P6|Overall Study|Protocol deviation|0
308775|NCT01494532|1046047|P5|Overall Study|Protocol deviation|3
308776|NCT01494532|1046048|P4|Overall Study|Protocol deviation|2
308777|NCT01494532|1046049|P3|Overall Study|Protocol deviation|3
308778|NCT01494532|1046050|P2|Overall Study|Protocol deviation|1
308779|NCT01494532|1046051|P1|Overall Study|Protocol deviation|2
308780|NCT01494532|1046046|P6|Overall Study|Lack of Efficacy|0
308781|NCT01494532|1046047|P5|Overall Study|Lack of Efficacy|2
308782|NCT01494532|1046048|P4|Overall Study|Lack of Efficacy|0
308783|NCT01494532|1046049|P3|Overall Study|Lack of Efficacy|0
308784|NCT01494532|1046050|P2|Overall Study|Lack of Efficacy|0
308785|NCT01494532|1046051|P1|Overall Study|Lack of Efficacy|0
308786|NCT01494532|1046046|P6|Overall Study|Adverse Event|0
308787|NCT01494532|1046047|P5|Overall Study|Adverse Event|5
308788|NCT01494532|1046048|P4|Overall Study|Adverse Event|6
308789|NCT01494532|1046049|P3|Overall Study|Adverse Event|8
308790|NCT01494532|1046050|P2|Overall Study|Adverse Event|1
308791|NCT01494532|1046051|P1|Overall Study|Adverse Event|4
308792|NCT01494506|1046206|P3|Overall Study|Other|1
308793|NCT01494506|1046207|P2|Overall Study|Other|3
308794|NCT01494506|1046208|P1|Overall Study|Other|0
308795|NCT01494506|1046206|P3|Overall Study|Sponsor Decision|1
308796|NCT01494506|1046207|P2|Overall Study|Sponsor Decision|0
308797|NCT01494506|1046208|P1|Overall Study|Sponsor Decision|0
308798|NCT01494506|1046206|P3|Overall Study|Clinical Deterioration|13
308799|NCT01494506|1046207|P2|Overall Study|Clinical Deterioration|17
308800|NCT01494506|1046208|P1|Overall Study|Clinical Deterioration|21
308801|NCT01494506|1046206|P3|Overall Study|Withdrawal by Subject|14
308802|NCT01494506|1046207|P2|Overall Study|Withdrawal by Subject|20
308803|NCT01494506|1046208|P1|Overall Study|Withdrawal by Subject|17
308804|NCT01494506|1046206|P3|Overall Study|Physician Decision|4
308805|NCT01494506|1046207|P2|Overall Study|Physician Decision|5
308806|NCT01494506|1046208|P1|Overall Study|Physician Decision|7
308807|NCT01494506|1046206|P3|Overall Study|Death|2
308808|NCT01494506|1046207|P2|Overall Study|Death|5
308809|NCT01494506|1046208|P1|Overall Study|Death|9
308810|NCT01494506|1046206|P3|Overall Study|Adverse Event|11
308811|NCT01494506|1046207|P2|Overall Study|Adverse Event|10
308812|NCT01494506|1046208|P1|Overall Study|Adverse Event|17
308813|NCT01494506|1046206|P3|Overall Study|Lack of Efficacy|57
308814|NCT01494506|1046207|P2|Overall Study|Lack of Efficacy|83
308815|NCT01494506|1046208|P1|Overall Study|Lack of Efficacy|77
308816|NCT01494467|1046245|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
308817|NCT01494467|1046246|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
308818|NCT01494467|1046245|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
308819|NCT01494467|1046246|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
308820|NCT01494467|1046245|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
308821|NCT01494467|1046246|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
308822|NCT01494467|1046245|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
308823|NCT01494467|1046246|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
308824|NCT01494467|1046245|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
308825|NCT01494467|1046246|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
308826|NCT01494467|1046245|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
308827|NCT01494467|1046246|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
308828|NCT01494467|1046245|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
308829|NCT01494467|1046246|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
308830|NCT01494467|1046245|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
308831|NCT01494467|1046246|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
308832|NCT01494467|1046245|P2|Part A Vehicle Control (12 Weeks)|Other|1
308833|NCT01494467|1046246|P1|Part A Vehicle Control (12 Weeks)|Other|1
308834|NCT01494467|1046245|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
308835|NCT01494467|1046246|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
308836|NCT01494467|1046245|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
308837|NCT01494467|1046246|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
308838|NCT01494467|1046245|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
308839|NCT01494467|1046246|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
308840|NCT01494467|1046245|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
308841|NCT01494467|1046246|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
308842|NCT01494467|1046245|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
308843|NCT01494467|1046246|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
308844|NCT01494350|1046262|P1|Overall Study|Worsening of lesion|1
308845|NCT01494298|1046272|P2|Overall Study|Protocol Violation|8
308846|NCT01494298|1046273|P1|Overall Study|Protocol Violation|2
308847|NCT01493960|1046285|P2|Overall Study|Non-specified|4
308848|NCT01493960|1046286|P1|Overall Study|Non-specified|4
308849|NCT01493960|1046285|P2|Overall Study|Withdrawal by Subject|4
308850|NCT01493960|1046286|P1|Overall Study|Withdrawal by Subject|10
308851|NCT01493960|1046285|P2|Overall Study|Protocol Violation|0
308852|NCT01493960|1046286|P1|Overall Study|Protocol Violation|3
308853|NCT01493960|1046285|P2|Overall Study|Lack of Efficacy|9
308854|NCT01493960|1046286|P1|Overall Study|Lack of Efficacy|15
308855|NCT01493960|1046285|P2|Overall Study|Adverse Event|1
308856|NCT01493960|1046286|P1|Overall Study|Adverse Event|0
308857|NCT01493687|1046319|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
308858|NCT01493687|1046320|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
308859|NCT01493687|1046319|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
308860|NCT01493687|1046320|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
308861|NCT01493687|1046319|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
308862|NCT01493687|1046320|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
308863|NCT01493687|1046319|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
308864|NCT01493687|1046320|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
308865|NCT01493687|1046319|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
308866|NCT01493687|1046320|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
308867|NCT01493687|1046319|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
308868|NCT01493687|1046320|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
308869|NCT01493687|1046319|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
308870|NCT01493687|1046320|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
308871|NCT01493687|1046319|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
308872|NCT01493687|1046320|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
308873|NCT01493687|1046319|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
308874|NCT01493687|1046320|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
308875|NCT01493687|1046319|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
308876|NCT01493687|1046320|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
308877|NCT01493687|1046319|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
308878|NCT01493687|1046320|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
308879|NCT01493687|1046319|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
308880|NCT01493687|1046320|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
308881|NCT01493687|1046319|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
308882|NCT01493687|1046320|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
308883|NCT01493687|1046319|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
308884|NCT01493687|1046320|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
308885|NCT01493687|1046319|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
308886|NCT01493687|1046320|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
308887|NCT01493557|1046339|P3|Adding the Second Strategy|Withdrawal by Subject|0
308888|NCT01493557|1046340|P2|Adding the Second Strategy|Withdrawal by Subject|1
308889|NCT01493557|1046341|P1|Adding the Second Strategy|Withdrawal by Subject|0
308890|NCT01493557|1046339|P3|Adding the Second Strategy|Other adverse event|0
308891|NCT01493557|1046340|P2|Adding the Second Strategy|Other adverse event|2
308892|NCT01493557|1046341|P1|Adding the Second Strategy|Other adverse event|1
308893|NCT01493557|1046339|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
308894|NCT01493557|1046340|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
308895|NCT01493557|1046341|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
308896|NCT01493557|1046339|P3|Randomized to Management Strategies|Other than stated above|0
308897|NCT01493557|1046340|P2|Randomized to Management Strategies|Other than stated above|3
308898|NCT01493557|1046341|P1|Randomized to Management Strategies|Other than stated above|1
308899|NCT01493557|1046339|P3|Randomized to Management Strategies|Withdrawal by Subject|0
308900|NCT01493557|1046340|P2|Randomized to Management Strategies|Withdrawal by Subject|1
308901|NCT01493557|1046341|P1|Randomized to Management Strategies|Withdrawal by Subject|0
308902|NCT01493557|1046339|P3|Randomized to Management Strategies|Protocol Violation|0
308903|NCT01493557|1046340|P2|Randomized to Management Strategies|Protocol Violation|0
308904|NCT01493557|1046341|P1|Randomized to Management Strategies|Protocol Violation|3
308905|NCT01493557|1046339|P3|Randomized to Management Strategies|Other adverse event|0
308906|NCT01493557|1046340|P2|Randomized to Management Strategies|Other adverse event|5
308907|NCT01493557|1046341|P1|Randomized to Management Strategies|Other adverse event|8
308908|NCT01493557|1046339|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
308909|NCT01493557|1046340|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
308910|NCT01493557|1046341|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
308911|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Other than stated above|21
308912|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Other than stated above|0
308913|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Other than stated above|0
308914|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Early termination|34
308915|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Early termination|0
308916|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Early termination|0
308917|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
308918|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
308919|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
308920|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
308921|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
308922|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
308923|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Protocol Violation|1
308924|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Protocol Violation|0
308925|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Protocol Violation|0
308926|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Other adverse event|54
308927|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Other adverse event|0
308928|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Other adverse event|0
308929|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
308930|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
308931|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
308932|NCT01493557|1046339|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
308933|NCT01493557|1046340|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
308934|NCT01493557|1046341|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
308935|NCT01493531|1046369|P3|Overall Study|Death|0
308936|NCT01493531|1046370|P2|Overall Study|Death|1
308937|NCT01493531|1046371|P1|Overall Study|Death|0
308938|NCT01493531|1046369|P3|Overall Study|Withdrawal by Subject|11
308939|NCT01493531|1046370|P2|Overall Study|Withdrawal by Subject|13
308940|NCT01493531|1046371|P1|Overall Study|Withdrawal by Subject|16
308941|NCT01493531|1046369|P3|Overall Study|Lost to Follow-up|11
308942|NCT01493531|1046370|P2|Overall Study|Lost to Follow-up|7
308943|NCT01493531|1046371|P1|Overall Study|Lost to Follow-up|5
308944|NCT01493531|1046369|P3|Overall Study|Sponsor terminated study|3
308945|NCT01493531|1046370|P2|Overall Study|Sponsor terminated study|2
308946|NCT01493531|1046371|P1|Overall Study|Sponsor terminated study|5
308947|NCT01493531|1046369|P3|Overall Study|Protocol Violation|12
308948|NCT01493531|1046370|P2|Overall Study|Protocol Violation|15
308949|NCT01493531|1046371|P1|Overall Study|Protocol Violation|8
308950|NCT01493531|1046369|P3|Overall Study|Gout flare|2
308951|NCT01493531|1046370|P2|Overall Study|Gout flare|0
308952|NCT01493531|1046371|P1|Overall Study|Gout flare|3
308953|NCT01493531|1046369|P3|Overall Study|Adverse Event|9
308954|NCT01493531|1046370|P2|Overall Study|Adverse Event|12
308955|NCT01493531|1046371|P1|Overall Study|Adverse Event|4
308956|NCT01493427|1046385|P1|Overall Study|Other|2
308957|NCT01493427|1046385|P1|Overall Study|Inability to Follow Instructions|2
308958|NCT01493427|1046385|P1|Overall Study|Lost to Follow-up|2
308959|NCT01493427|1046385|P1|Overall Study|Personal Reasons|4
308960|NCT01493427|1046385|P1|Overall Study|Adverse Event|10
308961|NCT01493284|1046390|P1|Overall Study|Withdrawal by Subject|32
308962|NCT01493284|1046390|P1|Overall Study|Death|29
308963|NCT01493089|1046412|P2|Overall Study|Physician Decision|1
308964|NCT01493089|1046413|P1|Overall Study|Physician Decision|0
308965|NCT01493089|1046412|P2|Overall Study|Withdrawal by Subject|0
308966|NCT01493089|1046413|P1|Overall Study|Withdrawal by Subject|1
308967|NCT01493089|1046412|P2|Overall Study|Protocol Violation|2
308968|NCT01493089|1046413|P1|Overall Study|Protocol Violation|2
308969|NCT01492439|1046512|P2|Overall Study|Withdrew from RTE|9
308970|NCT01492439|1046513|P1|Overall Study|Withdrew from RTE|4
308971|NCT01492426|1046561|P2|Follow-Up|Lost to Follow-up|6
308972|NCT01492426|1046562|P1|Follow-Up|Lost to Follow-up|12
308973|NCT01492426|1046561|P2|Follow-Up|Participant Withdrew Consent|1
308974|NCT01492426|1046562|P1|Follow-Up|Participant Withdrew Consent|6
308975|NCT01492426|1046561|P2|Follow-Up|Other|2
308976|NCT01492426|1046562|P1|Follow-Up|Other|4
308977|NCT01492426|1046561|P2|Follow-Up|Death|0
308978|NCT01492426|1046562|P1|Follow-Up|Death|1
308979|NCT01492426|1046561|P2|Follow-Up|Protocol Requires no Follow-Up|1
308980|NCT01492426|1046562|P1|Follow-Up|Protocol Requires no Follow-Up|2
308981|NCT01492426|1046561|P2|Treatment|Participant does not meet study criteria|0
308982|NCT01492426|1046562|P1|Treatment|Participant does not meet study criteria|1
308983|NCT01492426|1046561|P2|Treatment|Lost to Follow-up|4
308984|NCT01492426|1046562|P1|Treatment|Lost to Follow-up|9
308985|NCT01492426|1046561|P2|Treatment|Subject requested discontinue study drug|3
308986|NCT01492426|1046562|P1|Treatment|Subject requested discontinue study drug|7
308987|NCT01492426|1046561|P2|Treatment|Poor compliance/noncompliance|0
308988|NCT01492426|1046562|P1|Treatment|Poor compliance/noncompliance|1
308989|NCT01492426|1046561|P2|Treatment|Participant withdrew consent|2
308990|NCT01492426|1046562|P1|Treatment|Participant withdrew consent|1
308991|NCT01492426|1046561|P2|Treatment|Lack of Efficacy|5
308992|NCT01492426|1046562|P1|Treatment|Lack of Efficacy|38
308993|NCT01492426|1046561|P2|Treatment|Adverse Event|25
308994|NCT01492426|1046562|P1|Treatment|Adverse Event|25
308995|NCT01492426|1046561|P2|Treatment|Other|0
308996|NCT01492426|1046562|P1|Treatment|Other|1
308997|NCT01492426|1046561|P2|Treatment|Death|1
308998|NCT01492426|1046562|P1|Treatment|Death|0
308999|NCT01492400|1046580|P2|Overall Study|Adverse Event|5
309000|NCT01492400|1046581|P1|Overall Study|Adverse Event|10
309001|NCT01492400|1046580|P2|Overall Study|Lack of Efficacy|1
309002|NCT01492400|1046581|P1|Overall Study|Lack of Efficacy|1
309003|NCT01492400|1046580|P2|Overall Study|Pregnancy|1
309004|NCT01492400|1046581|P1|Overall Study|Pregnancy|0
309005|NCT01492400|1046580|P2|Overall Study|Lost to Follow-up|1
309006|NCT01492400|1046581|P1|Overall Study|Lost to Follow-up|3
309007|NCT01492400|1046580|P2|Overall Study|Personal Reasons|5
309008|NCT01492400|1046581|P1|Overall Study|Personal Reasons|0
309009|NCT01492400|1046580|P2|Overall Study|Miscellaneous Reasons|3
309010|NCT01492400|1046581|P1|Overall Study|Miscellaneous Reasons|2
309011|NCT01492088|1046605|P3|Overall Study|Reason Not Specified|12
309012|NCT01492088|1046606|P2|Overall Study|Reason Not Specified|6
309013|NCT01492088|1046607|P1|Overall Study|Reason Not Specified|2
309014|NCT01492088|1046605|P3|Overall Study|Death|1
309015|NCT01492088|1046606|P2|Overall Study|Death|6
309016|NCT01492088|1046607|P1|Overall Study|Death|1
309017|NCT01492088|1046605|P3|Overall Study|Withdrawal by Patient|0
309018|NCT01492088|1046606|P2|Overall Study|Withdrawal by Patient|2
309019|NCT01492088|1046607|P1|Overall Study|Withdrawal by Patient|0
309020|NCT01491919|1046688|P3|Overall Study|Insufficient PK sampling|1
309021|NCT01491919|1046689|P2|Overall Study|Insufficient PK sampling|2
309022|NCT01491919|1046690|P1|Overall Study|Insufficient PK sampling|1
309023|NCT01491802|1046736|P2|Overall Study|Withdrawal by Subject|1
309024|NCT01491802|1046737|P1|Overall Study|Withdrawal by Subject|0
309025|NCT01491802|1046736|P2|Overall Study|Adverse Event|1
309026|NCT01491802|1046737|P1|Overall Study|Adverse Event|1
309027|NCT01491737|1046764|P2|Overall Study|Reason not specified|3
309028|NCT01491737|1046765|P1|Overall Study|Reason not specified|2
309029|NCT01491737|1046764|P2|Overall Study|Death|28
309030|NCT01491737|1046765|P1|Overall Study|Death|33
309031|NCT01491737|1046764|P2|Overall Study|Lost to Follow-up|6
309032|NCT01491737|1046765|P1|Overall Study|Lost to Follow-up|1
309033|NCT01491737|1046764|P2|Overall Study|Withdrawal of consent|13
309034|NCT01491737|1046765|P1|Overall Study|Withdrawal of consent|13
309035|NCT01491672|1046788|P3|Overall Study|Death|0
309036|NCT01491672|1046789|P2|Overall Study|Death|4
309037|NCT01491672|1046790|P1|Overall Study|Death|0
309038|NCT01491672|1046788|P3|Overall Study|Protocol deviation|0
309039|NCT01491672|1046789|P2|Overall Study|Protocol deviation|1
309040|NCT01491672|1046790|P1|Overall Study|Protocol deviation|0
309041|NCT01491672|1046788|P3|Overall Study|Disease progression|6
309042|NCT01491672|1046789|P2|Overall Study|Disease progression|34
309043|NCT01491672|1046790|P1|Overall Study|Disease progression|42
309044|NCT01491672|1046788|P3|Overall Study|Adverse Event|4
309045|NCT01491672|1046789|P2|Overall Study|Adverse Event|10
309046|NCT01491672|1046790|P1|Overall Study|Adverse Event|8
309047|NCT01491672|1046788|P3|Overall Study|Withdrawal by Subject|0
309048|NCT01491672|1046789|P2|Overall Study|Withdrawal by Subject|7
309049|NCT01491672|1046790|P1|Overall Study|Withdrawal by Subject|6
309050|NCT01491672|1046788|P3|Overall Study|Lost to Follow-up|1
309051|NCT01491672|1046789|P2|Overall Study|Lost to Follow-up|4
309052|NCT01491672|1046790|P1|Overall Study|Lost to Follow-up|0
309053|NCT01491607|1046827|P1|Overall Study|Withdrawal by Subject|3
309054|NCT01491607|1046827|P1|Overall Study|Lost to Follow-up|7
309055|NCT01491178|1046932|P1|Overall Study|Other than specified above|657
309056|NCT01491178|1046932|P1|Overall Study|To take a contraindication|20
309057|NCT01491178|1046932|P1|Overall Study|Lost to follow−up (changing hospital)|545
309058|NCT01491178|1046932|P1|Overall Study|Lost to follow−up (unknown reason)|287
309059|NCT01491178|1046932|P1|Overall Study|To conduct invasive treatment|59
309060|NCT01491178|1046932|P1|Overall Study|Improvement of NVAF|210
309061|NCT01491178|1046932|P1|Overall Study|Adverse Event|1016
309062|NCT01491035|1047041|P8|Overall Study|Lost to Follow-up|0
309063|NCT01491035|1047042|P7|Overall Study|Lost to Follow-up|0
309064|NCT01491035|1047043|P6|Overall Study|Lost to Follow-up|0
309065|NCT01491035|1047044|P5|Overall Study|Lost to Follow-up|1
309066|NCT01491035|1047045|P4|Overall Study|Lost to Follow-up|0
309067|NCT01491035|1047046|P3|Overall Study|Lost to Follow-up|0
309068|NCT01491035|1047047|P2|Overall Study|Lost to Follow-up|0
309069|NCT01491035|1047048|P1|Overall Study|Lost to Follow-up|0
309070|NCT01490866|1047149|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
309071|NCT01490866|1047149|P1|Axitinib Maintenance Therapy|Protocol Violation|2
309072|NCT01490866|1047149|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
309073|NCT01490866|1047149|P1|Axitinib Maintenance Therapy|Adverse Event|12
309074|NCT01490866|1047149|P1|Axitinib Maintenance Therapy|Disease Progression|30
309075|NCT01490866|1047149|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
309076|NCT01490866|1047149|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
309077|NCT01490866|1047149|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
309078|NCT01490866|1047149|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
309079|NCT01490866|1047149|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
309080|NCT01490866|1047149|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
309081|NCT01490840|1047160|P2|Phase 2|Adverse Event|1
309082|NCT01490840|1047161|P1|Phase 2|Adverse Event|1
309083|NCT01490840|1047160|P2|Phase 2|Lost to Follow-up|1
309084|NCT01490840|1047161|P1|Phase 2|Lost to Follow-up|1
309085|NCT01490840|1047160|P2|Phase 2|Permanent interruption of fingolimod|1
309086|NCT01490840|1047161|P1|Phase 2|Permanent interruption of fingolimod|0
309087|NCT01490840|1047160|P2|Phase 2|Withdrawal by Subject|3
309088|NCT01490840|1047161|P1|Phase 2|Withdrawal by Subject|4
309089|NCT01490840|1047160|P2|Phase 1|Visit 6a omitted|0
309090|NCT01490840|1047161|P1|Phase 1|Visit 6a omitted|1
309091|NCT01490840|1047160|P2|Phase 1|Withdrawal by Subject|5
309092|NCT01490840|1047161|P1|Phase 1|Withdrawal by Subject|6
309093|NCT01490840|1047160|P2|Phase 1|Adverse Event|1
309094|NCT01490840|1047161|P1|Phase 1|Adverse Event|2
309095|NCT01490840|1047160|P2|Phase 1|Lost to Follow-up|0
309096|NCT01490840|1047161|P1|Phase 1|Lost to Follow-up|1
309097|NCT01490697|1047185|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
309098|NCT01490697|1047186|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
309099|NCT01490632|1047199|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
309100|NCT01490632|1047200|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
309101|NCT01490632|1047201|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
309102|NCT01490632|1047202|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
309103|NCT01490632|1047203|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
309104|NCT01490632|1047204|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
309105|NCT01490632|1047205|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
309106|NCT01490632|1047206|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
309107|NCT01490632|1047207|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
309108|NCT01490632|1047208|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
309109|NCT01490632|1047209|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
309110|NCT01490632|1047210|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
309111|NCT01490632|1047211|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
309112|NCT01490632|1047212|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
309113|NCT01490632|1047213|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
309114|NCT01490632|1047214|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
309115|NCT01490632|1047215|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
309116|NCT01490632|1047216|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
309117|NCT01490632|1047217|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
309118|NCT01490632|1047218|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
309119|NCT01490632|1047199|P20|Part D: Re-Treatment Period|Protocol Violation|0
309120|NCT01490632|1047200|P19|Part D: Re-Treatment Period|Protocol Violation|1
309121|NCT01490632|1047201|P18|Part D: Re-Treatment Period|Protocol Violation|0
309122|NCT01490632|1047202|P17|Part D: Re-Treatment Period|Protocol Violation|0
309123|NCT01490632|1047203|P16|Part D: Re-Treatment Period|Protocol Violation|0
309124|NCT01490632|1047204|P15|Part D: Re-Treatment Period|Protocol Violation|0
309125|NCT01490632|1047205|P14|Part D: Re-Treatment Period|Protocol Violation|0
309126|NCT01490632|1047206|P13|Part D: Re-Treatment Period|Protocol Violation|0
309127|NCT01490632|1047207|P12|Part D: Re-Treatment Period|Protocol Violation|0
309128|NCT01490632|1047208|P11|Part D: Re-Treatment Period|Protocol Violation|0
309129|NCT01490632|1047209|P10|Part D: Re-Treatment Period|Protocol Violation|0
309130|NCT01490632|1047210|P9|Part D: Re-Treatment Period|Protocol Violation|0
309131|NCT01490632|1047211|P8|Part D: Re-Treatment Period|Protocol Violation|0
309132|NCT01490632|1047212|P7|Part D: Re-Treatment Period|Protocol Violation|0
309133|NCT01490632|1047213|P6|Part D: Re-Treatment Period|Protocol Violation|0
309134|NCT01490632|1047214|P5|Part D: Re-Treatment Period|Protocol Violation|0
309135|NCT01490632|1047215|P4|Part D: Re-Treatment Period|Protocol Violation|0
309136|NCT01490632|1047216|P3|Part D: Re-Treatment Period|Protocol Violation|0
309137|NCT01490632|1047217|P2|Part D: Re-Treatment Period|Protocol Violation|0
309138|NCT01490632|1047218|P1|Part D: Re-Treatment Period|Protocol Violation|0
309139|NCT01490632|1047199|P20|Part D: Re-Treatment Period|Physician Decision|1
309140|NCT01490632|1047200|P19|Part D: Re-Treatment Period|Physician Decision|1
309141|NCT01490632|1047201|P18|Part D: Re-Treatment Period|Physician Decision|0
309142|NCT01490632|1047202|P17|Part D: Re-Treatment Period|Physician Decision|0
309143|NCT01490632|1047203|P16|Part D: Re-Treatment Period|Physician Decision|0
309144|NCT01490632|1047204|P15|Part D: Re-Treatment Period|Physician Decision|0
309145|NCT01490632|1047205|P14|Part D: Re-Treatment Period|Physician Decision|0
309146|NCT01490632|1047206|P13|Part D: Re-Treatment Period|Physician Decision|0
309147|NCT01490632|1047207|P12|Part D: Re-Treatment Period|Physician Decision|0
309148|NCT01490632|1047208|P11|Part D: Re-Treatment Period|Physician Decision|0
309149|NCT01490632|1047209|P10|Part D: Re-Treatment Period|Physician Decision|0
309150|NCT01490632|1047210|P9|Part D: Re-Treatment Period|Physician Decision|0
309151|NCT01490632|1047211|P8|Part D: Re-Treatment Period|Physician Decision|0
309152|NCT01490632|1047212|P7|Part D: Re-Treatment Period|Physician Decision|0
309153|NCT01490632|1047213|P6|Part D: Re-Treatment Period|Physician Decision|0
309154|NCT01490632|1047214|P5|Part D: Re-Treatment Period|Physician Decision|0
309155|NCT01490632|1047215|P4|Part D: Re-Treatment Period|Physician Decision|0
309156|NCT01490632|1047216|P3|Part D: Re-Treatment Period|Physician Decision|0
309157|NCT01490632|1047217|P2|Part D: Re-Treatment Period|Physician Decision|0
309158|NCT01490632|1047218|P1|Part D: Re-Treatment Period|Physician Decision|0
309159|NCT01490632|1047199|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
309160|NCT01490632|1047200|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
309161|NCT01490632|1047201|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
309162|NCT01490632|1047202|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
309163|NCT01490632|1047203|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
309164|NCT01490632|1047204|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
309165|NCT01490632|1047205|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
309166|NCT01490632|1047206|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
309167|NCT01490632|1047207|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
309168|NCT01490632|1047208|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
309169|NCT01490632|1047209|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
309170|NCT01490632|1047210|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
309171|NCT01490632|1047211|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
309172|NCT01490632|1047212|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
309173|NCT01490632|1047213|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
309174|NCT01490632|1047214|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
309175|NCT01490632|1047215|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
309176|NCT01490632|1047216|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
309177|NCT01490632|1047217|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
309178|NCT01490632|1047218|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
309179|NCT01490632|1047199|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
309180|NCT01490632|1047200|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
309181|NCT01490632|1047201|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
309182|NCT01490632|1047202|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
309183|NCT01490632|1047203|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
309184|NCT01490632|1047204|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
309185|NCT01490632|1047205|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
309186|NCT01490632|1047206|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
309187|NCT01490632|1047207|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
309188|NCT01490632|1047208|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
309189|NCT01490632|1047209|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
309190|NCT01490632|1047210|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
309191|NCT01490632|1047211|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
309192|NCT01490632|1047212|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
309193|NCT01490632|1047213|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
309194|NCT01490632|1047214|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
309195|NCT01490632|1047215|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
309196|NCT01490632|1047216|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
309197|NCT01490632|1047217|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
309198|NCT01490632|1047218|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
309199|NCT01490632|1047199|P20|Part D: Re-Treatment Period|Death|0
309200|NCT01490632|1047200|P19|Part D: Re-Treatment Period|Death|1
309201|NCT01490632|1047201|P18|Part D: Re-Treatment Period|Death|0
309202|NCT01490632|1047202|P17|Part D: Re-Treatment Period|Death|0
309203|NCT01490632|1047203|P16|Part D: Re-Treatment Period|Death|0
309204|NCT01490632|1047204|P15|Part D: Re-Treatment Period|Death|0
309205|NCT01490632|1047205|P14|Part D: Re-Treatment Period|Death|0
309206|NCT01490632|1047206|P13|Part D: Re-Treatment Period|Death|0
309207|NCT01490632|1047207|P12|Part D: Re-Treatment Period|Death|0
309208|NCT01490632|1047208|P11|Part D: Re-Treatment Period|Death|0
309209|NCT01490632|1047209|P10|Part D: Re-Treatment Period|Death|0
309210|NCT01490632|1047210|P9|Part D: Re-Treatment Period|Death|0
309211|NCT01490632|1047211|P8|Part D: Re-Treatment Period|Death|0
309212|NCT01490632|1047212|P7|Part D: Re-Treatment Period|Death|0
309213|NCT01490632|1047213|P6|Part D: Re-Treatment Period|Death|0
309214|NCT01490632|1047214|P5|Part D: Re-Treatment Period|Death|0
309215|NCT01490632|1047215|P4|Part D: Re-Treatment Period|Death|0
309216|NCT01490632|1047216|P3|Part D: Re-Treatment Period|Death|0
309217|NCT01490632|1047217|P2|Part D: Re-Treatment Period|Death|0
309218|NCT01490632|1047218|P1|Part D: Re-Treatment Period|Death|0
309219|NCT01490632|1047199|P20|Part D: Re-Treatment Period|Adverse Event|3
309220|NCT01490632|1047200|P19|Part D: Re-Treatment Period|Adverse Event|1
309221|NCT01490632|1047201|P18|Part D: Re-Treatment Period|Adverse Event|1
309222|NCT01490632|1047202|P17|Part D: Re-Treatment Period|Adverse Event|0
309223|NCT01490632|1047203|P16|Part D: Re-Treatment Period|Adverse Event|0
309224|NCT01490632|1047204|P15|Part D: Re-Treatment Period|Adverse Event|0
309225|NCT01490632|1047205|P14|Part D: Re-Treatment Period|Adverse Event|0
309226|NCT01490632|1047206|P13|Part D: Re-Treatment Period|Adverse Event|0
309227|NCT01490632|1047207|P12|Part D: Re-Treatment Period|Adverse Event|0
309228|NCT01490632|1047208|P11|Part D: Re-Treatment Period|Adverse Event|0
309229|NCT01490632|1047209|P10|Part D: Re-Treatment Period|Adverse Event|0
309230|NCT01490632|1047210|P9|Part D: Re-Treatment Period|Adverse Event|0
309231|NCT01490632|1047211|P8|Part D: Re-Treatment Period|Adverse Event|0
309232|NCT01490632|1047212|P7|Part D: Re-Treatment Period|Adverse Event|0
309233|NCT01490632|1047213|P6|Part D: Re-Treatment Period|Adverse Event|0
309234|NCT01490632|1047214|P5|Part D: Re-Treatment Period|Adverse Event|0
309235|NCT01490632|1047215|P4|Part D: Re-Treatment Period|Adverse Event|0
309236|NCT01490632|1047216|P3|Part D: Re-Treatment Period|Adverse Event|0
309237|NCT01490632|1047217|P2|Part D: Re-Treatment Period|Adverse Event|0
309238|NCT01490632|1047218|P1|Part D: Re-Treatment Period|Adverse Event|0
309239|NCT01490632|1047199|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309240|NCT01490632|1047200|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309241|NCT01490632|1047201|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309242|NCT01490632|1047202|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309243|NCT01490632|1047203|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
309244|NCT01490632|1047204|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
309245|NCT01490632|1047205|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
309246|NCT01490632|1047206|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
309247|NCT01490632|1047207|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309248|NCT01490632|1047208|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309249|NCT01490632|1047209|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309250|NCT01490632|1047210|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309251|NCT01490632|1047211|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309252|NCT01490632|1047212|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309253|NCT01490632|1047213|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309254|NCT01490632|1047214|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309255|NCT01490632|1047215|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309256|NCT01490632|1047216|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309257|NCT01490632|1047217|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309258|NCT01490632|1047218|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
309259|NCT01490632|1047199|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309260|NCT01490632|1047200|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309261|NCT01490632|1047201|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309262|NCT01490632|1047202|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309263|NCT01490632|1047203|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
309264|NCT01490632|1047204|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
309265|NCT01490632|1047205|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309266|NCT01490632|1047206|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309267|NCT01490632|1047207|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309268|NCT01490632|1047208|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309269|NCT01490632|1047209|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309270|NCT01490632|1047210|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309271|NCT01490632|1047211|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309272|NCT01490632|1047212|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309273|NCT01490632|1047213|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309274|NCT01490632|1047214|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309275|NCT01490632|1047215|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309276|NCT01490632|1047216|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309277|NCT01490632|1047217|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309278|NCT01490632|1047218|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
309279|NCT01490632|1047199|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309280|NCT01490632|1047200|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309281|NCT01490632|1047201|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309282|NCT01490632|1047202|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309283|NCT01490632|1047203|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309284|NCT01490632|1047204|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309285|NCT01490632|1047205|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
309286|NCT01490632|1047206|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309287|NCT01490632|1047207|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309288|NCT01490632|1047208|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309289|NCT01490632|1047209|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309290|NCT01490632|1047210|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309291|NCT01490632|1047211|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309292|NCT01490632|1047212|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309293|NCT01490632|1047213|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309294|NCT01490632|1047214|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309295|NCT01490632|1047215|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309296|NCT01490632|1047216|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309297|NCT01490632|1047217|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309671|NCT01490125|1047640|P3|Period I|Adverse Event|1
309298|NCT01490632|1047218|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
309299|NCT01490632|1047199|P20|Part C: Washout or Step-Down Period|Adverse Event|0
309300|NCT01490632|1047200|P19|Part C: Washout or Step-Down Period|Adverse Event|0
309301|NCT01490632|1047201|P18|Part C: Washout or Step-Down Period|Adverse Event|0
309302|NCT01490632|1047202|P17|Part C: Washout or Step-Down Period|Adverse Event|0
309303|NCT01490632|1047203|P16|Part C: Washout or Step-Down Period|Adverse Event|2
309304|NCT01490632|1047204|P15|Part C: Washout or Step-Down Period|Adverse Event|2
309305|NCT01490632|1047205|P14|Part C: Washout or Step-Down Period|Adverse Event|0
309306|NCT01490632|1047206|P13|Part C: Washout or Step-Down Period|Adverse Event|0
309307|NCT01490632|1047207|P12|Part C: Washout or Step-Down Period|Adverse Event|0
309308|NCT01490632|1047208|P11|Part C: Washout or Step-Down Period|Adverse Event|0
309309|NCT01490632|1047209|P10|Part C: Washout or Step-Down Period|Adverse Event|0
309310|NCT01490632|1047210|P9|Part C: Washout or Step-Down Period|Adverse Event|0
309311|NCT01490632|1047211|P8|Part C: Washout or Step-Down Period|Adverse Event|0
309312|NCT01490632|1047212|P7|Part C: Washout or Step-Down Period|Adverse Event|0
309313|NCT01490632|1047213|P6|Part C: Washout or Step-Down Period|Adverse Event|0
309314|NCT01490632|1047214|P5|Part C: Washout or Step-Down Period|Adverse Event|0
309315|NCT01490632|1047215|P4|Part C: Washout or Step-Down Period|Adverse Event|0
309316|NCT01490632|1047216|P3|Part C: Washout or Step-Down Period|Adverse Event|0
309317|NCT01490632|1047217|P2|Part C: Washout or Step-Down Period|Adverse Event|0
309318|NCT01490632|1047218|P1|Part C: Washout or Step-Down Period|Adverse Event|0
309319|NCT01490632|1047199|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309320|NCT01490632|1047200|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309321|NCT01490632|1047201|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309322|NCT01490632|1047202|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309323|NCT01490632|1047203|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309324|NCT01490632|1047204|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309325|NCT01490632|1047205|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309326|NCT01490632|1047206|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309327|NCT01490632|1047207|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
309328|NCT01490632|1047208|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
309329|NCT01490632|1047209|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
309330|NCT01490632|1047210|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
309331|NCT01490632|1047211|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
309332|NCT01490632|1047212|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
309333|NCT01490632|1047213|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
309334|NCT01490632|1047214|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309335|NCT01490632|1047215|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309336|NCT01490632|1047216|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309337|NCT01490632|1047217|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309338|NCT01490632|1047218|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
309339|NCT01490632|1047199|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309340|NCT01490632|1047200|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309341|NCT01490632|1047201|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309342|NCT01490632|1047202|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309343|NCT01490632|1047203|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309344|NCT01490632|1047204|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309345|NCT01490632|1047205|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309346|NCT01490632|1047206|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309347|NCT01490632|1047207|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
309348|NCT01490632|1047208|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
309349|NCT01490632|1047209|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309350|NCT01490632|1047210|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
309351|NCT01490632|1047211|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309352|NCT01490632|1047212|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
309353|NCT01490632|1047213|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309354|NCT01490632|1047214|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309355|NCT01490632|1047215|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309356|NCT01490632|1047216|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309357|NCT01490632|1047217|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309358|NCT01490632|1047218|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
309359|NCT01490632|1047199|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
309360|NCT01490632|1047200|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
309361|NCT01490632|1047201|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
309362|NCT01490632|1047202|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
309363|NCT01490632|1047203|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
309364|NCT01490632|1047204|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
309365|NCT01490632|1047205|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
309366|NCT01490632|1047206|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
309367|NCT01490632|1047207|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
309368|NCT01490632|1047208|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
309369|NCT01490632|1047209|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
309370|NCT01490632|1047210|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
309371|NCT01490632|1047211|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
309372|NCT01490632|1047212|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
309373|NCT01490632|1047213|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
309374|NCT01490632|1047214|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
309375|NCT01490632|1047215|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
309376|NCT01490632|1047216|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
309377|NCT01490632|1047217|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
309378|NCT01490632|1047218|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
309379|NCT01490632|1047199|P20|Part B: Extension or Step-Up Period|Physician Decision|0
309380|NCT01490632|1047200|P19|Part B: Extension or Step-Up Period|Physician Decision|0
309381|NCT01490632|1047201|P18|Part B: Extension or Step-Up Period|Physician Decision|0
309382|NCT01490632|1047202|P17|Part B: Extension or Step-Up Period|Physician Decision|0
309383|NCT01490632|1047203|P16|Part B: Extension or Step-Up Period|Physician Decision|0
309384|NCT01490632|1047204|P15|Part B: Extension or Step-Up Period|Physician Decision|0
309385|NCT01490632|1047205|P14|Part B: Extension or Step-Up Period|Physician Decision|0
309386|NCT01490632|1047206|P13|Part B: Extension or Step-Up Period|Physician Decision|0
309387|NCT01490632|1047207|P12|Part B: Extension or Step-Up Period|Physician Decision|0
309388|NCT01490632|1047208|P11|Part B: Extension or Step-Up Period|Physician Decision|0
309389|NCT01490632|1047209|P10|Part B: Extension or Step-Up Period|Physician Decision|0
309390|NCT01490632|1047210|P9|Part B: Extension or Step-Up Period|Physician Decision|0
309391|NCT01490632|1047211|P8|Part B: Extension or Step-Up Period|Physician Decision|0
309392|NCT01490632|1047212|P7|Part B: Extension or Step-Up Period|Physician Decision|1
309393|NCT01490632|1047213|P6|Part B: Extension or Step-Up Period|Physician Decision|0
309394|NCT01490632|1047214|P5|Part B: Extension or Step-Up Period|Physician Decision|0
309395|NCT01490632|1047215|P4|Part B: Extension or Step-Up Period|Physician Decision|0
309396|NCT01490632|1047216|P3|Part B: Extension or Step-Up Period|Physician Decision|0
309397|NCT01490632|1047217|P2|Part B: Extension or Step-Up Period|Physician Decision|0
309398|NCT01490632|1047218|P1|Part B: Extension or Step-Up Period|Physician Decision|0
309399|NCT01490632|1047199|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309400|NCT01490632|1047200|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309401|NCT01490632|1047201|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309402|NCT01490632|1047202|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309403|NCT01490632|1047203|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309404|NCT01490632|1047204|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309405|NCT01490632|1047205|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309406|NCT01490632|1047206|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309407|NCT01490632|1047207|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309408|NCT01490632|1047208|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309409|NCT01490632|1047209|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
309410|NCT01490632|1047210|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309411|NCT01490632|1047211|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309412|NCT01490632|1047212|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
309413|NCT01490632|1047213|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309414|NCT01490632|1047214|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309415|NCT01490632|1047215|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309416|NCT01490632|1047216|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309417|NCT01490632|1047217|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309418|NCT01490632|1047218|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
309419|NCT01490632|1047199|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309420|NCT01490632|1047200|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309421|NCT01490632|1047201|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309422|NCT01490632|1047202|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309423|NCT01490632|1047203|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309424|NCT01490632|1047204|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309425|NCT01490632|1047205|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309426|NCT01490632|1047206|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309427|NCT01490632|1047207|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309428|NCT01490632|1047208|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
309429|NCT01490632|1047209|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
309430|NCT01490632|1047210|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
309431|NCT01490632|1047211|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309432|NCT01490632|1047212|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
309433|NCT01490632|1047213|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309434|NCT01490632|1047214|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309435|NCT01490632|1047215|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309436|NCT01490632|1047216|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309437|NCT01490632|1047217|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309438|NCT01490632|1047218|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
309439|NCT01490632|1047199|P20|Part B: Extension or Step-Up Period|Adverse Event|0
309440|NCT01490632|1047200|P19|Part B: Extension or Step-Up Period|Adverse Event|0
309441|NCT01490632|1047201|P18|Part B: Extension or Step-Up Period|Adverse Event|0
309442|NCT01490632|1047202|P17|Part B: Extension or Step-Up Period|Adverse Event|0
309443|NCT01490632|1047203|P16|Part B: Extension or Step-Up Period|Adverse Event|0
309444|NCT01490632|1047204|P15|Part B: Extension or Step-Up Period|Adverse Event|0
309445|NCT01490632|1047205|P14|Part B: Extension or Step-Up Period|Adverse Event|0
309446|NCT01490632|1047206|P13|Part B: Extension or Step-Up Period|Adverse Event|0
309447|NCT01490632|1047207|P12|Part B: Extension or Step-Up Period|Adverse Event|1
309448|NCT01490632|1047208|P11|Part B: Extension or Step-Up Period|Adverse Event|3
309449|NCT01490632|1047209|P10|Part B: Extension or Step-Up Period|Adverse Event|2
309450|NCT01490632|1047210|P9|Part B: Extension or Step-Up Period|Adverse Event|0
309451|NCT01490632|1047211|P8|Part B: Extension or Step-Up Period|Adverse Event|0
309452|NCT01490632|1047212|P7|Part B: Extension or Step-Up Period|Adverse Event|2
309453|NCT01490632|1047213|P6|Part B: Extension or Step-Up Period|Adverse Event|2
309454|NCT01490632|1047214|P5|Part B: Extension or Step-Up Period|Adverse Event|0
309455|NCT01490632|1047215|P4|Part B: Extension or Step-Up Period|Adverse Event|0
309456|NCT01490632|1047216|P3|Part B: Extension or Step-Up Period|Adverse Event|0
309457|NCT01490632|1047217|P2|Part B: Extension or Step-Up Period|Adverse Event|0
309458|NCT01490632|1047218|P1|Part B: Extension or Step-Up Period|Adverse Event|0
309459|NCT01490632|1047199|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309460|NCT01490632|1047200|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309461|NCT01490632|1047201|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309462|NCT01490632|1047202|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309463|NCT01490632|1047203|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309464|NCT01490632|1047204|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309465|NCT01490632|1047205|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309466|NCT01490632|1047206|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309467|NCT01490632|1047207|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309468|NCT01490632|1047208|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309469|NCT01490632|1047209|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309470|NCT01490632|1047210|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309471|NCT01490632|1047211|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309472|NCT01490632|1047212|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309473|NCT01490632|1047213|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309474|NCT01490632|1047214|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
309475|NCT01490632|1047215|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309476|NCT01490632|1047216|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309477|NCT01490632|1047217|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309478|NCT01490632|1047218|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
309479|NCT01490632|1047199|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
309480|NCT01490632|1047200|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
309481|NCT01490632|1047201|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
309482|NCT01490632|1047202|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
309483|NCT01490632|1047203|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
309484|NCT01490632|1047204|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
309485|NCT01490632|1047205|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
309486|NCT01490632|1047206|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
309487|NCT01490632|1047207|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
309488|NCT01490632|1047208|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
309489|NCT01490632|1047209|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
309490|NCT01490632|1047210|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
309491|NCT01490632|1047211|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
309492|NCT01490632|1047212|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
309493|NCT01490632|1047213|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
309494|NCT01490632|1047214|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
309495|NCT01490632|1047215|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
309496|NCT01490632|1047216|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
309497|NCT01490632|1047217|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
309498|NCT01490632|1047218|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
309499|NCT01490632|1047199|P20|Part A: Initial Treatment Period|Sponsor Decision|0
309500|NCT01490632|1047200|P19|Part A: Initial Treatment Period|Sponsor Decision|0
309501|NCT01490632|1047201|P18|Part A: Initial Treatment Period|Sponsor Decision|0
309502|NCT01490632|1047202|P17|Part A: Initial Treatment Period|Sponsor Decision|0
309503|NCT01490632|1047203|P16|Part A: Initial Treatment Period|Sponsor Decision|0
309504|NCT01490632|1047204|P15|Part A: Initial Treatment Period|Sponsor Decision|0
309505|NCT01490632|1047205|P14|Part A: Initial Treatment Period|Sponsor Decision|0
309506|NCT01490632|1047206|P13|Part A: Initial Treatment Period|Sponsor Decision|0
309507|NCT01490632|1047207|P12|Part A: Initial Treatment Period|Sponsor Decision|0
309508|NCT01490632|1047208|P11|Part A: Initial Treatment Period|Sponsor Decision|0
309509|NCT01490632|1047209|P10|Part A: Initial Treatment Period|Sponsor Decision|0
309510|NCT01490632|1047210|P9|Part A: Initial Treatment Period|Sponsor Decision|0
309511|NCT01490632|1047211|P8|Part A: Initial Treatment Period|Sponsor Decision|0
309512|NCT01490632|1047212|P7|Part A: Initial Treatment Period|Sponsor Decision|0
309513|NCT01490632|1047213|P6|Part A: Initial Treatment Period|Sponsor Decision|0
309514|NCT01490632|1047214|P5|Part A: Initial Treatment Period|Sponsor Decision|0
309515|NCT01490632|1047215|P4|Part A: Initial Treatment Period|Sponsor Decision|0
309516|NCT01490632|1047216|P3|Part A: Initial Treatment Period|Sponsor Decision|0
309517|NCT01490632|1047217|P2|Part A: Initial Treatment Period|Sponsor Decision|0
309518|NCT01490632|1047218|P1|Part A: Initial Treatment Period|Sponsor Decision|2
309519|NCT01490632|1047199|P20|Part A: Initial Treatment Period|Physician Decision|0
309520|NCT01490632|1047200|P19|Part A: Initial Treatment Period|Physician Decision|0
309521|NCT01490632|1047201|P18|Part A: Initial Treatment Period|Physician Decision|0
309522|NCT01490632|1047202|P17|Part A: Initial Treatment Period|Physician Decision|0
309523|NCT01490632|1047203|P16|Part A: Initial Treatment Period|Physician Decision|0
309524|NCT01490632|1047204|P15|Part A: Initial Treatment Period|Physician Decision|0
309525|NCT01490632|1047205|P14|Part A: Initial Treatment Period|Physician Decision|0
309526|NCT01490632|1047206|P13|Part A: Initial Treatment Period|Physician Decision|0
309527|NCT01490632|1047207|P12|Part A: Initial Treatment Period|Physician Decision|0
309528|NCT01490632|1047208|P11|Part A: Initial Treatment Period|Physician Decision|0
309529|NCT01490632|1047209|P10|Part A: Initial Treatment Period|Physician Decision|0
309530|NCT01490632|1047210|P9|Part A: Initial Treatment Period|Physician Decision|0
309531|NCT01490632|1047211|P8|Part A: Initial Treatment Period|Physician Decision|0
309532|NCT01490632|1047212|P7|Part A: Initial Treatment Period|Physician Decision|0
309533|NCT01490632|1047213|P6|Part A: Initial Treatment Period|Physician Decision|0
309534|NCT01490632|1047214|P5|Part A: Initial Treatment Period|Physician Decision|0
309535|NCT01490632|1047215|P4|Part A: Initial Treatment Period|Physician Decision|1
309536|NCT01490632|1047216|P3|Part A: Initial Treatment Period|Physician Decision|0
309537|NCT01490632|1047217|P2|Part A: Initial Treatment Period|Physician Decision|1
309538|NCT01490632|1047218|P1|Part A: Initial Treatment Period|Physician Decision|0
309539|NCT01490632|1047199|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
309540|NCT01490632|1047200|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
309541|NCT01490632|1047201|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
309542|NCT01490632|1047202|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
309543|NCT01490632|1047203|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
309544|NCT01490632|1047204|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
309545|NCT01490632|1047205|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
309546|NCT01490632|1047206|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
309547|NCT01490632|1047207|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
309548|NCT01490632|1047208|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
309549|NCT01490632|1047209|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
309550|NCT01490632|1047210|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
309551|NCT01490632|1047211|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
309552|NCT01490632|1047212|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
309553|NCT01490632|1047213|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
309554|NCT01490632|1047214|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
309555|NCT01490632|1047215|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
309556|NCT01490632|1047216|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
309557|NCT01490632|1047217|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
309558|NCT01490632|1047218|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
309559|NCT01490632|1047199|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
309560|NCT01490632|1047200|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
309561|NCT01490632|1047201|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
309562|NCT01490632|1047202|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
309563|NCT01490632|1047203|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
309564|NCT01490632|1047204|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
309565|NCT01490632|1047205|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
309566|NCT01490632|1047206|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
309567|NCT01490632|1047207|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
309568|NCT01490632|1047208|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
309569|NCT01490632|1047209|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
309570|NCT01490632|1047210|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
309571|NCT01490632|1047211|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
309572|NCT01490632|1047212|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
309573|NCT01490632|1047213|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
309574|NCT01490632|1047214|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
309575|NCT01490632|1047215|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
309576|NCT01490632|1047216|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
309577|NCT01490632|1047217|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
309578|NCT01490632|1047218|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
309579|NCT01490632|1047199|P20|Part A: Initial Treatment Period|Adverse Event|0
309580|NCT01490632|1047200|P19|Part A: Initial Treatment Period|Adverse Event|0
309581|NCT01490632|1047201|P18|Part A: Initial Treatment Period|Adverse Event|0
309582|NCT01490632|1047202|P17|Part A: Initial Treatment Period|Adverse Event|0
309583|NCT01490632|1047203|P16|Part A: Initial Treatment Period|Adverse Event|0
309584|NCT01490632|1047204|P15|Part A: Initial Treatment Period|Adverse Event|0
309585|NCT01490632|1047205|P14|Part A: Initial Treatment Period|Adverse Event|0
309586|NCT01490632|1047206|P13|Part A: Initial Treatment Period|Adverse Event|0
309587|NCT01490632|1047207|P12|Part A: Initial Treatment Period|Adverse Event|0
309588|NCT01490632|1047208|P11|Part A: Initial Treatment Period|Adverse Event|0
309589|NCT01490632|1047209|P10|Part A: Initial Treatment Period|Adverse Event|0
309590|NCT01490632|1047210|P9|Part A: Initial Treatment Period|Adverse Event|0
309591|NCT01490632|1047211|P8|Part A: Initial Treatment Period|Adverse Event|0
309592|NCT01490632|1047212|P7|Part A: Initial Treatment Period|Adverse Event|0
309593|NCT01490632|1047213|P6|Part A: Initial Treatment Period|Adverse Event|0
309594|NCT01490632|1047214|P5|Part A: Initial Treatment Period|Adverse Event|4
309595|NCT01490632|1047215|P4|Part A: Initial Treatment Period|Adverse Event|4
309596|NCT01490632|1047216|P3|Part A: Initial Treatment Period|Adverse Event|2
309597|NCT01490632|1047217|P2|Part A: Initial Treatment Period|Adverse Event|0
309598|NCT01490632|1047218|P1|Part A: Initial Treatment Period|Adverse Event|0
309599|NCT01490294|1047373|P4|Overall Study|Adverse Event|0
309600|NCT01490294|1047374|P3|Overall Study|Adverse Event|0
309601|NCT01490294|1047375|P2|Overall Study|Adverse Event|0
309602|NCT01490294|1047376|P1|Overall Study|Adverse Event|1
309603|NCT01490294|1047373|P4|Overall Study|Prematurely discontinuation|1
309604|NCT01490294|1047374|P3|Overall Study|Prematurely discontinuation|1
309605|NCT01490294|1047375|P2|Overall Study|Prematurely discontinuation|0
309606|NCT01490294|1047376|P1|Overall Study|Prematurely discontinuation|4
309607|NCT01490190|1047610|P1|Overall Study|Ring expulsion|2
309608|NCT01490190|1047610|P1|Overall Study|Inconvenience|1
309609|NCT01490190|1047610|P1|Overall Study|Relocation|1
309610|NCT01490190|1047610|P1|Overall Study|Lost to Follow-up|13
309611|NCT01490190|1047610|P1|Overall Study|Protocol Violation|5
309612|NCT01490190|1047610|P1|Overall Study|Adverse Event|17
309613|NCT01490190|1047610|P1|Overall Study|Withdrawal by Subject|9
309614|NCT01490125|1047637|P6|Period III|Lack of Efficacy|0
309615|NCT01490125|1047638|P5|Period III|Lack of Efficacy|1
309616|NCT01490125|1047639|P4|Period III|Lack of Efficacy|0
309617|NCT01490125|1047640|P3|Period III|Lack of Efficacy|0
309618|NCT01490125|1047641|P2|Period III|Lack of Efficacy|0
309619|NCT01490125|1047642|P1|Period III|Lack of Efficacy|0
309620|NCT01490125|1047637|P6|Period III|Death|0
309621|NCT01490125|1047638|P5|Period III|Death|0
309622|NCT01490125|1047639|P4|Period III|Death|1
309623|NCT01490125|1047640|P3|Period III|Death|0
309624|NCT01490125|1047641|P2|Period III|Death|0
309625|NCT01490125|1047642|P1|Period III|Death|0
309626|NCT01490125|1047637|P6|Period III|Adverse Event|0
309627|NCT01490125|1047638|P5|Period III|Adverse Event|0
309628|NCT01490125|1047639|P4|Period III|Adverse Event|1
309629|NCT01490125|1047640|P3|Period III|Adverse Event|0
309630|NCT01490125|1047641|P2|Period III|Adverse Event|1
309631|NCT01490125|1047642|P1|Period III|Adverse Event|3
309632|NCT01490125|1047637|P6|Period II|Withdrawal by Subject|0
309633|NCT01490125|1047638|P5|Period II|Withdrawal by Subject|0
309634|NCT01490125|1047639|P4|Period II|Withdrawal by Subject|0
309635|NCT01490125|1047640|P3|Period II|Withdrawal by Subject|0
309636|NCT01490125|1047641|P2|Period II|Withdrawal by Subject|0
309637|NCT01490125|1047642|P1|Period II|Withdrawal by Subject|1
309638|NCT01490125|1047637|P6|Period II|Lost to Follow-up|0
309639|NCT01490125|1047638|P5|Period II|Lost to Follow-up|0
309640|NCT01490125|1047639|P4|Period II|Lost to Follow-up|0
309641|NCT01490125|1047640|P3|Period II|Lost to Follow-up|0
309642|NCT01490125|1047641|P2|Period II|Lost to Follow-up|1
309643|NCT01490125|1047642|P1|Period II|Lost to Follow-up|0
309644|NCT01490125|1047637|P6|Period II|Protocol Violation|0
309645|NCT01490125|1047638|P5|Period II|Protocol Violation|0
309646|NCT01490125|1047639|P4|Period II|Protocol Violation|1
309647|NCT01490125|1047640|P3|Period II|Protocol Violation|1
309648|NCT01490125|1047641|P2|Period II|Protocol Violation|0
309649|NCT01490125|1047642|P1|Period II|Protocol Violation|0
309650|NCT01490125|1047637|P6|Period II|Adverse Event|2
309651|NCT01490125|1047638|P5|Period II|Adverse Event|4
309652|NCT01490125|1047639|P4|Period II|Adverse Event|2
309653|NCT01490125|1047640|P3|Period II|Adverse Event|2
309654|NCT01490125|1047641|P2|Period II|Adverse Event|3
309655|NCT01490125|1047642|P1|Period II|Adverse Event|2
309656|NCT01490125|1047637|P6|Period I|Withdrawal by Subject|1
309657|NCT01490125|1047638|P5|Period I|Withdrawal by Subject|2
309658|NCT01490125|1047639|P4|Period I|Withdrawal by Subject|1
309659|NCT01490125|1047640|P3|Period I|Withdrawal by Subject|2
309660|NCT01490125|1047641|P2|Period I|Withdrawal by Subject|3
309661|NCT01490125|1047642|P1|Period I|Withdrawal by Subject|1
309662|NCT01490125|1047637|P6|Period I|Protocol Violation|0
309663|NCT01490125|1047638|P5|Period I|Protocol Violation|0
309664|NCT01490125|1047639|P4|Period I|Protocol Violation|1
309665|NCT01490125|1047640|P3|Period I|Protocol Violation|1
309666|NCT01490125|1047641|P2|Period I|Protocol Violation|1
309667|NCT01490125|1047642|P1|Period I|Protocol Violation|1
309668|NCT01490125|1047637|P6|Period I|Adverse Event|4
309669|NCT01490125|1047638|P5|Period I|Adverse Event|2
309670|NCT01490125|1047639|P4|Period I|Adverse Event|3
309672|NCT01490125|1047641|P2|Period I|Adverse Event|1
309673|NCT01490125|1047642|P1|Period I|Adverse Event|4
309674|NCT01490086|1047670|P5|Overall Study|Subject left hospital|0
309675|NCT01490086|1047671|P4|Overall Study|Subject left hospital|1
309676|NCT01490086|1047672|P3|Overall Study|Subject left hospital|0
309677|NCT01490086|1047673|P2|Overall Study|Subject left hospital|1
309678|NCT01490086|1047674|P1|Overall Study|Subject left hospital|0
309679|NCT01490086|1047670|P5|Overall Study|Subject uncontrollable and abusive|0
309680|NCT01490086|1047671|P4|Overall Study|Subject uncontrollable and abusive|0
309681|NCT01490086|1047672|P3|Overall Study|Subject uncontrollable and abusive|0
309682|NCT01490086|1047673|P2|Overall Study|Subject uncontrollable and abusive|1
309683|NCT01490086|1047674|P1|Overall Study|Subject uncontrollable and abusive|0
309684|NCT01490086|1047670|P5|Overall Study|Worsening of symptoms|0
309685|NCT01490086|1047671|P4|Overall Study|Worsening of symptoms|1
309686|NCT01490086|1047672|P3|Overall Study|Worsening of symptoms|0
309687|NCT01490086|1047673|P2|Overall Study|Worsening of symptoms|1
309688|NCT01490086|1047674|P1|Overall Study|Worsening of symptoms|0
309689|NCT01490086|1047670|P5|Overall Study|Lack of Efficacy|8
309690|NCT01490086|1047671|P4|Overall Study|Lack of Efficacy|0
309691|NCT01490086|1047672|P3|Overall Study|Lack of Efficacy|1
309692|NCT01490086|1047673|P2|Overall Study|Lack of Efficacy|3
309693|NCT01490086|1047674|P1|Overall Study|Lack of Efficacy|0
309694|NCT01490086|1047670|P5|Overall Study|Adverse Event|0
309695|NCT01490086|1047671|P4|Overall Study|Adverse Event|2
309696|NCT01490086|1047672|P3|Overall Study|Adverse Event|1
309697|NCT01490086|1047673|P2|Overall Study|Adverse Event|0
309698|NCT01490086|1047674|P1|Overall Study|Adverse Event|0
309699|NCT01490086|1047670|P5|Overall Study|Physician Decision|1
309700|NCT01490086|1047671|P4|Overall Study|Physician Decision|3
309701|NCT01490086|1047672|P3|Overall Study|Physician Decision|2
309702|NCT01490086|1047673|P2|Overall Study|Physician Decision|4
309703|NCT01490086|1047674|P1|Overall Study|Physician Decision|3
309704|NCT01490086|1047670|P5|Overall Study|Lost to Follow-up|1
309705|NCT01490086|1047671|P4|Overall Study|Lost to Follow-up|0
309706|NCT01490086|1047672|P3|Overall Study|Lost to Follow-up|0
309707|NCT01490086|1047673|P2|Overall Study|Lost to Follow-up|0
309708|NCT01490086|1047674|P1|Overall Study|Lost to Follow-up|0
309709|NCT01490086|1047670|P5|Overall Study|Abnormal laboratory findings|0
309710|NCT01490086|1047671|P4|Overall Study|Abnormal laboratory findings|0
309711|NCT01490086|1047672|P3|Overall Study|Abnormal laboratory findings|0
309712|NCT01490086|1047673|P2|Overall Study|Abnormal laboratory findings|0
309713|NCT01490086|1047674|P1|Overall Study|Abnormal laboratory findings|1
309714|NCT01490086|1047670|P5|Overall Study|Non-compliance|0
309715|NCT01490086|1047671|P4|Overall Study|Non-compliance|0
309716|NCT01490086|1047672|P3|Overall Study|Non-compliance|0
309717|NCT01490086|1047673|P2|Overall Study|Non-compliance|1
309718|NCT01490086|1047674|P1|Overall Study|Non-compliance|0
309719|NCT01490086|1047670|P5|Overall Study|Consent withdrawn|1
309720|NCT01490086|1047671|P4|Overall Study|Consent withdrawn|0
309721|NCT01490086|1047672|P3|Overall Study|Consent withdrawn|3
309722|NCT01490086|1047673|P2|Overall Study|Consent withdrawn|4
309723|NCT01490086|1047674|P1|Overall Study|Consent withdrawn|4
309724|NCT01490060|1047708|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
309725|NCT01490060|1047709|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
309726|NCT01490060|1047710|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
309727|NCT01490060|1047711|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
309728|NCT01490060|1047708|P4|Cycle 2|Non-Compliance|0
309729|NCT01490060|1047709|P3|Cycle 2|Non-Compliance|1
309730|NCT01490060|1047710|P2|Cycle 2|Non-Compliance|0
309731|NCT01490060|1047711|P1|Cycle 2|Non-Compliance|0
309732|NCT01490060|1047708|P4|Cycle 2|Change of Treatment|0
309733|NCT01490060|1047709|P3|Cycle 2|Change of Treatment|0
309734|NCT01490060|1047710|P2|Cycle 2|Change of Treatment|1
309735|NCT01490060|1047711|P1|Cycle 2|Change of Treatment|1
309736|NCT01490060|1047708|P4|Cycle 1|Treatment at Another Facility|1
309737|NCT01490060|1047709|P3|Cycle 1|Treatment at Another Facility|0
309738|NCT01490060|1047710|P2|Cycle 1|Treatment at Another Facility|0
309739|NCT01490060|1047711|P1|Cycle 1|Treatment at Another Facility|0
309740|NCT01490060|1047708|P4|Cycle 1|Withdrawal by Subject|1
309741|NCT01490060|1047709|P3|Cycle 1|Withdrawal by Subject|0
309742|NCT01490060|1047710|P2|Cycle 1|Withdrawal by Subject|0
309743|NCT01490060|1047711|P1|Cycle 1|Withdrawal by Subject|0
309744|NCT01490060|1047708|P4|Cycle 1|Insurance Denied|0
309745|NCT01490060|1047709|P3|Cycle 1|Insurance Denied|2
309746|NCT01490060|1047710|P2|Cycle 1|Insurance Denied|0
309747|NCT01490060|1047711|P1|Cycle 1|Insurance Denied|0
309748|NCT01490060|1047708|P4|Cycle 1|Change of Treatment|1
309749|NCT01490060|1047709|P3|Cycle 1|Change of Treatment|1
309750|NCT01490060|1047710|P2|Cycle 1|Change of Treatment|1
309751|NCT01490060|1047711|P1|Cycle 1|Change of Treatment|0
309752|NCT01489956|1047740|P3|Overall Study|Withdrawal by Subject|1
309753|NCT01489956|1047741|P2|Overall Study|Withdrawal by Subject|0
309754|NCT01489956|1047742|P1|Overall Study|Withdrawal by Subject|0
309755|NCT01489956|1047740|P3|Overall Study|Lost to Follow-up|0
309756|NCT01489956|1047741|P2|Overall Study|Lost to Follow-up|0
309757|NCT01489956|1047742|P1|Overall Study|Lost to Follow-up|1
309758|NCT01489891|1047779|P2|Overall Study|Endoscopy failure|0
309759|NCT01489891|1047780|P1|Overall Study|Endoscopy failure|1
309760|NCT01489527|1047918|P2|Overall Study|Not compliant|0
309761|NCT01489527|1047919|P1|Overall Study|Not compliant|1
309762|NCT01489527|1047918|P2|Overall Study|Procedures|0
309763|NCT01489527|1047919|P1|Overall Study|Procedures|1
309764|NCT01489527|1047918|P2|Overall Study|Lost to Follow-up|1
309765|NCT01489527|1047919|P1|Overall Study|Lost to Follow-up|5
309766|NCT01489527|1047918|P2|Overall Study|Withdrawal by Subject|4
309767|NCT01489527|1047919|P1|Overall Study|Withdrawal by Subject|0
309768|NCT01489527|1047918|P2|Overall Study|Participant moved|7
309769|NCT01489527|1047919|P1|Overall Study|Participant moved|6
309770|NCT01489527|1047918|P2|Overall Study|Pregnancy|14
309771|NCT01489527|1047919|P1|Overall Study|Pregnancy|9
309772|NCT01489358|1047936|P3|Overall Study|Lost to Follow-up|2
309773|NCT01489358|1047937|P2|Overall Study|Lost to Follow-up|0
309774|NCT01489358|1047938|P1|Overall Study|Lost to Follow-up|0
309775|NCT01489254|1047988|P4|Open-label Extension Part|Other reasons for not completing study|5
309776|NCT01489254|1047989|P3|Open-label Extension Part|Other reasons for not completing study|0
309777|NCT01489254|1047990|P2|Open-label Extension Part|Other reasons for not completing study|0
309778|NCT01489254|1047991|P1|Open-label Extension Part|Other reasons for not completing study|0
309779|NCT01489254|1047988|P4|Open-label Extension Part|Lost to Follow-up|9
309780|NCT01489254|1047989|P3|Open-label Extension Part|Lost to Follow-up|0
309781|NCT01489254|1047990|P2|Open-label Extension Part|Lost to Follow-up|0
309782|NCT01489254|1047991|P1|Open-label Extension Part|Lost to Follow-up|0
309783|NCT01489254|1047988|P4|Open-label Extension Part|Protocol Violation|1
309784|NCT01489254|1047989|P3|Open-label Extension Part|Protocol Violation|0
309785|NCT01489254|1047990|P2|Open-label Extension Part|Protocol Violation|0
309786|NCT01489254|1047991|P1|Open-label Extension Part|Protocol Violation|0
309787|NCT01489254|1047988|P4|Open-label Extension Part|Withdrawal by Subject|30
309788|NCT01489254|1047989|P3|Open-label Extension Part|Withdrawal by Subject|0
309789|NCT01489254|1047990|P2|Open-label Extension Part|Withdrawal by Subject|0
309790|NCT01489254|1047991|P1|Open-label Extension Part|Withdrawal by Subject|0
309791|NCT01489254|1047988|P4|Open-label Extension Part|Pregnancy|3
309792|NCT01489254|1047989|P3|Open-label Extension Part|Pregnancy|0
309793|NCT01489254|1047990|P2|Open-label Extension Part|Pregnancy|0
309794|NCT01489254|1047991|P1|Open-label Extension Part|Pregnancy|0
309795|NCT01489254|1047988|P4|Open-label Extension Part|Adverse Event|10
309796|NCT01489254|1047989|P3|Open-label Extension Part|Adverse Event|0
309797|NCT01489254|1047990|P2|Open-label Extension Part|Adverse Event|0
309798|NCT01489254|1047991|P1|Open-label Extension Part|Adverse Event|0
309799|NCT01489254|1047988|P4|Double-blind Part|Other reasons for not completing study|0
309800|NCT01489254|1047989|P3|Double-blind Part|Other reasons for not completing study|0
309801|NCT01489254|1047990|P2|Double-blind Part|Other reasons for not completing study|6
309802|NCT01489254|1047991|P1|Double-blind Part|Other reasons for not completing study|4
309803|NCT01489254|1047988|P4|Double-blind Part|Lost to Follow-up|0
309804|NCT01489254|1047989|P3|Double-blind Part|Lost to Follow-up|0
309805|NCT01489254|1047990|P2|Double-blind Part|Lost to Follow-up|2
309806|NCT01489254|1047991|P1|Double-blind Part|Lost to Follow-up|1
309807|NCT01489254|1047988|P4|Double-blind Part|Withdrawal by Subject|0
309808|NCT01489254|1047989|P3|Double-blind Part|Withdrawal by Subject|1
309809|NCT01489254|1047990|P2|Double-blind Part|Withdrawal by Subject|20
309810|NCT01489254|1047991|P1|Double-blind Part|Withdrawal by Subject|12
309811|NCT01489254|1047988|P4|Double-blind Part|Pregnancy|0
309812|NCT01489254|1047989|P3|Double-blind Part|Pregnancy|0
309813|NCT01489254|1047990|P2|Double-blind Part|Pregnancy|3
309814|NCT01489254|1047991|P1|Double-blind Part|Pregnancy|1
309815|NCT01489254|1047988|P4|Double-blind Part|Adverse Event|0
309816|NCT01489254|1047989|P3|Double-blind Part|Adverse Event|2
309817|NCT01489254|1047990|P2|Double-blind Part|Adverse Event|2
309818|NCT01489254|1047991|P1|Double-blind Part|Adverse Event|7
309819|NCT01489189|1048002|P2|Overall Study|Missed Visit|4
309820|NCT01489189|1048003|P1|Overall Study|Missed Visit|1
309821|NCT01489189|1048002|P2|Overall Study|Death|8
309822|NCT01489189|1048003|P1|Overall Study|Death|10
309823|NCT01489189|1048002|P2|Overall Study|Withdrawal by Subject|23
309824|NCT01489189|1048003|P1|Overall Study|Withdrawal by Subject|20
309825|NCT01488994|1048030|P2|Overall Study|Withdrawal by Subject|1
309826|NCT01488994|1048031|P1|Overall Study|Withdrawal by Subject|0
309827|NCT01488578|1048158|P1|Overall Study|Protocol Violation|1836
309828|NCT01488487|1048192|P1|Overall Study|Withdrawal by Subject|2
309829|NCT01488487|1048192|P1|Overall Study|Death|1
309830|NCT01488487|1048192|P1|Overall Study|Adverse Event|6
309831|NCT01488448|1048201|P2|Overall Study|Protocol Violation|3
309832|NCT01488448|1048202|P1|Overall Study|Protocol Violation|4
309833|NCT01488448|1048201|P2|Overall Study|Physician Decision|9
309834|NCT01488448|1048202|P1|Overall Study|Physician Decision|4
309835|NCT01488448|1048201|P2|Overall Study|Adverse Event|4
309836|NCT01488448|1048202|P1|Overall Study|Adverse Event|9
309837|NCT01488448|1048201|P2|Overall Study|Withdrawal by Subject|1
309838|NCT01488448|1048202|P1|Overall Study|Withdrawal by Subject|3
309839|NCT01488370|1048244|P3|Overall Study|Protocol Violation|1
309840|NCT01488370|1048245|P2|Overall Study|Protocol Violation|1
309841|NCT01488370|1048246|P1|Overall Study|Protocol Violation|0
309842|NCT01488071|1048317|P2|Overall Study|Administrative or Other Reason(s)|4
309843|NCT01488071|1048318|P1|Overall Study|Administrative or Other Reason(s)|5
309844|NCT01488071|1048317|P2|Overall Study|Lost to Follow-up|0
309845|NCT01488071|1048318|P1|Overall Study|Lost to Follow-up|1
309846|NCT01488071|1048317|P2|Overall Study|Withdrawal of Consent|12
309847|NCT01488071|1048318|P1|Overall Study|Withdrawal of Consent|14
309848|NCT01488071|1048317|P2|Overall Study|Protocol Violation|7
309849|NCT01488071|1048318|P1|Overall Study|Protocol Violation|5
309850|NCT01488071|1048317|P2|Overall Study|Non-compliance with study drug|0
309851|NCT01488071|1048318|P1|Overall Study|Non-compliance with study drug|2
309852|NCT01488071|1048317|P2|Overall Study|Lack of Efficacy|17
309853|NCT01488071|1048318|P1|Overall Study|Lack of Efficacy|11
309854|NCT01488071|1048317|P2|Overall Study|Adverse Event|23
309855|NCT01488071|1048318|P1|Overall Study|Adverse Event|15
309856|NCT01487863|1048398|P2|Overall Study|Death|19
309857|NCT01487863|1048399|P1|Overall Study|Death|19
309858|NCT01487577|1048416|P1|Overall Study|Became ineligible after signing consent|1
309859|NCT01487525|1048430|P2|Overall Study|Withdrawal by Subject|1
309860|NCT01487525|1048431|P1|Overall Study|Withdrawal by Subject|0
309861|NCT01487265|1048447|P1|Overall Study|Still on Treatment|1
309862|NCT01487265|1048447|P1|Overall Study|Death|2
309863|NCT01487265|1048447|P1|Overall Study|Disease Progression|21
309864|NCT01487265|1048447|P1|Overall Study|Withdrawal by Subject|5
309865|NCT01487265|1048447|P1|Overall Study|Adverse Event|8
309866|NCT01487161|1048459|P4|Overall Study|missing data|0
309867|NCT01487161|1048460|P3|Overall Study|missing data|0
309868|NCT01487161|1048461|P2|Overall Study|missing data|1
309869|NCT01487161|1048462|P1|Overall Study|missing data|0
309870|NCT01487161|1048459|P4|Overall Study|Withdrawal by Subject|2
309871|NCT01487161|1048460|P3|Overall Study|Withdrawal by Subject|1
309872|NCT01487161|1048461|P2|Overall Study|Withdrawal by Subject|1
309873|NCT01487161|1048462|P1|Overall Study|Withdrawal by Subject|1
309874|NCT01487161|1048459|P4|Overall Study|Adverse Event|0
309875|NCT01487161|1048460|P3|Overall Study|Adverse Event|0
309876|NCT01487161|1048461|P2|Overall Study|Adverse Event|0
309877|NCT01487161|1048462|P1|Overall Study|Adverse Event|1
309878|NCT01486966|1048527|P2|Overall Study|Withdrawal by Subject|1
309879|NCT01486966|1048528|P1|Overall Study|Withdrawal by Subject|0
309880|NCT01486966|1048527|P2|Overall Study|Adverse Event|1
309881|NCT01486966|1048528|P1|Overall Study|Adverse Event|0
309882|NCT01486927|1048552|P1|Overall Study|Subject did not reach 6 mo of treatment|1
309883|NCT01486927|1048552|P1|Overall Study|Withdrawal by Subject|8
309884|NCT01486927|1048552|P1|Overall Study|50 Exposure days not reached|2
309885|NCT01486927|1048552|P1|Overall Study|Physician Decision|1
309886|NCT01486927|1048552|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
309887|NCT01486758|1048585|P2|Overall Study|Lost to Follow-up|1
309888|NCT01486758|1048586|P1|Overall Study|Lost to Follow-up|0
309889|NCT01486446|1048653|P2|Overall Study|Adverse Event|0
309890|NCT01486446|1048654|P1|Overall Study|Adverse Event|1
309891|NCT01486238|1048676|P2|Overall Study|Lost to Follow-up|3
309892|NCT01486238|1048677|P1|Overall Study|Lost to Follow-up|0
309893|NCT01486238|1048676|P2|Overall Study|Withdrawal by Subject|1
309894|NCT01486238|1048677|P1|Overall Study|Withdrawal by Subject|2
309895|NCT01486238|1048676|P2|Overall Study|Death|2
309896|NCT01486238|1048677|P1|Overall Study|Death|0
309897|NCT01486199|1048685|P2|Two Year Period Between Study Days|Physician Decision|0
309898|NCT01486199|1048686|P1|Two Year Period Between Study Days|Physician Decision|1
309899|NCT01485991|1048706|P2|Overall Study|randomized but not treated|2
309900|NCT01485991|1048707|P1|Overall Study|randomized but not treated|6
309901|NCT01485991|1048706|P2|Overall Study|Withdrawal by Subject|20
309902|NCT01485991|1048707|P1|Overall Study|Withdrawal by Subject|13
309903|NCT01485991|1048706|P2|Overall Study|Lost to Follow-up|10
309904|NCT01485991|1048707|P1|Overall Study|Lost to Follow-up|13
309905|NCT01485991|1048706|P2|Overall Study|Adverse Event|4
309906|NCT01485991|1048707|P1|Overall Study|Adverse Event|0
309907|NCT01485887|1048717|P1|Overall Study|Primary disease markedly improved|1
309908|NCT01485887|1048717|P1|Overall Study|Deterioration of primary disease|1
309909|NCT01485887|1048717|P1|Overall Study|Adverse Event|8
309910|NCT01485887|1048717|P1|Overall Study|Withdrawal by Subject|2
309911|NCT01485796|1048729|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
309912|NCT01485796|1048729|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
309913|NCT01485796|1048729|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
309914|NCT01485796|1048729|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
309915|NCT01485796|1048729|P1|Period 2: Epoch 2|Switch to safety follow-up|26
309916|NCT01485796|1048729|P1|Period 2: Epoch 2|Adverse Event|3
309917|NCT01485796|1048729|P1|Period 2: Epoch 2|Withdrawal by Subject|6
309918|NCT01485796|1048729|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
309919|NCT01485640|1048751|P1|Overall Study|Terminated by Sponsor|95
309920|NCT01485640|1048751|P1|Overall Study|Withdrawal by Subject|14
309921|NCT01485640|1048751|P1|Overall Study|Protocol Violation|1
309922|NCT01485640|1048751|P1|Overall Study|Lack of Efficacy|2
309923|NCT01485640|1048751|P1|Overall Study|Adverse Event|10
309924|NCT01485536|1048756|P1|Overall Study|Adverse Event|1
309925|NCT01485536|1048756|P1|Overall Study|Withdrawal by Subject|3
309926|NCT01485354|1048765|P1|Overall Study|Withdrawal by Subject|5
309927|NCT01485172|1048779|P6|Overall Study|Withdrawal by Subject|1
309928|NCT01485172|1048780|P5|Overall Study|Withdrawal by Subject|1
309929|NCT01485172|1048781|P4|Overall Study|Withdrawal by Subject|1
309930|NCT01485172|1048782|P3|Overall Study|Withdrawal by Subject|0
309931|NCT01485172|1048783|P2|Overall Study|Withdrawal by Subject|0
309932|NCT01485172|1048784|P1|Overall Study|Withdrawal by Subject|2
309933|NCT01485172|1048779|P6|Overall Study|Physician Decision|0
309934|NCT01485172|1048780|P5|Overall Study|Physician Decision|1
309935|NCT01485172|1048781|P4|Overall Study|Physician Decision|0
309936|NCT01485172|1048782|P3|Overall Study|Physician Decision|0
309937|NCT01485172|1048783|P2|Overall Study|Physician Decision|0
309938|NCT01485172|1048784|P1|Overall Study|Physician Decision|0
309939|NCT01485172|1048779|P6|Overall Study|Lost to Follow-up|1
309940|NCT01485172|1048780|P5|Overall Study|Lost to Follow-up|0
309941|NCT01485172|1048781|P4|Overall Study|Lost to Follow-up|0
309942|NCT01485172|1048782|P3|Overall Study|Lost to Follow-up|1
309943|NCT01485172|1048783|P2|Overall Study|Lost to Follow-up|0
309944|NCT01485172|1048784|P1|Overall Study|Lost to Follow-up|0
309945|NCT01485172|1048779|P6|Overall Study|Protocol defined stopping criteria|0
309946|NCT01485172|1048780|P5|Overall Study|Protocol defined stopping criteria|1
309947|NCT01485172|1048781|P4|Overall Study|Protocol defined stopping criteria|0
309948|NCT01485172|1048782|P3|Overall Study|Protocol defined stopping criteria|0
309949|NCT01485172|1048783|P2|Overall Study|Protocol defined stopping criteria|0
309950|NCT01485172|1048784|P1|Overall Study|Protocol defined stopping criteria|1
309951|NCT01485172|1048779|P6|Overall Study|Protocol Violation|0
309952|NCT01485172|1048780|P5|Overall Study|Protocol Violation|1
309953|NCT01485172|1048781|P4|Overall Study|Protocol Violation|5
309954|NCT01485172|1048782|P3|Overall Study|Protocol Violation|4
309955|NCT01485172|1048783|P2|Overall Study|Protocol Violation|0
309956|NCT01485172|1048784|P1|Overall Study|Protocol Violation|0
309957|NCT01485172|1048779|P6|Overall Study|Lack of Efficacy|0
309958|NCT01485172|1048780|P5|Overall Study|Lack of Efficacy|0
309959|NCT01485172|1048781|P4|Overall Study|Lack of Efficacy|0
309960|NCT01485172|1048782|P3|Overall Study|Lack of Efficacy|0
309961|NCT01485172|1048783|P2|Overall Study|Lack of Efficacy|0
309962|NCT01485172|1048784|P1|Overall Study|Lack of Efficacy|2
309963|NCT01485172|1048779|P6|Overall Study|Adverse Event|2
309964|NCT01485172|1048780|P5|Overall Study|Adverse Event|1
309965|NCT01485172|1048781|P4|Overall Study|Adverse Event|2
309966|NCT01485172|1048782|P3|Overall Study|Adverse Event|2
309967|NCT01485172|1048783|P2|Overall Study|Adverse Event|1
309968|NCT01485172|1048784|P1|Overall Study|Adverse Event|2
309969|NCT01485094|1048861|P3|Overall Study|Withdrawal by Subject|0
309970|NCT01485094|1048862|P2|Overall Study|Withdrawal by Subject|1
309971|NCT01485094|1048863|P1|Overall Study|Withdrawal by Subject|1
309972|NCT01485094|1048861|P3|Overall Study|Lost to Follow-up|0
309973|NCT01485094|1048862|P2|Overall Study|Lost to Follow-up|0
309974|NCT01485094|1048863|P1|Overall Study|Lost to Follow-up|1
309975|NCT01485094|1048861|P3|Overall Study|Adverse Event|1
309976|NCT01485094|1048862|P2|Overall Study|Adverse Event|1
309977|NCT01485094|1048863|P1|Overall Study|Adverse Event|1
309978|NCT01484977|1048904|P1|Overall Study|Lack of Compliance|1
309979|NCT01484977|1048904|P1|Overall Study|Low White Blood Cell Count|1
309980|NCT01484977|1048904|P1|Overall Study|Moving Overseas|1
309981|NCT01484977|1048904|P1|Overall Study|Subject Protocol Non-compliant|1
309982|NCT01484977|1048904|P1|Overall Study|Withdrawal by Subject|4
309983|NCT01484977|1048904|P1|Overall Study|Lost to Follow-up|1
309984|NCT01484977|1048904|P1|Overall Study|Protocol Violation|6
309985|NCT01484977|1048904|P1|Overall Study|Lack of Efficacy|4
309986|NCT01484977|1048904|P1|Overall Study|Adverse Event|8
309987|NCT01484951|1048908|P1|Overall Study|Non-Compliance|1
309988|NCT01484951|1048908|P1|Overall Study|Personal Reasons|1
309989|NCT01484951|1048908|P1|Overall Study|Adverse Event|3
309990|NCT01484938|1048913|P1|Overall Study|Noncompliance|1
309991|NCT01484938|1048913|P1|Overall Study|Lost to Follow-up|1
309992|NCT01484938|1048913|P1|Overall Study|Adverse Event|2
309993|NCT01484912|1048920|P2|Overall Study|Physician Decision|1
309994|NCT01484912|1048921|P1|Overall Study|Physician Decision|0
309995|NCT01484912|1048920|P2|Overall Study|Withdrawal by Subject|0
309996|NCT01484912|1048921|P1|Overall Study|Withdrawal by Subject|1
309997|NCT01484873|1048931|P1|Overall Study|Withdrawal by Subject|2
309998|NCT01484834|1048943|P4|Overall Study|Lost to Follow-up|4
309999|NCT01484834|1048944|P3|Overall Study|Lost to Follow-up|1
310000|NCT01484834|1048945|P2|Overall Study|Lost to Follow-up|8
310001|NCT01484834|1048946|P1|Overall Study|Lost to Follow-up|5
310002|NCT01484561|1048983|P2|Overall Study|Adverse Event|4
310003|NCT01484561|1048984|P1|Overall Study|Adverse Event|1
310004|NCT01484561|1048983|P2|Overall Study|Not specified|1
310005|NCT01484561|1048984|P1|Overall Study|Not specified|1
310006|NCT01484561|1048983|P2|Overall Study|Withdrawal by Subject|0
310007|NCT01484561|1048984|P1|Overall Study|Withdrawal by Subject|3
310008|NCT01484561|1048983|P2|Overall Study|Lost to Follow-up|0
310009|NCT01484561|1048984|P1|Overall Study|Lost to Follow-up|1
310010|NCT01484561|1048983|P2|Overall Study|Lack of Efficacy|1
310011|NCT01484561|1048984|P1|Overall Study|Lack of Efficacy|3
310012|NCT01484496|1049074|P4|Period 2|Other|6
310013|NCT01484496|1049075|P3|Period 2|Other|9
310014|NCT01484496|1049076|P2|Period 2|Other|0
310015|NCT01484496|1049077|P1|Period 2|Other|0
310016|NCT01484496|1049074|P4|Period 2|Adverse Event|13
310017|NCT01484496|1049075|P3|Period 2|Adverse Event|5
310018|NCT01484496|1049076|P2|Period 2|Adverse Event|0
310019|NCT01484496|1049077|P1|Period 2|Adverse Event|0
310020|NCT01484496|1049074|P4|Period 2|Lack of Efficacy|3
310021|NCT01484496|1049075|P3|Period 2|Lack of Efficacy|1
310022|NCT01484496|1049076|P2|Period 2|Lack of Efficacy|0
310023|NCT01484496|1049077|P1|Period 2|Lack of Efficacy|0
310024|NCT01484496|1049074|P4|Period 1|Unable to Visit Site|0
310025|NCT01484496|1049075|P3|Period 1|Unable to Visit Site|0
310026|NCT01484496|1049076|P2|Period 1|Unable to Visit Site|2
310027|NCT01484496|1049077|P1|Period 1|Unable to Visit Site|0
310028|NCT01484496|1049074|P4|Period 1|Lack of Compliance|0
310029|NCT01484496|1049075|P3|Period 1|Lack of Compliance|0
310030|NCT01484496|1049076|P2|Period 1|Lack of Compliance|1
310031|NCT01484496|1049077|P1|Period 1|Lack of Compliance|2
310032|NCT01484496|1049074|P4|Period 1|Treatment Failure|0
310033|NCT01484496|1049075|P3|Period 1|Treatment Failure|0
310034|NCT01484496|1049076|P2|Period 1|Treatment Failure|6
310035|NCT01484496|1049077|P1|Period 1|Treatment Failure|3
310036|NCT01484496|1049074|P4|Period 1|Positive Pregnancy|0
310037|NCT01484496|1049075|P3|Period 1|Positive Pregnancy|0
310038|NCT01484496|1049076|P2|Period 1|Positive Pregnancy|6
310039|NCT01484496|1049077|P1|Period 1|Positive Pregnancy|1
310040|NCT01484496|1049074|P4|Period 1|Lost to Follow-up|0
310041|NCT01484496|1049075|P3|Period 1|Lost to Follow-up|0
310042|NCT01484496|1049076|P2|Period 1|Lost to Follow-up|6
310043|NCT01484496|1049077|P1|Period 1|Lost to Follow-up|2
310044|NCT01484496|1049074|P4|Period 1|Withdrawal by Subject|0
310045|NCT01484496|1049075|P3|Period 1|Withdrawal by Subject|0
310046|NCT01484496|1049076|P2|Period 1|Withdrawal by Subject|12
310047|NCT01484496|1049077|P1|Period 1|Withdrawal by Subject|15
310048|NCT01484496|1049074|P4|Period 1|Adverse Event|0
310049|NCT01484496|1049075|P3|Period 1|Adverse Event|0
310050|NCT01484496|1049076|P2|Period 1|Adverse Event|40
310051|NCT01484496|1049077|P1|Period 1|Adverse Event|25
310052|NCT01484496|1049074|P4|Period 1|Lack of Efficacy|0
310053|NCT01484496|1049075|P3|Period 1|Lack of Efficacy|0
310054|NCT01484496|1049076|P2|Period 1|Lack of Efficacy|15
310055|NCT01484496|1049077|P1|Period 1|Lack of Efficacy|10
310056|NCT01484496|1049074|P4|Period 1|Physician Decision|0
310057|NCT01484496|1049075|P3|Period 1|Physician Decision|0
310058|NCT01484496|1049076|P2|Period 1|Physician Decision|1
310059|NCT01484496|1049077|P1|Period 1|Physician Decision|5
310060|NCT01484496|1049074|P4|Period 1|Protocol Violation|0
310061|NCT01484496|1049075|P3|Period 1|Protocol Violation|0
310062|NCT01484496|1049076|P2|Period 1|Protocol Violation|4
310063|NCT01484496|1049077|P1|Period 1|Protocol Violation|3
310064|NCT01484197|1049095|P4|Treatment Period 2|Subject withdrew consent|1
310065|NCT01484197|1049096|P3|Treatment Period 2|Subject withdrew consent|0
310066|NCT01484197|1049097|P2|Treatment Period 2|Subject withdrew consent|0
310067|NCT01484197|1049098|P1|Treatment Period 2|Subject withdrew consent|0
310068|NCT01484197|1049095|P4|Treatment Period 1|Adverse Event|0
310069|NCT01484197|1049096|P3|Treatment Period 1|Adverse Event|0
310070|NCT01484197|1049097|P2|Treatment Period 1|Adverse Event|0
310071|NCT01484197|1049098|P1|Treatment Period 1|Adverse Event|1
310072|NCT01484132|1049181|P1|Overall Study|No post-treatment urine sample collected|10
310073|NCT01484132|1049181|P1|Overall Study|No pre-treatment urine sample collected|1
310074|NCT01484132|1049181|P1|Overall Study|Ineligible|1
310075|NCT01484132|1049181|P1|Overall Study|Difficulty with time commitment|2
310076|NCT01484132|1049181|P1|Overall Study|Lost to Follow-up|8
310077|NCT01484054|1049189|P2|Period 1|Withdrawal by Subject|1
310078|NCT01484054|1049190|P1|Period 1|Withdrawal by Subject|0
310079|NCT01484028|1049208|P4|Period 1|Lens Discomfort|0
310080|NCT01484028|1049209|P3|Period 1|Lens Discomfort|0
310081|NCT01484028|1049210|P2|Period 1|Lens Discomfort|1
310082|NCT01484028|1049211|P1|Period 1|Lens Discomfort|0
310083|NCT01484028|1049208|P4|Period 1|Non-Compliance to Protocol|1
310084|NCT01484028|1049209|P3|Period 1|Non-Compliance to Protocol|0
310085|NCT01484028|1049210|P2|Period 1|Non-Compliance to Protocol|1
310086|NCT01484028|1049211|P1|Period 1|Non-Compliance to Protocol|0
310087|NCT01484028|1049208|P4|Period 1|Lost to Follow-up|0
310088|NCT01484028|1049209|P3|Period 1|Lost to Follow-up|0
310089|NCT01484028|1049210|P2|Period 1|Lost to Follow-up|1
310090|NCT01484028|1049211|P1|Period 1|Lost to Follow-up|0
310091|NCT01483937|1049304|P2|Overall Study|Withdrawal by Subject|3
310092|NCT01483937|1049305|P1|Overall Study|Withdrawal by Subject|4
310093|NCT01483924|1049332|P5|Overall Study|Sponsor concern over ECG result|0
310094|NCT01483924|1049333|P4|Overall Study|Sponsor concern over ECG result|1
310095|NCT01483924|1049334|P3|Overall Study|Sponsor concern over ECG result|0
310096|NCT01483924|1049335|P2|Overall Study|Sponsor concern over ECG result|0
310097|NCT01483924|1049336|P1|Overall Study|Sponsor concern over ECG result|0
310098|NCT01483924|1049332|P5|Overall Study|Non-compliance|1
310099|NCT01483924|1049333|P4|Overall Study|Non-compliance|1
310100|NCT01483924|1049334|P3|Overall Study|Non-compliance|0
310101|NCT01483924|1049335|P2|Overall Study|Non-compliance|0
310102|NCT01483924|1049336|P1|Overall Study|Non-compliance|0
310103|NCT01483924|1049332|P5|Overall Study|Adverse Event|0
310104|NCT01483924|1049333|P4|Overall Study|Adverse Event|1
310105|NCT01483924|1049334|P3|Overall Study|Adverse Event|1
310106|NCT01483924|1049335|P2|Overall Study|Adverse Event|0
310107|NCT01483924|1049336|P1|Overall Study|Adverse Event|0
310108|NCT01483924|1049332|P5|Overall Study|Withdrawal by Subject|1
310109|NCT01483924|1049333|P4|Overall Study|Withdrawal by Subject|1
310110|NCT01483924|1049334|P3|Overall Study|Withdrawal by Subject|0
310111|NCT01483924|1049335|P2|Overall Study|Withdrawal by Subject|0
310112|NCT01483924|1049336|P1|Overall Study|Withdrawal by Subject|2
310113|NCT01483820|1049384|P1|Overall Study|Death|1
310114|NCT01483820|1049384|P1|Overall Study|Adverse Event|1
310115|NCT01483820|1049384|P1|Overall Study|Lack of Efficacy|6
310116|NCT01483651|1049393|P6|Overall Study|Withdrawal by Subject|1
310117|NCT01483651|1049394|P5|Overall Study|Withdrawal by Subject|0
310118|NCT01483651|1049395|P4|Overall Study|Withdrawal by Subject|0
310119|NCT01483651|1049396|P3|Overall Study|Withdrawal by Subject|1
310120|NCT01483651|1049397|P2|Overall Study|Withdrawal by Subject|1
310121|NCT01483651|1049398|P1|Overall Study|Withdrawal by Subject|0
310122|NCT01483625|1049408|P2|Overall Study|Due to other reason|0
310123|NCT01483625|1049409|P1|Overall Study|Due to other reason|1
310124|NCT01483625|1049408|P2|Overall Study|Refused to continue medication|1
310125|NCT01483625|1049409|P1|Overall Study|Refused to continue medication|2
310126|NCT01483625|1049408|P2|Overall Study|Adverse Event|1
310127|NCT01483625|1049409|P1|Overall Study|Adverse Event|1
310128|NCT01483599|1049432|P14|After Controlled Period(Week 16-Week 40)|Other|0
310129|NCT01483599|1049433|P13|After Controlled Period(Week 16-Week 40)|Other|1
310130|NCT01483599|1049434|P12|After Controlled Period(Week 16-Week 40)|Other|0
310131|NCT01483599|1049435|P11|After Controlled Period(Week 16-Week 40)|Other|0
310132|NCT01483599|1049436|P10|After Controlled Period(Week 16-Week 40)|Other|4
310133|NCT01483599|1049437|P9|After Controlled Period(Week 16-Week 40)|Other|0
310134|NCT01483599|1049438|P8|After Controlled Period(Week 16-Week 40)|Other|1
310135|NCT01483599|1049439|P7|After Controlled Period(Week 16-Week 40)|Other|0
310136|NCT01483599|1049440|P6|After Controlled Period(Week 16-Week 40)|Other|0
310137|NCT01483599|1049441|P5|After Controlled Period(Week 16-Week 40)|Other|0
310138|NCT01483599|1049442|P4|After Controlled Period(Week 16-Week 40)|Other|0
310139|NCT01483599|1049443|P3|After Controlled Period(Week 16-Week 40)|Other|0
310140|NCT01483599|1049444|P2|After Controlled Period(Week 16-Week 40)|Other|0
310141|NCT01483599|1049445|P1|After Controlled Period(Week 16-Week 40)|Other|0
310142|NCT01483599|1049432|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
310143|NCT01483599|1049433|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
310144|NCT01483599|1049434|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310145|NCT01483599|1049435|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310146|NCT01483599|1049436|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310147|NCT01483599|1049437|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
310148|NCT01483599|1049438|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310149|NCT01483599|1049439|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310150|NCT01483599|1049440|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310151|NCT01483599|1049441|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310152|NCT01483599|1049442|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310153|NCT01483599|1049443|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310154|NCT01483599|1049444|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310155|NCT01483599|1049445|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
310156|NCT01483599|1049432|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
310157|NCT01483599|1049433|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310158|NCT01483599|1049434|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310159|NCT01483599|1049435|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
310160|NCT01483599|1049436|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310161|NCT01483599|1049437|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
310162|NCT01483599|1049438|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310163|NCT01483599|1049439|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310164|NCT01483599|1049440|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310165|NCT01483599|1049441|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310166|NCT01483599|1049442|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310167|NCT01483599|1049443|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310168|NCT01483599|1049444|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310169|NCT01483599|1049445|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
310170|NCT01483599|1049432|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
310171|NCT01483599|1049433|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310172|NCT01483599|1049434|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
310173|NCT01483599|1049435|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310174|NCT01483599|1049436|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310175|NCT01483599|1049437|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
310176|NCT01483599|1049438|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310177|NCT01483599|1049439|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310178|NCT01483599|1049440|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310179|NCT01483599|1049441|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310180|NCT01483599|1049442|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310181|NCT01483599|1049443|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310182|NCT01483599|1049444|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310183|NCT01483599|1049445|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
310184|NCT01483599|1049432|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
310185|NCT01483599|1049433|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
310186|NCT01483599|1049434|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310187|NCT01483599|1049435|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310188|NCT01483599|1049436|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310189|NCT01483599|1049437|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
310190|NCT01483599|1049438|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
310191|NCT01483599|1049439|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310192|NCT01483599|1049440|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310193|NCT01483599|1049441|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310194|NCT01483599|1049442|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310195|NCT01483599|1049443|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310196|NCT01483599|1049444|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310197|NCT01483599|1049445|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
310198|NCT01483599|1049432|P14|After Controlled Period(Week 16-Week 40)|Death|0
310199|NCT01483599|1049433|P13|After Controlled Period(Week 16-Week 40)|Death|0
310200|NCT01483599|1049434|P12|After Controlled Period(Week 16-Week 40)|Death|0
310201|NCT01483599|1049435|P11|After Controlled Period(Week 16-Week 40)|Death|0
310202|NCT01483599|1049436|P10|After Controlled Period(Week 16-Week 40)|Death|0
310203|NCT01483599|1049437|P9|After Controlled Period(Week 16-Week 40)|Death|1
310204|NCT01483599|1049438|P8|After Controlled Period(Week 16-Week 40)|Death|0
310205|NCT01483599|1049439|P7|After Controlled Period(Week 16-Week 40)|Death|0
310206|NCT01483599|1049440|P6|After Controlled Period(Week 16-Week 40)|Death|0
310207|NCT01483599|1049441|P5|After Controlled Period(Week 16-Week 40)|Death|0
310208|NCT01483599|1049442|P4|After Controlled Period(Week 16-Week 40)|Death|0
310209|NCT01483599|1049443|P3|After Controlled Period(Week 16-Week 40)|Death|0
310210|NCT01483599|1049444|P2|After Controlled Period(Week 16-Week 40)|Death|0
310211|NCT01483599|1049445|P1|After Controlled Period(Week 16-Week 40)|Death|0
310212|NCT01483599|1049432|P14|Controlled Period (CP) (up to Week 16)|Other|0
310213|NCT01483599|1049433|P13|Controlled Period (CP) (up to Week 16)|Other|0
310214|NCT01483599|1049434|P12|Controlled Period (CP) (up to Week 16)|Other|0
310215|NCT01483599|1049435|P11|Controlled Period (CP) (up to Week 16)|Other|0
310216|NCT01483599|1049436|P10|Controlled Period (CP) (up to Week 16)|Other|0
310217|NCT01483599|1049437|P9|Controlled Period (CP) (up to Week 16)|Other|0
310218|NCT01483599|1049438|P8|Controlled Period (CP) (up to Week 16)|Other|0
310219|NCT01483599|1049439|P7|Controlled Period (CP) (up to Week 16)|Other|0
310220|NCT01483599|1049440|P6|Controlled Period (CP) (up to Week 16)|Other|0
310221|NCT01483599|1049441|P5|Controlled Period (CP) (up to Week 16)|Other|1
310222|NCT01483599|1049442|P4|Controlled Period (CP) (up to Week 16)|Other|1
310223|NCT01483599|1049443|P3|Controlled Period (CP) (up to Week 16)|Other|0
310224|NCT01483599|1049444|P2|Controlled Period (CP) (up to Week 16)|Other|2
310225|NCT01483599|1049445|P1|Controlled Period (CP) (up to Week 16)|Other|0
310226|NCT01483599|1049432|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310227|NCT01483599|1049433|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310228|NCT01483599|1049434|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310229|NCT01483599|1049435|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310230|NCT01483599|1049436|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310231|NCT01483599|1049437|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310232|NCT01483599|1049438|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310233|NCT01483599|1049439|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310234|NCT01483599|1049440|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310235|NCT01483599|1049441|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310236|NCT01483599|1049442|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310237|NCT01483599|1049443|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310238|NCT01483599|1049444|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
310239|NCT01483599|1049445|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
310240|NCT01483599|1049432|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310241|NCT01483599|1049433|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310242|NCT01483599|1049434|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310243|NCT01483599|1049435|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310244|NCT01483599|1049436|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310245|NCT01483599|1049437|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310246|NCT01483599|1049438|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310247|NCT01483599|1049439|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
310248|NCT01483599|1049440|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310249|NCT01483599|1049441|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310250|NCT01483599|1049442|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
310251|NCT01483599|1049443|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310252|NCT01483599|1049444|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
310253|NCT01483599|1049445|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
310254|NCT01483599|1049432|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310255|NCT01483599|1049433|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310256|NCT01483599|1049434|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310257|NCT01483599|1049435|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310346|NCT01482221|1049739|P3|Overall Study|Incorrect randomization|0
310258|NCT01483599|1049436|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310259|NCT01483599|1049437|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310260|NCT01483599|1049438|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310261|NCT01483599|1049439|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
310262|NCT01483599|1049440|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
310263|NCT01483599|1049441|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
310264|NCT01483599|1049442|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
310265|NCT01483599|1049443|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310266|NCT01483599|1049444|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
310267|NCT01483599|1049445|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
310268|NCT01483183|1049535|P10|Overall Study|Withdrawal by Subject|1
310269|NCT01483183|1049536|P9|Overall Study|Withdrawal by Subject|0
310270|NCT01483183|1049537|P8|Overall Study|Withdrawal by Subject|0
310271|NCT01483183|1049538|P7|Overall Study|Withdrawal by Subject|0
310272|NCT01483183|1049539|P6|Overall Study|Withdrawal by Subject|0
310273|NCT01483183|1049540|P5|Overall Study|Withdrawal by Subject|0
310274|NCT01483183|1049541|P4|Overall Study|Withdrawal by Subject|0
310275|NCT01483183|1049542|P3|Overall Study|Withdrawal by Subject|0
310276|NCT01483183|1049543|P2|Overall Study|Withdrawal by Subject|0
310277|NCT01483183|1049544|P1|Overall Study|Withdrawal by Subject|0
310278|NCT01483183|1049535|P10|Overall Study|Physician Decision|0
310279|NCT01483183|1049536|P9|Overall Study|Physician Decision|0
310280|NCT01483183|1049537|P8|Overall Study|Physician Decision|0
310281|NCT01483183|1049538|P7|Overall Study|Physician Decision|2
310282|NCT01483183|1049539|P6|Overall Study|Physician Decision|0
310283|NCT01483183|1049540|P5|Overall Study|Physician Decision|0
310284|NCT01483183|1049541|P4|Overall Study|Physician Decision|0
310285|NCT01483183|1049542|P3|Overall Study|Physician Decision|0
310286|NCT01483183|1049543|P2|Overall Study|Physician Decision|0
310287|NCT01483183|1049544|P1|Overall Study|Physician Decision|0
310288|NCT01483118|1049614|P2|Overall Study|Lost to Follow-up|16
310289|NCT01483118|1049615|P1|Overall Study|Lost to Follow-up|12
310290|NCT01482910|1049627|P2|Overall Study|Death|0
310291|NCT01482910|1049628|P1|Overall Study|Death|1
310292|NCT01482910|1049627|P2|Overall Study|Withdrawal by Subject|2
310293|NCT01482910|1049628|P1|Overall Study|Withdrawal by Subject|7
310294|NCT01482910|1049627|P2|Overall Study|Protocol Violation|1
310295|NCT01482910|1049628|P1|Overall Study|Protocol Violation|1
310296|NCT01482910|1049627|P2|Overall Study|Lost to Follow-up|1
310297|NCT01482910|1049628|P1|Overall Study|Lost to Follow-up|0
310298|NCT01482910|1049627|P2|Overall Study|Adverse Event|5
310299|NCT01482910|1049628|P1|Overall Study|Adverse Event|6
310300|NCT01482884|1049640|P2|Overall Study|Withdrawal by Subject|13
310301|NCT01482884|1049641|P1|Overall Study|Withdrawal by Subject|8
310302|NCT01482884|1049640|P2|Overall Study|Adverse Event|1
310303|NCT01482884|1049641|P1|Overall Study|Adverse Event|2
310304|NCT01482884|1049640|P2|Overall Study|Lack of Efficacy|1
310305|NCT01482884|1049641|P1|Overall Study|Lack of Efficacy|0
310306|NCT01482884|1049640|P2|Overall Study|Lost to Follow-up|2
310307|NCT01482884|1049641|P1|Overall Study|Lost to Follow-up|2
310308|NCT01482884|1049640|P2|Overall Study|Protocol Violation|0
310309|NCT01482884|1049641|P1|Overall Study|Protocol Violation|1
310310|NCT01482884|1049640|P2|Overall Study|Medical decision due to lack of efficacy|1
310311|NCT01482884|1049641|P1|Overall Study|Medical decision due to lack of efficacy|0
310312|NCT01482819|1049667|P1|Overall Study|Lost to Follow-up|2
310313|NCT01482767|1049687|P2|Overall Study|Nurse error|0
310314|NCT01482767|1049688|P1|Overall Study|Nurse error|1
310315|NCT01482767|1049687|P2|Overall Study|Ineligible|5
310316|NCT01482767|1049688|P1|Overall Study|Ineligible|0
310317|NCT01482767|1049687|P2|Overall Study|Alternate HCV treatment|8
310318|NCT01482767|1049688|P1|Overall Study|Alternate HCV treatment|7
310319|NCT01482767|1049687|P2|Overall Study|Non-adherence to study requirements|7
310320|NCT01482767|1049688|P1|Overall Study|Non-adherence to study requirements|4
310321|NCT01482767|1049687|P2|Overall Study|Site closure|14
310322|NCT01482767|1049688|P1|Overall Study|Site closure|22
310323|NCT01482767|1049687|P2|Overall Study|Adverse Event|3
310324|NCT01482767|1049688|P1|Overall Study|Adverse Event|0
310325|NCT01482767|1049687|P2|Overall Study|Lost to Follow-up|6
310326|NCT01482767|1049688|P1|Overall Study|Lost to Follow-up|12
310327|NCT01482767|1049687|P2|Overall Study|Withdrawal by Subject|5
310328|NCT01482767|1049688|P1|Overall Study|Withdrawal by Subject|7
310329|NCT01482767|1049687|P2|Overall Study|Death|1
310330|NCT01482767|1049688|P1|Overall Study|Death|1
310331|NCT01482429|1049710|P2|Protocol|Protocol Violation|0
310332|NCT01482429|1049711|P1|Protocol|Protocol Violation|275
310333|NCT01482429|1049710|P2|Care Usual|Lost to Follow-up|1
310334|NCT01482429|1049711|P1|Care Usual|Lost to Follow-up|0
310335|NCT01482429|1049710|P2|Care Usual|Protocol Violation|172
310336|NCT01482429|1049711|P1|Care Usual|Protocol Violation|0
310337|NCT01482312|1049723|P3|Period 2, 90 Minutes of Wear|Other|0
310338|NCT01482312|1049724|P2|Period 2, 90 Minutes of Wear|Other|0
310339|NCT01482312|1049725|P1|Period 2, 90 Minutes of Wear|Other|1
310340|NCT01482312|1049723|P3|Period 1, 90 Minutes of Wear|Other|0
310341|NCT01482312|1049724|P2|Period 1, 90 Minutes of Wear|Other|0
310342|NCT01482312|1049725|P1|Period 1, 90 Minutes of Wear|Other|1
310343|NCT01482221|1049739|P3|Overall Study|Physician Decision|0
310344|NCT01482221|1049740|P2|Overall Study|Physician Decision|1
310345|NCT01482221|1049741|P1|Overall Study|Physician Decision|0
310347|NCT01482221|1049740|P2|Overall Study|Incorrect randomization|1
310348|NCT01482221|1049741|P1|Overall Study|Incorrect randomization|0
310349|NCT01482221|1049739|P3|Overall Study|Withdrawal by Subject|12
310350|NCT01482221|1049740|P2|Overall Study|Withdrawal by Subject|7
310351|NCT01482221|1049741|P1|Overall Study|Withdrawal by Subject|10
310352|NCT01482221|1049739|P3|Overall Study|Adverse Event|3
310353|NCT01482221|1049740|P2|Overall Study|Adverse Event|7
310354|NCT01482221|1049741|P1|Overall Study|Adverse Event|1
310355|NCT01482221|1049739|P3|Overall Study|Severe Non-Compliance to Protocol|1
310356|NCT01482221|1049740|P2|Overall Study|Severe Non-Compliance to Protocol|0
310357|NCT01482221|1049741|P1|Overall Study|Severe Non-Compliance to Protocol|1
310358|NCT01482221|1049739|P3|Overall Study|Condition under Investigation Worsened|4
310359|NCT01482221|1049740|P2|Overall Study|Condition under Investigation Worsened|2
310360|NCT01482221|1049741|P1|Overall Study|Condition under Investigation Worsened|3
310361|NCT01482221|1049739|P3|Overall Study|Study-Specific Withdrawal Criteria|1
310362|NCT01482221|1049740|P2|Overall Study|Study-Specific Withdrawal Criteria|0
310363|NCT01482221|1049741|P1|Overall Study|Study-Specific Withdrawal Criteria|2
310364|NCT01482221|1049739|P3|Overall Study|Lost to Follow-up|1
310365|NCT01482221|1049740|P2|Overall Study|Lost to Follow-up|2
310366|NCT01482221|1049741|P1|Overall Study|Lost to Follow-up|3
310367|NCT01482221|1049739|P3|Overall Study|Lack of Efficacy|1
310368|NCT01482221|1049740|P2|Overall Study|Lack of Efficacy|0
310369|NCT01482221|1049741|P1|Overall Study|Lack of Efficacy|1
310370|NCT01482169|1049782|P1|Overall Study|Physician Decision|2
310371|NCT01482065|1049824|P2|Overall Study|Withdrawal by Subject|1
310372|NCT01482065|1049825|P1|Overall Study|Withdrawal by Subject|0
310373|NCT01481896|1049846|P1|Overall Study|Lost to Follow-up|12
310374|NCT01481779|1049862|P2|Overall Study|Sponsor Decision|1
310375|NCT01481779|1049863|P1|Overall Study|Sponsor Decision|3
310376|NCT01481779|1049862|P2|Overall Study|Physician Decision|4
310377|NCT01481779|1049863|P1|Overall Study|Physician Decision|13
310378|NCT01481779|1049862|P2|Overall Study|Withdrawal by Subject|13
310379|NCT01481779|1049863|P1|Overall Study|Withdrawal by Subject|26
310380|NCT01481779|1049862|P2|Overall Study|Protocol Violation|3
310381|NCT01481779|1049863|P1|Overall Study|Protocol Violation|2
310382|NCT01481779|1049862|P2|Overall Study|Lost to Follow-up|2
310383|NCT01481779|1049863|P1|Overall Study|Lost to Follow-up|3
310384|NCT01481779|1049862|P2|Overall Study|Adverse Event|5
310385|NCT01481779|1049863|P1|Overall Study|Adverse Event|23
310386|NCT01481324|1049948|P3|Overall Study|Missing Data|2
310387|NCT01481324|1049949|P2|Overall Study|Missing Data|2
310388|NCT01481324|1049950|P1|Overall Study|Missing Data|0
310389|NCT01481116|1049969|P3|Overall Study|Hypoglycemic Event|0
310390|NCT01481116|1049970|P2|Overall Study|Hypoglycemic Event|0
310391|NCT01481116|1049971|P1|Overall Study|Hypoglycemic Event|4
310392|NCT01481116|1049969|P3|Overall Study|Death|0
310393|NCT01481116|1049970|P2|Overall Study|Death|1
310394|NCT01481116|1049971|P1|Overall Study|Death|2
310395|NCT01481116|1049969|P3|Overall Study|Investigator's Discretion|0
310396|NCT01481116|1049970|P2|Overall Study|Investigator's Discretion|0
310397|NCT01481116|1049971|P1|Overall Study|Investigator's Discretion|2
310398|NCT01481116|1049969|P3|Overall Study|Non-Compliant With Study Drug|1
310399|NCT01481116|1049970|P2|Overall Study|Non-Compliant With Study Drug|1
310400|NCT01481116|1049971|P1|Overall Study|Non-Compliant With Study Drug|0
310401|NCT01481116|1049969|P3|Overall Study|Sponsor Decision|3
310402|NCT01481116|1049970|P2|Overall Study|Sponsor Decision|1
310403|NCT01481116|1049971|P1|Overall Study|Sponsor Decision|0
310404|NCT01481116|1049969|P3|Overall Study|Investigator Decision|1
310405|NCT01481116|1049970|P2|Overall Study|Investigator Decision|2
310406|NCT01481116|1049971|P1|Overall Study|Investigator Decision|3
310407|NCT01481116|1049969|P3|Overall Study|Participant Moved Out of Country|1
310408|NCT01481116|1049970|P2|Overall Study|Participant Moved Out of Country|0
310409|NCT01481116|1049971|P1|Overall Study|Participant Moved Out of Country|1
310410|NCT01481116|1049969|P3|Overall Study|Participant Moved Out of Area|1
310411|NCT01481116|1049970|P2|Overall Study|Participant Moved Out of Area|0
310412|NCT01481116|1049971|P1|Overall Study|Participant Moved Out of Area|2
310413|NCT01481116|1049969|P3|Overall Study|Participant Started Taking Glipizide|0
310414|NCT01481116|1049970|P2|Overall Study|Participant Started Taking Glipizide|0
310415|NCT01481116|1049971|P1|Overall Study|Participant Started Taking Glipizide|1
310416|NCT01481116|1049969|P3|Overall Study|Other|0
310417|NCT01481116|1049970|P2|Overall Study|Other|1
310418|NCT01481116|1049971|P1|Overall Study|Other|1
310419|NCT01481116|1049969|P3|Overall Study|Contraindications|0
310420|NCT01481116|1049970|P2|Overall Study|Contraindications|1
310421|NCT01481116|1049971|P1|Overall Study|Contraindications|1
310422|NCT01481116|1049969|P3|Overall Study|Lack of Efficacy|1
310423|NCT01481116|1049970|P2|Overall Study|Lack of Efficacy|3
310424|NCT01481116|1049971|P1|Overall Study|Lack of Efficacy|3
310425|NCT01481116|1049969|P3|Overall Study|Pregnancy|1
310426|NCT01481116|1049970|P2|Overall Study|Pregnancy|0
310427|NCT01481116|1049971|P1|Overall Study|Pregnancy|0
310428|NCT01481116|1049969|P3|Overall Study|Study Termination|713
310429|NCT01481116|1049970|P2|Overall Study|Study Termination|729
310430|NCT01481116|1049971|P1|Overall Study|Study Termination|730
310431|NCT01481116|1049969|P3|Overall Study|Withdrawal by Subject|37
310432|NCT01481116|1049970|P2|Overall Study|Withdrawal by Subject|33
310433|NCT01481116|1049971|P1|Overall Study|Withdrawal by Subject|37
310434|NCT01481116|1049969|P3|Overall Study|Lost to Follow-up|11
310435|NCT01481116|1049970|P2|Overall Study|Lost to Follow-up|12
310436|NCT01481116|1049971|P1|Overall Study|Lost to Follow-up|8
310437|NCT01481116|1049969|P3|Overall Study|Major Protocol Deviation|1
310438|NCT01481116|1049970|P2|Overall Study|Major Protocol Deviation|7
310439|NCT01481116|1049971|P1|Overall Study|Major Protocol Deviation|3
310440|NCT01481116|1049969|P3|Overall Study|Adverse Event|42
310441|NCT01481116|1049970|P2|Overall Study|Adverse Event|26
310442|NCT01481116|1049971|P1|Overall Study|Adverse Event|26
310443|NCT01480674|1050002|P1|Overall Study|visit not done|10
310444|NCT01480674|1050002|P1|Overall Study|Lost to Follow-up|2
310445|NCT01480674|1050002|P1|Overall Study|Death|23
310446|NCT01480596|1050016|P2|Overall Study|MG exacerbation or change in medication|2
310447|NCT01480596|1050017|P1|Overall Study|MG exacerbation or change in medication|2
310448|NCT01480596|1050016|P2|Overall Study|Adverse Event|0
310449|NCT01480596|1050017|P1|Overall Study|Adverse Event|3
310450|NCT01480284|1050065|P2|Overall Study|Physician Decision|0
310451|NCT01480284|1050066|P1|Overall Study|Physician Decision|1
310452|NCT01480284|1050065|P2|Overall Study|Lost to Follow-up|0
310453|NCT01480284|1050066|P1|Overall Study|Lost to Follow-up|1
310454|NCT01480284|1050065|P2|Overall Study|Study closed/terminated|0
310455|NCT01480284|1050066|P1|Overall Study|Study closed/terminated|3
310456|NCT01480284|1050065|P2|Overall Study|Adverse Event|0
310457|NCT01480284|1050066|P1|Overall Study|Adverse Event|1
310458|NCT01480284|1050065|P2|Overall Study|Withdrawal by Subject|0
310459|NCT01480284|1050066|P1|Overall Study|Withdrawal by Subject|2
310460|NCT01480076|1050149|P1|Overall Study|Not Specified|52
310461|NCT01480076|1050149|P1|Overall Study|Investigator Decision|13
310462|NCT01480076|1050149|P1|Overall Study|Lost to Follow-up|7
310463|NCT01480076|1050149|P1|Overall Study|Withdrawal by Subject|105
310464|NCT01480076|1050149|P1|Overall Study|Non-compliance With Study Protocol|15
310465|NCT01480076|1050149|P1|Overall Study|Disease Progression|5
310466|NCT01480076|1050149|P1|Overall Study|Death|2
310467|NCT01480076|1050149|P1|Overall Study|Adverse Event|39
310468|NCT01480076|1050149|P1|Overall Study|Run-in Failure|52
310469|NCT01479868|1050268|P1|Overall Study|Initiation of new HCV Therapy|1
310470|NCT01479868|1050268|P1|Overall Study|Sponsor's Decision|1
310471|NCT01479868|1050268|P1|Overall Study|Withdrawal by Subject|1
310472|NCT01479868|1050268|P1|Overall Study|Protocol Violation|1
310473|NCT01479868|1050268|P1|Overall Study|Lost to Follow-up|4
310474|NCT01479868|1050268|P1|Overall Study|Adverse Event|1
310475|NCT01479777|1050283|P1|Overall Study|Physician Decision|2
310476|NCT01479764|1050295|P2|Treated|Lost to Follow-up|2
310477|NCT01479764|1050296|P1|Treated|Lost to Follow-up|0
310478|NCT01479764|1050295|P2|Randomized|Withdrawal by Subject|0
310479|NCT01479764|1050296|P1|Randomized|Withdrawal by Subject|1
310480|NCT01479764|1050295|P2|Randomized|Adverse Event|1
310481|NCT01479764|1050296|P1|Randomized|Adverse Event|1
310482|NCT01479621|1050319|P7|Treatment Period|Met stopping criteria|6
310483|NCT01479621|1050320|P6|Treatment Period|Met stopping criteria|20
310484|NCT01479621|1050321|P5|Treatment Period|Met stopping criteria|9
310485|NCT01479621|1050322|P4|Treatment Period|Met stopping criteria|4
310486|NCT01479621|1050323|P3|Treatment Period|Met stopping criteria|7
310487|NCT01479621|1050324|P2|Treatment Period|Met stopping criteria|8
310488|NCT01479621|1050325|P1|Treatment Period|Met stopping criteria|0
310489|NCT01479621|1050319|P7|Treatment Period|Lost to Follow-up|1
310490|NCT01479621|1050320|P6|Treatment Period|Lost to Follow-up|2
310491|NCT01479621|1050321|P5|Treatment Period|Lost to Follow-up|2
310492|NCT01479621|1050322|P4|Treatment Period|Lost to Follow-up|0
310493|NCT01479621|1050323|P3|Treatment Period|Lost to Follow-up|1
310494|NCT01479621|1050324|P2|Treatment Period|Lost to Follow-up|0
310495|NCT01479621|1050325|P1|Treatment Period|Lost to Follow-up|0
310496|NCT01479621|1050319|P7|Treatment Period|Sponsor request subject to be withdrawn|3
310497|NCT01479621|1050320|P6|Treatment Period|Sponsor request subject to be withdrawn|1
310498|NCT01479621|1050321|P5|Treatment Period|Sponsor request subject to be withdrawn|1
310499|NCT01479621|1050322|P4|Treatment Period|Sponsor request subject to be withdrawn|1
310500|NCT01479621|1050323|P3|Treatment Period|Sponsor request subject to be withdrawn|3
310501|NCT01479621|1050324|P2|Treatment Period|Sponsor request subject to be withdrawn|2
310502|NCT01479621|1050325|P1|Treatment Period|Sponsor request subject to be withdrawn|0
310503|NCT01479621|1050319|P7|Treatment Period|Pregnancy|0
310504|NCT01479621|1050320|P6|Treatment Period|Pregnancy|0
310505|NCT01479621|1050321|P5|Treatment Period|Pregnancy|0
310506|NCT01479621|1050322|P4|Treatment Period|Pregnancy|0
310507|NCT01479621|1050323|P3|Treatment Period|Pregnancy|2
310508|NCT01479621|1050324|P2|Treatment Period|Pregnancy|0
310509|NCT01479621|1050325|P1|Treatment Period|Pregnancy|0
310510|NCT01479621|1050319|P7|Treatment Period|Protocol Violation|6
310511|NCT01479621|1050320|P6|Treatment Period|Protocol Violation|10
310512|NCT01479621|1050321|P5|Treatment Period|Protocol Violation|2
310513|NCT01479621|1050322|P4|Treatment Period|Protocol Violation|5
310514|NCT01479621|1050323|P3|Treatment Period|Protocol Violation|6
310515|NCT01479621|1050324|P2|Treatment Period|Protocol Violation|9
310516|NCT01479621|1050325|P1|Treatment Period|Protocol Violation|0
310517|NCT01479621|1050319|P7|Treatment Period|Non-compliance to study drug|1
310518|NCT01479621|1050320|P6|Treatment Period|Non-compliance to study drug|0
310519|NCT01479621|1050321|P5|Treatment Period|Non-compliance to study drug|0
310520|NCT01479621|1050322|P4|Treatment Period|Non-compliance to study drug|0
310521|NCT01479621|1050323|P3|Treatment Period|Non-compliance to study drug|0
310522|NCT01479621|1050324|P2|Treatment Period|Non-compliance to study drug|1
310523|NCT01479621|1050325|P1|Treatment Period|Non-compliance to study drug|0
310524|NCT01479621|1050319|P7|Treatment Period|Physician Decision|0
310525|NCT01479621|1050320|P6|Treatment Period|Physician Decision|1
310526|NCT01479621|1050321|P5|Treatment Period|Physician Decision|1
310527|NCT01479621|1050322|P4|Treatment Period|Physician Decision|0
310528|NCT01479621|1050323|P3|Treatment Period|Physician Decision|0
310529|NCT01479621|1050324|P2|Treatment Period|Physician Decision|0
310530|NCT01479621|1050325|P1|Treatment Period|Physician Decision|0
310531|NCT01479621|1050319|P7|Treatment Period|Withdrawal by Subject|1
310532|NCT01479621|1050320|P6|Treatment Period|Withdrawal by Subject|5
310533|NCT01479621|1050321|P5|Treatment Period|Withdrawal by Subject|5
310534|NCT01479621|1050322|P4|Treatment Period|Withdrawal by Subject|2
310535|NCT01479621|1050323|P3|Treatment Period|Withdrawal by Subject|2
310536|NCT01479621|1050324|P2|Treatment Period|Withdrawal by Subject|4
310537|NCT01479621|1050325|P1|Treatment Period|Withdrawal by Subject|0
310538|NCT01479621|1050319|P7|Treatment Period|Adverse Event|2
310539|NCT01479621|1050320|P6|Treatment Period|Adverse Event|2
310540|NCT01479621|1050321|P5|Treatment Period|Adverse Event|1
310541|NCT01479621|1050322|P4|Treatment Period|Adverse Event|0
310542|NCT01479621|1050323|P3|Treatment Period|Adverse Event|0
310543|NCT01479621|1050324|P2|Treatment Period|Adverse Event|0
310544|NCT01479621|1050325|P1|Treatment Period|Adverse Event|0
310545|NCT01479621|1050319|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
310546|NCT01479621|1050320|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
310547|NCT01479621|1050321|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
310548|NCT01479621|1050322|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
310549|NCT01479621|1050323|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
310550|NCT01479621|1050324|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
310551|NCT01479621|1050325|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
310552|NCT01479621|1050319|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
310553|NCT01479621|1050320|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
310554|NCT01479621|1050321|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
310555|NCT01479621|1050322|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
310556|NCT01479621|1050323|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
310557|NCT01479621|1050324|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
310558|NCT01479621|1050325|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
310559|NCT01479621|1050319|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
310560|NCT01479621|1050320|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
310561|NCT01479621|1050321|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
310562|NCT01479621|1050322|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
310563|NCT01479621|1050323|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
310564|NCT01479621|1050324|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
310565|NCT01479621|1050325|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
310566|NCT01479621|1050319|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
310567|NCT01479621|1050320|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
310568|NCT01479621|1050321|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
310569|NCT01479621|1050322|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
310570|NCT01479621|1050323|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
310571|NCT01479621|1050324|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
310572|NCT01479621|1050325|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
310573|NCT01479621|1050319|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
310574|NCT01479621|1050320|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
310575|NCT01479621|1050321|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
310576|NCT01479621|1050322|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
310577|NCT01479621|1050323|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
310578|NCT01479621|1050324|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
310579|NCT01479621|1050325|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
310580|NCT01479595|1050413|P2|Overall Study|Adverse Event|1
310581|NCT01479595|1050414|P1|Overall Study|Adverse Event|2
310582|NCT01479595|1050413|P2|Overall Study|Protocol deviation|1
310583|NCT01479595|1050414|P1|Overall Study|Protocol deviation|0
310584|NCT01479530|1050459|P2|Overall Study|Withdrawal of Consent|2
310585|NCT01479530|1050460|P1|Overall Study|Withdrawal of Consent|3
310586|NCT01479530|1050459|P2|Overall Study|Protocol Violation|3
310587|NCT01479530|1050460|P1|Overall Study|Protocol Violation|2
310588|NCT01479530|1050459|P2|Overall Study|Lack of Efficacy|1
310589|NCT01479530|1050460|P1|Overall Study|Lack of Efficacy|0
310590|NCT01479530|1050459|P2|Overall Study|Adverse Event|6
310591|NCT01479530|1050460|P1|Overall Study|Adverse Event|5
310592|NCT01479374|1050497|P3|Overall Study|Other|5
310593|NCT01479374|1050498|P2|Overall Study|Other|4
310594|NCT01479374|1050499|P1|Overall Study|Other|0
310595|NCT01479374|1050497|P3|Overall Study|Decision Unrelated to Adverse Event|0
310596|NCT01479374|1050498|P2|Overall Study|Decision Unrelated to Adverse Event|1
310597|NCT01479374|1050499|P1|Overall Study|Decision Unrelated to Adverse Event|0
310598|NCT01479374|1050497|P3|Overall Study|Lost to Follow-up|0
310599|NCT01479374|1050498|P2|Overall Study|Lost to Follow-up|2
310600|NCT01479374|1050499|P1|Overall Study|Lost to Follow-up|1
310601|NCT01479374|1050497|P3|Overall Study|Adverse Event|0
310602|NCT01479374|1050498|P2|Overall Study|Adverse Event|1
310603|NCT01479374|1050499|P1|Overall Study|Adverse Event|2
310604|NCT01478971|1050570|P1|Peginesatide Treatment Period|Other|4
310605|NCT01478971|1050570|P1|Peginesatide Treatment Period|Lost to Follow-up|4
310606|NCT01478971|1050570|P1|Peginesatide Treatment Period|Death|4
310607|NCT01478971|1050570|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
310608|NCT01478971|1050570|P1|Peginesatide Treatment Period|Adverse Event|1
310609|NCT01478971|1050570|P1|Standard of Care Period|Other|4
310610|NCT01478971|1050570|P1|Standard of Care Period|Lost to Follow-up|9
310611|NCT01478971|1050570|P1|Standard of Care Period|Death|8
310612|NCT01478971|1050570|P1|Standard of Care Period|Withdrawal by Subject|3
310613|NCT01478971|1050570|P1|Standard of Care Period|Adverse Event|1
310614|NCT01478958|1050587|P3|Overall Study|Unable to comply|2
310615|NCT01478958|1050588|P2|Overall Study|Unable to comply|0
310616|NCT01478958|1050589|P1|Overall Study|Unable to comply|0
310617|NCT01478958|1050587|P3|Overall Study|Re-located|0
310618|NCT01478958|1050588|P2|Overall Study|Re-located|1
310619|NCT01478958|1050589|P1|Overall Study|Re-located|0
310620|NCT01478958|1050587|P3|Overall Study|Weight loss|0
310621|NCT01478958|1050588|P2|Overall Study|Weight loss|0
310622|NCT01478958|1050589|P1|Overall Study|Weight loss|1
310623|NCT01478958|1050587|P3|Overall Study|Withdrawal by Subject|1
310624|NCT01478958|1050588|P2|Overall Study|Withdrawal by Subject|1
310625|NCT01478958|1050589|P1|Overall Study|Withdrawal by Subject|1
310626|NCT01478828|1050597|P1|Overall Study|Adverse Event|1
310627|NCT01478620|1050602|P1|Overall Study|Lost to Follow-up|6
310628|NCT01478594|1050608|P2|Overall Study|Study Closed by Sponsor|5
310629|NCT01478594|1050609|P1|Overall Study|Study Closed by Sponsor|8
310630|NCT01478594|1050608|P2|Overall Study|Withdrawal by Subject|3
310631|NCT01478594|1050609|P1|Overall Study|Withdrawal by Subject|9
310632|NCT01478594|1050608|P2|Overall Study|Lost to Follow-up|1
310633|NCT01478594|1050609|P1|Overall Study|Lost to Follow-up|3
310634|NCT01478594|1050608|P2|Overall Study|Death|18
310635|NCT01478594|1050609|P1|Overall Study|Death|45
310636|NCT01478594|1050608|P2|Overall Study|Randomized but Never Received Study Drug|1
310637|NCT01478594|1050609|P1|Overall Study|Randomized but Never Received Study Drug|0
310638|NCT01478373|1050734|P1|Survival Phase|Progressive Disease|27
310639|NCT01478373|1050734|P1|Survival Phase|crossover to another study|2
310640|NCT01478373|1050734|P1|Survival Phase|Protocol Violation|1
310641|NCT01478373|1050734|P1|Survival Phase|Adverse Event|8
310642|NCT01478373|1050734|P1|Treatment Phase|Protocol Violation|1
310643|NCT01478360|1050747|P2|Overall Study|Administrative problems|2
310644|NCT01478360|1050748|P1|Overall Study|Administrative problems|1
310645|NCT01478360|1050747|P2|Overall Study|Adverse Event|1
310646|NCT01478360|1050748|P1|Overall Study|Adverse Event|0
310647|NCT01478360|1050747|P2|Overall Study|Lost to Follow-up|0
310648|NCT01478360|1050748|P1|Overall Study|Lost to Follow-up|1
310649|NCT01478347|1050754|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
310650|NCT01478347|1050754|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
310651|NCT01478347|1050754|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
310652|NCT01478113|1050772|P2|Overall Study|Physician Decision|0
310653|NCT01478113|1050773|P1|Overall Study|Physician Decision|1
310654|NCT01478113|1050772|P2|Overall Study|Withdrawal by Subject|1
310655|NCT01478113|1050773|P1|Overall Study|Withdrawal by Subject|0
310656|NCT01478087|1050791|P1|Overall Study|due to sponsor closing study|1
310657|NCT01478048|1050798|P2|Overall Study|no longer meets study criteria|0
310658|NCT01478048|1050799|P1|Overall Study|no longer meets study criteria|1
310659|NCT01478048|1050798|P2|Overall Study|poor/non-compliance|1
310660|NCT01478048|1050799|P1|Overall Study|poor/non-compliance|0
310661|NCT01478048|1050798|P2|Overall Study|non-specified|4
310662|NCT01478048|1050799|P1|Overall Study|non-specified|6
310663|NCT01478048|1050798|P2|Overall Study|Withdrawal by Subject|5
310664|NCT01478048|1050799|P1|Overall Study|Withdrawal by Subject|2
310665|NCT01478048|1050798|P2|Overall Study|subject request to discontinue treatment|5
310666|NCT01478048|1050799|P1|Overall Study|subject request to discontinue treatment|3
310667|NCT01478048|1050798|P2|Overall Study|Adverse Event|11
310668|NCT01478048|1050799|P1|Overall Study|Adverse Event|2
310669|NCT01478048|1050798|P2|Overall Study|study drug toxicity|14
310670|NCT01478048|1050799|P1|Overall Study|study drug toxicity|11
310671|NCT01478048|1050798|P2|Overall Study|Disease Progression|35
310672|NCT01478048|1050799|P1|Overall Study|Disease Progression|52
310673|NCT01477892|1050828|P2|Overall Study|Withdrawal by Subject|2
310674|NCT01477892|1050829|P1|Overall Study|Withdrawal by Subject|0
310675|NCT01477853|1050840|P3|Phase B|Study terminated by sponsor|11
310676|NCT01477853|1050841|P2|Phase B|Study terminated by sponsor|10
310677|NCT01477853|1050842|P1|Phase B|Study terminated by sponsor|12
310678|NCT01477853|1050840|P3|Phase B|Lost to Follow-up|0
310679|NCT01477853|1050841|P2|Phase B|Lost to Follow-up|1
310680|NCT01477853|1050842|P1|Phase B|Lost to Follow-up|0
310681|NCT01477853|1050840|P3|Phase A|Study terminated by sponsor|39
310682|NCT01477853|1050841|P2|Phase A|Study terminated by sponsor|40
310683|NCT01477853|1050842|P1|Phase A|Study terminated by sponsor|37
310684|NCT01477853|1050840|P3|Phase A|Physician Decision|1
310685|NCT01477853|1050841|P2|Phase A|Physician Decision|0
310686|NCT01477853|1050842|P1|Phase A|Physician Decision|1
310687|NCT01477853|1050840|P3|Phase A|Lost to Follow-up|2
310688|NCT01477853|1050841|P2|Phase A|Lost to Follow-up|3
310689|NCT01477853|1050842|P1|Phase A|Lost to Follow-up|4
310690|NCT01477853|1050840|P3|Phase A|Adverse Event|2
310691|NCT01477853|1050841|P2|Phase A|Adverse Event|2
310692|NCT01477853|1050842|P1|Phase A|Adverse Event|1
310693|NCT01477749|1050909|P1|Overall Study|Physician Decision|4
310694|NCT01477333|1051017|P1|Overall Study|Clinical Deterioration|1
310695|NCT01477333|1051017|P1|Overall Study|Withdrawal by Subject|1
310696|NCT01477333|1051017|P1|Overall Study|Adverse Event|1
310697|NCT01476722|1051060|P1|Overall Study|Adverse Event|1
310698|NCT01476696|1051067|P3|Overall Study|Withdrawal by Subject|0
310699|NCT01476696|1051068|P2|Overall Study|Withdrawal by Subject|0
310700|NCT01476696|1051069|P1|Overall Study|Withdrawal by Subject|1
310701|NCT01476696|1051067|P3|Overall Study|Sponsor decision|0
310702|NCT01476696|1051068|P2|Overall Study|Sponsor decision|1
310703|NCT01476696|1051069|P1|Overall Study|Sponsor decision|2
310704|NCT01476475|1051085|P2|Overall Study|Other reasons|2
310705|NCT01476475|1051086|P1|Overall Study|Other reasons|4
310706|NCT01476475|1051085|P2|Overall Study|Poor compliance to protocol|1
310707|NCT01476475|1051086|P1|Overall Study|Poor compliance to protocol|1
310708|NCT01476475|1051085|P2|Overall Study|Adverse Event|0
310709|NCT01476475|1051086|P1|Overall Study|Adverse Event|6
310710|NCT01475851|1051515|P2|Overall Study|Protocol defined stopping criteria|0
310711|NCT01475851|1051516|P1|Overall Study|Protocol defined stopping criteria|1
310712|NCT01475838|1051544|P2|Extension Phase|Participant Noncompliance|0
310713|NCT01475838|1051545|P1|Extension Phase|Participant Noncompliance|1
310714|NCT01475838|1051544|P2|Randomized Phase|Protocol Violation|4
310715|NCT01475838|1051545|P1|Randomized Phase|Protocol Violation|9
310716|NCT01475838|1051544|P2|Randomized Phase|Participant Noncompliance|5
310717|NCT01475838|1051545|P1|Randomized Phase|Participant Noncompliance|1
310718|NCT01475838|1051544|P2|Randomized Phase|Lost to Follow-up|4
310719|NCT01475838|1051545|P1|Randomized Phase|Lost to Follow-up|3
310720|NCT01475838|1051544|P2|Randomized Phase|Withdrew Consent|14
310721|NCT01475838|1051545|P1|Randomized Phase|Withdrew Consent|10
310722|NCT01475838|1051544|P2|Randomized Phase|Investigators Discretion|2
310723|NCT01475838|1051545|P1|Randomized Phase|Investigators Discretion|1
310724|NCT01475838|1051544|P2|Randomized Phase|Pregnancy|1
310725|NCT01475838|1051545|P1|Randomized Phase|Pregnancy|0
310726|NCT01475838|1051544|P2|Randomized Phase|Adverse Event|1
310727|NCT01475838|1051545|P1|Randomized Phase|Adverse Event|6
310728|NCT01475838|1051544|P2|Randomized Phase|Randomized but Not Treated|5
310729|NCT01475838|1051545|P1|Randomized Phase|Randomized but Not Treated|0
310730|NCT01475734|1051560|P2|Overall Study|Physician Decision|1
310731|NCT01475734|1051561|P1|Overall Study|Physician Decision|0
310732|NCT01475734|1051560|P2|Overall Study|Protocol Violation|0
310733|NCT01475734|1051561|P1|Overall Study|Protocol Violation|1
310734|NCT01475734|1051560|P2|Overall Study|Withdrawal by Subject|0
310735|NCT01475734|1051561|P1|Overall Study|Withdrawal by Subject|1
310736|NCT01475721|1051589|P2|Overall Study|Withdrawal by Subject|8
310737|NCT01475721|1051590|P1|Overall Study|Withdrawal by Subject|8
310738|NCT01475721|1051589|P2|Overall Study|Death|6
310739|NCT01475721|1051590|P1|Overall Study|Death|3
310740|NCT01475487|1051606|P2|Overall Study|had to leave early for personal reasons|1
310741|NCT01475487|1051607|P1|Overall Study|had to leave early for personal reasons|2
310742|NCT01475474|1051619|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
310743|NCT01475474|1051619|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
310744|NCT01475461|1051630|P7|Treatment Period|Adverse Event|0
310745|NCT01475461|1051631|P6|Treatment Period|Adverse Event|0
310746|NCT01475461|1051632|P5|Treatment Period|Adverse Event|0
310747|NCT01475461|1051633|P4|Treatment Period|Adverse Event|1
310748|NCT01475461|1051634|P3|Treatment Period|Adverse Event|0
310749|NCT01475461|1051635|P2|Treatment Period|Adverse Event|0
310750|NCT01475461|1051636|P1|Treatment Period|Adverse Event|0
310751|NCT01475461|1051630|P7|Treatment Period|Medication Error|0
310752|NCT01475461|1051631|P6|Treatment Period|Medication Error|0
310753|NCT01475461|1051632|P5|Treatment Period|Medication Error|0
310754|NCT01475461|1051633|P4|Treatment Period|Medication Error|1
310755|NCT01475461|1051634|P3|Treatment Period|Medication Error|0
310756|NCT01475461|1051635|P2|Treatment Period|Medication Error|0
310757|NCT01475461|1051636|P1|Treatment Period|Medication Error|0
310758|NCT01475461|1051630|P7|Treatment Period|Lack of Efficacy|0
310759|NCT01475461|1051631|P6|Treatment Period|Lack of Efficacy|1
310760|NCT01475461|1051632|P5|Treatment Period|Lack of Efficacy|1
310761|NCT01475461|1051633|P4|Treatment Period|Lack of Efficacy|2
310762|NCT01475461|1051634|P3|Treatment Period|Lack of Efficacy|0
310763|NCT01475461|1051635|P2|Treatment Period|Lack of Efficacy|2
310764|NCT01475461|1051636|P1|Treatment Period|Lack of Efficacy|0
310765|NCT01475461|1051630|P7|Treatment Period|Protocol Violation|1
310766|NCT01475461|1051631|P6|Treatment Period|Protocol Violation|0
310767|NCT01475461|1051632|P5|Treatment Period|Protocol Violation|0
310768|NCT01475461|1051633|P4|Treatment Period|Protocol Violation|0
310769|NCT01475461|1051634|P3|Treatment Period|Protocol Violation|0
310770|NCT01475461|1051635|P2|Treatment Period|Protocol Violation|1
310771|NCT01475461|1051636|P1|Treatment Period|Protocol Violation|0
310772|NCT01475461|1051630|P7|Treatment Period|Other|0
310773|NCT01475461|1051631|P6|Treatment Period|Other|0
310774|NCT01475461|1051632|P5|Treatment Period|Other|0
310775|NCT01475461|1051633|P4|Treatment Period|Other|0
310776|NCT01475461|1051634|P3|Treatment Period|Other|0
310777|NCT01475461|1051635|P2|Treatment Period|Other|1
310778|NCT01475461|1051636|P1|Treatment Period|Other|0
310779|NCT01475461|1051630|P7|Treatment Period|Withdrawal by Subject|0
310780|NCT01475461|1051631|P6|Treatment Period|Withdrawal by Subject|2
310781|NCT01475461|1051632|P5|Treatment Period|Withdrawal by Subject|2
310782|NCT01475461|1051633|P4|Treatment Period|Withdrawal by Subject|0
310783|NCT01475461|1051634|P3|Treatment Period|Withdrawal by Subject|2
310784|NCT01475461|1051635|P2|Treatment Period|Withdrawal by Subject|2
310785|NCT01475461|1051636|P1|Treatment Period|Withdrawal by Subject|0
310786|NCT01475461|1051630|P7|Treatment Period|Lost to Follow-up|1
310787|NCT01475461|1051631|P6|Treatment Period|Lost to Follow-up|2
310788|NCT01475461|1051632|P5|Treatment Period|Lost to Follow-up|1
310789|NCT01475461|1051633|P4|Treatment Period|Lost to Follow-up|3
310790|NCT01475461|1051634|P3|Treatment Period|Lost to Follow-up|2
310791|NCT01475461|1051635|P2|Treatment Period|Lost to Follow-up|3
310792|NCT01475461|1051636|P1|Treatment Period|Lost to Follow-up|0
310793|NCT01475461|1051630|P7|Treatment Period|Death|0
310794|NCT01475461|1051631|P6|Treatment Period|Death|0
310795|NCT01475461|1051632|P5|Treatment Period|Death|0
310796|NCT01475461|1051633|P4|Treatment Period|Death|1
310797|NCT01475461|1051634|P3|Treatment Period|Death|0
310798|NCT01475461|1051635|P2|Treatment Period|Death|0
310799|NCT01475461|1051636|P1|Treatment Period|Death|0
310800|NCT01475461|1051630|P7|Run-in Period|Protocol Violation|0
310801|NCT01475461|1051631|P6|Run-in Period|Protocol Violation|0
310802|NCT01475461|1051632|P5|Run-in Period|Protocol Violation|0
310803|NCT01475461|1051633|P4|Run-in Period|Protocol Violation|0
310804|NCT01475461|1051634|P3|Run-in Period|Protocol Violation|0
310805|NCT01475461|1051635|P2|Run-in Period|Protocol Violation|0
310806|NCT01475461|1051636|P1|Run-in Period|Protocol Violation|4
310807|NCT01475461|1051630|P7|Run-in Period|Other|0
310808|NCT01475461|1051631|P6|Run-in Period|Other|0
310809|NCT01475461|1051632|P5|Run-in Period|Other|0
310810|NCT01475461|1051633|P4|Run-in Period|Other|0
310811|NCT01475461|1051634|P3|Run-in Period|Other|0
310812|NCT01475461|1051635|P2|Run-in Period|Other|0
310813|NCT01475461|1051636|P1|Run-in Period|Other|3
310814|NCT01475461|1051630|P7|Run-in Period|Withdrawal by Subject|0
310815|NCT01475461|1051631|P6|Run-in Period|Withdrawal by Subject|0
310816|NCT01475461|1051632|P5|Run-in Period|Withdrawal by Subject|0
310817|NCT01475461|1051633|P4|Run-in Period|Withdrawal by Subject|0
310818|NCT01475461|1051634|P3|Run-in Period|Withdrawal by Subject|0
310819|NCT01475461|1051635|P2|Run-in Period|Withdrawal by Subject|0
310820|NCT01475461|1051636|P1|Run-in Period|Withdrawal by Subject|11
310821|NCT01475461|1051630|P7|Run-in Period|Lost to Follow-up|0
310822|NCT01475461|1051631|P6|Run-in Period|Lost to Follow-up|0
310823|NCT01475461|1051632|P5|Run-in Period|Lost to Follow-up|0
310824|NCT01475461|1051633|P4|Run-in Period|Lost to Follow-up|0
310825|NCT01475461|1051634|P3|Run-in Period|Lost to Follow-up|0
310826|NCT01475461|1051635|P2|Run-in Period|Lost to Follow-up|0
310827|NCT01475461|1051636|P1|Run-in Period|Lost to Follow-up|7
310828|NCT01475461|1051630|P7|Run-in Period|Not meet eligibility criteria|0
310829|NCT01475461|1051631|P6|Run-in Period|Not meet eligibility criteria|0
310830|NCT01475461|1051632|P5|Run-in Period|Not meet eligibility criteria|0
310831|NCT01475461|1051633|P4|Run-in Period|Not meet eligibility criteria|0
310832|NCT01475461|1051634|P3|Run-in Period|Not meet eligibility criteria|0
310833|NCT01475461|1051635|P2|Run-in Period|Not meet eligibility criteria|0
310834|NCT01475461|1051636|P1|Run-in Period|Not meet eligibility criteria|16
310835|NCT01475331|1051716|P2|Overall Study|cyst found to be prohibitively small|1
310836|NCT01475331|1051717|P1|Overall Study|cyst found to be prohibitively small|0
310837|NCT01475331|1051716|P2|Overall Study|Sign of malignancy during the procedure|0
310838|NCT01475331|1051717|P1|Overall Study|Sign of malignancy during the procedure|2
310839|NCT01475331|1051716|P2|Overall Study|Loss of needle positioning due pt. cough|0
310840|NCT01475331|1051717|P1|Overall Study|Loss of needle positioning due pt. cough|1
310841|NCT01475331|1051716|P2|Overall Study|excessive main duct communication|1
310842|NCT01475331|1051717|P1|Overall Study|excessive main duct communication|1
310843|NCT01475331|1051716|P2|Overall Study|Osteophyte obstruction of the proximal|0
310844|NCT01475331|1051717|P1|Overall Study|Osteophyte obstruction of the proximal|1
310845|NCT01475253|1051769|P4|Randomized, Blinded Study|Lost to Follow-up|0
310846|NCT01475253|1051770|P3|Randomized, Blinded Study|Lost to Follow-up|0
310847|NCT01475253|1051771|P2|Randomized, Blinded Study|Lost to Follow-up|0
310848|NCT01475253|1051772|P1|Randomized, Blinded Study|Lost to Follow-up|1
310849|NCT01475253|1051769|P4|Randomized, Blinded Study|Withdrawal by Subject|0
310850|NCT01475253|1051770|P3|Randomized, Blinded Study|Withdrawal by Subject|0
310851|NCT01475253|1051771|P2|Randomized, Blinded Study|Withdrawal by Subject|1
310852|NCT01475253|1051772|P1|Randomized, Blinded Study|Withdrawal by Subject|1
310853|NCT01475214|1051801|P3|Overall Study|Withdrawal by Subject|1
310854|NCT01475214|1051802|P2|Overall Study|Withdrawal by Subject|4
310855|NCT01475214|1051803|P1|Overall Study|Withdrawal by Subject|2
310856|NCT01475214|1051801|P3|Overall Study|Physician Decision|0
310857|NCT01475214|1051802|P2|Overall Study|Physician Decision|0
310858|NCT01475214|1051803|P1|Overall Study|Physician Decision|2
310859|NCT01475214|1051801|P3|Overall Study|Lost to Follow-up|1
310860|NCT01475214|1051802|P2|Overall Study|Lost to Follow-up|0
310861|NCT01475214|1051803|P1|Overall Study|Lost to Follow-up|1
310862|NCT01475097|1051828|P2|Overall Study|Protocol Violation|1
310863|NCT01475097|1051829|P1|Overall Study|Protocol Violation|1
310864|NCT01475071|1051837|P1|Overall Study|Lost to Follow-up|1
310865|NCT01475071|1051837|P1|Overall Study|Withdrawal by Subject|6
310866|NCT01475071|1051837|P1|Overall Study|Physician Decision|1
310867|NCT01474993|1051847|P2|Overall Study|Adverse Event|1
310868|NCT01474993|1051848|P1|Overall Study|Adverse Event|0
310869|NCT01474993|1051847|P2|Overall Study|Lost to Follow-up|2
310870|NCT01474993|1051848|P1|Overall Study|Lost to Follow-up|1
310871|NCT01474876|1051886|P3|Overall Study|Investigator's decision and pt request|0
310872|NCT01474876|1051887|P2|Overall Study|Investigator's decision and pt request|0
310873|NCT01474876|1051888|P1|Overall Study|Investigator's decision and pt request|1
310874|NCT01474876|1051886|P3|Overall Study|Patient's request|0
310875|NCT01474876|1051887|P2|Overall Study|Patient's request|5
310876|NCT01474876|1051888|P1|Overall Study|Patient's request|19
310877|NCT01474876|1051886|P3|Overall Study|Investigator's decision|0
310878|NCT01474876|1051887|P2|Overall Study|Investigator's decision|6
310879|NCT01474876|1051888|P1|Overall Study|Investigator's decision|28
310880|NCT01474876|1051886|P3|Overall Study|Lost to Follow-up|0
310881|NCT01474876|1051887|P2|Overall Study|Lost to Follow-up|4
310882|NCT01474876|1051888|P1|Overall Study|Lost to Follow-up|5
310883|NCT01474876|1051886|P3|Overall Study|Serious Adverse Event|0
310884|NCT01474876|1051887|P2|Overall Study|Serious Adverse Event|3
310885|NCT01474876|1051888|P1|Overall Study|Serious Adverse Event|2
310886|NCT01474876|1051886|P3|Overall Study|Adverse Event|0
310887|NCT01474876|1051887|P2|Overall Study|Adverse Event|5
310888|NCT01474876|1051888|P1|Overall Study|Adverse Event|11
310889|NCT01474772|1051934|P2|Follow-up|AE not Related to Study Drug|1
310890|NCT01474772|1051935|P1|Follow-up|AE not Related to Study Drug|0
310891|NCT01474772|1051934|P2|Period 2|Reason not Specified|2
310892|NCT01474772|1051935|P1|Period 2|Reason not Specified|0
310893|NCT01474772|1051934|P2|Period 2|Lost to Follow-up|1
310894|NCT01474772|1051935|P1|Period 2|Lost to Follow-up|1
310895|NCT01474772|1051934|P2|Period 2|Withdrawal by Subject|4
310896|NCT01474772|1051935|P1|Period 2|Withdrawal by Subject|3
310897|NCT01474772|1051934|P2|Period 2|Lack of Efficacy|0
310898|NCT01474772|1051935|P1|Period 2|Lack of Efficacy|1
310899|NCT01474772|1051934|P2|Period 2|AE not Related to Study Drug|1
310900|NCT01474772|1051935|P1|Period 2|AE not Related to Study Drug|4
310901|NCT01474772|1051934|P2|Period 2|AE Related to Study Drug|1
310902|NCT01474772|1051935|P1|Period 2|AE Related to Study Drug|0
310903|NCT01474772|1051934|P2|Period 2|Death|1
310904|NCT01474772|1051935|P1|Period 2|Death|0
310905|NCT01474772|1051934|P2|Washout|Reason not Specified|1
310906|NCT01474772|1051935|P1|Washout|Reason not Specified|0
310907|NCT01474772|1051934|P2|Washout|Lost to Follow-up|1
310908|NCT01474772|1051935|P1|Washout|Lost to Follow-up|0
310909|NCT01474772|1051934|P2|Washout|Withdrawal by Subject|0
310910|NCT01474772|1051935|P1|Washout|Withdrawal by Subject|1
310911|NCT01474772|1051934|P2|Washout|AE not Related to Study Drug|0
310912|NCT01474772|1051935|P1|Washout|AE not Related to Study Drug|2
310913|NCT01474772|1051934|P2|Period 1|Reason not Specified|1
310914|NCT01474772|1051935|P1|Period 1|Reason not Specified|1
310915|NCT01474772|1051934|P2|Period 1|Lost to Follow-up|0
310916|NCT01474772|1051935|P1|Period 1|Lost to Follow-up|1
310917|NCT01474772|1051934|P2|Period 1|Withdrawal by Subject|1
310918|NCT01474772|1051935|P1|Period 1|Withdrawal by Subject|3
310919|NCT01474772|1051934|P2|Period 1|AE not Related to Study Drug|0
310920|NCT01474772|1051935|P1|Period 1|AE not Related to Study Drug|1
310921|NCT01474772|1051934|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
310922|NCT01474772|1051935|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
310923|NCT01474746|1051985|P2|Overall Study|Withdrawal by Subject|1
310924|NCT01474746|1051986|P1|Overall Study|Withdrawal by Subject|2
310925|NCT01474746|1051985|P2|Overall Study|Lost to Follow-up|1
310926|NCT01474746|1051986|P1|Overall Study|Lost to Follow-up|1
310927|NCT01474681|1052050|P4|Overall Study|Death|6
310928|NCT01474681|1052051|P3|Overall Study|Death|2
310929|NCT01474681|1052052|P2|Overall Study|Death|3
310930|NCT01474681|1052053|P1|Overall Study|Death|0
310931|NCT01474551|1052104|P1|Overall Study|Death|1
310932|NCT01474538|1052110|P2|Treatment Period 2|Protocol Violation|0
310933|NCT01474538|1052111|P1|Treatment Period 2|Protocol Violation|1
310934|NCT01474538|1052110|P2|Treatment Period 2|Physician Decision|1
310935|NCT01474538|1052111|P1|Treatment Period 2|Physician Decision|0
310936|NCT01474538|1052110|P2|Treatment Period 2|Sponsor decision|0
310937|NCT01474538|1052111|P1|Treatment Period 2|Sponsor decision|1
310938|NCT01474538|1052110|P2|Treatment Period 2|Withdrawal by Subject|0
310939|NCT01474538|1052111|P1|Treatment Period 2|Withdrawal by Subject|2
310940|NCT01474538|1052110|P2|Treatment Period 2|Adverse Event|1
310941|NCT01474538|1052111|P1|Treatment Period 2|Adverse Event|1
310942|NCT01474538|1052110|P2|Treatment Period 2|Death|0
310943|NCT01474538|1052111|P1|Treatment Period 2|Death|1
310944|NCT01474538|1052110|P2|Treatment Period 1|Protocol Violation|1
310945|NCT01474538|1052111|P1|Treatment Period 1|Protocol Violation|0
310946|NCT01474538|1052110|P2|Treatment Period 1|Withdrawal by Subject|3
310947|NCT01474538|1052111|P1|Treatment Period 1|Withdrawal by Subject|1
310948|NCT01474538|1052110|P2|Treatment Period 1|Physician Decision|0
310949|NCT01474538|1052111|P1|Treatment Period 1|Physician Decision|1
310950|NCT01474538|1052110|P2|Treatment Period 1|Death|0
310951|NCT01474538|1052111|P1|Treatment Period 1|Death|1
310952|NCT01474512|1052128|P10|Maintenance Period|Treated but Discontinued in Induction|0
310953|NCT01474512|1052129|P9|Maintenance Period|Treated but Discontinued in Induction|0
310954|NCT01474512|1052130|P8|Maintenance Period|Treated but Discontinued in Induction|0
310955|NCT01474512|1052131|P7|Maintenance Period|Treated but Discontinued in Induction|0
310956|NCT01474512|1052132|P6|Maintenance Period|Treated but Discontinued in Induction|0
310957|NCT01474512|1052133|P5|Maintenance Period|Treated but Discontinued in Induction|1
310958|NCT01474512|1052134|P4|Maintenance Period|Treated but Discontinued in Induction|0
310959|NCT01474512|1052135|P3|Maintenance Period|Treated but Discontinued in Induction|0
310960|NCT01474512|1052136|P2|Maintenance Period|Treated but Discontinued in Induction|0
310961|NCT01474512|1052137|P1|Maintenance Period|Treated but Discontinued in Induction|0
310962|NCT01474512|1052128|P10|Maintenance Period|Protocol Violation|1
310963|NCT01474512|1052129|P9|Maintenance Period|Protocol Violation|0
310964|NCT01474512|1052130|P8|Maintenance Period|Protocol Violation|1
310965|NCT01474512|1052131|P7|Maintenance Period|Protocol Violation|0
310966|NCT01474512|1052132|P6|Maintenance Period|Protocol Violation|0
310967|NCT01474512|1052133|P5|Maintenance Period|Protocol Violation|0
310968|NCT01474512|1052134|P4|Maintenance Period|Protocol Violation|1
310969|NCT01474512|1052135|P3|Maintenance Period|Protocol Violation|0
310970|NCT01474512|1052136|P2|Maintenance Period|Protocol Violation|0
310971|NCT01474512|1052137|P1|Maintenance Period|Protocol Violation|0
310972|NCT01474512|1052128|P10|Maintenance Period|Lack of Efficacy|12
310973|NCT01474512|1052129|P9|Maintenance Period|Lack of Efficacy|11
310974|NCT01474512|1052130|P8|Maintenance Period|Lack of Efficacy|11
310975|NCT01474512|1052131|P7|Maintenance Period|Lack of Efficacy|0
310976|NCT01474512|1052132|P6|Maintenance Period|Lack of Efficacy|0
310977|NCT01474512|1052133|P5|Maintenance Period|Lack of Efficacy|0
310978|NCT01474512|1052134|P4|Maintenance Period|Lack of Efficacy|1
310979|NCT01474512|1052135|P3|Maintenance Period|Lack of Efficacy|0
310980|NCT01474512|1052136|P2|Maintenance Period|Lack of Efficacy|0
310981|NCT01474512|1052137|P1|Maintenance Period|Lack of Efficacy|0
310982|NCT01474512|1052128|P10|Maintenance Period|Clinical Relapse|0
310983|NCT01474512|1052129|P9|Maintenance Period|Clinical Relapse|0
310984|NCT01474512|1052130|P8|Maintenance Period|Clinical Relapse|0
310985|NCT01474512|1052131|P7|Maintenance Period|Clinical Relapse|0
310986|NCT01474512|1052132|P6|Maintenance Period|Clinical Relapse|0
310987|NCT01474512|1052133|P5|Maintenance Period|Clinical Relapse|0
310988|NCT01474512|1052134|P4|Maintenance Period|Clinical Relapse|1
310989|NCT01474512|1052135|P3|Maintenance Period|Clinical Relapse|0
310990|NCT01474512|1052136|P2|Maintenance Period|Clinical Relapse|0
310991|NCT01474512|1052137|P1|Maintenance Period|Clinical Relapse|0
310992|NCT01474512|1052128|P10|Maintenance Period|Investigator Decision|0
310993|NCT01474512|1052129|P9|Maintenance Period|Investigator Decision|0
310994|NCT01474512|1052130|P8|Maintenance Period|Investigator Decision|2
310995|NCT01474512|1052131|P7|Maintenance Period|Investigator Decision|0
310996|NCT01474512|1052132|P6|Maintenance Period|Investigator Decision|1
310997|NCT01474512|1052133|P5|Maintenance Period|Investigator Decision|0
310998|NCT01474512|1052134|P4|Maintenance Period|Investigator Decision|0
310999|NCT01474512|1052135|P3|Maintenance Period|Investigator Decision|0
311000|NCT01474512|1052136|P2|Maintenance Period|Investigator Decision|0
311001|NCT01474512|1052137|P1|Maintenance Period|Investigator Decision|0
311002|NCT01474512|1052128|P10|Maintenance Period|Death|0
311003|NCT01474512|1052129|P9|Maintenance Period|Death|0
311004|NCT01474512|1052130|P8|Maintenance Period|Death|0
311005|NCT01474512|1052131|P7|Maintenance Period|Death|0
311006|NCT01474512|1052132|P6|Maintenance Period|Death|2
311007|NCT01474512|1052133|P5|Maintenance Period|Death|0
311008|NCT01474512|1052134|P4|Maintenance Period|Death|0
311009|NCT01474512|1052135|P3|Maintenance Period|Death|0
311010|NCT01474512|1052136|P2|Maintenance Period|Death|0
311011|NCT01474512|1052137|P1|Maintenance Period|Death|0
311012|NCT01474512|1052128|P10|Maintenance Period|Lost to Follow-up|1
311013|NCT01474512|1052129|P9|Maintenance Period|Lost to Follow-up|1
311014|NCT01474512|1052130|P8|Maintenance Period|Lost to Follow-up|2
311015|NCT01474512|1052131|P7|Maintenance Period|Lost to Follow-up|0
311016|NCT01474512|1052132|P6|Maintenance Period|Lost to Follow-up|0
311017|NCT01474512|1052133|P5|Maintenance Period|Lost to Follow-up|3
311018|NCT01474512|1052134|P4|Maintenance Period|Lost to Follow-up|3
311019|NCT01474512|1052135|P3|Maintenance Period|Lost to Follow-up|0
311020|NCT01474512|1052136|P2|Maintenance Period|Lost to Follow-up|0
311021|NCT01474512|1052137|P1|Maintenance Period|Lost to Follow-up|0
311022|NCT01474512|1052128|P10|Maintenance Period|Withdrawal by Subject|1
311023|NCT01474512|1052129|P9|Maintenance Period|Withdrawal by Subject|3
311024|NCT01474512|1052130|P8|Maintenance Period|Withdrawal by Subject|6
311025|NCT01474512|1052131|P7|Maintenance Period|Withdrawal by Subject|1
311026|NCT01474512|1052132|P6|Maintenance Period|Withdrawal by Subject|3
311027|NCT01474512|1052133|P5|Maintenance Period|Withdrawal by Subject|2
311028|NCT01474512|1052134|P4|Maintenance Period|Withdrawal by Subject|6
311029|NCT01474512|1052135|P3|Maintenance Period|Withdrawal by Subject|0
311030|NCT01474512|1052136|P2|Maintenance Period|Withdrawal by Subject|0
311031|NCT01474512|1052137|P1|Maintenance Period|Withdrawal by Subject|0
311032|NCT01474512|1052128|P10|Maintenance Period|Adverse Event|3
311033|NCT01474512|1052129|P9|Maintenance Period|Adverse Event|1
311034|NCT01474512|1052130|P8|Maintenance Period|Adverse Event|19
311035|NCT01474512|1052131|P7|Maintenance Period|Adverse Event|0
311036|NCT01474512|1052132|P6|Maintenance Period|Adverse Event|7
311037|NCT01474512|1052133|P5|Maintenance Period|Adverse Event|2
311038|NCT01474512|1052134|P4|Maintenance Period|Adverse Event|4
311039|NCT01474512|1052135|P3|Maintenance Period|Adverse Event|0
311040|NCT01474512|1052136|P2|Maintenance Period|Adverse Event|0
311041|NCT01474512|1052137|P1|Maintenance Period|Adverse Event|0
311042|NCT01474512|1052128|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
311043|NCT01474512|1052129|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
311044|NCT01474512|1052130|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
311045|NCT01474512|1052131|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
311046|NCT01474512|1052132|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
311047|NCT01474512|1052133|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
311048|NCT01474512|1052134|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
311049|NCT01474512|1052135|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
311050|NCT01474512|1052136|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
311051|NCT01474512|1052137|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
311052|NCT01474512|1052128|P10|Induction Period|Lost to Follow-up|0
311053|NCT01474512|1052129|P9|Induction Period|Lost to Follow-up|0
311054|NCT01474512|1052130|P8|Induction Period|Lost to Follow-up|0
311055|NCT01474512|1052131|P7|Induction Period|Lost to Follow-up|0
311056|NCT01474512|1052132|P6|Induction Period|Lost to Follow-up|0
311057|NCT01474512|1052133|P5|Induction Period|Lost to Follow-up|0
311058|NCT01474512|1052134|P4|Induction Period|Lost to Follow-up|0
311059|NCT01474512|1052135|P3|Induction Period|Lost to Follow-up|2
311060|NCT01474512|1052136|P2|Induction Period|Lost to Follow-up|0
311061|NCT01474512|1052137|P1|Induction Period|Lost to Follow-up|1
311062|NCT01474512|1052128|P10|Induction Period|Sponsor Decision|0
311063|NCT01474512|1052129|P9|Induction Period|Sponsor Decision|0
311064|NCT01474512|1052130|P8|Induction Period|Sponsor Decision|0
311065|NCT01474512|1052131|P7|Induction Period|Sponsor Decision|0
311066|NCT01474512|1052132|P6|Induction Period|Sponsor Decision|0
311067|NCT01474512|1052133|P5|Induction Period|Sponsor Decision|0
311068|NCT01474512|1052134|P4|Induction Period|Sponsor Decision|0
311069|NCT01474512|1052135|P3|Induction Period|Sponsor Decision|1
311070|NCT01474512|1052136|P2|Induction Period|Sponsor Decision|1
311071|NCT01474512|1052137|P1|Induction Period|Sponsor Decision|1
311072|NCT01474512|1052128|P10|Induction Period|Protocol Violation|0
311073|NCT01474512|1052129|P9|Induction Period|Protocol Violation|0
311074|NCT01474512|1052130|P8|Induction Period|Protocol Violation|0
311075|NCT01474512|1052131|P7|Induction Period|Protocol Violation|0
311076|NCT01474512|1052132|P6|Induction Period|Protocol Violation|0
311077|NCT01474512|1052133|P5|Induction Period|Protocol Violation|0
311078|NCT01474512|1052134|P4|Induction Period|Protocol Violation|0
311079|NCT01474512|1052135|P3|Induction Period|Protocol Violation|0
311080|NCT01474512|1052136|P2|Induction Period|Protocol Violation|6
311081|NCT01474512|1052137|P1|Induction Period|Protocol Violation|3
311082|NCT01474512|1052128|P10|Induction Period|Withdrawal by Subject|0
311083|NCT01474512|1052129|P9|Induction Period|Withdrawal by Subject|0
311084|NCT01474512|1052130|P8|Induction Period|Withdrawal by Subject|0
311085|NCT01474512|1052131|P7|Induction Period|Withdrawal by Subject|0
311086|NCT01474512|1052132|P6|Induction Period|Withdrawal by Subject|0
311087|NCT01474512|1052133|P5|Induction Period|Withdrawal by Subject|0
311088|NCT01474512|1052134|P4|Induction Period|Withdrawal by Subject|0
311089|NCT01474512|1052135|P3|Induction Period|Withdrawal by Subject|5
311090|NCT01474512|1052136|P2|Induction Period|Withdrawal by Subject|6
311091|NCT01474512|1052137|P1|Induction Period|Withdrawal by Subject|6
311092|NCT01474512|1052128|P10|Induction Period|Lack of Efficacy|0
311093|NCT01474512|1052129|P9|Induction Period|Lack of Efficacy|0
311094|NCT01474512|1052130|P8|Induction Period|Lack of Efficacy|0
311095|NCT01474512|1052131|P7|Induction Period|Lack of Efficacy|0
311096|NCT01474512|1052132|P6|Induction Period|Lack of Efficacy|0
311097|NCT01474512|1052133|P5|Induction Period|Lack of Efficacy|0
311098|NCT01474512|1052134|P4|Induction Period|Lack of Efficacy|0
311099|NCT01474512|1052135|P3|Induction Period|Lack of Efficacy|0
311100|NCT01474512|1052136|P2|Induction Period|Lack of Efficacy|1
311101|NCT01474512|1052137|P1|Induction Period|Lack of Efficacy|7
311102|NCT01474512|1052128|P10|Induction Period|Adverse Event|0
311103|NCT01474512|1052129|P9|Induction Period|Adverse Event|0
311104|NCT01474512|1052130|P8|Induction Period|Adverse Event|0
311105|NCT01474512|1052131|P7|Induction Period|Adverse Event|0
311106|NCT01474512|1052132|P6|Induction Period|Adverse Event|0
311107|NCT01474512|1052133|P5|Induction Period|Adverse Event|0
311108|NCT01474512|1052134|P4|Induction Period|Adverse Event|0
311109|NCT01474512|1052135|P3|Induction Period|Adverse Event|10
311110|NCT01474512|1052136|P2|Induction Period|Adverse Event|10
311111|NCT01474512|1052137|P1|Induction Period|Adverse Event|6
311112|NCT01474434|1052206|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
311113|NCT01474434|1052207|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
311114|NCT01474434|1052208|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
311115|NCT01474434|1052209|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
311116|NCT01474434|1052206|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
311117|NCT01474434|1052207|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
311118|NCT01474434|1052208|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
311119|NCT01474434|1052209|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
311120|NCT01474434|1052206|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
311121|NCT01474434|1052207|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
311122|NCT01474434|1052208|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
311123|NCT01474434|1052209|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
311124|NCT01474317|1052251|P1|Overall Study|Subject ineligible for study|1
311125|NCT01474317|1052251|P1|Overall Study|Adverse Event|1
311126|NCT01474291|1052260|P1|Overall Study|Death|2
311127|NCT01474291|1052260|P1|Overall Study|No Reason Reported|10
311128|NCT01474291|1052260|P1|Overall Study|Patient No Longer Wanted to Participate|12
311129|NCT01474291|1052260|P1|Overall Study|Lost to Follow-up|29
311130|NCT01474291|1052260|P1|Overall Study|Adverse Event|53
311131|NCT01474291|1052260|P1|Overall Study|Lack of Treatment Efficacy|88
311132|NCT01474291|1052260|P1|Overall Study|Not Evaluable for Efficacy|26
311133|NCT01474239|1052304|P2|Overall Study|Withdrawal for Economic Reason|0
311134|NCT01474239|1052305|P1|Overall Study|Withdrawal for Economic Reason|1
311135|NCT01474239|1052304|P2|Overall Study|Clinical Disease Progression|1
311136|NCT01474239|1052305|P1|Overall Study|Clinical Disease Progression|7
311137|NCT01474239|1052304|P2|Overall Study|Death|1
311138|NCT01474239|1052305|P1|Overall Study|Death|1
311139|NCT01474239|1052304|P2|Overall Study|Withdrawal by Subject|2
311140|NCT01474239|1052305|P1|Overall Study|Withdrawal by Subject|1
311141|NCT01474239|1052304|P2|Overall Study|Adverse Event|3
311142|NCT01474239|1052305|P1|Overall Study|Adverse Event|12
311143|NCT01474239|1052304|P2|Overall Study|Disease Progression|25
311144|NCT01474239|1052305|P1|Overall Study|Disease Progression|37
311145|NCT01473953|1052499|P5|Overall Study|Other|0
311146|NCT01473953|1052500|P4|Overall Study|Other|0
311147|NCT01473953|1052501|P3|Overall Study|Other|0
311148|NCT01473953|1052502|P2|Overall Study|Other|0
311149|NCT01473953|1052503|P1|Overall Study|Other|1
311150|NCT01473836|1052545|P1|Overall Study|Does not meet entrance criteria|1
311151|NCT01473836|1052545|P1|Overall Study|Lack of Efficacy|1
311152|NCT01473836|1052545|P1|Overall Study|Adverse Event|4
311153|NCT01473758|1052556|P4|Cycle 2|Adverse Event|0
311154|NCT01473758|1052557|P3|Cycle 2|Adverse Event|5
311155|NCT01473758|1052558|P2|Cycle 2|Adverse Event|0
311156|NCT01473758|1052559|P1|Cycle 2|Adverse Event|0
311157|NCT01473758|1052556|P4|Cycle 1|Withdrawal by Subject|0
311158|NCT01473758|1052557|P3|Cycle 1|Withdrawal by Subject|0
311159|NCT01473758|1052558|P2|Cycle 1|Withdrawal by Subject|1
311160|NCT01473758|1052559|P1|Cycle 1|Withdrawal by Subject|1
311161|NCT01473758|1052556|P4|Cycle 1|Adverse Event|0
311162|NCT01473758|1052557|P3|Cycle 1|Adverse Event|0
311163|NCT01473758|1052558|P2|Cycle 1|Adverse Event|2
311164|NCT01473758|1052559|P1|Cycle 1|Adverse Event|10
311165|NCT01473602|1052696|P2|Overall Study|Physician Decision|0
311166|NCT01473602|1052697|P1|Overall Study|Physician Decision|1
311167|NCT01473602|1052696|P2|Overall Study|Withdrawal by Subject|4
311168|NCT01473602|1052697|P1|Overall Study|Withdrawal by Subject|5
311169|NCT01473602|1052696|P2|Overall Study|Lost to Follow-up|1
311170|NCT01473602|1052697|P1|Overall Study|Lost to Follow-up|1
311171|NCT01473602|1052696|P2|Overall Study|Death|1
311172|NCT01473602|1052697|P1|Overall Study|Death|0
311173|NCT01473602|1052696|P2|Overall Study|Adverse Event|2
311174|NCT01473602|1052697|P1|Overall Study|Adverse Event|1
311175|NCT01473589|1052733|P2|Overall Study|Entry criteria not met|1
311176|NCT01473589|1052734|P1|Overall Study|Entry criteria not met|0
311177|NCT01473589|1052733|P2|Overall Study|Physician Decision|1
311178|NCT01473589|1052734|P1|Overall Study|Physician Decision|0
311179|NCT01473589|1052733|P2|Overall Study|Withdrawal by Subject|11
311180|NCT01473589|1052734|P1|Overall Study|Withdrawal by Subject|5
311181|NCT01473589|1052733|P2|Overall Study|Protocol Violation|0
311182|NCT01473589|1052734|P1|Overall Study|Protocol Violation|1
311183|NCT01473589|1052733|P2|Overall Study|Lost to Follow-up|2
311184|NCT01473589|1052734|P1|Overall Study|Lost to Follow-up|2
311185|NCT01473589|1052733|P2|Overall Study|Death|0
311186|NCT01473589|1052734|P1|Overall Study|Death|2
311187|NCT01473589|1052733|P2|Overall Study|Adverse Event|1
311188|NCT01473589|1052734|P1|Overall Study|Adverse Event|1
311189|NCT01473563|1052768|P1|Overall Study|Lost to FU post tx discontinuation|1
311190|NCT01473524|1052790|P3|Overall Study|Withdrawal by Subject|1
311191|NCT01473524|1052791|P2|Overall Study|Withdrawal by Subject|1
311192|NCT01473524|1052792|P1|Overall Study|Withdrawal by Subject|2
311193|NCT01473524|1052790|P3|Overall Study|Death|0
311194|NCT01473524|1052791|P2|Overall Study|Death|0
311195|NCT01473524|1052792|P1|Overall Study|Death|1
311196|NCT01473524|1052790|P3|Overall Study|Adverse Event|2
311197|NCT01473524|1052791|P2|Overall Study|Adverse Event|8
311198|NCT01473524|1052792|P1|Overall Study|Adverse Event|4
311199|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
311200|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
311201|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
311202|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
311203|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
311204|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
311205|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
311206|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
311207|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Site closure|1
311208|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Site closure|3
311209|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
311210|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
311211|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
311212|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
311213|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
311214|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
311215|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
311216|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
311217|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Physician Decision|2
311218|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Physician Decision|1
311219|NCT01473420|1052825|P2|Maintenance Period (16 Weeks)|Adverse Event|2
311220|NCT01473420|1052826|P1|Maintenance Period (16 Weeks)|Adverse Event|3
311221|NCT01473420|1052825|P2|Titration Period (18 Weeks)|Did not meet criteria|32
311222|NCT01473420|1052826|P1|Titration Period (18 Weeks)|Did not meet criteria|32
311223|NCT01473420|1052825|P2|Titration Period (18 Weeks)|Adverse Event|6
311224|NCT01473420|1052826|P1|Titration Period (18 Weeks)|Adverse Event|4
311225|NCT01473394|1052910|P2|Overall Study|Lost to Follow-up|11
311226|NCT01473394|1052911|P1|Overall Study|Lost to Follow-up|9
311227|NCT01473394|1052910|P2|Overall Study|Withdrew Consent|10
311228|NCT01473394|1052911|P1|Overall Study|Withdrew Consent|12
311229|NCT01473394|1052910|P2|Overall Study|Protocol Violation|5
311230|NCT01473394|1052911|P1|Overall Study|Protocol Violation|7
311231|NCT01473394|1052910|P2|Overall Study|Insufficient Therapeutic Response|1
311232|NCT01473394|1052911|P1|Overall Study|Insufficient Therapeutic Response|4
311233|NCT01473394|1052910|P2|Overall Study|Adverse Event|16
311234|NCT01473394|1052911|P1|Overall Study|Adverse Event|13
311235|NCT01473381|1052925|P4|Overall Study|Other Reasons|3
311236|NCT01473381|1052926|P3|Overall Study|Other Reasons|1
311237|NCT01473381|1052927|P2|Overall Study|Other Reasons|0
311238|NCT01473381|1052928|P1|Overall Study|Other Reasons|0
311239|NCT01473381|1052925|P4|Overall Study|Lost to Follow-up|23
311240|NCT01473381|1052926|P3|Overall Study|Lost to Follow-up|35
311241|NCT01473381|1052927|P2|Overall Study|Lost to Follow-up|28
311242|NCT01473381|1052928|P1|Overall Study|Lost to Follow-up|25
311243|NCT01473381|1052925|P4|Overall Study|Withdrawal of Consent|26
311244|NCT01473381|1052926|P3|Overall Study|Withdrawal of Consent|20
311245|NCT01473381|1052927|P2|Overall Study|Withdrawal of Consent|21
311246|NCT01473381|1052928|P1|Overall Study|Withdrawal of Consent|20
311247|NCT01473381|1052925|P4|Overall Study|Protocol Violation|17
311248|NCT01473381|1052926|P3|Overall Study|Protocol Violation|19
311249|NCT01473381|1052927|P2|Overall Study|Protocol Violation|23
311250|NCT01473381|1052928|P1|Overall Study|Protocol Violation|17
311251|NCT01473381|1052925|P4|Overall Study|Insufficient Therapeutic Response|3
311252|NCT01473381|1052926|P3|Overall Study|Insufficient Therapeutic Response|2
311253|NCT01473381|1052927|P2|Overall Study|Insufficient Therapeutic Response|1
311254|NCT01473381|1052928|P1|Overall Study|Insufficient Therapeutic Response|10
311255|NCT01473381|1052925|P4|Overall Study|Adverse Event|17
311256|NCT01473381|1052926|P3|Overall Study|Adverse Event|25
311257|NCT01473381|1052927|P2|Overall Study|Adverse Event|20
311258|NCT01473381|1052928|P1|Overall Study|Adverse Event|8
311259|NCT01472965|1053010|P2|Overall Study|Withdrawal by Subject|0
311260|NCT01472965|1053011|P1|Overall Study|Withdrawal by Subject|1
311261|NCT01472939|1053031|P4|Overall Study|Withdrawal by Subject|4
311262|NCT01472939|1053032|P3|Overall Study|Withdrawal by Subject|1
311263|NCT01472939|1053033|P2|Overall Study|Withdrawal by Subject|3
311264|NCT01472939|1053034|P1|Overall Study|Withdrawal by Subject|9
311265|NCT01472939|1053031|P4|Overall Study|Protocol Violation|1
311266|NCT01472939|1053032|P3|Overall Study|Protocol Violation|0
311267|NCT01472939|1053033|P2|Overall Study|Protocol Violation|3
311268|NCT01472939|1053034|P1|Overall Study|Protocol Violation|3
311269|NCT01472939|1053031|P4|Overall Study|Withdrawal By PI|0
311270|NCT01472939|1053032|P3|Overall Study|Withdrawal By PI|0
311271|NCT01472939|1053033|P2|Overall Study|Withdrawal By PI|0
311272|NCT01472939|1053034|P1|Overall Study|Withdrawal By PI|1
311273|NCT01472939|1053031|P4|Overall Study|Prohibited Medication|0
311274|NCT01472939|1053032|P3|Overall Study|Prohibited Medication|0
311275|NCT01472939|1053033|P2|Overall Study|Prohibited Medication|1
311276|NCT01472939|1053034|P1|Overall Study|Prohibited Medication|0
311277|NCT01472939|1053031|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
311278|NCT01472939|1053032|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
311279|NCT01472939|1053033|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
311280|NCT01472939|1053034|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
311281|NCT01472939|1053031|P4|Overall Study|Lost to Follow-up|0
311282|NCT01472939|1053032|P3|Overall Study|Lost to Follow-up|2
311283|NCT01472939|1053033|P2|Overall Study|Lost to Follow-up|0
311284|NCT01472939|1053034|P1|Overall Study|Lost to Follow-up|3
311285|NCT01472939|1053031|P4|Overall Study|Lack of Efficacy|1
311286|NCT01472939|1053032|P3|Overall Study|Lack of Efficacy|0
311287|NCT01472939|1053033|P2|Overall Study|Lack of Efficacy|0
311288|NCT01472939|1053034|P1|Overall Study|Lack of Efficacy|1
311289|NCT01472939|1053031|P4|Overall Study|Adverse Event|14
311290|NCT01472939|1053032|P3|Overall Study|Adverse Event|7
311291|NCT01472939|1053033|P2|Overall Study|Adverse Event|7
311292|NCT01472939|1053034|P1|Overall Study|Adverse Event|3
311293|NCT01472835|1053078|P2|Overall Study|Lost to Follow-up|0
311294|NCT01472835|1053079|P1|Overall Study|Lost to Follow-up|2
311295|NCT01472380|1053134|P1|1 Day Period Between Dosing|Protocol Violation|1
311296|NCT01472380|1053134|P1|Efavirenz Alone|Withdrawal by Subject|1
311297|NCT01472341|1053145|P1|Overall Study|Death|9
311298|NCT01472341|1053145|P1|Overall Study|Laboratory parameters unavailable|25
311299|NCT01472341|1053145|P1|Overall Study|Lost to Follow-up|52
311300|NCT01472341|1053145|P1|Overall Study|Withdrawal by Subject|39
311301|NCT01472341|1053145|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
311302|NCT01472341|1053145|P1|Overall Study|Started insulin therapy|55
311303|NCT01472289|1053151|P1|Overall Study|Death|2
311304|NCT01472185|1053163|P2|Overall Study|Subject Withdrew Consent|3
311305|NCT01472185|1053164|P1|Overall Study|Subject Withdrew Consent|6
311306|NCT01472185|1053163|P2|Overall Study|Subject Noncompliance|15
311307|NCT01472185|1053164|P1|Overall Study|Subject Noncompliance|8
311308|NCT01472185|1053163|P2|Overall Study|Protocol Violation|1
311309|NCT01472185|1053164|P1|Overall Study|Protocol Violation|5
311310|NCT01472185|1053163|P2|Overall Study|Lost to Follow-up|1
311311|NCT01472185|1053164|P1|Overall Study|Lost to Follow-up|4
311312|NCT01472185|1053163|P2|Overall Study|Investigator’s Discretion|1
311313|NCT01472185|1053164|P1|Overall Study|Investigator’s Discretion|3
311314|NCT01472185|1053163|P2|Overall Study|Hyperglycemia|2
311315|NCT01472185|1053164|P1|Overall Study|Hyperglycemia|5
311316|NCT01472185|1053163|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
311317|NCT01472185|1053164|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
311318|NCT01472185|1053163|P2|Overall Study|Randomized but Not Treated|1
311319|NCT01472185|1053164|P1|Overall Study|Randomized but Not Treated|0
311320|NCT01471782|1053184|P6|Overall Study|Death|1
311321|NCT01471782|1053185|P5|Overall Study|Death|0
311322|NCT01471782|1053186|P4|Overall Study|Death|0
311323|NCT01471782|1053187|P3|Overall Study|Death|0
311324|NCT01471782|1053188|P2|Overall Study|Death|0
311325|NCT01471782|1053189|P1|Overall Study|Death|0
311326|NCT01471782|1053184|P6|Overall Study|Withdrawal by Parent/Guardian|0
311327|NCT01471782|1053185|P5|Overall Study|Withdrawal by Parent/Guardian|1
311328|NCT01471782|1053186|P4|Overall Study|Withdrawal by Parent/Guardian|0
311329|NCT01471782|1053187|P3|Overall Study|Withdrawal by Parent/Guardian|0
311330|NCT01471782|1053188|P2|Overall Study|Withdrawal by Parent/Guardian|0
311331|NCT01471782|1053189|P1|Overall Study|Withdrawal by Parent/Guardian|0
311332|NCT01471782|1053184|P6|Overall Study|Physician Decision|8
311333|NCT01471782|1053185|P5|Overall Study|Physician Decision|3
311334|NCT01471782|1053186|P4|Overall Study|Physician Decision|0
311335|NCT01471782|1053187|P3|Overall Study|Physician Decision|0
311336|NCT01471782|1053188|P2|Overall Study|Physician Decision|0
311337|NCT01471782|1053189|P1|Overall Study|Physician Decision|0
311338|NCT01471782|1053184|P6|Overall Study|Disease Relapse|1
311339|NCT01471782|1053185|P5|Overall Study|Disease Relapse|2
311340|NCT01471782|1053186|P4|Overall Study|Disease Relapse|1
311341|NCT01471782|1053187|P3|Overall Study|Disease Relapse|0
311342|NCT01471782|1053188|P2|Overall Study|Disease Relapse|0
311343|NCT01471782|1053189|P1|Overall Study|Disease Relapse|0
311344|NCT01471782|1053184|P6|Overall Study|Change of Chemotherapy|4
311345|NCT01471782|1053185|P5|Overall Study|Change of Chemotherapy|1
311346|NCT01471782|1053186|P4|Overall Study|Change of Chemotherapy|0
311347|NCT01471782|1053187|P3|Overall Study|Change of Chemotherapy|0
311348|NCT01471782|1053188|P2|Overall Study|Change of Chemotherapy|1
311349|NCT01471782|1053189|P1|Overall Study|Change of Chemotherapy|1
311350|NCT01471782|1053184|P6|Overall Study|Other|5
311351|NCT01471782|1053185|P5|Overall Study|Other|6
311352|NCT01471782|1053186|P4|Overall Study|Other|1
311353|NCT01471782|1053187|P3|Overall Study|Other|1
311354|NCT01471782|1053188|P2|Overall Study|Other|0
311355|NCT01471782|1053189|P1|Overall Study|Other|0
311356|NCT01471782|1053184|P6|Overall Study|Adverse Event|1
311357|NCT01471782|1053185|P5|Overall Study|Adverse Event|3
311358|NCT01471782|1053186|P4|Overall Study|Adverse Event|2
311359|NCT01471782|1053187|P3|Overall Study|Adverse Event|2
311360|NCT01471782|1053188|P2|Overall Study|Adverse Event|1
311361|NCT01471782|1053189|P1|Overall Study|Adverse Event|1
311362|NCT01471782|1053184|P6|Overall Study|Lack of Efficacy|18
311363|NCT01471782|1053185|P5|Overall Study|Lack of Efficacy|5
311364|NCT01471782|1053186|P4|Overall Study|Lack of Efficacy|1
311365|NCT01471782|1053187|P3|Overall Study|Lack of Efficacy|1
311366|NCT01471782|1053188|P2|Overall Study|Lack of Efficacy|2
311367|NCT01471782|1053189|P1|Overall Study|Lack of Efficacy|1
311368|NCT01471782|1053184|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
311369|NCT01471782|1053185|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
311370|NCT01471782|1053186|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
311371|NCT01471782|1053187|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
311372|NCT01471782|1053188|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
311373|NCT01471782|1053189|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
311374|NCT01471691|1053243|P2|Overall Study|Lack of Efficacy|1
311375|NCT01471691|1053244|P1|Overall Study|Lack of Efficacy|0
311376|NCT01471379|1053253|P3|Overall Study|Study terminated|0
311377|NCT01471379|1053254|P2|Overall Study|Study terminated|1
311378|NCT01471379|1053255|P1|Overall Study|Study terminated|0
311379|NCT01471379|1053253|P3|Overall Study|Adverse Event|0
311380|NCT01471379|1053254|P2|Overall Study|Adverse Event|0
311381|NCT01471379|1053255|P1|Overall Study|Adverse Event|1
311382|NCT01471353|1053275|P1|Overall Study|remain on study|3
311383|NCT01471340|1053283|P2|Overall Study|Invalid informed consent|0
311384|NCT01471340|1053284|P1|Overall Study|Invalid informed consent|1
311385|NCT01471340|1053283|P2|Overall Study|Investigational site closure|1
311386|NCT01471340|1053284|P1|Overall Study|Investigational site closure|0
311387|NCT01471340|1053283|P2|Overall Study|Lost to Follow-up|1
311388|NCT01471340|1053284|P1|Overall Study|Lost to Follow-up|0
311389|NCT01471340|1053283|P2|Overall Study|Death|4
311390|NCT01471340|1053284|P1|Overall Study|Death|5
311391|NCT01471574|1053307|P4|Follow-up Period|Follow-up no longer required|0
311392|NCT01471574|1053308|P3|Follow-up Period|Follow-up no longer required|0
311393|NCT01471574|1053309|P2|Follow-up Period|Follow-up no longer required|1
311394|NCT01471574|1053310|P1|Follow-up Period|Follow-up no longer required|0
311395|NCT01471574|1053307|P4|Follow-up Period|Death|0
311396|NCT01471574|1053308|P3|Follow-up Period|Death|1
311397|NCT01471574|1053309|P2|Follow-up Period|Death|0
311398|NCT01471574|1053310|P1|Follow-up Period|Death|0
311399|NCT01471574|1053307|P4|Follow-up Period|Lost to Follow-up|2
311400|NCT01471574|1053308|P3|Follow-up Period|Lost to Follow-up|3
311401|NCT01471574|1053309|P2|Follow-up Period|Lost to Follow-up|1
311402|NCT01471574|1053310|P1|Follow-up Period|Lost to Follow-up|4
311403|NCT01471574|1053307|P4|Follow-up Period|Withdrawal by Subject|1
311404|NCT01471574|1053308|P3|Follow-up Period|Withdrawal by Subject|3
311405|NCT01471574|1053309|P2|Follow-up Period|Withdrawal by Subject|0
311406|NCT01471574|1053310|P1|Follow-up Period|Withdrawal by Subject|3
311407|NCT01471574|1053307|P4|Treatment Period|Not specified|0
311408|NCT01471574|1053308|P3|Treatment Period|Not specified|0
311409|NCT01471574|1053309|P2|Treatment Period|Not specified|0
311410|NCT01471574|1053310|P1|Treatment Period|Not specified|1
311411|NCT01471574|1053307|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
311412|NCT01471574|1053308|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
311413|NCT01471574|1053309|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
311414|NCT01471574|1053310|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
311415|NCT01471574|1053307|P4|Treatment Period|Lost to Follow-up|0
311416|NCT01471574|1053308|P3|Treatment Period|Lost to Follow-up|2
311417|NCT01471574|1053309|P2|Treatment Period|Lost to Follow-up|2
311418|NCT01471574|1053310|P1|Treatment Period|Lost to Follow-up|1
311419|NCT01471574|1053307|P4|Treatment Period|Patient Requested Discontinue Study drug|1
311420|NCT01471574|1053308|P3|Treatment Period|Patient Requested Discontinue Study drug|1
311421|NCT01471574|1053309|P2|Treatment Period|Patient Requested Discontinue Study drug|0
311422|NCT01471574|1053310|P1|Treatment Period|Patient Requested Discontinue Study drug|4
311423|NCT01471574|1053307|P4|Treatment Period|Withdrawal by Subject|0
311424|NCT01471574|1053308|P3|Treatment Period|Withdrawal by Subject|1
311425|NCT01471574|1053309|P2|Treatment Period|Withdrawal by Subject|1
311426|NCT01471574|1053310|P1|Treatment Period|Withdrawal by Subject|5
311427|NCT01471574|1053307|P4|Treatment Period|Adverse Event|1
311428|NCT01471574|1053308|P3|Treatment Period|Adverse Event|6
311429|NCT01471574|1053309|P2|Treatment Period|Adverse Event|3
311430|NCT01471574|1053310|P1|Treatment Period|Adverse Event|7
311431|NCT01471574|1053307|P4|Treatment Period|Lack of Efficacy|1
311432|NCT01471574|1053308|P3|Treatment Period|Lack of Efficacy|14
311433|NCT01471574|1053309|P2|Treatment Period|Lack of Efficacy|4
311434|NCT01471574|1053310|P1|Treatment Period|Lack of Efficacy|12
311435|NCT01471197|1053341|P2|Overall Study|Study Drug Toxicity|0
311436|NCT01471197|1053342|P1|Overall Study|Study Drug Toxicity|1
311437|NCT01471197|1053341|P2|Overall Study|Death|0
311438|NCT01471197|1053342|P1|Overall Study|Death|1
311439|NCT01471197|1053341|P2|Overall Study|Disease Progression|2
311440|NCT01471197|1053342|P1|Overall Study|Disease Progression|4
311441|NCT01471171|1053352|P2|Treatment Period 2|Adverse Event|0
311442|NCT01471171|1053353|P1|Treatment Period 2|Adverse Event|1
311443|NCT01471171|1053352|P2|Treatment Period 1|Adverse Event|1
311444|NCT01471171|1053353|P1|Treatment Period 1|Adverse Event|4
311445|NCT01471015|1053371|P3|Overall Study|Death|1
311446|NCT01471015|1053372|P2|Overall Study|Death|1
311447|NCT01471015|1053373|P1|Overall Study|Death|0
311448|NCT01470599|1053415|P2|Overall Study|Adverse event not related to study drug|5
311449|NCT01470599|1053416|P1|Overall Study|Adverse event not related to study drug|1
311450|NCT01470599|1053415|P2|Overall Study|Insufficient clinical response|27
311451|NCT01470599|1053416|P1|Overall Study|Insufficient clinical response|6
311452|NCT01470599|1053415|P2|Overall Study|Adverse event related to study drug|5
311453|NCT01470599|1053416|P1|Overall Study|Adverse event related to study drug|2
311454|NCT01470599|1053415|P2|Overall Study|Protocol Violation|1
311455|NCT01470599|1053416|P1|Overall Study|Protocol Violation|3
311456|NCT01470599|1053415|P2|Overall Study|Other|0
311457|NCT01470599|1053416|P1|Overall Study|Other|1
311458|NCT01470599|1053415|P2|Overall Study|Withdrawal by Subject|4
311459|NCT01470599|1053416|P1|Overall Study|Withdrawal by Subject|3
311460|NCT01470599|1053415|P2|Overall Study|Lost to Follow-up|1
311461|NCT01470599|1053416|P1|Overall Study|Lost to Follow-up|2
311462|NCT01470599|1053415|P2|Overall Study|Did not meet entrance criteria|0
311463|NCT01470599|1053416|P1|Overall Study|Did not meet entrance criteria|1
311464|NCT01470469|1053480|P2|Overall Study|Not specified|1
311465|NCT01470469|1053481|P1|Overall Study|Not specified|2
311466|NCT01470469|1053480|P2|Overall Study|Protocol Violation|1
311467|NCT01470469|1053481|P1|Overall Study|Protocol Violation|1
311468|NCT01470469|1053480|P2|Overall Study|Lost to Follow-up|2
311469|NCT01470469|1053481|P1|Overall Study|Lost to Follow-up|2
311470|NCT01470469|1053480|P2|Overall Study|Adverse Event|7
311471|NCT01470469|1053481|P1|Overall Study|Adverse Event|0
311472|NCT01470469|1053480|P2|Overall Study|Lack of Efficacy|7
311473|NCT01470469|1053481|P1|Overall Study|Lack of Efficacy|1
311474|NCT01470469|1053480|P2|Overall Study|Withdrawal by Subject|6
311475|NCT01470469|1053481|P1|Overall Study|Withdrawal by Subject|4
311476|NCT01470417|1053501|P2|Overall Study|Disease progression|2
311477|NCT01470417|1053502|P1|Overall Study|Disease progression|0
311478|NCT01470248|1053514|P1|Overall Study|Withdrawal by Subject|1
311479|NCT01470144|1053570|P1|Overall Study|Patient’s and investigator’s decision|1
311480|NCT01470144|1053570|P1|Overall Study|Lung transplant|6
311481|NCT01470144|1053570|P1|Overall Study|Death|1
311482|NCT01470144|1053570|P1|Overall Study|Adverse Event|2
311483|NCT01470001|1053675|P2|Overall Study|Withdrawal by Subject|1
311484|NCT01470001|1053676|P1|Overall Study|Withdrawal by Subject|2
311485|NCT01470001|1053675|P2|Overall Study|Physician Decision|0
311486|NCT01470001|1053676|P1|Overall Study|Physician Decision|2
311487|NCT01470001|1053675|P2|Overall Study|Lost to Follow-up|1
311488|NCT01470001|1053676|P1|Overall Study|Lost to Follow-up|1
311489|NCT01469819|1053686|P1|Overall Study|Technical malfunction of SmartPill data|3
311490|NCT01469819|1053686|P1|Overall Study|Could not swallow SmartPill|2
311491|NCT01469819|1053686|P1|Overall Study|Did not meet inclusionary criteria|2
311492|NCT01469819|1053686|P1|Overall Study|Withdrawal by Subject|1
311493|NCT01469637|1053710|P2|Second Intervention|Incarcerated|0
311494|NCT01469637|1053711|P1|Second Intervention|Incarcerated|1
311495|NCT01469637|1053710|P2|First Intervention|Unacceptable behavior|1
311496|NCT01469637|1053711|P1|First Intervention|Unacceptable behavior|0
311497|NCT01469546|1053719|P1|Received 5 mg Dose|Physician Decision|3
311498|NCT01469546|1053719|P1|Received 5 mg Dose|Progressive Disease|3
311499|NCT01469546|1053719|P1|Received 5 mg Dose|Protocol Violation|2
311500|NCT01469546|1053719|P1|Received 5 mg Dose|Death|2
311501|NCT01469546|1053719|P1|Received 5 mg Dose|Adverse Event|13
311502|NCT01469377|1053729|P3|Overall Study|Other Miscellaneous Reasons|0
311503|NCT01469377|1053730|P2|Overall Study|Other Miscellaneous Reasons|0
311504|NCT01469377|1053731|P1|Overall Study|Other Miscellaneous Reasons|2
311505|NCT01469377|1053729|P3|Overall Study|Insufficient Therapeutic Response|0
311506|NCT01469377|1053730|P2|Overall Study|Insufficient Therapeutic Response|4
311507|NCT01469377|1053731|P1|Overall Study|Insufficient Therapeutic Response|3
311508|NCT01469377|1053729|P3|Overall Study|Adverse Event|36
311509|NCT01469377|1053730|P2|Overall Study|Adverse Event|18
311510|NCT01469377|1053731|P1|Overall Study|Adverse Event|8
311511|NCT01469377|1053729|P3|Overall Study|Withdrawal of Consent|15
311512|NCT01469377|1053730|P2|Overall Study|Withdrawal of Consent|14
311513|NCT01469377|1053731|P1|Overall Study|Withdrawal of Consent|12
311514|NCT01469377|1053729|P3|Overall Study|Lost to Follow-up|5
311515|NCT01469377|1053730|P2|Overall Study|Lost to Follow-up|2
311516|NCT01469377|1053731|P1|Overall Study|Lost to Follow-up|3
311517|NCT01469377|1053729|P3|Overall Study|Protocol Deviation|10
311518|NCT01469377|1053730|P2|Overall Study|Protocol Deviation|10
311519|NCT01469377|1053731|P1|Overall Study|Protocol Deviation|7
311520|NCT01469364|1053742|P1|Overall Study|Withdrawal by Subject|1
311521|NCT01469364|1053742|P1|Overall Study|Adverse Event|1
311522|NCT01469221|1053793|P3|Double Blind Phase|Sponsor Terminate Study|0
311523|NCT01469221|1053794|P2|Double Blind Phase|Sponsor Terminate Study|16
311524|NCT01469221|1053795|P1|Double Blind Phase|Sponsor Terminate Study|12
311525|NCT01469221|1053793|P3|Double Blind Phase|Physician Decision|0
311526|NCT01469221|1053794|P2|Double Blind Phase|Physician Decision|1
311527|NCT01469221|1053795|P1|Double Blind Phase|Physician Decision|1
311528|NCT01469221|1053793|P3|Double Blind Phase|Protocol Violation|0
311529|NCT01469221|1053794|P2|Double Blind Phase|Protocol Violation|0
311530|NCT01469221|1053795|P1|Double Blind Phase|Protocol Violation|1
311531|NCT01469182|1053806|P2|Overall Study|Did not meet Protocol Eligibility|0
311532|NCT01469182|1053807|P1|Overall Study|Did not meet Protocol Eligibility|3
311533|NCT01469182|1053806|P2|Overall Study|Protocol Violation|2
311534|NCT01469182|1053807|P1|Overall Study|Protocol Violation|4
311535|NCT01469182|1053806|P2|Overall Study|Withdrawal by Subject|1
311536|NCT01469182|1053807|P1|Overall Study|Withdrawal by Subject|4
311537|NCT01469182|1053806|P2|Overall Study|Lost to Follow-up|0
311538|NCT01469182|1053807|P1|Overall Study|Lost to Follow-up|3
311539|NCT01469182|1053806|P2|Overall Study|Adverse Event|3
311540|NCT01469182|1053807|P1|Overall Study|Adverse Event|21
311541|NCT01469065|1053834|P5|Overall Study|Not specified|0
311542|NCT01469065|1053835|P4|Overall Study|Not specified|0
311543|NCT01469065|1053836|P3|Overall Study|Not specified|0
311544|NCT01469065|1053837|P2|Overall Study|Not specified|1
311545|NCT01469065|1053838|P1|Overall Study|Not specified|0
311546|NCT01469065|1053834|P5|Overall Study|Lack of Efficacy|1
311547|NCT01469065|1053835|P4|Overall Study|Lack of Efficacy|0
311548|NCT01469065|1053836|P3|Overall Study|Lack of Efficacy|0
311549|NCT01469065|1053837|P2|Overall Study|Lack of Efficacy|0
311550|NCT01469065|1053838|P1|Overall Study|Lack of Efficacy|0
311551|NCT01469052|1053934|P6|Overall Study|Other|0
311552|NCT01469052|1053935|P5|Overall Study|Other|1
311553|NCT01469052|1053936|P4|Overall Study|Other|0
311554|NCT01469052|1053937|P3|Overall Study|Other|0
311555|NCT01469052|1053938|P2|Overall Study|Other|1
311556|NCT01469052|1053939|P1|Overall Study|Other|0
311557|NCT01469052|1053934|P6|Overall Study|Moved to rollover protocol|1
311558|NCT01469052|1053935|P5|Overall Study|Moved to rollover protocol|0
311559|NCT01469052|1053936|P4|Overall Study|Moved to rollover protocol|0
311560|NCT01469052|1053937|P3|Overall Study|Moved to rollover protocol|1
311561|NCT01469052|1053938|P2|Overall Study|Moved to rollover protocol|0
311562|NCT01469052|1053939|P1|Overall Study|Moved to rollover protocol|1
311563|NCT01469052|1053934|P6|Overall Study|Lack of Efficacy|2
311564|NCT01469052|1053935|P5|Overall Study|Lack of Efficacy|0
311565|NCT01469052|1053936|P4|Overall Study|Lack of Efficacy|0
311566|NCT01469052|1053937|P3|Overall Study|Lack of Efficacy|0
311567|NCT01469052|1053938|P2|Overall Study|Lack of Efficacy|0
311568|NCT01469052|1053939|P1|Overall Study|Lack of Efficacy|0
311569|NCT01469052|1053934|P6|Overall Study|Progressive disease|2
311570|NCT01469052|1053935|P5|Overall Study|Progressive disease|7
311571|NCT01469052|1053936|P4|Overall Study|Progressive disease|3
311572|NCT01469052|1053937|P3|Overall Study|Progressive disease|5
311573|NCT01469052|1053938|P2|Overall Study|Progressive disease|0
311574|NCT01469052|1053939|P1|Overall Study|Progressive disease|3
311575|NCT01469052|1053934|P6|Overall Study|Adverse Event|1
311576|NCT01469052|1053935|P5|Overall Study|Adverse Event|0
311577|NCT01469052|1053936|P4|Overall Study|Adverse Event|2
311578|NCT01469052|1053937|P3|Overall Study|Adverse Event|0
311579|NCT01469052|1053938|P2|Overall Study|Adverse Event|3
311580|NCT01469052|1053939|P1|Overall Study|Adverse Event|2
311581|NCT01469000|1054001|P2|Overall Study|On treatment, not yet died or PD|7
311582|NCT01469000|1054002|P1|Overall Study|On treatment, not yet died or PD|23
311583|NCT01469000|1054001|P2|Overall Study|Entry Criteria Not Met|0
311584|NCT01469000|1054002|P1|Overall Study|Entry Criteria Not Met|1
311585|NCT01469000|1054001|P2|Overall Study|Physician Decision|1
311586|NCT01469000|1054002|P1|Overall Study|Physician Decision|0
311587|NCT01469000|1054001|P2|Overall Study|Withdrawal by Subject|1
311588|NCT01469000|1054002|P1|Overall Study|Withdrawal by Subject|9
311589|NCT01468987|1054018|P2|Overall Study|Sponsor Decision|0
311590|NCT01468987|1054019|P1|Overall Study|Sponsor Decision|1
311591|NCT01468987|1054018|P2|Overall Study|Physician Decision|15
311592|NCT01468987|1054019|P1|Overall Study|Physician Decision|8
311593|NCT01468987|1054018|P2|Overall Study|Withdrawal by Subject|28
311594|NCT01468987|1054019|P1|Overall Study|Withdrawal by Subject|28
311595|NCT01468987|1054018|P2|Overall Study|Protocol Violation|2
311596|NCT01468987|1054019|P1|Overall Study|Protocol Violation|8
311597|NCT01468987|1054018|P2|Overall Study|Lost to Follow-up|5
311598|NCT01468987|1054019|P1|Overall Study|Lost to Follow-up|10
311599|NCT01468987|1054018|P2|Overall Study|Death|1
311600|NCT01468987|1054019|P1|Overall Study|Death|4
311601|NCT01468987|1054018|P2|Overall Study|Adverse Event|9
311602|NCT01468987|1054019|P1|Overall Study|Adverse Event|12
311603|NCT01468818|1054082|P1|Overall Study|Death during treatment|2
311604|NCT01468311|1054140|P1|Overall Study|Withdrawal by Subject|1
311605|NCT01468311|1054140|P1|Overall Study|mobilization failure|1
311606|NCT01468233|1054152|P6|Treatment Period 2|Not specified|0
311607|NCT01468233|1054153|P5|Treatment Period 2|Not specified|1
311608|NCT01468233|1054154|P4|Treatment Period 2|Not specified|0
311609|NCT01468233|1054155|P3|Treatment Period 2|Not specified|3
311610|NCT01468233|1054156|P2|Treatment Period 2|Not specified|0
311611|NCT01468233|1054157|P1|Treatment Period 2|Not specified|0
311612|NCT01468233|1054152|P6|Treatment Period 2|Lost to Follow-up|0
311613|NCT01468233|1054153|P5|Treatment Period 2|Lost to Follow-up|2
311614|NCT01468233|1054154|P4|Treatment Period 2|Lost to Follow-up|0
311615|NCT01468233|1054155|P3|Treatment Period 2|Lost to Follow-up|3
311616|NCT01468233|1054156|P2|Treatment Period 2|Lost to Follow-up|0
311617|NCT01468233|1054157|P1|Treatment Period 2|Lost to Follow-up|0
311618|NCT01468233|1054152|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
311619|NCT01468233|1054153|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
311620|NCT01468233|1054154|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
311621|NCT01468233|1054155|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
311622|NCT01468233|1054156|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
311623|NCT01468233|1054157|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
311624|NCT01468233|1054152|P6|Treatment Period 2|Withdrawal by Subject|1
311625|NCT01468233|1054153|P5|Treatment Period 2|Withdrawal by Subject|1
311626|NCT01468233|1054154|P4|Treatment Period 2|Withdrawal by Subject|1
311627|NCT01468233|1054155|P3|Treatment Period 2|Withdrawal by Subject|9
311628|NCT01468233|1054156|P2|Treatment Period 2|Withdrawal by Subject|0
311629|NCT01468233|1054157|P1|Treatment Period 2|Withdrawal by Subject|0
311630|NCT01468233|1054152|P6|Treatment Period 2|Lack of Efficacy|1
311631|NCT01468233|1054153|P5|Treatment Period 2|Lack of Efficacy|0
311632|NCT01468233|1054154|P4|Treatment Period 2|Lack of Efficacy|2
311633|NCT01468233|1054155|P3|Treatment Period 2|Lack of Efficacy|9
311634|NCT01468233|1054156|P2|Treatment Period 2|Lack of Efficacy|0
311635|NCT01468233|1054157|P1|Treatment Period 2|Lack of Efficacy|0
311636|NCT01468233|1054152|P6|Treatment Period 2|Adverse Event|1
311637|NCT01468233|1054153|P5|Treatment Period 2|Adverse Event|2
311638|NCT01468233|1054154|P4|Treatment Period 2|Adverse Event|0
311639|NCT01468233|1054155|P3|Treatment Period 2|Adverse Event|3
311640|NCT01468233|1054156|P2|Treatment Period 2|Adverse Event|0
311641|NCT01468233|1054157|P1|Treatment Period 2|Adverse Event|0
311642|NCT01468233|1054152|P6|Treatment Period 1|Not specified|0
311643|NCT01468233|1054153|P5|Treatment Period 1|Not specified|0
311644|NCT01468233|1054154|P4|Treatment Period 1|Not specified|0
311645|NCT01468233|1054155|P3|Treatment Period 1|Not specified|0
311646|NCT01468233|1054156|P2|Treatment Period 1|Not specified|1
311647|NCT01468233|1054157|P1|Treatment Period 1|Not specified|1
311648|NCT01468233|1054152|P6|Treatment Period 1|Lost to Follow-up|0
311649|NCT01468233|1054153|P5|Treatment Period 1|Lost to Follow-up|0
311650|NCT01468233|1054154|P4|Treatment Period 1|Lost to Follow-up|0
311651|NCT01468233|1054155|P3|Treatment Period 1|Lost to Follow-up|0
311652|NCT01468233|1054156|P2|Treatment Period 1|Lost to Follow-up|0
311653|NCT01468233|1054157|P1|Treatment Period 1|Lost to Follow-up|3
311654|NCT01468233|1054152|P6|Treatment Period 1|Withdrawal by Subject|0
311655|NCT01468233|1054153|P5|Treatment Period 1|Withdrawal by Subject|0
311656|NCT01468233|1054154|P4|Treatment Period 1|Withdrawal by Subject|0
311657|NCT01468233|1054155|P3|Treatment Period 1|Withdrawal by Subject|0
311658|NCT01468233|1054156|P2|Treatment Period 1|Withdrawal by Subject|4
311659|NCT01468233|1054157|P1|Treatment Period 1|Withdrawal by Subject|3
311660|NCT01468233|1054152|P6|Treatment Period 1|Adverse Event|0
311661|NCT01468233|1054153|P5|Treatment Period 1|Adverse Event|0
311662|NCT01468233|1054154|P4|Treatment Period 1|Adverse Event|0
311663|NCT01468233|1054155|P3|Treatment Period 1|Adverse Event|0
311664|NCT01468233|1054156|P2|Treatment Period 1|Adverse Event|3
311665|NCT01468233|1054157|P1|Treatment Period 1|Adverse Event|5
311666|NCT01468207|1054179|P6|Treatment Period 2|Not specified|2
311667|NCT01468207|1054180|P5|Treatment Period 2|Not specified|1
311668|NCT01468207|1054181|P4|Treatment Period 2|Not specified|1
311669|NCT01468207|1054182|P3|Treatment Period 2|Not specified|5
311670|NCT01468207|1054183|P2|Treatment Period 2|Not specified|0
311671|NCT01468207|1054184|P1|Treatment Period 2|Not specified|0
311672|NCT01468207|1054179|P6|Treatment Period 2|Lost to Follow-up|0
311673|NCT01468207|1054180|P5|Treatment Period 2|Lost to Follow-up|0
311674|NCT01468207|1054181|P4|Treatment Period 2|Lost to Follow-up|1
311675|NCT01468207|1054182|P3|Treatment Period 2|Lost to Follow-up|5
311676|NCT01468207|1054183|P2|Treatment Period 2|Lost to Follow-up|0
311677|NCT01468207|1054184|P1|Treatment Period 2|Lost to Follow-up|0
311678|NCT01468207|1054179|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
311679|NCT01468207|1054180|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
311680|NCT01468207|1054181|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
311681|NCT01468207|1054182|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
311682|NCT01468207|1054183|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
311683|NCT01468207|1054184|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
311684|NCT01468207|1054179|P6|Treatment Period 2|Withdrawal by Subject|2
311685|NCT01468207|1054180|P5|Treatment Period 2|Withdrawal by Subject|0
311686|NCT01468207|1054181|P4|Treatment Period 2|Withdrawal by Subject|0
311687|NCT01468207|1054182|P3|Treatment Period 2|Withdrawal by Subject|5
311688|NCT01468207|1054183|P2|Treatment Period 2|Withdrawal by Subject|0
311689|NCT01468207|1054184|P1|Treatment Period 2|Withdrawal by Subject|0
311690|NCT01468207|1054179|P6|Treatment Period 2|Lack of Efficacy|2
311691|NCT01468207|1054180|P5|Treatment Period 2|Lack of Efficacy|0
311692|NCT01468207|1054181|P4|Treatment Period 2|Lack of Efficacy|1
311693|NCT01468207|1054182|P3|Treatment Period 2|Lack of Efficacy|1
311694|NCT01468207|1054183|P2|Treatment Period 2|Lack of Efficacy|0
311695|NCT01468207|1054184|P1|Treatment Period 2|Lack of Efficacy|0
311696|NCT01468207|1054179|P6|Treatment Period 2|Adverse Event|1
311697|NCT01468207|1054180|P5|Treatment Period 2|Adverse Event|2
311698|NCT01468207|1054181|P4|Treatment Period 2|Adverse Event|1
311699|NCT01468207|1054182|P3|Treatment Period 2|Adverse Event|6
311700|NCT01468207|1054183|P2|Treatment Period 2|Adverse Event|0
311701|NCT01468207|1054184|P1|Treatment Period 2|Adverse Event|0
311702|NCT01468207|1054179|P6|Treatment Period 1|Not specified|0
311703|NCT01468207|1054180|P5|Treatment Period 1|Not specified|0
311704|NCT01468207|1054181|P4|Treatment Period 1|Not specified|0
311705|NCT01468207|1054182|P3|Treatment Period 1|Not specified|0
311706|NCT01468207|1054183|P2|Treatment Period 1|Not specified|2
311707|NCT01468207|1054184|P1|Treatment Period 1|Not specified|0
311708|NCT01468207|1054179|P6|Treatment Period 1|Lost to Follow-up|0
311709|NCT01468207|1054180|P5|Treatment Period 1|Lost to Follow-up|0
311710|NCT01468207|1054181|P4|Treatment Period 1|Lost to Follow-up|0
311711|NCT01468207|1054182|P3|Treatment Period 1|Lost to Follow-up|0
311712|NCT01468207|1054183|P2|Treatment Period 1|Lost to Follow-up|1
311713|NCT01468207|1054184|P1|Treatment Period 1|Lost to Follow-up|2
311714|NCT01468207|1054179|P6|Treatment Period 1|Withdrawal by Subject|0
311715|NCT01468207|1054180|P5|Treatment Period 1|Withdrawal by Subject|0
311716|NCT01468207|1054181|P4|Treatment Period 1|Withdrawal by Subject|0
311717|NCT01468207|1054182|P3|Treatment Period 1|Withdrawal by Subject|0
311718|NCT01468207|1054183|P2|Treatment Period 1|Withdrawal by Subject|4
311719|NCT01468207|1054184|P1|Treatment Period 1|Withdrawal by Subject|5
311720|NCT01468207|1054179|P6|Treatment Period 1|Protocol Violation|0
311721|NCT01468207|1054180|P5|Treatment Period 1|Protocol Violation|0
311722|NCT01468207|1054181|P4|Treatment Period 1|Protocol Violation|0
311723|NCT01468207|1054182|P3|Treatment Period 1|Protocol Violation|0
311724|NCT01468207|1054183|P2|Treatment Period 1|Protocol Violation|1
311725|NCT01468207|1054184|P1|Treatment Period 1|Protocol Violation|1
311726|NCT01468207|1054179|P6|Treatment Period 1|Adverse Event|0
311727|NCT01468207|1054180|P5|Treatment Period 1|Adverse Event|0
311728|NCT01468207|1054181|P4|Treatment Period 1|Adverse Event|0
311729|NCT01468207|1054182|P3|Treatment Period 1|Adverse Event|0
311730|NCT01468207|1054183|P2|Treatment Period 1|Adverse Event|0
311731|NCT01468207|1054184|P1|Treatment Period 1|Adverse Event|1
311732|NCT01468181|1054209|P5|Overall Study|Withdrawal by Subject|0
311733|NCT01468181|1054210|P4|Overall Study|Withdrawal by Subject|0
311734|NCT01468181|1054211|P3|Overall Study|Withdrawal by Subject|0
311735|NCT01468181|1054212|P2|Overall Study|Withdrawal by Subject|1
311736|NCT01468181|1054213|P1|Overall Study|Withdrawal by Subject|0
311737|NCT01468181|1054209|P5|Overall Study|Lost to Follow-up|1
311738|NCT01468181|1054210|P4|Overall Study|Lost to Follow-up|0
311739|NCT01468181|1054211|P3|Overall Study|Lost to Follow-up|1
311740|NCT01468181|1054212|P2|Overall Study|Lost to Follow-up|0
311741|NCT01468181|1054213|P1|Overall Study|Lost to Follow-up|0
311742|NCT01468181|1054209|P5|Overall Study|Physician Decision|1
311743|NCT01468181|1054210|P4|Overall Study|Physician Decision|1
311744|NCT01468181|1054211|P3|Overall Study|Physician Decision|0
311745|NCT01468181|1054212|P2|Overall Study|Physician Decision|0
311746|NCT01468181|1054213|P1|Overall Study|Physician Decision|0
311747|NCT01468181|1054209|P5|Overall Study|Protocol Violation|1
311748|NCT01468181|1054210|P4|Overall Study|Protocol Violation|0
311749|NCT01468181|1054211|P3|Overall Study|Protocol Violation|1
311750|NCT01468181|1054212|P2|Overall Study|Protocol Violation|0
311751|NCT01468181|1054213|P1|Overall Study|Protocol Violation|2
311752|NCT01468181|1054209|P5|Overall Study|Adverse Event|2
311753|NCT01468181|1054210|P4|Overall Study|Adverse Event|2
311754|NCT01468181|1054211|P3|Overall Study|Adverse Event|6
311755|NCT01468181|1054212|P2|Overall Study|Adverse Event|1
311756|NCT01468181|1054213|P1|Overall Study|Adverse Event|8
311757|NCT01468077|1054262|P2|Overall Study|Physician Decision|0
311758|NCT01468077|1054263|P1|Overall Study|Physician Decision|1
311759|NCT01468077|1054262|P2|Overall Study|Lack of Efficacy|1
311760|NCT01468077|1054263|P1|Overall Study|Lack of Efficacy|1
311761|NCT01468077|1054262|P2|Overall Study|Adverse Event|2
311762|NCT01468077|1054263|P1|Overall Study|Adverse Event|2
311763|NCT01467960|1054321|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
311764|NCT01467960|1054322|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
311765|NCT01467960|1054323|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
311766|NCT01467960|1054324|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
311767|NCT01467960|1054325|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
311768|NCT01467960|1054326|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
311769|NCT01467713|1054385|P4|Overall Study|Reason not Specified|7
311770|NCT01467713|1054386|P3|Overall Study|Reason not Specified|8
311771|NCT01467713|1054387|P2|Overall Study|Reason not Specified|11
311772|NCT01467713|1054388|P1|Overall Study|Reason not Specified|6
311773|NCT01467713|1054385|P4|Overall Study|Relapse|35
311774|NCT01467713|1054386|P3|Overall Study|Relapse|28
311775|NCT01467713|1054387|P2|Overall Study|Relapse|25
311776|NCT01467713|1054388|P1|Overall Study|Relapse|35
311777|NCT01467713|1054385|P4|Overall Study|Pregnancy|3
311778|NCT01467713|1054386|P3|Overall Study|Pregnancy|1
311779|NCT01467713|1054387|P2|Overall Study|Pregnancy|1
311780|NCT01467713|1054388|P1|Overall Study|Pregnancy|0
311781|NCT01467713|1054385|P4|Overall Study|Study Termination|29
311782|NCT01467713|1054386|P3|Overall Study|Study Termination|28
311783|NCT01467713|1054387|P2|Overall Study|Study Termination|33
311784|NCT01467713|1054388|P1|Overall Study|Study Termination|23
311785|NCT01467713|1054385|P4|Overall Study|Voluntary Withdrawal|20
311786|NCT01467713|1054386|P3|Overall Study|Voluntary Withdrawal|21
311787|NCT01467713|1054387|P2|Overall Study|Voluntary Withdrawal|14
311788|NCT01467713|1054388|P1|Overall Study|Voluntary Withdrawal|18
311789|NCT01467713|1054385|P4|Overall Study|Lost to Follow-up|9
311790|NCT01467713|1054386|P3|Overall Study|Lost to Follow-up|6
311791|NCT01467713|1054387|P2|Overall Study|Lost to Follow-up|12
311792|NCT01467713|1054388|P1|Overall Study|Lost to Follow-up|9
311793|NCT01467713|1054385|P4|Overall Study|Major Protocol Deviation|1
311794|NCT01467713|1054386|P3|Overall Study|Major Protocol Deviation|4
311795|NCT01467713|1054387|P2|Overall Study|Major Protocol Deviation|4
311796|NCT01467713|1054388|P1|Overall Study|Major Protocol Deviation|2
311797|NCT01467713|1054385|P4|Overall Study|Pretreatment Event or Adverse Event|5
311798|NCT01467713|1054386|P3|Overall Study|Pretreatment Event or Adverse Event|6
311799|NCT01467713|1054387|P2|Overall Study|Pretreatment Event or Adverse Event|4
311800|NCT01467713|1054388|P1|Overall Study|Pretreatment Event or Adverse Event|9
311801|NCT01467700|1054442|P4|Overall Study|Reason not Specified|8
311802|NCT01467700|1054443|P3|Overall Study|Reason not Specified|2
311803|NCT01467700|1054444|P2|Overall Study|Reason not Specified|3
311804|NCT01467700|1054445|P1|Overall Study|Reason not Specified|1
311805|NCT01467700|1054442|P4|Overall Study|Lack of Efficacy|1
311806|NCT01467700|1054443|P3|Overall Study|Lack of Efficacy|2
311807|NCT01467700|1054444|P2|Overall Study|Lack of Efficacy|0
311808|NCT01467700|1054445|P1|Overall Study|Lack of Efficacy|2
311809|NCT01467700|1054442|P4|Overall Study|Pregnancy|0
311810|NCT01467700|1054443|P3|Overall Study|Pregnancy|1
311811|NCT01467700|1054444|P2|Overall Study|Pregnancy|1
311812|NCT01467700|1054445|P1|Overall Study|Pregnancy|0
311813|NCT01467700|1054442|P4|Overall Study|Study Termination|7
311814|NCT01467700|1054443|P3|Overall Study|Study Termination|10
311815|NCT01467700|1054444|P2|Overall Study|Study Termination|5
311816|NCT01467700|1054445|P1|Overall Study|Study Termination|6
311817|NCT01467700|1054442|P4|Overall Study|Voluntary Withdrawal|2
311818|NCT01467700|1054443|P3|Overall Study|Voluntary Withdrawal|6
311819|NCT01467700|1054444|P2|Overall Study|Voluntary Withdrawal|7
311820|NCT01467700|1054445|P1|Overall Study|Voluntary Withdrawal|5
311821|NCT01467700|1054442|P4|Overall Study|Lost to Follow-up|3
311822|NCT01467700|1054443|P3|Overall Study|Lost to Follow-up|2
311823|NCT01467700|1054444|P2|Overall Study|Lost to Follow-up|5
311824|NCT01467700|1054445|P1|Overall Study|Lost to Follow-up|6
311825|NCT01467700|1054442|P4|Overall Study|Major Protocol Deviation|3
311826|NCT01467700|1054443|P3|Overall Study|Major Protocol Deviation|2
311827|NCT01467700|1054444|P2|Overall Study|Major Protocol Deviation|3
311828|NCT01467700|1054445|P1|Overall Study|Major Protocol Deviation|3
311829|NCT01467700|1054442|P4|Overall Study|Pretreatment Event or Adverse Event|3
311830|NCT01467700|1054443|P3|Overall Study|Pretreatment Event or Adverse Event|2
311831|NCT01467700|1054444|P2|Overall Study|Pretreatment Event or Adverse Event|4
311832|NCT01467700|1054445|P1|Overall Study|Pretreatment Event or Adverse Event|6
311833|NCT01467661|1054487|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
311834|NCT01467661|1054487|P1|Overall Study|Lack of Efficacy|3
311835|NCT01467661|1054487|P1|Overall Study|Withdrawal by Subject|1
311836|NCT01467661|1054487|P1|Overall Study|Adverse Event|16
311837|NCT01467583|1054507|P3|Overall Study|Protocol Violation|2
311838|NCT01467583|1054508|P2|Overall Study|Protocol Violation|0
311839|NCT01467583|1054509|P1|Overall Study|Protocol Violation|0
311840|NCT01467583|1054507|P3|Overall Study|Withdrawal by Subject|0
311841|NCT01467583|1054508|P2|Overall Study|Withdrawal by Subject|0
311842|NCT01467583|1054509|P1|Overall Study|Withdrawal by Subject|1
311843|NCT01467583|1054507|P3|Overall Study|Death|0
311844|NCT01467583|1054508|P2|Overall Study|Death|1
311845|NCT01467583|1054509|P1|Overall Study|Death|1
311846|NCT01467570|1054522|P2|Overall Study|Lost to Follow-up|9
311847|NCT01467570|1054523|P1|Overall Study|Lost to Follow-up|8
311848|NCT01467505|1054560|P2|Overall Study|Study Terminated by Sponsor|3
311849|NCT01467505|1054561|P1|Overall Study|Study Terminated by Sponsor|28
311850|NCT01467505|1054560|P2|Overall Study|Withdrawal by Subject|0
311851|NCT01467505|1054561|P1|Overall Study|Withdrawal by Subject|4
311852|NCT01467505|1054560|P2|Overall Study|Adverse Event|0
311853|NCT01467505|1054561|P1|Overall Study|Adverse Event|1
311854|NCT01467492|1054593|P2|Overall Study|Enrolled But Not Treated|0
311855|NCT01467492|1054594|P1|Overall Study|Enrolled But Not Treated|1
311856|NCT01467492|1054593|P2|Overall Study|Undefined|0
311857|NCT01467492|1054594|P1|Overall Study|Undefined|2
311858|NCT01467492|1054593|P2|Overall Study|Lost to Follow-up|2
311859|NCT01467492|1054594|P1|Overall Study|Lost to Follow-up|3
311860|NCT01467492|1054593|P2|Overall Study|Adverse Event|3
311861|NCT01467492|1054594|P1|Overall Study|Adverse Event|4
311862|NCT01467492|1054593|P2|Overall Study|Study Terminated by Sponsor|4
311863|NCT01467492|1054594|P1|Overall Study|Study Terminated by Sponsor|6
311864|NCT01467492|1054593|P2|Overall Study|Withdrawal by Subject|4
311865|NCT01467492|1054594|P1|Overall Study|Withdrawal by Subject|6
311866|NCT01467479|1054618|P3|Overall Study|Other|0
311867|NCT01467479|1054619|P2|Overall Study|Other|0
311868|NCT01467479|1054620|P1|Overall Study|Other|1
311869|NCT01467479|1054618|P3|Overall Study|Study Terminated by Sponsor|3
311870|NCT01467479|1054619|P2|Overall Study|Study Terminated by Sponsor|3
311871|NCT01467479|1054620|P1|Overall Study|Study Terminated by Sponsor|1
311872|NCT01467479|1054618|P3|Overall Study|Withdrawal of Consent|7
311873|NCT01467479|1054619|P2|Overall Study|Withdrawal of Consent|7
311874|NCT01467479|1054620|P1|Overall Study|Withdrawal of Consent|3
311875|NCT01467479|1054618|P3|Overall Study|Lost to Follow-up|3
311876|NCT01467479|1054619|P2|Overall Study|Lost to Follow-up|5
311877|NCT01467479|1054620|P1|Overall Study|Lost to Follow-up|2
311878|NCT01467479|1054618|P3|Overall Study|Death|1
311879|NCT01467479|1054619|P2|Overall Study|Death|0
311880|NCT01467479|1054620|P1|Overall Study|Death|0
311881|NCT01467479|1054618|P3|Overall Study|Adverse Event|0
311882|NCT01467479|1054619|P2|Overall Study|Adverse Event|2
311883|NCT01467479|1054620|P1|Overall Study|Adverse Event|1
311884|NCT01467479|1054618|P3|Overall Study|No Study Medication|2
311885|NCT01467479|1054619|P2|Overall Study|No Study Medication|0
311886|NCT01467479|1054620|P1|Overall Study|No Study Medication|1
311887|NCT01467427|1054649|P2|Overall Study|Not continuing in extension phase|2
311888|NCT01467427|1054650|P1|Overall Study|Not continuing in extension phase|0
311889|NCT01467427|1054649|P2|Overall Study|Entered extension phase|11
311890|NCT01467427|1054650|P1|Overall Study|Entered extension phase|11
311891|NCT01467427|1054649|P2|Overall Study|Withdrawal by Subject|0
311892|NCT01467427|1054650|P1|Overall Study|Withdrawal by Subject|1
311893|NCT01467076|1054671|P3|Overall Study|Lost to Follow-up|0
311894|NCT01467076|1054672|P2|Overall Study|Lost to Follow-up|0
311895|NCT01467076|1054673|P1|Overall Study|Lost to Follow-up|1
311896|NCT01466881|1054690|P1|Overall Study|Other reason not protocol specified|5
311897|NCT01466881|1054690|P1|Overall Study|Death|4
311898|NCT01466881|1054690|P1|Overall Study|Progression/relapse|20
311899|NCT01466881|1054690|P1|Overall Study|Adverse Event|6
311900|NCT01466881|1054690|P1|Overall Study|Ineligible|5
311901|NCT01466790|1054707|P8|Overall Study|Withdrawal by Subject|1
311902|NCT01466790|1054708|P7|Overall Study|Withdrawal by Subject|1
311903|NCT01466790|1054709|P6|Overall Study|Withdrawal by Subject|0
311904|NCT01466790|1054710|P5|Overall Study|Withdrawal by Subject|1
311905|NCT01466790|1054711|P4|Overall Study|Withdrawal by Subject|0
311906|NCT01466790|1054712|P3|Overall Study|Withdrawal by Subject|0
311907|NCT01466790|1054713|P2|Overall Study|Withdrawal by Subject|1
311908|NCT01466790|1054714|P1|Overall Study|Withdrawal by Subject|1
311909|NCT01466790|1054707|P8|Overall Study|Lost to Follow-up|0
311910|NCT01466790|1054708|P7|Overall Study|Lost to Follow-up|0
311911|NCT01466790|1054709|P6|Overall Study|Lost to Follow-up|0
311912|NCT01466790|1054710|P5|Overall Study|Lost to Follow-up|0
311913|NCT01466790|1054711|P4|Overall Study|Lost to Follow-up|0
311914|NCT01466790|1054712|P3|Overall Study|Lost to Follow-up|0
311915|NCT01466790|1054713|P2|Overall Study|Lost to Follow-up|0
311916|NCT01466790|1054714|P1|Overall Study|Lost to Follow-up|2
311917|NCT01466790|1054707|P8|Overall Study|Adverse Event|0
311918|NCT01466790|1054708|P7|Overall Study|Adverse Event|0
311919|NCT01466790|1054709|P6|Overall Study|Adverse Event|0
311920|NCT01466790|1054710|P5|Overall Study|Adverse Event|2
311921|NCT01466790|1054711|P4|Overall Study|Adverse Event|0
311922|NCT01466790|1054712|P3|Overall Study|Adverse Event|0
311923|NCT01466790|1054713|P2|Overall Study|Adverse Event|0
311924|NCT01466790|1054714|P1|Overall Study|Adverse Event|1
311925|NCT01466673|1054799|P2|Overall Study|Adverse Event|1
311926|NCT01466673|1054800|P1|Overall Study|Adverse Event|2
311927|NCT01466673|1054799|P2|Overall Study|Lost to Follow-up|5
311928|NCT01466673|1054800|P1|Overall Study|Lost to Follow-up|3
311929|NCT01466673|1054799|P2|Overall Study|Non-compliance with study treatment|0
311930|NCT01466673|1054800|P1|Overall Study|Non-compliance with study treatment|2
311931|NCT01466660|1054826|P2|Overall Study|Other reason not defined above|6
311932|NCT01466660|1054827|P1|Overall Study|Other reason not defined above|3
311933|NCT01466660|1054826|P2|Overall Study|Refused continuation of trial medication|3
311934|NCT01466660|1054827|P1|Overall Study|Refused continuation of trial medication|4
311935|NCT01466660|1054826|P2|Overall Study|Protocol Violation|1
311936|NCT01466660|1054827|P1|Overall Study|Protocol Violation|1
311937|NCT01466660|1054826|P2|Overall Study|Other adverse event|17
311938|NCT01466660|1054827|P1|Overall Study|Other adverse event|18
311939|NCT01466660|1054826|P2|Overall Study|Worsening of underlying cancer disease|2
311940|NCT01466660|1054827|P1|Overall Study|Worsening of underlying cancer disease|5
311941|NCT01466660|1054826|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
311942|NCT01466660|1054827|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
311943|NCT01466595|1054853|P2|Overall Study|Withdrawal by Subject|1
311944|NCT01466595|1054854|P1|Overall Study|Withdrawal by Subject|0
311945|NCT01466491|1054948|P4|Overall Study|Missing Data|0
311946|NCT01466491|1054949|P3|Overall Study|Missing Data|1
311947|NCT01466491|1054950|P2|Overall Study|Missing Data|0
311948|NCT01466491|1054951|P1|Overall Study|Missing Data|0
311949|NCT01466491|1054948|P4|Overall Study|Protocol Violation|0
311950|NCT01466491|1054949|P3|Overall Study|Protocol Violation|2
311951|NCT01466491|1054950|P2|Overall Study|Protocol Violation|3
311952|NCT01466491|1054951|P1|Overall Study|Protocol Violation|0
311953|NCT01466387|1054971|P6|Overall Study|Protocol Violation|0
311954|NCT01466387|1054972|P5|Overall Study|Protocol Violation|0
311955|NCT01466387|1054973|P4|Overall Study|Protocol Violation|1
311956|NCT01466387|1054974|P3|Overall Study|Protocol Violation|0
311957|NCT01466387|1054975|P2|Overall Study|Protocol Violation|0
311958|NCT01466387|1054976|P1|Overall Study|Protocol Violation|1
311959|NCT01466387|1054971|P6|Overall Study|Lost to Follow-up|1
311960|NCT01466387|1054972|P5|Overall Study|Lost to Follow-up|0
311961|NCT01466387|1054973|P4|Overall Study|Lost to Follow-up|0
311962|NCT01466387|1054974|P3|Overall Study|Lost to Follow-up|0
311963|NCT01466387|1054975|P2|Overall Study|Lost to Follow-up|0
311964|NCT01466387|1054976|P1|Overall Study|Lost to Follow-up|0
311965|NCT01466387|1054971|P6|Overall Study|Adverse Event|0
311966|NCT01466387|1054972|P5|Overall Study|Adverse Event|0
311967|NCT01466387|1054973|P4|Overall Study|Adverse Event|1
311968|NCT01466387|1054974|P3|Overall Study|Adverse Event|1
311969|NCT01466387|1054975|P2|Overall Study|Adverse Event|0
311970|NCT01466387|1054976|P1|Overall Study|Adverse Event|0
311971|NCT01466348|1055037|P2|Period I - First Intervention|Withdrawal by Subject|1
311972|NCT01466348|1055038|P1|Period I - First Intervention|Withdrawal by Subject|0
311973|NCT01466270|1055066|P2|Overall Study|Multiple|1
311974|NCT01466270|1055067|P1|Overall Study|Multiple|1
311975|NCT01466270|1055066|P2|Overall Study|Toxicity|1
311976|NCT01466270|1055067|P1|Overall Study|Toxicity|4
311977|NCT01466270|1055066|P2|Overall Study|Progression|0
311978|NCT01466270|1055067|P1|Overall Study|Progression|1
311979|NCT01466270|1055066|P2|Overall Study|Lost to Follow-up|3
311980|NCT01466270|1055067|P1|Overall Study|Lost to Follow-up|1
311981|NCT01466270|1055066|P2|Overall Study|Physician Decision|0
311982|NCT01466270|1055067|P1|Overall Study|Physician Decision|1
311983|NCT01466270|1055066|P2|Overall Study|Withdrawal by Subject|1
311984|NCT01466270|1055067|P1|Overall Study|Withdrawal by Subject|4
311985|NCT01466192|1055079|P1|Overall Study|Withdrawal by Subject|3
311986|NCT01466192|1055079|P1|Overall Study|Physician Decision|1
311987|NCT01466179|1055083|P1|Overall Study|Other|3
311988|NCT01466179|1055083|P1|Overall Study|Protocol Violation|2
311989|NCT01466179|1055083|P1|Overall Study|Withdrawal by Subject|7
311990|NCT01466179|1055083|P1|Overall Study|Death|7
311991|NCT01466179|1055083|P1|Overall Study|Lack of Efficacy|14
311992|NCT01466179|1055083|P1|Overall Study|Disease relapse|23
311993|NCT01466179|1055083|P1|Overall Study|Adverse Event|32
311994|NCT01466179|1055083|P1|Overall Study|Progressive disease|43
311995|NCT01466179|1055083|P1|Overall Study|Physician Decision|46
311996|NCT01466179|1055083|P1|Overall Study|Ongoing in core study|2
311997|NCT01466153|1055106|P3|Overall Study|Other-Unspecified|2
311998|NCT01466153|1055107|P2|Overall Study|Other-Unspecified|4
311999|NCT01466153|1055108|P1|Overall Study|Other-Unspecified|6
312000|NCT01466153|1055106|P3|Overall Study|Randomized-Not Treated|4
312001|NCT01466153|1055107|P2|Overall Study|Randomized-Not Treated|3
312002|NCT01466153|1055108|P1|Overall Study|Randomized-Not Treated|2
312003|NCT01466153|1055106|P3|Overall Study|Investigator Discretion|2
312004|NCT01466153|1055107|P2|Overall Study|Investigator Discretion|2
312005|NCT01466153|1055108|P1|Overall Study|Investigator Discretion|3
312006|NCT01466153|1055106|P3|Overall Study|Withdrawal of Consent|0
312007|NCT01466153|1055107|P2|Overall Study|Withdrawal of Consent|0
312008|NCT01466153|1055108|P1|Overall Study|Withdrawal of Consent|2
312009|NCT01466153|1055106|P3|Overall Study|Adverse Event|17
312010|NCT01466153|1055107|P2|Overall Study|Adverse Event|13
312011|NCT01466153|1055108|P1|Overall Study|Adverse Event|14
312012|NCT01466153|1055106|P3|Overall Study|Disease Progression|0
312013|NCT01466153|1055107|P2|Overall Study|Disease Progression|2
312014|NCT01466153|1055108|P1|Overall Study|Disease Progression|2
312015|NCT01466062|1055163|P1|Overall Study|Withdrawal by Subject|1
312016|NCT01466062|1055163|P1|Overall Study|Adverse Event|1
312017|NCT01465997|1055186|P2|Overall Study|subject left participation SP0993|1
312018|NCT01465997|1055187|P1|Overall Study|subject left participation SP0993|0
312019|NCT01465997|1055186|P2|Overall Study|decision by site staff|1
312020|NCT01465997|1055187|P1|Overall Study|decision by site staff|0
312021|NCT01465997|1055186|P2|Overall Study|withdrew before follow-up|13
312022|NCT01465997|1055187|P1|Overall Study|withdrew before follow-up|0
312023|NCT01465997|1055186|P2|Overall Study|local lab unblinded site|0
312024|NCT01465997|1055187|P1|Overall Study|local lab unblinded site|1
312025|NCT01465997|1055186|P2|Overall Study|subject withdrew consent|0
312026|NCT01465997|1055187|P1|Overall Study|subject withdrew consent|1
312027|NCT01465997|1055186|P2|Overall Study|sponsor's decision|1
312028|NCT01465997|1055187|P1|Overall Study|sponsor's decision|1
312029|NCT01465997|1055186|P2|Overall Study|Death|1
312030|NCT01465997|1055187|P1|Overall Study|Death|0
312031|NCT01465997|1055186|P2|Overall Study|investigator's decision|1
312032|NCT01465997|1055187|P1|Overall Study|investigator's decision|1
312033|NCT01465997|1055186|P2|Overall Study|Withdrawal by Subject|35
312034|NCT01465997|1055187|P1|Overall Study|Withdrawal by Subject|32
312035|NCT01465997|1055186|P2|Overall Study|Lost to Follow-up|9
312036|NCT01465997|1055187|P1|Overall Study|Lost to Follow-up|6
312037|NCT01465997|1055186|P2|Overall Study|Protocol Violation|4
312038|NCT01465997|1055187|P1|Overall Study|Protocol Violation|1
312039|NCT01465997|1055186|P2|Overall Study|Lack of Efficacy|1
312040|NCT01465997|1055187|P1|Overall Study|Lack of Efficacy|13
312041|NCT01465997|1055186|P2|Overall Study|Adverse Event|22
312042|NCT01465997|1055187|P1|Overall Study|Adverse Event|12
312043|NCT01465958|1055197|P2|Subcutaneous (SC) Phase|Adverse Event|1
312044|NCT01465958|1055198|P1|Subcutaneous (SC) Phase|Adverse Event|0
312045|NCT01465958|1055197|P2|Run-in Phase|Protocol Violation|0
312046|NCT01465958|1055198|P1|Run-in Phase|Protocol Violation|1
312047|NCT01465802|1055211|P5|Overall Study|Death|2
312048|NCT01465802|1055212|P4|Overall Study|Death|10
312049|NCT01465802|1055213|P3|Overall Study|Death|0
312050|NCT01465802|1055214|P2|Overall Study|Death|12
312051|NCT01465802|1055215|P1|Overall Study|Death|15
312052|NCT01465802|1055211|P5|Overall Study|Reason not specified|2
312053|NCT01465802|1055212|P4|Overall Study|Reason not specified|10
312054|NCT01465802|1055213|P3|Overall Study|Reason not specified|0
312055|NCT01465802|1055214|P2|Overall Study|Reason not specified|4
312056|NCT01465802|1055215|P1|Overall Study|Reason not specified|9
312057|NCT01465802|1055211|P5|Overall Study|Lost to Follow-up|0
312058|NCT01465802|1055212|P4|Overall Study|Lost to Follow-up|0
312059|NCT01465802|1055213|P3|Overall Study|Lost to Follow-up|0
312060|NCT01465802|1055214|P2|Overall Study|Lost to Follow-up|1
312061|NCT01465802|1055215|P1|Overall Study|Lost to Follow-up|1
312062|NCT01465802|1055211|P5|Overall Study|Withdrawal by Subject|1
312063|NCT01465802|1055212|P4|Overall Study|Withdrawal by Subject|8
312064|NCT01465802|1055213|P3|Overall Study|Withdrawal by Subject|0
312065|NCT01465802|1055214|P2|Overall Study|Withdrawal by Subject|7
312066|NCT01465802|1055215|P1|Overall Study|Withdrawal by Subject|7
312067|NCT01465802|1055211|P5|Overall Study|Study terminated by sponsor|7
312068|NCT01465802|1055212|P4|Overall Study|Study terminated by sponsor|1
312069|NCT01465802|1055213|P3|Overall Study|Study terminated by sponsor|0
312070|NCT01465802|1055214|P2|Overall Study|Study terminated by sponsor|0
312071|NCT01465802|1055215|P1|Overall Study|Study terminated by sponsor|1
312072|NCT01465763|1055267|P3|Overall Study|Death|0
312073|NCT01465763|1055268|P2|Overall Study|Death|0
312074|NCT01465763|1055269|P1|Overall Study|Death|1
312075|NCT01465763|1055267|P3|Overall Study|Protocol Violation|1
312076|NCT01465763|1055268|P2|Overall Study|Protocol Violation|1
312077|NCT01465763|1055269|P1|Overall Study|Protocol Violation|4
312078|NCT01465763|1055267|P3|Overall Study|Other|0
312079|NCT01465763|1055268|P2|Overall Study|Other|0
312080|NCT01465763|1055269|P1|Overall Study|Other|2
312081|NCT01465763|1055267|P3|Overall Study|Adverse Event|1
312082|NCT01465763|1055268|P2|Overall Study|Adverse Event|0
312083|NCT01465763|1055269|P1|Overall Study|Adverse Event|9
312084|NCT01465763|1055267|P3|Overall Study|Insufficient Clinical Response|1
312085|NCT01465763|1055268|P2|Overall Study|Insufficient Clinical Response|0
312086|NCT01465763|1055269|P1|Overall Study|Insufficient Clinical Response|11
312087|NCT01465763|1055267|P3|Overall Study|Withdrawal by Subject|1
312088|NCT01465763|1055268|P2|Overall Study|Withdrawal by Subject|0
312089|NCT01465763|1055269|P1|Overall Study|Withdrawal by Subject|4
312090|NCT01465386|1055339|P1|Overall Study|Adverse Event|1
312091|NCT01465386|1055339|P1|Overall Study|Lack of Efficacy|3
312092|NCT01465347|1055343|P2|Overall Study|Admitted to hospice|1
312093|NCT01465347|1055344|P1|Overall Study|Admitted to hospice|0
312094|NCT01465347|1055343|P2|Overall Study|Physician Decision|1
312095|NCT01465347|1055344|P1|Overall Study|Physician Decision|0
312096|NCT01465347|1055343|P2|Overall Study|Withdrawal by Subject|1
312097|NCT01465347|1055344|P1|Overall Study|Withdrawal by Subject|1
312098|NCT01465230|1055354|P1|Overall Study|Withdrawal by Subject|2
312099|NCT01465178|1055360|P2|Overall Study|Withdrawal by Subject|0
312100|NCT01465178|1055361|P1|Overall Study|Withdrawal by Subject|1
312101|NCT01465022|1055385|P3|Overall Study|Not Randomized|70
312102|NCT01465022|1055386|P2|Overall Study|Not Randomized|0
312103|NCT01465022|1055387|P1|Overall Study|Not Randomized|0
312104|NCT01465022|1055385|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
312105|NCT01465022|1055386|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
312106|NCT01465022|1055387|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
312107|NCT01465022|1055385|P3|Overall Study|Lost to Follow-up|0
312108|NCT01465022|1055386|P2|Overall Study|Lost to Follow-up|14
312109|NCT01465022|1055387|P1|Overall Study|Lost to Follow-up|15
312110|NCT01464931|1055421|P2|Overall Study|Withdrawal by Subject|0
312111|NCT01464931|1055422|P1|Overall Study|Withdrawal by Subject|1
312112|NCT01464879|1055459|P1|Overall Study|Non-compliance|1
312113|NCT01464879|1055459|P1|Overall Study|Physician Decision|1
312114|NCT01464827|1055520|P14|Overall Study|Not Treated|2
312115|NCT01464827|1055521|P13|Overall Study|Not Treated|0
312116|NCT01464827|1055522|P12|Overall Study|Not Treated|1
312117|NCT01464827|1055523|P11|Overall Study|Not Treated|0
312118|NCT01464827|1055524|P10|Overall Study|Not Treated|2
312119|NCT01464827|1055525|P9|Overall Study|Not Treated|0
312120|NCT01464827|1055526|P8|Overall Study|Not Treated|0
312121|NCT01464827|1055527|P7|Overall Study|Not Treated|1
312122|NCT01464827|1055528|P6|Overall Study|Not Treated|0
312123|NCT01464827|1055529|P5|Overall Study|Not Treated|1
312124|NCT01464827|1055530|P4|Overall Study|Not Treated|0
312125|NCT01464827|1055531|P3|Overall Study|Not Treated|0
312126|NCT01464827|1055532|P2|Overall Study|Not Treated|2
312127|NCT01464827|1055533|P1|Overall Study|Not Treated|0
312128|NCT01464827|1055520|P14|Overall Study|Other|0
312129|NCT01464827|1055521|P13|Overall Study|Other|1
312130|NCT01464827|1055522|P12|Overall Study|Other|0
312131|NCT01464827|1055523|P11|Overall Study|Other|2
312132|NCT01464827|1055524|P10|Overall Study|Other|1
312133|NCT01464827|1055525|P9|Overall Study|Other|3
312134|NCT01464827|1055526|P8|Overall Study|Other|0
312135|NCT01464827|1055527|P7|Overall Study|Other|1
312136|NCT01464827|1055528|P6|Overall Study|Other|0
312137|NCT01464827|1055529|P5|Overall Study|Other|3
312138|NCT01464827|1055530|P4|Overall Study|Other|2
312139|NCT01464827|1055531|P3|Overall Study|Other|0
312140|NCT01464827|1055532|P2|Overall Study|Other|3
312141|NCT01464827|1055533|P1|Overall Study|Other|2
312142|NCT01464827|1055520|P14|Overall Study|Lost to Follow-up|1
312143|NCT01464827|1055521|P13|Overall Study|Lost to Follow-up|0
312144|NCT01464827|1055522|P12|Overall Study|Lost to Follow-up|1
312145|NCT01464827|1055523|P11|Overall Study|Lost to Follow-up|0
312146|NCT01464827|1055524|P10|Overall Study|Lost to Follow-up|0
312147|NCT01464827|1055525|P9|Overall Study|Lost to Follow-up|0
312148|NCT01464827|1055526|P8|Overall Study|Lost to Follow-up|2
312149|NCT01464827|1055527|P7|Overall Study|Lost to Follow-up|2
312150|NCT01464827|1055528|P6|Overall Study|Lost to Follow-up|1
312151|NCT01464827|1055529|P5|Overall Study|Lost to Follow-up|3
312152|NCT01464827|1055530|P4|Overall Study|Lost to Follow-up|2
312153|NCT01464827|1055531|P3|Overall Study|Lost to Follow-up|0
312154|NCT01464827|1055532|P2|Overall Study|Lost to Follow-up|2
312155|NCT01464827|1055533|P1|Overall Study|Lost to Follow-up|0
312156|NCT01464827|1055520|P14|Overall Study|Withdrawal by Subject|0
312157|NCT01464827|1055521|P13|Overall Study|Withdrawal by Subject|0
312158|NCT01464827|1055522|P12|Overall Study|Withdrawal by Subject|0
312159|NCT01464827|1055523|P11|Overall Study|Withdrawal by Subject|0
312160|NCT01464827|1055524|P10|Overall Study|Withdrawal by Subject|0
312161|NCT01464827|1055525|P9|Overall Study|Withdrawal by Subject|0
312162|NCT01464827|1055526|P8|Overall Study|Withdrawal by Subject|1
312163|NCT01464827|1055527|P7|Overall Study|Withdrawal by Subject|0
312164|NCT01464827|1055528|P6|Overall Study|Withdrawal by Subject|0
312165|NCT01464827|1055529|P5|Overall Study|Withdrawal by Subject|1
312166|NCT01464827|1055530|P4|Overall Study|Withdrawal by Subject|0
312167|NCT01464827|1055531|P3|Overall Study|Withdrawal by Subject|0
312168|NCT01464827|1055532|P2|Overall Study|Withdrawal by Subject|0
312169|NCT01464827|1055533|P1|Overall Study|Withdrawal by Subject|1
312170|NCT01464827|1055520|P14|Overall Study|Adverse Event|0
312171|NCT01464827|1055521|P13|Overall Study|Adverse Event|1
312172|NCT01464827|1055522|P12|Overall Study|Adverse Event|0
312173|NCT01464827|1055523|P11|Overall Study|Adverse Event|0
312174|NCT01464827|1055524|P10|Overall Study|Adverse Event|0
312175|NCT01464827|1055525|P9|Overall Study|Adverse Event|0
312176|NCT01464827|1055526|P8|Overall Study|Adverse Event|0
312177|NCT01464827|1055527|P7|Overall Study|Adverse Event|0
312178|NCT01464827|1055528|P6|Overall Study|Adverse Event|0
312179|NCT01464827|1055529|P5|Overall Study|Adverse Event|0
312180|NCT01464827|1055530|P4|Overall Study|Adverse Event|0
312181|NCT01464827|1055531|P3|Overall Study|Adverse Event|0
312182|NCT01464827|1055532|P2|Overall Study|Adverse Event|0
312183|NCT01464827|1055533|P1|Overall Study|Adverse Event|0
312184|NCT01464788|1055580|P3|Overall Study|Patient had hemorrhage after tPA started|0
312185|NCT01464788|1055581|P2|Overall Study|Patient had hemorrhage after tPA started|1
312186|NCT01464788|1055582|P1|Overall Study|Patient had hemorrhage after tPA started|0
312187|NCT01464788|1055580|P3|Overall Study|Lost to Follow-up|0
312188|NCT01464788|1055581|P2|Overall Study|Lost to Follow-up|1
312189|NCT01464788|1055582|P1|Overall Study|Lost to Follow-up|0
312190|NCT01464619|1055595|P2|Overall Study|Lost to Follow-up|4
312191|NCT01464619|1055596|P1|Overall Study|Lost to Follow-up|3
312192|NCT01464424|1055616|P2|Period 1, First 6 Weeks|Adverse Event|1
312193|NCT01464424|1055617|P1|Period 1, First 6 Weeks|Adverse Event|0
312194|NCT01464346|1055637|P3|Overall Study|Withdrawal by Subject|1
312195|NCT01464346|1055638|P2|Overall Study|Withdrawal by Subject|0
312196|NCT01464346|1055639|P1|Overall Study|Withdrawal by Subject|0
312197|NCT01464307|1055650|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
312198|NCT01464307|1055651|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
312199|NCT01464307|1055650|P2|Open-Label Extension Period|Non-compliance|0
312200|NCT01464307|1055651|P1|Open-Label Extension Period|Non-compliance|9
312201|NCT01464307|1055650|P2|Open-Label Extension Period|Lost to Follow-up|0
312202|NCT01464307|1055651|P1|Open-Label Extension Period|Lost to Follow-up|1
312203|NCT01464307|1055650|P2|Open-Label Extension Period|Death|0
312204|NCT01464307|1055651|P1|Open-Label Extension Period|Death|1
312205|NCT01464307|1055650|P2|Open-Label Extension Period|Lack of Efficacy|0
312206|NCT01464307|1055651|P1|Open-Label Extension Period|Lack of Efficacy|5
312207|NCT01464307|1055650|P2|Open-Label Extension Period|Withdrawal by Subject|0
312208|NCT01464307|1055651|P1|Open-Label Extension Period|Withdrawal by Subject|14
312209|NCT01464307|1055650|P2|Open-Label Extension Period|Adverse Event|0
312210|NCT01464307|1055651|P1|Open-Label Extension Period|Adverse Event|15
312211|NCT01464307|1055650|P2|Main Period|Predefined discontinuation criteria|1
312212|NCT01464307|1055651|P1|Main Period|Predefined discontinuation criteria|2
312213|NCT01464307|1055650|P2|Main Period|Withdrawal by Subject|2
312214|NCT01464307|1055651|P1|Main Period|Withdrawal by Subject|5
312215|NCT01464307|1055650|P2|Main Period|Lack of Efficacy|0
312216|NCT01464307|1055651|P1|Main Period|Lack of Efficacy|2
312217|NCT01464307|1055650|P2|Main Period|Adverse Event|1
312218|NCT01464307|1055651|P1|Main Period|Adverse Event|6
312219|NCT01464307|1055650|P2|Main Period|Death|1
312220|NCT01464307|1055651|P1|Main Period|Death|0
312221|NCT01464255|1055666|P2|Overall Study|unresolve corneal staining|1
312222|NCT01464255|1055667|P1|Overall Study|unresolve corneal staining|0
312223|NCT01464021|1055712|P1|Overall Study|various|11
312224|NCT01464021|1055712|P1|Overall Study|Lack of Efficacy|1
312225|NCT01464021|1055712|P1|Overall Study|Lost to Follow-up|1
312226|NCT01464021|1055712|P1|Overall Study|Withdrawal by Subject|13
312227|NCT01463982|1055728|P4|Overall Study|Treatment delay over 5 week|0
312228|NCT01463982|1055729|P3|Overall Study|Treatment delay over 5 week|1
312229|NCT01463982|1055730|P2|Overall Study|Treatment delay over 5 week|0
312230|NCT01463982|1055731|P1|Overall Study|Treatment delay over 5 week|0
312231|NCT01463982|1055728|P4|Overall Study|Withdrawal by Subject|0
312232|NCT01463982|1055729|P3|Overall Study|Withdrawal by Subject|1
312233|NCT01463982|1055730|P2|Overall Study|Withdrawal by Subject|1
312234|NCT01463982|1055731|P1|Overall Study|Withdrawal by Subject|0
312235|NCT01463878|1055747|P2|Overall Study|no longer met criteria for tube feed|2
312236|NCT01463878|1055748|P1|Overall Study|no longer met criteria for tube feed|2
312237|NCT01463696|1055762|P8|Overall Study|Not Treated|0
312238|NCT01463696|1055763|P7|Overall Study|Not Treated|1
312239|NCT01463696|1055764|P6|Overall Study|Not Treated|0
312240|NCT01463696|1055765|P5|Overall Study|Not Treated|0
312241|NCT01463696|1055766|P4|Overall Study|Not Treated|0
312242|NCT01463696|1055767|P3|Overall Study|Not Treated|0
312243|NCT01463696|1055768|P2|Overall Study|Not Treated|0
312244|NCT01463696|1055769|P1|Overall Study|Not Treated|0
312245|NCT01463696|1055762|P8|Overall Study|Withdrawal by Subject|0
312246|NCT01463696|1055763|P7|Overall Study|Withdrawal by Subject|2
312247|NCT01463696|1055764|P6|Overall Study|Withdrawal by Subject|1
312248|NCT01463696|1055765|P5|Overall Study|Withdrawal by Subject|1
312249|NCT01463696|1055766|P4|Overall Study|Withdrawal by Subject|1
312250|NCT01463696|1055767|P3|Overall Study|Withdrawal by Subject|0
312251|NCT01463696|1055768|P2|Overall Study|Withdrawal by Subject|0
312252|NCT01463696|1055769|P1|Overall Study|Withdrawal by Subject|0
312253|NCT01463696|1055762|P8|Overall Study|Progressive Disease|2
312254|NCT01463696|1055763|P7|Overall Study|Progressive Disease|4
312255|NCT01463696|1055764|P6|Overall Study|Progressive Disease|1
312256|NCT01463696|1055765|P5|Overall Study|Progressive Disease|0
312257|NCT01463696|1055766|P4|Overall Study|Progressive Disease|1
312258|NCT01463696|1055767|P3|Overall Study|Progressive Disease|0
312259|NCT01463696|1055768|P2|Overall Study|Progressive Disease|1
312260|NCT01463696|1055769|P1|Overall Study|Progressive Disease|0
312261|NCT01463696|1055762|P8|Overall Study|Lost to Follow-up|0
312262|NCT01463696|1055763|P7|Overall Study|Lost to Follow-up|0
312263|NCT01463696|1055764|P6|Overall Study|Lost to Follow-up|0
312264|NCT01463696|1055765|P5|Overall Study|Lost to Follow-up|0
312265|NCT01463696|1055766|P4|Overall Study|Lost to Follow-up|0
312266|NCT01463696|1055767|P3|Overall Study|Lost to Follow-up|1
312267|NCT01463696|1055768|P2|Overall Study|Lost to Follow-up|0
312268|NCT01463696|1055769|P1|Overall Study|Lost to Follow-up|0
312269|NCT01463696|1055762|P8|Overall Study|Adverse Event|2
312270|NCT01463696|1055763|P7|Overall Study|Adverse Event|3
312271|NCT01463696|1055764|P6|Overall Study|Adverse Event|1
312272|NCT01463696|1055765|P5|Overall Study|Adverse Event|0
312273|NCT01463696|1055766|P4|Overall Study|Adverse Event|2
312274|NCT01463696|1055767|P3|Overall Study|Adverse Event|0
312275|NCT01463696|1055768|P2|Overall Study|Adverse Event|1
312276|NCT01463696|1055769|P1|Overall Study|Adverse Event|0
312277|NCT01463683|1055822|P3|Overall Study|Withdrawal by Subject|2
312278|NCT01463683|1055823|P2|Overall Study|Withdrawal by Subject|17
312279|NCT01463683|1055824|P1|Overall Study|Withdrawal by Subject|5
312280|NCT01463683|1055822|P3|Overall Study|Pregnancy|1
312281|NCT01463683|1055823|P2|Overall Study|Pregnancy|2
312282|NCT01463683|1055824|P1|Overall Study|Pregnancy|2
312283|NCT01463683|1055822|P3|Overall Study|Physician Decision|1
312284|NCT01463683|1055823|P2|Overall Study|Physician Decision|3
312285|NCT01463683|1055824|P1|Overall Study|Physician Decision|0
312286|NCT01463683|1055822|P3|Overall Study|Lost to Follow-up|7
312287|NCT01463683|1055823|P2|Overall Study|Lost to Follow-up|9
312288|NCT01463683|1055824|P1|Overall Study|Lost to Follow-up|10
312289|NCT01463683|1055822|P3|Overall Study|Adverse Event|0
312290|NCT01463683|1055823|P2|Overall Study|Adverse Event|0
312291|NCT01463683|1055824|P1|Overall Study|Adverse Event|2
312292|NCT01463527|1055839|P2|Overall Study|Crying >20% of sedation|6
312293|NCT01463527|1055840|P1|Overall Study|Crying >20% of sedation|5
312294|NCT01463527|1055839|P2|Overall Study|Protocol Violation|1
312295|NCT01463527|1055840|P1|Overall Study|Protocol Violation|1
312296|NCT01463293|1055863|P3|Overall Study|Other|2
312297|NCT01463293|1055864|P2|Overall Study|Other|0
312298|NCT01463293|1055865|P1|Overall Study|Other|0
312299|NCT01463293|1055863|P3|Overall Study|Withdrawal by Subject|5
312300|NCT01463293|1055864|P2|Overall Study|Withdrawal by Subject|10
312301|NCT01463293|1055865|P1|Overall Study|Withdrawal by Subject|4
312302|NCT01463293|1055863|P3|Overall Study|Adverse Event|0
312303|NCT01463293|1055864|P2|Overall Study|Adverse Event|2
312304|NCT01463293|1055865|P1|Overall Study|Adverse Event|1
312305|NCT01463293|1055863|P3|Overall Study|Lost to Follow-up|5
312306|NCT01463293|1055864|P2|Overall Study|Lost to Follow-up|4
312307|NCT01463293|1055865|P1|Overall Study|Lost to Follow-up|1
312308|NCT01463111|1055888|P1|Overall Study|Physician Decision|2
312309|NCT01463111|1055888|P1|Overall Study|Lost to Follow-up|5
312310|NCT01463111|1055888|P1|Overall Study|Withdrawal by Subject|2
312311|NCT01463033|1055898|P2|Overall Study|Death|2
312312|NCT01463033|1055899|P1|Overall Study|Death|3
312313|NCT01463033|1055898|P2|Overall Study|Lost to Follow-up|4
312314|NCT01463033|1055899|P1|Overall Study|Lost to Follow-up|4
312315|NCT01463007|1055906|P1|Overall Study|Physician Decision|1
312316|NCT01462942|1055917|P5|Overall Study|Protocol Violation|6
312317|NCT01462942|1055918|P4|Overall Study|Protocol Violation|9
312318|NCT01462942|1055919|P3|Overall Study|Protocol Violation|9
312319|NCT01462942|1055920|P2|Overall Study|Protocol Violation|6
312320|NCT01462942|1055921|P1|Overall Study|Protocol Violation|4
312321|NCT01462942|1055917|P5|Overall Study|Lost to Follow-up|1
312322|NCT01462942|1055918|P4|Overall Study|Lost to Follow-up|1
312323|NCT01462942|1055919|P3|Overall Study|Lost to Follow-up|1
312324|NCT01462942|1055920|P2|Overall Study|Lost to Follow-up|1
312325|NCT01462942|1055921|P1|Overall Study|Lost to Follow-up|0
312326|NCT01462942|1055917|P5|Overall Study|Lack of Efficacy|3
312327|NCT01462942|1055918|P4|Overall Study|Lack of Efficacy|5
312328|NCT01462942|1055919|P3|Overall Study|Lack of Efficacy|4
312329|NCT01462942|1055920|P2|Overall Study|Lack of Efficacy|0
312330|NCT01462942|1055921|P1|Overall Study|Lack of Efficacy|6
312331|NCT01462942|1055917|P5|Overall Study|Withdrawal by Subject|19
312332|NCT01462942|1055918|P4|Overall Study|Withdrawal by Subject|16
312333|NCT01462942|1055919|P3|Overall Study|Withdrawal by Subject|14
312334|NCT01462942|1055920|P2|Overall Study|Withdrawal by Subject|10
312335|NCT01462942|1055921|P1|Overall Study|Withdrawal by Subject|14
312336|NCT01462942|1055917|P5|Overall Study|Other, including COPD exacerbation|5
312337|NCT01462942|1055918|P4|Overall Study|Other, including COPD exacerbation|8
312338|NCT01462942|1055919|P3|Overall Study|Other, including COPD exacerbation|2
312339|NCT01462942|1055920|P2|Overall Study|Other, including COPD exacerbation|5
312340|NCT01462942|1055921|P1|Overall Study|Other, including COPD exacerbation|3
312341|NCT01462942|1055917|P5|Overall Study|Adverse Event|11
312342|NCT01462942|1055918|P4|Overall Study|Adverse Event|11
312343|NCT01462942|1055919|P3|Overall Study|Adverse Event|10
312344|NCT01462942|1055920|P2|Overall Study|Adverse Event|12
312345|NCT01462942|1055921|P1|Overall Study|Adverse Event|7
312346|NCT01462929|1055951|P3|Overall Study|Lack of Efficacy|1
312347|NCT01462929|1055952|P2|Overall Study|Lack of Efficacy|0
312348|NCT01462929|1055953|P1|Overall Study|Lack of Efficacy|0
312349|NCT01462929|1055951|P3|Overall Study|Withdrawal by Subject|0
312350|NCT01462929|1055952|P2|Overall Study|Withdrawal by Subject|1
312351|NCT01462929|1055953|P1|Overall Study|Withdrawal by Subject|2
312352|NCT01462929|1055951|P3|Overall Study|Adverse Event|4
312353|NCT01462929|1055952|P2|Overall Study|Adverse Event|3
312354|NCT01462929|1055953|P1|Overall Study|Adverse Event|3
312355|NCT01462695|1055994|P2|Overall Study|Inevaluable (did not receive study drug)|0
312356|NCT01462695|1055995|P1|Overall Study|Inevaluable (did not receive study drug)|1
312357|NCT01462695|1055994|P2|Overall Study|Withdrawal by Subject|0
312358|NCT01462695|1055995|P1|Overall Study|Withdrawal by Subject|2
312359|NCT01462695|1055994|P2|Overall Study|Physician Decision|0
312360|NCT01462695|1055995|P1|Overall Study|Physician Decision|5
312361|NCT01462695|1055994|P2|Overall Study|Lack of Efficacy|12
312362|NCT01462695|1055995|P1|Overall Study|Lack of Efficacy|6
312363|NCT01462695|1055994|P2|Overall Study|Death|0
312364|NCT01462695|1055995|P1|Overall Study|Death|2
312365|NCT01462695|1055994|P2|Overall Study|Adverse Event|1
312366|NCT01462695|1055995|P1|Overall Study|Adverse Event|1
312367|NCT01462435|1056023|P4|Overall Study|Lost to Follow-up|1
312368|NCT01462435|1056024|P3|Overall Study|Lost to Follow-up|0
312369|NCT01462435|1056025|P2|Overall Study|Lost to Follow-up|0
312370|NCT01462435|1056026|P1|Overall Study|Lost to Follow-up|0
312371|NCT01462435|1056023|P4|Overall Study|Withdrawal by Subject|1
312372|NCT01462435|1056024|P3|Overall Study|Withdrawal by Subject|0
312373|NCT01462435|1056025|P2|Overall Study|Withdrawal by Subject|0
312374|NCT01462435|1056026|P1|Overall Study|Withdrawal by Subject|0
312375|NCT01462435|1056023|P4|Overall Study|Physician Decision|0
312376|NCT01462435|1056024|P3|Overall Study|Physician Decision|1
312377|NCT01462435|1056025|P2|Overall Study|Physician Decision|0
312378|NCT01462435|1056026|P1|Overall Study|Physician Decision|0
312379|NCT01462435|1056023|P4|Overall Study|Lack of Efficacy|3
312380|NCT01462435|1056024|P3|Overall Study|Lack of Efficacy|0
312381|NCT01462435|1056025|P2|Overall Study|Lack of Efficacy|0
312382|NCT01462435|1056026|P1|Overall Study|Lack of Efficacy|1
312383|NCT01462370|1056064|P2|Overall Study|Withdrawal by Subject|3
312384|NCT01462370|1056065|P1|Overall Study|Withdrawal by Subject|0
312385|NCT01462370|1056064|P2|Overall Study|Physician Decision|1
312386|NCT01462370|1056065|P1|Overall Study|Physician Decision|0
312387|NCT01462370|1056064|P2|Overall Study|Lack of Qualifying Event|1
312388|NCT01462370|1056065|P1|Overall Study|Lack of Qualifying Event|1
312389|NCT01462357|1056100|P3|Month 24|Migrated/moved from study area|0
312390|NCT01462357|1056101|P2|Month 24|Migrated/moved from study area|2
312391|NCT01462357|1056102|P1|Month 24|Migrated/moved from study area|0
312392|NCT01462357|1056100|P3|Month 24|Lost to Follow-up|6
312393|NCT01462357|1056101|P2|Month 24|Lost to Follow-up|4
312394|NCT01462357|1056102|P1|Month 24|Lost to Follow-up|2
312395|NCT01462357|1056100|P3|Month 24|Withdrawal by Subject|3
312396|NCT01462357|1056101|P2|Month 24|Withdrawal by Subject|8
312397|NCT01462357|1056102|P1|Month 24|Withdrawal by Subject|2
312398|NCT01462357|1056100|P3|Month 18|Other|1
312399|NCT01462357|1056101|P2|Month 18|Other|1
312400|NCT01462357|1056102|P1|Month 18|Other|0
312401|NCT01462357|1056100|P3|Month 18|Lost to Follow-up|5
312402|NCT01462357|1056101|P2|Month 18|Lost to Follow-up|4
312403|NCT01462357|1056102|P1|Month 18|Lost to Follow-up|1
312404|NCT01462357|1056100|P3|Month 18|Withdrawal by Subject|3
312405|NCT01462357|1056101|P2|Month 18|Withdrawal by Subject|6
312406|NCT01462357|1056102|P1|Month 18|Withdrawal by Subject|2
312407|NCT01462357|1056100|P3|Month 12|Lost to Follow-up|5
312408|NCT01462357|1056101|P2|Month 12|Lost to Follow-up|4
312409|NCT01462357|1056102|P1|Month 12|Lost to Follow-up|1
312410|NCT01462357|1056100|P3|Month 12|Withdrawal by Subject|3
312411|NCT01462357|1056101|P2|Month 12|Withdrawal by Subject|6
312412|NCT01462357|1056102|P1|Month 12|Withdrawal by Subject|2
312413|NCT01462357|1056100|P3|Month 7|Withdrawal by Subject|6
312414|NCT01462357|1056101|P2|Month 7|Withdrawal by Subject|5
312415|NCT01462357|1056102|P1|Month 7|Withdrawal by Subject|1
312416|NCT01462344|1056175|P2|Overall Study|Lost to Follow-up|7
312417|NCT01462344|1056176|P1|Overall Study|Lost to Follow-up|7
312418|NCT01462344|1056175|P2|Overall Study|Protocol Violation|53
312419|NCT01462344|1056176|P1|Overall Study|Protocol Violation|68
312420|NCT01462344|1056175|P2|Overall Study|Lack of Efficacy|6
312421|NCT01462344|1056176|P1|Overall Study|Lack of Efficacy|5
312422|NCT01462344|1056175|P2|Overall Study|Asthma Exacerbation|35
312423|NCT01462344|1056176|P1|Overall Study|Asthma Exacerbation|34
312424|NCT01462344|1056175|P2|Overall Study|Adverse Event|23
312425|NCT01462344|1056176|P1|Overall Study|Adverse Event|24
312426|NCT01462344|1056175|P2|Overall Study|Withdrawal by Subject|226
312427|NCT01462344|1056176|P1|Overall Study|Withdrawal by Subject|245
312428|NCT01462318|1056198|P3|Extension Phase|Adverse Event|22
312429|NCT01462318|1056199|P2|Extension Phase|Adverse Event|0
312430|NCT01462318|1056200|P1|Extension Phase|Adverse Event|0
312431|NCT01462318|1056198|P3|Extension Phase|Investigator Decision|5
312432|NCT01462318|1056199|P2|Extension Phase|Investigator Decision|0
312433|NCT01462318|1056200|P1|Extension Phase|Investigator Decision|0
312434|NCT01462318|1056198|P3|Extension Phase|Withdrawal by Subject|15
312435|NCT01462318|1056199|P2|Extension Phase|Withdrawal by Subject|0
312436|NCT01462318|1056200|P1|Extension Phase|Withdrawal by Subject|0
312437|NCT01462318|1056198|P3|Extension Phase|Disease Progression|1
312438|NCT01462318|1056199|P2|Extension Phase|Disease Progression|0
312439|NCT01462318|1056200|P1|Extension Phase|Disease Progression|0
312440|NCT01462318|1056198|P3|Extension Phase|Not Specified|1
312441|NCT01462318|1056199|P2|Extension Phase|Not Specified|0
312442|NCT01462318|1056200|P1|Extension Phase|Not Specified|0
312443|NCT01462318|1056198|P3|Extension Phase|Lost to Follow-up|1
312444|NCT01462318|1056199|P2|Extension Phase|Lost to Follow-up|0
312445|NCT01462318|1056200|P1|Extension Phase|Lost to Follow-up|0
312446|NCT01462318|1056198|P3|Main Study / TP-DI Study|Adverse Event|0
312447|NCT01462318|1056199|P2|Main Study / TP-DI Study|Adverse Event|0
312448|NCT01462318|1056200|P1|Main Study / TP-DI Study|Adverse Event|4
312449|NCT01462318|1056198|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
312450|NCT01462318|1056199|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
312451|NCT01462318|1056200|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
312452|NCT01462318|1056198|P3|Main Study / TP-DI Study|Not Specified|0
312453|NCT01462318|1056199|P2|Main Study / TP-DI Study|Not Specified|0
312454|NCT01462318|1056200|P1|Main Study / TP-DI Study|Not Specified|2
312455|NCT01462266|1056288|P2|Overall Study|Screen failure|1
312456|NCT01462266|1056289|P1|Overall Study|Screen failure|1
312457|NCT01462266|1056288|P2|Overall Study|Withdrawal by Subject|2
312458|NCT01462266|1056289|P1|Overall Study|Withdrawal by Subject|7
312459|NCT01462266|1056288|P2|Overall Study|Protocol Violation|3
312460|NCT01462266|1056289|P1|Overall Study|Protocol Violation|1
312461|NCT01462266|1056288|P2|Overall Study|Physician Decision|5
312462|NCT01462266|1056289|P1|Overall Study|Physician Decision|2
312463|NCT01462266|1056288|P2|Overall Study|Creatinine and eGFR, excluded medication|4
312464|NCT01462266|1056289|P1|Overall Study|Creatinine and eGFR, excluded medication|8
312465|NCT01462266|1056288|P2|Overall Study|Non-compliance with study drug|0
312466|NCT01462266|1056289|P1|Overall Study|Non-compliance with study drug|3
312467|NCT01462266|1056288|P2|Overall Study|Lost to Follow-up|3
312468|NCT01462266|1056289|P1|Overall Study|Lost to Follow-up|4
312469|NCT01462266|1056288|P2|Overall Study|Lack of Efficacy|2
312470|NCT01462266|1056289|P1|Overall Study|Lack of Efficacy|0
312471|NCT01462266|1056288|P2|Overall Study|Death|1
312472|NCT01462266|1056289|P1|Overall Study|Death|2
312473|NCT01462266|1056288|P2|Overall Study|Adverse Event|6
312474|NCT01462266|1056289|P1|Overall Study|Adverse Event|7
312475|NCT01462227|1056305|P4|Second Assignment|Protocol Violation|0
312476|NCT01462227|1056306|P3|Second Assignment|Protocol Violation|1
312477|NCT01462227|1056307|P2|Second Assignment|Protocol Violation|1
312478|NCT01462227|1056308|P1|Second Assignment|Protocol Violation|0
312479|NCT01462227|1056305|P4|Second Assignment|Lost to Follow-up|0
312480|NCT01462227|1056306|P3|Second Assignment|Lost to Follow-up|0
312481|NCT01462227|1056307|P2|Second Assignment|Lost to Follow-up|0
312482|NCT01462227|1056308|P1|Second Assignment|Lost to Follow-up|1
312483|NCT01462162|1056326|P1|Overall Study|Other|2
312484|NCT01462162|1056326|P1|Overall Study|Abnormal laboratory parameters|1
312485|NCT01462162|1056326|P1|Overall Study|Lack of Efficacy|4
312486|NCT01462162|1056326|P1|Overall Study|Adverse Event|5
312487|NCT01462084|1056351|P2|Overall Study|Protocol Violation|1
312488|NCT01462084|1056352|P1|Overall Study|Protocol Violation|1
312489|NCT01462084|1056351|P2|Overall Study|Withdrawal by Subject|0
312490|NCT01462084|1056352|P1|Overall Study|Withdrawal by Subject|1
312491|NCT01462045|1056363|P3|Overall Study|Family matter|0
312492|NCT01462045|1056364|P2|Overall Study|Family matter|1
312493|NCT01462045|1056365|P1|Overall Study|Family matter|0
312494|NCT01461993|1056379|P3|Overall Study|Other|6
312495|NCT01461993|1056380|P2|Overall Study|Other|15
312496|NCT01461993|1056381|P1|Overall Study|Other|13
312497|NCT01461993|1056379|P3|Overall Study|Did not meet entrance criteria|0
312498|NCT01461993|1056380|P2|Overall Study|Did not meet entrance criteria|3
312499|NCT01461993|1056381|P1|Overall Study|Did not meet entrance criteria|2
312500|NCT01461993|1056379|P3|Overall Study|No longer met eligibility criteria|10
312501|NCT01461993|1056380|P2|Overall Study|No longer met eligibility criteria|18
312502|NCT01461993|1056381|P1|Overall Study|No longer met eligibility criteria|13
312503|NCT01461993|1056379|P3|Overall Study|Adverse Event|3
312504|NCT01461993|1056380|P2|Overall Study|Adverse Event|11
312505|NCT01461993|1056381|P1|Overall Study|Adverse Event|9
312506|NCT01461993|1056379|P3|Overall Study|Protocol Violation|7
312507|NCT01461993|1056380|P2|Overall Study|Protocol Violation|9
312508|NCT01461993|1056381|P1|Overall Study|Protocol Violation|10
312509|NCT01461993|1056379|P3|Overall Study|Lost to Follow-up|22
312510|NCT01461993|1056380|P2|Overall Study|Lost to Follow-up|48
312511|NCT01461993|1056381|P1|Overall Study|Lost to Follow-up|44
312512|NCT01461993|1056379|P3|Overall Study|Withdrawal by Subject|16
312513|NCT01461993|1056380|P2|Overall Study|Withdrawal by Subject|53
312514|NCT01461993|1056381|P1|Overall Study|Withdrawal by Subject|60
312515|NCT01461980|1056406|P3|Overall Study|Randomized but not vaccinated|7
312516|NCT01461980|1056407|P2|Overall Study|Randomized but not vaccinated|8
312517|NCT01461980|1056408|P1|Overall Study|Randomized but not vaccinated|4
312518|NCT01461980|1056406|P3|Overall Study|No longer willing to participate|54
312519|NCT01461980|1056407|P2|Overall Study|No longer willing to participate|38
312520|NCT01461980|1056408|P1|Overall Study|No longer willing to participate|52
312521|NCT01461980|1056406|P3|Overall Study|Lost to Follow-up|51
312522|NCT01461980|1056407|P2|Overall Study|Lost to Follow-up|53
312523|NCT01461980|1056408|P1|Overall Study|Lost to Follow-up|52
312524|NCT01461980|1056406|P3|Overall Study|No longer meets eligibility criteria|19
312525|NCT01461980|1056407|P2|Overall Study|No longer meets eligibility criteria|9
312526|NCT01461980|1056408|P1|Overall Study|No longer meets eligibility criteria|18
312527|NCT01461980|1056406|P3|Overall Study|Protocol Violation|16
312528|NCT01461980|1056407|P2|Overall Study|Protocol Violation|19
312529|NCT01461980|1056408|P1|Overall Study|Protocol Violation|12
312530|NCT01461980|1056406|P3|Overall Study|Adverse Event|6
312531|NCT01461980|1056407|P2|Overall Study|Adverse Event|5
312532|NCT01461980|1056408|P1|Overall Study|Adverse Event|12
312533|NCT01461980|1056406|P3|Overall Study|Medication error|6
312534|NCT01461980|1056407|P2|Overall Study|Medication error|5
312535|NCT01461980|1056408|P1|Overall Study|Medication error|7
312536|NCT01461980|1056406|P3|Overall Study|Other|6
312537|NCT01461980|1056407|P2|Overall Study|Other|8
312538|NCT01461980|1056408|P1|Overall Study|Other|9
312539|NCT01461811|1056459|P2|Overall Study|Noncompliance|1
312540|NCT01461811|1056460|P1|Overall Study|Noncompliance|1
312541|NCT01461811|1056459|P2|Overall Study|Subject decision unrelated to an AE|1
312542|NCT01461811|1056460|P1|Overall Study|Subject decision unrelated to an AE|1
312543|NCT01461811|1056459|P2|Overall Study|Adverse Event|1
312544|NCT01461811|1056460|P1|Overall Study|Adverse Event|2
312545|NCT01461707|1056499|P2|Overall Study|Withdrawal by Subject|0
312546|NCT01461707|1056500|P1|Overall Study|Withdrawal by Subject|1
312547|NCT01461551|1056537|P3|Overall Study|Physician Decision|2
312548|NCT01461551|1056538|P2|Overall Study|Physician Decision|1
312549|NCT01461551|1056539|P1|Overall Study|Physician Decision|2
312550|NCT01461538|1056550|P3|Overall Study|Withdrawal by Subject|0
312551|NCT01461538|1056551|P2|Overall Study|Withdrawal by Subject|1
312552|NCT01461538|1056552|P1|Overall Study|Withdrawal by Subject|1
312553|NCT01461538|1056550|P3|Overall Study|Study Stopped by Sponsor|0
312554|NCT01461538|1056551|P2|Overall Study|Study Stopped by Sponsor|1
312555|NCT01461538|1056552|P1|Overall Study|Study Stopped by Sponsor|2
312556|NCT01461538|1056550|P3|Overall Study|Death|2
312557|NCT01461538|1056551|P2|Overall Study|Death|6
312558|NCT01461538|1056552|P1|Overall Study|Death|15
312559|NCT01461369|1056621|P3|Overall Study|Withdrawal by Subject|2
312560|NCT01461369|1056622|P2|Overall Study|Withdrawal by Subject|3
312561|NCT01461369|1056623|P1|Overall Study|Withdrawal by Subject|1
312562|NCT01461369|1056621|P3|Overall Study|Protocol Violation|2
312563|NCT01461369|1056622|P2|Overall Study|Protocol Violation|2
312564|NCT01461369|1056623|P1|Overall Study|Protocol Violation|1
312565|NCT01461369|1056621|P3|Overall Study|Adverse Event|4
312566|NCT01461369|1056622|P2|Overall Study|Adverse Event|12
312567|NCT01461369|1056623|P1|Overall Study|Adverse Event|9
312568|NCT01461369|1056621|P3|Overall Study|Lost to Follow-up|3
312569|NCT01461369|1056622|P2|Overall Study|Lost to Follow-up|0
312570|NCT01461369|1056623|P1|Overall Study|Lost to Follow-up|0
312571|NCT01461369|1056621|P3|Overall Study|Lack of Efficacy|6
312572|NCT01461369|1056622|P2|Overall Study|Lack of Efficacy|0
312573|NCT01461369|1056623|P1|Overall Study|Lack of Efficacy|2
312574|NCT01461096|1056648|P2|Overall Study|Lost to Follow-up|4
312575|NCT01461096|1056649|P1|Overall Study|Lost to Follow-up|8
312576|NCT01461096|1056648|P2|Overall Study|Subj not willing to adhere to reqs|4
312577|NCT01461096|1056649|P1|Overall Study|Subj not willing to adhere to reqs|3
312578|NCT01461096|1056648|P2|Overall Study|Withdrawal by Subject|3
312579|NCT01461096|1056649|P1|Overall Study|Withdrawal by Subject|5
312580|NCT01461096|1056648|P2|Overall Study|Site is closing|30
312581|NCT01461096|1056649|P1|Overall Study|Site is closing|27
312582|NCT01461096|1056648|P2|Overall Study|Subj not able to get to clinic|13
312583|NCT01461096|1056649|P1|Overall Study|Subj not able to get to clinic|15
312584|NCT01461096|1056648|P2|Overall Study|Severe debilitation, unable to continue|1
312585|NCT01461096|1056649|P1|Overall Study|Severe debilitation, unable to continue|1
312586|NCT01461096|1056648|P2|Overall Study|Death|6
312587|NCT01461096|1056649|P1|Overall Study|Death|3
312588|NCT01461057|1056665|P2|Overall Study|Physician Decision|1
312589|NCT01461057|1056666|P1|Overall Study|Physician Decision|0
312590|NCT01461057|1056665|P2|Overall Study|Withdrawal by Subject|3
312591|NCT01461057|1056666|P1|Overall Study|Withdrawal by Subject|2
312592|NCT01461057|1056665|P2|Overall Study|Death|8
312593|NCT01461057|1056666|P1|Overall Study|Death|7
312594|NCT01461057|1056665|P2|Overall Study|Currently in safety follow up|3
312595|NCT01461057|1056666|P1|Overall Study|Currently in safety follow up|4
312596|NCT01461057|1056665|P2|Overall Study|Currently in treatment|0
312597|NCT01461057|1056666|P1|Overall Study|Currently in treatment|2
312598|NCT01461044|1056676|P2|Overall Study|Lost to Follow-up|5
312599|NCT01461044|1056677|P1|Overall Study|Lost to Follow-up|12
312600|NCT01461044|1056676|P2|Overall Study|Death|35
312601|NCT01461044|1056677|P1|Overall Study|Death|58
312602|NCT01460628|1056777|P1|Overall Study|Withdrawal by Subject|2
312603|NCT01460628|1056777|P1|Overall Study|Adverse Event|3
312604|NCT01460446|1056789|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
312605|NCT01460446|1056790|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
312606|NCT01460446|1056789|P2|Overall Study|Pregnancy|0
312607|NCT01460446|1056790|P1|Overall Study|Pregnancy|1
312608|NCT01460446|1056789|P2|Overall Study|Surgery/Illness|1
312609|NCT01460446|1056790|P1|Overall Study|Surgery/Illness|1
312610|NCT01460446|1056789|P2|Overall Study|Non-compliance & Consent Withdrawn|3
312611|NCT01460446|1056790|P1|Overall Study|Non-compliance & Consent Withdrawn|1
312612|NCT01460446|1056789|P2|Overall Study|Consent Withdrawn|4
312613|NCT01460446|1056790|P1|Overall Study|Consent Withdrawn|0
312614|NCT01460446|1056789|P2|Overall Study|Non-compliance|9
312615|NCT01460446|1056790|P1|Overall Study|Non-compliance|2
312616|NCT01460342|1056819|P2|Overall Study|Lack of Efficacy|0
312617|NCT01460342|1056820|P1|Overall Study|Lack of Efficacy|1
312618|NCT01460342|1056819|P2|Overall Study|Physician Decision|3
312619|NCT01460342|1056820|P1|Overall Study|Physician Decision|1
312620|NCT01460342|1056819|P2|Overall Study|Withdrawal by Subject|4
312621|NCT01460342|1056820|P1|Overall Study|Withdrawal by Subject|3
312622|NCT01460342|1056819|P2|Overall Study|Protocol Violation|1
312623|NCT01460342|1056820|P1|Overall Study|Protocol Violation|0
312624|NCT01460342|1056819|P2|Overall Study|Lost to Follow-up|2
312625|NCT01460342|1056820|P1|Overall Study|Lost to Follow-up|1
312626|NCT01460342|1056819|P2|Overall Study|Adverse Event|4
312627|NCT01460342|1056820|P1|Overall Study|Adverse Event|5
312628|NCT01460290|1056851|P1|Overall Study|Elevated liver function|1
312629|NCT01460290|1056851|P1|Overall Study|Adverse Event|3
312630|NCT01459913|1056875|P4|Overall Study|Did Not Meet Inclusion Criteria|1
312631|NCT01459913|1056876|P3|Overall Study|Did Not Meet Inclusion Criteria|0
312632|NCT01459913|1056877|P2|Overall Study|Did Not Meet Inclusion Criteria|0
312633|NCT01459913|1056878|P1|Overall Study|Did Not Meet Inclusion Criteria|0
312634|NCT01459913|1056875|P4|Overall Study|Other|1
312635|NCT01459913|1056876|P3|Overall Study|Other|3
312636|NCT01459913|1056877|P2|Overall Study|Other|0
312637|NCT01459913|1056878|P1|Overall Study|Other|0
312638|NCT01459913|1056875|P4|Overall Study|Study Terminated by Sponsor|11
312639|NCT01459913|1056876|P3|Overall Study|Study Terminated by Sponsor|9
312640|NCT01459913|1056877|P2|Overall Study|Study Terminated by Sponsor|15
312641|NCT01459913|1056878|P1|Overall Study|Study Terminated by Sponsor|30
312642|NCT01459913|1056875|P4|Overall Study|Physician Decision|0
312643|NCT01459913|1056876|P3|Overall Study|Physician Decision|0
312644|NCT01459913|1056877|P2|Overall Study|Physician Decision|1
312645|NCT01459913|1056878|P1|Overall Study|Physician Decision|0
312646|NCT01459913|1056875|P4|Overall Study|Non- Compliance|3
312647|NCT01459913|1056876|P3|Overall Study|Non- Compliance|0
312648|NCT01459913|1056877|P2|Overall Study|Non- Compliance|0
312649|NCT01459913|1056878|P1|Overall Study|Non- Compliance|0
312650|NCT01459913|1056875|P4|Overall Study|Death|1
312651|NCT01459913|1056876|P3|Overall Study|Death|0
312652|NCT01459913|1056877|P2|Overall Study|Death|0
312653|NCT01459913|1056878|P1|Overall Study|Death|0
312654|NCT01459913|1056875|P4|Overall Study|Lost to Follow-up|8
312655|NCT01459913|1056876|P3|Overall Study|Lost to Follow-up|1
312656|NCT01459913|1056877|P2|Overall Study|Lost to Follow-up|4
312657|NCT01459913|1056878|P1|Overall Study|Lost to Follow-up|7
312658|NCT01459913|1056875|P4|Overall Study|Withdrawal by Subject|5
312659|NCT01459913|1056876|P3|Overall Study|Withdrawal by Subject|0
312660|NCT01459913|1056877|P2|Overall Study|Withdrawal by Subject|0
312661|NCT01459913|1056878|P1|Overall Study|Withdrawal by Subject|4
312662|NCT01459913|1056875|P4|Overall Study|Adverse Event|3
312663|NCT01459913|1056876|P3|Overall Study|Adverse Event|0
312664|NCT01459913|1056877|P2|Overall Study|Adverse Event|0
312665|NCT01459913|1056878|P1|Overall Study|Adverse Event|0
312666|NCT01459796|1056909|P2|Overall Study|Decision by the sponsor|108
312667|NCT01459796|1056910|P1|Overall Study|Decision by the sponsor|75
312668|NCT01459796|1056909|P2|Overall Study|Reason unspecified|2
312669|NCT01459796|1056910|P1|Overall Study|Reason unspecified|1
312670|NCT01459796|1056909|P2|Overall Study|Lost to Follow-up|4
312671|NCT01459796|1056910|P1|Overall Study|Lost to Follow-up|5
312672|NCT01459796|1056909|P2|Overall Study|Withdrawal by Subject|3
312673|NCT01459796|1056910|P1|Overall Study|Withdrawal by Subject|6
312674|NCT01459796|1056909|P2|Overall Study|Adverse Event|5
312675|NCT01459796|1056910|P1|Overall Study|Adverse Event|5
312676|NCT01459796|1056909|P2|Overall Study|Non compliance with protocol|4
312677|NCT01459796|1056910|P1|Overall Study|Non compliance with protocol|2
312678|NCT01459783|1056928|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
312679|NCT01459783|1056929|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
312680|NCT01459783|1056928|P2|6 Months to 12 Months|Lost to Follow-up|7
312681|NCT01459783|1056929|P1|6 Months to 12 Months|Lost to Follow-up|2
312682|NCT01459783|1056928|P2|6 Months to 12 Months|Withdrawal by Subject|5
312683|NCT01459783|1056929|P1|6 Months to 12 Months|Withdrawal by Subject|6
312684|NCT01459783|1056928|P2|6 Months to 12 Months|Death|1
312685|NCT01459783|1056929|P1|6 Months to 12 Months|Death|0
312686|NCT01459783|1056928|P2|Baseline to 6 Months|Lost to Follow-up|14
312687|NCT01459783|1056929|P1|Baseline to 6 Months|Lost to Follow-up|19
312688|NCT01459783|1056928|P2|Baseline to 6 Months|Withdrawal by Subject|6
312689|NCT01459783|1056929|P1|Baseline to 6 Months|Withdrawal by Subject|12
312690|NCT01459783|1056928|P2|Baseline to 6 Months|Death|0
312691|NCT01459783|1056929|P1|Baseline to 6 Months|Death|1
312692|NCT01459068|1057141|P2|Overall Study|Death|1
312693|NCT01459068|1057142|P1|Overall Study|Death|0
312694|NCT01459068|1057141|P2|Overall Study|Lost to Follow-up|15
312695|NCT01459068|1057142|P1|Overall Study|Lost to Follow-up|31
312696|NCT01459068|1057141|P2|Overall Study|Withdrawal by Subject|18
312697|NCT01459068|1057142|P1|Overall Study|Withdrawal by Subject|8
312698|NCT01459016|1057158|P1|Overall Study|Amendment Discontinuation Criteria|4
312699|NCT01459016|1057158|P1|Overall Study|Withdrawal by Subject|11
312700|NCT01458951|1057186|P3|Overall Study|Insufficient Clinical Response|11
312701|NCT01458951|1057187|P2|Overall Study|Insufficient Clinical Response|0
312702|NCT01458951|1057188|P1|Overall Study|Insufficient Clinical Response|17
312703|NCT01458951|1057186|P3|Overall Study|Adverse Event|2
312704|NCT01458951|1057187|P2|Overall Study|Adverse Event|0
312705|NCT01458951|1057188|P1|Overall Study|Adverse Event|7
312706|NCT01458951|1057186|P3|Overall Study|Withdrawal by Subject|2
312707|NCT01458951|1057187|P2|Overall Study|Withdrawal by Subject|0
312708|NCT01458951|1057188|P1|Overall Study|Withdrawal by Subject|2
312709|NCT01458951|1057186|P3|Overall Study|Protocol Violation|0
312710|NCT01458951|1057187|P2|Overall Study|Protocol Violation|1
312711|NCT01458951|1057188|P1|Overall Study|Protocol Violation|5
312712|NCT01458951|1057186|P3|Overall Study|Other|0
312713|NCT01458951|1057187|P2|Overall Study|Other|0
312714|NCT01458951|1057188|P1|Overall Study|Other|1
312715|NCT01458639|1057213|P1|Overall Study|Inability to obtain subject blood sample|1
312716|NCT01458639|1057213|P1|Overall Study|Equipment issue|1
312717|NCT01458639|1057213|P1|Overall Study|Physician Decision|4
312718|NCT01458587|1057225|P2|Overall Study|Withdrawal by Subject|0
312719|NCT01458587|1057226|P1|Overall Study|Withdrawal by Subject|1
312720|NCT01458574|1057389|P3|Overall Study|Randomized but not treated|0
312721|NCT01458574|1057390|P2|Overall Study|Randomized but not treated|1
312722|NCT01458574|1057391|P1|Overall Study|Randomized but not treated|0
312723|NCT01458574|1057389|P3|Overall Study|Other|0
312724|NCT01458574|1057390|P2|Overall Study|Other|1
312725|NCT01458574|1057391|P1|Overall Study|Other|2
312726|NCT01458574|1057389|P3|Overall Study|Withdrawal by Subject|5
312727|NCT01458574|1057390|P2|Overall Study|Withdrawal by Subject|3
312728|NCT01458574|1057391|P1|Overall Study|Withdrawal by Subject|6
312729|NCT01458574|1057389|P3|Overall Study|Protocol Violation|0
312730|NCT01458574|1057390|P2|Overall Study|Protocol Violation|1
312731|NCT01458574|1057391|P1|Overall Study|Protocol Violation|0
312732|NCT01458574|1057389|P3|Overall Study|Pregnancy|0
312733|NCT01458574|1057390|P2|Overall Study|Pregnancy|1
312734|NCT01458574|1057391|P1|Overall Study|Pregnancy|1
312735|NCT01458574|1057389|P3|Overall Study|Lost to Follow-up|1
312736|NCT01458574|1057390|P2|Overall Study|Lost to Follow-up|2
312737|NCT01458574|1057391|P1|Overall Study|Lost to Follow-up|3
312738|NCT01458574|1057389|P3|Overall Study|Lack of Efficacy|132
312739|NCT01458574|1057390|P2|Overall Study|Lack of Efficacy|53
312740|NCT01458574|1057391|P1|Overall Study|Lack of Efficacy|70
312741|NCT01458574|1057389|P3|Overall Study|Adverse Event|7
312742|NCT01458574|1057390|P2|Overall Study|Adverse Event|9
312743|NCT01458574|1057391|P1|Overall Study|Adverse Event|5
312744|NCT01458535|1057521|P6|Overall Study|Adverse Event|0
312745|NCT01458535|1057522|P5|Overall Study|Adverse Event|0
312746|NCT01458535|1057523|P4|Overall Study|Adverse Event|1
312747|NCT01458535|1057524|P3|Overall Study|Adverse Event|0
312748|NCT01458535|1057525|P2|Overall Study|Adverse Event|0
312749|NCT01458535|1057526|P1|Overall Study|Adverse Event|0
312750|NCT01458535|1057521|P6|Overall Study|Lost to Follow-up|2
312751|NCT01458535|1057522|P5|Overall Study|Lost to Follow-up|2
312752|NCT01458535|1057523|P4|Overall Study|Lost to Follow-up|3
312753|NCT01458535|1057524|P3|Overall Study|Lost to Follow-up|0
312754|NCT01458535|1057525|P2|Overall Study|Lost to Follow-up|2
312755|NCT01458535|1057526|P1|Overall Study|Lost to Follow-up|0
312756|NCT01458535|1057521|P6|Overall Study|Withdrawal by Subject|1
312757|NCT01458535|1057522|P5|Overall Study|Withdrawal by Subject|1
312758|NCT01458535|1057523|P4|Overall Study|Withdrawal by Subject|0
312759|NCT01458535|1057524|P3|Overall Study|Withdrawal by Subject|2
312760|NCT01458535|1057525|P2|Overall Study|Withdrawal by Subject|0
312761|NCT01458535|1057526|P1|Overall Study|Withdrawal by Subject|0
312762|NCT01458535|1057521|P6|Overall Study|Other|1
312763|NCT01458535|1057522|P5|Overall Study|Other|1
312764|NCT01458535|1057523|P4|Overall Study|Other|0
312765|NCT01458535|1057524|P3|Overall Study|Other|0
312766|NCT01458535|1057525|P2|Overall Study|Other|0
312767|NCT01458535|1057526|P1|Overall Study|Other|0
312768|NCT01458522|1057578|P2|Overall Study|Physician Decision|9
312769|NCT01458522|1057579|P1|Overall Study|Physician Decision|1
312770|NCT01458522|1057578|P2|Overall Study|Withdrawal by Subject|2
312771|NCT01458522|1057579|P1|Overall Study|Withdrawal by Subject|2
312772|NCT01458392|1057608|P3|Overall Study|Patient unwilling to comply with protoco|2
312773|NCT01458392|1057609|P2|Overall Study|Patient unwilling to comply with protoco|0
312774|NCT01458392|1057610|P1|Overall Study|Patient unwilling to comply with protoco|0
312775|NCT01458392|1057608|P3|Overall Study|At the discretion of the sponsor|7
312776|NCT01458392|1057609|P2|Overall Study|At the discretion of the sponsor|2
312777|NCT01458392|1057610|P1|Overall Study|At the discretion of the sponsor|0
312778|NCT01458392|1057608|P3|Overall Study|Death|22
312779|NCT01458392|1057609|P2|Overall Study|Death|11
312780|NCT01458392|1057610|P1|Overall Study|Death|2
312781|NCT01458275|1057642|P3|Overall Study|Withdrawal by Subject|1
312782|NCT01458275|1057643|P2|Overall Study|Withdrawal by Subject|2
312783|NCT01458275|1057644|P1|Overall Study|Withdrawal by Subject|3
312784|NCT01458275|1057642|P3|Overall Study|Protocol Violation|2
312785|NCT01458275|1057643|P2|Overall Study|Protocol Violation|5
312786|NCT01458275|1057644|P1|Overall Study|Protocol Violation|5
312787|NCT01458275|1057642|P3|Overall Study|Lost to Follow-up|5
312788|NCT01458275|1057643|P2|Overall Study|Lost to Follow-up|2
312789|NCT01458275|1057644|P1|Overall Study|Lost to Follow-up|3
312790|NCT01458275|1057642|P3|Overall Study|Adverse Event|1
312791|NCT01458275|1057643|P2|Overall Study|Adverse Event|4
312792|NCT01458275|1057644|P1|Overall Study|Adverse Event|3
312793|NCT01458249|1057686|P1|Overall Study|Ongoing|1
312794|NCT01458249|1057686|P1|Overall Study|Not specified|2
312795|NCT01458249|1057686|P1|Overall Study|Adverse Event|4
312796|NCT01458249|1057686|P1|Overall Study|Not treated|1
312797|NCT01458210|1057705|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
312798|NCT01458210|1057705|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
312799|NCT01458210|1057705|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
312800|NCT01458210|1057705|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
312801|NCT01458171|1057722|P1|Overall Study|Adverse Event|1
312802|NCT01458106|1057745|P2|Overall Study|Withdrawn Per Protocol|1
312803|NCT01458106|1057746|P1|Overall Study|Withdrawn Per Protocol|0
312804|NCT01458106|1057745|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
312805|NCT01458106|1057746|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
312806|NCT01458106|1057745|P2|Overall Study|Withdrawal by Subject|0
312807|NCT01458106|1057746|P1|Overall Study|Withdrawal by Subject|2
312808|NCT01457950|1057823|P4|Open-Label Phase|Withdrawal by Subject|0
312809|NCT01457950|1057824|P3|Open-Label Phase|Withdrawal by Subject|2
312810|NCT01457950|1057825|P2|Open-Label Phase|Withdrawal by Subject|0
312811|NCT01457950|1057826|P1|Open-Label Phase|Withdrawal by Subject|0
312812|NCT01457950|1057823|P4|Open-Label Phase|Protocol Violation|1
312813|NCT01457950|1057824|P3|Open-Label Phase|Protocol Violation|0
312814|NCT01457950|1057825|P2|Open-Label Phase|Protocol Violation|0
312815|NCT01457950|1057826|P1|Open-Label Phase|Protocol Violation|0
312816|NCT01457950|1057823|P4|Open-Label Phase|Adverse Event|1
312817|NCT01457950|1057824|P3|Open-Label Phase|Adverse Event|0
312818|NCT01457950|1057825|P2|Open-Label Phase|Adverse Event|0
312819|NCT01457950|1057826|P1|Open-Label Phase|Adverse Event|0
312820|NCT01457950|1057823|P4|Double-Blind Phase|Withdrawal by Subject|0
312821|NCT01457950|1057824|P3|Double-Blind Phase|Withdrawal by Subject|0
312822|NCT01457950|1057825|P2|Double-Blind Phase|Withdrawal by Subject|2
312823|NCT01457950|1057826|P1|Double-Blind Phase|Withdrawal by Subject|6
312824|NCT01457950|1057823|P4|Double-Blind Phase|Protocol Violation|0
312825|NCT01457950|1057824|P3|Double-Blind Phase|Protocol Violation|0
312826|NCT01457950|1057825|P2|Double-Blind Phase|Protocol Violation|1
312827|NCT01457950|1057826|P1|Double-Blind Phase|Protocol Violation|2
312828|NCT01457950|1057823|P4|Double-Blind Phase|Continuation Criteria Not Met|0
312829|NCT01457950|1057824|P3|Double-Blind Phase|Continuation Criteria Not Met|0
312830|NCT01457950|1057825|P2|Double-Blind Phase|Continuation Criteria Not Met|0
312831|NCT01457950|1057826|P1|Double-Blind Phase|Continuation Criteria Not Met|1
312832|NCT01457924|1057905|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
312833|NCT01457924|1057906|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
312834|NCT01457924|1057907|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
312835|NCT01457924|1057908|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
312836|NCT01457924|1057909|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
312837|NCT01457924|1057905|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
312838|NCT01457924|1057906|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
312839|NCT01457924|1057907|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
312840|NCT01457924|1057908|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
312841|NCT01457924|1057909|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
312842|NCT01457924|1057905|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
312843|NCT01457924|1057906|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
312844|NCT01457924|1057907|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
312845|NCT01457924|1057908|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
312846|NCT01457924|1057909|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
312847|NCT01457924|1057905|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
312848|NCT01457924|1057906|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
312849|NCT01457924|1057907|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
312850|NCT01457924|1057908|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
312851|NCT01457924|1057909|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
312852|NCT01457924|1057905|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
312853|NCT01457924|1057906|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
312854|NCT01457924|1057907|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
312855|NCT01457924|1057908|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
312856|NCT01457924|1057909|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
312857|NCT01457924|1057905|P5|FUP (Weeks 24-48)|Physician Decision|0
312858|NCT01457924|1057906|P4|FUP (Weeks 24-48)|Physician Decision|0
312859|NCT01457924|1057907|P3|FUP (Weeks 24-48)|Physician Decision|1
312860|NCT01457924|1057908|P2|FUP (Weeks 24-48)|Physician Decision|0
312861|NCT01457924|1057909|P1|FUP (Weeks 24-48)|Physician Decision|1
312862|NCT01457924|1057905|P5|FUP (Weeks 24-48)|Adverse Event|0
312863|NCT01457924|1057906|P4|FUP (Weeks 24-48)|Adverse Event|0
312864|NCT01457924|1057907|P3|FUP (Weeks 24-48)|Adverse Event|1
312865|NCT01457924|1057908|P2|FUP (Weeks 24-48)|Adverse Event|0
312866|NCT01457924|1057909|P1|FUP (Weeks 24-48)|Adverse Event|0
312867|NCT01457924|1057905|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
312868|NCT01457924|1057906|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
312869|NCT01457924|1057907|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
312870|NCT01457924|1057908|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
312871|NCT01457924|1057909|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
312872|NCT01457924|1057905|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
312873|NCT01457924|1057906|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
312874|NCT01457924|1057907|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
312875|NCT01457924|1057908|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
312876|NCT01457924|1057909|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
312877|NCT01457924|1057905|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
312878|NCT01457924|1057906|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
312879|NCT01457924|1057907|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
312880|NCT01457924|1057908|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
312881|NCT01457924|1057909|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
312882|NCT01457924|1057905|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
312883|NCT01457924|1057906|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
312884|NCT01457924|1057907|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
312885|NCT01457924|1057908|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
312886|NCT01457924|1057909|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
312887|NCT01457924|1057905|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
312888|NCT01457924|1057906|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
312889|NCT01457924|1057907|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
312890|NCT01457924|1057908|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
312891|NCT01457924|1057909|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
312892|NCT01457924|1057905|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
312893|NCT01457924|1057906|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
312894|NCT01457924|1057907|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
312895|NCT01457924|1057908|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
312896|NCT01457924|1057909|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
312897|NCT01457846|1057979|P2|Overall Study|Lost to Follow-up|0
312898|NCT01457846|1057980|P1|Overall Study|Lost to Follow-up|1
312899|NCT01457846|1057979|P2|Overall Study|Withdrawal by Subject|1
312900|NCT01457846|1057980|P1|Overall Study|Withdrawal by Subject|1
312901|NCT01457846|1057979|P2|Overall Study|Unclassified reason for not completed|10
312902|NCT01457846|1057980|P1|Overall Study|Unclassified reason for not completed|11
312903|NCT01457846|1057979|P2|Overall Study|Death|16
312904|NCT01457846|1057980|P1|Overall Study|Death|27
312905|NCT01457846|1057979|P2|Overall Study|Did not receive treatment|1
312906|NCT01457846|1057980|P1|Overall Study|Did not receive treatment|0
312907|NCT01457846|1057979|P2|Overall Study|Death before treatment|2
312908|NCT01457846|1057980|P1|Overall Study|Death before treatment|1
312909|NCT01457703|1057996|P2|Overall Study|Withdrawal by Subject|4
312910|NCT01457703|1057997|P1|Overall Study|Withdrawal by Subject|1
312911|NCT01457703|1057996|P2|Overall Study|Screen Failure|7
312912|NCT01457703|1057997|P1|Overall Study|Screen Failure|5
312913|NCT01457339|1058108|P2|Period 6 (250 mg)|Personal appointment|1
312914|NCT01457339|1058109|P1|Period 6 (250 mg)|Personal appointment|0
312915|NCT01457339|1058108|P2|Period 6 (250 mg)|Family Emergency|0
312916|NCT01457339|1058109|P1|Period 6 (250 mg)|Family Emergency|1
312917|NCT01457339|1058108|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
312918|NCT01457339|1058109|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
312919|NCT01457339|1058108|P2|Period 3 (100 mg)|Adverse Event|1
312920|NCT01457339|1058109|P1|Period 3 (100 mg)|Adverse Event|0
312921|NCT01457053|1058275|P2|Overall Study|Unable to undergo selected treatment|1
312922|NCT01457053|1058276|P1|Overall Study|Unable to undergo selected treatment|1
312923|NCT01457014|1058282|P4|First Night|Withdrawal by Subject|0
312924|NCT01457014|1058283|P3|First Night|Withdrawal by Subject|0
312925|NCT01457014|1058284|P2|First Night|Withdrawal by Subject|0
312926|NCT01457014|1058285|P1|First Night|Withdrawal by Subject|3
312927|NCT01457014|1058282|P4|First Night|Didn't meet inclusion/exclusion criteria|0
312928|NCT01457014|1058283|P3|First Night|Didn't meet inclusion/exclusion criteria|0
312929|NCT01457014|1058284|P2|First Night|Didn't meet inclusion/exclusion criteria|0
312930|NCT01457014|1058285|P1|First Night|Didn't meet inclusion/exclusion criteria|37
312931|NCT01456962|1058302|P2|Overall Study|Lost to Follow-up|1
312932|NCT01456962|1058303|P1|Overall Study|Lost to Follow-up|2
312933|NCT01456936|1058313|P4|Overall Study|Randomized but not treated|21
312934|NCT01456936|1058314|P3|Overall Study|Randomized but not treated|16
312935|NCT01456936|1058315|P2|Overall Study|Randomized but not treated|28
312936|NCT01456936|1058316|P1|Overall Study|Randomized but not treated|21
312937|NCT01456936|1058313|P4|Overall Study|Death|3
312938|NCT01456936|1058314|P3|Overall Study|Death|1
312939|NCT01456936|1058315|P2|Overall Study|Death|3
312940|NCT01456936|1058316|P1|Overall Study|Death|0
312941|NCT01456936|1058313|P4|Overall Study|Adverse event (study drug unrelated)|9
312942|NCT01456936|1058314|P3|Overall Study|Adverse event (study drug unrelated)|9
312943|NCT01456936|1058315|P2|Overall Study|Adverse event (study drug unrelated)|7
312944|NCT01456936|1058316|P1|Overall Study|Adverse event (study drug unrelated)|9
312945|NCT01456936|1058313|P4|Overall Study|Adverse event (study drug)|17
312946|NCT01456936|1058314|P3|Overall Study|Adverse event (study drug)|26
312947|NCT01456936|1058315|P2|Overall Study|Adverse event (study drug)|21
312948|NCT01456936|1058316|P1|Overall Study|Adverse event (study drug)|25
312949|NCT01456936|1058313|P4|Overall Study|Medication error|1
312950|NCT01456936|1058314|P3|Overall Study|Medication error|0
312951|NCT01456936|1058315|P2|Overall Study|Medication error|1
312952|NCT01456936|1058316|P1|Overall Study|Medication error|0
312953|NCT01456936|1058313|P4|Overall Study|Lost to Follow-up|127
312954|NCT01456936|1058314|P3|Overall Study|Lost to Follow-up|144
312955|NCT01456936|1058315|P2|Overall Study|Lost to Follow-up|126
312956|NCT01456936|1058316|P1|Overall Study|Lost to Follow-up|135
312957|NCT01456936|1058313|P4|Overall Study|No longer willing to participate|248
312958|NCT01456936|1058314|P3|Overall Study|No longer willing to participate|224
312959|NCT01456936|1058315|P2|Overall Study|No longer willing to participate|218
312960|NCT01456936|1058316|P1|Overall Study|No longer willing to participate|195
312961|NCT01456936|1058313|P4|Overall Study|Insufficient clinical response|13
312962|NCT01456936|1058314|P3|Overall Study|Insufficient clinical response|14
312963|NCT01456936|1058315|P2|Overall Study|Insufficient clinical response|4
312964|NCT01456936|1058316|P1|Overall Study|Insufficient clinical response|4
312965|NCT01456936|1058313|P4|Overall Study|Pregnancy|1
312966|NCT01456936|1058314|P3|Overall Study|Pregnancy|0
312967|NCT01456936|1058315|P2|Overall Study|Pregnancy|0
312968|NCT01456936|1058316|P1|Overall Study|Pregnancy|1
312969|NCT01456936|1058313|P4|Overall Study|Protocol Violation|5
312970|NCT01456936|1058314|P3|Overall Study|Protocol Violation|5
312971|NCT01456936|1058315|P2|Overall Study|Protocol Violation|2
312972|NCT01456936|1058316|P1|Overall Study|Protocol Violation|4
312973|NCT01456936|1058313|P4|Overall Study|No longer meets eligibility criteria|5
312974|NCT01456936|1058314|P3|Overall Study|No longer meets eligibility criteria|6
312975|NCT01456936|1058315|P2|Overall Study|No longer meets eligibility criteria|8
312976|NCT01456936|1058316|P1|Overall Study|No longer meets eligibility criteria|4
312977|NCT01456936|1058313|P4|Overall Study|Other reason|33
312978|NCT01456936|1058314|P3|Overall Study|Other reason|36
312979|NCT01456936|1058315|P2|Overall Study|Other reason|30
312980|NCT01456936|1058316|P1|Overall Study|Other reason|41
312981|NCT01456780|1058425|P3|Overall Study|Lost to Follow-up|0
312982|NCT01456780|1058426|P2|Overall Study|Lost to Follow-up|3
312983|NCT01456780|1058427|P1|Overall Study|Lost to Follow-up|3
312984|NCT01456195|1058460|P3|Overall Study|Other Reasons|3
312985|NCT01456195|1058461|P2|Overall Study|Other Reasons|1
312986|NCT01456195|1058462|P1|Overall Study|Other Reasons|2
312987|NCT01456195|1058460|P3|Overall Study|Lack of Efficacy|0
312988|NCT01456195|1058461|P2|Overall Study|Lack of Efficacy|1
312989|NCT01456195|1058462|P1|Overall Study|Lack of Efficacy|0
312990|NCT01456195|1058460|P3|Overall Study|Voluntary Withdrawal|7
312991|NCT01456195|1058461|P2|Overall Study|Voluntary Withdrawal|3
312992|NCT01456195|1058462|P1|Overall Study|Voluntary Withdrawal|5
312993|NCT01456195|1058460|P3|Overall Study|Lost to Follow-up|3
312994|NCT01456195|1058461|P2|Overall Study|Lost to Follow-up|1
312995|NCT01456195|1058462|P1|Overall Study|Lost to Follow-up|3
312996|NCT01456195|1058460|P3|Overall Study|Pretreatment Event/Adverse Event|1
312997|NCT01456195|1058461|P2|Overall Study|Pretreatment Event/Adverse Event|4
312998|NCT01456195|1058462|P1|Overall Study|Pretreatment Event/Adverse Event|1
312999|NCT01456169|1058482|P3|Overall Study|Other|0
313000|NCT01456169|1058483|P2|Overall Study|Other|1
313001|NCT01456169|1058484|P1|Overall Study|Other|1
313002|NCT01456169|1058482|P3|Overall Study|Lack of Efficacy|0
313003|NCT01456169|1058483|P2|Overall Study|Lack of Efficacy|0
313004|NCT01456169|1058484|P1|Overall Study|Lack of Efficacy|2
313005|NCT01456169|1058482|P3|Overall Study|Voluntary Withdrawal|2
313006|NCT01456169|1058483|P2|Overall Study|Voluntary Withdrawal|0
313007|NCT01456169|1058484|P1|Overall Study|Voluntary Withdrawal|3
313008|NCT01456169|1058482|P3|Overall Study|Major Protocol Deviation|3
313009|NCT01456169|1058483|P2|Overall Study|Major Protocol Deviation|2
313010|NCT01456169|1058484|P1|Overall Study|Major Protocol Deviation|3
313011|NCT01456169|1058482|P3|Overall Study|Adverse Event|7
313012|NCT01456169|1058483|P2|Overall Study|Adverse Event|2
313013|NCT01456169|1058484|P1|Overall Study|Adverse Event|1
313014|NCT01456130|1058544|P1|Overall Study|Other|1
313015|NCT01456130|1058544|P1|Overall Study|Lack of Efficacy|4
313016|NCT01456130|1058544|P1|Overall Study|Voluntary Withdrawal|1
313017|NCT01456130|1058544|P1|Overall Study|Adverse Event|4
313018|NCT01456052|1058554|P3|Overall Study|Treatment Failure|1
313019|NCT01456052|1058555|P2|Overall Study|Treatment Failure|1
313020|NCT01456052|1058556|P1|Overall Study|Treatment Failure|0
313021|NCT01456052|1058554|P3|Overall Study|Physician Decision|1
313022|NCT01456052|1058555|P2|Overall Study|Physician Decision|0
313023|NCT01456052|1058556|P1|Overall Study|Physician Decision|1
313024|NCT01456052|1058554|P3|Overall Study|Protocol Violation|0
313025|NCT01456052|1058555|P2|Overall Study|Protocol Violation|1
313026|NCT01456052|1058556|P1|Overall Study|Protocol Violation|0
313027|NCT01456052|1058554|P3|Overall Study|Consent withdrawn|1
313028|NCT01456052|1058555|P2|Overall Study|Consent withdrawn|2
313029|NCT01456052|1058556|P1|Overall Study|Consent withdrawn|0
313030|NCT01456052|1058554|P3|Overall Study|Adverse Event|2
313031|NCT01456052|1058555|P2|Overall Study|Adverse Event|1
313032|NCT01456052|1058556|P1|Overall Study|Adverse Event|1
313033|NCT01456039|1058576|P3|Phase 2 (Second Step)|Other|1
313034|NCT01456039|1058577|P2|Phase 2 (Second Step)|Other|0
313035|NCT01456039|1058578|P1|Phase 2 (Second Step)|Other|0
313036|NCT01456039|1058576|P3|Phase 2 (Second Step)|Protocol Violation|1
313037|NCT01456039|1058577|P2|Phase 2 (Second Step)|Protocol Violation|0
313038|NCT01456039|1058578|P1|Phase 2 (Second Step)|Protocol Violation|0
313039|NCT01456039|1058576|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
313040|NCT01456039|1058577|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
313041|NCT01456039|1058578|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
313042|NCT01456039|1058576|P3|Phase 2 (Second Step)|Adverse Event|10
313043|NCT01456039|1058577|P2|Phase 2 (Second Step)|Adverse Event|0
313044|NCT01456039|1058578|P1|Phase 2 (Second Step)|Adverse Event|0
313045|NCT01456039|1058576|P3|Phase 2 (Second Step)|Disease Progression|17
313046|NCT01456039|1058577|P2|Phase 2 (Second Step)|Disease Progression|0
313047|NCT01456039|1058578|P1|Phase 2 (Second Step)|Disease Progression|0
313048|NCT01456039|1058576|P3|Phase 1 (First Step)|Not specified|0
313049|NCT01456039|1058577|P2|Phase 1 (First Step)|Not specified|1
313050|NCT01456039|1058578|P1|Phase 1 (First Step)|Not specified|0
313051|NCT01456039|1058576|P3|Phase 1 (First Step)|Adverse Event|0
313052|NCT01456039|1058577|P2|Phase 1 (First Step)|Adverse Event|3
313053|NCT01456039|1058578|P1|Phase 1 (First Step)|Adverse Event|0
313054|NCT01456039|1058576|P3|Phase 1 (First Step)|Withdrawal by Subject|0
313055|NCT01456039|1058577|P2|Phase 1 (First Step)|Withdrawal by Subject|2
313056|NCT01456039|1058578|P1|Phase 1 (First Step)|Withdrawal by Subject|1
313057|NCT01456039|1058576|P3|Phase 1 (First Step)|Disease Progression|0
313058|NCT01456039|1058577|P2|Phase 1 (First Step)|Disease Progression|1
313059|NCT01456039|1058578|P1|Phase 1 (First Step)|Disease Progression|1
313060|NCT01455428|1058721|P2|Overall Study|Other|4
313061|NCT01455428|1058722|P1|Overall Study|Other|2
313062|NCT01455428|1058721|P2|Overall Study|Did not receive treatment|1
313063|NCT01455428|1058722|P1|Overall Study|Did not receive treatment|1
313064|NCT01455428|1058721|P2|Overall Study|Insufficient clinical response|2
313065|NCT01455428|1058722|P1|Overall Study|Insufficient clinical response|0
313066|NCT01455428|1058721|P2|Overall Study|Did not meet entrance criteria|2
313067|NCT01455428|1058722|P1|Overall Study|Did not meet entrance criteria|0
313068|NCT01455428|1058721|P2|Overall Study|Withdrawal by Subject|5
313069|NCT01455428|1058722|P1|Overall Study|Withdrawal by Subject|2
313070|NCT01455428|1058721|P2|Overall Study|Lost to Follow-up|1
313071|NCT01455428|1058722|P1|Overall Study|Lost to Follow-up|1
313072|NCT01455428|1058721|P2|Overall Study|Adverse Event|2
313073|NCT01455428|1058722|P1|Overall Study|Adverse Event|6
313074|NCT01455428|1058721|P2|Overall Study|Protocol Violation|1
313075|NCT01455428|1058722|P1|Overall Study|Protocol Violation|2
313076|NCT01455415|1058778|P2|Follow-up|Unspecified Reason|0
313077|NCT01455415|1058779|P1|Follow-up|Unspecified Reason|1
313078|NCT01455415|1058778|P2|Follow-up|Withdrawal by Subject|0
313079|NCT01455415|1058779|P1|Follow-up|Withdrawal by Subject|2
313080|NCT01455415|1058778|P2|Follow-up|Lack of Efficacy|1
313081|NCT01455415|1058779|P1|Follow-up|Lack of Efficacy|0
313082|NCT01455415|1058778|P2|Follow-up|AE Related to Study Drug|1
313083|NCT01455415|1058779|P1|Follow-up|AE Related to Study Drug|0
313084|NCT01455415|1058778|P2|Period 2|Protocol Violation|0
313085|NCT01455415|1058779|P1|Period 2|Protocol Violation|2
313086|NCT01455415|1058778|P2|Period 2|Unspecified Reason|3
313087|NCT01455415|1058779|P1|Period 2|Unspecified Reason|2
313088|NCT01455415|1058778|P2|Period 2|Withdrawal by Subject|3
313089|NCT01455415|1058779|P1|Period 2|Withdrawal by Subject|2
313090|NCT01455415|1058778|P2|Period 2|Lack of Efficacy|0
313091|NCT01455415|1058779|P1|Period 2|Lack of Efficacy|2
313092|NCT01455415|1058778|P2|Period 2|AE Not Related to Study Drug|1
313093|NCT01455415|1058779|P1|Period 2|AE Not Related to Study Drug|2
313094|NCT01455415|1058778|P2|Period 2|Lost to Follow-up|1
313095|NCT01455415|1058779|P1|Period 2|Lost to Follow-up|2
313096|NCT01455415|1058778|P2|Period 2|AE Related to Study Drug|2
313097|NCT01455415|1058779|P1|Period 2|AE Related to Study Drug|1
313098|NCT01455415|1058778|P2|Washout|Protocol Violation|1
313099|NCT01455415|1058779|P1|Washout|Protocol Violation|0
313100|NCT01455415|1058778|P2|Washout|Unspecified Reason|2
313101|NCT01455415|1058779|P1|Washout|Unspecified Reason|1
313102|NCT01455415|1058778|P2|Washout|AE Not Related to Study Drug|3
313103|NCT01455415|1058779|P1|Washout|AE Not Related to Study Drug|2
313104|NCT01455415|1058778|P2|Washout|Drug Error not Associated to AE|1
313105|NCT01455415|1058779|P1|Washout|Drug Error not Associated to AE|2
313106|NCT01455415|1058778|P2|Washout|Lost to Follow-up|0
313107|NCT01455415|1058779|P1|Washout|Lost to Follow-up|1
313108|NCT01455415|1058778|P2|Washout|AE Related to Study Drug|0
313109|NCT01455415|1058779|P1|Washout|AE Related to Study Drug|2
313110|NCT01455415|1058778|P2|Period 1|Protocol Violation|2
313111|NCT01455415|1058779|P1|Period 1|Protocol Violation|0
313112|NCT01455415|1058778|P2|Period 1|Unspecified Reason|1
313113|NCT01455415|1058779|P1|Period 1|Unspecified Reason|1
313114|NCT01455415|1058778|P2|Period 1|Withdrawal by Subject|5
313115|NCT01455415|1058779|P1|Period 1|Withdrawal by Subject|4
313116|NCT01455415|1058778|P2|Period 1|AE Not Related to Study Drug|6
313117|NCT01455415|1058779|P1|Period 1|AE Not Related to Study Drug|2
313118|NCT01455415|1058778|P2|Period 1|Drug Error not Associated to AE|1
313119|NCT01455415|1058779|P1|Period 1|Drug Error not Associated to AE|0
313120|NCT01455415|1058778|P2|Period 1|Lost To Follow-up Related to Study Drug|3
313121|NCT01455415|1058779|P1|Period 1|Lost To Follow-up Related to Study Drug|3
313122|NCT01455415|1058778|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
313123|NCT01455415|1058779|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
313124|NCT01455220|1058829|P1|Overall Study|screen fail|30
313125|NCT01455194|1058839|P4|Overall Study|Miscellaneous|4
313126|NCT01455194|1058840|P3|Overall Study|Miscellaneous|1
313127|NCT01455194|1058841|P2|Overall Study|Miscellaneous|5
313128|NCT01455194|1058842|P1|Overall Study|Miscellaneous|4
313129|NCT01455194|1058839|P4|Overall Study|Discontinuation criterion fulfilled|2
313130|NCT01455194|1058840|P3|Overall Study|Discontinuation criterion fulfilled|0
313131|NCT01455194|1058841|P2|Overall Study|Discontinuation criterion fulfilled|2
313132|NCT01455194|1058842|P1|Overall Study|Discontinuation criterion fulfilled|3
313133|NCT01455194|1058839|P4|Overall Study|Pregnancy|0
313134|NCT01455194|1058840|P3|Overall Study|Pregnancy|1
313135|NCT01455194|1058841|P2|Overall Study|Pregnancy|1
313136|NCT01455194|1058842|P1|Overall Study|Pregnancy|0
313137|NCT01455194|1058839|P4|Overall Study|Lost to Follow-up|1
313138|NCT01455194|1058840|P3|Overall Study|Lost to Follow-up|1
313139|NCT01455194|1058841|P2|Overall Study|Lost to Follow-up|0
313140|NCT01455194|1058842|P1|Overall Study|Lost to Follow-up|2
313141|NCT01455194|1058839|P4|Overall Study|Withdrawal by Subject|9
313142|NCT01455194|1058840|P3|Overall Study|Withdrawal by Subject|12
313143|NCT01455194|1058841|P2|Overall Study|Withdrawal by Subject|16
313144|NCT01455194|1058842|P1|Overall Study|Withdrawal by Subject|21
313145|NCT01455194|1058839|P4|Overall Study|Adverse Event|3
313146|NCT01455194|1058840|P3|Overall Study|Adverse Event|1
313147|NCT01455194|1058841|P2|Overall Study|Adverse Event|1
313148|NCT01455194|1058842|P1|Overall Study|Adverse Event|1
313149|NCT01455194|1058839|P4|Overall Study|Deterioration in asthma|9
313150|NCT01455194|1058840|P3|Overall Study|Deterioration in asthma|14
313151|NCT01455194|1058841|P2|Overall Study|Deterioration in asthma|6
313152|NCT01455194|1058842|P1|Overall Study|Deterioration in asthma|12
313153|NCT01455194|1058839|P4|Overall Study|Randomisation Failure|0
313154|NCT01455194|1058840|P3|Overall Study|Randomisation Failure|0
313155|NCT01455194|1058841|P2|Overall Study|Randomisation Failure|0
313156|NCT01455194|1058842|P1|Overall Study|Randomisation Failure|90
313157|NCT01455194|1058839|P4|Overall Study|Screen Failure|0
313158|NCT01455194|1058840|P3|Overall Study|Screen Failure|0
313159|NCT01455194|1058841|P2|Overall Study|Screen Failure|0
313160|NCT01455194|1058842|P1|Overall Study|Screen Failure|20
313161|NCT01455012|1058905|P2|Overall Study|Unknown reason|0
313162|NCT01455012|1058906|P1|Overall Study|Unknown reason|2
313163|NCT01455012|1058905|P2|Overall Study|Withdrawal by Subject|1
313164|NCT01455012|1058906|P1|Overall Study|Withdrawal by Subject|3
313165|NCT01455012|1058905|P2|Overall Study|Lack of Efficacy|1
313166|NCT01455012|1058906|P1|Overall Study|Lack of Efficacy|6
313167|NCT01455012|1058905|P2|Overall Study|Adverse Event|2
313168|NCT01455012|1058906|P1|Overall Study|Adverse Event|0
313169|NCT01454934|1058973|P2|Overall Study|Ongoing, survival follow-up|2
313170|NCT01454934|1058974|P1|Overall Study|Ongoing, survival follow-up|1
313171|NCT01454934|1058973|P2|Overall Study|Not treated|2
313172|NCT01454934|1058974|P1|Overall Study|Not treated|1
313173|NCT01454934|1058973|P2|Overall Study|Not specified|16
313174|NCT01454934|1058974|P1|Overall Study|Not specified|5
313175|NCT01454934|1058973|P2|Overall Study|Clinical progression|25
313176|NCT01454934|1058974|P1|Overall Study|Clinical progression|28
313177|NCT01454934|1058973|P2|Overall Study|Withdrawn consent|5
313178|NCT01454934|1058974|P1|Overall Study|Withdrawn consent|2
313179|NCT01454934|1058973|P2|Overall Study|Lost to Follow-up|1
313180|NCT01454934|1058974|P1|Overall Study|Lost to Follow-up|0
313181|NCT01454934|1058973|P2|Overall Study|Withdrawal by Subject|15
313182|NCT01454934|1058974|P1|Overall Study|Withdrawal by Subject|11
313183|NCT01454934|1058973|P2|Overall Study|Adverse Event|24
313184|NCT01454934|1058974|P1|Overall Study|Adverse Event|28
313185|NCT01454934|1058973|P2|Overall Study|Disease progression|180
313186|NCT01454934|1058974|P1|Overall Study|Disease progression|194
313187|NCT01454830|1058986|P2|Overall Study|Withdrawal - no polysomnography|2
313188|NCT01454830|1058987|P1|Overall Study|Withdrawal - no polysomnography|3
313189|NCT01454830|1058986|P2|Overall Study|Post-allocation Exclude-other treatment|7
313190|NCT01454830|1058987|P1|Overall Study|Post-allocation Exclude-other treatment|6
313191|NCT01454830|1058986|P2|Overall Study|Post-allocation Exclude-refused PAP|2
313192|NCT01454830|1058987|P1|Overall Study|Post-allocation Exclude-refused PAP|0
313193|NCT01454830|1058986|P2|Overall Study|Post-allocation Exclude- AHI<10|12
313194|NCT01454830|1058987|P1|Overall Study|Post-allocation Exclude- AHI<10|18
313195|NCT01454830|1058986|P2|Overall Study|Withdrawal by Subject|4
313196|NCT01454830|1058987|P1|Overall Study|Withdrawal by Subject|4
313197|NCT01454778|1059018|P1|Overall Study|Death|1
313198|NCT01454778|1059018|P1|Overall Study|Lost to Follow-up|2
313199|NCT01454726|1059029|P2|Overall Study|Withdrawal by Subject|1
313200|NCT01454726|1059030|P1|Overall Study|Withdrawal by Subject|0
313201|NCT01454583|1059039|P3|3rd Year|Lost to Follow-up|297
313202|NCT01454583|1059040|P2|3rd Year|Lost to Follow-up|512
313203|NCT01454583|1059041|P1|3rd Year|Lost to Follow-up|1959
313204|NCT01454583|1059039|P3|2nd Year|Lost to Follow-up|737
313205|NCT01454583|1059040|P2|2nd Year|Lost to Follow-up|1049
313206|NCT01454583|1059041|P1|2nd Year|Lost to Follow-up|3965
313207|NCT01454583|1059039|P3|1st Year|Lost to Follow-up|180
313208|NCT01454583|1059040|P2|1st Year|Lost to Follow-up|318
313209|NCT01454583|1059041|P1|1st Year|Lost to Follow-up|1057
313210|NCT01454531|1059109|P1|Overall Study|Other|1
313211|NCT01454531|1059109|P1|Overall Study|Delay in IMP administration|1
313212|NCT01454531|1059109|P1|Overall Study|Physician Decision|1
313213|NCT01454531|1059109|P1|Overall Study|Lost to Follow-up|1
313214|NCT01454531|1059109|P1|Overall Study|Withdrawal by Subject|5
313215|NCT01454531|1059109|P1|Overall Study|Adverse Event|14
313216|NCT01454401|1059145|P1|Overall Study|non-adherence|1
313217|NCT01454401|1059145|P1|Overall Study|osteomyelitis|2
313218|NCT01454401|1059145|P1|Overall Study|hospitalised|1
313219|NCT01454401|1059145|P1|Overall Study|Death|1
313220|NCT01454284|1059152|P2|Overall Study|Sponsor Decision|2
313221|NCT01454284|1059153|P1|Overall Study|Sponsor Decision|0
313222|NCT01454284|1059152|P2|Overall Study|Physician Decision|11
313223|NCT01454284|1059153|P1|Overall Study|Physician Decision|16
313224|NCT01454284|1059152|P2|Overall Study|Withdrawal by Subject|36
313225|NCT01454284|1059153|P1|Overall Study|Withdrawal by Subject|58
313226|NCT01454284|1059152|P2|Overall Study|Protocol Violation|6
313227|NCT01454284|1059153|P1|Overall Study|Protocol Violation|9
313228|NCT01454284|1059152|P2|Overall Study|Lost to Follow-up|8
313229|NCT01454284|1059153|P1|Overall Study|Lost to Follow-up|13
313230|NCT01454284|1059152|P2|Overall Study|Death|3
313231|NCT01454284|1059153|P1|Overall Study|Death|0
313232|NCT01454284|1059152|P2|Overall Study|Adverse Event|7
313233|NCT01454284|1059153|P1|Overall Study|Adverse Event|20
313234|NCT01454076|1059212|P5|Overall Study|Adverse Event|2
313235|NCT01454076|1059213|P4|Overall Study|Adverse Event|0
313236|NCT01454076|1059214|P3|Overall Study|Adverse Event|7
313237|NCT01454076|1059215|P2|Overall Study|Adverse Event|2
313238|NCT01454076|1059216|P1|Overall Study|Adverse Event|8
313239|NCT01454076|1059212|P5|Overall Study|Withdrawal by Subject|2
313240|NCT01454076|1059213|P4|Overall Study|Withdrawal by Subject|1
313241|NCT01454076|1059214|P3|Overall Study|Withdrawal by Subject|2
313242|NCT01454076|1059215|P2|Overall Study|Withdrawal by Subject|4
313243|NCT01454076|1059216|P1|Overall Study|Withdrawal by Subject|3
313244|NCT01454076|1059212|P5|Overall Study|Other|2
313245|NCT01454076|1059213|P4|Overall Study|Other|1
313246|NCT01454076|1059214|P3|Overall Study|Other|0
313247|NCT01454076|1059215|P2|Overall Study|Other|0
313248|NCT01454076|1059216|P1|Overall Study|Other|2
313249|NCT01454063|1059269|P2|Randomized|Protocol Violation|1
313250|NCT01454063|1059270|P1|Randomized|Protocol Violation|0
313251|NCT01454063|1059269|P2|Randomized|Adverse Event|1
313252|NCT01454063|1059270|P1|Randomized|Adverse Event|1
313253|NCT01453998|1059291|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
313254|NCT01453998|1059292|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
313255|NCT01453998|1059293|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
313256|NCT01453946|1059358|P1|Overall Study|Adverse Event|3
313257|NCT01453946|1059358|P1|Overall Study|Lack of Efficacy|3
313258|NCT01453946|1059358|P1|Overall Study|Protocol Violation|2
313259|NCT01453946|1059358|P1|Overall Study|Did not receive drug for the taper phase|1
313260|NCT01453855|1059375|P2|Overall Study|Other|1
313261|NCT01453855|1059376|P1|Overall Study|Other|0
313262|NCT01453855|1059375|P2|Overall Study|Inadequate Control of IOP|5
313263|NCT01453855|1059376|P1|Overall Study|Inadequate Control of IOP|1
313264|NCT01453855|1059375|P2|Overall Study|Noncompliance|0
313265|NCT01453855|1059376|P1|Overall Study|Noncompliance|1
313266|NCT01453855|1059375|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
313267|NCT01453855|1059376|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
313268|NCT01453855|1059375|P2|Overall Study|Lost to Follow-up|1
313269|NCT01453855|1059376|P1|Overall Study|Lost to Follow-up|2
313270|NCT01453855|1059375|P2|Overall Study|Adverse Event|4
313271|NCT01453855|1059376|P1|Overall Study|Adverse Event|3
313272|NCT01453725|1059384|P2|Overall Study|Physician Decision|1
313273|NCT01453725|1059385|P1|Overall Study|Physician Decision|1
313274|NCT01453725|1059384|P2|Overall Study|Pregnancy|0
313275|NCT01453725|1059385|P1|Overall Study|Pregnancy|1
313276|NCT01453725|1059384|P2|Overall Study|Pregnancy Wish|2
313277|NCT01453725|1059385|P1|Overall Study|Pregnancy Wish|0
313278|NCT01453725|1059384|P2|Overall Study|Withdrawal by Subject|3
313279|NCT01453725|1059385|P1|Overall Study|Withdrawal by Subject|2
313280|NCT01453725|1059384|P2|Overall Study|Protocol Violation|0
313281|NCT01453725|1059385|P1|Overall Study|Protocol Violation|1
313282|NCT01453725|1059384|P2|Overall Study|Non-compliance With Protocol|2
313283|NCT01453725|1059385|P1|Overall Study|Non-compliance With Protocol|1
313284|NCT01453725|1059384|P2|Overall Study|Lost to Follow-up|0
313285|NCT01453725|1059385|P1|Overall Study|Lost to Follow-up|4
313286|NCT01453725|1059384|P2|Overall Study|Adverse Event|3
313287|NCT01453725|1059385|P1|Overall Study|Adverse Event|3
313288|NCT01453595|1059408|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
313289|NCT01453595|1059409|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
313290|NCT01453595|1059410|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
313291|NCT01453374|1059529|P1|Overall Study|Incarcerated|2
313292|NCT01453374|1059529|P1|Overall Study|Withdrawal by Subject|5
313293|NCT01453374|1059529|P1|Overall Study|Lost to Follow-up|3
313294|NCT01453374|1059529|P1|Overall Study|Lack of Efficacy|1
313295|NCT01453374|1059529|P1|Overall Study|Adverse Event|7
313296|NCT01453361|1059545|P1|Overall Study|Screen-Failures|10
313297|NCT01453361|1059545|P1|Overall Study|Disease Progression|6
313298|NCT01453348|1059553|P3|Overall Study|Protocol Violation|0
313299|NCT01453348|1059554|P2|Overall Study|Protocol Violation|0
313300|NCT01453348|1059555|P1|Overall Study|Protocol Violation|1
313301|NCT01453348|1059553|P3|Overall Study|Withdrawal by Subject|0
313302|NCT01453348|1059554|P2|Overall Study|Withdrawal by Subject|1
313303|NCT01453348|1059555|P1|Overall Study|Withdrawal by Subject|0
313304|NCT01453348|1059553|P3|Overall Study|Death|1
313305|NCT01453348|1059554|P2|Overall Study|Death|0
313306|NCT01453348|1059555|P1|Overall Study|Death|0
313307|NCT01453296|1059571|P2|Treatment Period 2|Withdrawal by Subject|0
313308|NCT01453296|1059572|P1|Treatment Period 2|Withdrawal by Subject|1
313309|NCT01453296|1059571|P2|Treatment Period 2|Adverse Event|0
313310|NCT01453296|1059572|P1|Treatment Period 2|Adverse Event|1
313311|NCT01453296|1059571|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
313312|NCT01453296|1059572|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
313313|NCT01453296|1059571|P2|Treatment Period 1|Adverse Event|1
313314|NCT01453296|1059572|P1|Treatment Period 1|Adverse Event|0
313315|NCT01453205|1059639|P3|Overall Study|Other|35
313316|NCT01453205|1059640|P2|Overall Study|Other|27
313317|NCT01453205|1059641|P1|Overall Study|Other|45
313318|NCT01453205|1059639|P3|Overall Study|Death|18
313319|NCT01453205|1059640|P2|Overall Study|Death|22
313320|NCT01453205|1059641|P1|Overall Study|Death|24
313321|NCT01453205|1059639|P3|Overall Study|Withdrawal by Subject|0
313322|NCT01453205|1059640|P2|Overall Study|Withdrawal by Subject|3
313323|NCT01453205|1059641|P1|Overall Study|Withdrawal by Subject|8
313324|NCT01453205|1059639|P3|Overall Study|Lost to Follow-up|1
313325|NCT01453205|1059640|P2|Overall Study|Lost to Follow-up|0
313326|NCT01453205|1059641|P1|Overall Study|Lost to Follow-up|3
313327|NCT01453049|1059725|P2|Overall Study|Randomized in Error|0
313328|NCT01453049|1059726|P1|Overall Study|Randomized in Error|1
313329|NCT01453049|1059725|P2|Overall Study|Withdrawal by Subject|0
313330|NCT01453049|1059726|P1|Overall Study|Withdrawal by Subject|1
313331|NCT01453049|1059725|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
313332|NCT01453049|1059726|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
313333|NCT01453049|1059725|P2|Overall Study|Lost to Follow-up|1
313334|NCT01453049|1059726|P1|Overall Study|Lost to Follow-up|2
313335|NCT01453049|1059725|P2|Overall Study|Protocol Violation|5
313336|NCT01453049|1059726|P1|Overall Study|Protocol Violation|2
313337|NCT01453036|1059799|P3|Overall Study|Lost to Follow-up|31
313338|NCT01453036|1059800|P2|Overall Study|Lost to Follow-up|115
313339|NCT01453036|1059801|P1|Overall Study|Lost to Follow-up|26
313340|NCT01453023|1059809|P2|Treatment Period 2|Protocol Violation|1
313341|NCT01453023|1059810|P1|Treatment Period 2|Protocol Violation|0
313342|NCT01453023|1059809|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
313343|NCT01453023|1059810|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
313344|NCT01453023|1059809|P2|Treatment Period (TP) 1|Protocol Violation|0
313345|NCT01453023|1059810|P1|Treatment Period (TP) 1|Protocol Violation|1
313346|NCT01452529|1059884|P3|Double-blind (DB) Period|Administrative|7
313347|NCT01452529|1059885|P2|Double-blind (DB) Period|Administrative|11
313348|NCT01452529|1059886|P1|Double-blind (DB) Period|Administrative|0
313349|NCT01452529|1059884|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
313350|NCT01452529|1059885|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
313351|NCT01452529|1059886|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
313352|NCT01452529|1059884|P3|Double-blind (DB) Period|Lack of Efficacy|44
313353|NCT01452529|1059885|P2|Double-blind (DB) Period|Lack of Efficacy|16
313354|NCT01452529|1059886|P1|Double-blind (DB) Period|Lack of Efficacy|0
313355|NCT01452529|1059884|P3|Double-blind (DB) Period|Lost to Follow-up|3
313356|NCT01452529|1059885|P2|Double-blind (DB) Period|Lost to Follow-up|5
313357|NCT01452529|1059886|P1|Double-blind (DB) Period|Lost to Follow-up|0
313358|NCT01452529|1059884|P3|Double-blind (DB) Period|Withdrawal by Subject|14
313359|NCT01452529|1059885|P2|Double-blind (DB) Period|Withdrawal by Subject|15
313360|NCT01452529|1059886|P1|Double-blind (DB) Period|Withdrawal by Subject|0
313361|NCT01452529|1059884|P3|Double-blind (DB) Period|Adverse Event|11
313362|NCT01452529|1059885|P2|Double-blind (DB) Period|Adverse Event|18
313363|NCT01452529|1059886|P1|Double-blind (DB) Period|Adverse Event|0
313364|NCT01452529|1059884|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
313365|NCT01452529|1059885|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
313366|NCT01452529|1059886|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
313367|NCT01452529|1059884|P3|Run-in Period|Administrative|0
313368|NCT01452529|1059885|P2|Run-in Period|Administrative|0
313369|NCT01452529|1059886|P1|Run-in Period|Administrative|21
313370|NCT01452529|1059884|P3|Run-in Period|Confirmed or suspected diversion|0
313371|NCT01452529|1059885|P2|Run-in Period|Confirmed or suspected diversion|0
313372|NCT01452529|1059886|P1|Run-in Period|Confirmed or suspected diversion|23
313373|NCT01452529|1059884|P3|Run-in Period|Lack of Efficacy|0
313374|NCT01452529|1059885|P2|Run-in Period|Lack of Efficacy|0
313375|NCT01452529|1059886|P1|Run-in Period|Lack of Efficacy|46
313376|NCT01452529|1059884|P3|Run-in Period|Lost to Follow-up|0
313377|NCT01452529|1059885|P2|Run-in Period|Lost to Follow-up|0
313378|NCT01452529|1059886|P1|Run-in Period|Lost to Follow-up|19
313379|NCT01452529|1059884|P3|Run-in Period|Withdrawal by Subject|0
313380|NCT01452529|1059885|P2|Run-in Period|Withdrawal by Subject|0
313381|NCT01452529|1059886|P1|Run-in Period|Withdrawal by Subject|49
313382|NCT01452529|1059884|P3|Run-in Period|Adverse Event|0
313383|NCT01452529|1059885|P2|Run-in Period|Adverse Event|0
313384|NCT01452529|1059886|P1|Run-in Period|Adverse Event|96
313385|NCT01452347|1059908|P2|Overall Study|Other reason not defined above|0
313386|NCT01452347|1059909|P1|Overall Study|Other reason not defined above|2
313387|NCT01452347|1059908|P2|Overall Study|Not treated|3
313388|NCT01452347|1059909|P1|Overall Study|Not treated|6
313389|NCT01452347|1059908|P2|Overall Study|Withdrawal by Subject|3
313390|NCT01452347|1059909|P1|Overall Study|Withdrawal by Subject|3
313391|NCT01452347|1059908|P2|Overall Study|Lost to Follow-up|0
313392|NCT01452347|1059909|P1|Overall Study|Lost to Follow-up|2
313393|NCT01452347|1059908|P2|Overall Study|Non compliance protocol|0
313394|NCT01452347|1059909|P1|Overall Study|Non compliance protocol|2
313395|NCT01452347|1059908|P2|Overall Study|Adverse Event|1
313396|NCT01452347|1059909|P1|Overall Study|Adverse Event|2
313397|NCT01452152|1059941|P3|Overall Study|Study termination by sponsor|4
313398|NCT01452152|1059942|P2|Overall Study|Study termination by sponsor|0
313399|NCT01452152|1059943|P1|Overall Study|Study termination by sponsor|5
313400|NCT01451931|1060015|P3|Overall Study|Withdrawal by Subject|22
313401|NCT01451931|1060016|P2|Overall Study|Withdrawal by Subject|22
313402|NCT01451931|1060017|P1|Overall Study|Withdrawal by Subject|16
313403|NCT01451931|1060015|P3|Overall Study|Lost to Follow-up|21
313404|NCT01451931|1060016|P2|Overall Study|Lost to Follow-up|36
313405|NCT01451931|1060017|P1|Overall Study|Lost to Follow-up|17
313406|NCT01451814|1060039|P2|Overall Study|Lost to Follow-up|4
313407|NCT01451814|1060040|P1|Overall Study|Lost to Follow-up|5
313408|NCT01451814|1060039|P2|Overall Study|Withdrawal by Subject|1
313409|NCT01451814|1060040|P1|Overall Study|Withdrawal by Subject|1
313410|NCT01451762|1060072|P3|Overall Study|Lost to Follow-up|6
313411|NCT01451762|1060073|P2|Overall Study|Lost to Follow-up|6
313412|NCT01451762|1060074|P1|Overall Study|Lost to Follow-up|3
313413|NCT01451749|1060084|P2|Overall Study|Withdrawal by Subject|1
313414|NCT01451749|1060085|P1|Overall Study|Withdrawal by Subject|0
313415|NCT01451749|1060084|P2|Overall Study|Adverse Event|0
313416|NCT01451749|1060085|P1|Overall Study|Adverse Event|2
313417|NCT01451749|1060084|P2|Overall Study|Meet the exclusion criteria,and|1
313418|NCT01451749|1060085|P1|Overall Study|Meet the exclusion criteria,and|1
313419|NCT01451749|1060084|P2|Overall Study|Lost to Follow-up|5
313420|NCT01451749|1060085|P1|Overall Study|Lost to Follow-up|15
313421|NCT01451749|1060084|P2|Overall Study|Protocol Violation|7
313422|NCT01451749|1060085|P1|Overall Study|Protocol Violation|14
313423|NCT01451723|1060097|P2|Overall Study|study halted|5
313424|NCT01451723|1060098|P1|Overall Study|study halted|6
313425|NCT01451645|1060108|P2|Overall Study|Lost to Follow-up|3
313426|NCT01451645|1060109|P1|Overall Study|Lost to Follow-up|4
313427|NCT01451645|1060108|P2|Overall Study|Withdrawal by Subject|2
313428|NCT01451645|1060109|P1|Overall Study|Withdrawal by Subject|4
313429|NCT01451645|1060108|P2|Overall Study|Adverse Event|3
313430|NCT01451645|1060109|P1|Overall Study|Adverse Event|0
313431|NCT01451645|1060108|P2|Overall Study|Protocol Violation|0
313432|NCT01451645|1060109|P1|Overall Study|Protocol Violation|1
313433|NCT01451606|1060180|P2|Overall Study|Withdrawal by Subject|3
313434|NCT01451606|1060181|P1|Overall Study|Withdrawal by Subject|4
313435|NCT01451554|1060191|P2|Overall Study|Withdrawal by Subject|9
313436|NCT01451554|1060192|P1|Overall Study|Withdrawal by Subject|14
313437|NCT01451541|1060203|P3|Overall Study|randomization error, noncompliance|8
313438|NCT01451541|1060204|P2|Overall Study|randomization error, noncompliance|10
313439|NCT01451541|1060205|P1|Overall Study|randomization error, noncompliance|11
313440|NCT01451541|1060203|P3|Overall Study|Withdrawal by Subject|6
313441|NCT01451541|1060204|P2|Overall Study|Withdrawal by Subject|8
313442|NCT01451541|1060205|P1|Overall Study|Withdrawal by Subject|15
313443|NCT01451541|1060203|P3|Overall Study|Lost to Follow-up|7
313444|NCT01451541|1060204|P2|Overall Study|Lost to Follow-up|4
313445|NCT01451541|1060205|P1|Overall Study|Lost to Follow-up|4
313446|NCT01451541|1060203|P3|Overall Study|Lack of Efficacy|0
313447|NCT01451541|1060204|P2|Overall Study|Lack of Efficacy|0
313448|NCT01451541|1060205|P1|Overall Study|Lack of Efficacy|2
313449|NCT01451541|1060203|P3|Overall Study|Adverse Event|6
313450|NCT01451541|1060204|P2|Overall Study|Adverse Event|3
313451|NCT01451541|1060205|P1|Overall Study|Adverse Event|4
313452|NCT01451437|1060263|P9|Overall Study|Withdrawal by Subject|0
313453|NCT01451437|1060264|P8|Overall Study|Withdrawal by Subject|0
313454|NCT01451437|1060265|P7|Overall Study|Withdrawal by Subject|1
313455|NCT01451437|1060266|P6|Overall Study|Withdrawal by Subject|0
313456|NCT01451437|1060267|P5|Overall Study|Withdrawal by Subject|1
313457|NCT01451437|1060268|P4|Overall Study|Withdrawal by Subject|0
313458|NCT01451437|1060269|P3|Overall Study|Withdrawal by Subject|0
313459|NCT01451437|1060270|P2|Overall Study|Withdrawal by Subject|0
313460|NCT01451437|1060271|P1|Overall Study|Withdrawal by Subject|0
313461|NCT01451437|1060263|P9|Overall Study|Protocol Violation|0
313462|NCT01451437|1060264|P8|Overall Study|Protocol Violation|0
313463|NCT01451437|1060265|P7|Overall Study|Protocol Violation|1
313464|NCT01451437|1060266|P6|Overall Study|Protocol Violation|0
313465|NCT01451437|1060267|P5|Overall Study|Protocol Violation|0
313466|NCT01451437|1060268|P4|Overall Study|Protocol Violation|0
313467|NCT01451437|1060269|P3|Overall Study|Protocol Violation|0
313468|NCT01451437|1060270|P2|Overall Study|Protocol Violation|0
313469|NCT01451437|1060271|P1|Overall Study|Protocol Violation|0
313470|NCT01451437|1060263|P9|Overall Study|Disease Progression|3
313471|NCT01451437|1060264|P8|Overall Study|Disease Progression|1
313472|NCT01451437|1060265|P7|Overall Study|Disease Progression|3
313473|NCT01451437|1060266|P6|Overall Study|Disease Progression|2
313474|NCT01451437|1060267|P5|Overall Study|Disease Progression|3
313475|NCT01451437|1060268|P4|Overall Study|Disease Progression|1
313476|NCT01451437|1060269|P3|Overall Study|Disease Progression|1
313477|NCT01451437|1060270|P2|Overall Study|Disease Progression|0
313478|NCT01451437|1060271|P1|Overall Study|Disease Progression|0
313479|NCT01451437|1060263|P9|Overall Study|Physician Decision|0
313480|NCT01451437|1060264|P8|Overall Study|Physician Decision|0
313481|NCT01451437|1060265|P7|Overall Study|Physician Decision|0
313482|NCT01451437|1060266|P6|Overall Study|Physician Decision|0
313483|NCT01451437|1060267|P5|Overall Study|Physician Decision|0
313484|NCT01451437|1060268|P4|Overall Study|Physician Decision|0
313485|NCT01451437|1060269|P3|Overall Study|Physician Decision|2
313486|NCT01451437|1060270|P2|Overall Study|Physician Decision|1
313487|NCT01451437|1060271|P1|Overall Study|Physician Decision|1
313488|NCT01451437|1060263|P9|Overall Study|Adverse Event|1
313489|NCT01451437|1060264|P8|Overall Study|Adverse Event|2
313490|NCT01451437|1060265|P7|Overall Study|Adverse Event|1
313491|NCT01451437|1060266|P6|Overall Study|Adverse Event|1
313492|NCT01451437|1060267|P5|Overall Study|Adverse Event|0
313493|NCT01451437|1060268|P4|Overall Study|Adverse Event|0
313494|NCT01451437|1060269|P3|Overall Study|Adverse Event|0
313495|NCT01451437|1060270|P2|Overall Study|Adverse Event|0
313496|NCT01451437|1060271|P1|Overall Study|Adverse Event|0
313497|NCT01451424|1060403|P4|Overall Study|Adverse Event|1
313498|NCT01451424|1060404|P3|Overall Study|Adverse Event|0
313499|NCT01451424|1060405|P2|Overall Study|Adverse Event|0
313500|NCT01451424|1060406|P1|Overall Study|Adverse Event|0
313501|NCT01451424|1060403|P4|Overall Study|Physician Decision|1
313502|NCT01451424|1060404|P3|Overall Study|Physician Decision|1
313503|NCT01451424|1060405|P2|Overall Study|Physician Decision|0
313504|NCT01451424|1060406|P1|Overall Study|Physician Decision|0
313505|NCT01451424|1060403|P4|Overall Study|Lost to Follow-up|1
313506|NCT01451424|1060404|P3|Overall Study|Lost to Follow-up|0
313507|NCT01451424|1060405|P2|Overall Study|Lost to Follow-up|1
313508|NCT01451424|1060406|P1|Overall Study|Lost to Follow-up|0
313509|NCT01451424|1060403|P4|Overall Study|Withdrawal by Subject|2
313510|NCT01451424|1060404|P3|Overall Study|Withdrawal by Subject|0
313511|NCT01451424|1060405|P2|Overall Study|Withdrawal by Subject|1
313512|NCT01451424|1060406|P1|Overall Study|Withdrawal by Subject|1
313513|NCT01451398|1060464|P2|Overall Study|Lack of Efficacy|1
313514|NCT01451398|1060465|P1|Overall Study|Lack of Efficacy|0
313515|NCT01451398|1060464|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
313516|NCT01451398|1060465|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
313517|NCT01451398|1060464|P2|Overall Study|Moved out of country|1
313518|NCT01451398|1060465|P1|Overall Study|Moved out of country|0
313519|NCT01451398|1060464|P2|Overall Study|Non-compliance with protocol|1
313520|NCT01451398|1060465|P1|Overall Study|Non-compliance with protocol|1
313521|NCT01451398|1060464|P2|Overall Study|Non-compliance with study drug|3
313522|NCT01451398|1060465|P1|Overall Study|Non-compliance with study drug|1
313523|NCT01451398|1060464|P2|Overall Study|Lost to Follow-up|4
313524|NCT01451398|1060465|P1|Overall Study|Lost to Follow-up|6
313525|NCT01451398|1060464|P2|Overall Study|Withdrawal by Subject|14
313526|NCT01451398|1060465|P1|Overall Study|Withdrawal by Subject|10
313527|NCT01451398|1060464|P2|Overall Study|Physician Decision|1
313528|NCT01451398|1060465|P1|Overall Study|Physician Decision|1
313529|NCT01451398|1060464|P2|Overall Study|Protocol Violation|2
313530|NCT01451398|1060465|P1|Overall Study|Protocol Violation|1
313531|NCT01451398|1060464|P2|Overall Study|Adverse Event|9
313532|NCT01451398|1060465|P1|Overall Study|Adverse Event|7
313533|NCT01451203|1060499|P2|Post-treatment Period|Investigator decision|1
313534|NCT01451203|1060500|P1|Post-treatment Period|Investigator decision|0
313535|NCT01451203|1060499|P2|Post-treatment Period|Adverse Event|1
313536|NCT01451203|1060500|P1|Post-treatment Period|Adverse Event|0
313537|NCT01451203|1060499|P2|Post-treatment Period|Lack of Efficacy|28
313538|NCT01451203|1060500|P1|Post-treatment Period|Lack of Efficacy|12
313539|NCT01451203|1060499|P2|Post-treatment Period|Consent withdrawn|4
313540|NCT01451203|1060500|P1|Post-treatment Period|Consent withdrawn|2
313541|NCT01451203|1060499|P2|Double-blind Treatment Period|Investigator decision|0
313542|NCT01451203|1060500|P1|Double-blind Treatment Period|Investigator decision|2
313543|NCT01451203|1060499|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
313544|NCT01451203|1060500|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
313545|NCT01451203|1060499|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
313546|NCT01451203|1060500|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
313547|NCT01451203|1060499|P2|Double-blind Treatment Period|Adverse Event|9
313548|NCT01451203|1060500|P1|Double-blind Treatment Period|Adverse Event|6
313549|NCT01451203|1060499|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
313550|NCT01451203|1060500|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
313551|NCT01451203|1060499|P2|Double-blind Treatment Period|Lack of Efficacy|36
313552|NCT01451203|1060500|P1|Double-blind Treatment Period|Lack of Efficacy|71
313553|NCT01451203|1060499|P2|Double-blind Treatment Period|Consent Withdrawn|2
313554|NCT01451203|1060500|P1|Double-blind Treatment Period|Consent Withdrawn|3
313555|NCT01451203|1060499|P2|Double-blind Treatment Period|Did not receive treatment|2
313556|NCT01451203|1060500|P1|Double-blind Treatment Period|Did not receive treatment|1
313557|NCT01450813|1060533|P4|Overall Study|Physician Decision|3
313558|NCT01450813|1060534|P3|Overall Study|Physician Decision|0
313559|NCT01450813|1060535|P2|Overall Study|Physician Decision|1
313560|NCT01450813|1060536|P1|Overall Study|Physician Decision|1
313561|NCT01450800|1060550|P2|Overall Study|Protocol Violation|3
313562|NCT01450800|1060551|P1|Overall Study|Protocol Violation|1
313563|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
313564|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
313565|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
313566|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
313567|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Not reported|2
313568|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Not reported|2
313569|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
313570|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
313571|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
313572|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
313573|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
313574|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
313575|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
313576|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
313577|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Death|6
313578|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Death|5
313579|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
313580|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
313581|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
313582|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
313583|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
313584|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
313585|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
313586|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
313587|NCT01450761|1060586|P2|Treatment With Blinded Study Therapy|Disease progression|415
313588|NCT01450761|1060587|P1|Treatment With Blinded Study Therapy|Disease progression|318
313589|NCT01450761|1060586|P2|Lead-in Chemotherapy|Lost to Follow-up|0
313590|NCT01450761|1060587|P1|Lead-in Chemotherapy|Lost to Follow-up|2
313591|NCT01450761|1060586|P2|Lead-in Chemotherapy|Other|2
313592|NCT01450761|1060587|P1|Lead-in Chemotherapy|Other|2
313593|NCT01450761|1060586|P2|Lead-in Chemotherapy|Death|3
313594|NCT01450761|1060587|P1|Lead-in Chemotherapy|Death|3
313595|NCT01450761|1060586|P2|Lead-in Chemotherapy|No longer meets study criteria|7
313596|NCT01450761|1060587|P1|Lead-in Chemotherapy|No longer meets study criteria|3
313597|NCT01450761|1060586|P2|Lead-in Chemotherapy|Study drug toxicity|10
313598|NCT01450761|1060587|P1|Lead-in Chemotherapy|Study drug toxicity|6
313599|NCT01450761|1060586|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
313600|NCT01450761|1060587|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
313601|NCT01450761|1060586|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
313602|NCT01450761|1060587|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
313603|NCT01450761|1060586|P2|Lead-in Chemotherapy|Disease progression|32
313604|NCT01450761|1060587|P1|Lead-in Chemotherapy|Disease progression|33
313605|NCT01450761|1060586|P2|Randomization|Other|1
313606|NCT01450761|1060587|P1|Randomization|Other|0
313607|NCT01450761|1060586|P2|Randomization|Adverse Event unrelated to study drug|0
313608|NCT01450761|1060587|P1|Randomization|Adverse Event unrelated to study drug|1
313609|NCT01450761|1060586|P2|Randomization|Disease progression|2
313610|NCT01450761|1060587|P1|Randomization|Disease progression|0
313611|NCT01450761|1060586|P2|Randomization|Withdrawal by Subject|0
313612|NCT01450761|1060587|P1|Randomization|Withdrawal by Subject|2
313613|NCT01450761|1060586|P2|Randomization|Subject no longer meets study criteria|2
313614|NCT01450761|1060587|P1|Randomization|Subject no longer meets study criteria|1
313615|NCT01450696|1060599|P2|Overall Study|Study Terminated by Sponsor|58
313616|NCT01450696|1060600|P1|Overall Study|Study Terminated by Sponsor|53
313617|NCT01450696|1060599|P2|Overall Study|Withdrawal by Subject|2
313618|NCT01450696|1060600|P1|Overall Study|Withdrawal by Subject|13
313619|NCT01450696|1060599|P2|Overall Study|Non-Compliance|0
313620|NCT01450696|1060600|P1|Overall Study|Non-Compliance|1
313621|NCT01450696|1060599|P2|Overall Study|Lost to Follow-up|3
313622|NCT01450696|1060600|P1|Overall Study|Lost to Follow-up|3
313623|NCT01450696|1060599|P2|Overall Study|Death|84
313624|NCT01450696|1060600|P1|Overall Study|Death|77
313625|NCT01450696|1060599|P2|Overall Study|Never Treated|1
313626|NCT01450696|1060600|P1|Overall Study|Never Treated|1
313627|NCT01450683|1060622|P1|Overall Study|Adverse Event|2
313628|NCT01450631|1060628|P2|Overall Study|Withdrawal by Subject|0
313629|NCT01450631|1060629|P1|Overall Study|Withdrawal by Subject|1
313630|NCT01450631|1060628|P2|Overall Study|Lost to Follow-up|4
313631|NCT01450631|1060629|P1|Overall Study|Lost to Follow-up|2
313632|NCT01450007|1060760|P3|Overall Study|Adverse Event|0
313633|NCT01450007|1060761|P2|Overall Study|Adverse Event|1
313634|NCT01450007|1060762|P1|Overall Study|Adverse Event|0
313635|NCT01450007|1060760|P3|Overall Study|Protocol Violation|1
313636|NCT01450007|1060761|P2|Overall Study|Protocol Violation|1
313637|NCT01450007|1060762|P1|Overall Study|Protocol Violation|0
313638|NCT01450007|1060760|P3|Overall Study|Late exclusion before treatment|2
313720|NCT01449461|1061066|P3|Overall Study|Clinical progressive disease|0
313639|NCT01450007|1060761|P2|Overall Study|Late exclusion before treatment|3
313640|NCT01450007|1060762|P1|Overall Study|Late exclusion before treatment|2
313641|NCT01449955|1060781|P2|Overall Study|Withdrawal by Subject|2
313642|NCT01449955|1060782|P1|Overall Study|Withdrawal by Subject|1
313643|NCT01449929|1060790|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
313644|NCT01449929|1060791|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
313645|NCT01449929|1060792|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
313646|NCT01449929|1060790|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
313647|NCT01449929|1060791|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
313648|NCT01449929|1060792|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
313649|NCT01449929|1060790|P3|Extension Phase Approximately 3 Years|Adverse Event|2
313650|NCT01449929|1060791|P2|Extension Phase Approximately 3 Years|Adverse Event|0
313651|NCT01449929|1060792|P1|Extension Phase Approximately 3 Years|Adverse Event|0
313652|NCT01449929|1060790|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
313653|NCT01449929|1060791|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
313654|NCT01449929|1060792|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
313655|NCT01449929|1060790|P3|Randomization Phase 96 Week|Physician Decision|0
313656|NCT01449929|1060791|P2|Randomization Phase 96 Week|Physician Decision|3
313657|NCT01449929|1060792|P1|Randomization Phase 96 Week|Physician Decision|2
313658|NCT01449929|1060790|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
313659|NCT01449929|1060791|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
313660|NCT01449929|1060792|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
313661|NCT01449929|1060790|P3|Randomization Phase 96 Week|Lost to Follow-up|0
313662|NCT01449929|1060791|P2|Randomization Phase 96 Week|Lost to Follow-up|18
313663|NCT01449929|1060792|P1|Randomization Phase 96 Week|Lost to Follow-up|15
313664|NCT01449929|1060790|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
313665|NCT01449929|1060791|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
313666|NCT01449929|1060792|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
313667|NCT01449929|1060790|P3|Randomization Phase 96 Week|Protocol Violation|0
313668|NCT01449929|1060791|P2|Randomization Phase 96 Week|Protocol Violation|6
313669|NCT01449929|1060792|P1|Randomization Phase 96 Week|Protocol Violation|5
313670|NCT01449929|1060790|P3|Randomization Phase 96 Week|Lack of Efficacy|0
313671|NCT01449929|1060791|P2|Randomization Phase 96 Week|Lack of Efficacy|4
313672|NCT01449929|1060792|P1|Randomization Phase 96 Week|Lack of Efficacy|3
313673|NCT01449929|1060790|P3|Randomization Phase 96 Week|Adverse Event|0
313674|NCT01449929|1060791|P2|Randomization Phase 96 Week|Adverse Event|13
313675|NCT01449929|1060792|P1|Randomization Phase 96 Week|Adverse Event|5
313676|NCT01449812|1060832|P3|Overall Study|Lost to Follow-up|0
313677|NCT01449812|1060833|P2|Overall Study|Lost to Follow-up|0
313678|NCT01449812|1060834|P1|Overall Study|Lost to Follow-up|1
313679|NCT01449812|1060832|P3|Overall Study|Withdrawal by Subject|1
313680|NCT01449812|1060833|P2|Overall Study|Withdrawal by Subject|0
313681|NCT01449812|1060834|P1|Overall Study|Withdrawal by Subject|0
313682|NCT01449812|1060832|P3|Overall Study|Migrated/moved from study area|0
313683|NCT01449812|1060833|P2|Overall Study|Migrated/moved from study area|0
313684|NCT01449812|1060834|P1|Overall Study|Migrated/moved from study area|1
313685|NCT01449721|1060949|P2|Overall Study|Physician Decision|1
313686|NCT01449721|1060950|P1|Overall Study|Physician Decision|0
313687|NCT01449721|1060949|P2|Overall Study|Physician Decision|1
313688|NCT01449721|1060950|P1|Overall Study|Physician Decision|0
313689|NCT01449708|1060962|P2|Overall Study|respiratory failure|0
313690|NCT01449708|1060963|P1|Overall Study|respiratory failure|1
313691|NCT01449708|1060962|P2|Overall Study|surgical complication|2
313692|NCT01449708|1060963|P1|Overall Study|surgical complication|1
313693|NCT01449708|1060962|P2|Overall Study|Protocol Violation|1
313694|NCT01449708|1060963|P1|Overall Study|Protocol Violation|0
313695|NCT01449682|1060974|P2|Overall Study|Adverse Event|0
313696|NCT01449682|1060975|P1|Overall Study|Adverse Event|1
313697|NCT01449682|1060974|P2|Overall Study|Death|1
313698|NCT01449682|1060975|P1|Overall Study|Death|0
313699|NCT01449539|1060987|P1|Overall Study|Toxicity not study related|1
313700|NCT01449539|1060987|P1|Overall Study|Withdrawal by Subject|3
313701|NCT01449526|1060993|P2|Overall Study|Cannot maintain visits|1
313702|NCT01449526|1060994|P1|Overall Study|Cannot maintain visits|0
313703|NCT01449526|1060993|P2|Overall Study|Lack of Motivation|1
313704|NCT01449526|1060994|P1|Overall Study|Lack of Motivation|0
313705|NCT01449526|1060993|P2|Overall Study|Symptoms/complaints|1
313706|NCT01449526|1060994|P1|Overall Study|Symptoms/complaints|0
313707|NCT01449526|1060993|P2|Overall Study|Withdrawal by Subject|1
313708|NCT01449526|1060994|P1|Overall Study|Withdrawal by Subject|1
313709|NCT01449526|1060993|P2|Overall Study|Lost to Follow-up|2
313710|NCT01449526|1060994|P1|Overall Study|Lost to Follow-up|1
313711|NCT01449461|1061063|P6|Overall Study|Reason not specified|1
313712|NCT01449461|1061064|P5|Overall Study|Reason not specified|0
313713|NCT01449461|1061065|P4|Overall Study|Reason not specified|3
313714|NCT01449461|1061066|P3|Overall Study|Reason not specified|0
313715|NCT01449461|1061067|P2|Overall Study|Reason not specified|1
313716|NCT01449461|1061068|P1|Overall Study|Reason not specified|0
313717|NCT01449461|1061063|P6|Overall Study|Clinical progressive disease|3
313718|NCT01449461|1061064|P5|Overall Study|Clinical progressive disease|3
313719|NCT01449461|1061065|P4|Overall Study|Clinical progressive disease|0
313721|NCT01449461|1061067|P2|Overall Study|Clinical progressive disease|1
313722|NCT01449461|1061068|P1|Overall Study|Clinical progressive disease|2
313723|NCT01449461|1061063|P6|Overall Study|Documented progressive disease|5
313724|NCT01449461|1061064|P5|Overall Study|Documented progressive disease|21
313725|NCT01449461|1061065|P4|Overall Study|Documented progressive disease|11
313726|NCT01449461|1061066|P3|Overall Study|Documented progressive disease|14
313727|NCT01449461|1061067|P2|Overall Study|Documented progressive disease|6
313728|NCT01449461|1061068|P1|Overall Study|Documented progressive disease|4
313729|NCT01449461|1061063|P6|Overall Study|Death|1
313730|NCT01449461|1061064|P5|Overall Study|Death|4
313731|NCT01449461|1061065|P4|Overall Study|Death|0
313732|NCT01449461|1061066|P3|Overall Study|Death|0
313733|NCT01449461|1061067|P2|Overall Study|Death|1
313734|NCT01449461|1061068|P1|Overall Study|Death|0
313735|NCT01449461|1061063|P6|Overall Study|Adverse Event|3
313736|NCT01449461|1061064|P5|Overall Study|Adverse Event|3
313737|NCT01449461|1061065|P4|Overall Study|Adverse Event|3
313738|NCT01449461|1061066|P3|Overall Study|Adverse Event|2
313739|NCT01449461|1061067|P2|Overall Study|Adverse Event|3
313740|NCT01449461|1061068|P1|Overall Study|Adverse Event|0
313741|NCT01449461|1061063|P6|Overall Study|Ongoing|2
313742|NCT01449461|1061064|P5|Overall Study|Ongoing|17
313743|NCT01449461|1061065|P4|Overall Study|Ongoing|15
313744|NCT01449461|1061066|P3|Overall Study|Ongoing|2
313745|NCT01449461|1061067|P2|Overall Study|Ongoing|6
313746|NCT01449461|1061068|P1|Overall Study|Ongoing|0
313747|NCT01449370|1061205|P25|Overall Study|Death|1
313748|NCT01449370|1061206|P24|Overall Study|Death|0
313749|NCT01449370|1061207|P23|Overall Study|Death|0
313750|NCT01449370|1061208|P22|Overall Study|Death|0
313751|NCT01449370|1061209|P21|Overall Study|Death|0
313752|NCT01449370|1061210|P20|Overall Study|Death|0
313753|NCT01449370|1061211|P19|Overall Study|Death|0
313754|NCT01449370|1061212|P18|Overall Study|Death|0
313755|NCT01449370|1061213|P17|Overall Study|Death|0
313756|NCT01449370|1061214|P16|Overall Study|Death|0
313757|NCT01449370|1061215|P15|Overall Study|Death|0
313758|NCT01449370|1061216|P14|Overall Study|Death|0
313759|NCT01449370|1061217|P13|Overall Study|Death|0
313760|NCT01449370|1061218|P12|Overall Study|Death|0
313761|NCT01449370|1061219|P11|Overall Study|Death|0
313762|NCT01449370|1061220|P10|Overall Study|Death|0
313763|NCT01449370|1061221|P9|Overall Study|Death|0
313764|NCT01449370|1061222|P8|Overall Study|Death|0
313765|NCT01449370|1061223|P7|Overall Study|Death|0
313766|NCT01449370|1061224|P6|Overall Study|Death|0
313767|NCT01449370|1061225|P5|Overall Study|Death|0
313768|NCT01449370|1061226|P4|Overall Study|Death|0
313769|NCT01449370|1061227|P3|Overall Study|Death|0
313770|NCT01449370|1061228|P2|Overall Study|Death|0
313771|NCT01449370|1061229|P1|Overall Study|Death|0
313772|NCT01449370|1061205|P25|Overall Study|Medication Prohibited by Protocol|0
313773|NCT01449370|1061206|P24|Overall Study|Medication Prohibited by Protocol|1
313774|NCT01449370|1061207|P23|Overall Study|Medication Prohibited by Protocol|0
313775|NCT01449370|1061208|P22|Overall Study|Medication Prohibited by Protocol|0
313776|NCT01449370|1061209|P21|Overall Study|Medication Prohibited by Protocol|0
313777|NCT01449370|1061210|P20|Overall Study|Medication Prohibited by Protocol|0
313778|NCT01449370|1061211|P19|Overall Study|Medication Prohibited by Protocol|0
313779|NCT01449370|1061212|P18|Overall Study|Medication Prohibited by Protocol|0
313780|NCT01449370|1061213|P17|Overall Study|Medication Prohibited by Protocol|0
313781|NCT01449370|1061214|P16|Overall Study|Medication Prohibited by Protocol|0
313782|NCT01449370|1061215|P15|Overall Study|Medication Prohibited by Protocol|0
313783|NCT01449370|1061216|P14|Overall Study|Medication Prohibited by Protocol|0
313784|NCT01449370|1061217|P13|Overall Study|Medication Prohibited by Protocol|0
313785|NCT01449370|1061218|P12|Overall Study|Medication Prohibited by Protocol|0
313786|NCT01449370|1061219|P11|Overall Study|Medication Prohibited by Protocol|0
313787|NCT01449370|1061220|P10|Overall Study|Medication Prohibited by Protocol|0
313788|NCT01449370|1061221|P9|Overall Study|Medication Prohibited by Protocol|0
313789|NCT01449370|1061222|P8|Overall Study|Medication Prohibited by Protocol|0
313790|NCT01449370|1061223|P7|Overall Study|Medication Prohibited by Protocol|0
313791|NCT01449370|1061224|P6|Overall Study|Medication Prohibited by Protocol|0
313792|NCT01449370|1061225|P5|Overall Study|Medication Prohibited by Protocol|0
313793|NCT01449370|1061226|P4|Overall Study|Medication Prohibited by Protocol|0
313794|NCT01449370|1061227|P3|Overall Study|Medication Prohibited by Protocol|0
313795|NCT01449370|1061228|P2|Overall Study|Medication Prohibited by Protocol|0
313796|NCT01449370|1061229|P1|Overall Study|Medication Prohibited by Protocol|0
313797|NCT01449370|1061205|P25|Overall Study|Other|0
313798|NCT01449370|1061206|P24|Overall Study|Other|1
313799|NCT01449370|1061207|P23|Overall Study|Other|1
313800|NCT01449370|1061208|P22|Overall Study|Other|0
313801|NCT01449370|1061209|P21|Overall Study|Other|0
313802|NCT01449370|1061210|P20|Overall Study|Other|0
313803|NCT01449370|1061211|P19|Overall Study|Other|0
313804|NCT01449370|1061212|P18|Overall Study|Other|0
313805|NCT01449370|1061213|P17|Overall Study|Other|0
313806|NCT01449370|1061214|P16|Overall Study|Other|0
313807|NCT01449370|1061215|P15|Overall Study|Other|0
313808|NCT01449370|1061216|P14|Overall Study|Other|0
313809|NCT01449370|1061217|P13|Overall Study|Other|0
313810|NCT01449370|1061218|P12|Overall Study|Other|0
313811|NCT01449370|1061219|P11|Overall Study|Other|0
313812|NCT01449370|1061220|P10|Overall Study|Other|1
313813|NCT01449370|1061221|P9|Overall Study|Other|1
313814|NCT01449370|1061222|P8|Overall Study|Other|0
313815|NCT01449370|1061223|P7|Overall Study|Other|0
313816|NCT01449370|1061224|P6|Overall Study|Other|0
313817|NCT01449370|1061225|P5|Overall Study|Other|0
313818|NCT01449370|1061226|P4|Overall Study|Other|0
313819|NCT01449370|1061227|P3|Overall Study|Other|0
313820|NCT01449370|1061228|P2|Overall Study|Other|0
313821|NCT01449370|1061229|P1|Overall Study|Other|0
313822|NCT01449370|1061205|P25|Overall Study|Lost to Follow-up|0
313823|NCT01449370|1061206|P24|Overall Study|Lost to Follow-up|0
313824|NCT01449370|1061207|P23|Overall Study|Lost to Follow-up|0
313825|NCT01449370|1061208|P22|Overall Study|Lost to Follow-up|0
313826|NCT01449370|1061209|P21|Overall Study|Lost to Follow-up|1
313827|NCT01449370|1061210|P20|Overall Study|Lost to Follow-up|0
313828|NCT01449370|1061211|P19|Overall Study|Lost to Follow-up|0
313829|NCT01449370|1061212|P18|Overall Study|Lost to Follow-up|0
313830|NCT01449370|1061213|P17|Overall Study|Lost to Follow-up|0
313831|NCT01449370|1061214|P16|Overall Study|Lost to Follow-up|0
313832|NCT01449370|1061215|P15|Overall Study|Lost to Follow-up|0
313833|NCT01449370|1061216|P14|Overall Study|Lost to Follow-up|0
313834|NCT01449370|1061217|P13|Overall Study|Lost to Follow-up|0
313835|NCT01449370|1061218|P12|Overall Study|Lost to Follow-up|0
313836|NCT01449370|1061219|P11|Overall Study|Lost to Follow-up|0
313837|NCT01449370|1061220|P10|Overall Study|Lost to Follow-up|0
313838|NCT01449370|1061221|P9|Overall Study|Lost to Follow-up|0
313839|NCT01449370|1061222|P8|Overall Study|Lost to Follow-up|0
313840|NCT01449370|1061223|P7|Overall Study|Lost to Follow-up|0
313841|NCT01449370|1061224|P6|Overall Study|Lost to Follow-up|0
313842|NCT01449370|1061225|P5|Overall Study|Lost to Follow-up|0
313843|NCT01449370|1061226|P4|Overall Study|Lost to Follow-up|0
313844|NCT01449370|1061227|P3|Overall Study|Lost to Follow-up|0
313845|NCT01449370|1061228|P2|Overall Study|Lost to Follow-up|0
313846|NCT01449370|1061229|P1|Overall Study|Lost to Follow-up|0
313847|NCT01449370|1061205|P25|Overall Study|Participant Decision|1
313848|NCT01449370|1061206|P24|Overall Study|Participant Decision|0
313849|NCT01449370|1061207|P23|Overall Study|Participant Decision|0
313850|NCT01449370|1061208|P22|Overall Study|Participant Decision|1
313851|NCT01449370|1061209|P21|Overall Study|Participant Decision|0
313852|NCT01449370|1061210|P20|Overall Study|Participant Decision|0
313853|NCT01449370|1061211|P19|Overall Study|Participant Decision|1
313854|NCT01449370|1061212|P18|Overall Study|Participant Decision|0
313855|NCT01449370|1061213|P17|Overall Study|Participant Decision|3
313856|NCT01449370|1061214|P16|Overall Study|Participant Decision|1
313857|NCT01449370|1061215|P15|Overall Study|Participant Decision|0
313858|NCT01449370|1061216|P14|Overall Study|Participant Decision|1
313859|NCT01449370|1061217|P13|Overall Study|Participant Decision|1
313860|NCT01449370|1061218|P12|Overall Study|Participant Decision|0
313861|NCT01449370|1061219|P11|Overall Study|Participant Decision|0
313862|NCT01449370|1061220|P10|Overall Study|Participant Decision|0
313863|NCT01449370|1061221|P9|Overall Study|Participant Decision|1
313864|NCT01449370|1061222|P8|Overall Study|Participant Decision|1
313865|NCT01449370|1061223|P7|Overall Study|Participant Decision|0
313866|NCT01449370|1061224|P6|Overall Study|Participant Decision|0
313867|NCT01449370|1061225|P5|Overall Study|Participant Decision|0
313868|NCT01449370|1061226|P4|Overall Study|Participant Decision|0
313869|NCT01449370|1061227|P3|Overall Study|Participant Decision|0
313870|NCT01449370|1061228|P2|Overall Study|Participant Decision|0
313871|NCT01449370|1061229|P1|Overall Study|Participant Decision|0
313872|NCT01449370|1061205|P25|Overall Study|Adverse Event|3
313873|NCT01449370|1061206|P24|Overall Study|Adverse Event|1
313874|NCT01449370|1061207|P23|Overall Study|Adverse Event|0
313875|NCT01449370|1061208|P22|Overall Study|Adverse Event|1
313876|NCT01449370|1061209|P21|Overall Study|Adverse Event|0
313877|NCT01449370|1061210|P20|Overall Study|Adverse Event|1
313878|NCT01449370|1061211|P19|Overall Study|Adverse Event|1
313879|NCT01449370|1061212|P18|Overall Study|Adverse Event|0
313880|NCT01449370|1061213|P17|Overall Study|Adverse Event|0
313881|NCT01449370|1061214|P16|Overall Study|Adverse Event|1
313882|NCT01449370|1061215|P15|Overall Study|Adverse Event|0
313883|NCT01449370|1061216|P14|Overall Study|Adverse Event|2
313884|NCT01449370|1061217|P13|Overall Study|Adverse Event|0
313885|NCT01449370|1061218|P12|Overall Study|Adverse Event|0
313886|NCT01449370|1061219|P11|Overall Study|Adverse Event|0
313887|NCT01449370|1061220|P10|Overall Study|Adverse Event|1
313888|NCT01449370|1061221|P9|Overall Study|Adverse Event|1
313889|NCT01449370|1061222|P8|Overall Study|Adverse Event|0
313890|NCT01449370|1061223|P7|Overall Study|Adverse Event|0
313891|NCT01449370|1061224|P6|Overall Study|Adverse Event|0
313892|NCT01449370|1061225|P5|Overall Study|Adverse Event|0
313893|NCT01449370|1061226|P4|Overall Study|Adverse Event|1
313894|NCT01449370|1061227|P3|Overall Study|Adverse Event|0
313895|NCT01449370|1061228|P2|Overall Study|Adverse Event|2
313896|NCT01449370|1061229|P1|Overall Study|Adverse Event|1
313897|NCT01449370|1061205|P25|Overall Study|Disease Progression|3
313898|NCT01449370|1061206|P24|Overall Study|Disease Progression|7
313899|NCT01449370|1061207|P23|Overall Study|Disease Progression|3
313900|NCT01449370|1061208|P22|Overall Study|Disease Progression|2
313901|NCT01449370|1061209|P21|Overall Study|Disease Progression|5
313902|NCT01449370|1061210|P20|Overall Study|Disease Progression|2
313903|NCT01449370|1061211|P19|Overall Study|Disease Progression|1
313904|NCT01449370|1061212|P18|Overall Study|Disease Progression|3
313905|NCT01449370|1061213|P17|Overall Study|Disease Progression|4
313906|NCT01449370|1061214|P16|Overall Study|Disease Progression|1
313907|NCT01449370|1061215|P15|Overall Study|Disease Progression|3
313908|NCT01449370|1061216|P14|Overall Study|Disease Progression|8
313909|NCT01449370|1061217|P13|Overall Study|Disease Progression|2
313910|NCT01449370|1061218|P12|Overall Study|Disease Progression|3
313911|NCT01449370|1061219|P11|Overall Study|Disease Progression|3
313912|NCT01449370|1061220|P10|Overall Study|Disease Progression|1
313913|NCT01449370|1061221|P9|Overall Study|Disease Progression|9
313914|NCT01449370|1061222|P8|Overall Study|Disease Progression|2
313915|NCT01449370|1061223|P7|Overall Study|Disease Progression|3
313916|NCT01449370|1061224|P6|Overall Study|Disease Progression|3
313917|NCT01449370|1061225|P5|Overall Study|Disease Progression|3
313918|NCT01449370|1061226|P4|Overall Study|Disease Progression|3
313919|NCT01449370|1061227|P3|Overall Study|Disease Progression|8
313920|NCT01449370|1061228|P2|Overall Study|Disease Progression|4
313921|NCT01449370|1061229|P1|Overall Study|Disease Progression|5
313922|NCT01449279|1061607|P1|Overall Study|Toxicity|2
313923|NCT01449279|1061607|P1|Overall Study|Lack of Efficacy|5
313924|NCT01449006|1061632|P2|Overall Study|Protocol Violation|0
313925|NCT01449006|1061633|P1|Overall Study|Protocol Violation|1
313926|NCT01449006|1061632|P2|Overall Study|Withdrawal by Subject|0
313927|NCT01449006|1061633|P1|Overall Study|Withdrawal by Subject|1
313928|NCT01449006|1061632|P2|Overall Study|Lost to Follow-up|0
313929|NCT01449006|1061633|P1|Overall Study|Lost to Follow-up|1
313930|NCT01448850|1061647|P2|Overall Study|Other|12
313931|NCT01448850|1061648|P1|Overall Study|Other|15
313932|NCT01448850|1061647|P2|Overall Study|Lost to Follow-up|1
313933|NCT01448850|1061648|P1|Overall Study|Lost to Follow-up|3
313934|NCT01448850|1061647|P2|Overall Study|Withdrawal by Subject|21
313935|NCT01448850|1061648|P1|Overall Study|Withdrawal by Subject|13
313936|NCT01448850|1061647|P2|Overall Study|Death|6
313937|NCT01448850|1061648|P1|Overall Study|Death|3
313938|NCT01448707|1061673|P2|Overall Study|Other|4
313939|NCT01448707|1061674|P1|Overall Study|Other|7
313940|NCT01448707|1061673|P2|Overall Study|Withdrawal by Subject|7
313941|NCT01448707|1061674|P1|Overall Study|Withdrawal by Subject|6
313942|NCT01448707|1061673|P2|Overall Study|Lost to Follow-up|6
313943|NCT01448707|1061674|P1|Overall Study|Lost to Follow-up|2
313944|NCT01448707|1061673|P2|Overall Study|Adverse Event|1
313945|NCT01448707|1061674|P1|Overall Study|Adverse Event|3
313946|NCT01448616|1061695|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
313947|NCT01448616|1061696|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
313948|NCT01448616|1061697|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
313949|NCT01448616|1061698|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
313950|NCT01448616|1061695|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
313951|NCT01448616|1061696|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
313952|NCT01448616|1061697|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
313953|NCT01448616|1061698|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
313954|NCT01448616|1061695|P4|Study Drug (Treatment Phase)|Adverse Event|0
313955|NCT01448616|1061696|P3|Study Drug (Treatment Phase)|Adverse Event|1
313956|NCT01448616|1061697|P2|Study Drug (Treatment Phase)|Adverse Event|1
313957|NCT01448616|1061698|P1|Study Drug (Treatment Phase)|Adverse Event|0
313958|NCT01448616|1061695|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
313959|NCT01448616|1061696|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
313960|NCT01448616|1061697|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
313961|NCT01448616|1061698|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
313962|NCT01448616|1061695|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
313963|NCT01448616|1061696|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
313964|NCT01448616|1061697|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
313965|NCT01448616|1061698|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
313966|NCT01448213|1061745|P2|Overall Study|Protocol Violation|2
313967|NCT01448213|1061746|P1|Overall Study|Protocol Violation|1
313968|NCT01448213|1061745|P2|Overall Study|Adverse Event|10
313969|NCT01448213|1061746|P1|Overall Study|Adverse Event|4
313970|NCT01448213|1061745|P2|Overall Study|Lost to Follow-up|10
313971|NCT01448213|1061746|P1|Overall Study|Lost to Follow-up|12
313972|NCT01448057|1061756|P2|Overall Study|Withdrawal by Subject|0
313973|NCT01448057|1061757|P1|Overall Study|Withdrawal by Subject|2
313974|NCT01448057|1061756|P2|Overall Study|Adverse Event|2
313975|NCT01448057|1061757|P1|Overall Study|Adverse Event|0
313976|NCT01448057|1061756|P2|Overall Study|Lost to Follow-up|0
313977|NCT01448057|1061757|P1|Overall Study|Lost to Follow-up|3
313978|NCT01448057|1061756|P2|Overall Study|Protocol Violation|2
313979|NCT01448057|1061757|P1|Overall Study|Protocol Violation|3
313980|NCT01448044|1061767|P2|Follow Up Period|not specified|11
313981|NCT01448044|1061768|P1|Follow Up Period|not specified|5
313982|NCT01448044|1061767|P2|Follow Up Period|Lost to Follow-up|2
313983|NCT01448044|1061768|P1|Follow Up Period|Lost to Follow-up|6
313984|NCT01448044|1061767|P2|Follow Up Period|Withdrawal by Subject|1
313985|NCT01448044|1061768|P1|Follow Up Period|Withdrawal by Subject|1
313986|NCT01448044|1061767|P2|Treatment Period|Other reason|0
313987|NCT01448044|1061768|P1|Treatment Period|Other reason|2
313988|NCT01448044|1061767|P2|Treatment Period|Lost to Follow-up|1
313989|NCT01448044|1061768|P1|Treatment Period|Lost to Follow-up|2
313990|NCT01448044|1061767|P2|Treatment Period|Participant does not meet study criteria|0
313991|NCT01448044|1061768|P1|Treatment Period|Participant does not meet study criteria|1
313992|NCT01448044|1061767|P2|Treatment Period|Completed 24 weeks treatment period only|0
313993|NCT01448044|1061768|P1|Treatment Period|Completed 24 weeks treatment period only|8
313994|NCT01448044|1061767|P2|Treatment Period|Subject requested discontinue study drug|0
313995|NCT01448044|1061768|P1|Treatment Period|Subject requested discontinue study drug|1
313996|NCT01448044|1061767|P2|Treatment Period|Lack of Efficacy|12
313997|NCT01448044|1061768|P1|Treatment Period|Lack of Efficacy|5
313998|NCT01448044|1061767|P2|Treatment Period|Adverse Event|3
313999|NCT01448044|1061768|P1|Treatment Period|Adverse Event|4
314000|NCT01447927|1061784|P2|Overall Study|Withdrawal by Subject|0
314001|NCT01447927|1061785|P1|Overall Study|Withdrawal by Subject|1
314002|NCT01447927|1061784|P2|Overall Study|Adverse Event|3
314003|NCT01447927|1061785|P1|Overall Study|Adverse Event|4
314004|NCT01447719|1061815|P1|Overall Study|Family withdrew autopsy consent|7
314005|NCT01447719|1061815|P1|Overall Study|Withdrawal by Subject|2
314006|NCT01447719|1061815|P1|Overall Study|Subject still living at end of study|79
314007|NCT01447719|1061815|P1|Overall Study|Invalid image or not imaged|3
314008|NCT01447719|1061815|P1|Overall Study|Image acquisition failure|2
314009|NCT01447576|1061841|P1|Overall Study|Physician Decision|6
314010|NCT01447576|1061841|P1|Overall Study|Lack of Efficacy|68
314011|NCT01447576|1061841|P1|Overall Study|Protocol deviation|83
314012|NCT01447576|1061841|P1|Overall Study|Withdrawal by Subject|100
314013|NCT01447576|1061841|P1|Overall Study|Participant met withdrawal criteria|40
314014|NCT01447576|1061841|P1|Overall Study|Adverse Event|127
314015|NCT01447576|1061841|P1|Overall Study|Lost to Follow-up|52
314016|NCT01447446|1061874|P6|Overall Study|Reason not Specified|0
314017|NCT01447446|1061875|P5|Overall Study|Reason not Specified|1
314018|NCT01447446|1061876|P4|Overall Study|Reason not Specified|1
314019|NCT01447446|1061877|P3|Overall Study|Reason not Specified|1
314020|NCT01447446|1061878|P2|Overall Study|Reason not Specified|1
314021|NCT01447446|1061879|P1|Overall Study|Reason not Specified|1
314022|NCT01447446|1061874|P6|Overall Study|New Treatment Started|0
314023|NCT01447446|1061875|P5|Overall Study|New Treatment Started|2
314024|NCT01447446|1061876|P4|Overall Study|New Treatment Started|0
314025|NCT01447446|1061877|P3|Overall Study|New Treatment Started|1
314026|NCT01447446|1061878|P2|Overall Study|New Treatment Started|2
314027|NCT01447446|1061879|P1|Overall Study|New Treatment Started|8
314028|NCT01447446|1061874|P6|Overall Study|SVR12 Assessment|5
314029|NCT01447446|1061875|P5|Overall Study|SVR12 Assessment|5
314030|NCT01447446|1061876|P4|Overall Study|SVR12 Assessment|1
314031|NCT01447446|1061877|P3|Overall Study|SVR12 Assessment|2
314032|NCT01447446|1061878|P2|Overall Study|SVR12 Assessment|1
314033|NCT01447446|1061879|P1|Overall Study|SVR12 Assessment|13
314034|NCT01447446|1061874|P6|Overall Study|Administrative/Other|4
314035|NCT01447446|1061875|P5|Overall Study|Administrative/Other|33
314036|NCT01447446|1061876|P4|Overall Study|Administrative/Other|2
314037|NCT01447446|1061877|P3|Overall Study|Administrative/Other|10
314038|NCT01447446|1061878|P2|Overall Study|Administrative/Other|9
314039|NCT01447446|1061879|P1|Overall Study|Administrative/Other|34
314040|NCT01447446|1061874|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
314041|NCT01447446|1061875|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
314042|NCT01447446|1061876|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
314043|NCT01447446|1061877|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
314044|NCT01447446|1061878|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
314045|NCT01447446|1061879|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
314046|NCT01447446|1061874|P6|Overall Study|Failure to Return/Consent Withdrawn|9
314047|NCT01447446|1061875|P5|Overall Study|Failure to Return/Consent Withdrawn|69
314048|NCT01447446|1061876|P4|Overall Study|Failure to Return/Consent Withdrawn|7
314049|NCT01447446|1061877|P3|Overall Study|Failure to Return/Consent Withdrawn|31
314050|NCT01447446|1061878|P2|Overall Study|Failure to Return/Consent Withdrawn|78
314051|NCT01447446|1061879|P1|Overall Study|Failure to Return/Consent Withdrawn|357
314052|NCT01447446|1061874|P6|Overall Study|Adverse Event|0
314053|NCT01447446|1061875|P5|Overall Study|Adverse Event|2
314054|NCT01447446|1061876|P4|Overall Study|Adverse Event|0
314055|NCT01447446|1061877|P3|Overall Study|Adverse Event|1
314056|NCT01447446|1061878|P2|Overall Study|Adverse Event|0
314057|NCT01447446|1061879|P1|Overall Study|Adverse Event|3
314058|NCT01447446|1061874|P6|Overall Study|Death|0
314059|NCT01447446|1061875|P5|Overall Study|Death|7
314060|NCT01447446|1061876|P4|Overall Study|Death|1
314061|NCT01447446|1061877|P3|Overall Study|Death|2
314062|NCT01447446|1061878|P2|Overall Study|Death|3
314063|NCT01447446|1061879|P1|Overall Study|Death|6
314064|NCT01447433|1061969|P2|Overall Study|Protocol Violation|1
314065|NCT01447433|1061970|P1|Overall Study|Protocol Violation|1
314066|NCT01447433|1061969|P2|Overall Study|Withdrawal by Subject|3
314067|NCT01447433|1061970|P1|Overall Study|Withdrawal by Subject|3
314068|NCT01447433|1061969|P2|Overall Study|Lost to Follow-up|2
314069|NCT01447433|1061970|P1|Overall Study|Lost to Follow-up|0
314070|NCT01447420|1061997|P3|Overall Study|Lack of Efficacy|8
314071|NCT01447420|1061998|P2|Overall Study|Lack of Efficacy|19
314072|NCT01447420|1061999|P1|Overall Study|Lack of Efficacy|1
314073|NCT01447420|1061997|P3|Overall Study|Withdrawal by Subject|0
314074|NCT01447420|1061998|P2|Overall Study|Withdrawal by Subject|1
314075|NCT01447420|1061999|P1|Overall Study|Withdrawal by Subject|4
314076|NCT01447420|1061997|P3|Overall Study|Protocol Violation|0
314077|NCT01447420|1061998|P2|Overall Study|Protocol Violation|3
314078|NCT01447420|1061999|P1|Overall Study|Protocol Violation|3
314079|NCT01447420|1061997|P3|Overall Study|Adverse Event|2
314080|NCT01447420|1061998|P2|Overall Study|Adverse Event|4
314081|NCT01447420|1061999|P1|Overall Study|Adverse Event|2
314082|NCT01446874|1062115|P3|Overall Study|Withdrawal by Subject|2
314083|NCT01446874|1062116|P2|Overall Study|Withdrawal by Subject|0
314084|NCT01446874|1062117|P1|Overall Study|Withdrawal by Subject|0
314085|NCT01446874|1062115|P3|Overall Study|Participant died before returning diary|1
314086|NCT01446874|1062116|P2|Overall Study|Participant died before returning diary|0
314087|NCT01446874|1062117|P1|Overall Study|Participant died before returning diary|0
314088|NCT01446874|1062115|P3|Overall Study|Participant lost diary|1
314089|NCT01446874|1062116|P2|Overall Study|Participant lost diary|0
314090|NCT01446874|1062117|P1|Overall Study|Participant lost diary|0
314091|NCT01446874|1062115|P3|Overall Study|Metastatic disease|2
314092|NCT01446874|1062116|P2|Overall Study|Metastatic disease|0
314093|NCT01446874|1062117|P1|Overall Study|Metastatic disease|0
314094|NCT01446874|1062115|P3|Overall Study|Allergic reaction|1
314095|NCT01446874|1062116|P2|Overall Study|Allergic reaction|0
314096|NCT01446874|1062117|P1|Overall Study|Allergic reaction|0
314097|NCT01446874|1062115|P3|Overall Study|Non-compliance|10
314098|NCT01446874|1062116|P2|Overall Study|Non-compliance|4
314099|NCT01446874|1062117|P1|Overall Study|Non-compliance|0
314100|NCT01446874|1062115|P3|Overall Study|Did not proceed to surgery|4
314101|NCT01446874|1062116|P2|Overall Study|Did not proceed to surgery|0
314102|NCT01446874|1062117|P1|Overall Study|Did not proceed to surgery|1
314103|NCT01446874|1062115|P3|Overall Study|Not eligible|0
314104|NCT01446874|1062116|P2|Overall Study|Not eligible|0
314105|NCT01446874|1062117|P1|Overall Study|Not eligible|1
314106|NCT01446796|1062143|P2|Overall Study|Withdrawal by Subject|0
314107|NCT01446796|1062144|P1|Overall Study|Withdrawal by Subject|1
314108|NCT01446419|1062169|P2|Overall Study|Terminated per protocol|0
314109|NCT01446419|1062170|P1|Overall Study|Terminated per protocol|3
314110|NCT01446419|1062169|P2|Overall Study|Withdrawal by Subject|1
314111|NCT01446419|1062170|P1|Overall Study|Withdrawal by Subject|1
314112|NCT01446419|1062169|P2|Overall Study|Death|0
314113|NCT01446419|1062170|P1|Overall Study|Death|1
314114|NCT01446289|1062184|P4|Overall Study|Withdrawal by Subject|0
314115|NCT01446289|1062185|P3|Overall Study|Withdrawal by Subject|1
314116|NCT01446289|1062186|P2|Overall Study|Withdrawal by Subject|0
314117|NCT01446289|1062187|P1|Overall Study|Withdrawal by Subject|1
314118|NCT01446237|1062230|P1|Overall Study|Withdrawal by Subject|7
314119|NCT01446237|1062230|P1|Overall Study|Lost to Follow-up|2
314120|NCT01446237|1062230|P1|Overall Study|Adverse Event|1
314121|NCT01446042|1062241|P3|Overall Study|Other reasons|1
314122|NCT01446042|1062242|P2|Overall Study|Other reasons|1
314123|NCT01446042|1062243|P1|Overall Study|Other reasons|2
314124|NCT01446042|1062241|P3|Overall Study|Lost to Follow-up|0
314125|NCT01446042|1062242|P2|Overall Study|Lost to Follow-up|0
314126|NCT01446042|1062243|P1|Overall Study|Lost to Follow-up|5
314127|NCT01446042|1062241|P3|Overall Study|Adverse Event|4
314128|NCT01446042|1062242|P2|Overall Study|Adverse Event|0
314129|NCT01446042|1062243|P1|Overall Study|Adverse Event|1
314130|NCT01446042|1062241|P3|Overall Study|Withdrawal by Subject|4
314131|NCT01446042|1062242|P2|Overall Study|Withdrawal by Subject|2
314132|NCT01446042|1062243|P1|Overall Study|Withdrawal by Subject|12
314133|NCT01446003|1062254|P2|Period 2|Adverse Event|0
314134|NCT01446003|1062255|P1|Period 2|Adverse Event|1
314135|NCT01446003|1062254|P2|Period 1|Protocol Violation|0
314136|NCT01446003|1062255|P1|Period 1|Protocol Violation|2
314137|NCT01445951|1062276|P3|Overall Study|Cough|0
314138|NCT01445951|1062277|P2|Overall Study|Cough|1
314139|NCT01445951|1062278|P1|Overall Study|Cough|0
314140|NCT01445951|1062276|P3|Overall Study|Sponsor decision - subject travel|0
314141|NCT01445951|1062277|P2|Overall Study|Sponsor decision - subject travel|1
314142|NCT01445951|1062278|P1|Overall Study|Sponsor decision - subject travel|0
314143|NCT01445951|1062276|P3|Overall Study|Non-compliance with protocol|0
314144|NCT01445951|1062277|P2|Overall Study|Non-compliance with protocol|1
314145|NCT01445951|1062278|P1|Overall Study|Non-compliance with protocol|0
314146|NCT01445951|1062276|P3|Overall Study|Non-compliance with study drug|0
314147|NCT01445951|1062277|P2|Overall Study|Non-compliance with study drug|2
314148|NCT01445951|1062278|P1|Overall Study|Non-compliance with study drug|1
314149|NCT01445951|1062276|P3|Overall Study|Death|1
314150|NCT01445951|1062277|P2|Overall Study|Death|0
314151|NCT01445951|1062278|P1|Overall Study|Death|0
314152|NCT01445951|1062276|P3|Overall Study|Pregnancy|4
314153|NCT01445951|1062277|P2|Overall Study|Pregnancy|1
314154|NCT01445951|1062278|P1|Overall Study|Pregnancy|0
314155|NCT01445951|1062276|P3|Overall Study|Lost to Follow-up|4
314156|NCT01445951|1062277|P2|Overall Study|Lost to Follow-up|2
314157|NCT01445951|1062278|P1|Overall Study|Lost to Follow-up|1
314158|NCT01445951|1062276|P3|Overall Study|Physician Decision|0
314159|NCT01445951|1062277|P2|Overall Study|Physician Decision|1
314160|NCT01445951|1062278|P1|Overall Study|Physician Decision|3
314161|NCT01445951|1062276|P3|Overall Study|Withdrawal by Subject|8
314162|NCT01445951|1062277|P2|Overall Study|Withdrawal by Subject|16
314163|NCT01445951|1062278|P1|Overall Study|Withdrawal by Subject|21
314164|NCT01445951|1062276|P3|Overall Study|Protocol Violation|2
314165|NCT01445951|1062277|P2|Overall Study|Protocol Violation|2
314166|NCT01445951|1062278|P1|Overall Study|Protocol Violation|2
314167|NCT01445951|1062276|P3|Overall Study|Adverse Event|0
314168|NCT01445951|1062277|P2|Overall Study|Adverse Event|9
314169|NCT01445951|1062278|P1|Overall Study|Adverse Event|16
314170|NCT01445847|1062346|P2|Overall Study|Missed Data|0
314171|NCT01445847|1062347|P1|Overall Study|Missed Data|1
314172|NCT01445847|1062346|P2|Overall Study|Protocol Violation|14
314173|NCT01445847|1062347|P1|Overall Study|Protocol Violation|13
314174|NCT01445769|1062353|P1|Overall Study|Lost to Follow-up|5
314175|NCT01445769|1062353|P1|Overall Study|Disease Progression|1
314176|NCT01445769|1062353|P1|Overall Study|Consent Withdrawn|2
314177|NCT01445678|1062373|P2|Overall Study|Withdrawal by Subject|5
314178|NCT01445678|1062374|P1|Overall Study|Withdrawal by Subject|9
314179|NCT01445678|1062373|P2|Overall Study|Protocol Violation|1
314180|NCT01445678|1062374|P1|Overall Study|Protocol Violation|1
314181|NCT01445678|1062373|P2|Overall Study|Lost to Follow-up|5
314182|NCT01445678|1062374|P1|Overall Study|Lost to Follow-up|8
314183|NCT01445678|1062373|P2|Overall Study|Lack of Efficacy|2
314184|NCT01445678|1062374|P1|Overall Study|Lack of Efficacy|0
314185|NCT01445678|1062373|P2|Overall Study|Adverse Event|8
314186|NCT01445678|1062374|P1|Overall Study|Adverse Event|12
314187|NCT01445652|1062392|P2|Overall Study|Adverse Event|0
314188|NCT01445652|1062393|P1|Overall Study|Adverse Event|1
314189|NCT01445652|1062392|P2|Overall Study|Failed teach session|0
314190|NCT01445652|1062393|P1|Overall Study|Failed teach session|2
314191|NCT01445652|1062392|P2|Overall Study|Failed to attend scheduled visit|3
314192|NCT01445652|1062393|P1|Overall Study|Failed to attend scheduled visit|2
314193|NCT01445652|1062392|P2|Overall Study|Not comfortable in lenses|0
314194|NCT01445652|1062393|P1|Overall Study|Not comfortable in lenses|5
314195|NCT01445613|1062411|P1|1-year Follow-up|Received a non-study stent|2
314196|NCT01445613|1062411|P1|1-year Follow-up|Physician Decision|2
314197|NCT01445613|1062411|P1|1-year Follow-up|Death|30
314198|NCT01445613|1062411|P1|1-year Follow-up|Lost to Follow-up|2
314199|NCT01445613|1062411|P1|1-year Follow-up|Missed visit|29
314200|NCT01445613|1062411|P1|1-year Follow-up|Withdrawal by Subject|12
314201|NCT01445613|1062411|P1|30-day Follow-up|Death|3
314202|NCT01445613|1062411|P1|30-day Follow-up|Missed visit|23
314203|NCT01445613|1062411|P1|30-day Follow-up|Physician Decision|3
314204|NCT01445613|1062411|P1|30-day Follow-up|Withdrawal by Subject|6
314205|NCT01445548|1062429|P1|Overall Study|Adverse Event|1
314206|NCT01445301|1062453|P3|Overall Study|Withdrawal by Subject|4
314207|NCT01445301|1062454|P2|Overall Study|Withdrawal by Subject|6
314208|NCT01445301|1062455|P1|Overall Study|Withdrawal by Subject|5
314209|NCT01445301|1062453|P3|Overall Study|Physician Decision|0
314210|NCT01445301|1062454|P2|Overall Study|Physician Decision|2
314211|NCT01445301|1062455|P1|Overall Study|Physician Decision|0
314212|NCT01445301|1062453|P3|Overall Study|Protocol-Defined Stopping Criteria|1
314213|NCT01445301|1062454|P2|Overall Study|Protocol-Defined Stopping Criteria|1
314214|NCT01445301|1062455|P1|Overall Study|Protocol-Defined Stopping Criteria|0
314215|NCT01445301|1062453|P3|Overall Study|Protocol Violation|0
314216|NCT01445301|1062454|P2|Overall Study|Protocol Violation|0
314217|NCT01445301|1062455|P1|Overall Study|Protocol Violation|1
314218|NCT01445301|1062453|P3|Overall Study|Lack of Efficacy|0
314219|NCT01445301|1062454|P2|Overall Study|Lack of Efficacy|1
314220|NCT01445301|1062455|P1|Overall Study|Lack of Efficacy|0
314221|NCT01445301|1062453|P3|Overall Study|Adverse Event|4
314222|NCT01445301|1062454|P2|Overall Study|Adverse Event|25
314223|NCT01445301|1062455|P1|Overall Study|Adverse Event|15
314224|NCT01444898|1062525|P1|Overall Study|Withdrawal by Subject|1
314225|NCT01444781|1062540|P3|Overall Study|Withdrawal by Subject|2
314226|NCT01444781|1062541|P2|Overall Study|Withdrawal by Subject|1
314227|NCT01444781|1062542|P1|Overall Study|Withdrawal by Subject|3
314228|NCT01444781|1062540|P3|Overall Study|Lost to Follow-up|1
314229|NCT01444781|1062541|P2|Overall Study|Lost to Follow-up|3
314230|NCT01444781|1062542|P1|Overall Study|Lost to Follow-up|0
314231|NCT01444742|1062580|P1|Overall Study|Death|1
314232|NCT01444651|1062587|P2|Overall Study|Missing data|1
314233|NCT01444651|1062588|P1|Overall Study|Missing data|1
314234|NCT01444651|1062587|P2|Overall Study|Non-fasting|1
314235|NCT01444651|1062588|P1|Overall Study|Non-fasting|2
314236|NCT01444651|1062587|P2|Overall Study|Lost to Follow-up|5
314237|NCT01444651|1062588|P1|Overall Study|Lost to Follow-up|5
314238|NCT01444651|1062587|P2|Overall Study|Adverse Event|2
314239|NCT01444651|1062588|P1|Overall Study|Adverse Event|3
314240|NCT01444456|1062604|P1|Overall Study|Not treated|104
314241|NCT01444456|1062604|P1|Overall Study|Other|18
314242|NCT01444456|1062604|P1|Overall Study|Ineligibility determined|23
314243|NCT01444456|1062604|P1|Overall Study|Death|73
314244|NCT01444456|1062604|P1|Overall Study|Lost to Follow-up|37
314245|NCT01444456|1062604|P1|Overall Study|Physician Decision|9
314246|NCT01444456|1062604|P1|Overall Study|Withdrawal by Subject|21
314247|NCT01444430|1062615|P2|Overall Study|CRF termination module not completed.|1
314248|NCT01444430|1062616|P1|Overall Study|CRF termination module not completed.|0
314249|NCT01444430|1062615|P2|Overall Study|Lost to Follow-up|0
314250|NCT01444430|1062616|P1|Overall Study|Lost to Follow-up|2
314251|NCT01444430|1062615|P2|Overall Study|Death|8
314252|NCT01444430|1062616|P1|Overall Study|Death|6
314253|NCT01444430|1062615|P2|Overall Study|Withdrawal by Subject|72
314254|NCT01444430|1062616|P1|Overall Study|Withdrawal by Subject|53
314255|NCT01444417|1062638|P2|Overall Study|Withdrawal by Subject|0
314256|NCT01444417|1062639|P1|Overall Study|Withdrawal by Subject|2
314257|NCT01444417|1062638|P2|Overall Study|Ineligibility Determined|1
314258|NCT01444417|1062639|P1|Overall Study|Ineligibility Determined|0
314259|NCT01444391|1062655|P1|Overall Study|Death|1
314260|NCT01444378|1062663|P1|Overall Study|Missed Visits|10
314261|NCT01444378|1062663|P1|Overall Study|Administrative Closure Of The Study|2
314262|NCT01444378|1062663|P1|Overall Study|Death|3
314263|NCT01444378|1062663|P1|Overall Study|Withdrawal by Subject|1
314264|NCT01444378|1062663|P1|Overall Study|Lost to Follow-up|1
314265|NCT01444300|1062775|P2|Overall Study|Adverse Event|0
314266|NCT01444300|1062776|P1|Overall Study|Adverse Event|4
314267|NCT01444092|1062808|P1|Overall Study|Other Eligibility criteria|7
314268|NCT01444092|1062808|P1|Overall Study|Withdrawal by Subject|1
314269|NCT01444092|1062808|P1|Overall Study|Protocol Violation|1
314270|NCT01444092|1062808|P1|Overall Study|Adverse Event|8
314271|NCT01444027|1062817|P3|Overall Study|Lost to Follow-up|14
314272|NCT01444027|1062818|P2|Overall Study|Lost to Follow-up|20
314273|NCT01444027|1062819|P1|Overall Study|Lost to Follow-up|26
314274|NCT01444027|1062817|P3|Overall Study|Withdrawal by Subject|24
314275|NCT01444027|1062818|P2|Overall Study|Withdrawal by Subject|10
314276|NCT01444027|1062819|P1|Overall Study|Withdrawal by Subject|4
314277|NCT01443923|1062841|P2|Overall Study|Adverse Event|0
314278|NCT01443923|1062842|P1|Overall Study|Adverse Event|1
314279|NCT01443858|1062859|P3|Overall Study|Lost to Follow-up|2
314280|NCT01443858|1062860|P2|Overall Study|Lost to Follow-up|5
314281|NCT01443858|1062861|P1|Overall Study|Lost to Follow-up|5
314282|NCT01443858|1062859|P3|Overall Study|Lack of Efficacy|0
314283|NCT01443858|1062860|P2|Overall Study|Lack of Efficacy|0
314284|NCT01443858|1062861|P1|Overall Study|Lack of Efficacy|1
314285|NCT01443858|1062859|P3|Overall Study|Withdrawal by Subject|5
314286|NCT01443858|1062860|P2|Overall Study|Withdrawal by Subject|8
314287|NCT01443858|1062861|P1|Overall Study|Withdrawal by Subject|9
314288|NCT01443845|1062883|P2|Overall Study|Lost to Follow-up|13
314289|NCT01443845|1062884|P1|Overall Study|Lost to Follow-up|9
314290|NCT01443845|1062883|P2|Overall Study|Military Conflict - Site Terminated|21
314291|NCT01443845|1062884|P1|Overall Study|Military Conflict - Site Terminated|20
314292|NCT01443845|1062883|P2|Overall Study|Withdrawal by Subject|67
314293|NCT01443845|1062884|P1|Overall Study|Withdrawal by Subject|63
314294|NCT01443845|1062883|P2|Overall Study|Adverse Event|138
314295|NCT01443845|1062884|P1|Overall Study|Adverse Event|64
314296|NCT01443845|1062883|P2|Overall Study|Lack of Efficacy|5
314297|NCT01443845|1062884|P1|Overall Study|Lack of Efficacy|10
314298|NCT01443845|1062883|P2|Overall Study|Deterioration in pulmonary function|4
314299|NCT01443845|1062884|P1|Overall Study|Deterioration in pulmonary function|1
314300|NCT01443845|1062883|P2|Overall Study|Other reasons, such as COPD exacerbation|44
314301|NCT01443845|1062884|P1|Overall Study|Other reasons, such as COPD exacerbation|44
314302|NCT01443845|1062883|P2|Overall Study|Protocol Violation|45
314303|NCT01443845|1062884|P1|Overall Study|Protocol Violation|43
314304|NCT01443403|1062905|P4|Overall Study|Other - Miscellaneous|1
314305|NCT01443403|1062906|P3|Overall Study|Other - Miscellaneous|0
314306|NCT01443403|1062907|P2|Overall Study|Other - Miscellaneous|0
314307|NCT01443403|1062908|P1|Overall Study|Other - Miscellaneous|1
314308|NCT01443403|1062905|P4|Overall Study|Use of Prohibited Treatment|0
314309|NCT01443403|1062906|P3|Overall Study|Use of Prohibited Treatment|0
314310|NCT01443403|1062907|P2|Overall Study|Use of Prohibited Treatment|3
314311|NCT01443403|1062908|P1|Overall Study|Use of Prohibited Treatment|2
314312|NCT01443403|1062905|P4|Overall Study|Protocol Violation|1
314313|NCT01443403|1062906|P3|Overall Study|Protocol Violation|1
314314|NCT01443403|1062907|P2|Overall Study|Protocol Violation|1
314315|NCT01443403|1062908|P1|Overall Study|Protocol Violation|2
314316|NCT01443403|1062905|P4|Overall Study|Lost to Follow-up|1
314317|NCT01443403|1062906|P3|Overall Study|Lost to Follow-up|0
314318|NCT01443403|1062907|P2|Overall Study|Lost to Follow-up|0
314319|NCT01443403|1062908|P1|Overall Study|Lost to Follow-up|0
314320|NCT01443403|1062905|P4|Overall Study|Withdrawal by Subject|1
314321|NCT01443403|1062906|P3|Overall Study|Withdrawal by Subject|2
314322|NCT01443403|1062907|P2|Overall Study|Withdrawal by Subject|1
314323|NCT01443403|1062908|P1|Overall Study|Withdrawal by Subject|0
314324|NCT01443403|1062905|P4|Overall Study|Adverse Event|5
314325|NCT01443403|1062906|P3|Overall Study|Adverse Event|4
314326|NCT01443403|1062907|P2|Overall Study|Adverse Event|1
314327|NCT01443403|1062908|P1|Overall Study|Adverse Event|1
314328|NCT01443364|1063055|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
314329|NCT01443364|1063055|P1|Overall Study|AE, non-serious non-fatal|8
314330|NCT01443364|1063055|P1|Overall Study|SAE, non-fatal|6
314331|NCT01443364|1063055|P1|Overall Study|Other Reason|4
314332|NCT01443364|1063055|P1|Overall Study|Withdrawal by Subject|5
314333|NCT01443364|1063055|P1|Overall Study|Lost to Follow-up|3
314334|NCT01443364|1063055|P1|Overall Study|Lack of Efficacy|14
314335|NCT01443130|1063184|P6|Overall Study|Death of Subject's Infant|0
314336|NCT01443130|1063185|P5|Overall Study|Death of Subject's Infant|0
314337|NCT01443130|1063186|P4|Overall Study|Death of Subject's Infant|0
314338|NCT01443130|1063187|P3|Overall Study|Death of Subject's Infant|11
314339|NCT01443130|1063188|P2|Overall Study|Death of Subject's Infant|10
314340|NCT01443130|1063189|P1|Overall Study|Death of Subject's Infant|5
314341|NCT01443130|1063184|P6|Overall Study|Withdrawal by Subject|2
314342|NCT01443130|1063185|P5|Overall Study|Withdrawal by Subject|7
314343|NCT01443130|1063186|P4|Overall Study|Withdrawal by Subject|7
314344|NCT01443130|1063187|P3|Overall Study|Withdrawal by Subject|12
314345|NCT01443130|1063188|P2|Overall Study|Withdrawal by Subject|14
314346|NCT01443130|1063189|P1|Overall Study|Withdrawal by Subject|15
314347|NCT01443130|1063184|P6|Overall Study|Protocol Violation|3
314348|NCT01443130|1063185|P5|Overall Study|Protocol Violation|2
314349|NCT01443130|1063186|P4|Overall Study|Protocol Violation|2
314350|NCT01443130|1063187|P3|Overall Study|Protocol Violation|3
314351|NCT01443130|1063188|P2|Overall Study|Protocol Violation|1
314352|NCT01443130|1063189|P1|Overall Study|Protocol Violation|2
314353|NCT01443130|1063184|P6|Overall Study|Adverse Event|0
314354|NCT01443130|1063185|P5|Overall Study|Adverse Event|0
314355|NCT01443130|1063186|P4|Overall Study|Adverse Event|0
314356|NCT01443130|1063187|P3|Overall Study|Adverse Event|1
314357|NCT01443130|1063188|P2|Overall Study|Adverse Event|1
314358|NCT01443130|1063189|P1|Overall Study|Adverse Event|2
314359|NCT01443130|1063184|P6|Overall Study|Death|8
314360|NCT01443130|1063185|P5|Overall Study|Death|10
314361|NCT01443130|1063186|P4|Overall Study|Death|7
314362|NCT01443130|1063187|P3|Overall Study|Death|0
314363|NCT01443130|1063188|P2|Overall Study|Death|1
314364|NCT01443130|1063189|P1|Overall Study|Death|0
314365|NCT01443130|1063184|P6|Overall Study|Lost to Follow-up|21
314366|NCT01443130|1063185|P5|Overall Study|Lost to Follow-up|25
314367|NCT01443130|1063186|P4|Overall Study|Lost to Follow-up|23
314368|NCT01443130|1063187|P3|Overall Study|Lost to Follow-up|50
314369|NCT01443130|1063188|P2|Overall Study|Lost to Follow-up|42
314370|NCT01443130|1063189|P1|Overall Study|Lost to Follow-up|44
314371|NCT01443078|1063239|P1|Overall Study|Patient had brain mets|1
314372|NCT01443078|1063239|P1|Overall Study|Withdrawal by Subject|1
314373|NCT01443078|1063239|P1|Overall Study|Responded to neoadjuvant platinum txt|27
314374|NCT01443026|1063245|P2|Overall Study|Lost to Follow-up|1
314375|NCT01443026|1063246|P1|Overall Study|Lost to Follow-up|2
314376|NCT01443026|1063245|P2|Overall Study|Withdrawal by Subject|3
314377|NCT01443026|1063246|P1|Overall Study|Withdrawal by Subject|0
314378|NCT01443026|1063245|P2|Overall Study|Death|1
314379|NCT01443026|1063246|P1|Overall Study|Death|0
314380|NCT01443026|1063245|P2|Overall Study|Physician Decision|0
314381|NCT01443026|1063246|P1|Overall Study|Physician Decision|1
314382|NCT01442779|1063261|P1|Overall Study|Non-compliance|1
314383|NCT01442779|1063261|P1|Overall Study|Death|3
314384|NCT01442779|1063261|P1|Overall Study|Withdrawal by Subject|3
314385|NCT01442714|1063267|P1|Overall Study|Withdrawal by Subject|1
314386|NCT01442714|1063267|P1|Overall Study|Death|11
314387|NCT01442688|1063275|P2|Second Intervention|Adverse Event|0
314388|NCT01442688|1063276|P1|Second Intervention|Adverse Event|1
314389|NCT01442688|1063275|P2|First Intervention|subject incarcerated|0
314390|NCT01442688|1063276|P1|First Intervention|subject incarcerated|1
314391|NCT01442688|1063275|P2|First Intervention|Withdrawal by Subject|0
314392|NCT01442688|1063276|P1|First Intervention|Withdrawal by Subject|1
314393|NCT01442675|1063284|P1|Overall Study|Withdrawal by Subject|4
314394|NCT01442675|1063284|P1|Overall Study|Lost to Follow-up|2
314395|NCT01442675|1063284|P1|Overall Study|Protocol Violation|6
314396|NCT01442493|1063296|P2|Overall Study|withdrawn from study|2
314397|NCT01442493|1063297|P1|Overall Study|withdrawn from study|3
314398|NCT01442376|1063318|P3|Overall Study|Not eligible for subsequent cycles|0
314399|NCT01442376|1063319|P2|Overall Study|Not eligible for subsequent cycles|2
314400|NCT01442376|1063320|P1|Overall Study|Not eligible for subsequent cycles|1
314401|NCT01442376|1063318|P3|Overall Study|Patients not treated|1
314402|NCT01442376|1063319|P2|Overall Study|Patients not treated|3
314403|NCT01442376|1063320|P1|Overall Study|Patients not treated|2
314404|NCT01442376|1063318|P3|Overall Study|Withdrawal of consent|1
314405|NCT01442376|1063319|P2|Overall Study|Withdrawal of consent|0
314406|NCT01442376|1063320|P1|Overall Study|Withdrawal of consent|0
314407|NCT01442376|1063318|P3|Overall Study|Death|1
314408|NCT01442376|1063319|P2|Overall Study|Death|1
314409|NCT01442376|1063320|P1|Overall Study|Death|0
314410|NCT01442376|1063318|P3|Overall Study|Adverse Event|2
314411|NCT01442376|1063319|P2|Overall Study|Adverse Event|3
314412|NCT01442376|1063320|P1|Overall Study|Adverse Event|0
314413|NCT01442181|1063333|P2|Overall Study|atrial fibrillation not noted|1
314414|NCT01442181|1063334|P1|Overall Study|atrial fibrillation not noted|0
314415|NCT01442181|1063333|P2|Overall Study|patient in an additional study|0
314416|NCT01442181|1063334|P1|Overall Study|patient in an additional study|1
314417|NCT01442181|1063333|P2|Overall Study|Lost to Follow-up|1
314418|NCT01442181|1063334|P1|Overall Study|Lost to Follow-up|1
314419|NCT01442181|1063333|P2|Overall Study|low ejection factor|1
314420|NCT01442181|1063334|P1|Overall Study|low ejection factor|0
314421|NCT01442181|1063333|P2|Overall Study|no insurance for surgery|0
314422|NCT01442181|1063334|P1|Overall Study|no insurance for surgery|1
314423|NCT01442181|1063333|P2|Overall Study|patient refused surgery|0
314424|NCT01442181|1063334|P1|Overall Study|patient refused surgery|1
314425|NCT01442155|1063358|P1|Overall Study|Lost to Follow-up|2
314426|NCT01442155|1063358|P1|Overall Study|Adverse Event|2
314427|NCT01442155|1063358|P1|Overall Study|Recurrence|26
314428|NCT01442155|1063358|P1|Overall Study|Complete remission|35
314429|NCT01442103|1063374|P1|Overall Study|Lost to Follow-up|2
314430|NCT01442064|1063384|P6|Overall Study|Condition mandated other intervention|2
314431|NCT01442064|1063385|P5|Overall Study|Condition mandated other intervention|0
314432|NCT01442064|1063386|P4|Overall Study|Condition mandated other intervention|0
314433|NCT01442064|1063387|P3|Overall Study|Condition mandated other intervention|2
314434|NCT01442064|1063388|P2|Overall Study|Condition mandated other intervention|1
314435|NCT01442064|1063389|P1|Overall Study|Condition mandated other intervention|1
314436|NCT01442064|1063384|P6|Overall Study|Subject non-compliance|2
314437|NCT01442064|1063385|P5|Overall Study|Subject non-compliance|0
314438|NCT01442064|1063386|P4|Overall Study|Subject non-compliance|0
314439|NCT01442064|1063387|P3|Overall Study|Subject non-compliance|0
314440|NCT01442064|1063388|P2|Overall Study|Subject non-compliance|0
314441|NCT01442064|1063389|P1|Overall Study|Subject non-compliance|0
314442|NCT01442064|1063384|P6|Overall Study|Sponsor decision|87
314443|NCT01442064|1063385|P5|Overall Study|Sponsor decision|95
314444|NCT01442064|1063386|P4|Overall Study|Sponsor decision|88
314445|NCT01442064|1063387|P3|Overall Study|Sponsor decision|92
314446|NCT01442064|1063388|P2|Overall Study|Sponsor decision|88
314447|NCT01442064|1063389|P1|Overall Study|Sponsor decision|82
314448|NCT01442064|1063384|P6|Overall Study|Withdrawal by Subject|1
314449|NCT01442064|1063385|P5|Overall Study|Withdrawal by Subject|2
314450|NCT01442064|1063386|P4|Overall Study|Withdrawal by Subject|2
314451|NCT01442064|1063387|P3|Overall Study|Withdrawal by Subject|2
314452|NCT01442064|1063388|P2|Overall Study|Withdrawal by Subject|3
314453|NCT01442064|1063389|P1|Overall Study|Withdrawal by Subject|6
314454|NCT01442064|1063384|P6|Overall Study|Physician Decision|1
314455|NCT01442064|1063385|P5|Overall Study|Physician Decision|3
314456|NCT01442064|1063386|P4|Overall Study|Physician Decision|3
314457|NCT01442064|1063387|P3|Overall Study|Physician Decision|2
314458|NCT01442064|1063388|P2|Overall Study|Physician Decision|1
314459|NCT01442064|1063389|P1|Overall Study|Physician Decision|1
314460|NCT01442064|1063384|P6|Overall Study|Lost to Follow-up|3
314461|NCT01442064|1063385|P5|Overall Study|Lost to Follow-up|3
314462|NCT01442064|1063386|P4|Overall Study|Lost to Follow-up|1
314463|NCT01442064|1063387|P3|Overall Study|Lost to Follow-up|1
314464|NCT01442064|1063388|P2|Overall Study|Lost to Follow-up|5
314465|NCT01442064|1063389|P1|Overall Study|Lost to Follow-up|5
314466|NCT01442064|1063384|P6|Overall Study|Death|3
314467|NCT01442064|1063385|P5|Overall Study|Death|1
314468|NCT01442064|1063386|P4|Overall Study|Death|3
314469|NCT01442064|1063387|P3|Overall Study|Death|3
314470|NCT01442064|1063388|P2|Overall Study|Death|1
314471|NCT01442064|1063389|P1|Overall Study|Death|0
314472|NCT01442064|1063384|P6|Overall Study|Adverse Event|0
314473|NCT01442064|1063385|P5|Overall Study|Adverse Event|2
314474|NCT01442064|1063386|P4|Overall Study|Adverse Event|1
314475|NCT01442064|1063387|P3|Overall Study|Adverse Event|2
314476|NCT01442064|1063388|P2|Overall Study|Adverse Event|2
314477|NCT01442064|1063389|P1|Overall Study|Adverse Event|2
314478|NCT01442038|1063426|P2|Overall Study|Study Terminated By Sponsor|3
314479|NCT01442038|1063427|P1|Overall Study|Study Terminated By Sponsor|2
314480|NCT01442038|1063426|P2|Overall Study|Investigator's Discretion|16
314481|NCT01442038|1063427|P1|Overall Study|Investigator's Discretion|13
314482|NCT01442038|1063426|P2|Overall Study|Protocol Deviation|20
314483|NCT01442038|1063427|P1|Overall Study|Protocol Deviation|9
314484|NCT01442038|1063426|P2|Overall Study|Adverse Event|15
314485|NCT01442038|1063427|P1|Overall Study|Adverse Event|26
314486|NCT01442038|1063426|P2|Overall Study|Lost to Follow-up|51
314487|NCT01442038|1063427|P1|Overall Study|Lost to Follow-up|37
314488|NCT01442038|1063426|P2|Overall Study|Participant Withdrew Consent|102
314489|NCT01442038|1063427|P1|Overall Study|Participant Withdrew Consent|137
314490|NCT01442038|1063426|P2|Overall Study|Investigator-Initiated Early Closure|43
314491|NCT01442038|1063427|P1|Overall Study|Investigator-Initiated Early Closure|44
314492|NCT01442038|1063426|P2|Overall Study|Death|29
314493|NCT01442038|1063427|P1|Overall Study|Death|35
314494|NCT01441973|1063441|P2|Overall Study|Participant withdrew consent|1
314495|NCT01441973|1063442|P1|Overall Study|Participant withdrew consent|0
314496|NCT01441973|1063441|P2|Overall Study|Administrative reason by sponsor|5
314497|NCT01441973|1063442|P1|Overall Study|Administrative reason by sponsor|3
314498|NCT01441973|1063441|P2|Overall Study|Poor compliance/noncompliance|1
314499|NCT01441973|1063442|P1|Overall Study|Poor compliance/noncompliance|0
314500|NCT01441973|1063441|P2|Overall Study|Participant request to discontinue|1
314501|NCT01441973|1063442|P1|Overall Study|Participant request to discontinue|1
314502|NCT01441973|1063441|P2|Overall Study|Adverse event unrelated to study drug|2
314503|NCT01441973|1063442|P1|Overall Study|Adverse event unrelated to study drug|3
314504|NCT01441973|1063441|P2|Overall Study|Disease progression|6
314505|NCT01441973|1063442|P1|Overall Study|Disease progression|8
314506|NCT01441960|1063464|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
314507|NCT01441960|1063465|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
314508|NCT01441960|1063464|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
314509|NCT01441960|1063465|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
314510|NCT01441960|1063464|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
314511|NCT01441960|1063465|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
314512|NCT01441765|1063490|P2|Overall Study|Death|0
314513|NCT01441765|1063491|P1|Overall Study|Death|1
314514|NCT01441596|1063508|P3|Overall Study|Not treated|1
314515|NCT01441596|1063509|P2|Overall Study|Not treated|1
314516|NCT01441596|1063510|P1|Overall Study|Not treated|0
314517|NCT01441596|1063508|P3|Overall Study|Withdrawal by Subject|2
314518|NCT01441596|1063509|P2|Overall Study|Withdrawal by Subject|0
314519|NCT01441596|1063510|P1|Overall Study|Withdrawal by Subject|4
314520|NCT01441596|1063508|P3|Overall Study|Other reason not defined below|1
314521|NCT01441596|1063509|P2|Overall Study|Other reason not defined below|2
314522|NCT01441596|1063510|P1|Overall Study|Other reason not defined below|0
314523|NCT01441440|1063557|P3|Overall Study|Difficllty in keeping the schedule|0
314524|NCT01441440|1063558|P2|Overall Study|Difficllty in keeping the schedule|1
314525|NCT01441440|1063559|P1|Overall Study|Difficllty in keeping the schedule|1
314526|NCT01441440|1063557|P3|Overall Study|Work-related matter|0
314527|NCT01441440|1063558|P2|Overall Study|Work-related matter|1
314528|NCT01441440|1063559|P1|Overall Study|Work-related matter|0
314529|NCT01441440|1063557|P3|Overall Study|Moving|1
314530|NCT01441440|1063558|P2|Overall Study|Moving|1
314531|NCT01441440|1063559|P1|Overall Study|Moving|0
314532|NCT01441440|1063557|P3|Overall Study|Lack of Efficacy|1
314533|NCT01441440|1063558|P2|Overall Study|Lack of Efficacy|0
314534|NCT01441440|1063559|P1|Overall Study|Lack of Efficacy|1
314535|NCT01441440|1063557|P3|Overall Study|Pregnancy|0
314536|NCT01441440|1063558|P2|Overall Study|Pregnancy|0
314537|NCT01441440|1063559|P1|Overall Study|Pregnancy|1
314538|NCT01441440|1063557|P3|Overall Study|Withdrawal by Subject|9
314539|NCT01441440|1063558|P2|Overall Study|Withdrawal by Subject|9
314540|NCT01441440|1063559|P1|Overall Study|Withdrawal by Subject|11
314541|NCT01441440|1063557|P3|Overall Study|Lost to Follow-up|1
314542|NCT01441440|1063558|P2|Overall Study|Lost to Follow-up|2
314543|NCT01441440|1063559|P1|Overall Study|Lost to Follow-up|0
314544|NCT01441440|1063557|P3|Overall Study|Adverse Event|9
314545|NCT01441440|1063558|P2|Overall Study|Adverse Event|9
314546|NCT01441440|1063559|P1|Overall Study|Adverse Event|2
314547|NCT01441440|1063557|P3|Overall Study|Death|1
314548|NCT01441440|1063558|P2|Overall Study|Death|0
314549|NCT01441440|1063559|P1|Overall Study|Death|1
314550|NCT01441414|1063582|P1|Overall Study|Subject refused further follow-up|1
314551|NCT01441414|1063582|P1|Overall Study|Study terminated by sponsor|2
314552|NCT01441414|1063582|P1|Overall Study|Other reasons|3
314553|NCT01441414|1063582|P1|Overall Study|Participant died|9
314554|NCT01441180|1063661|P3|Overall Study|Discontinued|2
314555|NCT01441180|1063662|P2|Overall Study|Discontinued|0
314556|NCT01441180|1063663|P1|Overall Study|Discontinued|0
314557|NCT01441180|1063661|P3|Overall Study|Lost to Follow-up|1
314558|NCT01441180|1063662|P2|Overall Study|Lost to Follow-up|1
314559|NCT01441180|1063663|P1|Overall Study|Lost to Follow-up|1
314560|NCT01441102|1063674|P1|Overall Study|Withdrawal by Subject|2
314561|NCT01441102|1063674|P1|Overall Study|Adverse Event|1
314562|NCT01440972|1063714|P2|Overall Study|Withdrawal by Subject|2
314563|NCT01440972|1063715|P1|Overall Study|Withdrawal by Subject|3
314564|NCT01440946|1063739|P2|Overall Study|Physician Decision|0
314565|NCT01440946|1063740|P1|Overall Study|Physician Decision|1
314566|NCT01440946|1063739|P2|Overall Study|Lost to Follow-up|1
314567|NCT01440946|1063740|P1|Overall Study|Lost to Follow-up|1
314568|NCT01440881|1063779|P2|Overall Study|Death|1
314569|NCT01440881|1063780|P1|Overall Study|Death|0
314570|NCT01440816|1063794|P2|Overall Study|To Be Seen By Local Oncologist|2
314571|NCT01440816|1063795|P1|Overall Study|To Be Seen By Local Oncologist|1
314572|NCT01440816|1063794|P2|Overall Study|Disease Progression|9
314573|NCT01440816|1063795|P1|Overall Study|Disease Progression|0
314574|NCT01440647|1063838|P2|Overall Study|Death|3
314575|NCT01440647|1063839|P1|Overall Study|Death|2
314576|NCT01440595|1063858|P3|Overall Study|Study terminated by sponsor.|1
314577|NCT01440595|1063859|P2|Overall Study|Study terminated by sponsor.|2
314578|NCT01440595|1063860|P1|Overall Study|Study terminated by sponsor.|1
314579|NCT01440595|1063858|P3|Overall Study|Lost to Follow-up|0
314580|NCT01440595|1063859|P2|Overall Study|Lost to Follow-up|1
314581|NCT01440595|1063860|P1|Overall Study|Lost to Follow-up|0
314582|NCT01440569|1063880|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
314583|NCT01440569|1063881|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
314584|NCT01440569|1063880|P2|Open-Label Rollover Phase|Lost to Follow-up|3
314585|NCT01440569|1063881|P1|Open-Label Rollover Phase|Lost to Follow-up|26
314586|NCT01440569|1063880|P2|Open-Label Rollover Phase|Withdrew Consent|1
314587|NCT01440569|1063881|P1|Open-Label Rollover Phase|Withdrew Consent|11
314588|NCT01440569|1063880|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
314589|NCT01440569|1063881|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
314590|NCT01440569|1063880|P2|Open-Label Rollover Phase|Lack of Efficacy|0
314591|NCT01440569|1063881|P1|Open-Label Rollover Phase|Lack of Efficacy|2
314592|NCT01440569|1063880|P2|Open-Label Rollover Phase|Pregnancy|0
314593|NCT01440569|1063881|P1|Open-Label Rollover Phase|Pregnancy|1
314594|NCT01440569|1063880|P2|Open-Label Rollover Phase|Adverse Event|0
314595|NCT01440569|1063881|P1|Open-Label Rollover Phase|Adverse Event|3
314596|NCT01440569|1063880|P2|Main Study|Protocol Violation|0
314597|NCT01440569|1063881|P1|Main Study|Protocol Violation|1
314598|NCT01440569|1063880|P2|Main Study|Subject Non-Compliance|0
314599|NCT01440569|1063881|P1|Main Study|Subject Non-Compliance|3
314600|NCT01440569|1063880|P2|Main Study|Lost to Follow-up|2
314601|NCT01440569|1063881|P1|Main Study|Lost to Follow-up|13
314602|NCT01440569|1063880|P2|Main Study|Withdrew Consent|1
314603|NCT01440569|1063881|P1|Main Study|Withdrew Consent|7
314604|NCT01440569|1063880|P2|Main Study|Investigator's Discretion|1
314605|NCT01440569|1063881|P1|Main Study|Investigator's Discretion|1
314606|NCT01440569|1063880|P2|Main Study|Pregnancy|0
314607|NCT01440569|1063881|P1|Main Study|Pregnancy|1
314608|NCT01440569|1063880|P2|Main Study|Adverse Event|0
314609|NCT01440569|1063881|P1|Main Study|Adverse Event|9
314610|NCT01440569|1063880|P2|Main Study|Enrolled but not treated|0
314611|NCT01440569|1063881|P1|Main Study|Enrolled but not treated|1
314612|NCT01440517|1063916|P1|Overall Study|Subject withdrawn prior to dosing|1
314613|NCT01440374|1063947|P4|Part 3: Extension|Physician Decision|14
314614|NCT01440374|1063948|P3|Part 3: Extension|Physician Decision|0
314615|NCT01440374|1063949|P2|Part 3: Extension|Physician Decision|0
314616|NCT01440374|1063950|P1|Part 3: Extension|Physician Decision|0
314617|NCT01440374|1063947|P4|Part 3: Extension|Adverse Event|13
314618|NCT01440374|1063948|P3|Part 3: Extension|Adverse Event|0
314619|NCT01440374|1063949|P2|Part 3: Extension|Adverse Event|0
314620|NCT01440374|1063950|P1|Part 3: Extension|Adverse Event|0
314621|NCT01440374|1063947|P4|Part 3: Extension|Withdrawal by Subject|5
314622|NCT01440374|1063948|P3|Part 3: Extension|Withdrawal by Subject|0
314623|NCT01440374|1063949|P2|Part 3: Extension|Withdrawal by Subject|0
314624|NCT01440374|1063950|P1|Part 3: Extension|Withdrawal by Subject|0
314625|NCT01440374|1063947|P4|Part 2; Double-blind Phase|Not treated|0
314626|NCT01440374|1063948|P3|Part 2; Double-blind Phase|Not treated|1
314627|NCT01440374|1063949|P2|Part 2; Double-blind Phase|Not treated|0
314628|NCT01440374|1063950|P1|Part 2; Double-blind Phase|Not treated|0
314629|NCT01440374|1063947|P4|Part 2; Double-blind Phase|Adverse Event|0
314630|NCT01440374|1063948|P3|Part 2; Double-blind Phase|Adverse Event|31
314631|NCT01440374|1063949|P2|Part 2; Double-blind Phase|Adverse Event|7
314632|NCT01440374|1063950|P1|Part 2; Double-blind Phase|Adverse Event|0
314633|NCT01440374|1063947|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
314634|NCT01440374|1063948|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
314635|NCT01440374|1063949|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
314636|NCT01440374|1063950|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
314637|NCT01440374|1063947|P4|Part 2; Double-blind Phase|Protocol Violation|0
314638|NCT01440374|1063948|P3|Part 2; Double-blind Phase|Protocol Violation|1
314639|NCT01440374|1063949|P2|Part 2; Double-blind Phase|Protocol Violation|0
314640|NCT01440374|1063950|P1|Part 2; Double-blind Phase|Protocol Violation|0
314641|NCT01440374|1063947|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
314642|NCT01440374|1063948|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
314643|NCT01440374|1063949|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
314644|NCT01440374|1063950|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
314645|NCT01440374|1063947|P4|Part 2; Double-blind Phase|Physician Decision|0
314646|NCT01440374|1063948|P3|Part 2; Double-blind Phase|Physician Decision|17
314647|NCT01440374|1063949|P2|Part 2; Double-blind Phase|Physician Decision|8
314648|NCT01440374|1063950|P1|Part 2; Double-blind Phase|Physician Decision|0
314649|NCT01440374|1063947|P4|Part 1: Open-label Phase|Physician Decision|0
314650|NCT01440374|1063948|P3|Part 1: Open-label Phase|Physician Decision|0
314651|NCT01440374|1063949|P2|Part 1: Open-label Phase|Physician Decision|0
314652|NCT01440374|1063950|P1|Part 1: Open-label Phase|Physician Decision|1
314653|NCT01440374|1063947|P4|Part 1: Open-label Phase|Adverse Event|0
314654|NCT01440374|1063948|P3|Part 1: Open-label Phase|Adverse Event|0
314655|NCT01440374|1063949|P2|Part 1: Open-label Phase|Adverse Event|0
314656|NCT01440374|1063950|P1|Part 1: Open-label Phase|Adverse Event|5
314657|NCT01440322|1063985|P2|Overall Study|Other Non-Product Related|0
314658|NCT01440322|1063986|P1|Overall Study|Other Non-Product Related|1
314659|NCT01440322|1063985|P2|Overall Study|Unrelated Medical Problem|1
314660|NCT01440322|1063986|P1|Overall Study|Unrelated Medical Problem|0
314661|NCT01440322|1063985|P2|Overall Study|Other Product Related|0
314662|NCT01440322|1063986|P1|Overall Study|Other Product Related|1
314663|NCT01440322|1063985|P2|Overall Study|Unacceptable Subjective Vision|0
314664|NCT01440322|1063986|P1|Overall Study|Unacceptable Subjective Vision|1
314665|NCT01440322|1063985|P2|Overall Study|Symptoms and Problems|0
314666|NCT01440322|1063986|P1|Overall Study|Symptoms and Problems|1
314667|NCT01440322|1063985|P2|Overall Study|Biomicroscopy|0
314668|NCT01440322|1063986|P1|Overall Study|Biomicroscopy|1
314669|NCT01440322|1063985|P2|Overall Study|Discomfort|0
314670|NCT01440322|1063986|P1|Overall Study|Discomfort|2
314671|NCT01440283|1064008|P1|Overall Study|Physician Decision|3
314672|NCT01440283|1064008|P1|Overall Study|Withdrawal by Subject|4
314673|NCT01440283|1064008|P1|Overall Study|Death|3
314674|NCT01440101|1064023|P3|Overall Study|Not Specified|0
314675|NCT01440101|1064024|P2|Overall Study|Not Specified|1
314676|NCT01440101|1064025|P1|Overall Study|Not Specified|0
314677|NCT01440101|1064023|P3|Overall Study|Withdrawal by Subject|1
314678|NCT01440101|1064024|P2|Overall Study|Withdrawal by Subject|3
314679|NCT01440101|1064025|P1|Overall Study|Withdrawal by Subject|0
314680|NCT01440101|1064023|P3|Overall Study|Adverse Event|0
314681|NCT01440101|1064024|P2|Overall Study|Adverse Event|0
314682|NCT01440101|1064025|P1|Overall Study|Adverse Event|2
314683|NCT01440049|1064058|P1|Overall Study|Adverse Event|5
314684|NCT01439971|1064090|P5|Overall Study|Required number in cohort dosed|1
314685|NCT01439971|1064091|P4|Overall Study|Required number in cohort dosed|0
314686|NCT01439971|1064092|P3|Overall Study|Required number in cohort dosed|2
314687|NCT01439971|1064093|P2|Overall Study|Required number in cohort dosed|1
314688|NCT01439971|1064094|P1|Overall Study|Required number in cohort dosed|0
314689|NCT01439945|1064274|P4|Double-Blind Treatment Phase|Ineligible|1
314690|NCT01439945|1064275|P3|Double-Blind Treatment Phase|Ineligible|0
314691|NCT01439945|1064276|P2|Double-Blind Treatment Phase|Ineligible|2
314692|NCT01439945|1064277|P1|Double-Blind Treatment Phase|Ineligible|1
314693|NCT01439945|1064274|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
314694|NCT01439945|1064275|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
314695|NCT01439945|1064276|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
314696|NCT01439945|1064277|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
314697|NCT01439867|1064302|P2|Overall Study|Protocol-specified Criteria|0
314698|NCT01439867|1064303|P1|Overall Study|Protocol-specified Criteria|1
314699|NCT01439867|1064302|P2|Overall Study|Administrative Decision|5
314700|NCT01439867|1064303|P1|Overall Study|Administrative Decision|4
314701|NCT01439867|1064302|P2|Overall Study|Withdrawal by Subject|2
314702|NCT01439867|1064303|P1|Overall Study|Withdrawal by Subject|1
314703|NCT01439867|1064302|P2|Overall Study|Non-compliance|1
314704|NCT01439867|1064303|P1|Overall Study|Non-compliance|0
314705|NCT01439724|1064344|P2|Overall Study|missing consultation|8
314706|NCT01439724|1064345|P1|Overall Study|missing consultation|9
314707|NCT01439711|1064351|P1|Overall Study|No MRI|9
314708|NCT01439711|1064351|P1|Overall Study|Noncompliance|3
314709|NCT01439711|1064351|P1|Overall Study|Progression During Active Tx|3
314710|NCT01439711|1064351|P1|Overall Study|Withdrawal by Subject|3
314711|NCT01439711|1064351|P1|Overall Study|Adverse Event|5
314712|NCT01439711|1064351|P1|Overall Study|Progression Prior to Beginning Tx|1
314713|NCT01439711|1064351|P1|Overall Study|Cancel|3
314714|NCT01439711|1064351|P1|Overall Study|Ineligible|13
314715|NCT01439373|1064368|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
314716|NCT01439373|1064369|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
314717|NCT01439373|1064368|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
314718|NCT01439373|1064369|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
314719|NCT01439360|1064412|P2|Overall Study|Withdrawal by Subject|129
314720|NCT01439360|1064413|P1|Overall Study|Withdrawal by Subject|140
314721|NCT01439360|1064412|P2|Overall Study|Protocol Violation|0
314722|NCT01439360|1064413|P1|Overall Study|Protocol Violation|1
314723|NCT01439360|1064412|P2|Overall Study|Others|5
314724|NCT01439360|1064413|P1|Overall Study|Others|10
314725|NCT01439360|1064412|P2|Overall Study|Lost to Follow-up|58
314726|NCT01439360|1064413|P1|Overall Study|Lost to Follow-up|43
314727|NCT01439360|1064412|P2|Overall Study|Adverse Event|16
314728|NCT01439360|1064413|P1|Overall Study|Adverse Event|4
314729|NCT01439282|1064463|P2|Overall Study|Not specified|1
314730|NCT01439282|1064464|P1|Overall Study|Not specified|1
314731|NCT01439282|1064463|P2|Overall Study|Withdrawal by Subject|0
314732|NCT01439282|1064464|P1|Overall Study|Withdrawal by Subject|2
314733|NCT01439282|1064463|P2|Overall Study|Adverse Event|0
314734|NCT01439282|1064464|P1|Overall Study|Adverse Event|5
314735|NCT01439204|1064474|P2|Overall Study|poor/non-compliance|0
314736|NCT01439204|1064475|P1|Overall Study|poor/non-compliance|3
314737|NCT01439204|1064474|P2|Overall Study|No longer meets study criteria|0
314738|NCT01439204|1064475|P1|Overall Study|No longer meets study criteria|1
314739|NCT01439204|1064474|P2|Overall Study|Lost to Follow-up|2
314740|NCT01439204|1064475|P1|Overall Study|Lost to Follow-up|0
314741|NCT01439204|1064474|P2|Overall Study|Withdrawal by Subject|1
314742|NCT01439204|1064475|P1|Overall Study|Withdrawal by Subject|0
314743|NCT01439165|1064509|P2|Overall Study|Withdrawal by Subject|1
314744|NCT01439165|1064510|P1|Overall Study|Withdrawal by Subject|7
314745|NCT01439165|1064509|P2|Overall Study|Lost to Follow-up|1
314746|NCT01439165|1064510|P1|Overall Study|Lost to Follow-up|11
314747|NCT01439165|1064509|P2|Overall Study|Protocol Violation|0
314748|NCT01439165|1064510|P1|Overall Study|Protocol Violation|3
314749|NCT01439126|1064524|P2|Overall Study|Other-Miscellaneous|12
314750|NCT01439126|1064525|P1|Overall Study|Other-Miscellaneous|12
314751|NCT01439126|1064524|P2|Overall Study|Other-Use of prohibited treatment|2
314752|NCT01439126|1064525|P1|Overall Study|Other-Use of prohibited treatment|0
314753|NCT01439126|1064524|P2|Overall Study|Lost to Follow-up|3
314754|NCT01439126|1064525|P1|Overall Study|Lost to Follow-up|6
314755|NCT01439126|1064524|P2|Overall Study|Protocol Violation|4
314756|NCT01439126|1064525|P1|Overall Study|Protocol Violation|6
314757|NCT01439126|1064524|P2|Overall Study|Withdrawal by Subject|21
314758|NCT01439126|1064525|P1|Overall Study|Withdrawal by Subject|5
314759|NCT01439126|1064524|P2|Overall Study|Adverse Event|0
314760|NCT01439126|1064525|P1|Overall Study|Adverse Event|2
314761|NCT01439074|1064547|P2|Overall Study|Other|4
314762|NCT01439074|1064548|P1|Overall Study|Other|4
314763|NCT01439074|1064547|P2|Overall Study|Withdrawal by Subject|5
314764|NCT01439074|1064548|P1|Overall Study|Withdrawal by Subject|1
314765|NCT01439074|1064547|P2|Overall Study|Subject shedding|0
314766|NCT01439074|1064548|P1|Overall Study|Subject shedding|1
314767|NCT01439074|1064547|P2|Overall Study|Lost to Follow-up|4
314768|NCT01439074|1064548|P1|Overall Study|Lost to Follow-up|3
314769|NCT01438996|1064563|P3|Overall Study|Not meeting Inclusion Criteria|0
314770|NCT01438996|1064564|P2|Overall Study|Not meeting Inclusion Criteria|1
314771|NCT01438996|1064565|P1|Overall Study|Not meeting Inclusion Criteria|4
314772|NCT01438840|1064599|P3|Extension Phase|Not specified|1
314773|NCT01438840|1064600|P2|Extension Phase|Not specified|0
314774|NCT01438840|1064601|P1|Extension Phase|Not specified|0
314775|NCT01438840|1064599|P3|Extension Phase|Lack of Efficacy|2
314776|NCT01438840|1064600|P2|Extension Phase|Lack of Efficacy|0
314777|NCT01438840|1064601|P1|Extension Phase|Lack of Efficacy|0
314778|NCT01438840|1064599|P3|Extension Phase|Withdrawal by Subject|3
314779|NCT01438840|1064600|P2|Extension Phase|Withdrawal by Subject|0
314780|NCT01438840|1064601|P1|Extension Phase|Withdrawal by Subject|0
314781|NCT01438840|1064599|P3|Extension Phase|Lost to Follow-up|1
314782|NCT01438840|1064600|P2|Extension Phase|Lost to Follow-up|0
314783|NCT01438840|1064601|P1|Extension Phase|Lost to Follow-up|0
314784|NCT01438840|1064599|P3|Extension Phase|Adverse Event|3
314785|NCT01438840|1064600|P2|Extension Phase|Adverse Event|0
314786|NCT01438840|1064601|P1|Extension Phase|Adverse Event|0
314787|NCT01438840|1064599|P3|Core Study|Withdrawal of consent|0
314788|NCT01438840|1064600|P2|Core Study|Withdrawal of consent|0
314789|NCT01438840|1064601|P1|Core Study|Withdrawal of consent|1
314790|NCT01438840|1064599|P3|Core Study|Lack of Efficacy|0
314791|NCT01438840|1064600|P2|Core Study|Lack of Efficacy|7
314792|NCT01438840|1064601|P1|Core Study|Lack of Efficacy|15
314793|NCT01438840|1064599|P3|Core Study|Adverse Event|0
314794|NCT01438840|1064600|P2|Core Study|Adverse Event|3
314795|NCT01438840|1064601|P1|Core Study|Adverse Event|0
314796|NCT01438814|1064614|P2|Overall Study|Not specified|4
314797|NCT01438814|1064615|P1|Overall Study|Not specified|2
314798|NCT01438814|1064614|P2|Overall Study|Withdrawal by Subject|2
314799|NCT01438814|1064615|P1|Overall Study|Withdrawal by Subject|4
314800|NCT01438814|1064614|P2|Overall Study|Lost to Follow-up|3
314801|NCT01438814|1064615|P1|Overall Study|Lost to Follow-up|4
314802|NCT01438814|1064614|P2|Overall Study|Protocol Violation|2
314803|NCT01438814|1064615|P1|Overall Study|Protocol Violation|1
314804|NCT01438814|1064614|P2|Overall Study|Adverse Event|3
314805|NCT01438814|1064615|P1|Overall Study|Adverse Event|3
314806|NCT01438541|1064651|P1|Overall Study|discharge from the hospital|5
314807|NCT01438541|1064651|P1|Overall Study|Withdrawal by Subject|1
314808|NCT01438541|1064651|P1|Overall Study|Physician Decision|1
314809|NCT01438489|1064660|P3|Overall Study|Inadequate venous access|0
314810|NCT01438489|1064661|P2|Overall Study|Inadequate venous access|2
314811|NCT01438489|1064662|P1|Overall Study|Inadequate venous access|0
314812|NCT01438489|1064660|P3|Overall Study|Did not complete all 3 follow-up visits|2
314813|NCT01438489|1064661|P2|Overall Study|Did not complete all 3 follow-up visits|5
314814|NCT01438489|1064662|P1|Overall Study|Did not complete all 3 follow-up visits|2
314815|NCT01438489|1064660|P3|Overall Study|Received prohibited medication|0
314816|NCT01438489|1064661|P2|Overall Study|Received prohibited medication|0
314817|NCT01438489|1064662|P1|Overall Study|Received prohibited medication|1
314818|NCT01438489|1064660|P3|Overall Study|AE/SAEs|1
314819|NCT01438489|1064661|P2|Overall Study|AE/SAEs|1
314820|NCT01438489|1064662|P1|Overall Study|AE/SAEs|2
314821|NCT01438489|1064660|P3|Overall Study|Investigator decision|0
314822|NCT01438489|1064661|P2|Overall Study|Investigator decision|1
314823|NCT01438489|1064662|P1|Overall Study|Investigator decision|0
314824|NCT01438489|1064660|P3|Overall Study|Subject choice/Subject moved|1
314825|NCT01438489|1064661|P2|Overall Study|Subject choice/Subject moved|1
314826|NCT01438489|1064662|P1|Overall Study|Subject choice/Subject moved|2
314827|NCT01438489|1064660|P3|Overall Study|Sponsor decision|4
314828|NCT01438489|1064661|P2|Overall Study|Sponsor decision|1
314829|NCT01438489|1064662|P1|Overall Study|Sponsor decision|4
314830|NCT01438489|1064660|P3|Overall Study|Death|1
314831|NCT01438489|1064661|P2|Overall Study|Death|0
314832|NCT01438489|1064662|P1|Overall Study|Death|0
314833|NCT01438489|1064660|P3|Overall Study|Withdrawal by Subject|8
314834|NCT01438489|1064661|P2|Overall Study|Withdrawal by Subject|3
314835|NCT01438489|1064662|P1|Overall Study|Withdrawal by Subject|11
314836|NCT01438489|1064660|P3|Overall Study|Lost to Follow-up|2
314837|NCT01438489|1064661|P2|Overall Study|Lost to Follow-up|2
314838|NCT01438489|1064662|P1|Overall Study|Lost to Follow-up|4
314839|NCT01438424|1064705|P1|Overall Study|Participant noncompliance|20
314840|NCT01438424|1064705|P1|Overall Study|No longer met inclusion criteria|1
314841|NCT01438424|1064705|P1|Overall Study|Pregnancy|7
314842|NCT01438424|1064705|P1|Overall Study|Need for drug prohibited by protocol|14
314843|NCT01438424|1064705|P1|Overall Study|Abnormal laboratory test result|14
314844|NCT01438424|1064705|P1|Overall Study|Lost to Follow-up|17
314845|NCT01438424|1064705|P1|Overall Study|Adverse Event|17
314846|NCT01438424|1064705|P1|Overall Study|Death|22
314847|NCT01438424|1064705|P1|Overall Study|Progression of chronic hepatitis B|22
314848|NCT01438424|1064705|P1|Overall Study|Withdrawal by Subject|104
314849|NCT01438424|1064705|P1|Overall Study|Not identified|55
314850|NCT01438424|1064705|P1|Overall Study|Minimal virologic response|95
314851|NCT01438424|1064705|P1|Overall Study|Continuing treatment|29
314852|NCT01438307|1064743|P2|Overall Study|Death|1
314853|NCT01438307|1064744|P1|Overall Study|Death|1
314854|NCT01438294|1064758|P2|Overall Study|Lost to Follow-up|7
314855|NCT01438294|1064759|P1|Overall Study|Lost to Follow-up|3
314856|NCT01438177|1064802|P1|Overall Study|Initiation of new therapy|1
314857|NCT01438177|1064802|P1|Overall Study|Withdrawal by Subject|1
314858|NCT01438151|1064808|P1|Overall Study|study terminated|8
314859|NCT01438060|1064814|P2|On Study Beyond Week 140|Other Reason|3
314860|NCT01438060|1064815|P1|On Study Beyond Week 140|Other Reason|0
314861|NCT01438060|1064814|P2|On Study Beyond Week 140|Death|1
314862|NCT01438060|1064815|P1|On Study Beyond Week 140|Death|0
314863|NCT01438060|1064814|P2|On Study Beyond Week 140|Withdrawal by Subject|1
314864|NCT01438060|1064815|P1|On Study Beyond Week 140|Withdrawal by Subject|0
314865|NCT01438060|1064814|P2|On Study Beyond Week 140|Lack of Efficacy|1
314866|NCT01438060|1064815|P1|On Study Beyond Week 140|Lack of Efficacy|0
314867|NCT01438060|1064814|P2|On Study Beyond Week 140|Adverse Event|2
314868|NCT01438060|1064815|P1|On Study Beyond Week 140|Adverse Event|0
314869|NCT01438060|1064814|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
314870|NCT01438060|1064815|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
314871|NCT01438060|1064814|P2|Extension Phase: Week 10 to Week 130|Death|12
314872|NCT01438060|1064815|P1|Extension Phase: Week 10 to Week 130|Death|22
314873|NCT01438060|1064814|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
314874|NCT01438060|1064815|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
314875|NCT01438060|1064814|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
314876|NCT01438060|1064815|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
314877|NCT01438060|1064814|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
314878|NCT01438060|1064815|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
314879|NCT01438060|1064814|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
314880|NCT01438060|1064815|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
314881|NCT01438060|1064814|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
314882|NCT01438060|1064815|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
314883|NCT01438060|1064814|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
314884|NCT01438060|1064815|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
314885|NCT01438060|1064814|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
314886|NCT01438060|1064815|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
314887|NCT01438060|1064814|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
314888|NCT01438060|1064815|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
314889|NCT01438060|1064814|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
314890|NCT01438060|1064815|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
314891|NCT01438060|1064814|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
314892|NCT01438060|1064815|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
314893|NCT01438060|1064814|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
314894|NCT01438060|1064815|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
314895|NCT01437995|1064896|P3|Overall Study|Lost to Follow-up|20
314896|NCT01437995|1064897|P2|Overall Study|Lost to Follow-up|18
314897|NCT01437995|1064898|P1|Overall Study|Lost to Follow-up|11
314898|NCT01437943|1064920|P2|Overall Study|Adverse Event|0
314899|NCT01437943|1064921|P1|Overall Study|Adverse Event|2
314900|NCT01437943|1064920|P2|Overall Study|Subject expressed pregnancy plans|0
314901|NCT01437943|1064921|P1|Overall Study|Subject expressed pregnancy plans|1
314902|NCT01437943|1064920|P2|Overall Study|Aliskiren trials terminated by Novartis|2
314903|NCT01437943|1064921|P1|Overall Study|Aliskiren trials terminated by Novartis|4
314904|NCT01437878|1064929|P2|Overall Study|Withdrawal by Subject|0
314905|NCT01437878|1064930|P1|Overall Study|Withdrawal by Subject|1
314906|NCT01437540|1064972|P2|Overall Study|Withdrawal by Subject|15
314907|NCT01437540|1064973|P1|Overall Study|Withdrawal by Subject|31
314908|NCT01437540|1064972|P2|Overall Study|Adverse Event|13
314909|NCT01437540|1064973|P1|Overall Study|Adverse Event|26
314910|NCT01437540|1064972|P2|Overall Study|Protocol Violation|12
314911|NCT01437540|1064973|P1|Overall Study|Protocol Violation|24
314912|NCT01437540|1064972|P2|Overall Study|Lack of Efficacy|11
314913|NCT01437540|1064973|P1|Overall Study|Lack of Efficacy|23
314914|NCT01437540|1064972|P2|Overall Study|Lost to Follow-up|5
314915|NCT01437540|1064973|P1|Overall Study|Lost to Follow-up|3
314916|NCT01437540|1064972|P2|Overall Study|COPD exacerbation|3
314917|NCT01437540|1064973|P1|Overall Study|COPD exacerbation|13
314918|NCT01437540|1064972|P2|Overall Study|Not listed below|6
314919|NCT01437540|1064973|P1|Overall Study|Not listed below|7
314920|NCT01437423|1065003|P1|Overall Study|Off label usage|3
314921|NCT01437423|1065003|P1|Overall Study|Lost to Follow-up|12
314922|NCT01437397|1065015|P5|Overall Study|Site termination/COPD exacerbation/other|14
314923|NCT01437397|1065016|P4|Overall Study|Site termination/COPD exacerbation/other|9
314924|NCT01437397|1065017|P3|Overall Study|Site termination/COPD exacerbation/other|9
314925|NCT01437397|1065018|P2|Overall Study|Site termination/COPD exacerbation/other|8
314926|NCT01437397|1065019|P1|Overall Study|Site termination/COPD exacerbation/other|10
314927|NCT01437397|1065015|P5|Overall Study|Adverse Event|21
314928|NCT01437397|1065016|P4|Overall Study|Adverse Event|14
314929|NCT01437397|1065017|P3|Overall Study|Adverse Event|16
314930|NCT01437397|1065018|P2|Overall Study|Adverse Event|22
314931|NCT01437397|1065019|P1|Overall Study|Adverse Event|21
314932|NCT01437397|1065015|P5|Overall Study|Lack of Efficacy|20
314933|NCT01437397|1065016|P4|Overall Study|Lack of Efficacy|10
314934|NCT01437397|1065017|P3|Overall Study|Lack of Efficacy|8
314935|NCT01437397|1065018|P2|Overall Study|Lack of Efficacy|4
314936|NCT01437397|1065019|P1|Overall Study|Lack of Efficacy|5
314937|NCT01437397|1065015|P5|Overall Study|Protocol Violation|19
314938|NCT01437397|1065016|P4|Overall Study|Protocol Violation|21
314939|NCT01437397|1065017|P3|Overall Study|Protocol Violation|13
314940|NCT01437397|1065018|P2|Overall Study|Protocol Violation|12
314941|NCT01437397|1065019|P1|Overall Study|Protocol Violation|10
314942|NCT01437397|1065015|P5|Overall Study|Withdrawal by Subject|22
314943|NCT01437397|1065016|P4|Overall Study|Withdrawal by Subject|11
314944|NCT01437397|1065017|P3|Overall Study|Withdrawal by Subject|24
314945|NCT01437397|1065018|P2|Overall Study|Withdrawal by Subject|12
314946|NCT01437397|1065019|P1|Overall Study|Withdrawal by Subject|11
314947|NCT01437397|1065015|P5|Overall Study|Lost to Follow-up|5
314948|NCT01437397|1065016|P4|Overall Study|Lost to Follow-up|4
314949|NCT01437397|1065017|P3|Overall Study|Lost to Follow-up|2
314950|NCT01437397|1065018|P2|Overall Study|Lost to Follow-up|4
314951|NCT01437397|1065019|P1|Overall Study|Lost to Follow-up|9
314952|NCT01437319|1065046|P3|Phase II|Protocol Violation|0
314953|NCT01437319|1065047|P2|Phase II|Protocol Violation|1
314954|NCT01437319|1065048|P1|Phase II|Protocol Violation|0
314955|NCT01437319|1065046|P3|Phase II|Study related symptoms/complaints|19
314956|NCT01437319|1065047|P2|Phase II|Study related symptoms/complaints|28
314957|NCT01437319|1065048|P1|Phase II|Study related symptoms/complaints|0
314958|NCT01437319|1065046|P3|Phase II|Lost to Follow-up|2
314959|NCT01437319|1065047|P2|Phase II|Lost to Follow-up|7
314960|NCT01437319|1065048|P1|Phase II|Lost to Follow-up|0
314961|NCT01437319|1065046|P3|Phase II|Withdrawal by Subject|16
314962|NCT01437319|1065047|P2|Phase II|Withdrawal by Subject|8
314963|NCT01437319|1065048|P1|Phase II|Withdrawal by Subject|0
314964|NCT01437319|1065046|P3|Phase I|Withdrawal by Subject|0
314965|NCT01437319|1065047|P2|Phase I|Withdrawal by Subject|0
314966|NCT01437319|1065048|P1|Phase I|Withdrawal by Subject|25
314967|NCT01437319|1065046|P3|Phase I|Study related symptoms/complaints|0
314968|NCT01437319|1065047|P2|Phase I|Study related symptoms/complaints|0
314969|NCT01437319|1065048|P1|Phase I|Study related symptoms/complaints|27
314970|NCT01437319|1065046|P3|Phase I|Protocol Violation|0
314971|NCT01437319|1065047|P2|Phase I|Protocol Violation|0
314972|NCT01437319|1065048|P1|Phase I|Protocol Violation|1
314973|NCT01437319|1065046|P3|Phase I|Lost to Follow-up|0
314974|NCT01437319|1065047|P2|Phase I|Lost to Follow-up|0
314975|NCT01437319|1065048|P1|Phase I|Lost to Follow-up|2
314976|NCT01437267|1065063|P6|Overall Study|Protocol Violation|0
314977|NCT01437267|1065064|P5|Overall Study|Protocol Violation|0
314978|NCT01437267|1065065|P4|Overall Study|Protocol Violation|0
314979|NCT01437267|1065066|P3|Overall Study|Protocol Violation|0
314980|NCT01437267|1065067|P2|Overall Study|Protocol Violation|1
314981|NCT01437267|1065068|P1|Overall Study|Protocol Violation|0
314982|NCT01437267|1065063|P6|Overall Study|Withdrawal by Subject|0
314983|NCT01437267|1065064|P5|Overall Study|Withdrawal by Subject|0
314984|NCT01437267|1065065|P4|Overall Study|Withdrawal by Subject|1
314985|NCT01437267|1065066|P3|Overall Study|Withdrawal by Subject|0
314986|NCT01437267|1065067|P2|Overall Study|Withdrawal by Subject|0
314987|NCT01437267|1065068|P1|Overall Study|Withdrawal by Subject|0
314988|NCT01437111|1065111|P1|Overall Study|Protocol Violation|1
314989|NCT01437111|1065111|P1|Overall Study|Lost to Follow-up|5
314990|NCT01437111|1065111|P1|Overall Study|Physician Decision|1
314991|NCT01437111|1065111|P1|Overall Study|Not reported|5
314992|NCT01437111|1065111|P1|Overall Study|Withdrawal by Subject|4
314993|NCT01437111|1065111|P1|Overall Study|Adverse Event|2
314994|NCT01436643|1065189|P4|Core Phase (16 Weeks)|Protocol Violation|0
314995|NCT01436643|1065190|P3|Core Phase (16 Weeks)|Protocol Violation|1
314996|NCT01436643|1065191|P2|Core Phase (16 Weeks)|Protocol Violation|1
314997|NCT01436643|1065192|P1|Core Phase (16 Weeks)|Protocol Violation|1
314998|NCT01436643|1065189|P4|Core Phase (16 Weeks)|Abnormal Test result|0
314999|NCT01436643|1065190|P3|Core Phase (16 Weeks)|Abnormal Test result|1
315000|NCT01436643|1065191|P2|Core Phase (16 Weeks)|Abnormal Test result|0
315001|NCT01436643|1065192|P1|Core Phase (16 Weeks)|Abnormal Test result|0
315002|NCT01436643|1065189|P4|Core Phase (16 Weeks)|Adverse Event|0
315003|NCT01436643|1065190|P3|Core Phase (16 Weeks)|Adverse Event|1
315004|NCT01436643|1065191|P2|Core Phase (16 Weeks)|Adverse Event|3
315005|NCT01436643|1065192|P1|Core Phase (16 Weeks)|Adverse Event|0
315006|NCT01436643|1065189|P4|2-week Pre-treatment|Protocol Violation|4
315007|NCT01436643|1065190|P3|2-week Pre-treatment|Protocol Violation|0
315008|NCT01436643|1065191|P2|2-week Pre-treatment|Protocol Violation|0
315009|NCT01436643|1065192|P1|2-week Pre-treatment|Protocol Violation|0
315010|NCT01436643|1065189|P4|2-week Pre-treatment|Adverse Event|5
315011|NCT01436643|1065190|P3|2-week Pre-treatment|Adverse Event|0
315012|NCT01436643|1065191|P2|2-week Pre-treatment|Adverse Event|0
315013|NCT01436643|1065192|P1|2-week Pre-treatment|Adverse Event|0
315014|NCT01436643|1065189|P4|2-week Pre-treatment|Abnormal test result|1
315015|NCT01436643|1065190|P3|2-week Pre-treatment|Abnormal test result|0
315016|NCT01436643|1065191|P2|2-week Pre-treatment|Abnormal test result|0
315017|NCT01436643|1065192|P1|2-week Pre-treatment|Abnormal test result|0
315018|NCT01436500|1065227|P5|Overall Study|not specified|0
315019|NCT01436500|1065228|P4|Overall Study|not specified|1
315020|NCT01436500|1065229|P3|Overall Study|not specified|0
315021|NCT01436500|1065230|P2|Overall Study|not specified|1
315022|NCT01436500|1065231|P1|Overall Study|not specified|0
315023|NCT01436500|1065227|P5|Overall Study|discontinued study drug|0
315024|NCT01436500|1065228|P4|Overall Study|discontinued study drug|0
315025|NCT01436500|1065229|P3|Overall Study|discontinued study drug|0
315026|NCT01436500|1065230|P2|Overall Study|discontinued study drug|0
315027|NCT01436500|1065231|P1|Overall Study|discontinued study drug|1
315028|NCT01436500|1065227|P5|Overall Study|initiation of dialysis|1
315029|NCT01436500|1065228|P4|Overall Study|initiation of dialysis|0
315030|NCT01436500|1065229|P3|Overall Study|initiation of dialysis|0
315031|NCT01436500|1065230|P2|Overall Study|initiation of dialysis|0
315032|NCT01436500|1065231|P1|Overall Study|initiation of dialysis|0
315033|NCT01436500|1065227|P5|Overall Study|liver transplant|0
315034|NCT01436500|1065228|P4|Overall Study|liver transplant|0
315035|NCT01436500|1065229|P3|Overall Study|liver transplant|0
315036|NCT01436500|1065230|P2|Overall Study|liver transplant|0
315037|NCT01436500|1065231|P1|Overall Study|liver transplant|1
315038|NCT01436500|1065227|P5|Overall Study|Physician Decision|0
315039|NCT01436500|1065228|P4|Overall Study|Physician Decision|0
315040|NCT01436500|1065229|P3|Overall Study|Physician Decision|1
315041|NCT01436500|1065230|P2|Overall Study|Physician Decision|0
315042|NCT01436500|1065231|P1|Overall Study|Physician Decision|0
315043|NCT01436500|1065227|P5|Overall Study|Withdrawal by Subject|2
315044|NCT01436500|1065228|P4|Overall Study|Withdrawal by Subject|0
315045|NCT01436500|1065229|P3|Overall Study|Withdrawal by Subject|2
315046|NCT01436500|1065230|P2|Overall Study|Withdrawal by Subject|0
315047|NCT01436500|1065231|P1|Overall Study|Withdrawal by Subject|0
315048|NCT01436500|1065227|P5|Overall Study|Adverse Event|1
315049|NCT01436500|1065228|P4|Overall Study|Adverse Event|0
315050|NCT01436500|1065229|P3|Overall Study|Adverse Event|2
315051|NCT01436500|1065230|P2|Overall Study|Adverse Event|2
315052|NCT01436500|1065231|P1|Overall Study|Adverse Event|0
315053|NCT01436500|1065227|P5|Overall Study|Death|0
315054|NCT01436500|1065228|P4|Overall Study|Death|0
315055|NCT01436500|1065229|P3|Overall Study|Death|0
315056|NCT01436500|1065230|P2|Overall Study|Death|0
315057|NCT01436500|1065231|P1|Overall Study|Death|1
315058|NCT01436370|1065281|P8|Overall Study|Lost to Follow-up|0
315059|NCT01436370|1065282|P7|Overall Study|Lost to Follow-up|0
315060|NCT01436370|1065283|P6|Overall Study|Lost to Follow-up|0
315061|NCT01436370|1065284|P5|Overall Study|Lost to Follow-up|1
315062|NCT01436370|1065285|P4|Overall Study|Lost to Follow-up|0
315063|NCT01436370|1065286|P3|Overall Study|Lost to Follow-up|0
315064|NCT01436370|1065287|P2|Overall Study|Lost to Follow-up|0
315065|NCT01436370|1065288|P1|Overall Study|Lost to Follow-up|0
315066|NCT01436305|1065369|P3|Overall Study|Withdrawal by Subject|0
315067|NCT01436305|1065370|P2|Overall Study|Withdrawal by Subject|3
315068|NCT01436305|1065371|P1|Overall Study|Withdrawal by Subject|1
315069|NCT01436305|1065369|P3|Overall Study|Lost to Follow-up|0
315070|NCT01436305|1065370|P2|Overall Study|Lost to Follow-up|1
315071|NCT01436305|1065371|P1|Overall Study|Lost to Follow-up|0
315072|NCT01436305|1065369|P3|Overall Study|Death|0
315073|NCT01436305|1065370|P2|Overall Study|Death|0
315074|NCT01436305|1065371|P1|Overall Study|Death|1
315075|NCT01436253|1065498|P1|Overall Study|Not meeting all eligibility criteria|117
315076|NCT01436253|1065498|P1|Overall Study|Lost to Follow-up|182
315077|NCT01436201|1065503|P1|Overall Study|Protocol Violation|1
315078|NCT01436201|1065503|P1|Overall Study|Withdrawal by Subject|1
315079|NCT01436201|1065503|P1|Overall Study|Adverse Event|2
315080|NCT01436175|1065513|P1|Overall Study|Other|826
315081|NCT01436175|1065513|P1|Overall Study|Met blood pressure or pulse withdrawal|63
315082|NCT01436175|1065513|P1|Overall Study|Lack of Efficacy|24
315083|NCT01436175|1065513|P1|Overall Study|Lost to Follow-up|89
315084|NCT01436175|1065513|P1|Overall Study|Withdrawal by Subject|108
315085|NCT01436175|1065513|P1|Overall Study|Protocol Violation|49
315086|NCT01436175|1065513|P1|Overall Study|Adverse Event|111
315087|NCT01436162|1065540|P3|Randomized Phase|Not Specified|4
315088|NCT01436162|1065541|P2|Randomized Phase|Not Specified|5
315089|NCT01436162|1065542|P1|Randomized Phase|Not Specified|2
315090|NCT01436162|1065540|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
315091|NCT01436162|1065541|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
315092|NCT01436162|1065542|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
315093|NCT01436162|1065540|P3|Randomized Phase|Lack of Efficacy|1
315094|NCT01436162|1065541|P2|Randomized Phase|Lack of Efficacy|1
315095|NCT01436162|1065542|P1|Randomized Phase|Lack of Efficacy|0
315096|NCT01436162|1065540|P3|Randomized Phase|Lost to Follow-up|4
315097|NCT01436162|1065541|P2|Randomized Phase|Lost to Follow-up|5
315098|NCT01436162|1065542|P1|Randomized Phase|Lost to Follow-up|17
315099|NCT01436162|1065540|P3|Randomized Phase|Withdrawal by Subject|8
315100|NCT01436162|1065541|P2|Randomized Phase|Withdrawal by Subject|9
315101|NCT01436162|1065542|P1|Randomized Phase|Withdrawal by Subject|16
315102|NCT01436162|1065540|P3|Randomized Phase|Protocol Violation|2
315103|NCT01436162|1065541|P2|Randomized Phase|Protocol Violation|4
315104|NCT01436162|1065542|P1|Randomized Phase|Protocol Violation|4
315105|NCT01436162|1065540|P3|Randomized Phase|Adverse Event|6
315106|NCT01436162|1065541|P2|Randomized Phase|Adverse Event|5
315107|NCT01436162|1065542|P1|Randomized Phase|Adverse Event|1
315108|NCT01436162|1065540|P3|Single-blind Lead-in Phase|Not Specified|0
315109|NCT01436162|1065541|P2|Single-blind Lead-in Phase|Not Specified|0
315110|NCT01436162|1065542|P1|Single-blind Lead-in Phase|Not Specified|107
315111|NCT01436162|1065540|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
315112|NCT01436162|1065541|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
315113|NCT01436162|1065542|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
315114|NCT01436162|1065540|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
315115|NCT01436162|1065541|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
315116|NCT01436162|1065542|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
315117|NCT01436162|1065540|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
315118|NCT01436162|1065541|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
315119|NCT01436162|1065542|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
315120|NCT01436162|1065540|P3|Single-blind Lead-in Phase|Protocol Violation|0
315121|NCT01436162|1065541|P2|Single-blind Lead-in Phase|Protocol Violation|0
315122|NCT01436162|1065542|P1|Single-blind Lead-in Phase|Protocol Violation|24
315123|NCT01436162|1065540|P3|Single-blind Lead-in Phase|Adverse Event|0
315124|NCT01436162|1065541|P2|Single-blind Lead-in Phase|Adverse Event|0
315125|NCT01436162|1065542|P1|Single-blind Lead-in Phase|Adverse Event|26
315126|NCT01436149|1065576|P3|Randomized Phase|Not Specified|11
315127|NCT01436149|1065577|P2|Randomized Phase|Not Specified|5
315128|NCT01436149|1065578|P1|Randomized Phase|Not Specified|12
315129|NCT01436149|1065576|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
315130|NCT01436149|1065577|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
315131|NCT01436149|1065578|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
315132|NCT01436149|1065576|P3|Randomized Phase|Lack of Efficacy|1
315133|NCT01436149|1065577|P2|Randomized Phase|Lack of Efficacy|0
315134|NCT01436149|1065578|P1|Randomized Phase|Lack of Efficacy|0
315135|NCT01436149|1065576|P3|Randomized Phase|Lost to Follow-up|6
315136|NCT01436149|1065577|P2|Randomized Phase|Lost to Follow-up|5
315137|NCT01436149|1065578|P1|Randomized Phase|Lost to Follow-up|34
315138|NCT01436149|1065576|P3|Randomized Phase|Withdrawal by Subject|10
315139|NCT01436149|1065577|P2|Randomized Phase|Withdrawal by Subject|10
315140|NCT01436149|1065578|P1|Randomized Phase|Withdrawal by Subject|16
315141|NCT01436149|1065576|P3|Randomized Phase|Protocol Violation|0
315142|NCT01436149|1065577|P2|Randomized Phase|Protocol Violation|5
315143|NCT01436149|1065578|P1|Randomized Phase|Protocol Violation|4
315144|NCT01436149|1065576|P3|Randomized Phase|Adverse Event|11
315145|NCT01436149|1065577|P2|Randomized Phase|Adverse Event|10
315146|NCT01436149|1065578|P1|Randomized Phase|Adverse Event|9
315147|NCT01436149|1065576|P3|Antidepressant Lead-in Phase|Not Specified|0
315148|NCT01436149|1065577|P2|Antidepressant Lead-in Phase|Not Specified|0
315149|NCT01436149|1065578|P1|Antidepressant Lead-in Phase|Not Specified|119
315150|NCT01436149|1065576|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
315151|NCT01436149|1065577|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
315152|NCT01436149|1065578|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
315153|NCT01436149|1065576|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
315154|NCT01436149|1065577|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
315155|NCT01436149|1065578|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
315156|NCT01436149|1065576|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
315157|NCT01436149|1065577|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
315158|NCT01436149|1065578|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
315159|NCT01436149|1065576|P3|Antidepressant Lead-in Phase|Protocol Violation|0
315160|NCT01436149|1065577|P2|Antidepressant Lead-in Phase|Protocol Violation|0
315161|NCT01436149|1065578|P1|Antidepressant Lead-in Phase|Protocol Violation|29
315162|NCT01436149|1065576|P3|Antidepressant Lead-in Phase|Adverse Event|0
315163|NCT01436149|1065577|P2|Antidepressant Lead-in Phase|Adverse Event|0
315164|NCT01436149|1065578|P1|Antidepressant Lead-in Phase|Adverse Event|39
315165|NCT01436110|1065609|P3|Overall Study|Did Not Receive Trial Medication|3
315166|NCT01436110|1065610|P2|Overall Study|Did Not Receive Trial Medication|0
315167|NCT01436110|1065611|P1|Overall Study|Did Not Receive Trial Medication|1
315168|NCT01436110|1065609|P3|Overall Study|Protocol Violation|1
315169|NCT01436110|1065610|P2|Overall Study|Protocol Violation|1
315170|NCT01436110|1065611|P1|Overall Study|Protocol Violation|3
315171|NCT01436110|1065609|P3|Overall Study|Lost to Follow-up|3
315172|NCT01436110|1065610|P2|Overall Study|Lost to Follow-up|1
315173|NCT01436110|1065611|P1|Overall Study|Lost to Follow-up|1
315174|NCT01436110|1065609|P3|Overall Study|Physician Decision|1
315175|NCT01436110|1065610|P2|Overall Study|Physician Decision|1
315176|NCT01436110|1065611|P1|Overall Study|Physician Decision|3
315177|NCT01436110|1065609|P3|Overall Study|Adverse Event|2
315178|NCT01436110|1065610|P2|Overall Study|Adverse Event|1
315179|NCT01436110|1065611|P1|Overall Study|Adverse Event|2
315180|NCT01436110|1065609|P3|Overall Study|Withdrawal by Subject|4
315181|NCT01436110|1065610|P2|Overall Study|Withdrawal by Subject|8
315182|NCT01436110|1065611|P1|Overall Study|Withdrawal by Subject|6
315183|NCT01436110|1065609|P3|Overall Study|Lack of Efficacy|9
315184|NCT01436110|1065610|P2|Overall Study|Lack of Efficacy|14
315185|NCT01436110|1065611|P1|Overall Study|Lack of Efficacy|23
315186|NCT01436084|1065634|P1|Overall Study|Early Closure of Study|1
315187|NCT01436084|1065634|P1|Overall Study|Withdrawal by Subject|1
315188|NCT01436084|1065634|P1|Overall Study|Disease Progression|2
315189|NCT01436071|1065640|P2|Overall Study|Did Not Receive Trial Medication|3
315190|NCT01436071|1065641|P1|Overall Study|Did Not Receive Trial Medication|3
315191|NCT01436071|1065640|P2|Overall Study|Withdrawal by Subject|2
315192|NCT01436071|1065641|P1|Overall Study|Withdrawal by Subject|2
315193|NCT01436071|1065640|P2|Overall Study|Physician Decision|0
315194|NCT01436071|1065641|P1|Overall Study|Physician Decision|1
315195|NCT01436071|1065640|P2|Overall Study|Lost to Follow-up|1
315196|NCT01436071|1065641|P1|Overall Study|Lost to Follow-up|3
315197|NCT01436071|1065640|P2|Overall Study|Protocol Violation|1
315198|NCT01436071|1065641|P1|Overall Study|Protocol Violation|0
315199|NCT01436071|1065640|P2|Overall Study|Lack of Efficacy|7
315200|NCT01436071|1065641|P1|Overall Study|Lack of Efficacy|16
315201|NCT01436071|1065640|P2|Overall Study|Adverse Event|0
315202|NCT01436071|1065641|P1|Overall Study|Adverse Event|1
315203|NCT01435928|1065683|P3|Double Blind Phase - 28 Weeks|Administrative|2
315204|NCT01435928|1065684|P2|Double Blind Phase - 28 Weeks|Administrative|5
315205|NCT01435928|1065685|P1|Double Blind Phase - 28 Weeks|Administrative|0
315206|NCT01435928|1065683|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
315207|NCT01435928|1065684|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
315208|NCT01435928|1065685|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
315209|NCT01435928|1065683|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
315210|NCT01435928|1065684|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
315211|NCT01435928|1065685|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
315212|NCT01435928|1065683|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
315213|NCT01435928|1065684|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
315214|NCT01435928|1065685|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
315215|NCT01435928|1065683|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
315216|NCT01435928|1065684|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
315217|NCT01435928|1065685|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
315218|NCT01435928|1065683|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
315219|NCT01435928|1065684|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
315220|NCT01435928|1065685|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
315221|NCT01435928|1065683|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
315222|NCT01435928|1065684|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
315223|NCT01435928|1065685|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
315224|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Administrative|0
315225|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Administrative|0
315226|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Administrative|14
315227|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
315228|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
315229|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
315230|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
315231|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
315232|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
315233|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
315234|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
315235|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
315236|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
315237|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
315238|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
315239|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
315240|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
315241|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
315242|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
315243|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
315244|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
315245|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Death|0
315246|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Death|0
315247|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Death|1
315248|NCT01435928|1065683|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
315249|NCT01435928|1065684|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
315250|NCT01435928|1065685|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
315251|NCT01435798|1065712|P1|Overall Study|Withdrawal by Subject|1
315252|NCT01435772|1065729|P3|Overall Study|Other - study termination|10
315253|NCT01435772|1065730|P2|Overall Study|Other - study termination|2
315254|NCT01435772|1065731|P1|Overall Study|Other - study termination|2
315255|NCT01435772|1065729|P3|Overall Study|Withdrawal by Subject|3
315256|NCT01435772|1065730|P2|Overall Study|Withdrawal by Subject|1
315257|NCT01435772|1065731|P1|Overall Study|Withdrawal by Subject|0
315258|NCT01435772|1065729|P3|Overall Study|Adverse Event|2
315259|NCT01435772|1065730|P2|Overall Study|Adverse Event|0
315260|NCT01435772|1065731|P1|Overall Study|Adverse Event|1
315261|NCT01435759|1065781|P6|Double-blind Phase|Not Specified|0
315262|NCT01435759|1065782|P5|Double-blind Phase|Not Specified|0
315263|NCT01435759|1065783|P4|Double-blind Phase|Not Specified|2
315264|NCT01435759|1065784|P3|Double-blind Phase|Not Specified|0
315265|NCT01435759|1065785|P2|Double-blind Phase|Not Specified|2
315266|NCT01435759|1065786|P1|Double-blind Phase|Not Specified|8
315267|NCT01435759|1065781|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
315268|NCT01435759|1065782|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
315269|NCT01435759|1065783|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
315270|NCT01435759|1065784|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
315271|NCT01435759|1065785|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
315272|NCT01435759|1065786|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
315273|NCT01435759|1065781|P6|Double-blind Phase|Lost to Follow-up|3
315274|NCT01435759|1065782|P5|Double-blind Phase|Lost to Follow-up|3
315275|NCT01435759|1065783|P4|Double-blind Phase|Lost to Follow-up|0
315276|NCT01435759|1065784|P3|Double-blind Phase|Lost to Follow-up|2
315277|NCT01435759|1065785|P2|Double-blind Phase|Lost to Follow-up|1
315278|NCT01435759|1065786|P1|Double-blind Phase|Lost to Follow-up|31
315279|NCT01435759|1065781|P6|Double-blind Phase|Withdrawal by Subject|2
315280|NCT01435759|1065782|P5|Double-blind Phase|Withdrawal by Subject|2
315281|NCT01435759|1065783|P4|Double-blind Phase|Withdrawal by Subject|4
315282|NCT01435759|1065784|P3|Double-blind Phase|Withdrawal by Subject|3
315283|NCT01435759|1065785|P2|Double-blind Phase|Withdrawal by Subject|4
315284|NCT01435759|1065786|P1|Double-blind Phase|Withdrawal by Subject|17
315285|NCT01435759|1065781|P6|Double-blind Phase|Protocol Violation|1
315286|NCT01435759|1065782|P5|Double-blind Phase|Protocol Violation|0
315287|NCT01435759|1065783|P4|Double-blind Phase|Protocol Violation|2
315288|NCT01435759|1065784|P3|Double-blind Phase|Protocol Violation|1
315289|NCT01435759|1065785|P2|Double-blind Phase|Protocol Violation|0
315290|NCT01435759|1065786|P1|Double-blind Phase|Protocol Violation|2
315291|NCT01435759|1065781|P6|Double-blind Phase|Adverse Event|3
315292|NCT01435759|1065782|P5|Double-blind Phase|Adverse Event|1
315293|NCT01435759|1065783|P4|Double-blind Phase|Adverse Event|1
315294|NCT01435759|1065784|P3|Double-blind Phase|Adverse Event|1
315295|NCT01435759|1065785|P2|Double-blind Phase|Adverse Event|0
315296|NCT01435759|1065786|P1|Double-blind Phase|Adverse Event|7
315297|NCT01435759|1065781|P6|Antidepressant Lead-in Phase|Not Specified|0
315298|NCT01435759|1065782|P5|Antidepressant Lead-in Phase|Not Specified|0
315299|NCT01435759|1065783|P4|Antidepressant Lead-in Phase|Not Specified|0
315300|NCT01435759|1065784|P3|Antidepressant Lead-in Phase|Not Specified|0
315301|NCT01435759|1065785|P2|Antidepressant Lead-in Phase|Not Specified|0
315302|NCT01435759|1065786|P1|Antidepressant Lead-in Phase|Not Specified|119
315303|NCT01435759|1065781|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
315304|NCT01435759|1065782|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
315305|NCT01435759|1065783|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
315306|NCT01435759|1065784|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
315307|NCT01435759|1065785|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
315308|NCT01435759|1065786|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
315309|NCT01435759|1065781|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
315310|NCT01435759|1065782|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
315311|NCT01435759|1065783|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
315312|NCT01435759|1065784|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
315313|NCT01435759|1065785|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
315314|NCT01435759|1065786|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
315315|NCT01435759|1065781|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
315316|NCT01435759|1065782|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
315317|NCT01435759|1065783|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
315318|NCT01435759|1065784|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
315319|NCT01435759|1065785|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
315320|NCT01435759|1065786|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
315321|NCT01435759|1065781|P6|Antidepressant Lead-in Phase|Protocol Violation|0
315322|NCT01435759|1065782|P5|Antidepressant Lead-in Phase|Protocol Violation|0
315323|NCT01435759|1065783|P4|Antidepressant Lead-in Phase|Protocol Violation|0
315324|NCT01435759|1065784|P3|Antidepressant Lead-in Phase|Protocol Violation|0
315325|NCT01435759|1065785|P2|Antidepressant Lead-in Phase|Protocol Violation|0
315326|NCT01435759|1065786|P1|Antidepressant Lead-in Phase|Protocol Violation|16
315327|NCT01435759|1065781|P6|Antidepressant Lead-in Phase|Adverse Event|0
315328|NCT01435759|1065782|P5|Antidepressant Lead-in Phase|Adverse Event|0
315329|NCT01435759|1065783|P4|Antidepressant Lead-in Phase|Adverse Event|0
315330|NCT01435759|1065784|P3|Antidepressant Lead-in Phase|Adverse Event|0
315331|NCT01435759|1065785|P2|Antidepressant Lead-in Phase|Adverse Event|0
315332|NCT01435759|1065786|P1|Antidepressant Lead-in Phase|Adverse Event|40
315333|NCT01435655|1065813|P1|Overall Study|Other|1
315334|NCT01435655|1065813|P1|Overall Study|Death|2
315335|NCT01435616|1065827|P2|Overall Study|Sponsor Decision|0
315336|NCT01435616|1065828|P1|Overall Study|Sponsor Decision|1
315337|NCT01435616|1065827|P2|Overall Study|Physician Decision|7
315338|NCT01435616|1065828|P1|Overall Study|Physician Decision|20
315339|NCT01435616|1065827|P2|Overall Study|Withdrawal by Subject|24
315340|NCT01435616|1065828|P1|Overall Study|Withdrawal by Subject|66
315341|NCT01435616|1065827|P2|Overall Study|Protocol Violation|13
315342|NCT01435616|1065828|P1|Overall Study|Protocol Violation|16
315343|NCT01435616|1065827|P2|Overall Study|Lost to Follow-up|13
315344|NCT01435616|1065828|P1|Overall Study|Lost to Follow-up|22
315345|NCT01435616|1065827|P2|Overall Study|Death|2
315346|NCT01435616|1065828|P1|Overall Study|Death|7
315347|NCT01435616|1065827|P2|Overall Study|Adverse Event|21
315348|NCT01435616|1065828|P1|Overall Study|Adverse Event|39
315349|NCT01435577|1065883|P2|Overall Study|Alternative treatment started|1
315350|NCT01435577|1065884|P1|Overall Study|Alternative treatment started|0
315351|NCT01435577|1065883|P2|Overall Study|Lack of Efficacy|51
315352|NCT01435577|1065884|P1|Overall Study|Lack of Efficacy|7
315353|NCT01435577|1065883|P2|Overall Study|Adverse Event|0
315354|NCT01435577|1065884|P1|Overall Study|Adverse Event|10
315355|NCT01435460|1065934|P2|Overall Study|Did not meet eligibility criteria|0
315356|NCT01435460|1065935|P1|Overall Study|Did not meet eligibility criteria|2
315357|NCT01435460|1065934|P2|Overall Study|Protocol Violation|1
315358|NCT01435460|1065935|P1|Overall Study|Protocol Violation|0
315359|NCT01435460|1065934|P2|Overall Study|Withdrawal by Subject|3
315360|NCT01435460|1065935|P1|Overall Study|Withdrawal by Subject|1
315361|NCT01435460|1065934|P2|Overall Study|Lost to Follow-up|1
315362|NCT01435460|1065935|P1|Overall Study|Lost to Follow-up|6
315363|NCT01435460|1065934|P2|Overall Study|Adverse Event|1
315364|NCT01435460|1065935|P1|Overall Study|Adverse Event|2
315365|NCT01435265|1065968|P2|Overall Study|Lost to Follow-up|1
315366|NCT01435265|1065969|P1|Overall Study|Lost to Follow-up|0
315367|NCT01435122|1065983|P1|Overall Study|Early withdrawal due to toxicity|8
315368|NCT01435031|1065992|P1|ITT at 4 Years|Lost to Follow-up|1
315369|NCT01435031|1065992|P1|ITT at 4 Years|Withdrawal by Subject|2
315370|NCT01435031|1065992|P1|ITT at 4 Years|Death|4
315371|NCT01435031|1065992|P1|ITT at 3 Years|Lost to Follow-up|4
315372|NCT01435031|1065992|P1|ITT at 3 Years|Withdrawal by Subject|2
315373|NCT01435031|1065992|P1|ITT at 3 Years|Death|5
315374|NCT01435031|1065992|P1|ITT at 2 Years|Lost to Follow-up|4
315375|NCT01435031|1065992|P1|ITT at 2 Years|Withdrawal by Subject|2
315376|NCT01435031|1065992|P1|ITT at 2 Years|Death|7
315377|NCT01435031|1065992|P1|ITT at 1 Year|Lost to Follow-up|6
315378|NCT01435031|1065992|P1|ITT at 1 Year|Withdrawal by Subject|2
315379|NCT01435031|1065992|P1|ITT at 1 Year|Death|1
315380|NCT01435031|1065992|P1|ITT at 6 Months|Lost to Follow-up|3
315381|NCT01435031|1065992|P1|ITT at 6 Months|Death|2
315382|NCT01435031|1065992|P1|ITT at 1 Month|Lost to Follow-up|4
315383|NCT01435031|1065992|P1|ITT at 1 Month|Death|1
315384|NCT01435031|1065992|P1|ITT at 1 Month|Withdrawal by Subject|1
315385|NCT01434823|1066092|P2|Overall Study|Incomplete data in medical record|7
315386|NCT01434823|1066093|P1|Overall Study|Incomplete data in medical record|4
315387|NCT01434693|1066113|P4|Overall Study|Lost to Follow-up|0
315388|NCT01434693|1066114|P3|Overall Study|Lost to Follow-up|0
315389|NCT01434693|1066115|P2|Overall Study|Lost to Follow-up|0
315390|NCT01434693|1066116|P1|Overall Study|Lost to Follow-up|1
315391|NCT01434693|1066113|P4|Overall Study|Withdrawal by Subject|1
315392|NCT01434693|1066114|P3|Overall Study|Withdrawal by Subject|1
315393|NCT01434693|1066115|P2|Overall Study|Withdrawal by Subject|0
315394|NCT01434693|1066116|P1|Overall Study|Withdrawal by Subject|1
315395|NCT01434693|1066113|P4|Overall Study|Adverse Event|0
315396|NCT01434693|1066114|P3|Overall Study|Adverse Event|0
315397|NCT01434693|1066115|P2|Overall Study|Adverse Event|0
315398|NCT01434693|1066116|P1|Overall Study|Adverse Event|1
315399|NCT01434680|1066130|P4|Overall Study|Protocol Violation|0
315400|NCT01434680|1066131|P3|Overall Study|Protocol Violation|0
315401|NCT01434680|1066132|P2|Overall Study|Protocol Violation|1
315402|NCT01434680|1066133|P1|Overall Study|Protocol Violation|1
315403|NCT01434680|1066130|P4|Overall Study|Lost to Follow-up|0
315404|NCT01434680|1066131|P3|Overall Study|Lost to Follow-up|0
315405|NCT01434680|1066132|P2|Overall Study|Lost to Follow-up|1
315406|NCT01434680|1066133|P1|Overall Study|Lost to Follow-up|1
315407|NCT01434680|1066130|P4|Overall Study|Withdrawal by Subject|0
315408|NCT01434680|1066131|P3|Overall Study|Withdrawal by Subject|2
315409|NCT01434680|1066132|P2|Overall Study|Withdrawal by Subject|0
315410|NCT01434680|1066133|P1|Overall Study|Withdrawal by Subject|1
315411|NCT01434654|1066150|P2|Overall Study|Lost to Follow-up|0
315412|NCT01434654|1066151|P1|Overall Study|Lost to Follow-up|1
315413|NCT01434654|1066150|P2|Overall Study|Withdrawal by Subject|0
315414|NCT01434654|1066151|P1|Overall Study|Withdrawal by Subject|1
315415|NCT01434290|1066198|P2|Overall Study|No protocol treatment|4
315416|NCT01434290|1066199|P1|Overall Study|No protocol treatment|2
315417|NCT01434290|1066198|P2|Overall Study|Protocol Violation|3
315418|NCT01434290|1066199|P1|Overall Study|Protocol Violation|6
315419|NCT01433978|1066272|P3|Extension Phase|Study Terminated by Sponsor|4
315420|NCT01433978|1066273|P2|Extension Phase|Study Terminated by Sponsor|0
315421|NCT01433978|1066274|P1|Extension Phase|Study Terminated by Sponsor|0
315422|NCT01433978|1066272|P3|Extension Phase|Lack of Efficacy|1
315423|NCT01433978|1066273|P2|Extension Phase|Lack of Efficacy|0
315424|NCT01433978|1066274|P1|Extension Phase|Lack of Efficacy|0
315425|NCT01433978|1066272|P3|Extension Phase|Adverse Event, Non-Fatal|1
315426|NCT01433978|1066273|P2|Extension Phase|Adverse Event, Non-Fatal|0
315427|NCT01433978|1066274|P1|Extension Phase|Adverse Event, Non-Fatal|0
315428|NCT01433978|1066272|P3|Core Study|Study Terminated by Sponsor|0
315429|NCT01433978|1066273|P2|Core Study|Study Terminated by Sponsor|9
315430|NCT01433978|1066274|P1|Core Study|Study Terminated by Sponsor|6
315431|NCT01433978|1066272|P3|Core Study|Lack of Efficacy|0
315432|NCT01433978|1066273|P2|Core Study|Lack of Efficacy|1
315433|NCT01433978|1066274|P1|Core Study|Lack of Efficacy|5
315434|NCT01433978|1066272|P3|Core Study|Adverse Event, Non-Fatal|0
315435|NCT01433978|1066273|P2|Core Study|Adverse Event, Non-Fatal|1
315436|NCT01433978|1066274|P1|Core Study|Adverse Event, Non-Fatal|0
315437|NCT01433549|1066331|P2|Phase 2: Second Study Product|Adverse Event|1
315438|NCT01433549|1066332|P1|Phase 2: Second Study Product|Adverse Event|0
315439|NCT01433471|1066342|P2|Overall Study|Withdrawal by Subject|1
315440|NCT01433471|1066343|P1|Overall Study|Withdrawal by Subject|0
315441|NCT01433354|1066359|P1|Overall Study|Subject Withdrew Consent|3
315442|NCT01433354|1066359|P1|Overall Study|Lack of Efficacy|17
315443|NCT01433354|1066359|P1|Overall Study|Protocol Violation|2
315444|NCT01433354|1066359|P1|Overall Study|Administrative problems|90
315445|NCT01433354|1066359|P1|Overall Study|Lost to Follow-up|1
315446|NCT01433354|1066359|P1|Overall Study|Adverse Event|6
315447|NCT01433263|1066375|P2|Overall Study|Withdrawal by Subject|7
315448|NCT01433263|1066376|P1|Overall Study|Withdrawal by Subject|10
315449|NCT01433263|1066375|P2|Overall Study|Protocol Deviation|0
315450|NCT01433263|1066376|P1|Overall Study|Protocol Deviation|1
315451|NCT01433263|1066375|P2|Overall Study|Lost to Follow-up|1
315452|NCT01433263|1066376|P1|Overall Study|Lost to Follow-up|0
315453|NCT01433263|1066375|P2|Overall Study|Death|3
315454|NCT01433263|1066376|P1|Overall Study|Death|5
315455|NCT01433263|1066375|P2|Overall Study|Adverse Event|1
315456|NCT01433263|1066376|P1|Overall Study|Adverse Event|3
315457|NCT01433250|1066405|P2|Overall Study|Withdrawal by Subject|2
315458|NCT01433250|1066406|P1|Overall Study|Withdrawal by Subject|3
315459|NCT01433250|1066405|P2|Overall Study|Protocol Violation|1
315460|NCT01433250|1066406|P1|Overall Study|Protocol Violation|0
315461|NCT01433172|1066425|P3|Overall Study|Death|0
315462|NCT01433172|1066426|P2|Overall Study|Death|2
315463|NCT01433172|1066427|P1|Overall Study|Death|0
315464|NCT01433172|1066425|P3|Overall Study|Disease Progression|1
315465|NCT01433172|1066426|P2|Overall Study|Disease Progression|0
315466|NCT01433172|1066427|P1|Overall Study|Disease Progression|0
315467|NCT01433172|1066425|P3|Overall Study|Withdrawal by Subject|0
315468|NCT01433172|1066426|P2|Overall Study|Withdrawal by Subject|1
315469|NCT01433172|1066427|P1|Overall Study|Withdrawal by Subject|0
315470|NCT01433159|1066439|P2|Overall Study|Protocol Violation|1
315471|NCT01433159|1066440|P1|Overall Study|Protocol Violation|0
315472|NCT01433159|1066439|P2|Overall Study|Physician Decision|0
315473|NCT01433159|1066440|P1|Overall Study|Physician Decision|1
315474|NCT01433159|1066439|P2|Overall Study|Adverse Event|0
315475|NCT01433159|1066440|P1|Overall Study|Adverse Event|1
315476|NCT01433055|1066472|P2|Overall Study|Severely elevated triglycerides at entry|0
315477|NCT01433055|1066473|P1|Overall Study|Severely elevated triglycerides at entry|1
315478|NCT01433055|1066472|P2|Overall Study|Diagnosed with cancer unrelated to study|0
315479|NCT01433055|1066473|P1|Overall Study|Diagnosed with cancer unrelated to study|1
315480|NCT01432938|1066495|P2|Second Intervention|Adverse Event|0
315481|NCT01432938|1066496|P1|Second Intervention|Adverse Event|1
315482|NCT01432938|1066495|P2|First Intervention|Physician Decision|0
315483|NCT01432938|1066496|P1|First Intervention|Physician Decision|1
315484|NCT01432938|1066495|P2|First Intervention|Protocol Violation|0
315485|NCT01432938|1066496|P1|First Intervention|Protocol Violation|1
315486|NCT01432756|1066526|P4|Overall Study|Lost to Follow-up|1
315487|NCT01432756|1066527|P3|Overall Study|Lost to Follow-up|2
315488|NCT01432756|1066528|P2|Overall Study|Lost to Follow-up|0
315489|NCT01432756|1066529|P1|Overall Study|Lost to Follow-up|1
315490|NCT01432626|1066537|P1|Overall Study|Imaging agent not available|1
315491|NCT01432626|1066537|P1|Overall Study|Only 1 image competed|2
315492|NCT01432626|1066537|P1|Overall Study|Withdrawal by Subject|2
315493|NCT01432626|1066537|P1|Overall Study|LV function recovered|2
315494|NCT01432600|1066544|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
315495|NCT01432600|1066545|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
315496|NCT01432600|1066546|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
315497|NCT01432574|1066562|P1|Overall Study|Not interested|1
315498|NCT01432574|1066562|P1|Overall Study|Moved|2
315499|NCT01432457|1066608|P3|Overall Study|Did not take study drug|3
315500|NCT01432457|1066609|P2|Overall Study|Did not take study drug|6
315501|NCT01432457|1066610|P1|Overall Study|Did not take study drug|6
315502|NCT01432457|1066608|P3|Overall Study|Reasons not defined|4
315503|NCT01432457|1066609|P2|Overall Study|Reasons not defined|3
315504|NCT01432457|1066610|P1|Overall Study|Reasons not defined|2
315505|NCT01432457|1066608|P3|Overall Study|Withdrawal by Subject|9
315506|NCT01432457|1066609|P2|Overall Study|Withdrawal by Subject|11
315507|NCT01432457|1066610|P1|Overall Study|Withdrawal by Subject|6
315508|NCT01432457|1066608|P3|Overall Study|Protocol Violation|6
315509|NCT01432457|1066609|P2|Overall Study|Protocol Violation|2
315510|NCT01432457|1066610|P1|Overall Study|Protocol Violation|3
315511|NCT01432457|1066608|P3|Overall Study|Lost to Follow-up|20
315512|NCT01432457|1066609|P2|Overall Study|Lost to Follow-up|15
315513|NCT01432457|1066610|P1|Overall Study|Lost to Follow-up|11
315514|NCT01432457|1066608|P3|Overall Study|Lack of Efficacy|1
315515|NCT01432457|1066609|P2|Overall Study|Lack of Efficacy|1
315516|NCT01432457|1066610|P1|Overall Study|Lack of Efficacy|2
315517|NCT01432457|1066608|P3|Overall Study|Adverse Event|16
315518|NCT01432457|1066609|P2|Overall Study|Adverse Event|10
315519|NCT01432457|1066610|P1|Overall Study|Adverse Event|7
315520|NCT01432444|1066639|P3|Extension Phase|Withdrawal by Subject|13
315521|NCT01432444|1066640|P2|Extension Phase|Withdrawal by Subject|0
315522|NCT01432444|1066641|P1|Extension Phase|Withdrawal by Subject|0
315523|NCT01432444|1066639|P3|Extension Phase|Physician Decision|1
315524|NCT01432444|1066640|P2|Extension Phase|Physician Decision|0
315525|NCT01432444|1066641|P1|Extension Phase|Physician Decision|0
315526|NCT01432444|1066639|P3|Extension Phase|Met Withdrawal Criteria|144
315527|NCT01432444|1066640|P2|Extension Phase|Met Withdrawal Criteria|0
315528|NCT01432444|1066641|P1|Extension Phase|Met Withdrawal Criteria|0
315529|NCT01432444|1066639|P3|Extension Phase|Sponsor Discontinued Trial|7
315530|NCT01432444|1066640|P2|Extension Phase|Sponsor Discontinued Trial|0
315531|NCT01432444|1066641|P1|Extension Phase|Sponsor Discontinued Trial|0
315532|NCT01432444|1066639|P3|Extension Phase|Adverse Event|10
315533|NCT01432444|1066640|P2|Extension Phase|Adverse Event|0
315534|NCT01432444|1066641|P1|Extension Phase|Adverse Event|0
315535|NCT01432444|1066639|P3|Extension Phase|Lost to Follow-up|17
315536|NCT01432444|1066640|P2|Extension Phase|Lost to Follow-up|0
315537|NCT01432444|1066641|P1|Extension Phase|Lost to Follow-up|0
315538|NCT01432444|1066639|P3|Treatment Phase|Lack of Efficacy|0
315539|NCT01432444|1066640|P2|Treatment Phase|Lack of Efficacy|10
315540|NCT01432444|1066641|P1|Treatment Phase|Lack of Efficacy|0
315541|NCT01432444|1066639|P3|Treatment Phase|Protocol Deviation|0
315542|NCT01432444|1066640|P2|Treatment Phase|Protocol Deviation|3
315543|NCT01432444|1066641|P1|Treatment Phase|Protocol Deviation|0
315544|NCT01432444|1066639|P3|Treatment Phase|Withdrawal by Subject|0
315545|NCT01432444|1066640|P2|Treatment Phase|Withdrawal by Subject|41
315546|NCT01432444|1066641|P1|Treatment Phase|Withdrawal by Subject|0
315547|NCT01432444|1066639|P3|Treatment Phase|Physician Decision|0
315548|NCT01432444|1066640|P2|Treatment Phase|Physician Decision|5
315549|NCT01432444|1066641|P1|Treatment Phase|Physician Decision|0
315550|NCT01432444|1066639|P3|Treatment Phase|Met Withdrawal Criteria|0
315551|NCT01432444|1066640|P2|Treatment Phase|Met Withdrawal Criteria|11
315552|NCT01432444|1066641|P1|Treatment Phase|Met Withdrawal Criteria|0
315553|NCT01432444|1066639|P3|Treatment Phase|Adverse Event|0
315554|NCT01432444|1066640|P2|Treatment Phase|Adverse Event|37
315555|NCT01432444|1066641|P1|Treatment Phase|Adverse Event|0
315556|NCT01432444|1066639|P3|Treatment Phase|Lost to Follow-up|0
315557|NCT01432444|1066640|P2|Treatment Phase|Lost to Follow-up|33
315558|NCT01432444|1066641|P1|Treatment Phase|Lost to Follow-up|0
315559|NCT01432444|1066639|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
315560|NCT01432444|1066640|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
315561|NCT01432444|1066641|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
315562|NCT01432444|1066639|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
315563|NCT01432444|1066640|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
315564|NCT01432444|1066641|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
315565|NCT01432444|1066639|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
315566|NCT01432444|1066640|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
315567|NCT01432444|1066641|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
315568|NCT01432444|1066639|P3|Tolerability/Cross-titration Phase|Physician Decision|0
315569|NCT01432444|1066640|P2|Tolerability/Cross-titration Phase|Physician Decision|0
315570|NCT01432444|1066641|P1|Tolerability/Cross-titration Phase|Physician Decision|8
315571|NCT01432444|1066639|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
315572|NCT01432444|1066640|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
315573|NCT01432444|1066641|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
315574|NCT01432444|1066639|P3|Tolerability/Cross-titration Phase|Adverse Event|0
315575|NCT01432444|1066640|P2|Tolerability/Cross-titration Phase|Adverse Event|0
315576|NCT01432444|1066641|P1|Tolerability/Cross-titration Phase|Adverse Event|16
315577|NCT01432444|1066639|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
315578|NCT01432444|1066640|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
315579|NCT01432444|1066641|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
315580|NCT01432366|1066667|P1|Overall Study|Other|14
315581|NCT01432366|1066667|P1|Overall Study|Investigator Forget to Complete Visits|1
315582|NCT01432366|1066667|P1|Overall Study|Site Closed|20
315583|NCT01432366|1066667|P1|Overall Study|Lack of Efficacy|1
315584|NCT01432366|1066667|P1|Overall Study|Lost to Follow-up|13
315585|NCT01432366|1066667|P1|Overall Study|Pregnancy|1
315586|NCT01432366|1066667|P1|Overall Study|Withdrawal Due to Non-Compliance|3
315587|NCT01432366|1066667|P1|Overall Study|Adverse Event|8
315588|NCT01432366|1066667|P1|Overall Study|Non-Responder|7
315589|NCT01432327|1066689|P4|Posttest 1 Year|Allergic reaction|1
315590|NCT01432327|1066690|P3|Posttest 1 Year|Allergic reaction|1
315591|NCT01432327|1066691|P2|Posttest 1 Year|Allergic reaction|0
315592|NCT01432327|1066692|P1|Posttest 1 Year|Allergic reaction|0
315593|NCT01432327|1066689|P4|Posttest 1 Year|Lost to Follow-up|2
315594|NCT01432327|1066690|P3|Posttest 1 Year|Lost to Follow-up|4
315595|NCT01432327|1066691|P2|Posttest 1 Year|Lost to Follow-up|0
315596|NCT01432327|1066692|P1|Posttest 1 Year|Lost to Follow-up|0
315597|NCT01432327|1066689|P4|Posttest 1 Year|Measurement have to take place in future|20
315598|NCT01432327|1066690|P3|Posttest 1 Year|Measurement have to take place in future|15
315599|NCT01432327|1066691|P2|Posttest 1 Year|Measurement have to take place in future|28
315600|NCT01432327|1066692|P1|Posttest 1 Year|Measurement have to take place in future|24
315601|NCT01432327|1066689|P4|Posttest 6 Months|Withdrawal by Subject|0
315602|NCT01432327|1066690|P3|Posttest 6 Months|Withdrawal by Subject|1
315603|NCT01432327|1066691|P2|Posttest 6 Months|Withdrawal by Subject|0
315604|NCT01432327|1066692|P1|Posttest 6 Months|Withdrawal by Subject|0
315605|NCT01432327|1066689|P4|Posttest 6 Months|Allergic reaction|0
315606|NCT01432327|1066690|P3|Posttest 6 Months|Allergic reaction|1
315607|NCT01432327|1066691|P2|Posttest 6 Months|Allergic reaction|0
315608|NCT01432327|1066692|P1|Posttest 6 Months|Allergic reaction|0
315609|NCT01432327|1066689|P4|Posttest 6 Months|Lost to Follow-up|2
315610|NCT01432327|1066690|P3|Posttest 6 Months|Lost to Follow-up|3
315611|NCT01432327|1066691|P2|Posttest 6 Months|Lost to Follow-up|0
315612|NCT01432327|1066692|P1|Posttest 6 Months|Lost to Follow-up|0
315613|NCT01432327|1066689|P4|Posttest 3 Months|Allergic reaction|0
315614|NCT01432327|1066690|P3|Posttest 3 Months|Allergic reaction|0
315615|NCT01432327|1066691|P2|Posttest 3 Months|Allergic reaction|2
315616|NCT01432327|1066692|P1|Posttest 3 Months|Allergic reaction|0
315617|NCT01432327|1066689|P4|Posttest 3 Months|Lost to Follow-up|1
315618|NCT01432327|1066690|P3|Posttest 3 Months|Lost to Follow-up|2
315619|NCT01432327|1066691|P2|Posttest 3 Months|Lost to Follow-up|0
315620|NCT01432327|1066692|P1|Posttest 3 Months|Lost to Follow-up|1
315621|NCT01432327|1066689|P4|Posttest 3 Months|depression|0
315622|NCT01432327|1066690|P3|Posttest 3 Months|depression|0
315623|NCT01432327|1066691|P2|Posttest 3 Months|depression|0
315624|NCT01432327|1066692|P1|Posttest 3 Months|depression|3
315625|NCT01432275|1066702|P2|ADC With Calculator (10 Days)|Protocol Violation|1
315626|NCT01432275|1066703|P1|ADC With Calculator (10 Days)|Protocol Violation|0
315627|NCT01432275|1066702|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
315628|NCT01432275|1066703|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
315629|NCT01432275|1066702|P2|ADC With Calculator (10 Days)|Physician Decision|1
315630|NCT01432275|1066703|P1|ADC With Calculator (10 Days)|Physician Decision|1
315631|NCT01432275|1066702|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
315632|NCT01432275|1066703|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
315633|NCT01432275|1066702|P2|Second BG Meter System (7 Days)|Physician Decision|1
315634|NCT01432275|1066703|P1|Second BG Meter System (7 Days)|Physician Decision|0
315635|NCT01432275|1066702|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
315636|NCT01432275|1066703|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
315637|NCT01432275|1066702|P2|Second BG Meter System (7 Days)|Adverse Event|1
315638|NCT01432275|1066703|P1|Second BG Meter System (7 Days)|Adverse Event|1
315639|NCT01432275|1066702|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
315640|NCT01432275|1066703|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
315641|NCT01432275|1066702|P2|First BG Meter System (7 Days)|Adverse Event|2
315642|NCT01432275|1066703|P1|First BG Meter System (7 Days)|Adverse Event|0
315643|NCT01432262|1066712|P2|Overall Study|Withdrawal by Subject|1
315644|NCT01432262|1066713|P1|Overall Study|Withdrawal by Subject|2
315645|NCT01431976|1066807|P1|Overall Study|Withdrawal by Subject|1
315646|NCT01431976|1066807|P1|Overall Study|Physician Decision|1
315647|NCT01431976|1066807|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
315648|NCT01431976|1066807|P1|Overall Study|Lack of Efficacy|2
315649|NCT01431976|1066807|P1|Overall Study|Adverse Event|6
315650|NCT01431963|1066818|P1|Overall Study|Withdrawal by Subject|3
315651|NCT01431963|1066818|P1|Overall Study|Physician Decision|4
315652|NCT01431963|1066818|P1|Overall Study|Protocol-defined Stopping Criteria|2
315653|NCT01431963|1066818|P1|Overall Study|Protocol Violation|1
315654|NCT01431963|1066818|P1|Overall Study|Lack of Efficacy|7
315655|NCT01431963|1066818|P1|Overall Study|Adverse Event|18
315656|NCT01431950|1066826|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
315657|NCT01431950|1066827|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
315658|NCT01431950|1066826|P2|Overall Study|Lost to Follow-up|1
315659|NCT01431950|1066827|P1|Overall Study|Lost to Follow-up|0
315660|NCT01431950|1066826|P2|Overall Study|Lack of Efficacy|1
315661|NCT01431950|1066827|P1|Overall Study|Lack of Efficacy|2
315662|NCT01431950|1066826|P2|Overall Study|Physician Decision|1
315663|NCT01431950|1066827|P1|Overall Study|Physician Decision|2
315664|NCT01431950|1066826|P2|Overall Study|Adverse Event|2
315665|NCT01431950|1066827|P1|Overall Study|Adverse Event|2
315666|NCT01431950|1066826|P2|Overall Study|Protocol Violation|3
315667|NCT01431950|1066827|P1|Overall Study|Protocol Violation|2
315668|NCT01431950|1066826|P2|Overall Study|Withdrawal by Subject|3
315669|NCT01431950|1066827|P1|Overall Study|Withdrawal by Subject|4
315670|NCT01431950|1066826|P2|Overall Study|Study Site Closed/Terminated|3
315671|NCT01431950|1066827|P1|Overall Study|Study Site Closed/Terminated|7
315672|NCT01431716|1066865|P1|Overall Study|Withdrawal of consent|1
315673|NCT01431521|1066890|P4|Overall Study|Withdrawal by Subject|0
315674|NCT01431521|1066891|P3|Overall Study|Withdrawal by Subject|1
315675|NCT01431521|1066892|P2|Overall Study|Withdrawal by Subject|0
315676|NCT01431521|1066893|P1|Overall Study|Withdrawal by Subject|0
315677|NCT01431508|1066914|P1|Overall Study|Unable to Follow Protocol Procedures|1
315678|NCT01431508|1066914|P1|Overall Study|Lack of Efficacy|1
315679|NCT01431287|1066965|P5|Overall Study|not stated above|1
315680|NCT01431287|1066966|P4|Overall Study|not stated above|2
315681|NCT01431287|1066967|P3|Overall Study|not stated above|2
315682|NCT01431287|1066968|P2|Overall Study|not stated above|2
315683|NCT01431287|1066969|P1|Overall Study|not stated above|4
315684|NCT01431287|1066965|P5|Overall Study|Consent withdrawn not due to AE|29
315685|NCT01431287|1066966|P4|Overall Study|Consent withdrawn not due to AE|19
315686|NCT01431287|1066967|P3|Overall Study|Consent withdrawn not due to AE|34
315687|NCT01431287|1066968|P2|Overall Study|Consent withdrawn not due to AE|30
315688|NCT01431287|1066969|P1|Overall Study|Consent withdrawn not due to AE|29
315689|NCT01431287|1066965|P5|Overall Study|Lost to Follow-up|1
315690|NCT01431287|1066966|P4|Overall Study|Lost to Follow-up|3
315691|NCT01431287|1066967|P3|Overall Study|Lost to Follow-up|2
315692|NCT01431287|1066968|P2|Overall Study|Lost to Follow-up|3
315693|NCT01431287|1066969|P1|Overall Study|Lost to Follow-up|0
315694|NCT01431287|1066965|P5|Overall Study|Non compliant with protocol|5
315695|NCT01431287|1066966|P4|Overall Study|Non compliant with protocol|6
315696|NCT01431287|1066967|P3|Overall Study|Non compliant with protocol|5
315697|NCT01431287|1066968|P2|Overall Study|Non compliant with protocol|6
315698|NCT01431287|1066969|P1|Overall Study|Non compliant with protocol|6
315699|NCT01431287|1066965|P5|Overall Study|Adverse Event|41
315700|NCT01431287|1066966|P4|Overall Study|Adverse Event|33
315701|NCT01431287|1066967|P3|Overall Study|Adverse Event|53
315702|NCT01431287|1066968|P2|Overall Study|Adverse Event|57
315703|NCT01431287|1066969|P1|Overall Study|Adverse Event|59
315704|NCT01431287|1066965|P5|Overall Study|not treated|0
315705|NCT01431287|1066966|P4|Overall Study|not treated|0
315706|NCT01431287|1066967|P3|Overall Study|not treated|1
315707|NCT01431287|1066968|P2|Overall Study|not treated|0
315708|NCT01431287|1066969|P1|Overall Study|not treated|0
315709|NCT01431274|1067131|P5|Overall Study|Other reason not stated above|4
315710|NCT01431274|1067132|P4|Overall Study|Other reason not stated above|2
315711|NCT01431274|1067133|P3|Overall Study|Other reason not stated above|7
315712|NCT01431274|1067134|P2|Overall Study|Other reason not stated above|5
315713|NCT01431274|1067135|P1|Overall Study|Other reason not stated above|6
315714|NCT01431274|1067131|P5|Overall Study|Lost to Follow-up|0
315715|NCT01431274|1067132|P4|Overall Study|Lost to Follow-up|4
315716|NCT01431274|1067133|P3|Overall Study|Lost to Follow-up|1
315717|NCT01431274|1067134|P2|Overall Study|Lost to Follow-up|7
315718|NCT01431274|1067135|P1|Overall Study|Lost to Follow-up|6
315719|NCT01431274|1067131|P5|Overall Study|Non compliant with protocol|4
315720|NCT01431274|1067132|P4|Overall Study|Non compliant with protocol|4
315721|NCT01431274|1067133|P3|Overall Study|Non compliant with protocol|4
315722|NCT01431274|1067134|P2|Overall Study|Non compliant with protocol|8
315723|NCT01431274|1067135|P1|Overall Study|Non compliant with protocol|5
315724|NCT01431274|1067131|P5|Overall Study|Consent withdrawn not due to AE|11
315725|NCT01431274|1067132|P4|Overall Study|Consent withdrawn not due to AE|20
315726|NCT01431274|1067133|P3|Overall Study|Consent withdrawn not due to AE|17
315727|NCT01431274|1067134|P2|Overall Study|Consent withdrawn not due to AE|20
315728|NCT01431274|1067135|P1|Overall Study|Consent withdrawn not due to AE|29
315729|NCT01431274|1067131|P5|Overall Study|Adverse Event|37
315730|NCT01431274|1067132|P4|Overall Study|Adverse Event|30
315731|NCT01431274|1067133|P3|Overall Study|Adverse Event|43
315732|NCT01431274|1067134|P2|Overall Study|Adverse Event|37
315733|NCT01431274|1067135|P1|Overall Study|Adverse Event|51
315734|NCT01431144|1067313|P2|Overall Study|Implant mobility and removal|0
315735|NCT01431144|1067314|P1|Overall Study|Implant mobility and removal|2
315736|NCT01431079|1067333|P2|Overall Study|Lost to Follow-up|39
315737|NCT01431079|1067334|P1|Overall Study|Lost to Follow-up|35
315738|NCT01430754|1067413|P2|Run-In Phase|Lost to Follow-up|0
315739|NCT01430754|1067414|P1|Run-In Phase|Lost to Follow-up|1
315740|NCT01430754|1067413|P2|Run-In Phase|Withdrawal by Subject|0
315741|NCT01430754|1067414|P1|Run-In Phase|Withdrawal by Subject|2
315742|NCT01430754|1067413|P2|Run-In Phase|Other|0
315743|NCT01430754|1067414|P1|Run-In Phase|Other|2
315744|NCT01430754|1067413|P2|Run-In Phase|Adverse Event|0
315745|NCT01430754|1067414|P1|Run-In Phase|Adverse Event|2
315746|NCT01430754|1067413|P2|Run-In Phase|Protocol Violation|0
315747|NCT01430754|1067414|P1|Run-In Phase|Protocol Violation|6
315748|NCT01430754|1067413|P2|Run-In Phase|Circadian Period Ineligible|0
315749|NCT01430754|1067414|P1|Run-In Phase|Circadian Period Ineligible|24
315750|NCT01430624|1067472|P3|Overall Study|technical or eligibility|2
315751|NCT01430624|1067473|P2|Overall Study|technical or eligibility|5
315752|NCT01430624|1067474|P1|Overall Study|technical or eligibility|5
315753|NCT01430624|1067472|P3|Overall Study|Lost to Follow-up|27
315754|NCT01430624|1067473|P2|Overall Study|Lost to Follow-up|29
315755|NCT01430624|1067474|P1|Overall Study|Lost to Follow-up|23
315756|NCT01430611|1067505|P2|Overall Study|Withdrawal by Subject|14
315757|NCT01430611|1067506|P1|Overall Study|Withdrawal by Subject|15
315758|NCT01430611|1067505|P2|Overall Study|Lost to Follow-up|0
315759|NCT01430611|1067506|P1|Overall Study|Lost to Follow-up|1
315760|NCT01430611|1067505|P2|Overall Study|Protocol Violation|0
315761|NCT01430611|1067506|P1|Overall Study|Protocol Violation|1
315762|NCT01430611|1067505|P2|Overall Study|Adverse Event|1
315763|NCT01430611|1067506|P1|Overall Study|Adverse Event|0
315764|NCT01430585|1067524|P1|Overall Study|Other|7
315765|NCT01430585|1067524|P1|Overall Study|Study Terminated by Sponsor|3
315766|NCT01430585|1067524|P1|Overall Study|Objective Progression or Relapse|3
315767|NCT01430585|1067524|P1|Overall Study|Death|1
315768|NCT01430468|1067559|P2|Overall Study|Withdrawal by Subject|1
315769|NCT01430468|1067560|P1|Overall Study|Withdrawal by Subject|1
315770|NCT01430468|1067559|P2|Overall Study|Physician Decision|1
315771|NCT01430468|1067560|P1|Overall Study|Physician Decision|2
315772|NCT01430455|1067566|P1|Overall Study|Switched to follow-up phase|1
315773|NCT01430455|1067566|P1|Overall Study|Withdrawal by Subject|1
315774|NCT01430403|1067573|P3|Overall Study|Withdrawal by Subject|3
315775|NCT01430403|1067574|P2|Overall Study|Withdrawal by Subject|1
315776|NCT01430403|1067575|P1|Overall Study|Withdrawal by Subject|9
315777|NCT01430403|1067573|P3|Overall Study|Protocol Violation|2
315778|NCT01430403|1067574|P2|Overall Study|Protocol Violation|3
315779|NCT01430403|1067575|P1|Overall Study|Protocol Violation|2
315780|NCT01430403|1067573|P3|Overall Study|Physician Decision|0
315781|NCT01430403|1067574|P2|Overall Study|Physician Decision|0
315782|NCT01430403|1067575|P1|Overall Study|Physician Decision|1
315783|NCT01430403|1067573|P3|Overall Study|Lost to Follow-up|3
315784|NCT01430403|1067574|P2|Overall Study|Lost to Follow-up|5
315785|NCT01430403|1067575|P1|Overall Study|Lost to Follow-up|5
315786|NCT01430130|1067682|P1|Overall Study|Infection on Control Side of Incision|1
315787|NCT01430130|1067682|P1|Overall Study|Lost to Follow-up|1
315788|NCT01430104|1067688|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
315789|NCT01429623|1067741|P2|Overall Study|No post baseline data|4
315790|NCT01429623|1067742|P1|Overall Study|No post baseline data|4
315791|NCT01429623|1067741|P2|Overall Study|Conversion to Alzheimer's disease|21
315792|NCT01429623|1067742|P1|Overall Study|Conversion to Alzheimer's disease|14
315793|NCT01429623|1067741|P2|Overall Study|Assorted|2
315794|NCT01429623|1067742|P1|Overall Study|Assorted|1
315795|NCT01429623|1067741|P2|Overall Study|Protocol Violation|2
315796|NCT01429623|1067742|P1|Overall Study|Protocol Violation|3
315797|NCT01429623|1067741|P2|Overall Study|Physician Decision|3
315798|NCT01429623|1067742|P1|Overall Study|Physician Decision|2
315799|NCT01429623|1067741|P2|Overall Study|Withdrawal by Subject|13
315800|NCT01429623|1067742|P1|Overall Study|Withdrawal by Subject|19
315801|NCT01429623|1067741|P2|Overall Study|Adverse Event|14
315802|NCT01429623|1067742|P1|Overall Study|Adverse Event|7
315803|NCT01429623|1067741|P2|Overall Study|Death|0
315804|NCT01429623|1067742|P1|Overall Study|Death|1
315805|NCT01429584|1067756|P2|Overall Study|Protocol Violation|1
315806|NCT01429584|1067757|P1|Overall Study|Protocol Violation|0
315807|NCT01429584|1067756|P2|Overall Study|Withdrawal by Subject|0
315808|NCT01429584|1067757|P1|Overall Study|Withdrawal by Subject|1
315809|NCT01429441|1067788|P2|Overall Study|Withdrawal by Subject|18
315810|NCT01429441|1067789|P1|Overall Study|Withdrawal by Subject|27
315811|NCT01429441|1067788|P2|Overall Study|Physician Decision|0
315812|NCT01429441|1067789|P1|Overall Study|Physician Decision|1
315813|NCT01429441|1067788|P2|Overall Study|Lost to Follow-up|2
315814|NCT01429441|1067789|P1|Overall Study|Lost to Follow-up|5
315815|NCT01429441|1067788|P2|Overall Study|Death|2
315816|NCT01429441|1067789|P1|Overall Study|Death|0
315817|NCT01429441|1067788|P2|Overall Study|Adverse Event|1
315818|NCT01429441|1067789|P1|Overall Study|Adverse Event|5
315819|NCT01429298|1067799|P2|Overall Study|Protocol Violation|6
315820|NCT01429298|1067800|P1|Overall Study|Protocol Violation|4
315821|NCT01429285|1067816|P2|Overall Study|Erroneously Enrolled Twice|2
315822|NCT01429285|1067817|P1|Overall Study|Erroneously Enrolled Twice|8
315823|NCT01429285|1067816|P2|Overall Study|Missing Data|3
315824|NCT01429285|1067817|P1|Overall Study|Missing Data|5
315825|NCT01429285|1067816|P2|Overall Study|Protocol Violation|4
315826|NCT01429285|1067817|P1|Overall Study|Protocol Violation|9
315827|NCT01429077|1067863|P2|Overall Study|Lost to Follow-up|3
315828|NCT01429077|1067864|P1|Overall Study|Lost to Follow-up|0
315829|NCT01429051|1067887|P1|Tolerability Phase|Other|2
315830|NCT01429051|1067887|P1|Tolerability Phase|Physician Decision|1
315831|NCT01429051|1067887|P1|Tolerability Phase|Withdrawal by Subject|5
315832|NCT01429051|1067887|P1|Tolerability Phase|Adverse Event|2
315833|NCT01429051|1067887|P1|Tolerability Phase|Death|5
315834|NCT01429051|1067887|P1|Efficacy Phase|Death|1
315835|NCT01429051|1067887|P1|Efficacy Phase|Adverse Event|1
315836|NCT01429051|1067887|P1|Titration Phase|Less than 3 BTP episodes per week|2
315837|NCT01429051|1067887|P1|Titration Phase|Unsuccessful titration at any dose|1
315838|NCT01429051|1067887|P1|Titration Phase|Physician Decision|1
315839|NCT01429051|1067887|P1|Titration Phase|Withdrawal by Subject|7
315840|NCT01429051|1067887|P1|Titration Phase|Death|1
315841|NCT01428882|1067910|P2|Overall Study|Protocol Violation|3
315842|NCT01428882|1067911|P1|Overall Study|Protocol Violation|4
315843|NCT01428882|1067910|P2|Overall Study|Lack of Efficacy|7
315844|NCT01428882|1067911|P1|Overall Study|Lack of Efficacy|2
315845|NCT01428713|1067934|P2|Overall Study|Adverse Event|2
315846|NCT01428713|1067935|P1|Overall Study|Adverse Event|0
315847|NCT01428713|1067934|P2|Overall Study|Withdrawal by Subject|1
315848|NCT01428713|1067935|P1|Overall Study|Withdrawal by Subject|1
315849|NCT01428713|1067934|P2|Overall Study|Non-compliance|2
315850|NCT01428713|1067935|P1|Overall Study|Non-compliance|2
315851|NCT01428661|1067944|P3|Open Label Extension|**Various|185
315852|NCT01428661|1067945|P2|Open Label Extension|**Various|0
315853|NCT01428661|1067946|P1|Open Label Extension|**Various|0
315854|NCT01428661|1067944|P3|Open Label Extension|Lack of Efficacy|24
315855|NCT01428661|1067945|P2|Open Label Extension|Lack of Efficacy|0
315856|NCT01428661|1067946|P1|Open Label Extension|Lack of Efficacy|0
315857|NCT01428661|1067944|P3|Open Label Extension|Withdrawal by Subject|49
315858|NCT01428661|1067945|P2|Open Label Extension|Withdrawal by Subject|0
315859|NCT01428661|1067946|P1|Open Label Extension|Withdrawal by Subject|0
315860|NCT01428661|1067944|P3|Open Label Extension|Lost to Follow-up|38
315861|NCT01428661|1067945|P2|Open Label Extension|Lost to Follow-up|0
315862|NCT01428661|1067946|P1|Open Label Extension|Lost to Follow-up|0
315863|NCT01428661|1067944|P3|Open Label Extension|Adverse Event|15
315864|NCT01428661|1067945|P2|Open Label Extension|Adverse Event|0
315865|NCT01428661|1067946|P1|Open Label Extension|Adverse Event|0
315866|NCT01428661|1067944|P3|Open Label Extension|Protocol Violation|9
315867|NCT01428661|1067945|P2|Open Label Extension|Protocol Violation|0
315868|NCT01428661|1067946|P1|Open Label Extension|Protocol Violation|0
315869|NCT01428661|1067944|P3|Double-Masked Phase|*Various|0
315870|NCT01428661|1067945|P2|Double-Masked Phase|*Various|6
315871|NCT01428661|1067946|P1|Double-Masked Phase|*Various|1
315872|NCT01428661|1067944|P3|Double-Masked Phase|Lack of Efficacy|0
315873|NCT01428661|1067945|P2|Double-Masked Phase|Lack of Efficacy|1
315874|NCT01428661|1067946|P1|Double-Masked Phase|Lack of Efficacy|2
315875|NCT01428661|1067944|P3|Double-Masked Phase|Withdrawal by Subject|0
315876|NCT01428661|1067945|P2|Double-Masked Phase|Withdrawal by Subject|20
315877|NCT01428661|1067946|P1|Double-Masked Phase|Withdrawal by Subject|18
315878|NCT01428661|1067944|P3|Double-Masked Phase|Lost to Follow-up|0
315879|NCT01428661|1067945|P2|Double-Masked Phase|Lost to Follow-up|14
315880|NCT01428661|1067946|P1|Double-Masked Phase|Lost to Follow-up|14
315881|NCT01428661|1067944|P3|Double-Masked Phase|Adverse Event|0
315882|NCT01428661|1067945|P2|Double-Masked Phase|Adverse Event|4
315883|NCT01428661|1067946|P1|Double-Masked Phase|Adverse Event|13
315884|NCT01428661|1067944|P3|Double-Masked Phase|Protocol Violation|0
315885|NCT01428661|1067945|P2|Double-Masked Phase|Protocol Violation|4
315886|NCT01428661|1067946|P1|Double-Masked Phase|Protocol Violation|9
315887|NCT01428583|1067954|P1|Overall Study|Other|6
315888|NCT01428583|1067954|P1|Overall Study|Sponsor’s request|3
315889|NCT01428583|1067954|P1|Overall Study|Confirmed positive urine drug test|8
315890|NCT01428583|1067954|P1|Overall Study|Non-compliant|25
315891|NCT01428583|1067954|P1|Overall Study|Physician Decision|12
315892|NCT01428583|1067954|P1|Overall Study|Protocol Violation|1
315893|NCT01428583|1067954|P1|Overall Study|Pregnancy|1
315894|NCT01428583|1067954|P1|Overall Study|Death|1
315895|NCT01428583|1067954|P1|Overall Study|Lost to Follow-up|17
315896|NCT01428583|1067954|P1|Overall Study|Lack of Efficacy|37
315897|NCT01428583|1067954|P1|Overall Study|Withdrawal by Subject|51
315898|NCT01428583|1067954|P1|Overall Study|Adverse Event|75
315899|NCT01428258|1067991|P2|Intervention 1|Withdrawal by Subject|0
315900|NCT01428258|1067992|P1|Intervention 1|Withdrawal by Subject|2
315901|NCT01428219|1068010|P1|Overall Study|25 patients enrolled, 3 were not treated|3
315902|NCT01428193|1068021|P1|Overall Study|Elevated screening liver enzymes|1
315903|NCT01428193|1068021|P1|Overall Study|Physician Decision|1
315904|NCT01428128|1068025|P1|Overall Study|Adverse Event|1
315905|NCT01428128|1068025|P1|Overall Study|Received Neulasta in one cycle|2
315906|NCT01428128|1068025|P1|Overall Study|Screen failure by p53|10
315907|NCT01428128|1068025|P1|Overall Study|Withdrawal by Subject|4
315908|NCT01428115|1068030|P1|Overall Study|Withdrawal by Subject|4
315909|NCT01428115|1068030|P1|Overall Study|Protocol Violation|3
315910|NCT01428115|1068030|P1|Overall Study|Pregnancy|1
315911|NCT01428115|1068030|P1|Overall Study|Lost to Follow-up|10
315912|NCT01428115|1068030|P1|Overall Study|Lack of Efficacy|3
315913|NCT01428076|1068045|P2|Overall Study|Adverse Event|1
315914|NCT01428076|1068046|P1|Overall Study|Adverse Event|0
315915|NCT01428063|1068057|P3|Overall Study|No longer meets study criteria|0
315916|NCT01428063|1068058|P2|Overall Study|No longer meets study criteria|1
315917|NCT01428063|1068059|P1|Overall Study|No longer meets study criteria|0
315918|NCT01428063|1068057|P3|Overall Study|Lost to Follow-up|0
315919|NCT01428063|1068058|P2|Overall Study|Lost to Follow-up|2
315920|NCT01428063|1068059|P1|Overall Study|Lost to Follow-up|0
315921|NCT01428063|1068057|P3|Overall Study|Adverse Event|0
315922|NCT01428063|1068058|P2|Overall Study|Adverse Event|3
315923|NCT01428063|1068059|P1|Overall Study|Adverse Event|2
315924|NCT01428063|1068057|P3|Overall Study|Lack of Efficacy|1
315925|NCT01428063|1068058|P2|Overall Study|Lack of Efficacy|4
315926|NCT01428063|1068059|P1|Overall Study|Lack of Efficacy|8
315927|NCT01427933|1068130|P2|Overall Study|Investigator's Decision|0
315928|NCT01427933|1068131|P1|Overall Study|Investigator's Decision|1
315929|NCT01427933|1068130|P2|Overall Study|Not Specified|0
315930|NCT01427933|1068131|P1|Overall Study|Not Specified|1
315931|NCT01427933|1068130|P2|Overall Study|Lost to Follow-up|5
315932|NCT01427933|1068131|P1|Overall Study|Lost to Follow-up|1
315933|NCT01427933|1068130|P2|Overall Study|Withdrawal by Subject|8
315934|NCT01427933|1068131|P1|Overall Study|Withdrawal by Subject|5
315935|NCT01427920|1068151|P2|Overall Study|Unclassified|8
315936|NCT01427920|1068152|P1|Overall Study|Unclassified|2
315937|NCT01427920|1068151|P2|Overall Study|Withdrawal Criteria|4
315938|NCT01427920|1068152|P1|Overall Study|Withdrawal Criteria|4
315939|NCT01427920|1068151|P2|Overall Study|Protocol Violation|3
315940|NCT01427920|1068152|P1|Overall Study|Protocol Violation|1
315941|NCT01427920|1068151|P2|Overall Study|Lack of Efficacy|0
315942|NCT01427920|1068152|P1|Overall Study|Lack of Efficacy|1
315943|NCT01427920|1068151|P2|Overall Study|Adverse Event|2
315944|NCT01427920|1068152|P1|Overall Study|Adverse Event|1
315945|NCT01427907|1068172|P2|Overall Study|Withdrawal by Subject|4
315946|NCT01427907|1068173|P1|Overall Study|Withdrawal by Subject|3
315947|NCT01427803|1068194|P2|Overall Study|did not take product|0
315948|NCT01427803|1068195|P1|Overall Study|did not take product|1
315949|NCT01427803|1068194|P2|Overall Study|Physician Decision|0
315950|NCT01427803|1068195|P1|Overall Study|Physician Decision|3
315951|NCT01427803|1068194|P2|Overall Study|Protocol Violation|0
315952|NCT01427803|1068195|P1|Overall Study|Protocol Violation|1
315953|NCT01427803|1068194|P2|Overall Study|Unable to complete full treatment period|0
315954|NCT01427803|1068195|P1|Overall Study|Unable to complete full treatment period|6
315955|NCT01427803|1068194|P2|Overall Study|Withdrawal by Subject|0
315956|NCT01427803|1068195|P1|Overall Study|Withdrawal by Subject|20
315957|NCT01427803|1068194|P2|Overall Study|Lost to Follow-up|26
315958|NCT01427803|1068195|P1|Overall Study|Lost to Follow-up|32
315959|NCT01427751|1068209|P2|Overall Study|Other miscellaneous reasons|4
315960|NCT01427751|1068210|P1|Overall Study|Other miscellaneous reasons|6
315961|NCT01427751|1068209|P2|Overall Study|Death|0
315962|NCT01427751|1068210|P1|Overall Study|Death|2
315963|NCT01427751|1068209|P2|Overall Study|Protocol Violation|4
315964|NCT01427751|1068210|P1|Overall Study|Protocol Violation|6
315965|NCT01427751|1068209|P2|Overall Study|Withdrawal of consent|2
315966|NCT01427751|1068210|P1|Overall Study|Withdrawal of consent|2
315967|NCT01427751|1068209|P2|Overall Study|Lost to Follow-up|1
315968|NCT01427751|1068210|P1|Overall Study|Lost to Follow-up|3
315969|NCT01427751|1068209|P2|Overall Study|No further treatment benefit expected|1
315970|NCT01427751|1068210|P1|Overall Study|No further treatment benefit expected|5
315971|NCT01427751|1068209|P2|Overall Study|Adverse Event|2
315972|NCT01427751|1068210|P1|Overall Study|Adverse Event|18
315973|NCT01427738|1068230|P2|Overall Study|Lost to Follow-up|5
315974|NCT01427738|1068231|P1|Overall Study|Lost to Follow-up|1
315975|NCT01427738|1068230|P2|Overall Study|Subject not willing to adhere to reqs|2
315976|NCT01427738|1068231|P1|Overall Study|Subject not willing to adhere to reqs|1
315977|NCT01427738|1068230|P2|Overall Study|Withdrawal by Subject|2
315978|NCT01427738|1068231|P1|Overall Study|Withdrawal by Subject|0
315979|NCT01427738|1068230|P2|Overall Study|Subject unable to get to clinic|2
315980|NCT01427738|1068231|P1|Overall Study|Subject unable to get to clinic|5
315981|NCT01427738|1068230|P2|Overall Study|Severe debilitation, unable to continue|1
315982|NCT01427738|1068231|P1|Overall Study|Severe debilitation, unable to continue|0
315983|NCT01427738|1068230|P2|Overall Study|Death|9
315984|NCT01427738|1068231|P1|Overall Study|Death|12
315985|NCT01427309|1068294|P4|Overall Study|Withdrawal by Subject|55
315986|NCT01427309|1068295|P3|Overall Study|Withdrawal by Subject|61
315987|NCT01427309|1068296|P2|Overall Study|Withdrawal by Subject|148
315988|NCT01427309|1068297|P1|Overall Study|Withdrawal by Subject|148
315989|NCT01427309|1068294|P4|Overall Study|Serious adverse event|61
315990|NCT01427309|1068295|P3|Overall Study|Serious adverse event|50
315991|NCT01427309|1068296|P2|Overall Study|Serious adverse event|45
315992|NCT01427309|1068297|P1|Overall Study|Serious adverse event|52
315993|NCT01427309|1068294|P4|Overall Study|Adverse Event|1
315994|NCT01427309|1068295|P3|Overall Study|Adverse Event|3
315995|NCT01427309|1068296|P2|Overall Study|Adverse Event|0
315996|NCT01427309|1068297|P1|Overall Study|Adverse Event|0
315997|NCT01427309|1068294|P4|Overall Study|Protocol Violation|124
315998|NCT01427309|1068295|P3|Overall Study|Protocol Violation|125
315999|NCT01427309|1068296|P2|Overall Study|Protocol Violation|69
316000|NCT01427309|1068297|P1|Overall Study|Protocol Violation|42
316001|NCT01427309|1068294|P4|Overall Study|Lost to Follow-up|135
316002|NCT01427309|1068295|P3|Overall Study|Lost to Follow-up|122
316003|NCT01427309|1068296|P2|Overall Study|Lost to Follow-up|145
316004|NCT01427309|1068297|P1|Overall Study|Lost to Follow-up|130
316005|NCT01426958|1068344|P1|Overall Study|Adverse Event|2
316006|NCT01426854|1068373|P2|Overall Study|Other|2
316007|NCT01426854|1068374|P1|Overall Study|Other|3
316008|NCT01426854|1068373|P2|Overall Study|Protocol Deviation|1
316009|NCT01426854|1068374|P1|Overall Study|Protocol Deviation|0
316010|NCT01426854|1068373|P2|Overall Study|Treatment Failure|16
316011|NCT01426854|1068374|P1|Overall Study|Treatment Failure|0
316012|NCT01426854|1068373|P2|Overall Study|Noncompliance|1
316013|NCT01426854|1068374|P1|Overall Study|Noncompliance|0
316014|NCT01426854|1068373|P2|Overall Study|Lost to Follow-up|0
316015|NCT01426854|1068374|P1|Overall Study|Lost to Follow-up|3
316016|NCT01426854|1068373|P2|Overall Study|Subject Decision Unrelated to AE|6
316017|NCT01426854|1068374|P1|Overall Study|Subject Decision Unrelated to AE|5
316018|NCT01426854|1068373|P2|Overall Study|Adverse Event|5
316019|NCT01426854|1068374|P1|Overall Study|Adverse Event|1
316020|NCT01426789|1068384|P6|Part 2|Adverse Event|0
316021|NCT01426789|1068385|P5|Part 2|Adverse Event|1
316022|NCT01426789|1068386|P4|Part 2|Adverse Event|0
316023|NCT01426789|1068387|P3|Part 2|Adverse Event|2
316024|NCT01426789|1068388|P2|Part 2|Adverse Event|0
316025|NCT01426789|1068389|P1|Part 2|Adverse Event|0
316026|NCT01426789|1068384|P6|Part 2|Lack of Efficacy|0
316027|NCT01426789|1068385|P5|Part 2|Lack of Efficacy|2
316028|NCT01426789|1068386|P4|Part 2|Lack of Efficacy|0
316029|NCT01426789|1068387|P3|Part 2|Lack of Efficacy|5
316030|NCT01426789|1068388|P2|Part 2|Lack of Efficacy|0
316031|NCT01426789|1068389|P1|Part 2|Lack of Efficacy|0
316032|NCT01426789|1068384|P6|Part 2|Withdrawal by Subject|0
316033|NCT01426789|1068385|P5|Part 2|Withdrawal by Subject|2
316034|NCT01426789|1068386|P4|Part 2|Withdrawal by Subject|1
316035|NCT01426789|1068387|P3|Part 2|Withdrawal by Subject|0
316036|NCT01426789|1068388|P2|Part 2|Withdrawal by Subject|0
316037|NCT01426789|1068389|P1|Part 2|Withdrawal by Subject|0
316038|NCT01426789|1068384|P6|Part 2|Lost to Follow-up|0
316039|NCT01426789|1068385|P5|Part 2|Lost to Follow-up|1
316040|NCT01426789|1068386|P4|Part 2|Lost to Follow-up|0
316041|NCT01426789|1068387|P3|Part 2|Lost to Follow-up|4
316042|NCT01426789|1068388|P2|Part 2|Lost to Follow-up|0
316043|NCT01426789|1068389|P1|Part 2|Lost to Follow-up|0
316044|NCT01426789|1068384|P6|Part 2|Administrative problems|0
316045|NCT01426789|1068385|P5|Part 2|Administrative problems|1
316046|NCT01426789|1068386|P4|Part 2|Administrative problems|0
316047|NCT01426789|1068387|P3|Part 2|Administrative problems|2
316048|NCT01426789|1068388|P2|Part 2|Administrative problems|0
316049|NCT01426789|1068389|P1|Part 2|Administrative problems|0
316050|NCT01426789|1068384|P6|Part 2|Death|0
316051|NCT01426789|1068385|P5|Part 2|Death|1
316052|NCT01426789|1068386|P4|Part 2|Death|0
316053|NCT01426789|1068387|P3|Part 2|Death|1
316054|NCT01426789|1068388|P2|Part 2|Death|0
316055|NCT01426789|1068389|P1|Part 2|Death|0
316056|NCT01426789|1068384|P6|Part 2|Protocol deviation|0
316057|NCT01426789|1068385|P5|Part 2|Protocol deviation|0
316058|NCT01426789|1068386|P4|Part 2|Protocol deviation|0
316059|NCT01426789|1068387|P3|Part 2|Protocol deviation|1
316060|NCT01426789|1068388|P2|Part 2|Protocol deviation|0
316061|NCT01426789|1068389|P1|Part 2|Protocol deviation|0
316062|NCT01426789|1068384|P6|Part 1|Adverse Event|0
316063|NCT01426789|1068385|P5|Part 1|Adverse Event|0
316064|NCT01426789|1068386|P4|Part 1|Adverse Event|0
316065|NCT01426789|1068387|P3|Part 1|Adverse Event|0
316066|NCT01426789|1068388|P2|Part 1|Adverse Event|0
316067|NCT01426789|1068389|P1|Part 1|Adverse Event|3
316068|NCT01426789|1068384|P6|Part 1|Lack of Efficacy|0
316069|NCT01426789|1068385|P5|Part 1|Lack of Efficacy|0
316070|NCT01426789|1068386|P4|Part 1|Lack of Efficacy|0
316071|NCT01426789|1068387|P3|Part 1|Lack of Efficacy|0
316072|NCT01426789|1068388|P2|Part 1|Lack of Efficacy|1
316073|NCT01426789|1068389|P1|Part 1|Lack of Efficacy|2
316074|NCT01426789|1068384|P6|Part 1|Lost to Follow-up|0
316075|NCT01426789|1068385|P5|Part 1|Lost to Follow-up|0
316076|NCT01426789|1068386|P4|Part 1|Lost to Follow-up|0
316077|NCT01426789|1068387|P3|Part 1|Lost to Follow-up|0
316078|NCT01426789|1068388|P2|Part 1|Lost to Follow-up|2
316079|NCT01426789|1068389|P1|Part 1|Lost to Follow-up|1
316080|NCT01426789|1068384|P6|Part 1|Protocol deviation|0
316081|NCT01426789|1068385|P5|Part 1|Protocol deviation|0
316082|NCT01426789|1068386|P4|Part 1|Protocol deviation|0
316083|NCT01426789|1068387|P3|Part 1|Protocol deviation|0
316084|NCT01426789|1068388|P2|Part 1|Protocol deviation|1
316085|NCT01426789|1068389|P1|Part 1|Protocol deviation|0
316086|NCT01426438|1068434|P2|Overall Study|Missed Scan|2
316087|NCT01426438|1068435|P1|Overall Study|Missed Scan|2
316088|NCT01426438|1068434|P2|Overall Study|Poor scan quality|2
316089|NCT01426438|1068435|P1|Overall Study|Poor scan quality|3
316090|NCT01426438|1068434|P2|Overall Study|Off study Treatment|3
316091|NCT01426438|1068435|P1|Overall Study|Off study Treatment|9
316092|NCT01426438|1068434|P2|Overall Study|Lost to Follow-up|3
316093|NCT01426438|1068435|P1|Overall Study|Lost to Follow-up|1
316094|NCT01426425|1068467|P1|Overall Study|Met inclusion/exclusion, not treated|2
316095|NCT01426425|1068467|P1|Overall Study|Inclusion/exclusion criteria not met|151
316096|NCT01426425|1068467|P1|Overall Study|Exited prior to EP study|22
316097|NCT01426373|1068473|P1|Overall Study|Miscellaneous Reasons|4
316098|NCT01426373|1068473|P1|Overall Study|Participant Convenience|10
316099|NCT01426373|1068473|P1|Overall Study|Lost to Follow-up|14
316100|NCT01426373|1068473|P1|Overall Study|Adverse Event|6
316101|NCT01426347|1068506|P2|Overall Study|Withdrawal by Subject|0
316102|NCT01426347|1068507|P1|Overall Study|Withdrawal by Subject|5
316103|NCT01426347|1068506|P2|Overall Study|Protocol Violation|0
316104|NCT01426347|1068507|P1|Overall Study|Protocol Violation|2
316105|NCT01426347|1068506|P2|Overall Study|Lost to Follow-up|3
316106|NCT01426347|1068507|P1|Overall Study|Lost to Follow-up|0
316107|NCT01426269|1068515|P3|Period 2: 40 Weeks|Relapsed|18
316108|NCT01426269|1068516|P2|Period 2: 40 Weeks|Relapsed|9
316109|NCT01426269|1068517|P1|Period 2: 40 Weeks|Relapsed|0
316110|NCT01426269|1068515|P3|Period 2: 40 Weeks|Site closed|5
316111|NCT01426269|1068516|P2|Period 2: 40 Weeks|Site closed|6
316112|NCT01426269|1068517|P1|Period 2: 40 Weeks|Site closed|0
316113|NCT01426269|1068515|P3|Period 2: 40 Weeks|Lost to Follow-up|6
316114|NCT01426269|1068516|P2|Period 2: 40 Weeks|Lost to Follow-up|8
316115|NCT01426269|1068517|P1|Period 2: 40 Weeks|Lost to Follow-up|0
316116|NCT01426269|1068515|P3|Period 2: 40 Weeks|Protocol Violation|5
316117|NCT01426269|1068516|P2|Period 2: 40 Weeks|Protocol Violation|5
316118|NCT01426269|1068517|P1|Period 2: 40 Weeks|Protocol Violation|0
316119|NCT01426269|1068515|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
316120|NCT01426269|1068516|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
316121|NCT01426269|1068517|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
316122|NCT01426269|1068515|P3|Period 2: 40 Weeks|Adverse Event|2
316123|NCT01426269|1068516|P2|Period 2: 40 Weeks|Adverse Event|1
316124|NCT01426269|1068517|P1|Period 2: 40 Weeks|Adverse Event|0
316125|NCT01426269|1068515|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
316126|NCT01426269|1068516|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
316127|NCT01426269|1068517|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
316128|NCT01426269|1068515|P3|Eligibility for Period 2, Randomization|Did not qualify|0
316129|NCT01426269|1068516|P2|Eligibility for Period 2, Randomization|Did not qualify|0
316130|NCT01426269|1068517|P1|Eligibility for Period 2, Randomization|Did not qualify|42
316131|NCT01426269|1068515|P3|Period 1: 12 Weeks|Pregnancy|0
316132|NCT01426269|1068516|P2|Period 1: 12 Weeks|Pregnancy|0
316133|NCT01426269|1068517|P1|Period 1: 12 Weeks|Pregnancy|1
316134|NCT01426269|1068515|P3|Period 1: 12 Weeks|Lost to Follow-up|0
316135|NCT01426269|1068516|P2|Period 1: 12 Weeks|Lost to Follow-up|0
316136|NCT01426269|1068517|P1|Period 1: 12 Weeks|Lost to Follow-up|22
316137|NCT01426269|1068515|P3|Period 1: 12 Weeks|Protocol Violation|0
316138|NCT01426269|1068516|P2|Period 1: 12 Weeks|Protocol Violation|0
316139|NCT01426269|1068517|P1|Period 1: 12 Weeks|Protocol Violation|5
316140|NCT01426269|1068515|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
316141|NCT01426269|1068516|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
316142|NCT01426269|1068517|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
316143|NCT01426269|1068515|P3|Period 1: 12 Weeks|Adverse Event|0
316144|NCT01426269|1068516|P2|Period 1: 12 Weeks|Adverse Event|0
316145|NCT01426269|1068517|P1|Period 1: 12 Weeks|Adverse Event|5
316146|NCT01426113|1068552|P2|Overall Study|Adverse Event|1
316147|NCT01426113|1068553|P1|Overall Study|Adverse Event|0
316148|NCT01426113|1068552|P2|Overall Study|Study Discontinued|1
316149|NCT01426113|1068553|P1|Overall Study|Study Discontinued|1
316150|NCT01426009|1068559|P1|Washout 4|Lost to Follow-up|1
316151|NCT01426009|1068559|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
316152|NCT01426009|1068559|P1|Washout 3|personal reasons|1
316153|NCT01426009|1068559|P1|Washout 2|electrive surgery|1
316154|NCT01426009|1068559|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
316155|NCT01426009|1068559|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
316156|NCT01426009|1068559|P1|Washout 1|Personal Reasons|1
316157|NCT01426009|1068559|P1|Washout 1|Withdrawal by Subject|1
316158|NCT01426009|1068559|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
316159|NCT01426009|1068559|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
316160|NCT01425814|1068655|P6|Period 5|Stability criteria not fulfilled|1
316161|NCT01425814|1068656|P5|Period 5|Stability criteria not fulfilled|0
316162|NCT01425814|1068657|P4|Period 5|Stability criteria not fulfilled|0
316163|NCT01425814|1068658|P3|Period 5|Stability criteria not fulfilled|1
316164|NCT01425814|1068659|P2|Period 5|Stability criteria not fulfilled|0
316165|NCT01425814|1068660|P1|Period 5|Stability criteria not fulfilled|0
316166|NCT01425814|1068655|P6|Period 4|Adverse Event|0
316167|NCT01425814|1068656|P5|Period 4|Adverse Event|0
316168|NCT01425814|1068657|P4|Period 4|Adverse Event|0
316169|NCT01425814|1068658|P3|Period 4|Adverse Event|1
316170|NCT01425814|1068659|P2|Period 4|Adverse Event|0
316171|NCT01425814|1068660|P1|Period 4|Adverse Event|1
316172|NCT01425814|1068655|P6|Period 3|Adverse Event|1
316173|NCT01425814|1068656|P5|Period 3|Adverse Event|0
316174|NCT01425814|1068657|P4|Period 3|Adverse Event|0
316175|NCT01425814|1068658|P3|Period 3|Adverse Event|0
316176|NCT01425814|1068659|P2|Period 3|Adverse Event|0
316177|NCT01425814|1068660|P1|Period 3|Adverse Event|0
316178|NCT01425814|1068655|P6|Period 2|Stability criteria not fulfilled|0
316179|NCT01425814|1068656|P5|Period 2|Stability criteria not fulfilled|0
316180|NCT01425814|1068657|P4|Period 2|Stability criteria not fulfilled|0
316181|NCT01425814|1068658|P3|Period 2|Stability criteria not fulfilled|0
316182|NCT01425814|1068659|P2|Period 2|Stability criteria not fulfilled|1
316183|NCT01425814|1068660|P1|Period 2|Stability criteria not fulfilled|0
316184|NCT01425814|1068655|P6|Period 1|Stability criteria not fulfilled|0
316185|NCT01425814|1068656|P5|Period 1|Stability criteria not fulfilled|0
316186|NCT01425814|1068657|P4|Period 1|Stability criteria not fulfilled|0
316187|NCT01425814|1068658|P3|Period 1|Stability criteria not fulfilled|0
316188|NCT01425814|1068659|P2|Period 1|Stability criteria not fulfilled|1
316189|NCT01425814|1068660|P1|Period 1|Stability criteria not fulfilled|0
316190|NCT01425801|1068752|P6|Period 4|Not able to maintain visit schedule|0
316191|NCT01425801|1068753|P5|Period 4|Not able to maintain visit schedule|0
316192|NCT01425801|1068754|P4|Period 4|Not able to maintain visit schedule|0
316193|NCT01425801|1068755|P3|Period 4|Not able to maintain visit schedule|1
316194|NCT01425801|1068756|P2|Period 4|Not able to maintain visit schedule|0
316195|NCT01425801|1068757|P1|Period 4|Not able to maintain visit schedule|0
316196|NCT01425801|1068752|P6|Period 3|Stability criteria not fullfilled|0
316197|NCT01425801|1068753|P5|Period 3|Stability criteria not fullfilled|0
316198|NCT01425801|1068754|P4|Period 3|Stability criteria not fullfilled|0
316199|NCT01425801|1068755|P3|Period 3|Stability criteria not fullfilled|1
316200|NCT01425801|1068756|P2|Period 3|Stability criteria not fullfilled|0
316201|NCT01425801|1068757|P1|Period 3|Stability criteria not fullfilled|0
316202|NCT01425801|1068752|P6|Period 2|Withdrawal by Subject|0
316203|NCT01425801|1068753|P5|Period 2|Withdrawal by Subject|1
316204|NCT01425801|1068754|P4|Period 2|Withdrawal by Subject|0
316205|NCT01425801|1068755|P3|Period 2|Withdrawal by Subject|0
316206|NCT01425801|1068756|P2|Period 2|Withdrawal by Subject|0
316207|NCT01425801|1068757|P1|Period 2|Withdrawal by Subject|0
316208|NCT01425801|1068752|P6|Period 1|Withdrawal by Subject|0
316209|NCT01425801|1068753|P5|Period 1|Withdrawal by Subject|1
316210|NCT01425801|1068754|P4|Period 1|Withdrawal by Subject|0
316211|NCT01425801|1068755|P3|Period 1|Withdrawal by Subject|0
316212|NCT01425801|1068756|P2|Period 1|Withdrawal by Subject|0
316213|NCT01425801|1068757|P1|Period 1|Withdrawal by Subject|0
316214|NCT01425749|1068863|P2|Overall Study|progression of melanoma|1
316215|NCT01425749|1068864|P1|Overall Study|progression of melanoma|0
316216|NCT01425632|1068882|P3|Overall Study|Withdrawal by Subject|1
316217|NCT01425632|1068883|P2|Overall Study|Withdrawal by Subject|0
316218|NCT01425632|1068884|P1|Overall Study|Withdrawal by Subject|0
316219|NCT01425632|1068882|P3|Overall Study|Protocol Violation|2
316220|NCT01425632|1068883|P2|Overall Study|Protocol Violation|0
316221|NCT01425632|1068884|P1|Overall Study|Protocol Violation|0
316222|NCT01425632|1068882|P3|Overall Study|Physician Decision|0
316223|NCT01425632|1068883|P2|Overall Study|Physician Decision|0
316224|NCT01425632|1068884|P1|Overall Study|Physician Decision|1
316225|NCT01425632|1068882|P3|Overall Study|Adverse Event|1
316226|NCT01425632|1068883|P2|Overall Study|Adverse Event|1
316227|NCT01425632|1068884|P1|Overall Study|Adverse Event|0
316228|NCT01425528|1068894|P2|Overall Study|Withdrawal by Subject|1
316229|NCT01425528|1068895|P1|Overall Study|Withdrawal by Subject|1
316230|NCT01425463|1068903|P2|Overall Study|Unknown Reason|7
316231|NCT01425463|1068904|P1|Overall Study|Unknown Reason|4
316232|NCT01425463|1068903|P2|Overall Study|Withdrawal by Subject|5
316233|NCT01425463|1068904|P1|Overall Study|Withdrawal by Subject|7
316234|NCT01425463|1068903|P2|Overall Study|Lost to Follow-up|2
316235|NCT01425463|1068904|P1|Overall Study|Lost to Follow-up|5
316236|NCT01425463|1068903|P2|Overall Study|Protocol Violation|2
316237|NCT01425463|1068904|P1|Overall Study|Protocol Violation|2
316238|NCT01425463|1068903|P2|Overall Study|Lack of Efficacy|1
316239|NCT01425463|1068904|P1|Overall Study|Lack of Efficacy|1
316240|NCT01425463|1068903|P2|Overall Study|Adverse Event|7
316241|NCT01425463|1068904|P1|Overall Study|Adverse Event|5
316242|NCT01425359|1068920|P2|Overall Study|Did Not Meet Qualifying Criteria|5
316243|NCT01425359|1068921|P1|Overall Study|Did Not Meet Qualifying Criteria|3
316244|NCT01425359|1068920|P2|Overall Study|Investigator’s Discretion|0
316245|NCT01425359|1068921|P1|Overall Study|Investigator’s Discretion|2
316246|NCT01425359|1068920|P2|Overall Study|Subject Withdrew Consent|2
316247|NCT01425359|1068921|P1|Overall Study|Subject Withdrew Consent|1
316248|NCT01425359|1068920|P2|Overall Study|Protocol Violation|2
316249|NCT01425359|1068921|P1|Overall Study|Protocol Violation|1
316250|NCT01425359|1068920|P2|Overall Study|Unsatisfactory Response|0
316251|NCT01425359|1068921|P1|Overall Study|Unsatisfactory Response|1
316252|NCT01425359|1068920|P2|Overall Study|Death|1
316253|NCT01425359|1068921|P1|Overall Study|Death|0
316254|NCT01425359|1068920|P2|Overall Study|Revascularization|1
316255|NCT01425359|1068921|P1|Overall Study|Revascularization|0
316256|NCT01425359|1068920|P2|Overall Study|Adverse Event|8
316257|NCT01425359|1068921|P1|Overall Study|Adverse Event|9
316258|NCT01425359|1068920|P2|Overall Study|Randomized but Not Treated|3
316259|NCT01425359|1068921|P1|Overall Study|Randomized but Not Treated|2
316260|NCT01425268|1068952|P2|Overall Study|Physician Decision|0
316261|NCT01425268|1068953|P1|Overall Study|Physician Decision|1
316262|NCT01425268|1068952|P2|Overall Study|Sponsor Decision|0
316263|NCT01425268|1068953|P1|Overall Study|Sponsor Decision|5
316264|NCT01425268|1068952|P2|Overall Study|Withdrawal by Subject|0
316265|NCT01425268|1068953|P1|Overall Study|Withdrawal by Subject|2
316266|NCT01425203|1068974|P3|Crossover Phase|Other virologic failure criteria|3
316267|NCT01425203|1068975|P2|Crossover Phase|Other virologic failure criteria|0
316268|NCT01425203|1068976|P1|Crossover Phase|Other virologic failure criteria|0
316269|NCT01425203|1068974|P3|Crossover Phase|Failure at futility timepoint|3
316270|NCT01425203|1068975|P2|Crossover Phase|Failure at futility timepoint|0
316271|NCT01425203|1068976|P1|Crossover Phase|Failure at futility timepoint|0
316272|NCT01425203|1068974|P3|Treatment Phase|Did not receive treatment|0
316273|NCT01425203|1068975|P2|Treatment Phase|Did not receive treatment|1
316274|NCT01425203|1068976|P1|Treatment Phase|Did not receive treatment|0
316275|NCT01425203|1068974|P3|Treatment Phase|Unidentified reasons|0
316276|NCT01425203|1068975|P2|Treatment Phase|Unidentified reasons|5
316277|NCT01425203|1068976|P1|Treatment Phase|Unidentified reasons|11
316278|NCT01425203|1068974|P3|Treatment Phase|Other virologic failure criteria|0
316279|NCT01425203|1068975|P2|Treatment Phase|Other virologic failure criteria|3
316280|NCT01425203|1068976|P1|Treatment Phase|Other virologic failure criteria|5
316281|NCT01425203|1068974|P3|Treatment Phase|Failure at futility timepoint|0
316282|NCT01425203|1068975|P2|Treatment Phase|Failure at futility timepoint|27
316283|NCT01425203|1068976|P1|Treatment Phase|Failure at futility timepoint|8
316284|NCT01425203|1068974|P3|Treatment Phase|DC during PR Lead-in Phase|0
316285|NCT01425203|1068975|P2|Treatment Phase|DC during PR Lead-in Phase|1
316286|NCT01425203|1068976|P1|Treatment Phase|DC during PR Lead-in Phase|3
316287|NCT01425190|1068993|P3|Overall Study|Full dose not consumed.|0
316288|NCT01425190|1068994|P2|Overall Study|Full dose not consumed.|0
316289|NCT01425190|1068995|P1|Overall Study|Full dose not consumed.|1
316290|NCT01424930|1069031|P2|Overall Study|Reason not specified|6
316291|NCT01424930|1069032|P1|Overall Study|Reason not specified|0
316292|NCT01424930|1069031|P2|Overall Study|Screen Failure|1
316293|NCT01424930|1069032|P1|Overall Study|Screen Failure|0
316294|NCT01424930|1069031|P2|Overall Study|Progressive Disease|6
316295|NCT01424930|1069032|P1|Overall Study|Progressive Disease|3
316296|NCT01424930|1069031|P2|Overall Study|Death|0
316297|NCT01424930|1069032|P1|Overall Study|Death|1
316298|NCT01424930|1069031|P2|Overall Study|Adverse Event|1
316299|NCT01424930|1069032|P1|Overall Study|Adverse Event|0
316300|NCT01424813|1069046|P2|Overall Study|not specified|2
316301|NCT01424813|1069047|P1|Overall Study|not specified|1
316302|NCT01424813|1069046|P2|Overall Study|Protocol Violation|0
316303|NCT01424813|1069047|P1|Overall Study|Protocol Violation|1
316304|NCT01424813|1069046|P2|Overall Study|Withdrawal by Subject|0
316305|NCT01424813|1069047|P1|Overall Study|Withdrawal by Subject|3
316306|NCT01424644|1069067|P2|Overall Study|Unable to Classify|0
316307|NCT01424644|1069068|P1|Overall Study|Unable to Classify|1
316308|NCT01424644|1069067|P2|Overall Study|Administrative Reason|0
316309|NCT01424644|1069068|P1|Overall Study|Administrative Reason|1
316310|NCT01424644|1069067|P2|Overall Study|Protocol Violation|3
316311|NCT01424644|1069068|P1|Overall Study|Protocol Violation|4
316312|NCT01424644|1069067|P2|Overall Study|Lost to Follow-up|12
316313|NCT01424644|1069068|P1|Overall Study|Lost to Follow-up|16
316314|NCT01424644|1069067|P2|Overall Study|Withdrawal by Subject|12
316315|NCT01424644|1069068|P1|Overall Study|Withdrawal by Subject|9
316316|NCT01424644|1069067|P2|Overall Study|Adverse Event|0
316317|NCT01424644|1069068|P1|Overall Study|Adverse Event|2
316318|NCT01424566|1069082|P3|Double-blind Treatment|Lack of Efficacy|1
316319|NCT01424566|1069083|P2|Double-blind Treatment|Lack of Efficacy|1
316320|NCT01424566|1069084|P1|Double-blind Treatment|Lack of Efficacy|0
316321|NCT01424566|1069082|P3|Double-blind Treatment|Withdrawal by Investigator|1
316322|NCT01424566|1069083|P2|Double-blind Treatment|Withdrawal by Investigator|1
316323|NCT01424566|1069084|P1|Double-blind Treatment|Withdrawal by Investigator|0
316324|NCT01424566|1069082|P3|Double-blind Treatment|Withdrawal by Subject|0
316325|NCT01424566|1069083|P2|Double-blind Treatment|Withdrawal by Subject|2
316326|NCT01424566|1069084|P1|Double-blind Treatment|Withdrawal by Subject|0
316327|NCT01424566|1069082|P3|Double-blind Treatment|Adverse Event|13
316328|NCT01424566|1069083|P2|Double-blind Treatment|Adverse Event|21
316329|NCT01424566|1069084|P1|Double-blind Treatment|Adverse Event|0
316330|NCT01424566|1069082|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
316331|NCT01424566|1069083|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
316332|NCT01424566|1069084|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
316333|NCT01424566|1069082|P3|Single-blind Treatment|Met Exclusion Criteria|0
316334|NCT01424566|1069083|P2|Single-blind Treatment|Met Exclusion Criteria|0
316335|NCT01424566|1069084|P1|Single-blind Treatment|Met Exclusion Criteria|1
316336|NCT01424566|1069082|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
316337|NCT01424566|1069083|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
316338|NCT01424566|1069084|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
316339|NCT01424566|1069082|P3|Single-blind Treatment|Withdrawal by Investigator|0
316340|NCT01424566|1069083|P2|Single-blind Treatment|Withdrawal by Investigator|0
316341|NCT01424566|1069084|P1|Single-blind Treatment|Withdrawal by Investigator|2
316342|NCT01424566|1069082|P3|Single-blind Treatment|Withdrawal by Subject|0
316343|NCT01424566|1069083|P2|Single-blind Treatment|Withdrawal by Subject|0
316344|NCT01424566|1069084|P1|Single-blind Treatment|Withdrawal by Subject|16
316345|NCT01424566|1069082|P3|Single-blind Treatment|Adverse Event|0
316346|NCT01424566|1069083|P2|Single-blind Treatment|Adverse Event|0
316347|NCT01424566|1069084|P1|Single-blind Treatment|Adverse Event|71
316348|NCT01424514|1069111|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
316349|NCT01424514|1069112|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
316350|NCT01424514|1069111|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
316351|NCT01424514|1069112|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
316352|NCT01424501|1069157|P6|Overall Study|Lost to Follow-up|0
316353|NCT01424501|1069158|P5|Overall Study|Lost to Follow-up|0
316354|NCT01424501|1069159|P4|Overall Study|Lost to Follow-up|0
316355|NCT01424501|1069160|P3|Overall Study|Lost to Follow-up|1
316356|NCT01424501|1069161|P2|Overall Study|Lost to Follow-up|0
316357|NCT01424501|1069162|P1|Overall Study|Lost to Follow-up|0
316358|NCT01424501|1069157|P6|Overall Study|Withdrawal by Subject|0
316359|NCT01424501|1069158|P5|Overall Study|Withdrawal by Subject|0
316360|NCT01424501|1069159|P4|Overall Study|Withdrawal by Subject|0
316361|NCT01424501|1069160|P3|Overall Study|Withdrawal by Subject|1
316362|NCT01424501|1069161|P2|Overall Study|Withdrawal by Subject|1
316363|NCT01424501|1069162|P1|Overall Study|Withdrawal by Subject|1
316364|NCT01424306|1069326|P6|Overall Study|Protocol Violation|0
316365|NCT01424306|1069327|P5|Overall Study|Protocol Violation|1
316366|NCT01424306|1069328|P4|Overall Study|Protocol Violation|0
316367|NCT01424306|1069329|P3|Overall Study|Protocol Violation|0
316368|NCT01424306|1069330|P2|Overall Study|Protocol Violation|0
316369|NCT01424306|1069331|P1|Overall Study|Protocol Violation|0
316370|NCT01424228|1069380|P2|Overall Study|Unplanned journey|1
316371|NCT01424228|1069381|P1|Overall Study|Unplanned journey|0
316372|NCT01424228|1069380|P2|Overall Study|Worsening of symptoms|0
316373|NCT01424228|1069381|P1|Overall Study|Worsening of symptoms|1
316374|NCT01424228|1069380|P2|Overall Study|Non-compliance|0
316375|NCT01424228|1069381|P1|Overall Study|Non-compliance|2
316376|NCT01424228|1069380|P2|Overall Study|inclusion/exclusion criteria not met|2
316377|NCT01424228|1069381|P1|Overall Study|inclusion/exclusion criteria not met|2
316378|NCT01424228|1069380|P2|Overall Study|Lack of Efficacy|7
316379|NCT01424228|1069381|P1|Overall Study|Lack of Efficacy|5
316380|NCT01424228|1069380|P2|Overall Study|Sponsor's decision|12
316381|NCT01424228|1069381|P1|Overall Study|Sponsor's decision|9
316382|NCT01424228|1069380|P2|Overall Study|Adverse Event|14
316383|NCT01424228|1069381|P1|Overall Study|Adverse Event|10
316384|NCT01424228|1069380|P2|Overall Study|Withdrawal by Subject|11
316385|NCT01424228|1069381|P1|Overall Study|Withdrawal by Subject|27
316396|NCT01423916|1069463|P3|Overall Study|Protocol Deviation|0
316397|NCT01423916|1069464|P2|Overall Study|Protocol Deviation|0
316398|NCT01423916|1069465|P1|Overall Study|Protocol Deviation|1
316399|NCT01423916|1069463|P3|Overall Study|Withdrawal by Subject|3
316400|NCT01423916|1069464|P2|Overall Study|Withdrawal by Subject|10
316401|NCT01423916|1069465|P1|Overall Study|Withdrawal by Subject|3
316402|NCT01423916|1069463|P3|Overall Study|Physician Decision|1
316403|NCT01423916|1069464|P2|Overall Study|Physician Decision|0
316404|NCT01423916|1069465|P1|Overall Study|Physician Decision|1
316405|NCT01423916|1069463|P3|Overall Study|Met Withdrawal Criteria|1
316406|NCT01423916|1069464|P2|Overall Study|Met Withdrawal Criteria|1
316407|NCT01423916|1069465|P1|Overall Study|Met Withdrawal Criteria|1
316408|NCT01423916|1069463|P3|Overall Study|Adverse Event|2
316409|NCT01423916|1069464|P2|Overall Study|Adverse Event|9
316410|NCT01423916|1069465|P1|Overall Study|Adverse Event|5
316411|NCT01423812|1069521|P2|Overall Study|Withdrawal by Subject|2
316412|NCT01423812|1069522|P1|Overall Study|Withdrawal by Subject|1
316413|NCT01423812|1069521|P2|Overall Study|Lost to Follow-up|2
316414|NCT01423812|1069522|P1|Overall Study|Lost to Follow-up|2
316415|NCT01423617|1069550|P2|Overall Study|Lost to Follow-up|1
316416|NCT01423617|1069551|P1|Overall Study|Lost to Follow-up|0
316417|NCT01423604|1069568|P2|Randomized|Patient decision|9
316418|NCT01423604|1069569|P1|Randomized|Patient decision|5
316419|NCT01423604|1069568|P2|Randomized|Other - unspecified|31
316420|NCT01423604|1069569|P1|Randomized|Other - unspecified|37
316421|NCT01423604|1069568|P2|Randomized|Physician Decision|13
316422|NCT01423604|1069569|P1|Randomized|Physician Decision|16
316423|NCT01423604|1069568|P2|Randomized|Death|0
316424|NCT01423604|1069569|P1|Randomized|Death|1
316425|NCT01423604|1069568|P2|Randomized|Adverse Event|10
316426|NCT01423604|1069569|P1|Randomized|Adverse Event|4
316427|NCT01423604|1069568|P2|Safety Run-In|Patient decision|0
316428|NCT01423604|1069569|P1|Safety Run-In|Patient decision|1
316429|NCT01423604|1069568|P2|Safety Run-In|Disease progression|0
316430|NCT01423604|1069569|P1|Safety Run-In|Disease progression|3
316431|NCT01423604|1069568|P2|Safety Run-In|Physician Decision|0
316432|NCT01423604|1069569|P1|Safety Run-In|Physician Decision|1
316433|NCT01423604|1069568|P2|Safety Run-In|Death|0
316434|NCT01423604|1069569|P1|Safety Run-In|Death|1
316435|NCT01423604|1069568|P2|Safety Run-In|Adverse Event|0
316436|NCT01423604|1069569|P1|Safety Run-In|Adverse Event|3
316437|NCT01423253|1069584|P1|Overall Study|Withdrawal by Subject|2
316438|NCT01423253|1069584|P1|Overall Study|Protocol Violation|2
316439|NCT01423253|1069584|P1|Overall Study|Lost to Follow-up|1
316440|NCT01423253|1069584|P1|Overall Study|Lack of Efficacy|2
316441|NCT01423253|1069584|P1|Overall Study|Adverse Event|2
316442|NCT01423084|1069606|P2|Overall Study|Withdrawal by Subject|3
316443|NCT01423084|1069607|P1|Overall Study|Withdrawal by Subject|2
316444|NCT01423084|1069606|P2|Overall Study|Adverse Event|1
316445|NCT01423084|1069607|P1|Overall Study|Adverse Event|0
316446|NCT01422915|1069637|P1|Overall Study|Adverse Event|1
316447|NCT01422889|1069642|P1|Overall Study|No Data Entered for Study Stent|9
316448|NCT01422876|1069657|P10|Week 52|Death|0
316449|NCT01422876|1069658|P9|Week 52|Death|1
316450|NCT01422876|1069659|P8|Week 52|Death|3
316451|NCT01422876|1069660|P7|Week 52|Death|1
316452|NCT01422876|1069661|P6|Week 52|Death|0
316453|NCT01422876|1069662|P5|Week 52|Death|0
316454|NCT01422876|1069663|P4|Week 52|Death|1
316455|NCT01422876|1069664|P3|Week 52|Death|0
316456|NCT01422876|1069665|P2|Week 52|Death|1
316457|NCT01422876|1069666|P1|Week 52|Death|0
316458|NCT01422876|1069657|P10|Week 52|Consent withdrawn|9
316459|NCT01422876|1069658|P9|Week 52|Consent withdrawn|13
316460|NCT01422876|1069659|P8|Week 52|Consent withdrawn|12
316461|NCT01422876|1069660|P7|Week 52|Consent withdrawn|10
316462|NCT01422876|1069661|P6|Week 52|Consent withdrawn|12
316463|NCT01422876|1069662|P5|Week 52|Consent withdrawn|7
316464|NCT01422876|1069663|P4|Week 52|Consent withdrawn|12
316465|NCT01422876|1069664|P3|Week 52|Consent withdrawn|6
316466|NCT01422876|1069665|P2|Week 52|Consent withdrawn|4
316467|NCT01422876|1069666|P1|Week 52|Consent withdrawn|9
316468|NCT01422876|1069657|P10|Week 52|Lost to Follow-up|8
316469|NCT01422876|1069658|P9|Week 52|Lost to Follow-up|7
316470|NCT01422876|1069659|P8|Week 52|Lost to Follow-up|8
316471|NCT01422876|1069660|P7|Week 52|Lost to Follow-up|5
316472|NCT01422876|1069661|P6|Week 52|Lost to Follow-up|5
316473|NCT01422876|1069662|P5|Week 52|Lost to Follow-up|8
316474|NCT01422876|1069663|P4|Week 52|Lost to Follow-up|5
316475|NCT01422876|1069664|P3|Week 52|Lost to Follow-up|7
316476|NCT01422876|1069665|P2|Week 52|Lost to Follow-up|5
316477|NCT01422876|1069666|P1|Week 52|Lost to Follow-up|3
316478|NCT01422876|1069657|P10|Week 24|Death|0
316479|NCT01422876|1069658|P9|Week 24|Death|0
316480|NCT01422876|1069659|P8|Week 24|Death|0
316481|NCT01422876|1069660|P7|Week 24|Death|0
316482|NCT01422876|1069661|P6|Week 24|Death|0
316483|NCT01422876|1069662|P5|Week 24|Death|0
316484|NCT01422876|1069663|P4|Week 24|Death|0
316485|NCT01422876|1069664|P3|Week 24|Death|0
316486|NCT01422876|1069665|P2|Week 24|Death|1
316487|NCT01422876|1069666|P1|Week 24|Death|0
316488|NCT01422876|1069657|P10|Week 24|Consent withdrawn|6
316489|NCT01422876|1069658|P9|Week 24|Consent withdrawn|3
316490|NCT01422876|1069659|P8|Week 24|Consent withdrawn|4
316491|NCT01422876|1069660|P7|Week 24|Consent withdrawn|5
316492|NCT01422876|1069661|P6|Week 24|Consent withdrawn|6
316493|NCT01422876|1069662|P5|Week 24|Consent withdrawn|5
316494|NCT01422876|1069663|P4|Week 24|Consent withdrawn|4
316495|NCT01422876|1069664|P3|Week 24|Consent withdrawn|3
316496|NCT01422876|1069665|P2|Week 24|Consent withdrawn|1
316497|NCT01422876|1069666|P1|Week 24|Consent withdrawn|5
316498|NCT01422876|1069657|P10|Week 24|Lost to Follow-up|4
316499|NCT01422876|1069658|P9|Week 24|Lost to Follow-up|3
316500|NCT01422876|1069659|P8|Week 24|Lost to Follow-up|3
316501|NCT01422876|1069660|P7|Week 24|Lost to Follow-up|1
316502|NCT01422876|1069661|P6|Week 24|Lost to Follow-up|0
316503|NCT01422876|1069662|P5|Week 24|Lost to Follow-up|2
316504|NCT01422876|1069663|P4|Week 24|Lost to Follow-up|4
316505|NCT01422876|1069664|P3|Week 24|Lost to Follow-up|2
316506|NCT01422876|1069665|P2|Week 24|Lost to Follow-up|1
316507|NCT01422876|1069666|P1|Week 24|Lost to Follow-up|1
316508|NCT01422850|1069713|P1|Overall Study|Physician Decision|3
316509|NCT01422824|1069719|P1|Overall Study|Lost to Follow-up|37
316510|NCT01422824|1069719|P1|Overall Study|Case record form not evaluated|1
316511|NCT01422720|1069724|P1|Overall Study|Ineligibility|1
316512|NCT01422720|1069724|P1|Overall Study|Withdrawal by Subject|4
316513|NCT01422720|1069724|P1|Overall Study|Lack of Efficacy|1
316514|NCT01422720|1069724|P1|Overall Study|Adverse Event|16
316515|NCT01422538|1069735|P3|Overall Study|Missed visit|1
316516|NCT01422538|1069736|P2|Overall Study|Missed visit|1
316517|NCT01422538|1069737|P1|Overall Study|Missed visit|0
316518|NCT01422538|1069735|P3|Overall Study|Lost to Follow-up|1
316519|NCT01422538|1069736|P2|Overall Study|Lost to Follow-up|1
316520|NCT01422538|1069737|P1|Overall Study|Lost to Follow-up|0
316521|NCT01422408|1069781|P1|Overall Study|Withdrawal by Subject|3
316522|NCT01422408|1069781|P1|Overall Study|Adverse Event|1
316523|NCT01422382|1069810|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
316524|NCT01422304|1069826|P2|Overall Study|Not Treated|11
316525|NCT01422304|1069827|P1|Overall Study|Not Treated|3
316526|NCT01422304|1069826|P2|Overall Study|Did Not Meet Protocol Eligibility|2
316527|NCT01422304|1069827|P1|Overall Study|Did Not Meet Protocol Eligibility|0
316528|NCT01422304|1069826|P2|Overall Study|Withdrawal by Subject|2
316529|NCT01422304|1069827|P1|Overall Study|Withdrawal by Subject|4
316530|NCT01422304|1069826|P2|Overall Study|Protocol Violation|0
316531|NCT01422304|1069827|P1|Overall Study|Protocol Violation|1
316532|NCT01422304|1069826|P2|Overall Study|Never Entered Follow-up|1
316533|NCT01422304|1069827|P1|Overall Study|Never Entered Follow-up|2
316534|NCT01422304|1069826|P2|Overall Study|Lost to Follow-up|20
316535|NCT01422304|1069827|P1|Overall Study|Lost to Follow-up|14
316536|NCT01422304|1069826|P2|Overall Study|Adverse Event|1
316537|NCT01422304|1069827|P1|Overall Study|Adverse Event|0
316538|NCT01422239|1069859|P2|Overall Study|Lost to Follow-up|3
316539|NCT01422239|1069860|P1|Overall Study|Lost to Follow-up|4
316540|NCT01422213|1069882|P3|Overall Study|Administrative or Other Reason(s)|2
316541|NCT01422213|1069883|P2|Overall Study|Administrative or Other Reason(s)|4
316542|NCT01422213|1069884|P1|Overall Study|Administrative or Other Reason(s)|5
316543|NCT01422213|1069882|P3|Overall Study|Lost to Follow-up|5
316544|NCT01422213|1069883|P2|Overall Study|Lost to Follow-up|3
316545|NCT01422213|1069884|P1|Overall Study|Lost to Follow-up|3
316546|NCT01422213|1069882|P3|Overall Study|Withdrawal of Consent|5
316547|NCT01422213|1069883|P2|Overall Study|Withdrawal of Consent|3
316548|NCT01422213|1069884|P1|Overall Study|Withdrawal of Consent|7
316549|NCT01422213|1069882|P3|Overall Study|Protocol Violation|4
316550|NCT01422213|1069883|P2|Overall Study|Protocol Violation|2
316551|NCT01422213|1069884|P1|Overall Study|Protocol Violation|0
316552|NCT01422213|1069882|P3|Overall Study|Non-compliance with study drug|0
316553|NCT01422213|1069883|P2|Overall Study|Non-compliance with study drug|1
316554|NCT01422213|1069884|P1|Overall Study|Non-compliance with study drug|0
316555|NCT01422213|1069882|P3|Overall Study|Lack of Efficacy|2
316556|NCT01422213|1069883|P2|Overall Study|Lack of Efficacy|2
316557|NCT01422213|1069884|P1|Overall Study|Lack of Efficacy|10
316558|NCT01422213|1069882|P3|Overall Study|Adverse Event|11
316559|NCT01422213|1069883|P2|Overall Study|Adverse Event|7
316560|NCT01422213|1069884|P1|Overall Study|Adverse Event|8
316561|NCT01422187|1069945|P3|Overall Study|Lost to Follow-up|0
316562|NCT01422187|1069946|P2|Overall Study|Lost to Follow-up|1
316563|NCT01422187|1069947|P1|Overall Study|Lost to Follow-up|0
316564|NCT01422187|1069945|P3|Overall Study|Personal reason|0
316565|NCT01422187|1069946|P2|Overall Study|Personal reason|0
316566|NCT01422187|1069947|P1|Overall Study|Personal reason|1
316567|NCT01421719|1069978|P1|Overall Study|Withdrawal by Subject|4
316568|NCT01421667|1069987|P4|Overall Study|Lost to Follow-up|0
316569|NCT01421667|1069988|P3|Overall Study|Lost to Follow-up|0
316570|NCT01421667|1069989|P2|Overall Study|Lost to Follow-up|1
316571|NCT01421667|1069990|P1|Overall Study|Lost to Follow-up|0
316572|NCT01421667|1069987|P4|Overall Study|Withdrawal by Subject|1
316573|NCT01421667|1069988|P3|Overall Study|Withdrawal by Subject|2
316574|NCT01421667|1069989|P2|Overall Study|Withdrawal by Subject|1
316575|NCT01421667|1069990|P1|Overall Study|Withdrawal by Subject|0
316576|NCT01421641|1070051|P2|Overall Study|Protocol Violation|2
316577|NCT01421641|1070052|P1|Overall Study|Protocol Violation|2
316578|NCT01421511|1070074|P2|Overall Study|Death|1
316579|NCT01421511|1070075|P1|Overall Study|Death|1
316580|NCT01421511|1070074|P2|Overall Study|Withdrawal by Subject|5
316581|NCT01421511|1070075|P1|Overall Study|Withdrawal by Subject|6
316582|NCT01421511|1070074|P2|Overall Study|Physician Decision|1
316583|NCT01421511|1070075|P1|Overall Study|Physician Decision|0
316584|NCT01421511|1070074|P2|Overall Study|Randomized but didn't receive study drug|7
316585|NCT01421511|1070075|P1|Overall Study|Randomized but didn't receive study drug|1
316586|NCT01421511|1070074|P2|Overall Study|Lost to Follow-up|14
316587|NCT01421511|1070075|P1|Overall Study|Lost to Follow-up|11
316588|NCT01421459|1070125|P2|Overall Study|Withdrawal by Subject|16
316589|NCT01421459|1070126|P1|Overall Study|Withdrawal by Subject|12
316590|NCT01421459|1070125|P2|Overall Study|Protocol Violation|5
316591|NCT01421459|1070126|P1|Overall Study|Protocol Violation|8
316592|NCT01421459|1070125|P2|Overall Study|Physician Decision|9
316593|NCT01421459|1070126|P1|Overall Study|Physician Decision|9
316594|NCT01421459|1070125|P2|Overall Study|Lost to Follow-up|9
316595|NCT01421459|1070126|P1|Overall Study|Lost to Follow-up|8
316596|NCT01421459|1070125|P2|Overall Study|Lack of Efficacy|2
316597|NCT01421459|1070126|P1|Overall Study|Lack of Efficacy|1
316598|NCT01421459|1070125|P2|Overall Study|Death|1
316599|NCT01421459|1070126|P1|Overall Study|Death|1
316600|NCT01421459|1070125|P2|Overall Study|Adverse Event|10
316601|NCT01421459|1070126|P1|Overall Study|Adverse Event|6
316602|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
316603|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
316604|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
316605|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
316606|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
316607|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
316608|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
316609|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
316610|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
316611|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
316612|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
316613|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
316614|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
316615|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
316616|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
316617|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
316618|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
316619|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
316620|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
316621|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
316622|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
316623|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
316624|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
316625|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
316626|NCT01421342|1070167|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
316627|NCT01421342|1070168|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
316628|NCT01421342|1070169|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
316629|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
316630|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
316631|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
316632|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
316633|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
316634|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
316635|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
316636|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
316637|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
316638|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
316639|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
316640|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
316641|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
316642|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
316643|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
316644|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
316645|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
316646|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
316647|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
316648|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
316649|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
316650|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
316651|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
316652|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
316653|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
316654|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
316655|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
316656|NCT01421342|1070167|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
316657|NCT01421342|1070168|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
316658|NCT01421342|1070169|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
316659|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
316660|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
316661|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
316662|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
316663|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
316664|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
316665|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
316666|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
316667|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
316668|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
316669|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
316670|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
316671|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
316672|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
316673|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
316674|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Death|3
316675|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Death|0
316676|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Death|0
316677|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
316678|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
316679|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
316680|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
316681|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
316682|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
316683|NCT01421342|1070167|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
316684|NCT01421342|1070168|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
316685|NCT01421342|1070169|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
316686|NCT01421303|1070186|P1|Overall Study|Withdrawal by Subject|1
316687|NCT01421303|1070186|P1|Overall Study|Other|7
316688|NCT01421303|1070186|P1|Overall Study|Non compliance with study procedure|1
316689|NCT01421303|1070186|P1|Overall Study|Lost to Follow-up|13
316690|NCT01421277|1070213|P2|Overall Study|Incomplete baseline data|31
316691|NCT01421277|1070214|P1|Overall Study|Incomplete baseline data|0
316692|NCT01421277|1070213|P2|Overall Study|Lack of qualifying event|61
316693|NCT01421277|1070214|P1|Overall Study|Lack of qualifying event|0
316694|NCT01421147|1070226|P2|Extension Period|Withdrawal by Subject|3
316695|NCT01421147|1070227|P1|Extension Period|Withdrawal by Subject|5
316696|NCT01421147|1070226|P2|Extension Period|Physician Decision|0
316697|NCT01421147|1070227|P1|Extension Period|Physician Decision|1
316698|NCT01421147|1070226|P2|Extension Period|Lost to Follow-up|5
316699|NCT01421147|1070227|P1|Extension Period|Lost to Follow-up|2
316700|NCT01421147|1070226|P2|Extension Period|Death|1
316701|NCT01421147|1070227|P1|Extension Period|Death|0
316702|NCT01421147|1070226|P2|Extension Period|Adverse Event|2
316703|NCT01421147|1070227|P1|Extension Period|Adverse Event|0
316704|NCT01421147|1070226|P2|Treatment Period|Withdrawal by Subject|5
316705|NCT01421147|1070227|P1|Treatment Period|Withdrawal by Subject|10
316706|NCT01421147|1070226|P2|Treatment Period|Physician Decision|2
316707|NCT01421147|1070227|P1|Treatment Period|Physician Decision|2
316708|NCT01421147|1070226|P2|Treatment Period|Lost to Follow-up|1
316709|NCT01421147|1070227|P1|Treatment Period|Lost to Follow-up|2
316710|NCT01421147|1070226|P2|Treatment Period|Adverse Event|3
316711|NCT01421147|1070227|P1|Treatment Period|Adverse Event|2
316712|NCT01421134|1070259|P2|Overall Study|Lost to Follow-up|1
316713|NCT01421134|1070260|P1|Overall Study|Lost to Follow-up|1
316714|NCT01421134|1070259|P2|Overall Study|Administrative|1
316715|NCT01421134|1070260|P1|Overall Study|Administrative|0
316716|NCT01421134|1070259|P2|Overall Study|Withdrawal by Subject|1
316717|NCT01421134|1070260|P1|Overall Study|Withdrawal by Subject|1
316718|NCT01421134|1070259|P2|Overall Study|Protocol Violation|3
316719|NCT01421134|1070260|P1|Overall Study|Protocol Violation|0
316720|NCT01421134|1070259|P2|Overall Study|Lack of Efficacy|4
316721|NCT01421134|1070260|P1|Overall Study|Lack of Efficacy|2
316722|NCT01421134|1070259|P2|Overall Study|Adverse Event|5
316723|NCT01421134|1070260|P1|Overall Study|Adverse Event|3
316724|NCT01420926|1070280|P2|Overall Study|Continues on active treatment|3
316725|NCT01420926|1070281|P1|Overall Study|Continues on active treatment|1
316726|NCT01420926|1070280|P2|Overall Study|Physician Decision|5
316727|NCT01420926|1070281|P1|Overall Study|Physician Decision|7
316728|NCT01420926|1070280|P2|Overall Study|Non-protocol treatment|20
316729|NCT01420926|1070281|P1|Overall Study|Non-protocol treatment|17
316730|NCT01420926|1070280|P2|Overall Study|Withdrawal by Subject|16
316731|NCT01420926|1070281|P1|Overall Study|Withdrawal by Subject|11
316732|NCT01420926|1070280|P2|Overall Study|Death|17
316733|NCT01420926|1070281|P1|Overall Study|Death|18
316734|NCT01420926|1070280|P2|Overall Study|Adverse Event|4
316735|NCT01420926|1070281|P1|Overall Study|Adverse Event|6
316736|NCT01420081|1070339|P9|Overall Study|Other Reasons|0
316737|NCT01420081|1070340|P8|Overall Study|Other Reasons|0
316738|NCT01420081|1070341|P7|Overall Study|Other Reasons|0
316739|NCT01420081|1070342|P6|Overall Study|Other Reasons|0
316740|NCT01420081|1070343|P5|Overall Study|Other Reasons|0
316741|NCT01420081|1070344|P4|Overall Study|Other Reasons|0
316742|NCT01420081|1070345|P3|Overall Study|Other Reasons|1
316743|NCT01420081|1070346|P2|Overall Study|Other Reasons|0
316744|NCT01420081|1070347|P1|Overall Study|Other Reasons|0
316745|NCT01420081|1070339|P9|Overall Study|Subject Refused Futher Follow-up|0
316746|NCT01420081|1070340|P8|Overall Study|Subject Refused Futher Follow-up|0
316747|NCT01420081|1070341|P7|Overall Study|Subject Refused Futher Follow-up|0
316748|NCT01420081|1070342|P6|Overall Study|Subject Refused Futher Follow-up|0
316749|NCT01420081|1070343|P5|Overall Study|Subject Refused Futher Follow-up|1
316750|NCT01420081|1070344|P4|Overall Study|Subject Refused Futher Follow-up|0
316751|NCT01420081|1070345|P3|Overall Study|Subject Refused Futher Follow-up|1
316752|NCT01420081|1070346|P2|Overall Study|Subject Refused Futher Follow-up|0
316753|NCT01420081|1070347|P1|Overall Study|Subject Refused Futher Follow-up|0
316754|NCT01420081|1070339|P9|Overall Study|Study Terminated by Sponsor|2
316755|NCT01420081|1070340|P8|Overall Study|Study Terminated by Sponsor|2
316756|NCT01420081|1070341|P7|Overall Study|Study Terminated by Sponsor|3
316757|NCT01420081|1070342|P6|Overall Study|Study Terminated by Sponsor|7
316758|NCT01420081|1070343|P5|Overall Study|Study Terminated by Sponsor|11
316759|NCT01420081|1070344|P4|Overall Study|Study Terminated by Sponsor|3
316760|NCT01420081|1070345|P3|Overall Study|Study Terminated by Sponsor|1
316761|NCT01420081|1070346|P2|Overall Study|Study Terminated by Sponsor|1
316762|NCT01420081|1070347|P1|Overall Study|Study Terminated by Sponsor|2
316763|NCT01420081|1070339|P9|Overall Study|Lost to Follow-up|0
316764|NCT01420081|1070340|P8|Overall Study|Lost to Follow-up|0
316765|NCT01420081|1070341|P7|Overall Study|Lost to Follow-up|0
316766|NCT01420081|1070342|P6|Overall Study|Lost to Follow-up|1
316767|NCT01420081|1070343|P5|Overall Study|Lost to Follow-up|1
316768|NCT01420081|1070344|P4|Overall Study|Lost to Follow-up|0
316769|NCT01420081|1070345|P3|Overall Study|Lost to Follow-up|0
316770|NCT01420081|1070346|P2|Overall Study|Lost to Follow-up|0
316771|NCT01420081|1070347|P1|Overall Study|Lost to Follow-up|0
316772|NCT01420081|1070339|P9|Overall Study|Death|1
316773|NCT01420081|1070340|P8|Overall Study|Death|1
316774|NCT01420081|1070341|P7|Overall Study|Death|0
316775|NCT01420081|1070342|P6|Overall Study|Death|12
316776|NCT01420081|1070343|P5|Overall Study|Death|7
316777|NCT01420081|1070344|P4|Overall Study|Death|0
316778|NCT01420081|1070345|P3|Overall Study|Death|8
316779|NCT01420081|1070346|P2|Overall Study|Death|0
316780|NCT01420081|1070347|P1|Overall Study|Death|1
316781|NCT01419769|1070466|P1|Overall Study|Not evaluable due to pigtail stents|1
316782|NCT01419769|1070466|P1|Overall Study|Did not receive the AXIOS stent|3
316783|NCT01419314|1070487|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
316784|NCT01419314|1070488|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
316785|NCT01419314|1070487|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
316786|NCT01419314|1070488|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
316787|NCT01419314|1070487|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
316788|NCT01419314|1070488|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
316789|NCT01419236|1070529|P2|Overall Study|Entry Criteria Not Met|0
316790|NCT01419236|1070530|P1|Overall Study|Entry Criteria Not Met|1
316791|NCT01419236|1070529|P2|Overall Study|Withdrawal by Subject|4
316792|NCT01419236|1070530|P1|Overall Study|Withdrawal by Subject|1
316793|NCT01419236|1070529|P2|Overall Study|Physician Decision|0
316794|NCT01419236|1070530|P1|Overall Study|Physician Decision|1
316795|NCT01419236|1070529|P2|Overall Study|Lost to Follow-up|0
316796|NCT01419236|1070530|P1|Overall Study|Lost to Follow-up|1
316797|NCT01419236|1070529|P2|Overall Study|Lack of Efficacy|1
316798|NCT01419236|1070530|P1|Overall Study|Lack of Efficacy|0
316799|NCT01419236|1070529|P2|Overall Study|Adverse Event|0
316800|NCT01419236|1070530|P1|Overall Study|Adverse Event|1
316801|NCT01419197|1070554|P2|Overall Study|Lost to Follow-up|4
316802|NCT01419197|1070555|P1|Overall Study|Lost to Follow-up|14
316803|NCT01419197|1070554|P2|Overall Study|Reason Not Specified|1
316804|NCT01419197|1070555|P1|Overall Study|Reason Not Specified|0
316805|NCT01419197|1070554|P2|Overall Study|Study Completed by Sponsor|34
316806|NCT01419197|1070555|P1|Overall Study|Study Completed by Sponsor|103
316807|NCT01419197|1070554|P2|Overall Study|Withdrawal by Subject|32
316808|NCT01419197|1070555|P1|Overall Study|Withdrawal by Subject|33
316809|NCT01419197|1070554|P2|Overall Study|Non-compliance|1
316810|NCT01419197|1070555|P1|Overall Study|Non-compliance|3
316811|NCT01419197|1070554|P2|Overall Study|Physician Decision|4
316812|NCT01419197|1070555|P1|Overall Study|Physician Decision|4
316813|NCT01419197|1070554|P2|Overall Study|Death|122
316814|NCT01419197|1070555|P1|Overall Study|Death|247
316815|NCT01419184|1070580|P2|Overall Study|Participant randomized, not treated|0
316816|NCT01419184|1070581|P1|Overall Study|Participant randomized, not treated|1
316817|NCT01419184|1070580|P2|Overall Study|No IRLOS-No adverse event treatment date|1
316818|NCT01419184|1070581|P1|Overall Study|No IRLOS-No adverse event treatment date|0
316819|NCT01419184|1070580|P2|Overall Study|No IRLOS-non trial antibiotic used|2
316820|NCT01419184|1070581|P1|Overall Study|No IRLOS-non trial antibiotic used|1
316821|NCT01419184|1070580|P2|Overall Study|No IRLOS-randomized, not treated|4
316822|NCT01419184|1070581|P1|Overall Study|No IRLOS-randomized, not treated|2
316823|NCT01419184|1070580|P2|Overall Study|No IRLOS-No in-patient end date reported|6
316824|NCT01419184|1070581|P1|Overall Study|No IRLOS-No in-patient end date reported|3
316825|NCT01419184|1070580|P2|Overall Study|Site data not available|2
316826|NCT01419184|1070581|P1|Overall Study|Site data not available|3
316827|NCT01418937|1070619|P1|Overall Study|Withdrawal by Subject|1
316828|NCT01418937|1070619|P1|Overall Study|Pregnancy|1
316829|NCT01418937|1070619|P1|Overall Study|Protocol Violation|1
316830|NCT01418937|1070619|P1|Overall Study|Lost to Follow-up|5
316831|NCT01418365|1070650|P2|Second Intervention|Withdrawal by Subject|1
316832|NCT01418365|1070651|P1|Second Intervention|Withdrawal by Subject|0
316833|NCT01418365|1070650|P2|First Intervention|Non-compliance|0
316834|NCT01418365|1070651|P1|First Intervention|Non-compliance|1
316835|NCT01418365|1070650|P2|First Intervention|Withdrawal by Subject|1
316836|NCT01418365|1070651|P1|First Intervention|Withdrawal by Subject|0
316837|NCT01418209|1070662|P3|Overall Study|Did not provide hot flash diary data|3
316838|NCT01418209|1070663|P2|Overall Study|Did not provide hot flash diary data|3
316839|NCT01418209|1070664|P1|Overall Study|Did not provide hot flash diary data|1
316840|NCT01418209|1070662|P3|Overall Study|Withdrawal by Subject|1
316841|NCT01418209|1070663|P2|Overall Study|Withdrawal by Subject|0
316842|NCT01418209|1070664|P1|Overall Study|Withdrawal by Subject|1
316843|NCT01417481|1070719|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
316844|NCT01417481|1070720|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
316845|NCT01417377|1070785|P1|Overall Study|Enrolled, but not treated|1
316846|NCT01417377|1070785|P1|Overall Study|Lost to Follow-up|12
316847|NCT01417195|1070794|P2|Overall Study|No transfer due to elevated progesterone|0
316848|NCT01417195|1070795|P1|Overall Study|No transfer due to elevated progesterone|1
316849|NCT01417195|1070794|P2|Overall Study|No transfer due to risk of OHSS|0
316850|NCT01417195|1070795|P1|Overall Study|No transfer due to risk of OHSS|1
316851|NCT01417195|1070794|P2|Overall Study|No embryos for transfer|1
316852|NCT01417195|1070795|P1|Overall Study|No embryos for transfer|0
316853|NCT01417195|1070794|P2|Overall Study|Stimulation failure|0
316854|NCT01417195|1070795|P1|Overall Study|Stimulation failure|1
316855|NCT01417156|1070811|P1|Overall Study|Protocol Violation|2
316856|NCT01417156|1070811|P1|Overall Study|Adverse Event|12
316857|NCT01417104|1070821|P2|Overall Study|Adverse Event|0
316858|NCT01417104|1070822|P1|Overall Study|Adverse Event|1
316859|NCT01417104|1070821|P2|Overall Study|Failure to make contact|1
316860|NCT01417104|1070822|P1|Overall Study|Failure to make contact|0
316861|NCT01417104|1070821|P2|Overall Study|Withdrawal by Subject|1
316862|NCT01417104|1070822|P1|Overall Study|Withdrawal by Subject|5
316863|NCT01417078|1070832|P1|Overall Study|Withdrawal by Subject|1
316864|NCT01417000|1070857|P2|Overall Study|Study Terminated by Sponsor|1
316865|NCT01417000|1070858|P1|Overall Study|Study Terminated by Sponsor|1
316866|NCT01417000|1070857|P2|Overall Study|Lost to Follow-up|0
316867|NCT01417000|1070858|P1|Overall Study|Lost to Follow-up|1
316868|NCT01417000|1070857|P2|Overall Study|Death|28
316869|NCT01417000|1070858|P1|Overall Study|Death|59
316870|NCT01416610|1070866|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
316871|NCT01416610|1070866|P1|Overall Study|Lost to Follow-up|7
316872|NCT01416610|1070866|P1|Overall Study|Withdrawal by Subject|13
316873|NCT01416610|1070866|P1|Overall Study|No reason given|5
316874|NCT01416610|1070866|P1|Overall Study|Lack of Efficacy|4
316875|NCT01416610|1070866|P1|Overall Study|Adverse Event -Patient decision|3
316876|NCT01416610|1070866|P1|Overall Study|Adverse Event|4
316877|NCT01416571|1070920|P1|Overall Study|Lost to Follow-up|2
316878|NCT01416389|1070949|P2|Overall Study|Started New Therapy|0
316879|NCT01416389|1070950|P1|Overall Study|Started New Therapy|2
316880|NCT01416389|1070949|P2|Overall Study|Lost to Follow-up|0
316881|NCT01416389|1070950|P1|Overall Study|Lost to Follow-up|1
316882|NCT01416272|1070967|P1|Overall Study|Study related complaints|1
316883|NCT01416272|1070967|P1|Overall Study|Lost to Follow-up|1
316884|NCT01416272|1070967|P1|Overall Study|Unacceptable distance visual acuity|2
316885|NCT01416181|1070975|P2|Part 2|Lost to Follow-up|2
316886|NCT01416181|1070976|P1|Part 2|Lost to Follow-up|2
316887|NCT01416181|1070975|P2|Part 2|Lack of Efficacy|1
316888|NCT01416181|1070976|P1|Part 2|Lack of Efficacy|4
316889|NCT01416181|1070975|P2|Part 2|Withdrawal by Subject|5
316890|NCT01416181|1070976|P1|Part 2|Withdrawal by Subject|14
316891|NCT01416181|1070975|P2|Part 2|Investigator Decision|7
316892|NCT01416181|1070976|P1|Part 2|Investigator Decision|6
316893|NCT01416181|1070975|P2|Part 2|Not Specified|267
316894|NCT01416181|1070976|P1|Part 2|Not Specified|234
316895|NCT01416181|1070975|P2|Part 2|Adverse Event|4
316896|NCT01416181|1070976|P1|Part 2|Adverse Event|11
316897|NCT01416181|1070975|P2|Part 1|Ongoing in Follow-Up|8
316898|NCT01416181|1070976|P1|Part 1|Ongoing in Follow-Up|14
316899|NCT01416181|1070975|P2|Part 1|Adverse Event|18
316900|NCT01416181|1070976|P1|Part 1|Adverse Event|15
316901|NCT01416181|1070975|P2|Part 1|Lost to Follow-up|1
316902|NCT01416181|1070976|P1|Part 1|Lost to Follow-up|1
316903|NCT01416181|1070975|P2|Part 1|Lack of Efficacy|8
316904|NCT01416181|1070976|P1|Part 1|Lack of Efficacy|16
316905|NCT01416181|1070975|P2|Part 1|Withdrawal by Subject|48
316906|NCT01416181|1070976|P1|Part 1|Withdrawal by Subject|74
316907|NCT01416181|1070975|P2|Part 1|Investigator Decision|6
316908|NCT01416181|1070976|P1|Part 1|Investigator Decision|7
316909|NCT01416181|1070975|P2|Part 1|Death|1
316910|NCT01416181|1070976|P1|Part 1|Death|0
316911|NCT01416181|1070975|P2|Part 1|Not Specified|24
316912|NCT01416181|1070976|P1|Part 1|Not Specified|10
316913|NCT01416155|1071038|P1|Overall Study|Not specified|7
316914|NCT01416155|1071038|P1|Overall Study|Investigator decision|8
316915|NCT01416155|1071038|P1|Overall Study|Withdrawal by Subject|33
316916|NCT01416155|1071038|P1|Overall Study|Positive for anti-BG00002 antibodies|2
316917|NCT01416155|1071038|P1|Overall Study|Adverse Event|8
316918|NCT01416142|1071045|P3|PureVision2 HD|Inability to maintain lens wear|1
316919|NCT01416142|1071046|P2|PureVision2 HD|Inability to maintain lens wear|0
316920|NCT01416142|1071047|P1|PureVision2 HD|Inability to maintain lens wear|0
316921|NCT01415986|1071074|P1|Overall Study|Lost to Follow-up|1
316922|NCT01415921|1071091|P2|Overall Study|Other|0
316923|NCT01415921|1071092|P1|Overall Study|Other|2
316924|NCT01415921|1071091|P2|Overall Study|Withdrawal by Subject|1
316925|NCT01415921|1071092|P1|Overall Study|Withdrawal by Subject|0
316926|NCT01415921|1071091|P2|Overall Study|Physician Decision|1
316927|NCT01415921|1071092|P1|Overall Study|Physician Decision|1
316928|NCT01415921|1071091|P2|Overall Study|Adverse Event|1
316929|NCT01415921|1071092|P1|Overall Study|Adverse Event|0
316930|NCT01415908|1071102|P2|Overall Study|Withdrawal by Subject|0
316931|NCT01415908|1071103|P1|Overall Study|Withdrawal by Subject|1
316932|NCT01415531|1071140|P2|Overall Study|Other Reasons|2
316933|NCT01415531|1071141|P1|Overall Study|Other Reasons|3
316934|NCT01415531|1071140|P2|Overall Study|Lack of Compliance|4
316935|NCT01415531|1071141|P1|Overall Study|Lack of Compliance|1
316936|NCT01415531|1071140|P2|Overall Study|Lost to Follow-up|14
316937|NCT01415531|1071141|P1|Overall Study|Lost to Follow-up|6
316938|NCT01415531|1071140|P2|Overall Study|Withdrawal by Subject|4
316939|NCT01415531|1071141|P1|Overall Study|Withdrawal by Subject|5
316940|NCT01415531|1071140|P2|Overall Study|Protocol Violation|1
316941|NCT01415531|1071141|P1|Overall Study|Protocol Violation|0
316942|NCT01415531|1071140|P2|Overall Study|Lack of Efficacy|2
316943|NCT01415531|1071141|P1|Overall Study|Lack of Efficacy|3
316944|NCT01415531|1071140|P2|Overall Study|Adverse Event|10
316945|NCT01415531|1071141|P1|Overall Study|Adverse Event|7
316946|NCT01415518|1071151|P2|Overall Study|Condition under Investigation Worsened|1
316947|NCT01415518|1071152|P1|Overall Study|Condition under Investigation Worsened|1
316948|NCT01415518|1071151|P2|Overall Study|Death|1
316949|NCT01415518|1071152|P1|Overall Study|Death|1
316950|NCT01415518|1071151|P2|Overall Study|Adverse Event|4
316951|NCT01415518|1071152|P1|Overall Study|Adverse Event|3
316952|NCT01415518|1071151|P2|Overall Study|Lost to Follow-up|5
316953|NCT01415518|1071152|P1|Overall Study|Lost to Follow-up|3
316954|NCT01415518|1071151|P2|Overall Study|Protocol Violation|8
316955|NCT01415518|1071152|P1|Overall Study|Protocol Violation|6
316956|NCT01415518|1071151|P2|Overall Study|Withdrawal by Subject|12
316957|NCT01415518|1071152|P1|Overall Study|Withdrawal by Subject|2
316958|NCT01415401|1071252|P1|Overall Study|Terminated by Sponsor|1
316959|NCT01415401|1071252|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
316960|NCT01415401|1071252|P1|Overall Study|Adverse Event|5
316961|NCT01415349|1071257|P2|Treatment Period 1|Withdrawal by Subject|1
316962|NCT01415349|1071258|P1|Treatment Period 1|Withdrawal by Subject|0
316963|NCT01415349|1071257|P2|Treatment Period 1|Adverse Event|1
316964|NCT01415349|1071258|P1|Treatment Period 1|Adverse Event|0
316965|NCT01414855|1071270|P1|Overall Study|Withdrawal by Subject|7
316966|NCT01414855|1071270|P1|Overall Study|Lost to Follow-up|5
316967|NCT01414855|1071270|P1|Overall Study|Death|17
316968|NCT01414205|1071336|P2|Overall Study|Randomized but not Treated|1
316969|NCT01414205|1071337|P1|Overall Study|Randomized but not Treated|1
316970|NCT01414205|1071336|P2|Overall Study|Physician Decision|1
316971|NCT01414205|1071337|P1|Overall Study|Physician Decision|0
316972|NCT01414205|1071336|P2|Overall Study|Lost to Follow-up|4
316973|NCT01414205|1071337|P1|Overall Study|Lost to Follow-up|1
316974|NCT01414205|1071336|P2|Overall Study|Death|1
316975|NCT01414205|1071337|P1|Overall Study|Death|5
316976|NCT01414166|1071406|P2|Overall Study|Withdrawal by Subject|5
316977|NCT01414166|1071407|P1|Overall Study|Withdrawal by Subject|3
316978|NCT01414166|1071406|P2|Overall Study|Study terminated by Sponsor|75
316979|NCT01414166|1071407|P1|Overall Study|Study terminated by Sponsor|68
316980|NCT01414166|1071406|P2|Overall Study|Protocol Violation|0
316981|NCT01414166|1071407|P1|Overall Study|Protocol Violation|2
316982|NCT01414166|1071406|P2|Overall Study|Physician Decision|0
316983|NCT01414166|1071407|P1|Overall Study|Physician Decision|2
316984|NCT01414166|1071406|P2|Overall Study|Non-compliance with study drug|0
316985|NCT01414166|1071407|P1|Overall Study|Non-compliance with study drug|2
316986|NCT01414166|1071406|P2|Overall Study|Lost to Follow-up|1
316987|NCT01414166|1071407|P1|Overall Study|Lost to Follow-up|4
316988|NCT01414166|1071406|P2|Overall Study|Adverse Event|2
316989|NCT01414166|1071407|P1|Overall Study|Adverse Event|10
316990|NCT01414114|1071470|P1|Overall Study|Other|2
316991|NCT01414114|1071470|P1|Overall Study|Withdrawal by Subject|1
316992|NCT01414114|1071470|P1|Overall Study|Adverse Event|2
316993|NCT01413958|1071526|P2|Overall Study|Lost to Follow-up|1
316994|NCT01413958|1071527|P1|Overall Study|Lost to Follow-up|0
316995|NCT01413542|1071578|P4|Overall Study|Adverse Event|1
316996|NCT01413542|1071579|P3|Overall Study|Adverse Event|0
316997|NCT01413542|1071580|P2|Overall Study|Adverse Event|0
316998|NCT01413542|1071581|P1|Overall Study|Adverse Event|0
316999|NCT01413542|1071578|P4|Overall Study|Physician Decision|0
317000|NCT01413542|1071579|P3|Overall Study|Physician Decision|3
317001|NCT01413542|1071580|P2|Overall Study|Physician Decision|0
317002|NCT01413542|1071581|P1|Overall Study|Physician Decision|1
317003|NCT01413360|1071603|P1|Overall Study|Adverse Event|1
317004|NCT01413360|1071603|P1|Overall Study|Lost to Follow-up|2
317005|NCT01413204|1071611|P3|Overall Study|Fasting plasma glucose level increased|10
317006|NCT01413204|1071612|P2|Overall Study|Fasting plasma glucose level increased|0
317007|NCT01413204|1071613|P1|Overall Study|Fasting plasma glucose level increased|1
317008|NCT01413204|1071611|P3|Overall Study|Clearly not eligible for the study|1
317009|NCT01413204|1071612|P2|Overall Study|Clearly not eligible for the study|0
317010|NCT01413204|1071613|P1|Overall Study|Clearly not eligible for the study|0
317011|NCT01413204|1071611|P3|Overall Study|Withdrawal by Subject|4
317012|NCT01413204|1071612|P2|Overall Study|Withdrawal by Subject|4
317013|NCT01413204|1071613|P1|Overall Study|Withdrawal by Subject|1
317014|NCT01413204|1071611|P3|Overall Study|Physician Decision|2
317015|NCT01413204|1071612|P2|Overall Study|Physician Decision|0
317016|NCT01413204|1071613|P1|Overall Study|Physician Decision|3
317017|NCT01413204|1071611|P3|Overall Study|Adverse Event|2
317018|NCT01413204|1071612|P2|Overall Study|Adverse Event|2
317019|NCT01413204|1071613|P1|Overall Study|Adverse Event|1
317020|NCT01413191|1071621|P1|Overall Study|Death|1
317021|NCT01413191|1071621|P1|Overall Study|Disease Progression|5
317022|NCT01413191|1071621|P1|Overall Study|Lost to Follow-up|5
317023|NCT01412983|1071625|P2|1st Period|Inability to maintain wear|1
317024|NCT01412983|1071626|P1|1st Period|Inability to maintain wear|0
317025|NCT01412983|1071625|P2|1st Period|Unacceptable lens movement|1
317026|NCT01412983|1071626|P1|1st Period|Unacceptable lens movement|0
317027|NCT01412983|1071625|P2|1st Period|Positive slit lamp finding|1
317028|NCT01412983|1071626|P1|1st Period|Positive slit lamp finding|0
317029|NCT01412983|1071625|P2|1st Period|Ineligible|1
317030|NCT01412983|1071626|P1|1st Period|Ineligible|0
317031|NCT01412957|1071636|P2|Overall Study|Death|133
317032|NCT01412957|1071637|P1|Overall Study|Death|136
317033|NCT01412957|1071636|P2|Overall Study|Lost to Follow-up|2
317034|NCT01412957|1071637|P1|Overall Study|Lost to Follow-up|7
317035|NCT01412957|1071636|P2|Overall Study|Withdrawal by Subject|22
317036|NCT01412957|1071637|P1|Overall Study|Withdrawal by Subject|6
317037|NCT01412944|1071659|P6|Entire: IV + Maintenance|Adverse Event|0
317038|NCT01412944|1071660|P5|Entire: IV + Maintenance|Adverse Event|0
317039|NCT01412944|1071661|P4|Entire: IV + Maintenance|Adverse Event|0
317040|NCT01412944|1071662|P3|Entire: IV + Maintenance|Adverse Event|0
317041|NCT01412944|1071663|P2|Entire: IV + Maintenance|Adverse Event|1
317042|NCT01412944|1071664|P1|Entire: IV + Maintenance|Adverse Event|0
317043|NCT01412944|1071659|P6|Entire: IV + Maintenance|Lack of Efficacy|0
317044|NCT01412944|1071660|P5|Entire: IV + Maintenance|Lack of Efficacy|0
317045|NCT01412944|1071661|P4|Entire: IV + Maintenance|Lack of Efficacy|0
317046|NCT01412944|1071662|P3|Entire: IV + Maintenance|Lack of Efficacy|0
317047|NCT01412944|1071663|P2|Entire: IV + Maintenance|Lack of Efficacy|1
317048|NCT01412944|1071664|P1|Entire: IV + Maintenance|Lack of Efficacy|0
317049|NCT01412944|1071659|P6|Entire: IV + Maintenance|Lost to Follow-up|0
317050|NCT01412944|1071660|P5|Entire: IV + Maintenance|Lost to Follow-up|0
317051|NCT01412944|1071661|P4|Entire: IV + Maintenance|Lost to Follow-up|0
317052|NCT01412944|1071662|P3|Entire: IV + Maintenance|Lost to Follow-up|0
317053|NCT01412944|1071663|P2|Entire: IV + Maintenance|Lost to Follow-up|1
317054|NCT01412944|1071664|P1|Entire: IV + Maintenance|Lost to Follow-up|0
317055|NCT01412944|1071659|P6|Entire: IV + Maintenance|Protocol deviation|0
317056|NCT01412944|1071660|P5|Entire: IV + Maintenance|Protocol deviation|0
317057|NCT01412944|1071661|P4|Entire: IV + Maintenance|Protocol deviation|0
317058|NCT01412944|1071662|P3|Entire: IV + Maintenance|Protocol deviation|0
317059|NCT01412944|1071663|P2|Entire: IV + Maintenance|Protocol deviation|1
317060|NCT01412944|1071664|P1|Entire: IV + Maintenance|Protocol deviation|0
317061|NCT01412944|1071659|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
317062|NCT01412944|1071660|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
317063|NCT01412944|1071661|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
317064|NCT01412944|1071662|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
317065|NCT01412944|1071663|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
317066|NCT01412944|1071664|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
317067|NCT01412944|1071659|P6|Entire: IV + Maintenance|Lack of Efficacy|0
317068|NCT01412944|1071660|P5|Entire: IV + Maintenance|Lack of Efficacy|1
317069|NCT01412944|1071661|P4|Entire: IV + Maintenance|Lack of Efficacy|0
317070|NCT01412944|1071662|P3|Entire: IV + Maintenance|Lack of Efficacy|0
317071|NCT01412944|1071663|P2|Entire: IV + Maintenance|Lack of Efficacy|0
317072|NCT01412944|1071664|P1|Entire: IV + Maintenance|Lack of Efficacy|0
317073|NCT01412944|1071659|P6|Entire: IV + Maintenance|Lost to Follow-up|1
317074|NCT01412944|1071660|P5|Entire: IV + Maintenance|Lost to Follow-up|0
317075|NCT01412944|1071661|P4|Entire: IV + Maintenance|Lost to Follow-up|0
317076|NCT01412944|1071662|P3|Entire: IV + Maintenance|Lost to Follow-up|0
317077|NCT01412944|1071663|P2|Entire: IV + Maintenance|Lost to Follow-up|0
317078|NCT01412944|1071664|P1|Entire: IV + Maintenance|Lost to Follow-up|0
317079|NCT01412944|1071659|P6|Entire: IV + Maintenance|Protocol deviation|1
317080|NCT01412944|1071660|P5|Entire: IV + Maintenance|Protocol deviation|0
317081|NCT01412944|1071661|P4|Entire: IV + Maintenance|Protocol deviation|0
317082|NCT01412944|1071662|P3|Entire: IV + Maintenance|Protocol deviation|0
317083|NCT01412944|1071663|P2|Entire: IV + Maintenance|Protocol deviation|0
317084|NCT01412944|1071664|P1|Entire: IV + Maintenance|Protocol deviation|0
317085|NCT01412944|1071659|P6|Entire: IV + Maintenance|Adverse Event|0
317086|NCT01412944|1071660|P5|Entire: IV + Maintenance|Adverse Event|1
317087|NCT01412944|1071661|P4|Entire: IV + Maintenance|Adverse Event|0
317088|NCT01412944|1071662|P3|Entire: IV + Maintenance|Adverse Event|0
317089|NCT01412944|1071663|P2|Entire: IV + Maintenance|Adverse Event|0
317090|NCT01412944|1071664|P1|Entire: IV + Maintenance|Adverse Event|0
317091|NCT01412944|1071659|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
317092|NCT01412944|1071660|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
317093|NCT01412944|1071661|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
317094|NCT01412944|1071662|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
317095|NCT01412944|1071663|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
317096|NCT01412944|1071664|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
317097|NCT01412944|1071659|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
317098|NCT01412944|1071660|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
317099|NCT01412944|1071661|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
317100|NCT01412944|1071662|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
317101|NCT01412944|1071663|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
317102|NCT01412944|1071664|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
317103|NCT01412944|1071659|P6|IV: Per CAIN457A2307|Protocol deviation|0
317104|NCT01412944|1071660|P5|IV: Per CAIN457A2307|Protocol deviation|0
317105|NCT01412944|1071661|P4|IV: Per CAIN457A2307|Protocol deviation|0
317106|NCT01412944|1071662|P3|IV: Per CAIN457A2307|Protocol deviation|0
317107|NCT01412944|1071663|P2|IV: Per CAIN457A2307|Protocol deviation|1
317108|NCT01412944|1071664|P1|IV: Per CAIN457A2307|Protocol deviation|0
317109|NCT01412944|1071659|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
317110|NCT01412944|1071660|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
317111|NCT01412944|1071661|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
317112|NCT01412944|1071662|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
317113|NCT01412944|1071663|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
317114|NCT01412944|1071664|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
317115|NCT01412944|1071659|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
317116|NCT01412944|1071660|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
317117|NCT01412944|1071661|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
317118|NCT01412944|1071662|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
317119|NCT01412944|1071663|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
317120|NCT01412944|1071664|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
317121|NCT01412944|1071659|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
317122|NCT01412944|1071660|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
317123|NCT01412944|1071661|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
317124|NCT01412944|1071662|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
317125|NCT01412944|1071663|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
317126|NCT01412944|1071664|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
317127|NCT01412944|1071659|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
317128|NCT01412944|1071660|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
317129|NCT01412944|1071661|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
317130|NCT01412944|1071662|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
317131|NCT01412944|1071663|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
317132|NCT01412944|1071664|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
317133|NCT01412879|1071710|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
317134|NCT01412879|1071711|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
317135|NCT01412879|1071712|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
317136|NCT01412879|1071710|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
317137|NCT01412879|1071711|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
317138|NCT01412879|1071712|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
317139|NCT01412879|1071710|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
317140|NCT01412879|1071711|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
317141|NCT01412879|1071712|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
317142|NCT01412879|1071710|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
317143|NCT01412879|1071711|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
317144|NCT01412879|1071712|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
317145|NCT01412879|1071710|P3|Initial Registration (Induction Therapy)|Adverse Event|0
317146|NCT01412879|1071711|P2|Initial Registration (Induction Therapy)|Adverse Event|3
317147|NCT01412879|1071712|P1|Initial Registration (Induction Therapy)|Adverse Event|5
317148|NCT01412801|1071732|P6|Overall Study|Relocated to another area|0
317149|NCT01412801|1071733|P5|Overall Study|Relocated to another area|0
317150|NCT01412801|1071734|P4|Overall Study|Relocated to another area|0
317151|NCT01412801|1071735|P3|Overall Study|Relocated to another area|2
317152|NCT01412801|1071736|P2|Overall Study|Relocated to another area|0
317153|NCT01412801|1071737|P1|Overall Study|Relocated to another area|0
317154|NCT01412801|1071732|P6|Overall Study|Withdrawal by Subject|0
317155|NCT01412801|1071733|P5|Overall Study|Withdrawal by Subject|0
317156|NCT01412801|1071734|P4|Overall Study|Withdrawal by Subject|0
317157|NCT01412801|1071735|P3|Overall Study|Withdrawal by Subject|1
317158|NCT01412801|1071736|P2|Overall Study|Withdrawal by Subject|2
317159|NCT01412801|1071737|P1|Overall Study|Withdrawal by Subject|3
317160|NCT01412801|1071732|P6|Overall Study|Lost to Follow-up|1
317161|NCT01412801|1071733|P5|Overall Study|Lost to Follow-up|1
317162|NCT01412801|1071734|P4|Overall Study|Lost to Follow-up|0
317163|NCT01412801|1071735|P3|Overall Study|Lost to Follow-up|4
317164|NCT01412801|1071736|P2|Overall Study|Lost to Follow-up|2
317165|NCT01412801|1071737|P1|Overall Study|Lost to Follow-up|1
317166|NCT01412801|1071732|P6|Overall Study|Death|2
317167|NCT01412801|1071733|P5|Overall Study|Death|2
317168|NCT01412801|1071734|P4|Overall Study|Death|4
317169|NCT01412801|1071735|P3|Overall Study|Death|0
317170|NCT01412801|1071736|P2|Overall Study|Death|1
317171|NCT01412801|1071737|P1|Overall Study|Death|0
317172|NCT01412424|1071896|P1|Extension Treatment Period|Patient Request|2
317173|NCT01412424|1071896|P1|Extension Treatment Period|Treatment Failure|2
317174|NCT01412424|1071896|P1|Extension Treatment Period|Adverse Event|2
317175|NCT01412424|1071896|P1|Core Treatment Period|Sponsor Request|1
317176|NCT01412424|1071896|P1|Core Treatment Period|Lost to Follow-up|2
317177|NCT01412424|1071896|P1|Core Treatment Period|Patient Request|5
317178|NCT01412424|1071896|P1|Core Treatment Period|Adverse Event|21
317179|NCT01412424|1071896|P1|Core Treatment Period|Treatment Failure|24
317180|NCT01412333|1071914|P2|Overall Study|Lost to Follow-up|6
317181|NCT01412333|1071915|P1|Overall Study|Lost to Follow-up|10
317182|NCT01412333|1071914|P2|Overall Study|Adverse Event|16
317183|NCT01412333|1071915|P1|Overall Study|Adverse Event|25
317184|NCT01412333|1071914|P2|Overall Study|Consent withdrawn by participant|12
317185|NCT01412333|1071915|P1|Overall Study|Consent withdrawn by participant|25
317186|NCT01412333|1071914|P2|Overall Study|Pregnancy|0
317187|NCT01412333|1071915|P1|Overall Study|Pregnancy|3
317188|NCT01412333|1071914|P2|Overall Study|Lack of Efficacy|6
317189|NCT01412333|1071915|P1|Overall Study|Lack of Efficacy|15
317190|NCT01412333|1071914|P2|Overall Study|Non-compliance|3
317191|NCT01412333|1071915|P1|Overall Study|Non-compliance|1
317192|NCT01412333|1071914|P2|Overall Study|Protocol Violation|1
317193|NCT01412333|1071915|P1|Overall Study|Protocol Violation|1
317194|NCT01412333|1071914|P2|Overall Study|Non-compliance with study drug|1
317195|NCT01412333|1071915|P1|Overall Study|Non-compliance with study drug|1
317196|NCT01412333|1071914|P2|Overall Study|Reason not specified|10
317197|NCT01412333|1071915|P1|Overall Study|Reason not specified|16
317198|NCT01412333|1071914|P2|Overall Study|Physician Decision|1
317199|NCT01412333|1071915|P1|Overall Study|Physician Decision|0
317200|NCT01412333|1071914|P2|Overall Study|Death|1
317201|NCT01412333|1071915|P1|Overall Study|Death|1
317202|NCT01412229|1071975|P1|Overall Study|Physician Decision|1
317203|NCT01412151|1071991|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
317204|NCT01412151|1071991|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
317205|NCT01412151|1071991|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
317206|NCT01412151|1071991|P1|Week 0 - 306 - Treatment Period|Death|1
317207|NCT01411995|1072004|P2|Overall Study|Failed IUD insertion|1
317208|NCT01411995|1072005|P1|Overall Study|Failed IUD insertion|0
317209|NCT01411891|1072013|P2|Overall Study|Catheter dislodgement or loss to follow-|2
317210|NCT01411891|1072014|P1|Overall Study|Catheter dislodgement or loss to follow-|3
317211|NCT01411852|1072022|P2|Hospital Intervention Phase|Vascular access failed|0
317212|NCT01411852|1072023|P1|Hospital Intervention Phase|Vascular access failed|1
317213|NCT01411852|1072022|P2|Hospital Intervention Phase|Withdrawal by Subject|0
317214|NCT01411852|1072023|P1|Hospital Intervention Phase|Withdrawal by Subject|1
317215|NCT01411852|1072022|P2|Hospital Intervention Phase|Spinal cord injury|0
317216|NCT01411852|1072023|P1|Hospital Intervention Phase|Spinal cord injury|2
317217|NCT01411852|1072022|P2|Hospital Intervention Phase|Other ineligible|2
317218|NCT01411852|1072023|P1|Hospital Intervention Phase|Other ineligible|2
317219|NCT01411852|1072022|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
317220|NCT01411852|1072023|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
317221|NCT01411852|1072022|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
317222|NCT01411852|1072023|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
317223|NCT01411852|1072022|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
317224|NCT01411852|1072023|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
317225|NCT01411852|1072022|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
317226|NCT01411852|1072023|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
317227|NCT01411852|1072022|P2|Hospital Intervention Phase|CPR administered|1
317228|NCT01411852|1072023|P1|Hospital Intervention Phase|CPR administered|3
317229|NCT01411852|1072022|P2|Hospital Intervention Phase|Miscommunication error|2
317230|NCT01411852|1072023|P1|Hospital Intervention Phase|Miscommunication error|1
317231|NCT01411852|1072022|P2|Hospital Intervention Phase|No qualifying SBP|1
317232|NCT01411852|1072023|P1|Hospital Intervention Phase|No qualifying SBP|5
317233|NCT01411852|1072022|P2|Hospital Intervention Phase|Severe head injury|4
317234|NCT01411852|1072023|P1|Hospital Intervention Phase|Severe head injury|5
317235|NCT01411852|1072022|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
317236|NCT01411852|1072023|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
317237|NCT01411852|1072022|P2|Prehospital Intervention Phase|Found to be under age|1
317238|NCT01411852|1072023|P1|Prehospital Intervention Phase|Found to be under age|0
317239|NCT01411852|1072022|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
317240|NCT01411852|1072023|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
317241|NCT01411852|1072022|P2|Prehospital Intervention Phase|No qualifying SBP|4
317242|NCT01411852|1072023|P1|Prehospital Intervention Phase|No qualifying SBP|5
317243|NCT01411839|1072068|P2|Overall Study|Lost to Follow-up|3
317244|NCT01411839|1072069|P1|Overall Study|Lost to Follow-up|4
317245|NCT01411774|1072081|P2|Overall Study|Withdrawal by Subject|3
317246|NCT01411774|1072082|P1|Overall Study|Withdrawal by Subject|0
317247|NCT01411228|1072157|P3|Overall Study|Withdrawal by Subject|0
317248|NCT01411228|1072158|P2|Overall Study|Withdrawal by Subject|0
317249|NCT01411228|1072159|P1|Overall Study|Withdrawal by Subject|1
317250|NCT01411228|1072157|P3|Overall Study|Lost to Follow-up|1
317251|NCT01411228|1072158|P2|Overall Study|Lost to Follow-up|0
317252|NCT01411228|1072159|P1|Overall Study|Lost to Follow-up|0
317253|NCT01411215|1072181|P2|Overall Study|Screen failure|1
317254|NCT01411215|1072182|P1|Overall Study|Screen failure|0
317255|NCT01411215|1072181|P2|Overall Study|Other|17
317256|NCT01411215|1072182|P1|Overall Study|Other|12
317257|NCT01411215|1072181|P2|Overall Study|Withdrawal by Subject|21
317258|NCT01411215|1072182|P1|Overall Study|Withdrawal by Subject|34
317259|NCT01411215|1072181|P2|Overall Study|Protocol Violation|5
317260|NCT01411215|1072182|P1|Overall Study|Protocol Violation|3
317261|NCT01411215|1072181|P2|Overall Study|Study terminated by sponsor|15
317262|NCT01411215|1072182|P1|Overall Study|Study terminated by sponsor|2
317263|NCT01411215|1072181|P2|Overall Study|Did not meet entrance criteria|1
317264|NCT01411215|1072182|P1|Overall Study|Did not meet entrance criteria|0
317265|NCT01411215|1072181|P2|Overall Study|Lost to Follow-up|18
317266|NCT01411215|1072182|P1|Overall Study|Lost to Follow-up|12
317267|NCT01411215|1072181|P2|Overall Study|Lack of Efficacy|4
317268|NCT01411215|1072182|P1|Overall Study|Lack of Efficacy|2
317269|NCT01411215|1072181|P2|Overall Study|Adverse Event|2
317270|NCT01411215|1072182|P1|Overall Study|Adverse Event|1
317271|NCT01411085|1072234|P1|Overall Study|Adverse Event|1
317272|NCT01411085|1072234|P1|Overall Study|Protocol Violation|1
317273|NCT01411085|1072234|P1|Overall Study|Physician Decision|1
317274|NCT01410604|1072245|P2|Overall Study|Physician Decision|1
317275|NCT01410604|1072246|P1|Overall Study|Physician Decision|0
317276|NCT01410604|1072245|P2|Overall Study|Lost to Follow-up|0
317277|NCT01410604|1072246|P1|Overall Study|Lost to Follow-up|1
317278|NCT01410604|1072245|P2|Overall Study|Adverse Event|1
317279|NCT01410604|1072246|P1|Overall Study|Adverse Event|2
317280|NCT01410474|1072287|P2|Overall Study|Withdrawal by Subject|1
317281|NCT01410474|1072288|P1|Overall Study|Withdrawal by Subject|0
317282|NCT01410448|1072311|P2|Overall Study|Death|3
317283|NCT01410448|1072312|P1|Overall Study|Death|2
317284|NCT01410448|1072311|P2|Overall Study|Protocol Violation|4
317285|NCT01410448|1072312|P1|Overall Study|Protocol Violation|0
317286|NCT01410448|1072311|P2|Overall Study|Withdrawal by Subject|2
317287|NCT01410448|1072312|P1|Overall Study|Withdrawal by Subject|3
317288|NCT01410448|1072311|P2|Overall Study|Lost to Follow-up|0
317289|NCT01410448|1072312|P1|Overall Study|Lost to Follow-up|1
317290|NCT01410448|1072311|P2|Overall Study|Administrative issues|1
317291|NCT01410448|1072312|P1|Overall Study|Administrative issues|2
317292|NCT01410448|1072311|P2|Overall Study|Graft loss|1
317293|NCT01410448|1072312|P1|Overall Study|Graft loss|4
317294|NCT01410448|1072311|P2|Overall Study|No conversion to everolimus|24
317295|NCT01410448|1072312|P1|Overall Study|No conversion to everolimus|0
317296|NCT01410357|1072377|P2|Overall Study|Lost to Follow-up|21
317297|NCT01410357|1072378|P1|Overall Study|Lost to Follow-up|23
317298|NCT01410357|1072377|P2|Overall Study|Withdrawal by Subject|2
317299|NCT01410357|1072378|P1|Overall Study|Withdrawal by Subject|1
317300|NCT01410357|1072377|P2|Overall Study|Death|1
317301|NCT01410357|1072378|P1|Overall Study|Death|2
317302|NCT01410240|1072439|P3|Overall Study|Missed week 6 assessments|1
317303|NCT01410240|1072440|P2|Overall Study|Missed week 6 assessments|1
317304|NCT01410240|1072441|P1|Overall Study|Missed week 6 assessments|1
317305|NCT01410240|1072439|P3|Overall Study|Physician Decision|1
317306|NCT01410240|1072440|P2|Overall Study|Physician Decision|0
317307|NCT01410240|1072441|P1|Overall Study|Physician Decision|0
317308|NCT01410227|1072512|P4|Overall Study|Met Excl. Criteria After Starting Study|0
317309|NCT01410227|1072513|P3|Overall Study|Met Excl. Criteria After Starting Study|1
317310|NCT01410227|1072514|P2|Overall Study|Met Excl. Criteria After Starting Study|0
317311|NCT01410227|1072515|P1|Overall Study|Met Excl. Criteria After Starting Study|0
317312|NCT01410227|1072512|P4|Overall Study|Pregnancy|1
317313|NCT01410227|1072513|P3|Overall Study|Pregnancy|0
317314|NCT01410227|1072514|P2|Overall Study|Pregnancy|0
317315|NCT01410227|1072515|P1|Overall Study|Pregnancy|0
317316|NCT01410227|1072512|P4|Overall Study|Withdrawal by Subject|0
317317|NCT01410227|1072513|P3|Overall Study|Withdrawal by Subject|1
317318|NCT01410227|1072514|P2|Overall Study|Withdrawal by Subject|0
317319|NCT01410227|1072515|P1|Overall Study|Withdrawal by Subject|3
317320|NCT01410227|1072512|P4|Overall Study|Adverse Event|0
317321|NCT01410227|1072513|P3|Overall Study|Adverse Event|0
317322|NCT01410227|1072514|P2|Overall Study|Adverse Event|0
317323|NCT01410227|1072515|P1|Overall Study|Adverse Event|1
317324|NCT01410110|1072587|P2|Overall Study|Withdrawal by Subject|2
317325|NCT01410110|1072588|P1|Overall Study|Withdrawal by Subject|4
317326|NCT01409993|1072637|P4|Overall Study|Lost to Follow-up|0
317327|NCT01409993|1072638|P3|Overall Study|Lost to Follow-up|0
317328|NCT01409993|1072639|P2|Overall Study|Lost to Follow-up|1
317329|NCT01409993|1072640|P1|Overall Study|Lost to Follow-up|0
317330|NCT01409993|1072637|P4|Overall Study|Withdrawal by Subject|4
317331|NCT01409993|1072638|P3|Overall Study|Withdrawal by Subject|0
317332|NCT01409993|1072639|P2|Overall Study|Withdrawal by Subject|0
317333|NCT01409993|1072640|P1|Overall Study|Withdrawal by Subject|0
317334|NCT01409993|1072637|P4|Overall Study|Adverse Event|1
317335|NCT01409993|1072638|P3|Overall Study|Adverse Event|3
317336|NCT01409993|1072639|P2|Overall Study|Adverse Event|4
317337|NCT01409993|1072640|P1|Overall Study|Adverse Event|4
317338|NCT01409837|1072660|P2|Overall Study|Physician Decision|1
317339|NCT01409837|1072661|P1|Overall Study|Physician Decision|0
317340|NCT01409837|1072660|P2|Overall Study|Lost to Follow-up|0
317341|NCT01409837|1072661|P1|Overall Study|Lost to Follow-up|1
317342|NCT01409837|1072660|P2|Overall Study|Withdrawal by Subject|1
317343|NCT01409837|1072661|P1|Overall Study|Withdrawal by Subject|2
317344|NCT01409707|1072686|P3|Overall Study|Withdrawal by Subject|16
317345|NCT01409707|1072687|P2|Overall Study|Withdrawal by Subject|17
317346|NCT01409707|1072688|P1|Overall Study|Withdrawal by Subject|5
317347|NCT01409564|1072700|P2|Overall Study|brain abnormalities found in T1 MR|2
317348|NCT01409564|1072701|P1|Overall Study|brain abnormalities found in T1 MR|1
317349|NCT01409564|1072700|P2|Overall Study|low medication compliance|3
317350|NCT01409564|1072701|P1|Overall Study|low medication compliance|4
317351|NCT01409434|1072719|P1|Overall Study|Protocol Violation|4
317352|NCT01409382|1072729|P2|Overall Study|Had a 2nd trimester loss after accident|0
317353|NCT01409382|1072730|P1|Overall Study|Had a 2nd trimester loss after accident|1
317354|NCT01409382|1072729|P2|Overall Study|Did not manage to get pregnant|70
317355|NCT01409382|1072730|P1|Overall Study|Did not manage to get pregnant|64
317356|NCT01409382|1072729|P2|Overall Study|Still pregnant when study ended|2
317357|NCT01409382|1072730|P1|Overall Study|Still pregnant when study ended|13
317358|NCT01409382|1072729|P2|Overall Study|Multiple pregnancy|4
317359|NCT01409382|1072730|P1|Overall Study|Multiple pregnancy|2
317360|NCT01409382|1072729|P2|Overall Study|Protocol Violation|3
317361|NCT01409382|1072730|P1|Overall Study|Protocol Violation|0
317362|NCT01409382|1072729|P2|Overall Study|Lost to Follow-up|1
317363|NCT01409382|1072730|P1|Overall Study|Lost to Follow-up|1
317364|NCT01408914|1072797|P3|Overall Study|Change in local TB/HIV norms|1
317365|NCT01408914|1072798|P2|Overall Study|Change in local TB/HIV norms|1
317366|NCT01408914|1072799|P1|Overall Study|Change in local TB/HIV norms|0
317367|NCT01408914|1072797|P3|Overall Study|Late exclusion|3
317368|NCT01408914|1072798|P2|Overall Study|Late exclusion|3
317369|NCT01408914|1072799|P1|Overall Study|Late exclusion|0
317370|NCT01408914|1072797|P3|Overall Study|Moved out of study jurisdiction|0
317371|NCT01408914|1072798|P2|Overall Study|Moved out of study jurisdiction|1
317372|NCT01408914|1072799|P1|Overall Study|Moved out of study jurisdiction|1
317373|NCT01408914|1072797|P3|Overall Study|Withdrawal by Subject|1
317374|NCT01408914|1072798|P2|Overall Study|Withdrawal by Subject|0
317375|NCT01408914|1072799|P1|Overall Study|Withdrawal by Subject|1
317376|NCT01408914|1072797|P3|Overall Study|Physician Decision|0
317377|NCT01408914|1072798|P2|Overall Study|Physician Decision|1
317378|NCT01408914|1072799|P1|Overall Study|Physician Decision|1
317379|NCT01408914|1072797|P3|Overall Study|Lost to Follow-up|2
317380|NCT01408914|1072798|P2|Overall Study|Lost to Follow-up|1
317381|NCT01408914|1072799|P1|Overall Study|Lost to Follow-up|4
317382|NCT01408914|1072797|P3|Overall Study|Could not complete tx in protocol period|6
317383|NCT01408914|1072798|P2|Overall Study|Could not complete tx in protocol period|5
317384|NCT01408914|1072799|P1|Overall Study|Could not complete tx in protocol period|5
317385|NCT01408888|1072813|P2|Second Intervention|Adverse Event|0
317386|NCT01408888|1072814|P1|Second Intervention|Adverse Event|1
317387|NCT01408888|1072813|P2|Second Intervention|Withdrawal by Subject|0
317388|NCT01408888|1072814|P1|Second Intervention|Withdrawal by Subject|1
317389|NCT01408888|1072813|P2|First Intervention|Withdrawal by Subject|2
317390|NCT01408888|1072814|P1|First Intervention|Withdrawal by Subject|0
317391|NCT01408888|1072813|P2|First Intervention|Adverse Event|1
317392|NCT01408888|1072814|P1|First Intervention|Adverse Event|0
317393|NCT01408732|1072842|P2|Overall Study|Withdrawal by Subject|2
317394|NCT01408732|1072843|P1|Overall Study|Withdrawal by Subject|2
317395|NCT01408706|1072900|P2|Overall Study|Physician Decision|0
317396|NCT01408706|1072901|P1|Overall Study|Physician Decision|1
317397|NCT01408641|1072913|P2|Overall Study|Physician Decision|0
317398|NCT01408641|1072914|P1|Overall Study|Physician Decision|1
317399|NCT01408628|1072922|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
317400|NCT01408628|1072922|P1|Completed 6 Month Follow-Up|Protocol Violation|6
317401|NCT01408628|1072922|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
317402|NCT01408628|1072922|P1|Consented|Withdrawal by Subject|12
317403|NCT01408537|1072928|P1|Overall Study|Lost to Follow-up|3
317404|NCT01408537|1072928|P1|Overall Study|Protocol Violation|3
317405|NCT01408537|1072928|P1|Overall Study|Withdrawal by Subject|2
317406|NCT01408485|1072944|P1|Overall Study|Withdrawal by Subject|21
317407|NCT01408303|1072962|P3|Overall Study|Noncompliance|1
317408|NCT01408303|1072963|P2|Overall Study|Noncompliance|0
317409|NCT01408303|1072964|P1|Overall Study|Noncompliance|1
317410|NCT01408303|1072962|P3|Overall Study|Protocol Violation|0
317411|NCT01408303|1072963|P2|Overall Study|Protocol Violation|1
317412|NCT01408303|1072964|P1|Overall Study|Protocol Violation|0
317413|NCT01408303|1072962|P3|Overall Study|Withdrawal by Subject|1
317414|NCT01408303|1072963|P2|Overall Study|Withdrawal by Subject|3
317415|NCT01408303|1072964|P1|Overall Study|Withdrawal by Subject|2
317416|NCT01408303|1072962|P3|Overall Study|Lost to Follow-up|2
317417|NCT01408303|1072963|P2|Overall Study|Lost to Follow-up|1
317418|NCT01408303|1072964|P1|Overall Study|Lost to Follow-up|0
317419|NCT01408303|1072962|P3|Overall Study|Adverse Event|2
317420|NCT01408303|1072963|P2|Overall Study|Adverse Event|7
317421|NCT01408303|1072964|P1|Overall Study|Adverse Event|3
317422|NCT01408277|1072974|P2|Overall Study|Protocol Violation|0
317423|NCT01408277|1072975|P1|Overall Study|Protocol Violation|2
317424|NCT01408277|1072974|P2|Overall Study|Withdrawal by Subject|0
317425|NCT01408277|1072975|P1|Overall Study|Withdrawal by Subject|2
317426|NCT01408277|1072974|P2|Overall Study|Lost to Follow-up|0
317427|NCT01408277|1072975|P1|Overall Study|Lost to Follow-up|1
317428|NCT01408277|1072974|P2|Overall Study|Adverse Event|4
317429|NCT01408277|1072975|P1|Overall Study|Adverse Event|3
317430|NCT01407354|1073012|P2|First Intervention|Physician Decision|0
317431|NCT01407354|1073013|P1|First Intervention|Physician Decision|1
317432|NCT01407354|1073012|P2|First Intervention|Adverse Event|0
317433|NCT01407354|1073013|P1|First Intervention|Adverse Event|1
317434|NCT01407354|1073012|P2|First Intervention|Withdrawal by Subject|2
317435|NCT01407354|1073013|P1|First Intervention|Withdrawal by Subject|0
317436|NCT01407276|1073029|P8|Overall Study|Withdrawal by Subject|1
317437|NCT01407276|1073030|P7|Overall Study|Withdrawal by Subject|0
317438|NCT01407276|1073031|P6|Overall Study|Withdrawal by Subject|0
317439|NCT01407276|1073032|P5|Overall Study|Withdrawal by Subject|0
317440|NCT01407276|1073033|P4|Overall Study|Withdrawal by Subject|0
317441|NCT01407276|1073034|P3|Overall Study|Withdrawal by Subject|0
317442|NCT01407276|1073035|P2|Overall Study|Withdrawal by Subject|0
317443|NCT01407276|1073036|P1|Overall Study|Withdrawal by Subject|0
317444|NCT01406938|1073175|P6|Follow up|Lost to Follow-up|1
317445|NCT01406938|1073176|P5|Follow up|Lost to Follow-up|2
317446|NCT01406938|1073177|P4|Follow up|Lost to Follow-up|1
317447|NCT01406938|1073178|P3|Follow up|Lost to Follow-up|0
317448|NCT01406938|1073179|P2|Follow up|Lost to Follow-up|1
317449|NCT01406938|1073180|P1|Follow up|Lost to Follow-up|1
317450|NCT01406938|1073175|P6|Follow up|Physician Decision|1
317451|NCT01406938|1073176|P5|Follow up|Physician Decision|3
317452|NCT01406938|1073177|P4|Follow up|Physician Decision|0
317453|NCT01406938|1073178|P3|Follow up|Physician Decision|2
317454|NCT01406938|1073179|P2|Follow up|Physician Decision|0
317455|NCT01406938|1073180|P1|Follow up|Physician Decision|0
317456|NCT01406938|1073175|P6|Follow up|Protocol Violation|0
317457|NCT01406938|1073176|P5|Follow up|Protocol Violation|0
317458|NCT01406938|1073177|P4|Follow up|Protocol Violation|0
317459|NCT01406938|1073178|P3|Follow up|Protocol Violation|1
317460|NCT01406938|1073179|P2|Follow up|Protocol Violation|0
317461|NCT01406938|1073180|P1|Follow up|Protocol Violation|0
317462|NCT01406938|1073175|P6|Follow up|Patient/guardian decision|1
317463|NCT01406938|1073176|P5|Follow up|Patient/guardian decision|4
317464|NCT01406938|1073177|P4|Follow up|Patient/guardian decision|2
317465|NCT01406938|1073178|P3|Follow up|Patient/guardian decision|4
317466|NCT01406938|1073179|P2|Follow up|Patient/guardian decision|2
317467|NCT01406938|1073180|P1|Follow up|Patient/guardian decision|4
317468|NCT01406938|1073175|P6|Follow up|Lack of Efficacy|0
317469|NCT01406938|1073176|P5|Follow up|Lack of Efficacy|0
317470|NCT01406938|1073177|P4|Follow up|Lack of Efficacy|0
317471|NCT01406938|1073178|P3|Follow up|Lack of Efficacy|1
317472|NCT01406938|1073179|P2|Follow up|Lack of Efficacy|2
317473|NCT01406938|1073180|P1|Follow up|Lack of Efficacy|3
317474|NCT01406938|1073175|P6|Maintenance Period|Lack of Efficacy|5
317475|NCT01406938|1073176|P5|Maintenance Period|Lack of Efficacy|3
317476|NCT01406938|1073177|P4|Maintenance Period|Lack of Efficacy|1
317477|NCT01406938|1073178|P3|Maintenance Period|Lack of Efficacy|2
317478|NCT01406938|1073179|P2|Maintenance Period|Lack of Efficacy|0
317479|NCT01406938|1073180|P1|Maintenance Period|Lack of Efficacy|0
317480|NCT01406938|1073175|P6|Maintenance Period|Lost to Follow-up|0
317481|NCT01406938|1073176|P5|Maintenance Period|Lost to Follow-up|4
317482|NCT01406938|1073177|P4|Maintenance Period|Lost to Follow-up|0
317483|NCT01406938|1073178|P3|Maintenance Period|Lost to Follow-up|0
317484|NCT01406938|1073179|P2|Maintenance Period|Lost to Follow-up|0
317485|NCT01406938|1073180|P1|Maintenance Period|Lost to Follow-up|0
317486|NCT01406938|1073175|P6|Maintenance Period|Pregnancy|0
317487|NCT01406938|1073176|P5|Maintenance Period|Pregnancy|1
317488|NCT01406938|1073177|P4|Maintenance Period|Pregnancy|0
317489|NCT01406938|1073178|P3|Maintenance Period|Pregnancy|0
317490|NCT01406938|1073179|P2|Maintenance Period|Pregnancy|0
317491|NCT01406938|1073180|P1|Maintenance Period|Pregnancy|0
317492|NCT01406938|1073175|P6|Maintenance Period|Protocol Violation|2
317493|NCT01406938|1073176|P5|Maintenance Period|Protocol Violation|2
317494|NCT01406938|1073177|P4|Maintenance Period|Protocol Violation|2
317495|NCT01406938|1073178|P3|Maintenance Period|Protocol Violation|2
317496|NCT01406938|1073179|P2|Maintenance Period|Protocol Violation|0
317497|NCT01406938|1073180|P1|Maintenance Period|Protocol Violation|0
317498|NCT01406938|1073175|P6|Maintenance Period|Subject/guardian decision|7
317499|NCT01406938|1073176|P5|Maintenance Period|Subject/guardian decision|10
317500|NCT01406938|1073177|P4|Maintenance Period|Subject/guardian decision|7
317501|NCT01406938|1073178|P3|Maintenance Period|Subject/guardian decision|11
317502|NCT01406938|1073179|P2|Maintenance Period|Subject/guardian decision|0
317503|NCT01406938|1073180|P1|Maintenance Period|Subject/guardian decision|0
317504|NCT01406938|1073175|P6|Maintenance Period|Death|0
317505|NCT01406938|1073176|P5|Maintenance Period|Death|1
317506|NCT01406938|1073177|P4|Maintenance Period|Death|0
317507|NCT01406938|1073178|P3|Maintenance Period|Death|0
317508|NCT01406938|1073179|P2|Maintenance Period|Death|0
317509|NCT01406938|1073180|P1|Maintenance Period|Death|0
317510|NCT01406938|1073175|P6|Maintenance Period|Adverse Event|2
317511|NCT01406938|1073176|P5|Maintenance Period|Adverse Event|4
317512|NCT01406938|1073177|P4|Maintenance Period|Adverse Event|8
317513|NCT01406938|1073178|P3|Maintenance Period|Adverse Event|2
317514|NCT01406938|1073179|P2|Maintenance Period|Adverse Event|0
317515|NCT01406938|1073180|P1|Maintenance Period|Adverse Event|0
317516|NCT01406938|1073175|P6|Induction Period|Lost to Follow-up|0
317517|NCT01406938|1073176|P5|Induction Period|Lost to Follow-up|0
317518|NCT01406938|1073177|P4|Induction Period|Lost to Follow-up|0
317519|NCT01406938|1073178|P3|Induction Period|Lost to Follow-up|0
317520|NCT01406938|1073179|P2|Induction Period|Lost to Follow-up|3
317521|NCT01406938|1073180|P1|Induction Period|Lost to Follow-up|2
317522|NCT01406938|1073175|P6|Induction Period|Lack of Efficacy|0
317523|NCT01406938|1073176|P5|Induction Period|Lack of Efficacy|0
317524|NCT01406938|1073177|P4|Induction Period|Lack of Efficacy|0
317525|NCT01406938|1073178|P3|Induction Period|Lack of Efficacy|0
317526|NCT01406938|1073179|P2|Induction Period|Lack of Efficacy|0
317527|NCT01406938|1073180|P1|Induction Period|Lack of Efficacy|1
317528|NCT01406938|1073175|P6|Induction Period|Adverse Event|0
317529|NCT01406938|1073176|P5|Induction Period|Adverse Event|0
317530|NCT01406938|1073177|P4|Induction Period|Adverse Event|0
317531|NCT01406938|1073178|P3|Induction Period|Adverse Event|0
317532|NCT01406938|1073179|P2|Induction Period|Adverse Event|9
317533|NCT01406938|1073180|P1|Induction Period|Adverse Event|8
317534|NCT01406938|1073175|P6|Induction Period|Protocol deviation|0
317535|NCT01406938|1073176|P5|Induction Period|Protocol deviation|0
317536|NCT01406938|1073177|P4|Induction Period|Protocol deviation|0
317537|NCT01406938|1073178|P3|Induction Period|Protocol deviation|0
317538|NCT01406938|1073179|P2|Induction Period|Protocol deviation|0
317539|NCT01406938|1073180|P1|Induction Period|Protocol deviation|1
317540|NCT01406938|1073175|P6|Induction Period|Subject/guardian decision|0
317541|NCT01406938|1073176|P5|Induction Period|Subject/guardian decision|0
317542|NCT01406938|1073177|P4|Induction Period|Subject/guardian decision|0
317543|NCT01406938|1073178|P3|Induction Period|Subject/guardian decision|0
317544|NCT01406938|1073179|P2|Induction Period|Subject/guardian decision|8
317545|NCT01406938|1073180|P1|Induction Period|Subject/guardian decision|6
317546|NCT01406873|1073298|P2|Overall Study|Withdrawal by Subject|1
317547|NCT01406873|1073299|P1|Overall Study|Withdrawal by Subject|1
317548|NCT01406795|1073330|P1|Overall Study|Withdrawal by Subject|1
317549|NCT01406574|1073344|P4|Overall Study|Definite progression of primary disease|0
317550|NCT01406574|1073345|P3|Overall Study|Definite progression of primary disease|0
317551|NCT01406574|1073346|P2|Overall Study|Definite progression of primary disease|0
317552|NCT01406574|1073347|P1|Overall Study|Definite progression of primary disease|1
317553|NCT01406574|1073344|P4|Overall Study|Withdrawal by Subject|0
317554|NCT01406574|1073345|P3|Overall Study|Withdrawal by Subject|0
317555|NCT01406574|1073346|P2|Overall Study|Withdrawal by Subject|1
317556|NCT01406574|1073347|P1|Overall Study|Withdrawal by Subject|0
317557|NCT01406574|1073344|P4|Overall Study|Physician Decision|1
317558|NCT01406574|1073345|P3|Overall Study|Physician Decision|0
317559|NCT01406574|1073346|P2|Overall Study|Physician Decision|0
317560|NCT01406574|1073347|P1|Overall Study|Physician Decision|0
317561|NCT01406574|1073344|P4|Overall Study|Adverse Event|3
317562|NCT01406574|1073345|P3|Overall Study|Adverse Event|1
317563|NCT01406574|1073346|P2|Overall Study|Adverse Event|0
317564|NCT01406574|1073347|P1|Overall Study|Adverse Event|0
317565|NCT01406015|1073382|P2|Overall Study|Withdrawal by Subject|3
317566|NCT01406015|1073383|P1|Overall Study|Withdrawal by Subject|3
317567|NCT01405950|1073399|P4|Overall Study|Withdrawal by Subject|0
317568|NCT01405950|1073400|P3|Overall Study|Withdrawal by Subject|0
317569|NCT01405950|1073401|P2|Overall Study|Withdrawal by Subject|0
317570|NCT01405950|1073402|P1|Overall Study|Withdrawal by Subject|1
317571|NCT01405924|1073437|P1|Overall Study|Missing/Incomplete Data|2
317572|NCT01405924|1073437|P1|Overall Study|Protocol Violation|8
317573|NCT01405898|1073449|P2|Overall Study|Withdrawal by Subject|2
317574|NCT01405898|1073450|P1|Overall Study|Withdrawal by Subject|2
317575|NCT01405820|1073474|P6|Open-Label Treatment Period|Adverse Event|0
317576|NCT01405820|1073475|P5|Open-Label Treatment Period|Adverse Event|0
317577|NCT01405820|1073476|P4|Open-Label Treatment Period|Adverse Event|1
317578|NCT01405820|1073477|P3|Open-Label Treatment Period|Adverse Event|0
317579|NCT01405820|1073478|P2|Open-Label Treatment Period|Adverse Event|0
317580|NCT01405820|1073479|P1|Open-Label Treatment Period|Adverse Event|0
317581|NCT01405820|1073474|P6|Open-Label Treatment Period|Physician Decision|0
317582|NCT01405820|1073475|P5|Open-Label Treatment Period|Physician Decision|1
317583|NCT01405820|1073476|P4|Open-Label Treatment Period|Physician Decision|2
317584|NCT01405820|1073477|P3|Open-Label Treatment Period|Physician Decision|1
317585|NCT01405820|1073478|P2|Open-Label Treatment Period|Physician Decision|0
317586|NCT01405820|1073479|P1|Open-Label Treatment Period|Physician Decision|0
317587|NCT01405820|1073474|P6|Open-Label Treatment Period|Not Specified|1
317588|NCT01405820|1073475|P5|Open-Label Treatment Period|Not Specified|1
317589|NCT01405820|1073476|P4|Open-Label Treatment Period|Not Specified|1
317590|NCT01405820|1073477|P3|Open-Label Treatment Period|Not Specified|1
317591|NCT01405820|1073478|P2|Open-Label Treatment Period|Not Specified|1
317592|NCT01405820|1073479|P1|Open-Label Treatment Period|Not Specified|1
317593|NCT01405820|1073474|P6|Open-Label Treatment Period|Withdrawal by Subject|1
317594|NCT01405820|1073475|P5|Open-Label Treatment Period|Withdrawal by Subject|0
317595|NCT01405820|1073476|P4|Open-Label Treatment Period|Withdrawal by Subject|1
317596|NCT01405820|1073477|P3|Open-Label Treatment Period|Withdrawal by Subject|1
317597|NCT01405820|1073478|P2|Open-Label Treatment Period|Withdrawal by Subject|1
317598|NCT01405820|1073479|P1|Open-Label Treatment Period|Withdrawal by Subject|3
317599|NCT01405820|1073474|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
317600|NCT01405820|1073475|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
317601|NCT01405820|1073476|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
317602|NCT01405820|1073477|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
317603|NCT01405820|1073478|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
317604|NCT01405820|1073479|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
317605|NCT01405820|1073474|P6|Randomized Treatment Period|Death|0
317606|NCT01405820|1073475|P5|Randomized Treatment Period|Death|0
317607|NCT01405820|1073476|P4|Randomized Treatment Period|Death|1
317608|NCT01405820|1073477|P3|Randomized Treatment Period|Death|0
317609|NCT01405820|1073478|P2|Randomized Treatment Period|Death|0
317610|NCT01405820|1073479|P1|Randomized Treatment Period|Death|0
317611|NCT01405820|1073474|P6|Randomized Treatment Period|Treatment Arm Closed|28
317612|NCT01405820|1073475|P5|Randomized Treatment Period|Treatment Arm Closed|33
317613|NCT01405820|1073476|P4|Randomized Treatment Period|Treatment Arm Closed|36
317614|NCT01405820|1073477|P3|Randomized Treatment Period|Treatment Arm Closed|20
317615|NCT01405820|1073478|P2|Randomized Treatment Period|Treatment Arm Closed|0
317616|NCT01405820|1073479|P1|Randomized Treatment Period|Treatment Arm Closed|0
317617|NCT01405820|1073474|P6|Randomized Treatment Period|Incorrect Study Treatment|0
317618|NCT01405820|1073475|P5|Randomized Treatment Period|Incorrect Study Treatment|2
317619|NCT01405820|1073476|P4|Randomized Treatment Period|Incorrect Study Treatment|0
317620|NCT01405820|1073477|P3|Randomized Treatment Period|Incorrect Study Treatment|3
317621|NCT01405820|1073478|P2|Randomized Treatment Period|Incorrect Study Treatment|0
317622|NCT01405820|1073479|P1|Randomized Treatment Period|Incorrect Study Treatment|0
317623|NCT01405820|1073474|P6|Randomized Treatment Period|Rescue|8
317624|NCT01405820|1073475|P5|Randomized Treatment Period|Rescue|8
317625|NCT01405820|1073476|P4|Randomized Treatment Period|Rescue|10
317626|NCT01405820|1073477|P3|Randomized Treatment Period|Rescue|13
317627|NCT01405820|1073478|P2|Randomized Treatment Period|Rescue|1
317628|NCT01405820|1073479|P1|Randomized Treatment Period|Rescue|0
317629|NCT01405820|1073474|P6|Randomized Treatment Period|Physician Decision|0
317630|NCT01405820|1073475|P5|Randomized Treatment Period|Physician Decision|0
317631|NCT01405820|1073476|P4|Randomized Treatment Period|Physician Decision|0
317632|NCT01405820|1073477|P3|Randomized Treatment Period|Physician Decision|1
317633|NCT01405820|1073478|P2|Randomized Treatment Period|Physician Decision|2
317634|NCT01405820|1073479|P1|Randomized Treatment Period|Physician Decision|0
317635|NCT01405820|1073474|P6|Randomized Treatment Period|Not Specified|0
317636|NCT01405820|1073475|P5|Randomized Treatment Period|Not Specified|0
317637|NCT01405820|1073476|P4|Randomized Treatment Period|Not Specified|1
317638|NCT01405820|1073477|P3|Randomized Treatment Period|Not Specified|1
317639|NCT01405820|1073478|P2|Randomized Treatment Period|Not Specified|2
317640|NCT01405820|1073479|P1|Randomized Treatment Period|Not Specified|2
317641|NCT01405820|1073474|P6|Randomized Treatment Period|Withdrawal by Subject|0
317642|NCT01405820|1073475|P5|Randomized Treatment Period|Withdrawal by Subject|0
317643|NCT01405820|1073476|P4|Randomized Treatment Period|Withdrawal by Subject|2
317644|NCT01405820|1073477|P3|Randomized Treatment Period|Withdrawal by Subject|2
317645|NCT01405820|1073478|P2|Randomized Treatment Period|Withdrawal by Subject|2
317646|NCT01405820|1073479|P1|Randomized Treatment Period|Withdrawal by Subject|6
317647|NCT01405820|1073474|P6|Randomized Treatment Period|Adverse Event|1
317648|NCT01405820|1073475|P5|Randomized Treatment Period|Adverse Event|2
317649|NCT01405820|1073476|P4|Randomized Treatment Period|Adverse Event|0
317650|NCT01405820|1073477|P3|Randomized Treatment Period|Adverse Event|3
317651|NCT01405820|1073478|P2|Randomized Treatment Period|Adverse Event|3
317652|NCT01405820|1073479|P1|Randomized Treatment Period|Adverse Event|3
317653|NCT01405768|1073575|P2|Overall Study|Didn't complete questionnaire correctly|0
317654|NCT01405768|1073576|P1|Overall Study|Didn't complete questionnaire correctly|4
317655|NCT01405742|1073588|P2|Overall Study|Lost to Follow-up|0
317656|NCT01405742|1073589|P1|Overall Study|Lost to Follow-up|1
317657|NCT01405560|1073599|P1|Overall Study|Physician Decision|1
317658|NCT01405508|1073614|P4|Overall Study|AE, non-serious non-fatal|0
317659|NCT01405508|1073615|P3|Overall Study|AE, non-serious non-fatal|0
317660|NCT01405508|1073616|P2|Overall Study|AE, non-serious non-fatal|1
317661|NCT01405508|1073617|P1|Overall Study|AE, non-serious non-fatal|1
317662|NCT01405456|1073649|P2|Overall Study|Physician Decision|0
317663|NCT01405456|1073650|P1|Overall Study|Physician Decision|1
317664|NCT01405456|1073649|P2|Overall Study|Lost to Follow-up|1
317665|NCT01405456|1073650|P1|Overall Study|Lost to Follow-up|2
317666|NCT01405196|1073690|P4|Overall Study|Lost to Follow-up|1
317667|NCT01405196|1073691|P3|Overall Study|Lost to Follow-up|3
317668|NCT01405196|1073692|P2|Overall Study|Lost to Follow-up|2
317669|NCT01405196|1073693|P1|Overall Study|Lost to Follow-up|2
317670|NCT01405196|1073690|P4|Overall Study|Death|0
317671|NCT01405196|1073691|P3|Overall Study|Death|3
317672|NCT01405196|1073692|P2|Overall Study|Death|0
317673|NCT01405196|1073693|P1|Overall Study|Death|1
317674|NCT01405196|1073690|P4|Overall Study|Adverse Event|2
317675|NCT01405196|1073691|P3|Overall Study|Adverse Event|0
317676|NCT01405196|1073692|P2|Overall Study|Adverse Event|2
317677|NCT01405196|1073693|P1|Overall Study|Adverse Event|2
317678|NCT01405196|1073690|P4|Overall Study|Withdrawal by Subject|6
317679|NCT01405196|1073691|P3|Overall Study|Withdrawal by Subject|3
317680|NCT01405196|1073692|P2|Overall Study|Withdrawal by Subject|6
317681|NCT01405196|1073693|P1|Overall Study|Withdrawal by Subject|4
317682|NCT01405196|1073690|P4|Overall Study|Other|0
317683|NCT01405196|1073691|P3|Overall Study|Other|5
317684|NCT01405196|1073692|P2|Overall Study|Other|2
317685|NCT01405196|1073693|P1|Overall Study|Other|2
317686|NCT01405196|1073690|P4|Overall Study|Study Terminated by Sponsor|0
317687|NCT01405196|1073691|P3|Overall Study|Study Terminated by Sponsor|9
317688|NCT01405196|1073692|P2|Overall Study|Study Terminated by Sponsor|0
317689|NCT01405196|1073693|P1|Overall Study|Study Terminated by Sponsor|0
317690|NCT01405027|1073780|P2|Overall Study|Other or Unknown|25
317691|NCT01405027|1073781|P1|Overall Study|Other or Unknown|12
317692|NCT01405027|1073780|P2|Overall Study|Death|0
317693|NCT01405027|1073781|P1|Overall Study|Death|1
317694|NCT01405027|1073780|P2|Overall Study|Investigator judgement|2
317695|NCT01405027|1073781|P1|Overall Study|Investigator judgement|0
317696|NCT01405027|1073780|P2|Overall Study|Lost to Follow-up|24
317697|NCT01405027|1073781|P1|Overall Study|Lost to Follow-up|16
317698|NCT01405027|1073780|P2|Overall Study|Withdrawn consent|0
317699|NCT01405027|1073781|P1|Overall Study|Withdrawn consent|3
317700|NCT01404988|1073798|P3|Overall Study|Lost to Follow-up|1
317701|NCT01404988|1073799|P2|Overall Study|Lost to Follow-up|2
317702|NCT01404988|1073800|P1|Overall Study|Lost to Follow-up|1
317703|NCT01404988|1073798|P3|Overall Study|Withdrawal by Subject|0
317704|NCT01404988|1073799|P2|Overall Study|Withdrawal by Subject|2
317705|NCT01404988|1073800|P1|Overall Study|Withdrawal by Subject|2
317706|NCT01404988|1073798|P3|Overall Study|Adverse Event|0
317707|NCT01404988|1073799|P2|Overall Study|Adverse Event|0
317708|NCT01404988|1073800|P1|Overall Study|Adverse Event|1
317709|NCT01404988|1073798|P3|Overall Study|Death|2
317710|NCT01404988|1073799|P2|Overall Study|Death|0
317711|NCT01404988|1073800|P1|Overall Study|Death|2
317712|NCT01404234|1073928|P1|Overall Study|Withdrawal by Subject|2
317713|NCT01404208|1073944|P2|Overall Study|Discontinued|0
317714|NCT01404208|1073945|P1|Overall Study|Discontinued|3
317715|NCT01403987|1074010|P3|Overall Study|Residents forgot their secret PIN|18
317716|NCT01403987|1074011|P2|Overall Study|Residents forgot their secret PIN|17
317717|NCT01403987|1074012|P1|Overall Study|Residents forgot their secret PIN|18
317718|NCT01403805|1074028|P2|Overall Study|Death|1
317719|NCT01403805|1074029|P1|Overall Study|Death|0
317720|NCT01403805|1074028|P2|Overall Study|Lost to Follow-up|2
317721|NCT01403805|1074029|P1|Overall Study|Lost to Follow-up|0
317722|NCT01403805|1074028|P2|Overall Study|Withdrawal by Subject|4
317723|NCT01403805|1074029|P1|Overall Study|Withdrawal by Subject|0
317724|NCT01403194|1074073|P1|Overall Study|Lost to Follow-up|8
317725|NCT01403194|1074073|P1|Overall Study|Screen Failure|2
317726|NCT01403051|1074085|P2|Overall Study|Lost to Follow-up|5
317727|NCT01403051|1074086|P1|Overall Study|Lost to Follow-up|5
317728|NCT01403051|1074085|P2|Overall Study|Withdrawal by Subject|1
317729|NCT01403051|1074086|P1|Overall Study|Withdrawal by Subject|2
317730|NCT01403051|1074085|P2|Overall Study|Death|0
317731|NCT01403051|1074086|P1|Overall Study|Death|1
317732|NCT01403051|1074085|P2|Overall Study|Protocol Violation|0
317733|NCT01403051|1074086|P1|Overall Study|Protocol Violation|2
317734|NCT01402986|1074122|P4|Overall Study|Other|6
317735|NCT01402986|1074123|P3|Overall Study|Other|1
317736|NCT01402986|1074124|P2|Overall Study|Other|5
317737|NCT01402986|1074125|P1|Overall Study|Other|2
317738|NCT01402986|1074122|P4|Overall Study|Lost to Follow-up|1
317739|NCT01402986|1074123|P3|Overall Study|Lost to Follow-up|0
317740|NCT01402986|1074124|P2|Overall Study|Lost to Follow-up|0
317741|NCT01402986|1074125|P1|Overall Study|Lost to Follow-up|0
317742|NCT01402986|1074122|P4|Overall Study|Death|2
317743|NCT01402986|1074123|P3|Overall Study|Death|0
317744|NCT01402986|1074124|P2|Overall Study|Death|0
317745|NCT01402986|1074125|P1|Overall Study|Death|0
317746|NCT01402986|1074122|P4|Overall Study|Withdrawal by Subject|13
317747|NCT01402986|1074123|P3|Overall Study|Withdrawal by Subject|7
317748|NCT01402986|1074124|P2|Overall Study|Withdrawal by Subject|10
317749|NCT01402986|1074125|P1|Overall Study|Withdrawal by Subject|7
317750|NCT01402947|1074260|P2|First Intervention|Adverse Event|1
317751|NCT01402947|1074261|P1|First Intervention|Adverse Event|0
317752|NCT01402869|1074272|P3|Overall Study|Required Tooth Extraction|1
317753|NCT01402869|1074273|P2|Overall Study|Required Tooth Extraction|0
317754|NCT01402869|1074274|P1|Overall Study|Required Tooth Extraction|0
317755|NCT01402817|1074288|P1|Overall Study|Study Suspended by FDA|8
317756|NCT01402817|1074288|P1|Overall Study|Withdrawal by Subject|3
317757|NCT01402700|1074293|P1|Overall Study|Missed Visit|1
317758|NCT01402700|1074293|P1|Overall Study|Withdrawal by Subject|3
317759|NCT01402700|1074293|P1|Overall Study|Death|3
317760|NCT01402570|1074297|P1|Overall Study|Adverse Event|1
317761|NCT01402284|1074368|P1|Overall Study|Non compliance|2
317762|NCT01402284|1074368|P1|Overall Study|Disease progression on study|9
317763|NCT01402284|1074368|P1|Overall Study|Physician Decision|1
317764|NCT01402284|1074368|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
317765|NCT01402284|1074368|P1|Overall Study|Withdrawal consent|1
317766|NCT01402102|1074450|P2|Overall Study|Withdrawal by Subject|2
317767|NCT01402102|1074451|P1|Overall Study|Withdrawal by Subject|0
317768|NCT01402102|1074450|P2|Overall Study|Insufficiency of compliance|1
317769|NCT01402102|1074451|P1|Overall Study|Insufficiency of compliance|1
317770|NCT01402102|1074450|P2|Overall Study|Protocol Violation|0
317771|NCT01402102|1074451|P1|Overall Study|Protocol Violation|1
317772|NCT01402063|1074471|P2|Overall Study|Withdrawal by Subject|3
317773|NCT01402063|1074472|P1|Overall Study|Withdrawal by Subject|3
317774|NCT01401959|1074481|P3|Treated|Protocol Violation|0
317775|NCT01401959|1074482|P2|Treated|Protocol Violation|1
317776|NCT01401959|1074483|P1|Treated|Protocol Violation|0
317777|NCT01401959|1074481|P3|Treated|Withdrawal by Subject|2
317778|NCT01401959|1074482|P2|Treated|Withdrawal by Subject|2
317779|NCT01401959|1074483|P1|Treated|Withdrawal by Subject|1
317780|NCT01401959|1074481|P3|Treated|Adverse Event|2
317781|NCT01401959|1074482|P2|Treated|Adverse Event|3
317782|NCT01401959|1074483|P1|Treated|Adverse Event|4
317783|NCT01401959|1074481|P3|Treated|Disease Progression|1
317784|NCT01401959|1074482|P2|Treated|Disease Progression|2
317785|NCT01401959|1074483|P1|Treated|Disease Progression|2
317786|NCT01401959|1074481|P3|Enrolled|Withdrawal by Subject|0
317787|NCT01401959|1074482|P2|Enrolled|Withdrawal by Subject|0
317788|NCT01401959|1074483|P1|Enrolled|Withdrawal by Subject|1
317789|NCT01401842|1074520|P2|Overall Study|other/unknown|17
317790|NCT01401842|1074521|P1|Overall Study|other/unknown|28
317791|NCT01401842|1074520|P2|Overall Study|on profile|5
317792|NCT01401842|1074521|P1|Overall Study|on profile|9
317793|NCT01401842|1074520|P2|Overall Study|invalid follow-up strength data|4
317794|NCT01401842|1074521|P1|Overall Study|invalid follow-up strength data|1
317795|NCT01401842|1074520|P2|Overall Study|discharged from US Army|4
317796|NCT01401842|1074521|P1|Overall Study|discharged from US Army|3
317797|NCT01401842|1074520|P2|Overall Study|changed companies|34
317798|NCT01401842|1074521|P1|Overall Study|changed companies|20
317799|NCT01401842|1074520|P2|Overall Study|academic reason|1
317800|NCT01401842|1074521|P1|Overall Study|academic reason|4
317801|NCT01401842|1074520|P2|Overall Study|Withdrawal by Subject|2
317802|NCT01401842|1074521|P1|Overall Study|Withdrawal by Subject|3
317803|NCT01401647|1074534|P3|Overall Study|Lost to Follow-up|1
317804|NCT01401647|1074535|P2|Overall Study|Lost to Follow-up|3
317805|NCT01401647|1074536|P1|Overall Study|Lost to Follow-up|3
317806|NCT01401647|1074534|P3|Overall Study|Withdrawal by Subject|2
317807|NCT01401647|1074535|P2|Overall Study|Withdrawal by Subject|5
317808|NCT01401647|1074536|P1|Overall Study|Withdrawal by Subject|1
317809|NCT01401478|1074591|P1|Overall Study|Serious adverse event|1
317810|NCT01401478|1074591|P1|Overall Study|Low intact parathyroid hormone|1
317811|NCT01401478|1074591|P1|Overall Study|Hyperphosphatemia and adverse event|1
317812|NCT01401478|1074591|P1|Overall Study|Blood samples not available|1
317813|NCT01401478|1074591|P1|Overall Study|Withdrawal by Subject|3
317814|NCT01401478|1074591|P1|Overall Study|Kidney transplantation|3
317815|NCT01401478|1074591|P1|Overall Study|Lost to Follow-up|5
317816|NCT01401478|1074591|P1|Overall Study|Hyperphosphatemia|5
317817|NCT01401478|1074591|P1|Overall Study|Adverse Event|5
317818|NCT01401478|1074591|P1|Overall Study|Study drug not available|6
317819|NCT01401465|1074604|P2|Treatment Period 2|Withdrawal by Subject|1
317820|NCT01401465|1074605|P1|Treatment Period 2|Withdrawal by Subject|0
317821|NCT01401465|1074604|P2|Treatment Period 2|Lost to Follow-up|1
317822|NCT01401465|1074605|P1|Treatment Period 2|Lost to Follow-up|0
317823|NCT01401465|1074604|P2|Treatment Period 1|Scheduling Difficulties|1
317824|NCT01401465|1074605|P1|Treatment Period 1|Scheduling Difficulties|1
317825|NCT01401465|1074604|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
317826|NCT01401465|1074605|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
317827|NCT01401465|1074604|P2|Treatment Period 1|Non-Compliance to Study Drug|0
317828|NCT01401465|1074605|P1|Treatment Period 1|Non-Compliance to Study Drug|1
317829|NCT01401465|1074604|P2|Treatment Period 1|Withdrawal by Subject|4
317830|NCT01401465|1074605|P1|Treatment Period 1|Withdrawal by Subject|1
317831|NCT01401465|1074604|P2|Treatment Period 1|Protocol Violation|0
317832|NCT01401465|1074605|P1|Treatment Period 1|Protocol Violation|5
317833|NCT01401465|1074604|P2|Treatment Period 1|Pregnancy|1
317834|NCT01401465|1074605|P1|Treatment Period 1|Pregnancy|0
317835|NCT01401465|1074604|P2|Treatment Period 1|Adverse Event|1
317836|NCT01401465|1074605|P1|Treatment Period 1|Adverse Event|4
317837|NCT01401452|1074668|P1|Overall Study|Participant withdrew consent|1
317838|NCT01401452|1074668|P1|Overall Study|Subject chose to discontinue treatment|1
317839|NCT01401452|1074668|P1|Overall Study|Subject withdrew because of Tx success|1
317840|NCT01401452|1074668|P1|Overall Study|Unsatisfactory output|1
317841|NCT01401452|1074668|P1|Overall Study|Treatment failure|1
317842|NCT01401452|1074668|P1|Overall Study|Discontinuation for personal reasons|1
317843|NCT01401452|1074668|P1|Overall Study|Participant stopped Tx|2
317844|NCT01401452|1074668|P1|Overall Study|Psoriatic arthritis|1
317845|NCT01401452|1074668|P1|Overall Study|Subject's wife wants to get pregnant|1
317846|NCT01401452|1074668|P1|Overall Study|Subject moved to another city|1
317847|NCT01401452|1074668|P1|Overall Study|Subject didn't return for routine visits|1
317848|NCT01401452|1074668|P1|Overall Study|Subject did not come to follow up visits|2
317849|NCT01401452|1074668|P1|Overall Study|No more visits within the 36 wk followup|4
317850|NCT01401452|1074668|P1|Overall Study|Tx stopped by psychiatrist|1
317851|NCT01401452|1074668|P1|Overall Study|Tx stopped due to financial reasons|1
317852|NCT01401452|1074668|P1|Overall Study|Participant developed breast cancer|1
317853|NCT01401452|1074668|P1|Overall Study|Lack of Efficacy|30
317854|NCT01401452|1074668|P1|Overall Study|Lost to Follow-up|12
317855|NCT01401452|1074668|P1|Overall Study|Adverse reaction|9
317856|NCT01401361|1074680|P1|Overall Study|Subject/family decision post procedure|2
317857|NCT01401361|1074680|P1|Overall Study|Lost to Follow-up|3
317858|NCT01401361|1074680|P1|Overall Study|Physician Decision|1
317859|NCT01401361|1074680|P1|Overall Study|Lack of Efficacy|6
317860|NCT01401361|1074680|P1|Overall Study|Withdrawal by Subject|16
317861|NCT01401322|1074686|P1|Overall Study|Physician Decision|1
317862|NCT01401322|1074686|P1|Overall Study|Withdrawal by Subject|1
317863|NCT01401283|1074692|P2|Overall Study|suspicion of malignant hyperthermia|1
317864|NCT01401283|1074693|P1|Overall Study|suspicion of malignant hyperthermia|0
317865|NCT01401283|1074692|P2|Overall Study|no central venous access|1
317866|NCT01401283|1074693|P1|Overall Study|no central venous access|0
317867|NCT01401283|1074692|P2|Overall Study|preoperative arrhythmia|0
317868|NCT01401283|1074693|P1|Overall Study|preoperative arrhythmia|5
317869|NCT01401283|1074692|P2|Overall Study|surgery cancelled|8
317870|NCT01401283|1074693|P1|Overall Study|surgery cancelled|5
317871|NCT01401153|1074759|P2|Second Test Day|illness|5
317872|NCT01401153|1074760|P1|Second Test Day|illness|0
317873|NCT01401153|1074759|P2|First Test Day|Learning disabilities; illness|10
317874|NCT01401153|1074760|P1|First Test Day|Learning disabilities; illness|1
317875|NCT01401062|1074807|P2|Overall Study|Withdrawal by Subject|1
317876|NCT01401062|1074808|P1|Overall Study|Withdrawal by Subject|1
317877|NCT01401062|1074807|P2|Overall Study|Physician Decision|0
317878|NCT01401062|1074808|P1|Overall Study|Physician Decision|1
317879|NCT01401062|1074807|P2|Overall Study|Death|7
317880|NCT01401062|1074808|P1|Overall Study|Death|9
317881|NCT01401010|1074835|P2|Overall Study|Could not interpret assay results|0
317882|NCT01401010|1074836|P1|Overall Study|Could not interpret assay results|1
317883|NCT01400958|1074861|P2|Overall Study|Adverse Event|0
317884|NCT01400958|1074862|P1|Overall Study|Adverse Event|1
317885|NCT01400958|1074861|P2|Overall Study|Withdrawal by Subject|1
317886|NCT01400958|1074862|P1|Overall Study|Withdrawal by Subject|0
317887|NCT01400958|1074861|P2|Overall Study|Physician Decision|1
317888|NCT01400958|1074862|P1|Overall Study|Physician Decision|0
317889|NCT01400932|1074872|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
317890|NCT01400932|1074873|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
317891|NCT01400932|1074872|P2|Overall Study|Protocol Deviation|1
317892|NCT01400932|1074873|P1|Overall Study|Protocol Deviation|0
317893|NCT01400932|1074872|P2|Overall Study|Lost to Follow-up|0
317894|NCT01400932|1074873|P1|Overall Study|Lost to Follow-up|1
317895|NCT01400932|1074872|P2|Overall Study|Withdrawal by Subject|6
317896|NCT01400932|1074873|P1|Overall Study|Withdrawal by Subject|2
317897|NCT01400932|1074872|P2|Overall Study|Lack of Efficacy|3
317898|NCT01400932|1074873|P1|Overall Study|Lack of Efficacy|0
317899|NCT01400932|1074872|P2|Overall Study|Adverse Event|5
317900|NCT01400932|1074873|P1|Overall Study|Adverse Event|10
317901|NCT01400919|1074895|P1|Overall Study|Missed visit|2
317902|NCT01400919|1074895|P1|Overall Study|Lost to Follow-up|2
317903|NCT01400919|1074895|P1|Overall Study|Withdrawal by Subject|4
317904|NCT01400893|1074938|P2|Overall Study|Lost to Follow-up|6
317905|NCT01400893|1074939|P1|Overall Study|Lost to Follow-up|0
317906|NCT01400893|1074938|P2|Overall Study|Death|21
317907|NCT01400893|1074939|P1|Overall Study|Death|27
317908|NCT01400841|1074951|P1|Extended Study Phase (2 Years)|Adverse Event|2
317909|NCT01400841|1074951|P1|Initial Study Phase (6 Months)|Death|1
317910|NCT01400698|1074989|P6|Overall Study|Other|0
317911|NCT01400698|1074990|P5|Overall Study|Other|1
317912|NCT01400698|1074991|P4|Overall Study|Other|2
317913|NCT01400698|1074992|P3|Overall Study|Other|0
317914|NCT01400698|1074993|P2|Overall Study|Other|2
317915|NCT01400698|1074994|P1|Overall Study|Other|4
317916|NCT01400698|1074989|P6|Overall Study|Adverse Event|0
317917|NCT01400698|1074990|P5|Overall Study|Adverse Event|0
317918|NCT01400698|1074991|P4|Overall Study|Adverse Event|0
317919|NCT01400698|1074992|P3|Overall Study|Adverse Event|0
317920|NCT01400698|1074993|P2|Overall Study|Adverse Event|0
317921|NCT01400698|1074994|P1|Overall Study|Adverse Event|1
317922|NCT01400698|1074989|P6|Overall Study|Non-compliance|0
317923|NCT01400698|1074990|P5|Overall Study|Non-compliance|0
317924|NCT01400698|1074991|P4|Overall Study|Non-compliance|1
317925|NCT01400698|1074992|P3|Overall Study|Non-compliance|0
317926|NCT01400698|1074993|P2|Overall Study|Non-compliance|1
317927|NCT01400698|1074994|P1|Overall Study|Non-compliance|0
317928|NCT01400698|1074989|P6|Overall Study|Protocol Violation|0
317929|NCT01400698|1074990|P5|Overall Study|Protocol Violation|1
317930|NCT01400698|1074991|P4|Overall Study|Protocol Violation|0
317931|NCT01400698|1074992|P3|Overall Study|Protocol Violation|0
317932|NCT01400698|1074993|P2|Overall Study|Protocol Violation|1
317933|NCT01400698|1074994|P1|Overall Study|Protocol Violation|0
317934|NCT01400698|1074989|P6|Overall Study|Withdrawal by Subject|3
317935|NCT01400698|1074990|P5|Overall Study|Withdrawal by Subject|1
317936|NCT01400698|1074991|P4|Overall Study|Withdrawal by Subject|4
317937|NCT01400698|1074992|P3|Overall Study|Withdrawal by Subject|0
317938|NCT01400698|1074993|P2|Overall Study|Withdrawal by Subject|2
317939|NCT01400698|1074994|P1|Overall Study|Withdrawal by Subject|8
317940|NCT01400698|1074989|P6|Overall Study|Lost to Follow-up|3
317941|NCT01400698|1074990|P5|Overall Study|Lost to Follow-up|4
317942|NCT01400698|1074991|P4|Overall Study|Lost to Follow-up|1
317943|NCT01400698|1074992|P3|Overall Study|Lost to Follow-up|2
317944|NCT01400698|1074993|P2|Overall Study|Lost to Follow-up|5
317945|NCT01400698|1074994|P1|Overall Study|Lost to Follow-up|2
317946|NCT01400516|1075018|P2|Primary Trial|Withdrawal by Subject|2
317947|NCT01400516|1075019|P1|Primary Trial|Withdrawal by Subject|0
317948|NCT01400503|1075029|P1|Overall Study|Other|1
317949|NCT01400503|1075029|P1|Overall Study|Study Terminated by Sponsor|58
317950|NCT01400503|1075029|P1|Overall Study|Withdrawal by Subject|1
317951|NCT01400451|1075041|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
317952|NCT01400451|1075042|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
317953|NCT01400451|1075043|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
317954|NCT01400451|1075041|P3|Combination Treatment (or Intended)|Disease Progression|1
317955|NCT01400451|1075042|P2|Combination Treatment (or Intended)|Disease Progression|1
317956|NCT01400451|1075043|P1|Combination Treatment (or Intended)|Disease Progression|3
317957|NCT01400451|1075041|P3|Combination Treatment (or Intended)|Adverse Event|0
317958|NCT01400451|1075042|P2|Combination Treatment (or Intended)|Adverse Event|0
317959|NCT01400451|1075043|P1|Combination Treatment (or Intended)|Adverse Event|1
317960|NCT01400451|1075041|P3|Combination Treatment (or Intended)|Drug Toxicity|0
317961|NCT01400451|1075042|P2|Combination Treatment (or Intended)|Drug Toxicity|1
317962|NCT01400451|1075043|P1|Combination Treatment (or Intended)|Drug Toxicity|0
317963|NCT01400451|1075041|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
317964|NCT01400451|1075042|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
317965|NCT01400451|1075043|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
317966|NCT01400425|1075057|P1|Overall Study|Withdrawal by Subject|10
317967|NCT01400412|1075070|P2|Overall Study|Never started study treatment|3
317968|NCT01400412|1075071|P1|Overall Study|Never started study treatment|0
317969|NCT01400412|1075070|P2|Overall Study|Unable to complete|3
317970|NCT01400412|1075071|P1|Overall Study|Unable to complete|3
317971|NCT01400412|1075070|P2|Overall Study|Withdrawal by Subject|4
317972|NCT01400412|1075071|P1|Overall Study|Withdrawal by Subject|3
317973|NCT01400412|1075070|P2|Overall Study|Lost to Follow-up|7
317974|NCT01400412|1075071|P1|Overall Study|Lost to Follow-up|4
317975|NCT01400243|1075117|P2|Overall Study|Protocol Violation|11
317976|NCT01400243|1075118|P1|Overall Study|Protocol Violation|8
317977|NCT01400139|1075140|P1|HYD Extension Period|Administrative|10
317978|NCT01400139|1075140|P1|HYD Extension Period|Withdrawal by Subject|5
317979|NCT01400139|1075140|P1|HYD Extension Period|Adverse Event|8
317980|NCT01400139|1075140|P1|HYD Core Study|Did not qualify for Maintenance Period|14
317981|NCT01400139|1075140|P1|HYD Core Study|Administrative|56
317982|NCT01400139|1075140|P1|HYD Core Study|Confirmed or suspected diversion|20
317983|NCT01400139|1075140|P1|HYD Core Study|Lost to Follow-up|39
317984|NCT01400139|1075140|P1|HYD Core Study|Withdrawal by Subject|114
317985|NCT01400139|1075140|P1|HYD Core Study|Lack of Efficacy|59
317986|NCT01400139|1075140|P1|HYD Core Study|Adverse Event|210
317987|NCT01400113|1075150|P2|Overall Study|Withdrawal by Subject|1
317988|NCT01400113|1075151|P1|Overall Study|Withdrawal by Subject|1
317989|NCT01399788|1075176|P2|First Intervention Period|Adverse Event|0
317990|NCT01399788|1075177|P1|First Intervention Period|Adverse Event|1
317991|NCT01399723|1075199|P2|Overall Study|Lost to Follow-up|1
317992|NCT01399723|1075200|P1|Overall Study|Lost to Follow-up|0
317993|NCT01399697|1075213|P3|Overall Study|Sponsor Decision|0
317994|NCT01399697|1075214|P2|Overall Study|Sponsor Decision|0
317995|NCT01399697|1075215|P1|Overall Study|Sponsor Decision|1
317996|NCT01399697|1075213|P3|Overall Study|Clinical RA remission|0
317997|NCT01399697|1075214|P2|Overall Study|Clinical RA remission|0
317998|NCT01399697|1075215|P1|Overall Study|Clinical RA remission|1
317999|NCT01399697|1075213|P3|Overall Study|Positive result for hepatitis B|0
318000|NCT01399697|1075214|P2|Overall Study|Positive result for hepatitis B|0
318001|NCT01399697|1075215|P1|Overall Study|Positive result for hepatitis B|1
318002|NCT01399697|1075213|P3|Overall Study|Inclusion Error|0
318003|NCT01399697|1075214|P2|Overall Study|Inclusion Error|0
318004|NCT01399697|1075215|P1|Overall Study|Inclusion Error|2
318005|NCT01399697|1075213|P3|Overall Study|Non-Compliant|0
318006|NCT01399697|1075214|P2|Overall Study|Non-Compliant|0
318007|NCT01399697|1075215|P1|Overall Study|Non-Compliant|1
318008|NCT01399697|1075213|P3|Overall Study|Protocol Violation|0
318009|NCT01399697|1075214|P2|Overall Study|Protocol Violation|0
318010|NCT01399697|1075215|P1|Overall Study|Protocol Violation|2
318011|NCT01399697|1075213|P3|Overall Study|Lack of Efficacy|1
318012|NCT01399697|1075214|P2|Overall Study|Lack of Efficacy|0
318013|NCT01399697|1075215|P1|Overall Study|Lack of Efficacy|9
318014|NCT01399697|1075213|P3|Overall Study|Investigator Decisión|2
318015|NCT01399697|1075214|P2|Overall Study|Investigator Decisión|0
318016|NCT01399697|1075215|P1|Overall Study|Investigator Decisión|1
318017|NCT01399697|1075213|P3|Overall Study|Withdrawal by Subject|0
318018|NCT01399697|1075214|P2|Overall Study|Withdrawal by Subject|0
318019|NCT01399697|1075215|P1|Overall Study|Withdrawal by Subject|8
318020|NCT01399697|1075213|P3|Overall Study|Lost to Follow-up|0
318021|NCT01399697|1075214|P2|Overall Study|Lost to Follow-up|0
318022|NCT01399697|1075215|P1|Overall Study|Lost to Follow-up|2
318023|NCT01399697|1075213|P3|Overall Study|Adverse Event|1
318024|NCT01399697|1075214|P2|Overall Study|Adverse Event|3
318025|NCT01399697|1075215|P1|Overall Study|Adverse Event|13
318026|NCT01399619|1075242|P4|Overall Study|Not treated|2
318027|NCT01399619|1075243|P3|Overall Study|Not treated|0
318028|NCT01399619|1075244|P2|Overall Study|Not treated|0
318029|NCT01399619|1075245|P1|Overall Study|Not treated|0
318030|NCT01399619|1075242|P4|Overall Study|Protocol Violation|1
318031|NCT01399619|1075243|P3|Overall Study|Protocol Violation|0
318032|NCT01399619|1075244|P2|Overall Study|Protocol Violation|0
318033|NCT01399619|1075245|P1|Overall Study|Protocol Violation|0
318034|NCT01399619|1075242|P4|Overall Study|Withdrawal by Subject|4
318035|NCT01399619|1075243|P3|Overall Study|Withdrawal by Subject|3
318036|NCT01399619|1075244|P2|Overall Study|Withdrawal by Subject|0
318037|NCT01399619|1075245|P1|Overall Study|Withdrawal by Subject|6
318038|NCT01399619|1075242|P4|Overall Study|Lack of Efficacy|0
318039|NCT01399619|1075243|P3|Overall Study|Lack of Efficacy|5
318040|NCT01399619|1075244|P2|Overall Study|Lack of Efficacy|0
318041|NCT01399619|1075245|P1|Overall Study|Lack of Efficacy|9
318042|NCT01399619|1075242|P4|Overall Study|Adverse Event|10
318043|NCT01399619|1075243|P3|Overall Study|Adverse Event|4
318044|NCT01399619|1075244|P2|Overall Study|Adverse Event|0
318045|NCT01399619|1075245|P1|Overall Study|Adverse Event|10
318046|NCT01399593|1075308|P2|Overall Study|Transplantectomy|1
318047|NCT01399593|1075309|P1|Overall Study|Transplantectomy|0
318048|NCT01399593|1075308|P2|Overall Study|Death|1
318049|NCT01399593|1075309|P1|Overall Study|Death|1
318050|NCT01399593|1075308|P2|Overall Study|Adverse Event|0
318051|NCT01399593|1075309|P1|Overall Study|Adverse Event|1
318052|NCT01399593|1075308|P2|Overall Study|Physician Decision|0
318053|NCT01399593|1075309|P1|Overall Study|Physician Decision|1
318054|NCT01399190|1075342|P1|Overall Study|Physician Decision|2
318055|NCT01399190|1075342|P1|Overall Study|Participant's Request|5
318056|NCT01399190|1075342|P1|Overall Study|Adverse Event|8
318057|NCT01399190|1075342|P1|Overall Study|Not Eligible for Final Analysis|5
318058|NCT01399125|1075350|P2|Overall Study|Protocol Deviation|2
318059|NCT01399125|1075351|P1|Overall Study|Protocol Deviation|5
318060|NCT01399125|1075350|P2|Overall Study|Death|1
318061|NCT01399125|1075351|P1|Overall Study|Death|0
318062|NCT01399125|1075350|P2|Overall Study|Administrative Problems|11
318063|NCT01399125|1075351|P1|Overall Study|Administrative Problems|7
318064|NCT01399125|1075350|P2|Overall Study|Lost to Follow-up|3
318065|NCT01399125|1075351|P1|Overall Study|Lost to Follow-up|2
318066|NCT01399125|1075350|P2|Overall Study|Withdrawal by Subject|8
318067|NCT01399125|1075351|P1|Overall Study|Withdrawal by Subject|5
318068|NCT01399125|1075350|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
318069|NCT01399125|1075351|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
318070|NCT01399125|1075350|P2|Overall Study|Abnormal Lab values|1
318071|NCT01399125|1075351|P1|Overall Study|Abnormal Lab values|0
318072|NCT01399125|1075350|P2|Overall Study|Adverse Event|30
318073|NCT01399125|1075351|P1|Overall Study|Adverse Event|32
318074|NCT01399099|1075365|P1|Overall Study|Miscellaneous|4
318075|NCT01399099|1075365|P1|Overall Study|Infection|1
318076|NCT01399099|1075365|P1|Overall Study|Skin Irritation|13
318077|NCT01399099|1075365|P1|Overall Study|Protocol Violation|1
318078|NCT01399099|1075365|P1|Overall Study|Physician Decision|1
318079|NCT01399099|1075365|P1|Overall Study|Lost to Follow-up|11
318080|NCT01399047|1075372|P2|Overall Study|Withdrawal by Subject|1
318081|NCT01399047|1075373|P1|Overall Study|Withdrawal by Subject|0
318082|NCT01398956|1075401|P1|Overall Study|Subject moved a long distance|1
318083|NCT01398956|1075401|P1|Overall Study|Withdrawal Criteria No.3|1
318084|NCT01398956|1075401|P1|Overall Study|AE, non-serious non-fatal|4
318085|NCT01398956|1075401|P1|Overall Study|Withdrawal by Subject|4
318086|NCT01398787|1075433|P1|Overall Study|Adverse Event|1
318087|NCT01398514|1075451|P2|Overall Study|Failure to show a conditioned response|3
318088|NCT01398514|1075452|P1|Overall Study|Failure to show a conditioned response|4
318089|NCT01398514|1075451|P2|Overall Study|Physiologic non-responsiveness|3
318090|NCT01398514|1075452|P1|Overall Study|Physiologic non-responsiveness|1
318091|NCT01398514|1075451|P2|Overall Study|Non-compliance with study procedures|0
318092|NCT01398514|1075452|P1|Overall Study|Non-compliance with study procedures|2
318093|NCT01398514|1075451|P2|Overall Study|Adverse Event|0
318094|NCT01398514|1075452|P1|Overall Study|Adverse Event|1
318095|NCT01398410|1075487|P2|Overall Study|Not Specified|29
318096|NCT01398410|1075488|P1|Overall Study|Not Specified|36
318097|NCT01398410|1075487|P2|Overall Study|Inadequate Therapeutic Effect|0
318098|NCT01398410|1075488|P1|Overall Study|Inadequate Therapeutic Effect|2
318099|NCT01398410|1075487|P2|Overall Study|Participants Choice|11
318100|NCT01398410|1075488|P1|Overall Study|Participants Choice|8
318101|NCT01398410|1075487|P2|Overall Study|Adverse Event|16
318102|NCT01398410|1075488|P1|Overall Study|Adverse Event|12
318103|NCT01398358|1075499|P3|Overall Study|no longer eligible|1
318104|NCT01398358|1075500|P2|Overall Study|no longer eligible|0
318105|NCT01398358|1075501|P1|Overall Study|no longer eligible|1
318106|NCT01398358|1075499|P3|Overall Study|Withdrawal by Subject|2
318107|NCT01398358|1075500|P2|Overall Study|Withdrawal by Subject|2
318108|NCT01398358|1075501|P1|Overall Study|Withdrawal by Subject|3
318109|NCT01398358|1075499|P3|Overall Study|Lost to Follow-up|18
318110|NCT01398358|1075500|P2|Overall Study|Lost to Follow-up|21
318111|NCT01398358|1075501|P1|Overall Study|Lost to Follow-up|11
318112|NCT01398176|1075514|P2|Overall Study|Physician Decision|3
318113|NCT01398176|1075515|P1|Overall Study|Physician Decision|2
318114|NCT01398176|1075514|P2|Overall Study|Lost to Follow-up|3
318115|NCT01398176|1075515|P1|Overall Study|Lost to Follow-up|1
318116|NCT01397890|1075523|P2|Overall Study|Others|1
318117|NCT01397890|1075524|P1|Overall Study|Others|2
318118|NCT01397890|1075523|P2|Overall Study|Severe Non-Compliance to Protocol|1
318119|NCT01397890|1075524|P1|Overall Study|Severe Non-Compliance to Protocol|2
318120|NCT01397890|1075523|P2|Overall Study|Adverse Event|2
318121|NCT01397890|1075524|P1|Overall Study|Adverse Event|1
318122|NCT01397890|1075523|P2|Overall Study|Condition under Investigation Worsened|3
318123|NCT01397890|1075524|P1|Overall Study|Condition under Investigation Worsened|1
318124|NCT01397890|1075523|P2|Overall Study|Lost to Follow-up|4
318125|NCT01397890|1075524|P1|Overall Study|Lost to Follow-up|1
318126|NCT01397890|1075523|P2|Overall Study|Death|3
318127|NCT01397890|1075524|P1|Overall Study|Death|2
318128|NCT01397890|1075523|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
318129|NCT01397890|1075524|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
318130|NCT01397890|1075523|P2|Overall Study|Withdrawal by Subject|11
318131|NCT01397890|1075524|P1|Overall Study|Withdrawal by Subject|7
318132|NCT01397825|1075595|P5|Overall Study|Withdrawal by Subject|0
318133|NCT01397825|1075596|P4|Overall Study|Withdrawal by Subject|1
318134|NCT01397825|1075597|P3|Overall Study|Withdrawal by Subject|5
318135|NCT01397825|1075598|P2|Overall Study|Withdrawal by Subject|0
318136|NCT01397825|1075599|P1|Overall Study|Withdrawal by Subject|1
318137|NCT01397825|1075595|P5|Overall Study|Adverse Event|0
318138|NCT01397825|1075596|P4|Overall Study|Adverse Event|1
318139|NCT01397825|1075597|P3|Overall Study|Adverse Event|5
318140|NCT01397825|1075598|P2|Overall Study|Adverse Event|1
318141|NCT01397825|1075599|P1|Overall Study|Adverse Event|0
318142|NCT01397825|1075595|P5|Overall Study|Symptomatic Deterioration|0
318143|NCT01397825|1075596|P4|Overall Study|Symptomatic Deterioration|0
318144|NCT01397825|1075597|P3|Overall Study|Symptomatic Deterioration|4
318145|NCT01397825|1075598|P2|Overall Study|Symptomatic Deterioration|0
318146|NCT01397825|1075599|P1|Overall Study|Symptomatic Deterioration|2
318147|NCT01397825|1075595|P5|Overall Study|Progressive Disease|0
318148|NCT01397825|1075596|P4|Overall Study|Progressive Disease|1
318149|NCT01397825|1075597|P3|Overall Study|Progressive Disease|11
318150|NCT01397825|1075598|P2|Overall Study|Progressive Disease|3
318151|NCT01397825|1075599|P1|Overall Study|Progressive Disease|10
318152|NCT01397786|1075669|P3|Phase B|Lack of Efficacy|14
318153|NCT01397786|1075670|P2|Phase B|Lack of Efficacy|7
318154|NCT01397786|1075671|P1|Phase B|Lack of Efficacy|22
318155|NCT01397786|1075669|P3|Phase B|Protocol Deviation|4
318156|NCT01397786|1075670|P2|Phase B|Protocol Deviation|2
318157|NCT01397786|1075671|P1|Phase B|Protocol Deviation|1
318158|NCT01397786|1075669|P3|Phase B|Withdrawal by Subject|30
318159|NCT01397786|1075670|P2|Phase B|Withdrawal by Subject|45
318160|NCT01397786|1075671|P1|Phase B|Withdrawal by Subject|102
318161|NCT01397786|1075669|P3|Phase B|Physician Decision|3
318162|NCT01397786|1075670|P2|Phase B|Physician Decision|1
318163|NCT01397786|1075671|P1|Phase B|Physician Decision|9
318164|NCT01397786|1075669|P3|Phase B|Subject Met Withdrawal Criteria|38
318165|NCT01397786|1075670|P2|Phase B|Subject Met Withdrawal Criteria|5
318166|NCT01397786|1075671|P1|Phase B|Subject Met Withdrawal Criteria|38
318167|NCT01397786|1075669|P3|Phase B|Adverse Event|27
318168|NCT01397786|1075670|P2|Phase B|Adverse Event|23
318169|NCT01397786|1075671|P1|Phase B|Adverse Event|109
318170|NCT01397786|1075669|P3|Phase B|Lost to Follow-up|22
318171|NCT01397786|1075670|P2|Phase B|Lost to Follow-up|12
318172|NCT01397786|1075671|P1|Phase B|Lost to Follow-up|22
318173|NCT01397786|1075669|P3|Phase A|Lack of Efficacy|1
318174|NCT01397786|1075670|P2|Phase A|Lack of Efficacy|0
318175|NCT01397786|1075671|P1|Phase A|Lack of Efficacy|0
318176|NCT01397786|1075669|P3|Phase A|Withdrawal by Subject|5
318177|NCT01397786|1075670|P2|Phase A|Withdrawal by Subject|0
318178|NCT01397786|1075671|P1|Phase A|Withdrawal by Subject|0
318179|NCT01397786|1075669|P3|Phase A|Physician Decision|1
318180|NCT01397786|1075670|P2|Phase A|Physician Decision|0
318181|NCT01397786|1075671|P1|Phase A|Physician Decision|0
318182|NCT01397786|1075669|P3|Phase A|Subject Met Withdrawal Criteria|7
318183|NCT01397786|1075670|P2|Phase A|Subject Met Withdrawal Criteria|0
318184|NCT01397786|1075671|P1|Phase A|Subject Met Withdrawal Criteria|0
318185|NCT01397786|1075669|P3|Phase A|Adverse Event|8
318186|NCT01397786|1075670|P2|Phase A|Adverse Event|0
318187|NCT01397786|1075671|P1|Phase A|Adverse Event|0
318188|NCT01397786|1075669|P3|Phase A|Lost to Follow-up|6
318189|NCT01397786|1075670|P2|Phase A|Lost to Follow-up|0
318190|NCT01397786|1075671|P1|Phase A|Lost to Follow-up|0
318191|NCT01397747|1075737|P1|Overall Study|FIT excluded|34
318192|NCT01397747|1075737|P1|Overall Study|Colonoscopy excluded|304
318193|NCT01397747|1075737|P1|Overall Study|Multitarget DNA test excluded|689
318194|NCT01397461|1075769|P3|Overall Study|Not treated|1
318195|NCT01397461|1075770|P2|Overall Study|Not treated|0
318196|NCT01397461|1075771|P1|Overall Study|Not treated|0
318197|NCT01397461|1075769|P3|Overall Study|Lack of Efficacy|0
318198|NCT01397461|1075770|P2|Overall Study|Lack of Efficacy|3
318199|NCT01397461|1075771|P1|Overall Study|Lack of Efficacy|0
318200|NCT01397461|1075769|P3|Overall Study|Lost to Follow-up|1
318201|NCT01397461|1075770|P2|Overall Study|Lost to Follow-up|2
318202|NCT01397461|1075771|P1|Overall Study|Lost to Follow-up|0
318203|NCT01397461|1075769|P3|Overall Study|Withdrawal by Subject|0
318204|NCT01397461|1075770|P2|Overall Study|Withdrawal by Subject|1
318205|NCT01397461|1075771|P1|Overall Study|Withdrawal by Subject|2
318206|NCT01397448|1075782|P3|Overall Study|Not specified|4
318207|NCT01397448|1075783|P2|Overall Study|Not specified|7
318208|NCT01397448|1075784|P1|Overall Study|Not specified|8
318209|NCT01397448|1075782|P3|Overall Study|Lack of Efficacy|5
318210|NCT01397448|1075783|P2|Overall Study|Lack of Efficacy|0
318211|NCT01397448|1075784|P1|Overall Study|Lack of Efficacy|2
318212|NCT01397448|1075782|P3|Overall Study|Withdrawal by Subject|3
318213|NCT01397448|1075783|P2|Overall Study|Withdrawal by Subject|4
318214|NCT01397448|1075784|P1|Overall Study|Withdrawal by Subject|4
318215|NCT01397448|1075782|P3|Overall Study|Adverse Event|6
318216|NCT01397448|1075783|P2|Overall Study|Adverse Event|4
318217|NCT01397448|1075784|P1|Overall Study|Adverse Event|4
318218|NCT01397422|1075799|P4|Overall Study|Increased bradykinesia related to PD|0
318219|NCT01397422|1075800|P3|Overall Study|Increased bradykinesia related to PD|0
318220|NCT01397422|1075801|P2|Overall Study|Increased bradykinesia related to PD|0
318221|NCT01397422|1075802|P1|Overall Study|Increased bradykinesia related to PD|1
318222|NCT01397422|1075799|P4|Overall Study|Withdrawal by Subject|0
318223|NCT01397422|1075800|P3|Overall Study|Withdrawal by Subject|0
318224|NCT01397422|1075801|P2|Overall Study|Withdrawal by Subject|0
318225|NCT01397422|1075802|P1|Overall Study|Withdrawal by Subject|1
318226|NCT01397422|1075799|P4|Overall Study|Adverse Event|8
318227|NCT01397422|1075800|P3|Overall Study|Adverse Event|3
318228|NCT01397422|1075801|P2|Overall Study|Adverse Event|3
318229|NCT01397422|1075802|P1|Overall Study|Adverse Event|0
318230|NCT01397409|1075842|P10|Stage 3|Other Miscellaneous Reasons|0
318231|NCT01397409|1075843|P9|Stage 3|Other Miscellaneous Reasons|0
318232|NCT01397409|1075844|P8|Stage 3|Other Miscellaneous Reasons|1
318233|NCT01397409|1075845|P7|Stage 3|Other Miscellaneous Reasons|0
318234|NCT01397409|1075846|P6|Stage 3|Other Miscellaneous Reasons|0
318235|NCT01397409|1075847|P5|Stage 3|Other Miscellaneous Reasons|0
318236|NCT01397409|1075848|P4|Stage 3|Other Miscellaneous Reasons|0
318237|NCT01397409|1075849|P3|Stage 3|Other Miscellaneous Reasons|0
318238|NCT01397409|1075850|P2|Stage 3|Other Miscellaneous Reasons|0
318239|NCT01397409|1075851|P1|Stage 3|Other Miscellaneous Reasons|0
318240|NCT01397409|1075842|P10|Stage 3|Adverse Event|0
318241|NCT01397409|1075843|P9|Stage 3|Adverse Event|0
318242|NCT01397409|1075844|P8|Stage 3|Adverse Event|1
318243|NCT01397409|1075845|P7|Stage 3|Adverse Event|0
318244|NCT01397409|1075846|P6|Stage 3|Adverse Event|0
318245|NCT01397409|1075847|P5|Stage 3|Adverse Event|0
318246|NCT01397409|1075848|P4|Stage 3|Adverse Event|0
318247|NCT01397409|1075849|P3|Stage 3|Adverse Event|0
318248|NCT01397409|1075850|P2|Stage 3|Adverse Event|0
318249|NCT01397409|1075851|P1|Stage 3|Adverse Event|0
318250|NCT01397409|1075842|P10|Stage 2|Other Miscellaneous Reasons|0
318251|NCT01397409|1075843|P9|Stage 2|Other Miscellaneous Reasons|0
318252|NCT01397409|1075844|P8|Stage 2|Other Miscellaneous Reasons|0
318253|NCT01397409|1075845|P7|Stage 2|Other Miscellaneous Reasons|0
318254|NCT01397409|1075846|P6|Stage 2|Other Miscellaneous Reasons|1
318255|NCT01397409|1075847|P5|Stage 2|Other Miscellaneous Reasons|1
318256|NCT01397409|1075848|P4|Stage 2|Other Miscellaneous Reasons|0
318257|NCT01397409|1075849|P3|Stage 2|Other Miscellaneous Reasons|0
318258|NCT01397409|1075850|P2|Stage 2|Other Miscellaneous Reasons|0
318259|NCT01397409|1075851|P1|Stage 2|Other Miscellaneous Reasons|0
318260|NCT01397409|1075842|P10|Stage 2|Personal Reasons|0
318261|NCT01397409|1075843|P9|Stage 2|Personal Reasons|0
318262|NCT01397409|1075844|P8|Stage 2|Personal Reasons|0
318263|NCT01397409|1075845|P7|Stage 2|Personal Reasons|0
318264|NCT01397409|1075846|P6|Stage 2|Personal Reasons|0
318265|NCT01397409|1075847|P5|Stage 2|Personal Reasons|1
318266|NCT01397409|1075848|P4|Stage 2|Personal Reasons|0
318267|NCT01397409|1075849|P3|Stage 2|Personal Reasons|0
318268|NCT01397409|1075850|P2|Stage 2|Personal Reasons|0
318269|NCT01397409|1075851|P1|Stage 2|Personal Reasons|0
318270|NCT01397409|1075842|P10|Stage 2|Adverse Event|0
318271|NCT01397409|1075843|P9|Stage 2|Adverse Event|0
318272|NCT01397409|1075844|P8|Stage 2|Adverse Event|0
318273|NCT01397409|1075845|P7|Stage 2|Adverse Event|0
318274|NCT01397409|1075846|P6|Stage 2|Adverse Event|3
318275|NCT01397409|1075847|P5|Stage 2|Adverse Event|6
318276|NCT01397409|1075848|P4|Stage 2|Adverse Event|0
318277|NCT01397409|1075849|P3|Stage 2|Adverse Event|0
318278|NCT01397409|1075850|P2|Stage 2|Adverse Event|0
318279|NCT01397409|1075851|P1|Stage 2|Adverse Event|0
318280|NCT01397253|1075891|P2|Overall Study|Reviewed by only 1 pharmacist|149
318281|NCT01397253|1075892|P1|Overall Study|Reviewed by only 1 pharmacist|126
318282|NCT01397084|1075898|P1|Overall Study|Used other proton pump inhibitor|1
318283|NCT01397084|1075898|P1|Overall Study|Lost to Follow-up|1
318284|NCT01397084|1075898|P1|Overall Study|Withdrawal by Subject|1
318285|NCT01397084|1075898|P1|Overall Study|Adverse Event|2
318286|NCT01397084|1075898|P1|Overall Study|Protocol Violation|2
318287|NCT01397084|1075898|P1|Overall Study|Severe Non-Compliance to Protocol|1
318288|NCT01396525|1075905|P1|Overall Study|Lost to Follow-up|4
318289|NCT01396525|1075905|P1|Overall Study|Death|14
318290|NCT01396525|1075905|P1|Overall Study|Withdrawal by Subject|8
318291|NCT01396512|1076005|P2|Overall Study|Withdrawal by Subject|1
318292|NCT01396512|1076006|P1|Overall Study|Withdrawal by Subject|0
318293|NCT01396447|1076022|P4|Overall Study|Other Miscellaneous Reasons|0
318294|NCT01396447|1076023|P3|Overall Study|Other Miscellaneous Reasons|1
318295|NCT01396447|1076024|P2|Overall Study|Other Miscellaneous Reasons|2
318296|NCT01396447|1076025|P1|Overall Study|Other Miscellaneous Reasons|0
318297|NCT01396447|1076022|P4|Overall Study|Lost to Follow-up|9
318298|NCT01396447|1076023|P3|Overall Study|Lost to Follow-up|7
318299|NCT01396447|1076024|P2|Overall Study|Lost to Follow-up|8
318300|NCT01396447|1076025|P1|Overall Study|Lost to Follow-up|4
318301|NCT01396447|1076022|P4|Overall Study|Withdrawal of Consent|15
318302|NCT01396447|1076023|P3|Overall Study|Withdrawal of Consent|4
318303|NCT01396447|1076024|P2|Overall Study|Withdrawal of Consent|9
318304|NCT01396447|1076025|P1|Overall Study|Withdrawal of Consent|11
318305|NCT01396447|1076022|P4|Overall Study|Protocol Violation|7
318306|NCT01396447|1076023|P3|Overall Study|Protocol Violation|3
318307|NCT01396447|1076024|P2|Overall Study|Protocol Violation|2
318308|NCT01396447|1076025|P1|Overall Study|Protocol Violation|5
318309|NCT01396447|1076022|P4|Overall Study|Insufficient Therapeutic Response|4
318310|NCT01396447|1076023|P3|Overall Study|Insufficient Therapeutic Response|2
318311|NCT01396447|1076024|P2|Overall Study|Insufficient Therapeutic Response|5
318312|NCT01396447|1076025|P1|Overall Study|Insufficient Therapeutic Response|5
318313|NCT01396447|1076022|P4|Overall Study|Adverse Event|17
318314|NCT01396447|1076023|P3|Overall Study|Adverse Event|12
318315|NCT01396447|1076024|P2|Overall Study|Adverse Event|12
318316|NCT01396447|1076025|P1|Overall Study|Adverse Event|15
318317|NCT01396447|1076022|P4|Overall Study|Did Not Receive Treatment|0
318318|NCT01396447|1076023|P3|Overall Study|Did Not Receive Treatment|1
318319|NCT01396447|1076024|P2|Overall Study|Did Not Receive Treatment|2
318320|NCT01396447|1076025|P1|Overall Study|Did Not Receive Treatment|3
318321|NCT01396434|1076042|P3|Overall Study|Other|0
318322|NCT01396434|1076043|P2|Overall Study|Other|0
318323|NCT01396434|1076044|P1|Overall Study|Other|10
318324|NCT01396434|1076042|P3|Overall Study|Lost to Follow-up|0
318325|NCT01396434|1076043|P2|Overall Study|Lost to Follow-up|0
318326|NCT01396434|1076044|P1|Overall Study|Lost to Follow-up|1
318327|NCT01396421|1076056|P4|Overall Study|Lack of Efficacy|18
318328|NCT01396421|1076057|P3|Overall Study|Lack of Efficacy|7
318329|NCT01396421|1076058|P2|Overall Study|Lack of Efficacy|17
318330|NCT01396421|1076059|P1|Overall Study|Lack of Efficacy|7
318331|NCT01396421|1076056|P4|Overall Study|Protocol Deviation|0
318332|NCT01396421|1076057|P3|Overall Study|Protocol Deviation|1
318333|NCT01396421|1076058|P2|Overall Study|Protocol Deviation|1
318334|NCT01396421|1076059|P1|Overall Study|Protocol Deviation|2
318335|NCT01396421|1076056|P4|Overall Study|Withdrawal by Subject|21
318336|NCT01396421|1076057|P3|Overall Study|Withdrawal by Subject|13
318337|NCT01396421|1076058|P2|Overall Study|Withdrawal by Subject|24
318338|NCT01396421|1076059|P1|Overall Study|Withdrawal by Subject|31
318339|NCT01396421|1076056|P4|Overall Study|Physician Decision|3
318340|NCT01396421|1076057|P3|Overall Study|Physician Decision|0
318341|NCT01396421|1076058|P2|Overall Study|Physician Decision|1
318342|NCT01396421|1076059|P1|Overall Study|Physician Decision|1
318343|NCT01396421|1076056|P4|Overall Study|Participant Met Withdrawal Criteria|0
318344|NCT01396421|1076057|P3|Overall Study|Participant Met Withdrawal Criteria|1
318345|NCT01396421|1076058|P2|Overall Study|Participant Met Withdrawal Criteria|0
318346|NCT01396421|1076059|P1|Overall Study|Participant Met Withdrawal Criteria|1
318347|NCT01396421|1076056|P4|Overall Study|Adverse Event|32
318348|NCT01396421|1076057|P3|Overall Study|Adverse Event|12
318349|NCT01396421|1076058|P2|Overall Study|Adverse Event|15
318350|NCT01396421|1076059|P1|Overall Study|Adverse Event|17
318351|NCT01396421|1076056|P4|Overall Study|Lost to Follow-up|1
318352|NCT01396421|1076057|P3|Overall Study|Lost to Follow-up|0
318353|NCT01396421|1076058|P2|Overall Study|Lost to Follow-up|0
318354|NCT01396421|1076059|P1|Overall Study|Lost to Follow-up|0
318355|NCT01396395|1076131|P2|Overall Study|Other|1
318356|NCT01396395|1076132|P1|Overall Study|Other|0
318357|NCT01396395|1076131|P2|Overall Study|Lost to Follow-up|11
318358|NCT01396395|1076132|P1|Overall Study|Lost to Follow-up|17
318359|NCT01396395|1076131|P2|Overall Study|Adverse Event|2
318360|NCT01396395|1076132|P1|Overall Study|Adverse Event|10
318361|NCT01396395|1076131|P2|Overall Study|Protocol Violation|1
318362|NCT01396395|1076132|P1|Overall Study|Protocol Violation|3
318363|NCT01396395|1076131|P2|Overall Study|Withdrawal by Subject|12
318364|NCT01396395|1076132|P1|Overall Study|Withdrawal by Subject|10
318365|NCT01396317|1076174|P2|Overall Study|Adverse Event|0
318366|NCT01396317|1076175|P1|Overall Study|Adverse Event|1
318367|NCT01396265|1076189|P1|Rifa+Afatinib|Withdrawal by Subject|1
318368|NCT01396187|1076278|P5|Overall Study|Other|1
318369|NCT01396187|1076279|P4|Overall Study|Other|0
318370|NCT01396187|1076280|P3|Overall Study|Other|0
318371|NCT01396187|1076281|P2|Overall Study|Other|1
318372|NCT01396187|1076282|P1|Overall Study|Other|1
318373|NCT01396187|1076278|P5|Overall Study|Withdrawal by Subject|0
318374|NCT01396187|1076279|P4|Overall Study|Withdrawal by Subject|0
318375|NCT01396187|1076280|P3|Overall Study|Withdrawal by Subject|1
318376|NCT01396187|1076281|P2|Overall Study|Withdrawal by Subject|1
318377|NCT01396187|1076282|P1|Overall Study|Withdrawal by Subject|0
318378|NCT01396187|1076278|P5|Overall Study|Adverse Event|0
318379|NCT01396187|1076279|P4|Overall Study|Adverse Event|0
318380|NCT01396187|1076280|P3|Overall Study|Adverse Event|0
318381|NCT01396187|1076281|P2|Overall Study|Adverse Event|1
318382|NCT01396187|1076282|P1|Overall Study|Adverse Event|0
318383|NCT01396161|1076382|P7|Overall Study|Other|1
318384|NCT01396161|1076383|P6|Overall Study|Other|0
318385|NCT01396161|1076384|P5|Overall Study|Other|0
318386|NCT01396161|1076385|P4|Overall Study|Other|0
318387|NCT01396161|1076386|P3|Overall Study|Other|0
318388|NCT01396161|1076387|P2|Overall Study|Other|0
318389|NCT01396161|1076388|P1|Overall Study|Other|0
318390|NCT01396161|1076382|P7|Overall Study|Withdrawal by Subject|0
318391|NCT01396161|1076383|P6|Overall Study|Withdrawal by Subject|0
318392|NCT01396161|1076384|P5|Overall Study|Withdrawal by Subject|1
318393|NCT01396161|1076385|P4|Overall Study|Withdrawal by Subject|0
318394|NCT01396161|1076386|P3|Overall Study|Withdrawal by Subject|0
318395|NCT01396161|1076387|P2|Overall Study|Withdrawal by Subject|0
318396|NCT01396161|1076388|P1|Overall Study|Withdrawal by Subject|0
318397|NCT01396148|1076441|P1|Overall Study|Patient Decision|1
318398|NCT01396083|1076468|P2|Overall Study|Lost to Follow-up|0
318399|NCT01396083|1076469|P1|Overall Study|Lost to Follow-up|1
318400|NCT01396083|1076468|P2|Overall Study|Administrative problems|0
318401|NCT01396083|1076469|P1|Overall Study|Administrative problems|1
318402|NCT01396083|1076468|P2|Overall Study|Abnormal laboratory value(s)|0
318403|NCT01396083|1076469|P1|Overall Study|Abnormal laboratory value(s)|1
318404|NCT01396083|1076468|P2|Overall Study|Protocol deviation(s)|1
318405|NCT01396083|1076469|P1|Overall Study|Protocol deviation(s)|0
318406|NCT01396083|1076468|P2|Overall Study|Consent withdrawn|5
318407|NCT01396083|1076469|P1|Overall Study|Consent withdrawn|4
318408|NCT01396083|1076468|P2|Overall Study|Unsatisfactory therapeutic effect|13
318409|NCT01396083|1076469|P1|Overall Study|Unsatisfactory therapeutic effect|2
318410|NCT01396083|1076468|P2|Overall Study|Adverse Event|28
318411|NCT01396083|1076469|P1|Overall Study|Adverse Event|2
318412|NCT01396070|1076493|P1|Overall Study|Lack of Efficacy|4
318413|NCT01396070|1076493|P1|Overall Study|Physician Decision|3
318414|NCT01396070|1076493|P1|Overall Study|Adverse Event|8
318415|NCT01396070|1076493|P1|Overall Study|Death|2
318416|NCT01396070|1076493|P1|Overall Study|Withdrawal by Subject|2
318417|NCT01396057|1076502|P2|Overall Study|Consent withdrawn|2
318418|NCT01396057|1076503|P1|Overall Study|Consent withdrawn|3
318419|NCT01396057|1076502|P2|Overall Study|Protocol deviation|4
318420|NCT01396057|1076503|P1|Overall Study|Protocol deviation|4
318421|NCT01396057|1076502|P2|Overall Study|Unsatisfactory therapeutic effect|6
318422|NCT01396057|1076503|P1|Overall Study|Unsatisfactory therapeutic effect|2
318423|NCT01396057|1076502|P2|Overall Study|Adverse Event|6
318424|NCT01396057|1076503|P1|Overall Study|Adverse Event|2
318425|NCT01396005|1076552|P2|Overall Study|Non-compliance with protocol|1
318426|NCT01396005|1076553|P1|Overall Study|Non-compliance with protocol|0
318427|NCT01396005|1076552|P2|Overall Study|Withdrawal by Subject|1
318428|NCT01396005|1076553|P1|Overall Study|Withdrawal by Subject|0
318429|NCT01395914|1076584|P2|Overall Study|Lost to Follow-up|2
318430|NCT01395914|1076585|P1|Overall Study|Lost to Follow-up|6
318431|NCT01395914|1076584|P2|Overall Study|Study drug-related AE|0
318432|NCT01395914|1076585|P1|Overall Study|Study drug-related AE|1
318433|NCT01395914|1076584|P2|Overall Study|Withdrawal by patient|14
318434|NCT01395914|1076585|P1|Overall Study|Withdrawal by patient|27
318435|NCT01395914|1076584|P2|Overall Study|Other|3
318436|NCT01395914|1076585|P1|Overall Study|Other|9
318437|NCT01395914|1076584|P2|Overall Study|Death|17
318438|NCT01395914|1076585|P1|Overall Study|Death|23
318439|NCT01395914|1076584|P2|Overall Study|Unrelated to study drug AE|1
318440|NCT01395914|1076585|P1|Overall Study|Unrelated to study drug AE|6
318441|NCT01395901|1076599|P2|Overall Study|Withdrawal of consent|0
318442|NCT01395901|1076600|P1|Overall Study|Withdrawal of consent|1
318443|NCT01395901|1076599|P2|Overall Study|Adverse Event|1
318444|NCT01395901|1076600|P1|Overall Study|Adverse Event|0
318445|NCT01395901|1076599|P2|Overall Study|Randomized but not received study drug|4
318446|NCT01395901|1076600|P1|Overall Study|Randomized but not received study drug|5
318447|NCT01395901|1076599|P2|Overall Study|Lost to Follow-up|0
318448|NCT01395901|1076600|P1|Overall Study|Lost to Follow-up|4
318449|NCT01395888|1076616|P3|Treatment Period (TP)|Withdrawal by Subject|3
318450|NCT01395888|1076617|P2|Treatment Period (TP)|Withdrawal by Subject|2
318451|NCT01395888|1076618|P1|Treatment Period (TP)|Withdrawal by Subject|0
318452|NCT01395888|1076616|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
318453|NCT01395888|1076617|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
318454|NCT01395888|1076618|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
318455|NCT01395888|1076616|P3|Treatment Period (TP)|Protocol Violation|5
318456|NCT01395888|1076617|P2|Treatment Period (TP)|Protocol Violation|1
318457|NCT01395888|1076618|P1|Treatment Period (TP)|Protocol Violation|0
318458|NCT01395888|1076616|P3|Treatment Period (TP)|Lack of Efficacy|3
318459|NCT01395888|1076617|P2|Treatment Period (TP)|Lack of Efficacy|4
318460|NCT01395888|1076618|P1|Treatment Period (TP)|Lack of Efficacy|0
318461|NCT01395888|1076616|P3|Treatment Period (TP)|Adverse Event|6
318462|NCT01395888|1076617|P2|Treatment Period (TP)|Adverse Event|7
318463|NCT01395888|1076618|P1|Treatment Period (TP)|Adverse Event|0
318464|NCT01395888|1076616|P3|2-week Run-in Period|Withdrawal by Subject|0
318465|NCT01395888|1076617|P2|2-week Run-in Period|Withdrawal by Subject|0
318466|NCT01395888|1076618|P1|2-week Run-in Period|Withdrawal by Subject|4
318467|NCT01395888|1076616|P3|2-week Run-in Period|Protocol Violation|0
318468|NCT01395888|1076617|P2|2-week Run-in Period|Protocol Violation|0
318469|NCT01395888|1076618|P1|2-week Run-in Period|Protocol Violation|2
318470|NCT01395888|1076616|P3|2-week Run-in Period|Lost to Follow-up|0
318471|NCT01395888|1076617|P2|2-week Run-in Period|Lost to Follow-up|0
318472|NCT01395888|1076618|P1|2-week Run-in Period|Lost to Follow-up|1
318473|NCT01395888|1076616|P3|2-week Run-in Period|Continuation Criteria Not Met|0
318474|NCT01395888|1076617|P2|2-week Run-in Period|Continuation Criteria Not Met|0
318475|NCT01395888|1076618|P1|2-week Run-in Period|Continuation Criteria Not Met|13
318476|NCT01395888|1076616|P3|2-week Run-in Period|Adverse Event|0
318477|NCT01395888|1076617|P2|2-week Run-in Period|Adverse Event|0
318478|NCT01395888|1076618|P1|2-week Run-in Period|Adverse Event|2
318479|NCT01395823|1076626|P2|Overall Study|Withdrawal by Subject|4
318480|NCT01395823|1076627|P1|Overall Study|Withdrawal by Subject|5
318481|NCT01395823|1076626|P2|Overall Study|GI symptoms|0
318482|NCT01395823|1076627|P1|Overall Study|GI symptoms|1
318483|NCT01395823|1076626|P2|Overall Study|Transplant|0
318484|NCT01395823|1076627|P1|Overall Study|Transplant|1
318485|NCT01395823|1076626|P2|Overall Study|Lost to Follow-up|0
318486|NCT01395823|1076627|P1|Overall Study|Lost to Follow-up|1
318487|NCT01395823|1076626|P2|Overall Study|Physician Decision|1
318488|NCT01395823|1076627|P1|Overall Study|Physician Decision|3
318489|NCT01395823|1076626|P2|Overall Study|Death|4
318490|NCT01395823|1076627|P1|Overall Study|Death|4
318491|NCT01395810|1076637|P4|Overall Study|Unclassified|0
318492|NCT01395810|1076638|P3|Overall Study|Unclassified|0
318493|NCT01395810|1076639|P2|Overall Study|Unclassified|0
318494|NCT01395810|1076640|P1|Overall Study|Unclassified|2
318495|NCT01395810|1076637|P4|Overall Study|Withdrawal criteria|0
318496|NCT01395810|1076638|P3|Overall Study|Withdrawal criteria|0
318497|NCT01395810|1076639|P2|Overall Study|Withdrawal criteria|2
318498|NCT01395810|1076640|P1|Overall Study|Withdrawal criteria|0
318499|NCT01395810|1076637|P4|Overall Study|Lack of Efficacy|0
318500|NCT01395810|1076638|P3|Overall Study|Lack of Efficacy|0
318501|NCT01395810|1076639|P2|Overall Study|Lack of Efficacy|1
318502|NCT01395810|1076640|P1|Overall Study|Lack of Efficacy|0
318503|NCT01395810|1076637|P4|Overall Study|Adverse Event|0
318504|NCT01395810|1076638|P3|Overall Study|Adverse Event|0
318505|NCT01395810|1076639|P2|Overall Study|Adverse Event|1
318506|NCT01395810|1076640|P1|Overall Study|Adverse Event|0
318507|NCT01395784|1076699|P1|Overall Study|Physician Decision|5
318508|NCT01395784|1076699|P1|Overall Study|Withdrawal by Subject|3
318509|NCT01395784|1076699|P1|Overall Study|Lost to Follow-up|7
318510|NCT01395758|1076706|P3|Open-label Treatment Period|Withdrawal by Subject|0
318511|NCT01395758|1076707|P2|Open-label Treatment Period|Withdrawal by Subject|0
318512|NCT01395758|1076708|P1|Open-label Treatment Period|Withdrawal by Subject|4
318513|NCT01395524|1076722|P3|Overall Study|Subject had spinal surgery|1
318514|NCT01395524|1076723|P2|Overall Study|Subject had spinal surgery|0
318515|NCT01395524|1076724|P1|Overall Study|Subject had spinal surgery|0
318516|NCT01395524|1076722|P3|Overall Study|Did not receive treatment|3
318517|NCT01395524|1076723|P2|Overall Study|Did not receive treatment|1
318518|NCT01395524|1076724|P1|Overall Study|Did not receive treatment|1
318519|NCT01395524|1076722|P3|Overall Study|Withdrawal by Subject|8
318520|NCT01395524|1076723|P2|Overall Study|Withdrawal by Subject|8
318521|NCT01395524|1076724|P1|Overall Study|Withdrawal by Subject|4
318522|NCT01395524|1076722|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
318523|NCT01395524|1076723|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
318524|NCT01395524|1076724|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
318525|NCT01395524|1076722|P3|Overall Study|Death|0
318526|NCT01395524|1076723|P2|Overall Study|Death|0
318527|NCT01395524|1076724|P1|Overall Study|Death|1
318528|NCT01395524|1076722|P3|Overall Study|Adverse Event|3
318529|NCT01395524|1076723|P2|Overall Study|Adverse Event|4
318530|NCT01395524|1076724|P1|Overall Study|Adverse Event|4
318531|NCT01395524|1076722|P3|Overall Study|Severe noncompliance with protocol|0
318532|NCT01395524|1076723|P2|Overall Study|Severe noncompliance with protocol|0
318533|NCT01395524|1076724|P1|Overall Study|Severe noncompliance with protocol|1
318534|NCT01395524|1076722|P3|Overall Study|Study-Specific Withdrawal Criteria|0
318535|NCT01395524|1076723|P2|Overall Study|Study-Specific Withdrawal Criteria|2
318536|NCT01395524|1076724|P1|Overall Study|Study-Specific Withdrawal Criteria|1
318537|NCT01395524|1076722|P3|Overall Study|Lost to Follow-up|1
318538|NCT01395524|1076723|P2|Overall Study|Lost to Follow-up|1
318539|NCT01395524|1076724|P1|Overall Study|Lost to Follow-up|3
318540|NCT01395524|1076722|P3|Overall Study|Non-compliance with study schedule|1
318541|NCT01395524|1076723|P2|Overall Study|Non-compliance with study schedule|0
318542|NCT01395524|1076724|P1|Overall Study|Non-compliance with study schedule|1
318543|NCT01395394|1076747|P3|Baseline Study Visit|Protocol Violation|0
318544|NCT01395394|1076748|P2|Baseline Study Visit|Protocol Violation|0
318545|NCT01395394|1076749|P1|Baseline Study Visit|Protocol Violation|1
318546|NCT01395368|1076760|P1|Overall Study|Withdrawal by Subject|2
318547|NCT01395368|1076760|P1|Overall Study|Physician Decision|14
318548|NCT01395017|1076782|P2|Overall Study|Sponsor discontinued study|4
318549|NCT01395017|1076783|P1|Overall Study|Sponsor discontinued study|1
318550|NCT01395017|1076782|P2|Overall Study|Disease progression|58
318551|NCT01395017|1076783|P1|Overall Study|Disease progression|42
318552|NCT01395017|1076782|P2|Overall Study|Death|3
318553|NCT01395017|1076783|P1|Overall Study|Death|4
318554|NCT01395017|1076782|P2|Overall Study|Protocol deviation|2
318555|NCT01395017|1076783|P1|Overall Study|Protocol deviation|1
318556|NCT01395017|1076782|P2|Overall Study|Withdrawal by Subject|8
318557|NCT01395017|1076783|P1|Overall Study|Withdrawal by Subject|14
318558|NCT01395017|1076782|P2|Overall Study|Physician Decision|15
318559|NCT01395017|1076783|P1|Overall Study|Physician Decision|11
318560|NCT01395017|1076782|P2|Overall Study|Adverse Event|12
318561|NCT01395017|1076783|P1|Overall Study|Adverse Event|26
318562|NCT01395017|1076782|P2|Overall Study|Lost to Follow-up|0
318563|NCT01395017|1076783|P1|Overall Study|Lost to Follow-up|1
318564|NCT01394991|1076793|P2|Overall Study|Prematurely Termination of Trial|10
318565|NCT01394991|1076794|P1|Overall Study|Prematurely Termination of Trial|9
318566|NCT01394991|1076793|P2|Overall Study|Disease Progression|7
318567|NCT01394991|1076794|P1|Overall Study|Disease Progression|7
318568|NCT01394991|1076793|P2|Overall Study|Chemotherapy Termination|15
318569|NCT01394991|1076794|P1|Overall Study|Chemotherapy Termination|10
318570|NCT01394991|1076793|P2|Overall Study|Withdrawal by Subject|17
318571|NCT01394991|1076794|P1|Overall Study|Withdrawal by Subject|20
318572|NCT01394991|1076793|P2|Overall Study|Protocol Violation|1
318573|NCT01394991|1076794|P1|Overall Study|Protocol Violation|1
318574|NCT01394991|1076793|P2|Overall Study|Physician Decision|3
318575|NCT01394991|1076794|P1|Overall Study|Physician Decision|1
318576|NCT01394991|1076793|P2|Overall Study|Lost to Follow-up|8
318577|NCT01394991|1076794|P1|Overall Study|Lost to Follow-up|6
318578|NCT01394991|1076793|P2|Overall Study|Lack of Efficacy|7
318579|NCT01394991|1076794|P1|Overall Study|Lack of Efficacy|5
318580|NCT01394991|1076793|P2|Overall Study|Adverse Event|4
318581|NCT01394991|1076794|P1|Overall Study|Adverse Event|0
318582|NCT01394978|1076816|P2|Overall Study|Death|7
318583|NCT01394978|1076817|P1|Overall Study|Death|6
318584|NCT01394978|1076816|P2|Overall Study|Lost to Follow-up|20
318585|NCT01394978|1076817|P1|Overall Study|Lost to Follow-up|13
318586|NCT01394978|1076816|P2|Overall Study|Withdrawal by Subject|4
318587|NCT01394978|1076817|P1|Overall Study|Withdrawal by Subject|2
318588|NCT01394718|1076834|P2|Overall Study|Met protocol-specific stopping criteria|1
318589|NCT01394718|1076835|P1|Overall Study|Met protocol-specific stopping criteria|2
318590|NCT01394627|1076856|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
318591|NCT01394627|1076857|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
318592|NCT01394627|1076856|P2|First Intervention (1 Day)|poor intravenous access|1
318593|NCT01394627|1076857|P1|First Intervention (1 Day)|poor intravenous access|0
318594|NCT01394523|1076877|P3|Overall Study|Unable to place block|0
318595|NCT01394523|1076878|P2|Overall Study|Unable to place block|0
318596|NCT01394523|1076879|P1|Overall Study|Unable to place block|1
318597|NCT01394276|1076893|P1|Overall Study|Symptoms of concurrent diseases|1
318598|NCT01394276|1076893|P1|Overall Study|unavailability of drug at the Hospital|2
318599|NCT01394276|1076893|P1|Overall Study|Pregnancy|1
318600|NCT01394276|1076893|P1|Overall Study|Participant moved to another site|1
318601|NCT01394276|1076893|P1|Overall Study|Lost to Follow-up|5
318602|NCT01394276|1076893|P1|Overall Study|Insufficient compliance|9
318603|NCT01394276|1076893|P1|Overall Study|Insufficient therapeutic effect|17
318604|NCT01394276|1076893|P1|Overall Study|Remission of disease|2
318605|NCT01394276|1076893|P1|Overall Study|Not related AEs|9
318606|NCT01394276|1076893|P1|Overall Study|Related Adverse event (AEs)|15
318607|NCT01394250|1076917|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
318608|NCT01394250|1076918|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
318609|NCT01394250|1076917|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
318610|NCT01394250|1076918|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
318611|NCT01394185|1076926|P6|Overall Study|Protocol Violation|1
318612|NCT01394185|1076927|P5|Overall Study|Protocol Violation|0
318613|NCT01394185|1076928|P4|Overall Study|Protocol Violation|1
318614|NCT01394185|1076929|P3|Overall Study|Protocol Violation|0
318615|NCT01394185|1076930|P2|Overall Study|Protocol Violation|0
318616|NCT01394185|1076931|P1|Overall Study|Protocol Violation|1
318617|NCT01394185|1076926|P6|Overall Study|Change in protocol|0
318618|NCT01394185|1076927|P5|Overall Study|Change in protocol|3
318619|NCT01394185|1076928|P4|Overall Study|Change in protocol|0
318620|NCT01394185|1076929|P3|Overall Study|Change in protocol|0
318621|NCT01394185|1076930|P2|Overall Study|Change in protocol|0
318622|NCT01394185|1076931|P1|Overall Study|Change in protocol|3
318623|NCT01394185|1076926|P6|Overall Study|Withdrawal by Subject|0
318624|NCT01394185|1076927|P5|Overall Study|Withdrawal by Subject|1
318625|NCT01394185|1076928|P4|Overall Study|Withdrawal by Subject|0
318626|NCT01394185|1076929|P3|Overall Study|Withdrawal by Subject|0
318627|NCT01394185|1076930|P2|Overall Study|Withdrawal by Subject|0
318628|NCT01394185|1076931|P1|Overall Study|Withdrawal by Subject|2
318629|NCT01393964|1076969|P3|Overall Study|Subject to receive non-protocol therapy|1
318630|NCT01393964|1076970|P2|Overall Study|Subject to receive non-protocol therapy|0
318631|NCT01393964|1076971|P1|Overall Study|Subject to receive non-protocol therapy|0
318632|NCT01393964|1076969|P3|Overall Study|Subject converted to roll-over study|0
318633|NCT01393964|1076970|P2|Overall Study|Subject converted to roll-over study|1
318634|NCT01393964|1076971|P1|Overall Study|Subject converted to roll-over study|0
318635|NCT01393964|1076969|P3|Overall Study|Investigator removed subject from study|0
318636|NCT01393964|1076970|P2|Overall Study|Investigator removed subject from study|1
318637|NCT01393964|1076971|P1|Overall Study|Investigator removed subject from study|0
318638|NCT01393964|1076969|P3|Overall Study|Subject plateaued in terms of effect|0
318639|NCT01393964|1076970|P2|Overall Study|Subject plateaued in terms of effect|0
318640|NCT01393964|1076971|P1|Overall Study|Subject plateaued in terms of effect|1
318641|NCT01393964|1076969|P3|Overall Study|Subject switched to commercial supply|2
318642|NCT01393964|1076970|P2|Overall Study|Subject switched to commercial supply|0
318643|NCT01393964|1076971|P1|Overall Study|Subject switched to commercial supply|1
318644|NCT01393964|1076969|P3|Overall Study|Subject decided to move to transplant|0
318645|NCT01393964|1076970|P2|Overall Study|Subject decided to move to transplant|0
318646|NCT01393964|1076971|P1|Overall Study|Subject decided to move to transplant|1
318647|NCT01393964|1076969|P3|Overall Study|Subject request stop study treatment|0
318648|NCT01393964|1076970|P2|Overall Study|Subject request stop study treatment|1
318649|NCT01393964|1076971|P1|Overall Study|Subject request stop study treatment|0
318650|NCT01393964|1076969|P3|Overall Study|Adverse event unrelated to study drug|0
318651|NCT01393964|1076970|P2|Overall Study|Adverse event unrelated to study drug|3
318652|NCT01393964|1076971|P1|Overall Study|Adverse event unrelated to study drug|0
318653|NCT01393964|1076969|P3|Overall Study|Withdrawal by Subject|1
318654|NCT01393964|1076970|P2|Overall Study|Withdrawal by Subject|0
318655|NCT01393964|1076971|P1|Overall Study|Withdrawal by Subject|0
318656|NCT01393964|1076969|P3|Overall Study|Study drug toxicity|0
318657|NCT01393964|1076970|P2|Overall Study|Study drug toxicity|0
318658|NCT01393964|1076971|P1|Overall Study|Study drug toxicity|1
318659|NCT01393964|1076969|P3|Overall Study|Disease Progression|5
318660|NCT01393964|1076970|P2|Overall Study|Disease Progression|3
318661|NCT01393964|1076971|P1|Overall Study|Disease Progression|4
318662|NCT01393899|1077012|P3|Overall Study|Adverse Event|3
318663|NCT01393899|1077013|P2|Overall Study|Adverse Event|5
318664|NCT01393899|1077014|P1|Overall Study|Adverse Event|1
318665|NCT01393899|1077012|P3|Overall Study|Lack of Efficacy|16
318666|NCT01393899|1077013|P2|Overall Study|Lack of Efficacy|21
318667|NCT01393899|1077014|P1|Overall Study|Lack of Efficacy|26
318668|NCT01393899|1077012|P3|Overall Study|Does not meet entrance criteria|1
318669|NCT01393899|1077013|P2|Overall Study|Does not meet entrance criteria|0
318670|NCT01393899|1077014|P1|Overall Study|Does not meet entrance criteria|1
318671|NCT01393899|1077012|P3|Overall Study|Lost to Follow-up|1
318672|NCT01393899|1077013|P2|Overall Study|Lost to Follow-up|0
318673|NCT01393899|1077014|P1|Overall Study|Lost to Follow-up|0
318674|NCT01393899|1077012|P3|Overall Study|Withdrawal by Subject|1
318675|NCT01393899|1077013|P2|Overall Study|Withdrawal by Subject|2
318676|NCT01393899|1077014|P1|Overall Study|Withdrawal by Subject|2
318677|NCT01393899|1077012|P3|Overall Study|Other|0
318678|NCT01393899|1077013|P2|Overall Study|Other|0
318679|NCT01393899|1077014|P1|Overall Study|Other|1
318680|NCT01393899|1077012|P3|Overall Study|Study terminated by sponsor|1
318681|NCT01393899|1077013|P2|Overall Study|Study terminated by sponsor|0
318682|NCT01393899|1077014|P1|Overall Study|Study terminated by sponsor|1
318683|NCT01393743|1077068|P3|Extension Phase|Not specified|14
318684|NCT01393743|1077069|P2|Extension Phase|Not specified|0
318685|NCT01393743|1077070|P1|Extension Phase|Not specified|0
318686|NCT01393743|1077068|P3|Extension Phase|Pregnancy|1
318687|NCT01393743|1077069|P2|Extension Phase|Pregnancy|0
318688|NCT01393743|1077070|P1|Extension Phase|Pregnancy|0
318689|NCT01393743|1077068|P3|Extension Phase|Withdrawal by Subject|8
318690|NCT01393743|1077069|P2|Extension Phase|Withdrawal by Subject|0
318691|NCT01393743|1077070|P1|Extension Phase|Withdrawal by Subject|0
318692|NCT01393743|1077068|P3|Extension Phase|Inadequate therapeutic effect|7
318693|NCT01393743|1077069|P2|Extension Phase|Inadequate therapeutic effect|0
318694|NCT01393743|1077070|P1|Extension Phase|Inadequate therapeutic effect|0
318695|NCT01393743|1077068|P3|Extension Phase|Participant choice|16
318696|NCT01393743|1077069|P2|Extension Phase|Participant choice|0
318697|NCT01393743|1077070|P1|Extension Phase|Participant choice|0
318698|NCT01393743|1077068|P3|Extension Phase|Lost to Follow-up|2
318699|NCT01393743|1077069|P2|Extension Phase|Lost to Follow-up|0
318700|NCT01393743|1077070|P1|Extension Phase|Lost to Follow-up|0
318701|NCT01393743|1077068|P3|Extension Phase|Adverse Event|12
318702|NCT01393743|1077069|P2|Extension Phase|Adverse Event|0
318703|NCT01393743|1077070|P1|Extension Phase|Adverse Event|0
318704|NCT01393743|1077068|P3|Core Study|Inadequate therapeutic effect|0
318705|NCT01393743|1077069|P2|Core Study|Inadequate therapeutic effect|0
318706|NCT01393743|1077070|P1|Core Study|Inadequate therapeutic effect|2
318707|NCT01393743|1077068|P3|Core Study|Participant's Choice|0
318708|NCT01393743|1077069|P2|Core Study|Participant's Choice|3
318709|NCT01393743|1077070|P1|Core Study|Participant's Choice|2
318710|NCT01393743|1077068|P3|Core Study|Lost to Follow-up|0
318711|NCT01393743|1077069|P2|Core Study|Lost to Follow-up|1
318712|NCT01393743|1077070|P1|Core Study|Lost to Follow-up|1
318713|NCT01393743|1077068|P3|Core Study|Adverse Event|0
318714|NCT01393743|1077069|P2|Core Study|Adverse Event|9
318715|NCT01393743|1077070|P1|Core Study|Adverse Event|5
318716|NCT01393730|1077093|P1|Overall Study|Adverse Event|1
318717|NCT01393730|1077093|P1|Overall Study|Other|2
318718|NCT01393730|1077093|P1|Overall Study|Withdrawal by Subject|3
318719|NCT01393626|1077139|P4|Overall Study|Protocol Violation|0
318720|NCT01393626|1077140|P3|Overall Study|Protocol Violation|2
318721|NCT01393626|1077141|P2|Overall Study|Protocol Violation|0
318722|NCT01393626|1077142|P1|Overall Study|Protocol Violation|1
318723|NCT01393626|1077139|P4|Overall Study|Other|0
318724|NCT01393626|1077140|P3|Overall Study|Other|0
318725|NCT01393626|1077141|P2|Overall Study|Other|0
318726|NCT01393626|1077142|P1|Overall Study|Other|1
318727|NCT01393626|1077139|P4|Overall Study|Withdrawal by Subject|0
318728|NCT01393626|1077140|P3|Overall Study|Withdrawal by Subject|0
318729|NCT01393626|1077141|P2|Overall Study|Withdrawal by Subject|4
318730|NCT01393626|1077142|P1|Overall Study|Withdrawal by Subject|6
318731|NCT01393626|1077139|P4|Overall Study|Lost to Follow-up|0
318732|NCT01393626|1077140|P3|Overall Study|Lost to Follow-up|1
318733|NCT01393626|1077141|P2|Overall Study|Lost to Follow-up|1
318734|NCT01393626|1077142|P1|Overall Study|Lost to Follow-up|1
318735|NCT01393626|1077139|P4|Overall Study|Lack of Efficacy|1
318736|NCT01393626|1077140|P3|Overall Study|Lack of Efficacy|4
318737|NCT01393626|1077141|P2|Overall Study|Lack of Efficacy|6
318738|NCT01393626|1077142|P1|Overall Study|Lack of Efficacy|6
318739|NCT01393626|1077139|P4|Overall Study|Did not meet entrance criteria|0
318740|NCT01393626|1077140|P3|Overall Study|Did not meet entrance criteria|0
318741|NCT01393626|1077141|P2|Overall Study|Did not meet entrance criteria|0
318742|NCT01393626|1077142|P1|Overall Study|Did not meet entrance criteria|1
318743|NCT01393626|1077139|P4|Overall Study|Adverse Event|0
318744|NCT01393626|1077140|P3|Overall Study|Adverse Event|5
318745|NCT01393626|1077141|P2|Overall Study|Adverse Event|1
318746|NCT01393626|1077142|P1|Overall Study|Adverse Event|2
318747|NCT01393613|1077222|P4|Overall Study|Lack of Efficacy|21
318748|NCT01393613|1077223|P3|Overall Study|Lack of Efficacy|16
318749|NCT01393613|1077224|P2|Overall Study|Lack of Efficacy|20
318750|NCT01393613|1077225|P1|Overall Study|Lack of Efficacy|9
318751|NCT01393613|1077222|P4|Overall Study|Protocol Deviation|0
318752|NCT01393613|1077223|P3|Overall Study|Protocol Deviation|0
318753|NCT01393613|1077224|P2|Overall Study|Protocol Deviation|1
318754|NCT01393613|1077225|P1|Overall Study|Protocol Deviation|2
318755|NCT01393613|1077222|P4|Overall Study|Withdrawal by Subject|21
318756|NCT01393613|1077223|P3|Overall Study|Withdrawal by Subject|23
318757|NCT01393613|1077224|P2|Overall Study|Withdrawal by Subject|25
318758|NCT01393613|1077225|P1|Overall Study|Withdrawal by Subject|15
318759|NCT01393613|1077222|P4|Overall Study|Physician Decision|1
318760|NCT01393613|1077223|P3|Overall Study|Physician Decision|0
318761|NCT01393613|1077224|P2|Overall Study|Physician Decision|0
318762|NCT01393613|1077225|P1|Overall Study|Physician Decision|2
318763|NCT01393613|1077222|P4|Overall Study|Participant Met Withdrawal Criteria|1
318764|NCT01393613|1077223|P3|Overall Study|Participant Met Withdrawal Criteria|2
318765|NCT01393613|1077224|P2|Overall Study|Participant Met Withdrawal Criteria|0
318766|NCT01393613|1077225|P1|Overall Study|Participant Met Withdrawal Criteria|0
318767|NCT01393613|1077222|P4|Overall Study|Adverse Event|22
318768|NCT01393613|1077223|P3|Overall Study|Adverse Event|13
318769|NCT01393613|1077224|P2|Overall Study|Adverse Event|11
318770|NCT01393613|1077225|P1|Overall Study|Adverse Event|11
318771|NCT01393600|1077287|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
318772|NCT01393600|1077288|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
318773|NCT01393600|1077289|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
318774|NCT01393600|1077290|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
318775|NCT01393600|1077287|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
318776|NCT01393600|1077288|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
318777|NCT01393600|1077289|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
318778|NCT01393600|1077290|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
318779|NCT01393600|1077287|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
318780|NCT01393600|1077288|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
318781|NCT01393600|1077289|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
318782|NCT01393600|1077290|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
318783|NCT01393600|1077287|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
318784|NCT01393600|1077288|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
318785|NCT01393600|1077289|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
318786|NCT01393600|1077290|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
318787|NCT01393600|1077287|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
318788|NCT01393600|1077288|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
318789|NCT01393600|1077289|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
318790|NCT01393600|1077290|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
318791|NCT01393600|1077287|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
318792|NCT01393600|1077288|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
318793|NCT01393600|1077289|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
318794|NCT01393600|1077290|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
318795|NCT01393600|1077287|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
318796|NCT01393600|1077288|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
318797|NCT01393600|1077289|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
318798|NCT01393600|1077290|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
318799|NCT01393444|1077326|P1|Overall Study|Determined ineligible during screening.|2
318800|NCT01393444|1077326|P1|Overall Study|Withdrawal by Subject|1
318801|NCT01393405|1077331|P3|Maintenance Period Week|Lost to Follow-up|0
318802|NCT01393405|1077332|P2|Maintenance Period Week|Lost to Follow-up|1
318803|NCT01393405|1077333|P1|Maintenance Period Week|Lost to Follow-up|0
318804|NCT01393405|1077331|P3|Maintenance Period Week|Withdrawal by Subject|0
318805|NCT01393405|1077332|P2|Maintenance Period Week|Withdrawal by Subject|1
318806|NCT01393405|1077333|P1|Maintenance Period Week|Withdrawal by Subject|0
318807|NCT01393405|1077331|P3|Maintenance Period Week|Adverse Event|2
318808|NCT01393405|1077332|P2|Maintenance Period Week|Adverse Event|5
318809|NCT01393405|1077333|P1|Maintenance Period Week|Adverse Event|0
318810|NCT01393405|1077331|P3|Maintenance Period Week|Lack of Efficacy|22
318811|NCT01393405|1077332|P2|Maintenance Period Week|Lack of Efficacy|22
318812|NCT01393405|1077333|P1|Maintenance Period Week|Lack of Efficacy|0
318813|NCT01393405|1077331|P3|Induction Period (week1-16)|Withdrawal by Subject|0
318814|NCT01393405|1077332|P2|Induction Period (week1-16)|Withdrawal by Subject|0
318815|NCT01393405|1077333|P1|Induction Period (week1-16)|Withdrawal by Subject|9
318816|NCT01393405|1077331|P3|Induction Period (week1-16)|Adverse Event|0
318817|NCT01393405|1077332|P2|Induction Period (week1-16)|Adverse Event|0
318818|NCT01393405|1077333|P1|Induction Period (week1-16)|Adverse Event|16
318819|NCT01393405|1077331|P3|Induction Period (week1-16)|Lack of Efficacy|0
318820|NCT01393405|1077332|P2|Induction Period (week1-16)|Lack of Efficacy|0
318821|NCT01393405|1077333|P1|Induction Period (week1-16)|Lack of Efficacy|70
318822|NCT01393106|1077365|P1|Overall Study|Lack of Efficacy|1
318823|NCT01393106|1077365|P1|Overall Study|Withdrawal by Subject|1
318824|NCT01393106|1077365|P1|Overall Study|Adverse Event|3
318825|NCT01392742|1077382|P1|Overall Study|Missing information|13
318826|NCT01392742|1077382|P1|Overall Study|Other|3
318827|NCT01392742|1077382|P1|Overall Study|Protocol Violation|14
318828|NCT01392742|1077382|P1|Overall Study|Adverse event/intercurrent illness|17
318829|NCT01392742|1077382|P1|Overall Study|ITR and Protocol deviation|1
318830|NCT01392742|1077382|P1|Overall Study|Insufficient therapeutic response (ITR)|30
318831|NCT01392742|1077382|P1|Overall Study|Lost to Follow-up|34
318832|NCT01392742|1077382|P1|Overall Study|No treatment/no cooperation/withdrew|12
318833|NCT01392742|1077382|P1|Overall Study|Failure to return|35
318834|NCT01392742|1077382|P1|Overall Study|Premature study termination|42
318835|NCT01392677|1077428|P2|Overall Study|Other reason|2
318836|NCT01392677|1077429|P1|Overall Study|Other reason|3
318837|NCT01392677|1077428|P2|Overall Study|Incorrect enrollment|3
318838|NCT01392677|1077429|P1|Overall Study|Incorrect enrollment|2
318839|NCT01392677|1077428|P2|Overall Study|Withdrawal by Subject|2
318840|NCT01392677|1077429|P1|Overall Study|Withdrawal by Subject|0
318841|NCT01392677|1077428|P2|Overall Study|Adverse Event|1
318842|NCT01392677|1077429|P1|Overall Study|Adverse Event|3
318843|NCT01392573|1077464|P2|Overall Study|Unclassified|6
318844|NCT01392573|1077465|P1|Overall Study|Unclassified|9
318845|NCT01392573|1077464|P2|Overall Study|Site closure|7
318846|NCT01392573|1077465|P1|Overall Study|Site closure|8
318847|NCT01392573|1077464|P2|Overall Study|Withdrawal Criteria|15
318848|NCT01392573|1077465|P1|Overall Study|Withdrawal Criteria|13
318849|NCT01392573|1077464|P2|Overall Study|Protocol Violation|2
318850|NCT01392573|1077465|P1|Overall Study|Protocol Violation|0
318851|NCT01392573|1077464|P2|Overall Study|Lack of Efficacy|2
318852|NCT01392573|1077465|P1|Overall Study|Lack of Efficacy|1
318853|NCT01392573|1077464|P2|Overall Study|Adverse Event|3
318854|NCT01392573|1077465|P1|Overall Study|Adverse Event|1
318855|NCT01392560|1077473|P1|Overall Study|discontinued during placebo run-in|2
318856|NCT01392560|1077473|P1|Overall Study|not entered|8
318857|NCT01392560|1077473|P1|Overall Study|Adverse Event|2
318858|NCT01392547|1077479|P1|Overall Study|Unclassified|1
318859|NCT01392547|1077479|P1|Overall Study|Withdrawal criteria|3
318860|NCT01392547|1077479|P1|Overall Study|Non-compliance|2
318861|NCT01392547|1077479|P1|Overall Study|Adverse Event|2
318862|NCT01392495|1077493|P1|Overall Study|Adverse Event|3
318863|NCT01392495|1077493|P1|Overall Study|Withdrawal by Subject|2
318864|NCT01392495|1077493|P1|Overall Study|Administrative problems|8
318865|NCT01392495|1077493|P1|Overall Study|Death|3
318866|NCT01392378|1077510|P5|Toddler Dose|Withdrawal by Parent|1
318867|NCT01392378|1077511|P4|Toddler Dose|Withdrawal by Parent|1
318868|NCT01392378|1077512|P3|Toddler Dose|Withdrawal by Parent|0
318869|NCT01392378|1077513|P2|Toddler Dose|Withdrawal by Parent|1
318870|NCT01392378|1077514|P1|Toddler Dose|Withdrawal by Parent|0
318871|NCT01392378|1077510|P5|Toddler Dose|Lost to Follow-up|0
318872|NCT01392378|1077511|P4|Toddler Dose|Lost to Follow-up|1
318873|NCT01392378|1077512|P3|Toddler Dose|Lost to Follow-up|0
318874|NCT01392378|1077513|P2|Toddler Dose|Lost to Follow-up|0
318875|NCT01392378|1077514|P1|Toddler Dose|Lost to Follow-up|0
318876|NCT01392378|1077510|P5|After Infant Series|Withdrawal by Parent|1
318877|NCT01392378|1077511|P4|After Infant Series|Withdrawal by Parent|0
318878|NCT01392378|1077512|P3|After Infant Series|Withdrawal by Parent|1
318879|NCT01392378|1077513|P2|After Infant Series|Withdrawal by Parent|1
318880|NCT01392378|1077514|P1|After Infant Series|Withdrawal by Parent|0
318881|NCT01392378|1077510|P5|After Infant Series|Lost to Follow-up|0
318882|NCT01392378|1077511|P4|After Infant Series|Lost to Follow-up|0
318883|NCT01392378|1077512|P3|After Infant Series|Lost to Follow-up|1
318884|NCT01392378|1077513|P2|After Infant Series|Lost to Follow-up|0
318885|NCT01392378|1077514|P1|After Infant Series|Lost to Follow-up|0
318886|NCT01392378|1077510|P5|Infant Series|Withdrawal by Parent|0
318887|NCT01392378|1077511|P4|Infant Series|Withdrawal by Parent|0
318888|NCT01392378|1077512|P3|Infant Series|Withdrawal by Parent|0
318889|NCT01392378|1077513|P2|Infant Series|Withdrawal by Parent|1
318890|NCT01392378|1077514|P1|Infant Series|Withdrawal by Parent|4
318891|NCT01392378|1077510|P5|Infant Series|Protocol Violation|0
318892|NCT01392378|1077511|P4|Infant Series|Protocol Violation|0
318893|NCT01392378|1077512|P3|Infant Series|Protocol Violation|0
318894|NCT01392378|1077513|P2|Infant Series|Protocol Violation|1
318895|NCT01392378|1077514|P1|Infant Series|Protocol Violation|0
318896|NCT01392378|1077510|P5|Infant Series|Lost to Follow-up|0
318897|NCT01392378|1077511|P4|Infant Series|Lost to Follow-up|1
318898|NCT01392378|1077512|P3|Infant Series|Lost to Follow-up|0
318899|NCT01392378|1077513|P2|Infant Series|Lost to Follow-up|0
318900|NCT01392378|1077514|P1|Infant Series|Lost to Follow-up|0
318901|NCT01392378|1077510|P5|Infant Series|Adverse Event|0
318902|NCT01392378|1077511|P4|Infant Series|Adverse Event|1
318903|NCT01392378|1077512|P3|Infant Series|Adverse Event|0
318904|NCT01392378|1077513|P2|Infant Series|Adverse Event|0
318905|NCT01392378|1077514|P1|Infant Series|Adverse Event|0
318906|NCT01392326|1077654|P3|Overall Study|Adverse Event|11
318907|NCT01392326|1077655|P2|Overall Study|Adverse Event|6
318908|NCT01392326|1077656|P1|Overall Study|Adverse Event|9
318909|NCT01392326|1077654|P3|Overall Study|Lack of Efficacy|15
318910|NCT01392326|1077655|P2|Overall Study|Lack of Efficacy|10
318911|NCT01392326|1077656|P1|Overall Study|Lack of Efficacy|14
318912|NCT01392326|1077654|P3|Overall Study|Lost to Follow-up|4
318913|NCT01392326|1077655|P2|Overall Study|Lost to Follow-up|3
318914|NCT01392326|1077656|P1|Overall Study|Lost to Follow-up|1
318915|NCT01392326|1077654|P3|Overall Study|Physician Decision|2
318916|NCT01392326|1077655|P2|Overall Study|Physician Decision|5
318917|NCT01392326|1077656|P1|Overall Study|Physician Decision|7
318918|NCT01392326|1077654|P3|Overall Study|Pregnancy|1
318919|NCT01392326|1077655|P2|Overall Study|Pregnancy|0
318920|NCT01392326|1077656|P1|Overall Study|Pregnancy|0
318921|NCT01392326|1077654|P3|Overall Study|Protocol Violation|0
318922|NCT01392326|1077655|P2|Overall Study|Protocol Violation|0
318923|NCT01392326|1077656|P1|Overall Study|Protocol Violation|2
318924|NCT01392326|1077654|P3|Overall Study|Withdrawal by Subject|15
318925|NCT01392326|1077655|P2|Overall Study|Withdrawal by Subject|11
318926|NCT01392326|1077656|P1|Overall Study|Withdrawal by Subject|12
318927|NCT01392326|1077654|P3|Overall Study|Death|0
318928|NCT01392326|1077655|P2|Overall Study|Death|0
318929|NCT01392326|1077656|P1|Overall Study|Death|2
318930|NCT01392300|1077693|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
318931|NCT01392300|1077694|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
318932|NCT01392300|1077695|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
318933|NCT01392300|1077693|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
318934|NCT01392300|1077694|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
318935|NCT01392300|1077695|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
318936|NCT01392300|1077693|P3|Open Label Extension (OLEX) Period|Adverse Event|7
318937|NCT01392300|1077694|P2|Open Label Extension (OLEX) Period|Adverse Event|0
318938|NCT01392300|1077695|P1|Open Label Extension (OLEX) Period|Adverse Event|0
318939|NCT01392300|1077693|P3|Open Label Extension (OLEX) Period|Death|4
318940|NCT01392300|1077694|P2|Open Label Extension (OLEX) Period|Death|0
318941|NCT01392300|1077695|P1|Open Label Extension (OLEX) Period|Death|0
318942|NCT01392300|1077693|P3|Open Label Extension (OLEX) Period|Non-compliance|1
318943|NCT01392300|1077694|P2|Open Label Extension (OLEX) Period|Non-compliance|0
318944|NCT01392300|1077695|P1|Open Label Extension (OLEX) Period|Non-compliance|0
318945|NCT01392300|1077693|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
318946|NCT01392300|1077694|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
318947|NCT01392300|1077695|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
318948|NCT01392300|1077693|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
318949|NCT01392300|1077694|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
318950|NCT01392300|1077695|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
318951|NCT01392300|1077693|P3|Main Period (MP)|Non-compliance|0
318952|NCT01392300|1077694|P2|Main Period (MP)|Non-compliance|0
318953|NCT01392300|1077695|P1|Main Period (MP)|Non-compliance|1
318954|NCT01392300|1077693|P3|Main Period (MP)|Lost to Follow-up|0
318955|NCT01392300|1077694|P2|Main Period (MP)|Lost to Follow-up|3
318956|NCT01392300|1077695|P1|Main Period (MP)|Lost to Follow-up|3
318957|NCT01392300|1077693|P3|Main Period (MP)|Withdrawal by Subject|0
318958|NCT01392300|1077694|P2|Main Period (MP)|Withdrawal by Subject|1
318959|NCT01392300|1077695|P1|Main Period (MP)|Withdrawal by Subject|5
318960|NCT01392300|1077693|P3|Main Period (MP)|Predefined discontinuation criteria|0
318961|NCT01392300|1077694|P2|Main Period (MP)|Predefined discontinuation criteria|3
318962|NCT01392300|1077695|P1|Main Period (MP)|Predefined discontinuation criteria|2
318963|NCT01392170|1077800|P1|Overall Study|Ineligible|1
318964|NCT01392170|1077800|P1|Overall Study|Withdrawal by Subject|1
318965|NCT01391819|1077848|P1|Overall Study|Other|9
318966|NCT01391819|1077848|P1|Overall Study|Death|3
318967|NCT01391819|1077848|P1|Overall Study|Lost to Follow-up|252
318968|NCT01391819|1077848|P1|Overall Study|Migrated/moved from study area|82
318969|NCT01391819|1077848|P1|Overall Study|Withdrawal by Subject|56
318970|NCT01391663|1077879|P4|Overall Study|Withdrawal by Subject|0
318971|NCT01391663|1077880|P3|Overall Study|Withdrawal by Subject|1
318972|NCT01391663|1077881|P2|Overall Study|Withdrawal by Subject|0
318973|NCT01391663|1077882|P1|Overall Study|Withdrawal by Subject|0
318974|NCT01391546|1077926|P2|Overall Study|History of Herpes Zoster (HZ)|0
318975|NCT01391546|1077927|P1|Overall Study|History of Herpes Zoster (HZ)|1
318976|NCT01391507|1077949|P4|Overall Study|Protocol Violation|2
318977|NCT01391507|1077950|P3|Overall Study|Protocol Violation|1
318978|NCT01391507|1077951|P2|Overall Study|Protocol Violation|1
318979|NCT01391507|1077952|P1|Overall Study|Protocol Violation|2
318980|NCT01391507|1077949|P4|Overall Study|Lack of Efficacy|1
318981|NCT01391507|1077950|P3|Overall Study|Lack of Efficacy|0
318982|NCT01391507|1077951|P2|Overall Study|Lack of Efficacy|0
318983|NCT01391507|1077952|P1|Overall Study|Lack of Efficacy|0
318984|NCT01391507|1077949|P4|Overall Study|Withdrawal by Subject|1
318985|NCT01391507|1077950|P3|Overall Study|Withdrawal by Subject|1
318986|NCT01391507|1077951|P2|Overall Study|Withdrawal by Subject|2
318987|NCT01391507|1077952|P1|Overall Study|Withdrawal by Subject|1
318988|NCT01391507|1077949|P4|Overall Study|Adverse Event|2
318989|NCT01391507|1077950|P3|Overall Study|Adverse Event|2
318990|NCT01391507|1077951|P2|Overall Study|Adverse Event|1
318991|NCT01391507|1077952|P1|Overall Study|Adverse Event|1
318992|NCT01391507|1077949|P4|Overall Study|Death|1
318993|NCT01391507|1077950|P3|Overall Study|Death|0
318994|NCT01391507|1077951|P2|Overall Study|Death|0
318995|NCT01391507|1077952|P1|Overall Study|Death|0
318996|NCT01391000|1078131|P2|Overall Study|Lost to Follow-up|0
318997|NCT01391000|1078132|P1|Overall Study|Lost to Follow-up|2
318998|NCT01390948|1078145|P3|Overall Study|Withdrew consent from survival follow-up|0
318999|NCT01390948|1078146|P2|Overall Study|Withdrew consent from survival follow-up|5
319000|NCT01390948|1078147|P1|Overall Study|Withdrew consent from survival follow-up|3
319001|NCT01390948|1078145|P3|Overall Study|Ongoing|0
319002|NCT01390948|1078146|P2|Overall Study|Ongoing|6
319003|NCT01390948|1078147|P1|Overall Study|Ongoing|6
319004|NCT01390948|1078145|P3|Overall Study|Death|2
319005|NCT01390948|1078146|P2|Overall Study|Death|34
319006|NCT01390948|1078147|P1|Overall Study|Death|30
319007|NCT01390948|1078145|P3|Overall Study|Alive in follow-up|1
319008|NCT01390948|1078146|P2|Overall Study|Alive in follow-up|17
319009|NCT01390948|1078147|P1|Overall Study|Alive in follow-up|20
319010|NCT01390857|1078213|P1|Overall Study|No Visit after the First Visit|7
319011|NCT01390857|1078213|P1|Overall Study|Lost to Follow-up|1
319012|NCT01390857|1078213|P1|Overall Study|Protocol Violation|2
319013|NCT01390844|1078224|P4|Follow-Up Phase|Non-Medical Reasons|0
319014|NCT01390844|1078225|P3|Follow-Up Phase|Non-Medical Reasons|1
319015|NCT01390844|1078226|P2|Follow-Up Phase|Non-Medical Reasons|1
319016|NCT01390844|1078227|P1|Follow-Up Phase|Non-Medical Reasons|1
319017|NCT01390844|1078224|P4|Treatment Phase|Non-GCP Compliant|3
319018|NCT01390844|1078225|P3|Treatment Phase|Non-GCP Compliant|10
319019|NCT01390844|1078226|P2|Treatment Phase|Non-GCP Compliant|0
319020|NCT01390844|1078227|P1|Treatment Phase|Non-GCP Compliant|0
319021|NCT01390844|1078224|P4|Treatment Phase|Non-Medical Reasons|1
319022|NCT01390844|1078225|P3|Treatment Phase|Non-Medical Reasons|8
319023|NCT01390844|1078226|P2|Treatment Phase|Non-Medical Reasons|1
319024|NCT01390844|1078227|P1|Treatment Phase|Non-Medical Reasons|5
319025|NCT01390844|1078224|P4|Treatment Phase|Treatment Failure|13
319026|NCT01390844|1078225|P3|Treatment Phase|Treatment Failure|10
319027|NCT01390844|1078226|P2|Treatment Phase|Treatment Failure|25
319028|NCT01390844|1078227|P1|Treatment Phase|Treatment Failure|23
319029|NCT01390844|1078224|P4|Treatment Phase|Adverse Event|2
319030|NCT01390844|1078225|P3|Treatment Phase|Adverse Event|3
319031|NCT01390844|1078226|P2|Treatment Phase|Adverse Event|2
319032|NCT01390844|1078227|P1|Treatment Phase|Adverse Event|12
319033|NCT01390779|1078554|P1|Overall Study|Physician Decision|1
319034|NCT01390649|1078559|P1|Overall Study|Physician Decision|1
319035|NCT01390441|1078569|P5|Extension Period|Protocol Violation|0
319036|NCT01390441|1078570|P4|Extension Period|Protocol Violation|1
319037|NCT01390441|1078571|P3|Extension Period|Protocol Violation|0
319038|NCT01390441|1078572|P2|Extension Period|Protocol Violation|1
319039|NCT01390441|1078573|P1|Extension Period|Protocol Violation|3
319040|NCT01390441|1078569|P5|Treatment Period|Lost to Follow-up|0
319041|NCT01390441|1078570|P4|Treatment Period|Lost to Follow-up|0
319042|NCT01390441|1078571|P3|Treatment Period|Lost to Follow-up|0
319043|NCT01390441|1078572|P2|Treatment Period|Lost to Follow-up|0
319044|NCT01390441|1078573|P1|Treatment Period|Lost to Follow-up|1
319045|NCT01390441|1078569|P5|Treatment Period|Withdrawal by Subject|1
319046|NCT01390441|1078570|P4|Treatment Period|Withdrawal by Subject|0
319047|NCT01390441|1078571|P3|Treatment Period|Withdrawal by Subject|1
319048|NCT01390441|1078572|P2|Treatment Period|Withdrawal by Subject|0
319049|NCT01390441|1078573|P1|Treatment Period|Withdrawal by Subject|0
319050|NCT01390441|1078569|P5|Treatment Period|Adverse Event|2
319051|NCT01390441|1078570|P4|Treatment Period|Adverse Event|1
319052|NCT01390441|1078571|P3|Treatment Period|Adverse Event|1
319053|NCT01390441|1078572|P2|Treatment Period|Adverse Event|0
319054|NCT01390441|1078573|P1|Treatment Period|Adverse Event|0
319055|NCT01390441|1078569|P5|Treatment Period|Unknown due to early stopping of study|7
319056|NCT01390441|1078570|P4|Treatment Period|Unknown due to early stopping of study|11
319057|NCT01390441|1078571|P3|Treatment Period|Unknown due to early stopping of study|8
319058|NCT01390441|1078572|P2|Treatment Period|Unknown due to early stopping of study|0
319059|NCT01390441|1078573|P1|Treatment Period|Unknown due to early stopping of study|0
319060|NCT01390441|1078569|P5|Treatment Period|Lack of Efficacy|1
319061|NCT01390441|1078570|P4|Treatment Period|Lack of Efficacy|0
319062|NCT01390441|1078571|P3|Treatment Period|Lack of Efficacy|0
319063|NCT01390441|1078572|P2|Treatment Period|Lack of Efficacy|0
319064|NCT01390441|1078573|P1|Treatment Period|Lack of Efficacy|0
319065|NCT01390441|1078569|P5|Treatment Period|Physician Decision|0
319066|NCT01390441|1078570|P4|Treatment Period|Physician Decision|1
319067|NCT01390441|1078571|P3|Treatment Period|Physician Decision|0
319068|NCT01390441|1078572|P2|Treatment Period|Physician Decision|0
319069|NCT01390441|1078573|P1|Treatment Period|Physician Decision|0
319070|NCT01390441|1078569|P5|Treatment Period|Protocol Violation|0
319071|NCT01390441|1078570|P4|Treatment Period|Protocol Violation|0
319072|NCT01390441|1078571|P3|Treatment Period|Protocol Violation|0
319073|NCT01390441|1078572|P2|Treatment Period|Protocol Violation|1
319074|NCT01390441|1078573|P1|Treatment Period|Protocol Violation|0
319075|NCT01390428|1078638|P6|Overall Study|Withdrawal by Subject|0
319076|NCT01390428|1078639|P5|Overall Study|Withdrawal by Subject|0
319077|NCT01390428|1078640|P4|Overall Study|Withdrawal by Subject|0
319078|NCT01390428|1078641|P3|Overall Study|Withdrawal by Subject|1
319079|NCT01390428|1078642|P2|Overall Study|Withdrawal by Subject|0
319080|NCT01390428|1078643|P1|Overall Study|Withdrawal by Subject|0
319081|NCT01390428|1078638|P6|Overall Study|Elective Surgery|0
319082|NCT01390428|1078639|P5|Overall Study|Elective Surgery|1
319083|NCT01390428|1078640|P4|Overall Study|Elective Surgery|0
319084|NCT01390428|1078641|P3|Overall Study|Elective Surgery|0
319085|NCT01390428|1078642|P2|Overall Study|Elective Surgery|0
319086|NCT01390428|1078643|P1|Overall Study|Elective Surgery|0
319087|NCT01390402|1078706|P1|Overall Study|Disease Progression|4
319088|NCT01390402|1078706|P1|Overall Study|Death|1
319089|NCT01390389|1078712|P2|Overall Study|Screen Fail|1
319090|NCT01390389|1078713|P1|Overall Study|Screen Fail|2
319091|NCT01390389|1078712|P2|Overall Study|Withdrawal by Subject|0
319092|NCT01390389|1078713|P1|Overall Study|Withdrawal by Subject|2
319093|NCT01390181|1078761|P1|Overall Study|Study Terminated due to Low Accrual|3
319094|NCT01390181|1078761|P1|Overall Study|Lost to Follow-up|1
319095|NCT01390038|1078765|P1|Overall Study|Simpliciti System Removal|2
319096|NCT01390038|1078765|P1|Overall Study|Withdrawal by Subject|4
319097|NCT01390038|1078765|P1|Overall Study|Lost to Follow-up|1
319098|NCT01390038|1078765|P1|Overall Study|Death|1
319099|NCT01389973|1078775|P1|Overall Study|Other|10
319100|NCT01389973|1078775|P1|Overall Study|Trial Stopped by Sponsor|9
319101|NCT01389973|1078775|P1|Overall Study|Lost to Follow-up|1
319102|NCT01389882|1078785|P2|Overall Study|Withdrawal by Subject|1
319103|NCT01389882|1078786|P1|Overall Study|Withdrawal by Subject|0
319104|NCT01389882|1078785|P2|Overall Study|Respiratory rate > 80/min during study|3
319105|NCT01389882|1078786|P1|Overall Study|Respiratory rate > 80/min during study|1
319106|NCT01389817|1078874|P2|Overall Study|Withdrawal by Subject|0
319107|NCT01389817|1078875|P1|Overall Study|Withdrawal by Subject|2
319108|NCT01389817|1078874|P2|Overall Study|Lost to Follow-up|0
319109|NCT01389817|1078875|P1|Overall Study|Lost to Follow-up|1
319110|NCT01389817|1078874|P2|Overall Study|Physician Decision|0
319111|NCT01389817|1078875|P1|Overall Study|Physician Decision|1
319112|NCT01389596|1078884|P3|Overall Study|Other Unspecified|0
319113|NCT01389596|1078885|P2|Overall Study|Other Unspecified|1
319114|NCT01389596|1078886|P1|Overall Study|Other Unspecified|2
319115|NCT01389596|1078884|P3|Overall Study|Death|0
319116|NCT01389596|1078885|P2|Overall Study|Death|1
319117|NCT01389596|1078886|P1|Overall Study|Death|0
319118|NCT01389596|1078884|P3|Overall Study|Adverse Event|0
319119|NCT01389596|1078885|P2|Overall Study|Adverse Event|4
319120|NCT01389596|1078886|P1|Overall Study|Adverse Event|1
319121|NCT01389596|1078884|P3|Overall Study|Insufficient Clinical Response|5
319122|NCT01389596|1078885|P2|Overall Study|Insufficient Clinical Response|4
319123|NCT01389596|1078886|P1|Overall Study|Insufficient Clinical Response|3
319124|NCT01389596|1078884|P3|Overall Study|Withdrawal by Subject|2
319125|NCT01389596|1078885|P2|Overall Study|Withdrawal by Subject|2
319126|NCT01389596|1078886|P1|Overall Study|Withdrawal by Subject|1
319127|NCT01389596|1078884|P3|Overall Study|Protocol Violation|3
319128|NCT01389596|1078885|P2|Overall Study|Protocol Violation|4
319129|NCT01389596|1078886|P1|Overall Study|Protocol Violation|3
319130|NCT01389323|1078945|P1|Follow-up Period (up to 48 Weeks)|Other|3
319131|NCT01389323|1078945|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
319132|NCT01389323|1078945|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
319133|NCT01389323|1078945|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
319134|NCT01389323|1078945|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
319135|NCT01389323|1078945|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
319136|NCT01389323|1078945|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
319137|NCT01389323|1078945|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
319138|NCT01389323|1078945|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
319139|NCT01389323|1078945|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
319140|NCT01389323|1078945|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
319141|NCT01389102|1079008|P6|Overall Study|Investigator Judgement|0
319142|NCT01389102|1079009|P5|Overall Study|Investigator Judgement|0
319143|NCT01389102|1079010|P4|Overall Study|Investigator Judgement|0
319144|NCT01389102|1079011|P3|Overall Study|Investigator Judgement|0
319145|NCT01389102|1079012|P2|Overall Study|Investigator Judgement|1
319146|NCT01389102|1079013|P1|Overall Study|Investigator Judgement|0
319147|NCT01389102|1079008|P6|Overall Study|Unavailable due to husband's illness|0
319148|NCT01389102|1079009|P5|Overall Study|Unavailable due to husband's illness|0
319149|NCT01389102|1079010|P4|Overall Study|Unavailable due to husband's illness|0
319150|NCT01389102|1079011|P3|Overall Study|Unavailable due to husband's illness|0
319151|NCT01389102|1079012|P2|Overall Study|Unavailable due to husband's illness|1
319152|NCT01389102|1079013|P1|Overall Study|Unavailable due to husband's illness|0
319153|NCT01389102|1079008|P6|Overall Study|Subject Moved|0
319154|NCT01389102|1079009|P5|Overall Study|Subject Moved|0
319155|NCT01389102|1079010|P4|Overall Study|Subject Moved|0
319156|NCT01389102|1079011|P3|Overall Study|Subject Moved|1
319157|NCT01389102|1079012|P2|Overall Study|Subject Moved|0
319158|NCT01389102|1079013|P1|Overall Study|Subject Moved|2
319159|NCT01389102|1079008|P6|Overall Study|Subject Traveling Out of Country|0
319160|NCT01389102|1079009|P5|Overall Study|Subject Traveling Out of Country|0
319161|NCT01389102|1079010|P4|Overall Study|Subject Traveling Out of Country|1
319162|NCT01389102|1079011|P3|Overall Study|Subject Traveling Out of Country|0
319163|NCT01389102|1079012|P2|Overall Study|Subject Traveling Out of Country|0
319164|NCT01389102|1079013|P1|Overall Study|Subject Traveling Out of Country|0
319165|NCT01389102|1079008|P6|Overall Study|Withdrawal by Subject|3
319166|NCT01389102|1079009|P5|Overall Study|Withdrawal by Subject|3
319167|NCT01389102|1079010|P4|Overall Study|Withdrawal by Subject|2
319168|NCT01389102|1079011|P3|Overall Study|Withdrawal by Subject|9
319169|NCT01389102|1079012|P2|Overall Study|Withdrawal by Subject|4
319170|NCT01389102|1079013|P1|Overall Study|Withdrawal by Subject|7
319171|NCT01389102|1079008|P6|Overall Study|Protocol Violation|1
319172|NCT01389102|1079009|P5|Overall Study|Protocol Violation|1
319173|NCT01389102|1079010|P4|Overall Study|Protocol Violation|0
319174|NCT01389102|1079011|P3|Overall Study|Protocol Violation|3
319175|NCT01389102|1079012|P2|Overall Study|Protocol Violation|0
319176|NCT01389102|1079013|P1|Overall Study|Protocol Violation|0
319177|NCT01389102|1079008|P6|Overall Study|Lost to Follow-up|1
319178|NCT01389102|1079009|P5|Overall Study|Lost to Follow-up|4
319179|NCT01389102|1079010|P4|Overall Study|Lost to Follow-up|2
319180|NCT01389102|1079011|P3|Overall Study|Lost to Follow-up|1
319181|NCT01389102|1079012|P2|Overall Study|Lost to Follow-up|1
319182|NCT01389102|1079013|P1|Overall Study|Lost to Follow-up|4
319183|NCT01389102|1079008|P6|Overall Study|Hurricane Katrina|1
319184|NCT01389102|1079009|P5|Overall Study|Hurricane Katrina|3
319185|NCT01389102|1079010|P4|Overall Study|Hurricane Katrina|0
319186|NCT01389102|1079011|P3|Overall Study|Hurricane Katrina|3
319187|NCT01389102|1079012|P2|Overall Study|Hurricane Katrina|2
319188|NCT01389102|1079013|P1|Overall Study|Hurricane Katrina|4
319189|NCT01389102|1079008|P6|Overall Study|Adverse Event|2
319190|NCT01389102|1079009|P5|Overall Study|Adverse Event|2
319191|NCT01389102|1079010|P4|Overall Study|Adverse Event|2
319192|NCT01389102|1079011|P3|Overall Study|Adverse Event|2
319193|NCT01389102|1079012|P2|Overall Study|Adverse Event|3
319194|NCT01389102|1079013|P1|Overall Study|Adverse Event|1
319195|NCT01388907|1079091|P2|Overall Study|Adverse Event|0
319196|NCT01388907|1079092|P1|Overall Study|Adverse Event|2
319197|NCT01388816|1079108|P4|Overall Study|Protocol Violation|0
319198|NCT01388816|1079109|P3|Overall Study|Protocol Violation|2
319199|NCT01388816|1079110|P2|Overall Study|Protocol Violation|0
319200|NCT01388816|1079111|P1|Overall Study|Protocol Violation|0
319201|NCT01388816|1079108|P4|Overall Study|Withdrawal by Subject|0
319202|NCT01388816|1079109|P3|Overall Study|Withdrawal by Subject|1
319203|NCT01388816|1079110|P2|Overall Study|Withdrawal by Subject|1
319204|NCT01388816|1079111|P1|Overall Study|Withdrawal by Subject|2
319205|NCT01388816|1079108|P4|Overall Study|Lost to Follow-up|0
319206|NCT01388816|1079109|P3|Overall Study|Lost to Follow-up|0
319207|NCT01388816|1079110|P2|Overall Study|Lost to Follow-up|1
319208|NCT01388816|1079111|P1|Overall Study|Lost to Follow-up|0
319209|NCT01388816|1079108|P4|Overall Study|Adverse Event|0
319210|NCT01388816|1079109|P3|Overall Study|Adverse Event|0
319211|NCT01388816|1079110|P2|Overall Study|Adverse Event|2
319212|NCT01388816|1079111|P1|Overall Study|Adverse Event|0
319213|NCT01388790|1079140|P1|Overall Study|Ongoing at data cut−off date|8
319214|NCT01388647|1079147|P2|Overall Study|Adverse Event|2
319215|NCT01388647|1079148|P1|Overall Study|Adverse Event|1
319216|NCT01388530|1079159|P1|Overall Study|Lost to Follow-up|5
319217|NCT01388491|1079168|P2|Overall Study|Pregnancy|0
319218|NCT01388491|1079169|P1|Overall Study|Pregnancy|1
319219|NCT01388491|1079168|P2|Overall Study|Noncompliance|0
319220|NCT01388491|1079169|P1|Overall Study|Noncompliance|2
319221|NCT01388491|1079168|P2|Overall Study|Protocol Violation|0
319222|NCT01388491|1079169|P1|Overall Study|Protocol Violation|2
319223|NCT01388491|1079168|P2|Overall Study|Lost to Follow-up|3
319224|NCT01388491|1079169|P1|Overall Study|Lost to Follow-up|4
319225|NCT01388491|1079168|P2|Overall Study|Withdrawal by Subject|10
319226|NCT01388491|1079169|P1|Overall Study|Withdrawal by Subject|6
319227|NCT01388491|1079168|P2|Overall Study|Sponsor Request|7
319228|NCT01388491|1079169|P1|Overall Study|Sponsor Request|9
319229|NCT01388491|1079168|P2|Overall Study|Adverse Event|9
319230|NCT01388491|1079169|P1|Overall Study|Adverse Event|10
319231|NCT01388361|1079204|P3|Overall Study|Unclassified|1
319232|NCT01388361|1079205|P2|Overall Study|Unclassified|0
319233|NCT01388361|1079206|P1|Overall Study|Unclassified|0
319234|NCT01388361|1079204|P3|Overall Study|Withdrawal criteria|10
319235|NCT01388361|1079205|P2|Overall Study|Withdrawal criteria|7
319236|NCT01388361|1079206|P1|Overall Study|Withdrawal criteria|12
319237|NCT01388361|1079204|P3|Overall Study|Protocol Violation|2
319238|NCT01388361|1079205|P2|Overall Study|Protocol Violation|0
319239|NCT01388361|1079206|P1|Overall Study|Protocol Violation|0
319240|NCT01388361|1079204|P3|Overall Study|Adverse Event|1
319241|NCT01388361|1079205|P2|Overall Study|Adverse Event|5
319242|NCT01388361|1079206|P1|Overall Study|Adverse Event|0
319243|NCT01388166|1079223|P1|Overall Study|Others than specified above|13
319244|NCT01388166|1079223|P1|Overall Study|Lost to Follow-up|30
319245|NCT01388166|1079223|P1|Overall Study|Adverse Event|16
319246|NCT01387789|1079229|P1|Overall Study|Lost to Follow-up|1
319247|NCT01387789|1079229|P1|Overall Study|Lack of Efficacy|2
319248|NCT01387789|1079229|P1|Overall Study|Adverse Event|5
319249|NCT01387737|1079243|P2|Overall Study|Clearly not eligible for the study|3
319250|NCT01387737|1079244|P1|Overall Study|Clearly not eligible for the study|1
319251|NCT01387737|1079243|P2|Overall Study|Withdrawal by Subject|31
319252|NCT01387737|1079244|P1|Overall Study|Withdrawal by Subject|27
319253|NCT01387737|1079243|P2|Overall Study|Physician Decision|10
319254|NCT01387737|1079244|P1|Overall Study|Physician Decision|3
319255|NCT01387737|1079243|P2|Overall Study|Lack of Efficacy|0
319256|NCT01387737|1079244|P1|Overall Study|Lack of Efficacy|1
319257|NCT01387737|1079243|P2|Overall Study|Adverse Event|30
319258|NCT01387737|1079244|P1|Overall Study|Adverse Event|20
319259|NCT01387594|1079278|P2|Overall Study|Lost to Follow-up|1
319260|NCT01387594|1079279|P1|Overall Study|Lost to Follow-up|0
319261|NCT01387594|1079278|P2|Overall Study|Withdrawal by Subject|2
319262|NCT01387594|1079279|P1|Overall Study|Withdrawal by Subject|0
319263|NCT01387542|1079307|P1|Overall Study|Lost to Follow-up|1
319264|NCT01387542|1079307|P1|Overall Study|Non-compliant|1
319265|NCT01387542|1079307|P1|Overall Study|Insufficient response|1
319266|NCT01387542|1079307|P1|Overall Study|Changed diagnosis|1
319267|NCT01387542|1079307|P1|Overall Study|Withdrawal by Subject|1
319268|NCT01387542|1079307|P1|Overall Study|Adverse Event|3
319269|NCT01387347|1079325|P2|Overall Study|Lost to Follow-up|1
319270|NCT01387347|1079326|P1|Overall Study|Lost to Follow-up|2
319271|NCT01387282|1079338|P2|Overall Study|Lost to Follow-up|1
319272|NCT01387282|1079339|P1|Overall Study|Lost to Follow-up|4
319273|NCT01387282|1079338|P2|Overall Study|Study drug-related AE|2
319274|NCT01387282|1079339|P1|Overall Study|Study drug-related AE|2
319275|NCT01387282|1079338|P2|Overall Study|Withdrawal by patient|23
319276|NCT01387282|1079339|P1|Overall Study|Withdrawal by patient|33
319277|NCT01387282|1079338|P2|Overall Study|Unrelated AE|4
319278|NCT01387282|1079339|P1|Overall Study|Unrelated AE|6
319279|NCT01387282|1079338|P2|Overall Study|Other|1
319280|NCT01387282|1079339|P1|Overall Study|Other|5
319281|NCT01387282|1079338|P2|Overall Study|Death|16
319282|NCT01387282|1079339|P1|Overall Study|Death|47
319283|NCT01387269|1079355|P2|Overall Study|Lost to Follow-up|0
319284|NCT01387269|1079356|P1|Overall Study|Lost to Follow-up|1
319285|NCT01387269|1079355|P2|Overall Study|Study drug-related AE|0
319286|NCT01387269|1079356|P1|Overall Study|Study drug-related AE|1
319287|NCT01387269|1079355|P2|Overall Study|Withdrawal by patient|10
319288|NCT01387269|1079356|P1|Overall Study|Withdrawal by patient|32
319289|NCT01387269|1079355|P2|Overall Study|Unrelated AE|3
319290|NCT01387269|1079356|P1|Overall Study|Unrelated AE|12
319291|NCT01387269|1079355|P2|Overall Study|Other|7
319292|NCT01387269|1079356|P1|Overall Study|Other|8
319293|NCT01387269|1079355|P2|Overall Study|Death|20
319294|NCT01387269|1079356|P1|Overall Study|Death|38
319295|NCT01387230|1079373|P3|Overall Study|Withdrawal by Subject|0
319296|NCT01387230|1079374|P2|Overall Study|Withdrawal by Subject|1
319297|NCT01387230|1079375|P1|Overall Study|Withdrawal by Subject|4
319298|NCT01387230|1079373|P3|Overall Study|Lost to Follow-up|1
319299|NCT01387230|1079374|P2|Overall Study|Lost to Follow-up|0
319300|NCT01387230|1079375|P1|Overall Study|Lost to Follow-up|0
319301|NCT01387230|1079373|P3|Overall Study|Protocol-defined Stopping Criteria|5
319302|NCT01387230|1079374|P2|Overall Study|Protocol-defined Stopping Criteria|0
319303|NCT01387230|1079375|P1|Overall Study|Protocol-defined Stopping Criteria|6
319304|NCT01387230|1079373|P3|Overall Study|Lack of Efficacy|4
319305|NCT01387230|1079374|P2|Overall Study|Lack of Efficacy|5
319306|NCT01387230|1079375|P1|Overall Study|Lack of Efficacy|8
319307|NCT01387230|1079373|P3|Overall Study|Adverse Event|3
319308|NCT01387230|1079374|P2|Overall Study|Adverse Event|1
319309|NCT01387230|1079375|P1|Overall Study|Adverse Event|0
319310|NCT01387074|1079421|P1|Overall Study|Lack of Efficacy|1
319311|NCT01387074|1079421|P1|Overall Study|Lost to Follow-up|7
319312|NCT01387022|1079434|P2|Overall Study|Lost to Follow-up|3
319313|NCT01387022|1079435|P1|Overall Study|Lost to Follow-up|0
319314|NCT01387022|1079434|P2|Overall Study|Death|1
319315|NCT01387022|1079435|P1|Overall Study|Death|1
319316|NCT01386944|1079462|P1|Overall Study|Unspecified reason|8
319317|NCT01386944|1079462|P1|Overall Study|Lost to Follow-up|8
319318|NCT01386944|1079462|P1|Overall Study|Lack of Efficacy|14
319319|NCT01386944|1079462|P1|Overall Study|Adverse Event|26
319320|NCT01386788|1079472|P1|Overall Study|Lost to Follow-up|2
319321|NCT01386684|1079477|P1|Overall Study|Missing|3
319322|NCT01386684|1079477|P1|Overall Study|Protocol Violation|4
319323|NCT01386684|1079477|P1|Overall Study|Noncompliance|8
319324|NCT01386684|1079477|P1|Overall Study|Adverse Event|20
319325|NCT01386684|1079477|P1|Overall Study|Disease Progression|28
319326|NCT01386684|1079477|P1|Overall Study|Alternative Therapy Required|37
319327|NCT01386684|1079477|P1|Overall Study|Withdrawal of Consent|44
319328|NCT01386684|1079477|P1|Overall Study|Death|47
319329|NCT01386684|1079477|P1|Overall Study|Not Specified|51
319330|NCT01386684|1079477|P1|Overall Study|Lost to Follow-up|51
319331|NCT01386606|1079531|P4|Overall Study|T levels too high|0
319332|NCT01386606|1079532|P3|Overall Study|T levels too high|1
319333|NCT01386606|1079533|P2|Overall Study|T levels too high|1
319334|NCT01386606|1079534|P1|Overall Study|T levels too high|0
319335|NCT01386606|1079531|P4|Overall Study|Unable to draw PK|0
319336|NCT01386606|1079532|P3|Overall Study|Unable to draw PK|0
319337|NCT01386606|1079533|P2|Overall Study|Unable to draw PK|0
319338|NCT01386606|1079534|P1|Overall Study|Unable to draw PK|1
319339|NCT01386606|1079531|P4|Overall Study|Subject incarcerated|0
319340|NCT01386606|1079532|P3|Overall Study|Subject incarcerated|0
319341|NCT01386606|1079533|P2|Overall Study|Subject incarcerated|1
319342|NCT01386606|1079534|P1|Overall Study|Subject incarcerated|0
319343|NCT01386606|1079531|P4|Overall Study|Lost to Follow-up|0
319344|NCT01386606|1079532|P3|Overall Study|Lost to Follow-up|0
319345|NCT01386606|1079533|P2|Overall Study|Lost to Follow-up|0
319346|NCT01386606|1079534|P1|Overall Study|Lost to Follow-up|2
319347|NCT01386606|1079531|P4|Overall Study|Protocol Violation|1
319348|NCT01386606|1079532|P3|Overall Study|Protocol Violation|1
319349|NCT01386606|1079533|P2|Overall Study|Protocol Violation|0
319350|NCT01386606|1079534|P1|Overall Study|Protocol Violation|1
319351|NCT01386606|1079531|P4|Overall Study|Withdrawal by Subject|0
319352|NCT01386606|1079532|P3|Overall Study|Withdrawal by Subject|1
319353|NCT01386606|1079533|P2|Overall Study|Withdrawal by Subject|1
319354|NCT01386606|1079534|P1|Overall Study|Withdrawal by Subject|0
319355|NCT01386606|1079531|P4|Overall Study|Adverse Event|0
319356|NCT01386606|1079532|P3|Overall Study|Adverse Event|0
319357|NCT01386606|1079533|P2|Overall Study|Adverse Event|1
319358|NCT01386606|1079534|P1|Overall Study|Adverse Event|0
319359|NCT01386125|1079593|P2|Overall Study|Participant Leaving Country|0
319360|NCT01386125|1079594|P1|Overall Study|Participant Leaving Country|1
319361|NCT01386125|1079593|P2|Overall Study|Lack of Efficacy|1
319362|NCT01386125|1079594|P1|Overall Study|Lack of Efficacy|0
319363|NCT01386125|1079593|P2|Overall Study|Adverse Event|5
319364|NCT01386125|1079594|P1|Overall Study|Adverse Event|2
319365|NCT01386125|1079593|P2|Overall Study|Withdrawal by Subject|12
319366|NCT01386125|1079594|P1|Overall Study|Withdrawal by Subject|13
319367|NCT01386125|1079593|P2|Overall Study|Disease Progress|2
319368|NCT01386125|1079594|P1|Overall Study|Disease Progress|1
319369|NCT01386125|1079593|P2|Overall Study|Protocol Violation|7
319370|NCT01386125|1079594|P1|Overall Study|Protocol Violation|5
319371|NCT01386125|1079593|P2|Overall Study|Physician Decision|1
319372|NCT01386125|1079594|P1|Overall Study|Physician Decision|0
319373|NCT01386125|1079593|P2|Overall Study|Lost to Follow-up|9
319374|NCT01386125|1079594|P1|Overall Study|Lost to Follow-up|3
319375|NCT01386008|1079602|P1|Overall Study|Adverse Event|3
319376|NCT01386008|1079602|P1|Overall Study|exited w/o incident /study discontinued|17
319377|NCT01385995|1079611|P2|Period 1, 2 Months|Physician Decision|0
319378|NCT01385995|1079612|P1|Period 1, 2 Months|Physician Decision|1
319379|NCT01385748|1079629|P3|Overall Study|Adverse Event|1
319380|NCT01385748|1079630|P2|Overall Study|Adverse Event|2
319381|NCT01385748|1079631|P1|Overall Study|Adverse Event|4
319382|NCT01385748|1079629|P3|Overall Study|Not specified|1
319383|NCT01385748|1079630|P2|Overall Study|Not specified|7
319384|NCT01385748|1079631|P1|Overall Study|Not specified|1
319385|NCT01385748|1079629|P3|Overall Study|Noncompliance|6
319386|NCT01385748|1079630|P2|Overall Study|Noncompliance|1
319387|NCT01385748|1079631|P1|Overall Study|Noncompliance|3
319388|NCT01385748|1079629|P3|Overall Study|Withdrawal by Subject|5
319389|NCT01385748|1079630|P2|Overall Study|Withdrawal by Subject|4
319390|NCT01385748|1079631|P1|Overall Study|Withdrawal by Subject|7
319391|NCT01385566|1079716|P6|Overall Study|Withdrawal by Subject|0
319392|NCT01385566|1079717|P5|Overall Study|Withdrawal by Subject|0
319393|NCT01385566|1079718|P4|Overall Study|Withdrawal by Subject|1
319394|NCT01385566|1079719|P3|Overall Study|Withdrawal by Subject|0
319395|NCT01385566|1079720|P2|Overall Study|Withdrawal by Subject|0
319396|NCT01385566|1079721|P1|Overall Study|Withdrawal by Subject|0
319397|NCT01385566|1079716|P6|Overall Study|Lost to Follow-up|0
319398|NCT01385566|1079717|P5|Overall Study|Lost to Follow-up|0
319399|NCT01385566|1079718|P4|Overall Study|Lost to Follow-up|0
319400|NCT01385566|1079719|P3|Overall Study|Lost to Follow-up|0
319401|NCT01385566|1079720|P2|Overall Study|Lost to Follow-up|0
319402|NCT01385566|1079721|P1|Overall Study|Lost to Follow-up|1
319403|NCT01385371|1079775|P2|Overall Study|Administrative|2
319404|NCT01385371|1079776|P1|Overall Study|Administrative|2
319405|NCT01385371|1079775|P2|Overall Study|Protocol Violation|21
319406|NCT01385371|1079776|P1|Overall Study|Protocol Violation|25
319407|NCT01385371|1079775|P2|Overall Study|Withdrawal by Subject|39
319408|NCT01385371|1079776|P1|Overall Study|Withdrawal by Subject|52
319409|NCT01385371|1079775|P2|Overall Study|Lost to Follow-up|16
319410|NCT01385371|1079776|P1|Overall Study|Lost to Follow-up|16
319411|NCT01385371|1079775|P2|Overall Study|Adverse Event|19
319412|NCT01385371|1079776|P1|Overall Study|Adverse Event|54
319413|NCT01385202|1079806|P1|Overall Study|Withdrawn|1
319414|NCT01385202|1079806|P1|Overall Study|Not Eligible|11
319415|NCT01385202|1079806|P1|Overall Study|Lost to Follow-up|6
319416|NCT01385098|1079858|P1|Overall Study|Lost to Follow-up|4
319417|NCT01385098|1079858|P1|Overall Study|Adverse Event|10
319418|NCT01384760|1079880|P2|Overall Study|Protocol Violation|0
319419|NCT01384760|1079881|P1|Overall Study|Protocol Violation|16
319420|NCT01384760|1079880|P2|Overall Study|Lost to Follow-up|6
319421|NCT01384760|1079881|P1|Overall Study|Lost to Follow-up|0
319422|NCT01384292|1080034|P3|Part B|Severe non-compliance to protocol|0
319423|NCT01384292|1080035|P2|Part B|Severe non-compliance to protocol|0
319424|NCT01384292|1080036|P1|Part B|Severe non-compliance to protocol|1
319425|NCT01384019|1080048|P2|Overall Study|MRI refusal|6
319426|NCT01384019|1080049|P1|Overall Study|MRI refusal|6
319427|NCT01384019|1080048|P2|Overall Study|Death|0
319428|NCT01384019|1080049|P1|Overall Study|Death|1
319429|NCT01384019|1080048|P2|Overall Study|Withdrawal by Subject|0
319430|NCT01384019|1080049|P1|Overall Study|Withdrawal by Subject|3
319431|NCT01383993|1080058|P3|Overall Study|Marketed voriconazole in post-therapy|0
319432|NCT01383993|1080059|P2|Overall Study|Marketed voriconazole in post-therapy|0
319433|NCT01383993|1080060|P1|Overall Study|Marketed voriconazole in post-therapy|2
319434|NCT01383993|1080058|P3|Overall Study|Withdrawal by Subject|1
319435|NCT01383993|1080059|P2|Overall Study|Withdrawal by Subject|0
319436|NCT01383993|1080060|P1|Overall Study|Withdrawal by Subject|0
319437|NCT01383993|1080058|P3|Overall Study|Adverse Event|0
319438|NCT01383993|1080059|P2|Overall Study|Adverse Event|1
319439|NCT01383993|1080060|P1|Overall Study|Adverse Event|1
319440|NCT01383954|1080107|P1|Overall Study|Reason Not Specified|9
319441|NCT01383954|1080107|P1|Overall Study|Adverse Event|1
319442|NCT01383954|1080107|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
319443|NCT01383954|1080107|P1|Overall Study|Lack of Efficacy|2
319444|NCT01383928|1080115|P3|Phase 2|Unsatisfactory therapeutic response|1
319445|NCT01383928|1080116|P2|Phase 2|Unsatisfactory therapeutic response|0
319446|NCT01383928|1080117|P1|Phase 2|Unsatisfactory therapeutic response|0
319447|NCT01383928|1080115|P3|Phase 2|Withdrawal by Subject|4
319448|NCT01383928|1080116|P2|Phase 2|Withdrawal by Subject|0
319449|NCT01383928|1080117|P1|Phase 2|Withdrawal by Subject|0
319450|NCT01383928|1080115|P3|Phase 2|Progressive Disease|5
319451|NCT01383928|1080116|P2|Phase 2|Progressive Disease|0
319452|NCT01383928|1080117|P1|Phase 2|Progressive Disease|0
319453|NCT01383928|1080115|P3|Phase 2|Other|4
319454|NCT01383928|1080116|P2|Phase 2|Other|0
319455|NCT01383928|1080117|P1|Phase 2|Other|0
319456|NCT01383928|1080115|P3|Phase 2|Adverse Event|8
319457|NCT01383928|1080116|P2|Phase 2|Adverse Event|0
319458|NCT01383928|1080117|P1|Phase 2|Adverse Event|0
319459|NCT01383928|1080115|P3|Phase 2|Autologous Stem Cell Transplantation|18
319460|NCT01383928|1080116|P2|Phase 2|Autologous Stem Cell Transplantation|0
319461|NCT01383928|1080117|P1|Phase 2|Autologous Stem Cell Transplantation|0
319462|NCT01383928|1080115|P3|Phase 1|Progressive Disease|0
319463|NCT01383928|1080116|P2|Phase 1|Progressive Disease|1
319464|NCT01383928|1080117|P1|Phase 1|Progressive Disease|1
319465|NCT01383928|1080115|P3|Phase 1|Other|0
319466|NCT01383928|1080116|P2|Phase 1|Other|3
319467|NCT01383928|1080117|P1|Phase 1|Other|1
319468|NCT01383928|1080115|P3|Phase 1|Adverse Event|0
319469|NCT01383928|1080116|P2|Phase 1|Adverse Event|2
319470|NCT01383928|1080117|P1|Phase 1|Adverse Event|1
319471|NCT01383928|1080115|P3|Phase 1|Autologous Stem Cell Transplantation|0
319472|NCT01383928|1080116|P2|Phase 1|Autologous Stem Cell Transplantation|1
319473|NCT01383928|1080117|P1|Phase 1|Autologous Stem Cell Transplantation|2
319474|NCT01383707|1080181|P1|Overall Study|Progressive disease|23
319475|NCT01383707|1080181|P1|Overall Study|Adverse Event|14
319476|NCT01383707|1080181|P1|Overall Study|Sponsor's decision|2
319477|NCT01383707|1080181|P1|Overall Study|Not specified|8
319478|NCT01383707|1080181|P1|Overall Study|Death|19
319479|NCT01383707|1080181|P1|Overall Study|Consent withdrawal|6
319480|NCT01383499|1080221|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
319481|NCT01383499|1080222|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
319482|NCT01383499|1080223|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
319483|NCT01383499|1080224|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
319484|NCT01383486|1080274|P1|Overall Study|Did not take any product|6
319485|NCT01383486|1080274|P1|Overall Study|Incomplete information for analysis|2
319486|NCT01383486|1080274|P1|Overall Study|Lost to Follow-up|10
319487|NCT01383356|1080351|P2|Period 1|Personal|2
319488|NCT01383356|1080352|P1|Period 1|Personal|0
319489|NCT01383356|1080351|P2|Period 1|Out of Range Mid-study-Test|1
319490|NCT01383356|1080352|P1|Period 1|Out of Range Mid-study-Test|0
319491|NCT01383356|1080351|P2|Period 1|Non-compliance|0
319492|NCT01383356|1080352|P1|Period 1|Non-compliance|3
319493|NCT01383356|1080351|P2|Period 1|Adverse Event|3
319494|NCT01383356|1080352|P1|Period 1|Adverse Event|5
319495|NCT01383317|1080364|P2|Overall Study|Adverse Event|1
319496|NCT01383317|1080365|P1|Overall Study|Adverse Event|0
319497|NCT01383317|1080364|P2|Overall Study|Death|0
319498|NCT01383317|1080365|P1|Overall Study|Death|1
319499|NCT01383317|1080364|P2|Overall Study|Lost to Follow-up|1
319500|NCT01383317|1080365|P1|Overall Study|Lost to Follow-up|2
319501|NCT01383174|1080407|P2|6 Month Assessment|Refused to complete|0
319502|NCT01383174|1080408|P1|6 Month Assessment|Refused to complete|4
319503|NCT01383174|1080407|P2|6 Month Assessment|Lost to Follow-up|1
319504|NCT01383174|1080408|P1|6 Month Assessment|Lost to Follow-up|1
319505|NCT01383174|1080407|P2|3 Month Assessment|Refused to complete|0
319506|NCT01383174|1080408|P1|3 Month Assessment|Refused to complete|4
319507|NCT01383174|1080407|P2|3 Month Assessment|Lost to Follow-up|0
319508|NCT01383174|1080408|P1|3 Month Assessment|Lost to Follow-up|2
319509|NCT01383174|1080407|P2|3 Month Assessment|Death|1
319510|NCT01383174|1080408|P1|3 Month Assessment|Death|0
319511|NCT01383161|1080434|P2|Overall Study|Lack of Efficacy|1
319512|NCT01383161|1080435|P1|Overall Study|Lack of Efficacy|0
319513|NCT01383161|1080434|P2|Overall Study|Withdrawal by Subject|2
319514|NCT01383161|1080435|P1|Overall Study|Withdrawal by Subject|0
319515|NCT01383161|1080434|P2|Overall Study|Adverse Event|1
319516|NCT01383161|1080435|P1|Overall Study|Adverse Event|5
319517|NCT01383096|1080454|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
319518|NCT01383096|1080455|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
319519|NCT01383096|1080456|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
319520|NCT01383096|1080454|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
319521|NCT01383096|1080455|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
319522|NCT01383096|1080456|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
319523|NCT01383096|1080454|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
319524|NCT01383096|1080455|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
319525|NCT01383096|1080456|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
319526|NCT01383096|1080454|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
319527|NCT01383096|1080455|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
319528|NCT01383096|1080456|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
319529|NCT01383096|1080454|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
319530|NCT01383096|1080455|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
319531|NCT01383096|1080456|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
319532|NCT01383096|1080454|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
319533|NCT01383096|1080455|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
319534|NCT01383096|1080456|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
319535|NCT01383096|1080454|P3|Third Intervention (8 Days)|Adverse Event|0
319536|NCT01383096|1080455|P2|Third Intervention (8 Days)|Adverse Event|0
319537|NCT01383096|1080456|P1|Third Intervention (8 Days)|Adverse Event|1
319538|NCT01383096|1080454|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
319539|NCT01383096|1080455|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
319540|NCT01383096|1080456|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
319541|NCT01383096|1080454|P3|Third Intervention (8 Days)|Elevated AST|0
319542|NCT01383096|1080455|P2|Third Intervention (8 Days)|Elevated AST|1
319543|NCT01383096|1080456|P1|Third Intervention (8 Days)|Elevated AST|0
319544|NCT01383096|1080454|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
319545|NCT01383096|1080455|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
319546|NCT01383096|1080456|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
319547|NCT01383096|1080454|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
319548|NCT01383096|1080455|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
319549|NCT01383096|1080456|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
319550|NCT01382940|1080524|P1|Overall Study|Protocol Violation|20
319551|NCT01382940|1080524|P1|Overall Study|Withdrawal by Subject|23
319552|NCT01382940|1080524|P1|Overall Study|Physician Decision|7
319553|NCT01382940|1080524|P1|Overall Study|Lost to Follow-up|4
319554|NCT01382940|1080524|P1|Overall Study|Adverse Event|19
319555|NCT01382602|1080586|P2|Overall Study|Withdrawal by Subject|1
319556|NCT01382602|1080587|P1|Overall Study|Withdrawal by Subject|0
319557|NCT01382602|1080586|P2|Overall Study|Protocol Violation|3
319558|NCT01382602|1080587|P1|Overall Study|Protocol Violation|0
319559|NCT01382446|1080595|P2|Overall Study|Removal from Mechanical Ventilation|3
319560|NCT01382446|1080596|P1|Overall Study|Removal from Mechanical Ventilation|3
319561|NCT01382446|1080595|P2|Overall Study|Withdrawal by Subject|1
319562|NCT01382446|1080596|P1|Overall Study|Withdrawal by Subject|0
319563|NCT01382251|1080623|P2|Overall Study|Contacted after study closed|1
319564|NCT01382251|1080624|P1|Overall Study|Contacted after study closed|1
319565|NCT01382251|1080623|P2|Overall Study|Lost to Follow-up|4
319566|NCT01382251|1080624|P1|Overall Study|Lost to Follow-up|4
319567|NCT01382251|1080623|P2|Overall Study|Surgeries cancelled or delayed|16
319568|NCT01382251|1080624|P1|Overall Study|Surgeries cancelled or delayed|16
319569|NCT01382225|1080637|P2|Overall Study|Other|2
319570|NCT01382225|1080638|P1|Overall Study|Other|4
319571|NCT01382225|1080637|P2|Overall Study|Subject Withdrew Consent|2
319572|NCT01382225|1080638|P1|Overall Study|Subject Withdrew Consent|5
319573|NCT01382225|1080637|P2|Overall Study|Protocol Violation|1
319574|NCT01382225|1080638|P1|Overall Study|Protocol Violation|2
319575|NCT01382225|1080637|P2|Overall Study|Adverse Event|2
319576|NCT01382225|1080638|P1|Overall Study|Adverse Event|3
319577|NCT01382212|1080660|P1|Overall Study|Withdrew consent|1
319578|NCT01382212|1080660|P1|Overall Study|Kidney transplant|1
319579|NCT01381926|1080723|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
319580|NCT01381926|1080724|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
319581|NCT01381926|1080723|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
319582|NCT01381926|1080724|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
319583|NCT01381900|1080737|P3|Overall Study|Early withdraw|1
319584|NCT01381900|1080738|P2|Overall Study|Early withdraw|1
319585|NCT01381900|1080739|P1|Overall Study|Early withdraw|3
319586|NCT01381900|1080737|P3|Overall Study|Withdrawal by Subject|1
319587|NCT01381900|1080738|P2|Overall Study|Withdrawal by Subject|0
319588|NCT01381900|1080739|P1|Overall Study|Withdrawal by Subject|0
319589|NCT01381900|1080737|P3|Overall Study|Protocol Violation|1
319590|NCT01381900|1080738|P2|Overall Study|Protocol Violation|1
319591|NCT01381900|1080739|P1|Overall Study|Protocol Violation|0
319592|NCT01381900|1080737|P3|Overall Study|Physician Decision|1
319593|NCT01381900|1080738|P2|Overall Study|Physician Decision|1
319594|NCT01381900|1080739|P1|Overall Study|Physician Decision|0
319595|NCT01381900|1080737|P3|Overall Study|Noncompliance with study drug|1
319596|NCT01381900|1080738|P2|Overall Study|Noncompliance with study drug|0
319597|NCT01381900|1080739|P1|Overall Study|Noncompliance with study drug|0
319598|NCT01381900|1080737|P3|Overall Study|Adverse Event|7
319599|NCT01381900|1080738|P2|Overall Study|Adverse Event|6
319600|NCT01381900|1080739|P1|Overall Study|Adverse Event|4
319601|NCT01381900|1080737|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
319602|NCT01381900|1080738|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
319603|NCT01381900|1080739|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
319604|NCT01381679|1080759|P1|Overall Study|Lost to Follow-up|885
319605|NCT01381679|1080759|P1|Overall Study|Adverse Event|3
319606|NCT01381575|1080774|P3|Overall Study|Withdrawal by Subject|4
319607|NCT01381575|1080775|P2|Overall Study|Withdrawal by Subject|0
319608|NCT01381575|1080776|P1|Overall Study|Withdrawal by Subject|0
319609|NCT01381575|1080774|P3|Overall Study|Protocol Violation|1
319610|NCT01381575|1080775|P2|Overall Study|Protocol Violation|0
319611|NCT01381575|1080776|P1|Overall Study|Protocol Violation|0
319612|NCT01381575|1080774|P3|Overall Study|Lost to Follow-up|1
319613|NCT01381575|1080775|P2|Overall Study|Lost to Follow-up|0
319614|NCT01381575|1080776|P1|Overall Study|Lost to Follow-up|0
319615|NCT01381575|1080774|P3|Overall Study|Adverse Event|1
319616|NCT01381575|1080775|P2|Overall Study|Adverse Event|0
319617|NCT01381575|1080776|P1|Overall Study|Adverse Event|0
319618|NCT01381575|1080774|P3|Overall Study|Other|0
319619|NCT01381575|1080775|P2|Overall Study|Other|10
319620|NCT01381575|1080776|P1|Overall Study|Other|2
319621|NCT01381562|1080833|P3|Overall Study|Adverse Event|0
319622|NCT01381562|1080834|P2|Overall Study|Adverse Event|1
319623|NCT01381562|1080835|P1|Overall Study|Adverse Event|0
319624|NCT01381549|1080903|P3|Overall Study|Ineligible: No organisms isolated|1
319625|NCT01381549|1080904|P2|Overall Study|Ineligible: No organisms isolated|0
319626|NCT01381549|1080905|P1|Overall Study|Ineligible: No organisms isolated|0
319627|NCT01381016|1081031|P2|Overall Study|Physician Decision|2
319628|NCT01381016|1081032|P1|Overall Study|Physician Decision|0
319629|NCT01381016|1081031|P2|Overall Study|Withdrawal by Subject|1
319630|NCT01381016|1081032|P1|Overall Study|Withdrawal by Subject|0
319631|NCT01381016|1081031|P2|Overall Study|Screen Failure|2
319632|NCT01381016|1081032|P1|Overall Study|Screen Failure|2
319633|NCT01381016|1081031|P2|Overall Study|Lost to Follow-up|1
319634|NCT01381016|1081032|P1|Overall Study|Lost to Follow-up|1
319635|NCT01380834|1081042|P2|Overall Study|Physician Decision|0
319636|NCT01380834|1081043|P1|Overall Study|Physician Decision|1
319637|NCT01380782|1081055|P4|Overall Study|Withdrawal by Subject|1
319638|NCT01380782|1081056|P3|Overall Study|Withdrawal by Subject|1
319639|NCT01380782|1081057|P2|Overall Study|Withdrawal by Subject|0
319640|NCT01380782|1081058|P1|Overall Study|Withdrawal by Subject|0
319641|NCT01380782|1081055|P4|Overall Study|Physician Decision|0
319642|NCT01380782|1081056|P3|Overall Study|Physician Decision|0
319643|NCT01380782|1081057|P2|Overall Study|Physician Decision|0
319644|NCT01380782|1081058|P1|Overall Study|Physician Decision|1
319645|NCT01380782|1081055|P4|Overall Study|Lack of Efficacy|3
319646|NCT01380782|1081056|P3|Overall Study|Lack of Efficacy|10
319647|NCT01380782|1081057|P2|Overall Study|Lack of Efficacy|9
319648|NCT01380782|1081058|P1|Overall Study|Lack of Efficacy|10
319649|NCT01380782|1081055|P4|Overall Study|Death|0
319650|NCT01380782|1081056|P3|Overall Study|Death|0
319651|NCT01380782|1081057|P2|Overall Study|Death|0
319652|NCT01380782|1081058|P1|Overall Study|Death|1
319653|NCT01380782|1081055|P4|Overall Study|Adverse Event|0
319654|NCT01380782|1081056|P3|Overall Study|Adverse Event|0
319655|NCT01380782|1081057|P2|Overall Study|Adverse Event|1
319656|NCT01380782|1081058|P1|Overall Study|Adverse Event|0
319657|NCT01380769|1081081|P2|Overall Study|Protocol Violation|1
319658|NCT01380769|1081082|P1|Overall Study|Protocol Violation|0
319659|NCT01380769|1081081|P2|Overall Study|Adverse Event|1
319660|NCT01380769|1081082|P1|Overall Study|Adverse Event|1
319661|NCT01380769|1081081|P2|Overall Study|Physician Decision|1
319662|NCT01380769|1081082|P1|Overall Study|Physician Decision|1
319663|NCT01380769|1081081|P2|Overall Study|Withdrawal by Subject|11
319664|NCT01380769|1081082|P1|Overall Study|Withdrawal by Subject|7
319665|NCT01380730|1081098|P8|Overall Study|Death|0
319666|NCT01380730|1081099|P7|Overall Study|Death|0
319667|NCT01380730|1081100|P6|Overall Study|Death|0
319668|NCT01380730|1081101|P5|Overall Study|Death|1
319669|NCT01380730|1081102|P4|Overall Study|Death|0
319670|NCT01380730|1081103|P3|Overall Study|Death|0
319671|NCT01380730|1081104|P2|Overall Study|Death|0
319672|NCT01380730|1081105|P1|Overall Study|Death|0
319673|NCT01380379|1081172|P1|Overall Study|Pregnancy|1
319674|NCT01380327|1081185|P3|Overall Study|Questionable onset of epilepsy|1
319675|NCT01380327|1081186|P2|Overall Study|Questionable onset of epilepsy|0
319676|NCT01380327|1081187|P1|Overall Study|Questionable onset of epilepsy|0
319677|NCT01380327|1081185|P3|Overall Study|Housing situation precluded ability to k|1
319678|NCT01380327|1081186|P2|Overall Study|Housing situation precluded ability to k|0
319679|NCT01380327|1081187|P1|Overall Study|Housing situation precluded ability to k|0
319680|NCT01380327|1081185|P3|Overall Study|Withdrawal by Subject|1
319681|NCT01380327|1081186|P2|Overall Study|Withdrawal by Subject|0
319682|NCT01380327|1081187|P1|Overall Study|Withdrawal by Subject|0
319683|NCT01380327|1081185|P3|Overall Study|Protocol Violation|3
319684|NCT01380327|1081186|P2|Overall Study|Protocol Violation|2
319685|NCT01380327|1081187|P1|Overall Study|Protocol Violation|3
319686|NCT01380327|1081185|P3|Overall Study|Lost to Follow-up|1
319687|NCT01380327|1081186|P2|Overall Study|Lost to Follow-up|1
319688|NCT01380327|1081187|P1|Overall Study|Lost to Follow-up|0
319689|NCT01380145|1081218|P1|Overall Study|Progressive disease|4
319690|NCT01380093|1081226|P9|Treatment Phase: Third Intervention|Other|1
319691|NCT01380093|1081227|P8|Treatment Phase: Third Intervention|Other|0
319692|NCT01380093|1081228|P7|Treatment Phase: Third Intervention|Other|0
319693|NCT01380093|1081229|P6|Treatment Phase: Third Intervention|Other|0
319694|NCT01380093|1081230|P5|Treatment Phase: Third Intervention|Other|0
319695|NCT01380093|1081231|P4|Treatment Phase: Third Intervention|Other|0
319696|NCT01380093|1081232|P3|Treatment Phase: Third Intervention|Other|0
319697|NCT01380093|1081233|P2|Treatment Phase: Third Intervention|Other|0
319698|NCT01380093|1081234|P1|Treatment Phase: Third Intervention|Other|0
319699|NCT01380093|1081226|P9|Treatment Phase: Third Intervention|Non-compliance|1
319700|NCT01380093|1081227|P8|Treatment Phase: Third Intervention|Non-compliance|0
319701|NCT01380093|1081228|P7|Treatment Phase: Third Intervention|Non-compliance|0
319702|NCT01380093|1081229|P6|Treatment Phase: Third Intervention|Non-compliance|0
319703|NCT01380093|1081230|P5|Treatment Phase: Third Intervention|Non-compliance|0
319704|NCT01380093|1081231|P4|Treatment Phase: Third Intervention|Non-compliance|0
319705|NCT01380093|1081232|P3|Treatment Phase: Third Intervention|Non-compliance|0
319706|NCT01380093|1081233|P2|Treatment Phase: Third Intervention|Non-compliance|0
319707|NCT01380093|1081234|P1|Treatment Phase: Third Intervention|Non-compliance|0
319708|NCT01380093|1081226|P9|Treatment Phase: Second Intervention|Other|0
319709|NCT01380093|1081227|P8|Treatment Phase: Second Intervention|Other|0
319710|NCT01380093|1081228|P7|Treatment Phase: Second Intervention|Other|0
319711|NCT01380093|1081229|P6|Treatment Phase: Second Intervention|Other|0
319712|NCT01380093|1081230|P5|Treatment Phase: Second Intervention|Other|0
319713|NCT01380093|1081231|P4|Treatment Phase: Second Intervention|Other|1
319714|NCT01380093|1081232|P3|Treatment Phase: Second Intervention|Other|0
319715|NCT01380093|1081233|P2|Treatment Phase: Second Intervention|Other|0
319716|NCT01380093|1081234|P1|Treatment Phase: Second Intervention|Other|0
319717|NCT01380093|1081226|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
319718|NCT01380093|1081227|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
319719|NCT01380093|1081228|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
319720|NCT01380093|1081229|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
319721|NCT01380093|1081230|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
319722|NCT01380093|1081231|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
319723|NCT01380093|1081232|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
319724|NCT01380093|1081233|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
319725|NCT01380093|1081234|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
319726|NCT01380093|1081226|P9|Drug Discrimination Phase: Day 2|Backup participant|0
319727|NCT01380093|1081227|P8|Drug Discrimination Phase: Day 2|Backup participant|0
319728|NCT01380093|1081228|P7|Drug Discrimination Phase: Day 2|Backup participant|0
319729|NCT01380093|1081229|P6|Drug Discrimination Phase: Day 2|Backup participant|0
319730|NCT01380093|1081230|P5|Drug Discrimination Phase: Day 2|Backup participant|0
319731|NCT01380093|1081231|P4|Drug Discrimination Phase: Day 2|Backup participant|0
319732|NCT01380093|1081232|P3|Drug Discrimination Phase: Day 2|Backup participant|1
319733|NCT01380093|1081233|P2|Drug Discrimination Phase: Day 2|Backup participant|0
319734|NCT01380093|1081234|P1|Drug Discrimination Phase: Day 2|Backup participant|0
319735|NCT01380093|1081226|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
319736|NCT01380093|1081227|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
319737|NCT01380093|1081228|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
319738|NCT01380093|1081229|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
319739|NCT01380093|1081230|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
319740|NCT01380093|1081231|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
319741|NCT01380093|1081232|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
319742|NCT01380093|1081233|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
319743|NCT01380093|1081234|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
319744|NCT01380093|1081226|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
319745|NCT01380093|1081227|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
319746|NCT01380093|1081228|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
319747|NCT01380093|1081229|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
319748|NCT01380093|1081230|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
319749|NCT01380093|1081231|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
319750|NCT01380093|1081232|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
319751|NCT01380093|1081233|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
319752|NCT01380093|1081234|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
319753|NCT01380093|1081226|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319754|NCT01380093|1081227|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319755|NCT01380093|1081228|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319756|NCT01380093|1081229|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319757|NCT01380093|1081230|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319758|NCT01380093|1081231|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319759|NCT01380093|1081232|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319760|NCT01380093|1081233|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
319761|NCT01380093|1081234|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
319762|NCT01380093|1081226|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
319763|NCT01380093|1081227|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
319764|NCT01380093|1081228|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
319765|NCT01380093|1081229|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
319766|NCT01380093|1081230|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
319767|NCT01380093|1081231|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
319768|NCT01380093|1081232|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
319769|NCT01380093|1081233|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
319770|NCT01380093|1081234|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
319771|NCT01380093|1081226|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
319772|NCT01380093|1081227|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
319773|NCT01380093|1081228|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
319774|NCT01380093|1081229|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
319775|NCT01380093|1081230|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
319776|NCT01380093|1081231|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
319777|NCT01380093|1081232|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
319778|NCT01380093|1081233|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
319779|NCT01380093|1081234|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
319780|NCT01380093|1081226|P9|Naloxone Challenge Phase|Screen failures|0
319781|NCT01380093|1081227|P8|Naloxone Challenge Phase|Screen failures|0
319782|NCT01380093|1081228|P7|Naloxone Challenge Phase|Screen failures|0
319783|NCT01380093|1081229|P6|Naloxone Challenge Phase|Screen failures|0
319784|NCT01380093|1081230|P5|Naloxone Challenge Phase|Screen failures|0
319785|NCT01380093|1081231|P4|Naloxone Challenge Phase|Screen failures|0
319786|NCT01380093|1081232|P3|Naloxone Challenge Phase|Screen failures|0
319787|NCT01380093|1081233|P2|Naloxone Challenge Phase|Screen failures|0
319788|NCT01380093|1081234|P1|Naloxone Challenge Phase|Screen failures|21
319789|NCT01380080|1081526|P2|Overall Study|Lost to Follow-up|0
319790|NCT01380080|1081527|P1|Overall Study|Lost to Follow-up|2
319791|NCT01380080|1081526|P2|Overall Study|Not willing to adhere to requirements|1
319792|NCT01380080|1081527|P1|Overall Study|Not willing to adhere to requirements|3
319793|NCT01380080|1081526|P2|Overall Study|Not able to get to clinic|0
319794|NCT01380080|1081527|P1|Overall Study|Not able to get to clinic|4
319795|NCT01380080|1081526|P2|Overall Study|Withdrawal by Subject|0
319796|NCT01380080|1081527|P1|Overall Study|Withdrawal by Subject|4
319797|NCT01380080|1081526|P2|Overall Study|Death|22
319798|NCT01380080|1081527|P1|Overall Study|Death|20
319799|NCT01379937|1081552|P4|Overall Study|Lost to Follow-up|0
319800|NCT01379937|1081553|P3|Overall Study|Lost to Follow-up|2
319801|NCT01379937|1081554|P2|Overall Study|Lost to Follow-up|2
319802|NCT01379937|1081555|P1|Overall Study|Lost to Follow-up|1
319803|NCT01379937|1081552|P4|Overall Study|Consent withdrawal|0
319804|NCT01379937|1081553|P3|Overall Study|Consent withdrawal|0
319805|NCT01379937|1081554|P2|Overall Study|Consent withdrawal|1
319806|NCT01379937|1081555|P1|Overall Study|Consent withdrawal|0
319807|NCT01379937|1081552|P4|Overall Study|Protocol Violation|1
319808|NCT01379937|1081553|P3|Overall Study|Protocol Violation|0
319809|NCT01379937|1081554|P2|Overall Study|Protocol Violation|0
319810|NCT01379937|1081555|P1|Overall Study|Protocol Violation|0
319811|NCT01379781|1081637|P2|Overall Study|Lost to Follow-up|8
319812|NCT01379781|1081638|P1|Overall Study|Lost to Follow-up|11
319813|NCT01379768|1081647|P3|Overall Study|Lost to Follow-up|0
319814|NCT01379768|1081648|P2|Overall Study|Lost to Follow-up|0
319815|NCT01379768|1081649|P1|Overall Study|Lost to Follow-up|2
319816|NCT01379768|1081647|P3|Overall Study|Adverse Event|0
319817|NCT01379768|1081648|P2|Overall Study|Adverse Event|1
319818|NCT01379768|1081649|P1|Overall Study|Adverse Event|1
319819|NCT01379703|1081672|P3|9 Months Through 18 Months|Reason Unknown|0
319820|NCT01379703|1081673|P2|9 Months Through 18 Months|Reason Unknown|23
319821|NCT01379703|1081674|P1|9 Months Through 18 Months|Reason Unknown|0
319822|NCT01379703|1081672|P3|9 Months Through 18 Months|Fatigue|0
319823|NCT01379703|1081673|P2|9 Months Through 18 Months|Fatigue|1
319824|NCT01379703|1081674|P1|9 Months Through 18 Months|Fatigue|0
319825|NCT01379703|1081672|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
319826|NCT01379703|1081673|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
319827|NCT01379703|1081674|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
319828|NCT01379703|1081672|P3|9 Months Through 18 Months|Patient Noncompliance|0
319829|NCT01379703|1081673|P2|9 Months Through 18 Months|Patient Noncompliance|4
319830|NCT01379703|1081674|P1|9 Months Through 18 Months|Patient Noncompliance|0
319831|NCT01379703|1081672|P3|9 Months Through 18 Months|Treatment failure|0
319832|NCT01379703|1081673|P2|9 Months Through 18 Months|Treatment failure|5
319833|NCT01379703|1081674|P1|9 Months Through 18 Months|Treatment failure|0
319834|NCT01379703|1081672|P3|9 Months Through 18 Months|Adverse Event|0
319835|NCT01379703|1081673|P2|9 Months Through 18 Months|Adverse Event|6
319836|NCT01379703|1081674|P1|9 Months Through 18 Months|Adverse Event|0
319837|NCT01379703|1081672|P3|9 Months Through 18 Months|Withdrawal by Subject|0
319838|NCT01379703|1081673|P2|9 Months Through 18 Months|Withdrawal by Subject|11
319839|NCT01379703|1081674|P1|9 Months Through 18 Months|Withdrawal by Subject|0
319840|NCT01379703|1081672|P3|9 Months Through 18 Months|Lost to Follow-up|0
319841|NCT01379703|1081673|P2|9 Months Through 18 Months|Lost to Follow-up|178
319842|NCT01379703|1081674|P1|9 Months Through 18 Months|Lost to Follow-up|0
319843|NCT01379703|1081672|P3|Study Start Through 9 Months|Reason unknown|24
319844|NCT01379703|1081673|P2|Study Start Through 9 Months|Reason unknown|31
319845|NCT01379703|1081674|P1|Study Start Through 9 Months|Reason unknown|2
319846|NCT01379703|1081672|P3|Study Start Through 9 Months|Increased triglycerides|0
319847|NCT01379703|1081673|P2|Study Start Through 9 Months|Increased triglycerides|1
319848|NCT01379703|1081674|P1|Study Start Through 9 Months|Increased triglycerides|0
319849|NCT01379703|1081672|P3|Study Start Through 9 Months|Poor general condition|0
319850|NCT01379703|1081673|P2|Study Start Through 9 Months|Poor general condition|1
319851|NCT01379703|1081674|P1|Study Start Through 9 Months|Poor general condition|0
319852|NCT01379703|1081672|P3|Study Start Through 9 Months|Medication not available|1
319853|NCT01379703|1081673|P2|Study Start Through 9 Months|Medication not available|2
319854|NCT01379703|1081674|P1|Study Start Through 9 Months|Medication not available|0
319855|NCT01379703|1081672|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
319856|NCT01379703|1081673|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
319857|NCT01379703|1081674|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
319858|NCT01379703|1081672|P3|Study Start Through 9 Months|Patient Noncompliance|1
319859|NCT01379703|1081673|P2|Study Start Through 9 Months|Patient Noncompliance|0
319860|NCT01379703|1081674|P1|Study Start Through 9 Months|Patient Noncompliance|0
319861|NCT01379703|1081672|P3|Study Start Through 9 Months|Treatment Failure|2
319862|NCT01379703|1081673|P2|Study Start Through 9 Months|Treatment Failure|2
319863|NCT01379703|1081674|P1|Study Start Through 9 Months|Treatment Failure|0
319864|NCT01379703|1081672|P3|Study Start Through 9 Months|Withdrawal by Subject|1
319865|NCT01379703|1081673|P2|Study Start Through 9 Months|Withdrawal by Subject|6
319866|NCT01379703|1081674|P1|Study Start Through 9 Months|Withdrawal by Subject|0
319867|NCT01379703|1081672|P3|Study Start Through 9 Months|Adverse Event|10
319868|NCT01379703|1081673|P2|Study Start Through 9 Months|Adverse Event|14
319869|NCT01379703|1081674|P1|Study Start Through 9 Months|Adverse Event|0
319870|NCT01379703|1081672|P3|Study Start Through 9 Months|Lost to Follow-up|104
319871|NCT01379703|1081673|P2|Study Start Through 9 Months|Lost to Follow-up|61
319872|NCT01379703|1081674|P1|Study Start Through 9 Months|Lost to Follow-up|2
319873|NCT01379534|1081774|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
319874|NCT01379534|1081775|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
319875|NCT01379534|1081774|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
319876|NCT01379534|1081775|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
319877|NCT01379534|1081774|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
319878|NCT01379534|1081775|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
319879|NCT01379534|1081774|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
319880|NCT01379534|1081775|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
319881|NCT01379534|1081774|P2|Treatment Phase|Adverse Event|7
319882|NCT01379534|1081775|P1|Treatment Phase|Adverse Event|7
319883|NCT01379534|1081774|P2|Treatment Phase|Progressive disease|22
319884|NCT01379534|1081775|P1|Treatment Phase|Progressive disease|13
319885|NCT01379534|1081774|P2|Treatment Phase|Withdrawal by Subject|2
319886|NCT01379534|1081775|P1|Treatment Phase|Withdrawal by Subject|2
319887|NCT01379521|1081795|P2|Post-Treatment Evaluations|Death|0
319888|NCT01379521|1081796|P1|Post-Treatment Evaluations|Death|1
319889|NCT01379521|1081795|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
319890|NCT01379521|1081796|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
319891|NCT01379521|1081795|P2|Post-Treatment Evaluations|Disease Progression|20
319892|NCT01379521|1081796|P1|Post-Treatment Evaluations|Disease Progression|22
319893|NCT01379521|1081795|P2|Overall Study -Treatment Period|Death|1
319894|NCT01379521|1081796|P1|Overall Study -Treatment Period|Death|2
319895|NCT01379521|1081795|P2|Overall Study -Treatment Period|Administrative Problems|0
319896|NCT01379521|1081796|P1|Overall Study -Treatment Period|Administrative Problems|1
319897|NCT01379521|1081795|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
319898|NCT01379521|1081796|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
319899|NCT01379521|1081795|P2|Overall Study -Treatment Period|Protocol Deviation|2
319900|NCT01379521|1081796|P1|Overall Study -Treatment Period|Protocol Deviation|0
319901|NCT01379521|1081795|P2|Overall Study -Treatment Period|New Cancer Therapy|0
319902|NCT01379521|1081796|P1|Overall Study -Treatment Period|New Cancer Therapy|1
319903|NCT01379521|1081795|P2|Overall Study -Treatment Period|Disease Progression|22
319904|NCT01379521|1081796|P1|Overall Study -Treatment Period|Disease Progression|23
319905|NCT01379521|1081795|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
319906|NCT01379521|1081796|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
319907|NCT01379521|1081795|P2|Overall Study -Treatment Period|Adverse Event|0
319908|NCT01379521|1081796|P1|Overall Study -Treatment Period|Adverse Event|3
319909|NCT01378975|1081866|P2|Overall Study|Withdrew Consent|3
319910|NCT01378975|1081867|P1|Overall Study|Withdrew Consent|4
319911|NCT01378975|1081866|P2|Overall Study|Lost to Follow-up|1
319912|NCT01378975|1081867|P1|Overall Study|Lost to Follow-up|4
319913|NCT01378975|1081866|P2|Overall Study|Investigator Request|0
319914|NCT01378975|1081867|P1|Overall Study|Investigator Request|1
319915|NCT01378975|1081866|P2|Overall Study|Death|46
319916|NCT01378975|1081867|P1|Overall Study|Death|77
319917|NCT01378962|1081893|P1|Overall Study|Other|2
319918|NCT01378962|1081893|P1|Overall Study|Lost to Follow-up|1
319919|NCT01378962|1081893|P1|Overall Study|Death|14
319920|NCT01378429|1081919|P2|Overall Study|Noncompliance with study drug|0
319921|NCT01378429|1081920|P1|Overall Study|Noncompliance with study drug|1
319922|NCT01378325|1081962|P2|Overall Study|Protocol Violation|1
319923|NCT01378325|1081963|P1|Overall Study|Protocol Violation|0
319924|NCT01378195|1081980|P2|Overall Study|Lost to Follow-up|18
319925|NCT01378195|1081981|P1|Overall Study|Lost to Follow-up|29
319926|NCT01378117|1081994|P3|Overall Study|discharged before med given|1
319927|NCT01378117|1081995|P2|Overall Study|discharged before med given|0
319928|NCT01378117|1081996|P1|Overall Study|discharged before med given|2
319929|NCT01378117|1081994|P3|Overall Study|withdrawal|2
319930|NCT01378117|1081995|P2|Overall Study|withdrawal|1
319931|NCT01378117|1081996|P1|Overall Study|withdrawal|2
319932|NCT01378104|1082006|P2|Overall Study|Withdrawal by Subject|13
319933|NCT01378104|1082007|P1|Overall Study|Withdrawal by Subject|12
319934|NCT01378104|1082006|P2|Overall Study|Lack of Efficacy|5
319935|NCT01378104|1082007|P1|Overall Study|Lack of Efficacy|7
319936|NCT01378104|1082006|P2|Overall Study|Adverse Event|8
319937|NCT01378104|1082007|P1|Overall Study|Adverse Event|8
319938|NCT01377987|1082052|P2|Washout (7 Days)|Withdrawal by Subject|1
319939|NCT01377987|1082053|P1|Washout (7 Days)|Withdrawal by Subject|1
319940|NCT01377922|1082071|P2|Overall Study|rescue tx after part 2, entered part 4|0
319941|NCT01377922|1082072|P1|Overall Study|rescue tx after part 2, entered part 4|1
319942|NCT01377480|1082157|P4|Overall Study|Not specified|6
319943|NCT01377480|1082158|P3|Overall Study|Not specified|7
319944|NCT01377480|1082159|P2|Overall Study|Not specified|0
319945|NCT01377480|1082160|P1|Overall Study|Not specified|0
319946|NCT01377480|1082157|P4|Overall Study|Serious adverse event|1
319947|NCT01377480|1082158|P3|Overall Study|Serious adverse event|1
319948|NCT01377480|1082159|P2|Overall Study|Serious adverse event|0
319949|NCT01377480|1082160|P1|Overall Study|Serious adverse event|0
319950|NCT01377480|1082157|P4|Overall Study|Withdrawal by Subject|0
319951|NCT01377480|1082158|P3|Overall Study|Withdrawal by Subject|1
319952|NCT01377480|1082159|P2|Overall Study|Withdrawal by Subject|0
319953|NCT01377480|1082160|P1|Overall Study|Withdrawal by Subject|0
319954|NCT01377480|1082157|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
319955|NCT01377480|1082158|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
319956|NCT01377480|1082159|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
319957|NCT01377480|1082160|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
319958|NCT01377480|1082157|P4|Overall Study|Protocol Violation|4
319959|NCT01377480|1082158|P3|Overall Study|Protocol Violation|0
319960|NCT01377480|1082159|P2|Overall Study|Protocol Violation|0
319961|NCT01377480|1082160|P1|Overall Study|Protocol Violation|0
319962|NCT01377233|1082241|P5|Double-blind|Administrative or other|1
319963|NCT01377233|1082242|P4|Double-blind|Administrative or other|1
319964|NCT01377233|1082243|P3|Double-blind|Administrative or other|0
319965|NCT01377233|1082244|P2|Double-blind|Administrative or other|0
319966|NCT01377233|1082245|P1|Double-blind|Administrative or other|0
319967|NCT01377233|1082241|P5|Double-blind|Withdrawal by Subject|0
319968|NCT01377233|1082242|P4|Double-blind|Withdrawal by Subject|1
319969|NCT01377233|1082243|P3|Double-blind|Withdrawal by Subject|0
319970|NCT01377233|1082244|P2|Double-blind|Withdrawal by Subject|0
319971|NCT01377233|1082245|P1|Double-blind|Withdrawal by Subject|0
319972|NCT01377233|1082241|P5|Double-blind|Protocol Violation|1
319973|NCT01377233|1082242|P4|Double-blind|Protocol Violation|0
319974|NCT01377233|1082243|P3|Double-blind|Protocol Violation|0
319975|NCT01377233|1082244|P2|Double-blind|Protocol Violation|0
319976|NCT01377233|1082245|P1|Double-blind|Protocol Violation|0
319977|NCT01377233|1082241|P5|Double-blind|Adverse Event|0
319978|NCT01377233|1082242|P4|Double-blind|Adverse Event|2
319979|NCT01377233|1082243|P3|Double-blind|Adverse Event|2
319980|NCT01377233|1082244|P2|Double-blind|Adverse Event|1
319981|NCT01377233|1082245|P1|Double-blind|Adverse Event|0
319982|NCT01377233|1082241|P5|Open-label|Withdrawal by Subject|0
319983|NCT01377233|1082242|P4|Open-label|Withdrawal by Subject|0
319984|NCT01377233|1082243|P3|Open-label|Withdrawal by Subject|0
319985|NCT01377233|1082244|P2|Open-label|Withdrawal by Subject|0
319986|NCT01377233|1082245|P1|Open-label|Withdrawal by Subject|3
319987|NCT01377233|1082241|P5|Open-label|Adverse Event|0
319988|NCT01377233|1082242|P4|Open-label|Adverse Event|0
319989|NCT01377233|1082243|P3|Open-label|Adverse Event|0
319990|NCT01377233|1082244|P2|Open-label|Adverse Event|0
319991|NCT01377233|1082245|P1|Open-label|Adverse Event|1
319992|NCT01377194|1082272|P3|Overall Study|Lost to Follow-up|11
319993|NCT01377194|1082273|P2|Overall Study|Lost to Follow-up|8
319994|NCT01377194|1082274|P1|Overall Study|Lost to Follow-up|14
319995|NCT01377194|1082272|P3|Overall Study|Withdrawal by Subject|7
319996|NCT01377194|1082273|P2|Overall Study|Withdrawal by Subject|10
319997|NCT01377194|1082274|P1|Overall Study|Withdrawal by Subject|8
319998|NCT01377194|1082272|P3|Overall Study|Protocol Violation|6
319999|NCT01377194|1082273|P2|Overall Study|Protocol Violation|10
320000|NCT01377194|1082274|P1|Overall Study|Protocol Violation|4
320001|NCT01377194|1082272|P3|Overall Study|Lack of Efficacy|3
320002|NCT01377194|1082273|P2|Overall Study|Lack of Efficacy|3
320003|NCT01377194|1082274|P1|Overall Study|Lack of Efficacy|3
320004|NCT01377194|1082272|P3|Overall Study|Adverse Event|19
320005|NCT01377194|1082273|P2|Overall Study|Adverse Event|12
320006|NCT01377194|1082274|P1|Overall Study|Adverse Event|3
320007|NCT01377012|1082288|P3|Extension Study, Weeks 104-260|Adverse Event|1
320008|NCT01377012|1082289|P2|Extension Study, Weeks 104-260|Adverse Event|2
320009|NCT01377012|1082290|P1|Extension Study, Weeks 104-260|Adverse Event|0
320010|NCT01377012|1082288|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
320011|NCT01377012|1082289|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
320012|NCT01377012|1082290|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
320013|NCT01377012|1082288|P3|Extension Study, Weeks 104-260|Physician Decision|0
320014|NCT01377012|1082289|P2|Extension Study, Weeks 104-260|Physician Decision|0
320015|NCT01377012|1082290|P1|Extension Study, Weeks 104-260|Physician Decision|1
320016|NCT01377012|1082288|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
320017|NCT01377012|1082289|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
320018|NCT01377012|1082290|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
320019|NCT01377012|1082288|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
320020|NCT01377012|1082289|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
320021|NCT01377012|1082290|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
320022|NCT01377012|1082288|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
320023|NCT01377012|1082289|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
320024|NCT01377012|1082290|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
320025|NCT01377012|1082288|P3|Core Study|Adverse Event|13
320026|NCT01377012|1082289|P2|Core Study|Adverse Event|14
320027|NCT01377012|1082290|P1|Core Study|Adverse Event|10
320028|NCT01377012|1082288|P3|Core Study|Death|1
320029|NCT01377012|1082289|P2|Core Study|Death|1
320030|NCT01377012|1082290|P1|Core Study|Death|1
320031|NCT01377012|1082288|P3|Core Study|Lack of Efficacy|37
320032|NCT01377012|1082289|P2|Core Study|Lack of Efficacy|28
320033|NCT01377012|1082290|P1|Core Study|Lack of Efficacy|41
320034|NCT01377012|1082288|P3|Core Study|Lost to Follow-up|4
320035|NCT01377012|1082289|P2|Core Study|Lost to Follow-up|5
320036|NCT01377012|1082290|P1|Core Study|Lost to Follow-up|7
320037|NCT01377012|1082288|P3|Core Study|No Longer require treatment|1
320038|NCT01377012|1082289|P2|Core Study|No Longer require treatment|0
320039|NCT01377012|1082290|P1|Core Study|No Longer require treatment|0
320040|NCT01377012|1082288|P3|Core Study|Non-Compliant with study treatment|1
320041|NCT01377012|1082289|P2|Core Study|Non-Compliant with study treatment|0
320042|NCT01377012|1082290|P1|Core Study|Non-Compliant with study treatment|0
320043|NCT01377012|1082288|P3|Core Study|Physician Decision|10
320044|NCT01377012|1082289|P2|Core Study|Physician Decision|4
320045|NCT01377012|1082290|P1|Core Study|Physician Decision|5
320046|NCT01377012|1082288|P3|Core Study|Pregnancy|1
320047|NCT01377012|1082289|P2|Core Study|Pregnancy|0
320048|NCT01377012|1082290|P1|Core Study|Pregnancy|0
320049|NCT01377012|1082288|P3|Core Study|Protocol Violation|2
320050|NCT01377012|1082289|P2|Core Study|Protocol Violation|3
320051|NCT01377012|1082290|P1|Core Study|Protocol Violation|7
320052|NCT01377012|1082288|P3|Core Study|Withdrawal by Subject|18
320053|NCT01377012|1082289|P2|Core Study|Withdrawal by Subject|23
320054|NCT01377012|1082290|P1|Core Study|Withdrawal by Subject|15
320055|NCT01377012|1082288|P3|Core Study|Technical problems|0
320056|NCT01377012|1082289|P2|Core Study|Technical problems|0
320057|NCT01377012|1082290|P1|Core Study|Technical problems|1
320058|NCT01377012|1082288|P3|Core Study|Study terminated by Sponsor|46
320059|NCT01377012|1082289|P2|Core Study|Study terminated by Sponsor|54
320060|NCT01377012|1082290|P1|Core Study|Study terminated by Sponsor|47
320061|NCT01376908|1082327|P2|Overall Study|Withdrawal by Subject|2
320062|NCT01376908|1082328|P1|Overall Study|Withdrawal by Subject|1
320063|NCT01376908|1082327|P2|Overall Study|Protocol Violation|1
320064|NCT01376908|1082328|P1|Overall Study|Protocol Violation|1
320065|NCT01376804|1082361|P1|Treatment Period|Patient did not receive study drug|1
320066|NCT01376804|1082361|P1|Treatment Period|Adverse Event|6
320067|NCT01376804|1082361|P1|Treatment Period|Withdrawal by Subject|1
320068|NCT01376700|1082372|P1|Overall Study|Low or high titer inhibitor|8
320069|NCT01376700|1082372|P1|Overall Study|Sponsor terminated study early|8
320070|NCT01376388|1082434|P1|Overall Study|Withdrawal by Subject|3
320071|NCT01376388|1082434|P1|Overall Study|Lack of Efficacy|2
320072|NCT01376388|1082434|P1|Overall Study|Adverse Event|13
320073|NCT01376349|1082472|P3|Raondomized Treatment|Alternative Treatment|1
320074|NCT01376349|1082473|P2|Raondomized Treatment|Alternative Treatment|0
320075|NCT01376349|1082474|P1|Raondomized Treatment|Alternative Treatment|0
320076|NCT01376349|1082472|P3|Raondomized Treatment|Unkown|1
320077|NCT01376349|1082473|P2|Raondomized Treatment|Unkown|2
320078|NCT01376349|1082474|P1|Raondomized Treatment|Unkown|1
320079|NCT01376349|1082472|P3|Raondomized Treatment|Adverse Event|14
320080|NCT01376349|1082473|P2|Raondomized Treatment|Adverse Event|17
320081|NCT01376349|1082474|P1|Raondomized Treatment|Adverse Event|13
320082|NCT01376349|1082472|P3|Raondomized Treatment|Withdrawal by Subject|13
320083|NCT01376349|1082473|P2|Raondomized Treatment|Withdrawal by Subject|16
320084|NCT01376349|1082474|P1|Raondomized Treatment|Withdrawal by Subject|10
320085|NCT01376323|1082488|P5|Overall Study|Withdrawal by Subject|0
320086|NCT01376323|1082489|P4|Overall Study|Withdrawal by Subject|0
320087|NCT01376323|1082490|P3|Overall Study|Withdrawal by Subject|1
320088|NCT01376323|1082491|P2|Overall Study|Withdrawal by Subject|1
320089|NCT01376323|1082492|P1|Overall Study|Withdrawal by Subject|0
320090|NCT01376323|1082488|P5|Overall Study|Physician Decision|1
320091|NCT01376323|1082489|P4|Overall Study|Physician Decision|1
320092|NCT01376323|1082490|P3|Overall Study|Physician Decision|2
320093|NCT01376323|1082491|P2|Overall Study|Physician Decision|0
320094|NCT01376323|1082492|P1|Overall Study|Physician Decision|1
320095|NCT01376323|1082488|P5|Overall Study|Lost to Follow-up|0
320096|NCT01376323|1082489|P4|Overall Study|Lost to Follow-up|2
320097|NCT01376323|1082490|P3|Overall Study|Lost to Follow-up|0
320098|NCT01376323|1082491|P2|Overall Study|Lost to Follow-up|0
320099|NCT01376323|1082492|P1|Overall Study|Lost to Follow-up|0
320100|NCT01376323|1082488|P5|Overall Study|Adverse Event|0
320101|NCT01376323|1082489|P4|Overall Study|Adverse Event|2
320102|NCT01376323|1082490|P3|Overall Study|Adverse Event|0
320103|NCT01376323|1082491|P2|Overall Study|Adverse Event|0
320104|NCT01376323|1082492|P1|Overall Study|Adverse Event|1
320105|NCT01376245|1082587|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
320106|NCT01376245|1082588|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
320107|NCT01376245|1082589|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
320108|NCT01376245|1082590|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
320109|NCT01376245|1082591|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
320110|NCT01376245|1082587|P5|24-week, Double-blind Treatment Period|Physician Decision|0
320111|NCT01376245|1082588|P4|24-week, Double-blind Treatment Period|Physician Decision|1
320112|NCT01376245|1082589|P3|24-week, Double-blind Treatment Period|Physician Decision|1
320113|NCT01376245|1082590|P2|24-week, Double-blind Treatment Period|Physician Decision|0
320114|NCT01376245|1082591|P1|24-week, Double-blind Treatment Period|Physician Decision|0
320115|NCT01376245|1082587|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
320116|NCT01376245|1082588|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
320117|NCT01376245|1082589|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
320118|NCT01376245|1082590|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
320119|NCT01376245|1082591|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
320120|NCT01376245|1082587|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
320121|NCT01376245|1082588|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
320122|NCT01376245|1082589|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
320123|NCT01376245|1082590|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
320124|NCT01376245|1082591|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
320125|NCT01376245|1082587|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
320126|NCT01376245|1082588|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
320127|NCT01376245|1082589|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
320128|NCT01376245|1082590|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
320129|NCT01376245|1082591|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
320130|NCT01376245|1082587|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
320131|NCT01376245|1082588|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
320132|NCT01376245|1082589|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
320133|NCT01376245|1082590|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
320134|NCT01376245|1082591|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
320135|NCT01376245|1082587|P5|24-week, Double-blind Treatment Period|Adverse Event|18
320136|NCT01376245|1082588|P4|24-week, Double-blind Treatment Period|Adverse Event|8
320137|NCT01376245|1082589|P3|24-week, Double-blind Treatment Period|Adverse Event|7
320138|NCT01376245|1082590|P2|24-week, Double-blind Treatment Period|Adverse Event|16
320139|NCT01376245|1082591|P1|24-week, Double-blind Treatment Period|Adverse Event|0
320140|NCT01376245|1082587|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
320141|NCT01376245|1082588|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
320142|NCT01376245|1082589|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
320143|NCT01376245|1082590|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
320144|NCT01376245|1082591|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
320145|NCT01376245|1082587|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
320146|NCT01376245|1082588|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
320147|NCT01376245|1082589|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
320148|NCT01376245|1082590|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
320149|NCT01376245|1082591|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
320150|NCT01376245|1082587|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
320151|NCT01376245|1082588|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
320152|NCT01376245|1082589|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
320153|NCT01376245|1082590|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
320154|NCT01376245|1082591|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
320155|NCT01376245|1082587|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
320156|NCT01376245|1082588|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
320157|NCT01376245|1082589|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
320158|NCT01376245|1082590|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
320159|NCT01376245|1082591|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
320160|NCT01376245|1082587|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
320161|NCT01376245|1082588|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
320162|NCT01376245|1082589|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
320163|NCT01376245|1082590|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
320164|NCT01376245|1082591|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
320165|NCT01376167|1082608|P3|Overall Study|Withdrawal by Subject|4
320166|NCT01376167|1082609|P2|Overall Study|Withdrawal by Subject|5
320167|NCT01376167|1082610|P1|Overall Study|Withdrawal by Subject|1
320168|NCT01376167|1082608|P3|Overall Study|Physician Decision|0
320169|NCT01376167|1082609|P2|Overall Study|Physician Decision|1
320170|NCT01376167|1082610|P1|Overall Study|Physician Decision|1
320171|NCT01376167|1082608|P3|Overall Study|Lost to Follow-up|2
320172|NCT01376167|1082609|P2|Overall Study|Lost to Follow-up|4
320173|NCT01376167|1082610|P1|Overall Study|Lost to Follow-up|2
320174|NCT01376089|1082681|P2|Overall Study|Patient received no contrast media|4
320175|NCT01376089|1082682|P1|Overall Study|Patient received no contrast media|3
320176|NCT01376037|1082705|P2|Overall Study|Lost to Follow-up|2
320177|NCT01376037|1082706|P1|Overall Study|Lost to Follow-up|0
320178|NCT01375777|1082729|P9|Overall Study|Other|1
320179|NCT01375777|1082730|P8|Overall Study|Other|0
320180|NCT01375777|1082731|P7|Overall Study|Other|0
320181|NCT01375777|1082732|P6|Overall Study|Other|0
320182|NCT01375777|1082733|P5|Overall Study|Other|0
320183|NCT01375777|1082734|P4|Overall Study|Other|0
320184|NCT01375777|1082735|P3|Overall Study|Other|0
320185|NCT01375777|1082736|P2|Overall Study|Other|1
320186|NCT01375777|1082737|P1|Overall Study|Other|1
320187|NCT01375777|1082729|P9|Overall Study|Lost to Follow-up|0
320188|NCT01375777|1082730|P8|Overall Study|Lost to Follow-up|0
320189|NCT01375777|1082731|P7|Overall Study|Lost to Follow-up|1
320190|NCT01375777|1082732|P6|Overall Study|Lost to Follow-up|0
320191|NCT01375777|1082733|P5|Overall Study|Lost to Follow-up|0
320192|NCT01375777|1082734|P4|Overall Study|Lost to Follow-up|0
320193|NCT01375777|1082735|P3|Overall Study|Lost to Follow-up|0
320194|NCT01375777|1082736|P2|Overall Study|Lost to Follow-up|0
320195|NCT01375777|1082737|P1|Overall Study|Lost to Follow-up|1
320196|NCT01375777|1082729|P9|Overall Study|Withdrawal by Subject|1
320197|NCT01375777|1082730|P8|Overall Study|Withdrawal by Subject|2
320198|NCT01375777|1082731|P7|Overall Study|Withdrawal by Subject|1
320199|NCT01375777|1082732|P6|Overall Study|Withdrawal by Subject|1
320200|NCT01375777|1082733|P5|Overall Study|Withdrawal by Subject|1
320201|NCT01375777|1082734|P4|Overall Study|Withdrawal by Subject|0
320202|NCT01375777|1082735|P3|Overall Study|Withdrawal by Subject|1
320203|NCT01375777|1082736|P2|Overall Study|Withdrawal by Subject|2
320204|NCT01375777|1082737|P1|Overall Study|Withdrawal by Subject|0
320205|NCT01375764|1082807|P5|Overall Study|Other|0
320206|NCT01375764|1082808|P4|Overall Study|Other|1
320207|NCT01375764|1082809|P3|Overall Study|Other|0
320208|NCT01375764|1082810|P2|Overall Study|Other|0
320209|NCT01375764|1082811|P1|Overall Study|Other|0
320210|NCT01375764|1082807|P5|Overall Study|Withdrawal by Subject|1
320211|NCT01375764|1082808|P4|Overall Study|Withdrawal by Subject|0
320212|NCT01375764|1082809|P3|Overall Study|Withdrawal by Subject|0
320213|NCT01375764|1082810|P2|Overall Study|Withdrawal by Subject|0
320214|NCT01375764|1082811|P1|Overall Study|Withdrawal by Subject|2
320215|NCT01375764|1082807|P5|Overall Study|Lost to Follow-up|0
320216|NCT01375764|1082808|P4|Overall Study|Lost to Follow-up|0
320217|NCT01375764|1082809|P3|Overall Study|Lost to Follow-up|0
320218|NCT01375764|1082810|P2|Overall Study|Lost to Follow-up|1
320219|NCT01375764|1082811|P1|Overall Study|Lost to Follow-up|0
320220|NCT01375751|1082857|P3|Overall Study|Other|0
320221|NCT01375751|1082858|P2|Overall Study|Other|1
320222|NCT01375751|1082859|P1|Overall Study|Other|0
320223|NCT01375608|1082903|P1|Overall Study|Withdrawal by Subject|2
320224|NCT01375374|1082912|P1|Overall Study|Adverse Event|1
320225|NCT01375049|1082962|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
320226|NCT01375049|1082962|P1|Overall Study|Withdrawal by Subject|2
320227|NCT01375049|1082962|P1|Overall Study|Lost to Follow-up|1
320228|NCT01375049|1082962|P1|Overall Study|Adverse Event|2
320229|NCT01374971|1082977|P1|Overall Study|Withdrawal by Subject|1
320230|NCT01374919|1082982|P1|Overall Study|Withdrawal by Subject|2
320231|NCT01374906|1082989|P2|Overall Study|Unsatisfactory therapeutic effect|19
320232|NCT01374906|1082990|P1|Overall Study|Unsatisfactory therapeutic effect|11
320233|NCT01374906|1082989|P2|Overall Study|Withdrawal by Subject|9
320234|NCT01374906|1082990|P1|Overall Study|Withdrawal by Subject|15
320235|NCT01374906|1082989|P2|Overall Study|Protocol Violation|2
320236|NCT01374906|1082990|P1|Overall Study|Protocol Violation|2
320237|NCT01374906|1082989|P2|Overall Study|Death|2
320238|NCT01374906|1082990|P1|Overall Study|Death|0
320239|NCT01374906|1082989|P2|Overall Study|Adverse Event|11
320240|NCT01374906|1082990|P1|Overall Study|Adverse Event|10
320241|NCT01374906|1082989|P2|Overall Study|Administrative problems|2
320242|NCT01374906|1082990|P1|Overall Study|Administrative problems|2
320243|NCT01374906|1082989|P2|Overall Study|Abnormal laboratory value(s)|3
320244|NCT01374906|1082990|P1|Overall Study|Abnormal laboratory value(s)|0
320245|NCT01374568|1083071|P2|Overall Study|Lab unable to analyze BTM|2
320246|NCT01374568|1083072|P1|Overall Study|Lab unable to analyze BTM|0
320247|NCT01374451|1083082|P2|Overall Study|Administrative problems|0
320248|NCT01374451|1083083|P1|Overall Study|Administrative problems|1
320249|NCT01374425|1083129|P2|Overall Study|Not Specified|43
320250|NCT01374425|1083130|P1|Overall Study|Not Specified|41
320251|NCT01374425|1083129|P2|Overall Study|Lost to Follow-up|1
320252|NCT01374425|1083130|P1|Overall Study|Lost to Follow-up|2
320253|NCT01374425|1083129|P2|Overall Study|Sponsor Decision|1
320254|NCT01374425|1083130|P1|Overall Study|Sponsor Decision|0
320255|NCT01374425|1083129|P2|Overall Study|Protocol Violation|3
320256|NCT01374425|1083130|P1|Overall Study|Protocol Violation|2
320257|NCT01374425|1083129|P2|Overall Study|Refused Treatment|24
320258|NCT01374425|1083130|P1|Overall Study|Refused Treatment|10
320259|NCT01374425|1083129|P2|Overall Study|Withdrawal by Subject|7
320260|NCT01374425|1083130|P1|Overall Study|Withdrawal by Subject|6
320261|NCT01374425|1083129|P2|Overall Study|Death (Adverse Event)|4
320262|NCT01374425|1083130|P1|Overall Study|Death (Adverse Event)|2
320263|NCT01374425|1083129|P2|Overall Study|Death (Progression of Disease)|0
320264|NCT01374425|1083130|P1|Overall Study|Death (Progression of Disease)|1
320265|NCT01374425|1083129|P2|Overall Study|Adverse Event|18
320266|NCT01374425|1083130|P1|Overall Study|Adverse Event|29
320267|NCT01374425|1083129|P2|Overall Study|Clinical Disease Progression|6
320268|NCT01374425|1083130|P1|Overall Study|Clinical Disease Progression|9
320269|NCT01374425|1083129|P2|Overall Study|Radiographic Disease Progression|81
320270|NCT01374425|1083130|P1|Overall Study|Radiographic Disease Progression|86
320271|NCT01374269|1083210|P2|Overall Study|closed research|2
320272|NCT01374269|1083211|P1|Overall Study|closed research|1
320273|NCT01374269|1083210|P2|Overall Study|Lost to Follow-up|3
320274|NCT01374269|1083211|P1|Overall Study|Lost to Follow-up|1
320275|NCT01374269|1083210|P2|Overall Study|Withdrawal by Subject|0
320276|NCT01374269|1083211|P1|Overall Study|Withdrawal by Subject|4
320277|NCT01374178|1083339|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
320278|NCT01374178|1083340|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
320279|NCT01374178|1083339|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
320280|NCT01374178|1083340|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
320281|NCT01374087|1083358|P2|Overall Study|Not provided|13
320282|NCT01374087|1083359|P1|Overall Study|Not provided|13
320283|NCT01374087|1083358|P2|Overall Study|Disease progression|2
320284|NCT01374087|1083359|P1|Overall Study|Disease progression|2
320285|NCT01374087|1083358|P2|Overall Study|Adverse Event|1
320286|NCT01374087|1083359|P1|Overall Study|Adverse Event|0
320287|NCT01373918|1083369|P2|Overall Study|Physician Decision|1
320288|NCT01373918|1083370|P1|Overall Study|Physician Decision|0
320289|NCT01373346|1083420|P1|Overall Study|Death|1
320290|NCT01373294|1083443|P2|Overall Study|Adverse Event|0
320291|NCT01373294|1083444|P1|Overall Study|Adverse Event|1
320292|NCT01373281|1083453|P2|Overall Study|Serious adverse event|5
320293|NCT01373281|1083454|P1|Overall Study|Serious adverse event|6
320294|NCT01373281|1083453|P2|Overall Study|Adverse Event|4
320295|NCT01373281|1083454|P1|Overall Study|Adverse Event|4
320296|NCT01373281|1083453|P2|Overall Study|Lost to Follow-up|1
320297|NCT01373281|1083454|P1|Overall Study|Lost to Follow-up|4
320298|NCT01373281|1083453|P2|Overall Study|Protocol Violation|4
320299|NCT01373281|1083454|P1|Overall Study|Protocol Violation|13
320300|NCT01373281|1083453|P2|Overall Study|Withdrawal by Subject|31
320301|NCT01373281|1083454|P1|Overall Study|Withdrawal by Subject|52
320302|NCT01373229|1083470|P1|Overall Study|Physician Decision|3
320303|NCT01373229|1083470|P1|Overall Study|Death|3
320304|NCT01373164|1083484|P5|Overall Study|Withdrawal by Subject|2
320305|NCT01373164|1083485|P4|Overall Study|Withdrawal by Subject|10
320306|NCT01373164|1083486|P3|Overall Study|Withdrawal by Subject|0
320307|NCT01373164|1083487|P2|Overall Study|Withdrawal by Subject|1
320308|NCT01373164|1083488|P1|Overall Study|Withdrawal by Subject|0
320309|NCT01373164|1083484|P5|Overall Study|Lost to Follow-up|0
320310|NCT01373164|1083485|P4|Overall Study|Lost to Follow-up|2
320311|NCT01373164|1083486|P3|Overall Study|Lost to Follow-up|1
320312|NCT01373164|1083487|P2|Overall Study|Lost to Follow-up|0
320313|NCT01373164|1083488|P1|Overall Study|Lost to Follow-up|0
320314|NCT01372995|1083522|P3|Overall Study|Physician Decision|1
320315|NCT01372995|1083523|P2|Overall Study|Physician Decision|0
320316|NCT01372995|1083524|P1|Overall Study|Physician Decision|0
320317|NCT01372995|1083522|P3|Overall Study|Spouse withdrew participant from study|0
320318|NCT01372995|1083523|P2|Overall Study|Spouse withdrew participant from study|1
320319|NCT01372995|1083524|P1|Overall Study|Spouse withdrew participant from study|0
320320|NCT01372878|1083571|P1|Overall Study|incomplete study procedure|104
320321|NCT01372878|1083571|P1|Overall Study|Protocol Violation|17
320322|NCT01372878|1083571|P1|Overall Study|Withdrawal by Subject|63
320323|NCT01372748|1083591|P2|Overall Study|Withdrawal by Subject|5
320324|NCT01372748|1083592|P1|Overall Study|Withdrawal by Subject|7
320325|NCT01372748|1083591|P2|Overall Study|Lost to Follow-up|34
320326|NCT01372748|1083592|P1|Overall Study|Lost to Follow-up|16
320327|NCT01372618|1083600|P1|Overall Study|PI Died. Study Terminated|9
320328|NCT01372605|1083608|P2|Overall Study|Changed medical home|0
320329|NCT01372605|1083609|P1|Overall Study|Changed medical home|2
320330|NCT01372605|1083608|P2|Overall Study|Moved|0
320331|NCT01372605|1083609|P1|Overall Study|Moved|3
320332|NCT01372605|1083608|P2|Overall Study|Withdrawal by Subject|7
320333|NCT01372605|1083609|P1|Overall Study|Withdrawal by Subject|4
320334|NCT01372605|1083608|P2|Overall Study|Lost to Follow-up|1
320335|NCT01372605|1083609|P1|Overall Study|Lost to Follow-up|2
320336|NCT01372605|1083608|P2|Overall Study|Death|2
320337|NCT01372605|1083609|P1|Overall Study|Death|1
320338|NCT01372501|1083635|P1|Overall Study|Device migration|1
320339|NCT01372501|1083635|P1|Overall Study|Adverse Event|4
320340|NCT01372410|1083658|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
320341|NCT01372410|1083659|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
320342|NCT01372410|1083660|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
320343|NCT01372410|1083661|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
320344|NCT01372410|1083662|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
320345|NCT01372410|1083663|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
320346|NCT01372410|1083664|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
320347|NCT01372410|1083665|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
320348|NCT01372410|1083658|P8|Treatment Period 3 (7 Days)|Adverse Event|0
320349|NCT01372410|1083659|P7|Treatment Period 3 (7 Days)|Adverse Event|0
320350|NCT01372410|1083660|P6|Treatment Period 3 (7 Days)|Adverse Event|0
320351|NCT01372410|1083661|P5|Treatment Period 3 (7 Days)|Adverse Event|0
320352|NCT01372410|1083662|P4|Treatment Period 3 (7 Days)|Adverse Event|0
320353|NCT01372410|1083663|P3|Treatment Period 3 (7 Days)|Adverse Event|1
320354|NCT01372410|1083664|P2|Treatment Period 3 (7 Days)|Adverse Event|0
320355|NCT01372410|1083665|P1|Treatment Period 3 (7 Days)|Adverse Event|0
320356|NCT01372410|1083658|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
320357|NCT01372410|1083659|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
320358|NCT01372410|1083660|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
320359|NCT01372410|1083661|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
320360|NCT01372410|1083662|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
320361|NCT01372410|1083663|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
320362|NCT01372410|1083664|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
320363|NCT01372410|1083665|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
320364|NCT01372410|1083658|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
320365|NCT01372410|1083659|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
320366|NCT01372410|1083660|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
320367|NCT01372410|1083661|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
320368|NCT01372410|1083662|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
320369|NCT01372410|1083663|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
320370|NCT01372410|1083664|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
320371|NCT01372410|1083665|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
320372|NCT01372410|1083658|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
320373|NCT01372410|1083659|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
320374|NCT01372410|1083660|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
320375|NCT01372410|1083661|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
320376|NCT01372410|1083662|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
320377|NCT01372410|1083663|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
320378|NCT01372410|1083664|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
320379|NCT01372410|1083665|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
320380|NCT01372410|1083658|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
320381|NCT01372410|1083659|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
320382|NCT01372410|1083660|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
320383|NCT01372410|1083661|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
320384|NCT01372410|1083662|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
320385|NCT01372410|1083663|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
320386|NCT01372410|1083664|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
320387|NCT01372410|1083665|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
320388|NCT01372410|1083658|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
320389|NCT01372410|1083659|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
320390|NCT01372410|1083660|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
320391|NCT01372410|1083661|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
320392|NCT01372410|1083662|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
320393|NCT01372410|1083663|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
320394|NCT01372410|1083664|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
320395|NCT01372410|1083665|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
320396|NCT01372410|1083658|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
320397|NCT01372410|1083659|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
320398|NCT01372410|1083660|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
320399|NCT01372410|1083661|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
320400|NCT01372410|1083662|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
320401|NCT01372410|1083663|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
320402|NCT01372410|1083664|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
320403|NCT01372410|1083665|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
320404|NCT01372410|1083658|P8|Treatment Period 1 (7 Days)|Adverse Event|0
320405|NCT01372410|1083659|P7|Treatment Period 1 (7 Days)|Adverse Event|1
320406|NCT01372410|1083660|P6|Treatment Period 1 (7 Days)|Adverse Event|0
320407|NCT01372410|1083661|P5|Treatment Period 1 (7 Days)|Adverse Event|0
320408|NCT01372410|1083662|P4|Treatment Period 1 (7 Days)|Adverse Event|0
320409|NCT01372410|1083663|P3|Treatment Period 1 (7 Days)|Adverse Event|0
320410|NCT01372410|1083664|P2|Treatment Period 1 (7 Days)|Adverse Event|1
320411|NCT01372410|1083665|P1|Treatment Period 1 (7 Days)|Adverse Event|0
320412|NCT01372410|1083658|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
320413|NCT01372410|1083659|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
320414|NCT01372410|1083660|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
320415|NCT01372410|1083661|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
320416|NCT01372410|1083662|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
320417|NCT01372410|1083663|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
320418|NCT01372410|1083664|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
320419|NCT01372410|1083665|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
320420|NCT01372384|1083702|P1|Overall Study|Progression of disease|3
320421|NCT01372150|1083725|P3|Overall Study|Randomized but not treated|0
320422|NCT01372150|1083726|P2|Overall Study|Randomized but not treated|1
320423|NCT01372150|1083727|P1|Overall Study|Randomized but not treated|0
320424|NCT01372150|1083725|P3|Overall Study|Adverse Event|2
320425|NCT01372150|1083726|P2|Overall Study|Adverse Event|1
320426|NCT01372150|1083727|P1|Overall Study|Adverse Event|2
320427|NCT01372150|1083725|P3|Overall Study|Other|2
320428|NCT01372150|1083726|P2|Overall Study|Other|0
320429|NCT01372150|1083727|P1|Overall Study|Other|1
320430|NCT01372150|1083725|P3|Overall Study|Withdrawal by Subject|2
320431|NCT01372150|1083726|P2|Overall Study|Withdrawal by Subject|7
320432|NCT01372150|1083727|P1|Overall Study|Withdrawal by Subject|2
320433|NCT01372150|1083725|P3|Overall Study|Protocol Violation|3
320434|NCT01372150|1083726|P2|Overall Study|Protocol Violation|0
320435|NCT01372150|1083727|P1|Overall Study|Protocol Violation|1
320436|NCT01372150|1083725|P3|Overall Study|Lost to Follow-up|6
320437|NCT01372150|1083726|P2|Overall Study|Lost to Follow-up|5
320438|NCT01372150|1083727|P1|Overall Study|Lost to Follow-up|4
320439|NCT01372150|1083725|P3|Overall Study|Lack of Efficacy|1
320440|NCT01372150|1083726|P2|Overall Study|Lack of Efficacy|0
320441|NCT01372150|1083727|P1|Overall Study|Lack of Efficacy|3
320442|NCT01371994|1083746|P2|Overall Study|Miscellaneous Reasons|4
320443|NCT01371994|1083747|P1|Overall Study|Miscellaneous Reasons|6
320444|NCT01371994|1083746|P2|Overall Study|Physician Decision|1
320445|NCT01371994|1083747|P1|Overall Study|Physician Decision|1
320446|NCT01371994|1083746|P2|Overall Study|Randomized but Never Received Study Drug|6
320447|NCT01371994|1083747|P1|Overall Study|Randomized but Never Received Study Drug|6
320448|NCT01371994|1083746|P2|Overall Study|Protocol Violation|17
320449|NCT01371994|1083747|P1|Overall Study|Protocol Violation|24
320450|NCT01371994|1083746|P2|Overall Study|Lost to Follow-up|1
320451|NCT01371994|1083747|P1|Overall Study|Lost to Follow-up|1
320452|NCT01371994|1083746|P2|Overall Study|Withdrawal by Subject|7
320453|NCT01371994|1083747|P1|Overall Study|Withdrawal by Subject|13
320454|NCT01371994|1083746|P2|Overall Study|Lack of Efficacy|0
320455|NCT01371994|1083747|P1|Overall Study|Lack of Efficacy|3
320456|NCT01371994|1083746|P2|Overall Study|Adverse Event|6
320457|NCT01371994|1083747|P1|Overall Study|Adverse Event|3
320458|NCT01371877|1083791|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
320459|NCT01371877|1083792|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
320460|NCT01371851|1083804|P2|Overall Study|Blood Pressure outside study parameters|0
320461|NCT01371851|1083805|P1|Overall Study|Blood Pressure outside study parameters|2
320462|NCT01371851|1083804|P2|Overall Study|non study related adverse event|0
320463|NCT01371851|1083805|P1|Overall Study|non study related adverse event|1
320464|NCT01371851|1083804|P2|Overall Study|was arrested and put in jail|1
320465|NCT01371851|1083805|P1|Overall Study|was arrested and put in jail|0
320466|NCT01371851|1083804|P2|Overall Study|Lost to Follow-up|8
320467|NCT01371851|1083805|P1|Overall Study|Lost to Follow-up|5
320468|NCT01371838|1083813|P2|Overall Study|Surgery|0
320469|NCT01371838|1083814|P1|Overall Study|Surgery|1
320470|NCT01371838|1083813|P2|Overall Study|Lack of therapeutic response|1
320471|NCT01371838|1083814|P1|Overall Study|Lack of therapeutic response|0
320472|NCT01371838|1083813|P2|Overall Study|Last follow-up visit not conducted|0
320473|NCT01371838|1083814|P1|Overall Study|Last follow-up visit not conducted|2
320474|NCT01371838|1083813|P2|Overall Study|Investigator Decision|8
320475|NCT01371838|1083814|P1|Overall Study|Investigator Decision|3
320476|NCT01371838|1083813|P2|Overall Study|Protocol Violation|0
320477|NCT01371838|1083814|P1|Overall Study|Protocol Violation|3
320478|NCT01371838|1083813|P2|Overall Study|Death|4
320479|NCT01371838|1083814|P1|Overall Study|Death|3
320480|NCT01371838|1083813|P2|Overall Study|Lost to Follow-up|20
320481|NCT01371838|1083814|P1|Overall Study|Lost to Follow-up|10
320482|NCT01371838|1083813|P2|Overall Study|Withdrawal by Subject|33
320483|NCT01371838|1083814|P1|Overall Study|Withdrawal by Subject|27
320484|NCT01371825|1083850|P1|Primary Efficacy Analysis Period|Death|3
320485|NCT01371747|1083885|P6|Overall Study|Other Reasons|1
320486|NCT01371747|1083886|P5|Overall Study|Other Reasons|0
320487|NCT01371747|1083887|P4|Overall Study|Other Reasons|0
320488|NCT01371747|1083888|P3|Overall Study|Other Reasons|2
320489|NCT01371747|1083889|P2|Overall Study|Other Reasons|1
320490|NCT01371747|1083890|P1|Overall Study|Other Reasons|2
320491|NCT01371747|1083885|P6|Overall Study|Withdrawal by Subject|4
320492|NCT01371747|1083886|P5|Overall Study|Withdrawal by Subject|2
320493|NCT01371747|1083887|P4|Overall Study|Withdrawal by Subject|2
320494|NCT01371747|1083888|P3|Overall Study|Withdrawal by Subject|5
320495|NCT01371747|1083889|P2|Overall Study|Withdrawal by Subject|12
320496|NCT01371747|1083890|P1|Overall Study|Withdrawal by Subject|6
320497|NCT01371747|1083885|P6|Overall Study|Physician Decision|0
320498|NCT01371747|1083886|P5|Overall Study|Physician Decision|1
320499|NCT01371747|1083887|P4|Overall Study|Physician Decision|0
320500|NCT01371747|1083888|P3|Overall Study|Physician Decision|0
320501|NCT01371747|1083889|P2|Overall Study|Physician Decision|0
320502|NCT01371747|1083890|P1|Overall Study|Physician Decision|0
320503|NCT01371747|1083885|P6|Overall Study|Non-Compliance|1
320504|NCT01371747|1083886|P5|Overall Study|Non-Compliance|0
320505|NCT01371747|1083887|P4|Overall Study|Non-Compliance|0
320506|NCT01371747|1083888|P3|Overall Study|Non-Compliance|3
320507|NCT01371747|1083889|P2|Overall Study|Non-Compliance|4
320508|NCT01371747|1083890|P1|Overall Study|Non-Compliance|3
320509|NCT01371747|1083885|P6|Overall Study|Protocol Violation|0
320510|NCT01371747|1083886|P5|Overall Study|Protocol Violation|0
320511|NCT01371747|1083887|P4|Overall Study|Protocol Violation|0
320512|NCT01371747|1083888|P3|Overall Study|Protocol Violation|1
320513|NCT01371747|1083889|P2|Overall Study|Protocol Violation|0
320514|NCT01371747|1083890|P1|Overall Study|Protocol Violation|0
320515|NCT01371747|1083885|P6|Overall Study|Low Serum Potassium Results|3
320516|NCT01371747|1083886|P5|Overall Study|Low Serum Potassium Results|0
320517|NCT01371747|1083887|P4|Overall Study|Low Serum Potassium Results|1
320518|NCT01371747|1083888|P3|Overall Study|Low Serum Potassium Results|1
320519|NCT01371747|1083889|P2|Overall Study|Low Serum Potassium Results|1
320520|NCT01371747|1083890|P1|Overall Study|Low Serum Potassium Results|1
320521|NCT01371747|1083885|P6|Overall Study|High Serum Potassium Results|2
320522|NCT01371747|1083886|P5|Overall Study|High Serum Potassium Results|0
320523|NCT01371747|1083887|P4|Overall Study|High Serum Potassium Results|2
320524|NCT01371747|1083888|P3|Overall Study|High Serum Potassium Results|1
320525|NCT01371747|1083889|P2|Overall Study|High Serum Potassium Results|1
320526|NCT01371747|1083890|P1|Overall Study|High Serum Potassium Results|1
320527|NCT01371747|1083885|P6|Overall Study|Abnormal Renal Function|1
320528|NCT01371747|1083886|P5|Overall Study|Abnormal Renal Function|0
320529|NCT01371747|1083887|P4|Overall Study|Abnormal Renal Function|1
320530|NCT01371747|1083888|P3|Overall Study|Abnormal Renal Function|0
320531|NCT01371747|1083889|P2|Overall Study|Abnormal Renal Function|2
320532|NCT01371747|1083890|P1|Overall Study|Abnormal Renal Function|0
320533|NCT01371747|1083885|P6|Overall Study|Death|0
320534|NCT01371747|1083886|P5|Overall Study|Death|2
320535|NCT01371747|1083887|P4|Overall Study|Death|1
320536|NCT01371747|1083888|P3|Overall Study|Death|4
320537|NCT01371747|1083889|P2|Overall Study|Death|0
320538|NCT01371747|1083890|P1|Overall Study|Death|1
320539|NCT01371747|1083885|P6|Overall Study|Adverse Event|2
320540|NCT01371747|1083886|P5|Overall Study|Adverse Event|2
320541|NCT01371747|1083887|P4|Overall Study|Adverse Event|2
320542|NCT01371747|1083888|P3|Overall Study|Adverse Event|7
320543|NCT01371747|1083889|P2|Overall Study|Adverse Event|2
320544|NCT01371747|1083890|P1|Overall Study|Adverse Event|4
320545|NCT01371734|1083955|P3|Overall Study|Lack of Efficacy|0
320546|NCT01371734|1083956|P2|Overall Study|Lack of Efficacy|2
320547|NCT01371734|1083957|P1|Overall Study|Lack of Efficacy|2
320548|NCT01371734|1083955|P3|Overall Study|Adverse Event|3
320549|NCT01371734|1083956|P2|Overall Study|Adverse Event|8
320550|NCT01371734|1083957|P1|Overall Study|Adverse Event|8
320551|NCT01371734|1083955|P3|Overall Study|Protocol Violation|2
320552|NCT01371734|1083956|P2|Overall Study|Protocol Violation|1
320553|NCT01371734|1083957|P1|Overall Study|Protocol Violation|3
320554|NCT01371734|1083955|P3|Overall Study|Lost to Follow-up|1
320555|NCT01371734|1083956|P2|Overall Study|Lost to Follow-up|3
320556|NCT01371734|1083957|P1|Overall Study|Lost to Follow-up|5
320557|NCT01371734|1083955|P3|Overall Study|Withdrawal by Subject|9
320558|NCT01371734|1083956|P2|Overall Study|Withdrawal by Subject|4
320559|NCT01371734|1083957|P1|Overall Study|Withdrawal by Subject|3
320560|NCT01371734|1083955|P3|Overall Study|Not specified|2
320561|NCT01371734|1083956|P2|Overall Study|Not specified|1
320562|NCT01371734|1083957|P1|Overall Study|Not specified|2
320563|NCT01371721|1083977|P3|Overall Study|Randomized but not treated|0
320564|NCT01371721|1083978|P2|Overall Study|Randomized but not treated|0
320565|NCT01371721|1083979|P1|Overall Study|Randomized but not treated|1
320566|NCT01371721|1083977|P3|Overall Study|Lack of Efficacy|3
320567|NCT01371721|1083978|P2|Overall Study|Lack of Efficacy|4
320568|NCT01371721|1083979|P1|Overall Study|Lack of Efficacy|2
320569|NCT01371721|1083977|P3|Overall Study|Not specified|0
320570|NCT01371721|1083978|P2|Overall Study|Not specified|3
320571|NCT01371721|1083979|P1|Overall Study|Not specified|2
320572|NCT01371721|1083977|P3|Overall Study|Withdrawal by Subject|11
320573|NCT01371721|1083978|P2|Overall Study|Withdrawal by Subject|7
320574|NCT01371721|1083979|P1|Overall Study|Withdrawal by Subject|5
320575|NCT01371721|1083977|P3|Overall Study|Lost to Follow-up|6
320576|NCT01371721|1083978|P2|Overall Study|Lost to Follow-up|2
320577|NCT01371721|1083979|P1|Overall Study|Lost to Follow-up|8
320578|NCT01371721|1083977|P3|Overall Study|Protocol Violation|5
320579|NCT01371721|1083978|P2|Overall Study|Protocol Violation|4
320580|NCT01371721|1083979|P1|Overall Study|Protocol Violation|6
320581|NCT01371721|1083977|P3|Overall Study|Adverse Event|5
320582|NCT01371721|1083978|P2|Overall Study|Adverse Event|4
320583|NCT01371721|1083979|P1|Overall Study|Adverse Event|5
320584|NCT01371708|1084012|P3|Overall Study|Started but did not receive treatment|1
320585|NCT01371708|1084013|P2|Overall Study|Started but did not receive treatment|0
320586|NCT01371708|1084014|P1|Overall Study|Started but did not receive treatment|1
320587|NCT01371708|1084012|P3|Overall Study|Adverse Event|12
320588|NCT01371708|1084013|P2|Overall Study|Adverse Event|8
320589|NCT01371708|1084014|P1|Overall Study|Adverse Event|5
320590|NCT01371708|1084012|P3|Overall Study|Not specified|4
320591|NCT01371708|1084013|P2|Overall Study|Not specified|2
320592|NCT01371708|1084014|P1|Overall Study|Not specified|3
320593|NCT01371708|1084012|P3|Overall Study|Medication error/not related to AE|0
320594|NCT01371708|1084013|P2|Overall Study|Medication error/not related to AE|1
320595|NCT01371708|1084014|P1|Overall Study|Medication error/not related to AE|0
320596|NCT01371708|1084012|P3|Overall Study|No longer willing to participate|13
320597|NCT01371708|1084013|P2|Overall Study|No longer willing to participate|7
320598|NCT01371708|1084014|P1|Overall Study|No longer willing to participate|7
320599|NCT01371708|1084012|P3|Overall Study|Protocol Violation|2
320600|NCT01371708|1084013|P2|Overall Study|Protocol Violation|1
320601|NCT01371708|1084014|P1|Overall Study|Protocol Violation|2
320602|NCT01371708|1084012|P3|Overall Study|Lost to Follow-up|7
320603|NCT01371708|1084013|P2|Overall Study|Lost to Follow-up|9
320604|NCT01371708|1084014|P1|Overall Study|Lost to Follow-up|5
320605|NCT01371708|1084012|P3|Overall Study|Insufficient clinical response|0
320606|NCT01371708|1084013|P2|Overall Study|Insufficient clinical response|2
320607|NCT01371708|1084014|P1|Overall Study|Insufficient clinical response|3
320608|NCT01371656|1084046|P2|Overall Study|Ineligible|3
320609|NCT01371656|1084047|P1|Overall Study|Ineligible|4
320610|NCT01371656|1084046|P2|Overall Study|Withdrawal by Subject|0
320611|NCT01371656|1084047|P1|Overall Study|Withdrawal by Subject|7
320612|NCT01371656|1084046|P2|Overall Study|Physician Decision|7
320613|NCT01371656|1084047|P1|Overall Study|Physician Decision|46
320614|NCT01371656|1084046|P2|Overall Study|Death|4
320615|NCT01371656|1084047|P1|Overall Study|Death|7
320616|NCT01371643|1084067|P2|Overall Study|Withdrawal by Subject|0
320617|NCT01371643|1084068|P1|Overall Study|Withdrawal by Subject|3
320618|NCT01371565|1084078|P1|Overall Study|Resection of neuroendocrine tumor|1
320619|NCT01371565|1084078|P1|Overall Study|Death|1
320620|NCT01371565|1084078|P1|Overall Study|Withdrawal by Subject|1
320621|NCT01371552|1084082|P6|Part 1, First 3 Days|Inconvenience|0
320622|NCT01371552|1084083|P5|Part 1, First 3 Days|Inconvenience|0
320623|NCT01371552|1084084|P4|Part 1, First 3 Days|Inconvenience|0
320624|NCT01371552|1084085|P3|Part 1, First 3 Days|Inconvenience|1
320625|NCT01371552|1084086|P2|Part 1, First 3 Days|Inconvenience|0
320626|NCT01371552|1084087|P1|Part 1, First 3 Days|Inconvenience|0
320627|NCT01371539|1084114|P2|Period Two: One Week|Time/job conflict|1
320628|NCT01371539|1084115|P1|Period Two: One Week|Time/job conflict|0
320629|NCT01371539|1084114|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
320630|NCT01371539|1084115|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
320631|NCT01371539|1084114|P2|Period Two: One Week|Lost to Follow-up|1
320632|NCT01371539|1084115|P1|Period Two: One Week|Lost to Follow-up|0
320633|NCT01371539|1084114|P2|Period One: One Week|Lost to Follow-up|1
320634|NCT01371539|1084115|P1|Period One: One Week|Lost to Follow-up|0
320635|NCT01371006|1084136|P2|Overall Study|Adverse Event|0
320636|NCT01371006|1084137|P1|Overall Study|Adverse Event|1
320637|NCT01370863|1084178|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
320638|NCT01370863|1084179|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
320639|NCT01370863|1084178|P2|Overall Study|Did not want second pH/MII monitoring|1
320640|NCT01370863|1084179|P1|Overall Study|Did not want second pH/MII monitoring|1
320641|NCT01370863|1084178|P2|Overall Study|Adverse Event|1
320642|NCT01370863|1084179|P1|Overall Study|Adverse Event|1
320643|NCT01370733|1084204|P2|Overall Study|Protocol Violation|3
320644|NCT01370733|1084205|P1|Overall Study|Protocol Violation|1
320645|NCT01370733|1084204|P2|Overall Study|Physician Decision|2
320646|NCT01370733|1084205|P1|Overall Study|Physician Decision|0
320647|NCT01370733|1084204|P2|Overall Study|Lack of Efficacy|5
320648|NCT01370733|1084205|P1|Overall Study|Lack of Efficacy|3
320649|NCT01370733|1084204|P2|Overall Study|Adverse Event|4
320650|NCT01370733|1084205|P1|Overall Study|Adverse Event|2
320651|NCT01370733|1084204|P2|Overall Study|Lost to Follow-up|0
320652|NCT01370733|1084205|P1|Overall Study|Lost to Follow-up|3
320653|NCT01370733|1084204|P2|Overall Study|Withdrawal by Subject|8
320654|NCT01370733|1084205|P1|Overall Study|Withdrawal by Subject|8
320655|NCT01370694|1084227|P1|Overall Study|Progressive disease|2
320656|NCT01370694|1084227|P1|Overall Study|Switched to rituximab|4
320657|NCT01370655|1084249|P12|Period 2|Withdrawal by Subject|0
320658|NCT01370655|1084250|P11|Period 2|Withdrawal by Subject|0
320659|NCT01370655|1084251|P10|Period 2|Withdrawal by Subject|0
320660|NCT01370655|1084252|P9|Period 2|Withdrawal by Subject|1
320661|NCT01370655|1084253|P8|Period 2|Withdrawal by Subject|0
320662|NCT01370655|1084254|P7|Period 2|Withdrawal by Subject|0
320663|NCT01370655|1084255|P6|Period 2|Withdrawal by Subject|0
320664|NCT01370655|1084256|P5|Period 2|Withdrawal by Subject|0
320665|NCT01370655|1084257|P4|Period 2|Withdrawal by Subject|0
320666|NCT01370655|1084258|P3|Period 2|Withdrawal by Subject|0
320667|NCT01370655|1084259|P2|Period 2|Withdrawal by Subject|0
320668|NCT01370655|1084260|P1|Period 2|Withdrawal by Subject|0
320669|NCT01370655|1084249|P12|Period 2|met protocol specified stopping criteria|0
320670|NCT01370655|1084250|P11|Period 2|met protocol specified stopping criteria|1
320671|NCT01370655|1084251|P10|Period 2|met protocol specified stopping criteria|0
320672|NCT01370655|1084252|P9|Period 2|met protocol specified stopping criteria|1
320673|NCT01370655|1084253|P8|Period 2|met protocol specified stopping criteria|0
320674|NCT01370655|1084254|P7|Period 2|met protocol specified stopping criteria|1
320675|NCT01370655|1084255|P6|Period 2|met protocol specified stopping criteria|0
320676|NCT01370655|1084256|P5|Period 2|met protocol specified stopping criteria|0
320677|NCT01370655|1084257|P4|Period 2|met protocol specified stopping criteria|0
320678|NCT01370655|1084258|P3|Period 2|met protocol specified stopping criteria|1
320679|NCT01370655|1084259|P2|Period 2|met protocol specified stopping criteria|0
320680|NCT01370655|1084260|P1|Period 2|met protocol specified stopping criteria|0
320681|NCT01370655|1084249|P12|Period 2|Adverse Event|0
320682|NCT01370655|1084250|P11|Period 2|Adverse Event|0
320683|NCT01370655|1084251|P10|Period 2|Adverse Event|0
320684|NCT01370655|1084252|P9|Period 2|Adverse Event|0
320685|NCT01370655|1084253|P8|Period 2|Adverse Event|1
320686|NCT01370655|1084254|P7|Period 2|Adverse Event|0
320687|NCT01370655|1084255|P6|Period 2|Adverse Event|0
320688|NCT01370655|1084256|P5|Period 2|Adverse Event|1
320689|NCT01370655|1084257|P4|Period 2|Adverse Event|0
320690|NCT01370655|1084258|P3|Period 2|Adverse Event|1
320691|NCT01370655|1084259|P2|Period 2|Adverse Event|0
320692|NCT01370655|1084260|P1|Period 2|Adverse Event|0
320693|NCT01370655|1084249|P12|Period 1|Adverse Event|0
320694|NCT01370655|1084250|P11|Period 1|Adverse Event|0
320695|NCT01370655|1084251|P10|Period 1|Adverse Event|0
320696|NCT01370655|1084252|P9|Period 1|Adverse Event|0
320697|NCT01370655|1084253|P8|Period 1|Adverse Event|0
320698|NCT01370655|1084254|P7|Period 1|Adverse Event|1
320699|NCT01370655|1084255|P6|Period 1|Adverse Event|0
320700|NCT01370655|1084256|P5|Period 1|Adverse Event|0
320701|NCT01370655|1084257|P4|Period 1|Adverse Event|0
320702|NCT01370655|1084258|P3|Period 1|Adverse Event|0
320703|NCT01370655|1084259|P2|Period 1|Adverse Event|0
320704|NCT01370655|1084260|P1|Period 1|Adverse Event|2
320705|NCT01370642|1084297|P3|Overall Study|Withdrawal by Subject|3
320706|NCT01370642|1084298|P2|Overall Study|Withdrawal by Subject|4
320707|NCT01370642|1084299|P1|Overall Study|Withdrawal by Subject|2
320708|NCT01370642|1084297|P3|Overall Study|Physician Decision|2
320709|NCT01370642|1084298|P2|Overall Study|Physician Decision|1
320710|NCT01370642|1084299|P1|Overall Study|Physician Decision|4
320711|NCT01370642|1084297|P3|Overall Study|Lost to Follow-up|1
320712|NCT01370642|1084298|P2|Overall Study|Lost to Follow-up|0
320713|NCT01370642|1084299|P1|Overall Study|Lost to Follow-up|0
320714|NCT01370642|1084297|P3|Overall Study|Detectable HCV RNA|22
320715|NCT01370642|1084298|P2|Overall Study|Detectable HCV RNA|0
320716|NCT01370642|1084299|P1|Overall Study|Detectable HCV RNA|0
320717|NCT01370642|1084297|P3|Overall Study|Adverse Event|1
320718|NCT01370642|1084298|P2|Overall Study|Adverse Event|1
320719|NCT01370642|1084299|P1|Overall Study|Adverse Event|2
320720|NCT01370616|1084330|P2|Overall Study|Withdrawal by Subject|34
320721|NCT01370616|1084331|P1|Overall Study|Withdrawal by Subject|34
320722|NCT01370616|1084330|P2|Overall Study|Technical Problems|5
320723|NCT01370616|1084331|P1|Overall Study|Technical Problems|3
320724|NCT01370616|1084330|P2|Overall Study|Recovery|0
320725|NCT01370616|1084331|P1|Overall Study|Recovery|1
320726|NCT01370616|1084330|P2|Overall Study|Progressive Disease|1
320727|NCT01370616|1084331|P1|Overall Study|Progressive Disease|0
320728|NCT01370616|1084330|P2|Overall Study|Physician Decision|6
320729|NCT01370616|1084331|P1|Overall Study|Physician Decision|6
320730|NCT01370616|1084330|P2|Overall Study|Lost to Follow-up|3
320731|NCT01370616|1084331|P1|Overall Study|Lost to Follow-up|0
320732|NCT01370616|1084330|P2|Overall Study|Lack of Efficacy|2
320733|NCT01370616|1084331|P1|Overall Study|Lack of Efficacy|6
320734|NCT01370616|1084330|P2|Overall Study|Death|0
320735|NCT01370616|1084331|P1|Overall Study|Death|1
320736|NCT01370616|1084330|P2|Overall Study|Adverse Event|16
320737|NCT01370616|1084331|P1|Overall Study|Adverse Event|11
320738|NCT01370603|1084355|P2|Period 2|Withdrawal by Subject|0
320739|NCT01370603|1084356|P1|Period 2|Withdrawal by Subject|1
320740|NCT01370603|1084355|P2|Period 2|Lost to Follow-up|0
320741|NCT01370603|1084356|P1|Period 2|Lost to Follow-up|1
320742|NCT01370603|1084355|P2|Period 2|Adverse Event|4
320743|NCT01370603|1084356|P1|Period 2|Adverse Event|1
320744|NCT01370603|1084355|P2|Crossover Washout|Non-compliance with Study Drug|2
320745|NCT01370603|1084356|P1|Crossover Washout|Non-compliance with Study Drug|0
320746|NCT01370603|1084355|P2|Crossover Washout|Withdrawal by Subject|1
320747|NCT01370603|1084356|P1|Crossover Washout|Withdrawal by Subject|4
320748|NCT01370603|1084355|P2|Crossover Washout|Protocol Violation|0
320749|NCT01370603|1084356|P1|Crossover Washout|Protocol Violation|1
320750|NCT01370603|1084355|P2|Crossover Washout|Lost to Follow-up|0
320751|NCT01370603|1084356|P1|Crossover Washout|Lost to Follow-up|2
320752|NCT01370603|1084355|P2|Crossover Washout|Adverse Event|1
320753|NCT01370603|1084356|P1|Crossover Washout|Adverse Event|2
320754|NCT01370603|1084355|P2|Period 1|Withdrawal by Subject|5
320755|NCT01370603|1084356|P1|Period 1|Withdrawal by Subject|5
320756|NCT01370603|1084355|P2|Period 1|Protocol Violation|2
320757|NCT01370603|1084356|P1|Period 1|Protocol Violation|2
320758|NCT01370603|1084355|P2|Period 1|Lost to Follow-up|0
320759|NCT01370603|1084356|P1|Period 1|Lost to Follow-up|2
320760|NCT01370603|1084355|P2|Period 1|Adverse Event|3
320761|NCT01370603|1084356|P1|Period 1|Adverse Event|5
320762|NCT01370590|1084374|P2|Period 2|Withdrawal by Subject|1
320763|NCT01370590|1084375|P1|Period 2|Withdrawal by Subject|1
320764|NCT01370590|1084374|P2|Period 2|Adverse Event|1
320765|NCT01370590|1084375|P1|Period 2|Adverse Event|0
320766|NCT01370590|1084374|P2|Crossover Washout Period|Withdrawal by Subject|2
320767|NCT01370590|1084375|P1|Crossover Washout Period|Withdrawal by Subject|2
320768|NCT01370590|1084374|P2|Crossover Washout Period|Non-compliance with Study Drug|0
320769|NCT01370590|1084375|P1|Crossover Washout Period|Non-compliance with Study Drug|1
320770|NCT01370590|1084374|P2|Crossover Washout Period|Lost to Follow-up|0
320771|NCT01370590|1084375|P1|Crossover Washout Period|Lost to Follow-up|2
320772|NCT01370590|1084374|P2|Crossover Washout Period|Adverse Event|4
320773|NCT01370590|1084375|P1|Crossover Washout Period|Adverse Event|1
320774|NCT01370590|1084374|P2|Period 1|Could not access randomization system|1
320775|NCT01370590|1084375|P1|Period 1|Could not access randomization system|0
320776|NCT01370590|1084374|P2|Period 1|Withdrawal by Subject|2
320777|NCT01370590|1084375|P1|Period 1|Withdrawal by Subject|4
320778|NCT01370590|1084374|P2|Period 1|Protocol Violation|2
320779|NCT01370590|1084375|P1|Period 1|Protocol Violation|2
320780|NCT01370590|1084374|P2|Period 1|Lost to Follow-up|2
320781|NCT01370590|1084375|P1|Period 1|Lost to Follow-up|2
320782|NCT01370590|1084374|P2|Period 1|Adverse Event|4
320783|NCT01370590|1084375|P1|Period 1|Adverse Event|8
320784|NCT01370538|1084393|P2|Overall Study|Lost to follow up|10
320785|NCT01370538|1084394|P1|Overall Study|Lost to follow up|6
320786|NCT01370538|1084393|P2|Overall Study|Development of study specific withdrawal|1
320787|NCT01370538|1084394|P1|Overall Study|Development of study specific withdrawal|1
320788|NCT01370538|1084393|P2|Overall Study|Protocol Violation|5
320789|NCT01370538|1084394|P1|Overall Study|Protocol Violation|8
320790|NCT01370538|1084393|P2|Overall Study|Adverse Event|0
320791|NCT01370538|1084394|P1|Overall Study|Adverse Event|1
320792|NCT01370538|1084393|P2|Overall Study|Eligibility criteria not fulfilled|1
320793|NCT01370538|1084394|P1|Overall Study|Eligibility criteria not fulfilled|0
320794|NCT01370538|1084393|P2|Overall Study|Voluntary Discontinuation by Subject|2
320795|NCT01370538|1084394|P1|Overall Study|Voluntary Discontinuation by Subject|3
320796|NCT01370525|1084410|P2|Overall Study|Lost to follow up|6
320797|NCT01370525|1084411|P1|Overall Study|Lost to follow up|2
320798|NCT01370525|1084410|P2|Overall Study|Protocol Violation|1
320799|NCT01370525|1084411|P1|Overall Study|Protocol Violation|2
320800|NCT01370525|1084410|P2|Overall Study|Adverse Event|1
320801|NCT01370525|1084411|P1|Overall Study|Adverse Event|0
320802|NCT01370525|1084410|P2|Overall Study|Eligibility criteria not fulfilled|0
320803|NCT01370525|1084411|P1|Overall Study|Eligibility criteria not fulfilled|2
320804|NCT01370525|1084410|P2|Overall Study|Voluntary Discontinuation by Subject|3
320805|NCT01370525|1084411|P1|Overall Study|Voluntary Discontinuation by Subject|2
320806|NCT01370408|1084435|P1|Overall Study|treatment failure|9
320807|NCT01370356|1084495|P2|Overall Study|AE Not Related to Study Drug|4
320808|NCT01370356|1084496|P1|Overall Study|AE Not Related to Study Drug|1
320809|NCT01370356|1084495|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
320810|NCT01370356|1084496|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
320811|NCT01370356|1084495|P2|Overall Study|Protocol Violation|3
320812|NCT01370356|1084496|P1|Overall Study|Protocol Violation|3
320813|NCT01370356|1084495|P2|Overall Study|Reason not specified|43
320814|NCT01370356|1084496|P1|Overall Study|Reason not specified|39
320815|NCT01370356|1084495|P2|Overall Study|Withdrawal by Subject|59
320816|NCT01370356|1084496|P1|Overall Study|Withdrawal by Subject|54
320817|NCT01370356|1084495|P2|Overall Study|Lost to Follow-up|81
320818|NCT01370356|1084496|P1|Overall Study|Lost to Follow-up|76
320819|NCT01370356|1084495|P2|Overall Study|Lack of Efficacy|28
320820|NCT01370356|1084496|P1|Overall Study|Lack of Efficacy|6
320821|NCT01370356|1084495|P2|Overall Study|Death|0
320822|NCT01370356|1084496|P1|Overall Study|Death|1
320823|NCT01370265|1084510|P2|First Intervention|Adverse Event|1
320824|NCT01370265|1084511|P1|First Intervention|Adverse Event|1
320825|NCT01370083|1084530|P2|Overall Study|Adverse Event|1
320826|NCT01370083|1084531|P1|Overall Study|Adverse Event|0
320827|NCT01370083|1084530|P2|Overall Study|Lost to Follow-up|0
320828|NCT01370083|1084531|P1|Overall Study|Lost to Follow-up|2
320829|NCT01370005|1084544|P3|Overall Study|Other reason not defined above|2
320830|NCT01370005|1084545|P2|Overall Study|Other reason not defined above|0
320831|NCT01370005|1084546|P1|Overall Study|Other reason not defined above|3
320832|NCT01370005|1084544|P3|Overall Study|Patient refusal to continue,not due toAE|0
320833|NCT01370005|1084545|P2|Overall Study|Patient refusal to continue,not due toAE|4
320834|NCT01370005|1084546|P1|Overall Study|Patient refusal to continue,not due toAE|5
320835|NCT01370005|1084544|P3|Overall Study|Lost to Follow-up|1
320836|NCT01370005|1084545|P2|Overall Study|Lost to Follow-up|1
320837|NCT01370005|1084546|P1|Overall Study|Lost to Follow-up|1
320838|NCT01370005|1084544|P3|Overall Study|Non compliant with protocol|2
320839|NCT01370005|1084545|P2|Overall Study|Non compliant with protocol|1
320840|NCT01370005|1084546|P1|Overall Study|Non compliant with protocol|0
320841|NCT01370005|1084544|P3|Overall Study|Lack of Efficacy|0
320842|NCT01370005|1084545|P2|Overall Study|Lack of Efficacy|0
320843|NCT01370005|1084546|P1|Overall Study|Lack of Efficacy|1
320844|NCT01370005|1084544|P3|Overall Study|Adverse Event|6
320845|NCT01370005|1084545|P2|Overall Study|Adverse Event|5
320846|NCT01370005|1084546|P1|Overall Study|Adverse Event|5
320847|NCT01370005|1084544|P3|Overall Study|Not treated|0
320848|NCT01370005|1084545|P2|Overall Study|Not treated|0
320849|NCT01370005|1084546|P1|Overall Study|Not treated|1
320850|NCT01369849|1084628|P3|Overall Study|Ineligible after receiving treatment|0
320851|NCT01369849|1084629|P2|Overall Study|Ineligible after receiving treatment|1
320852|NCT01369849|1084630|P1|Overall Study|Ineligible after receiving treatment|0
320853|NCT01369849|1084628|P3|Overall Study|Ineligible prior to treatment|1
320854|NCT01369849|1084629|P2|Overall Study|Ineligible prior to treatment|0
320855|NCT01369849|1084630|P1|Overall Study|Ineligible prior to treatment|0
320856|NCT01369784|1084652|P1|Overall Study|Protocol Violation|12
320857|NCT01369680|1084740|P4|Overall Study|Lost to Follow-up|2
320858|NCT01369680|1084741|P3|Overall Study|Lost to Follow-up|1
320859|NCT01369680|1084742|P2|Overall Study|Lost to Follow-up|0
320860|NCT01369680|1084743|P1|Overall Study|Lost to Follow-up|0
320861|NCT01369641|1084764|P1|Overall Study|Withdrawal by Subject|1
320862|NCT01369615|1084770|P2|Overall Study|Lost to Follow-up|1
320863|NCT01369615|1084771|P1|Overall Study|Lost to Follow-up|0
320864|NCT01369615|1084770|P2|Overall Study|Withdrawal by Subject|1
320865|NCT01369615|1084771|P1|Overall Study|Withdrawal by Subject|0
320866|NCT01369511|1084781|P4|Overall Study|Withdrawal by Subject|6
320867|NCT01369511|1084782|P3|Overall Study|Withdrawal by Subject|4
320868|NCT01369511|1084783|P2|Overall Study|Withdrawal by Subject|6
320869|NCT01369511|1084784|P1|Overall Study|Withdrawal by Subject|5
320870|NCT01369511|1084781|P4|Overall Study|Sponsor decision|0
320871|NCT01369511|1084782|P3|Overall Study|Sponsor decision|1
320872|NCT01369511|1084783|P2|Overall Study|Sponsor decision|0
320873|NCT01369511|1084784|P1|Overall Study|Sponsor decision|2
320874|NCT01369511|1084781|P4|Overall Study|Physician Decision|0
320875|NCT01369511|1084782|P3|Overall Study|Physician Decision|0
320876|NCT01369511|1084783|P2|Overall Study|Physician Decision|4
320877|NCT01369511|1084784|P1|Overall Study|Physician Decision|3
320878|NCT01369511|1084781|P4|Overall Study|Protocol Violation|2
320879|NCT01369511|1084782|P3|Overall Study|Protocol Violation|0
320880|NCT01369511|1084783|P2|Overall Study|Protocol Violation|1
320881|NCT01369511|1084784|P1|Overall Study|Protocol Violation|0
320882|NCT01369511|1084781|P4|Overall Study|Lost to Follow-up|2
320883|NCT01369511|1084782|P3|Overall Study|Lost to Follow-up|1
320884|NCT01369511|1084783|P2|Overall Study|Lost to Follow-up|1
320885|NCT01369511|1084784|P1|Overall Study|Lost to Follow-up|0
320886|NCT01369511|1084781|P4|Overall Study|Entry criteria not met|1
320887|NCT01369511|1084782|P3|Overall Study|Entry criteria not met|0
320888|NCT01369511|1084783|P2|Overall Study|Entry criteria not met|0
320889|NCT01369511|1084784|P1|Overall Study|Entry criteria not met|2
320890|NCT01369511|1084781|P4|Overall Study|Adverse Event|0
320891|NCT01369511|1084782|P3|Overall Study|Adverse Event|5
320892|NCT01369511|1084783|P2|Overall Study|Adverse Event|1
320893|NCT01369511|1084784|P1|Overall Study|Adverse Event|1
320894|NCT01369485|1084800|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
320895|NCT01369485|1084801|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
320896|NCT01369485|1084800|P2|Open Label Phase (Week 12 to Month 12)|Death|1
320897|NCT01369485|1084801|P1|Open Label Phase (Week 12 to Month 12)|Death|0
320898|NCT01369485|1084800|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
320899|NCT01369485|1084801|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
320900|NCT01369485|1084800|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
320901|NCT01369485|1084801|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
320902|NCT01369485|1084800|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
320903|NCT01369485|1084801|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
320904|NCT01369485|1084800|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
320905|NCT01369485|1084801|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
320906|NCT01369485|1084800|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
320907|NCT01369485|1084801|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
320908|NCT01369485|1084800|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
320909|NCT01369485|1084801|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
320910|NCT01369485|1084800|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
320911|NCT01369485|1084801|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
320912|NCT01369485|1084800|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
320913|NCT01369485|1084801|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
320914|NCT01369355|1084847|P6|Overall Study|Not Treated|0
320915|NCT01369355|1084848|P5|Overall Study|Not Treated|0
320916|NCT01369355|1084849|P4|Overall Study|Not Treated|0
320917|NCT01369355|1084850|P3|Overall Study|Not Treated|1
320918|NCT01369355|1084851|P2|Overall Study|Not Treated|0
320919|NCT01369355|1084852|P1|Overall Study|Not Treated|0
320920|NCT01369355|1084847|P6|Overall Study|Other|0
320921|NCT01369355|1084848|P5|Overall Study|Other|1
320922|NCT01369355|1084849|P4|Overall Study|Other|0
320923|NCT01369355|1084850|P3|Overall Study|Other|0
320924|NCT01369355|1084851|P2|Overall Study|Other|0
320925|NCT01369355|1084852|P1|Overall Study|Other|0
320926|NCT01369355|1084847|P6|Overall Study|Withdrawal by Subject|22
320927|NCT01369355|1084848|P5|Overall Study|Withdrawal by Subject|8
320928|NCT01369355|1084849|P4|Overall Study|Withdrawal by Subject|6
320929|NCT01369355|1084850|P3|Overall Study|Withdrawal by Subject|7
320930|NCT01369355|1084851|P2|Overall Study|Withdrawal by Subject|2
320931|NCT01369355|1084852|P1|Overall Study|Withdrawal by Subject|6
320932|NCT01369355|1084847|P6|Overall Study|Lost to Follow-up|6
320933|NCT01369355|1084848|P5|Overall Study|Lost to Follow-up|5
320934|NCT01369355|1084849|P4|Overall Study|Lost to Follow-up|2
320935|NCT01369355|1084850|P3|Overall Study|Lost to Follow-up|1
320936|NCT01369355|1084851|P2|Overall Study|Lost to Follow-up|0
320937|NCT01369355|1084852|P1|Overall Study|Lost to Follow-up|1
320938|NCT01369355|1084847|P6|Overall Study|Protocol Violation|2
320939|NCT01369355|1084848|P5|Overall Study|Protocol Violation|0
320940|NCT01369355|1084849|P4|Overall Study|Protocol Violation|0
320941|NCT01369355|1084850|P3|Overall Study|Protocol Violation|1
320942|NCT01369355|1084851|P2|Overall Study|Protocol Violation|1
320943|NCT01369355|1084852|P1|Overall Study|Protocol Violation|0
320944|NCT01369355|1084847|P6|Overall Study|Lack of Efficacy|217
320945|NCT01369355|1084848|P5|Overall Study|Lack of Efficacy|126
320946|NCT01369355|1084849|P4|Overall Study|Lack of Efficacy|15
320947|NCT01369355|1084850|P3|Overall Study|Lack of Efficacy|15
320948|NCT01369355|1084851|P2|Overall Study|Lack of Efficacy|14
320949|NCT01369355|1084852|P1|Overall Study|Lack of Efficacy|15
320950|NCT01369355|1084847|P6|Overall Study|Adverse Event|25
320951|NCT01369355|1084848|P5|Overall Study|Adverse Event|14
320952|NCT01369355|1084849|P4|Overall Study|Adverse Event|7
320953|NCT01369355|1084850|P3|Overall Study|Adverse Event|6
320954|NCT01369355|1084851|P2|Overall Study|Adverse Event|12
320955|NCT01369355|1084852|P1|Overall Study|Adverse Event|9
320956|NCT01369342|1084881|P3|Overall Study|Not Treated|0
320957|NCT01369342|1084882|P2|Overall Study|Not Treated|0
320958|NCT01369342|1084883|P1|Overall Study|Not Treated|1
320959|NCT01369342|1084881|P3|Overall Study|Lost to Follow-up|1
320960|NCT01369342|1084882|P2|Overall Study|Lost to Follow-up|2
320961|NCT01369342|1084883|P1|Overall Study|Lost to Follow-up|5
320962|NCT01369342|1084881|P3|Overall Study|Withdrawal by Subject|2
320963|NCT01369342|1084882|P2|Overall Study|Withdrawal by Subject|7
320964|NCT01369342|1084883|P1|Overall Study|Withdrawal by Subject|7
320965|NCT01369329|1084906|P3|Overall Study|Other|2
320966|NCT01369329|1084907|P2|Overall Study|Other|3
320967|NCT01369329|1084908|P1|Overall Study|Other|2
320968|NCT01369329|1084906|P3|Overall Study|Lost to Follow-up|2
320969|NCT01369329|1084907|P2|Overall Study|Lost to Follow-up|2
320970|NCT01369329|1084908|P1|Overall Study|Lost to Follow-up|2
320971|NCT01369329|1084906|P3|Overall Study|Withdrawal by Subject|10
320972|NCT01369329|1084907|P2|Overall Study|Withdrawal by Subject|6
320973|NCT01369329|1084908|P1|Overall Study|Withdrawal by Subject|8
320974|NCT01369225|1084934|P6|Overall Study|Adverse Event|0
320975|NCT01369225|1084935|P5|Overall Study|Adverse Event|1
320976|NCT01369225|1084936|P4|Overall Study|Adverse Event|1
320977|NCT01369225|1084937|P3|Overall Study|Adverse Event|0
320978|NCT01369225|1084938|P2|Overall Study|Adverse Event|0
320979|NCT01369225|1084939|P1|Overall Study|Adverse Event|0
320980|NCT01369225|1084934|P6|Overall Study|Other|0
320981|NCT01369225|1084935|P5|Overall Study|Other|1
320982|NCT01369225|1084936|P4|Overall Study|Other|0
320983|NCT01369225|1084937|P3|Overall Study|Other|0
320984|NCT01369225|1084938|P2|Overall Study|Other|0
320985|NCT01369225|1084939|P1|Overall Study|Other|1
320986|NCT01369225|1084934|P6|Overall Study|Does Not Meet Entrance Criteria|0
320987|NCT01369225|1084935|P5|Overall Study|Does Not Meet Entrance Criteria|0
320988|NCT01369225|1084936|P4|Overall Study|Does Not Meet Entrance Criteria|0
320989|NCT01369225|1084937|P3|Overall Study|Does Not Meet Entrance Criteria|1
320990|NCT01369225|1084938|P2|Overall Study|Does Not Meet Entrance Criteria|0
320991|NCT01369225|1084939|P1|Overall Study|Does Not Meet Entrance Criteria|0
320992|NCT01369225|1084934|P6|Overall Study|Withdrawal by Subject|0
320993|NCT01369225|1084935|P5|Overall Study|Withdrawal by Subject|0
320994|NCT01369225|1084936|P4|Overall Study|Withdrawal by Subject|1
320995|NCT01369225|1084937|P3|Overall Study|Withdrawal by Subject|2
320996|NCT01369225|1084938|P2|Overall Study|Withdrawal by Subject|0
320997|NCT01369225|1084939|P1|Overall Study|Withdrawal by Subject|1
320998|NCT01368965|1085044|P1|Overall Study|Lost to Follow-up|12
320999|NCT01368900|1085053|P1|Overall Study|Lost to Follow-up|7
321000|NCT01368835|1085128|P1|Overall Study|Lost to Follow-up|11
321001|NCT01368835|1085128|P1|Overall Study|Inclusion criteria/photography quality|22
321002|NCT01368536|1085170|P3|Overall Study|Protocol deviation|1
321003|NCT01368536|1085171|P2|Overall Study|Protocol deviation|3
321004|NCT01368536|1085172|P1|Overall Study|Protocol deviation|0
321005|NCT01368536|1085170|P3|Overall Study|Administrative problems|35
321006|NCT01368536|1085171|P2|Overall Study|Administrative problems|39
321007|NCT01368536|1085172|P1|Overall Study|Administrative problems|34
321008|NCT01368536|1085170|P3|Overall Study|Lost to Follow-up|5
321009|NCT01368536|1085171|P2|Overall Study|Lost to Follow-up|3
321010|NCT01368536|1085172|P1|Overall Study|Lost to Follow-up|3
321011|NCT01368536|1085170|P3|Overall Study|Withdrawal by Subject|4
321012|NCT01368536|1085171|P2|Overall Study|Withdrawal by Subject|5
321013|NCT01368536|1085172|P1|Overall Study|Withdrawal by Subject|2
321014|NCT01368536|1085170|P3|Overall Study|No longer required study medication|1
321015|NCT01368536|1085171|P2|Overall Study|No longer required study medication|0
321016|NCT01368536|1085172|P1|Overall Study|No longer required study medication|0
321017|NCT01368536|1085170|P3|Overall Study|Unsatisfactory therapeutic effect|2
321018|NCT01368536|1085171|P2|Overall Study|Unsatisfactory therapeutic effect|2
321019|NCT01368536|1085172|P1|Overall Study|Unsatisfactory therapeutic effect|7
321020|NCT01368536|1085170|P3|Overall Study|Abnormal test procedure result(s)|1
321021|NCT01368536|1085171|P2|Overall Study|Abnormal test procedure result(s)|0
321022|NCT01368536|1085172|P1|Overall Study|Abnormal test procedure result(s)|0
321023|NCT01368536|1085170|P3|Overall Study|Abnormal laboratory value(s)|2
321024|NCT01368536|1085171|P2|Overall Study|Abnormal laboratory value(s)|1
321025|NCT01368536|1085172|P1|Overall Study|Abnormal laboratory value(s)|0
321026|NCT01368536|1085170|P3|Overall Study|Adverse Event|8
321027|NCT01368536|1085171|P2|Overall Study|Adverse Event|6
321028|NCT01368536|1085172|P1|Overall Study|Adverse Event|5
321029|NCT01368432|1085195|P2|Overall Study|Lost to Follow-up|1
321030|NCT01368432|1085196|P1|Overall Study|Lost to Follow-up|0
321031|NCT01368406|1085230|P2|Overall Study|started working|3
321032|NCT01368406|1085231|P1|Overall Study|started working|2
321033|NCT01368406|1085230|P2|Overall Study|relapse of the disease|2
321034|NCT01368406|1085231|P1|Overall Study|relapse of the disease|3
321035|NCT01368406|1085230|P2|Overall Study|Withdrawal by Subject|4
321036|NCT01368406|1085231|P1|Overall Study|Withdrawal by Subject|8
321037|NCT01368406|1085230|P2|Overall Study|Lost to Follow-up|4
321038|NCT01368406|1085231|P1|Overall Study|Lost to Follow-up|8
321039|NCT01368276|1085239|P2|Overall Study|Death|10
321040|NCT01368276|1085240|P1|Overall Study|Death|1
321041|NCT01368211|1085277|P2|Second Platelets Transfusion|No need for additional transfusion|2
321042|NCT01368211|1085278|P1|Second Platelets Transfusion|No need for additional transfusion|1
321043|NCT01368081|1085306|P13|Overall Study|Other reason not defined above|3
321044|NCT01368081|1085307|P12|Overall Study|Other reason not defined above|0
321045|NCT01368081|1085308|P11|Overall Study|Other reason not defined above|0
321046|NCT01368081|1085309|P10|Overall Study|Other reason not defined above|1
321047|NCT01368081|1085310|P9|Overall Study|Other reason not defined above|0
321048|NCT01368081|1085311|P8|Overall Study|Other reason not defined above|0
321049|NCT01368081|1085312|P7|Overall Study|Other reason not defined above|2
321050|NCT01368081|1085313|P6|Overall Study|Other reason not defined above|1
321051|NCT01368081|1085314|P5|Overall Study|Other reason not defined above|0
321052|NCT01368081|1085315|P4|Overall Study|Other reason not defined above|1
321053|NCT01368081|1085316|P3|Overall Study|Other reason not defined above|0
321054|NCT01368081|1085317|P2|Overall Study|Other reason not defined above|0
321055|NCT01368081|1085318|P1|Overall Study|Other reason not defined above|2
321056|NCT01368081|1085306|P13|Overall Study|Withdrawal by Subject|0
321057|NCT01368081|1085307|P12|Overall Study|Withdrawal by Subject|2
321058|NCT01368081|1085308|P11|Overall Study|Withdrawal by Subject|3
321059|NCT01368081|1085309|P10|Overall Study|Withdrawal by Subject|4
321060|NCT01368081|1085310|P9|Overall Study|Withdrawal by Subject|5
321061|NCT01368081|1085311|P8|Overall Study|Withdrawal by Subject|2
321062|NCT01368081|1085312|P7|Overall Study|Withdrawal by Subject|4
321063|NCT01368081|1085313|P6|Overall Study|Withdrawal by Subject|3
321064|NCT01368081|1085314|P5|Overall Study|Withdrawal by Subject|0
321065|NCT01368081|1085315|P4|Overall Study|Withdrawal by Subject|1
321066|NCT01368081|1085316|P3|Overall Study|Withdrawal by Subject|1
321067|NCT01368081|1085317|P2|Overall Study|Withdrawal by Subject|4
321068|NCT01368081|1085318|P1|Overall Study|Withdrawal by Subject|4
321069|NCT01368081|1085306|P13|Overall Study|Lost to Follow-up|1
321070|NCT01368081|1085307|P12|Overall Study|Lost to Follow-up|0
321071|NCT01368081|1085308|P11|Overall Study|Lost to Follow-up|0
321072|NCT01368081|1085309|P10|Overall Study|Lost to Follow-up|0
321073|NCT01368081|1085310|P9|Overall Study|Lost to Follow-up|0
321074|NCT01368081|1085311|P8|Overall Study|Lost to Follow-up|0
321075|NCT01368081|1085312|P7|Overall Study|Lost to Follow-up|0
321076|NCT01368081|1085313|P6|Overall Study|Lost to Follow-up|0
321077|NCT01368081|1085314|P5|Overall Study|Lost to Follow-up|0
321078|NCT01368081|1085315|P4|Overall Study|Lost to Follow-up|0
321079|NCT01368081|1085316|P3|Overall Study|Lost to Follow-up|0
321080|NCT01368081|1085317|P2|Overall Study|Lost to Follow-up|0
321081|NCT01368081|1085318|P1|Overall Study|Lost to Follow-up|0
321082|NCT01368081|1085306|P13|Overall Study|Protocol Violation|0
321083|NCT01368081|1085307|P12|Overall Study|Protocol Violation|0
321084|NCT01368081|1085308|P11|Overall Study|Protocol Violation|0
321085|NCT01368081|1085309|P10|Overall Study|Protocol Violation|0
321086|NCT01368081|1085310|P9|Overall Study|Protocol Violation|0
321087|NCT01368081|1085311|P8|Overall Study|Protocol Violation|1
321088|NCT01368081|1085312|P7|Overall Study|Protocol Violation|0
321089|NCT01368081|1085313|P6|Overall Study|Protocol Violation|1
321090|NCT01368081|1085314|P5|Overall Study|Protocol Violation|0
321091|NCT01368081|1085315|P4|Overall Study|Protocol Violation|0
321092|NCT01368081|1085316|P3|Overall Study|Protocol Violation|0
321093|NCT01368081|1085317|P2|Overall Study|Protocol Violation|0
321094|NCT01368081|1085318|P1|Overall Study|Protocol Violation|0
321095|NCT01368081|1085306|P13|Overall Study|Lack of Efficacy|0
321096|NCT01368081|1085307|P12|Overall Study|Lack of Efficacy|0
321097|NCT01368081|1085308|P11|Overall Study|Lack of Efficacy|0
321098|NCT01368081|1085309|P10|Overall Study|Lack of Efficacy|0
321099|NCT01368081|1085310|P9|Overall Study|Lack of Efficacy|0
321100|NCT01368081|1085311|P8|Overall Study|Lack of Efficacy|2
321101|NCT01368081|1085312|P7|Overall Study|Lack of Efficacy|0
321102|NCT01368081|1085313|P6|Overall Study|Lack of Efficacy|0
321103|NCT01368081|1085314|P5|Overall Study|Lack of Efficacy|0
321104|NCT01368081|1085315|P4|Overall Study|Lack of Efficacy|1
321105|NCT01368081|1085316|P3|Overall Study|Lack of Efficacy|0
321106|NCT01368081|1085317|P2|Overall Study|Lack of Efficacy|1
321107|NCT01368081|1085318|P1|Overall Study|Lack of Efficacy|0
321108|NCT01368081|1085306|P13|Overall Study|Adverse Event|3
321109|NCT01368081|1085307|P12|Overall Study|Adverse Event|1
321110|NCT01368081|1085308|P11|Overall Study|Adverse Event|6
321111|NCT01368081|1085309|P10|Overall Study|Adverse Event|5
321112|NCT01368081|1085310|P9|Overall Study|Adverse Event|3
321113|NCT01368081|1085311|P8|Overall Study|Adverse Event|2
321114|NCT01368081|1085312|P7|Overall Study|Adverse Event|6
321115|NCT01368081|1085313|P6|Overall Study|Adverse Event|5
321116|NCT01368081|1085314|P5|Overall Study|Adverse Event|2
321117|NCT01368081|1085315|P4|Overall Study|Adverse Event|2
321118|NCT01368081|1085316|P3|Overall Study|Adverse Event|3
321119|NCT01368081|1085317|P2|Overall Study|Adverse Event|4
321120|NCT01368081|1085318|P1|Overall Study|Adverse Event|4
321121|NCT01368042|1085372|P1|Overall Study|Transplanted|1
321122|NCT01368042|1085372|P1|Overall Study|Lost to Follow-up|4
321123|NCT01368042|1085372|P1|Overall Study|Protocol Violation|11
321124|NCT01368042|1085372|P1|Overall Study|Death|14
321125|NCT01367886|1085392|P1|Overall Study|Death|1
321126|NCT01367886|1085392|P1|Overall Study|Lack of Efficacy|2
321127|NCT01367886|1085392|P1|Overall Study|Lost to Follow-up|4
321128|NCT01367834|1085442|P2|Overall Study|Study was ended.|1
321129|NCT01367834|1085443|P1|Overall Study|Study was ended.|0
321130|NCT01367834|1085442|P2|Overall Study|Withdrawal by Subject|2
321131|NCT01367834|1085443|P1|Overall Study|Withdrawal by Subject|2
321132|NCT01367704|1085467|P2|Overall Study|Lost to Follow-up|161
321133|NCT01367704|1085468|P1|Overall Study|Lost to Follow-up|47
321134|NCT01367457|1085481|P3|Overall Study|Suspected DP/suspected active infection|0
321135|NCT01367457|1085482|P2|Overall Study|Suspected DP/suspected active infection|0
321136|NCT01367457|1085483|P1|Overall Study|Suspected DP/suspected active infection|1
321137|NCT01367457|1085481|P3|Overall Study|Palliative. Overall decline|0
321138|NCT01367457|1085482|P2|Overall Study|Palliative. Overall decline|0
321139|NCT01367457|1085483|P1|Overall Study|Palliative. Overall decline|1
321140|NCT01367457|1085481|P3|Overall Study|Patient's Wish|0
321141|NCT01367457|1085482|P2|Overall Study|Patient's Wish|0
321142|NCT01367457|1085483|P1|Overall Study|Patient's Wish|1
321143|NCT01367457|1085481|P3|Overall Study|CD, Suspected disease progression (DP)|0
321144|NCT01367457|1085482|P2|Overall Study|CD, Suspected disease progression (DP)|0
321145|NCT01367457|1085483|P1|Overall Study|CD, Suspected disease progression (DP)|1
321146|NCT01367457|1085481|P3|Overall Study|Death from septic shock|0
321147|NCT01367457|1085482|P2|Overall Study|Death from septic shock|0
321148|NCT01367457|1085483|P1|Overall Study|Death from septic shock|1
321149|NCT01367457|1085481|P3|Overall Study|Lost to Follow-up|0
321150|NCT01367457|1085482|P2|Overall Study|Lost to Follow-up|0
321151|NCT01367457|1085483|P1|Overall Study|Lost to Follow-up|1
321152|NCT01367457|1085481|P3|Overall Study|Rejection of treatment|0
321153|NCT01367457|1085482|P2|Overall Study|Rejection of treatment|0
321154|NCT01367457|1085483|P1|Overall Study|Rejection of treatment|1
321155|NCT01367457|1085481|P3|Overall Study|Overall decline|0
321156|NCT01367457|1085482|P2|Overall Study|Overall decline|0
321157|NCT01367457|1085483|P1|Overall Study|Overall decline|1
321158|NCT01367457|1085481|P3|Overall Study|Intestinal obstruction with necrosis|0
321159|NCT01367457|1085482|P2|Overall Study|Intestinal obstruction with necrosis|0
321160|NCT01367457|1085483|P1|Overall Study|Intestinal obstruction with necrosis|1
321161|NCT01367457|1085481|P3|Overall Study|No clinical benefit|0
321162|NCT01367457|1085482|P2|Overall Study|No clinical benefit|0
321163|NCT01367457|1085483|P1|Overall Study|No clinical benefit|1
321164|NCT01367457|1085481|P3|Overall Study|Stabilisation + frequent infections|0
321165|NCT01367457|1085482|P2|Overall Study|Stabilisation + frequent infections|0
321166|NCT01367457|1085483|P1|Overall Study|Stabilisation + frequent infections|1
321167|NCT01367457|1085481|P3|Overall Study|Overall status worsens to grade 4|0
321168|NCT01367457|1085482|P2|Overall Study|Overall status worsens to grade 4|0
321169|NCT01367457|1085483|P1|Overall Study|Overall status worsens to grade 4|1
321170|NCT01367457|1085481|P3|Overall Study|Uncontrolled pain|0
321171|NCT01367457|1085482|P2|Overall Study|Uncontrolled pain|0
321172|NCT01367457|1085483|P1|Overall Study|Uncontrolled pain|1
321173|NCT01367457|1085481|P3|Overall Study|CD, associated leukaemia|0
321174|NCT01367457|1085482|P2|Overall Study|CD, associated leukaemia|0
321175|NCT01367457|1085483|P1|Overall Study|CD, associated leukaemia|1
321176|NCT01367457|1085481|P3|Overall Study|Withdrawal by Subject|0
321177|NCT01367457|1085482|P2|Overall Study|Withdrawal by Subject|0
321178|NCT01367457|1085483|P1|Overall Study|Withdrawal by Subject|1
321179|NCT01367457|1085481|P3|Overall Study|Choledocolithiasis and pancreatitis|0
321180|NCT01367457|1085482|P2|Overall Study|Choledocolithiasis and pancreatitis|0
321181|NCT01367457|1085483|P1|Overall Study|Choledocolithiasis and pancreatitis|1
321182|NCT01367457|1085481|P3|Overall Study|low grade toxicities + stable disease|0
321183|NCT01367457|1085482|P2|Overall Study|low grade toxicities + stable disease|0
321184|NCT01367457|1085483|P1|Overall Study|low grade toxicities + stable disease|1
321185|NCT01367457|1085481|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
321186|NCT01367457|1085482|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
321187|NCT01367457|1085483|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
321188|NCT01367457|1085481|P3|Overall Study|Bleeding from cavernous haemangioma|0
321189|NCT01367457|1085482|P2|Overall Study|Bleeding from cavernous haemangioma|0
321190|NCT01367457|1085483|P1|Overall Study|Bleeding from cavernous haemangioma|1
321191|NCT01367457|1085481|P3|Overall Study|Investigator's opinion, stable disease|0
321192|NCT01367457|1085482|P2|Overall Study|Investigator's opinion, stable disease|0
321282|NCT01366534|1085802|P1|Overall Study|Lost to Follow-up|1
321193|NCT01367457|1085483|P1|Overall Study|Investigator's opinion, stable disease|1
321194|NCT01367457|1085481|P3|Overall Study|Patient asks for rest + slow progression|0
321195|NCT01367457|1085482|P2|Overall Study|Patient asks for rest + slow progression|0
321196|NCT01367457|1085483|P1|Overall Study|Patient asks for rest + slow progression|1
321197|NCT01367457|1085481|P3|Overall Study|Progression|0
321198|NCT01367457|1085482|P2|Overall Study|Progression|0
321199|NCT01367457|1085483|P1|Overall Study|Progression|137
321200|NCT01367457|1085481|P3|Overall Study|Toxicity|0
321201|NCT01367457|1085482|P2|Overall Study|Toxicity|0
321202|NCT01367457|1085483|P1|Overall Study|Toxicity|16
321203|NCT01367457|1085481|P3|Overall Study|Progression and death|0
321204|NCT01367457|1085482|P2|Overall Study|Progression and death|0
321205|NCT01367457|1085483|P1|Overall Study|Progression and death|8
321206|NCT01367457|1085481|P3|Overall Study|Clinical decline (CD)|0
321207|NCT01367457|1085482|P2|Overall Study|Clinical decline (CD)|0
321208|NCT01367457|1085483|P1|Overall Study|Clinical decline (CD)|2
321209|NCT01367457|1085481|P3|Overall Study|Investigator's decision|0
321210|NCT01367457|1085482|P2|Overall Study|Investigator's decision|0
321211|NCT01367457|1085483|P1|Overall Study|Investigator's decision|2
321212|NCT01367457|1085481|P3|Overall Study|Death|0
321213|NCT01367457|1085482|P2|Overall Study|Death|0
321214|NCT01367457|1085483|P1|Overall Study|Death|2
321215|NCT01367249|1085505|P2|Overall Study|Not Specified|10
321216|NCT01367249|1085506|P1|Overall Study|Not Specified|3
321217|NCT01367249|1085505|P2|Overall Study|Withdrawal by Subject|6
321218|NCT01367249|1085506|P1|Overall Study|Withdrawal by Subject|6
321219|NCT01367158|1085525|P11|Overall Study|Protocol Violation|0
321220|NCT01367158|1085526|P10|Overall Study|Protocol Violation|0
321221|NCT01367158|1085527|P9|Overall Study|Protocol Violation|0
321222|NCT01367158|1085528|P8|Overall Study|Protocol Violation|0
321223|NCT01367158|1085529|P7|Overall Study|Protocol Violation|0
321224|NCT01367158|1085530|P6|Overall Study|Protocol Violation|0
321225|NCT01367158|1085531|P5|Overall Study|Protocol Violation|0
321226|NCT01367158|1085532|P4|Overall Study|Protocol Violation|0
321227|NCT01367158|1085533|P3|Overall Study|Protocol Violation|0
321228|NCT01367158|1085534|P2|Overall Study|Protocol Violation|1
321229|NCT01367158|1085535|P1|Overall Study|Protocol Violation|0
321230|NCT01367158|1085525|P11|Overall Study|Lost to Follow-up|1
321231|NCT01367158|1085526|P10|Overall Study|Lost to Follow-up|0
321232|NCT01367158|1085527|P9|Overall Study|Lost to Follow-up|0
321233|NCT01367158|1085528|P8|Overall Study|Lost to Follow-up|1
321234|NCT01367158|1085529|P7|Overall Study|Lost to Follow-up|0
321235|NCT01367158|1085530|P6|Overall Study|Lost to Follow-up|2
321236|NCT01367158|1085531|P5|Overall Study|Lost to Follow-up|0
321237|NCT01367158|1085532|P4|Overall Study|Lost to Follow-up|1
321238|NCT01367158|1085533|P3|Overall Study|Lost to Follow-up|0
321239|NCT01367158|1085534|P2|Overall Study|Lost to Follow-up|0
321240|NCT01367158|1085535|P1|Overall Study|Lost to Follow-up|0
321241|NCT01367158|1085525|P11|Overall Study|Withdrew consent|0
321242|NCT01367158|1085526|P10|Overall Study|Withdrew consent|0
321243|NCT01367158|1085527|P9|Overall Study|Withdrew consent|0
321244|NCT01367158|1085528|P8|Overall Study|Withdrew consent|1
321245|NCT01367158|1085529|P7|Overall Study|Withdrew consent|0
321246|NCT01367158|1085530|P6|Overall Study|Withdrew consent|0
321247|NCT01367158|1085531|P5|Overall Study|Withdrew consent|2
321248|NCT01367158|1085532|P4|Overall Study|Withdrew consent|0
321249|NCT01367158|1085533|P3|Overall Study|Withdrew consent|1
321250|NCT01367158|1085534|P2|Overall Study|Withdrew consent|2
321251|NCT01367158|1085535|P1|Overall Study|Withdrew consent|0
321252|NCT01367119|1085679|P2|Overall Study|Withdrawal by Subject|1
321253|NCT01367119|1085680|P1|Overall Study|Withdrawal by Subject|1
321254|NCT01367119|1085679|P2|Overall Study|Adverse Event|0
321255|NCT01367119|1085680|P1|Overall Study|Adverse Event|1
321256|NCT01366846|1085735|P4|Overall Study|Scheduling Conflicts|0
321257|NCT01366846|1085736|P3|Overall Study|Scheduling Conflicts|1
321258|NCT01366846|1085737|P2|Overall Study|Scheduling Conflicts|0
321259|NCT01366846|1085738|P1|Overall Study|Scheduling Conflicts|0
321260|NCT01366846|1085735|P4|Overall Study|Communication Difficulties|1
321261|NCT01366846|1085736|P3|Overall Study|Communication Difficulties|0
321262|NCT01366846|1085737|P2|Overall Study|Communication Difficulties|4
321263|NCT01366846|1085738|P1|Overall Study|Communication Difficulties|1
321264|NCT01366846|1085735|P4|Overall Study|Withdrawal by Subject|0
321265|NCT01366846|1085736|P3|Overall Study|Withdrawal by Subject|0
321266|NCT01366846|1085737|P2|Overall Study|Withdrawal by Subject|0
321267|NCT01366846|1085738|P1|Overall Study|Withdrawal by Subject|2
321268|NCT01366638|1085761|P3|Overall Study|Not specified|0
321269|NCT01366638|1085762|P2|Overall Study|Not specified|0
321270|NCT01366638|1085763|P1|Overall Study|Not specified|1
321271|NCT01366638|1085761|P3|Overall Study|Withdrawal by Subject|6
321272|NCT01366638|1085762|P2|Overall Study|Withdrawal by Subject|0
321273|NCT01366638|1085763|P1|Overall Study|Withdrawal by Subject|0
321274|NCT01366534|1085800|P3|Overall Study|Declined challenged|0
321275|NCT01366534|1085801|P2|Overall Study|Declined challenged|1
321276|NCT01366534|1085802|P1|Overall Study|Declined challenged|0
321277|NCT01366534|1085800|P3|Overall Study|Migrated|0
321278|NCT01366534|1085801|P2|Overall Study|Migrated|1
321279|NCT01366534|1085802|P1|Overall Study|Migrated|1
321280|NCT01366534|1085800|P3|Overall Study|Lost to Follow-up|0
321281|NCT01366534|1085801|P2|Overall Study|Lost to Follow-up|0
321283|NCT01366521|1085852|P4|Overall Study|Withdrawal by Subject|0
321284|NCT01366521|1085853|P3|Overall Study|Withdrawal by Subject|0
321285|NCT01366521|1085854|P2|Overall Study|Withdrawal by Subject|1
321286|NCT01366521|1085855|P1|Overall Study|Withdrawal by Subject|0
321287|NCT01366521|1085852|P4|Overall Study|Physician Decision|0
321288|NCT01366521|1085853|P3|Overall Study|Physician Decision|1
321289|NCT01366521|1085854|P2|Overall Study|Physician Decision|0
321290|NCT01366521|1085855|P1|Overall Study|Physician Decision|0
321291|NCT01366521|1085852|P4|Overall Study|Protocol Violation|0
321292|NCT01366521|1085853|P3|Overall Study|Protocol Violation|1
321293|NCT01366521|1085854|P2|Overall Study|Protocol Violation|0
321294|NCT01366521|1085855|P1|Overall Study|Protocol Violation|0
321295|NCT01366521|1085852|P4|Overall Study|Adverse Event|0
321296|NCT01366521|1085853|P3|Overall Study|Adverse Event|0
321297|NCT01366521|1085854|P2|Overall Study|Adverse Event|0
321298|NCT01366521|1085855|P1|Overall Study|Adverse Event|1
321299|NCT01366443|1085930|P1|Overall Study|Under 18 yo|1
321300|NCT01366443|1085930|P1|Overall Study|Lost to Follow-up|2
321301|NCT01366209|1085944|P2|Overall Study|Withdrew consent|3
321302|NCT01366209|1085945|P1|Overall Study|Withdrew consent|4
321303|NCT01366209|1085944|P2|Overall Study|Sponsors decision|1
321304|NCT01366209|1085945|P1|Overall Study|Sponsors decision|0
321305|NCT01366209|1085944|P2|Overall Study|Physician Decision|0
321306|NCT01366209|1085945|P1|Overall Study|Physician Decision|1
321307|NCT01366209|1085944|P2|Overall Study|Lost to Follow-up|1
321308|NCT01366209|1085945|P1|Overall Study|Lost to Follow-up|2
321309|NCT01366209|1085944|P2|Overall Study|Lung transplantation|1
321310|NCT01366209|1085945|P1|Overall Study|Lung transplantation|6
321311|NCT01366209|1085944|P2|Overall Study|Death|19
321312|NCT01366209|1085945|P1|Overall Study|Death|12
321313|NCT01366209|1085944|P2|Overall Study|Withdrawal by Subject|4
321314|NCT01366209|1085945|P1|Overall Study|Withdrawal by Subject|4
321315|NCT01366209|1085944|P2|Overall Study|Adverse Event|7
321316|NCT01366209|1085945|P1|Overall Study|Adverse Event|6
321317|NCT01366092|1085968|P1|Overall Study|Withdrawal by Subject|1
321318|NCT01366092|1085968|P1|Overall Study|Physician Decision|1
321319|NCT01366092|1085968|P1|Overall Study|Progressive cGVHD|2
321320|NCT01365910|1085977|P1|Overall Study|pt did not get tx, nausea/vomiting|1
321321|NCT01365910|1085977|P1|Overall Study|other complicating disease|1
321322|NCT01365910|1085977|P1|Overall Study|Adverse Event|3
321323|NCT01365910|1085977|P1|Overall Study|disease progression|18
321324|NCT01365910|1085977|P1|Overall Study|Withdrawal by Subject|7
321325|NCT01365546|1086113|P1|Overall Study|Study termination|1
321326|NCT01365546|1086113|P1|Overall Study|Screen failure|9
321327|NCT01365546|1086113|P1|Overall Study|Withdrawal by Subject|1
321328|NCT01365507|1086123|P2|Overall Study|Unclassified|4
321329|NCT01365507|1086124|P1|Overall Study|Unclassified|1
321330|NCT01365507|1086123|P2|Overall Study|Withdrawal Criteria|5
321331|NCT01365507|1086124|P1|Overall Study|Withdrawal Criteria|8
321332|NCT01365494|1086140|P2|Overall Study|Lost to Follow-up|2
321333|NCT01365494|1086141|P1|Overall Study|Lost to Follow-up|1
321334|NCT01365494|1086140|P2|Overall Study|Withdrawal by Subject|1
321335|NCT01365494|1086141|P1|Overall Study|Withdrawal by Subject|0
321336|NCT01365494|1086140|P2|Overall Study|Adverse Event|0
321337|NCT01365494|1086141|P1|Overall Study|Adverse Event|1
321338|NCT01365481|1086157|P4|Overall Study|Unsatisfactory therapeutic effect|0
321339|NCT01365481|1086158|P3|Overall Study|Unsatisfactory therapeutic effect|1
321340|NCT01365481|1086159|P2|Overall Study|Unsatisfactory therapeutic effect|0
321341|NCT01365481|1086160|P1|Overall Study|Unsatisfactory therapeutic effect|0
321342|NCT01365481|1086157|P4|Overall Study|Protocol deviation|1
321343|NCT01365481|1086158|P3|Overall Study|Protocol deviation|0
321344|NCT01365481|1086159|P2|Overall Study|Protocol deviation|1
321345|NCT01365481|1086160|P1|Overall Study|Protocol deviation|0
321346|NCT01365481|1086157|P4|Overall Study|Administrative problems|0
321347|NCT01365481|1086158|P3|Overall Study|Administrative problems|0
321348|NCT01365481|1086159|P2|Overall Study|Administrative problems|1
321349|NCT01365481|1086160|P1|Overall Study|Administrative problems|0
321350|NCT01365481|1086157|P4|Overall Study|Abnormal laboratory value(s)|0
321351|NCT01365481|1086158|P3|Overall Study|Abnormal laboratory value(s)|0
321352|NCT01365481|1086159|P2|Overall Study|Abnormal laboratory value(s)|1
321353|NCT01365481|1086160|P1|Overall Study|Abnormal laboratory value(s)|0
321354|NCT01365481|1086157|P4|Overall Study|Lost to Follow-up|3
321355|NCT01365481|1086158|P3|Overall Study|Lost to Follow-up|2
321356|NCT01365481|1086159|P2|Overall Study|Lost to Follow-up|1
321357|NCT01365481|1086160|P1|Overall Study|Lost to Follow-up|1
321358|NCT01365481|1086157|P4|Overall Study|Withdrawal by Subject|1
321359|NCT01365481|1086158|P3|Overall Study|Withdrawal by Subject|1
321360|NCT01365481|1086159|P2|Overall Study|Withdrawal by Subject|2
321361|NCT01365481|1086160|P1|Overall Study|Withdrawal by Subject|0
321362|NCT01365481|1086157|P4|Overall Study|Adverse Event|2
321363|NCT01365481|1086158|P3|Overall Study|Adverse Event|0
321364|NCT01365481|1086159|P2|Overall Study|Adverse Event|9
321365|NCT01365481|1086160|P1|Overall Study|Adverse Event|6
321366|NCT01365468|1086180|P2|Overall Study|Lost to Follow-up|0
321367|NCT01365468|1086181|P1|Overall Study|Lost to Follow-up|2
321368|NCT01365468|1086180|P2|Overall Study|Disease progression|0
321369|NCT01365468|1086181|P1|Overall Study|Disease progression|1
321370|NCT01365468|1086180|P2|Overall Study|Physician Decision|0
321371|NCT01365468|1086181|P1|Overall Study|Physician Decision|1
321372|NCT01365455|1086196|P5|Maintenance Period|Subject/guardian decision|1
321373|NCT01365455|1086197|P4|Maintenance Period|Subject/guardian decision|4
321374|NCT01365455|1086198|P3|Maintenance Period|Subject/guardian decision|2
321375|NCT01365455|1086199|P2|Maintenance Period|Subject/guardian decision|6
321376|NCT01365455|1086200|P1|Maintenance Period|Subject/guardian decision|4
321377|NCT01365455|1086196|P5|Maintenance Period|Protocol deviation|0
321378|NCT01365455|1086197|P4|Maintenance Period|Protocol deviation|0
321379|NCT01365455|1086198|P3|Maintenance Period|Protocol deviation|0
321380|NCT01365455|1086199|P2|Maintenance Period|Protocol deviation|1
321381|NCT01365455|1086200|P1|Maintenance Period|Protocol deviation|1
321382|NCT01365455|1086196|P5|Maintenance Period|Pregnancy|2
321383|NCT01365455|1086197|P4|Maintenance Period|Pregnancy|0
321384|NCT01365455|1086198|P3|Maintenance Period|Pregnancy|0
321385|NCT01365455|1086199|P2|Maintenance Period|Pregnancy|4
321386|NCT01365455|1086200|P1|Maintenance Period|Pregnancy|0
321387|NCT01365455|1086196|P5|Maintenance Period|Physician Decision|1
321388|NCT01365455|1086197|P4|Maintenance Period|Physician Decision|0
321389|NCT01365455|1086198|P3|Maintenance Period|Physician Decision|0
321390|NCT01365455|1086199|P2|Maintenance Period|Physician Decision|1
321391|NCT01365455|1086200|P1|Maintenance Period|Physician Decision|0
321392|NCT01365455|1086196|P5|Maintenance Period|Non-compliance with study treatment|0
321393|NCT01365455|1086197|P4|Maintenance Period|Non-compliance with study treatment|1
321394|NCT01365455|1086198|P3|Maintenance Period|Non-compliance with study treatment|0
321395|NCT01365455|1086199|P2|Maintenance Period|Non-compliance with study treatment|0
321396|NCT01365455|1086200|P1|Maintenance Period|Non-compliance with study treatment|0
321397|NCT01365455|1086196|P5|Maintenance Period|Lost to Follow-up|3
321398|NCT01365455|1086197|P4|Maintenance Period|Lost to Follow-up|0
321399|NCT01365455|1086198|P3|Maintenance Period|Lost to Follow-up|0
321400|NCT01365455|1086199|P2|Maintenance Period|Lost to Follow-up|4
321401|NCT01365455|1086200|P1|Maintenance Period|Lost to Follow-up|2
321402|NCT01365455|1086196|P5|Maintenance Period|Lack of Efficacy|2
321403|NCT01365455|1086197|P4|Maintenance Period|Lack of Efficacy|2
321404|NCT01365455|1086198|P3|Maintenance Period|Lack of Efficacy|0
321405|NCT01365455|1086199|P2|Maintenance Period|Lack of Efficacy|2
321406|NCT01365455|1086200|P1|Maintenance Period|Lack of Efficacy|10
321407|NCT01365455|1086196|P5|Maintenance Period|Adverse Event|4
321408|NCT01365455|1086197|P4|Maintenance Period|Adverse Event|2
321409|NCT01365455|1086198|P3|Maintenance Period|Adverse Event|1
321410|NCT01365455|1086199|P2|Maintenance Period|Adverse Event|5
321411|NCT01365455|1086200|P1|Maintenance Period|Adverse Event|12
321412|NCT01365455|1086196|P5|Induction Period|Lost to Follow-up|0
321413|NCT01365455|1086197|P4|Induction Period|Lost to Follow-up|0
321414|NCT01365455|1086198|P3|Induction Period|Lost to Follow-up|3
321415|NCT01365455|1086199|P2|Induction Period|Lost to Follow-up|0
321416|NCT01365455|1086200|P1|Induction Period|Lost to Follow-up|0
321417|NCT01365455|1086196|P5|Induction Period|Subject/guardian decision|0
321418|NCT01365455|1086197|P4|Induction Period|Subject/guardian decision|0
321419|NCT01365455|1086198|P3|Induction Period|Subject/guardian decision|8
321420|NCT01365455|1086199|P2|Induction Period|Subject/guardian decision|1
321421|NCT01365455|1086200|P1|Induction Period|Subject/guardian decision|9
321422|NCT01365455|1086196|P5|Induction Period|Protocol deviation|0
321423|NCT01365455|1086197|P4|Induction Period|Protocol deviation|0
321424|NCT01365455|1086198|P3|Induction Period|Protocol deviation|1
321425|NCT01365455|1086199|P2|Induction Period|Protocol deviation|1
321426|NCT01365455|1086200|P1|Induction Period|Protocol deviation|0
321427|NCT01365455|1086196|P5|Induction Period|Pregnancy|0
321428|NCT01365455|1086197|P4|Induction Period|Pregnancy|0
321429|NCT01365455|1086198|P3|Induction Period|Pregnancy|0
321430|NCT01365455|1086199|P2|Induction Period|Pregnancy|1
321431|NCT01365455|1086200|P1|Induction Period|Pregnancy|0
321432|NCT01365455|1086196|P5|Induction Period|Lack of Efficacy|0
321433|NCT01365455|1086197|P4|Induction Period|Lack of Efficacy|0
321434|NCT01365455|1086198|P3|Induction Period|Lack of Efficacy|0
321435|NCT01365455|1086199|P2|Induction Period|Lack of Efficacy|1
321436|NCT01365455|1086200|P1|Induction Period|Lack of Efficacy|1
321437|NCT01365455|1086196|P5|Induction Period|Adverse Event|0
321438|NCT01365455|1086197|P4|Induction Period|Adverse Event|0
321439|NCT01365455|1086198|P3|Induction Period|Adverse Event|4
321440|NCT01365455|1086199|P2|Induction Period|Adverse Event|3
321441|NCT01365455|1086200|P1|Induction Period|Adverse Event|5
321442|NCT01365273|1086290|P2|Overall Study|Physician Decision|0
321443|NCT01365273|1086291|P1|Overall Study|Physician Decision|1
321444|NCT01365273|1086290|P2|Overall Study|Protocol Violation|1
321445|NCT01365273|1086291|P1|Overall Study|Protocol Violation|0
321446|NCT01365273|1086290|P2|Overall Study|Lost to Follow-up|0
321447|NCT01365273|1086291|P1|Overall Study|Lost to Follow-up|1
321448|NCT01365130|1086301|P1|Overall Study|Progression/worsening of Dx prior to txt|2
321449|NCT01365091|1086310|P4|Period 2|Adverse Event|0
321450|NCT01365091|1086311|P3|Period 2|Adverse Event|1
321451|NCT01365091|1086312|P2|Period 2|Adverse Event|0
321452|NCT01365091|1086313|P1|Period 2|Adverse Event|0
321453|NCT01365091|1086310|P4|Period 2|Withdrawal by Subject|0
321454|NCT01365091|1086311|P3|Period 2|Withdrawal by Subject|0
321455|NCT01365091|1086312|P2|Period 2|Withdrawal by Subject|0
321456|NCT01365091|1086313|P1|Period 2|Withdrawal by Subject|1
321457|NCT01365091|1086310|P4|Period 1|Personal reasons|0
321458|NCT01365091|1086311|P3|Period 1|Personal reasons|1
321459|NCT01365091|1086312|P2|Period 1|Personal reasons|0
321460|NCT01365091|1086313|P1|Period 1|Personal reasons|0
321461|NCT01365091|1086310|P4|Period 1|Withdrawal by Subject|0
321462|NCT01365091|1086311|P3|Period 1|Withdrawal by Subject|0
321463|NCT01365091|1086312|P2|Period 1|Withdrawal by Subject|1
321464|NCT01365091|1086313|P1|Period 1|Withdrawal by Subject|0
321465|NCT01365091|1086310|P4|Period 1|No longer met study criteria|0
321466|NCT01365091|1086311|P3|Period 1|No longer met study criteria|0
321467|NCT01365091|1086312|P2|Period 1|No longer met study criteria|1
321468|NCT01365091|1086313|P1|Period 1|No longer met study criteria|0
321469|NCT01365091|1086310|P4|Period 1|Positive test result for drugs of abuse|0
321470|NCT01365091|1086311|P3|Period 1|Positive test result for drugs of abuse|0
321471|NCT01365091|1086312|P2|Period 1|Positive test result for drugs of abuse|0
321472|NCT01365091|1086313|P1|Period 1|Positive test result for drugs of abuse|1
321473|NCT01365091|1086310|P4|Period 1|Adverse Event|3
321474|NCT01365091|1086311|P3|Period 1|Adverse Event|2
321475|NCT01365091|1086312|P2|Period 1|Adverse Event|0
321476|NCT01365091|1086313|P1|Period 1|Adverse Event|1
321477|NCT01365052|1086341|P2|Overall Study|Adverse Event|4
321478|NCT01365052|1086342|P1|Overall Study|Adverse Event|4
321479|NCT01365039|1086358|P2|Overall Study|Study related symptoms and complaints|0
321480|NCT01365039|1086359|P1|Overall Study|Study related symptoms and complaints|1
321481|NCT01364922|1086370|P3|Double-Blind (DB) Period|Other, Unspecified|0
321482|NCT01364922|1086371|P2|Double-Blind (DB) Period|Other, Unspecified|1
321483|NCT01364922|1086372|P1|Double-Blind (DB) Period|Other, Unspecified|0
321484|NCT01364922|1086370|P3|Double-Blind (DB) Period|Adverse Event|1
321485|NCT01364922|1086371|P2|Double-Blind (DB) Period|Adverse Event|0
321486|NCT01364922|1086372|P1|Double-Blind (DB) Period|Adverse Event|0
321487|NCT01364922|1086370|P3|Double-Blind (DB) Period|Subject Noncompliant|0
321488|NCT01364922|1086371|P2|Double-Blind (DB) Period|Subject Noncompliant|1
321489|NCT01364922|1086372|P1|Double-Blind (DB) Period|Subject Noncompliant|0
321490|NCT01364922|1086370|P3|Double-Blind (DB) Period|Lack of Efficacy|4
321491|NCT01364922|1086371|P2|Double-Blind (DB) Period|Lack of Efficacy|3
321492|NCT01364922|1086372|P1|Double-Blind (DB) Period|Lack of Efficacy|0
321493|NCT01364922|1086370|P3|Open-label (OL) Period|Other, Unspecified|0
321494|NCT01364922|1086371|P2|Open-label (OL) Period|Other, Unspecified|0
321495|NCT01364922|1086372|P1|Open-label (OL) Period|Other, Unspecified|1
321496|NCT01364922|1086370|P3|Open-label (OL) Period|Lost to Follow-up|0
321497|NCT01364922|1086371|P2|Open-label (OL) Period|Lost to Follow-up|0
321498|NCT01364922|1086372|P1|Open-label (OL) Period|Lost to Follow-up|1
321499|NCT01364922|1086370|P3|Open-label (OL) Period|Lack of Efficacy|0
321500|NCT01364922|1086371|P2|Open-label (OL) Period|Lack of Efficacy|0
321501|NCT01364922|1086372|P1|Open-label (OL) Period|Lack of Efficacy|3
321502|NCT01364922|1086370|P3|Open-label (OL) Period|Withdrawal by Subject|0
321503|NCT01364922|1086371|P2|Open-label (OL) Period|Withdrawal by Subject|0
321504|NCT01364922|1086372|P1|Open-label (OL) Period|Withdrawal by Subject|4
321505|NCT01364922|1086370|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
321506|NCT01364922|1086371|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
321507|NCT01364922|1086372|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
321508|NCT01364922|1086370|P3|Open-label (OL) Period|Adverse Event|0
321509|NCT01364922|1086371|P2|Open-label (OL) Period|Adverse Event|0
321510|NCT01364922|1086372|P1|Open-label (OL) Period|Adverse Event|7
321511|NCT01364870|1086394|P3|Overall Study|Protocol Violation|0
321512|NCT01364870|1086395|P2|Overall Study|Protocol Violation|0
321513|NCT01364870|1086396|P1|Overall Study|Protocol Violation|1
321514|NCT01364870|1086394|P3|Overall Study|Adverse Event|4
321515|NCT01364870|1086395|P2|Overall Study|Adverse Event|6
321516|NCT01364870|1086396|P1|Overall Study|Adverse Event|8
321517|NCT01364870|1086394|P3|Overall Study|Withdrawal by Subject|10
321518|NCT01364870|1086395|P2|Overall Study|Withdrawal by Subject|24
321519|NCT01364870|1086396|P1|Overall Study|Withdrawal by Subject|13
321520|NCT01364727|1086415|P1|Overall Study|Not Eligible|2
321521|NCT01364649|1086423|P2|Overall Study|Other|1
321522|NCT01364649|1086424|P1|Overall Study|Other|4
321523|NCT01364649|1086423|P2|Overall Study|Lost to Follow-up|13
321524|NCT01364649|1086424|P1|Overall Study|Lost to Follow-up|12
321525|NCT01364649|1086423|P2|Overall Study|Withdrawal of Consent|7
321526|NCT01364649|1086424|P1|Overall Study|Withdrawal of Consent|9
321527|NCT01364649|1086423|P2|Overall Study|Protocol Deviations|8
321528|NCT01364649|1086424|P1|Overall Study|Protocol Deviations|4
321529|NCT01364649|1086423|P2|Overall Study|Non-compliance with Investigational Drug|0
321530|NCT01364649|1086424|P1|Overall Study|Non-compliance with Investigational Drug|1
321531|NCT01364649|1086423|P2|Overall Study|Lack of Efficacy|0
321532|NCT01364649|1086424|P1|Overall Study|Lack of Efficacy|6
321533|NCT01364649|1086423|P2|Overall Study|Pretreatment Event or Adverse Event|14
321534|NCT01364649|1086424|P1|Overall Study|Pretreatment Event or Adverse Event|20
321535|NCT01364428|1086446|P2|Overall Study|Other|3
321536|NCT01364428|1086447|P1|Overall Study|Other|3
321537|NCT01364428|1086446|P2|Overall Study|Withdrawal Criteria|10
321538|NCT01364428|1086447|P1|Overall Study|Withdrawal Criteria|14
321539|NCT01364428|1086446|P2|Overall Study|Protocol Violation|0
321540|NCT01364428|1086447|P1|Overall Study|Protocol Violation|2
321541|NCT01364428|1086446|P2|Overall Study|Adverse Event|2
321542|NCT01364428|1086447|P1|Overall Study|Adverse Event|1
321543|NCT01364389|1086464|P3|Overall Study|Adverse Event|0
321544|NCT01364389|1086465|P2|Overall Study|Adverse Event|0
321545|NCT01364389|1086466|P1|Overall Study|Adverse Event|1
321546|NCT01364389|1086464|P3|Overall Study|Administrative problems|0
321547|NCT01364389|1086465|P2|Overall Study|Administrative problems|0
321548|NCT01364389|1086466|P1|Overall Study|Administrative problems|1
321549|NCT01364389|1086464|P3|Overall Study|Protocol deviation|1
321550|NCT01364389|1086465|P2|Overall Study|Protocol deviation|0
321551|NCT01364389|1086466|P1|Overall Study|Protocol deviation|0
321552|NCT01364389|1086464|P3|Overall Study|Withdrawal by Subject|0
321553|NCT01364389|1086465|P2|Overall Study|Withdrawal by Subject|1
321554|NCT01364389|1086466|P1|Overall Study|Withdrawal by Subject|0
321555|NCT01364298|1086485|P2|Overall Study|Other|3
321556|NCT01364298|1086486|P1|Overall Study|Other|1
321557|NCT01364298|1086485|P2|Overall Study|Withdrawal by Subject|3
321558|NCT01364298|1086486|P1|Overall Study|Withdrawal by Subject|3
321559|NCT01364298|1086485|P2|Overall Study|Lost to Follow-up|10
321560|NCT01364298|1086486|P1|Overall Study|Lost to Follow-up|5
321561|NCT01364298|1086485|P2|Overall Study|Lack of Efficacy|0
321562|NCT01364298|1086486|P1|Overall Study|Lack of Efficacy|1
321563|NCT01364298|1086485|P2|Overall Study|Lack of adherence to treatment|3
321564|NCT01364298|1086486|P1|Overall Study|Lack of adherence to treatment|1
321565|NCT01364298|1086485|P2|Overall Study|Adverse Event|4
321566|NCT01364298|1086486|P1|Overall Study|Adverse Event|3
321567|NCT01363986|1086541|P1|Overall Study|Disease progression|1
321568|NCT01363908|1086551|P2|Chronic Dosing (CD) Phase|Early study termination|3
321569|NCT01363908|1086552|P1|Chronic Dosing (CD) Phase|Early study termination|9
321570|NCT01363908|1086551|P2|Chronic Dosing (CD) Phase|Physician Decision|1
321571|NCT01363908|1086552|P1|Chronic Dosing (CD) Phase|Physician Decision|0
321572|NCT01363908|1086551|P2|Chronic Dosing (CD) Phase|Patient decision|1
321573|NCT01363908|1086552|P1|Chronic Dosing (CD) Phase|Patient decision|0
321574|NCT01363908|1086551|P2|Chronic Dosing (CD) Phase|Adverse Event|1
321575|NCT01363908|1086552|P1|Chronic Dosing (CD) Phase|Adverse Event|1
321576|NCT01363765|1086588|P2|Overall Study|smear during intervention|0
321577|NCT01363765|1086589|P1|Overall Study|smear during intervention|2170
321578|NCT01363765|1086588|P2|Overall Study|age not recorded (used for cross-linkage|354
321579|NCT01363765|1086589|P1|Overall Study|age not recorded (used for cross-linkage|117
321580|NCT01363765|1086588|P2|Overall Study|non-resident|76
321581|NCT01363765|1086589|P1|Overall Study|non-resident|156
321582|NCT01363765|1086588|P2|Overall Study|duplicate records|3177
321583|NCT01363765|1086589|P1|Overall Study|duplicate records|736
321584|NCT01363765|1086588|P2|Overall Study|non-diagnostic|1124
321585|NCT01363765|1086589|P1|Overall Study|non-diagnostic|2621
321586|NCT01363713|1086601|P1|Overall Study|Withdrawal by Subject|2
321587|NCT01363713|1086601|P1|Overall Study|Protocol Violation|3
321588|NCT01363713|1086601|P1|Overall Study|Adverse Event|1
321589|NCT01363700|1086610|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
321590|NCT01363700|1086611|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
321591|NCT01363700|1086612|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
321592|NCT01363700|1086613|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
321593|NCT01363700|1086614|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
321594|NCT01363661|1086633|P2|Overall Study|Lost to Follow-up|1
321595|NCT01363661|1086634|P1|Overall Study|Lost to Follow-up|3
321596|NCT01363661|1086633|P2|Overall Study|Protocol Violation|0
321597|NCT01363661|1086634|P1|Overall Study|Protocol Violation|1
321598|NCT01363661|1086633|P2|Overall Study|Withdrawal by Subject|1
321599|NCT01363661|1086634|P1|Overall Study|Withdrawal by Subject|1
321600|NCT01363661|1086633|P2|Overall Study|Adverse Event|2
321601|NCT01363661|1086634|P1|Overall Study|Adverse Event|9
321602|NCT01363440|1086675|P3|Overall Study|Other|2
321603|NCT01363440|1086676|P2|Overall Study|Other|5
321604|NCT01363440|1086677|P1|Overall Study|Other|4
321605|NCT01363440|1086675|P3|Overall Study|Lost to Follow-up|5
321606|NCT01363440|1086676|P2|Overall Study|Lost to Follow-up|4
321607|NCT01363440|1086677|P1|Overall Study|Lost to Follow-up|2
321608|NCT01363440|1086675|P3|Overall Study|Withdrawal by Subject|11
321609|NCT01363440|1086676|P2|Overall Study|Withdrawal by Subject|11
321610|NCT01363440|1086677|P1|Overall Study|Withdrawal by Subject|9
321611|NCT01363440|1086675|P3|Overall Study|Death|5
321612|NCT01363440|1086676|P2|Overall Study|Death|7
321613|NCT01363440|1086677|P1|Overall Study|Death|3
321614|NCT01363440|1086675|P3|Overall Study|Adverse Event|4
321615|NCT01363440|1086676|P2|Overall Study|Adverse Event|4
321616|NCT01363440|1086677|P1|Overall Study|Adverse Event|5
321617|NCT01363349|1086723|P2|Overall Study|missing|2
321618|NCT01363349|1086724|P1|Overall Study|missing|1
321619|NCT01363349|1086723|P2|Overall Study|Not reported|37
321620|NCT01363349|1086724|P1|Overall Study|Not reported|36
321621|NCT01363349|1086723|P2|Overall Study|Lost to Follow-up|6
321622|NCT01363349|1086724|P1|Overall Study|Lost to Follow-up|5
321623|NCT01363349|1086723|P2|Overall Study|Withdrawal by Subject|6
321624|NCT01363349|1086724|P1|Overall Study|Withdrawal by Subject|14
321625|NCT01363349|1086723|P2|Overall Study|Non compliance/Protocol deviations|2
321626|NCT01363349|1086724|P1|Overall Study|Non compliance/Protocol deviations|2
321627|NCT01363349|1086723|P2|Overall Study|Lack of Efficacy|10
321628|NCT01363349|1086724|P1|Overall Study|Lack of Efficacy|3
321629|NCT01363349|1086723|P2|Overall Study|Adverse Event|7
321630|NCT01363349|1086724|P1|Overall Study|Adverse Event|6
321631|NCT01363297|1086735|P5|Overall Study|Death|30
321632|NCT01363297|1086736|P4|Overall Study|Death|10
321633|NCT01363297|1086737|P3|Overall Study|Death|6
321634|NCT01363297|1086738|P2|Overall Study|Death|6
321635|NCT01363297|1086739|P1|Overall Study|Death|3
321636|NCT01363297|1086735|P5|Overall Study|Not specified|1
321637|NCT01363297|1086736|P4|Overall Study|Not specified|0
321638|NCT01363297|1086737|P3|Overall Study|Not specified|0
321639|NCT01363297|1086738|P2|Overall Study|Not specified|0
321640|NCT01363297|1086739|P1|Overall Study|Not specified|0
321641|NCT01363076|1086842|P2|Overall Study|Withdrawal by Subject|1
321642|NCT01363076|1086843|P1|Overall Study|Withdrawal by Subject|0
321643|NCT01363011|1086875|P2|Extension Phase|Rolled Over to Another Gilead Study|1
321644|NCT01363011|1086876|P1|Extension Phase|Rolled Over to Another Gilead Study|2
321645|NCT01363011|1086875|P2|Extension Phase|Lost to Follow-up|2
321646|NCT01363011|1086876|P1|Extension Phase|Lost to Follow-up|0
321647|NCT01363011|1086875|P2|Extension Phase|Withdrew Consent|1
321648|NCT01363011|1086876|P1|Extension Phase|Withdrew Consent|0
321649|NCT01363011|1086875|P2|Extension Phase|Investigator's Discretion|2
321650|NCT01363011|1086876|P1|Extension Phase|Investigator's Discretion|2
321651|NCT01363011|1086875|P2|Extension Phase|Lack of Efficacy|1
321652|NCT01363011|1086876|P1|Extension Phase|Lack of Efficacy|0
321653|NCT01363011|1086875|P2|Extension Phase|Adverse Event|1
321654|NCT01363011|1086876|P1|Extension Phase|Adverse Event|1
321655|NCT01363011|1086875|P2|Main Study|Protocol Violation|1
321656|NCT01363011|1086876|P1|Main Study|Protocol Violation|0
321657|NCT01363011|1086875|P2|Main Study|Withdrew Consent|4
321658|NCT01363011|1086876|P1|Main Study|Withdrew Consent|1
321659|NCT01363011|1086875|P2|Main Study|Investigator's Discretion|1
321660|NCT01363011|1086876|P1|Main Study|Investigator's Discretion|1
321661|NCT01363011|1086875|P2|Main Study|Adverse Event|3
321662|NCT01363011|1086876|P1|Main Study|Adverse Event|2
321663|NCT01362608|1087001|P2|Overall Study|Adverse Event|2
321664|NCT01362608|1087002|P1|Overall Study|Adverse Event|0
321665|NCT01362608|1087001|P2|Overall Study|Lack of Efficacy|2
321666|NCT01362608|1087002|P1|Overall Study|Lack of Efficacy|0
321667|NCT01362608|1087001|P2|Overall Study|Withdrawal by Subject|2
321668|NCT01362608|1087002|P1|Overall Study|Withdrawal by Subject|1
321669|NCT01362608|1087001|P2|Overall Study|Lost to Follow-up|1
321670|NCT01362608|1087002|P1|Overall Study|Lost to Follow-up|3
321671|NCT01362608|1087001|P2|Overall Study|Protocol Violation|1
321672|NCT01362608|1087002|P1|Overall Study|Protocol Violation|0
321673|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
321674|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
321675|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
321676|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
321677|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
321678|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
321679|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
321680|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
321681|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
321682|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
321683|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
321684|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
321685|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
321686|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
321687|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
321688|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
321689|NCT01362530|1087040|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
321690|NCT01362530|1087041|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
321691|NCT01362530|1087040|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
321692|NCT01362530|1087041|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
321693|NCT01362530|1087040|P2|Base Study (Cycle 1)|Protocol Violation|0
321694|NCT01362530|1087041|P1|Base Study (Cycle 1)|Protocol Violation|2
321695|NCT01362530|1087040|P2|Base Study (Cycle 1)|Physician Decision|1
321696|NCT01362530|1087041|P1|Base Study (Cycle 1)|Physician Decision|0
321697|NCT01362530|1087040|P2|Base Study (Cycle 1)|Adverse Event|0
321698|NCT01362530|1087041|P1|Base Study (Cycle 1)|Adverse Event|2
321699|NCT01362517|1087054|P1|Overall Study|Lost to Follow-up|1
321700|NCT01362517|1087054|P1|Overall Study|Protocol Violation|1
321701|NCT01362491|1087065|P3|Overall Study|Ineligible|0
321702|NCT01362491|1087066|P2|Overall Study|Ineligible|0
321703|NCT01362491|1087067|P1|Overall Study|Ineligible|1
321704|NCT01362439|1087115|P1|Overall Study|Participant who withdrew consent|8
321705|NCT01362439|1087115|P1|Overall Study|Study medication non-compliant|1
321706|NCT01362439|1087115|P1|Overall Study|Lost to Follow-up|2
321707|NCT01362439|1087115|P1|Overall Study|Lack of Efficacy|3
321708|NCT01362439|1087115|P1|Overall Study|Adverse Event|1
321709|NCT01362348|1087130|P1|Overall Study|Study closed/terminated|5
321710|NCT01362348|1087130|P1|Overall Study|Protocol-defined stopping criteria|9
321711|NCT01362296|1087149|P4|Crossover Phase|Study Closed/Terminated|0
321712|NCT01362296|1087150|P3|Crossover Phase|Study Closed/Terminated|1
321713|NCT01362296|1087151|P2|Crossover Phase|Study Closed/Terminated|0
321714|NCT01362296|1087152|P1|Crossover Phase|Study Closed/Terminated|0
321715|NCT01362296|1087149|P4|Crossover Phase|Adverse Event|0
321716|NCT01362296|1087150|P3|Crossover Phase|Adverse Event|4
321717|NCT01362296|1087151|P2|Crossover Phase|Adverse Event|0
321718|NCT01362296|1087152|P1|Crossover Phase|Adverse Event|0
321719|NCT01362296|1087149|P4|Crossover Phase|Withdrawal by Subject|1
321720|NCT01362296|1087150|P3|Crossover Phase|Withdrawal by Subject|2
321721|NCT01362296|1087151|P2|Crossover Phase|Withdrawal by Subject|0
321722|NCT01362296|1087152|P1|Crossover Phase|Withdrawal by Subject|0
321723|NCT01362296|1087149|P4|Crossover Phase|PD including Death due to PD|1
321724|NCT01362296|1087150|P3|Crossover Phase|PD including Death due to PD|16
321725|NCT01362296|1087151|P2|Crossover Phase|PD including Death due to PD|0
321726|NCT01362296|1087152|P1|Crossover Phase|PD including Death due to PD|0
321727|NCT01362296|1087149|P4|Randomized Phase (RP)|Study Closed/Terminated|0
321728|NCT01362296|1087150|P3|Randomized Phase (RP)|Study Closed/Terminated|0
321729|NCT01362296|1087151|P2|Randomized Phase (RP)|Study Closed/Terminated|1
321730|NCT01362296|1087152|P1|Randomized Phase (RP)|Study Closed/Terminated|8
321731|NCT01362296|1087149|P4|Randomized Phase (RP)|Adverse Event|0
321732|NCT01362296|1087150|P3|Randomized Phase (RP)|Adverse Event|0
321733|NCT01362296|1087151|P2|Randomized Phase (RP)|Adverse Event|4
321734|NCT01362296|1087152|P1|Randomized Phase (RP)|Adverse Event|20
321735|NCT01362296|1087149|P4|Randomized Phase (RP)|Withdrawal by Subject|0
321736|NCT01362296|1087150|P3|Randomized Phase (RP)|Withdrawal by Subject|0
321737|NCT01362296|1087151|P2|Randomized Phase (RP)|Withdrawal by Subject|1
321738|NCT01362296|1087152|P1|Randomized Phase (RP)|Withdrawal by Subject|2
321739|NCT01362296|1087149|P4|Randomized Phase (RP)|Physician Decision|0
321740|NCT01362296|1087150|P3|Randomized Phase (RP)|Physician Decision|0
321741|NCT01362296|1087151|P2|Randomized Phase (RP)|Physician Decision|9
321742|NCT01362296|1087152|P1|Randomized Phase (RP)|Physician Decision|1
321743|NCT01362296|1087149|P4|Randomized Phase (RP)|PD including Death due to PD|0
321744|NCT01362296|1087150|P3|Randomized Phase (RP)|PD including Death due to PD|0
321745|NCT01362296|1087151|P2|Randomized Phase (RP)|PD including Death due to PD|28
321746|NCT01362296|1087152|P1|Randomized Phase (RP)|PD including Death due to PD|56
321747|NCT01362244|1087200|P2|Overall Study|Protocol Defined Stopping Criteria|1
321748|NCT01362244|1087201|P1|Overall Study|Protocol Defined Stopping Criteria|0
321749|NCT01362244|1087200|P2|Overall Study|Did not Meet Continuation Criteria|11
321750|NCT01362244|1087201|P1|Overall Study|Did not Meet Continuation Criteria|17
321751|NCT01362244|1087200|P2|Overall Study|Withdrawal by Subject|1
321752|NCT01362244|1087201|P1|Overall Study|Withdrawal by Subject|2
321753|NCT01362244|1087200|P2|Overall Study|Protocol Violation|1
321754|NCT01362244|1087201|P1|Overall Study|Protocol Violation|5
321755|NCT01362244|1087200|P2|Overall Study|Lost to Follow-up|2
321756|NCT01362244|1087201|P1|Overall Study|Lost to Follow-up|0
321757|NCT01362244|1087200|P2|Overall Study|Lack of Efficacy|11
321758|NCT01362244|1087201|P1|Overall Study|Lack of Efficacy|5
321759|NCT01362244|1087200|P2|Overall Study|Adverse Event|5
321760|NCT01362244|1087201|P1|Overall Study|Adverse Event|3
321761|NCT01362140|1087313|P2|Overall Study|Discontinued Without Receiving Treatment|1
321762|NCT01362140|1087314|P1|Overall Study|Discontinued Without Receiving Treatment|0
321763|NCT01362140|1087313|P2|Overall Study|Protocol-specified Criteria|2
321764|NCT01362140|1087314|P1|Overall Study|Protocol-specified Criteria|1
321765|NCT01362140|1087313|P2|Overall Study|Other|1
321766|NCT01362140|1087314|P1|Overall Study|Other|1
321767|NCT01362140|1087313|P2|Overall Study|Death|1
321768|NCT01362140|1087314|P1|Overall Study|Death|2
321769|NCT01362140|1087313|P2|Overall Study|Administrative Decision|1
321770|NCT01362140|1087314|P1|Overall Study|Administrative Decision|0
321771|NCT01362140|1087313|P2|Overall Study|Withdrawal by Subject|3
321772|NCT01362140|1087314|P1|Overall Study|Withdrawal by Subject|3
321773|NCT01362140|1087313|P2|Overall Study|Adverse Event|2
321774|NCT01362140|1087314|P1|Overall Study|Adverse Event|2
321775|NCT01362140|1087313|P2|Overall Study|Noncompliance|0
321776|NCT01362140|1087314|P1|Overall Study|Noncompliance|1
321777|NCT01362062|1087338|P2|Overall Study|Had significant improvement|0
321778|NCT01362062|1087339|P1|Overall Study|Had significant improvement|9
321779|NCT01362062|1087338|P2|Overall Study|Detected with Spondylo-arthritis|0
321780|NCT01362062|1087339|P1|Overall Study|Detected with Spondylo-arthritis|1
321781|NCT01362062|1087338|P2|Overall Study|Non-compliant participant|0
321782|NCT01362062|1087339|P1|Overall Study|Non-compliant participant|2
321783|NCT01362062|1087338|P2|Overall Study|Withdrawal by Subject|0
321784|NCT01362062|1087339|P1|Overall Study|Withdrawal by Subject|2
321785|NCT01362062|1087338|P2|Overall Study|Lost to Follow-up|0
321786|NCT01362062|1087339|P1|Overall Study|Lost to Follow-up|11
321787|NCT01362062|1087338|P2|Overall Study|Adverse Event|0
321788|NCT01362062|1087339|P1|Overall Study|Adverse Event|1
321789|NCT01362049|1087360|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
321790|NCT01362049|1087361|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
321791|NCT01362049|1087362|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
321792|NCT01362049|1087363|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
321793|NCT01362049|1087360|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
321794|NCT01362049|1087361|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
321795|NCT01362049|1087362|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
321796|NCT01362049|1087363|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
321797|NCT01361607|1087428|P2|Overall Study|Met Withdrawal Criteria|1
321798|NCT01361607|1087429|P1|Overall Study|Met Withdrawal Criteria|1
321799|NCT01361607|1087428|P2|Overall Study|Lost to Follow-up|0
321800|NCT01361607|1087429|P1|Overall Study|Lost to Follow-up|1
321801|NCT01361607|1087428|P2|Overall Study|Withdrawal by Investigator|3
321802|NCT01361607|1087429|P1|Overall Study|Withdrawal by Investigator|5
321803|NCT01361607|1087428|P2|Overall Study|Withdrawal by Subject|8
321804|NCT01361607|1087429|P1|Overall Study|Withdrawal by Subject|19
321805|NCT01361607|1087428|P2|Overall Study|Adverse Event|29
321806|NCT01361607|1087429|P1|Overall Study|Adverse Event|38
321807|NCT01361594|1087457|P2|Overall Study|Withdrawal by Subject|2
321808|NCT01361594|1087458|P1|Overall Study|Withdrawal by Subject|1
321809|NCT01361568|1087472|P6|Overall Study|Withdrawal by Subject|1
321810|NCT01361568|1087473|P5|Overall Study|Withdrawal by Subject|0
321811|NCT01361568|1087474|P4|Overall Study|Withdrawal by Subject|0
321812|NCT01361568|1087475|P3|Overall Study|Withdrawal by Subject|0
321813|NCT01361568|1087476|P2|Overall Study|Withdrawal by Subject|1
321814|NCT01361568|1087477|P1|Overall Study|Withdrawal by Subject|2
321815|NCT01361568|1087472|P6|Overall Study|Physician Decision|1
321816|NCT01361568|1087473|P5|Overall Study|Physician Decision|0
321817|NCT01361568|1087474|P4|Overall Study|Physician Decision|0
321818|NCT01361568|1087475|P3|Overall Study|Physician Decision|0
321819|NCT01361568|1087476|P2|Overall Study|Physician Decision|0
321820|NCT01361568|1087477|P1|Overall Study|Physician Decision|0
321821|NCT01361568|1087472|P6|Overall Study|Adverse Event|0
321822|NCT01361568|1087473|P5|Overall Study|Adverse Event|1
321823|NCT01361568|1087474|P4|Overall Study|Adverse Event|0
321824|NCT01361568|1087475|P3|Overall Study|Adverse Event|0
321825|NCT01361568|1087476|P2|Overall Study|Adverse Event|0
321826|NCT01361568|1087477|P1|Overall Study|Adverse Event|0
321827|NCT01361464|1087507|P1|Overall Study|Withdrawal by Subject|2
321828|NCT01361464|1087507|P1|Overall Study|Death|1
321829|NCT01361308|1087516|P2|Overall Study|Not Specified|1
321830|NCT01361308|1087517|P1|Overall Study|Not Specified|0
321831|NCT01361308|1087516|P2|Overall Study|Failed C-SSRS|2
321832|NCT01361308|1087517|P1|Overall Study|Failed C-SSRS|5
321833|NCT01361308|1087516|P2|Overall Study|Eligibility Criteria Not Met|3
321834|NCT01361308|1087517|P1|Overall Study|Eligibility Criteria Not Met|2
321835|NCT01361308|1087516|P2|Overall Study|Adverse Event|4
321836|NCT01361308|1087517|P1|Overall Study|Adverse Event|8
321837|NCT01361308|1087516|P2|Overall Study|Lost to Follow-up|4
321838|NCT01361308|1087517|P1|Overall Study|Lost to Follow-up|5
321839|NCT01361308|1087516|P2|Overall Study|Protocol Violation|0
321840|NCT01361308|1087517|P1|Overall Study|Protocol Violation|1
321841|NCT01361308|1087516|P2|Overall Study|Lack of Efficacy|0
321842|NCT01361308|1087517|P1|Overall Study|Lack of Efficacy|2
321843|NCT01361308|1087516|P2|Overall Study|Physician Decision|3
321844|NCT01361308|1087517|P1|Overall Study|Physician Decision|3
321845|NCT01361308|1087516|P2|Overall Study|Withdrawal by Subject|13
321846|NCT01361308|1087517|P1|Overall Study|Withdrawal by Subject|9
321847|NCT01361178|1087565|P2|Overall Study|Death|0
321848|NCT01361178|1087566|P1|Overall Study|Death|13
321849|NCT01361126|1087574|P2|Overall Study|Sponsor decision|2
321850|NCT01361126|1087575|P1|Overall Study|Sponsor decision|0
321851|NCT01361009|1087614|P1|Overall Study|Protocol Violation|116
321852|NCT01360996|1087624|P3|Overall Study|Noncompliant|0
321853|NCT01360996|1087625|P2|Overall Study|Noncompliant|0
321854|NCT01360996|1087626|P1|Overall Study|Noncompliant|2
321855|NCT01360996|1087624|P3|Overall Study|Withdrawal by Subject|2
321856|NCT01360996|1087625|P2|Overall Study|Withdrawal by Subject|3
321857|NCT01360996|1087626|P1|Overall Study|Withdrawal by Subject|4
321858|NCT01360840|1087648|P3|Overall Study|Ongoing at data cut-off|9
321859|NCT01360840|1087649|P2|Overall Study|Ongoing at data cut-off|10
321860|NCT01360840|1087650|P1|Overall Study|Ongoing at data cut-off|10
321861|NCT01360645|1087702|P4|Phase A+|Protocol Deviation|4
321862|NCT01360645|1087703|P3|Phase A+|Protocol Deviation|0
321863|NCT01360645|1087704|P2|Phase A+|Protocol Deviation|0
321864|NCT01360645|1087705|P1|Phase A+|Protocol Deviation|0
321865|NCT01360645|1087702|P4|Phase A+|Withdrawal by Subject|5
321866|NCT01360645|1087703|P3|Phase A+|Withdrawal by Subject|0
321867|NCT01360645|1087704|P2|Phase A+|Withdrawal by Subject|0
321868|NCT01360645|1087705|P1|Phase A+|Withdrawal by Subject|0
321869|NCT01360645|1087702|P4|Phase A+|Physician Decision|2
321870|NCT01360645|1087703|P3|Phase A+|Physician Decision|0
321871|NCT01360645|1087704|P2|Phase A+|Physician Decision|0
321872|NCT01360645|1087705|P1|Phase A+|Physician Decision|0
321873|NCT01360645|1087702|P4|Phase A+|Met Withdrawal Criteria|4
321874|NCT01360645|1087703|P3|Phase A+|Met Withdrawal Criteria|0
321875|NCT01360645|1087704|P2|Phase A+|Met Withdrawal Criteria|0
321876|NCT01360645|1087705|P1|Phase A+|Met Withdrawal Criteria|0
321877|NCT01360645|1087702|P4|Phase A+|Adverse Event|2
321878|NCT01360645|1087703|P3|Phase A+|Adverse Event|0
321879|NCT01360645|1087704|P2|Phase A+|Adverse Event|0
321880|NCT01360645|1087705|P1|Phase A+|Adverse Event|0
321881|NCT01360645|1087702|P4|Phase A+|Lost to Follow-up|7
321882|NCT01360645|1087703|P3|Phase A+|Lost to Follow-up|0
321883|NCT01360645|1087704|P2|Phase A+|Lost to Follow-up|0
321884|NCT01360645|1087705|P1|Phase A+|Lost to Follow-up|0
321885|NCT01360645|1087702|P4|Phase B (6 Weeks)|Protocol Deviation|0
321886|NCT01360645|1087703|P3|Phase B (6 Weeks)|Protocol Deviation|3
321887|NCT01360645|1087704|P2|Phase B (6 Weeks)|Protocol Deviation|1
321888|NCT01360645|1087705|P1|Phase B (6 Weeks)|Protocol Deviation|0
321889|NCT01360645|1087702|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
321890|NCT01360645|1087703|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
321891|NCT01360645|1087704|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
321892|NCT01360645|1087705|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
321893|NCT01360645|1087702|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
321894|NCT01360645|1087703|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
321895|NCT01360645|1087704|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
321896|NCT01360645|1087705|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
321897|NCT01360645|1087702|P4|Phase B (6 Weeks)|Adverse Event|0
321898|NCT01360645|1087703|P3|Phase B (6 Weeks)|Adverse Event|0
321899|NCT01360645|1087704|P2|Phase B (6 Weeks)|Adverse Event|6
321900|NCT01360645|1087705|P1|Phase B (6 Weeks)|Adverse Event|0
321901|NCT01360645|1087702|P4|Phase B (6 Weeks)|Lost to Follow-up|0
321902|NCT01360645|1087703|P3|Phase B (6 Weeks)|Lost to Follow-up|0
321903|NCT01360645|1087704|P2|Phase B (6 Weeks)|Lost to Follow-up|1
321904|NCT01360645|1087705|P1|Phase B (6 Weeks)|Lost to Follow-up|0
321905|NCT01360645|1087702|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
321906|NCT01360645|1087703|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
321907|NCT01360645|1087704|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
321908|NCT01360645|1087705|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
321909|NCT01360645|1087702|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
321910|NCT01360645|1087703|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
321911|NCT01360645|1087704|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
321912|NCT01360645|1087705|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
321913|NCT01360645|1087702|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
321914|NCT01360645|1087703|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
321915|NCT01360645|1087704|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
321916|NCT01360645|1087705|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
321917|NCT01360645|1087702|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
321918|NCT01360645|1087703|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
321919|NCT01360645|1087704|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
321920|NCT01360645|1087705|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
321921|NCT01360645|1087702|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
321922|NCT01360645|1087703|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
321923|NCT01360645|1087704|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
321924|NCT01360645|1087705|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
321925|NCT01360645|1087702|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
321926|NCT01360645|1087703|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
321927|NCT01360645|1087704|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
321928|NCT01360645|1087705|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
321929|NCT01360632|1087760|P5|Phase A+|Protocol Deviation|3
321930|NCT01360632|1087761|P4|Phase A+|Protocol Deviation|0
321931|NCT01360632|1087762|P3|Phase A+|Protocol Deviation|0
321932|NCT01360632|1087763|P2|Phase A+|Protocol Deviation|0
321933|NCT01360632|1087764|P1|Phase A+|Protocol Deviation|0
321934|NCT01360632|1087760|P5|Phase A+|Withdrawal by Subject|8
321935|NCT01360632|1087761|P4|Phase A+|Withdrawal by Subject|0
321936|NCT01360632|1087762|P3|Phase A+|Withdrawal by Subject|0
321937|NCT01360632|1087763|P2|Phase A+|Withdrawal by Subject|0
321938|NCT01360632|1087764|P1|Phase A+|Withdrawal by Subject|0
321939|NCT01360632|1087760|P5|Phase A+|Physician Decision|3
321940|NCT01360632|1087761|P4|Phase A+|Physician Decision|0
321941|NCT01360632|1087762|P3|Phase A+|Physician Decision|0
321942|NCT01360632|1087763|P2|Phase A+|Physician Decision|0
321943|NCT01360632|1087764|P1|Phase A+|Physician Decision|0
321944|NCT01360632|1087760|P5|Phase A+|Met Withdrawal Criteria|7
321945|NCT01360632|1087761|P4|Phase A+|Met Withdrawal Criteria|0
321946|NCT01360632|1087762|P3|Phase A+|Met Withdrawal Criteria|0
321947|NCT01360632|1087763|P2|Phase A+|Met Withdrawal Criteria|0
321948|NCT01360632|1087764|P1|Phase A+|Met Withdrawal Criteria|0
321949|NCT01360632|1087760|P5|Phase A+|Adverse Event|2
321950|NCT01360632|1087761|P4|Phase A+|Adverse Event|0
321951|NCT01360632|1087762|P3|Phase A+|Adverse Event|0
321952|NCT01360632|1087763|P2|Phase A+|Adverse Event|0
321953|NCT01360632|1087764|P1|Phase A+|Adverse Event|0
321954|NCT01360632|1087760|P5|Phase A+|Lost to Follow-up|2
321955|NCT01360632|1087761|P4|Phase A+|Lost to Follow-up|0
321956|NCT01360632|1087762|P3|Phase A+|Lost to Follow-up|0
321957|NCT01360632|1087763|P2|Phase A+|Lost to Follow-up|0
321958|NCT01360632|1087764|P1|Phase A+|Lost to Follow-up|0
321959|NCT01360632|1087760|P5|Phase B (6 Weeks)|Lack of Efficacy|0
321960|NCT01360632|1087761|P4|Phase B (6 Weeks)|Lack of Efficacy|0
321961|NCT01360632|1087762|P3|Phase B (6 Weeks)|Lack of Efficacy|0
321962|NCT01360632|1087763|P2|Phase B (6 Weeks)|Lack of Efficacy|1
321963|NCT01360632|1087764|P1|Phase B (6 Weeks)|Lack of Efficacy|0
321964|NCT01360632|1087760|P5|Phase B (6 Weeks)|Protocol Deviation|0
321965|NCT01360632|1087761|P4|Phase B (6 Weeks)|Protocol Deviation|1
321966|NCT01360632|1087762|P3|Phase B (6 Weeks)|Protocol Deviation|4
321967|NCT01360632|1087763|P2|Phase B (6 Weeks)|Protocol Deviation|1
321968|NCT01360632|1087764|P1|Phase B (6 Weeks)|Protocol Deviation|0
321969|NCT01360632|1087760|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
321970|NCT01360632|1087761|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
321971|NCT01360632|1087762|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
321972|NCT01360632|1087763|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
321973|NCT01360632|1087764|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
321974|NCT01360632|1087760|P5|Phase B (6 Weeks)|Physician Decision|0
321975|NCT01360632|1087761|P4|Phase B (6 Weeks)|Physician Decision|1
321976|NCT01360632|1087762|P3|Phase B (6 Weeks)|Physician Decision|0
321977|NCT01360632|1087763|P2|Phase B (6 Weeks)|Physician Decision|0
321978|NCT01360632|1087764|P1|Phase B (6 Weeks)|Physician Decision|0
321979|NCT01360632|1087760|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
321980|NCT01360632|1087761|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
321981|NCT01360632|1087762|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
321982|NCT01360632|1087763|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
321983|NCT01360632|1087764|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
321984|NCT01360632|1087760|P5|Phase B (6 Weeks)|Adverse Event|0
321985|NCT01360632|1087761|P4|Phase B (6 Weeks)|Adverse Event|3
321986|NCT01360632|1087762|P3|Phase B (6 Weeks)|Adverse Event|9
321987|NCT01360632|1087763|P2|Phase B (6 Weeks)|Adverse Event|3
321988|NCT01360632|1087764|P1|Phase B (6 Weeks)|Adverse Event|0
321989|NCT01360632|1087760|P5|Phase B (6 Weeks)|Lost to Follow-up|0
321990|NCT01360632|1087761|P4|Phase B (6 Weeks)|Lost to Follow-up|0
321991|NCT01360632|1087762|P3|Phase B (6 Weeks)|Lost to Follow-up|1
321992|NCT01360632|1087763|P2|Phase B (6 Weeks)|Lost to Follow-up|1
321993|NCT01360632|1087764|P1|Phase B (6 Weeks)|Lost to Follow-up|0
321994|NCT01360632|1087760|P5|Phase A (8 Weeks)|Protocol Deviation|0
321995|NCT01360632|1087761|P4|Phase A (8 Weeks)|Protocol Deviation|0
321996|NCT01360632|1087762|P3|Phase A (8 Weeks)|Protocol Deviation|0
321997|NCT01360632|1087763|P2|Phase A (8 Weeks)|Protocol Deviation|0
321998|NCT01360632|1087764|P1|Phase A (8 Weeks)|Protocol Deviation|39
321999|NCT01360632|1087760|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
322000|NCT01360632|1087761|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
322001|NCT01360632|1087762|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
322002|NCT01360632|1087763|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
322003|NCT01360632|1087764|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
322004|NCT01360632|1087760|P5|Phase A (8 Weeks)|Physician Decision|0
322005|NCT01360632|1087761|P4|Phase A (8 Weeks)|Physician Decision|0
322006|NCT01360632|1087762|P3|Phase A (8 Weeks)|Physician Decision|0
322007|NCT01360632|1087763|P2|Phase A (8 Weeks)|Physician Decision|0
322008|NCT01360632|1087764|P1|Phase A (8 Weeks)|Physician Decision|10
322009|NCT01360632|1087760|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
322010|NCT01360632|1087761|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
322011|NCT01360632|1087762|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
322012|NCT01360632|1087763|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
322013|NCT01360632|1087764|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
322014|NCT01360632|1087760|P5|Phase A (8 Weeks)|Adverse Event|0
322015|NCT01360632|1087761|P4|Phase A (8 Weeks)|Adverse Event|0
322016|NCT01360632|1087762|P3|Phase A (8 Weeks)|Adverse Event|0
322017|NCT01360632|1087763|P2|Phase A (8 Weeks)|Adverse Event|0
322018|NCT01360632|1087764|P1|Phase A (8 Weeks)|Adverse Event|60
322019|NCT01360632|1087760|P5|Phase A (8 Weeks)|Lost to Follow-up|0
322020|NCT01360632|1087761|P4|Phase A (8 Weeks)|Lost to Follow-up|0
322021|NCT01360632|1087762|P3|Phase A (8 Weeks)|Lost to Follow-up|0
322022|NCT01360632|1087763|P2|Phase A (8 Weeks)|Lost to Follow-up|0
322023|NCT01360632|1087764|P1|Phase A (8 Weeks)|Lost to Follow-up|27
322024|NCT01360554|1087843|P2|Overall Study|Randomized but not treated.|3
322025|NCT01360554|1087844|P1|Overall Study|Randomized but not treated.|3
322026|NCT01360554|1087843|P2|Overall Study|Other, not specified|0
322027|NCT01360554|1087844|P1|Overall Study|Other, not specified|1
322028|NCT01360554|1087843|P2|Overall Study|Study terminated by sponsor|37
322029|NCT01360554|1087844|P1|Overall Study|Study terminated by sponsor|49
322030|NCT01360554|1087843|P2|Overall Study|Withdrawal by Subject|24
322031|NCT01360554|1087844|P1|Overall Study|Withdrawal by Subject|23
322032|NCT01360554|1087843|P2|Overall Study|Lost to Follow-up|4
322033|NCT01360554|1087844|P1|Overall Study|Lost to Follow-up|4
322034|NCT01360554|1087843|P2|Overall Study|Death|371
322035|NCT01360554|1087844|P1|Overall Study|Death|359
322036|NCT01360021|1087896|P3|Overall Study|Adverse Event|3
322037|NCT01360021|1087897|P2|Overall Study|Adverse Event|3
322038|NCT01360021|1087898|P1|Overall Study|Adverse Event|2
322039|NCT01360021|1087896|P3|Overall Study|Withdrawal by Subject|2
322040|NCT01360021|1087897|P2|Overall Study|Withdrawal by Subject|0
322041|NCT01360021|1087898|P1|Overall Study|Withdrawal by Subject|4
322042|NCT01360021|1087896|P3|Overall Study|Protocol Violation|1
322043|NCT01360021|1087897|P2|Overall Study|Protocol Violation|0
322044|NCT01360021|1087898|P1|Overall Study|Protocol Violation|0
322045|NCT01360021|1087896|P3|Overall Study|Eligibility criteria + other|1
322046|NCT01360021|1087897|P2|Overall Study|Eligibility criteria + other|1
322047|NCT01360021|1087898|P1|Overall Study|Eligibility criteria + other|2
322048|NCT01359943|1087924|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
322049|NCT01359943|1087925|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
322050|NCT01359943|1087926|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
322051|NCT01359943|1087924|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
322052|NCT01359943|1087925|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
322053|NCT01359943|1087926|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
322054|NCT01359943|1087924|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
322055|NCT01359943|1087925|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
322056|NCT01359943|1087926|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
322057|NCT01359943|1087924|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
322058|NCT01359943|1087925|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
322059|NCT01359943|1087926|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
322060|NCT01359943|1087924|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
322061|NCT01359943|1087925|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
322062|NCT01359943|1087926|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
322063|NCT01359943|1087924|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
322064|NCT01359943|1087925|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
322065|NCT01359943|1087926|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
322066|NCT01359943|1087924|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
322067|NCT01359943|1087925|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
322068|NCT01359943|1087926|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
322069|NCT01359943|1087924|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
322070|NCT01359943|1087925|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
322071|NCT01359943|1087926|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
322072|NCT01359943|1087924|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
322073|NCT01359943|1087925|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
322074|NCT01359943|1087926|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
322075|NCT01359943|1087924|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
322076|NCT01359943|1087925|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
322077|NCT01359943|1087926|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
322078|NCT01359943|1087924|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
322079|NCT01359943|1087925|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
322080|NCT01359943|1087926|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
322081|NCT01359943|1087924|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
322082|NCT01359943|1087925|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
322083|NCT01359943|1087926|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
322084|NCT01359943|1087924|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
322085|NCT01359943|1087925|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
322086|NCT01359943|1087926|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
322087|NCT01359943|1087924|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
322088|NCT01359943|1087925|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
322089|NCT01359943|1087926|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
322090|NCT01359943|1087924|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
322091|NCT01359943|1087925|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
322092|NCT01359943|1087926|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
322093|NCT01359904|1087974|P2|Overall Study|Withdrawal by Subject|0
322094|NCT01359904|1087975|P1|Overall Study|Withdrawal by Subject|1
322095|NCT01359644|1088029|P10|Follow-up Period|Lost to Follow-up|0
322096|NCT01359644|1088030|P9|Follow-up Period|Lost to Follow-up|0
322097|NCT01359644|1088031|P8|Follow-up Period|Lost to Follow-up|2
322098|NCT01359644|1088032|P7|Follow-up Period|Lost to Follow-up|1
322099|NCT01359644|1088033|P6|Follow-up Period|Lost to Follow-up|0
322100|NCT01359644|1088034|P5|Follow-up Period|Lost to Follow-up|0
322101|NCT01359644|1088035|P4|Follow-up Period|Lost to Follow-up|0
322102|NCT01359644|1088036|P3|Follow-up Period|Lost to Follow-up|0
322103|NCT01359644|1088037|P2|Follow-up Period|Lost to Follow-up|0
322104|NCT01359644|1088038|P1|Follow-up Period|Lost to Follow-up|0
322105|NCT01359644|1088029|P10|Follow-up Period|Withdrawal by Subject|0
322106|NCT01359644|1088030|P9|Follow-up Period|Withdrawal by Subject|0
322107|NCT01359644|1088031|P8|Follow-up Period|Withdrawal by Subject|0
322108|NCT01359644|1088032|P7|Follow-up Period|Withdrawal by Subject|0
322109|NCT01359644|1088033|P6|Follow-up Period|Withdrawal by Subject|1
322110|NCT01359644|1088034|P5|Follow-up Period|Withdrawal by Subject|0
322111|NCT01359644|1088035|P4|Follow-up Period|Withdrawal by Subject|0
322112|NCT01359644|1088036|P3|Follow-up Period|Withdrawal by Subject|0
322113|NCT01359644|1088037|P2|Follow-up Period|Withdrawal by Subject|0
322114|NCT01359644|1088038|P1|Follow-up Period|Withdrawal by Subject|0
322115|NCT01359644|1088029|P10|Treatment Period|Lost to Follow-up|0
322116|NCT01359644|1088030|P9|Treatment Period|Lost to Follow-up|0
322117|NCT01359644|1088031|P8|Treatment Period|Lost to Follow-up|0
322118|NCT01359644|1088032|P7|Treatment Period|Lost to Follow-up|0
322119|NCT01359644|1088033|P6|Treatment Period|Lost to Follow-up|1
322120|NCT01359644|1088034|P5|Treatment Period|Lost to Follow-up|0
322121|NCT01359644|1088035|P4|Treatment Period|Lost to Follow-up|0
322122|NCT01359644|1088036|P3|Treatment Period|Lost to Follow-up|0
322123|NCT01359644|1088037|P2|Treatment Period|Lost to Follow-up|0
322124|NCT01359644|1088038|P1|Treatment Period|Lost to Follow-up|0
322125|NCT01359644|1088029|P10|Treatment Period|Adverse Event|0
322126|NCT01359644|1088030|P9|Treatment Period|Adverse Event|0
322127|NCT01359644|1088031|P8|Treatment Period|Adverse Event|0
322128|NCT01359644|1088032|P7|Treatment Period|Adverse Event|0
322129|NCT01359644|1088033|P6|Treatment Period|Adverse Event|1
322130|NCT01359644|1088034|P5|Treatment Period|Adverse Event|0
322131|NCT01359644|1088035|P4|Treatment Period|Adverse Event|0
322132|NCT01359644|1088036|P3|Treatment Period|Adverse Event|1
322133|NCT01359644|1088037|P2|Treatment Period|Adverse Event|0
322134|NCT01359644|1088038|P1|Treatment Period|Adverse Event|0
322135|NCT01359644|1088029|P10|Treatment Period|Lack of Efficacy|0
322136|NCT01359644|1088030|P9|Treatment Period|Lack of Efficacy|0
322137|NCT01359644|1088031|P8|Treatment Period|Lack of Efficacy|0
322138|NCT01359644|1088032|P7|Treatment Period|Lack of Efficacy|0
322139|NCT01359644|1088033|P6|Treatment Period|Lack of Efficacy|0
322140|NCT01359644|1088034|P5|Treatment Period|Lack of Efficacy|0
322141|NCT01359644|1088035|P4|Treatment Period|Lack of Efficacy|0
322142|NCT01359644|1088036|P3|Treatment Period|Lack of Efficacy|0
322143|NCT01359644|1088037|P2|Treatment Period|Lack of Efficacy|1
322144|NCT01359644|1088038|P1|Treatment Period|Lack of Efficacy|0
322145|NCT01359449|1088082|P2|Overall Study|Withdrawal by Subject|2
322146|NCT01359449|1088083|P1|Overall Study|Withdrawal by Subject|3
322147|NCT01359449|1088082|P2|Overall Study|Protocol Violation|2
322148|NCT01359449|1088083|P1|Overall Study|Protocol Violation|0
322149|NCT01359449|1088082|P2|Overall Study|Lost to Follow-up|0
322150|NCT01359449|1088083|P1|Overall Study|Lost to Follow-up|1
322151|NCT01359254|1088129|P2|Overall Study|Death|0
322152|NCT01359254|1088130|P1|Overall Study|Death|1
322153|NCT01359150|1088140|P2|Overall Study|Other|0
322154|NCT01359150|1088141|P1|Overall Study|Other|1
322155|NCT01359150|1088140|P2|Overall Study|Adverse Event|3
322156|NCT01359150|1088141|P1|Overall Study|Adverse Event|4
322157|NCT01359150|1088140|P2|Overall Study|Withdrawal by Subject|1
322158|NCT01359150|1088141|P1|Overall Study|Withdrawal by Subject|1
322159|NCT01359150|1088140|P2|Overall Study|Lack of Efficacy|1
322160|NCT01359150|1088141|P1|Overall Study|Lack of Efficacy|1
322161|NCT01358877|1088180|P2|Overall Study|Other|129
322162|NCT01358877|1088181|P1|Overall Study|Other|142
322163|NCT01358877|1088180|P2|Overall Study|Ongoing follow-up for overall survival|5
322164|NCT01358877|1088181|P1|Overall Study|Ongoing follow-up for overall survival|7
322165|NCT01358877|1088180|P2|Overall Study|Ongoing follow-up for IDFS event|2073
322166|NCT01358877|1088181|P1|Overall Study|Ongoing follow-up for IDFS event|2084
322167|NCT01358877|1088180|P2|Overall Study|Ongoing follow-up for post-recurrence|108
322168|NCT01358877|1088181|P1|Overall Study|Ongoing follow-up for post-recurrence|87
322169|NCT01358877|1088180|P2|Overall Study|Death|89
322170|NCT01358877|1088181|P1|Overall Study|Death|80
322171|NCT01358864|1088251|P8|Overall Study|Not treated|0
322172|NCT01358864|1088252|P7|Overall Study|Not treated|1
322173|NCT01358864|1088253|P6|Overall Study|Not treated|0
322174|NCT01358864|1088254|P5|Overall Study|Not treated|0
322175|NCT01358864|1088255|P4|Overall Study|Not treated|0
322176|NCT01358864|1088256|P3|Overall Study|Not treated|0
322177|NCT01358864|1088257|P2|Overall Study|Not treated|0
322178|NCT01358864|1088258|P1|Overall Study|Not treated|0
322179|NCT01358864|1088251|P8|Overall Study|Other reason not defined above|0
322180|NCT01358864|1088252|P7|Overall Study|Other reason not defined above|2
322181|NCT01358864|1088253|P6|Overall Study|Other reason not defined above|0
322182|NCT01358864|1088254|P5|Overall Study|Other reason not defined above|0
322183|NCT01358864|1088255|P4|Overall Study|Other reason not defined above|0
322184|NCT01358864|1088256|P3|Overall Study|Other reason not defined above|0
322185|NCT01358864|1088257|P2|Overall Study|Other reason not defined above|0
322186|NCT01358864|1088258|P1|Overall Study|Other reason not defined above|2
322187|NCT01358864|1088251|P8|Overall Study|Withdrawal by Subject|3
322188|NCT01358864|1088252|P7|Overall Study|Withdrawal by Subject|1
322189|NCT01358864|1088253|P6|Overall Study|Withdrawal by Subject|1
322190|NCT01358864|1088254|P5|Overall Study|Withdrawal by Subject|0
322191|NCT01358864|1088255|P4|Overall Study|Withdrawal by Subject|0
322192|NCT01358864|1088256|P3|Overall Study|Withdrawal by Subject|2
322193|NCT01358864|1088257|P2|Overall Study|Withdrawal by Subject|4
322194|NCT01358864|1088258|P1|Overall Study|Withdrawal by Subject|3
322195|NCT01358864|1088251|P8|Overall Study|Lost to Follow-up|1
322196|NCT01358864|1088252|P7|Overall Study|Lost to Follow-up|0
322197|NCT01358864|1088253|P6|Overall Study|Lost to Follow-up|0
322198|NCT01358864|1088254|P5|Overall Study|Lost to Follow-up|0
322199|NCT01358864|1088255|P4|Overall Study|Lost to Follow-up|0
322200|NCT01358864|1088256|P3|Overall Study|Lost to Follow-up|1
322201|NCT01358864|1088257|P2|Overall Study|Lost to Follow-up|0
322202|NCT01358864|1088258|P1|Overall Study|Lost to Follow-up|0
322203|NCT01358864|1088251|P8|Overall Study|Lack of Efficacy|44
322204|NCT01358864|1088252|P7|Overall Study|Lack of Efficacy|49
322205|NCT01358864|1088253|P6|Overall Study|Lack of Efficacy|4
322206|NCT01358864|1088254|P5|Overall Study|Lack of Efficacy|7
322207|NCT01358864|1088255|P4|Overall Study|Lack of Efficacy|19
322208|NCT01358864|1088256|P3|Overall Study|Lack of Efficacy|4
322209|NCT01358864|1088257|P2|Overall Study|Lack of Efficacy|3
322210|NCT01358864|1088258|P1|Overall Study|Lack of Efficacy|26
322211|NCT01358864|1088251|P8|Overall Study|Adverse Event|7
322212|NCT01358864|1088252|P7|Overall Study|Adverse Event|12
322213|NCT01358864|1088253|P6|Overall Study|Adverse Event|8
322214|NCT01358864|1088254|P5|Overall Study|Adverse Event|4
322215|NCT01358864|1088255|P4|Overall Study|Adverse Event|0
322216|NCT01358864|1088256|P3|Overall Study|Adverse Event|9
322217|NCT01358864|1088257|P2|Overall Study|Adverse Event|6
322218|NCT01358864|1088258|P1|Overall Study|Adverse Event|0
322219|NCT01358825|1088349|P2|Overall Study|Blood sample not drawn|1
322220|NCT01358825|1088350|P1|Overall Study|Blood sample not drawn|0
322221|NCT01358760|1088374|P3|Overall Study|Entry criteria not met/Non-compliance|16
322222|NCT01358760|1088375|P2|Overall Study|Entry criteria not met/Non-compliance|12
322223|NCT01358760|1088376|P1|Overall Study|Entry criteria not met/Non-compliance|12
322224|NCT01358760|1088374|P3|Overall Study|Physician Decision|1
322225|NCT01358760|1088375|P2|Overall Study|Physician Decision|0
322226|NCT01358760|1088376|P1|Overall Study|Physician Decision|1
322227|NCT01358760|1088374|P3|Overall Study|Withdrawal by Subject|2
322228|NCT01358760|1088375|P2|Overall Study|Withdrawal by Subject|3
322229|NCT01358760|1088376|P1|Overall Study|Withdrawal by Subject|5
322230|NCT01358760|1088374|P3|Overall Study|Lost to Follow-up|3
322231|NCT01358760|1088375|P2|Overall Study|Lost to Follow-up|1
322232|NCT01358760|1088376|P1|Overall Study|Lost to Follow-up|1
322233|NCT01358760|1088374|P3|Overall Study|Adverse Event|3
322234|NCT01358760|1088375|P2|Overall Study|Adverse Event|4
322235|NCT01358760|1088376|P1|Overall Study|Adverse Event|3
322236|NCT01358734|1088411|P3|Overall Study|Not Specified|4
322237|NCT01358734|1088412|P2|Overall Study|Not Specified|5
322238|NCT01358734|1088413|P1|Overall Study|Not Specified|2
322239|NCT01358734|1088411|P3|Overall Study|Non-compliance with study drug|1
322240|NCT01358734|1088412|P2|Overall Study|Non-compliance with study drug|0
322241|NCT01358734|1088413|P1|Overall Study|Non-compliance with study drug|0
322242|NCT01358734|1088411|P3|Overall Study|Progressive Disease|13
322243|NCT01358734|1088412|P2|Overall Study|Progressive Disease|11
322244|NCT01358734|1088413|P1|Overall Study|Progressive Disease|5
322245|NCT01358734|1088411|P3|Overall Study|Death|2
322246|NCT01358734|1088412|P2|Overall Study|Death|7
322247|NCT01358734|1088413|P1|Overall Study|Death|3
322248|NCT01358734|1088411|P3|Overall Study|Withdrawal by Subject|3
322249|NCT01358734|1088412|P2|Overall Study|Withdrawal by Subject|6
322250|NCT01358734|1088413|P1|Overall Study|Withdrawal by Subject|1
322251|NCT01358734|1088411|P3|Overall Study|Lack of Efficacy|3
322252|NCT01358734|1088412|P2|Overall Study|Lack of Efficacy|1
322253|NCT01358734|1088413|P1|Overall Study|Lack of Efficacy|0
322254|NCT01358734|1088411|P3|Overall Study|Adverse Event|3
322255|NCT01358734|1088412|P2|Overall Study|Adverse Event|7
322256|NCT01358734|1088413|P1|Overall Study|Adverse Event|4
322257|NCT01358708|1088432|P2|Double-Blind Treatment Phase|Protocol Violation|0
322258|NCT01358708|1088433|P1|Double-Blind Treatment Phase|Protocol Violation|1
322259|NCT01358708|1088432|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
322260|NCT01358708|1088433|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
322261|NCT01358578|1088456|P6|Follow-up Period|Physician Decision|0
322262|NCT01358578|1088457|P5|Follow-up Period|Physician Decision|0
322263|NCT01358578|1088458|P4|Follow-up Period|Physician Decision|2
322264|NCT01358578|1088459|P3|Follow-up Period|Physician Decision|0
322265|NCT01358578|1088460|P2|Follow-up Period|Physician Decision|1
322266|NCT01358578|1088461|P1|Follow-up Period|Physician Decision|1
322267|NCT01358578|1088456|P6|Follow-up Period|Withdrawal by Subject|0
322268|NCT01358578|1088457|P5|Follow-up Period|Withdrawal by Subject|0
322269|NCT01358578|1088458|P4|Follow-up Period|Withdrawal by Subject|12
322270|NCT01358578|1088459|P3|Follow-up Period|Withdrawal by Subject|1
322271|NCT01358578|1088460|P2|Follow-up Period|Withdrawal by Subject|3
322272|NCT01358578|1088461|P1|Follow-up Period|Withdrawal by Subject|3
322273|NCT01358578|1088456|P6|Follow-up Period|Pregnancy|0
322274|NCT01358578|1088457|P5|Follow-up Period|Pregnancy|0
322275|NCT01358578|1088458|P4|Follow-up Period|Pregnancy|0
322276|NCT01358578|1088459|P3|Follow-up Period|Pregnancy|0
322277|NCT01358578|1088460|P2|Follow-up Period|Pregnancy|0
322278|NCT01358578|1088461|P1|Follow-up Period|Pregnancy|1
322279|NCT01358578|1088456|P6|Follow-up Period|non- compliance with study treatment|0
322280|NCT01358578|1088457|P5|Follow-up Period|non- compliance with study treatment|0
322281|NCT01358578|1088458|P4|Follow-up Period|non- compliance with study treatment|0
322282|NCT01358578|1088459|P3|Follow-up Period|non- compliance with study treatment|0
322283|NCT01358578|1088460|P2|Follow-up Period|non- compliance with study treatment|0
322284|NCT01358578|1088461|P1|Follow-up Period|non- compliance with study treatment|1
322285|NCT01358578|1088456|P6|Follow-up Period|Lost to Follow-up|0
322286|NCT01358578|1088457|P5|Follow-up Period|Lost to Follow-up|0
322287|NCT01358578|1088458|P4|Follow-up Period|Lost to Follow-up|4
322288|NCT01358578|1088459|P3|Follow-up Period|Lost to Follow-up|0
322289|NCT01358578|1088460|P2|Follow-up Period|Lost to Follow-up|1
322290|NCT01358578|1088461|P1|Follow-up Period|Lost to Follow-up|0
322291|NCT01358578|1088456|P6|Follow-up Period|Lack of Efficacy|0
322292|NCT01358578|1088457|P5|Follow-up Period|Lack of Efficacy|0
322293|NCT01358578|1088458|P4|Follow-up Period|Lack of Efficacy|1
322294|NCT01358578|1088459|P3|Follow-up Period|Lack of Efficacy|4
322295|NCT01358578|1088460|P2|Follow-up Period|Lack of Efficacy|0
322296|NCT01358578|1088461|P1|Follow-up Period|Lack of Efficacy|3
322297|NCT01358578|1088456|P6|Follow-up Period|Adverse Event|0
322298|NCT01358578|1088457|P5|Follow-up Period|Adverse Event|0
322299|NCT01358578|1088458|P4|Follow-up Period|Adverse Event|0
322300|NCT01358578|1088459|P3|Follow-up Period|Adverse Event|0
322301|NCT01358578|1088460|P2|Follow-up Period|Adverse Event|1
322302|NCT01358578|1088461|P1|Follow-up Period|Adverse Event|1
322303|NCT01358578|1088456|P6|Maintenance Period|Withdrawal by Subject|3
322304|NCT01358578|1088457|P5|Maintenance Period|Withdrawal by Subject|6
322305|NCT01358578|1088458|P4|Maintenance Period|Withdrawal by Subject|15
322306|NCT01358578|1088459|P3|Maintenance Period|Withdrawal by Subject|2
322307|NCT01358578|1088460|P2|Maintenance Period|Withdrawal by Subject|7
322308|NCT01358578|1088461|P1|Maintenance Period|Withdrawal by Subject|12
322309|NCT01358578|1088456|P6|Maintenance Period|Protocol deviation|2
322310|NCT01358578|1088457|P5|Maintenance Period|Protocol deviation|2
322311|NCT01358578|1088458|P4|Maintenance Period|Protocol deviation|2
322312|NCT01358578|1088459|P3|Maintenance Period|Protocol deviation|0
322313|NCT01358578|1088460|P2|Maintenance Period|Protocol deviation|4
322314|NCT01358578|1088461|P1|Maintenance Period|Protocol deviation|7
322315|NCT01358578|1088456|P6|Maintenance Period|Pregnancy|0
322316|NCT01358578|1088457|P5|Maintenance Period|Pregnancy|0
322317|NCT01358578|1088458|P4|Maintenance Period|Pregnancy|0
322318|NCT01358578|1088459|P3|Maintenance Period|Pregnancy|0
322319|NCT01358578|1088460|P2|Maintenance Period|Pregnancy|0
322320|NCT01358578|1088461|P1|Maintenance Period|Pregnancy|1
322321|NCT01358578|1088456|P6|Maintenance Period|Physician Decision|0
322322|NCT01358578|1088457|P5|Maintenance Period|Physician Decision|0
322323|NCT01358578|1088458|P4|Maintenance Period|Physician Decision|1
322324|NCT01358578|1088459|P3|Maintenance Period|Physician Decision|0
322325|NCT01358578|1088460|P2|Maintenance Period|Physician Decision|1
322326|NCT01358578|1088461|P1|Maintenance Period|Physician Decision|0
322327|NCT01358578|1088456|P6|Maintenance Period|Non-compliance with study treatment|2
322328|NCT01358578|1088457|P5|Maintenance Period|Non-compliance with study treatment|1
322329|NCT01358578|1088458|P4|Maintenance Period|Non-compliance with study treatment|2
322330|NCT01358578|1088459|P3|Maintenance Period|Non-compliance with study treatment|0
322331|NCT01358578|1088460|P2|Maintenance Period|Non-compliance with study treatment|1
322332|NCT01358578|1088461|P1|Maintenance Period|Non-compliance with study treatment|3
322333|NCT01358578|1088456|P6|Maintenance Period|Lost to Follow-up|1
322334|NCT01358578|1088457|P5|Maintenance Period|Lost to Follow-up|1
322335|NCT01358578|1088458|P4|Maintenance Period|Lost to Follow-up|5
322336|NCT01358578|1088459|P3|Maintenance Period|Lost to Follow-up|0
322337|NCT01358578|1088460|P2|Maintenance Period|Lost to Follow-up|0
322338|NCT01358578|1088461|P1|Maintenance Period|Lost to Follow-up|4
322339|NCT01358578|1088456|P6|Maintenance Period|Lack of Efficacy|0
322340|NCT01358578|1088457|P5|Maintenance Period|Lack of Efficacy|3
322341|NCT01358578|1088458|P4|Maintenance Period|Lack of Efficacy|11
322342|NCT01358578|1088459|P3|Maintenance Period|Lack of Efficacy|0
322343|NCT01358578|1088460|P2|Maintenance Period|Lack of Efficacy|2
322344|NCT01358578|1088461|P1|Maintenance Period|Lack of Efficacy|10
322345|NCT01358578|1088456|P6|Maintenance Period|Adverse Event|3
322346|NCT01358578|1088457|P5|Maintenance Period|Adverse Event|4
322347|NCT01358578|1088458|P4|Maintenance Period|Adverse Event|6
322348|NCT01358578|1088459|P3|Maintenance Period|Adverse Event|0
322349|NCT01358578|1088460|P2|Maintenance Period|Adverse Event|7
322350|NCT01358578|1088461|P1|Maintenance Period|Adverse Event|2
322351|NCT01358578|1088456|P6|Induction Period|Withdrawal by Subject|0
322352|NCT01358578|1088457|P5|Induction Period|Withdrawal by Subject|0
322353|NCT01358578|1088458|P4|Induction Period|Withdrawal by Subject|6
322354|NCT01358578|1088459|P3|Induction Period|Withdrawal by Subject|10
322355|NCT01358578|1088460|P2|Induction Period|Withdrawal by Subject|5
322356|NCT01358578|1088461|P1|Induction Period|Withdrawal by Subject|5
322357|NCT01358578|1088456|P6|Induction Period|technical problems|0
322358|NCT01358578|1088457|P5|Induction Period|technical problems|0
322359|NCT01358578|1088458|P4|Induction Period|technical problems|1
322360|NCT01358578|1088459|P3|Induction Period|technical problems|1
322361|NCT01358578|1088460|P2|Induction Period|technical problems|0
322362|NCT01358578|1088461|P1|Induction Period|technical problems|0
322363|NCT01358578|1088456|P6|Induction Period|Protocol Deviation|0
322364|NCT01358578|1088457|P5|Induction Period|Protocol Deviation|0
322365|NCT01358578|1088458|P4|Induction Period|Protocol Deviation|3
322366|NCT01358578|1088459|P3|Induction Period|Protocol Deviation|0
322367|NCT01358578|1088460|P2|Induction Period|Protocol Deviation|5
322368|NCT01358578|1088461|P1|Induction Period|Protocol Deviation|3
322369|NCT01358578|1088456|P6|Induction Period|Physician Decision|0
322370|NCT01358578|1088457|P5|Induction Period|Physician Decision|0
322371|NCT01358578|1088458|P4|Induction Period|Physician Decision|0
322372|NCT01358578|1088459|P3|Induction Period|Physician Decision|2
322373|NCT01358578|1088460|P2|Induction Period|Physician Decision|1
322374|NCT01358578|1088461|P1|Induction Period|Physician Decision|2
322375|NCT01358578|1088456|P6|Induction Period|Lost to Follow-up|0
322376|NCT01358578|1088457|P5|Induction Period|Lost to Follow-up|0
322377|NCT01358578|1088458|P4|Induction Period|Lost to Follow-up|4
322378|NCT01358578|1088459|P3|Induction Period|Lost to Follow-up|1
322379|NCT01358578|1088460|P2|Induction Period|Lost to Follow-up|0
322380|NCT01358578|1088461|P1|Induction Period|Lost to Follow-up|0
322381|NCT01358578|1088456|P6|Induction Period|Lack of Efficacy|0
322382|NCT01358578|1088457|P5|Induction Period|Lack of Efficacy|0
322383|NCT01358578|1088458|P4|Induction Period|Lack of Efficacy|1
322384|NCT01358578|1088459|P3|Induction Period|Lack of Efficacy|9
322385|NCT01358578|1088460|P2|Induction Period|Lack of Efficacy|0
322386|NCT01358578|1088461|P1|Induction Period|Lack of Efficacy|0
322387|NCT01358578|1088456|P6|Induction Period|Adverse Event|0
322388|NCT01358578|1088457|P5|Induction Period|Adverse Event|0
322389|NCT01358578|1088458|P4|Induction Period|Adverse Event|6
322390|NCT01358578|1088459|P3|Induction Period|Adverse Event|2
322391|NCT01358578|1088460|P2|Induction Period|Adverse Event|4
322392|NCT01358578|1088461|P1|Induction Period|Adverse Event|2
322393|NCT01358526|1088513|P3|Double-blind Phase|Administrative|10
322394|NCT01358526|1088514|P2|Double-blind Phase|Administrative|6
322395|NCT01358526|1088515|P1|Double-blind Phase|Administrative|0
322396|NCT01358526|1088513|P3|Double-blind Phase|Confirmed or suspected diversion|6
322397|NCT01358526|1088514|P2|Double-blind Phase|Confirmed or suspected diversion|5
322398|NCT01358526|1088515|P1|Double-blind Phase|Confirmed or suspected diversion|0
322399|NCT01358526|1088513|P3|Double-blind Phase|Lack of Efficacy|73
322400|NCT01358526|1088514|P2|Double-blind Phase|Lack of Efficacy|31
322401|NCT01358526|1088515|P1|Double-blind Phase|Lack of Efficacy|0
322402|NCT01358526|1088513|P3|Double-blind Phase|Lost to Follow-up|1
322403|NCT01358526|1088514|P2|Double-blind Phase|Lost to Follow-up|4
322404|NCT01358526|1088515|P1|Double-blind Phase|Lost to Follow-up|0
322405|NCT01358526|1088513|P3|Double-blind Phase|Withdrawal by Subject|8
322406|NCT01358526|1088514|P2|Double-blind Phase|Withdrawal by Subject|10
322407|NCT01358526|1088515|P1|Double-blind Phase|Withdrawal by Subject|0
322408|NCT01358526|1088513|P3|Double-blind Phase|Adverse Event|23
322409|NCT01358526|1088514|P2|Double-blind Phase|Adverse Event|24
322410|NCT01358526|1088515|P1|Double-blind Phase|Adverse Event|0
322411|NCT01358526|1088513|P3|Open-label Titration Period|Did not qualify|0
322412|NCT01358526|1088514|P2|Open-label Titration Period|Did not qualify|0
322413|NCT01358526|1088515|P1|Open-label Titration Period|Did not qualify|178
322414|NCT01358526|1088513|P3|Open-label Titration Period|Administrative|0
322415|NCT01358526|1088514|P2|Open-label Titration Period|Administrative|0
322416|NCT01358526|1088515|P1|Open-label Titration Period|Administrative|8
322417|NCT01358526|1088513|P3|Open-label Titration Period|Confirmed or suspected diversion|0
322418|NCT01358526|1088514|P2|Open-label Titration Period|Confirmed or suspected diversion|0
322419|NCT01358526|1088515|P1|Open-label Titration Period|Confirmed or suspected diversion|16
322420|NCT01358526|1088513|P3|Open-label Titration Period|Lack of Efficacy|0
322421|NCT01358526|1088514|P2|Open-label Titration Period|Lack of Efficacy|0
322422|NCT01358526|1088515|P1|Open-label Titration Period|Lack of Efficacy|107
322423|NCT01358526|1088513|P3|Open-label Titration Period|Lost to Follow-up|0
322424|NCT01358526|1088514|P2|Open-label Titration Period|Lost to Follow-up|0
322425|NCT01358526|1088515|P1|Open-label Titration Period|Lost to Follow-up|25
322426|NCT01358526|1088513|P3|Open-label Titration Period|Withdrawal by Subject|0
322427|NCT01358526|1088514|P2|Open-label Titration Period|Withdrawal by Subject|0
322428|NCT01358526|1088515|P1|Open-label Titration Period|Withdrawal by Subject|65
322429|NCT01358526|1088513|P3|Open-label Titration Period|Adverse Event|0
322430|NCT01358526|1088514|P2|Open-label Titration Period|Adverse Event|0
322431|NCT01358526|1088515|P1|Open-label Titration Period|Adverse Event|95
322432|NCT01358357|1088532|P3|Double-Blind Phase|Administrative|0
322433|NCT01358357|1088533|P2|Double-Blind Phase|Administrative|1
322434|NCT01358357|1088534|P1|Double-Blind Phase|Administrative|0
322435|NCT01358357|1088532|P3|Double-Blind Phase|Recurrence of mood event|0
322436|NCT01358357|1088533|P2|Double-Blind Phase|Recurrence of mood event|64
322437|NCT01358357|1088534|P1|Double-Blind Phase|Recurrence of mood event|48
322438|NCT01358357|1088532|P3|Double-Blind Phase|Terminated at study completion|0
322439|NCT01358357|1088533|P2|Double-Blind Phase|Terminated at study completion|0
322440|NCT01358357|1088534|P1|Double-Blind Phase|Terminated at study completion|2
322441|NCT01358357|1088532|P3|Double-Blind Phase|Protocol Violation|0
322442|NCT01358357|1088533|P2|Double-Blind Phase|Protocol Violation|12
322443|NCT01358357|1088534|P1|Double-Blind Phase|Protocol Violation|16
322444|NCT01358357|1088532|P3|Double-Blind Phase|Protocol Violation|0
322445|NCT01358357|1088533|P2|Double-Blind Phase|Protocol Violation|11
322446|NCT01358357|1088534|P1|Double-Blind Phase|Protocol Violation|1
322447|NCT01358357|1088532|P3|Double-Blind Phase|Lost to Follow-up|0
322448|NCT01358357|1088533|P2|Double-Blind Phase|Lost to Follow-up|7
322449|NCT01358357|1088534|P1|Double-Blind Phase|Lost to Follow-up|5
322450|NCT01358357|1088532|P3|Double-Blind Phase|Adverse Event|0
322451|NCT01358357|1088533|P2|Double-Blind Phase|Adverse Event|5
322452|NCT01358357|1088534|P1|Double-Blind Phase|Adverse Event|8
322453|NCT01358357|1088532|P3|Open Label Phase|Mood episode|42
322454|NCT01358357|1088533|P2|Open Label Phase|Mood episode|0
322455|NCT01358357|1088534|P1|Open Label Phase|Mood episode|0
322456|NCT01358357|1088532|P3|Open Label Phase|Terminated at study completion|5
322457|NCT01358357|1088533|P2|Open Label Phase|Terminated at study completion|0
322458|NCT01358357|1088534|P1|Open Label Phase|Terminated at study completion|0
322459|NCT01358357|1088532|P3|Open Label Phase|Did not meet criteria for DB phase|16
322460|NCT01358357|1088533|P2|Open Label Phase|Did not meet criteria for DB phase|0
322461|NCT01358357|1088534|P1|Open Label Phase|Did not meet criteria for DB phase|0
322462|NCT01358357|1088532|P3|Open Label Phase|Withdrawal by Subject|112
322463|NCT01358357|1088533|P2|Open Label Phase|Withdrawal by Subject|0
322464|NCT01358357|1088534|P1|Open Label Phase|Withdrawal by Subject|0
322465|NCT01358357|1088532|P3|Open Label Phase|Protocol Violation|45
322466|NCT01358357|1088533|P2|Open Label Phase|Protocol Violation|0
322467|NCT01358357|1088534|P1|Open Label Phase|Protocol Violation|0
322468|NCT01358357|1088532|P3|Open Label Phase|Lost to Follow-up|76
322469|NCT01358357|1088533|P2|Open Label Phase|Lost to Follow-up|0
322470|NCT01358357|1088534|P1|Open Label Phase|Lost to Follow-up|0
322471|NCT01358357|1088532|P3|Open Label Phase|Lack of Efficacy|107
322472|NCT01358357|1088533|P2|Open Label Phase|Lack of Efficacy|0
322473|NCT01358357|1088534|P1|Open Label Phase|Lack of Efficacy|0
322474|NCT01358357|1088532|P3|Open Label Phase|Adverse Event|59
322475|NCT01358357|1088533|P2|Open Label Phase|Adverse Event|0
322476|NCT01358357|1088534|P1|Open Label Phase|Adverse Event|0
322477|NCT01358175|1088570|P3|Overall Study|Adverse Event|11
322478|NCT01358175|1088571|P2|Overall Study|Adverse Event|11
322479|NCT01358175|1088572|P1|Overall Study|Adverse Event|6
322480|NCT01358175|1088570|P3|Overall Study|Lack of Efficacy|6
322481|NCT01358175|1088571|P2|Overall Study|Lack of Efficacy|8
322482|NCT01358175|1088572|P1|Overall Study|Lack of Efficacy|3
322483|NCT01358175|1088570|P3|Overall Study|Lost to Follow-up|3
322484|NCT01358175|1088571|P2|Overall Study|Lost to Follow-up|1
322485|NCT01358175|1088572|P1|Overall Study|Lost to Follow-up|1
322486|NCT01358175|1088570|P3|Overall Study|Non Compliance with Study Treatment|1
322487|NCT01358175|1088571|P2|Overall Study|Non Compliance with Study Treatment|1
322488|NCT01358175|1088572|P1|Overall Study|Non Compliance with Study Treatment|0
322489|NCT01358175|1088570|P3|Overall Study|Physician Decision|0
322490|NCT01358175|1088571|P2|Overall Study|Physician Decision|0
322491|NCT01358175|1088572|P1|Overall Study|Physician Decision|1
322492|NCT01358175|1088570|P3|Overall Study|Pregnancy|0
322493|NCT01358175|1088571|P2|Overall Study|Pregnancy|1
322494|NCT01358175|1088572|P1|Overall Study|Pregnancy|0
322495|NCT01358175|1088570|P3|Overall Study|Technical issues|0
322496|NCT01358175|1088571|P2|Overall Study|Technical issues|1
322497|NCT01358175|1088572|P1|Overall Study|Technical issues|0
322498|NCT01358175|1088570|P3|Overall Study|Withdrawal by Subject|10
322499|NCT01358175|1088571|P2|Overall Study|Withdrawal by Subject|5
322500|NCT01358175|1088572|P1|Overall Study|Withdrawal by Subject|9
322501|NCT01358175|1088570|P3|Overall Study|Death|1
322502|NCT01358175|1088571|P2|Overall Study|Death|0
322503|NCT01358175|1088572|P1|Overall Study|Death|1
322504|NCT01357980|1088609|P4|Overall Study|Consent withdrawn|0
322505|NCT01357980|1088610|P3|Overall Study|Consent withdrawn|1
322506|NCT01357980|1088611|P2|Overall Study|Consent withdrawn|0
322507|NCT01357980|1088612|P1|Overall Study|Consent withdrawn|0
322508|NCT01357980|1088609|P4|Overall Study|Lack of Efficacy|0
322509|NCT01357980|1088610|P3|Overall Study|Lack of Efficacy|0
322510|NCT01357980|1088611|P2|Overall Study|Lack of Efficacy|1
322511|NCT01357980|1088612|P1|Overall Study|Lack of Efficacy|0
322512|NCT01357915|1088656|P2|Overall Study|Lost to Follow-up|0
322513|NCT01357915|1088657|P1|Overall Study|Lost to Follow-up|3
322514|NCT01357889|1088672|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
322515|NCT01357889|1088673|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
322516|NCT01357889|1088672|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
322517|NCT01357889|1088673|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
322518|NCT01357889|1088672|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
322519|NCT01357889|1088673|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
322520|NCT01357889|1088672|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
322521|NCT01357889|1088673|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
322522|NCT01357889|1088672|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
322523|NCT01357889|1088673|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
322524|NCT01357889|1088672|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
322525|NCT01357889|1088673|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
322526|NCT01357889|1088672|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
322527|NCT01357889|1088673|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
322528|NCT01357889|1088672|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
322529|NCT01357889|1088673|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
322530|NCT01357889|1088672|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
322531|NCT01357889|1088673|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
322532|NCT01357889|1088672|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
322533|NCT01357889|1088673|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
322534|NCT01357889|1088672|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
322535|NCT01357889|1088673|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
322536|NCT01357889|1088672|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
322537|NCT01357889|1088673|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
322538|NCT01357889|1088672|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
322539|NCT01357889|1088673|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
322540|NCT01357850|1088717|P4|Overall Study|Lost to Follow-up|0
322541|NCT01357850|1088718|P3|Overall Study|Lost to Follow-up|0
322542|NCT01357850|1088719|P2|Overall Study|Lost to Follow-up|0
322543|NCT01357850|1088720|P1|Overall Study|Lost to Follow-up|1
322544|NCT01357655|1088811|P2|Overall Study|Subject Withdrew Consent|0
322545|NCT01357655|1088812|P1|Overall Study|Subject Withdrew Consent|1
322546|NCT01357655|1088811|P2|Overall Study|Study Drug Toxicity|0
322547|NCT01357655|1088812|P1|Overall Study|Study Drug Toxicity|11
322548|NCT01357655|1088811|P2|Overall Study|Reason Unspecified|0
322549|NCT01357655|1088812|P1|Overall Study|Reason Unspecified|1
322550|NCT01357655|1088811|P2|Overall Study|Maximum Clinical Benefit|0
322551|NCT01357655|1088812|P1|Overall Study|Maximum Clinical Benefit|2
322552|NCT01357655|1088811|P2|Overall Study|Lost to Follow-up|0
322553|NCT01357655|1088812|P1|Overall Study|Lost to Follow-up|2
322554|NCT01357655|1088811|P2|Overall Study|Disease Progression|0
322555|NCT01357655|1088812|P1|Overall Study|Disease Progression|1
322556|NCT01357655|1088811|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
322557|NCT01357655|1088812|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
322558|NCT01357655|1088811|P2|Overall Study|Administrative Reason by Sponsor|0
322559|NCT01357655|1088812|P1|Overall Study|Administrative Reason by Sponsor|45
322560|NCT01357616|1088829|P2|Overall Study|Withdrawal by Subject|0
322561|NCT01357616|1088830|P1|Overall Study|Withdrawal by Subject|1
322562|NCT01357616|1088829|P2|Overall Study|Decision Unrelated to Adverse Event|1
322563|NCT01357616|1088830|P1|Overall Study|Decision Unrelated to Adverse Event|3
322564|NCT01357616|1088829|P2|Overall Study|Inadequate Control of IOP|2
322565|NCT01357616|1088830|P1|Overall Study|Inadequate Control of IOP|1
322566|NCT01357616|1088829|P2|Overall Study|Protocol Violation|2
322567|NCT01357616|1088830|P1|Overall Study|Protocol Violation|0
322568|NCT01357616|1088829|P2|Overall Study|Lost to Follow-up|3
322569|NCT01357616|1088830|P1|Overall Study|Lost to Follow-up|4
322570|NCT01357616|1088829|P2|Overall Study|Adverse Event|1
322571|NCT01357616|1088830|P1|Overall Study|Adverse Event|1
322572|NCT01357551|1088844|P2|Overall Study|Lost to Follow-up|6
322573|NCT01357551|1088845|P1|Overall Study|Lost to Follow-up|16
322574|NCT01357551|1088844|P2|Overall Study|Death|1
322575|NCT01357551|1088845|P1|Overall Study|Death|0
322576|NCT01357551|1088844|P2|Overall Study|Withdrawal by Subject|4
322577|NCT01357551|1088845|P1|Overall Study|Withdrawal by Subject|6
322578|NCT01357239|1088872|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
322579|NCT01357239|1088873|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
322580|NCT01357239|1088874|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
322581|NCT01357239|1088875|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
322582|NCT01357239|1088872|P4|Stratum II: Partially-Methylated|Adverse Event|1
322583|NCT01357239|1088873|P3|Stratum II: Partially-Methylated|Adverse Event|0
322584|NCT01357239|1088874|P2|Stratum II: Partially-Methylated|Adverse Event|0
322585|NCT01357239|1088875|P1|Stratum II: Partially-Methylated|Adverse Event|0
322586|NCT01357239|1088872|P4|Stratum I: Fully-Methylated|Adverse Event|0
322587|NCT01357239|1088873|P3|Stratum I: Fully-Methylated|Adverse Event|1
322588|NCT01357239|1088874|P2|Stratum I: Fully-Methylated|Adverse Event|0
322589|NCT01357239|1088875|P1|Stratum I: Fully-Methylated|Adverse Event|0
322590|NCT01357239|1088872|P4|Stratum: All Patients|Subject withdrew consent|1
322591|NCT01357239|1088873|P3|Stratum: All Patients|Subject withdrew consent|1
322592|NCT01357239|1088874|P2|Stratum: All Patients|Subject withdrew consent|0
322593|NCT01357239|1088875|P1|Stratum: All Patients|Subject withdrew consent|0
322594|NCT01357239|1088872|P4|Stratum: All Patients|Adverse Event|1
322595|NCT01357239|1088873|P3|Stratum: All Patients|Adverse Event|1
322596|NCT01357239|1088874|P2|Stratum: All Patients|Adverse Event|0
322597|NCT01357239|1088875|P1|Stratum: All Patients|Adverse Event|0
322598|NCT01357161|1088933|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
322599|NCT01357161|1088934|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
322600|NCT01357161|1088935|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
322601|NCT01357161|1088933|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
322602|NCT01357161|1088934|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
322603|NCT01357161|1088935|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
322604|NCT01357161|1088933|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
322605|NCT01357161|1088934|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
322606|NCT01357161|1088935|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
322607|NCT01357161|1088933|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
322608|NCT01357161|1088934|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
322609|NCT01357161|1088935|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
322610|NCT01357161|1088933|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
322611|NCT01357161|1088934|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
322612|NCT01357161|1088935|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
322613|NCT01357161|1088933|P3|Part 2 (Double-Blind Comparison)|Death|19
322614|NCT01357161|1088934|P2|Part 2 (Double-Blind Comparison)|Death|22
322615|NCT01357161|1088935|P1|Part 2 (Double-Blind Comparison)|Death|0
322616|NCT01357161|1088933|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
322617|NCT01357161|1088934|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
322618|NCT01357161|1088935|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
322619|NCT01357161|1088933|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
322620|NCT01357161|1088934|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
322621|NCT01357161|1088935|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
322622|NCT01357161|1088933|P3|Part 1 (Open Label Run-in)|Physician Decision|0
322623|NCT01357161|1088934|P2|Part 1 (Open Label Run-in)|Physician Decision|0
322624|NCT01357161|1088935|P1|Part 1 (Open Label Run-in)|Physician Decision|1
322625|NCT01357161|1088933|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
322626|NCT01357161|1088934|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
322627|NCT01357161|1088935|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
322628|NCT01357161|1088933|P3|Part 1 (Open Label Run-in)|Death|0
322629|NCT01357161|1088934|P2|Part 1 (Open Label Run-in)|Death|0
322630|NCT01357161|1088935|P1|Part 1 (Open Label Run-in)|Death|5
322631|NCT01356966|1088987|P2|Overall Study|Physician Decision|0
322632|NCT01356966|1088988|P1|Overall Study|Physician Decision|1
322633|NCT01356966|1088987|P2|Overall Study|Withdrawal by Subject|2
322634|NCT01356966|1088988|P1|Overall Study|Withdrawal by Subject|1
322635|NCT01356940|1089000|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
322636|NCT01356940|1089001|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
322637|NCT01356940|1089000|P2|First Intervention (28 Days)|Adverse Event|0
322638|NCT01356940|1089001|P1|First Intervention (28 Days)|Adverse Event|1
322639|NCT01356602|1089028|P3|Overall Study|Adverse Event|1
322640|NCT01356602|1089029|P2|Overall Study|Adverse Event|1
322641|NCT01356602|1089030|P1|Overall Study|Adverse Event|0
322642|NCT01356602|1089028|P3|Overall Study|Lack of Efficacy|4
322643|NCT01356602|1089029|P2|Overall Study|Lack of Efficacy|1
322644|NCT01356602|1089030|P1|Overall Study|Lack of Efficacy|0
322645|NCT01356602|1089028|P3|Overall Study|Withdrawal by Subject|7
322646|NCT01356602|1089029|P2|Overall Study|Withdrawal by Subject|3
322647|NCT01356602|1089030|P1|Overall Study|Withdrawal by Subject|4
322648|NCT01356602|1089028|P3|Overall Study|Lost to Follow-up|6
322649|NCT01356602|1089029|P2|Overall Study|Lost to Follow-up|5
322650|NCT01356602|1089030|P1|Overall Study|Lost to Follow-up|4
322651|NCT01356602|1089028|P3|Overall Study|Administrative Problems|5
322652|NCT01356602|1089029|P2|Overall Study|Administrative Problems|4
322653|NCT01356602|1089030|P1|Overall Study|Administrative Problems|1
322654|NCT01356602|1089028|P3|Overall Study|Protocol Deviation|1
322655|NCT01356602|1089029|P2|Overall Study|Protocol Deviation|1
322656|NCT01356602|1089030|P1|Overall Study|Protocol Deviation|0
322657|NCT01356589|1089089|P1|Overall Study|Dose data not recorded|2
322658|NCT01356589|1089089|P1|Overall Study|Enrolled, but not treated|3
322659|NCT01356407|1089146|P2|Overall Study|Not complete Endoscopy|2
322660|NCT01356407|1089147|P1|Overall Study|Not complete Endoscopy|2
322661|NCT01356407|1089146|P2|Overall Study|Could not afford IMP administration|1
322662|NCT01356407|1089147|P1|Overall Study|Could not afford IMP administration|0
322663|NCT01356407|1089146|P2|Overall Study|Patient Withdrew Consent|1
322664|NCT01356407|1089147|P1|Overall Study|Patient Withdrew Consent|2
322665|NCT01356407|1089146|P2|Overall Study|Lost to Follow-up|0
322666|NCT01356407|1089147|P1|Overall Study|Lost to Follow-up|2
322667|NCT01355679|1089185|P1|Overall Study|benign tumor types found at biopsy|2
322668|NCT01355627|1089194|P2|Overall Study|Other|1
322669|NCT01355627|1089195|P1|Overall Study|Other|1
322670|NCT01355627|1089194|P2|Overall Study|Fatal Adverse Event|23
322671|NCT01355627|1089195|P1|Overall Study|Fatal Adverse Event|19
322672|NCT01355627|1089194|P2|Overall Study|Lost to Follow-up|7
322673|NCT01355627|1089195|P1|Overall Study|Lost to Follow-up|8
322674|NCT01355627|1089194|P2|Overall Study|Request By the Patient to Discontinue|7
322675|NCT01355627|1089195|P1|Overall Study|Request By the Patient to Discontinue|5
322676|NCT01355523|1089234|P2|Overall Study|Adverse Event|2
322677|NCT01355523|1089235|P1|Overall Study|Adverse Event|0
322678|NCT01355523|1089234|P2|Overall Study|Protocol Violation|2
322679|NCT01355523|1089235|P1|Overall Study|Protocol Violation|0
322680|NCT01355523|1089234|P2|Overall Study|Lost to Follow-up|2
322681|NCT01355523|1089235|P1|Overall Study|Lost to Follow-up|0
322682|NCT01355523|1089234|P2|Overall Study|Withdrawal by Subject|4
322683|NCT01355523|1089235|P1|Overall Study|Withdrawal by Subject|1
322684|NCT01355302|1089311|P3|Phase 1b|Study terminated by sponsor|0
322685|NCT01355302|1089312|P2|Phase 1b|Study terminated by sponsor|0
322686|NCT01355302|1089313|P1|Phase 1b|Study terminated by sponsor|2
322687|NCT01355302|1089311|P3|Phase 1b|Death|0
322688|NCT01355302|1089312|P2|Phase 1b|Death|0
322689|NCT01355302|1089313|P1|Phase 1b|Death|4
322690|NCT01355289|1089328|P5|Open Label Extension|Not specified|3
322691|NCT01355289|1089329|P4|Open Label Extension|Not specified|0
322692|NCT01355289|1089330|P3|Open Label Extension|Not specified|0
322693|NCT01355289|1089331|P2|Open Label Extension|Not specified|0
322694|NCT01355289|1089332|P1|Open Label Extension|Not specified|0
322695|NCT01355289|1089328|P5|Open Label Extension|Inadequate Therapeutic Effect|29
322696|NCT01355289|1089329|P4|Open Label Extension|Inadequate Therapeutic Effect|0
322697|NCT01355289|1089330|P3|Open Label Extension|Inadequate Therapeutic Effect|0
322698|NCT01355289|1089331|P2|Open Label Extension|Inadequate Therapeutic Effect|0
322699|NCT01355289|1089332|P1|Open Label Extension|Inadequate Therapeutic Effect|0
322700|NCT01355289|1089328|P5|Open Label Extension|Lost to Follow-up|1
322701|NCT01355289|1089329|P4|Open Label Extension|Lost to Follow-up|0
322702|NCT01355289|1089330|P3|Open Label Extension|Lost to Follow-up|0
322703|NCT01355289|1089331|P2|Open Label Extension|Lost to Follow-up|0
322704|NCT01355289|1089332|P1|Open Label Extension|Lost to Follow-up|0
322705|NCT01355289|1089328|P5|Open Label Extension|Adverse Event, Non-Fatal|1
322706|NCT01355289|1089329|P4|Open Label Extension|Adverse Event, Non-Fatal|0
322707|NCT01355289|1089330|P3|Open Label Extension|Adverse Event, Non-Fatal|0
322708|NCT01355289|1089331|P2|Open Label Extension|Adverse Event, Non-Fatal|0
322709|NCT01355289|1089332|P1|Open Label Extension|Adverse Event, Non-Fatal|0
322710|NCT01355289|1089328|P5|Core Study|Not specified|0
322711|NCT01355289|1089329|P4|Core Study|Not specified|1
322712|NCT01355289|1089330|P3|Core Study|Not specified|0
322713|NCT01355289|1089331|P2|Core Study|Not specified|0
322714|NCT01355289|1089332|P1|Core Study|Not specified|0
322715|NCT01355289|1089328|P5|Core Study|Inadequate Therapeutic Effect|0
322716|NCT01355289|1089329|P4|Core Study|Inadequate Therapeutic Effect|1
322717|NCT01355289|1089330|P3|Core Study|Inadequate Therapeutic Effect|0
322718|NCT01355289|1089331|P2|Core Study|Inadequate Therapeutic Effect|0
322719|NCT01355289|1089332|P1|Core Study|Inadequate Therapeutic Effect|0
322720|NCT01355289|1089328|P5|Core Study|Adverse Event, Non-Fatal|0
322721|NCT01355289|1089329|P4|Core Study|Adverse Event, Non-Fatal|0
322722|NCT01355289|1089330|P3|Core Study|Adverse Event, Non-Fatal|0
322723|NCT01355289|1089331|P2|Core Study|Adverse Event, Non-Fatal|0
322724|NCT01355289|1089332|P1|Core Study|Adverse Event, Non-Fatal|1
322725|NCT01355081|1089385|P3|Overall Study|Non Compliance with Study Medication|0
322726|NCT01355081|1089386|P2|Overall Study|Non Compliance with Study Medication|1
322727|NCT01355081|1089387|P1|Overall Study|Non Compliance with Study Medication|0
322728|NCT01355081|1089385|P3|Overall Study|Lack of Efficacy|1
322729|NCT01355081|1089386|P2|Overall Study|Lack of Efficacy|1
322730|NCT01355081|1089387|P1|Overall Study|Lack of Efficacy|2
322731|NCT01355081|1089385|P3|Overall Study|Withdrawal of Consent|3
322732|NCT01355081|1089386|P2|Overall Study|Withdrawal of Consent|3
322733|NCT01355081|1089387|P1|Overall Study|Withdrawal of Consent|2
322734|NCT01355081|1089385|P3|Overall Study|Lost to Follow-up|1
322735|NCT01355081|1089386|P2|Overall Study|Lost to Follow-up|0
322736|NCT01355081|1089387|P1|Overall Study|Lost to Follow-up|0
322737|NCT01355081|1089385|P3|Overall Study|Major Protocol Deviation|0
322738|NCT01355081|1089386|P2|Overall Study|Major Protocol Deviation|1
322739|NCT01355081|1089387|P1|Overall Study|Major Protocol Deviation|0
322740|NCT01355081|1089385|P3|Overall Study|Pretreatment Event or Adverse Event|6
322741|NCT01355081|1089386|P2|Overall Study|Pretreatment Event or Adverse Event|4
322742|NCT01355081|1089387|P1|Overall Study|Pretreatment Event or Adverse Event|3
322743|NCT01355068|1089410|P2|First Intervention Period|Withdrawal by Subject|1
322744|NCT01355068|1089411|P1|First Intervention Period|Withdrawal by Subject|0
322745|NCT01355068|1089410|P2|First Intervention Period|Adverse Event|1
322746|NCT01355068|1089411|P1|First Intervention Period|Adverse Event|0
322747|NCT01354938|1089434|P1|Overall Study|Lost to Follow-up|1
322748|NCT01354899|1089440|P1|Overall Study|Protocol Violation|1
322749|NCT01354899|1089440|P1|Overall Study|discharge from the hospital|2
322750|NCT01354431|1089489|P3|Participants Treated|Withdrawal by Subject|1
322751|NCT01354431|1089490|P2|Participants Treated|Withdrawal by Subject|2
322752|NCT01354431|1089491|P1|Participants Treated|Withdrawal by Subject|1
322753|NCT01354431|1089489|P3|Participants Treated|Adverse Event|4
322754|NCT01354431|1089490|P2|Participants Treated|Adverse Event|2
322755|NCT01354431|1089491|P1|Participants Treated|Adverse Event|1
322756|NCT01354431|1089489|P3|Participants Treated|Death|0
322757|NCT01354431|1089490|P2|Participants Treated|Death|1
322758|NCT01354431|1089491|P1|Participants Treated|Death|0
322759|NCT01354431|1089489|P3|Participants Treated|Study Drug Toxicity|4
322760|NCT01354431|1089490|P2|Participants Treated|Study Drug Toxicity|7
322761|NCT01354431|1089491|P1|Participants Treated|Study Drug Toxicity|2
322762|NCT01354431|1089489|P3|Participants Treated|Disease Progression|41
322763|NCT01354431|1089490|P2|Participants Treated|Disease Progression|40
322764|NCT01354431|1089491|P1|Participants Treated|Disease Progression|49
322765|NCT01354431|1089489|P3|Participants Treated|Continuing Treatment|4
322766|NCT01354431|1089490|P2|Participants Treated|Continuing Treatment|2
322767|NCT01354431|1089491|P1|Participants Treated|Continuing Treatment|6
322768|NCT01354431|1089489|P3|Randomized to Enter Treatment Period|No longer met criteria|0
322769|NCT01354431|1089490|P2|Randomized to Enter Treatment Period|No longer met criteria|0
322770|NCT01354431|1089491|P1|Randomized to Enter Treatment Period|No longer met criteria|1
322771|NCT01354314|1089515|P4|Overall Study|Less than 90% Adherence|4
322772|NCT01354314|1089516|P3|Overall Study|Less than 90% Adherence|6
322773|NCT01354314|1089517|P2|Overall Study|Less than 90% Adherence|2
322774|NCT01354314|1089518|P1|Overall Study|Less than 90% Adherence|4
322775|NCT01354314|1089515|P4|Overall Study|Protocol Violation|0
322776|NCT01354314|1089516|P3|Overall Study|Protocol Violation|0
322777|NCT01354314|1089517|P2|Overall Study|Protocol Violation|1
322778|NCT01354314|1089518|P1|Overall Study|Protocol Violation|1
322779|NCT01354314|1089515|P4|Overall Study|Adverse Event|1
322780|NCT01354314|1089516|P3|Overall Study|Adverse Event|0
322781|NCT01354314|1089517|P2|Overall Study|Adverse Event|0
322782|NCT01354314|1089518|P1|Overall Study|Adverse Event|0
322783|NCT01354314|1089515|P4|Overall Study|Withdrawal by Subject|0
322784|NCT01354314|1089516|P3|Overall Study|Withdrawal by Subject|1
322785|NCT01354314|1089517|P2|Overall Study|Withdrawal by Subject|0
322786|NCT01354314|1089518|P1|Overall Study|Withdrawal by Subject|0
322787|NCT01354314|1089515|P4|Overall Study|Lost to Follow-up|1
322788|NCT01354314|1089516|P3|Overall Study|Lost to Follow-up|1
322789|NCT01354314|1089517|P2|Overall Study|Lost to Follow-up|0
322790|NCT01354314|1089518|P1|Overall Study|Lost to Follow-up|1
322791|NCT01354223|1089654|P2|Overall Study|Withdrawal by Subject|1
322792|NCT01354223|1089655|P1|Overall Study|Withdrawal by Subject|3
322793|NCT01354132|1089714|P2|1 Month Post Study Medication|Withdrawal by Subject|3
322794|NCT01354132|1089715|P1|1 Month Post Study Medication|Withdrawal by Subject|1
322795|NCT01354132|1089714|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
322796|NCT01354132|1089715|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
322797|NCT01354132|1089714|P2|Double Blind (Visits 1-7)|Adverse Event|0
322798|NCT01354132|1089715|P1|Double Blind (Visits 1-7)|Adverse Event|1
322799|NCT01354132|1089714|P2|Randomization|Withdrawal by Subject|1
322800|NCT01354132|1089715|P1|Randomization|Withdrawal by Subject|0
322801|NCT01354132|1089714|P2|Randomization|Physician Decision|0
322802|NCT01354132|1089715|P1|Randomization|Physician Decision|1
322803|NCT01354106|1089753|P1|Overall Study|Withdrawal by Subject|2
322804|NCT01354028|1089759|P2|Overall Study|No quiet alert state|1
322805|NCT01354028|1089760|P1|Overall Study|No quiet alert state|0
322806|NCT01354028|1089759|P2|Overall Study|Discharged before study start|2
322807|NCT01354028|1089760|P1|Overall Study|Discharged before study start|2
322808|NCT01354028|1089759|P2|Overall Study|Physician Decision|2
322809|NCT01354028|1089760|P1|Overall Study|Physician Decision|0
322810|NCT01353963|1089796|P1|Overall Study|Adverse Event|2
322811|NCT01353911|1089814|P8|Overall Study|Status Not Recorded|0
322812|NCT01353911|1089815|P7|Overall Study|Status Not Recorded|0
322813|NCT01353911|1089816|P6|Overall Study|Status Not Recorded|0
322814|NCT01353911|1089817|P5|Overall Study|Status Not Recorded|0
322815|NCT01353911|1089818|P4|Overall Study|Status Not Recorded|0
322816|NCT01353911|1089819|P3|Overall Study|Status Not Recorded|1
322817|NCT01353911|1089820|P2|Overall Study|Status Not Recorded|0
322818|NCT01353911|1089821|P1|Overall Study|Status Not Recorded|4
322819|NCT01353911|1089814|P8|Overall Study|Withdrawal by Subject|9
322820|NCT01353911|1089815|P7|Overall Study|Withdrawal by Subject|3
322821|NCT01353911|1089816|P6|Overall Study|Withdrawal by Subject|3
322822|NCT01353911|1089817|P5|Overall Study|Withdrawal by Subject|2
322823|NCT01353911|1089818|P4|Overall Study|Withdrawal by Subject|2
322824|NCT01353911|1089819|P3|Overall Study|Withdrawal by Subject|4
322825|NCT01353911|1089820|P2|Overall Study|Withdrawal by Subject|3
322826|NCT01353911|1089821|P1|Overall Study|Withdrawal by Subject|2
322827|NCT01353911|1089814|P8|Overall Study|Lost to Follow-up|6
322828|NCT01353911|1089815|P7|Overall Study|Lost to Follow-up|3
322829|NCT01353911|1089816|P6|Overall Study|Lost to Follow-up|4
322830|NCT01353911|1089817|P5|Overall Study|Lost to Follow-up|4
322831|NCT01353911|1089818|P4|Overall Study|Lost to Follow-up|0
322832|NCT01353911|1089819|P3|Overall Study|Lost to Follow-up|4
322833|NCT01353911|1089820|P2|Overall Study|Lost to Follow-up|6
322834|NCT01353911|1089821|P1|Overall Study|Lost to Follow-up|2
322835|NCT01353898|1089901|P6|Overall Study|Study site terminated|1
322836|NCT01353898|1089902|P5|Overall Study|Study site terminated|0
322837|NCT01353898|1089903|P4|Overall Study|Study site terminated|0
322838|NCT01353898|1089904|P3|Overall Study|Study site terminated|0
322839|NCT01353898|1089905|P2|Overall Study|Study site terminated|0
322840|NCT01353898|1089906|P1|Overall Study|Study site terminated|0
322841|NCT01353859|1089932|P1|Overall Study|Lack of Efficacy|1
322842|NCT01353859|1089932|P1|Overall Study|Adverse Event|3
322843|NCT01353664|1089945|P1|Overall Study|Disease Progression|16
322844|NCT01353664|1089945|P1|Overall Study|Other|3
322845|NCT01353586|1089951|P2|Overall Study|Neurological exam not done|1
322846|NCT01353586|1089952|P1|Overall Study|Neurological exam not done|0
322847|NCT01353586|1089951|P2|Overall Study|Never had insertion of study catheter|1
322848|NCT01353586|1089952|P1|Overall Study|Never had insertion of study catheter|4
322849|NCT01353586|1089951|P2|Overall Study|Procedure terminated prior to ablation|0
322850|NCT01353586|1089952|P1|Overall Study|Procedure terminated prior to ablation|3
322851|NCT01353508|1089970|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
322852|NCT01353508|1089971|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
322853|NCT01353508|1089972|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
322854|NCT01353508|1089973|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
322855|NCT01353508|1089970|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
322856|NCT01353508|1089971|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
322857|NCT01353508|1089972|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
322858|NCT01353508|1089973|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
322859|NCT01353274|1090051|P1|Overall Study|No case report form (CRF) collected|28
322860|NCT01353222|1090061|P2|Overall Study|Site closed research department|0
322861|NCT01353222|1090062|P1|Overall Study|Site closed research department|1
322862|NCT01353222|1090061|P2|Overall Study|Study Terminated|37
322863|NCT01353222|1090062|P1|Overall Study|Study Terminated|31
322864|NCT01353222|1090061|P2|Overall Study|Withdrawal by Subject|5
322865|NCT01353222|1090062|P1|Overall Study|Withdrawal by Subject|8
322866|NCT01353222|1090061|P2|Overall Study|Death|30
322867|NCT01353222|1090062|P1|Overall Study|Death|30
322868|NCT01352845|1090096|P2|Overall Study|Death|0
322869|NCT01352845|1090097|P1|Overall Study|Death|3
322870|NCT01352845|1090096|P2|Overall Study|Protocol Violation|6
322871|NCT01352845|1090097|P1|Overall Study|Protocol Violation|12
322872|NCT01352845|1090096|P2|Overall Study|Other|7
322873|NCT01352845|1090097|P1|Overall Study|Other|17
322874|NCT01352845|1090096|P2|Overall Study|Adverse Event|6
322875|NCT01352845|1090097|P1|Overall Study|Adverse Event|22
322876|NCT01352845|1090096|P2|Overall Study|Pregnancy|7
322877|NCT01352845|1090097|P1|Overall Study|Pregnancy|27
322878|NCT01352845|1090096|P2|Overall Study|No Longer Meets Eligibility Criteria|11
322879|NCT01352845|1090097|P1|Overall Study|No Longer Meets Eligibility Criteria|24
322880|NCT01352845|1090096|P2|Overall Study|Withdrawal by Subject|16
322881|NCT01352845|1090097|P1|Overall Study|Withdrawal by Subject|48
322882|NCT01352845|1090096|P2|Overall Study|No Longer Willing to Participate|58
322883|NCT01352845|1090097|P1|Overall Study|No Longer Willing to Participate|205
322884|NCT01352845|1090096|P2|Overall Study|Lost to Follow-up|92
322885|NCT01352845|1090097|P1|Overall Study|Lost to Follow-up|313
322886|NCT01352793|1090186|P2|Overall Study|No longer meets eligibility criteria|15
322887|NCT01352793|1090187|P1|Overall Study|No longer meets eligibility criteria|25
322888|NCT01352793|1090186|P2|Overall Study|Randomized but not vaccinated|0
322889|NCT01352793|1090187|P1|Overall Study|Randomized but not vaccinated|8
322890|NCT01352793|1090186|P2|Overall Study|Death|0
322891|NCT01352793|1090187|P1|Overall Study|Death|1
322892|NCT01352793|1090186|P2|Overall Study|Medication error|2
322893|NCT01352793|1090187|P1|Overall Study|Medication error|2
322894|NCT01352793|1090186|P2|Overall Study|Other|7
322895|NCT01352793|1090187|P1|Overall Study|Other|25
322896|NCT01352793|1090186|P2|Overall Study|Pregnancy|8
322897|NCT01352793|1090187|P1|Overall Study|Pregnancy|26
322898|NCT01352793|1090186|P2|Overall Study|Physician Decision|0
322899|NCT01352793|1090187|P1|Overall Study|Physician Decision|1
322900|NCT01352793|1090186|P2|Overall Study|Adverse Event|10
322901|NCT01352793|1090187|P1|Overall Study|Adverse Event|44
322902|NCT01352793|1090186|P2|Overall Study|Protocol Violation|23
322903|NCT01352793|1090187|P1|Overall Study|Protocol Violation|44
322904|NCT01352793|1090186|P2|Overall Study|Withdrawal by Subject|55
322905|NCT01352793|1090187|P1|Overall Study|Withdrawal by Subject|120
322906|NCT01352793|1090186|P2|Overall Study|Lost to Follow-up|125
322907|NCT01352793|1090187|P1|Overall Study|Lost to Follow-up|289
322908|NCT01352741|1090211|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
322909|NCT01352741|1090212|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
322910|NCT01352741|1090211|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
322911|NCT01352741|1090212|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
322912|NCT01352741|1090211|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
322913|NCT01352741|1090212|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
322914|NCT01352741|1090211|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
322915|NCT01352741|1090212|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
322916|NCT01352741|1090211|P2|Double-blind Comparative Period|Not Specified|2
322917|NCT01352741|1090212|P1|Double-blind Comparative Period|Not Specified|1
322918|NCT01352741|1090211|P2|Double-blind Comparative Period|Withdrawal of consent|3
322919|NCT01352741|1090212|P1|Double-blind Comparative Period|Withdrawal of consent|8
322920|NCT01352741|1090211|P2|Double-blind Comparative Period|Death|1
322921|NCT01352741|1090212|P1|Double-blind Comparative Period|Death|0
322922|NCT01352741|1090211|P2|Double-blind Comparative Period|Lost to Follow-up|0
322923|NCT01352741|1090212|P1|Double-blind Comparative Period|Lost to Follow-up|1
322924|NCT01352741|1090211|P2|Double-blind Comparative Period|Adverse Event|17
322925|NCT01352741|1090212|P1|Double-blind Comparative Period|Adverse Event|16
322926|NCT01352741|1090211|P2|Double-blind Comparative Period|Lack of Efficacy|3
322927|NCT01352741|1090212|P1|Double-blind Comparative Period|Lack of Efficacy|0
322928|NCT01352741|1090211|P2|Double-blind Comparative Period|Protocol Violation|0
322929|NCT01352741|1090212|P1|Double-blind Comparative Period|Protocol Violation|2
322930|NCT01352741|1090211|P2|Open-label Tapentadol Titration Period|Not Specified|0
322931|NCT01352741|1090212|P1|Open-label Tapentadol Titration Period|Not Specified|4
322932|NCT01352741|1090211|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
322933|NCT01352741|1090212|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
322934|NCT01352741|1090211|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
322935|NCT01352741|1090212|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
322936|NCT01352741|1090211|P2|Open-label Tapentadol Titration Period|Adverse Event|0
322937|NCT01352741|1090212|P1|Open-label Tapentadol Titration Period|Adverse Event|34
322938|NCT01352741|1090211|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
322939|NCT01352741|1090212|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
322940|NCT01352741|1090211|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
322941|NCT01352741|1090212|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
322942|NCT01352715|1090306|P2|Overall Study|major ineligibility|1
322943|NCT01352715|1090307|P1|Overall Study|major ineligibility|2
322944|NCT01352715|1090306|P2|Overall Study|no final visit in closeout period|12
322945|NCT01352715|1090307|P1|Overall Study|no final visit in closeout period|15
322946|NCT01352715|1090306|P2|Overall Study|site closure|15
322947|NCT01352715|1090307|P1|Overall Study|site closure|16
322948|NCT01352715|1090306|P2|Overall Study|Withdrawal by Subject|8
322949|NCT01352715|1090307|P1|Overall Study|Withdrawal by Subject|4
322950|NCT01352715|1090306|P2|Overall Study|Lost to Follow-up|7
322951|NCT01352715|1090307|P1|Overall Study|Lost to Follow-up|5
322952|NCT01352715|1090306|P2|Overall Study|Death|3
322953|NCT01352715|1090307|P1|Overall Study|Death|3
322954|NCT01352585|1090329|P1|Overall Study|Not specified|7
322955|NCT01352585|1090329|P1|Overall Study|Lost to Follow-up|1
322956|NCT01352585|1090329|P1|Overall Study|Adverse Event|3
322957|NCT01352507|1090346|P2|Treatment Period 2|Lack of Efficacy|0
322958|NCT01352507|1090347|P1|Treatment Period 2|Lack of Efficacy|1
322959|NCT01352507|1090346|P2|Treatment Period 2|Withdrawal by Subject|3
322960|NCT01352507|1090347|P1|Treatment Period 2|Withdrawal by Subject|4
322961|NCT01352507|1090346|P2|Treatment Period 2|Entry Criteria Not Met|0
322962|NCT01352507|1090347|P1|Treatment Period 2|Entry Criteria Not Met|1
322963|NCT01352507|1090346|P2|Washout Period|Withdrawal by Subject|1
322964|NCT01352507|1090347|P1|Washout Period|Withdrawal by Subject|0
322965|NCT01352507|1090346|P2|Treatment Period 1|Physician Decision|0
322966|NCT01352507|1090347|P1|Treatment Period 1|Physician Decision|1
322967|NCT01352507|1090346|P2|Treatment Period 1|Withdrawal by Subject|5
322968|NCT01352507|1090347|P1|Treatment Period 1|Withdrawal by Subject|7
322969|NCT01352507|1090346|P2|Treatment Period 1|Lost to Follow-up|4
322970|NCT01352507|1090347|P1|Treatment Period 1|Lost to Follow-up|3
322971|NCT01352507|1090346|P2|Treatment Period 1|Adverse Event|0
322972|NCT01352507|1090347|P1|Treatment Period 1|Adverse Event|3
322973|NCT01352416|1090400|P4|Overall Study|Physician Decision|1
322974|NCT01352416|1090401|P3|Overall Study|Physician Decision|2
322975|NCT01352416|1090402|P2|Overall Study|Physician Decision|2
322976|NCT01352416|1090403|P1|Overall Study|Physician Decision|1
322977|NCT01352221|1090415|P4|Open-label Phase|Worsening of IBD|0
322978|NCT01352221|1090416|P3|Open-label Phase|Worsening of IBD|1
322979|NCT01352221|1090417|P2|Open-label Phase|Worsening of IBD|0
322980|NCT01352221|1090418|P1|Open-label Phase|Worsening of IBD|0
322981|NCT01352221|1090415|P4|Open-label Phase|Withdrawal by Subject|6
322982|NCT01352221|1090416|P3|Open-label Phase|Withdrawal by Subject|1
322983|NCT01352221|1090417|P2|Open-label Phase|Withdrawal by Subject|0
322984|NCT01352221|1090418|P1|Open-label Phase|Withdrawal by Subject|0
322985|NCT01352221|1090415|P4|Open-label Phase|Adverse Event|4
322986|NCT01352221|1090416|P3|Open-label Phase|Adverse Event|8
322987|NCT01352221|1090417|P2|Open-label Phase|Adverse Event|0
322988|NCT01352221|1090418|P1|Open-label Phase|Adverse Event|0
322989|NCT01352221|1090415|P4|Open-label Phase|Pregnancy|0
322990|NCT01352221|1090416|P3|Open-label Phase|Pregnancy|1
322991|NCT01352221|1090417|P2|Open-label Phase|Pregnancy|0
322992|NCT01352221|1090418|P1|Open-label Phase|Pregnancy|0
322993|NCT01352221|1090415|P4|Open-label Phase|Physician Decision|1
322994|NCT01352221|1090416|P3|Open-label Phase|Physician Decision|2
322995|NCT01352221|1090417|P2|Open-label Phase|Physician Decision|0
322996|NCT01352221|1090418|P1|Open-label Phase|Physician Decision|0
322997|NCT01352221|1090415|P4|Double-blind Phase|Protocol Violation|0
322998|NCT01352221|1090416|P3|Double-blind Phase|Protocol Violation|0
322999|NCT01352221|1090417|P2|Double-blind Phase|Protocol Violation|1
323000|NCT01352221|1090418|P1|Double-blind Phase|Protocol Violation|0
323001|NCT01352221|1090415|P4|Double-blind Phase|Lost to Follow-up|0
323002|NCT01352221|1090416|P3|Double-blind Phase|Lost to Follow-up|0
323003|NCT01352221|1090417|P2|Double-blind Phase|Lost to Follow-up|1
323004|NCT01352221|1090418|P1|Double-blind Phase|Lost to Follow-up|0
323005|NCT01352221|1090415|P4|Double-blind Phase|Withdrawal by Subject|0
323006|NCT01352221|1090416|P3|Double-blind Phase|Withdrawal by Subject|0
323007|NCT01352221|1090417|P2|Double-blind Phase|Withdrawal by Subject|5
323008|NCT01352221|1090418|P1|Double-blind Phase|Withdrawal by Subject|3
323009|NCT01352221|1090415|P4|Double-blind Phase|Adverse Event|0
323010|NCT01352221|1090416|P3|Double-blind Phase|Adverse Event|0
323011|NCT01352221|1090417|P2|Double-blind Phase|Adverse Event|4
323012|NCT01352221|1090418|P1|Double-blind Phase|Adverse Event|6
323013|NCT01352117|1090478|P2|Overall Study|Ineligible (no KS diagnosis)|0
323014|NCT01352117|1090479|P1|Overall Study|Ineligible (no KS diagnosis)|1
323015|NCT01352117|1090478|P2|Overall Study|Did not initiate study treatment|0
323016|NCT01352117|1090479|P1|Overall Study|Did not initiate study treatment|1
323017|NCT01352117|1090478|P2|Overall Study|Non-adherent to study requirements|0
323018|NCT01352117|1090479|P1|Overall Study|Non-adherent to study requirements|1
323019|NCT01352117|1090478|P2|Overall Study|Lost to Follow-up|4
323020|NCT01352117|1090479|P1|Overall Study|Lost to Follow-up|2
323021|NCT01352117|1090478|P2|Overall Study|Withdrawal by Subject|0
323022|NCT01352117|1090479|P1|Overall Study|Withdrawal by Subject|1
323023|NCT01352117|1090478|P2|Overall Study|Death|12
323024|NCT01352117|1090479|P1|Overall Study|Death|13
323025|NCT01352117|1090478|P2|Overall Study|On study|80
323026|NCT01352117|1090479|P1|Overall Study|On study|49
323027|NCT01351623|1090531|P1|Overall Study|Death|2
323028|NCT01351623|1090531|P1|Overall Study|Withdrawal by Subject|1
323029|NCT01351623|1090531|P1|Overall Study|Adverse Event|4
323030|NCT01351623|1090531|P1|Overall Study|Protocol Violation|2
323031|NCT01351415|1090557|P2|Overall Study|Never Started|5
323032|NCT01351415|1090558|P1|Overall Study|Never Started|5
323033|NCT01351415|1090557|P2|Overall Study|Reason unknown|2
323034|NCT01351415|1090558|P1|Overall Study|Reason unknown|0
323035|NCT01351415|1090557|P2|Overall Study|Physician Decision|3
323036|NCT01351415|1090558|P1|Overall Study|Physician Decision|2
323037|NCT01351415|1090557|P2|Overall Study|Death|187
323038|NCT01351415|1090558|P1|Overall Study|Death|190
323039|NCT01351415|1090557|P2|Overall Study|Lost to Follow-up|7
323040|NCT01351415|1090558|P1|Overall Study|Lost to Follow-up|5
323041|NCT01351415|1090557|P2|Overall Study|Trial termination by the Sponsor|19
323042|NCT01351415|1090558|P1|Overall Study|Trial termination by the Sponsor|28
323043|NCT01351415|1090557|P2|Overall Study|Withdrawal by Subject|17
323044|NCT01351415|1090558|P1|Overall Study|Withdrawal by Subject|15
323045|NCT01351025|1090636|P2|Week 24 - 44|unable to get to clinic|1
323046|NCT01351025|1090637|P1|Week 24 - 44|unable to get to clinic|1
323047|NCT01351025|1090636|P2|Week 24 - 44|Site closed|1
323048|NCT01351025|1090637|P1|Week 24 - 44|Site closed|0
323049|NCT01351025|1090636|P2|Week 24 - 44|Lost to Follow-up|2
323050|NCT01351025|1090637|P1|Week 24 - 44|Lost to Follow-up|0
323051|NCT01351025|1090636|P2|Week 0 - 20|Withdrawal by Subject|0
323052|NCT01351025|1090637|P1|Week 0 - 20|Withdrawal by Subject|1
323053|NCT01351025|1090636|P2|Week 0 - 20|Lost to Follow-up|1
323054|NCT01351025|1090637|P1|Week 0 - 20|Lost to Follow-up|2
323055|NCT01350999|1090670|P3|Overall Study|Difficulty Making it to Study Visit|5
323056|NCT01350999|1090671|P2|Overall Study|Difficulty Making it to Study Visit|1
323057|NCT01350999|1090672|P1|Overall Study|Difficulty Making it to Study Visit|1
323058|NCT01350999|1090670|P3|Overall Study|Voluntary withdrawal|6
323059|NCT01350999|1090671|P2|Overall Study|Voluntary withdrawal|4
323060|NCT01350999|1090672|P1|Overall Study|Voluntary withdrawal|3
323061|NCT01350999|1090670|P3|Overall Study|Adverse Event|10
323062|NCT01350999|1090671|P2|Overall Study|Adverse Event|9
323063|NCT01350999|1090672|P1|Overall Study|Adverse Event|4
323064|NCT01350973|1090710|P3|Overall Study|Voluntary Withdrawal|1
323065|NCT01350973|1090711|P2|Overall Study|Voluntary Withdrawal|1
323066|NCT01350973|1090712|P1|Overall Study|Voluntary Withdrawal|2
323067|NCT01350973|1090710|P3|Overall Study|Adverse Event|7
323068|NCT01350973|1090711|P2|Overall Study|Adverse Event|7
323069|NCT01350973|1090712|P1|Overall Study|Adverse Event|4
323070|NCT01350934|1090753|P2|Extension Study|Withdrawal by Subject|1
323071|NCT01350934|1090754|P1|Extension Study|Withdrawal by Subject|0
323072|NCT01350934|1090753|P2|Extension Study|Lack of Efficacy|1
323073|NCT01350934|1090754|P1|Extension Study|Lack of Efficacy|0
323074|NCT01350934|1090753|P2|Extension Study|Protocol Violation|1
323075|NCT01350934|1090754|P1|Extension Study|Protocol Violation|1
323076|NCT01350934|1090753|P2|Extension Study|Lost to Follow-up|0
323077|NCT01350934|1090754|P1|Extension Study|Lost to Follow-up|2
323078|NCT01350934|1090753|P2|Extension Study|Adverse Event|1
323079|NCT01350934|1090754|P1|Extension Study|Adverse Event|2
323080|NCT01350934|1090753|P2|Base Study|Non-Compliance With Study Drug|0
323081|NCT01350934|1090754|P1|Base Study|Non-Compliance With Study Drug|2
323082|NCT01350934|1090753|P2|Base Study|Withdrawal by Subject|2
323083|NCT01350934|1090754|P1|Base Study|Withdrawal by Subject|1
323084|NCT01350934|1090753|P2|Base Study|Protocol Violation|1
323085|NCT01350934|1090754|P1|Base Study|Protocol Violation|1
323086|NCT01350934|1090753|P2|Base Study|Lost to Follow-up|0
323087|NCT01350934|1090754|P1|Base Study|Lost to Follow-up|1
323088|NCT01350934|1090753|P2|Base Study|Adverse Event|0
323089|NCT01350934|1090754|P1|Base Study|Adverse Event|6
323090|NCT01350804|1090776|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
323091|NCT01350804|1090777|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
323092|NCT01350804|1090778|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
323093|NCT01350804|1090779|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
323094|NCT01350804|1090776|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
323095|NCT01350804|1090777|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
323096|NCT01350804|1090778|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
323097|NCT01350804|1090779|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
323098|NCT01350804|1090776|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
323099|NCT01350804|1090777|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
323100|NCT01350804|1090778|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
323101|NCT01350804|1090779|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
323102|NCT01350804|1090776|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
323103|NCT01350804|1090777|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
323104|NCT01350804|1090778|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
323105|NCT01350804|1090779|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
323106|NCT01350804|1090776|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
323107|NCT01350804|1090777|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
323108|NCT01350804|1090778|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
323109|NCT01350804|1090779|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
323110|NCT01350804|1090776|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
323111|NCT01350804|1090777|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
323112|NCT01350804|1090778|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
323113|NCT01350804|1090779|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
323114|NCT01350804|1090776|P4|Core Study|Adverse Event|8
323115|NCT01350804|1090777|P3|Core Study|Adverse Event|8
323116|NCT01350804|1090778|P2|Core Study|Adverse Event|10
323117|NCT01350804|1090779|P1|Core Study|Adverse Event|8
323118|NCT01350804|1090776|P4|Core Study|Death|0
323119|NCT01350804|1090777|P3|Core Study|Death|1
323120|NCT01350804|1090778|P2|Core Study|Death|1
323121|NCT01350804|1090779|P1|Core Study|Death|1
323122|NCT01350804|1090776|P4|Core Study|Lack of Efficacy|5
323123|NCT01350804|1090777|P3|Core Study|Lack of Efficacy|18
323124|NCT01350804|1090778|P2|Core Study|Lack of Efficacy|19
323125|NCT01350804|1090779|P1|Core Study|Lack of Efficacy|16
323126|NCT01350804|1090776|P4|Core Study|Lost to Follow-up|1
323127|NCT01350804|1090777|P3|Core Study|Lost to Follow-up|2
323128|NCT01350804|1090778|P2|Core Study|Lost to Follow-up|0
323129|NCT01350804|1090779|P1|Core Study|Lost to Follow-up|3
323130|NCT01350804|1090776|P4|Core Study|Physician Decision|3
323131|NCT01350804|1090777|P3|Core Study|Physician Decision|1
323132|NCT01350804|1090778|P2|Core Study|Physician Decision|0
323133|NCT01350804|1090779|P1|Core Study|Physician Decision|1
323134|NCT01350804|1090776|P4|Core Study|Protocol deviation|0
323135|NCT01350804|1090777|P3|Core Study|Protocol deviation|1
323136|NCT01350804|1090778|P2|Core Study|Protocol deviation|0
323137|NCT01350804|1090779|P1|Core Study|Protocol deviation|1
323138|NCT01350804|1090776|P4|Core Study|Study terminated by Sponsor|2
323139|NCT01350804|1090777|P3|Core Study|Study terminated by Sponsor|0
323140|NCT01350804|1090778|P2|Core Study|Study terminated by Sponsor|0
323141|NCT01350804|1090779|P1|Core Study|Study terminated by Sponsor|0
323142|NCT01350804|1090776|P4|Core Study|Withdrawal by Subject|7
323143|NCT01350804|1090777|P3|Core Study|Withdrawal by Subject|16
323144|NCT01350804|1090778|P2|Core Study|Withdrawal by Subject|17
323145|NCT01350804|1090779|P1|Core Study|Withdrawal by Subject|11
323146|NCT01350544|1090876|P2|Overall Study|Lost to Follow-up|15
323147|NCT01350544|1090877|P1|Overall Study|Lost to Follow-up|18
323148|NCT01350544|1090876|P2|Overall Study|Incarceration|0
323149|NCT01350544|1090877|P1|Overall Study|Incarceration|1
323150|NCT01350544|1090876|P2|Overall Study|Withdrawal by Subject|1
323151|NCT01350544|1090877|P1|Overall Study|Withdrawal by Subject|0
323152|NCT01350544|1090876|P2|Overall Study|Medical Issues|1
323153|NCT01350544|1090877|P1|Overall Study|Medical Issues|1
323154|NCT01350544|1090876|P2|Overall Study|Moved out of LA County|2
323155|NCT01350544|1090877|P1|Overall Study|Moved out of LA County|2
323156|NCT01350544|1090876|P2|Overall Study|Death|2
323157|NCT01350544|1090877|P1|Overall Study|Death|1
323158|NCT01350544|1090876|P2|Overall Study|Administrative Withdrawal|1
323159|NCT01350544|1090877|P1|Overall Study|Administrative Withdrawal|0
323160|NCT01350414|1090892|P1|Overall Study|Physician Decision|2
323161|NCT01350414|1090892|P1|Overall Study|Withdrawal by Subject|4
323162|NCT01350414|1090892|P1|Overall Study|Lost to Follow-up|13
323163|NCT01350271|1090941|P3|Overall Study|Lost to Follow-up|26
323164|NCT01350271|1090942|P2|Overall Study|Lost to Follow-up|17
323165|NCT01350271|1090943|P1|Overall Study|Lost to Follow-up|21
323166|NCT01350141|1090985|P3|Overall Study|Randomized but not treated|0
323167|NCT01350141|1090986|P2|Overall Study|Randomized but not treated|0
323168|NCT01350141|1090987|P1|Overall Study|Randomized but not treated|1
323169|NCT01350141|1090985|P3|Overall Study|Withdrawal by Subject|0
323170|NCT01350141|1090986|P2|Overall Study|Withdrawal by Subject|0
323171|NCT01350141|1090987|P1|Overall Study|Withdrawal by Subject|1
323172|NCT01350141|1090985|P3|Overall Study|Lost to Follow-up|1
323173|NCT01350141|1090986|P2|Overall Study|Lost to Follow-up|0
323174|NCT01350141|1090987|P1|Overall Study|Lost to Follow-up|1
323175|NCT01350128|1091021|P1|Overall Study|Lost to Follow-up|2
323176|NCT01350128|1091021|P1|Overall Study|Physician Decision|1
323177|NCT01350128|1091021|P1|Overall Study|Protocol discontinuation criteria|8
323178|NCT01350128|1091021|P1|Overall Study|Withdrawal by Subject|3
323179|NCT01350115|1091085|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
323180|NCT01350115|1091086|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
323181|NCT01350115|1091085|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
323182|NCT01350115|1091086|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
323183|NCT01350115|1091085|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
323184|NCT01350115|1091086|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
323185|NCT01350102|1091102|P4|Overall Study|Adverse Event|0
323186|NCT01350102|1091103|P3|Overall Study|Adverse Event|1
323187|NCT01350102|1091104|P2|Overall Study|Adverse Event|0
323188|NCT01350102|1091105|P1|Overall Study|Adverse Event|0
323189|NCT01349959|1091142|P1|Overall Study|Patients are followed for survival|7
323190|NCT01349907|1091178|P2|Overall Study|Administrative|1
323191|NCT01349907|1091179|P1|Overall Study|Administrative|1
323192|NCT01349907|1091178|P2|Overall Study|Protocol Violation|13
323193|NCT01349907|1091179|P1|Overall Study|Protocol Violation|33
323194|NCT01349907|1091178|P2|Overall Study|Withdrawal by Subject|8
323195|NCT01349907|1091179|P1|Overall Study|Withdrawal by Subject|30
323196|NCT01349907|1091178|P2|Overall Study|Lost to Follow-up|6
323197|NCT01349907|1091179|P1|Overall Study|Lost to Follow-up|25
323198|NCT01349907|1091178|P2|Overall Study|Treatment failure|4
323199|NCT01349907|1091179|P1|Overall Study|Treatment failure|13
323200|NCT01349907|1091178|P2|Overall Study|Adverse Event|11
323201|NCT01349907|1091179|P1|Overall Study|Adverse Event|37
323202|NCT01349829|1091217|P2|Overall Study|Migrated/moved|7
323203|NCT01349829|1091218|P1|Overall Study|Migrated/moved|2
323204|NCT01349829|1091217|P2|Overall Study|Consent withdrawal|8
323205|NCT01349829|1091218|P1|Overall Study|Consent withdrawal|3
323206|NCT01349829|1091217|P2|Overall Study|Lost to Follow-up|8
323207|NCT01349829|1091218|P1|Overall Study|Lost to Follow-up|4
323208|NCT01349816|1091236|P1|Overall Study|Protocol-specified criteria|8
323209|NCT01349816|1091236|P1|Overall Study|Protocol Violation|1
323210|NCT01349816|1091236|P1|Overall Study|Lost to Follow-up|2
323211|NCT01349816|1091236|P1|Overall Study|Adverse Event|14
323212|NCT01349816|1091236|P1|Overall Study|Physician Decision|1
323213|NCT01349816|1091236|P1|Overall Study|Withdrawal by Subject|4
323214|NCT01349803|1091302|P4|Overall Study|Protocol-specified criteria|0
323215|NCT01349803|1091303|P3|Overall Study|Protocol-specified criteria|3
323216|NCT01349803|1091304|P2|Overall Study|Protocol-specified criteria|1
323217|NCT01349803|1091305|P1|Overall Study|Protocol-specified criteria|0
323218|NCT01349803|1091302|P4|Overall Study|Withdrawal by Subject|0
323219|NCT01349803|1091303|P3|Overall Study|Withdrawal by Subject|0
323220|NCT01349803|1091304|P2|Overall Study|Withdrawal by Subject|0
323221|NCT01349803|1091305|P1|Overall Study|Withdrawal by Subject|1
323222|NCT01349803|1091302|P4|Overall Study|Adverse Event|2
323223|NCT01349803|1091303|P3|Overall Study|Adverse Event|0
323224|NCT01349803|1091304|P2|Overall Study|Adverse Event|0
323225|NCT01349803|1091305|P1|Overall Study|Adverse Event|0
323226|NCT01349790|1091375|P1|Overall Study|Lost to Follow-up|1
323227|NCT01349790|1091375|P1|Overall Study|Adverse Event|1
323228|NCT01349790|1091375|P1|Overall Study|Withdrawal by Patient|2
323229|NCT01349790|1091375|P1|Overall Study|Death|2
323230|NCT01349790|1091375|P1|Overall Study|Investigator Judgement|3
323231|NCT01349660|1091397|P3|Overall Study|Declining Performance Status|1
323232|NCT01349660|1091398|P2|Overall Study|Declining Performance Status|0
323233|NCT01349660|1091399|P1|Overall Study|Declining Performance Status|0
323234|NCT01349660|1091397|P3|Overall Study|Study Compliance|1
323235|NCT01349660|1091398|P2|Overall Study|Study Compliance|0
323236|NCT01349660|1091399|P1|Overall Study|Study Compliance|0
323237|NCT01349660|1091397|P3|Overall Study|Non-Permitted Interventions|2
323238|NCT01349660|1091398|P2|Overall Study|Non-Permitted Interventions|0
323239|NCT01349660|1091399|P1|Overall Study|Non-Permitted Interventions|0
323240|NCT01349660|1091397|P3|Overall Study|Death|0
323241|NCT01349660|1091398|P2|Overall Study|Death|1
323242|NCT01349660|1091399|P1|Overall Study|Death|1
323243|NCT01349660|1091397|P3|Overall Study|Withdrawal by Subject|9
323244|NCT01349660|1091398|P2|Overall Study|Withdrawal by Subject|0
323245|NCT01349660|1091399|P1|Overall Study|Withdrawal by Subject|2
323246|NCT01349660|1091397|P3|Overall Study|Adverse Event|12
323247|NCT01349660|1091398|P2|Overall Study|Adverse Event|1
323248|NCT01349660|1091399|P1|Overall Study|Adverse Event|1
323249|NCT01349660|1091397|P3|Overall Study|Disease Progression|50
323250|NCT01349660|1091398|P2|Overall Study|Disease Progression|4
323251|NCT01349660|1091399|P1|Overall Study|Disease Progression|2
323252|NCT01349660|1091397|P3|Overall Study|Still Receiving Study Treatment|1
323253|NCT01349660|1091398|P2|Overall Study|Still Receiving Study Treatment|0
323254|NCT01349660|1091399|P1|Overall Study|Still Receiving Study Treatment|0
323255|NCT01349595|1091417|P2|Overall Study|Lack of funding|2
323256|NCT01349595|1091418|P1|Overall Study|Lack of funding|2
323257|NCT01349465|1091435|P2|Overall Study|Subject Ineligible To Continue The Trial|19
323258|NCT01349465|1091436|P1|Overall Study|Subject Ineligible To Continue The Trial|0
323259|NCT01349465|1091435|P2|Overall Study|Withdrawal by Subject|2
323260|NCT01349465|1091436|P1|Overall Study|Withdrawal by Subject|4
323261|NCT01349465|1091435|P2|Overall Study|Lost to Follow-up|1
323262|NCT01349465|1091436|P1|Overall Study|Lost to Follow-up|10
323263|NCT01349465|1091435|P2|Overall Study|Death|0
323264|NCT01349465|1091436|P1|Overall Study|Death|3
323265|NCT01349465|1091435|P2|Overall Study|Adverse Event|0
323266|NCT01349465|1091436|P1|Overall Study|Adverse Event|1
323267|NCT01349192|1091457|P2|Overall Study|Failure to adhere to Protocol|0
323268|NCT01349192|1091458|P1|Overall Study|Failure to adhere to Protocol|2
323269|NCT01349192|1091457|P2|Overall Study|Lost to Follow-up|3
323270|NCT01349192|1091458|P1|Overall Study|Lost to Follow-up|1
323271|NCT01349192|1091457|P2|Overall Study|Withdrawal by Subject|2
323272|NCT01349192|1091458|P1|Overall Study|Withdrawal by Subject|0
323273|NCT01349192|1091457|P2|Overall Study|Protocol Violation|1
323274|NCT01349192|1091458|P1|Overall Study|Protocol Violation|0
323275|NCT01348854|1091483|P2|Overall Study|Withdrawal by Subject|0
323276|NCT01348854|1091484|P1|Overall Study|Withdrawal by Subject|1
323277|NCT01348854|1091483|P2|Overall Study|Lost to Follow-up|1
323278|NCT01348854|1091484|P1|Overall Study|Lost to Follow-up|2
323279|NCT01348789|1091492|P1|Overall Study|Withdrawal by Subject|2
323280|NCT01348789|1091492|P1|Overall Study|Protocol Violation|2
323281|NCT01348776|1091503|P1|Overall Study|Lost to Follow-up|3
323282|NCT01348425|1091534|P2|Overall Study|Imaging was not taken.|1
323283|NCT01348425|1091535|P1|Overall Study|Imaging was not taken.|1
323284|NCT01348165|1091547|P7|Overall Study|Adverse Event|1
323285|NCT01348165|1091548|P6|Overall Study|Adverse Event|0
323286|NCT01348165|1091549|P5|Overall Study|Adverse Event|0
323287|NCT01348165|1091550|P4|Overall Study|Adverse Event|0
323288|NCT01348165|1091551|P3|Overall Study|Adverse Event|0
323289|NCT01348165|1091552|P2|Overall Study|Adverse Event|0
323290|NCT01348165|1091553|P1|Overall Study|Adverse Event|0
323291|NCT01348139|1091682|P6|Period 1|Adverse Event|0
323292|NCT01348139|1091683|P5|Period 1|Adverse Event|0
323293|NCT01348139|1091684|P4|Period 1|Adverse Event|0
323294|NCT01348139|1091685|P3|Period 1|Adverse Event|0
323295|NCT01348139|1091686|P2|Period 1|Adverse Event|0
323296|NCT01348139|1091687|P1|Period 1|Adverse Event|1
323297|NCT01348100|1091768|P7|Overall Study|Administrative Problems|1
323298|NCT01348100|1091769|P6|Overall Study|Administrative Problems|1
323299|NCT01348100|1091770|P5|Overall Study|Administrative Problems|0
323300|NCT01348100|1091771|P4|Overall Study|Administrative Problems|0
323301|NCT01348100|1091772|P3|Overall Study|Administrative Problems|0
323302|NCT01348100|1091773|P2|Overall Study|Administrative Problems|0
323303|NCT01348100|1091774|P1|Overall Study|Administrative Problems|0
323304|NCT01348100|1091768|P7|Overall Study|Lost to Follow-up|1
323305|NCT01348100|1091769|P6|Overall Study|Lost to Follow-up|0
323306|NCT01348100|1091770|P5|Overall Study|Lost to Follow-up|0
323307|NCT01348100|1091771|P4|Overall Study|Lost to Follow-up|0
323308|NCT01348100|1091772|P3|Overall Study|Lost to Follow-up|0
323309|NCT01348100|1091773|P2|Overall Study|Lost to Follow-up|0
323310|NCT01348100|1091774|P1|Overall Study|Lost to Follow-up|0
323311|NCT01348100|1091768|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
323312|NCT01348100|1091769|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
323313|NCT01348100|1091770|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
323314|NCT01348100|1091771|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
323315|NCT01348100|1091772|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
323316|NCT01348100|1091773|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
323317|NCT01348100|1091774|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
323318|NCT01348100|1091768|P7|Overall Study|Protocol Deviation|0
323319|NCT01348100|1091769|P6|Overall Study|Protocol Deviation|0
323320|NCT01348100|1091770|P5|Overall Study|Protocol Deviation|0
323321|NCT01348100|1091771|P4|Overall Study|Protocol Deviation|1
323322|NCT01348100|1091772|P3|Overall Study|Protocol Deviation|0
323323|NCT01348100|1091773|P2|Overall Study|Protocol Deviation|0
323324|NCT01348100|1091774|P1|Overall Study|Protocol Deviation|0
323325|NCT01348100|1091768|P7|Overall Study|Subject Withdrew Consent|1
323326|NCT01348100|1091769|P6|Overall Study|Subject Withdrew Consent|0
323327|NCT01348100|1091770|P5|Overall Study|Subject Withdrew Consent|1
323328|NCT01348100|1091771|P4|Overall Study|Subject Withdrew Consent|0
323329|NCT01348100|1091772|P3|Overall Study|Subject Withdrew Consent|2
323330|NCT01348100|1091773|P2|Overall Study|Subject Withdrew Consent|0
323331|NCT01348100|1091774|P1|Overall Study|Subject Withdrew Consent|0
323332|NCT01348087|1091819|P1|Overall Study|Adverse Event|25
323333|NCT01348087|1091819|P1|Overall Study|Subject withdrew consent|7
323334|NCT01348087|1091819|P1|Overall Study|Lost to Follow-up|1
323335|NCT01348087|1091819|P1|Overall Study|protocol deviation|1
323336|NCT01348087|1091819|P1|Overall Study|Administrative problems|79
323337|NCT01348087|1091819|P1|Overall Study|Unsatisfactory therapeutic effect|35
323338|NCT01347931|1091833|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
323339|NCT01347879|1091845|P2|Overall Study|Other|3
323340|NCT01347879|1091846|P1|Overall Study|Other|2
323341|NCT01347879|1091845|P2|Overall Study|Withdrawal by Subject|2
323342|NCT01347879|1091846|P1|Overall Study|Withdrawal by Subject|3
323343|NCT01347879|1091845|P2|Overall Study|Lost to Follow-up|0
323344|NCT01347879|1091846|P1|Overall Study|Lost to Follow-up|2
323345|NCT01347879|1091845|P2|Overall Study|Adverse Event|12
323346|NCT01347879|1091846|P1|Overall Study|Adverse Event|0
323347|NCT01347840|1091878|P1|Overall Study|Withdrawal by Subject|1
323348|NCT01347762|1091905|P4|Overall Study|Withdrawal by Subject|3
323349|NCT01347762|1091906|P3|Overall Study|Withdrawal by Subject|3
323350|NCT01347762|1091907|P2|Overall Study|Withdrawal by Subject|1
323351|NCT01347762|1091908|P1|Overall Study|Withdrawal by Subject|4
323352|NCT01347762|1091905|P4|Overall Study|Lost to Follow-up|5
323353|NCT01347762|1091906|P3|Overall Study|Lost to Follow-up|6
323354|NCT01347762|1091907|P2|Overall Study|Lost to Follow-up|1
323355|NCT01347762|1091908|P1|Overall Study|Lost to Follow-up|0
323356|NCT01347710|1091934|P1|Overall Study|Other|3
323357|NCT01347710|1091934|P1|Overall Study|Physician Decision|2
323358|NCT01347710|1091934|P1|Overall Study|Lost to Follow-up|1
323359|NCT01347710|1091934|P1|Overall Study|issue with vitals prior to dosing|1
323360|NCT01347710|1091934|P1|Overall Study|Angio or SPECT not completed|18
323361|NCT01347710|1091934|P1|Overall Study|Adverse Event|4
323362|NCT01347710|1091934|P1|Overall Study|Withdrawal by Subject|2
323363|NCT01347580|1091956|P2|Overall Study|Had other reason|6
323364|NCT01347580|1091957|P1|Overall Study|Had other reason|9
323365|NCT01347580|1091956|P2|Overall Study|Lost to Follow-up|1
323366|NCT01347580|1091957|P1|Overall Study|Lost to Follow-up|3
323367|NCT01347580|1091956|P2|Overall Study|Protocol Violation|7
323368|NCT01347580|1091957|P1|Overall Study|Protocol Violation|10
323369|NCT01347580|1091956|P2|Overall Study|Death|19
323370|NCT01347580|1091957|P1|Overall Study|Death|30
323371|NCT01347580|1091956|P2|Overall Study|Withdrawal by Subject|23
323372|NCT01347580|1091957|P1|Overall Study|Withdrawal by Subject|13
323373|NCT01347554|1091987|P2|Overall Study|Lack of Efficacy|11
323374|NCT01347554|1091988|P1|Overall Study|Lack of Efficacy|7
323375|NCT01347112|1092025|P2|Overall Study|Lost to Follow-up|5
323376|NCT01347112|1092026|P1|Overall Study|Lost to Follow-up|3
323377|NCT01347112|1092025|P2|Overall Study|Withdrawal by Subject|7
323378|NCT01347112|1092026|P1|Overall Study|Withdrawal by Subject|1
323379|NCT01347086|1092046|P10|Overall Study|failed screening visit|1
323380|NCT01347086|1092047|P9|Overall Study|failed screening visit|0
323381|NCT01347086|1092048|P8|Overall Study|failed screening visit|1
323382|NCT01347086|1092049|P7|Overall Study|failed screening visit|1
323383|NCT01347086|1092050|P6|Overall Study|failed screening visit|0
323384|NCT01347086|1092051|P5|Overall Study|failed screening visit|0
323385|NCT01347086|1092052|P4|Overall Study|failed screening visit|0
323386|NCT01347086|1092053|P3|Overall Study|failed screening visit|1
323387|NCT01347086|1092054|P2|Overall Study|failed screening visit|0
323388|NCT01347086|1092055|P1|Overall Study|failed screening visit|0
323389|NCT01347073|1092154|P1|Overall Study|Liver Transplant|1
323390|NCT01347073|1092154|P1|Overall Study|Adverse Event|1
323391|NCT01346774|1092233|P2|Overall Study|Adverse Event|2
323392|NCT01346774|1092234|P1|Overall Study|Adverse Event|1
323393|NCT01346774|1092233|P2|Overall Study|Protocol Violation|3
323394|NCT01346774|1092234|P1|Overall Study|Protocol Violation|2
323395|NCT01346774|1092233|P2|Overall Study|Withdrawal by Subject|4
323396|NCT01346774|1092234|P1|Overall Study|Withdrawal by Subject|1
323397|NCT01346774|1092233|P2|Overall Study|Lost to Follow-up|4
323398|NCT01346774|1092234|P1|Overall Study|Lost to Follow-up|3
323399|NCT01346774|1092233|P2|Overall Study|Did not take a single dose|4
323400|NCT01346774|1092234|P1|Overall Study|Did not take a single dose|6
323401|NCT01346592|1092243|P3|Overall Study|Unable to Classify|6
323402|NCT01346592|1092244|P2|Overall Study|Unable to Classify|3
323403|NCT01346592|1092245|P1|Overall Study|Unable to Classify|7
323404|NCT01346592|1092243|P3|Overall Study|Administrative reason|0
323405|NCT01346592|1092244|P2|Overall Study|Administrative reason|0
323406|NCT01346592|1092245|P1|Overall Study|Administrative reason|1
323407|NCT01346592|1092243|P3|Overall Study|Inappropriate enrollment|1
323408|NCT01346592|1092244|P2|Overall Study|Inappropriate enrollment|1
323409|NCT01346592|1092245|P1|Overall Study|Inappropriate enrollment|3
323410|NCT01346592|1092243|P3|Overall Study|Withdrawal by Subject|38
323411|NCT01346592|1092244|P2|Overall Study|Withdrawal by Subject|51
323412|NCT01346592|1092245|P1|Overall Study|Withdrawal by Subject|77
323413|NCT01346592|1092243|P3|Overall Study|Adverse Event|0
323414|NCT01346592|1092244|P2|Overall Study|Adverse Event|1
323415|NCT01346592|1092245|P1|Overall Study|Adverse Event|0
323416|NCT01346592|1092243|P3|Overall Study|Death|4
323417|NCT01346592|1092244|P2|Overall Study|Death|3
323418|NCT01346592|1092245|P1|Overall Study|Death|1
323419|NCT01346592|1092243|P3|Overall Study|Protocol Violation|0
323420|NCT01346592|1092244|P2|Overall Study|Protocol Violation|1
323421|NCT01346592|1092245|P1|Overall Study|Protocol Violation|2
323422|NCT01346592|1092243|P3|Overall Study|Lost to Follow-up|29
323423|NCT01346592|1092244|P2|Overall Study|Lost to Follow-up|29
323424|NCT01346592|1092245|P1|Overall Study|Lost to Follow-up|62
323425|NCT01346514|1092337|P2|Overall Study|Death|4
323426|NCT01346514|1092338|P1|Overall Study|Death|3
323427|NCT01346514|1092337|P2|Overall Study|Withdrawal by Subject|3
323428|NCT01346514|1092338|P1|Overall Study|Withdrawal by Subject|7
323429|NCT01346514|1092337|P2|Overall Study|Lost to Follow-up|30
323430|NCT01346514|1092338|P1|Overall Study|Lost to Follow-up|19
323431|NCT01346501|1092358|P2|Overall Study|Not Specified|12
323432|NCT01346501|1092359|P1|Overall Study|Not Specified|8
323433|NCT01346501|1092358|P2|Overall Study|Initiated Other Biological Agents|1
323434|NCT01346501|1092359|P1|Overall Study|Initiated Other Biological Agents|3
323435|NCT01346475|1092392|P2|First Intervention|Lost to Follow-up|3
323436|NCT01346475|1092393|P1|First Intervention|Lost to Follow-up|4
323437|NCT01346410|1092405|P1|Overall Study|Death|1
323438|NCT01346293|1092422|P2|Overall Study|Other|0
323439|NCT01346293|1092423|P1|Overall Study|Other|1
323440|NCT01346293|1092422|P2|Overall Study|Withdrawal by Subject|4
323441|NCT01346293|1092423|P1|Overall Study|Withdrawal by Subject|15
323442|NCT01346293|1092422|P2|Overall Study|Lost to Follow-up|8
323443|NCT01346293|1092423|P1|Overall Study|Lost to Follow-up|21
323444|NCT01346293|1092422|P2|Overall Study|Protocol Violation|9
323445|NCT01346293|1092423|P1|Overall Study|Protocol Violation|30
323446|NCT01346189|1092453|P4|Overall Study|Travel|3
323447|NCT01346189|1092454|P3|Overall Study|Travel|0
323448|NCT01346189|1092455|P2|Overall Study|Travel|0
323449|NCT01346189|1092456|P1|Overall Study|Travel|0
323450|NCT01346189|1092453|P4|Overall Study|Non-health system primary care physician|0
323451|NCT01346189|1092454|P3|Overall Study|Non-health system primary care physician|0
323452|NCT01346189|1092455|P2|Overall Study|Non-health system primary care physician|5
323453|NCT01346189|1092456|P1|Overall Study|Non-health system primary care physician|0
323454|NCT01346189|1092453|P4|Overall Study|Death|0
323455|NCT01346189|1092454|P3|Overall Study|Death|0
323456|NCT01346189|1092455|P2|Overall Study|Death|3
323457|NCT01346189|1092456|P1|Overall Study|Death|0
323458|NCT01346189|1092453|P4|Overall Study|Other|3
323459|NCT01346189|1092454|P3|Overall Study|Other|7
323460|NCT01346189|1092455|P2|Overall Study|Other|4
323461|NCT01346189|1092456|P1|Overall Study|Other|2
323462|NCT01346189|1092453|P4|Overall Study|Moved|0
323463|NCT01346189|1092454|P3|Overall Study|Moved|4
323464|NCT01346189|1092455|P2|Overall Study|Moved|0
323465|NCT01346189|1092456|P1|Overall Study|Moved|3
323466|NCT01346189|1092453|P4|Overall Study|Physician Decision|0
323467|NCT01346189|1092454|P3|Overall Study|Physician Decision|0
323468|NCT01346189|1092455|P2|Overall Study|Physician Decision|0
323469|NCT01346189|1092456|P1|Overall Study|Physician Decision|4
323470|NCT01346189|1092453|P4|Overall Study|Withdrawal by Subject|5
323471|NCT01346189|1092454|P3|Overall Study|Withdrawal by Subject|3
323472|NCT01346189|1092455|P2|Overall Study|Withdrawal by Subject|5
323473|NCT01346189|1092456|P1|Overall Study|Withdrawal by Subject|7
323474|NCT01346176|1092473|P3|Completed Satisfaction Survey|Lost to Follow-up|4
323475|NCT01346176|1092474|P2|Completed Satisfaction Survey|Lost to Follow-up|4
323476|NCT01346176|1092475|P1|Completed Satisfaction Survey|Lost to Follow-up|3
323477|NCT01346176|1092473|P3|Completed Satisfaction Survey|Death|2
323478|NCT01346176|1092474|P2|Completed Satisfaction Survey|Death|0
323479|NCT01346176|1092475|P1|Completed Satisfaction Survey|Death|3
323480|NCT01346176|1092473|P3|Completed Advance Directive|Other reason did not complete AD|7
323481|NCT01346176|1092474|P2|Completed Advance Directive|Other reason did not complete AD|12
323482|NCT01346176|1092475|P1|Completed Advance Directive|Other reason did not complete AD|7
323483|NCT01346176|1092473|P3|Completed Advance Directive|Became Ineligible|1
323484|NCT01346176|1092474|P2|Completed Advance Directive|Became Ineligible|0
323485|NCT01346176|1092475|P1|Completed Advance Directive|Became Ineligible|3
323486|NCT01346176|1092473|P3|Completed Advance Directive|Death|2
323487|NCT01346176|1092474|P2|Completed Advance Directive|Death|2
323488|NCT01346176|1092475|P1|Completed Advance Directive|Death|3
323489|NCT01346176|1092473|P3|Recruited|Protocol Violation|0
323490|NCT01346176|1092474|P2|Recruited|Protocol Violation|0
323491|NCT01346176|1092475|P1|Recruited|Protocol Violation|1
323492|NCT01346059|1092504|P2|Overall Study|Withdrawal by Subject|0
323493|NCT01346059|1092505|P1|Overall Study|Withdrawal by Subject|1
323494|NCT01345929|1092517|P2|Overall Study|Patient withdrawal|1
323495|NCT01345929|1092518|P1|Overall Study|Patient withdrawal|0
323496|NCT01345929|1092517|P2|Overall Study|40,000 CFU/ML|0
323497|NCT01345929|1092518|P1|Overall Study|40,000 CFU/ML|1
323498|NCT01345929|1092517|P2|Overall Study|Didn't meet eligibility criteria|0
323499|NCT01345929|1092518|P1|Overall Study|Didn't meet eligibility criteria|2
323500|NCT01345929|1092517|P2|Overall Study|Adverse Event|1
323501|NCT01345929|1092518|P1|Overall Study|Adverse Event|0
323502|NCT01345929|1092517|P2|Overall Study|Lost to Follow-up|9
323503|NCT01345929|1092518|P1|Overall Study|Lost to Follow-up|9
323504|NCT01345929|1092517|P2|Overall Study|Withdrawal by Subject|8
323505|NCT01345929|1092518|P1|Overall Study|Withdrawal by Subject|9
323506|NCT01345786|1092530|P4|Overall Study|Lost to Follow-up|2
323507|NCT01345786|1092531|P3|Overall Study|Lost to Follow-up|0
323508|NCT01345786|1092532|P2|Overall Study|Lost to Follow-up|0
323509|NCT01345786|1092533|P1|Overall Study|Lost to Follow-up|0
323510|NCT01345786|1092530|P4|Overall Study|Administrative|0
323511|NCT01345786|1092531|P3|Overall Study|Administrative|0
323512|NCT01345786|1092532|P2|Overall Study|Administrative|5
323513|NCT01345786|1092533|P1|Overall Study|Administrative|3
323514|NCT01345786|1092530|P4|Overall Study|Noncompliance with protocol|0
323515|NCT01345786|1092531|P3|Overall Study|Noncompliance with protocol|1
323516|NCT01345786|1092532|P2|Overall Study|Noncompliance with protocol|0
323517|NCT01345786|1092533|P1|Overall Study|Noncompliance with protocol|1
323518|NCT01345786|1092530|P4|Overall Study|Subject withdrew consent|0
323519|NCT01345786|1092531|P3|Overall Study|Subject withdrew consent|1
323520|NCT01345786|1092532|P2|Overall Study|Subject withdrew consent|2
323521|NCT01345786|1092533|P1|Overall Study|Subject withdrew consent|2
323522|NCT01345786|1092530|P4|Overall Study|Adverse Event|1
323523|NCT01345786|1092531|P3|Overall Study|Adverse Event|3
323524|NCT01345786|1092532|P2|Overall Study|Adverse Event|1
323525|NCT01345786|1092533|P1|Overall Study|Adverse Event|0
323526|NCT01345682|1092613|P2|Overall Study|Reason other than those specified above|3
323527|NCT01345682|1092614|P1|Overall Study|Reason other than those specified above|4
323528|NCT01345682|1092613|P2|Overall Study|Not treated|1
323529|NCT01345682|1092614|P1|Overall Study|Not treated|2
323530|NCT01345682|1092613|P2|Overall Study|Refused to continue trial medication|9
323531|NCT01345682|1092614|P1|Overall Study|Refused to continue trial medication|16
323532|NCT01345682|1092613|P2|Overall Study|Lost to Follow-up|1
323533|NCT01345682|1092614|P1|Overall Study|Lost to Follow-up|0
323534|NCT01345682|1092613|P2|Overall Study|Non-compliance with protocol|1
323535|NCT01345682|1092614|P1|Overall Study|Non-compliance with protocol|0
323536|NCT01345682|1092613|P2|Overall Study|Adverse Event|41
323537|NCT01345682|1092614|P1|Overall Study|Adverse Event|51
323538|NCT01345682|1092613|P2|Overall Study|Worsening of underlying cancer disease|12
323539|NCT01345682|1092614|P1|Overall Study|Worsening of underlying cancer disease|23
323540|NCT01345682|1092613|P2|Overall Study|Progressive disease per RECIST|93
323541|NCT01345682|1092614|P1|Overall Study|Progressive disease per RECIST|226
323542|NCT01345669|1092648|P2|Overall Study|Other Reasons|60
323543|NCT01345669|1092649|P1|Overall Study|Other Reasons|111
323544|NCT01345669|1092648|P2|Overall Study|Withdrawal by Subject|13
323545|NCT01345669|1092649|P1|Overall Study|Withdrawal by Subject|52
323546|NCT01345669|1092648|P2|Overall Study|Lost to Follow-up|1
323547|NCT01345669|1092649|P1|Overall Study|Lost to Follow-up|1
323548|NCT01345669|1092648|P2|Overall Study|Protocol Violation|1
323549|NCT01345669|1092649|P1|Overall Study|Protocol Violation|3
323550|NCT01345669|1092648|P2|Overall Study|Adverse Event|9
323551|NCT01345669|1092649|P1|Overall Study|Adverse Event|63
323552|NCT01345669|1092648|P2|Overall Study|Second primary tumour|3
323553|NCT01345669|1092649|P1|Overall Study|Second primary tumour|4
323554|NCT01345669|1092648|P2|Overall Study|Primary tumour recurrence|32
323555|NCT01345669|1092649|P1|Overall Study|Primary tumour recurrence|53
323556|NCT01345630|1092667|P2|Overall Study|Insufficient clinical response|11
323557|NCT01345630|1092668|P1|Overall Study|Insufficient clinical response|48
323558|NCT01345630|1092667|P2|Overall Study|No longer willing to participate|12
323559|NCT01345630|1092668|P1|Overall Study|No longer willing to participate|9
323560|NCT01345630|1092667|P2|Overall Study|Withdrawn due to pregnancy|2
323561|NCT01345630|1092668|P1|Overall Study|Withdrawn due to pregnancy|1
323562|NCT01345630|1092667|P2|Overall Study|Other reasons|8
323563|NCT01345630|1092668|P1|Overall Study|Other reasons|6
323564|NCT01345630|1092667|P2|Overall Study|Study terminated by sponsor|285
323565|NCT01345630|1092668|P1|Overall Study|Study terminated by sponsor|254
323566|NCT01345630|1092667|P2|Overall Study|Medication error without associated AE|1
323567|NCT01345630|1092668|P1|Overall Study|Medication error without associated AE|0
323568|NCT01345630|1092667|P2|Overall Study|Protocol Violation|1
323569|NCT01345630|1092668|P1|Overall Study|Protocol Violation|4
323570|NCT01345630|1092667|P2|Overall Study|Lost to Follow-up|16
323571|NCT01345630|1092668|P1|Overall Study|Lost to Follow-up|17
323572|NCT01345630|1092667|P2|Overall Study|Adverse Event|23
323573|NCT01345630|1092668|P1|Overall Study|Adverse Event|22
323574|NCT01345591|1092724|P1|Overall Study|Lost to Follow-up|1
323575|NCT01345318|1092733|P1|Overall Study|Other|3
323576|NCT01345318|1092733|P1|Overall Study|Withdrawal by Subject|41
323577|NCT01345318|1092733|P1|Overall Study|Protocol Violation|1
323578|NCT01345318|1092733|P1|Overall Study|Lost to Follow-up|2
323579|NCT01345318|1092733|P1|Overall Study|Lack of Efficacy|17
323580|NCT01345318|1092733|P1|Overall Study|Adverse Event|16
323581|NCT01345292|1092741|P3|Overall Study|Withdrawal by Subject|1
323582|NCT01345292|1092742|P2|Overall Study|Withdrawal by Subject|0
323583|NCT01345292|1092743|P1|Overall Study|Withdrawal by Subject|2
323584|NCT01345253|1092774|P2|Overall Study|Withdrawal by Subject|19
323585|NCT01345253|1092775|P1|Overall Study|Withdrawal by Subject|9
323586|NCT01345253|1092774|P2|Overall Study|Physician Decision|12
323587|NCT01345253|1092775|P1|Overall Study|Physician Decision|4
323588|NCT01345253|1092774|P2|Overall Study|Lost to Follow-up|8
323589|NCT01345253|1092775|P1|Overall Study|Lost to Follow-up|3
323590|NCT01345253|1092774|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
323591|NCT01345253|1092775|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
323592|NCT01345253|1092774|P2|Overall Study|Protocol Violation|5
323593|NCT01345253|1092775|P1|Overall Study|Protocol Violation|1
323594|NCT01345253|1092774|P2|Overall Study|Lack of Efficacy|7
323595|NCT01345253|1092775|P1|Overall Study|Lack of Efficacy|11
323596|NCT01345253|1092774|P2|Overall Study|Adverse Event|27
323597|NCT01345253|1092775|P1|Overall Study|Adverse Event|22
323598|NCT01345240|1092794|P5|Overall Study|Serious Adverse Event|1
323599|NCT01345240|1092795|P4|Overall Study|Serious Adverse Event|2
323600|NCT01345240|1092796|P3|Overall Study|Serious Adverse Event|2
323601|NCT01345240|1092797|P2|Overall Study|Serious Adverse Event|2
323602|NCT01345240|1092798|P1|Overall Study|Serious Adverse Event|1
323603|NCT01345240|1092794|P5|Overall Study|Lost to Follow-up|6
323604|NCT01345240|1092795|P4|Overall Study|Lost to Follow-up|8
323605|NCT01345240|1092796|P3|Overall Study|Lost to Follow-up|8
323606|NCT01345240|1092797|P2|Overall Study|Lost to Follow-up|12
323607|NCT01345240|1092798|P1|Overall Study|Lost to Follow-up|1
323608|NCT01345162|1092893|P2|Overall Study|Protocol Violation|4
323609|NCT01345162|1092894|P1|Overall Study|Protocol Violation|2
323610|NCT01345123|1092903|P3|Overall Study|participants no longer with health plan|88
323611|NCT01345123|1092904|P2|Overall Study|participants no longer with health plan|85
323612|NCT01345123|1092905|P1|Overall Study|participants no longer with health plan|79
323613|NCT01345058|1092927|P2|Overall Study|Participant No-Show at Multiple Visits|0
323614|NCT01345058|1092928|P1|Overall Study|Participant No-Show at Multiple Visits|1
323615|NCT01345058|1092927|P2|Overall Study|Participant Stopped Taking Study Drug|0
323616|NCT01345058|1092928|P1|Overall Study|Participant Stopped Taking Study Drug|1
323617|NCT01345058|1092927|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
323618|NCT01345058|1092928|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
323619|NCT01345058|1092927|P2|Overall Study|Participant Reported Increase in Events|0
323620|NCT01345058|1092928|P1|Overall Study|Participant Reported Increase in Events|1
323621|NCT01345058|1092927|P2|Overall Study|Withdrawal by Subject|0
323622|NCT01345058|1092928|P1|Overall Study|Withdrawal by Subject|1
323623|NCT01345019|1092944|P2|Overall Study|Other|3
323624|NCT01345019|1092945|P1|Overall Study|Other|1
323625|NCT01345019|1092944|P2|Overall Study|Protocol Deviation|0
323626|NCT01345019|1092945|P1|Overall Study|Protocol Deviation|5
323627|NCT01345019|1092944|P2|Overall Study|Lost to Follow-up|2
323628|NCT01345019|1092945|P1|Overall Study|Lost to Follow-up|4
323629|NCT01345019|1092944|P2|Overall Study|Ineligibility Determined|6
323630|NCT01345019|1092945|P1|Overall Study|Ineligibility Determined|1
323631|NCT01345019|1092944|P2|Overall Study|Noncompliance|4
323632|NCT01345019|1092945|P1|Overall Study|Noncompliance|4
323633|NCT01345019|1092944|P2|Overall Study|Administrative Decision|5
323634|NCT01345019|1092945|P1|Overall Study|Administrative Decision|8
323635|NCT01345019|1092944|P2|Overall Study|Adverse Event|13
323636|NCT01345019|1092945|P1|Overall Study|Adverse Event|4
323637|NCT01345019|1092944|P2|Overall Study|Disease Progression|8
323638|NCT01345019|1092945|P1|Overall Study|Disease Progression|11
323639|NCT01345019|1092944|P2|Overall Study|Completed Survival Follow-up|4
323640|NCT01345019|1092945|P1|Overall Study|Completed Survival Follow-up|16
323641|NCT01345019|1092944|P2|Overall Study|Withdrawal by Subject|107
323642|NCT01345019|1092945|P1|Overall Study|Withdrawal by Subject|82
323643|NCT01345019|1092944|P2|Overall Study|Death|120
323644|NCT01345019|1092945|P1|Overall Study|Death|127
323645|NCT01344876|1092965|P5|Overall Study|Definite progression of primary disease|0
323646|NCT01344876|1092966|P4|Overall Study|Definite progression of primary disease|3
323647|NCT01344876|1092967|P3|Overall Study|Definite progression of primary disease|0
323648|NCT01344876|1092968|P2|Overall Study|Definite progression of primary disease|0
323649|NCT01344876|1092969|P1|Overall Study|Definite progression of primary disease|1
323650|NCT01344876|1092965|P5|Overall Study|Withdrawal by Subject|0
323651|NCT01344876|1092966|P4|Overall Study|Withdrawal by Subject|0
323652|NCT01344876|1092967|P3|Overall Study|Withdrawal by Subject|1
323653|NCT01344876|1092968|P2|Overall Study|Withdrawal by Subject|0
323654|NCT01344876|1092969|P1|Overall Study|Withdrawal by Subject|0
323655|NCT01344876|1092965|P5|Overall Study|Adverse Event|1
323656|NCT01344876|1092966|P4|Overall Study|Adverse Event|0
323657|NCT01344876|1092967|P3|Overall Study|Adverse Event|0
323658|NCT01344876|1092968|P2|Overall Study|Adverse Event|0
323659|NCT01344876|1092969|P1|Overall Study|Adverse Event|0
323660|NCT01344824|1092983|P1|Overall Study|Progression|15
323661|NCT01344824|1092983|P1|Overall Study|Other complicating disease|1
323662|NCT01344824|1092983|P1|Overall Study|Withdrawal by Subject|6
323663|NCT01344824|1092983|P1|Overall Study|Adverse Event|15
323664|NCT01344759|1092991|P2|Overall Study|Patients failed to reach sedation level|2
323665|NCT01344759|1092992|P1|Overall Study|Patients failed to reach sedation level|0
323666|NCT01344629|1093024|P2|Crossover Period 2|Withdrawal by Subject|1
323667|NCT01344629|1093025|P1|Crossover Period 2|Withdrawal by Subject|0
323668|NCT01344538|1093054|P2|Overall Study|Lost to Follow-up|0
323669|NCT01344538|1093055|P1|Overall Study|Lost to Follow-up|1
323670|NCT01344538|1093054|P2|Overall Study|Adverse Event|1
323671|NCT01344538|1093055|P1|Overall Study|Adverse Event|1
323672|NCT01344460|1093061|P1|Overall Study|Lost to Follow-up|2
323673|NCT01344460|1093061|P1|Overall Study|Withdrawal by Subject|1
323674|NCT01344447|1093106|P1|Overall Study|Error of power injector|1
323675|NCT01344447|1093106|P1|Overall Study|Bolus tracking failed|1
323676|NCT01344447|1093106|P1|Overall Study|MRA unsuccessful|1
323677|NCT01344447|1093106|P1|Overall Study|Physician Decision|1
323678|NCT01344447|1093106|P1|Overall Study|The contrast was not seen|1
323679|NCT01344447|1093106|P1|Overall Study|Withdrawal by Subject|1
323680|NCT01344447|1093106|P1|Overall Study|Protocol Violation|1
323681|NCT01344447|1093106|P1|Overall Study|Adverse Event|1
323682|NCT01344369|1093150|P2|Second Intervention|Emesis within 2 x Tmax|1
323683|NCT01344369|1093151|P1|Second Intervention|Emesis within 2 x Tmax|0
323684|NCT01344369|1093150|P2|Washout of 28 Days|Physician Decision|1
323685|NCT01344369|1093151|P1|Washout of 28 Days|Physician Decision|0
323686|NCT01344369|1093150|P2|Washout of 28 Days|Withdrawal by Subject|0
323687|NCT01344369|1093151|P1|Washout of 28 Days|Withdrawal by Subject|1
323688|NCT01344161|1093169|P2|Overall Study|Protocol Violation|1
323689|NCT01344161|1093170|P1|Overall Study|Protocol Violation|1
323690|NCT01344161|1093169|P2|Overall Study|Pregnancy|1
323691|NCT01344161|1093170|P1|Overall Study|Pregnancy|0
323692|NCT01344161|1093169|P2|Overall Study|Lost to Follow-up|1
323693|NCT01344161|1093170|P1|Overall Study|Lost to Follow-up|4
323694|NCT01344057|1093182|P1|Overall Study|Premature Withdrawal|1
323695|NCT01343901|1093189|P1|Overall Study|Participant decision|1
323696|NCT01343901|1093189|P1|Overall Study|Management by another medical team|11
323697|NCT01343901|1093189|P1|Overall Study|Lost to Follow-up|12
323698|NCT01343901|1093189|P1|Overall Study|Physician Decision|4
323699|NCT01343901|1093189|P1|Overall Study|Death|85
323700|NCT01343888|1093213|P3|Overall Study|other than stated above|1
323701|NCT01343888|1093214|P2|Overall Study|other than stated above|0
323702|NCT01343888|1093215|P1|Overall Study|other than stated above|0
323703|NCT01343888|1093213|P3|Overall Study|Withdrawal by Subject|2
323704|NCT01343888|1093214|P2|Overall Study|Withdrawal by Subject|4
323705|NCT01343888|1093215|P1|Overall Study|Withdrawal by Subject|4
323706|NCT01343888|1093213|P3|Overall Study|Protocol Violation|0
323707|NCT01343888|1093214|P2|Overall Study|Protocol Violation|2
323708|NCT01343888|1093215|P1|Overall Study|Protocol Violation|0
323709|NCT01343888|1093213|P3|Overall Study|Lost to Follow-up|1
323710|NCT01343888|1093214|P2|Overall Study|Lost to Follow-up|2
323711|NCT01343888|1093215|P1|Overall Study|Lost to Follow-up|0
323712|NCT01343888|1093213|P3|Overall Study|Lack of Efficacy|13
323713|NCT01343888|1093214|P2|Overall Study|Lack of Efficacy|9
323714|NCT01343888|1093215|P1|Overall Study|Lack of Efficacy|9
323715|NCT01343888|1093213|P3|Overall Study|Adverse Event|5
323716|NCT01343888|1093214|P2|Overall Study|Adverse Event|22
323717|NCT01343888|1093215|P1|Overall Study|Adverse Event|12
323718|NCT01343823|1093257|P4|Overall Study|Withdrawal by Subject|0
323719|NCT01343823|1093258|P3|Overall Study|Withdrawal by Subject|0
323720|NCT01343823|1093259|P2|Overall Study|Withdrawal by Subject|0
323721|NCT01343823|1093260|P1|Overall Study|Withdrawal by Subject|1
323722|NCT01343823|1093257|P4|Overall Study|Study Terminated|1
323723|NCT01343823|1093258|P3|Overall Study|Study Terminated|0
323724|NCT01343823|1093259|P2|Overall Study|Study Terminated|0
323725|NCT01343823|1093260|P1|Overall Study|Study Terminated|1
323726|NCT01343368|1093294|P2|Overall Study|Lost to Follow-up|0
323727|NCT01343368|1093295|P1|Overall Study|Lost to Follow-up|1
323728|NCT01343368|1093294|P2|Overall Study|Death|0
323729|NCT01343368|1093295|P1|Overall Study|Death|1
323730|NCT01343277|1093331|P2|Overall Study|Subsequent anticancer therapy|0
323731|NCT01343277|1093332|P1|Overall Study|Subsequent anticancer therapy|1
323732|NCT01343277|1093331|P2|Overall Study|Treatment ongoing|2
323733|NCT01343277|1093332|P1|Overall Study|Treatment ongoing|8
323734|NCT01343277|1093331|P2|Overall Study|Randomized not treated|21
323735|NCT01343277|1093332|P1|Overall Study|Randomized not treated|6
323736|NCT01343277|1093331|P2|Overall Study|Disease progression|138
323737|NCT01343277|1093332|P1|Overall Study|Disease progression|270
323738|NCT01343277|1093331|P2|Overall Study|Adverse Event|13
323739|NCT01343277|1093332|P1|Overall Study|Adverse Event|67
323740|NCT01343277|1093331|P2|Overall Study|Death|1
323741|NCT01343277|1093332|P1|Overall Study|Death|10
323742|NCT01343277|1093331|P2|Overall Study|Physician Decision|2
323743|NCT01343277|1093332|P1|Overall Study|Physician Decision|1
323744|NCT01343277|1093331|P2|Overall Study|Withdrawal by Subject|13
323745|NCT01343277|1093332|P1|Overall Study|Withdrawal by Subject|18
323746|NCT01343277|1093331|P2|Overall Study|Other|3
323747|NCT01343277|1093332|P1|Overall Study|Other|3
323748|NCT01343082|1093393|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
323749|NCT01343082|1093394|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
323750|NCT01343082|1093395|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
323751|NCT01343082|1093393|P3|Treatment Period , Switched to DE-111|Physician Decision|2
323752|NCT01343082|1093394|P2|Treatment Period , Switched to DE-111|Physician Decision|2
323753|NCT01343082|1093395|P1|Treatment Period , Switched to DE-111|Physician Decision|0
323754|NCT01343082|1093393|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
323755|NCT01343082|1093394|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
323756|NCT01343082|1093395|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
323757|NCT01343082|1093393|P3|Treatment Period , Switched to DE-111|Adverse Event|3
323758|NCT01343082|1093394|P2|Treatment Period , Switched to DE-111|Adverse Event|4
323759|NCT01343082|1093395|P1|Treatment Period , Switched to DE-111|Adverse Event|1
323760|NCT01343082|1093393|P3|The run-in Period|Not meeting criteria|5
323761|NCT01343082|1093394|P2|The run-in Period|Not meeting criteria|4
323762|NCT01343082|1093395|P1|The run-in Period|Not meeting criteria|3
323763|NCT01343056|1093403|P4|Overall Study|Lost to Follow-up|9
323764|NCT01343056|1093404|P3|Overall Study|Lost to Follow-up|3
323765|NCT01343056|1093405|P2|Overall Study|Lost to Follow-up|5
323766|NCT01343056|1093406|P1|Overall Study|Lost to Follow-up|7
323767|NCT01342965|1093474|P2|Overall Study|Withdrawal by Subject|9
323768|NCT01342965|1093475|P1|Overall Study|Withdrawal by Subject|2
323769|NCT01342965|1093474|P2|Overall Study|Other Reasons- Unspecified|38
323770|NCT01342965|1093475|P1|Overall Study|Other Reasons- Unspecified|44
323771|NCT01342965|1093474|P2|Overall Study|Lost to Follow-up|3
323772|NCT01342965|1093475|P1|Overall Study|Lost to Follow-up|5
323773|NCT01342965|1093474|P2|Overall Study|Death|57
323774|NCT01342965|1093475|P1|Overall Study|Death|58
323775|NCT01342926|1093493|P4|Overall Study|Withdrawal by Subject|5
323776|NCT01342926|1093494|P3|Overall Study|Withdrawal by Subject|3
323777|NCT01342926|1093495|P2|Overall Study|Withdrawal by Subject|4
323778|NCT01342926|1093496|P1|Overall Study|Withdrawal by Subject|2
323779|NCT01342926|1093493|P4|Overall Study|Investigator Discretion|0
323780|NCT01342926|1093494|P3|Overall Study|Investigator Discretion|0
323781|NCT01342926|1093495|P2|Overall Study|Investigator Discretion|2
323782|NCT01342926|1093496|P1|Overall Study|Investigator Discretion|2
323783|NCT01342926|1093493|P4|Overall Study|Lost to Follow-up|0
323784|NCT01342926|1093494|P3|Overall Study|Lost to Follow-up|1
323785|NCT01342926|1093495|P2|Overall Study|Lost to Follow-up|1
323786|NCT01342926|1093496|P1|Overall Study|Lost to Follow-up|0
323787|NCT01342926|1093493|P4|Overall Study|Adverse Event|7
323788|NCT01342926|1093494|P3|Overall Study|Adverse Event|10
323789|NCT01342926|1093495|P2|Overall Study|Adverse Event|8
323790|NCT01342926|1093496|P1|Overall Study|Adverse Event|5
323791|NCT01342913|1093576|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
323792|NCT01342913|1093577|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
323793|NCT01342913|1093578|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
323794|NCT01342913|1093576|P3|Double-Blind Treatment Period|Physician Decision|0
323795|NCT01342913|1093577|P2|Double-Blind Treatment Period|Physician Decision|2
323796|NCT01342913|1093578|P1|Double-Blind Treatment Period|Physician Decision|0
323797|NCT01342913|1093576|P3|Double-Blind Treatment Period|Lost to Follow-up|3
323798|NCT01342913|1093577|P2|Double-Blind Treatment Period|Lost to Follow-up|1
323799|NCT01342913|1093578|P1|Double-Blind Treatment Period|Lost to Follow-up|0
323800|NCT01342913|1093576|P3|Double-Blind Treatment Period|Protocol Violation|9
323801|NCT01342913|1093577|P2|Double-Blind Treatment Period|Protocol Violation|6
323802|NCT01342913|1093578|P1|Double-Blind Treatment Period|Protocol Violation|0
323803|NCT01342913|1093576|P3|Double-Blind Treatment Period|Lack of Efficacy|3
323804|NCT01342913|1093577|P2|Double-Blind Treatment Period|Lack of Efficacy|2
323805|NCT01342913|1093578|P1|Double-Blind Treatment Period|Lack of Efficacy|0
323806|NCT01342913|1093576|P3|Double-Blind Treatment Period|Adverse Event|6
323807|NCT01342913|1093577|P2|Double-Blind Treatment Period|Adverse Event|3
323808|NCT01342913|1093578|P1|Double-Blind Treatment Period|Adverse Event|0
323809|NCT01342913|1093576|P3|2-week Run-in Period|Continuation Criteria Not Met|0
323810|NCT01342913|1093577|P2|2-week Run-in Period|Continuation Criteria Not Met|0
323811|NCT01342913|1093578|P1|2-week Run-in Period|Continuation Criteria Not Met|88
323812|NCT01342913|1093576|P3|2-week Run-in Period|Protocol Violation|0
323813|NCT01342913|1093577|P2|2-week Run-in Period|Protocol Violation|0
323814|NCT01342913|1093578|P1|2-week Run-in Period|Protocol Violation|5
323815|NCT01342913|1093576|P3|2-week Run-in Period|Adverse Event|0
323816|NCT01342913|1093577|P2|2-week Run-in Period|Adverse Event|0
323817|NCT01342913|1093578|P1|2-week Run-in Period|Adverse Event|2
323818|NCT01342913|1093576|P3|2-week Run-in Period|Withdrawal by Subject|0
323819|NCT01342913|1093577|P2|2-week Run-in Period|Withdrawal by Subject|0
323820|NCT01342913|1093578|P1|2-week Run-in Period|Withdrawal by Subject|7
323821|NCT01342913|1093576|P3|2-week Run-in Period|Physician Decision|0
323822|NCT01342913|1093577|P2|2-week Run-in Period|Physician Decision|0
323823|NCT01342913|1093578|P1|2-week Run-in Period|Physician Decision|6
323824|NCT01342913|1093576|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
323825|NCT01342913|1093577|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
323826|NCT01342913|1093578|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
323827|NCT01342887|1093588|P1|Overall Study|Death|2
323828|NCT01342640|1093629|P1|Overall Study|Other|1
323829|NCT01342640|1093629|P1|Overall Study|Lost to Follow-up|21
323830|NCT01342640|1093629|P1|Overall Study|Protocol Violation|16
323831|NCT01342640|1093629|P1|Overall Study|Adverse Event|3
323832|NCT01342510|1093724|P4|Overall Study|Protocol Violation|11
323833|NCT01342510|1093725|P3|Overall Study|Protocol Violation|13
323834|NCT01342510|1093726|P2|Overall Study|Protocol Violation|6
323835|NCT01342510|1093727|P1|Overall Study|Protocol Violation|12
323836|NCT01342484|1093740|P3|Overall Study|Withdrawal by Subject|0
323837|NCT01342484|1093741|P2|Overall Study|Withdrawal by Subject|0
323838|NCT01342484|1093742|P1|Overall Study|Withdrawal by Subject|1
323839|NCT01342484|1093740|P3|Overall Study|Protocol Violation|1
323840|NCT01342484|1093741|P2|Overall Study|Protocol Violation|0
323841|NCT01342484|1093742|P1|Overall Study|Protocol Violation|0
323842|NCT01342484|1093740|P3|Overall Study|Other Reasons|0
323843|NCT01342484|1093741|P2|Overall Study|Other Reasons|0
323844|NCT01342484|1093742|P1|Overall Study|Other Reasons|1
323845|NCT01342445|1093798|P2|Overall Study|Experienced side effects|2
323846|NCT01342445|1093799|P1|Overall Study|Experienced side effects|0
323847|NCT01342341|1093815|P2|Overall Study|Lost to Follow-up|4
323848|NCT01342341|1093816|P1|Overall Study|Lost to Follow-up|4
323849|NCT01342211|1093827|P5|Overall Study|Randomized, but not Treated|1
323850|NCT01342211|1093828|P4|Overall Study|Randomized, but not Treated|0
323851|NCT01342211|1093829|P3|Overall Study|Randomized, but not Treated|0
323852|NCT01342211|1093830|P2|Overall Study|Randomized, but not Treated|2
323853|NCT01342211|1093831|P1|Overall Study|Randomized, but not Treated|0
323854|NCT01342211|1093827|P5|Overall Study|Withdrawal by Subject|0
323855|NCT01342211|1093828|P4|Overall Study|Withdrawal by Subject|1
323856|NCT01342211|1093829|P3|Overall Study|Withdrawal by Subject|0
323857|NCT01342211|1093830|P2|Overall Study|Withdrawal by Subject|0
323858|NCT01342211|1093831|P1|Overall Study|Withdrawal by Subject|0
323859|NCT01342211|1093827|P5|Overall Study|Adverse Event|1
323860|NCT01342211|1093828|P4|Overall Study|Adverse Event|0
323861|NCT01342211|1093829|P3|Overall Study|Adverse Event|0
323862|NCT01342211|1093830|P2|Overall Study|Adverse Event|0
323863|NCT01342211|1093831|P1|Overall Study|Adverse Event|0
323864|NCT01342211|1093827|P5|Overall Study|Lost to Follow-up|0
323865|NCT01342211|1093828|P4|Overall Study|Lost to Follow-up|1
323866|NCT01342211|1093829|P3|Overall Study|Lost to Follow-up|0
323867|NCT01342211|1093830|P2|Overall Study|Lost to Follow-up|0
323868|NCT01342211|1093831|P1|Overall Study|Lost to Follow-up|0
323869|NCT01342094|1093912|P2|Overall Study|Withdrawal by Subject|2
323870|NCT01342094|1093913|P1|Overall Study|Withdrawal by Subject|0
323871|NCT01342094|1093912|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
323872|NCT01342094|1093913|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
323873|NCT01342094|1093912|P2|Overall Study|Adverse Event|0
323874|NCT01342094|1093913|P1|Overall Study|Adverse Event|5
323875|NCT01342081|1093922|P3|Overall Study|Withdrawal by Subject|0
323876|NCT01342081|1093923|P2|Overall Study|Withdrawal by Subject|1
323877|NCT01342081|1093924|P1|Overall Study|Withdrawal by Subject|1
323878|NCT01342081|1093922|P3|Overall Study|Physician Decision|0
323879|NCT01342081|1093923|P2|Overall Study|Physician Decision|1
323880|NCT01342081|1093924|P1|Overall Study|Physician Decision|0
323881|NCT01342081|1093922|P3|Overall Study|Adverse Event|0
323882|NCT01342081|1093923|P2|Overall Study|Adverse Event|0
323883|NCT01342081|1093924|P1|Overall Study|Adverse Event|1
323884|NCT01342081|1093922|P3|Overall Study|Did not receive allocated intervention|1
323885|NCT01342081|1093923|P2|Overall Study|Did not receive allocated intervention|0
323886|NCT01342081|1093924|P1|Overall Study|Did not receive allocated intervention|0
323887|NCT01341990|1093943|P2|Overall Study|Withdrawal by Subject|0
323888|NCT01341990|1093944|P1|Overall Study|Withdrawal by Subject|2
323889|NCT01341990|1093943|P2|Overall Study|Torn Study Lens|0
323890|NCT01341990|1093944|P1|Overall Study|Torn Study Lens|1
323891|NCT01341990|1093943|P2|Overall Study|Adverse Event|1
323892|NCT01341990|1093944|P1|Overall Study|Adverse Event|0
323893|NCT01341782|1093968|P2|Overall Study|Other|0
323894|NCT01341782|1093969|P1|Overall Study|Other|5
323895|NCT01341782|1093968|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
323896|NCT01341782|1093969|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
323897|NCT01341782|1093968|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
323898|NCT01341782|1093969|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
323899|NCT01341782|1093968|P2|Overall Study|Missed 3 consecutive doses|4
323900|NCT01341782|1093969|P1|Overall Study|Missed 3 consecutive doses|0
323901|NCT01341782|1093968|P2|Overall Study|Withdrawal by Subject|5
323902|NCT01341782|1093969|P1|Overall Study|Withdrawal by Subject|6
323903|NCT01341782|1093968|P2|Overall Study|Adverse Event|1
323904|NCT01341782|1093969|P1|Overall Study|Adverse Event|1
323905|NCT01341587|1094009|P2|Overall Study|stopped using the meters|10
323906|NCT01341587|1094010|P1|Overall Study|stopped using the meters|2
323907|NCT01341587|1094009|P2|Overall Study|Lost to Follow-up|0
323908|NCT01341587|1094010|P1|Overall Study|Lost to Follow-up|2
323909|NCT01340937|1094043|P4|Period 3: Toddler Vaccinations|Technical problem|0
323910|NCT01340937|1094044|P3|Period 3: Toddler Vaccinations|Technical problem|1
323911|NCT01340937|1094045|P2|Period 3: Toddler Vaccinations|Technical problem|1
323912|NCT01340937|1094046|P1|Period 3: Toddler Vaccinations|Technical problem|1
323913|NCT01340937|1094043|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
323914|NCT01340937|1094044|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
323915|NCT01340937|1094045|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
323916|NCT01340937|1094046|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
323917|NCT01340937|1094043|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
323918|NCT01340937|1094044|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
323919|NCT01340937|1094045|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
323920|NCT01340937|1094046|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
323921|NCT01340937|1094043|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
323922|NCT01340937|1094044|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
323923|NCT01340937|1094045|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
323924|NCT01340937|1094046|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
323925|NCT01340937|1094043|P4|Period 2: Interim Period|Technical problems|3
323926|NCT01340937|1094044|P3|Period 2: Interim Period|Technical problems|6
323927|NCT01340937|1094045|P2|Period 2: Interim Period|Technical problems|4
323928|NCT01340937|1094046|P1|Period 2: Interim Period|Technical problems|4
323929|NCT01340937|1094043|P4|Period 2: Interim Period|Protocol Violation|3
323930|NCT01340937|1094044|P3|Period 2: Interim Period|Protocol Violation|6
323931|NCT01340937|1094045|P2|Period 2: Interim Period|Protocol Violation|3
323932|NCT01340937|1094046|P1|Period 2: Interim Period|Protocol Violation|5
323933|NCT01340937|1094043|P4|Period 2: Interim Period|Physician Decision|0
323934|NCT01340937|1094044|P3|Period 2: Interim Period|Physician Decision|1
323935|NCT01340937|1094045|P2|Period 2: Interim Period|Physician Decision|1
323936|NCT01340937|1094046|P1|Period 2: Interim Period|Physician Decision|0
323937|NCT01340937|1094043|P4|Period 2: Interim Period|Lost to Follow-up|23
323938|NCT01340937|1094044|P3|Period 2: Interim Period|Lost to Follow-up|53
323939|NCT01340937|1094045|P2|Period 2: Interim Period|Lost to Follow-up|48
323940|NCT01340937|1094046|P1|Period 2: Interim Period|Lost to Follow-up|29
323941|NCT01340937|1094043|P4|Period 2: Interim Period|Adverse Event|0
323942|NCT01340937|1094044|P3|Period 2: Interim Period|Adverse Event|1
323943|NCT01340937|1094045|P2|Period 2: Interim Period|Adverse Event|0
323944|NCT01340937|1094046|P1|Period 2: Interim Period|Adverse Event|1
323945|NCT01340937|1094043|P4|Period 2: Interim Period|Withdrawal by Subject|12
323946|NCT01340937|1094044|P3|Period 2: Interim Period|Withdrawal by Subject|17
323947|NCT01340937|1094045|P2|Period 2: Interim Period|Withdrawal by Subject|23
323948|NCT01340937|1094046|P1|Period 2: Interim Period|Withdrawal by Subject|28
323949|NCT01340937|1094043|P4|Period 1: Infant Series|Randomized but not vaccinated|1
323950|NCT01340937|1094044|P3|Period 1: Infant Series|Randomized but not vaccinated|2
323951|NCT01340937|1094045|P2|Period 1: Infant Series|Randomized but not vaccinated|5
323952|NCT01340937|1094046|P1|Period 1: Infant Series|Randomized but not vaccinated|0
323953|NCT01340937|1094043|P4|Period 1: Infant Series|Withdrawal by Subject|15
323954|NCT01340937|1094044|P3|Period 1: Infant Series|Withdrawal by Subject|30
323955|NCT01340937|1094045|P2|Period 1: Infant Series|Withdrawal by Subject|32
323956|NCT01340937|1094046|P1|Period 1: Infant Series|Withdrawal by Subject|33
323957|NCT01340937|1094043|P4|Period 1: Infant Series|Protocol Violation|3
323958|NCT01340937|1094044|P3|Period 1: Infant Series|Protocol Violation|4
323959|NCT01340937|1094045|P2|Period 1: Infant Series|Protocol Violation|4
323960|NCT01340937|1094046|P1|Period 1: Infant Series|Protocol Violation|1
323961|NCT01340937|1094043|P4|Period 1: Infant Series|Physician Decision|0
323962|NCT01340937|1094044|P3|Period 1: Infant Series|Physician Decision|1
323963|NCT01340937|1094045|P2|Period 1: Infant Series|Physician Decision|3
323964|NCT01340937|1094046|P1|Period 1: Infant Series|Physician Decision|2
323965|NCT01340937|1094043|P4|Period 1: Infant Series|Lost to Follow-up|13
323966|NCT01340937|1094044|P3|Period 1: Infant Series|Lost to Follow-up|12
323967|NCT01340937|1094045|P2|Period 1: Infant Series|Lost to Follow-up|14
323968|NCT01340937|1094046|P1|Period 1: Infant Series|Lost to Follow-up|20
323969|NCT01340937|1094043|P4|Period 1: Infant Series|Death|0
323970|NCT01340937|1094044|P3|Period 1: Infant Series|Death|2
323971|NCT01340937|1094045|P2|Period 1: Infant Series|Death|0
323972|NCT01340937|1094046|P1|Period 1: Infant Series|Death|2
323973|NCT01340937|1094043|P4|Period 1: Infant Series|Adverse Event|0
323974|NCT01340937|1094044|P3|Period 1: Infant Series|Adverse Event|4
323975|NCT01340937|1094045|P2|Period 1: Infant Series|Adverse Event|1
323976|NCT01340937|1094046|P1|Period 1: Infant Series|Adverse Event|0
323977|NCT01340937|1094043|P4|Period 1: Infant Series|Other protocol criterion not met|0
323978|NCT01340937|1094044|P3|Period 1: Infant Series|Other protocol criterion not met|1
323979|NCT01340937|1094045|P2|Period 1: Infant Series|Other protocol criterion not met|1
323980|NCT01340937|1094046|P1|Period 1: Infant Series|Other protocol criterion not met|0
323981|NCT01340794|1094205|P2|Overall Study|Withdrawal by Subject|1
323982|NCT01340794|1094206|P1|Overall Study|Withdrawal by Subject|0
323983|NCT01340768|1094222|P2|Overall Study|Other|0
323984|NCT01340768|1094223|P1|Overall Study|Other|2
323985|NCT01340768|1094222|P2|Overall Study|Withdrawal by Subject|1
323986|NCT01340768|1094223|P1|Overall Study|Withdrawal by Subject|5
323987|NCT01340768|1094222|P2|Overall Study|Lost to Follow-up|4
323988|NCT01340768|1094223|P1|Overall Study|Lost to Follow-up|10
323989|NCT01340664|1094234|P3|Overall Study|Not specified|2
323990|NCT01340664|1094235|P2|Overall Study|Not specified|2
323991|NCT01340664|1094236|P1|Overall Study|Not specified|1
323992|NCT01340664|1094234|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
323993|NCT01340664|1094235|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
323994|NCT01340664|1094236|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
323995|NCT01340664|1094234|P3|Overall Study|Glycemic withdrawal criteria|0
323996|NCT01340664|1094235|P2|Overall Study|Glycemic withdrawal criteria|0
323997|NCT01340664|1094236|P1|Overall Study|Glycemic withdrawal criteria|2
323998|NCT01340664|1094234|P3|Overall Study|Withdrawal by Subject|0
323999|NCT01340664|1094235|P2|Overall Study|Withdrawal by Subject|4
324000|NCT01340664|1094236|P1|Overall Study|Withdrawal by Subject|2
324001|NCT01340664|1094234|P3|Overall Study|Lost to Follow-up|2
324002|NCT01340664|1094235|P2|Overall Study|Lost to Follow-up|0
324003|NCT01340664|1094236|P1|Overall Study|Lost to Follow-up|2
324004|NCT01340664|1094234|P3|Overall Study|Adverse Event|7
324005|NCT01340664|1094235|P2|Overall Study|Adverse Event|1
324006|NCT01340664|1094236|P1|Overall Study|Adverse Event|0
324007|NCT01340651|1094253|P1|Overall Study|Commercial Supply per Sponsor|12
324008|NCT01340651|1094253|P1|Overall Study|Consent Withdrawn|2
324009|NCT01340651|1094253|P1|Overall Study|Adverse Event|3
324010|NCT01340625|1094269|P2|Washout Period of 28 Days|Withdrawal by Subject|0
324011|NCT01340625|1094270|P1|Washout Period of 28 Days|Withdrawal by Subject|1
324012|NCT01340625|1094269|P2|First Intervention|Adverse Event|0
324013|NCT01340625|1094270|P1|First Intervention|Adverse Event|1
324014|NCT01340495|1094375|P1|Overall Study|Withdrawal by Subject|1
324015|NCT01340300|1094385|P4|Overall Study|Unrelated sickness|1
324016|NCT01340300|1094386|P3|Overall Study|Unrelated sickness|0
324017|NCT01340300|1094387|P2|Overall Study|Unrelated sickness|2
324018|NCT01340300|1094388|P1|Overall Study|Unrelated sickness|0
324019|NCT01340300|1094385|P4|Overall Study|Physician Decision|0
324020|NCT01340300|1094386|P3|Overall Study|Physician Decision|0
324021|NCT01340300|1094387|P2|Overall Study|Physician Decision|1
324022|NCT01340300|1094388|P1|Overall Study|Physician Decision|0
324023|NCT01340300|1094385|P4|Overall Study|Adverse Event|0
324024|NCT01340300|1094386|P3|Overall Study|Adverse Event|4
324025|NCT01340300|1094387|P2|Overall Study|Adverse Event|0
324026|NCT01340300|1094388|P1|Overall Study|Adverse Event|1
324027|NCT01340300|1094385|P4|Overall Study|Withdrawal by Subject|3
324028|NCT01340300|1094386|P3|Overall Study|Withdrawal by Subject|6
324029|NCT01340300|1094387|P2|Overall Study|Withdrawal by Subject|6
324030|NCT01340300|1094388|P1|Overall Study|Withdrawal by Subject|5
324031|NCT01340300|1094385|P4|Overall Study|Lost to Follow-up|10
324032|NCT01340300|1094386|P3|Overall Study|Lost to Follow-up|5
324033|NCT01340300|1094387|P2|Overall Study|Lost to Follow-up|0
324034|NCT01340300|1094388|P1|Overall Study|Lost to Follow-up|3
324035|NCT01340209|1094421|P3|Overall Study|Other reason not defined above|4
324036|NCT01340209|1094422|P2|Overall Study|Other reason not defined above|5
324037|NCT01340209|1094423|P1|Overall Study|Other reason not defined above|3
324038|NCT01340209|1094421|P3|Overall Study|Withdrawal by Subject|1
324039|NCT01340209|1094422|P2|Overall Study|Withdrawal by Subject|0
324040|NCT01340209|1094423|P1|Overall Study|Withdrawal by Subject|0
324041|NCT01340209|1094421|P3|Overall Study|Protocol Violation|1
324042|NCT01340209|1094422|P2|Overall Study|Protocol Violation|2
324043|NCT01340209|1094423|P1|Overall Study|Protocol Violation|1
324044|NCT01340209|1094421|P3|Overall Study|Adverse Event|2
324045|NCT01340209|1094422|P2|Overall Study|Adverse Event|1
324046|NCT01340209|1094423|P1|Overall Study|Adverse Event|1
324047|NCT01340196|1094458|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
324048|NCT01340066|1094498|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
324049|NCT01340066|1094499|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
324050|NCT01340066|1094500|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
324051|NCT01340066|1094498|P3|5 Week Double Blind Randomization Period|Physician Decision|0
324052|NCT01340066|1094499|P2|5 Week Double Blind Randomization Period|Physician Decision|1
324053|NCT01340066|1094500|P1|5 Week Double Blind Randomization Period|Physician Decision|0
324054|NCT01340066|1094498|P3|5 Week Double Blind Randomization Period|Adverse Event|2
324055|NCT01340066|1094499|P2|5 Week Double Blind Randomization Period|Adverse Event|2
324056|NCT01340066|1094500|P1|5 Week Double Blind Randomization Period|Adverse Event|0
324057|NCT01340066|1094498|P3|Placebo Run in Period|Screen Failures|0
324058|NCT01340066|1094499|P2|Placebo Run in Period|Screen Failures|0
324059|NCT01340066|1094500|P1|Placebo Run in Period|Screen Failures|27
324060|NCT01340027|1094519|P12|Overall Study|Miscellaneous|0
324061|NCT01340027|1094520|P11|Overall Study|Miscellaneous|1
324062|NCT01340027|1094521|P10|Overall Study|Miscellaneous|0
324063|NCT01340027|1094522|P9|Overall Study|Miscellaneous|0
324064|NCT01340027|1094523|P8|Overall Study|Miscellaneous|0
324065|NCT01340027|1094524|P7|Overall Study|Miscellaneous|0
324066|NCT01340027|1094525|P6|Overall Study|Miscellaneous|0
324067|NCT01340027|1094526|P5|Overall Study|Miscellaneous|0
324068|NCT01340027|1094527|P4|Overall Study|Miscellaneous|1
324069|NCT01340027|1094528|P3|Overall Study|Miscellaneous|0
324070|NCT01340027|1094529|P2|Overall Study|Miscellaneous|0
324071|NCT01340027|1094530|P1|Overall Study|Miscellaneous|0
324072|NCT01340027|1094519|P12|Overall Study|Withdrawal by Subject|1
324073|NCT01340027|1094520|P11|Overall Study|Withdrawal by Subject|0
324074|NCT01340027|1094521|P10|Overall Study|Withdrawal by Subject|2
324075|NCT01340027|1094522|P9|Overall Study|Withdrawal by Subject|1
324076|NCT01340027|1094523|P8|Overall Study|Withdrawal by Subject|4
324077|NCT01340027|1094524|P7|Overall Study|Withdrawal by Subject|3
324078|NCT01340027|1094525|P6|Overall Study|Withdrawal by Subject|2
324079|NCT01340027|1094526|P5|Overall Study|Withdrawal by Subject|3
324080|NCT01340027|1094527|P4|Overall Study|Withdrawal by Subject|3
324081|NCT01340027|1094528|P3|Overall Study|Withdrawal by Subject|1
324082|NCT01340027|1094529|P2|Overall Study|Withdrawal by Subject|3
324083|NCT01340027|1094530|P1|Overall Study|Withdrawal by Subject|4
324084|NCT01340027|1094519|P12|Overall Study|Protocol Violation|0
324085|NCT01340027|1094520|P11|Overall Study|Protocol Violation|0
324086|NCT01340027|1094521|P10|Overall Study|Protocol Violation|2
324087|NCT01340027|1094522|P9|Overall Study|Protocol Violation|2
324088|NCT01340027|1094523|P8|Overall Study|Protocol Violation|1
324089|NCT01340027|1094524|P7|Overall Study|Protocol Violation|0
324090|NCT01340027|1094525|P6|Overall Study|Protocol Violation|0
324091|NCT01340027|1094526|P5|Overall Study|Protocol Violation|6
324092|NCT01340027|1094527|P4|Overall Study|Protocol Violation|0
324093|NCT01340027|1094528|P3|Overall Study|Protocol Violation|0
324094|NCT01340027|1094529|P2|Overall Study|Protocol Violation|2
324095|NCT01340027|1094530|P1|Overall Study|Protocol Violation|1
324096|NCT01340027|1094519|P12|Overall Study|Lost to Follow-up|0
324097|NCT01340027|1094520|P11|Overall Study|Lost to Follow-up|0
324098|NCT01340027|1094521|P10|Overall Study|Lost to Follow-up|1
324099|NCT01340027|1094522|P9|Overall Study|Lost to Follow-up|0
324100|NCT01340027|1094523|P8|Overall Study|Lost to Follow-up|0
324101|NCT01340027|1094524|P7|Overall Study|Lost to Follow-up|1
324102|NCT01340027|1094525|P6|Overall Study|Lost to Follow-up|0
324103|NCT01340027|1094526|P5|Overall Study|Lost to Follow-up|0
324104|NCT01340027|1094527|P4|Overall Study|Lost to Follow-up|0
324105|NCT01340027|1094528|P3|Overall Study|Lost to Follow-up|0
324106|NCT01340027|1094529|P2|Overall Study|Lost to Follow-up|1
324107|NCT01340027|1094530|P1|Overall Study|Lost to Follow-up|0
324108|NCT01340027|1094519|P12|Overall Study|Lack of Efficacy|0
324109|NCT01340027|1094520|P11|Overall Study|Lack of Efficacy|0
324110|NCT01340027|1094521|P10|Overall Study|Lack of Efficacy|0
324111|NCT01340027|1094522|P9|Overall Study|Lack of Efficacy|1
324112|NCT01340027|1094523|P8|Overall Study|Lack of Efficacy|1
324113|NCT01340027|1094524|P7|Overall Study|Lack of Efficacy|1
324114|NCT01340027|1094525|P6|Overall Study|Lack of Efficacy|0
324115|NCT01340027|1094526|P5|Overall Study|Lack of Efficacy|0
324116|NCT01340027|1094527|P4|Overall Study|Lack of Efficacy|0
324117|NCT01340027|1094528|P3|Overall Study|Lack of Efficacy|0
324118|NCT01340027|1094529|P2|Overall Study|Lack of Efficacy|0
324119|NCT01340027|1094530|P1|Overall Study|Lack of Efficacy|0
324120|NCT01340027|1094519|P12|Overall Study|Adverse Event|3
324121|NCT01340027|1094520|P11|Overall Study|Adverse Event|1
324122|NCT01340027|1094521|P10|Overall Study|Adverse Event|1
324123|NCT01340027|1094522|P9|Overall Study|Adverse Event|4
324124|NCT01340027|1094523|P8|Overall Study|Adverse Event|1
324125|NCT01340027|1094524|P7|Overall Study|Adverse Event|2
324126|NCT01340027|1094525|P6|Overall Study|Adverse Event|2
324127|NCT01340027|1094526|P5|Overall Study|Adverse Event|1
324128|NCT01340027|1094527|P4|Overall Study|Adverse Event|0
324129|NCT01340027|1094528|P3|Overall Study|Adverse Event|2
324130|NCT01340027|1094529|P2|Overall Study|Adverse Event|1
324131|NCT01340027|1094530|P1|Overall Study|Adverse Event|0
324132|NCT01340027|1094519|P12|Overall Study|Randomized but Never Received Study Drug|0
324133|NCT01340027|1094520|P11|Overall Study|Randomized but Never Received Study Drug|0
324134|NCT01340027|1094521|P10|Overall Study|Randomized but Never Received Study Drug|0
324135|NCT01340027|1094522|P9|Overall Study|Randomized but Never Received Study Drug|0
324136|NCT01340027|1094523|P8|Overall Study|Randomized but Never Received Study Drug|0
324137|NCT01340027|1094524|P7|Overall Study|Randomized but Never Received Study Drug|0
324138|NCT01340027|1094525|P6|Overall Study|Randomized but Never Received Study Drug|0
324139|NCT01340027|1094526|P5|Overall Study|Randomized but Never Received Study Drug|0
324140|NCT01340027|1094527|P4|Overall Study|Randomized but Never Received Study Drug|0
324141|NCT01340027|1094528|P3|Overall Study|Randomized but Never Received Study Drug|1
324142|NCT01340027|1094529|P2|Overall Study|Randomized but Never Received Study Drug|0
324143|NCT01340027|1094530|P1|Overall Study|Randomized but Never Received Study Drug|0
324144|NCT01340014|1094906|P2|Period 2, Second 7 Days|Adverse Event|1
324145|NCT01340014|1094907|P1|Period 2, Second 7 Days|Adverse Event|0
324146|NCT01340014|1094906|P2|Period 1, First 7 Days|Personal Reasons|0
324147|NCT01340014|1094907|P1|Period 1, First 7 Days|Personal Reasons|1
324148|NCT01340014|1094906|P2|Period 1, First 7 Days|Adverse Event|0
324149|NCT01340014|1094907|P1|Period 1, First 7 Days|Adverse Event|1
324150|NCT01339923|1094928|P7|Overall Study|Withdrawal by Subject|2
324151|NCT01339923|1094929|P6|Overall Study|Withdrawal by Subject|3
324152|NCT01339923|1094930|P5|Overall Study|Withdrawal by Subject|4
324153|NCT01339923|1094931|P4|Overall Study|Withdrawal by Subject|1
324154|NCT01339923|1094932|P3|Overall Study|Withdrawal by Subject|6
324155|NCT01339923|1094933|P2|Overall Study|Withdrawal by Subject|11
324156|NCT01339923|1094934|P1|Overall Study|Withdrawal by Subject|7
324157|NCT01339923|1094928|P7|Overall Study|Unable to Classify|5
324158|NCT01339923|1094929|P6|Overall Study|Unable to Classify|1
324159|NCT01339923|1094930|P5|Overall Study|Unable to Classify|0
324160|NCT01339923|1094931|P4|Overall Study|Unable to Classify|0
324161|NCT01339923|1094932|P3|Overall Study|Unable to Classify|1
324162|NCT01339923|1094933|P2|Overall Study|Unable to Classify|0
324163|NCT01339923|1094934|P1|Overall Study|Unable to Classify|1
324164|NCT01339923|1094928|P7|Overall Study|Protocol Violation|1
324165|NCT01339923|1094929|P6|Overall Study|Protocol Violation|3
324166|NCT01339923|1094930|P5|Overall Study|Protocol Violation|0
324167|NCT01339923|1094931|P4|Overall Study|Protocol Violation|0
324168|NCT01339923|1094932|P3|Overall Study|Protocol Violation|0
324169|NCT01339923|1094933|P2|Overall Study|Protocol Violation|0
324170|NCT01339923|1094934|P1|Overall Study|Protocol Violation|0
324171|NCT01339923|1094928|P7|Overall Study|Lost to Follow-up|5
324172|NCT01339923|1094929|P6|Overall Study|Lost to Follow-up|1
324173|NCT01339923|1094930|P5|Overall Study|Lost to Follow-up|1
324174|NCT01339923|1094931|P4|Overall Study|Lost to Follow-up|3
324175|NCT01339923|1094932|P3|Overall Study|Lost to Follow-up|0
324176|NCT01339923|1094933|P2|Overall Study|Lost to Follow-up|4
324177|NCT01339923|1094934|P1|Overall Study|Lost to Follow-up|4
324178|NCT01339923|1094928|P7|Overall Study|Inappropriate Enrollment|0
324179|NCT01339923|1094929|P6|Overall Study|Inappropriate Enrollment|1
324180|NCT01339923|1094930|P5|Overall Study|Inappropriate Enrollment|0
324181|NCT01339923|1094931|P4|Overall Study|Inappropriate Enrollment|0
324182|NCT01339923|1094932|P3|Overall Study|Inappropriate Enrollment|0
324183|NCT01339923|1094933|P2|Overall Study|Inappropriate Enrollment|0
324184|NCT01339923|1094934|P1|Overall Study|Inappropriate Enrollment|1
324185|NCT01339923|1094928|P7|Overall Study|Adverse Event|1
324186|NCT01339923|1094929|P6|Overall Study|Adverse Event|0
324187|NCT01339923|1094930|P5|Overall Study|Adverse Event|0
324188|NCT01339923|1094931|P4|Overall Study|Adverse Event|0
324189|NCT01339923|1094932|P3|Overall Study|Adverse Event|1
324190|NCT01339923|1094933|P2|Overall Study|Adverse Event|1
324191|NCT01339923|1094934|P1|Overall Study|Adverse Event|1
324192|NCT01339910|1095005|P2|Overall Study|Disease relapse|4
324193|NCT01339910|1095006|P1|Overall Study|Disease relapse|1
324194|NCT01339910|1095005|P2|Overall Study|Physician Decision|0
324195|NCT01339910|1095006|P1|Overall Study|Physician Decision|1
324196|NCT01339910|1095005|P2|Overall Study|Withdrawal by Subject|0
324197|NCT01339910|1095006|P1|Overall Study|Withdrawal by Subject|1
324198|NCT01339897|1095044|P4|Overall Study|Adverse Event|1
324199|NCT01339897|1095045|P3|Overall Study|Adverse Event|0
324200|NCT01339897|1095046|P2|Overall Study|Adverse Event|0
324201|NCT01339897|1095047|P1|Overall Study|Adverse Event|1
324202|NCT01339832|1095073|P1|Overall Study|Death|11
324203|NCT01339832|1095073|P1|Overall Study|Lost to Follow-up|3
324204|NCT01339429|1095084|P1|Overall Study|Physician Decision|3
324205|NCT01339429|1095084|P1|Overall Study|Withdrawal by Subject|1
324206|NCT01339390|1095124|P2|Overall Study|Lost to Follow-up|127
324207|NCT01339390|1095125|P1|Overall Study|Lost to Follow-up|125
324208|NCT01339390|1095124|P2|Overall Study|Death|29
324209|NCT01339390|1095125|P1|Overall Study|Death|32
324210|NCT01339052|1095183|P2|Overall Study|Physician Decision|0
324211|NCT01339052|1095184|P1|Overall Study|Physician Decision|1
324212|NCT01339052|1095183|P2|Overall Study|Withdrawal by Subject|3
324213|NCT01339052|1095184|P1|Overall Study|Withdrawal by Subject|0
324214|NCT01339052|1095183|P2|Overall Study|Adverse Event|1
324215|NCT01339052|1095184|P1|Overall Study|Adverse Event|1
324216|NCT01339052|1095183|P2|Overall Study|Disease progression|46
324217|NCT01339052|1095184|P1|Overall Study|Disease progression|13
324218|NCT01339000|1095210|P2|Overall Study|study closed due to lack of drug supply|0
324219|NCT01339000|1095211|P1|Overall Study|study closed due to lack of drug supply|1
324220|NCT01338870|1095231|P6|Overall Study|Adverse Event|1
324221|NCT01338870|1095232|P5|Overall Study|Adverse Event|4
324222|NCT01338870|1095233|P4|Overall Study|Adverse Event|5
324223|NCT01338870|1095234|P3|Overall Study|Adverse Event|1
324224|NCT01338870|1095235|P2|Overall Study|Adverse Event|4
324225|NCT01338870|1095236|P1|Overall Study|Adverse Event|4
324226|NCT01338870|1095231|P6|Overall Study|Protocol Violation|1
324227|NCT01338870|1095232|P5|Overall Study|Protocol Violation|1
324228|NCT01338870|1095233|P4|Overall Study|Protocol Violation|2
324229|NCT01338870|1095234|P3|Overall Study|Protocol Violation|2
324230|NCT01338870|1095235|P2|Overall Study|Protocol Violation|2
324231|NCT01338870|1095236|P1|Overall Study|Protocol Violation|0
324232|NCT01338870|1095231|P6|Overall Study|Other|2
324233|NCT01338870|1095232|P5|Overall Study|Other|0
324234|NCT01338870|1095233|P4|Overall Study|Other|2
324235|NCT01338870|1095234|P3|Overall Study|Other|3
324236|NCT01338870|1095235|P2|Overall Study|Other|3
324237|NCT01338870|1095236|P1|Overall Study|Other|3
324238|NCT01338870|1095231|P6|Overall Study|Withdrawal by Subject|2
324239|NCT01338870|1095232|P5|Overall Study|Withdrawal by Subject|0
324240|NCT01338870|1095233|P4|Overall Study|Withdrawal by Subject|0
324241|NCT01338870|1095234|P3|Overall Study|Withdrawal by Subject|4
324242|NCT01338870|1095235|P2|Overall Study|Withdrawal by Subject|3
324243|NCT01338870|1095236|P1|Overall Study|Withdrawal by Subject|2
324244|NCT01338870|1095231|P6|Overall Study|Lost to Follow-up|0
324245|NCT01338870|1095232|P5|Overall Study|Lost to Follow-up|1
324246|NCT01338870|1095233|P4|Overall Study|Lost to Follow-up|0
324247|NCT01338870|1095234|P3|Overall Study|Lost to Follow-up|1
324248|NCT01338870|1095235|P2|Overall Study|Lost to Follow-up|0
324249|NCT01338870|1095236|P1|Overall Study|Lost to Follow-up|0
324250|NCT01338818|1095291|P1|Overall Study|Protocol Deviation|4
324251|NCT01338818|1095291|P1|Overall Study|Administrative problems|3
324252|NCT01338818|1095291|P1|Overall Study|Lost to Follow-up|4
324253|NCT01338818|1095291|P1|Overall Study|Withdrawal by Subject|11
324254|NCT01338818|1095291|P1|Overall Study|no longer require study drug|1
324255|NCT01338818|1095291|P1|Overall Study|Lack of Efficacy|5
324256|NCT01338818|1095291|P1|Overall Study|Adverse Event|8
324257|NCT01338792|1095297|P1|Overall Study|Withdrawal by Subject|1
324258|NCT01338792|1095297|P1|Overall Study|Death|1
324259|NCT01338792|1095297|P1|Overall Study|Adverse Event|2
324260|NCT01338636|1095312|P1|Overall Study|Withdrawn due to lack of improvement|8
324261|NCT01338610|1095326|P3|Overall Study|Adverse Event|0
324262|NCT01338610|1095327|P2|Overall Study|Adverse Event|0
324263|NCT01338610|1095328|P1|Overall Study|Adverse Event|3
324264|NCT01338610|1095326|P3|Overall Study|Protocol Violation|1
324265|NCT01338610|1095327|P2|Overall Study|Protocol Violation|0
324266|NCT01338610|1095328|P1|Overall Study|Protocol Violation|1
324267|NCT01338610|1095326|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
324268|NCT01338610|1095327|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
324269|NCT01338610|1095328|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
324270|NCT01338493|1095335|P1|12 Months Follow up|Lost to Follow-up|9
324271|NCT01338493|1095335|P1|6 Months Follow up|Missed visit|8
324272|NCT01338493|1095335|P1|6 Months Follow up|Lost to Follow-up|11
324273|NCT01338493|1095335|P1|Discharge|Missed visit|1
324274|NCT01338493|1095335|P1|Discharge|Death|1
324275|NCT01338493|1095335|P1|Enrolled|Patient not implanted|4
324276|NCT01338493|1095335|P1|Enrolled|Withdrawal by Subject|1
324277|NCT01338415|1095342|P2|Overall Study|Other (administrative reason)|0
324278|NCT01338415|1095343|P1|Overall Study|Other (administrative reason)|1
324279|NCT01338415|1095342|P2|Overall Study|Other (PAH not the main etiology of PH)|2
324280|NCT01338415|1095343|P1|Overall Study|Other (PAH not the main etiology of PH)|0
324281|NCT01338415|1095342|P2|Overall Study|Withdrawal by Subject|1
324282|NCT01338415|1095343|P1|Overall Study|Withdrawal by Subject|1
324283|NCT01338415|1095342|P2|Overall Study|Adverse Event|6
324284|NCT01338415|1095343|P1|Overall Study|Adverse Event|8
324285|NCT01338298|1095365|P2|Overall Study|Non-adherence|0
324286|NCT01338298|1095366|P1|Overall Study|Non-adherence|1
324287|NCT01338298|1095365|P2|Overall Study|Depressive symptoms and nausea|0
324288|NCT01338298|1095366|P1|Overall Study|Depressive symptoms and nausea|1
324289|NCT01338298|1095365|P2|Overall Study|Positive symptom worsening|0
324290|NCT01338298|1095366|P1|Overall Study|Positive symptom worsening|1
324291|NCT01338298|1095365|P2|Overall Study|Administrative error|1
324292|NCT01338298|1095366|P1|Overall Study|Administrative error|0
324293|NCT01338298|1095365|P2|Overall Study|Abdominal Pain and scheduled surgery|1
324294|NCT01338298|1095366|P1|Overall Study|Abdominal Pain and scheduled surgery|0
324295|NCT01338298|1095365|P2|Overall Study|Withdrawal by Subject|1
324296|NCT01338298|1095366|P1|Overall Study|Withdrawal by Subject|1
324297|NCT01338025|1095376|P2|Overall Study|Found ineligible after starting|0
324298|NCT01338025|1095377|P1|Overall Study|Found ineligible after starting|1
324299|NCT01338025|1095376|P2|Overall Study|Withdrawal by Subject|2
324300|NCT01338025|1095377|P1|Overall Study|Withdrawal by Subject|0
324301|NCT01338025|1095376|P2|Overall Study|Unexpected closure of study|9
324302|NCT01338025|1095377|P1|Overall Study|Unexpected closure of study|10
324303|NCT01338012|1095389|P1|Overall Study|Study terminated|4
324304|NCT01338012|1095389|P1|Overall Study|Death|4
324305|NCT01337960|1095396|P3|Overall Study|Withdrawal by Subject|0
324306|NCT01337960|1095397|P2|Overall Study|Withdrawal by Subject|0
324307|NCT01337960|1095398|P1|Overall Study|Withdrawal by Subject|1
324308|NCT01337960|1095396|P3|Overall Study|Lost to Follow-up|0
324309|NCT01337960|1095397|P2|Overall Study|Lost to Follow-up|0
324310|NCT01337960|1095398|P1|Overall Study|Lost to Follow-up|1
324311|NCT01337674|1095431|P4|Treatment Period 2|Withdrawal by Subject|0
324312|NCT01337674|1095432|P3|Treatment Period 2|Withdrawal by Subject|1
324313|NCT01337674|1095433|P2|Treatment Period 2|Withdrawal by Subject|0
324314|NCT01337674|1095434|P1|Treatment Period 2|Withdrawal by Subject|0
324315|NCT01337674|1095431|P4|Treatment Period 1|Discontinued due to blood draws|1
324316|NCT01337674|1095432|P3|Treatment Period 1|Discontinued due to blood draws|0
324317|NCT01337674|1095433|P2|Treatment Period 1|Discontinued due to blood draws|0
324318|NCT01337674|1095434|P1|Treatment Period 1|Discontinued due to blood draws|0
324319|NCT01337674|1095431|P4|Treatment Period 1|Adverse Event|0
324320|NCT01337674|1095432|P3|Treatment Period 1|Adverse Event|0
324321|NCT01337674|1095433|P2|Treatment Period 1|Adverse Event|1
324322|NCT01337674|1095434|P1|Treatment Period 1|Adverse Event|0
324323|NCT01337635|1095452|P2|Overall Study|Lost to Follow-up|1
324324|NCT01337635|1095453|P1|Overall Study|Lost to Follow-up|0
324325|NCT01337297|1095501|P2|Overall Study|Lost to Follow-up|3
324326|NCT01337297|1095502|P1|Overall Study|Lost to Follow-up|1
324327|NCT01337297|1095501|P2|Overall Study|They entered to single anodal tDCS|3
324328|NCT01337297|1095502|P1|Overall Study|They entered to single anodal tDCS|4
324329|NCT01337167|1095510|P2|Toddler Vaccinations|Withdrawal by Subject|0
324330|NCT01337167|1095511|P1|Toddler Vaccinations|Withdrawal by Subject|3
324331|NCT01337167|1095510|P2|Toddler Vaccinations|Protocol Violation|1
324332|NCT01337167|1095511|P1|Toddler Vaccinations|Protocol Violation|0
324333|NCT01337167|1095510|P2|Toddler Vaccinations|Lost to Follow-up|12
324334|NCT01337167|1095511|P1|Toddler Vaccinations|Lost to Follow-up|11
324335|NCT01337167|1095510|P2|Interim Period|Other protocol criterion not met|1
324336|NCT01337167|1095511|P1|Interim Period|Other protocol criterion not met|0
324337|NCT01337167|1095510|P2|Interim Period|Withdrawal by Subject|10
324338|NCT01337167|1095511|P1|Interim Period|Withdrawal by Subject|18
324339|NCT01337167|1095510|P2|Interim Period|Protocol Violation|3
324340|NCT01337167|1095511|P1|Interim Period|Protocol Violation|5
324341|NCT01337167|1095510|P2|Interim Period|Physician Decision|3
324342|NCT01337167|1095511|P1|Interim Period|Physician Decision|6
324343|NCT01337167|1095510|P2|Interim Period|Non-compliance with study drug|0
324344|NCT01337167|1095511|P1|Interim Period|Non-compliance with study drug|1
324345|NCT01337167|1095510|P2|Interim Period|Lost to Follow-up|23
324346|NCT01337167|1095511|P1|Interim Period|Lost to Follow-up|51
324347|NCT01337167|1095510|P2|Infant Series|Randomized but not vaccinated|3
324348|NCT01337167|1095511|P1|Infant Series|Randomized but not vaccinated|5
324349|NCT01337167|1095510|P2|Infant Series|Withdrawal by Subject|4
324350|NCT01337167|1095511|P1|Infant Series|Withdrawal by Subject|15
324351|NCT01337167|1095510|P2|Infant Series|Protocol Violation|9
324352|NCT01337167|1095511|P1|Infant Series|Protocol Violation|22
324353|NCT01337167|1095510|P2|Infant Series|Physician Decision|1
324354|NCT01337167|1095511|P1|Infant Series|Physician Decision|3
324355|NCT01337167|1095510|P2|Infant Series|Non-compliance with study drug|1
324356|NCT01337167|1095511|P1|Infant Series|Non-compliance with study drug|2
324357|NCT01337167|1095510|P2|Infant Series|Lost to Follow-up|7
324358|NCT01337167|1095511|P1|Infant Series|Lost to Follow-up|13
324359|NCT01337167|1095510|P2|Infant Series|Death|1
324360|NCT01337167|1095511|P1|Infant Series|Death|1
324361|NCT01337167|1095510|P2|Infant Series|Adverse Event|1
324362|NCT01337167|1095511|P1|Infant Series|Adverse Event|1
324363|NCT01337115|1095579|P2|Overall Study|Protocol Violation|0
324364|NCT01337115|1095580|P1|Overall Study|Protocol Violation|2
324365|NCT01337089|1095592|P1|Overall Study|Lost to Follow-up|2
324366|NCT01337089|1095592|P1|Overall Study|Met Withdrawal Criteria|3
324367|NCT01337089|1095592|P1|Overall Study|Withdrawal by Investigator|33
324368|NCT01337089|1095592|P1|Overall Study|Withdrawal by Subject|129
324369|NCT01337089|1095592|P1|Overall Study|Adverse Event|237
324370|NCT01337050|1095607|P3|Overall Study|Participants refused further follow-up|7
324371|NCT01337050|1095608|P2|Overall Study|Participants refused further follow-up|7
324372|NCT01337050|1095609|P1|Overall Study|Participants refused further follow-up|0
324373|NCT01337050|1095607|P3|Overall Study|Other|8
324374|NCT01337050|1095608|P2|Overall Study|Other|6
324375|NCT01337050|1095609|P1|Overall Study|Other|4
324376|NCT01337050|1095607|P3|Overall Study|Death|4
324377|NCT01337050|1095608|P2|Overall Study|Death|0
324378|NCT01337050|1095609|P1|Overall Study|Death|0
324379|NCT01336972|1095670|P3|Overall Study|Adverse Event|0
324380|NCT01336972|1095671|P2|Overall Study|Adverse Event|1
324381|NCT01336972|1095672|P1|Overall Study|Adverse Event|1
324382|NCT01336894|1095718|P2|Follow-up|Study terminated prematurely|7
324383|NCT01336894|1095719|P1|Follow-up|Study terminated prematurely|2
324384|NCT01336764|1095739|P2|Overall Study|Withdrawal by Subject|5
324385|NCT01336764|1095740|P1|Overall Study|Withdrawal by Subject|5
324386|NCT01336738|1095751|P5|Overall Study|Other|4
324387|NCT01336738|1095752|P4|Overall Study|Other|3
324388|NCT01336738|1095753|P3|Overall Study|Other|2
324389|NCT01336738|1095754|P2|Overall Study|Other|3
324390|NCT01336738|1095755|P1|Overall Study|Other|3
324391|NCT01336738|1095751|P5|Overall Study|Withdrawal by Subject|1
324392|NCT01336738|1095752|P4|Overall Study|Withdrawal by Subject|1
324393|NCT01336738|1095753|P3|Overall Study|Withdrawal by Subject|2
324394|NCT01336738|1095754|P2|Overall Study|Withdrawal by Subject|0
324395|NCT01336738|1095755|P1|Overall Study|Withdrawal by Subject|2
324396|NCT01336738|1095751|P5|Overall Study|Protocol Violation|0
324397|NCT01336738|1095752|P4|Overall Study|Protocol Violation|0
324398|NCT01336738|1095753|P3|Overall Study|Protocol Violation|0
324399|NCT01336738|1095754|P2|Overall Study|Protocol Violation|1
324400|NCT01336738|1095755|P1|Overall Study|Protocol Violation|0
324401|NCT01336738|1095751|P5|Overall Study|Did not meet entrance criteria|0
324402|NCT01336738|1095752|P4|Overall Study|Did not meet entrance criteria|0
324403|NCT01336738|1095753|P3|Overall Study|Did not meet entrance criteria|0
324404|NCT01336738|1095754|P2|Overall Study|Did not meet entrance criteria|1
324405|NCT01336738|1095755|P1|Overall Study|Did not meet entrance criteria|0
324406|NCT01336738|1095751|P5|Overall Study|Lost to Follow-up|2
324407|NCT01336738|1095752|P4|Overall Study|Lost to Follow-up|2
324408|NCT01336738|1095753|P3|Overall Study|Lost to Follow-up|2
324409|NCT01336738|1095754|P2|Overall Study|Lost to Follow-up|1
324410|NCT01336738|1095755|P1|Overall Study|Lost to Follow-up|2
324411|NCT01336738|1095751|P5|Overall Study|Adverse Event|3
324412|NCT01336738|1095752|P4|Overall Study|Adverse Event|1
324413|NCT01336738|1095753|P3|Overall Study|Adverse Event|2
324414|NCT01336738|1095754|P2|Overall Study|Adverse Event|3
324415|NCT01336738|1095755|P1|Overall Study|Adverse Event|0
324416|NCT01336712|1095797|P1|Overall Study|Lack of Efficacy|1
324417|NCT01336712|1095797|P1|Overall Study|Death|2
324418|NCT01336647|1095810|P3|Overall Study|Lost to Follow-up|3
324419|NCT01336647|1095811|P2|Overall Study|Lost to Follow-up|1
324420|NCT01336647|1095812|P1|Overall Study|Lost to Follow-up|4
324421|NCT01336634|1095826|P3|Overall Study|Ongoing|24
324422|NCT01336634|1095827|P2|Overall Study|Ongoing|22
324423|NCT01336634|1095828|P1|Overall Study|Ongoing|15
324424|NCT01336634|1095826|P3|Overall Study|Physician Decision|0
324425|NCT01336634|1095827|P2|Overall Study|Physician Decision|1
324426|NCT01336634|1095828|P1|Overall Study|Physician Decision|1
324427|NCT01336634|1095826|P3|Overall Study|Withdrawal by Subject|1
324428|NCT01336634|1095827|P2|Overall Study|Withdrawal by Subject|0
324429|NCT01336634|1095828|P1|Overall Study|Withdrawal by Subject|6
324430|NCT01336634|1095826|P3|Overall Study|Lost to Follow-up|1
324431|NCT01336634|1095827|P2|Overall Study|Lost to Follow-up|1
324432|NCT01336634|1095828|P1|Overall Study|Lost to Follow-up|2
324433|NCT01336634|1095826|P3|Overall Study|Death|10
324434|NCT01336634|1095827|P2|Overall Study|Death|33
324435|NCT01336634|1095828|P1|Overall Study|Death|60
324436|NCT01336621|1095869|P1|Overall Study|Other: lost to follow up|2
324437|NCT01336621|1095869|P1|Overall Study|Other: Reached stopping criteria|22
324438|NCT01336621|1095869|P1|Overall Study|Physician Decision|3
324439|NCT01336621|1095869|P1|Overall Study|Other: study terminated|11
324440|NCT01336621|1095869|P1|Overall Study|Withdrawal by Subject|28
324441|NCT01336621|1095869|P1|Overall Study|Protocol Violation|12
324442|NCT01336621|1095869|P1|Overall Study|Lack of Efficacy|3
324443|NCT01336621|1095869|P1|Overall Study|Adverse Event|17
324444|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
324445|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
324446|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
324447|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
324448|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Physician Decision|1
324449|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Physician Decision|1
324450|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Physician Decision|3
324451|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Physician Decision|0
324452|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
324453|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
324454|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
324455|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
324456|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
324457|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
324458|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
324459|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
324460|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
324461|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
324462|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
324463|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
324464|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
324465|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
324466|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
324467|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
324468|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
324469|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
324470|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
324471|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
324472|NCT01336608|1095913|P4|24-week, Double-blind Treatment Period|Adverse Event|7
324473|NCT01336608|1095914|P3|24-week, Double-blind Treatment Period|Adverse Event|6
324474|NCT01336608|1095915|P2|24-week, Double-blind Treatment Period|Adverse Event|8
324475|NCT01336608|1095916|P1|24-week, Double-blind Treatment Period|Adverse Event|0
324476|NCT01336608|1095913|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
324477|NCT01336608|1095914|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
324478|NCT01336608|1095915|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
324479|NCT01336608|1095916|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
324480|NCT01336608|1095913|P4|2-week, Single-blind Run-In Period|Physician Decision|0
324481|NCT01336608|1095914|P3|2-week, Single-blind Run-In Period|Physician Decision|0
324482|NCT01336608|1095915|P2|2-week, Single-blind Run-In Period|Physician Decision|0
324483|NCT01336608|1095916|P1|2-week, Single-blind Run-In Period|Physician Decision|1
324484|NCT01336608|1095913|P4|2-week, Single-blind Run-In Period|Adverse Event|0
324485|NCT01336608|1095914|P3|2-week, Single-blind Run-In Period|Adverse Event|0
324486|NCT01336608|1095915|P2|2-week, Single-blind Run-In Period|Adverse Event|0
324487|NCT01336608|1095916|P1|2-week, Single-blind Run-In Period|Adverse Event|1
324488|NCT01336608|1095913|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
324489|NCT01336608|1095914|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
324490|NCT01336608|1095915|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
324491|NCT01336608|1095916|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
324492|NCT01336608|1095913|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
324493|NCT01336608|1095914|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
324494|NCT01336608|1095915|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
324495|NCT01336608|1095916|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
324496|NCT01336569|1095930|P1|Overall Study|Lost to Follow-up|4
324497|NCT01336205|1095972|P2|Overall Study|Did not receive treatment|0
324498|NCT01336205|1095973|P1|Overall Study|Did not receive treatment|4
324499|NCT01336205|1095972|P2|Overall Study|Withdrawal by Subject|38
324500|NCT01336205|1095973|P1|Overall Study|Withdrawal by Subject|72
324501|NCT01336205|1095972|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
324502|NCT01336205|1095973|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
324503|NCT01336205|1095972|P2|Overall Study|Death|1
324504|NCT01336205|1095973|P1|Overall Study|Death|1
324505|NCT01336205|1095972|P2|Overall Study|Adverse Event|6
324506|NCT01336205|1095973|P1|Overall Study|Adverse Event|56
324507|NCT01336205|1095972|P2|Overall Study|Severe noncompliance with protocol|2
324508|NCT01336205|1095973|P1|Overall Study|Severe noncompliance with protocol|9
324509|NCT01336205|1095972|P2|Overall Study|Lack of Efficacy|0
324510|NCT01336205|1095973|P1|Overall Study|Lack of Efficacy|4
324511|NCT01336205|1095972|P2|Overall Study|Study-Specific Withdrawal Criteria|7
324512|NCT01336205|1095973|P1|Overall Study|Study-Specific Withdrawal Criteria|16
324513|NCT01336205|1095972|P2|Overall Study|Lost to Follow-up|20
324514|NCT01336205|1095973|P1|Overall Study|Lost to Follow-up|40
324515|NCT01336205|1095972|P2|Overall Study|Other|9
324516|NCT01336205|1095973|P1|Overall Study|Other|22
324517|NCT01336023|1096001|P3|Week 27 to 52|Unclassified|9
324518|NCT01336023|1096002|P2|Week 27 to 52|Unclassified|18
324519|NCT01336023|1096003|P1|Week 27 to 52|Unclassified|13
324520|NCT01336023|1096001|P3|Week 27 to 52|Withdrawal Criteria|16
324521|NCT01336023|1096002|P2|Week 27 to 52|Withdrawal Criteria|19
324522|NCT01336023|1096003|P1|Week 27 to 52|Withdrawal Criteria|14
324523|NCT01336023|1096001|P3|Week 27 to 52|Protocol Violation|1
324524|NCT01336023|1096002|P2|Week 27 to 52|Protocol Violation|2
324525|NCT01336023|1096003|P1|Week 27 to 52|Protocol Violation|0
324526|NCT01336023|1096001|P3|Week 27 to 52|Adverse Event|2
324527|NCT01336023|1096002|P2|Week 27 to 52|Adverse Event|5
324528|NCT01336023|1096003|P1|Week 27 to 52|Adverse Event|1
324529|NCT01336023|1096001|P3|Week 0 to Week 26|Unclassified|9
324530|NCT01336023|1096002|P2|Week 0 to Week 26|Unclassified|16
324531|NCT01336023|1096003|P1|Week 0 to Week 26|Unclassified|5
324532|NCT01336023|1096001|P3|Week 0 to Week 26|Withdrawal Criteria|40
324533|NCT01336023|1096002|P2|Week 0 to Week 26|Withdrawal Criteria|69
324534|NCT01336023|1096003|P1|Week 0 to Week 26|Withdrawal Criteria|34
324535|NCT01336023|1096001|P3|Week 0 to Week 26|Protocol Violation|0
324536|NCT01336023|1096002|P2|Week 0 to Week 26|Protocol Violation|2
324537|NCT01336023|1096003|P1|Week 0 to Week 26|Protocol Violation|1
324538|NCT01336023|1096001|P3|Week 0 to Week 26|Lack of Efficacy|0
324539|NCT01336023|1096002|P2|Week 0 to Week 26|Lack of Efficacy|1
324540|NCT01336023|1096003|P1|Week 0 to Week 26|Lack of Efficacy|0
324541|NCT01336023|1096001|P3|Week 0 to Week 26|Adverse Event|24
324542|NCT01336023|1096002|P2|Week 0 to Week 26|Adverse Event|10
324543|NCT01336023|1096003|P1|Week 0 to Week 26|Adverse Event|8
324544|NCT01335997|1096024|P2|Period III|Lost to Follow-up|0
324545|NCT01335997|1096025|P1|Period III|Lost to Follow-up|1
324546|NCT01335997|1096024|P2|Period III|Protocol Violation|1
324547|NCT01335997|1096025|P1|Period III|Protocol Violation|0
324548|NCT01335997|1096024|P2|Period III|Study Terminated by Sponsor|76
324549|NCT01335997|1096025|P1|Period III|Study Terminated by Sponsor|77
324550|NCT01335997|1096024|P2|Period III|Adverse Event|2
324551|NCT01335997|1096025|P1|Period III|Adverse Event|0
324552|NCT01335997|1096024|P2|Period I and II|Physician Decision|1
324553|NCT01335997|1096025|P1|Period I and II|Physician Decision|2
324554|NCT01335997|1096024|P2|Period I and II|Protocol Violation|10
324555|NCT01335997|1096025|P1|Period I and II|Protocol Violation|9
324556|NCT01335997|1096024|P2|Period I and II|Study Terminated by Sponsor|415
324557|NCT01335997|1096025|P1|Period I and II|Study Terminated by Sponsor|406
324558|NCT01335997|1096024|P2|Period I and II|Withdrawal by Subject|4
324559|NCT01335997|1096025|P1|Period I and II|Withdrawal by Subject|9
324560|NCT01335997|1096024|P2|Period I and II|Lost to Follow-up|5
324561|NCT01335997|1096025|P1|Period I and II|Lost to Follow-up|3
324562|NCT01335997|1096024|P2|Period I and II|Noncompliance with Study Drug|1
324563|NCT01335997|1096025|P1|Period I and II|Noncompliance with Study Drug|1
324564|NCT01335997|1096024|P2|Period I and II|Adverse Event|43
324565|NCT01335997|1096025|P1|Period I and II|Adverse Event|63
324566|NCT01335971|1096038|P3|Overall Study|Did not complete bronchoscopy|1
324567|NCT01335971|1096039|P2|Overall Study|Did not complete bronchoscopy|1
324568|NCT01335971|1096040|P1|Overall Study|Did not complete bronchoscopy|1
324569|NCT01335971|1096038|P3|Overall Study|Withdrawal by Subject|0
324570|NCT01335971|1096039|P2|Overall Study|Withdrawal by Subject|0
324571|NCT01335971|1096040|P1|Overall Study|Withdrawal by Subject|1
324572|NCT01335698|1096145|P5|Treatment Stage 2|Continuing treatment|6
324573|NCT01335698|1096146|P4|Treatment Stage 2|Continuing treatment|19
324574|NCT01335698|1096147|P3|Treatment Stage 2|Continuing treatment|13
324575|NCT01335698|1096148|P2|Treatment Stage 2|Continuing treatment|3
324576|NCT01335698|1096149|P1|Treatment Stage 2|Continuing treatment|11
324577|NCT01335698|1096145|P5|Treatment Stage 2|Poor compliance/noncompliance|0
324578|NCT01335698|1096146|P4|Treatment Stage 2|Poor compliance/noncompliance|3
324579|NCT01335698|1096147|P3|Treatment Stage 2|Poor compliance/noncompliance|0
324580|NCT01335698|1096148|P2|Treatment Stage 2|Poor compliance/noncompliance|0
324581|NCT01335698|1096149|P1|Treatment Stage 2|Poor compliance/noncompliance|1
324582|NCT01335698|1096145|P5|Treatment Stage 2|Withdrawal by Subject|0
324583|NCT01335698|1096146|P4|Treatment Stage 2|Withdrawal by Subject|0
324584|NCT01335698|1096147|P3|Treatment Stage 2|Withdrawal by Subject|0
324585|NCT01335698|1096148|P2|Treatment Stage 2|Withdrawal by Subject|0
324586|NCT01335698|1096149|P1|Treatment Stage 2|Withdrawal by Subject|1
324587|NCT01335698|1096145|P5|Treatment Stage 2|Adverse Event|0
324588|NCT01335698|1096146|P4|Treatment Stage 2|Adverse Event|1
324589|NCT01335698|1096147|P3|Treatment Stage 2|Adverse Event|0
324590|NCT01335698|1096148|P2|Treatment Stage 2|Adverse Event|0
324591|NCT01335698|1096149|P1|Treatment Stage 2|Adverse Event|0
324592|NCT01335698|1096145|P5|Treatment Stage 2|Lack of Efficacy|0
324593|NCT01335698|1096146|P4|Treatment Stage 2|Lack of Efficacy|1
324594|NCT01335698|1096147|P3|Treatment Stage 2|Lack of Efficacy|3
324595|NCT01335698|1096148|P2|Treatment Stage 2|Lack of Efficacy|1
324596|NCT01335698|1096149|P1|Treatment Stage 2|Lack of Efficacy|2
324597|NCT01335698|1096145|P5|Treatment Stage 1|Not specified|0
324598|NCT01335698|1096146|P4|Treatment Stage 1|Not specified|1
324599|NCT01335698|1096147|P3|Treatment Stage 1|Not specified|0
324600|NCT01335698|1096148|P2|Treatment Stage 1|Not specified|0
324601|NCT01335698|1096149|P1|Treatment Stage 1|Not specified|1
324602|NCT01335698|1096145|P5|Treatment Stage 1|No longer meets study criteria|0
324603|NCT01335698|1096146|P4|Treatment Stage 1|No longer meets study criteria|1
324604|NCT01335698|1096147|P3|Treatment Stage 1|No longer meets study criteria|0
324605|NCT01335698|1096148|P2|Treatment Stage 1|No longer meets study criteria|1
324606|NCT01335698|1096149|P1|Treatment Stage 1|No longer meets study criteria|1
324607|NCT01335698|1096145|P5|Treatment Stage 1|Poor compliance/noncompliance|0
324608|NCT01335698|1096146|P4|Treatment Stage 1|Poor compliance/noncompliance|2
324609|NCT01335698|1096147|P3|Treatment Stage 1|Poor compliance/noncompliance|0
324610|NCT01335698|1096148|P2|Treatment Stage 1|Poor compliance/noncompliance|1
324611|NCT01335698|1096149|P1|Treatment Stage 1|Poor compliance/noncompliance|0
324612|NCT01335698|1096145|P5|Treatment Stage 1|Lost to Follow-up|0
324613|NCT01335698|1096146|P4|Treatment Stage 1|Lost to Follow-up|0
324614|NCT01335698|1096147|P3|Treatment Stage 1|Lost to Follow-up|0
324615|NCT01335698|1096148|P2|Treatment Stage 1|Lost to Follow-up|1
324616|NCT01335698|1096149|P1|Treatment Stage 1|Lost to Follow-up|1
324617|NCT01335698|1096145|P5|Treatment Stage 1|Withdrawal by Subject|0
324618|NCT01335698|1096146|P4|Treatment Stage 1|Withdrawal by Subject|1
324619|NCT01335698|1096147|P3|Treatment Stage 1|Withdrawal by Subject|0
324620|NCT01335698|1096148|P2|Treatment Stage 1|Withdrawal by Subject|2
324621|NCT01335698|1096149|P1|Treatment Stage 1|Withdrawal by Subject|1
324622|NCT01335698|1096145|P5|Treatment Stage 1|Adverse Event|1
324623|NCT01335698|1096146|P4|Treatment Stage 1|Adverse Event|1
324624|NCT01335698|1096147|P3|Treatment Stage 1|Adverse Event|2
324625|NCT01335698|1096148|P2|Treatment Stage 1|Adverse Event|2
324626|NCT01335698|1096149|P1|Treatment Stage 1|Adverse Event|1
324627|NCT01335698|1096145|P5|Treatment Stage 1|Lack of Efficacy|1
324628|NCT01335698|1096146|P4|Treatment Stage 1|Lack of Efficacy|3
324629|NCT01335698|1096147|P3|Treatment Stage 1|Lack of Efficacy|3
324630|NCT01335698|1096148|P2|Treatment Stage 1|Lack of Efficacy|1
324631|NCT01335698|1096149|P1|Treatment Stage 1|Lack of Efficacy|3
324632|NCT01335685|1096200|P8|Overall Study|Reason not Specified|0
324633|NCT01335685|1096201|P7|Overall Study|Reason not Specified|0
324634|NCT01335685|1096202|P6|Overall Study|Reason not Specified|1
324635|NCT01335685|1096203|P5|Overall Study|Reason not Specified|0
324636|NCT01335685|1096204|P4|Overall Study|Reason not Specified|0
324637|NCT01335685|1096205|P3|Overall Study|Reason not Specified|1
324638|NCT01335685|1096206|P2|Overall Study|Reason not Specified|0
324639|NCT01335685|1096207|P1|Overall Study|Reason not Specified|0
324640|NCT01335685|1096200|P8|Overall Study|Withdrawal by Subject|0
324641|NCT01335685|1096201|P7|Overall Study|Withdrawal by Subject|0
324642|NCT01335685|1096202|P6|Overall Study|Withdrawal by Subject|0
324643|NCT01335685|1096203|P5|Overall Study|Withdrawal by Subject|0
324644|NCT01335685|1096204|P4|Overall Study|Withdrawal by Subject|1
324645|NCT01335685|1096205|P3|Overall Study|Withdrawal by Subject|0
324646|NCT01335685|1096206|P2|Overall Study|Withdrawal by Subject|0
324647|NCT01335685|1096207|P1|Overall Study|Withdrawal by Subject|1
324648|NCT01335685|1096200|P8|Overall Study|Study Terminated by Sponsor|3
324649|NCT01335685|1096201|P7|Overall Study|Study Terminated by Sponsor|2
324650|NCT01335685|1096202|P6|Overall Study|Study Terminated by Sponsor|4
324651|NCT01335685|1096203|P5|Overall Study|Study Terminated by Sponsor|0
324652|NCT01335685|1096204|P4|Overall Study|Study Terminated by Sponsor|10
324653|NCT01335685|1096205|P3|Overall Study|Study Terminated by Sponsor|1
324654|NCT01335685|1096206|P2|Overall Study|Study Terminated by Sponsor|1
324655|NCT01335685|1096207|P1|Overall Study|Study Terminated by Sponsor|2
324656|NCT01335477|1096320|P2|Overall Study|Reason other than those stated above|2
324657|NCT01335477|1096321|P1|Overall Study|Reason other than those stated above|2
324658|NCT01335477|1096320|P2|Overall Study|Not treated|2
324659|NCT01335477|1096321|P1|Overall Study|Not treated|1
324660|NCT01335477|1096320|P2|Overall Study|Consent withdrawn, not due to AE|9
324661|NCT01335477|1096321|P1|Overall Study|Consent withdrawn, not due to AE|7
324662|NCT01335477|1096320|P2|Overall Study|Lost to Follow-up|2
324663|NCT01335477|1096321|P1|Overall Study|Lost to Follow-up|1
324664|NCT01335477|1096320|P2|Overall Study|Non compliant with protocol|2
324665|NCT01335477|1096321|P1|Overall Study|Non compliant with protocol|0
324666|NCT01335477|1096320|P2|Overall Study|Adverse Event|42
324667|NCT01335477|1096321|P1|Overall Study|Adverse Event|30
324668|NCT01335464|1096385|P2|Overall Study|Reason other than those stated above|1
324669|NCT01335464|1096386|P1|Overall Study|Reason other than those stated above|1
324670|NCT01335464|1096385|P2|Overall Study|Not treated|0
324671|NCT01335464|1096386|P1|Overall Study|Not treated|2
324672|NCT01335464|1096385|P2|Overall Study|Consent withdrawn, not due to AE|23
324673|NCT01335464|1096386|P1|Overall Study|Consent withdrawn, not due to AE|12
324674|NCT01335464|1096385|P2|Overall Study|Non compliant with protocol|0
324675|NCT01335464|1096386|P1|Overall Study|Non compliant with protocol|2
324676|NCT01335464|1096385|P2|Overall Study|Adverse Event|25
324677|NCT01335464|1096386|P1|Overall Study|Adverse Event|15
324678|NCT01334918|1096546|P2|Overall Study|Withdrawal by Subject|1
324679|NCT01334918|1096547|P1|Overall Study|Withdrawal by Subject|0
324680|NCT01334918|1096546|P2|Overall Study|Adverse Event|0
324681|NCT01334918|1096547|P1|Overall Study|Adverse Event|2
324682|NCT01334918|1096546|P2|Overall Study|Did not receive study drug|0
324683|NCT01334918|1096547|P1|Overall Study|Did not receive study drug|6
324684|NCT01334866|1096573|P1|Overall Study|medically necessary post-procedure|1
324685|NCT01334866|1096573|P1|Overall Study|medically necessary prior to procedure|2
324686|NCT01334866|1096573|P1|Overall Study|Physician Decision|3
324687|NCT01334866|1096573|P1|Overall Study|Lost to Follow-up|3
324688|NCT01334866|1096573|P1|Overall Study|Withdrawal by Subject|10
324689|NCT01334710|1096610|P1|Overall Study|Trial was terminated|3
324690|NCT01334606|1096615|P1|Overall Study|Study Terminated due to slow enrolment|18
324691|NCT01334554|1096623|P2|Overall Study|Adverse Event|2
324692|NCT01334554|1096624|P1|Overall Study|Adverse Event|4
324693|NCT01334515|1096634|P2|Overall Study|Withdrawal by Subject|1
324694|NCT01334515|1096635|P1|Overall Study|Withdrawal by Subject|1
324695|NCT01334515|1096634|P2|Overall Study|Physician Decision|1
324696|NCT01334515|1096635|P1|Overall Study|Physician Decision|1
324697|NCT01334515|1096634|P2|Overall Study|Lack of Efficacy|21
324698|NCT01334515|1096635|P1|Overall Study|Lack of Efficacy|8
324699|NCT01334515|1096634|P2|Overall Study|Death|0
324700|NCT01334515|1096635|P1|Overall Study|Death|1
324701|NCT01334515|1096634|P2|Overall Study|Adverse Event|6
324702|NCT01334515|1096635|P1|Overall Study|Adverse Event|1
324703|NCT01334125|1096673|P2|Overall Study|Lost to Follow-up|3
324704|NCT01334125|1096674|P1|Overall Study|Lost to Follow-up|3
324705|NCT01333956|1096690|P4|Overall Study|Withdrawal by Subject|0
324706|NCT01333956|1096691|P3|Overall Study|Withdrawal by Subject|1
324707|NCT01333956|1096692|P2|Overall Study|Withdrawal by Subject|2
324708|NCT01333956|1096693|P1|Overall Study|Withdrawal by Subject|0
324709|NCT01333956|1096690|P4|Overall Study|Unable to complete study procedure|1
324710|NCT01333956|1096691|P3|Overall Study|Unable to complete study procedure|0
324711|NCT01333956|1096692|P2|Overall Study|Unable to complete study procedure|0
324712|NCT01333956|1096693|P1|Overall Study|Unable to complete study procedure|1
324713|NCT01333956|1096690|P4|Overall Study|Lost to Follow-up|1
324714|NCT01333956|1096691|P3|Overall Study|Lost to Follow-up|0
324715|NCT01333956|1096692|P2|Overall Study|Lost to Follow-up|2
324716|NCT01333956|1096693|P1|Overall Study|Lost to Follow-up|1
324717|NCT01333943|1096729|P2|Overall Study|Known neuropathy|0
324718|NCT01333943|1096730|P1|Overall Study|Known neuropathy|1
324719|NCT01333865|1096746|P1|Overall Study|Adverse Event|2
324720|NCT01333722|1096766|P2|Overall Study|Withdrawal by Subject|1
324721|NCT01333722|1096767|P1|Overall Study|Withdrawal by Subject|0
324722|NCT01333722|1096766|P2|Overall Study|Lack of Efficacy|2
324723|NCT01333722|1096767|P1|Overall Study|Lack of Efficacy|0
324724|NCT01333501|1096792|P2|Overall Study|Withdrawn consent|12
324725|NCT01333501|1096793|P1|Overall Study|Withdrawn consent|3
324726|NCT01333501|1096792|P2|Overall Study|Unsatisfactory therapeutic effect|7
324727|NCT01333501|1096793|P1|Overall Study|Unsatisfactory therapeutic effect|1
324728|NCT01333501|1096792|P2|Overall Study|Abnormal laboratory value|1
324729|NCT01333501|1096793|P1|Overall Study|Abnormal laboratory value|2
324730|NCT01333501|1096792|P2|Overall Study|Adverse Event|1
324731|NCT01333501|1096793|P1|Overall Study|Adverse Event|3
324732|NCT01333475|1096860|P2|Overall Study|Toxicity|3
324733|NCT01333475|1096861|P1|Overall Study|Toxicity|1
324734|NCT01333475|1096860|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
324735|NCT01333475|1096861|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
324736|NCT01333397|1096887|P5|Overall Study|Lost to Follow-up|0
324737|NCT01333397|1096888|P4|Overall Study|Lost to Follow-up|1
324738|NCT01333397|1096889|P3|Overall Study|Lost to Follow-up|0
324739|NCT01333397|1096890|P2|Overall Study|Lost to Follow-up|0
324740|NCT01333397|1096891|P1|Overall Study|Lost to Follow-up|1
324741|NCT01333189|1096965|P2|Overall Study|Moved from region|1
324742|NCT01333189|1096966|P1|Overall Study|Moved from region|0
324743|NCT01333189|1096965|P2|Overall Study|Transportation difficulties|1
324744|NCT01333189|1096966|P1|Overall Study|Transportation difficulties|0
324745|NCT01333189|1096965|P2|Overall Study|Adverse Event|0
324746|NCT01333189|1096966|P1|Overall Study|Adverse Event|1
324747|NCT01333189|1096965|P2|Overall Study|Time constraints|0
324748|NCT01333189|1096966|P1|Overall Study|Time constraints|1
324749|NCT01333111|1096997|P3|Overall Study|Ineffective therapy|1
324750|NCT01333111|1096998|P2|Overall Study|Ineffective therapy|0
324751|NCT01333111|1096999|P1|Overall Study|Ineffective therapy|0
324752|NCT01333111|1096997|P3|Overall Study|Non-compliance|0
324753|NCT01333111|1096998|P2|Overall Study|Non-compliance|0
324754|NCT01333111|1096999|P1|Overall Study|Non-compliance|1
324755|NCT01333111|1096997|P3|Overall Study|withdrawal criteria|0
324756|NCT01333111|1096998|P2|Overall Study|withdrawal criteria|1
324757|NCT01333111|1096999|P1|Overall Study|withdrawal criteria|0
324758|NCT01333111|1096997|P3|Overall Study|unclassified|0
324759|NCT01333111|1096998|P2|Overall Study|unclassified|0
324760|NCT01333111|1096999|P1|Overall Study|unclassified|1
324761|NCT01333111|1096997|P3|Overall Study|personal reasons|1
324762|NCT01333111|1096998|P2|Overall Study|personal reasons|0
324763|NCT01333111|1096999|P1|Overall Study|personal reasons|0
324764|NCT01333111|1096997|P3|Overall Study|patient undergoing major surgery|0
324765|NCT01333111|1096998|P2|Overall Study|patient undergoing major surgery|2
324766|NCT01333111|1096999|P1|Overall Study|patient undergoing major surgery|0
324767|NCT01332994|1097023|P1|Overall Study|Not Specified|8
324768|NCT01332994|1097023|P1|Overall Study|Administrative Problem|2
324769|NCT01332994|1097023|P1|Overall Study|Withdrawal by Subject|15
324770|NCT01332994|1097023|P1|Overall Study|Protocol Violation|6
324771|NCT01332994|1097023|P1|Overall Study|Lost to Follow-up|4
324772|NCT01332994|1097023|P1|Overall Study|Lack of Efficacy|1
324773|NCT01332994|1097023|P1|Overall Study|Death|1
324774|NCT01332994|1097023|P1|Overall Study|Adverse Event|34
324775|NCT01332968|1097092|P8|Follow-Up Period|Lost to Follow-up|2
324776|NCT01332968|1097093|P7|Follow-Up Period|Lost to Follow-up|1
324777|NCT01332968|1097094|P6|Follow-Up Period|Lost to Follow-up|0
324778|NCT01332968|1097095|P5|Follow-Up Period|Lost to Follow-up|0
324779|NCT01332968|1097096|P4|Follow-Up Period|Lost to Follow-up|0
324780|NCT01332968|1097097|P3|Follow-Up Period|Lost to Follow-up|0
324781|NCT01332968|1097098|P2|Follow-Up Period|Lost to Follow-up|0
324782|NCT01332968|1097099|P1|Follow-Up Period|Lost to Follow-up|0
324783|NCT01332968|1097092|P8|Follow-Up Period|Withdrawal by Subject|2
324784|NCT01332968|1097093|P7|Follow-Up Period|Withdrawal by Subject|1
324785|NCT01332968|1097094|P6|Follow-Up Period|Withdrawal by Subject|0
324786|NCT01332968|1097095|P5|Follow-Up Period|Withdrawal by Subject|0
324787|NCT01332968|1097096|P4|Follow-Up Period|Withdrawal by Subject|0
324788|NCT01332968|1097097|P3|Follow-Up Period|Withdrawal by Subject|0
324789|NCT01332968|1097098|P2|Follow-Up Period|Withdrawal by Subject|0
324790|NCT01332968|1097099|P1|Follow-Up Period|Withdrawal by Subject|0
324791|NCT01332968|1097092|P8|Follow-Up Period|Follow-up ongoing|505
324792|NCT01332968|1097093|P7|Follow-Up Period|Follow-up ongoing|502
324793|NCT01332968|1097094|P6|Follow-Up Period|Follow-up ongoing|0
324794|NCT01332968|1097095|P5|Follow-Up Period|Follow-up ongoing|0
324795|NCT01332968|1097096|P4|Follow-Up Period|Follow-up ongoing|0
324796|NCT01332968|1097097|P3|Follow-Up Period|Follow-up ongoing|0
324797|NCT01332968|1097098|P2|Follow-Up Period|Follow-up ongoing|0
324798|NCT01332968|1097099|P1|Follow-Up Period|Follow-up ongoing|0
324799|NCT01332968|1097092|P8|Follow-Up Period|Death|22
324800|NCT01332968|1097093|P7|Follow-Up Period|Death|38
324801|NCT01332968|1097094|P6|Follow-Up Period|Death|0
324802|NCT01332968|1097095|P5|Follow-Up Period|Death|0
324803|NCT01332968|1097096|P4|Follow-Up Period|Death|0
324804|NCT01332968|1097097|P3|Follow-Up Period|Death|0
324805|NCT01332968|1097098|P2|Follow-Up Period|Death|0
324806|NCT01332968|1097099|P1|Follow-Up Period|Death|0
324807|NCT01332968|1097092|P8|Maintenance/Observation Period|Treatment ongoing|0
324808|NCT01332968|1097093|P7|Maintenance/Observation Period|Treatment ongoing|0
324809|NCT01332968|1097094|P6|Maintenance/Observation Period|Treatment ongoing|8
324810|NCT01332968|1097095|P5|Maintenance/Observation Period|Treatment ongoing|10
324811|NCT01332968|1097096|P4|Maintenance/Observation Period|Treatment ongoing|62
324812|NCT01332968|1097097|P3|Maintenance/Observation Period|Treatment ongoing|54
324813|NCT01332968|1097098|P2|Maintenance/Observation Period|Treatment ongoing|0
324814|NCT01332968|1097099|P1|Maintenance/Observation Period|Treatment ongoing|0
324815|NCT01332968|1097092|P8|Maintenance/Observation Period|Adverse Event|0
324816|NCT01332968|1097093|P7|Maintenance/Observation Period|Adverse Event|0
324817|NCT01332968|1097094|P6|Maintenance/Observation Period|Adverse Event|0
324818|NCT01332968|1097095|P5|Maintenance/Observation Period|Adverse Event|0
324819|NCT01332968|1097096|P4|Maintenance/Observation Period|Adverse Event|65
324820|NCT01332968|1097097|P3|Maintenance/Observation Period|Adverse Event|50
324821|NCT01332968|1097098|P2|Maintenance/Observation Period|Adverse Event|0
324822|NCT01332968|1097099|P1|Maintenance/Observation Period|Adverse Event|0
324823|NCT01332968|1097092|P8|Maintenance/Observation Period|Death|0
324824|NCT01332968|1097093|P7|Maintenance/Observation Period|Death|0
324825|NCT01332968|1097094|P6|Maintenance/Observation Period|Death|0
324826|NCT01332968|1097095|P5|Maintenance/Observation Period|Death|0
324827|NCT01332968|1097096|P4|Maintenance/Observation Period|Death|6
324828|NCT01332968|1097097|P3|Maintenance/Observation Period|Death|5
324829|NCT01332968|1097098|P2|Maintenance/Observation Period|Death|0
324830|NCT01332968|1097099|P1|Maintenance/Observation Period|Death|0
324831|NCT01332968|1097092|P8|Maintenance/Observation Period|Lost to Follow-up|0
324832|NCT01332968|1097093|P7|Maintenance/Observation Period|Lost to Follow-up|0
324833|NCT01332968|1097094|P6|Maintenance/Observation Period|Lost to Follow-up|0
324834|NCT01332968|1097095|P5|Maintenance/Observation Period|Lost to Follow-up|0
324835|NCT01332968|1097096|P4|Maintenance/Observation Period|Lost to Follow-up|2
324836|NCT01332968|1097097|P3|Maintenance/Observation Period|Lost to Follow-up|1
324837|NCT01332968|1097098|P2|Maintenance/Observation Period|Lost to Follow-up|0
324838|NCT01332968|1097099|P1|Maintenance/Observation Period|Lost to Follow-up|0
324839|NCT01332968|1097092|P8|Maintenance/Observation Period|Non-compliance|0
324840|NCT01332968|1097093|P7|Maintenance/Observation Period|Non-compliance|0
324841|NCT01332968|1097094|P6|Maintenance/Observation Period|Non-compliance|1
324842|NCT01332968|1097095|P5|Maintenance/Observation Period|Non-compliance|0
324843|NCT01332968|1097096|P4|Maintenance/Observation Period|Non-compliance|3
324844|NCT01332968|1097097|P3|Maintenance/Observation Period|Non-compliance|2
324845|NCT01332968|1097098|P2|Maintenance/Observation Period|Non-compliance|0
324846|NCT01332968|1097099|P1|Maintenance/Observation Period|Non-compliance|0
324847|NCT01332968|1097092|P8|Maintenance/Observation Period|Other|0
324848|NCT01332968|1097093|P7|Maintenance/Observation Period|Other|0
324849|NCT01332968|1097094|P6|Maintenance/Observation Period|Other|0
324850|NCT01332968|1097095|P5|Maintenance/Observation Period|Other|0
324851|NCT01332968|1097096|P4|Maintenance/Observation Period|Other|5
324852|NCT01332968|1097097|P3|Maintenance/Observation Period|Other|4
324853|NCT01332968|1097098|P2|Maintenance/Observation Period|Other|0
324854|NCT01332968|1097099|P1|Maintenance/Observation Period|Other|0
324855|NCT01332968|1097092|P8|Maintenance/Observation Period|Physician Decision|0
324856|NCT01332968|1097093|P7|Maintenance/Observation Period|Physician Decision|0
324857|NCT01332968|1097094|P6|Maintenance/Observation Period|Physician Decision|0
324858|NCT01332968|1097095|P5|Maintenance/Observation Period|Physician Decision|0
324859|NCT01332968|1097096|P4|Maintenance/Observation Period|Physician Decision|19
324860|NCT01332968|1097097|P3|Maintenance/Observation Period|Physician Decision|14
324861|NCT01332968|1097098|P2|Maintenance/Observation Period|Physician Decision|0
324862|NCT01332968|1097099|P1|Maintenance/Observation Period|Physician Decision|0
324863|NCT01332968|1097092|P8|Maintenance/Observation Period|Progressive disease|0
324864|NCT01332968|1097093|P7|Maintenance/Observation Period|Progressive disease|0
324865|NCT01332968|1097094|P6|Maintenance/Observation Period|Progressive disease|0
324866|NCT01332968|1097095|P5|Maintenance/Observation Period|Progressive disease|0
324867|NCT01332968|1097096|P4|Maintenance/Observation Period|Progressive disease|39
324868|NCT01332968|1097097|P3|Maintenance/Observation Period|Progressive disease|72
324869|NCT01332968|1097098|P2|Maintenance/Observation Period|Progressive disease|0
324870|NCT01332968|1097099|P1|Maintenance/Observation Period|Progressive disease|0
324871|NCT01332968|1097092|P8|Maintenance/Observation Period|Protocol Violation|0
324872|NCT01332968|1097093|P7|Maintenance/Observation Period|Protocol Violation|0
324873|NCT01332968|1097094|P6|Maintenance/Observation Period|Protocol Violation|0
324874|NCT01332968|1097095|P5|Maintenance/Observation Period|Protocol Violation|0
324875|NCT01332968|1097096|P4|Maintenance/Observation Period|Protocol Violation|1
324876|NCT01332968|1097097|P3|Maintenance/Observation Period|Protocol Violation|1
324877|NCT01332968|1097098|P2|Maintenance/Observation Period|Protocol Violation|0
324878|NCT01332968|1097099|P1|Maintenance/Observation Period|Protocol Violation|0
324879|NCT01332968|1097092|P8|Maintenance/Observation Period|Withdrawal by Subject|0
324880|NCT01332968|1097093|P7|Maintenance/Observation Period|Withdrawal by Subject|0
324881|NCT01332968|1097094|P6|Maintenance/Observation Period|Withdrawal by Subject|0
324882|NCT01332968|1097095|P5|Maintenance/Observation Period|Withdrawal by Subject|0
324883|NCT01332968|1097096|P4|Maintenance/Observation Period|Withdrawal by Subject|5
324884|NCT01332968|1097097|P3|Maintenance/Observation Period|Withdrawal by Subject|10
324885|NCT01332968|1097098|P2|Maintenance/Observation Period|Withdrawal by Subject|0
324886|NCT01332968|1097099|P1|Maintenance/Observation Period|Withdrawal by Subject|0
324887|NCT01332968|1097092|P8|Induction Period|Randomized, but not treated|0
324888|NCT01332968|1097093|P7|Induction Period|Randomized, but not treated|0
324889|NCT01332968|1097094|P6|Induction Period|Randomized, but not treated|0
324890|NCT01332968|1097095|P5|Induction Period|Randomized, but not treated|0
324891|NCT01332968|1097096|P4|Induction Period|Randomized, but not treated|0
324892|NCT01332968|1097097|P3|Induction Period|Randomized, but not treated|0
324893|NCT01332968|1097098|P2|Induction Period|Randomized, but not treated|7
324894|NCT01332968|1097099|P1|Induction Period|Randomized, but not treated|4
324895|NCT01332968|1097092|P8|Induction Period|Adverse Event|0
324896|NCT01332968|1097093|P7|Induction Period|Adverse Event|0
324897|NCT01332968|1097094|P6|Induction Period|Adverse Event|0
324898|NCT01332968|1097095|P5|Induction Period|Adverse Event|0
324899|NCT01332968|1097096|P4|Induction Period|Adverse Event|0
324900|NCT01332968|1097097|P3|Induction Period|Adverse Event|0
324901|NCT01332968|1097098|P2|Induction Period|Adverse Event|26
324902|NCT01332968|1097099|P1|Induction Period|Adverse Event|23
324903|NCT01332968|1097092|P8|Induction Period|Death|0
324904|NCT01332968|1097093|P7|Induction Period|Death|0
324905|NCT01332968|1097094|P6|Induction Period|Death|0
324906|NCT01332968|1097095|P5|Induction Period|Death|0
324907|NCT01332968|1097096|P4|Induction Period|Death|0
324908|NCT01332968|1097097|P3|Induction Period|Death|0
324909|NCT01332968|1097098|P2|Induction Period|Death|4
324910|NCT01332968|1097099|P1|Induction Period|Death|1
324911|NCT01332968|1097092|P8|Induction Period|Non-compliance|0
324912|NCT01332968|1097093|P7|Induction Period|Non-compliance|0
324913|NCT01332968|1097094|P6|Induction Period|Non-compliance|0
324914|NCT01332968|1097095|P5|Induction Period|Non-compliance|0
324915|NCT01332968|1097096|P4|Induction Period|Non-compliance|0
324916|NCT01332968|1097097|P3|Induction Period|Non-compliance|0
324917|NCT01332968|1097098|P2|Induction Period|Non-compliance|0
324918|NCT01332968|1097099|P1|Induction Period|Non-compliance|1
324919|NCT01332968|1097092|P8|Induction Period|Other|0
324920|NCT01332968|1097093|P7|Induction Period|Other|0
324921|NCT01332968|1097094|P6|Induction Period|Other|0
324922|NCT01332968|1097095|P5|Induction Period|Other|0
324923|NCT01332968|1097096|P4|Induction Period|Other|0
324924|NCT01332968|1097097|P3|Induction Period|Other|0
324925|NCT01332968|1097098|P2|Induction Period|Other|2
324926|NCT01332968|1097099|P1|Induction Period|Other|2
324927|NCT01332968|1097092|P8|Induction Period|Physician Decision|0
324928|NCT01332968|1097093|P7|Induction Period|Physician Decision|0
324929|NCT01332968|1097094|P6|Induction Period|Physician Decision|0
324930|NCT01332968|1097095|P5|Induction Period|Physician Decision|0
324931|NCT01332968|1097096|P4|Induction Period|Physician Decision|0
324932|NCT01332968|1097097|P3|Induction Period|Physician Decision|0
324933|NCT01332968|1097098|P2|Induction Period|Physician Decision|1
324934|NCT01332968|1097099|P1|Induction Period|Physician Decision|6
324935|NCT01332968|1097092|P8|Induction Period|Progressive disease|0
324936|NCT01332968|1097093|P7|Induction Period|Progressive disease|0
324937|NCT01332968|1097094|P6|Induction Period|Progressive disease|0
324938|NCT01332968|1097095|P5|Induction Period|Progressive disease|0
324939|NCT01332968|1097096|P4|Induction Period|Progressive disease|0
324940|NCT01332968|1097097|P3|Induction Period|Progressive disease|0
324941|NCT01332968|1097098|P2|Induction Period|Progressive disease|7
324942|NCT01332968|1097099|P1|Induction Period|Progressive disease|15
324943|NCT01332968|1097092|P8|Induction Period|Protocol Violation|0
324944|NCT01332968|1097093|P7|Induction Period|Protocol Violation|0
324945|NCT01332968|1097094|P6|Induction Period|Protocol Violation|0
324946|NCT01332968|1097095|P5|Induction Period|Protocol Violation|0
324947|NCT01332968|1097096|P4|Induction Period|Protocol Violation|0
324948|NCT01332968|1097097|P3|Induction Period|Protocol Violation|0
324949|NCT01332968|1097098|P2|Induction Period|Protocol Violation|4
324950|NCT01332968|1097099|P1|Induction Period|Protocol Violation|3
324951|NCT01332968|1097092|P8|Induction Period|Withdrawal by Subject|0
324952|NCT01332968|1097093|P7|Induction Period|Withdrawal by Subject|0
324953|NCT01332968|1097094|P6|Induction Period|Withdrawal by Subject|0
324954|NCT01332968|1097095|P5|Induction Period|Withdrawal by Subject|0
324955|NCT01332968|1097096|P4|Induction Period|Withdrawal by Subject|0
324956|NCT01332968|1097097|P3|Induction Period|Withdrawal by Subject|0
324957|NCT01332968|1097098|P2|Induction Period|Withdrawal by Subject|5
324958|NCT01332968|1097099|P1|Induction Period|Withdrawal by Subject|3
324959|NCT01332851|1097165|P2|Overall Study|Lost to Follow-up|11
324960|NCT01332851|1097166|P1|Overall Study|Lost to Follow-up|7
324961|NCT01332851|1097165|P2|Overall Study|Withdrawal by Subject|2
324962|NCT01332851|1097166|P1|Overall Study|Withdrawal by Subject|4
324963|NCT01332318|1097318|P4|Overall Study|Protocol Violation|1
324964|NCT01332318|1097319|P3|Overall Study|Protocol Violation|1
324965|NCT01332318|1097320|P2|Overall Study|Protocol Violation|0
324966|NCT01332318|1097321|P1|Overall Study|Protocol Violation|1
324967|NCT01332318|1097318|P4|Overall Study|Withdrawal by Subject|1
324968|NCT01332318|1097319|P3|Overall Study|Withdrawal by Subject|0
324969|NCT01332318|1097320|P2|Overall Study|Withdrawal by Subject|1
324970|NCT01332318|1097321|P1|Overall Study|Withdrawal by Subject|1
324971|NCT01332318|1097318|P4|Overall Study|Adverse Event|0
324972|NCT01332318|1097319|P3|Overall Study|Adverse Event|0
324973|NCT01332318|1097320|P2|Overall Study|Adverse Event|3
324974|NCT01332318|1097321|P1|Overall Study|Adverse Event|0
324975|NCT01332305|1097432|P5|Overall Study|Physician Decision|0
324976|NCT01332305|1097433|P4|Overall Study|Physician Decision|1
324977|NCT01332305|1097434|P3|Overall Study|Physician Decision|0
324978|NCT01332305|1097435|P2|Overall Study|Physician Decision|0
324979|NCT01332305|1097436|P1|Overall Study|Physician Decision|0
324980|NCT01332305|1097432|P5|Overall Study|Treatment Failure|0
324981|NCT01332305|1097433|P4|Overall Study|Treatment Failure|0
324982|NCT01332305|1097434|P3|Overall Study|Treatment Failure|0
324983|NCT01332305|1097435|P2|Overall Study|Treatment Failure|1
324984|NCT01332305|1097436|P1|Overall Study|Treatment Failure|1
324985|NCT01332305|1097432|P5|Overall Study|Withdrawal by Sponsor|1
324986|NCT01332305|1097433|P4|Overall Study|Withdrawal by Sponsor|1
324987|NCT01332305|1097434|P3|Overall Study|Withdrawal by Sponsor|0
324988|NCT01332305|1097435|P2|Overall Study|Withdrawal by Sponsor|0
324989|NCT01332305|1097436|P1|Overall Study|Withdrawal by Sponsor|1
324990|NCT01332305|1097432|P5|Overall Study|Protocol Violation|3
324991|NCT01332305|1097433|P4|Overall Study|Protocol Violation|0
324992|NCT01332305|1097434|P3|Overall Study|Protocol Violation|1
324993|NCT01332305|1097435|P2|Overall Study|Protocol Violation|2
324994|NCT01332305|1097436|P1|Overall Study|Protocol Violation|1
324995|NCT01332305|1097432|P5|Overall Study|Lost to Follow-up|3
324996|NCT01332305|1097433|P4|Overall Study|Lost to Follow-up|2
324997|NCT01332305|1097434|P3|Overall Study|Lost to Follow-up|3
324998|NCT01332305|1097435|P2|Overall Study|Lost to Follow-up|2
324999|NCT01332305|1097436|P1|Overall Study|Lost to Follow-up|0
325000|NCT01332305|1097432|P5|Overall Study|Withdrawal by Subject|0
325001|NCT01332305|1097433|P4|Overall Study|Withdrawal by Subject|1
325002|NCT01332305|1097434|P3|Overall Study|Withdrawal by Subject|4
325003|NCT01332305|1097435|P2|Overall Study|Withdrawal by Subject|5
325004|NCT01332305|1097436|P1|Overall Study|Withdrawal by Subject|6
325005|NCT01332305|1097432|P5|Overall Study|Adverse Event|5
325006|NCT01332305|1097433|P4|Overall Study|Adverse Event|3
325007|NCT01332305|1097434|P3|Overall Study|Adverse Event|6
325008|NCT01332305|1097435|P2|Overall Study|Adverse Event|4
325009|NCT01332305|1097436|P1|Overall Study|Adverse Event|1
325010|NCT01332292|1097458|P2|Treatment Period 2 (14 Days)|Physician Decision|1
325011|NCT01332292|1097459|P1|Treatment Period 2 (14 Days)|Physician Decision|1
325012|NCT01332292|1097458|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
325013|NCT01332292|1097459|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
325014|NCT01332292|1097458|P2|Treatment Period 1 (14 Days)|Adverse Event|0
325015|NCT01332292|1097459|P1|Treatment Period 1 (14 Days)|Adverse Event|1
325016|NCT01332227|1097550|P2|Overall Study|Patient began prohibited medication|1
325017|NCT01332227|1097551|P1|Overall Study|Patient began prohibited medication|0
325018|NCT01332227|1097550|P2|Overall Study|Patient moved from area|0
325019|NCT01332227|1097551|P1|Overall Study|Patient moved from area|1
325020|NCT01332227|1097550|P2|Overall Study|Poor compliance/noncompliance|1
325021|NCT01332227|1097551|P1|Overall Study|Poor compliance/noncompliance|1
325022|NCT01332227|1097550|P2|Overall Study|Lack of Efficacy|1
325023|NCT01332227|1097551|P1|Overall Study|Lack of Efficacy|3
325024|NCT01332227|1097550|P2|Overall Study|Lost to Follow-up|0
325025|NCT01332227|1097551|P1|Overall Study|Lost to Follow-up|2
325026|NCT01332227|1097550|P2|Overall Study|Withdrawal by Subject|1
325027|NCT01332227|1097551|P1|Overall Study|Withdrawal by Subject|5
325028|NCT01332227|1097550|P2|Overall Study|Adverse Event|1
325029|NCT01332227|1097551|P1|Overall Study|Adverse Event|4
325030|NCT01332149|1097732|P2|Overall Study|Randomized but not treated|2
325031|NCT01332149|1097733|P1|Overall Study|Randomized but not treated|1
325032|NCT01332149|1097732|P2|Overall Study|Did not meet entrance criteria|4
325033|NCT01332149|1097733|P1|Overall Study|Did not meet entrance criteria|3
325034|NCT01332149|1097732|P2|Overall Study|Insufficient clinical response|7
325035|NCT01332149|1097733|P1|Overall Study|Insufficient clinical response|4
325036|NCT01332149|1097732|P2|Overall Study|Lost to Follow-up|1
325037|NCT01332149|1097733|P1|Overall Study|Lost to Follow-up|1
325038|NCT01332149|1097732|P2|Overall Study|Withdrawal by Subject|5
325039|NCT01332149|1097733|P1|Overall Study|Withdrawal by Subject|4
325040|NCT01332149|1097732|P2|Overall Study|Protocol Violation|3
325041|NCT01332149|1097733|P1|Overall Study|Protocol Violation|1
325042|NCT01332149|1097732|P2|Overall Study|Other unspecified|7
325043|NCT01332149|1097733|P1|Overall Study|Other unspecified|5
325044|NCT01332149|1097732|P2|Overall Study|Adverse Event|9
325045|NCT01332149|1097733|P1|Overall Study|Adverse Event|11
325046|NCT01332019|1097811|P2|Overall Study|Adverse Event|22
325047|NCT01332019|1097812|P1|Overall Study|Adverse Event|13
325048|NCT01332019|1097811|P2|Overall Study|Lost to Follow-up|7
325049|NCT01332019|1097812|P1|Overall Study|Lost to Follow-up|4
325050|NCT01332019|1097811|P2|Overall Study|Withdrawal by Subject|71
325051|NCT01332019|1097812|P1|Overall Study|Withdrawal by Subject|73
325052|NCT01332019|1097811|P2|Overall Study|Physician Decision|3
325053|NCT01332019|1097812|P1|Overall Study|Physician Decision|4
325054|NCT01332019|1097811|P2|Overall Study|Death|1
325055|NCT01332019|1097812|P1|Overall Study|Death|2
325056|NCT01332019|1097811|P2|Overall Study|Not Specified|18
325057|NCT01332019|1097812|P1|Overall Study|Not Specified|16
325058|NCT01332019|1097811|P2|Overall Study|Was Not Dosed|0
325059|NCT01332019|1097812|P1|Overall Study|Was Not Dosed|1
325060|NCT01331837|1097896|P2|Overall Study|Withdrawal by Subject|16
325061|NCT01331837|1097897|P1|Overall Study|Withdrawal by Subject|13
325062|NCT01331837|1097896|P2|Overall Study|Info not recorded|16
325063|NCT01331837|1097897|P1|Overall Study|Info not recorded|10
325064|NCT01331837|1097896|P2|Overall Study|Lost to Follow-up|1
325065|NCT01331837|1097897|P1|Overall Study|Lost to Follow-up|3
325066|NCT01331837|1097896|P2|Overall Study|Death|34
325067|NCT01331837|1097897|P1|Overall Study|Death|30
325068|NCT01331824|1097937|P1|Overall Study|Withdrawal by Subject|1
325069|NCT01331824|1097937|P1|Overall Study|Disease Progression|9
325070|NCT01331824|1097937|P1|Overall Study|Death|1
325071|NCT01331824|1097937|P1|Overall Study|Adverse Event|2
325072|NCT01331681|1097972|P3|Overall Study|Not Received Study Treatment|2
325073|NCT01331681|1097973|P2|Overall Study|Not Received Study Treatment|0
325074|NCT01331681|1097974|P1|Overall Study|Not Received Study Treatment|0
325075|NCT01331681|1097972|P3|Overall Study|Switching to other therapy|1
325076|NCT01331681|1097973|P2|Overall Study|Switching to other therapy|0
325077|NCT01331681|1097974|P1|Overall Study|Switching to other therapy|0
325078|NCT01331681|1097972|P3|Overall Study|Sponsor decision|0
325079|NCT01331681|1097973|P2|Overall Study|Sponsor decision|1
325080|NCT01331681|1097974|P1|Overall Study|Sponsor decision|1
325081|NCT01331681|1097972|P3|Overall Study|Therapeutic procedure required|0
325082|NCT01331681|1097973|P2|Overall Study|Therapeutic procedure required|0
325083|NCT01331681|1097974|P1|Overall Study|Therapeutic procedure required|1
325084|NCT01331681|1097972|P3|Overall Study|Physician Decision|4
325085|NCT01331681|1097973|P2|Overall Study|Physician Decision|0
325086|NCT01331681|1097974|P1|Overall Study|Physician Decision|2
325087|NCT01331681|1097972|P3|Overall Study|Lost to Follow-up|1
325088|NCT01331681|1097973|P2|Overall Study|Lost to Follow-up|4
325089|NCT01331681|1097974|P1|Overall Study|Lost to Follow-up|2
325090|NCT01331681|1097972|P3|Overall Study|Protocol Violation|0
325091|NCT01331681|1097973|P2|Overall Study|Protocol Violation|1
325092|NCT01331681|1097974|P1|Overall Study|Protocol Violation|1
325093|NCT01331681|1097972|P3|Overall Study|Withdrawal by Subject|15
325094|NCT01331681|1097973|P2|Overall Study|Withdrawal by Subject|8
325095|NCT01331681|1097974|P1|Overall Study|Withdrawal by Subject|12
325096|NCT01331681|1097972|P3|Overall Study|Lack of Efficacy|0
325097|NCT01331681|1097973|P2|Overall Study|Lack of Efficacy|1
325098|NCT01331681|1097974|P1|Overall Study|Lack of Efficacy|0
325099|NCT01331681|1097972|P3|Overall Study|Death|2
325100|NCT01331681|1097973|P2|Overall Study|Death|6
325101|NCT01331681|1097974|P1|Overall Study|Death|6
325102|NCT01331681|1097972|P3|Overall Study|Adverse Event|10
325103|NCT01331681|1097973|P2|Overall Study|Adverse Event|13
325104|NCT01331681|1097974|P1|Overall Study|Adverse Event|10
325105|NCT01331291|1098017|P2|Overall Study|Death|1
325106|NCT01331291|1098018|P1|Overall Study|Death|0
325107|NCT01331291|1098017|P2|Overall Study|Lack of Efficacy|8
325108|NCT01331291|1098018|P1|Overall Study|Lack of Efficacy|2
325109|NCT01331161|1098052|P2|Overall Study|Pregnancy|1
325110|NCT01331161|1098053|P1|Overall Study|Pregnancy|0
325111|NCT01331161|1098052|P2|Overall Study|Lost to Follow-up|1
325112|NCT01331161|1098053|P1|Overall Study|Lost to Follow-up|0
325113|NCT01331161|1098052|P2|Overall Study|Physician Decision|0
325114|NCT01331161|1098053|P1|Overall Study|Physician Decision|1
325115|NCT01331109|1098061|P1|Overall Study|Study Terminated by Sponsor|38
325116|NCT01331109|1098061|P1|Overall Study|Lost to Follow-up|1
325117|NCT01331109|1098061|P1|Overall Study|Withdrawal by Subject|7
325118|NCT01331109|1098061|P1|Overall Study|Protocol Violation|3
325119|NCT01331109|1098061|P1|Overall Study|Lack of Efficacy|2
325120|NCT01331109|1098061|P1|Overall Study|Adverse Event|6
325121|NCT01331005|1098073|P2|Overall Study|Withdrawal by Subject|3
325122|NCT01331005|1098074|P1|Overall Study|Withdrawal by Subject|2
325123|NCT01331005|1098073|P2|Overall Study|Lost to Follow-up|1
325124|NCT01331005|1098074|P1|Overall Study|Lost to Follow-up|2
325125|NCT01330914|1098080|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
325126|NCT01330914|1098080|P1|Overall Study|Withdrawal by Subject|4
325127|NCT01330628|1098086|P2|Overall Study|Didn't receive study treatment|0
325128|NCT01330628|1098087|P1|Overall Study|Didn't receive study treatment|1
325129|NCT01330628|1098086|P2|Overall Study|Withdrawn|6
325130|NCT01330628|1098087|P1|Overall Study|Withdrawn|18
325131|NCT01330628|1098086|P2|Overall Study|Adverse Event|25
325132|NCT01330628|1098087|P1|Overall Study|Adverse Event|44
325133|NCT01330628|1098086|P2|Overall Study|Lost to Follow-up|6
325134|NCT01330628|1098087|P1|Overall Study|Lost to Follow-up|5
325135|NCT01330628|1098086|P2|Overall Study|Death|3
325136|NCT01330628|1098087|P1|Overall Study|Death|2
325137|NCT01330433|1098097|P2|Overall Study|Lost to Follow-up|0
325138|NCT01330433|1098098|P1|Overall Study|Lost to Follow-up|1
325139|NCT01330433|1098097|P2|Overall Study|Death|3
325140|NCT01330433|1098098|P1|Overall Study|Death|1
325141|NCT01330381|1098137|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
325142|NCT01330381|1098138|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
325143|NCT01330381|1098139|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
325144|NCT01330381|1098137|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
325145|NCT01330381|1098138|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
325146|NCT01330381|1098139|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
325147|NCT01330381|1098137|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
325148|NCT01330381|1098138|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
325149|NCT01330381|1098139|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
325150|NCT01330381|1098137|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
325151|NCT01330381|1098138|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
325152|NCT01330381|1098139|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
325153|NCT01330381|1098137|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
325154|NCT01330381|1098138|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
325155|NCT01330381|1098139|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
325156|NCT01330381|1098137|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
325157|NCT01330381|1098138|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
325158|NCT01330381|1098139|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
325159|NCT01330381|1098137|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
325160|NCT01330381|1098138|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
325161|NCT01330381|1098139|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
325162|NCT01330381|1098137|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
325163|NCT01330381|1098138|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
325164|NCT01330381|1098139|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
325165|NCT01330381|1098137|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
325166|NCT01330381|1098138|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
325167|NCT01330381|1098139|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
325168|NCT01330381|1098137|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
325169|NCT01330381|1098138|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
325170|NCT01330381|1098139|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
325171|NCT01330316|1098200|P2|Overall Study|other than above|1
325172|NCT01330316|1098201|P1|Overall Study|other than above|0
325173|NCT01330316|1098200|P2|Overall Study|Withdrawal by Subject|1
325174|NCT01330316|1098201|P1|Overall Study|Withdrawal by Subject|0
325175|NCT01330316|1098200|P2|Overall Study|Lost to Follow-up|1
325176|NCT01330316|1098201|P1|Overall Study|Lost to Follow-up|0
325177|NCT01330316|1098200|P2|Overall Study|Lack of Efficacy|10
325178|NCT01330316|1098201|P1|Overall Study|Lack of Efficacy|0
325179|NCT01330316|1098200|P2|Overall Study|Adverse Event|2
325180|NCT01330316|1098201|P1|Overall Study|Adverse Event|2
325181|NCT01330303|1098237|P2|Period 1|Withdrawal by Subject|1
325182|NCT01330303|1098238|P1|Period 1|Withdrawal by Subject|0
325183|NCT01330303|1098237|P2|Period 1|Protocol Violation|1
325184|NCT01330303|1098238|P1|Period 1|Protocol Violation|0
325185|NCT01330303|1098237|P2|Period 1|Adverse Event|0
325186|NCT01330303|1098238|P1|Period 1|Adverse Event|1
325187|NCT01330108|1098285|P1|Overall Study|Withdrawal by Subject|4
325188|NCT01330030|1098303|P2|Overall Study|Lost to Follow-up|17
325189|NCT01330030|1098304|P1|Overall Study|Lost to Follow-up|16
325190|NCT01330017|1098315|P5|Overall Study|Unknown Reason|2
325191|NCT01330017|1098316|P4|Overall Study|Unknown Reason|7
325192|NCT01330017|1098317|P3|Overall Study|Unknown Reason|5
325193|NCT01330017|1098318|P2|Overall Study|Unknown Reason|3
325194|NCT01330017|1098319|P1|Overall Study|Unknown Reason|5
325195|NCT01330017|1098315|P5|Overall Study|Protocol Violation|0
325196|NCT01330017|1098316|P4|Overall Study|Protocol Violation|1
325197|NCT01330017|1098317|P3|Overall Study|Protocol Violation|0
325198|NCT01330017|1098318|P2|Overall Study|Protocol Violation|0
325199|NCT01330017|1098319|P1|Overall Study|Protocol Violation|0
325200|NCT01330017|1098315|P5|Overall Study|Lost to Follow-up|0
325201|NCT01330017|1098316|P4|Overall Study|Lost to Follow-up|0
325202|NCT01330017|1098317|P3|Overall Study|Lost to Follow-up|1
325203|NCT01330017|1098318|P2|Overall Study|Lost to Follow-up|0
325204|NCT01330017|1098319|P1|Overall Study|Lost to Follow-up|0
325205|NCT01330017|1098315|P5|Overall Study|Withdrawal by Subject|1
325206|NCT01330017|1098316|P4|Overall Study|Withdrawal by Subject|0
325207|NCT01330017|1098317|P3|Overall Study|Withdrawal by Subject|1
325208|NCT01330017|1098318|P2|Overall Study|Withdrawal by Subject|0
325209|NCT01330017|1098319|P1|Overall Study|Withdrawal by Subject|0
325210|NCT01330017|1098315|P5|Overall Study|Adverse Event|0
325211|NCT01330017|1098316|P4|Overall Study|Adverse Event|4
325212|NCT01330017|1098317|P3|Overall Study|Adverse Event|1
325213|NCT01330017|1098318|P2|Overall Study|Adverse Event|1
325214|NCT01330017|1098319|P1|Overall Study|Adverse Event|0
325215|NCT01329978|1098368|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
325216|NCT01329978|1098369|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
325217|NCT01329978|1098370|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
325218|NCT01329978|1098371|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
325219|NCT01329978|1098372|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
325220|NCT01329978|1098368|P5|Rerandomization Treatment Period|Lost to Follow-up|3
325221|NCT01329978|1098369|P4|Rerandomization Treatment Period|Lost to Follow-up|5
325222|NCT01329978|1098370|P3|Rerandomization Treatment Period|Lost to Follow-up|0
325223|NCT01329978|1098371|P2|Rerandomization Treatment Period|Lost to Follow-up|0
325224|NCT01329978|1098372|P1|Rerandomization Treatment Period|Lost to Follow-up|0
325225|NCT01329978|1098368|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
325226|NCT01329978|1098369|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
325227|NCT01329978|1098370|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
325228|NCT01329978|1098371|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
325229|NCT01329978|1098372|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
325230|NCT01329978|1098368|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
325231|NCT01329978|1098369|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
325232|NCT01329978|1098370|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
325233|NCT01329978|1098371|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
325234|NCT01329978|1098372|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
325235|NCT01329978|1098368|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
325236|NCT01329978|1098369|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
325237|NCT01329978|1098370|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
325238|NCT01329978|1098371|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
325239|NCT01329978|1098372|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
325240|NCT01329978|1098368|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
325241|NCT01329978|1098369|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
325242|NCT01329978|1098370|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
325243|NCT01329978|1098371|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
325244|NCT01329978|1098372|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
325245|NCT01329978|1098368|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
325246|NCT01329978|1098369|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
325247|NCT01329978|1098370|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
325248|NCT01329978|1098371|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
325249|NCT01329978|1098372|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
325250|NCT01329939|1098446|P4|Overall Study|Adverse Event|3
325251|NCT01329939|1098447|P3|Overall Study|Adverse Event|0
325252|NCT01329939|1098448|P2|Overall Study|Adverse Event|0
325253|NCT01329939|1098449|P1|Overall Study|Adverse Event|0
325254|NCT01329939|1098446|P4|Overall Study|Withdrawal by Subject|0
325255|NCT01329939|1098447|P3|Overall Study|Withdrawal by Subject|0
325256|NCT01329939|1098448|P2|Overall Study|Withdrawal by Subject|1
325257|NCT01329939|1098449|P1|Overall Study|Withdrawal by Subject|0
325258|NCT01329939|1098446|P4|Overall Study|Lost to Follow-up|2
325259|NCT01329939|1098447|P3|Overall Study|Lost to Follow-up|1
325260|NCT01329939|1098448|P2|Overall Study|Lost to Follow-up|0
325261|NCT01329939|1098449|P1|Overall Study|Lost to Follow-up|3
325262|NCT01329562|1098513|P2|Overall Study|Physician Decision|1
325263|NCT01329562|1098514|P1|Overall Study|Physician Decision|0
325264|NCT01329562|1098513|P2|Overall Study|Subject withdrew due to personal issues.|2
325265|NCT01329562|1098514|P1|Overall Study|Subject withdrew due to personal issues.|3
325266|NCT01329562|1098513|P2|Overall Study|Lost to Follow-up|1
325267|NCT01329562|1098514|P1|Overall Study|Lost to Follow-up|1
325268|NCT01329562|1098513|P2|Overall Study|Protocol Violation|3
325269|NCT01329562|1098514|P1|Overall Study|Protocol Violation|5
325270|NCT01329549|1098563|P1|Overall Study|Adverse Event|1
325271|NCT01329549|1098563|P1|Overall Study|Withdrawal by Subject|1
325272|NCT01329419|1098574|P1|Overall Study|Protocol Violation|235
325273|NCT01329263|1098582|P2|Overall Study|Withdrawal by Subject|2
325274|NCT01329263|1098583|P1|Overall Study|Withdrawal by Subject|1
325275|NCT01329263|1098582|P2|Overall Study|Lost to Follow-up|21
325276|NCT01329263|1098583|P1|Overall Study|Lost to Follow-up|4
325277|NCT01329029|1098620|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
325278|NCT01329029|1098621|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
325279|NCT01329029|1098620|P2|Overall Study|Lost to Follow-up|5
325280|NCT01329029|1098621|P1|Overall Study|Lost to Follow-up|8
325281|NCT01329029|1098620|P2|Overall Study|Physician Decision|13
325282|NCT01329029|1098621|P1|Overall Study|Physician Decision|16
325283|NCT01329029|1098620|P2|Overall Study|COPD Exacerbation|18
325284|NCT01329029|1098621|P1|Overall Study|COPD Exacerbation|11
325285|NCT01329029|1098620|P2|Overall Study|Other|20
325286|NCT01329029|1098621|P1|Overall Study|Other|14
325287|NCT01329029|1098620|P2|Overall Study|Death|19
325288|NCT01329029|1098621|P1|Overall Study|Death|16
325289|NCT01329029|1098620|P2|Overall Study|Adverse Event|29
325290|NCT01329029|1098621|P1|Overall Study|Adverse Event|82
325291|NCT01329029|1098620|P2|Overall Study|Withdrawal by Subject|87
325292|NCT01329029|1098621|P1|Overall Study|Withdrawal by Subject|117
325293|NCT01328951|1098711|P2|Overall Study|Not Specified|6
325294|NCT01328951|1098712|P1|Overall Study|Not Specified|11
325295|NCT01328951|1098711|P2|Overall Study|Study Closed by the Sponsor|31
325296|NCT01328951|1098712|P1|Overall Study|Study Closed by the Sponsor|36
325297|NCT01328951|1098711|P2|Overall Study|Withdrawal by Subject|6
325298|NCT01328951|1098712|P1|Overall Study|Withdrawal by Subject|6
325299|NCT01328951|1098711|P2|Overall Study|Lost to Follow-up|7
325300|NCT01328951|1098712|P1|Overall Study|Lost to Follow-up|6
325301|NCT01328951|1098711|P2|Overall Study|Death|258
325302|NCT01328951|1098712|P1|Overall Study|Death|243
325303|NCT01328951|1098711|P2|Overall Study|Adverse Event|0
325304|NCT01328951|1098712|P1|Overall Study|Adverse Event|2
325305|NCT01328951|1098711|P2|Overall Study|Disease Progression|14
325306|NCT01328951|1098712|P1|Overall Study|Disease Progression|17
325307|NCT01328756|1098781|P1|Overall Study|Other|29
325308|NCT01328756|1098781|P1|Overall Study|Lost to Follow-up|5
325309|NCT01328756|1098781|P1|Overall Study|Withdrawal by Subject|41
325310|NCT01328756|1098781|P1|Overall Study|Lack of Efficacy|5
325311|NCT01328756|1098781|P1|Overall Study|Adverse Event|39
325312|NCT01328756|1098781|P1|Overall Study|Protocol Violation|4
325313|NCT01328717|1098798|P1|Overall Study|Adverse Event|1
325314|NCT01328574|1098803|P1|Overall Study|Refused further treatment|1
325315|NCT01328548|1098817|P2|Overall Study|Protocol Violation|0
325316|NCT01328548|1098818|P1|Overall Study|Protocol Violation|1
325317|NCT01328548|1098817|P2|Overall Study|Death|0
325318|NCT01328548|1098818|P1|Overall Study|Death|3
325319|NCT01328496|1098838|P2|Overall Study|Significant Change in Health Status|0
325320|NCT01328496|1098839|P1|Overall Study|Significant Change in Health Status|1
325321|NCT01328444|1098857|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
325322|NCT01328444|1098858|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
325323|NCT01328444|1098859|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
325324|NCT01328444|1098860|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
325325|NCT01328444|1098861|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
325326|NCT01328444|1098862|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
325327|NCT01328444|1098857|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
325328|NCT01328444|1098858|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
325329|NCT01328444|1098859|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
325330|NCT01328444|1098860|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
325331|NCT01328444|1098861|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
325332|NCT01328444|1098862|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
325333|NCT01328444|1098857|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
325334|NCT01328444|1098858|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
325335|NCT01328444|1098859|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
325336|NCT01328444|1098860|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
325337|NCT01328444|1098861|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
325338|NCT01328444|1098862|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
325339|NCT01328444|1098857|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
325340|NCT01328444|1098858|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
325341|NCT01328444|1098859|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
325342|NCT01328444|1098860|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
325343|NCT01328444|1098861|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
325344|NCT01328444|1098862|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
325345|NCT01328444|1098857|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
325346|NCT01328444|1098858|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
325347|NCT01328444|1098859|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
325348|NCT01328444|1098860|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
325349|NCT01328444|1098861|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
325350|NCT01328444|1098862|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
325351|NCT01328444|1098857|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
325352|NCT01328444|1098858|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
325353|NCT01328444|1098859|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
325354|NCT01328444|1098860|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
325355|NCT01328444|1098861|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
325356|NCT01328444|1098862|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
325357|NCT01328444|1098857|P6|Washout Period (14 Days)|Withdrawal by Subject|1
325358|NCT01328444|1098858|P5|Washout Period (14 Days)|Withdrawal by Subject|0
325359|NCT01328444|1098859|P4|Washout Period (14 Days)|Withdrawal by Subject|0
325360|NCT01328444|1098860|P3|Washout Period (14 Days)|Withdrawal by Subject|0
325361|NCT01328444|1098861|P2|Washout Period (14 Days)|Withdrawal by Subject|0
325362|NCT01328444|1098862|P1|Washout Period (14 Days)|Withdrawal by Subject|0
325363|NCT01328444|1098857|P6|Washout Period (14 Days)|Lack of Efficacy|1
325364|NCT01328444|1098858|P5|Washout Period (14 Days)|Lack of Efficacy|0
325365|NCT01328444|1098859|P4|Washout Period (14 Days)|Lack of Efficacy|0
325366|NCT01328444|1098860|P3|Washout Period (14 Days)|Lack of Efficacy|0
325367|NCT01328444|1098861|P2|Washout Period (14 Days)|Lack of Efficacy|0
325368|NCT01328444|1098862|P1|Washout Period (14 Days)|Lack of Efficacy|0
325369|NCT01328444|1098857|P6|Washout Period (14 Days)|Adverse Event|2
325370|NCT01328444|1098858|P5|Washout Period (14 Days)|Adverse Event|1
325371|NCT01328444|1098859|P4|Washout Period (14 Days)|Adverse Event|1
325372|NCT01328444|1098860|P3|Washout Period (14 Days)|Adverse Event|0
325373|NCT01328444|1098861|P2|Washout Period (14 Days)|Adverse Event|1
325374|NCT01328444|1098862|P1|Washout Period (14 Days)|Adverse Event|1
325375|NCT01328444|1098857|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
325376|NCT01328444|1098858|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
325377|NCT01328444|1098859|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
325378|NCT01328444|1098860|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
325379|NCT01328444|1098861|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
325380|NCT01328444|1098862|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
325381|NCT01328444|1098857|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
325382|NCT01328444|1098858|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325383|NCT01328444|1098859|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
325384|NCT01328444|1098860|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325385|NCT01328444|1098861|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325386|NCT01328444|1098862|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
325387|NCT01328444|1098857|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
325388|NCT01328444|1098858|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
325389|NCT01328444|1098859|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
325390|NCT01328444|1098860|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
325391|NCT01328444|1098861|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
325392|NCT01328444|1098862|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
325393|NCT01328444|1098857|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
325394|NCT01328444|1098858|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
325395|NCT01328444|1098859|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
325396|NCT01328444|1098860|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
325397|NCT01328444|1098861|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
325398|NCT01328444|1098862|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
325399|NCT01328444|1098857|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
325400|NCT01328444|1098858|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
325401|NCT01328444|1098859|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
325402|NCT01328444|1098860|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
325403|NCT01328444|1098861|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
325404|NCT01328444|1098862|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
325405|NCT01328444|1098857|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
325406|NCT01328444|1098858|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
325407|NCT01328444|1098859|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
325408|NCT01328444|1098860|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
325409|NCT01328444|1098861|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
325410|NCT01328444|1098862|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
325411|NCT01328431|1098908|P2|12 Month (12M)|Lost to Follow-up|91
325412|NCT01328431|1098909|P1|12 Month (12M)|Lost to Follow-up|82
325413|NCT01328431|1098908|P2|12 Month (12M)|Death|6
325414|NCT01328431|1098909|P1|12 Month (12M)|Death|2
325415|NCT01328431|1098908|P2|3 Month (3M)|Lost to Follow-up|70
325416|NCT01328431|1098909|P1|3 Month (3M)|Lost to Follow-up|75
325417|NCT01328431|1098908|P2|3 Month (3M)|Death|2
325418|NCT01328431|1098909|P1|3 Month (3M)|Death|2
325419|NCT01328431|1098908|P2|1 Month (1M)|Lost to Follow-up|58
325420|NCT01328431|1098909|P1|1 Month (1M)|Lost to Follow-up|55
325421|NCT01328431|1098908|P2|Baseline|Protocol Violation|2
325422|NCT01328431|1098909|P1|Baseline|Protocol Violation|0
325423|NCT01328366|1098965|P1|Overall Study|Lost to Follow-up|7
325424|NCT01328366|1098965|P1|Overall Study|Withdrawal by Subject|2
325425|NCT01328366|1098965|P1|Overall Study|Death|1
325426|NCT01328080|1099061|P1|Overall Study|Lost to Follow-up|5
325427|NCT01328054|1099065|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
325428|NCT01328054|1099066|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
325429|NCT01328054|1099065|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
325430|NCT01328054|1099066|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
325431|NCT01328054|1099065|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
325432|NCT01328054|1099066|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
325433|NCT01328041|1099091|P1|Overall Study|Withdrawal by Subject|7
325434|NCT01328041|1099091|P1|Overall Study|Physician Decision|2
325435|NCT01328041|1099091|P1|Overall Study|Lost to Follow-up|7
325436|NCT01328041|1099091|P1|Overall Study|Protocol Violation|7
325437|NCT01328041|1099091|P1|Overall Study|Lack of Efficacy|27
325438|NCT01328041|1099091|P1|Overall Study|Adverse Event|7
325439|NCT01327885|1099140|P2|Overall Study|Ongoing|1
325440|NCT01327885|1099141|P1|Overall Study|Ongoing|1
325441|NCT01327885|1099140|P2|Overall Study|Not treated|1
325442|NCT01327885|1099141|P1|Overall Study|Not treated|1
325443|NCT01327885|1099140|P2|Overall Study|Withdrawal of consent from study|4
325444|NCT01327885|1099141|P1|Overall Study|Withdrawal of consent from study|2
325445|NCT01327885|1099140|P2|Overall Study|Not specified|6
325446|NCT01327885|1099141|P1|Overall Study|Not specified|8
325447|NCT01327885|1099140|P2|Overall Study|Subject choice|10
325448|NCT01327885|1099141|P1|Overall Study|Subject choice|5
325449|NCT01327885|1099140|P2|Overall Study|Adverse Event|10
325450|NCT01327885|1099141|P1|Overall Study|Adverse Event|14
325451|NCT01327885|1099140|P2|Overall Study|Clinical progression|27
325452|NCT01327885|1099141|P1|Overall Study|Clinical progression|24
325453|NCT01327885|1099140|P2|Overall Study|Disease progression-according to RECIST|165
325454|NCT01327885|1099141|P1|Overall Study|Disease progression-according to RECIST|173
325455|NCT01327703|1099153|P2|Second Treatment Period|Protocol Violation|1
325456|NCT01327703|1099154|P1|Second Treatment Period|Protocol Violation|0
325457|NCT01327703|1099153|P2|Second Treatment Period|Adverse Event|1
325458|NCT01327703|1099154|P1|Second Treatment Period|Adverse Event|1
325459|NCT01327651|1099210|P9|Post Study Follow-up|Lost to Follow-up|2
325460|NCT01327651|1099211|P8|Post Study Follow-up|Lost to Follow-up|1
325461|NCT01327651|1099212|P7|Post Study Follow-up|Lost to Follow-up|4
325462|NCT01327651|1099213|P6|Post Study Follow-up|Lost to Follow-up|0
325463|NCT01327651|1099214|P5|Post Study Follow-up|Lost to Follow-up|0
325464|NCT01327651|1099215|P4|Post Study Follow-up|Lost to Follow-up|0
325465|NCT01327651|1099216|P3|Post Study Follow-up|Lost to Follow-up|1
325466|NCT01327651|1099217|P2|Post Study Follow-up|Lost to Follow-up|1
325467|NCT01327651|1099218|P1|Post Study Follow-up|Lost to Follow-up|0
325468|NCT01327651|1099210|P9|Self-administered Dosing Period|Withdrawal by Subject|1
325469|NCT01327651|1099211|P8|Self-administered Dosing Period|Withdrawal by Subject|1
325470|NCT01327651|1099212|P7|Self-administered Dosing Period|Withdrawal by Subject|2
325471|NCT01327651|1099213|P6|Self-administered Dosing Period|Withdrawal by Subject|0
325472|NCT01327651|1099214|P5|Self-administered Dosing Period|Withdrawal by Subject|0
325473|NCT01327651|1099215|P4|Self-administered Dosing Period|Withdrawal by Subject|1
325474|NCT01327651|1099216|P3|Self-administered Dosing Period|Withdrawal by Subject|0
325475|NCT01327651|1099217|P2|Self-administered Dosing Period|Withdrawal by Subject|1
325476|NCT01327651|1099218|P1|Self-administered Dosing Period|Withdrawal by Subject|0
325477|NCT01327651|1099210|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
325478|NCT01327651|1099211|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
325479|NCT01327651|1099212|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
325480|NCT01327651|1099213|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
325481|NCT01327651|1099214|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
325482|NCT01327651|1099215|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
325483|NCT01327651|1099216|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
325484|NCT01327651|1099217|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
325485|NCT01327651|1099218|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
325486|NCT01327651|1099210|P9|Self-administered Dosing Period|Lost to Follow-up|10
325487|NCT01327651|1099211|P8|Self-administered Dosing Period|Lost to Follow-up|9
325488|NCT01327651|1099212|P7|Self-administered Dosing Period|Lost to Follow-up|8
325489|NCT01327651|1099213|P6|Self-administered Dosing Period|Lost to Follow-up|0
325490|NCT01327651|1099214|P5|Self-administered Dosing Period|Lost to Follow-up|3
325491|NCT01327651|1099215|P4|Self-administered Dosing Period|Lost to Follow-up|2
325492|NCT01327651|1099216|P3|Self-administered Dosing Period|Lost to Follow-up|4
325493|NCT01327651|1099217|P2|Self-administered Dosing Period|Lost to Follow-up|2
325494|NCT01327651|1099218|P1|Self-administered Dosing Period|Lost to Follow-up|3
325495|NCT01327599|1099337|P1|Overall Study|Withdrawal of Consent|1
325496|NCT01327599|1099337|P1|Overall Study|Could Not Attend Visit|1
325497|NCT01327599|1099337|P1|Overall Study|Adverse Event|1
325498|NCT01327547|1099347|P2|Overall Study|By investigator in subject’s interest|1
325499|NCT01327547|1099348|P1|Overall Study|By investigator in subject’s interest|0
325500|NCT01327547|1099347|P2|Overall Study|Non-compliance with study procedures|0
325501|NCT01327547|1099348|P1|Overall Study|Non-compliance with study procedures|1
325502|NCT01327547|1099347|P2|Overall Study|Required prohibited medication|0
325503|NCT01327547|1099348|P1|Overall Study|Required prohibited medication|2
325504|NCT01327547|1099347|P2|Overall Study|Non-compliance due to alcohol intake|1
325505|NCT01327547|1099348|P1|Overall Study|Non-compliance due to alcohol intake|0
325506|NCT01327547|1099347|P2|Overall Study|Protocol Violation|0
325507|NCT01327547|1099348|P1|Overall Study|Protocol Violation|1
325508|NCT01327547|1099347|P2|Overall Study|Does Not Meet Entrance Criteria|2
325509|NCT01327547|1099348|P1|Overall Study|Does Not Meet Entrance Criteria|2
325510|NCT01327547|1099347|P2|Overall Study|Withdrawal by Subject|7
325511|NCT01327547|1099348|P1|Overall Study|Withdrawal by Subject|3
325512|NCT01327547|1099347|P2|Overall Study|Non-Compliance With Study Treatment|2
325513|NCT01327547|1099348|P1|Overall Study|Non-Compliance With Study Treatment|0
325514|NCT01327547|1099347|P2|Overall Study|Lost to Follow-up|6
325515|NCT01327547|1099348|P1|Overall Study|Lost to Follow-up|6
325516|NCT01327547|1099347|P2|Overall Study|Death|2
325517|NCT01327547|1099348|P1|Overall Study|Death|1
325518|NCT01327547|1099347|P2|Overall Study|Adverse Event|1
325519|NCT01327547|1099348|P1|Overall Study|Adverse Event|4
325520|NCT01327495|1099416|P6|Overall Study|Physician Decision|0
325521|NCT01327495|1099417|P5|Overall Study|Physician Decision|2
325522|NCT01327495|1099418|P4|Overall Study|Physician Decision|0
325523|NCT01327495|1099419|P3|Overall Study|Physician Decision|0
325524|NCT01327495|1099420|P2|Overall Study|Physician Decision|0
325525|NCT01327495|1099421|P1|Overall Study|Physician Decision|0
325526|NCT01327495|1099416|P6|Overall Study|Withdrawal by Subject|0
325527|NCT01327495|1099417|P5|Overall Study|Withdrawal by Subject|1
325528|NCT01327495|1099418|P4|Overall Study|Withdrawal by Subject|0
325529|NCT01327495|1099419|P3|Overall Study|Withdrawal by Subject|1
325530|NCT01327495|1099420|P2|Overall Study|Withdrawal by Subject|1
325531|NCT01327495|1099421|P1|Overall Study|Withdrawal by Subject|0
325532|NCT01327495|1099416|P6|Overall Study|Adverse Event|2
325533|NCT01327495|1099417|P5|Overall Study|Adverse Event|0
325534|NCT01327495|1099418|P4|Overall Study|Adverse Event|0
325535|NCT01327495|1099419|P3|Overall Study|Adverse Event|1
325536|NCT01327495|1099420|P2|Overall Study|Adverse Event|1
325537|NCT01327495|1099421|P1|Overall Study|Adverse Event|2
325538|NCT01327482|1099513|P1|Overall Study|Adverse Event|1
325539|NCT01327339|1099518|P1|Overall Study|Protocol Violation|8
325540|NCT01327300|1099653|P2|Washout (3 Weeks)|Withdrawal by Subject|0
325541|NCT01327300|1099654|P1|Washout (3 Weeks)|Withdrawal by Subject|1
325542|NCT01327053|1099679|P2|Overall Study|Untreated|1
325543|NCT01327053|1099680|P1|Overall Study|Untreated|0
325544|NCT01327053|1099679|P2|Overall Study|Withdrawal by Subject|28
325545|NCT01327053|1099680|P1|Overall Study|Withdrawal by Subject|5
325546|NCT01327053|1099679|P2|Overall Study|Protocol Violation|1
325547|NCT01327053|1099680|P1|Overall Study|Protocol Violation|0
325548|NCT01327053|1099679|P2|Overall Study|Progressive Disease|6
325549|NCT01327053|1099680|P1|Overall Study|Progressive Disease|15
325550|NCT01327053|1099679|P2|Overall Study|Physician Decision|10
325551|NCT01327053|1099680|P1|Overall Study|Physician Decision|3
325552|NCT01327053|1099679|P2|Overall Study|Non-compliance with study treatment|3
325553|NCT01327053|1099680|P1|Overall Study|Non-compliance with study treatment|0
325554|NCT01327053|1099679|P2|Overall Study|Lost to Follow-up|4
325555|NCT01327053|1099680|P1|Overall Study|Lost to Follow-up|1
325556|NCT01327053|1099679|P2|Overall Study|Death|4
325557|NCT01327053|1099680|P1|Overall Study|Death|0
325558|NCT01327053|1099679|P2|Overall Study|Adverse Event|48
325559|NCT01327053|1099680|P1|Overall Study|Adverse Event|16
325560|NCT01326962|1099708|P1|Overall Study|Not Specified|2
325561|NCT01326962|1099708|P1|Overall Study|Lost to Follow-up|3
325562|NCT01326962|1099708|P1|Overall Study|Withdrawal by Subject|1
325563|NCT01326962|1099708|P1|Overall Study|Adverse Event|1
325564|NCT01326910|1099726|P2|Overall Study|Protocol Violation|1
325565|NCT01326910|1099727|P1|Overall Study|Protocol Violation|1
325566|NCT01326910|1099726|P2|Overall Study|Withdrawal by Subject|2
325567|NCT01326910|1099727|P1|Overall Study|Withdrawal by Subject|3
325568|NCT01326845|1099741|P2|Overall Study|Misisng|3
325569|NCT01326845|1099742|P1|Overall Study|Misisng|1
325570|NCT01326845|1099741|P2|Overall Study|Adverse Event|0
325571|NCT01326845|1099742|P1|Overall Study|Adverse Event|1
325572|NCT01326845|1099741|P2|Overall Study|Administrative Problems|2
325573|NCT01326845|1099742|P1|Overall Study|Administrative Problems|5
325574|NCT01326728|1099766|P2|Overall Study|Early closure of study|9
325575|NCT01326728|1099767|P1|Overall Study|Early closure of study|34
325576|NCT01326728|1099766|P2|Overall Study|Death|0
325577|NCT01326728|1099767|P1|Overall Study|Death|13
325578|NCT01326533|1099786|P2|Overall Study|Adverse Event|0
325579|NCT01326533|1099787|P1|Overall Study|Adverse Event|1
325580|NCT01326533|1099786|P2|Overall Study|Withdrawal by Subject|0
325581|NCT01326533|1099787|P1|Overall Study|Withdrawal by Subject|1
325582|NCT01326533|1099786|P2|Overall Study|Lost to Follow-up|0
325583|NCT01326533|1099787|P1|Overall Study|Lost to Follow-up|2
325584|NCT01326026|1099797|P2|Overall Study|Other|3
325585|NCT01326026|1099798|P1|Overall Study|Other|3
325586|NCT01326026|1099797|P2|Overall Study|Withdrawal Criteria|7
325587|NCT01326026|1099798|P1|Overall Study|Withdrawal Criteria|5
325588|NCT01326026|1099797|P2|Overall Study|Adverse Event|3
325589|NCT01326026|1099798|P1|Overall Study|Adverse Event|4
325590|NCT01325701|1099863|P2|Overall Study|Rollerover Extension Study|0
325591|NCT01325701|1099864|P1|Overall Study|Rollerover Extension Study|4
325592|NCT01325701|1099863|P2|Overall Study|Withdrawal by Subject|1
325593|NCT01325701|1099864|P1|Overall Study|Withdrawal by Subject|2
325594|NCT01325701|1099863|P2|Overall Study|Physician Decision|2
325595|NCT01325701|1099864|P1|Overall Study|Physician Decision|2
325596|NCT01325701|1099863|P2|Overall Study|Protocol Violation|0
325597|NCT01325701|1099864|P1|Overall Study|Protocol Violation|1
325598|NCT01325701|1099863|P2|Overall Study|Adverse Event|0
325599|NCT01325701|1099864|P1|Overall Study|Adverse Event|12
325600|NCT01325623|1099874|P1|Overall Study|Withdrawal by Subject|3
325601|NCT01325584|1099916|P1|Overall Study|Death|1
325602|NCT01325532|1099926|P2|Overall Study|Withdrawal by Subject|0
325603|NCT01325532|1099927|P1|Overall Study|Withdrawal by Subject|2
325604|NCT01325493|1099939|P2|Overall Study|Allergy|0
325605|NCT01325493|1099940|P1|Overall Study|Allergy|1
325606|NCT01325493|1099939|P2|Overall Study|loss of neuromonitoring signals|2
325607|NCT01325493|1099940|P1|Overall Study|loss of neuromonitoring signals|0
325608|NCT01325493|1099939|P2|Overall Study|Protocol Violation|1
325609|NCT01325493|1099940|P1|Overall Study|Protocol Violation|0
325610|NCT01325428|1099952|P1|Part B|Other reason not defined above|1
325611|NCT01325428|1099952|P1|Part B|Refused continue taking trial medication|2
325612|NCT01325428|1099952|P1|Part A|Other reason not defined above|2
325613|NCT01325428|1099952|P1|Part A|Refused continue taking trial medication|2
325614|NCT01325428|1099952|P1|Part A|Other adverse event|1
325615|NCT01325428|1099952|P1|Part A|Clinical signs, symptoms of progression|2
325616|NCT01325428|1099952|P1|Part A|Progressive disease according to RECIST|9
325617|NCT01325350|1099972|P5|Overall Study|Did Not Receive Treatment|1
325618|NCT01325350|1099973|P4|Overall Study|Did Not Receive Treatment|0
325619|NCT01325350|1099974|P3|Overall Study|Did Not Receive Treatment|1
325620|NCT01325350|1099975|P2|Overall Study|Did Not Receive Treatment|1
325621|NCT01325350|1099976|P1|Overall Study|Did Not Receive Treatment|0
325622|NCT01325350|1099972|P5|Overall Study|Withdrawal by Subject|0
325623|NCT01325350|1099973|P4|Overall Study|Withdrawal by Subject|1
325624|NCT01325350|1099974|P3|Overall Study|Withdrawal by Subject|1
325625|NCT01325350|1099975|P2|Overall Study|Withdrawal by Subject|0
325626|NCT01325350|1099976|P1|Overall Study|Withdrawal by Subject|0
325627|NCT01325350|1099972|P5|Overall Study|Protocol Violation|0
325628|NCT01325350|1099973|P4|Overall Study|Protocol Violation|1
325629|NCT01325350|1099974|P3|Overall Study|Protocol Violation|0
325630|NCT01325350|1099975|P2|Overall Study|Protocol Violation|0
325631|NCT01325350|1099976|P1|Overall Study|Protocol Violation|0
325632|NCT01325350|1099972|P5|Overall Study|Personal Reasons|3
325633|NCT01325350|1099973|P4|Overall Study|Personal Reasons|5
325634|NCT01325350|1099974|P3|Overall Study|Personal Reasons|6
325635|NCT01325350|1099975|P2|Overall Study|Personal Reasons|1
325636|NCT01325350|1099976|P1|Overall Study|Personal Reasons|2
325637|NCT01325350|1099972|P5|Overall Study|Lost to Follow-up|5
325638|NCT01325350|1099973|P4|Overall Study|Lost to Follow-up|1
325639|NCT01325350|1099974|P3|Overall Study|Lost to Follow-up|5
325640|NCT01325350|1099975|P2|Overall Study|Lost to Follow-up|0
325641|NCT01325350|1099976|P1|Overall Study|Lost to Follow-up|1
325642|NCT01325350|1099972|P5|Overall Study|Pregnancy|1
325643|NCT01325350|1099973|P4|Overall Study|Pregnancy|0
325644|NCT01325350|1099974|P3|Overall Study|Pregnancy|1
325645|NCT01325350|1099975|P2|Overall Study|Pregnancy|0
325646|NCT01325350|1099976|P1|Overall Study|Pregnancy|0
325647|NCT01325350|1099972|P5|Overall Study|Adverse Event|2
325648|NCT01325350|1099973|P4|Overall Study|Adverse Event|1
325649|NCT01325350|1099974|P3|Overall Study|Adverse Event|3
325650|NCT01325350|1099975|P2|Overall Study|Adverse Event|3
325651|NCT01325350|1099976|P1|Overall Study|Adverse Event|3
325652|NCT01325337|1100018|P5|Overall Study|Withdrawal by Subject|1
325653|NCT01325337|1100019|P4|Overall Study|Withdrawal by Subject|0
325654|NCT01325337|1100020|P3|Overall Study|Withdrawal by Subject|1
325655|NCT01325337|1100021|P2|Overall Study|Withdrawal by Subject|0
325656|NCT01325337|1100022|P1|Overall Study|Withdrawal by Subject|1
325657|NCT01325337|1100018|P5|Overall Study|Personal Reasons|3
325658|NCT01325337|1100019|P4|Overall Study|Personal Reasons|8
325659|NCT01325337|1100020|P3|Overall Study|Personal Reasons|4
325660|NCT01325337|1100021|P2|Overall Study|Personal Reasons|5
325661|NCT01325337|1100022|P1|Overall Study|Personal Reasons|2
325662|NCT01325337|1100018|P5|Overall Study|Lost to Follow-up|2
325663|NCT01325337|1100019|P4|Overall Study|Lost to Follow-up|1
325664|NCT01325337|1100020|P3|Overall Study|Lost to Follow-up|2
325665|NCT01325337|1100021|P2|Overall Study|Lost to Follow-up|2
325666|NCT01325337|1100022|P1|Overall Study|Lost to Follow-up|2
325667|NCT01325337|1100018|P5|Overall Study|Adverse Event|2
325668|NCT01325337|1100019|P4|Overall Study|Adverse Event|1
325669|NCT01325337|1100020|P3|Overall Study|Adverse Event|2
325670|NCT01325337|1100021|P2|Overall Study|Adverse Event|2
325671|NCT01325337|1100022|P1|Overall Study|Adverse Event|0
325672|NCT01324999|1100105|P1|Overall Study|Withdrawal by Subject|2
325673|NCT01324999|1100105|P1|Overall Study|Adverse Event|3
325674|NCT01324947|1100116|P1|Overall Study|1 discontinued before starting drug|1
325675|NCT01324947|1100116|P1|Overall Study|Withdrawal by Subject|3
325676|NCT01324947|1100116|P1|Overall Study|Progressive Disease|50
325677|NCT01324947|1100116|P1|Overall Study|Other|3
325678|NCT01324947|1100116|P1|Overall Study|Death|10
325679|NCT01324947|1100116|P1|Overall Study|Adverse Event|7
325680|NCT01324622|1100172|P2|Overall Study|Lack of Efficacy|0
325681|NCT01324622|1100173|P1|Overall Study|Lack of Efficacy|1
325682|NCT01324622|1100172|P2|Overall Study|Death|0
325683|NCT01324622|1100173|P1|Overall Study|Death|1
325684|NCT01324622|1100172|P2|Overall Study|Lost to Follow-up|7
325685|NCT01324622|1100173|P1|Overall Study|Lost to Follow-up|7
325686|NCT01324570|1100203|P2|Overall Study|Administrative|2
325687|NCT01324570|1100204|P1|Overall Study|Administrative|0
325688|NCT01324570|1100203|P2|Overall Study|Confirmed or suspected diversion|1
325689|NCT01324570|1100204|P1|Overall Study|Confirmed or suspected diversion|0
325690|NCT01324570|1100203|P2|Overall Study|Lack of Efficacy|1
325691|NCT01324570|1100204|P1|Overall Study|Lack of Efficacy|0
325692|NCT01324570|1100203|P2|Overall Study|Withdrawal by Subject|3
325693|NCT01324570|1100204|P1|Overall Study|Withdrawal by Subject|0
325694|NCT01324570|1100203|P2|Overall Study|Adverse Event|7
325695|NCT01324570|1100204|P1|Overall Study|Adverse Event|4
325696|NCT01324440|1100241|P2|Overall Study|Subject moved|1
325697|NCT01324440|1100242|P1|Overall Study|Subject moved|0
325698|NCT01324401|1100256|P2|Overall Study|Adverse Event|3
325699|NCT01324401|1100257|P1|Overall Study|Adverse Event|1
325700|NCT01324401|1100256|P2|Overall Study|Withdrawn before any treatment|3
325701|NCT01324401|1100257|P1|Overall Study|Withdrawn before any treatment|0
325702|NCT01324388|1100268|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
325703|NCT01324388|1100269|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
325704|NCT01324388|1100270|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
325705|NCT01324388|1100271|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
325706|NCT01324388|1100268|P4|Part 2 of Study: First Intervention|Protocol Violation|1
325707|NCT01324388|1100269|P3|Part 2 of Study: First Intervention|Protocol Violation|0
325708|NCT01324388|1100270|P2|Part 2 of Study: First Intervention|Protocol Violation|0
325709|NCT01324388|1100271|P1|Part 2 of Study: First Intervention|Protocol Violation|0
325710|NCT01324388|1100268|P4|Part 1 of Study|Physician Decision|0
325711|NCT01324388|1100269|P3|Part 1 of Study|Physician Decision|0
325712|NCT01324388|1100270|P2|Part 1 of Study|Physician Decision|0
325713|NCT01324388|1100271|P1|Part 1 of Study|Physician Decision|1
325714|NCT01324388|1100268|P4|Part 1 of Study|Protocol Violation|0
325715|NCT01324388|1100269|P3|Part 1 of Study|Protocol Violation|0
325716|NCT01324388|1100270|P2|Part 1 of Study|Protocol Violation|2
325717|NCT01324388|1100271|P1|Part 1 of Study|Protocol Violation|1
325718|NCT01324388|1100268|P4|Part 1 of Study|Adverse Event|0
325719|NCT01324388|1100269|P3|Part 1 of Study|Adverse Event|0
325720|NCT01324388|1100270|P2|Part 1 of Study|Adverse Event|0
325721|NCT01324388|1100271|P1|Part 1 of Study|Adverse Event|2
325722|NCT01324349|1100292|P2|Overall Study|Withdrawal by Subject|1
325723|NCT01324349|1100293|P1|Overall Study|Withdrawal by Subject|0
325724|NCT01324349|1100292|P2|Overall Study|Death|1
325725|NCT01324349|1100293|P1|Overall Study|Death|1
325726|NCT01324323|1100303|P1|Overall Study|Withdrawal by Subject|1
325727|NCT01324310|1100323|P1|Overall Study|Disease Progression|1
325728|NCT01324310|1100323|P1|Overall Study|Adverse Event|1
325729|NCT01324271|1100343|P2|Overall Study|Physician Decision|0
325730|NCT01324271|1100344|P1|Overall Study|Physician Decision|1
325731|NCT01324271|1100343|P2|Overall Study|Lost to Follow-up|0
325732|NCT01324271|1100344|P1|Overall Study|Lost to Follow-up|3
325733|NCT01324102|1100367|P2|Overall Study|illness|6
325734|NCT01324102|1100368|P1|Overall Study|illness|1
325735|NCT01324024|1100375|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
325736|NCT01324024|1100376|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
325737|NCT01323972|1100414|P4|Overall Study|Lost to Follow-up|1
325738|NCT01323972|1100415|P3|Overall Study|Lost to Follow-up|1
325739|NCT01323972|1100416|P2|Overall Study|Lost to Follow-up|1
325740|NCT01323972|1100417|P1|Overall Study|Lost to Follow-up|0
325741|NCT01323972|1100414|P4|Overall Study|Migrated/moved from study area|0
325742|NCT01323972|1100415|P3|Overall Study|Migrated/moved from study area|0
325743|NCT01323972|1100416|P2|Overall Study|Migrated/moved from study area|2
325744|NCT01323972|1100417|P1|Overall Study|Migrated/moved from study area|1
325745|NCT01323972|1100414|P4|Overall Study|Withdrawal by Subject|0
325746|NCT01323972|1100415|P3|Overall Study|Withdrawal by Subject|1
325747|NCT01323972|1100416|P2|Overall Study|Withdrawal by Subject|0
325748|NCT01323972|1100417|P1|Overall Study|Withdrawal by Subject|1
325749|NCT01323920|1100510|P1|Overall Study|Withdrawal by Subject|1
325750|NCT01323920|1100510|P1|Overall Study|Death|5
325751|NCT01323790|1100551|P3|Overall Study|Severe non-compliance with protocol|2
325752|NCT01323790|1100552|P2|Overall Study|Severe non-compliance with protocol|2
325753|NCT01323790|1100553|P1|Overall Study|Severe non-compliance with protocol|2
325754|NCT01323790|1100551|P3|Overall Study|Did Not Receive Treatment|1
325755|NCT01323790|1100552|P2|Overall Study|Did Not Receive Treatment|0
325756|NCT01323790|1100553|P1|Overall Study|Did Not Receive Treatment|2
325757|NCT01323790|1100551|P3|Overall Study|Withdrawal by Subject|13
325758|NCT01323790|1100552|P2|Overall Study|Withdrawal by Subject|20
325759|NCT01323790|1100553|P1|Overall Study|Withdrawal by Subject|23
325760|NCT01323790|1100551|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
325761|NCT01323790|1100552|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
325762|NCT01323790|1100553|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
325763|NCT01323790|1100551|P3|Overall Study|Adverse Event|12
325764|NCT01323790|1100552|P2|Overall Study|Adverse Event|24
325765|NCT01323790|1100553|P1|Overall Study|Adverse Event|11
325766|NCT01323790|1100551|P3|Overall Study|Lack of Efficacy|3
325767|NCT01323790|1100552|P2|Overall Study|Lack of Efficacy|0
325768|NCT01323790|1100553|P1|Overall Study|Lack of Efficacy|3
325769|NCT01323790|1100551|P3|Overall Study|Study-Specific Withdrawal Criteria|3
325770|NCT01323790|1100552|P2|Overall Study|Study-Specific Withdrawal Criteria|3
325771|NCT01323790|1100553|P1|Overall Study|Study-Specific Withdrawal Criteria|0
325772|NCT01323790|1100551|P3|Overall Study|Lost to Follow-up|9
325773|NCT01323790|1100552|P2|Overall Study|Lost to Follow-up|9
325774|NCT01323790|1100553|P1|Overall Study|Lost to Follow-up|11
325775|NCT01323790|1100551|P3|Overall Study|Other|1
325776|NCT01323790|1100552|P2|Overall Study|Other|2
325777|NCT01323790|1100553|P1|Overall Study|Other|3
325778|NCT01323673|1100604|P2|Overall Study|Withdrawal by Subject|3
325779|NCT01323673|1100605|P1|Overall Study|Withdrawal by Subject|2
325780|NCT01323673|1100604|P2|Overall Study|Protocol Violation|0
325781|NCT01323673|1100605|P1|Overall Study|Protocol Violation|1
325782|NCT01323673|1100604|P2|Overall Study|Lost to Follow-up|1
325783|NCT01323673|1100605|P1|Overall Study|Lost to Follow-up|0
325784|NCT01323673|1100604|P2|Overall Study|Adverse Event|1
325785|NCT01323673|1100605|P1|Overall Study|Adverse Event|0
325786|NCT01323660|1100625|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
325787|NCT01323660|1100626|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
325788|NCT01323660|1100627|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
325789|NCT01323660|1100628|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
325790|NCT01323660|1100629|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
325791|NCT01323660|1100630|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
325792|NCT01323660|1100625|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
325793|NCT01323660|1100626|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
325794|NCT01323660|1100627|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
325795|NCT01323660|1100628|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
325796|NCT01323660|1100629|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
325797|NCT01323660|1100630|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
325798|NCT01323660|1100625|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
325799|NCT01323660|1100626|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
325800|NCT01323660|1100627|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
325801|NCT01323660|1100628|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
325802|NCT01323660|1100629|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
325803|NCT01323660|1100630|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
325804|NCT01323660|1100625|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
325805|NCT01323660|1100626|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
325806|NCT01323660|1100627|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
325807|NCT01323660|1100628|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
325808|NCT01323660|1100629|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
325809|NCT01323660|1100630|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
325810|NCT01323660|1100625|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
325811|NCT01323660|1100626|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
325812|NCT01323660|1100627|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
325813|NCT01323660|1100628|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
325814|NCT01323660|1100629|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
325815|NCT01323660|1100630|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
325816|NCT01323660|1100625|P6|Washout Period (14 Days)|Lack of Efficacy|2
325817|NCT01323660|1100626|P5|Washout Period (14 Days)|Lack of Efficacy|2
325818|NCT01323660|1100627|P4|Washout Period (14 Days)|Lack of Efficacy|3
325819|NCT01323660|1100628|P3|Washout Period (14 Days)|Lack of Efficacy|1
325820|NCT01323660|1100629|P2|Washout Period (14 Days)|Lack of Efficacy|0
325821|NCT01323660|1100630|P1|Washout Period (14 Days)|Lack of Efficacy|0
325822|NCT01323660|1100625|P6|Washout Period (14 Days)|Adverse Event|0
325823|NCT01323660|1100626|P5|Washout Period (14 Days)|Adverse Event|1
325824|NCT01323660|1100627|P4|Washout Period (14 Days)|Adverse Event|0
325825|NCT01323660|1100628|P3|Washout Period (14 Days)|Adverse Event|0
325826|NCT01323660|1100629|P2|Washout Period (14 Days)|Adverse Event|0
325827|NCT01323660|1100630|P1|Washout Period (14 Days)|Adverse Event|0
325828|NCT01323660|1100625|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
325829|NCT01323660|1100626|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
325830|NCT01323660|1100627|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
325831|NCT01323660|1100628|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
325832|NCT01323660|1100629|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
325833|NCT01323660|1100630|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
325834|NCT01323660|1100625|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325835|NCT01323660|1100626|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
325836|NCT01323660|1100627|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325837|NCT01323660|1100628|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325838|NCT01323660|1100629|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325839|NCT01323660|1100630|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
325840|NCT01323660|1100625|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
325841|NCT01323660|1100626|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
325842|NCT01323660|1100627|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
325843|NCT01323660|1100628|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
325844|NCT01323660|1100629|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
325845|NCT01323660|1100630|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
325846|NCT01323660|1100625|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
325847|NCT01323660|1100626|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
325848|NCT01323660|1100627|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
325849|NCT01323660|1100628|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
325850|NCT01323660|1100629|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
325851|NCT01323660|1100630|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
325852|NCT01323660|1100625|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
325853|NCT01323660|1100626|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
325854|NCT01323660|1100627|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
325855|NCT01323660|1100628|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
325856|NCT01323660|1100629|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
325857|NCT01323660|1100630|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
325858|NCT01323660|1100625|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
325859|NCT01323660|1100626|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
325860|NCT01323660|1100627|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
325861|NCT01323660|1100628|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
325862|NCT01323660|1100629|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
325863|NCT01323660|1100630|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
325864|NCT01323647|1100676|P2|Overall Study|Lost to Follow-up|0
325865|NCT01323647|1100677|P1|Overall Study|Lost to Follow-up|2
325866|NCT01323647|1100676|P2|Overall Study|Withdrawal by Subject|0
325867|NCT01323647|1100677|P1|Overall Study|Withdrawal by Subject|5
325868|NCT01323647|1100676|P2|Overall Study|Migrated/moved from study area|0
325869|NCT01323647|1100677|P1|Overall Study|Migrated/moved from study area|2
325870|NCT01323634|1100694|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
325871|NCT01323634|1100695|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
325872|NCT01323634|1100696|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
325873|NCT01323634|1100694|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
325874|NCT01323634|1100695|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
325875|NCT01323634|1100696|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
325876|NCT01323634|1100694|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
325877|NCT01323634|1100695|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
325878|NCT01323634|1100696|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
325879|NCT01323634|1100694|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
325880|NCT01323634|1100695|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
325881|NCT01323634|1100696|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
325882|NCT01323634|1100694|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
325883|NCT01323634|1100695|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
325884|NCT01323634|1100696|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
325885|NCT01323634|1100694|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
325886|NCT01323634|1100695|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
325887|NCT01323634|1100696|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
325888|NCT01323634|1100694|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
325889|NCT01323634|1100695|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
325890|NCT01323634|1100696|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
325891|NCT01323634|1100694|P3|2-week Run-in Period|Adverse Event|0
325892|NCT01323634|1100695|P2|2-week Run-in Period|Adverse Event|0
325893|NCT01323634|1100696|P1|2-week Run-in Period|Adverse Event|1
325894|NCT01323634|1100694|P3|2-week Run-in Period|Protocol Violation|0
325895|NCT01323634|1100695|P2|2-week Run-in Period|Protocol Violation|0
325896|NCT01323634|1100696|P1|2-week Run-in Period|Protocol Violation|1
325897|NCT01323634|1100694|P3|2-week Run-in Period|Physician Decision|0
325898|NCT01323634|1100695|P2|2-week Run-in Period|Physician Decision|0
325899|NCT01323634|1100696|P1|2-week Run-in Period|Physician Decision|5
325900|NCT01323634|1100694|P3|2-week Run-in Period|Withdrawal by Subject|0
325901|NCT01323634|1100695|P2|2-week Run-in Period|Withdrawal by Subject|0
325902|NCT01323634|1100696|P1|2-week Run-in Period|Withdrawal by Subject|7
325903|NCT01323634|1100694|P3|2-week Run-in Period|Continuation Criteria not Met|0
325904|NCT01323634|1100695|P2|2-week Run-in Period|Continuation Criteria not Met|0
325905|NCT01323634|1100696|P1|2-week Run-in Period|Continuation Criteria not Met|73
325906|NCT01323634|1100694|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
325907|NCT01323634|1100695|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
325908|NCT01323634|1100696|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
325909|NCT01323621|1100706|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
325910|NCT01323621|1100707|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
325911|NCT01323621|1100708|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
325912|NCT01323621|1100706|P3|12-week, Double-blind Treatment Period|Physician Decision|1
325913|NCT01323621|1100707|P2|12-week, Double-blind Treatment Period|Physician Decision|2
325914|NCT01323621|1100708|P1|12-week, Double-blind Treatment Period|Physician Decision|0
325915|NCT01323621|1100706|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
325916|NCT01323621|1100707|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
325917|NCT01323621|1100708|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
325918|NCT01323621|1100706|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
325919|NCT01323621|1100707|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
325920|NCT01323621|1100708|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
325921|NCT01323621|1100706|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
325922|NCT01323621|1100707|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
325923|NCT01323621|1100708|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
325924|NCT01323621|1100706|P3|12-week, Double-blind Treatment Period|Adverse Event|5
325925|NCT01323621|1100707|P2|12-week, Double-blind Treatment Period|Adverse Event|1
325926|NCT01323621|1100708|P1|12-week, Double-blind Treatment Period|Adverse Event|0
325927|NCT01323621|1100706|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
325928|NCT01323621|1100707|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
325929|NCT01323621|1100708|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
325930|NCT01323621|1100706|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
325931|NCT01323621|1100707|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
325932|NCT01323621|1100708|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
325933|NCT01323621|1100706|P3|2-week, Single-blind Run In Period|Protocol Violation|0
325934|NCT01323621|1100707|P2|2-week, Single-blind Run In Period|Protocol Violation|0
325935|NCT01323621|1100708|P1|2-week, Single-blind Run In Period|Protocol Violation|1
326022|NCT01321749|1101131|P2|Overall Study|Withdrawal by Subject|4
325936|NCT01323621|1100706|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
325937|NCT01323621|1100707|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
325938|NCT01323621|1100708|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
325939|NCT01323621|1100706|P3|2-week, Single-blind Run In Period|Physician Decision|0
325940|NCT01323621|1100707|P2|2-week, Single-blind Run In Period|Physician Decision|0
325941|NCT01323621|1100708|P1|2-week, Single-blind Run In Period|Physician Decision|7
325942|NCT01323621|1100706|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
325943|NCT01323621|1100707|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
325944|NCT01323621|1100708|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
325945|NCT01323582|1100727|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
325946|NCT01323582|1100728|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
325947|NCT01323582|1100727|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
325948|NCT01323582|1100728|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
325949|NCT01323582|1100727|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
325950|NCT01323582|1100728|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
325951|NCT01323478|1100751|P1|Overall Study|Administrative or Other Reasons|8
325952|NCT01323478|1100751|P1|Overall Study|Withdrawal of Consent|1
325953|NCT01323478|1100751|P1|Overall Study|Protocol Violation|1
325954|NCT01323478|1100751|P1|Overall Study|Non-compliance With Study Product|3
325955|NCT01323478|1100751|P1|Overall Study|Lack of Efficacy|4
325956|NCT01323478|1100751|P1|Overall Study|Adverse Event|7
325957|NCT01323387|1100764|P1|Overall Study|Randomized but Never Treated|16
325958|NCT01323387|1100764|P1|Overall Study|Protocol Violation|12
325959|NCT01323387|1100764|P1|Overall Study|Revision|14
325960|NCT01323387|1100764|P1|Overall Study|Radiographic Data Unavailable|1
325961|NCT01323387|1100764|P1|Overall Study|Withdrawal by Subject|41
325962|NCT01323270|1100777|P2|Overall Study|Randomized, but not vaccinated|0
325963|NCT01323270|1100778|P1|Overall Study|Randomized, but not vaccinated|1
325964|NCT01323270|1100777|P2|Overall Study|Death|0
325965|NCT01323270|1100778|P1|Overall Study|Death|1
325966|NCT01323270|1100777|P2|Overall Study|Not eligible|1
325967|NCT01323270|1100778|P1|Overall Study|Not eligible|1
325968|NCT01323270|1100777|P2|Overall Study|Physician Decision|2
325969|NCT01323270|1100778|P1|Overall Study|Physician Decision|0
325970|NCT01323270|1100777|P2|Overall Study|Other|3
325971|NCT01323270|1100778|P1|Overall Study|Other|0
325972|NCT01323270|1100777|P2|Overall Study|Adverse Event|0
325973|NCT01323270|1100778|P1|Overall Study|Adverse Event|8
325974|NCT01323270|1100777|P2|Overall Study|Lost to Follow-up|6
325975|NCT01323270|1100778|P1|Overall Study|Lost to Follow-up|4
325976|NCT01323270|1100777|P2|Overall Study|Protocol Violation|7
325977|NCT01323270|1100778|P1|Overall Study|Protocol Violation|9
325978|NCT01323270|1100777|P2|Overall Study|Withdrawal by Subject|10
325979|NCT01323270|1100778|P1|Overall Study|Withdrawal by Subject|19
325980|NCT01323192|1100800|P2|Overall Study|Nonmedical reasons|1
325981|NCT01323192|1100801|P1|Overall Study|Nonmedical reasons|0
325982|NCT01323192|1100800|P2|Overall Study|Noncompliance with study medication|3
325983|NCT01323192|1100801|P1|Overall Study|Noncompliance with study medication|0
325984|NCT01323192|1100800|P2|Overall Study|Withdrawal by Subject|1
325985|NCT01323192|1100801|P1|Overall Study|Withdrawal by Subject|3
325986|NCT01323192|1100800|P2|Overall Study|Adverse Event|1
325987|NCT01323192|1100801|P1|Overall Study|Adverse Event|6
325988|NCT01322386|1101040|P2|Overall Study|Physician Decision|1
325989|NCT01322386|1101041|P1|Overall Study|Physician Decision|0
325990|NCT01322386|1101040|P2|Overall Study|Protocol Violation|1
325991|NCT01322386|1101041|P1|Overall Study|Protocol Violation|0
325992|NCT01322347|1101056|P2|Overall Study|moved/changed dialysis|4
325993|NCT01322347|1101057|P1|Overall Study|moved/changed dialysis|2
325994|NCT01322347|1101056|P2|Overall Study|study drug withheld > 12 wks|1
325995|NCT01322347|1101057|P1|Overall Study|study drug withheld > 12 wks|0
325996|NCT01322347|1101056|P2|Overall Study|kidney transplant|1
325997|NCT01322347|1101057|P1|Overall Study|kidney transplant|3
325998|NCT01322347|1101056|P2|Overall Study|ineligible|3
325999|NCT01322347|1101057|P1|Overall Study|ineligible|6
326000|NCT01322347|1101056|P2|Overall Study|sponsor decision|3
326001|NCT01322347|1101057|P1|Overall Study|sponsor decision|1
326002|NCT01322347|1101056|P2|Overall Study|blood transfusion|5
326003|NCT01322347|1101057|P1|Overall Study|blood transfusion|5
326004|NCT01322347|1101056|P2|Overall Study|non-protocol change to ESA or IV iron|6
326005|NCT01322347|1101057|P1|Overall Study|non-protocol change to ESA or IV iron|14
326006|NCT01322347|1101056|P2|Overall Study|Withdrawal by Subject|4
326007|NCT01322347|1101057|P1|Overall Study|Withdrawal by Subject|1
326008|NCT01322347|1101056|P2|Overall Study|Protocol Violation|2
326009|NCT01322347|1101057|P1|Overall Study|Protocol Violation|5
326010|NCT01322347|1101056|P2|Overall Study|Physician Decision|1
326011|NCT01322347|1101057|P1|Overall Study|Physician Decision|2
326012|NCT01322347|1101056|P2|Overall Study|Death|3
326013|NCT01322347|1101057|P1|Overall Study|Death|5
326014|NCT01322347|1101056|P2|Overall Study|Adverse Event|2
326015|NCT01322347|1101057|P1|Overall Study|Adverse Event|7
326016|NCT01322009|1101120|P2|Overall Study|ng tube discontinued|1
326017|NCT01322009|1101121|P1|Overall Study|ng tube discontinued|0
326018|NCT01322009|1101120|P2|Overall Study|Adverse Event|1
326019|NCT01322009|1101121|P1|Overall Study|Adverse Event|0
326020|NCT01322009|1101120|P2|Overall Study|Death|1
326021|NCT01322009|1101121|P1|Overall Study|Death|0
326023|NCT01321749|1101132|P1|Overall Study|Withdrawal by Subject|5
326024|NCT01321749|1101131|P2|Overall Study|Protocol Violation|7
326025|NCT01321749|1101132|P1|Overall Study|Protocol Violation|4
326026|NCT01321749|1101131|P2|Overall Study|Lost to Follow-up|11
326027|NCT01321749|1101132|P1|Overall Study|Lost to Follow-up|4
326028|NCT01321723|1101141|P3|Overall Study|Withdrawal by Subject|2
326029|NCT01321723|1101142|P2|Overall Study|Withdrawal by Subject|0
326030|NCT01321723|1101143|P1|Overall Study|Withdrawal by Subject|2
326031|NCT01321723|1101141|P3|Overall Study|Adverse Event|2
326032|NCT01321723|1101142|P2|Overall Study|Adverse Event|5
326033|NCT01321723|1101143|P1|Overall Study|Adverse Event|3
326034|NCT01321710|1101165|P3|Overall Study|Lost to Follow-up|0
326035|NCT01321710|1101166|P2|Overall Study|Lost to Follow-up|5
326036|NCT01321710|1101167|P1|Overall Study|Lost to Follow-up|4
326037|NCT01321697|1101182|P1|Overall Study|Study Terminated|7
326038|NCT01321554|1101188|P4|OOL Lenvatinib Treatment Period|Death|1
326039|NCT01321554|1101189|P3|OOL Lenvatinib Treatment Period|Death|1
326040|NCT01321554|1101190|P2|OOL Lenvatinib Treatment Period|Death|0
326041|NCT01321554|1101191|P1|OOL Lenvatinib Treatment Period|Death|0
326042|NCT01321554|1101188|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
326043|NCT01321554|1101189|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
326044|NCT01321554|1101190|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
326045|NCT01321554|1101191|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
326046|NCT01321554|1101188|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
326047|NCT01321554|1101189|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
326048|NCT01321554|1101190|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
326049|NCT01321554|1101191|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
326050|NCT01321554|1101188|P4|OOL Lenvatinib Treatment Period|Not specified|0
326051|NCT01321554|1101189|P3|OOL Lenvatinib Treatment Period|Not specified|5
326052|NCT01321554|1101190|P2|OOL Lenvatinib Treatment Period|Not specified|0
326053|NCT01321554|1101191|P1|OOL Lenvatinib Treatment Period|Not specified|0
326054|NCT01321554|1101188|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
326055|NCT01321554|1101189|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
326056|NCT01321554|1101190|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
326057|NCT01321554|1101191|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
326058|NCT01321554|1101188|P4|OOL Lenvatinib Treatment Period|Participant choice|0
326059|NCT01321554|1101189|P3|OOL Lenvatinib Treatment Period|Participant choice|3
326060|NCT01321554|1101190|P2|OOL Lenvatinib Treatment Period|Participant choice|0
326061|NCT01321554|1101191|P1|OOL Lenvatinib Treatment Period|Participant choice|0
326062|NCT01321554|1101188|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
326063|NCT01321554|1101189|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
326064|NCT01321554|1101190|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
326065|NCT01321554|1101191|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
326066|NCT01321554|1101188|P4|Randomization Phase|Death|0
326067|NCT01321554|1101189|P3|Randomization Phase|Death|0
326068|NCT01321554|1101190|P2|Randomization Phase|Death|1
326069|NCT01321554|1101191|P1|Randomization Phase|Death|0
326070|NCT01321554|1101188|P4|Randomization Phase|Withdrawal by Subject|0
326071|NCT01321554|1101189|P3|Randomization Phase|Withdrawal by Subject|0
326072|NCT01321554|1101190|P2|Randomization Phase|Withdrawal by Subject|0
326073|NCT01321554|1101191|P1|Randomization Phase|Withdrawal by Subject|4
326074|NCT01321554|1101188|P4|Randomization Phase|Participant choice|0
326075|NCT01321554|1101189|P3|Randomization Phase|Participant choice|0
326076|NCT01321554|1101190|P2|Randomization Phase|Participant choice|0
326077|NCT01321554|1101191|P1|Randomization Phase|Participant choice|4
326078|NCT01321554|1101188|P4|Randomization Phase|Adverse Event|0
326079|NCT01321554|1101189|P3|Randomization Phase|Adverse Event|0
326080|NCT01321554|1101190|P2|Randomization Phase|Adverse Event|3
326081|NCT01321554|1101191|P1|Randomization Phase|Adverse Event|37
326082|NCT01321073|1101204|P1|Overall Study|Death|3
326083|NCT01321073|1101204|P1|Overall Study|Did not attempt implant|4
326084|NCT01321008|1101208|P1|Overall Study|Early Study Termination|1
326085|NCT01320943|1101214|P2|Overall Study|Randomized but not Treated|1
326086|NCT01320943|1101215|P1|Overall Study|Randomized but not Treated|0
326087|NCT01320943|1101214|P2|Overall Study|Physician Decision|1
326088|NCT01320943|1101215|P1|Overall Study|Physician Decision|0
326089|NCT01320943|1101214|P2|Overall Study|Lost to Follow-up|0
326090|NCT01320943|1101215|P1|Overall Study|Lost to Follow-up|1
326091|NCT01320735|1101249|P1|Overall Study|Investigator Unable to be Contacted|17
326092|NCT01320735|1101249|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
326093|NCT01320735|1101249|P1|Overall Study|Not Specified|1
326094|NCT01320735|1101249|P1|Overall Study|Protocol Violation|1
326095|NCT01320735|1101249|P1|Overall Study|Progression/Hormone-Refractory Pca|55
326096|NCT01320735|1101249|P1|Overall Study|Administrative Reason|6
326097|NCT01320735|1101249|P1|Overall Study|Lost to Follow-up|13
326098|NCT01320735|1101249|P1|Overall Study|Withdrawal by Subject|3
326099|NCT01320735|1101249|P1|Overall Study|Adverse Event|3
326100|NCT01320722|1101271|P5|Overall Study|Withdrew due to Health Condition|1
326101|NCT01320722|1101272|P4|Overall Study|Withdrew due to Health Condition|0
326102|NCT01320722|1101273|P3|Overall Study|Withdrew due to Health Condition|0
326103|NCT01320722|1101274|P2|Overall Study|Withdrew due to Health Condition|0
326104|NCT01320722|1101275|P1|Overall Study|Withdrew due to Health Condition|0
326105|NCT01320722|1101271|P5|Overall Study|Started an Exclusionary Medication|1
326106|NCT01320722|1101272|P4|Overall Study|Started an Exclusionary Medication|0
326107|NCT01320722|1101273|P3|Overall Study|Started an Exclusionary Medication|0
326108|NCT01320722|1101274|P2|Overall Study|Started an Exclusionary Medication|0
326109|NCT01320722|1101275|P1|Overall Study|Started an Exclusionary Medication|0
326110|NCT01320722|1101271|P5|Overall Study|Pregnancy|0
326111|NCT01320722|1101272|P4|Overall Study|Pregnancy|1
326112|NCT01320722|1101273|P3|Overall Study|Pregnancy|0
326113|NCT01320722|1101274|P2|Overall Study|Pregnancy|0
326114|NCT01320722|1101275|P1|Overall Study|Pregnancy|0
326115|NCT01320722|1101271|P5|Overall Study|Not Compliant with Study Procedures|0
326116|NCT01320722|1101272|P4|Overall Study|Not Compliant with Study Procedures|4
326117|NCT01320722|1101273|P3|Overall Study|Not Compliant with Study Procedures|0
326118|NCT01320722|1101274|P2|Overall Study|Not Compliant with Study Procedures|0
326119|NCT01320722|1101275|P1|Overall Study|Not Compliant with Study Procedures|0
326120|NCT01320722|1101271|P5|Overall Study|Adverse Event|0
326121|NCT01320722|1101272|P4|Overall Study|Adverse Event|6
326122|NCT01320722|1101273|P3|Overall Study|Adverse Event|3
326123|NCT01320722|1101274|P2|Overall Study|Adverse Event|0
326124|NCT01320722|1101275|P1|Overall Study|Adverse Event|0
326125|NCT01320722|1101271|P5|Overall Study|Non-compliant with Medication|0
326126|NCT01320722|1101272|P4|Overall Study|Non-compliant with Medication|0
326127|NCT01320722|1101273|P3|Overall Study|Non-compliant with Medication|1
326128|NCT01320722|1101274|P2|Overall Study|Non-compliant with Medication|0
326129|NCT01320722|1101275|P1|Overall Study|Non-compliant with Medication|0
326130|NCT01320722|1101271|P5|Overall Study|Participant Developed a Rash|1
326131|NCT01320722|1101272|P4|Overall Study|Participant Developed a Rash|1
326132|NCT01320722|1101273|P3|Overall Study|Participant Developed a Rash|2
326133|NCT01320722|1101274|P2|Overall Study|Participant Developed a Rash|0
326134|NCT01320722|1101275|P1|Overall Study|Participant Developed a Rash|0
326135|NCT01320722|1101271|P5|Overall Study|Not Available for the 8 Week Visit|0
326136|NCT01320722|1101272|P4|Overall Study|Not Available for the 8 Week Visit|0
326137|NCT01320722|1101273|P3|Overall Study|Not Available for the 8 Week Visit|0
326138|NCT01320722|1101274|P2|Overall Study|Not Available for the 8 Week Visit|3
326139|NCT01320722|1101275|P1|Overall Study|Not Available for the 8 Week Visit|0
326140|NCT01320722|1101271|P5|Overall Study|Lost to Follow-up|3
326141|NCT01320722|1101272|P4|Overall Study|Lost to Follow-up|1
326142|NCT01320722|1101273|P3|Overall Study|Lost to Follow-up|0
326143|NCT01320722|1101274|P2|Overall Study|Lost to Follow-up|1
326144|NCT01320722|1101275|P1|Overall Study|Lost to Follow-up|0
326145|NCT01320722|1101271|P5|Overall Study|Did not Receive Intervention|2
326146|NCT01320722|1101272|P4|Overall Study|Did not Receive Intervention|1
326147|NCT01320722|1101273|P3|Overall Study|Did not Receive Intervention|1
326148|NCT01320722|1101274|P2|Overall Study|Did not Receive Intervention|2
326149|NCT01320722|1101275|P1|Overall Study|Did not Receive Intervention|3
326150|NCT01320683|1101312|P1|Overall Study|Positive antibody response|1
326151|NCT01320293|1101338|P1|Overall Study|Adverse Event|1
326152|NCT01320293|1101338|P1|Overall Study|Lack of Efficacy|1
326153|NCT01320202|1101346|P2|Overall Study|regained renal function|0
326154|NCT01320202|1101347|P1|Overall Study|regained renal function|1
326155|NCT01320202|1101346|P2|Overall Study|ineligible|0
326156|NCT01320202|1101347|P1|Overall Study|ineligible|3
326157|NCT01320202|1101346|P2|Overall Study|sponsor request|0
326158|NCT01320202|1101347|P1|Overall Study|sponsor request|2
326159|NCT01320202|1101346|P2|Overall Study|moved/changed dialysis|2
326160|NCT01320202|1101347|P1|Overall Study|moved/changed dialysis|5
326161|NCT01320202|1101346|P2|Overall Study|blood transfusion|7
326162|NCT01320202|1101347|P1|Overall Study|blood transfusion|1
326163|NCT01320202|1101346|P2|Overall Study|kidney transplant|2
326164|NCT01320202|1101347|P1|Overall Study|kidney transplant|1
326165|NCT01320202|1101346|P2|Overall Study|non-protocol change to ESA or IV iron|20
326166|NCT01320202|1101347|P1|Overall Study|non-protocol change to ESA or IV iron|17
326167|NCT01320202|1101346|P2|Overall Study|Withdrawal by Subject|3
326168|NCT01320202|1101347|P1|Overall Study|Withdrawal by Subject|10
326169|NCT01320202|1101346|P2|Overall Study|Protocol Violation|1
326170|NCT01320202|1101347|P1|Overall Study|Protocol Violation|2
326171|NCT01320202|1101346|P2|Overall Study|Physician Decision|1
326172|NCT01320202|1101347|P1|Overall Study|Physician Decision|3
326173|NCT01320202|1101346|P2|Overall Study|Lost to Follow-up|0
326174|NCT01320202|1101347|P1|Overall Study|Lost to Follow-up|1
326175|NCT01320202|1101346|P2|Overall Study|Death|3
326176|NCT01320202|1101347|P1|Overall Study|Death|5
326177|NCT01320202|1101346|P2|Overall Study|Adverse Event|5
326178|NCT01320202|1101347|P1|Overall Study|Adverse Event|5
326179|NCT01319877|1101411|P2|Overall Study|Reason Not Specified|5
326180|NCT01319877|1101412|P1|Overall Study|Reason Not Specified|4
326181|NCT01319877|1101411|P2|Overall Study|Withdrawal by Subject|1
326182|NCT01319877|1101412|P1|Overall Study|Withdrawal by Subject|0
326183|NCT01319877|1101411|P2|Overall Study|Disease Progression|2
326184|NCT01319877|1101412|P1|Overall Study|Disease Progression|2
326185|NCT01319877|1101411|P2|Overall Study|Physician Decision|0
326186|NCT01319877|1101412|P1|Overall Study|Physician Decision|2
326187|NCT01319877|1101411|P2|Overall Study|Lost to Follow-up|37
326188|NCT01319877|1101412|P1|Overall Study|Lost to Follow-up|100
326189|NCT01319721|1101562|P2|Overall Study|Lost to Follow-up|6
326190|NCT01319721|1101563|P1|Overall Study|Lost to Follow-up|1
326191|NCT01319422|1101616|P2|Overall Study|Withdrawal by Subject|0
326192|NCT01319422|1101617|P1|Overall Study|Withdrawal by Subject|1
326193|NCT01319383|1101635|P2|Overall Study|No in vivo response to interval doses|1
326194|NCT01319383|1101636|P1|Overall Study|No in vivo response to interval doses|0
326195|NCT01319383|1101635|P2|Overall Study|Lack of Efficacy|9
326196|NCT01319383|1101636|P1|Overall Study|Lack of Efficacy|5
326197|NCT01319383|1101635|P2|Overall Study|Physician Decision|0
326198|NCT01319383|1101636|P1|Overall Study|Physician Decision|3
326199|NCT01319383|1101635|P2|Overall Study|No ex vivo or in vivo response|0
326200|NCT01319383|1101636|P1|Overall Study|No ex vivo or in vivo response|4
326201|NCT01318993|1101675|P1|Overall Study|Withdrawal by Subject|24
326202|NCT01318993|1101675|P1|Overall Study|Physician Decision|13
326203|NCT01318993|1101675|P1|Overall Study|Lost to Follow-up|4
326204|NCT01318993|1101675|P1|Overall Study|Study closed or terminated|174
326205|NCT01318993|1101675|P1|Overall Study|Protocol based stopping criteria|6
326206|NCT01318993|1101675|P1|Overall Study|Protocol Violation|3
326207|NCT01318993|1101675|P1|Overall Study|Lack of Efficacy|121
326208|NCT01318993|1101675|P1|Overall Study|Adverse Event|53
326209|NCT01318915|1101696|P1|Overall Study|Ongoing in study|7
326210|NCT01318915|1101696|P1|Overall Study|Lost to Follow-up|1
326211|NCT01318876|1101700|P1|Day 29 Survey|survey not completed-don't know why|1825
326212|NCT01318876|1101700|P1|Day 8 Survey|survey not completed-don't know why|1724
326213|NCT01318876|1101700|P1|Day 8 Survey|email address invalid|96
326214|NCT01318512|1101798|P1|Maintenance Period (6 Months)|Protocol Violation|9
326215|NCT01318512|1101798|P1|Maintenance Period (6 Months)|Death|2
326216|NCT01318499|1101817|P3|Overall Study|Not Specified|22
326217|NCT01318499|1101818|P2|Overall Study|Not Specified|10
326218|NCT01318499|1101819|P1|Overall Study|Not Specified|7
326219|NCT01318499|1101817|P3|Overall Study|Patient Did Not Use Study Medication|14
326220|NCT01318499|1101818|P2|Overall Study|Patient Did Not Use Study Medication|28
326221|NCT01318499|1101819|P1|Overall Study|Patient Did Not Use Study Medication|18
326222|NCT01318499|1101817|P3|Overall Study|Protocol Violation|2
326223|NCT01318499|1101818|P2|Overall Study|Protocol Violation|4
326224|NCT01318499|1101819|P1|Overall Study|Protocol Violation|2
326225|NCT01318499|1101817|P3|Overall Study|Treatment Failure|101
326226|NCT01318499|1101818|P2|Overall Study|Treatment Failure|19
326227|NCT01318499|1101819|P1|Overall Study|Treatment Failure|19
326228|NCT01318499|1101817|P3|Overall Study|Noncompliance|0
326229|NCT01318499|1101818|P2|Overall Study|Noncompliance|3
326230|NCT01318499|1101819|P1|Overall Study|Noncompliance|2
326231|NCT01318499|1101817|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
326232|NCT01318499|1101818|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
326233|NCT01318499|1101819|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
326234|NCT01318499|1101817|P3|Overall Study|Adverse Event|6
326235|NCT01318499|1101818|P2|Overall Study|Adverse Event|11
326236|NCT01318499|1101819|P1|Overall Study|Adverse Event|16
326237|NCT01318382|1101842|P1|Overall Study|Protocol Violation|1
326238|NCT01318382|1101842|P1|Overall Study|Device Malfunction|10
326239|NCT01318382|1101842|P1|Overall Study|Physician Decision|2
326240|NCT01318135|1101900|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
326241|NCT01318135|1101901|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
326242|NCT01318135|1101902|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
326243|NCT01318135|1101903|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
326244|NCT01318135|1101904|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
326245|NCT01318135|1101905|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
326246|NCT01318135|1101906|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
326247|NCT01318135|1101907|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
326248|NCT01318135|1101900|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
326249|NCT01318135|1101901|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
326250|NCT01318135|1101902|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
326251|NCT01318135|1101903|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
326252|NCT01318135|1101904|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
326253|NCT01318135|1101905|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
326254|NCT01318135|1101906|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
326255|NCT01318135|1101907|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
326256|NCT01318135|1101900|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
326257|NCT01318135|1101901|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
326258|NCT01318135|1101902|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
326259|NCT01318135|1101903|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
326260|NCT01318135|1101904|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
326261|NCT01318135|1101905|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
326262|NCT01318135|1101906|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
326263|NCT01318135|1101907|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
326264|NCT01318135|1101900|P8|Entered - Long-Term Extension Study|Protocol Violation|0
326265|NCT01318135|1101901|P7|Entered - Long-Term Extension Study|Protocol Violation|0
326266|NCT01318135|1101902|P6|Entered - Long-Term Extension Study|Protocol Violation|0
326267|NCT01318135|1101903|P5|Entered - Long-Term Extension Study|Protocol Violation|1
326268|NCT01318135|1101904|P4|Entered - Long-Term Extension Study|Protocol Violation|0
326269|NCT01318135|1101905|P3|Entered - Long-Term Extension Study|Protocol Violation|0
326270|NCT01318135|1101906|P2|Entered - Long-Term Extension Study|Protocol Violation|1
326271|NCT01318135|1101907|P1|Entered - Long-Term Extension Study|Protocol Violation|1
326272|NCT01318135|1101900|P8|Entered - Long-Term Extension Study|Adverse Event|0
326273|NCT01318135|1101901|P7|Entered - Long-Term Extension Study|Adverse Event|0
326274|NCT01318135|1101902|P6|Entered - Long-Term Extension Study|Adverse Event|2
326275|NCT01318135|1101903|P5|Entered - Long-Term Extension Study|Adverse Event|4
326276|NCT01318135|1101904|P4|Entered - Long-Term Extension Study|Adverse Event|3
326277|NCT01318135|1101905|P3|Entered - Long-Term Extension Study|Adverse Event|4
326278|NCT01318135|1101906|P2|Entered - Long-Term Extension Study|Adverse Event|3
326279|NCT01318135|1101907|P1|Entered - Long-Term Extension Study|Adverse Event|9
326280|NCT01318135|1101900|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
326281|NCT01318135|1101901|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
326282|NCT01318135|1101902|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
326283|NCT01318135|1101903|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
326284|NCT01318135|1101904|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
326285|NCT01318135|1101905|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
326286|NCT01318135|1101906|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
326287|NCT01318135|1101907|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
326288|NCT01318135|1101900|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
326289|NCT01318135|1101901|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
326290|NCT01318135|1101902|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
326291|NCT01318135|1101903|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
326292|NCT01318135|1101904|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
326293|NCT01318135|1101905|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
326294|NCT01318135|1101906|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
326295|NCT01318135|1101907|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
326296|NCT01318122|1102039|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
326297|NCT01318122|1102040|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
326298|NCT01318122|1102041|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
326299|NCT01318122|1102042|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
326300|NCT01318122|1102039|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
326301|NCT01318122|1102040|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
326302|NCT01318122|1102041|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
326303|NCT01318122|1102042|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
326304|NCT01318122|1102039|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
326305|NCT01318122|1102040|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
326306|NCT01318122|1102041|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
326307|NCT01318122|1102042|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
326308|NCT01318122|1102039|P4|Entered - Long-Term Extension Study|Adverse Event|4
326309|NCT01318122|1102040|P3|Entered - Long-Term Extension Study|Adverse Event|2
326310|NCT01318122|1102041|P2|Entered - Long-Term Extension Study|Adverse Event|6
326311|NCT01318122|1102042|P1|Entered - Long-Term Extension Study|Adverse Event|6
326312|NCT01318122|1102039|P4|Enrolled - Long-Term Extension Study|Other|0
326313|NCT01318122|1102040|P3|Enrolled - Long-Term Extension Study|Other|0
326314|NCT01318122|1102041|P2|Enrolled - Long-Term Extension Study|Other|0
326315|NCT01318122|1102042|P1|Enrolled - Long-Term Extension Study|Other|1
326316|NCT01318122|1102039|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
326317|NCT01318122|1102040|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
326318|NCT01318122|1102041|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
326319|NCT01318122|1102042|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
326320|NCT01318109|1102111|P3|Overall Study|Schedule Conflict|0
326321|NCT01318109|1102112|P2|Overall Study|Schedule Conflict|1
326322|NCT01318109|1102113|P1|Overall Study|Schedule Conflict|0
326323|NCT01318109|1102111|P3|Overall Study|Withdrawal by Subject|0
326324|NCT01318109|1102112|P2|Overall Study|Withdrawal by Subject|0
326325|NCT01318109|1102113|P1|Overall Study|Withdrawal by Subject|1
326326|NCT01318109|1102111|P3|Overall Study|Adverse Event|0
326327|NCT01318109|1102112|P2|Overall Study|Adverse Event|2
326328|NCT01318109|1102113|P1|Overall Study|Adverse Event|0
326329|NCT01318083|1102148|P3|Overall Study|Lack of Study Medication Compliance|0
326330|NCT01318083|1102149|P2|Overall Study|Lack of Study Medication Compliance|1
326331|NCT01318083|1102150|P1|Overall Study|Lack of Study Medication Compliance|0
326332|NCT01318083|1102148|P3|Overall Study|Treatment Complications|0
326333|NCT01318083|1102149|P2|Overall Study|Treatment Complications|0
326334|NCT01318083|1102150|P1|Overall Study|Treatment Complications|1
326335|NCT01318083|1102148|P3|Overall Study|Lack of Efficacy|1
326336|NCT01318083|1102149|P2|Overall Study|Lack of Efficacy|0
326337|NCT01318083|1102150|P1|Overall Study|Lack of Efficacy|0
326338|NCT01318083|1102148|P3|Overall Study|Withdrawal by Subject|2
326339|NCT01318083|1102149|P2|Overall Study|Withdrawal by Subject|0
326340|NCT01318083|1102150|P1|Overall Study|Withdrawal by Subject|1
326341|NCT01318083|1102148|P3|Overall Study|Adverse Event|2
326342|NCT01318083|1102149|P2|Overall Study|Adverse Event|1
326343|NCT01318083|1102150|P1|Overall Study|Adverse Event|4
326344|NCT01318070|1102185|P3|Overall Study|Principal Investigator Discretion|0
326345|NCT01318070|1102186|P2|Overall Study|Principal Investigator Discretion|0
326346|NCT01318070|1102187|P1|Overall Study|Principal Investigator Discretion|1
326347|NCT01318070|1102185|P3|Overall Study|Lack of Efficacy|1
326348|NCT01318070|1102186|P2|Overall Study|Lack of Efficacy|0
326349|NCT01318070|1102187|P1|Overall Study|Lack of Efficacy|0
326350|NCT01318070|1102185|P3|Overall Study|Withdrawal by Subject|1
326351|NCT01318070|1102186|P2|Overall Study|Withdrawal by Subject|1
326352|NCT01318070|1102187|P1|Overall Study|Withdrawal by Subject|0
326353|NCT01318070|1102185|P3|Overall Study|Adverse Event|5
326354|NCT01318070|1102186|P2|Overall Study|Adverse Event|1
326355|NCT01318070|1102187|P1|Overall Study|Adverse Event|1
326356|NCT01317797|1102231|P3|Overall Study|Withdrawal of Patient|1
326357|NCT01317797|1102232|P2|Overall Study|Withdrawal of Patient|0
326358|NCT01317797|1102233|P1|Overall Study|Withdrawal of Patient|0
326359|NCT01317797|1102231|P3|Overall Study|Other|0
326360|NCT01317797|1102232|P2|Overall Study|Other|1
326361|NCT01317797|1102233|P1|Overall Study|Other|0
326362|NCT01317641|1102310|P9|Overall Study|Withdrawal by Subject|0
326363|NCT01317641|1102311|P8|Overall Study|Withdrawal by Subject|0
326364|NCT01317641|1102312|P7|Overall Study|Withdrawal by Subject|1
326365|NCT01317641|1102313|P6|Overall Study|Withdrawal by Subject|0
326366|NCT01317641|1102314|P5|Overall Study|Withdrawal by Subject|0
326367|NCT01317641|1102315|P4|Overall Study|Withdrawal by Subject|0
326368|NCT01317641|1102316|P3|Overall Study|Withdrawal by Subject|0
326369|NCT01317641|1102317|P2|Overall Study|Withdrawal by Subject|0
326370|NCT01317641|1102318|P1|Overall Study|Withdrawal by Subject|0
326371|NCT01317641|1102310|P9|Overall Study|Disease progression|4
326372|NCT01317641|1102311|P8|Overall Study|Disease progression|3
326373|NCT01317641|1102312|P7|Overall Study|Disease progression|0
326374|NCT01317641|1102313|P6|Overall Study|Disease progression|0
326375|NCT01317641|1102314|P5|Overall Study|Disease progression|0
326376|NCT01317641|1102315|P4|Overall Study|Disease progression|0
326377|NCT01317641|1102316|P3|Overall Study|Disease progression|0
326378|NCT01317641|1102317|P2|Overall Study|Disease progression|0
326379|NCT01317641|1102318|P1|Overall Study|Disease progression|0
326380|NCT01317641|1102310|P9|Overall Study|Protocol Violation|0
326381|NCT01317641|1102311|P8|Overall Study|Protocol Violation|0
326382|NCT01317641|1102312|P7|Overall Study|Protocol Violation|0
326383|NCT01317641|1102313|P6|Overall Study|Protocol Violation|0
326384|NCT01317641|1102314|P5|Overall Study|Protocol Violation|0
326385|NCT01317641|1102315|P4|Overall Study|Protocol Violation|0
326386|NCT01317641|1102316|P3|Overall Study|Protocol Violation|0
326387|NCT01317641|1102317|P2|Overall Study|Protocol Violation|0
326388|NCT01317641|1102318|P1|Overall Study|Protocol Violation|1
326389|NCT01317641|1102310|P9|Overall Study|Adverse Event|0
326390|NCT01317641|1102311|P8|Overall Study|Adverse Event|1
326391|NCT01317641|1102312|P7|Overall Study|Adverse Event|2
326392|NCT01317641|1102313|P6|Overall Study|Adverse Event|0
326393|NCT01317641|1102314|P5|Overall Study|Adverse Event|0
326394|NCT01317641|1102315|P4|Overall Study|Adverse Event|1
326395|NCT01317641|1102316|P3|Overall Study|Adverse Event|0
326396|NCT01317641|1102317|P2|Overall Study|Adverse Event|1
326397|NCT01317641|1102318|P1|Overall Study|Adverse Event|0
326398|NCT01317641|1102310|P9|Overall Study|Not treated|1
326399|NCT01317641|1102311|P8|Overall Study|Not treated|1
326400|NCT01317641|1102312|P7|Overall Study|Not treated|0
326401|NCT01317641|1102313|P6|Overall Study|Not treated|0
326402|NCT01317641|1102314|P5|Overall Study|Not treated|0
326403|NCT01317641|1102315|P4|Overall Study|Not treated|0
326404|NCT01317641|1102316|P3|Overall Study|Not treated|0
326405|NCT01317641|1102317|P2|Overall Study|Not treated|0
326406|NCT01317641|1102318|P1|Overall Study|Not treated|0
326407|NCT01317615|1102420|P1|Overall Study|Adverse Event|7
326408|NCT01317615|1102420|P1|Overall Study|Abnormal laboratory value(s)|1
326409|NCT01317615|1102420|P1|Overall Study|Withdrawal by Subject|5
326410|NCT01317615|1102420|P1|Overall Study|Death|6
326411|NCT01317615|1102420|P1|Overall Study|New cancer therapy|5
326412|NCT01317615|1102420|P1|Overall Study|Disease progression|25
326413|NCT01317160|1102431|P2|Overall Study|Withdrawal by Subject|2
326414|NCT01317160|1102432|P1|Overall Study|Withdrawal by Subject|0
326415|NCT01317160|1102431|P2|Overall Study|Lost to Follow-up|3
326416|NCT01317160|1102432|P1|Overall Study|Lost to Follow-up|3
326417|NCT01317160|1102431|P2|Overall Study|Incorrect inclusion|1
326418|NCT01317160|1102432|P1|Overall Study|Incorrect inclusion|1
326419|NCT01317004|1102457|P2|Overall Study|Adverse Event|3
326420|NCT01317004|1102458|P1|Overall Study|Adverse Event|3
326421|NCT01317004|1102457|P2|Overall Study|Protocol Violation|2
326422|NCT01317004|1102458|P1|Overall Study|Protocol Violation|0
326423|NCT01317004|1102457|P2|Overall Study|Withdrawal by Subject|4
326424|NCT01317004|1102458|P1|Overall Study|Withdrawal by Subject|1
326425|NCT01316939|1102479|P3|Overall Study|Protocol Violation|0
326426|NCT01316939|1102480|P2|Overall Study|Protocol Violation|1
326427|NCT01316939|1102481|P1|Overall Study|Protocol Violation|0
326428|NCT01316939|1102479|P3|Overall Study|Met Liver chemistry stopping criteria|1
326429|NCT01316939|1102480|P2|Overall Study|Met Liver chemistry stopping criteria|0
326430|NCT01316939|1102481|P1|Overall Study|Met Liver chemistry stopping criteria|1
326431|NCT01316939|1102479|P3|Overall Study|Lost to Follow-up|2
326432|NCT01316939|1102480|P2|Overall Study|Lost to Follow-up|0
326433|NCT01316939|1102481|P1|Overall Study|Lost to Follow-up|0
326434|NCT01316939|1102479|P3|Overall Study|Physician Decision|1
326435|NCT01316939|1102480|P2|Overall Study|Physician Decision|2
326436|NCT01316939|1102481|P1|Overall Study|Physician Decision|2
326437|NCT01316939|1102479|P3|Overall Study|Withdrawal by Subject|6
326438|NCT01316939|1102480|P2|Overall Study|Withdrawal by Subject|3
326439|NCT01316939|1102481|P1|Overall Study|Withdrawal by Subject|1
326440|NCT01316939|1102479|P3|Overall Study|Adverse Event|11
326441|NCT01316939|1102480|P2|Overall Study|Adverse Event|12
326442|NCT01316939|1102481|P1|Overall Study|Adverse Event|9
326443|NCT01316939|1102479|P3|Overall Study|Lack of Efficacy|25
326444|NCT01316939|1102480|P2|Overall Study|Lack of Efficacy|25
326445|NCT01316939|1102481|P1|Overall Study|Lack of Efficacy|24
326446|NCT01316939|1102479|P3|Overall Study|Study closed/terminated|23
326447|NCT01316939|1102480|P2|Overall Study|Study closed/terminated|25
326448|NCT01316939|1102481|P1|Overall Study|Study closed/terminated|26
326449|NCT01316913|1102576|P4|Overall Study|Withdrawal by Subject|6
326450|NCT01316913|1102577|P3|Overall Study|Withdrawal by Subject|10
326451|NCT01316913|1102578|P2|Overall Study|Withdrawal by Subject|9
326452|NCT01316913|1102579|P1|Overall Study|Withdrawal by Subject|10
326453|NCT01316913|1102576|P4|Overall Study|Lost to Follow-up|2
326454|NCT01316913|1102577|P3|Overall Study|Lost to Follow-up|0
326455|NCT01316913|1102578|P2|Overall Study|Lost to Follow-up|1
326456|NCT01316913|1102579|P1|Overall Study|Lost to Follow-up|0
326457|NCT01316913|1102576|P4|Overall Study|Protocol-defined Stopping Criteria|6
326458|NCT01316913|1102577|P3|Overall Study|Protocol-defined Stopping Criteria|11
326459|NCT01316913|1102578|P2|Overall Study|Protocol-defined Stopping Criteria|8
326460|NCT01316913|1102579|P1|Overall Study|Protocol-defined Stopping Criteria|7
326461|NCT01316913|1102576|P4|Overall Study|Protocol Violation|1
326462|NCT01316913|1102577|P3|Overall Study|Protocol Violation|4
326463|NCT01316913|1102578|P2|Overall Study|Protocol Violation|4
326464|NCT01316913|1102579|P1|Overall Study|Protocol Violation|1
326465|NCT01316913|1102576|P4|Overall Study|Lack of Efficacy|13
326466|NCT01316913|1102577|P3|Overall Study|Lack of Efficacy|9
326467|NCT01316913|1102578|P2|Overall Study|Lack of Efficacy|12
326468|NCT01316913|1102579|P1|Overall Study|Lack of Efficacy|22
326469|NCT01316913|1102576|P4|Overall Study|Adverse Event|11
326470|NCT01316913|1102577|P3|Overall Study|Adverse Event|15
326471|NCT01316913|1102578|P2|Overall Study|Adverse Event|20
326472|NCT01316913|1102579|P1|Overall Study|Adverse Event|17
326473|NCT01316900|1102601|P4|Overall Study|Withdrawal by Subject|9
326474|NCT01316900|1102602|P3|Overall Study|Withdrawal by Subject|6
326475|NCT01316900|1102603|P2|Overall Study|Withdrawal by Subject|8
326476|NCT01316900|1102604|P1|Overall Study|Withdrawal by Subject|7
326477|NCT01316900|1102601|P4|Overall Study|Lost to Follow-up|1
326478|NCT01316900|1102602|P3|Overall Study|Lost to Follow-up|1
326479|NCT01316900|1102603|P2|Overall Study|Lost to Follow-up|0
326480|NCT01316900|1102604|P1|Overall Study|Lost to Follow-up|1
326481|NCT01316900|1102601|P4|Overall Study|Protocol-defined Stopping Criteria|5
326482|NCT01316900|1102602|P3|Overall Study|Protocol-defined Stopping Criteria|10
326483|NCT01316900|1102603|P2|Overall Study|Protocol-defined Stopping Criteria|3
326484|NCT01316900|1102604|P1|Overall Study|Protocol-defined Stopping Criteria|2
326485|NCT01316900|1102601|P4|Overall Study|Protocol Violation|0
326486|NCT01316900|1102602|P3|Overall Study|Protocol Violation|4
326487|NCT01316900|1102603|P2|Overall Study|Protocol Violation|1
326488|NCT01316900|1102604|P1|Overall Study|Protocol Violation|7
326489|NCT01316900|1102601|P4|Overall Study|Lack of Efficacy|7
326490|NCT01316900|1102602|P3|Overall Study|Lack of Efficacy|5
326491|NCT01316900|1102603|P2|Overall Study|Lack of Efficacy|9
326492|NCT01316900|1102604|P1|Overall Study|Lack of Efficacy|17
326493|NCT01316900|1102601|P4|Overall Study|Adverse Event|9
326494|NCT01316900|1102602|P3|Overall Study|Adverse Event|15
326495|NCT01316900|1102603|P2|Overall Study|Adverse Event|10
326496|NCT01316900|1102604|P1|Overall Study|Adverse Event|10
326497|NCT01316887|1102625|P3|Overall Study|Withdrawal by Subject|15
326498|NCT01316887|1102626|P2|Overall Study|Withdrawal by Subject|16
326499|NCT01316887|1102627|P1|Overall Study|Withdrawal by Subject|8
326500|NCT01316887|1102625|P3|Overall Study|Lost to Follow-up|5
326501|NCT01316887|1102626|P2|Overall Study|Lost to Follow-up|7
326502|NCT01316887|1102627|P1|Overall Study|Lost to Follow-up|1
326503|NCT01316887|1102625|P3|Overall Study|Study Closed/Terminated|3
326504|NCT01316887|1102626|P2|Overall Study|Study Closed/Terminated|4
326505|NCT01316887|1102627|P1|Overall Study|Study Closed/Terminated|2
326506|NCT01316887|1102625|P3|Overall Study|Protocol-defined Stopping Criteria|36
326507|NCT01316887|1102626|P2|Overall Study|Protocol-defined Stopping Criteria|37
326508|NCT01316887|1102627|P1|Overall Study|Protocol-defined Stopping Criteria|8
326509|NCT01316887|1102625|P3|Overall Study|Protocol Violation|6
326510|NCT01316887|1102626|P2|Overall Study|Protocol Violation|6
326511|NCT01316887|1102627|P1|Overall Study|Protocol Violation|2
326512|NCT01316887|1102625|P3|Overall Study|Lack of Efficacy|1
326513|NCT01316887|1102626|P2|Overall Study|Lack of Efficacy|3
326514|NCT01316887|1102627|P1|Overall Study|Lack of Efficacy|9
326515|NCT01316887|1102625|P3|Overall Study|Adverse Event|17
326516|NCT01316887|1102626|P2|Overall Study|Adverse Event|21
326517|NCT01316887|1102627|P1|Overall Study|Adverse Event|13
326518|NCT01316692|1102689|P1|Overall Study|Disease Progression|7
326519|NCT01316692|1102689|P1|Overall Study|Adverse Event|5
326520|NCT01316614|1102698|P1|Overall Study|Medically unstable|1
326521|NCT01316614|1102698|P1|Overall Study|Inadequate number of passes|2
326522|NCT01316614|1102698|P1|Overall Study|Cystic lesion|5
326523|NCT01316614|1102698|P1|Overall Study|Cytology slides not available for review|4
326524|NCT01316614|1102698|P1|Overall Study|No solid lesion and FNA not indicated|25
326525|NCT01316575|1102715|P2|Overall Study|Required alternate treatment|1
326526|NCT01316575|1102716|P1|Overall Study|Required alternate treatment|0
326527|NCT01316575|1102715|P2|Overall Study|Withdrawal by Subject|0
326528|NCT01316575|1102716|P1|Overall Study|Withdrawal by Subject|2
326529|NCT01316419|1102728|P1|Overall Study|Lost to Follow-up|19
326530|NCT01316419|1102728|P1|Overall Study|Violated inclusion/exclusion criterion|143
326531|NCT01316419|1102728|P1|Overall Study|Not treated|103
326532|NCT01316380|1102754|P3|Overall Study|Not treated|0
326533|NCT01316380|1102755|P2|Overall Study|Not treated|0
326534|NCT01316380|1102756|P1|Overall Study|Not treated|1
326535|NCT01316380|1102754|P3|Overall Study|Other|1
326536|NCT01316380|1102755|P2|Overall Study|Other|1
326537|NCT01316380|1102756|P1|Overall Study|Other|0
326538|NCT01316380|1102754|P3|Overall Study|Withdrawal by Subject|0
326539|NCT01316380|1102755|P2|Overall Study|Withdrawal by Subject|2
326540|NCT01316380|1102756|P1|Overall Study|Withdrawal by Subject|1
326541|NCT01316380|1102754|P3|Overall Study|Protocol Violation|1
326542|NCT01316380|1102755|P2|Overall Study|Protocol Violation|0
326543|NCT01316380|1102756|P1|Overall Study|Protocol Violation|0
326544|NCT01316380|1102754|P3|Overall Study|Adverse Event|1
326545|NCT01316380|1102755|P2|Overall Study|Adverse Event|2
326546|NCT01316380|1102756|P1|Overall Study|Adverse Event|0
326547|NCT01316224|1102922|P1|Overall Study|Not Specified|1
326548|NCT01316224|1102922|P1|Overall Study|Adverse Event With Treatment Failure|1
326549|NCT01316224|1102922|P1|Overall Study|Withdrawal by Subject|1
326550|NCT01316224|1102922|P1|Overall Study|Lack of Efficacy|1
326551|NCT01316224|1102922|P1|Overall Study|Adverse Event|3
326552|NCT01316224|1102922|P1|Overall Study|Protocol Violation|3
326553|NCT01316055|1102939|P3|Overall Study|Lost to Follow-up|0
326554|NCT01316055|1102940|P2|Overall Study|Lost to Follow-up|0
326555|NCT01316055|1102941|P1|Overall Study|Lost to Follow-up|1
326556|NCT01315847|1102972|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
326557|NCT01315847|1102973|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
326558|NCT01315847|1102972|P2|Part I, Period 1|Reached maximum number of arterial lines|0
326559|NCT01315847|1102973|P1|Part I, Period 1|Reached maximum number of arterial lines|3
326560|NCT01315353|1103018|P3|Overall Study|Inadvertent randomization/assignment|2
326561|NCT01315353|1103019|P2|Overall Study|Inadvertent randomization/assignment|0
326562|NCT01315353|1103020|P1|Overall Study|Inadvertent randomization/assignment|0
326563|NCT01315353|1103018|P3|Overall Study|Taken off study by site in error|0
326564|NCT01315353|1103019|P2|Overall Study|Taken off study by site in error|1
326565|NCT01315353|1103020|P1|Overall Study|Taken off study by site in error|0
326566|NCT01315353|1103018|P3|Overall Study|Site closing|0
326567|NCT01315353|1103019|P2|Overall Study|Site closing|4
326568|NCT01315353|1103020|P1|Overall Study|Site closing|7
326569|NCT01315353|1103018|P3|Overall Study|Unwilling to adhere to requirements|4
326570|NCT01315353|1103019|P2|Overall Study|Unwilling to adhere to requirements|5
326571|NCT01315353|1103020|P1|Overall Study|Unwilling to adhere to requirements|5
326572|NCT01315353|1103018|P3|Overall Study|Lost to Follow-up|6
326573|NCT01315353|1103019|P2|Overall Study|Lost to Follow-up|6
326574|NCT01315353|1103020|P1|Overall Study|Lost to Follow-up|13
326575|NCT01315353|1103018|P3|Overall Study|Withdrawal by Subject|1
326576|NCT01315353|1103019|P2|Overall Study|Withdrawal by Subject|6
326577|NCT01315353|1103020|P1|Overall Study|Withdrawal by Subject|2
326578|NCT01315353|1103018|P3|Overall Study|Death|0
326579|NCT01315353|1103019|P2|Overall Study|Death|1
326580|NCT01315353|1103020|P1|Overall Study|Death|2
326581|NCT01315249|1103047|P2|Overall Study|Death|1
326582|NCT01315249|1103048|P1|Overall Study|Death|0
326583|NCT01315249|1103047|P2|Overall Study|Lost to Follow-up|2
326584|NCT01315249|1103048|P1|Overall Study|Lost to Follow-up|0
326585|NCT01315249|1103047|P2|Overall Study|Lack of Efficacy|1
326586|NCT01315249|1103048|P1|Overall Study|Lack of Efficacy|0
326587|NCT01315249|1103047|P2|Overall Study|inability to use device|0
326588|NCT01315249|1103048|P1|Overall Study|inability to use device|1
326589|NCT01315249|1103047|P2|Overall Study|Administrative problems|0
326590|NCT01315249|1103048|P1|Overall Study|Administrative problems|1
326591|NCT01315249|1103047|P2|Overall Study|Abnormal test results|2
326592|NCT01315249|1103048|P1|Overall Study|Abnormal test results|1
326593|NCT01315249|1103047|P2|Overall Study|Protocol Violation|5
326594|NCT01315249|1103048|P1|Overall Study|Protocol Violation|8
326595|NCT01315249|1103047|P2|Overall Study|Withdrawal by Subject|10
326596|NCT01315249|1103048|P1|Overall Study|Withdrawal by Subject|11
326597|NCT01315249|1103047|P2|Overall Study|Adverse Event|26
326598|NCT01315249|1103048|P1|Overall Study|Adverse Event|22
326599|NCT01315028|1103110|P2|Overall Study|Death|1
326600|NCT01315028|1103111|P1|Overall Study|Death|0
326601|NCT01315028|1103110|P2|Overall Study|Lost to Follow-up|0
326602|NCT01315028|1103111|P1|Overall Study|Lost to Follow-up|1
326603|NCT01314872|1103147|P15|Period 2|Lost to Follow-up|6
326604|NCT01314872|1103148|P14|Period 2|Lost to Follow-up|2
326605|NCT01314872|1103149|P13|Period 2|Lost to Follow-up|7
326606|NCT01314872|1103150|P12|Period 2|Lost to Follow-up|6
326607|NCT01314872|1103151|P11|Period 2|Lost to Follow-up|0
326608|NCT01314872|1103152|P10|Period 2|Lost to Follow-up|0
326609|NCT01314872|1103153|P9|Period 2|Lost to Follow-up|0
326610|NCT01314872|1103154|P8|Period 2|Lost to Follow-up|0
326611|NCT01314872|1103155|P7|Period 2|Lost to Follow-up|0
326612|NCT01314872|1103156|P6|Period 2|Lost to Follow-up|0
326613|NCT01314872|1103157|P5|Period 2|Lost to Follow-up|0
326614|NCT01314872|1103158|P4|Period 2|Lost to Follow-up|0
326615|NCT01314872|1103159|P3|Period 2|Lost to Follow-up|0
326616|NCT01314872|1103160|P2|Period 2|Lost to Follow-up|0
326617|NCT01314872|1103161|P1|Period 2|Lost to Follow-up|0
326618|NCT01314872|1103147|P15|Period 2|Withdrawal by Subject|4
326619|NCT01314872|1103148|P14|Period 2|Withdrawal by Subject|12
326620|NCT01314872|1103149|P13|Period 2|Withdrawal by Subject|17
326621|NCT01314872|1103150|P12|Period 2|Withdrawal by Subject|14
326622|NCT01314872|1103151|P11|Period 2|Withdrawal by Subject|0
326623|NCT01314872|1103152|P10|Period 2|Withdrawal by Subject|0
326624|NCT01314872|1103153|P9|Period 2|Withdrawal by Subject|0
326625|NCT01314872|1103154|P8|Period 2|Withdrawal by Subject|0
326626|NCT01314872|1103155|P7|Period 2|Withdrawal by Subject|0
326627|NCT01314872|1103156|P6|Period 2|Withdrawal by Subject|0
326628|NCT01314872|1103157|P5|Period 2|Withdrawal by Subject|0
326629|NCT01314872|1103158|P4|Period 2|Withdrawal by Subject|0
326630|NCT01314872|1103159|P3|Period 2|Withdrawal by Subject|0
326631|NCT01314872|1103160|P2|Period 2|Withdrawal by Subject|0
326632|NCT01314872|1103161|P1|Period 2|Withdrawal by Subject|0
326633|NCT01314872|1103147|P15|Period 2|Adverse event, non-fatal|9
326634|NCT01314872|1103148|P14|Period 2|Adverse event, non-fatal|24
326635|NCT01314872|1103149|P13|Period 2|Adverse event, non-fatal|16
326636|NCT01314872|1103150|P12|Period 2|Adverse event, non-fatal|13
326637|NCT01314872|1103151|P11|Period 2|Adverse event, non-fatal|0
326638|NCT01314872|1103152|P10|Period 2|Adverse event, non-fatal|0
326639|NCT01314872|1103153|P9|Period 2|Adverse event, non-fatal|0
326640|NCT01314872|1103154|P8|Period 2|Adverse event, non-fatal|0
326641|NCT01314872|1103155|P7|Period 2|Adverse event, non-fatal|0
326642|NCT01314872|1103156|P6|Period 2|Adverse event, non-fatal|0
326643|NCT01314872|1103157|P5|Period 2|Adverse event, non-fatal|0
326644|NCT01314872|1103158|P4|Period 2|Adverse event, non-fatal|0
326645|NCT01314872|1103159|P3|Period 2|Adverse event, non-fatal|0
326646|NCT01314872|1103160|P2|Period 2|Adverse event, non-fatal|0
326647|NCT01314872|1103161|P1|Period 2|Adverse event, non-fatal|0
326648|NCT01314872|1103147|P15|Period 2|Study terminated by Sponsor|0
326649|NCT01314872|1103148|P14|Period 2|Study terminated by Sponsor|3
326650|NCT01314872|1103149|P13|Period 2|Study terminated by Sponsor|2
326651|NCT01314872|1103150|P12|Period 2|Study terminated by Sponsor|2
326652|NCT01314872|1103151|P11|Period 2|Study terminated by Sponsor|0
326653|NCT01314872|1103152|P10|Period 2|Study terminated by Sponsor|0
326654|NCT01314872|1103153|P9|Period 2|Study terminated by Sponsor|0
326655|NCT01314872|1103154|P8|Period 2|Study terminated by Sponsor|0
326656|NCT01314872|1103155|P7|Period 2|Study terminated by Sponsor|0
326657|NCT01314872|1103156|P6|Period 2|Study terminated by Sponsor|0
326658|NCT01314872|1103157|P5|Period 2|Study terminated by Sponsor|0
326659|NCT01314872|1103158|P4|Period 2|Study terminated by Sponsor|0
326660|NCT01314872|1103159|P3|Period 2|Study terminated by Sponsor|0
326661|NCT01314872|1103160|P2|Period 2|Study terminated by Sponsor|0
326662|NCT01314872|1103161|P1|Period 2|Study terminated by Sponsor|0
326663|NCT01314872|1103147|P15|Period 2|Pregnancy|1
326664|NCT01314872|1103148|P14|Period 2|Pregnancy|0
326665|NCT01314872|1103149|P13|Period 2|Pregnancy|0
326666|NCT01314872|1103150|P12|Period 2|Pregnancy|0
326667|NCT01314872|1103151|P11|Period 2|Pregnancy|0
326668|NCT01314872|1103152|P10|Period 2|Pregnancy|0
326669|NCT01314872|1103153|P9|Period 2|Pregnancy|0
326670|NCT01314872|1103154|P8|Period 2|Pregnancy|0
326671|NCT01314872|1103155|P7|Period 2|Pregnancy|0
326672|NCT01314872|1103156|P6|Period 2|Pregnancy|0
326673|NCT01314872|1103157|P5|Period 2|Pregnancy|0
326674|NCT01314872|1103158|P4|Period 2|Pregnancy|0
326675|NCT01314872|1103159|P3|Period 2|Pregnancy|0
326676|NCT01314872|1103160|P2|Period 2|Pregnancy|0
326677|NCT01314872|1103161|P1|Period 2|Pregnancy|0
326678|NCT01314872|1103147|P15|Period 2|Lack of Efficacy|2
326679|NCT01314872|1103148|P14|Period 2|Lack of Efficacy|9
326680|NCT01314872|1103149|P13|Period 2|Lack of Efficacy|12
326681|NCT01314872|1103150|P12|Period 2|Lack of Efficacy|7
326682|NCT01314872|1103151|P11|Period 2|Lack of Efficacy|0
326683|NCT01314872|1103152|P10|Period 2|Lack of Efficacy|0
326684|NCT01314872|1103153|P9|Period 2|Lack of Efficacy|0
326685|NCT01314872|1103154|P8|Period 2|Lack of Efficacy|0
326686|NCT01314872|1103155|P7|Period 2|Lack of Efficacy|0
326687|NCT01314872|1103156|P6|Period 2|Lack of Efficacy|0
326688|NCT01314872|1103157|P5|Period 2|Lack of Efficacy|0
326689|NCT01314872|1103158|P4|Period 2|Lack of Efficacy|0
326690|NCT01314872|1103159|P3|Period 2|Lack of Efficacy|0
326691|NCT01314872|1103160|P2|Period 2|Lack of Efficacy|0
326692|NCT01314872|1103161|P1|Period 2|Lack of Efficacy|0
326693|NCT01314872|1103147|P15|Period 2|Non-compliance with study drug|2
326694|NCT01314872|1103148|P14|Period 2|Non-compliance with study drug|1
326695|NCT01314872|1103149|P13|Period 2|Non-compliance with study drug|3
326696|NCT01314872|1103150|P12|Period 2|Non-compliance with study drug|3
326697|NCT01314872|1103151|P11|Period 2|Non-compliance with study drug|0
326698|NCT01314872|1103152|P10|Period 2|Non-compliance with study drug|0
326699|NCT01314872|1103153|P9|Period 2|Non-compliance with study drug|0
326700|NCT01314872|1103154|P8|Period 2|Non-compliance with study drug|0
326701|NCT01314872|1103155|P7|Period 2|Non-compliance with study drug|0
326702|NCT01314872|1103156|P6|Period 2|Non-compliance with study drug|0
326703|NCT01314872|1103157|P5|Period 2|Non-compliance with study drug|0
326704|NCT01314872|1103158|P4|Period 2|Non-compliance with study drug|0
326705|NCT01314872|1103159|P3|Period 2|Non-compliance with study drug|0
326706|NCT01314872|1103160|P2|Period 2|Non-compliance with study drug|0
326707|NCT01314872|1103161|P1|Period 2|Non-compliance with study drug|0
326708|NCT01314872|1103147|P15|Period 2|Protocol Violation|0
326709|NCT01314872|1103148|P14|Period 2|Protocol Violation|2
326710|NCT01314872|1103149|P13|Period 2|Protocol Violation|3
326711|NCT01314872|1103150|P12|Period 2|Protocol Violation|3
326712|NCT01314872|1103151|P11|Period 2|Protocol Violation|0
326713|NCT01314872|1103152|P10|Period 2|Protocol Violation|0
326714|NCT01314872|1103153|P9|Period 2|Protocol Violation|0
326715|NCT01314872|1103154|P8|Period 2|Protocol Violation|0
326716|NCT01314872|1103155|P7|Period 2|Protocol Violation|0
326717|NCT01314872|1103156|P6|Period 2|Protocol Violation|0
326718|NCT01314872|1103157|P5|Period 2|Protocol Violation|0
326719|NCT01314872|1103158|P4|Period 2|Protocol Violation|0
326720|NCT01314872|1103159|P3|Period 2|Protocol Violation|0
326721|NCT01314872|1103160|P2|Period 2|Protocol Violation|0
326722|NCT01314872|1103161|P1|Period 2|Protocol Violation|0
326723|NCT01314872|1103147|P15|Treatment Period 1|Lost to Follow-up|0
326724|NCT01314872|1103148|P14|Treatment Period 1|Lost to Follow-up|0
326725|NCT01314872|1103149|P13|Treatment Period 1|Lost to Follow-up|0
326726|NCT01314872|1103150|P12|Treatment Period 1|Lost to Follow-up|0
326727|NCT01314872|1103151|P11|Treatment Period 1|Lost to Follow-up|0
326728|NCT01314872|1103152|P10|Treatment Period 1|Lost to Follow-up|0
326729|NCT01314872|1103153|P9|Treatment Period 1|Lost to Follow-up|1
326730|NCT01314872|1103154|P8|Treatment Period 1|Lost to Follow-up|1
326731|NCT01314872|1103155|P7|Treatment Period 1|Lost to Follow-up|1
326732|NCT01314872|1103156|P6|Treatment Period 1|Lost to Follow-up|1
326733|NCT01314872|1103157|P5|Treatment Period 1|Lost to Follow-up|1
326734|NCT01314872|1103158|P4|Treatment Period 1|Lost to Follow-up|2
326735|NCT01314872|1103159|P3|Treatment Period 1|Lost to Follow-up|2
326736|NCT01314872|1103160|P2|Treatment Period 1|Lost to Follow-up|1
326737|NCT01314872|1103161|P1|Treatment Period 1|Lost to Follow-up|0
326738|NCT01314872|1103147|P15|Treatment Period 1|Withdrawal by Subject|0
326739|NCT01314872|1103148|P14|Treatment Period 1|Withdrawal by Subject|0
326740|NCT01314872|1103149|P13|Treatment Period 1|Withdrawal by Subject|0
326741|NCT01314872|1103150|P12|Treatment Period 1|Withdrawal by Subject|0
326742|NCT01314872|1103151|P11|Treatment Period 1|Withdrawal by Subject|1
326743|NCT01314872|1103152|P10|Treatment Period 1|Withdrawal by Subject|2
326744|NCT01314872|1103153|P9|Treatment Period 1|Withdrawal by Subject|2
326745|NCT01314872|1103154|P8|Treatment Period 1|Withdrawal by Subject|2
326746|NCT01314872|1103155|P7|Treatment Period 1|Withdrawal by Subject|3
326747|NCT01314872|1103156|P6|Treatment Period 1|Withdrawal by Subject|1
326748|NCT01314872|1103157|P5|Treatment Period 1|Withdrawal by Subject|3
326749|NCT01314872|1103158|P4|Treatment Period 1|Withdrawal by Subject|2
326750|NCT01314872|1103159|P3|Treatment Period 1|Withdrawal by Subject|0
326751|NCT01314872|1103160|P2|Treatment Period 1|Withdrawal by Subject|1
326752|NCT01314872|1103161|P1|Treatment Period 1|Withdrawal by Subject|3
326753|NCT01314872|1103147|P15|Treatment Period 1|Adverse event, non-fatal|0
326754|NCT01314872|1103148|P14|Treatment Period 1|Adverse event, non-fatal|0
326755|NCT01314872|1103149|P13|Treatment Period 1|Adverse event, non-fatal|0
326756|NCT01314872|1103150|P12|Treatment Period 1|Adverse event, non-fatal|0
326757|NCT01314872|1103151|P11|Treatment Period 1|Adverse event, non-fatal|1
326758|NCT01314872|1103152|P10|Treatment Period 1|Adverse event, non-fatal|0
326759|NCT01314872|1103153|P9|Treatment Period 1|Adverse event, non-fatal|3
326760|NCT01314872|1103154|P8|Treatment Period 1|Adverse event, non-fatal|2
326761|NCT01314872|1103155|P7|Treatment Period 1|Adverse event, non-fatal|4
326762|NCT01314872|1103156|P6|Treatment Period 1|Adverse event, non-fatal|4
326763|NCT01314872|1103157|P5|Treatment Period 1|Adverse event, non-fatal|2
326764|NCT01314872|1103158|P4|Treatment Period 1|Adverse event, non-fatal|2
326765|NCT01314872|1103159|P3|Treatment Period 1|Adverse event, non-fatal|3
326766|NCT01314872|1103160|P2|Treatment Period 1|Adverse event, non-fatal|2
326767|NCT01314872|1103161|P1|Treatment Period 1|Adverse event, non-fatal|4
326768|NCT01314872|1103147|P15|Treatment Period 1|Lack of Efficacy|0
326769|NCT01314872|1103148|P14|Treatment Period 1|Lack of Efficacy|0
326770|NCT01314872|1103149|P13|Treatment Period 1|Lack of Efficacy|0
326771|NCT01314872|1103150|P12|Treatment Period 1|Lack of Efficacy|0
326772|NCT01314872|1103151|P11|Treatment Period 1|Lack of Efficacy|0
326773|NCT01314872|1103152|P10|Treatment Period 1|Lack of Efficacy|0
326774|NCT01314872|1103153|P9|Treatment Period 1|Lack of Efficacy|0
326775|NCT01314872|1103154|P8|Treatment Period 1|Lack of Efficacy|2
326776|NCT01314872|1103155|P7|Treatment Period 1|Lack of Efficacy|0
326777|NCT01314872|1103156|P6|Treatment Period 1|Lack of Efficacy|1
326778|NCT01314872|1103157|P5|Treatment Period 1|Lack of Efficacy|0
326779|NCT01314872|1103158|P4|Treatment Period 1|Lack of Efficacy|0
326780|NCT01314872|1103159|P3|Treatment Period 1|Lack of Efficacy|0
326781|NCT01314872|1103160|P2|Treatment Period 1|Lack of Efficacy|0
326782|NCT01314872|1103161|P1|Treatment Period 1|Lack of Efficacy|1
326783|NCT01314872|1103147|P15|Treatment Period 1|Physician Decision|0
326784|NCT01314872|1103148|P14|Treatment Period 1|Physician Decision|0
326785|NCT01314872|1103149|P13|Treatment Period 1|Physician Decision|0
326786|NCT01314872|1103150|P12|Treatment Period 1|Physician Decision|0
326787|NCT01314872|1103151|P11|Treatment Period 1|Physician Decision|0
326788|NCT01314872|1103152|P10|Treatment Period 1|Physician Decision|1
326789|NCT01314872|1103153|P9|Treatment Period 1|Physician Decision|0
326790|NCT01314872|1103154|P8|Treatment Period 1|Physician Decision|0
326791|NCT01314872|1103155|P7|Treatment Period 1|Physician Decision|0
326792|NCT01314872|1103156|P6|Treatment Period 1|Physician Decision|0
326793|NCT01314872|1103157|P5|Treatment Period 1|Physician Decision|0
326794|NCT01314872|1103158|P4|Treatment Period 1|Physician Decision|1
326795|NCT01314872|1103159|P3|Treatment Period 1|Physician Decision|0
326796|NCT01314872|1103160|P2|Treatment Period 1|Physician Decision|1
326797|NCT01314872|1103161|P1|Treatment Period 1|Physician Decision|0
326798|NCT01314872|1103147|P15|Treatment Period 1|Protocol Violation|0
326799|NCT01314872|1103148|P14|Treatment Period 1|Protocol Violation|0
326800|NCT01314872|1103149|P13|Treatment Period 1|Protocol Violation|0
326801|NCT01314872|1103150|P12|Treatment Period 1|Protocol Violation|0
326802|NCT01314872|1103151|P11|Treatment Period 1|Protocol Violation|1
326803|NCT01314872|1103152|P10|Treatment Period 1|Protocol Violation|1
326804|NCT01314872|1103153|P9|Treatment Period 1|Protocol Violation|0
326805|NCT01314872|1103154|P8|Treatment Period 1|Protocol Violation|0
326806|NCT01314872|1103155|P7|Treatment Period 1|Protocol Violation|0
326807|NCT01314872|1103156|P6|Treatment Period 1|Protocol Violation|0
326808|NCT01314872|1103157|P5|Treatment Period 1|Protocol Violation|1
326809|NCT01314872|1103158|P4|Treatment Period 1|Protocol Violation|0
326810|NCT01314872|1103159|P3|Treatment Period 1|Protocol Violation|1
326811|NCT01314872|1103160|P2|Treatment Period 1|Protocol Violation|1
326812|NCT01314872|1103161|P1|Treatment Period 1|Protocol Violation|2
326813|NCT01314716|1103265|P2|Open-Label Phase|Physician Decision|4
326814|NCT01314716|1103266|P1|Open-Label Phase|Physician Decision|5
326815|NCT01314716|1103265|P2|Open-Label Phase|Withdrawal by Subject|2
326816|NCT01314716|1103266|P1|Open-Label Phase|Withdrawal by Subject|1
326817|NCT01314716|1103265|P2|Open-Label Phase|Adverse Event|6
326818|NCT01314716|1103266|P1|Open-Label Phase|Adverse Event|4
326819|NCT01314716|1103265|P2|Double-Blind Phase|Physician Decision|1
326820|NCT01314716|1103266|P1|Double-Blind Phase|Physician Decision|0
326821|NCT01314716|1103265|P2|Double-Blind Phase|Sponsor request|2
326822|NCT01314716|1103266|P1|Double-Blind Phase|Sponsor request|1
326823|NCT01314716|1103265|P2|Double-Blind Phase|Lost to Follow-up|1
326824|NCT01314716|1103266|P1|Double-Blind Phase|Lost to Follow-up|0
326825|NCT01314716|1103265|P2|Double-Blind Phase|Withdrawal by Subject|6
326826|NCT01314716|1103266|P1|Double-Blind Phase|Withdrawal by Subject|5
326827|NCT01314716|1103265|P2|Double-Blind Phase|Adverse Event|4
326828|NCT01314716|1103266|P1|Double-Blind Phase|Adverse Event|10
326829|NCT01314716|1103265|P2|Double-Blind Phase|Randomized but not treated|1
326830|NCT01314716|1103266|P1|Double-Blind Phase|Randomized but not treated|1
326831|NCT01314703|1103278|P1|Overall Study|screen failure and closed enrollment|8
326832|NCT01314443|1103287|P4|Overall Study|Protocol Violation|1
326833|NCT01314443|1103288|P3|Overall Study|Protocol Violation|1
326834|NCT01314443|1103289|P2|Overall Study|Protocol Violation|2
326835|NCT01314443|1103290|P1|Overall Study|Protocol Violation|2
326836|NCT01314443|1103287|P4|Overall Study|Withdrawal by Subject|1
326837|NCT01314443|1103288|P3|Overall Study|Withdrawal by Subject|1
326838|NCT01314443|1103289|P2|Overall Study|Withdrawal by Subject|1
326839|NCT01314443|1103290|P1|Overall Study|Withdrawal by Subject|2
326840|NCT01314261|1103339|P4|Overall Study|Virologic Failure|1
326841|NCT01314261|1103340|P3|Overall Study|Virologic Failure|0
326842|NCT01314261|1103341|P2|Overall Study|Virologic Failure|1
326843|NCT01314261|1103342|P1|Overall Study|Virologic Failure|0
326844|NCT01314261|1103339|P4|Overall Study|Lost to Follow-up|2
326845|NCT01314261|1103340|P3|Overall Study|Lost to Follow-up|2
326846|NCT01314261|1103341|P2|Overall Study|Lost to Follow-up|0
326847|NCT01314261|1103342|P1|Overall Study|Lost to Follow-up|1
326848|NCT01314261|1103339|P4|Overall Study|Withdrawal by Subject|0
326849|NCT01314261|1103340|P3|Overall Study|Withdrawal by Subject|1
326850|NCT01314261|1103341|P2|Overall Study|Withdrawal by Subject|3
326851|NCT01314261|1103342|P1|Overall Study|Withdrawal by Subject|0
326852|NCT01314261|1103339|P4|Overall Study|Adverse Event|0
326853|NCT01314261|1103340|P3|Overall Study|Adverse Event|0
326854|NCT01314261|1103341|P2|Overall Study|Adverse Event|0
326855|NCT01314261|1103342|P1|Overall Study|Adverse Event|1
326856|NCT01314118|1103393|P1|Overall Study|Ongoing|62
326857|NCT01314118|1103393|P1|Overall Study|Other|2
326858|NCT01314118|1103393|P1|Overall Study|Withdrawal by Subject|11
326859|NCT01314118|1103393|P1|Overall Study|Protocol Violation|5
326860|NCT01314118|1103393|P1|Overall Study|Death|4
326861|NCT01314118|1103393|P1|Overall Study|Physician Decision|11
326862|NCT01314118|1103393|P1|Overall Study|Progressive disease|27
326863|NCT01314118|1103393|P1|Overall Study|Adverse Event|9
326864|NCT01314105|1103402|P2|Overall Study|Other Adverse Event|1
326865|NCT01314105|1103403|P1|Overall Study|Other Adverse Event|1
326866|NCT01314105|1103402|P2|Overall Study|Refused to continue taking medication|1
326867|NCT01314105|1103403|P1|Overall Study|Refused to continue taking medication|0
326868|NCT01314105|1103402|P2|Overall Study|Progressive Disease|10
326869|NCT01314105|1103403|P1|Overall Study|Progressive Disease|6
326870|NCT01313923|1103516|P1|Overall Study|Physician Decision|3
326871|NCT01313884|1103532|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
326872|NCT01313858|1103540|P3|Overall Study|Lost to Follow-up|47
326873|NCT01313858|1103541|P2|Overall Study|Lost to Follow-up|51
326874|NCT01313858|1103542|P1|Overall Study|Lost to Follow-up|35
326875|NCT01313858|1103540|P3|Overall Study|Premature Treatment Termination|191
326876|NCT01313858|1103541|P2|Overall Study|Premature Treatment Termination|219
326877|NCT01313858|1103542|P1|Overall Study|Premature Treatment Termination|251
326878|NCT01313780|1103565|P2|Overall Study|missing data|3
326879|NCT01313780|1103566|P1|Overall Study|missing data|3
326880|NCT01313780|1103565|P2|Overall Study|Protocol Violation|4
326881|NCT01313780|1103566|P1|Overall Study|Protocol Violation|10
326882|NCT01313780|1103565|P2|Overall Study|Withdrawal by Subject|8
326883|NCT01313780|1103566|P1|Overall Study|Withdrawal by Subject|2
326884|NCT01313780|1103565|P2|Overall Study|Adverse Event|11
326885|NCT01313780|1103566|P1|Overall Study|Adverse Event|6
326886|NCT01313780|1103565|P2|Overall Study|Lack of Efficacy|2
326887|NCT01313780|1103566|P1|Overall Study|Lack of Efficacy|4
326888|NCT01313728|1103574|P1|Informed Consent to Baseline|Withdrawal by Subject|1
326889|NCT01313689|1103594|P5|24-Week Randomization 2|Physician Decision|4
326890|NCT01313689|1103595|P4|24-Week Randomization 2|Physician Decision|0
326891|NCT01313689|1103596|P3|24-Week Randomization 2|Physician Decision|0
326892|NCT01313689|1103597|P2|24-Week Randomization 2|Physician Decision|0
326893|NCT01313689|1103598|P1|24-Week Randomization 2|Physician Decision|0
326894|NCT01313689|1103594|P5|24-Week Randomization 2|Withdrawal by Subject|3
326895|NCT01313689|1103595|P4|24-Week Randomization 2|Withdrawal by Subject|1
326896|NCT01313689|1103596|P3|24-Week Randomization 2|Withdrawal by Subject|1
326897|NCT01313689|1103597|P2|24-Week Randomization 2|Withdrawal by Subject|0
326898|NCT01313689|1103598|P1|24-Week Randomization 2|Withdrawal by Subject|0
326899|NCT01313689|1103594|P5|24-Week Randomization 2|Adverse Event|8
326900|NCT01313689|1103595|P4|24-Week Randomization 2|Adverse Event|0
326901|NCT01313689|1103596|P3|24-Week Randomization 2|Adverse Event|2
326902|NCT01313689|1103597|P2|24-Week Randomization 2|Adverse Event|0
326903|NCT01313689|1103598|P1|24-Week Randomization 2|Adverse Event|0
326904|NCT01313689|1103594|P5|24-Week Randomization 1|Withdrawal by Subject|0
326905|NCT01313689|1103595|P4|24-Week Randomization 1|Withdrawal by Subject|0
326906|NCT01313689|1103596|P3|24-Week Randomization 1|Withdrawal by Subject|0
326907|NCT01313689|1103597|P2|24-Week Randomization 1|Withdrawal by Subject|0
326908|NCT01313689|1103598|P1|24-Week Randomization 1|Withdrawal by Subject|5
326909|NCT01313689|1103594|P5|24-Week Randomization 1|Physician Decision|0
326910|NCT01313689|1103595|P4|24-Week Randomization 1|Physician Decision|0
326911|NCT01313689|1103596|P3|24-Week Randomization 1|Physician Decision|0
326912|NCT01313689|1103597|P2|24-Week Randomization 1|Physician Decision|5
326913|NCT01313689|1103598|P1|24-Week Randomization 1|Physician Decision|4
326914|NCT01313689|1103594|P5|24-Week Randomization 1|Adverse Event|0
326915|NCT01313689|1103595|P4|24-Week Randomization 1|Adverse Event|0
326916|NCT01313689|1103596|P3|24-Week Randomization 1|Adverse Event|0
326917|NCT01313689|1103597|P2|24-Week Randomization 1|Adverse Event|5
326918|NCT01313689|1103598|P1|24-Week Randomization 1|Adverse Event|10
326919|NCT01313676|1103677|P4|Overall Study|Missing|0
326920|NCT01313676|1103678|P3|Overall Study|Missing|1
326921|NCT01313676|1103679|P2|Overall Study|Missing|1
326922|NCT01313676|1103680|P1|Overall Study|Missing|1
326923|NCT01313676|1103677|P4|Overall Study|Investigator Site Closed|10
326924|NCT01313676|1103678|P3|Overall Study|Investigator Site Closed|15
326925|NCT01313676|1103679|P2|Overall Study|Investigator Site Closed|11
326926|NCT01313676|1103680|P1|Overall Study|Investigator Site Closed|12
326927|NCT01313676|1103677|P4|Overall Study|Sponsor Terminated Study Treatment|1
326928|NCT01313676|1103678|P3|Overall Study|Sponsor Terminated Study Treatment|0
326929|NCT01313676|1103679|P2|Overall Study|Sponsor Terminated Study Treatment|1
326930|NCT01313676|1103680|P1|Overall Study|Sponsor Terminated Study Treatment|1
326931|NCT01313676|1103677|P4|Overall Study|Decision by Participant or Proxy|492
326932|NCT01313676|1103678|P3|Overall Study|Decision by Participant or Proxy|515
326933|NCT01313676|1103679|P2|Overall Study|Decision by Participant or Proxy|527
326934|NCT01313676|1103680|P1|Overall Study|Decision by Participant or Proxy|643
326935|NCT01313676|1103677|P4|Overall Study|Physician Decision|48
326936|NCT01313676|1103678|P3|Overall Study|Physician Decision|62
326937|NCT01313676|1103679|P2|Overall Study|Physician Decision|64
326938|NCT01313676|1103680|P1|Overall Study|Physician Decision|53
326939|NCT01313676|1103677|P4|Overall Study|Lost to Follow-up|0
326940|NCT01313676|1103678|P3|Overall Study|Lost to Follow-up|1
326941|NCT01313676|1103679|P2|Overall Study|Lost to Follow-up|0
326942|NCT01313676|1103680|P1|Overall Study|Lost to Follow-up|0
326943|NCT01313676|1103677|P4|Overall Study|Study Closed/terminated|9
326944|NCT01313676|1103678|P3|Overall Study|Study Closed/terminated|9
326945|NCT01313676|1103679|P2|Overall Study|Study Closed/terminated|6
326946|NCT01313676|1103680|P1|Overall Study|Study Closed/terminated|7
326947|NCT01313676|1103677|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
326948|NCT01313676|1103678|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
326949|NCT01313676|1103679|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
326950|NCT01313676|1103680|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
326951|NCT01313676|1103677|P4|Overall Study|Protocol Violation|44
326952|NCT01313676|1103678|P3|Overall Study|Protocol Violation|46
326953|NCT01313676|1103679|P2|Overall Study|Protocol Violation|44
326954|NCT01313676|1103680|P1|Overall Study|Protocol Violation|37
326955|NCT01313676|1103677|P4|Overall Study|Lack of Efficacy|46
326956|NCT01313676|1103678|P3|Overall Study|Lack of Efficacy|65
326957|NCT01313676|1103679|P2|Overall Study|Lack of Efficacy|90
326958|NCT01313676|1103680|P1|Overall Study|Lack of Efficacy|98
326959|NCT01313676|1103677|P4|Overall Study|Adverse Event|333
326960|NCT01313676|1103678|P3|Overall Study|Adverse Event|372
326961|NCT01313676|1103679|P2|Overall Study|Adverse Event|365
326962|NCT01313676|1103680|P1|Overall Study|Adverse Event|395
326963|NCT01313663|1103700|P2|Overall Study|Withdrawal by Subject|1
326964|NCT01313663|1103701|P1|Overall Study|Withdrawal by Subject|2
326965|NCT01313663|1103700|P2|Overall Study|Physician Decision|2
326966|NCT01313663|1103701|P1|Overall Study|Physician Decision|0
326967|NCT01313663|1103700|P2|Overall Study|Lost to Follow-up|1
326968|NCT01313663|1103701|P1|Overall Study|Lost to Follow-up|0
326969|NCT01313663|1103700|P2|Overall Study|Study Closed/Terminated|4
326970|NCT01313663|1103701|P1|Overall Study|Study Closed/Terminated|2
326971|NCT01313650|1103739|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
326972|NCT01313650|1103740|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
326973|NCT01313650|1103741|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
326974|NCT01313650|1103742|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
326975|NCT01313650|1103739|P4|Overall Study|Protocol Violation|6
326976|NCT01313650|1103740|P3|Overall Study|Protocol Violation|5
326977|NCT01313650|1103741|P2|Overall Study|Protocol Violation|7
326978|NCT01313650|1103742|P1|Overall Study|Protocol Violation|4
326979|NCT01313650|1103739|P4|Overall Study|Withdrawal by Subject|15
326980|NCT01313650|1103740|P3|Overall Study|Withdrawal by Subject|15
326981|NCT01313650|1103741|P2|Overall Study|Withdrawal by Subject|20
326982|NCT01313650|1103742|P1|Overall Study|Withdrawal by Subject|16
326983|NCT01313650|1103739|P4|Overall Study|Lost to Follow-up|2
326984|NCT01313650|1103740|P3|Overall Study|Lost to Follow-up|3
326985|NCT01313650|1103741|P2|Overall Study|Lost to Follow-up|0
326986|NCT01313650|1103742|P1|Overall Study|Lost to Follow-up|1
326987|NCT01313650|1103739|P4|Overall Study|Lack of Efficacy|20
326988|NCT01313650|1103740|P3|Overall Study|Lack of Efficacy|32
326989|NCT01313650|1103741|P2|Overall Study|Lack of Efficacy|20
326990|NCT01313650|1103742|P1|Overall Study|Lack of Efficacy|37
326991|NCT01313650|1103739|P4|Overall Study|Adverse Event|23
326992|NCT01313650|1103740|P3|Overall Study|Adverse Event|24
326993|NCT01313650|1103741|P2|Overall Study|Adverse Event|34
326994|NCT01313650|1103742|P1|Overall Study|Adverse Event|9
326995|NCT01313637|1103768|P4|Overall Study|Withdrawal by Subject|15
326996|NCT01313637|1103769|P3|Overall Study|Withdrawal by Subject|18
326997|NCT01313637|1103770|P2|Overall Study|Withdrawal by Subject|13
326998|NCT01313637|1103771|P1|Overall Study|Withdrawal by Subject|11
326999|NCT01313637|1103768|P4|Overall Study|Lost to Follow-up|3
327000|NCT01313637|1103769|P3|Overall Study|Lost to Follow-up|1
327001|NCT01313637|1103770|P2|Overall Study|Lost to Follow-up|2
327002|NCT01313637|1103771|P1|Overall Study|Lost to Follow-up|0
327003|NCT01313637|1103768|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
327004|NCT01313637|1103769|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
327005|NCT01313637|1103770|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
327006|NCT01313637|1103771|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
327007|NCT01313637|1103768|P4|Overall Study|Protocol Violation|5
327008|NCT01313637|1103769|P3|Overall Study|Protocol Violation|11
327009|NCT01313637|1103770|P2|Overall Study|Protocol Violation|3
327010|NCT01313637|1103771|P1|Overall Study|Protocol Violation|4
327011|NCT01313637|1103768|P4|Overall Study|Lack of Efficacy|24
327012|NCT01313637|1103769|P3|Overall Study|Lack of Efficacy|37
327013|NCT01313637|1103770|P2|Overall Study|Lack of Efficacy|38
327014|NCT01313637|1103771|P1|Overall Study|Lack of Efficacy|44
327015|NCT01313637|1103768|P4|Overall Study|Adverse Event|18
327016|NCT01313637|1103769|P3|Overall Study|Adverse Event|25
327017|NCT01313637|1103770|P2|Overall Study|Adverse Event|24
327018|NCT01313637|1103771|P1|Overall Study|Adverse Event|17
327019|NCT01313624|1103795|P2|Open-Label Phase|Lost to Follow-up|1
327020|NCT01313624|1103796|P1|Open-Label Phase|Lost to Follow-up|1
327021|NCT01313624|1103795|P2|Open-Label Phase|Withdrawal by Subject|2
327022|NCT01313624|1103796|P1|Open-Label Phase|Withdrawal by Subject|2
327023|NCT01313624|1103795|P2|Open-Label Phase|Adverse Event|10
327024|NCT01313624|1103796|P1|Open-Label Phase|Adverse Event|1
327025|NCT01313624|1103795|P2|Double-Blind Phase|Lack of Efficacy|0
327026|NCT01313624|1103796|P1|Double-Blind Phase|Lack of Efficacy|1
327027|NCT01313624|1103795|P2|Double-Blind Phase|Physician Decision|0
327028|NCT01313624|1103796|P1|Double-Blind Phase|Physician Decision|1
327029|NCT01313624|1103795|P2|Double-Blind Phase|Lost to Follow-up|2
327030|NCT01313624|1103796|P1|Double-Blind Phase|Lost to Follow-up|0
327031|NCT01313624|1103795|P2|Double-Blind Phase|Withdrawal by Subject|4
327032|NCT01313624|1103796|P1|Double-Blind Phase|Withdrawal by Subject|9
327033|NCT01313624|1103795|P2|Double-Blind Phase|Adverse Event|4
327034|NCT01313624|1103796|P1|Double-Blind Phase|Adverse Event|27
327035|NCT01313559|1103810|P2|Overall Study|Rising PSA|0
327036|NCT01313559|1103811|P1|Overall Study|Rising PSA|2
327037|NCT01313559|1103810|P2|Overall Study|Disease progression|0
327038|NCT01313559|1103811|P1|Overall Study|Disease progression|1
327039|NCT01313559|1103810|P2|Overall Study|Withdrawal by Subject|2
327040|NCT01313559|1103811|P1|Overall Study|Withdrawal by Subject|1
327041|NCT01313312|1103907|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
327042|NCT01313312|1103907|P1|Overall Study|Subject Withdrawn Early in Error|4
327043|NCT01313312|1103907|P1|Overall Study|Observational Phase|1
327044|NCT01313312|1103907|P1|Overall Study|Investigator Decision|1
327045|NCT01313312|1103907|P1|Overall Study|Lack of Efficacy|3
327046|NCT01313312|1103907|P1|Overall Study|Withdrawal by Subject|18
327047|NCT01313312|1103907|P1|Overall Study|Adverse Event|5
327048|NCT01313299|1103954|P3|Overall Study|Lack of subject compliance|1
327049|NCT01313299|1103955|P2|Overall Study|Lack of subject compliance|0
327050|NCT01313299|1103956|P1|Overall Study|Lack of subject compliance|0
327051|NCT01313299|1103954|P3|Overall Study|Family reason and moved out of state|0
327052|NCT01313299|1103955|P2|Overall Study|Family reason and moved out of state|2
327053|NCT01313299|1103956|P1|Overall Study|Family reason and moved out of state|0
327054|NCT01313299|1103954|P3|Overall Study|Withdrawal by Subject|2
327055|NCT01313299|1103955|P2|Overall Study|Withdrawal by Subject|0
327056|NCT01313299|1103956|P1|Overall Study|Withdrawal by Subject|1
327057|NCT01313299|1103954|P3|Overall Study|Protocol Violation|0
327058|NCT01313299|1103955|P2|Overall Study|Protocol Violation|0
327059|NCT01313299|1103956|P1|Overall Study|Protocol Violation|2
327060|NCT01313299|1103954|P3|Overall Study|Lost to Follow-up|0
327061|NCT01313299|1103955|P2|Overall Study|Lost to Follow-up|0
327062|NCT01313299|1103956|P1|Overall Study|Lost to Follow-up|1
327063|NCT01313299|1103954|P3|Overall Study|Adverse Event|1
327064|NCT01313299|1103955|P2|Overall Study|Adverse Event|1
327065|NCT01313299|1103956|P1|Overall Study|Adverse Event|3
327066|NCT01313273|1103972|P2|Overall Study|Screening Chromogranin A-in normal range|1
327067|NCT01313273|1103973|P1|Overall Study|Screening Chromogranin A-in normal range|0
327068|NCT01313273|1103972|P2|Overall Study|Withdrawal by Subject|0
327069|NCT01313273|1103973|P1|Overall Study|Withdrawal by Subject|1
327070|NCT01313273|1103972|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
327071|NCT01313273|1103973|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
327072|NCT01313221|1103988|P3|Overall Study|Pregnancy|2
327073|NCT01313221|1103989|P2|Overall Study|Pregnancy|0
327074|NCT01313221|1103990|P1|Overall Study|Pregnancy|0
327075|NCT01313221|1103988|P3|Overall Study|Physician Decision|2
327076|NCT01313221|1103989|P2|Overall Study|Physician Decision|0
327077|NCT01313221|1103990|P1|Overall Study|Physician Decision|0
327078|NCT01313221|1103988|P3|Overall Study|Disease progression|2
327079|NCT01313221|1103989|P2|Overall Study|Disease progression|0
327080|NCT01313221|1103990|P1|Overall Study|Disease progression|0
327081|NCT01313221|1103988|P3|Overall Study|Adverse Event|7
327082|NCT01313221|1103989|P2|Overall Study|Adverse Event|0
327083|NCT01313221|1103990|P1|Overall Study|Adverse Event|0
327084|NCT01313221|1103988|P3|Overall Study|Other|0
327085|NCT01313221|1103989|P2|Overall Study|Other|0
327086|NCT01313221|1103990|P1|Overall Study|Other|1
327087|NCT01313221|1103988|P3|Overall Study|Lost to Follow-up|1
327088|NCT01313221|1103989|P2|Overall Study|Lost to Follow-up|3
327089|NCT01313221|1103990|P1|Overall Study|Lost to Follow-up|6
327090|NCT01313221|1103988|P3|Overall Study|Requirement for alternative therapy|1
327091|NCT01313221|1103989|P2|Overall Study|Requirement for alternative therapy|1
327092|NCT01313221|1103990|P1|Overall Study|Requirement for alternative therapy|0
327093|NCT01313221|1103988|P3|Overall Study|Withdrawal by Subject|5
327094|NCT01313221|1103989|P2|Overall Study|Withdrawal by Subject|3
327095|NCT01313221|1103990|P1|Overall Study|Withdrawal by Subject|2
327096|NCT01313221|1103988|P3|Overall Study|Non-compliance|2
327097|NCT01313221|1103989|P2|Overall Study|Non-compliance|0
327098|NCT01313221|1103990|P1|Overall Study|Non-compliance|3
327099|NCT01313221|1103988|P3|Overall Study|Protocol Violation|1
327100|NCT01313221|1103989|P2|Overall Study|Protocol Violation|1
327101|NCT01313221|1103990|P1|Overall Study|Protocol Violation|0
327102|NCT01313208|1104042|P2|Open-label Phase (Weeks 13 - 24)|Other|0
327103|NCT01313208|1104043|P1|Open-label Phase (Weeks 13 - 24)|Other|2
327104|NCT01313208|1104042|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
327105|NCT01313208|1104043|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
327106|NCT01313208|1104042|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
327107|NCT01313208|1104043|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
327108|NCT01313208|1104042|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
327109|NCT01313208|1104043|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
327110|NCT01313208|1104042|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
327111|NCT01313208|1104043|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
327112|NCT01313208|1104042|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
327113|NCT01313208|1104043|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
327114|NCT01313208|1104042|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
327115|NCT01313208|1104043|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
327116|NCT01313208|1104042|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
327117|NCT01313208|1104043|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
327118|NCT01313208|1104042|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
327119|NCT01313208|1104043|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
327120|NCT01313182|1104133|P2|Overall Study|Protocol Violation|92
327121|NCT01313182|1104134|P1|Overall Study|Protocol Violation|66
327122|NCT01313117|1104140|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
327123|NCT01313117|1104140|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
327124|NCT01313078|1104147|P1|Overall Study|Withdrawal by Subject|1
327125|NCT01313078|1104147|P1|Overall Study|Discontinued study drug|1
327126|NCT01313078|1104147|P1|Overall Study|Death|1
327127|NCT01313039|1104152|P1|Overall Study|Adverse Event|1
327128|NCT01313039|1104152|P1|Overall Study|Physician Decision|1
327129|NCT01312961|1104158|P2|Overall Study|Other than specified above|3
327130|NCT01312961|1104159|P1|Overall Study|Other than specified above|2
327131|NCT01312961|1104158|P2|Overall Study|Poor compliance to protocol|0
327132|NCT01312961|1104159|P1|Overall Study|Poor compliance to protocol|1
327133|NCT01312961|1104158|P2|Overall Study|Lack of Efficacy|1
327134|NCT01312961|1104159|P1|Overall Study|Lack of Efficacy|11
327135|NCT01312961|1104158|P2|Overall Study|Adverse Event|3
327136|NCT01312961|1104159|P1|Overall Study|Adverse Event|3
327137|NCT01312909|1104195|P3|Overall Study|Entrance criteria not met|2
327138|NCT01312909|1104196|P2|Overall Study|Entrance criteria not met|0
327139|NCT01312909|1104197|P1|Overall Study|Entrance criteria not met|0
327140|NCT01312909|1104195|P3|Overall Study|Insufficient clinical response|1
327141|NCT01312909|1104196|P2|Overall Study|Insufficient clinical response|0
327142|NCT01312909|1104197|P1|Overall Study|Insufficient clinical response|0
327143|NCT01312909|1104195|P3|Overall Study|Lost to Follow-up|20
327144|NCT01312909|1104196|P2|Overall Study|Lost to Follow-up|17
327145|NCT01312909|1104197|P1|Overall Study|Lost to Follow-up|21
327146|NCT01312909|1104195|P3|Overall Study|Withdrawal by Subject|7
327147|NCT01312909|1104196|P2|Overall Study|Withdrawal by Subject|10
327148|NCT01312909|1104197|P1|Overall Study|Withdrawal by Subject|8
327149|NCT01312909|1104195|P3|Overall Study|Other|11
327150|NCT01312909|1104196|P2|Overall Study|Other|6
327151|NCT01312909|1104197|P1|Overall Study|Other|9
327152|NCT01312909|1104195|P3|Overall Study|Protocol Violation|2
327153|NCT01312909|1104196|P2|Overall Study|Protocol Violation|0
327154|NCT01312909|1104197|P1|Overall Study|Protocol Violation|2
327155|NCT01312909|1104195|P3|Overall Study|Adverse Event|3
327156|NCT01312909|1104196|P2|Overall Study|Adverse Event|0
327157|NCT01312909|1104197|P1|Overall Study|Adverse Event|1
327158|NCT01312909|1104195|P3|Overall Study|Randomized but not treated|1
327159|NCT01312909|1104196|P2|Overall Study|Randomized but not treated|3
327160|NCT01312909|1104197|P1|Overall Study|Randomized but not treated|1
327161|NCT01312467|1104328|P1|Overall Study|Ineligible|4
327162|NCT01312467|1104328|P1|Overall Study|Another medical condition|1
327163|NCT01312467|1104328|P1|Overall Study|Deported to country of origin|1
327164|NCT01312467|1104328|P1|Overall Study|Withdrawal by Subject|2
327165|NCT01312467|1104328|P1|Overall Study|Lost to Follow-up|1
327166|NCT01312467|1104328|P1|Overall Study|Adverse Event|4
327167|NCT01312428|1104337|P2|Overall Study|Study Termination|4
327168|NCT01312428|1104338|P1|Overall Study|Study Termination|3
327169|NCT01312129|1104383|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
327170|NCT01312129|1104384|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
327171|NCT01311687|1104414|P2|PFS Follow-up Phase|On PFS follow-up at data cut-off|1
327172|NCT01311687|1104415|P1|PFS Follow-up Phase|On PFS follow-up at data cut-off|3
327173|NCT01311687|1104414|P2|Treatment Phase|On treatment at data cut-off|11
327174|NCT01311687|1104415|P1|Treatment Phase|On treatment at data cut-off|60
327175|NCT01311661|1104465|P1|Overall Study|Withdrawal by Subject|2
327176|NCT01311661|1104465|P1|Overall Study|Protocol Violation|3
327177|NCT01311661|1104465|P1|Overall Study|Adverse Event|2
327178|NCT01311557|1104609|P2|Overall Study|Withdrawal by Subject|2
327179|NCT01311557|1104610|P1|Overall Study|Withdrawal by Subject|1
327180|NCT01311557|1104609|P2|Overall Study|Lost to Follow-up|1
327181|NCT01311557|1104610|P1|Overall Study|Lost to Follow-up|0
327182|NCT01311557|1104609|P2|Overall Study|Protocol Violation|2
327183|NCT01311557|1104610|P1|Overall Study|Protocol Violation|4
327184|NCT01311557|1104609|P2|Overall Study|Serious adverse event|1
327185|NCT01311557|1104610|P1|Overall Study|Serious adverse event|0
327186|NCT01311505|1104626|P2|First Intervention Period|Protocol Violation|1
327187|NCT01311505|1104627|P1|First Intervention Period|Protocol Violation|0
327188|NCT01311024|1104683|P2|Overall Study|Protocol Violation|22
327189|NCT01311024|1104684|P1|Overall Study|Protocol Violation|35
327190|NCT01310868|1104690|P1|Overall Study|Do not have histologically confirmed GBM|13
327191|NCT01310803|1104707|P2|Overall Study|Subject terminated by Sponsor|0
327192|NCT01310803|1104708|P1|Overall Study|Subject terminated by Sponsor|1
327193|NCT01310777|1104719|P3|Overall Study|Other|2
327194|NCT01310777|1104720|P2|Overall Study|Other|1
327195|NCT01310777|1104721|P1|Overall Study|Other|4
327196|NCT01310777|1104719|P3|Overall Study|Inadequate Control of IOP|10
327197|NCT01310777|1104720|P2|Overall Study|Inadequate Control of IOP|7
327198|NCT01310777|1104721|P1|Overall Study|Inadequate Control of IOP|5
327199|NCT01310777|1104719|P3|Overall Study|Patient's Decision Unrelated to AE|2
327200|NCT01310777|1104720|P2|Overall Study|Patient's Decision Unrelated to AE|1
327201|NCT01310777|1104721|P1|Overall Study|Patient's Decision Unrelated to AE|1
327202|NCT01310777|1104719|P3|Overall Study|Lost to Follow-up|1
327203|NCT01310777|1104720|P2|Overall Study|Lost to Follow-up|4
327204|NCT01310777|1104721|P1|Overall Study|Lost to Follow-up|0
327205|NCT01310777|1104719|P3|Overall Study|Adverse Event|15
327206|NCT01310777|1104720|P2|Overall Study|Adverse Event|1
327207|NCT01310777|1104721|P1|Overall Study|Adverse Event|23
327208|NCT01310699|1104731|P2|Overall Study|Patients did not complete tandem.|6
327209|NCT01310699|1104732|P1|Overall Study|Patients did not complete tandem.|4
327210|NCT01310413|1104759|P7|From Day U0 to Day U385|Lost to Follow-up|2
327211|NCT01310413|1104760|P6|From Day U0 to Day U385|Lost to Follow-up|0
327212|NCT01310413|1104761|P5|From Day U0 to Day U385|Lost to Follow-up|0
327213|NCT01310413|1104762|P4|From Day U0 to Day U385|Lost to Follow-up|0
327214|NCT01310413|1104763|P3|From Day U0 to Day U385|Lost to Follow-up|0
327215|NCT01310413|1104764|P2|From Day U0 to Day U385|Lost to Follow-up|0
327216|NCT01310413|1104765|P1|From Day U0 to Day U385|Lost to Follow-up|0
327217|NCT01310413|1104759|P7|From Day U0 to Day U385|Withdrawal by Subject|1
327218|NCT01310413|1104760|P6|From Day U0 to Day U385|Withdrawal by Subject|0
327219|NCT01310413|1104761|P5|From Day U0 to Day U385|Withdrawal by Subject|0
327220|NCT01310413|1104762|P4|From Day U0 to Day U385|Withdrawal by Subject|0
327221|NCT01310413|1104763|P3|From Day U0 to Day U385|Withdrawal by Subject|0
327222|NCT01310413|1104764|P2|From Day U0 to Day U385|Withdrawal by Subject|0
327223|NCT01310413|1104765|P1|From Day U0 to Day U385|Withdrawal by Subject|0
327224|NCT01310413|1104759|P7|Day 0 to Day 385|Other|0
327225|NCT01310413|1104760|P6|Day 0 to Day 385|Other|0
327226|NCT01310413|1104761|P5|Day 0 to Day 385|Other|0
327227|NCT01310413|1104762|P4|Day 0 to Day 385|Other|0
327228|NCT01310413|1104763|P3|Day 0 to Day 385|Other|3
327229|NCT01310413|1104764|P2|Day 0 to Day 385|Other|0
327230|NCT01310413|1104765|P1|Day 0 to Day 385|Other|1
327231|NCT01310413|1104759|P7|Day 0 to Day 385|Migrated/moved from study area|0
327232|NCT01310413|1104760|P6|Day 0 to Day 385|Migrated/moved from study area|0
327233|NCT01310413|1104761|P5|Day 0 to Day 385|Migrated/moved from study area|1
327234|NCT01310413|1104762|P4|Day 0 to Day 385|Migrated/moved from study area|1
327235|NCT01310413|1104763|P3|Day 0 to Day 385|Migrated/moved from study area|1
327236|NCT01310413|1104764|P2|Day 0 to Day 385|Migrated/moved from study area|3
327237|NCT01310413|1104765|P1|Day 0 to Day 385|Migrated/moved from study area|3
327238|NCT01310413|1104759|P7|Day 0 to Day 385|Lost to Follow-up|0
327239|NCT01310413|1104760|P6|Day 0 to Day 385|Lost to Follow-up|2
327240|NCT01310413|1104761|P5|Day 0 to Day 385|Lost to Follow-up|1
327241|NCT01310413|1104762|P4|Day 0 to Day 385|Lost to Follow-up|5
327242|NCT01310413|1104763|P3|Day 0 to Day 385|Lost to Follow-up|3
327243|NCT01310413|1104764|P2|Day 0 to Day 385|Lost to Follow-up|3
327244|NCT01310413|1104765|P1|Day 0 to Day 385|Lost to Follow-up|18
327245|NCT01310413|1104759|P7|Day 0 to Day 385|Withdrawal by Subject|0
327246|NCT01310413|1104760|P6|Day 0 to Day 385|Withdrawal by Subject|1
327247|NCT01310413|1104761|P5|Day 0 to Day 385|Withdrawal by Subject|1
327248|NCT01310413|1104762|P4|Day 0 to Day 385|Withdrawal by Subject|2
327249|NCT01310413|1104763|P3|Day 0 to Day 385|Withdrawal by Subject|0
327250|NCT01310413|1104764|P2|Day 0 to Day 385|Withdrawal by Subject|2
327251|NCT01310413|1104765|P1|Day 0 to Day 385|Withdrawal by Subject|5
327252|NCT01310127|1104947|P2|Overall Study|advanced psc cataract outlier|0
327253|NCT01310127|1104948|P1|Overall Study|advanced psc cataract outlier|1
327254|NCT01310127|1104947|P2|Overall Study|Protocol Violation|1
327255|NCT01310127|1104948|P1|Overall Study|Protocol Violation|1
327256|NCT01309997|1104962|P2|Overall Study|Withdrawal by Subject|1
327257|NCT01309997|1104963|P1|Overall Study|Withdrawal by Subject|1
327258|NCT01309997|1104962|P2|Overall Study|Lack of Efficacy|2
327259|NCT01309997|1104963|P1|Overall Study|Lack of Efficacy|2
327260|NCT01309997|1104962|P2|Overall Study|Death|3
327261|NCT01309997|1104963|P1|Overall Study|Death|1
327262|NCT01309997|1104962|P2|Overall Study|Adverse Event|0
327263|NCT01309997|1104963|P1|Overall Study|Adverse Event|1
327264|NCT01309919|1104987|P2|Overall Study|Did not receive a postpartum IUD|48
327265|NCT01309919|1104988|P1|Overall Study|Did not receive a postpartum IUD|17
327266|NCT01309893|1105000|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
327267|NCT01309893|1105001|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
327268|NCT01309893|1105000|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
327269|NCT01309893|1105001|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
327270|NCT01309841|1105025|P3|Overall Study|Severe non-compliance with protocol|2
327271|NCT01309841|1105026|P2|Overall Study|Severe non-compliance with protocol|5
327272|NCT01309841|1105027|P1|Overall Study|Severe non-compliance with protocol|0
327273|NCT01309841|1105025|P3|Overall Study|Did Not Receive Treatment|1
327274|NCT01309841|1105026|P2|Overall Study|Did Not Receive Treatment|0
327275|NCT01309841|1105027|P1|Overall Study|Did Not Receive Treatment|2
327276|NCT01309841|1105025|P3|Overall Study|Withdrawal by Subject|13
327277|NCT01309841|1105026|P2|Overall Study|Withdrawal by Subject|6
327278|NCT01309841|1105027|P1|Overall Study|Withdrawal by Subject|17
327279|NCT01309841|1105025|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
327280|NCT01309841|1105026|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
327281|NCT01309841|1105027|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
327282|NCT01309841|1105025|P3|Overall Study|Death|0
327283|NCT01309841|1105026|P2|Overall Study|Death|0
327284|NCT01309841|1105027|P1|Overall Study|Death|1
327285|NCT01309841|1105025|P3|Overall Study|Adverse Event|11
327286|NCT01309841|1105026|P2|Overall Study|Adverse Event|22
327287|NCT01309841|1105027|P1|Overall Study|Adverse Event|9
327288|NCT01309841|1105025|P3|Overall Study|Lack of Efficacy|2
327289|NCT01309841|1105026|P2|Overall Study|Lack of Efficacy|0
327290|NCT01309841|1105027|P1|Overall Study|Lack of Efficacy|0
327291|NCT01309841|1105025|P3|Overall Study|Study-Specific Withdrawal Criteria|2
327292|NCT01309841|1105026|P2|Overall Study|Study-Specific Withdrawal Criteria|1
327293|NCT01309841|1105027|P1|Overall Study|Study-Specific Withdrawal Criteria|3
327294|NCT01309841|1105025|P3|Overall Study|Lost to Follow-up|4
327295|NCT01309841|1105026|P2|Overall Study|Lost to Follow-up|6
327296|NCT01309841|1105027|P1|Overall Study|Lost to Follow-up|7
327297|NCT01309841|1105025|P3|Overall Study|Other|1
327298|NCT01309841|1105026|P2|Overall Study|Other|1
327299|NCT01309841|1105027|P1|Overall Study|Other|0
327300|NCT01309828|1105067|P2|Overall Study|Other|0
327301|NCT01309828|1105068|P1|Overall Study|Other|1
327302|NCT01309828|1105067|P2|Overall Study|Major Protocol Deviation|1
327303|NCT01309828|1105068|P1|Overall Study|Major Protocol Deviation|0
327304|NCT01309828|1105067|P2|Overall Study|Voluntary Withdrawal|4
327305|NCT01309828|1105068|P1|Overall Study|Voluntary Withdrawal|5
327306|NCT01309828|1105067|P2|Overall Study|Adverse Event|11
327307|NCT01309828|1105068|P1|Overall Study|Adverse Event|10
327308|NCT01309737|1105102|P5|Week 16 to 52|Other|0
327309|NCT01309737|1105103|P4|Week 16 to 52|Other|2
327310|NCT01309737|1105104|P3|Week 16 to 52|Other|0
327311|NCT01309737|1105105|P2|Week 16 to 52|Other|12
327312|NCT01309737|1105106|P1|Week 16 to 52|Other|10
327313|NCT01309737|1105102|P5|Week 16 to 52|Withdrawal by Subject|2
327314|NCT01309737|1105103|P4|Week 16 to 52|Withdrawal by Subject|0
327315|NCT01309737|1105104|P3|Week 16 to 52|Withdrawal by Subject|0
327316|NCT01309737|1105105|P2|Week 16 to 52|Withdrawal by Subject|6
327317|NCT01309737|1105106|P1|Week 16 to 52|Withdrawal by Subject|5
327318|NCT01309737|1105102|P5|Week 16 to 52|Lost to Follow-up|4
327319|NCT01309737|1105103|P4|Week 16 to 52|Lost to Follow-up|1
327320|NCT01309737|1105104|P3|Week 16 to 52|Lost to Follow-up|0
327321|NCT01309737|1105105|P2|Week 16 to 52|Lost to Follow-up|2
327322|NCT01309737|1105106|P1|Week 16 to 52|Lost to Follow-up|4
327323|NCT01309737|1105102|P5|Week 16 to 52|Lack of Efficacy|21
327324|NCT01309737|1105103|P4|Week 16 to 52|Lack of Efficacy|25
327325|NCT01309737|1105104|P3|Week 16 to 52|Lack of Efficacy|0
327326|NCT01309737|1105105|P2|Week 16 to 52|Lack of Efficacy|76
327327|NCT01309737|1105106|P1|Week 16 to 52|Lack of Efficacy|107
327328|NCT01309737|1105102|P5|Week 16 to 52|Adverse Event|5
327329|NCT01309737|1105103|P4|Week 16 to 52|Adverse Event|6
327330|NCT01309737|1105104|P3|Week 16 to 52|Adverse Event|0
327331|NCT01309737|1105105|P2|Week 16 to 52|Adverse Event|7
327332|NCT01309737|1105106|P1|Week 16 to 52|Adverse Event|7
327333|NCT01309737|1105102|P5|Week 16 to 52|Death|1
327334|NCT01309737|1105103|P4|Week 16 to 52|Death|0
327335|NCT01309737|1105104|P3|Week 16 to 52|Death|0
327336|NCT01309737|1105105|P2|Week 16 to 52|Death|0
327337|NCT01309737|1105106|P1|Week 16 to 52|Death|0
327338|NCT01309737|1105102|P5|Week 0 to 16|Randomized, but not treated|0
327339|NCT01309737|1105103|P4|Week 0 to 16|Randomized, but not treated|0
327340|NCT01309737|1105104|P3|Week 0 to 16|Randomized, but not treated|0
327341|NCT01309737|1105105|P2|Week 0 to 16|Randomized, but not treated|0
327342|NCT01309737|1105106|P1|Week 0 to 16|Randomized, but not treated|1
327343|NCT01309737|1105102|P5|Week 0 to 16|Other|0
327344|NCT01309737|1105103|P4|Week 0 to 16|Other|0
327345|NCT01309737|1105104|P3|Week 0 to 16|Other|4
327346|NCT01309737|1105105|P2|Week 0 to 16|Other|14
327347|NCT01309737|1105106|P1|Week 0 to 16|Other|10
327348|NCT01309737|1105102|P5|Week 0 to 16|Withdrawal by Subject|0
327349|NCT01309737|1105103|P4|Week 0 to 16|Withdrawal by Subject|0
327350|NCT01309737|1105104|P3|Week 0 to 16|Withdrawal by Subject|7
327351|NCT01309737|1105105|P2|Week 0 to 16|Withdrawal by Subject|6
327352|NCT01309737|1105106|P1|Week 0 to 16|Withdrawal by Subject|7
327353|NCT01309737|1105102|P5|Week 0 to 16|Lost to Follow-up|0
327354|NCT01309737|1105103|P4|Week 0 to 16|Lost to Follow-up|0
327355|NCT01309737|1105104|P3|Week 0 to 16|Lost to Follow-up|3
327356|NCT01309737|1105105|P2|Week 0 to 16|Lost to Follow-up|8
327357|NCT01309737|1105106|P1|Week 0 to 16|Lost to Follow-up|7
327358|NCT01309737|1105102|P5|Week 0 to 16|Lack of Efficacy|0
327359|NCT01309737|1105103|P4|Week 0 to 16|Lack of Efficacy|0
327360|NCT01309737|1105104|P3|Week 0 to 16|Lack of Efficacy|24
327361|NCT01309737|1105105|P2|Week 0 to 16|Lack of Efficacy|2
327362|NCT01309737|1105106|P1|Week 0 to 16|Lack of Efficacy|15
327363|NCT01309737|1105102|P5|Week 0 to 16|Adverse Event|0
327364|NCT01309737|1105103|P4|Week 0 to 16|Adverse Event|0
327365|NCT01309737|1105104|P3|Week 0 to 16|Adverse Event|5
327366|NCT01309737|1105105|P2|Week 0 to 16|Adverse Event|10
327367|NCT01309737|1105106|P1|Week 0 to 16|Adverse Event|11
327368|NCT01309737|1105102|P5|Week 0 to 16|Death|0
327369|NCT01309737|1105103|P4|Week 0 to 16|Death|0
327370|NCT01309737|1105104|P3|Week 0 to 16|Death|1
327371|NCT01309737|1105105|P2|Week 0 to 16|Death|0
327372|NCT01309737|1105106|P1|Week 0 to 16|Death|1
327373|NCT01309672|1105301|P1|Overall Study|Withdrawal by Subject|3
327374|NCT01309672|1105301|P1|Overall Study|Adverse Event|5
327375|NCT01309672|1105301|P1|Overall Study|Other|9
327376|NCT01309672|1105301|P1|Overall Study|Lack of Efficacy|20
327377|NCT01309659|1105311|P2|Overall Study|Protocol Violation|1
327378|NCT01309659|1105312|P1|Overall Study|Protocol Violation|0
327379|NCT01309386|1105417|P2|Overall Study|Adverse Event|8
327380|NCT01309386|1105418|P1|Overall Study|Adverse Event|5
327381|NCT01309386|1105417|P2|Overall Study|Lack of Efficacy|1
327382|NCT01309386|1105418|P1|Overall Study|Lack of Efficacy|3
327383|NCT01309386|1105417|P2|Overall Study|Physician Decision|1
327384|NCT01309386|1105418|P1|Overall Study|Physician Decision|1
327385|NCT01309386|1105417|P2|Overall Study|Progressive disease|11
327386|NCT01309386|1105418|P1|Overall Study|Progressive disease|9
327387|NCT01309386|1105417|P2|Overall Study|Withdrawal by Subject|0
327388|NCT01309386|1105418|P1|Overall Study|Withdrawal by Subject|2
327389|NCT01309386|1105417|P2|Overall Study|Other|0
327390|NCT01309386|1105418|P1|Overall Study|Other|2
327391|NCT01309308|1105466|P2|Overall Study|Lost to Follow-up|4
327392|NCT01309308|1105467|P1|Overall Study|Lost to Follow-up|6
327393|NCT01309282|1105475|P1|Overall Study|Lost to Follow-up|1
327394|NCT01309269|1105492|P1|Overall Study|Enrolled but not Treated|107
327395|NCT01309269|1105492|P1|Overall Study|Study Completion Data Not Recorded|95
327396|NCT01309269|1105492|P1|Overall Study|Other|1
327397|NCT01309269|1105492|P1|Overall Study|Other|256
327398|NCT01309269|1105492|P1|Overall Study|Administrative Problems|141
327399|NCT01309269|1105492|P1|Overall Study|Kidney Transplant|25
327400|NCT01309269|1105492|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
327401|NCT01309269|1105492|P1|Overall Study|Lack of Acceptance|15
327402|NCT01309269|1105492|P1|Overall Study|Withdrawal by Subject|25
327403|NCT01309269|1105492|P1|Overall Study|Adverse Event|56
327404|NCT01309243|1105500|P2|Extension Phase|Lost to Follow-up|0
327405|NCT01309243|1105501|P1|Extension Phase|Lost to Follow-up|6
327406|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Protocol Violation|1
327407|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Protocol Violation|1
327408|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
327409|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
327410|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
327411|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
327412|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Withdrew Consent|18
327413|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Withdrew Consent|12
327414|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Investigators Discretion|6
327415|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Investigators Discretion|3
327416|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
327417|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
327418|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Pregnancy|0
327419|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Pregnancy|2
327420|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Death|1
327421|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Death|0
327422|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Adverse Event|43
327423|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Adverse Event|12
327424|NCT01309243|1105500|P2|Randomized Phase Through Week 96|Randomized but not treated|7
327425|NCT01309243|1105501|P1|Randomized Phase Through Week 96|Randomized but not treated|6
327426|NCT01309204|1105527|P2|Overall Study|Other|1
327427|NCT01309204|1105528|P1|Overall Study|Other|4
327428|NCT01309204|1105527|P2|Overall Study|Inadequate control of IOP|4
327429|NCT01309204|1105528|P1|Overall Study|Inadequate control of IOP|4
327430|NCT01309204|1105527|P2|Overall Study|Subject's decision unrelated to an AE|10
327431|NCT01309204|1105528|P1|Overall Study|Subject's decision unrelated to an AE|9
327432|NCT01309204|1105527|P2|Overall Study|Lost to Follow-up|2
327433|NCT01309204|1105528|P1|Overall Study|Lost to Follow-up|2
327434|NCT01309204|1105527|P2|Overall Study|Adverse Event|58
327435|NCT01309204|1105528|P1|Overall Study|Adverse Event|48
327436|NCT01309100|1105534|P1|Overall Study|Positive Slit lamp finding|1
327437|NCT01309100|1105534|P1|Overall Study|Protocol Violation|1
327438|NCT01308788|1105582|P2|2-year Treatment|medication change by treating physician|11
327439|NCT01308788|1105583|P1|2-year Treatment|medication change by treating physician|4
327440|NCT01308762|1105618|P3|Overall Study|Protocol Violation|0
327441|NCT01308762|1105619|P2|Overall Study|Protocol Violation|1
327442|NCT01308762|1105620|P1|Overall Study|Protocol Violation|0
327443|NCT01308749|1105633|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
327444|NCT01308749|1105634|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
327445|NCT01308749|1105633|P2|Period 2: Open Label Treatment|Adverse Event|1
327446|NCT01308749|1105634|P1|Period 2: Open Label Treatment|Adverse Event|0
327447|NCT01308749|1105633|P2|Period 1: Double Blind Treatment|Adverse Event|0
327448|NCT01308749|1105634|P1|Period 1: Double Blind Treatment|Adverse Event|1
327449|NCT01308736|1105664|P2|Overall Study|Did not attend a single session|5
327450|NCT01308736|1105665|P1|Overall Study|Did not attend a single session|6
327451|NCT01308580|1105688|P2|Overall Study|Lost to Follow-up|7
327452|NCT01308580|1105689|P1|Overall Study|Lost to Follow-up|12
327453|NCT01308567|1105732|P3|Overall Study|Lost to Follow-up|4
327454|NCT01308567|1105733|P2|Overall Study|Lost to Follow-up|4
327455|NCT01308567|1105734|P1|Overall Study|Lost to Follow-up|2
327456|NCT01308476|1105774|P2|Overall Study|Other|0
327457|NCT01308476|1105775|P1|Overall Study|Other|1
327458|NCT01308476|1105774|P2|Overall Study|Lost to Follow-up|2
327459|NCT01308476|1105775|P1|Overall Study|Lost to Follow-up|2
327460|NCT01308463|1105795|P1|Overall Study|Revision|2
327461|NCT01308463|1105795|P1|Overall Study|Death|4
327462|NCT01308463|1105795|P1|Overall Study|Study Discontinued|23
327463|NCT01308424|1105808|P3|Randomization|Physician Decision|1
327464|NCT01308424|1105809|P2|Randomization|Physician Decision|1
327465|NCT01308424|1105810|P1|Randomization|Physician Decision|0
327466|NCT01308424|1105808|P3|Randomization|Lost to Follow-up|0
327467|NCT01308424|1105809|P2|Randomization|Lost to Follow-up|1
327468|NCT01308424|1105810|P1|Randomization|Lost to Follow-up|0
327469|NCT01308424|1105808|P3|Randomization|Adverse Event|1
327470|NCT01308424|1105809|P2|Randomization|Adverse Event|1
327471|NCT01308424|1105810|P1|Randomization|Adverse Event|0
327472|NCT01308424|1105808|P3|Baseline Eligibility|Screen Failures|0
327473|NCT01308424|1105809|P2|Baseline Eligibility|Screen Failures|0
327474|NCT01308424|1105810|P1|Baseline Eligibility|Screen Failures|71
327475|NCT01307891|1105823|P2|Overall Study|Progressive Disease|1
327476|NCT01307891|1105824|P1|Overall Study|Progressive Disease|3
327477|NCT01307787|1105836|P2|Overall Study|Withdrawal by Subject|0
327478|NCT01307787|1105837|P1|Overall Study|Withdrawal by Subject|2
327479|NCT01307423|1105901|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
327480|NCT01307423|1105902|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
327481|NCT01307423|1105903|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
327482|NCT01307423|1105904|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
327483|NCT01307423|1105905|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
327484|NCT01307423|1105906|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
327485|NCT01307423|1105907|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
327486|NCT01307423|1105901|P7|Active Treatment Phase (Week 25-52)|Other|0
327487|NCT01307423|1105902|P6|Active Treatment Phase (Week 25-52)|Other|0
327488|NCT01307423|1105903|P5|Active Treatment Phase (Week 25-52)|Other|0
327489|NCT01307423|1105904|P4|Active Treatment Phase (Week 25-52)|Other|1
327490|NCT01307423|1105905|P3|Active Treatment Phase (Week 25-52)|Other|0
327491|NCT01307423|1105906|P2|Active Treatment Phase (Week 25-52)|Other|0
327492|NCT01307423|1105907|P1|Active Treatment Phase (Week 25-52)|Other|0
327493|NCT01307423|1105901|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
327494|NCT01307423|1105902|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
327495|NCT01307423|1105903|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
327496|NCT01307423|1105904|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
327497|NCT01307423|1105905|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
327498|NCT01307423|1105906|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
327499|NCT01307423|1105907|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
327500|NCT01307423|1105901|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
327501|NCT01307423|1105902|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
327502|NCT01307423|1105903|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
327503|NCT01307423|1105904|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
327504|NCT01307423|1105905|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
327505|NCT01307423|1105906|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
327506|NCT01307423|1105907|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
327507|NCT01307423|1105901|P7|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
327508|NCT01307423|1105902|P6|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|1
327509|NCT01307423|1105903|P5|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
327510|NCT01307423|1105904|P4|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
327511|NCT01307423|1105905|P3|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
327512|NCT01307423|1105906|P2|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
327513|NCT01307423|1105907|P1|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
327514|NCT01307423|1105901|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
327515|NCT01307423|1105902|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
327516|NCT01307423|1105903|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
327517|NCT01307423|1105904|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
327518|NCT01307423|1105905|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
327519|NCT01307423|1105906|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
327520|NCT01307423|1105907|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
327521|NCT01307423|1105901|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
327522|NCT01307423|1105902|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
327523|NCT01307423|1105903|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
327524|NCT01307423|1105904|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
327525|NCT01307423|1105905|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
327526|NCT01307423|1105906|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
327527|NCT01307423|1105907|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
327528|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
327529|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
327530|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
327531|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
327532|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
327533|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
327534|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
327535|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
327536|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
327537|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
327538|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
327539|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
327540|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
327541|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
327542|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
327543|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
327544|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
327545|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
327702|NCT01306877|1106195|P1|Overall Study|Lost to Follow-up|3
327546|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
327547|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
327548|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
327549|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
327550|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
327551|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
327552|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
327553|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
327554|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
327555|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
327556|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
327557|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
327558|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
327559|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
327560|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
327561|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
327562|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
327563|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
327564|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
327565|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
327566|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
327567|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
327568|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
327569|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
327570|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
327571|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
327572|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
327573|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
327574|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
327575|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
327576|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
327577|NCT01307423|1105901|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
327578|NCT01307423|1105902|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
327579|NCT01307423|1105903|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
327580|NCT01307423|1105904|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
327581|NCT01307423|1105905|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
327582|NCT01307423|1105906|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
327583|NCT01307423|1105907|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
327584|NCT01307319|1106038|P3|Overall Study|Not specified|3
327585|NCT01307319|1106039|P2|Overall Study|Not specified|4
327586|NCT01307319|1106040|P1|Overall Study|Not specified|0
327587|NCT01307319|1106038|P3|Overall Study|Withdrawal by Subject|2
327588|NCT01307319|1106039|P2|Overall Study|Withdrawal by Subject|1
327589|NCT01307319|1106040|P1|Overall Study|Withdrawal by Subject|0
327590|NCT01307319|1106038|P3|Overall Study|Protocol Violation|0
327591|NCT01307319|1106039|P2|Overall Study|Protocol Violation|1
327592|NCT01307319|1106040|P1|Overall Study|Protocol Violation|1
327593|NCT01307319|1106038|P3|Overall Study|Lost to Follow-up|1
327594|NCT01307319|1106039|P2|Overall Study|Lost to Follow-up|0
327595|NCT01307319|1106040|P1|Overall Study|Lost to Follow-up|1
327596|NCT01307319|1106038|P3|Overall Study|Adverse Event|1
327597|NCT01307319|1106039|P2|Overall Study|Adverse Event|2
327598|NCT01307319|1106040|P1|Overall Study|Adverse Event|2
327599|NCT01307111|1106054|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
327600|NCT01307111|1106055|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
327601|NCT01307111|1106054|P2|IUD Insertion|Lost to Follow-up|0
327602|NCT01307111|1106055|P1|IUD Insertion|Lost to Follow-up|2
327603|NCT01307046|1106065|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
327604|NCT01307046|1106066|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
327605|NCT01307046|1106065|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
327606|NCT01307046|1106066|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
327607|NCT01307046|1106065|P2|Overall Study|Withdrawal by Subject|1
327608|NCT01307046|1106066|P1|Overall Study|Withdrawal by Subject|1
327609|NCT01307046|1106065|P2|Overall Study|Physician Decision|0
327610|NCT01307046|1106066|P1|Overall Study|Physician Decision|2
327611|NCT01307046|1106065|P2|Overall Study|Lack of Efficacy|2
327612|NCT01307046|1106066|P1|Overall Study|Lack of Efficacy|0
327613|NCT01307046|1106065|P2|Overall Study|Adverse Event|3
327614|NCT01307046|1106066|P1|Overall Study|Adverse Event|3
327615|NCT01307033|1106078|P4|44-week Open-label Extension|Death|1
327616|NCT01307033|1106079|P3|44-week Open-label Extension|Death|0
327617|NCT01307033|1106080|P2|44-week Open-label Extension|Death|0
327618|NCT01307033|1106081|P1|44-week Open-label Extension|Death|0
327619|NCT01307033|1106078|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
327620|NCT01307033|1106079|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
327621|NCT01307033|1106080|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
327622|NCT01307033|1106081|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
327623|NCT01307033|1106078|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
327624|NCT01307033|1106079|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
327625|NCT01307033|1106080|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
327626|NCT01307033|1106081|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
327627|NCT01307033|1106078|P4|44-week Open-label Extension|Physician Decision|0
327628|NCT01307033|1106079|P3|44-week Open-label Extension|Physician Decision|1
327629|NCT01307033|1106080|P2|44-week Open-label Extension|Physician Decision|0
327630|NCT01307033|1106081|P1|44-week Open-label Extension|Physician Decision|0
327631|NCT01307033|1106078|P4|44-week Open-label Extension|Withdrawal by Subject|1
327632|NCT01307033|1106079|P3|44-week Open-label Extension|Withdrawal by Subject|2
327633|NCT01307033|1106080|P2|44-week Open-label Extension|Withdrawal by Subject|0
327634|NCT01307033|1106081|P1|44-week Open-label Extension|Withdrawal by Subject|0
327635|NCT01307033|1106078|P4|44-week Open-label Extension|Adverse Event|1
327636|NCT01307033|1106079|P3|44-week Open-label Extension|Adverse Event|2
327637|NCT01307033|1106080|P2|44-week Open-label Extension|Adverse Event|0
327638|NCT01307033|1106081|P1|44-week Open-label Extension|Adverse Event|0
327639|NCT01307033|1106078|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
327640|NCT01307033|1106079|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
327641|NCT01307033|1106080|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
327642|NCT01307033|1106081|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
327643|NCT01307033|1106078|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
327644|NCT01307033|1106079|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
327645|NCT01307033|1106080|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
327646|NCT01307033|1106081|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
327647|NCT01307033|1106078|P4|8-week Double-blind Period|Lack of Efficacy|0
327648|NCT01307033|1106079|P3|8-week Double-blind Period|Lack of Efficacy|0
327649|NCT01307033|1106080|P2|8-week Double-blind Period|Lack of Efficacy|0
327650|NCT01307033|1106081|P1|8-week Double-blind Period|Lack of Efficacy|1
327651|NCT01307033|1106078|P4|8-week Double-blind Period|Withdrawal by Subject|0
327652|NCT01307033|1106079|P3|8-week Double-blind Period|Withdrawal by Subject|0
327653|NCT01307033|1106080|P2|8-week Double-blind Period|Withdrawal by Subject|1
327654|NCT01307033|1106081|P1|8-week Double-blind Period|Withdrawal by Subject|4
327655|NCT01307033|1106078|P4|8-week Double-blind Period|Adverse Event|0
327656|NCT01307033|1106079|P3|8-week Double-blind Period|Adverse Event|0
327657|NCT01307033|1106080|P2|8-week Double-blind Period|Adverse Event|0
327658|NCT01307033|1106081|P1|8-week Double-blind Period|Adverse Event|2
327659|NCT01307020|1106103|P10|Overall Study|Electronic data capture failure|0
327660|NCT01307020|1106104|P9|Overall Study|Electronic data capture failure|0
327661|NCT01307020|1106105|P8|Overall Study|Electronic data capture failure|0
327662|NCT01307020|1106106|P7|Overall Study|Electronic data capture failure|0
327663|NCT01307020|1106107|P6|Overall Study|Electronic data capture failure|0
327664|NCT01307020|1106108|P5|Overall Study|Electronic data capture failure|0
327665|NCT01307020|1106109|P4|Overall Study|Electronic data capture failure|0
327666|NCT01307020|1106110|P3|Overall Study|Electronic data capture failure|0
327667|NCT01307020|1106111|P2|Overall Study|Electronic data capture failure|1
327668|NCT01307020|1106112|P1|Overall Study|Electronic data capture failure|0
327669|NCT01307020|1106103|P10|Overall Study|Lost to Follow-up|0
327670|NCT01307020|1106104|P9|Overall Study|Lost to Follow-up|0
327671|NCT01307020|1106105|P8|Overall Study|Lost to Follow-up|0
327672|NCT01307020|1106106|P7|Overall Study|Lost to Follow-up|1
327673|NCT01307020|1106107|P6|Overall Study|Lost to Follow-up|0
327674|NCT01307020|1106108|P5|Overall Study|Lost to Follow-up|0
327675|NCT01307020|1106109|P4|Overall Study|Lost to Follow-up|1
327676|NCT01307020|1106110|P3|Overall Study|Lost to Follow-up|1
327677|NCT01307020|1106111|P2|Overall Study|Lost to Follow-up|0
327678|NCT01307020|1106112|P1|Overall Study|Lost to Follow-up|0
327679|NCT01306968|1106167|P4|Overall Study|Withdrew over privacy concerns|1
327680|NCT01306968|1106168|P3|Overall Study|Withdrew over privacy concerns|0
327681|NCT01306968|1106169|P2|Overall Study|Withdrew over privacy concerns|0
327682|NCT01306968|1106170|P1|Overall Study|Withdrew over privacy concerns|0
327683|NCT01306968|1106167|P4|Overall Study|Withdrew - time commitment|2
327684|NCT01306968|1106168|P3|Overall Study|Withdrew - time commitment|0
327685|NCT01306968|1106169|P2|Overall Study|Withdrew - time commitment|0
327686|NCT01306968|1106170|P1|Overall Study|Withdrew - time commitment|0
327687|NCT01306968|1106167|P4|Overall Study|Relocated and left active duty|1
327688|NCT01306968|1106168|P3|Overall Study|Relocated and left active duty|1
327689|NCT01306968|1106169|P2|Overall Study|Relocated and left active duty|1
327690|NCT01306968|1106170|P1|Overall Study|Relocated and left active duty|0
327691|NCT01306968|1106167|P4|Overall Study|Physician Decision|0
327692|NCT01306968|1106168|P3|Overall Study|Physician Decision|0
327693|NCT01306968|1106169|P2|Overall Study|Physician Decision|1
327694|NCT01306968|1106170|P1|Overall Study|Physician Decision|0
327695|NCT01306968|1106167|P4|Overall Study|Lost to Follow-up|0
327696|NCT01306968|1106168|P3|Overall Study|Lost to Follow-up|0
327697|NCT01306968|1106169|P2|Overall Study|Lost to Follow-up|1
327698|NCT01306968|1106170|P1|Overall Study|Lost to Follow-up|1
327699|NCT01306877|1106194|P2|Overall Study|Physician Decision|1
327700|NCT01306877|1106195|P1|Overall Study|Physician Decision|0
327701|NCT01306877|1106194|P2|Overall Study|Lost to Follow-up|3
327703|NCT01306643|1106213|P1|Overall Study|Other: Change in Eligibility Status|1
327704|NCT01306643|1106213|P1|Overall Study|Disease Progression|7
327705|NCT01306643|1106213|P1|Overall Study|Adverse Event|5
327706|NCT01306617|1106225|P3|Overall Study|Non-compliance|0
327707|NCT01306617|1106226|P2|Overall Study|Non-compliance|1
327708|NCT01306617|1106227|P1|Overall Study|Non-compliance|0
327709|NCT01306617|1106225|P3|Overall Study|Virologic Failure|5
327710|NCT01306617|1106226|P2|Overall Study|Virologic Failure|0
327711|NCT01306617|1106227|P1|Overall Study|Virologic Failure|0
327712|NCT01306617|1106225|P3|Overall Study|Adverse Event|0
327713|NCT01306617|1106226|P2|Overall Study|Adverse Event|0
327714|NCT01306617|1106227|P1|Overall Study|Adverse Event|1
327715|NCT01306305|1106270|P2|Overall Study|Withdrew consent|0
327716|NCT01306305|1106271|P1|Overall Study|Withdrew consent|1
327717|NCT01306305|1106270|P2|Overall Study|Lost to Follow-up|0
327718|NCT01306305|1106271|P1|Overall Study|Lost to Follow-up|1
327719|NCT01306253|1106308|P2|Overall Study|Lost to Follow-up|1
327720|NCT01306253|1106309|P1|Overall Study|Lost to Follow-up|1
327721|NCT01306214|1106326|P3|Overall Study|Not treated|1
327722|NCT01306214|1106327|P2|Overall Study|Not treated|1
327723|NCT01306214|1106328|P1|Overall Study|Not treated|1
327724|NCT01306214|1106326|P3|Overall Study|Withdrawal by Subject|16
327725|NCT01306214|1106327|P2|Overall Study|Withdrawal by Subject|22
327726|NCT01306214|1106328|P1|Overall Study|Withdrawal by Subject|24
327727|NCT01306214|1106326|P3|Overall Study|Lost to Follow-up|4
327728|NCT01306214|1106327|P2|Overall Study|Lost to Follow-up|5
327729|NCT01306214|1106328|P1|Overall Study|Lost to Follow-up|3
327730|NCT01306214|1106326|P3|Overall Study|Death|1
327731|NCT01306214|1106327|P2|Overall Study|Death|0
327732|NCT01306214|1106328|P1|Overall Study|Death|0
327733|NCT01306201|1106345|P1|Overall Study|Files unreadable|3
327734|NCT01306201|1106345|P1|Overall Study|Files could not be processed|3
327735|NCT01306201|1106345|P1|Overall Study|Arrhythmia|4
327736|NCT01306162|1106367|P4|Washout 1|Non-compliance to protocol|0
327737|NCT01306162|1106368|P3|Washout 1|Non-compliance to protocol|0
327738|NCT01306162|1106369|P2|Washout 1|Non-compliance to protocol|1
327739|NCT01306162|1106370|P1|Washout 1|Non-compliance to protocol|0
327740|NCT01306162|1106367|P4|Period 1|Adverse Event|1
327741|NCT01306162|1106368|P3|Period 1|Adverse Event|0
327742|NCT01306162|1106369|P2|Period 1|Adverse Event|0
327743|NCT01306162|1106370|P1|Period 1|Adverse Event|0
327744|NCT01306058|1106398|P1|Overall Study|Enrolled but did not get treatment|1
327745|NCT01306058|1106398|P1|Overall Study|Death|1
327746|NCT01306032|1106424|P6|Disease Progression/Crossover|other/symptomatic progression|0
327747|NCT01306032|1106425|P5|Disease Progression/Crossover|other/symptomatic progression|0
327748|NCT01306032|1106426|P4|Disease Progression/Crossover|other/symptomatic progression|2
327749|NCT01306032|1106427|P3|Disease Progression/Crossover|other/symptomatic progression|0
327750|NCT01306032|1106428|P2|Disease Progression/Crossover|other/symptomatic progression|2
327751|NCT01306032|1106429|P1|Disease Progression/Crossover|other/symptomatic progression|0
327752|NCT01306032|1106424|P6|Disease Progression/Crossover|Withdrawal by Subject|0
327753|NCT01306032|1106425|P5|Disease Progression/Crossover|Withdrawal by Subject|0
327754|NCT01306032|1106426|P4|Disease Progression/Crossover|Withdrawal by Subject|1
327755|NCT01306032|1106427|P3|Disease Progression/Crossover|Withdrawal by Subject|0
327756|NCT01306032|1106428|P2|Disease Progression/Crossover|Withdrawal by Subject|0
327757|NCT01306032|1106429|P1|Disease Progression/Crossover|Withdrawal by Subject|0
327758|NCT01306032|1106424|P6|First Intervention|Progressive disease|0
327759|NCT01306032|1106425|P5|First Intervention|Progressive disease|2
327760|NCT01306032|1106426|P4|First Intervention|Progressive disease|0
327761|NCT01306032|1106427|P3|First Intervention|Progressive disease|0
327762|NCT01306032|1106428|P2|First Intervention|Progressive disease|0
327763|NCT01306032|1106429|P1|First Intervention|Progressive disease|0
327764|NCT01306032|1106424|P6|First Intervention|Ineligible|1
327765|NCT01306032|1106425|P5|First Intervention|Ineligible|0
327766|NCT01306032|1106426|P4|First Intervention|Ineligible|0
327767|NCT01306032|1106427|P3|First Intervention|Ineligible|0
327768|NCT01306032|1106428|P2|First Intervention|Ineligible|0
327769|NCT01306032|1106429|P1|First Intervention|Ineligible|0
327770|NCT01306032|1106424|P6|First Intervention|Death|0
327771|NCT01306032|1106425|P5|First Intervention|Death|0
327772|NCT01306032|1106426|P4|First Intervention|Death|0
327773|NCT01306032|1106427|P3|First Intervention|Death|1
327774|NCT01306032|1106428|P2|First Intervention|Death|0
327775|NCT01306032|1106429|P1|First Intervention|Death|0
327776|NCT01306032|1106424|P6|First Intervention|Withdrawal by Subject|0
327777|NCT01306032|1106425|P5|First Intervention|Withdrawal by Subject|0
327778|NCT01306032|1106426|P4|First Intervention|Withdrawal by Subject|1
327779|NCT01306032|1106427|P3|First Intervention|Withdrawal by Subject|0
327780|NCT01306032|1106428|P2|First Intervention|Withdrawal by Subject|2
327781|NCT01306032|1106429|P1|First Intervention|Withdrawal by Subject|0
327782|NCT01306032|1106424|P6|First Intervention|Adverse Event|1
327783|NCT01306032|1106425|P5|First Intervention|Adverse Event|0
327784|NCT01306032|1106426|P4|First Intervention|Adverse Event|0
327785|NCT01306032|1106427|P3|First Intervention|Adverse Event|1
327786|NCT01306032|1106428|P2|First Intervention|Adverse Event|0
327787|NCT01306032|1106429|P1|First Intervention|Adverse Event|1
327788|NCT01305941|1106481|P1|Overall Study|Death|1
327789|NCT01305941|1106481|P1|Overall Study|Withdrawal by Subject|1
327790|NCT01305941|1106481|P1|Overall Study|Clinical decline|2
327791|NCT01305941|1106481|P1|Overall Study|Adverse Event|6
327792|NCT01305577|1106521|P3|Overall Study|Protocol Deviation|1
327793|NCT01305577|1106522|P2|Overall Study|Protocol Deviation|1
327794|NCT01305577|1106523|P1|Overall Study|Protocol Deviation|0
327795|NCT01305577|1106521|P3|Overall Study|Lost to Follow-up|2
327796|NCT01305577|1106522|P2|Overall Study|Lost to Follow-up|3
327797|NCT01305577|1106523|P1|Overall Study|Lost to Follow-up|4
327798|NCT01305577|1106521|P3|Overall Study|Withdrawal by Subject|6
327799|NCT01305577|1106522|P2|Overall Study|Withdrawal by Subject|5
327800|NCT01305577|1106523|P1|Overall Study|Withdrawal by Subject|7
327801|NCT01305577|1106521|P3|Overall Study|Adverse Event|1
327802|NCT01305577|1106522|P2|Overall Study|Adverse Event|2
327803|NCT01305577|1106523|P1|Overall Study|Adverse Event|2
327804|NCT01305564|1106552|P1|Overall Study|Physician Decision|3
327805|NCT01305564|1106552|P1|Overall Study|Withdrawal by Subject|1
327806|NCT01305564|1106552|P1|Overall Study|Lost to Follow-up|12
327807|NCT01305564|1106552|P1|Overall Study|Death|21
327808|NCT01305408|1106579|P2|Overall Study|Not specified|0
327809|NCT01305408|1106580|P1|Overall Study|Not specified|1
327810|NCT01305408|1106579|P2|Overall Study|Noncompliance with study procedures|1
327811|NCT01305408|1106580|P1|Overall Study|Noncompliance with study procedures|0
327812|NCT01305408|1106579|P2|Overall Study|Noncompliance with study medication|1
327813|NCT01305408|1106580|P1|Overall Study|Noncompliance with study medication|0
327814|NCT01305408|1106579|P2|Overall Study|Lost to Follow-up|3
327815|NCT01305408|1106580|P1|Overall Study|Lost to Follow-up|5
327816|NCT01305408|1106579|P2|Overall Study|Protocol Violation|6
327817|NCT01305408|1106580|P1|Overall Study|Protocol Violation|4
327818|NCT01305408|1106579|P2|Overall Study|Withdrawal by Subject|9
327819|NCT01305408|1106580|P1|Overall Study|Withdrawal by Subject|9
327820|NCT01305408|1106579|P2|Overall Study|Lack of Efficacy|4
327821|NCT01305408|1106580|P1|Overall Study|Lack of Efficacy|3
327822|NCT01305408|1106579|P2|Overall Study|Adverse Event|7
327823|NCT01305408|1106580|P1|Overall Study|Adverse Event|10
327824|NCT01305239|1106656|P1|Overall Study|Exemestane taken prior to inclusion only|1
327825|NCT01305239|1106656|P1|Overall Study|Adverse Event|22
327826|NCT01305200|1106686|P3|Overall Study|Death|0
327827|NCT01305200|1106687|P2|Overall Study|Death|2
327828|NCT01305200|1106688|P1|Overall Study|Death|0
327829|NCT01305200|1106686|P3|Overall Study|Ineligible|1
327830|NCT01305200|1106687|P2|Overall Study|Ineligible|2
327831|NCT01305200|1106688|P1|Overall Study|Ineligible|1
327832|NCT01305200|1106686|P3|Overall Study|Withdrawal by Subject|1
327833|NCT01305200|1106687|P2|Overall Study|Withdrawal by Subject|21
327834|NCT01305200|1106688|P1|Overall Study|Withdrawal by Subject|24
327835|NCT01305200|1106686|P3|Overall Study|Physician Decision|1
327836|NCT01305200|1106687|P2|Overall Study|Physician Decision|6
327837|NCT01305200|1106688|P1|Overall Study|Physician Decision|4
327838|NCT01305044|1106718|P2|Overall Study|Withdrawal by Subject|6
327839|NCT01305044|1106719|P1|Overall Study|Withdrawal by Subject|3
327840|NCT01304706|1106749|P1|Overall Study|Discontinued due to failed drug admin.|1
327841|NCT01304706|1106749|P1|Overall Study|Lost to Follow-up|7
327842|NCT01304706|1106749|P1|Overall Study|Withdrawal by Subject|3
327843|NCT01304706|1106749|P1|Overall Study|Death|3
327844|NCT01304706|1106749|P1|Overall Study|Lack of Efficacy|1
327845|NCT01304706|1106749|P1|Overall Study|Adverse Event|2
327846|NCT01304693|1106758|P5|Overall Study|Decision Unrelated to an Adverse Event|0
327847|NCT01304693|1106759|P4|Overall Study|Decision Unrelated to an Adverse Event|1
327848|NCT01304693|1106760|P3|Overall Study|Decision Unrelated to an Adverse Event|1
327849|NCT01304693|1106761|P2|Overall Study|Decision Unrelated to an Adverse Event|0
327850|NCT01304693|1106762|P1|Overall Study|Decision Unrelated to an Adverse Event|0
327851|NCT01304693|1106758|P5|Overall Study|Adverse Event|1
327852|NCT01304693|1106759|P4|Overall Study|Adverse Event|0
327853|NCT01304693|1106760|P3|Overall Study|Adverse Event|0
327854|NCT01304693|1106761|P2|Overall Study|Adverse Event|0
327855|NCT01304693|1106762|P1|Overall Study|Adverse Event|0
327856|NCT01304498|1106809|P2|Overall Study|Lost to Follow-up|1
327857|NCT01304498|1106810|P1|Overall Study|Lost to Follow-up|2
327858|NCT01304498|1106809|P2|Overall Study|Protocol Violation|0
327859|NCT01304498|1106810|P1|Overall Study|Protocol Violation|1
327860|NCT01304498|1106809|P2|Overall Study|Withdrawal by Subject|3
327861|NCT01304498|1106810|P1|Overall Study|Withdrawal by Subject|2
327862|NCT01304498|1106809|P2|Overall Study|Adverse Event|1
327863|NCT01304498|1106810|P1|Overall Study|Adverse Event|1
327864|NCT01304329|1106830|P6|Third Intervention (3 Days)|Adverse Event|0
327865|NCT01304329|1106831|P5|Third Intervention (3 Days)|Adverse Event|0
327866|NCT01304329|1106832|P4|Third Intervention (3 Days)|Adverse Event|0
327867|NCT01304329|1106833|P3|Third Intervention (3 Days)|Adverse Event|0
327868|NCT01304329|1106834|P2|Third Intervention (3 Days)|Adverse Event|1
327869|NCT01304329|1106835|P1|Third Intervention (3 Days)|Adverse Event|0
327870|NCT01304147|1106969|P2|Second Intervention (7days)|Withdrawal by Subject|1
327871|NCT01304147|1106970|P1|Second Intervention (7days)|Withdrawal by Subject|1
327872|NCT01303861|1107004|P4|Overall Study|Pregnancy|0
327873|NCT01303861|1107005|P3|Overall Study|Pregnancy|0
327874|NCT01303861|1107006|P2|Overall Study|Pregnancy|0
327875|NCT01303861|1107007|P1|Overall Study|Pregnancy|1
327876|NCT01303861|1107004|P4|Overall Study|Adverse Event|5
327877|NCT01303861|1107005|P3|Overall Study|Adverse Event|0
327878|NCT01303861|1107006|P2|Overall Study|Adverse Event|1
327879|NCT01303861|1107007|P1|Overall Study|Adverse Event|4
327880|NCT01303861|1107004|P4|Overall Study|Withdrawal by Subject|23
327881|NCT01303861|1107005|P3|Overall Study|Withdrawal by Subject|8
327882|NCT01303861|1107006|P2|Overall Study|Withdrawal by Subject|8
327883|NCT01303861|1107007|P1|Overall Study|Withdrawal by Subject|16
327884|NCT01303861|1107004|P4|Overall Study|Lack of Efficacy|0
327885|NCT01303861|1107005|P3|Overall Study|Lack of Efficacy|1
327886|NCT01303861|1107006|P2|Overall Study|Lack of Efficacy|2
327887|NCT01303861|1107007|P1|Overall Study|Lack of Efficacy|3
327888|NCT01303861|1107004|P4|Overall Study|Lost to Follow-up|31
327889|NCT01303861|1107005|P3|Overall Study|Lost to Follow-up|27
327890|NCT01303861|1107006|P2|Overall Study|Lost to Follow-up|14
327891|NCT01303861|1107007|P1|Overall Study|Lost to Follow-up|34
327892|NCT01303627|1107066|P2|Overall Study|the failure while performing URS|1
327893|NCT01303627|1107067|P1|Overall Study|the failure while performing URS|0
327894|NCT01303510|1107075|P2|Overall Study|Lost to Follow-up|0
327895|NCT01303510|1107076|P1|Overall Study|Lost to Follow-up|1
327896|NCT01303445|1107090|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
327897|NCT01303445|1107091|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
327898|NCT01303445|1107090|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
327899|NCT01303445|1107091|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
327900|NCT01303445|1107090|P2|Washout (14 Days)|Lost to Follow-up|2
327901|NCT01303445|1107091|P1|Washout (14 Days)|Lost to Follow-up|0
327902|NCT01303445|1107090|P2|Washout (14 Days)|Protocol Violation|0
327903|NCT01303445|1107091|P1|Washout (14 Days)|Protocol Violation|1
327904|NCT01303445|1107090|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
327905|NCT01303445|1107091|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
327906|NCT01303445|1107090|P2|Second Intervention (7 Days)|Adverse Event|2
327907|NCT01303445|1107091|P1|Second Intervention (7 Days)|Adverse Event|0
327908|NCT01303445|1107090|P2|First Intervention (7 Days)|Withdrawal by Subject|0
327909|NCT01303445|1107091|P1|First Intervention (7 Days)|Withdrawal by Subject|1
327910|NCT01303380|1107132|P1|Overall Study|Lack of compliance to study procedures|1
327911|NCT01303159|1107191|P1|Overall Study|Study Termination|7
327912|NCT01303159|1107191|P1|Overall Study|Death|16
327913|NCT01302938|1107198|P2|Overall Study|Adverse Event|0
327914|NCT01302938|1107199|P1|Overall Study|Adverse Event|1
327915|NCT01302938|1107198|P2|Overall Study|Withdrawal by Subject|0
327916|NCT01302938|1107199|P1|Overall Study|Withdrawal by Subject|1
327917|NCT01302899|1107244|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
327918|NCT01302899|1107245|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
327919|NCT01302899|1107244|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
327920|NCT01302899|1107245|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
327921|NCT01302691|1107325|P2|Overall Study|Protocol Violation|0
327922|NCT01302691|1107326|P1|Overall Study|Protocol Violation|1
327923|NCT01302691|1107325|P2|Overall Study|Physician Decision|1
327924|NCT01302691|1107326|P1|Overall Study|Physician Decision|0
327925|NCT01302691|1107325|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
327926|NCT01302691|1107326|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
327927|NCT01302691|1107325|P2|Overall Study|Lost to Follow-up|0
327928|NCT01302691|1107326|P1|Overall Study|Lost to Follow-up|1
327929|NCT01302691|1107325|P2|Overall Study|Death|1
327930|NCT01302691|1107326|P1|Overall Study|Death|0
327931|NCT01302691|1107325|P2|Overall Study|Adverse Event|0
327932|NCT01302691|1107326|P1|Overall Study|Adverse Event|2
327933|NCT01302548|1107346|P2|Overall Study|Lost to Follow-up|1
327934|NCT01302548|1107347|P1|Overall Study|Lost to Follow-up|2
327935|NCT01302418|1107397|P1|Overall Study|Non-evaluable|9
327936|NCT01302418|1107397|P1|Overall Study|Protocol Violation|9
327937|NCT01302392|1107403|P2|Overall Study|Withdrawal by Subject|1
327938|NCT01302392|1107404|P1|Overall Study|Withdrawal by Subject|6
327939|NCT01302392|1107403|P2|Overall Study|Lost to Follow-up|0
327940|NCT01302392|1107404|P1|Overall Study|Lost to Follow-up|1
327941|NCT01302366|1107424|P1|Overall Study|patient choice or noncompliance|5
327942|NCT01302119|1107432|P2|Overall Study|Non-specific|1
327943|NCT01302119|1107433|P1|Overall Study|Non-specific|4
327944|NCT01302119|1107432|P2|Overall Study|Non-compliance|2
327945|NCT01302119|1107433|P1|Overall Study|Non-compliance|4
327946|NCT01302119|1107432|P2|Overall Study|Adverse Event|1
327947|NCT01302119|1107433|P1|Overall Study|Adverse Event|2
327948|NCT01302119|1107432|P2|Overall Study|Lost to Follow-up|4
327949|NCT01302119|1107433|P1|Overall Study|Lost to Follow-up|10
327950|NCT01302119|1107432|P2|Overall Study|Withdrawal by Subject|20
327951|NCT01302119|1107433|P1|Overall Study|Withdrawal by Subject|30
327952|NCT01302067|1107448|P3|Overall Study|Adverse Event|45
327953|NCT01302067|1107449|P2|Overall Study|Adverse Event|14
327954|NCT01302067|1107450|P1|Overall Study|Adverse Event|27
327955|NCT01302067|1107448|P3|Overall Study|Protocol Violation|8
327956|NCT01302067|1107449|P2|Overall Study|Protocol Violation|0
327957|NCT01302067|1107450|P1|Overall Study|Protocol Violation|11
327958|NCT01302067|1107448|P3|Overall Study|Not specified|3
327959|NCT01302067|1107449|P2|Overall Study|Not specified|1
327960|NCT01302067|1107450|P1|Overall Study|Not specified|1
327961|NCT01302067|1107448|P3|Overall Study|Withdrawal by Subject|10
327962|NCT01302067|1107449|P2|Overall Study|Withdrawal by Subject|6
327963|NCT01302067|1107450|P1|Overall Study|Withdrawal by Subject|13
327964|NCT01302067|1107448|P3|Overall Study|Lost to Follow-up|15
327965|NCT01302067|1107449|P2|Overall Study|Lost to Follow-up|4
327966|NCT01302067|1107450|P1|Overall Study|Lost to Follow-up|9
327967|NCT01302067|1107448|P3|Overall Study|Lack of Efficacy|2
327968|NCT01302067|1107449|P2|Overall Study|Lack of Efficacy|4
327969|NCT01302067|1107450|P1|Overall Study|Lack of Efficacy|8
327970|NCT01302067|1107448|P3|Overall Study|Physician Decision|14
327971|NCT01302067|1107449|P2|Overall Study|Physician Decision|5
327972|NCT01302067|1107450|P1|Overall Study|Physician Decision|9
327973|NCT01302067|1107448|P3|Overall Study|Death|1
327974|NCT01302067|1107449|P2|Overall Study|Death|0
327975|NCT01302067|1107450|P1|Overall Study|Death|0
327976|NCT01302054|1107521|P3|Double-Blind Treatment Phase|Other|9
327977|NCT01302054|1107522|P2|Double-Blind Treatment Phase|Other|4
327978|NCT01302054|1107523|P1|Double-Blind Treatment Phase|Other|0
327979|NCT01302054|1107521|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
327980|NCT01302054|1107522|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
327981|NCT01302054|1107523|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
327982|NCT01302054|1107521|P3|Double-Blind Treatment Phase|Adverse Event|10
327983|NCT01302054|1107522|P2|Double-Blind Treatment Phase|Adverse Event|10
327984|NCT01302054|1107523|P1|Double-Blind Treatment Phase|Adverse Event|0
327985|NCT01302054|1107521|P3|Double-Blind Treatment Phase|Protocol Violation|6
327986|NCT01302054|1107522|P2|Double-Blind Treatment Phase|Protocol Violation|3
327987|NCT01302054|1107523|P1|Double-Blind Treatment Phase|Protocol Violation|0
327988|NCT01302054|1107521|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
327989|NCT01302054|1107522|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
327990|NCT01302054|1107523|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
327991|NCT01302054|1107521|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
327992|NCT01302054|1107522|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
327993|NCT01302054|1107523|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
327994|NCT01302054|1107521|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
327995|NCT01302054|1107522|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
327996|NCT01302054|1107523|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
327997|NCT01302054|1107521|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
327998|NCT01302054|1107522|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
327999|NCT01302054|1107523|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
328000|NCT01302054|1107521|P3|Tolterodine Open-Label Run-In Phase|Other|0
328001|NCT01302054|1107522|P2|Tolterodine Open-Label Run-In Phase|Other|0
328002|NCT01302054|1107523|P1|Tolterodine Open-Label Run-In Phase|Other|7
328003|NCT01302054|1107521|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
328004|NCT01302054|1107522|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
328005|NCT01302054|1107523|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
328006|NCT01302054|1107521|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
328007|NCT01302054|1107522|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
328008|NCT01302054|1107523|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
328009|NCT01302054|1107521|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
328010|NCT01302054|1107522|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
328011|NCT01302054|1107523|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
328012|NCT01302054|1107521|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
328013|NCT01302054|1107522|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
328014|NCT01302054|1107523|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
328015|NCT01302054|1107521|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
328016|NCT01302054|1107522|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
328017|NCT01302054|1107523|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
328018|NCT01302054|1107521|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
328019|NCT01302054|1107522|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
328020|NCT01302054|1107523|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
328021|NCT01302041|1107550|P1|Overall Study|Other-Miscellaneous Reason|2
328022|NCT01302041|1107550|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
328023|NCT01302041|1107550|P1|Overall Study|Withdrawal by Subject|4
328024|NCT01302041|1107550|P1|Overall Study|Death|5
328025|NCT01301950|1107592|P2|Overall Study|Surgery was cancelled by patient|1
328026|NCT01301950|1107593|P1|Overall Study|Surgery was cancelled by patient|0
328027|NCT01301833|1107611|P4|Overall Study|Personal matter|0
328028|NCT01301833|1107612|P3|Overall Study|Personal matter|0
328029|NCT01301833|1107613|P2|Overall Study|Personal matter|0
328030|NCT01301833|1107614|P1|Overall Study|Personal matter|1
328031|NCT01301833|1107611|P4|Overall Study|Withdrawal by Subject|2
328032|NCT01301833|1107612|P3|Overall Study|Withdrawal by Subject|1
328033|NCT01301833|1107613|P2|Overall Study|Withdrawal by Subject|1
328034|NCT01301833|1107614|P1|Overall Study|Withdrawal by Subject|3
328035|NCT01301833|1107611|P4|Overall Study|Physician Decision|0
328036|NCT01301833|1107612|P3|Overall Study|Physician Decision|1
328037|NCT01301833|1107613|P2|Overall Study|Physician Decision|1
328038|NCT01301833|1107614|P1|Overall Study|Physician Decision|3
328039|NCT01301833|1107611|P4|Overall Study|Lack of Efficacy|0
328040|NCT01301833|1107612|P3|Overall Study|Lack of Efficacy|0
328041|NCT01301833|1107613|P2|Overall Study|Lack of Efficacy|1
328042|NCT01301833|1107614|P1|Overall Study|Lack of Efficacy|1
328043|NCT01301833|1107611|P4|Overall Study|Adverse Event|5
328044|NCT01301833|1107612|P3|Overall Study|Adverse Event|5
328045|NCT01301833|1107613|P2|Overall Study|Adverse Event|5
328046|NCT01301833|1107614|P1|Overall Study|Adverse Event|7
328047|NCT01301729|1107652|P1|Overall Study|Violated Selection Criteria|1
328048|NCT01301729|1107652|P1|Overall Study|Participant did not Return for Treatment|1
328049|NCT01301729|1107652|P1|Overall Study|Withdrawal by Subject|2
328050|NCT01301508|1107665|P2|Overall Study|Lost to Follow-up|1
328051|NCT01301508|1107666|P1|Overall Study|Lost to Follow-up|0
328052|NCT01301508|1107665|P2|Overall Study|Withdrawal by Subject|2
328053|NCT01301508|1107666|P1|Overall Study|Withdrawal by Subject|1
328054|NCT01301456|1107696|P12|Stage 2|Adverse Event|0
328055|NCT01301456|1107697|P11|Stage 2|Adverse Event|1
328056|NCT01301456|1107698|P10|Stage 2|Adverse Event|0
328057|NCT01301456|1107699|P9|Stage 2|Adverse Event|0
328058|NCT01301456|1107700|P8|Stage 2|Adverse Event|0
328059|NCT01301456|1107701|P7|Stage 2|Adverse Event|0
328060|NCT01301456|1107702|P6|Stage 2|Adverse Event|0
328061|NCT01301456|1107703|P5|Stage 2|Adverse Event|0
328062|NCT01301456|1107704|P4|Stage 2|Adverse Event|0
328063|NCT01301456|1107705|P3|Stage 2|Adverse Event|0
328064|NCT01301456|1107706|P2|Stage 2|Adverse Event|0
328065|NCT01301456|1107707|P1|Stage 2|Adverse Event|0
328066|NCT01301456|1107696|P12|Stage 1|Randomized but not treated|0
328067|NCT01301456|1107697|P11|Stage 1|Randomized but not treated|0
328068|NCT01301456|1107698|P10|Stage 1|Randomized but not treated|0
328069|NCT01301456|1107699|P9|Stage 1|Randomized but not treated|0
328070|NCT01301456|1107700|P8|Stage 1|Randomized but not treated|0
328071|NCT01301456|1107701|P7|Stage 1|Randomized but not treated|1
328072|NCT01301456|1107702|P6|Stage 1|Randomized but not treated|0
328073|NCT01301456|1107703|P5|Stage 1|Randomized but not treated|0
328074|NCT01301456|1107704|P4|Stage 1|Randomized but not treated|0
328075|NCT01301456|1107705|P3|Stage 1|Randomized but not treated|0
328076|NCT01301456|1107706|P2|Stage 1|Randomized but not treated|0
328077|NCT01301456|1107707|P1|Stage 1|Randomized but not treated|0
328078|NCT01301456|1107696|P12|Stage 1|Withdrawal by Subject|0
328079|NCT01301456|1107697|P11|Stage 1|Withdrawal by Subject|0
328080|NCT01301456|1107698|P10|Stage 1|Withdrawal by Subject|0
328081|NCT01301456|1107699|P9|Stage 1|Withdrawal by Subject|0
328082|NCT01301456|1107700|P8|Stage 1|Withdrawal by Subject|0
328083|NCT01301456|1107701|P7|Stage 1|Withdrawal by Subject|0
328084|NCT01301456|1107702|P6|Stage 1|Withdrawal by Subject|0
328085|NCT01301456|1107703|P5|Stage 1|Withdrawal by Subject|1
328086|NCT01301456|1107704|P4|Stage 1|Withdrawal by Subject|0
328087|NCT01301456|1107705|P3|Stage 1|Withdrawal by Subject|1
328088|NCT01301456|1107706|P2|Stage 1|Withdrawal by Subject|0
328089|NCT01301456|1107707|P1|Stage 1|Withdrawal by Subject|0
328090|NCT01301274|1107935|P2|Overall Study|Physician Decision|1
328091|NCT01301274|1107936|P1|Overall Study|Physician Decision|2
328092|NCT01301092|1107951|P3|Overall Study|Lost to Follow-up|1
328093|NCT01301092|1107952|P2|Overall Study|Lost to Follow-up|0
328094|NCT01301092|1107953|P1|Overall Study|Lost to Follow-up|0
328095|NCT01301079|1107970|P2|Overall Study|Lost to Follow-up|2
328096|NCT01301079|1107971|P1|Overall Study|Lost to Follow-up|2
328097|NCT01301066|1108049|P2|Overall Study|Other|0
328098|NCT01301066|1108050|P1|Overall Study|Other|2
328099|NCT01301066|1108049|P2|Overall Study|Physician Decision|1
328100|NCT01301066|1108050|P1|Overall Study|Physician Decision|0
328101|NCT01301066|1108049|P2|Overall Study|Sponsor Decision|1
328102|NCT01301066|1108050|P1|Overall Study|Sponsor Decision|2
328103|NCT01301066|1108049|P2|Overall Study|Adverse Event|6
328104|NCT01301066|1108050|P1|Overall Study|Adverse Event|6
328105|NCT01301066|1108049|P2|Overall Study|Withdrawal by Subject|9
328106|NCT01301066|1108050|P1|Overall Study|Withdrawal by Subject|4
328107|NCT01301066|1108049|P2|Overall Study|Protocol Violation|7
328108|NCT01301066|1108050|P1|Overall Study|Protocol Violation|8
328109|NCT01301066|1108049|P2|Overall Study|Lost to Follow-up|11
328110|NCT01301066|1108050|P1|Overall Study|Lost to Follow-up|5
328111|NCT01301027|1108058|P2|Overall Study|Volume Overload|0
328112|NCT01301027|1108059|P1|Overall Study|Volume Overload|3
328113|NCT01301027|1108058|P2|Overall Study|Transplant|2
328114|NCT01301027|1108059|P1|Overall Study|Transplant|0
328115|NCT01301027|1108058|P2|Overall Study|Fracture|3
328116|NCT01301027|1108059|P1|Overall Study|Fracture|1
328117|NCT01301027|1108058|P2|Overall Study|Adverse Event|2
328118|NCT01301027|1108059|P1|Overall Study|Adverse Event|0
328119|NCT01301027|1108058|P2|Overall Study|Withdrawal by Subject|3
328120|NCT01301027|1108059|P1|Overall Study|Withdrawal by Subject|2
328121|NCT01301027|1108058|P2|Overall Study|Physician Decision|0
328122|NCT01301027|1108059|P1|Overall Study|Physician Decision|2
328123|NCT01301001|1108071|P2|Second Intervention|Withdrawal by Subject|0
328124|NCT01301001|1108072|P1|Second Intervention|Withdrawal by Subject|2
328125|NCT01301001|1108071|P2|Second Intervention|Adverse Event|0
328126|NCT01301001|1108072|P1|Second Intervention|Adverse Event|2
328127|NCT01301001|1108071|P2|First Intervention|Protocol Violation|1
328128|NCT01301001|1108072|P1|First Intervention|Protocol Violation|0
328129|NCT01301001|1108071|P2|First Intervention|Adverse Event|0
328130|NCT01301001|1108072|P1|First Intervention|Adverse Event|5
328131|NCT01301001|1108071|P2|First Intervention|Withdrawal by Subject|4
328132|NCT01301001|1108072|P1|First Intervention|Withdrawal by Subject|1
328133|NCT01301001|1108071|P2|First Intervention|Lost to Follow-up|4
328134|NCT01301001|1108072|P1|First Intervention|Lost to Follow-up|4
328135|NCT01300923|1108082|P2|Overall Study|Physician Decision|2
328136|NCT01300923|1108083|P1|Overall Study|Physician Decision|0
328137|NCT01300819|1108096|P2|Overall Study|Follow up call was not done|0
328138|NCT01300819|1108097|P1|Overall Study|Follow up call was not done|1
328139|NCT01300819|1108096|P2|Overall Study|Safety follow up not done by mistake|1
328140|NCT01300819|1108097|P1|Overall Study|Safety follow up not done by mistake|0
328141|NCT01300819|1108096|P2|Overall Study|Administrative reason|1
328142|NCT01300819|1108097|P1|Overall Study|Administrative reason|0
328143|NCT01300819|1108096|P2|Overall Study|Refusal to down titrate study drug|1
328144|NCT01300819|1108097|P1|Overall Study|Refusal to down titrate study drug|0
328145|NCT01300819|1108096|P2|Overall Study|Patient was 1 month late for Visit 10|1
328146|NCT01300819|1108097|P1|Overall Study|Patient was 1 month late for Visit 10|0
328147|NCT01300819|1108096|P2|Overall Study|Withdrawal by Subject|12
328148|NCT01300819|1108097|P1|Overall Study|Withdrawal by Subject|10
328149|NCT01300819|1108096|P2|Overall Study|Lack of Efficacy|1
328150|NCT01300819|1108097|P1|Overall Study|Lack of Efficacy|2
328151|NCT01300819|1108096|P2|Overall Study|Adverse Event|27
328152|NCT01300819|1108097|P1|Overall Study|Adverse Event|9
328153|NCT01300767|1108125|P1|Overall Study|Unacceptable fit|1
328154|NCT01300767|1108125|P1|Overall Study|Biomicroscopy|1
328155|NCT01300767|1108125|P1|Overall Study|Discomfort|2
328156|NCT01300741|1108153|P1|Overall Study|Discomfort|1
328157|NCT01300741|1108153|P1|Overall Study|Lost to Follow-up|1
328158|NCT01300741|1108153|P1|Overall Study|Lens deposits|1
328159|NCT01300728|1108183|P2|Overall Study|Physician Decision|0
328160|NCT01300728|1108184|P1|Overall Study|Physician Decision|1
328161|NCT01300728|1108183|P2|Overall Study|Withdrawal by Subject|1
328162|NCT01300728|1108184|P1|Overall Study|Withdrawal by Subject|1
328163|NCT01300650|1108198|P1|Overall Study|Adverse Event|1
328164|NCT01300546|1108225|P2|Overall Study|Adverse Event|1
328165|NCT01300546|1108226|P1|Overall Study|Adverse Event|0
328166|NCT01300546|1108225|P2|Overall Study|Lack of Efficacy|3
328167|NCT01300546|1108226|P1|Overall Study|Lack of Efficacy|0
328168|NCT01300546|1108225|P2|Overall Study|Lost to Follow-up|2
328169|NCT01300546|1108226|P1|Overall Study|Lost to Follow-up|0
328170|NCT01300546|1108225|P2|Overall Study|Withdrawal by Subject|0
328171|NCT01300546|1108226|P1|Overall Study|Withdrawal by Subject|1
328172|NCT01300455|1108256|P2|Washout|Withdrawal by Subject|0
328173|NCT01300455|1108257|P1|Washout|Withdrawal by Subject|1
328174|NCT01300351|1108277|P2|Overall Study|Withdrawal by Subject|10
328175|NCT01300351|1108278|P1|Overall Study|Withdrawal by Subject|7
328176|NCT01300351|1108277|P2|Overall Study|Adverse Event|4
328177|NCT01300351|1108278|P1|Overall Study|Adverse Event|0
328178|NCT01300351|1108277|P2|Overall Study|Lost to Follow-up|1
328179|NCT01300351|1108278|P1|Overall Study|Lost to Follow-up|0
328180|NCT01300351|1108277|P2|Overall Study|Ongoing treatment at data cut-off|23
328181|NCT01300351|1108278|P1|Overall Study|Ongoing treatment at data cut-off|27
328182|NCT01300351|1108277|P2|Overall Study|Did not receive treatment|0
328183|NCT01300351|1108278|P1|Overall Study|Did not receive treatment|2
328184|NCT01300338|1108294|P2|Overall Study|Lost to Follow-up|0
328185|NCT01300338|1108295|P1|Overall Study|Lost to Follow-up|5
328186|NCT01300286|1108303|P1|Overall Study|did not get dosed|1
328187|NCT01300260|1108313|P2|Period 2 of Study: Second Intervention|Adverse Event|1
328188|NCT01300260|1108314|P1|Period 2 of Study: Second Intervention|Adverse Event|0
328189|NCT01300260|1108313|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
328190|NCT01300260|1108314|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
328191|NCT01300260|1108313|P2|Period 1 of Study: First Intervention|Adverse Event|1
328192|NCT01300260|1108314|P1|Period 1 of Study: First Intervention|Adverse Event|0
328193|NCT01300247|1108346|P2|Overall Study|Non-Compliance|1
328194|NCT01300247|1108347|P1|Overall Study|Non-Compliance|0
328195|NCT01300247|1108346|P2|Overall Study|Withdrawal by Subject|0
328196|NCT01300247|1108347|P1|Overall Study|Withdrawal by Subject|1
328197|NCT01300247|1108346|P2|Overall Study|Lost to Follow-up|0
328198|NCT01300247|1108347|P1|Overall Study|Lost to Follow-up|2
328199|NCT01300247|1108346|P2|Overall Study|Death|1
328200|NCT01300247|1108347|P1|Overall Study|Death|1
328201|NCT01300234|1108379|P2|Overall Study|Lost to Follow-up|2
328202|NCT01300234|1108380|P1|Overall Study|Lost to Follow-up|0
328203|NCT01300234|1108379|P2|Overall Study|Withdrawal by Subject|5
328204|NCT01300234|1108380|P1|Overall Study|Withdrawal by Subject|1
328205|NCT01300234|1108379|P2|Overall Study|Protocol Violation|3
328206|NCT01300234|1108380|P1|Overall Study|Protocol Violation|2
328207|NCT01300234|1108379|P2|Overall Study|Adverse Event|0
328208|NCT01300234|1108380|P1|Overall Study|Adverse Event|1
328209|NCT01300052|1108412|P2|Overall Study|Protocol Violation|1
328210|NCT01300052|1108413|P1|Overall Study|Protocol Violation|1
328211|NCT01300052|1108412|P2|Overall Study|Withdrawal by Subject|2
328212|NCT01300052|1108413|P1|Overall Study|Withdrawal by Subject|2
328213|NCT01300052|1108412|P2|Overall Study|Adverse Event|0
328214|NCT01300052|1108413|P1|Overall Study|Adverse Event|3
328215|NCT01299961|1108431|P1|Overall Study|Lost to Follow-up|1
328216|NCT01299961|1108431|P1|Overall Study|Lack of Efficacy|2
328217|NCT01299961|1108431|P1|Overall Study|Adverse Event|3
328218|NCT01299909|1108440|P3|Overall Study|Lost to Follow-up|17
328219|NCT01299909|1108441|P2|Overall Study|Lost to Follow-up|18
328220|NCT01299909|1108442|P1|Overall Study|Lost to Follow-up|22
328221|NCT01299896|1108457|P2|Overall Study|Lost to Follow-up|11
328222|NCT01299896|1108458|P1|Overall Study|Lost to Follow-up|0
328223|NCT01299896|1108457|P2|Overall Study|Withdrawal by Subject|7
328224|NCT01299896|1108458|P1|Overall Study|Withdrawal by Subject|1
328225|NCT01299805|1108466|P2|Overall Study|Adverse Event|0
328226|NCT01299805|1108467|P1|Overall Study|Adverse Event|2
328227|NCT01299584|1108545|P1|Overall Study|Protocol Violation|9
328228|NCT01299571|1108552|P1|Overall Study|Protocol Violation|107
328229|NCT01299480|1108563|P5|Overall Study|Started, but not vaccinated|0
328230|NCT01299480|1108564|P4|Overall Study|Started, but not vaccinated|1
328231|NCT01299480|1108565|P3|Overall Study|Started, but not vaccinated|1
328232|NCT01299480|1108566|P2|Overall Study|Started, but not vaccinated|0
328233|NCT01299480|1108567|P1|Overall Study|Started, but not vaccinated|0
328234|NCT01299480|1108563|P5|Overall Study|Other|3
328235|NCT01299480|1108564|P4|Overall Study|Other|0
328236|NCT01299480|1108565|P3|Overall Study|Other|3
328237|NCT01299480|1108566|P2|Overall Study|Other|2
328238|NCT01299480|1108567|P1|Overall Study|Other|3
328239|NCT01299480|1108563|P5|Overall Study|Lost to Follow-up|2
328240|NCT01299480|1108564|P4|Overall Study|Lost to Follow-up|1
328241|NCT01299480|1108565|P3|Overall Study|Lost to Follow-up|2
328242|NCT01299480|1108566|P2|Overall Study|Lost to Follow-up|1
328243|NCT01299480|1108567|P1|Overall Study|Lost to Follow-up|3
328244|NCT01299480|1108563|P5|Overall Study|Physician Decision|0
328245|NCT01299480|1108564|P4|Overall Study|Physician Decision|2
328246|NCT01299480|1108565|P3|Overall Study|Physician Decision|0
328247|NCT01299480|1108566|P2|Overall Study|Physician Decision|1
328248|NCT01299480|1108567|P1|Overall Study|Physician Decision|1
328249|NCT01299480|1108563|P5|Overall Study|Withdrawal due to pregnancy|0
328250|NCT01299480|1108564|P4|Overall Study|Withdrawal due to pregnancy|0
328251|NCT01299480|1108565|P3|Overall Study|Withdrawal due to pregnancy|1
328252|NCT01299480|1108566|P2|Overall Study|Withdrawal due to pregnancy|1
328253|NCT01299480|1108567|P1|Overall Study|Withdrawal due to pregnancy|0
328254|NCT01299480|1108563|P5|Overall Study|Adverse Event|0
328255|NCT01299480|1108564|P4|Overall Study|Adverse Event|4
328256|NCT01299480|1108565|P3|Overall Study|Adverse Event|5
328257|NCT01299480|1108566|P2|Overall Study|Adverse Event|4
328258|NCT01299480|1108567|P1|Overall Study|Adverse Event|6
328259|NCT01299480|1108563|P5|Overall Study|Withdrawal by Subject|4
328260|NCT01299480|1108564|P4|Overall Study|Withdrawal by Subject|3
328261|NCT01299480|1108565|P3|Overall Study|Withdrawal by Subject|7
328262|NCT01299480|1108566|P2|Overall Study|Withdrawal by Subject|4
328263|NCT01299480|1108567|P1|Overall Study|Withdrawal by Subject|3
328264|NCT01299480|1108563|P5|Overall Study|Protocol Violation|1
328265|NCT01299480|1108564|P4|Overall Study|Protocol Violation|1
328266|NCT01299480|1108565|P3|Overall Study|Protocol Violation|8
328267|NCT01299480|1108566|P2|Overall Study|Protocol Violation|5
328268|NCT01299480|1108567|P1|Overall Study|Protocol Violation|7
328269|NCT01299480|1108563|P5|Overall Study|No longer willing to participate|10
328270|NCT01299480|1108564|P4|Overall Study|No longer willing to participate|13
328271|NCT01299480|1108565|P3|Overall Study|No longer willing to participate|14
328272|NCT01299480|1108566|P2|Overall Study|No longer willing to participate|17
328273|NCT01299480|1108567|P1|Overall Study|No longer willing to participate|19
328274|NCT01299389|1108769|P4|Post-observational|Other|6
328275|NCT01299389|1108770|P3|Post-observational|Other|12
328276|NCT01299389|1108771|P2|Post-observational|Other|0
328277|NCT01299389|1108772|P1|Post-observational|Other|0
328278|NCT01299389|1108769|P4|Double-blind|fail to meet “study population” criteria|0
328279|NCT01299389|1108770|P3|Double-blind|fail to meet “study population” criteria|0
328280|NCT01299389|1108771|P2|Double-blind|fail to meet “study population” criteria|1
328281|NCT01299389|1108772|P1|Double-blind|fail to meet “study population” criteria|0
328282|NCT01299389|1108769|P4|Double-blind|Other|0
328283|NCT01299389|1108770|P3|Double-blind|Other|0
328284|NCT01299389|1108771|P2|Double-blind|Other|1
328285|NCT01299389|1108772|P1|Double-blind|Other|1
328286|NCT01299389|1108769|P4|Double-blind|Withdrawal by Subject|0
328287|NCT01299389|1108770|P3|Double-blind|Withdrawal by Subject|0
328288|NCT01299389|1108771|P2|Double-blind|Withdrawal by Subject|13
328289|NCT01299389|1108772|P1|Double-blind|Withdrawal by Subject|16
328290|NCT01299389|1108769|P4|Double-blind|Lost to Follow-up|0
328291|NCT01299389|1108770|P3|Double-blind|Lost to Follow-up|0
328292|NCT01299389|1108771|P2|Double-blind|Lost to Follow-up|1
328293|NCT01299389|1108772|P1|Double-blind|Lost to Follow-up|2
328294|NCT01299389|1108769|P4|Double-blind|Lack of Efficacy|0
328295|NCT01299389|1108770|P3|Double-blind|Lack of Efficacy|0
328296|NCT01299389|1108771|P2|Double-blind|Lack of Efficacy|21
328297|NCT01299389|1108772|P1|Double-blind|Lack of Efficacy|45
328298|NCT01299389|1108769|P4|Double-blind|Adverse Event|0
328299|NCT01299389|1108770|P3|Double-blind|Adverse Event|0
328300|NCT01299389|1108771|P2|Double-blind|Adverse Event|27
328301|NCT01299389|1108772|P1|Double-blind|Adverse Event|45
328302|NCT01299376|1108794|P2|Extension (Weeks 9 to 52)|Physician Decision|0
328303|NCT01299376|1108795|P1|Extension (Weeks 9 to 52)|Physician Decision|1
328304|NCT01299376|1108794|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
328305|NCT01299376|1108795|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
328306|NCT01299376|1108794|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
328307|NCT01299376|1108795|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
328308|NCT01299376|1108794|P2|Extension (Weeks 9 to 52)|Adverse Event|3
328309|NCT01299376|1108795|P1|Extension (Weeks 9 to 52)|Adverse Event|2
328310|NCT01299376|1108794|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
328311|NCT01299376|1108795|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
328312|NCT01299376|1108794|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
328313|NCT01299376|1108795|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
328314|NCT01299376|1108794|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
328315|NCT01299376|1108795|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
328316|NCT01299376|1108794|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
328317|NCT01299376|1108795|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
328318|NCT01299376|1108794|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
328319|NCT01299376|1108795|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
328320|NCT01299376|1108794|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
328321|NCT01299376|1108795|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
328322|NCT01299376|1108794|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
328323|NCT01299376|1108795|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
328324|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
328325|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
328326|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
328327|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
328328|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Physician Decision|1
328329|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Physician Decision|2
328330|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Physician Decision|0
328331|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Physician Decision|0
328332|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
328333|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
328334|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
328335|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
328336|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
328337|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
328338|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
328339|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
328340|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
328341|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
328342|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
328343|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
328344|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Adverse Event|9
328345|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Adverse Event|8
328346|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Adverse Event|0
328347|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Adverse Event|0
328348|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
328349|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
328350|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
328351|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
328352|NCT01299272|1108838|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
328353|NCT01299272|1108839|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
328354|NCT01299272|1108840|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
328355|NCT01299272|1108841|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
328356|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Physician Decision|0
328357|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Physician Decision|0
328358|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Physician Decision|3
328359|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Physician Decision|0
328360|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
328361|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
328362|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
328363|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
328364|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
328365|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
328366|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
328367|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
328368|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
328369|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
328370|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
328371|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
328372|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
328373|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
328374|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
328375|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
328376|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
328377|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
328378|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
328379|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
328380|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Adverse Event|0
328381|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Adverse Event|0
328382|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Adverse Event|42
328383|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Adverse Event|0
328384|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
328385|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
328386|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
328387|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
328388|NCT01299272|1108838|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
328389|NCT01299272|1108839|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
328390|NCT01299272|1108840|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
328391|NCT01299272|1108841|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
328392|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Physician Decision|0
328393|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Physician Decision|0
328394|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Physician Decision|0
328395|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Physician Decision|5
328396|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
328397|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
328398|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
328399|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
328400|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Sponsor Decision|0
328401|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Sponsor Decision|0
328402|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Sponsor Decision|0
328403|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Sponsor Decision|13
328404|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
328405|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
328406|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
328407|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
328408|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Protocol Violation|0
328409|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Protocol Violation|0
328410|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Protocol Violation|0
328411|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Protocol Violation|36
328412|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
328413|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
328414|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
328415|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
328416|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Adverse Event|0
328417|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Adverse Event|0
328418|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Adverse Event|0
328419|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Adverse Event|140
328420|NCT01299272|1108838|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
328421|NCT01299272|1108839|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
328422|NCT01299272|1108840|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
328423|NCT01299272|1108841|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
328424|NCT01299116|1108896|P3|Overall Study|Lost to Follow-up|11
328425|NCT01299116|1108897|P2|Overall Study|Lost to Follow-up|9
328426|NCT01299116|1108898|P1|Overall Study|Lost to Follow-up|65
328427|NCT01299025|1108943|P2|Overall Study|Lost to Follow-up|0
328428|NCT01299025|1108944|P1|Overall Study|Lost to Follow-up|1
328429|NCT01299025|1108943|P2|Overall Study|Withdrawal by Subject|1
328430|NCT01299025|1108944|P1|Overall Study|Withdrawal by Subject|2
328431|NCT01298778|1108958|P2|Overall Study|not meet inclusion/exclusion criteria|1
328432|NCT01298778|1108959|P1|Overall Study|not meet inclusion/exclusion criteria|0
328433|NCT01298778|1108958|P2|Overall Study|Protocol Violation|1
328434|NCT01298778|1108959|P1|Overall Study|Protocol Violation|0
328435|NCT01298778|1108958|P2|Overall Study|Withdrawal by Subject|1
328436|NCT01298778|1108959|P1|Overall Study|Withdrawal by Subject|0
328437|NCT01298778|1108958|P2|Overall Study|Incorrect use of VAS|0
328438|NCT01298778|1108959|P1|Overall Study|Incorrect use of VAS|1
328439|NCT01298778|1108958|P2|Overall Study|Lost to Follow-up|3
328440|NCT01298778|1108959|P1|Overall Study|Lost to Follow-up|2
328441|NCT01298661|1108982|P3|Overall Study|Withdrawal by Subject|2
328442|NCT01298661|1108983|P2|Overall Study|Withdrawal by Subject|0
328443|NCT01298661|1108984|P1|Overall Study|Withdrawal by Subject|2
328444|NCT01298648|1109062|P1|Overall Study|Lost to Follow-up|21
328445|NCT01298648|1109062|P1|Overall Study|Withdrawal by Subject|2
328446|NCT01298570|1109073|P2|Overall Study|Ineligibility|1
328447|NCT01298570|1109074|P1|Overall Study|Ineligibility|0
328448|NCT01298570|1109073|P2|Overall Study|Death|1
328449|NCT01298570|1109074|P1|Overall Study|Death|0
328450|NCT01298570|1109073|P2|Overall Study|Symptomatic progression/deterioration|2
328451|NCT01298570|1109074|P1|Overall Study|Symptomatic progression/deterioration|3
328452|NCT01298570|1109073|P2|Overall Study|Surgery|1
328453|NCT01298570|1109074|P1|Overall Study|Surgery|2
328454|NCT01298570|1109073|P2|Overall Study|Other complicating disease|1
328455|NCT01298570|1109074|P1|Overall Study|Other complicating disease|2
328456|NCT01298570|1109073|P2|Overall Study|Physician Decision|2
328457|NCT01298570|1109074|P1|Overall Study|Physician Decision|4
328458|NCT01298570|1109073|P2|Overall Study|Treatment delay > 4 weeks|5
328459|NCT01298570|1109074|P1|Overall Study|Treatment delay > 4 weeks|4
328460|NCT01298570|1109073|P2|Overall Study|Withdrawal by Subject|6
328461|NCT01298570|1109074|P1|Overall Study|Withdrawal by Subject|21
328462|NCT01298570|1109073|P2|Overall Study|Adverse Event|2
328463|NCT01298570|1109074|P1|Overall Study|Adverse Event|20
328464|NCT01298570|1109073|P2|Overall Study|Disease progression, relapse during acti|40
328465|NCT01298570|1109074|P1|Overall Study|Disease progression, relapse during acti|64
328466|NCT01298531|1109101|P2|Overall Study|Not specified|1
328467|NCT01298531|1109102|P1|Overall Study|Not specified|2
328468|NCT01298531|1109101|P2|Overall Study|Does not meet entrance criteria|1
328469|NCT01298531|1109102|P1|Overall Study|Does not meet entrance criteria|0
328470|NCT01298531|1109101|P2|Overall Study|Adverse Event|3
328471|NCT01298531|1109102|P1|Overall Study|Adverse Event|4
328472|NCT01298531|1109101|P2|Overall Study|Protocol Violation|1
328473|NCT01298531|1109102|P1|Overall Study|Protocol Violation|1
328474|NCT01298531|1109101|P2|Overall Study|Lost to Follow-up|0
328475|NCT01298531|1109102|P1|Overall Study|Lost to Follow-up|2
328476|NCT01298531|1109101|P2|Overall Study|Lack of Efficacy|1
328477|NCT01298531|1109102|P1|Overall Study|Lack of Efficacy|0
328478|NCT01298518|1109231|P3|Overall Study|Withdrawal by Subject|1
328479|NCT01298518|1109232|P2|Overall Study|Withdrawal by Subject|0
328480|NCT01298518|1109233|P1|Overall Study|Withdrawal by Subject|0
328481|NCT01298492|1109285|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
328482|NCT01298492|1109285|P1|Overall Study|Adverse Event(Related to Study Drug)|8
328483|NCT01298492|1109285|P1|Overall Study|Protocol Violation|2
328484|NCT01298492|1109285|P1|Overall Study|Withdrawn Due to Pregnancy|1
328485|NCT01298492|1109285|P1|Overall Study|Other (Unspecified)|7
328486|NCT01298492|1109285|P1|Overall Study|Withdrawal by Subject|47
328487|NCT01298492|1109285|P1|Overall Study|Lost to Follow-up|12
328488|NCT01298492|1109285|P1|Overall Study|Insufficient Clinical Response|22
328489|NCT01298492|1109285|P1|Overall Study|Death|2
328490|NCT01298362|1109293|P2|Overall Study|Did not provide 12month BMD measurements|43
328491|NCT01298362|1109294|P1|Overall Study|Did not provide 12month BMD measurements|38
328492|NCT01298323|1109314|P2|Overall Study|Eligibility criteria not fulfilled|1
328493|NCT01298323|1109315|P1|Overall Study|Eligibility criteria not fulfilled|0
328494|NCT01298323|1109314|P2|Overall Study|Ongoing|55
328495|NCT01298323|1109315|P1|Overall Study|Ongoing|55
328496|NCT01298323|1109314|P2|Overall Study|Other|9
328497|NCT01298323|1109315|P1|Overall Study|Other|10
328498|NCT01298323|1109314|P2|Overall Study|Protocol Violation|0
328499|NCT01298323|1109315|P1|Overall Study|Protocol Violation|1
328500|NCT01298323|1109314|P2|Overall Study|Withdrawal by Subject|3
328501|NCT01298323|1109315|P1|Overall Study|Withdrawal by Subject|6
328502|NCT01298323|1109314|P2|Overall Study|Lost to Follow-up|0
328503|NCT01298323|1109315|P1|Overall Study|Lost to Follow-up|1
328504|NCT01298323|1109314|P2|Overall Study|Death|16
328505|NCT01298323|1109315|P1|Overall Study|Death|11
328506|NCT01298323|1109314|P2|Overall Study|Adverse Event|4
328507|NCT01298323|1109315|P1|Overall Study|Adverse Event|2
328508|NCT01297920|1109378|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
328509|NCT01297920|1109379|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
328510|NCT01297920|1109380|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
328511|NCT01297920|1109378|P3|Overall Study|Inadequate Control of IOP|17
328512|NCT01297920|1109379|P2|Overall Study|Inadequate Control of IOP|9
328513|NCT01297920|1109380|P1|Overall Study|Inadequate Control of IOP|7
328514|NCT01297920|1109378|P3|Overall Study|Protocol Violation|0
328515|NCT01297920|1109379|P2|Overall Study|Protocol Violation|3
328516|NCT01297920|1109380|P1|Overall Study|Protocol Violation|1
328517|NCT01297920|1109378|P3|Overall Study|Noncompliance|0
328518|NCT01297920|1109379|P2|Overall Study|Noncompliance|0
328519|NCT01297920|1109380|P1|Overall Study|Noncompliance|1
328520|NCT01297920|1109378|P3|Overall Study|Patient Decision Unrelated to AE|2
328521|NCT01297920|1109379|P2|Overall Study|Patient Decision Unrelated to AE|5
328522|NCT01297920|1109380|P1|Overall Study|Patient Decision Unrelated to AE|6
328523|NCT01297920|1109378|P3|Overall Study|Adverse Event|38
328524|NCT01297920|1109379|P2|Overall Study|Adverse Event|10
328525|NCT01297920|1109380|P1|Overall Study|Adverse Event|42
328526|NCT01297517|1109424|P3|Overall Study|Inadequate Control of IOP|2
328527|NCT01297517|1109425|P2|Overall Study|Inadequate Control of IOP|1
328528|NCT01297517|1109426|P1|Overall Study|Inadequate Control of IOP|1
328529|NCT01297517|1109424|P3|Overall Study|Protocol Violation|1
328530|NCT01297517|1109425|P2|Overall Study|Protocol Violation|1
328531|NCT01297517|1109426|P1|Overall Study|Protocol Violation|1
328532|NCT01297517|1109424|P3|Overall Study|Noncompliance|0
328533|NCT01297517|1109425|P2|Overall Study|Noncompliance|0
328534|NCT01297517|1109426|P1|Overall Study|Noncompliance|1
328535|NCT01297517|1109424|P3|Overall Study|Patient Decision Unrelated to AE|7
328536|NCT01297517|1109425|P2|Overall Study|Patient Decision Unrelated to AE|3
328537|NCT01297517|1109426|P1|Overall Study|Patient Decision Unrelated to AE|2
328538|NCT01297517|1109424|P3|Overall Study|Lost to Follow-up|1
328539|NCT01297517|1109425|P2|Overall Study|Lost to Follow-up|0
328540|NCT01297517|1109426|P1|Overall Study|Lost to Follow-up|1
328541|NCT01297517|1109424|P3|Overall Study|Adverse Event|16
328542|NCT01297517|1109425|P2|Overall Study|Adverse Event|7
328543|NCT01297517|1109426|P1|Overall Study|Adverse Event|21
328544|NCT01297504|1109434|P1|Overall Study|Protocol Violation|3
328545|NCT01297504|1109434|P1|Overall Study|Site Closure|3
328546|NCT01297504|1109434|P1|Overall Study|Withdrawal by Subject|9
328547|NCT01297504|1109434|P1|Overall Study|Lost to Follow-up|43
328548|NCT01297504|1109434|P1|Overall Study|Death|3
328549|NCT01297504|1109434|P1|Overall Study|No Study Visits|4
328550|NCT01297504|1109434|P1|Overall Study|Received Palivizumab in Previous Season|1
328551|NCT01297504|1109434|P1|Overall Study|Invalid Consent|1
328552|NCT01297491|1109448|P2|Overall Study|Death|1
328553|NCT01297491|1109449|P1|Overall Study|Death|2
328554|NCT01297491|1109448|P2|Overall Study|Patient/Guardian decision|4
328555|NCT01297491|1109449|P1|Overall Study|Patient/Guardian decision|3
328556|NCT01297491|1109448|P2|Overall Study|Progressive disease|20
328557|NCT01297491|1109449|P1|Overall Study|Progressive disease|11
328558|NCT01297491|1109448|P2|Overall Study|Physician Decision|2
328559|NCT01297491|1109449|P1|Overall Study|Physician Decision|3
328560|NCT01297491|1109448|P2|Overall Study|Adverse Event|6
328561|NCT01297491|1109449|P1|Overall Study|Adverse Event|11
328562|NCT01297465|1109467|P2|Overall Study|Intention to Freeze all Embryos|1
328563|NCT01297465|1109468|P1|Overall Study|Intention to Freeze all Embryos|0
328564|NCT01297465|1109467|P2|Overall Study|All Embryos Discarded|1
328565|NCT01297465|1109468|P1|Overall Study|All Embryos Discarded|0
328566|NCT01297465|1109467|P2|Overall Study|No Fertilization|4
328567|NCT01297465|1109468|P1|Overall Study|No Fertilization|6
328568|NCT01297465|1109467|P2|Overall Study|Poor oocyte quality|1
328569|NCT01297465|1109468|P1|Overall Study|Poor oocyte quality|0
328570|NCT01297465|1109467|P2|Overall Study|No Oocytes Retrieved|1
328571|NCT01297465|1109468|P1|Overall Study|No Oocytes Retrieved|1
328572|NCT01297465|1109467|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
328573|NCT01297465|1109468|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
328574|NCT01297465|1109467|P2|Overall Study|Lack of Ovarian Response|1
328575|NCT01297465|1109468|P1|Overall Study|Lack of Ovarian Response|1
328576|NCT01297322|1109521|P2|Overall Study|Withdrawal by Subject|1
328577|NCT01297322|1109522|P1|Overall Study|Withdrawal by Subject|0
328578|NCT01297322|1109521|P2|Overall Study|Lost to Follow-up|0
328579|NCT01297322|1109522|P1|Overall Study|Lost to Follow-up|1
328580|NCT01297270|1109550|P3|Overall Study|Not treated|0
328581|NCT01297270|1109551|P2|Overall Study|Not treated|1
328582|NCT01297270|1109552|P1|Overall Study|Not treated|0
328583|NCT01297270|1109550|P3|Overall Study|Other reason not defined above|1
328584|NCT01297270|1109551|P2|Overall Study|Other reason not defined above|3
328585|NCT01297270|1109552|P1|Overall Study|Other reason not defined above|3
328586|NCT01297270|1109550|P3|Overall Study|Withdrawal by Subject|7
328587|NCT01297270|1109551|P2|Overall Study|Withdrawal by Subject|15
328588|NCT01297270|1109552|P1|Overall Study|Withdrawal by Subject|7
328589|NCT01297270|1109550|P3|Overall Study|Protocol Violation|0
328590|NCT01297270|1109551|P2|Overall Study|Protocol Violation|2
328591|NCT01297270|1109552|P1|Overall Study|Protocol Violation|0
328592|NCT01297270|1109550|P3|Overall Study|Lost to Follow-up|1
328593|NCT01297270|1109551|P2|Overall Study|Lost to Follow-up|2
328594|NCT01297270|1109552|P1|Overall Study|Lost to Follow-up|1
328595|NCT01297270|1109550|P3|Overall Study|Lack of Efficacy|15
328596|NCT01297270|1109551|P2|Overall Study|Lack of Efficacy|17
328597|NCT01297270|1109552|P1|Overall Study|Lack of Efficacy|15
328598|NCT01297270|1109550|P3|Overall Study|Adverse Event|5
328599|NCT01297270|1109551|P2|Overall Study|Adverse Event|32
328600|NCT01297270|1109552|P1|Overall Study|Adverse Event|19
328601|NCT01297062|1109601|P7|Overall Study|Subject Decision|2
328602|NCT01297062|1109602|P6|Overall Study|Subject Decision|1
328603|NCT01297062|1109603|P5|Overall Study|Subject Decision|1
328604|NCT01297062|1109604|P4|Overall Study|Subject Decision|1
328605|NCT01297062|1109605|P3|Overall Study|Subject Decision|0
328606|NCT01297062|1109606|P2|Overall Study|Subject Decision|1
328607|NCT01297062|1109607|P1|Overall Study|Subject Decision|1
328608|NCT01297062|1109601|P7|Overall Study|Protocol Violation|0
328609|NCT01297062|1109602|P6|Overall Study|Protocol Violation|0
328610|NCT01297062|1109603|P5|Overall Study|Protocol Violation|1
328611|NCT01297062|1109604|P4|Overall Study|Protocol Violation|0
328612|NCT01297062|1109605|P3|Overall Study|Protocol Violation|0
328613|NCT01297062|1109606|P2|Overall Study|Protocol Violation|0
328614|NCT01297062|1109607|P1|Overall Study|Protocol Violation|0
328615|NCT01297062|1109601|P7|Overall Study|Physician Decision|6
328616|NCT01297062|1109602|P6|Overall Study|Physician Decision|0
328617|NCT01297062|1109603|P5|Overall Study|Physician Decision|0
328618|NCT01297062|1109604|P4|Overall Study|Physician Decision|0
328619|NCT01297062|1109605|P3|Overall Study|Physician Decision|1
328620|NCT01297062|1109606|P2|Overall Study|Physician Decision|0
328621|NCT01297062|1109607|P1|Overall Study|Physician Decision|1
328622|NCT01297062|1109601|P7|Overall Study|Adverse Event|0
328623|NCT01297062|1109602|P6|Overall Study|Adverse Event|0
328624|NCT01297062|1109603|P5|Overall Study|Adverse Event|0
328625|NCT01297062|1109604|P4|Overall Study|Adverse Event|0
328626|NCT01297062|1109605|P3|Overall Study|Adverse Event|1
328627|NCT01297062|1109606|P2|Overall Study|Adverse Event|0
328628|NCT01297062|1109607|P1|Overall Study|Adverse Event|2
328629|NCT01296698|1109669|P2|Overall Study|Study Terminated by Sponsor|12
328630|NCT01296698|1109670|P1|Overall Study|Study Terminated by Sponsor|209
328631|NCT01296698|1109669|P2|Overall Study|Difficulty Contacting Subject|0
328632|NCT01296698|1109670|P1|Overall Study|Difficulty Contacting Subject|2
328633|NCT01296698|1109669|P2|Overall Study|Withdrawal by Subject|0
328634|NCT01296698|1109670|P1|Overall Study|Withdrawal by Subject|12
328635|NCT01296698|1109669|P2|Overall Study|Lost to Follow-up|1
328636|NCT01296698|1109670|P1|Overall Study|Lost to Follow-up|19
328637|NCT01296698|1109669|P2|Overall Study|Death|0
328638|NCT01296698|1109670|P1|Overall Study|Death|1
328639|NCT01296698|1109669|P2|Overall Study|Adverse Event|0
328640|NCT01296698|1109670|P1|Overall Study|Adverse Event|1
328641|NCT01296672|1109724|P2|Overall Study|Lost to Follow-up|18
328642|NCT01296672|1109725|P1|Overall Study|Lost to Follow-up|73
328643|NCT01296412|1109748|P2|Overall Study|Withdrawal by Subject|13
328644|NCT01296412|1109749|P1|Overall Study|Withdrawal by Subject|10
328645|NCT01296412|1109748|P2|Overall Study|Pregnancy|1
328646|NCT01296412|1109749|P1|Overall Study|Pregnancy|0
328647|NCT01296412|1109748|P2|Overall Study|Physician Decision|3
328648|NCT01296412|1109749|P1|Overall Study|Physician Decision|1
328649|NCT01296412|1109748|P2|Overall Study|Other reason not specified|15
328650|NCT01296412|1109749|P1|Overall Study|Other reason not specified|20
328651|NCT01296412|1109748|P2|Overall Study|Non-compliance with study drug|2
328652|NCT01296412|1109749|P1|Overall Study|Non-compliance with study drug|1
328653|NCT01296412|1109748|P2|Overall Study|Lost to Follow-up|7
328654|NCT01296412|1109749|P1|Overall Study|Lost to Follow-up|10
328655|NCT01296412|1109748|P2|Overall Study|Lack of Efficacy|0
328656|NCT01296412|1109749|P1|Overall Study|Lack of Efficacy|1
328657|NCT01296412|1109748|P2|Overall Study|Adverse Event|29
328658|NCT01296412|1109749|P1|Overall Study|Adverse Event|8
328659|NCT01296152|1109779|P1|Overall Study|Unwilling to adhere to study requirement|1
328660|NCT01296035|1109806|P1|Overall Study|Withdrawal by Subject|1
328661|NCT01295905|1109813|P2|Overall Study|Met exclusion criteria|0
328662|NCT01295905|1109814|P1|Overall Study|Met exclusion criteria|1
328663|NCT01295905|1109813|P2|Overall Study|Did not meet inclusion criteria|0
328664|NCT01295905|1109814|P1|Overall Study|Did not meet inclusion criteria|1
328665|NCT01295814|1109848|P2|Overall Study|Withdrawal by Subject|0
328666|NCT01295814|1109849|P1|Overall Study|Withdrawal by Subject|2
328667|NCT01295814|1109848|P2|Overall Study|Lack of Efficacy|2
328668|NCT01295814|1109849|P1|Overall Study|Lack of Efficacy|0
328669|NCT01295671|1109866|P3|Overall Study|Withdrawal by Subject|0
328670|NCT01295671|1109867|P2|Overall Study|Withdrawal by Subject|1
328671|NCT01295671|1109868|P1|Overall Study|Withdrawal by Subject|3
328672|NCT01295671|1109866|P3|Overall Study|Lost to Follow-up|3
328673|NCT01295671|1109867|P2|Overall Study|Lost to Follow-up|6
328674|NCT01295671|1109868|P1|Overall Study|Lost to Follow-up|4
328675|NCT01295320|1109906|P1|Overall Study|Unable to travel|1
328676|NCT01295320|1109906|P1|Overall Study|Subject was bedridden|1
328677|NCT01295320|1109906|P1|Overall Study|Withdrawal by Subject|2
328678|NCT01295320|1109906|P1|Overall Study|Lost to Follow-up|4
328679|NCT01295320|1109906|P1|Overall Study|Adverse Event|2
328680|NCT01295281|1109923|P2|First Intervention (7 Days)|Death|1
328681|NCT01295281|1109924|P1|First Intervention (7 Days)|Death|0
328682|NCT01295034|1109962|P2|Overall Study|Lost to Follow-up|5
328683|NCT01295034|1109963|P1|Overall Study|Lost to Follow-up|5
328684|NCT01294917|1109971|P1|Overall Study|Inconvenience|1
328685|NCT01294917|1109971|P1|Overall Study|Relocation|5
328686|NCT01294800|1109981|P4|Overall Study|Did Not Meet Protocol Eligibility|0
328687|NCT01294800|1109982|P3|Overall Study|Did Not Meet Protocol Eligibility|1
328688|NCT01294800|1109983|P2|Overall Study|Did Not Meet Protocol Eligibility|1
328689|NCT01294800|1109984|P1|Overall Study|Did Not Meet Protocol Eligibility|2
328690|NCT01294800|1109981|P4|Overall Study|Non-compliance With Protocol|0
328691|NCT01294800|1109982|P3|Overall Study|Non-compliance With Protocol|1
328692|NCT01294800|1109983|P2|Overall Study|Non-compliance With Protocol|1
328693|NCT01294800|1109984|P1|Overall Study|Non-compliance With Protocol|0
328694|NCT01294800|1109981|P4|Overall Study|Lost to Follow-up|0
328695|NCT01294800|1109982|P3|Overall Study|Lost to Follow-up|1
328696|NCT01294800|1109983|P2|Overall Study|Lost to Follow-up|0
328697|NCT01294800|1109984|P1|Overall Study|Lost to Follow-up|0
328698|NCT01294800|1109981|P4|Overall Study|Subject Withdrew Consent|11
328699|NCT01294800|1109982|P3|Overall Study|Subject Withdrew Consent|2
328700|NCT01294800|1109983|P2|Overall Study|Subject Withdrew Consent|2
328701|NCT01294800|1109984|P1|Overall Study|Subject Withdrew Consent|2
328702|NCT01294800|1109981|P4|Overall Study|Adverse Event|5
328703|NCT01294800|1109982|P3|Overall Study|Adverse Event|12
328704|NCT01294800|1109983|P2|Overall Study|Adverse Event|6
328705|NCT01294800|1109984|P1|Overall Study|Adverse Event|7
328706|NCT01294787|1110010|P6|Period 3|Adverse Event|0
328707|NCT01294787|1110011|P5|Period 3|Adverse Event|1
328708|NCT01294787|1110012|P4|Period 3|Adverse Event|0
328709|NCT01294787|1110013|P3|Period 3|Adverse Event|0
328710|NCT01294787|1110014|P2|Period 3|Adverse Event|0
328711|NCT01294787|1110015|P1|Period 3|Adverse Event|0
328712|NCT01294787|1110010|P6|Period 2|No longer needs study drug|0
328713|NCT01294787|1110011|P5|Period 2|No longer needs study drug|0
328714|NCT01294787|1110012|P4|Period 2|No longer needs study drug|1
328715|NCT01294787|1110013|P3|Period 2|No longer needs study drug|0
328716|NCT01294787|1110014|P2|Period 2|No longer needs study drug|0
328717|NCT01294787|1110015|P1|Period 2|No longer needs study drug|0
328718|NCT01294787|1110010|P6|Period 2|Adverse Event|0
328719|NCT01294787|1110011|P5|Period 2|Adverse Event|0
328720|NCT01294787|1110012|P4|Period 2|Adverse Event|1
328721|NCT01294787|1110013|P3|Period 2|Adverse Event|0
328722|NCT01294787|1110014|P2|Period 2|Adverse Event|3
328723|NCT01294787|1110015|P1|Period 2|Adverse Event|0
328724|NCT01294787|1110010|P6|Period 1|Administrative problem|1
328725|NCT01294787|1110011|P5|Period 1|Administrative problem|0
328726|NCT01294787|1110012|P4|Period 1|Administrative problem|0
328727|NCT01294787|1110013|P3|Period 1|Administrative problem|1
328728|NCT01294787|1110014|P2|Period 1|Administrative problem|0
328729|NCT01294787|1110015|P1|Period 1|Administrative problem|0
328730|NCT01294787|1110010|P6|Period 1|Withdrawal by Subject|1
328731|NCT01294787|1110011|P5|Period 1|Withdrawal by Subject|1
328732|NCT01294787|1110012|P4|Period 1|Withdrawal by Subject|1
328733|NCT01294787|1110013|P3|Period 1|Withdrawal by Subject|0
328734|NCT01294787|1110014|P2|Period 1|Withdrawal by Subject|0
328735|NCT01294787|1110015|P1|Period 1|Withdrawal by Subject|0
328736|NCT01294787|1110010|P6|Period 1|Adverse Event|0
328737|NCT01294787|1110011|P5|Period 1|Adverse Event|1
328738|NCT01294787|1110012|P4|Period 1|Adverse Event|0
328739|NCT01294787|1110013|P3|Period 1|Adverse Event|0
328740|NCT01294787|1110014|P2|Period 1|Adverse Event|0
328741|NCT01294787|1110015|P1|Period 1|Adverse Event|0
328742|NCT01294696|1110106|P1|Overall Study|Site closure|52
328743|NCT01294696|1110106|P1|Overall Study|Missing BPI Response|7
328744|NCT01294696|1110106|P1|Overall Study|Protocol Violation|8
328745|NCT01294696|1110106|P1|Overall Study|Screening failures|7
328746|NCT01294683|1110120|P2|Post Crossover (Period III)|Withdrawal by Subject|2
328747|NCT01294683|1110121|P1|Post Crossover (Period III)|Withdrawal by Subject|3
328748|NCT01294683|1110120|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
328749|NCT01294683|1110121|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
328750|NCT01294683|1110120|P2|Post Crossover (Period III)|Lost to Follow-up|3
328751|NCT01294683|1110121|P1|Post Crossover (Period III)|Lost to Follow-up|1
328752|NCT01294683|1110120|P2|Post Crossover (Period III)|Adverse Event|6
328753|NCT01294683|1110121|P1|Post Crossover (Period III)|Adverse Event|6
328754|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
328755|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
328756|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Technical Problems|1
328757|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Technical Problems|0
328758|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
328759|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
328760|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Protocol Violation|5
328761|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Protocol Violation|5
328762|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Physician Decision|0
328763|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Physician Decision|1
328764|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
328765|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
328766|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
328767|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
328768|NCT01294683|1110120|P2|Precrossover (Periods I/II)|Adverse Event|52
328769|NCT01294683|1110121|P1|Precrossover (Periods I/II)|Adverse Event|49
328770|NCT01294644|1110174|P3|Overall Study|Miscellaneous Reason|4
328771|NCT01294644|1110175|P2|Overall Study|Miscellaneous Reason|1
328772|NCT01294644|1110176|P1|Overall Study|Miscellaneous Reason|2
328773|NCT01294644|1110174|P3|Overall Study|Lost to Follow-up|5
328774|NCT01294644|1110175|P2|Overall Study|Lost to Follow-up|2
328775|NCT01294644|1110176|P1|Overall Study|Lost to Follow-up|3
328776|NCT01294644|1110174|P3|Overall Study|Withdrawal by Subject|4
328777|NCT01294644|1110175|P2|Overall Study|Withdrawal by Subject|7
328778|NCT01294644|1110176|P1|Overall Study|Withdrawal by Subject|3
328779|NCT01294644|1110174|P3|Overall Study|Adverse Event|1
328780|NCT01294644|1110175|P2|Overall Study|Adverse Event|0
328781|NCT01294644|1110176|P1|Overall Study|Adverse Event|2
328782|NCT01294592|1110207|P2|Overall Study|Withdrawal by Subject|28
328783|NCT01294592|1110208|P1|Overall Study|Withdrawal by Subject|28
328784|NCT01294592|1110207|P2|Overall Study|Physician Decision|11
328785|NCT01294592|1110208|P1|Overall Study|Physician Decision|6
328786|NCT01294592|1110207|P2|Overall Study|Lost to Follow-up|9
328787|NCT01294592|1110208|P1|Overall Study|Lost to Follow-up|7
328788|NCT01294592|1110207|P2|Overall Study|Protocol Violation|7
328789|NCT01294592|1110208|P1|Overall Study|Protocol Violation|1
328790|NCT01294592|1110207|P2|Overall Study|Lack of Efficacy|5
328791|NCT01294592|1110208|P1|Overall Study|Lack of Efficacy|7
328792|NCT01294592|1110207|P2|Overall Study|Adverse Event|13
328793|NCT01294592|1110208|P1|Overall Study|Adverse Event|28
328794|NCT01294553|1110236|P1|Overall Study|Protocol Violation|268
328795|NCT01294553|1110236|P1|Overall Study|Duplicated Participants|1
328796|NCT01294514|1110242|P1|Overall Study|Excluded due to Arrhythmia|1
328797|NCT01294462|1110252|P2|Overall Study|Withdrawal by Subject|63
328798|NCT01294462|1110253|P1|Overall Study|Withdrawal by Subject|65
328799|NCT01294462|1110252|P2|Overall Study|Lost to Follow-up|0
328800|NCT01294462|1110253|P1|Overall Study|Lost to Follow-up|1
328801|NCT01294449|1110267|P2|Overall Study|Withdrawal by Subject|3
328802|NCT01294449|1110268|P1|Overall Study|Withdrawal by Subject|1
328803|NCT01294449|1110267|P2|Overall Study|Death|12
328804|NCT01294449|1110268|P1|Overall Study|Death|11
328805|NCT01294436|1110276|P2|Overall Study|poor/non-compliance|5
328806|NCT01294436|1110277|P1|Overall Study|poor/non-compliance|2
328807|NCT01294436|1110276|P2|Overall Study|subject no longer meets study criteria|20
328808|NCT01294436|1110277|P1|Overall Study|subject no longer meets study criteria|5
328809|NCT01294436|1110276|P2|Overall Study|Withdrawal by Subject|28
328810|NCT01294436|1110277|P1|Overall Study|Withdrawal by Subject|11
328811|NCT01294436|1110276|P2|Overall Study|Adverse Event|17
328812|NCT01294436|1110277|P1|Overall Study|Adverse Event|10
328813|NCT01294423|1110312|P3|Overall Study|poor/non-compliance|1
328814|NCT01294423|1110313|P2|Overall Study|poor/non-compliance|0
328815|NCT01294423|1110314|P1|Overall Study|poor/non-compliance|1
328816|NCT01294423|1110312|P3|Overall Study|subject no longer meets study criteria|2
328817|NCT01294423|1110313|P2|Overall Study|subject no longer meets study criteria|5
328818|NCT01294423|1110314|P1|Overall Study|subject no longer meets study criteria|2
328819|NCT01294423|1110312|P3|Overall Study|Withdrawal by Subject|2
328820|NCT01294423|1110313|P2|Overall Study|Withdrawal by Subject|2
328821|NCT01294423|1110314|P1|Overall Study|Withdrawal by Subject|1
328822|NCT01294423|1110312|P3|Overall Study|Adverse Event|3
328823|NCT01294423|1110313|P2|Overall Study|Adverse Event|2
328824|NCT01294423|1110314|P1|Overall Study|Adverse Event|1
328825|NCT01294397|1110328|P1|Overall Study|Administrative Decision|1
328826|NCT01294397|1110328|P1|Overall Study|Withdrawal by Subject|1
328827|NCT01294371|1110372|P1|Overall Study|Other|14
328828|NCT01294371|1110372|P1|Overall Study|Administrative Reason|1
328829|NCT01294371|1110372|P1|Overall Study|Lost to Follow-up|6
328830|NCT01294371|1110372|P1|Overall Study|Withdrawal by Subject|12
328831|NCT01294371|1110372|P1|Overall Study|Adverse Event|1
328832|NCT01294150|1110454|P2|Overall Study|Physician Decision|2
328833|NCT01294150|1110455|P1|Overall Study|Physician Decision|2
328834|NCT01294046|1110484|P1|Overall Study|Stimulation response inadqequate|1
328835|NCT01294046|1110484|P1|Overall Study|Eligibility criteria expanded|1
328836|NCT01294046|1110484|P1|Overall Study|Infection and surgical explant|1
328837|NCT01293968|1110499|P2|Overall Study|non-cooperation|3
328838|NCT01293968|1110500|P1|Overall Study|non-cooperation|3
328839|NCT01293695|1110520|P2|Overall Study|Lost to Follow-up|6
328840|NCT01293695|1110521|P1|Overall Study|Lost to Follow-up|8
328841|NCT01293695|1110520|P2|Overall Study|Withdrawal by Subject|1
328842|NCT01293695|1110521|P1|Overall Study|Withdrawal by Subject|7
328843|NCT01293539|1110535|P1|Overall Study|Physician Decision|1
328844|NCT01293240|1110539|P1|Overall Study|Noncompliance|2
328845|NCT01293084|1110554|P1|Overall Study|Withdrawal by Subject|2
328846|NCT01293084|1110554|P1|Overall Study|Physician Decision|3
328847|NCT01293032|1110566|P4|Treatment|Disease Progression, relapse|0
328848|NCT01293032|1110567|P3|Treatment|Disease Progression, relapse|0
328849|NCT01293032|1110568|P2|Treatment|Disease Progression, relapse|1
328850|NCT01293032|1110569|P1|Treatment|Disease Progression, relapse|0
328851|NCT01293032|1110566|P4|Treatment|Withdrawal by Subject|0
328852|NCT01293032|1110567|P3|Treatment|Withdrawal by Subject|0
328853|NCT01293032|1110568|P2|Treatment|Withdrawal by Subject|4
328854|NCT01293032|1110569|P1|Treatment|Withdrawal by Subject|2
328855|NCT01293032|1110566|P4|Treatment|Adverse Event|1
328856|NCT01293032|1110567|P3|Treatment|Adverse Event|1
328857|NCT01293032|1110568|P2|Treatment|Adverse Event|0
328858|NCT01293032|1110569|P1|Treatment|Adverse Event|0
328859|NCT01293032|1110566|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
328860|NCT01293032|1110567|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
328861|NCT01293032|1110568|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
328862|NCT01293032|1110569|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
328863|NCT01293006|1110580|P4|Period 2|Lost to Follow-up|0
328864|NCT01293006|1110581|P3|Period 2|Lost to Follow-up|0
328865|NCT01293006|1110582|P2|Period 2|Lost to Follow-up|0
328866|NCT01293006|1110583|P1|Period 2|Lost to Follow-up|1
328867|NCT01292928|1110604|P1|Overall Study|Physician Decision|2
328868|NCT01292928|1110604|P1|Overall Study|Lost to Follow-up|6
328869|NCT01292928|1110604|P1|Overall Study|Withdrawal by Subject|8
328870|NCT01292928|1110604|P1|Overall Study|Death|8
328871|NCT01292876|1110621|P1|Overall Study|Physician Decision|4
328872|NCT01292837|1110627|P1|Overall Study|Further treatment determined|1
328873|NCT01292837|1110627|P1|Overall Study|Adverse Event|1
328874|NCT01292603|1110664|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
328875|NCT01292603|1110665|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
328876|NCT01292603|1110666|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
328877|NCT01292603|1110667|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
328878|NCT01292603|1110668|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
328879|NCT01292603|1110669|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
328880|NCT01292603|1110664|P6|Part 2: Survival Follow-UP|Death|3
328881|NCT01292603|1110665|P5|Part 2: Survival Follow-UP|Death|1
328882|NCT01292603|1110666|P4|Part 2: Survival Follow-UP|Death|0
328883|NCT01292603|1110667|P3|Part 2: Survival Follow-UP|Death|0
328884|NCT01292603|1110668|P2|Part 2: Survival Follow-UP|Death|0
328885|NCT01292603|1110669|P1|Part 2: Survival Follow-UP|Death|0
328886|NCT01292603|1110664|P6|Part 2: Regular Follow-Up|Noncompliance|0
328887|NCT01292603|1110665|P5|Part 2: Regular Follow-Up|Noncompliance|1
328888|NCT01292603|1110666|P4|Part 2: Regular Follow-Up|Noncompliance|0
328889|NCT01292603|1110667|P3|Part 2: Regular Follow-Up|Noncompliance|0
328890|NCT01292603|1110668|P2|Part 2: Regular Follow-Up|Noncompliance|0
328891|NCT01292603|1110669|P1|Part 2: Regular Follow-Up|Noncompliance|0
328892|NCT01292603|1110664|P6|Part 2: Regular Follow-Up|Disease Progression|4
328893|NCT01292603|1110665|P5|Part 2: Regular Follow-Up|Disease Progression|2
328894|NCT01292603|1110666|P4|Part 2: Regular Follow-Up|Disease Progression|0
328895|NCT01292603|1110667|P3|Part 2: Regular Follow-Up|Disease Progression|0
328896|NCT01292603|1110668|P2|Part 2: Regular Follow-Up|Disease Progression|0
328897|NCT01292603|1110669|P1|Part 2: Regular Follow-Up|Disease Progression|0
328898|NCT01292603|1110664|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
328899|NCT01292603|1110665|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
328900|NCT01292603|1110666|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
328901|NCT01292603|1110667|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
328902|NCT01292603|1110668|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
328903|NCT01292603|1110669|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
328904|NCT01292603|1110664|P6|Part 2: Regular Follow-Up|Death|2
328905|NCT01292603|1110665|P5|Part 2: Regular Follow-Up|Death|2
328906|NCT01292603|1110666|P4|Part 2: Regular Follow-Up|Death|0
328907|NCT01292603|1110667|P3|Part 2: Regular Follow-Up|Death|0
328908|NCT01292603|1110668|P2|Part 2: Regular Follow-Up|Death|0
328909|NCT01292603|1110669|P1|Part 2: Regular Follow-Up|Death|0
328910|NCT01292603|1110664|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
328911|NCT01292603|1110665|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
328912|NCT01292603|1110666|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
328913|NCT01292603|1110667|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
328914|NCT01292603|1110668|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
328915|NCT01292603|1110669|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
328916|NCT01292603|1110664|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
328917|NCT01292603|1110665|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
328918|NCT01292603|1110666|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
328919|NCT01292603|1110667|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
328920|NCT01292603|1110668|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
328921|NCT01292603|1110669|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
328922|NCT01292603|1110664|P6|Part 2: Dose Confirmation Period|Adverse Event|9
328923|NCT01292603|1110665|P5|Part 2: Dose Confirmation Period|Adverse Event|7
328924|NCT01292603|1110666|P4|Part 2: Dose Confirmation Period|Adverse Event|0
328925|NCT01292603|1110667|P3|Part 2: Dose Confirmation Period|Adverse Event|0
328926|NCT01292603|1110668|P2|Part 2: Dose Confirmation Period|Adverse Event|0
328927|NCT01292603|1110669|P1|Part 2: Dose Confirmation Period|Adverse Event|0
328928|NCT01292603|1110664|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
328929|NCT01292603|1110665|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
328930|NCT01292603|1110666|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
328931|NCT01292603|1110667|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
328932|NCT01292603|1110668|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
328933|NCT01292603|1110669|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
328934|NCT01292603|1110664|P6|Part 2: Dose Confirmation Period|Physician Decision|0
328935|NCT01292603|1110665|P5|Part 2: Dose Confirmation Period|Physician Decision|2
328936|NCT01292603|1110666|P4|Part 2: Dose Confirmation Period|Physician Decision|0
328937|NCT01292603|1110667|P3|Part 2: Dose Confirmation Period|Physician Decision|0
328938|NCT01292603|1110668|P2|Part 2: Dose Confirmation Period|Physician Decision|0
328939|NCT01292603|1110669|P1|Part 2: Dose Confirmation Period|Physician Decision|0
328940|NCT01292603|1110664|P6|Part 2: Dose Confirmation Period|Death|0
328941|NCT01292603|1110665|P5|Part 2: Dose Confirmation Period|Death|1
328942|NCT01292603|1110666|P4|Part 2: Dose Confirmation Period|Death|0
328943|NCT01292603|1110667|P3|Part 2: Dose Confirmation Period|Death|0
328944|NCT01292603|1110668|P2|Part 2: Dose Confirmation Period|Death|0
328945|NCT01292603|1110669|P1|Part 2: Dose Confirmation Period|Death|0
328946|NCT01292603|1110664|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
328947|NCT01292603|1110665|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
328948|NCT01292603|1110666|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
328949|NCT01292603|1110667|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
328950|NCT01292603|1110668|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
328951|NCT01292603|1110669|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
328952|NCT01292603|1110664|P6|Part 1: Survival Follow-Up|Death|0
328953|NCT01292603|1110665|P5|Part 1: Survival Follow-Up|Death|0
328954|NCT01292603|1110666|P4|Part 1: Survival Follow-Up|Death|0
328955|NCT01292603|1110667|P3|Part 1: Survival Follow-Up|Death|1
328956|NCT01292603|1110668|P2|Part 1: Survival Follow-Up|Death|0
328957|NCT01292603|1110669|P1|Part 1: Survival Follow-Up|Death|1
328958|NCT01292603|1110664|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
328959|NCT01292603|1110665|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
328960|NCT01292603|1110666|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
328961|NCT01292603|1110667|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
328962|NCT01292603|1110668|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
328963|NCT01292603|1110669|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
328964|NCT01292603|1110664|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
328965|NCT01292603|1110665|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
328966|NCT01292603|1110666|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
328967|NCT01292603|1110667|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
328968|NCT01292603|1110668|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
328969|NCT01292603|1110669|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
328970|NCT01292603|1110664|P6|Part 1: Regular Follow-Up Period|Death|0
328971|NCT01292603|1110665|P5|Part 1: Regular Follow-Up Period|Death|0
328972|NCT01292603|1110666|P4|Part 1: Regular Follow-Up Period|Death|0
328973|NCT01292603|1110667|P3|Part 1: Regular Follow-Up Period|Death|2
328974|NCT01292603|1110668|P2|Part 1: Regular Follow-Up Period|Death|0
328975|NCT01292603|1110669|P1|Part 1: Regular Follow-Up Period|Death|1
328976|NCT01292603|1110664|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
328977|NCT01292603|1110665|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
328978|NCT01292603|1110666|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
328979|NCT01292603|1110667|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
328980|NCT01292603|1110668|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
328981|NCT01292603|1110669|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
328982|NCT01292603|1110664|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
328983|NCT01292603|1110665|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
328984|NCT01292603|1110666|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
328985|NCT01292603|1110667|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
328986|NCT01292603|1110668|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
328987|NCT01292603|1110669|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
328988|NCT01292603|1110664|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
328989|NCT01292603|1110665|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
328990|NCT01292603|1110666|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
328991|NCT01292603|1110667|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
328992|NCT01292603|1110668|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
328993|NCT01292603|1110669|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
328994|NCT01292603|1110664|P6|Part 1: Pilot Dose Selection Period|Death|0
328995|NCT01292603|1110665|P5|Part 1: Pilot Dose Selection Period|Death|0
328996|NCT01292603|1110666|P4|Part 1: Pilot Dose Selection Period|Death|1
328997|NCT01292603|1110667|P3|Part 1: Pilot Dose Selection Period|Death|0
328998|NCT01292603|1110668|P2|Part 1: Pilot Dose Selection Period|Death|0
328999|NCT01292603|1110669|P1|Part 1: Pilot Dose Selection Period|Death|0
329000|NCT01292603|1110664|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
329001|NCT01292603|1110665|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
329002|NCT01292603|1110666|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
329003|NCT01292603|1110667|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
329004|NCT01292603|1110668|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
329005|NCT01292603|1110669|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
329006|NCT01292486|1110722|P1|Overall Study|Physician Decision|1
329007|NCT01292486|1110722|P1|Overall Study|Adverse Event|1
329008|NCT01292486|1110722|P1|Overall Study|Did not meet screening criteria|2
329009|NCT01292486|1110722|P1|Overall Study|Protocol Violation|2
329010|NCT01292473|1110736|P4|Overall Study|Disease Progression|6
329011|NCT01292473|1110737|P3|Overall Study|Disease Progression|3
329012|NCT01292473|1110738|P2|Overall Study|Disease Progression|1
329013|NCT01292473|1110739|P1|Overall Study|Disease Progression|0
329014|NCT01292473|1110736|P4|Overall Study|Physician Decision|0
329015|NCT01292473|1110737|P3|Overall Study|Physician Decision|0
329016|NCT01292473|1110738|P2|Overall Study|Physician Decision|1
329017|NCT01292473|1110739|P1|Overall Study|Physician Decision|0
329018|NCT01292473|1110736|P4|Overall Study|Withdrawal by Subject|3
329019|NCT01292473|1110737|P3|Overall Study|Withdrawal by Subject|3
329020|NCT01292473|1110738|P2|Overall Study|Withdrawal by Subject|4
329021|NCT01292473|1110739|P1|Overall Study|Withdrawal by Subject|3
329022|NCT01292473|1110736|P4|Overall Study|Lost to Follow-up|2
329023|NCT01292473|1110737|P3|Overall Study|Lost to Follow-up|2
329024|NCT01292473|1110738|P2|Overall Study|Lost to Follow-up|1
329025|NCT01292473|1110739|P1|Overall Study|Lost to Follow-up|1
329026|NCT01292473|1110736|P4|Overall Study|Adverse Event|1
329027|NCT01292473|1110737|P3|Overall Study|Adverse Event|1
329028|NCT01292473|1110738|P2|Overall Study|Adverse Event|0
329029|NCT01292473|1110739|P1|Overall Study|Adverse Event|1
329030|NCT01292239|1110798|P2|Overall Study|Withdrawal by Subject|6
329031|NCT01292239|1110799|P1|Overall Study|Withdrawal by Subject|3
329032|NCT01292239|1110798|P2|Overall Study|Not specified|1
329033|NCT01292239|1110799|P1|Overall Study|Not specified|1
329034|NCT01292226|1110820|P1|Overall Study|Not specified|2
329035|NCT01292226|1110820|P1|Overall Study|Withdrawal by Subject|1
329036|NCT01292226|1110820|P1|Overall Study|Protocol Violation|3
329037|NCT01292226|1110820|P1|Overall Study|Graft loss|1
329038|NCT01292226|1110820|P1|Overall Study|Death|1
329039|NCT01292226|1110820|P1|Overall Study|Adverse Event|5
329040|NCT01292187|1110853|P2|Overall Study|All other reasons|3
329041|NCT01292187|1110854|P1|Overall Study|All other reasons|1
329042|NCT01292187|1110853|P2|Overall Study|Withdrawal by Subject|5
329043|NCT01292187|1110854|P1|Overall Study|Withdrawal by Subject|6
329044|NCT01292187|1110853|P2|Overall Study|Adverse Event|5
329045|NCT01292187|1110854|P1|Overall Study|Adverse Event|10
329046|NCT01292057|1110889|P2|Overall Study|Lost to Follow-up|1
329047|NCT01292057|1110890|P1|Overall Study|Lost to Follow-up|1
329048|NCT01292057|1110889|P2|Overall Study|Protocol Violation|1
329049|NCT01292057|1110890|P1|Overall Study|Protocol Violation|1
329050|NCT01291277|1110962|P2|Overall Study|Lost to Follow-up|1
329051|NCT01291277|1110963|P1|Overall Study|Lost to Follow-up|3
329052|NCT01291277|1110962|P2|Overall Study|Death|2
329053|NCT01291277|1110963|P1|Overall Study|Death|2
329054|NCT01291225|1110975|P2|Overall Study|Lost to Follow-up|39
329055|NCT01291225|1110976|P1|Overall Study|Lost to Follow-up|85
329056|NCT01291173|1110990|P4|Overall Study|Excluded therapy|0
329057|NCT01291173|1110991|P3|Overall Study|Excluded therapy|1
329058|NCT01291173|1110992|P2|Overall Study|Excluded therapy|0
329059|NCT01291173|1110993|P1|Overall Study|Excluded therapy|0
329060|NCT01291173|1110990|P4|Overall Study|Subject was unblinded|0
329061|NCT01291173|1110991|P3|Overall Study|Subject was unblinded|1
329062|NCT01291173|1110992|P2|Overall Study|Subject was unblinded|0
329063|NCT01291173|1110993|P1|Overall Study|Subject was unblinded|0
329064|NCT01291173|1110990|P4|Overall Study|Lack of compliance|1
329065|NCT01291173|1110991|P3|Overall Study|Lack of compliance|0
329066|NCT01291173|1110992|P2|Overall Study|Lack of compliance|0
329067|NCT01291173|1110993|P1|Overall Study|Lack of compliance|0
329068|NCT01291173|1110990|P4|Overall Study|Unable to meet visit schedule|0
329069|NCT01291173|1110991|P3|Overall Study|Unable to meet visit schedule|1
329070|NCT01291173|1110992|P2|Overall Study|Unable to meet visit schedule|0
329071|NCT01291173|1110993|P1|Overall Study|Unable to meet visit schedule|0
329072|NCT01291173|1110990|P4|Overall Study|Lost to Follow-up|2
329073|NCT01291173|1110991|P3|Overall Study|Lost to Follow-up|3
329074|NCT01291173|1110992|P2|Overall Study|Lost to Follow-up|6
329075|NCT01291173|1110993|P1|Overall Study|Lost to Follow-up|4
329076|NCT01291173|1110990|P4|Overall Study|Withdrawal by Subject|2
329077|NCT01291173|1110991|P3|Overall Study|Withdrawal by Subject|4
329078|NCT01291173|1110992|P2|Overall Study|Withdrawal by Subject|4
329079|NCT01291173|1110993|P1|Overall Study|Withdrawal by Subject|6
329080|NCT01291173|1110990|P4|Overall Study|Protocol Violation|5
329081|NCT01291173|1110991|P3|Overall Study|Protocol Violation|2
329082|NCT01291173|1110992|P2|Overall Study|Protocol Violation|2
329083|NCT01291173|1110993|P1|Overall Study|Protocol Violation|7
329084|NCT01291173|1110990|P4|Overall Study|Adverse Event|3
329085|NCT01291173|1110991|P3|Overall Study|Adverse Event|1
329086|NCT01291173|1110992|P2|Overall Study|Adverse Event|3
329087|NCT01291173|1110993|P1|Overall Study|Adverse Event|0
329088|NCT01291017|1111102|P1|Overall Study|Withdrawal by Subject|3
329089|NCT01291017|1111102|P1|Overall Study|Lost to Follow-up|2
329090|NCT01290887|1111135|P2|Overall Study|Not specified|6
329091|NCT01290887|1111136|P1|Overall Study|Not specified|3
329092|NCT01290887|1111135|P2|Overall Study|Sponsor closure of study|476
329093|NCT01290887|1111136|P1|Overall Study|Sponsor closure of study|420
329094|NCT01290887|1111135|P2|Overall Study|Non-compliance to study medications|0
329095|NCT01290887|1111136|P1|Overall Study|Non-compliance to study medications|1
329096|NCT01290887|1111135|P2|Overall Study|Non-compliance to study procedures|1
329097|NCT01290887|1111136|P1|Overall Study|Non-compliance to study procedures|0
329098|NCT01290887|1111135|P2|Overall Study|Lost to Follow-up|4
329099|NCT01290887|1111136|P1|Overall Study|Lost to Follow-up|4
329100|NCT01290887|1111135|P2|Overall Study|Protocol Violation|1
329101|NCT01290887|1111136|P1|Overall Study|Protocol Violation|2
329102|NCT01290887|1111135|P2|Overall Study|Withdrawal by Subject|32
329103|NCT01290887|1111136|P1|Overall Study|Withdrawal by Subject|26
329104|NCT01290887|1111135|P2|Overall Study|Lack of Efficacy|5
329105|NCT01290887|1111136|P1|Overall Study|Lack of Efficacy|4
329106|NCT01290887|1111135|P2|Overall Study|Adverse Event|11
329107|NCT01290887|1111136|P1|Overall Study|Adverse Event|6
329108|NCT01290822|1111197|P1|Overall Study|Physician Decision|10
329109|NCT01290822|1111197|P1|Overall Study|Withdrawal by Subject|1
329110|NCT01290796|1111206|P1|Overall Study|Withdrawal by Sponsor|1
329111|NCT01290796|1111206|P1|Overall Study|Secondary Surgical Intervention|2
329112|NCT01290796|1111206|P1|Overall Study|Physician Decision|2
329113|NCT01290796|1111206|P1|Overall Study|Withdrawal by Subject|4
329114|NCT01290796|1111206|P1|Overall Study|Lost to Follow-up|21
329115|NCT01290757|1111222|P2|Overall Study|Other|1
329116|NCT01290757|1111223|P1|Overall Study|Other|0
329117|NCT01290757|1111222|P2|Overall Study|Protocol Violation|1
329118|NCT01290757|1111223|P1|Overall Study|Protocol Violation|1
329119|NCT01290757|1111222|P2|Overall Study|Adverse Event|0
329120|NCT01290757|1111223|P1|Overall Study|Adverse Event|1
329121|NCT01290731|1111239|P1|Overall Study|Withdrawal by Subject|1
329122|NCT01290718|1111251|P1|Overall Study|Early termination of the study|4
329123|NCT01290679|1111260|P2|Overall Study|Subject Entered Another Trial|5
329124|NCT01290679|1111261|P1|Overall Study|Subject Entered Another Trial|0
329125|NCT01290679|1111260|P2|Overall Study|Withdrawal by Subject|5
329126|NCT01290679|1111261|P1|Overall Study|Withdrawal by Subject|6
329127|NCT01290679|1111260|P2|Overall Study|Protocol Violation|1
329128|NCT01290679|1111261|P1|Overall Study|Protocol Violation|0
329129|NCT01290679|1111260|P2|Overall Study|Lost to Follow-up|10
329130|NCT01290679|1111261|P1|Overall Study|Lost to Follow-up|8
329131|NCT01290679|1111260|P2|Overall Study|Adverse Event|0
329132|NCT01290679|1111261|P1|Overall Study|Adverse Event|2
329133|NCT01290666|1111330|P1|Overall Study|Early Termination of Study|4
329134|NCT01290666|1111330|P1|Overall Study|Withdrawal by Subject|23
329135|NCT01290666|1111330|P1|Overall Study|Lost to Follow-up|11
329136|NCT01290601|1111383|P4|Overall Study|Protocol Violation|0
329137|NCT01290601|1111384|P3|Overall Study|Protocol Violation|0
329138|NCT01290601|1111385|P2|Overall Study|Protocol Violation|0
329139|NCT01290601|1111386|P1|Overall Study|Protocol Violation|1
329140|NCT01290601|1111383|P4|Overall Study|Other|0
329141|NCT01290601|1111384|P3|Overall Study|Other|0
329142|NCT01290601|1111385|P2|Overall Study|Other|0
329143|NCT01290601|1111386|P1|Overall Study|Other|1
329144|NCT01290601|1111383|P4|Overall Study|Lost to Follow-up|0
329145|NCT01290601|1111384|P3|Overall Study|Lost to Follow-up|0
329146|NCT01290601|1111385|P2|Overall Study|Lost to Follow-up|2
329147|NCT01290601|1111386|P1|Overall Study|Lost to Follow-up|7
329148|NCT01290601|1111383|P4|Overall Study|Lack of Efficacy|0
329149|NCT01290601|1111384|P3|Overall Study|Lack of Efficacy|0
329150|NCT01290601|1111385|P2|Overall Study|Lack of Efficacy|1
329151|NCT01290601|1111386|P1|Overall Study|Lack of Efficacy|2
329152|NCT01290601|1111383|P4|Overall Study|Adverse Event|0
329153|NCT01290601|1111384|P3|Overall Study|Adverse Event|0
329154|NCT01290601|1111385|P2|Overall Study|Adverse Event|2
329155|NCT01290601|1111386|P1|Overall Study|Adverse Event|0
329156|NCT01290341|1111418|P2|Overall Study|Negative baseline culture and others|11
329157|NCT01290341|1111419|P1|Overall Study|Negative baseline culture and others|44
329158|NCT01290341|1111418|P2|Overall Study|Withdrawal by Subject|5
329159|NCT01290341|1111419|P1|Overall Study|Withdrawal by Subject|19
329160|NCT01290341|1111418|P2|Overall Study|Lost to Follow-up|10
329161|NCT01290341|1111419|P1|Overall Study|Lost to Follow-up|21
329162|NCT01290341|1111418|P2|Overall Study|Adverse Event|0
329163|NCT01290341|1111419|P1|Overall Study|Adverse Event|1
329164|NCT01290341|1111418|P2|Overall Study|Protocol Violation|3
329165|NCT01290341|1111419|P1|Overall Study|Protocol Violation|7
329166|NCT01290315|1111431|P4|Overall Study|Withdrawal by Subject|0
329167|NCT01290315|1111432|P3|Overall Study|Withdrawal by Subject|0
329168|NCT01290315|1111433|P2|Overall Study|Withdrawal by Subject|1
329169|NCT01290315|1111434|P1|Overall Study|Withdrawal by Subject|1
329170|NCT01290315|1111431|P4|Overall Study|Lost to Follow-up|0
329171|NCT01290315|1111432|P3|Overall Study|Lost to Follow-up|0
329172|NCT01290315|1111433|P2|Overall Study|Lost to Follow-up|1
329173|NCT01290315|1111434|P1|Overall Study|Lost to Follow-up|0
329174|NCT01290315|1111431|P4|Overall Study|Selection criteria/compliance|2
329175|NCT01290315|1111432|P3|Overall Study|Selection criteria/compliance|0
329176|NCT01290315|1111433|P2|Overall Study|Selection criteria/compliance|1
329177|NCT01290315|1111434|P1|Overall Study|Selection criteria/compliance|2
329178|NCT01290315|1111431|P4|Overall Study|Adverse Event|3
329179|NCT01290315|1111432|P3|Overall Study|Adverse Event|0
329180|NCT01290315|1111433|P2|Overall Study|Adverse Event|0
329181|NCT01290315|1111434|P1|Overall Study|Adverse Event|0
329182|NCT01290263|1111456|P5|Overall Study|Participant Non-Compliance|1
329183|NCT01290263|1111457|P4|Overall Study|Participant Non-Compliance|1
329184|NCT01290263|1111458|P3|Overall Study|Participant Non-Compliance|0
329185|NCT01290263|1111459|P2|Overall Study|Participant Non-Compliance|0
329186|NCT01290263|1111460|P1|Overall Study|Participant Non-Compliance|0
329187|NCT01290263|1111456|P5|Overall Study|Withdrawal by Subject|2
329188|NCT01290263|1111457|P4|Overall Study|Withdrawal by Subject|1
329189|NCT01290263|1111458|P3|Overall Study|Withdrawal by Subject|0
329190|NCT01290263|1111459|P2|Overall Study|Withdrawal by Subject|1
329191|NCT01290263|1111460|P1|Overall Study|Withdrawal by Subject|3
329192|NCT01290263|1111456|P5|Overall Study|Lack of Efficacy|33
329193|NCT01290263|1111457|P4|Overall Study|Lack of Efficacy|24
329194|NCT01290263|1111458|P3|Overall Study|Lack of Efficacy|7
329195|NCT01290263|1111459|P2|Overall Study|Lack of Efficacy|2
329196|NCT01290263|1111460|P1|Overall Study|Lack of Efficacy|8
329197|NCT01290263|1111456|P5|Overall Study|Adverse Event|1
329198|NCT01290263|1111457|P4|Overall Study|Adverse Event|1
329199|NCT01290263|1111458|P3|Overall Study|Adverse Event|0
329200|NCT01290263|1111459|P2|Overall Study|Adverse Event|0
329201|NCT01290263|1111460|P1|Overall Study|Adverse Event|0
329202|NCT01290224|1111487|P1|Overall Study|Refused Further Treatment|4
329203|NCT01290224|1111487|P1|Overall Study|Adverse Event|1
329204|NCT01290094|1111498|P1|Overall Study|Lost to Follow-up|5
329205|NCT01290094|1111498|P1|Overall Study|Withdrawal by Subject|1
329206|NCT01290068|1111511|P2|Overall Study|Other|1
329207|NCT01290068|1111512|P1|Overall Study|Other|3
329208|NCT01290068|1111511|P2|Overall Study|Withdrawal by subject prior to implant|2
329209|NCT01290068|1111512|P1|Overall Study|Withdrawal by subject prior to implant|0
329210|NCT01290068|1111511|P2|Overall Study|Lost to Follow-up|0
329211|NCT01290068|1111512|P1|Overall Study|Lost to Follow-up|3
329212|NCT01290068|1111511|P2|Overall Study|Adverse Event|3
329213|NCT01290068|1111512|P1|Overall Study|Adverse Event|1
329214|NCT01290029|1111524|P1|Overall Study|Other|2
329215|NCT01289990|1111550|P13|Overall Study|Not treated|0
329216|NCT01289990|1111551|P12|Overall Study|Not treated|2
329217|NCT01289990|1111552|P11|Overall Study|Not treated|1
329218|NCT01289990|1111553|P10|Overall Study|Not treated|0
329219|NCT01289990|1111554|P9|Overall Study|Not treated|1
329220|NCT01289990|1111555|P8|Overall Study|Not treated|0
329221|NCT01289990|1111556|P7|Overall Study|Not treated|1
329222|NCT01289990|1111557|P6|Overall Study|Not treated|0
329223|NCT01289990|1111558|P5|Overall Study|Not treated|0
329224|NCT01289990|1111559|P4|Overall Study|Not treated|0
329225|NCT01289990|1111560|P3|Overall Study|Not treated|0
329226|NCT01289990|1111561|P2|Overall Study|Not treated|0
329227|NCT01289990|1111562|P1|Overall Study|Not treated|0
329228|NCT01289990|1111550|P13|Overall Study|did not continue in extension|56
329229|NCT01289990|1111551|P12|Overall Study|did not continue in extension|34
329230|NCT01289990|1111552|P11|Overall Study|did not continue in extension|45
329231|NCT01289990|1111553|P10|Overall Study|did not continue in extension|48
329232|NCT01289990|1111554|P9|Overall Study|did not continue in extension|44
329233|NCT01289990|1111555|P8|Overall Study|did not continue in extension|36
329234|NCT01289990|1111556|P7|Overall Study|did not continue in extension|54
329235|NCT01289990|1111557|P6|Overall Study|did not continue in extension|50
329236|NCT01289990|1111558|P5|Overall Study|did not continue in extension|48
329237|NCT01289990|1111559|P4|Overall Study|did not continue in extension|51
329238|NCT01289990|1111560|P3|Overall Study|did not continue in extension|51
329239|NCT01289990|1111561|P2|Overall Study|did not continue in extension|45
329240|NCT01289990|1111562|P1|Overall Study|did not continue in extension|41
329241|NCT01289990|1111550|P13|Overall Study|discontinued in preceding trial|24
329242|NCT01289990|1111551|P12|Overall Study|discontinued in preceding trial|17
329243|NCT01289990|1111552|P11|Overall Study|discontinued in preceding trial|17
329244|NCT01289990|1111553|P10|Overall Study|discontinued in preceding trial|21
329245|NCT01289990|1111554|P9|Overall Study|discontinued in preceding trial|17
329246|NCT01289990|1111555|P8|Overall Study|discontinued in preceding trial|8
329247|NCT01289990|1111556|P7|Overall Study|discontinued in preceding trial|18
329248|NCT01289990|1111557|P6|Overall Study|discontinued in preceding trial|12
329249|NCT01289990|1111558|P5|Overall Study|discontinued in preceding trial|11
329250|NCT01289990|1111559|P4|Overall Study|discontinued in preceding trial|17
329251|NCT01289990|1111560|P3|Overall Study|discontinued in preceding trial|41
329252|NCT01289990|1111561|P2|Overall Study|discontinued in preceding trial|20
329253|NCT01289990|1111562|P1|Overall Study|discontinued in preceding trial|18
329254|NCT01289990|1111550|P13|Overall Study|Withdrawal by Subject|16
329255|NCT01289990|1111551|P12|Overall Study|Withdrawal by Subject|13
329256|NCT01289990|1111552|P11|Overall Study|Withdrawal by Subject|11
329257|NCT01289990|1111553|P10|Overall Study|Withdrawal by Subject|13
329258|NCT01289990|1111554|P9|Overall Study|Withdrawal by Subject|12
329259|NCT01289990|1111555|P8|Overall Study|Withdrawal by Subject|9
329260|NCT01289990|1111556|P7|Overall Study|Withdrawal by Subject|13
329261|NCT01289990|1111557|P6|Overall Study|Withdrawal by Subject|7
329262|NCT01289990|1111558|P5|Overall Study|Withdrawal by Subject|8
329263|NCT01289990|1111559|P4|Overall Study|Withdrawal by Subject|13
329264|NCT01289990|1111560|P3|Overall Study|Withdrawal by Subject|12
329265|NCT01289990|1111561|P2|Overall Study|Withdrawal by Subject|14
329266|NCT01289990|1111562|P1|Overall Study|Withdrawal by Subject|15
329267|NCT01289990|1111550|P13|Overall Study|Lost to Follow-up|2
329268|NCT01289990|1111551|P12|Overall Study|Lost to Follow-up|1
329269|NCT01289990|1111552|P11|Overall Study|Lost to Follow-up|2
329270|NCT01289990|1111553|P10|Overall Study|Lost to Follow-up|4
329271|NCT01289990|1111554|P9|Overall Study|Lost to Follow-up|1
329272|NCT01289990|1111555|P8|Overall Study|Lost to Follow-up|2
329273|NCT01289990|1111556|P7|Overall Study|Lost to Follow-up|2
329274|NCT01289990|1111557|P6|Overall Study|Lost to Follow-up|4
329275|NCT01289990|1111558|P5|Overall Study|Lost to Follow-up|3
329276|NCT01289990|1111559|P4|Overall Study|Lost to Follow-up|5
329277|NCT01289990|1111560|P3|Overall Study|Lost to Follow-up|5
329278|NCT01289990|1111561|P2|Overall Study|Lost to Follow-up|2
329279|NCT01289990|1111562|P1|Overall Study|Lost to Follow-up|3
329280|NCT01289990|1111550|P13|Overall Study|Death|0
329281|NCT01289990|1111551|P12|Overall Study|Death|1
329282|NCT01289990|1111552|P11|Overall Study|Death|0
329283|NCT01289990|1111553|P10|Overall Study|Death|0
329284|NCT01289990|1111554|P9|Overall Study|Death|0
329285|NCT01289990|1111555|P8|Overall Study|Death|0
329286|NCT01289990|1111556|P7|Overall Study|Death|0
329287|NCT01289990|1111557|P6|Overall Study|Death|1
329288|NCT01289990|1111558|P5|Overall Study|Death|2
329289|NCT01289990|1111559|P4|Overall Study|Death|1
329290|NCT01289990|1111560|P3|Overall Study|Death|0
329291|NCT01289990|1111561|P2|Overall Study|Death|0
329292|NCT01289990|1111562|P1|Overall Study|Death|0
329293|NCT01289847|1111779|P1|Overall Study|Patient could not comply with visits|1
329294|NCT01289821|1111788|P1|Survival Follow-up Period|Clinical endpoint reached|16
329295|NCT01289821|1111788|P1|Survival Follow-up Period|Lost to Follow-up|1
329296|NCT01289821|1111788|P1|Survival Follow-up Period|Protocol Violation|1
329297|NCT01289821|1111788|P1|Safety Follow-up Period|Unspecified reason|1
329298|NCT01289821|1111788|P1|Safety Follow-up Period|Protocol Violation|3
329299|NCT01289821|1111788|P1|Safety Follow-up Period|Withdrawal by Subject|1
329300|NCT01289821|1111788|P1|Treatment Period|Therapeutic procedure required|1
329301|NCT01289821|1111788|P1|Treatment Period|Clinical Progression|2
329302|NCT01289821|1111788|P1|Treatment Period|Radiological Progression|43
329303|NCT01289821|1111788|P1|Treatment Period|Adverse Event|4
329304|NCT01289821|1111788|P1|Treatment Period|Physician Decision|3
329305|NCT01289821|1111788|P1|Treatment Period|Withdrawal by Subject|1
329306|NCT01289782|1111799|P2|Overall Study|Reason not specified|2
329307|NCT01289782|1111800|P1|Overall Study|Reason not specified|1
329308|NCT01289782|1111799|P2|Overall Study|Sponsor's Decision|0
329309|NCT01289782|1111800|P1|Overall Study|Sponsor's Decision|1
329310|NCT01289782|1111799|P2|Overall Study|Withdrawal by Subject|2
329311|NCT01289782|1111800|P1|Overall Study|Withdrawal by Subject|8
329312|NCT01289782|1111799|P2|Overall Study|Protocol Violation|1
329313|NCT01289782|1111800|P1|Overall Study|Protocol Violation|1
329314|NCT01289782|1111799|P2|Overall Study|Lost to Follow-up|7
329315|NCT01289782|1111800|P1|Overall Study|Lost to Follow-up|14
329316|NCT01289639|1111872|P3|Overall Study|Lost to Follow-up|0
329317|NCT01289639|1111873|P2|Overall Study|Lost to Follow-up|0
329318|NCT01289639|1111874|P1|Overall Study|Lost to Follow-up|1
329319|NCT01289574|1111900|P3|Overall Study|Subject wanted alternate treatment|0
329320|NCT01289574|1111901|P2|Overall Study|Subject wanted alternate treatment|1
329321|NCT01289574|1111902|P1|Overall Study|Subject wanted alternate treatment|0
329322|NCT01289574|1111900|P3|Overall Study|Adverse Event|0
329323|NCT01289574|1111901|P2|Overall Study|Adverse Event|1
329324|NCT01289574|1111902|P1|Overall Study|Adverse Event|0
329325|NCT01289574|1111900|P3|Overall Study|Withdrawal by Subject|1
329326|NCT01289574|1111901|P2|Overall Study|Withdrawal by Subject|1
329327|NCT01289574|1111902|P1|Overall Study|Withdrawal by Subject|1
329328|NCT01289574|1111900|P3|Overall Study|Lost to Follow-up|1
329329|NCT01289574|1111901|P2|Overall Study|Lost to Follow-up|0
329330|NCT01289574|1111902|P1|Overall Study|Lost to Follow-up|2
329331|NCT01289574|1111900|P3|Overall Study|Lack of Efficacy|1
329332|NCT01289574|1111901|P2|Overall Study|Lack of Efficacy|0
329333|NCT01289574|1111902|P1|Overall Study|Lack of Efficacy|4
329334|NCT01289418|1111974|P1|Day 29 Survey|participants did not complete the survey|2185
329335|NCT01289418|1111974|P1|Day 29 Survey|email address invalid|283
329336|NCT01289418|1111974|P1|Day 8 Survey|participants did not complete the survey|1935
329337|NCT01289418|1111974|P1|Day 8 Survey|email address invalid|283
329338|NCT01289210|1112010|P1|Overall Study|Adverse Event|1
329339|NCT01289119|1112020|P6|Overall Study|Other|0
329340|NCT01289119|1112021|P5|Overall Study|Other|0
329341|NCT01289119|1112022|P4|Overall Study|Other|0
329342|NCT01289119|1112023|P3|Overall Study|Other|1
329343|NCT01289119|1112024|P2|Overall Study|Other|0
329344|NCT01289119|1112025|P1|Overall Study|Other|1
329345|NCT01289119|1112020|P6|Overall Study|Lack of Efficacy|1
329346|NCT01289119|1112021|P5|Overall Study|Lack of Efficacy|1
329347|NCT01289119|1112022|P4|Overall Study|Lack of Efficacy|1
329348|NCT01289119|1112023|P3|Overall Study|Lack of Efficacy|1
329349|NCT01289119|1112024|P2|Overall Study|Lack of Efficacy|1
329350|NCT01289119|1112025|P1|Overall Study|Lack of Efficacy|0
329351|NCT01289119|1112020|P6|Overall Study|Pregnancy|0
329352|NCT01289119|1112021|P5|Overall Study|Pregnancy|0
329353|NCT01289119|1112022|P4|Overall Study|Pregnancy|0
329354|NCT01289119|1112023|P3|Overall Study|Pregnancy|0
329355|NCT01289119|1112024|P2|Overall Study|Pregnancy|1
329356|NCT01289119|1112025|P1|Overall Study|Pregnancy|0
329357|NCT01289119|1112020|P6|Overall Study|Withdrawal by Subject|1
329358|NCT01289119|1112021|P5|Overall Study|Withdrawal by Subject|1
329359|NCT01289119|1112022|P4|Overall Study|Withdrawal by Subject|3
329360|NCT01289119|1112023|P3|Overall Study|Withdrawal by Subject|4
329361|NCT01289119|1112024|P2|Overall Study|Withdrawal by Subject|2
329362|NCT01289119|1112025|P1|Overall Study|Withdrawal by Subject|4
329363|NCT01289119|1112020|P6|Overall Study|Lost to Follow-up|1
329364|NCT01289119|1112021|P5|Overall Study|Lost to Follow-up|0
329365|NCT01289119|1112022|P4|Overall Study|Lost to Follow-up|0
329366|NCT01289119|1112023|P3|Overall Study|Lost to Follow-up|0
329367|NCT01289119|1112024|P2|Overall Study|Lost to Follow-up|3
329368|NCT01289119|1112025|P1|Overall Study|Lost to Follow-up|0
329369|NCT01289119|1112020|P6|Overall Study|Major Protocol Deviation|1
329370|NCT01289119|1112021|P5|Overall Study|Major Protocol Deviation|2
329371|NCT01289119|1112022|P4|Overall Study|Major Protocol Deviation|0
329372|NCT01289119|1112023|P3|Overall Study|Major Protocol Deviation|3
329373|NCT01289119|1112024|P2|Overall Study|Major Protocol Deviation|1
329374|NCT01289119|1112025|P1|Overall Study|Major Protocol Deviation|2
329375|NCT01289119|1112020|P6|Overall Study|Adverse Event|0
329376|NCT01289119|1112021|P5|Overall Study|Adverse Event|1
329377|NCT01289119|1112022|P4|Overall Study|Adverse Event|2
329378|NCT01289119|1112023|P3|Overall Study|Adverse Event|0
329379|NCT01289119|1112024|P2|Overall Study|Adverse Event|1
329380|NCT01289119|1112025|P1|Overall Study|Adverse Event|2
329381|NCT01289041|1112146|P1|Overall Study|Death|1
329382|NCT01289041|1112146|P1|Overall Study|Withdrawal by Subject|3
329383|NCT01289041|1112146|P1|Overall Study|Progressive Disease|41
329384|NCT01289041|1112146|P1|Overall Study|Physician Decision|1
329385|NCT01289041|1112146|P1|Overall Study|Adverse Event|24
329386|NCT01289028|1112158|P1|Overall Study|Missing reason for discon|1
329387|NCT01289028|1112158|P1|Overall Study|Abnormal Lab Value|1
329388|NCT01289028|1112158|P1|Overall Study|New Cancer Therapy|2
329389|NCT01289028|1112158|P1|Overall Study|Lost to Follow-up|2
329390|NCT01289028|1112158|P1|Overall Study|No longer required|2
329391|NCT01289028|1112158|P1|Overall Study|Lack of Efficacy|2
329392|NCT01289028|1112158|P1|Overall Study|Death|4
329393|NCT01289028|1112158|P1|Overall Study|Withdrawal by Subject|6
329394|NCT01289028|1112158|P1|Overall Study|Adverse Event|14
329395|NCT01289028|1112158|P1|Overall Study|Progressive Disease|49
329396|NCT01289015|1112172|P2|Overall Study|Negative baseline culture and others|20
329397|NCT01289015|1112173|P1|Overall Study|Negative baseline culture and others|33
329398|NCT01289015|1112172|P2|Overall Study|Disease progression|0
329399|NCT01289015|1112173|P1|Overall Study|Disease progression|1
329400|NCT01289015|1112172|P2|Overall Study|Withdrawal by Subject|8
329401|NCT01289015|1112173|P1|Overall Study|Withdrawal by Subject|17
329402|NCT01289015|1112172|P2|Overall Study|Lost to Follow-up|17
329403|NCT01289015|1112173|P1|Overall Study|Lost to Follow-up|33
329404|NCT01289015|1112172|P2|Overall Study|Adverse Event|0
329405|NCT01289015|1112173|P1|Overall Study|Adverse Event|3
329406|NCT01289015|1112172|P2|Overall Study|Protocol Violation|9
329407|NCT01289015|1112173|P1|Overall Study|Protocol Violation|12
329408|NCT01288976|1112184|P3|Overall Study|Data unavailable|7
329409|NCT01288976|1112185|P2|Overall Study|Data unavailable|9
329410|NCT01288976|1112186|P1|Overall Study|Data unavailable|22
329411|NCT01288976|1112184|P3|Overall Study|Death|4
329412|NCT01288976|1112185|P2|Overall Study|Death|6
329413|NCT01288976|1112186|P1|Overall Study|Death|98
329414|NCT01288976|1112184|P3|Overall Study|Withdrawal by Subject|9
329415|NCT01288976|1112185|P2|Overall Study|Withdrawal by Subject|12
329416|NCT01288976|1112186|P1|Overall Study|Withdrawal by Subject|58
329417|NCT01288911|1112215|P2|Overall Study|Randomized but never received study drug|2
329418|NCT01288911|1112216|P1|Overall Study|Randomized but never received study drug|1
329419|NCT01288911|1112215|P2|Overall Study|Miscellaneous Reason|39
329420|NCT01288911|1112216|P1|Overall Study|Miscellaneous Reason|23
329421|NCT01288911|1112215|P2|Overall Study|Withdrawal by Subject|21
329422|NCT01288911|1112216|P1|Overall Study|Withdrawal by Subject|21
329423|NCT01288911|1112215|P2|Overall Study|Protocol Violation|0
329424|NCT01288911|1112216|P1|Overall Study|Protocol Violation|1
329425|NCT01288911|1112215|P2|Overall Study|Progressive Disease|99
329426|NCT01288911|1112216|P1|Overall Study|Progressive Disease|69
329427|NCT01288911|1112215|P2|Overall Study|Lost to Follow-up|2
329428|NCT01288911|1112216|P1|Overall Study|Lost to Follow-up|0
329429|NCT01288911|1112215|P2|Overall Study|Death|7
329430|NCT01288911|1112216|P1|Overall Study|Death|10
329431|NCT01288729|1112315|P2|Overall Study|Withdrawal by Subject|0
329432|NCT01288729|1112316|P1|Overall Study|Withdrawal by Subject|1
329433|NCT01288612|1112325|P3|Overall Study|Unable to intubate|0
329434|NCT01288612|1112326|P2|Overall Study|Unable to intubate|3
329435|NCT01288612|1112327|P1|Overall Study|Unable to intubate|0
329436|NCT01288612|1112325|P3|Overall Study|Declined|62
329437|NCT01288612|1112326|P2|Overall Study|Declined|63
329438|NCT01288612|1112327|P1|Overall Study|Declined|78
329439|NCT01288612|1112325|P3|Overall Study|Unable to contact|20
329440|NCT01288612|1112326|P2|Overall Study|Unable to contact|16
329441|NCT01288612|1112327|P1|Overall Study|Unable to contact|11
329442|NCT01288469|1112376|P3|Overall Study|Exclusion criteria finally met|0
329443|NCT01288469|1112377|P2|Overall Study|Exclusion criteria finally met|0
329444|NCT01288469|1112378|P1|Overall Study|Exclusion criteria finally met|1
329445|NCT01288469|1112376|P3|Overall Study|Consent withdrawn by subject|1
329446|NCT01288469|1112377|P2|Overall Study|Consent withdrawn by subject|1
329447|NCT01288469|1112378|P1|Overall Study|Consent withdrawn by subject|1
329448|NCT01288469|1112376|P3|Overall Study|Participant Moved|0
329449|NCT01288469|1112377|P2|Overall Study|Participant Moved|0
329450|NCT01288469|1112378|P1|Overall Study|Participant Moved|1
329451|NCT01288469|1112376|P3|Overall Study|Poor compliance to protocol|0
329452|NCT01288469|1112377|P2|Overall Study|Poor compliance to protocol|1
329453|NCT01288469|1112378|P1|Overall Study|Poor compliance to protocol|0
329454|NCT01288469|1112376|P3|Overall Study|Adverse Event|1
329455|NCT01288469|1112377|P2|Overall Study|Adverse Event|1
329456|NCT01288469|1112378|P1|Overall Study|Adverse Event|4
329457|NCT01288443|1112410|P6|Overall Study|Other than above|0
329458|NCT01288443|1112411|P5|Overall Study|Other than above|1
329459|NCT01288443|1112412|P4|Overall Study|Other than above|2
329460|NCT01288443|1112413|P3|Overall Study|Other than above|0
329461|NCT01288443|1112414|P2|Overall Study|Other than above|0
329462|NCT01288443|1112415|P1|Overall Study|Other than above|0
329463|NCT01288443|1112410|P6|Overall Study|Study drug auto-injector administration|1
329464|NCT01288443|1112411|P5|Overall Study|Study drug auto-injector administration|1
329465|NCT01288443|1112412|P4|Overall Study|Study drug auto-injector administration|0
329466|NCT01288443|1112413|P3|Overall Study|Study drug auto-injector administration|0
329467|NCT01288443|1112414|P2|Overall Study|Study drug auto-injector administration|0
329468|NCT01288443|1112415|P1|Overall Study|Study drug auto-injector administration|0
329469|NCT01288443|1112410|P6|Overall Study|Lost to Follow-up|0
329470|NCT01288443|1112411|P5|Overall Study|Lost to Follow-up|0
329471|NCT01288443|1112412|P4|Overall Study|Lost to Follow-up|0
329472|NCT01288443|1112413|P3|Overall Study|Lost to Follow-up|0
329473|NCT01288443|1112414|P2|Overall Study|Lost to Follow-up|1
329474|NCT01288443|1112415|P1|Overall Study|Lost to Follow-up|0
329475|NCT01288443|1112410|P6|Overall Study|Consent withdrawn by Participant|1
329476|NCT01288443|1112411|P5|Overall Study|Consent withdrawn by Participant|0
329477|NCT01288443|1112412|P4|Overall Study|Consent withdrawn by Participant|0
329478|NCT01288443|1112413|P3|Overall Study|Consent withdrawn by Participant|0
329479|NCT01288443|1112414|P2|Overall Study|Consent withdrawn by Participant|0
329480|NCT01288443|1112415|P1|Overall Study|Consent withdrawn by Participant|0
329481|NCT01288443|1112410|P6|Overall Study|Participant Moved|1
329482|NCT01288443|1112411|P5|Overall Study|Participant Moved|2
329483|NCT01288443|1112412|P4|Overall Study|Participant Moved|1
329484|NCT01288443|1112413|P3|Overall Study|Participant Moved|0
329485|NCT01288443|1112414|P2|Overall Study|Participant Moved|0
329486|NCT01288443|1112415|P1|Overall Study|Participant Moved|0
329487|NCT01288443|1112410|P6|Overall Study|Poor compliance to protocol|1
329488|NCT01288443|1112411|P5|Overall Study|Poor compliance to protocol|0
329489|NCT01288443|1112412|P4|Overall Study|Poor compliance to protocol|0
329490|NCT01288443|1112413|P3|Overall Study|Poor compliance to protocol|0
329491|NCT01288443|1112414|P2|Overall Study|Poor compliance to protocol|0
329492|NCT01288443|1112415|P1|Overall Study|Poor compliance to protocol|0
329493|NCT01288443|1112410|P6|Overall Study|Adverse Event|1
329494|NCT01288443|1112411|P5|Overall Study|Adverse Event|3
329495|NCT01288443|1112412|P4|Overall Study|Adverse Event|1
329496|NCT01288443|1112413|P3|Overall Study|Adverse Event|1
329497|NCT01288443|1112414|P2|Overall Study|Adverse Event|0
329498|NCT01288443|1112415|P1|Overall Study|Adverse Event|0
329499|NCT01288287|1112465|P1|Overall Study|Unknown Status|7
329500|NCT01288287|1112465|P1|Overall Study|Unknown Reason|1
329501|NCT01288287|1112465|P1|Overall Study|Other Reason|13
329502|NCT01288287|1112465|P1|Overall Study|Lack of Efficacy|13
329503|NCT01288287|1112465|P1|Overall Study|Withdrawal by Subject|4
329504|NCT01288287|1112465|P1|Overall Study|Lost to Follow-up|8
329505|NCT01288209|1112480|P2|Overall Study|Not specified|0
329506|NCT01288209|1112481|P1|Overall Study|Not specified|1
329507|NCT01288209|1112480|P2|Overall Study|Withdrawal by Subject|3
329508|NCT01288209|1112481|P1|Overall Study|Withdrawal by Subject|1
329509|NCT01288079|1112511|P4|Overall Study|Other or Study Termination|8
329510|NCT01288079|1112512|P3|Overall Study|Other or Study Termination|14
329511|NCT01288079|1112513|P2|Overall Study|Other or Study Termination|15
329512|NCT01288079|1112514|P1|Overall Study|Other or Study Termination|11
329513|NCT01288079|1112511|P4|Overall Study|Lost to Follow-up|0
329514|NCT01288079|1112512|P3|Overall Study|Lost to Follow-up|1
329515|NCT01288079|1112513|P2|Overall Study|Lost to Follow-up|1
329516|NCT01288079|1112514|P1|Overall Study|Lost to Follow-up|1
329517|NCT01288079|1112511|P4|Overall Study|Study-Specific Withdrawal Criteria|0
329518|NCT01288079|1112512|P3|Overall Study|Study-Specific Withdrawal Criteria|0
329519|NCT01288079|1112513|P2|Overall Study|Study-Specific Withdrawal Criteria|1
329520|NCT01288079|1112514|P1|Overall Study|Study-Specific Withdrawal Criteria|1
329521|NCT01288079|1112511|P4|Overall Study|Lack of Efficacy|2
329522|NCT01288079|1112512|P3|Overall Study|Lack of Efficacy|0
329523|NCT01288079|1112513|P2|Overall Study|Lack of Efficacy|2
329524|NCT01288079|1112514|P1|Overall Study|Lack of Efficacy|2
329525|NCT01288079|1112511|P4|Overall Study|Condition under Investigation Worsened|1
329526|NCT01288079|1112512|P3|Overall Study|Condition under Investigation Worsened|0
329527|NCT01288079|1112513|P2|Overall Study|Condition under Investigation Worsened|0
329528|NCT01288079|1112514|P1|Overall Study|Condition under Investigation Worsened|0
329529|NCT01288079|1112511|P4|Overall Study|Severe Non-Compliance to Protocol|3
329530|NCT01288079|1112512|P3|Overall Study|Severe Non-Compliance to Protocol|1
329531|NCT01288079|1112513|P2|Overall Study|Severe Non-Compliance to Protocol|3
329532|NCT01288079|1112514|P1|Overall Study|Severe Non-Compliance to Protocol|1
329533|NCT01288079|1112511|P4|Overall Study|Adverse Event|3
329534|NCT01288079|1112512|P3|Overall Study|Adverse Event|2
329535|NCT01288079|1112513|P2|Overall Study|Adverse Event|1
329536|NCT01288079|1112514|P1|Overall Study|Adverse Event|2
329537|NCT01288079|1112511|P4|Overall Study|Withdrawal by Subject|0
329538|NCT01288079|1112512|P3|Overall Study|Withdrawal by Subject|1
329539|NCT01288079|1112513|P2|Overall Study|Withdrawal by Subject|4
329540|NCT01288079|1112514|P1|Overall Study|Withdrawal by Subject|2
329541|NCT01287897|1112538|P4|Overall Study|Other|0
329542|NCT01287897|1112539|P3|Overall Study|Other|1
329543|NCT01287897|1112540|P2|Overall Study|Other|0
329544|NCT01287897|1112541|P1|Overall Study|Other|1
329545|NCT01287897|1112538|P4|Overall Study|Not meeting entrance criteria|0
329546|NCT01287897|1112539|P3|Overall Study|Not meeting entrance criteria|0
329547|NCT01287897|1112540|P2|Overall Study|Not meeting entrance criteria|1
329548|NCT01287897|1112541|P1|Overall Study|Not meeting entrance criteria|1
329549|NCT01287897|1112538|P4|Overall Study|Not consented properly|0
329550|NCT01287897|1112539|P3|Overall Study|Not consented properly|0
329551|NCT01287897|1112540|P2|Overall Study|Not consented properly|1
329552|NCT01287897|1112541|P1|Overall Study|Not consented properly|0
329553|NCT01287897|1112538|P4|Overall Study|Withdrawal by Subject|2
329554|NCT01287897|1112539|P3|Overall Study|Withdrawal by Subject|3
329555|NCT01287897|1112540|P2|Overall Study|Withdrawal by Subject|5
329556|NCT01287897|1112541|P1|Overall Study|Withdrawal by Subject|1
329557|NCT01287897|1112538|P4|Overall Study|Lost to Follow-up|0
329558|NCT01287897|1112539|P3|Overall Study|Lost to Follow-up|2
329559|NCT01287897|1112540|P2|Overall Study|Lost to Follow-up|0
329560|NCT01287897|1112541|P1|Overall Study|Lost to Follow-up|0
329561|NCT01287897|1112538|P4|Overall Study|Protocol Violation|1
329562|NCT01287897|1112539|P3|Overall Study|Protocol Violation|0
329563|NCT01287897|1112540|P2|Overall Study|Protocol Violation|1
329564|NCT01287897|1112541|P1|Overall Study|Protocol Violation|1
329565|NCT01287897|1112538|P4|Overall Study|Lack of Efficacy|0
329566|NCT01287897|1112539|P3|Overall Study|Lack of Efficacy|0
329567|NCT01287897|1112540|P2|Overall Study|Lack of Efficacy|0
329568|NCT01287897|1112541|P1|Overall Study|Lack of Efficacy|2
329569|NCT01287897|1112538|P4|Overall Study|Adverse Event|4
329570|NCT01287897|1112539|P3|Overall Study|Adverse Event|6
329571|NCT01287897|1112540|P2|Overall Study|Adverse Event|3
329572|NCT01287897|1112541|P1|Overall Study|Adverse Event|5
329573|NCT01287832|1112592|P2|Overall Study|Death|1
329574|NCT01287832|1112593|P1|Overall Study|Death|0
329575|NCT01287832|1112592|P2|Overall Study|Adverse Event|0
329576|NCT01287832|1112593|P1|Overall Study|Adverse Event|1
329577|NCT01287754|1112601|P2|Overall Study|Protocol Violation|3
329578|NCT01287754|1112602|P1|Overall Study|Protocol Violation|0
329579|NCT01287754|1112601|P2|Overall Study|Lost to Follow-up|6
329580|NCT01287754|1112602|P1|Overall Study|Lost to Follow-up|1
329581|NCT01287754|1112601|P2|Overall Study|Death|12
329582|NCT01287754|1112602|P1|Overall Study|Death|2
329583|NCT01287741|1112614|P2|Overall Study|Reason not specified|9
329584|NCT01287741|1112615|P1|Overall Study|Reason not specified|14
329585|NCT01287741|1112614|P2|Overall Study|Progressive disease|148
329586|NCT01287741|1112615|P1|Overall Study|Progressive disease|173
329587|NCT01287741|1112614|P2|Overall Study|Continued in the study|455
329588|NCT01287741|1112615|P1|Overall Study|Continued in the study|446
329589|NCT01287741|1112614|P2|Overall Study|Adverse Event|4
329590|NCT01287741|1112615|P1|Overall Study|Adverse Event|3
329591|NCT01287741|1112614|P2|Overall Study|Death|38
329592|NCT01287741|1112615|P1|Overall Study|Death|31
329593|NCT01287741|1112614|P2|Overall Study|Lost to Follow-up|8
329594|NCT01287741|1112615|P1|Overall Study|Lost to Follow-up|5
329595|NCT01287741|1112614|P2|Overall Study|Non-compliance|3
329596|NCT01287741|1112615|P1|Overall Study|Non-compliance|2
329597|NCT01287741|1112614|P2|Overall Study|Physician Decision|19
329598|NCT01287741|1112615|P1|Overall Study|Physician Decision|12
329599|NCT01287741|1112614|P2|Overall Study|Protocol Violation|0
329600|NCT01287741|1112615|P1|Overall Study|Protocol Violation|1
329601|NCT01287741|1112614|P2|Overall Study|Withdrawal by Subject|22
329602|NCT01287741|1112615|P1|Overall Study|Withdrawal by Subject|25
329603|NCT01287611|1112651|P2|Overall Study|Exclusion due to expanded Kerr incision|3
329604|NCT01287611|1112652|P1|Overall Study|Exclusion due to expanded Kerr incision|4
329605|NCT01287611|1112651|P2|Overall Study|Lost to Follow-up|16
329606|NCT01287611|1112652|P1|Overall Study|Lost to Follow-up|29
329607|NCT01287416|1112662|P2|6 Month Follow-up|Lost to Follow-up|2
329608|NCT01287416|1112663|P1|6 Month Follow-up|Lost to Follow-up|3
329609|NCT01287416|1112662|P2|Pre-post Training|Lost to Follow-up|1
329610|NCT01287416|1112663|P1|Pre-post Training|Lost to Follow-up|5
329611|NCT01287416|1112662|P2|Pre-post Training|Withdrawal by Subject|24
329612|NCT01287416|1112663|P1|Pre-post Training|Withdrawal by Subject|17
329613|NCT01287403|1112699|P1|1st Intervention (1 Day)|Adverse Event|1
329614|NCT01287364|1112715|P2|Overall Study|Other Reason|2
329615|NCT01287364|1112716|P1|Overall Study|Other Reason|4
329616|NCT01287364|1112715|P2|Overall Study|Protocol Violation|5
329617|NCT01287364|1112716|P1|Overall Study|Protocol Violation|5
329618|NCT01287364|1112715|P2|Overall Study|Adverse Event|3
329619|NCT01287364|1112716|P1|Overall Study|Adverse Event|0
329620|NCT01287221|1112738|P2|Overall Study|Withdrawal by Subject|1
329621|NCT01287221|1112739|P1|Overall Study|Withdrawal by Subject|0
329622|NCT01287221|1112738|P2|Overall Study|Adverse Event|3
329623|NCT01287221|1112739|P1|Overall Study|Adverse Event|3
329624|NCT01287221|1112738|P2|Overall Study|Lack of Perceived Benefit|1
329625|NCT01287221|1112739|P1|Overall Study|Lack of Perceived Benefit|1
329626|NCT01287195|1112774|P1|Overall Study|Withdrawal by Subject|2
329627|NCT01287117|1112789|P4|Overall Study|Disease Progression|5
329628|NCT01287117|1112790|P3|Overall Study|Disease Progression|6
329629|NCT01287117|1112791|P2|Overall Study|Disease Progression|5
329630|NCT01287117|1112792|P1|Overall Study|Disease Progression|10
329631|NCT01287117|1112789|P4|Overall Study|Patient/Legal Guardian's Decision|5
329632|NCT01287117|1112790|P3|Overall Study|Patient/Legal Guardian's Decision|8
329633|NCT01287117|1112791|P2|Overall Study|Patient/Legal Guardian's Decision|6
329634|NCT01287117|1112792|P1|Overall Study|Patient/Legal Guardian's Decision|2
329635|NCT01287117|1112789|P4|Overall Study|Physician Decision|1
329636|NCT01287117|1112790|P3|Overall Study|Physician Decision|1
329637|NCT01287117|1112791|P2|Overall Study|Physician Decision|1
329638|NCT01287117|1112792|P1|Overall Study|Physician Decision|0
329639|NCT01287117|1112789|P4|Overall Study|Lost to Follow-up|0
329640|NCT01287117|1112790|P3|Overall Study|Lost to Follow-up|0
329641|NCT01287117|1112791|P2|Overall Study|Lost to Follow-up|1
329642|NCT01287117|1112792|P1|Overall Study|Lost to Follow-up|1
329643|NCT01287117|1112789|P4|Overall Study|Adverse Event|1
329644|NCT01287117|1112790|P3|Overall Study|Adverse Event|1
329645|NCT01287117|1112791|P2|Overall Study|Adverse Event|1
329646|NCT01287117|1112792|P1|Overall Study|Adverse Event|2
329647|NCT01287065|1112838|P6|Treatment Period 1|Withdrawal by Subject|1
329648|NCT01287065|1112839|P5|Treatment Period 1|Withdrawal by Subject|0
329649|NCT01287065|1112840|P4|Treatment Period 1|Withdrawal by Subject|0
329650|NCT01287065|1112841|P3|Treatment Period 1|Withdrawal by Subject|0
329651|NCT01287065|1112842|P2|Treatment Period 1|Withdrawal by Subject|0
329652|NCT01287065|1112843|P1|Treatment Period 1|Withdrawal by Subject|0
329653|NCT01287065|1112838|P6|Treatment Period 1|Adverse Event|0
329654|NCT01287065|1112839|P5|Treatment Period 1|Adverse Event|1
329655|NCT01287065|1112840|P4|Treatment Period 1|Adverse Event|0
329656|NCT01287065|1112841|P3|Treatment Period 1|Adverse Event|0
329657|NCT01287065|1112842|P2|Treatment Period 1|Adverse Event|0
329658|NCT01287065|1112843|P1|Treatment Period 1|Adverse Event|0
329659|NCT01287039|1112862|P2|Overall Study|Lost to Follow-up|2
329660|NCT01287039|1112863|P1|Overall Study|Lost to Follow-up|3
329661|NCT01287039|1112862|P2|Overall Study|Withdrawal by Subject|11
329662|NCT01287039|1112863|P1|Overall Study|Withdrawal by Subject|14
329663|NCT01287039|1112862|P2|Overall Study|Adverse Event|4
329664|NCT01287039|1112863|P1|Overall Study|Adverse Event|7
329665|NCT01287039|1112862|P2|Overall Study|Change of residence|0
329666|NCT01287039|1112863|P1|Overall Study|Change of residence|1
329667|NCT01287039|1112862|P2|Overall Study|Death|0
329668|NCT01287039|1112863|P1|Overall Study|Death|1
329669|NCT01287039|1112862|P2|Overall Study|Problem with travel|1
329670|NCT01287039|1112863|P1|Overall Study|Problem with travel|0
329671|NCT01287039|1112862|P2|Overall Study|Noncompliance with study medication|1
329672|NCT01287039|1112863|P1|Overall Study|Noncompliance with study medication|0
329673|NCT01287039|1112862|P2|Overall Study|Excluded medication taken|0
329674|NCT01287039|1112863|P1|Overall Study|Excluded medication taken|1
329675|NCT01287039|1112862|P2|Overall Study|Protocol Violation|3
329676|NCT01287039|1112863|P1|Overall Study|Protocol Violation|2
329677|NCT01287039|1112862|P2|Overall Study|Elective surgery|1
329678|NCT01287039|1112863|P1|Overall Study|Elective surgery|0
329679|NCT01287039|1112862|P2|Overall Study|Change of location/residence|3
329680|NCT01287039|1112863|P1|Overall Study|Change of location/residence|0
329681|NCT01287039|1112862|P2|Overall Study|Noncompliance with study procedures|1
329682|NCT01287039|1112863|P1|Overall Study|Noncompliance with study procedures|0
329683|NCT01287013|1112896|P3|Overall Study|Non-evaluable|21
329684|NCT01287013|1112897|P2|Overall Study|Non-evaluable|5
329685|NCT01287013|1112898|P1|Overall Study|Non-evaluable|3
329686|NCT01286753|1112950|P2|Overall Study|Participant to Receive Radiotherapy|0
329687|NCT01286753|1112951|P1|Overall Study|Participant to Receive Radiotherapy|1
329688|NCT01286753|1112950|P2|Overall Study|Discontinued to Join Extension Study|4
329689|NCT01286753|1112951|P1|Overall Study|Discontinued to Join Extension Study|6
329690|NCT01286753|1112950|P2|Overall Study|Withdrawal of Consent|2
329691|NCT01286753|1112951|P1|Overall Study|Withdrawal of Consent|0
329692|NCT01286753|1112950|P2|Overall Study|Refused Treatment|0
329693|NCT01286753|1112951|P1|Overall Study|Refused Treatment|1
329694|NCT01286753|1112950|P2|Overall Study|Progression|13
329695|NCT01286753|1112951|P1|Overall Study|Progression|11
329696|NCT01286753|1112950|P2|Overall Study|Adverse Event|6
329697|NCT01286753|1112951|P1|Overall Study|Adverse Event|7
329698|NCT01286740|1112969|P1|Overall Study|Protocol Violation|1
329699|NCT01286740|1112969|P1|Overall Study|Enrolled but not treated|1
329700|NCT01286558|1112987|P2|Overall Study|Withdrawal by Subject|1
329701|NCT01286558|1112988|P1|Overall Study|Withdrawal by Subject|0
329702|NCT01286558|1112987|P2|Overall Study|Adverse Event|1
329703|NCT01286558|1112988|P1|Overall Study|Adverse Event|1
329704|NCT01286480|1113024|P2|Overall Study|Withdrawal by Subject|3
329705|NCT01286480|1113025|P1|Overall Study|Withdrawal by Subject|5
329706|NCT01286311|1113111|P2|Overall Study|Physician did not want outreach sent|0
329707|NCT01286311|1113112|P1|Overall Study|Physician did not want outreach sent|14
329708|NCT01286207|1113129|P3|Overall Study|Other|13
329709|NCT01286207|1113130|P2|Overall Study|Other|47
329710|NCT01286207|1113131|P1|Overall Study|Other|37
329711|NCT01286207|1113129|P3|Overall Study|Lack of Response|8
329712|NCT01286207|1113130|P2|Overall Study|Lack of Response|38
329713|NCT01286207|1113131|P1|Overall Study|Lack of Response|92
329714|NCT01286207|1113129|P3|Overall Study|Withdrawal by Subject|41
329715|NCT01286207|1113130|P2|Overall Study|Withdrawal by Subject|79
329716|NCT01286207|1113131|P1|Overall Study|Withdrawal by Subject|93
329717|NCT01286207|1113129|P3|Overall Study|Lost to Follow-up|20
329718|NCT01286207|1113130|P2|Overall Study|Lost to Follow-up|43
329719|NCT01286207|1113131|P1|Overall Study|Lost to Follow-up|49
329720|NCT01286207|1113129|P3|Overall Study|Adverse Event|8
329721|NCT01286207|1113130|P2|Overall Study|Adverse Event|41
329722|NCT01286207|1113131|P1|Overall Study|Adverse Event|27
329723|NCT01286168|1113151|P1|Overall Study|Surgical Drains Fell Out at Home|2
329724|NCT01286168|1113151|P1|Overall Study|Withdrawal by Subject|1
329725|NCT01286129|1113165|P2|Overall Study|Could not comply with study requirements|4
329726|NCT01286129|1113166|P1|Overall Study|Could not comply with study requirements|4
329727|NCT01286129|1113165|P2|Overall Study|Withdrawal by Subject|1
329728|NCT01286129|1113166|P1|Overall Study|Withdrawal by Subject|4
329729|NCT01286077|1113176|P2|Overall Study|refill medication not received in time|0
329730|NCT01286077|1113177|P1|Overall Study|refill medication not received in time|1
329731|NCT01286077|1113176|P2|Overall Study|Progression of disease|1
329732|NCT01286077|1113177|P1|Overall Study|Progression of disease|0
329733|NCT01286077|1113176|P2|Overall Study|Patient's decision to stop treatment|0
329734|NCT01286077|1113177|P1|Overall Study|Patient's decision to stop treatment|3
329735|NCT01286077|1113176|P2|Overall Study|The subject starts with alternative MMY|3
329736|NCT01286077|1113177|P1|Overall Study|The subject starts with alternative MMY|0
329737|NCT01286077|1113176|P2|Overall Study|Non-compliance|0
329738|NCT01286077|1113177|P1|Overall Study|Non-compliance|1
329739|NCT01286077|1113176|P2|Overall Study|Intercurrent illness|0
329740|NCT01286077|1113177|P1|Overall Study|Intercurrent illness|1
329741|NCT01286077|1113176|P2|Overall Study|Withdrawal by Subject|2
329742|NCT01286077|1113177|P1|Overall Study|Withdrawal by Subject|0
329743|NCT01286077|1113176|P2|Overall Study|Protocol Violation|1
329744|NCT01286077|1113177|P1|Overall Study|Protocol Violation|1
329745|NCT01286077|1113176|P2|Overall Study|Death|0
329746|NCT01286077|1113177|P1|Overall Study|Death|1
329747|NCT01286077|1113176|P2|Overall Study|Adverse Event|0
329748|NCT01286077|1113177|P1|Overall Study|Adverse Event|2
329749|NCT01286012|1113213|P2|Overall Study|peritoneal dialysis, randomized in error|3
329750|NCT01286012|1113214|P1|Overall Study|peritoneal dialysis, randomized in error|1
329751|NCT01286012|1113213|P2|Overall Study|Physician Decision|0
329752|NCT01286012|1113214|P1|Overall Study|Physician Decision|2
329753|NCT01286012|1113213|P2|Overall Study|Withdrawal by Subject|4
329754|NCT01286012|1113214|P1|Overall Study|Withdrawal by Subject|4
329755|NCT01286012|1113213|P2|Overall Study|Protocol Violation|1
329756|NCT01286012|1113214|P1|Overall Study|Protocol Violation|1
329757|NCT01286012|1113213|P2|Overall Study|Death|3
329758|NCT01286012|1113214|P1|Overall Study|Death|2
329759|NCT01286012|1113213|P2|Overall Study|Adverse Event|3
329760|NCT01286012|1113214|P1|Overall Study|Adverse Event|3
329761|NCT01285908|1113231|P3|Baseline Measurement|unable to tolerate procedure|0
329762|NCT01285908|1113232|P2|Baseline Measurement|unable to tolerate procedure|0
329763|NCT01285908|1113233|P1|Baseline Measurement|unable to tolerate procedure|1
329764|NCT01285908|1113231|P3|Baseline Measurement|History of stroke, exclusion criteria|0
329765|NCT01285908|1113232|P2|Baseline Measurement|History of stroke, exclusion criteria|0
329766|NCT01285908|1113233|P1|Baseline Measurement|History of stroke, exclusion criteria|1
329767|NCT01285908|1113231|P3|Baseline Measurement|unable to insert catheter|0
329768|NCT01285908|1113232|P2|Baseline Measurement|unable to insert catheter|0
329769|NCT01285908|1113233|P1|Baseline Measurement|unable to insert catheter|1
329770|NCT01285609|1113327|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
329771|NCT01285609|1113328|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
329772|NCT01285609|1113327|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
329773|NCT01285609|1113328|P1|Treated With Blinded Therapy|Poor/Non-Compliance|0
329774|NCT01285609|1113327|P2|Treated With Blinded Therapy|Not Reported|4
329775|NCT01285609|1113328|P1|Treated With Blinded Therapy|Not Reported|4
329776|NCT01285609|1113327|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
329777|NCT01285609|1113328|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
329778|NCT01285609|1113327|P2|Treated With Blinded Therapy|Death|3
329779|NCT01285609|1113328|P1|Treated With Blinded Therapy|Death|11
329780|NCT01285609|1113327|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
329781|NCT01285609|1113328|P1|Treated With Blinded Therapy|Withdrawal by Subject|18
329782|NCT01285609|1113327|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
329783|NCT01285609|1113328|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
329784|NCT01285609|1113327|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
329785|NCT01285609|1113328|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
329786|NCT01285609|1113327|P2|Treated With Blinded Therapy|Progressive Disease|305
329787|NCT01285609|1113328|P1|Treated With Blinded Therapy|Progressive Disease|220
329788|NCT01285609|1113327|P2|Randomized|Randomized but not Treated|4
329789|NCT01285609|1113328|P1|Randomized|Randomized but not Treated|4
329790|NCT01285609|1113327|P2|Randomized|Undisclosed Reasons|0
329791|NCT01285609|1113328|P1|Randomized|Undisclosed Reasons|1
329792|NCT01285609|1113327|P2|Randomized|Subject No Longer Met Study Criteria|1
329793|NCT01285609|1113328|P1|Randomized|Subject No Longer Met Study Criteria|1
329794|NCT01285609|1113327|P2|Randomized|Withdrawal by Subject|11
329795|NCT01285609|1113328|P1|Randomized|Withdrawal by Subject|8
329796|NCT01285609|1113327|P2|Randomized|Death|7
329797|NCT01285609|1113328|P1|Randomized|Death|5
329798|NCT01285609|1113327|P2|Randomized|Study Drug Toxicity|14
329799|NCT01285609|1113328|P1|Randomized|Study Drug Toxicity|13
329800|NCT01285609|1113327|P2|Randomized|Adverse Event Unrelated to Study Drug|18
329801|NCT01285609|1113328|P1|Randomized|Adverse Event Unrelated to Study Drug|18
329802|NCT01285609|1113327|P2|Randomized|Progressive Disease|61
329803|NCT01285609|1113328|P1|Randomized|Progressive Disease|41
329804|NCT01285518|1113346|P8|Overall Study|Lost to Follow-up|0
329805|NCT01285518|1113347|P7|Overall Study|Lost to Follow-up|0
329806|NCT01285518|1113348|P6|Overall Study|Lost to Follow-up|1
329807|NCT01285518|1113349|P5|Overall Study|Lost to Follow-up|0
329808|NCT01285518|1113350|P4|Overall Study|Lost to Follow-up|0
329809|NCT01285518|1113351|P3|Overall Study|Lost to Follow-up|0
329810|NCT01285518|1113352|P2|Overall Study|Lost to Follow-up|0
329811|NCT01285518|1113353|P1|Overall Study|Lost to Follow-up|0
329812|NCT01285492|1113613|P2|Overall Study|Death|0
329813|NCT01285492|1113614|P1|Overall Study|Death|1
329814|NCT01285492|1113613|P2|Overall Study|Withdrawal by Subject|1
329815|NCT01285492|1113614|P1|Overall Study|Withdrawal by Subject|2
329816|NCT01285492|1113613|P2|Overall Study|Protocol Violation|0
329817|NCT01285492|1113614|P1|Overall Study|Protocol Violation|3
329818|NCT01285492|1113613|P2|Overall Study|Adverse Event|0
329819|NCT01285492|1113614|P1|Overall Study|Adverse Event|11
329820|NCT01285401|1113646|P2|Overall Study|Prematurely withdrawn from the study|29
329821|NCT01285401|1113647|P1|Overall Study|Prematurely withdrawn from the study|17
329822|NCT01285323|1113687|P2|Overall Study|Not specified|3
329823|NCT01285323|1113688|P1|Overall Study|Not specified|1
329824|NCT01285323|1113687|P2|Overall Study|Lost to Follow-up|1
329825|NCT01285323|1113688|P1|Overall Study|Lost to Follow-up|1
329826|NCT01285323|1113687|P2|Overall Study|Non-compliance with study procedures|3
329827|NCT01285323|1113688|P1|Overall Study|Non-compliance with study procedures|2
329828|NCT01285323|1113687|P2|Overall Study|Protocol Violation|2
329829|NCT01285323|1113688|P1|Overall Study|Protocol Violation|1
329830|NCT01285323|1113687|P2|Overall Study|Withdrawal by Subject|11
329831|NCT01285323|1113688|P1|Overall Study|Withdrawal by Subject|15
329832|NCT01285323|1113687|P2|Overall Study|Lack of Efficacy|2
329833|NCT01285323|1113688|P1|Overall Study|Lack of Efficacy|4
329834|NCT01285323|1113687|P2|Overall Study|Adverse Event|8
329835|NCT01285323|1113688|P1|Overall Study|Adverse Event|9
329836|NCT01285310|1113723|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
329837|NCT01285310|1113724|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
329838|NCT01285310|1113725|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
329839|NCT01285310|1113726|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
329840|NCT01285310|1113727|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
329841|NCT01285310|1113723|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
329842|NCT01285310|1113724|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
329843|NCT01285310|1113725|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
329844|NCT01285310|1113726|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
329845|NCT01285310|1113727|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
329846|NCT01285310|1113723|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
329847|NCT01285310|1113724|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
329848|NCT01285310|1113725|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
329849|NCT01285310|1113726|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
329850|NCT01285310|1113727|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
329851|NCT01285310|1113723|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
329852|NCT01285310|1113724|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
329853|NCT01285310|1113725|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
329854|NCT01285310|1113726|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
329855|NCT01285310|1113727|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
329856|NCT01285310|1113723|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
329857|NCT01285310|1113724|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
329858|NCT01285310|1113725|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
329859|NCT01285310|1113726|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
329860|NCT01285310|1113727|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
329861|NCT01285310|1113723|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
329862|NCT01285310|1113724|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
329863|NCT01285310|1113725|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
329864|NCT01285310|1113726|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
329865|NCT01285310|1113727|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
329866|NCT01285310|1113723|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
329867|NCT01285310|1113724|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
329868|NCT01285310|1113725|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
329869|NCT01285310|1113726|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
329870|NCT01285310|1113727|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
329871|NCT01285310|1113723|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
329872|NCT01285310|1113724|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
329873|NCT01285310|1113725|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
329874|NCT01285310|1113726|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
329875|NCT01285310|1113727|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
329876|NCT01285310|1113723|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
329877|NCT01285310|1113724|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
329878|NCT01285310|1113725|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
329879|NCT01285310|1113726|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
329880|NCT01285310|1113727|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
329881|NCT01285310|1113723|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
329882|NCT01285310|1113724|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
329883|NCT01285310|1113725|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
329884|NCT01285310|1113726|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
329885|NCT01285310|1113727|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
329886|NCT01285310|1113723|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
329887|NCT01285310|1113724|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
329888|NCT01285310|1113725|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
329889|NCT01285310|1113726|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
329890|NCT01285310|1113727|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
329891|NCT01285310|1113723|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
329892|NCT01285310|1113724|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
329893|NCT01285310|1113725|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
329894|NCT01285310|1113726|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
329895|NCT01285310|1113727|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
329896|NCT01284959|1113992|P3|Overall Study|Adverse Event|1
329897|NCT01284959|1113993|P2|Overall Study|Adverse Event|0
329898|NCT01284959|1113994|P1|Overall Study|Adverse Event|0
329899|NCT01284959|1113992|P3|Overall Study|Withdrawal by Subject|0
329900|NCT01284959|1113993|P2|Overall Study|Withdrawal by Subject|0
329901|NCT01284959|1113994|P1|Overall Study|Withdrawal by Subject|1
329902|NCT01284634|1114024|P4|Overall Study|Adverse Event|1
329903|NCT01284634|1114025|P3|Overall Study|Adverse Event|2
329904|NCT01284634|1114026|P2|Overall Study|Adverse Event|0
329905|NCT01284634|1114027|P1|Overall Study|Adverse Event|1
329906|NCT01284621|1114169|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
329907|NCT01284621|1114170|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
329908|NCT01284621|1114171|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
329909|NCT01284621|1114172|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
329910|NCT01284621|1114173|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
329911|NCT01284621|1114174|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
329912|NCT01284491|1114242|P1|Overall Study|Study termination|13
329913|NCT01284361|1114252|P1|Overall Study|Lost to Follow-up|2
329914|NCT01284361|1114252|P1|Overall Study|Adverse Event|1
329915|NCT01284361|1114252|P1|Overall Study|Protocol Violation|5
329916|NCT01284361|1114252|P1|Overall Study|Withdrawal by Subject|1
329917|NCT01284140|1114275|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
329918|NCT01284140|1114276|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
329919|NCT01284140|1114275|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
329920|NCT01284140|1114276|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
329921|NCT01284114|1114290|P1|Overall Study|dizziness|1
329922|NCT01284114|1114290|P1|Overall Study|Symptomatic hypotension|1
329923|NCT01284114|1114290|P1|Overall Study|From the results of ALLTITUDE study|1
329924|NCT01284114|1114290|P1|Overall Study|viral infection|1
329925|NCT01284062|1114302|P4|Overall Study|Site Closed|0
329926|NCT01284062|1114303|P3|Overall Study|Site Closed|1
329927|NCT01284062|1114304|P2|Overall Study|Site Closed|0
329928|NCT01284062|1114305|P1|Overall Study|Site Closed|0
329929|NCT01284062|1114302|P4|Overall Study|Other|1
329930|NCT01284062|1114303|P3|Overall Study|Other|0
329931|NCT01284062|1114304|P2|Overall Study|Other|0
329932|NCT01284062|1114305|P1|Overall Study|Other|0
329933|NCT01284062|1114302|P4|Overall Study|Withdrawal by Subject|5
329934|NCT01284062|1114303|P3|Overall Study|Withdrawal by Subject|2
329935|NCT01284062|1114304|P2|Overall Study|Withdrawal by Subject|1
329936|NCT01284062|1114305|P1|Overall Study|Withdrawal by Subject|3
329937|NCT01284062|1114302|P4|Overall Study|Protocol Violation|2
329938|NCT01284062|1114303|P3|Overall Study|Protocol Violation|0
329939|NCT01284062|1114304|P2|Overall Study|Protocol Violation|0
329940|NCT01284062|1114305|P1|Overall Study|Protocol Violation|1
329941|NCT01284062|1114302|P4|Overall Study|Medication error without adverse event|0
329942|NCT01284062|1114303|P3|Overall Study|Medication error without adverse event|1
329943|NCT01284062|1114304|P2|Overall Study|Medication error without adverse event|0
329944|NCT01284062|1114305|P1|Overall Study|Medication error without adverse event|0
329945|NCT01284062|1114302|P4|Overall Study|Lack of Efficacy|1
329946|NCT01284062|1114303|P3|Overall Study|Lack of Efficacy|2
329947|NCT01284062|1114304|P2|Overall Study|Lack of Efficacy|2
329948|NCT01284062|1114305|P1|Overall Study|Lack of Efficacy|3
329949|NCT01284062|1114302|P4|Overall Study|Adverse Event|5
329950|NCT01284062|1114303|P3|Overall Study|Adverse Event|0
329951|NCT01284062|1114304|P2|Overall Study|Adverse Event|5
329952|NCT01284062|1114305|P1|Overall Study|Adverse Event|4
329953|NCT01283971|1114379|P2|Overall Study|Administrative reasons|1
329954|NCT01283971|1114380|P1|Overall Study|Administrative reasons|1
329955|NCT01283971|1114379|P2|Overall Study|Failure to return|1
329956|NCT01283971|1114380|P1|Overall Study|Failure to return|0
329957|NCT01283971|1114379|P2|Overall Study|Refused treatment|1
329958|NCT01283971|1114380|P1|Overall Study|Refused treatment|3
329959|NCT01283971|1114379|P2|Overall Study|Protocol Violation|1
329960|NCT01283971|1114380|P1|Overall Study|Protocol Violation|5
329961|NCT01283971|1114379|P2|Overall Study|Insufficient therapeutic responses|3
329962|NCT01283971|1114380|P1|Overall Study|Insufficient therapeutic responses|3
329963|NCT01283971|1114379|P2|Overall Study|Adverse Event|5
329964|NCT01283971|1114380|P1|Overall Study|Adverse Event|3
329965|NCT01283581|1114427|P3|Overall Study|"Early termination"|1
329966|NCT01283581|1114428|P2|Overall Study|"Early termination"|0
329967|NCT01283581|1114429|P1|Overall Study|"Early termination"|0
329968|NCT01283581|1114427|P3|Overall Study|Investigator unblinded|1
329969|NCT01283581|1114428|P2|Overall Study|Investigator unblinded|0
329970|NCT01283581|1114429|P1|Overall Study|Investigator unblinded|0
329971|NCT01283581|1114427|P3|Overall Study|Noncompliance|0
329972|NCT01283581|1114428|P2|Overall Study|Noncompliance|0
329973|NCT01283581|1114429|P1|Overall Study|Noncompliance|1
329974|NCT01283581|1114427|P3|Overall Study|Protocol Violation|2
329975|NCT01283581|1114428|P2|Overall Study|Protocol Violation|1
329976|NCT01283581|1114429|P1|Overall Study|Protocol Violation|0
329977|NCT01283581|1114427|P3|Overall Study|Physician Decision|2
329978|NCT01283581|1114428|P2|Overall Study|Physician Decision|1
329979|NCT01283581|1114429|P1|Overall Study|Physician Decision|0
329980|NCT01283581|1114427|P3|Overall Study|Adverse Event|4
329981|NCT01283581|1114428|P2|Overall Study|Adverse Event|1
329982|NCT01283581|1114429|P1|Overall Study|Adverse Event|1
329983|NCT01283581|1114427|P3|Overall Study|Withdrawal by Subject|2
329984|NCT01283581|1114428|P2|Overall Study|Withdrawal by Subject|5
329985|NCT01283581|1114429|P1|Overall Study|Withdrawal by Subject|2
329986|NCT01283581|1114427|P3|Overall Study|Lost to Follow-up|8
329987|NCT01283581|1114428|P2|Overall Study|Lost to Follow-up|6
329988|NCT01283581|1114429|P1|Overall Study|Lost to Follow-up|8
329989|NCT01283516|1114493|P9|Overall Study|Withdrawal by Subject|11
329990|NCT01283516|1114494|P8|Overall Study|Withdrawal by Subject|0
329991|NCT01283516|1114495|P7|Overall Study|Withdrawal by Subject|0
329992|NCT01283516|1114496|P6|Overall Study|Withdrawal by Subject|0
329993|NCT01283516|1114497|P5|Overall Study|Withdrawal by Subject|1
329994|NCT01283516|1114498|P4|Overall Study|Withdrawal by Subject|0
329995|NCT01283516|1114499|P3|Overall Study|Withdrawal by Subject|0
329996|NCT01283516|1114500|P2|Overall Study|Withdrawal by Subject|0
329997|NCT01283516|1114501|P1|Overall Study|Withdrawal by Subject|0
329998|NCT01283516|1114493|P9|Overall Study|Disease Progression|81
329999|NCT01283516|1114494|P8|Overall Study|Disease Progression|2
330000|NCT01283516|1114495|P7|Overall Study|Disease Progression|6
330001|NCT01283516|1114496|P6|Overall Study|Disease Progression|7
330002|NCT01283516|1114497|P5|Overall Study|Disease Progression|12
330003|NCT01283516|1114498|P4|Overall Study|Disease Progression|3
330004|NCT01283516|1114499|P3|Overall Study|Disease Progression|2
330005|NCT01283516|1114500|P2|Overall Study|Disease Progression|2
330006|NCT01283516|1114501|P1|Overall Study|Disease Progression|2
330007|NCT01283516|1114493|P9|Overall Study|Death|6
330008|NCT01283516|1114494|P8|Overall Study|Death|1
330009|NCT01283516|1114495|P7|Overall Study|Death|0
330010|NCT01283516|1114496|P6|Overall Study|Death|1
330011|NCT01283516|1114497|P5|Overall Study|Death|0
330012|NCT01283516|1114498|P4|Overall Study|Death|0
330013|NCT01283516|1114499|P3|Overall Study|Death|0
330014|NCT01283516|1114500|P2|Overall Study|Death|0
330015|NCT01283516|1114501|P1|Overall Study|Death|0
330016|NCT01283516|1114493|P9|Overall Study|Adverse Event|24
330017|NCT01283516|1114494|P8|Overall Study|Adverse Event|0
330018|NCT01283516|1114495|P7|Overall Study|Adverse Event|2
330019|NCT01283516|1114496|P6|Overall Study|Adverse Event|0
330020|NCT01283516|1114497|P5|Overall Study|Adverse Event|0
330021|NCT01283516|1114498|P4|Overall Study|Adverse Event|0
330022|NCT01283516|1114499|P3|Overall Study|Adverse Event|0
330023|NCT01283516|1114500|P2|Overall Study|Adverse Event|0
330024|NCT01283516|1114501|P1|Overall Study|Adverse Event|0
330025|NCT01283464|1114525|P2|Overall Study|Physician Decision|0
330026|NCT01283464|1114526|P1|Overall Study|Physician Decision|1
330027|NCT01283464|1114525|P2|Overall Study|Withdrawal by Subject|0
330028|NCT01283464|1114526|P1|Overall Study|Withdrawal by Subject|1
330029|NCT01283464|1114525|P2|Overall Study|Lost to Follow-up|1
330030|NCT01283464|1114526|P1|Overall Study|Lost to Follow-up|0
330031|NCT01283334|1114532|P1|Overall Study|Physician Decision|1
330032|NCT01283334|1114532|P1|Overall Study|Adverse Event|4
330033|NCT01283334|1114532|P1|Overall Study|Inability to Swallow Everolimus Pills|1
330034|NCT01283334|1114532|P1|Overall Study|Withdrawal by Subject|1
330035|NCT01283282|1114555|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
330036|NCT01283282|1114556|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
330037|NCT01283282|1114555|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
330038|NCT01283282|1114556|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
330039|NCT01283282|1114555|P2|First Intervention (6 Weeks)|Physician Decision|1
330040|NCT01283282|1114556|P1|First Intervention (6 Weeks)|Physician Decision|0
330041|NCT01283152|1114576|P2|Overall Study|Refused HESA|0
330042|NCT01283152|1114577|P1|Overall Study|Refused HESA|1
330043|NCT01283152|1114576|P2|Overall Study|Discharged prior to 24 hr assessment|0
330044|NCT01283152|1114577|P1|Overall Study|Discharged prior to 24 hr assessment|1
330045|NCT01283139|1114591|P4|Overall Study|Participant randomized in error|0
330046|NCT01283139|1114592|P3|Overall Study|Participant randomized in error|1
330047|NCT01283139|1114593|P2|Overall Study|Participant randomized in error|0
330048|NCT01283139|1114594|P1|Overall Study|Participant randomized in error|0
330049|NCT01283139|1114591|P4|Overall Study|Missed follow-up visit|2
330050|NCT01283139|1114592|P3|Overall Study|Missed follow-up visit|2
330051|NCT01283139|1114593|P2|Overall Study|Missed follow-up visit|1
330052|NCT01283139|1114594|P1|Overall Study|Missed follow-up visit|0
330053|NCT01283139|1114591|P4|Overall Study|Pregnancy|0
330054|NCT01283139|1114592|P3|Overall Study|Pregnancy|1
330055|NCT01283139|1114593|P2|Overall Study|Pregnancy|1
330056|NCT01283139|1114594|P1|Overall Study|Pregnancy|0
330057|NCT01283139|1114591|P4|Overall Study|Participant's refusal to continue|1
330058|NCT01283139|1114592|P3|Overall Study|Participant's refusal to continue|1
330059|NCT01283139|1114593|P2|Overall Study|Participant's refusal to continue|3
330060|NCT01283139|1114594|P1|Overall Study|Participant's refusal to continue|0
330061|NCT01283139|1114591|P4|Overall Study|Early termination due to AE/SAE|0
330062|NCT01283139|1114592|P3|Overall Study|Early termination due to AE/SAE|0
330063|NCT01283139|1114593|P2|Overall Study|Early termination due to AE/SAE|1
330064|NCT01283139|1114594|P1|Overall Study|Early termination due to AE/SAE|1
330065|NCT01283139|1114591|P4|Overall Study|Lack of Efficacy|1
330066|NCT01283139|1114592|P3|Overall Study|Lack of Efficacy|2
330067|NCT01283139|1114593|P2|Overall Study|Lack of Efficacy|2
330068|NCT01283139|1114594|P1|Overall Study|Lack of Efficacy|1
330069|NCT01283139|1114591|P4|Overall Study|Death|2
330070|NCT01283139|1114592|P3|Overall Study|Death|2
330071|NCT01283139|1114593|P2|Overall Study|Death|0
330072|NCT01283139|1114594|P1|Overall Study|Death|2
330073|NCT01283139|1114591|P4|Overall Study|Withdrawal by Subject|8
330074|NCT01283139|1114592|P3|Overall Study|Withdrawal by Subject|6
330075|NCT01283139|1114593|P2|Overall Study|Withdrawal by Subject|8
330076|NCT01283139|1114594|P1|Overall Study|Withdrawal by Subject|8
330077|NCT01283139|1114591|P4|Overall Study|Lost to Follow-up|1
330078|NCT01283139|1114592|P3|Overall Study|Lost to Follow-up|3
330079|NCT01283139|1114593|P2|Overall Study|Lost to Follow-up|2
330080|NCT01283139|1114594|P1|Overall Study|Lost to Follow-up|5
330081|NCT01283035|1114636|P1|Overall Study|Subject later found ineligible|1
330082|NCT01282866|1114651|P1|Overall Study|Adverse Event|1
330083|NCT01282814|1114659|P2|Washout of 7 Days|Withdrawal by Subject|0
330084|NCT01282814|1114660|P1|Washout of 7 Days|Withdrawal by Subject|2
330085|NCT01282814|1114659|P2|First Intervention|Emesis During Dosing Interval|3
330086|NCT01282814|1114660|P1|First Intervention|Emesis During Dosing Interval|0
330087|NCT01282801|1114672|P2|Second Intervention|Emesis During Critical Breakfast|1
330088|NCT01282801|1114673|P1|Second Intervention|Emesis During Critical Breakfast|0
330089|NCT01282476|1114697|P1|Overall Study|Death|11
330090|NCT01282424|1114703|P1|Overall Study|Investigator Request|7
330091|NCT01282424|1114703|P1|Overall Study|Withdrew Consent|4
330092|NCT01282424|1114703|P1|Overall Study|Adverse Event|25
330093|NCT01282424|1114703|P1|Overall Study|Treatment Ongoing|40
330094|NCT01282372|1114720|P1|Overall Study|Adverse Event|12
330095|NCT01282372|1114720|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
330096|NCT01282372|1114720|P1|Overall Study|Presence of AE, Regression of Symptoms|1
330097|NCT01282372|1114720|P1|Overall Study|Presence of AE, Lack of Efficacy|1
330098|NCT01282372|1114720|P1|Overall Study|Death|1
330099|NCT01282372|1114720|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
330100|NCT01282372|1114720|P1|Overall Study|Withdrawal by Subject|11
330101|NCT01282372|1114720|P1|Overall Study|Lost to Follow-up|23
330102|NCT01282372|1114720|P1|Overall Study|Lack of Efficacy / Exacerbation|25
330103|NCT01282294|1114748|P1|Overall Study|Physician Decision|1
330104|NCT01282294|1114748|P1|Overall Study|Patient non-compliance|2
330105|NCT01282294|1114748|P1|Overall Study|Adverse Event|1
330106|NCT01282294|1114748|P1|Overall Study|Screening failure|1
330107|NCT01282294|1114748|P1|Overall Study|Lost to Follow-up|14
330108|NCT01282229|1114777|P1|Overall Study|Protocol Violation|2
330109|NCT01282203|1114807|P1|Overall Study|Adverse Event|1
330110|NCT01282164|1114829|P2|Overall Study|Lack of hypoglycemia during ITT|0
330111|NCT01282164|1114830|P1|Overall Study|Lack of hypoglycemia during ITT|1
330112|NCT01281917|1114881|P1|Overall Study|Withdrawal by Subject|1
330113|NCT01281865|1114893|P2|Overall Study|Lack of Efficacy|0
330114|NCT01281865|1114894|P1|Overall Study|Lack of Efficacy|1
330115|NCT01281865|1114893|P2|Overall Study|Withdrawal by Subject|0
330116|NCT01281865|1114894|P1|Overall Study|Withdrawal by Subject|1
330117|NCT01281865|1114893|P2|Overall Study|Adverse Event|1
330118|NCT01281865|1114894|P1|Overall Study|Adverse Event|1
330119|NCT01281839|1114902|P2|Overall Study|Reason not specified|1
330120|NCT01281839|1114903|P1|Overall Study|Reason not specified|0
330121|NCT01281839|1114902|P2|Overall Study|Withdrawal by Subject|10
330122|NCT01281839|1114903|P1|Overall Study|Withdrawal by Subject|4
330123|NCT01281839|1114902|P2|Overall Study|Lost to Follow-up|3
330124|NCT01281839|1114903|P1|Overall Study|Lost to Follow-up|6
330125|NCT01281644|1114964|P1|Overall Study|Withdrawal by Subject|2
330126|NCT01281644|1114964|P1|Overall Study|Lost to Follow-up|3
330127|NCT01281306|1115005|P7|Overall Study|Randomized in error|0
330128|NCT01281306|1115006|P6|Overall Study|Randomized in error|0
330129|NCT01281306|1115007|P5|Overall Study|Randomized in error|0
330130|NCT01281306|1115008|P4|Overall Study|Randomized in error|1
330131|NCT01281306|1115009|P3|Overall Study|Randomized in error|0
330132|NCT01281306|1115010|P2|Overall Study|Randomized in error|0
330133|NCT01281306|1115011|P1|Overall Study|Randomized in error|1
330134|NCT01281306|1115005|P7|Overall Study|Adverse Event|3
330135|NCT01281306|1115006|P6|Overall Study|Adverse Event|3
330136|NCT01281306|1115007|P5|Overall Study|Adverse Event|5
330137|NCT01281306|1115008|P4|Overall Study|Adverse Event|3
330138|NCT01281306|1115009|P3|Overall Study|Adverse Event|2
330139|NCT01281306|1115010|P2|Overall Study|Adverse Event|2
330140|NCT01281306|1115011|P1|Overall Study|Adverse Event|3
330141|NCT01281306|1115005|P7|Overall Study|Death|0
330142|NCT01281306|1115006|P6|Overall Study|Death|0
330143|NCT01281306|1115007|P5|Overall Study|Death|0
330144|NCT01281306|1115008|P4|Overall Study|Death|0
330145|NCT01281306|1115009|P3|Overall Study|Death|0
330146|NCT01281306|1115010|P2|Overall Study|Death|0
330147|NCT01281306|1115011|P1|Overall Study|Death|1
330148|NCT01281306|1115005|P7|Overall Study|Lost to Follow-up|1
330149|NCT01281306|1115006|P6|Overall Study|Lost to Follow-up|0
330150|NCT01281306|1115007|P5|Overall Study|Lost to Follow-up|0
330151|NCT01281306|1115008|P4|Overall Study|Lost to Follow-up|2
330152|NCT01281306|1115009|P3|Overall Study|Lost to Follow-up|0
330153|NCT01281306|1115010|P2|Overall Study|Lost to Follow-up|0
330154|NCT01281306|1115011|P1|Overall Study|Lost to Follow-up|1
330155|NCT01281306|1115005|P7|Overall Study|Condition no longer requires study drug|1
330156|NCT01281306|1115006|P6|Overall Study|Condition no longer requires study drug|1
330157|NCT01281306|1115007|P5|Overall Study|Condition no longer requires study drug|0
330158|NCT01281306|1115008|P4|Overall Study|Condition no longer requires study drug|0
330159|NCT01281306|1115009|P3|Overall Study|Condition no longer requires study drug|0
330160|NCT01281306|1115010|P2|Overall Study|Condition no longer requires study drug|0
330161|NCT01281306|1115011|P1|Overall Study|Condition no longer requires study drug|1
330162|NCT01281306|1115005|P7|Overall Study|Protocol deviation|0
330163|NCT01281306|1115006|P6|Overall Study|Protocol deviation|0
330164|NCT01281306|1115007|P5|Overall Study|Protocol deviation|1
330165|NCT01281306|1115008|P4|Overall Study|Protocol deviation|1
330166|NCT01281306|1115009|P3|Overall Study|Protocol deviation|1
330167|NCT01281306|1115010|P2|Overall Study|Protocol deviation|1
330168|NCT01281306|1115011|P1|Overall Study|Protocol deviation|0
330169|NCT01281306|1115005|P7|Overall Study|Withdrawal by Subject|1
330170|NCT01281306|1115006|P6|Overall Study|Withdrawal by Subject|3
330171|NCT01281306|1115007|P5|Overall Study|Withdrawal by Subject|1
330172|NCT01281306|1115008|P4|Overall Study|Withdrawal by Subject|4
330173|NCT01281306|1115009|P3|Overall Study|Withdrawal by Subject|2
330174|NCT01281306|1115010|P2|Overall Study|Withdrawal by Subject|0
330175|NCT01281306|1115011|P1|Overall Study|Withdrawal by Subject|1
330176|NCT01281306|1115005|P7|Overall Study|Lack of Efficacy|1
330177|NCT01281306|1115006|P6|Overall Study|Lack of Efficacy|0
330178|NCT01281306|1115007|P5|Overall Study|Lack of Efficacy|2
330179|NCT01281306|1115008|P4|Overall Study|Lack of Efficacy|0
330180|NCT01281306|1115009|P3|Overall Study|Lack of Efficacy|3
330181|NCT01281306|1115010|P2|Overall Study|Lack of Efficacy|1
330182|NCT01281306|1115011|P1|Overall Study|Lack of Efficacy|0
330183|NCT01281202|1115127|P2|Overall Study|Incarceration|3
330184|NCT01281202|1115128|P1|Overall Study|Incarceration|0
330185|NCT01281202|1115127|P2|Overall Study|Lost to Follow-up|13
330186|NCT01281202|1115128|P1|Overall Study|Lost to Follow-up|11
330187|NCT01281202|1115127|P2|Overall Study|Administrative|8
330188|NCT01281202|1115128|P1|Overall Study|Administrative|2
330189|NCT01281202|1115127|P2|Overall Study|Protocol Violation|10
330190|NCT01281202|1115128|P1|Overall Study|Protocol Violation|11
330191|NCT01281202|1115127|P2|Overall Study|Withdrawal by Subject|2
330192|NCT01281202|1115128|P1|Overall Study|Withdrawal by Subject|2
330193|NCT01281202|1115127|P2|Overall Study|Adverse Event|0
330194|NCT01281202|1115128|P1|Overall Study|Adverse Event|2
330195|NCT01281124|1115136|P1|Overall Study|Death|1
330196|NCT01280981|1115151|P1|Overall Study|Study site closure|1
330197|NCT01280981|1115151|P1|Overall Study|Elective surgery|2
330198|NCT01280981|1115151|P1|Overall Study|Withdrawal of consent|3
330199|NCT01280981|1115151|P1|Overall Study|Non-compliance with protocol|3
330200|NCT01280981|1115151|P1|Overall Study|Failed to return|45
330201|NCT01280981|1115151|P1|Overall Study|Irregular or discontinued menses|3
330202|NCT01280981|1115151|P1|Overall Study|Adverse Event|6
330203|NCT01280981|1115151|P1|Overall Study|Lost to Follow-up|3
330204|NCT01280981|1115151|P1|Overall Study|Lack of Efficacy|13
330205|NCT01280981|1115151|P1|Overall Study|Protocol Violation|2
330206|NCT01280981|1115151|P1|Overall Study|Withdrawal by Subject|11
330207|NCT01280968|1115162|P2|Overall Study|Unable to Smoke in Supine Position|0
330208|NCT01280968|1115163|P1|Overall Study|Unable to Smoke in Supine Position|1
330209|NCT01280968|1115162|P2|Overall Study|Pre-existing Neurological Condition|0
330210|NCT01280968|1115163|P1|Overall Study|Pre-existing Neurological Condition|1
330211|NCT01280968|1115162|P2|Overall Study|Scheduling Conflicts|1
330212|NCT01280968|1115163|P1|Overall Study|Scheduling Conflicts|1
330213|NCT01280968|1115162|P2|Overall Study|Adverse Event|0
330214|NCT01280968|1115163|P1|Overall Study|Adverse Event|1
330215|NCT01280968|1115162|P2|Overall Study|Anxiety|0
330216|NCT01280968|1115163|P1|Overall Study|Anxiety|2
330217|NCT01280968|1115162|P2|Overall Study|Commuting Problems|0
330218|NCT01280968|1115163|P1|Overall Study|Commuting Problems|2
330219|NCT01280968|1115162|P2|Overall Study|Unable to Follow Experimental Protocol|0
330220|NCT01280968|1115163|P1|Overall Study|Unable to Follow Experimental Protocol|2
330221|NCT01280968|1115162|P2|Overall Study|Lost to Follow-up|2
330222|NCT01280968|1115163|P1|Overall Study|Lost to Follow-up|8
330223|NCT01280955|1115179|P1|Overall Study|Withdrawal by Subject|1
330224|NCT01280955|1115179|P1|Overall Study|Death|2
330225|NCT01280903|1115223|P2|Overall Study|Lost to Follow-up|16
330226|NCT01280903|1115224|P1|Overall Study|Lost to Follow-up|23
330227|NCT01280656|1115337|P3|Overall Study|Other|7
330228|NCT01280656|1115338|P2|Overall Study|Other|7
330229|NCT01280656|1115339|P1|Overall Study|Other|1
330230|NCT01280656|1115337|P3|Overall Study|Treatment shortening (RGT)|5
330231|NCT01280656|1115338|P2|Overall Study|Treatment shortening (RGT)|4
330232|NCT01280656|1115339|P1|Overall Study|Treatment shortening (RGT)|0
330233|NCT01280656|1115337|P3|Overall Study|Lack of Efficacy|38
330234|NCT01280656|1115338|P2|Overall Study|Lack of Efficacy|22
330235|NCT01280656|1115339|P1|Overall Study|Lack of Efficacy|1
330236|NCT01280656|1115337|P3|Overall Study|Adverse Event|13
330237|NCT01280656|1115338|P2|Overall Study|Adverse Event|14
330238|NCT01280656|1115339|P1|Overall Study|Adverse Event|1
330239|NCT01280591|1115406|P4|Overall Study|Does not meet exclusion #27 criteria|1
330240|NCT01280591|1115407|P3|Overall Study|Does not meet exclusion #27 criteria|0
330241|NCT01280591|1115408|P2|Overall Study|Does not meet exclusion #27 criteria|0
330242|NCT01280591|1115409|P1|Overall Study|Does not meet exclusion #27 criteria|0
330243|NCT01280591|1115406|P4|Overall Study|Withdrawal by Subject|2
330244|NCT01280591|1115407|P3|Overall Study|Withdrawal by Subject|0
330245|NCT01280591|1115408|P2|Overall Study|Withdrawal by Subject|0
330246|NCT01280591|1115409|P1|Overall Study|Withdrawal by Subject|0
330247|NCT01280357|1115514|P1|Overall Study|IInsufficient data/No data supplied|12
330248|NCT01280357|1115514|P1|Overall Study|Excluded no internal monitoring|14
330249|NCT01280266|1115523|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
330250|NCT01280266|1115524|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
330251|NCT01280266|1115523|P2|First Intervention (Week 1-4)|Adverse Event|0
330252|NCT01280266|1115524|P1|First Intervention (Week 1-4)|Adverse Event|1
330253|NCT01279681|1115606|P2|Overall Study|Other Reason|2
330254|NCT01279681|1115607|P1|Overall Study|Other Reason|0
330255|NCT01279681|1115606|P2|Overall Study|Physician Decision|0
330256|NCT01279681|1115607|P1|Overall Study|Physician Decision|1
330257|NCT01279681|1115606|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
330258|NCT01279681|1115607|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
330259|NCT01279681|1115606|P2|Overall Study|Death|1
330260|NCT01279681|1115607|P1|Overall Study|Death|0
330261|NCT01279681|1115606|P2|Overall Study|Adverse Event|3
330262|NCT01279681|1115607|P1|Overall Study|Adverse Event|2
330263|NCT01279681|1115606|P2|Overall Study|Withdrawal by Subject|4
330264|NCT01279681|1115607|P1|Overall Study|Withdrawal by Subject|3
330265|NCT01279681|1115606|P2|Overall Study|Disease Progression|6
330266|NCT01279681|1115607|P1|Overall Study|Disease Progression|9
330267|NCT01279447|1115630|P2|Overall Study|Lost to Follow-up|1
330268|NCT01279447|1115631|P1|Overall Study|Lost to Follow-up|3
330269|NCT01279200|1115658|P2|Overall Study|Adverse Event|0
330270|NCT01279200|1115659|P1|Overall Study|Adverse Event|1
330271|NCT01279200|1115658|P2|Overall Study|Lost to Follow-up|1
330272|NCT01279200|1115659|P1|Overall Study|Lost to Follow-up|0
330273|NCT01279200|1115658|P2|Overall Study|ultrasound screening failure|1
330274|NCT01279200|1115659|P1|Overall Study|ultrasound screening failure|0
330275|NCT01279200|1115658|P2|Overall Study|Inconvenience of ultrasound visit|1
330276|NCT01279200|1115659|P1|Overall Study|Inconvenience of ultrasound visit|0
330277|NCT01279200|1115658|P2|Overall Study|Patient withdrawal due to high cost|1
330278|NCT01279200|1115659|P1|Overall Study|Patient withdrawal due to high cost|0
330279|NCT01279200|1115658|P2|Overall Study|Withdrawal by Subject|3
330280|NCT01279200|1115659|P1|Overall Study|Withdrawal by Subject|1
330281|NCT01279070|1115697|P2|Overall Study|Acute exacerbation|1
330282|NCT01279070|1115698|P1|Overall Study|Acute exacerbation|3
330283|NCT01279070|1115697|P2|Overall Study|Withdrawal by Subject|3
330284|NCT01279070|1115698|P1|Overall Study|Withdrawal by Subject|2
330285|NCT01279044|1115717|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
330286|NCT01279044|1115718|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
330287|NCT01279044|1115719|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
330288|NCT01279044|1115717|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
330289|NCT01279044|1115718|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
330290|NCT01279044|1115719|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
330291|NCT01279044|1115717|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
330292|NCT01279044|1115718|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
330293|NCT01279044|1115719|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
330294|NCT01278797|1115793|P2|Period 1|Protocol Violation|0
330295|NCT01278797|1115794|P1|Period 1|Protocol Violation|1
330296|NCT01278797|1115793|P2|Period 1|Adverse Event|1
330297|NCT01278797|1115794|P1|Period 1|Adverse Event|0
330298|NCT01278745|1115806|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
330299|NCT01278745|1115807|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
330300|NCT01278745|1115808|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
330301|NCT01278745|1115809|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
330302|NCT01278745|1115806|P4|Overall Study|Ineligible|61
330303|NCT01278745|1115807|P3|Overall Study|Ineligible|42
330304|NCT01278745|1115808|P2|Overall Study|Ineligible|0
330305|NCT01278745|1115809|P1|Overall Study|Ineligible|0
330306|NCT01278745|1115806|P4|Overall Study|Sponsor Decision|6
330307|NCT01278745|1115807|P3|Overall Study|Sponsor Decision|62
330308|NCT01278745|1115808|P2|Overall Study|Sponsor Decision|0
330309|NCT01278745|1115809|P1|Overall Study|Sponsor Decision|1
330310|NCT01278745|1115806|P4|Overall Study|Withdrawal by Subject|1
330311|NCT01278745|1115807|P3|Overall Study|Withdrawal by Subject|5
330312|NCT01278745|1115808|P2|Overall Study|Withdrawal by Subject|1
330313|NCT01278745|1115809|P1|Overall Study|Withdrawal by Subject|1
330314|NCT01278745|1115806|P4|Overall Study|Physician Decision|9
330315|NCT01278745|1115807|P3|Overall Study|Physician Decision|0
330316|NCT01278745|1115808|P2|Overall Study|Physician Decision|0
330317|NCT01278745|1115809|P1|Overall Study|Physician Decision|1
330318|NCT01278745|1115806|P4|Overall Study|Death|0
330319|NCT01278745|1115807|P3|Overall Study|Death|7
330320|NCT01278745|1115808|P2|Overall Study|Death|5
330321|NCT01278745|1115809|P1|Overall Study|Death|2
330322|NCT01278615|1115841|P1|Overall Study|Withdrawal by Subject|2
330323|NCT01278407|1115867|P5|Extension Phase|Not Specified|3
330324|NCT01278407|1115868|P4|Extension Phase|Not Specified|1
330325|NCT01278407|1115869|P3|Extension Phase|Not Specified|0
330326|NCT01278407|1115870|P2|Extension Phase|Not Specified|0
330327|NCT01278407|1115871|P1|Extension Phase|Not Specified|0
330328|NCT01278407|1115867|P5|Extension Phase|Participant's Choice|11
330329|NCT01278407|1115868|P4|Extension Phase|Participant's Choice|4
330330|NCT01278407|1115869|P3|Extension Phase|Participant's Choice|0
330331|NCT01278407|1115870|P2|Extension Phase|Participant's Choice|0
330332|NCT01278407|1115871|P1|Extension Phase|Participant's Choice|0
330333|NCT01278407|1115867|P5|Extension Phase|Adverse Event|16
330334|NCT01278407|1115868|P4|Extension Phase|Adverse Event|7
330335|NCT01278407|1115869|P3|Extension Phase|Adverse Event|0
330336|NCT01278407|1115870|P2|Extension Phase|Adverse Event|0
330337|NCT01278407|1115871|P1|Extension Phase|Adverse Event|0
330338|NCT01278407|1115867|P5|Confirmatory Phase|Not Specified|0
330339|NCT01278407|1115868|P4|Confirmatory Phase|Not Specified|0
330340|NCT01278407|1115869|P3|Confirmatory Phase|Not Specified|2
330341|NCT01278407|1115870|P2|Confirmatory Phase|Not Specified|1
330342|NCT01278407|1115871|P1|Confirmatory Phase|Not Specified|1
330343|NCT01278407|1115867|P5|Confirmatory Phase|Participant's Choice|0
330344|NCT01278407|1115868|P4|Confirmatory Phase|Participant's Choice|0
330345|NCT01278407|1115869|P3|Confirmatory Phase|Participant's Choice|3
330346|NCT01278407|1115870|P2|Confirmatory Phase|Participant's Choice|5
330347|NCT01278407|1115871|P1|Confirmatory Phase|Participant's Choice|3
330348|NCT01278407|1115867|P5|Confirmatory Phase|Adverse Event|0
330349|NCT01278407|1115868|P4|Confirmatory Phase|Adverse Event|0
330350|NCT01278407|1115869|P3|Confirmatory Phase|Adverse Event|1
330351|NCT01278407|1115870|P2|Confirmatory Phase|Adverse Event|10
330352|NCT01278407|1115871|P1|Confirmatory Phase|Adverse Event|5
330353|NCT01278394|1115884|P1|Overall Study|Lost to Follow-up|1
330354|NCT01278342|1115897|P3|Overall Study|Other|0
330355|NCT01278342|1115898|P2|Overall Study|Other|0
330356|NCT01278342|1115899|P1|Overall Study|Other|1
330357|NCT01278342|1115897|P3|Overall Study|Administrative problems|0
330358|NCT01278342|1115898|P2|Overall Study|Administrative problems|0
330359|NCT01278342|1115899|P1|Overall Study|Administrative problems|2
330360|NCT01278342|1115897|P3|Overall Study|Lost to Follow-up|0
330361|NCT01278342|1115898|P2|Overall Study|Lost to Follow-up|0
330362|NCT01278342|1115899|P1|Overall Study|Lost to Follow-up|1
330363|NCT01278342|1115897|P3|Overall Study|Physician Decision|0
330364|NCT01278342|1115898|P2|Overall Study|Physician Decision|1
330365|NCT01278342|1115899|P1|Overall Study|Physician Decision|0
330366|NCT01278173|1115919|P1|Overall Study|Withdrawal by Subject|1
330367|NCT01278173|1115919|P1|Overall Study|Protocol Violation|1
330368|NCT01278173|1115919|P1|Overall Study|Administrative or other reason|4
330369|NCT01278173|1115919|P1|Overall Study|Adverse Event|8
330370|NCT01278173|1115919|P1|Overall Study|Lack of Efficacy|13
330371|NCT01278160|1115926|P2|Overall Study|Unclassified|2
330372|NCT01278160|1115927|P1|Overall Study|Unclassified|1
330373|NCT01278160|1115926|P2|Overall Study|Withdrawal by Subject|2
330374|NCT01278160|1115927|P1|Overall Study|Withdrawal by Subject|3
330375|NCT01278160|1115926|P2|Overall Study|Lost to Follow-up|1
330376|NCT01278160|1115927|P1|Overall Study|Lost to Follow-up|0
330377|NCT01278160|1115926|P2|Overall Study|Adverse Event|1
330378|NCT01278160|1115927|P1|Overall Study|Adverse Event|1
330379|NCT01278030|1115943|P2|Overall Study|Withdrawal by Subject|4
330380|NCT01278030|1115944|P1|Overall Study|Withdrawal by Subject|8
330381|NCT01277887|1115952|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
330382|NCT01277887|1115953|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
330383|NCT01277887|1115952|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
330384|NCT01277887|1115953|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
330385|NCT01277887|1115952|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
330386|NCT01277887|1115953|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
330387|NCT01277861|1115965|P2|Overall Study|Physician Decision|2
330388|NCT01277861|1115966|P1|Overall Study|Physician Decision|2
330389|NCT01277822|1115978|P2|Overall Study|Participant moved|0
330390|NCT01277822|1115979|P1|Overall Study|Participant moved|1
330391|NCT01277822|1115978|P2|Overall Study|Contraindicated medication used|1
330392|NCT01277822|1115979|P1|Overall Study|Contraindicated medication used|2
330393|NCT01277822|1115978|P2|Overall Study|Lost to Follow-up|1
330394|NCT01277822|1115979|P1|Overall Study|Lost to Follow-up|2
330395|NCT01277822|1115978|P2|Overall Study|Protocol Violation|0
330396|NCT01277822|1115979|P1|Overall Study|Protocol Violation|1
330397|NCT01277822|1115978|P2|Overall Study|Physician Decision|1
330398|NCT01277822|1115979|P1|Overall Study|Physician Decision|1
330399|NCT01277822|1115978|P2|Overall Study|Withdrawal by Subject|7
330400|NCT01277822|1115979|P1|Overall Study|Withdrawal by Subject|6
330401|NCT01277822|1115978|P2|Overall Study|Adverse Event|1
330402|NCT01277822|1115979|P1|Overall Study|Adverse Event|2
330403|NCT01277757|1115999|P1|Overall Study|Withdrawal by Subject|1
330404|NCT01277757|1115999|P1|Overall Study|Disease Progression|1
330405|NCT01277718|1116006|P2|Period 2 - Second Intervention|Physician Decision|2
330406|NCT01277718|1116007|P1|Period 2 - Second Intervention|Physician Decision|0
330407|NCT01277718|1116006|P2|Period 2 - Second Intervention|Protocol Violation|1
330408|NCT01277718|1116007|P1|Period 2 - Second Intervention|Protocol Violation|0
330409|NCT01277666|1116021|P3|Overall Study|Death|1
330410|NCT01277666|1116022|P2|Overall Study|Death|0
330411|NCT01277666|1116023|P1|Overall Study|Death|0
330412|NCT01277666|1116021|P3|Overall Study|Withdrawal by Subject|6
330413|NCT01277666|1116022|P2|Overall Study|Withdrawal by Subject|8
330414|NCT01277666|1116023|P1|Overall Study|Withdrawal by Subject|7
330415|NCT01277666|1116021|P3|Overall Study|Lost to Follow-up|2
330416|NCT01277666|1116022|P2|Overall Study|Lost to Follow-up|1
330417|NCT01277666|1116023|P1|Overall Study|Lost to Follow-up|1
330418|NCT01277666|1116021|P3|Overall Study|Protocol Defined Stopping criteria|6
330419|NCT01277666|1116022|P2|Overall Study|Protocol Defined Stopping criteria|2
330420|NCT01277666|1116023|P1|Overall Study|Protocol Defined Stopping criteria|1
330421|NCT01277666|1116021|P3|Overall Study|Protocol Violation|2
330422|NCT01277666|1116022|P2|Overall Study|Protocol Violation|3
330423|NCT01277666|1116023|P1|Overall Study|Protocol Violation|2
330424|NCT01277666|1116021|P3|Overall Study|Lack of Efficacy|12
330425|NCT01277666|1116022|P2|Overall Study|Lack of Efficacy|20
330426|NCT01277666|1116023|P1|Overall Study|Lack of Efficacy|8
330427|NCT01277666|1116021|P3|Overall Study|Adverse Event|20
330428|NCT01277666|1116022|P2|Overall Study|Adverse Event|25
330429|NCT01277666|1116023|P1|Overall Study|Adverse Event|26
330430|NCT01277601|1116056|P4|Overall Study|Subject Terminated from Study by Sponsor|2
330431|NCT01277601|1116057|P3|Overall Study|Subject Terminated from Study by Sponsor|0
330432|NCT01277601|1116058|P2|Overall Study|Subject Terminated from Study by Sponsor|1
330433|NCT01277601|1116059|P1|Overall Study|Subject Terminated from Study by Sponsor|0
330434|NCT01277601|1116056|P4|Overall Study|Protocol Violation|0
330435|NCT01277601|1116057|P3|Overall Study|Protocol Violation|5
330436|NCT01277601|1116058|P2|Overall Study|Protocol Violation|2
330437|NCT01277601|1116059|P1|Overall Study|Protocol Violation|0
330438|NCT01277601|1116056|P4|Overall Study|Subject Never Dosed with Study Drug|1
330439|NCT01277601|1116057|P3|Overall Study|Subject Never Dosed with Study Drug|3
330440|NCT01277601|1116058|P2|Overall Study|Subject Never Dosed with Study Drug|2
330441|NCT01277601|1116059|P1|Overall Study|Subject Never Dosed with Study Drug|1
330442|NCT01277601|1116056|P4|Overall Study|Noncompliance with Study Drug|0
330443|NCT01277601|1116057|P3|Overall Study|Noncompliance with Study Drug|2
330444|NCT01277601|1116058|P2|Overall Study|Noncompliance with Study Drug|3
330445|NCT01277601|1116059|P1|Overall Study|Noncompliance with Study Drug|1
330446|NCT01277601|1116056|P4|Overall Study|Pregnancy|1
330447|NCT01277601|1116057|P3|Overall Study|Pregnancy|4
330448|NCT01277601|1116058|P2|Overall Study|Pregnancy|2
330449|NCT01277601|1116059|P1|Overall Study|Pregnancy|2
330450|NCT01277601|1116056|P4|Overall Study|Physician Decision|6
330451|NCT01277601|1116057|P3|Overall Study|Physician Decision|1
330452|NCT01277601|1116058|P2|Overall Study|Physician Decision|5
330453|NCT01277601|1116059|P1|Overall Study|Physician Decision|3
330454|NCT01277601|1116056|P4|Overall Study|Lost to Follow-up|2
330455|NCT01277601|1116057|P3|Overall Study|Lost to Follow-up|4
330456|NCT01277601|1116058|P2|Overall Study|Lost to Follow-up|9
330457|NCT01277601|1116059|P1|Overall Study|Lost to Follow-up|7
330458|NCT01277601|1116056|P4|Overall Study|Withdrawal by Subject|17
330459|NCT01277601|1116057|P3|Overall Study|Withdrawal by Subject|8
330460|NCT01277601|1116058|P2|Overall Study|Withdrawal by Subject|21
330461|NCT01277601|1116059|P1|Overall Study|Withdrawal by Subject|18
330462|NCT01277601|1116056|P4|Overall Study|Adverse Event|7
330463|NCT01277601|1116057|P3|Overall Study|Adverse Event|0
330464|NCT01277601|1116058|P2|Overall Study|Adverse Event|3
330465|NCT01277601|1116059|P1|Overall Study|Adverse Event|5
330466|NCT01277549|1116150|P2|Overall Study|Physician Decision|1
330467|NCT01277549|1116151|P1|Overall Study|Physician Decision|2
330468|NCT01277549|1116150|P2|Overall Study|Protocol Violation|1
330469|NCT01277549|1116151|P1|Overall Study|Protocol Violation|10
330470|NCT01277549|1116150|P2|Overall Study|Withdrawal by Subject|3
330471|NCT01277549|1116151|P1|Overall Study|Withdrawal by Subject|1
330472|NCT01277549|1116150|P2|Overall Study|Failed to meet eligibility criteria|9
330473|NCT01277549|1116151|P1|Overall Study|Failed to meet eligibility criteria|13
330474|NCT01277523|1116168|P3|Overall Study|Other Reason not Defined|0
330475|NCT01277523|1116169|P2|Overall Study|Other Reason not Defined|1
330476|NCT01277523|1116170|P1|Overall Study|Other Reason not Defined|0
330477|NCT01277523|1116168|P3|Overall Study|Protocol Violation|0
330478|NCT01277523|1116169|P2|Overall Study|Protocol Violation|0
330479|NCT01277523|1116170|P1|Overall Study|Protocol Violation|2
330480|NCT01277523|1116168|P3|Overall Study|Adverse Event|0
330481|NCT01277523|1116169|P2|Overall Study|Adverse Event|0
330482|NCT01277523|1116170|P1|Overall Study|Adverse Event|1
330483|NCT01277510|1116222|P2|Open-label Phase|Never received investigational product|0
330484|NCT01277510|1116223|P1|Open-label Phase|Never received investigational product|2
330485|NCT01277510|1116222|P2|Open-label Phase|Protocol-specified criteria|0
330486|NCT01277510|1116223|P1|Open-label Phase|Protocol-specified criteria|1
330487|NCT01277510|1116222|P2|Open-label Phase|Administrative decision|3
330488|NCT01277510|1116223|P1|Open-label Phase|Administrative decision|4
330489|NCT01277510|1116222|P2|Double-blind Phase|Other|1
330490|NCT01277510|1116223|P1|Double-blind Phase|Other|1
330491|NCT01277510|1116222|P2|Double-blind Phase|Protocol-specified criteria|6
330492|NCT01277510|1116223|P1|Double-blind Phase|Protocol-specified criteria|2
330493|NCT01277510|1116222|P2|Double-blind Phase|Death|1
330494|NCT01277510|1116223|P1|Double-blind Phase|Death|0
330495|NCT01277510|1116222|P2|Double-blind Phase|Administrative decision|9
330496|NCT01277510|1116223|P1|Double-blind Phase|Administrative decision|7
330497|NCT01277510|1116222|P2|Double-blind Phase|Withdrawal by Subject|0
330498|NCT01277510|1116223|P1|Double-blind Phase|Withdrawal by Subject|2
330499|NCT01277510|1116222|P2|Double-blind Phase|Adverse Event|0
330500|NCT01277510|1116223|P1|Double-blind Phase|Adverse Event|1
330501|NCT01277510|1116222|P2|Double-blind Phase|Non-compliance|1
330502|NCT01277510|1116223|P1|Double-blind Phase|Non-compliance|0
330503|NCT01277302|1116257|P3|8-Month Alternate Dose Regimen Period|Relocation|1
330504|NCT01277302|1116258|P2|8-Month Alternate Dose Regimen Period|Relocation|0
330505|NCT01277302|1116259|P1|8-Month Alternate Dose Regimen Period|Relocation|1
330506|NCT01277302|1116257|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
330507|NCT01277302|1116258|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
330508|NCT01277302|1116259|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
330509|NCT01277302|1116257|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
330510|NCT01277302|1116258|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
330511|NCT01277302|1116259|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
330512|NCT01277302|1116257|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
330513|NCT01277302|1116258|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
330514|NCT01277302|1116259|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
330515|NCT01277302|1116257|P3|8-Month Alternate Dose Regimen Period|Death|0
330516|NCT01277302|1116258|P2|8-Month Alternate Dose Regimen Period|Death|1
330517|NCT01277302|1116259|P1|8-Month Alternate Dose Regimen Period|Death|0
330518|NCT01277302|1116257|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
330519|NCT01277302|1116258|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
330520|NCT01277302|1116259|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
330521|NCT01277302|1116257|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
330522|NCT01277302|1116258|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
330523|NCT01277302|1116259|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
330524|NCT01277302|1116257|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
330525|NCT01277302|1116258|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
330526|NCT01277302|1116259|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
330527|NCT01277302|1116257|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
330528|NCT01277302|1116258|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
330529|NCT01277302|1116259|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
330530|NCT01277211|1116291|P2|Overall Study|Discontinued prior to treatment|13
330531|NCT01277211|1116292|P1|Overall Study|Discontinued prior to treatment|24
330532|NCT01277211|1116291|P2|Overall Study|Pregnancy wish|2
330533|NCT01277211|1116292|P1|Overall Study|Pregnancy wish|0
330534|NCT01277211|1116291|P2|Overall Study|Administrative|0
330535|NCT01277211|1116292|P1|Overall Study|Administrative|3
330536|NCT01277211|1116291|P2|Overall Study|Did not meet protocol eligibility|0
330537|NCT01277211|1116292|P1|Overall Study|Did not meet protocol eligibility|1
330538|NCT01277211|1116291|P2|Overall Study|Non-compliance with protocol|4
330539|NCT01277211|1116292|P1|Overall Study|Non-compliance with protocol|13
330540|NCT01277211|1116291|P2|Overall Study|Withdrew Consent|9
330541|NCT01277211|1116292|P1|Overall Study|Withdrew Consent|9
330542|NCT01277211|1116291|P2|Overall Study|Did not wish to continue|0
330543|NCT01277211|1116292|P1|Overall Study|Did not wish to continue|17
330544|NCT01277211|1116291|P2|Overall Study|Lost to Follow-up|9
330545|NCT01277211|1116292|P1|Overall Study|Lost to Follow-up|14
330546|NCT01277211|1116291|P2|Overall Study|Pregnancy|4
330547|NCT01277211|1116292|P1|Overall Study|Pregnancy|9
330548|NCT01277211|1116291|P2|Overall Study|Adverse Event|22
330549|NCT01277211|1116292|P1|Overall Study|Adverse Event|60
330550|NCT01277042|1116344|P2|Overall Study|Withdrawal by Subject|0
330551|NCT01277042|1116345|P1|Overall Study|Withdrawal by Subject|2
330552|NCT01277042|1116344|P2|Overall Study|Lost to Follow-up|2
330553|NCT01277042|1116345|P1|Overall Study|Lost to Follow-up|2
330554|NCT01277042|1116344|P2|Overall Study|Adverse Event|3
330555|NCT01277042|1116345|P1|Overall Study|Adverse Event|4
330556|NCT01276847|1116370|P3|Overall Study|Withdrawal by Subject|0
330557|NCT01276847|1116371|P2|Overall Study|Withdrawal by Subject|0
330558|NCT01276847|1116372|P1|Overall Study|Withdrawal by Subject|1
330559|NCT01276821|1116382|P2|Overall Study|Protocol Violation|1
330560|NCT01276821|1116383|P1|Overall Study|Protocol Violation|0
330561|NCT01276756|1116403|P2|Overall Study|Adverse Event|2
330562|NCT01276756|1116404|P1|Overall Study|Adverse Event|3
330563|NCT01276756|1116403|P2|Overall Study|Lost to Follow-up|0
330564|NCT01276756|1116404|P1|Overall Study|Lost to Follow-up|2
330565|NCT01276639|1116449|P5|Week 16 to 52|Other|3
330566|NCT01276639|1116450|P4|Week 16 to 52|Other|1
330567|NCT01276639|1116451|P3|Week 16 to 52|Other|0
330568|NCT01276639|1116452|P2|Week 16 to 52|Other|12
330569|NCT01276639|1116453|P1|Week 16 to 52|Other|10
330570|NCT01276639|1116449|P5|Week 16 to 52|Withdrawal by Subject|1
330571|NCT01276639|1116450|P4|Week 16 to 52|Withdrawal by Subject|0
330572|NCT01276639|1116451|P3|Week 16 to 52|Withdrawal by Subject|0
330573|NCT01276639|1116452|P2|Week 16 to 52|Withdrawal by Subject|4
330574|NCT01276639|1116453|P1|Week 16 to 52|Withdrawal by Subject|4
330575|NCT01276639|1116449|P5|Week 16 to 52|Lost to Follow-up|1
330576|NCT01276639|1116450|P4|Week 16 to 52|Lost to Follow-up|0
330577|NCT01276639|1116451|P3|Week 16 to 52|Lost to Follow-up|0
330578|NCT01276639|1116452|P2|Week 16 to 52|Lost to Follow-up|1
330579|NCT01276639|1116453|P1|Week 16 to 52|Lost to Follow-up|3
330580|NCT01276639|1116449|P5|Week 16 to 52|Lack of Efficacy|13
330581|NCT01276639|1116450|P4|Week 16 to 52|Lack of Efficacy|14
330582|NCT01276639|1116451|P3|Week 16 to 52|Lack of Efficacy|0
330583|NCT01276639|1116452|P2|Week 16 to 52|Lack of Efficacy|71
330584|NCT01276639|1116453|P1|Week 16 to 52|Lack of Efficacy|99
330585|NCT01276639|1116449|P5|Week 16 to 52|Adverse Event|3
330586|NCT01276639|1116450|P4|Week 16 to 52|Adverse Event|1
330587|NCT01276639|1116451|P3|Week 16 to 52|Adverse Event|0
330588|NCT01276639|1116452|P2|Week 16 to 52|Adverse Event|13
330589|NCT01276639|1116453|P1|Week 16 to 52|Adverse Event|10
330590|NCT01276639|1116449|P5|Week 16 to 52|Death|0
330591|NCT01276639|1116450|P4|Week 16 to 52|Death|0
330592|NCT01276639|1116451|P3|Week 16 to 52|Death|0
330593|NCT01276639|1116452|P2|Week 16 to 52|Death|0
330594|NCT01276639|1116453|P1|Week 16 to 52|Death|1
330595|NCT01276639|1116449|P5|Week 0 to 16|Randomized, But Not Treated|0
330596|NCT01276639|1116450|P4|Week 0 to 16|Randomized, But Not Treated|0
330597|NCT01276639|1116451|P3|Week 0 to 16|Randomized, But Not Treated|0
330598|NCT01276639|1116452|P2|Week 0 to 16|Randomized, But Not Treated|1
330599|NCT01276639|1116453|P1|Week 0 to 16|Randomized, But Not Treated|0
330600|NCT01276639|1116449|P5|Week 0 to 16|Other|0
330601|NCT01276639|1116450|P4|Week 0 to 16|Other|0
330602|NCT01276639|1116451|P3|Week 0 to 16|Other|2
330603|NCT01276639|1116452|P2|Week 0 to 16|Other|7
330604|NCT01276639|1116453|P1|Week 0 to 16|Other|7
330605|NCT01276639|1116449|P5|Week 0 to 16|Withdrawal by Subject|0
330606|NCT01276639|1116450|P4|Week 0 to 16|Withdrawal by Subject|0
330607|NCT01276639|1116451|P3|Week 0 to 16|Withdrawal by Subject|4
330608|NCT01276639|1116452|P2|Week 0 to 16|Withdrawal by Subject|5
330609|NCT01276639|1116453|P1|Week 0 to 16|Withdrawal by Subject|8
330610|NCT01276639|1116449|P5|Week 0 to 16|Lost to Follow-up|0
330611|NCT01276639|1116450|P4|Week 0 to 16|Lost to Follow-up|0
330612|NCT01276639|1116451|P3|Week 0 to 16|Lost to Follow-up|3
330613|NCT01276639|1116452|P2|Week 0 to 16|Lost to Follow-up|5
330614|NCT01276639|1116453|P1|Week 0 to 16|Lost to Follow-up|3
330615|NCT01276639|1116449|P5|Week 0 to 16|Lack of Efficacy|0
330616|NCT01276639|1116450|P4|Week 0 to 16|Lack of Efficacy|0
330617|NCT01276639|1116451|P3|Week 0 to 16|Lack of Efficacy|25
330618|NCT01276639|1116452|P2|Week 0 to 16|Lack of Efficacy|15
330619|NCT01276639|1116453|P1|Week 0 to 16|Lack of Efficacy|20
330620|NCT01276639|1116449|P5|Week 0 to 16|Adverse Event|0
330621|NCT01276639|1116450|P4|Week 0 to 16|Adverse Event|0
330622|NCT01276639|1116451|P3|Week 0 to 16|Adverse Event|11
330623|NCT01276639|1116452|P2|Week 0 to 16|Adverse Event|8
330624|NCT01276639|1116453|P1|Week 0 to 16|Adverse Event|11
330625|NCT01276639|1116449|P5|Week 0 to 16|Death|0
330626|NCT01276639|1116450|P4|Week 0 to 16|Death|0
330627|NCT01276639|1116451|P3|Week 0 to 16|Death|0
330628|NCT01276639|1116452|P2|Week 0 to 16|Death|0
330629|NCT01276639|1116453|P1|Week 0 to 16|Death|1
330630|NCT01276509|1116658|P4|Overall Study|Other|0
330631|NCT01276509|1116659|P3|Overall Study|Other|0
330632|NCT01276509|1116660|P2|Overall Study|Other|1
330633|NCT01276509|1116661|P1|Overall Study|Other|0
330634|NCT01276509|1116658|P4|Overall Study|Withdrawal by Subject|0
330635|NCT01276509|1116659|P3|Overall Study|Withdrawal by Subject|0
330636|NCT01276509|1116660|P2|Overall Study|Withdrawal by Subject|2
330637|NCT01276509|1116661|P1|Overall Study|Withdrawal by Subject|1
330638|NCT01276509|1116658|P4|Overall Study|Pregnancy|0
330639|NCT01276509|1116659|P3|Overall Study|Pregnancy|0
330640|NCT01276509|1116660|P2|Overall Study|Pregnancy|0
330641|NCT01276509|1116661|P1|Overall Study|Pregnancy|1
330642|NCT01276509|1116658|P4|Overall Study|Lack of Efficacy|2
330643|NCT01276509|1116659|P3|Overall Study|Lack of Efficacy|1
330644|NCT01276509|1116660|P2|Overall Study|Lack of Efficacy|1
330645|NCT01276509|1116661|P1|Overall Study|Lack of Efficacy|2
330646|NCT01276509|1116658|P4|Overall Study|Adverse Event|3
330647|NCT01276509|1116659|P3|Overall Study|Adverse Event|4
330648|NCT01276509|1116660|P2|Overall Study|Adverse Event|8
330649|NCT01276509|1116661|P1|Overall Study|Adverse Event|9
330650|NCT01276457|1116714|P2|Extension Study|Lack of Efficacy|1
330651|NCT01276457|1116715|P1|Extension Study|Lack of Efficacy|3
330652|NCT01276457|1116714|P2|Extension Study|Death|1
330653|NCT01276457|1116715|P1|Extension Study|Death|0
330654|NCT01276457|1116714|P2|Extension Study|Lost to Follow-up|0
330655|NCT01276457|1116715|P1|Extension Study|Lost to Follow-up|3
330656|NCT01276457|1116714|P2|Core Study|Lack of Efficacy|12
330657|NCT01276457|1116715|P1|Core Study|Lack of Efficacy|3
330658|NCT01276457|1116714|P2|Core Study|Death|2
330659|NCT01276457|1116715|P1|Core Study|Death|2
330660|NCT01276457|1116714|P2|Core Study|Administrative problems|1
330661|NCT01276457|1116715|P1|Core Study|Administrative problems|1
330662|NCT01276457|1116714|P2|Core Study|Lost to Follow-up|2
330663|NCT01276457|1116715|P1|Core Study|Lost to Follow-up|1
330664|NCT01276457|1116714|P2|Core Study|Adverse Event|3
330665|NCT01276457|1116715|P1|Core Study|Adverse Event|6
330666|NCT01276353|1116729|P2|Extension|Prohibited concomitant medications|1
330667|NCT01276353|1116730|P1|Extension|Prohibited concomitant medications|0
330668|NCT01276353|1116729|P2|Extension|Physician Decision|0
330669|NCT01276353|1116730|P1|Extension|Physician Decision|1
330670|NCT01276353|1116729|P2|Extension|Withdrawal of study drug 4 days in a row|1
330671|NCT01276353|1116730|P1|Extension|Withdrawal of study drug 4 days in a row|3
330672|NCT01276353|1116729|P2|Extension|Withdrawal by Subject|2
330673|NCT01276353|1116730|P1|Extension|Withdrawal by Subject|1
330674|NCT01276353|1116729|P2|Extension|Adverse Event|5
330675|NCT01276353|1116730|P1|Extension|Adverse Event|2
330676|NCT01276353|1116729|P2|Double-blind|Withdrawal by Subject|0
330677|NCT01276353|1116730|P1|Double-blind|Withdrawal by Subject|1
330678|NCT01276353|1116729|P2|Double-blind|Adverse Event|0
330679|NCT01276353|1116730|P1|Double-blind|Adverse Event|2
330680|NCT01276327|1116742|P2|Overall Study|Withdrawal by Subject|0
330681|NCT01276327|1116743|P1|Overall Study|Withdrawal by Subject|1
330682|NCT01276327|1116742|P2|Overall Study|Adverse Event|3
330683|NCT01276327|1116743|P1|Overall Study|Adverse Event|1
330684|NCT01276288|1116810|P4|Overall Study|not treated|0
330685|NCT01276288|1116811|P3|Overall Study|not treated|0
330686|NCT01276288|1116812|P2|Overall Study|not treated|0
330687|NCT01276288|1116813|P1|Overall Study|not treated|1
330688|NCT01276288|1116810|P4|Overall Study|Adverse Event|0
330689|NCT01276288|1116811|P3|Overall Study|Adverse Event|0
330690|NCT01276288|1116812|P2|Overall Study|Adverse Event|1
330691|NCT01276288|1116813|P1|Overall Study|Adverse Event|1
330692|NCT01276223|1116940|P3|Overall Study|Protocol Violation|0
330693|NCT01276223|1116941|P2|Overall Study|Protocol Violation|0
330694|NCT01276223|1116942|P1|Overall Study|Protocol Violation|1
330695|NCT01276223|1116940|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
330696|NCT01276223|1116941|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
330697|NCT01276223|1116942|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
330698|NCT01276223|1116940|P3|Overall Study|Not specified|1
330699|NCT01276223|1116941|P2|Overall Study|Not specified|0
330700|NCT01276223|1116942|P1|Overall Study|Not specified|0
330701|NCT01276223|1116940|P3|Overall Study|Lost to Follow-up|1
330702|NCT01276223|1116941|P2|Overall Study|Lost to Follow-up|0
330703|NCT01276223|1116942|P1|Overall Study|Lost to Follow-up|0
330704|NCT01276223|1116940|P3|Overall Study|Adverse Event|1
330705|NCT01276223|1116941|P2|Overall Study|Adverse Event|4
330706|NCT01276223|1116942|P1|Overall Study|Adverse Event|7
330707|NCT01276106|1116983|P4|Overall Study|Insufficient therapeutic effects|0
330708|NCT01276106|1116984|P3|Overall Study|Insufficient therapeutic effects|2
330709|NCT01276106|1116985|P2|Overall Study|Insufficient therapeutic effects|0
330710|NCT01276106|1116986|P1|Overall Study|Insufficient therapeutic effects|0
330711|NCT01276106|1116983|P4|Overall Study|Protocol Violation|2
330712|NCT01276106|1116984|P3|Overall Study|Protocol Violation|0
330713|NCT01276106|1116985|P2|Overall Study|Protocol Violation|1
330714|NCT01276106|1116986|P1|Overall Study|Protocol Violation|1
330715|NCT01276106|1116983|P4|Overall Study|Physician Decision|1
330716|NCT01276106|1116984|P3|Overall Study|Physician Decision|1
330717|NCT01276106|1116985|P2|Overall Study|Physician Decision|0
330718|NCT01276106|1116986|P1|Overall Study|Physician Decision|0
330719|NCT01276106|1116983|P4|Overall Study|Lost to Follow-up|0
330720|NCT01276106|1116984|P3|Overall Study|Lost to Follow-up|1
330721|NCT01276106|1116985|P2|Overall Study|Lost to Follow-up|1
330722|NCT01276106|1116986|P1|Overall Study|Lost to Follow-up|2
330723|NCT01276106|1116983|P4|Overall Study|Lack of Efficacy|1
330724|NCT01276106|1116984|P3|Overall Study|Lack of Efficacy|0
330725|NCT01276106|1116985|P2|Overall Study|Lack of Efficacy|1
330726|NCT01276106|1116986|P1|Overall Study|Lack of Efficacy|0
330727|NCT01276106|1116983|P4|Overall Study|Withdrawal by Subject|6
330728|NCT01276106|1116984|P3|Overall Study|Withdrawal by Subject|1
330729|NCT01276106|1116985|P2|Overall Study|Withdrawal by Subject|3
330730|NCT01276106|1116986|P1|Overall Study|Withdrawal by Subject|6
330731|NCT01276106|1116983|P4|Overall Study|Adverse Event|3
330732|NCT01276106|1116984|P3|Overall Study|Adverse Event|11
330733|NCT01276106|1116985|P2|Overall Study|Adverse Event|3
330734|NCT01276106|1116986|P1|Overall Study|Adverse Event|3
330735|NCT01276054|1116998|P2|Overall Study|No one to oversee trial after P.I. left|2
330736|NCT01276054|1116999|P1|Overall Study|No one to oversee trial after P.I. left|2
330737|NCT01275833|1117007|P2|Overall Study|Study terminated|1
330738|NCT01275833|1117008|P1|Overall Study|Study terminated|1
330739|NCT01275755|1117016|P2|Run-out Placebo Period|Lost to Follow-up|0
330740|NCT01275755|1117017|P1|Run-out Placebo Period|Lost to Follow-up|1
330741|NCT01275755|1117016|P2|Double-blind Treatment Period|Withdrawal by Subject|0
330742|NCT01275755|1117017|P1|Double-blind Treatment Period|Withdrawal by Subject|1
330743|NCT01275755|1117016|P2|Double-blind Treatment Period|Lost to Follow-up|1
330744|NCT01275755|1117017|P1|Double-blind Treatment Period|Lost to Follow-up|1
330745|NCT01275755|1117016|P2|Double-blind Treatment Period|Adverse Event|2
330746|NCT01275755|1117017|P1|Double-blind Treatment Period|Adverse Event|0
330747|NCT01275625|1117031|P1|Overall Study|Not specified|1
330748|NCT01275625|1117031|P1|Overall Study|Adverse Event|4
330749|NCT01275625|1117031|P1|Overall Study|Protocol Violation|1
330750|NCT01275625|1117031|P1|Overall Study|Withdrawal by Subject|3
330751|NCT01275625|1117031|P1|Overall Study|Lost to Follow-up|1
330752|NCT01275625|1117031|P1|Overall Study|Lack of Efficacy|2
330753|NCT01275625|1117031|P1|Overall Study|Death|1
330754|NCT01275430|1117049|P1|Overall Study|Inability to achieve maximum p-wave|1
330755|NCT01275430|1117049|P1|Overall Study|Device Malfunction|1
330756|NCT01275430|1117049|P1|Overall Study|No Contrast Injection|6
330757|NCT01275430|1117049|P1|Overall Study|Adverse Event|1
330758|NCT01275196|1117121|P2|Overall Study|Suboptimal response/treatment failure|6
330759|NCT01275196|1117122|P1|Overall Study|Suboptimal response/treatment failure|5
330760|NCT01275196|1117121|P2|Overall Study|Protocol Violation|0
330761|NCT01275196|1117122|P1|Overall Study|Protocol Violation|1
330762|NCT01275196|1117121|P2|Overall Study|Disease Progression|5
330763|NCT01275196|1117122|P1|Overall Study|Disease Progression|6
330764|NCT01275196|1117121|P2|Overall Study|Lost to Follow-up|0
330765|NCT01275196|1117122|P1|Overall Study|Lost to Follow-up|1
330766|NCT01275196|1117121|P2|Overall Study|Withdrawal by Subject|5
330767|NCT01275196|1117122|P1|Overall Study|Withdrawal by Subject|4
330768|NCT01275196|1117121|P2|Overall Study|Adverse Event|5
330769|NCT01275196|1117122|P1|Overall Study|Adverse Event|3
330770|NCT01275131|1117165|P4|Period 2 (Crossover)|Withdrawal by Subject|2
330771|NCT01275131|1117166|P3|Period 2 (Crossover)|Withdrawal by Subject|1
330772|NCT01275131|1117167|P2|Period 2 (Crossover)|Withdrawal by Subject|0
330773|NCT01275131|1117168|P1|Period 2 (Crossover)|Withdrawal by Subject|1
330774|NCT01275131|1117165|P4|Period 2 (Crossover)|Adverse Event|0
330775|NCT01275131|1117166|P3|Period 2 (Crossover)|Adverse Event|0
330776|NCT01275131|1117167|P2|Period 2 (Crossover)|Adverse Event|1
330777|NCT01275131|1117168|P1|Period 2 (Crossover)|Adverse Event|0
330778|NCT01275131|1117165|P4|Period 1|Physician Decision|0
330779|NCT01275131|1117166|P3|Period 1|Physician Decision|0
330780|NCT01275131|1117167|P2|Period 1|Physician Decision|0
330781|NCT01275131|1117168|P1|Period 1|Physician Decision|1
330782|NCT01275131|1117165|P4|Period 1|Withdrawal by Subject|2
330783|NCT01275131|1117166|P3|Period 1|Withdrawal by Subject|3
330784|NCT01275131|1117167|P2|Period 1|Withdrawal by Subject|0
330785|NCT01275131|1117168|P1|Period 1|Withdrawal by Subject|1
330786|NCT01275066|1117211|P3|Overall Study|Not Diagnosed w/ Disease|0
330787|NCT01275066|1117212|P2|Overall Study|Not Diagnosed w/ Disease|0
330788|NCT01275066|1117213|P1|Overall Study|Not Diagnosed w/ Disease|1
330789|NCT01275066|1117211|P3|Overall Study|Withdrawal by Subject|1
330790|NCT01275066|1117212|P2|Overall Study|Withdrawal by Subject|0
330791|NCT01275066|1117213|P1|Overall Study|Withdrawal by Subject|0
330792|NCT01274715|1117246|P1|Overall Study|After consent, met exclusion criteria.|1
330793|NCT01274715|1117246|P1|Overall Study|After consent, met exclusion criteria.|1
330794|NCT01274715|1117246|P1|Overall Study|After consent, met exclusion criteria.|1
330795|NCT01274715|1117246|P1|Overall Study|Lost to Follow-up|1
330796|NCT01274637|1117253|P2|Overall Study|Lost to Follow-up|1
330797|NCT01274637|1117254|P1|Overall Study|Lost to Follow-up|0
330798|NCT01274637|1117253|P2|Overall Study|Withdrawal by Subject|1
330799|NCT01274637|1117254|P1|Overall Study|Withdrawal by Subject|0
330800|NCT01274559|1117293|P2|Overall Study|Withdrawal by Subject|13
330801|NCT01274559|1117294|P1|Overall Study|Withdrawal by Subject|25
330802|NCT01274559|1117293|P2|Overall Study|Study Terminated by Sponsor|87
330803|NCT01274559|1117294|P1|Overall Study|Study Terminated by Sponsor|79
330804|NCT01274559|1117293|P2|Overall Study|Protocol Violation|23
330805|NCT01274559|1117294|P1|Overall Study|Protocol Violation|28
330806|NCT01274559|1117293|P2|Overall Study|Physician Decision|1
330807|NCT01274559|1117294|P1|Overall Study|Physician Decision|2
330808|NCT01274559|1117293|P2|Overall Study|Non-compliance with Study Drug|4
330809|NCT01274559|1117294|P1|Overall Study|Non-compliance with Study Drug|2
330810|NCT01274559|1117293|P2|Overall Study|Lost to Follow-up|3
330811|NCT01274559|1117294|P1|Overall Study|Lost to Follow-up|3
330812|NCT01274559|1117293|P2|Overall Study|Death|1
330813|NCT01274559|1117294|P1|Overall Study|Death|1
330814|NCT01274559|1117293|P2|Overall Study|Adverse Event|13
330815|NCT01274559|1117294|P1|Overall Study|Adverse Event|57
330816|NCT01274533|1117344|P1|Overall Study|Disease progression|2
330817|NCT01274533|1117344|P1|Overall Study|Non-compliance|1
330818|NCT01274533|1117344|P1|Overall Study|Withdrawal by Subject|1
330819|NCT01274429|1117349|P1|Overall Study|Study closed do to lack of funding|5
330820|NCT01274182|1117357|P3|Overall Study|Death|1
330821|NCT01274182|1117358|P2|Overall Study|Death|0
330822|NCT01274182|1117359|P1|Overall Study|Death|1
330823|NCT01274182|1117357|P3|Overall Study|Protocol Violation|0
330824|NCT01274182|1117358|P2|Overall Study|Protocol Violation|2
330825|NCT01274182|1117359|P1|Overall Study|Protocol Violation|3
330826|NCT01274182|1117357|P3|Overall Study|Lost to Follow-up|1
330827|NCT01274182|1117358|P2|Overall Study|Lost to Follow-up|3
330828|NCT01274182|1117359|P1|Overall Study|Lost to Follow-up|2
330829|NCT01274182|1117357|P3|Overall Study|Withdrawal by Subject|3
330830|NCT01274182|1117358|P2|Overall Study|Withdrawal by Subject|5
330831|NCT01274182|1117359|P1|Overall Study|Withdrawal by Subject|5
330832|NCT01274182|1117357|P3|Overall Study|Adverse Event|3
330833|NCT01274182|1117358|P2|Overall Study|Adverse Event|5
330834|NCT01274182|1117359|P1|Overall Study|Adverse Event|4
330835|NCT01274182|1117357|P3|Overall Study|Unsatisfactory therapeutic effect|4
330836|NCT01274182|1117358|P2|Overall Study|Unsatisfactory therapeutic effect|3
330837|NCT01274182|1117359|P1|Overall Study|Unsatisfactory therapeutic effect|6
330838|NCT01273883|1117400|P2|Second Intervention|Lack of Efficacy|0
330839|NCT01273883|1117401|P1|Second Intervention|Lack of Efficacy|1
330840|NCT01273883|1117400|P2|Second Intervention|Lost to Follow-up|1
330841|NCT01273883|1117401|P1|Second Intervention|Lost to Follow-up|1
330842|NCT01273883|1117400|P2|First Intervention|Adverse Event|1
330843|NCT01273883|1117401|P1|First Intervention|Adverse Event|2
330844|NCT01273818|1117427|P3|Overall Study|Physician Decision|9
330845|NCT01273818|1117428|P2|Overall Study|Physician Decision|2
330846|NCT01273818|1117429|P1|Overall Study|Physician Decision|13
330847|NCT01273805|1117439|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
330848|NCT01273805|1117440|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
330849|NCT01273623|1117471|P1|Overall Study|did not meet IVUS criteria|29
330850|NCT01273597|1117478|P1|Overall Study|Reason Not Reported|1
330851|NCT01273597|1117478|P1|Overall Study|Underwent Kidney Transplantation|2
330852|NCT01273597|1117478|P1|Overall Study|Adverse Event|5
330853|NCT01273519|1117493|P3|Overall Study|Not Specified|1
330854|NCT01273519|1117494|P2|Overall Study|Not Specified|1
330855|NCT01273519|1117495|P1|Overall Study|Not Specified|6
330856|NCT01273519|1117493|P3|Overall Study|Lack of Efficacy|4
330857|NCT01273519|1117494|P2|Overall Study|Lack of Efficacy|3
330858|NCT01273519|1117495|P1|Overall Study|Lack of Efficacy|8
330859|NCT01273519|1117493|P3|Overall Study|Lost to Follow-up|3
330860|NCT01273519|1117494|P2|Overall Study|Lost to Follow-up|1
330861|NCT01273519|1117495|P1|Overall Study|Lost to Follow-up|2
330862|NCT01273519|1117493|P3|Overall Study|Adverse Event|0
330863|NCT01273519|1117494|P2|Overall Study|Adverse Event|0
330864|NCT01273519|1117495|P1|Overall Study|Adverse Event|3
330865|NCT01273181|1117532|P4|Phase 2, Dose 2|Death during treatment|1
330866|NCT01273181|1117533|P3|Phase 2, Dose 2|Death during treatment|0
330867|NCT01273181|1117534|P2|Phase 2, Dose 2|Death during treatment|0
330868|NCT01273181|1117535|P1|Phase 2, Dose 2|Death during treatment|0
330869|NCT01273181|1117532|P4|Phase 2, Dose 1|Study termination|0
330870|NCT01273181|1117533|P3|Phase 2, Dose 1|Study termination|1
330871|NCT01273181|1117534|P2|Phase 2, Dose 1|Study termination|0
330872|NCT01273181|1117535|P1|Phase 2, Dose 1|Study termination|0
330873|NCT01273181|1117532|P4|Phase I, Dose 2|Death during treatment|0
330874|NCT01273181|1117533|P3|Phase I, Dose 2|Death during treatment|0
330875|NCT01273181|1117534|P2|Phase I, Dose 2|Death during treatment|1
330876|NCT01273181|1117535|P1|Phase I, Dose 2|Death during treatment|0
330877|NCT01273181|1117532|P4|Phase I, Dose 1|Study termination|0
330878|NCT01273181|1117533|P3|Phase I, Dose 1|Study termination|0
330879|NCT01273181|1117534|P2|Phase I, Dose 1|Study termination|0
330880|NCT01273181|1117535|P1|Phase I, Dose 1|Study termination|1
330881|NCT01273064|1117554|P5|Overall Study|Physician Decision|1
330882|NCT01273064|1117555|P4|Overall Study|Physician Decision|0
330883|NCT01273064|1117556|P3|Overall Study|Physician Decision|0
330884|NCT01273064|1117557|P2|Overall Study|Physician Decision|0
330885|NCT01273064|1117558|P1|Overall Study|Physician Decision|0
330886|NCT01273064|1117554|P5|Overall Study|Lost to Follow-up|0
330887|NCT01273064|1117555|P4|Overall Study|Lost to Follow-up|0
330888|NCT01273064|1117556|P3|Overall Study|Lost to Follow-up|0
330889|NCT01273064|1117557|P2|Overall Study|Lost to Follow-up|0
330890|NCT01273064|1117558|P1|Overall Study|Lost to Follow-up|1
330891|NCT01273064|1117554|P5|Overall Study|Study Termination|8
330892|NCT01273064|1117555|P4|Overall Study|Study Termination|16
330893|NCT01273064|1117556|P3|Overall Study|Study Termination|26
330894|NCT01273064|1117557|P2|Overall Study|Study Termination|27
330895|NCT01273064|1117558|P1|Overall Study|Study Termination|13
330896|NCT01273064|1117554|P5|Overall Study|Withdrawal by Subject|0
330897|NCT01273064|1117555|P4|Overall Study|Withdrawal by Subject|2
330898|NCT01273064|1117556|P3|Overall Study|Withdrawal by Subject|2
330899|NCT01273064|1117557|P2|Overall Study|Withdrawal by Subject|2
330900|NCT01273064|1117558|P1|Overall Study|Withdrawal by Subject|4
330901|NCT01273064|1117554|P5|Overall Study|Adverse Event|1
330902|NCT01273064|1117555|P4|Overall Study|Adverse Event|2
330903|NCT01273064|1117556|P3|Overall Study|Adverse Event|3
330904|NCT01273064|1117557|P2|Overall Study|Adverse Event|1
330905|NCT01273064|1117558|P1|Overall Study|Adverse Event|5
330906|NCT01273038|1117577|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
330907|NCT01273038|1117578|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
330908|NCT01273038|1117577|P2|Second Intervention (14 Days)|Adverse Event|1
330909|NCT01273038|1117578|P1|Second Intervention (14 Days)|Adverse Event|0
330910|NCT01272947|1117601|P2|Overall Study|Abnormal Laboratory Value|2
330911|NCT01272947|1117602|P1|Overall Study|Abnormal Laboratory Value|2
330912|NCT01272934|1117612|P2|Overall Study|Abnormal Laboratory Value|1
330913|NCT01272934|1117613|P1|Overall Study|Abnormal Laboratory Value|0
330914|NCT01272934|1117612|P2|Overall Study|Adverse Event|1
330915|NCT01272934|1117613|P1|Overall Study|Adverse Event|0
330916|NCT01272921|1117623|P2|Overall Study|Protocol Violation|1
330917|NCT01272921|1117624|P1|Overall Study|Protocol Violation|2
330918|NCT01272908|1117632|P1|Re-Treatment Period|Withdrawal by Subject|1
330919|NCT01272908|1117632|P1|Re-Treatment Period|Lack of Efficacy|3
330920|NCT01272908|1117632|P1|Re-Treatment Period|Adverse Event|2
330921|NCT01272908|1117632|P1|Initial Treatment Period|Withdrawal by Subject|1
330922|NCT01272908|1117632|P1|Initial Treatment Period|Protocol Violation|1
330923|NCT01272908|1117632|P1|Initial Treatment Period|Lack of Efficacy|5
330924|NCT01272908|1117632|P1|Initial Treatment Period|Adverse Event|1
330925|NCT01272869|1117672|P2|Period 2 (14 Days)|Adverse Event|0
330926|NCT01272869|1117673|P1|Period 2 (14 Days)|Adverse Event|1
330927|NCT01272804|1117700|P6|Overall Study|Adverse Event|1
330928|NCT01272804|1117701|P5|Overall Study|Adverse Event|2
330929|NCT01272804|1117702|P4|Overall Study|Adverse Event|0
330930|NCT01272804|1117703|P3|Overall Study|Adverse Event|0
330931|NCT01272804|1117704|P2|Overall Study|Adverse Event|0
330932|NCT01272804|1117705|P1|Overall Study|Adverse Event|1
330933|NCT01272661|1117863|P3|Overall Study|lost to followup/case closed/ no birth|72
330934|NCT01272661|1117864|P2|Overall Study|lost to followup/case closed/ no birth|209
330935|NCT01272661|1117865|P1|Overall Study|lost to followup/case closed/ no birth|126
330936|NCT01272635|1117890|P4|Overall Study|Lost to Follow-up|23
330937|NCT01272635|1117891|P3|Overall Study|Lost to Follow-up|31
330938|NCT01272635|1117892|P2|Overall Study|Lost to Follow-up|20
330939|NCT01272635|1117893|P1|Overall Study|Lost to Follow-up|31
330940|NCT01272232|1117966|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
330941|NCT01272232|1117967|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
330942|NCT01272232|1117968|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
330943|NCT01272232|1117966|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
330944|NCT01272232|1117967|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
330945|NCT01272232|1117968|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
330946|NCT01272232|1117966|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
330947|NCT01272232|1117967|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
330948|NCT01272232|1117968|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
330949|NCT01272232|1117966|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
330950|NCT01272232|1117967|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
330951|NCT01272232|1117968|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
330952|NCT01272232|1117966|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
330953|NCT01272232|1117967|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
330954|NCT01272232|1117968|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
330955|NCT01272232|1117966|P3|Weeks 0-56|Unclassified|12
330956|NCT01272232|1117967|P2|Weeks 0-56|Unclassified|7
330957|NCT01272232|1117968|P1|Weeks 0-56|Unclassified|16
330958|NCT01272232|1117966|P3|Weeks 0-56|Withdrawal criteria|37
330959|NCT01272232|1117967|P2|Weeks 0-56|Withdrawal criteria|14
330960|NCT01272232|1117968|P1|Weeks 0-56|Withdrawal criteria|32
330961|NCT01272232|1117966|P3|Weeks 0-56|Protocol Violation|13
330962|NCT01272232|1117967|P2|Weeks 0-56|Protocol Violation|8
330963|NCT01272232|1117968|P1|Weeks 0-56|Protocol Violation|12
330964|NCT01272232|1117966|P3|Weeks 0-56|Lack of Efficacy|3
330965|NCT01272232|1117967|P2|Weeks 0-56|Lack of Efficacy|0
330966|NCT01272232|1117968|P1|Weeks 0-56|Lack of Efficacy|0
330967|NCT01272232|1117966|P3|Weeks 0-56|Adverse Event|7
330968|NCT01272232|1117967|P2|Weeks 0-56|Adverse Event|18
330969|NCT01272232|1117968|P1|Weeks 0-56|Adverse Event|39
330970|NCT01272219|1118013|P6|Main + Extension Period: Week 0-172|Unclassified|51
330971|NCT01272219|1118014|P5|Main + Extension Period: Week 0-172|Unclassified|61
330972|NCT01272219|1118015|P4|Main + Extension Period: Week 0-172|Unclassified|0
330973|NCT01272219|1118016|P3|Main + Extension Period: Week 0-172|Unclassified|0
330974|NCT01272219|1118017|P2|Main + Extension Period: Week 0-172|Unclassified|0
330975|NCT01272219|1118018|P1|Main + Extension Period: Week 0-172|Unclassified|0
330976|NCT01272219|1118013|P6|Main + Extension Period: Week 0-172|Missing reason|0
330977|NCT01272219|1118014|P5|Main + Extension Period: Week 0-172|Missing reason|1
330978|NCT01272219|1118015|P4|Main + Extension Period: Week 0-172|Missing reason|0
330979|NCT01272219|1118016|P3|Main + Extension Period: Week 0-172|Missing reason|0
330980|NCT01272219|1118017|P2|Main + Extension Period: Week 0-172|Missing reason|0
330981|NCT01272219|1118018|P1|Main + Extension Period: Week 0-172|Missing reason|0
330982|NCT01272219|1118013|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
330983|NCT01272219|1118014|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
330984|NCT01272219|1118015|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
330985|NCT01272219|1118016|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
330986|NCT01272219|1118017|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
330987|NCT01272219|1118018|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
330988|NCT01272219|1118013|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
330989|NCT01272219|1118014|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
330990|NCT01272219|1118015|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
330991|NCT01272219|1118016|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
330992|NCT01272219|1118017|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
330993|NCT01272219|1118018|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
330994|NCT01272219|1118013|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
330995|NCT01272219|1118014|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
330996|NCT01272219|1118015|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
330997|NCT01272219|1118016|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
330998|NCT01272219|1118017|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
330999|NCT01272219|1118018|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
331000|NCT01272219|1118013|P6|Main + Extension Period: Week 0-172|Adverse Event|43
331001|NCT01272219|1118014|P5|Main + Extension Period: Week 0-172|Adverse Event|191
331002|NCT01272219|1118015|P4|Main + Extension Period: Week 0-172|Adverse Event|0
331003|NCT01272219|1118016|P3|Main + Extension Period: Week 0-172|Adverse Event|0
331004|NCT01272219|1118017|P2|Main + Extension Period: Week 0-172|Adverse Event|0
331005|NCT01272219|1118018|P1|Main + Extension Period: Week 0-172|Adverse Event|0
331006|NCT01272219|1118013|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
331007|NCT01272219|1118014|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
331008|NCT01272219|1118015|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
331009|NCT01272219|1118016|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
331010|NCT01272219|1118017|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
331011|NCT01272219|1118018|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
331012|NCT01272219|1118013|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
331013|NCT01272219|1118014|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
331014|NCT01272219|1118015|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
331015|NCT01272219|1118016|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
331016|NCT01272219|1118017|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
331017|NCT01272219|1118018|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
331018|NCT01272219|1118013|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
331019|NCT01272219|1118014|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
331020|NCT01272219|1118015|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
331021|NCT01272219|1118016|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
331022|NCT01272219|1118017|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
331023|NCT01272219|1118018|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
331024|NCT01272219|1118013|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
331025|NCT01272219|1118014|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
331026|NCT01272219|1118015|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
331027|NCT01272219|1118016|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
331028|NCT01272219|1118017|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
331029|NCT01272219|1118018|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
331030|NCT01272219|1118013|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
331031|NCT01272219|1118014|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
331032|NCT01272219|1118015|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
331033|NCT01272219|1118016|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
331034|NCT01272219|1118017|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
331035|NCT01272219|1118018|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
331036|NCT01272219|1118013|P6|Main Period: Week 0 to Week 56|Unclassified|34
331037|NCT01272219|1118014|P5|Main Period: Week 0 to Week 56|Unclassified|42
331038|NCT01272219|1118015|P4|Main Period: Week 0 to Week 56|Unclassified|29
331039|NCT01272219|1118016|P3|Main Period: Week 0 to Week 56|Unclassified|0
331040|NCT01272219|1118017|P2|Main Period: Week 0 to Week 56|Unclassified|0
331041|NCT01272219|1118018|P1|Main Period: Week 0 to Week 56|Unclassified|36
331042|NCT01272219|1118013|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
331043|NCT01272219|1118014|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
331044|NCT01272219|1118015|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
331045|NCT01272219|1118016|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
331046|NCT01272219|1118017|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
331047|NCT01272219|1118018|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
331048|NCT01272219|1118013|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
331049|NCT01272219|1118014|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
331050|NCT01272219|1118015|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
331051|NCT01272219|1118016|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
331052|NCT01272219|1118017|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
331053|NCT01272219|1118018|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
331054|NCT01272219|1118013|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
331055|NCT01272219|1118014|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
331056|NCT01272219|1118015|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
331057|NCT01272219|1118016|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
331058|NCT01272219|1118017|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
331059|NCT01272219|1118018|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
331060|NCT01272219|1118013|P6|Main Period: Week 0 to Week 56|Adverse Event|29
331061|NCT01272219|1118014|P5|Main Period: Week 0 to Week 56|Adverse Event|152
331062|NCT01272219|1118015|P4|Main Period: Week 0 to Week 56|Adverse Event|16
331063|NCT01272219|1118016|P3|Main Period: Week 0 to Week 56|Adverse Event|0
331064|NCT01272219|1118017|P2|Main Period: Week 0 to Week 56|Adverse Event|0
331065|NCT01272219|1118018|P1|Main Period: Week 0 to Week 56|Adverse Event|86
331066|NCT01272193|1118052|P2|Overall Study|Unclassified|7
331067|NCT01272193|1118053|P1|Overall Study|Unclassified|8
331068|NCT01272193|1118052|P2|Overall Study|Withdrawal Criteria|1
331069|NCT01272193|1118053|P1|Overall Study|Withdrawal Criteria|1
331070|NCT01272193|1118052|P2|Overall Study|Lack of Efficacy|3
331071|NCT01272193|1118053|P1|Overall Study|Lack of Efficacy|0
331072|NCT01272193|1118052|P2|Overall Study|Adverse Event|1
331073|NCT01272193|1118053|P1|Overall Study|Adverse Event|1
331074|NCT01272180|1118073|P4|Overall Study|Protocol Violation|1
331075|NCT01272180|1118074|P3|Overall Study|Protocol Violation|0
331076|NCT01272180|1118075|P2|Overall Study|Protocol Violation|1
331077|NCT01272180|1118076|P1|Overall Study|Protocol Violation|0
331078|NCT01272180|1118073|P4|Overall Study|Inappropriate enrollment|1
331079|NCT01272180|1118074|P3|Overall Study|Inappropriate enrollment|1
331080|NCT01272180|1118075|P2|Overall Study|Inappropriate enrollment|0
331081|NCT01272180|1118076|P1|Overall Study|Inappropriate enrollment|0
331082|NCT01272180|1118073|P4|Overall Study|Lost to Follow-up|10
331083|NCT01272180|1118074|P3|Overall Study|Lost to Follow-up|8
331084|NCT01272180|1118075|P2|Overall Study|Lost to Follow-up|14
331085|NCT01272180|1118076|P1|Overall Study|Lost to Follow-up|15
331086|NCT01272180|1118073|P4|Overall Study|Withdrawal by Subject|2
331087|NCT01272180|1118074|P3|Overall Study|Withdrawal by Subject|3
331088|NCT01272180|1118075|P2|Overall Study|Withdrawal by Subject|6
331089|NCT01272180|1118076|P1|Overall Study|Withdrawal by Subject|2
331090|NCT01272180|1118073|P4|Overall Study|Adverse Event|0
331091|NCT01272180|1118074|P3|Overall Study|Adverse Event|1
331092|NCT01272180|1118075|P2|Overall Study|Adverse Event|0
331093|NCT01272180|1118076|P1|Overall Study|Adverse Event|0
331094|NCT01272011|1118125|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
331095|NCT01272011|1118126|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
331096|NCT01272011|1118127|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
331265|NCT01271712|1118391|P2|Survival Follow-up|Ongoing survival follow-up|6
331266|NCT01271712|1118392|P1|Survival Follow-up|Ongoing survival follow-up|15
331267|NCT01271712|1118391|P2|Safety Follow-up|Progressive disease|0
331268|NCT01271712|1118392|P1|Safety Follow-up|Progressive disease|1
331269|NCT01271712|1118391|P2|Safety Follow-up|No follow-up|1
331270|NCT01271712|1118392|P1|Safety Follow-up|No follow-up|1
331271|NCT01271712|1118391|P2|Safety Follow-up|Ongoing safety follow-up|4
331272|NCT01271712|1118392|P1|Safety Follow-up|Ongoing safety follow-up|3
331273|NCT01271712|1118391|P2|Safety Follow-up|Protocol Violation|1
331274|NCT01271712|1118392|P1|Safety Follow-up|Protocol Violation|1
331275|NCT01271712|1118391|P2|Safety Follow-up|Withdrawal by Subject|2
331276|NCT01271712|1118392|P1|Safety Follow-up|Withdrawal by Subject|4
331277|NCT01271712|1118391|P2|Safety Follow-up|Death|7
331278|NCT01271712|1118392|P1|Safety Follow-up|Death|11
331279|NCT01271712|1118391|P2|Open Label Treatment|Switching to other therapy|1
331280|NCT01271712|1118392|P1|Open Label Treatment|Switching to other therapy|2
331281|NCT01271712|1118391|P2|Open Label Treatment|Protocol Violation|1
331282|NCT01271712|1118392|P1|Open Label Treatment|Protocol Violation|0
331283|NCT01271712|1118391|P2|Open Label Treatment|Non-compliance with study drug|0
331284|NCT01271712|1118392|P1|Open Label Treatment|Non-compliance with study drug|1
331285|NCT01271712|1118391|P2|Open Label Treatment|Ongoing with open-label treatment|1
331286|NCT01271712|1118392|P1|Open Label Treatment|Ongoing with open-label treatment|6
331287|NCT01271712|1118391|P2|Open Label Treatment|Progressive disease|31
331288|NCT01271712|1118392|P1|Open Label Treatment|Progressive disease|56
331289|NCT01271712|1118391|P2|Open Label Treatment|Adverse Event|8
331290|NCT01271712|1118392|P1|Open Label Treatment|Adverse Event|12
331291|NCT01271712|1118391|P2|Open Label Treatment|Physician Decision|0
331292|NCT01271712|1118392|P1|Open Label Treatment|Physician Decision|2
331293|NCT01271712|1118391|P2|Open Label Treatment|Withdrawal by Subject|11
331294|NCT01271712|1118392|P1|Open Label Treatment|Withdrawal by Subject|6
331295|NCT01271712|1118391|P2|Open Label Treatment|Death|5
331296|NCT01271712|1118392|P1|Open Label Treatment|Death|6
331297|NCT01271712|1118391|P2|Double Blind Treatment|receive no study drug|0
331298|NCT01271712|1118392|P1|Double Blind Treatment|receive no study drug|1
331299|NCT01271712|1118391|P2|Double Blind Treatment|Non compliance with study drug|0
331300|NCT01271712|1118392|P1|Double Blind Treatment|Non compliance with study drug|2
331301|NCT01271712|1118391|P2|Double Blind Treatment|Withdrawal by Subject|1
331302|NCT01271712|1118392|P1|Double Blind Treatment|Withdrawal by Subject|4
331303|NCT01271712|1118391|P2|Double Blind Treatment|Progressive disease|3
331304|NCT01271712|1118392|P1|Double Blind Treatment|Progressive disease|23
331305|NCT01271712|1118391|P2|Double Blind Treatment|Adverse Event|4
331306|NCT01271712|1118392|P1|Double Blind Treatment|Adverse Event|9
331307|NCT01271712|1118391|P2|Double Blind Treatment|Lack of Efficacy|0
331308|NCT01271712|1118392|P1|Double Blind Treatment|Lack of Efficacy|1
331309|NCT01271712|1118391|P2|Double Blind Treatment|Death|0
331310|NCT01271712|1118392|P1|Double Blind Treatment|Death|2
331311|NCT01271010|1118486|P1|Overall Study|Disease progression|27
331312|NCT01271010|1118486|P1|Overall Study|Withdrawal by Subject|18
331313|NCT01271010|1118486|P1|Overall Study|Progression and relapse of disease|1
331314|NCT01271010|1118486|P1|Overall Study|Death|2
331315|NCT01271010|1118486|P1|Overall Study|Protocol Violation|1
331316|NCT01271010|1118486|P1|Overall Study|Start of new CLL therapy|1
331317|NCT01271010|1118486|P1|Overall Study|Reason not specified|11
331318|NCT01270971|1118501|P2|Overall Study|Non-specific|3
331319|NCT01270971|1118502|P1|Overall Study|Non-specific|7
331320|NCT01270971|1118501|P2|Overall Study|Non compliance|2
331321|NCT01270971|1118502|P1|Overall Study|Non compliance|2
331322|NCT01270971|1118501|P2|Overall Study|Adverse Event|2
331323|NCT01270971|1118502|P1|Overall Study|Adverse Event|1
331324|NCT01270971|1118501|P2|Overall Study|Lost to Follow-up|5
331325|NCT01270971|1118502|P1|Overall Study|Lost to Follow-up|18
331326|NCT01270971|1118501|P2|Overall Study|Withdrawal by Subject|11
331327|NCT01270971|1118502|P1|Overall Study|Withdrawal by Subject|24
331328|NCT01270958|1118514|P1|Overall Study|Did not meet inclusion criteria for age|2
331329|NCT01270958|1118514|P1|Overall Study|Lost to Follow-up|2
331330|NCT01270880|1118543|P1|Overall Study|Never rec'd treatment, but registered.|1
331331|NCT01270841|1118568|P4|Overall Study|Enrolled in error|0
331332|NCT01270841|1118569|P3|Overall Study|Enrolled in error|0
331333|NCT01270841|1118570|P2|Overall Study|Enrolled in error|1
331334|NCT01270841|1118571|P1|Overall Study|Enrolled in error|0
331335|NCT01270841|1118568|P4|Overall Study|Protocol Violation|0
331336|NCT01270841|1118569|P3|Overall Study|Protocol Violation|0
331337|NCT01270841|1118570|P2|Overall Study|Protocol Violation|5
331338|NCT01270841|1118571|P1|Overall Study|Protocol Violation|1
331339|NCT01270841|1118568|P4|Overall Study|Did not qualify|5
331340|NCT01270841|1118569|P3|Overall Study|Did not qualify|4
331341|NCT01270841|1118570|P2|Overall Study|Did not qualify|3
331342|NCT01270841|1118571|P1|Overall Study|Did not qualify|6
331343|NCT01270841|1118568|P4|Overall Study|Physician Decision|0
331344|NCT01270841|1118569|P3|Overall Study|Physician Decision|0
331345|NCT01270841|1118570|P2|Overall Study|Physician Decision|1
331346|NCT01270841|1118571|P1|Overall Study|Physician Decision|0
331347|NCT01270841|1118568|P4|Overall Study|Lost to Follow-up|2
331348|NCT01270841|1118569|P3|Overall Study|Lost to Follow-up|4
331349|NCT01270841|1118570|P2|Overall Study|Lost to Follow-up|1
331350|NCT01270841|1118571|P1|Overall Study|Lost to Follow-up|3
331351|NCT01270841|1118568|P4|Overall Study|Withdrawal by Subject|3
331352|NCT01270841|1118569|P3|Overall Study|Withdrawal by Subject|3
331353|NCT01270841|1118570|P2|Overall Study|Withdrawal by Subject|2
331354|NCT01270841|1118571|P1|Overall Study|Withdrawal by Subject|3
331355|NCT01270841|1118568|P4|Overall Study|Adverse Event|3
331356|NCT01270841|1118569|P3|Overall Study|Adverse Event|0
331357|NCT01270841|1118570|P2|Overall Study|Adverse Event|1
331358|NCT01270841|1118571|P1|Overall Study|Adverse Event|0
331359|NCT01270828|1118595|P3|Double Blind Phase|Adverse event related to study drug|0
331360|NCT01270828|1118596|P2|Double Blind Phase|Adverse event related to study drug|7
331361|NCT01270828|1118597|P1|Double Blind Phase|Adverse event related to study drug|5
331362|NCT01270828|1118595|P3|Double Blind Phase|Adverse event not related to study drug|0
331363|NCT01270828|1118596|P2|Double Blind Phase|Adverse event not related to study drug|1
331364|NCT01270828|1118597|P1|Double Blind Phase|Adverse event not related to study drug|1
331365|NCT01270828|1118595|P3|Double Blind Phase|Lack of Efficacy|0
331366|NCT01270828|1118596|P2|Double Blind Phase|Lack of Efficacy|11
331367|NCT01270828|1118597|P1|Double Blind Phase|Lack of Efficacy|2
331368|NCT01270828|1118595|P3|Double Blind Phase|Lost to Follow-up|0
331369|NCT01270828|1118596|P2|Double Blind Phase|Lost to Follow-up|2
331370|NCT01270828|1118597|P1|Double Blind Phase|Lost to Follow-up|1
331371|NCT01270828|1118595|P3|Double Blind Phase|Withdrawal by Subject|0
331372|NCT01270828|1118596|P2|Double Blind Phase|Withdrawal by Subject|15
331373|NCT01270828|1118597|P1|Double Blind Phase|Withdrawal by Subject|6
331374|NCT01270828|1118595|P3|Double Blind Phase|Reason Unspecified|0
331375|NCT01270828|1118596|P2|Double Blind Phase|Reason Unspecified|4
331376|NCT01270828|1118597|P1|Double Blind Phase|Reason Unspecified|7
331377|NCT01270828|1118595|P3|Double Blind Phase|Protocol and GCP non-compliance|0
331378|NCT01270828|1118596|P2|Double Blind Phase|Protocol and GCP non-compliance|3
331379|NCT01270828|1118597|P1|Double Blind Phase|Protocol and GCP non-compliance|4
331380|NCT01270828|1118595|P3|Double Blind Phase|Protocol Violation|0
331381|NCT01270828|1118596|P2|Double Blind Phase|Protocol Violation|1
331382|NCT01270828|1118597|P1|Double Blind Phase|Protocol Violation|0
331383|NCT01270828|1118595|P3|Double Blind Phase|Death|0
331384|NCT01270828|1118596|P2|Double Blind Phase|Death|1
331385|NCT01270828|1118597|P1|Double Blind Phase|Death|0
331386|NCT01270828|1118595|P3|Pregabalin CR SB|Protocol Violation|8
331387|NCT01270828|1118596|P2|Pregabalin CR SB|Protocol Violation|0
331388|NCT01270828|1118597|P1|Pregabalin CR SB|Protocol Violation|0
331389|NCT01270828|1118595|P3|Pregabalin CR SB|Unrelated AE|8
331390|NCT01270828|1118596|P2|Pregabalin CR SB|Unrelated AE|0
331391|NCT01270828|1118597|P1|Pregabalin CR SB|Unrelated AE|0
331392|NCT01270828|1118595|P3|Pregabalin CR SB|Lost to Follow-up|10
331393|NCT01270828|1118596|P2|Pregabalin CR SB|Lost to Follow-up|0
331394|NCT01270828|1118597|P1|Pregabalin CR SB|Lost to Follow-up|0
331395|NCT01270828|1118595|P3|Pregabalin CR SB|Withdrawal by Subject|29
331396|NCT01270828|1118596|P2|Pregabalin CR SB|Withdrawal by Subject|0
331397|NCT01270828|1118597|P1|Pregabalin CR SB|Withdrawal by Subject|0
331398|NCT01270828|1118595|P3|Pregabalin CR SB|Lack of Efficacy|32
331399|NCT01270828|1118596|P2|Pregabalin CR SB|Lack of Efficacy|0
331400|NCT01270828|1118597|P1|Pregabalin CR SB|Lack of Efficacy|0
331401|NCT01270828|1118595|P3|Pregabalin CR SB|Related adverse event|46
331402|NCT01270828|1118596|P2|Pregabalin CR SB|Related adverse event|0
331403|NCT01270828|1118597|P1|Pregabalin CR SB|Related adverse event|0
331404|NCT01270828|1118595|P3|Pregabalin CR SB|Enrolled but not treated|5
331405|NCT01270828|1118596|P2|Pregabalin CR SB|Enrolled but not treated|0
331406|NCT01270828|1118597|P1|Pregabalin CR SB|Enrolled but not treated|0
331407|NCT01270828|1118595|P3|Pregabalin CR SB|Reason Unspecified|8
331408|NCT01270828|1118596|P2|Pregabalin CR SB|Reason Unspecified|0
331409|NCT01270828|1118597|P1|Pregabalin CR SB|Reason Unspecified|0
331410|NCT01270802|1118639|P2|Overall Study|Lost to Follow-up|1
331411|NCT01270802|1118640|P1|Overall Study|Lost to Follow-up|0
331412|NCT01270802|1118639|P2|Overall Study|Adverse Event|0
331413|NCT01270802|1118640|P1|Overall Study|Adverse Event|1
331414|NCT01270802|1118639|P2|Overall Study|Withdrawal by Subject|0
331415|NCT01270802|1118640|P1|Overall Study|Withdrawal by Subject|1
331416|NCT01270620|1118787|P2|Overall Study|Withdrawal by Subject|3
331417|NCT01270620|1118788|P1|Overall Study|Withdrawal by Subject|1
331418|NCT01270503|1118883|P1|Overall Study|Lost to Follow-up|1
331419|NCT01270464|1118891|P3|Overall Study|Not Specified|3
331420|NCT01270464|1118892|P2|Overall Study|Not Specified|1
331421|NCT01270464|1118893|P1|Overall Study|Not Specified|1
331422|NCT01270464|1118891|P3|Overall Study|Lost to Follow-up|1
331423|NCT01270464|1118892|P2|Overall Study|Lost to Follow-up|3
331424|NCT01270464|1118893|P1|Overall Study|Lost to Follow-up|2
331425|NCT01270464|1118891|P3|Overall Study|Withdrawal by Subject|4
331426|NCT01270464|1118892|P2|Overall Study|Withdrawal by Subject|1
331427|NCT01270464|1118893|P1|Overall Study|Withdrawal by Subject|2
331428|NCT01270464|1118891|P3|Overall Study|Adverse Event|7
331429|NCT01270464|1118892|P2|Overall Study|Adverse Event|1
331430|NCT01270464|1118893|P1|Overall Study|Adverse Event|9
331431|NCT01270464|1118891|P3|Overall Study|Lack of Efficacy|1
331432|NCT01270464|1118892|P2|Overall Study|Lack of Efficacy|3
331433|NCT01270464|1118893|P1|Overall Study|Lack of Efficacy|2
331434|NCT01270464|1118891|P3|Overall Study|Protocol Violation|2
331435|NCT01270464|1118892|P2|Overall Study|Protocol Violation|3
331436|NCT01270464|1118893|P1|Overall Study|Protocol Violation|4
331437|NCT01270256|1118942|P2|Overall Study|Withdrawal by Subject|0
331438|NCT01270256|1118943|P1|Overall Study|Withdrawal by Subject|1
331439|NCT01270139|1118952|P3|Overall Study|Lost to Follow-up|2
331440|NCT01270139|1118953|P2|Overall Study|Lost to Follow-up|9
331441|NCT01270139|1118954|P1|Overall Study|Lost to Follow-up|10
331442|NCT01270139|1118952|P3|Overall Study|Adverse Event|18
331443|NCT01270139|1118953|P2|Overall Study|Adverse Event|17
331444|NCT01270139|1118954|P1|Overall Study|Adverse Event|8
331445|NCT01269918|1119023|P2|Overall Study|Did not receive study drug|3
331446|NCT01269918|1119024|P1|Overall Study|Did not receive study drug|0
331447|NCT01269346|1119099|P1|Extension Phase|Started a prohibited con med|1
331448|NCT01269346|1119099|P1|Extension Phase|Clinical progression|1
331449|NCT01269346|1119099|P1|Extension Phase|Physician decision or participant choice|9
331450|NCT01269346|1119099|P1|Extension Phase|Disease progression|22
331451|NCT01269346|1119099|P1|Extension Phase|Withdrawal by Subject|4
331452|NCT01269346|1119099|P1|Extension Phase|Adverse Event|6
331453|NCT01269346|1119099|P1|Treatment Phase|Not specified|2
331454|NCT01269346|1119099|P1|Treatment Phase|Withdrawal by Subject|1
331455|NCT01269346|1119099|P1|Treatment Phase|Adverse Event|3
331456|NCT01269346|1119099|P1|Treatment Phase|Disease progression|3
331457|NCT01269125|1119110|P3|Overall Study|Lost to Follow-up|0
331458|NCT01269125|1119111|P2|Overall Study|Lost to Follow-up|0
331459|NCT01269125|1119112|P1|Overall Study|Lost to Follow-up|4
331460|NCT01269125|1119110|P3|Overall Study|Adverse Event|0
331461|NCT01269125|1119111|P2|Overall Study|Adverse Event|5
331462|NCT01269125|1119112|P1|Overall Study|Adverse Event|3
331463|NCT01268891|1119171|P2|Overall Study|Administrative or other reason(s)|0
331464|NCT01268891|1119172|P1|Overall Study|Administrative or other reason(s)|1
331465|NCT01268891|1119171|P2|Overall Study|Withdrawal of Consent|1
331466|NCT01268891|1119172|P1|Overall Study|Withdrawal of Consent|3
331467|NCT01268891|1119171|P2|Overall Study|Lack of Efficacy|0
331468|NCT01268891|1119172|P1|Overall Study|Lack of Efficacy|1
331469|NCT01268891|1119171|P2|Overall Study|Adverse Event|7
331470|NCT01268891|1119172|P1|Overall Study|Adverse Event|3
331471|NCT01268566|1119191|P1|Overall Study|Death|30
331472|NCT01268566|1119191|P1|Overall Study|Withdrawal by Subject|12
331473|NCT01268566|1119191|P1|Overall Study|Lost to Follow-up|1
331474|NCT01268501|1119218|P1|Overall Study|Handling Difficulties|2
331475|NCT01268501|1119218|P1|Overall Study|Unacceptable Subjective Vision|3
331476|NCT01268501|1119218|P1|Overall Study|Withdrawal by Subject|3
331477|NCT01268501|1119218|P1|Overall Study|Lost to Follow-up|1
331478|NCT01268488|1119222|P1|Overall Study|Physician Decision|2
331479|NCT01268488|1119222|P1|Overall Study|Adverse Event|3
331480|NCT01268306|1119229|P1|Overall Study|Lost to Follow-up|1
331481|NCT01268293|1119233|P1|Overall Study|Subject choice|1
331482|NCT01268293|1119233|P1|Overall Study|Adverse Event|1
331483|NCT01268293|1119233|P1|Overall Study|Disease progression|7
331484|NCT01268267|1119238|P1|Overall Study|Protocol Violation|1
331485|NCT01268150|1119259|P1|Extension Phase|Not specified|6
331486|NCT01268150|1119259|P1|Extension Phase|Disease progression|18
331487|NCT01268150|1119259|P1|Extension Phase|Adverse Event|3
331488|NCT01268150|1119259|P1|Treatment Phase|Not specified|4
331489|NCT01268150|1119259|P1|Treatment Phase|Withdrawal by Subject|3
331490|NCT01268150|1119259|P1|Treatment Phase|Adverse Event|3
331491|NCT01268150|1119259|P1|Treatment Phase|Progression of disease|18
331492|NCT01268098|1119278|P2|Overall Study|Adverse Event|0
331493|NCT01268098|1119279|P1|Overall Study|Adverse Event|1
331494|NCT01267994|1119287|P1|Overall Study|Adverse Event|2
331495|NCT01267266|1119392|P2|Lead-in Phase|Withdrawal by Subject|0
331496|NCT01267266|1119393|P1|Lead-in Phase|Withdrawal by Subject|1
331497|NCT01267266|1119392|P2|Lead-in Phase|Adverse Event|0
331498|NCT01267266|1119393|P1|Lead-in Phase|Adverse Event|2
331499|NCT01267266|1119392|P2|Lead-in Phase|Lack of Efficacy|0
331500|NCT01267266|1119393|P1|Lead-in Phase|Lack of Efficacy|20
331501|NCT01267266|1119392|P2|Enrollment Phase|Withdrawal by Subject|0
331502|NCT01267266|1119393|P1|Enrollment Phase|Withdrawal by Subject|2
331503|NCT01267253|1119406|P1|Overall Study|Inevaluable-never received study treatme|2
331504|NCT01267253|1119406|P1|Overall Study|Ineligible - required test not done|1
331505|NCT01267201|1119445|P6|Second Intervention Period|Withdrawal by Subject|0
331506|NCT01267201|1119446|P5|Second Intervention Period|Withdrawal by Subject|0
331507|NCT01267201|1119447|P4|Second Intervention Period|Withdrawal by Subject|0
331508|NCT01267201|1119448|P3|Second Intervention Period|Withdrawal by Subject|0
331509|NCT01267201|1119449|P2|Second Intervention Period|Withdrawal by Subject|1
331510|NCT01267201|1119450|P1|Second Intervention Period|Withdrawal by Subject|0
331511|NCT01267201|1119445|P6|First Intervention Period|Withdrawal by Subject|0
331512|NCT01267201|1119446|P5|First Intervention Period|Withdrawal by Subject|0
331513|NCT01267201|1119447|P4|First Intervention Period|Withdrawal by Subject|0
331514|NCT01267201|1119448|P3|First Intervention Period|Withdrawal by Subject|0
331515|NCT01267201|1119449|P2|First Intervention Period|Withdrawal by Subject|0
331516|NCT01267201|1119450|P1|First Intervention Period|Withdrawal by Subject|1
331517|NCT01267175|1119467|P1|Overall Study|Lost to Follow-up|1
331518|NCT01267175|1119467|P1|Overall Study|Withdrawal by Subject|1
331519|NCT01266967|1119539|P2|Overall Study|Withdrawal by Subject|3
331520|NCT01266967|1119540|P1|Overall Study|Withdrawal by Subject|3
331521|NCT01266967|1119539|P2|Overall Study|Physician Decision|1
331522|NCT01266967|1119540|P1|Overall Study|Physician Decision|0
331523|NCT01266967|1119539|P2|Overall Study|Lost to Follow-up|1
331524|NCT01266967|1119540|P1|Overall Study|Lost to Follow-up|2
331525|NCT01266967|1119539|P2|Overall Study|Study Closed/Terminated|17
331526|NCT01266967|1119540|P1|Overall Study|Study Closed/Terminated|15
331527|NCT01266967|1119539|P2|Overall Study|Death|61
331528|NCT01266967|1119540|P1|Overall Study|Death|69
331529|NCT01266876|1119592|P5|Overall Study|Adverse Event|0
331530|NCT01266876|1119593|P4|Overall Study|Adverse Event|1
331531|NCT01266876|1119594|P3|Overall Study|Adverse Event|0
331532|NCT01266876|1119595|P2|Overall Study|Adverse Event|0
331533|NCT01266876|1119596|P1|Overall Study|Adverse Event|0
331534|NCT01266850|1119703|P5|Overall Study|Site Closure|0
331535|NCT01266850|1119704|P4|Overall Study|Site Closure|1
331536|NCT01266850|1119705|P3|Overall Study|Site Closure|1
331537|NCT01266850|1119706|P2|Overall Study|Site Closure|1
331538|NCT01266850|1119707|P1|Overall Study|Site Closure|0
331539|NCT01266850|1119703|P5|Overall Study|Adverse Event|1
331540|NCT01266850|1119704|P4|Overall Study|Adverse Event|0
331541|NCT01266850|1119705|P3|Overall Study|Adverse Event|0
331542|NCT01266850|1119706|P2|Overall Study|Adverse Event|0
331543|NCT01266850|1119707|P1|Overall Study|Adverse Event|0
331544|NCT01266850|1119703|P5|Overall Study|Protocol Violation|2
331545|NCT01266850|1119704|P4|Overall Study|Protocol Violation|1
331546|NCT01266850|1119705|P3|Overall Study|Protocol Violation|0
331547|NCT01266850|1119706|P2|Overall Study|Protocol Violation|1
331548|NCT01266850|1119707|P1|Overall Study|Protocol Violation|0
331549|NCT01266850|1119703|P5|Overall Study|Physician Decision|3
331550|NCT01266850|1119704|P4|Overall Study|Physician Decision|4
331551|NCT01266850|1119705|P3|Overall Study|Physician Decision|4
331552|NCT01266850|1119706|P2|Overall Study|Physician Decision|6
331553|NCT01266850|1119707|P1|Overall Study|Physician Decision|3
331554|NCT01266850|1119703|P5|Overall Study|Withdrawal by Subject|12
331555|NCT01266850|1119704|P4|Overall Study|Withdrawal by Subject|9
331556|NCT01266850|1119705|P3|Overall Study|Withdrawal by Subject|6
331557|NCT01266850|1119706|P2|Overall Study|Withdrawal by Subject|9
331558|NCT01266850|1119707|P1|Overall Study|Withdrawal by Subject|8
331559|NCT01266850|1119703|P5|Overall Study|Lost to Follow-up|12
331560|NCT01266850|1119704|P4|Overall Study|Lost to Follow-up|13
331561|NCT01266850|1119705|P3|Overall Study|Lost to Follow-up|13
331562|NCT01266850|1119706|P2|Overall Study|Lost to Follow-up|19
331563|NCT01266850|1119707|P1|Overall Study|Lost to Follow-up|19
331564|NCT01266824|1119761|P2|Overall Study|Study terminated prior to completion|3
331565|NCT01266824|1119762|P1|Overall Study|Study terminated prior to completion|2
331566|NCT01266317|1119783|P1|Overall Study|Withdrawal by Subject|2
331567|NCT01266291|1119788|P1|Overall Study|Adverse Event|1
331568|NCT01266265|1119795|P2|Overall Study|Clinical worsening|1
331569|NCT01266265|1119796|P1|Overall Study|Clinical worsening|1
331570|NCT01266265|1119795|P2|Overall Study|Site closed early|3
331571|NCT01266265|1119796|P1|Overall Study|Site closed early|4
331572|NCT01266265|1119795|P2|Overall Study|Lung transplant|5
331573|NCT01266265|1119796|P1|Overall Study|Lung transplant|6
331574|NCT01266265|1119795|P2|Overall Study|Non-compliance|5
331575|NCT01266265|1119796|P1|Overall Study|Non-compliance|8
331576|NCT01266265|1119795|P2|Overall Study|Enrolled in another clinical study|26
331577|NCT01266265|1119796|P1|Overall Study|Enrolled in another clinical study|15
331578|NCT01266265|1119795|P2|Overall Study|Stopped/changed PAH medication(s)|9
331579|NCT01266265|1119796|P1|Overall Study|Stopped/changed PAH medication(s)|16
331580|NCT01266265|1119795|P2|Overall Study|Transferred care to another provider|28
331581|NCT01266265|1119796|P1|Overall Study|Transferred care to another provider|22
331582|NCT01266265|1119795|P2|Overall Study|Respiratory-related adverse event|1
331583|NCT01266265|1119796|P1|Overall Study|Respiratory-related adverse event|2
331584|NCT01266265|1119795|P2|Overall Study|Withdrawal by Subject|11
331585|NCT01266265|1119796|P1|Overall Study|Withdrawal by Subject|13
331586|NCT01266265|1119795|P2|Overall Study|Lost to Follow-up|28
331587|NCT01266265|1119796|P1|Overall Study|Lost to Follow-up|23
331588|NCT01266265|1119795|P2|Overall Study|Death|73
331589|NCT01266265|1119796|P1|Overall Study|Death|95
331590|NCT01266148|1119804|P2|Overall Study|missing mGFR value + AE|0
331591|NCT01266148|1119805|P1|Overall Study|missing mGFR value + AE|1
331592|NCT01266148|1119804|P2|Overall Study|Death|3
331593|NCT01266148|1119805|P1|Overall Study|Death|2
331594|NCT01266148|1119804|P2|Overall Study|2 2R rejections|0
331595|NCT01266148|1119805|P1|Overall Study|2 2R rejections|1
331596|NCT01266148|1119804|P2|Overall Study|Ongoing rejection|0
331597|NCT01266148|1119805|P1|Overall Study|Ongoing rejection|1
331598|NCT01266148|1119804|P2|Overall Study|Adverse Event|0
331599|NCT01266148|1119805|P1|Overall Study|Adverse Event|2
331600|NCT01266122|1119833|P2|Overall Study|Lost to Follow-up|6
331601|NCT01266122|1119834|P1|Overall Study|Lost to Follow-up|6
331602|NCT01266070|1119842|P1|Overall Study|Protocol Violation|1
331603|NCT01266070|1119842|P1|Overall Study|Adverse Event|3
331604|NCT01266031|1119850|P3|Overall Study|Adverse Event|3
331605|NCT01266031|1119851|P2|Overall Study|Adverse Event|0
331606|NCT01266031|1119852|P1|Overall Study|Adverse Event|0
331607|NCT01266031|1119850|P3|Overall Study|Not treated|0
331608|NCT01266031|1119851|P2|Overall Study|Not treated|3
331609|NCT01266031|1119852|P1|Overall Study|Not treated|0
331610|NCT01266018|1119860|P2|Overall Study|Progressive disease|1
331611|NCT01266018|1119861|P1|Overall Study|Progressive disease|0
331612|NCT01266018|1119860|P2|Overall Study|Physician Decision|0
331613|NCT01266018|1119861|P1|Overall Study|Physician Decision|1
331614|NCT01265992|1119872|P1|Overall Study|Did not receive treatment|1
331615|NCT01265992|1119872|P1|Overall Study|Stopped treatment|3
331616|NCT01265992|1119872|P1|Overall Study|Administrative reasons|2
331617|NCT01265992|1119872|P1|Overall Study|Adverse Event|1
331618|NCT01265992|1119872|P1|Overall Study|Withdrawal by Subject|1
331619|NCT01265992|1119872|P1|Overall Study|Lost to Follow-up|1
331620|NCT01265953|1119900|P2|Overall Study|Non compliance|3
331621|NCT01265953|1119901|P1|Overall Study|Non compliance|5
331622|NCT01265875|1119913|P1|Overall Study|Uncooperative/unreliable|1
331623|NCT01265823|1119921|P1|Overall Study|Participant Request|1
331624|NCT01265823|1119921|P1|Overall Study|Protocol Violation|1
331625|NCT01265823|1119921|P1|Overall Study|Failure to Return|4
331626|NCT01265823|1119921|P1|Overall Study|Unsatisfactory Response Efficacy|1
331627|NCT01265797|1119950|P2|Open Label Month|Lost to Follow-up|1
331628|NCT01265797|1119951|P1|Open Label Month|Lost to Follow-up|0
331629|NCT01265797|1119950|P2|Blinded Month|Diary data incomplete|1
331630|NCT01265797|1119951|P1|Blinded Month|Diary data incomplete|0
331631|NCT01265797|1119950|P2|Blinded Month|Adverse Event|0
331632|NCT01265797|1119951|P1|Blinded Month|Adverse Event|2
331633|NCT01265797|1119950|P2|Blinded Month|Protocol Violation|1
331634|NCT01265797|1119951|P1|Blinded Month|Protocol Violation|2
331635|NCT01265797|1119950|P2|Blinded Month|Lost to Follow-up|0
331636|NCT01265797|1119951|P1|Blinded Month|Lost to Follow-up|1
331637|NCT01265797|1119950|P2|Blinded Month|Lack of Efficacy|0
331638|NCT01265797|1119951|P1|Blinded Month|Lack of Efficacy|5
331639|NCT01265797|1119950|P2|Run-in Month|1st seizure during run-in month|1
331640|NCT01265797|1119951|P1|Run-in Month|1st seizure during run-in month|0
331641|NCT01265797|1119950|P2|Run-in Month|Withdrawal by Subject|4
331642|NCT01265797|1119951|P1|Run-in Month|Withdrawal by Subject|0
331643|NCT01265784|1119982|P3|Overall Study|Incorrectly Randomized|1
331644|NCT01265784|1119983|P2|Overall Study|Incorrectly Randomized|0
331645|NCT01265784|1119984|P1|Overall Study|Incorrectly Randomized|0
331646|NCT01265784|1119982|P3|Overall Study|Protocol Violation|0
331647|NCT01265784|1119983|P2|Overall Study|Protocol Violation|0
331648|NCT01265784|1119984|P1|Overall Study|Protocol Violation|2
331649|NCT01265784|1119982|P3|Overall Study|Death|0
331650|NCT01265784|1119983|P2|Overall Study|Death|0
331651|NCT01265784|1119984|P1|Overall Study|Death|3
331652|NCT01265784|1119982|P3|Overall Study|Adverse Event|0
331653|NCT01265784|1119983|P2|Overall Study|Adverse Event|0
331654|NCT01265784|1119984|P1|Overall Study|Adverse Event|1
331655|NCT01265784|1119982|P3|Overall Study|Physician Decision|1
331656|NCT01265784|1119983|P2|Overall Study|Physician Decision|0
331657|NCT01265784|1119984|P1|Overall Study|Physician Decision|1
331658|NCT01265784|1119982|P3|Overall Study|Withdrawal by Subject|0
331659|NCT01265784|1119983|P2|Overall Study|Withdrawal by Subject|5
331660|NCT01265784|1119984|P1|Overall Study|Withdrawal by Subject|0
331661|NCT01265784|1119982|P3|Overall Study|Lost to Follow-up|2
331662|NCT01265784|1119983|P2|Overall Study|Lost to Follow-up|3
331663|NCT01265784|1119984|P1|Overall Study|Lost to Follow-up|5
331664|NCT01265615|1120069|P4|Overall Study|Protocol Violation|3
331665|NCT01265615|1120070|P3|Overall Study|Protocol Violation|4
331666|NCT01265615|1120071|P2|Overall Study|Protocol Violation|2
331667|NCT01265615|1120072|P1|Overall Study|Protocol Violation|2
331668|NCT01265563|1120123|P5|Overall Study|Withdrawal by Subject|2
331669|NCT01265563|1120124|P4|Overall Study|Withdrawal by Subject|0
331670|NCT01265563|1120125|P3|Overall Study|Withdrawal by Subject|1
331671|NCT01265563|1120126|P2|Overall Study|Withdrawal by Subject|1
331672|NCT01265563|1120127|P1|Overall Study|Withdrawal by Subject|0
331673|NCT01265511|1120222|P2|Overall Study|Met stopping rules|2
331674|NCT01265511|1120223|P1|Overall Study|Met stopping rules|0
331675|NCT01265511|1120222|P2|Overall Study|Lack of Efficacy|1
331676|NCT01265511|1120223|P1|Overall Study|Lack of Efficacy|2
331677|NCT01265498|1120237|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
331678|NCT01265498|1120238|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
331679|NCT01265420|1120374|P1|Overall Study|Lost to Follow-up|1
331680|NCT01265394|1120378|P1|Overall Study|Subjects withdrawn|37
331681|NCT01265056|1120385|P2|Follow up|Lost to Follow-up|3
331682|NCT01265056|1120386|P1|Follow up|Lost to Follow-up|7
331683|NCT01265056|1120385|P2|Initial Study Period|Withdrawal by Subject|1
331684|NCT01265056|1120386|P1|Initial Study Period|Withdrawal by Subject|1
331685|NCT01265056|1120385|P2|Initial Study Period|Withdrawal by Subject|1
331686|NCT01265056|1120386|P1|Initial Study Period|Withdrawal by Subject|1
331687|NCT01264939|1120417|P2|Overall Study|Disease Progression|11
331688|NCT01264939|1120418|P1|Overall Study|Disease Progression|8
331689|NCT01264939|1120417|P2|Overall Study|Patient/Guardian Decision|10
331690|NCT01264939|1120418|P1|Overall Study|Patient/Guardian Decision|8
331691|NCT01264939|1120417|P2|Overall Study|Physician Decision|1
331692|NCT01264939|1120418|P1|Overall Study|Physician Decision|1
331693|NCT01264939|1120417|P2|Overall Study|Lost to Follow-up|3
331694|NCT01264939|1120418|P1|Overall Study|Lost to Follow-up|0
331695|NCT01264939|1120417|P2|Overall Study|Adverse Event|3
331696|NCT01264939|1120418|P1|Overall Study|Adverse Event|1
331697|NCT01264887|1120444|P1|Overall Study|Not Specified|2
331698|NCT01264887|1120444|P1|Overall Study|Sponsor Decision Administrative Reasons|2
331699|NCT01264887|1120444|P1|Overall Study|Withdrawal by Subject|6
331700|NCT01264887|1120444|P1|Overall Study|Physician Decision|4
331701|NCT01264887|1120444|P1|Overall Study|Lack of Efficacy|5
331702|NCT01264887|1120444|P1|Overall Study|Death|7
331703|NCT01264887|1120444|P1|Overall Study|Adverse Event|5
331704|NCT01264835|1120455|P1|Overall Study|Lost to Follow-up|1
331705|NCT01264770|1120465|P6|Overall Study|Adverse Event|1
331706|NCT01264770|1120466|P5|Overall Study|Adverse Event|2
331707|NCT01264770|1120467|P4|Overall Study|Adverse Event|0
331708|NCT01264770|1120468|P3|Overall Study|Adverse Event|8
331709|NCT01264770|1120469|P2|Overall Study|Adverse Event|7
331710|NCT01264770|1120470|P1|Overall Study|Adverse Event|7
331711|NCT01264770|1120465|P6|Overall Study|Lost to Follow-up|0
331712|NCT01264770|1120466|P5|Overall Study|Lost to Follow-up|0
331713|NCT01264770|1120467|P4|Overall Study|Lost to Follow-up|1
331714|NCT01264770|1120468|P3|Overall Study|Lost to Follow-up|1
331715|NCT01264770|1120469|P2|Overall Study|Lost to Follow-up|0
331716|NCT01264770|1120470|P1|Overall Study|Lost to Follow-up|0
331717|NCT01264770|1120465|P6|Overall Study|Dev. of study specific discont. criteria|1
331718|NCT01264770|1120466|P5|Overall Study|Dev. of study specific discont. criteria|1
331719|NCT01264770|1120467|P4|Overall Study|Dev. of study specific discont. criteria|0
331720|NCT01264770|1120468|P3|Overall Study|Dev. of study specific discont. criteria|0
331721|NCT01264770|1120469|P2|Overall Study|Dev. of study specific discont. criteria|0
331722|NCT01264770|1120470|P1|Overall Study|Dev. of study specific discont. criteria|2
331723|NCT01264770|1120465|P6|Overall Study|Lack of therapeutic response|0
331724|NCT01264770|1120466|P5|Overall Study|Lack of therapeutic response|1
331725|NCT01264770|1120467|P4|Overall Study|Lack of therapeutic response|1
331726|NCT01264770|1120468|P3|Overall Study|Lack of therapeutic response|2
331727|NCT01264770|1120469|P2|Overall Study|Lack of therapeutic response|0
331728|NCT01264770|1120470|P1|Overall Study|Lack of therapeutic response|1
331729|NCT01264770|1120465|P6|Overall Study|Severe non-compliance to protocol|0
331730|NCT01264770|1120466|P5|Overall Study|Severe non-compliance to protocol|0
331731|NCT01264770|1120467|P4|Overall Study|Severe non-compliance to protocol|1
331732|NCT01264770|1120468|P3|Overall Study|Severe non-compliance to protocol|1
331733|NCT01264770|1120469|P2|Overall Study|Severe non-compliance to protocol|0
331734|NCT01264770|1120470|P1|Overall Study|Severe non-compliance to protocol|0
331735|NCT01264770|1120465|P6|Overall Study|e.g., change in circumstances|4
331736|NCT01264770|1120466|P5|Overall Study|e.g., change in circumstances|4
331737|NCT01264770|1120467|P4|Overall Study|e.g., change in circumstances|3
331738|NCT01264770|1120468|P3|Overall Study|e.g., change in circumstances|3
331739|NCT01264770|1120469|P2|Overall Study|e.g., change in circumstances|3
331740|NCT01264770|1120470|P1|Overall Study|e.g., change in circumstances|8
331741|NCT01264770|1120465|P6|Overall Study|Not reported|0
331742|NCT01264770|1120466|P5|Overall Study|Not reported|0
331743|NCT01264770|1120467|P4|Overall Study|Not reported|0
331744|NCT01264770|1120468|P3|Overall Study|Not reported|1
331745|NCT01264770|1120469|P2|Overall Study|Not reported|0
331746|NCT01264770|1120470|P1|Overall Study|Not reported|0
331747|NCT01264679|1120554|P1|Overall Study|Withdrawal by Subject|1
331748|NCT01264679|1120554|P1|Overall Study|Sponsor's Suspension of Dosing|2
331749|NCT01264679|1120554|P1|Overall Study|Physician Decision|1
331750|NCT01264679|1120554|P1|Overall Study|Participation in Another Clinical Trial|1
331751|NCT01264380|1120588|P3|Period C|Adverse Event|1
331752|NCT01264380|1120589|P2|Period C|Adverse Event|0
331753|NCT01264380|1120590|P1|Period C|Adverse Event|0
331754|NCT01264380|1120588|P3|Period C|Withdrawal by Subject|1
331755|NCT01264380|1120589|P2|Period C|Withdrawal by Subject|0
331756|NCT01264380|1120590|P1|Period C|Withdrawal by Subject|0
331757|NCT01264380|1120588|P3|Period C|Follow-up for survival status|6
331758|NCT01264380|1120589|P2|Period C|Follow-up for survival status|0
331759|NCT01264380|1120590|P1|Period C|Follow-up for survival status|0
331760|NCT01264380|1120588|P3|Period C|Death|2
331761|NCT01264380|1120589|P2|Period C|Death|0
331762|NCT01264380|1120590|P1|Period C|Death|0
331763|NCT01264380|1120588|P3|Period C|Disease Progression|4
331764|NCT01264380|1120589|P2|Period C|Disease Progression|0
331765|NCT01264380|1120590|P1|Period C|Disease Progression|0
331766|NCT01264081|1120611|P1|Started Treatment|Not complete cycle 1 due to death|1
331767|NCT01264081|1120611|P1|Started Treatment|Withdrawal by Subject|1
331768|NCT01264081|1120611|P1|Participants Screened|Screening failures|30
331769|NCT01264016|1120616|P1|Overall Study|Felt faint at sight of blood|1
331770|NCT01264016|1120616|P1|Overall Study|Withdrawal by Subject|1
331771|NCT01263925|1120624|P2|Overall Study|Withdrawal/ Not specified|1
331772|NCT01263925|1120625|P1|Overall Study|Withdrawal/ Not specified|0
331773|NCT01263925|1120624|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
331774|NCT01263925|1120625|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
331775|NCT01263925|1120624|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
331776|NCT01263925|1120625|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
331777|NCT01263925|1120624|P2|Overall Study|AE/ Withdrawal|4
331778|NCT01263925|1120625|P1|Overall Study|AE/ Withdrawal|1
331779|NCT01263925|1120624|P2|Overall Study|AE/ Unsatisfactory Compliance|2
331780|NCT01263925|1120625|P1|Overall Study|AE/ Unsatisfactory Compliance|2
331781|NCT01263925|1120624|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
331782|NCT01263925|1120625|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
331783|NCT01263925|1120624|P2|Overall Study|Lost to Follow-up|1
331784|NCT01263925|1120625|P1|Overall Study|Lost to Follow-up|3
331785|NCT01263925|1120624|P2|Overall Study|Not specified|4
331786|NCT01263925|1120625|P1|Overall Study|Not specified|4
331787|NCT01263925|1120624|P2|Overall Study|Withdrawal by Subject|8
331788|NCT01263925|1120625|P1|Overall Study|Withdrawal by Subject|6
331789|NCT01263925|1120624|P2|Overall Study|Unsatisfactory Compliance of Subject|5
331790|NCT01263925|1120625|P1|Overall Study|Unsatisfactory Compliance of Subject|8
331791|NCT01263925|1120624|P2|Overall Study|Adverse Event|22
331792|NCT01263925|1120625|P1|Overall Study|Adverse Event|23
331793|NCT01263925|1120624|P2|Overall Study|Lack of Efficacy|1
331794|NCT01263925|1120625|P1|Overall Study|Lack of Efficacy|0
331795|NCT01263925|1120624|P2|Overall Study|Protocol Violation|0
331796|NCT01263925|1120625|P1|Overall Study|Protocol Violation|1
331797|NCT01263873|1120659|P2|Overall Study|One provider unable to complete numbers|1
331798|NCT01263873|1120660|P1|Overall Study|One provider unable to complete numbers|1
331799|NCT01263704|1120701|P1|Overall Study|Principal Investigator (PI) decision|1
331800|NCT01263704|1120701|P1|Overall Study|Colon metastases|1
331801|NCT01263704|1120701|P1|Overall Study|Lost to Follow-up|1
331802|NCT01263704|1120701|P1|Overall Study|Eligibility criteria not fulfilled|1
331803|NCT01263704|1120701|P1|Overall Study|Patient withdrew consent|2
331804|NCT01263704|1120701|P1|Overall Study|Death|2
331805|NCT01263704|1120701|P1|Overall Study|Adverse Event|3
331806|NCT01263704|1120701|P1|Overall Study|Progressive disease|18
331807|NCT01263691|1120716|P6|Overall Study|Adverse Event|0
331808|NCT01263691|1120717|P5|Overall Study|Adverse Event|0
331809|NCT01263691|1120718|P4|Overall Study|Adverse Event|0
331810|NCT01263691|1120719|P3|Overall Study|Adverse Event|0
331811|NCT01263691|1120720|P2|Overall Study|Adverse Event|0
331812|NCT01263691|1120721|P1|Overall Study|Adverse Event|1
331813|NCT01263691|1120716|P6|Overall Study|Withdrawal by Subject|0
331814|NCT01263691|1120717|P5|Overall Study|Withdrawal by Subject|0
331815|NCT01263691|1120718|P4|Overall Study|Withdrawal by Subject|0
331816|NCT01263691|1120719|P3|Overall Study|Withdrawal by Subject|0
331817|NCT01263691|1120720|P2|Overall Study|Withdrawal by Subject|0
331818|NCT01263691|1120721|P1|Overall Study|Withdrawal by Subject|1
331819|NCT01263691|1120716|P6|Overall Study|Lost to Follow-up|0
331820|NCT01263691|1120717|P5|Overall Study|Lost to Follow-up|0
331821|NCT01263691|1120718|P4|Overall Study|Lost to Follow-up|1
331822|NCT01263691|1120719|P3|Overall Study|Lost to Follow-up|1
331823|NCT01263691|1120720|P2|Overall Study|Lost to Follow-up|0
331824|NCT01263691|1120721|P1|Overall Study|Lost to Follow-up|1
331825|NCT01263665|1120831|P1|Overall Study|Surgical Bypass|2
331826|NCT01263665|1120831|P1|Overall Study|Amputation above the ankle|1
331827|NCT01263665|1120831|P1|Overall Study|Death|2
331828|NCT01263665|1120831|P1|Overall Study|Lost to Follow-up|3
331829|NCT01263665|1120831|P1|Overall Study|Withdrew Consent|1
331830|NCT01263639|1120838|P2|Overall Study|Exclusion =Admission greater than 7 days|9
331831|NCT01263639|1120839|P1|Overall Study|Exclusion =Admission greater than 7 days|7
331832|NCT01263639|1120838|P2|Overall Study|Lost to Follow-up|70
331833|NCT01263639|1120839|P1|Overall Study|Lost to Follow-up|66
331834|NCT01263561|1120847|P2|Overall Study|Death|2
331835|NCT01263561|1120848|P1|Overall Study|Death|1
331836|NCT01263509|1120860|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
331837|NCT01263509|1120861|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
331838|NCT01263509|1120862|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
331839|NCT01263509|1120863|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
331840|NCT01263509|1120860|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
331841|NCT01263509|1120861|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
331842|NCT01263509|1120862|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
331843|NCT01263509|1120863|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
331844|NCT01263509|1120860|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
331845|NCT01263509|1120861|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
331846|NCT01263509|1120862|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
331847|NCT01263509|1120863|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
331848|NCT01263509|1120860|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
331849|NCT01263509|1120861|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
331850|NCT01263509|1120862|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
331851|NCT01263509|1120863|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
331852|NCT01263509|1120860|P4|Entered - Long-Term Extension Study|Adverse Event|1
331853|NCT01263509|1120861|P3|Entered - Long-Term Extension Study|Adverse Event|4
331854|NCT01263509|1120862|P2|Entered - Long-Term Extension Study|Adverse Event|5
331855|NCT01263509|1120863|P1|Entered - Long-Term Extension Study|Adverse Event|5
331856|NCT01263496|1120992|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
331857|NCT01263496|1120993|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
331858|NCT01263496|1120994|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
331859|NCT01263496|1120995|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
331860|NCT01263496|1120996|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
331861|NCT01263496|1120997|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
331862|NCT01263496|1120998|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
331863|NCT01263496|1120999|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
331864|NCT01263496|1121000|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
331865|NCT01263496|1120992|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
331866|NCT01263496|1120993|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
331867|NCT01263496|1120994|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
331868|NCT01263496|1120995|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
331869|NCT01263496|1120996|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
331870|NCT01263496|1120997|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
331871|NCT01263496|1120998|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
331872|NCT01263496|1120999|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
331873|NCT01263496|1121000|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
331874|NCT01263496|1120992|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
331875|NCT01263496|1120993|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
331876|NCT01263496|1120994|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
331877|NCT01263496|1120995|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
331878|NCT01263496|1120996|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
331879|NCT01263496|1120997|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
331880|NCT01263496|1120998|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
331881|NCT01263496|1120999|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
331882|NCT01263496|1121000|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
331883|NCT01263496|1120992|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
331884|NCT01263496|1120993|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
331885|NCT01263496|1120994|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
331886|NCT01263496|1120995|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
331887|NCT01263496|1120996|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
331888|NCT01263496|1120997|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
331889|NCT01263496|1120998|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
331890|NCT01263496|1120999|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
331891|NCT01263496|1121000|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
331892|NCT01263496|1120992|P9|Entered - Long-Term Extension Study|Adverse Event|1
331893|NCT01263496|1120993|P8|Entered - Long-Term Extension Study|Adverse Event|0
331894|NCT01263496|1120994|P7|Entered - Long-Term Extension Study|Adverse Event|0
331895|NCT01263496|1120995|P6|Entered - Long-Term Extension Study|Adverse Event|0
331896|NCT01263496|1120996|P5|Entered - Long-Term Extension Study|Adverse Event|1
331897|NCT01263496|1120997|P4|Entered - Long-Term Extension Study|Adverse Event|3
331898|NCT01263496|1120998|P3|Entered - Long-Term Extension Study|Adverse Event|6
331899|NCT01263496|1120999|P2|Entered - Long-Term Extension Study|Adverse Event|5
331900|NCT01263496|1121000|P1|Entered - Long-Term Extension Study|Adverse Event|0
331901|NCT01263496|1120992|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
331902|NCT01263496|1120993|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
331903|NCT01263496|1120994|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
331904|NCT01263496|1120995|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
331905|NCT01263496|1120996|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
331906|NCT01263496|1120997|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
331907|NCT01263496|1120998|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
331908|NCT01263496|1120999|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
331909|NCT01263496|1121000|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
331910|NCT01263496|1120992|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
331911|NCT01263496|1120993|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
331912|NCT01263496|1120994|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
331913|NCT01263496|1120995|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
331914|NCT01263496|1120996|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
331915|NCT01263496|1120997|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
331916|NCT01263496|1120998|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
331917|NCT01263496|1120999|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
331918|NCT01263496|1121000|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
331919|NCT01263483|1121295|P3|Overall Study|Participant Unavailability|1
331920|NCT01263483|1121296|P2|Overall Study|Participant Unavailability|1
331921|NCT01263483|1121297|P1|Overall Study|Participant Unavailability|0
331922|NCT01263483|1121295|P3|Overall Study|Protocol Violation|1
331923|NCT01263483|1121296|P2|Overall Study|Protocol Violation|1
331924|NCT01263483|1121297|P1|Overall Study|Protocol Violation|0
331925|NCT01263483|1121295|P3|Overall Study|Lack of Efficacy|0
331926|NCT01263483|1121296|P2|Overall Study|Lack of Efficacy|0
331927|NCT01263483|1121297|P1|Overall Study|Lack of Efficacy|2
331928|NCT01263483|1121295|P3|Overall Study|Withdrawal by Subject|0
331929|NCT01263483|1121296|P2|Overall Study|Withdrawal by Subject|0
331930|NCT01263483|1121297|P1|Overall Study|Withdrawal by Subject|1
331931|NCT01263483|1121295|P3|Overall Study|Adverse Event|3
331932|NCT01263483|1121296|P2|Overall Study|Adverse Event|0
331933|NCT01263483|1121297|P1|Overall Study|Adverse Event|4
331934|NCT01263470|1121359|P6|Overall Study|Study Drug Non-compliance|0
331935|NCT01263470|1121360|P5|Overall Study|Study Drug Non-compliance|1
331936|NCT01263470|1121361|P4|Overall Study|Study Drug Non-compliance|0
331937|NCT01263470|1121362|P3|Overall Study|Study Drug Non-compliance|0
331938|NCT01263470|1121363|P2|Overall Study|Study Drug Non-compliance|0
331939|NCT01263470|1121364|P1|Overall Study|Study Drug Non-compliance|0
331940|NCT01263470|1121359|P6|Overall Study|Participant Unavailability|0
331941|NCT01263470|1121360|P5|Overall Study|Participant Unavailability|0
331942|NCT01263470|1121361|P4|Overall Study|Participant Unavailability|0
331943|NCT01263470|1121362|P3|Overall Study|Participant Unavailability|0
331944|NCT01263470|1121363|P2|Overall Study|Participant Unavailability|1
331945|NCT01263470|1121364|P1|Overall Study|Participant Unavailability|0
331946|NCT01263470|1121359|P6|Overall Study|Lack of Efficacy|0
331947|NCT01263470|1121360|P5|Overall Study|Lack of Efficacy|0
331948|NCT01263470|1121361|P4|Overall Study|Lack of Efficacy|0
331949|NCT01263470|1121362|P3|Overall Study|Lack of Efficacy|2
331950|NCT01263470|1121363|P2|Overall Study|Lack of Efficacy|0
331951|NCT01263470|1121364|P1|Overall Study|Lack of Efficacy|0
331952|NCT01263470|1121359|P6|Overall Study|Withdrawal by Subject|2
331953|NCT01263470|1121360|P5|Overall Study|Withdrawal by Subject|0
331954|NCT01263470|1121361|P4|Overall Study|Withdrawal by Subject|2
331955|NCT01263470|1121362|P3|Overall Study|Withdrawal by Subject|1
331956|NCT01263470|1121363|P2|Overall Study|Withdrawal by Subject|1
331957|NCT01263470|1121364|P1|Overall Study|Withdrawal by Subject|0
331958|NCT01263470|1121359|P6|Overall Study|Protocol Violation|1
331959|NCT01263470|1121360|P5|Overall Study|Protocol Violation|0
331960|NCT01263470|1121361|P4|Overall Study|Protocol Violation|0
331961|NCT01263470|1121362|P3|Overall Study|Protocol Violation|0
331962|NCT01263470|1121363|P2|Overall Study|Protocol Violation|1
331963|NCT01263470|1121364|P1|Overall Study|Protocol Violation|0
331964|NCT01263470|1121359|P6|Overall Study|Adverse Event|2
331965|NCT01263470|1121360|P5|Overall Study|Adverse Event|2
331966|NCT01263470|1121361|P4|Overall Study|Adverse Event|1
331967|NCT01263470|1121362|P3|Overall Study|Adverse Event|1
331968|NCT01263470|1121363|P2|Overall Study|Adverse Event|2
331969|NCT01263470|1121364|P1|Overall Study|Adverse Event|2
331970|NCT01263444|1121474|P1|Overall Study|Protocol Violation|1
331971|NCT01263444|1121474|P1|Overall Study|Withdrawal by Subject|1
331972|NCT01263444|1121474|P1|Overall Study|Adverse Event|8
331973|NCT01263054|1121515|P2|Overall Study|Other|1
331974|NCT01263054|1121516|P1|Overall Study|Other|0
331975|NCT01263054|1121515|P2|Overall Study|Qualification Violation|0
331976|NCT01263054|1121516|P1|Overall Study|Qualification Violation|1
331977|NCT01263054|1121515|P2|Overall Study|Withdrawal by Subject|3
331978|NCT01263054|1121516|P1|Overall Study|Withdrawal by Subject|1
331979|NCT01263054|1121515|P2|Overall Study|Lost to Follow-up|2
331980|NCT01263054|1121516|P1|Overall Study|Lost to Follow-up|2
331981|NCT01263054|1121515|P2|Overall Study|Death|0
331982|NCT01263054|1121516|P1|Overall Study|Death|1
331983|NCT01263028|1121534|P1|Overall Study|Study terminated due to low enrollment.|4
331984|NCT01263028|1121534|P1|Overall Study|Adverse Event|1
331985|NCT01263028|1121534|P1|Overall Study|Withdrawal by Subject|1
331986|NCT01263015|1121544|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
331987|NCT01263015|1121545|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
331988|NCT01263015|1121544|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
331989|NCT01263015|1121545|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
331990|NCT01263015|1121544|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
331991|NCT01263015|1121545|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
331992|NCT01263015|1121544|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
331993|NCT01263015|1121545|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
331994|NCT01263015|1121544|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
331995|NCT01263015|1121545|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
331996|NCT01263015|1121544|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
331997|NCT01263015|1121545|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
331998|NCT01263015|1121544|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
331999|NCT01263015|1121545|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
332000|NCT01263015|1121544|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
332001|NCT01263015|1121545|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
332002|NCT01263015|1121544|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
332003|NCT01263015|1121545|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
332004|NCT01263015|1121544|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
332005|NCT01263015|1121545|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
332006|NCT01263015|1121544|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
332007|NCT01263015|1121545|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
332008|NCT01263015|1121544|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
332009|NCT01263015|1121545|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
332010|NCT01262989|1121571|P2|Period 2|Intercurrent disease|1
332011|NCT01262989|1121572|P1|Period 2|Intercurrent disease|0
332012|NCT01262989|1121571|P2|Period 1|Positive answer for exclusion criteria|1
332013|NCT01262989|1121572|P1|Period 1|Positive answer for exclusion criteria|0
332014|NCT01262989|1121571|P2|Period 1|Intercurrent disease|1
332015|NCT01262989|1121572|P1|Period 1|Intercurrent disease|0
332016|NCT01262989|1121571|P2|Period 1|Lost to Follow-up|1
332017|NCT01262989|1121572|P1|Period 1|Lost to Follow-up|1
332018|NCT01262898|1121586|P4|Overall Study|Withdrawal by Subject|0
332019|NCT01262898|1121587|P3|Overall Study|Withdrawal by Subject|0
332020|NCT01262898|1121588|P2|Overall Study|Withdrawal by Subject|1
332021|NCT01262898|1121589|P1|Overall Study|Withdrawal by Subject|1
332022|NCT01262898|1121586|P4|Overall Study|Lost to Follow-up|0
332023|NCT01262898|1121587|P3|Overall Study|Lost to Follow-up|0
332024|NCT01262898|1121588|P2|Overall Study|Lost to Follow-up|0
332025|NCT01262898|1121589|P1|Overall Study|Lost to Follow-up|1
332026|NCT01262898|1121586|P4|Overall Study|Protocol Violation|0
332027|NCT01262898|1121587|P3|Overall Study|Protocol Violation|0
332028|NCT01262898|1121588|P2|Overall Study|Protocol Violation|1
332029|NCT01262898|1121589|P1|Overall Study|Protocol Violation|1
332030|NCT01262872|1121717|P8|Step 2|Migrated/moved from study area|3
332031|NCT01262872|1121718|P7|Step 2|Migrated/moved from study area|2
332032|NCT01262872|1121719|P6|Step 2|Migrated/moved from study area|6
332033|NCT01262872|1121720|P5|Step 2|Migrated/moved from study area|2
332034|NCT01262872|1121721|P4|Step 2|Migrated/moved from study area|3
332035|NCT01262872|1121722|P3|Step 2|Migrated/moved from study area|4
332036|NCT01262872|1121723|P2|Step 2|Migrated/moved from study area|0
332037|NCT01262872|1121724|P1|Step 2|Migrated/moved from study area|0
332038|NCT01262872|1121717|P8|Step 2|Withdrawal by Subject|1
332039|NCT01262872|1121718|P7|Step 2|Withdrawal by Subject|2
332040|NCT01262872|1121719|P6|Step 2|Withdrawal by Subject|1
332041|NCT01262872|1121720|P5|Step 2|Withdrawal by Subject|3
332042|NCT01262872|1121721|P4|Step 2|Withdrawal by Subject|6
332043|NCT01262872|1121722|P3|Step 2|Withdrawal by Subject|4
332044|NCT01262872|1121723|P2|Step 2|Withdrawal by Subject|0
332045|NCT01262872|1121724|P1|Step 2|Withdrawal by Subject|0
332046|NCT01262872|1121717|P8|Step 2|Protocol Violation|1
332047|NCT01262872|1121718|P7|Step 2|Protocol Violation|3
332048|NCT01262872|1121719|P6|Step 2|Protocol Violation|0
332049|NCT01262872|1121720|P5|Step 2|Protocol Violation|0
332050|NCT01262872|1121721|P4|Step 2|Protocol Violation|0
332051|NCT01262872|1121722|P3|Step 2|Protocol Violation|1
332052|NCT01262872|1121723|P2|Step 2|Protocol Violation|0
332053|NCT01262872|1121724|P1|Step 2|Protocol Violation|0
332054|NCT01262872|1121717|P8|Step 2|Death|1
332055|NCT01262872|1121718|P7|Step 2|Death|2
332056|NCT01262872|1121719|P6|Step 2|Death|2
332057|NCT01262872|1121720|P5|Step 2|Death|0
332058|NCT01262872|1121721|P4|Step 2|Death|1
332059|NCT01262872|1121722|P3|Step 2|Death|0
332060|NCT01262872|1121723|P2|Step 2|Death|0
332061|NCT01262872|1121724|P1|Step 2|Death|0
332062|NCT01262820|1121986|P1|Overall Study|Drug held for 21+ days|1
332063|NCT01262820|1121986|P1|Overall Study|Lack of Efficacy|9
332064|NCT01262820|1121986|P1|Overall Study|Adverse Event|5
332065|NCT01262677|1122000|P3|Overall Study|Adverse Event (AE) related to study drug|3
332066|NCT01262677|1122001|P2|Overall Study|Adverse Event (AE) related to study drug|8
332067|NCT01262677|1122002|P1|Overall Study|Adverse Event (AE) related to study drug|3
332068|NCT01262677|1122000|P3|Overall Study|Protocol Violation|1
332069|NCT01262677|1122001|P2|Overall Study|Protocol Violation|1
332070|NCT01262677|1122002|P1|Overall Study|Protocol Violation|0
332071|NCT01262677|1122000|P3|Overall Study|Reason not provided|3
332072|NCT01262677|1122001|P2|Overall Study|Reason not provided|1
332073|NCT01262677|1122002|P1|Overall Study|Reason not provided|2
332074|NCT01262677|1122000|P3|Overall Study|No longer willing to participate|2
332075|NCT01262677|1122001|P2|Overall Study|No longer willing to participate|3
332076|NCT01262677|1122002|P1|Overall Study|No longer willing to participate|3
332077|NCT01262677|1122000|P3|Overall Study|Lost to Follow-up|2
332078|NCT01262677|1122001|P2|Overall Study|Lost to Follow-up|0
332079|NCT01262677|1122002|P1|Overall Study|Lost to Follow-up|1
332080|NCT01262677|1122000|P3|Overall Study|Insufficient clinical response|1
332081|NCT01262677|1122001|P2|Overall Study|Insufficient clinical response|0
332082|NCT01262677|1122002|P1|Overall Study|Insufficient clinical response|0
332083|NCT01262677|1122000|P3|Overall Study|Does not meet entrance criteria|0
332084|NCT01262677|1122001|P2|Overall Study|Does not meet entrance criteria|2
332085|NCT01262677|1122002|P1|Overall Study|Does not meet entrance criteria|0
332086|NCT01262651|1122093|P2|Overall Study|Met Withdrawal Criteria|0
332087|NCT01262651|1122094|P1|Overall Study|Met Withdrawal Criteria|1
332088|NCT01262651|1122093|P2|Overall Study|Withdrawal by Investigator|2
332089|NCT01262651|1122094|P1|Overall Study|Withdrawal by Investigator|2
332090|NCT01262651|1122093|P2|Overall Study|Withdrawal by Subject|11
332091|NCT01262651|1122094|P1|Overall Study|Withdrawal by Subject|15
332092|NCT01262651|1122093|P2|Overall Study|Adverse Event|35
332093|NCT01262651|1122094|P1|Overall Study|Adverse Event|40
332094|NCT01262573|1122131|P2|Overall Study|Withdrawal by Subject|1
332095|NCT01262573|1122132|P1|Overall Study|Withdrawal by Subject|0
332096|NCT01262560|1122143|P3|Overall Study|Protocol Violation|2
332097|NCT01262560|1122144|P2|Overall Study|Protocol Violation|1
332098|NCT01262560|1122145|P1|Overall Study|Protocol Violation|0
332099|NCT01262456|1122194|P3|1-Month Open-Label Extension Period|Other Reason|0
332100|NCT01262456|1122195|P2|1-Month Open-Label Extension Period|Other Reason|1
332101|NCT01262456|1122196|P1|1-Month Open-Label Extension Period|Other Reason|0
332102|NCT01262456|1122194|P3|1-Month Open-Label Extension Period|Protocol Violation|2
332103|NCT01262456|1122195|P2|1-Month Open-Label Extension Period|Protocol Violation|0
332104|NCT01262456|1122196|P1|1-Month Open-Label Extension Period|Protocol Violation|1
332105|NCT01262456|1122194|P3|1-Month Open-Label Extension Period|Adverse Event|2
332106|NCT01262456|1122195|P2|1-Month Open-Label Extension Period|Adverse Event|0
332107|NCT01262456|1122196|P1|1-Month Open-Label Extension Period|Adverse Event|2
332108|NCT01262456|1122194|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
332109|NCT01262456|1122195|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
332110|NCT01262456|1122196|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
332111|NCT01262456|1122194|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
332112|NCT01262456|1122195|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
332113|NCT01262456|1122196|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
332114|NCT01262456|1122194|P3|3-Month Double-Blind Period|Protocol Violation|6
332115|NCT01262456|1122195|P2|3-Month Double-Blind Period|Protocol Violation|6
332116|NCT01262456|1122196|P1|3-Month Double-Blind Period|Protocol Violation|3
332117|NCT01262456|1122194|P3|3-Month Double-Blind Period|Adverse Event|8
332118|NCT01262456|1122195|P2|3-Month Double-Blind Period|Adverse Event|4
332119|NCT01262456|1122196|P1|3-Month Double-Blind Period|Adverse Event|6
332120|NCT01262456|1122194|P3|3-Month Double-Blind Period|Lost to Follow-up|3
332121|NCT01262456|1122195|P2|3-Month Double-Blind Period|Lost to Follow-up|5
332122|NCT01262456|1122196|P1|3-Month Double-Blind Period|Lost to Follow-up|4
332123|NCT01262456|1122194|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
332124|NCT01262456|1122195|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
332125|NCT01262456|1122196|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
332168|NCT01262352|1122267|P2|Washout|Extended Washout|1
332169|NCT01262352|1122268|P1|Washout|Extended Washout|0
332170|NCT01262352|1122267|P2|Washout|Adverse Event|1
332171|NCT01262352|1122268|P1|Washout|Adverse Event|1
332172|NCT01262352|1122267|P2|Period 1|Illness after randomization|0
332173|NCT01262352|1122268|P1|Period 1|Illness after randomization|1
332174|NCT01262287|1122286|P2|Overall Study|Lost to Follow-up|1
332175|NCT01262287|1122287|P1|Overall Study|Lost to Follow-up|2
332176|NCT01262092|1122348|P2|Gabapentin Taper|noncompliance - missed medications|0
332177|NCT01262092|1122349|P1|Gabapentin Taper|noncompliance - missed medications|1
332178|NCT01262092|1122348|P2|Buprenorphine Taper|noncompliance - missed medication|1
332179|NCT01262092|1122349|P1|Buprenorphine Taper|noncompliance - missed medication|1
332180|NCT01262092|1122348|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
332181|NCT01262092|1122349|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
332182|NCT01262092|1122348|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
332183|NCT01262092|1122349|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
332184|NCT01262027|1122355|P1|Overall Study|Protocol Violation|1
332185|NCT01262027|1122355|P1|Overall Study|Withdrawal by Subject|3
332186|NCT01262027|1122355|P1|Overall Study|Adverse Event|1
332187|NCT01261975|1122360|P1|Overall Study|Surgical complication|1
332233|NCT01261780|1122409|P2|Overall Study|Event not related to subject|2
332234|NCT01261780|1122410|P1|Overall Study|Event not related to subject|1
332235|NCT01261780|1122409|P2|Overall Study|Withdrawal by Subject|0
332236|NCT01261780|1122410|P1|Overall Study|Withdrawal by Subject|1
332237|NCT01261624|1122420|P2|Week 13 to Week 24|Insufficient Response|1
332238|NCT01261624|1122421|P1|Week 13 to Week 24|Insufficient Response|0
332239|NCT01261624|1122420|P2|Week 0 to Week 12|Insufficient Response|2
332240|NCT01261624|1122421|P1|Week 0 to Week 12|Insufficient Response|0
332241|NCT01261624|1122420|P2|Week 0 to Week 12|Disease Progression|1
332242|NCT01261624|1122421|P1|Week 0 to Week 12|Disease Progression|1
332243|NCT01261390|1122462|P4|Overall Study|Lost to Follow-up|6
332244|NCT01261390|1122463|P3|Overall Study|Lost to Follow-up|5
332245|NCT01261390|1122464|P2|Overall Study|Lost to Follow-up|6
332246|NCT01261390|1122465|P1|Overall Study|Lost to Follow-up|1
332247|NCT01261390|1122462|P4|Overall Study|Loss of Interest in the Study|0
332248|NCT01261390|1122463|P3|Overall Study|Loss of Interest in the Study|0
332249|NCT01261390|1122464|P2|Overall Study|Loss of Interest in the Study|1
332250|NCT01261390|1122465|P1|Overall Study|Loss of Interest in the Study|3
332251|NCT01261390|1122462|P4|Overall Study|Relocation|0
332252|NCT01261390|1122463|P3|Overall Study|Relocation|0
332253|NCT01261390|1122464|P2|Overall Study|Relocation|1
332254|NCT01261390|1122465|P1|Overall Study|Relocation|0
332255|NCT01261390|1122462|P4|Overall Study|Dissatisfaction with Treatment|2
332256|NCT01261390|1122463|P3|Overall Study|Dissatisfaction with Treatment|1
332257|NCT01261390|1122464|P2|Overall Study|Dissatisfaction with Treatment|1
332258|NCT01261390|1122465|P1|Overall Study|Dissatisfaction with Treatment|2
332259|NCT01261390|1122462|P4|Overall Study|Significant Concurrent Illness|0
332260|NCT01261390|1122463|P3|Overall Study|Significant Concurrent Illness|1
332261|NCT01261390|1122464|P2|Overall Study|Significant Concurrent Illness|0
332262|NCT01261390|1122465|P1|Overall Study|Significant Concurrent Illness|1
332263|NCT01261325|1122630|P3|Overall Study|AE, serious fatal|2
332264|NCT01261325|1122631|P2|Overall Study|AE, serious fatal|0
332265|NCT01261325|1122632|P1|Overall Study|AE, serious fatal|0
332266|NCT01261325|1122630|P3|Overall Study|Lost to Follow-up|3
332267|NCT01261325|1122631|P2|Overall Study|Lost to Follow-up|1
332268|NCT01261325|1122632|P1|Overall Study|Lost to Follow-up|0
332269|NCT01261325|1122630|P3|Overall Study|Protocol Violation|1
332270|NCT01261325|1122631|P2|Overall Study|Protocol Violation|3
332271|NCT01261325|1122632|P1|Overall Study|Protocol Violation|0
332272|NCT01261325|1122630|P3|Overall Study|Randomized in Error|1
332273|NCT01261325|1122631|P2|Overall Study|Randomized in Error|0
332274|NCT01261325|1122632|P1|Overall Study|Randomized in Error|0
332275|NCT01261325|1122630|P3|Overall Study|Screen Failure|0
332276|NCT01261325|1122631|P2|Overall Study|Screen Failure|0
332277|NCT01261325|1122632|P1|Overall Study|Screen Failure|1
332278|NCT01261325|1122630|P3|Overall Study|Erroneously Randomized|0
332279|NCT01261325|1122631|P2|Overall Study|Erroneously Randomized|0
332280|NCT01261325|1122632|P1|Overall Study|Erroneously Randomized|1
332281|NCT01261325|1122630|P3|Overall Study|Patient Randomized by Mistake|0
332282|NCT01261325|1122631|P2|Overall Study|Patient Randomized by Mistake|1
332283|NCT01261325|1122632|P1|Overall Study|Patient Randomized by Mistake|0
332284|NCT01261325|1122630|P3|Overall Study|Non Compliance|0
332285|NCT01261325|1122631|P2|Overall Study|Non Compliance|0
332286|NCT01261325|1122632|P1|Overall Study|Non Compliance|2
332287|NCT01261325|1122630|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
332288|NCT01261325|1122631|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
332289|NCT01261325|1122632|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
332290|NCT01261325|1122630|P3|Overall Study|AE, non-serious non-fatal|13
332291|NCT01261325|1122631|P2|Overall Study|AE, non-serious non-fatal|15
332292|NCT01261325|1122632|P1|Overall Study|AE, non-serious non-fatal|9
332293|NCT01261325|1122630|P3|Overall Study|SAE, non-fatal|1
332294|NCT01261325|1122631|P2|Overall Study|SAE, non-fatal|5
332295|NCT01261325|1122632|P1|Overall Study|SAE, non-fatal|1
332296|NCT01261325|1122630|P3|Overall Study|Withdrawal by Subject|4
332297|NCT01261325|1122631|P2|Overall Study|Withdrawal by Subject|2
332298|NCT01261325|1122632|P1|Overall Study|Withdrawal by Subject|2
332299|NCT01261325|1122630|P3|Overall Study|Lack of Efficacy|0
332300|NCT01261325|1122631|P2|Overall Study|Lack of Efficacy|1
332301|NCT01261325|1122632|P1|Overall Study|Lack of Efficacy|1
332302|NCT01261247|1122664|P1|Overall Study|Ineligible|2
332303|NCT01261000|1122677|P1|Overall Study|Screen failure|1
332304|NCT01260948|1122683|P2|Second Intervention|Emesis|1
332305|NCT01260948|1122684|P1|Second Intervention|Emesis|0
332306|NCT01260948|1122683|P2|Washout of 28 Days|Withdrawal by Subject|3
332307|NCT01260948|1122684|P1|Washout of 28 Days|Withdrawal by Subject|1
332308|NCT01260922|1122694|P2|Second Intervention|Emesis|2
332309|NCT01260922|1122695|P1|Second Intervention|Emesis|0
332310|NCT01260922|1122694|P2|Washout of 28 Days|Withdrawal by Subject|2
332311|NCT01260922|1122695|P1|Washout of 28 Days|Withdrawal by Subject|4
332312|NCT01260922|1122694|P2|First Intervention|Withdrawal by Subject|1
332313|NCT01260922|1122695|P1|First Intervention|Withdrawal by Subject|0
332314|NCT01260896|1122705|P2|First Intervention|Withdrawn Due to Emesis|0
332315|NCT01260896|1122706|P1|First Intervention|Withdrawn Due to Emesis|2
332316|NCT01260701|1122764|P1|Overall Study|Did not begin protocol therapy|1
332317|NCT01260701|1122764|P1|Overall Study|Ineligible|4
332318|NCT01260701|1122764|P1|Overall Study|Under review|1
332319|NCT01260701|1122764|P1|Overall Study|Not protocol specified|3
332320|NCT01260701|1122764|P1|Overall Study|Death|2
332321|NCT01260701|1122764|P1|Overall Study|Progression|53
332322|NCT01260701|1122764|P1|Overall Study|Withdrawal by Subject|2
332323|NCT01260701|1122764|P1|Overall Study|Adverse Event|9
332324|NCT01260584|1122845|P4|Period 2|Withdrawal by Subject|0
332325|NCT01260584|1122846|P3|Period 2|Withdrawal by Subject|0
332326|NCT01260584|1122847|P2|Period 2|Withdrawal by Subject|1
332327|NCT01260584|1122848|P1|Period 2|Withdrawal by Subject|0
332328|NCT01260584|1122845|P4|Period 2|Adverse Event|0
332329|NCT01260584|1122846|P3|Period 2|Adverse Event|2
332330|NCT01260584|1122847|P2|Period 2|Adverse Event|0
332331|NCT01260584|1122848|P1|Period 2|Adverse Event|1
332332|NCT01260584|1122845|P4|Period 2|Protocol Violation|1
332333|NCT01260584|1122846|P3|Period 2|Protocol Violation|3
332334|NCT01260584|1122847|P2|Period 2|Protocol Violation|2
332335|NCT01260584|1122848|P1|Period 2|Protocol Violation|0
332336|NCT01260584|1122845|P4|Period 1|Adverse Event|0
332337|NCT01260584|1122846|P3|Period 1|Adverse Event|1
332338|NCT01260584|1122847|P2|Period 1|Adverse Event|0
332339|NCT01260584|1122848|P1|Period 1|Adverse Event|0
332340|NCT01260584|1122845|P4|Period 1|Protocol Violation|1
332341|NCT01260584|1122846|P3|Period 1|Protocol Violation|1
332342|NCT01260584|1122847|P2|Period 1|Protocol Violation|0
332343|NCT01260584|1122848|P1|Period 1|Protocol Violation|0
332344|NCT01260467|1122891|P1|Overall Study|Withdrawal by Subject|2
332345|NCT01260350|1122923|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
332346|NCT01260350|1122924|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
332347|NCT01260350|1122925|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
332348|NCT01260350|1122926|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
332349|NCT01260350|1122927|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
332350|NCT01260350|1122928|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
332351|NCT01260350|1122929|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
332352|NCT01260350|1122930|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
332353|NCT01260350|1122931|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
332354|NCT01260350|1122932|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
332355|NCT01260350|1122933|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
332356|NCT01260350|1122934|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
332357|NCT01260350|1122935|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
332358|NCT01260350|1122936|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
332359|NCT01260350|1122937|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
332360|NCT01260350|1122938|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
332361|NCT01260350|1122939|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
332362|NCT01260350|1122940|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
332363|NCT01260350|1122941|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
332364|NCT01260350|1122942|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
332365|NCT01260350|1122943|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
332366|NCT01260350|1122944|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
332367|NCT01260350|1122923|P22|Overall Study|Lack of Efficacy|0
332368|NCT01260350|1122924|P21|Overall Study|Lack of Efficacy|3
332369|NCT01260350|1122925|P20|Overall Study|Lack of Efficacy|0
332370|NCT01260350|1122926|P19|Overall Study|Lack of Efficacy|0
332371|NCT01260350|1122927|P18|Overall Study|Lack of Efficacy|1
332372|NCT01260350|1122928|P17|Overall Study|Lack of Efficacy|0
332373|NCT01260350|1122929|P16|Overall Study|Lack of Efficacy|0
332374|NCT01260350|1122930|P15|Overall Study|Lack of Efficacy|0
332375|NCT01260350|1122931|P14|Overall Study|Lack of Efficacy|0
332376|NCT01260350|1122932|P13|Overall Study|Lack of Efficacy|0
332377|NCT01260350|1122933|P12|Overall Study|Lack of Efficacy|0
332378|NCT01260350|1122934|P11|Overall Study|Lack of Efficacy|0
332379|NCT01260350|1122935|P10|Overall Study|Lack of Efficacy|0
332380|NCT01260350|1122936|P9|Overall Study|Lack of Efficacy|0
332381|NCT01260350|1122937|P8|Overall Study|Lack of Efficacy|0
332382|NCT01260350|1122938|P7|Overall Study|Lack of Efficacy|0
332383|NCT01260350|1122939|P6|Overall Study|Lack of Efficacy|0
332384|NCT01260350|1122940|P5|Overall Study|Lack of Efficacy|0
332385|NCT01260350|1122941|P4|Overall Study|Lack of Efficacy|0
332386|NCT01260350|1122942|P3|Overall Study|Lack of Efficacy|0
332387|NCT01260350|1122943|P2|Overall Study|Lack of Efficacy|0
332388|NCT01260350|1122944|P1|Overall Study|Lack of Efficacy|0
332389|NCT01260311|1123151|P1|Overall Study|Fesoterodine Started Before Enrollment|1
332390|NCT01260311|1123151|P1|Overall Study|Medication Stopped|1
332391|NCT01260311|1123151|P1|Overall Study|Gone to Province|2
332392|NCT01260311|1123151|P1|Overall Study|Financial Constraints|77
332393|NCT01260311|1123151|P1|Overall Study|Withdrawal by Subject|6
332394|NCT01260311|1123151|P1|Overall Study|Lost to Follow-up|25
332395|NCT01260311|1123151|P1|Overall Study|Lack of Efficacy|4
332396|NCT01260311|1123151|P1|Overall Study|Adverse Event|11
332397|NCT01260194|1123182|P1|Overall Study|Withdrawal of Consent|1
332398|NCT01260142|1123200|P6|Treatment Period 1|Withdrawal by Subject|1
332399|NCT01260142|1123201|P5|Treatment Period 1|Withdrawal by Subject|0
332400|NCT01260142|1123202|P4|Treatment Period 1|Withdrawal by Subject|0
332401|NCT01260142|1123203|P3|Treatment Period 1|Withdrawal by Subject|0
332402|NCT01260142|1123204|P2|Treatment Period 1|Withdrawal by Subject|0
332403|NCT01260142|1123205|P1|Treatment Period 1|Withdrawal by Subject|0
332404|NCT01260142|1123200|P6|Treatment Period 1|Unexplained elevated sys. BP|0
332405|NCT01260142|1123201|P5|Treatment Period 1|Unexplained elevated sys. BP|1
332406|NCT01260142|1123202|P4|Treatment Period 1|Unexplained elevated sys. BP|0
332407|NCT01260142|1123203|P3|Treatment Period 1|Unexplained elevated sys. BP|0
332408|NCT01260142|1123204|P2|Treatment Period 1|Unexplained elevated sys. BP|0
332409|NCT01260142|1123205|P1|Treatment Period 1|Unexplained elevated sys. BP|0
332410|NCT01260142|1123200|P6|Treatment Period 1|Study on hold|2
332411|NCT01260142|1123201|P5|Treatment Period 1|Study on hold|1
332412|NCT01260142|1123202|P4|Treatment Period 1|Study on hold|0
332413|NCT01260142|1123203|P3|Treatment Period 1|Study on hold|0
332414|NCT01260142|1123204|P2|Treatment Period 1|Study on hold|1
332415|NCT01260142|1123205|P1|Treatment Period 1|Study on hold|1
332416|NCT01259726|1123259|P4|Overall Study|Lost to Follow-up|3
332417|NCT01259726|1123260|P3|Overall Study|Lost to Follow-up|1
332418|NCT01259726|1123261|P2|Overall Study|Lost to Follow-up|1
332419|NCT01259726|1123262|P1|Overall Study|Lost to Follow-up|1
332420|NCT01259726|1123259|P4|Overall Study|Withdrawal by Subject|1
332421|NCT01259726|1123260|P3|Overall Study|Withdrawal by Subject|2
332422|NCT01259726|1123261|P2|Overall Study|Withdrawal by Subject|3
332423|NCT01259726|1123262|P1|Overall Study|Withdrawal by Subject|1
332424|NCT01259726|1123259|P4|Overall Study|Physician Decision|1
332425|NCT01259726|1123260|P3|Overall Study|Physician Decision|1
332426|NCT01259726|1123261|P2|Overall Study|Physician Decision|0
332427|NCT01259726|1123262|P1|Overall Study|Physician Decision|2
332428|NCT01259726|1123259|P4|Overall Study|Death|0
332429|NCT01259726|1123260|P3|Overall Study|Death|0
332430|NCT01259726|1123261|P2|Overall Study|Death|0
332431|NCT01259726|1123262|P1|Overall Study|Death|1
332432|NCT01259713|1123294|P2|Overall Study|Subject Withdrew Consent|7
332433|NCT01259713|1123295|P1|Overall Study|Subject Withdrew Consent|12
332434|NCT01259713|1123294|P2|Overall Study|Protocol Violation|4
332435|NCT01259713|1123295|P1|Overall Study|Protocol Violation|5
332436|NCT01259713|1123294|P2|Overall Study|Lack of Efficacy|0
332437|NCT01259713|1123295|P1|Overall Study|Lack of Efficacy|2
332438|NCT01259713|1123294|P2|Overall Study|Investigators Discretion|6
332439|NCT01259713|1123295|P1|Overall Study|Investigators Discretion|14
332440|NCT01259713|1123294|P2|Overall Study|Death Not Related to IFI|1
332441|NCT01259713|1123295|P1|Overall Study|Death Not Related to IFI|8
332442|NCT01259713|1123294|P2|Overall Study|Adverse Event|23
332443|NCT01259713|1123295|P1|Overall Study|Adverse Event|54
332444|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
332445|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
332446|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
332447|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
332448|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
332449|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
332450|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
332451|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
332452|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
332453|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
332454|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
332455|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
332456|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
332457|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
332458|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
332459|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
332460|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
332461|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
332462|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
332463|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
332464|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
332465|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
332466|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
332467|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
332468|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
332469|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
332470|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
332471|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
332472|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
332473|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
332474|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
332475|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
332476|NCT01259492|1123342|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
332477|NCT01259492|1123343|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
332478|NCT01259492|1123344|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
332479|NCT01259492|1123345|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
332480|NCT01259492|1123342|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
332481|NCT01259492|1123343|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
332482|NCT01259492|1123344|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
332483|NCT01259492|1123345|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
332484|NCT01259492|1123342|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
332485|NCT01259492|1123343|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
332486|NCT01259492|1123344|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
332487|NCT01259492|1123345|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
332488|NCT01259492|1123342|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
332489|NCT01259492|1123343|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
332490|NCT01259492|1123344|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
332491|NCT01259492|1123345|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
332492|NCT01259492|1123342|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
332493|NCT01259492|1123343|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
332494|NCT01259492|1123344|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
332495|NCT01259492|1123345|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
332496|NCT01259492|1123342|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
332497|NCT01259492|1123343|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
332498|NCT01259492|1123344|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
332499|NCT01259492|1123345|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
332500|NCT01259492|1123342|P4|Period 1 (9 Weeks)|Protocol Violation|1
332501|NCT01259492|1123343|P3|Period 1 (9 Weeks)|Protocol Violation|3
332502|NCT01259492|1123344|P2|Period 1 (9 Weeks)|Protocol Violation|6
332503|NCT01259492|1123345|P1|Period 1 (9 Weeks)|Protocol Violation|5
332504|NCT01259492|1123342|P4|Period 1 (9 Weeks)|Administrative Problems|2
332505|NCT01259492|1123343|P3|Period 1 (9 Weeks)|Administrative Problems|1
332506|NCT01259492|1123344|P2|Period 1 (9 Weeks)|Administrative Problems|1
332507|NCT01259492|1123345|P1|Period 1 (9 Weeks)|Administrative Problems|0
332508|NCT01259492|1123342|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
332509|NCT01259492|1123343|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
332510|NCT01259492|1123344|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
332511|NCT01259492|1123345|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
332512|NCT01259492|1123342|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
332513|NCT01259492|1123343|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
332514|NCT01259492|1123344|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
332515|NCT01259492|1123345|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
332516|NCT01259492|1123342|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
332517|NCT01259492|1123343|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
332518|NCT01259492|1123344|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
332519|NCT01259492|1123345|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
332520|NCT01259492|1123342|P4|Period 1 (9 Weeks)|Adverse Event|3
332521|NCT01259492|1123343|P3|Period 1 (9 Weeks)|Adverse Event|26
332522|NCT01259492|1123344|P2|Period 1 (9 Weeks)|Adverse Event|18
332523|NCT01259492|1123345|P1|Period 1 (9 Weeks)|Adverse Event|13
332524|NCT01259466|1123394|P2|Overall Study|Withdrawal by Subject|9
332525|NCT01259466|1123395|P1|Overall Study|Withdrawal by Subject|1
332526|NCT01259401|1123433|P2|4-month Follow-up|Lost to Follow-up|1
332527|NCT01259401|1123434|P1|4-month Follow-up|Lost to Follow-up|0
332528|NCT01259401|1123433|P2|4-month Follow-up|Death|1
332529|NCT01259401|1123434|P1|4-month Follow-up|Death|0
332530|NCT01259375|1123442|P1|Overall Study|Adverse Event|1
332531|NCT01259297|1123459|P8|Double Blind Randomized Period|Other reasons|1
332532|NCT01259297|1123460|P7|Double Blind Randomized Period|Other reasons|3
332533|NCT01259297|1123461|P6|Double Blind Randomized Period|Other reasons|2
332534|NCT01259297|1123462|P5|Double Blind Randomized Period|Other reasons|1
332535|NCT01259297|1123463|P4|Double Blind Randomized Period|Other reasons|0
332536|NCT01259297|1123464|P3|Double Blind Randomized Period|Other reasons|0
332537|NCT01259297|1123465|P2|Double Blind Randomized Period|Other reasons|1
332538|NCT01259297|1123466|P1|Double Blind Randomized Period|Other reasons|0
332539|NCT01259297|1123459|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
332540|NCT01259297|1123460|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
332541|NCT01259297|1123461|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
332542|NCT01259297|1123462|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
332543|NCT01259297|1123463|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
332544|NCT01259297|1123464|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
332545|NCT01259297|1123465|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
332546|NCT01259297|1123466|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
332547|NCT01259297|1123459|P8|Double Blind Randomized Period|Death|1
332548|NCT01259297|1123460|P7|Double Blind Randomized Period|Death|2
332549|NCT01259297|1123461|P6|Double Blind Randomized Period|Death|5
332550|NCT01259297|1123462|P5|Double Blind Randomized Period|Death|1
332551|NCT01259297|1123463|P4|Double Blind Randomized Period|Death|2
332552|NCT01259297|1123464|P3|Double Blind Randomized Period|Death|1
332553|NCT01259297|1123465|P2|Double Blind Randomized Period|Death|1
332554|NCT01259297|1123466|P1|Double Blind Randomized Period|Death|1
332555|NCT01259284|1123497|P3|Overall Study|Study Termination|0
332556|NCT01259284|1123498|P2|Overall Study|Study Termination|0
332557|NCT01259284|1123499|P1|Overall Study|Study Termination|2
332558|NCT01259245|1123509|P2|Overall Study|Death|2
332559|NCT01259245|1123510|P1|Overall Study|Death|1
332560|NCT01259245|1123509|P2|Overall Study|Withdrawal by Subject|24
332561|NCT01259245|1123510|P1|Overall Study|Withdrawal by Subject|27
332562|NCT01259115|1123534|P2|Period 2|Adverse Event|0
332563|NCT01259115|1123535|P1|Period 2|Adverse Event|1
332564|NCT01259115|1123534|P2|Period 1|Lost to Follow-up|1
332565|NCT01259115|1123535|P1|Period 1|Lost to Follow-up|0
332566|NCT01259115|1123534|P2|Period 1|Protocol Violation|0
332567|NCT01259115|1123535|P1|Period 1|Protocol Violation|2
332568|NCT01259115|1123534|P2|Period 1|Adverse Event|0
332569|NCT01259115|1123535|P1|Period 1|Adverse Event|1
332570|NCT01259102|1123571|P5|Overall Study|Other|1
332571|NCT01259102|1123572|P4|Overall Study|Other|1
332572|NCT01259102|1123573|P3|Overall Study|Other|1
332573|NCT01259102|1123574|P2|Overall Study|Other|0
332574|NCT01259102|1123575|P1|Overall Study|Other|0
332575|NCT01259102|1123571|P5|Overall Study|Adverse Event|0
332576|NCT01259102|1123572|P4|Overall Study|Adverse Event|1
332577|NCT01259102|1123573|P3|Overall Study|Adverse Event|1
332578|NCT01259102|1123574|P2|Overall Study|Adverse Event|0
332579|NCT01259102|1123575|P1|Overall Study|Adverse Event|1
332580|NCT01259024|1123641|P1|Overall Study|Physician Decision|1
332581|NCT01258998|1123661|P1|Overall Study|Ineligible|1
332582|NCT01258803|1123694|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
332583|NCT01258803|1123695|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
332584|NCT01258803|1123696|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
332585|NCT01258803|1123697|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
332586|NCT01258803|1123698|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
332587|NCT01258803|1123699|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
332588|NCT01258803|1123694|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
332589|NCT01258803|1123695|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
332590|NCT01258803|1123696|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
332591|NCT01258803|1123697|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
332592|NCT01258803|1123698|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
332593|NCT01258803|1123699|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
332594|NCT01258803|1123694|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
332595|NCT01258803|1123695|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
332596|NCT01258803|1123696|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
332597|NCT01258803|1123697|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
332598|NCT01258803|1123698|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
332599|NCT01258803|1123699|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
332600|NCT01258738|1123736|P2|Open-label Period|Withdrawn due to pregnancy|1
332601|NCT01258738|1123737|P1|Open-label Period|Withdrawn due to pregnancy|1
332602|NCT01258738|1123736|P2|Open-label Period|Other Reasons|1
332603|NCT01258738|1123737|P1|Open-label Period|Other Reasons|0
332604|NCT01258738|1123736|P2|Open-label Period|Adverse Event|5
332605|NCT01258738|1123737|P1|Open-label Period|Adverse Event|4
332606|NCT01258738|1123736|P2|Open-label Period|Protocol Violation|2
332607|NCT01258738|1123737|P1|Open-label Period|Protocol Violation|2
332608|NCT01258738|1123736|P2|Open-label Period|Withdrawal by Subject|6
332609|NCT01258738|1123737|P1|Open-label Period|Withdrawal by Subject|5
332610|NCT01258738|1123736|P2|Open-label Period|Lost to Follow-up|2
332611|NCT01258738|1123737|P1|Open-label Period|Lost to Follow-up|0
332612|NCT01258738|1123736|P2|Open-label Period|Insufficient clinical response|3
332613|NCT01258738|1123737|P1|Open-label Period|Insufficient clinical response|5
332614|NCT01258738|1123736|P2|Open-label Period|Did not meet inclusion criteria|1
332615|NCT01258738|1123737|P1|Open-label Period|Did not meet inclusion criteria|0
332616|NCT01258738|1123736|P2|Double-blind Period|Adverse Event|1
332617|NCT01258738|1123737|P1|Double-blind Period|Adverse Event|3
332618|NCT01258738|1123736|P2|Double-blind Period|Protocol Violation|1
332619|NCT01258738|1123737|P1|Double-blind Period|Protocol Violation|1
332620|NCT01258738|1123736|P2|Double-blind Period|Withdrawal by Subject|2
332621|NCT01258738|1123737|P1|Double-blind Period|Withdrawal by Subject|2
332622|NCT01258738|1123736|P2|Double-blind Period|Did not meet inclusion criteria|3
332623|NCT01258738|1123737|P1|Double-blind Period|Did not meet inclusion criteria|3
332624|NCT01258660|1123875|P2|Overall Study|Invalid for primary analysis data set|6
332625|NCT01258660|1123876|P1|Overall Study|Invalid for primary analysis data set|4
332626|NCT01258660|1123875|P2|Overall Study|Protocol Violation|1
332627|NCT01258660|1123876|P1|Overall Study|Protocol Violation|0
332628|NCT01258660|1123875|P2|Overall Study|due to relocation|0
332629|NCT01258660|1123876|P1|Overall Study|due to relocation|2
332630|NCT01258660|1123875|P2|Overall Study|Withdrawal by Subject|0
332631|NCT01258660|1123876|P1|Overall Study|Withdrawal by Subject|3
332632|NCT01258660|1123875|P2|Overall Study|Adverse Event|4
332633|NCT01258660|1123876|P1|Overall Study|Adverse Event|2
332634|NCT01258595|1123895|P2|Overall Study|Withdrawal by Subject|1
332635|NCT01258595|1123896|P1|Overall Study|Withdrawal by Subject|0
332636|NCT01258595|1123895|P2|Overall Study|Lost to Follow-up|0
332637|NCT01258595|1123896|P1|Overall Study|Lost to Follow-up|1
332638|NCT01258101|1124018|P4|Overall Study|Other reason|8
332639|NCT01258101|1124019|P3|Overall Study|Other reason|1
332640|NCT01258101|1124020|P2|Overall Study|Other reason|8
332641|NCT01258101|1124021|P1|Overall Study|Other reason|7
332642|NCT01258101|1124018|P4|Overall Study|PCR positive at week 24|1
332643|NCT01258101|1124019|P3|Overall Study|PCR positive at week 24|0
332644|NCT01258101|1124020|P2|Overall Study|PCR positive at week 24|0
332645|NCT01258101|1124021|P1|Overall Study|PCR positive at week 24|0
332646|NCT01258101|1124018|P4|Overall Study|Lost to Follow-up|6
332647|NCT01258101|1124019|P3|Overall Study|Lost to Follow-up|0
332648|NCT01258101|1124020|P2|Overall Study|Lost to Follow-up|5
332649|NCT01258101|1124021|P1|Overall Study|Lost to Follow-up|5
332650|NCT01258101|1124018|P4|Overall Study|Patient´s compliance|2
332651|NCT01258101|1124019|P3|Overall Study|Patient´s compliance|1
332652|NCT01258101|1124020|P2|Overall Study|Patient´s compliance|3
332653|NCT01258101|1124021|P1|Overall Study|Patient´s compliance|4
332654|NCT01258101|1124018|P4|Overall Study|Patient is not able to attend visits|6
332655|NCT01258101|1124019|P3|Overall Study|Patient is not able to attend visits|7
332656|NCT01258101|1124020|P2|Overall Study|Patient is not able to attend visits|9
332657|NCT01258101|1124021|P1|Overall Study|Patient is not able to attend visits|8
332658|NCT01258101|1124018|P4|Overall Study|Informed consent has been withdrawn|1
332659|NCT01258101|1124019|P3|Overall Study|Informed consent has been withdrawn|1
332660|NCT01258101|1124020|P2|Overall Study|Informed consent has been withdrawn|2
332661|NCT01258101|1124021|P1|Overall Study|Informed consent has been withdrawn|2
332662|NCT01258101|1124018|P4|Overall Study|Extra exclusion criterion amended|1
332663|NCT01258101|1124019|P3|Overall Study|Extra exclusion criterion amended|1
332664|NCT01258101|1124020|P2|Overall Study|Extra exclusion criterion amended|1
332665|NCT01258101|1124021|P1|Overall Study|Extra exclusion criterion amended|2
332666|NCT01258101|1124018|P4|Overall Study|Adverse Event|0
332667|NCT01258101|1124019|P3|Overall Study|Adverse Event|0
332668|NCT01258101|1124020|P2|Overall Study|Adverse Event|6
332669|NCT01258101|1124021|P1|Overall Study|Adverse Event|5
332670|NCT01257737|1124151|P2|Overall Study|Withdrew from study|1
332671|NCT01257737|1124152|P1|Overall Study|Withdrew from study|0
332672|NCT01257737|1124151|P2|Overall Study|Relocation out of the country|1
332673|NCT01257737|1124152|P1|Overall Study|Relocation out of the country|0
332674|NCT01257737|1124151|P2|Overall Study|Liver transplant|0
332675|NCT01257737|1124152|P1|Overall Study|Liver transplant|1
332676|NCT01257737|1124151|P2|Overall Study|Lost to Follow-up|2
332677|NCT01257737|1124152|P1|Overall Study|Lost to Follow-up|1
332678|NCT01257581|1124173|P3|Overall Study|Death|4
332679|NCT01257581|1124174|P2|Overall Study|Death|2
332680|NCT01257581|1124175|P1|Overall Study|Death|2
332681|NCT01257581|1124173|P3|Overall Study|Early Termination|2
332682|NCT01257581|1124174|P2|Overall Study|Early Termination|1
332683|NCT01257581|1124175|P1|Overall Study|Early Termination|3
332684|NCT01257542|1124215|P2|Overall Study|Withdrawal by Subject|2
332685|NCT01257542|1124216|P1|Overall Study|Withdrawal by Subject|0
332686|NCT01257542|1124215|P2|Overall Study|Protocol Violation|5
332687|NCT01257542|1124216|P1|Overall Study|Protocol Violation|3
332688|NCT01257503|1124236|P2|Overall Study|strep culture positive at enrollment|0
332689|NCT01257503|1124237|P1|Overall Study|strep culture positive at enrollment|1
332690|NCT01257503|1124236|P2|Overall Study|Over 5 years old at enrollment|1
332691|NCT01257503|1124237|P1|Overall Study|Over 5 years old at enrollment|0
332692|NCT01257503|1124236|P2|Overall Study|Lost to Follow-up|10
332693|NCT01257503|1124237|P1|Overall Study|Lost to Follow-up|7
332694|NCT01257425|1124266|P2|Overall Study|Death|0
332695|NCT01257425|1124267|P1|Overall Study|Death|1
332696|NCT01257425|1124266|P2|Overall Study|Withdrawal by Subject|1
332697|NCT01257425|1124267|P1|Overall Study|Withdrawal by Subject|0
332698|NCT01257425|1124266|P2|Overall Study|Protocol Violation|1
332699|NCT01257425|1124267|P1|Overall Study|Protocol Violation|1
332700|NCT01257425|1124266|P2|Overall Study|Adverse Event|1
332701|NCT01257425|1124267|P1|Overall Study|Adverse Event|1
332702|NCT01257425|1124266|P2|Overall Study|Lack of Efficacy|3
332703|NCT01257425|1124267|P1|Overall Study|Lack of Efficacy|3
332704|NCT01257230|1124309|P3|Overall Study|Other reason not defined above|3
332705|NCT01257230|1124310|P2|Overall Study|Other reason not defined above|5
332706|NCT01257230|1124311|P1|Overall Study|Other reason not defined above|1
332707|NCT01257230|1124309|P3|Overall Study|Withdrawal by Subject|1
332708|NCT01257230|1124310|P2|Overall Study|Withdrawal by Subject|4
332709|NCT01257230|1124311|P1|Overall Study|Withdrawal by Subject|0
332710|NCT01257230|1124309|P3|Overall Study|Protocol Violation|1
332711|NCT01257230|1124310|P2|Overall Study|Protocol Violation|0
332712|NCT01257230|1124311|P1|Overall Study|Protocol Violation|3
332713|NCT01257230|1124309|P3|Overall Study|Lack of Efficacy|0
332714|NCT01257230|1124310|P2|Overall Study|Lack of Efficacy|1
332715|NCT01257230|1124311|P1|Overall Study|Lack of Efficacy|0
332716|NCT01257230|1124309|P3|Overall Study|Adverse Event|0
332717|NCT01257230|1124310|P2|Overall Study|Adverse Event|0
332718|NCT01257230|1124311|P1|Overall Study|Adverse Event|2
332719|NCT01257230|1124309|P3|Overall Study|Not Treated|1
332720|NCT01257230|1124310|P2|Overall Study|Not Treated|0
332721|NCT01257230|1124311|P1|Overall Study|Not Treated|0
332722|NCT01257204|1124388|P3|Follow-up Period (up to Week 48)|Other|5
332723|NCT01257204|1124389|P2|Follow-up Period (up to Week 48)|Other|0
332724|NCT01257204|1124390|P1|Follow-up Period (up to Week 48)|Other|0
332725|NCT01257204|1124388|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
332726|NCT01257204|1124389|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
332727|NCT01257204|1124390|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
332728|NCT01257204|1124388|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
332729|NCT01257204|1124389|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
332730|NCT01257204|1124390|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
332731|NCT01257204|1124388|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
332732|NCT01257204|1124389|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
332733|NCT01257204|1124390|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
332734|NCT01257204|1124388|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
332735|NCT01257204|1124389|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
332736|NCT01257204|1124390|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
332737|NCT01257204|1124388|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
332738|NCT01257204|1124389|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
332739|NCT01257204|1124390|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
332740|NCT01257204|1124388|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
332741|NCT01257204|1124389|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
332742|NCT01257204|1124390|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
332743|NCT01257204|1124388|P3|Treatment Period (up to Week 24)|Adverse Event|2
332744|NCT01257204|1124389|P2|Treatment Period (up to Week 24)|Adverse Event|1
332745|NCT01257204|1124390|P1|Treatment Period (up to Week 24)|Adverse Event|3
332746|NCT01257204|1124388|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
332747|NCT01257204|1124389|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
332748|NCT01257204|1124390|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
332749|NCT01256684|1124501|P3|Overall Study|Entry criteria not met/non-compliance|6
332750|NCT01256684|1124502|P2|Overall Study|Entry criteria not met/non-compliance|7
332751|NCT01256684|1124503|P1|Overall Study|Entry criteria not met/non-compliance|4
332752|NCT01256684|1124501|P3|Overall Study|Lack of Efficacy|1
332753|NCT01256684|1124502|P2|Overall Study|Lack of Efficacy|1
332754|NCT01256684|1124503|P1|Overall Study|Lack of Efficacy|0
332755|NCT01256684|1124501|P3|Overall Study|Physician Decision|0
332756|NCT01256684|1124502|P2|Overall Study|Physician Decision|1
332757|NCT01256684|1124503|P1|Overall Study|Physician Decision|0
332758|NCT01256684|1124501|P3|Overall Study|Withdrawal by Subject|2
332759|NCT01256684|1124502|P2|Overall Study|Withdrawal by Subject|0
332760|NCT01256684|1124503|P1|Overall Study|Withdrawal by Subject|4
332761|NCT01256684|1124501|P3|Overall Study|Adverse Event|2
332762|NCT01256684|1124502|P2|Overall Study|Adverse Event|4
332763|NCT01256684|1124503|P1|Overall Study|Adverse Event|1
332764|NCT01256671|1124535|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
332765|NCT01256671|1124535|P1|Overall Study|Lack of Efficacy|4
332766|NCT01256671|1124535|P1|Overall Study|Physician Decision|3
332767|NCT01256671|1124535|P1|Overall Study|Withdrawal by Subject|31
332768|NCT01256671|1124535|P1|Overall Study|Lost to Follow-up|16
332769|NCT01256671|1124535|P1|Overall Study|Adverse Event|29
332770|NCT01256658|1124548|P2|Period 1|Death|44
332771|NCT01256658|1124549|P1|Period 1|Death|48
332772|NCT01256658|1124548|P2|Period 1|Withdrawal by Subject|43
332773|NCT01256658|1124549|P1|Period 1|Withdrawal by Subject|35
332774|NCT01256658|1124548|P2|Period 1|Lost to Follow-up|661
332775|NCT01256658|1124549|P1|Period 1|Lost to Follow-up|837
332776|NCT01256567|1124599|P1|Overall Study|Withdrawal by Subject|1
332777|NCT01256502|1124609|P1|Overall Study|Protocol deviation|1
332778|NCT01256502|1124609|P1|Overall Study|Personal reasons|5
332779|NCT01256502|1124609|P1|Overall Study|Had scaffold removed|4
332780|NCT01256476|1124621|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
332781|NCT01256476|1124622|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
332782|NCT01256476|1124621|P2|Overall Study|Subject non-compliance|1
332783|NCT01256476|1124622|P1|Overall Study|Subject non-compliance|0
332784|NCT01256476|1124621|P2|Overall Study|Physician Decision|1
332785|NCT01256476|1124622|P1|Overall Study|Physician Decision|0
332786|NCT01256476|1124621|P2|Overall Study|Persistent ALT or AST elevation|0
332787|NCT01256476|1124622|P1|Overall Study|Persistent ALT or AST elevation|1
332788|NCT01256476|1124621|P2|Overall Study|Lost to Follow-up|2
332789|NCT01256476|1124622|P1|Overall Study|Lost to Follow-up|1
332790|NCT01256476|1124621|P2|Overall Study|Withdrawal by Subject|1
332791|NCT01256476|1124622|P1|Overall Study|Withdrawal by Subject|2
332792|NCT01256476|1124621|P2|Overall Study|Adverse Event|1
332793|NCT01256476|1124622|P1|Overall Study|Adverse Event|2
332794|NCT01256450|1124630|P3|Double-blind Treatment|Not specified|12
332795|NCT01256450|1124631|P2|Double-blind Treatment|Not specified|9
332796|NCT01256450|1124632|P1|Double-blind Treatment|Not specified|0
332797|NCT01256450|1124630|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
332798|NCT01256450|1124631|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
332799|NCT01256450|1124632|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
332800|NCT01256450|1124630|P3|Double-blind Treatment|Non-compliance|4
332801|NCT01256450|1124631|P2|Double-blind Treatment|Non-compliance|5
332802|NCT01256450|1124632|P1|Double-blind Treatment|Non-compliance|0
332803|NCT01256450|1124630|P3|Double-blind Treatment|Lack of analgesic effect|6
332804|NCT01256450|1124631|P2|Double-blind Treatment|Lack of analgesic effect|5
332805|NCT01256450|1124632|P1|Double-blind Treatment|Lack of analgesic effect|0
332806|NCT01256450|1124630|P3|Double-blind Treatment|Withdrawal by Subject|1
332807|NCT01256450|1124631|P2|Double-blind Treatment|Withdrawal by Subject|0
332808|NCT01256450|1124632|P1|Double-blind Treatment|Withdrawal by Subject|0
332809|NCT01256450|1124630|P3|Double-blind Treatment|Lost to Follow-up|7
332810|NCT01256450|1124631|P2|Double-blind Treatment|Lost to Follow-up|1
332811|NCT01256450|1124632|P1|Double-blind Treatment|Lost to Follow-up|0
332812|NCT01256450|1124630|P3|Double-blind Treatment|Adverse Event|6
332813|NCT01256450|1124631|P2|Double-blind Treatment|Adverse Event|8
332814|NCT01256450|1124632|P1|Double-blind Treatment|Adverse Event|0
332815|NCT01256450|1124630|P3|Open-label Titration|Not specified|0
332816|NCT01256450|1124631|P2|Open-label Titration|Not specified|0
332817|NCT01256450|1124632|P1|Open-label Titration|Not specified|13
332818|NCT01256450|1124630|P3|Open-label Titration|Screen failure|0
332819|NCT01256450|1124631|P2|Open-label Titration|Screen failure|0
332820|NCT01256450|1124632|P1|Open-label Titration|Screen failure|1
332821|NCT01256450|1124630|P3|Open-label Titration|Non-compliance|0
332822|NCT01256450|1124631|P2|Open-label Titration|Non-compliance|0
332823|NCT01256450|1124632|P1|Open-label Titration|Non-compliance|9
332824|NCT01256450|1124630|P3|Open-label Titration|Lack of analgesic effect|0
332825|NCT01256450|1124631|P2|Open-label Titration|Lack of analgesic effect|0
332826|NCT01256450|1124632|P1|Open-label Titration|Lack of analgesic effect|30
332827|NCT01256450|1124630|P3|Open-label Titration|Lost to Follow-up|0
332828|NCT01256450|1124631|P2|Open-label Titration|Lost to Follow-up|0
332829|NCT01256450|1124632|P1|Open-label Titration|Lost to Follow-up|7
332830|NCT01256450|1124630|P3|Open-label Titration|Adverse Event|0
332831|NCT01256450|1124631|P2|Open-label Titration|Adverse Event|0
332832|NCT01256450|1124632|P1|Open-label Titration|Adverse Event|39
332833|NCT01256411|1124690|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
332834|NCT01256411|1124691|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
332835|NCT01256411|1124692|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
332836|NCT01256411|1124693|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
332837|NCT01256411|1124694|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
332838|NCT01256411|1124695|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
332839|NCT01256411|1124690|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
332840|NCT01256411|1124691|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
332841|NCT01256411|1124692|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
332842|NCT01256411|1124693|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
332843|NCT01256411|1124694|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
332844|NCT01256411|1124695|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
332845|NCT01256411|1124690|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
332846|NCT01256411|1124691|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
332847|NCT01256411|1124692|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
332848|NCT01256411|1124693|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
332849|NCT01256411|1124694|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
332850|NCT01256411|1124695|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
332851|NCT01256411|1124690|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
332852|NCT01256411|1124691|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
332853|NCT01256411|1124692|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
332854|NCT01256411|1124693|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
332855|NCT01256411|1124694|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
332856|NCT01256411|1124695|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
332857|NCT01256411|1124690|P6|Extension by Mono or Combination Therapy|Adverse Event|1
332858|NCT01256411|1124691|P5|Extension by Mono or Combination Therapy|Adverse Event|6
332859|NCT01256411|1124692|P4|Extension by Mono or Combination Therapy|Adverse Event|0
332860|NCT01256411|1124693|P3|Extension by Mono or Combination Therapy|Adverse Event|0
332861|NCT01256411|1124694|P2|Extension by Mono or Combination Therapy|Adverse Event|0
332862|NCT01256411|1124695|P1|Extension by Mono or Combination Therapy|Adverse Event|0
332863|NCT01256411|1124690|P6|Extension by Maximum Treatment|Adverse Event|0
332864|NCT01256411|1124691|P5|Extension by Maximum Treatment|Adverse Event|0
332865|NCT01256411|1124692|P4|Extension by Maximum Treatment|Adverse Event|0
332866|NCT01256411|1124693|P3|Extension by Maximum Treatment|Adverse Event|1
332867|NCT01256411|1124694|P2|Extension by Maximum Treatment|Adverse Event|2
332868|NCT01256411|1124695|P1|Extension by Maximum Treatment|Adverse Event|4
332869|NCT01256411|1124690|P6|Extension by Maximum Treatment|Lack of Efficacy|0
332870|NCT01256411|1124691|P5|Extension by Maximum Treatment|Lack of Efficacy|0
332871|NCT01256411|1124692|P4|Extension by Maximum Treatment|Lack of Efficacy|0
332872|NCT01256411|1124693|P3|Extension by Maximum Treatment|Lack of Efficacy|1
332873|NCT01256411|1124694|P2|Extension by Maximum Treatment|Lack of Efficacy|0
332874|NCT01256411|1124695|P1|Extension by Maximum Treatment|Lack of Efficacy|1
332875|NCT01256411|1124690|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
332876|NCT01256411|1124691|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
332877|NCT01256411|1124692|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
332878|NCT01256411|1124693|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
332879|NCT01256411|1124694|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
332880|NCT01256411|1124695|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
332881|NCT01256411|1124690|P6|Extension by Maximum Treatment|Lost to Follow-up|0
332882|NCT01256411|1124691|P5|Extension by Maximum Treatment|Lost to Follow-up|0
332883|NCT01256411|1124692|P4|Extension by Maximum Treatment|Lost to Follow-up|0
332884|NCT01256411|1124693|P3|Extension by Maximum Treatment|Lost to Follow-up|0
332885|NCT01256411|1124694|P2|Extension by Maximum Treatment|Lost to Follow-up|2
332971|NCT01255722|1125013|P3|Overall Study|beta-blocker contraindicated|0
332886|NCT01256411|1124695|P1|Extension by Maximum Treatment|Lost to Follow-up|1
332887|NCT01256411|1124690|P6|Extension by Maximum Treatment|Protocol deviation|0
332888|NCT01256411|1124691|P5|Extension by Maximum Treatment|Protocol deviation|0
332889|NCT01256411|1124692|P4|Extension by Maximum Treatment|Protocol deviation|0
332890|NCT01256411|1124693|P3|Extension by Maximum Treatment|Protocol deviation|1
332891|NCT01256411|1124694|P2|Extension by Maximum Treatment|Protocol deviation|0
332892|NCT01256411|1124695|P1|Extension by Maximum Treatment|Protocol deviation|0
332893|NCT01256385|1124721|P2|Overall Study|Withdrawal by Subject|2
332894|NCT01256385|1124722|P1|Overall Study|Withdrawal by Subject|2
332895|NCT01256385|1124721|P2|Overall Study|Physician Decision|1
332896|NCT01256385|1124722|P1|Overall Study|Physician Decision|1
332897|NCT01256294|1124742|P2|Overall Study|Protocol deviation|1
332898|NCT01256294|1124743|P1|Overall Study|Protocol deviation|2
332899|NCT01256294|1124742|P2|Overall Study|Withdrawal by Subject|1
332900|NCT01256294|1124743|P1|Overall Study|Withdrawal by Subject|1
332901|NCT01256294|1124742|P2|Overall Study|Adverse Event|0
332902|NCT01256294|1124743|P1|Overall Study|Adverse Event|1
332903|NCT01256190|1124765|P2|Overall Study|Lost to Follow-up|0
332904|NCT01256190|1124766|P1|Overall Study|Lost to Follow-up|2
332905|NCT01256177|1124782|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
332906|NCT01256177|1124783|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
332907|NCT01256177|1124782|P2|Overall Study|Lack of Efficacy|2
332908|NCT01256177|1124783|P1|Overall Study|Lack of Efficacy|11
332909|NCT01256177|1124782|P2|Overall Study|Condition under Investigation Worsened|0
332910|NCT01256177|1124783|P1|Overall Study|Condition under Investigation Worsened|1
332911|NCT01256177|1124782|P2|Overall Study|Severe Non-Compliance to Protocol|2
332912|NCT01256177|1124783|P1|Overall Study|Severe Non-Compliance to Protocol|4
332913|NCT01256177|1124782|P2|Overall Study|Adverse Event|9
332914|NCT01256177|1124783|P1|Overall Study|Adverse Event|8
332915|NCT01256177|1124782|P2|Overall Study|Lost to Follow-up|2
332916|NCT01256177|1124783|P1|Overall Study|Lost to Follow-up|2
332917|NCT01256177|1124782|P2|Overall Study|Withdrawal by Subject|22
332918|NCT01256177|1124783|P1|Overall Study|Withdrawal by Subject|23
332919|NCT01256060|1124839|P4|Overall Study|Lost to Follow-up|0
332920|NCT01256060|1124840|P3|Overall Study|Lost to Follow-up|0
332921|NCT01256060|1124841|P2|Overall Study|Lost to Follow-up|1
332922|NCT01256060|1124842|P1|Overall Study|Lost to Follow-up|0
332923|NCT01256008|1124861|P3|Overall Study|Withdrawal by Subject|10
332924|NCT01256008|1124862|P2|Overall Study|Withdrawal by Subject|3
332925|NCT01256008|1124863|P1|Overall Study|Withdrawal by Subject|2
332926|NCT01256008|1124861|P3|Overall Study|Lost to Follow-up|11
332927|NCT01256008|1124862|P2|Overall Study|Lost to Follow-up|4
332928|NCT01256008|1124863|P1|Overall Study|Lost to Follow-up|6
332929|NCT01255904|1124885|P2|Overall Study|Physician Decision|4
332930|NCT01255904|1124886|P1|Overall Study|Physician Decision|1
332931|NCT01255787|1124896|P4|Overall Study|Noncompliance with Study Drug|0
332932|NCT01255787|1124897|P3|Overall Study|Noncompliance with Study Drug|0
332933|NCT01255787|1124898|P2|Overall Study|Noncompliance with Study Drug|1
332934|NCT01255787|1124899|P1|Overall Study|Noncompliance with Study Drug|3
332935|NCT01255787|1124896|P4|Overall Study|Lack of Efficacy|2
332936|NCT01255787|1124897|P3|Overall Study|Lack of Efficacy|2
332937|NCT01255787|1124898|P2|Overall Study|Lack of Efficacy|2
332938|NCT01255787|1124899|P1|Overall Study|Lack of Efficacy|2
332939|NCT01255787|1124896|P4|Overall Study|Pregnancy|1
332940|NCT01255787|1124897|P3|Overall Study|Pregnancy|0
332941|NCT01255787|1124898|P2|Overall Study|Pregnancy|0
332942|NCT01255787|1124899|P1|Overall Study|Pregnancy|0
332943|NCT01255787|1124896|P4|Overall Study|Withdrawal of Consent|4
332944|NCT01255787|1124897|P3|Overall Study|Withdrawal of Consent|3
332945|NCT01255787|1124898|P2|Overall Study|Withdrawal of Consent|9
332946|NCT01255787|1124899|P1|Overall Study|Withdrawal of Consent|3
332947|NCT01255787|1124896|P4|Overall Study|Lost to Follow-up|2
332948|NCT01255787|1124897|P3|Overall Study|Lost to Follow-up|4
332949|NCT01255787|1124898|P2|Overall Study|Lost to Follow-up|2
332950|NCT01255787|1124899|P1|Overall Study|Lost to Follow-up|1
332951|NCT01255787|1124896|P4|Overall Study|Major Protocol Deviation|4
332952|NCT01255787|1124897|P3|Overall Study|Major Protocol Deviation|0
332953|NCT01255787|1124898|P2|Overall Study|Major Protocol Deviation|1
332954|NCT01255787|1124899|P1|Overall Study|Major Protocol Deviation|1
332955|NCT01255787|1124896|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
332956|NCT01255787|1124897|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
332957|NCT01255787|1124898|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
332958|NCT01255787|1124899|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
332959|NCT01255761|1124927|P2|Overall Study|Other Reasons|18
332960|NCT01255761|1124928|P1|Overall Study|Other Reasons|37
332961|NCT01255761|1124927|P2|Overall Study|Withdrawal by Subject|27
332962|NCT01255761|1124928|P1|Overall Study|Withdrawal by Subject|11
332963|NCT01255761|1124927|P2|Overall Study|Lost to Follow-up|8
332964|NCT01255761|1124928|P1|Overall Study|Lost to Follow-up|10
332965|NCT01255761|1124927|P2|Overall Study|Protocol Violation|5
332966|NCT01255761|1124928|P1|Overall Study|Protocol Violation|9
332967|NCT01255761|1124927|P2|Overall Study|Lack of Efficacy|74
332968|NCT01255761|1124928|P1|Overall Study|Lack of Efficacy|86
332969|NCT01255761|1124927|P2|Overall Study|Adverse Event|43
332970|NCT01255761|1124928|P1|Overall Study|Adverse Event|29
332972|NCT01255722|1125014|P2|Overall Study|beta-blocker contraindicated|0
332973|NCT01255722|1125015|P1|Overall Study|beta-blocker contraindicated|2
332974|NCT01255722|1125013|P3|Overall Study|asymptomatic patient|0
332975|NCT01255722|1125014|P2|Overall Study|asymptomatic patient|0
332976|NCT01255722|1125015|P1|Overall Study|asymptomatic patient|1
332977|NCT01255722|1125013|P3|Overall Study|Adverse Event|1
332978|NCT01255722|1125014|P2|Overall Study|Adverse Event|1
332979|NCT01255722|1125015|P1|Overall Study|Adverse Event|0
332980|NCT01255631|1125040|P2|Overall Study|poor enrollment, no data analyzed|6
332981|NCT01255631|1125041|P1|Overall Study|poor enrollment, no data analyzed|9
332982|NCT01255592|1125059|P2|Overall Study|Other|1
332983|NCT01255592|1125060|P1|Overall Study|Other|0
332984|NCT01255592|1125059|P2|Overall Study|Withdrawal by Subject|0
332985|NCT01255592|1125060|P1|Overall Study|Withdrawal by Subject|1
332986|NCT01255592|1125059|P2|Overall Study|Adverse Event|0
332987|NCT01255592|1125060|P1|Overall Study|Adverse Event|5
332988|NCT01255436|1125123|P2|Overall Study|Death, stroke, or MI|3
332989|NCT01255436|1125124|P1|Overall Study|Death, stroke, or MI|4
332990|NCT01255436|1125123|P2|Overall Study|Lost to Follow-up|191
332991|NCT01255436|1125124|P1|Overall Study|Lost to Follow-up|178
332992|NCT01255423|1125138|P2|Overall Study|Use of prohibited medications|1
332993|NCT01255423|1125139|P1|Overall Study|Use of prohibited medications|0
332994|NCT01255423|1125138|P2|Overall Study|Abnormal Laboratory value|2
332995|NCT01255423|1125139|P1|Overall Study|Abnormal Laboratory value|3
332996|NCT01255306|1125155|P2|Overall Study|Physician Decision|1
332997|NCT01255306|1125156|P1|Overall Study|Physician Decision|1
332998|NCT01255163|1125167|P2|Overall Study|AstraZeneca stopped support of the study|3
332999|NCT01255163|1125168|P1|Overall Study|AstraZeneca stopped support of the study|1
333000|NCT01255163|1125167|P2|Overall Study|Adverse Event|2
333001|NCT01255163|1125168|P1|Overall Study|Adverse Event|0
333002|NCT01255163|1125167|P2|Overall Study|Lost to Follow-up|0
333003|NCT01255163|1125168|P1|Overall Study|Lost to Follow-up|2
333004|NCT01255163|1125167|P2|Overall Study|Withdrawal by Subject|0
333005|NCT01255163|1125168|P1|Overall Study|Withdrawal by Subject|1
333006|NCT01254890|1125197|P2|Overall Study|Disease Progression|5
333007|NCT01254890|1125198|P1|Overall Study|Disease Progression|0
333008|NCT01254890|1125197|P2|Overall Study|Withdrawal by Subject|2
333009|NCT01254890|1125198|P1|Overall Study|Withdrawal by Subject|1
333010|NCT01254890|1125197|P2|Overall Study|Ineligible|3
333011|NCT01254890|1125198|P1|Overall Study|Ineligible|0
333012|NCT01254747|1125260|P4|Overall Study|Discomfort|0
333013|NCT01254747|1125261|P3|Overall Study|Discomfort|0
333014|NCT01254747|1125262|P2|Overall Study|Discomfort|4
333015|NCT01254747|1125263|P1|Overall Study|Discomfort|0
333016|NCT01254747|1125260|P4|Overall Study|Biomicroscopy|0
333017|NCT01254747|1125261|P3|Overall Study|Biomicroscopy|1
333018|NCT01254747|1125262|P2|Overall Study|Biomicroscopy|0
333019|NCT01254747|1125263|P1|Overall Study|Biomicroscopy|0
333020|NCT01254747|1125260|P4|Overall Study|Lost to Follow-up|0
333021|NCT01254747|1125261|P3|Overall Study|Lost to Follow-up|1
333022|NCT01254747|1125262|P2|Overall Study|Lost to Follow-up|0
333023|NCT01254747|1125263|P1|Overall Study|Lost to Follow-up|0
333024|NCT01254747|1125260|P4|Overall Study|Symptoms and problems|0
333025|NCT01254747|1125261|P3|Overall Study|Symptoms and problems|1
333026|NCT01254747|1125262|P2|Overall Study|Symptoms and problems|2
333027|NCT01254747|1125263|P1|Overall Study|Symptoms and problems|0
333028|NCT01254747|1125260|P4|Overall Study|Difficult removal handling|0
333029|NCT01254747|1125261|P3|Overall Study|Difficult removal handling|1
333030|NCT01254747|1125262|P2|Overall Study|Difficult removal handling|0
333031|NCT01254747|1125263|P1|Overall Study|Difficult removal handling|0
333032|NCT01254747|1125260|P4|Overall Study|Unacceptable subjective vision|2
333033|NCT01254747|1125261|P3|Overall Study|Unacceptable subjective vision|0
333034|NCT01254747|1125262|P2|Overall Study|Unacceptable subjective vision|0
333035|NCT01254747|1125263|P1|Overall Study|Unacceptable subjective vision|0
333036|NCT01254721|1125303|P2|Overall Study|Wrongly randomization|1
333037|NCT01254721|1125304|P1|Overall Study|Wrongly randomization|0
333038|NCT01254721|1125303|P2|Overall Study|Withdrawal by Subject|11
333039|NCT01254721|1125304|P1|Overall Study|Withdrawal by Subject|8
333040|NCT01254721|1125303|P2|Overall Study|Adverse Event|3
333041|NCT01254721|1125304|P1|Overall Study|Adverse Event|2
333042|NCT01254721|1125303|P2|Overall Study|technical problum|0
333043|NCT01254721|1125304|P1|Overall Study|technical problum|1
333044|NCT01254721|1125303|P2|Overall Study|Death|1
333045|NCT01254721|1125304|P1|Overall Study|Death|0
333046|NCT01254721|1125303|P2|Overall Study|Lack of Efficacy|2
333047|NCT01254721|1125304|P1|Overall Study|Lack of Efficacy|4
333048|NCT01254721|1125303|P2|Overall Study|Lost to Follow-up|4
333049|NCT01254721|1125304|P1|Overall Study|Lost to Follow-up|0
333050|NCT01254669|1125314|P2|Overall Study|called to clinic during intervention|1
333051|NCT01254669|1125315|P1|Overall Study|called to clinic during intervention|1
333052|NCT01254669|1125314|P2|Overall Study|time constraint|2
333053|NCT01254669|1125315|P1|Overall Study|time constraint|2
333054|NCT01254669|1125314|P2|Overall Study|Withdrawal by Subject|1
333055|NCT01254669|1125315|P1|Overall Study|Withdrawal by Subject|0
333056|NCT01254656|1125326|P3|Overall Study|Death|0
333057|NCT01254656|1125327|P2|Overall Study|Death|1
333058|NCT01254656|1125328|P1|Overall Study|Death|0
333059|NCT01254656|1125326|P3|Overall Study|Adverse Event|0
333060|NCT01254656|1125327|P2|Overall Study|Adverse Event|1
333061|NCT01254656|1125328|P1|Overall Study|Adverse Event|1
333062|NCT01254656|1125326|P3|Overall Study|Pregnancy|2
333063|NCT01254656|1125327|P2|Overall Study|Pregnancy|0
333064|NCT01254656|1125328|P1|Overall Study|Pregnancy|0
333065|NCT01254656|1125326|P3|Overall Study|Withdrawal by Subject|1
333066|NCT01254656|1125327|P2|Overall Study|Withdrawal by Subject|2
333067|NCT01254656|1125328|P1|Overall Study|Withdrawal by Subject|2
333068|NCT01254656|1125326|P3|Overall Study|Lost to Follow-up|2
333069|NCT01254656|1125327|P2|Overall Study|Lost to Follow-up|0
333070|NCT01254656|1125328|P1|Overall Study|Lost to Follow-up|1
333071|NCT01254656|1125326|P3|Overall Study|Lack of Efficacy|0
333072|NCT01254656|1125327|P2|Overall Study|Lack of Efficacy|0
333073|NCT01254656|1125328|P1|Overall Study|Lack of Efficacy|3
333074|NCT01254656|1125326|P3|Overall Study|Discontinued due to termination of study|13
333075|NCT01254656|1125327|P2|Overall Study|Discontinued due to termination of study|39
333076|NCT01254656|1125328|P1|Overall Study|Discontinued due to termination of study|40
333077|NCT01254643|1125354|P1|Overall Study|Withdrawal by Subject|1
333078|NCT01254630|1125366|P4|Overall Study|Status not recorded|0
333079|NCT01254630|1125367|P3|Overall Study|Status not recorded|1
333080|NCT01254630|1125368|P2|Overall Study|Status not recorded|0
333081|NCT01254630|1125369|P1|Overall Study|Status not recorded|0
333082|NCT01254630|1125366|P4|Overall Study|Study terminated by sponsor|1010
333083|NCT01254630|1125367|P3|Overall Study|Study terminated by sponsor|0
333084|NCT01254630|1125368|P2|Overall Study|Study terminated by sponsor|994
333085|NCT01254630|1125369|P1|Overall Study|Study terminated by sponsor|0
333086|NCT01254630|1125366|P4|Overall Study|Withdrawal by Subject|89
333087|NCT01254630|1125367|P3|Overall Study|Withdrawal by Subject|188
333088|NCT01254630|1125368|P2|Overall Study|Withdrawal by Subject|94
333089|NCT01254630|1125369|P1|Overall Study|Withdrawal by Subject|201
333090|NCT01254630|1125366|P4|Overall Study|Physician Decision|7
333091|NCT01254630|1125367|P3|Overall Study|Physician Decision|16
333092|NCT01254630|1125368|P2|Overall Study|Physician Decision|8
333093|NCT01254630|1125369|P1|Overall Study|Physician Decision|24
333094|NCT01254630|1125366|P4|Overall Study|Lost to Follow-up|32
333095|NCT01254630|1125367|P3|Overall Study|Lost to Follow-up|89
333096|NCT01254630|1125368|P2|Overall Study|Lost to Follow-up|26
333097|NCT01254630|1125369|P1|Overall Study|Lost to Follow-up|80
333098|NCT01254630|1125366|P4|Overall Study|Death|139
333099|NCT01254630|1125367|P3|Overall Study|Death|478
333100|NCT01254630|1125368|P2|Overall Study|Death|151
333101|NCT01254630|1125369|P1|Overall Study|Death|461
333102|NCT01254630|1125366|P4|Overall Study|Adverse Event|8
333103|NCT01254630|1125367|P3|Overall Study|Adverse Event|40
333104|NCT01254630|1125368|P2|Overall Study|Adverse Event|15
333105|NCT01254630|1125369|P1|Overall Study|Adverse Event|36
333106|NCT01254604|1125389|P2|Overall Study|Adverse Event|2
333107|NCT01254604|1125390|P1|Overall Study|Adverse Event|3
333108|NCT01254604|1125389|P2|Overall Study|Withdrawal by Subject|4
333109|NCT01254604|1125390|P1|Overall Study|Withdrawal by Subject|2
333110|NCT01254604|1125389|P2|Overall Study|Protocol Violation|2
333111|NCT01254604|1125390|P1|Overall Study|Protocol Violation|2
333112|NCT01254604|1125389|P2|Overall Study|Lost to Follow-up|1
333113|NCT01254604|1125390|P1|Overall Study|Lost to Follow-up|1
333114|NCT01254565|1125408|P6|Overall Study|Other|0
333115|NCT01254565|1125409|P5|Overall Study|Other|0
333116|NCT01254565|1125410|P4|Overall Study|Other|1
333117|NCT01254565|1125411|P3|Overall Study|Other|0
333118|NCT01254565|1125412|P2|Overall Study|Other|0
333119|NCT01254565|1125413|P1|Overall Study|Other|0
333120|NCT01254565|1125408|P6|Overall Study|Did not Receive Treatment|4
333121|NCT01254565|1125409|P5|Overall Study|Did not Receive Treatment|3
333122|NCT01254565|1125410|P4|Overall Study|Did not Receive Treatment|0
333123|NCT01254565|1125411|P3|Overall Study|Did not Receive Treatment|0
333124|NCT01254565|1125412|P2|Overall Study|Did not Receive Treatment|1
333125|NCT01254565|1125413|P1|Overall Study|Did not Receive Treatment|1
333126|NCT01254565|1125408|P6|Overall Study|Non-compliance to Study Procedures|0
333127|NCT01254565|1125409|P5|Overall Study|Non-compliance to Study Procedures|1
333128|NCT01254565|1125410|P4|Overall Study|Non-compliance to Study Procedures|0
333129|NCT01254565|1125411|P3|Overall Study|Non-compliance to Study Procedures|0
333130|NCT01254565|1125412|P2|Overall Study|Non-compliance to Study Procedures|0
333131|NCT01254565|1125413|P1|Overall Study|Non-compliance to Study Procedures|0
333132|NCT01254409|1125467|P4|Overall Study|Adverse Event|0
333133|NCT01254409|1125468|P3|Overall Study|Adverse Event|0
333134|NCT01254409|1125469|P2|Overall Study|Adverse Event|1
333135|NCT01254409|1125470|P1|Overall Study|Adverse Event|0
333136|NCT01254344|1125539|P2|Overall Study|Withdrawal by Subject|6
333137|NCT01254344|1125540|P1|Overall Study|Withdrawal by Subject|3
333138|NCT01254344|1125539|P2|Overall Study|Protocol Violation|4
333139|NCT01254344|1125540|P1|Overall Study|Protocol Violation|1
333140|NCT01254344|1125539|P2|Overall Study|Physician Decision|4
333141|NCT01254344|1125540|P1|Overall Study|Physician Decision|7
333142|NCT01254344|1125539|P2|Overall Study|Adverse Event|5
333143|NCT01254344|1125540|P1|Overall Study|Adverse Event|2
333144|NCT01254331|1125548|P1|Extension Phase|Lost to Follow-up|3
333145|NCT01254331|1125548|P1|Extension Phase|Lack of Efficacy|1
333146|NCT01254331|1125548|P1|Initial Phase|Pregnancy|1
333147|NCT01254331|1125548|P1|Initial Phase|Withdrawal by Subject|1
333148|NCT01254331|1125548|P1|Initial Phase|Adverse Event|3
333149|NCT01254318|1125566|P1|Overall Study|Death|47
333150|NCT01254318|1125566|P1|Overall Study|Lost to Follow-up|5
333151|NCT01254305|1125575|P3|Overall Study|Other Reasons|2
333152|NCT01254305|1125576|P2|Overall Study|Other Reasons|0
333153|NCT01254305|1125577|P1|Overall Study|Other Reasons|0
333154|NCT01254305|1125575|P3|Overall Study|Lost to Follow-up|5
333155|NCT01254305|1125576|P2|Overall Study|Lost to Follow-up|6
333156|NCT01254305|1125577|P1|Overall Study|Lost to Follow-up|10
333157|NCT01254305|1125575|P3|Overall Study|Withdrawal by Subject|4
333158|NCT01254305|1125576|P2|Overall Study|Withdrawal by Subject|2
333159|NCT01254305|1125577|P1|Overall Study|Withdrawal by Subject|4
333160|NCT01254305|1125575|P3|Overall Study|Protocol Violation|3
333161|NCT01254305|1125576|P2|Overall Study|Protocol Violation|7
333162|NCT01254305|1125577|P1|Overall Study|Protocol Violation|1
333163|NCT01254305|1125575|P3|Overall Study|Lack of Efficacy|1
333164|NCT01254305|1125576|P2|Overall Study|Lack of Efficacy|0
333165|NCT01254305|1125577|P1|Overall Study|Lack of Efficacy|1
333166|NCT01254305|1125575|P3|Overall Study|Adverse Event|2
333167|NCT01254305|1125576|P2|Overall Study|Adverse Event|3
333168|NCT01254305|1125577|P1|Overall Study|Adverse Event|6
333169|NCT01254292|1125593|P2|LCS12 Extension Phase|Lost to Follow-up|0
333170|NCT01254292|1125594|P1|LCS12 Extension Phase|Lost to Follow-up|1
333171|NCT01254292|1125593|P2|LCS12 Extension Phase|Pregnancy|0
333172|NCT01254292|1125594|P1|LCS12 Extension Phase|Pregnancy|2
333173|NCT01254292|1125593|P2|LCS12 Extension Phase|Other unknown|0
333174|NCT01254292|1125594|P1|LCS12 Extension Phase|Other unknown|4
333175|NCT01254292|1125593|P2|LCS12 Extension Phase|Withdrawal by Subject|0
333176|NCT01254292|1125594|P1|LCS12 Extension Phase|Withdrawal by Subject|7
333177|NCT01254292|1125593|P2|LCS12 Extension Phase|Adverse Event|0
333178|NCT01254292|1125594|P1|LCS12 Extension Phase|Adverse Event|9
333179|NCT01254292|1125593|P2|LCS12 Extension Phase|Wish for pregnancy|0
333180|NCT01254292|1125594|P1|LCS12 Extension Phase|Wish for pregnancy|14
333181|NCT01254292|1125593|P2|Comparative Phase|Wish for pregnancy|6
333182|NCT01254292|1125594|P1|Comparative Phase|Wish for pregnancy|4
333183|NCT01254292|1125593|P2|Comparative Phase|Protocol Violation|2
333184|NCT01254292|1125594|P1|Comparative Phase|Protocol Violation|1
333185|NCT01254292|1125593|P2|Comparative Phase|Withdrawal by Subject|21
333186|NCT01254292|1125594|P1|Comparative Phase|Withdrawal by Subject|20
333187|NCT01254292|1125593|P2|Comparative Phase|Pregnancy|6
333188|NCT01254292|1125594|P1|Comparative Phase|Pregnancy|2
333189|NCT01254292|1125593|P2|Comparative Phase|Lost to Follow-up|21
333190|NCT01254292|1125594|P1|Comparative Phase|Lost to Follow-up|3
333191|NCT01254292|1125593|P2|Comparative Phase|Adverse Event|25
333192|NCT01254292|1125594|P1|Comparative Phase|Adverse Event|25
333193|NCT01254188|1125671|P1|Overall Study|per investigator discretion|20
333194|NCT01254188|1125671|P1|Overall Study|Adverse Event|43
333195|NCT01254188|1125671|P1|Overall Study|Withdrawal by Subject|7
333196|NCT01254188|1125671|P1|Overall Study|Lost to Follow-up|5
333197|NCT01254188|1125671|P1|Overall Study|Death|4
333198|NCT01254188|1125671|P1|Overall Study|Pregnancy|2
333199|NCT01254188|1125671|P1|Overall Study|Protocol Violation|6
333200|NCT01254188|1125671|P1|Overall Study|Disease Progression|6
333201|NCT01254045|1125682|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
333202|NCT01254045|1125683|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
333203|NCT01254045|1125684|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
333204|NCT01254045|1125685|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
333205|NCT01254045|1125686|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
333206|NCT01254045|1125687|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
333207|NCT01253811|1125741|P1|Overall Study|Withdrawal criteria|1
333208|NCT01253577|1125772|P1|Overall Study|Lost to Follow-up|3
333209|NCT01253564|1125780|P1|Overall Study|Serious Adverse Event|1
333210|NCT01253564|1125780|P1|Overall Study|Withdrawal by Subject|1
333211|NCT01253564|1125780|P1|Overall Study|Disease Progression|22
333212|NCT01253447|1125824|P1|Overall Study|Adverse Event|2
333213|NCT01253421|1125832|P5|Drug+Scanning Visit|Physician Decision|1
333214|NCT01253421|1125833|P4|Drug+Scanning Visit|Physician Decision|0
333215|NCT01253421|1125834|P3|Drug+Scanning Visit|Physician Decision|0
333216|NCT01253421|1125835|P2|Drug+Scanning Visit|Physician Decision|0
333217|NCT01253421|1125836|P1|Drug+Scanning Visit|Physician Decision|0
333218|NCT01253421|1125832|P5|Assessment and Scheduling|Physician Decision|0
333219|NCT01253421|1125833|P4|Assessment and Scheduling|Physician Decision|0
333220|NCT01253421|1125834|P3|Assessment and Scheduling|Physician Decision|0
333221|NCT01253421|1125835|P2|Assessment and Scheduling|Physician Decision|0
333222|NCT01253421|1125836|P1|Assessment and Scheduling|Physician Decision|1
333223|NCT01253421|1125832|P5|Assessment and Scheduling|Withdrawal by Subject|0
333224|NCT01253421|1125833|P4|Assessment and Scheduling|Withdrawal by Subject|0
333225|NCT01253421|1125834|P3|Assessment and Scheduling|Withdrawal by Subject|0
333226|NCT01253421|1125835|P2|Assessment and Scheduling|Withdrawal by Subject|0
333227|NCT01253421|1125836|P1|Assessment and Scheduling|Withdrawal by Subject|7
333228|NCT01253421|1125832|P5|Assessment and Scheduling|Lost to Follow-up|0
333229|NCT01253421|1125833|P4|Assessment and Scheduling|Lost to Follow-up|0
333230|NCT01253421|1125834|P3|Assessment and Scheduling|Lost to Follow-up|0
333231|NCT01253421|1125835|P2|Assessment and Scheduling|Lost to Follow-up|0
333232|NCT01253421|1125836|P1|Assessment and Scheduling|Lost to Follow-up|17
333233|NCT01253421|1125832|P5|Assessment and Scheduling|Found to be Ineligible|0
333234|NCT01253421|1125833|P4|Assessment and Scheduling|Found to be Ineligible|0
333235|NCT01253421|1125834|P3|Assessment and Scheduling|Found to be Ineligible|0
333236|NCT01253421|1125835|P2|Assessment and Scheduling|Found to be Ineligible|0
333237|NCT01253421|1125836|P1|Assessment and Scheduling|Found to be Ineligible|74
333238|NCT01253408|1125885|P3|Overall Study|Adverse Event|0
333239|NCT01253408|1125886|P2|Overall Study|Adverse Event|1
333240|NCT01253408|1125887|P1|Overall Study|Adverse Event|0
333241|NCT01253369|1125910|P1|Overall Study|Not Evaluable|3
333242|NCT01253369|1125910|P1|Overall Study|Progressive disease|23
333243|NCT01253369|1125910|P1|Overall Study|Death|1
333244|NCT01253369|1125910|P1|Overall Study|Withdrawal by Subject|2
333245|NCT01253369|1125910|P1|Overall Study|Adverse Event|4
333246|NCT01253317|1125940|P1|Overall Study|Adverse Event|2
333247|NCT01253304|1125952|P4|Overall Study|Adverse Event|1
333248|NCT01253304|1125953|P3|Overall Study|Adverse Event|0
333249|NCT01253304|1125954|P2|Overall Study|Adverse Event|0
333250|NCT01253304|1125955|P1|Overall Study|Adverse Event|0
333251|NCT01253265|1125994|P5|Overall Study|Withdrawal by Subject|1
333252|NCT01253265|1125995|P4|Overall Study|Withdrawal by Subject|0
333253|NCT01253265|1125996|P3|Overall Study|Withdrawal by Subject|0
333254|NCT01253265|1125997|P2|Overall Study|Withdrawal by Subject|0
333255|NCT01253265|1125998|P1|Overall Study|Withdrawal by Subject|0
333256|NCT01253265|1125994|P5|Overall Study|Met Predefined Discontinuation Criteria|0
333257|NCT01253265|1125995|P4|Overall Study|Met Predefined Discontinuation Criteria|0
333258|NCT01253265|1125996|P3|Overall Study|Met Predefined Discontinuation Criteria|0
333259|NCT01253265|1125997|P2|Overall Study|Met Predefined Discontinuation Criteria|0
333260|NCT01253265|1125998|P1|Overall Study|Met Predefined Discontinuation Criteria|1
333261|NCT01253200|1126047|P5|Overall Study|Attempts|0
333262|NCT01253200|1126048|P4|Overall Study|Attempts|2
333263|NCT01253200|1126049|P3|Overall Study|Attempts|1
333264|NCT01253200|1126050|P2|Overall Study|Attempts|4
333265|NCT01253200|1126051|P1|Overall Study|Attempts|6
333266|NCT01253200|1126047|P5|Overall Study|intents|0
333267|NCT01253200|1126048|P4|Overall Study|intents|3
333268|NCT01253200|1126049|P3|Overall Study|intents|1
333269|NCT01253200|1126050|P2|Overall Study|intents|10
333270|NCT01253200|1126051|P1|Overall Study|intents|10
333271|NCT01253200|1126047|P5|Overall Study|Protocol Violation|5
333272|NCT01253200|1126048|P4|Overall Study|Protocol Violation|0
333273|NCT01253200|1126049|P3|Overall Study|Protocol Violation|0
333274|NCT01253200|1126050|P2|Overall Study|Protocol Violation|4
333275|NCT01253200|1126051|P1|Overall Study|Protocol Violation|1
333276|NCT01253200|1126047|P5|Overall Study|Withdrawal by Subject|0
333277|NCT01253200|1126048|P4|Overall Study|Withdrawal by Subject|0
333278|NCT01253200|1126049|P3|Overall Study|Withdrawal by Subject|0
333279|NCT01253200|1126050|P2|Overall Study|Withdrawal by Subject|0
333280|NCT01253200|1126051|P1|Overall Study|Withdrawal by Subject|2
333281|NCT01253200|1126047|P5|Overall Study|Lost to Follow-up|0
333282|NCT01253200|1126048|P4|Overall Study|Lost to Follow-up|0
333283|NCT01253200|1126049|P3|Overall Study|Lost to Follow-up|0
333284|NCT01253200|1126050|P2|Overall Study|Lost to Follow-up|1
333285|NCT01253200|1126051|P1|Overall Study|Lost to Follow-up|1
333286|NCT01253200|1126047|P5|Overall Study|Death|0
333287|NCT01253200|1126048|P4|Overall Study|Death|0
333288|NCT01253200|1126049|P3|Overall Study|Death|0
333289|NCT01253200|1126050|P2|Overall Study|Death|0
333290|NCT01253200|1126051|P1|Overall Study|Death|1
333291|NCT01253187|1126066|P6|Period 3|non-compliance|0
333292|NCT01253187|1126067|P5|Period 3|non-compliance|1
333293|NCT01253187|1126068|P4|Period 3|non-compliance|0
333294|NCT01253187|1126069|P3|Period 3|non-compliance|0
333295|NCT01253187|1126070|P2|Period 3|non-compliance|0
333296|NCT01253187|1126071|P1|Period 3|non-compliance|0
333297|NCT01253187|1126066|P6|Period 3|difficulty with blood sampling|0
333298|NCT01253187|1126067|P5|Period 3|difficulty with blood sampling|0
333299|NCT01253187|1126068|P4|Period 3|difficulty with blood sampling|0
333300|NCT01253187|1126069|P3|Period 3|difficulty with blood sampling|0
333301|NCT01253187|1126070|P2|Period 3|difficulty with blood sampling|1
333302|NCT01253187|1126071|P1|Period 3|difficulty with blood sampling|0
333303|NCT01253187|1126066|P6|Period 3|Pregnancy|0
333304|NCT01253187|1126067|P5|Period 3|Pregnancy|0
333305|NCT01253187|1126068|P4|Period 3|Pregnancy|0
333306|NCT01253187|1126069|P3|Period 3|Pregnancy|0
333307|NCT01253187|1126070|P2|Period 3|Pregnancy|0
333308|NCT01253187|1126071|P1|Period 3|Pregnancy|1
333309|NCT01253187|1126066|P6|Period 2|Withdrawal by Subject|0
333310|NCT01253187|1126067|P5|Period 2|Withdrawal by Subject|1
333311|NCT01253187|1126068|P4|Period 2|Withdrawal by Subject|0
333312|NCT01253187|1126069|P3|Period 2|Withdrawal by Subject|0
333313|NCT01253187|1126070|P2|Period 2|Withdrawal by Subject|0
333314|NCT01253187|1126071|P1|Period 2|Withdrawal by Subject|0
333315|NCT01253174|1126100|P6|Period 3|Pregnancy|0
333316|NCT01253174|1126101|P5|Period 3|Pregnancy|0
333317|NCT01253174|1126102|P4|Period 3|Pregnancy|0
333318|NCT01253174|1126103|P3|Period 3|Pregnancy|1
333319|NCT01253174|1126104|P2|Period 3|Pregnancy|0
333320|NCT01253174|1126105|P1|Period 3|Pregnancy|0
333321|NCT01253174|1126100|P6|Period 3|Withdrawal by Subject|0
333322|NCT01253174|1126101|P5|Period 3|Withdrawal by Subject|1
333323|NCT01253174|1126102|P4|Period 3|Withdrawal by Subject|0
333324|NCT01253174|1126103|P3|Period 3|Withdrawal by Subject|0
333325|NCT01253174|1126104|P2|Period 3|Withdrawal by Subject|1
333326|NCT01253174|1126105|P1|Period 3|Withdrawal by Subject|0
333327|NCT01253174|1126100|P6|Period 2|Adverse Event|0
333328|NCT01253174|1126101|P5|Period 2|Adverse Event|0
333329|NCT01253174|1126102|P4|Period 2|Adverse Event|0
333330|NCT01253174|1126103|P3|Period 2|Adverse Event|1
333331|NCT01253174|1126104|P2|Period 2|Adverse Event|0
333332|NCT01253174|1126105|P1|Period 2|Adverse Event|0
333333|NCT01253174|1126100|P6|Period 1|Randomized but not treated|0
333334|NCT01253174|1126101|P5|Period 1|Randomized but not treated|1
333335|NCT01253174|1126102|P4|Period 1|Randomized but not treated|0
333336|NCT01253174|1126103|P3|Period 1|Randomized but not treated|1
333337|NCT01253174|1126104|P2|Period 1|Randomized but not treated|1
333338|NCT01253174|1126105|P1|Period 1|Randomized but not treated|0
333339|NCT01253135|1126140|P1|Amended Protocol|Non-compliance|1
333340|NCT01253135|1126140|P1|Original Protocol|Protocol Amendment|15
333341|NCT01253044|1126159|P2|Overall Study|Lost to Follow-up|29
333342|NCT01253044|1126160|P1|Overall Study|Lost to Follow-up|38
333343|NCT01253018|1126170|P2|Overall Study|Withdrawal by Subject|1
333344|NCT01253018|1126171|P1|Overall Study|Withdrawal by Subject|1
333345|NCT01253018|1126170|P2|Overall Study|Robot Repair Issues|0
333346|NCT01253018|1126171|P1|Overall Study|Robot Repair Issues|2
333347|NCT01253018|1126170|P2|Overall Study|Lost to Follow-up|1
333348|NCT01253018|1126171|P1|Overall Study|Lost to Follow-up|1
333349|NCT01252966|1126185|P2|Overall Study|Withdrawal by Subject|3
333350|NCT01252966|1126186|P1|Overall Study|Withdrawal by Subject|7
333351|NCT01252966|1126185|P2|Overall Study|Lost to Follow-up|10
333352|NCT01252966|1126186|P1|Overall Study|Lost to Follow-up|16
333353|NCT01252953|1126202|P2|Overall Study|Lost to Follow-up|21
333354|NCT01252953|1126203|P1|Overall Study|Lost to Follow-up|22
333355|NCT01252953|1126202|P2|Overall Study|Withdrawal by Subject|17
333356|NCT01252953|1126203|P1|Overall Study|Withdrawal by Subject|16
333357|NCT01252940|1126217|P2|Extension Phase|Withdrawal by Subject|1
333358|NCT01252940|1126218|P1|Extension Phase|Withdrawal by Subject|1
333359|NCT01252940|1126217|P2|Extension Phase|Subject Non-compliance|0
333360|NCT01252940|1126218|P1|Extension Phase|Subject Non-compliance|1
333361|NCT01252940|1126217|P2|Extension Phase|Physician Decision|1
333362|NCT01252940|1126218|P1|Extension Phase|Physician Decision|0
333363|NCT01252940|1126217|P2|Extension Phase|Lost to Follow-up|0
333364|NCT01252940|1126218|P1|Extension Phase|Lost to Follow-up|5
333365|NCT01252940|1126217|P2|Extension Phase|Lack of Efficacy|0
333366|NCT01252940|1126218|P1|Extension Phase|Lack of Efficacy|1
333367|NCT01252940|1126217|P2|Extension Phase|Adverse Event|1
333368|NCT01252940|1126218|P1|Extension Phase|Adverse Event|2
333369|NCT01252940|1126217|P2|Main Study Phase|Subject Non-compliance|1
333370|NCT01252940|1126218|P1|Main Study Phase|Subject Non-compliance|1
333371|NCT01252940|1126217|P2|Main Study Phase|Withdrawal by Subject|5
333372|NCT01252940|1126218|P1|Main Study Phase|Withdrawal by Subject|6
333373|NCT01252940|1126217|P2|Main Study Phase|Protocol Violation|2
333374|NCT01252940|1126218|P1|Main Study Phase|Protocol Violation|4
333375|NCT01252940|1126217|P2|Main Study Phase|Physician Decision|0
333376|NCT01252940|1126218|P1|Main Study Phase|Physician Decision|1
333377|NCT01252940|1126217|P2|Main Study Phase|Lost to Follow-up|1
333378|NCT01252940|1126218|P1|Main Study Phase|Lost to Follow-up|6
333379|NCT01252940|1126217|P2|Main Study Phase|Lack of Efficacy|0
333380|NCT01252940|1126218|P1|Main Study Phase|Lack of Efficacy|1
333381|NCT01252940|1126217|P2|Main Study Phase|Adverse Event|1
333382|NCT01252940|1126218|P1|Main Study Phase|Adverse Event|3
333383|NCT01252940|1126217|P2|Main Study Phase|Randomized but not treated|2
333384|NCT01252940|1126218|P1|Main Study Phase|Randomized but not treated|4
333385|NCT01252810|1126249|P2|Overall Study|Various reasons|0
333386|NCT01252810|1126250|P1|Overall Study|Various reasons|8
333387|NCT01252810|1126249|P2|Overall Study|Physician Decision|1
333388|NCT01252810|1126250|P1|Overall Study|Physician Decision|2
333389|NCT01252810|1126249|P2|Overall Study|Lost to Follow-up|1
333390|NCT01252810|1126250|P1|Overall Study|Lost to Follow-up|0
333391|NCT01252810|1126249|P2|Overall Study|Withdrawal by Subject|1
333392|NCT01252810|1126250|P1|Overall Study|Withdrawal by Subject|4
333393|NCT01252355|1126282|P3|Overall Study|Other Than Above|7
333394|NCT01252355|1126283|P2|Overall Study|Other Than Above|7
333395|NCT01252355|1126284|P1|Overall Study|Other Than Above|8
333396|NCT01252355|1126282|P3|Overall Study|Randomized but not Treated|0
333397|NCT01252355|1126283|P2|Overall Study|Randomized but not Treated|0
333398|NCT01252355|1126284|P1|Overall Study|Randomized but not Treated|2
333399|NCT01252355|1126282|P3|Overall Study|Sponsor Early Termination of Study|146
333400|NCT01252355|1126283|P2|Overall Study|Sponsor Early Termination of Study|149
333401|NCT01252355|1126284|P1|Overall Study|Sponsor Early Termination of Study|149
333402|NCT01252355|1126282|P3|Overall Study|Progressive Disease|0
333403|NCT01252355|1126283|P2|Overall Study|Progressive Disease|0
333404|NCT01252355|1126284|P1|Overall Study|Progressive Disease|2
333405|NCT01252355|1126282|P3|Overall Study|Poor Compliance to Protocol|1
333406|NCT01252355|1126283|P2|Overall Study|Poor Compliance to Protocol|1
333407|NCT01252355|1126284|P1|Overall Study|Poor Compliance to Protocol|1
333408|NCT01252355|1126282|P3|Overall Study|Lost to Follow-up|1
333409|NCT01252355|1126283|P2|Overall Study|Lost to Follow-up|0
333410|NCT01252355|1126284|P1|Overall Study|Lost to Follow-up|0
333411|NCT01252355|1126282|P3|Overall Study|Lack of Efficacy|2
333412|NCT01252355|1126283|P2|Overall Study|Lack of Efficacy|4
333413|NCT01252355|1126284|P1|Overall Study|Lack of Efficacy|6
333414|NCT01252355|1126282|P3|Overall Study|Adverse Event|22
333415|NCT01252355|1126283|P2|Overall Study|Adverse Event|17
333416|NCT01252355|1126284|P1|Overall Study|Adverse Event|9
333417|NCT01252290|1126322|P1|Overall Study|Withdrawal by Subject|1
333418|NCT01252251|1126338|P1|Overall Study|Withdrawal by Subject|1
333419|NCT01252238|1126350|P3|Overall Study|Sponsor terminated study|4
333420|NCT01252238|1126351|P2|Overall Study|Sponsor terminated study|4
333421|NCT01252238|1126352|P1|Overall Study|Sponsor terminated study|4
333422|NCT01252186|1126369|P3|Overall Study|Other - Miscellaneous Reasons|7
333423|NCT01252186|1126370|P2|Overall Study|Other - Miscellaneous Reasons|5
333424|NCT01252186|1126371|P1|Overall Study|Other - Miscellaneous Reasons|5
333425|NCT01252186|1126369|P3|Overall Study|Lost to Follow-up|11
333426|NCT01252186|1126370|P2|Overall Study|Lost to Follow-up|10
333427|NCT01252186|1126371|P1|Overall Study|Lost to Follow-up|10
333428|NCT01252186|1126369|P3|Overall Study|Sponsor Request|0
333429|NCT01252186|1126370|P2|Overall Study|Sponsor Request|1
333430|NCT01252186|1126371|P1|Overall Study|Sponsor Request|2
333431|NCT01252186|1126369|P3|Overall Study|Pregnancy|0
333432|NCT01252186|1126370|P2|Overall Study|Pregnancy|2
333433|NCT01252186|1126371|P1|Overall Study|Pregnancy|2
333434|NCT01252186|1126369|P3|Overall Study|Protocol Violation|1
333435|NCT01252186|1126370|P2|Overall Study|Protocol Violation|0
333436|NCT01252186|1126371|P1|Overall Study|Protocol Violation|0
333437|NCT01252186|1126369|P3|Overall Study|Non-compliance|4
333438|NCT01252186|1126370|P2|Overall Study|Non-compliance|3
333439|NCT01252186|1126371|P1|Overall Study|Non-compliance|0
333440|NCT01252186|1126369|P3|Overall Study|Physician Decision|1
333441|NCT01252186|1126370|P2|Overall Study|Physician Decision|0
333442|NCT01252186|1126371|P1|Overall Study|Physician Decision|0
333443|NCT01252186|1126369|P3|Overall Study|Withdrawal by Subject|2
333444|NCT01252186|1126370|P2|Overall Study|Withdrawal by Subject|5
333445|NCT01252186|1126371|P1|Overall Study|Withdrawal by Subject|2
333446|NCT01252186|1126369|P3|Overall Study|Adverse Event|8
333447|NCT01252186|1126370|P2|Overall Study|Adverse Event|6
333448|NCT01252186|1126371|P1|Overall Study|Adverse Event|9
333449|NCT01252134|1126444|P6|Period 1, 8 Hours|Personal Reasons|0
333450|NCT01252134|1126445|P5|Period 1, 8 Hours|Personal Reasons|0
333451|NCT01252134|1126446|P4|Period 1, 8 Hours|Personal Reasons|0
333452|NCT01252134|1126447|P3|Period 1, 8 Hours|Personal Reasons|1
333453|NCT01252134|1126448|P2|Period 1, 8 Hours|Personal Reasons|1
333454|NCT01252134|1126449|P1|Period 1, 8 Hours|Personal Reasons|0
333455|NCT01252095|1126468|P2|Overall Study|Disease progression|0
333456|NCT01252095|1126469|P1|Overall Study|Disease progression|1
333457|NCT01251952|1126487|P1|Overall Study|Adverse Event|1
333458|NCT01251770|1126493|P2|Overall Study|Protocol Violation|7
333459|NCT01251770|1126494|P1|Overall Study|Protocol Violation|13
333460|NCT01251653|1126545|P9|Overall Study|Other reason not mentioned above|0
333461|NCT01251653|1126546|P8|Overall Study|Other reason not mentioned above|2
333462|NCT01251653|1126547|P7|Overall Study|Other reason not mentioned above|0
333463|NCT01251653|1126548|P6|Overall Study|Other reason not mentioned above|0
333464|NCT01251653|1126549|P5|Overall Study|Other reason not mentioned above|0
333465|NCT01251653|1126550|P4|Overall Study|Other reason not mentioned above|0
333466|NCT01251653|1126551|P3|Overall Study|Other reason not mentioned above|0
333467|NCT01251653|1126552|P2|Overall Study|Other reason not mentioned above|0
333468|NCT01251653|1126553|P1|Overall Study|Other reason not mentioned above|0
333469|NCT01251653|1126545|P9|Overall Study|Withdrawal by Subject|0
333470|NCT01251653|1126546|P8|Overall Study|Withdrawal by Subject|1
333471|NCT01251653|1126547|P7|Overall Study|Withdrawal by Subject|0
333472|NCT01251653|1126548|P6|Overall Study|Withdrawal by Subject|1
333473|NCT01251653|1126549|P5|Overall Study|Withdrawal by Subject|1
333474|NCT01251653|1126550|P4|Overall Study|Withdrawal by Subject|0
333475|NCT01251653|1126551|P3|Overall Study|Withdrawal by Subject|1
333476|NCT01251653|1126552|P2|Overall Study|Withdrawal by Subject|0
333477|NCT01251653|1126553|P1|Overall Study|Withdrawal by Subject|1
333478|NCT01251653|1126545|P9|Overall Study|Adverse Event|1
333479|NCT01251653|1126546|P8|Overall Study|Adverse Event|2
333480|NCT01251653|1126547|P7|Overall Study|Adverse Event|2
333481|NCT01251653|1126548|P6|Overall Study|Adverse Event|0
333482|NCT01251653|1126549|P5|Overall Study|Adverse Event|1
333483|NCT01251653|1126550|P4|Overall Study|Adverse Event|1
333484|NCT01251653|1126551|P3|Overall Study|Adverse Event|2
333485|NCT01251653|1126552|P2|Overall Study|Adverse Event|0
333486|NCT01251653|1126553|P1|Overall Study|Adverse Event|1
333487|NCT01251653|1126545|P9|Overall Study|Dose-limiting toxicity|0
333488|NCT01251653|1126546|P8|Overall Study|Dose-limiting toxicity|0
333489|NCT01251653|1126547|P7|Overall Study|Dose-limiting toxicity|2
333490|NCT01251653|1126548|P6|Overall Study|Dose-limiting toxicity|0
333491|NCT01251653|1126549|P5|Overall Study|Dose-limiting toxicity|0
333492|NCT01251653|1126550|P4|Overall Study|Dose-limiting toxicity|1
333493|NCT01251653|1126551|P3|Overall Study|Dose-limiting toxicity|1
333494|NCT01251653|1126552|P2|Overall Study|Dose-limiting toxicity|1
333495|NCT01251653|1126553|P1|Overall Study|Dose-limiting toxicity|0
333496|NCT01251653|1126545|P9|Overall Study|Progressive Disease|5
333497|NCT01251653|1126546|P8|Overall Study|Progressive Disease|7
333498|NCT01251653|1126547|P7|Overall Study|Progressive Disease|14
333499|NCT01251653|1126548|P6|Overall Study|Progressive Disease|17
333500|NCT01251653|1126549|P5|Overall Study|Progressive Disease|0
333501|NCT01251653|1126550|P4|Overall Study|Progressive Disease|4
333502|NCT01251653|1126551|P3|Overall Study|Progressive Disease|16
333503|NCT01251653|1126552|P2|Overall Study|Progressive Disease|7
333504|NCT01251653|1126553|P1|Overall Study|Progressive Disease|1
333505|NCT01251614|1126681|P3|Overall Study|Lost to Follow-up|0
333506|NCT01251614|1126682|P2|Overall Study|Lost to Follow-up|1
333507|NCT01251614|1126683|P1|Overall Study|Lost to Follow-up|0
333508|NCT01251614|1126681|P3|Overall Study|Withdrawal by Subject|1
333509|NCT01251614|1126682|P2|Overall Study|Withdrawal by Subject|2
333510|NCT01251614|1126683|P1|Overall Study|Withdrawal by Subject|0
333511|NCT01251614|1126681|P3|Overall Study|Loss of Disease Control|0
333512|NCT01251614|1126682|P2|Overall Study|Loss of Disease Control|1
333513|NCT01251614|1126683|P1|Overall Study|Loss of Disease Control|0
333514|NCT01251614|1126681|P3|Overall Study|Pregnancy|2
333515|NCT01251614|1126682|P2|Overall Study|Pregnancy|0
333516|NCT01251614|1126683|P1|Overall Study|Pregnancy|0
333517|NCT01251614|1126681|P3|Overall Study|Clearing of Psoriatic Lesions|0
333518|NCT01251614|1126682|P2|Overall Study|Clearing of Psoriatic Lesions|0
333519|NCT01251614|1126683|P1|Overall Study|Clearing of Psoriatic Lesions|1
333520|NCT01251614|1126681|P3|Overall Study|Lack of Efficacy|4
333521|NCT01251614|1126682|P2|Overall Study|Lack of Efficacy|9
333522|NCT01251614|1126683|P1|Overall Study|Lack of Efficacy|1
333523|NCT01251614|1126681|P3|Overall Study|Adverse Event|1
333524|NCT01251614|1126682|P2|Overall Study|Adverse Event|0
333525|NCT01251614|1126683|P1|Overall Study|Adverse Event|1
333526|NCT01251380|1126790|P1|Overall Study|Lost to Follow-up|2
333527|NCT01251380|1126790|P1|Overall Study|Adverse Event|1
333528|NCT01251380|1126790|P1|Overall Study|Lack of Efficacy|1
333529|NCT01251380|1126790|P1|Overall Study|Withdrawal by Subject|6
333530|NCT01251380|1126790|P1|Overall Study|Other (Not otherwise specified)|12
333531|NCT01251367|1126814|P1|Overall Study|End of Study Visit Performed in Error|1
333532|NCT01251367|1126814|P1|Overall Study|Subject had Personal or Medical Issues|4
333533|NCT01251367|1126814|P1|Overall Study|No Study Drug Available|1
333534|NCT01251367|1126814|P1|Overall Study|Subject Required Alternative Treatment|7
333535|NCT01251367|1126814|P1|Overall Study|Lost to Follow-up|5
333536|NCT01251367|1126814|P1|Overall Study|Withdrawal by Subject|36
333537|NCT01251367|1126814|P1|Overall Study|Adverse Event|19
333538|NCT01251367|1126814|P1|Overall Study|Lack of Efficacy|2
333539|NCT01251367|1126814|P1|Overall Study|Protocol Violation|1
333540|NCT01251354|1126849|P1|Overall Study|Disease Progression|4
333541|NCT01251354|1126849|P1|Overall Study|Investigator's Decision|1
333542|NCT01251354|1126849|P1|Overall Study|Adverse Event|1
333543|NCT01251276|1126892|P2|Overall Study|Lost to Follow-up|1
333544|NCT01251276|1126893|P1|Overall Study|Lost to Follow-up|0
333545|NCT01251276|1126892|P2|Overall Study|Protocol Violation|0
333546|NCT01251276|1126893|P1|Overall Study|Protocol Violation|1
333547|NCT01251146|1126911|P2|Overall Study|Lost to Follow-up|10
333548|NCT01251146|1126912|P1|Overall Study|Lost to Follow-up|3
333549|NCT01251120|1126934|P2|Overall Study|Lack of Efficacy|1
333550|NCT01251120|1126935|P1|Overall Study|Lack of Efficacy|0
333551|NCT01250925|1127000|P3|Overall Study|Adverse Event|1
333552|NCT01250925|1127001|P2|Overall Study|Adverse Event|0
333553|NCT01250925|1127002|P1|Overall Study|Adverse Event|0
333554|NCT01250925|1127000|P3|Overall Study|Physician Decision|1
333555|NCT01250925|1127001|P2|Overall Study|Physician Decision|2
333556|NCT01250925|1127002|P1|Overall Study|Physician Decision|0
333557|NCT01250925|1127000|P3|Overall Study|Protocol Violation|0
333558|NCT01250925|1127001|P2|Overall Study|Protocol Violation|0
333559|NCT01250925|1127002|P1|Overall Study|Protocol Violation|2
333560|NCT01250925|1127000|P3|Overall Study|Withdrawal by Subject|0
333561|NCT01250925|1127001|P2|Overall Study|Withdrawal by Subject|0
333562|NCT01250925|1127002|P1|Overall Study|Withdrawal by Subject|2
333563|NCT01250925|1127000|P3|Overall Study|Lost to Follow-up|0
333564|NCT01250925|1127001|P2|Overall Study|Lost to Follow-up|1
333565|NCT01250925|1127002|P1|Overall Study|Lost to Follow-up|1
333566|NCT01250769|1127068|P4|Overall Study|Adverse Event|0
333567|NCT01250769|1127069|P3|Overall Study|Adverse Event|1
333568|NCT01250769|1127070|P2|Overall Study|Adverse Event|0
333569|NCT01250769|1127071|P1|Overall Study|Adverse Event|0
333570|NCT01250769|1127068|P4|Overall Study|Withdrawal by Subject|0
333571|NCT01250769|1127069|P3|Overall Study|Withdrawal by Subject|1
333572|NCT01250769|1127070|P2|Overall Study|Withdrawal by Subject|1
333573|NCT01250769|1127071|P1|Overall Study|Withdrawal by Subject|0
333574|NCT01250756|1127103|P2|After Toddler Dose|Adverse Event|1
333575|NCT01250756|1127104|P1|After Toddler Dose|Adverse Event|0
333576|NCT01250756|1127103|P2|Toddler Dose|Adverse Event|1
333577|NCT01250756|1127104|P1|Toddler Dose|Adverse Event|0
333578|NCT01250756|1127103|P2|After Infant Series|Other|1
333579|NCT01250756|1127104|P1|After Infant Series|Other|2
333580|NCT01250756|1127103|P2|After Infant Series|Withdrawal by Subject|1
333581|NCT01250756|1127104|P1|After Infant Series|Withdrawal by Subject|4
333582|NCT01250756|1127103|P2|After Infant Series|Adverse Event|2
333583|NCT01250756|1127104|P1|After Infant Series|Adverse Event|5
333584|NCT01250756|1127103|P2|Infant Series|Other|0
333585|NCT01250756|1127104|P1|Infant Series|Other|22
333586|NCT01250756|1127103|P2|Infant Series|Randomized, Not Vaccinated|2
333587|NCT01250756|1127104|P1|Infant Series|Randomized, Not Vaccinated|2
333588|NCT01250756|1127103|P2|Infant Series|Withdrawal by Subject|5
333589|NCT01250756|1127104|P1|Infant Series|Withdrawal by Subject|4
333590|NCT01250509|1127221|P2|Overall Study|Lost to Follow-up|2
333591|NCT01250509|1127222|P1|Overall Study|Lost to Follow-up|5
333592|NCT01250418|1127236|P2|Overall Study|monitor data failure|1
333593|NCT01250418|1127237|P1|Overall Study|monitor data failure|1
333594|NCT01250379|1127245|P2|Overall Study|Participant noncompliance|0
333595|NCT01250379|1127246|P1|Overall Study|Participant noncompliance|2
333596|NCT01250379|1127245|P2|Overall Study|Not specified|4
333597|NCT01250379|1127246|P1|Overall Study|Not specified|0
333598|NCT01250379|1127245|P2|Overall Study|Adverse Event|4
333599|NCT01250379|1127246|P1|Overall Study|Adverse Event|5
333600|NCT01250379|1127245|P2|Overall Study|Lost to Follow-up|6
333601|NCT01250379|1127246|P1|Overall Study|Lost to Follow-up|9
333602|NCT01250379|1127245|P2|Overall Study|Protocol Violation|8
333603|NCT01250379|1127246|P1|Overall Study|Protocol Violation|2
333604|NCT01250379|1127245|P2|Overall Study|Physician Decision|3
333605|NCT01250379|1127246|P1|Overall Study|Physician Decision|11
333606|NCT01250379|1127245|P2|Overall Study|Withdrawal by Subject|20
333607|NCT01250379|1127246|P1|Overall Study|Withdrawal by Subject|32
333608|NCT01250379|1127245|P2|Overall Study|Death|148
333609|NCT01250379|1127246|P1|Overall Study|Death|141
333610|NCT01250171|1127335|P3|Overall Study|Administrative reasons|0
333611|NCT01250171|1127336|P2|Overall Study|Administrative reasons|0
333612|NCT01250171|1127337|P1|Overall Study|Administrative reasons|1
333613|NCT01250145|1127368|P2|Overall Study|Withdrawal by Subject|4
333614|NCT01250145|1127369|P1|Overall Study|Withdrawal by Subject|0
333615|NCT01250145|1127368|P2|Overall Study|Adverse Event|1
333616|NCT01250145|1127369|P1|Overall Study|Adverse Event|2
333617|NCT01250119|1127389|P2|Treatment Phase|Unknown reason|4
333618|NCT01250119|1127390|P1|Treatment Phase|Unknown reason|0
333619|NCT01250119|1127389|P2|Treatment Phase|Adverse Event|2
333620|NCT01250119|1127390|P1|Treatment Phase|Adverse Event|0
333621|NCT01250119|1127389|P2|Treatment Phase|Withdrawal by Subject|1
333622|NCT01250119|1127390|P1|Treatment Phase|Withdrawal by Subject|0
333623|NCT01250119|1127389|P2|Treatment Phase|Death|2
333624|NCT01250119|1127390|P1|Treatment Phase|Death|0
333625|NCT01250119|1127389|P2|Treatment Phase|Progressive Disease|32
333626|NCT01250119|1127390|P1|Treatment Phase|Progressive Disease|0
333627|NCT01250119|1127389|P2|Diagnostic Phase|Participants Not Tested|0
333628|NCT01250119|1127390|P1|Diagnostic Phase|Participants Not Tested|44
333629|NCT01250119|1127389|P2|Diagnostic Phase|Failed to Produce a Test Results|0
333630|NCT01250119|1127390|P1|Diagnostic Phase|Failed to Produce a Test Results|69
333631|NCT01250054|1127405|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
333632|NCT01250054|1127406|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
333633|NCT01250002|1127414|P2|Overall Study|Change to open surgical procedure|3
333634|NCT01250002|1127415|P1|Overall Study|Change to open surgical procedure|4
333635|NCT01249833|1127480|P2|Overall Study|Lost to Follow-up|1
333636|NCT01249833|1127481|P1|Overall Study|Lost to Follow-up|0
333637|NCT01249664|1127495|P2|Overall Study|Adverse Event|0
333638|NCT01249664|1127496|P1|Overall Study|Adverse Event|1
333639|NCT01249664|1127495|P2|Overall Study|Withdrawal by Subject|0
333640|NCT01249664|1127496|P1|Overall Study|Withdrawal by Subject|5
333641|NCT01249651|1127546|P1|Overall Study|Sponsor Decision|1
333642|NCT01249651|1127546|P1|Overall Study|Protocol Violation|1
333643|NCT01249651|1127546|P1|Overall Study|Adverse Event|1
333644|NCT01249651|1127546|P1|Overall Study|Withdrawal by Subject|4
333645|NCT01249417|1127556|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
333646|NCT01249417|1127557|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
333647|NCT01249417|1127558|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
333648|NCT01249417|1127556|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
333649|NCT01249417|1127557|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
333650|NCT01249417|1127558|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
333651|NCT01249417|1127556|P3|Treatment Phase - ITT Population|Adverse Event|1
333652|NCT01249417|1127557|P2|Treatment Phase - ITT Population|Adverse Event|0
333653|NCT01249417|1127558|P1|Treatment Phase - ITT Population|Adverse Event|0
333654|NCT01249417|1127556|P3|Treatment Phase - ITT Population|Not specified|1
333655|NCT01249417|1127557|P2|Treatment Phase - ITT Population|Not specified|0
333656|NCT01249417|1127558|P1|Treatment Phase - ITT Population|Not specified|0
333657|NCT01249417|1127556|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
333658|NCT01249417|1127557|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
333659|NCT01249417|1127558|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
333660|NCT01249417|1127556|P3|Randomised Population|Study treatment not received|2
333661|NCT01249417|1127557|P2|Randomised Population|Study treatment not received|0
333662|NCT01249417|1127558|P1|Randomised Population|Study treatment not received|0
333663|NCT01249404|1127575|P3|Overall Study|Non compliance to visit schedule|0
333664|NCT01249404|1127576|P2|Overall Study|Non compliance to visit schedule|1
333665|NCT01249404|1127577|P1|Overall Study|Non compliance to visit schedule|0
333666|NCT01249404|1127575|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
333667|NCT01249404|1127576|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
333668|NCT01249404|1127577|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
333669|NCT01249404|1127575|P3|Overall Study|Withdrawal by Subject|0
333670|NCT01249404|1127576|P2|Overall Study|Withdrawal by Subject|2
333671|NCT01249404|1127577|P1|Overall Study|Withdrawal by Subject|2
333672|NCT01249404|1127575|P3|Overall Study|Adverse Event|2
333673|NCT01249404|1127576|P2|Overall Study|Adverse Event|2
333674|NCT01249404|1127577|P1|Overall Study|Adverse Event|2
333675|NCT01249404|1127575|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
333676|NCT01249404|1127576|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
333677|NCT01249404|1127577|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
333678|NCT01249404|1127575|P3|Overall Study|Study treatment not received|2
333679|NCT01249404|1127576|P2|Overall Study|Study treatment not received|1
333680|NCT01249404|1127577|P1|Overall Study|Study treatment not received|0
333681|NCT01249274|1127656|P2|Overall Study|Received inpatient substance treatment|2
333682|NCT01249274|1127657|P1|Overall Study|Received inpatient substance treatment|1
333683|NCT01249274|1127656|P2|Overall Study|Lost to Follow-up|4
333684|NCT01249274|1127657|P1|Overall Study|Lost to Follow-up|3
333685|NCT01249261|1127683|P2|Overall Study|Withdrawal by Subject|0
333686|NCT01249261|1127684|P1|Overall Study|Withdrawal by Subject|1
333687|NCT01249157|1127712|P1|Overall Study|Withdrawal by Subject|1
333688|NCT01249131|1127716|P6|Washout Period of 10 Days|Adverse Event|0
333689|NCT01249131|1127717|P5|Washout Period of 10 Days|Adverse Event|1
333690|NCT01249131|1127718|P4|Washout Period of 10 Days|Adverse Event|0
333691|NCT01249131|1127719|P3|Washout Period of 10 Days|Adverse Event|0
333692|NCT01249131|1127720|P2|Washout Period of 10 Days|Adverse Event|0
333693|NCT01249131|1127721|P1|Washout Period of 10 Days|Adverse Event|0
333694|NCT01249118|1127741|P3|First Washout Period|Physician Decision|0
333695|NCT01249118|1127742|P2|First Washout Period|Physician Decision|1
333696|NCT01249118|1127743|P1|First Washout Period|Physician Decision|0
333697|NCT01249092|1127777|P1|Overall Study|Unable to tolerate expected SE -nausea|1
333698|NCT01249092|1127777|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
333699|NCT01248949|1127788|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
333700|NCT01248949|1127789|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
333701|NCT01248949|1127790|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
333702|NCT01248949|1127791|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
333703|NCT01248949|1127792|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
333704|NCT01248949|1127788|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
333705|NCT01248949|1127789|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
333706|NCT01248949|1127790|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
333707|NCT01248949|1127791|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
333708|NCT01248949|1127792|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
333709|NCT01248949|1127788|P5|Overall Study|Pi Decision Due To Declining Status|0
333710|NCT01248949|1127789|P4|Overall Study|Pi Decision Due To Declining Status|0
333711|NCT01248949|1127790|P3|Overall Study|Pi Decision Due To Declining Status|1
333712|NCT01248949|1127791|P2|Overall Study|Pi Decision Due To Declining Status|0
333713|NCT01248949|1127792|P1|Overall Study|Pi Decision Due To Declining Status|0
333714|NCT01248949|1127788|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
333715|NCT01248949|1127789|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
333716|NCT01248949|1127790|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
333717|NCT01248949|1127791|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
333718|NCT01248949|1127792|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
333719|NCT01248949|1127788|P5|Overall Study|Participant Went To Hospice|0
333720|NCT01248949|1127789|P4|Overall Study|Participant Went To Hospice|0
333721|NCT01248949|1127790|P3|Overall Study|Participant Went To Hospice|1
333722|NCT01248949|1127791|P2|Overall Study|Participant Went To Hospice|0
333723|NCT01248949|1127792|P1|Overall Study|Participant Went To Hospice|0
333724|NCT01248949|1127788|P5|Overall Study|Entered Hospice And Refused Follow Up|1
333725|NCT01248949|1127789|P4|Overall Study|Entered Hospice And Refused Follow Up|0
333726|NCT01248949|1127790|P3|Overall Study|Entered Hospice And Refused Follow Up|0
333727|NCT01248949|1127791|P2|Overall Study|Entered Hospice And Refused Follow Up|0
333728|NCT01248949|1127792|P1|Overall Study|Entered Hospice And Refused Follow Up|0
333729|NCT01248949|1127788|P5|Overall Study|Palliative Radiation To Brain Metastases|0
333730|NCT01248949|1127789|P4|Overall Study|Palliative Radiation To Brain Metastases|0
333731|NCT01248949|1127790|P3|Overall Study|Palliative Radiation To Brain Metastases|0
333732|NCT01248949|1127791|P2|Overall Study|Palliative Radiation To Brain Metastases|0
333733|NCT01248949|1127792|P1|Overall Study|Palliative Radiation To Brain Metastases|1
333734|NCT01248949|1127788|P5|Overall Study|Alternative Therapy.|0
333735|NCT01248949|1127789|P4|Overall Study|Alternative Therapy.|0
333736|NCT01248949|1127790|P3|Overall Study|Alternative Therapy.|0
333737|NCT01248949|1127791|P2|Overall Study|Alternative Therapy.|0
333738|NCT01248949|1127792|P1|Overall Study|Alternative Therapy.|1
333739|NCT01248949|1127788|P5|Overall Study|Alternative Therapy|0
333740|NCT01248949|1127789|P4|Overall Study|Alternative Therapy|0
333741|NCT01248949|1127790|P3|Overall Study|Alternative Therapy|0
333742|NCT01248949|1127791|P2|Overall Study|Alternative Therapy|0
333743|NCT01248949|1127792|P1|Overall Study|Alternative Therapy|1
333744|NCT01248949|1127788|P5|Overall Study|Death|2
333745|NCT01248949|1127789|P4|Overall Study|Death|6
333746|NCT01248949|1127790|P3|Overall Study|Death|21
333747|NCT01248949|1127791|P2|Overall Study|Death|7
333748|NCT01248949|1127792|P1|Overall Study|Death|22
333749|NCT01248949|1127788|P5|Overall Study|Withdrawal by Subject|1
333750|NCT01248949|1127789|P4|Overall Study|Withdrawal by Subject|3
333751|NCT01248949|1127790|P3|Overall Study|Withdrawal by Subject|11
333752|NCT01248949|1127791|P2|Overall Study|Withdrawal by Subject|3
333753|NCT01248949|1127792|P1|Overall Study|Withdrawal by Subject|5
333754|NCT01248949|1127788|P5|Overall Study|Lost to Follow-up|0
333755|NCT01248949|1127789|P4|Overall Study|Lost to Follow-up|1
333756|NCT01248949|1127790|P3|Overall Study|Lost to Follow-up|2
333757|NCT01248949|1127791|P2|Overall Study|Lost to Follow-up|2
333758|NCT01248949|1127792|P1|Overall Study|Lost to Follow-up|2
333759|NCT01248936|1127904|P1|Overall Study|Other reason|3
333760|NCT01248936|1127904|P1|Overall Study|Refused Treatment|1
333761|NCT01248936|1127904|P1|Overall Study|Lost to Follow-up|7
333762|NCT01248936|1127904|P1|Overall Study|Adverse Event|8
333763|NCT01248936|1127904|P1|Overall Study|Withdrawal of Consent|20
333764|NCT01248936|1127904|P1|Overall Study|Death|26
333765|NCT01248936|1127904|P1|Overall Study|Progression of Disease|50
333766|NCT01248936|1127904|P1|Overall Study|Sponsor Decision|259
333767|NCT01248884|1127917|P3|Overall Study|Adverse Event|0
333768|NCT01248884|1127918|P2|Overall Study|Adverse Event|0
333769|NCT01248884|1127919|P1|Overall Study|Adverse Event|1
333770|NCT01248884|1127917|P3|Overall Study|Withdrawal by Subject|1
333771|NCT01248884|1127918|P2|Overall Study|Withdrawal by Subject|3
333772|NCT01248884|1127919|P1|Overall Study|Withdrawal by Subject|1
333773|NCT01248793|1127971|P2|Overall Study|Withdrawal by Subject|3
333774|NCT01248793|1127972|P1|Overall Study|Withdrawal by Subject|3
333775|NCT01248793|1127971|P2|Overall Study|Protocol Violation|1
333776|NCT01248793|1127972|P1|Overall Study|Protocol Violation|0
333777|NCT01248793|1127971|P2|Overall Study|Adverse Event|1
333778|NCT01248793|1127972|P1|Overall Study|Adverse Event|1
333779|NCT01248793|1127971|P2|Overall Study|Lost to Follow-up|1
333780|NCT01248793|1127972|P1|Overall Study|Lost to Follow-up|0
333781|NCT01248780|1127986|P2|Overall Study|Not treated|1
333782|NCT01248780|1127987|P1|Overall Study|Not treated|0
333783|NCT01248780|1127986|P2|Overall Study|Withdrawal by Subject|4
333784|NCT01248780|1127987|P1|Overall Study|Withdrawal by Subject|4
333785|NCT01248780|1127986|P2|Overall Study|Protocol Violation|1
333786|NCT01248780|1127987|P1|Overall Study|Protocol Violation|1
333787|NCT01248780|1127986|P2|Overall Study|Adverse Event|7
333788|NCT01248780|1127987|P1|Overall Study|Adverse Event|2
333789|NCT01248780|1127986|P2|Overall Study|Death|1
333790|NCT01248780|1127987|P1|Overall Study|Death|0
333791|NCT01248780|1127986|P2|Overall Study|Lost to Follow-up|1
333792|NCT01248780|1127987|P1|Overall Study|Lost to Follow-up|0
333793|NCT01248780|1127986|P2|Overall Study|Lack of Efficacy|0
333794|NCT01248780|1127987|P1|Overall Study|Lack of Efficacy|2
333795|NCT01248728|1128001|P2|Overall Study|Lack of Efficacy|0
333796|NCT01248728|1128002|P1|Overall Study|Lack of Efficacy|1
333797|NCT01248728|1128001|P2|Overall Study|Withdrawal by Subject|1
333798|NCT01248728|1128002|P1|Overall Study|Withdrawal by Subject|2
333799|NCT01248728|1128001|P2|Overall Study|Adverse Event|1
333800|NCT01248728|1128002|P1|Overall Study|Adverse Event|1
333801|NCT01248715|1128018|P2|Overall Study|Not influenza positive|510
333802|NCT01248715|1128019|P1|Overall Study|Not influenza positive|501
333803|NCT01248468|1128040|P3|Overall Study|Withdrawal by Subject|0
333804|NCT01248468|1128041|P2|Overall Study|Withdrawal by Subject|2
333805|NCT01248468|1128042|P1|Overall Study|Withdrawal by Subject|4
333806|NCT01248468|1128040|P3|Overall Study|Pregnancy|0
333807|NCT01248468|1128041|P2|Overall Study|Pregnancy|0
333808|NCT01248468|1128042|P1|Overall Study|Pregnancy|1
333809|NCT01248468|1128040|P3|Overall Study|Lost to Follow-up|4
333810|NCT01248468|1128041|P2|Overall Study|Lost to Follow-up|12
333811|NCT01248468|1128042|P1|Overall Study|Lost to Follow-up|9
333812|NCT01248468|1128040|P3|Overall Study|Administrative problem|0
333813|NCT01248468|1128041|P2|Overall Study|Administrative problem|0
333814|NCT01248468|1128042|P1|Overall Study|Administrative problem|1
333815|NCT01248455|1128059|P1|Overall Study|switched to alternate treatment|1
333816|NCT01248364|1128104|P4|Overall Study|Adverse Event|0
333817|NCT01248364|1128105|P3|Overall Study|Adverse Event|0
333818|NCT01248364|1128106|P2|Overall Study|Adverse Event|1
333819|NCT01248364|1128107|P1|Overall Study|Adverse Event|0
333820|NCT01248130|1128170|P2|Overall Study|Ineligible|0
333821|NCT01248130|1128171|P1|Overall Study|Ineligible|1
333822|NCT01248130|1128170|P2|Overall Study|Protocol Violation|0
333823|NCT01248130|1128171|P1|Overall Study|Protocol Violation|1
333824|NCT01248065|1128181|P2|Overall Study|Other|5
333825|NCT01248065|1128182|P1|Overall Study|Other|3
333826|NCT01248065|1128181|P2|Overall Study|Third treatment failure event|1
333827|NCT01248065|1128182|P1|Overall Study|Third treatment failure event|3
333828|NCT01248065|1128181|P2|Overall Study|Adverse Event|0
333829|NCT01248065|1128182|P1|Overall Study|Adverse Event|3
333830|NCT01248065|1128181|P2|Overall Study|Withdrawal by Subject|11
333831|NCT01248065|1128182|P1|Overall Study|Withdrawal by Subject|14
333832|NCT01248065|1128181|P2|Overall Study|Lost to Follow-up|5
333833|NCT01248065|1128182|P1|Overall Study|Lost to Follow-up|3
333834|NCT01248013|1128192|P1|Overall Study|Withdrawal by Subject|14
333835|NCT01247922|1128207|P1|Overall Study|Disease progression|4
333836|NCT01247350|1128276|P5|Overall Study|Entry criteria not met|1
333837|NCT01247350|1128277|P4|Overall Study|Entry criteria not met|0
333838|NCT01247350|1128278|P3|Overall Study|Entry criteria not met|0
333839|NCT01247350|1128279|P2|Overall Study|Entry criteria not met|0
333840|NCT01247350|1128280|P1|Overall Study|Entry criteria not met|0
333841|NCT01247350|1128276|P5|Overall Study|Withdrawal by Subject|0
333842|NCT01247350|1128277|P4|Overall Study|Withdrawal by Subject|1
333843|NCT01247350|1128278|P3|Overall Study|Withdrawal by Subject|0
333844|NCT01247350|1128279|P2|Overall Study|Withdrawal by Subject|0
333845|NCT01247350|1128280|P1|Overall Study|Withdrawal by Subject|0
333846|NCT01247350|1128276|P5|Overall Study|Adverse Event|0
333847|NCT01247350|1128277|P4|Overall Study|Adverse Event|0
333848|NCT01247350|1128278|P3|Overall Study|Adverse Event|1
333849|NCT01247350|1128279|P2|Overall Study|Adverse Event|0
333850|NCT01247350|1128280|P1|Overall Study|Adverse Event|0
333851|NCT01247324|1128338|P2|Overall Study|Lost to Follow-up|1
333852|NCT01247324|1128339|P1|Overall Study|Lost to Follow-up|1
333853|NCT01247324|1128338|P2|Overall Study|Adverse Event|13
333854|NCT01247324|1128339|P1|Overall Study|Adverse Event|25
333855|NCT01247324|1128338|P2|Overall Study|Consent withdrawn by participant|8
333856|NCT01247324|1128339|P1|Overall Study|Consent withdrawn by participant|13
333857|NCT01247324|1128338|P2|Overall Study|Reason not specified|8
333858|NCT01247324|1128339|P1|Overall Study|Reason not specified|11
333859|NCT01247324|1128338|P2|Overall Study|Protocol Violation|2
333860|NCT01247324|1128339|P1|Overall Study|Protocol Violation|1
333861|NCT01247324|1128338|P2|Overall Study|Pregnancy|3
333862|NCT01247324|1128339|P1|Overall Study|Pregnancy|2
333863|NCT01247324|1128338|P2|Overall Study|Non-compliance|0
333864|NCT01247324|1128339|P1|Overall Study|Non-compliance|2
333865|NCT01247324|1128338|P2|Overall Study|Lack of Efficacy|8
333866|NCT01247324|1128339|P1|Overall Study|Lack of Efficacy|12
333867|NCT01247324|1128338|P2|Overall Study|Non-compliance with study drug|0
333868|NCT01247324|1128339|P1|Overall Study|Non-compliance with study drug|3
333869|NCT01247324|1128338|P2|Overall Study|Physician Decision|1
333870|NCT01247324|1128339|P1|Overall Study|Physician Decision|0
333871|NCT01247324|1128338|P2|Overall Study|Death|0
333872|NCT01247324|1128339|P1|Overall Study|Death|1
333873|NCT01247090|1128432|P3|Overall Study|Withdrawal by Subject|0
333874|NCT01247090|1128433|P2|Overall Study|Withdrawal by Subject|1
333875|NCT01247090|1128434|P1|Overall Study|Withdrawal by Subject|0
333876|NCT01247090|1128432|P3|Overall Study|Physician Decision|0
333877|NCT01247090|1128433|P2|Overall Study|Physician Decision|0
333878|NCT01247090|1128434|P1|Overall Study|Physician Decision|1
333879|NCT01246999|1128463|P4|Overall Study|Withdrawal by Subject|2
333880|NCT01246999|1128464|P3|Overall Study|Withdrawal by Subject|0
333881|NCT01246999|1128465|P2|Overall Study|Withdrawal by Subject|0
333882|NCT01246999|1128466|P1|Overall Study|Withdrawal by Subject|0
333883|NCT01246999|1128463|P4|Overall Study|Lost to Follow-up|0
333884|NCT01246999|1128464|P3|Overall Study|Lost to Follow-up|0
333885|NCT01246999|1128465|P2|Overall Study|Lost to Follow-up|1
333886|NCT01246999|1128466|P1|Overall Study|Lost to Follow-up|0
333887|NCT01246973|1128501|P2|Overall Study|Withdrawal by Subject|13
333888|NCT01246973|1128502|P1|Overall Study|Withdrawal by Subject|7
333889|NCT01246973|1128501|P2|Overall Study|Adverse Event|9
333890|NCT01246973|1128502|P1|Overall Study|Adverse Event|16
333891|NCT01246973|1128501|P2|Overall Study|Other|25
333892|NCT01246973|1128502|P1|Overall Study|Other|38
333893|NCT01246960|1128512|P2|Overall Study|Withdrawal (by participant or physician)|3
333894|NCT01246960|1128513|P1|Overall Study|Withdrawal (by participant or physician)|3
333895|NCT01246960|1128512|P2|Overall Study|Lost to Follow-up|1
333896|NCT01246960|1128513|P1|Overall Study|Lost to Follow-up|3
333897|NCT01246206|1128621|P1|Overall Study|Patient did not receive study regiments.|1
333898|NCT01246011|1128644|P3|Overall Study|Withdrawal by Subject|1
333899|NCT01246011|1128645|P2|Overall Study|Withdrawal by Subject|0
333900|NCT01246011|1128646|P1|Overall Study|Withdrawal by Subject|0
333901|NCT01246011|1128644|P3|Overall Study|If needed warfarin clinically, withdrawn|3
333902|NCT01246011|1128645|P2|Overall Study|If needed warfarin clinically, withdrawn|0
333903|NCT01246011|1128646|P1|Overall Study|If needed warfarin clinically, withdrawn|0
333904|NCT01245764|1128661|P4|Study Phase A|Lost to Follow-up|0
333905|NCT01245764|1128662|P3|Study Phase A|Lost to Follow-up|5
333906|NCT01245764|1128663|P2|Study Phase A|Lost to Follow-up|0
333907|NCT01245764|1128664|P1|Study Phase A|Lost to Follow-up|0
333908|NCT01245764|1128661|P4|Study Phase A|Protocol Violation|2
333909|NCT01245764|1128662|P3|Study Phase A|Protocol Violation|2
333910|NCT01245764|1128663|P2|Study Phase A|Protocol Violation|3
333911|NCT01245764|1128664|P1|Study Phase A|Protocol Violation|6
333912|NCT01245764|1128661|P4|Study Phase A|Other|1
333913|NCT01245764|1128662|P3|Study Phase A|Other|3
333914|NCT01245764|1128663|P2|Study Phase A|Other|2
333915|NCT01245764|1128664|P1|Study Phase A|Other|3
333916|NCT01245751|1128702|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
333917|NCT01245751|1128703|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
333918|NCT01245751|1128704|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
333919|NCT01245751|1128705|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
333920|NCT01245751|1128702|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
333921|NCT01245751|1128703|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
333922|NCT01245751|1128704|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
333923|NCT01245751|1128705|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
333924|NCT01245751|1128702|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
333925|NCT01245751|1128703|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
333926|NCT01245751|1128704|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
333927|NCT01245751|1128705|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
333928|NCT01245387|1128799|P1|Overall Study|Missing discontinuation status|369
333929|NCT01245387|1128799|P1|Overall Study|Other|131
333930|NCT01245387|1128799|P1|Overall Study|Death|3
333931|NCT01245387|1128799|P1|Overall Study|Adverse Event|9
333932|NCT01245387|1128799|P1|Overall Study|Lack of Efficacy|195
333933|NCT01245387|1128799|P1|Overall Study|Lost to Follow-up|106
333934|NCT01245374|1128848|P1|Overall Study|Withdrawal by Subject|3
333935|NCT01245374|1128848|P1|Overall Study|Protocol Violation|1
333936|NCT01245283|1128871|P3|Overall Study|Lost to Follow-up|11
333937|NCT01245283|1128872|P2|Overall Study|Lost to Follow-up|11
333938|NCT01245283|1128873|P1|Overall Study|Lost to Follow-up|14
333939|NCT01245140|1128918|P2|Overall Study|Refused Treatment/Did Not Coopera|1
333940|NCT01245140|1128919|P1|Overall Study|Refused Treatment/Did Not Coopera|0
333941|NCT01245140|1128918|P2|Overall Study|Withdrawal by Subject|1
333942|NCT01245140|1128919|P1|Overall Study|Withdrawal by Subject|0
333943|NCT01245140|1128918|P2|Overall Study|Protocol Violation|1
333944|NCT01245140|1128919|P1|Overall Study|Protocol Violation|0
333945|NCT01245140|1128918|P2|Overall Study|Lack of Efficacy|4
333946|NCT01245140|1128919|P1|Overall Study|Lack of Efficacy|2
333947|NCT01245140|1128918|P2|Overall Study|Adverse Event|3
333948|NCT01245140|1128919|P1|Overall Study|Adverse Event|1
333949|NCT01245101|1128975|P2|Period 3 (Treatment)|Withdrawal by Subject|0
333950|NCT01245101|1128976|P1|Period 3 (Treatment)|Withdrawal by Subject|1
333951|NCT01245101|1128975|P2|Period 2 (Washout)|Withdrawal by Subject|0
333952|NCT01245101|1128976|P1|Period 2 (Washout)|Withdrawal by Subject|1
333953|NCT01245101|1128975|P2|Period 1 (Treatment)|Withdrawal by Subject|0
333954|NCT01245101|1128976|P1|Period 1 (Treatment)|Withdrawal by Subject|2
333955|NCT01245062|1128986|P3|Cross-over Phase|Study closed/ terminated|11
333956|NCT01245062|1128987|P2|Cross-over Phase|Study closed/ terminated|0
333957|NCT01245062|1128988|P1|Cross-over Phase|Study closed/ terminated|0
333958|NCT01245062|1128986|P3|Cross-over Phase|Withdrew Consent|4
333959|NCT01245062|1128987|P2|Cross-over Phase|Withdrew Consent|0
333960|NCT01245062|1128988|P1|Cross-over Phase|Withdrew Consent|0
333961|NCT01245062|1128986|P3|Cross-over Phase|Physician Decision|1
333962|NCT01245062|1128987|P2|Cross-over Phase|Physician Decision|0
333963|NCT01245062|1128988|P1|Cross-over Phase|Physician Decision|0
333964|NCT01245062|1128986|P3|Cross-over Phase|Lost to Follow-up|1
333965|NCT01245062|1128987|P2|Cross-over Phase|Lost to Follow-up|0
333966|NCT01245062|1128988|P1|Cross-over Phase|Lost to Follow-up|0
333967|NCT01245062|1128986|P3|Randomization and Crossover Phase|Study closed/ terminated|0
333968|NCT01245062|1128987|P2|Randomization and Crossover Phase|Study closed/ terminated|14
333969|NCT01245062|1128988|P1|Randomization and Crossover Phase|Study closed/ terminated|23
333970|NCT01245062|1128986|P3|Randomization and Crossover Phase|Withdrew Consent|0
333971|NCT01245062|1128987|P2|Randomization and Crossover Phase|Withdrew Consent|11
333972|NCT01245062|1128988|P1|Randomization and Crossover Phase|Withdrew Consent|12
333973|NCT01245062|1128986|P3|Randomization and Crossover Phase|Physician Decision|0
333974|NCT01245062|1128987|P2|Randomization and Crossover Phase|Physician Decision|4
333975|NCT01245062|1128988|P1|Randomization and Crossover Phase|Physician Decision|2
333976|NCT01245062|1128986|P3|Randomization and Crossover Phase|Lost to Follow-up|0
333977|NCT01245062|1128987|P2|Randomization and Crossover Phase|Lost to Follow-up|2
333978|NCT01245062|1128988|P1|Randomization and Crossover Phase|Lost to Follow-up|4
333979|NCT01245049|1129026|P2|Overall Study|Lost to Follow-up|2
333980|NCT01245049|1129027|P1|Overall Study|Lost to Follow-up|1
333981|NCT01245049|1129026|P2|Overall Study|Withdrawal by Subject|1
333982|NCT01245049|1129027|P1|Overall Study|Withdrawal by Subject|0
333983|NCT01245049|1129026|P2|Overall Study|Migrated/moved from study area|1
333984|NCT01245049|1129027|P1|Overall Study|Migrated/moved from study area|0
333985|NCT01244984|1129080|P3|Overall Study|Withdrawal by Subject|2
333986|NCT01244984|1129081|P2|Overall Study|Withdrawal by Subject|2
333987|NCT01244984|1129082|P1|Overall Study|Withdrawal by Subject|1
333988|NCT01244984|1129080|P3|Overall Study|Protocol Defined Stopping Criteria|0
333989|NCT01244984|1129081|P2|Overall Study|Protocol Defined Stopping Criteria|1
333990|NCT01244984|1129082|P1|Overall Study|Protocol Defined Stopping Criteria|1
333991|NCT01244984|1129080|P3|Overall Study|Protocol Violation|0
333992|NCT01244984|1129081|P2|Overall Study|Protocol Violation|0
333993|NCT01244984|1129082|P1|Overall Study|Protocol Violation|1
333994|NCT01244984|1129080|P3|Overall Study|Adverse Event|2
333995|NCT01244984|1129081|P2|Overall Study|Adverse Event|11
333996|NCT01244984|1129082|P1|Overall Study|Adverse Event|2
333997|NCT01244906|1129156|P1|Overall Study|Progression of disease post treatment|6
333998|NCT01244906|1129156|P1|Overall Study|Death|2
333999|NCT01244893|1129165|P2|1-Week Follow Up|Lost to Follow-up|0
334000|NCT01244893|1129166|P1|1-Week Follow Up|Lost to Follow-up|1
334001|NCT01244893|1129165|P2|Baseline|Protocol Violation|1
334002|NCT01244893|1129166|P1|Baseline|Protocol Violation|0
334003|NCT01244828|1129178|P1|Overall Study|Other reason (not specified)|1
334004|NCT01244828|1129178|P1|Overall Study|Lost to Follow-up|2
334005|NCT01244828|1129178|P1|Overall Study|Lack of Efficacy|7
334006|NCT01244828|1129178|P1|Overall Study|Withdrawal by Subject|31
334007|NCT01244828|1129178|P1|Overall Study|Adverse Event|37
334008|NCT01244815|1129194|P4|Overall Study|Did Not Meet Protocol Eligibility|0
334009|NCT01244815|1129195|P3|Overall Study|Did Not Meet Protocol Eligibility|0
334010|NCT01244815|1129196|P2|Overall Study|Did Not Meet Protocol Eligibility|1
334011|NCT01244815|1129197|P1|Overall Study|Did Not Meet Protocol Eligibility|0
334012|NCT01244815|1129194|P4|Overall Study|Protocol Violation|1
334013|NCT01244815|1129195|P3|Overall Study|Protocol Violation|3
334014|NCT01244815|1129196|P2|Overall Study|Protocol Violation|4
334015|NCT01244815|1129197|P1|Overall Study|Protocol Violation|7
334016|NCT01244815|1129194|P4|Overall Study|Withdrawal by Subject|3
334017|NCT01244815|1129195|P3|Overall Study|Withdrawal by Subject|0
334018|NCT01244815|1129196|P2|Overall Study|Withdrawal by Subject|2
334019|NCT01244815|1129197|P1|Overall Study|Withdrawal by Subject|0
334020|NCT01244815|1129194|P4|Overall Study|Lost to Follow-up|2
334021|NCT01244815|1129195|P3|Overall Study|Lost to Follow-up|3
334022|NCT01244815|1129196|P2|Overall Study|Lost to Follow-up|2
334023|NCT01244815|1129197|P1|Overall Study|Lost to Follow-up|3
334024|NCT01244815|1129194|P4|Overall Study|Treatment Failure|1
334025|NCT01244815|1129195|P3|Overall Study|Treatment Failure|0
334026|NCT01244815|1129196|P2|Overall Study|Treatment Failure|0
334027|NCT01244815|1129197|P1|Overall Study|Treatment Failure|0
334028|NCT01244815|1129194|P4|Overall Study|Adverse Event|5
334029|NCT01244815|1129195|P3|Overall Study|Adverse Event|5
334030|NCT01244815|1129196|P2|Overall Study|Adverse Event|7
334031|NCT01244815|1129197|P1|Overall Study|Adverse Event|4
334032|NCT01244815|1129194|P4|Overall Study|Not Treated|0
334033|NCT01244815|1129195|P3|Overall Study|Not Treated|0
334034|NCT01244815|1129196|P2|Overall Study|Not Treated|1
334035|NCT01244815|1129197|P1|Overall Study|Not Treated|0
334036|NCT01244620|1129283|P4|Overall Study|Study terminated|4
334037|NCT01244620|1129284|P3|Overall Study|Study terminated|4
334038|NCT01244620|1129285|P2|Overall Study|Study terminated|4
334039|NCT01244620|1129286|P1|Overall Study|Study terminated|4
334040|NCT01244516|1129345|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
334041|NCT01244516|1129346|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
334042|NCT01244516|1129347|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
334043|NCT01244516|1129345|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
334044|NCT01244516|1129346|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
334045|NCT01244516|1129347|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
334046|NCT01244516|1129345|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
334047|NCT01244516|1129346|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
334048|NCT01244516|1129347|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
334049|NCT01244516|1129345|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
334050|NCT01244516|1129346|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
334051|NCT01244516|1129347|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
334052|NCT01244516|1129345|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
334053|NCT01244516|1129346|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
334054|NCT01244516|1129347|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
334055|NCT01244516|1129345|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
334056|NCT01244516|1129346|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
334057|NCT01244516|1129347|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
334058|NCT01244516|1129345|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
334059|NCT01244516|1129346|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
334060|NCT01244516|1129347|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
334061|NCT01244490|1129368|P3|Overall Study|Not specified|1
334062|NCT01244490|1129369|P2|Overall Study|Not specified|0
334063|NCT01244490|1129370|P1|Overall Study|Not specified|0
334064|NCT01244490|1129368|P3|Overall Study|Lost to Follow-up|3
334065|NCT01244490|1129369|P2|Overall Study|Lost to Follow-up|6
334066|NCT01244490|1129370|P1|Overall Study|Lost to Follow-up|0
334067|NCT01244490|1129368|P3|Overall Study|Adverse Event|5
334068|NCT01244490|1129369|P2|Overall Study|Adverse Event|9
334069|NCT01244490|1129370|P1|Overall Study|Adverse Event|1
334070|NCT01244490|1129368|P3|Overall Study|Withdrawal by Subject|9
334071|NCT01244490|1129369|P2|Overall Study|Withdrawal by Subject|4
334072|NCT01244490|1129370|P1|Overall Study|Withdrawal by Subject|4
334073|NCT01244490|1129368|P3|Overall Study|Lack of Efficacy|5
334074|NCT01244490|1129369|P2|Overall Study|Lack of Efficacy|5
334075|NCT01244490|1129370|P1|Overall Study|Lack of Efficacy|14
334076|NCT01244425|1129438|P2|Overall Study|Adverse Event|1
334077|NCT01244425|1129439|P1|Overall Study|Adverse Event|1
334078|NCT01244425|1129438|P2|Overall Study|Withdrawal by Subject|2
334079|NCT01244425|1129439|P1|Overall Study|Withdrawal by Subject|2
334080|NCT01244126|1129471|P3|Overall Study|Protocol Violation|9
334081|NCT01244126|1129472|P2|Overall Study|Protocol Violation|3
334082|NCT01244126|1129473|P1|Overall Study|Protocol Violation|3
334083|NCT01244061|1129486|P2|Overall Study|Randomized but not treated|2
334084|NCT01244061|1129487|P1|Overall Study|Randomized but not treated|2
334085|NCT01244061|1129486|P2|Overall Study|Adverse Event|2
334086|NCT01244061|1129487|P1|Overall Study|Adverse Event|5
334087|NCT01244061|1129486|P2|Overall Study|Protocol Violation|1
334088|NCT01244061|1129487|P1|Overall Study|Protocol Violation|1
334089|NCT01244061|1129486|P2|Overall Study|Not specified|19
334090|NCT01244061|1129487|P1|Overall Study|Not specified|8
334091|NCT01244061|1129486|P2|Overall Study|Withdrawal by Subject|46
334092|NCT01244061|1129487|P1|Overall Study|Withdrawal by Subject|29
334093|NCT01244061|1129486|P2|Overall Study|Lost to Follow-up|30
334094|NCT01244061|1129487|P1|Overall Study|Lost to Follow-up|34
334095|NCT01244061|1129486|P2|Overall Study|Lack of Efficacy|3
334096|NCT01244061|1129487|P1|Overall Study|Lack of Efficacy|1
334097|NCT01244061|1129486|P2|Overall Study|Did not meet entrance criteria|0
334098|NCT01244061|1129487|P1|Overall Study|Did not meet entrance criteria|1
334099|NCT01244061|1129486|P2|Overall Study|Death|0
334100|NCT01244061|1129487|P1|Overall Study|Death|1
334101|NCT01243944|1129501|P2|Overall Study|Physician Decision|2
334102|NCT01243944|1129502|P1|Overall Study|Physician Decision|2
334103|NCT01243944|1129501|P2|Overall Study|Patient decision|5
334104|NCT01243944|1129502|P1|Overall Study|Patient decision|6
334105|NCT01243944|1129501|P2|Overall Study|Disease progression|1
334106|NCT01243944|1129502|P1|Overall Study|Disease progression|5
334107|NCT01243944|1129501|P2|Overall Study|Lack of Efficacy|98
334108|NCT01243944|1129502|P1|Overall Study|Lack of Efficacy|0
334109|NCT01243944|1129501|P2|Overall Study|Adverse Event|2
334110|NCT01243944|1129502|P1|Overall Study|Adverse Event|4
334111|NCT01243892|1129526|P2|Overall Study|Did not meet eligibility criteria|0
334112|NCT01243892|1129527|P1|Overall Study|Did not meet eligibility criteria|2
334113|NCT01243775|1129537|P1|Overall Study|Withdrawal by Subject|2
334114|NCT01243762|1129551|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
334115|NCT01243762|1129552|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
334116|NCT01243762|1129553|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
334117|NCT01243762|1129554|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
334118|NCT01243762|1129555|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
334119|NCT01243762|1129556|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
334120|NCT01243762|1129557|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
334121|NCT01243762|1129551|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
334122|NCT01243762|1129552|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
334123|NCT01243762|1129553|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
334124|NCT01243762|1129554|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
334125|NCT01243762|1129555|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
334126|NCT01243762|1129556|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
334127|NCT01243762|1129557|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
334128|NCT01243762|1129551|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
334129|NCT01243762|1129552|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
334130|NCT01243762|1129553|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
334131|NCT01243762|1129554|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
334132|NCT01243762|1129555|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
334133|NCT01243762|1129556|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
334134|NCT01243762|1129557|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
334135|NCT01243762|1129551|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
334136|NCT01243762|1129552|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
334137|NCT01243762|1129553|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
334138|NCT01243762|1129554|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
334139|NCT01243762|1129555|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
334140|NCT01243762|1129556|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
334141|NCT01243762|1129557|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
334142|NCT01243762|1129551|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
334143|NCT01243762|1129552|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
334144|NCT01243762|1129553|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
334145|NCT01243762|1129554|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
334146|NCT01243762|1129555|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
334147|NCT01243762|1129556|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
334148|NCT01243762|1129557|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
334149|NCT01243762|1129551|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
334150|NCT01243762|1129552|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
334151|NCT01243762|1129553|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
334152|NCT01243762|1129554|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
334153|NCT01243762|1129555|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
334154|NCT01243762|1129556|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
334155|NCT01243762|1129557|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
334156|NCT01243762|1129551|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
334157|NCT01243762|1129552|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
334158|NCT01243762|1129553|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
334159|NCT01243762|1129554|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
334160|NCT01243762|1129555|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
334161|NCT01243762|1129556|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
334162|NCT01243762|1129557|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
334163|NCT01243762|1129551|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
334164|NCT01243762|1129552|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
334165|NCT01243762|1129553|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
334166|NCT01243762|1129554|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
334167|NCT01243762|1129555|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
334168|NCT01243762|1129556|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
334169|NCT01243762|1129557|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
334170|NCT01243671|1129576|P1|Overall Study|Not Specified|1
334171|NCT01243671|1129576|P1|Overall Study|Anti-adalimumab antibody positive|1
334172|NCT01243671|1129576|P1|Overall Study|Adverse Event|3
334173|NCT01243411|1129653|P1|Overall Study|Other|8
334174|NCT01243411|1129653|P1|Overall Study|Adverse Event|5
334175|NCT01243411|1129653|P1|Overall Study|Lost to Follow-up|10
334176|NCT01243411|1129653|P1|Overall Study|Withdrawal by Subject|18
334177|NCT01243242|1129760|P2|Overall Study|non compliance|0
334178|NCT01243242|1129761|P1|Overall Study|non compliance|1
334179|NCT01243242|1129760|P2|Overall Study|sponsor decision|1
334180|NCT01243242|1129761|P1|Overall Study|sponsor decision|0
334181|NCT01243242|1129760|P2|Overall Study|Physician Decision|1
334182|NCT01243242|1129761|P1|Overall Study|Physician Decision|0
334183|NCT01243242|1129760|P2|Overall Study|Withdrawal by Subject|1
334184|NCT01243242|1129761|P1|Overall Study|Withdrawal by Subject|1
334185|NCT01243242|1129760|P2|Overall Study|Adverse Event|1
334186|NCT01243242|1129761|P1|Overall Study|Adverse Event|1
334187|NCT01243177|1129775|P2|Overall Study|Other Reason|12
334188|NCT01243177|1129776|P1|Overall Study|Other Reason|11
334189|NCT01243177|1129775|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
334190|NCT01243177|1129776|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
334191|NCT01243177|1129775|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
334192|NCT01243177|1129776|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
334193|NCT01243177|1129775|P2|Overall Study|AE, non-serious non-fatal|58
334194|NCT01243177|1129776|P1|Overall Study|AE, non-serious non-fatal|40
334195|NCT01243177|1129775|P2|Overall Study|SAE, non-fatal|9
334196|NCT01243177|1129776|P1|Overall Study|SAE, non-fatal|7
334197|NCT01243177|1129775|P2|Overall Study|AE, serious fatal|1
334198|NCT01243177|1129776|P1|Overall Study|AE, serious fatal|0
334199|NCT01243177|1129775|P2|Overall Study|Withdrawal by Subject|38
334200|NCT01243177|1129776|P1|Overall Study|Withdrawal by Subject|46
334201|NCT01243177|1129775|P2|Overall Study|Lost to Follow-up|18
334202|NCT01243177|1129776|P1|Overall Study|Lost to Follow-up|15
334203|NCT01243177|1129775|P2|Overall Study|Protocol Violation|10
334204|NCT01243177|1129776|P1|Overall Study|Protocol Violation|11
334205|NCT01243177|1129775|P2|Overall Study|Lack of Efficacy|31
334206|NCT01243177|1129776|P1|Overall Study|Lack of Efficacy|47
334207|NCT01242813|1129797|P1|Overall Study|Lost to Follow-up|2
334208|NCT01242748|1129819|P2|Overall Study|Miscellaneous reasons|3
334209|NCT01242748|1129820|P1|Overall Study|Miscellaneous reasons|8
334210|NCT01242748|1129819|P2|Overall Study|Withdrawal by Subject|2
334211|NCT01242748|1129820|P1|Overall Study|Withdrawal by Subject|10
334212|NCT01242748|1129819|P2|Overall Study|Protocol Violation|0
334213|NCT01242748|1129820|P1|Overall Study|Protocol Violation|1
334214|NCT01242748|1129819|P2|Overall Study|Physician Decision|2
334215|NCT01242748|1129820|P1|Overall Study|Physician Decision|3
334216|NCT01242748|1129819|P2|Overall Study|Lost to Follow-up|2
334217|NCT01242748|1129820|P1|Overall Study|Lost to Follow-up|6
334218|NCT01242748|1129819|P2|Overall Study|Adverse Event|5
334219|NCT01242748|1129820|P1|Overall Study|Adverse Event|10
334220|NCT01242514|1129860|P3|Overall Study|Adverse Event|19
334221|NCT01242514|1129861|P2|Overall Study|Adverse Event|18
334222|NCT01242514|1129862|P1|Overall Study|Adverse Event|129
334223|NCT01242514|1129860|P3|Overall Study|Lost to Follow-up|4
334224|NCT01242514|1129861|P2|Overall Study|Lost to Follow-up|5
334225|NCT01242514|1129862|P1|Overall Study|Lost to Follow-up|14
334226|NCT01242514|1129860|P3|Overall Study|Dev. of study specific discont. criteria|5
334227|NCT01242514|1129861|P2|Overall Study|Dev. of study specific discont. criteria|3
334228|NCT01242514|1129862|P1|Overall Study|Dev. of study specific discont. criteria|21
334229|NCT01242514|1129860|P3|Overall Study|Lack of therapeutic response|10
334230|NCT01242514|1129861|P2|Overall Study|Lack of therapeutic response|16
334231|NCT01242514|1129862|P1|Overall Study|Lack of therapeutic response|99
334232|NCT01242514|1129860|P3|Overall Study|Severe non-compliance to protocol|1
334233|NCT01242514|1129861|P2|Overall Study|Severe non-compliance to protocol|2
334234|NCT01242514|1129862|P1|Overall Study|Severe non-compliance to protocol|5
334235|NCT01242514|1129860|P3|Overall Study|Subject decision|2
334236|NCT01242514|1129861|P2|Overall Study|Subject decision|8
334237|NCT01242514|1129862|P1|Overall Study|Subject decision|33
334238|NCT01242514|1129860|P3|Overall Study|e.g., project closure|171
334239|NCT01242514|1129861|P2|Overall Study|e.g., project closure|305
334240|NCT01242514|1129862|P1|Overall Study|e.g., project closure|1042
334241|NCT01242371|1129881|P2|Overall Study|Protocol Violation|3
334242|NCT01242371|1129882|P1|Overall Study|Protocol Violation|0
334243|NCT01242371|1129881|P2|Overall Study|Withdrawal by Subject|2
334244|NCT01242371|1129882|P1|Overall Study|Withdrawal by Subject|2
334245|NCT01242176|1129888|P2|Washout Period of 7 Days|Non-compliant with protocol|0
334246|NCT01242176|1129889|P1|Washout Period of 7 Days|Non-compliant with protocol|1
334247|NCT01242176|1129888|P2|Washout Period of 7 Days|Adverse Event|2
334248|NCT01242176|1129889|P1|Washout Period of 7 Days|Adverse Event|0
334249|NCT01242111|1129899|P1|Overall Study|Did not consent to MOR-100 follow-up|1
334250|NCT01242111|1129899|P1|Overall Study|Withdrawal by Subject|1
334251|NCT01242111|1129899|P1|Overall Study|Adverse Event|1
334252|NCT01242085|1129911|P3|Overall Study|medically unable to have surgery|0
334253|NCT01242085|1129912|P2|Overall Study|medically unable to have surgery|5
334254|NCT01242085|1129913|P1|Overall Study|medically unable to have surgery|4
334255|NCT01242085|1129911|P3|Overall Study|Withdrawal by Subject|0
334256|NCT01242085|1129912|P2|Overall Study|Withdrawal by Subject|2
334257|NCT01242085|1129913|P1|Overall Study|Withdrawal by Subject|4
334258|NCT01242020|1129923|P2|Overall Study|Failed screening|0
334259|NCT01242020|1129924|P1|Overall Study|Failed screening|1
334260|NCT01242020|1129923|P2|Overall Study|Withdrawal by Subject|0
334261|NCT01242020|1129924|P1|Overall Study|Withdrawal by Subject|2
334262|NCT01241760|1129954|P2|Overall Study|Not specified|1
334263|NCT01241760|1129955|P1|Overall Study|Not specified|1
334264|NCT01241760|1129954|P2|Overall Study|Switch To Commercially Available Medicat|4
334265|NCT01241760|1129955|P1|Overall Study|Switch To Commercially Available Medicat|1
334266|NCT01241760|1129954|P2|Overall Study|Withdrawal by Subject|13
334267|NCT01241760|1129955|P1|Overall Study|Withdrawal by Subject|13
334268|NCT01241760|1129954|P2|Overall Study|Lost to Follow-up|22
334269|NCT01241760|1129955|P1|Overall Study|Lost to Follow-up|18
334270|NCT01241760|1129954|P2|Overall Study|Adverse Event|0
334271|NCT01241760|1129955|P1|Overall Study|Adverse Event|1
334272|NCT01241591|1129978|P4|Overall Study|Adverse Event|4
334273|NCT01241591|1129979|P3|Overall Study|Adverse Event|12
334274|NCT01241591|1129980|P2|Overall Study|Adverse Event|11
334275|NCT01241591|1129981|P1|Overall Study|Adverse Event|3
334276|NCT01241591|1129978|P4|Overall Study|Not specified|1
334277|NCT01241591|1129979|P3|Overall Study|Not specified|0
334278|NCT01241591|1129980|P2|Overall Study|Not specified|1
334279|NCT01241591|1129981|P1|Overall Study|Not specified|0
334280|NCT01241591|1129978|P4|Overall Study|Withdrawal by Subject|2
334281|NCT01241591|1129979|P3|Overall Study|Withdrawal by Subject|2
334282|NCT01241591|1129980|P2|Overall Study|Withdrawal by Subject|4
334283|NCT01241591|1129981|P1|Overall Study|Withdrawal by Subject|6
334284|NCT01241591|1129978|P4|Overall Study|Screen Failure|0
334285|NCT01241591|1129979|P3|Overall Study|Screen Failure|1
334286|NCT01241591|1129980|P2|Overall Study|Screen Failure|2
334287|NCT01241591|1129981|P1|Overall Study|Screen Failure|3
334288|NCT01241591|1129978|P4|Overall Study|Lost to Follow-up|2
334289|NCT01241591|1129979|P3|Overall Study|Lost to Follow-up|2
334290|NCT01241591|1129980|P2|Overall Study|Lost to Follow-up|2
334291|NCT01241591|1129981|P1|Overall Study|Lost to Follow-up|1
334292|NCT01241591|1129978|P4|Overall Study|Protocol Violation|0
334293|NCT01241591|1129979|P3|Overall Study|Protocol Violation|3
334294|NCT01241591|1129980|P2|Overall Study|Protocol Violation|2
334295|NCT01241591|1129981|P1|Overall Study|Protocol Violation|5
334296|NCT01241591|1129978|P4|Overall Study|Lack of Efficacy|3
334297|NCT01241591|1129979|P3|Overall Study|Lack of Efficacy|2
334298|NCT01241591|1129980|P2|Overall Study|Lack of Efficacy|2
334299|NCT01241591|1129981|P1|Overall Study|Lack of Efficacy|5
334300|NCT01241552|1130184|P4|Overall Study|Lost to Follow-up|16
334301|NCT01241552|1130185|P3|Overall Study|Lost to Follow-up|15
334302|NCT01241552|1130186|P2|Overall Study|Lost to Follow-up|11
334303|NCT01241552|1130187|P1|Overall Study|Lost to Follow-up|2
334304|NCT01241552|1130184|P4|Overall Study|Physician Decision|3
334305|NCT01241552|1130185|P3|Overall Study|Physician Decision|2
334306|NCT01241552|1130186|P2|Overall Study|Physician Decision|4
334307|NCT01241552|1130187|P1|Overall Study|Physician Decision|2
334308|NCT01241552|1130184|P4|Overall Study|Withdrawal by Subject|15
334309|NCT01241552|1130185|P3|Overall Study|Withdrawal by Subject|14
334310|NCT01241552|1130186|P2|Overall Study|Withdrawal by Subject|15
334311|NCT01241552|1130187|P1|Overall Study|Withdrawal by Subject|7
334312|NCT01241552|1130184|P4|Overall Study|Protocol Violation|1
334313|NCT01241552|1130185|P3|Overall Study|Protocol Violation|6
334314|NCT01241552|1130186|P2|Overall Study|Protocol Violation|2
334315|NCT01241552|1130187|P1|Overall Study|Protocol Violation|0
334316|NCT01241552|1130184|P4|Overall Study|Progressive Disease|2
334317|NCT01241552|1130185|P3|Overall Study|Progressive Disease|1
334318|NCT01241552|1130186|P2|Overall Study|Progressive Disease|0
334319|NCT01241552|1130187|P1|Overall Study|Progressive Disease|0
334320|NCT01241552|1130184|P4|Overall Study|Technical Problems|2
334321|NCT01241552|1130185|P3|Overall Study|Technical Problems|2
334322|NCT01241552|1130186|P2|Overall Study|Technical Problems|0
334323|NCT01241552|1130187|P1|Overall Study|Technical Problems|2
334324|NCT01241552|1130184|P4|Overall Study|Adverse Event|0
334325|NCT01241552|1130185|P3|Overall Study|Adverse Event|0
334326|NCT01241552|1130186|P2|Overall Study|Adverse Event|1
334327|NCT01241552|1130187|P1|Overall Study|Adverse Event|1
334328|NCT01241552|1130184|P4|Overall Study|Death|25
334329|NCT01241552|1130185|P3|Overall Study|Death|20
334330|NCT01241552|1130186|P2|Overall Study|Death|30
334331|NCT01241552|1130187|P1|Overall Study|Death|26
334332|NCT01241552|1130184|P4|Overall Study|Lack of Efficacy|0
334333|NCT01241552|1130185|P3|Overall Study|Lack of Efficacy|0
334334|NCT01241552|1130186|P2|Overall Study|Lack of Efficacy|0
334335|NCT01241552|1130187|P1|Overall Study|Lack of Efficacy|1
334336|NCT01241448|1130284|P4|Overall Study|Excluded due to data integrity issues|2
334337|NCT01241448|1130285|P3|Overall Study|Excluded due to data integrity issues|2
334338|NCT01241448|1130286|P2|Overall Study|Excluded due to data integrity issues|2
334339|NCT01241448|1130287|P1|Overall Study|Excluded due to data integrity issues|3
334340|NCT01241448|1130284|P4|Overall Study|Withdrawal by Subject|6
334341|NCT01241448|1130285|P3|Overall Study|Withdrawal by Subject|3
334342|NCT01241448|1130286|P2|Overall Study|Withdrawal by Subject|5
334343|NCT01241448|1130287|P1|Overall Study|Withdrawal by Subject|4
334344|NCT01241448|1130284|P4|Overall Study|Sponsor Decision|6
334345|NCT01241448|1130285|P3|Overall Study|Sponsor Decision|12
334346|NCT01241448|1130286|P2|Overall Study|Sponsor Decision|14
334347|NCT01241448|1130287|P1|Overall Study|Sponsor Decision|17
334348|NCT01241448|1130284|P4|Overall Study|Protocol Violation|6
334349|NCT01241448|1130285|P3|Overall Study|Protocol Violation|3
334350|NCT01241448|1130286|P2|Overall Study|Protocol Violation|5
334351|NCT01241448|1130287|P1|Overall Study|Protocol Violation|10
334352|NCT01241448|1130284|P4|Overall Study|Physician Decision|0
334353|NCT01241448|1130285|P3|Overall Study|Physician Decision|0
334354|NCT01241448|1130286|P2|Overall Study|Physician Decision|2
334355|NCT01241448|1130287|P1|Overall Study|Physician Decision|0
334356|NCT01241448|1130284|P4|Overall Study|Lost to Follow-up|1
334357|NCT01241448|1130285|P3|Overall Study|Lost to Follow-up|1
334358|NCT01241448|1130286|P2|Overall Study|Lost to Follow-up|1
334359|NCT01241448|1130287|P1|Overall Study|Lost to Follow-up|2
334360|NCT01241448|1130284|P4|Overall Study|Adverse Event|2
334361|NCT01241448|1130285|P3|Overall Study|Adverse Event|2
334362|NCT01241448|1130286|P2|Overall Study|Adverse Event|0
334363|NCT01241448|1130287|P1|Overall Study|Adverse Event|1
334364|NCT01241292|1130353|P2|Overall Study|Participant Discontinued Treatment|2
334365|NCT01241292|1130354|P1|Overall Study|Participant Discontinued Treatment|0
334366|NCT01241292|1130353|P2|Overall Study|Study Drug Toxicity|1
334367|NCT01241292|1130354|P1|Overall Study|Study Drug Toxicity|0
334368|NCT01241292|1130353|P2|Overall Study|Disease Progression|0
334369|NCT01241292|1130354|P1|Overall Study|Disease Progression|2
334370|NCT01241292|1130353|P2|Overall Study|Administrative Reason by Sponsor|0
334371|NCT01241292|1130354|P1|Overall Study|Administrative Reason by Sponsor|1
334372|NCT01241279|1130378|P2|Overall Study|Lost to Follow-up|1
334373|NCT01241279|1130379|P1|Overall Study|Lost to Follow-up|0
334374|NCT01241240|1130389|P2|Overall Study|Personal Reasons|1
334375|NCT01241240|1130390|P1|Overall Study|Personal Reasons|1
334376|NCT01241240|1130389|P2|Overall Study|Lost to Follow-up|4
334377|NCT01241240|1130390|P1|Overall Study|Lost to Follow-up|2
334378|NCT01241240|1130389|P2|Overall Study|Adverse Event|4
334379|NCT01241240|1130390|P1|Overall Study|Adverse Event|5
334380|NCT01240915|1130408|P9|Overall Study|Insufficient Clinical Response|3
334381|NCT01240915|1130409|P8|Overall Study|Insufficient Clinical Response|0
334382|NCT01240915|1130410|P7|Overall Study|Insufficient Clinical Response|6
334383|NCT01240915|1130411|P6|Overall Study|Insufficient Clinical Response|3
334384|NCT01240915|1130412|P5|Overall Study|Insufficient Clinical Response|1
334385|NCT01240915|1130413|P4|Overall Study|Insufficient Clinical Response|0
334386|NCT01240915|1130414|P3|Overall Study|Insufficient Clinical Response|0
334387|NCT01240915|1130415|P2|Overall Study|Insufficient Clinical Response|0
334388|NCT01240915|1130416|P1|Overall Study|Insufficient Clinical Response|0
334389|NCT01240915|1130408|P9|Overall Study|Other|0
334390|NCT01240915|1130409|P8|Overall Study|Other|0
334391|NCT01240915|1130410|P7|Overall Study|Other|0
334392|NCT01240915|1130411|P6|Overall Study|Other|0
334393|NCT01240915|1130412|P5|Overall Study|Other|2
334394|NCT01240915|1130413|P4|Overall Study|Other|0
334395|NCT01240915|1130414|P3|Overall Study|Other|0
334396|NCT01240915|1130415|P2|Overall Study|Other|0
334397|NCT01240915|1130416|P1|Overall Study|Other|0
334398|NCT01240915|1130408|P9|Overall Study|Withdrawal by Subject|3
334399|NCT01240915|1130409|P8|Overall Study|Withdrawal by Subject|3
334400|NCT01240915|1130410|P7|Overall Study|Withdrawal by Subject|2
334401|NCT01240915|1130411|P6|Overall Study|Withdrawal by Subject|4
334402|NCT01240915|1130412|P5|Overall Study|Withdrawal by Subject|0
334403|NCT01240915|1130413|P4|Overall Study|Withdrawal by Subject|2
334404|NCT01240915|1130414|P3|Overall Study|Withdrawal by Subject|0
334405|NCT01240915|1130415|P2|Overall Study|Withdrawal by Subject|1
334406|NCT01240915|1130416|P1|Overall Study|Withdrawal by Subject|2
334407|NCT01240915|1130408|P9|Overall Study|Lost to Follow-up|1
334408|NCT01240915|1130409|P8|Overall Study|Lost to Follow-up|1
334409|NCT01240915|1130410|P7|Overall Study|Lost to Follow-up|0
334410|NCT01240915|1130411|P6|Overall Study|Lost to Follow-up|1
334411|NCT01240915|1130412|P5|Overall Study|Lost to Follow-up|1
334412|NCT01240915|1130413|P4|Overall Study|Lost to Follow-up|0
334413|NCT01240915|1130414|P3|Overall Study|Lost to Follow-up|0
334414|NCT01240915|1130415|P2|Overall Study|Lost to Follow-up|0
334415|NCT01240915|1130416|P1|Overall Study|Lost to Follow-up|0
334416|NCT01240915|1130408|P9|Overall Study|Adverse Event|1
334417|NCT01240915|1130409|P8|Overall Study|Adverse Event|0
334418|NCT01240915|1130410|P7|Overall Study|Adverse Event|0
334419|NCT01240915|1130411|P6|Overall Study|Adverse Event|2
334420|NCT01240915|1130412|P5|Overall Study|Adverse Event|0
334421|NCT01240915|1130413|P4|Overall Study|Adverse Event|1
334422|NCT01240915|1130414|P3|Overall Study|Adverse Event|0
334423|NCT01240915|1130415|P2|Overall Study|Adverse Event|0
334424|NCT01240915|1130416|P1|Overall Study|Adverse Event|0
334425|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
334426|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
334427|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
334428|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
334429|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
334430|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
334431|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
334432|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
334433|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
334434|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
334435|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
334436|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
334437|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
334438|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
334439|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
334440|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
334441|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
334442|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
334443|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
334444|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
334445|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
334446|NCT01240863|1130690|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
334447|NCT01240863|1130691|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
334448|NCT01240863|1130692|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
334449|NCT01240863|1130690|P3|Open-label Titration Period|Not specified|0
334450|NCT01240863|1130691|P2|Open-label Titration Period|Not specified|0
334451|NCT01240863|1130692|P1|Open-label Titration Period|Not specified|7
334452|NCT01240863|1130690|P3|Open-label Titration Period|Dropped out prior to dosing|0
334453|NCT01240863|1130691|P2|Open-label Titration Period|Dropped out prior to dosing|0
334454|NCT01240863|1130692|P1|Open-label Titration Period|Dropped out prior to dosing|2
334455|NCT01240863|1130690|P3|Open-label Titration Period|Noncompliance to study procedures|0
334456|NCT01240863|1130691|P2|Open-label Titration Period|Noncompliance to study procedures|0
334457|NCT01240863|1130692|P1|Open-label Titration Period|Noncompliance to study procedures|3
334458|NCT01240863|1130690|P3|Open-label Titration Period|Noncompliance to study drug admin|0
334459|NCT01240863|1130691|P2|Open-label Titration Period|Noncompliance to study drug admin|0
334460|NCT01240863|1130692|P1|Open-label Titration Period|Noncompliance to study drug admin|3
334461|NCT01240863|1130690|P3|Open-label Titration Period|Protocol Violation|0
334462|NCT01240863|1130691|P2|Open-label Titration Period|Protocol Violation|0
334463|NCT01240863|1130692|P1|Open-label Titration Period|Protocol Violation|7
334464|NCT01240863|1130690|P3|Open-label Titration Period|Withdrawal by Subject|0
334465|NCT01240863|1130691|P2|Open-label Titration Period|Withdrawal by Subject|0
334466|NCT01240863|1130692|P1|Open-label Titration Period|Withdrawal by Subject|9
334467|NCT01240863|1130690|P3|Open-label Titration Period|Lack of Efficacy|0
334468|NCT01240863|1130691|P2|Open-label Titration Period|Lack of Efficacy|0
334469|NCT01240863|1130692|P1|Open-label Titration Period|Lack of Efficacy|19
334470|NCT01240863|1130690|P3|Open-label Titration Period|Adverse Event|0
334471|NCT01240863|1130691|P2|Open-label Titration Period|Adverse Event|0
334472|NCT01240863|1130692|P1|Open-label Titration Period|Adverse Event|47
334473|NCT01240811|1130754|P3|Overall Study|Withdrawal by Subject|1
334474|NCT01240811|1130755|P2|Overall Study|Withdrawal by Subject|0
334475|NCT01240811|1130756|P1|Overall Study|Withdrawal by Subject|0
334476|NCT01240811|1130754|P3|Overall Study|Physician Decision|0
334477|NCT01240811|1130755|P2|Overall Study|Physician Decision|1
334478|NCT01240811|1130756|P1|Overall Study|Physician Decision|0
334479|NCT01240785|1130772|P2|Overall Study|Protocol Violation|3
334480|NCT01240785|1130773|P1|Overall Study|Protocol Violation|0
334481|NCT01240785|1130772|P2|Overall Study|Lost to Follow-up|0
334482|NCT01240785|1130773|P1|Overall Study|Lost to Follow-up|1
334483|NCT01240746|1130804|P3|Overall Study|Withdrawal by Subject|59
334484|NCT01240746|1130805|P2|Overall Study|Withdrawal by Subject|13
334485|NCT01240746|1130806|P1|Overall Study|Withdrawal by Subject|10
334486|NCT01240746|1130804|P3|Overall Study|Protocol Violation|72
334487|NCT01240746|1130805|P2|Overall Study|Protocol Violation|15
334488|NCT01240746|1130806|P1|Overall Study|Protocol Violation|24
334489|NCT01240746|1130804|P3|Overall Study|Lost to Follow-up|102
334490|NCT01240746|1130805|P2|Overall Study|Lost to Follow-up|20
334491|NCT01240746|1130806|P1|Overall Study|Lost to Follow-up|23
334492|NCT01240746|1130804|P3|Overall Study|Adverse Event|10
334493|NCT01240746|1130805|P2|Overall Study|Adverse Event|0
334494|NCT01240746|1130806|P1|Overall Study|Adverse Event|2
334495|NCT01240590|1130861|P5|Phase II|Refused further treatment|1
334496|NCT01240590|1130862|P4|Phase II|Refused further treatment|2
334497|NCT01240590|1130863|P3|Phase II|Refused further treatment|0
334498|NCT01240590|1130864|P2|Phase II|Refused further treatment|0
334499|NCT01240590|1130865|P1|Phase II|Refused further treatment|0
334500|NCT01240590|1130861|P5|Phase I|Refused further treatment|0
334501|NCT01240590|1130862|P4|Phase I|Refused further treatment|0
334502|NCT01240590|1130863|P3|Phase I|Refused further treatment|3
334503|NCT01240590|1130864|P2|Phase I|Refused further treatment|0
334504|NCT01240590|1130865|P1|Phase I|Refused further treatment|0
334505|NCT01240551|1130893|P2|Overall Study|Lost to Follow-up|1
334506|NCT01240551|1130894|P1|Overall Study|Lost to Follow-up|1
334507|NCT01240551|1130893|P2|Overall Study|Refused further treatment|2
334508|NCT01240551|1130894|P1|Overall Study|Refused further treatment|3
334509|NCT01240382|1130904|P2|Overall Study|Fear of adverse events|1
334510|NCT01240382|1130905|P1|Overall Study|Fear of adverse events|0
334511|NCT01240382|1130904|P2|Overall Study|Lack of Efficacy|2
334512|NCT01240382|1130905|P1|Overall Study|Lack of Efficacy|0
334513|NCT01240382|1130904|P2|Overall Study|Adverse Event|1
334514|NCT01240382|1130905|P1|Overall Study|Adverse Event|2
334515|NCT01240356|1130915|P2|Overall Study|MRI contraindication|0
334516|NCT01240356|1130916|P1|Overall Study|MRI contraindication|1
334517|NCT01240356|1130915|P2|Overall Study|Withdrawal by Subject|0
334518|NCT01240356|1130916|P1|Overall Study|Withdrawal by Subject|2
334519|NCT01240200|1130935|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
334520|NCT01240200|1130936|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
334521|NCT01240135|1130944|P2|Period Two, 14 Days of Wear|Adverse Event|1
334522|NCT01240135|1130945|P1|Period Two, 14 Days of Wear|Adverse Event|0
334523|NCT01240135|1130944|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
334524|NCT01240135|1130945|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
334525|NCT01239992|1130962|P1|Overall Study|Withdrawal by Subject|2
334526|NCT01239797|1130971|P2|Treated Participants|Poor/Non-compliance|1
334527|NCT01239797|1130972|P1|Treated Participants|Poor/Non-compliance|0
334528|NCT01239797|1130971|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
334529|NCT01239797|1130972|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
334530|NCT01239797|1130971|P2|Treated Participants|Death|1
334531|NCT01239797|1130972|P1|Treated Participants|Death|1
334532|NCT01239797|1130971|P2|Treated Participants|Non-specified|11
334533|NCT01239797|1130972|P1|Treated Participants|Non-specified|1
334534|NCT01239797|1130971|P2|Treated Participants|Withdrawal by Subject|23
334535|NCT01239797|1130972|P1|Treated Participants|Withdrawal by Subject|27
334536|NCT01239797|1130971|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
334537|NCT01239797|1130972|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
334538|NCT01239797|1130971|P2|Treated Participants|Study Drug Toxicity|44
334539|NCT01239797|1130972|P1|Treated Participants|Study Drug Toxicity|30
334540|NCT01239797|1130971|P2|Treated Participants|Disease Progression|161
334541|NCT01239797|1130972|P1|Treated Participants|Disease Progression|153
334542|NCT01239745|1130980|P1|Overall Study|Adverse Event|1
334543|NCT01239745|1130980|P1|Overall Study|Study terminated by sponsor|45
334544|NCT01239732|1130991|P1|Overall Study|Other|19
334545|NCT01239732|1130991|P1|Overall Study|Treatment failure|2
334546|NCT01239732|1130991|P1|Overall Study|Investigator's decision|4
334547|NCT01239732|1130991|P1|Overall Study|Study termination by sponsor|2
334548|NCT01239732|1130991|P1|Overall Study|Participant non compliance|5
334549|NCT01239732|1130991|P1|Overall Study|Protocol Violation|3
334550|NCT01239732|1130991|P1|Overall Study|Adverse Event|6
334551|NCT01239732|1130991|P1|Overall Study|Withdrawal by Subject|87
334552|NCT01239732|1130991|P1|Overall Study|Death|226
334553|NCT01239732|1130991|P1|Overall Study|Termination of study per protocol|667
334554|NCT01239680|1131004|P2|Overall Study|Withdrawal by Subject|0
334555|NCT01239680|1131005|P1|Overall Study|Withdrawal by Subject|2
334556|NCT01239394|1131028|P1|Overall Study|Adverse Event|1
334557|NCT01239381|1131035|P1|Overall Study|Withdrawal by Subject|1
334558|NCT01239381|1131035|P1|Overall Study|Protocol Violation|1
334559|NCT01239342|1131053|P2|Overall Study|Reason Unknown|1
334560|NCT01239342|1131054|P1|Overall Study|Reason Unknown|1
334561|NCT01239342|1131053|P2|Overall Study|Withdrawal by Subject|5
334562|NCT01239342|1131054|P1|Overall Study|Withdrawal by Subject|1
334563|NCT01239342|1131053|P2|Overall Study|Adverse Event|0
334564|NCT01239342|1131054|P1|Overall Study|Adverse Event|1
334565|NCT01239316|1131070|P1|Overall Study|Adverse Event|1
334566|NCT01239316|1131070|P1|Overall Study|Progression/Relapse|11
334567|NCT01239121|1131085|P3|Overall Study|Withdrawal by Subject|0
334568|NCT01239121|1131086|P2|Overall Study|Withdrawal by Subject|4
334569|NCT01239121|1131087|P1|Overall Study|Withdrawal by Subject|2
334570|NCT01239043|1131109|P2|Overall Study|Protocol Violation|1
334571|NCT01239043|1131110|P1|Overall Study|Protocol Violation|2
334572|NCT01238991|1131138|P10|Overall Study|Admission to a nursing home|0
334573|NCT01238991|1131139|P9|Overall Study|Admission to a nursing home|0
334574|NCT01238991|1131140|P8|Overall Study|Admission to a nursing home|0
334575|NCT01238991|1131141|P7|Overall Study|Admission to a nursing home|0
334576|NCT01238991|1131142|P6|Overall Study|Admission to a nursing home|0
334577|NCT01238991|1131143|P5|Overall Study|Admission to a nursing home|0
334578|NCT01238991|1131144|P4|Overall Study|Admission to a nursing home|0
334579|NCT01238991|1131145|P3|Overall Study|Admission to a nursing home|1
334580|NCT01238991|1131146|P2|Overall Study|Admission to a nursing home|0
334581|NCT01238991|1131147|P1|Overall Study|Admission to a nursing home|1
334582|NCT01238991|1131138|P10|Overall Study|Caregiver's request|0
334583|NCT01238991|1131139|P9|Overall Study|Caregiver's request|1
334584|NCT01238991|1131140|P8|Overall Study|Caregiver's request|0
334585|NCT01238991|1131141|P7|Overall Study|Caregiver's request|0
334586|NCT01238991|1131142|P6|Overall Study|Caregiver's request|0
334587|NCT01238991|1131143|P5|Overall Study|Caregiver's request|0
334588|NCT01238991|1131144|P4|Overall Study|Caregiver's request|0
334589|NCT01238991|1131145|P3|Overall Study|Caregiver's request|0
334590|NCT01238991|1131146|P2|Overall Study|Caregiver's request|0
334591|NCT01238991|1131147|P1|Overall Study|Caregiver's request|0
334592|NCT01238991|1131138|P10|Overall Study|Study Terminated by Sponsor|2
334593|NCT01238991|1131139|P9|Overall Study|Study Terminated by Sponsor|2
334594|NCT01238991|1131140|P8|Overall Study|Study Terminated by Sponsor|4
334595|NCT01238991|1131141|P7|Overall Study|Study Terminated by Sponsor|7
334596|NCT01238991|1131142|P6|Overall Study|Study Terminated by Sponsor|0
334597|NCT01238991|1131143|P5|Overall Study|Study Terminated by Sponsor|1
334598|NCT01238991|1131144|P4|Overall Study|Study Terminated by Sponsor|0
334599|NCT01238991|1131145|P3|Overall Study|Study Terminated by Sponsor|0
334600|NCT01238991|1131146|P2|Overall Study|Study Terminated by Sponsor|0
334601|NCT01238991|1131147|P1|Overall Study|Study Terminated by Sponsor|0
334602|NCT01238991|1131138|P10|Overall Study|Withdrawal by Subject|0
334603|NCT01238991|1131139|P9|Overall Study|Withdrawal by Subject|0
334604|NCT01238991|1131140|P8|Overall Study|Withdrawal by Subject|0
334605|NCT01238991|1131141|P7|Overall Study|Withdrawal by Subject|0
334606|NCT01238991|1131142|P6|Overall Study|Withdrawal by Subject|0
334607|NCT01238991|1131143|P5|Overall Study|Withdrawal by Subject|0
334608|NCT01238991|1131144|P4|Overall Study|Withdrawal by Subject|0
334609|NCT01238991|1131145|P3|Overall Study|Withdrawal by Subject|1
334610|NCT01238991|1131146|P2|Overall Study|Withdrawal by Subject|0
334611|NCT01238991|1131147|P1|Overall Study|Withdrawal by Subject|0
334612|NCT01238991|1131138|P10|Overall Study|Lack of Efficacy|0
334613|NCT01238991|1131139|P9|Overall Study|Lack of Efficacy|1
334614|NCT01238991|1131140|P8|Overall Study|Lack of Efficacy|0
334615|NCT01238991|1131141|P7|Overall Study|Lack of Efficacy|0
334616|NCT01238991|1131142|P6|Overall Study|Lack of Efficacy|0
334617|NCT01238991|1131143|P5|Overall Study|Lack of Efficacy|0
334618|NCT01238991|1131144|P4|Overall Study|Lack of Efficacy|0
334619|NCT01238991|1131145|P3|Overall Study|Lack of Efficacy|1
334620|NCT01238991|1131146|P2|Overall Study|Lack of Efficacy|0
334621|NCT01238991|1131147|P1|Overall Study|Lack of Efficacy|0
334622|NCT01238991|1131138|P10|Overall Study|Death|0
334623|NCT01238991|1131139|P9|Overall Study|Death|0
334624|NCT01238991|1131140|P8|Overall Study|Death|0
334625|NCT01238991|1131141|P7|Overall Study|Death|0
334626|NCT01238991|1131142|P6|Overall Study|Death|0
334627|NCT01238991|1131143|P5|Overall Study|Death|0
334628|NCT01238991|1131144|P4|Overall Study|Death|1
334629|NCT01238991|1131145|P3|Overall Study|Death|0
334630|NCT01238991|1131146|P2|Overall Study|Death|0
334631|NCT01238991|1131147|P1|Overall Study|Death|0
334632|NCT01238991|1131138|P10|Overall Study|Adverse Event|0
334633|NCT01238991|1131139|P9|Overall Study|Adverse Event|0
334634|NCT01238991|1131140|P8|Overall Study|Adverse Event|1
334635|NCT01238991|1131141|P7|Overall Study|Adverse Event|1
334636|NCT01238991|1131142|P6|Overall Study|Adverse Event|0
334637|NCT01238991|1131143|P5|Overall Study|Adverse Event|1
334638|NCT01238991|1131144|P4|Overall Study|Adverse Event|1
334639|NCT01238991|1131145|P3|Overall Study|Adverse Event|3
334640|NCT01238991|1131146|P2|Overall Study|Adverse Event|0
334641|NCT01238991|1131147|P1|Overall Study|Adverse Event|1
334642|NCT01238900|1131234|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
334643|NCT01238900|1131234|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
334644|NCT01238861|1131248|P6|Overall Study|Withdrawal by Subject|9
334645|NCT01238861|1131249|P5|Overall Study|Withdrawal by Subject|10
334646|NCT01238861|1131250|P4|Overall Study|Withdrawal by Subject|8
334647|NCT01238861|1131251|P3|Overall Study|Withdrawal by Subject|4
334648|NCT01238861|1131252|P2|Overall Study|Withdrawal by Subject|5
334649|NCT01238861|1131253|P1|Overall Study|Withdrawal by Subject|6
334650|NCT01238861|1131248|P6|Overall Study|Adverse Event|0
334651|NCT01238861|1131249|P5|Overall Study|Adverse Event|0
334652|NCT01238861|1131250|P4|Overall Study|Adverse Event|0
334653|NCT01238861|1131251|P3|Overall Study|Adverse Event|0
334654|NCT01238861|1131252|P2|Overall Study|Adverse Event|1
334655|NCT01238861|1131253|P1|Overall Study|Adverse Event|0
334656|NCT01238861|1131248|P6|Overall Study|Lack of compliance|1
334657|NCT01238861|1131249|P5|Overall Study|Lack of compliance|0
334658|NCT01238861|1131250|P4|Overall Study|Lack of compliance|0
334659|NCT01238861|1131251|P3|Overall Study|Lack of compliance|0
334660|NCT01238861|1131252|P2|Overall Study|Lack of compliance|0
334661|NCT01238861|1131253|P1|Overall Study|Lack of compliance|0
334662|NCT01238861|1131248|P6|Overall Study|Serious adverse event|1
334663|NCT01238861|1131249|P5|Overall Study|Serious adverse event|0
334664|NCT01238861|1131250|P4|Overall Study|Serious adverse event|0
334665|NCT01238861|1131251|P3|Overall Study|Serious adverse event|0
334666|NCT01238861|1131252|P2|Overall Study|Serious adverse event|0
334667|NCT01238861|1131253|P1|Overall Study|Serious adverse event|0
334668|NCT01238861|1131248|P6|Overall Study|Unable to continue visits|1
334669|NCT01238861|1131249|P5|Overall Study|Unable to continue visits|0
334670|NCT01238861|1131250|P4|Overall Study|Unable to continue visits|1
334671|NCT01238861|1131251|P3|Overall Study|Unable to continue visits|0
334672|NCT01238861|1131252|P2|Overall Study|Unable to continue visits|0
334673|NCT01238861|1131253|P1|Overall Study|Unable to continue visits|0
334674|NCT01238861|1131248|P6|Overall Study|Personal problems|0
334675|NCT01238861|1131249|P5|Overall Study|Personal problems|0
334676|NCT01238861|1131250|P4|Overall Study|Personal problems|1
334677|NCT01238861|1131251|P3|Overall Study|Personal problems|0
334678|NCT01238861|1131252|P2|Overall Study|Personal problems|0
334679|NCT01238861|1131253|P1|Overall Study|Personal problems|0
334680|NCT01238861|1131248|P6|Overall Study|Strongyloides stercoralis antibodies +|0
334681|NCT01238861|1131249|P5|Overall Study|Strongyloides stercoralis antibodies +|0
334682|NCT01238861|1131250|P4|Overall Study|Strongyloides stercoralis antibodies +|1
334683|NCT01238861|1131251|P3|Overall Study|Strongyloides stercoralis antibodies +|0
334684|NCT01238861|1131252|P2|Overall Study|Strongyloides stercoralis antibodies +|0
334685|NCT01238861|1131253|P1|Overall Study|Strongyloides stercoralis antibodies +|0
334686|NCT01238861|1131248|P6|Overall Study|Subject moved out of state/area|0
334687|NCT01238861|1131249|P5|Overall Study|Subject moved out of state/area|0
334688|NCT01238861|1131250|P4|Overall Study|Subject moved out of state/area|1
334689|NCT01238861|1131251|P3|Overall Study|Subject moved out of state/area|1
334690|NCT01238861|1131252|P2|Overall Study|Subject moved out of state/area|0
334691|NCT01238861|1131253|P1|Overall Study|Subject moved out of state/area|0
334692|NCT01238861|1131248|P6|Overall Study|Subject traveled to Argentina by 1 year|0
334693|NCT01238861|1131249|P5|Overall Study|Subject traveled to Argentina by 1 year|0
334694|NCT01238861|1131250|P4|Overall Study|Subject traveled to Argentina by 1 year|0
334695|NCT01238861|1131251|P3|Overall Study|Subject traveled to Argentina by 1 year|1
334696|NCT01238861|1131252|P2|Overall Study|Subject traveled to Argentina by 1 year|0
334697|NCT01238861|1131253|P1|Overall Study|Subject traveled to Argentina by 1 year|0
334698|NCT01238861|1131248|P6|Overall Study|Incorrect enrollment/randomization|0
334699|NCT01238861|1131249|P5|Overall Study|Incorrect enrollment/randomization|1
334700|NCT01238861|1131250|P4|Overall Study|Incorrect enrollment/randomization|0
334701|NCT01238861|1131251|P3|Overall Study|Incorrect enrollment/randomization|1
334702|NCT01238861|1131252|P2|Overall Study|Incorrect enrollment/randomization|0
334703|NCT01238861|1131253|P1|Overall Study|Incorrect enrollment/randomization|0
334704|NCT01238861|1131248|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
334705|NCT01238861|1131249|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
334706|NCT01238861|1131250|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
334707|NCT01238861|1131251|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
334708|NCT01238861|1131252|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
334709|NCT01238861|1131253|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
334710|NCT01238861|1131248|P6|Overall Study|Unplanned surgery|0
334711|NCT01238861|1131249|P5|Overall Study|Unplanned surgery|0
334712|NCT01238861|1131250|P4|Overall Study|Unplanned surgery|0
334713|NCT01238861|1131251|P3|Overall Study|Unplanned surgery|0
334714|NCT01238861|1131252|P2|Overall Study|Unplanned surgery|0
334715|NCT01238861|1131253|P1|Overall Study|Unplanned surgery|1
334716|NCT01238861|1131248|P6|Overall Study|Lost to Follow-up|2
334717|NCT01238861|1131249|P5|Overall Study|Lost to Follow-up|1
334718|NCT01238861|1131250|P4|Overall Study|Lost to Follow-up|1
334719|NCT01238861|1131251|P3|Overall Study|Lost to Follow-up|3
334720|NCT01238861|1131252|P2|Overall Study|Lost to Follow-up|2
334721|NCT01238861|1131253|P1|Overall Study|Lost to Follow-up|4
334722|NCT01238848|1131333|P2|Overall Study|Physician Decision|5
334723|NCT01238848|1131334|P1|Overall Study|Physician Decision|13
334724|NCT01238822|1131342|P1|Overall Study|COULD NOT SWALLOW PILLS|3
334725|NCT01238588|1131369|P1|Overall Study|Physician Decision|2
334726|NCT01238588|1131369|P1|Overall Study|Withdrawal by Subject|1
334727|NCT01238575|1131382|P2|Overall Study|Adverse Event|0
334728|NCT01238575|1131383|P1|Overall Study|Adverse Event|2
334729|NCT01238575|1131382|P2|Overall Study|Lack of Efficacy|4
334730|NCT01238575|1131383|P1|Overall Study|Lack of Efficacy|2
334731|NCT01238211|1131450|P1|Overall Study|Investigator/Patient Decision|3
334732|NCT01238211|1131450|P1|Overall Study|Non-protocol treatment|4
334733|NCT01238211|1131450|P1|Overall Study|Withdrawal by Subject|7
334734|NCT01238211|1131450|P1|Overall Study|Relapse/Progression|2
334735|NCT01238211|1131450|P1|Overall Study|Death|4
334736|NCT01238211|1131450|P1|Overall Study|Adverse Event|7
334737|NCT01238211|1131450|P1|Overall Study|Continues active treatment|31
334738|NCT01237678|1131457|P3|Phase II|Randomized but were not treated|3
334739|NCT01237678|1131458|P2|Phase II|Randomized but were not treated|4
334740|NCT01237678|1131459|P1|Phase II|Randomized but were not treated|0
334741|NCT01237678|1131457|P3|Phase II|Sponsor Decision/Study Closed|7
334742|NCT01237678|1131458|P2|Phase II|Sponsor Decision/Study Closed|18
334743|NCT01237678|1131459|P1|Phase II|Sponsor Decision/Study Closed|0
334744|NCT01237678|1131457|P3|Phase II|Completed Cycles 4-6|21
334745|NCT01237678|1131458|P2|Phase II|Completed Cycles 4-6|11
334746|NCT01237678|1131459|P1|Phase II|Completed Cycles 4-6|0
334747|NCT01237678|1131457|P3|Phase II|Withdrawal by Subject|5
334748|NCT01237678|1131458|P2|Phase II|Withdrawal by Subject|1
334749|NCT01237678|1131459|P1|Phase II|Withdrawal by Subject|0
334750|NCT01237678|1131457|P3|Phase II|Lack of Efficacy|3
334751|NCT01237678|1131458|P2|Phase II|Lack of Efficacy|25
334752|NCT01237678|1131459|P1|Phase II|Lack of Efficacy|0
334753|NCT01237678|1131457|P3|Phase II|Death|2
334754|NCT01237678|1131458|P2|Phase II|Death|0
334755|NCT01237678|1131459|P1|Phase II|Death|0
334756|NCT01237678|1131457|P3|Phase II|Adverse Event|9
334757|NCT01237678|1131458|P2|Phase II|Adverse Event|39
334758|NCT01237678|1131459|P1|Phase II|Adverse Event|0
334759|NCT01237678|1131457|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
334760|NCT01237678|1131458|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
334761|NCT01237678|1131459|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
334762|NCT01237678|1131457|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
334763|NCT01237678|1131458|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
334764|NCT01237678|1131459|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
334765|NCT01237678|1131457|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
334766|NCT01237678|1131458|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
334767|NCT01237678|1131459|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
334768|NCT01237678|1131457|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
334769|NCT01237678|1131458|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
334770|NCT01237678|1131459|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
334771|NCT01237340|1131507|P1|Overall Study|Early termination of the trial|36
334772|NCT01237340|1131507|P1|Overall Study|Withdrawal by Subject|1
334773|NCT01237340|1131507|P1|Overall Study|Adverse Event|3
334774|NCT01237327|1131521|P2|Overall Study|Lost to Follow-up|0
334775|NCT01237327|1131522|P1|Overall Study|Lost to Follow-up|3
334776|NCT01237327|1131521|P2|Overall Study|Withdrawal by Subject|3
334777|NCT01237327|1131522|P1|Overall Study|Withdrawal by Subject|1
334778|NCT01237327|1131521|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
334779|NCT01237327|1131522|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
334780|NCT01237327|1131521|P2|Overall Study|Progression of Disease: Extension Study|13
334781|NCT01237327|1131522|P1|Overall Study|Progression of Disease: Extension Study|15
334782|NCT01237327|1131521|P2|Overall Study|Progression of Disease: Core Study|22
334783|NCT01237327|1131522|P1|Overall Study|Progression of Disease: Core Study|18
334784|NCT01237327|1131521|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
334785|NCT01237327|1131522|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
334786|NCT01237327|1131521|P2|Overall Study|Protocol Violation: Core Study|0
334787|NCT01237327|1131522|P1|Overall Study|Protocol Violation: Core Study|1
334788|NCT01237223|1131551|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
334789|NCT01237223|1131552|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
334790|NCT01237223|1131553|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
334791|NCT01237223|1131554|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
334792|NCT01237223|1131555|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
334793|NCT01237223|1131556|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
334794|NCT01237223|1131551|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
334795|NCT01237223|1131552|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
334796|NCT01237223|1131553|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
334797|NCT01237223|1131554|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
334798|NCT01237223|1131555|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
334799|NCT01237223|1131556|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
334800|NCT01237223|1131551|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
334801|NCT01237223|1131552|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
334802|NCT01237223|1131553|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
334803|NCT01237223|1131554|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
334804|NCT01237223|1131555|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
334805|NCT01237223|1131556|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
334806|NCT01237223|1131551|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
334807|NCT01237223|1131552|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
334808|NCT01237223|1131553|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
334809|NCT01237223|1131554|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
334810|NCT01237223|1131555|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
334811|NCT01237223|1131556|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
334812|NCT01237223|1131551|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
334813|NCT01237223|1131552|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
334814|NCT01237223|1131553|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
334815|NCT01237223|1131554|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
334816|NCT01237223|1131555|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
334817|NCT01237223|1131556|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
334818|NCT01237223|1131551|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
334819|NCT01237223|1131552|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
334820|NCT01237223|1131553|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
334821|NCT01237223|1131554|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
334822|NCT01237223|1131555|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
334823|NCT01237223|1131556|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
334824|NCT01237223|1131551|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
334825|NCT01237223|1131552|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
334826|NCT01237223|1131553|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
334827|NCT01237223|1131554|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
334828|NCT01237223|1131555|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
334829|NCT01237223|1131556|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
334830|NCT01237223|1131551|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
334831|NCT01237223|1131552|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
334832|NCT01237223|1131553|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
334833|NCT01237223|1131554|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
334834|NCT01237223|1131555|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
334835|NCT01237223|1131556|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
334836|NCT01237223|1131551|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
334837|NCT01237223|1131552|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
334838|NCT01237223|1131553|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
334839|NCT01237223|1131554|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
334840|NCT01237223|1131555|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
334841|NCT01237223|1131556|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
334842|NCT01237223|1131551|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
334843|NCT01237223|1131552|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
334844|NCT01237223|1131553|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
334845|NCT01237223|1131554|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
334846|NCT01237223|1131555|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
334847|NCT01237223|1131556|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
334848|NCT01237054|1131615|P1|Overall Study|imaging 10C0096|1
334849|NCT01236573|1131680|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
334850|NCT01236573|1131681|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334851|NCT01236573|1131682|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334852|NCT01236573|1131683|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334853|NCT01236573|1131684|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334854|NCT01236573|1131685|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334855|NCT01236573|1131686|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334856|NCT01236573|1131687|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334857|NCT01236573|1131688|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334858|NCT01236573|1131689|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334859|NCT01236573|1131690|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
334860|NCT01236573|1131680|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334861|NCT01236573|1131681|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334862|NCT01236573|1131682|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
334863|NCT01236573|1131683|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334864|NCT01236573|1131684|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334865|NCT01236573|1131685|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334866|NCT01236573|1131686|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334867|NCT01236573|1131687|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334868|NCT01236573|1131688|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334869|NCT01236573|1131689|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334870|NCT01236573|1131690|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
334871|NCT01236573|1131680|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334872|NCT01236573|1131681|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
334873|NCT01236573|1131682|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
334874|NCT01236573|1131683|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334875|NCT01236573|1131684|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
334876|NCT01236573|1131685|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334877|NCT01236573|1131686|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334878|NCT01236573|1131687|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334879|NCT01236573|1131688|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334880|NCT01236573|1131689|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334881|NCT01236573|1131690|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
334882|NCT01236534|1131728|P2|Overall Study|Adverse Event|0
334883|NCT01236534|1131729|P1|Overall Study|Adverse Event|3
334884|NCT01236521|1131739|P2|Overall Study|Lost to Follow-up|7
334885|NCT01236521|1131740|P1|Overall Study|Lost to Follow-up|7
334886|NCT01236521|1131739|P2|Overall Study|Death|1
334887|NCT01236521|1131740|P1|Overall Study|Death|2
334888|NCT01236521|1131739|P2|Overall Study|Withdrawal by Subject|17
334889|NCT01236521|1131740|P1|Overall Study|Withdrawal by Subject|12
334890|NCT01236365|1131790|P2|Overall Study|Dropped at Randomization due to high LFT|0
334891|NCT01236365|1131791|P1|Overall Study|Dropped at Randomization due to high LFT|1
334892|NCT01236365|1131790|P2|Overall Study|Moved Out of State|0
334893|NCT01236365|1131791|P1|Overall Study|Moved Out of State|1
334894|NCT01236365|1131790|P2|Overall Study|Lost to Follow-up|2
334895|NCT01236365|1131791|P1|Overall Study|Lost to Follow-up|0
334896|NCT01236339|1131805|P2|Overall Study|Termination of study by sponsor|13
334897|NCT01236339|1131806|P1|Overall Study|Termination of study by sponsor|11
334898|NCT01236118|1131874|P3|Overall Study|Withdrawal by Subject|1
334899|NCT01236118|1131875|P2|Overall Study|Withdrawal by Subject|0
334900|NCT01236118|1131876|P1|Overall Study|Withdrawal by Subject|0
334901|NCT01236118|1131874|P3|Overall Study|Physician Decision|0
334902|NCT01236118|1131875|P2|Overall Study|Physician Decision|1
334903|NCT01236118|1131876|P1|Overall Study|Physician Decision|0
334904|NCT01236118|1131874|P3|Overall Study|Adverse Event|2
334905|NCT01236118|1131875|P2|Overall Study|Adverse Event|0
334906|NCT01236118|1131876|P1|Overall Study|Adverse Event|2
334907|NCT01236001|1132077|P2|Overall Study|Planned Visit After End of Study|1
334908|NCT01236001|1132078|P1|Overall Study|Planned Visit After End of Study|0
334909|NCT01236001|1132077|P2|Overall Study|Incompliance|0
334910|NCT01236001|1132078|P1|Overall Study|Incompliance|1
334911|NCT01236001|1132077|P2|Overall Study|Lost to Follow-up|1
334912|NCT01236001|1132078|P1|Overall Study|Lost to Follow-up|6
334913|NCT01236001|1132077|P2|Overall Study|Lack of Efficacy|6
334914|NCT01236001|1132078|P1|Overall Study|Lack of Efficacy|6
334915|NCT01236001|1132077|P2|Overall Study|Adverse Event|14
334916|NCT01236001|1132078|P1|Overall Study|Adverse Event|5
334917|NCT01235975|1132110|P2|Overall Study|Lost to Follow-up|3
334918|NCT01235975|1132111|P1|Overall Study|Lost to Follow-up|7
334919|NCT01235975|1132110|P2|Overall Study|Migrated/moved from study area|1
334920|NCT01235975|1132111|P1|Overall Study|Migrated/moved from study area|2
334921|NCT01235975|1132110|P2|Overall Study|Withdrawal by Subject|2
334922|NCT01235975|1132111|P1|Overall Study|Withdrawal by Subject|8
334923|NCT01235975|1132110|P2|Overall Study|Serious Adverse Event|1
334924|NCT01235975|1132111|P1|Overall Study|Serious Adverse Event|0
334925|NCT01235741|1132168|P3|Follow-Up Post Treatment up to Month 6|not specified|0
334926|NCT01235741|1132169|P2|Follow-Up Post Treatment up to Month 6|not specified|1
334927|NCT01235741|1132170|P1|Follow-Up Post Treatment up to Month 6|not specified|0
334928|NCT01235741|1132168|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
334929|NCT01235741|1132169|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
334930|NCT01235741|1132170|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
334931|NCT01235741|1132168|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
334932|NCT01235741|1132169|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
334933|NCT01235741|1132170|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
334934|NCT01235741|1132168|P3|Randomized to Treatment|Sponsor terminated study|34
334935|NCT01235741|1132169|P2|Randomized to Treatment|Sponsor terminated study|35
334936|NCT01235741|1132170|P1|Randomized to Treatment|Sponsor terminated study|0
334937|NCT01235741|1132168|P3|Randomized to Treatment|Adverse Event|1
334938|NCT01235741|1132169|P2|Randomized to Treatment|Adverse Event|1
334939|NCT01235741|1132170|P1|Randomized to Treatment|Adverse Event|0
334940|NCT01235741|1132168|P3|Randomized to Treatment|Withdrawal by Subject|1
334941|NCT01235741|1132169|P2|Randomized to Treatment|Withdrawal by Subject|0
334942|NCT01235741|1132170|P1|Randomized to Treatment|Withdrawal by Subject|0
334943|NCT01235741|1132168|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
334944|NCT01235741|1132169|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
334945|NCT01235741|1132170|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
334946|NCT01235741|1132168|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
334947|NCT01235741|1132169|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
334948|NCT01235741|1132170|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
334949|NCT01235741|1132168|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
334950|NCT01235741|1132169|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
334951|NCT01235741|1132170|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
334952|NCT01235741|1132168|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
334953|NCT01235741|1132169|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
334954|NCT01235741|1132170|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
334955|NCT01235741|1132168|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
334956|NCT01235741|1132169|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
334957|NCT01235741|1132170|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
334958|NCT01235741|1132168|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
334959|NCT01235741|1132169|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
334960|NCT01235741|1132170|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
334961|NCT01235728|1132197|P8|Overall Study|Protocol Violation|0
334962|NCT01235728|1132198|P7|Overall Study|Protocol Violation|0
334963|NCT01235728|1132199|P6|Overall Study|Protocol Violation|0
334964|NCT01235728|1132200|P5|Overall Study|Protocol Violation|0
334965|NCT01235728|1132201|P4|Overall Study|Protocol Violation|1
334966|NCT01235728|1132202|P3|Overall Study|Protocol Violation|0
334967|NCT01235728|1132203|P2|Overall Study|Protocol Violation|0
334968|NCT01235728|1132204|P1|Overall Study|Protocol Violation|0
334969|NCT01235715|1132214|P2|Overall Study|Physician Decision|2
334970|NCT01235715|1132215|P1|Overall Study|Physician Decision|0
334971|NCT01235689|1132255|P2|Overall Study|Miscellaneous|5
334972|NCT01235689|1132256|P1|Overall Study|Miscellaneous|1
334973|NCT01235689|1132255|P2|Overall Study|Lost to Follow-up|2
334974|NCT01235689|1132256|P1|Overall Study|Lost to Follow-up|1
334975|NCT01235689|1132255|P2|Overall Study|Withdrawal by Subject|4
334976|NCT01235689|1132256|P1|Overall Study|Withdrawal by Subject|3
334977|NCT01235689|1132255|P2|Overall Study|Lack of Efficacy|5
334978|NCT01235689|1132256|P1|Overall Study|Lack of Efficacy|12
334979|NCT01235689|1132255|P2|Overall Study|Adverse Event|16
334980|NCT01235689|1132256|P1|Overall Study|Adverse Event|12
334981|NCT01235598|1132328|P2|Overall Study|Withdrawal by Subject|0
334982|NCT01235598|1132329|P1|Overall Study|Withdrawal by Subject|1
334983|NCT01235598|1132328|P2|Overall Study|Lack of Efficacy|1
334984|NCT01235598|1132329|P1|Overall Study|Lack of Efficacy|0
334985|NCT01235598|1132328|P2|Overall Study|Adverse Event|3
334986|NCT01235598|1132329|P1|Overall Study|Adverse Event|0
334987|NCT01235546|1132374|P2|Overall Study|Protocol Violation|1
334988|NCT01235546|1132375|P1|Overall Study|Protocol Violation|1
334989|NCT01235546|1132374|P2|Overall Study|Staff error, medication not administered|0
334990|NCT01235546|1132375|P1|Overall Study|Staff error, medication not administered|1
334991|NCT01235507|1132399|P1|Overall Study|Withdrawal by Subject|1
334992|NCT01235507|1132399|P1|Overall Study|Adverse Event|1
334993|NCT01235442|1132413|P2|Overall Study|Other unspecified|2
334994|NCT01235442|1132414|P1|Overall Study|Other unspecified|1
334995|NCT01235442|1132413|P2|Overall Study|Administrative decision|2
334996|NCT01235442|1132414|P1|Overall Study|Administrative decision|1
334997|NCT01235442|1132413|P2|Overall Study|Noncompliance|2
334998|NCT01235442|1132414|P1|Overall Study|Noncompliance|1
334999|NCT01235442|1132413|P2|Overall Study|Lack of Efficacy|3
335000|NCT01235442|1132414|P1|Overall Study|Lack of Efficacy|1
335001|NCT01235442|1132413|P2|Overall Study|Withdrawal by Subject|9
335002|NCT01235442|1132414|P1|Overall Study|Withdrawal by Subject|15
335003|NCT01235442|1132413|P2|Overall Study|Adverse Event|6
335004|NCT01235442|1132414|P1|Overall Study|Adverse Event|4
335005|NCT01235442|1132413|P2|Overall Study|Protocol Violation|3
335006|NCT01235442|1132414|P1|Overall Study|Protocol Violation|3
335007|NCT01235442|1132413|P2|Overall Study|Ineligibility determined|4
335008|NCT01235442|1132414|P1|Overall Study|Ineligibility determined|5
335009|NCT01235442|1132413|P2|Overall Study|Pregnancy|1
335010|NCT01235442|1132414|P1|Overall Study|Pregnancy|1
335011|NCT01235442|1132413|P2|Overall Study|Death|2
335012|NCT01235442|1132414|P1|Overall Study|Death|0
335013|NCT01235442|1132413|P2|Overall Study|Lost to Follow-up|10
335014|NCT01235442|1132414|P1|Overall Study|Lost to Follow-up|12
335015|NCT01235403|1132432|P1|Overall Study|Other reasons for premature termination|4
335016|NCT01235403|1132432|P1|Overall Study|Lack of Efficacy|2
335017|NCT01235403|1132432|P1|Overall Study|Withdrawal by Subject|4
335018|NCT01235403|1132432|P1|Overall Study|Lost to Follow-up|2
335019|NCT01235403|1132432|P1|Overall Study|Adverse Event|14
335020|NCT01235338|1132449|P2|Overall Study|Prohibited meds|0
335021|NCT01235338|1132450|P1|Overall Study|Prohibited meds|1
335022|NCT01235338|1132449|P2|Overall Study|Positive drug screen|1
335023|NCT01235338|1132450|P1|Overall Study|Positive drug screen|0
335024|NCT01235338|1132449|P2|Overall Study|Exclusion criteria violations|1
335025|NCT01235338|1132450|P1|Overall Study|Exclusion criteria violations|1
335026|NCT01235338|1132449|P2|Overall Study|Withdrawal by Subject|0
335027|NCT01235338|1132450|P1|Overall Study|Withdrawal by Subject|5
335028|NCT01235338|1132449|P2|Overall Study|Protocol Violation|1
335029|NCT01235338|1132450|P1|Overall Study|Protocol Violation|1
335030|NCT01235338|1132449|P2|Overall Study|Adverse Event|2
335031|NCT01235338|1132450|P1|Overall Study|Adverse Event|3
335032|NCT01235234|1132495|P3|Overall Study|Adverse Event|1
335033|NCT01235234|1132496|P2|Overall Study|Adverse Event|2
335034|NCT01235234|1132497|P1|Overall Study|Adverse Event|2
335035|NCT01234883|1132545|P2|Overall Study|Inclusion/exclusion failure|0
335036|NCT01234883|1132546|P1|Overall Study|Inclusion/exclusion failure|1
335037|NCT01234883|1132545|P2|Overall Study|Technical difficulties with IV infusion|1
335038|NCT01234883|1132546|P1|Overall Study|Technical difficulties with IV infusion|0
335039|NCT01234883|1132545|P2|Overall Study|Parent/guardian withdrew consent|2
335040|NCT01234883|1132546|P1|Overall Study|Parent/guardian withdrew consent|1
335041|NCT01234883|1132545|P2|Overall Study|Early treatment release|10
335042|NCT01234883|1132546|P1|Overall Study|Early treatment release|8
335043|NCT01234675|1132593|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
335044|NCT01234675|1132594|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
335045|NCT01234675|1132593|P2|First Intervention (6 Weeks)|Adverse Event|1
335046|NCT01234675|1132594|P1|First Intervention (6 Weeks)|Adverse Event|0
335047|NCT01234467|1132608|P1|Overall Study|Other complicating disease (stroke)|1
335048|NCT01234467|1132608|P1|Overall Study|Physician Decision|1
335049|NCT01234467|1132608|P1|Overall Study|Clinical deterioration|1
335050|NCT01234467|1132608|P1|Overall Study|Disease Progression|2
335051|NCT01234467|1132608|P1|Overall Study|Withdrawal by Subject|2
335052|NCT01234467|1132608|P1|Overall Study|Death|2
335053|NCT01234467|1132608|P1|Overall Study|Adverse Event|3
335054|NCT01234337|1132619|P2|Overall Study|Withdrawal by Subject|7
335055|NCT01234337|1132620|P1|Overall Study|Withdrawal by Subject|11
335056|NCT01234337|1132619|P2|Overall Study|Protocol Violation|3
335057|NCT01234337|1132620|P1|Overall Study|Protocol Violation|2
335058|NCT01234337|1132619|P2|Overall Study|Lost to Follow-up|1
335059|NCT01234337|1132620|P1|Overall Study|Lost to Follow-up|0
335060|NCT01234337|1132619|P2|Overall Study|Randomized but not Treated|4
335061|NCT01234337|1132620|P1|Overall Study|Randomized but not Treated|6
335062|NCT01234337|1132619|P2|Overall Study|Non-compliant with study medication|2
335063|NCT01234337|1132620|P1|Overall Study|Non-compliant with study medication|3
335064|NCT01234337|1132619|P2|Overall Study|InvestigatorDecision notProtocolDriven|3
335065|NCT01234337|1132620|P1|Overall Study|InvestigatorDecision notProtocolDriven|4
335066|NCT01234337|1132619|P2|Overall Study|Ongoing|24
335067|NCT01234337|1132620|P1|Overall Study|Ongoing|16
335068|NCT01234337|1132619|P2|Overall Study|Adverse Event|20
335069|NCT01234337|1132620|P1|Overall Study|Adverse Event|55
335070|NCT01233999|1132680|P1|Overall Study|Lost to Follow-up|1
335071|NCT01233999|1132680|P1|Overall Study|Withdrawal by Subject|1
335072|NCT01233869|1132699|P4|Extended Treatment Period (46 Months)|Adverse Event|1
335073|NCT01233869|1132700|P3|Extended Treatment Period (46 Months)|Adverse Event|0
335074|NCT01233869|1132701|P2|Extended Treatment Period (46 Months)|Adverse Event|0
335075|NCT01233869|1132702|P1|Extended Treatment Period (46 Months)|Adverse Event|1
335076|NCT01233869|1132699|P4|Extended Treatment Period (46 Months)|Other|3
335077|NCT01233869|1132700|P3|Extended Treatment Period (46 Months)|Other|0
335078|NCT01233869|1132701|P2|Extended Treatment Period (46 Months)|Other|0
335079|NCT01233869|1132702|P1|Extended Treatment Period (46 Months)|Other|3
335080|NCT01233869|1132699|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
335081|NCT01233869|1132700|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
335082|NCT01233869|1132701|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
335083|NCT01233869|1132702|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
335084|NCT01233869|1132699|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
335085|NCT01233869|1132700|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
335086|NCT01233869|1132701|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
335087|NCT01233869|1132702|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
335088|NCT01233869|1132699|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
335089|NCT01233869|1132700|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
335090|NCT01233869|1132701|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
335091|NCT01233869|1132702|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
335092|NCT01233869|1132699|P4|Initial Treatment Period (24 Months)|Adverse Event|3
335093|NCT01233869|1132700|P3|Initial Treatment Period (24 Months)|Adverse Event|0
335094|NCT01233869|1132701|P2|Initial Treatment Period (24 Months)|Adverse Event|17
335095|NCT01233869|1132702|P1|Initial Treatment Period (24 Months)|Adverse Event|9
335096|NCT01233869|1132699|P4|Initial Treatment Period (24 Months)|Death|0
335097|NCT01233869|1132700|P3|Initial Treatment Period (24 Months)|Death|0
335098|NCT01233869|1132701|P2|Initial Treatment Period (24 Months)|Death|0
335099|NCT01233869|1132702|P1|Initial Treatment Period (24 Months)|Death|1
335100|NCT01233817|1132788|P1|Overall Study|Withdrawal by Subject|2
335101|NCT01233817|1132788|P1|Overall Study|Lost to Follow-up|1
335102|NCT01233687|1132835|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
335103|NCT01233687|1132835|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
335104|NCT01233687|1132835|P1|Phase II AMG 102 + Erlotinib|Death|1
335105|NCT01233609|1132845|P2|Overall Study|Withdrawal by Subject|0
335106|NCT01233609|1132846|P1|Overall Study|Withdrawal by Subject|3
335107|NCT01233609|1132845|P2|Overall Study|Adverse Event|1
335108|NCT01233609|1132846|P1|Overall Study|Adverse Event|2
335109|NCT01233609|1132845|P2|Overall Study|Lost to Follow-up|1
335110|NCT01233609|1132846|P1|Overall Study|Lost to Follow-up|3
335111|NCT01233609|1132845|P2|Overall Study|Death|0
335112|NCT01233609|1132846|P1|Overall Study|Death|1
335113|NCT01233284|1132870|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
335114|NCT01233284|1132871|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
335115|NCT01233284|1132872|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
335116|NCT01233284|1132873|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
335117|NCT01233284|1132874|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
335118|NCT01233284|1132870|P5|Period 4 (4 Weeks)|Adverse Event|0
335119|NCT01233284|1132871|P4|Period 4 (4 Weeks)|Adverse Event|0
335120|NCT01233284|1132872|P3|Period 4 (4 Weeks)|Adverse Event|0
335121|NCT01233284|1132873|P2|Period 4 (4 Weeks)|Adverse Event|1
335122|NCT01233284|1132874|P1|Period 4 (4 Weeks)|Adverse Event|0
335123|NCT01233284|1132870|P5|Period 3 (4 Weeks)|Other|0
335124|NCT01233284|1132871|P4|Period 3 (4 Weeks)|Other|1
335125|NCT01233284|1132872|P3|Period 3 (4 Weeks)|Other|0
335126|NCT01233284|1132873|P2|Period 3 (4 Weeks)|Other|0
335127|NCT01233284|1132874|P1|Period 3 (4 Weeks)|Other|0
335128|NCT01233284|1132870|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
335129|NCT01233284|1132871|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
335130|NCT01233284|1132872|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
335131|NCT01233284|1132873|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
335132|NCT01233284|1132874|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
335133|NCT01233284|1132870|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
335134|NCT01233284|1132871|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
335135|NCT01233284|1132872|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
335136|NCT01233284|1132873|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
335137|NCT01233284|1132874|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
335138|NCT01233284|1132870|P5|Period 1 (4 Weeks)|Other|0
335139|NCT01233284|1132871|P4|Period 1 (4 Weeks)|Other|0
335140|NCT01233284|1132872|P3|Period 1 (4 Weeks)|Other|1
335141|NCT01233284|1132873|P2|Period 1 (4 Weeks)|Other|0
335142|NCT01233284|1132874|P1|Period 1 (4 Weeks)|Other|0
335143|NCT01233284|1132870|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
335144|NCT01233284|1132871|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
335145|NCT01233284|1132872|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
335146|NCT01233284|1132873|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
335147|NCT01233284|1132874|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
335148|NCT01233284|1132870|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
335149|NCT01233284|1132871|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
335150|NCT01233284|1132872|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
335151|NCT01233284|1132873|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
335152|NCT01233284|1132874|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
335153|NCT01233258|1132955|P6|First Intervention (6 Months)|Non-compliance with study medication|0
335154|NCT01233258|1132956|P5|First Intervention (6 Months)|Non-compliance with study medication|0
335155|NCT01233258|1132957|P4|First Intervention (6 Months)|Non-compliance with study medication|0
335156|NCT01233258|1132958|P3|First Intervention (6 Months)|Non-compliance with study medication|0
335157|NCT01233258|1132959|P2|First Intervention (6 Months)|Non-compliance with study medication|0
335158|NCT01233258|1132960|P1|First Intervention (6 Months)|Non-compliance with study medication|1
335159|NCT01233258|1132955|P6|First Intervention (6 Months)|Protocol Violation|0
335160|NCT01233258|1132956|P5|First Intervention (6 Months)|Protocol Violation|0
335161|NCT01233258|1132957|P4|First Intervention (6 Months)|Protocol Violation|0
335162|NCT01233258|1132958|P3|First Intervention (6 Months)|Protocol Violation|1
335163|NCT01233258|1132959|P2|First Intervention (6 Months)|Protocol Violation|0
335164|NCT01233258|1132960|P1|First Intervention (6 Months)|Protocol Violation|0
335165|NCT01233258|1132955|P6|First Intervention (6 Months)|Withdrawal by Subject|1
335166|NCT01233258|1132956|P5|First Intervention (6 Months)|Withdrawal by Subject|0
335167|NCT01233258|1132957|P4|First Intervention (6 Months)|Withdrawal by Subject|1
335168|NCT01233258|1132958|P3|First Intervention (6 Months)|Withdrawal by Subject|0
335169|NCT01233258|1132959|P2|First Intervention (6 Months)|Withdrawal by Subject|0
335170|NCT01233258|1132960|P1|First Intervention (6 Months)|Withdrawal by Subject|0
335171|NCT01233232|1132980|P3|Overall Study|Voluntary Discontinuation by Subject|0
335172|NCT01233232|1132981|P2|Overall Study|Voluntary Discontinuation by Subject|0
335173|NCT01233232|1132982|P1|Overall Study|Voluntary Discontinuation by Subject|1
335174|NCT01233076|1133035|P2|Period 2, One Week|Lost to Follow-up|0
335175|NCT01233076|1133036|P1|Period 2, One Week|Lost to Follow-up|1
335176|NCT01233050|1133044|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
335177|NCT01233050|1133045|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
335178|NCT01232894|1133078|P2|Overall Study|Physician Decision|1
335179|NCT01232894|1133079|P1|Overall Study|Physician Decision|2
335180|NCT01232894|1133078|P2|Overall Study|Withdrawal by Subject|5
335181|NCT01232894|1133079|P1|Overall Study|Withdrawal by Subject|8
335182|NCT01232894|1133078|P2|Overall Study|Protocol Violation|1
335183|NCT01232894|1133079|P1|Overall Study|Protocol Violation|1
335184|NCT01232894|1133078|P2|Overall Study|Death|0
335185|NCT01232894|1133079|P1|Overall Study|Death|1
335186|NCT01232894|1133078|P2|Overall Study|Lost to Follow-up|1
335187|NCT01232894|1133079|P1|Overall Study|Lost to Follow-up|0
335188|NCT01232868|1133087|P2|Overall Study|Lost to Follow-up|4
335189|NCT01232868|1133088|P1|Overall Study|Lost to Follow-up|2
335190|NCT01232790|1133102|P2|Second Crossover|Withdrawal by Subject|2
335191|NCT01232790|1133103|P1|Second Crossover|Withdrawal by Subject|1
335192|NCT01232790|1133102|P2|First Crossover|Withdrawal by Subject|0
335193|NCT01232790|1133103|P1|First Crossover|Withdrawal by Subject|1
335194|NCT01232790|1133102|P2|Initial Assessment|Withdrawal by Subject|1
335195|NCT01232790|1133103|P1|Initial Assessment|Withdrawal by Subject|0
335196|NCT01232790|1133102|P2|Randomization|Physician Decision|1
335197|NCT01232790|1133103|P1|Randomization|Physician Decision|0
335198|NCT01232790|1133102|P2|Randomization|Protocol Violation|1
335199|NCT01232790|1133103|P1|Randomization|Protocol Violation|0
335200|NCT01232790|1133102|P2|Randomization|Withdrawal by Subject|0
335201|NCT01232790|1133103|P1|Randomization|Withdrawal by Subject|2
335202|NCT01232738|1133157|P1|Overall Study|Adverse Event|5
335203|NCT01232738|1133157|P1|Overall Study|Withdrawal by Subject|2
335204|NCT01232738|1133157|P1|Overall Study|Lost to Follow-up|1
335205|NCT01232738|1133157|P1|Overall Study|Physician Decision|2
335206|NCT01232738|1133157|P1|Overall Study|Death|3
335207|NCT01232569|1133173|P4|Double-blind Treatment Period|Death|0
335208|NCT01232569|1133174|P3|Double-blind Treatment Period|Death|0
335209|NCT01232569|1133175|P2|Double-blind Treatment Period|Death|0
335210|NCT01232569|1133176|P1|Double-blind Treatment Period|Death|2
335211|NCT01232569|1133173|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
335212|NCT01232569|1133174|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
335213|NCT01232569|1133175|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
335214|NCT01232569|1133176|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
335215|NCT01232569|1133173|P4|Double-blind Treatment Period|Physician Decision|0
335216|NCT01232569|1133174|P3|Double-blind Treatment Period|Physician Decision|0
335217|NCT01232569|1133175|P2|Double-blind Treatment Period|Physician Decision|0
335218|NCT01232569|1133176|P1|Double-blind Treatment Period|Physician Decision|1
335219|NCT01232569|1133173|P4|Double-blind Treatment Period|Lack of Efficacy|0
335220|NCT01232569|1133174|P3|Double-blind Treatment Period|Lack of Efficacy|0
335221|NCT01232569|1133175|P2|Double-blind Treatment Period|Lack of Efficacy|2
335222|NCT01232569|1133176|P1|Double-blind Treatment Period|Lack of Efficacy|1
335223|NCT01232569|1133173|P4|Double-blind Treatment Period|Lost to Follow-up|0
335224|NCT01232569|1133174|P3|Double-blind Treatment Period|Lost to Follow-up|0
335225|NCT01232569|1133175|P2|Double-blind Treatment Period|Lost to Follow-up|0
335226|NCT01232569|1133176|P1|Double-blind Treatment Period|Lost to Follow-up|4
335227|NCT01232569|1133173|P4|Double-blind Treatment Period|Escape|0
335228|NCT01232569|1133174|P3|Double-blind Treatment Period|Escape|0
335229|NCT01232569|1133175|P2|Double-blind Treatment Period|Escape|2
335230|NCT01232569|1133176|P1|Double-blind Treatment Period|Escape|2
335231|NCT01232569|1133173|P4|Double-blind Treatment Period|Withdrawal by Subject|0
335232|NCT01232569|1133174|P3|Double-blind Treatment Period|Withdrawal by Subject|0
335233|NCT01232569|1133175|P2|Double-blind Treatment Period|Withdrawal by Subject|2
335234|NCT01232569|1133176|P1|Double-blind Treatment Period|Withdrawal by Subject|9
335235|NCT01232491|1133256|P2|Overall Study|Other|18
335236|NCT01232491|1133257|P1|Overall Study|Other|21
335237|NCT01232491|1133256|P2|Overall Study|Withdrawal Criteria|21
335238|NCT01232491|1133257|P1|Overall Study|Withdrawal Criteria|12
335239|NCT01232491|1133256|P2|Overall Study|Protocol Violation|11
335240|NCT01232491|1133257|P1|Overall Study|Protocol Violation|13
335241|NCT01232491|1133256|P2|Overall Study|Lack of Efficacy|5
335242|NCT01232491|1133257|P1|Overall Study|Lack of Efficacy|1
335243|NCT01232491|1133256|P2|Overall Study|Adverse Event|8
335244|NCT01232491|1133257|P1|Overall Study|Adverse Event|13
335245|NCT01232452|1133286|P2|Overall Study|Protocol Violation|1
335246|NCT01232452|1133287|P1|Overall Study|Protocol Violation|0
335247|NCT01232452|1133286|P2|Overall Study|Sponsor Decision|1
335248|NCT01232452|1133287|P1|Overall Study|Sponsor Decision|3
335249|NCT01232452|1133286|P2|Overall Study|Protocol entry criterion not met|2
335250|NCT01232452|1133287|P1|Overall Study|Protocol entry criterion not met|0
335251|NCT01232452|1133286|P2|Overall Study|Physician Decision|12
335252|NCT01232452|1133287|P1|Overall Study|Physician Decision|8
335253|NCT01232452|1133286|P2|Overall Study|Withdrawal by Subject|8
335254|NCT01232452|1133287|P1|Overall Study|Withdrawal by Subject|11
335255|NCT01232452|1133286|P2|Overall Study|Adverse Event|15
335256|NCT01232452|1133287|P1|Overall Study|Adverse Event|17
335257|NCT01232296|1133313|P2|Overall Study|Death|6
335258|NCT01232296|1133314|P1|Overall Study|Death|1
335259|NCT01232296|1133313|P2|Overall Study|Subject/guardian decision|2
335260|NCT01232296|1133314|P1|Overall Study|Subject/guardian decision|10
335261|NCT01232296|1133313|P2|Overall Study|Technical problems|0
335262|NCT01232296|1133314|P1|Overall Study|Technical problems|3
335263|NCT01232296|1133313|P2|Overall Study|Study terminated by sponsor|1
335264|NCT01232296|1133314|P1|Overall Study|Study terminated by sponsor|0
335265|NCT01232296|1133313|P2|Overall Study|Progressive disease|61
335266|NCT01232296|1133314|P1|Overall Study|Progressive disease|43
335267|NCT01232296|1133313|P2|Overall Study|Physician Decision|1
335268|NCT01232296|1133314|P1|Overall Study|Physician Decision|1
335269|NCT01232296|1133313|P2|Overall Study|Adverse Event|12
335270|NCT01232296|1133314|P1|Overall Study|Adverse Event|24
335271|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
335272|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
335273|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335274|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335275|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335276|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335277|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335278|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335279|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335280|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
335281|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335282|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
335283|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335284|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335285|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335286|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335287|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335288|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335289|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335290|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
335291|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
335292|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
335293|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
335294|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
335295|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
335296|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
335297|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
335298|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
335299|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
335300|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
335301|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
335302|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
335303|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335304|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335305|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335306|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335307|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335308|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335309|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335310|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
335311|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
335312|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
335313|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335314|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335315|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335316|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335317|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335318|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335319|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335320|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
335321|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
335322|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
335622|NCT01231607|1133591|P1|Overall Study|Protocol Violation|3
335323|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335324|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335325|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335326|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335327|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335328|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335329|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335330|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
335331|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
335332|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
335333|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335334|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335335|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335336|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335337|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335338|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335339|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335340|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
335341|NCT01232283|1133331|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
335342|NCT01232283|1133332|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
335343|NCT01232283|1133333|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335344|NCT01232283|1133334|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335345|NCT01232283|1133335|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335346|NCT01232283|1133336|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335347|NCT01232283|1133337|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335348|NCT01232283|1133338|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335349|NCT01232283|1133339|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335350|NCT01232283|1133340|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
335351|NCT01232283|1133331|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335352|NCT01232283|1133332|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335353|NCT01232283|1133333|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335354|NCT01232283|1133334|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335355|NCT01232283|1133335|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
335356|NCT01232283|1133336|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335357|NCT01232283|1133337|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335358|NCT01232283|1133338|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335359|NCT01232283|1133339|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335360|NCT01232283|1133340|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
335361|NCT01232283|1133331|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335362|NCT01232283|1133332|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335363|NCT01232283|1133333|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
335364|NCT01232283|1133334|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335365|NCT01232283|1133335|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335366|NCT01232283|1133336|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335367|NCT01232283|1133337|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335368|NCT01232283|1133338|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335369|NCT01232283|1133339|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335370|NCT01232283|1133340|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
335371|NCT01232283|1133331|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
335372|NCT01232283|1133332|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
335373|NCT01232283|1133333|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
335374|NCT01232283|1133334|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
335375|NCT01232283|1133335|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
335376|NCT01232283|1133336|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
335377|NCT01232283|1133337|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
335378|NCT01232283|1133338|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
335379|NCT01232283|1133339|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
335380|NCT01232283|1133340|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
335381|NCT01232283|1133331|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335382|NCT01232283|1133332|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335383|NCT01232283|1133333|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335384|NCT01232283|1133334|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335385|NCT01232283|1133335|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335386|NCT01232283|1133336|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
335387|NCT01232283|1133337|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335388|NCT01232283|1133338|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335389|NCT01232283|1133339|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335390|NCT01232283|1133340|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
335391|NCT01232283|1133331|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
335392|NCT01232283|1133332|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
335393|NCT01232283|1133333|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
335394|NCT01232283|1133334|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
335395|NCT01232283|1133335|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
335396|NCT01232283|1133336|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
335397|NCT01232283|1133337|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
335398|NCT01232283|1133338|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
335399|NCT01232283|1133339|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
335400|NCT01232283|1133340|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
335401|NCT01232283|1133331|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
335402|NCT01232283|1133332|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
335403|NCT01232283|1133333|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
335404|NCT01232283|1133334|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
335405|NCT01232283|1133335|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
335406|NCT01232283|1133336|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
335407|NCT01232283|1133337|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
335408|NCT01232283|1133338|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
335409|NCT01232283|1133339|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
335410|NCT01232283|1133340|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
335411|NCT01232283|1133331|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
335412|NCT01232283|1133332|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
335413|NCT01232283|1133333|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
335414|NCT01232283|1133334|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
335415|NCT01232283|1133335|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
335416|NCT01232283|1133336|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
335417|NCT01232283|1133337|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
335418|NCT01232283|1133338|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
335419|NCT01232283|1133339|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
335420|NCT01232283|1133340|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
335421|NCT01232283|1133331|P10|Maintenance Phase (Weeks16-32)|Other|0
335422|NCT01232283|1133332|P9|Maintenance Phase (Weeks16-32)|Other|0
335423|NCT01232283|1133333|P8|Maintenance Phase (Weeks16-32)|Other|0
335424|NCT01232283|1133334|P7|Maintenance Phase (Weeks16-32)|Other|0
335425|NCT01232283|1133335|P6|Maintenance Phase (Weeks16-32)|Other|0
335426|NCT01232283|1133336|P5|Maintenance Phase (Weeks16-32)|Other|0
335427|NCT01232283|1133337|P4|Maintenance Phase (Weeks16-32)|Other|0
335428|NCT01232283|1133338|P3|Maintenance Phase (Weeks16-32)|Other|2
335429|NCT01232283|1133339|P2|Maintenance Phase (Weeks16-32)|Other|0
335430|NCT01232283|1133340|P1|Maintenance Phase (Weeks16-32)|Other|0
335431|NCT01232283|1133331|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335432|NCT01232283|1133332|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335433|NCT01232283|1133333|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335434|NCT01232283|1133334|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335435|NCT01232283|1133335|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335436|NCT01232283|1133336|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335437|NCT01232283|1133337|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
335438|NCT01232283|1133338|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
335439|NCT01232283|1133339|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335440|NCT01232283|1133340|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
335441|NCT01232283|1133331|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335442|NCT01232283|1133332|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335443|NCT01232283|1133333|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335444|NCT01232283|1133334|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335445|NCT01232283|1133335|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335446|NCT01232283|1133336|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335447|NCT01232283|1133337|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
335448|NCT01232283|1133338|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
335449|NCT01232283|1133339|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335450|NCT01232283|1133340|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
335451|NCT01232283|1133331|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335452|NCT01232283|1133332|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335453|NCT01232283|1133333|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335454|NCT01232283|1133334|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335455|NCT01232283|1133335|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335456|NCT01232283|1133336|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335457|NCT01232283|1133337|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335458|NCT01232283|1133338|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
335459|NCT01232283|1133339|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335460|NCT01232283|1133340|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
335461|NCT01232283|1133331|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335462|NCT01232283|1133332|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335463|NCT01232283|1133333|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335464|NCT01232283|1133334|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335465|NCT01232283|1133335|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335623|NCT01231607|1133587|P5|Overall Study|Physician Decision|4
335466|NCT01232283|1133336|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335467|NCT01232283|1133337|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
335468|NCT01232283|1133338|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
335469|NCT01232283|1133339|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335470|NCT01232283|1133340|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
335471|NCT01232283|1133331|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
335472|NCT01232283|1133332|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
335473|NCT01232283|1133333|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
335474|NCT01232283|1133334|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
335475|NCT01232283|1133335|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
335476|NCT01232283|1133336|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
335477|NCT01232283|1133337|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
335478|NCT01232283|1133338|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
335479|NCT01232283|1133339|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
335480|NCT01232283|1133340|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
335481|NCT01232283|1133331|P10|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335482|NCT01232283|1133332|P9|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335483|NCT01232283|1133333|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335484|NCT01232283|1133334|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335485|NCT01232283|1133335|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335486|NCT01232283|1133336|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335487|NCT01232283|1133337|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335488|NCT01232283|1133338|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
335489|NCT01232283|1133339|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
335490|NCT01232283|1133340|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
335491|NCT01232283|1133331|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335492|NCT01232283|1133332|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335493|NCT01232283|1133333|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335494|NCT01232283|1133334|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335495|NCT01232283|1133335|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335496|NCT01232283|1133336|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335497|NCT01232283|1133337|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335498|NCT01232283|1133338|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
335499|NCT01232283|1133339|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
335500|NCT01232283|1133340|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
335501|NCT01232283|1133331|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335502|NCT01232283|1133332|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335503|NCT01232283|1133333|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335504|NCT01232283|1133334|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335505|NCT01232283|1133335|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335506|NCT01232283|1133336|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335507|NCT01232283|1133337|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335508|NCT01232283|1133338|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
335509|NCT01232283|1133339|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
335510|NCT01232283|1133340|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
335511|NCT01232283|1133331|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335512|NCT01232283|1133332|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335513|NCT01232283|1133333|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335514|NCT01232283|1133334|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335515|NCT01232283|1133335|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335516|NCT01232283|1133336|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335517|NCT01232283|1133337|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335518|NCT01232283|1133338|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
335519|NCT01232283|1133339|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
335520|NCT01232283|1133340|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
335521|NCT01232283|1133331|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335522|NCT01232283|1133332|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335523|NCT01232283|1133333|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335524|NCT01232283|1133334|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335525|NCT01232283|1133335|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335526|NCT01232283|1133336|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335527|NCT01232283|1133337|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335528|NCT01232283|1133338|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335529|NCT01232283|1133339|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
335530|NCT01232283|1133340|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
335531|NCT01232283|1133331|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335532|NCT01232283|1133332|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335533|NCT01232283|1133333|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335534|NCT01232283|1133334|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335535|NCT01232283|1133335|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335536|NCT01232283|1133336|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335537|NCT01232283|1133337|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335538|NCT01232283|1133338|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
335539|NCT01232283|1133339|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
335540|NCT01232283|1133340|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
335541|NCT01232283|1133331|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335542|NCT01232283|1133332|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335543|NCT01232283|1133333|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335544|NCT01232283|1133334|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335545|NCT01232283|1133335|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335546|NCT01232283|1133336|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335547|NCT01232283|1133337|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335548|NCT01232283|1133338|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
335549|NCT01232283|1133339|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
335550|NCT01232283|1133340|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
335551|NCT01232127|1133381|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
335552|NCT01232127|1133382|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
335553|NCT01232127|1133383|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
335554|NCT01231984|1133407|P4|Study Period 2|Did not continue to meet I/E Criteria|1
335555|NCT01231984|1133408|P3|Study Period 2|Did not continue to meet I/E Criteria|0
335556|NCT01231984|1133409|P2|Study Period 2|Did not continue to meet I/E Criteria|1
335557|NCT01231984|1133410|P1|Study Period 2|Did not continue to meet I/E Criteria|1
335558|NCT01231984|1133407|P4|Study Period 2|Lost to Follow-up|3
335559|NCT01231984|1133408|P3|Study Period 2|Lost to Follow-up|0
335560|NCT01231984|1133409|P2|Study Period 2|Lost to Follow-up|0
335561|NCT01231984|1133410|P1|Study Period 2|Lost to Follow-up|1
335562|NCT01231984|1133407|P4|Study Period 2|Withdrawal by Subject|0
335563|NCT01231984|1133408|P3|Study Period 2|Withdrawal by Subject|0
335564|NCT01231984|1133409|P2|Study Period 2|Withdrawal by Subject|1
335565|NCT01231984|1133410|P1|Study Period 2|Withdrawal by Subject|1
335566|NCT01231984|1133407|P4|Study Period 1|Not Specified|1
335567|NCT01231984|1133408|P3|Study Period 1|Not Specified|0
335568|NCT01231984|1133409|P2|Study Period 1|Not Specified|0
335569|NCT01231984|1133410|P1|Study Period 1|Not Specified|0
335570|NCT01231984|1133407|P4|Study Period 1|Adverse Event|0
335571|NCT01231984|1133408|P3|Study Period 1|Adverse Event|0
335572|NCT01231984|1133409|P2|Study Period 1|Adverse Event|0
335573|NCT01231984|1133410|P1|Study Period 1|Adverse Event|1
335574|NCT01231984|1133407|P4|Study Period 1|Protocol Violation|3
335575|NCT01231984|1133408|P3|Study Period 1|Protocol Violation|2
335576|NCT01231984|1133409|P2|Study Period 1|Protocol Violation|4
335577|NCT01231984|1133410|P1|Study Period 1|Protocol Violation|3
335578|NCT01231984|1133407|P4|Study Period 1|Non-compliance with study requirements|1
335579|NCT01231984|1133408|P3|Study Period 1|Non-compliance with study requirements|2
335580|NCT01231984|1133409|P2|Study Period 1|Non-compliance with study requirements|0
335581|NCT01231984|1133410|P1|Study Period 1|Non-compliance with study requirements|5
335582|NCT01231984|1133407|P4|Study Period 1|Screen Failure|1
335583|NCT01231984|1133408|P3|Study Period 1|Screen Failure|0
335584|NCT01231984|1133409|P2|Study Period 1|Screen Failure|0
335585|NCT01231984|1133410|P1|Study Period 1|Screen Failure|0
335586|NCT01231984|1133407|P4|Study Period 1|Did not continue to meet I/E Criteria|2
335587|NCT01231984|1133408|P3|Study Period 1|Did not continue to meet I/E Criteria|2
335588|NCT01231984|1133409|P2|Study Period 1|Did not continue to meet I/E Criteria|2
335589|NCT01231984|1133410|P1|Study Period 1|Did not continue to meet I/E Criteria|2
335590|NCT01231984|1133407|P4|Study Period 1|Lost to Follow-up|0
335591|NCT01231984|1133408|P3|Study Period 1|Lost to Follow-up|1
335592|NCT01231984|1133409|P2|Study Period 1|Lost to Follow-up|1
335593|NCT01231984|1133410|P1|Study Period 1|Lost to Follow-up|1
335594|NCT01231984|1133407|P4|Study Period 1|Withdrawal by Subject|1
335595|NCT01231984|1133408|P3|Study Period 1|Withdrawal by Subject|0
335596|NCT01231984|1133409|P2|Study Period 1|Withdrawal by Subject|0
335597|NCT01231984|1133410|P1|Study Period 1|Withdrawal by Subject|0
335598|NCT01231620|1133479|P3|Overall Study|Lost to Follow-up|9
335599|NCT01231620|1133480|P2|Overall Study|Lost to Follow-up|4
335600|NCT01231620|1133481|P1|Overall Study|Lost to Follow-up|3
335601|NCT01231620|1133479|P3|Overall Study|Withdrawal by Subject|8
335602|NCT01231620|1133480|P2|Overall Study|Withdrawal by Subject|6
335603|NCT01231620|1133481|P1|Overall Study|Withdrawal by Subject|6
335604|NCT01231620|1133479|P3|Overall Study|Adverse Event|1
335605|NCT01231620|1133480|P2|Overall Study|Adverse Event|2
335606|NCT01231620|1133481|P1|Overall Study|Adverse Event|2
335607|NCT01231620|1133479|P3|Overall Study|Death|11
335608|NCT01231620|1133480|P2|Overall Study|Death|14
335609|NCT01231620|1133481|P1|Overall Study|Death|12
335610|NCT01231620|1133479|P3|Overall Study|Physician Decision|10
335611|NCT01231620|1133480|P2|Overall Study|Physician Decision|5
335612|NCT01231620|1133481|P1|Overall Study|Physician Decision|3
335613|NCT01231607|1133587|P5|Overall Study|Withdrawal by Subject|9
335614|NCT01231607|1133588|P4|Overall Study|Withdrawal by Subject|17
335615|NCT01231607|1133589|P3|Overall Study|Withdrawal by Subject|14
335616|NCT01231607|1133590|P2|Overall Study|Withdrawal by Subject|9
335617|NCT01231607|1133591|P1|Overall Study|Withdrawal by Subject|9
335618|NCT01231607|1133587|P5|Overall Study|Protocol Violation|2
335619|NCT01231607|1133588|P4|Overall Study|Protocol Violation|2
335620|NCT01231607|1133589|P3|Overall Study|Protocol Violation|0
335621|NCT01231607|1133590|P2|Overall Study|Protocol Violation|2
335624|NCT01231607|1133588|P4|Overall Study|Physician Decision|5
335625|NCT01231607|1133589|P3|Overall Study|Physician Decision|3
335626|NCT01231607|1133590|P2|Overall Study|Physician Decision|4
335627|NCT01231607|1133591|P1|Overall Study|Physician Decision|4
335628|NCT01231607|1133587|P5|Overall Study|Lost to Follow-up|4
335629|NCT01231607|1133588|P4|Overall Study|Lost to Follow-up|10
335630|NCT01231607|1133589|P3|Overall Study|Lost to Follow-up|10
335631|NCT01231607|1133590|P2|Overall Study|Lost to Follow-up|11
335632|NCT01231607|1133591|P1|Overall Study|Lost to Follow-up|13
335633|NCT01231607|1133587|P5|Overall Study|Adverse Event|5
335634|NCT01231607|1133588|P4|Overall Study|Adverse Event|4
335635|NCT01231607|1133589|P3|Overall Study|Adverse Event|4
335636|NCT01231607|1133590|P2|Overall Study|Adverse Event|8
335637|NCT01231607|1133591|P1|Overall Study|Adverse Event|0
335638|NCT01231581|1133683|P2|Overall Study|Ongoing|0
335639|NCT01231581|1133684|P1|Overall Study|Ongoing|1
335640|NCT01231581|1133683|P2|Overall Study|Death|64
335641|NCT01231581|1133684|P1|Overall Study|Death|65
335642|NCT01231581|1133683|P2|Overall Study|Study Closed/Terminated|5
335643|NCT01231581|1133684|P1|Overall Study|Study Closed/Terminated|6
335644|NCT01231581|1133683|P2|Overall Study|Withdrawal by Subject|9
335645|NCT01231581|1133684|P1|Overall Study|Withdrawal by Subject|6
335646|NCT01231581|1133683|P2|Overall Study|Lost to Follow-up|2
335647|NCT01231581|1133684|P1|Overall Study|Lost to Follow-up|2
335648|NCT01231555|1133705|P3|Overall Study|Withdrawal by Subject|0
335649|NCT01231555|1133706|P2|Overall Study|Withdrawal by Subject|2
335650|NCT01231555|1133707|P1|Overall Study|Withdrawal by Subject|0
335651|NCT01231555|1133705|P3|Overall Study|Study terminated|8
335652|NCT01231555|1133706|P2|Overall Study|Study terminated|5
335653|NCT01231555|1133707|P1|Overall Study|Study terminated|8
335654|NCT01231516|1133738|P2|Open-label Phase|Ongoing at the time of analysis|23
335655|NCT01231516|1133739|P1|Open-label Phase|Ongoing at the time of analysis|282
335656|NCT01231516|1133738|P2|Open-label Phase|Withdrawal by Subject|0
335657|NCT01231516|1133739|P1|Open-label Phase|Withdrawal by Subject|1
335658|NCT01231516|1133738|P2|Open-label Phase|Lost to Follow-up|0
335659|NCT01231516|1133739|P1|Open-label Phase|Lost to Follow-up|3
335660|NCT01231516|1133738|P2|Open-label Phase|Protocol Violation|0
335661|NCT01231516|1133739|P1|Open-label Phase|Protocol Violation|2
335662|NCT01231516|1133738|P2|Open-label Phase|Lack of Efficacy|3
335663|NCT01231516|1133739|P1|Open-label Phase|Lack of Efficacy|7
335664|NCT01231516|1133738|P2|48 Week Double-blind Phase|Site Closed|1
335665|NCT01231516|1133739|P1|48 Week Double-blind Phase|Site Closed|3
335666|NCT01231516|1133738|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
335667|NCT01231516|1133739|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
335668|NCT01231516|1133738|P2|48 Week Double-blind Phase|Physician Decision|1
335669|NCT01231516|1133739|P1|48 Week Double-blind Phase|Physician Decision|1
335670|NCT01231516|1133738|P2|48 Week Double-blind Phase|Lost to Follow-up|10
335671|NCT01231516|1133739|P1|48 Week Double-blind Phase|Lost to Follow-up|5
335672|NCT01231516|1133738|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
335673|NCT01231516|1133739|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
335674|NCT01231516|1133738|P2|48 Week Double-blind Phase|Protocol Violation|6
335675|NCT01231516|1133739|P1|48 Week Double-blind Phase|Protocol Violation|9
335676|NCT01231516|1133738|P2|48 Week Double-blind Phase|Lack of Efficacy|42
335677|NCT01231516|1133739|P1|48 Week Double-blind Phase|Lack of Efficacy|20
335678|NCT01231516|1133738|P2|48 Week Double-blind Phase|Adverse Event|11
335679|NCT01231516|1133739|P1|48 Week Double-blind Phase|Adverse Event|4
335680|NCT01231503|1133769|P8|Overall Study|Protocol Violation|0
335681|NCT01231503|1133770|P7|Overall Study|Protocol Violation|0
335682|NCT01231503|1133771|P6|Overall Study|Protocol Violation|0
335683|NCT01231503|1133772|P5|Overall Study|Protocol Violation|0
335684|NCT01231503|1133773|P4|Overall Study|Protocol Violation|1
335685|NCT01231503|1133774|P3|Overall Study|Protocol Violation|0
335686|NCT01231503|1133775|P2|Overall Study|Protocol Violation|0
335687|NCT01231503|1133776|P1|Overall Study|Protocol Violation|0
335688|NCT01231503|1133769|P8|Overall Study|Lost to Follow-up|6
335689|NCT01231503|1133770|P7|Overall Study|Lost to Follow-up|6
335690|NCT01231503|1133771|P6|Overall Study|Lost to Follow-up|9
335691|NCT01231503|1133772|P5|Overall Study|Lost to Follow-up|7
335692|NCT01231503|1133773|P4|Overall Study|Lost to Follow-up|5
335693|NCT01231503|1133774|P3|Overall Study|Lost to Follow-up|8
335694|NCT01231503|1133775|P2|Overall Study|Lost to Follow-up|10
335695|NCT01231503|1133776|P1|Overall Study|Lost to Follow-up|8
335696|NCT01231503|1133769|P8|Overall Study|Withdrawal by Subject|2
335697|NCT01231503|1133770|P7|Overall Study|Withdrawal by Subject|1
335698|NCT01231503|1133771|P6|Overall Study|Withdrawal by Subject|5
335699|NCT01231503|1133772|P5|Overall Study|Withdrawal by Subject|3
335700|NCT01231503|1133773|P4|Overall Study|Withdrawal by Subject|1
335701|NCT01231503|1133774|P3|Overall Study|Withdrawal by Subject|3
335702|NCT01231503|1133775|P2|Overall Study|Withdrawal by Subject|3
335703|NCT01231503|1133776|P1|Overall Study|Withdrawal by Subject|6
335704|NCT01231503|1133769|P8|Overall Study|Adverse event, serious fatal|0
335705|NCT01231503|1133770|P7|Overall Study|Adverse event, serious fatal|0
335706|NCT01231503|1133771|P6|Overall Study|Adverse event, serious fatal|1
335707|NCT01231503|1133772|P5|Overall Study|Adverse event, serious fatal|0
335708|NCT01231503|1133773|P4|Overall Study|Adverse event, serious fatal|1
335709|NCT01231503|1133774|P3|Overall Study|Adverse event, serious fatal|1
335710|NCT01231503|1133775|P2|Overall Study|Adverse event, serious fatal|0
335711|NCT01231503|1133776|P1|Overall Study|Adverse event, serious fatal|0
335712|NCT01231503|1133769|P8|Overall Study|Adverse Event|0
335713|NCT01231503|1133770|P7|Overall Study|Adverse Event|0
335714|NCT01231503|1133771|P6|Overall Study|Adverse Event|1
335715|NCT01231503|1133772|P5|Overall Study|Adverse Event|0
335716|NCT01231503|1133773|P4|Overall Study|Adverse Event|0
335717|NCT01231503|1133774|P3|Overall Study|Adverse Event|0
335718|NCT01231503|1133775|P2|Overall Study|Adverse Event|0
335719|NCT01231503|1133776|P1|Overall Study|Adverse Event|0
335720|NCT01231464|1134000|P2|Overall Study|Withdrawal by Subject|2
335721|NCT01231464|1134001|P1|Overall Study|Withdrawal by Subject|3
335722|NCT01231464|1134000|P2|Overall Study|Lost to Follow-up|2
335723|NCT01231464|1134001|P1|Overall Study|Lost to Follow-up|1
335724|NCT01231464|1134000|P2|Overall Study|Protocol Violation|2
335725|NCT01231464|1134001|P1|Overall Study|Protocol Violation|1
335726|NCT01231464|1134000|P2|Overall Study|Adverse Event|1
335727|NCT01231464|1134001|P1|Overall Study|Adverse Event|0
335728|NCT01231373|1134050|P4|Overall Study|Withdrew Consent|0
335729|NCT01231373|1134051|P3|Overall Study|Withdrew Consent|0
335730|NCT01231373|1134052|P2|Overall Study|Withdrew Consent|0
335731|NCT01231373|1134053|P1|Overall Study|Withdrew Consent|1
335732|NCT01231373|1134050|P4|Overall Study|Lost to Follow-up|1
335733|NCT01231373|1134051|P3|Overall Study|Lost to Follow-up|0
335734|NCT01231373|1134052|P2|Overall Study|Lost to Follow-up|0
335735|NCT01231373|1134053|P1|Overall Study|Lost to Follow-up|0
335736|NCT01231373|1134050|P4|Overall Study|Withdrew consent prior to randomization|0
335737|NCT01231373|1134051|P3|Overall Study|Withdrew consent prior to randomization|0
335738|NCT01231373|1134052|P2|Overall Study|Withdrew consent prior to randomization|1
335739|NCT01231373|1134053|P1|Overall Study|Withdrew consent prior to randomization|2
335740|NCT01231321|1134092|P1|Overall Study|Lack of Efficacy|2
335741|NCT01231321|1134092|P1|Overall Study|Adverse Event|3
335742|NCT01230892|1134115|P2|Overall Study|Lost to Follow-up|0
335743|NCT01230892|1134116|P1|Overall Study|Lost to Follow-up|2
335744|NCT01230892|1134115|P2|Overall Study|Withdrawal by Subject|1
335745|NCT01230892|1134116|P1|Overall Study|Withdrawal by Subject|1
335746|NCT01230827|1134126|P4|Overall Study|Study terminated by Sponsor|63
335747|NCT01230827|1134127|P3|Overall Study|Study terminated by Sponsor|56
335748|NCT01230827|1134128|P2|Overall Study|Study terminated by Sponsor|2
335749|NCT01230827|1134129|P1|Overall Study|Study terminated by Sponsor|0
335750|NCT01230827|1134126|P4|Overall Study|Recovery|0
335751|NCT01230827|1134127|P3|Overall Study|Recovery|0
335752|NCT01230827|1134128|P2|Overall Study|Recovery|6
335753|NCT01230827|1134129|P1|Overall Study|Recovery|0
335754|NCT01230827|1134126|P4|Overall Study|Adverse Event|7
335755|NCT01230827|1134127|P3|Overall Study|Adverse Event|3
335756|NCT01230827|1134128|P2|Overall Study|Adverse Event|2
335757|NCT01230827|1134129|P1|Overall Study|Adverse Event|4
335758|NCT01230827|1134126|P4|Overall Study|Lack of Efficacy|3
335759|NCT01230827|1134127|P3|Overall Study|Lack of Efficacy|2
335760|NCT01230827|1134128|P2|Overall Study|Lack of Efficacy|1
335761|NCT01230827|1134129|P1|Overall Study|Lack of Efficacy|14
335762|NCT01230827|1134126|P4|Overall Study|Withdrawal by Subject|2
335763|NCT01230827|1134127|P3|Overall Study|Withdrawal by Subject|3
335764|NCT01230827|1134128|P2|Overall Study|Withdrawal by Subject|0
335765|NCT01230827|1134129|P1|Overall Study|Withdrawal by Subject|1
335766|NCT01230827|1134126|P4|Overall Study|Lost to Follow-up|3
335767|NCT01230827|1134127|P3|Overall Study|Lost to Follow-up|1
335768|NCT01230827|1134128|P2|Overall Study|Lost to Follow-up|0
335769|NCT01230827|1134129|P1|Overall Study|Lost to Follow-up|0
335770|NCT01230814|1134145|P2|Overall Study|Discontinued (not due to adverse event)|1
335771|NCT01230814|1134146|P1|Overall Study|Discontinued (not due to adverse event)|2
335772|NCT01230814|1134145|P2|Overall Study|Lost to Follow-up|3
335773|NCT01230814|1134146|P1|Overall Study|Lost to Follow-up|11
335774|NCT01230788|1134196|P1|Overall Study|Prescribed exclusion drug|1
335775|NCT01230749|1134208|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
335776|NCT01230749|1134209|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
335777|NCT01230749|1134210|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
335778|NCT01230749|1134211|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
335779|NCT01230749|1134208|P4|Overall Study|Withdrawal by Subject|0
335780|NCT01230749|1134209|P3|Overall Study|Withdrawal by Subject|0
335781|NCT01230749|1134210|P2|Overall Study|Withdrawal by Subject|1
335782|NCT01230749|1134211|P1|Overall Study|Withdrawal by Subject|0
335783|NCT01230749|1134208|P4|Overall Study|Physician Decision|0
335784|NCT01230749|1134209|P3|Overall Study|Physician Decision|1
335785|NCT01230749|1134210|P2|Overall Study|Physician Decision|0
335786|NCT01230749|1134211|P1|Overall Study|Physician Decision|0
335787|NCT01230749|1134208|P4|Overall Study|Adverse Event|1
335788|NCT01230749|1134209|P3|Overall Study|Adverse Event|0
335789|NCT01230749|1134210|P2|Overall Study|Adverse Event|0
335790|NCT01230749|1134211|P1|Overall Study|Adverse Event|0
335791|NCT01230710|1134246|P1|Overall Study|Withdrawal of Consent|1
335792|NCT01230710|1134246|P1|Overall Study|Death|4
335793|NCT01230710|1134246|P1|Overall Study|Lost to Follow-up|3
335794|NCT01230710|1134246|P1|Overall Study|Disease Progression|41
335795|NCT01230307|1134317|P2|Overall Study|LVAD Placement|2
335796|NCT01230307|1134318|P1|Overall Study|LVAD Placement|0
335797|NCT01230060|1134338|P1|Overall Study|Withdrawal by Subject|1
335798|NCT01229735|1134411|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
335799|NCT01229735|1134412|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
335800|NCT01229735|1134411|P2|Overall Study|AE, non-serious non-fatal|17
335801|NCT01229735|1134412|P1|Overall Study|AE, non-serious non-fatal|13
335802|NCT01229735|1134411|P2|Overall Study|SAE, non-fatal|4
335803|NCT01229735|1134412|P1|Overall Study|SAE, non-fatal|0
335804|NCT01229735|1134411|P2|Overall Study|Other Reason|10
335805|NCT01229735|1134412|P1|Overall Study|Other Reason|13
335806|NCT01229735|1134411|P2|Overall Study|Withdrawal by Subject|17
335807|NCT01229735|1134412|P1|Overall Study|Withdrawal by Subject|18
335808|NCT01229735|1134411|P2|Overall Study|Lost to Follow-up|2
335809|NCT01229735|1134412|P1|Overall Study|Lost to Follow-up|0
335810|NCT01229735|1134411|P2|Overall Study|Protocol Violation|8
335811|NCT01229735|1134412|P1|Overall Study|Protocol Violation|13
335812|NCT01229735|1134411|P2|Overall Study|Lack of Efficacy|8
335813|NCT01229735|1134412|P1|Overall Study|Lack of Efficacy|8
335814|NCT01229436|1134460|P1|Overall Study|Lost to Follow-up|3
335815|NCT01229436|1134460|P1|Overall Study|Withdrawal by Subject|2
335816|NCT01229397|1134522|P2|Overall Study|Migrated/moved from study area|0
335817|NCT01229397|1134523|P1|Overall Study|Migrated/moved from study area|1
335818|NCT01229397|1134522|P2|Overall Study|Lost to Follow-up|6
335819|NCT01229397|1134523|P1|Overall Study|Lost to Follow-up|7
335820|NCT01229397|1134522|P2|Overall Study|Withdrawal by Subject|3
335821|NCT01229397|1134523|P1|Overall Study|Withdrawal by Subject|3
335822|NCT01229371|1134541|P4|Overall Study|Withdrawal by Subject|0
335823|NCT01229371|1134542|P3|Overall Study|Withdrawal by Subject|0
335824|NCT01229371|1134543|P2|Overall Study|Withdrawal by Subject|1
335825|NCT01229371|1134544|P1|Overall Study|Withdrawal by Subject|0
335826|NCT01229254|1134569|P3|Overall Study|Non-compliance with Study Drug|1
335827|NCT01229254|1134570|P2|Overall Study|Non-compliance with Study Drug|1
335828|NCT01229254|1134571|P1|Overall Study|Non-compliance with Study Drug|0
335829|NCT01229254|1134569|P3|Overall Study|Withdrawal by Subject|1
335830|NCT01229254|1134570|P2|Overall Study|Withdrawal by Subject|0
335831|NCT01229254|1134571|P1|Overall Study|Withdrawal by Subject|1
335832|NCT01229254|1134569|P3|Overall Study|Protocol Violation|5
335833|NCT01229254|1134570|P2|Overall Study|Protocol Violation|6
335834|NCT01229254|1134571|P1|Overall Study|Protocol Violation|4
335835|NCT01229254|1134569|P3|Overall Study|Physician Decision|0
335836|NCT01229254|1134570|P2|Overall Study|Physician Decision|3
335837|NCT01229254|1134571|P1|Overall Study|Physician Decision|0
335838|NCT01229254|1134569|P3|Overall Study|Lost to Follow-up|1
335839|NCT01229254|1134570|P2|Overall Study|Lost to Follow-up|0
335840|NCT01229254|1134571|P1|Overall Study|Lost to Follow-up|3
335841|NCT01229254|1134569|P3|Overall Study|Adverse Event|3
335842|NCT01229254|1134570|P2|Overall Study|Adverse Event|5
335843|NCT01229254|1134571|P1|Overall Study|Adverse Event|4
335844|NCT01229254|1134569|P3|Overall Study|Not Continuing Into Safety Extension|1
335845|NCT01229254|1134570|P2|Overall Study|Not Continuing Into Safety Extension|1
335846|NCT01229254|1134571|P1|Overall Study|Not Continuing Into Safety Extension|3
335847|NCT01229176|1134609|P8|Overall Study|Lost to Follow-up|2
335848|NCT01229176|1134610|P7|Overall Study|Lost to Follow-up|0
335849|NCT01229176|1134611|P6|Overall Study|Lost to Follow-up|1
335850|NCT01229176|1134612|P5|Overall Study|Lost to Follow-up|1
335851|NCT01229176|1134613|P4|Overall Study|Lost to Follow-up|0
335852|NCT01229176|1134614|P3|Overall Study|Lost to Follow-up|0
335853|NCT01229176|1134615|P2|Overall Study|Lost to Follow-up|3
335854|NCT01229176|1134616|P1|Overall Study|Lost to Follow-up|0
335855|NCT01229176|1134609|P8|Overall Study|Withdrawal by Subject|1
335856|NCT01229176|1134610|P7|Overall Study|Withdrawal by Subject|0
335857|NCT01229176|1134611|P6|Overall Study|Withdrawal by Subject|1
335858|NCT01229176|1134612|P5|Overall Study|Withdrawal by Subject|1
335859|NCT01229176|1134613|P4|Overall Study|Withdrawal by Subject|1
335860|NCT01229176|1134614|P3|Overall Study|Withdrawal by Subject|0
335861|NCT01229176|1134615|P2|Overall Study|Withdrawal by Subject|0
335862|NCT01229176|1134616|P1|Overall Study|Withdrawal by Subject|0
335863|NCT01229150|1134670|P4|Overall Study|Toxicity|0
335864|NCT01229150|1134671|P3|Overall Study|Toxicity|0
335865|NCT01229150|1134672|P2|Overall Study|Toxicity|2
335866|NCT01229150|1134673|P1|Overall Study|Toxicity|2
335867|NCT01229111|1134730|P1|Overall Study|Death|1
335868|NCT01228747|1134779|P2|Overall Study|Other Reason|5
335869|NCT01228747|1134780|P1|Overall Study|Other Reason|2
335870|NCT01228747|1134779|P2|Overall Study|Withdrawal by Subject|1
335871|NCT01228747|1134780|P1|Overall Study|Withdrawal by Subject|5
335872|NCT01228747|1134779|P2|Overall Study|Lost to Follow-up|3
335873|NCT01228747|1134780|P1|Overall Study|Lost to Follow-up|4
335874|NCT01228747|1134779|P2|Overall Study|Protocol Violation|5
335875|NCT01228747|1134780|P1|Overall Study|Protocol Violation|6
335876|NCT01228747|1134779|P2|Overall Study|Lack of Efficacy|27
335877|NCT01228747|1134780|P1|Overall Study|Lack of Efficacy|40
335878|NCT01228747|1134779|P2|Overall Study|Adverse Event|4
335879|NCT01228747|1134780|P1|Overall Study|Adverse Event|8
335884|NCT01228591|1134811|P2|Baseline|Lack of Efficacy|2
335885|NCT01228591|1134812|P1|Baseline|Lack of Efficacy|1
335886|NCT01228318|1134841|P2|Overall Study|Incarcerated|0
335887|NCT01228318|1134842|P1|Overall Study|Incarcerated|1
335888|NCT01228318|1134841|P2|Overall Study|Moved|2
335889|NCT01228318|1134842|P1|Overall Study|Moved|0
335890|NCT01228318|1134841|P2|Overall Study|Unable to contact|5
335891|NCT01228318|1134842|P1|Overall Study|Unable to contact|2
335892|NCT01228318|1134841|P2|Overall Study|Clinic no show to receive intervention|0
335893|NCT01228318|1134842|P1|Overall Study|Clinic no show to receive intervention|1
335894|NCT01228175|1134858|P2|Overall Study|Physician Decision|1
335895|NCT01228175|1134859|P1|Overall Study|Physician Decision|1
335896|NCT01228175|1134858|P2|Overall Study|Withdrawal by Subject|2
335897|NCT01228175|1134859|P1|Overall Study|Withdrawal by Subject|1
335898|NCT01228175|1134858|P2|Overall Study|Lost to Follow-up|50
335899|NCT01228175|1134859|P1|Overall Study|Lost to Follow-up|64
335900|NCT01228071|1134901|P1|Overall Study|Withdrawal by Subject|1
335901|NCT01228071|1134901|P1|Overall Study|Protocol Violation|1
335902|NCT01228019|1134907|P1|Overall Study|Violation of Entry Criterion|9
335903|NCT01228019|1134907|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
335904|NCT01228019|1134907|P1|Overall Study|Missing pre-treatment data|72
335905|NCT01228019|1134907|P1|Overall Study|Duplicate enrollment|1
335906|NCT01228019|1134907|P1|Overall Study|Dose Violation|70
335907|NCT01227967|1134973|P2|Overall Study|Taking Additional Antiviral Drug|0
335908|NCT01227967|1134974|P1|Overall Study|Taking Additional Antiviral Drug|1
335909|NCT01227967|1134973|P2|Overall Study|Never Started Treatment|4
335910|NCT01227967|1134974|P1|Overall Study|Never Started Treatment|0
335911|NCT01227967|1134973|P2|Overall Study|Physician Decision|1
335912|NCT01227967|1134974|P1|Overall Study|Physician Decision|0
335913|NCT01227967|1134973|P2|Overall Study|Withdrawal by Subject|3
335914|NCT01227967|1134974|P1|Overall Study|Withdrawal by Subject|4
335915|NCT01227967|1134973|P2|Overall Study|Lost to Follow-up|3
335916|NCT01227967|1134974|P1|Overall Study|Lost to Follow-up|8
335917|NCT01227967|1134973|P2|Overall Study|Death|1
335918|NCT01227967|1134974|P1|Overall Study|Death|0
335919|NCT01227967|1134973|P2|Overall Study|Protocol Violation|1
335920|NCT01227967|1134974|P1|Overall Study|Protocol Violation|3
335921|NCT01227954|1135008|P1|Overall Study|No protocol treatment|7
335922|NCT01227954|1135008|P1|Overall Study|Protocol Violation|6
335923|NCT01227928|1135022|P2|Overall Study|Death|12
335924|NCT01227928|1135023|P1|Overall Study|Death|14
335925|NCT01227928|1135022|P2|Overall Study|Withdrawal by Subject|3
335926|NCT01227928|1135023|P1|Overall Study|Withdrawal by Subject|4
335927|NCT01227928|1135022|P2|Overall Study|Lost to Follow-up|2
335928|NCT01227928|1135023|P1|Overall Study|Lost to Follow-up|4
335929|NCT01227902|1135061|P4|Overall Study|Withdrawal by Subject|3
335930|NCT01227902|1135062|P3|Overall Study|Withdrawal by Subject|4
335931|NCT01227902|1135063|P2|Overall Study|Withdrawal by Subject|2
335932|NCT01227902|1135064|P1|Overall Study|Withdrawal by Subject|4
335933|NCT01227902|1135061|P4|Overall Study|Physician Decision|0
335934|NCT01227902|1135062|P3|Overall Study|Physician Decision|1
335935|NCT01227902|1135063|P2|Overall Study|Physician Decision|1
335936|NCT01227902|1135064|P1|Overall Study|Physician Decision|0
335937|NCT01227902|1135061|P4|Overall Study|Lost to Follow-up|2
335938|NCT01227902|1135062|P3|Overall Study|Lost to Follow-up|1
335939|NCT01227902|1135063|P2|Overall Study|Lost to Follow-up|0
335940|NCT01227902|1135064|P1|Overall Study|Lost to Follow-up|0
335941|NCT01227902|1135061|P4|Overall Study|Protocol Violation|0
335942|NCT01227902|1135062|P3|Overall Study|Protocol Violation|0
335943|NCT01227902|1135063|P2|Overall Study|Protocol Violation|0
335944|NCT01227902|1135064|P1|Overall Study|Protocol Violation|1
335945|NCT01227902|1135061|P4|Overall Study|Lack of Efficacy|1
335946|NCT01227902|1135062|P3|Overall Study|Lack of Efficacy|2
335947|NCT01227902|1135063|P2|Overall Study|Lack of Efficacy|2
335948|NCT01227902|1135064|P1|Overall Study|Lack of Efficacy|1
335949|NCT01227902|1135061|P4|Overall Study|Adverse Event|4
335950|NCT01227902|1135062|P3|Overall Study|Adverse Event|11
335951|NCT01227902|1135063|P2|Overall Study|Adverse Event|8
335952|NCT01227902|1135064|P1|Overall Study|Adverse Event|12
335953|NCT01227889|1135157|P2|Crossover Phase|Withdrawal by Subject|1
335954|NCT01227889|1135158|P1|Crossover Phase|Withdrawal by Subject|0
335955|NCT01227889|1135157|P2|Crossover Phase|Study Terminated By Sponsor|1
335956|NCT01227889|1135158|P1|Crossover Phase|Study Terminated By Sponsor|0
335957|NCT01227889|1135157|P2|Crossover Phase|Progressive Disease|31
335958|NCT01227889|1135158|P1|Crossover Phase|Progressive Disease|0
335959|NCT01227889|1135157|P2|Crossover Phase|Physician Decision|3
335960|NCT01227889|1135158|P1|Crossover Phase|Physician Decision|0
335961|NCT01227889|1135157|P2|Crossover Phase|Adverse Event|1
335962|NCT01227889|1135158|P1|Crossover Phase|Adverse Event|0
335963|NCT01227889|1135157|P2|Randomized Phase (RP)|Withdrawal by Subject|3
335964|NCT01227889|1135158|P1|Randomized Phase (RP)|Withdrawal by Subject|15
335965|NCT01227889|1135157|P2|Randomized Phase (RP)|Missing|3
335966|NCT01227889|1135158|P1|Randomized Phase (RP)|Missing|1
335967|NCT01227889|1135157|P2|Randomized Phase (RP)|Study terminated by sponsor|0
335968|NCT01227889|1135158|P1|Randomized Phase (RP)|Study terminated by sponsor|10
335969|NCT01227889|1135157|P2|Randomized Phase (RP)|Progressive Disease|52
335970|NCT01227889|1135158|P1|Randomized Phase (RP)|Progressive Disease|135
335971|NCT01227889|1135157|P2|Randomized Phase (RP)|Physician Decision|5
335972|NCT01227889|1135158|P1|Randomized Phase (RP)|Physician Decision|13
335973|NCT01227889|1135157|P2|Randomized Phase (RP)|Adverse Event|0
335974|NCT01227889|1135158|P1|Randomized Phase (RP)|Adverse Event|13
335975|NCT01227824|1135185|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
335976|NCT01227824|1135186|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
335977|NCT01227824|1135187|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
335978|NCT01227824|1135185|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
335979|NCT01227824|1135186|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
335980|NCT01227824|1135187|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
335981|NCT01227824|1135185|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
335982|NCT01227824|1135186|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
335983|NCT01227824|1135187|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
335984|NCT01227824|1135185|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
335985|NCT01227824|1135186|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
335986|NCT01227824|1135187|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
335987|NCT01227824|1135185|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
335988|NCT01227824|1135186|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
335989|NCT01227824|1135187|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
335990|NCT01227824|1135185|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
335991|NCT01227824|1135186|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
335992|NCT01227824|1135187|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
335993|NCT01227824|1135185|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
335994|NCT01227824|1135186|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
335995|NCT01227824|1135187|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
335996|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
335997|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
335998|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
335999|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
336000|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
336001|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
336002|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
336003|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
336004|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
336005|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
336006|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
336007|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
336008|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
336009|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
336010|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
336011|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
336012|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
336013|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
336014|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
336015|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
336016|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
336017|NCT01227824|1135185|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
336018|NCT01227824|1135186|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
336019|NCT01227824|1135187|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
336020|NCT01227707|1135282|P1|Overall Study|Death|1
336021|NCT01227707|1135282|P1|Overall Study|Medical decision|6
336022|NCT01227707|1135282|P1|Overall Study|Patient non-compliance|3
336023|NCT01227707|1135282|P1|Overall Study|Withdrawal by Subject|1
336024|NCT01227707|1135282|P1|Overall Study|Progression of disease|3
336025|NCT01227707|1135282|P1|Overall Study|Adverse Event|10
336026|NCT01227668|1135309|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
336027|NCT01227668|1135310|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
336028|NCT01227668|1135309|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
336029|NCT01227668|1135310|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
336030|NCT01227668|1135309|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
336031|NCT01227668|1135310|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
336032|NCT01227668|1135309|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
336033|NCT01227668|1135310|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
336034|NCT01227668|1135309|P2|Phase 2 (Randomization Phase)|Adverse Event|1
336035|NCT01227668|1135310|P1|Phase 2 (Randomization Phase)|Adverse Event|0
336036|NCT01227668|1135309|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
336037|NCT01227668|1135310|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
336038|NCT01227668|1135309|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
336039|NCT01227668|1135310|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
336040|NCT01227668|1135309|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
336041|NCT01227668|1135310|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
336042|NCT01227668|1135309|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
336043|NCT01227668|1135310|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
336044|NCT01227668|1135309|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
336045|NCT01227668|1135310|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
336046|NCT01227668|1135309|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
336047|NCT01227668|1135310|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
336048|NCT01227668|1135309|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
336049|NCT01227668|1135310|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
336050|NCT01227629|1135356|P10|Overall Study|Not Specified|1
336051|NCT01227629|1135357|P9|Overall Study|Not Specified|2
336052|NCT01227629|1135358|P8|Overall Study|Not Specified|0
336053|NCT01227629|1135359|P7|Overall Study|Not Specified|0
336054|NCT01227629|1135360|P6|Overall Study|Not Specified|0
336055|NCT01227629|1135361|P5|Overall Study|Not Specified|0
336056|NCT01227629|1135362|P4|Overall Study|Not Specified|1
336057|NCT01227629|1135363|P3|Overall Study|Not Specified|0
336058|NCT01227629|1135364|P2|Overall Study|Not Specified|0
336059|NCT01227629|1135365|P1|Overall Study|Not Specified|0
336060|NCT01227629|1135356|P10|Overall Study|Withdrawal by Subject|1
336061|NCT01227629|1135357|P9|Overall Study|Withdrawal by Subject|0
336062|NCT01227629|1135358|P8|Overall Study|Withdrawal by Subject|0
336063|NCT01227629|1135359|P7|Overall Study|Withdrawal by Subject|2
336064|NCT01227629|1135360|P6|Overall Study|Withdrawal by Subject|0
336065|NCT01227629|1135361|P5|Overall Study|Withdrawal by Subject|0
336066|NCT01227629|1135362|P4|Overall Study|Withdrawal by Subject|0
336067|NCT01227629|1135363|P3|Overall Study|Withdrawal by Subject|0
336068|NCT01227629|1135364|P2|Overall Study|Withdrawal by Subject|0
336069|NCT01227629|1135365|P1|Overall Study|Withdrawal by Subject|0
336070|NCT01227629|1135356|P10|Overall Study|Lost to Follow-up|0
336071|NCT01227629|1135357|P9|Overall Study|Lost to Follow-up|0
336072|NCT01227629|1135358|P8|Overall Study|Lost to Follow-up|0
336073|NCT01227629|1135359|P7|Overall Study|Lost to Follow-up|0
336074|NCT01227629|1135360|P6|Overall Study|Lost to Follow-up|0
336075|NCT01227629|1135361|P5|Overall Study|Lost to Follow-up|1
336076|NCT01227629|1135362|P4|Overall Study|Lost to Follow-up|0
336077|NCT01227629|1135363|P3|Overall Study|Lost to Follow-up|0
336078|NCT01227629|1135364|P2|Overall Study|Lost to Follow-up|0
336079|NCT01227629|1135365|P1|Overall Study|Lost to Follow-up|0
336080|NCT01227629|1135356|P10|Overall Study|Protocol Violation|0
336081|NCT01227629|1135357|P9|Overall Study|Protocol Violation|0
336082|NCT01227629|1135358|P8|Overall Study|Protocol Violation|0
336083|NCT01227629|1135359|P7|Overall Study|Protocol Violation|0
336084|NCT01227629|1135360|P6|Overall Study|Protocol Violation|0
336085|NCT01227629|1135361|P5|Overall Study|Protocol Violation|0
336086|NCT01227629|1135362|P4|Overall Study|Protocol Violation|1
336087|NCT01227629|1135363|P3|Overall Study|Protocol Violation|0
336088|NCT01227629|1135364|P2|Overall Study|Protocol Violation|0
336089|NCT01227629|1135365|P1|Overall Study|Protocol Violation|0
336090|NCT01227629|1135356|P10|Overall Study|Adverse Event|0
336091|NCT01227629|1135357|P9|Overall Study|Adverse Event|4
336092|NCT01227629|1135358|P8|Overall Study|Adverse Event|6
336093|NCT01227629|1135359|P7|Overall Study|Adverse Event|6
336094|NCT01227629|1135360|P6|Overall Study|Adverse Event|1
336095|NCT01227629|1135361|P5|Overall Study|Adverse Event|1
336096|NCT01227629|1135362|P4|Overall Study|Adverse Event|6
336097|NCT01227629|1135363|P3|Overall Study|Adverse Event|1
336098|NCT01227629|1135364|P2|Overall Study|Adverse Event|2
336099|NCT01227629|1135365|P1|Overall Study|Adverse Event|2
336100|NCT01227577|1135601|P1|Overall Study|Adverse Event|17
336101|NCT01227577|1135601|P1|Overall Study|Lack of Efficacy|5
336102|NCT01227577|1135601|P1|Overall Study|Withdrawal by Subject|4
336103|NCT01227577|1135601|P1|Overall Study|Lost to Follow-up|1
336104|NCT01227577|1135601|P1|Overall Study|Administrative problems|2
336105|NCT01227577|1135601|P1|Overall Study|Death|3
336106|NCT01227577|1135601|P1|Overall Study|Protocol deviation|3
336107|NCT01227564|1135616|P3|Overall Study|Participant moved to another town|1
336108|NCT01227564|1135617|P2|Overall Study|Participant moved to another town|0
336109|NCT01227564|1135618|P1|Overall Study|Participant moved to another town|0
336110|NCT01227564|1135616|P3|Overall Study|No Longer Willing to Participate|5
336111|NCT01227564|1135617|P2|Overall Study|No Longer Willing to Participate|2
336112|NCT01227564|1135618|P1|Overall Study|No Longer Willing to Participate|4
336113|NCT01227512|1135756|P2|Overall Study|Participant met withdrawal criteria|1
336114|NCT01227512|1135757|P1|Overall Study|Participant met withdrawal criteria|0
336115|NCT01227512|1135756|P2|Overall Study|Withdrawal by Subject|0
336116|NCT01227512|1135757|P1|Overall Study|Withdrawal by Subject|3
336117|NCT01227512|1135756|P2|Overall Study|Adverse Event|3
336118|NCT01227512|1135757|P1|Overall Study|Adverse Event|4
336119|NCT01227512|1135756|P2|Overall Study|Physician Decision|6
336120|NCT01227512|1135757|P1|Overall Study|Physician Decision|6
336121|NCT01227421|1135791|P3|Overall Study|Randomized in error|0
336122|NCT01227421|1135792|P2|Overall Study|Randomized in error|1
336123|NCT01227421|1135793|P1|Overall Study|Randomized in error|1
336124|NCT01227421|1135791|P3|Overall Study|Protocol Violation|2
336125|NCT01227421|1135792|P2|Overall Study|Protocol Violation|1
336126|NCT01227421|1135793|P1|Overall Study|Protocol Violation|1
336127|NCT01227421|1135791|P3|Overall Study|Withdrawal by Subject|1
336128|NCT01227421|1135792|P2|Overall Study|Withdrawal by Subject|2
336129|NCT01227421|1135793|P1|Overall Study|Withdrawal by Subject|1
336130|NCT01227421|1135791|P3|Overall Study|Adverse Event|2
336131|NCT01227421|1135792|P2|Overall Study|Adverse Event|7
336132|NCT01227421|1135793|P1|Overall Study|Adverse Event|2
336133|NCT01227421|1135791|P3|Overall Study|Lost to Follow-up|5
336134|NCT01227421|1135792|P2|Overall Study|Lost to Follow-up|7
336135|NCT01227421|1135793|P1|Overall Study|Lost to Follow-up|6
336136|NCT01227395|1135845|P2|Overall Study|Protocol Violation|1
336137|NCT01227395|1135846|P1|Overall Study|Protocol Violation|0
336138|NCT01227278|1135886|P2|Overall Study|Other|2
336139|NCT01227278|1135887|P1|Overall Study|Other|1
336140|NCT01227278|1135886|P2|Overall Study|Death|2
336141|NCT01227278|1135887|P1|Overall Study|Death|0
336142|NCT01227278|1135886|P2|Overall Study|Withdrawal by Subject|4
336143|NCT01227278|1135887|P1|Overall Study|Withdrawal by Subject|4
336144|NCT01227265|1135914|P3|Overall Study|Adverse Event|5
336145|NCT01227265|1135915|P2|Overall Study|Adverse Event|10
336146|NCT01227265|1135916|P1|Overall Study|Adverse Event|6
336147|NCT01227265|1135914|P3|Overall Study|Lost to Follow-up|3
336148|NCT01227265|1135915|P2|Overall Study|Lost to Follow-up|0
336149|NCT01227265|1135916|P1|Overall Study|Lost to Follow-up|2
336150|NCT01227265|1135914|P3|Overall Study|Withdrawal by Subject|3
336151|NCT01227265|1135915|P2|Overall Study|Withdrawal by Subject|7
336152|NCT01227265|1135916|P1|Overall Study|Withdrawal by Subject|7
336153|NCT01227265|1135914|P3|Overall Study|Protocol Violation|0
336154|NCT01227265|1135915|P2|Overall Study|Protocol Violation|1
336155|NCT01227265|1135916|P1|Overall Study|Protocol Violation|2
336156|NCT01227265|1135914|P3|Overall Study|Did Not Meet Protocol Eligibility|1
336157|NCT01227265|1135915|P2|Overall Study|Did Not Meet Protocol Eligibility|0
336158|NCT01227265|1135916|P1|Overall Study|Did Not Meet Protocol Eligibility|0
336159|NCT01227265|1135914|P3|Overall Study|Administrative|2
336160|NCT01227265|1135915|P2|Overall Study|Administrative|0
336161|NCT01227265|1135916|P1|Overall Study|Administrative|1
336162|NCT01227265|1135914|P3|Overall Study|Did Not Receive Treatment|0
336163|NCT01227265|1135915|P2|Overall Study|Did Not Receive Treatment|2
336164|NCT01227265|1135916|P1|Overall Study|Did Not Receive Treatment|1
336165|NCT01227018|1135953|P1|Overall Study|Withdrew after beginning treatment|4
336166|NCT01227018|1135953|P1|Overall Study|Toxicity|2
336167|NCT01227018|1135953|P1|Overall Study|Disease progression|9
336168|NCT01226745|1135980|P6|Overall Study|Other|1
336169|NCT01226745|1135981|P5|Overall Study|Other|3
336170|NCT01226745|1135982|P4|Overall Study|Other|4
336171|NCT01226745|1135983|P3|Overall Study|Other|8
336172|NCT01226745|1135984|P2|Overall Study|Other|7
336173|NCT01226745|1135985|P1|Overall Study|Other|6
336174|NCT01226745|1135980|P6|Overall Study|Death|1
336175|NCT01226745|1135981|P5|Overall Study|Death|0
336176|NCT01226745|1135982|P4|Overall Study|Death|0
336177|NCT01226745|1135983|P3|Overall Study|Death|0
336178|NCT01226745|1135984|P2|Overall Study|Death|0
336179|NCT01226745|1135985|P1|Overall Study|Death|1
336180|NCT01226745|1135980|P6|Overall Study|Lost to Follow-up|2
336181|NCT01226745|1135981|P5|Overall Study|Lost to Follow-up|1
336182|NCT01226745|1135982|P4|Overall Study|Lost to Follow-up|1
336183|NCT01226745|1135983|P3|Overall Study|Lost to Follow-up|6
336184|NCT01226745|1135984|P2|Overall Study|Lost to Follow-up|6
336185|NCT01226745|1135985|P1|Overall Study|Lost to Follow-up|2
336186|NCT01226745|1135980|P6|Overall Study|Did not complete schedule of assessments|1
336187|NCT01226745|1135981|P5|Overall Study|Did not complete schedule of assessments|0
336188|NCT01226745|1135982|P4|Overall Study|Did not complete schedule of assessments|0
336189|NCT01226745|1135983|P3|Overall Study|Did not complete schedule of assessments|6
336190|NCT01226745|1135984|P2|Overall Study|Did not complete schedule of assessments|3
336191|NCT01226745|1135985|P1|Overall Study|Did not complete schedule of assessments|8
336192|NCT01226511|1136181|P2|Taper Period|Parent/Caregiver Decision|1
336193|NCT01226511|1136182|P1|Taper Period|Parent/Caregiver Decision|1
336194|NCT01226511|1136181|P2|Taper Period|Protocol Violation|0
336195|NCT01226511|1136182|P1|Taper Period|Protocol Violation|1
336196|NCT01226511|1136181|P2|Taper Period|Lost to Follow-up|2
336197|NCT01226511|1136182|P1|Taper Period|Lost to Follow-up|2
336198|NCT01226511|1136181|P2|Taper Period|Adverse Event|0
336199|NCT01226511|1136182|P1|Taper Period|Adverse Event|1
336200|NCT01226511|1136181|P2|Extension Treatment Period|Sponsor Decision|1
336201|NCT01226511|1136182|P1|Extension Treatment Period|Sponsor Decision|1
336202|NCT01226511|1136181|P2|Extension Treatment Period|Parent/Caregiver Decision|8
336203|NCT01226511|1136182|P1|Extension Treatment Period|Parent/Caregiver Decision|8
336204|NCT01226511|1136181|P2|Extension Treatment Period|Withdrawal by Subject|3
336205|NCT01226511|1136182|P1|Extension Treatment Period|Withdrawal by Subject|1
336206|NCT01226511|1136181|P2|Extension Treatment Period|Protocol Violation|2
336207|NCT01226511|1136182|P1|Extension Treatment Period|Protocol Violation|2
336208|NCT01226511|1136181|P2|Extension Treatment Period|Lost to Follow-up|3
336209|NCT01226511|1136182|P1|Extension Treatment Period|Lost to Follow-up|4
336210|NCT01226511|1136181|P2|Extension Treatment Period|Lack of Efficacy|2
336211|NCT01226511|1136182|P1|Extension Treatment Period|Lack of Efficacy|3
336212|NCT01226511|1136181|P2|Extension Treatment Period|Adverse Event|8
336213|NCT01226511|1136182|P1|Extension Treatment Period|Adverse Event|8
336214|NCT01226511|1136181|P2|Acute Treatment Period|Withdrawal by Subject|6
336215|NCT01226511|1136182|P1|Acute Treatment Period|Withdrawal by Subject|10
336216|NCT01226511|1136181|P2|Acute Treatment Period|Protocol Violation|5
336217|NCT01226511|1136182|P1|Acute Treatment Period|Protocol Violation|5
336218|NCT01226511|1136181|P2|Acute Treatment Period|Parent/caregiver decision|7
336219|NCT01226511|1136182|P1|Acute Treatment Period|Parent/caregiver decision|5
336220|NCT01226511|1136181|P2|Acute Treatment Period|Lost to Follow-up|6
336221|NCT01226511|1136182|P1|Acute Treatment Period|Lost to Follow-up|3
336222|NCT01226511|1136181|P2|Acute Treatment Period|Lack of Efficacy|1
336223|NCT01226511|1136182|P1|Acute Treatment Period|Lack of Efficacy|2
336224|NCT01226511|1136181|P2|Acute Treatment Period|Adverse Event|6
336225|NCT01226511|1136182|P1|Acute Treatment Period|Adverse Event|7
336226|NCT01226459|1136220|P2|Overall Study|Pregnancy|0
336227|NCT01226459|1136221|P1|Overall Study|Pregnancy|1
336228|NCT01226459|1136220|P2|Overall Study|Lost to Follow-up|8
336229|NCT01226459|1136221|P1|Overall Study|Lost to Follow-up|4
336230|NCT01226459|1136220|P2|Overall Study|Withdrawal by Subject|13
336231|NCT01226459|1136221|P1|Overall Study|Withdrawal by Subject|10
336232|NCT01226459|1136220|P2|Overall Study|Protocol Violation|3
336233|NCT01226459|1136221|P1|Overall Study|Protocol Violation|4
336234|NCT01226459|1136220|P2|Overall Study|Adverse Event|8
336235|NCT01226459|1136221|P1|Overall Study|Adverse Event|2
336236|NCT01226121|1136239|P3|Overall Study|Lost to Follow-up|1
336237|NCT01226121|1136240|P2|Overall Study|Lost to Follow-up|0
336238|NCT01226121|1136241|P1|Overall Study|Lost to Follow-up|2
336239|NCT01226095|1136252|P1|Overall Study|Poor compliance|1
336240|NCT01226043|1136277|P4|30-week Observational Phase|Physician Decision|2
336241|NCT01226043|1136278|P3|30-week Observational Phase|Physician Decision|2
336242|NCT01226043|1136279|P2|30-week Observational Phase|Physician Decision|0
336243|NCT01226043|1136280|P1|30-week Observational Phase|Physician Decision|0
336244|NCT01226043|1136277|P4|30-week Observational Phase|Withdrawal by Subject|7
336245|NCT01226043|1136278|P3|30-week Observational Phase|Withdrawal by Subject|1
336246|NCT01226043|1136279|P2|30-week Observational Phase|Withdrawal by Subject|0
336247|NCT01226043|1136280|P1|30-week Observational Phase|Withdrawal by Subject|0
336248|NCT01226043|1136277|P4|30-week Observational Phase|Lost to Follow-up|2
336249|NCT01226043|1136278|P3|30-week Observational Phase|Lost to Follow-up|2
336250|NCT01226043|1136279|P2|30-week Observational Phase|Lost to Follow-up|0
336251|NCT01226043|1136280|P1|30-week Observational Phase|Lost to Follow-up|0
336252|NCT01226043|1136277|P4|30-week Observational Phase|Protocol Violation|1
336253|NCT01226043|1136278|P3|30-week Observational Phase|Protocol Violation|0
336254|NCT01226043|1136279|P2|30-week Observational Phase|Protocol Violation|0
336255|NCT01226043|1136280|P1|30-week Observational Phase|Protocol Violation|0
336256|NCT01226043|1136277|P4|30-week Observational Phase|Adverse Event|1
336257|NCT01226043|1136278|P3|30-week Observational Phase|Adverse Event|1
336258|NCT01226043|1136279|P2|30-week Observational Phase|Adverse Event|0
336259|NCT01226043|1136280|P1|30-week Observational Phase|Adverse Event|0
336260|NCT01226043|1136277|P4|6-week Re-randomization Phase|completed in error|1
336261|NCT01226043|1136278|P3|6-week Re-randomization Phase|completed in error|0
336262|NCT01226043|1136279|P2|6-week Re-randomization Phase|completed in error|0
336263|NCT01226043|1136280|P1|6-week Re-randomization Phase|completed in error|0
336264|NCT01226043|1136277|P4|6-week Re-randomization Phase|Physician Decision|2
336265|NCT01226043|1136278|P3|6-week Re-randomization Phase|Physician Decision|3
336266|NCT01226043|1136279|P2|6-week Re-randomization Phase|Physician Decision|0
336267|NCT01226043|1136280|P1|6-week Re-randomization Phase|Physician Decision|0
336268|NCT01226043|1136277|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
336269|NCT01226043|1136278|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
336270|NCT01226043|1136279|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
336271|NCT01226043|1136280|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
336272|NCT01226043|1136277|P4|6-week Re-randomization Phase|Lost to Follow-up|3
336273|NCT01226043|1136278|P3|6-week Re-randomization Phase|Lost to Follow-up|1
336274|NCT01226043|1136279|P2|6-week Re-randomization Phase|Lost to Follow-up|0
336275|NCT01226043|1136280|P1|6-week Re-randomization Phase|Lost to Follow-up|0
336276|NCT01226043|1136277|P4|6-week Re-randomization Phase|Protocol Violation|1
336277|NCT01226043|1136278|P3|6-week Re-randomization Phase|Protocol Violation|1
336278|NCT01226043|1136279|P2|6-week Re-randomization Phase|Protocol Violation|0
336279|NCT01226043|1136280|P1|6-week Re-randomization Phase|Protocol Violation|0
336280|NCT01226043|1136277|P4|6-week Re-randomization Phase|Adverse Event|1
336281|NCT01226043|1136278|P3|6-week Re-randomization Phase|Adverse Event|1
336282|NCT01226043|1136279|P2|6-week Re-randomization Phase|Adverse Event|0
336283|NCT01226043|1136280|P1|6-week Re-randomization Phase|Adverse Event|0
336284|NCT01226043|1136277|P4|4-week Crossover Phase - Period 2|Physician Decision|0
336285|NCT01226043|1136278|P3|4-week Crossover Phase - Period 2|Physician Decision|0
336286|NCT01226043|1136279|P2|4-week Crossover Phase - Period 2|Physician Decision|5
336287|NCT01226043|1136280|P1|4-week Crossover Phase - Period 2|Physician Decision|4
336288|NCT01226043|1136277|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
336289|NCT01226043|1136278|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
336290|NCT01226043|1136279|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
336291|NCT01226043|1136280|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
336292|NCT01226043|1136277|P4|4-week Crossover Phase - Period 1|Physician Decision|0
336293|NCT01226043|1136278|P3|4-week Crossover Phase - Period 1|Physician Decision|0
336294|NCT01226043|1136279|P2|4-week Crossover Phase - Period 1|Physician Decision|6
336295|NCT01226043|1136280|P1|4-week Crossover Phase - Period 1|Physician Decision|0
336296|NCT01226043|1136277|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
336297|NCT01226043|1136278|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
336298|NCT01226043|1136279|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
336299|NCT01226043|1136280|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
336300|NCT01226043|1136277|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
336301|NCT01226043|1136278|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
336302|NCT01226043|1136279|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
336303|NCT01226043|1136280|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
336304|NCT01226043|1136277|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
336305|NCT01226043|1136278|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
336306|NCT01226043|1136279|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
336307|NCT01226043|1136280|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
336308|NCT01225991|1136318|P1|Overall Study|Withdrawal by Subject|6
336309|NCT01225952|1136329|P3|Overall Study|Surgical complications|0
336310|NCT01225952|1136330|P2|Overall Study|Surgical complications|0
336311|NCT01225952|1136331|P1|Overall Study|Surgical complications|1
336312|NCT01225952|1136329|P3|Overall Study|Withdrawal by Subject|5
336313|NCT01225952|1136330|P2|Overall Study|Withdrawal by Subject|4
336314|NCT01225952|1136331|P1|Overall Study|Withdrawal by Subject|4
336315|NCT01225952|1136329|P3|Overall Study|Study Eye Explanted|1
336316|NCT01225952|1136330|P2|Overall Study|Study Eye Explanted|0
336317|NCT01225952|1136331|P1|Overall Study|Study Eye Explanted|0
336318|NCT01225952|1136329|P3|Overall Study|Lost to Follow-up|0
336319|NCT01225952|1136330|P2|Overall Study|Lost to Follow-up|0
336320|NCT01225952|1136331|P1|Overall Study|Lost to Follow-up|1
336321|NCT01225887|1136423|P1|Overall Study|Ineligible:inadequate pathology|2
336322|NCT01225887|1136423|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
336323|NCT01225887|1136423|P1|Overall Study|Ineligible:required test not done|2
336324|NCT01225835|1136433|P2|Overall Study|not specified|1
336325|NCT01225835|1136434|P1|Overall Study|not specified|1
336326|NCT01225835|1136433|P2|Overall Study|Adverse Event|1
336327|NCT01225835|1136434|P1|Overall Study|Adverse Event|2
336328|NCT01225835|1136433|P2|Overall Study|Did not meet hCG criterion|0
336329|NCT01225835|1136434|P1|Overall Study|Did not meet hCG criterion|2
336330|NCT01225835|1136433|P2|Overall Study|Completed protocol|1
336331|NCT01225835|1136434|P1|Overall Study|Completed protocol|2
336332|NCT01225822|1136482|P5|Overall Study|Not Specified|7
336333|NCT01225822|1136483|P4|Overall Study|Not Specified|10
336334|NCT01225822|1136484|P3|Overall Study|Not Specified|7
336335|NCT01225822|1136485|P2|Overall Study|Not Specified|10
336336|NCT01225822|1136486|P1|Overall Study|Not Specified|13
336337|NCT01225822|1136482|P5|Overall Study|Withdrawal by Subject|6
336338|NCT01225822|1136483|P4|Overall Study|Withdrawal by Subject|11
336339|NCT01225822|1136484|P3|Overall Study|Withdrawal by Subject|7
336340|NCT01225822|1136485|P2|Overall Study|Withdrawal by Subject|7
336341|NCT01225822|1136486|P1|Overall Study|Withdrawal by Subject|6
336342|NCT01225822|1136482|P5|Overall Study|Lost to Follow-up|0
336343|NCT01225822|1136483|P4|Overall Study|Lost to Follow-up|1
336344|NCT01225822|1136484|P3|Overall Study|Lost to Follow-up|0
336345|NCT01225822|1136485|P2|Overall Study|Lost to Follow-up|0
336346|NCT01225822|1136486|P1|Overall Study|Lost to Follow-up|0
336347|NCT01225822|1136482|P5|Overall Study|Protocol Violation|4
336348|NCT01225822|1136483|P4|Overall Study|Protocol Violation|7
336349|NCT01225822|1136484|P3|Overall Study|Protocol Violation|6
336350|NCT01225822|1136485|P2|Overall Study|Protocol Violation|8
336351|NCT01225822|1136486|P1|Overall Study|Protocol Violation|6
336352|NCT01225822|1136482|P5|Overall Study|Adverse Event|14
336353|NCT01225822|1136483|P4|Overall Study|Adverse Event|23
336354|NCT01225822|1136484|P3|Overall Study|Adverse Event|18
336355|NCT01225822|1136485|P2|Overall Study|Adverse Event|31
336356|NCT01225822|1136486|P1|Overall Study|Adverse Event|13
336357|NCT01225731|1136553|P13|Part 3|Withdrawal by Subject|4
336358|NCT01225731|1136554|P12|Part 3|Withdrawal by Subject|6
336359|NCT01225731|1136555|P11|Part 3|Withdrawal by Subject|4
336360|NCT01225731|1136556|P10|Part 3|Withdrawal by Subject|0
336361|NCT01225731|1136557|P9|Part 3|Withdrawal by Subject|0
336362|NCT01225731|1136558|P8|Part 3|Withdrawal by Subject|0
336363|NCT01225731|1136559|P7|Part 3|Withdrawal by Subject|0
336364|NCT01225731|1136560|P6|Part 3|Withdrawal by Subject|0
336365|NCT01225731|1136561|P5|Part 3|Withdrawal by Subject|0
336366|NCT01225731|1136562|P4|Part 3|Withdrawal by Subject|0
336367|NCT01225731|1136563|P3|Part 3|Withdrawal by Subject|0
336368|NCT01225731|1136564|P2|Part 3|Withdrawal by Subject|0
336369|NCT01225731|1136565|P1|Part 3|Withdrawal by Subject|0
336370|NCT01225731|1136553|P13|Part 3|Physician Decision|2
336371|NCT01225731|1136554|P12|Part 3|Physician Decision|1
336372|NCT01225731|1136555|P11|Part 3|Physician Decision|0
336373|NCT01225731|1136556|P10|Part 3|Physician Decision|0
336374|NCT01225731|1136557|P9|Part 3|Physician Decision|0
336375|NCT01225731|1136558|P8|Part 3|Physician Decision|0
336376|NCT01225731|1136559|P7|Part 3|Physician Decision|0
336377|NCT01225731|1136560|P6|Part 3|Physician Decision|0
336378|NCT01225731|1136561|P5|Part 3|Physician Decision|0
336379|NCT01225731|1136562|P4|Part 3|Physician Decision|0
336380|NCT01225731|1136563|P3|Part 3|Physician Decision|0
336381|NCT01225731|1136564|P2|Part 3|Physician Decision|0
336382|NCT01225731|1136565|P1|Part 3|Physician Decision|0
336383|NCT01225731|1136553|P13|Part 3|Lost to Follow-up|1
336384|NCT01225731|1136554|P12|Part 3|Lost to Follow-up|2
336385|NCT01225731|1136555|P11|Part 3|Lost to Follow-up|1
336386|NCT01225731|1136556|P10|Part 3|Lost to Follow-up|0
336387|NCT01225731|1136557|P9|Part 3|Lost to Follow-up|0
336388|NCT01225731|1136558|P8|Part 3|Lost to Follow-up|0
336389|NCT01225731|1136559|P7|Part 3|Lost to Follow-up|0
336390|NCT01225731|1136560|P6|Part 3|Lost to Follow-up|0
336391|NCT01225731|1136561|P5|Part 3|Lost to Follow-up|0
336392|NCT01225731|1136562|P4|Part 3|Lost to Follow-up|0
336393|NCT01225731|1136563|P3|Part 3|Lost to Follow-up|0
336394|NCT01225731|1136564|P2|Part 3|Lost to Follow-up|0
336395|NCT01225731|1136565|P1|Part 3|Lost to Follow-up|0
336396|NCT01225731|1136553|P13|Part 3|Adverse Event|0
336397|NCT01225731|1136554|P12|Part 3|Adverse Event|1
336398|NCT01225731|1136555|P11|Part 3|Adverse Event|1
336399|NCT01225731|1136556|P10|Part 3|Adverse Event|0
336400|NCT01225731|1136557|P9|Part 3|Adverse Event|0
336401|NCT01225731|1136558|P8|Part 3|Adverse Event|0
336402|NCT01225731|1136559|P7|Part 3|Adverse Event|0
336403|NCT01225731|1136560|P6|Part 3|Adverse Event|0
336404|NCT01225731|1136561|P5|Part 3|Adverse Event|0
336405|NCT01225731|1136562|P4|Part 3|Adverse Event|0
336406|NCT01225731|1136563|P3|Part 3|Adverse Event|0
336407|NCT01225731|1136564|P2|Part 3|Adverse Event|0
336408|NCT01225731|1136565|P1|Part 3|Adverse Event|0
336409|NCT01225731|1136553|P13|Part 2|Withdrawal by Subject|0
336410|NCT01225731|1136554|P12|Part 2|Withdrawal by Subject|0
336411|NCT01225731|1136555|P11|Part 2|Withdrawal by Subject|0
336412|NCT01225731|1136556|P10|Part 2|Withdrawal by Subject|0
336413|NCT01225731|1136557|P9|Part 2|Withdrawal by Subject|1
336414|NCT01225731|1136558|P8|Part 2|Withdrawal by Subject|4
336415|NCT01225731|1136559|P7|Part 2|Withdrawal by Subject|3
336416|NCT01225731|1136560|P6|Part 2|Withdrawal by Subject|1
336417|NCT01225731|1136561|P5|Part 2|Withdrawal by Subject|0
336418|NCT01225731|1136562|P4|Part 2|Withdrawal by Subject|0
336419|NCT01225731|1136563|P3|Part 2|Withdrawal by Subject|0
336420|NCT01225731|1136564|P2|Part 2|Withdrawal by Subject|0
336421|NCT01225731|1136565|P1|Part 2|Withdrawal by Subject|0
336422|NCT01225731|1136553|P13|Part 2|Physician Decision|0
336423|NCT01225731|1136554|P12|Part 2|Physician Decision|0
336424|NCT01225731|1136555|P11|Part 2|Physician Decision|0
336425|NCT01225731|1136556|P10|Part 2|Physician Decision|0
336426|NCT01225731|1136557|P9|Part 2|Physician Decision|2
336427|NCT01225731|1136558|P8|Part 2|Physician Decision|2
336428|NCT01225731|1136559|P7|Part 2|Physician Decision|0
336429|NCT01225731|1136560|P6|Part 2|Physician Decision|0
336430|NCT01225731|1136561|P5|Part 2|Physician Decision|0
336431|NCT01225731|1136562|P4|Part 2|Physician Decision|0
336432|NCT01225731|1136563|P3|Part 2|Physician Decision|0
336433|NCT01225731|1136564|P2|Part 2|Physician Decision|0
336434|NCT01225731|1136565|P1|Part 2|Physician Decision|0
336435|NCT01225731|1136553|P13|Part 2|Lost to Follow-up|0
336436|NCT01225731|1136554|P12|Part 2|Lost to Follow-up|0
336437|NCT01225731|1136555|P11|Part 2|Lost to Follow-up|0
336438|NCT01225731|1136556|P10|Part 2|Lost to Follow-up|0
336439|NCT01225731|1136557|P9|Part 2|Lost to Follow-up|1
336440|NCT01225731|1136558|P8|Part 2|Lost to Follow-up|3
336441|NCT01225731|1136559|P7|Part 2|Lost to Follow-up|0
336442|NCT01225731|1136560|P6|Part 2|Lost to Follow-up|0
336443|NCT01225731|1136561|P5|Part 2|Lost to Follow-up|0
336444|NCT01225731|1136562|P4|Part 2|Lost to Follow-up|0
336445|NCT01225731|1136563|P3|Part 2|Lost to Follow-up|0
336446|NCT01225731|1136564|P2|Part 2|Lost to Follow-up|0
336447|NCT01225731|1136565|P1|Part 2|Lost to Follow-up|0
336448|NCT01225731|1136553|P13|Part 2|Pregnancy|0
336449|NCT01225731|1136554|P12|Part 2|Pregnancy|0
336450|NCT01225731|1136555|P11|Part 2|Pregnancy|0
336451|NCT01225731|1136556|P10|Part 2|Pregnancy|0
336452|NCT01225731|1136557|P9|Part 2|Pregnancy|1
336453|NCT01225731|1136558|P8|Part 2|Pregnancy|0
336454|NCT01225731|1136559|P7|Part 2|Pregnancy|1
336455|NCT01225731|1136560|P6|Part 2|Pregnancy|0
336456|NCT01225731|1136561|P5|Part 2|Pregnancy|0
336457|NCT01225731|1136562|P4|Part 2|Pregnancy|0
336458|NCT01225731|1136563|P3|Part 2|Pregnancy|0
336459|NCT01225731|1136564|P2|Part 2|Pregnancy|0
336460|NCT01225731|1136565|P1|Part 2|Pregnancy|0
336461|NCT01225731|1136553|P13|Part 2|Lack of Efficacy|0
336462|NCT01225731|1136554|P12|Part 2|Lack of Efficacy|0
336463|NCT01225731|1136555|P11|Part 2|Lack of Efficacy|0
336464|NCT01225731|1136556|P10|Part 2|Lack of Efficacy|0
336465|NCT01225731|1136557|P9|Part 2|Lack of Efficacy|3
336466|NCT01225731|1136558|P8|Part 2|Lack of Efficacy|12
336467|NCT01225731|1136559|P7|Part 2|Lack of Efficacy|0
336468|NCT01225731|1136560|P6|Part 2|Lack of Efficacy|1
336469|NCT01225731|1136561|P5|Part 2|Lack of Efficacy|0
336470|NCT01225731|1136562|P4|Part 2|Lack of Efficacy|0
336471|NCT01225731|1136563|P3|Part 2|Lack of Efficacy|0
336472|NCT01225731|1136564|P2|Part 2|Lack of Efficacy|0
336473|NCT01225731|1136565|P1|Part 2|Lack of Efficacy|0
336474|NCT01225731|1136553|P13|Part 2|Adverse Event|0
336475|NCT01225731|1136554|P12|Part 2|Adverse Event|0
336476|NCT01225731|1136555|P11|Part 2|Adverse Event|0
336477|NCT01225731|1136556|P10|Part 2|Adverse Event|0
336478|NCT01225731|1136557|P9|Part 2|Adverse Event|2
336479|NCT01225731|1136558|P8|Part 2|Adverse Event|4
336480|NCT01225731|1136559|P7|Part 2|Adverse Event|4
336481|NCT01225731|1136560|P6|Part 2|Adverse Event|0
336482|NCT01225731|1136561|P5|Part 2|Adverse Event|0
336483|NCT01225731|1136562|P4|Part 2|Adverse Event|0
336484|NCT01225731|1136563|P3|Part 2|Adverse Event|0
336485|NCT01225731|1136564|P2|Part 2|Adverse Event|0
336486|NCT01225731|1136565|P1|Part 2|Adverse Event|0
336487|NCT01225731|1136553|P13|Part 2|Protocol Violation|0
336488|NCT01225731|1136554|P12|Part 2|Protocol Violation|0
336489|NCT01225731|1136555|P11|Part 2|Protocol Violation|0
336490|NCT01225731|1136556|P10|Part 2|Protocol Violation|0
336491|NCT01225731|1136557|P9|Part 2|Protocol Violation|1
336492|NCT01225731|1136558|P8|Part 2|Protocol Violation|0
336493|NCT01225731|1136559|P7|Part 2|Protocol Violation|0
336494|NCT01225731|1136560|P6|Part 2|Protocol Violation|1
336495|NCT01225731|1136561|P5|Part 2|Protocol Violation|0
336496|NCT01225731|1136562|P4|Part 2|Protocol Violation|0
336497|NCT01225731|1136563|P3|Part 2|Protocol Violation|0
336498|NCT01225731|1136564|P2|Part 2|Protocol Violation|0
336499|NCT01225731|1136565|P1|Part 2|Protocol Violation|0
336500|NCT01225731|1136553|P13|Part 1|Protocol Violation|0
336501|NCT01225731|1136554|P12|Part 1|Protocol Violation|0
336502|NCT01225731|1136555|P11|Part 1|Protocol Violation|0
336503|NCT01225731|1136556|P10|Part 1|Protocol Violation|0
336504|NCT01225731|1136557|P9|Part 1|Protocol Violation|0
336505|NCT01225731|1136558|P8|Part 1|Protocol Violation|0
336506|NCT01225731|1136559|P7|Part 1|Protocol Violation|0
336507|NCT01225731|1136560|P6|Part 1|Protocol Violation|0
336508|NCT01225731|1136561|P5|Part 1|Protocol Violation|0
336509|NCT01225731|1136562|P4|Part 1|Protocol Violation|1
336510|NCT01225731|1136563|P3|Part 1|Protocol Violation|0
336511|NCT01225731|1136564|P2|Part 1|Protocol Violation|0
336512|NCT01225731|1136565|P1|Part 1|Protocol Violation|0
336513|NCT01225731|1136553|P13|Part 1|Withdrawal by Subject|0
336514|NCT01225731|1136554|P12|Part 1|Withdrawal by Subject|0
336515|NCT01225731|1136555|P11|Part 1|Withdrawal by Subject|0
336516|NCT01225731|1136556|P10|Part 1|Withdrawal by Subject|0
336517|NCT01225731|1136557|P9|Part 1|Withdrawal by Subject|0
336518|NCT01225731|1136558|P8|Part 1|Withdrawal by Subject|0
336519|NCT01225731|1136559|P7|Part 1|Withdrawal by Subject|0
336520|NCT01225731|1136560|P6|Part 1|Withdrawal by Subject|0
336521|NCT01225731|1136561|P5|Part 1|Withdrawal by Subject|4
336522|NCT01225731|1136562|P4|Part 1|Withdrawal by Subject|0
336523|NCT01225731|1136563|P3|Part 1|Withdrawal by Subject|0
336524|NCT01225731|1136564|P2|Part 1|Withdrawal by Subject|3
336525|NCT01225731|1136565|P1|Part 1|Withdrawal by Subject|0
336526|NCT01225731|1136553|P13|Part 1|Adverse Event|0
336527|NCT01225731|1136554|P12|Part 1|Adverse Event|0
336528|NCT01225731|1136555|P11|Part 1|Adverse Event|0
336529|NCT01225731|1136556|P10|Part 1|Adverse Event|0
336530|NCT01225731|1136557|P9|Part 1|Adverse Event|0
336531|NCT01225731|1136558|P8|Part 1|Adverse Event|0
336532|NCT01225731|1136559|P7|Part 1|Adverse Event|0
336533|NCT01225731|1136560|P6|Part 1|Adverse Event|0
336534|NCT01225731|1136561|P5|Part 1|Adverse Event|1
336535|NCT01225731|1136562|P4|Part 1|Adverse Event|1
336536|NCT01225731|1136563|P3|Part 1|Adverse Event|1
336537|NCT01225731|1136564|P2|Part 1|Adverse Event|2
336538|NCT01225731|1136565|P1|Part 1|Adverse Event|1
336539|NCT01225731|1136553|P13|Part 1|Did not meet eligibility criteria|0
336540|NCT01225731|1136554|P12|Part 1|Did not meet eligibility criteria|0
336541|NCT01225731|1136555|P11|Part 1|Did not meet eligibility criteria|0
336542|NCT01225731|1136556|P10|Part 1|Did not meet eligibility criteria|0
336543|NCT01225731|1136557|P9|Part 1|Did not meet eligibility criteria|0
336544|NCT01225731|1136558|P8|Part 1|Did not meet eligibility criteria|0
336545|NCT01225731|1136559|P7|Part 1|Did not meet eligibility criteria|0
336546|NCT01225731|1136560|P6|Part 1|Did not meet eligibility criteria|0
336547|NCT01225731|1136561|P5|Part 1|Did not meet eligibility criteria|1
336548|NCT01225731|1136562|P4|Part 1|Did not meet eligibility criteria|0
336549|NCT01225731|1136563|P3|Part 1|Did not meet eligibility criteria|0
336550|NCT01225731|1136564|P2|Part 1|Did not meet eligibility criteria|0
336551|NCT01225731|1136565|P1|Part 1|Did not meet eligibility criteria|1
336552|NCT01225562|1136660|P3|Overall Study|Lost to Follow-up|1
336553|NCT01225562|1136661|P2|Overall Study|Lost to Follow-up|6
336554|NCT01225562|1136662|P1|Overall Study|Lost to Follow-up|3
336555|NCT01225562|1136660|P3|Overall Study|Withdrawal by Subject|52
336556|NCT01225562|1136661|P2|Overall Study|Withdrawal by Subject|50
336557|NCT01225562|1136662|P1|Overall Study|Withdrawal by Subject|52
336558|NCT01225549|1136679|P10|Period 6 - Washout|Disallowed medication|0
336559|NCT01225549|1136680|P9|Period 6 - Washout|Disallowed medication|0
336560|NCT01225549|1136681|P8|Period 6 - Washout|Disallowed medication|0
336561|NCT01225549|1136682|P7|Period 6 - Washout|Disallowed medication|0
336562|NCT01225549|1136683|P6|Period 6 - Washout|Disallowed medication|0
336563|NCT01225549|1136684|P5|Period 6 - Washout|Disallowed medication|0
336564|NCT01225549|1136685|P4|Period 6 - Washout|Disallowed medication|1
336565|NCT01225549|1136686|P3|Period 6 - Washout|Disallowed medication|0
336566|NCT01225549|1136687|P2|Period 6 - Washout|Disallowed medication|0
336567|NCT01225549|1136688|P1|Period 6 - Washout|Disallowed medication|0
336568|NCT01225549|1136679|P10|Period 4 - Washout|Disallowed medication|0
336569|NCT01225549|1136680|P9|Period 4 - Washout|Disallowed medication|0
336570|NCT01225549|1136681|P8|Period 4 - Washout|Disallowed medication|0
336571|NCT01225549|1136682|P7|Period 4 - Washout|Disallowed medication|0
336572|NCT01225549|1136683|P6|Period 4 - Washout|Disallowed medication|0
336573|NCT01225549|1136684|P5|Period 4 - Washout|Disallowed medication|0
336574|NCT01225549|1136685|P4|Period 4 - Washout|Disallowed medication|0
336575|NCT01225549|1136686|P3|Period 4 - Washout|Disallowed medication|0
336576|NCT01225549|1136687|P2|Period 4 - Washout|Disallowed medication|1
336577|NCT01225549|1136688|P1|Period 4 - Washout|Disallowed medication|0
336578|NCT01225211|1136771|P10|Overall Study|Other|1
336579|NCT01225211|1136772|P9|Overall Study|Other|0
336580|NCT01225211|1136773|P8|Overall Study|Other|0
336581|NCT01225211|1136774|P7|Overall Study|Other|0
336582|NCT01225211|1136775|P6|Overall Study|Other|0
336583|NCT01225211|1136776|P5|Overall Study|Other|0
336584|NCT01225211|1136777|P4|Overall Study|Other|0
336585|NCT01225211|1136778|P3|Overall Study|Other|0
336586|NCT01225211|1136779|P2|Overall Study|Other|0
336587|NCT01225211|1136780|P1|Overall Study|Other|0
336588|NCT01225211|1136771|P10|Overall Study|Withdrawal by Subject|3
336589|NCT01225211|1136772|P9|Overall Study|Withdrawal by Subject|1
336590|NCT01225211|1136773|P8|Overall Study|Withdrawal by Subject|0
336591|NCT01225211|1136774|P7|Overall Study|Withdrawal by Subject|1
336592|NCT01225211|1136775|P6|Overall Study|Withdrawal by Subject|0
336593|NCT01225211|1136776|P5|Overall Study|Withdrawal by Subject|0
336594|NCT01225211|1136777|P4|Overall Study|Withdrawal by Subject|0
336595|NCT01225211|1136778|P3|Overall Study|Withdrawal by Subject|0
336596|NCT01225211|1136779|P2|Overall Study|Withdrawal by Subject|0
336597|NCT01225211|1136780|P1|Overall Study|Withdrawal by Subject|0
336598|NCT01225211|1136771|P10|Overall Study|Adverse Event|1
336599|NCT01225211|1136772|P9|Overall Study|Adverse Event|0
336600|NCT01225211|1136773|P8|Overall Study|Adverse Event|0
336601|NCT01225211|1136774|P7|Overall Study|Adverse Event|0
336602|NCT01225211|1136775|P6|Overall Study|Adverse Event|0
336603|NCT01225211|1136776|P5|Overall Study|Adverse Event|0
336604|NCT01225211|1136777|P4|Overall Study|Adverse Event|0
336605|NCT01225211|1136778|P3|Overall Study|Adverse Event|1
336606|NCT01225211|1136779|P2|Overall Study|Adverse Event|0
336607|NCT01225211|1136780|P1|Overall Study|Adverse Event|0
336608|NCT01225159|1136883|P2|Overall Study|Change operation|0
336609|NCT01225159|1136884|P1|Overall Study|Change operation|1
336610|NCT01225146|1136894|P2|Overall Study|Sponsor discontinued making 2mg drug|2
336611|NCT01225146|1136895|P1|Overall Study|Sponsor discontinued making 2mg drug|0
336612|NCT01224821|1136961|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
336613|NCT01224821|1136961|P1|Long-Term Follow-Up|Death|2
336614|NCT01224821|1136961|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
336615|NCT01224821|1136961|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
336616|NCT01224821|1136961|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
336617|NCT01224821|1136961|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
336618|NCT01224821|1136961|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
336619|NCT01224821|1136961|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
336620|NCT01224782|1136980|P1|Overall Study|Transplantation|1
336621|NCT01224782|1136980|P1|Overall Study|Deterioration|1
336622|NCT01224782|1136980|P1|Overall Study|Financial Reasons|1
336623|NCT01224782|1136980|P1|Overall Study|Change of Treatment|1
336624|NCT01224782|1136980|P1|Overall Study|Start of Dialysis|3
336625|NCT01224782|1136980|P1|Overall Study|Not Specified|4
336626|NCT01224782|1136980|P1|Overall Study|Noncompliance|10
336627|NCT01224782|1136980|P1|Overall Study|Adverse Reaction|11
336628|NCT01224782|1136980|P1|Overall Study|Adverse Event|12
336629|NCT01224782|1136980|P1|Overall Study|Improvement|13
336630|NCT01224782|1136980|P1|Overall Study|Death|14
336631|NCT01224782|1136980|P1|Overall Study|Withdrawal by Subject|16
336632|NCT01224782|1136980|P1|Overall Study|Lost to Follow-up|177
336633|NCT01224639|1137006|P8|Overall Study|Adverse Event|1
336634|NCT01224639|1137007|P7|Overall Study|Adverse Event|0
336635|NCT01224639|1137008|P6|Overall Study|Adverse Event|0
336636|NCT01224639|1137009|P5|Overall Study|Adverse Event|0
336637|NCT01224639|1137010|P4|Overall Study|Adverse Event|0
336638|NCT01224639|1137011|P3|Overall Study|Adverse Event|0
336639|NCT01224639|1137012|P2|Overall Study|Adverse Event|0
336640|NCT01224639|1137013|P1|Overall Study|Adverse Event|0
336641|NCT01224639|1137006|P8|Overall Study|Withdrawal by Subject|1
336642|NCT01224639|1137007|P7|Overall Study|Withdrawal by Subject|1
336643|NCT01224639|1137008|P6|Overall Study|Withdrawal by Subject|0
336644|NCT01224639|1137009|P5|Overall Study|Withdrawal by Subject|2
336645|NCT01224639|1137010|P4|Overall Study|Withdrawal by Subject|0
336646|NCT01224639|1137011|P3|Overall Study|Withdrawal by Subject|0
336647|NCT01224639|1137012|P2|Overall Study|Withdrawal by Subject|0
336648|NCT01224639|1137013|P1|Overall Study|Withdrawal by Subject|0
336649|NCT01224431|1137131|P2|Overall Study|no video record|1
336650|NCT01224431|1137132|P1|Overall Study|no video record|0
336651|NCT01224431|1137131|P2|Overall Study|not randomized|4
336652|NCT01224431|1137132|P1|Overall Study|not randomized|0
336653|NCT01224171|1137151|P2|Overall Study|Lost to Follow-up|3
336654|NCT01224171|1137152|P1|Overall Study|Lost to Follow-up|0
336655|NCT01224171|1137151|P2|Overall Study|Withdrawal of Consent|4
336656|NCT01224171|1137152|P1|Overall Study|Withdrawal of Consent|2
336657|NCT01224171|1137151|P2|Overall Study|Lack of Efficacy|1
336658|NCT01224171|1137152|P1|Overall Study|Lack of Efficacy|5
336659|NCT01224171|1137151|P2|Overall Study|Protocol Violation|1
336660|NCT01224171|1137152|P1|Overall Study|Protocol Violation|0
336661|NCT01224171|1137151|P2|Overall Study|Adverse Event|4
336662|NCT01224171|1137152|P1|Overall Study|Adverse Event|8
336663|NCT01223937|1137192|P2|Overall Study|Not specified|1
336664|NCT01223937|1137193|P1|Overall Study|Not specified|4
336665|NCT01223937|1137192|P2|Overall Study|Protocol Violation|7
336666|NCT01223937|1137193|P1|Overall Study|Protocol Violation|8
336667|NCT01223937|1137192|P2|Overall Study|Adverse Event|4
336668|NCT01223937|1137193|P1|Overall Study|Adverse Event|1
336669|NCT01223937|1137192|P2|Overall Study|Lost to Follow-up|4
336670|NCT01223937|1137193|P1|Overall Study|Lost to Follow-up|1
336671|NCT01223937|1137192|P2|Overall Study|Withdrawal by Subject|2
336672|NCT01223937|1137193|P1|Overall Study|Withdrawal by Subject|3
336673|NCT01223404|1137239|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
336674|NCT01223404|1137240|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
336675|NCT01223404|1137241|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
336676|NCT01223404|1137242|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
336677|NCT01223404|1137243|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
336678|NCT01223404|1137244|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
336679|NCT01223404|1137239|P6|Second Intervention (1 Day)|Adverse Event|0
336680|NCT01223404|1137240|P5|Second Intervention (1 Day)|Adverse Event|0
336681|NCT01223404|1137241|P4|Second Intervention (1 Day)|Adverse Event|0
336682|NCT01223404|1137242|P3|Second Intervention (1 Day)|Adverse Event|0
336683|NCT01223404|1137243|P2|Second Intervention (1 Day)|Adverse Event|0
336684|NCT01223404|1137244|P1|Second Intervention (1 Day)|Adverse Event|1
336685|NCT01223404|1137239|P6|First Intervention (1 Day)|Adverse Event|0
336686|NCT01223404|1137240|P5|First Intervention (1 Day)|Adverse Event|0
336687|NCT01223404|1137241|P4|First Intervention (1 Day)|Adverse Event|1
336688|NCT01223404|1137242|P3|First Intervention (1 Day)|Adverse Event|0
336689|NCT01223404|1137243|P2|First Intervention (1 Day)|Adverse Event|0
336690|NCT01223404|1137244|P1|First Intervention (1 Day)|Adverse Event|0
336691|NCT01223365|1137267|P1|Open-label Treatment Period|Physician Decision|2
336692|NCT01223365|1137267|P1|Open-label Treatment Period|Starting physical therapy|1
336693|NCT01223365|1137267|P1|Open-label Treatment Period|"Out of window"|1
336694|NCT01223365|1137267|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
336695|NCT01223365|1137267|P1|Open-label Treatment Period|Moved out of area|2
336696|NCT01223365|1137267|P1|Open-label Treatment Period|Noncompliance with study procedures|6
336697|NCT01223365|1137267|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
336698|NCT01223365|1137267|P1|Open-label Treatment Period|Lost to Follow-up|7
336699|NCT01223365|1137267|P1|Open-label Treatment Period|Protocol Violation|15
336700|NCT01223365|1137267|P1|Open-label Treatment Period|Withdrawal by Subject|19
336701|NCT01223365|1137267|P1|Open-label Treatment Period|Lack of Efficacy|2
336702|NCT01223365|1137267|P1|Open-label Treatment Period|Adverse Event|39
336703|NCT01223365|1137267|P1|Open-label Titration Period|Starting physical therapy|1
336704|NCT01223365|1137267|P1|Open-label Titration Period|Noncompliance with study procedures|2
336705|NCT01223365|1137267|P1|Open-label Titration Period|Noncompliance with study drug admin|1
336706|NCT01223365|1137267|P1|Open-label Titration Period|Lost to Follow-up|2
336707|NCT01223365|1137267|P1|Open-label Titration Period|Protocol Violation|1
336708|NCT01223365|1137267|P1|Open-label Titration Period|Withdrawal by Subject|5
336709|NCT01223365|1137267|P1|Open-label Titration Period|Lack of Efficacy|3
336710|NCT01223365|1137267|P1|Open-label Titration Period|Adverse Event|23
336711|NCT01223365|1137267|P1|Open-label Titration Period|Enrolled but not treated|1
336712|NCT01223235|1137331|P1|Overall Study|Withdrawal by Subject|1
336713|NCT01223196|1137339|P2|Overall Study|Withdrawal by Subject|0
336714|NCT01223196|1137340|P1|Overall Study|Withdrawal by Subject|1
336715|NCT01223196|1137339|P2|Overall Study|Physician Decision|0
336716|NCT01223196|1137340|P1|Overall Study|Physician Decision|1
336717|NCT01223196|1137339|P2|Overall Study|Lost to Follow-up|0
336718|NCT01223196|1137340|P1|Overall Study|Lost to Follow-up|2
336719|NCT01223183|1137352|P2|Washout Period (5-24 Days)|Physician Decision|0
336720|NCT01223183|1137353|P1|Washout Period (5-24 Days)|Physician Decision|1
336721|NCT01223183|1137352|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
336722|NCT01223183|1137353|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
336723|NCT01223183|1137352|P2|Imaging Day 1|Physician Decision|1
336724|NCT01223183|1137353|P1|Imaging Day 1|Physician Decision|0
336725|NCT01223027|1137363|P2|Overall Study|Study terminated by sponsor|8
336726|NCT01223027|1137364|P1|Overall Study|Study terminated by sponsor|2
336727|NCT01223027|1137363|P2|Overall Study|New therapy for study indication|8
336728|NCT01223027|1137364|P1|Overall Study|New therapy for study indication|17
336729|NCT01223027|1137363|P2|Overall Study|Subject/guardian decicion|16
336730|NCT01223027|1137364|P1|Overall Study|Subject/guardian decicion|18
336731|NCT01223027|1137363|P2|Overall Study|Protocol Violation|1
336732|NCT01223027|1137364|P1|Overall Study|Protocol Violation|2
336733|NCT01223027|1137363|P2|Overall Study|Progressive Disease|183
336734|NCT01223027|1137364|P1|Overall Study|Progressive Disease|167
336735|NCT01223027|1137363|P2|Overall Study|Physician Decision|8
336736|NCT01223027|1137364|P1|Overall Study|Physician Decision|4
336737|NCT01223027|1137363|P2|Overall Study|Lost to Follow-up|1
336738|NCT01223027|1137364|P1|Overall Study|Lost to Follow-up|2
336739|NCT01223027|1137363|P2|Overall Study|Death|42
336740|NCT01223027|1137364|P1|Overall Study|Death|42
336741|NCT01223027|1137363|P2|Overall Study|Adverse Event|10
336742|NCT01223027|1137364|P1|Overall Study|Adverse Event|20
336743|NCT01222715|1137426|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
336744|NCT01222715|1137427|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
336745|NCT01222715|1137426|P2|Overall Study|Ineligible|1
336746|NCT01222715|1137427|P1|Overall Study|Ineligible|0
336747|NCT01222715|1137426|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
336748|NCT01222715|1137427|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
336749|NCT01222715|1137426|P2|Overall Study|Refusal of further protocol therapy|4
336750|NCT01222715|1137427|P1|Overall Study|Refusal of further protocol therapy|0
336751|NCT01222715|1137426|P2|Overall Study|Physician Decision|2
336752|NCT01222715|1137427|P1|Overall Study|Physician Decision|12
336753|NCT01222715|1137426|P2|Overall Study|Lack of Efficacy|14
336754|NCT01222715|1137427|P1|Overall Study|Lack of Efficacy|22
336755|NCT01222715|1137426|P2|Overall Study|Death|1
336756|NCT01222715|1137427|P1|Overall Study|Death|0
336757|NCT01222715|1137426|P2|Overall Study|Adverse Event|4
336758|NCT01222715|1137427|P1|Overall Study|Adverse Event|0
336759|NCT01222533|1137466|P1|Overall Study|Other|4
336760|NCT01222533|1137466|P1|Overall Study|Withdrawal by Subject|5
336761|NCT01222533|1137466|P1|Overall Study|Adverse Event|5
336762|NCT01222520|1137605|P2|Double-blind Period|Study medication stolen|0
336763|NCT01222520|1137606|P1|Double-blind Period|Study medication stolen|1
336764|NCT01222520|1137605|P2|Double-blind Period|Lack of Efficacy|1
336765|NCT01222520|1137606|P1|Double-blind Period|Lack of Efficacy|0
336766|NCT01222520|1137605|P2|Double-blind Period|Adverse Event|1
336767|NCT01222520|1137606|P1|Double-blind Period|Adverse Event|0
336768|NCT01222520|1137605|P2|Open-label run-in Period|Number of patients fulfilled|3
336769|NCT01222520|1137606|P1|Open-label run-in Period|Number of patients fulfilled|0
336770|NCT01222520|1137605|P2|Open-label run-in Period|Blood pressure criteria not met|18
336771|NCT01222520|1137606|P1|Open-label run-in Period|Blood pressure criteria not met|0
336772|NCT01222520|1137605|P2|Open-label run-in Period|Withdrawal by Subject|2
336773|NCT01222520|1137606|P1|Open-label run-in Period|Withdrawal by Subject|0
336774|NCT01222507|1137624|P1|Overall Study|Withdrawal by Subject|1
336775|NCT01222507|1137624|P1|Overall Study|Physician Decision|1
336776|NCT01222416|1137630|P2|Overall Study|Death|0
336777|NCT01222416|1137631|P1|Overall Study|Death|1
336778|NCT01222416|1137630|P2|Overall Study|missed view/scan|0
336779|NCT01222416|1137631|P1|Overall Study|missed view/scan|1
336780|NCT01222416|1137630|P2|Overall Study|scheduling|0
336781|NCT01222416|1137631|P1|Overall Study|scheduling|6
336782|NCT01222416|1137630|P2|Overall Study|Withdrawal by Subject|0
336783|NCT01222416|1137631|P1|Overall Study|Withdrawal by Subject|5
336784|NCT01222416|1137630|P2|Overall Study|Adverse Event|0
336785|NCT01222416|1137631|P1|Overall Study|Adverse Event|4
336786|NCT01222416|1137630|P2|Overall Study|ineligible;metastasis|0
336787|NCT01222416|1137631|P1|Overall Study|ineligible;metastasis|3
336788|NCT01222403|1137641|P2|Overall Study|Inappropriate enrollment|2
336789|NCT01222403|1137642|P1|Overall Study|Inappropriate enrollment|0
336790|NCT01222104|1137751|P1|Overall Study|Death|10
336791|NCT01222104|1137751|P1|Overall Study|Lost to Follow-up|37
336792|NCT01222078|1137774|P1|Overall Study|Early termination of the study|1
336793|NCT01221948|1137808|P1|Overall Study|Protocol Violation|4
336794|NCT01221948|1137808|P1|Overall Study|Death|1
336795|NCT01221948|1137808|P1|Overall Study|not disclosed|2
336796|NCT01221948|1137808|P1|Overall Study|Withdrawal by Subject|2
336797|NCT01221948|1137808|P1|Overall Study|Physician Decision|5
336798|NCT01221753|1137819|P1|Overall Study|Adverse Event|1
336799|NCT01221727|1137826|P2|Overall Study|Withdrawal by Subject|1
336800|NCT01221727|1137827|P1|Overall Study|Withdrawal by Subject|1
336801|NCT01221727|1137826|P2|Overall Study|Physician Decision|0
336802|NCT01221727|1137827|P1|Overall Study|Physician Decision|2
336803|NCT01221623|1137848|P2|Overall Study|Other|2
336804|NCT01221623|1137849|P1|Overall Study|Other|5
336805|NCT01221623|1137848|P2|Overall Study|Death|0
336806|NCT01221623|1137849|P1|Overall Study|Death|1
336807|NCT01221623|1137848|P2|Overall Study|Adverse Event|3
336808|NCT01221623|1137849|P1|Overall Study|Adverse Event|6
336809|NCT01221623|1137848|P2|Overall Study|Lost to Follow-up|1
336810|NCT01221623|1137849|P1|Overall Study|Lost to Follow-up|7
336811|NCT01221623|1137848|P2|Overall Study|Withdrawal by Subject|8
336812|NCT01221623|1137849|P1|Overall Study|Withdrawal by Subject|19
336813|NCT01221597|1137873|P2|Overall Study|Death|0
336814|NCT01221597|1137874|P1|Overall Study|Death|2
336815|NCT01221597|1137873|P2|Overall Study|Other|4
336816|NCT01221597|1137874|P1|Overall Study|Other|3
336817|NCT01221597|1137873|P2|Overall Study|Protocol Violation|0
336818|NCT01221597|1137874|P1|Overall Study|Protocol Violation|1
336819|NCT01221597|1137873|P2|Overall Study|Lost to Follow-up|5
336820|NCT01221597|1137874|P1|Overall Study|Lost to Follow-up|6
336821|NCT01221597|1137873|P2|Overall Study|Withdrawal by Subject|6
336822|NCT01221597|1137874|P1|Overall Study|Withdrawal by Subject|20
336823|NCT01221597|1137873|P2|Overall Study|Adverse Event|1
336824|NCT01221597|1137874|P1|Overall Study|Adverse Event|4
336825|NCT01221363|1137931|P2|Overall Study|Withdrawal by Subject|5
336826|NCT01221363|1137932|P1|Overall Study|Withdrawal by Subject|11
336827|NCT01221363|1137931|P2|Overall Study|Pregnancy|0
336828|NCT01221363|1137932|P1|Overall Study|Pregnancy|1
336829|NCT01221350|1137942|P2|Overall Study|Withdrawal by Subject|2
336830|NCT01221350|1137943|P1|Overall Study|Withdrawal by Subject|4
336831|NCT01221350|1137942|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
336832|NCT01221350|1137943|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
336833|NCT01221350|1137942|P2|Overall Study|Discontinued intervention (GERD)|0
336834|NCT01221350|1137943|P1|Overall Study|Discontinued intervention (GERD)|1
336835|NCT01221285|1138002|P1|Overall Study|Withdrawal by Subject|1
336836|NCT01221272|1138011|P2|Period 2|Adverse Event|2
336837|NCT01221272|1138012|P1|Period 2|Adverse Event|0
336838|NCT01221272|1138011|P2|Period 1|Significant Dosing Noncompliance|1
336839|NCT01221272|1138012|P1|Period 1|Significant Dosing Noncompliance|0
336840|NCT01221272|1138011|P2|Period 1|Consent Withdrawal|1
336841|NCT01221272|1138012|P1|Period 1|Consent Withdrawal|0
336842|NCT01221272|1138011|P2|Period 1|Adverse Event|0
336843|NCT01221272|1138012|P1|Period 1|Adverse Event|2
336844|NCT01221090|1138031|P4|Overall Study|Withdrawal by Subject|2
336845|NCT01221090|1138032|P3|Overall Study|Withdrawal by Subject|27
336846|NCT01221090|1138033|P2|Overall Study|Withdrawal by Subject|22
336847|NCT01221090|1138034|P1|Overall Study|Withdrawal by Subject|0
336848|NCT01221090|1138031|P4|Overall Study|Non-Compliant or Unable to Contact|20
336849|NCT01221090|1138032|P3|Overall Study|Non-Compliant or Unable to Contact|15
336850|NCT01221090|1138033|P2|Overall Study|Non-Compliant or Unable to Contact|12
336851|NCT01221090|1138034|P1|Overall Study|Non-Compliant or Unable to Contact|15
336852|NCT01220609|1138083|P1|Overall Study|Ineligible-Never treated|1
336853|NCT01220609|1138083|P1|Overall Study|Ineligible- Wrong cell type|1
336854|NCT01220609|1138083|P1|Overall Study|Ineligible-Wrong primary cancer site|1
336855|NCT01220557|1138097|P2|Overall Study|attended less than 6 lessons|2
336856|NCT01220557|1138098|P1|Overall Study|attended less than 6 lessons|1
336857|NCT01220557|1138097|P2|Overall Study|Lost to Follow-up|3
336858|NCT01220557|1138098|P1|Overall Study|Lost to Follow-up|5
336859|NCT01220414|1138131|P4|Overall Study|Withdrawal by Subject|1
336860|NCT01220414|1138132|P3|Overall Study|Withdrawal by Subject|0
336861|NCT01220414|1138133|P2|Overall Study|Withdrawal by Subject|0
336862|NCT01220414|1138134|P1|Overall Study|Withdrawal by Subject|1
336863|NCT01220401|1138141|P1|Overall Study|Protocol Violation|1
336864|NCT01220401|1138141|P1|Overall Study|Withdrawal by Subject|2
336865|NCT01220297|1138150|P1|Overall Study|Lost to Follow-up|1
336866|NCT01220297|1138150|P1|Overall Study|Death|2
336867|NCT01220180|1138167|P1|Overall Study|Randomized but not treated|1
336868|NCT01220180|1138167|P1|Overall Study|Death|1
336869|NCT01220180|1138167|P1|Overall Study|Lack of Efficacy|22
336870|NCT01220180|1138167|P1|Overall Study|Adverse Event|35
336871|NCT01220180|1138167|P1|Overall Study|Other|72
336872|NCT01220180|1138167|P1|Overall Study|Lost to Follow-up|76
336873|NCT01220128|1138197|P7|Overall Study|Consent withdrawn by subject|0
336874|NCT01220128|1138198|P6|Overall Study|Consent withdrawn by subject|0
336875|NCT01220128|1138199|P5|Overall Study|Consent withdrawn by subject|0
336876|NCT01220128|1138200|P4|Overall Study|Consent withdrawn by subject|0
336877|NCT01220128|1138201|P3|Overall Study|Consent withdrawn by subject|0
336878|NCT01220128|1138202|P2|Overall Study|Consent withdrawn by subject|0
336879|NCT01220128|1138203|P1|Overall Study|Consent withdrawn by subject|1
336880|NCT01220128|1138197|P7|Overall Study|Other|0
336881|NCT01220128|1138198|P6|Overall Study|Other|0
336882|NCT01220128|1138199|P5|Overall Study|Other|0
336883|NCT01220128|1138200|P4|Overall Study|Other|0
336884|NCT01220128|1138201|P3|Overall Study|Other|1
336885|NCT01220128|1138202|P2|Overall Study|Other|0
336886|NCT01220128|1138203|P1|Overall Study|Other|0
336887|NCT01220128|1138197|P7|Overall Study|Adverse event, non-fatal|3
336888|NCT01220128|1138198|P6|Overall Study|Adverse event, non-fatal|0
336889|NCT01220128|1138199|P5|Overall Study|Adverse event, non-fatal|0
336890|NCT01220128|1138200|P4|Overall Study|Adverse event, non-fatal|0
336891|NCT01220128|1138201|P3|Overall Study|Adverse event, non-fatal|0
336892|NCT01220128|1138202|P2|Overall Study|Adverse event, non-fatal|0
336893|NCT01220128|1138203|P1|Overall Study|Adverse event, non-fatal|1
336894|NCT01220128|1138197|P7|Overall Study|Adverse event, serious fatal|1
336895|NCT01220128|1138198|P6|Overall Study|Adverse event, serious fatal|0
336896|NCT01220128|1138199|P5|Overall Study|Adverse event, serious fatal|0
336897|NCT01220128|1138200|P4|Overall Study|Adverse event, serious fatal|0
336898|NCT01220128|1138201|P3|Overall Study|Adverse event, serious fatal|0
336899|NCT01220128|1138202|P2|Overall Study|Adverse event, serious fatal|0
336900|NCT01220128|1138203|P1|Overall Study|Adverse event, serious fatal|2
336901|NCT01220128|1138197|P7|Overall Study|Sponsor study termination|1
336902|NCT01220128|1138198|P6|Overall Study|Sponsor study termination|0
336903|NCT01220128|1138199|P5|Overall Study|Sponsor study termination|0
336904|NCT01220128|1138200|P4|Overall Study|Sponsor study termination|0
336905|NCT01220128|1138201|P3|Overall Study|Sponsor study termination|0
336906|NCT01220128|1138202|P2|Overall Study|Sponsor study termination|1
336907|NCT01220128|1138203|P1|Overall Study|Sponsor study termination|0
336908|NCT01220128|1138197|P7|Overall Study|Progressive disease|0
336909|NCT01220128|1138198|P6|Overall Study|Progressive disease|0
336910|NCT01220128|1138199|P5|Overall Study|Progressive disease|0
336911|NCT01220128|1138200|P4|Overall Study|Progressive disease|0
336912|NCT01220128|1138201|P3|Overall Study|Progressive disease|2
336913|NCT01220128|1138202|P2|Overall Study|Progressive disease|0
336914|NCT01220128|1138203|P1|Overall Study|Progressive disease|0
336915|NCT01219985|1138408|P1|Overall Study|Physician Decision|20
336916|NCT01219933|1138414|P1|Overall Study|Lack of Efficacy|1
336917|NCT01219933|1138414|P1|Overall Study|Protocol Violation|8
336918|NCT01219933|1138414|P1|Overall Study|Withdrawal by Subject|5
336919|NCT01219933|1138414|P1|Overall Study|GC free|1
336920|NCT01219933|1138414|P1|Overall Study|Lost to Follow-up|3
336921|NCT01219933|1138414|P1|Overall Study|No LDA maintained|7
336922|NCT01219933|1138414|P1|Overall Study|No LDA reached|5
336923|NCT01219933|1138414|P1|Overall Study|Adverse Event|8
336924|NCT01218867|1138624|P11|Overall Study|Death during treatment|0
336925|NCT01218867|1138625|P10|Overall Study|Death during treatment|0
336926|NCT01218867|1138626|P9|Overall Study|Death during treatment|0
336927|NCT01218867|1138627|P8|Overall Study|Death during treatment|0
336928|NCT01218867|1138628|P7|Overall Study|Death during treatment|1
336929|NCT01218867|1138629|P6|Overall Study|Death during treatment|0
336930|NCT01218867|1138630|P5|Overall Study|Death during treatment|0
336931|NCT01218867|1138631|P4|Overall Study|Death during treatment|0
336932|NCT01218867|1138632|P3|Overall Study|Death during treatment|0
336933|NCT01218867|1138633|P2|Overall Study|Death during treatment|0
336934|NCT01218867|1138634|P1|Overall Study|Death during treatment|0
336935|NCT01218802|1138682|P2|Overall Study|Incarcerated|0
336936|NCT01218802|1138683|P1|Overall Study|Incarcerated|2
336937|NCT01218802|1138682|P2|Overall Study|Adverse Event|2
336938|NCT01218802|1138683|P1|Overall Study|Adverse Event|0
336939|NCT01218802|1138682|P2|Overall Study|Withdrawal by Subject|10
336940|NCT01218802|1138683|P1|Overall Study|Withdrawal by Subject|3
336941|NCT01218802|1138682|P2|Overall Study|Lost to Follow-up|6
336942|NCT01218802|1138683|P1|Overall Study|Lost to Follow-up|5
336943|NCT01218646|1138695|P4|Overall Study|Protocol Violation|1
336944|NCT01218646|1138696|P3|Overall Study|Protocol Violation|1
336945|NCT01218646|1138697|P2|Overall Study|Protocol Violation|0
336946|NCT01218646|1138698|P1|Overall Study|Protocol Violation|0
336947|NCT01218646|1138695|P4|Overall Study|Lost to Follow-up|0
336948|NCT01218646|1138696|P3|Overall Study|Lost to Follow-up|0
336949|NCT01218646|1138697|P2|Overall Study|Lost to Follow-up|0
336950|NCT01218646|1138698|P1|Overall Study|Lost to Follow-up|1
336951|NCT01218646|1138695|P4|Overall Study|Adverse Event|0
336952|NCT01218646|1138696|P3|Overall Study|Adverse Event|1
336953|NCT01218646|1138697|P2|Overall Study|Adverse Event|0
336954|NCT01218646|1138698|P1|Overall Study|Adverse Event|0
336955|NCT01218594|1138736|P1|Overall Study|Physician Decision|6
336956|NCT01218594|1138736|P1|Overall Study|Adverse Event|2
336957|NCT01218594|1138736|P1|Overall Study|Withdrawal by Subject|3
336958|NCT01218594|1138736|P1|Overall Study|Death|1
336959|NCT01218477|1138744|P4|Overall Study|Maximum clinical benefit|0
336960|NCT01218477|1138745|P3|Overall Study|Maximum clinical benefit|0
336961|NCT01218477|1138746|P2|Overall Study|Maximum clinical benefit|2
336962|NCT01218477|1138747|P1|Overall Study|Maximum clinical benefit|0
336963|NCT01218477|1138744|P4|Overall Study|Administrative reason by sponsor|0
336964|NCT01218477|1138745|P3|Overall Study|Administrative reason by sponsor|1
336965|NCT01218477|1138746|P2|Overall Study|Administrative reason by sponsor|0
336966|NCT01218477|1138747|P1|Overall Study|Administrative reason by sponsor|0
336967|NCT01218477|1138744|P4|Overall Study|Prepared for cell transplantation|0
336968|NCT01218477|1138745|P3|Overall Study|Prepared for cell transplantation|1
336969|NCT01218477|1138746|P2|Overall Study|Prepared for cell transplantation|1
336970|NCT01218477|1138747|P1|Overall Study|Prepared for cell transplantation|0
336971|NCT01218477|1138744|P4|Overall Study|Withdrawal by Subject|0
336972|NCT01218477|1138745|P3|Overall Study|Withdrawal by Subject|1
336973|NCT01218477|1138746|P2|Overall Study|Withdrawal by Subject|0
336974|NCT01218477|1138747|P1|Overall Study|Withdrawal by Subject|0
336975|NCT01218477|1138744|P4|Overall Study|No longer meets study criteria|0
336976|NCT01218477|1138745|P3|Overall Study|No longer meets study criteria|0
336977|NCT01218477|1138746|P2|Overall Study|No longer meets study criteria|0
336978|NCT01218477|1138747|P1|Overall Study|No longer meets study criteria|1
336979|NCT01218477|1138744|P4|Overall Study|Study drug toxicity|0
336980|NCT01218477|1138745|P3|Overall Study|Study drug toxicity|5
336981|NCT01218477|1138746|P2|Overall Study|Study drug toxicity|2
336982|NCT01218477|1138747|P1|Overall Study|Study drug toxicity|0
336983|NCT01218477|1138744|P4|Overall Study|Disease progression|2
336984|NCT01218477|1138745|P3|Overall Study|Disease progression|6
336985|NCT01218477|1138746|P2|Overall Study|Disease progression|3
336986|NCT01218477|1138747|P1|Overall Study|Disease progression|2
336987|NCT01218438|1138764|P1|Epoch 4|Withdrawal by Subject|2
336988|NCT01218438|1138764|P1|Epoch 4|Physician Decision|1
336989|NCT01218438|1138764|P1|Epoch 3|Adverse Event|1
336990|NCT01218438|1138764|P1|Epoch 3|Withdrawal by Subject|3
336991|NCT01218438|1138764|P1|Epoch 1|Adverse Event|1
336992|NCT01218438|1138764|P1|Epoch 1|Physician Decision|2
336993|NCT01218308|1138930|P2|Overall Study|Other|21
336994|NCT01218308|1138931|P1|Overall Study|Other|14
336995|NCT01218308|1138930|P2|Overall Study|Lost to Follow-up|31
336996|NCT01218308|1138931|P1|Overall Study|Lost to Follow-up|27
336997|NCT01218308|1138930|P2|Overall Study|Withdrawal by Subject|64
336998|NCT01218308|1138931|P1|Overall Study|Withdrawal by Subject|61
336999|NCT01218308|1138930|P2|Overall Study|Protocol Violation|2
337000|NCT01218308|1138931|P1|Overall Study|Protocol Violation|0
337001|NCT01218308|1138930|P2|Overall Study|Adverse Event|2
337002|NCT01218308|1138931|P1|Overall Study|Adverse Event|1
337003|NCT01218243|1138975|P2|Overall Study|Protocol Violation|10
337004|NCT01218243|1138976|P1|Overall Study|Protocol Violation|5
337005|NCT01218243|1138975|P2|Overall Study|Lost to Follow-up|3
337006|NCT01218243|1138976|P1|Overall Study|Lost to Follow-up|3
337007|NCT01218243|1138975|P2|Overall Study|Lack of Efficacy|1
337008|NCT01218243|1138976|P1|Overall Study|Lack of Efficacy|1
337009|NCT01218204|1138992|P4|Part B Pooled Treatment Arm|Protocol Violation|1
337010|NCT01218204|1138993|P3|Part B Pooled Treatment Arm|Protocol Violation|0
337011|NCT01218204|1138994|P2|Part B Pooled Treatment Arm|Protocol Violation|0
337012|NCT01218204|1138995|P1|Part B Pooled Treatment Arm|Protocol Violation|0
337013|NCT01218204|1138992|P4|Part B Pooled Treatment Arm|Adverse Event|2
337014|NCT01218204|1138993|P3|Part B Pooled Treatment Arm|Adverse Event|0
337015|NCT01218204|1138994|P2|Part B Pooled Treatment Arm|Adverse Event|0
337016|NCT01218204|1138995|P1|Part B Pooled Treatment Arm|Adverse Event|0
337017|NCT01218204|1138992|P4|Part B Run-in|Withdrawal by Subject|0
337018|NCT01218204|1138993|P3|Part B Run-in|Withdrawal by Subject|3
337019|NCT01218204|1138994|P2|Part B Run-in|Withdrawal by Subject|0
337020|NCT01218204|1138995|P1|Part B Run-in|Withdrawal by Subject|0
337021|NCT01218204|1138992|P4|Part B Run-in|Protocol Violation|0
337022|NCT01218204|1138993|P3|Part B Run-in|Protocol Violation|2
337023|NCT01218204|1138994|P2|Part B Run-in|Protocol Violation|0
337024|NCT01218204|1138995|P1|Part B Run-in|Protocol Violation|0
337025|NCT01218204|1138992|P4|Part B Run-in|Adverse Event|0
337026|NCT01218204|1138993|P3|Part B Run-in|Adverse Event|1
337027|NCT01218204|1138994|P2|Part B Run-in|Adverse Event|0
337028|NCT01218204|1138995|P1|Part B Run-in|Adverse Event|0
337029|NCT01218204|1138992|P4|Part B Washout|Did not meet continuation criteria|0
337030|NCT01218204|1138993|P3|Part B Washout|Did not meet continuation criteria|0
337031|NCT01218204|1138994|P2|Part B Washout|Did not meet continuation criteria|112
337032|NCT01218204|1138995|P1|Part B Washout|Did not meet continuation criteria|0
337033|NCT01218204|1138992|P4|Part B Washout|Reached defined stopping criteria|0
337034|NCT01218204|1138993|P3|Part B Washout|Reached defined stopping criteria|0
337035|NCT01218204|1138994|P2|Part B Washout|Reached defined stopping criteria|2
337036|NCT01218204|1138995|P1|Part B Washout|Reached defined stopping criteria|0
337037|NCT01218204|1138992|P4|Part B Washout|Withdrawal by Subject|0
337038|NCT01218204|1138993|P3|Part B Washout|Withdrawal by Subject|0
337039|NCT01218204|1138994|P2|Part B Washout|Withdrawal by Subject|14
337040|NCT01218204|1138995|P1|Part B Washout|Withdrawal by Subject|0
337041|NCT01218204|1138992|P4|Part B Washout|Physician Decision|0
337042|NCT01218204|1138993|P3|Part B Washout|Physician Decision|0
337043|NCT01218204|1138994|P2|Part B Washout|Physician Decision|14
337044|NCT01218204|1138995|P1|Part B Washout|Physician Decision|0
337045|NCT01218204|1138992|P4|Part B Washout|Lost to Follow-up|0
337046|NCT01218204|1138993|P3|Part B Washout|Lost to Follow-up|0
337047|NCT01218204|1138994|P2|Part B Washout|Lost to Follow-up|2
337048|NCT01218204|1138995|P1|Part B Washout|Lost to Follow-up|0
337049|NCT01218204|1138992|P4|Part B Washout|Adverse Event|0
337050|NCT01218204|1138993|P3|Part B Washout|Adverse Event|0
337051|NCT01218204|1138994|P2|Part B Washout|Adverse Event|1
337052|NCT01218204|1138995|P1|Part B Washout|Adverse Event|0
337053|NCT01218126|1139259|P4|Overall Study|Withdrawal by Subject|6
337054|NCT01218126|1139260|P3|Overall Study|Withdrawal by Subject|4
337055|NCT01218126|1139261|P2|Overall Study|Withdrawal by Subject|5
337056|NCT01218126|1139262|P1|Overall Study|Withdrawal by Subject|2
337057|NCT01218126|1139259|P4|Overall Study|Physician Decision|2
337058|NCT01218126|1139260|P3|Overall Study|Physician Decision|4
337059|NCT01218126|1139261|P2|Overall Study|Physician Decision|2
337060|NCT01218126|1139262|P1|Overall Study|Physician Decision|1
337061|NCT01218126|1139259|P4|Overall Study|Lost to Follow-up|2
337062|NCT01218126|1139260|P3|Overall Study|Lost to Follow-up|0
337063|NCT01218126|1139261|P2|Overall Study|Lost to Follow-up|0
337064|NCT01218126|1139262|P1|Overall Study|Lost to Follow-up|0
337065|NCT01218126|1139259|P4|Overall Study|Protocol-defined stopping criteria|0
337066|NCT01218126|1139260|P3|Overall Study|Protocol-defined stopping criteria|0
337067|NCT01218126|1139261|P2|Overall Study|Protocol-defined stopping criteria|1
337068|NCT01218126|1139262|P1|Overall Study|Protocol-defined stopping criteria|1
337069|NCT01218126|1139259|P4|Overall Study|Protocol Violation|3
337070|NCT01218126|1139260|P3|Overall Study|Protocol Violation|2
337071|NCT01218126|1139261|P2|Overall Study|Protocol Violation|2
337072|NCT01218126|1139262|P1|Overall Study|Protocol Violation|5
337073|NCT01218126|1139259|P4|Overall Study|Lack of Efficacy|6
337074|NCT01218126|1139260|P3|Overall Study|Lack of Efficacy|2
337075|NCT01218126|1139261|P2|Overall Study|Lack of Efficacy|2
337076|NCT01218126|1139262|P1|Overall Study|Lack of Efficacy|7
337077|NCT01218126|1139259|P4|Overall Study|Adverse Event|16
337078|NCT01218126|1139260|P3|Overall Study|Adverse Event|12
337079|NCT01218126|1139261|P2|Overall Study|Adverse Event|10
337080|NCT01218126|1139262|P1|Overall Study|Adverse Event|8
337081|NCT01218113|1139303|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
337082|NCT01218113|1139304|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
337083|NCT01218113|1139305|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
337084|NCT01218113|1139303|P3|Overall Study|Lost to Follow-up|4
337085|NCT01218113|1139304|P2|Overall Study|Lost to Follow-up|1
337086|NCT01218113|1139305|P1|Overall Study|Lost to Follow-up|4
337087|NCT01218113|1139303|P3|Overall Study|Withdrawal by Subject|1
337088|NCT01218113|1139304|P2|Overall Study|Withdrawal by Subject|0
337089|NCT01218113|1139305|P1|Overall Study|Withdrawal by Subject|1
337090|NCT01218100|1139486|P4|Overall Study|Other Reason|4
337091|NCT01218100|1139487|P3|Overall Study|Other Reason|6
337092|NCT01218100|1139488|P2|Overall Study|Other Reason|2
337093|NCT01218100|1139489|P1|Overall Study|Other Reason|2
337094|NCT01218100|1139486|P4|Overall Study|Lost to Follow-up|1
337095|NCT01218100|1139487|P3|Overall Study|Lost to Follow-up|2
337096|NCT01218100|1139488|P2|Overall Study|Lost to Follow-up|8
337097|NCT01218100|1139489|P1|Overall Study|Lost to Follow-up|3
337098|NCT01218100|1139486|P4|Overall Study|Withdrawal by Subject|7
337099|NCT01218100|1139487|P3|Overall Study|Withdrawal by Subject|6
337100|NCT01218100|1139488|P2|Overall Study|Withdrawal by Subject|2
337101|NCT01218100|1139489|P1|Overall Study|Withdrawal by Subject|5
337102|NCT01218100|1139486|P4|Overall Study|Protocol Violation|1
337103|NCT01218100|1139487|P3|Overall Study|Protocol Violation|1
337104|NCT01218100|1139488|P2|Overall Study|Protocol Violation|0
337105|NCT01218100|1139489|P1|Overall Study|Protocol Violation|0
337106|NCT01218100|1139486|P4|Overall Study|Lack of Efficacy|12
337107|NCT01218100|1139487|P3|Overall Study|Lack of Efficacy|5
337108|NCT01218100|1139488|P2|Overall Study|Lack of Efficacy|6
337109|NCT01218100|1139489|P1|Overall Study|Lack of Efficacy|9
337110|NCT01218100|1139486|P4|Overall Study|Adverse Event|7
337111|NCT01218100|1139487|P3|Overall Study|Adverse Event|6
337112|NCT01218100|1139488|P2|Overall Study|Adverse Event|6
337113|NCT01218100|1139489|P1|Overall Study|Adverse Event|4
337114|NCT01218100|1139486|P4|Overall Study|Did not meet InclusionExclusion criteria|2
337115|NCT01218100|1139487|P3|Overall Study|Did not meet InclusionExclusion criteria|1
337116|NCT01218100|1139488|P2|Overall Study|Did not meet InclusionExclusion criteria|1
337117|NCT01218100|1139489|P1|Overall Study|Did not meet InclusionExclusion criteria|1
337118|NCT01218087|1139505|P2|Overall Study|Transferred|5
337119|NCT01218087|1139506|P1|Overall Study|Transferred|8
337120|NCT01218087|1139505|P2|Overall Study|Withdrawal by Subject|0
337121|NCT01218087|1139506|P1|Overall Study|Withdrawal by Subject|5
337122|NCT01218087|1139505|P2|Overall Study|Death|1
337123|NCT01218087|1139506|P1|Overall Study|Death|2
337124|NCT01218009|1139516|P2|Overall Study|Sponsor terminated study|163
337125|NCT01218009|1139517|P1|Overall Study|Sponsor terminated study|161
337126|NCT01218009|1139516|P2|Overall Study|Withdrawal by Subject|1
337127|NCT01218009|1139517|P1|Overall Study|Withdrawal by Subject|3
337128|NCT01218009|1139516|P2|Overall Study|Protocol Violation|1
337129|NCT01218009|1139517|P1|Overall Study|Protocol Violation|2
337130|NCT01217957|1139540|P5|Phase 2|Withdrawal by Patient|1
337131|NCT01217957|1139541|P4|Phase 2|Withdrawal by Patient|0
337132|NCT01217957|1139542|P3|Phase 2|Withdrawal by Patient|0
337133|NCT01217957|1139543|P2|Phase 2|Withdrawal by Patient|0
337134|NCT01217957|1139544|P1|Phase 2|Withdrawal by Patient|0
337135|NCT01217957|1139540|P5|Phase 1|Withdrawal by Patient|0
337136|NCT01217957|1139541|P4|Phase 1|Withdrawal by Patient|1
337137|NCT01217957|1139542|P3|Phase 1|Withdrawal by Patient|1
337138|NCT01217957|1139543|P2|Phase 1|Withdrawal by Patient|0
337139|NCT01217957|1139544|P1|Phase 1|Withdrawal by Patient|1
337140|NCT01217944|1139603|P3|Overall Study|Lack of Efficacy|0
337141|NCT01217944|1139604|P2|Overall Study|Lack of Efficacy|0
337142|NCT01217944|1139605|P1|Overall Study|Lack of Efficacy|1
337143|NCT01217944|1139603|P3|Overall Study|Withdrawal by Subject|0
337144|NCT01217944|1139604|P2|Overall Study|Withdrawal by Subject|2
337145|NCT01217944|1139605|P1|Overall Study|Withdrawal by Subject|1
337146|NCT01217944|1139603|P3|Overall Study|Lost to Follow-up|0
337147|NCT01217944|1139604|P2|Overall Study|Lost to Follow-up|1
337148|NCT01217944|1139605|P1|Overall Study|Lost to Follow-up|3
337149|NCT01217944|1139603|P3|Overall Study|Protocol Violation|0
337150|NCT01217944|1139604|P2|Overall Study|Protocol Violation|1
337151|NCT01217944|1139605|P1|Overall Study|Protocol Violation|1
337152|NCT01217892|1139648|P4|Overall Study|Poor/Non-Compliance|0
337153|NCT01217892|1139649|P3|Overall Study|Poor/Non-Compliance|1
337154|NCT01217892|1139650|P2|Overall Study|Poor/Non-Compliance|0
337155|NCT01217892|1139651|P1|Overall Study|Poor/Non-Compliance|0
337156|NCT01217892|1139648|P4|Overall Study|Incorrect enrollment|0
337157|NCT01217892|1139649|P3|Overall Study|Incorrect enrollment|1
337158|NCT01217892|1139650|P2|Overall Study|Incorrect enrollment|1
337159|NCT01217892|1139651|P1|Overall Study|Incorrect enrollment|0
337160|NCT01217892|1139648|P4|Overall Study|Subject no longer meets study criteria|8
337161|NCT01217892|1139649|P3|Overall Study|Subject no longer meets study criteria|4
337162|NCT01217892|1139650|P2|Overall Study|Subject no longer meets study criteria|2
337163|NCT01217892|1139651|P1|Overall Study|Subject no longer meets study criteria|5
337164|NCT01217892|1139648|P4|Overall Study|Lab value|0
337165|NCT01217892|1139649|P3|Overall Study|Lab value|1
337166|NCT01217892|1139650|P2|Overall Study|Lab value|0
337167|NCT01217892|1139651|P1|Overall Study|Lab value|1
337168|NCT01217892|1139648|P4|Overall Study|Withdrawal by Subject|0
337169|NCT01217892|1139649|P3|Overall Study|Withdrawal by Subject|1
337170|NCT01217892|1139650|P2|Overall Study|Withdrawal by Subject|2
337171|NCT01217892|1139651|P1|Overall Study|Withdrawal by Subject|0
337172|NCT01217892|1139648|P4|Overall Study|Adverse Event|0
337173|NCT01217892|1139649|P3|Overall Study|Adverse Event|1
337174|NCT01217892|1139650|P2|Overall Study|Adverse Event|1
337175|NCT01217892|1139651|P1|Overall Study|Adverse Event|1
337176|NCT01217814|1139714|P3|Overall Study|Lack of Efficacy|1
337177|NCT01217814|1139715|P2|Overall Study|Lack of Efficacy|0
337178|NCT01217814|1139716|P1|Overall Study|Lack of Efficacy|0
337179|NCT01217814|1139714|P3|Overall Study|Adverse Event|0
337180|NCT01217814|1139715|P2|Overall Study|Adverse Event|1
337181|NCT01217814|1139716|P1|Overall Study|Adverse Event|1
337182|NCT01217801|1139742|P2|Period 1|Withdrawal by Subject|1
337183|NCT01217801|1139743|P1|Period 1|Withdrawal by Subject|0
337184|NCT01217801|1139742|P2|Period 1|Protocol Violation|1
337185|NCT01217801|1139743|P1|Period 1|Protocol Violation|1
337186|NCT01217606|1139772|P2|9-Month Masked Extension|Lack of Efficacy|0
337187|NCT01217606|1139773|P1|9-Month Masked Extension|Lack of Efficacy|2
337188|NCT01217606|1139772|P2|9-Month Masked Extension|Pregnancy|0
337189|NCT01217606|1139773|P1|9-Month Masked Extension|Pregnancy|1
337190|NCT01217606|1139772|P2|9-Month Masked Extension|Lost to Follow-up|0
337191|NCT01217606|1139773|P1|9-Month Masked Extension|Lost to Follow-up|1
337192|NCT01217606|1139772|P2|9-Month Masked Extension|Personal Reasons|1
337193|NCT01217606|1139773|P1|9-Month Masked Extension|Personal Reasons|2
337194|NCT01217606|1139772|P2|9-Month Masked Extension|Other Reasons|4
337195|NCT01217606|1139773|P1|9-Month Masked Extension|Other Reasons|4
337196|NCT01217606|1139772|P2|9-Month Masked Extension|Adverse Event|6
337197|NCT01217606|1139773|P1|9-Month Masked Extension|Adverse Event|3
337198|NCT01217606|1139772|P2|Initial Treatment Phase|Adverse Event|6
337199|NCT01217606|1139773|P1|Initial Treatment Phase|Adverse Event|10
337200|NCT01217606|1139772|P2|Initial Treatment Phase|Lack of Efficacy|0
337201|NCT01217606|1139773|P1|Initial Treatment Phase|Lack of Efficacy|1
337202|NCT01217606|1139772|P2|Initial Treatment Phase|Personal Reasons|2
337203|NCT01217606|1139773|P1|Initial Treatment Phase|Personal Reasons|0
337204|NCT01217606|1139772|P2|Initial Treatment Phase|Protocol Violation|2
337205|NCT01217606|1139773|P1|Initial Treatment Phase|Protocol Violation|3
337206|NCT01217606|1139772|P2|Initial Treatment Phase|Other Reasons|2
337207|NCT01217606|1139773|P1|Initial Treatment Phase|Other Reasons|0
337208|NCT01217476|1139804|P2|Overall Study|Other|0
337209|NCT01217476|1139805|P1|Overall Study|Other|2
337210|NCT01217476|1139804|P2|Overall Study|Protocol Deviation|0
337211|NCT01217476|1139805|P1|Overall Study|Protocol Deviation|1
337212|NCT01217476|1139804|P2|Overall Study|Surgery on the Target Limb|2
337213|NCT01217476|1139805|P1|Overall Study|Surgery on the Target Limb|0
337214|NCT01217476|1139804|P2|Overall Study|Withdrawal by Subject|3
337215|NCT01217476|1139805|P1|Overall Study|Withdrawal by Subject|3
337216|NCT01217476|1139804|P2|Overall Study|Physician Decision|1
337217|NCT01217476|1139805|P1|Overall Study|Physician Decision|0
337218|NCT01217476|1139804|P2|Overall Study|Adverse Event|1
337219|NCT01217476|1139805|P1|Overall Study|Adverse Event|6
337220|NCT01217463|1139815|P2|Overall Study|Other|1
337221|NCT01217463|1139816|P1|Overall Study|Other|1
337222|NCT01217463|1139815|P2|Overall Study|Patient Non-compliant|0
337223|NCT01217463|1139816|P1|Overall Study|Patient Non-compliant|1
337224|NCT01217463|1139815|P2|Overall Study|Surgery on the Target Limb|1
337225|NCT01217463|1139816|P1|Overall Study|Surgery on the Target Limb|0
337226|NCT01217463|1139815|P2|Overall Study|Withdrawal by Subject|0
337227|NCT01217463|1139816|P1|Overall Study|Withdrawal by Subject|3
337228|NCT01217463|1139815|P2|Overall Study|Physician Decision|1
337229|NCT01217463|1139816|P1|Overall Study|Physician Decision|0
337230|NCT01217463|1139815|P2|Overall Study|Adverse Event|5
337231|NCT01217463|1139816|P1|Overall Study|Adverse Event|8
337232|NCT01217307|1139836|P2|Overall Study|Withdrawal by Subject|1
337233|NCT01217307|1139837|P1|Overall Study|Withdrawal by Subject|0
337234|NCT01217112|1139852|P5|Overall Study|Physician Decision|1
337235|NCT01217112|1139853|P4|Overall Study|Physician Decision|0
337236|NCT01217112|1139854|P3|Overall Study|Physician Decision|0
337237|NCT01217112|1139855|P2|Overall Study|Physician Decision|0
337238|NCT01217112|1139856|P1|Overall Study|Physician Decision|0
337239|NCT01217112|1139852|P5|Overall Study|Withdrawal by Subject|0
337240|NCT01217112|1139853|P4|Overall Study|Withdrawal by Subject|0
337241|NCT01217112|1139854|P3|Overall Study|Withdrawal by Subject|1
337242|NCT01217112|1139855|P2|Overall Study|Withdrawal by Subject|0
337243|NCT01217112|1139856|P1|Overall Study|Withdrawal by Subject|0
337244|NCT01217112|1139852|P5|Overall Study|Adverse Event|0
337245|NCT01217112|1139853|P4|Overall Study|Adverse Event|2
337246|NCT01217112|1139854|P3|Overall Study|Adverse Event|0
337247|NCT01217112|1139855|P2|Overall Study|Adverse Event|2
337248|NCT01217112|1139856|P1|Overall Study|Adverse Event|0
337249|NCT01217073|1140089|P8|Extension Period|Withdrawal by Subject|8
337250|NCT01217073|1140090|P7|Extension Period|Withdrawal by Subject|30
337251|NCT01217073|1140091|P6|Extension Period|Withdrawal by Subject|0
337252|NCT01217073|1140092|P5|Extension Period|Withdrawal by Subject|0
337253|NCT01217073|1140093|P4|Extension Period|Withdrawal by Subject|0
337254|NCT01217073|1140094|P3|Extension Period|Withdrawal by Subject|0
337255|NCT01217073|1140095|P2|Extension Period|Withdrawal by Subject|0
337256|NCT01217073|1140096|P1|Extension Period|Withdrawal by Subject|0
337257|NCT01217073|1140089|P8|Extension Period|Site discontinued study participation|2
337258|NCT01217073|1140090|P7|Extension Period|Site discontinued study participation|7
337259|NCT01217073|1140091|P6|Extension Period|Site discontinued study participation|0
337260|NCT01217073|1140092|P5|Extension Period|Site discontinued study participation|0
337261|NCT01217073|1140093|P4|Extension Period|Site discontinued study participation|0
337262|NCT01217073|1140094|P3|Extension Period|Site discontinued study participation|0
337263|NCT01217073|1140095|P2|Extension Period|Site discontinued study participation|0
337264|NCT01217073|1140096|P1|Extension Period|Site discontinued study participation|0
337265|NCT01217073|1140089|P8|Extension Period|Protocol Violation|1
337266|NCT01217073|1140090|P7|Extension Period|Protocol Violation|2
337267|NCT01217073|1140091|P6|Extension Period|Protocol Violation|0
337268|NCT01217073|1140092|P5|Extension Period|Protocol Violation|0
337269|NCT01217073|1140093|P4|Extension Period|Protocol Violation|0
337270|NCT01217073|1140094|P3|Extension Period|Protocol Violation|0
337271|NCT01217073|1140095|P2|Extension Period|Protocol Violation|0
337272|NCT01217073|1140096|P1|Extension Period|Protocol Violation|0
337273|NCT01217073|1140089|P8|Extension Period|Physician Decision|1
337274|NCT01217073|1140090|P7|Extension Period|Physician Decision|4
337275|NCT01217073|1140091|P6|Extension Period|Physician Decision|0
337276|NCT01217073|1140092|P5|Extension Period|Physician Decision|0
337277|NCT01217073|1140093|P4|Extension Period|Physician Decision|0
337278|NCT01217073|1140094|P3|Extension Period|Physician Decision|0
337279|NCT01217073|1140095|P2|Extension Period|Physician Decision|0
337280|NCT01217073|1140096|P1|Extension Period|Physician Decision|0
337281|NCT01217073|1140089|P8|Extension Period|Non-compliance with study drug|1
337282|NCT01217073|1140090|P7|Extension Period|Non-compliance with study drug|0
337283|NCT01217073|1140091|P6|Extension Period|Non-compliance with study drug|0
337284|NCT01217073|1140092|P5|Extension Period|Non-compliance with study drug|0
337285|NCT01217073|1140093|P4|Extension Period|Non-compliance with study drug|0
337286|NCT01217073|1140094|P3|Extension Period|Non-compliance with study drug|0
337287|NCT01217073|1140095|P2|Extension Period|Non-compliance with study drug|0
337288|NCT01217073|1140096|P1|Extension Period|Non-compliance with study drug|0
337289|NCT01217073|1140089|P8|Extension Period|Lost to Follow-up|1
337290|NCT01217073|1140090|P7|Extension Period|Lost to Follow-up|9
337291|NCT01217073|1140091|P6|Extension Period|Lost to Follow-up|0
337292|NCT01217073|1140092|P5|Extension Period|Lost to Follow-up|0
337293|NCT01217073|1140093|P4|Extension Period|Lost to Follow-up|0
337294|NCT01217073|1140094|P3|Extension Period|Lost to Follow-up|0
337295|NCT01217073|1140095|P2|Extension Period|Lost to Follow-up|0
337296|NCT01217073|1140096|P1|Extension Period|Lost to Follow-up|0
337297|NCT01217073|1140089|P8|Extension Period|Lack of Efficacy|0
337298|NCT01217073|1140090|P7|Extension Period|Lack of Efficacy|3
337299|NCT01217073|1140091|P6|Extension Period|Lack of Efficacy|0
337300|NCT01217073|1140092|P5|Extension Period|Lack of Efficacy|0
337301|NCT01217073|1140093|P4|Extension Period|Lack of Efficacy|0
337302|NCT01217073|1140094|P3|Extension Period|Lack of Efficacy|0
337303|NCT01217073|1140095|P2|Extension Period|Lack of Efficacy|0
337304|NCT01217073|1140096|P1|Extension Period|Lack of Efficacy|0
337305|NCT01217073|1140089|P8|Extension Period|Excluded medication|0
337306|NCT01217073|1140090|P7|Extension Period|Excluded medication|2
337307|NCT01217073|1140091|P6|Extension Period|Excluded medication|0
337308|NCT01217073|1140092|P5|Extension Period|Excluded medication|0
337309|NCT01217073|1140093|P4|Extension Period|Excluded medication|0
337310|NCT01217073|1140094|P3|Extension Period|Excluded medication|0
337311|NCT01217073|1140095|P2|Extension Period|Excluded medication|0
337312|NCT01217073|1140096|P1|Extension Period|Excluded medication|0
337313|NCT01217073|1140089|P8|Extension Period|Death|0
337314|NCT01217073|1140090|P7|Extension Period|Death|1
337315|NCT01217073|1140091|P6|Extension Period|Death|0
337316|NCT01217073|1140092|P5|Extension Period|Death|0
337317|NCT01217073|1140093|P4|Extension Period|Death|0
337318|NCT01217073|1140094|P3|Extension Period|Death|0
337319|NCT01217073|1140095|P2|Extension Period|Death|0
337320|NCT01217073|1140096|P1|Extension Period|Death|0
337321|NCT01217073|1140089|P8|Extension Period|Creatinine/eGFR|1
337322|NCT01217073|1140090|P7|Extension Period|Creatinine/eGFR|11
337323|NCT01217073|1140091|P6|Extension Period|Creatinine/eGFR|0
337324|NCT01217073|1140092|P5|Extension Period|Creatinine/eGFR|0
337325|NCT01217073|1140093|P4|Extension Period|Creatinine/eGFR|0
337326|NCT01217073|1140094|P3|Extension Period|Creatinine/eGFR|0
337327|NCT01217073|1140095|P2|Extension Period|Creatinine/eGFR|0
337328|NCT01217073|1140096|P1|Extension Period|Creatinine/eGFR|0
337329|NCT01217073|1140089|P8|Extension Period|Contraindication to study medication|0
337330|NCT01217073|1140090|P7|Extension Period|Contraindication to study medication|1
337331|NCT01217073|1140091|P6|Extension Period|Contraindication to study medication|0
337332|NCT01217073|1140092|P5|Extension Period|Contraindication to study medication|0
337333|NCT01217073|1140093|P4|Extension Period|Contraindication to study medication|0
337334|NCT01217073|1140094|P3|Extension Period|Contraindication to study medication|0
337335|NCT01217073|1140095|P2|Extension Period|Contraindication to study medication|0
337336|NCT01217073|1140096|P1|Extension Period|Contraindication to study medication|0
337337|NCT01217073|1140089|P8|Extension Period|ALT/AST|0
337338|NCT01217073|1140090|P7|Extension Period|ALT/AST|2
337339|NCT01217073|1140091|P6|Extension Period|ALT/AST|0
337340|NCT01217073|1140092|P5|Extension Period|ALT/AST|0
337341|NCT01217073|1140093|P4|Extension Period|ALT/AST|0
337342|NCT01217073|1140094|P3|Extension Period|ALT/AST|0
337343|NCT01217073|1140095|P2|Extension Period|ALT/AST|0
337344|NCT01217073|1140096|P1|Extension Period|ALT/AST|0
337345|NCT01217073|1140089|P8|Extension Period|Adverse Event|5
337346|NCT01217073|1140090|P7|Extension Period|Adverse Event|19
337347|NCT01217073|1140091|P6|Extension Period|Adverse Event|0
337348|NCT01217073|1140092|P5|Extension Period|Adverse Event|0
337349|NCT01217073|1140093|P4|Extension Period|Adverse Event|0
337350|NCT01217073|1140094|P3|Extension Period|Adverse Event|0
337351|NCT01217073|1140095|P2|Extension Period|Adverse Event|0
337352|NCT01217073|1140096|P1|Extension Period|Adverse Event|0
337353|NCT01217073|1140089|P8|Base Period|Withdrawal by Subject|0
337354|NCT01217073|1140090|P7|Base Period|Withdrawal by Subject|0
337355|NCT01217073|1140091|P6|Base Period|Withdrawal by Subject|5
337356|NCT01217073|1140092|P5|Base Period|Withdrawal by Subject|5
337357|NCT01217073|1140093|P4|Base Period|Withdrawal by Subject|1
337358|NCT01217073|1140094|P3|Base Period|Withdrawal by Subject|5
337359|NCT01217073|1140095|P2|Base Period|Withdrawal by Subject|5
337360|NCT01217073|1140096|P1|Base Period|Withdrawal by Subject|4
337361|NCT01217073|1140089|P8|Base Period|Protocol Violation|0
337362|NCT01217073|1140090|P7|Base Period|Protocol Violation|0
337363|NCT01217073|1140091|P6|Base Period|Protocol Violation|2
337364|NCT01217073|1140092|P5|Base Period|Protocol Violation|1
337365|NCT01217073|1140093|P4|Base Period|Protocol Violation|0
337366|NCT01217073|1140094|P3|Base Period|Protocol Violation|0
337367|NCT01217073|1140095|P2|Base Period|Protocol Violation|0
337368|NCT01217073|1140096|P1|Base Period|Protocol Violation|1
337369|NCT01217073|1140089|P8|Base Period|Physician Decision|0
337370|NCT01217073|1140090|P7|Base Period|Physician Decision|0
337371|NCT01217073|1140091|P6|Base Period|Physician Decision|0
337372|NCT01217073|1140092|P5|Base Period|Physician Decision|1
337373|NCT01217073|1140093|P4|Base Period|Physician Decision|0
337374|NCT01217073|1140094|P3|Base Period|Physician Decision|0
337375|NCT01217073|1140095|P2|Base Period|Physician Decision|0
337376|NCT01217073|1140096|P1|Base Period|Physician Decision|0
337377|NCT01217073|1140089|P8|Base Period|Lost to Follow-up|0
337378|NCT01217073|1140090|P7|Base Period|Lost to Follow-up|0
337379|NCT01217073|1140091|P6|Base Period|Lost to Follow-up|0
337380|NCT01217073|1140092|P5|Base Period|Lost to Follow-up|3
337381|NCT01217073|1140093|P4|Base Period|Lost to Follow-up|1
337382|NCT01217073|1140094|P3|Base Period|Lost to Follow-up|1
337383|NCT01217073|1140095|P2|Base Period|Lost to Follow-up|0
337384|NCT01217073|1140096|P1|Base Period|Lost to Follow-up|0
337385|NCT01217073|1140089|P8|Base Period|Lack of Efficacy|0
337386|NCT01217073|1140090|P7|Base Period|Lack of Efficacy|0
337387|NCT01217073|1140091|P6|Base Period|Lack of Efficacy|1
337388|NCT01217073|1140092|P5|Base Period|Lack of Efficacy|0
337389|NCT01217073|1140093|P4|Base Period|Lack of Efficacy|0
337390|NCT01217073|1140094|P3|Base Period|Lack of Efficacy|0
337391|NCT01217073|1140095|P2|Base Period|Lack of Efficacy|0
337392|NCT01217073|1140096|P1|Base Period|Lack of Efficacy|0
337393|NCT01217073|1140089|P8|Base Period|Excluded medication|0
337394|NCT01217073|1140090|P7|Base Period|Excluded medication|0
337395|NCT01217073|1140091|P6|Base Period|Excluded medication|0
337396|NCT01217073|1140092|P5|Base Period|Excluded medication|1
337397|NCT01217073|1140093|P4|Base Period|Excluded medication|0
337398|NCT01217073|1140094|P3|Base Period|Excluded medication|0
337399|NCT01217073|1140095|P2|Base Period|Excluded medication|0
337400|NCT01217073|1140096|P1|Base Period|Excluded medication|0
337401|NCT01217073|1140089|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
337402|NCT01217073|1140090|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
337403|NCT01217073|1140091|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
337404|NCT01217073|1140092|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
337405|NCT01217073|1140093|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
337406|NCT01217073|1140094|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
337407|NCT01217073|1140095|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
337408|NCT01217073|1140096|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
337409|NCT01217073|1140089|P8|Base Period|Adverse Event|0
337410|NCT01217073|1140090|P7|Base Period|Adverse Event|0
337411|NCT01217073|1140091|P6|Base Period|Adverse Event|1
337412|NCT01217073|1140092|P5|Base Period|Adverse Event|4
337413|NCT01217073|1140093|P4|Base Period|Adverse Event|0
337414|NCT01217073|1140094|P3|Base Period|Adverse Event|1
337415|NCT01217073|1140095|P2|Base Period|Adverse Event|0
337416|NCT01217073|1140096|P1|Base Period|Adverse Event|1
337417|NCT01216319|1140285|P1|Overall Study|Unanticipated chemo for breast cancer|2
337418|NCT01216319|1140285|P1|Overall Study|Lost to Follow-up|2
337419|NCT01216163|1140302|P3|Overall Study|Withdrawal by Subject|0
337420|NCT01216163|1140303|P2|Overall Study|Withdrawal by Subject|1
337421|NCT01216163|1140304|P1|Overall Study|Withdrawal by Subject|1
337422|NCT01216072|1140356|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
337423|NCT01216072|1140357|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
337424|NCT01216072|1140356|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
337425|NCT01216072|1140357|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
337426|NCT01216072|1140356|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
337427|NCT01216072|1140357|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
337428|NCT01216072|1140356|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
337429|NCT01216072|1140357|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
337430|NCT01216072|1140356|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
337431|NCT01216072|1140357|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
337432|NCT01216072|1140356|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
337433|NCT01216072|1140357|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
337434|NCT01216072|1140356|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
337435|NCT01216072|1140357|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
337436|NCT01216072|1140356|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
337437|NCT01216072|1140357|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
337438|NCT01216072|1140356|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
337439|NCT01216072|1140357|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
337440|NCT01216072|1140356|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
337441|NCT01216072|1140357|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
337442|NCT01215981|1140385|P2|Overall Study|Withdrawal by Subject|0
337443|NCT01215981|1140386|P1|Overall Study|Withdrawal by Subject|1
337444|NCT01215981|1140385|P2|Overall Study|Protocol Violation|0
337445|NCT01215981|1140386|P1|Overall Study|Protocol Violation|1
337446|NCT01215981|1140385|P2|Overall Study|Physician Decision|1
337447|NCT01215981|1140386|P1|Overall Study|Physician Decision|0
337448|NCT01215968|1140396|P2|Overall Study|Not received study drug|1
337449|NCT01215968|1140397|P1|Overall Study|Not received study drug|0
337450|NCT01215968|1140396|P2|Overall Study|Protocol Violation|4
337451|NCT01215968|1140397|P1|Overall Study|Protocol Violation|2
337452|NCT01215968|1140396|P2|Overall Study|Adverse Event|2
337453|NCT01215968|1140397|P1|Overall Study|Adverse Event|0
337454|NCT01215955|1140417|P4|Overall Study|Quality Issues|2
337455|NCT01215955|1140418|P3|Overall Study|Quality Issues|3
337456|NCT01215955|1140419|P2|Overall Study|Quality Issues|0
337457|NCT01215955|1140420|P1|Overall Study|Quality Issues|0
337458|NCT01215955|1140417|P4|Overall Study|Withdrawal by Subject|9
337459|NCT01215955|1140418|P3|Overall Study|Withdrawal by Subject|13
337460|NCT01215955|1140419|P2|Overall Study|Withdrawal by Subject|15
337461|NCT01215955|1140420|P1|Overall Study|Withdrawal by Subject|14
337462|NCT01215955|1140417|P4|Overall Study|Sponsor Decision|1
337463|NCT01215955|1140418|P3|Overall Study|Sponsor Decision|0
337464|NCT01215955|1140419|P2|Overall Study|Sponsor Decision|2
337465|NCT01215955|1140420|P1|Overall Study|Sponsor Decision|1
337466|NCT01215955|1140417|P4|Overall Study|Protocol Violation|8
337467|NCT01215955|1140418|P3|Overall Study|Protocol Violation|8
337468|NCT01215955|1140419|P2|Overall Study|Protocol Violation|13
337469|NCT01215955|1140420|P1|Overall Study|Protocol Violation|17
337470|NCT01215955|1140417|P4|Overall Study|Physician Decision|11
337471|NCT01215955|1140418|P3|Overall Study|Physician Decision|8
337472|NCT01215955|1140419|P2|Overall Study|Physician Decision|10
337473|NCT01215955|1140420|P1|Overall Study|Physician Decision|4
337474|NCT01215955|1140417|P4|Overall Study|Lost to Follow-up|9
337475|NCT01215955|1140418|P3|Overall Study|Lost to Follow-up|8
337476|NCT01215955|1140419|P2|Overall Study|Lost to Follow-up|4
337477|NCT01215955|1140420|P1|Overall Study|Lost to Follow-up|4
337478|NCT01215955|1140417|P4|Overall Study|Lack of Efficacy|0
337479|NCT01215955|1140418|P3|Overall Study|Lack of Efficacy|1
337480|NCT01215955|1140419|P2|Overall Study|Lack of Efficacy|2
337481|NCT01215955|1140420|P1|Overall Study|Lack of Efficacy|1
337482|NCT01215955|1140417|P4|Overall Study|Entry Criteria Not Met|7
337483|NCT01215955|1140418|P3|Overall Study|Entry Criteria Not Met|4
337484|NCT01215955|1140419|P2|Overall Study|Entry Criteria Not Met|3
337485|NCT01215955|1140420|P1|Overall Study|Entry Criteria Not Met|1
337486|NCT01215955|1140417|P4|Overall Study|Death|3
337487|NCT01215955|1140418|P3|Overall Study|Death|1
337488|NCT01215955|1140419|P2|Overall Study|Death|0
337489|NCT01215955|1140420|P1|Overall Study|Death|2
337490|NCT01215955|1140417|P4|Overall Study|Adverse Event|3
337491|NCT01215955|1140418|P3|Overall Study|Adverse Event|2
337492|NCT01215955|1140419|P2|Overall Study|Adverse Event|4
337493|NCT01215955|1140420|P1|Overall Study|Adverse Event|1
337494|NCT01215942|1140488|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
337495|NCT01215942|1140489|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
337496|NCT01215942|1140488|P2|Post-Treatment Follow-Up Period|Physician Decision|2
337497|NCT01215942|1140489|P1|Post-Treatment Follow-Up Period|Physician Decision|1
337498|NCT01215942|1140488|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
337499|NCT01215942|1140489|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
337500|NCT01215942|1140488|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
337501|NCT01215942|1140489|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
337502|NCT01215942|1140488|P2|Post-Treatment Follow-Up Period|Death|1
337503|NCT01215942|1140489|P1|Post-Treatment Follow-Up Period|Death|0
337504|NCT01215942|1140488|P2|Treatment Period|Sponsor Decision|530
337505|NCT01215942|1140489|P1|Treatment Period|Sponsor Decision|349
337506|NCT01215942|1140488|P2|Treatment Period|Protocol Violation|1
337507|NCT01215942|1140489|P1|Treatment Period|Protocol Violation|0
337508|NCT01215942|1140488|P2|Treatment Period|Physician Decision|5
337509|NCT01215942|1140489|P1|Treatment Period|Physician Decision|5
337510|NCT01215942|1140488|P2|Treatment Period|Withdrawal by Subject|40
337511|NCT01215942|1140489|P1|Treatment Period|Withdrawal by Subject|17
337512|NCT01215942|1140488|P2|Treatment Period|Lost to Follow-up|4
337513|NCT01215942|1140489|P1|Treatment Period|Lost to Follow-up|3
337514|NCT01215942|1140488|P2|Treatment Period|Lack of Efficacy|62
337515|NCT01215942|1140489|P1|Treatment Period|Lack of Efficacy|23
337516|NCT01215942|1140488|P2|Treatment Period|Death|4
337517|NCT01215942|1140489|P1|Treatment Period|Death|2
337518|NCT01215942|1140488|P2|Treatment Period|Adverse Event|26
337519|NCT01215942|1140489|P1|Treatment Period|Adverse Event|15
337520|NCT01215851|1140619|P6|Follow up Period|Lost to Follow-up|1
337521|NCT01215851|1140620|P5|Follow up Period|Lost to Follow-up|0
337522|NCT01215851|1140621|P4|Follow up Period|Lost to Follow-up|0
337523|NCT01215851|1140622|P3|Follow up Period|Lost to Follow-up|0
337524|NCT01215851|1140623|P2|Follow up Period|Lost to Follow-up|0
337525|NCT01215851|1140624|P1|Follow up Period|Lost to Follow-up|0
337526|NCT01215851|1140619|P6|Treatment Period|Adverse Event|1
337527|NCT01215851|1140620|P5|Treatment Period|Adverse Event|0
337528|NCT01215851|1140621|P4|Treatment Period|Adverse Event|3
337529|NCT01215851|1140622|P3|Treatment Period|Adverse Event|1
337530|NCT01215851|1140623|P2|Treatment Period|Adverse Event|1
337531|NCT01215851|1140624|P1|Treatment Period|Adverse Event|1
337532|NCT01215734|1140683|P2|Overall Study|Death|1
337533|NCT01215734|1140684|P1|Overall Study|Death|0
337534|NCT01215721|1140692|P1|Overall Study|Adverse Event|2
337535|NCT01215513|1140824|P1|Overall Study|Miscellaneous reasons (CS42A)|2
337536|NCT01215513|1140824|P1|Overall Study|Withdrawal by subject (CS42A)|5
337537|NCT01215513|1140824|P1|Overall Study|Physician decision (CS42A)|6
337538|NCT01215513|1140824|P1|Overall Study|Adverse event (CS42A)|2
337539|NCT01215513|1140824|P1|Overall Study|Not enrolled from CS42 to CS42A|21
337540|NCT01215513|1140824|P1|Overall Study|Not completed CS42|9
337541|NCT01215435|1140833|P2|Overall Study|Unclassified|5
337542|NCT01215435|1140834|P1|Overall Study|Unclassified|5
337543|NCT01215435|1140833|P2|Overall Study|Lost to Follow-up|0
337544|NCT01215435|1140834|P1|Overall Study|Lost to Follow-up|3
337545|NCT01215435|1140833|P2|Overall Study|Withdrawal Criteria|11
337546|NCT01215435|1140834|P1|Overall Study|Withdrawal Criteria|8
337547|NCT01215435|1140833|P2|Overall Study|Protocol Violation|0
337548|NCT01215435|1140834|P1|Overall Study|Protocol Violation|2
337549|NCT01215435|1140833|P2|Overall Study|Adverse Event|0
337550|NCT01215435|1140834|P1|Overall Study|Adverse Event|1
337551|NCT01215422|1140848|P4|Overall Study|Did not complete all intubations|0
337552|NCT01215422|1140849|P3|Overall Study|Did not complete all intubations|0
337553|NCT01215422|1140850|P2|Overall Study|Did not complete all intubations|0
337554|NCT01215422|1140851|P1|Overall Study|Did not complete all intubations|7
337555|NCT01215422|1140848|P4|Overall Study|Failed intubations|8
337556|NCT01215422|1140849|P3|Overall Study|Failed intubations|3
337557|NCT01215422|1140850|P2|Overall Study|Failed intubations|0
337558|NCT01215422|1140851|P1|Overall Study|Failed intubations|0
337559|NCT01215422|1140848|P4|Overall Study|Relocation|0
337560|NCT01215422|1140849|P3|Overall Study|Relocation|0
337561|NCT01215422|1140850|P2|Overall Study|Relocation|0
337562|NCT01215422|1140851|P1|Overall Study|Relocation|1
337563|NCT01215357|1140873|P1|Overall Study|Protocol Violation|9
337564|NCT01215357|1140873|P1|Overall Study|Withdrawal by Subject|3
337565|NCT01215253|1140988|P2|Overall Study|Other|12
337566|NCT01215253|1140989|P1|Overall Study|Other|14
337567|NCT01215253|1140988|P2|Overall Study|Lost to Follow-up|4
337568|NCT01215253|1140989|P1|Overall Study|Lost to Follow-up|6
337569|NCT01215253|1140988|P2|Overall Study|Physician Decision|12
337570|NCT01215253|1140989|P1|Overall Study|Physician Decision|9
337571|NCT01215253|1140988|P2|Overall Study|Withdrawal by Subject|35
337572|NCT01215253|1140989|P1|Overall Study|Withdrawal by Subject|57
337573|NCT01215227|1141023|P6|Overall Study|Randomized but not treated|1
337574|NCT01215227|1141024|P5|Overall Study|Randomized but not treated|0
337575|NCT01215227|1141025|P4|Overall Study|Randomized but not treated|1
337576|NCT01215227|1141026|P3|Overall Study|Randomized but not treated|1
337577|NCT01215227|1141027|P2|Overall Study|Randomized but not treated|0
337578|NCT01215227|1141028|P1|Overall Study|Randomized but not treated|0
337579|NCT01215227|1141023|P6|Overall Study|Missing Status|0
337580|NCT01215227|1141024|P5|Overall Study|Missing Status|0
337581|NCT01215227|1141025|P4|Overall Study|Missing Status|0
337582|NCT01215227|1141026|P3|Overall Study|Missing Status|0
337583|NCT01215227|1141027|P2|Overall Study|Missing Status|1
337584|NCT01215227|1141028|P1|Overall Study|Missing Status|0
337585|NCT01215227|1141023|P6|Overall Study|Administrative|40
337586|NCT01215227|1141024|P5|Overall Study|Administrative|28
337587|NCT01215227|1141025|P4|Overall Study|Administrative|24
337588|NCT01215227|1141026|P3|Overall Study|Administrative|42
337589|NCT01215227|1141027|P2|Overall Study|Administrative|73
337590|NCT01215227|1141028|P1|Overall Study|Administrative|83
337591|NCT01215227|1141023|P6|Overall Study|Non-Compliance With Protocol|0
337592|NCT01215227|1141024|P5|Overall Study|Non-Compliance With Protocol|0
337593|NCT01215227|1141025|P4|Overall Study|Non-Compliance With Protocol|0
337594|NCT01215227|1141026|P3|Overall Study|Non-Compliance With Protocol|1
337595|NCT01215227|1141027|P2|Overall Study|Non-Compliance With Protocol|6
337596|NCT01215227|1141028|P1|Overall Study|Non-Compliance With Protocol|2
337597|NCT01215227|1141023|P6|Overall Study|Subject Withdrew Consent|8
337598|NCT01215227|1141024|P5|Overall Study|Subject Withdrew Consent|11
337599|NCT01215227|1141025|P4|Overall Study|Subject Withdrew Consent|10
337600|NCT01215227|1141026|P3|Overall Study|Subject Withdrew Consent|7
337601|NCT01215227|1141027|P2|Overall Study|Subject Withdrew Consent|20
337602|NCT01215227|1141028|P1|Overall Study|Subject Withdrew Consent|16
337603|NCT01215227|1141023|P6|Overall Study|Lost to Follow-up|2
337604|NCT01215227|1141024|P5|Overall Study|Lost to Follow-up|1
337605|NCT01215227|1141025|P4|Overall Study|Lost to Follow-up|1
337606|NCT01215227|1141026|P3|Overall Study|Lost to Follow-up|1
337607|NCT01215227|1141027|P2|Overall Study|Lost to Follow-up|4
337608|NCT01215227|1141028|P1|Overall Study|Lost to Follow-up|1
337609|NCT01215227|1141023|P6|Overall Study|Treatment Failure|1
337610|NCT01215227|1141024|P5|Overall Study|Treatment Failure|1
337611|NCT01215227|1141025|P4|Overall Study|Treatment Failure|5
337612|NCT01215227|1141026|P3|Overall Study|Treatment Failure|1
337613|NCT01215227|1141027|P2|Overall Study|Treatment Failure|4
337614|NCT01215227|1141028|P1|Overall Study|Treatment Failure|8
337615|NCT01215227|1141023|P6|Overall Study|Adverse Event|6
337616|NCT01215227|1141024|P5|Overall Study|Adverse Event|7
337617|NCT01215227|1141025|P4|Overall Study|Adverse Event|8
337618|NCT01215227|1141026|P3|Overall Study|Adverse Event|4
337619|NCT01215227|1141027|P2|Overall Study|Adverse Event|11
337620|NCT01215227|1141028|P1|Overall Study|Adverse Event|11
337621|NCT01215097|1141147|P2|Overall Study|patient's private reason|1
337622|NCT01215097|1141148|P1|Overall Study|patient's private reason|1
337623|NCT01215097|1141147|P2|Overall Study|patient's refusal to come|2
337624|NCT01215097|1141148|P1|Overall Study|patient's refusal to come|2
337625|NCT01215097|1141147|P2|Overall Study|Lack of Efficacy|3
337626|NCT01215097|1141148|P1|Overall Study|Lack of Efficacy|0
337627|NCT01215097|1141147|P2|Overall Study|Withdrawal by Subject|3
337628|NCT01215097|1141148|P1|Overall Study|Withdrawal by Subject|6
337629|NCT01215097|1141147|P2|Overall Study|Lost to Follow-up|0
337630|NCT01215097|1141148|P1|Overall Study|Lost to Follow-up|2
337631|NCT01215097|1141147|P2|Overall Study|Protocol Violation|2
337632|NCT01215097|1141148|P1|Overall Study|Protocol Violation|0
337633|NCT01215097|1141147|P2|Overall Study|Adverse Event|3
337634|NCT01215097|1141148|P1|Overall Study|Adverse Event|1
337635|NCT01215032|1141180|P1|Overall Study|Lack of Efficacy|17
337636|NCT01215032|1141180|P1|Overall Study|Adverse Event|3
337637|NCT01214915|1141205|P1|Overall Study|Lack of Efficacy|3
337638|NCT01214915|1141205|P1|Overall Study|Adverse Event|8
337639|NCT01214850|1141216|P3|Overall Study|Unable to classify|1
337640|NCT01214850|1141217|P2|Overall Study|Unable to classify|1
337641|NCT01214850|1141218|P1|Overall Study|Unable to classify|2
337642|NCT01214850|1141216|P3|Overall Study|Administrative reason|0
337643|NCT01214850|1141217|P2|Overall Study|Administrative reason|0
337644|NCT01214850|1141218|P1|Overall Study|Administrative reason|1
337645|NCT01214850|1141216|P3|Overall Study|Inappropriate enrollment|0
337646|NCT01214850|1141217|P2|Overall Study|Inappropriate enrollment|1
337647|NCT01214850|1141218|P1|Overall Study|Inappropriate enrollment|2
337648|NCT01214850|1141216|P3|Overall Study|Adverse event or death|3
337649|NCT01214850|1141217|P2|Overall Study|Adverse event or death|8
337650|NCT01214850|1141218|P1|Overall Study|Adverse event or death|11
337651|NCT01214850|1141216|P3|Overall Study|Protocol Violation|6
337652|NCT01214850|1141217|P2|Overall Study|Protocol Violation|5
337653|NCT01214850|1141218|P1|Overall Study|Protocol Violation|5
337654|NCT01214850|1141216|P3|Overall Study|Lost to Follow-up|123
337655|NCT01214850|1141217|P2|Overall Study|Lost to Follow-up|98
337656|NCT01214850|1141218|P1|Overall Study|Lost to Follow-up|124
337657|NCT01214850|1141216|P3|Overall Study|Withdrawal by Subject|28
337658|NCT01214850|1141217|P2|Overall Study|Withdrawal by Subject|31
337659|NCT01214850|1141218|P1|Overall Study|Withdrawal by Subject|38
337660|NCT01214837|1141302|P3|Overall Study|Unable to Classify|0
337661|NCT01214837|1141303|P2|Overall Study|Unable to Classify|3
337662|NCT01214837|1141304|P1|Overall Study|Unable to Classify|1
337663|NCT01214837|1141302|P3|Overall Study|Protocol Violation|5
337664|NCT01214837|1141303|P2|Overall Study|Protocol Violation|1
337665|NCT01214837|1141304|P1|Overall Study|Protocol Violation|3
337666|NCT01214837|1141302|P3|Overall Study|Administrative Reason|4
337667|NCT01214837|1141303|P2|Overall Study|Administrative Reason|6
337668|NCT01214837|1141304|P1|Overall Study|Administrative Reason|2
337669|NCT01214837|1141302|P3|Overall Study|Inappropriate Enrolment|2
337670|NCT01214837|1141303|P2|Overall Study|Inappropriate Enrolment|1
337671|NCT01214837|1141304|P1|Overall Study|Inappropriate Enrolment|0
337672|NCT01214837|1141302|P3|Overall Study|Lost to Follow-up|21
337673|NCT01214837|1141303|P2|Overall Study|Lost to Follow-up|15
337674|NCT01214837|1141304|P1|Overall Study|Lost to Follow-up|20
337675|NCT01214837|1141302|P3|Overall Study|Withdrawal by Subject|28
337676|NCT01214837|1141303|P2|Overall Study|Withdrawal by Subject|36
337677|NCT01214837|1141304|P1|Overall Study|Withdrawal by Subject|27
337678|NCT01214837|1141302|P3|Overall Study|Adverse Event|1
337679|NCT01214837|1141303|P2|Overall Study|Adverse Event|2
337680|NCT01214837|1141304|P1|Overall Study|Adverse Event|1
337681|NCT01214837|1141302|P3|Overall Study|Death|1
337682|NCT01214837|1141303|P2|Overall Study|Death|0
337683|NCT01214837|1141304|P1|Overall Study|Death|0
337684|NCT01214720|1141360|P2|Overall Study|Lost to Follow-up|2
337685|NCT01214720|1141361|P1|Overall Study|Lost to Follow-up|6
337686|NCT01214720|1141360|P2|Overall Study|Alive and in follow-up|48
337687|NCT01214720|1141361|P1|Overall Study|Alive and in follow-up|45
337688|NCT01214720|1141360|P2|Overall Study|Alive and still on treatment|18
337689|NCT01214720|1141361|P1|Overall Study|Alive and still on treatment|34
337690|NCT01214616|1141382|P4|Overall Study|Withdrawal by Subject|1
337691|NCT01214616|1141383|P3|Overall Study|Withdrawal by Subject|0
337692|NCT01214616|1141384|P2|Overall Study|Withdrawal by Subject|0
337693|NCT01214616|1141385|P1|Overall Study|Withdrawal by Subject|1
337694|NCT01214616|1141382|P4|Overall Study|Other adverse events|1
337695|NCT01214616|1141383|P3|Overall Study|Other adverse events|1
337696|NCT01214616|1141384|P2|Overall Study|Other adverse events|1
337697|NCT01214616|1141385|P1|Overall Study|Other adverse events|0
337698|NCT01214616|1141382|P4|Overall Study|Dose limiting toxicity|0
337699|NCT01214616|1141383|P3|Overall Study|Dose limiting toxicity|0
337700|NCT01214616|1141384|P2|Overall Study|Dose limiting toxicity|2
337701|NCT01214616|1141385|P1|Overall Study|Dose limiting toxicity|0
337702|NCT01214616|1141382|P4|Overall Study|Progressive disease|4
337703|NCT01214616|1141383|P3|Overall Study|Progressive disease|2
337704|NCT01214616|1141384|P2|Overall Study|Progressive disease|2
337705|NCT01214616|1141385|P1|Overall Study|Progressive disease|2
337706|NCT01214434|1141421|P2|Overall Study|Site error|0
337707|NCT01214434|1141422|P1|Overall Study|Site error|1
337708|NCT01214434|1141421|P2|Overall Study|Lost to Follow-up|2
337709|NCT01214434|1141422|P1|Overall Study|Lost to Follow-up|2
337710|NCT01214434|1141421|P2|Overall Study|Withdrawal by Subject|0
337711|NCT01214434|1141422|P1|Overall Study|Withdrawal by Subject|1
337712|NCT01214395|1141438|P1|Overall Study|All patients had infection|5
337713|NCT01214252|1141447|P1|Overall Study|Not eligible per protocol|82
337714|NCT01214239|1141455|P2|Overall Study|patient's private reason|1
337715|NCT01214239|1141456|P1|Overall Study|patient's private reason|1
337716|NCT01214239|1141455|P2|Overall Study|Lack of Efficacy|2
337717|NCT01214239|1141456|P1|Overall Study|Lack of Efficacy|1
337718|NCT01214239|1141455|P2|Overall Study|Withdrawal by Subject|9
337719|NCT01214239|1141456|P1|Overall Study|Withdrawal by Subject|4
337720|NCT01214239|1141455|P2|Overall Study|Lost to Follow-up|1
337721|NCT01214239|1141456|P1|Overall Study|Lost to Follow-up|1
337722|NCT01214239|1141455|P2|Overall Study|Protocol Violation|1
337723|NCT01214239|1141456|P1|Overall Study|Protocol Violation|2
337724|NCT01214239|1141455|P2|Overall Study|Adverse Event|4
337725|NCT01214239|1141456|P1|Overall Study|Adverse Event|3
337726|NCT01214187|1141490|P2|Overall Study|Withdrawal by Subject|3
337727|NCT01214187|1141491|P1|Overall Study|Withdrawal by Subject|0
337728|NCT01214187|1141490|P2|Overall Study|Death|1
337729|NCT01214187|1141491|P1|Overall Study|Death|1
337730|NCT01214187|1141490|P2|Overall Study|Adverse Event|2
337731|NCT01214187|1141491|P1|Overall Study|Adverse Event|6
337732|NCT01214174|1141508|P3|Overall Study|Withdrawal by Subject|1
337733|NCT01214174|1141509|P2|Overall Study|Withdrawal by Subject|0
337734|NCT01214174|1141510|P1|Overall Study|Withdrawal by Subject|0
337735|NCT01213966|1141664|P4|Overall Study|Protocol Violation|1
337736|NCT01213966|1141665|P3|Overall Study|Protocol Violation|3
337737|NCT01213966|1141666|P2|Overall Study|Protocol Violation|0
337738|NCT01213966|1141667|P1|Overall Study|Protocol Violation|1
337739|NCT01213836|1141679|P2|Period 1, First Intervention|Withdrawal by Subject|1
337740|NCT01213836|1141680|P1|Period 1, First Intervention|Withdrawal by Subject|1
337741|NCT01213836|1141679|P2|Period 1, First Intervention|Protocol Violation|1
337742|NCT01213836|1141680|P1|Period 1, First Intervention|Protocol Violation|0
337743|NCT01213836|1141679|P2|Period 1, First Intervention|Adverse Event|1
337744|NCT01213836|1141680|P1|Period 1, First Intervention|Adverse Event|2
337745|NCT01213264|1141793|P3|Overall Study|Lost to Follow-up|6
337746|NCT01213264|1141794|P2|Overall Study|Lost to Follow-up|2
337747|NCT01213264|1141795|P1|Overall Study|Lost to Follow-up|1
337748|NCT01213264|1141793|P3|Overall Study|Adverse Event|0
337749|NCT01213264|1141794|P2|Overall Study|Adverse Event|0
337750|NCT01213264|1141795|P1|Overall Study|Adverse Event|1
337751|NCT01213251|1141815|P3|Overall Study|Missed 18-Month Follow-up|1
337752|NCT01213251|1141816|P2|Overall Study|Missed 18-Month Follow-up|0
337753|NCT01213251|1141817|P1|Overall Study|Missed 18-Month Follow-up|0
337754|NCT01213251|1141815|P3|Overall Study|Protocol Violation|0
337755|NCT01213251|1141816|P2|Overall Study|Protocol Violation|1
337756|NCT01213251|1141817|P1|Overall Study|Protocol Violation|1
337757|NCT01213251|1141815|P3|Overall Study|Exit|8
337758|NCT01213251|1141816|P2|Overall Study|Exit|2
337759|NCT01213251|1141817|P1|Overall Study|Exit|3
337760|NCT01213251|1141815|P3|Overall Study|Death|2
337761|NCT01213251|1141816|P2|Overall Study|Death|1
337762|NCT01213251|1141817|P1|Overall Study|Death|2
337763|NCT01213173|1141844|P2|Overall Study|Incorrect Enrollment|3
337764|NCT01213173|1141845|P1|Overall Study|Incorrect Enrollment|1
337765|NCT01213173|1141844|P2|Overall Study|Withdrawal by Subject|5
337766|NCT01213173|1141845|P1|Overall Study|Withdrawal by Subject|5
337767|NCT01213173|1141844|P2|Overall Study|Adverse Event|8
337768|NCT01213173|1141845|P1|Overall Study|Adverse Event|4
337769|NCT01213173|1141844|P2|Overall Study|Protocol Violation|0
337770|NCT01213173|1141845|P1|Overall Study|Protocol Violation|2
337771|NCT01212991|1141906|P2|Overall Study|Continuing Treatment|61
337772|NCT01212991|1141907|P1|Overall Study|Continuing Treatment|367
337773|NCT01212991|1141906|P2|Overall Study|Withdrawal by Subject|14
337774|NCT01212991|1141907|P1|Overall Study|Withdrawal by Subject|4
337775|NCT01212991|1141906|P2|Overall Study|Death|299
337776|NCT01212991|1141907|P1|Overall Study|Death|241
337777|NCT01212991|1141906|P2|Overall Study|Lost to Follow-up|0
337778|NCT01212991|1141907|P1|Overall Study|Lost to Follow-up|1
337779|NCT01212770|1141939|P9|Long-term Safety Phase (Year 5)|Death|0
337780|NCT01212770|1141940|P8|Long-term Safety Phase (Year 5)|Death|1
337781|NCT01212770|1141941|P7|Long-term Safety Phase (Year 5)|Death|0
337782|NCT01212770|1141942|P6|Long-term Safety Phase (Year 5)|Death|0
337783|NCT01212770|1141943|P5|Long-term Safety Phase (Year 5)|Death|0
337784|NCT01212770|1141944|P4|Long-term Safety Phase (Year 5)|Death|0
337785|NCT01212770|1141945|P3|Long-term Safety Phase (Year 5)|Death|0
337786|NCT01212770|1141946|P2|Long-term Safety Phase (Year 5)|Death|0
337787|NCT01212770|1141947|P1|Long-term Safety Phase (Year 5)|Death|0
337788|NCT01212770|1141939|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
337789|NCT01212770|1141940|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
337790|NCT01212770|1141941|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
337791|NCT01212770|1141942|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
337792|NCT01212770|1141943|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
337793|NCT01212770|1141944|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
337794|NCT01212770|1141945|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
337795|NCT01212770|1141946|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
337796|NCT01212770|1141947|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
337797|NCT01212770|1141939|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337798|NCT01212770|1141940|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337799|NCT01212770|1141941|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337800|NCT01212770|1141942|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337801|NCT01212770|1141943|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337802|NCT01212770|1141944|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337803|NCT01212770|1141945|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
337804|NCT01212770|1141946|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337805|NCT01212770|1141947|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
337806|NCT01212770|1141939|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
337807|NCT01212770|1141940|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
337808|NCT01212770|1141941|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
337809|NCT01212770|1141942|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
337810|NCT01212770|1141943|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
337811|NCT01212770|1141944|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
337812|NCT01212770|1141945|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
337813|NCT01212770|1141946|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
337814|NCT01212770|1141947|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
337815|NCT01212770|1141939|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
337816|NCT01212770|1141940|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
337817|NCT01212770|1141941|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
337818|NCT01212770|1141942|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
337819|NCT01212770|1141943|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
337820|NCT01212770|1141944|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
337821|NCT01212770|1141945|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
337822|NCT01212770|1141946|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
337823|NCT01212770|1141947|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
337824|NCT01212770|1141939|P9|Long-term Safety Phase (Year 5)|Missing|0
337825|NCT01212770|1141940|P8|Long-term Safety Phase (Year 5)|Missing|0
337826|NCT01212770|1141941|P7|Long-term Safety Phase (Year 5)|Missing|0
337827|NCT01212770|1141942|P6|Long-term Safety Phase (Year 5)|Missing|0
337828|NCT01212770|1141943|P5|Long-term Safety Phase (Year 5)|Missing|0
337829|NCT01212770|1141944|P4|Long-term Safety Phase (Year 5)|Missing|0
337830|NCT01212770|1141945|P3|Long-term Safety Phase (Year 5)|Missing|1
337831|NCT01212770|1141946|P2|Long-term Safety Phase (Year 5)|Missing|0
337832|NCT01212770|1141947|P1|Long-term Safety Phase (Year 5)|Missing|0
337833|NCT01212770|1141939|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
337834|NCT01212770|1141940|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
337835|NCT01212770|1141941|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
337836|NCT01212770|1141942|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
337837|NCT01212770|1141943|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
337838|NCT01212770|1141944|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
337839|NCT01212770|1141945|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
337840|NCT01212770|1141946|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
337841|NCT01212770|1141947|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
337842|NCT01212770|1141939|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337843|NCT01212770|1141940|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337844|NCT01212770|1141941|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337845|NCT01212770|1141942|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337846|NCT01212770|1141943|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337847|NCT01212770|1141944|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337848|NCT01212770|1141945|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
337849|NCT01212770|1141946|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337850|NCT01212770|1141947|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
337851|NCT01212770|1141939|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
337852|NCT01212770|1141940|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
337853|NCT01212770|1141941|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
337854|NCT01212770|1141942|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
337855|NCT01212770|1141943|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
337856|NCT01212770|1141944|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
337857|NCT01212770|1141945|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
337858|NCT01212770|1141946|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
337859|NCT01212770|1141947|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
337860|NCT01212770|1141939|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
337861|NCT01212770|1141940|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
337862|NCT01212770|1141941|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
337863|NCT01212770|1141942|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
337864|NCT01212770|1141943|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
337865|NCT01212770|1141944|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
337866|NCT01212770|1141945|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
337867|NCT01212770|1141946|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
337868|NCT01212770|1141947|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
337869|NCT01212770|1141939|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
337870|NCT01212770|1141940|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
337871|NCT01212770|1141941|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
337872|NCT01212770|1141942|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
337873|NCT01212770|1141943|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
337874|NCT01212770|1141944|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
337875|NCT01212770|1141945|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
337876|NCT01212770|1141946|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
337877|NCT01212770|1141947|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
337878|NCT01212770|1141939|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
337879|NCT01212770|1141940|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
337880|NCT01212770|1141941|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
337881|NCT01212770|1141942|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
337882|NCT01212770|1141943|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
337883|NCT01212770|1141944|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
337884|NCT01212770|1141945|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
337885|NCT01212770|1141946|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
337886|NCT01212770|1141947|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
337887|NCT01212770|1141939|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
337888|NCT01212770|1141940|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
337889|NCT01212770|1141941|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
337890|NCT01212770|1141942|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
337891|NCT01212770|1141943|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
337892|NCT01212770|1141944|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
337893|NCT01212770|1141945|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
337894|NCT01212770|1141946|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
337895|NCT01212770|1141947|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
337896|NCT01212770|1141939|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
337897|NCT01212770|1141940|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
337898|NCT01212770|1141941|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
337899|NCT01212770|1141942|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
337900|NCT01212770|1141943|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
337901|NCT01212770|1141944|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
337902|NCT01212770|1141945|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
337903|NCT01212770|1141946|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
337904|NCT01212770|1141947|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
337905|NCT01212770|1141939|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337906|NCT01212770|1141940|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337907|NCT01212770|1141941|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337908|NCT01212770|1141942|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337909|NCT01212770|1141943|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337910|NCT01212770|1141944|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337911|NCT01212770|1141945|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337912|NCT01212770|1141946|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
337913|NCT01212770|1141947|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
337914|NCT01212770|1141939|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
337915|NCT01212770|1141940|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
337916|NCT01212770|1141941|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
337917|NCT01212770|1141942|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
337918|NCT01212770|1141943|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
337919|NCT01212770|1141944|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
337920|NCT01212770|1141945|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
337921|NCT01212770|1141946|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
337922|NCT01212770|1141947|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
337923|NCT01212770|1141939|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
337924|NCT01212770|1141940|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
337925|NCT01212770|1141941|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
337926|NCT01212770|1141942|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
337927|NCT01212770|1141943|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
337928|NCT01212770|1141944|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
337929|NCT01212770|1141945|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
337930|NCT01212770|1141946|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
337931|NCT01212770|1141947|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
337932|NCT01212770|1141939|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
337933|NCT01212770|1141940|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
337934|NCT01212770|1141941|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
337935|NCT01212770|1141942|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
337936|NCT01212770|1141943|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
337937|NCT01212770|1141944|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
337938|NCT01212770|1141945|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
337939|NCT01212770|1141946|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
337940|NCT01212770|1141947|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
337941|NCT01212770|1141939|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
337942|NCT01212770|1141940|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
337943|NCT01212770|1141941|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
337944|NCT01212770|1141942|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
337945|NCT01212770|1141943|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
337946|NCT01212770|1141944|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
337947|NCT01212770|1141945|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
337948|NCT01212770|1141946|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
337949|NCT01212770|1141947|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
337950|NCT01212770|1141939|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
337951|NCT01212770|1141940|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
337952|NCT01212770|1141941|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
337953|NCT01212770|1141942|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
337954|NCT01212770|1141943|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
337955|NCT01212770|1141944|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
337956|NCT01212770|1141945|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
337957|NCT01212770|1141946|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
337958|NCT01212770|1141947|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
337959|NCT01212770|1141939|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
337960|NCT01212770|1141940|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
337961|NCT01212770|1141941|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
337962|NCT01212770|1141942|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
337963|NCT01212770|1141943|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
337964|NCT01212770|1141944|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
337965|NCT01212770|1141945|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
337966|NCT01212770|1141946|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
337967|NCT01212770|1141947|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
337968|NCT01212770|1141939|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337969|NCT01212770|1141940|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337970|NCT01212770|1141941|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337971|NCT01212770|1141942|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337972|NCT01212770|1141943|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337973|NCT01212770|1141944|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337974|NCT01212770|1141945|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337975|NCT01212770|1141946|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
337976|NCT01212770|1141947|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
337977|NCT01212770|1141939|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
337978|NCT01212770|1141940|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
337979|NCT01212770|1141941|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
337980|NCT01212770|1141942|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
337981|NCT01212770|1141943|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
337982|NCT01212770|1141944|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
337983|NCT01212770|1141945|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
337984|NCT01212770|1141946|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
337985|NCT01212770|1141947|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
337986|NCT01212770|1141939|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
337987|NCT01212770|1141940|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
337988|NCT01212770|1141941|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
337989|NCT01212770|1141942|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
337990|NCT01212770|1141943|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
337991|NCT01212770|1141944|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
337992|NCT01212770|1141945|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
337993|NCT01212770|1141946|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
337994|NCT01212770|1141947|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
337995|NCT01212770|1141939|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
337996|NCT01212770|1141940|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
337997|NCT01212770|1141941|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
337998|NCT01212770|1141942|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
337999|NCT01212770|1141943|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
338000|NCT01212770|1141944|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
338001|NCT01212770|1141945|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
338002|NCT01212770|1141946|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
338003|NCT01212770|1141947|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
338004|NCT01212770|1141939|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338005|NCT01212770|1141940|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338006|NCT01212770|1141941|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338007|NCT01212770|1141942|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338008|NCT01212770|1141943|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338009|NCT01212770|1141944|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
338010|NCT01212770|1141945|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338011|NCT01212770|1141946|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338012|NCT01212770|1141947|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
338013|NCT01212770|1141939|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338014|NCT01212770|1141940|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338015|NCT01212770|1141941|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338016|NCT01212770|1141942|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338017|NCT01212770|1141943|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338018|NCT01212770|1141944|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338019|NCT01212770|1141945|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
338020|NCT01212770|1141946|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338021|NCT01212770|1141947|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
338022|NCT01212770|1141939|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
338023|NCT01212770|1141940|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
338024|NCT01212770|1141941|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
338025|NCT01212770|1141942|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
338026|NCT01212770|1141943|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
338027|NCT01212770|1141944|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
338028|NCT01212770|1141945|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
338029|NCT01212770|1141946|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
338030|NCT01212770|1141947|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
338031|NCT01212770|1141939|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
338032|NCT01212770|1141940|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
338033|NCT01212770|1141941|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
338034|NCT01212770|1141942|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
338035|NCT01212770|1141943|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
338036|NCT01212770|1141944|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
338037|NCT01212770|1141945|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
338038|NCT01212770|1141946|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
338039|NCT01212770|1141947|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
338040|NCT01212770|1141939|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
338041|NCT01212770|1141940|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
338042|NCT01212770|1141941|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
338043|NCT01212770|1141942|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
338044|NCT01212770|1141943|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
338045|NCT01212770|1141944|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
338046|NCT01212770|1141945|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
338047|NCT01212770|1141946|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
338048|NCT01212770|1141947|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
338049|NCT01212770|1141939|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
338050|NCT01212770|1141940|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
338051|NCT01212770|1141941|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
338052|NCT01212770|1141942|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
338053|NCT01212770|1141943|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
338054|NCT01212770|1141944|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
338055|NCT01212770|1141945|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
338056|NCT01212770|1141946|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
338057|NCT01212770|1141947|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
338058|NCT01212770|1141939|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338059|NCT01212770|1141940|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338060|NCT01212770|1141941|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338061|NCT01212770|1141942|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338062|NCT01212770|1141943|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338063|NCT01212770|1141944|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338064|NCT01212770|1141945|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
338065|NCT01212770|1141946|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338066|NCT01212770|1141947|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338067|NCT01212770|1141939|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338068|NCT01212770|1141940|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338069|NCT01212770|1141941|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338070|NCT01212770|1141942|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338071|NCT01212770|1141943|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338072|NCT01212770|1141944|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338073|NCT01212770|1141945|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
338074|NCT01212770|1141946|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338075|NCT01212770|1141947|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
338076|NCT01212770|1141939|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338077|NCT01212770|1141940|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338078|NCT01212770|1141941|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338079|NCT01212770|1141942|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338080|NCT01212770|1141943|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338081|NCT01212770|1141944|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338082|NCT01212770|1141945|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
338083|NCT01212770|1141946|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
338084|NCT01212770|1141947|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
338085|NCT01212770|1141939|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338086|NCT01212770|1141940|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338087|NCT01212770|1141941|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338088|NCT01212770|1141942|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338089|NCT01212770|1141943|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338090|NCT01212770|1141944|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338091|NCT01212770|1141945|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
338092|NCT01212770|1141946|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
338093|NCT01212770|1141947|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
338094|NCT01212770|1141939|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338095|NCT01212770|1141940|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338096|NCT01212770|1141941|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338097|NCT01212770|1141942|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338098|NCT01212770|1141943|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338099|NCT01212770|1141944|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338100|NCT01212770|1141945|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
338101|NCT01212770|1141946|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
338102|NCT01212770|1141947|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
338103|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
338104|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
338105|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
338106|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
338107|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
338108|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
338109|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
338110|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
338111|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
338112|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338113|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338114|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338115|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338116|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338117|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338118|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338119|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
338120|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
338121|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
338122|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
338123|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
338124|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
338125|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
338126|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
338127|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
338128|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
338129|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
338130|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
338131|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
338132|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
338133|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
338134|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
338135|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
338136|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
338137|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
338138|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
338139|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
338140|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
338141|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
338142|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
338143|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
338144|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
338145|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
338146|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
338147|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
338148|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338149|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
338150|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338151|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338152|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338153|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338154|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338155|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338156|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
338157|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 4)|Death|1
338158|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 4)|Death|0
338159|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 4)|Death|0
338160|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 4)|Death|0
338161|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 4)|Death|0
338162|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 4)|Death|0
338163|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 4)|Death|1
338164|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 4)|Death|0
338165|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 4)|Death|0
338166|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
338167|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
338168|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
338169|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
338170|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
338171|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
338172|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
338173|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
338174|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
338175|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
338176|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
338177|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
338178|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
338179|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
338180|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
338181|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
338182|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
338183|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
338184|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
338185|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
338186|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
338187|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
338188|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
338189|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
338190|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
338191|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
338192|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
338193|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
338194|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
338195|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
338196|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
338197|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
338198|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
338199|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
338200|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
338201|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
338202|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
338203|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
338204|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
338205|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
338206|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
338207|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
338208|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
338209|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
338210|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
338211|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338212|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338213|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338214|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338215|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338216|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338217|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338218|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
338219|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
338220|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
338221|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338222|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338223|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338224|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338225|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338226|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338227|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338228|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
338229|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
338230|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
338231|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
338232|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
338233|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
338234|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
338235|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
338236|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
338237|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
338238|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338239|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338240|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338241|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338242|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338243|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338244|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
338245|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338246|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
338247|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
338248|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
338249|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
338250|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
338251|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
338252|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
338253|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
338254|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
338255|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
338256|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
338257|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
338258|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
338259|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
338260|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
338261|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
338262|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
338263|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
338264|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
338265|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338266|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338267|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338268|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338269|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338270|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338271|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
338272|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338273|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
338274|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
338275|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
338276|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
338277|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
338278|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
338279|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
338280|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
338281|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
338282|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
338283|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
338284|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
338285|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
338286|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
338287|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
338288|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
338289|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
338290|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
338291|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
338292|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
338293|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
338294|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
338295|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
338296|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
338297|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
338298|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
338299|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
338300|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
338301|NCT01212757|1142144|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
338302|NCT01212757|1142145|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338303|NCT01212757|1142146|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338304|NCT01212757|1142147|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338305|NCT01212757|1142148|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338306|NCT01212757|1142149|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338307|NCT01212757|1142150|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338308|NCT01212757|1142151|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338309|NCT01212757|1142152|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
338310|NCT01212757|1142144|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
338311|NCT01212757|1142145|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
338312|NCT01212757|1142146|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
338313|NCT01212757|1142147|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
338314|NCT01212757|1142148|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
338315|NCT01212757|1142149|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
338316|NCT01212757|1142150|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
338317|NCT01212757|1142151|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
338318|NCT01212757|1142152|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
338319|NCT01212757|1142144|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
338320|NCT01212757|1142145|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
338321|NCT01212757|1142146|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
338322|NCT01212757|1142147|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
338323|NCT01212757|1142148|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
338324|NCT01212757|1142149|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
338325|NCT01212757|1142150|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
338326|NCT01212757|1142151|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
338327|NCT01212757|1142152|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
338328|NCT01212757|1142144|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
338329|NCT01212757|1142145|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
338330|NCT01212757|1142146|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
338331|NCT01212757|1142147|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
338332|NCT01212757|1142148|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
338333|NCT01212757|1142149|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
338334|NCT01212757|1142150|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
338335|NCT01212757|1142151|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
338336|NCT01212757|1142152|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
338337|NCT01212757|1142144|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338338|NCT01212757|1142145|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338339|NCT01212757|1142146|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338340|NCT01212757|1142147|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338341|NCT01212757|1142148|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338342|NCT01212757|1142149|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338343|NCT01212757|1142150|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
338344|NCT01212757|1142151|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338345|NCT01212757|1142152|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
338346|NCT01212757|1142144|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
338347|NCT01212757|1142145|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
338348|NCT01212757|1142146|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
338349|NCT01212757|1142147|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
338350|NCT01212757|1142148|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
338351|NCT01212757|1142149|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
338352|NCT01212757|1142150|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
338353|NCT01212757|1142151|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
338354|NCT01212757|1142152|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
338355|NCT01212757|1142144|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
338356|NCT01212757|1142145|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
338357|NCT01212757|1142146|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
338358|NCT01212757|1142147|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
338359|NCT01212757|1142148|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
338360|NCT01212757|1142149|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
338361|NCT01212757|1142150|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
338362|NCT01212757|1142151|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
338363|NCT01212757|1142152|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
338364|NCT01212757|1142144|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
338365|NCT01212757|1142145|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
338366|NCT01212757|1142146|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
338367|NCT01212757|1142147|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
338368|NCT01212757|1142148|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
338369|NCT01212757|1142149|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
338370|NCT01212757|1142150|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
338371|NCT01212757|1142151|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
338372|NCT01212757|1142152|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
338373|NCT01212757|1142144|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338374|NCT01212757|1142145|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338375|NCT01212757|1142146|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338376|NCT01212757|1142147|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338377|NCT01212757|1142148|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338378|NCT01212757|1142149|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338379|NCT01212757|1142150|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
338380|NCT01212757|1142151|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
338381|NCT01212757|1142152|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
338382|NCT01212757|1142144|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338383|NCT01212757|1142145|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338384|NCT01212757|1142146|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338385|NCT01212757|1142147|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338386|NCT01212757|1142148|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338387|NCT01212757|1142149|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
338388|NCT01212757|1142150|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
338389|NCT01212757|1142151|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
338390|NCT01212757|1142152|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
338391|NCT01212757|1142144|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
338392|NCT01212757|1142145|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
338393|NCT01212757|1142146|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
338394|NCT01212757|1142147|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
338395|NCT01212757|1142148|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
338396|NCT01212757|1142149|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
338397|NCT01212757|1142150|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
338398|NCT01212757|1142151|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
338399|NCT01212757|1142152|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
338400|NCT01212757|1142144|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338401|NCT01212757|1142145|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338402|NCT01212757|1142146|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338403|NCT01212757|1142147|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338404|NCT01212757|1142148|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338405|NCT01212757|1142149|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
338406|NCT01212757|1142150|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
338407|NCT01212757|1142151|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
338408|NCT01212757|1142152|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
338409|NCT01212757|1142144|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338410|NCT01212757|1142145|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338411|NCT01212757|1142146|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338412|NCT01212757|1142147|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338413|NCT01212757|1142148|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338414|NCT01212757|1142149|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
338415|NCT01212757|1142150|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
338416|NCT01212757|1142151|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
338417|NCT01212757|1142152|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
338418|NCT01212757|1142144|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338419|NCT01212757|1142145|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338420|NCT01212757|1142146|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338421|NCT01212757|1142147|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338422|NCT01212757|1142148|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338423|NCT01212757|1142149|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
338424|NCT01212757|1142150|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
338425|NCT01212757|1142151|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
338426|NCT01212757|1142152|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
338427|NCT01212185|1142391|P2|Overall Study|Protocol Violation|1
338428|NCT01212185|1142392|P1|Overall Study|Protocol Violation|2
338429|NCT01212159|1142411|P2|Overall Study|Withdrawal by Subject|12
338430|NCT01212159|1142412|P1|Overall Study|Withdrawal by Subject|12
338431|NCT01212094|1142425|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
338432|NCT01212094|1142426|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
338433|NCT01212094|1142427|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
338434|NCT01212094|1142425|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
338435|NCT01212094|1142426|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
338436|NCT01212094|1142427|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
338437|NCT01212094|1142425|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
338438|NCT01212094|1142426|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
338439|NCT01212094|1142427|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
338440|NCT01212094|1142425|P3|Year 1: Baseline Monitoring|Started on DMT|0
338441|NCT01212094|1142426|P2|Year 1: Baseline Monitoring|Started on DMT|0
338442|NCT01212094|1142427|P1|Year 1: Baseline Monitoring|Started on DMT|2
338443|NCT01212094|1142425|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
338444|NCT01212094|1142426|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
338445|NCT01212094|1142427|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
338446|NCT01212094|1142425|P3|Year 1: Baseline Monitoring|Study terminated|0
338447|NCT01212094|1142426|P2|Year 1: Baseline Monitoring|Study terminated|0
338448|NCT01212094|1142427|P1|Year 1: Baseline Monitoring|Study terminated|7
338449|NCT01211769|1142474|P4|Overall Study|Adverse Event|1
338450|NCT01211769|1142475|P3|Overall Study|Adverse Event|1
338451|NCT01211769|1142476|P2|Overall Study|Adverse Event|1
338452|NCT01211769|1142477|P1|Overall Study|Adverse Event|0
338453|NCT01211769|1142474|P4|Overall Study|Physician Decision|1
338454|NCT01211769|1142475|P3|Overall Study|Physician Decision|2
338455|NCT01211769|1142476|P2|Overall Study|Physician Decision|0
338456|NCT01211769|1142477|P1|Overall Study|Physician Decision|2
338457|NCT01211769|1142474|P4|Overall Study|Lost to Follow-up|9
338458|NCT01211769|1142475|P3|Overall Study|Lost to Follow-up|5
338459|NCT01211769|1142476|P2|Overall Study|Lost to Follow-up|9
338460|NCT01211769|1142477|P1|Overall Study|Lost to Follow-up|7
338461|NCT01211665|1142516|P2|Overall Study|Death|0
338462|NCT01211665|1142517|P1|Overall Study|Death|1
338463|NCT01211665|1142516|P2|Overall Study|Withdrawal by Subject|0
338464|NCT01211665|1142517|P1|Overall Study|Withdrawal by Subject|1
338465|NCT01211613|1142544|P3|Overall Study|Withdrawal by Subject|0
338466|NCT01211613|1142545|P2|Overall Study|Withdrawal by Subject|0
338467|NCT01211613|1142546|P1|Overall Study|Withdrawal by Subject|1
338468|NCT01211613|1142544|P3|Overall Study|Lost to Follow-up|2
338469|NCT01211613|1142545|P2|Overall Study|Lost to Follow-up|2
338470|NCT01211613|1142546|P1|Overall Study|Lost to Follow-up|2
338471|NCT01211535|1142559|P2|Overall Study|Adverse Event|1
338472|NCT01211535|1142560|P1|Overall Study|Adverse Event|0
338473|NCT01211197|1142579|P6|Washout Period 2 (7 Days)|Adverse Event|0
338474|NCT01211197|1142580|P5|Washout Period 2 (7 Days)|Adverse Event|0
338475|NCT01211197|1142581|P4|Washout Period 2 (7 Days)|Adverse Event|0
338476|NCT01211197|1142582|P3|Washout Period 2 (7 Days)|Adverse Event|0
338477|NCT01211197|1142583|P2|Washout Period 2 (7 Days)|Adverse Event|0
338478|NCT01211197|1142584|P1|Washout Period 2 (7 Days)|Adverse Event|1
338479|NCT01211197|1142579|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
338480|NCT01211197|1142580|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
338481|NCT01211197|1142581|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
338482|NCT01211197|1142582|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
338483|NCT01211197|1142583|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
338484|NCT01211197|1142584|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
338485|NCT01211184|1142631|P3|Overall Study|Withdrawal by Subject|1
338486|NCT01211184|1142632|P2|Overall Study|Withdrawal by Subject|2
338487|NCT01211184|1142633|P1|Overall Study|Withdrawal by Subject|0
338488|NCT01211145|1142648|P4|Overall Study|Patient decision|2
338489|NCT01211145|1142649|P3|Overall Study|Patient decision|0
338490|NCT01211145|1142650|P2|Overall Study|Patient decision|1
338491|NCT01211145|1142651|P1|Overall Study|Patient decision|2
338492|NCT01211145|1142648|P4|Overall Study|Eligibility criteria not fulfilled|15
338493|NCT01211145|1142649|P3|Overall Study|Eligibility criteria not fulfilled|10
338494|NCT01211145|1142650|P2|Overall Study|Eligibility criteria not fulfilled|12
338495|NCT01211145|1142651|P1|Overall Study|Eligibility criteria not fulfilled|16
338496|NCT01211145|1142648|P4|Overall Study|Severe noncompliance to protocol|0
338497|NCT01211145|1142649|P3|Overall Study|Severe noncompliance to protocol|0
338498|NCT01211145|1142650|P2|Overall Study|Severe noncompliance to protocol|0
338499|NCT01211145|1142651|P1|Overall Study|Severe noncompliance to protocol|1
338500|NCT01211145|1142648|P4|Overall Study|Study-specific withdrawal criteria|0
338501|NCT01211145|1142649|P3|Overall Study|Study-specific withdrawal criteria|0
338502|NCT01211145|1142650|P2|Overall Study|Study-specific withdrawal criteria|0
338503|NCT01211145|1142651|P1|Overall Study|Study-specific withdrawal criteria|1
338504|NCT01211145|1142648|P4|Overall Study|Lost to Follow-up|2
338505|NCT01211145|1142649|P3|Overall Study|Lost to Follow-up|1
338506|NCT01211145|1142650|P2|Overall Study|Lost to Follow-up|2
338507|NCT01211145|1142651|P1|Overall Study|Lost to Follow-up|3
338508|NCT01211145|1142648|P4|Overall Study|Reason not specified|1
338509|NCT01211145|1142649|P3|Overall Study|Reason not specified|2
338510|NCT01211145|1142650|P2|Overall Study|Reason not specified|2
338511|NCT01211145|1142651|P1|Overall Study|Reason not specified|3
338512|NCT01210807|1142705|P2|Overall Study|Not implanted bilaterally|1
338513|NCT01210807|1142706|P1|Overall Study|Not implanted bilaterally|2
338514|NCT01210807|1142705|P2|Overall Study|Lost to Follow-up|2
338515|NCT01210807|1142706|P1|Overall Study|Lost to Follow-up|1
338516|NCT01210690|1142721|P1|Overall Study|Patient could not take glucose|1
338517|NCT01210690|1142721|P1|Overall Study|Patient refused to swallow|1
338518|NCT01210690|1142721|P1|Overall Study|Withdrawal by Subject|1
338519|NCT01210690|1142721|P1|Overall Study|Disease Remission|1
338520|NCT01210690|1142721|P1|Overall Study|Lost to Follow-up|3
338521|NCT01210690|1142721|P1|Overall Study|Lack of Efficacy|12
338522|NCT01210690|1142721|P1|Overall Study|Adverse Event|7
338523|NCT01210651|1142736|P2|Overall Study|Injury outside study|0
338524|NCT01210651|1142737|P1|Overall Study|Injury outside study|2
338525|NCT01210651|1142736|P2|Overall Study|Withdrawal by Subject|1
338526|NCT01210651|1142737|P1|Overall Study|Withdrawal by Subject|1
338527|NCT01210651|1142736|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
338528|NCT01210651|1142737|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
338529|NCT01210651|1142736|P2|Overall Study|schedule conflicts|5
338530|NCT01210651|1142737|P1|Overall Study|schedule conflicts|1
338531|NCT01210651|1142736|P2|Overall Study|Lost to Follow-up|1
338532|NCT01210651|1142737|P1|Overall Study|Lost to Follow-up|1
338533|NCT01210495|1142857|P4|Overall Study|Other unspecified|0
338534|NCT01210495|1142858|P3|Overall Study|Other unspecified|6
338535|NCT01210495|1142859|P2|Overall Study|Other unspecified|0
338536|NCT01210495|1142860|P1|Overall Study|Other unspecified|0
338537|NCT01210495|1142857|P4|Overall Study|Lost to Follow-up|1
338538|NCT01210495|1142858|P3|Overall Study|Lost to Follow-up|1
338539|NCT01210495|1142859|P2|Overall Study|Lost to Follow-up|0
338540|NCT01210495|1142860|P1|Overall Study|Lost to Follow-up|0
338541|NCT01210495|1142857|P4|Overall Study|Study Terminated by Sponsor|11
338542|NCT01210495|1142858|P3|Overall Study|Study Terminated by Sponsor|4
338543|NCT01210495|1142859|P2|Overall Study|Study Terminated by Sponsor|0
338544|NCT01210495|1142860|P1|Overall Study|Study Terminated by Sponsor|0
338545|NCT01210495|1142857|P4|Overall Study|Death|54
338546|NCT01210495|1142858|P3|Overall Study|Death|112
338547|NCT01210495|1142859|P2|Overall Study|Death|7
338548|NCT01210495|1142860|P1|Overall Study|Death|14
338549|NCT01210495|1142857|P4|Overall Study|Participant Refused Further Follow-Up|2
338550|NCT01210495|1142858|P3|Overall Study|Participant Refused Further Follow-Up|11
338551|NCT01210495|1142859|P2|Overall Study|Participant Refused Further Follow-Up|0
338552|NCT01210495|1142860|P1|Overall Study|Participant Refused Further Follow-Up|1
338553|NCT01210443|1142922|P1|Overall Study|Study terminated by sponsor|2
338554|NCT01210222|1142930|P1|Overall Study|Never treated|1
338555|NCT01210222|1142930|P1|Overall Study|Ineligible|2
338556|NCT01210144|1142966|P2|Overall Study|No transfer|0
338557|NCT01210144|1142967|P1|Overall Study|No transfer|1
338558|NCT01210144|1142966|P2|Overall Study|No fertilization|0
338559|NCT01210144|1142967|P1|Overall Study|No fertilization|1
338560|NCT01210144|1142966|P2|Overall Study|Lack of ovarian response|0
338561|NCT01210144|1142967|P1|Overall Study|Lack of ovarian response|1
338562|NCT01210118|1142989|P2|Overall Study|Spontaneous abortion|3
338563|NCT01210118|1142990|P1|Overall Study|Spontaneous abortion|1
338564|NCT01210118|1142989|P2|Overall Study|Protocol Violation|1
338565|NCT01210118|1142990|P1|Overall Study|Protocol Violation|1
338566|NCT01210118|1142989|P2|Overall Study|Lost to Follow-up|1
338567|NCT01210118|1142990|P1|Overall Study|Lost to Follow-up|1
338568|NCT01210001|1143014|P3|Overall Study|Other reason not defined above|1
338569|NCT01210001|1143015|P2|Overall Study|Other reason not defined above|2
338570|NCT01210001|1143016|P1|Overall Study|Other reason not defined above|2
338571|NCT01210001|1143014|P3|Overall Study|Patient refusal to continue,not due toAE|1
338572|NCT01210001|1143015|P2|Overall Study|Patient refusal to continue,not due toAE|2
338573|NCT01210001|1143016|P1|Overall Study|Patient refusal to continue,not due toAE|6
338574|NCT01210001|1143014|P3|Overall Study|Lost to Follow-up|2
338575|NCT01210001|1143015|P2|Overall Study|Lost to Follow-up|3
338576|NCT01210001|1143016|P1|Overall Study|Lost to Follow-up|4
338577|NCT01210001|1143014|P3|Overall Study|Non compliant with protocol|3
338578|NCT01210001|1143015|P2|Overall Study|Non compliant with protocol|2
338579|NCT01210001|1143016|P1|Overall Study|Non compliant with protocol|2
338580|NCT01210001|1143014|P3|Overall Study|Adverse Event|5
338581|NCT01210001|1143015|P2|Overall Study|Adverse Event|2
338582|NCT01210001|1143016|P1|Overall Study|Adverse Event|4
338583|NCT01210001|1143014|P3|Overall Study|Not treated|0
338584|NCT01210001|1143015|P2|Overall Study|Not treated|0
338585|NCT01210001|1143016|P1|Overall Study|Not treated|1
338586|NCT01209949|1143036|P1|Overall Study|Lost to Follow-up|3
338587|NCT01209780|1143046|P5|Overall Study|Inappropriate enrollment|1
338588|NCT01209780|1143047|P4|Overall Study|Inappropriate enrollment|0
338589|NCT01209780|1143048|P3|Overall Study|Inappropriate enrollment|0
338590|NCT01209780|1143049|P2|Overall Study|Inappropriate enrollment|2
338591|NCT01209780|1143050|P1|Overall Study|Inappropriate enrollment|0
338592|NCT01209780|1143046|P5|Overall Study|Protocol Violation|0
338593|NCT01209780|1143047|P4|Overall Study|Protocol Violation|0
338594|NCT01209780|1143048|P3|Overall Study|Protocol Violation|0
338595|NCT01209780|1143049|P2|Overall Study|Protocol Violation|1
338596|NCT01209780|1143050|P1|Overall Study|Protocol Violation|0
338597|NCT01209780|1143046|P5|Overall Study|Lost to Follow-up|4
338598|NCT01209780|1143047|P4|Overall Study|Lost to Follow-up|9
338599|NCT01209780|1143048|P3|Overall Study|Lost to Follow-up|3
338600|NCT01209780|1143049|P2|Overall Study|Lost to Follow-up|12
338601|NCT01209780|1143050|P1|Overall Study|Lost to Follow-up|17
338602|NCT01209780|1143046|P5|Overall Study|Withdrawal by Subject|0
338603|NCT01209780|1143047|P4|Overall Study|Withdrawal by Subject|1
338604|NCT01209780|1143048|P3|Overall Study|Withdrawal by Subject|1
338605|NCT01209780|1143049|P2|Overall Study|Withdrawal by Subject|2
338606|NCT01209780|1143050|P1|Overall Study|Withdrawal by Subject|9
338607|NCT01209780|1143046|P5|Overall Study|Adverse Event|0
338608|NCT01209780|1143047|P4|Overall Study|Adverse Event|0
338609|NCT01209780|1143048|P3|Overall Study|Adverse Event|0
338610|NCT01209780|1143049|P2|Overall Study|Adverse Event|1
338611|NCT01209780|1143050|P1|Overall Study|Adverse Event|0
338612|NCT01209767|1143076|P1|Overall Study|Lost to Follow-up|3
338613|NCT01209767|1143076|P1|Overall Study|Withdrawal by Subject|1
338614|NCT01209689|1143145|P2|Overall Study|Sponsor's Decision to Stop the Study|17
338615|NCT01209689|1143146|P1|Overall Study|Sponsor's Decision to Stop the Study|68
338616|NCT01209689|1143145|P2|Overall Study|Failure to Return|0
338617|NCT01209689|1143146|P1|Overall Study|Failure to Return|3
338618|NCT01209689|1143145|P2|Overall Study|Violation of Selection Criteria at Entry|0
338619|NCT01209689|1143146|P1|Overall Study|Violation of Selection Criteria at Entry|1
338620|NCT01209689|1143145|P2|Overall Study|Adverse Event|0
338621|NCT01209689|1143146|P1|Overall Study|Adverse Event|4
338622|NCT01209689|1143145|P2|Overall Study|Refused Treatment|3
338623|NCT01209689|1143146|P1|Overall Study|Refused Treatment|8
338624|NCT01209689|1143145|P2|Overall Study|Insufficient Therapeutic Response|2
338625|NCT01209689|1143146|P1|Overall Study|Insufficient Therapeutic Response|7
338626|NCT01209624|1143152|P1|Overall Study|Other|4
338627|NCT01209624|1143152|P1|Overall Study|Lost to Follow-up|290
338628|NCT01209624|1143152|P1|Overall Study|Lack of Efficacy|17
338629|NCT01209624|1143152|P1|Overall Study|Adverse Event|13
338630|NCT01209624|1143152|P1|Overall Study|Death|2
338631|NCT01209598|1143185|P2|Overall Study|Withdrawal by Subject|0
338632|NCT01209598|1143186|P1|Overall Study|Withdrawal by Subject|1
338633|NCT01209520|1143194|P1|Overall Study|Withdrawal by Subject|3
338634|NCT01209286|1143202|P3|Overall Study|Other|0
338635|NCT01209286|1143203|P2|Overall Study|Other|1
338636|NCT01209286|1143204|P1|Overall Study|Other|0
338637|NCT01209286|1143202|P3|Overall Study|Physician Decision|0
338638|NCT01209286|1143203|P2|Overall Study|Physician Decision|2
338639|NCT01209286|1143204|P1|Overall Study|Physician Decision|0
338640|NCT01209286|1143202|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
338641|NCT01209286|1143203|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
338642|NCT01209286|1143204|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
338643|NCT01209286|1143202|P3|Overall Study|Hematological Relapse After Remission|1
338644|NCT01209286|1143203|P2|Overall Study|Hematological Relapse After Remission|1
338645|NCT01209286|1143204|P1|Overall Study|Hematological Relapse After Remission|0
338646|NCT01209286|1143202|P3|Overall Study|Adverse Event|1
338647|NCT01209286|1143203|P2|Overall Study|Adverse Event|3
338648|NCT01209286|1143204|P1|Overall Study|Adverse Event|4
338649|NCT01209143|1143313|P2|Overall Study|Disease progression|16
338650|NCT01209143|1143314|P1|Overall Study|Disease progression|11
338651|NCT01209143|1143313|P2|Overall Study|Withdrawal by Subject|1
338652|NCT01209143|1143314|P1|Overall Study|Withdrawal by Subject|2
338653|NCT01209143|1143313|P2|Overall Study|Lost to Follow-up|0
338654|NCT01209143|1143314|P1|Overall Study|Lost to Follow-up|1
338655|NCT01209143|1143313|P2|Overall Study|Physician Decision|1
338656|NCT01209143|1143314|P1|Overall Study|Physician Decision|3
338657|NCT01209143|1143313|P2|Overall Study|Death|1
338658|NCT01209143|1143314|P1|Overall Study|Death|0
338659|NCT01209143|1143313|P2|Overall Study|Adverse Event|1
338660|NCT01209143|1143314|P1|Overall Study|Adverse Event|2
338661|NCT01209078|1143324|P2|Overall Study|Withdrawal by Subject|1
338662|NCT01209078|1143325|P1|Overall Study|Withdrawal by Subject|2
338663|NCT01209078|1143324|P2|Overall Study|Physician Decision|2
338664|NCT01209078|1143325|P1|Overall Study|Physician Decision|5
338665|NCT01209078|1143324|P2|Overall Study|Lost to Follow-up|0
338666|NCT01209078|1143325|P1|Overall Study|Lost to Follow-up|4
338667|NCT01209078|1143324|P2|Overall Study|Adverse Event|0
338668|NCT01209078|1143325|P1|Overall Study|Adverse Event|5
338669|NCT01208961|1143400|P2|High-Fat Period III|Protocol Violation|0
338670|NCT01208961|1143401|P1|High-Fat Period III|Protocol Violation|1
338671|NCT01208870|1143412|P2|Overall Study|Lost to Follow-up|8
338672|NCT01208870|1143413|P1|Overall Study|Lost to Follow-up|2
338673|NCT01208415|1143429|P1|Overall Study|Still be eligible for follow-up|33
338674|NCT01208415|1143429|P1|Overall Study|Device not placed|1
338675|NCT01208415|1143429|P1|Overall Study|Withdrawal by Subject|3
338676|NCT01208415|1143429|P1|Overall Study|Lost to Follow-up|2
338677|NCT01208415|1143429|P1|Overall Study|Death|1
338678|NCT01208402|1143435|P2|Overall Study|Withdrawal by Subject|0
338679|NCT01208402|1143436|P1|Overall Study|Withdrawal by Subject|1
338680|NCT01208337|1143452|P1|Overall Study|Death|3
338681|NCT01208233|1143466|P6|Overall Study|Withdrawal by Subject|2
338682|NCT01208233|1143467|P5|Overall Study|Withdrawal by Subject|4
338683|NCT01208233|1143468|P4|Overall Study|Withdrawal by Subject|1
338684|NCT01208233|1143469|P3|Overall Study|Withdrawal by Subject|1
338685|NCT01208233|1143470|P2|Overall Study|Withdrawal by Subject|0
338686|NCT01208233|1143471|P1|Overall Study|Withdrawal by Subject|1
338687|NCT01208233|1143466|P6|Overall Study|Other|1
338688|NCT01208233|1143467|P5|Overall Study|Other|0
338689|NCT01208233|1143468|P4|Overall Study|Other|0
338690|NCT01208233|1143469|P3|Overall Study|Other|0
338691|NCT01208233|1143470|P2|Overall Study|Other|1
338692|NCT01208233|1143471|P1|Overall Study|Other|2
338693|NCT01208233|1143466|P6|Overall Study|Protocol Violation|0
338694|NCT01208233|1143467|P5|Overall Study|Protocol Violation|3
338695|NCT01208233|1143468|P4|Overall Study|Protocol Violation|0
338696|NCT01208233|1143469|P3|Overall Study|Protocol Violation|0
338697|NCT01208233|1143470|P2|Overall Study|Protocol Violation|0
338698|NCT01208233|1143471|P1|Overall Study|Protocol Violation|0
338699|NCT01208233|1143466|P6|Overall Study|Study terminated by sponsor|7
338700|NCT01208233|1143467|P5|Overall Study|Study terminated by sponsor|10
338701|NCT01208233|1143468|P4|Overall Study|Study terminated by sponsor|0
338702|NCT01208233|1143469|P3|Overall Study|Study terminated by sponsor|0
338703|NCT01208233|1143470|P2|Overall Study|Study terminated by sponsor|0
338704|NCT01208233|1143471|P1|Overall Study|Study terminated by sponsor|0
338705|NCT01208233|1143466|P6|Overall Study|Medication error without adverse event|1
338706|NCT01208233|1143467|P5|Overall Study|Medication error without adverse event|0
338707|NCT01208233|1143468|P4|Overall Study|Medication error without adverse event|0
338708|NCT01208233|1143469|P3|Overall Study|Medication error without adverse event|0
338709|NCT01208233|1143470|P2|Overall Study|Medication error without adverse event|0
338710|NCT01208233|1143471|P1|Overall Study|Medication error without adverse event|0
338711|NCT01208233|1143466|P6|Overall Study|Did not meet entrance criteria|0
338712|NCT01208233|1143467|P5|Overall Study|Did not meet entrance criteria|1
338713|NCT01208233|1143468|P4|Overall Study|Did not meet entrance criteria|0
338714|NCT01208233|1143469|P3|Overall Study|Did not meet entrance criteria|1
338715|NCT01208233|1143470|P2|Overall Study|Did not meet entrance criteria|1
338716|NCT01208233|1143471|P1|Overall Study|Did not meet entrance criteria|2
338717|NCT01208233|1143466|P6|Overall Study|Death|5
338718|NCT01208233|1143467|P5|Overall Study|Death|3
338719|NCT01208233|1143468|P4|Overall Study|Death|0
338720|NCT01208233|1143469|P3|Overall Study|Death|0
338721|NCT01208233|1143470|P2|Overall Study|Death|0
338722|NCT01208233|1143471|P1|Overall Study|Death|0
338723|NCT01208233|1143466|P6|Overall Study|Adverse Event|5
338724|NCT01208233|1143467|P5|Overall Study|Adverse Event|3
338725|NCT01208233|1143468|P4|Overall Study|Adverse Event|0
338726|NCT01208233|1143469|P3|Overall Study|Adverse Event|2
338727|NCT01208233|1143470|P2|Overall Study|Adverse Event|1
338728|NCT01208233|1143471|P1|Overall Study|Adverse Event|0
338729|NCT01208207|1143596|P7|Part II|Technical Problems|0
338730|NCT01208207|1143597|P6|Part II|Technical Problems|1
338731|NCT01208207|1143598|P5|Part II|Technical Problems|0
338732|NCT01208207|1143599|P4|Part II|Technical Problems|1
338733|NCT01208207|1143600|P3|Part II|Technical Problems|0
338734|NCT01208207|1143601|P2|Part II|Technical Problems|0
338735|NCT01208207|1143602|P1|Part II|Technical Problems|0
338736|NCT01208207|1143596|P7|Part II|Protocol Violation|0
338737|NCT01208207|1143597|P6|Part II|Protocol Violation|0
338738|NCT01208207|1143598|P5|Part II|Protocol Violation|0
338739|NCT01208207|1143599|P4|Part II|Protocol Violation|1
338740|NCT01208207|1143600|P3|Part II|Protocol Violation|0
338741|NCT01208207|1143601|P2|Part II|Protocol Violation|0
338742|NCT01208207|1143602|P1|Part II|Protocol Violation|0
338743|NCT01208207|1143596|P7|Part II|Physician Decision|0
338744|NCT01208207|1143597|P6|Part II|Physician Decision|2
338745|NCT01208207|1143598|P5|Part II|Physician Decision|0
338746|NCT01208207|1143599|P4|Part II|Physician Decision|1
338747|NCT01208207|1143600|P3|Part II|Physician Decision|0
338748|NCT01208207|1143601|P2|Part II|Physician Decision|0
338749|NCT01208207|1143602|P1|Part II|Physician Decision|0
338750|NCT01208207|1143596|P7|Part II|Non-Compliance With Study Drug|0
338751|NCT01208207|1143597|P6|Part II|Non-Compliance With Study Drug|1
338752|NCT01208207|1143598|P5|Part II|Non-Compliance With Study Drug|1
338753|NCT01208207|1143599|P4|Part II|Non-Compliance With Study Drug|4
338754|NCT01208207|1143600|P3|Part II|Non-Compliance With Study Drug|0
338755|NCT01208207|1143601|P2|Part II|Non-Compliance With Study Drug|0
338756|NCT01208207|1143602|P1|Part II|Non-Compliance With Study Drug|0
338757|NCT01208207|1143596|P7|Part II|Lost to Follow-up|1
338758|NCT01208207|1143597|P6|Part II|Lost to Follow-up|2
338759|NCT01208207|1143598|P5|Part II|Lost to Follow-up|0
338760|NCT01208207|1143599|P4|Part II|Lost to Follow-up|4
338761|NCT01208207|1143600|P3|Part II|Lost to Follow-up|0
338762|NCT01208207|1143601|P2|Part II|Lost to Follow-up|0
338763|NCT01208207|1143602|P1|Part II|Lost to Follow-up|0
338764|NCT01208207|1143596|P7|Part II|Lack of Efficacy|3
338765|NCT01208207|1143597|P6|Part II|Lack of Efficacy|3
338766|NCT01208207|1143598|P5|Part II|Lack of Efficacy|4
338767|NCT01208207|1143599|P4|Part II|Lack of Efficacy|6
338768|NCT01208207|1143600|P3|Part II|Lack of Efficacy|0
338769|NCT01208207|1143601|P2|Part II|Lack of Efficacy|0
338770|NCT01208207|1143602|P1|Part II|Lack of Efficacy|0
338771|NCT01208207|1143596|P7|Part II|Adverse Event|2
338772|NCT01208207|1143597|P6|Part II|Adverse Event|4
338773|NCT01208207|1143598|P5|Part II|Adverse Event|9
338774|NCT01208207|1143599|P4|Part II|Adverse Event|5
338775|NCT01208207|1143600|P3|Part II|Adverse Event|0
338776|NCT01208207|1143601|P2|Part II|Adverse Event|0
338777|NCT01208207|1143602|P1|Part II|Adverse Event|0
338778|NCT01208207|1143596|P7|Part II|Withdrawal by Subject|5
338779|NCT01208207|1143597|P6|Part II|Withdrawal by Subject|3
338780|NCT01208207|1143598|P5|Part II|Withdrawal by Subject|9
338781|NCT01208207|1143599|P4|Part II|Withdrawal by Subject|10
338782|NCT01208207|1143600|P3|Part II|Withdrawal by Subject|0
338783|NCT01208207|1143601|P2|Part II|Withdrawal by Subject|0
338784|NCT01208207|1143602|P1|Part II|Withdrawal by Subject|0
338785|NCT01208207|1143596|P7|Part I|Withdrawal by Subject|0
338786|NCT01208207|1143597|P6|Part I|Withdrawal by Subject|0
338787|NCT01208207|1143598|P5|Part I|Withdrawal by Subject|0
338788|NCT01208207|1143599|P4|Part I|Withdrawal by Subject|0
338789|NCT01208207|1143600|P3|Part I|Withdrawal by Subject|4
338790|NCT01208207|1143601|P2|Part I|Withdrawal by Subject|4
338791|NCT01208207|1143602|P1|Part I|Withdrawal by Subject|14
338792|NCT01208207|1143596|P7|Part I|Protocol Violation|0
338793|NCT01208207|1143597|P6|Part I|Protocol Violation|0
338794|NCT01208207|1143598|P5|Part I|Protocol Violation|0
338795|NCT01208207|1143599|P4|Part I|Protocol Violation|0
338796|NCT01208207|1143600|P3|Part I|Protocol Violation|2
338797|NCT01208207|1143601|P2|Part I|Protocol Violation|0
338798|NCT01208207|1143602|P1|Part I|Protocol Violation|8
338799|NCT01208207|1143596|P7|Part I|Progressive Disease|0
338800|NCT01208207|1143597|P6|Part I|Progressive Disease|0
338801|NCT01208207|1143598|P5|Part I|Progressive Disease|0
338802|NCT01208207|1143599|P4|Part I|Progressive Disease|0
338803|NCT01208207|1143600|P3|Part I|Progressive Disease|0
338804|NCT01208207|1143601|P2|Part I|Progressive Disease|0
338805|NCT01208207|1143602|P1|Part I|Progressive Disease|1
338806|NCT01208207|1143596|P7|Part I|Physician Decision|0
338807|NCT01208207|1143597|P6|Part I|Physician Decision|0
338808|NCT01208207|1143598|P5|Part I|Physician Decision|0
338809|NCT01208207|1143599|P4|Part I|Physician Decision|0
338810|NCT01208207|1143600|P3|Part I|Physician Decision|0
338811|NCT01208207|1143601|P2|Part I|Physician Decision|1
338812|NCT01208207|1143602|P1|Part I|Physician Decision|0
338813|NCT01208207|1143596|P7|Part I|Non-Compliance With Study Drug|0
338814|NCT01208207|1143597|P6|Part I|Non-Compliance With Study Drug|0
338815|NCT01208207|1143598|P5|Part I|Non-Compliance With Study Drug|0
338816|NCT01208207|1143599|P4|Part I|Non-Compliance With Study Drug|0
338817|NCT01208207|1143600|P3|Part I|Non-Compliance With Study Drug|1
338818|NCT01208207|1143601|P2|Part I|Non-Compliance With Study Drug|0
338819|NCT01208207|1143602|P1|Part I|Non-Compliance With Study Drug|1
338820|NCT01208207|1143596|P7|Part I|Lost to Follow-up|0
338821|NCT01208207|1143597|P6|Part I|Lost to Follow-up|0
338822|NCT01208207|1143598|P5|Part I|Lost to Follow-up|0
338823|NCT01208207|1143599|P4|Part I|Lost to Follow-up|0
338824|NCT01208207|1143600|P3|Part I|Lost to Follow-up|0
338825|NCT01208207|1143601|P2|Part I|Lost to Follow-up|1
338826|NCT01208207|1143602|P1|Part I|Lost to Follow-up|6
338827|NCT01208207|1143596|P7|Part I|Lack of Efficacy|0
338828|NCT01208207|1143597|P6|Part I|Lack of Efficacy|0
338829|NCT01208207|1143598|P5|Part I|Lack of Efficacy|0
338830|NCT01208207|1143599|P4|Part I|Lack of Efficacy|0
338831|NCT01208207|1143600|P3|Part I|Lack of Efficacy|2
338832|NCT01208207|1143601|P2|Part I|Lack of Efficacy|3
338833|NCT01208207|1143602|P1|Part I|Lack of Efficacy|21
338834|NCT01208207|1143596|P7|Part I|Adverse Event|0
338835|NCT01208207|1143597|P6|Part I|Adverse Event|0
338836|NCT01208207|1143598|P5|Part I|Adverse Event|0
338837|NCT01208207|1143599|P4|Part I|Adverse Event|0
338838|NCT01208207|1143600|P3|Part I|Adverse Event|6
338839|NCT01208207|1143601|P2|Part I|Adverse Event|2
338840|NCT01208207|1143602|P1|Part I|Adverse Event|19
338841|NCT01208181|1143629|P5|Part 2|Lack of Efficacy|0
338842|NCT01208181|1143630|P4|Part 2|Lack of Efficacy|7
338843|NCT01208181|1143631|P3|Part 2|Lack of Efficacy|5
338844|NCT01208181|1143632|P2|Part 2|Lack of Efficacy|0
338845|NCT01208181|1143633|P1|Part 2|Lack of Efficacy|0
338846|NCT01208181|1143629|P5|Part 2|Lost to Follow-up|0
338847|NCT01208181|1143630|P4|Part 2|Lost to Follow-up|2
338848|NCT01208181|1143631|P3|Part 2|Lost to Follow-up|1
338849|NCT01208181|1143632|P2|Part 2|Lost to Follow-up|0
338850|NCT01208181|1143633|P1|Part 2|Lost to Follow-up|0
338851|NCT01208181|1143629|P5|Part 2|Non-compliance with study drug|0
338852|NCT01208181|1143630|P4|Part 2|Non-compliance with study drug|1
338853|NCT01208181|1143631|P3|Part 2|Non-compliance with study drug|1
338854|NCT01208181|1143632|P2|Part 2|Non-compliance with study drug|0
338855|NCT01208181|1143633|P1|Part 2|Non-compliance with study drug|0
338856|NCT01208181|1143629|P5|Part 2|Physician Decision|0
338857|NCT01208181|1143630|P4|Part 2|Physician Decision|2
338858|NCT01208181|1143631|P3|Part 2|Physician Decision|1
338859|NCT01208181|1143632|P2|Part 2|Physician Decision|0
338860|NCT01208181|1143633|P1|Part 2|Physician Decision|0
338861|NCT01208181|1143629|P5|Part 2|Protocol Violation|0
338862|NCT01208181|1143630|P4|Part 2|Protocol Violation|0
338863|NCT01208181|1143631|P3|Part 2|Protocol Violation|1
338864|NCT01208181|1143632|P2|Part 2|Protocol Violation|0
338865|NCT01208181|1143633|P1|Part 2|Protocol Violation|0
338866|NCT01208181|1143629|P5|Part 2|Withdrawal by Subject|0
338867|NCT01208181|1143630|P4|Part 2|Withdrawal by Subject|1
338868|NCT01208181|1143631|P3|Part 2|Withdrawal by Subject|1
338869|NCT01208181|1143632|P2|Part 2|Withdrawal by Subject|0
338870|NCT01208181|1143633|P1|Part 2|Withdrawal by Subject|0
338871|NCT01208181|1143629|P5|Part 2|Adverse Event|0
338872|NCT01208181|1143630|P4|Part 2|Adverse Event|7
338873|NCT01208181|1143631|P3|Part 2|Adverse Event|6
338874|NCT01208181|1143632|P2|Part 2|Adverse Event|0
338875|NCT01208181|1143633|P1|Part 2|Adverse Event|0
338876|NCT01208181|1143629|P5|Part 1|Adverse Event|4
338877|NCT01208181|1143630|P4|Part 1|Adverse Event|0
338878|NCT01208181|1143631|P3|Part 1|Adverse Event|0
338879|NCT01208181|1143632|P2|Part 1|Adverse Event|24
338880|NCT01208181|1143633|P1|Part 1|Adverse Event|26
338881|NCT01208181|1143629|P5|Part 1|Lack of Efficacy|17
338882|NCT01208181|1143630|P4|Part 1|Lack of Efficacy|0
338883|NCT01208181|1143631|P3|Part 1|Lack of Efficacy|0
338884|NCT01208181|1143632|P2|Part 1|Lack of Efficacy|12
338885|NCT01208181|1143633|P1|Part 1|Lack of Efficacy|37
338886|NCT01208181|1143629|P5|Part 1|Lost to Follow-up|1
338887|NCT01208181|1143630|P4|Part 1|Lost to Follow-up|0
338888|NCT01208181|1143631|P3|Part 1|Lost to Follow-up|0
338889|NCT01208181|1143632|P2|Part 1|Lost to Follow-up|3
338890|NCT01208181|1143633|P1|Part 1|Lost to Follow-up|5
338891|NCT01208181|1143629|P5|Part 1|Non-compliance with study drug|0
338892|NCT01208181|1143630|P4|Part 1|Non-compliance with study drug|0
338893|NCT01208181|1143631|P3|Part 1|Non-compliance with study drug|0
338894|NCT01208181|1143632|P2|Part 1|Non-compliance with study drug|1
338895|NCT01208181|1143633|P1|Part 1|Non-compliance with study drug|1
338896|NCT01208181|1143629|P5|Part 1|Physician Decision|0
338897|NCT01208181|1143630|P4|Part 1|Physician Decision|0
338898|NCT01208181|1143631|P3|Part 1|Physician Decision|0
338899|NCT01208181|1143632|P2|Part 1|Physician Decision|0
338900|NCT01208181|1143633|P1|Part 1|Physician Decision|4
338901|NCT01208181|1143629|P5|Part 1|Protocol Violation|0
338902|NCT01208181|1143630|P4|Part 1|Protocol Violation|0
338903|NCT01208181|1143631|P3|Part 1|Protocol Violation|0
338904|NCT01208181|1143632|P2|Part 1|Protocol Violation|5
338905|NCT01208181|1143633|P1|Part 1|Protocol Violation|10
338906|NCT01208181|1143629|P5|Part 1|Technical problem|0
338907|NCT01208181|1143630|P4|Part 1|Technical problem|0
338908|NCT01208181|1143631|P3|Part 1|Technical problem|0
338909|NCT01208181|1143632|P2|Part 1|Technical problem|0
338910|NCT01208181|1143633|P1|Part 1|Technical problem|5
338911|NCT01208181|1143629|P5|Part 1|Withdrawal by Subject|0
338912|NCT01208181|1143630|P4|Part 1|Withdrawal by Subject|0
338913|NCT01208181|1143631|P3|Part 1|Withdrawal by Subject|0
338914|NCT01208181|1143632|P2|Part 1|Withdrawal by Subject|10
338915|NCT01208181|1143633|P1|Part 1|Withdrawal by Subject|11
338916|NCT01207687|1143690|P1|Overall Study|Withdrawal by Subject|1
338917|NCT01207687|1143690|P1|Overall Study|Adverse Event|1
338918|NCT01207596|1143724|P1|Overall Study|Withdrawal by Subject|1
338919|NCT01207596|1143724|P1|Overall Study|Adverse Event|3
338920|NCT01207596|1143724|P1|Overall Study|Lack of Efficacy|1
338921|NCT01207596|1143724|P1|Overall Study|Physician Decision|4
338922|NCT01207583|1143737|P3|Overall Study|Lost to Follow-up|0
338923|NCT01207583|1143738|P2|Overall Study|Lost to Follow-up|2
338924|NCT01207583|1143739|P1|Overall Study|Lost to Follow-up|0
338925|NCT01207583|1143737|P3|Overall Study|Participant failed to return|0
338926|NCT01207583|1143738|P2|Overall Study|Participant failed to return|0
338927|NCT01207583|1143739|P1|Overall Study|Participant failed to return|1
338928|NCT01207583|1143737|P3|Overall Study|Withdrawal by Subject|1
338929|NCT01207583|1143738|P2|Overall Study|Withdrawal by Subject|3
338930|NCT01207583|1143739|P1|Overall Study|Withdrawal by Subject|0
338931|NCT01207492|1143792|P1|Overall Study|Toxicity|1
338932|NCT01207492|1143792|P1|Overall Study|Progressive disease|3
338933|NCT01207492|1143792|P1|Overall Study|Physician Decision|1
338934|NCT01207492|1143792|P1|Overall Study|Withdrawal by Subject|9
338935|NCT01207492|1143792|P1|Overall Study|Still on study|1
338936|NCT01207453|1143807|P2|2nd Intervention|Lost to Follow-up|0
338937|NCT01207453|1143808|P1|2nd Intervention|Lost to Follow-up|1
338938|NCT01207453|1143807|P2|2nd Intervention|Adverse Event|2
338939|NCT01207453|1143808|P1|2nd Intervention|Adverse Event|1
338940|NCT01207453|1143807|P2|Washout|Lost to Follow-up|0
338941|NCT01207453|1143808|P1|Washout|Lost to Follow-up|1
338942|NCT01207453|1143807|P2|Washout|Adverse Event|0
338943|NCT01207453|1143808|P1|Washout|Adverse Event|1
338944|NCT01207453|1143807|P2|First Intervention|Adverse Event|1
338945|NCT01207453|1143808|P1|First Intervention|Adverse Event|2
338946|NCT01207427|1143830|P3|Double-blind Treatment Period|Withdrawal by Subject|0
338947|NCT01207427|1143831|P2|Double-blind Treatment Period|Withdrawal by Subject|0
338948|NCT01207427|1143832|P1|Double-blind Treatment Period|Withdrawal by Subject|1
338949|NCT01207427|1143830|P3|Double-blind Treatment Period|Protocol Violation|1
338950|NCT01207427|1143831|P2|Double-blind Treatment Period|Protocol Violation|1
338951|NCT01207427|1143832|P1|Double-blind Treatment Period|Protocol Violation|2
338952|NCT01207427|1143830|P3|Double-blind Treatment Period|Lost to Follow-up|1
338953|NCT01207427|1143831|P2|Double-blind Treatment Period|Lost to Follow-up|0
338954|NCT01207427|1143832|P1|Double-blind Treatment Period|Lost to Follow-up|0
338955|NCT01207427|1143830|P3|Double-blind Treatment Period|Adverse Event|0
338956|NCT01207427|1143831|P2|Double-blind Treatment Period|Adverse Event|1
338957|NCT01207427|1143832|P1|Double-blind Treatment Period|Adverse Event|0
338958|NCT01207414|1143842|P2|Overall Study|Randomized in error|0
338959|NCT01207414|1143843|P1|Overall Study|Randomized in error|1
338960|NCT01207414|1143842|P2|Overall Study|Protocol deviation|9
338961|NCT01207414|1143843|P1|Overall Study|Protocol deviation|12
338962|NCT01207414|1143842|P2|Overall Study|Administrative problems|1
338963|NCT01207414|1143843|P1|Overall Study|Administrative problems|1
338964|NCT01207414|1143842|P2|Overall Study|Lost to Follow-up|17
338965|NCT01207414|1143843|P1|Overall Study|Lost to Follow-up|15
338966|NCT01207414|1143842|P2|Overall Study|Patient withdrew consent|11
338967|NCT01207414|1143843|P1|Overall Study|Patient withdrew consent|14
338968|NCT01207414|1143842|P2|Overall Study|Unsatisfactory therapeutic effect|4
338969|NCT01207414|1143843|P1|Overall Study|Unsatisfactory therapeutic effect|5
338970|NCT01207414|1143842|P2|Overall Study|Abnormal test procedure results|1
338971|NCT01207414|1143843|P1|Overall Study|Abnormal test procedure results|0
338972|NCT01207414|1143842|P2|Overall Study|Adverse Event|39
338973|NCT01207414|1143843|P1|Overall Study|Adverse Event|25
338974|NCT01207388|1143868|P1|Overall Study|Other|1
338975|NCT01207388|1143868|P1|Overall Study|Physician Decision|2
338976|NCT01207388|1143868|P1|Overall Study|Disease Relapse|10
338977|NCT01207388|1143868|P1|Overall Study|Adverse Event|20
338978|NCT01207219|1143891|P3|Overall Study|Lost to Follow-up|6
338979|NCT01207219|1143892|P2|Overall Study|Lost to Follow-up|8
338980|NCT01207219|1143893|P1|Overall Study|Lost to Follow-up|6
338981|NCT01207219|1143891|P3|Overall Study|changed diagnosis during study period|1
338982|NCT01207219|1143892|P2|Overall Study|changed diagnosis during study period|3
338983|NCT01207219|1143893|P1|Overall Study|changed diagnosis during study period|5
338984|NCT01207102|1143913|P1|Overall Study|Withdrawal by Treating Physician|1
338985|NCT01207102|1143913|P1|Overall Study|progression|2
338986|NCT01207102|1143913|P1|Overall Study|Adverse Event|2
338987|NCT01207102|1143913|P1|Overall Study|Withdrawal by Subject|5
338988|NCT01206777|1143918|P1|Overall Study|Adverse Event|1
338989|NCT01206777|1143918|P1|Overall Study|Death|1
338990|NCT01206582|1143974|P2|Overall Study|Discontinued intervention before week 8|2
338991|NCT01206582|1143975|P1|Overall Study|Discontinued intervention before week 8|1
338992|NCT01206582|1143974|P2|Overall Study|Withdrew prior to study|0
338993|NCT01206582|1143975|P1|Overall Study|Withdrew prior to study|1
338994|NCT01206517|1144007|P6|Overall Study|Withdrawal by Subject|0
338995|NCT01206517|1144008|P5|Overall Study|Withdrawal by Subject|1
338996|NCT01206517|1144009|P4|Overall Study|Withdrawal by Subject|0
338997|NCT01206517|1144010|P3|Overall Study|Withdrawal by Subject|2
338998|NCT01206517|1144011|P2|Overall Study|Withdrawal by Subject|0
338999|NCT01206517|1144012|P1|Overall Study|Withdrawal by Subject|0
339000|NCT01206439|1144069|P1|Overall Study|subject did not meet inclusion criteria|1
339001|NCT01206322|1144092|P4|Overall Study|Adverse Event|1
339002|NCT01206322|1144093|P3|Overall Study|Adverse Event|0
339003|NCT01206322|1144094|P2|Overall Study|Adverse Event|0
339004|NCT01206322|1144095|P1|Overall Study|Adverse Event|0
339005|NCT01206140|1144111|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
339006|NCT01206140|1144112|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
339007|NCT01206101|1144124|P2|Overall Study|Unclassified|0
339008|NCT01206101|1144125|P1|Overall Study|Unclassified|1
339009|NCT01206101|1144124|P2|Overall Study|Physician Decision|1
339010|NCT01206101|1144125|P1|Overall Study|Physician Decision|0
339011|NCT01206101|1144124|P2|Overall Study|Adverse Event|0
339012|NCT01206101|1144125|P1|Overall Study|Adverse Event|1
339013|NCT01205776|1144166|P2|3 Years Follow-up|Withdrawal by Subject|2
339014|NCT01205776|1144167|P1|3 Years Follow-up|Withdrawal by Subject|1
339015|NCT01205776|1144166|P2|3 Years Follow-up|Lost to Follow-up|22
339016|NCT01205776|1144167|P1|3 Years Follow-up|Lost to Follow-up|15
339017|NCT01205776|1144166|P2|2 Years Follow-up|Withdrawal by Subject|19
339018|NCT01205776|1144167|P1|2 Years Follow-up|Withdrawal by Subject|4
339019|NCT01205776|1144166|P2|2 Years Follow-up|Lost to Follow-up|13
339020|NCT01205776|1144167|P1|2 Years Follow-up|Lost to Follow-up|12
339021|NCT01205776|1144166|P2|1 Month Follow-up|Withdrawal by Subject|10
339022|NCT01205776|1144167|P1|1 Month Follow-up|Withdrawal by Subject|5
339023|NCT01205776|1144166|P2|1 Month Follow-up|Lost to Follow-up|2
339024|NCT01205776|1144167|P1|1 Month Follow-up|Lost to Follow-up|0
339025|NCT01205685|1144307|P1|Overall Study|Withdrawal by Subject|1
339026|NCT01205685|1144307|P1|Overall Study|Disease Progression|10
339027|NCT01205581|1144327|P6|Overall Study|Withdrawal by Subject|0
339028|NCT01205581|1144328|P5|Overall Study|Withdrawal by Subject|0
339029|NCT01205581|1144329|P4|Overall Study|Withdrawal by Subject|0
339030|NCT01205581|1144330|P3|Overall Study|Withdrawal by Subject|0
339031|NCT01205581|1144331|P2|Overall Study|Withdrawal by Subject|0
339032|NCT01205581|1144332|P1|Overall Study|Withdrawal by Subject|1
339033|NCT01205529|1144402|P1|Overall Study|No longer met criteria|30
339034|NCT01205529|1144402|P1|Overall Study|Unstable post op|15
339035|NCT01205529|1144402|P1|Overall Study|Physician Decision|4
339036|NCT01205529|1144402|P1|Overall Study|Withdrawal by Subject|2
339037|NCT01205529|1144402|P1|Overall Study|Procedure Cancelled|4
339038|NCT01205451|1144425|P2|Overall Study|Withdrawal by Subject|9
339039|NCT01205451|1144426|P1|Overall Study|Withdrawal by Subject|5
339040|NCT01205451|1144425|P2|Overall Study|Lost to Follow-up|1
339041|NCT01205451|1144426|P1|Overall Study|Lost to Follow-up|1
339042|NCT01205438|1144471|P3|Overall Study|Sponsor Decision|1
339043|NCT01205438|1144472|P2|Overall Study|Sponsor Decision|1
339044|NCT01205438|1144473|P1|Overall Study|Sponsor Decision|0
339045|NCT01205438|1144471|P3|Overall Study|Protocol Violation|4
339046|NCT01205438|1144472|P2|Overall Study|Protocol Violation|7
339047|NCT01205438|1144473|P1|Overall Study|Protocol Violation|2
339048|NCT01205438|1144471|P3|Overall Study|Physician Decision|2
339049|NCT01205438|1144472|P2|Overall Study|Physician Decision|3
339050|NCT01205438|1144473|P1|Overall Study|Physician Decision|0
339051|NCT01205438|1144471|P3|Overall Study|Withdrawal by Subject|19
339052|NCT01205438|1144472|P2|Overall Study|Withdrawal by Subject|25
339053|NCT01205438|1144473|P1|Overall Study|Withdrawal by Subject|19
339054|NCT01205438|1144471|P3|Overall Study|Lost to Follow-up|8
339055|NCT01205438|1144472|P2|Overall Study|Lost to Follow-up|7
339056|NCT01205438|1144473|P1|Overall Study|Lost to Follow-up|6
339057|NCT01205438|1144471|P3|Overall Study|Lack of Efficacy|14
339058|NCT01205438|1144472|P2|Overall Study|Lack of Efficacy|11
339059|NCT01205438|1144473|P1|Overall Study|Lack of Efficacy|14
339060|NCT01205438|1144471|P3|Overall Study|Entry Criteria Not Met|13
339061|NCT01205438|1144472|P2|Overall Study|Entry Criteria Not Met|15
339062|NCT01205438|1144473|P1|Overall Study|Entry Criteria Not Met|16
339063|NCT01205438|1144471|P3|Overall Study|Death|3
339064|NCT01205438|1144472|P2|Overall Study|Death|1
339065|NCT01205438|1144473|P1|Overall Study|Death|1
339066|NCT01205438|1144471|P3|Overall Study|Adverse Event|24
339067|NCT01205438|1144472|P2|Overall Study|Adverse Event|17
339068|NCT01205438|1144473|P1|Overall Study|Adverse Event|19
339069|NCT01205269|1144529|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
339070|NCT01205269|1144530|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
339071|NCT01205269|1144531|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
339072|NCT01205269|1144532|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
339073|NCT01205269|1144533|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
339074|NCT01205269|1144534|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
339075|NCT01205230|1144574|P2|Overall Study|Physician Decision|0
339076|NCT01205230|1144575|P1|Overall Study|Physician Decision|1
339077|NCT01205230|1144574|P2|Overall Study|Adverse Event|0
339078|NCT01205230|1144575|P1|Overall Study|Adverse Event|4
339079|NCT01205165|1144618|P1|Overall Study|Lost to Follow-up|2
339080|NCT01205152|1144631|P1|Overall Study|Death|1
339081|NCT01205126|1144644|P2|Maintenance Phase|Withdrawal by Subject|11
339082|NCT01205126|1144645|P1|Maintenance Phase|Withdrawal by Subject|8
339083|NCT01205126|1144644|P2|Maintenance Phase|Lost to Follow-up|5
339084|NCT01205126|1144645|P1|Maintenance Phase|Lost to Follow-up|5
339085|NCT01205126|1144644|P2|Maintenance Phase|Other|8
339086|NCT01205126|1144645|P1|Maintenance Phase|Other|11
339087|NCT01205126|1144644|P2|Maintenance Phase|Prohibited drugs used|0
339088|NCT01205126|1144645|P1|Maintenance Phase|Prohibited drugs used|1
339089|NCT01205126|1144644|P2|Maintenance Phase|More than the maximum dosage required|5
339090|NCT01205126|1144645|P1|Maintenance Phase|More than the maximum dosage required|5
339091|NCT01205126|1144644|P2|Maintenance Phase|Death|4
339092|NCT01205126|1144645|P1|Maintenance Phase|Death|4
339093|NCT01205126|1144644|P2|Maintenance Phase|Adverse Event|7
339094|NCT01205126|1144645|P1|Maintenance Phase|Adverse Event|3
339095|NCT01205126|1144644|P2|Between Titration & Maintenance Phase|Other|4
339096|NCT01205126|1144645|P1|Between Titration & Maintenance Phase|Other|0
339097|NCT01205126|1144644|P2|Titration Phase|Other|6
339098|NCT01205126|1144645|P1|Titration Phase|Other|8
339099|NCT01205126|1144644|P2|Titration Phase|More than maximum dosage required|3
339100|NCT01205126|1144645|P1|Titration Phase|More than maximum dosage required|2
339101|NCT01205126|1144644|P2|Titration Phase|No stable titration dose|0
339102|NCT01205126|1144645|P1|Titration Phase|No stable titration dose|1
339103|NCT01205126|1144644|P2|Titration Phase|Lost to Follow-up|2
339104|NCT01205126|1144645|P1|Titration Phase|Lost to Follow-up|2
339105|NCT01205126|1144644|P2|Titration Phase|Withdrawal by Subject|5
339106|NCT01205126|1144645|P1|Titration Phase|Withdrawal by Subject|5
339107|NCT01205126|1144644|P2|Titration Phase|Adverse Event|3
339108|NCT01205126|1144645|P1|Titration Phase|Adverse Event|5
339109|NCT01205035|1144663|P2|Overall Study|Physician Decision|0
339110|NCT01205035|1144664|P1|Overall Study|Physician Decision|1
339111|NCT01205035|1144663|P2|Overall Study|Withdrawal by Subject|0
339112|NCT01205035|1144664|P1|Overall Study|Withdrawal by Subject|1
339113|NCT01204918|1144681|P3|Overall Study|Withdrawal by Subject|5
339114|NCT01204918|1144682|P2|Overall Study|Withdrawal by Subject|10
339115|NCT01204918|1144683|P1|Overall Study|Withdrawal by Subject|4
339116|NCT01204775|1144721|P2|Overall Study|Withdrawal by Subject|0
339117|NCT01204775|1144722|P1|Overall Study|Withdrawal by Subject|1
339118|NCT01204775|1144721|P2|Overall Study|Poor/non-compliance|1
339119|NCT01204775|1144722|P1|Overall Study|Poor/non-compliance|0
339120|NCT01204697|1144747|P2|Overall Study|Randomized, but not treated|1
339121|NCT01204697|1144748|P1|Overall Study|Randomized, but not treated|0
339122|NCT01204697|1144747|P2|Overall Study|Withdrawal by Subject|4
339123|NCT01204697|1144748|P1|Overall Study|Withdrawal by Subject|2
339124|NCT01204697|1144747|P2|Overall Study|Lost to Follow-up|4
339125|NCT01204697|1144748|P1|Overall Study|Lost to Follow-up|3
339126|NCT01204697|1144747|P2|Overall Study|Death|27
339127|NCT01204697|1144748|P1|Overall Study|Death|26
339128|NCT01204671|1144769|P5|Overall Study|Physician Decision|0
339129|NCT01204671|1144770|P4|Overall Study|Physician Decision|1
339130|NCT01204671|1144771|P3|Overall Study|Physician Decision|0
339131|NCT01204671|1144772|P2|Overall Study|Physician Decision|0
339132|NCT01204671|1144773|P1|Overall Study|Physician Decision|0
339133|NCT01204671|1144769|P5|Overall Study|Unknown Completion Status|0
339134|NCT01204671|1144770|P4|Overall Study|Unknown Completion Status|0
339135|NCT01204671|1144771|P3|Overall Study|Unknown Completion Status|0
339136|NCT01204671|1144772|P2|Overall Study|Unknown Completion Status|1
339137|NCT01204671|1144773|P1|Overall Study|Unknown Completion Status|1
339138|NCT01204671|1144769|P5|Overall Study|Lost to Follow-up|0
339139|NCT01204671|1144770|P4|Overall Study|Lost to Follow-up|4
339140|NCT01204671|1144771|P3|Overall Study|Lost to Follow-up|6
339141|NCT01204671|1144772|P2|Overall Study|Lost to Follow-up|8
339142|NCT01204671|1144773|P1|Overall Study|Lost to Follow-up|7
339143|NCT01204671|1144769|P5|Overall Study|Withdrawal by Subject|3
339144|NCT01204671|1144770|P4|Overall Study|Withdrawal by Subject|5
339145|NCT01204671|1144771|P3|Overall Study|Withdrawal by Subject|4
339146|NCT01204671|1144772|P2|Overall Study|Withdrawal by Subject|3
339147|NCT01204671|1144773|P1|Overall Study|Withdrawal by Subject|2
339148|NCT01204671|1144769|P5|Overall Study|Adverse Event|1
339149|NCT01204671|1144770|P4|Overall Study|Adverse Event|3
339150|NCT01204671|1144771|P3|Overall Study|Adverse Event|3
339151|NCT01204671|1144772|P2|Overall Study|Adverse Event|3
339152|NCT01204671|1144773|P1|Overall Study|Adverse Event|4
339153|NCT01204658|1144835|P4|Primary Phase|Adverse Event|0
339154|NCT01204658|1144836|P3|Primary Phase|Adverse Event|1
339155|NCT01204658|1144837|P2|Primary Phase|Adverse Event|0
339156|NCT01204658|1144838|P1|Primary Phase|Adverse Event|0
339157|NCT01204398|1144948|P1|Overall Study|Adverse Event|1
339158|NCT01204294|1144965|P7|Overall Study|Other (house moving)|0
339159|NCT01204294|1144966|P6|Overall Study|Other (house moving)|0
339160|NCT01204294|1144967|P5|Overall Study|Other (house moving)|0
339161|NCT01204294|1144968|P4|Overall Study|Other (house moving)|0
339162|NCT01204294|1144969|P3|Overall Study|Other (house moving)|1
339163|NCT01204294|1144970|P2|Overall Study|Other (house moving)|0
339164|NCT01204294|1144971|P1|Overall Study|Other (house moving)|0
339165|NCT01204294|1144965|P7|Overall Study|Lack of Efficacy|0
339166|NCT01204294|1144966|P6|Overall Study|Lack of Efficacy|0
339167|NCT01204294|1144967|P5|Overall Study|Lack of Efficacy|0
339168|NCT01204294|1144968|P4|Overall Study|Lack of Efficacy|2
339169|NCT01204294|1144969|P3|Overall Study|Lack of Efficacy|0
339170|NCT01204294|1144970|P2|Overall Study|Lack of Efficacy|0
339171|NCT01204294|1144971|P1|Overall Study|Lack of Efficacy|0
339172|NCT01204294|1144965|P7|Overall Study|Withdrawal by Subject|2
339173|NCT01204294|1144966|P6|Overall Study|Withdrawal by Subject|1
339174|NCT01204294|1144967|P5|Overall Study|Withdrawal by Subject|1
339175|NCT01204294|1144968|P4|Overall Study|Withdrawal by Subject|1
339176|NCT01204294|1144969|P3|Overall Study|Withdrawal by Subject|2
339177|NCT01204294|1144970|P2|Overall Study|Withdrawal by Subject|2
339178|NCT01204294|1144971|P1|Overall Study|Withdrawal by Subject|0
339179|NCT01204294|1144965|P7|Overall Study|Protocol Violation|0
339180|NCT01204294|1144966|P6|Overall Study|Protocol Violation|0
339181|NCT01204294|1144967|P5|Overall Study|Protocol Violation|0
339182|NCT01204294|1144968|P4|Overall Study|Protocol Violation|1
339183|NCT01204294|1144969|P3|Overall Study|Protocol Violation|2
339184|NCT01204294|1144970|P2|Overall Study|Protocol Violation|0
339185|NCT01204294|1144971|P1|Overall Study|Protocol Violation|1
339186|NCT01204294|1144965|P7|Overall Study|Adverse Event|0
339187|NCT01204294|1144966|P6|Overall Study|Adverse Event|4
339188|NCT01204294|1144967|P5|Overall Study|Adverse Event|1
339189|NCT01204294|1144968|P4|Overall Study|Adverse Event|7
339190|NCT01204294|1144969|P3|Overall Study|Adverse Event|0
339191|NCT01204294|1144970|P2|Overall Study|Adverse Event|6
339192|NCT01204294|1144971|P1|Overall Study|Adverse Event|2
339193|NCT01203956|1145005|P2|Second Two-week Period|Non-compliant: no evaluable results|6
339194|NCT01203956|1145006|P1|Second Two-week Period|Non-compliant: no evaluable results|5
339195|NCT01203930|1145015|P2|Overall Study|Adverse Event|5
339196|NCT01203930|1145016|P1|Overall Study|Adverse Event|17
339197|NCT01203930|1145015|P2|Overall Study|Poor tolerance of study drug|1
339198|NCT01203930|1145016|P1|Overall Study|Poor tolerance of study drug|0
339199|NCT01203930|1145015|P2|Overall Study|Study Terminated by Sponsor|12
339200|NCT01203930|1145016|P1|Overall Study|Study Terminated by Sponsor|0
339201|NCT01203930|1145015|P2|Overall Study|Investigator Request|8
339202|NCT01203930|1145016|P1|Overall Study|Investigator Request|0
339203|NCT01203930|1145015|P2|Overall Study|Withdrew Consent|10
339204|NCT01203930|1145016|P1|Overall Study|Withdrew Consent|1
339205|NCT01203930|1145015|P2|Overall Study|Death|1
339206|NCT01203930|1145016|P1|Overall Study|Death|3
339207|NCT01203930|1145015|P2|Overall Study|Disease Progression|4
339208|NCT01203930|1145016|P1|Overall Study|Disease Progression|0
339209|NCT01203917|1145038|P1|Overall Study|Due to EGFR M+I patient|1
339210|NCT01203917|1145038|P1|Overall Study|Due to objective disease progression|1
339211|NCT01203917|1145038|P1|Overall Study|Withdrawal by Subject|3
339212|NCT01203917|1145038|P1|Overall Study|Lost to Follow-up|2
339213|NCT01203917|1145038|P1|Overall Study|Death|29
339214|NCT01203878|1145051|P3|Overall Study|Adverse Event|2
339215|NCT01203878|1145052|P2|Overall Study|Adverse Event|0
339216|NCT01203878|1145053|P1|Overall Study|Adverse Event|0
339217|NCT01203878|1145051|P3|Overall Study|Withdrawal by Subject|1
339218|NCT01203878|1145052|P2|Overall Study|Withdrawal by Subject|0
339219|NCT01203878|1145053|P1|Overall Study|Withdrawal by Subject|0
339220|NCT01203852|1145064|P1|Washout 2 Weeks|Physician Decision|46
339221|NCT01203852|1145064|P1|Metoprolol 8 Weeks|Physician Decision|470
339222|NCT01203787|1145082|P2|Overall Study|Adverse Event|15
339223|NCT01203787|1145083|P1|Overall Study|Adverse Event|11
339224|NCT01203787|1145082|P2|Overall Study|Lost to Follow-up|0
339225|NCT01203787|1145083|P1|Overall Study|Lost to Follow-up|2
339226|NCT01203787|1145082|P2|Overall Study|Withdrawal by Subject|2
339227|NCT01203787|1145083|P1|Overall Study|Withdrawal by Subject|6
339228|NCT01203787|1145082|P2|Overall Study|Death|10
339229|NCT01203787|1145083|P1|Overall Study|Death|12
339230|NCT01203098|1145154|P3|Overall Study|Withdrawal by Subject|3
339231|NCT01203098|1145155|P2|Overall Study|Withdrawal by Subject|1
339232|NCT01203098|1145156|P1|Overall Study|Withdrawal by Subject|1
339233|NCT01203098|1145154|P3|Overall Study|Physician Decision|0
339234|NCT01203098|1145155|P2|Overall Study|Physician Decision|2
339235|NCT01203098|1145156|P1|Overall Study|Physician Decision|2
339236|NCT01203098|1145154|P3|Overall Study|Lost to Follow-up|1
339237|NCT01203098|1145155|P2|Overall Study|Lost to Follow-up|0
339238|NCT01203098|1145156|P1|Overall Study|Lost to Follow-up|0
339239|NCT01203098|1145154|P3|Overall Study|Adverse Event|7
339240|NCT01203098|1145155|P2|Overall Study|Adverse Event|1
339241|NCT01203098|1145156|P1|Overall Study|Adverse Event|3
339242|NCT01203072|1145172|P5|Overall Study|Withdrawal by Subject|3
339243|NCT01203072|1145173|P4|Overall Study|Withdrawal by Subject|2
339244|NCT01203072|1145174|P3|Overall Study|Withdrawal by Subject|1
339245|NCT01203072|1145175|P2|Overall Study|Withdrawal by Subject|2
339246|NCT01203072|1145176|P1|Overall Study|Withdrawal by Subject|2
339247|NCT01203072|1145172|P5|Overall Study|Protocol Violation|1
339248|NCT01203072|1145173|P4|Overall Study|Protocol Violation|0
339249|NCT01203072|1145174|P3|Overall Study|Protocol Violation|0
339250|NCT01203072|1145175|P2|Overall Study|Protocol Violation|0
339251|NCT01203072|1145176|P1|Overall Study|Protocol Violation|2
339252|NCT01203072|1145172|P5|Overall Study|Lost to Follow-up|0
339253|NCT01203072|1145173|P4|Overall Study|Lost to Follow-up|0
339254|NCT01203072|1145174|P3|Overall Study|Lost to Follow-up|0
339255|NCT01203072|1145175|P2|Overall Study|Lost to Follow-up|1
339256|NCT01203072|1145176|P1|Overall Study|Lost to Follow-up|0
339257|NCT01203072|1145172|P5|Overall Study|Lack of Efficacy|0
339258|NCT01203072|1145173|P4|Overall Study|Lack of Efficacy|0
339259|NCT01203072|1145174|P3|Overall Study|Lack of Efficacy|0
339260|NCT01203072|1145175|P2|Overall Study|Lack of Efficacy|0
339261|NCT01203072|1145176|P1|Overall Study|Lack of Efficacy|1
339262|NCT01203072|1145172|P5|Overall Study|Adverse Event|2
339263|NCT01203072|1145173|P4|Overall Study|Adverse Event|4
339264|NCT01203072|1145174|P3|Overall Study|Adverse Event|2
339265|NCT01203072|1145175|P2|Overall Study|Adverse Event|3
339266|NCT01203072|1145176|P1|Overall Study|Adverse Event|5
339267|NCT01202955|1145211|P2|Period 1: 10 Days|Withdrawal by Subject|2
339268|NCT01202955|1145212|P1|Period 1: 10 Days|Withdrawal by Subject|0
339269|NCT01202903|1145224|P2|Overall Study|Withdrawal by Subject|4
339270|NCT01202903|1145225|P1|Overall Study|Withdrawal by Subject|4
339271|NCT01202903|1145224|P2|Overall Study|Adverse Event|3
339272|NCT01202903|1145225|P1|Overall Study|Adverse Event|3
339273|NCT01202903|1145224|P2|Overall Study|Lack of Efficacy|3
339274|NCT01202903|1145225|P1|Overall Study|Lack of Efficacy|1
339275|NCT01202903|1145224|P2|Overall Study|Lost to Follow-up|1
339276|NCT01202903|1145225|P1|Overall Study|Lost to Follow-up|1
339277|NCT01202903|1145224|P2|Overall Study|Death|0
339278|NCT01202903|1145225|P1|Overall Study|Death|1
339279|NCT01202903|1145224|P2|Overall Study|Protocol Violation|1
339280|NCT01202903|1145225|P1|Overall Study|Protocol Violation|0
339281|NCT01202903|1145224|P2|Overall Study|Administrative Probelms|4
339282|NCT01202903|1145225|P1|Overall Study|Administrative Probelms|1
339283|NCT01202877|1145252|P3|Overall Study|Death|1
339284|NCT01202877|1145253|P2|Overall Study|Death|0
339285|NCT01202877|1145254|P1|Overall Study|Death|0
339286|NCT01202877|1145252|P3|Overall Study|Withdrawal by Subject|1
339287|NCT01202877|1145253|P2|Overall Study|Withdrawal by Subject|0
339288|NCT01202877|1145254|P1|Overall Study|Withdrawal by Subject|0
339289|NCT01202877|1145252|P3|Overall Study|Adverse Event|2
339290|NCT01202877|1145253|P2|Overall Study|Adverse Event|0
339291|NCT01202877|1145254|P1|Overall Study|Adverse Event|0
339292|NCT01202877|1145252|P3|Overall Study|Disease Progression|2
339293|NCT01202877|1145253|P2|Overall Study|Disease Progression|1
339294|NCT01202877|1145254|P1|Overall Study|Disease Progression|0
339295|NCT01202773|1145266|P3|Overall Study|Sponsor Decision|23
339296|NCT01202773|1145267|P2|Overall Study|Sponsor Decision|20
339297|NCT01202773|1145268|P1|Overall Study|Sponsor Decision|19
339298|NCT01202773|1145266|P3|Overall Study|Protocol Violation|10
339299|NCT01202773|1145267|P2|Overall Study|Protocol Violation|6
339300|NCT01202773|1145268|P1|Overall Study|Protocol Violation|11
339301|NCT01202773|1145266|P3|Overall Study|Physician Decision|0
339302|NCT01202773|1145267|P2|Overall Study|Physician Decision|0
339303|NCT01202773|1145268|P1|Overall Study|Physician Decision|2
339304|NCT01202773|1145266|P3|Overall Study|Withdrawal by Subject|5
339305|NCT01202773|1145267|P2|Overall Study|Withdrawal by Subject|6
339306|NCT01202773|1145268|P1|Overall Study|Withdrawal by Subject|13
339307|NCT01202773|1145266|P3|Overall Study|Lost to Follow-up|2
339308|NCT01202773|1145267|P2|Overall Study|Lost to Follow-up|2
339309|NCT01202773|1145268|P1|Overall Study|Lost to Follow-up|1
339310|NCT01202773|1145266|P3|Overall Study|Entry Criteria Not Met|1
339311|NCT01202773|1145267|P2|Overall Study|Entry Criteria Not Met|0
339312|NCT01202773|1145268|P1|Overall Study|Entry Criteria Not Met|2
339313|NCT01202773|1145266|P3|Overall Study|Lack of Efficacy|9
339314|NCT01202773|1145267|P2|Overall Study|Lack of Efficacy|4
339315|NCT01202773|1145268|P1|Overall Study|Lack of Efficacy|5
339316|NCT01202773|1145266|P3|Overall Study|Adverse Event|5
339317|NCT01202773|1145267|P2|Overall Study|Adverse Event|5
339318|NCT01202773|1145268|P1|Overall Study|Adverse Event|4
339319|NCT01202760|1145345|P3|Overall Study|Sponsor Decision|0
339320|NCT01202760|1145346|P2|Overall Study|Sponsor Decision|4
339321|NCT01202760|1145347|P1|Overall Study|Sponsor Decision|4
339322|NCT01202760|1145345|P3|Overall Study|Protocol Violation|2
339323|NCT01202760|1145346|P2|Overall Study|Protocol Violation|5
339324|NCT01202760|1145347|P1|Overall Study|Protocol Violation|7
339325|NCT01202760|1145345|P3|Overall Study|Physician Decision|0
339326|NCT01202760|1145346|P2|Overall Study|Physician Decision|1
339327|NCT01202760|1145347|P1|Overall Study|Physician Decision|0
339328|NCT01202760|1145345|P3|Overall Study|Withdrawal by Subject|14
339329|NCT01202760|1145346|P2|Overall Study|Withdrawal by Subject|18
339330|NCT01202760|1145347|P1|Overall Study|Withdrawal by Subject|17
339331|NCT01202760|1145345|P3|Overall Study|Parent / Caregiver Decision|0
339332|NCT01202760|1145346|P2|Overall Study|Parent / Caregiver Decision|1
339333|NCT01202760|1145347|P1|Overall Study|Parent / Caregiver Decision|0
339334|NCT01202760|1145345|P3|Overall Study|Lost to Follow-up|1
339335|NCT01202760|1145346|P2|Overall Study|Lost to Follow-up|2
339336|NCT01202760|1145347|P1|Overall Study|Lost to Follow-up|0
339337|NCT01202760|1145345|P3|Overall Study|Lack of Efficacy|7
339338|NCT01202760|1145346|P2|Overall Study|Lack of Efficacy|8
339339|NCT01202760|1145347|P1|Overall Study|Lack of Efficacy|6
339340|NCT01202760|1145345|P3|Overall Study|Death|0
339341|NCT01202760|1145346|P2|Overall Study|Death|1
339342|NCT01202760|1145347|P1|Overall Study|Death|2
339343|NCT01202760|1145345|P3|Overall Study|Adverse Event|10
339344|NCT01202760|1145346|P2|Overall Study|Adverse Event|9
339345|NCT01202760|1145347|P1|Overall Study|Adverse Event|11
339346|NCT01202760|1145345|P3|Overall Study|Entry Criteria Not Met|1
339347|NCT01202760|1145346|P2|Overall Study|Entry Criteria Not Met|3
339348|NCT01202760|1145347|P1|Overall Study|Entry Criteria Not Met|0
339349|NCT01202747|1145415|P1|Overall Study|Withdrawal by Subject|1
339350|NCT01202591|1145447|P6|Overall Study|Objective Disease Progression|0
339351|NCT01202591|1145448|P5|Overall Study|Objective Disease Progression|2
339352|NCT01202591|1145449|P4|Overall Study|Objective Disease Progression|0
339353|NCT01202591|1145450|P3|Overall Study|Objective Disease Progression|0
339354|NCT01202591|1145451|P2|Overall Study|Objective Disease Progression|0
339355|NCT01202591|1145452|P1|Overall Study|Objective Disease Progression|0
339356|NCT01202591|1145447|P6|Overall Study|Withdrawal by Subject|1
339357|NCT01202591|1145448|P5|Overall Study|Withdrawal by Subject|2
339358|NCT01202591|1145449|P4|Overall Study|Withdrawal by Subject|0
339359|NCT01202591|1145450|P3|Overall Study|Withdrawal by Subject|0
339360|NCT01202591|1145451|P2|Overall Study|Withdrawal by Subject|0
339361|NCT01202591|1145452|P1|Overall Study|Withdrawal by Subject|0
339362|NCT01202591|1145447|P6|Overall Study|Other reason as per investigator|3
339363|NCT01202591|1145448|P5|Overall Study|Other reason as per investigator|1
339364|NCT01202591|1145449|P4|Overall Study|Other reason as per investigator|3
339365|NCT01202591|1145450|P3|Overall Study|Other reason as per investigator|7
339366|NCT01202591|1145451|P2|Overall Study|Other reason as per investigator|4
339367|NCT01202591|1145452|P1|Overall Study|Other reason as per investigator|3
339368|NCT01202591|1145447|P6|Overall Study|Adverse Event|0
339369|NCT01202591|1145448|P5|Overall Study|Adverse Event|0
339370|NCT01202591|1145449|P4|Overall Study|Adverse Event|4
339371|NCT01202591|1145450|P3|Overall Study|Adverse Event|4
339372|NCT01202591|1145451|P2|Overall Study|Adverse Event|1
339373|NCT01202591|1145452|P1|Overall Study|Adverse Event|2
339374|NCT01202279|1145498|P2|Overall Study|study compliance|2
339375|NCT01202279|1145499|P1|Overall Study|study compliance|5
339376|NCT01202279|1145498|P2|Overall Study|Protocol Violation|1
339377|NCT01202279|1145499|P1|Overall Study|Protocol Violation|1
339378|NCT01202279|1145498|P2|Overall Study|Lost to Follow-up|7
339379|NCT01202279|1145499|P1|Overall Study|Lost to Follow-up|10
339380|NCT01202279|1145498|P2|Overall Study|Physician Decision|1
339381|NCT01202279|1145499|P1|Overall Study|Physician Decision|0
339382|NCT01202279|1145498|P2|Overall Study|Withdrawal by Subject|10
339383|NCT01202279|1145499|P1|Overall Study|Withdrawal by Subject|13
339384|NCT01202279|1145498|P2|Overall Study|Adverse Event|6
339385|NCT01202279|1145499|P1|Overall Study|Adverse Event|8
339386|NCT01202227|1145551|P1|Overall Study|Lack of Efficacy|1
339387|NCT01202227|1145551|P1|Overall Study|Withdrawal by Subject|2
339388|NCT01202227|1145551|P1|Overall Study|Adverse Event|16
339389|NCT01202188|1145575|P5|Overall Study|Abnormal test procedure result (s)|0
339390|NCT01202188|1145576|P4|Overall Study|Abnormal test procedure result (s)|0
339391|NCT01202188|1145577|P3|Overall Study|Abnormal test procedure result (s)|2
339392|NCT01202188|1145578|P2|Overall Study|Abnormal test procedure result (s)|0
339393|NCT01202188|1145579|P1|Overall Study|Abnormal test procedure result (s)|0
339394|NCT01202188|1145575|P5|Overall Study|Death|0
339395|NCT01202188|1145576|P4|Overall Study|Death|1
339396|NCT01202188|1145577|P3|Overall Study|Death|1
339397|NCT01202188|1145578|P2|Overall Study|Death|1
339398|NCT01202188|1145579|P1|Overall Study|Death|1
339399|NCT01202188|1145575|P5|Overall Study|Lost to Follow-up|1
339400|NCT01202188|1145576|P4|Overall Study|Lost to Follow-up|4
339401|NCT01202188|1145577|P3|Overall Study|Lost to Follow-up|0
339402|NCT01202188|1145578|P2|Overall Study|Lost to Follow-up|1
339403|NCT01202188|1145579|P1|Overall Study|Lost to Follow-up|1
339404|NCT01202188|1145575|P5|Overall Study|Unsatisfactory therapeutic effect|8
339405|NCT01202188|1145576|P4|Overall Study|Unsatisfactory therapeutic effect|5
339406|NCT01202188|1145577|P3|Overall Study|Unsatisfactory therapeutic effect|2
339407|NCT01202188|1145578|P2|Overall Study|Unsatisfactory therapeutic effect|8
339408|NCT01202188|1145579|P1|Overall Study|Unsatisfactory therapeutic effect|2
339409|NCT01202188|1145575|P5|Overall Study|Administrative problems|2
339410|NCT01202188|1145576|P4|Overall Study|Administrative problems|1
339411|NCT01202188|1145577|P3|Overall Study|Administrative problems|1
339412|NCT01202188|1145578|P2|Overall Study|Administrative problems|2
339413|NCT01202188|1145579|P1|Overall Study|Administrative problems|3
339414|NCT01202188|1145575|P5|Overall Study|Adverse Event|10
339415|NCT01202188|1145576|P4|Overall Study|Adverse Event|10
339416|NCT01202188|1145577|P3|Overall Study|Adverse Event|13
339417|NCT01202188|1145578|P2|Overall Study|Adverse Event|23
339418|NCT01202188|1145579|P1|Overall Study|Adverse Event|5
339419|NCT01202188|1145575|P5|Overall Study|Subject withdrew consent|13
339420|NCT01202188|1145576|P4|Overall Study|Subject withdrew consent|11
339421|NCT01202188|1145577|P3|Overall Study|Subject withdrew consent|22
339422|NCT01202188|1145578|P2|Overall Study|Subject withdrew consent|13
339423|NCT01202188|1145579|P1|Overall Study|Subject withdrew consent|12
339424|NCT01202188|1145575|P5|Overall Study|Protocol deviation|11
339425|NCT01202188|1145576|P4|Overall Study|Protocol deviation|10
339426|NCT01202188|1145577|P3|Overall Study|Protocol deviation|12
339427|NCT01202188|1145578|P2|Overall Study|Protocol deviation|8
339428|NCT01202188|1145579|P1|Overall Study|Protocol deviation|14
339429|NCT01201967|1145726|P2|Overall Study|Lost to Follow-up|5
339430|NCT01201967|1145727|P1|Overall Study|Lost to Follow-up|6
339431|NCT01201915|1145752|P3|Overall Study|Target Lesion Progression|0
339432|NCT01201915|1145753|P2|Overall Study|Target Lesion Progression|3
339433|NCT01201915|1145754|P1|Overall Study|Target Lesion Progression|0
339434|NCT01201915|1145752|P3|Overall Study|Subject Decision|5
339435|NCT01201915|1145753|P2|Overall Study|Subject Decision|3
339436|NCT01201915|1145754|P1|Overall Study|Subject Decision|3
339437|NCT01201915|1145752|P3|Overall Study|Physician Decision|0
339438|NCT01201915|1145753|P2|Overall Study|Physician Decision|0
339439|NCT01201915|1145754|P1|Overall Study|Physician Decision|3
339440|NCT01201915|1145752|P3|Overall Study|Lost to Follow-up|0
339441|NCT01201915|1145753|P2|Overall Study|Lost to Follow-up|4
339442|NCT01201915|1145754|P1|Overall Study|Lost to Follow-up|0
339443|NCT01201915|1145752|P3|Overall Study|Adverse Event|1
339444|NCT01201915|1145753|P2|Overall Study|Adverse Event|1
339445|NCT01201915|1145754|P1|Overall Study|Adverse Event|2
339446|NCT01201811|1145765|P1|Overall Study|Physician Decision|1
339447|NCT01201811|1145765|P1|Overall Study|Treatment Failure|2
339448|NCT01201811|1145765|P1|Overall Study|Death|4
339449|NCT01201811|1145765|P1|Overall Study|Withdrawal by Subject|3
339450|NCT01201811|1145765|P1|Overall Study|Disease progression|3
339451|NCT01201811|1145765|P1|Overall Study|Adverse Event|6
339452|NCT01201798|1145787|P2|Overall Study|Treatment Failure|8
339453|NCT01201798|1145788|P1|Overall Study|Treatment Failure|1
339454|NCT01201798|1145787|P2|Overall Study|Protocol Violation|1
339455|NCT01201798|1145788|P1|Overall Study|Protocol Violation|1
339456|NCT01201798|1145787|P2|Overall Study|Noncompliance|0
339457|NCT01201798|1145788|P1|Overall Study|Noncompliance|1
339458|NCT01201798|1145787|P2|Overall Study|Decision Unrelated to an Adverse Event|1
339459|NCT01201798|1145788|P1|Overall Study|Decision Unrelated to an Adverse Event|1
339460|NCT01201798|1145787|P2|Overall Study|Lost to Follow-up|5
339461|NCT01201798|1145788|P1|Overall Study|Lost to Follow-up|3
339462|NCT01201798|1145787|P2|Overall Study|Adverse Event|0
339463|NCT01201798|1145788|P1|Overall Study|Adverse Event|2
339464|NCT01201785|1145812|P1|Overall Study|Lost to Follow-up|16
339465|NCT01201759|1145829|P2|Visit 4 Crossover|Lost to Follow-up|1
339466|NCT01201759|1145830|P1|Visit 4 Crossover|Lost to Follow-up|0
339467|NCT01201759|1145829|P2|Visit 3 - Washout|Lost to Follow-up|0
339468|NCT01201759|1145830|P1|Visit 3 - Washout|Lost to Follow-up|1
339469|NCT01201759|1145829|P2|Visit 3 - Washout|Adverse Event|3
339470|NCT01201759|1145830|P1|Visit 3 - Washout|Adverse Event|0
339471|NCT01201759|1145829|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
339472|NCT01201759|1145830|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
339473|NCT01201343|1145859|P1|Overall Study|Randomized, not treated|3
339474|NCT01201343|1145859|P1|Overall Study|Participant wrongly included in trial|1
339475|NCT01201343|1145859|P1|Overall Study|Lack of Efficacy|2
339476|NCT01201343|1145859|P1|Overall Study|Lost to Follow-up|2
339477|NCT01201343|1145859|P1|Overall Study|Withdrawal by Subject|5
339478|NCT01201343|1145859|P1|Overall Study|Adverse Event|6
339479|NCT01201317|1145873|P3|Overall Study|Safety, possible history of tuberculosis|1
339480|NCT01201317|1145874|P2|Overall Study|Safety, possible history of tuberculosis|0
339481|NCT01201317|1145875|P1|Overall Study|Safety, possible history of tuberculosis|0
339482|NCT01201317|1145873|P3|Overall Study|Lack of Efficacy|0
339483|NCT01201317|1145874|P2|Overall Study|Lack of Efficacy|0
339484|NCT01201317|1145875|P1|Overall Study|Lack of Efficacy|1
339485|NCT01201317|1145873|P3|Overall Study|Decrease in renal function|0
339486|NCT01201317|1145874|P2|Overall Study|Decrease in renal function|1
339487|NCT01201317|1145875|P1|Overall Study|Decrease in renal function|0
339488|NCT01201317|1145873|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
339489|NCT01201317|1145874|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
339490|NCT01201317|1145875|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
339491|NCT01201317|1145873|P3|Overall Study|Study-specific withdrawal criteria|1
339492|NCT01201317|1145874|P2|Overall Study|Study-specific withdrawal criteria|0
339493|NCT01201317|1145875|P1|Overall Study|Study-specific withdrawal criteria|0
339494|NCT01201317|1145873|P3|Overall Study|Death|0
339495|NCT01201317|1145874|P2|Overall Study|Death|1
339496|NCT01201317|1145875|P1|Overall Study|Death|0
339497|NCT01201317|1145873|P3|Overall Study|Protocol Violation|1
339498|NCT01201317|1145874|P2|Overall Study|Protocol Violation|1
339499|NCT01201317|1145875|P1|Overall Study|Protocol Violation|0
339500|NCT01201317|1145873|P3|Overall Study|Screen failure|0
339501|NCT01201317|1145874|P2|Overall Study|Screen failure|1
339502|NCT01201317|1145875|P1|Overall Study|Screen failure|1
339503|NCT01201317|1145873|P3|Overall Study|Adverse Event|2
339504|NCT01201317|1145874|P2|Overall Study|Adverse Event|2
339505|NCT01201317|1145875|P1|Overall Study|Adverse Event|2
339506|NCT01201317|1145873|P3|Overall Study|Withdrawal by Subject|3
339507|NCT01201317|1145874|P2|Overall Study|Withdrawal by Subject|0
339508|NCT01201317|1145875|P1|Overall Study|Withdrawal by Subject|5
339509|NCT01201265|1145895|P1|Overall Study|Disease Progression|4
339510|NCT01201265|1145895|P1|Overall Study|Withdrawal by Subject|7
339511|NCT01201265|1145895|P1|Overall Study|Lost to Follow-up|10
339512|NCT01201265|1145895|P1|Overall Study|Insufficient Therapeutic Response|3
339513|NCT01201265|1145895|P1|Overall Study|Death|14
339514|NCT01200992|1145909|P2|Overall Study|Randomized but not treated|0
339515|NCT01200992|1145910|P1|Overall Study|Randomized but not treated|2
339516|NCT01200992|1145909|P2|Overall Study|Study terminated early|41
339517|NCT01200992|1145910|P1|Overall Study|Study terminated early|35
339518|NCT01200810|1145924|P2|Overall Study|Sponsor stopped making study drug|3
339519|NCT01200810|1145925|P1|Overall Study|Sponsor stopped making study drug|3
339520|NCT01200810|1145924|P2|Overall Study|Withdrawal by Subject|2
339521|NCT01200810|1145925|P1|Overall Study|Withdrawal by Subject|1
339522|NCT01200810|1145924|P2|Overall Study|Physician Decision|0
339523|NCT01200810|1145925|P1|Overall Study|Physician Decision|1
339524|NCT01200797|1145945|P1|Overall Study|Disease Progression|13
339525|NCT01200797|1145945|P1|Overall Study|Adverse Event|4
339526|NCT01200797|1145945|P1|Overall Study|symptomatic deterioration|2
339527|NCT01200758|1145955|P4|Stage 2|Death|5
339528|NCT01200758|1145956|P3|Stage 2|Death|3
339529|NCT01200758|1145957|P2|Stage 2|Death|0
339530|NCT01200758|1145958|P1|Stage 2|Death|0
339531|NCT01200758|1145955|P4|Stage 2|Protocol Violation|4
339532|NCT01200758|1145956|P3|Stage 2|Protocol Violation|1
339533|NCT01200758|1145957|P2|Stage 2|Protocol Violation|0
339534|NCT01200758|1145958|P1|Stage 2|Protocol Violation|0
339535|NCT01200758|1145955|P4|Stage 2|Lost to Follow-up|1
339536|NCT01200758|1145956|P3|Stage 2|Lost to Follow-up|3
339537|NCT01200758|1145957|P2|Stage 2|Lost to Follow-up|0
339538|NCT01200758|1145958|P1|Stage 2|Lost to Follow-up|0
339539|NCT01200758|1145955|P4|Stage 2|Withdrawal by Subject|1
339540|NCT01200758|1145956|P3|Stage 2|Withdrawal by Subject|4
339541|NCT01200758|1145957|P2|Stage 2|Withdrawal by Subject|0
339542|NCT01200758|1145958|P1|Stage 2|Withdrawal by Subject|0
339543|NCT01200758|1145955|P4|Stage 2|Adverse Event|9
339544|NCT01200758|1145956|P3|Stage 2|Adverse Event|5
339545|NCT01200758|1145957|P2|Stage 2|Adverse Event|0
339546|NCT01200758|1145958|P1|Stage 2|Adverse Event|0
339547|NCT01200758|1145955|P4|Stage 2|Physician Decision|7
339548|NCT01200758|1145956|P3|Stage 2|Physician Decision|5
339549|NCT01200758|1145957|P2|Stage 2|Physician Decision|0
339550|NCT01200758|1145958|P1|Stage 2|Physician Decision|0
339551|NCT01200758|1145955|P4|Stage 2|Lack of Efficacy|2
339552|NCT01200758|1145956|P3|Stage 2|Lack of Efficacy|4
339553|NCT01200758|1145957|P2|Stage 2|Lack of Efficacy|0
339554|NCT01200758|1145958|P1|Stage 2|Lack of Efficacy|0
339555|NCT01200758|1145955|P4|Stage 2|Disease Progression|21
339556|NCT01200758|1145956|P3|Stage 2|Disease Progression|16
339557|NCT01200758|1145957|P2|Stage 2|Disease Progression|0
339558|NCT01200758|1145958|P1|Stage 2|Disease Progression|0
339559|NCT01200758|1145955|P4|Stage I|Disease Progression|0
339560|NCT01200758|1145956|P3|Stage I|Disease Progression|0
339561|NCT01200758|1145957|P2|Stage I|Disease Progression|7
339562|NCT01200758|1145958|P1|Stage I|Disease Progression|9
339563|NCT01200758|1145955|P4|Stage I|Withdrawal by Subject|0
339564|NCT01200758|1145956|P3|Stage I|Withdrawal by Subject|0
339565|NCT01200758|1145957|P2|Stage I|Withdrawal by Subject|2
339566|NCT01200758|1145958|P1|Stage I|Withdrawal by Subject|1
339567|NCT01200758|1145955|P4|Stage I|Adverse Event|0
339568|NCT01200758|1145956|P3|Stage I|Adverse Event|0
339569|NCT01200758|1145957|P2|Stage I|Adverse Event|5
339570|NCT01200758|1145958|P1|Stage I|Adverse Event|5
339571|NCT01200758|1145955|P4|Stage I|Lack of Efficacy|0
339572|NCT01200758|1145956|P3|Stage I|Lack of Efficacy|0
339573|NCT01200758|1145957|P2|Stage I|Lack of Efficacy|1
339574|NCT01200758|1145958|P1|Stage I|Lack of Efficacy|2
339575|NCT01200758|1145955|P4|Stage I|Physician Decision|0
339576|NCT01200758|1145956|P3|Stage I|Physician Decision|0
339577|NCT01200758|1145957|P2|Stage I|Physician Decision|1
339578|NCT01200758|1145958|P1|Stage I|Physician Decision|1
339579|NCT01200758|1145955|P4|Stage I|Death|0
339580|NCT01200758|1145956|P3|Stage I|Death|0
339581|NCT01200758|1145957|P2|Stage I|Death|1
339582|NCT01200758|1145958|P1|Stage I|Death|0
339583|NCT01200589|1146031|P2|Overall Study|Study terminated|172
339584|NCT01200589|1146032|P1|Overall Study|Study terminated|170
339585|NCT01200589|1146031|P2|Overall Study|Lost to Follow-up|4
339586|NCT01200589|1146032|P1|Overall Study|Lost to Follow-up|5
339587|NCT01200589|1146031|P2|Overall Study|Physician Decision|2
339588|NCT01200589|1146032|P1|Overall Study|Physician Decision|2
339589|NCT01200589|1146031|P2|Overall Study|Withdrawal by Subject|11
339590|NCT01200589|1146032|P1|Overall Study|Withdrawal by Subject|13
339591|NCT01200524|1146059|P3|Overall Study|Non availability of study nurse|1
339592|NCT01200524|1146060|P2|Overall Study|Non availability of study nurse|0
339593|NCT01200524|1146061|P1|Overall Study|Non availability of study nurse|0
339594|NCT01200524|1146059|P3|Overall Study|Adverse Event|0
339595|NCT01200524|1146060|P2|Overall Study|Adverse Event|0
339596|NCT01200524|1146061|P1|Overall Study|Adverse Event|1
339597|NCT01200524|1146059|P3|Overall Study|Withdrawal by Subject|3
339598|NCT01200524|1146060|P2|Overall Study|Withdrawal by Subject|1
339599|NCT01200524|1146061|P1|Overall Study|Withdrawal by Subject|1
339600|NCT01200511|1146081|P1|Overall Study|Adverse Event|1
339601|NCT01200511|1146081|P1|Overall Study|Withdrawal by Subject|1
339602|NCT01200511|1146081|P1|Overall Study|Lost to Follow-up|3
339603|NCT01200368|1146119|P3|Toddler Dose|Adverse Event|1
339604|NCT01200368|1146120|P2|Toddler Dose|Adverse Event|3
339605|NCT01200368|1146121|P1|Toddler Dose|Adverse Event|0
339606|NCT01200368|1146119|P3|After Infant Series|Other|2
339607|NCT01200368|1146120|P2|After Infant Series|Other|2
339608|NCT01200368|1146121|P1|After Infant Series|Other|1
339609|NCT01200368|1146119|P3|After Infant Series|Lost to Follow-up|0
339610|NCT01200368|1146120|P2|After Infant Series|Lost to Follow-up|0
339611|NCT01200368|1146121|P1|After Infant Series|Lost to Follow-up|1
339612|NCT01200368|1146119|P3|After Infant Series|Withdrawal by Subject|4
339613|NCT01200368|1146120|P2|After Infant Series|Withdrawal by Subject|8
339614|NCT01200368|1146121|P1|After Infant Series|Withdrawal by Subject|10
339615|NCT01200368|1146119|P3|After Infant Series|Adverse Event|3
339616|NCT01200368|1146120|P2|After Infant Series|Adverse Event|6
339617|NCT01200368|1146121|P1|After Infant Series|Adverse Event|6
339618|NCT01200368|1146119|P3|Infant Series|Other|0
339619|NCT01200368|1146120|P2|Infant Series|Other|0
339620|NCT01200368|1146121|P1|Infant Series|Other|1
339621|NCT01200368|1146119|P3|Infant Series|Randomized, not vaccinated|1
339622|NCT01200368|1146120|P2|Infant Series|Randomized, not vaccinated|1
339623|NCT01200368|1146121|P1|Infant Series|Randomized, not vaccinated|0
339624|NCT01200368|1146119|P3|Infant Series|Did not meet entrance criteria|0
339625|NCT01200368|1146120|P2|Infant Series|Did not meet entrance criteria|1
339626|NCT01200368|1146121|P1|Infant Series|Did not meet entrance criteria|0
339627|NCT01200368|1146119|P3|Infant Series|Withdrawal by Subject|2
339628|NCT01200368|1146120|P2|Infant Series|Withdrawal by Subject|2
339629|NCT01200368|1146121|P1|Infant Series|Withdrawal by Subject|0
339630|NCT01200368|1146119|P3|Infant Series|Adverse Event|3
339631|NCT01200368|1146120|P2|Infant Series|Adverse Event|2
339632|NCT01200368|1146121|P1|Infant Series|Adverse Event|2
339633|NCT01200355|1146187|P2|Overall Study|Death|2
339634|NCT01200355|1146188|P1|Overall Study|Death|7
339635|NCT01200342|1146202|P1|Overall Study|Disease Progression|1
339636|NCT01200290|1146207|P1|Post-Treatment Follow-Up Period|Death|2
339637|NCT01200290|1146207|P1|Treatment Period|Adverse Event|1
339638|NCT01200238|1146220|P2|Overall Study|Withdrawal by Subject|1
339639|NCT01200238|1146221|P1|Overall Study|Withdrawal by Subject|0
339640|NCT01200238|1146220|P2|Overall Study|Progressive Disease|8
339641|NCT01200238|1146221|P1|Overall Study|Progressive Disease|5
339642|NCT01200238|1146220|P2|Overall Study|Adverse Event|1
339643|NCT01200238|1146221|P1|Overall Study|Adverse Event|2
339644|NCT01200069|1146245|P2|Overall Study|Withdrawal by Subject|1
339645|NCT01200069|1146246|P1|Overall Study|Withdrawal by Subject|0
339646|NCT01199939|1146315|P1|Overall Study|Reached a virologic endpoint|4
339647|NCT01199939|1146315|P1|Overall Study|Lost to Follow-up|2
339648|NCT01199939|1146315|P1|Overall Study|Protocol Violation|3
339649|NCT01199939|1146315|P1|Overall Study|Adverse Event|4
339650|NCT01199861|1146347|P2|Overall Study|Adverse Event|0
339651|NCT01199861|1146348|P1|Overall Study|Adverse Event|1
339652|NCT01199861|1146347|P2|Overall Study|Administrative problems|0
339653|NCT01199861|1146348|P1|Overall Study|Administrative problems|1
339654|NCT01199822|1146369|P3|Overall Study|Investigator discontinued therapy|0
339655|NCT01199822|1146370|P2|Overall Study|Investigator discontinued therapy|1
339656|NCT01199822|1146371|P1|Overall Study|Investigator discontinued therapy|0
339657|NCT01199731|1146420|P3|Overall Study|Withdrawal by Subject|0
339658|NCT01199731|1146421|P2|Overall Study|Withdrawal by Subject|0
339659|NCT01199731|1146422|P1|Overall Study|Withdrawal by Subject|2
339660|NCT01199731|1146420|P3|Overall Study|Physician Decision|1
339661|NCT01199731|1146421|P2|Overall Study|Physician Decision|1
339662|NCT01199731|1146422|P1|Overall Study|Physician Decision|0
339663|NCT01199731|1146420|P3|Overall Study|Lost to Follow-up|2
339664|NCT01199731|1146421|P2|Overall Study|Lost to Follow-up|0
339665|NCT01199731|1146422|P1|Overall Study|Lost to Follow-up|0
339666|NCT01199731|1146420|P3|Overall Study|Study closed/terminated|7
339667|NCT01199731|1146421|P2|Overall Study|Study closed/terminated|9
339668|NCT01199731|1146422|P1|Overall Study|Study closed/terminated|7
339669|NCT01199731|1146420|P3|Overall Study|Adverse Event|0
339670|NCT01199731|1146421|P2|Overall Study|Adverse Event|1
339671|NCT01199731|1146422|P1|Overall Study|Adverse Event|0
339672|NCT01199705|1146460|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
339673|NCT01199601|1146492|P2|Overall Study|Insecurity prevented staff interviewing.|9
339674|NCT01199601|1146493|P1|Overall Study|Insecurity prevented staff interviewing.|7
339675|NCT01199601|1146492|P2|Overall Study|Withdrawal by Subject|3
339676|NCT01199601|1146493|P1|Overall Study|Withdrawal by Subject|15
339677|NCT01199601|1146492|P2|Overall Study|Lost to Follow-up|66
339678|NCT01199601|1146493|P1|Overall Study|Lost to Follow-up|47
339679|NCT01199471|1146503|P1|Overall Study|Physician Decision|1
339680|NCT01199471|1146503|P1|Overall Study|Withdrawal by Subject|1
339681|NCT01199471|1146503|P1|Overall Study|Protocol Violation|4
339682|NCT01199042|1146535|P1|At Home (3 Months)|Lost to Follow-up|1
339683|NCT01199042|1146535|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
339684|NCT01199016|1146544|P1|Overall Study|Lost to Follow-up|25
339685|NCT01199016|1146544|P1|Overall Study|Withdrawal by Subject|21
339686|NCT01199016|1146544|P1|Overall Study|Other|13
339687|NCT01199016|1146544|P1|Overall Study|Protocol Violation|9
339688|NCT01199016|1146544|P1|Overall Study|Entrance criteria|5
339689|NCT01199016|1146544|P1|Overall Study|No longer meets eligibility criteria|4
339690|NCT01198977|1146553|P2|Overall Study|Lost to Follow-up|0
339691|NCT01198977|1146554|P1|Overall Study|Lost to Follow-up|1
339692|NCT01198873|1146566|P2|Overall Study|Other than above|2
339693|NCT01198873|1146567|P1|Overall Study|Other than above|4
339694|NCT01198873|1146566|P2|Overall Study|Study closure|23
339695|NCT01198873|1146567|P1|Overall Study|Study closure|29
339696|NCT01198873|1146566|P2|Overall Study|Adverse Event|7
339697|NCT01198873|1146567|P1|Overall Study|Adverse Event|4
339698|NCT01198795|1146581|P1|Overall Study|Other Reason|4
339699|NCT01198795|1146581|P1|Overall Study|Protocol Violation|2
339700|NCT01198795|1146581|P1|Overall Study|Lack of Efficacy|5
339701|NCT01198795|1146581|P1|Overall Study|Adverse Event|9
339702|NCT01198795|1146581|P1|Overall Study|Lost to Follow-up|15
339703|NCT01198795|1146581|P1|Overall Study|Withdrawal by Subject|17
339704|NCT01198795|1146581|P1|Overall Study|Did not meet InclusionExclusion criteria|30
339705|NCT01198756|1146598|P4|Overall Study|Lost to Follow-up|18
339706|NCT01198756|1146599|P3|Overall Study|Lost to Follow-up|23
339707|NCT01198756|1146600|P2|Overall Study|Lost to Follow-up|36
339708|NCT01198756|1146601|P1|Overall Study|Lost to Follow-up|29
339709|NCT01198756|1146598|P4|Overall Study|Withdrawal by Subject|5
339710|NCT01198756|1146599|P3|Overall Study|Withdrawal by Subject|7
339711|NCT01198756|1146600|P2|Overall Study|Withdrawal by Subject|4
339712|NCT01198756|1146601|P1|Overall Study|Withdrawal by Subject|9
339713|NCT01198756|1146598|P4|Overall Study|Protocol Violation|2
339714|NCT01198756|1146599|P3|Overall Study|Protocol Violation|0
339715|NCT01198756|1146600|P2|Overall Study|Protocol Violation|0
339716|NCT01198756|1146601|P1|Overall Study|Protocol Violation|0
339717|NCT01198756|1146598|P4|Overall Study|Adverse Event|1
339718|NCT01198756|1146599|P3|Overall Study|Adverse Event|0
339719|NCT01198756|1146600|P2|Overall Study|Adverse Event|0
339720|NCT01198756|1146601|P1|Overall Study|Adverse Event|0
339721|NCT01198600|1146712|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
339722|NCT01198600|1146713|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
339723|NCT01198600|1146714|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
339724|NCT01198600|1146715|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
339725|NCT01198600|1146712|P4|Phase 2: 56 Days of Wear|Relocation|0
339726|NCT01198600|1146713|P3|Phase 2: 56 Days of Wear|Relocation|2
339727|NCT01198600|1146714|P2|Phase 2: 56 Days of Wear|Relocation|0
339728|NCT01198600|1146715|P1|Phase 2: 56 Days of Wear|Relocation|0
339729|NCT01198600|1146712|P4|Phase 2: 56 Days of Wear|Inconvenience|0
339730|NCT01198600|1146713|P3|Phase 2: 56 Days of Wear|Inconvenience|2
339731|NCT01198600|1146714|P2|Phase 2: 56 Days of Wear|Inconvenience|0
339732|NCT01198600|1146715|P1|Phase 2: 56 Days of Wear|Inconvenience|0
339733|NCT01198600|1146712|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
339734|NCT01198600|1146713|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
339735|NCT01198600|1146714|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
339736|NCT01198600|1146715|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
339737|NCT01198600|1146712|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
339738|NCT01198600|1146713|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
339739|NCT01198600|1146714|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
339740|NCT01198600|1146715|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
339741|NCT01198600|1146712|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
339742|NCT01198600|1146713|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
339743|NCT01198600|1146714|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
339744|NCT01198600|1146715|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
339745|NCT01198600|1146712|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
339746|NCT01198600|1146713|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
339747|NCT01198600|1146714|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
339748|NCT01198600|1146715|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
339749|NCT01198574|1146741|P4|Overall Study|Resigned from schools|4
339750|NCT01198574|1146742|P3|Overall Study|Resigned from schools|1
339751|NCT01198574|1146743|P2|Overall Study|Resigned from schools|1
339752|NCT01198574|1146744|P1|Overall Study|Resigned from schools|4
339753|NCT01198548|1146762|P1|Overall Study|Administrative Decision|1
339754|NCT01198548|1146762|P1|Overall Study|Disease Progression|9
339755|NCT01198509|1146777|P6|Overall Study|Withdrawal by Subject|0
339756|NCT01198509|1146778|P5|Overall Study|Withdrawal by Subject|0
339757|NCT01198509|1146779|P4|Overall Study|Withdrawal by Subject|0
339758|NCT01198509|1146780|P3|Overall Study|Withdrawal by Subject|0
339759|NCT01198509|1146781|P2|Overall Study|Withdrawal by Subject|0
339760|NCT01198509|1146782|P1|Overall Study|Withdrawal by Subject|1
339761|NCT01198275|1146858|P2|Overall Study|spontaneous return to sinus rhythm|2
339762|NCT01198275|1146859|P1|Overall Study|spontaneous return to sinus rhythm|4
339763|NCT01198275|1146858|P2|Overall Study|Adverse Event|3
339764|NCT01198275|1146859|P1|Overall Study|Adverse Event|2
339765|NCT01198145|1146867|P2|Overall Study|Withdrawal by Subject|1
339766|NCT01198145|1146868|P1|Overall Study|Withdrawal by Subject|1
339767|NCT01198132|1146890|P2|Overall Study|Protocol Violation|0
339768|NCT01198132|1146891|P1|Overall Study|Protocol Violation|1
339769|NCT01198132|1146890|P2|Overall Study|Adverse Event|1
339770|NCT01198132|1146891|P1|Overall Study|Adverse Event|0
339771|NCT01198132|1146890|P2|Overall Study|Abnormal/clinically significant biologic|1
339772|NCT01198132|1146891|P1|Overall Study|Abnormal/clinically significant biologic|1
339773|NCT01198132|1146890|P2|Overall Study|Sign/symptoms of underlying disease|1
339774|NCT01198132|1146891|P1|Overall Study|Sign/symptoms of underlying disease|2
339775|NCT01198132|1146890|P2|Overall Study|Lack of Efficacy|3
339776|NCT01198132|1146891|P1|Overall Study|Lack of Efficacy|2
339777|NCT01198132|1146890|P2|Overall Study|Other Unspecified|6
339778|NCT01198132|1146891|P1|Overall Study|Other Unspecified|3
339779|NCT01198132|1146890|P2|Overall Study|Physician Decision|4
339780|NCT01198132|1146891|P1|Overall Study|Physician Decision|5
339781|NCT01198132|1146890|P2|Overall Study|Withdrawal by Subject|5
339782|NCT01198132|1146891|P1|Overall Study|Withdrawal by Subject|4
339783|NCT01198002|1146918|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
339784|NCT01198002|1146919|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
339785|NCT01198002|1146920|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
339786|NCT01198002|1146918|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
339787|NCT01198002|1146919|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
339788|NCT01198002|1146920|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
339789|NCT01198002|1146918|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
339790|NCT01198002|1146919|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
339791|NCT01198002|1146920|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
339792|NCT01198002|1146918|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
339793|NCT01198002|1146919|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
339794|NCT01198002|1146920|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
339795|NCT01198002|1146918|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
339796|NCT01198002|1146919|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
339797|NCT01198002|1146920|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
339798|NCT01198002|1146918|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
339799|NCT01198002|1146919|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
339800|NCT01198002|1146920|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
339801|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
339802|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
339803|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
339804|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
339805|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
339806|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
339807|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
339808|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
339809|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
339810|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
339811|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
339812|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
339813|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
339814|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
339815|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
339816|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
339817|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
339818|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
339819|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
339820|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
339821|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
339822|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Death|1
339823|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Death|0
339824|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Death|2
339825|NCT01198002|1146918|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
339826|NCT01198002|1146919|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
339827|NCT01198002|1146920|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
339828|NCT01197911|1147035|P3|Overall Study|Adverse Event|1
339829|NCT01197911|1147036|P2|Overall Study|Adverse Event|0
339830|NCT01197911|1147037|P1|Overall Study|Adverse Event|0
339831|NCT01197794|1147152|P7|Overall Study|Other|4
339832|NCT01197794|1147153|P6|Overall Study|Other|2
339833|NCT01197794|1147154|P5|Overall Study|Other|2
339834|NCT01197794|1147155|P4|Overall Study|Other|0
339835|NCT01197794|1147156|P3|Overall Study|Other|3
339836|NCT01197794|1147157|P2|Overall Study|Other|1
339837|NCT01197794|1147158|P1|Overall Study|Other|1
339838|NCT01197794|1147152|P7|Overall Study|Lost to Follow-up|0
339839|NCT01197794|1147153|P6|Overall Study|Lost to Follow-up|1
339840|NCT01197794|1147154|P5|Overall Study|Lost to Follow-up|0
339841|NCT01197794|1147155|P4|Overall Study|Lost to Follow-up|1
339842|NCT01197794|1147156|P3|Overall Study|Lost to Follow-up|0
339843|NCT01197794|1147157|P2|Overall Study|Lost to Follow-up|1
339844|NCT01197794|1147158|P1|Overall Study|Lost to Follow-up|1
339845|NCT01197794|1147152|P7|Overall Study|Withdrawal by Subject|6
339846|NCT01197794|1147153|P6|Overall Study|Withdrawal by Subject|5
339847|NCT01197794|1147154|P5|Overall Study|Withdrawal by Subject|1
339848|NCT01197794|1147155|P4|Overall Study|Withdrawal by Subject|1
339849|NCT01197794|1147156|P3|Overall Study|Withdrawal by Subject|4
339850|NCT01197794|1147157|P2|Overall Study|Withdrawal by Subject|3
339851|NCT01197794|1147158|P1|Overall Study|Withdrawal by Subject|3
339852|NCT01197794|1147152|P7|Overall Study|Eligibility criteria not fulfilled|6
339853|NCT01197794|1147153|P6|Overall Study|Eligibility criteria not fulfilled|9
339854|NCT01197794|1147154|P5|Overall Study|Eligibility criteria not fulfilled|5
339855|NCT01197794|1147155|P4|Overall Study|Eligibility criteria not fulfilled|5
339856|NCT01197794|1147156|P3|Overall Study|Eligibility criteria not fulfilled|2
339857|NCT01197794|1147157|P2|Overall Study|Eligibility criteria not fulfilled|8
339858|NCT01197794|1147158|P1|Overall Study|Eligibility criteria not fulfilled|5
339859|NCT01197794|1147152|P7|Overall Study|Development of study withdrawal criteria|1
339860|NCT01197794|1147153|P6|Overall Study|Development of study withdrawal criteria|0
339861|NCT01197794|1147154|P5|Overall Study|Development of study withdrawal criteria|0
339862|NCT01197794|1147155|P4|Overall Study|Development of study withdrawal criteria|1
339863|NCT01197794|1147156|P3|Overall Study|Development of study withdrawal criteria|0
339864|NCT01197794|1147157|P2|Overall Study|Development of study withdrawal criteria|0
339865|NCT01197794|1147158|P1|Overall Study|Development of study withdrawal criteria|3
339866|NCT01197794|1147152|P7|Overall Study|Protocol Violation|1
339867|NCT01197794|1147153|P6|Overall Study|Protocol Violation|0
339868|NCT01197794|1147154|P5|Overall Study|Protocol Violation|2
339869|NCT01197794|1147155|P4|Overall Study|Protocol Violation|0
339870|NCT01197794|1147156|P3|Overall Study|Protocol Violation|0
339871|NCT01197794|1147157|P2|Overall Study|Protocol Violation|0
339872|NCT01197794|1147158|P1|Overall Study|Protocol Violation|0
339873|NCT01197794|1147152|P7|Overall Study|Adverse Event|3
339874|NCT01197794|1147153|P6|Overall Study|Adverse Event|2
339875|NCT01197794|1147154|P5|Overall Study|Adverse Event|4
339876|NCT01197794|1147155|P4|Overall Study|Adverse Event|4
339877|NCT01197794|1147156|P3|Overall Study|Adverse Event|4
339878|NCT01197794|1147157|P2|Overall Study|Adverse Event|2
339879|NCT01197794|1147158|P1|Overall Study|Adverse Event|3
339880|NCT01197755|1147240|P3|Overall Study|eg, change in circumstances|2
339881|NCT01197755|1147241|P2|Overall Study|eg, change in circumstances|3
339882|NCT01197755|1147242|P1|Overall Study|eg, change in circumstances|7
339883|NCT01197755|1147240|P3|Overall Study|Lost to Follow-up|1
339884|NCT01197755|1147241|P2|Overall Study|Lost to Follow-up|0
339885|NCT01197755|1147242|P1|Overall Study|Lost to Follow-up|0
339886|NCT01197755|1147240|P3|Overall Study|Withdrawal by Subject|0
339887|NCT01197755|1147241|P2|Overall Study|Withdrawal by Subject|0
339888|NCT01197755|1147242|P1|Overall Study|Withdrawal by Subject|1
339889|NCT01197755|1147240|P3|Overall Study|Severe non-compliance to the protocol|2
339890|NCT01197755|1147241|P2|Overall Study|Severe non-compliance to the protocol|1
339891|NCT01197755|1147242|P1|Overall Study|Severe non-compliance to the protocol|2
339892|NCT01197755|1147240|P3|Overall Study|Lack of therapeutic response|4
339893|NCT01197755|1147241|P2|Overall Study|Lack of therapeutic response|7
339894|NCT01197755|1147242|P1|Overall Study|Lack of therapeutic response|0
339895|NCT01197755|1147240|P3|Overall Study|Entered the long-term extension study|35
339896|NCT01197755|1147241|P2|Overall Study|Entered the long-term extension study|21
339897|NCT01197755|1147242|P1|Overall Study|Entered the long-term extension study|18
339898|NCT01197755|1147240|P3|Overall Study|Study-specific discontinuation criteria|0
339899|NCT01197755|1147241|P2|Overall Study|Study-specific discontinuation criteria|1
339900|NCT01197755|1147242|P1|Overall Study|Study-specific discontinuation criteria|2
339901|NCT01197755|1147240|P3|Overall Study|Adverse Event|10
339902|NCT01197755|1147241|P2|Overall Study|Adverse Event|10
339903|NCT01197755|1147242|P1|Overall Study|Adverse Event|8
339904|NCT01197560|1147295|P2|Overall Study|Missing|1
339905|NCT01197560|1147296|P1|Overall Study|Missing|0
339906|NCT01197560|1147295|P2|Overall Study|Elected to discontinue before cycle end|2
339907|NCT01197560|1147296|P1|Overall Study|Elected to discontinue before cycle end|0
339908|NCT01197560|1147295|P2|Overall Study|Proceeded to transplant|1
339909|NCT01197560|1147296|P1|Overall Study|Proceeded to transplant|1
339910|NCT01197560|1147295|P2|Overall Study|Disease progression|35
339911|NCT01197560|1147296|P1|Overall Study|Disease progression|39
339912|NCT01197560|1147295|P2|Overall Study|Withdrawal by Subject|1
339913|NCT01197560|1147296|P1|Overall Study|Withdrawal by Subject|1
339914|NCT01197560|1147295|P2|Overall Study|Death|5
339915|NCT01197560|1147296|P1|Overall Study|Death|1
339916|NCT01197560|1147295|P2|Overall Study|Adverse Event|8
339917|NCT01197560|1147296|P1|Overall Study|Adverse Event|4
339918|NCT01197534|1147329|P3|Overall Study|Adverse Event|24
339919|NCT01197534|1147330|P2|Overall Study|Adverse Event|36
339920|NCT01197534|1147331|P1|Overall Study|Adverse Event|35
339921|NCT01197534|1147329|P3|Overall Study|Lost to Follow-up|2
339922|NCT01197534|1147330|P2|Overall Study|Lost to Follow-up|4
339923|NCT01197534|1147331|P1|Overall Study|Lost to Follow-up|1
339924|NCT01197534|1147329|P3|Overall Study|Dev. of study specific discont. criteria|2
339925|NCT01197534|1147330|P2|Overall Study|Dev. of study specific discont. criteria|6
339926|NCT01197534|1147331|P1|Overall Study|Dev. of study specific discont. criteria|13
339927|NCT01197534|1147329|P3|Overall Study|Lack of therapeutic response|9
339928|NCT01197534|1147330|P2|Overall Study|Lack of therapeutic response|4
339929|NCT01197534|1147331|P1|Overall Study|Lack of therapeutic response|9
339930|NCT01197534|1147329|P3|Overall Study|Severe non-compliance to protocol|1
339931|NCT01197534|1147330|P2|Overall Study|Severe non-compliance to protocol|4
339932|NCT01197534|1147331|P1|Overall Study|Severe non-compliance to protocol|3
339933|NCT01197534|1147329|P3|Overall Study|Enrolment in long term extension|119
339934|NCT01197534|1147330|P2|Overall Study|Enrolment in long term extension|66
339935|NCT01197534|1147331|P1|Overall Study|Enrolment in long term extension|57
339936|NCT01197534|1147329|P3|Overall Study|Not reported|16
339937|NCT01197534|1147330|P2|Overall Study|Not reported|10
339938|NCT01197534|1147331|P1|Overall Study|Not reported|16
339939|NCT01197521|1147375|P3|Overall Study|Adverse Event|24
339940|NCT01197521|1147376|P2|Overall Study|Adverse Event|28
339941|NCT01197521|1147377|P1|Overall Study|Adverse Event|25
339942|NCT01197521|1147375|P3|Overall Study|Lost to Follow-up|2
339943|NCT01197521|1147376|P2|Overall Study|Lost to Follow-up|2
339944|NCT01197521|1147377|P1|Overall Study|Lost to Follow-up|3
339945|NCT01197521|1147375|P3|Overall Study|Dev. of study specific discont. criteria|2
339946|NCT01197521|1147376|P2|Overall Study|Dev. of study specific discont. criteria|16
339947|NCT01197521|1147377|P1|Overall Study|Dev. of study specific discont. criteria|6
339948|NCT01197521|1147375|P3|Overall Study|Lack of therapeutic response|4
339949|NCT01197521|1147376|P2|Overall Study|Lack of therapeutic response|3
339950|NCT01197521|1147377|P1|Overall Study|Lack of therapeutic response|2
339951|NCT01197521|1147375|P3|Overall Study|Severe non-compliance to protocol|3
339952|NCT01197521|1147376|P2|Overall Study|Severe non-compliance to protocol|3
339953|NCT01197521|1147377|P1|Overall Study|Severe non-compliance to protocol|1
339954|NCT01197521|1147375|P3|Overall Study|Enrolment in long term extension|87
339955|NCT01197521|1147376|P2|Overall Study|Enrolment in long term extension|36
339956|NCT01197521|1147377|P1|Overall Study|Enrolment in long term extension|42
339957|NCT01197521|1147375|P3|Overall Study|Not reported|21
339958|NCT01197521|1147376|P2|Overall Study|Not reported|25
339959|NCT01197521|1147377|P1|Overall Study|Not reported|24
339960|NCT01197508|1147422|P4|Overall Study|Not specified|2
339961|NCT01197508|1147423|P3|Overall Study|Not specified|2
339962|NCT01197508|1147424|P2|Overall Study|Not specified|3
339963|NCT01197508|1147425|P1|Overall Study|Not specified|2
339964|NCT01197508|1147422|P4|Overall Study|Lost to Follow-up|0
339965|NCT01197508|1147423|P3|Overall Study|Lost to Follow-up|2
339966|NCT01197508|1147424|P2|Overall Study|Lost to Follow-up|1
339967|NCT01197508|1147425|P1|Overall Study|Lost to Follow-up|1
339968|NCT01197508|1147422|P4|Overall Study|Study-specific withdrawal criteria|2
339969|NCT01197508|1147423|P3|Overall Study|Study-specific withdrawal criteria|1
339970|NCT01197508|1147424|P2|Overall Study|Study-specific withdrawal criteria|0
339971|NCT01197508|1147425|P1|Overall Study|Study-specific withdrawal criteria|0
339972|NCT01197508|1147422|P4|Overall Study|Lack of Efficacy|1
339973|NCT01197508|1147423|P3|Overall Study|Lack of Efficacy|2
339974|NCT01197508|1147424|P2|Overall Study|Lack of Efficacy|2
339975|NCT01197508|1147425|P1|Overall Study|Lack of Efficacy|1
339976|NCT01197508|1147422|P4|Overall Study|Condition under investigation worsened|1
339977|NCT01197508|1147423|P3|Overall Study|Condition under investigation worsened|1
339978|NCT01197508|1147424|P2|Overall Study|Condition under investigation worsened|1
339979|NCT01197508|1147425|P1|Overall Study|Condition under investigation worsened|1
339980|NCT01197508|1147422|P4|Overall Study|Severe non-compliance to protocol|3
339981|NCT01197508|1147423|P3|Overall Study|Severe non-compliance to protocol|1
339982|NCT01197508|1147424|P2|Overall Study|Severe non-compliance to protocol|3
339983|NCT01197508|1147425|P1|Overall Study|Severe non-compliance to protocol|0
339984|NCT01197508|1147422|P4|Overall Study|Adverse Event|3
339985|NCT01197508|1147423|P3|Overall Study|Adverse Event|23
339986|NCT01197508|1147424|P2|Overall Study|Adverse Event|13
339987|NCT01197508|1147425|P1|Overall Study|Adverse Event|10
339988|NCT01197508|1147422|P4|Overall Study|Eligiblity criteria not fulfilled|0
339989|NCT01197508|1147423|P3|Overall Study|Eligiblity criteria not fulfilled|2
339990|NCT01197508|1147424|P2|Overall Study|Eligiblity criteria not fulfilled|0
339991|NCT01197508|1147425|P1|Overall Study|Eligiblity criteria not fulfilled|0
339992|NCT01197508|1147422|P4|Overall Study|Withdrawal by Subject|4
339993|NCT01197508|1147423|P3|Overall Study|Withdrawal by Subject|15
339994|NCT01197508|1147424|P2|Overall Study|Withdrawal by Subject|7
339995|NCT01197508|1147425|P1|Overall Study|Withdrawal by Subject|8
339996|NCT01197417|1147535|P2|Overall Study|No 25-hour magnesium level|2
339997|NCT01197417|1147536|P1|Overall Study|No 25-hour magnesium level|0
339998|NCT01197417|1147535|P2|Overall Study|Found to be ineligible|5
339999|NCT01197417|1147536|P1|Overall Study|Found to be ineligible|2
340000|NCT01197417|1147535|P2|Overall Study|Hypotension|2
340001|NCT01197417|1147536|P1|Overall Study|Hypotension|1
340002|NCT01197417|1147535|P2|Overall Study|Not consented in time to receive drug|1
340003|NCT01197417|1147536|P1|Overall Study|Not consented in time to receive drug|0
340004|NCT01197417|1147535|P2|Overall Study|Subject transferred to intensive care|1
340005|NCT01197417|1147536|P1|Overall Study|Subject transferred to intensive care|0
340006|NCT01197417|1147535|P2|Overall Study|Site miscommunication|1
340007|NCT01197417|1147536|P1|Overall Study|Site miscommunication|0
340008|NCT01197417|1147535|P2|Overall Study|Withdrawal by Subject|4
340009|NCT01197417|1147536|P1|Overall Study|Withdrawal by Subject|2
340010|NCT01197417|1147535|P2|Overall Study|Physician Decision|2
340011|NCT01197417|1147536|P1|Overall Study|Physician Decision|3
340012|NCT01196988|1147569|P4|Overall Study|Other|0
340013|NCT01196988|1147570|P3|Overall Study|Other|0
340014|NCT01196988|1147571|P2|Overall Study|Other|0
340015|NCT01196988|1147572|P1|Overall Study|Other|2
340016|NCT01196988|1147569|P4|Overall Study|Lost to Follow-up|1
340017|NCT01196988|1147570|P3|Overall Study|Lost to Follow-up|21
340018|NCT01196988|1147571|P2|Overall Study|Lost to Follow-up|29
340019|NCT01196988|1147572|P1|Overall Study|Lost to Follow-up|16
340020|NCT01196988|1147569|P4|Overall Study|Withdrawal by Subject|0
340021|NCT01196988|1147570|P3|Overall Study|Withdrawal by Subject|4
340022|NCT01196988|1147571|P2|Overall Study|Withdrawal by Subject|1
340023|NCT01196988|1147572|P1|Overall Study|Withdrawal by Subject|5
340024|NCT01196988|1147569|P4|Overall Study|Adverse Event|0
340025|NCT01196988|1147570|P3|Overall Study|Adverse Event|0
340026|NCT01196988|1147571|P2|Overall Study|Adverse Event|2
340027|NCT01196988|1147572|P1|Overall Study|Adverse Event|1
340028|NCT01196975|1147666|P5|Overall Study|Lost to Follow-up|11
340029|NCT01196975|1147667|P4|Overall Study|Lost to Follow-up|5
340030|NCT01196975|1147668|P3|Overall Study|Lost to Follow-up|5
340031|NCT01196975|1147669|P2|Overall Study|Lost to Follow-up|6
340032|NCT01196975|1147670|P1|Overall Study|Lost to Follow-up|11
340033|NCT01196975|1147666|P5|Overall Study|Withdrawal by Subject|0
340034|NCT01196975|1147667|P4|Overall Study|Withdrawal by Subject|1
340035|NCT01196975|1147668|P3|Overall Study|Withdrawal by Subject|0
340036|NCT01196975|1147669|P2|Overall Study|Withdrawal by Subject|1
340037|NCT01196975|1147670|P1|Overall Study|Withdrawal by Subject|2
340038|NCT01196975|1147666|P5|Overall Study|Adverse Event|2
340039|NCT01196975|1147667|P4|Overall Study|Adverse Event|0
340040|NCT01196975|1147668|P3|Overall Study|Adverse Event|0
340041|NCT01196975|1147669|P2|Overall Study|Adverse Event|2
340042|NCT01196975|1147670|P1|Overall Study|Adverse Event|2
340043|NCT01196741|1147831|P2|Overall Study|Protocol Violation|1
340044|NCT01196741|1147832|P1|Overall Study|Protocol Violation|2
340045|NCT01196741|1147831|P2|Overall Study|Other|2
340046|NCT01196741|1147832|P1|Overall Study|Other|3
340047|NCT01196741|1147831|P2|Overall Study|Other reason|3
340048|NCT01196741|1147832|P1|Overall Study|Other reason|3
340049|NCT01196741|1147831|P2|Overall Study|Withdrawal by Subject|0
340050|NCT01196741|1147832|P1|Overall Study|Withdrawal by Subject|3
340051|NCT01196741|1147831|P2|Overall Study|Dose limiting Adverse Event|1
340052|NCT01196741|1147832|P1|Overall Study|Dose limiting Adverse Event|2
340053|NCT01196741|1147831|P2|Overall Study|Serious Adverse Event|1
340054|NCT01196741|1147832|P1|Overall Study|Serious Adverse Event|3
340055|NCT01196741|1147831|P2|Overall Study|Adverse Event|6
340056|NCT01196741|1147832|P1|Overall Study|Adverse Event|10
340057|NCT01196741|1147831|P2|Overall Study|Disease progression|14
340058|NCT01196741|1147832|P1|Overall Study|Disease progression|34
340059|NCT01196429|1147858|P2|Overall Study|Refused – Never Treated|0
340060|NCT01196429|1147859|P1|Overall Study|Refused – Never Treated|1
340061|NCT01196429|1147858|P2|Overall Study|Ineligible - wrong cell type|0
340062|NCT01196429|1147859|P1|Overall Study|Ineligible - wrong cell type|1
340063|NCT01196429|1147858|P2|Overall Study|Ineligible - inadequate pathology|0
340064|NCT01196429|1147859|P1|Overall Study|Ineligible - inadequate pathology|1
340065|NCT01196416|1147875|P1|Overall Study|Withdrawal by Subject|2
340066|NCT01196104|1147901|P2|Overall Study|Various|1
340067|NCT01196104|1147902|P1|Overall Study|Various|0
340068|NCT01196104|1147901|P2|Overall Study|Withdrawal by Subject|3
340069|NCT01196104|1147902|P1|Overall Study|Withdrawal by Subject|3
340070|NCT01196104|1147901|P2|Overall Study|Physician Decision|1
340071|NCT01196104|1147902|P1|Overall Study|Physician Decision|0
340072|NCT01196104|1147901|P2|Overall Study|Lost to Follow-up|0
340073|NCT01196104|1147902|P1|Overall Study|Lost to Follow-up|1
340074|NCT01196091|1147945|P3|Overall Study|Randomized, No Study Drug Received|1
340075|NCT01196091|1147946|P2|Overall Study|Randomized, No Study Drug Received|0
340076|NCT01196091|1147947|P1|Overall Study|Randomized, No Study Drug Received|1
340077|NCT01196091|1147945|P3|Overall Study|Excluded Site|8
340078|NCT01196091|1147946|P2|Overall Study|Excluded Site|11
340079|NCT01196091|1147947|P1|Overall Study|Excluded Site|5
340080|NCT01196091|1147945|P3|Overall Study|Sponsor Decision|4
340081|NCT01196091|1147946|P2|Overall Study|Sponsor Decision|5
340082|NCT01196091|1147947|P1|Overall Study|Sponsor Decision|6
340083|NCT01196091|1147945|P3|Overall Study|Protocol Violation|3
340084|NCT01196091|1147946|P2|Overall Study|Protocol Violation|3
340085|NCT01196091|1147947|P1|Overall Study|Protocol Violation|1
340086|NCT01196091|1147945|P3|Overall Study|Physician Decision|4
340087|NCT01196091|1147946|P2|Overall Study|Physician Decision|3
340088|NCT01196091|1147947|P1|Overall Study|Physician Decision|3
340089|NCT01196091|1147945|P3|Overall Study|Withdrawal by Subject|22
340090|NCT01196091|1147946|P2|Overall Study|Withdrawal by Subject|19
340091|NCT01196091|1147947|P1|Overall Study|Withdrawal by Subject|16
340092|NCT01196091|1147945|P3|Overall Study|Parent/Caregiver Decision|1
340093|NCT01196091|1147946|P2|Overall Study|Parent/Caregiver Decision|0
340094|NCT01196091|1147947|P1|Overall Study|Parent/Caregiver Decision|0
340095|NCT01196091|1147945|P3|Overall Study|Lost to Follow-up|6
340096|NCT01196091|1147946|P2|Overall Study|Lost to Follow-up|5
340097|NCT01196091|1147947|P1|Overall Study|Lost to Follow-up|5
340098|NCT01196091|1147945|P3|Overall Study|Lack of Efficacy|17
340099|NCT01196091|1147946|P2|Overall Study|Lack of Efficacy|12
340100|NCT01196091|1147947|P1|Overall Study|Lack of Efficacy|15
340101|NCT01196091|1147945|P3|Overall Study|Entry Criteria Not Met|10
340102|NCT01196091|1147946|P2|Overall Study|Entry Criteria Not Met|11
340103|NCT01196091|1147947|P1|Overall Study|Entry Criteria Not Met|11
340104|NCT01196091|1147945|P3|Overall Study|Death|2
340105|NCT01196091|1147946|P2|Overall Study|Death|2
340106|NCT01196091|1147947|P1|Overall Study|Death|3
340107|NCT01196091|1147945|P3|Overall Study|Adverse Event|26
340108|NCT01196091|1147946|P2|Overall Study|Adverse Event|27
340109|NCT01196091|1147947|P1|Overall Study|Adverse Event|22
340110|NCT01196078|1147999|P2|Overall Study|Death|4
340111|NCT01196078|1148000|P1|Overall Study|Death|6
340112|NCT01196078|1147999|P2|Overall Study|Lost to Follow-up|0
340113|NCT01196078|1148000|P1|Overall Study|Lost to Follow-up|1
340114|NCT01196078|1147999|P2|Overall Study|Lack of Efficacy|23
340115|NCT01196078|1148000|P1|Overall Study|Lack of Efficacy|17
340116|NCT01196078|1147999|P2|Overall Study|Protocol Violation|1
340117|NCT01196078|1148000|P1|Overall Study|Protocol Violation|2
340118|NCT01196078|1147999|P2|Overall Study|Adverse Event|4
340119|NCT01196078|1148000|P1|Overall Study|Adverse Event|4
340120|NCT01196078|1147999|P2|Overall Study|Withdrawal by Subject|5
340121|NCT01196078|1148000|P1|Overall Study|Withdrawal by Subject|3
340122|NCT01196052|1148028|P1|Overall Study|Withdrawal by Subject|6
340123|NCT01196052|1148028|P1|Overall Study|Reason not Specified|5
340124|NCT01196052|1148028|P1|Overall Study|Noncompliance to Protocol Requirements|2
340125|NCT01196052|1148028|P1|Overall Study|Lost to Follow-up|1
340126|NCT01196052|1148028|P1|Overall Study|Adverse Event|9
340127|NCT01196026|1148045|P6|Overall Study|Other|0
340128|NCT01196026|1148046|P5|Overall Study|Other|0
340129|NCT01196026|1148047|P4|Overall Study|Other|0
340130|NCT01196026|1148048|P3|Overall Study|Other|0
340131|NCT01196026|1148049|P2|Overall Study|Other|1
340132|NCT01196026|1148050|P1|Overall Study|Other|0
340133|NCT01196026|1148045|P6|Overall Study|Lost to Follow-up|0
340134|NCT01196026|1148046|P5|Overall Study|Lost to Follow-up|1
340135|NCT01196026|1148047|P4|Overall Study|Lost to Follow-up|0
340136|NCT01196026|1148048|P3|Overall Study|Lost to Follow-up|0
340137|NCT01196026|1148049|P2|Overall Study|Lost to Follow-up|3
340138|NCT01196026|1148050|P1|Overall Study|Lost to Follow-up|0
340139|NCT01196026|1148045|P6|Overall Study|Withdrawal by Subject|0
340140|NCT01196026|1148046|P5|Overall Study|Withdrawal by Subject|0
340141|NCT01196026|1148047|P4|Overall Study|Withdrawal by Subject|0
340142|NCT01196026|1148048|P3|Overall Study|Withdrawal by Subject|0
340143|NCT01196026|1148049|P2|Overall Study|Withdrawal by Subject|4
340144|NCT01196026|1148050|P1|Overall Study|Withdrawal by Subject|1
340145|NCT01195948|1148286|P3|Overall Study|Lost to Follow-up|2
340146|NCT01195948|1148287|P2|Overall Study|Lost to Follow-up|1
340147|NCT01195948|1148288|P1|Overall Study|Lost to Follow-up|0
340148|NCT01195844|1148320|P1|Overall Study|Fecal sample not collected|40
340149|NCT01195831|1148337|P2|Overall Study|Protocol Violation|2
340150|NCT01195831|1148338|P1|Overall Study|Protocol Violation|0
340151|NCT01195831|1148337|P2|Overall Study|Adverse Event|2
340152|NCT01195831|1148338|P1|Overall Study|Adverse Event|4
340153|NCT01195831|1148337|P2|Overall Study|Withdrawal by Subject|2
340154|NCT01195831|1148338|P1|Overall Study|Withdrawal by Subject|2
340155|NCT01195831|1148337|P2|Overall Study|Lost to Follow-up|4
340156|NCT01195831|1148338|P1|Overall Study|Lost to Follow-up|2
340157|NCT01195675|1148578|P1|Overall Study|Withdrawal by Subject|2
340158|NCT01195675|1148578|P1|Overall Study|Adverse Event|1
340159|NCT01195662|1148611|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
340160|NCT01195662|1148612|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
340161|NCT01195662|1148613|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
340162|NCT01195662|1148611|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
340163|NCT01195662|1148612|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
340164|NCT01195662|1148613|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
340165|NCT01195662|1148611|P3|Double Blind Treatment Period|Missing disposition information|1
340166|NCT01195662|1148612|P2|Double Blind Treatment Period|Missing disposition information|1
340167|NCT01195662|1148613|P1|Double Blind Treatment Period|Missing disposition information|0
340168|NCT01195662|1148611|P3|Double Blind Treatment Period|Non-specified|0
340169|NCT01195662|1148612|P2|Double Blind Treatment Period|Non-specified|0
340170|NCT01195662|1148613|P1|Double Blind Treatment Period|Non-specified|3
340171|NCT01195662|1148611|P3|Double Blind Treatment Period|Lack of Efficacy|0
340172|NCT01195662|1148612|P2|Double Blind Treatment Period|Lack of Efficacy|0
340173|NCT01195662|1148613|P1|Double Blind Treatment Period|Lack of Efficacy|2
340174|NCT01195662|1148611|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
340175|NCT01195662|1148612|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
340176|NCT01195662|1148613|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
340177|NCT01195662|1148611|P3|Double Blind Treatment Period|Requested discontinue treatment|1
340178|NCT01195662|1148612|P2|Double Blind Treatment Period|Requested discontinue treatment|0
340179|NCT01195662|1148613|P1|Double Blind Treatment Period|Requested discontinue treatment|1
340180|NCT01195662|1148611|P3|Double Blind Treatment Period|Administrative reason|1
340181|NCT01195662|1148612|P2|Double Blind Treatment Period|Administrative reason|1
340182|NCT01195662|1148613|P1|Double Blind Treatment Period|Administrative reason|2
340183|NCT01195662|1148611|P3|Double Blind Treatment Period|Lost to Follow-up|3
340184|NCT01195662|1148612|P2|Double Blind Treatment Period|Lost to Follow-up|2
340185|NCT01195662|1148613|P1|Double Blind Treatment Period|Lost to Follow-up|3
340186|NCT01195662|1148611|P3|Double Blind Treatment Period|Withdrawal by Subject|4
340187|NCT01195662|1148612|P2|Double Blind Treatment Period|Withdrawal by Subject|4
340188|NCT01195662|1148613|P1|Double Blind Treatment Period|Withdrawal by Subject|6
340189|NCT01195662|1148611|P3|Double Blind Treatment Period|Adverse Event|2
340190|NCT01195662|1148612|P2|Double Blind Treatment Period|Adverse Event|1
340191|NCT01195662|1148613|P1|Double Blind Treatment Period|Adverse Event|4
340192|NCT01195636|1148643|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
340193|NCT01195636|1148644|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
340194|NCT01195636|1148643|P2|Second Intervention (3 Weeks)|Adverse Event|1
340195|NCT01195636|1148644|P1|Second Intervention (3 Weeks)|Adverse Event|1
340196|NCT01195636|1148643|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
340197|NCT01195636|1148644|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
340198|NCT01195636|1148643|P2|Washout Period (2 Weeks)|Adverse Event|1
340199|NCT01195636|1148644|P1|Washout Period (2 Weeks)|Adverse Event|1
340200|NCT01195636|1148643|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
340201|NCT01195636|1148644|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
340202|NCT01195636|1148643|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
340203|NCT01195636|1148644|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
340204|NCT01195636|1148643|P2|First Intervention (3 Weeks)|Protocol Violation|0
340205|NCT01195636|1148644|P1|First Intervention (3 Weeks)|Protocol Violation|1
340206|NCT01195636|1148643|P2|First Intervention (3 Weeks)|Adverse Event|3
340207|NCT01195636|1148644|P1|First Intervention (3 Weeks)|Adverse Event|2
340208|NCT01195623|1148670|P2|Overall Study|Lost to Follow-up|37
340209|NCT01195623|1148671|P1|Overall Study|Lost to Follow-up|35
340210|NCT01195415|1148705|P1|Overall Study|No repeat biopsy due to progression|2
340211|NCT01195363|1148714|P2|Overall Study|incarceration|0
340212|NCT01195363|1148715|P1|Overall Study|incarceration|1
340213|NCT01195363|1148714|P2|Overall Study|Lack of Efficacy|4
340214|NCT01195363|1148715|P1|Overall Study|Lack of Efficacy|0
340215|NCT01195363|1148714|P2|Overall Study|Adverse Event|1
340216|NCT01195363|1148715|P1|Overall Study|Adverse Event|3
340217|NCT01195363|1148714|P2|Overall Study|Lost to Follow-up|4
340218|NCT01195363|1148715|P1|Overall Study|Lost to Follow-up|7
340219|NCT01195272|1148721|P1|Overall Study|Lack of Efficacy|3
340220|NCT01195272|1148721|P1|Overall Study|Adverse Event|1
340221|NCT01195103|1148750|P3|Overall Study|Withdrawal by Subject|0
340222|NCT01195103|1148751|P2|Overall Study|Withdrawal by Subject|0
340223|NCT01195103|1148752|P1|Overall Study|Withdrawal by Subject|1
340224|NCT01195090|1148762|P2|Overall Study|Protocol Violation|4
340225|NCT01195090|1148763|P1|Overall Study|Protocol Violation|3
340226|NCT01195090|1148762|P2|Overall Study|Lost to Follow-up|2
340227|NCT01195090|1148763|P1|Overall Study|Lost to Follow-up|2
340228|NCT01195090|1148762|P2|Overall Study|Adverse Event|2
340229|NCT01195090|1148763|P1|Overall Study|Adverse Event|1
340230|NCT01194999|1148832|P1|Overall Study|Lost to Follow-up|17
340231|NCT01194973|1148836|P1|26 Week Treatment Period|Pregnancy|1
340232|NCT01194973|1148836|P1|26 Week Treatment Period|Lack of Efficacy|1
340233|NCT01194973|1148836|P1|26 Week Treatment Period|Adverse Event|1
340234|NCT01194973|1148836|P1|Screening Period|Screen Failure|3
340235|NCT01194869|1148856|P1|Overall Study|Toxicity|2
340236|NCT01194869|1148856|P1|Overall Study|Disease Progression|2
340237|NCT01194830|1148887|P2|Overall Study|Other Reason|8
340238|NCT01194830|1148888|P1|Overall Study|Other Reason|12
340239|NCT01194830|1148887|P2|Overall Study|Non-compliance issues|4
340240|NCT01194830|1148888|P1|Overall Study|Non-compliance issues|4
340241|NCT01194830|1148887|P2|Overall Study|Lack of Efficacy|1
340242|NCT01194830|1148888|P1|Overall Study|Lack of Efficacy|1
340243|NCT01194830|1148887|P2|Overall Study|Withdrawal by Subject|1
340244|NCT01194830|1148888|P1|Overall Study|Withdrawal by Subject|2
340245|NCT01194830|1148887|P2|Overall Study|Lost to Follow-up|7
340246|NCT01194830|1148888|P1|Overall Study|Lost to Follow-up|9
340247|NCT01194830|1148887|P2|Overall Study|Protocol Violation|4
340248|NCT01194830|1148888|P1|Overall Study|Protocol Violation|5
340249|NCT01194830|1148887|P2|Overall Study|Adverse Event|2
340250|NCT01194830|1148888|P1|Overall Study|Adverse Event|3
340251|NCT01194570|1148919|P2|Overall Study|Lost to Follow-up|4
340252|NCT01194570|1148920|P1|Overall Study|Lost to Follow-up|1
340253|NCT01194570|1148919|P2|Overall Study|Pregnancy|1
340254|NCT01194570|1148920|P1|Overall Study|Pregnancy|1
340255|NCT01194570|1148919|P2|Overall Study|Withdrawal by Subject|22
340256|NCT01194570|1148920|P1|Overall Study|Withdrawal by Subject|21
340257|NCT01194570|1148919|P2|Overall Study|Lack of Efficacy|21
340258|NCT01194570|1148920|P1|Overall Study|Lack of Efficacy|27
340259|NCT01194570|1148919|P2|Overall Study|Non-compliance|2
340260|NCT01194570|1148920|P1|Overall Study|Non-compliance|2
340261|NCT01194570|1148919|P2|Overall Study|Adverse Event|18
340262|NCT01194570|1148920|P1|Overall Study|Adverse Event|12
340263|NCT01194570|1148919|P2|Overall Study|Non-compliance with study drug|2
340264|NCT01194570|1148920|P1|Overall Study|Non-compliance with study drug|2
340265|NCT01194570|1148919|P2|Overall Study|Protocol Violation|2
340266|NCT01194570|1148920|P1|Overall Study|Protocol Violation|0
340267|NCT01194570|1148919|P2|Overall Study|Reason not specified|20
340268|NCT01194570|1148920|P1|Overall Study|Reason not specified|13
340269|NCT01194570|1148919|P2|Overall Study|Physician Decision|6
340270|NCT01194570|1148920|P1|Overall Study|Physician Decision|2
340271|NCT01194570|1148919|P2|Overall Study|Ongoing at CCOD|387
340272|NCT01194570|1148920|P1|Overall Study|Ongoing at CCOD|162
340273|NCT01194570|1148919|P2|Overall Study|Death|3
340274|NCT01194570|1148920|P1|Overall Study|Death|1
340275|NCT01194531|1148940|P2|Overall Study|Physician Decision|2
340276|NCT01194531|1148941|P1|Overall Study|Physician Decision|0
340277|NCT01194531|1148940|P2|Overall Study|Protocol Violation|1
340278|NCT01194531|1148941|P1|Overall Study|Protocol Violation|4
340279|NCT01194531|1148940|P2|Overall Study|Withdrawal by Subject|0
340280|NCT01194531|1148941|P1|Overall Study|Withdrawal by Subject|1
340281|NCT01194440|1148985|P1|Overall Study|Lost to Follow-up|1
340282|NCT01194440|1148985|P1|Overall Study|Withdrawal by Subject|2
340283|NCT01194440|1148985|P1|Overall Study|Adverse Event|9
340284|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Death|2
340285|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Death|0
340286|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Death|2
340287|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Death|1
340288|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
340289|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
340290|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
340291|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
340292|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Adverse Event|12
340293|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Adverse Event|2
340294|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Adverse Event|21
340295|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Adverse Event|35
340296|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Protocol Violation|1
340297|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Protocol Violation|0
340298|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Protocol Violation|0
340299|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Protocol Violation|0
340300|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Other|0
340301|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Other|0
340302|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Other|1
340303|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Other|2
340304|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Pregnancy|1
340305|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Pregnancy|1
340306|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Pregnancy|3
340307|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Pregnancy|1
340308|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
340309|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
340310|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
340311|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
340312|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
340313|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
340314|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
340315|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
340316|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
340317|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
340318|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
340319|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
340320|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
340321|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
340322|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
340323|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
340324|NCT01194414|1148995|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
340325|NCT01194414|1148996|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
340326|NCT01194414|1148997|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
340327|NCT01194414|1148998|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
340328|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Death|0
340329|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Death|0
340330|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Death|1
340331|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Death|0
340332|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
340333|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
340334|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
340335|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
340336|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Adverse Event|0
340337|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Adverse Event|0
340338|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Adverse Event|40
340339|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Adverse Event|28
340340|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Other|0
340341|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Other|0
340342|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Other|1
340343|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Other|0
340344|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
340345|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
340346|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
340347|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
340348|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Pregnancy|0
340349|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Pregnancy|0
340350|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Pregnancy|2
340351|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Pregnancy|2
340352|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
340353|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
340354|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
340355|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
340356|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Protocol Violation|0
340357|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Protocol Violation|0
340358|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Protocol Violation|3
340359|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Protocol Violation|5
340360|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
340361|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
340362|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
340363|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
340364|NCT01194414|1148995|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
340365|NCT01194414|1148996|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
340366|NCT01194414|1148997|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
340367|NCT01194414|1148998|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
340368|NCT01194258|1149069|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
340369|NCT01194258|1149070|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
340370|NCT01194258|1149071|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
340371|NCT01194258|1149072|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
340372|NCT01194258|1149073|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
340373|NCT01194258|1149069|P5|Period 2 (12 Weeks)|Adverse Event|0
340374|NCT01194258|1149070|P4|Period 2 (12 Weeks)|Adverse Event|0
340375|NCT01194258|1149071|P3|Period 2 (12 Weeks)|Adverse Event|0
340376|NCT01194258|1149072|P2|Period 2 (12 Weeks)|Adverse Event|1
340377|NCT01194258|1149073|P1|Period 2 (12 Weeks)|Adverse Event|0
340378|NCT01194258|1149069|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
340379|NCT01194258|1149070|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
340380|NCT01194258|1149071|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
340381|NCT01194258|1149072|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
340382|NCT01194258|1149073|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
340383|NCT01194258|1149069|P5|Period 1 (12 Weeks)|Death|1
340384|NCT01194258|1149070|P4|Period 1 (12 Weeks)|Death|0
340385|NCT01194258|1149071|P3|Period 1 (12 Weeks)|Death|0
340386|NCT01194258|1149072|P2|Period 1 (12 Weeks)|Death|0
340387|NCT01194258|1149073|P1|Period 1 (12 Weeks)|Death|0
340388|NCT01194258|1149069|P5|Titration Period|Titration failure|0
340389|NCT01194258|1149070|P4|Titration Period|Titration failure|0
340390|NCT01194258|1149071|P3|Titration Period|Titration failure|0
340391|NCT01194258|1149072|P2|Titration Period|Titration failure|0
340392|NCT01194258|1149073|P1|Titration Period|Titration failure|3
340393|NCT01194258|1149069|P5|Titration Period|Lost to Follow-up|0
340394|NCT01194258|1149070|P4|Titration Period|Lost to Follow-up|0
340395|NCT01194258|1149071|P3|Titration Period|Lost to Follow-up|0
340396|NCT01194258|1149072|P2|Titration Period|Lost to Follow-up|0
340397|NCT01194258|1149073|P1|Titration Period|Lost to Follow-up|2
340398|NCT01194258|1149069|P5|Titration Period|Withdrawal by Subject|0
340399|NCT01194258|1149070|P4|Titration Period|Withdrawal by Subject|0
340400|NCT01194258|1149071|P3|Titration Period|Withdrawal by Subject|0
340401|NCT01194258|1149072|P2|Titration Period|Withdrawal by Subject|0
340402|NCT01194258|1149073|P1|Titration Period|Withdrawal by Subject|6
340403|NCT01194245|1149097|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
340404|NCT01194245|1149098|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
340405|NCT01194245|1149099|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
340406|NCT01194245|1149100|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
340407|NCT01194245|1149101|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
340408|NCT01194245|1149097|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
340409|NCT01194245|1149098|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
340410|NCT01194245|1149099|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
340411|NCT01194245|1149100|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
340412|NCT01194245|1149101|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
340413|NCT01194245|1149097|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
340414|NCT01194245|1149098|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
340415|NCT01194245|1149099|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
340416|NCT01194245|1149100|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
340417|NCT01194245|1149101|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
340418|NCT01194245|1149097|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
340419|NCT01194245|1149098|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
340420|NCT01194245|1149099|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
340421|NCT01194245|1149100|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
340422|NCT01194245|1149101|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
340423|NCT01194245|1149097|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
340424|NCT01194245|1149098|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
340425|NCT01194245|1149099|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
340426|NCT01194245|1149100|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
340427|NCT01194245|1149101|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
340428|NCT01194245|1149097|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
340429|NCT01194245|1149098|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
340430|NCT01194245|1149099|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
340431|NCT01194245|1149100|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
340432|NCT01194245|1149101|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
340433|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
340434|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
340435|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340436|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340437|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340438|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340439|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340440|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340441|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340442|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
340443|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340444|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
340445|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340446|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340447|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340448|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340449|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340450|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340451|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340452|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
340453|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
340454|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
340455|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340456|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340457|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340458|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340459|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340460|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340461|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340462|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
340463|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Death|1
340464|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Death|1
340465|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Death|0
340466|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Death|0
340467|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Death|0
340468|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Death|0
340469|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Death|0
340470|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Death|0
340471|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Death|0
340472|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Death|0
340473|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
340474|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
340475|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340476|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340477|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340478|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340479|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340480|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340481|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340482|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
340483|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
340484|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
340485|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340486|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340487|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340488|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340489|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340490|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340491|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340492|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
340493|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
340494|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
340495|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340496|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340497|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340498|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340499|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340500|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340501|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340502|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
340503|NCT01194219|1149122|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
340504|NCT01194219|1149123|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
340505|NCT01194219|1149124|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340506|NCT01194219|1149125|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340507|NCT01194219|1149126|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340508|NCT01194219|1149127|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340509|NCT01194219|1149128|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340510|NCT01194219|1149129|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340511|NCT01194219|1149130|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340512|NCT01194219|1149131|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
340513|NCT01194219|1149122|P10|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340514|NCT01194219|1149123|P9|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340515|NCT01194219|1149124|P8|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340516|NCT01194219|1149125|P7|Randomized Withdrawal Phase-Weeks 32-52|Not specified|1
340517|NCT01194219|1149126|P6|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340518|NCT01194219|1149127|P5|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340519|NCT01194219|1149128|P4|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340520|NCT01194219|1149129|P3|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340521|NCT01194219|1149130|P2|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340522|NCT01194219|1149131|P1|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
340523|NCT01194219|1149122|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340524|NCT01194219|1149123|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340525|NCT01194219|1149124|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
340526|NCT01194219|1149125|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340527|NCT01194219|1149126|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340528|NCT01194219|1149127|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340529|NCT01194219|1149128|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340530|NCT01194219|1149129|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340531|NCT01194219|1149130|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340532|NCT01194219|1149131|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
340533|NCT01194219|1149122|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
340534|NCT01194219|1149123|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
340535|NCT01194219|1149124|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
340536|NCT01194219|1149125|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
340537|NCT01194219|1149126|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
340538|NCT01194219|1149127|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
340539|NCT01194219|1149128|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
340540|NCT01194219|1149129|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
340541|NCT01194219|1149130|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
340542|NCT01194219|1149131|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
340543|NCT01194219|1149122|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
340544|NCT01194219|1149123|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
340545|NCT01194219|1149124|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
340546|NCT01194219|1149125|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
340547|NCT01194219|1149126|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
340548|NCT01194219|1149127|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
340549|NCT01194219|1149128|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
340550|NCT01194219|1149129|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
340551|NCT01194219|1149130|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
340552|NCT01194219|1149131|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
340553|NCT01194219|1149122|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340554|NCT01194219|1149123|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340555|NCT01194219|1149124|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340556|NCT01194219|1149125|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
340557|NCT01194219|1149126|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340558|NCT01194219|1149127|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
340559|NCT01194219|1149128|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340560|NCT01194219|1149129|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340561|NCT01194219|1149130|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340562|NCT01194219|1149131|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
340563|NCT01194219|1149122|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
340564|NCT01194219|1149123|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
340565|NCT01194219|1149124|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
340566|NCT01194219|1149125|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
340567|NCT01194219|1149126|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
340568|NCT01194219|1149127|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
340569|NCT01194219|1149128|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
340570|NCT01194219|1149129|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
340571|NCT01194219|1149130|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
340572|NCT01194219|1149131|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
340573|NCT01194219|1149122|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
340574|NCT01194219|1149123|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
340575|NCT01194219|1149124|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
340576|NCT01194219|1149125|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
340577|NCT01194219|1149126|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
340578|NCT01194219|1149127|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
340579|NCT01194219|1149128|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
340580|NCT01194219|1149129|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
340581|NCT01194219|1149130|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
340582|NCT01194219|1149131|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
340583|NCT01194219|1149122|P10|Maintenance Phase Weeks16-32|Other|0
340584|NCT01194219|1149123|P9|Maintenance Phase Weeks16-32|Other|0
340585|NCT01194219|1149124|P8|Maintenance Phase Weeks16-32|Other|0
340586|NCT01194219|1149125|P7|Maintenance Phase Weeks16-32|Other|0
340587|NCT01194219|1149126|P6|Maintenance Phase Weeks16-32|Other|0
340588|NCT01194219|1149127|P5|Maintenance Phase Weeks16-32|Other|0
340589|NCT01194219|1149128|P4|Maintenance Phase Weeks16-32|Other|1
340590|NCT01194219|1149129|P3|Maintenance Phase Weeks16-32|Other|2
340591|NCT01194219|1149130|P2|Maintenance Phase Weeks16-32|Other|0
340592|NCT01194219|1149131|P1|Maintenance Phase Weeks16-32|Other|0
340593|NCT01194219|1149122|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
340594|NCT01194219|1149123|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
340595|NCT01194219|1149124|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
340596|NCT01194219|1149125|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
340597|NCT01194219|1149126|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
340598|NCT01194219|1149127|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
340599|NCT01194219|1149128|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
340600|NCT01194219|1149129|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
340601|NCT01194219|1149130|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
340602|NCT01194219|1149131|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
340603|NCT01194219|1149122|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340604|NCT01194219|1149123|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340605|NCT01194219|1149124|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340606|NCT01194219|1149125|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340607|NCT01194219|1149126|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340608|NCT01194219|1149127|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340609|NCT01194219|1149128|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340610|NCT01194219|1149129|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
340611|NCT01194219|1149130|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340612|NCT01194219|1149131|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
340613|NCT01194219|1149122|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340614|NCT01194219|1149123|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340615|NCT01194219|1149124|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340616|NCT01194219|1149125|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340617|NCT01194219|1149126|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340618|NCT01194219|1149127|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340619|NCT01194219|1149128|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
340620|NCT01194219|1149129|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
340621|NCT01194219|1149130|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340622|NCT01194219|1149131|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
340623|NCT01194219|1149122|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340624|NCT01194219|1149123|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340625|NCT01194219|1149124|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340626|NCT01194219|1149125|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340627|NCT01194219|1149126|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340628|NCT01194219|1149127|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340629|NCT01194219|1149128|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
340630|NCT01194219|1149129|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
340631|NCT01194219|1149130|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340632|NCT01194219|1149131|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
340633|NCT01194219|1149122|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340634|NCT01194219|1149123|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340635|NCT01194219|1149124|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340636|NCT01194219|1149125|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340637|NCT01194219|1149126|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340638|NCT01194219|1149127|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340639|NCT01194219|1149128|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
340640|NCT01194219|1149129|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
340641|NCT01194219|1149130|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340642|NCT01194219|1149131|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
340643|NCT01194219|1149122|P10|Maintenance Phase Weeks16-32|Adverse Event|0
340644|NCT01194219|1149123|P9|Maintenance Phase Weeks16-32|Adverse Event|0
340645|NCT01194219|1149124|P8|Maintenance Phase Weeks16-32|Adverse Event|0
340646|NCT01194219|1149125|P7|Maintenance Phase Weeks16-32|Adverse Event|0
340647|NCT01194219|1149126|P6|Maintenance Phase Weeks16-32|Adverse Event|0
340648|NCT01194219|1149127|P5|Maintenance Phase Weeks16-32|Adverse Event|0
340649|NCT01194219|1149128|P4|Maintenance Phase Weeks16-32|Adverse Event|9
340650|NCT01194219|1149129|P3|Maintenance Phase Weeks16-32|Adverse Event|8
340651|NCT01194219|1149130|P2|Maintenance Phase Weeks16-32|Adverse Event|0
340652|NCT01194219|1149131|P1|Maintenance Phase Weeks16-32|Adverse Event|0
340653|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340654|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340655|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340656|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340657|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340658|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340659|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340660|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
340661|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
340662|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
340663|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340664|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340665|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340666|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340667|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340668|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340669|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340670|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
340671|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
340672|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
340673|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340674|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340675|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340676|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340677|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340678|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340679|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340680|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
340681|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
340682|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
340683|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
340684|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
340685|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
340686|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
340687|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
340688|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
340689|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
340690|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
340691|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
340692|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
340693|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340694|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340695|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340696|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340697|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340698|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340699|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340700|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
340701|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
340702|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
340703|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340704|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340705|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340706|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340707|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340708|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340709|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340710|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340711|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
340712|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
340713|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340714|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340715|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340716|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340717|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340718|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340719|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340720|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
340721|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
340722|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
340723|NCT01194219|1149122|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340724|NCT01194219|1149123|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340725|NCT01194219|1149124|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340726|NCT01194219|1149125|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340727|NCT01194219|1149126|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340728|NCT01194219|1149127|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340729|NCT01194219|1149128|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340730|NCT01194219|1149129|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
340731|NCT01194219|1149130|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
340732|NCT01194219|1149131|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
340733|NCT01194154|1149165|P2|Overall Study|Did not receive study medication|4
340734|NCT01194154|1149166|P1|Overall Study|Did not receive study medication|2
340735|NCT01194154|1149165|P2|Overall Study|Other|0
340736|NCT01194154|1149166|P1|Overall Study|Other|4
340737|NCT01194154|1149165|P2|Overall Study|Treatment with prohibited medication|5
340738|NCT01194154|1149166|P1|Overall Study|Treatment with prohibited medication|4
340739|NCT01194154|1149165|P2|Overall Study|Skipping of CERA treatment at two visits|0
340740|NCT01194154|1149166|P1|Overall Study|Skipping of CERA treatment at two visits|3
340741|NCT01194154|1149165|P2|Overall Study|Hemoglobin increase|3
340742|NCT01194154|1149166|P1|Overall Study|Hemoglobin increase|12
340743|NCT01194154|1149165|P2|Overall Study|Hemoglobin decrease|1
340744|NCT01194154|1149166|P1|Overall Study|Hemoglobin decrease|0
340745|NCT01194154|1149165|P2|Overall Study|Blood pressure increase|3
340746|NCT01194154|1149166|P1|Overall Study|Blood pressure increase|5
340747|NCT01194154|1149165|P2|Overall Study|Withdrawal by Subject|6
340748|NCT01194154|1149166|P1|Overall Study|Withdrawal by Subject|5
340749|NCT01194154|1149165|P2|Overall Study|Protocol Violation|1
340750|NCT01194154|1149166|P1|Overall Study|Protocol Violation|0
340751|NCT01194154|1149165|P2|Overall Study|Lost to Follow-up|3
340752|NCT01194154|1149166|P1|Overall Study|Lost to Follow-up|2
340753|NCT01194154|1149165|P2|Overall Study|Adverse Event|7
340754|NCT01194154|1149166|P1|Overall Study|Adverse Event|12
340755|NCT01193920|1149207|P10|Overall Study|Unable to classify|0
340756|NCT01193920|1149208|P9|Overall Study|Unable to classify|0
340757|NCT01193920|1149209|P8|Overall Study|Unable to classify|1
340758|NCT01193920|1149210|P7|Overall Study|Unable to classify|0
340759|NCT01193920|1149211|P6|Overall Study|Unable to classify|0
340760|NCT01193920|1149212|P5|Overall Study|Unable to classify|0
340761|NCT01193920|1149213|P4|Overall Study|Unable to classify|1
340762|NCT01193920|1149214|P3|Overall Study|Unable to classify|0
340763|NCT01193920|1149215|P2|Overall Study|Unable to classify|0
340764|NCT01193920|1149216|P1|Overall Study|Unable to classify|0
340765|NCT01193920|1149207|P10|Overall Study|Death|4
340766|NCT01193920|1149208|P9|Overall Study|Death|2
340767|NCT01193920|1149209|P8|Overall Study|Death|3
340768|NCT01193920|1149210|P7|Overall Study|Death|2
340769|NCT01193920|1149211|P6|Overall Study|Death|0
340770|NCT01193920|1149212|P5|Overall Study|Death|0
340771|NCT01193920|1149213|P4|Overall Study|Death|1
340772|NCT01193920|1149214|P3|Overall Study|Death|0
340773|NCT01193920|1149215|P2|Overall Study|Death|0
340774|NCT01193920|1149216|P1|Overall Study|Death|0
340775|NCT01193920|1149207|P10|Overall Study|Protocol Violation|0
340776|NCT01193920|1149208|P9|Overall Study|Protocol Violation|0
340777|NCT01193920|1149209|P8|Overall Study|Protocol Violation|0
340778|NCT01193920|1149210|P7|Overall Study|Protocol Violation|0
340779|NCT01193920|1149211|P6|Overall Study|Protocol Violation|0
340780|NCT01193920|1149212|P5|Overall Study|Protocol Violation|0
340781|NCT01193920|1149213|P4|Overall Study|Protocol Violation|0
340782|NCT01193920|1149214|P3|Overall Study|Protocol Violation|0
340783|NCT01193920|1149215|P2|Overall Study|Protocol Violation|0
340784|NCT01193920|1149216|P1|Overall Study|Protocol Violation|1
340785|NCT01193920|1149207|P10|Overall Study|Lost to Follow-up|3
340786|NCT01193920|1149208|P9|Overall Study|Lost to Follow-up|2
340787|NCT01193920|1149209|P8|Overall Study|Lost to Follow-up|0
340788|NCT01193920|1149210|P7|Overall Study|Lost to Follow-up|1
340789|NCT01193920|1149211|P6|Overall Study|Lost to Follow-up|3
340790|NCT01193920|1149212|P5|Overall Study|Lost to Follow-up|3
340791|NCT01193920|1149213|P4|Overall Study|Lost to Follow-up|1
340792|NCT01193920|1149214|P3|Overall Study|Lost to Follow-up|1
340793|NCT01193920|1149215|P2|Overall Study|Lost to Follow-up|0
340794|NCT01193920|1149216|P1|Overall Study|Lost to Follow-up|1
340795|NCT01193920|1149207|P10|Overall Study|Withdrawal by Subject|0
340796|NCT01193920|1149208|P9|Overall Study|Withdrawal by Subject|1
340797|NCT01193920|1149209|P8|Overall Study|Withdrawal by Subject|0
340798|NCT01193920|1149210|P7|Overall Study|Withdrawal by Subject|3
340799|NCT01193920|1149211|P6|Overall Study|Withdrawal by Subject|1
340800|NCT01193920|1149212|P5|Overall Study|Withdrawal by Subject|3
340801|NCT01193920|1149213|P4|Overall Study|Withdrawal by Subject|1
340802|NCT01193920|1149214|P3|Overall Study|Withdrawal by Subject|5
340803|NCT01193920|1149215|P2|Overall Study|Withdrawal by Subject|0
340804|NCT01193920|1149216|P1|Overall Study|Withdrawal by Subject|1
340805|NCT01193842|1149312|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
340806|NCT01193842|1149313|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
340807|NCT01193842|1149314|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
340808|NCT01193842|1149315|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
340809|NCT01193842|1149316|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
340810|NCT01193842|1149312|P5|Phase II: Randomized Groups|Ineligible|1
340811|NCT01193842|1149313|P4|Phase II: Randomized Groups|Ineligible|0
340812|NCT01193842|1149314|P3|Phase II: Randomized Groups|Ineligible|0
340813|NCT01193842|1149315|P2|Phase II: Randomized Groups|Ineligible|0
340814|NCT01193842|1149316|P1|Phase II: Randomized Groups|Ineligible|0
340815|NCT01193842|1149312|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
340816|NCT01193842|1149313|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
340817|NCT01193842|1149314|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
340818|NCT01193842|1149315|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
340819|NCT01193842|1149316|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
340820|NCT01193842|1149312|P5|Phase II: Randomized Groups|Adverse Event|3
340821|NCT01193842|1149313|P4|Phase II: Randomized Groups|Adverse Event|5
340822|NCT01193842|1149314|P3|Phase II: Randomized Groups|Adverse Event|0
340823|NCT01193842|1149315|P2|Phase II: Randomized Groups|Adverse Event|0
340824|NCT01193842|1149316|P1|Phase II: Randomized Groups|Adverse Event|0
340825|NCT01193842|1149312|P5|Phase II: Randomized Groups|Death|1
340826|NCT01193842|1149313|P4|Phase II: Randomized Groups|Death|1
340827|NCT01193842|1149314|P3|Phase II: Randomized Groups|Death|0
340828|NCT01193842|1149315|P2|Phase II: Randomized Groups|Death|0
340829|NCT01193842|1149316|P1|Phase II: Randomized Groups|Death|0
340830|NCT01193842|1149312|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
340831|NCT01193842|1149313|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
340832|NCT01193842|1149314|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
340833|NCT01193842|1149315|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
340834|NCT01193842|1149316|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
340835|NCT01193842|1149312|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
340836|NCT01193842|1149313|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
340837|NCT01193842|1149314|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
340838|NCT01193842|1149315|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
340839|NCT01193842|1149316|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
340840|NCT01193842|1149312|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
340841|NCT01193842|1149313|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
340842|NCT01193842|1149314|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
340843|NCT01193842|1149315|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
340844|NCT01193842|1149316|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
340845|NCT01193686|1149351|P2|Overall Study|Removed by Investigators; unable to matc|0
340846|NCT01193686|1149352|P1|Overall Study|Removed by Investigators; unable to matc|3
340847|NCT01193686|1149351|P2|Overall Study|Withdrawal by Subject|1
340848|NCT01193686|1149352|P1|Overall Study|Withdrawal by Subject|4
340849|NCT01193660|1149369|P3|Overall Study|Physician Decision|1
340850|NCT01193660|1149370|P2|Overall Study|Physician Decision|0
340851|NCT01193660|1149371|P1|Overall Study|Physician Decision|1
340852|NCT01193660|1149369|P3|Overall Study|Death|0
340853|NCT01193660|1149370|P2|Overall Study|Death|0
340854|NCT01193660|1149371|P1|Overall Study|Death|1
340855|NCT01193660|1149369|P3|Overall Study|Withdrawal by Subject|1
340856|NCT01193660|1149370|P2|Overall Study|Withdrawal by Subject|3
340857|NCT01193660|1149371|P1|Overall Study|Withdrawal by Subject|2
340858|NCT01193608|1149415|P6|Overall Study|Adverse Event|0
340859|NCT01193608|1149416|P5|Overall Study|Adverse Event|1
340860|NCT01193608|1149417|P4|Overall Study|Adverse Event|0
340861|NCT01193608|1149418|P3|Overall Study|Adverse Event|0
340862|NCT01193608|1149419|P2|Overall Study|Adverse Event|0
340863|NCT01193608|1149420|P1|Overall Study|Adverse Event|0
340864|NCT01193608|1149415|P6|Overall Study|Lost to Follow-up|2
340865|NCT01193608|1149416|P5|Overall Study|Lost to Follow-up|1
340866|NCT01193608|1149417|P4|Overall Study|Lost to Follow-up|0
340867|NCT01193608|1149418|P3|Overall Study|Lost to Follow-up|0
340868|NCT01193608|1149419|P2|Overall Study|Lost to Follow-up|0
340869|NCT01193608|1149420|P1|Overall Study|Lost to Follow-up|0
340870|NCT01193608|1149415|P6|Overall Study|Withdrawal by Subject|0
340871|NCT01193608|1149416|P5|Overall Study|Withdrawal by Subject|3
340872|NCT01193608|1149417|P4|Overall Study|Withdrawal by Subject|3
340873|NCT01193608|1149418|P3|Overall Study|Withdrawal by Subject|2
340874|NCT01193608|1149419|P2|Overall Study|Withdrawal by Subject|1
340875|NCT01193608|1149420|P1|Overall Study|Withdrawal by Subject|0
340876|NCT01193608|1149415|P6|Overall Study|Other|0
340877|NCT01193608|1149416|P5|Overall Study|Other|0
340878|NCT01193608|1149417|P4|Overall Study|Other|0
340879|NCT01193608|1149418|P3|Overall Study|Other|0
340880|NCT01193608|1149419|P2|Overall Study|Other|1
340881|NCT01193608|1149420|P1|Overall Study|Other|0
340882|NCT01193582|1149657|P4|12 Month Follow-up|Withdrawal by Subject|11
340883|NCT01193582|1149658|P3|12 Month Follow-up|Withdrawal by Subject|3
340884|NCT01193582|1149659|P2|12 Month Follow-up|Withdrawal by Subject|0
340885|NCT01193582|1149660|P1|12 Month Follow-up|Withdrawal by Subject|6
340886|NCT01193582|1149657|P4|12 Month Follow-up|Death|0
340887|NCT01193582|1149658|P3|12 Month Follow-up|Death|1
340888|NCT01193582|1149659|P2|12 Month Follow-up|Death|0
340889|NCT01193582|1149660|P1|12 Month Follow-up|Death|0
340890|NCT01193582|1149657|P4|Vaccination Series|Withdrawal by Subject|3
340891|NCT01193582|1149658|P3|Vaccination Series|Withdrawal by Subject|8
340892|NCT01193582|1149659|P2|Vaccination Series|Withdrawal by Subject|13
340893|NCT01193582|1149660|P1|Vaccination Series|Withdrawal by Subject|11
340894|NCT01193556|1149690|P2|Overall Study|Study termination|25
340895|NCT01193556|1149691|P1|Overall Study|Study termination|26
340896|NCT01193348|1149699|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
340897|NCT01193348|1149699|P1|Extension Treatment Period|Physician Decision|1
340898|NCT01193348|1149699|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
340899|NCT01193348|1149699|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
340900|NCT01193348|1149699|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
340901|NCT01193348|1149699|P1|Screening Period|Screen Failure|5
340902|NCT01193335|1149719|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
340903|NCT01193335|1149720|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
340904|NCT01193335|1149719|P2|2-Year Follow-up|No Longer Willing to Participate|6
340905|NCT01193335|1149720|P1|2-Year Follow-up|No Longer Willing to Participate|5
340906|NCT01193335|1149719|P2|1-Year Follow-up|Lost to Follow-up|0
340907|NCT01193335|1149720|P1|1-Year Follow-up|Lost to Follow-up|4
340908|NCT01193335|1149719|P2|1-Year Follow-up|No Longer Willing to Participate|9
340909|NCT01193335|1149720|P1|1-Year Follow-up|No Longer Willing to Participate|7
340910|NCT01193335|1149719|P2|After Infant Series|No Longer Met Eligibility Criteria|1
340911|NCT01193335|1149720|P1|After Infant Series|No Longer Met Eligibility Criteria|0
340912|NCT01193335|1149719|P2|After Infant Series|Lost to Follow-up|2
340913|NCT01193335|1149720|P1|After Infant Series|Lost to Follow-up|1
340914|NCT01193283|1149815|P1|Overall Study|Death|1
340915|NCT01193244|1149821|P2|Overall Study|Lost to Follow-up|15
340916|NCT01193244|1149822|P1|Overall Study|Lost to Follow-up|6
340917|NCT01193244|1149821|P2|Overall Study|Other|278
340918|NCT01193244|1149822|P1|Overall Study|Other|303
340919|NCT01193244|1149821|P2|Overall Study|Withdrawal by Subject|97
340920|NCT01193244|1149822|P1|Overall Study|Withdrawal by Subject|79
340921|NCT01193218|1149877|P8|12-52 Weeks|Other reason than above|0
340922|NCT01193218|1149878|P7|12-52 Weeks|Other reason than above|0
340923|NCT01193218|1149879|P6|12-52 Weeks|Other reason than above|0
340924|NCT01193218|1149880|P5|12-52 Weeks|Other reason than above|1
340925|NCT01193218|1149881|P4|12-52 Weeks|Other reason than above|1
340926|NCT01193218|1149882|P3|12-52 Weeks|Other reason than above|0
340927|NCT01193218|1149883|P2|12-52 Weeks|Other reason than above|0
340928|NCT01193218|1149884|P1|12-52 Weeks|Other reason than above|1
340929|NCT01193218|1149877|P8|12-52 Weeks|Withdrawal by Subject|2
340930|NCT01193218|1149878|P7|12-52 Weeks|Withdrawal by Subject|1
340931|NCT01193218|1149879|P6|12-52 Weeks|Withdrawal by Subject|2
340932|NCT01193218|1149880|P5|12-52 Weeks|Withdrawal by Subject|0
340933|NCT01193218|1149881|P4|12-52 Weeks|Withdrawal by Subject|0
340934|NCT01193218|1149882|P3|12-52 Weeks|Withdrawal by Subject|3
340935|NCT01193218|1149883|P2|12-52 Weeks|Withdrawal by Subject|0
340936|NCT01193218|1149884|P1|12-52 Weeks|Withdrawal by Subject|3
340937|NCT01193218|1149877|P8|12-52 Weeks|Lack of Efficacy|0
340938|NCT01193218|1149878|P7|12-52 Weeks|Lack of Efficacy|1
340939|NCT01193218|1149879|P6|12-52 Weeks|Lack of Efficacy|0
340940|NCT01193218|1149880|P5|12-52 Weeks|Lack of Efficacy|0
340941|NCT01193218|1149881|P4|12-52 Weeks|Lack of Efficacy|0
340942|NCT01193218|1149882|P3|12-52 Weeks|Lack of Efficacy|0
340943|NCT01193218|1149883|P2|12-52 Weeks|Lack of Efficacy|0
340944|NCT01193218|1149884|P1|12-52 Weeks|Lack of Efficacy|0
340945|NCT01193218|1149877|P8|12-52 Weeks|Adverse Event|2
340946|NCT01193218|1149878|P7|12-52 Weeks|Adverse Event|1
340947|NCT01193218|1149879|P6|12-52 Weeks|Adverse Event|3
340948|NCT01193218|1149880|P5|12-52 Weeks|Adverse Event|3
340949|NCT01193218|1149881|P4|12-52 Weeks|Adverse Event|2
340950|NCT01193218|1149882|P3|12-52 Weeks|Adverse Event|1
340951|NCT01193218|1149883|P2|12-52 Weeks|Adverse Event|0
340952|NCT01193218|1149884|P1|12-52 Weeks|Adverse Event|1
340953|NCT01193218|1149877|P8|0-12 Weeks|Withdrawal by Subject|0
340954|NCT01193218|1149878|P7|0-12 Weeks|Withdrawal by Subject|1
340955|NCT01193218|1149879|P6|0-12 Weeks|Withdrawal by Subject|0
340956|NCT01193218|1149880|P5|0-12 Weeks|Withdrawal by Subject|0
340957|NCT01193218|1149881|P4|0-12 Weeks|Withdrawal by Subject|0
340958|NCT01193218|1149882|P3|0-12 Weeks|Withdrawal by Subject|2
340959|NCT01193218|1149883|P2|0-12 Weeks|Withdrawal by Subject|0
340960|NCT01193218|1149884|P1|0-12 Weeks|Withdrawal by Subject|3
340961|NCT01193218|1149877|P8|0-12 Weeks|Protocol Violation|0
340962|NCT01193218|1149878|P7|0-12 Weeks|Protocol Violation|0
340963|NCT01193218|1149879|P6|0-12 Weeks|Protocol Violation|1
340964|NCT01193218|1149880|P5|0-12 Weeks|Protocol Violation|1
340965|NCT01193218|1149881|P4|0-12 Weeks|Protocol Violation|0
340966|NCT01193218|1149882|P3|0-12 Weeks|Protocol Violation|0
340967|NCT01193218|1149883|P2|0-12 Weeks|Protocol Violation|0
340968|NCT01193218|1149884|P1|0-12 Weeks|Protocol Violation|0
340969|NCT01193218|1149877|P8|0-12 Weeks|Adverse Event|0
340970|NCT01193218|1149878|P7|0-12 Weeks|Adverse Event|2
340971|NCT01193218|1149879|P6|0-12 Weeks|Adverse Event|2
340972|NCT01193218|1149880|P5|0-12 Weeks|Adverse Event|0
340973|NCT01193218|1149881|P4|0-12 Weeks|Adverse Event|0
340974|NCT01193218|1149882|P3|0-12 Weeks|Adverse Event|1
340975|NCT01193218|1149883|P2|0-12 Weeks|Adverse Event|0
340976|NCT01193218|1149884|P1|0-12 Weeks|Adverse Event|6
340977|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
340978|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
340979|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
340980|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
340981|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
340982|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
340983|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|Pregnancy|0
340984|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|Pregnancy|1
340985|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
340986|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
340987|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|Death|0
340988|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|Death|2
340989|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|Adverse Event|3
340990|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|Adverse Event|12
340991|NCT01193153|1149915|P2|Double Blind Relapse Prevention Period|Other|3
340992|NCT01193153|1149916|P1|Double Blind Relapse Prevention Period|Other|2
340993|NCT01193153|1149915|P2|Open-label Stabilization Period|Other|0
340994|NCT01193153|1149916|P1|Open-label Stabilization Period|Other|8
340995|NCT01193153|1149915|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
340996|NCT01193153|1149916|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
340997|NCT01193153|1149915|P2|Open-label Stabilization Period|Withdrawal by Subject|0
340998|NCT01193153|1149916|P1|Open-label Stabilization Period|Withdrawal by Subject|29
340999|NCT01193153|1149915|P2|Open-label Stabilization Period|Lack of Efficacy|0
341000|NCT01193153|1149916|P1|Open-label Stabilization Period|Lack of Efficacy|5
341001|NCT01193153|1149915|P2|Open-label Stabilization Period|Lost to Follow-up|0
341002|NCT01193153|1149916|P1|Open-label Stabilization Period|Lost to Follow-up|10
341003|NCT01193153|1149915|P2|Open-label Stabilization Period|Death|0
341004|NCT01193153|1149916|P1|Open-label Stabilization Period|Death|2
341005|NCT01193153|1149915|P2|Open-label Stabilization Period|Adverse Event|0
341006|NCT01193153|1149916|P1|Open-label Stabilization Period|Adverse Event|9
341007|NCT01193153|1149915|P2|Open-label Lead in Period|Lack of Efficacy|0
341008|NCT01193153|1149916|P1|Open-label Lead in Period|Lack of Efficacy|26
341009|NCT01193153|1149915|P2|Open-label Lead in Period|Death|0
341010|NCT01193153|1149916|P1|Open-label Lead in Period|Death|1
341011|NCT01193153|1149915|P2|Open-label Lead in Period|Adverse Event|0
341012|NCT01193153|1149916|P1|Open-label Lead in Period|Adverse Event|41
341013|NCT01193153|1149915|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
341014|NCT01193153|1149916|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
341015|NCT01193153|1149915|P2|Open-label Lead in Period|Other|0
341016|NCT01193153|1149916|P1|Open-label Lead in Period|Other|14
341017|NCT01193153|1149915|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
341018|NCT01193153|1149916|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
341019|NCT01193153|1149915|P2|Open-label Lead in Period|Withdrawal by Subject|0
341020|NCT01193153|1149916|P1|Open-label Lead in Period|Withdrawal by Subject|69
341021|NCT01193153|1149915|P2|Open-label Lead in Period|Pregnancy|0
341022|NCT01193153|1149916|P1|Open-label Lead in Period|Pregnancy|1
341023|NCT01193153|1149915|P2|Open-label Lead in Period|Lost to Follow-up|0
341024|NCT01193153|1149916|P1|Open-label Lead in Period|Lost to Follow-up|32
341025|NCT01193127|1149951|P4|Treated|Withdrawal by Subject|1
341026|NCT01193127|1149952|P3|Treated|Withdrawal by Subject|0
341027|NCT01193127|1149953|P2|Treated|Withdrawal by Subject|0
341028|NCT01193127|1149954|P1|Treated|Withdrawal by Subject|0
341029|NCT01193127|1149951|P4|Randomized|Surgery Cancelled|1
341030|NCT01193127|1149952|P3|Randomized|Surgery Cancelled|0
341031|NCT01193127|1149953|P2|Randomized|Surgery Cancelled|0
341032|NCT01193127|1149954|P1|Randomized|Surgery Cancelled|0
341033|NCT01193101|1150279|P4|Overall Study|Abnormal test procedure results|0
341034|NCT01193101|1150280|P3|Overall Study|Abnormal test procedure results|0
341035|NCT01193101|1150281|P2|Overall Study|Abnormal test procedure results|1
341036|NCT01193101|1150282|P1|Overall Study|Abnormal test procedure results|0
341037|NCT01193101|1150279|P4|Overall Study|Administrative problems|0
341038|NCT01193101|1150280|P3|Overall Study|Administrative problems|1
341039|NCT01193101|1150281|P2|Overall Study|Administrative problems|0
341040|NCT01193101|1150282|P1|Overall Study|Administrative problems|0
341041|NCT01193101|1150279|P4|Overall Study|Withdrawal by Subject|1
341042|NCT01193101|1150280|P3|Overall Study|Withdrawal by Subject|1
341043|NCT01193101|1150281|P2|Overall Study|Withdrawal by Subject|4
341044|NCT01193101|1150282|P1|Overall Study|Withdrawal by Subject|2
341045|NCT01193101|1150279|P4|Overall Study|Lack of Efficacy|8
341046|NCT01193101|1150280|P3|Overall Study|Lack of Efficacy|0
341047|NCT01193101|1150281|P2|Overall Study|Lack of Efficacy|1
341048|NCT01193101|1150282|P1|Overall Study|Lack of Efficacy|3
341049|NCT01193101|1150279|P4|Overall Study|Adverse Event|3
341050|NCT01193101|1150280|P3|Overall Study|Adverse Event|1
341051|NCT01193101|1150281|P2|Overall Study|Adverse Event|1
341052|NCT01193101|1150282|P1|Overall Study|Adverse Event|0
341053|NCT01192776|1150373|P4|Overall Study|Lost to Follow-up|5
341054|NCT01192776|1150374|P3|Overall Study|Lost to Follow-up|3
341055|NCT01192776|1150375|P2|Overall Study|Lost to Follow-up|6
341056|NCT01192776|1150376|P1|Overall Study|Lost to Follow-up|3
341057|NCT01192776|1150373|P4|Overall Study|Death|15
341058|NCT01192776|1150374|P3|Overall Study|Death|18
341059|NCT01192776|1150375|P2|Overall Study|Death|15
341060|NCT01192776|1150376|P1|Overall Study|Death|8
341061|NCT01192516|1150450|P3|Overall Study|Unable to follow Actiwatch instructions|0
341062|NCT01192516|1150451|P2|Overall Study|Unable to follow Actiwatch instructions|2
341063|NCT01192516|1150452|P1|Overall Study|Unable to follow Actiwatch instructions|4
341064|NCT01192516|1150450|P3|Overall Study|started new treatment|0
341065|NCT01192516|1150451|P2|Overall Study|started new treatment|1
341066|NCT01192516|1150452|P1|Overall Study|started new treatment|5
341067|NCT01192516|1150450|P3|Overall Study|Withdrawal by Subject|1
341068|NCT01192516|1150451|P2|Overall Study|Withdrawal by Subject|4
341069|NCT01192516|1150452|P1|Overall Study|Withdrawal by Subject|4
341070|NCT01192516|1150450|P3|Overall Study|Lost to Follow-up|7
341071|NCT01192516|1150451|P2|Overall Study|Lost to Follow-up|10
341072|NCT01192516|1150452|P1|Overall Study|Lost to Follow-up|7
341073|NCT01192412|1150486|P2|Overall Study|Withdrawal by Subject|1
341074|NCT01192412|1150487|P1|Overall Study|Withdrawal by Subject|2
341075|NCT01192412|1150486|P2|Overall Study|Lost to Follow-up|1
341076|NCT01192412|1150487|P1|Overall Study|Lost to Follow-up|2
341077|NCT01192399|1150495|P1|Overall Study|Lack of Efficacy|2
341078|NCT01192347|1150505|P1|Overall Study|Patient did not show up for visits|1
341079|NCT01192347|1150505|P1|Overall Study|Patient not visiting hospital regularly|1
341080|NCT01192347|1150505|P1|Overall Study|Patient seen in different hospital|1
341081|NCT01192347|1150505|P1|Overall Study|Suspected serious adverse drug reaction|1
341082|NCT01192347|1150505|P1|Overall Study|Adverse Event|1
341083|NCT01192347|1150505|P1|Overall Study|Withdrawal by Subject|1
341084|NCT01192347|1150505|P1|Overall Study|Lost to Follow-up|3
341085|NCT01192347|1150505|P1|Overall Study|Death|3
341086|NCT01192295|1150528|P2|Overall Study|Administrative|6
341087|NCT01192295|1150529|P1|Overall Study|Administrative|4
341088|NCT01192295|1150528|P2|Overall Study|Lack of Efficacy|5
341089|NCT01192295|1150529|P1|Overall Study|Lack of Efficacy|0
341090|NCT01192295|1150528|P2|Overall Study|Lost to Follow-up|1
341091|NCT01192295|1150529|P1|Overall Study|Lost to Follow-up|0
341092|NCT01192295|1150528|P2|Overall Study|Withdrawal by Subject|4
341093|NCT01192295|1150529|P1|Overall Study|Withdrawal by Subject|3
341094|NCT01192295|1150528|P2|Overall Study|Adverse Event|7
341095|NCT01192295|1150529|P1|Overall Study|Adverse Event|3
341096|NCT01192204|1150563|P2|Overall Study|could not keep recall appointments|0
341097|NCT01192204|1150564|P1|Overall Study|could not keep recall appointments|1
341098|NCT01192191|1150576|P2|Overall Study|Withdrawal by Subject|6
341099|NCT01192191|1150577|P1|Overall Study|Withdrawal by Subject|1
341100|NCT01192191|1150576|P2|Overall Study|Lost to Follow-up|1
341101|NCT01192191|1150577|P1|Overall Study|Lost to Follow-up|0
341102|NCT01192191|1150576|P2|Overall Study|Participants Reached Stopping Criteria|2
341103|NCT01192191|1150577|P1|Overall Study|Participants Reached Stopping Criteria|3
341104|NCT01192191|1150576|P2|Overall Study|Adverse Event|12
341105|NCT01192191|1150577|P1|Overall Study|Adverse Event|7
341106|NCT01192178|1150603|P2|Overall Study|Lack of Efficacy|2
341107|NCT01192178|1150604|P1|Overall Study|Lack of Efficacy|1
341108|NCT01192178|1150603|P2|Overall Study|Adverse Event|1
341109|NCT01192178|1150604|P1|Overall Study|Adverse Event|2
341110|NCT01192178|1150603|P2|Overall Study|Lost to Follow-up|3
341111|NCT01192178|1150604|P1|Overall Study|Lost to Follow-up|3
341112|NCT01192178|1150603|P2|Overall Study|Physician Decision|4
341113|NCT01192178|1150604|P1|Overall Study|Physician Decision|2
341114|NCT01192178|1150603|P2|Overall Study|Protocol Violation|3
341115|NCT01192178|1150604|P1|Overall Study|Protocol Violation|10
341116|NCT01192178|1150603|P2|Overall Study|Withdrawal by Subject|10
341117|NCT01192178|1150604|P1|Overall Study|Withdrawal by Subject|6
341118|NCT01192152|1150624|P2|Period 3|family emergency|0
341119|NCT01192152|1150625|P1|Period 3|family emergency|1
341120|NCT01192152|1150624|P2|Period 1|left prematurely (while on treatment B)|1
341121|NCT01192152|1150625|P1|Period 1|left prematurely (while on treatment B)|0
341122|NCT01192126|1150796|P2|First Intervention (1 Week)|Lost to Follow-up|1
341123|NCT01192126|1150797|P1|First Intervention (1 Week)|Lost to Follow-up|1
341124|NCT01192126|1150796|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
341125|NCT01192126|1150797|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
341126|NCT01192022|1150809|P5|Overall Study|Parents did not allow all follow up|0
341127|NCT01192022|1150810|P4|Overall Study|Parents did not allow all follow up|1
341128|NCT01192022|1150811|P3|Overall Study|Parents did not allow all follow up|0
341129|NCT01192022|1150812|P2|Overall Study|Parents did not allow all follow up|0
341130|NCT01192022|1150813|P1|Overall Study|Parents did not allow all follow up|0
341131|NCT01192022|1150809|P5|Overall Study|Patient needed surgery|0
341132|NCT01192022|1150810|P4|Overall Study|Patient needed surgery|0
341133|NCT01192022|1150811|P3|Overall Study|Patient needed surgery|0
341134|NCT01192022|1150812|P2|Overall Study|Patient needed surgery|1
341135|NCT01192022|1150813|P1|Overall Study|Patient needed surgery|0
341136|NCT01192022|1150809|P5|Overall Study|Patient too sick from chemotherapy|0
341137|NCT01192022|1150810|P4|Overall Study|Patient too sick from chemotherapy|0
341138|NCT01192022|1150811|P3|Overall Study|Patient too sick from chemotherapy|0
341139|NCT01192022|1150812|P2|Overall Study|Patient too sick from chemotherapy|1
341140|NCT01192022|1150813|P1|Overall Study|Patient too sick from chemotherapy|0
341141|NCT01192022|1150809|P5|Overall Study|Physician withdrew-patient hardship|0
341142|NCT01192022|1150810|P4|Overall Study|Physician withdrew-patient hardship|0
341143|NCT01192022|1150811|P3|Overall Study|Physician withdrew-patient hardship|0
341144|NCT01192022|1150812|P2|Overall Study|Physician withdrew-patient hardship|0
341145|NCT01192022|1150813|P1|Overall Study|Physician withdrew-patient hardship|1
341146|NCT01192022|1150809|P5|Overall Study|Fatal Adverse Event|1
341147|NCT01192022|1150810|P4|Overall Study|Fatal Adverse Event|0
341148|NCT01192022|1150811|P3|Overall Study|Fatal Adverse Event|0
341149|NCT01192022|1150812|P2|Overall Study|Fatal Adverse Event|6
341150|NCT01192022|1150813|P1|Overall Study|Fatal Adverse Event|4
341151|NCT01192022|1150809|P5|Overall Study|Adverse Event|0
341152|NCT01192022|1150810|P4|Overall Study|Adverse Event|0
341153|NCT01192022|1150811|P3|Overall Study|Adverse Event|0
341154|NCT01192022|1150812|P2|Overall Study|Adverse Event|0
341155|NCT01192022|1150813|P1|Overall Study|Adverse Event|1
341156|NCT01192022|1150809|P5|Overall Study|Lost to Follow-up|0
341157|NCT01192022|1150810|P4|Overall Study|Lost to Follow-up|1
341158|NCT01192022|1150811|P3|Overall Study|Lost to Follow-up|1
341159|NCT01192022|1150812|P2|Overall Study|Lost to Follow-up|2
341160|NCT01192022|1150813|P1|Overall Study|Lost to Follow-up|4
341161|NCT01192022|1150809|P5|Overall Study|Withdrawal of Consent|0
341162|NCT01192022|1150810|P4|Overall Study|Withdrawal of Consent|0
341163|NCT01192022|1150811|P3|Overall Study|Withdrawal of Consent|0
341164|NCT01192022|1150812|P2|Overall Study|Withdrawal of Consent|1
341165|NCT01192022|1150813|P1|Overall Study|Withdrawal of Consent|3
341166|NCT01191944|1150836|P2|Overall Study|Other|3
341167|NCT01191944|1150837|P1|Overall Study|Other|1
341168|NCT01191944|1150836|P2|Overall Study|Withdrawal by Subject|2
341169|NCT01191944|1150837|P1|Overall Study|Withdrawal by Subject|4
341170|NCT01191944|1150836|P2|Overall Study|Protocol Violation|2
341171|NCT01191944|1150837|P1|Overall Study|Protocol Violation|1
341172|NCT01191944|1150836|P2|Overall Study|Adverse Event|12
341173|NCT01191944|1150837|P1|Overall Study|Adverse Event|11
341174|NCT01191840|1150883|P2|Overall Study|Withdrawal by Subject|0
341175|NCT01191840|1150884|P1|Overall Study|Withdrawal by Subject|2
341176|NCT01191840|1150883|P2|Overall Study|lab error speciation - non Staph infecti|1
341177|NCT01191840|1150884|P1|Overall Study|lab error speciation - non Staph infecti|0
341178|NCT01191840|1150883|P2|Overall Study|IRB approval lapse|2
341179|NCT01191840|1150884|P1|Overall Study|IRB approval lapse|0
341180|NCT01191840|1150883|P2|Overall Study|ineligible at enrollment|0
341181|NCT01191840|1150884|P1|Overall Study|ineligible at enrollment|1
341182|NCT01191840|1150883|P2|Overall Study|Non Staph Infection|3
341183|NCT01191840|1150884|P1|Overall Study|Non Staph Infection|4
341184|NCT01191840|1150883|P2|Overall Study|Lost to Follow-up|6
341185|NCT01191840|1150884|P1|Overall Study|Lost to Follow-up|4
341186|NCT01191840|1150883|P2|Overall Study|Subject discontinued treatment|2
341187|NCT01191840|1150884|P1|Overall Study|Subject discontinued treatment|1
341188|NCT01191840|1150883|P2|Overall Study|withdrew consent|1
341189|NCT01191840|1150884|P1|Overall Study|withdrew consent|2
341190|NCT01191801|1150909|P2|Overall Study|Not Provided|27
341191|NCT01191801|1150910|P1|Overall Study|Not Provided|45
341192|NCT01191801|1150909|P2|Overall Study|Withdrawal by Subject|4
341193|NCT01191801|1150910|P1|Overall Study|Withdrawal by Subject|1
341194|NCT01191801|1150909|P2|Overall Study|Physician Decision|24
341195|NCT01191801|1150910|P1|Overall Study|Physician Decision|47
341196|NCT01191801|1150909|P2|Overall Study|Protocol Violation|4
341197|NCT01191801|1150910|P1|Overall Study|Protocol Violation|2
341198|NCT01191801|1150909|P2|Overall Study|Adverse Event|8
341199|NCT01191801|1150910|P1|Overall Study|Adverse Event|9
341200|NCT01191801|1150909|P2|Overall Study|Lack of Efficacy|258
341201|NCT01191801|1150910|P1|Overall Study|Lack of Efficacy|176
341202|NCT01191801|1150909|P2|Overall Study|Death|12
341203|NCT01191801|1150910|P1|Overall Study|Death|36
341204|NCT01191788|1150930|P2|Overall Study|Lost to Follow-up|22
341205|NCT01191788|1150931|P1|Overall Study|Lost to Follow-up|21
341206|NCT01191762|1150941|P2|Overall Study|Adverse Event|0
341207|NCT01191762|1150942|P1|Overall Study|Adverse Event|1
341208|NCT01191268|1151100|P3|Overall Study|Sponsor Decision|0
341209|NCT01191268|1151101|P2|Overall Study|Sponsor Decision|2
341210|NCT01191268|1151102|P1|Overall Study|Sponsor Decision|0
341211|NCT01191268|1151100|P3|Overall Study|Protocol Violation|1
341212|NCT01191268|1151101|P2|Overall Study|Protocol Violation|0
341213|NCT01191268|1151102|P1|Overall Study|Protocol Violation|1
341214|NCT01191268|1151100|P3|Overall Study|Death|3
341215|NCT01191268|1151101|P2|Overall Study|Death|1
341216|NCT01191268|1151102|P1|Overall Study|Death|0
341217|NCT01191268|1151100|P3|Overall Study|Entry Criteria Not Met|1
341218|NCT01191268|1151101|P2|Overall Study|Entry Criteria Not Met|1
341219|NCT01191268|1151102|P1|Overall Study|Entry Criteria Not Met|3
341220|NCT01191268|1151100|P3|Overall Study|Lost to Follow-up|9
341221|NCT01191268|1151101|P2|Overall Study|Lost to Follow-up|5
341222|NCT01191268|1151102|P1|Overall Study|Lost to Follow-up|8
341223|NCT01191268|1151100|P3|Overall Study|Physician Decision|9
341224|NCT01191268|1151101|P2|Overall Study|Physician Decision|8
341225|NCT01191268|1151102|P1|Overall Study|Physician Decision|6
341226|NCT01191268|1151100|P3|Overall Study|Adverse Event|8
341227|NCT01191268|1151101|P2|Overall Study|Adverse Event|13
341228|NCT01191268|1151102|P1|Overall Study|Adverse Event|21
341229|NCT01191268|1151100|P3|Overall Study|Withdrawal by Subject|21
341230|NCT01191268|1151101|P2|Overall Study|Withdrawal by Subject|25
341231|NCT01191268|1151102|P1|Overall Study|Withdrawal by Subject|19
341232|NCT01191190|1151243|P1|Overall Study|Withdrawal by Subject|1
341233|NCT01191086|1151256|P1|Overall Study|Other|1
341234|NCT01191086|1151256|P1|Overall Study|Discontinuation criterion met|1
341235|NCT01191086|1151256|P1|Overall Study|Withdrawal by Subject|24
341236|NCT01191086|1151256|P1|Overall Study|Physician Decision|2
341237|NCT01191086|1151256|P1|Overall Study|Lost to Follow-up|4
341238|NCT01191086|1151256|P1|Overall Study|Lack of Efficacy|10
341239|NCT01191086|1151256|P1|Overall Study|Adverse Event|20
341240|NCT01191008|1151260|P1|Overall Study|Lost to Follow-up|8
341241|NCT01191008|1151260|P1|Overall Study|Protocol Violation|7
341242|NCT01190891|1151268|P2|Overall Study|Withdrawal by Subject|0
341243|NCT01190891|1151269|P1|Overall Study|Withdrawal by Subject|5
341244|NCT01190891|1151268|P2|Overall Study|Protocol Violation|0
341245|NCT01190891|1151269|P1|Overall Study|Protocol Violation|1
341246|NCT01190865|1151294|P1|Overall Study|Non-compliance|2
341247|NCT01190865|1151294|P1|Overall Study|Withdrawal by Subject|1
341248|NCT01190839|1151301|P2|Overall Study|Randomized but not treated|4
341249|NCT01190839|1151302|P1|Overall Study|Randomized but not treated|2
341250|NCT01190839|1151301|P2|Overall Study|Undefined|31
341251|NCT01190839|1151302|P1|Overall Study|Undefined|35
341252|NCT01190839|1151301|P2|Overall Study|Trial stopped by Sponsor|68
341253|NCT01190839|1151302|P1|Overall Study|Trial stopped by Sponsor|71
341254|NCT01190839|1151301|P2|Overall Study|Death|0
341255|NCT01190839|1151302|P1|Overall Study|Death|1
341256|NCT01190839|1151301|P2|Overall Study|Lost to Follow-up|1
341257|NCT01190839|1151302|P1|Overall Study|Lost to Follow-up|7
341258|NCT01190839|1151301|P2|Overall Study|Protocol Violation|2
341259|NCT01190839|1151302|P1|Overall Study|Protocol Violation|2
341260|NCT01190839|1151301|P2|Overall Study|Adverse Event|41
341261|NCT01190839|1151302|P1|Overall Study|Adverse Event|32
341262|NCT01190813|1151316|P2|Overall Study|Adverse Event|1
341263|NCT01190813|1151317|P1|Overall Study|Adverse Event|0
341264|NCT01190813|1151316|P2|Overall Study|Refused study treatment after randomized|0
341265|NCT01190813|1151317|P1|Overall Study|Refused study treatment after randomized|1
341266|NCT01190813|1151316|P2|Overall Study|Withdrawal by Subject|1
341267|NCT01190813|1151317|P1|Overall Study|Withdrawal by Subject|2
341268|NCT01190813|1151316|P2|Overall Study|Lost to Follow-up|2
341269|NCT01190813|1151317|P1|Overall Study|Lost to Follow-up|1
341270|NCT01190514|1151438|P4|Third Intervention (Period 3)|Adverse Event|0
341271|NCT01190514|1151439|P3|Third Intervention (Period 3)|Adverse Event|0
341272|NCT01190514|1151440|P2|Third Intervention (Period 3)|Adverse Event|0
341273|NCT01190514|1151441|P1|Third Intervention (Period 3)|Adverse Event|1
341274|NCT01190514|1151438|P4|First Intervention (Period 1)|Adverse Event|0
341275|NCT01190514|1151439|P3|First Intervention (Period 1)|Adverse Event|0
341276|NCT01190514|1151440|P2|First Intervention (Period 1)|Adverse Event|0
341277|NCT01190514|1151441|P1|First Intervention (Period 1)|Adverse Event|1
341278|NCT01190436|1151484|P1|Overall Study|Other|4
341279|NCT01190436|1151484|P1|Overall Study|Lost to Follow-up|35
341280|NCT01190267|1151509|P2|Overall Study|Protocol Violation|1
341281|NCT01190267|1151510|P1|Overall Study|Protocol Violation|8
341282|NCT01190267|1151509|P2|Overall Study|Withdrawal by Subject|1
341283|NCT01190267|1151510|P1|Overall Study|Withdrawal by Subject|13
341284|NCT01190267|1151509|P2|Overall Study|Lost to Follow-up|0
341285|NCT01190267|1151510|P1|Overall Study|Lost to Follow-up|2
341286|NCT01190267|1151509|P2|Overall Study|Treatment Failure|2
341287|NCT01190267|1151510|P1|Overall Study|Treatment Failure|8
341288|NCT01190267|1151509|P2|Overall Study|Adverse Event|0
341289|NCT01190267|1151510|P1|Overall Study|Adverse Event|10
341290|NCT01190254|1151521|P3|Overall Study|Did not meet protocol eligibility|0
341291|NCT01190254|1151522|P2|Overall Study|Did not meet protocol eligibility|0
341292|NCT01190254|1151523|P1|Overall Study|Did not meet protocol eligibility|1
341293|NCT01190254|1151521|P3|Overall Study|Protocol Violation|2
341294|NCT01190254|1151522|P2|Overall Study|Protocol Violation|0
341295|NCT01190254|1151523|P1|Overall Study|Protocol Violation|2
341296|NCT01190254|1151521|P3|Overall Study|Withdrawal by Subject|7
341297|NCT01190254|1151522|P2|Overall Study|Withdrawal by Subject|5
341298|NCT01190254|1151523|P1|Overall Study|Withdrawal by Subject|4
341299|NCT01190254|1151521|P3|Overall Study|Lost to Follow-up|0
341300|NCT01190254|1151522|P2|Overall Study|Lost to Follow-up|2
341301|NCT01190254|1151523|P1|Overall Study|Lost to Follow-up|4
341302|NCT01190254|1151521|P3|Overall Study|Lack of Efficacy|5
341303|NCT01190254|1151522|P2|Overall Study|Lack of Efficacy|4
341304|NCT01190254|1151523|P1|Overall Study|Lack of Efficacy|7
341305|NCT01190254|1151521|P3|Overall Study|Adverse Event|8
341306|NCT01190254|1151522|P2|Overall Study|Adverse Event|6
341307|NCT01190254|1151523|P1|Overall Study|Adverse Event|3
341308|NCT01190228|1151588|P3|Overall Study|Withdrawal by Subject|0
341309|NCT01190228|1151589|P2|Overall Study|Withdrawal by Subject|0
341310|NCT01190228|1151590|P1|Overall Study|Withdrawal by Subject|1
341311|NCT01190228|1151588|P3|Overall Study|Protocol Violation|0
341312|NCT01190228|1151589|P2|Overall Study|Protocol Violation|0
341313|NCT01190228|1151590|P1|Overall Study|Protocol Violation|4
341314|NCT01190215|1151613|P2|Up to Month 6|Lost to Follow-up|0
341315|NCT01190215|1151614|P1|Up to Month 6|Lost to Follow-up|2
341316|NCT01190150|1151684|P2|Washout|Difficulty in adherence|1
341317|NCT01190150|1151685|P1|Washout|Difficulty in adherence|0
341318|NCT01190150|1151684|P2|Washout|Withdrawal by Subject|1
341319|NCT01190150|1151685|P1|Washout|Withdrawal by Subject|0
341320|NCT01190150|1151684|P2|First Treatment|Withdrawal by Subject|0
341321|NCT01190150|1151685|P1|First Treatment|Withdrawal by Subject|1
341322|NCT01190124|1151712|P3|Overall Study|Lost to Follow-up|0
341323|NCT01190124|1151713|P2|Overall Study|Lost to Follow-up|0
341324|NCT01190124|1151714|P1|Overall Study|Lost to Follow-up|2
341325|NCT01190124|1151712|P3|Overall Study|Therapeutic Failure|1
341326|NCT01190124|1151713|P2|Overall Study|Therapeutic Failure|0
341327|NCT01190124|1151714|P1|Overall Study|Therapeutic Failure|12
341328|NCT01190124|1151712|P3|Overall Study|Death|0
341329|NCT01190124|1151713|P2|Overall Study|Death|0
341330|NCT01190124|1151714|P1|Overall Study|Death|3
341331|NCT01190098|1151752|P2|Overall Study|Other|1
341332|NCT01190098|1151753|P1|Overall Study|Other|0
341333|NCT01190098|1151752|P2|Overall Study|Lack of transportation|0
341334|NCT01190098|1151753|P1|Overall Study|Lack of transportation|1
341335|NCT01190098|1151752|P2|Overall Study|Patient coomorbidity|1
341336|NCT01190098|1151753|P1|Overall Study|Patient coomorbidity|0
341337|NCT01190098|1151752|P2|Overall Study|Adverse Event|0
341338|NCT01190098|1151753|P1|Overall Study|Adverse Event|2
341339|NCT01190007|1151792|P1|Overall Study|Participant was arrested|1
341340|NCT01190007|1151792|P1|Overall Study|Difficulty of visit for complications|1
341341|NCT01190007|1151792|P1|Overall Study|Adverse Event|8
341342|NCT01190007|1151792|P1|Overall Study|Withdrawal by Subject|4
341343|NCT01189890|1151809|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
341344|NCT01189890|1151810|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
341345|NCT01189890|1151809|P2|Overall Study|Physician Decision|4
341346|NCT01189890|1151810|P1|Overall Study|Physician Decision|5
341347|NCT01189890|1151809|P2|Overall Study|Non Compliance|1
341348|NCT01189890|1151810|P1|Overall Study|Non Compliance|0
341349|NCT01189890|1151809|P2|Overall Study|Withdrawal by Subject|11
341350|NCT01189890|1151810|P1|Overall Study|Withdrawal by Subject|15
341351|NCT01189890|1151809|P2|Overall Study|Protocol Violation|5
341352|NCT01189890|1151810|P1|Overall Study|Protocol Violation|1
341353|NCT01189890|1151809|P2|Overall Study|Lost to Follow-up|7
341354|NCT01189890|1151810|P1|Overall Study|Lost to Follow-up|1
341355|NCT01189890|1151809|P2|Overall Study|Lack of Efficacy|2
341356|NCT01189890|1151810|P1|Overall Study|Lack of Efficacy|7
341357|NCT01189890|1151809|P2|Overall Study|Adverse Event|4
341358|NCT01189890|1151810|P1|Overall Study|Adverse Event|3
341359|NCT01189812|1151832|P2|Overall Study|Moved out of State|2
341360|NCT01189812|1151833|P1|Overall Study|Moved out of State|1
341361|NCT01189812|1151832|P2|Overall Study|Out of Window|3
341362|NCT01189812|1151833|P1|Overall Study|Out of Window|4
341363|NCT01189812|1151832|P2|Overall Study|Adverse Event|0
341364|NCT01189812|1151833|P1|Overall Study|Adverse Event|1
341365|NCT01189812|1151832|P2|Overall Study|Withdrawal by Subject|3
341366|NCT01189812|1151833|P1|Overall Study|Withdrawal by Subject|2
341367|NCT01189604|1151917|P7|Overall Study|Withdrawal by Subject|0
341368|NCT01189604|1151918|P6|Overall Study|Withdrawal by Subject|0
341369|NCT01189604|1151919|P5|Overall Study|Withdrawal by Subject|0
341370|NCT01189604|1151920|P4|Overall Study|Withdrawal by Subject|0
341371|NCT01189604|1151921|P3|Overall Study|Withdrawal by Subject|0
341372|NCT01189604|1151922|P2|Overall Study|Withdrawal by Subject|0
341373|NCT01189604|1151923|P1|Overall Study|Withdrawal by Subject|1
341374|NCT01189604|1151917|P7|Overall Study|Adverse Event|1
341375|NCT01189604|1151918|P6|Overall Study|Adverse Event|0
341376|NCT01189604|1151919|P5|Overall Study|Adverse Event|2
341377|NCT01189604|1151920|P4|Overall Study|Adverse Event|0
341378|NCT01189604|1151921|P3|Overall Study|Adverse Event|0
341379|NCT01189604|1151922|P2|Overall Study|Adverse Event|1
341380|NCT01189604|1151923|P1|Overall Study|Adverse Event|0
341381|NCT01189604|1151917|P7|Overall Study|Impossible to visit|0
341382|NCT01189604|1151918|P6|Overall Study|Impossible to visit|1
341383|NCT01189604|1151919|P5|Overall Study|Impossible to visit|0
341384|NCT01189604|1151920|P4|Overall Study|Impossible to visit|0
341385|NCT01189604|1151921|P3|Overall Study|Impossible to visit|0
341386|NCT01189604|1151922|P2|Overall Study|Impossible to visit|0
341387|NCT01189604|1151923|P1|Overall Study|Impossible to visit|0
341388|NCT01189500|1151967|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
341389|NCT01189500|1151967|P1|Period 1: TAMOX Alone|Adverse Event|1
341390|NCT01189487|1152028|P1|Overall Study|Adverse Event|1
341391|NCT01189487|1152028|P1|Overall Study|Lack of Efficacy|2
341392|NCT01189461|1152036|P1|Overall Study|Other|8
341393|NCT01189461|1152036|P1|Overall Study|Did not meet entrance criteria|3
341394|NCT01189461|1152036|P1|Overall Study|Adverse Event|2
341395|NCT01189461|1152036|P1|Overall Study|Protocol Violation|1
341396|NCT01189461|1152036|P1|Overall Study|Withdrawal by Subject|6
341397|NCT01189461|1152036|P1|Overall Study|Lost to Follow-up|1
341398|NCT01189461|1152036|P1|Overall Study|Lack of Efficacy|13
341399|NCT01189435|1152043|P1|Overall Study|Physician Decision|1
341400|NCT01189435|1152043|P1|Overall Study|Withdrawal by Subject|1
341401|NCT01189227|1152125|P2|Overall Study|Study terminated due to low accrual|3
341402|NCT01189227|1152126|P1|Overall Study|Study terminated due to low accrual|6
341403|NCT01189201|1152132|P1|Overall Study|Adverse Event|1
341404|NCT01189032|1152235|P3|Overall Study|Protocol Violation|1
341405|NCT01189032|1152236|P2|Overall Study|Protocol Violation|1
341406|NCT01189032|1152237|P1|Overall Study|Protocol Violation|1
341407|NCT01189032|1152235|P3|Overall Study|Withdrawal by Subject|1
341408|NCT01189032|1152236|P2|Overall Study|Withdrawal by Subject|0
341409|NCT01189032|1152237|P1|Overall Study|Withdrawal by Subject|1
341410|NCT01189032|1152235|P3|Overall Study|Lack of Efficacy|0
341411|NCT01189032|1152236|P2|Overall Study|Lack of Efficacy|3
341412|NCT01189032|1152237|P1|Overall Study|Lack of Efficacy|2
341413|NCT01189032|1152235|P3|Overall Study|Adverse Event|4
341414|NCT01189032|1152236|P2|Overall Study|Adverse Event|3
341415|NCT01189032|1152237|P1|Overall Study|Adverse Event|1
341416|NCT01188967|1152247|P2|Overall Study|Lost to Follow-up|2
341417|NCT01188967|1152248|P1|Overall Study|Lost to Follow-up|3
341418|NCT01188967|1152247|P2|Overall Study|Physician Decision|1
341419|NCT01188967|1152248|P1|Overall Study|Physician Decision|1
341420|NCT01188967|1152247|P2|Overall Study|Withdrawal by Subject|1
341421|NCT01188967|1152248|P1|Overall Study|Withdrawal by Subject|1
341422|NCT01188811|1152301|P2|Overall Study|Adverse Event|0
341423|NCT01188811|1152302|P1|Overall Study|Adverse Event|6
341424|NCT01188811|1152301|P2|Overall Study|Withdrawal by Subject|2
341425|NCT01188811|1152302|P1|Overall Study|Withdrawal by Subject|0
341426|NCT01188798|1152314|P2|Overall Study|Protocol closure|1
341427|NCT01188798|1152315|P1|Overall Study|Protocol closure|1
341428|NCT01188798|1152314|P2|Overall Study|Required additional transplant|1
341429|NCT01188798|1152315|P1|Overall Study|Required additional transplant|1
341430|NCT01188798|1152314|P2|Overall Study|Death|1
341431|NCT01188798|1152315|P1|Overall Study|Death|0
341432|NCT01188772|1152327|P4|Overall Study|Withdrawal by Subject|0
341433|NCT01188772|1152328|P3|Overall Study|Withdrawal by Subject|2
341434|NCT01188772|1152329|P2|Overall Study|Withdrawal by Subject|0
341435|NCT01188772|1152330|P1|Overall Study|Withdrawal by Subject|0
341436|NCT01188772|1152327|P4|Overall Study|Virologic Failure|0
341437|NCT01188772|1152328|P3|Overall Study|Virologic Failure|0
341438|NCT01188772|1152329|P2|Overall Study|Virologic Failure|0
341439|NCT01188772|1152330|P1|Overall Study|Virologic Failure|1
341440|NCT01188772|1152327|P4|Overall Study|Treatment Failure|0
341441|NCT01188772|1152328|P3|Overall Study|Treatment Failure|1
341442|NCT01188772|1152329|P2|Overall Study|Treatment Failure|0
341443|NCT01188772|1152330|P1|Overall Study|Treatment Failure|0
341444|NCT01188772|1152327|P4|Overall Study|Terminated by Sponsor|0
341445|NCT01188772|1152328|P3|Overall Study|Terminated by Sponsor|1
341446|NCT01188772|1152329|P2|Overall Study|Terminated by Sponsor|0
341447|NCT01188772|1152330|P1|Overall Study|Terminated by Sponsor|0
341448|NCT01188772|1152327|P4|Overall Study|Physician Decision|0
341449|NCT01188772|1152328|P3|Overall Study|Physician Decision|1
341450|NCT01188772|1152329|P2|Overall Study|Physician Decision|0
341451|NCT01188772|1152330|P1|Overall Study|Physician Decision|0
341452|NCT01188772|1152327|P4|Overall Study|Non-responder|0
341453|NCT01188772|1152328|P3|Overall Study|Non-responder|3
341454|NCT01188772|1152329|P2|Overall Study|Non-responder|0
341455|NCT01188772|1152330|P1|Overall Study|Non-responder|0
341456|NCT01188772|1152327|P4|Overall Study|Lost to Follow-up|1
341457|NCT01188772|1152328|P3|Overall Study|Lost to Follow-up|1
341458|NCT01188772|1152329|P2|Overall Study|Lost to Follow-up|1
341459|NCT01188772|1152330|P1|Overall Study|Lost to Follow-up|4
341460|NCT01188772|1152327|P4|Overall Study|Adverse Event|0
341461|NCT01188772|1152328|P3|Overall Study|Adverse Event|2
341462|NCT01188772|1152329|P2|Overall Study|Adverse Event|1
341463|NCT01188772|1152330|P1|Overall Study|Adverse Event|0
341464|NCT01188772|1152327|P4|Overall Study|Randomized but Not Treated|0
341465|NCT01188772|1152328|P3|Overall Study|Randomized but Not Treated|0
341466|NCT01188772|1152329|P2|Overall Study|Randomized but Not Treated|1
341467|NCT01188772|1152330|P1|Overall Study|Randomized but Not Treated|0
341468|NCT01188681|1152402|P4|Overall Study|Withdrawal by Subject|1
341469|NCT01188681|1152403|P3|Overall Study|Withdrawal by Subject|0
341470|NCT01188681|1152404|P2|Overall Study|Withdrawal by Subject|0
341471|NCT01188681|1152405|P1|Overall Study|Withdrawal by Subject|0
341472|NCT01188681|1152402|P4|Overall Study|bladder cancer|0
341473|NCT01188681|1152403|P3|Overall Study|bladder cancer|1
341474|NCT01188681|1152404|P2|Overall Study|bladder cancer|0
341475|NCT01188681|1152405|P1|Overall Study|bladder cancer|0
341476|NCT01188668|1152419|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
341477|NCT01188668|1152419|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
341478|NCT01188668|1152419|P1|Period 1: ARIP Alone|Protocol Violation|2
341479|NCT01188655|1152452|P1|Overall Study|Other|11
341480|NCT01188655|1152452|P1|Overall Study|Lost to Follow-up|1
341481|NCT01188655|1152452|P1|Overall Study|Lack of Efficacy|1
341482|NCT01188564|1152496|P2|Double-blind Phase|randomized not treated|0
341483|NCT01188564|1152497|P1|Double-blind Phase|randomized not treated|1
341484|NCT01188551|1152509|P4|Overall Study|Pharmacy issues|0
341485|NCT01188551|1152510|P3|Overall Study|Pharmacy issues|0
341486|NCT01188551|1152511|P2|Overall Study|Pharmacy issues|0
341487|NCT01188551|1152512|P1|Overall Study|Pharmacy issues|1
341488|NCT01188538|1152528|P2|Overall Study|Lost to Follow-up|1
341489|NCT01188538|1152529|P1|Overall Study|Lost to Follow-up|0
341490|NCT01188343|1152616|P3|Overall Study|Withdrawal by Subject|0
341491|NCT01188343|1152617|P2|Overall Study|Withdrawal by Subject|24
341492|NCT01188343|1152618|P1|Overall Study|Withdrawal by Subject|1
341493|NCT01188343|1152616|P3|Overall Study|Not vaccinated|1
341494|NCT01188343|1152617|P2|Overall Study|Not vaccinated|2
341495|NCT01188343|1152618|P1|Overall Study|Not vaccinated|0
341496|NCT01188226|1152644|P1|Overall Study|Withdrawal by Subject|4
341497|NCT01187953|1152690|P2|Overall Study|Withdrawal by Subject|3
341498|NCT01187953|1152691|P1|Overall Study|Withdrawal by Subject|3
341499|NCT01187953|1152690|P2|Overall Study|Lost to Follow-up|3
341500|NCT01187953|1152691|P1|Overall Study|Lost to Follow-up|0
341501|NCT01187953|1152690|P2|Overall Study|Adverse Event|2
341502|NCT01187953|1152691|P1|Overall Study|Adverse Event|1
341503|NCT01187953|1152690|P2|Overall Study|Death|13
341504|NCT01187953|1152691|P1|Overall Study|Death|11
341505|NCT01187901|1152705|P2|Overall Study|Pregnancy|2
341506|NCT01187901|1152706|P1|Overall Study|Pregnancy|0
341507|NCT01187901|1152705|P2|Overall Study|No Endpoint due to Early Study Halt|3
341508|NCT01187901|1152706|P1|Overall Study|No Endpoint due to Early Study Halt|2
341509|NCT01187901|1152705|P2|Overall Study|Adverse Event|0
341510|NCT01187901|1152706|P1|Overall Study|Adverse Event|3
341511|NCT01187901|1152705|P2|Overall Study|Suspected Allergic Reaction|1
341512|NCT01187901|1152706|P1|Overall Study|Suspected Allergic Reaction|1
341513|NCT01187901|1152705|P2|Overall Study|Unrelated Health Reasons|2
341514|NCT01187901|1152706|P1|Overall Study|Unrelated Health Reasons|1
341515|NCT01187901|1152705|P2|Overall Study|Lost to Follow-up|2
341516|NCT01187901|1152706|P1|Overall Study|Lost to Follow-up|1
341517|NCT01187901|1152705|P2|Overall Study|Protocol Violation|0
341518|NCT01187901|1152706|P1|Overall Study|Protocol Violation|1
341519|NCT01187550|1152747|P2|Overall Study|Randomized but not treated|0
341520|NCT01187550|1152748|P1|Overall Study|Randomized but not treated|8
341521|NCT01187550|1152747|P2|Overall Study|Other|0
341522|NCT01187550|1152748|P1|Overall Study|Other|3
341523|NCT01187550|1152747|P2|Overall Study|Protocol Violation|1
341524|NCT01187550|1152748|P1|Overall Study|Protocol Violation|3
341525|NCT01187446|1152904|P2|Overall Study|Patient started non-protocol therapy|1
341526|NCT01187446|1152905|P1|Overall Study|Patient started non-protocol therapy|0
341527|NCT01187433|1152921|P2|Overall Study|Withdrawal by Subject|2
341528|NCT01187433|1152922|P1|Overall Study|Withdrawal by Subject|5
341529|NCT01187433|1152921|P2|Overall Study|Protocol Violation|2
341530|NCT01187433|1152922|P1|Overall Study|Protocol Violation|6
341531|NCT01187407|1152952|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
341532|NCT01187407|1152953|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
341533|NCT01187407|1152954|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
341534|NCT01187407|1152955|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
341535|NCT01187407|1152956|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
341536|NCT01187407|1152952|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
341537|NCT01187407|1152953|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
341538|NCT01187407|1152954|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
341539|NCT01187407|1152955|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
341540|NCT01187407|1152956|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
341541|NCT01187407|1152952|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
341542|NCT01187407|1152953|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
341543|NCT01187407|1152954|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
341544|NCT01187407|1152955|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
341545|NCT01187407|1152956|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
341546|NCT01187407|1152952|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
341547|NCT01187407|1152953|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
341548|NCT01187407|1152954|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
341549|NCT01187407|1152955|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
341550|NCT01187407|1152956|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
341551|NCT01187407|1152952|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
341552|NCT01187407|1152953|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
341553|NCT01187407|1152954|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
341554|NCT01187407|1152955|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
341555|NCT01187407|1152956|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
341556|NCT01187407|1152952|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
341557|NCT01187407|1152953|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
341558|NCT01187407|1152954|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
341559|NCT01187407|1152955|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
341560|NCT01187407|1152956|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
341561|NCT01187407|1152952|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
341562|NCT01187407|1152953|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
341563|NCT01187407|1152954|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
341564|NCT01187407|1152955|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
341565|NCT01187407|1152956|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
341566|NCT01187407|1152952|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
341567|NCT01187407|1152953|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
341568|NCT01187407|1152954|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
341569|NCT01187407|1152955|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
341570|NCT01187407|1152956|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
341571|NCT01187407|1152952|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
341572|NCT01187407|1152953|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
341573|NCT01187407|1152954|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
341574|NCT01187407|1152955|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
341575|NCT01187407|1152956|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
341576|NCT01187407|1152952|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
341577|NCT01187407|1152953|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
341578|NCT01187407|1152954|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
341579|NCT01187407|1152955|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
341580|NCT01187407|1152956|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
341581|NCT01187407|1152952|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
341582|NCT01187407|1152953|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
341583|NCT01187407|1152954|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
341584|NCT01187407|1152955|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
341585|NCT01187407|1152956|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
341586|NCT01187407|1152952|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
341587|NCT01187407|1152953|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
341588|NCT01187407|1152954|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
341589|NCT01187407|1152955|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
341590|NCT01187407|1152956|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
341591|NCT01187407|1152952|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
341592|NCT01187407|1152953|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
341593|NCT01187407|1152954|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
341594|NCT01187407|1152955|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
341595|NCT01187407|1152956|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
341596|NCT01187407|1152952|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
341597|NCT01187407|1152953|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
341598|NCT01187407|1152954|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
341599|NCT01187407|1152955|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
341600|NCT01187407|1152956|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
341601|NCT01187043|1153054|P5|Overall Study|Unable to make scheduled visits|1
341602|NCT01187043|1153055|P4|Overall Study|Unable to make scheduled visits|0
341603|NCT01187043|1153056|P3|Overall Study|Unable to make scheduled visits|4
341604|NCT01187043|1153057|P2|Overall Study|Unable to make scheduled visits|0
341605|NCT01187043|1153058|P1|Overall Study|Unable to make scheduled visits|1
341606|NCT01187043|1153054|P5|Overall Study|Adverse Event|1
341607|NCT01187043|1153055|P4|Overall Study|Adverse Event|0
341608|NCT01187043|1153056|P3|Overall Study|Adverse Event|0
341609|NCT01187043|1153057|P2|Overall Study|Adverse Event|0
341610|NCT01187043|1153058|P1|Overall Study|Adverse Event|0
341611|NCT01186939|1153084|P1|Overall Study|Transformation to AML|1
341612|NCT01186939|1153084|P1|Overall Study|Bone marrow transplant|1
341613|NCT01186939|1153084|P1|Overall Study|Myocardial infarction|1
341614|NCT01186939|1153084|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
341615|NCT01186939|1153084|P1|Overall Study|Started additional treatment|1
341616|NCT01186939|1153084|P1|Overall Study|Sponsor decision|4
341617|NCT01186939|1153084|P1|Overall Study|Program closed|5
341618|NCT01186939|1153084|P1|Overall Study|No longer receiving clinical benefit|17
341619|NCT01186939|1153084|P1|Overall Study|Withdrawal by Subject|2
341620|NCT01186939|1153084|P1|Overall Study|Death|7
341621|NCT01186848|1153088|P1|Overall Study|Adverse Event|2
341622|NCT01186848|1153088|P1|Overall Study|Withdrawal by Subject|2
341623|NCT01186848|1153088|P1|Overall Study|Lost to Follow-up|4
341624|NCT01186796|1153096|P2|Overall Study|Protocol Violation|1
341625|NCT01186796|1153097|P1|Overall Study|Protocol Violation|0
341626|NCT01186796|1153096|P2|Overall Study|Withdrawal by Subject|1
341627|NCT01186796|1153097|P1|Overall Study|Withdrawal by Subject|1
341628|NCT01186796|1153096|P2|Overall Study|Adverse Event|0
341629|NCT01186796|1153097|P1|Overall Study|Adverse Event|3
341630|NCT01186744|1153117|P6|Overall Study|Death|0
341631|NCT01186744|1153118|P5|Overall Study|Death|0
341632|NCT01186744|1153119|P4|Overall Study|Death|0
341633|NCT01186744|1153120|P3|Overall Study|Death|0
341634|NCT01186744|1153121|P2|Overall Study|Death|0
341635|NCT01186744|1153122|P1|Overall Study|Death|1
341636|NCT01186744|1153117|P6|Overall Study|Adverse Event|4
341637|NCT01186744|1153118|P5|Overall Study|Adverse Event|1
341638|NCT01186744|1153119|P4|Overall Study|Adverse Event|0
341639|NCT01186744|1153120|P3|Overall Study|Adverse Event|1
341640|NCT01186744|1153121|P2|Overall Study|Adverse Event|14
341641|NCT01186744|1153122|P1|Overall Study|Adverse Event|10
341642|NCT01186744|1153117|P6|Overall Study|Not specified|5
341643|NCT01186744|1153118|P5|Overall Study|Not specified|1
341644|NCT01186744|1153119|P4|Overall Study|Not specified|2
341645|NCT01186744|1153120|P3|Overall Study|Not specified|1
341646|NCT01186744|1153121|P2|Overall Study|Not specified|10
341647|NCT01186744|1153122|P1|Overall Study|Not specified|9
341648|NCT01186744|1153117|P6|Overall Study|Study terminated by Sponsor|0
341649|NCT01186744|1153118|P5|Overall Study|Study terminated by Sponsor|0
341650|NCT01186744|1153119|P4|Overall Study|Study terminated by Sponsor|0
341651|NCT01186744|1153120|P3|Overall Study|Study terminated by Sponsor|0
341652|NCT01186744|1153121|P2|Overall Study|Study terminated by Sponsor|0
341653|NCT01186744|1153122|P1|Overall Study|Study terminated by Sponsor|1
341654|NCT01186744|1153117|P6|Overall Study|Withdrawal by Subject|6
341655|NCT01186744|1153118|P5|Overall Study|Withdrawal by Subject|0
341656|NCT01186744|1153119|P4|Overall Study|Withdrawal by Subject|5
341657|NCT01186744|1153120|P3|Overall Study|Withdrawal by Subject|2
341658|NCT01186744|1153121|P2|Overall Study|Withdrawal by Subject|10
341659|NCT01186744|1153122|P1|Overall Study|Withdrawal by Subject|14
341660|NCT01186744|1153117|P6|Overall Study|Screen failure|0
341661|NCT01186744|1153118|P5|Overall Study|Screen failure|0
341662|NCT01186744|1153119|P4|Overall Study|Screen failure|1
341663|NCT01186744|1153120|P3|Overall Study|Screen failure|0
341664|NCT01186744|1153121|P2|Overall Study|Screen failure|1
341665|NCT01186744|1153122|P1|Overall Study|Screen failure|1
341666|NCT01186744|1153117|P6|Overall Study|Lost to Follow-up|4
341667|NCT01186744|1153118|P5|Overall Study|Lost to Follow-up|1
341668|NCT01186744|1153119|P4|Overall Study|Lost to Follow-up|1
341669|NCT01186744|1153120|P3|Overall Study|Lost to Follow-up|2
341670|NCT01186744|1153121|P2|Overall Study|Lost to Follow-up|16
341671|NCT01186744|1153122|P1|Overall Study|Lost to Follow-up|15
341672|NCT01186744|1153117|P6|Overall Study|Protocol Violation|2
341673|NCT01186744|1153118|P5|Overall Study|Protocol Violation|1
341674|NCT01186744|1153119|P4|Overall Study|Protocol Violation|1
341675|NCT01186744|1153120|P3|Overall Study|Protocol Violation|0
341676|NCT01186744|1153121|P2|Overall Study|Protocol Violation|2
341677|NCT01186744|1153122|P1|Overall Study|Protocol Violation|1
341678|NCT01186744|1153117|P6|Overall Study|Lack of Efficacy|5
341679|NCT01186744|1153118|P5|Overall Study|Lack of Efficacy|2
341680|NCT01186744|1153119|P4|Overall Study|Lack of Efficacy|2
341681|NCT01186744|1153120|P3|Overall Study|Lack of Efficacy|0
341682|NCT01186744|1153121|P2|Overall Study|Lack of Efficacy|99
341683|NCT01186744|1153122|P1|Overall Study|Lack of Efficacy|156
341684|NCT01186692|1153542|P1|Overall Study|Adverse Event|2
341685|NCT01186692|1153542|P1|Overall Study|Futher testing contraindicated implant|19
341686|NCT01186692|1153542|P1|Overall Study|Not Catheterized|11
341687|NCT01186458|1153569|P1|Overall Study|Adverse Event|1
341688|NCT01186419|1153578|P2|Overall Study|Not specified|1
341689|NCT01186419|1153579|P1|Overall Study|Not specified|1
341690|NCT01186419|1153578|P2|Overall Study|Physician Decision|3
341691|NCT01186419|1153579|P1|Overall Study|Physician Decision|0
341692|NCT01186419|1153578|P2|Overall Study|Adverse Event|2
341693|NCT01186419|1153579|P1|Overall Study|Adverse Event|1
341694|NCT01186419|1153578|P2|Overall Study|Withdrawal by Subject|3
341695|NCT01186419|1153579|P1|Overall Study|Withdrawal by Subject|5
341696|NCT01185964|1153617|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
341697|NCT01185964|1153618|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
341698|NCT01185964|1153619|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
341699|NCT01185964|1153620|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
341700|NCT01185964|1153617|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
341701|NCT01185964|1153618|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
341702|NCT01185964|1153619|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
341703|NCT01185964|1153620|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
341704|NCT01185964|1153617|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
341705|NCT01185964|1153618|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
341706|NCT01185964|1153619|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
341707|NCT01185964|1153620|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
341708|NCT01185964|1153617|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
341709|NCT01185964|1153618|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
341710|NCT01185964|1153619|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
341711|NCT01185964|1153620|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
341712|NCT01185964|1153617|P4|Phase 1b and Phase 2|Adverse Event|0
341713|NCT01185964|1153618|P3|Phase 1b and Phase 2|Adverse Event|2
341714|NCT01185964|1153619|P2|Phase 1b and Phase 2|Adverse Event|0
341715|NCT01185964|1153620|P1|Phase 1b and Phase 2|Adverse Event|1
341716|NCT01185964|1153617|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
341717|NCT01185964|1153618|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
341718|NCT01185964|1153619|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
341719|NCT01185964|1153620|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
341720|NCT01185964|1153617|P4|Phase 1b and Phase 2|Other Therapy Started|0
341721|NCT01185964|1153618|P3|Phase 1b and Phase 2|Other Therapy Started|3
341722|NCT01185964|1153619|P2|Phase 1b and Phase 2|Other Therapy Started|3
341723|NCT01185964|1153620|P1|Phase 1b and Phase 2|Other Therapy Started|0
341724|NCT01185964|1153617|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
341725|NCT01185964|1153618|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
341726|NCT01185964|1153619|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
341727|NCT01185964|1153620|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
341728|NCT01185834|1153646|P1|Overall Study|Early exit - Site error|2
341729|NCT01185834|1153646|P1|Overall Study|Time/Job Conflict|2
341730|NCT01185834|1153646|P1|Overall Study|Biomicroscopy|4
341731|NCT01185834|1153646|P1|Overall Study|Discomfort|4
341732|NCT01185834|1153646|P1|Overall Study|Lost to Follow-up|2
341733|NCT01185821|1153656|P5|Overall Study|Administrative problems|2
341734|NCT01185821|1153657|P4|Overall Study|Administrative problems|1
341735|NCT01185821|1153658|P3|Overall Study|Administrative problems|1
341736|NCT01185821|1153659|P2|Overall Study|Administrative problems|0
341737|NCT01185821|1153660|P1|Overall Study|Administrative problems|0
341738|NCT01185821|1153656|P5|Overall Study|Lost to Follow-up|2
341739|NCT01185821|1153657|P4|Overall Study|Lost to Follow-up|1
341740|NCT01185821|1153658|P3|Overall Study|Lost to Follow-up|2
341741|NCT01185821|1153659|P2|Overall Study|Lost to Follow-up|1
341742|NCT01185821|1153660|P1|Overall Study|Lost to Follow-up|1
341743|NCT01185821|1153656|P5|Overall Study|Withdrawal by Subject|3
341744|NCT01185821|1153657|P4|Overall Study|Withdrawal by Subject|1
341745|NCT01185821|1153658|P3|Overall Study|Withdrawal by Subject|2
341746|NCT01185821|1153659|P2|Overall Study|Withdrawal by Subject|2
341747|NCT01185821|1153660|P1|Overall Study|Withdrawal by Subject|3
341748|NCT01185821|1153656|P5|Overall Study|Lack of Efficacy|9
341749|NCT01185821|1153657|P4|Overall Study|Lack of Efficacy|0
341750|NCT01185821|1153658|P3|Overall Study|Lack of Efficacy|3
341751|NCT01185821|1153659|P2|Overall Study|Lack of Efficacy|0
341752|NCT01185821|1153660|P1|Overall Study|Lack of Efficacy|0
341753|NCT01185821|1153656|P5|Overall Study|Adverse Event|5
341754|NCT01185821|1153657|P4|Overall Study|Adverse Event|2
341755|NCT01185821|1153658|P3|Overall Study|Adverse Event|1
341756|NCT01185821|1153659|P2|Overall Study|Adverse Event|3
341757|NCT01185821|1153660|P1|Overall Study|Adverse Event|2
341758|NCT01185821|1153656|P5|Overall Study|Condition no longer required study drug|1
341759|NCT01185821|1153657|P4|Overall Study|Condition no longer required study drug|0
341760|NCT01185821|1153658|P3|Overall Study|Condition no longer required study drug|0
341761|NCT01185821|1153659|P2|Overall Study|Condition no longer required study drug|0
341762|NCT01185821|1153660|P1|Overall Study|Condition no longer required study drug|0
341763|NCT01185821|1153656|P5|Overall Study|Death|0
341764|NCT01185821|1153657|P4|Overall Study|Death|0
341765|NCT01185821|1153658|P3|Overall Study|Death|0
341766|NCT01185821|1153659|P2|Overall Study|Death|1
341767|NCT01185821|1153660|P1|Overall Study|Death|0
341768|NCT01185821|1153656|P5|Overall Study|Abnormal test procedure result|1
341769|NCT01185821|1153657|P4|Overall Study|Abnormal test procedure result|0
341770|NCT01185821|1153658|P3|Overall Study|Abnormal test procedure result|0
341771|NCT01185821|1153659|P2|Overall Study|Abnormal test procedure result|0
341772|NCT01185821|1153660|P1|Overall Study|Abnormal test procedure result|0
341773|NCT01185821|1153656|P5|Overall Study|Protocol Violation|1
341774|NCT01185821|1153657|P4|Overall Study|Protocol Violation|1
341775|NCT01185821|1153658|P3|Overall Study|Protocol Violation|0
341776|NCT01185821|1153659|P2|Overall Study|Protocol Violation|0
341777|NCT01185821|1153660|P1|Overall Study|Protocol Violation|0
341778|NCT01185821|1153656|P5|Overall Study|Abnormal laboratory value(s)|0
341779|NCT01185821|1153657|P4|Overall Study|Abnormal laboratory value(s)|0
341780|NCT01185821|1153658|P3|Overall Study|Abnormal laboratory value(s)|1
341781|NCT01185821|1153659|P2|Overall Study|Abnormal laboratory value(s)|2
341782|NCT01185821|1153660|P1|Overall Study|Abnormal laboratory value(s)|1
341783|NCT01185782|1153711|P2|Overall Study|Randomized but not treated|4
341784|NCT01185782|1153712|P1|Overall Study|Randomized but not treated|0
341785|NCT01185782|1153711|P2|Overall Study|Other|5
341786|NCT01185782|1153712|P1|Overall Study|Other|2
341787|NCT01185782|1153711|P2|Overall Study|Poor Response to Treatment|1
341788|NCT01185782|1153712|P1|Overall Study|Poor Response to Treatment|3
341789|NCT01185782|1153711|P2|Overall Study|Protocol Violation|0
341790|NCT01185782|1153712|P1|Overall Study|Protocol Violation|1
341791|NCT01185782|1153711|P2|Overall Study|Adverse Event|1
341792|NCT01185782|1153712|P1|Overall Study|Adverse Event|0
341793|NCT01185704|1153740|P2|Overall Study|Ectopic pregnancy|1
341794|NCT01185704|1153741|P1|Overall Study|Ectopic pregnancy|0
341795|NCT01185704|1153740|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
341796|NCT01185704|1153741|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
341797|NCT01185704|1153740|P2|Overall Study|Lack of ovarian response|1
341798|NCT01185704|1153741|P1|Overall Study|Lack of ovarian response|5
341799|NCT01185704|1153740|P2|Overall Study|Randomized but not treated|3
341800|NCT01185704|1153741|P1|Overall Study|Randomized but not treated|3
341801|NCT01185600|1153777|P2|Overall Study|Hold by DSMB|2
341802|NCT01185600|1153778|P1|Overall Study|Hold by DSMB|1
341803|NCT01185600|1153777|P2|Overall Study|Withdrawal by Subject|1
341804|NCT01185600|1153778|P1|Overall Study|Withdrawal by Subject|1
341805|NCT01185600|1153777|P2|Overall Study|Physician Decision|35
341806|NCT01185600|1153778|P1|Overall Study|Physician Decision|29
341807|NCT01185600|1153777|P2|Overall Study|Lost to Follow-up|5
341808|NCT01185600|1153778|P1|Overall Study|Lost to Follow-up|0
341809|NCT01185600|1153777|P2|Overall Study|Death|1
341810|NCT01185600|1153778|P1|Overall Study|Death|0
341811|NCT01185600|1153777|P2|Overall Study|Adverse Event|1
341812|NCT01185600|1153778|P1|Overall Study|Adverse Event|1
341813|NCT01185561|1153800|P2|Overall Study|Withdrawal by Subject|8
341814|NCT01185561|1153801|P1|Overall Study|Withdrawal by Subject|2
341815|NCT01185561|1153800|P2|Overall Study|Lost to Follow-up|4
341816|NCT01185561|1153801|P1|Overall Study|Lost to Follow-up|0
341817|NCT01185522|1153813|P1|Overall Study|Other reasons|12
341818|NCT01185522|1153813|P1|Overall Study|Poor tolerance|39
341819|NCT01185522|1153813|P1|Overall Study|Withdrawal by Subject|10
341820|NCT01185522|1153813|P1|Overall Study|Lost to Follow-up|19
341821|NCT01185522|1153813|P1|Overall Study|Lack of Efficacy|28
341822|NCT01185509|1153839|P2|Overall Study|Intercurrent Illness|1
341823|NCT01185509|1153840|P1|Overall Study|Intercurrent Illness|0
341824|NCT01185509|1153839|P2|Overall Study|Death|1
341825|NCT01185509|1153840|P1|Overall Study|Death|0
341826|NCT01185509|1153839|P2|Overall Study|Withdrawal by Subject|1
341827|NCT01185509|1153840|P1|Overall Study|Withdrawal by Subject|0
341828|NCT01185509|1153839|P2|Overall Study|Physician Decision|2
341829|NCT01185509|1153840|P1|Overall Study|Physician Decision|2
341830|NCT01185509|1153839|P2|Overall Study|Progression/Relapse|15
341831|NCT01185509|1153840|P1|Overall Study|Progression/Relapse|9
341832|NCT01185353|1153855|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
341833|NCT01185353|1153856|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
341834|NCT01185353|1153857|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
341835|NCT01185353|1153858|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
341836|NCT01185353|1153859|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
341837|NCT01185353|1153860|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
341838|NCT01185353|1153861|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
341839|NCT01185353|1153862|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
341840|NCT01185353|1153863|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
341841|NCT01185353|1153864|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
341842|NCT01185353|1153855|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
341843|NCT01185353|1153856|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
341844|NCT01185353|1153857|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
341845|NCT01185353|1153858|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
341846|NCT01185353|1153859|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
341847|NCT01185353|1153860|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
341848|NCT01185353|1153861|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
341849|NCT01185353|1153862|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
341850|NCT01185353|1153863|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
341851|NCT01185353|1153864|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
341852|NCT01185353|1153855|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341853|NCT01185353|1153856|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
341854|NCT01185353|1153857|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
341855|NCT01185353|1153858|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341856|NCT01185353|1153859|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341857|NCT01185353|1153860|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341858|NCT01185353|1153861|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341859|NCT01185353|1153862|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341860|NCT01185353|1153863|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341861|NCT01185353|1153864|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
341862|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Reason missing|0
341863|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Reason missing|1
341864|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Reason missing|0
341865|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Reason missing|0
341866|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Reason missing|0
341867|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Reason missing|0
341868|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Reason missing|0
341869|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Reason missing|0
341870|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Reason missing|0
341871|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Reason missing|0
341872|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
341873|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
341874|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
341875|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
341876|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
341877|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
341878|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
341879|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
341880|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
341881|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
341882|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
341883|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341884|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341885|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341886|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341887|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341888|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341889|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341890|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341891|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
341892|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Death|1
341893|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Death|0
341894|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Death|0
341895|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Death|0
341896|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Death|0
341897|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Death|0
341898|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Death|0
341899|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Death|0
341900|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Death|0
341901|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Death|0
341902|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341903|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
341904|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341905|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341906|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341907|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341908|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341909|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341910|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341911|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
341912|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
341913|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
341914|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
341915|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
341916|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
341917|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
341918|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
341919|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
341920|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
341921|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
341922|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
341923|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
341924|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
341925|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
341926|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
341927|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
341928|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
341929|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
341930|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
341931|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
341932|NCT01185353|1153855|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
341933|NCT01185353|1153856|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
341934|NCT01185353|1153857|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
341935|NCT01185353|1153858|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
341936|NCT01185353|1153859|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
341937|NCT01185353|1153860|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
341938|NCT01185353|1153861|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
341939|NCT01185353|1153862|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
341940|NCT01185353|1153863|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
341941|NCT01185353|1153864|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
341942|NCT01185353|1153855|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341943|NCT01185353|1153856|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341944|NCT01185353|1153857|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341945|NCT01185353|1153858|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
341946|NCT01185353|1153859|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341947|NCT01185353|1153860|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341948|NCT01185353|1153861|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341949|NCT01185353|1153862|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341950|NCT01185353|1153863|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341951|NCT01185353|1153864|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
341952|NCT01185353|1153855|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
341953|NCT01185353|1153856|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
341954|NCT01185353|1153857|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
341955|NCT01185353|1153858|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
341956|NCT01185353|1153859|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
341957|NCT01185353|1153860|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
341958|NCT01185353|1153861|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
341959|NCT01185353|1153862|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
341960|NCT01185353|1153863|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
341961|NCT01185353|1153864|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
341962|NCT01185353|1153855|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341963|NCT01185353|1153856|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341964|NCT01185353|1153857|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341965|NCT01185353|1153858|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
341966|NCT01185353|1153859|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341967|NCT01185353|1153860|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341968|NCT01185353|1153861|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
341969|NCT01185353|1153862|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341970|NCT01185353|1153863|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341971|NCT01185353|1153864|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
341972|NCT01185353|1153855|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341973|NCT01185353|1153856|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341974|NCT01185353|1153857|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341975|NCT01185353|1153858|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341976|NCT01185353|1153859|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341977|NCT01185353|1153860|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341978|NCT01185353|1153861|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
341979|NCT01185353|1153862|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341980|NCT01185353|1153863|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
341981|NCT01185353|1153864|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
341982|NCT01185353|1153855|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
341983|NCT01185353|1153856|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
341984|NCT01185353|1153857|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
341985|NCT01185353|1153858|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
341986|NCT01185353|1153859|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
341987|NCT01185353|1153860|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
341988|NCT01185353|1153861|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
341989|NCT01185353|1153862|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
341990|NCT01185353|1153863|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
341991|NCT01185353|1153864|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
341992|NCT01185353|1153855|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
341993|NCT01185353|1153856|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
341994|NCT01185353|1153857|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
341995|NCT01185353|1153858|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
341996|NCT01185353|1153859|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
341997|NCT01185353|1153860|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
341998|NCT01185353|1153861|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
341999|NCT01185353|1153862|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
342000|NCT01185353|1153863|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
342001|NCT01185353|1153864|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
342002|NCT01185353|1153855|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
342003|NCT01185353|1153856|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
342004|NCT01185353|1153857|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
342005|NCT01185353|1153858|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
342006|NCT01185353|1153859|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
342007|NCT01185353|1153860|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
342008|NCT01185353|1153861|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
342009|NCT01185353|1153862|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
342010|NCT01185353|1153863|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
342011|NCT01185353|1153864|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
342012|NCT01185353|1153855|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
342013|NCT01185353|1153856|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
342014|NCT01185353|1153857|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
342015|NCT01185353|1153858|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
342016|NCT01185353|1153859|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
342017|NCT01185353|1153860|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
342018|NCT01185353|1153861|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
342019|NCT01185353|1153862|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
342020|NCT01185353|1153863|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
342021|NCT01185353|1153864|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
342022|NCT01185353|1153855|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342023|NCT01185353|1153856|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342024|NCT01185353|1153857|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342025|NCT01185353|1153858|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342026|NCT01185353|1153859|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342027|NCT01185353|1153860|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
342028|NCT01185353|1153861|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342029|NCT01185353|1153862|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342030|NCT01185353|1153863|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
342031|NCT01185353|1153864|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
342032|NCT01185353|1153855|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342033|NCT01185353|1153856|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342034|NCT01185353|1153857|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342035|NCT01185353|1153858|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342036|NCT01185353|1153859|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342037|NCT01185353|1153860|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
342038|NCT01185353|1153861|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342039|NCT01185353|1153862|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342040|NCT01185353|1153863|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342041|NCT01185353|1153864|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
342042|NCT01185353|1153855|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
342043|NCT01185353|1153856|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
342044|NCT01185353|1153857|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
342045|NCT01185353|1153858|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
342046|NCT01185353|1153859|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
342047|NCT01185353|1153860|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
342048|NCT01185353|1153861|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
342049|NCT01185353|1153862|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
342050|NCT01185353|1153863|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
342051|NCT01185353|1153864|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
342052|NCT01185340|1154025|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
342053|NCT01185340|1154026|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
342054|NCT01185340|1154027|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
342055|NCT01185340|1154028|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
342056|NCT01185340|1154025|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
342057|NCT01185340|1154026|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
342058|NCT01185340|1154027|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
342059|NCT01185340|1154028|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
342060|NCT01185340|1154025|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
342061|NCT01185340|1154026|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
342062|NCT01185340|1154027|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
342063|NCT01185340|1154028|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
342064|NCT01185340|1154025|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
342065|NCT01185340|1154026|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
342066|NCT01185340|1154027|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
342067|NCT01185340|1154028|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
342068|NCT01185340|1154025|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
342069|NCT01185340|1154026|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
342070|NCT01185340|1154027|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
342071|NCT01185340|1154028|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
342072|NCT01185340|1154025|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
342073|NCT01185340|1154026|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
342074|NCT01185340|1154027|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
342075|NCT01185340|1154028|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
342076|NCT01185340|1154025|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
342077|NCT01185340|1154026|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
342078|NCT01185340|1154027|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
342079|NCT01185340|1154028|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
342080|NCT01185340|1154025|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
342081|NCT01185340|1154026|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
342082|NCT01185340|1154027|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
342083|NCT01185340|1154028|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
342084|NCT01185340|1154025|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
342085|NCT01185340|1154026|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
342086|NCT01185340|1154027|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
342087|NCT01185340|1154028|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
342088|NCT01185340|1154025|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
342089|NCT01185340|1154026|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
342090|NCT01185340|1154027|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
342091|NCT01185340|1154028|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
342092|NCT01185340|1154025|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
342093|NCT01185340|1154026|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
342094|NCT01185340|1154027|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
342095|NCT01185340|1154028|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
342096|NCT01185340|1154025|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
342097|NCT01185340|1154026|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
342098|NCT01185340|1154027|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
342099|NCT01185340|1154028|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
342100|NCT01185340|1154025|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
342101|NCT01185340|1154026|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
342102|NCT01185340|1154027|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
342103|NCT01185340|1154028|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
342104|NCT01185340|1154025|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
342105|NCT01185340|1154026|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
342106|NCT01185340|1154027|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
342107|NCT01185340|1154028|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
342108|NCT01185301|1154080|P4|Overall Study|Other Reason|2
342109|NCT01185301|1154081|P3|Overall Study|Other Reason|2
342110|NCT01185301|1154082|P2|Overall Study|Other Reason|2
342111|NCT01185301|1154083|P1|Overall Study|Other Reason|3
342112|NCT01185301|1154080|P4|Overall Study|Lost to Follow-up|1
342113|NCT01185301|1154081|P3|Overall Study|Lost to Follow-up|0
342114|NCT01185301|1154082|P2|Overall Study|Lost to Follow-up|0
342115|NCT01185301|1154083|P1|Overall Study|Lost to Follow-up|2
342116|NCT01185301|1154080|P4|Overall Study|Withdrawal by Subject|3
342117|NCT01185301|1154081|P3|Overall Study|Withdrawal by Subject|2
342118|NCT01185301|1154082|P2|Overall Study|Withdrawal by Subject|5
342119|NCT01185301|1154083|P1|Overall Study|Withdrawal by Subject|7
342120|NCT01185301|1154080|P4|Overall Study|Adverse Event|3
342121|NCT01185301|1154081|P3|Overall Study|Adverse Event|2
342122|NCT01185301|1154082|P2|Overall Study|Adverse Event|0
342123|NCT01185301|1154083|P1|Overall Study|Adverse Event|3
342124|NCT01185288|1154143|P2|Overall Study|Noncompliance|1
342125|NCT01185288|1154144|P1|Overall Study|Noncompliance|0
342126|NCT01185288|1154143|P2|Overall Study|Did not meet inclusion criteria|0
342127|NCT01185288|1154144|P1|Overall Study|Did not meet inclusion criteria|1
342128|NCT01185288|1154143|P2|Overall Study|Investigator discretion|0
342129|NCT01185288|1154144|P1|Overall Study|Investigator discretion|1
342130|NCT01185288|1154143|P2|Overall Study|Lack of Efficacy|0
342131|NCT01185288|1154144|P1|Overall Study|Lack of Efficacy|2
342132|NCT01185288|1154143|P2|Overall Study|Lost to Follow-up|5
342133|NCT01185288|1154144|P1|Overall Study|Lost to Follow-up|2
342134|NCT01185288|1154143|P2|Overall Study|Withdrawal by Subject|4
342135|NCT01185288|1154144|P1|Overall Study|Withdrawal by Subject|6
342136|NCT01185288|1154143|P2|Overall Study|Adverse Event|6
342137|NCT01185288|1154144|P1|Overall Study|Adverse Event|7
342138|NCT01185249|1154162|P1|Overall Study|Patients discharged or change in status|42
342139|NCT01185080|1154170|P3|Overall Study|Personal reasons|1
342140|NCT01185080|1154171|P2|Overall Study|Personal reasons|0
342141|NCT01185080|1154172|P1|Overall Study|Personal reasons|0
342142|NCT01185080|1154170|P3|Overall Study|Adverse Event|0
342143|NCT01185080|1154171|P2|Overall Study|Adverse Event|1
342144|NCT01185080|1154172|P1|Overall Study|Adverse Event|1
342145|NCT01184989|1154224|P1|Overall Study|Withdrawal by Subject|1
342146|NCT01184989|1154224|P1|Overall Study|Adverse Event|11
342147|NCT01184872|1154244|P2|Overall Study|Protocol deviation|0
342148|NCT01184872|1154245|P1|Overall Study|Protocol deviation|1
342149|NCT01184872|1154244|P2|Overall Study|Administrative problems|1
342150|NCT01184872|1154245|P1|Overall Study|Administrative problems|1
342151|NCT01184872|1154244|P2|Overall Study|Lost to Follow-up|1
342152|NCT01184872|1154245|P1|Overall Study|Lost to Follow-up|0
342153|NCT01184872|1154244|P2|Overall Study|Withdrawal by Subject|0
342154|NCT01184872|1154245|P1|Overall Study|Withdrawal by Subject|2
342155|NCT01184872|1154244|P2|Overall Study|Unsatisfactory therapeutic effect|2
342156|NCT01184872|1154245|P1|Overall Study|Unsatisfactory therapeutic effect|3
342157|NCT01184872|1154244|P2|Overall Study|Adverse Event|4
342158|NCT01184872|1154245|P1|Overall Study|Adverse Event|3
342159|NCT01184859|1154264|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
342160|NCT01184859|1154265|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
342161|NCT01184859|1154266|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
342162|NCT01184859|1154267|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
342163|NCT01184859|1154268|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
342164|NCT01184859|1154264|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
342165|NCT01184859|1154265|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
342166|NCT01184859|1154266|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
342167|NCT01184859|1154267|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
342168|NCT01184859|1154268|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
342169|NCT01184859|1154264|P5|Period 1: Single Dose|Adverse Event|1
342170|NCT01184859|1154265|P4|Period 1: Single Dose|Adverse Event|0
342171|NCT01184859|1154266|P3|Period 1: Single Dose|Adverse Event|0
342172|NCT01184859|1154267|P2|Period 1: Single Dose|Adverse Event|0
342173|NCT01184859|1154268|P1|Period 1: Single Dose|Adverse Event|0
342174|NCT01184859|1154264|P5|Period 1: Single Dose|Protocol Violation|0
342175|NCT01184859|1154265|P4|Period 1: Single Dose|Protocol Violation|0
342176|NCT01184859|1154266|P3|Period 1: Single Dose|Protocol Violation|0
342177|NCT01184859|1154267|P2|Period 1: Single Dose|Protocol Violation|1
342178|NCT01184859|1154268|P1|Period 1: Single Dose|Protocol Violation|0
342179|NCT01184859|1154264|P5|Period 1: Single Dose|Insufficient urine production|0
342180|NCT01184859|1154265|P4|Period 1: Single Dose|Insufficient urine production|0
342181|NCT01184859|1154266|P3|Period 1: Single Dose|Insufficient urine production|0
342182|NCT01184859|1154267|P2|Period 1: Single Dose|Insufficient urine production|1
342183|NCT01184859|1154268|P1|Period 1: Single Dose|Insufficient urine production|0
342184|NCT01184846|1154360|P1|Overall Study|Insufficient response|1
342185|NCT01184846|1154360|P1|Overall Study|Adverse Event|2
342186|NCT01184118|1154414|P1|Overall Study|Withdrawal by Subject|5
342187|NCT01184118|1154414|P1|Overall Study|Exclusionary medical condition|2
342188|NCT01184118|1154414|P1|Overall Study|FEV1 <60% predicted|2
342189|NCT01184118|1154414|P1|Overall Study|No physiologic confirmation of asthma|8
342190|NCT01184118|1154414|P1|Overall Study|Only asthma step 1 - screen fail|1
342191|NCT01184079|1154422|P2|Overall Study|Lost to Follow-up|2
342192|NCT01184079|1154423|P1|Overall Study|Lost to Follow-up|14
342193|NCT01184053|1154433|P1|Overall Study|progression while on treatment|3
342194|NCT01183975|1154449|P1|Overall Study|Lost to Follow-up|73
342195|NCT01183858|1154456|P2|Overall Study|Lost to Follow-up|1
342196|NCT01183858|1154457|P1|Overall Study|Lost to Follow-up|1
342197|NCT01183858|1154456|P2|Overall Study|Death related to Progressive Disease|5
342198|NCT01183858|1154457|P1|Overall Study|Death related to Progressive Disease|4
342199|NCT01183858|1154456|P2|Overall Study|Progressive Disease|115
342200|NCT01183858|1154457|P1|Overall Study|Progressive Disease|112
342201|NCT01183858|1154456|P2|Overall Study|Administrative/Other|6
342202|NCT01183858|1154457|P1|Overall Study|Administrative/Other|6
342203|NCT01183858|1154456|P2|Overall Study|Protocol Violation|0
342204|NCT01183858|1154457|P1|Overall Study|Protocol Violation|1
342205|NCT01183858|1154456|P2|Overall Study|Discontinued Smoking|1
342206|NCT01183858|1154457|P1|Overall Study|Discontinued Smoking|3
342207|NCT01183858|1154456|P2|Overall Study|Withdrew Consent|4
342208|NCT01183858|1154457|P1|Overall Study|Withdrew Consent|4
342209|NCT01183858|1154456|P2|Overall Study|Refused Treatment|4
342210|NCT01183858|1154457|P1|Overall Study|Refused Treatment|1
342211|NCT01183858|1154456|P2|Overall Study|Insufficient Therapeutic Response|0
342212|NCT01183858|1154457|P1|Overall Study|Insufficient Therapeutic Response|2
342213|NCT01183858|1154456|P2|Overall Study|Investigator's Decision|3
342214|NCT01183858|1154457|P1|Overall Study|Investigator's Decision|0
342215|NCT01183858|1154456|P2|Overall Study|Adverse Event|11
342216|NCT01183858|1154457|P1|Overall Study|Adverse Event|14
342217|NCT01183858|1154456|P2|Overall Study|Death not related to Progressive Disease|6
342218|NCT01183858|1154457|P1|Overall Study|Death not related to Progressive Disease|5
342219|NCT01183780|1154479|P2|Overall Study|Lost to Follow-up|11
342220|NCT01183780|1154480|P1|Overall Study|Lost to Follow-up|6
342221|NCT01183780|1154479|P2|Overall Study|Withdrawal by Subject|14
342222|NCT01183780|1154480|P1|Overall Study|Withdrawal by Subject|25
342223|NCT01183468|1154613|P4|Overall Study|Withdrawal by Subject|0
342224|NCT01183468|1154614|P3|Overall Study|Withdrawal by Subject|0
342225|NCT01183468|1154615|P2|Overall Study|Withdrawal by Subject|1
342226|NCT01183468|1154616|P1|Overall Study|Withdrawal by Subject|0
342227|NCT01183468|1154613|P4|Overall Study|Physician Decision|0
342228|NCT01183468|1154614|P3|Overall Study|Physician Decision|0
342229|NCT01183468|1154615|P2|Overall Study|Physician Decision|0
342230|NCT01183468|1154616|P1|Overall Study|Physician Decision|1
342231|NCT01183468|1154613|P4|Overall Study|Lost to Follow-up|0
342232|NCT01183468|1154614|P3|Overall Study|Lost to Follow-up|0
342233|NCT01183468|1154615|P2|Overall Study|Lost to Follow-up|1
342234|NCT01183468|1154616|P1|Overall Study|Lost to Follow-up|2
342235|NCT01183390|1154626|P2|First Intervention|Adverse Event|1
342236|NCT01183390|1154627|P1|First Intervention|Adverse Event|0
342237|NCT01183260|1154660|P2|Overall Study|Death|0
342238|NCT01183260|1154661|P1|Overall Study|Death|1
342239|NCT01183260|1154660|P2|Overall Study|Revised within 30 days|1
342240|NCT01183260|1154661|P1|Overall Study|Revised within 30 days|0
342241|NCT01183260|1154660|P2|Overall Study|Withdrawal by Subject|1
342242|NCT01183260|1154661|P1|Overall Study|Withdrawal by Subject|1
342243|NCT01183260|1154660|P2|Overall Study|Intraop screen failure|0
342244|NCT01183260|1154661|P1|Overall Study|Intraop screen failure|2
342245|NCT01183234|1154671|P2|First Intervention|Adverse Event|0
342246|NCT01183234|1154672|P1|First Intervention|Adverse Event|1
342247|NCT01183143|1154764|P1|Overall Study|Subjects enrolled, but not treated|11
342248|NCT01183143|1154764|P1|Overall Study|Subject Questionnaires not returned|5
342249|NCT01183143|1154764|P1|Overall Study|Withdrawal by Subject|19
342250|NCT01183143|1154764|P1|Overall Study|Protocol Violation|115
342251|NCT01183104|1154780|P2|Overall Study|Did not receive study drug|9
342252|NCT01183104|1154781|P1|Overall Study|Did not receive study drug|5
342253|NCT01183104|1154780|P2|Overall Study|Nonparticipation in Extension Study|50
342254|NCT01183104|1154781|P1|Overall Study|Nonparticipation in Extension Study|39
342255|NCT01183104|1154780|P2|Overall Study|Withdrawal by Subject|11
342256|NCT01183104|1154781|P1|Overall Study|Withdrawal by Subject|6
342257|NCT01183104|1154780|P2|Overall Study|Physician Decision|8
342258|NCT01183104|1154781|P1|Overall Study|Physician Decision|5
342259|NCT01183104|1154780|P2|Overall Study|Lost to Follow-up|7
342260|NCT01183104|1154781|P1|Overall Study|Lost to Follow-up|14
342261|NCT01183104|1154780|P2|Overall Study|Death|1
342262|NCT01183104|1154781|P1|Overall Study|Death|0
342263|NCT01183104|1154780|P2|Overall Study|Adverse Event|6
342264|NCT01183104|1154781|P1|Overall Study|Adverse Event|8
342265|NCT01183065|1154797|P1|Overall Study|Patient no longer fits eligibility crite|1
342266|NCT01183013|1154808|P7|Overall Study|Reasons other than stated above|13
342267|NCT01183013|1154809|P6|Overall Study|Reasons other than stated above|15
342268|NCT01183013|1154810|P5|Overall Study|Reasons other than stated above|12
342269|NCT01183013|1154811|P4|Overall Study|Reasons other than stated above|12
342270|NCT01183013|1154812|P3|Overall Study|Reasons other than stated above|17
342271|NCT01183013|1154813|P2|Overall Study|Reasons other than stated above|11
342272|NCT01183013|1154814|P1|Overall Study|Reasons other than stated above|15
342273|NCT01183013|1154808|P7|Overall Study|Withdrawal by Subject|10
342274|NCT01183013|1154809|P6|Overall Study|Withdrawal by Subject|9
342275|NCT01183013|1154810|P5|Overall Study|Withdrawal by Subject|7
342276|NCT01183013|1154811|P4|Overall Study|Withdrawal by Subject|8
342277|NCT01183013|1154812|P3|Overall Study|Withdrawal by Subject|10
342278|NCT01183013|1154813|P2|Overall Study|Withdrawal by Subject|13
342279|NCT01183013|1154814|P1|Overall Study|Withdrawal by Subject|9
342280|NCT01183013|1154808|P7|Overall Study|Lost to Follow-up|5
342281|NCT01183013|1154809|P6|Overall Study|Lost to Follow-up|6
342282|NCT01183013|1154810|P5|Overall Study|Lost to Follow-up|2
342283|NCT01183013|1154811|P4|Overall Study|Lost to Follow-up|3
342284|NCT01183013|1154812|P3|Overall Study|Lost to Follow-up|4
342285|NCT01183013|1154813|P2|Overall Study|Lost to Follow-up|3
342286|NCT01183013|1154814|P1|Overall Study|Lost to Follow-up|7
342287|NCT01183013|1154808|P7|Overall Study|Protocol Violation|3
342288|NCT01183013|1154809|P6|Overall Study|Protocol Violation|3
342289|NCT01183013|1154810|P5|Overall Study|Protocol Violation|4
342290|NCT01183013|1154811|P4|Overall Study|Protocol Violation|0
342291|NCT01183013|1154812|P3|Overall Study|Protocol Violation|4
342292|NCT01183013|1154813|P2|Overall Study|Protocol Violation|2
342293|NCT01183013|1154814|P1|Overall Study|Protocol Violation|5
342294|NCT01183013|1154808|P7|Overall Study|Lack of Efficacy|0
342295|NCT01183013|1154809|P6|Overall Study|Lack of Efficacy|2
342296|NCT01183013|1154810|P5|Overall Study|Lack of Efficacy|1
342297|NCT01183013|1154811|P4|Overall Study|Lack of Efficacy|2
342298|NCT01183013|1154812|P3|Overall Study|Lack of Efficacy|1
342299|NCT01183013|1154813|P2|Overall Study|Lack of Efficacy|2
342300|NCT01183013|1154814|P1|Overall Study|Lack of Efficacy|3
342301|NCT01183013|1154808|P7|Overall Study|Adverse Event|6
342302|NCT01183013|1154809|P6|Overall Study|Adverse Event|10
342303|NCT01183013|1154810|P5|Overall Study|Adverse Event|10
342304|NCT01183013|1154811|P4|Overall Study|Adverse Event|5
342305|NCT01183013|1154812|P3|Overall Study|Adverse Event|5
342306|NCT01183013|1154813|P2|Overall Study|Adverse Event|8
342307|NCT01183013|1154814|P1|Overall Study|Adverse Event|6
342308|NCT01182428|1154950|P2|Overall Study|Withdrawal by Subject|0
342309|NCT01182428|1154951|P1|Overall Study|Withdrawal by Subject|1
342310|NCT01182428|1154950|P2|Overall Study|Lost to Follow-up|1
342311|NCT01182428|1154951|P1|Overall Study|Lost to Follow-up|9
342312|NCT01182428|1154950|P2|Overall Study|Physician Decision|0
342313|NCT01182428|1154951|P1|Overall Study|Physician Decision|1
342314|NCT01182415|1155015|P1|Overall Study|Lost to Follow-up|1
342315|NCT01182337|1155033|P2|Overall Study|Lost to Follow-up|1
342316|NCT01182337|1155034|P1|Overall Study|Lost to Follow-up|0
342317|NCT01182337|1155033|P2|Overall Study|Withdrawal by Subject|1
342318|NCT01182337|1155034|P1|Overall Study|Withdrawal by Subject|3
342319|NCT01182298|1155052|P1|Overall Study|Withdrawal by Subject|2
342320|NCT01182298|1155052|P1|Overall Study|Lack of Efficacy|4
342321|NCT01182285|1155056|P3|Third Intervention Week 11-52|Other|2
342322|NCT01182285|1155057|P2|Third Intervention Week 11-52|Other|0
342323|NCT01182285|1155058|P1|Third Intervention Week 11-52|Other|0
342324|NCT01182285|1155056|P3|Third Intervention Week 11-52|Disease Progression|6
342325|NCT01182285|1155057|P2|Third Intervention Week 11-52|Disease Progression|0
342326|NCT01182285|1155058|P1|Third Intervention Week 11-52|Disease Progression|0
342327|NCT01182285|1155056|P3|First Intervention Week 1-10|Non-compliance|0
342328|NCT01182285|1155057|P2|First Intervention Week 1-10|Non-compliance|0
342329|NCT01182285|1155058|P1|First Intervention Week 1-10|Non-compliance|1
342330|NCT01182285|1155056|P3|First Intervention Week 1-10|Adverse Event|0
342331|NCT01182285|1155057|P2|First Intervention Week 1-10|Adverse Event|0
342332|NCT01182285|1155058|P1|First Intervention Week 1-10|Adverse Event|1
342333|NCT01182285|1155056|P3|First Intervention Week 1-10|Disease progression|0
342334|NCT01182285|1155057|P2|First Intervention Week 1-10|Disease progression|0
342335|NCT01182285|1155058|P1|First Intervention Week 1-10|Disease progression|1
342336|NCT01182207|1155068|P2|Second Intervention|Emeses within 1 hour of dosing|0
342337|NCT01182207|1155069|P1|Second Intervention|Emeses within 1 hour of dosing|1
342338|NCT01182207|1155068|P2|First Intervention|Positive Hepatitis Results|1
342339|NCT01182207|1155069|P1|First Intervention|Positive Hepatitis Results|0
342340|NCT01182194|1155087|P2|Washout of 28 Days|Withdrawal by Subject|0
342341|NCT01182194|1155088|P1|Washout of 28 Days|Withdrawal by Subject|1
342342|NCT01182181|1155106|P2|Washout of 21 Days|Withdrawal by Subject|1
342343|NCT01182181|1155107|P1|Washout of 21 Days|Withdrawal by Subject|0
342344|NCT01182181|1155106|P2|First Intervention|Adverse Event|0
342345|NCT01182181|1155107|P1|First Intervention|Adverse Event|1
342346|NCT01181986|1155132|P3|Phase 2|Medical condition|0
342347|NCT01181986|1155133|P2|Phase 2|Medical condition|1
342348|NCT01181986|1155134|P1|Phase 2|Medical condition|0
342349|NCT01181986|1155132|P3|Phase 2|Adverse Event|0
342350|NCT01181986|1155133|P2|Phase 2|Adverse Event|3
342351|NCT01181986|1155134|P1|Phase 2|Adverse Event|0
342352|NCT01181986|1155132|P3|Phase 1|Protocol Violation|0
342353|NCT01181986|1155133|P2|Phase 1|Protocol Violation|0
342354|NCT01181986|1155134|P1|Phase 1|Protocol Violation|1
342355|NCT01181986|1155132|P3|Phase 1|Adverse Event|1
342356|NCT01181986|1155133|P2|Phase 1|Adverse Event|0
342357|NCT01181986|1155134|P1|Phase 1|Adverse Event|0
342358|NCT01181986|1155132|P3|Phase 1|Lost to Follow-up|1
342359|NCT01181986|1155133|P2|Phase 1|Lost to Follow-up|1
342360|NCT01181986|1155134|P1|Phase 1|Lost to Follow-up|0
342361|NCT01181921|1155155|P1|Overall Study|Lost to Follow-up|1
342362|NCT01181895|1155162|P3|Overall Study|Withdrawal by Subject|5
342363|NCT01181895|1155163|P2|Overall Study|Withdrawal by Subject|0
342364|NCT01181895|1155164|P1|Overall Study|Withdrawal by Subject|3
342365|NCT01181895|1155162|P3|Overall Study|Investigator Discretion|1
342366|NCT01181895|1155163|P2|Overall Study|Investigator Discretion|2
342367|NCT01181895|1155164|P1|Overall Study|Investigator Discretion|1
342368|NCT01181895|1155162|P3|Overall Study|Lost to Follow-up|2
342369|NCT01181895|1155163|P2|Overall Study|Lost to Follow-up|1
342370|NCT01181895|1155164|P1|Overall Study|Lost to Follow-up|0
342371|NCT01181895|1155162|P3|Overall Study|Protocol Violation|0
342372|NCT01181895|1155163|P2|Overall Study|Protocol Violation|1
342373|NCT01181895|1155164|P1|Overall Study|Protocol Violation|2
342374|NCT01181895|1155162|P3|Overall Study|Lack of Efficacy|9
342375|NCT01181895|1155163|P2|Overall Study|Lack of Efficacy|9
342376|NCT01181895|1155164|P1|Overall Study|Lack of Efficacy|8
342377|NCT01181895|1155162|P3|Overall Study|Adverse Event|1
342378|NCT01181895|1155163|P2|Overall Study|Adverse Event|1
342379|NCT01181895|1155164|P1|Overall Study|Adverse Event|3
342380|NCT01181778|1155222|P1|Overall Study|Physician Decision|48
342381|NCT01181726|1155230|P2|First Intervention|Adverse Event|0
342382|NCT01181726|1155231|P1|First Intervention|Adverse Event|1
342383|NCT01181609|1155277|P1|Overall Study|Death|50
342384|NCT01181609|1155277|P1|Overall Study|Lost to Follow-up|1
342385|NCT01181609|1155277|P1|Overall Study|Withdrawal by Subject|1
342386|NCT01181609|1155277|P1|Overall Study|Adverse Event|1
342387|NCT01181531|1155290|P2|Overall Study|Adverse Event|1
342388|NCT01181531|1155291|P1|Overall Study|Adverse Event|0
342389|NCT01181531|1155290|P2|Overall Study|Death|12
342390|NCT01181531|1155291|P1|Overall Study|Death|9
342391|NCT01181531|1155290|P2|Overall Study|Protocol Violation|6
342392|NCT01181531|1155291|P1|Overall Study|Protocol Violation|6
342393|NCT01181531|1155290|P2|Overall Study|Withdrawal by Subject|7
342394|NCT01181531|1155291|P1|Overall Study|Withdrawal by Subject|8
342395|NCT01181531|1155290|P2|Overall Study|Pregnancy|1
342396|NCT01181531|1155291|P1|Overall Study|Pregnancy|0
342397|NCT01181531|1155290|P2|Overall Study|Protocol Specified Criteria|8
342398|NCT01181531|1155291|P1|Overall Study|Protocol Specified Criteria|15
342399|NCT01181531|1155290|P2|Overall Study|Ineligibility determined|2
342400|NCT01181531|1155291|P1|Overall Study|Ineligibility determined|1
342401|NCT01181531|1155290|P2|Overall Study|Noncompliance|2
342402|NCT01181531|1155291|P1|Overall Study|Noncompliance|2
342403|NCT01181531|1155290|P2|Overall Study|Physician Decision|1
342404|NCT01181531|1155291|P1|Overall Study|Physician Decision|3
342405|NCT01181531|1155290|P2|Overall Study|Partial consent by subject withdrawn|1
342406|NCT01181531|1155291|P1|Overall Study|Partial consent by subject withdrawn|0
342407|NCT01181531|1155290|P2|Overall Study|Other|12
342408|NCT01181531|1155291|P1|Overall Study|Other|17
342409|NCT01181271|1155414|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
342410|NCT01181271|1155414|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
342411|NCT01181271|1155414|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
342412|NCT01181271|1155414|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
342413|NCT01181167|1155438|P2|Overall Study|Withdrawal by Subject|8
342414|NCT01181167|1155439|P1|Overall Study|Withdrawal by Subject|6
342415|NCT01181167|1155438|P2|Overall Study|Protocol Violation|0
342416|NCT01181167|1155439|P1|Overall Study|Protocol Violation|3
342417|NCT01181167|1155438|P2|Overall Study|Physician Decision|3
342418|NCT01181167|1155439|P1|Overall Study|Physician Decision|2
342419|NCT01181167|1155438|P2|Overall Study|Lost to Follow-up|0
342420|NCT01181167|1155439|P1|Overall Study|Lost to Follow-up|1
342421|NCT01181167|1155438|P2|Overall Study|Adverse Event|21
342422|NCT01181167|1155439|P1|Overall Study|Adverse Event|11
342423|NCT01181141|1155449|P2|Overall Study|Withdrawal by Subject|1
342424|NCT01181141|1155450|P1|Overall Study|Withdrawal by Subject|3
342425|NCT01181141|1155449|P2|Overall Study|Protocol Violation|1
342426|NCT01181141|1155450|P1|Overall Study|Protocol Violation|3
342427|NCT01181141|1155449|P2|Overall Study|Physician Decision|0
342428|NCT01181141|1155450|P1|Overall Study|Physician Decision|2
342429|NCT01181141|1155449|P2|Overall Study|Lost to Follow-up|1
342430|NCT01181141|1155450|P1|Overall Study|Lost to Follow-up|1
342431|NCT01181141|1155449|P2|Overall Study|Lack of Efficacy|0
342432|NCT01181141|1155450|P1|Overall Study|Lack of Efficacy|1
342433|NCT01181141|1155449|P2|Overall Study|Adverse Event|1
342434|NCT01181141|1155450|P1|Overall Study|Adverse Event|2
342435|NCT01181128|1155459|P3|Overall Study|Not Specified|1
342436|NCT01181128|1155460|P2|Overall Study|Not Specified|1
342437|NCT01181128|1155461|P1|Overall Study|Not Specified|1
342438|NCT01181128|1155459|P3|Overall Study|Adverse Event|0
342439|NCT01181128|1155460|P2|Overall Study|Adverse Event|2
342440|NCT01181128|1155461|P1|Overall Study|Adverse Event|0
342441|NCT01181128|1155459|P3|Overall Study|Physician Decision|0
342442|NCT01181128|1155460|P2|Overall Study|Physician Decision|0
342443|NCT01181128|1155461|P1|Overall Study|Physician Decision|2
342444|NCT01181128|1155459|P3|Overall Study|Death|0
342445|NCT01181128|1155460|P2|Overall Study|Death|0
342446|NCT01181128|1155461|P1|Overall Study|Death|1
342447|NCT01181128|1155459|P3|Overall Study|Withdrawal by Subject|0
342448|NCT01181128|1155460|P2|Overall Study|Withdrawal by Subject|2
342449|NCT01181128|1155461|P1|Overall Study|Withdrawal by Subject|2
342450|NCT01181102|1155549|P2|Overall Study|Withdrawal by Subject|12
342451|NCT01181102|1155550|P1|Overall Study|Withdrawal by Subject|10
342452|NCT01181102|1155549|P2|Overall Study|Protocol Violation|6
342453|NCT01181102|1155550|P1|Overall Study|Protocol Violation|5
342454|NCT01181102|1155549|P2|Overall Study|Physician Decision|1
342455|NCT01181102|1155550|P1|Overall Study|Physician Decision|3
342456|NCT01181102|1155549|P2|Overall Study|Lost to Follow-up|0
342457|NCT01181102|1155550|P1|Overall Study|Lost to Follow-up|2
342458|NCT01181102|1155549|P2|Overall Study|Lack of Efficacy|1
342459|NCT01181102|1155550|P1|Overall Study|Lack of Efficacy|3
342460|NCT01181102|1155549|P2|Overall Study|Adverse Event|26
342461|NCT01181102|1155550|P1|Overall Study|Adverse Event|28
342462|NCT01181011|1155571|P1|Overall Study|Lost to Follow-up|1
342463|NCT01181011|1155571|P1|Overall Study|Adverse Event|2
342464|NCT01180998|1155621|P3|Overall Study|Poor lens handling|2
342465|NCT01180998|1155622|P2|Overall Study|Poor lens handling|0
342466|NCT01180998|1155623|P1|Overall Study|Poor lens handling|0
342467|NCT01180998|1155621|P3|Overall Study|Poor comfort|4
342468|NCT01180998|1155622|P2|Overall Study|Poor comfort|0
342469|NCT01180998|1155623|P1|Overall Study|Poor comfort|3
342470|NCT01180998|1155621|P3|Overall Study|Withdrawal by Subject|1
342471|NCT01180998|1155622|P2|Overall Study|Withdrawal by Subject|0
342472|NCT01180998|1155623|P1|Overall Study|Withdrawal by Subject|0
342473|NCT01180998|1155621|P3|Overall Study|Protocol Violation|0
342474|NCT01180998|1155622|P2|Overall Study|Protocol Violation|2
342475|NCT01180998|1155623|P1|Overall Study|Protocol Violation|1
342476|NCT01180998|1155621|P3|Overall Study|Lost to Follow-up|1
342477|NCT01180998|1155622|P2|Overall Study|Lost to Follow-up|0
342478|NCT01180998|1155623|P1|Overall Study|Lost to Follow-up|0
342479|NCT01180998|1155621|P3|Overall Study|Poor Vision|2
342480|NCT01180998|1155622|P2|Overall Study|Poor Vision|2
342481|NCT01180998|1155623|P1|Overall Study|Poor Vision|0
342482|NCT01180985|1155637|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
342483|NCT01180985|1155638|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
342484|NCT01180790|1155677|P7|Overall Study|Severe coronary atherosclerosis (death)|0
342485|NCT01180790|1155678|P6|Overall Study|Severe coronary atherosclerosis (death)|0
342486|NCT01180790|1155679|P5|Overall Study|Severe coronary atherosclerosis (death)|0
342487|NCT01180790|1155680|P4|Overall Study|Severe coronary atherosclerosis (death)|0
342488|NCT01180790|1155681|P3|Overall Study|Severe coronary atherosclerosis (death)|1
342489|NCT01180790|1155682|P2|Overall Study|Severe coronary atherosclerosis (death)|0
342490|NCT01180790|1155683|P1|Overall Study|Severe coronary atherosclerosis (death)|0
342491|NCT01180790|1155677|P7|Overall Study|compliance|0
342492|NCT01180790|1155678|P6|Overall Study|compliance|0
342493|NCT01180790|1155679|P5|Overall Study|compliance|0
342494|NCT01180790|1155680|P4|Overall Study|compliance|0
342495|NCT01180790|1155681|P3|Overall Study|compliance|0
342496|NCT01180790|1155682|P2|Overall Study|compliance|1
342497|NCT01180790|1155683|P1|Overall Study|compliance|0
342498|NCT01180790|1155677|P7|Overall Study|Lack of Efficacy|0
342499|NCT01180790|1155678|P6|Overall Study|Lack of Efficacy|3
342500|NCT01180790|1155679|P5|Overall Study|Lack of Efficacy|1
342501|NCT01180790|1155680|P4|Overall Study|Lack of Efficacy|6
342502|NCT01180790|1155681|P3|Overall Study|Lack of Efficacy|5
342503|NCT01180790|1155682|P2|Overall Study|Lack of Efficacy|2
342504|NCT01180790|1155683|P1|Overall Study|Lack of Efficacy|1
342505|NCT01180790|1155677|P7|Overall Study|Physician Decision|0
342506|NCT01180790|1155678|P6|Overall Study|Physician Decision|0
342507|NCT01180790|1155679|P5|Overall Study|Physician Decision|0
342508|NCT01180790|1155680|P4|Overall Study|Physician Decision|1
342509|NCT01180790|1155681|P3|Overall Study|Physician Decision|0
342510|NCT01180790|1155682|P2|Overall Study|Physician Decision|0
342511|NCT01180790|1155683|P1|Overall Study|Physician Decision|1
342512|NCT01180790|1155677|P7|Overall Study|Lost to Follow-up|1
342513|NCT01180790|1155678|P6|Overall Study|Lost to Follow-up|0
342514|NCT01180790|1155679|P5|Overall Study|Lost to Follow-up|1
342515|NCT01180790|1155680|P4|Overall Study|Lost to Follow-up|2
342516|NCT01180790|1155681|P3|Overall Study|Lost to Follow-up|0
342517|NCT01180790|1155682|P2|Overall Study|Lost to Follow-up|1
342518|NCT01180790|1155683|P1|Overall Study|Lost to Follow-up|3
342519|NCT01180790|1155677|P7|Overall Study|Withdrawal by Subject|0
342520|NCT01180790|1155678|P6|Overall Study|Withdrawal by Subject|1
342521|NCT01180790|1155679|P5|Overall Study|Withdrawal by Subject|2
342522|NCT01180790|1155680|P4|Overall Study|Withdrawal by Subject|0
342523|NCT01180790|1155681|P3|Overall Study|Withdrawal by Subject|5
342524|NCT01180790|1155682|P2|Overall Study|Withdrawal by Subject|0
342525|NCT01180790|1155683|P1|Overall Study|Withdrawal by Subject|3
342526|NCT01180790|1155677|P7|Overall Study|Adverse Event|0
342527|NCT01180790|1155678|P6|Overall Study|Adverse Event|3
342528|NCT01180790|1155679|P5|Overall Study|Adverse Event|1
342529|NCT01180790|1155680|P4|Overall Study|Adverse Event|0
342530|NCT01180790|1155681|P3|Overall Study|Adverse Event|2
342531|NCT01180790|1155682|P2|Overall Study|Adverse Event|1
342532|NCT01180790|1155683|P1|Overall Study|Adverse Event|1
342533|NCT01180777|1155748|P1|Overall Study|Adverse Event|1
342534|NCT01180777|1155748|P1|Overall Study|Lost to Follow-up|1
342535|NCT01180777|1155748|P1|Overall Study|Poor lens fit|4
342536|NCT01180777|1155748|P1|Overall Study|Protocol Violation|6
342537|NCT01180660|1155762|P2|Overall Study|Changed to open surgery|0
342538|NCT01180660|1155763|P1|Overall Study|Changed to open surgery|1
342539|NCT01180647|1155773|P2|Overall Study|Lost to Follow-up|6
342540|NCT01180647|1155774|P1|Overall Study|Lost to Follow-up|5
342541|NCT01180400|1155809|P2|Overall Study|Not specified|1
342542|NCT01180400|1155810|P1|Overall Study|Not specified|0
342543|NCT01180400|1155809|P2|Overall Study|Lost to Follow-up|3
342544|NCT01180400|1155810|P1|Overall Study|Lost to Follow-up|2
342545|NCT01180400|1155809|P2|Overall Study|Study-specific withdrawal criteria|2
342546|NCT01180400|1155810|P1|Overall Study|Study-specific withdrawal criteria|1
342547|NCT01180400|1155809|P2|Overall Study|Lack of Efficacy|0
342548|NCT01180400|1155810|P1|Overall Study|Lack of Efficacy|2
342549|NCT01180400|1155809|P2|Overall Study|Condition under investigation worsened|1
342550|NCT01180400|1155810|P1|Overall Study|Condition under investigation worsened|2
342551|NCT01180400|1155809|P2|Overall Study|Severe non-compliance to protocol|2
342552|NCT01180400|1155810|P1|Overall Study|Severe non-compliance to protocol|1
342553|NCT01180400|1155809|P2|Overall Study|Adverse Event|10
342554|NCT01180400|1155810|P1|Overall Study|Adverse Event|12
342555|NCT01180400|1155809|P2|Overall Study|Eligibility criteria not fulfilled|2
342556|NCT01180400|1155810|P1|Overall Study|Eligibility criteria not fulfilled|0
342557|NCT01180400|1155809|P2|Overall Study|Withdrawal by Subject|6
342558|NCT01180400|1155810|P1|Overall Study|Withdrawal by Subject|5
342559|NCT01180296|1155858|P2|Overall Study|Protocol Violation|2
342560|NCT01180296|1155859|P1|Overall Study|Protocol Violation|1
342561|NCT01180244|1155867|P2|Overall Study|Lost to Follow-up|0
342562|NCT01180244|1155868|P1|Overall Study|Lost to Follow-up|1
342563|NCT01180244|1155867|P2|Overall Study|Protocol Violation|0
342564|NCT01180244|1155868|P1|Overall Study|Protocol Violation|1
342565|NCT01180244|1155867|P2|Overall Study|Withdrawal by Subject|1
342566|NCT01180244|1155868|P1|Overall Study|Withdrawal by Subject|0
342567|NCT01180244|1155867|P2|Overall Study|Adverse Event|0
342568|NCT01180244|1155868|P1|Overall Study|Adverse Event|1
342569|NCT01180244|1155867|P2|Overall Study|Physician Decision|0
342570|NCT01180244|1155868|P1|Overall Study|Physician Decision|3
342571|NCT01180244|1155867|P2|Overall Study|Lack of Efficacy|7
342572|NCT01180244|1155868|P1|Overall Study|Lack of Efficacy|0
342573|NCT01180049|1155913|P2|Overall Study|Ongoing on treatment|10
342574|NCT01180049|1155914|P1|Overall Study|Ongoing on treatment|18
342575|NCT01180049|1155913|P2|Overall Study|Death|28
342576|NCT01180049|1155914|P1|Overall Study|Death|23
342577|NCT01180049|1155913|P2|Overall Study|Lost to Follow-up|1
342578|NCT01180049|1155914|P1|Overall Study|Lost to Follow-up|0
342579|NCT01180049|1155913|P2|Overall Study|Participant Refused Follow Up|3
342580|NCT01180049|1155914|P1|Overall Study|Participant Refused Follow Up|5
342749|NCT01178125|1156648|P1|Overall Study|Sponsor Decision|28
342581|NCT01180049|1155913|P2|Overall Study|Enrolled to Another Clinical Trial|1
342582|NCT01180049|1155914|P1|Overall Study|Enrolled to Another Clinical Trial|1
342583|NCT01179919|1155940|P1|Overall Study|Adverse Event|1
342584|NCT01179919|1155940|P1|Overall Study|Protocol Violation|1
342585|NCT01179737|1155949|P4|Extension|The study was terminated|0
342586|NCT01179737|1155950|P3|Extension|The study was terminated|0
342587|NCT01179737|1155951|P2|Extension|The study was terminated|0
342588|NCT01179737|1155952|P1|Extension|The study was terminated|3
342589|NCT01179737|1155949|P4|Cohort 1 & Cohort 2 Expansion|Death|0
342590|NCT01179737|1155950|P3|Cohort 1 & Cohort 2 Expansion|Death|0
342591|NCT01179737|1155951|P2|Cohort 1 & Cohort 2 Expansion|Death|0
342592|NCT01179737|1155952|P1|Cohort 1 & Cohort 2 Expansion|Death|1
342593|NCT01179737|1155949|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
342594|NCT01179737|1155950|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
342595|NCT01179737|1155951|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
342596|NCT01179737|1155952|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
342597|NCT01179737|1155949|P4|Cohort 1 & Cohort 2|Death|0
342598|NCT01179737|1155950|P3|Cohort 1 & Cohort 2|Death|1
342599|NCT01179737|1155951|P2|Cohort 1 & Cohort 2|Death|0
342600|NCT01179737|1155952|P1|Cohort 1 & Cohort 2|Death|0
342601|NCT01179737|1155949|P4|Cohort 1 & Cohort 2|Administrative problems|4
342602|NCT01179737|1155950|P3|Cohort 1 & Cohort 2|Administrative problems|2
342603|NCT01179737|1155951|P2|Cohort 1 & Cohort 2|Administrative problems|0
342604|NCT01179737|1155952|P1|Cohort 1 & Cohort 2|Administrative problems|0
342605|NCT01179737|1155949|P4|Cohort 1 & Cohort 2|Withdrew consent|0
342606|NCT01179737|1155950|P3|Cohort 1 & Cohort 2|Withdrew consent|0
342607|NCT01179737|1155951|P2|Cohort 1 & Cohort 2|Withdrew consent|0
342608|NCT01179737|1155952|P1|Cohort 1 & Cohort 2|Withdrew consent|2
342609|NCT01179737|1155949|P4|Cohort 1 & Cohort 2|Adverse Event|0
342610|NCT01179737|1155950|P3|Cohort 1 & Cohort 2|Adverse Event|1
342611|NCT01179737|1155951|P2|Cohort 1 & Cohort 2|Adverse Event|1
342612|NCT01179737|1155952|P1|Cohort 1 & Cohort 2|Adverse Event|3
342613|NCT01179672|1155963|P2|Overall Study|Physician Decision|1
342614|NCT01179672|1155964|P1|Overall Study|Physician Decision|1
342615|NCT01179672|1155963|P2|Overall Study|Protocol Violation|2
342616|NCT01179672|1155964|P1|Overall Study|Protocol Violation|2
342617|NCT01179672|1155963|P2|Overall Study|Lost to Follow-up|1
342618|NCT01179672|1155964|P1|Overall Study|Lost to Follow-up|0
342619|NCT01179672|1155963|P2|Overall Study|Entry Criteria Not Met|2
342620|NCT01179672|1155964|P1|Overall Study|Entry Criteria Not Met|0
342621|NCT01179672|1155963|P2|Overall Study|Withdrawal by Subject|12
342622|NCT01179672|1155964|P1|Overall Study|Withdrawal by Subject|10
342623|NCT01179672|1155963|P2|Overall Study|Adverse Event|8
342624|NCT01179672|1155964|P1|Overall Study|Adverse Event|17
342625|NCT01179516|1156020|P3|Overall Study|Other|2
342626|NCT01179516|1156021|P2|Overall Study|Other|0
342627|NCT01179516|1156022|P1|Overall Study|Other|2
342628|NCT01179516|1156020|P3|Overall Study|Lost to Follow-up|3
342629|NCT01179516|1156021|P2|Overall Study|Lost to Follow-up|7
342630|NCT01179516|1156022|P1|Overall Study|Lost to Follow-up|7
342631|NCT01179516|1156020|P3|Overall Study|Withdrawal of Consent|10
342632|NCT01179516|1156021|P2|Overall Study|Withdrawal of Consent|6
342633|NCT01179516|1156022|P1|Overall Study|Withdrawal of Consent|2
342634|NCT01179516|1156020|P3|Overall Study|Protocol Deviations|3
342635|NCT01179516|1156021|P2|Overall Study|Protocol Deviations|3
342636|NCT01179516|1156022|P1|Overall Study|Protocol Deviations|4
342637|NCT01179516|1156020|P3|Overall Study|Noncompliance with Study Drug|1
342638|NCT01179516|1156021|P2|Overall Study|Noncompliance with Study Drug|0
342639|NCT01179516|1156022|P1|Overall Study|Noncompliance with Study Drug|2
342640|NCT01179516|1156020|P3|Overall Study|Lack of Efficacy|0
342641|NCT01179516|1156021|P2|Overall Study|Lack of Efficacy|2
342642|NCT01179516|1156022|P1|Overall Study|Lack of Efficacy|4
342643|NCT01179516|1156020|P3|Overall Study|Pretreatment Event or Adverse Event|12
342644|NCT01179516|1156021|P2|Overall Study|Pretreatment Event or Adverse Event|8
342645|NCT01179516|1156022|P1|Overall Study|Pretreatment Event or Adverse Event|6
342646|NCT01179399|1156066|P1|Overall Study|Withdrawal by Subject|1
342647|NCT01179399|1156066|P1|Overall Study|Lack of Efficacy|30
342648|NCT01179399|1156066|P1|Overall Study|Adverse Event|1
342649|NCT01179347|1156072|P2|Open-label Period (12 Weeks)|Other|4
342650|NCT01179347|1156073|P1|Open-label Period (12 Weeks)|Other|7
342651|NCT01179347|1156072|P2|Open-label Period (12 Weeks)|Protocol Violation|0
342652|NCT01179347|1156073|P1|Open-label Period (12 Weeks)|Protocol Violation|1
342653|NCT01179347|1156072|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
342654|NCT01179347|1156073|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
342655|NCT01179347|1156072|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
342656|NCT01179347|1156073|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
342657|NCT01179347|1156072|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
342658|NCT01179347|1156073|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
342659|NCT01179347|1156072|P2|Open-label Period (12 Weeks)|Adverse Event|9
342660|NCT01179347|1156073|P1|Open-label Period (12 Weeks)|Adverse Event|5
342661|NCT01179347|1156072|P2|Double-blind Period (12 Weeks)|Other|4
342662|NCT01179347|1156073|P1|Double-blind Period (12 Weeks)|Other|2
342663|NCT01179347|1156072|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
342664|NCT01179347|1156073|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
342665|NCT01179347|1156072|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
342666|NCT01179347|1156073|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
342667|NCT01179347|1156072|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
342668|NCT01179347|1156073|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
342669|NCT01179347|1156072|P2|Double-blind Period (12 Weeks)|Adverse Event|6
342670|NCT01179347|1156073|P1|Double-blind Period (12 Weeks)|Adverse Event|2
342671|NCT01179334|1156095|P2|Long-term Extension (LTE) Period|Adverse Event|4
342672|NCT01179334|1156096|P1|Long-term Extension (LTE) Period|Adverse Event|2
342673|NCT01179334|1156095|P2|Long-term Extension (LTE) Period|Death|0
342674|NCT01179334|1156096|P1|Long-term Extension (LTE) Period|Death|3
342675|NCT01179334|1156095|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
342676|NCT01179334|1156096|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
342677|NCT01179334|1156095|P2|Treatment Period|Adverse Event|0
342678|NCT01179334|1156096|P1|Treatment Period|Adverse Event|1
342679|NCT01179191|1156151|P1|Maintenance Phase (8 Weeks)|Other|66
342680|NCT01179191|1156151|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
342681|NCT01179191|1156151|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
342682|NCT01179191|1156151|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
342683|NCT01179191|1156151|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
342684|NCT01179191|1156151|P1|Titration Phase (up to 6 Weeks)|Other|62
342685|NCT01179191|1156151|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
342686|NCT01179191|1156151|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
342687|NCT01179191|1156151|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
342688|NCT01179191|1156151|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
342689|NCT01179191|1156151|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
342690|NCT01179048|1156183|P2|Overall Study|Alive|142
342691|NCT01179048|1156184|P1|Overall Study|Alive|127
342692|NCT01179048|1156183|P2|Overall Study|Lost to Follow-up|9
342693|NCT01179048|1156184|P1|Overall Study|Lost to Follow-up|8
342694|NCT01179048|1156183|P2|Overall Study|Withdrawn - does not allow contact|8
342695|NCT01179048|1156184|P1|Overall Study|Withdrawn - does not allow contact|4
342696|NCT01178853|1156211|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
342697|NCT01178853|1156212|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
342698|NCT01178853|1156211|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
342699|NCT01178853|1156212|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
342700|NCT01178853|1156211|P2|Period 3 (Warfarin Titration)|Adverse Event|0
342701|NCT01178853|1156212|P1|Period 3 (Warfarin Titration)|Adverse Event|1
342702|NCT01178853|1156211|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
342703|NCT01178853|1156212|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
342704|NCT01178853|1156211|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
342705|NCT01178853|1156212|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
342706|NCT01178762|1156252|P1|Overall Study|Lost to Follow-up|15
342707|NCT01178671|1156258|P2|Overall Study|Physician Decision|6
342708|NCT01178671|1156259|P1|Overall Study|Physician Decision|4
342709|NCT01178671|1156258|P2|Overall Study|Lost to Follow-up|1
342710|NCT01178671|1156259|P1|Overall Study|Lost to Follow-up|3
342711|NCT01178671|1156258|P2|Overall Study|Lack of Efficacy|1
342712|NCT01178671|1156259|P1|Overall Study|Lack of Efficacy|0
342713|NCT01178671|1156258|P2|Overall Study|Protocol Violation|1
342714|NCT01178671|1156259|P1|Overall Study|Protocol Violation|1
342715|NCT01178671|1156258|P2|Overall Study|Adverse Event|6
342716|NCT01178671|1156259|P1|Overall Study|Adverse Event|4
342717|NCT01178385|1156307|P2|Overall Study|Withdrawal by Subject|0
342718|NCT01178385|1156308|P1|Overall Study|Withdrawal by Subject|2
342719|NCT01178294|1156377|P1|Overall Study|Completion status could not be verified|1
342720|NCT01178294|1156377|P1|Overall Study|Subject status is terminal|1
342721|NCT01178294|1156377|P1|Overall Study|Development of inhibitors to OBI-1|1
342722|NCT01178294|1156377|P1|Overall Study|Death|1
342723|NCT01178294|1156377|P1|Overall Study|Lack of Efficacy|1
342724|NCT01178294|1156377|P1|Overall Study|Lost to Follow-up|2
342725|NCT01178294|1156377|P1|Overall Study|Adverse Event|4
342726|NCT01178281|1156400|P2|Overall Study|Prohibited Medications|2
342727|NCT01178281|1156401|P1|Overall Study|Prohibited Medications|0
342728|NCT01178281|1156400|P2|Overall Study|Adverse Event|9
342729|NCT01178281|1156401|P1|Overall Study|Adverse Event|39
342730|NCT01178281|1156400|P2|Overall Study|Withdrawal by Subject|7
342731|NCT01178281|1156401|P1|Overall Study|Withdrawal by Subject|18
342732|NCT01178281|1156400|P2|Overall Study|Death|5
342733|NCT01178281|1156401|P1|Overall Study|Death|4
342734|NCT01178281|1156400|P2|Overall Study|Disease Progression|6
342735|NCT01178281|1156401|P1|Overall Study|Disease Progression|18
342736|NCT01178281|1156400|P2|Overall Study|Non-compliance to study drug|0
342737|NCT01178281|1156401|P1|Overall Study|Non-compliance to study drug|1
342738|NCT01178281|1156400|P2|Overall Study|Lack of Efficacy|38
342739|NCT01178281|1156401|P1|Overall Study|Lack of Efficacy|60
342740|NCT01178281|1156400|P2|Overall Study|Loss of Clinical Benefit|7
342741|NCT01178281|1156401|P1|Overall Study|Loss of Clinical Benefit|5
342742|NCT01178281|1156400|P2|Overall Study|Physician Decision|3
342743|NCT01178281|1156401|P1|Overall Study|Physician Decision|4
342744|NCT01178138|1156627|P1|Overall Study|Physician Decision|8
342745|NCT01178138|1156627|P1|Overall Study|Withdrawal by Subject|7
342746|NCT01178138|1156627|P1|Overall Study|Lost to Follow-up|8
342747|NCT01178125|1156648|P1|Overall Study|Investigator Decision|5
342748|NCT01178125|1156648|P1|Overall Study|Protocol Violation|17
342750|NCT01178125|1156648|P1|Overall Study|Other Reason|39
342751|NCT01178125|1156648|P1|Overall Study|Pregnancy|55
342752|NCT01178125|1156648|P1|Overall Study|Noncompliance|184
342753|NCT01178125|1156648|P1|Overall Study|Withdrawal by Subject|209
342754|NCT01178125|1156648|P1|Overall Study|Adverse Event|244
342755|NCT01178125|1156648|P1|Overall Study|Lost to Follow-up|397
342756|NCT01178099|1156679|P2|Overall Study|Physician Decision|1
342757|NCT01178099|1156680|P1|Overall Study|Physician Decision|0
342758|NCT01178073|1156721|P3|Overall Study|Missing Completion Status|0
342759|NCT01178073|1156722|P2|Overall Study|Missing Completion Status|0
342760|NCT01178073|1156723|P1|Overall Study|Missing Completion Status|1
342761|NCT01178073|1156721|P3|Overall Study|Withdrawal by Subject|8
342762|NCT01178073|1156722|P2|Overall Study|Withdrawal by Subject|6
342763|NCT01178073|1156723|P1|Overall Study|Withdrawal by Subject|10
342764|NCT01178073|1156721|P3|Overall Study|Physician Decision|10
342765|NCT01178073|1156722|P2|Overall Study|Physician Decision|10
342766|NCT01178073|1156723|P1|Overall Study|Physician Decision|14
342767|NCT01178073|1156721|P3|Overall Study|Lost to Follow-up|3
342768|NCT01178073|1156722|P2|Overall Study|Lost to Follow-up|0
342769|NCT01178073|1156723|P1|Overall Study|Lost to Follow-up|2
342770|NCT01178073|1156721|P3|Overall Study|Protocol Violation|1
342771|NCT01178073|1156722|P2|Overall Study|Protocol Violation|1
342772|NCT01178073|1156723|P1|Overall Study|Protocol Violation|1
342773|NCT01178073|1156721|P3|Overall Study|Adverse Event|24
342774|NCT01178073|1156722|P2|Overall Study|Adverse Event|27
342775|NCT01178073|1156723|P1|Overall Study|Adverse Event|34
342776|NCT01177969|1156754|P2|Overall Study|Withdrawal by Subject|2
342777|NCT01177969|1156755|P1|Overall Study|Withdrawal by Subject|1
342778|NCT01177969|1156754|P2|Overall Study|Protocol Violation|1
342779|NCT01177969|1156755|P1|Overall Study|Protocol Violation|2
342780|NCT01177943|1156778|P2|First Intervention|Withdrawal by Subject|0
342781|NCT01177943|1156779|P1|First Intervention|Withdrawal by Subject|2
342782|NCT01177813|1156792|P5|Overall Study|Other reason not defined above|2
342783|NCT01177813|1156793|P4|Overall Study|Other reason not defined above|3
342784|NCT01177813|1156794|P3|Overall Study|Other reason not defined above|2
342785|NCT01177813|1156795|P2|Overall Study|Other reason not defined above|2
342786|NCT01177813|1156796|P1|Overall Study|Other reason not defined above|5
342787|NCT01177813|1156792|P5|Overall Study|Withdrawal by Subject|3
342788|NCT01177813|1156793|P4|Overall Study|Withdrawal by Subject|5
342789|NCT01177813|1156794|P3|Overall Study|Withdrawal by Subject|6
342790|NCT01177813|1156795|P2|Overall Study|Withdrawal by Subject|7
342791|NCT01177813|1156796|P1|Overall Study|Withdrawal by Subject|12
342792|NCT01177813|1156792|P5|Overall Study|Lost to Follow-up|0
342793|NCT01177813|1156793|P4|Overall Study|Lost to Follow-up|3
342794|NCT01177813|1156794|P3|Overall Study|Lost to Follow-up|6
342795|NCT01177813|1156795|P2|Overall Study|Lost to Follow-up|5
342796|NCT01177813|1156796|P1|Overall Study|Lost to Follow-up|12
342797|NCT01177813|1156792|P5|Overall Study|Protocol Violation|1
342798|NCT01177813|1156793|P4|Overall Study|Protocol Violation|0
342799|NCT01177813|1156794|P3|Overall Study|Protocol Violation|2
342800|NCT01177813|1156795|P2|Overall Study|Protocol Violation|2
342801|NCT01177813|1156796|P1|Overall Study|Protocol Violation|3
342802|NCT01177813|1156792|P5|Overall Study|Lack of Efficacy|0
342803|NCT01177813|1156793|P4|Overall Study|Lack of Efficacy|0
342804|NCT01177813|1156794|P3|Overall Study|Lack of Efficacy|0
342805|NCT01177813|1156795|P2|Overall Study|Lack of Efficacy|0
342806|NCT01177813|1156796|P1|Overall Study|Lack of Efficacy|1
342807|NCT01177813|1156792|P5|Overall Study|Adverse Event|3
342808|NCT01177813|1156793|P4|Overall Study|Adverse Event|6
342809|NCT01177813|1156794|P3|Overall Study|Adverse Event|4
342810|NCT01177813|1156795|P2|Overall Study|Adverse Event|2
342811|NCT01177813|1156796|P1|Overall Study|Adverse Event|8
342812|NCT01177800|1156825|P2|Overall Study|Withdrawal of informed consent|1
342813|NCT01177800|1156826|P1|Overall Study|Withdrawal of informed consent|0
342814|NCT01177800|1156825|P2|Overall Study|Physician Decision|0
342815|NCT01177800|1156826|P1|Overall Study|Physician Decision|1
342816|NCT01177800|1156825|P2|Overall Study|Protocol Violation|1
342817|NCT01177800|1156826|P1|Overall Study|Protocol Violation|0
342818|NCT01177800|1156825|P2|Overall Study|Adverse Event|3
342819|NCT01177800|1156826|P1|Overall Study|Adverse Event|9
342820|NCT01177722|1156848|P4|Overall Study|Withdrawal by Subject|6
342821|NCT01177722|1156849|P3|Overall Study|Withdrawal by Subject|4
342822|NCT01177722|1156850|P2|Overall Study|Withdrawal by Subject|6
342823|NCT01177722|1156851|P1|Overall Study|Withdrawal by Subject|10
342824|NCT01177722|1156848|P4|Overall Study|Lost to Follow-up|1
342825|NCT01177722|1156849|P3|Overall Study|Lost to Follow-up|3
342826|NCT01177722|1156850|P2|Overall Study|Lost to Follow-up|4
342827|NCT01177722|1156851|P1|Overall Study|Lost to Follow-up|3
342828|NCT01177722|1156848|P4|Overall Study|Protocol Violation|0
342829|NCT01177722|1156849|P3|Overall Study|Protocol Violation|1
342830|NCT01177722|1156850|P2|Overall Study|Protocol Violation|0
342831|NCT01177722|1156851|P1|Overall Study|Protocol Violation|0
342832|NCT01177722|1156848|P4|Overall Study|Serious Adverse Event|0
342833|NCT01177722|1156849|P3|Overall Study|Serious Adverse Event|1
342834|NCT01177722|1156850|P2|Overall Study|Serious Adverse Event|0
342835|NCT01177722|1156851|P1|Overall Study|Serious Adverse Event|0
342836|NCT01177670|1156883|P1|Overall Study|Withdrawal by Subject|4
342837|NCT01177670|1156883|P1|Overall Study|Physician Decision|50
342838|NCT01177670|1156883|P1|Overall Study|Study Terminated|115
342839|NCT01177553|1156890|P2|Overall Study|babies not yet 6 months of age|0
342840|NCT01177553|1156891|P1|Overall Study|babies not yet 6 months of age|1
342841|NCT01177410|1156900|P3|Overall Study|Lost to Follow-up|0
342842|NCT01177410|1156901|P2|Overall Study|Lost to Follow-up|1
342843|NCT01177410|1156902|P1|Overall Study|Lost to Follow-up|0
342844|NCT01177410|1156900|P3|Overall Study|Withdrawal by Subject|3
342845|NCT01177410|1156901|P2|Overall Study|Withdrawal by Subject|4
342846|NCT01177410|1156902|P1|Overall Study|Withdrawal by Subject|1
342847|NCT01177410|1156900|P3|Overall Study|Adverse Event|2
342848|NCT01177410|1156901|P2|Overall Study|Adverse Event|2
342849|NCT01177410|1156902|P1|Overall Study|Adverse Event|0
342850|NCT01177384|1156915|P2|Overall Study|Withdrawal by Subject|12
342851|NCT01177384|1156916|P1|Overall Study|Withdrawal by Subject|5
342852|NCT01177384|1156915|P2|Overall Study|Protocol Violation|2
342853|NCT01177384|1156916|P1|Overall Study|Protocol Violation|0
342854|NCT01177384|1156915|P2|Overall Study|Physician Decision|3
342855|NCT01177384|1156916|P1|Overall Study|Physician Decision|0
342856|NCT01177384|1156915|P2|Overall Study|Lost to Follow-up|4
342857|NCT01177384|1156916|P1|Overall Study|Lost to Follow-up|3
342858|NCT01177384|1156915|P2|Overall Study|Lack of Efficacy|1
342859|NCT01177384|1156916|P1|Overall Study|Lack of Efficacy|0
342860|NCT01177384|1156915|P2|Overall Study|Adverse Event|4
342861|NCT01177384|1156916|P1|Overall Study|Adverse Event|6
342862|NCT01177293|1156928|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
342863|NCT01177293|1156929|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
342864|NCT01177228|1156947|P4|Overall Study|Withdrawal by Subject|0
342865|NCT01177228|1156948|P3|Overall Study|Withdrawal by Subject|0
342866|NCT01177228|1156949|P2|Overall Study|Withdrawal by Subject|1
342867|NCT01177228|1156950|P1|Overall Study|Withdrawal by Subject|0
342868|NCT01177228|1156947|P4|Overall Study|Worsening disease activity|0
342869|NCT01177228|1156948|P3|Overall Study|Worsening disease activity|0
342870|NCT01177228|1156949|P2|Overall Study|Worsening disease activity|0
342871|NCT01177228|1156950|P1|Overall Study|Worsening disease activity|1
342872|NCT01177228|1156947|P4|Overall Study|Positive tuberculosis test|0
342873|NCT01177228|1156948|P3|Overall Study|Positive tuberculosis test|0
342874|NCT01177228|1156949|P2|Overall Study|Positive tuberculosis test|1
342875|NCT01177228|1156950|P1|Overall Study|Positive tuberculosis test|0
342876|NCT01177007|1157007|P1|Overall Study|Change in treatment modality|21
342877|NCT01177007|1157007|P1|Overall Study|Required additional Y90 treatment|6
342878|NCT01177007|1157007|P1|Overall Study|Entered hospice care|5
342879|NCT01177007|1157007|P1|Overall Study|Death|4
342880|NCT01177007|1157007|P1|Overall Study|Lost to Follow-up|2
342881|NCT01176968|1157021|P2|Overall Study|Reason not defined|3
342882|NCT01176968|1157022|P1|Overall Study|Reason not defined|5
342883|NCT01176968|1157021|P2|Overall Study|Study terminated by sponsor|1
342884|NCT01176968|1157022|P1|Overall Study|Study terminated by sponsor|0
342885|NCT01176968|1157021|P2|Overall Study|Did Not Meet Entrance Criteria|0
342886|NCT01176968|1157022|P1|Overall Study|Did Not Meet Entrance Criteria|1
342887|NCT01176968|1157021|P2|Overall Study|Protocol Violation|1
342888|NCT01176968|1157022|P1|Overall Study|Protocol Violation|2
342889|NCT01176968|1157021|P2|Overall Study|Withdrawal by Subject|48
342890|NCT01176968|1157022|P1|Overall Study|Withdrawal by Subject|48
342891|NCT01176968|1157021|P2|Overall Study|Lost to Follow-up|14
342892|NCT01176968|1157022|P1|Overall Study|Lost to Follow-up|16
342893|NCT01176968|1157021|P2|Overall Study|Lack of Efficacy|1
342894|NCT01176968|1157022|P1|Overall Study|Lack of Efficacy|0
342895|NCT01176968|1157021|P2|Overall Study|Death|3
342896|NCT01176968|1157022|P1|Overall Study|Death|2
342897|NCT01176968|1157021|P2|Overall Study|Adverse Event|11
342898|NCT01176968|1157022|P1|Overall Study|Adverse Event|10
342899|NCT01176773|1157073|P1|Overall Study|Withdrew consent|1
342900|NCT01176773|1157073|P1|Overall Study|Screen Failure|2
342901|NCT01176565|1157097|P2|Overall Study|Not Analyzed (any other reason)|2
342902|NCT01176565|1157098|P1|Overall Study|Not Analyzed (any other reason)|1
342903|NCT01176565|1157097|P2|Overall Study|Withdrawal by Subject|1
342904|NCT01176565|1157098|P1|Overall Study|Withdrawal by Subject|7
342905|NCT01176565|1157097|P2|Overall Study|Lost to Follow-up|16
342906|NCT01176565|1157098|P1|Overall Study|Lost to Follow-up|12
342907|NCT01176513|1157116|P1|Overall Study|Withdrew subjects prior to dosing|3
342908|NCT01176292|1157144|P2|Overall Study|Has not scheduled one-year visit yet|2
342909|NCT01176292|1157145|P1|Overall Study|Has not scheduled one-year visit yet|2
342910|NCT01176292|1157144|P2|Overall Study|Physician Decision|2
342911|NCT01176292|1157145|P1|Overall Study|Physician Decision|0
342912|NCT01176292|1157144|P2|Overall Study|Adverse Event|1
342913|NCT01176292|1157145|P1|Overall Study|Adverse Event|1
342914|NCT01176292|1157144|P2|Overall Study|Lost to Follow-up|4
342915|NCT01176292|1157145|P1|Overall Study|Lost to Follow-up|2
342916|NCT01176266|1157163|P1|Overall Study|Withdrawal by Subject|3
342917|NCT01176266|1157163|P1|Overall Study|Death|6
342918|NCT01176240|1157187|P2|Study 306B|withdrew prior to dosing|1
342919|NCT01176240|1157188|P1|Study 306B|withdrew prior to dosing|2
342920|NCT01176240|1157187|P2|Study 306B|Lost to Follow-up|1
342921|NCT01176240|1157188|P1|Study 306B|Lost to Follow-up|0
342922|NCT01176240|1157187|P2|Study 306B|Supine Hypertension|2
342923|NCT01176240|1157188|P1|Study 306B|Supine Hypertension|1
342924|NCT01176240|1157187|P2|Study 306B|Physician Decision|1
342925|NCT01176240|1157188|P1|Study 306B|Physician Decision|2
342926|NCT01176240|1157187|P2|Study 306B|Withdrawal by Subject|1
342927|NCT01176240|1157188|P1|Study 306B|Withdrawal by Subject|4
342928|NCT01176240|1157187|P2|Study 306B|Protocol Violation|3
342929|NCT01176240|1157188|P1|Study 306B|Protocol Violation|2
342930|NCT01176240|1157187|P2|Study 306B|Adverse Event|5
342931|NCT01176240|1157188|P1|Study 306B|Adverse Event|10
342932|NCT01176240|1157187|P2|Study 306B|Lack of Efficacy|3
342933|NCT01176240|1157188|P1|Study 306B|Lack of Efficacy|5
342934|NCT01176240|1157187|P2|Study 306A|Stop due to diverse problems|0
342935|NCT01176240|1157188|P1|Study 306A|Stop due to diverse problems|1
342936|NCT01176240|1157187|P2|Study 306A|Withdrawal by Subject|1
342937|NCT01176240|1157188|P1|Study 306A|Withdrawal by Subject|0
342938|NCT01176240|1157187|P2|Study 306A|Protocol Violation|1
342939|NCT01176240|1157188|P1|Study 306A|Protocol Violation|0
342940|NCT01176240|1157187|P2|Study 306A|Lack of Efficacy|1
342941|NCT01176240|1157188|P1|Study 306A|Lack of Efficacy|2
342942|NCT01176058|1157214|P2|Overall Study|Withdrawal by Subject|0
342943|NCT01176058|1157215|P1|Overall Study|Withdrawal by Subject|1
342944|NCT01176058|1157214|P2|Overall Study|Insufficient mycological response|1
342945|NCT01176058|1157215|P1|Overall Study|Insufficient mycological response|0
342946|NCT01176058|1157214|P2|Overall Study|Insufficient clinical response|2
342947|NCT01176058|1157215|P1|Overall Study|Insufficient clinical response|2
342948|NCT01176058|1157214|P2|Overall Study|Adverse Event|0
342949|NCT01176058|1157215|P1|Overall Study|Adverse Event|1
342950|NCT01176032|1157239|P2|Overall Study|Not available|0
342951|NCT01176032|1157240|P1|Overall Study|Not available|1
342952|NCT01176032|1157239|P2|Overall Study|Informed consent withdrawn|0
342953|NCT01176032|1157240|P1|Overall Study|Informed consent withdrawn|3
342954|NCT01176032|1157239|P2|Overall Study|Protocol Violation|0
342955|NCT01176032|1157240|P1|Overall Study|Protocol Violation|1
342956|NCT01176032|1157239|P2|Overall Study|Unsatisfactory therapeutic effect|1
342957|NCT01176032|1157240|P1|Overall Study|Unsatisfactory therapeutic effect|0
342958|NCT01176032|1157239|P2|Overall Study|Adverse Event|0
342959|NCT01176032|1157240|P1|Overall Study|Adverse Event|1
342960|NCT01175824|1157364|P2|Overall Study|Entry Criteria Not Met|4
342961|NCT01175824|1157365|P1|Overall Study|Entry Criteria Not Met|6
342962|NCT01175824|1157364|P2|Overall Study|Sponsor Decision|0
342963|NCT01175824|1157365|P1|Overall Study|Sponsor Decision|1
342964|NCT01175824|1157364|P2|Overall Study|Withdrawal by Subject|7
342965|NCT01175824|1157365|P1|Overall Study|Withdrawal by Subject|3
342966|NCT01175824|1157364|P2|Overall Study|Protocol Violation|5
342967|NCT01175824|1157365|P1|Overall Study|Protocol Violation|2
342968|NCT01175824|1157364|P2|Overall Study|Physician Decision|4
342969|NCT01175824|1157365|P1|Overall Study|Physician Decision|0
342970|NCT01175824|1157364|P2|Overall Study|Lost to Follow-up|1
342971|NCT01175824|1157365|P1|Overall Study|Lost to Follow-up|0
342972|NCT01175824|1157364|P2|Overall Study|Lack of Efficacy|0
342973|NCT01175824|1157365|P1|Overall Study|Lack of Efficacy|2
342974|NCT01175824|1157364|P2|Overall Study|Adverse Event|1
342975|NCT01175824|1157365|P1|Overall Study|Adverse Event|2
342976|NCT01175811|1157399|P2|Overall Study|Withdrawal by Subject|7
342977|NCT01175811|1157400|P1|Overall Study|Withdrawal by Subject|6
342978|NCT01175811|1157399|P2|Overall Study|Protocol Violation|2
342979|NCT01175811|1157400|P1|Overall Study|Protocol Violation|1
342980|NCT01175811|1157399|P2|Overall Study|Physician Decision|1
342981|NCT01175811|1157400|P1|Overall Study|Physician Decision|1
342982|NCT01175811|1157399|P2|Overall Study|Lost to Follow-up|2
342983|NCT01175811|1157400|P1|Overall Study|Lost to Follow-up|3
342984|NCT01175811|1157399|P2|Overall Study|Lack of Efficacy|0
342985|NCT01175811|1157400|P1|Overall Study|Lack of Efficacy|1
342986|NCT01175811|1157399|P2|Overall Study|Entry criteria not met|1
342987|NCT01175811|1157400|P1|Overall Study|Entry criteria not met|3
342988|NCT01175811|1157399|P2|Overall Study|Adverse Event|1
342989|NCT01175811|1157400|P1|Overall Study|Adverse Event|1
342990|NCT01175707|1157435|P2|Overall Study|Adverse Event|6
342991|NCT01175707|1157436|P1|Overall Study|Adverse Event|4
342992|NCT01175668|1157472|P2|Overall Study|Withdrawal by Subject|0
342993|NCT01175668|1157473|P1|Overall Study|Withdrawal by Subject|2
342994|NCT01175590|1157483|P2|Overall Study|Protocol Violation|1
342995|NCT01175590|1157484|P1|Overall Study|Protocol Violation|0
342996|NCT01175590|1157483|P2|Overall Study|Herpes Simplex Dermatitis|0
342997|NCT01175590|1157484|P1|Overall Study|Herpes Simplex Dermatitis|1
342998|NCT01175590|1157483|P2|Overall Study|Treated not as randomized|2
342999|NCT01175590|1157484|P1|Overall Study|Treated not as randomized|3
343000|NCT01175590|1157483|P2|Overall Study|Residual Bacterial Conjunctivitis|0
343001|NCT01175590|1157484|P1|Overall Study|Residual Bacterial Conjunctivitis|1
343002|NCT01175590|1157483|P2|Overall Study|Lack of Efficacy|1
343003|NCT01175590|1157484|P1|Overall Study|Lack of Efficacy|1
343004|NCT01175590|1157483|P2|Overall Study|Physician Decision|4
343005|NCT01175590|1157484|P1|Overall Study|Physician Decision|1
343006|NCT01175590|1157483|P2|Overall Study|Adverse Event|0
343007|NCT01175590|1157484|P1|Overall Study|Adverse Event|4
343008|NCT01175590|1157483|P2|Overall Study|Withdrawal by Subject|2
343009|NCT01175590|1157484|P1|Overall Study|Withdrawal by Subject|0
343010|NCT01175590|1157483|P2|Overall Study|Lost to Follow-up|0
343011|NCT01175590|1157484|P1|Overall Study|Lost to Follow-up|1
343012|NCT01175473|1157518|P2|Overall Study|Adverse Event|2
343013|NCT01175473|1157519|P1|Overall Study|Adverse Event|2
343014|NCT01175382|1157560|P3|Overall Study|Unable to tolerate study meds|1
343015|NCT01175382|1157561|P2|Overall Study|Unable to tolerate study meds|1
343016|NCT01175382|1157562|P1|Overall Study|Unable to tolerate study meds|0
343017|NCT01175382|1157560|P3|Overall Study|Unwilling to follow protocol|0
343018|NCT01175382|1157561|P2|Overall Study|Unwilling to follow protocol|1
343019|NCT01175382|1157562|P1|Overall Study|Unwilling to follow protocol|0
343020|NCT01175382|1157560|P3|Overall Study|Unable/unwilling to attend visits|2
343021|NCT01175382|1157561|P2|Overall Study|Unable/unwilling to attend visits|1
343022|NCT01175382|1157562|P1|Overall Study|Unable/unwilling to attend visits|3
343023|NCT01175382|1157560|P3|Overall Study|No longer having problem|1
343024|NCT01175382|1157561|P2|Overall Study|No longer having problem|0
343025|NCT01175382|1157562|P1|Overall Study|No longer having problem|1
343026|NCT01175382|1157560|P3|Overall Study|Withdrawal by Subject|1
343027|NCT01175382|1157561|P2|Overall Study|Withdrawal by Subject|0
343028|NCT01175382|1157562|P1|Overall Study|Withdrawal by Subject|0
343029|NCT01175382|1157560|P3|Overall Study|Physician Decision|0
343030|NCT01175382|1157561|P2|Overall Study|Physician Decision|1
343031|NCT01175382|1157562|P1|Overall Study|Physician Decision|0
343032|NCT01175382|1157560|P3|Overall Study|Lost to Follow-up|1
343033|NCT01175382|1157561|P2|Overall Study|Lost to Follow-up|3
343034|NCT01175382|1157562|P1|Overall Study|Lost to Follow-up|4
343035|NCT01175356|1157648|P1|Overall Study|Initiation other tx prior to completion|9
343036|NCT01175356|1157648|P1|Overall Study|Inadequate stem cell for transplant|1
343037|NCT01175356|1157648|P1|Overall Study|On other COG study w/tumor tx intent|7
343038|NCT01175356|1157648|P1|Overall Study|Pts MIBG non-avid after enrollment|2
343039|NCT01175356|1157648|P1|Overall Study|Refusal by patient/parent/guardian|6
343040|NCT01175356|1157648|P1|Overall Study|Treatment Slot Not Available|18
343041|NCT01175356|1157648|P1|Overall Study|Ineligible|1
343042|NCT01175356|1157648|P1|Overall Study|Physician Decision|23
343043|NCT01175356|1157648|P1|Overall Study|Lost to Follow-up|1
343044|NCT01175356|1157648|P1|Overall Study|Lack of Efficacy|12
343045|NCT01175356|1157648|P1|Overall Study|Death|1
343046|NCT01175213|1157688|P2|Safety Follow-up|Adverse Event|0
343047|NCT01175213|1157689|P1|Safety Follow-up|Adverse Event|1
343048|NCT01175213|1157688|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
343049|NCT01175213|1157689|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
343050|NCT01175213|1157688|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
343051|NCT01175213|1157689|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
343052|NCT01175213|1157688|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
343053|NCT01175213|1157689|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
343054|NCT01175213|1157688|P2|IGSC, 10%/rHuPH20|Death|0
343055|NCT01175213|1157689|P1|IGSC, 10%/rHuPH20|Death|1
343056|NCT01175213|1157688|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
343057|NCT01175213|1157689|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
343058|NCT01175135|1157746|P4|Overall Study|Randomized But Not Treated|0
343059|NCT01175135|1157747|P3|Overall Study|Randomized But Not Treated|1
343060|NCT01175135|1157748|P2|Overall Study|Randomized But Not Treated|0
343061|NCT01175135|1157749|P1|Overall Study|Randomized But Not Treated|0
343062|NCT01175135|1157746|P4|Overall Study|Other|0
343063|NCT01175135|1157747|P3|Overall Study|Other|3
343064|NCT01175135|1157748|P2|Overall Study|Other|1
343065|NCT01175135|1157749|P1|Overall Study|Other|3
343066|NCT01175135|1157746|P4|Overall Study|Withdrawal by Subject|5
343067|NCT01175135|1157747|P3|Overall Study|Withdrawal by Subject|5
343068|NCT01175135|1157748|P2|Overall Study|Withdrawal by Subject|8
343069|NCT01175135|1157749|P1|Overall Study|Withdrawal by Subject|4
343070|NCT01175135|1157746|P4|Overall Study|Protocol Violation|0
343071|NCT01175135|1157747|P3|Overall Study|Protocol Violation|0
343072|NCT01175135|1157748|P2|Overall Study|Protocol Violation|1
343073|NCT01175135|1157749|P1|Overall Study|Protocol Violation|1
343074|NCT01175135|1157746|P4|Overall Study|Lost to Follow-up|0
343075|NCT01175135|1157747|P3|Overall Study|Lost to Follow-up|0
343076|NCT01175135|1157748|P2|Overall Study|Lost to Follow-up|2
343077|NCT01175135|1157749|P1|Overall Study|Lost to Follow-up|1
343078|NCT01175135|1157746|P4|Overall Study|Lack of Efficacy|5
343079|NCT01175135|1157747|P3|Overall Study|Lack of Efficacy|0
343080|NCT01175135|1157748|P2|Overall Study|Lack of Efficacy|5
343081|NCT01175135|1157749|P1|Overall Study|Lack of Efficacy|4
343082|NCT01175135|1157746|P4|Overall Study|Death|0
343083|NCT01175135|1157747|P3|Overall Study|Death|0
343084|NCT01175135|1157748|P2|Overall Study|Death|0
343085|NCT01175135|1157749|P1|Overall Study|Death|1
343086|NCT01175135|1157746|P4|Overall Study|Adverse Event|4
343087|NCT01175135|1157747|P3|Overall Study|Adverse Event|3
343088|NCT01175135|1157748|P2|Overall Study|Adverse Event|5
343089|NCT01175135|1157749|P1|Overall Study|Adverse Event|2
343090|NCT01175018|1157841|P2|Overall Study|Adverse Event|1
343091|NCT01175018|1157842|P1|Overall Study|Adverse Event|3
343092|NCT01174550|1157931|P2|Overall Study|Withdrawal by Subject|289
343093|NCT01174550|1157932|P1|Overall Study|Withdrawal by Subject|543
343094|NCT01174550|1157931|P2|Overall Study|Lost to Follow-up|510
343095|NCT01174550|1157932|P1|Overall Study|Lost to Follow-up|652
343096|NCT01174550|1157931|P2|Overall Study|Death|74
343097|NCT01174550|1157932|P1|Overall Study|Death|75
343098|NCT01174459|1157960|P1|Overall Study|case report form (CRF) not collected|5
343099|NCT01174446|1157965|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
343100|NCT01174446|1157966|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
343101|NCT01174446|1157967|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
343102|NCT01174446|1157968|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
343103|NCT01174446|1157965|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
343104|NCT01174446|1157966|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
343105|NCT01174446|1157967|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
343106|NCT01174446|1157968|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
343107|NCT01174446|1157965|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
343108|NCT01174446|1157966|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
343109|NCT01174446|1157967|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
343110|NCT01174446|1157968|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
343111|NCT01174446|1157965|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
343112|NCT01174446|1157966|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
343113|NCT01174446|1157967|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
343114|NCT01174446|1157968|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
343115|NCT01174342|1158155|P1|Overall Study|Conversion to cesarean section|4
343116|NCT01174264|1158162|P3|Steady-state Pharmacokinetics|Not evaluable|2
343117|NCT01174264|1158163|P2|Steady-state Pharmacokinetics|Not evaluable|0
343118|NCT01174264|1158164|P1|Steady-state Pharmacokinetics|Not evaluable|6
343119|NCT01174264|1158162|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
343120|NCT01174264|1158163|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
343121|NCT01174264|1158164|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
343122|NCT01174264|1158162|P3|Single Dose Pharmacokinetics|Early progressive disease|1
343123|NCT01174264|1158163|P2|Single Dose Pharmacokinetics|Early progressive disease|0
343124|NCT01174264|1158164|P1|Single Dose Pharmacokinetics|Early progressive disease|1
343125|NCT01174238|1158196|P1|Overall Study|Lost to Follow-up|2
343126|NCT01174186|1158207|P2|Overall Study|Withdrawal by Subject|2
343127|NCT01174186|1158208|P1|Overall Study|Withdrawal by Subject|0
343128|NCT01174186|1158207|P2|Overall Study|Lost to Follow-up|1
343129|NCT01174186|1158208|P1|Overall Study|Lost to Follow-up|0
343130|NCT01174173|1158215|P1|Overall Study|drug-drug interaction|1
343131|NCT01174160|1158226|P2|Overall Study|Withdrawal by Subject|0
343132|NCT01174160|1158227|P1|Overall Study|Withdrawal by Subject|1
343133|NCT01174160|1158226|P2|Overall Study|Protocol Violation|6
343134|NCT01174160|1158227|P1|Overall Study|Protocol Violation|4
343135|NCT01174160|1158226|P2|Overall Study|Physician Decision|0
343136|NCT01174160|1158227|P1|Overall Study|Physician Decision|1
343137|NCT01174160|1158226|P2|Overall Study|Lost to Follow-up|0
343138|NCT01174160|1158227|P1|Overall Study|Lost to Follow-up|1
343139|NCT01174160|1158226|P2|Overall Study|Adverse Event|0
343140|NCT01174160|1158227|P1|Overall Study|Adverse Event|1
343141|NCT01174043|1158242|P1|Overall Study|Withdrawal by Subject|2
343142|NCT01174043|1158242|P1|Overall Study|Death|1
343143|NCT01174043|1158242|P1|Overall Study|Adverse Event|3
343144|NCT01174043|1158242|P1|Overall Study|Disease progression|5
343145|NCT01174004|1158281|P2|Overall Study|Physician Decision|0
343146|NCT01174004|1158282|P1|Overall Study|Physician Decision|1
343147|NCT01174004|1158281|P2|Overall Study|Protocol Violation|1
343148|NCT01174004|1158282|P1|Overall Study|Protocol Violation|0
343149|NCT01174004|1158281|P2|Overall Study|At Discretion of Sponsor|2
343150|NCT01174004|1158282|P1|Overall Study|At Discretion of Sponsor|2
343151|NCT01174004|1158281|P2|Overall Study|Withdrawal by Subject|3
343152|NCT01174004|1158282|P1|Overall Study|Withdrawal by Subject|2
343153|NCT01174004|1158281|P2|Overall Study|Adverse Event|10
343154|NCT01174004|1158282|P1|Overall Study|Adverse Event|2
343155|NCT01173718|1158313|P1|Overall Study|Abandonment of study graft|27
343156|NCT01173718|1158313|P1|Overall Study|Death|17
343157|NCT01173679|1158322|P1|Overall Study|Death|1
343158|NCT01173653|1158330|P2|Overall Study|Pts unwilling to provide follow-up|41
343159|NCT01173653|1158331|P1|Overall Study|Pts unwilling to provide follow-up|53
343160|NCT01173601|1158341|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
343161|NCT01173601|1158342|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
343162|NCT01173601|1158343|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
343163|NCT01173601|1158344|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
343164|NCT01173601|1158345|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
343165|NCT01173601|1158341|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
343166|NCT01173601|1158342|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
343167|NCT01173601|1158343|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
343168|NCT01173601|1158344|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
343169|NCT01173601|1158345|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
343170|NCT01173601|1158341|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
343171|NCT01173601|1158342|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
343172|NCT01173601|1158343|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
343173|NCT01173601|1158344|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
343174|NCT01173601|1158345|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
343175|NCT01173601|1158341|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
343176|NCT01173601|1158342|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
343177|NCT01173601|1158343|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
343178|NCT01173601|1158344|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
343179|NCT01173601|1158345|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
343180|NCT01173601|1158341|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
343181|NCT01173601|1158342|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
343182|NCT01173601|1158343|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
343183|NCT01173601|1158344|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
343184|NCT01173601|1158345|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
343185|NCT01173601|1158341|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
343186|NCT01173601|1158342|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
343187|NCT01173601|1158343|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
343188|NCT01173601|1158344|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
343189|NCT01173601|1158345|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
343190|NCT01173601|1158341|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
343191|NCT01173601|1158342|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
343192|NCT01173601|1158343|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
343193|NCT01173601|1158344|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
343194|NCT01173601|1158345|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
343195|NCT01173601|1158341|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
343196|NCT01173601|1158342|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
343197|NCT01173601|1158343|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
343198|NCT01173601|1158344|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
343199|NCT01173601|1158345|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
343200|NCT01173601|1158341|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
343201|NCT01173601|1158342|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
343202|NCT01173601|1158343|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
343203|NCT01173601|1158344|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
343204|NCT01173601|1158345|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
343205|NCT01173601|1158341|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
343206|NCT01173601|1158342|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
343207|NCT01173601|1158343|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
343208|NCT01173601|1158344|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
343209|NCT01173601|1158345|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
343210|NCT01173601|1158341|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
343211|NCT01173601|1158342|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
343212|NCT01173601|1158343|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
343213|NCT01173601|1158344|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
343214|NCT01173601|1158345|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
343215|NCT01173601|1158341|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
343216|NCT01173601|1158342|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
343217|NCT01173601|1158343|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
343218|NCT01173601|1158344|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
343219|NCT01173601|1158345|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
343220|NCT01173601|1158341|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
343221|NCT01173601|1158342|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
343222|NCT01173601|1158343|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
343223|NCT01173601|1158344|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
343224|NCT01173601|1158345|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
343225|NCT01173601|1158341|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
343226|NCT01173601|1158342|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
343227|NCT01173601|1158343|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
343228|NCT01173601|1158344|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
343229|NCT01173601|1158345|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
343230|NCT01173523|1158422|P2|Overall Study|Other|3
343231|NCT01173523|1158423|P1|Overall Study|Other|2
343232|NCT01173523|1158422|P2|Overall Study|Progressive Disease|8
343233|NCT01173523|1158423|P1|Overall Study|Progressive Disease|10
343234|NCT01173523|1158422|P2|Overall Study|Clinical Progression|1
343235|NCT01173523|1158423|P1|Overall Study|Clinical Progression|1
343236|NCT01173471|1158439|P4|Overall Study|Reason given as Other|0
343237|NCT01173471|1158440|P3|Overall Study|Reason given as Other|1
343238|NCT01173471|1158441|P2|Overall Study|Reason given as Other|0
343239|NCT01173471|1158442|P1|Overall Study|Reason given as Other|0
343240|NCT01173471|1158439|P4|Overall Study|Lost to Follow-up|0
343241|NCT01173471|1158440|P3|Overall Study|Lost to Follow-up|1
343242|NCT01173471|1158441|P2|Overall Study|Lost to Follow-up|0
343243|NCT01173471|1158442|P1|Overall Study|Lost to Follow-up|0
343244|NCT01173471|1158439|P4|Overall Study|Condition under investigation worsened|0
343245|NCT01173471|1158440|P3|Overall Study|Condition under investigation worsened|0
343246|NCT01173471|1158441|P2|Overall Study|Condition under investigation worsened|0
343247|NCT01173471|1158442|P1|Overall Study|Condition under investigation worsened|2
343248|NCT01173471|1158439|P4|Overall Study|Eligibility criteria not fulfilled|1
343249|NCT01173471|1158440|P3|Overall Study|Eligibility criteria not fulfilled|1
343250|NCT01173471|1158441|P2|Overall Study|Eligibility criteria not fulfilled|0
343251|NCT01173471|1158442|P1|Overall Study|Eligibility criteria not fulfilled|0
343252|NCT01173120|1158572|P1|Overall Study|Switch-Difficulty With Device|12
343253|NCT01173120|1158572|P1|Overall Study|Switch-Participant Decision|12
343254|NCT01173120|1158572|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
343255|NCT01173120|1158572|P1|Overall Study|Participant Decision|2
343256|NCT01173120|1158572|P1|Overall Study|Lost to Follow-up|1
343257|NCT01173120|1158572|P1|Overall Study|Lack of Efficacy|2
343258|NCT01173055|1158590|P2|Period 2 - Day 64 to 112|Adverse Event|1
343259|NCT01173055|1158591|P1|Period 2 - Day 64 to 112|Adverse Event|0
343260|NCT01173055|1158590|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
343261|NCT01173055|1158591|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
343262|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
343263|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343264|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343265|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343266|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343267|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343268|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343269|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343270|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
343271|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343272|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343273|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343274|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343275|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343276|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343277|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
343278|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343279|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
343280|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
343281|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
343282|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
343283|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
343284|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
343285|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
343286|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
343287|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
343288|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
343289|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
343290|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
343291|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
343292|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
343293|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
343294|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
343295|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
343296|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
343297|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
343298|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
343299|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
343300|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
343301|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
343302|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
343303|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
343304|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
343305|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
343306|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
343307|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343308|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343309|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343310|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343311|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343312|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343313|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
343314|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343315|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
343316|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
343317|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
343318|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
343319|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
343320|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
343321|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
343322|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
343323|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
343324|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
343325|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343326|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
343327|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343328|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343329|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343330|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343331|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343332|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343333|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
343334|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
343335|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
343336|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
343337|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
343338|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
343339|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
343340|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
343341|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
343342|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
343343|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
343344|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
343345|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
343346|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
343347|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
343348|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
343349|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
343350|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
343351|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
343352|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
343353|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
343354|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
343355|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
343356|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
343357|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
343358|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
343359|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
343360|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
343361|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
343362|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
343363|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
343364|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
343365|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
343366|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
343367|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
343368|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
343369|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
343370|NCT01172938|1158630|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343371|NCT01172938|1158631|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343372|NCT01172938|1158632|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343373|NCT01172938|1158633|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343374|NCT01172938|1158634|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343375|NCT01172938|1158635|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343376|NCT01172938|1158636|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
343377|NCT01172938|1158637|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343378|NCT01172938|1158638|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
343379|NCT01172938|1158630|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343380|NCT01172938|1158631|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343381|NCT01172938|1158632|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343382|NCT01172938|1158633|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343383|NCT01172938|1158634|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343384|NCT01172938|1158635|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343385|NCT01172938|1158636|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343386|NCT01172938|1158637|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
343387|NCT01172938|1158638|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
343388|NCT01172938|1158630|P9|Active-Treatment Phase Weeks (104-156)|Death|0
343389|NCT01172938|1158631|P8|Active-Treatment Phase Weeks (104-156)|Death|1
343390|NCT01172938|1158632|P7|Active-Treatment Phase Weeks (104-156)|Death|0
343391|NCT01172938|1158633|P6|Active-Treatment Phase Weeks (104-156)|Death|0
343392|NCT01172938|1158634|P5|Active-Treatment Phase Weeks (104-156)|Death|0
343393|NCT01172938|1158635|P4|Active-Treatment Phase Weeks (104-156)|Death|0
343394|NCT01172938|1158636|P3|Active-Treatment Phase Weeks (104-156)|Death|0
343395|NCT01172938|1158637|P2|Active-Treatment Phase Weeks (104-156)|Death|0
343396|NCT01172938|1158638|P1|Active-Treatment Phase Weeks (104-156)|Death|0
343703|NCT01171820|1159372|P1|Overall Study|Withdrawal by Subject|2
343397|NCT01172938|1158630|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
343398|NCT01172938|1158631|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
343399|NCT01172938|1158632|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
343400|NCT01172938|1158633|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
343401|NCT01172938|1158634|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
343402|NCT01172938|1158635|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
343403|NCT01172938|1158636|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
343404|NCT01172938|1158637|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
343405|NCT01172938|1158638|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
343406|NCT01172938|1158630|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
343407|NCT01172938|1158631|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
343408|NCT01172938|1158632|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
343409|NCT01172938|1158633|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
343410|NCT01172938|1158634|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
343411|NCT01172938|1158635|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
343412|NCT01172938|1158636|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
343413|NCT01172938|1158637|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
343414|NCT01172938|1158638|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
343415|NCT01172938|1158630|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
343416|NCT01172938|1158631|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343417|NCT01172938|1158632|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343418|NCT01172938|1158633|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343419|NCT01172938|1158634|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343420|NCT01172938|1158635|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343421|NCT01172938|1158636|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343422|NCT01172938|1158637|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343423|NCT01172938|1158638|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
343424|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
343425|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
343426|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
343427|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
343428|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
343429|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
343430|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
343431|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
343432|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
343433|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
343434|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
343435|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
343436|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
343437|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
343438|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
343439|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
343440|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
343441|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
343442|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
343443|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
343444|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
343445|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
343446|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
343447|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
343448|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
343449|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
343450|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
343451|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
343452|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
343453|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
343454|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
343455|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
343456|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
343457|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
343458|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
343459|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
343460|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
343461|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
343462|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
343463|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
343464|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
343465|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
343466|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
343467|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
343468|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
343469|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343470|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343471|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343472|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343473|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343474|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343475|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
343476|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343477|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
343478|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
343479|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
343480|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
343481|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
343482|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
343483|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
343484|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
343485|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
343486|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
343487|NCT01172938|1158630|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
343488|NCT01172938|1158631|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
343489|NCT01172938|1158632|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
343490|NCT01172938|1158633|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
343491|NCT01172938|1158634|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
343492|NCT01172938|1158635|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
343493|NCT01172938|1158636|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
343494|NCT01172938|1158637|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
343495|NCT01172938|1158638|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
343496|NCT01172938|1158630|P9|Active Treatment Phase (Weeks 25-52)|Not specified|0
343497|NCT01172938|1158631|P8|Active Treatment Phase (Weeks 25-52)|Not specified|0
343498|NCT01172938|1158632|P7|Active Treatment Phase (Weeks 25-52)|Not specified|1
343499|NCT01172938|1158633|P6|Active Treatment Phase (Weeks 25-52)|Not specified|1
343500|NCT01172938|1158634|P5|Active Treatment Phase (Weeks 25-52)|Not specified|0
343501|NCT01172938|1158635|P4|Active Treatment Phase (Weeks 25-52)|Not specified|0
343502|NCT01172938|1158636|P3|Active Treatment Phase (Weeks 25-52)|Not specified|0
343503|NCT01172938|1158637|P2|Active Treatment Phase (Weeks 25-52)|Not specified|0
343504|NCT01172938|1158638|P1|Active Treatment Phase (Weeks 25-52)|Not specified|0
343505|NCT01172938|1158630|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
343506|NCT01172938|1158631|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
343507|NCT01172938|1158632|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
343508|NCT01172938|1158633|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
343509|NCT01172938|1158634|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
343510|NCT01172938|1158635|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
343511|NCT01172938|1158636|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
343512|NCT01172938|1158637|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
343513|NCT01172938|1158638|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
343514|NCT01172938|1158630|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
343515|NCT01172938|1158631|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
343516|NCT01172938|1158632|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
343517|NCT01172938|1158633|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
343518|NCT01172938|1158634|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
343519|NCT01172938|1158635|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
343520|NCT01172938|1158636|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
343521|NCT01172938|1158637|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
343522|NCT01172938|1158638|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
343523|NCT01172938|1158630|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343524|NCT01172938|1158631|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343525|NCT01172938|1158632|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343526|NCT01172938|1158633|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343527|NCT01172938|1158634|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343528|NCT01172938|1158635|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343529|NCT01172938|1158636|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
343530|NCT01172938|1158637|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343531|NCT01172938|1158638|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
343532|NCT01172938|1158630|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
343533|NCT01172938|1158631|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
343534|NCT01172938|1158632|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
343535|NCT01172938|1158633|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
343536|NCT01172938|1158634|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
343537|NCT01172938|1158635|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
343538|NCT01172938|1158636|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
343539|NCT01172938|1158637|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
343540|NCT01172938|1158638|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
343541|NCT01172938|1158630|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
343542|NCT01172938|1158631|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
343543|NCT01172938|1158632|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
343544|NCT01172938|1158633|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
343545|NCT01172938|1158634|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
343546|NCT01172938|1158635|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
343547|NCT01172938|1158636|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
343548|NCT01172938|1158637|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
343549|NCT01172938|1158638|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
343550|NCT01172938|1158630|P9|Placebo-controlled Phase (Week 0-24)|Not specified|0
343551|NCT01172938|1158631|P8|Placebo-controlled Phase (Week 0-24)|Not specified|0
343552|NCT01172938|1158632|P7|Placebo-controlled Phase (Week 0-24)|Not specified|0
343553|NCT01172938|1158633|P6|Placebo-controlled Phase (Week 0-24)|Not specified|0
343554|NCT01172938|1158634|P5|Placebo-controlled Phase (Week 0-24)|Not specified|0
343555|NCT01172938|1158635|P4|Placebo-controlled Phase (Week 0-24)|Not specified|0
343556|NCT01172938|1158636|P3|Placebo-controlled Phase (Week 0-24)|Not specified|1
343557|NCT01172938|1158637|P2|Placebo-controlled Phase (Week 0-24)|Not specified|2
343558|NCT01172938|1158638|P1|Placebo-controlled Phase (Week 0-24)|Not specified|0
343559|NCT01172938|1158630|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343560|NCT01172938|1158631|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343561|NCT01172938|1158632|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343562|NCT01172938|1158633|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343563|NCT01172938|1158634|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343564|NCT01172938|1158635|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343565|NCT01172938|1158636|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343566|NCT01172938|1158637|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
343567|NCT01172938|1158638|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
343568|NCT01172938|1158630|P9|Placebo-controlled Phase (Week 0-24)|Death|0
343569|NCT01172938|1158631|P8|Placebo-controlled Phase (Week 0-24)|Death|0
343570|NCT01172938|1158632|P7|Placebo-controlled Phase (Week 0-24)|Death|0
343571|NCT01172938|1158633|P6|Placebo-controlled Phase (Week 0-24)|Death|0
343572|NCT01172938|1158634|P5|Placebo-controlled Phase (Week 0-24)|Death|0
343573|NCT01172938|1158635|P4|Placebo-controlled Phase (Week 0-24)|Death|0
343574|NCT01172938|1158636|P3|Placebo-controlled Phase (Week 0-24)|Death|0
343575|NCT01172938|1158637|P2|Placebo-controlled Phase (Week 0-24)|Death|1
343576|NCT01172938|1158638|P1|Placebo-controlled Phase (Week 0-24)|Death|0
343577|NCT01172938|1158630|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
343578|NCT01172938|1158631|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
343579|NCT01172938|1158632|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
343580|NCT01172938|1158633|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
343581|NCT01172938|1158634|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
343582|NCT01172938|1158635|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
343583|NCT01172938|1158636|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
343584|NCT01172938|1158637|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
343585|NCT01172938|1158638|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
343586|NCT01172938|1158630|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
343587|NCT01172938|1158631|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
343588|NCT01172938|1158632|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
343589|NCT01172938|1158633|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
343590|NCT01172938|1158634|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
343591|NCT01172938|1158635|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
343592|NCT01172938|1158636|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
343593|NCT01172938|1158637|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
343594|NCT01172938|1158638|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
343595|NCT01172938|1158630|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
343596|NCT01172938|1158631|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
343597|NCT01172938|1158632|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
343598|NCT01172938|1158633|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
343599|NCT01172938|1158634|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
343600|NCT01172938|1158635|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
343601|NCT01172938|1158636|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
343602|NCT01172938|1158637|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
343603|NCT01172938|1158638|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
343604|NCT01172938|1158630|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
343605|NCT01172938|1158631|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
343606|NCT01172938|1158632|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
343607|NCT01172938|1158633|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
343608|NCT01172938|1158634|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
343609|NCT01172938|1158635|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
343610|NCT01172938|1158636|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
343611|NCT01172938|1158637|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
343612|NCT01172938|1158638|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
343613|NCT01172873|1158824|P2|Overall Study|Withdrawal by Subject|2
343614|NCT01172873|1158825|P1|Overall Study|Withdrawal by Subject|3
343615|NCT01172847|1158835|P1|Overall Study|Withdrawal by Subject|3
343616|NCT01172821|1158864|P4|Overall Study|Other|3
343617|NCT01172821|1158865|P3|Overall Study|Other|5
343618|NCT01172821|1158866|P2|Overall Study|Other|4
343619|NCT01172821|1158867|P1|Overall Study|Other|3
343620|NCT01172821|1158864|P4|Overall Study|Withdrawal by Subject|3
343621|NCT01172821|1158865|P3|Overall Study|Withdrawal by Subject|3
343622|NCT01172821|1158866|P2|Overall Study|Withdrawal by Subject|3
343623|NCT01172821|1158867|P1|Overall Study|Withdrawal by Subject|2
343624|NCT01172821|1158864|P4|Overall Study|Lost to Follow-up|2
343625|NCT01172821|1158865|P3|Overall Study|Lost to Follow-up|2
343626|NCT01172821|1158866|P2|Overall Study|Lost to Follow-up|1
343627|NCT01172821|1158867|P1|Overall Study|Lost to Follow-up|4
343628|NCT01172821|1158864|P4|Overall Study|Protocol Violation|2
343629|NCT01172821|1158865|P3|Overall Study|Protocol Violation|1
343630|NCT01172821|1158866|P2|Overall Study|Protocol Violation|2
343631|NCT01172821|1158867|P1|Overall Study|Protocol Violation|0
343632|NCT01172821|1158864|P4|Overall Study|Adverse Event|7
343633|NCT01172821|1158865|P3|Overall Study|Adverse Event|2
343634|NCT01172821|1158866|P2|Overall Study|Adverse Event|2
343635|NCT01172821|1158867|P1|Overall Study|Adverse Event|5
343636|NCT01172808|1158957|P4|Overall Study|Other|7
343637|NCT01172808|1158958|P3|Overall Study|Other|9
343638|NCT01172808|1158959|P2|Overall Study|Other|5
343639|NCT01172808|1158960|P1|Overall Study|Other|6
343640|NCT01172808|1158957|P4|Overall Study|Withdrawal by Subject|2
343641|NCT01172808|1158958|P3|Overall Study|Withdrawal by Subject|3
343642|NCT01172808|1158959|P2|Overall Study|Withdrawal by Subject|1
343643|NCT01172808|1158960|P1|Overall Study|Withdrawal by Subject|4
343644|NCT01172808|1158957|P4|Overall Study|Lost to Follow-up|3
343645|NCT01172808|1158958|P3|Overall Study|Lost to Follow-up|1
343646|NCT01172808|1158959|P2|Overall Study|Lost to Follow-up|1
343647|NCT01172808|1158960|P1|Overall Study|Lost to Follow-up|0
343648|NCT01172808|1158957|P4|Overall Study|Protocol Violation|0
343649|NCT01172808|1158958|P3|Overall Study|Protocol Violation|2
343650|NCT01172808|1158959|P2|Overall Study|Protocol Violation|2
343651|NCT01172808|1158960|P1|Overall Study|Protocol Violation|2
343652|NCT01172808|1158957|P4|Overall Study|Lack of Efficacy|0
343653|NCT01172808|1158958|P3|Overall Study|Lack of Efficacy|0
343654|NCT01172808|1158959|P2|Overall Study|Lack of Efficacy|0
343655|NCT01172808|1158960|P1|Overall Study|Lack of Efficacy|1
343656|NCT01172808|1158957|P4|Overall Study|Adverse Event|3
343657|NCT01172808|1158958|P3|Overall Study|Adverse Event|8
343658|NCT01172808|1158959|P2|Overall Study|Adverse Event|4
343659|NCT01172808|1158960|P1|Overall Study|Adverse Event|8
343660|NCT01172535|1159079|P1|Overall Study|Unwilling to adhere to study requirement|1
343661|NCT01172535|1159079|P1|Overall Study|Ineligible at study entry|1
343662|NCT01172535|1159079|P1|Overall Study|Lost to Follow-up|1
343663|NCT01172535|1159079|P1|Overall Study|Withdrawal by Subject|2
343664|NCT01172535|1159079|P1|Overall Study|Death|3
343665|NCT01172288|1159132|P2|Overall Study|Protocol Violation|1
343666|NCT01172288|1159133|P1|Overall Study|Protocol Violation|0
343667|NCT01172288|1159132|P2|Overall Study|Adverse Event|0
343668|NCT01172288|1159133|P1|Overall Study|Adverse Event|1
343669|NCT01171989|1159188|P3|Overall Study|Lost to Follow-up|1
343670|NCT01171989|1159189|P2|Overall Study|Lost to Follow-up|0
343671|NCT01171989|1159190|P1|Overall Study|Lost to Follow-up|0
343672|NCT01171976|1159264|P3|Overall Study|Adverse Event|5
343673|NCT01171976|1159265|P2|Overall Study|Adverse Event|2
343674|NCT01171976|1159266|P1|Overall Study|Adverse Event|6
343675|NCT01171976|1159264|P3|Overall Study|Abnormal test result|0
343676|NCT01171976|1159265|P2|Overall Study|Abnormal test result|0
343677|NCT01171976|1159266|P1|Overall Study|Abnormal test result|1
343678|NCT01171976|1159264|P3|Overall Study|Withdrawal by Subject|6
343679|NCT01171976|1159265|P2|Overall Study|Withdrawal by Subject|5
343680|NCT01171976|1159266|P1|Overall Study|Withdrawal by Subject|1
343681|NCT01171976|1159264|P3|Overall Study|Lost to Follow-up|2
343682|NCT01171976|1159265|P2|Overall Study|Lost to Follow-up|0
343683|NCT01171976|1159266|P1|Overall Study|Lost to Follow-up|4
343684|NCT01171976|1159264|P3|Overall Study|Death|1
343685|NCT01171976|1159265|P2|Overall Study|Death|4
343686|NCT01171976|1159266|P1|Overall Study|Death|2
343687|NCT01171976|1159264|P3|Overall Study|Protocol Violation|1
343688|NCT01171976|1159265|P2|Overall Study|Protocol Violation|0
343689|NCT01171976|1159266|P1|Overall Study|Protocol Violation|0
343690|NCT01171963|1159303|P2|Overall Study|Withdrawal by Subject|129
343691|NCT01171963|1159304|P1|Overall Study|Withdrawal by Subject|114
343692|NCT01171963|1159303|P2|Overall Study|Other - diarrhoea|0
343693|NCT01171963|1159304|P1|Overall Study|Other - diarrhoea|1
343694|NCT01171963|1159303|P2|Overall Study|Lost to Follow-up|24
343695|NCT01171963|1159304|P1|Overall Study|Lost to Follow-up|23
343696|NCT01171963|1159303|P2|Overall Study|Adverse Event|15
343697|NCT01171963|1159304|P1|Overall Study|Adverse Event|10
343698|NCT01171820|1159371|P2|Overall Study|1-Year Missed Visit|1
343699|NCT01171820|1159372|P1|Overall Study|1-Year Missed Visit|1
343700|NCT01171820|1159371|P2|Overall Study|Physician Decision|1
343701|NCT01171820|1159372|P1|Overall Study|Physician Decision|0
343702|NCT01171820|1159371|P2|Overall Study|Withdrawal by Subject|0
343704|NCT01171820|1159371|P2|Overall Study|Lost to Follow-up|1
343705|NCT01171820|1159372|P1|Overall Study|Lost to Follow-up|0
343706|NCT01171820|1159371|P2|Overall Study|Death|3
343707|NCT01171820|1159372|P1|Overall Study|Death|3
343708|NCT01171677|1159450|P2|Overall Study|completed <70% IntenSati classes|0
343709|NCT01171677|1159451|P1|Overall Study|completed <70% IntenSati classes|5
343710|NCT01171677|1159450|P2|Overall Study|Adverse Event|0
343711|NCT01171677|1159451|P1|Overall Study|Adverse Event|1
343712|NCT01171677|1159450|P2|Overall Study|Withdrawal by Subject|3
343713|NCT01171677|1159451|P1|Overall Study|Withdrawal by Subject|0
343714|NCT01171612|1159483|P1|Overall Study|Lost to Follow-up|51
343715|NCT01171534|1159493|P2|Overall Study|screen failure|1
343716|NCT01171534|1159494|P1|Overall Study|screen failure|0
343717|NCT01171534|1159493|P2|Overall Study|Lost to Follow-up|2
343718|NCT01171534|1159494|P1|Overall Study|Lost to Follow-up|0
343719|NCT01171521|1159506|P1|Overall Study|screen failure|1
343720|NCT01171521|1159506|P1|Overall Study|Lost to Follow-up|5
343721|NCT01171183|1159513|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
343722|NCT01171183|1159514|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
343723|NCT01171183|1159513|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
343724|NCT01171183|1159514|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
343725|NCT01171183|1159513|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
343726|NCT01171183|1159514|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
343727|NCT01171183|1159513|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
343728|NCT01171183|1159514|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
343729|NCT01171183|1159513|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
343730|NCT01171183|1159514|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
343731|NCT01171183|1159513|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
343732|NCT01171183|1159514|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
343733|NCT01170962|1159535|P3|Follow up Period|Others|3
343734|NCT01170962|1159536|P2|Follow up Period|Others|7
343735|NCT01170962|1159537|P1|Follow up Period|Others|10
343736|NCT01170962|1159535|P3|Follow up Period|Death|0
343737|NCT01170962|1159536|P2|Follow up Period|Death|2
343738|NCT01170962|1159537|P1|Follow up Period|Death|2
343739|NCT01170962|1159535|P3|Follow up Period|Lost to Follow-up|1
343740|NCT01170962|1159536|P2|Follow up Period|Lost to Follow-up|8
343741|NCT01170962|1159537|P1|Follow up Period|Lost to Follow-up|13
343742|NCT01170962|1159535|P3|Follow up Period|Withdrawal by Subject|2
343743|NCT01170962|1159536|P2|Follow up Period|Withdrawal by Subject|10
343744|NCT01170962|1159537|P1|Follow up Period|Withdrawal by Subject|14
343745|NCT01170962|1159535|P3|Treatment Period|Completed 24 Week treatment period only|0
343746|NCT01170962|1159536|P2|Treatment Period|Completed 24 Week treatment period only|2
343747|NCT01170962|1159537|P1|Treatment Period|Completed 24 Week treatment period only|10
343748|NCT01170962|1159535|P3|Treatment Period|Request to discontinue treatment|1
343749|NCT01170962|1159536|P2|Treatment Period|Request to discontinue treatment|3
343750|NCT01170962|1159537|P1|Treatment Period|Request to discontinue treatment|7
343751|NCT01170962|1159535|P3|Treatment Period|Participant no longer meets criteria|0
343752|NCT01170962|1159536|P2|Treatment Period|Participant no longer meets criteria|1
343753|NCT01170962|1159537|P1|Treatment Period|Participant no longer meets criteria|0
343754|NCT01170962|1159535|P3|Treatment Period|Lost to Follow-up|1
343755|NCT01170962|1159536|P2|Treatment Period|Lost to Follow-up|1
343756|NCT01170962|1159537|P1|Treatment Period|Lost to Follow-up|1
343757|NCT01170962|1159535|P3|Treatment Period|Withdrawal by Subject|0
343758|NCT01170962|1159536|P2|Treatment Period|Withdrawal by Subject|1
343759|NCT01170962|1159537|P1|Treatment Period|Withdrawal by Subject|2
343760|NCT01170962|1159535|P3|Treatment Period|Adverse Event|3
343761|NCT01170962|1159536|P2|Treatment Period|Adverse Event|12
343762|NCT01170962|1159537|P1|Treatment Period|Adverse Event|11
343763|NCT01170962|1159535|P3|Treatment Period|Lack of Efficacy|7
343764|NCT01170962|1159536|P2|Treatment Period|Lack of Efficacy|91
343765|NCT01170962|1159537|P1|Treatment Period|Lack of Efficacy|96
343766|NCT01170663|1159632|P2|Overall Study|Withdrawal of consent without follow-up|11
343767|NCT01170663|1159633|P1|Overall Study|Withdrawal of consent without follow-up|11
343768|NCT01170663|1159632|P2|Overall Study|Lost to Follow-up|9
343769|NCT01170663|1159633|P1|Overall Study|Lost to Follow-up|3
343770|NCT01170598|1159661|P1|Overall Study|Refused|1
343771|NCT01170598|1159661|P1|Overall Study|Lost to Follow-up|1
343772|NCT01170598|1159661|P1|Overall Study|Death|3
343773|NCT01170598|1159661|P1|Overall Study|Withdrawal by Subject|1
343774|NCT01170364|1159724|P2|Overall Study|Protocol Violation|1
343775|NCT01170364|1159725|P1|Overall Study|Protocol Violation|4
343776|NCT01170273|1159733|P2|Overall Study|Adverse Event|1
343777|NCT01170273|1159734|P1|Overall Study|Adverse Event|0
343778|NCT01170273|1159733|P2|Overall Study|Death|0
343779|NCT01170273|1159734|P1|Overall Study|Death|1
343780|NCT01170273|1159733|P2|Overall Study|Protocol Violation|0
343781|NCT01170273|1159734|P1|Overall Study|Protocol Violation|1
343782|NCT01170273|1159733|P2|Overall Study|Lost to Follow-up|8
343783|NCT01170273|1159734|P1|Overall Study|Lost to Follow-up|6
343784|NCT01170221|1159751|P2|Overall Study|Randomized but not treated|0
343785|NCT01170221|1159752|P1|Overall Study|Randomized but not treated|1
343786|NCT01170221|1159751|P2|Overall Study|Subject completed only screening and LFU|0
343787|NCT01170221|1159752|P1|Overall Study|Subject completed only screening and LFU|1
343788|NCT01170221|1159751|P2|Overall Study|Withdrawal by Subject|7
343789|NCT01170221|1159752|P1|Overall Study|Withdrawal by Subject|9
343790|NCT01170221|1159751|P2|Overall Study|Lost to Follow-up|21
343791|NCT01170221|1159752|P1|Overall Study|Lost to Follow-up|22
343792|NCT01170208|1159775|P3|Overall Study|Protocol Violation|1
343793|NCT01170208|1159776|P2|Overall Study|Protocol Violation|0
343794|NCT01170208|1159777|P1|Overall Study|Protocol Violation|1
343795|NCT01170208|1159775|P3|Overall Study|Withdrawal by Subject|1
343796|NCT01170208|1159776|P2|Overall Study|Withdrawal by Subject|0
343797|NCT01170208|1159777|P1|Overall Study|Withdrawal by Subject|5
343798|NCT01170091|1159796|P1|Overall Study|Treatment duration is less than 4 weeks|21
343799|NCT01170091|1159796|P1|Overall Study|Missing efficacy evaluation|3
343800|NCT01170039|1159805|P2|Overall Study|Lack of funding, drug not available|3
343801|NCT01170039|1159806|P1|Overall Study|Lack of funding, drug not available|3
343802|NCT01170039|1159805|P2|Overall Study|Withdrawal by Subject|3
343803|NCT01170039|1159806|P1|Overall Study|Withdrawal by Subject|5
343804|NCT01169987|1159818|P1|Overall Study|Not Specified|4
343805|NCT01169987|1159818|P1|Overall Study|Lost to Follow-up|24
343806|NCT01169987|1159818|P1|Overall Study|Withdrawal by Subject|3
343807|NCT01169779|1159884|P2|Overall Study|Familial and personal reasons|3
343808|NCT01169779|1159885|P1|Overall Study|Familial and personal reasons|3
343809|NCT01169779|1159884|P2|Overall Study|Withdrawal by Subject|2
343810|NCT01169779|1159885|P1|Overall Study|Withdrawal by Subject|3
343811|NCT01169779|1159884|P2|Overall Study|Protocol Violation|1
343812|NCT01169779|1159885|P1|Overall Study|Protocol Violation|1
343813|NCT01169779|1159884|P2|Overall Study|Lack of Efficacy|0
343814|NCT01169779|1159885|P1|Overall Study|Lack of Efficacy|1
343815|NCT01169779|1159884|P2|Overall Study|Adverse Event|11
343816|NCT01169779|1159885|P1|Overall Study|Adverse Event|3
343817|NCT01169701|1159920|P2|Overall Study|Sponsor decision|1
343818|NCT01169701|1159921|P1|Overall Study|Sponsor decision|0
343819|NCT01169701|1159920|P2|Overall Study|Serious adverse event|1
343820|NCT01169701|1159921|P1|Overall Study|Serious adverse event|0
343821|NCT01169701|1159920|P2|Overall Study|Administrative problems|1
343822|NCT01169701|1159921|P1|Overall Study|Administrative problems|0
343823|NCT01169701|1159920|P2|Overall Study|Death|1
343824|NCT01169701|1159921|P1|Overall Study|Death|0
343825|NCT01169701|1159920|P2|Overall Study|Exclusion criteria|0
343826|NCT01169701|1159921|P1|Overall Study|Exclusion criteria|2
343827|NCT01169701|1159920|P2|Overall Study|Adverse Event|2
343828|NCT01169701|1159921|P1|Overall Study|Adverse Event|1
343829|NCT01169701|1159920|P2|Overall Study|Withdrawal by Subject|3
343830|NCT01169701|1159921|P1|Overall Study|Withdrawal by Subject|1
343831|NCT01169701|1159920|P2|Overall Study|Lost to Follow-up|1
343832|NCT01169701|1159921|P1|Overall Study|Lost to Follow-up|1
343833|NCT01169675|1159958|P5|Overall Study|Other Reason Not Defined Above|1
343834|NCT01169675|1159959|P4|Overall Study|Other Reason Not Defined Above|1
343835|NCT01169675|1159960|P3|Overall Study|Other Reason Not Defined Above|0
343836|NCT01169675|1159961|P2|Overall Study|Other Reason Not Defined Above|0
343837|NCT01169675|1159962|P1|Overall Study|Other Reason Not Defined Above|0
343838|NCT01169675|1159958|P5|Overall Study|Withdrawal by Subject|2
343839|NCT01169675|1159959|P4|Overall Study|Withdrawal by Subject|1
343840|NCT01169675|1159960|P3|Overall Study|Withdrawal by Subject|0
343841|NCT01169675|1159961|P2|Overall Study|Withdrawal by Subject|0
343842|NCT01169675|1159962|P1|Overall Study|Withdrawal by Subject|1
343843|NCT01169675|1159958|P5|Overall Study|Adverse Event|0
343844|NCT01169675|1159959|P4|Overall Study|Adverse Event|0
343845|NCT01169675|1159960|P3|Overall Study|Adverse Event|2
343846|NCT01169675|1159961|P2|Overall Study|Adverse Event|1
343847|NCT01169675|1159962|P1|Overall Study|Adverse Event|5
343848|NCT01169675|1159958|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
343849|NCT01169675|1159959|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
343850|NCT01169675|1159960|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
343851|NCT01169675|1159961|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
343852|NCT01169675|1159962|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
343853|NCT01169675|1159958|P5|Overall Study|Progressive disease|1
343854|NCT01169675|1159959|P4|Overall Study|Progressive disease|15
343855|NCT01169675|1159960|P3|Overall Study|Progressive disease|5
343856|NCT01169675|1159961|P2|Overall Study|Progressive disease|2
343857|NCT01169675|1159962|P1|Overall Study|Progressive disease|13
343858|NCT01169649|1159999|P1|Overall Study|Patient Not Treated|3
343859|NCT01169558|1160011|P1|Overall Study|Partial response|2
343860|NCT01169558|1160011|P1|Overall Study|Protocol Violation|2
343861|NCT01169558|1160011|P1|Overall Study|Non-compliance|2
343862|NCT01169558|1160011|P1|Overall Study|Need for Surgery|4
343863|NCT01169558|1160011|P1|Overall Study|Lost to Follow-up|4
343864|NCT01169558|1160011|P1|Overall Study|Stable Disease|4
343865|NCT01169558|1160011|P1|Overall Study|Medical Decision|7
343866|NCT01169558|1160011|P1|Overall Study|Withdrawal of Consent|8
343867|NCT01169558|1160011|P1|Overall Study|Adverse Event|25
343868|NCT01169558|1160011|P1|Overall Study|Disease progression|98
343869|NCT01169493|1160036|P6|Period 3 (6 Months)|Physician Decision|0
343870|NCT01169493|1160037|P5|Period 3 (6 Months)|Physician Decision|0
343871|NCT01169493|1160038|P4|Period 3 (6 Months)|Physician Decision|0
343872|NCT01169493|1160039|P3|Period 3 (6 Months)|Physician Decision|1
343873|NCT01169493|1160040|P2|Period 3 (6 Months)|Physician Decision|1
343874|NCT01169493|1160041|P1|Period 3 (6 Months)|Physician Decision|0
343875|NCT01169493|1160036|P6|Period 3 (6 Months)|Adverse Event|0
343876|NCT01169493|1160037|P5|Period 3 (6 Months)|Adverse Event|0
343877|NCT01169493|1160038|P4|Period 3 (6 Months)|Adverse Event|0
343878|NCT01169493|1160039|P3|Period 3 (6 Months)|Adverse Event|0
343879|NCT01169493|1160040|P2|Period 3 (6 Months)|Adverse Event|1
343880|NCT01169493|1160041|P1|Period 3 (6 Months)|Adverse Event|0
343881|NCT01169493|1160036|P6|Period 1 (6 Months)|Withdrawal by Subject|3
343882|NCT01169493|1160037|P5|Period 1 (6 Months)|Withdrawal by Subject|0
343883|NCT01169493|1160038|P4|Period 1 (6 Months)|Withdrawal by Subject|0
343884|NCT01169493|1160039|P3|Period 1 (6 Months)|Withdrawal by Subject|2
343885|NCT01169493|1160040|P2|Period 1 (6 Months)|Withdrawal by Subject|1
343886|NCT01169493|1160041|P1|Period 1 (6 Months)|Withdrawal by Subject|0
343887|NCT01169350|1160087|P1|Overall Study|Lost to Follow-up|2
343888|NCT01169350|1160087|P1|Overall Study|Physician Decision|3
343889|NCT01169103|1160108|P2|Overall Study|Withdrawal by Subject|1
343890|NCT01169103|1160109|P1|Overall Study|Withdrawal by Subject|3
343891|NCT01169103|1160108|P2|Overall Study|Lost to Follow-up|3
343892|NCT01169103|1160109|P1|Overall Study|Lost to Follow-up|3
343893|NCT01169038|1160136|P1|Overall Study|Required antibiotic administration|1
343894|NCT01169038|1160136|P1|Overall Study|Adverse Event|5
343895|NCT01169038|1160136|P1|Overall Study|Death|1
343896|NCT01168999|1160144|P4|Overall Study|Lost to Follow-up|0
343897|NCT01168999|1160145|P3|Overall Study|Lost to Follow-up|0
343898|NCT01168999|1160146|P2|Overall Study|Lost to Follow-up|1
343899|NCT01168999|1160147|P1|Overall Study|Lost to Follow-up|2
343900|NCT01168973|1160213|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
343901|NCT01168973|1160214|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
343902|NCT01168973|1160213|P2|Overall Study|Sponsor Decision|1
343903|NCT01168973|1160214|P1|Overall Study|Sponsor Decision|2
343904|NCT01168973|1160213|P2|Overall Study|Physician Decision|19
343905|NCT01168973|1160214|P1|Overall Study|Physician Decision|37
343906|NCT01168973|1160213|P2|Overall Study|Death|45
343907|NCT01168973|1160214|P1|Overall Study|Death|42
343908|NCT01168973|1160213|P2|Overall Study|Withdrawal by Subject|53
343909|NCT01168973|1160214|P1|Overall Study|Withdrawal by Subject|90
343910|NCT01168973|1160213|P2|Overall Study|Adverse Event|55
343911|NCT01168973|1160214|P1|Overall Study|Adverse Event|94
343912|NCT01168973|1160213|P2|Overall Study|Progressive Disease|429
343913|NCT01168973|1160214|P1|Overall Study|Progressive Disease|341
343914|NCT01168856|1160287|P2|Overall Study|Protocol Violation|6
343915|NCT01168856|1160288|P1|Overall Study|Protocol Violation|4
343916|NCT01168856|1160287|P2|Overall Study|Other|291
343917|NCT01168856|1160288|P1|Overall Study|Other|1
343918|NCT01168856|1160287|P2|Overall Study|Death|2
343919|NCT01168856|1160288|P1|Overall Study|Death|0
343920|NCT01168856|1160287|P2|Overall Study|Participant received anti-HCV treatment|0
343921|NCT01168856|1160288|P1|Overall Study|Participant received anti-HCV treatment|1
343922|NCT01168856|1160287|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
343923|NCT01168856|1160288|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
343924|NCT01168856|1160287|P2|Overall Study|Physician Decision|1
343925|NCT01168856|1160288|P1|Overall Study|Physician Decision|2
343926|NCT01168856|1160287|P2|Overall Study|Withdrawal by Subject|8
343927|NCT01168856|1160288|P1|Overall Study|Withdrawal by Subject|6
343928|NCT01168856|1160287|P2|Overall Study|Lost to Follow-up|34
343929|NCT01168856|1160288|P1|Overall Study|Lost to Follow-up|4
343930|NCT01168596|1160386|P2|Overall Study|Withdrawal by Subject|1
343931|NCT01168596|1160387|P1|Overall Study|Withdrawal by Subject|3
343932|NCT01168427|1160431|P1|Overall Study|Patient exited prior to implant|1
343933|NCT01168349|1160436|P1|Overall Study|Protocol Violation|76
343934|NCT01168349|1160436|P1|Overall Study|Other|22
343935|NCT01168349|1160436|P1|Overall Study|Kidney transplantation|3
343936|NCT01168349|1160436|P1|Overall Study|Withdrawal by Subject|9
343937|NCT01168349|1160436|P1|Overall Study|Lost to Follow-up|34
343938|NCT01168349|1160436|P1|Overall Study|Death|157
343939|NCT01168232|1160542|P1|Overall Study|Ineligible-Inadequate pathology|1
343940|NCT01168232|1160542|P1|Overall Study|Ineligible- Wrong cell type|6
343941|NCT01168232|1160542|P1|Overall Study|Ineligible-Second primary cancer site|1
343942|NCT01167907|1160570|P2|Overall Study|saphenous catheter dislodged before comp|1
343943|NCT01167907|1160571|P1|Overall Study|saphenous catheter dislodged before comp|1
343944|NCT01167907|1160570|P2|Overall Study|Protocol Violation|0
343945|NCT01167907|1160571|P1|Overall Study|Protocol Violation|1
343946|NCT01167881|1160589|P2|Overall Study|Other not defined above|55
343947|NCT01167881|1160590|P1|Overall Study|Other not defined above|31
343948|NCT01167881|1160589|P2|Overall Study|Not treated|0
343949|NCT01167881|1160590|P1|Overall Study|Not treated|4
343950|NCT01167881|1160589|P2|Overall Study|Patient refusal to cont., not due to AE|40
343951|NCT01167881|1160590|P1|Overall Study|Patient refusal to cont., not due to AE|45
343952|NCT01167881|1160589|P2|Overall Study|Lost to Follow-up|20
343953|NCT01167881|1160590|P1|Overall Study|Lost to Follow-up|19
343954|NCT01167881|1160589|P2|Overall Study|Non compliant with protocol|18
343955|NCT01167881|1160590|P1|Overall Study|Non compliant with protocol|9
343956|NCT01167881|1160589|P2|Overall Study|Lack of Efficacy|7
343957|NCT01167881|1160590|P1|Overall Study|Lack of Efficacy|4
343958|NCT01167881|1160589|P2|Overall Study|Adverse Event|51
343959|NCT01167881|1160590|P1|Overall Study|Adverse Event|47
343960|NCT01167634|1160644|P4|Overall Study|Withdrawal by Subject|0
343961|NCT01167634|1160645|P3|Overall Study|Withdrawal by Subject|0
343962|NCT01167634|1160646|P2|Overall Study|Withdrawal by Subject|1
343963|NCT01167634|1160647|P1|Overall Study|Withdrawal by Subject|1
343964|NCT01167634|1160644|P4|Overall Study|Lost to Follow-up|4
343965|NCT01167634|1160645|P3|Overall Study|Lost to Follow-up|3
343966|NCT01167634|1160646|P2|Overall Study|Lost to Follow-up|3
343967|NCT01167634|1160647|P1|Overall Study|Lost to Follow-up|1
343968|NCT01167582|1160668|P2|Overall Study|Lost to Follow-up|1
343969|NCT01167582|1160669|P1|Overall Study|Lost to Follow-up|0
343970|NCT01167426|1160691|P1|Overall Study|Sponsor Decision|1
343971|NCT01167426|1160691|P1|Overall Study|Withdrawal by Subject|2
343972|NCT01167426|1160691|P1|Overall Study|Protocol Violation|1
343973|NCT01167426|1160691|P1|Overall Study|Lost to Follow-up|6
343974|NCT01167257|1160699|P2|Overall Study|Withdrew consent|1
343975|NCT01167257|1160700|P1|Overall Study|Withdrew consent|1
343976|NCT01167257|1160699|P2|Overall Study|Lost to Follow-up|2
343977|NCT01167257|1160700|P1|Overall Study|Lost to Follow-up|2
343978|NCT01167192|1160722|P1|Overall Study|Insurance denial|1
343979|NCT01167192|1160722|P1|Overall Study|Withdrawal by Subject|1
343980|NCT01167192|1160722|P1|Overall Study|Death|1
343981|NCT01167192|1160722|P1|Overall Study|Adverse Event|1
343982|NCT01167179|1160739|P2|Overall Study|diverse|5
343983|NCT01167179|1160740|P1|Overall Study|diverse|6
343984|NCT01167179|1160739|P2|Overall Study|Withdrawal by Subject|2
343985|NCT01167179|1160740|P1|Overall Study|Withdrawal by Subject|1
343986|NCT01167179|1160739|P2|Overall Study|Death|10
343987|NCT01167179|1160740|P1|Overall Study|Death|4
343988|NCT01167179|1160739|P2|Overall Study|disease recurrence|4
343989|NCT01167179|1160740|P1|Overall Study|disease recurrence|4
343990|NCT01167153|1160750|P2|Overall Study|Subject initiation withdrawal, Other|8
343991|NCT01167153|1160751|P1|Overall Study|Subject initiation withdrawal, Other|5
343992|NCT01167153|1160750|P2|Overall Study|Withdrawal consent|1
343993|NCT01167153|1160751|P1|Overall Study|Withdrawal consent|1
343994|NCT01167153|1160750|P2|Overall Study|Investigator initiation withdrawal,Other|1
343995|NCT01167153|1160751|P1|Overall Study|Investigator initiation withdrawal,Other|1
343996|NCT01167153|1160750|P2|Overall Study|Non-compliance to concomitant medication|2
343997|NCT01167153|1160751|P1|Overall Study|Non-compliance to concomitant medication|0
343998|NCT01167153|1160750|P2|Overall Study|Lost to Follow-up|9
343999|NCT01167153|1160751|P1|Overall Study|Lost to Follow-up|7
344000|NCT01167153|1160750|P2|Overall Study|Hypotension|0
344001|NCT01167153|1160751|P1|Overall Study|Hypotension|1
344002|NCT01167153|1160750|P2|Overall Study|AE including clinical laboratory AE|8
344003|NCT01167153|1160751|P1|Overall Study|AE including clinical laboratory AE|2
344004|NCT01167153|1160750|P2|Overall Study|Non-effective therapy|4
344005|NCT01167153|1160751|P1|Overall Study|Non-effective therapy|1
344006|NCT01167140|1160769|P1|Overall Study|Withdrawal by Subject|1
344007|NCT01167023|1160777|P3|Overall Study|Withdrawal by Subject|1
344008|NCT01167023|1160778|P2|Overall Study|Withdrawal by Subject|0
344009|NCT01167023|1160779|P1|Overall Study|Withdrawal by Subject|0
344010|NCT01167023|1160777|P3|Overall Study|Sponsor Decision|0
344011|NCT01167023|1160778|P2|Overall Study|Sponsor Decision|1
344012|NCT01167023|1160779|P1|Overall Study|Sponsor Decision|0
344013|NCT01167023|1160777|P3|Overall Study|Screen Failure|0
344014|NCT01167023|1160778|P2|Overall Study|Screen Failure|1
344015|NCT01167023|1160779|P1|Overall Study|Screen Failure|0
344016|NCT01167023|1160777|P3|Overall Study|Lost to Follow-up|1
344017|NCT01167023|1160778|P2|Overall Study|Lost to Follow-up|1
344018|NCT01167023|1160779|P1|Overall Study|Lost to Follow-up|0
344019|NCT01166958|1160819|P2|Overall Study|Withdrawal by Subject|0
344020|NCT01166958|1160820|P1|Overall Study|Withdrawal by Subject|1
344021|NCT01166763|1160834|P1|Overall Study|Withdrawal by Subject|3
344022|NCT01166750|1160842|P2|Overall Study|Lost to Follow-up|0
344023|NCT01166750|1160843|P1|Overall Study|Lost to Follow-up|1
344024|NCT01166659|1160860|P1|Overall Study|Study Closed at Site|1
344025|NCT01166659|1160860|P1|Overall Study|Lost to Follow-up|1
344026|NCT01166659|1160860|P1|Overall Study|Death|1
344027|NCT01166659|1160860|P1|Overall Study|Investigator Decision|2
344028|NCT01166659|1160860|P1|Overall Study|Subject Decision|8
344029|NCT01166646|1160869|P2|Overall Study|Adverse Event|0
344030|NCT01166646|1160870|P1|Overall Study|Adverse Event|1
344031|NCT01166646|1160869|P2|Overall Study|Protocol Violation|1
344032|NCT01166646|1160870|P1|Overall Study|Protocol Violation|0
344033|NCT01166438|1160888|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
344034|NCT01166438|1160889|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
344035|NCT01166438|1160888|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
344036|NCT01166438|1160889|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
344037|NCT01166438|1160888|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
344038|NCT01166438|1160889|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
344039|NCT01166438|1160888|P2|Double-blind Phase: 1st 6 Months|Not treated|1
344040|NCT01166438|1160889|P1|Double-blind Phase: 1st 6 Months|Not treated|1
344041|NCT01166438|1160888|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
344042|NCT01166438|1160889|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
344043|NCT01166438|1160888|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
344044|NCT01166438|1160889|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
344045|NCT01166282|1160938|P3|Open-label Period|Irregular Compliance|1
344046|NCT01166282|1160939|P2|Open-label Period|Irregular Compliance|0
344047|NCT01166282|1160940|P1|Open-label Period|Irregular Compliance|0
344048|NCT01166282|1160938|P3|Open-label Period|Remission|4
344049|NCT01166282|1160939|P2|Open-label Period|Remission|0
344050|NCT01166282|1160940|P1|Open-label Period|Remission|0
344051|NCT01166282|1160938|P3|Open-label Period|Lack of Efficacy|2
344052|NCT01166282|1160939|P2|Open-label Period|Lack of Efficacy|0
344053|NCT01166282|1160940|P1|Open-label Period|Lack of Efficacy|0
344054|NCT01166282|1160938|P3|Open-label Period|Withdrawal by Subject|4
344055|NCT01166282|1160939|P2|Open-label Period|Withdrawal by Subject|0
344056|NCT01166282|1160940|P1|Open-label Period|Withdrawal by Subject|0
344057|NCT01166282|1160938|P3|Open-label Period|Adverse Event|6
344058|NCT01166282|1160939|P2|Open-label Period|Adverse Event|0
344059|NCT01166282|1160940|P1|Open-label Period|Adverse Event|0
344060|NCT01166178|1160979|P2|Overall Study|Study was terminated|8
344061|NCT01166178|1160980|P1|Overall Study|Study was terminated|20
344062|NCT01166178|1160979|P2|Overall Study|Withdrawal by Subject|0
344063|NCT01166178|1160980|P1|Overall Study|Withdrawal by Subject|1
344064|NCT01165996|1161019|P1|Overall Study|Physician Decision|1
344065|NCT01165996|1161019|P1|Overall Study|Death|1
344066|NCT01165684|1161086|P2|Overall Study|Unclassified|22
344067|NCT01165684|1161087|P1|Overall Study|Unclassified|16
344068|NCT01165684|1161086|P2|Overall Study|Withdrawal Criteria|13
344069|NCT01165684|1161087|P1|Overall Study|Withdrawal Criteria|2
344070|NCT01165684|1161086|P2|Overall Study|Protocol Violation|15
344071|NCT01165684|1161087|P1|Overall Study|Protocol Violation|7
344072|NCT01165684|1161086|P2|Overall Study|Lack of Efficacy|1
344073|NCT01165684|1161087|P1|Overall Study|Lack of Efficacy|2
344074|NCT01165684|1161086|P2|Overall Study|Adverse Event|1
344075|NCT01165684|1161087|P1|Overall Study|Adverse Event|1
344076|NCT01165554|1161121|P1|Overall Study|Withdrawal by Subject|23
344077|NCT01165424|1161144|P1|Overall Study|Participant moved (relocated)|1
344078|NCT01165424|1161144|P1|Overall Study|Did not meet entry criteria|1
344079|NCT01165424|1161144|P1|Overall Study|Laboratory adverse experiences|1
344080|NCT01165424|1161144|P1|Overall Study|Clinical adverse experiences|1
344081|NCT01165320|1161151|P3|Overall Study|Reason unknown|0
344082|NCT01165320|1161152|P2|Overall Study|Reason unknown|1
344083|NCT01165320|1161153|P1|Overall Study|Reason unknown|0
344084|NCT01165320|1161151|P3|Overall Study|Lack of Efficacy|0
344085|NCT01165320|1161152|P2|Overall Study|Lack of Efficacy|2
344086|NCT01165320|1161153|P1|Overall Study|Lack of Efficacy|0
344087|NCT01165320|1161151|P3|Overall Study|Laboratory adverse experience|0
344088|NCT01165320|1161152|P2|Overall Study|Laboratory adverse experience|0
344089|NCT01165320|1161153|P1|Overall Study|Laboratory adverse experience|1
344090|NCT01165320|1161151|P3|Overall Study|Clinical adverse experience|0
344091|NCT01165320|1161152|P2|Overall Study|Clinical adverse experience|1
344092|NCT01165320|1161153|P1|Overall Study|Clinical adverse experience|2
344093|NCT01165307|1161163|P2|Overall Study|Subject not available for contact|0
344094|NCT01165307|1161164|P1|Overall Study|Subject not available for contact|1
344095|NCT01165307|1161163|P2|Overall Study|Withdrawal by Subject|0
344096|NCT01165307|1161164|P1|Overall Study|Withdrawal by Subject|2
344097|NCT01165307|1161163|P2|Overall Study|Lost to Follow-up|3
344098|NCT01165307|1161164|P1|Overall Study|Lost to Follow-up|11
344099|NCT01165281|1161194|P2|Overall Study|Other|0
344100|NCT01165281|1161195|P1|Overall Study|Other|6
344101|NCT01165281|1161194|P2|Overall Study|Progressive Disease|14
344102|NCT01165281|1161195|P1|Overall Study|Progressive Disease|10
344103|NCT01165281|1161194|P2|Overall Study|Noncompliance with Study Drug|4
344104|NCT01165281|1161195|P1|Overall Study|Noncompliance with Study Drug|1
344105|NCT01165281|1161194|P2|Overall Study|Withdrawal by Subject|7
344106|NCT01165281|1161195|P1|Overall Study|Withdrawal by Subject|8
344107|NCT01165281|1161194|P2|Overall Study|Protocol Violation|5
344108|NCT01165281|1161195|P1|Overall Study|Protocol Violation|6
344109|NCT01165281|1161194|P2|Overall Study|Physician Decision|1
344110|NCT01165281|1161195|P1|Overall Study|Physician Decision|8
344111|NCT01165281|1161194|P2|Overall Study|Lost to Follow-up|1
344112|NCT01165281|1161195|P1|Overall Study|Lost to Follow-up|0
344113|NCT01165281|1161194|P2|Overall Study|Lack of Efficacy|1
344114|NCT01165281|1161195|P1|Overall Study|Lack of Efficacy|4
344115|NCT01165281|1161194|P2|Overall Study|Death|4
344116|NCT01165281|1161195|P1|Overall Study|Death|3
344117|NCT01165281|1161194|P2|Overall Study|Adverse Event|14
344118|NCT01165281|1161195|P1|Overall Study|Adverse Event|12
344119|NCT01165242|1161216|P3|Overall Study|Lost to Follow-up|10
344120|NCT01165242|1161217|P2|Overall Study|Lost to Follow-up|7
344121|NCT01165242|1161218|P1|Overall Study|Lost to Follow-up|9
344122|NCT01165242|1161216|P3|Overall Study|Extended Holiday|1
344123|NCT01165242|1161217|P2|Overall Study|Extended Holiday|0
344124|NCT01165242|1161218|P1|Overall Study|Extended Holiday|0
344125|NCT01165242|1161216|P3|Overall Study|Withdrawal by Subject|2
344126|NCT01165242|1161217|P2|Overall Study|Withdrawal by Subject|2
344127|NCT01165242|1161218|P1|Overall Study|Withdrawal by Subject|0
344128|NCT01165242|1161216|P3|Overall Study|Visit 2 Declined by Subject|1
344129|NCT01165242|1161217|P2|Overall Study|Visit 2 Declined by Subject|0
344130|NCT01165242|1161218|P1|Overall Study|Visit 2 Declined by Subject|0
344131|NCT01165242|1161216|P3|Overall Study|Incarcerated Subjects|0
344132|NCT01165242|1161217|P2|Overall Study|Incarcerated Subjects|1
344133|NCT01165242|1161218|P1|Overall Study|Incarcerated Subjects|0
344134|NCT01165242|1161216|P3|Overall Study|Unreachable Subjects|0
344135|NCT01165242|1161217|P2|Overall Study|Unreachable Subjects|0
344136|NCT01165242|1161218|P1|Overall Study|Unreachable Subjects|1
344137|NCT01165229|1161252|P2|Overall Study|Screening criteria unmet|0
344138|NCT01165229|1161253|P1|Overall Study|Screening criteria unmet|1
344139|NCT01165229|1161252|P2|Overall Study|Lack of time|0
344140|NCT01165229|1161253|P1|Overall Study|Lack of time|1
344141|NCT01165229|1161252|P2|Overall Study|Missed visit|0
344142|NCT01165229|1161253|P1|Overall Study|Missed visit|1
344143|NCT01165229|1161252|P2|Overall Study|Sponsor study termination|0
344144|NCT01165229|1161253|P1|Overall Study|Sponsor study termination|1
344145|NCT01165229|1161252|P2|Overall Study|Investigator decision|2
344146|NCT01165229|1161253|P1|Overall Study|Investigator decision|0
344147|NCT01165229|1161252|P2|Overall Study|Personal reason|4
344148|NCT01165229|1161253|P1|Overall Study|Personal reason|10
344149|NCT01165229|1161252|P2|Overall Study|Site closure|20
344150|NCT01165229|1161253|P1|Overall Study|Site closure|18
344151|NCT01165229|1161252|P2|Overall Study|Health issues|56
344152|NCT01165229|1161253|P1|Overall Study|Health issues|61
344153|NCT01165229|1161252|P2|Overall Study|Patient not eligible|1
344154|NCT01165229|1161253|P1|Overall Study|Patient not eligible|0
344155|NCT01165229|1161252|P2|Overall Study|Page entered in error|1
344156|NCT01165229|1161253|P1|Overall Study|Page entered in error|0
344157|NCT01165229|1161252|P2|Overall Study|No reason from the subject|1
344158|NCT01165229|1161253|P1|Overall Study|No reason from the subject|0
344159|NCT01165229|1161252|P2|Overall Study|Suspected HZ Episode|2
344160|NCT01165229|1161253|P1|Overall Study|Suspected HZ Episode|0
344161|NCT01165229|1161252|P2|Overall Study|Lost to Follow-up|138
344162|NCT01165229|1161253|P1|Overall Study|Lost to Follow-up|124
344163|NCT01165229|1161252|P2|Overall Study|Migrated/moved from study area|46
344164|NCT01165229|1161253|P1|Overall Study|Migrated/moved from study area|51
344165|NCT01165229|1161252|P2|Overall Study|Withdrawal by Subject|403
344166|NCT01165229|1161253|P1|Overall Study|Withdrawal by Subject|396
344167|NCT01165229|1161252|P2|Overall Study|Protocol Violation|12
344168|NCT01165229|1161253|P1|Overall Study|Protocol Violation|10
344169|NCT01165229|1161252|P2|Overall Study|Non-Serious Adverse Event|15
344170|NCT01165229|1161253|P1|Overall Study|Non-Serious Adverse Event|47
344171|NCT01165229|1161252|P2|Overall Study|Serious Adverse Event|487
344172|NCT01165229|1161253|P1|Overall Study|Serious Adverse Event|459
344173|NCT01165229|1161252|P2|Overall Study|Unknown completion status|1
344174|NCT01165229|1161253|P1|Overall Study|Unknown completion status|0
344175|NCT01165216|1161381|P2|Overall Study|Disease progression|3
344176|NCT01165216|1161382|P1|Overall Study|Disease progression|1
344177|NCT01165216|1161381|P2|Overall Study|Withdrawal by Subject|1
344178|NCT01165216|1161382|P1|Overall Study|Withdrawal by Subject|1
344179|NCT01165216|1161381|P2|Overall Study|Adverse Event|3
344180|NCT01165216|1161382|P1|Overall Study|Adverse Event|6
344181|NCT01165203|1161404|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
344182|NCT01165203|1161405|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
344183|NCT01165203|1161404|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
344184|NCT01165203|1161405|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
344185|NCT01165203|1161404|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
344186|NCT01165203|1161405|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
344187|NCT01165203|1161404|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
344188|NCT01165203|1161405|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
344189|NCT01165203|1161404|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
344190|NCT01165203|1161405|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
344191|NCT01165203|1161404|P2|Active Phase|Lost to Follow-up|0
344192|NCT01165203|1161405|P1|Active Phase|Lost to Follow-up|2
344193|NCT01165203|1161404|P2|Active Phase|Migrated/moved from study area|1
344194|NCT01165203|1161405|P1|Active Phase|Migrated/moved from study area|0
344195|NCT01165203|1161404|P2|Active Phase|Withdrawal by Subject|1
344196|NCT01165203|1161405|P1|Active Phase|Withdrawal by Subject|2
344197|NCT01165203|1161404|P2|Active Phase|Serious Adverse Event|0
344198|NCT01165203|1161405|P1|Active Phase|Serious Adverse Event|1
344199|NCT01165177|1161495|P2|Overall Study|Death|1
344200|NCT01165177|1161496|P1|Overall Study|Death|0
344201|NCT01165177|1161495|P2|Overall Study|Personal Reasons|4
344202|NCT01165177|1161496|P1|Overall Study|Personal Reasons|1
344203|NCT01165177|1161495|P2|Overall Study|Physician Decision|1
344204|NCT01165177|1161496|P1|Overall Study|Physician Decision|0
344205|NCT01165177|1161495|P2|Overall Study|Non-serious Adverse Event|20
344206|NCT01165177|1161496|P1|Overall Study|Non-serious Adverse Event|32
344207|NCT01165177|1161495|P2|Overall Study|Migrated/moved from study area|43
344208|NCT01165177|1161496|P1|Overall Study|Migrated/moved from study area|48
344209|NCT01165177|1161495|P2|Overall Study|Subject missed visit|2
344210|NCT01165177|1161496|P1|Overall Study|Subject missed visit|5
344211|NCT01165177|1161495|P2|Overall Study|Previous health issues worsening|11
344212|NCT01165177|1161496|P1|Overall Study|Previous health issues worsening|9
344213|NCT01165177|1161495|P2|Overall Study|Subject non-compliant with procedures|2
344214|NCT01165177|1161496|P1|Overall Study|Subject non-compliant with procedures|12
344215|NCT01165177|1161495|P2|Overall Study|Site closure|5
344216|NCT01165177|1161496|P1|Overall Study|Site closure|7
344217|NCT01165177|1161495|P2|Overall Study|Protocol Violation|22
344218|NCT01165177|1161496|P1|Overall Study|Protocol Violation|19
344219|NCT01165177|1161495|P2|Overall Study|Lost to Follow-up|195
344220|NCT01165177|1161496|P1|Overall Study|Lost to Follow-up|188
344221|NCT01165177|1161495|P2|Overall Study|Serious Adverse Event|240
344222|NCT01165177|1161496|P1|Overall Study|Serious Adverse Event|229
344223|NCT01165177|1161495|P2|Overall Study|Withdrawal by Subject|356
344224|NCT01165177|1161496|P1|Overall Study|Withdrawal by Subject|372
344225|NCT01165138|1161621|P4|Overall Study|Withdrawal by Subject|3
344226|NCT01165138|1161622|P3|Overall Study|Withdrawal by Subject|6
344227|NCT01165138|1161623|P2|Overall Study|Withdrawal by Subject|6
344228|NCT01165138|1161624|P1|Overall Study|Withdrawal by Subject|0
344229|NCT01165138|1161621|P4|Overall Study|Physician Decision|6
344230|NCT01165138|1161622|P3|Overall Study|Physician Decision|7
344231|NCT01165138|1161623|P2|Overall Study|Physician Decision|6
344232|NCT01165138|1161624|P1|Overall Study|Physician Decision|0
344233|NCT01165138|1161621|P4|Overall Study|Lost to Follow-up|2
344234|NCT01165138|1161622|P3|Overall Study|Lost to Follow-up|1
344235|NCT01165138|1161623|P2|Overall Study|Lost to Follow-up|0
344236|NCT01165138|1161624|P1|Overall Study|Lost to Follow-up|0
344237|NCT01165138|1161621|P4|Overall Study|Protocol Violation|2
344238|NCT01165138|1161622|P3|Overall Study|Protocol Violation|0
344239|NCT01165138|1161623|P2|Overall Study|Protocol Violation|7
344240|NCT01165138|1161624|P1|Overall Study|Protocol Violation|0
344241|NCT01165138|1161621|P4|Overall Study|Lack of Efficacy|7
344242|NCT01165138|1161622|P3|Overall Study|Lack of Efficacy|6
344243|NCT01165138|1161623|P2|Overall Study|Lack of Efficacy|32
344244|NCT01165138|1161624|P1|Overall Study|Lack of Efficacy|0
344245|NCT01165138|1161621|P4|Overall Study|Adverse Event|2
344246|NCT01165138|1161622|P3|Overall Study|Adverse Event|0
344247|NCT01165138|1161623|P2|Overall Study|Adverse Event|1
344248|NCT01165138|1161624|P1|Overall Study|Adverse Event|0
344249|NCT01165021|1161694|P1|Overall Study|Death|1
344250|NCT01164891|1161702|P1|Overall Study|Adverse Event|1
344251|NCT01164891|1161702|P1|Overall Study|Disease Progression|5
344252|NCT01164865|1161722|P2|Overall Study|Lost to Follow-up|1
344253|NCT01164865|1161723|P1|Overall Study|Lost to Follow-up|2
344254|NCT01164722|1161733|P2|Overall Study|enrolled on other study, concomitant med|3
344255|NCT01164722|1161734|P1|Overall Study|enrolled on other study, concomitant med|1
344256|NCT01164722|1161733|P2|Overall Study|met protocol criteria for non-treatment|1
344257|NCT01164722|1161734|P1|Overall Study|met protocol criteria for non-treatment|11
344258|NCT01164722|1161733|P2|Overall Study|Lost to Follow-up|6
344259|NCT01164722|1161734|P1|Overall Study|Lost to Follow-up|3
344260|NCT01164722|1161733|P2|Overall Study|Withdrawal by Subject|4
344261|NCT01164722|1161734|P1|Overall Study|Withdrawal by Subject|3
344262|NCT01164722|1161733|P2|Overall Study|Adverse Event|1
344263|NCT01164722|1161734|P1|Overall Study|Adverse Event|0
344264|NCT01164579|1161764|P3|Overall Study|Reason not specified|0
344265|NCT01164579|1161765|P2|Overall Study|Reason not specified|0
344266|NCT01164579|1161766|P1|Overall Study|Reason not specified|1
344267|NCT01164579|1161764|P3|Overall Study|Adverse Event|5
344268|NCT01164579|1161765|P2|Overall Study|Adverse Event|2
344269|NCT01164579|1161766|P1|Overall Study|Adverse Event|4
344270|NCT01164579|1161764|P3|Overall Study|Protocol Violation|2
344271|NCT01164579|1161765|P2|Overall Study|Protocol Violation|1
344272|NCT01164579|1161766|P1|Overall Study|Protocol Violation|0
344273|NCT01164579|1161764|P3|Overall Study|Withdrawal by Subject|3
344274|NCT01164579|1161765|P2|Overall Study|Withdrawal by Subject|5
344275|NCT01164579|1161766|P1|Overall Study|Withdrawal by Subject|2
344276|NCT01164579|1161764|P3|Overall Study|Lost to Follow-up|0
344277|NCT01164579|1161765|P2|Overall Study|Lost to Follow-up|1
344278|NCT01164579|1161766|P1|Overall Study|Lost to Follow-up|1
344279|NCT01164579|1161764|P3|Overall Study|Lack of Efficacy|6
344280|NCT01164579|1161765|P2|Overall Study|Lack of Efficacy|0
344281|NCT01164579|1161766|P1|Overall Study|Lack of Efficacy|0
344282|NCT01164501|1161846|P3|Overall Study|Other reason not defined above|4
344283|NCT01164501|1161847|P2|Overall Study|Other reason not defined above|1
344284|NCT01164501|1161848|P1|Overall Study|Other reason not defined above|9
344285|NCT01164501|1161846|P3|Overall Study|Patient refusal to continue,not due toAE|8
344286|NCT01164501|1161847|P2|Overall Study|Patient refusal to continue,not due toAE|4
344287|NCT01164501|1161848|P1|Overall Study|Patient refusal to continue,not due toAE|10
344288|NCT01164501|1161846|P3|Overall Study|Lost to Follow-up|3
344289|NCT01164501|1161847|P2|Overall Study|Lost to Follow-up|0
344290|NCT01164501|1161848|P1|Overall Study|Lost to Follow-up|3
344291|NCT01164501|1161846|P3|Overall Study|Non compliant with protocol|4
344292|NCT01164501|1161847|P2|Overall Study|Non compliant with protocol|1
344293|NCT01164501|1161848|P1|Overall Study|Non compliant with protocol|1
344294|NCT01164501|1161846|P3|Overall Study|Lack of Efficacy|1
344295|NCT01164501|1161847|P2|Overall Study|Lack of Efficacy|0
344296|NCT01164501|1161848|P1|Overall Study|Lack of Efficacy|0
344297|NCT01164501|1161846|P3|Overall Study|Adverse Event|21
344298|NCT01164501|1161847|P2|Overall Study|Adverse Event|4
344299|NCT01164501|1161848|P1|Overall Study|Adverse Event|18
344300|NCT01164501|1161846|P3|Overall Study|Not treated|1
344301|NCT01164501|1161847|P2|Overall Study|Not treated|0
344302|NCT01164501|1161848|P1|Overall Study|Not treated|2
344303|NCT01164475|1161865|P2|Overall Study|Protocol Violation|0
344304|NCT01164475|1161866|P1|Overall Study|Protocol Violation|1
344305|NCT01164475|1161865|P2|Overall Study|Progressive disease|1
344306|NCT01164475|1161866|P1|Overall Study|Progressive disease|0
344307|NCT01164475|1161865|P2|Overall Study|Other|1
344308|NCT01164475|1161866|P1|Overall Study|Other|0
344309|NCT01164475|1161865|P2|Overall Study|Lack of Efficacy|0
344310|NCT01164475|1161866|P1|Overall Study|Lack of Efficacy|1
344311|NCT01164007|1161907|P1|Overall Study|Medical Decision|3
344312|NCT01164007|1161907|P1|Overall Study|Withdrawal by Subject|1
344313|NCT01164007|1161907|P1|Overall Study|Protocol Violation|1
344314|NCT01164007|1161907|P1|Overall Study|Progression of Disease|30
344315|NCT01164007|1161907|P1|Overall Study|Adverse Event|5
344316|NCT01163916|1161933|P3|Overall Study|Other|16
344317|NCT01163916|1161934|P2|Overall Study|Other|4
344318|NCT01163916|1161935|P1|Overall Study|Other|24
344319|NCT01163916|1161933|P3|Overall Study|Lack of Efficacy|1
344320|NCT01163916|1161934|P2|Overall Study|Lack of Efficacy|0
344321|NCT01163916|1161935|P1|Overall Study|Lack of Efficacy|2
344322|NCT01163916|1161933|P3|Overall Study|Adverse Event|1
344323|NCT01163916|1161934|P2|Overall Study|Adverse Event|0
344324|NCT01163916|1161935|P1|Overall Study|Adverse Event|2
344325|NCT01163916|1161933|P3|Overall Study|Withdrawal by Subject|2
344326|NCT01163916|1161934|P2|Overall Study|Withdrawal by Subject|0
344327|NCT01163916|1161935|P1|Overall Study|Withdrawal by Subject|2
344328|NCT01163851|1161973|P2|Overall Study|Enrolled but not treated|0
344329|NCT01163851|1161974|P1|Overall Study|Enrolled but not treated|1
344330|NCT01163851|1161973|P2|Overall Study|Site Closure|1
344331|NCT01163851|1161974|P1|Overall Study|Site Closure|0
344332|NCT01163747|1162069|P2|Overall Study|Refused Treatment|4
344333|NCT01163747|1162070|P1|Overall Study|Refused Treatment|6
344334|NCT01163747|1162069|P2|Overall Study|Protocol Violation|1
344335|NCT01163747|1162070|P1|Overall Study|Protocol Violation|0
344336|NCT01163747|1162069|P2|Overall Study|Insufficient Therapeutic Response|1
344337|NCT01163747|1162070|P1|Overall Study|Insufficient Therapeutic Response|0
344338|NCT01163747|1162069|P2|Overall Study|Adverse Event|5
344339|NCT01163747|1162070|P1|Overall Study|Adverse Event|0
344340|NCT01163721|1162090|P2|Overall Study|Physician Decision|1
344341|NCT01163721|1162091|P1|Overall Study|Physician Decision|0
344342|NCT01163721|1162090|P2|Overall Study|Lost to Follow-up|1
344343|NCT01163721|1162091|P1|Overall Study|Lost to Follow-up|0
344344|NCT01163721|1162090|P2|Overall Study|Withdrawal by Subject|4
344345|NCT01163721|1162091|P1|Overall Study|Withdrawal by Subject|3
344346|NCT01163721|1162090|P2|Overall Study|Adverse Event|6
344347|NCT01163721|1162091|P1|Overall Study|Adverse Event|5
344348|NCT01163617|1162110|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
344349|NCT01163617|1162111|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
344350|NCT01163617|1162112|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
344351|NCT01163617|1162113|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
344352|NCT01163617|1162114|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
344353|NCT01163617|1162115|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
344354|NCT01163617|1162116|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
344355|NCT01163617|1162117|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
344356|NCT01163617|1162110|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
344357|NCT01163617|1162111|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
344358|NCT01163617|1162112|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
344359|NCT01163617|1162113|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
344360|NCT01163617|1162114|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
344361|NCT01163617|1162115|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
344362|NCT01163617|1162116|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
344363|NCT01163617|1162117|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
344364|NCT01163617|1162110|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
344365|NCT01163617|1162111|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
344366|NCT01163617|1162112|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
344367|NCT01163617|1162113|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
344368|NCT01163617|1162114|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
344369|NCT01163617|1162115|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
344370|NCT01163617|1162116|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
344371|NCT01163617|1162117|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
344372|NCT01163474|1162146|P1|Overall Study|Lost to Follow-up|3
344373|NCT01163474|1162146|P1|Overall Study|Tech barriers to videoteleconference vis|12
344374|NCT01163474|1162146|P1|Overall Study|Withdrawal by Subject|1
344375|NCT01163318|1162157|P1|Overall Study|Multiple Reasons Per Participant|224
344376|NCT01163318|1162157|P1|Overall Study|Participants Without Case Report Form|7
344377|NCT01163318|1162157|P1|Overall Study|History/comorbidity of malignant tumor|3
344378|NCT01163318|1162157|P1|Overall Study|Did Not Continue Use of Adalimumab|26
344379|NCT01163318|1162157|P1|Overall Study|Off-Label Use of Adalimumab|8
344380|NCT01163292|1162166|P2|Overall Study|No further visits|7
344381|NCT01163292|1162167|P1|Overall Study|No further visits|5
344382|NCT01163292|1162166|P2|Overall Study|Economic reasons|0
344383|NCT01163292|1162167|P1|Overall Study|Economic reasons|6
344384|NCT01163292|1162166|P2|Overall Study|Refusal to receive adalimumab|0
344385|NCT01163292|1162167|P1|Overall Study|Refusal to receive adalimumab|7
344386|NCT01163292|1162166|P2|Overall Study|Sufficient response to adalimumab|0
344387|NCT01163292|1162167|P1|Overall Study|Sufficient response to adalimumab|8
344388|NCT01163292|1162166|P2|Overall Study|Initiation of biological therapy|15
344389|NCT01163292|1162167|P1|Overall Study|Initiation of biological therapy|0
344390|NCT01163292|1162166|P2|Overall Study|Adverse Event|0
344391|NCT01163292|1162167|P1|Overall Study|Adverse Event|6
344392|NCT01163292|1162166|P2|Overall Study|Lack of Efficacy|0
344393|NCT01163292|1162167|P1|Overall Study|Lack of Efficacy|9
344394|NCT01163279|1162183|P2|Overall Study|Withdrawal by Subject|0
344395|NCT01163279|1162184|P1|Overall Study|Withdrawal by Subject|2
344396|NCT01163266|1162213|P3|Overall Study|Other|2
344397|NCT01163266|1162214|P2|Overall Study|Other|1
344398|NCT01163266|1162215|P1|Overall Study|Other|1
344399|NCT01163266|1162213|P3|Overall Study|Lost to Follow-up|10
344400|NCT01163266|1162214|P2|Overall Study|Lost to Follow-up|7
344401|NCT01163266|1162215|P1|Overall Study|Lost to Follow-up|7
344402|NCT01163266|1162213|P3|Overall Study|Withdrawal of Consent|3
344403|NCT01163266|1162214|P2|Overall Study|Withdrawal of Consent|7
344404|NCT01163266|1162215|P1|Overall Study|Withdrawal of Consent|5
344405|NCT01163266|1162213|P3|Overall Study|Protocol Deviations|5
344406|NCT01163266|1162214|P2|Overall Study|Protocol Deviations|2
344407|NCT01163266|1162215|P1|Overall Study|Protocol Deviations|2
344408|NCT01163266|1162213|P3|Overall Study|Noncompliance with Study Drug|0
344409|NCT01163266|1162214|P2|Overall Study|Noncompliance with Study Drug|2
344410|NCT01163266|1162215|P1|Overall Study|Noncompliance with Study Drug|0
344411|NCT01163266|1162213|P3|Overall Study|Lack of Efficacy|1
344412|NCT01163266|1162214|P2|Overall Study|Lack of Efficacy|3
344413|NCT01163266|1162215|P1|Overall Study|Lack of Efficacy|1
344414|NCT01163266|1162213|P3|Overall Study|Pretreatment Event or Adverse Event|7
344415|NCT01163266|1162214|P2|Overall Study|Pretreatment Event or Adverse Event|9
344416|NCT01163266|1162215|P1|Overall Study|Pretreatment Event or Adverse Event|2
344417|NCT01163253|1162240|P2|Overall Study|Other Unspecified|34
344418|NCT01163253|1162241|P1|Overall Study|Other Unspecified|170
344419|NCT01163253|1162240|P2|Overall Study|Ongoing|4
344420|NCT01163253|1162241|P1|Overall Study|Ongoing|13
344421|NCT01163253|1162240|P2|Overall Study|Death|5
344422|NCT01163253|1162241|P1|Overall Study|Death|17
344423|NCT01163253|1162240|P2|Overall Study|Adverse Event|78
344424|NCT01163253|1162241|P1|Overall Study|Adverse Event|300
344425|NCT01163253|1162240|P2|Overall Study|Insufficient Clinical Response|29
344426|NCT01163253|1162241|P1|Overall Study|Insufficient Clinical Response|423
344427|NCT01163253|1162240|P2|Overall Study|Lost to Follow-up|23
344428|NCT01163253|1162241|P1|Overall Study|Lost to Follow-up|125
344429|NCT01163253|1162240|P2|Overall Study|Medication Error|0
344430|NCT01163253|1162241|P1|Overall Study|Medication Error|1
344431|NCT01163253|1162240|P2|Overall Study|Withdrawal by Subject|50
344432|NCT01163253|1162241|P1|Overall Study|Withdrawal by Subject|199
344433|NCT01163253|1162240|P2|Overall Study|Protocol Violation|12
344434|NCT01163253|1162241|P1|Overall Study|Protocol Violation|43
344435|NCT01163253|1162240|P2|Overall Study|Study Terminated by Sponsor|349
344436|NCT01163253|1162241|P1|Overall Study|Study Terminated by Sponsor|978
344437|NCT01163253|1162240|P2|Overall Study|Withdrawn Due to Pregnancy|2
344438|NCT01163253|1162241|P1|Overall Study|Withdrawn Due to Pregnancy|12
344439|NCT01163149|1162429|P3|Extension Treatment Period|Noncompliance|1
344440|NCT01163149|1162430|P2|Extension Treatment Period|Noncompliance|0
344441|NCT01163149|1162431|P1|Extension Treatment Period|Noncompliance|0
344442|NCT01163149|1162429|P3|Extension Treatment Period|Adverse Event|0
344443|NCT01163149|1162430|P2|Extension Treatment Period|Adverse Event|1
344444|NCT01163149|1162431|P1|Extension Treatment Period|Adverse Event|0
344445|NCT01163149|1162429|P3|Extension Treatment Period|Withdrawal by Subject|1
344446|NCT01163149|1162430|P2|Extension Treatment Period|Withdrawal by Subject|0
344447|NCT01163149|1162431|P1|Extension Treatment Period|Withdrawal by Subject|2
344448|NCT01163032|1162531|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
344449|NCT01163032|1162532|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
344450|NCT01163032|1162533|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
344451|NCT01163032|1162531|P3|Open Label Extension Phase|Study Termination|7
344452|NCT01163032|1162532|P2|Open Label Extension Phase|Study Termination|0
344453|NCT01163032|1162533|P1|Open Label Extension Phase|Study Termination|0
344454|NCT01163032|1162531|P3|Open Label Extension Phase|Protocol Violation|1
344455|NCT01163032|1162532|P2|Open Label Extension Phase|Protocol Violation|0
344456|NCT01163032|1162533|P1|Open Label Extension Phase|Protocol Violation|0
344457|NCT01163032|1162531|P3|Open Label Extension Phase|Withdrawal by Subject|3
344458|NCT01163032|1162532|P2|Open Label Extension Phase|Withdrawal by Subject|0
344459|NCT01163032|1162533|P1|Open Label Extension Phase|Withdrawal by Subject|0
344460|NCT01163032|1162531|P3|Open Label Extension Phase|Adverse Event|3
344461|NCT01163032|1162532|P2|Open Label Extension Phase|Adverse Event|0
344462|NCT01163032|1162533|P1|Open Label Extension Phase|Adverse Event|0
344463|NCT01163032|1162531|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
344464|NCT01163032|1162532|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
344465|NCT01163032|1162533|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
344466|NCT01163032|1162531|P3|Randomization Phase|Various*|0
344467|NCT01163032|1162532|P2|Randomization Phase|Various*|4
344468|NCT01163032|1162533|P1|Randomization Phase|Various*|5
344469|NCT01163032|1162531|P3|Randomization Phase|Protocol Violation|0
344470|NCT01163032|1162532|P2|Randomization Phase|Protocol Violation|1
344471|NCT01163032|1162533|P1|Randomization Phase|Protocol Violation|0
344472|NCT01163032|1162531|P3|Randomization Phase|Adverse Event|0
344473|NCT01163032|1162532|P2|Randomization Phase|Adverse Event|3
344474|NCT01163032|1162533|P1|Randomization Phase|Adverse Event|3
344475|NCT01163032|1162531|P3|Randomization Phase|Withdrawal by Subject|0
344476|NCT01163032|1162532|P2|Randomization Phase|Withdrawal by Subject|3
344477|NCT01163032|1162533|P1|Randomization Phase|Withdrawal by Subject|2
344478|NCT01162863|1162566|P3|Overall Study|Adverse Event|0
344479|NCT01162863|1162567|P2|Overall Study|Adverse Event|1
344480|NCT01162863|1162568|P1|Overall Study|Adverse Event|0
344481|NCT01162863|1162566|P3|Overall Study|Lack of Efficacy|0
344482|NCT01162863|1162567|P2|Overall Study|Lack of Efficacy|0
344483|NCT01162863|1162568|P1|Overall Study|Lack of Efficacy|1
344484|NCT01162499|1162593|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
344485|NCT01162499|1162594|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
344486|NCT01162473|1162616|P2|Overall Study|Withdrawal by Subject|4
344487|NCT01162473|1162617|P1|Overall Study|Withdrawal by Subject|0
344488|NCT01162473|1162616|P2|Overall Study|Adverse Event|1
344489|NCT01162473|1162617|P1|Overall Study|Adverse Event|2
344490|NCT01162421|1162625|P2|Overall Study|Not specified|3
344491|NCT01162421|1162626|P1|Overall Study|Not specified|2
344492|NCT01162421|1162625|P2|Overall Study|Lack of Efficacy|2
344493|NCT01162421|1162626|P1|Overall Study|Lack of Efficacy|2
344494|NCT01162421|1162625|P2|Overall Study|Lost to Follow-up|2
344495|NCT01162421|1162626|P1|Overall Study|Lost to Follow-up|0
344496|NCT01162421|1162625|P2|Overall Study|Adverse Event|5
344497|NCT01162421|1162626|P1|Overall Study|Adverse Event|2
344498|NCT01162421|1162625|P2|Overall Study|Did not receive study drug|1
344499|NCT01162421|1162626|P1|Overall Study|Did not receive study drug|2
344500|NCT01162343|1162704|P1|Overall Study|Refused psychiatrist assessment|12
344501|NCT01162343|1162704|P1|Overall Study|Left ED prior to psychiatrist assessment|80
344502|NCT01162304|1162719|P1|Overall Study|Beck scale to high|11
344503|NCT01162135|1162733|P1|Overall Study|Ineligible|1
344504|NCT01162135|1162733|P1|Overall Study|Severe back pain|1
344505|NCT01162135|1162733|P1|Overall Study|Withdrawal by Subject|1
344506|NCT01162122|1162739|P2|Overall Study|Missing primary reason|0
344507|NCT01162122|1162740|P1|Overall Study|Missing primary reason|1
344508|NCT01162122|1162739|P2|Overall Study|Unable to classify|7
344509|NCT01162122|1162740|P1|Overall Study|Unable to classify|3
344510|NCT01162122|1162739|P2|Overall Study|Administrative reason|1
344511|NCT01162122|1162740|P1|Overall Study|Administrative reason|1
344512|NCT01162122|1162739|P2|Overall Study|Inappropriate enrollment|4
344513|NCT01162122|1162740|P1|Overall Study|Inappropriate enrollment|5
344514|NCT01162122|1162739|P2|Overall Study|Protocol Violation|2
344515|NCT01162122|1162740|P1|Overall Study|Protocol Violation|2
344516|NCT01162122|1162739|P2|Overall Study|Death|46
344517|NCT01162122|1162740|P1|Overall Study|Death|51
344518|NCT01162122|1162739|P2|Overall Study|Adverse Event|2
344519|NCT01162122|1162740|P1|Overall Study|Adverse Event|3
344520|NCT01162122|1162739|P2|Overall Study|Lost to Follow-up|91
344521|NCT01162122|1162740|P1|Overall Study|Lost to Follow-up|73
344522|NCT01162122|1162739|P2|Overall Study|Withdrawal by Subject|43
344523|NCT01162122|1162740|P1|Overall Study|Withdrawal by Subject|52
344524|NCT01161628|1162835|P1|Overall Study|Lack of Efficacy|2
344525|NCT01161628|1162835|P1|Overall Study|Death|6
344526|NCT01161537|1162858|P1|Part B|Withdrawal by Subject|2
344527|NCT01161498|1162876|P2|Overall Study|Disease Progression|1
344528|NCT01161498|1162877|P1|Overall Study|Disease Progression|0
344529|NCT01161472|1162901|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
344530|NCT01161472|1162902|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
344531|NCT01161472|1162903|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
344532|NCT01161472|1162904|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
344533|NCT01161446|1162960|P2|Overall Study|Withdrawal by Subject|1
344534|NCT01161446|1162961|P1|Overall Study|Withdrawal by Subject|0
344535|NCT01161446|1162960|P2|Overall Study|Lost to Follow-up|14
344536|NCT01161446|1162961|P1|Overall Study|Lost to Follow-up|18
344537|NCT01161407|1162987|P2|Overall Study|Protocol Violation|1
344538|NCT01161407|1162988|P1|Overall Study|Protocol Violation|3
344539|NCT01161173|1163043|P1|Overall Study|Reasons Not Specified|23
344540|NCT01161173|1163043|P1|Overall Study|End of Study|2
344541|NCT01161173|1163043|P1|Overall Study|Death|194
344542|NCT01161173|1163043|P1|Overall Study|Unacceptable Toxicity|21
344543|NCT01161173|1163043|P1|Overall Study|Withdrawal of Consent|5
344544|NCT01161173|1163043|P1|Overall Study|Progressive Disease|82
344545|NCT01161173|1163043|P1|Overall Study|Lost to Follow-up|7
344546|NCT01161173|1163043|P1|Overall Study|Protocol Violation|13
344547|NCT01160822|1163170|P7|Overall Study|Protocol deviation|0
344548|NCT01160822|1163171|P6|Overall Study|Protocol deviation|0
344549|NCT01160822|1163172|P5|Overall Study|Protocol deviation|2
344550|NCT01160822|1163173|P4|Overall Study|Protocol deviation|0
344551|NCT01160822|1163174|P3|Overall Study|Protocol deviation|0
344552|NCT01160822|1163175|P2|Overall Study|Protocol deviation|0
344553|NCT01160822|1163176|P1|Overall Study|Protocol deviation|0
344554|NCT01160822|1163170|P7|Overall Study|Administrative problems|0
344555|NCT01160822|1163171|P6|Overall Study|Administrative problems|0
344556|NCT01160822|1163172|P5|Overall Study|Administrative problems|1
344557|NCT01160822|1163173|P4|Overall Study|Administrative problems|0
344558|NCT01160822|1163174|P3|Overall Study|Administrative problems|0
344559|NCT01160822|1163175|P2|Overall Study|Administrative problems|0
344560|NCT01160822|1163176|P1|Overall Study|Administrative problems|0
344561|NCT01160822|1163170|P7|Overall Study|Lost to Follow-up|0
344562|NCT01160822|1163171|P6|Overall Study|Lost to Follow-up|0
344563|NCT01160822|1163172|P5|Overall Study|Lost to Follow-up|1
344564|NCT01160822|1163173|P4|Overall Study|Lost to Follow-up|0
344565|NCT01160822|1163174|P3|Overall Study|Lost to Follow-up|0
344566|NCT01160822|1163175|P2|Overall Study|Lost to Follow-up|0
344567|NCT01160822|1163176|P1|Overall Study|Lost to Follow-up|0
344568|NCT01160822|1163170|P7|Overall Study|Withdrawal by Subject|1
344569|NCT01160822|1163171|P6|Overall Study|Withdrawal by Subject|0
344570|NCT01160822|1163172|P5|Overall Study|Withdrawal by Subject|0
344571|NCT01160822|1163173|P4|Overall Study|Withdrawal by Subject|0
344572|NCT01160822|1163174|P3|Overall Study|Withdrawal by Subject|0
344573|NCT01160822|1163175|P2|Overall Study|Withdrawal by Subject|0
344574|NCT01160822|1163176|P1|Overall Study|Withdrawal by Subject|0
344575|NCT01160822|1163170|P7|Overall Study|Unsatisfactory therapeutic effect|3
344576|NCT01160822|1163171|P6|Overall Study|Unsatisfactory therapeutic effect|5
344577|NCT01160822|1163172|P5|Overall Study|Unsatisfactory therapeutic effect|4
344578|NCT01160822|1163173|P4|Overall Study|Unsatisfactory therapeutic effect|0
344579|NCT01160822|1163174|P3|Overall Study|Unsatisfactory therapeutic effect|0
344580|NCT01160822|1163175|P2|Overall Study|Unsatisfactory therapeutic effect|0
344581|NCT01160822|1163176|P1|Overall Study|Unsatisfactory therapeutic effect|0
344582|NCT01160822|1163170|P7|Overall Study|Adverse Event|5
344583|NCT01160822|1163171|P6|Overall Study|Adverse Event|2
344584|NCT01160822|1163172|P5|Overall Study|Adverse Event|1
344585|NCT01160822|1163173|P4|Overall Study|Adverse Event|0
344586|NCT01160822|1163174|P3|Overall Study|Adverse Event|0
344587|NCT01160822|1163175|P2|Overall Study|Adverse Event|0
344588|NCT01160822|1163176|P1|Overall Study|Adverse Event|0
344589|NCT01160770|1163265|P1|Overall Study|Other Reasons|1
344590|NCT01160770|1163265|P1|Overall Study|Lack of Efficacy|15
344591|NCT01160770|1163265|P1|Overall Study|Death|9
344592|NCT01160770|1163265|P1|Overall Study|Study termination or sponsor request|1
344593|NCT01160770|1163265|P1|Overall Study|Lost to Follow-up|7
344594|NCT01160770|1163265|P1|Overall Study|Physician Decision|1
344595|NCT01160770|1163265|P1|Overall Study|Subject/parent/caregiver request|33
344596|NCT01160770|1163265|P1|Overall Study|Protocol Violation|2
344597|NCT01160770|1163265|P1|Overall Study|Adverse Event|10
344598|NCT01160744|1163278|P4|Overall Study|Alive and Still on Treatment|14
344599|NCT01160744|1163279|P3|Overall Study|Alive and Still on Treatment|8
344600|NCT01160744|1163280|P2|Overall Study|Alive and Still on Treatment|11
344601|NCT01160744|1163281|P1|Overall Study|Alive and Still on Treatment|9
344602|NCT01160744|1163278|P4|Overall Study|Not Specified|4
344603|NCT01160744|1163279|P3|Overall Study|Not Specified|5
344604|NCT01160744|1163280|P2|Overall Study|Not Specified|9
344605|NCT01160744|1163281|P1|Overall Study|Not Specified|5
344606|NCT01160744|1163278|P4|Overall Study|Not meet inclusion/exclusion criteria|0
344607|NCT01160744|1163279|P3|Overall Study|Not meet inclusion/exclusion criteria|1
344608|NCT01160744|1163280|P2|Overall Study|Not meet inclusion/exclusion criteria|0
344609|NCT01160744|1163281|P1|Overall Study|Not meet inclusion/exclusion criteria|0
344610|NCT01160744|1163278|P4|Overall Study|Withdrawal by Subject|4
344611|NCT01160744|1163279|P3|Overall Study|Withdrawal by Subject|6
344612|NCT01160744|1163280|P2|Overall Study|Withdrawal by Subject|5
344613|NCT01160744|1163281|P1|Overall Study|Withdrawal by Subject|6
344614|NCT01160640|1163317|P2|Overall Study|Withdrawal by Subject|3
344615|NCT01160640|1163318|P1|Overall Study|Withdrawal by Subject|0
344616|NCT01160640|1163317|P2|Overall Study|Incarceration|0
344617|NCT01160640|1163318|P1|Overall Study|Incarceration|1
344618|NCT01160640|1163317|P2|Overall Study|Physician Decision|3
344619|NCT01160640|1163318|P1|Overall Study|Physician Decision|3
344620|NCT01160614|1163334|P2|Overall Study|Withdrawal by Subject|2
344621|NCT01160614|1163335|P1|Overall Study|Withdrawal by Subject|0
344622|NCT01160484|1163383|P1|Overall Study|inclusion/exclusion criteria failure|1
344623|NCT01160484|1163383|P1|Overall Study|Withdrawal by Subject|2
344624|NCT01160484|1163383|P1|Overall Study|Adverse Event|6
344625|NCT01160484|1163383|P1|Overall Study|Lack of Efficacy|9
344626|NCT01160198|1163464|P3|Overall Study|Participant lost drug; withdrew consent|1
344627|NCT01160198|1163465|P2|Overall Study|Participant lost drug; withdrew consent|0
344628|NCT01160198|1163466|P1|Overall Study|Participant lost drug; withdrew consent|0
344629|NCT01160198|1163464|P3|Overall Study|Lost to Follow-up|0
344630|NCT01160198|1163465|P2|Overall Study|Lost to Follow-up|1
344631|NCT01160198|1163466|P1|Overall Study|Lost to Follow-up|0
344632|NCT01160198|1163464|P3|Overall Study|Adverse Event|0
344633|NCT01160198|1163465|P2|Overall Study|Adverse Event|1
344634|NCT01160198|1163466|P1|Overall Study|Adverse Event|0
344635|NCT01160198|1163464|P3|Overall Study|Withdrawal by Subject|0
344636|NCT01160198|1163465|P2|Overall Study|Withdrawal by Subject|1
344637|NCT01160198|1163466|P1|Overall Study|Withdrawal by Subject|2
344638|NCT01159938|1163488|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
344639|NCT01159938|1163489|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
344640|NCT01159938|1163490|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
344641|NCT01159938|1163491|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
344642|NCT01159938|1163492|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
344643|NCT01159912|1163555|P3|Overall Study|Withdrawal by Subject|3
344644|NCT01159912|1163556|P2|Overall Study|Withdrawal by Subject|3
344645|NCT01159912|1163557|P1|Overall Study|Withdrawal by Subject|10
344646|NCT01159912|1163555|P3|Overall Study|Physician Decision|3
344647|NCT01159912|1163556|P2|Overall Study|Physician Decision|0
344648|NCT01159912|1163557|P1|Overall Study|Physician Decision|0
344649|NCT01159912|1163555|P3|Overall Study|Lost to Follow-up|0
344650|NCT01159912|1163556|P2|Overall Study|Lost to Follow-up|0
344651|NCT01159912|1163557|P1|Overall Study|Lost to Follow-up|4
344652|NCT01159912|1163555|P3|Overall Study|Protocol Violation|3
344653|NCT01159912|1163556|P2|Overall Study|Protocol Violation|2
344654|NCT01159912|1163557|P1|Overall Study|Protocol Violation|1
344655|NCT01159912|1163555|P3|Overall Study|Lack of Efficacy|14
344656|NCT01159912|1163556|P2|Overall Study|Lack of Efficacy|15
344657|NCT01159912|1163557|P1|Overall Study|Lack of Efficacy|23
344658|NCT01159912|1163555|P3|Overall Study|Adverse Event|3
344659|NCT01159912|1163556|P2|Overall Study|Adverse Event|2
344660|NCT01159912|1163557|P1|Overall Study|Adverse Event|2
344661|NCT01159769|1163580|P1|Overall Study|Adverse Event|1
344662|NCT01159691|1163600|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
344663|NCT01159691|1163600|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
344664|NCT01159691|1163600|P1|Overall Study|Disc. Neupro other & unknown reasons|7
344665|NCT01159691|1163600|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
344666|NCT01159691|1163600|P1|Overall Study|Discontinued Neupro due to other reasons|1
344667|NCT01159691|1163600|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
344668|NCT01159691|1163600|P1|Overall Study|Unknown reasons|1
344669|NCT01159691|1163600|P1|Overall Study|Lost to Follow-up|2
344670|NCT01159665|1163613|P6|Overall Study|Withdrawal by Subject|0
344671|NCT01159665|1163614|P5|Overall Study|Withdrawal by Subject|0
344672|NCT01159665|1163615|P4|Overall Study|Withdrawal by Subject|0
344673|NCT01159665|1163616|P3|Overall Study|Withdrawal by Subject|0
344674|NCT01159665|1163617|P2|Overall Study|Withdrawal by Subject|1
344675|NCT01159665|1163618|P1|Overall Study|Withdrawal by Subject|0
344676|NCT01159600|1163646|P8|Overall Study|Other reason not defined above|3
344677|NCT01159600|1163647|P7|Overall Study|Other reason not defined above|3
344678|NCT01159600|1163648|P6|Overall Study|Other reason not defined above|7
344679|NCT01159600|1163649|P5|Overall Study|Other reason not defined above|5
344680|NCT01159600|1163650|P4|Overall Study|Other reason not defined above|2
344681|NCT01159600|1163651|P3|Overall Study|Other reason not defined above|4
344682|NCT01159600|1163652|P2|Overall Study|Other reason not defined above|0
344683|NCT01159600|1163653|P1|Overall Study|Other reason not defined above|3
344684|NCT01159600|1163646|P8|Overall Study|Patient refusal to continue,not due toAE|5
344685|NCT01159600|1163647|P7|Overall Study|Patient refusal to continue,not due toAE|2
344686|NCT01159600|1163648|P6|Overall Study|Patient refusal to continue,not due toAE|4
344687|NCT01159600|1163649|P5|Overall Study|Patient refusal to continue,not due toAE|4
344688|NCT01159600|1163650|P4|Overall Study|Patient refusal to continue,not due toAE|5
344689|NCT01159600|1163651|P3|Overall Study|Patient refusal to continue,not due toAE|4
344690|NCT01159600|1163652|P2|Overall Study|Patient refusal to continue,not due toAE|2
344691|NCT01159600|1163653|P1|Overall Study|Patient refusal to continue,not due toAE|7
344692|NCT01159600|1163646|P8|Overall Study|Lost to Follow-up|2
344693|NCT01159600|1163647|P7|Overall Study|Lost to Follow-up|3
344694|NCT01159600|1163648|P6|Overall Study|Lost to Follow-up|0
344695|NCT01159600|1163649|P5|Overall Study|Lost to Follow-up|3
344696|NCT01159600|1163650|P4|Overall Study|Lost to Follow-up|3
344697|NCT01159600|1163651|P3|Overall Study|Lost to Follow-up|4
344698|NCT01159600|1163652|P2|Overall Study|Lost to Follow-up|3
344699|NCT01159600|1163653|P1|Overall Study|Lost to Follow-up|2
344700|NCT01159600|1163646|P8|Overall Study|Non compliant with protocol|0
344701|NCT01159600|1163647|P7|Overall Study|Non compliant with protocol|2
344702|NCT01159600|1163648|P6|Overall Study|Non compliant with protocol|0
344703|NCT01159600|1163649|P5|Overall Study|Non compliant with protocol|2
344704|NCT01159600|1163650|P4|Overall Study|Non compliant with protocol|0
344705|NCT01159600|1163651|P3|Overall Study|Non compliant with protocol|0
344706|NCT01159600|1163652|P2|Overall Study|Non compliant with protocol|1
344707|NCT01159600|1163653|P1|Overall Study|Non compliant with protocol|2
344708|NCT01159600|1163646|P8|Overall Study|Lack of Efficacy|1
344709|NCT01159600|1163647|P7|Overall Study|Lack of Efficacy|0
344710|NCT01159600|1163648|P6|Overall Study|Lack of Efficacy|0
344711|NCT01159600|1163649|P5|Overall Study|Lack of Efficacy|2
344712|NCT01159600|1163650|P4|Overall Study|Lack of Efficacy|0
344713|NCT01159600|1163651|P3|Overall Study|Lack of Efficacy|0
344714|NCT01159600|1163652|P2|Overall Study|Lack of Efficacy|0
344715|NCT01159600|1163653|P1|Overall Study|Lack of Efficacy|0
344716|NCT01159600|1163646|P8|Overall Study|Adverse Event|5
344717|NCT01159600|1163647|P7|Overall Study|Adverse Event|7
344718|NCT01159600|1163648|P6|Overall Study|Adverse Event|6
344719|NCT01159600|1163649|P5|Overall Study|Adverse Event|8
344720|NCT01159600|1163650|P4|Overall Study|Adverse Event|1
344721|NCT01159600|1163651|P3|Overall Study|Adverse Event|5
344722|NCT01159600|1163652|P2|Overall Study|Adverse Event|2
344723|NCT01159600|1163653|P1|Overall Study|Adverse Event|7
344724|NCT01159600|1163646|P8|Overall Study|Not treated|2
344725|NCT01159600|1163647|P7|Overall Study|Not treated|2
344726|NCT01159600|1163648|P6|Overall Study|Not treated|1
344727|NCT01159600|1163649|P5|Overall Study|Not treated|0
344728|NCT01159600|1163650|P4|Overall Study|Not treated|0
344729|NCT01159600|1163651|P3|Overall Study|Not treated|1
344730|NCT01159600|1163652|P2|Overall Study|Not treated|0
344731|NCT01159600|1163653|P1|Overall Study|Not treated|0
344732|NCT01159574|1163695|P1|Follow Up Phase|still being followed for overall surviva|18
344733|NCT01159574|1163695|P1|Follow Up Phase|Lost to Follow-up|2
344734|NCT01159574|1163695|P1|Treatment Phase|still on treatment|2
344735|NCT01159574|1163695|P1|Treatment Phase|Withdrawal by Subject|7
344736|NCT01159574|1163695|P1|Treatment Phase|Physician Decision|2
344737|NCT01159574|1163695|P1|Treatment Phase|Death|6
344738|NCT01159574|1163695|P1|Treatment Phase|Adverse Event|3
344739|NCT01159574|1163695|P1|Treatment Phase|non-evaluable/not included in analysis|1
344740|NCT01159431|1163716|P2|Overall Study|Lack of Efficacy|3
344741|NCT01159431|1163717|P1|Overall Study|Lack of Efficacy|0
344742|NCT01159431|1163716|P2|Overall Study|non-compliance|1
344743|NCT01159431|1163717|P1|Overall Study|non-compliance|1
344744|NCT01159431|1163716|P2|Overall Study|Adverse Event|2
344745|NCT01159431|1163717|P1|Overall Study|Adverse Event|1
344746|NCT01159171|1163770|P1|Overall Study|Death|1
344747|NCT01159171|1163770|P1|Overall Study|Medical Decision|4
344748|NCT01159171|1163770|P1|Overall Study|Need for Surgery|5
344749|NCT01159171|1163770|P1|Overall Study|Protocol Violation|1
344750|NCT01159171|1163770|P1|Overall Study|Progression of Disease|28
344751|NCT01159171|1163770|P1|Overall Study|Adverse Event|11
344752|NCT01158924|1163844|P2|Overall Study|Lost to Follow-up|1
344753|NCT01158924|1163845|P1|Overall Study|Lost to Follow-up|0
344754|NCT01158924|1163844|P2|Overall Study|Withdrawal by Subject|2
344755|NCT01158924|1163845|P1|Overall Study|Withdrawal by Subject|1
344756|NCT01158534|1163916|P1|Overall Study|Other|1
344757|NCT01158534|1163916|P1|Overall Study|Death|1
344758|NCT01158534|1163916|P1|Overall Study|Withdrawal by Subject|1
344759|NCT01158378|1163926|P2|Overall Study|Withdrawal by Subject|0
344760|NCT01158378|1163927|P1|Overall Study|Withdrawal by Subject|4
344761|NCT01158378|1163926|P2|Overall Study|Lost to Follow-up|4
344762|NCT01158378|1163927|P1|Overall Study|Lost to Follow-up|2
344763|NCT01158378|1163926|P2|Overall Study|Death|5
344764|NCT01158378|1163927|P1|Overall Study|Death|4
344765|NCT01158261|1163939|P1|Overall Study|Withdrawal by Subject|1
344766|NCT01158261|1163939|P1|Overall Study|Death|7
344767|NCT01158261|1163939|P1|Overall Study|Lost to Follow-up|9
344768|NCT01158118|1163945|P2|Overall Study|Death|1
344769|NCT01158118|1163946|P1|Overall Study|Death|0
344770|NCT01158118|1163945|P2|Overall Study|Suffered stroke prior to transplant|1
344771|NCT01158118|1163946|P1|Overall Study|Suffered stroke prior to transplant|0
344772|NCT01158118|1163945|P2|Overall Study|Donor match was a screen failure|1
344773|NCT01158118|1163946|P1|Overall Study|Donor match was a screen failure|0
344774|NCT01158118|1163945|P2|Overall Study|Screen failure|0
344775|NCT01158118|1163946|P1|Overall Study|Screen failure|1
344776|NCT01157845|1163962|P1|Overall Study|Device malfunction|1
344777|NCT01157845|1163962|P1|Overall Study|Study was ended|1
344778|NCT01157845|1163962|P1|Overall Study|Protocol Violation|13
344779|NCT01157845|1163962|P1|Overall Study|Physician Decision|3
344780|NCT01157845|1163962|P1|Overall Study|Withdrawal by Subject|12
344781|NCT01157845|1163962|P1|Overall Study|Lost to Follow-up|5
344782|NCT01157377|1163996|P7|Overall Study|Other Miscellaneous Reasons|1
344783|NCT01157377|1163997|P6|Overall Study|Other Miscellaneous Reasons|1
344784|NCT01157377|1163998|P5|Overall Study|Other Miscellaneous Reasons|1
344785|NCT01157377|1163999|P4|Overall Study|Other Miscellaneous Reasons|0
344786|NCT01157377|1164000|P3|Overall Study|Other Miscellaneous Reasons|0
344787|NCT01157377|1164001|P2|Overall Study|Other Miscellaneous Reasons|2
344788|NCT01157377|1164002|P1|Overall Study|Other Miscellaneous Reasons|0
344789|NCT01157377|1163996|P7|Overall Study|Lack of Efficacy|1
344790|NCT01157377|1163997|P6|Overall Study|Lack of Efficacy|0
344791|NCT01157377|1163998|P5|Overall Study|Lack of Efficacy|0
344792|NCT01157377|1163999|P4|Overall Study|Lack of Efficacy|0
344793|NCT01157377|1164000|P3|Overall Study|Lack of Efficacy|0
344794|NCT01157377|1164001|P2|Overall Study|Lack of Efficacy|0
344795|NCT01157377|1164002|P1|Overall Study|Lack of Efficacy|0
344796|NCT01157377|1163996|P7|Overall Study|Protocol Violation|0
344797|NCT01157377|1163997|P6|Overall Study|Protocol Violation|1
344798|NCT01157377|1163998|P5|Overall Study|Protocol Violation|0
344799|NCT01157377|1163999|P4|Overall Study|Protocol Violation|0
344800|NCT01157377|1164000|P3|Overall Study|Protocol Violation|0
344801|NCT01157377|1164001|P2|Overall Study|Protocol Violation|0
344802|NCT01157377|1164002|P1|Overall Study|Protocol Violation|0
344803|NCT01157377|1163996|P7|Overall Study|Personal Reasons|0
344804|NCT01157377|1163997|P6|Overall Study|Personal Reasons|0
344805|NCT01157377|1163998|P5|Overall Study|Personal Reasons|0
344806|NCT01157377|1163999|P4|Overall Study|Personal Reasons|1
344807|NCT01157377|1164000|P3|Overall Study|Personal Reasons|0
344808|NCT01157377|1164001|P2|Overall Study|Personal Reasons|1
344809|NCT01157377|1164002|P1|Overall Study|Personal Reasons|2
344810|NCT01157377|1163996|P7|Overall Study|Lost to Follow-up|0
344811|NCT01157377|1163997|P6|Overall Study|Lost to Follow-up|1
344812|NCT01157377|1163998|P5|Overall Study|Lost to Follow-up|1
344813|NCT01157377|1163999|P4|Overall Study|Lost to Follow-up|0
344814|NCT01157377|1164000|P3|Overall Study|Lost to Follow-up|1
344815|NCT01157377|1164001|P2|Overall Study|Lost to Follow-up|0
344816|NCT01157377|1164002|P1|Overall Study|Lost to Follow-up|0
344817|NCT01157351|1164020|P2|Overall Study|Randomized but not Treated|2
344818|NCT01157351|1164021|P1|Overall Study|Randomized but not Treated|4
344819|NCT01157351|1164020|P2|Overall Study|Noncompliance with Study Drug|3
344820|NCT01157351|1164021|P1|Overall Study|Noncompliance with Study Drug|0
344821|NCT01157351|1164020|P2|Overall Study|Other|36
344822|NCT01157351|1164021|P1|Overall Study|Other|32
344823|NCT01157351|1164020|P2|Overall Study|Protocol Violation|1
344824|NCT01157351|1164021|P1|Overall Study|Protocol Violation|0
344825|NCT01157351|1164020|P2|Overall Study|Physician Decision|4
344826|NCT01157351|1164021|P1|Overall Study|Physician Decision|5
344827|NCT01157351|1164020|P2|Overall Study|Withdrawal by Subject|27
344828|NCT01157351|1164021|P1|Overall Study|Withdrawal by Subject|37
344829|NCT01157351|1164020|P2|Overall Study|Lost to Follow-up|55
344830|NCT01157351|1164021|P1|Overall Study|Lost to Follow-up|53
344831|NCT01157351|1164020|P2|Overall Study|Death|0
344832|NCT01157351|1164021|P1|Overall Study|Death|1
344833|NCT01157351|1164020|P2|Overall Study|Adverse Event|4
344834|NCT01157351|1164021|P1|Overall Study|Adverse Event|5
344835|NCT01157234|1164039|P2|Overall Study|Withdrawal by Subject|0
344836|NCT01157234|1164040|P1|Overall Study|Withdrawal by Subject|1
344837|NCT01157182|1164072|P2|Washout of 28 Days|Adverse Event|0
344838|NCT01157182|1164073|P1|Washout of 28 Days|Adverse Event|2
344839|NCT01157169|1164121|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
344840|NCT01157169|1164122|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
344841|NCT01157169|1164121|P2|First Intervention|Emesis Within 4 hrs of Administration|2
344842|NCT01157169|1164122|P1|First Intervention|Emesis Within 4 hrs of Administration|4
344843|NCT01157169|1164121|P2|First Intervention|Protocol Violation|0
344844|NCT01157169|1164122|P1|First Intervention|Protocol Violation|0
344845|NCT01157117|1164141|P3|Overall Study|Unknown (Pending Final Form Submission)|13
344846|NCT01157117|1164142|P2|Overall Study|Unknown (Pending Final Form Submission)|5
344847|NCT01157117|1164143|P1|Overall Study|Unknown (Pending Final Form Submission)|4
344848|NCT01157117|1164141|P3|Overall Study|Lost to Follow-up|1
344849|NCT01157117|1164142|P2|Overall Study|Lost to Follow-up|0
344850|NCT01157117|1164143|P1|Overall Study|Lost to Follow-up|0
344851|NCT01157117|1164141|P3|Overall Study|Lack of Efficacy|0
344852|NCT01157117|1164142|P2|Overall Study|Lack of Efficacy|1
344853|NCT01157117|1164143|P1|Overall Study|Lack of Efficacy|1
344854|NCT01157117|1164141|P3|Overall Study|Withdrawal by Subject|1
344855|NCT01157117|1164142|P2|Overall Study|Withdrawal by Subject|1
344856|NCT01157117|1164143|P1|Overall Study|Withdrawal by Subject|4
344857|NCT01157117|1164141|P3|Overall Study|Dosing Symptoms|0
344858|NCT01157117|1164142|P2|Overall Study|Dosing Symptoms|4
344859|NCT01157117|1164143|P1|Overall Study|Dosing Symptoms|0
344860|NCT01157078|1164184|P2|Overall Study|Not specified|4
344861|NCT01157078|1164185|P1|Overall Study|Not specified|2
344862|NCT01157078|1164184|P2|Overall Study|Lost to Follow-up|5
344863|NCT01157078|1164185|P1|Overall Study|Lost to Follow-up|7
344864|NCT01157078|1164184|P2|Overall Study|Study-specific withdrawal criteria|2
344865|NCT01157078|1164185|P1|Overall Study|Study-specific withdrawal criteria|2
344866|NCT01157078|1164184|P2|Overall Study|Lack of Efficacy|0
344867|NCT01157078|1164185|P1|Overall Study|Lack of Efficacy|2
344868|NCT01157078|1164184|P2|Overall Study|Condition under investigation worsened|1
344869|NCT01157078|1164185|P1|Overall Study|Condition under investigation worsened|0
344870|NCT01157078|1164184|P2|Overall Study|Severe non-compliance to protocol|4
344871|NCT01157078|1164185|P1|Overall Study|Severe non-compliance to protocol|2
344872|NCT01157078|1164184|P2|Overall Study|Adverse Event|6
344873|NCT01157078|1164185|P1|Overall Study|Adverse Event|6
344874|NCT01157078|1164184|P2|Overall Study|Eligibility criteria not fulfilled|0
344875|NCT01157078|1164185|P1|Overall Study|Eligibility criteria not fulfilled|2
344876|NCT01157078|1164184|P2|Overall Study|Withdrawal by Subject|14
344877|NCT01157078|1164185|P1|Overall Study|Withdrawal by Subject|12
344878|NCT01157065|1164235|P2|Overall Study|Death|1
344879|NCT01157065|1164236|P1|Overall Study|Death|0
344880|NCT01156844|1164257|P4|Overall Study|Protocol deviation|0
344881|NCT01156844|1164258|P3|Overall Study|Protocol deviation|0
344882|NCT01156844|1164259|P2|Overall Study|Protocol deviation|0
344883|NCT01156844|1164260|P1|Overall Study|Protocol deviation|2
344884|NCT01156844|1164257|P4|Overall Study|Administrative problems|1
344885|NCT01156844|1164258|P3|Overall Study|Administrative problems|0
344886|NCT01156844|1164259|P2|Overall Study|Administrative problems|1
344887|NCT01156844|1164260|P1|Overall Study|Administrative problems|0
344888|NCT01156844|1164257|P4|Overall Study|Lost to Follow-up|0
344889|NCT01156844|1164258|P3|Overall Study|Lost to Follow-up|1
344890|NCT01156844|1164259|P2|Overall Study|Lost to Follow-up|0
344891|NCT01156844|1164260|P1|Overall Study|Lost to Follow-up|0
344892|NCT01156844|1164257|P4|Overall Study|Withdrawal by Subject|2
344893|NCT01156844|1164258|P3|Overall Study|Withdrawal by Subject|2
344894|NCT01156844|1164259|P2|Overall Study|Withdrawal by Subject|0
344895|NCT01156844|1164260|P1|Overall Study|Withdrawal by Subject|0
344896|NCT01156844|1164257|P4|Overall Study|Abnormal test procedure result(s)|2
344897|NCT01156844|1164258|P3|Overall Study|Abnormal test procedure result(s)|2
344898|NCT01156844|1164259|P2|Overall Study|Abnormal test procedure result(s)|1
344899|NCT01156844|1164260|P1|Overall Study|Abnormal test procedure result(s)|0
344900|NCT01156844|1164257|P4|Overall Study|Adverse Event|1
344901|NCT01156844|1164258|P3|Overall Study|Adverse Event|1
344902|NCT01156844|1164259|P2|Overall Study|Adverse Event|0
344903|NCT01156844|1164260|P1|Overall Study|Adverse Event|0
344904|NCT01156792|1164279|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
344905|NCT01156792|1164279|P1|Overall Study|Withdrawal by Subject|9
344906|NCT01156792|1164279|P1|Overall Study|Physician Decision|3
344907|NCT01156792|1164279|P1|Overall Study|Lost to Follow-up|3
344908|NCT01156792|1164279|P1|Overall Study|Protocol Violation|6
344909|NCT01156792|1164279|P1|Overall Study|Lack of Efficacy|36
344910|NCT01156792|1164279|P1|Overall Study|Adverse Event|1
344911|NCT01156675|1164384|P3|Overall Study|No data|2
344912|NCT01156675|1164385|P2|Overall Study|No data|22
344913|NCT01156675|1164386|P1|Overall Study|No data|29
344914|NCT01156675|1164384|P3|Overall Study|Death|0
344915|NCT01156675|1164385|P2|Overall Study|Death|3
344916|NCT01156675|1164386|P1|Overall Study|Death|5
344917|NCT01156532|1164444|P1|Overall Study|Lost to Follow-up|1
344918|NCT01156532|1164444|P1|Overall Study|Family Reasons|1
344919|NCT01156480|1164456|P2|Overall Study|change in diagnosis|1
344920|NCT01156480|1164457|P1|Overall Study|change in diagnosis|0
344921|NCT01156376|1164468|P3|Overall Study|Withdrawal by Subject|3
344922|NCT01156376|1164469|P2|Overall Study|Withdrawal by Subject|0
344923|NCT01156376|1164470|P1|Overall Study|Withdrawal by Subject|0
344924|NCT01156376|1164468|P3|Overall Study|Adverse Event|1
344925|NCT01156376|1164469|P2|Overall Study|Adverse Event|0
344926|NCT01156376|1164470|P1|Overall Study|Adverse Event|1
344927|NCT01156363|1164691|P1|Overall Study|Other|6
344928|NCT01156363|1164691|P1|Overall Study|Refused Treatment|4
344929|NCT01156363|1164691|P1|Overall Study|Failure to Return|1
344930|NCT01156363|1164691|P1|Overall Study|Insufficient Therapeutic Response|5
344931|NCT01156363|1164691|P1|Overall Study|Adverse Event|6
344932|NCT01156311|1164713|P4|6-month Add-on Therapy Period|Not Specified|2
344933|NCT01156311|1164714|P3|6-month Add-on Therapy Period|Not Specified|1
344934|NCT01156311|1164715|P2|6-month Add-on Therapy Period|Not Specified|0
344935|NCT01156311|1164716|P1|6-month Add-on Therapy Period|Not Specified|0
344936|NCT01156311|1164713|P4|6-month Add-on Therapy Period|Physician Decision|0
344937|NCT01156311|1164714|P3|6-month Add-on Therapy Period|Physician Decision|1
344938|NCT01156311|1164715|P2|6-month Add-on Therapy Period|Physician Decision|0
344939|NCT01156311|1164716|P1|6-month Add-on Therapy Period|Physician Decision|0
344940|NCT01156311|1164713|P4|6-month Add-on Therapy Period|Disease Activity|2
344941|NCT01156311|1164714|P3|6-month Add-on Therapy Period|Disease Activity|1
344942|NCT01156311|1164715|P2|6-month Add-on Therapy Period|Disease Activity|0
344943|NCT01156311|1164716|P1|6-month Add-on Therapy Period|Disease Activity|0
344944|NCT01156311|1164713|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
344945|NCT01156311|1164714|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
344946|NCT01156311|1164715|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
344947|NCT01156311|1164716|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
344948|NCT01156311|1164713|P4|6-month Add-on Therapy Period|Adverse Event|6
344949|NCT01156311|1164714|P3|6-month Add-on Therapy Period|Adverse Event|7
344950|NCT01156311|1164715|P2|6-month Add-on Therapy Period|Adverse Event|0
344951|NCT01156311|1164716|P1|6-month Add-on Therapy Period|Adverse Event|0
344952|NCT01156311|1164713|P4|2-Month Monotherapy Period|Not specified|0
344953|NCT01156311|1164714|P3|2-Month Monotherapy Period|Not specified|0
344954|NCT01156311|1164715|P2|2-Month Monotherapy Period|Not specified|0
344955|NCT01156311|1164716|P1|2-Month Monotherapy Period|Not specified|1
344956|NCT01156311|1164713|P4|2-Month Monotherapy Period|Physician Decision|0
344957|NCT01156311|1164714|P3|2-Month Monotherapy Period|Physician Decision|0
344958|NCT01156311|1164715|P2|2-Month Monotherapy Period|Physician Decision|1
344959|NCT01156311|1164716|P1|2-Month Monotherapy Period|Physician Decision|0
344960|NCT01156311|1164713|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
344961|NCT01156311|1164714|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
344962|NCT01156311|1164715|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
344963|NCT01156311|1164716|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
344964|NCT01156142|1164740|P2|Overall Study|Ineligible|1
344965|NCT01156142|1164741|P1|Overall Study|Ineligible|0
344966|NCT01156142|1164740|P2|Overall Study|Withdrawal by Subject|6
344967|NCT01156142|1164741|P1|Overall Study|Withdrawal by Subject|8
344968|NCT01156116|1164759|P2|Overall Study|CPAP intolerance|0
344969|NCT01156116|1164760|P1|Overall Study|CPAP intolerance|2
344970|NCT01156116|1164759|P2|Overall Study|Withdrawal by Subject|1
344971|NCT01156116|1164760|P1|Overall Study|Withdrawal by Subject|3
344972|NCT01156051|1164774|P2|Overall Study|patient not compliant with protocol|1
344973|NCT01156051|1164775|P1|Overall Study|patient not compliant with protocol|0
344974|NCT01156051|1164774|P2|Overall Study|Lost to Follow-up|0
344975|NCT01156051|1164775|P1|Overall Study|Lost to Follow-up|1
344976|NCT01156012|1164789|P2|Overall Study|Non respect of one of inclusion criteria|1
344977|NCT01156012|1164790|P1|Overall Study|Non respect of one of inclusion criteria|2
344978|NCT01156012|1164789|P2|Overall Study|use of commercial drug instead of study|1
344979|NCT01156012|1164790|P1|Overall Study|use of commercial drug instead of study|0
344980|NCT01156012|1164789|P2|Overall Study|Withdrawal by Subject|0
344981|NCT01156012|1164790|P1|Overall Study|Withdrawal by Subject|1
344982|NCT01156012|1164789|P2|Overall Study|Lost to Follow-up|0
344983|NCT01156012|1164790|P1|Overall Study|Lost to Follow-up|1
344984|NCT01156012|1164789|P2|Overall Study|Adverse Event|1
344985|NCT01156012|1164790|P1|Overall Study|Adverse Event|3
344986|NCT01155869|1164807|P2|Overall Study|Lost to Follow-up|1
344987|NCT01155869|1164808|P1|Overall Study|Lost to Follow-up|3
344988|NCT01155726|1164832|P4|Period 1, 3 Days (Masked)|Inconvenience|0
344989|NCT01155726|1164833|P3|Period 1, 3 Days (Masked)|Inconvenience|2
344990|NCT01155726|1164834|P2|Period 1, 3 Days (Masked)|Inconvenience|0
344991|NCT01155726|1164835|P1|Period 1, 3 Days (Masked)|Inconvenience|1
344992|NCT01155661|1164857|P1|Overall Study|Sponsor Decision|13
344993|NCT01155661|1164857|P1|Overall Study|Withdrawal by Subject|73
344994|NCT01155661|1164857|P1|Overall Study|Protocol Violation|35
344995|NCT01155661|1164857|P1|Overall Study|Physician Decision|3
344996|NCT01155661|1164857|P1|Overall Study|Lost to Follow-up|22
344997|NCT01155661|1164857|P1|Overall Study|Lack of Efficacy|32
344998|NCT01155661|1164857|P1|Overall Study|Death|1
344999|NCT01155661|1164857|P1|Overall Study|Adverse Event|101
345000|NCT01155570|1164883|P1|Overall Study|Other Reasons|23
345001|NCT01155570|1164883|P1|Overall Study|Participant's Economic Reasons + Other|1
345002|NCT01155570|1164883|P1|Overall Study|Adverse Event + Other Reasons|7
345003|NCT01155570|1164883|P1|Overall Study|Adverse Event + Lack of Efficacy|2
345004|NCT01155570|1164883|P1|Overall Study|No Hospital Visits|7
345005|NCT01155570|1164883|P1|Overall Study|Participant's Economic Reasons|17
345006|NCT01155570|1164883|P1|Overall Study|Lack of Efficacy|46
345007|NCT01155570|1164883|P1|Overall Study|Adverse Event|39
345008|NCT01155531|1164917|P4|Overall Study|Withdrawal by Subject|0
345009|NCT01155531|1164918|P3|Overall Study|Withdrawal by Subject|1
345010|NCT01155531|1164919|P2|Overall Study|Withdrawal by Subject|0
345011|NCT01155531|1164920|P1|Overall Study|Withdrawal by Subject|1
345012|NCT01155531|1164917|P4|Overall Study|Lost to Follow-up|1
345013|NCT01155531|1164918|P3|Overall Study|Lost to Follow-up|0
345014|NCT01155531|1164919|P2|Overall Study|Lost to Follow-up|0
345015|NCT01155531|1164920|P1|Overall Study|Lost to Follow-up|0
345016|NCT01155531|1164917|P4|Overall Study|Adverse Event|0
345017|NCT01155531|1164918|P3|Overall Study|Adverse Event|1
345018|NCT01155531|1164919|P2|Overall Study|Adverse Event|0
345019|NCT01155531|1164920|P1|Overall Study|Adverse Event|0
345020|NCT01155479|1164943|P5|Part II|Non-Compliance with Protocol|0
345021|NCT01155479|1164944|P4|Part II|Non-Compliance with Protocol|2
345022|NCT01155479|1164945|P3|Part II|Non-Compliance with Protocol|0
345023|NCT01155479|1164946|P2|Part II|Non-Compliance with Protocol|1
345024|NCT01155479|1164947|P1|Part II|Non-Compliance with Protocol|0
345025|NCT01155479|1164943|P5|Part II|Treatment Failure|1
345026|NCT01155479|1164944|P4|Part II|Treatment Failure|0
345027|NCT01155479|1164945|P3|Part II|Treatment Failure|2
345028|NCT01155479|1164946|P2|Part II|Treatment Failure|1
345029|NCT01155479|1164947|P1|Part II|Treatment Failure|0
345030|NCT01155479|1164943|P5|Part II|Lost to Follow-up|1
345031|NCT01155479|1164944|P4|Part II|Lost to Follow-up|0
345032|NCT01155479|1164945|P3|Part II|Lost to Follow-up|0
345033|NCT01155479|1164946|P2|Part II|Lost to Follow-up|0
345034|NCT01155479|1164947|P1|Part II|Lost to Follow-up|1
345035|NCT01155479|1164943|P5|Part II|Withdrawal by Subject|3
345036|NCT01155479|1164944|P4|Part II|Withdrawal by Subject|7
345037|NCT01155479|1164945|P3|Part II|Withdrawal by Subject|12
345038|NCT01155479|1164946|P2|Part II|Withdrawal by Subject|4
345039|NCT01155479|1164947|P1|Part II|Withdrawal by Subject|8
345040|NCT01155479|1164943|P5|Part II|Administrative|46
345041|NCT01155479|1164944|P4|Part II|Administrative|38
345042|NCT01155479|1164945|P3|Part II|Administrative|36
345043|NCT01155479|1164946|P2|Part II|Administrative|49
345044|NCT01155479|1164947|P1|Part II|Administrative|43
345045|NCT01155479|1164943|P5|Part II|Adverse Event|4
345046|NCT01155479|1164944|P4|Part II|Adverse Event|3
345047|NCT01155479|1164945|P3|Part II|Adverse Event|8
345048|NCT01155479|1164946|P2|Part II|Adverse Event|6
345049|NCT01155479|1164947|P1|Part II|Adverse Event|7
345050|NCT01155479|1164943|P5|Part I|Non-Compliance with Protocol|2
345051|NCT01155479|1164944|P4|Part I|Non-Compliance with Protocol|3
345052|NCT01155479|1164945|P3|Part I|Non-Compliance with Protocol|3
345053|NCT01155479|1164946|P2|Part I|Non-Compliance with Protocol|1
345054|NCT01155479|1164947|P1|Part I|Non-Compliance with Protocol|2
345055|NCT01155479|1164943|P5|Part I|Did Not Receive Treatment|1
345056|NCT01155479|1164944|P4|Part I|Did Not Receive Treatment|6
345057|NCT01155479|1164945|P3|Part I|Did Not Receive Treatment|2
345058|NCT01155479|1164946|P2|Part I|Did Not Receive Treatment|2
345059|NCT01155479|1164947|P1|Part I|Did Not Receive Treatment|4
345060|NCT01155479|1164943|P5|Part I|Treatment Failure|2
345061|NCT01155479|1164944|P4|Part I|Treatment Failure|1
345062|NCT01155479|1164945|P3|Part I|Treatment Failure|3
345063|NCT01155479|1164946|P2|Part I|Treatment Failure|0
345064|NCT01155479|1164947|P1|Part I|Treatment Failure|3
345065|NCT01155479|1164943|P5|Part I|Lost to Follow-up|0
345066|NCT01155479|1164944|P4|Part I|Lost to Follow-up|1
345067|NCT01155479|1164945|P3|Part I|Lost to Follow-up|1
345068|NCT01155479|1164946|P2|Part I|Lost to Follow-up|0
345069|NCT01155479|1164947|P1|Part I|Lost to Follow-up|0
345070|NCT01155479|1164943|P5|Part I|Withdrawal by Subject|9
345071|NCT01155479|1164944|P4|Part I|Withdrawal by Subject|8
345072|NCT01155479|1164945|P3|Part I|Withdrawal by Subject|8
345073|NCT01155479|1164946|P2|Part I|Withdrawal by Subject|13
345074|NCT01155479|1164947|P1|Part I|Withdrawal by Subject|11
345075|NCT01155479|1164943|P5|Part I|Did Not Meet Protocol Eligibility|3
345076|NCT01155479|1164944|P4|Part I|Did Not Meet Protocol Eligibility|1
345077|NCT01155479|1164945|P3|Part I|Did Not Meet Protocol Eligibility|2
345078|NCT01155479|1164946|P2|Part I|Did Not Meet Protocol Eligibility|1
345079|NCT01155479|1164947|P1|Part I|Did Not Meet Protocol Eligibility|3
345080|NCT01155479|1164943|P5|Part I|Administrative|0
345081|NCT01155479|1164944|P4|Part I|Administrative|0
345082|NCT01155479|1164945|P3|Part I|Administrative|2
345083|NCT01155479|1164946|P2|Part I|Administrative|2
345084|NCT01155479|1164947|P1|Part I|Administrative|2
345085|NCT01155479|1164943|P5|Part I|Adverse Event|6
345086|NCT01155479|1164944|P4|Part I|Adverse Event|7
345087|NCT01155479|1164945|P3|Part I|Adverse Event|18
345088|NCT01155479|1164946|P2|Part I|Adverse Event|8
345089|NCT01155479|1164947|P1|Part I|Adverse Event|13
345090|NCT01155466|1164999|P5|Overall Study|Randomized not treated|2
345091|NCT01155466|1165000|P4|Overall Study|Randomized not treated|0
345092|NCT01155466|1165001|P3|Overall Study|Randomized not treated|3
345093|NCT01155466|1165002|P2|Overall Study|Randomized not treated|2
345094|NCT01155466|1165003|P1|Overall Study|Randomized not treated|2
345095|NCT01155466|1164999|P5|Overall Study|Administrative|0
345096|NCT01155466|1165000|P4|Overall Study|Administrative|0
345097|NCT01155466|1165001|P3|Overall Study|Administrative|0
345098|NCT01155466|1165002|P2|Overall Study|Administrative|3
345099|NCT01155466|1165003|P1|Overall Study|Administrative|0
345100|NCT01155466|1164999|P5|Overall Study|Protocol Violation|1
345101|NCT01155466|1165000|P4|Overall Study|Protocol Violation|0
345102|NCT01155466|1165001|P3|Overall Study|Protocol Violation|2
345103|NCT01155466|1165002|P2|Overall Study|Protocol Violation|0
345104|NCT01155466|1165003|P1|Overall Study|Protocol Violation|0
345105|NCT01155466|1164999|P5|Overall Study|Withdrawal by Subject|4
345106|NCT01155466|1165000|P4|Overall Study|Withdrawal by Subject|4
345107|NCT01155466|1165001|P3|Overall Study|Withdrawal by Subject|9
345108|NCT01155466|1165002|P2|Overall Study|Withdrawal by Subject|5
345109|NCT01155466|1165003|P1|Overall Study|Withdrawal by Subject|7
345110|NCT01155466|1164999|P5|Overall Study|Lost to Follow-up|2
345111|NCT01155466|1165000|P4|Overall Study|Lost to Follow-up|0
345112|NCT01155466|1165001|P3|Overall Study|Lost to Follow-up|0
345113|NCT01155466|1165002|P2|Overall Study|Lost to Follow-up|0
345114|NCT01155466|1165003|P1|Overall Study|Lost to Follow-up|0
345115|NCT01155466|1164999|P5|Overall Study|Adverse Event|18
345116|NCT01155466|1165000|P4|Overall Study|Adverse Event|17
345117|NCT01155466|1165001|P3|Overall Study|Adverse Event|6
345118|NCT01155466|1165002|P2|Overall Study|Adverse Event|15
345119|NCT01155466|1165003|P1|Overall Study|Adverse Event|13
345120|NCT01155388|1165057|P2|Overall Study|Adverse Event|0
345121|NCT01155388|1165058|P1|Overall Study|Adverse Event|1
345122|NCT01155375|1165068|P2|Overall Study|Adverse Event|0
345123|NCT01155375|1165069|P1|Overall Study|Adverse Event|1
345124|NCT01155323|1165088|P2|Second Intervention|Lost to Follow-up|1
345125|NCT01155323|1165089|P1|Second Intervention|Lost to Follow-up|1
345126|NCT01155323|1165088|P2|First Intervention|exclusion criteria|1
345127|NCT01155323|1165089|P1|First Intervention|exclusion criteria|1
345128|NCT01155284|1165107|P2|Overall Study|Adverse Event|0
345129|NCT01155284|1165108|P1|Overall Study|Adverse Event|1
345130|NCT01155284|1165107|P2|Overall Study|Physician Decision|0
345131|NCT01155284|1165108|P1|Overall Study|Physician Decision|1
345132|NCT01155284|1165107|P2|Overall Study|Lost to Follow-up|2
345133|NCT01155284|1165108|P1|Overall Study|Lost to Follow-up|1
345134|NCT01155284|1165107|P2|Overall Study|Withdrawal by Subject|3
345135|NCT01155284|1165108|P1|Overall Study|Withdrawal by Subject|4
345136|NCT01155219|1165118|P2|Overall Study|non-medical reason|2
345137|NCT01155219|1165119|P1|Overall Study|non-medical reason|1
345138|NCT01155219|1165118|P2|Overall Study|Adverse Event|1
345139|NCT01155219|1165119|P1|Overall Study|Adverse Event|3
345140|NCT01155167|1165136|P2|Overall Study|Access site changed to femoral artery|0
345141|NCT01155167|1165137|P1|Overall Study|Access site changed to femoral artery|1
345142|NCT01155167|1165136|P2|Overall Study|Insufficient ultrasound data|0
345143|NCT01155167|1165137|P1|Overall Study|Insufficient ultrasound data|2
345144|NCT01155141|1165160|P1|Overall Study|Screen Failure|1
345145|NCT01155141|1165160|P1|Overall Study|Withdrawal by Subject|1
345146|NCT01155063|1165172|P1|Overall Study|Study terminated by sponsor|87
345147|NCT01155063|1165172|P1|Overall Study|Withdrawal by Subject|1
345148|NCT01155063|1165172|P1|Overall Study|Adverse Event|1
345149|NCT01155024|1165182|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
345150|NCT01155024|1165183|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
345151|NCT01155024|1165182|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
345152|NCT01155024|1165183|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
345153|NCT01155024|1165182|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
345154|NCT01155024|1165183|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
345155|NCT01155011|1165193|P2|6 to 12 Months|Death|5
345156|NCT01155011|1165194|P1|6 to 12 Months|Death|1
345157|NCT01155011|1165193|P2|6 to 12 Months|Withdrawal by Subject|5
345158|NCT01155011|1165194|P1|6 to 12 Months|Withdrawal by Subject|8
345159|NCT01155011|1165193|P2|Baseline to 6 Months|Death|1
345160|NCT01155011|1165194|P1|Baseline to 6 Months|Death|0
345161|NCT01155011|1165193|P2|Baseline to 6 Months|investigator decision, moved|5
345162|NCT01155011|1165194|P1|Baseline to 6 Months|investigator decision, moved|4
345163|NCT01155011|1165193|P2|Baseline to 6 Months|Withdrawal by Subject|19
345164|NCT01155011|1165194|P1|Baseline to 6 Months|Withdrawal by Subject|18
345165|NCT01154816|1165235|P12|Overall Study|Adverse Event|0
345166|NCT01154816|1165236|P11|Overall Study|Adverse Event|0
345167|NCT01154816|1165237|P10|Overall Study|Adverse Event|0
345168|NCT01154816|1165238|P9|Overall Study|Adverse Event|0
345169|NCT01154816|1165239|P8|Overall Study|Adverse Event|1
345170|NCT01154816|1165240|P7|Overall Study|Adverse Event|1
345171|NCT01154816|1165241|P6|Overall Study|Adverse Event|0
345172|NCT01154816|1165242|P5|Overall Study|Adverse Event|0
345173|NCT01154816|1165243|P4|Overall Study|Adverse Event|0
345174|NCT01154816|1165244|P3|Overall Study|Adverse Event|0
345175|NCT01154816|1165245|P2|Overall Study|Adverse Event|2
345176|NCT01154816|1165246|P1|Overall Study|Adverse Event|5
345177|NCT01154816|1165235|P12|Overall Study|Physician Decision|1
345178|NCT01154816|1165236|P11|Overall Study|Physician Decision|1
345179|NCT01154816|1165237|P10|Overall Study|Physician Decision|1
345180|NCT01154816|1165238|P9|Overall Study|Physician Decision|0
345181|NCT01154816|1165239|P8|Overall Study|Physician Decision|0
345182|NCT01154816|1165240|P7|Overall Study|Physician Decision|0
345183|NCT01154816|1165241|P6|Overall Study|Physician Decision|0
345184|NCT01154816|1165242|P5|Overall Study|Physician Decision|2
345185|NCT01154816|1165243|P4|Overall Study|Physician Decision|0
345186|NCT01154816|1165244|P3|Overall Study|Physician Decision|1
345187|NCT01154816|1165245|P2|Overall Study|Physician Decision|0
345188|NCT01154816|1165246|P1|Overall Study|Physician Decision|1
345189|NCT01154816|1165235|P12|Overall Study|Progressive Disease|3
345190|NCT01154816|1165236|P11|Overall Study|Progressive Disease|10
345191|NCT01154816|1165237|P10|Overall Study|Progressive Disease|6
345192|NCT01154816|1165238|P9|Overall Study|Progressive Disease|8
345193|NCT01154816|1165239|P8|Overall Study|Progressive Disease|6
345194|NCT01154816|1165240|P7|Overall Study|Progressive Disease|5
345195|NCT01154816|1165241|P6|Overall Study|Progressive Disease|8
345196|NCT01154816|1165242|P5|Overall Study|Progressive Disease|8
345197|NCT01154816|1165243|P4|Overall Study|Progressive Disease|9
345198|NCT01154816|1165244|P3|Overall Study|Progressive Disease|9
345199|NCT01154816|1165245|P2|Overall Study|Progressive Disease|8
345200|NCT01154816|1165246|P1|Overall Study|Progressive Disease|13
345201|NCT01154816|1165235|P12|Overall Study|Withdrawal by Subject|0
345202|NCT01154816|1165236|P11|Overall Study|Withdrawal by Subject|0
345203|NCT01154816|1165237|P10|Overall Study|Withdrawal by Subject|3
345204|NCT01154816|1165238|P9|Overall Study|Withdrawal by Subject|1
345205|NCT01154816|1165239|P8|Overall Study|Withdrawal by Subject|0
345206|NCT01154816|1165240|P7|Overall Study|Withdrawal by Subject|0
345207|NCT01154816|1165241|P6|Overall Study|Withdrawal by Subject|0
345208|NCT01154816|1165242|P5|Overall Study|Withdrawal by Subject|0
345209|NCT01154816|1165243|P4|Overall Study|Withdrawal by Subject|1
345210|NCT01154816|1165244|P3|Overall Study|Withdrawal by Subject|0
345211|NCT01154816|1165245|P2|Overall Study|Withdrawal by Subject|0
345212|NCT01154816|1165246|P1|Overall Study|Withdrawal by Subject|1
345213|NCT01154673|1165323|P2|Overall Study|moved out of province|0
345214|NCT01154673|1165324|P1|Overall Study|moved out of province|1
345215|NCT01154673|1165323|P2|Overall Study|Lost to Follow-up|0
345216|NCT01154673|1165324|P1|Overall Study|Lost to Follow-up|1
345217|NCT01154452|1165379|P4|Phase II|Adverse Event|4
345218|NCT01154452|1165380|P3|Phase II|Adverse Event|4
345219|NCT01154452|1165381|P2|Phase II|Adverse Event|0
345220|NCT01154452|1165382|P1|Phase II|Adverse Event|0
345221|NCT01154452|1165379|P4|Phase II|Withdrawal by Subject|2
345222|NCT01154452|1165380|P3|Phase II|Withdrawal by Subject|1
345223|NCT01154452|1165381|P2|Phase II|Withdrawal by Subject|0
345224|NCT01154452|1165382|P1|Phase II|Withdrawal by Subject|0
345225|NCT01154452|1165379|P4|Phase Ib|Adverse Event|0
345226|NCT01154452|1165380|P3|Phase Ib|Adverse Event|0
345227|NCT01154452|1165381|P2|Phase Ib|Adverse Event|1
345228|NCT01154452|1165382|P1|Phase Ib|Adverse Event|2
345229|NCT01154452|1165379|P4|Phase Ib|Not Treated|0
345230|NCT01154452|1165380|P3|Phase Ib|Not Treated|0
345231|NCT01154452|1165381|P2|Phase Ib|Not Treated|0
345232|NCT01154452|1165382|P1|Phase Ib|Not Treated|1
345233|NCT01154296|1165412|P2|6-month Follow-up|Declined by Study Coordinator|4
345234|NCT01154296|1165413|P1|6-month Follow-up|Declined by Study Coordinator|5
345235|NCT01154296|1165412|P2|6-month Follow-up|Death|2
345236|NCT01154296|1165413|P1|6-month Follow-up|Death|3
345237|NCT01154296|1165412|P2|6-month Follow-up|Withdrew consent|15
345238|NCT01154296|1165413|P1|6-month Follow-up|Withdrew consent|14
345239|NCT01154296|1165412|P2|6-month Follow-up|Incarcerated|32
345240|NCT01154296|1165413|P1|6-month Follow-up|Incarcerated|37
345241|NCT01154296|1165412|P2|6-month Follow-up|Lost contact|275
345242|NCT01154296|1165413|P1|6-month Follow-up|Lost contact|269
345243|NCT01154296|1165412|P2|Randomization and Intervention|Left clinic early|0
345244|NCT01154296|1165413|P1|Randomization and Intervention|Left clinic early|2
345245|NCT01154296|1165412|P2|Randomization and Intervention|Left before test|1
345246|NCT01154296|1165413|P1|Randomization and Intervention|Left before test|0
345247|NCT01154296|1165412|P2|Randomization and Intervention|Did not return|0
345248|NCT01154296|1165413|P1|Randomization and Intervention|Did not return|1
345249|NCT01154296|1165412|P2|Randomization and Intervention|Declined by staff|0
345250|NCT01154296|1165413|P1|Randomization and Intervention|Declined by staff|1
345251|NCT01154296|1165412|P2|Randomization and Intervention|Decided to decline|1
345252|NCT01154296|1165413|P1|Randomization and Intervention|Decided to decline|1
345253|NCT01154283|1165431|P2|7-12 Weeks|Withdrawal by Subject|1
345254|NCT01154283|1165432|P1|7-12 Weeks|Withdrawal by Subject|0
345255|NCT01154283|1165431|P2|7-12 Weeks|Death|0
345256|NCT01154283|1165432|P1|7-12 Weeks|Death|1
345257|NCT01154283|1165431|P2|0-6 Weeks|Death|1
345258|NCT01154283|1165432|P1|0-6 Weeks|Death|0
345259|NCT01154283|1165431|P2|0-6 Weeks|Withdrawal by Subject|2
345260|NCT01154283|1165432|P1|0-6 Weeks|Withdrawal by Subject|7
345261|NCT01154231|1165444|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
345262|NCT01154231|1165444|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
345263|NCT01154218|1165450|P4|Fourth Intervention Period|Withdrawal by Subject|0
345264|NCT01154218|1165451|P3|Fourth Intervention Period|Withdrawal by Subject|0
345265|NCT01154218|1165452|P2|Fourth Intervention Period|Withdrawal by Subject|0
345266|NCT01154218|1165453|P1|Fourth Intervention Period|Withdrawal by Subject|1
345267|NCT01154218|1165450|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
345268|NCT01154218|1165451|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
345269|NCT01154218|1165452|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
345270|NCT01154218|1165453|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
345271|NCT01154218|1165450|P4|Third Intervention Period|Adverse Event|0
345272|NCT01154218|1165451|P3|Third Intervention Period|Adverse Event|0
345273|NCT01154218|1165452|P2|Third Intervention Period|Adverse Event|1
345274|NCT01154218|1165453|P1|Third Intervention Period|Adverse Event|0
345275|NCT01154166|1165505|P2|Overall Study|Poor Compliance|0
345276|NCT01154166|1165506|P1|Overall Study|Poor Compliance|1
345277|NCT01154166|1165505|P2|Overall Study|Disease Progression|0
345278|NCT01154166|1165506|P1|Overall Study|Disease Progression|1
345279|NCT01154166|1165505|P2|Overall Study|Lack of Efficacy|0
345280|NCT01154166|1165506|P1|Overall Study|Lack of Efficacy|3
345281|NCT01154166|1165505|P2|Overall Study|Withdrawal by Subject|1
345282|NCT01154166|1165506|P1|Overall Study|Withdrawal by Subject|10
345283|NCT01154166|1165505|P2|Overall Study|Protocol Violation|1
345284|NCT01154166|1165506|P1|Overall Study|Protocol Violation|4
345285|NCT01154166|1165505|P2|Overall Study|Lost to Follow-up|1
345286|NCT01154166|1165506|P1|Overall Study|Lost to Follow-up|1
345287|NCT01154166|1165505|P2|Overall Study|Adverse Event|9
345288|NCT01154166|1165506|P1|Overall Study|Adverse Event|14
345289|NCT01154153|1165538|P2|Overall Study|Withdrew consent|0
345290|NCT01154153|1165539|P1|Overall Study|Withdrew consent|1
345291|NCT01154153|1165538|P2|Overall Study|Unable to use labs|3
345292|NCT01154153|1165539|P1|Overall Study|Unable to use labs|2
345293|NCT01154153|1165538|P2|Overall Study|Poor compliance to protocol|0
345294|NCT01154153|1165539|P1|Overall Study|Poor compliance to protocol|2
345295|NCT01154140|1165557|P2|Overall Study|Randomized but not treated|2
345296|NCT01154140|1165558|P1|Overall Study|Randomized but not treated|1
345297|NCT01154140|1165557|P2|Overall Study|Other|1
345298|NCT01154140|1165558|P1|Overall Study|Other|3
345299|NCT01154140|1165557|P2|Overall Study|Withdrawal by Subject|13
345300|NCT01154140|1165558|P1|Overall Study|Withdrawal by Subject|12
345301|NCT01154140|1165557|P2|Overall Study|Lost to Follow-up|5
345302|NCT01154140|1165558|P1|Overall Study|Lost to Follow-up|4
345303|NCT01154140|1165557|P2|Overall Study|Death|81
345304|NCT01154140|1165558|P1|Overall Study|Death|71
345305|NCT01154127|1165611|P2|Period 2 (21 Days)|Protocol Deviation|1
345306|NCT01154127|1165612|P1|Period 2 (21 Days)|Protocol Deviation|0
345307|NCT01154127|1165611|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
345308|NCT01154127|1165612|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
345309|NCT01154127|1165611|P2|Washout (14 - 28 Days)|Adverse Event|0
345310|NCT01154127|1165612|P1|Washout (14 - 28 Days)|Adverse Event|2
345311|NCT01154127|1165611|P2|Period 1 (21 Days)|Withdrawal by Subject|2
345312|NCT01154127|1165612|P1|Period 1 (21 Days)|Withdrawal by Subject|0
345313|NCT01154127|1165611|P2|Period 1 (21 Days)|Adverse Event|4
345314|NCT01154127|1165612|P1|Period 1 (21 Days)|Adverse Event|3
345315|NCT01154101|1165639|P5|Overall Study|Withdrawal by Subject|1
345316|NCT01154101|1165640|P4|Overall Study|Withdrawal by Subject|0
345317|NCT01154101|1165641|P3|Overall Study|Withdrawal by Subject|2
345318|NCT01154101|1165642|P2|Overall Study|Withdrawal by Subject|1
345319|NCT01154101|1165643|P1|Overall Study|Withdrawal by Subject|0
345320|NCT01154101|1165639|P5|Overall Study|Lost to Follow-up|0
345321|NCT01154101|1165640|P4|Overall Study|Lost to Follow-up|1
345322|NCT01154101|1165641|P3|Overall Study|Lost to Follow-up|0
345323|NCT01154101|1165642|P2|Overall Study|Lost to Follow-up|1
345324|NCT01154101|1165643|P1|Overall Study|Lost to Follow-up|0
345325|NCT01154101|1165639|P5|Overall Study|Adverse Event|0
345326|NCT01154101|1165640|P4|Overall Study|Adverse Event|1
345327|NCT01154101|1165641|P3|Overall Study|Adverse Event|1
345328|NCT01154101|1165642|P2|Overall Study|Adverse Event|2
345329|NCT01154101|1165643|P1|Overall Study|Adverse Event|0
345330|NCT01154036|1165698|P8|Phase II|Withdrawal by Subject|4
345331|NCT01154036|1165699|P7|Phase II|Withdrawal by Subject|5
345332|NCT01154036|1165700|P6|Phase II|Withdrawal by Subject|2
345333|NCT01154036|1165701|P5|Phase II|Withdrawal by Subject|4
345334|NCT01154036|1165702|P4|Phase II|Withdrawal by Subject|0
345335|NCT01154036|1165703|P3|Phase II|Withdrawal by Subject|0
345336|NCT01154036|1165704|P2|Phase II|Withdrawal by Subject|0
345337|NCT01154036|1165705|P1|Phase II|Withdrawal by Subject|0
345338|NCT01154036|1165698|P8|Phase II|Protocol Violation|0
345339|NCT01154036|1165699|P7|Phase II|Protocol Violation|0
345340|NCT01154036|1165700|P6|Phase II|Protocol Violation|2
345341|NCT01154036|1165701|P5|Phase II|Protocol Violation|1
345342|NCT01154036|1165702|P4|Phase II|Protocol Violation|0
345343|NCT01154036|1165703|P3|Phase II|Protocol Violation|0
345344|NCT01154036|1165704|P2|Phase II|Protocol Violation|0
345345|NCT01154036|1165705|P1|Phase II|Protocol Violation|0
345346|NCT01154036|1165698|P8|Phase II|Lost to Follow-up|1
345347|NCT01154036|1165699|P7|Phase II|Lost to Follow-up|2
345348|NCT01154036|1165700|P6|Phase II|Lost to Follow-up|0
345349|NCT01154036|1165701|P5|Phase II|Lost to Follow-up|2
345350|NCT01154036|1165702|P4|Phase II|Lost to Follow-up|1
345351|NCT01154036|1165703|P3|Phase II|Lost to Follow-up|0
345352|NCT01154036|1165704|P2|Phase II|Lost to Follow-up|0
345353|NCT01154036|1165705|P1|Phase II|Lost to Follow-up|0
345354|NCT01154036|1165698|P8|Phase II|Physician Decision|0
345355|NCT01154036|1165699|P7|Phase II|Physician Decision|1
345356|NCT01154036|1165700|P6|Phase II|Physician Decision|0
345357|NCT01154036|1165701|P5|Phase II|Physician Decision|0
345358|NCT01154036|1165702|P4|Phase II|Physician Decision|0
345359|NCT01154036|1165703|P3|Phase II|Physician Decision|0
345360|NCT01154036|1165704|P2|Phase II|Physician Decision|0
345361|NCT01154036|1165705|P1|Phase II|Physician Decision|0
345362|NCT01154036|1165698|P8|Phase II|Adverse Event|1
345363|NCT01154036|1165699|P7|Phase II|Adverse Event|1
345364|NCT01154036|1165700|P6|Phase II|Adverse Event|1
345365|NCT01154036|1165701|P5|Phase II|Adverse Event|1
345366|NCT01154036|1165702|P4|Phase II|Adverse Event|0
345367|NCT01154036|1165703|P3|Phase II|Adverse Event|0
345368|NCT01154036|1165704|P2|Phase II|Adverse Event|0
345369|NCT01154036|1165705|P1|Phase II|Adverse Event|0
345370|NCT01154036|1165698|P8|Phase I|Adverse Event|0
345371|NCT01154036|1165699|P7|Phase I|Adverse Event|0
345372|NCT01154036|1165700|P6|Phase I|Adverse Event|0
345373|NCT01154036|1165701|P5|Phase I|Adverse Event|0
345374|NCT01154036|1165702|P4|Phase I|Adverse Event|0
345375|NCT01154036|1165703|P3|Phase I|Adverse Event|12
345376|NCT01154036|1165704|P2|Phase I|Adverse Event|11
345377|NCT01154036|1165705|P1|Phase I|Adverse Event|1
345378|NCT01154036|1165698|P8|Phase I|Withdrawal by Subject|0
345379|NCT01154036|1165699|P7|Phase I|Withdrawal by Subject|0
345380|NCT01154036|1165700|P6|Phase I|Withdrawal by Subject|0
345381|NCT01154036|1165701|P5|Phase I|Withdrawal by Subject|0
345382|NCT01154036|1165702|P4|Phase I|Withdrawal by Subject|0
345383|NCT01154036|1165703|P3|Phase I|Withdrawal by Subject|29
345384|NCT01154036|1165704|P2|Phase I|Withdrawal by Subject|10
345385|NCT01154036|1165705|P1|Phase I|Withdrawal by Subject|2
345386|NCT01154036|1165698|P8|Phase I|Protocol Violation|0
345387|NCT01154036|1165699|P7|Phase I|Protocol Violation|0
345388|NCT01154036|1165700|P6|Phase I|Protocol Violation|0
345389|NCT01154036|1165701|P5|Phase I|Protocol Violation|0
345390|NCT01154036|1165702|P4|Phase I|Protocol Violation|0
345391|NCT01154036|1165703|P3|Phase I|Protocol Violation|9
345392|NCT01154036|1165704|P2|Phase I|Protocol Violation|3
345393|NCT01154036|1165705|P1|Phase I|Protocol Violation|0
345394|NCT01154036|1165698|P8|Phase I|Lost to Follow-up|0
345395|NCT01154036|1165699|P7|Phase I|Lost to Follow-up|0
345396|NCT01154036|1165700|P6|Phase I|Lost to Follow-up|0
345397|NCT01154036|1165701|P5|Phase I|Lost to Follow-up|0
345398|NCT01154036|1165702|P4|Phase I|Lost to Follow-up|0
345399|NCT01154036|1165703|P3|Phase I|Lost to Follow-up|6
345400|NCT01154036|1165704|P2|Phase I|Lost to Follow-up|3
345401|NCT01154036|1165705|P1|Phase I|Lost to Follow-up|0
345402|NCT01154036|1165698|P8|Phase I|Physician Decision|0
345403|NCT01154036|1165699|P7|Phase I|Physician Decision|0
345404|NCT01154036|1165700|P6|Phase I|Physician Decision|0
345405|NCT01154036|1165701|P5|Phase I|Physician Decision|0
345406|NCT01154036|1165702|P4|Phase I|Physician Decision|0
345407|NCT01154036|1165703|P3|Phase I|Physician Decision|0
345408|NCT01154036|1165704|P2|Phase I|Physician Decision|1
345409|NCT01154036|1165705|P1|Phase I|Physician Decision|0
345410|NCT01154010|1165829|P2|Overall Study|Lost to Follow-up|1
345411|NCT01154010|1165830|P1|Overall Study|Lost to Follow-up|0
345412|NCT01153984|1165836|P1|Overall Study|Adverse Event|1
345413|NCT01153984|1165836|P1|Overall Study|Withdrawal by Subject|1
345414|NCT01153971|1165847|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
345415|NCT01153971|1165847|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
345416|NCT01153971|1165847|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
345417|NCT01153971|1165847|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
345418|NCT01153971|1165847|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
345419|NCT01153971|1165847|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
345420|NCT01153971|1165847|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
345421|NCT01153958|1165870|P2|Overall Study|Study Terminated|32
345422|NCT01153958|1165871|P1|Overall Study|Study Terminated|36
345423|NCT01153893|1165889|P2|Overall Study|Adverse Event|0
345424|NCT01153893|1165890|P1|Overall Study|Adverse Event|1
345425|NCT01153841|1165916|P2|Overall Study|Lost to Follow-up|0
345426|NCT01153841|1165917|P1|Overall Study|Lost to Follow-up|2
345427|NCT01153841|1165916|P2|Overall Study|Protocol Violation|0
345428|NCT01153841|1165917|P1|Overall Study|Protocol Violation|2
345429|NCT01153841|1165916|P2|Overall Study|Withdrawal by Subject|0
345430|NCT01153841|1165917|P1|Overall Study|Withdrawal by Subject|1
345431|NCT01153841|1165916|P2|Overall Study|Adverse Event|0
345432|NCT01153841|1165917|P1|Overall Study|Adverse Event|1
345433|NCT01153815|1165933|P2|Overall Study|Withdrawal by Subject|4
345434|NCT01153815|1165934|P1|Overall Study|Withdrawal by Subject|6
345435|NCT01153815|1165933|P2|Overall Study|Adverse Event|1
345436|NCT01153815|1165934|P1|Overall Study|Adverse Event|3
345437|NCT01153763|1165956|P1|Overall Study|Withdrawal by Subject|2
345438|NCT01153763|1165956|P1|Overall Study|Physician Decision|2
345439|NCT01153763|1165956|P1|Overall Study|Lost to Follow-up|1
345440|NCT01153763|1165956|P1|Overall Study|Study Closed|16
345441|NCT01153724|1165972|P1|Treatment Period 2|Other reason not defined above|1
345442|NCT01153724|1165972|P1|Treatment Period 2|Adverse Event|1
345443|NCT01153724|1165972|P1|Treatment Period 1|Withdrawal by Subject|1
345444|NCT01153698|1166012|P1|Overall Study|Not treated with Pradaxa|5
345445|NCT01153698|1166012|P1|Overall Study|Other|2
345446|NCT01153698|1166012|P1|Overall Study|Switch to other anticoagulants|4
345447|NCT01153698|1166012|P1|Overall Study|Withdrawal by Subject|2
345448|NCT01153698|1166012|P1|Overall Study|Lost to Follow-up|4
345449|NCT01153698|1166012|P1|Overall Study|Adverse Event|12
345450|NCT01153633|1166063|P2|Overall Study|Therapeutic failure|3
345451|NCT01153633|1166064|P1|Overall Study|Therapeutic failure|3
345452|NCT01153633|1166063|P2|Overall Study|Protocol Violation|1
345453|NCT01153633|1166064|P1|Overall Study|Protocol Violation|1
345454|NCT01153425|1166114|P2|Overall Study|Withdrawal by Subject|3
345455|NCT01153425|1166115|P1|Overall Study|Withdrawal by Subject|3
345456|NCT01153347|1166127|P4|Overall Study|Death|0
345457|NCT01153347|1166128|P3|Overall Study|Death|0
345458|NCT01153347|1166129|P2|Overall Study|Death|0
345459|NCT01153347|1166130|P1|Overall Study|Death|1
345460|NCT01153347|1166127|P4|Overall Study|Not specified|0
345461|NCT01153347|1166128|P3|Overall Study|Not specified|4
345462|NCT01153347|1166129|P2|Overall Study|Not specified|5
345463|NCT01153347|1166130|P1|Overall Study|Not specified|5
345464|NCT01153347|1166127|P4|Overall Study|Lost to Follow-up|8
345465|NCT01153347|1166128|P3|Overall Study|Lost to Follow-up|11
345466|NCT01153347|1166129|P2|Overall Study|Lost to Follow-up|9
345467|NCT01153347|1166130|P1|Overall Study|Lost to Follow-up|4
345468|NCT01153347|1166127|P4|Overall Study|Study-specific withdrawal criteria|2
345469|NCT01153347|1166128|P3|Overall Study|Study-specific withdrawal criteria|1
345470|NCT01153347|1166129|P2|Overall Study|Study-specific withdrawal criteria|3
345471|NCT01153347|1166130|P1|Overall Study|Study-specific withdrawal criteria|4
345472|NCT01153347|1166127|P4|Overall Study|Lack of Efficacy|4
345473|NCT01153347|1166128|P3|Overall Study|Lack of Efficacy|0
345474|NCT01153347|1166129|P2|Overall Study|Lack of Efficacy|2
345475|NCT01153347|1166130|P1|Overall Study|Lack of Efficacy|2
345476|NCT01153347|1166127|P4|Overall Study|Condition under investigation worsened|0
345477|NCT01153347|1166128|P3|Overall Study|Condition under investigation worsened|0
345478|NCT01153347|1166129|P2|Overall Study|Condition under investigation worsened|1
345479|NCT01153347|1166130|P1|Overall Study|Condition under investigation worsened|1
345480|NCT01153347|1166127|P4|Overall Study|Severe non-compliance to protocol|3
345481|NCT01153347|1166128|P3|Overall Study|Severe non-compliance to protocol|4
345482|NCT01153347|1166129|P2|Overall Study|Severe non-compliance to protocol|7
345483|NCT01153347|1166130|P1|Overall Study|Severe non-compliance to protocol|6
345484|NCT01153347|1166127|P4|Overall Study|Adverse Event|7
345485|NCT01153347|1166128|P3|Overall Study|Adverse Event|21
345486|NCT01153347|1166129|P2|Overall Study|Adverse Event|9
345487|NCT01153347|1166130|P1|Overall Study|Adverse Event|3
345488|NCT01153347|1166127|P4|Overall Study|Eligibility criteria not fulfilled|1
345489|NCT01153347|1166128|P3|Overall Study|Eligibility criteria not fulfilled|2
345490|NCT01153347|1166129|P2|Overall Study|Eligibility criteria not fulfilled|1
345491|NCT01153347|1166130|P1|Overall Study|Eligibility criteria not fulfilled|0
345492|NCT01153347|1166127|P4|Overall Study|Withdrawal by Subject|7
345493|NCT01153347|1166128|P3|Overall Study|Withdrawal by Subject|7
345494|NCT01153347|1166129|P2|Overall Study|Withdrawal by Subject|7
345495|NCT01153347|1166130|P1|Overall Study|Withdrawal by Subject|7
345496|NCT01153321|1166230|P2|Overall Study|Adverse Event|1
345497|NCT01153321|1166231|P1|Overall Study|Adverse Event|1
345498|NCT01153321|1166230|P2|Overall Study|Withdrawal by Subject|1
345499|NCT01153321|1166231|P1|Overall Study|Withdrawal by Subject|0
345500|NCT01153321|1166230|P2|Overall Study|Development of study withdrawal criteria|1
345501|NCT01153321|1166231|P1|Overall Study|Development of study withdrawal criteria|0
345502|NCT01153269|1166343|P1|Overall Study|Antiretroviral therapy break|1
345503|NCT01153269|1166343|P1|Overall Study|Withdrawal by Subject|1
345504|NCT01153009|1166406|P4|Overall Study|Other|2
345505|NCT01153009|1166407|P3|Overall Study|Other|3
345506|NCT01153009|1166408|P2|Overall Study|Other|1
345507|NCT01153009|1166409|P1|Overall Study|Other|1
345508|NCT01153009|1166406|P4|Overall Study|Lost to Follow-up|15
345509|NCT01153009|1166407|P3|Overall Study|Lost to Follow-up|11
345510|NCT01153009|1166408|P2|Overall Study|Lost to Follow-up|8
345511|NCT01153009|1166409|P1|Overall Study|Lost to Follow-up|8
345512|NCT01153009|1166406|P4|Overall Study|Withdrawal of Consent|6
345513|NCT01153009|1166407|P3|Overall Study|Withdrawal of Consent|4
345514|NCT01153009|1166408|P2|Overall Study|Withdrawal of Consent|5
345515|NCT01153009|1166409|P1|Overall Study|Withdrawal of Consent|5
345516|NCT01153009|1166406|P4|Overall Study|Protocol Deviations|2
345517|NCT01153009|1166407|P3|Overall Study|Protocol Deviations|3
345518|NCT01153009|1166408|P2|Overall Study|Protocol Deviations|3
345519|NCT01153009|1166409|P1|Overall Study|Protocol Deviations|4
345520|NCT01153009|1166406|P4|Overall Study|Noncompliance with Study Medication|1
345521|NCT01153009|1166407|P3|Overall Study|Noncompliance with Study Medication|4
345522|NCT01153009|1166408|P2|Overall Study|Noncompliance with Study Medication|3
345523|NCT01153009|1166409|P1|Overall Study|Noncompliance with Study Medication|1
345524|NCT01153009|1166406|P4|Overall Study|Lack of Efficacy|1
345525|NCT01153009|1166407|P3|Overall Study|Lack of Efficacy|2
345526|NCT01153009|1166408|P2|Overall Study|Lack of Efficacy|0
345527|NCT01153009|1166409|P1|Overall Study|Lack of Efficacy|9
345528|NCT01153009|1166406|P4|Overall Study|Adverse Event|10
345529|NCT01153009|1166407|P3|Overall Study|Adverse Event|14
345530|NCT01153009|1166408|P2|Overall Study|Adverse Event|14
345531|NCT01153009|1166409|P1|Overall Study|Adverse Event|4
345532|NCT01152996|1166439|P1|Overall Study|Elevated liver enzymes|1
345533|NCT01152996|1166439|P1|Overall Study|Protocol Violation|22
345534|NCT01152996|1166439|P1|Overall Study|Other|36
345535|NCT01152996|1166439|P1|Overall Study|Noncompliance|41
345536|NCT01152996|1166439|P1|Overall Study|Lack of Efficacy|68
345537|NCT01152996|1166439|P1|Overall Study|Lost to Follow-up|112
345538|NCT01152996|1166439|P1|Overall Study|Adverse Event|115
345539|NCT01152996|1166439|P1|Overall Study|Withdrawal by Subject|142
345540|NCT01152814|1166452|P1|Overall Study|Lost to Follow-up|2
345541|NCT01152788|1166461|P2|Overall Study|No treatment|1
345542|NCT01152788|1166462|P1|Overall Study|No treatment|0
345543|NCT01152788|1166461|P2|Overall Study|Withdrawal by Subject|3
345544|NCT01152788|1166462|P1|Overall Study|Withdrawal by Subject|0
345545|NCT01152580|1166499|P2|Overall Study|Withdrawal by Subject|1
345546|NCT01152580|1166500|P1|Overall Study|Withdrawal by Subject|0
345547|NCT01152554|1166522|P2|Overall Study|Death|1
345548|NCT01152554|1166523|P1|Overall Study|Death|1
345549|NCT01152554|1166522|P2|Overall Study|Not specified|8
345550|NCT01152554|1166523|P1|Overall Study|Not specified|28
345551|NCT01152554|1166522|P2|Overall Study|Lost to Follow-up|32
345552|NCT01152554|1166523|P1|Overall Study|Lost to Follow-up|87
345553|NCT01152554|1166522|P2|Overall Study|Study-specific withdrawal criteria|8
345554|NCT01152554|1166523|P1|Overall Study|Study-specific withdrawal criteria|17
345555|NCT01152554|1166522|P2|Overall Study|Lack of Efficacy|3
345556|NCT01152554|1166523|P1|Overall Study|Lack of Efficacy|20
345557|NCT01152554|1166522|P2|Overall Study|Condition under investigation worsened|2
345558|NCT01152554|1166523|P1|Overall Study|Condition under investigation worsened|5
345559|NCT01152554|1166522|P2|Overall Study|Severe non-compliance to protocol|14
345560|NCT01152554|1166523|P1|Overall Study|Severe non-compliance to protocol|36
345561|NCT01152554|1166522|P2|Overall Study|Adverse Event|14
345562|NCT01152554|1166523|P1|Overall Study|Adverse Event|67
345563|NCT01152554|1166522|P2|Overall Study|Eligiblity criteria not fulfilled|1
345564|NCT01152554|1166523|P1|Overall Study|Eligiblity criteria not fulfilled|0
345565|NCT01152554|1166522|P2|Overall Study|Withdrawal by Subject|28
345566|NCT01152554|1166523|P1|Overall Study|Withdrawal by Subject|73
345567|NCT01152450|1166545|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
345568|NCT01152450|1166546|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
345569|NCT01152450|1166547|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
345570|NCT01152450|1166548|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
345571|NCT01152450|1166549|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
345572|NCT01152450|1166550|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
345573|NCT01152450|1166545|P6|Period 1 (4 Weeks)|Protocol Violation|0
345574|NCT01152450|1166546|P5|Period 1 (4 Weeks)|Protocol Violation|1
345575|NCT01152450|1166547|P4|Period 1 (4 Weeks)|Protocol Violation|0
345576|NCT01152450|1166548|P3|Period 1 (4 Weeks)|Protocol Violation|0
345577|NCT01152450|1166549|P2|Period 1 (4 Weeks)|Protocol Violation|0
345578|NCT01152450|1166550|P1|Period 1 (4 Weeks)|Protocol Violation|0
345579|NCT01152450|1166545|P6|Period 1 (4 Weeks)|Adverse Event|1
345580|NCT01152450|1166546|P5|Period 1 (4 Weeks)|Adverse Event|1
345581|NCT01152450|1166547|P4|Period 1 (4 Weeks)|Adverse Event|0
345582|NCT01152450|1166548|P3|Period 1 (4 Weeks)|Adverse Event|0
345583|NCT01152450|1166549|P2|Period 1 (4 Weeks)|Adverse Event|0
345584|NCT01152450|1166550|P1|Period 1 (4 Weeks)|Adverse Event|0
345585|NCT01152437|1166621|P3|Overall Study|Refusal to continue taking trial medicat|2
345586|NCT01152437|1166622|P2|Overall Study|Refusal to continue taking trial medicat|0
345587|NCT01152437|1166623|P1|Overall Study|Refusal to continue taking trial medicat|1
345588|NCT01152437|1166621|P3|Overall Study|Progressive disease|32
345589|NCT01152437|1166622|P2|Overall Study|Progressive disease|13
345590|NCT01152437|1166623|P1|Overall Study|Progressive disease|27
345591|NCT01152437|1166621|P3|Overall Study|Not treated|2
345592|NCT01152437|1166622|P2|Overall Study|Not treated|1
345593|NCT01152437|1166623|P1|Overall Study|Not treated|0
345594|NCT01152437|1166621|P3|Overall Study|Other Adverse Event|7
345595|NCT01152437|1166622|P2|Overall Study|Other Adverse Event|1
345596|NCT01152437|1166623|P1|Overall Study|Other Adverse Event|8
345597|NCT01152385|1166643|P4|Overall Study|Other|3
345598|NCT01152385|1166644|P3|Overall Study|Other|2
345599|NCT01152385|1166645|P2|Overall Study|Other|3
345600|NCT01152385|1166646|P1|Overall Study|Other|4
345601|NCT01152385|1166643|P4|Overall Study|Study-specific withdrawal criteria|0
345602|NCT01152385|1166644|P3|Overall Study|Study-specific withdrawal criteria|2
345603|NCT01152385|1166645|P2|Overall Study|Study-specific withdrawal criteria|1
345604|NCT01152385|1166646|P1|Overall Study|Study-specific withdrawal criteria|1
345605|NCT01152385|1166643|P4|Overall Study|Adverse Event|0
345606|NCT01152385|1166644|P3|Overall Study|Adverse Event|0
345607|NCT01152385|1166645|P2|Overall Study|Adverse Event|1
345608|NCT01152385|1166646|P1|Overall Study|Adverse Event|1
345609|NCT01152385|1166643|P4|Overall Study|Protocol Violation|1
345610|NCT01152385|1166644|P3|Overall Study|Protocol Violation|0
345611|NCT01152385|1166645|P2|Overall Study|Protocol Violation|0
345612|NCT01152385|1166646|P1|Overall Study|Protocol Violation|0
345613|NCT01152385|1166643|P4|Overall Study|Withdrawal by Subject|1
345614|NCT01152385|1166644|P3|Overall Study|Withdrawal by Subject|1
345615|NCT01152385|1166645|P2|Overall Study|Withdrawal by Subject|1
345616|NCT01152385|1166646|P1|Overall Study|Withdrawal by Subject|3
345617|NCT01152190|1166713|P2|Overall Study|Withdrawal by Subject|3
345618|NCT01152190|1166714|P1|Overall Study|Withdrawal by Subject|1
345619|NCT01152190|1166713|P2|Overall Study|Protocol Violation|1
345620|NCT01152190|1166714|P1|Overall Study|Protocol Violation|1
345621|NCT01152190|1166713|P2|Overall Study|Death|0
345622|NCT01152190|1166714|P1|Overall Study|Death|1
345623|NCT01152190|1166713|P2|Overall Study|Adverse Event|4
345624|NCT01152190|1166714|P1|Overall Study|Adverse Event|2
345625|NCT01151579|1166773|P2|Overall Study|Not meet inclusion criteria|4
345626|NCT01151579|1166774|P1|Overall Study|Not meet inclusion criteria|6
345627|NCT01151579|1166773|P2|Overall Study|Withdrawal by Subject|2
345628|NCT01151579|1166774|P1|Overall Study|Withdrawal by Subject|3
345629|NCT01151579|1166773|P2|Overall Study|Physician Decision|1
345630|NCT01151579|1166774|P1|Overall Study|Physician Decision|3
345631|NCT01151410|1166828|P2|Overall Study|Abnormal laboratory value(s)|1
345632|NCT01151410|1166829|P1|Overall Study|Abnormal laboratory value(s)|0
345633|NCT01151410|1166828|P2|Overall Study|Unsatisfactory therapeutic effect|1
345634|NCT01151410|1166829|P1|Overall Study|Unsatisfactory therapeutic effect|1
345635|NCT01151410|1166828|P2|Overall Study|Administrative problems|1
345636|NCT01151410|1166829|P1|Overall Study|Administrative problems|1
345637|NCT01151410|1166828|P2|Overall Study|Protocol deviation|1
345638|NCT01151410|1166829|P1|Overall Study|Protocol deviation|2
345639|NCT01151410|1166828|P2|Overall Study|Adverse Event|2
345640|NCT01151410|1166829|P1|Overall Study|Adverse Event|1
345641|NCT01151410|1166828|P2|Overall Study|Lost to Follow-up|4
345642|NCT01151410|1166829|P1|Overall Study|Lost to Follow-up|3
345643|NCT01151410|1166828|P2|Overall Study|Withdrawal by Subject|5
345644|NCT01151410|1166829|P1|Overall Study|Withdrawal by Subject|3
345645|NCT01151345|1166873|P2|First Intervention Period|Protocol Violation|1
345646|NCT01151345|1166874|P1|First Intervention Period|Protocol Violation|0
345647|NCT01151280|1166888|P1|Overall Study|Lack of Efficacy|3
345648|NCT01151280|1166888|P1|Overall Study|Adverse Event|1
345649|NCT01151215|1166901|P3|Overall Study|Safety as judged by the investigator|1
345650|NCT01151215|1166902|P2|Overall Study|Safety as judged by the investigator|0
345651|NCT01151215|1166903|P1|Overall Study|Safety as judged by the investigator|0
345652|NCT01151215|1166901|P3|Overall Study|Disease progression|1
345653|NCT01151215|1166902|P2|Overall Study|Disease progression|1
345654|NCT01151215|1166903|P1|Overall Study|Disease progression|0
345655|NCT01151215|1166901|P3|Overall Study|Withdrawal by Subject|2
345656|NCT01151215|1166902|P2|Overall Study|Withdrawal by Subject|1
345657|NCT01151215|1166903|P1|Overall Study|Withdrawal by Subject|3
345658|NCT01151215|1166901|P3|Overall Study|Lost to Follow-up|3
345659|NCT01151215|1166902|P2|Overall Study|Lost to Follow-up|0
345660|NCT01151215|1166903|P1|Overall Study|Lost to Follow-up|0
345661|NCT01151215|1166901|P3|Overall Study|Death|11
345662|NCT01151215|1166902|P2|Overall Study|Death|20
345663|NCT01151215|1166903|P1|Overall Study|Death|16
345664|NCT01151215|1166901|P3|Overall Study|Worsening of condition under study|1
345665|NCT01151215|1166902|P2|Overall Study|Worsening of condition under study|1
345666|NCT01151215|1166903|P1|Overall Study|Worsening of condition under study|1
345667|NCT01151137|1166941|P2|Overall Study|Lost to Follow-up|1
345668|NCT01151137|1166942|P1|Overall Study|Lost to Follow-up|1
345669|NCT01151137|1166941|P2|Overall Study|Death|27
345670|NCT01151137|1166942|P1|Overall Study|Death|15
345671|NCT01151098|1166960|P1|Overall Study|Miscellaneous|13
345672|NCT01151098|1166960|P1|Overall Study|Protocol Violation|1
345673|NCT01151098|1166960|P1|Overall Study|Lack of Efficacy|15
345674|NCT01151098|1166960|P1|Overall Study|Lost to Follow-up|6
345675|NCT01151098|1166960|P1|Overall Study|Adverse Event|82
345676|NCT01151085|1166964|P1|Overall Study|Protocol Violation|25
345677|NCT01151085|1166964|P1|Overall Study|Lost to Follow-up|31
345678|NCT01151020|1166995|P1|Overall Study|Still be eligible for follow-up|79
345679|NCT01151020|1166995|P1|Overall Study|Patients did not receive the device|2
345680|NCT01151020|1166995|P1|Overall Study|Withdrawal by Subject|12
345681|NCT01151020|1166995|P1|Overall Study|Lost to Follow-up|1
345682|NCT01151020|1166995|P1|Overall Study|Conversion to open repair|1
345683|NCT01151020|1166995|P1|Overall Study|Death|15
345684|NCT01150474|1167074|P2|Overall Study|Surgery Changed|0
345685|NCT01150474|1167075|P1|Overall Study|Surgery Changed|1
345686|NCT01150474|1167074|P2|Overall Study|Drug not administered|0
345687|NCT01150474|1167075|P1|Overall Study|Drug not administered|1
345688|NCT01150474|1167074|P2|Overall Study|Drug did not arrive in time|0
345689|NCT01150474|1167075|P1|Overall Study|Drug did not arrive in time|1
345690|NCT01150474|1167074|P2|Overall Study|Rectotomy|0
345691|NCT01150474|1167075|P1|Overall Study|Rectotomy|1
345692|NCT01150474|1167074|P2|Overall Study|Multiple Studies|1
345693|NCT01150474|1167075|P1|Overall Study|Multiple Studies|0
345694|NCT01150474|1167074|P2|Overall Study|Cancer found|0
345695|NCT01150474|1167075|P1|Overall Study|Cancer found|1
345696|NCT01150474|1167074|P2|Overall Study|Withdrawal by Subject|2
345697|NCT01150474|1167075|P1|Overall Study|Withdrawal by Subject|5
345698|NCT01150357|1167120|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
345699|NCT01150357|1167121|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
345700|NCT01150357|1167122|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
345701|NCT01150357|1167120|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
345702|NCT01150357|1167121|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
345703|NCT01150357|1167122|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
345704|NCT01150357|1167120|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
345705|NCT01150357|1167121|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
345706|NCT01150357|1167122|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
345707|NCT01150357|1167120|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
345708|NCT01150357|1167121|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
345709|NCT01150357|1167122|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
345710|NCT01150357|1167120|P3|Dose Response Phase (Phase 1)|Adverse Event|1
345711|NCT01150357|1167121|P2|Dose Response Phase (Phase 1)|Adverse Event|0
345712|NCT01150357|1167122|P1|Dose Response Phase (Phase 1)|Adverse Event|0
345713|NCT01150357|1167120|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
345714|NCT01150357|1167121|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
345715|NCT01150357|1167122|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
345716|NCT01150357|1167120|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
345717|NCT01150357|1167121|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
345718|NCT01150357|1167122|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
345719|NCT01150123|1167202|P18|Overall Study|Lost to Follow-up|0
345720|NCT01150123|1167203|P17|Overall Study|Lost to Follow-up|0
345721|NCT01150123|1167204|P16|Overall Study|Lost to Follow-up|0
345722|NCT01150123|1167205|P15|Overall Study|Lost to Follow-up|0
345723|NCT01150123|1167206|P14|Overall Study|Lost to Follow-up|0
345724|NCT01150123|1167207|P13|Overall Study|Lost to Follow-up|2
345725|NCT01150123|1167208|P12|Overall Study|Lost to Follow-up|1
345726|NCT01150123|1167209|P11|Overall Study|Lost to Follow-up|1
345727|NCT01150123|1167210|P10|Overall Study|Lost to Follow-up|1
345728|NCT01150123|1167211|P9|Overall Study|Lost to Follow-up|3
345729|NCT01150123|1167212|P8|Overall Study|Lost to Follow-up|0
345730|NCT01150123|1167213|P7|Overall Study|Lost to Follow-up|0
345731|NCT01150123|1167214|P6|Overall Study|Lost to Follow-up|5
345732|NCT01150123|1167215|P5|Overall Study|Lost to Follow-up|2
345733|NCT01150123|1167216|P4|Overall Study|Lost to Follow-up|2
345734|NCT01150123|1167217|P3|Overall Study|Lost to Follow-up|2
345735|NCT01150123|1167218|P2|Overall Study|Lost to Follow-up|1
345736|NCT01150123|1167219|P1|Overall Study|Lost to Follow-up|2
345737|NCT01150123|1167202|P18|Overall Study|Withdrawal by Subject|1
345738|NCT01150123|1167203|P17|Overall Study|Withdrawal by Subject|0
345739|NCT01150123|1167204|P16|Overall Study|Withdrawal by Subject|1
345740|NCT01150123|1167205|P15|Overall Study|Withdrawal by Subject|0
345741|NCT01150123|1167206|P14|Overall Study|Withdrawal by Subject|0
345742|NCT01150123|1167207|P13|Overall Study|Withdrawal by Subject|1
345743|NCT01150123|1167208|P12|Overall Study|Withdrawal by Subject|0
345744|NCT01150123|1167209|P11|Overall Study|Withdrawal by Subject|1
345745|NCT01150123|1167210|P10|Overall Study|Withdrawal by Subject|0
345746|NCT01150123|1167211|P9|Overall Study|Withdrawal by Subject|2
345747|NCT01150123|1167212|P8|Overall Study|Withdrawal by Subject|3
345748|NCT01150123|1167213|P7|Overall Study|Withdrawal by Subject|0
345749|NCT01150123|1167214|P6|Overall Study|Withdrawal by Subject|1
345750|NCT01150123|1167215|P5|Overall Study|Withdrawal by Subject|1
345751|NCT01150123|1167216|P4|Overall Study|Withdrawal by Subject|1
345752|NCT01150123|1167217|P3|Overall Study|Withdrawal by Subject|2
345753|NCT01150123|1167218|P2|Overall Study|Withdrawal by Subject|1
345754|NCT01150123|1167219|P1|Overall Study|Withdrawal by Subject|1
345755|NCT01150097|1167395|P3|Months 24 to 48 Post-transplantation|Death|0
345756|NCT01150097|1167396|P2|Months 24 to 48 Post-transplantation|Death|0
345757|NCT01150097|1167397|P1|Months 24 to 48 Post-transplantation|Death|2
345758|NCT01150097|1167395|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
345759|NCT01150097|1167396|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
345760|NCT01150097|1167397|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
345761|NCT01150097|1167395|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
345762|NCT01150097|1167396|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
345763|NCT01150097|1167397|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
345764|NCT01150097|1167395|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
345765|NCT01150097|1167396|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
345766|NCT01150097|1167397|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
345767|NCT01150097|1167395|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
345768|NCT01150097|1167396|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
345769|NCT01150097|1167397|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
345770|NCT01150097|1167395|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
345771|NCT01150097|1167396|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
345772|NCT01150097|1167397|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
345773|NCT01150097|1167395|P3|Months 24 to 36 Post-transplantation|Death|0
345774|NCT01150097|1167396|P2|Months 24 to 36 Post-transplantation|Death|0
345775|NCT01150097|1167397|P1|Months 24 to 36 Post-transplantation|Death|2
345776|NCT01149863|1167441|P1|Overall Study|Missing data or Not receiveing studydrug|3
345777|NCT01149655|1167518|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
345778|NCT01149655|1167519|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
345779|NCT01149655|1167520|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
345780|NCT01149655|1167521|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
345781|NCT01149655|1167518|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
345782|NCT01149655|1167519|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
345783|NCT01149655|1167520|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
345784|NCT01149655|1167521|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
345785|NCT01149655|1167518|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
345786|NCT01149655|1167519|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
345787|NCT01149655|1167520|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
345788|NCT01149655|1167521|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
345789|NCT01149655|1167518|P4|Period 3-DB Maintenance Phase|Physician Decision|0
345790|NCT01149655|1167519|P3|Period 3-DB Maintenance Phase|Physician Decision|1
345791|NCT01149655|1167520|P2|Period 3-DB Maintenance Phase|Physician Decision|0
345792|NCT01149655|1167521|P1|Period 3-DB Maintenance Phase|Physician Decision|0
345793|NCT01149655|1167518|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
345794|NCT01149655|1167519|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
345795|NCT01149655|1167520|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
345796|NCT01149655|1167521|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
345797|NCT01149655|1167518|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
345798|NCT01149655|1167519|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
345799|NCT01149655|1167520|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
345800|NCT01149655|1167521|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
345801|NCT01149655|1167518|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
345802|NCT01149655|1167519|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
345803|NCT01149655|1167520|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
345804|NCT01149655|1167521|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
345805|NCT01149655|1167518|P4|Period 2-Stabilization Phase|Physician Decision|0
345806|NCT01149655|1167519|P3|Period 2-Stabilization Phase|Physician Decision|0
345807|NCT01149655|1167520|P2|Period 2-Stabilization Phase|Physician Decision|3
345808|NCT01149655|1167521|P1|Period 2-Stabilization Phase|Physician Decision|0
345809|NCT01149655|1167518|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
345810|NCT01149655|1167519|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
345811|NCT01149655|1167520|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
345812|NCT01149655|1167521|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
345813|NCT01149655|1167518|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
345814|NCT01149655|1167519|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
345815|NCT01149655|1167520|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
345816|NCT01149655|1167521|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
345817|NCT01149655|1167518|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
345818|NCT01149655|1167519|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
345819|NCT01149655|1167520|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
345820|NCT01149655|1167521|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
345821|NCT01149655|1167518|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
345822|NCT01149655|1167519|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
345823|NCT01149655|1167520|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
345824|NCT01149655|1167521|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
345825|NCT01149655|1167518|P4|Period 1 - Conversion Phase|Physician Decision|0
345826|NCT01149655|1167519|P3|Period 1 - Conversion Phase|Physician Decision|0
345827|NCT01149655|1167520|P2|Period 1 - Conversion Phase|Physician Decision|0
345828|NCT01149655|1167521|P1|Period 1 - Conversion Phase|Physician Decision|2
345829|NCT01149655|1167518|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
345830|NCT01149655|1167519|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
345831|NCT01149655|1167520|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
345832|NCT01149655|1167521|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
345833|NCT01149655|1167518|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
345834|NCT01149655|1167519|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
345835|NCT01149655|1167520|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
345836|NCT01149655|1167521|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
345837|NCT01149655|1167518|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
345838|NCT01149655|1167519|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
345839|NCT01149655|1167520|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
345840|NCT01149655|1167521|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
345841|NCT01149538|1167564|P2|Overall Study|Withdrawal by Subject|3
345842|NCT01149538|1167565|P1|Overall Study|Withdrawal by Subject|5
345843|NCT01149538|1167564|P2|Overall Study|Lost to Follow-up|1
345844|NCT01149538|1167565|P1|Overall Study|Lost to Follow-up|0
345845|NCT01149486|1167586|P2|First Intervention|Adverse Event|1
345846|NCT01149486|1167587|P1|First Intervention|Adverse Event|0
345847|NCT01149473|1167611|P2|Washout of 7 Days|Withdrawal by Subject|1
345848|NCT01149473|1167612|P1|Washout of 7 Days|Withdrawal by Subject|1
345849|NCT01149473|1167611|P2|First Intervention|Adverse Event|1
345850|NCT01149473|1167612|P1|First Intervention|Adverse Event|1
345851|NCT01149460|1167630|P2|Overall Study|Withdrawal by Subject|2
345852|NCT01149460|1167631|P1|Overall Study|Withdrawal by Subject|0
345853|NCT01149421|1167664|P3|Overall Study|Protocol Violation|6
345854|NCT01149421|1167665|P2|Overall Study|Protocol Violation|2
345855|NCT01149421|1167666|P1|Overall Study|Protocol Violation|2
345856|NCT01149421|1167664|P3|Overall Study|Entry Criteria Not Met|2
345857|NCT01149421|1167665|P2|Overall Study|Entry Criteria Not Met|1
345858|NCT01149421|1167666|P1|Overall Study|Entry Criteria Not Met|1
345859|NCT01149421|1167664|P3|Overall Study|Physician Decision|6
345860|NCT01149421|1167665|P2|Overall Study|Physician Decision|3
345861|NCT01149421|1167666|P1|Overall Study|Physician Decision|5
345862|NCT01149421|1167664|P3|Overall Study|Lost to Follow-up|5
345863|NCT01149421|1167665|P2|Overall Study|Lost to Follow-up|4
345864|NCT01149421|1167666|P1|Overall Study|Lost to Follow-up|2
345865|NCT01149421|1167664|P3|Overall Study|Sponsor Decision|1
345866|NCT01149421|1167665|P2|Overall Study|Sponsor Decision|1
345867|NCT01149421|1167666|P1|Overall Study|Sponsor Decision|0
345868|NCT01149421|1167664|P3|Overall Study|Withdrawal by Subject|13
345869|NCT01149421|1167665|P2|Overall Study|Withdrawal by Subject|12
345870|NCT01149421|1167666|P1|Overall Study|Withdrawal by Subject|20
345871|NCT01149421|1167664|P3|Overall Study|Adverse Event|11
345872|NCT01149421|1167665|P2|Overall Study|Adverse Event|6
345873|NCT01149421|1167666|P1|Overall Study|Adverse Event|22
345874|NCT01149148|1167747|P2|Overall Study|Death|0
345875|NCT01149148|1167748|P1|Overall Study|Death|1
345876|NCT01149148|1167747|P2|Overall Study|Lost to Follow-up|2
345877|NCT01149148|1167748|P1|Overall Study|Lost to Follow-up|1
345878|NCT01149057|1167756|P1|Overall Study|Other|6
345879|NCT01149057|1167756|P1|Overall Study|High Parathyroid Hormone Value|1
345880|NCT01149057|1167756|P1|Overall Study|Lost to Follow-up|1
345881|NCT01149057|1167756|P1|Overall Study|Participant Non-Compliance|2
345882|NCT01149057|1167756|P1|Overall Study|B Cell Depletion|4
345883|NCT01149057|1167756|P1|Overall Study|Positive Hepatitis B Core Antibody|5
345884|NCT01149057|1167756|P1|Overall Study|Withdrawal by Subject|9
345885|NCT01149057|1167756|P1|Overall Study|Adverse Event|13
345886|NCT01149057|1167756|P1|Overall Study|Lack of Efficacy|16
345887|NCT01148979|1167783|P2|Overall Study|Lost to Follow-up|1
345888|NCT01148979|1167784|P1|Overall Study|Lost to Follow-up|0
345889|NCT01148862|1167790|P2|Second Intervention|Withdrawal by Subject|2
345890|NCT01148862|1167791|P1|Second Intervention|Withdrawal by Subject|0
345891|NCT01148771|1167823|P2|Washout Period|Withdrawal by Subject|1
345892|NCT01148771|1167824|P1|Washout Period|Withdrawal by Subject|0
345893|NCT01148693|1167844|P2|Overall Study|Attempts for cannulation were failed|10
345894|NCT01148693|1167845|P1|Overall Study|Attempts for cannulation were failed|13
345895|NCT01148537|1167865|P3|Overall Study|Adverse Event|1
345896|NCT01148537|1167866|P2|Overall Study|Adverse Event|0
345897|NCT01148537|1167867|P1|Overall Study|Adverse Event|2
345898|NCT01148537|1167865|P3|Overall Study|Withdrawal by Subject|2
345899|NCT01148537|1167866|P2|Overall Study|Withdrawal by Subject|0
345900|NCT01148537|1167867|P1|Overall Study|Withdrawal by Subject|1
345901|NCT01148511|1167953|P3|Randomized|Not Specified|1
345902|NCT01148511|1167954|P2|Randomized|Not Specified|1
345903|NCT01148511|1167955|P1|Randomized|Not Specified|0
345904|NCT01148511|1167953|P3|Randomized|Consent withdrawal|3
345905|NCT01148511|1167954|P2|Randomized|Consent withdrawal|5
345906|NCT01148511|1167955|P1|Randomized|Consent withdrawal|0
345907|NCT01148511|1167953|P3|Randomized|Lost to Follow-up|1
345908|NCT01148511|1167954|P2|Randomized|Lost to Follow-up|1
345909|NCT01148511|1167955|P1|Randomized|Lost to Follow-up|0
345910|NCT01148511|1167953|P3|Randomized|Protocol Violation|1
345911|NCT01148511|1167954|P2|Randomized|Protocol Violation|2
345912|NCT01148511|1167955|P1|Randomized|Protocol Violation|0
345913|NCT01148511|1167953|P3|Randomized|Adverse Event|0
345914|NCT01148511|1167954|P2|Randomized|Adverse Event|1
345915|NCT01148511|1167955|P1|Randomized|Adverse Event|0
345916|NCT01148511|1167953|P3|Exposed to Study Drug|Lost to Follow-up|0
345917|NCT01148511|1167954|P2|Exposed to Study Drug|Lost to Follow-up|0
345918|NCT01148511|1167955|P1|Exposed to Study Drug|Lost to Follow-up|4
345919|NCT01148511|1167953|P3|Exposed to Study Drug|Protocol Violation|0
345920|NCT01148511|1167954|P2|Exposed to Study Drug|Protocol Violation|0
345921|NCT01148511|1167955|P1|Exposed to Study Drug|Protocol Violation|2
345922|NCT01148017|1167993|P4|Overall Study|Unable to classify|0
345923|NCT01148017|1167994|P3|Overall Study|Unable to classify|0
345924|NCT01148017|1167995|P2|Overall Study|Unable to classify|1
345925|NCT01148017|1167996|P1|Overall Study|Unable to classify|3
345926|NCT01148017|1167993|P4|Overall Study|Administrative reason|0
345927|NCT01148017|1167994|P3|Overall Study|Administrative reason|0
345928|NCT01148017|1167995|P2|Overall Study|Administrative reason|9
345929|NCT01148017|1167996|P1|Overall Study|Administrative reason|22
345930|NCT01148017|1167993|P4|Overall Study|Inappropriate enrollment|0
345931|NCT01148017|1167994|P3|Overall Study|Inappropriate enrollment|0
345932|NCT01148017|1167995|P2|Overall Study|Inappropriate enrollment|0
345933|NCT01148017|1167996|P1|Overall Study|Inappropriate enrollment|1
345934|NCT01148017|1167993|P4|Overall Study|Lost to Follow-up|0
345935|NCT01148017|1167994|P3|Overall Study|Lost to Follow-up|0
345936|NCT01148017|1167995|P2|Overall Study|Lost to Follow-up|10
345937|NCT01148017|1167996|P1|Overall Study|Lost to Follow-up|23
345938|NCT01148017|1167993|P4|Overall Study|Withdrawal by Subject|0
345939|NCT01148017|1167994|P3|Overall Study|Withdrawal by Subject|0
345940|NCT01148017|1167995|P2|Overall Study|Withdrawal by Subject|14
345941|NCT01148017|1167996|P1|Overall Study|Withdrawal by Subject|31
345942|NCT01147926|1168035|P2|Overall Study|Colonoscopy result|1
345943|NCT01147926|1168036|P1|Overall Study|Colonoscopy result|0
345944|NCT01147926|1168035|P2|Overall Study|Went on holiday|1
345945|NCT01147926|1168036|P1|Overall Study|Went on holiday|0
345946|NCT01147926|1168035|P2|Overall Study|Too busy, no time for study|0
345947|NCT01147926|1168036|P1|Overall Study|Too busy, no time for study|1
345948|NCT01147926|1168035|P2|Overall Study|Lack of Efficacy|0
345949|NCT01147926|1168036|P1|Overall Study|Lack of Efficacy|1
345950|NCT01147926|1168035|P2|Overall Study|Sponsor's Decision|1
345951|NCT01147926|1168036|P1|Overall Study|Sponsor's Decision|0
345952|NCT01147926|1168035|P2|Overall Study|Lost to Follow-up|2
345953|NCT01147926|1168036|P1|Overall Study|Lost to Follow-up|0
345954|NCT01147926|1168035|P2|Overall Study|Selection criteria not met|1
345955|NCT01147926|1168036|P1|Overall Study|Selection criteria not met|3
345956|NCT01147926|1168035|P2|Overall Study|Principal investigator left hospital|3
345957|NCT01147926|1168036|P1|Overall Study|Principal investigator left hospital|1
345958|NCT01147926|1168035|P2|Overall Study|Subject Non-Compliant|4
345959|NCT01147926|1168036|P1|Overall Study|Subject Non-Compliant|5
345960|NCT01147926|1168035|P2|Overall Study|Adverse Event|6
345961|NCT01147926|1168036|P1|Overall Study|Adverse Event|7
345962|NCT01147926|1168035|P2|Overall Study|Subject Withdrew Consent|10
345963|NCT01147926|1168036|P1|Overall Study|Subject Withdrew Consent|9
345964|NCT01147900|1168071|P3|At Year 10|Lost to Follow-up|0
345965|NCT01147900|1168072|P2|At Year 10|Lost to Follow-up|1
345966|NCT01147900|1168073|P1|At Year 10|Lost to Follow-up|0
345967|NCT01147874|1168132|P1|Overall Study|Withdrawal by Subject|24
345968|NCT01147874|1168132|P1|Overall Study|Sponsor's Decision|2
345969|NCT01147874|1168132|P1|Overall Study|Protocol Violation|5
345970|NCT01147874|1168132|P1|Overall Study|Other|5
345971|NCT01147874|1168132|P1|Overall Study|Lost to Follow-up|25
345972|NCT01147874|1168132|P1|Overall Study|Investigator’s Request|1
345973|NCT01147874|1168132|P1|Overall Study|Adverse Event|5
345974|NCT01147848|1168140|P3|Randomized Phase|Withdrawal by Subject|9
345975|NCT01147848|1168141|P2|Randomized Phase|Withdrawal by Subject|7
345976|NCT01147848|1168142|P1|Randomized Phase|Withdrawal by Subject|0
345977|NCT01147848|1168140|P3|Randomized Phase|Physician Decision|1
345978|NCT01147848|1168141|P2|Randomized Phase|Physician Decision|0
345979|NCT01147848|1168142|P1|Randomized Phase|Physician Decision|0
345980|NCT01147848|1168140|P3|Randomized Phase|Lost to Follow-up|7
345981|NCT01147848|1168141|P2|Randomized Phase|Lost to Follow-up|5
345982|NCT01147848|1168142|P1|Randomized Phase|Lost to Follow-up|0
345983|NCT01147848|1168140|P3|Randomized Phase|Protocol Violation|10
345984|NCT01147848|1168141|P2|Randomized Phase|Protocol Violation|7
345985|NCT01147848|1168142|P1|Randomized Phase|Protocol Violation|0
345986|NCT01147848|1168140|P3|Randomized Phase|Lack of Efficacy|11
345987|NCT01147848|1168141|P2|Randomized Phase|Lack of Efficacy|20
345988|NCT01147848|1168142|P1|Randomized Phase|Lack of Efficacy|0
345989|NCT01147848|1168140|P3|Randomized Phase|Adverse Event|8
345990|NCT01147848|1168141|P2|Randomized Phase|Adverse Event|6
345991|NCT01147848|1168142|P1|Randomized Phase|Adverse Event|0
345992|NCT01147848|1168140|P3|Run-in Period|Run-in Failure|0
345993|NCT01147848|1168141|P2|Run-in Period|Run-in Failure|0
345994|NCT01147848|1168142|P1|Run-in Period|Run-in Failure|135
345995|NCT01147848|1168140|P3|Run-in Period|Screen Failure|0
345996|NCT01147848|1168141|P2|Run-in Period|Screen Failure|0
345997|NCT01147848|1168142|P1|Run-in Period|Screen Failure|623
345998|NCT01147822|1168174|P2|Overall Study|Not Completed/Ongoing|102
345999|NCT01147822|1168175|P1|Overall Study|Not Completed/Ongoing|111
346000|NCT01147822|1168174|P2|Overall Study|Withdrawal by Subject|13
346001|NCT01147822|1168175|P1|Overall Study|Withdrawal by Subject|8
346002|NCT01147822|1168174|P2|Overall Study|Physician Decision|2
346003|NCT01147822|1168175|P1|Overall Study|Physician Decision|0
346004|NCT01147822|1168174|P2|Overall Study|Lost to Follow-up|2
346005|NCT01147822|1168175|P1|Overall Study|Lost to Follow-up|3
346006|NCT01147822|1168174|P2|Overall Study|Protocol Violation|1
346007|NCT01147822|1168175|P1|Overall Study|Protocol Violation|0
346008|NCT01147822|1168174|P2|Overall Study|Death|59
346009|NCT01147822|1168175|P1|Overall Study|Death|66
346010|NCT01147809|1168195|P6|Phase II (168 Days)|Ongoing|0
346011|NCT01147809|1168196|P5|Phase II (168 Days)|Ongoing|1
346012|NCT01147809|1168197|P4|Phase II (168 Days)|Ongoing|0
346013|NCT01147809|1168198|P3|Phase II (168 Days)|Ongoing|0
346014|NCT01147809|1168199|P2|Phase II (168 Days)|Ongoing|0
346015|NCT01147809|1168200|P1|Phase II (168 Days)|Ongoing|0
346016|NCT01147809|1168195|P6|Phase II (168 Days)|Withdrawal by Subject|15
346017|NCT01147809|1168196|P5|Phase II (168 Days)|Withdrawal by Subject|7
346018|NCT01147809|1168197|P4|Phase II (168 Days)|Withdrawal by Subject|0
346019|NCT01147809|1168198|P3|Phase II (168 Days)|Withdrawal by Subject|0
346020|NCT01147809|1168199|P2|Phase II (168 Days)|Withdrawal by Subject|0
346021|NCT01147809|1168200|P1|Phase II (168 Days)|Withdrawal by Subject|0
346022|NCT01147809|1168195|P6|Phase II (168 Days)|Physician Decision|11
346023|NCT01147809|1168196|P5|Phase II (168 Days)|Physician Decision|5
346024|NCT01147809|1168197|P4|Phase II (168 Days)|Physician Decision|0
346025|NCT01147809|1168198|P3|Phase II (168 Days)|Physician Decision|0
346026|NCT01147809|1168199|P2|Phase II (168 Days)|Physician Decision|0
346027|NCT01147809|1168200|P1|Phase II (168 Days)|Physician Decision|0
346028|NCT01147809|1168195|P6|Phase II (168 Days)|Protocol Violation|1
346029|NCT01147809|1168196|P5|Phase II (168 Days)|Protocol Violation|0
346030|NCT01147809|1168197|P4|Phase II (168 Days)|Protocol Violation|0
346031|NCT01147809|1168198|P3|Phase II (168 Days)|Protocol Violation|0
346032|NCT01147809|1168199|P2|Phase II (168 Days)|Protocol Violation|0
346033|NCT01147809|1168200|P1|Phase II (168 Days)|Protocol Violation|0
346034|NCT01147809|1168195|P6|Phase II (168 Days)|Adverse Event|6
346035|NCT01147809|1168196|P5|Phase II (168 Days)|Adverse Event|3
346036|NCT01147809|1168197|P4|Phase II (168 Days)|Adverse Event|0
346037|NCT01147809|1168198|P3|Phase II (168 Days)|Adverse Event|0
346038|NCT01147809|1168199|P2|Phase II (168 Days)|Adverse Event|0
346039|NCT01147809|1168200|P1|Phase II (168 Days)|Adverse Event|0
346040|NCT01147809|1168195|P6|Phase I (168 Days)|Withdrawal by Subject|0
346041|NCT01147809|1168196|P5|Phase I (168 Days)|Withdrawal by Subject|0
346042|NCT01147809|1168197|P4|Phase I (168 Days)|Withdrawal by Subject|3
346043|NCT01147809|1168198|P3|Phase I (168 Days)|Withdrawal by Subject|0
346044|NCT01147809|1168199|P2|Phase I (168 Days)|Withdrawal by Subject|0
346045|NCT01147809|1168200|P1|Phase I (168 Days)|Withdrawal by Subject|0
346046|NCT01147809|1168195|P6|Phase I (168 Days)|Physician Decision|0
346047|NCT01147809|1168196|P5|Phase I (168 Days)|Physician Decision|0
346048|NCT01147809|1168197|P4|Phase I (168 Days)|Physician Decision|0
346049|NCT01147809|1168198|P3|Phase I (168 Days)|Physician Decision|2
346050|NCT01147809|1168199|P2|Phase I (168 Days)|Physician Decision|1
346051|NCT01147809|1168200|P1|Phase I (168 Days)|Physician Decision|0
346052|NCT01147809|1168195|P6|Phase I (168 Days)|Lost to Follow-up|0
346053|NCT01147809|1168196|P5|Phase I (168 Days)|Lost to Follow-up|0
346054|NCT01147809|1168197|P4|Phase I (168 Days)|Lost to Follow-up|1
346055|NCT01147809|1168198|P3|Phase I (168 Days)|Lost to Follow-up|0
346056|NCT01147809|1168199|P2|Phase I (168 Days)|Lost to Follow-up|0
346057|NCT01147809|1168200|P1|Phase I (168 Days)|Lost to Follow-up|1
346058|NCT01147809|1168195|P6|Phase I (168 Days)|Adverse Event|0
346059|NCT01147809|1168196|P5|Phase I (168 Days)|Adverse Event|0
346060|NCT01147809|1168197|P4|Phase I (168 Days)|Adverse Event|1
346061|NCT01147809|1168198|P3|Phase I (168 Days)|Adverse Event|0
346062|NCT01147809|1168199|P2|Phase I (168 Days)|Adverse Event|0
346063|NCT01147809|1168200|P1|Phase I (168 Days)|Adverse Event|0
346064|NCT01147744|1168321|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
346065|NCT01147744|1168322|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
346066|NCT01147744|1168323|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
346067|NCT01147744|1168324|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
346068|NCT01147744|1168325|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
346069|NCT01147744|1168326|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
346070|NCT01147744|1168327|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
346071|NCT01147744|1168321|P7|Overall Study|Sponsor decision to amend protocol|6
346072|NCT01147744|1168322|P6|Overall Study|Sponsor decision to amend protocol|2
346073|NCT01147744|1168323|P5|Overall Study|Sponsor decision to amend protocol|7
346074|NCT01147744|1168324|P4|Overall Study|Sponsor decision to amend protocol|5
346075|NCT01147744|1168325|P3|Overall Study|Sponsor decision to amend protocol|2
346076|NCT01147744|1168326|P2|Overall Study|Sponsor decision to amend protocol|4
346077|NCT01147744|1168327|P1|Overall Study|Sponsor decision to amend protocol|7
346078|NCT01147744|1168321|P7|Overall Study|Lost to Follow-up|0
346079|NCT01147744|1168322|P6|Overall Study|Lost to Follow-up|0
346080|NCT01147744|1168323|P5|Overall Study|Lost to Follow-up|0
346081|NCT01147744|1168324|P4|Overall Study|Lost to Follow-up|0
346082|NCT01147744|1168325|P3|Overall Study|Lost to Follow-up|0
346083|NCT01147744|1168326|P2|Overall Study|Lost to Follow-up|1
346084|NCT01147744|1168327|P1|Overall Study|Lost to Follow-up|0
346085|NCT01147744|1168321|P7|Overall Study|Withdrawal by Subject|2
346086|NCT01147744|1168322|P6|Overall Study|Withdrawal by Subject|5
346087|NCT01147744|1168323|P5|Overall Study|Withdrawal by Subject|2
346088|NCT01147744|1168324|P4|Overall Study|Withdrawal by Subject|2
346089|NCT01147744|1168325|P3|Overall Study|Withdrawal by Subject|2
346090|NCT01147744|1168326|P2|Overall Study|Withdrawal by Subject|4
346091|NCT01147744|1168327|P1|Overall Study|Withdrawal by Subject|8
346092|NCT01147744|1168321|P7|Overall Study|Adverse Event|2
346093|NCT01147744|1168322|P6|Overall Study|Adverse Event|1
346094|NCT01147744|1168323|P5|Overall Study|Adverse Event|2
346095|NCT01147744|1168324|P4|Overall Study|Adverse Event|0
346096|NCT01147744|1168325|P3|Overall Study|Adverse Event|3
346097|NCT01147744|1168326|P2|Overall Study|Adverse Event|2
346098|NCT01147744|1168327|P1|Overall Study|Adverse Event|1
346099|NCT01147744|1168321|P7|Overall Study|Lack of Efficacy|7
346100|NCT01147744|1168322|P6|Overall Study|Lack of Efficacy|8
346101|NCT01147744|1168323|P5|Overall Study|Lack of Efficacy|13
346102|NCT01147744|1168324|P4|Overall Study|Lack of Efficacy|11
346103|NCT01147744|1168325|P3|Overall Study|Lack of Efficacy|9
346104|NCT01147744|1168326|P2|Overall Study|Lack of Efficacy|11
346105|NCT01147744|1168327|P1|Overall Study|Lack of Efficacy|11
346106|NCT01147744|1168321|P7|Overall Study|Physician Decision|1
346107|NCT01147744|1168322|P6|Overall Study|Physician Decision|0
346108|NCT01147744|1168323|P5|Overall Study|Physician Decision|0
346109|NCT01147744|1168324|P4|Overall Study|Physician Decision|0
346110|NCT01147744|1168325|P3|Overall Study|Physician Decision|1
346111|NCT01147744|1168326|P2|Overall Study|Physician Decision|1
346112|NCT01147744|1168327|P1|Overall Study|Physician Decision|0
346113|NCT01147744|1168321|P7|Overall Study|Protocol Violation|1
346114|NCT01147744|1168322|P6|Overall Study|Protocol Violation|3
346115|NCT01147744|1168323|P5|Overall Study|Protocol Violation|1
346116|NCT01147744|1168324|P4|Overall Study|Protocol Violation|0
346117|NCT01147744|1168325|P3|Overall Study|Protocol Violation|1
346118|NCT01147744|1168326|P2|Overall Study|Protocol Violation|0
346119|NCT01147744|1168327|P1|Overall Study|Protocol Violation|1
346120|NCT01147653|1168422|P2|Year 2|Withdrawal by Subject|3
346121|NCT01147653|1168423|P1|Year 2|Withdrawal by Subject|2
346122|NCT01147640|1168484|P2|Overall Study|Didn't meet eligibility criteria|0
346123|NCT01147640|1168485|P1|Overall Study|Didn't meet eligibility criteria|1
346124|NCT01147640|1168484|P2|Overall Study|Lost to Follow-up|1
346125|NCT01147640|1168485|P1|Overall Study|Lost to Follow-up|0
346126|NCT01147640|1168484|P2|Overall Study|Withdrawal by Subject|0
346127|NCT01147640|1168485|P1|Overall Study|Withdrawal by Subject|1
346128|NCT01147640|1168484|P2|Overall Study|Physician Decision|0
346129|NCT01147640|1168485|P1|Overall Study|Physician Decision|1
346130|NCT01147640|1168484|P2|Overall Study|Adverse Event|0
346131|NCT01147640|1168485|P1|Overall Study|Adverse Event|2
346132|NCT01147497|1168517|P2|Overall Study|failed insertion|0
346133|NCT01147497|1168518|P1|Overall Study|failed insertion|2
346134|NCT01147471|1168538|P2|6 Month Follow Up|Lost to Follow-up|2
346135|NCT01147471|1168539|P1|6 Month Follow Up|Lost to Follow-up|4
346136|NCT01147471|1168538|P2|3 Month Follow Up|Physician Decision|1
346137|NCT01147471|1168539|P1|3 Month Follow Up|Physician Decision|0
346138|NCT01147471|1168538|P2|3 Month Follow Up|Lost to Follow-up|1
346139|NCT01147471|1168539|P1|3 Month Follow Up|Lost to Follow-up|1
346140|NCT01147471|1168538|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
346141|NCT01147471|1168539|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
346142|NCT01147471|1168538|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
346143|NCT01147471|1168539|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
346144|NCT01147471|1168538|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
346145|NCT01147471|1168539|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
346146|NCT01147458|1168553|P4|Second Intervention|Other|0
346147|NCT01147458|1168554|P3|Second Intervention|Other|1
346148|NCT01147458|1168555|P2|Second Intervention|Other|0
346149|NCT01147458|1168556|P1|Second Intervention|Other|0
346150|NCT01147458|1168553|P4|Second Intervention|Adverse Event|1
346151|NCT01147458|1168554|P3|Second Intervention|Adverse Event|1
346152|NCT01147458|1168555|P2|Second Intervention|Adverse Event|0
346153|NCT01147458|1168556|P1|Second Intervention|Adverse Event|2
346154|NCT01147458|1168553|P4|Second Intervention|Withdrawal by Subject|0
346155|NCT01147458|1168554|P3|Second Intervention|Withdrawal by Subject|0
346156|NCT01147458|1168555|P2|Second Intervention|Withdrawal by Subject|1
346157|NCT01147458|1168556|P1|Second Intervention|Withdrawal by Subject|0
346158|NCT01147458|1168553|P4|Second Intervention|Protocol Violation|0
346159|NCT01147458|1168554|P3|Second Intervention|Protocol Violation|1
346160|NCT01147458|1168555|P2|Second Intervention|Protocol Violation|1
346161|NCT01147458|1168556|P1|Second Intervention|Protocol Violation|0
346162|NCT01147458|1168553|P4|Second Intervention|Study terminated by sponsor|3
346163|NCT01147458|1168554|P3|Second Intervention|Study terminated by sponsor|5
346164|NCT01147458|1168555|P2|Second Intervention|Study terminated by sponsor|5
346165|NCT01147458|1168556|P1|Second Intervention|Study terminated by sponsor|7
346166|NCT01147458|1168553|P4|First Intervention|Other|0
346167|NCT01147458|1168554|P3|First Intervention|Other|0
346168|NCT01147458|1168555|P2|First Intervention|Other|2
346169|NCT01147458|1168556|P1|First Intervention|Other|1
346170|NCT01147458|1168553|P4|First Intervention|Adverse Event|3
346171|NCT01147458|1168554|P3|First Intervention|Adverse Event|2
346172|NCT01147458|1168555|P2|First Intervention|Adverse Event|3
346173|NCT01147458|1168556|P1|First Intervention|Adverse Event|0
346174|NCT01147458|1168553|P4|First Intervention|Withdrawal by Subject|0
346175|NCT01147458|1168554|P3|First Intervention|Withdrawal by Subject|1
346176|NCT01147458|1168555|P2|First Intervention|Withdrawal by Subject|0
346177|NCT01147458|1168556|P1|First Intervention|Withdrawal by Subject|3
346178|NCT01147458|1168553|P4|First Intervention|Protocol Violation|3
346179|NCT01147458|1168554|P3|First Intervention|Protocol Violation|2
346180|NCT01147458|1168555|P2|First Intervention|Protocol Violation|3
346181|NCT01147458|1168556|P1|First Intervention|Protocol Violation|2
346182|NCT01147458|1168553|P4|First Intervention|Study terminated by sponsor|8
346183|NCT01147458|1168554|P3|First Intervention|Study terminated by sponsor|7
346184|NCT01147458|1168555|P2|First Intervention|Study terminated by sponsor|8
346185|NCT01147458|1168556|P1|First Intervention|Study terminated by sponsor|8
346186|NCT01147393|1168635|P1|Dose Level -1|Dose Limited Toxicity|1
346187|NCT01147393|1168635|P1|Dose Level 1|Dose limiting Toxicity|2
346188|NCT01147341|1168656|P2|Open Label Period|Subject moved|0
346189|NCT01147341|1168657|P1|Open Label Period|Subject moved|1
346190|NCT01147341|1168656|P2|Open Label Period|Lack of Efficacy|0
346191|NCT01147341|1168657|P1|Open Label Period|Lack of Efficacy|3
346192|NCT01147341|1168656|P2|Double Blind Period|Withdrawal by Subject|1
346193|NCT01147341|1168657|P1|Double Blind Period|Withdrawal by Subject|0
346194|NCT01147341|1168656|P2|Double Blind Period|Lack of Efficacy|1
346195|NCT01147341|1168657|P1|Double Blind Period|Lack of Efficacy|1
346196|NCT01147250|1168720|P2|Overall Study|Other than specified|1
346197|NCT01147250|1168721|P1|Overall Study|Other than specified|0
346198|NCT01147250|1168720|P2|Overall Study|Site termination by sponsor|5
346199|NCT01147250|1168721|P1|Overall Study|Site termination by sponsor|13
346200|NCT01147250|1168720|P2|Overall Study|Withdrawal by Subject|88
346201|NCT01147250|1168721|P1|Overall Study|Withdrawal by Subject|83
346202|NCT01147250|1168720|P2|Overall Study|Lost to Follow-up|11
346203|NCT01147250|1168721|P1|Overall Study|Lost to Follow-up|14
346204|NCT01147172|1168733|P1|Overall Study|Lost to Follow-up|2
346205|NCT01147172|1168733|P1|Overall Study|Withdrawal by Subject|2
346206|NCT01147068|1168751|P7|Subjects That Completed Safety Follow-up|Ineligible|0
346207|NCT01147068|1168752|P6|Subjects That Completed Safety Follow-up|Ineligible|0
346208|NCT01147068|1168753|P5|Subjects That Completed Safety Follow-up|Ineligible|0
346209|NCT01147068|1168754|P4|Subjects That Completed Safety Follow-up|Ineligible|0
346210|NCT01147068|1168755|P3|Subjects That Completed Safety Follow-up|Ineligible|0
346211|NCT01147068|1168756|P2|Subjects That Completed Safety Follow-up|Ineligible|1
346212|NCT01147068|1168757|P1|Subjects That Completed Safety Follow-up|Ineligible|0
346213|NCT01147068|1168751|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
346214|NCT01147068|1168752|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
346215|NCT01147068|1168753|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
346216|NCT01147068|1168754|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
346217|NCT01147068|1168755|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
346218|NCT01147068|1168756|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
346219|NCT01147068|1168757|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
346220|NCT01147068|1168751|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
346221|NCT01147068|1168752|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
346222|NCT01147068|1168753|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
346223|NCT01147068|1168754|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
346224|NCT01147068|1168755|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
346225|NCT01147068|1168756|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
346226|NCT01147068|1168757|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
346227|NCT01147068|1168751|P7|Subjects That Received 2nd Dose|Other|0
346228|NCT01147068|1168752|P6|Subjects That Received 2nd Dose|Other|0
346229|NCT01147068|1168753|P5|Subjects That Received 2nd Dose|Other|1
346230|NCT01147068|1168754|P4|Subjects That Received 2nd Dose|Other|0
346231|NCT01147068|1168755|P3|Subjects That Received 2nd Dose|Other|3
346232|NCT01147068|1168756|P2|Subjects That Received 2nd Dose|Other|3
346233|NCT01147068|1168757|P1|Subjects That Received 2nd Dose|Other|0
346234|NCT01147068|1168751|P7|Subjects That Received 2nd Dose|Did not complete the study|0
346235|NCT01147068|1168752|P6|Subjects That Received 2nd Dose|Did not complete the study|1
346236|NCT01147068|1168753|P5|Subjects That Received 2nd Dose|Did not complete the study|0
346237|NCT01147068|1168754|P4|Subjects That Received 2nd Dose|Did not complete the study|0
346238|NCT01147068|1168755|P3|Subjects That Received 2nd Dose|Did not complete the study|0
346239|NCT01147068|1168756|P2|Subjects That Received 2nd Dose|Did not complete the study|1
346240|NCT01147068|1168757|P1|Subjects That Received 2nd Dose|Did not complete the study|0
346241|NCT01147068|1168751|P7|Subjects That Received 2nd Dose|Ineligible|0
346242|NCT01147068|1168752|P6|Subjects That Received 2nd Dose|Ineligible|0
346243|NCT01147068|1168753|P5|Subjects That Received 2nd Dose|Ineligible|0
346244|NCT01147068|1168754|P4|Subjects That Received 2nd Dose|Ineligible|0
346245|NCT01147068|1168755|P3|Subjects That Received 2nd Dose|Ineligible|0
346246|NCT01147068|1168756|P2|Subjects That Received 2nd Dose|Ineligible|1
346247|NCT01147068|1168757|P1|Subjects That Received 2nd Dose|Ineligible|0
346248|NCT01147068|1168751|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
346249|NCT01147068|1168752|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
346250|NCT01147068|1168753|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
346251|NCT01147068|1168754|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
346252|NCT01147068|1168755|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
346253|NCT01147068|1168756|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
346254|NCT01147068|1168757|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
346255|NCT01147055|1168787|P2|First Intervention Period|Lost to Follow-up|0
346256|NCT01147055|1168788|P1|First Intervention Period|Lost to Follow-up|1
346257|NCT01146951|1168830|P2|Overall Study|Adverse Event|1
346258|NCT01146951|1168831|P1|Overall Study|Adverse Event|4
346259|NCT01146912|1168852|P8|Overall Study|Duplicate patient|0
346260|NCT01146912|1168853|P7|Overall Study|Duplicate patient|0
346261|NCT01146912|1168854|P6|Overall Study|Duplicate patient|0
346262|NCT01146912|1168855|P5|Overall Study|Duplicate patient|0
346263|NCT01146912|1168856|P4|Overall Study|Duplicate patient|0
346264|NCT01146912|1168857|P3|Overall Study|Duplicate patient|1
346265|NCT01146912|1168858|P2|Overall Study|Duplicate patient|0
346266|NCT01146912|1168859|P1|Overall Study|Duplicate patient|0
346267|NCT01146912|1168852|P8|Overall Study|< 14 weeks gestational age|0
346268|NCT01146912|1168853|P7|Overall Study|< 14 weeks gestational age|0
346269|NCT01146912|1168854|P6|Overall Study|< 14 weeks gestational age|0
346270|NCT01146912|1168855|P5|Overall Study|< 14 weeks gestational age|0
346271|NCT01146912|1168856|P4|Overall Study|< 14 weeks gestational age|2
346272|NCT01146912|1168857|P3|Overall Study|< 14 weeks gestational age|3
346273|NCT01146912|1168858|P2|Overall Study|< 14 weeks gestational age|0
346274|NCT01146912|1168859|P1|Overall Study|< 14 weeks gestational age|0
346275|NCT01146912|1168852|P8|Overall Study|Already received influenza vaccination|0
346276|NCT01146912|1168853|P7|Overall Study|Already received influenza vaccination|56
346277|NCT01146912|1168854|P6|Overall Study|Already received influenza vaccination|61
346278|NCT01146912|1168855|P5|Overall Study|Already received influenza vaccination|41
346279|NCT01146912|1168856|P4|Overall Study|Already received influenza vaccination|15
346280|NCT01146912|1168857|P3|Overall Study|Already received influenza vaccination|13
346281|NCT01146912|1168858|P2|Overall Study|Already received influenza vaccination|822
346282|NCT01146912|1168859|P1|Overall Study|Already received influenza vaccination|817
346283|NCT01146873|1168881|P2|Overall Study|Transfer out|6
346284|NCT01146873|1168882|P1|Overall Study|Transfer out|0
346285|NCT01146860|1168898|P2|Overall Study|Withdrawal by Subject|1
346286|NCT01146860|1168899|P1|Overall Study|Withdrawal by Subject|0
346287|NCT01146782|1168919|P1|Primary Endpoint Cohort|Physician Decision|1
346288|NCT01146782|1168919|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
346289|NCT01146782|1168919|P1|Safety Cohort|TST <4 hrs|14
346290|NCT01146782|1168919|P1|Safety Cohort|Control AHI <5|4
346291|NCT01146782|1168919|P1|Safety Cohort|Withdrawal by Subject|4
346292|NCT01146782|1168919|P1|Safety Cohort|Screen Failure|61
346293|NCT01146782|1168919|P1|Screening Cohort|Withdrawal by Subject|29
346294|NCT01146782|1168919|P1|Screening Cohort|Physician Decision|1
346295|NCT01146782|1168919|P1|Screening Cohort|Lost to Follow-up|4
346296|NCT01146782|1168919|P1|Screening Cohort|Screen Failure|187
346297|NCT01146613|1168928|P2|Overall Study|Outpatient detox|0
346298|NCT01146613|1168929|P1|Overall Study|Outpatient detox|1
346299|NCT01146613|1168928|P2|Overall Study|schedule conflict|0
346300|NCT01146613|1168929|P1|Overall Study|schedule conflict|1
346301|NCT01146613|1168928|P2|Overall Study|Withdrawal by Subject|3
346302|NCT01146613|1168929|P1|Overall Study|Withdrawal by Subject|0
346303|NCT01146613|1168928|P2|Overall Study|Physician Decision|0
346304|NCT01146613|1168929|P1|Overall Study|Physician Decision|1
346305|NCT01146613|1168928|P2|Overall Study|Death|0
346306|NCT01146613|1168929|P1|Overall Study|Death|1
346307|NCT01146613|1168928|P2|Overall Study|Lack of Efficacy|1
346308|NCT01146613|1168929|P1|Overall Study|Lack of Efficacy|0
346309|NCT01146613|1168928|P2|Overall Study|Lost to Follow-up|8
346310|NCT01146613|1168929|P1|Overall Study|Lost to Follow-up|3
346311|NCT01146288|1169020|P2|First Intervention(1 Day)|Adverse Event|1
346312|NCT01146288|1169021|P1|First Intervention(1 Day)|Adverse Event|0
346313|NCT01146054|1169035|P1|Overall Study|Lost to Follow-up|1
346314|NCT01146054|1169035|P1|Overall Study|Other illness precluded treatment|2
346315|NCT01146054|1169035|P1|Overall Study|Rapid tumor progression|2
346316|NCT01146054|1169035|P1|Overall Study|Did not meet dose constraints for SBRT|5
346317|NCT01145898|1169045|P2|3-year Treatment|medication change by treating physician|16
346318|NCT01145898|1169046|P1|3-year Treatment|medication change by treating physician|3
346319|NCT01145755|1169080|P3|Overall Study|Positive urine ethanol|0
346320|NCT01145755|1169081|P2|Overall Study|Positive urine ethanol|1
346321|NCT01145755|1169082|P1|Overall Study|Positive urine ethanol|0
346322|NCT01145755|1169080|P3|Overall Study|Withdrawal by Subject|1
346323|NCT01145755|1169081|P2|Overall Study|Withdrawal by Subject|0
346324|NCT01145755|1169082|P1|Overall Study|Withdrawal by Subject|0
346325|NCT01145755|1169080|P3|Overall Study|Patient could not swollow medication|1
346326|NCT01145755|1169081|P2|Overall Study|Patient could not swollow medication|0
346327|NCT01145755|1169082|P1|Overall Study|Patient could not swollow medication|0
346328|NCT01145755|1169080|P3|Overall Study|Lack of Efficacy|0
346329|NCT01145755|1169081|P2|Overall Study|Lack of Efficacy|1
346330|NCT01145755|1169082|P1|Overall Study|Lack of Efficacy|0
346331|NCT01145755|1169080|P3|Overall Study|Study Closure|17
346332|NCT01145755|1169081|P2|Overall Study|Study Closure|14
346333|NCT01145755|1169082|P1|Overall Study|Study Closure|14
346334|NCT01145755|1169080|P3|Overall Study|Protocol Violation|1
346335|NCT01145755|1169081|P2|Overall Study|Protocol Violation|3
346336|NCT01145755|1169082|P1|Overall Study|Protocol Violation|0
346337|NCT01145755|1169080|P3|Overall Study|Lost to Follow-up|1
346338|NCT01145755|1169081|P2|Overall Study|Lost to Follow-up|3
346339|NCT01145755|1169082|P1|Overall Study|Lost to Follow-up|2
346340|NCT01145755|1169080|P3|Overall Study|Withdrawal by Subject|2
346341|NCT01145755|1169081|P2|Overall Study|Withdrawal by Subject|2
346342|NCT01145755|1169082|P1|Overall Study|Withdrawal by Subject|2
346343|NCT01145755|1169080|P3|Overall Study|Adverse Event|2
346344|NCT01145755|1169081|P2|Overall Study|Adverse Event|4
346345|NCT01145755|1169082|P1|Overall Study|Adverse Event|2
346346|NCT01145625|1169109|P2|Overall Study|Pregnancy|1
346347|NCT01145625|1169110|P1|Overall Study|Pregnancy|0
346348|NCT01145625|1169109|P2|Overall Study|Withdrawal by Subject|16
346349|NCT01145625|1169110|P1|Overall Study|Withdrawal by Subject|7
346350|NCT01145625|1169109|P2|Overall Study|Protocol Violation|1
346351|NCT01145625|1169110|P1|Overall Study|Protocol Violation|3
346352|NCT01145625|1169109|P2|Overall Study|Adverse Event|4
346353|NCT01145625|1169110|P1|Overall Study|Adverse Event|6
346354|NCT01145625|1169109|P2|Overall Study|Lost to Follow-up|9
346355|NCT01145625|1169110|P1|Overall Study|Lost to Follow-up|8
346356|NCT01145560|1169123|P3|Overall Study|Withdrawal of therapy|1
346357|NCT01145560|1169124|P2|Overall Study|Withdrawal of therapy|0
346358|NCT01145560|1169125|P1|Overall Study|Withdrawal of therapy|0
346359|NCT01145560|1169123|P3|Overall Study|False insurance information|0
346360|NCT01145560|1169124|P2|Overall Study|False insurance information|1
346361|NCT01145560|1169125|P1|Overall Study|False insurance information|0
346362|NCT01145560|1169123|P3|Overall Study|Accidental unblinding of study treatment|0
346363|NCT01145560|1169124|P2|Overall Study|Accidental unblinding of study treatment|1
346364|NCT01145560|1169125|P1|Overall Study|Accidental unblinding of study treatment|0
346365|NCT01145560|1169123|P3|Overall Study|No study drug by 24h after organ failure|0
346366|NCT01145560|1169124|P2|Overall Study|No study drug by 24h after organ failure|0
346367|NCT01145560|1169125|P1|Overall Study|No study drug by 24h after organ failure|1
346368|NCT01145560|1169123|P3|Overall Study|Lost to Follow-up|1
346369|NCT01145560|1169124|P2|Overall Study|Lost to Follow-up|1
346370|NCT01145560|1169125|P1|Overall Study|Lost to Follow-up|1
346371|NCT01145560|1169123|P3|Overall Study|Withdrawal by Subject|0
346372|NCT01145560|1169124|P2|Overall Study|Withdrawal by Subject|1
346373|NCT01145560|1169125|P1|Overall Study|Withdrawal by Subject|2
346374|NCT01145508|1169151|P2|Overall Study|Never started treatment|1
346375|NCT01145508|1169152|P1|Overall Study|Never started treatment|1
346376|NCT01145508|1169151|P2|Overall Study|Physician Decision|1
346377|NCT01145508|1169152|P1|Overall Study|Physician Decision|2
346378|NCT01145508|1169151|P2|Overall Study|Death|0
346379|NCT01145508|1169152|P1|Overall Study|Death|1
346380|NCT01145508|1169151|P2|Overall Study|Adverse Event|0
346381|NCT01145508|1169152|P1|Overall Study|Adverse Event|1
346382|NCT01145495|1169158|P1|Overall Study|Disease progression after respone|1
346383|NCT01145495|1169158|P1|Overall Study|Withdrawal by Subject|5
346384|NCT01145495|1169158|P1|Overall Study|Adverse Event|6
346385|NCT01145482|1169164|P2|First Intervention (1 Day)|Withdrawal by Subject|1
346386|NCT01145482|1169165|P1|First Intervention (1 Day)|Withdrawal by Subject|0
346387|NCT01145417|1169175|P2|Overall Study|Other|0
346388|NCT01145417|1169176|P1|Overall Study|Other|1
346389|NCT01145417|1169175|P2|Overall Study|Study terminated by sponsor|43
346390|NCT01145417|1169176|P1|Overall Study|Study terminated by sponsor|35
346391|NCT01145417|1169175|P2|Overall Study|Adverse Event|1
346392|NCT01145417|1169176|P1|Overall Study|Adverse Event|0
346393|NCT01145417|1169175|P2|Overall Study|Pregnancy|0
346394|NCT01145417|1169176|P1|Overall Study|Pregnancy|1
346395|NCT01145417|1169175|P2|Overall Study|Withdrawal by Subject|2
346396|NCT01145417|1169176|P1|Overall Study|Withdrawal by Subject|1
346397|NCT01145417|1169175|P2|Overall Study|Lost to Follow-up|1
346398|NCT01145417|1169176|P1|Overall Study|Lost to Follow-up|2
346399|NCT01145417|1169175|P2|Overall Study|Death|0
346400|NCT01145417|1169176|P1|Overall Study|Death|1
346401|NCT01145352|1169209|P1|Overall Study|Syringe formulation was used|1
346402|NCT01145352|1169209|P1|Overall Study|Treated before marketing approval|4
346403|NCT01145352|1169209|P1|Overall Study|Found to have been registered twice|6
346404|NCT01145053|1169217|P1|Overall Study|Other|18
346405|NCT01145053|1169217|P1|Overall Study|Withdrawal by Subject|25
346406|NCT01145053|1169217|P1|Overall Study|Lost to Follow-up|28
346407|NCT01145053|1169217|P1|Overall Study|Adverse Event|22
346408|NCT01144715|1169269|P2|Overall Study|Adverse Event|1
346409|NCT01144715|1169270|P1|Overall Study|Adverse Event|0
346410|NCT01144715|1169269|P2|Overall Study|Withdrawal by Subject|1
346411|NCT01144715|1169270|P1|Overall Study|Withdrawal by Subject|2
346412|NCT01144715|1169269|P2|Overall Study|Lost to Follow-up|1
346413|NCT01144715|1169270|P1|Overall Study|Lost to Follow-up|2
346414|NCT01144416|1169339|P2|Intervention Period|Other|5
346415|NCT01144416|1169340|P1|Intervention Period|Other|7
346416|NCT01144416|1169339|P2|Intervention Period|No/too few/bad quality embryos|3
346417|NCT01144416|1169340|P1|Intervention Period|No/too few/bad quality embryos|3
346418|NCT01144416|1169339|P2|Intervention Period|No or abnormal fertilization|10
346419|NCT01144416|1169340|P1|Intervention Period|No or abnormal fertilization|25
346420|NCT01144416|1169339|P2|Intervention Period|No/too few/bad oocytes|5
346421|NCT01144416|1169340|P1|Intervention Period|No/too few/bad oocytes|7
346422|NCT01144416|1169339|P2|Intervention Period|Too high ovarian response|2
346423|NCT01144416|1169340|P1|Intervention Period|Too high ovarian response|4
346424|NCT01144416|1169339|P2|Intervention Period|Risk of OHSS|1
346425|NCT01144416|1169340|P1|Intervention Period|Risk of OHSS|0
346426|NCT01144416|1169339|P2|Intervention Period|Insufficient ovarian response|17
346427|NCT01144416|1169340|P1|Intervention Period|Insufficient ovarian response|11
346428|NCT01144416|1169339|P2|Intervention Period|Adverse Event|6
346429|NCT01144416|1169340|P1|Intervention Period|Adverse Event|5
346430|NCT01144403|1169356|P1|Overall Study|Adverse Event|1
346431|NCT01144403|1169356|P1|Overall Study|Death|1
346432|NCT01144403|1169356|P1|Overall Study|Lost to Follow-up|3
346433|NCT01144377|1169368|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
346434|NCT01144377|1169369|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
346435|NCT01144377|1169370|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
346436|NCT01144377|1169371|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
346437|NCT01144377|1169372|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
346438|NCT01144377|1169368|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
346439|NCT01144377|1169369|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
346440|NCT01144377|1169370|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
346441|NCT01144377|1169371|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
346442|NCT01144377|1169372|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
346443|NCT01144377|1169368|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
346444|NCT01144377|1169369|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
346445|NCT01144377|1169370|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
346446|NCT01144377|1169371|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
346447|NCT01144377|1169372|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
346448|NCT01144377|1169368|P5|52 Week Treatment Period|Sponsor Decision|1
346449|NCT01144377|1169369|P4|52 Week Treatment Period|Sponsor Decision|0
346450|NCT01144377|1169370|P3|52 Week Treatment Period|Sponsor Decision|0
346451|NCT01144377|1169371|P2|52 Week Treatment Period|Sponsor Decision|0
346452|NCT01144377|1169372|P1|52 Week Treatment Period|Sponsor Decision|0
346453|NCT01144377|1169368|P5|52 Week Treatment Period|Withdrawal by Subject|0
346454|NCT01144377|1169369|P4|52 Week Treatment Period|Withdrawal by Subject|1
346455|NCT01144377|1169370|P3|52 Week Treatment Period|Withdrawal by Subject|1
346456|NCT01144377|1169371|P2|52 Week Treatment Period|Withdrawal by Subject|1
346457|NCT01144377|1169372|P1|52 Week Treatment Period|Withdrawal by Subject|4
346458|NCT01144377|1169368|P5|52 Week Treatment Period|Lost to Follow-up|0
346459|NCT01144377|1169369|P4|52 Week Treatment Period|Lost to Follow-up|0
346460|NCT01144377|1169370|P3|52 Week Treatment Period|Lost to Follow-up|0
346461|NCT01144377|1169371|P2|52 Week Treatment Period|Lost to Follow-up|0
346462|NCT01144377|1169372|P1|52 Week Treatment Period|Lost to Follow-up|1
346463|NCT01144377|1169368|P5|52 Week Treatment Period|Protocol Violation|1
346464|NCT01144377|1169369|P4|52 Week Treatment Period|Protocol Violation|0
346465|NCT01144377|1169370|P3|52 Week Treatment Period|Protocol Violation|0
346466|NCT01144377|1169371|P2|52 Week Treatment Period|Protocol Violation|0
346467|NCT01144377|1169372|P1|52 Week Treatment Period|Protocol Violation|0
346468|NCT01144377|1169368|P5|52 Week Treatment Period|Entry Criteria Not Met|0
346469|NCT01144377|1169369|P4|52 Week Treatment Period|Entry Criteria Not Met|1
346470|NCT01144377|1169370|P3|52 Week Treatment Period|Entry Criteria Not Met|1
346471|NCT01144377|1169371|P2|52 Week Treatment Period|Entry Criteria Not Met|0
346472|NCT01144377|1169372|P1|52 Week Treatment Period|Entry Criteria Not Met|0
346473|NCT01144377|1169368|P5|52 Week Treatment Period|Adverse Event|1
346474|NCT01144377|1169369|P4|52 Week Treatment Period|Adverse Event|2
346475|NCT01144377|1169370|P3|52 Week Treatment Period|Adverse Event|3
346476|NCT01144377|1169371|P2|52 Week Treatment Period|Adverse Event|0
346477|NCT01144377|1169372|P1|52 Week Treatment Period|Adverse Event|0
346478|NCT01144364|1169421|P3|Follow-Up/Maintenance Phase|Physician Decision|1
346479|NCT01144364|1169422|P2|Follow-Up/Maintenance Phase|Physician Decision|0
346480|NCT01144364|1169423|P1|Follow-Up/Maintenance Phase|Physician Decision|0
346481|NCT01144364|1169421|P3|Follow-Up/Maintenance Phase|Relapse|5
346482|NCT01144364|1169422|P2|Follow-Up/Maintenance Phase|Relapse|5
346483|NCT01144364|1169423|P1|Follow-Up/Maintenance Phase|Relapse|0
346484|NCT01144364|1169421|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
346485|NCT01144364|1169422|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
346486|NCT01144364|1169423|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
346487|NCT01144364|1169421|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
346488|NCT01144364|1169422|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
346489|NCT01144364|1169423|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
346490|NCT01144364|1169421|P3|Follow-Up/Maintenance Phase|Death|0
346491|NCT01144364|1169422|P2|Follow-Up/Maintenance Phase|Death|2
346492|NCT01144364|1169423|P1|Follow-Up/Maintenance Phase|Death|0
346493|NCT01144364|1169421|P3|Follow-Up/Maintenance Phase|Adverse Event|1
346494|NCT01144364|1169422|P2|Follow-Up/Maintenance Phase|Adverse Event|3
346495|NCT01144364|1169423|P1|Follow-Up/Maintenance Phase|Adverse Event|0
346496|NCT01144364|1169421|P3|Follow-Up/Maintenance Phase|Disease progression|29
346497|NCT01144364|1169422|P2|Follow-Up/Maintenance Phase|Disease progression|23
346498|NCT01144364|1169423|P1|Follow-Up/Maintenance Phase|Disease progression|0
346499|NCT01144364|1169421|P3|Induction Phase|Protocol Violation|0
346500|NCT01144364|1169422|P2|Induction Phase|Protocol Violation|0
346501|NCT01144364|1169423|P1|Induction Phase|Protocol Violation|1
346502|NCT01144364|1169421|P3|Induction Phase|Secondary neoplasia|0
346503|NCT01144364|1169422|P2|Induction Phase|Secondary neoplasia|0
346504|NCT01144364|1169423|P1|Induction Phase|Secondary neoplasia|1
346505|NCT01144364|1169421|P3|Induction Phase|Stable disease|0
346506|NCT01144364|1169422|P2|Induction Phase|Stable disease|0
346507|NCT01144364|1169423|P1|Induction Phase|Stable disease|2
346508|NCT01144364|1169421|P3|Induction Phase|Physician Decision|0
346509|NCT01144364|1169422|P2|Induction Phase|Physician Decision|0
346510|NCT01144364|1169423|P1|Induction Phase|Physician Decision|1
346511|NCT01144364|1169421|P3|Induction Phase|Lost to Follow-up|0
346512|NCT01144364|1169422|P2|Induction Phase|Lost to Follow-up|0
346513|NCT01144364|1169423|P1|Induction Phase|Lost to Follow-up|2
346514|NCT01144364|1169421|P3|Induction Phase|Withdrawal by Subject|0
346515|NCT01144364|1169422|P2|Induction Phase|Withdrawal by Subject|0
346516|NCT01144364|1169423|P1|Induction Phase|Withdrawal by Subject|1
346517|NCT01144364|1169421|P3|Induction Phase|Death|0
346518|NCT01144364|1169422|P2|Induction Phase|Death|0
346519|NCT01144364|1169423|P1|Induction Phase|Death|1
346520|NCT01144364|1169421|P3|Induction Phase|Adverse Event|0
346521|NCT01144364|1169422|P2|Induction Phase|Adverse Event|0
346522|NCT01144364|1169423|P1|Induction Phase|Adverse Event|9
346523|NCT01144364|1169421|P3|Induction Phase|Disease progression|0
346524|NCT01144364|1169422|P2|Induction Phase|Disease progression|0
346525|NCT01144364|1169423|P1|Induction Phase|Disease progression|14
346526|NCT01144299|1169449|P2|Overall Study|Withdrawal by Subject|0
346527|NCT01144299|1169450|P1|Overall Study|Withdrawal by Subject|1
346528|NCT01144299|1169449|P2|Overall Study|Lost to Follow-up|0
346529|NCT01144299|1169450|P1|Overall Study|Lost to Follow-up|1
346530|NCT01144182|1169495|P2|Overall Study|Lost to Follow-up|9
346531|NCT01144182|1169496|P1|Overall Study|Lost to Follow-up|9
346532|NCT01144182|1169495|P2|Overall Study|Withdrawal by Subject|6
346533|NCT01144182|1169496|P1|Overall Study|Withdrawal by Subject|3
346534|NCT01144182|1169495|P2|Overall Study|Death|6
346535|NCT01144182|1169496|P1|Overall Study|Death|5
346536|NCT01144052|1169556|P2|Overall Study|Withdrawal by Subject|1
346537|NCT01144052|1169557|P1|Overall Study|Withdrawal by Subject|1
346538|NCT01143896|1169588|P2|Overall Study|Death|3
346539|NCT01143896|1169589|P1|Overall Study|Death|6
346540|NCT01143896|1169588|P2|Overall Study|Withdrawal by Subject|5
346541|NCT01143896|1169589|P1|Overall Study|Withdrawal by Subject|13
346542|NCT01143896|1169588|P2|Overall Study|Lost to Follow-up|13
346543|NCT01143896|1169589|P1|Overall Study|Lost to Follow-up|18
346544|NCT01143896|1169588|P2|Overall Study|Did not complete Baseline Interview|4
346545|NCT01143896|1169589|P1|Overall Study|Did not complete Baseline Interview|5
346546|NCT01143714|1169701|P2|Overall Study|wound size increased|0
346547|NCT01143714|1169702|P1|Overall Study|wound size increased|1
346548|NCT01143714|1169701|P2|Overall Study|wound closed = deemed healed|0
346549|NCT01143714|1169702|P1|Overall Study|wound closed = deemed healed|1
346550|NCT01143714|1169701|P2|Overall Study|Subject non-compliance|1
346551|NCT01143714|1169702|P1|Overall Study|Subject non-compliance|0
346552|NCT01143714|1169701|P2|Overall Study|Withdrawal by Subject|0
346553|NCT01143714|1169702|P1|Overall Study|Withdrawal by Subject|1
346554|NCT01143714|1169701|P2|Overall Study|Adverse Event|2
346555|NCT01143714|1169702|P1|Overall Study|Adverse Event|4
346556|NCT01143402|1169807|P3|Overall Study|Not Treated|1
346557|NCT01143402|1169808|P2|Overall Study|Not Treated|0
346558|NCT01143402|1169809|P1|Overall Study|Not Treated|0
346559|NCT01143402|1169807|P3|Overall Study|Rapid clinical decline|0
346560|NCT01143402|1169808|P2|Overall Study|Rapid clinical decline|1
346561|NCT01143402|1169809|P1|Overall Study|Rapid clinical decline|1
346562|NCT01143389|1169820|P2|Overall Study|Lost to Follow-up|25
346563|NCT01143389|1169821|P1|Overall Study|Lost to Follow-up|26
346564|NCT01143337|1169835|P3|Overall Study|Other reason|5
346565|NCT01143337|1169836|P2|Overall Study|Other reason|0
346566|NCT01143337|1169837|P1|Overall Study|Other reason|0
346567|NCT01143337|1169835|P3|Overall Study|Withdrawal by Subject|1
346568|NCT01143337|1169836|P2|Overall Study|Withdrawal by Subject|0
346569|NCT01143337|1169837|P1|Overall Study|Withdrawal by Subject|0
346570|NCT01143337|1169835|P3|Overall Study|Protocol Violation|0
346571|NCT01143337|1169836|P2|Overall Study|Protocol Violation|0
346572|NCT01143337|1169837|P1|Overall Study|Protocol Violation|1
346573|NCT01143337|1169835|P3|Overall Study|Lack of Efficacy|1
346574|NCT01143337|1169836|P2|Overall Study|Lack of Efficacy|2
346575|NCT01143337|1169837|P1|Overall Study|Lack of Efficacy|6
346576|NCT01143337|1169835|P3|Overall Study|Adverse Event|5
346577|NCT01143337|1169836|P2|Overall Study|Adverse Event|9
346578|NCT01143337|1169837|P1|Overall Study|Adverse Event|3
346579|NCT01143324|1169851|P1|Overall Study|Explant of the device|4
346580|NCT01143324|1169851|P1|Overall Study|Withdrawal by Subject|4
346581|NCT01143324|1169851|P1|Overall Study|Lost to Follow-up|11
346582|NCT01143259|1169890|P2|Overall Study|Screen Failure|9
346583|NCT01143259|1169891|P1|Overall Study|Screen Failure|7
346584|NCT01143259|1169890|P2|Overall Study|Protocol Violation|9
346585|NCT01143259|1169891|P1|Overall Study|Protocol Violation|13
346586|NCT01143259|1169890|P2|Overall Study|Withdrawal by Subject|2
346587|NCT01143259|1169891|P1|Overall Study|Withdrawal by Subject|3
346588|NCT01143207|1169899|P1|Overall Study|Lost to Follow-up|2
346589|NCT01143090|1169919|P1|Overall Study|Administrative|1
346590|NCT01143090|1169919|P1|Overall Study|Failure to meet eligibility criteria|1
346591|NCT01143090|1169919|P1|Overall Study|Non-compliance with study drug|1
346592|NCT01143090|1169919|P1|Overall Study|Withdrawal by Subject|18
346593|NCT01143090|1169919|P1|Overall Study|Protocol Violation|2
346594|NCT01143090|1169919|P1|Overall Study|Lost to Follow-up|9
346595|NCT01143090|1169919|P1|Overall Study|Adverse Event|17
346596|NCT01143090|1169919|P1|Overall Study|Lack of Efficacy|2
346597|NCT01143077|1169926|P3|Overall Study|Principal Investigator Decision|1
346598|NCT01143077|1169927|P2|Overall Study|Principal Investigator Decision|0
346599|NCT01143077|1169928|P1|Overall Study|Principal Investigator Decision|2
346600|NCT01143077|1169926|P3|Overall Study|Administrative|0
346601|NCT01143077|1169927|P2|Overall Study|Administrative|0
346602|NCT01143077|1169928|P1|Overall Study|Administrative|1
346603|NCT01143077|1169926|P3|Overall Study|Non-compliance with study drug|1
346604|NCT01143077|1169927|P2|Overall Study|Non-compliance with study drug|1
346605|NCT01143077|1169928|P1|Overall Study|Non-compliance with study drug|0
346606|NCT01143077|1169926|P3|Overall Study|Withdrawal by Subject|3
346607|NCT01143077|1169927|P2|Overall Study|Withdrawal by Subject|3
346608|NCT01143077|1169928|P1|Overall Study|Withdrawal by Subject|4
346609|NCT01143077|1169926|P3|Overall Study|Protocol Violation|0
346610|NCT01143077|1169927|P2|Overall Study|Protocol Violation|0
346611|NCT01143077|1169928|P1|Overall Study|Protocol Violation|2
346612|NCT01143077|1169926|P3|Overall Study|Lost to Follow-up|4
346613|NCT01143077|1169927|P2|Overall Study|Lost to Follow-up|3
346614|NCT01143077|1169928|P1|Overall Study|Lost to Follow-up|2
346615|NCT01143077|1169926|P3|Overall Study|Adverse Event|5
346616|NCT01143077|1169927|P2|Overall Study|Adverse Event|6
346617|NCT01143077|1169928|P1|Overall Study|Adverse Event|5
346618|NCT01143077|1169926|P3|Overall Study|Lack of Efficacy|1
346619|NCT01143077|1169927|P2|Overall Study|Lack of Efficacy|2
346620|NCT01143077|1169928|P1|Overall Study|Lack of Efficacy|0
346621|NCT01143051|1169945|P6|3-14 Day Washout|Withdrawal by Subject|1
346622|NCT01143051|1169946|P5|3-14 Day Washout|Withdrawal by Subject|0
346623|NCT01143051|1169947|P4|3-14 Day Washout|Withdrawal by Subject|0
346624|NCT01143051|1169948|P3|3-14 Day Washout|Withdrawal by Subject|0
346625|NCT01143051|1169949|P2|3-14 Day Washout|Withdrawal by Subject|0
346626|NCT01143051|1169950|P1|3-14 Day Washout|Withdrawal by Subject|0
346627|NCT01143051|1169945|P6|3-14 Day Washout|Withdrawal by Subject|0
346628|NCT01143051|1169946|P5|3-14 Day Washout|Withdrawal by Subject|0
346629|NCT01143051|1169947|P4|3-14 Day Washout|Withdrawal by Subject|0
346630|NCT01143051|1169948|P3|3-14 Day Washout|Withdrawal by Subject|1
346631|NCT01143051|1169949|P2|3-14 Day Washout|Withdrawal by Subject|0
346632|NCT01143051|1169950|P1|3-14 Day Washout|Withdrawal by Subject|0
346633|NCT01143038|1169973|P1|Overall Study|Death|1
346634|NCT01143038|1169973|P1|Overall Study|Protocol Deviation|1
346635|NCT01143038|1169973|P1|Overall Study|Lost to Follow-up|2
346636|NCT01143038|1169973|P1|Overall Study|Adverse Event|3
346637|NCT01143038|1169973|P1|Overall Study|Requirement for alternative therapy|5
346638|NCT01143038|1169973|P1|Overall Study|Withdrawal by Subject|4
346639|NCT01142908|1169983|P2|Overall Study|Withdrawal by Subject|0
346640|NCT01142908|1169984|P1|Overall Study|Withdrawal by Subject|3
346641|NCT01142908|1169983|P2|Overall Study|Excluded - did not meet criteria|5
346642|NCT01142908|1169984|P1|Overall Study|Excluded - did not meet criteria|9
346643|NCT01142908|1169983|P2|Overall Study|Death|4
346644|NCT01142908|1169984|P1|Overall Study|Death|1
346645|NCT01142908|1169983|P2|Overall Study|Lost to Follow-up|13
346646|NCT01142908|1169984|P1|Overall Study|Lost to Follow-up|19
346647|NCT01142726|1170033|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
346648|NCT01142726|1170034|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
346649|NCT01142726|1170035|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
346650|NCT01142726|1170033|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
346651|NCT01142726|1170034|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
346652|NCT01142726|1170035|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
346653|NCT01142726|1170033|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
346654|NCT01142726|1170034|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
346655|NCT01142726|1170035|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
346656|NCT01142726|1170033|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
346657|NCT01142726|1170034|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
346658|NCT01142726|1170035|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
346659|NCT01142726|1170033|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
346660|NCT01142726|1170034|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
346661|NCT01142726|1170035|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
346662|NCT01142726|1170033|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
346663|NCT01142726|1170034|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
346664|NCT01142726|1170035|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
346665|NCT01142726|1170033|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
346666|NCT01142726|1170034|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
346667|NCT01142726|1170035|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
346668|NCT01142726|1170033|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
346669|NCT01142726|1170034|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
346670|NCT01142726|1170035|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
346671|NCT01142726|1170033|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
346672|NCT01142726|1170034|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
346673|NCT01142726|1170035|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
346674|NCT01142726|1170033|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
346675|NCT01142726|1170034|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
346676|NCT01142726|1170035|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
346677|NCT01142726|1170033|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
346678|NCT01142726|1170034|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
346679|NCT01142726|1170035|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
346680|NCT01142726|1170033|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
346681|NCT01142726|1170034|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
346682|NCT01142726|1170035|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
346683|NCT01142726|1170033|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
346684|NCT01142726|1170034|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
346685|NCT01142726|1170035|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
346686|NCT01142726|1170033|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
346687|NCT01142726|1170034|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
346688|NCT01142726|1170035|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
346689|NCT01142726|1170033|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
346690|NCT01142726|1170034|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
346691|NCT01142726|1170035|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
346692|NCT01142726|1170033|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
346693|NCT01142726|1170034|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
346694|NCT01142726|1170035|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
346695|NCT01142661|1170098|P1|Overall Study|Physician Decision|1
346696|NCT01142661|1170098|P1|Overall Study|Withdrawal by Subject|1
346697|NCT01142661|1170098|P1|Overall Study|Adverse Event|2
346698|NCT01142596|1170105|P2|Overall Study|Other reason (not specified)|4
346699|NCT01142596|1170106|P1|Overall Study|Other reason (not specified)|5
346700|NCT01142596|1170105|P2|Overall Study|Lost to Follow-up|3
346701|NCT01142596|1170106|P1|Overall Study|Lost to Follow-up|2
346702|NCT01142596|1170105|P2|Overall Study|Lack of Efficacy|9
346703|NCT01142596|1170106|P1|Overall Study|Lack of Efficacy|5
346704|NCT01142596|1170105|P2|Overall Study|Adverse Event|35
346705|NCT01142596|1170106|P1|Overall Study|Adverse Event|8
346706|NCT01142596|1170105|P2|Overall Study|Withdrawal by Subject|35
346707|NCT01142596|1170106|P1|Overall Study|Withdrawal by Subject|9
346708|NCT01142466|1170158|P2|Overall Study|Withdrawal by Subject|1
346709|NCT01142466|1170159|P1|Overall Study|Withdrawal by Subject|1
346710|NCT01142466|1170158|P2|Overall Study|Adverse Event|1
346711|NCT01142466|1170159|P1|Overall Study|Adverse Event|2
346712|NCT01142388|1170179|P2|Overall Study|Never started therapy|3
346713|NCT01142388|1170180|P1|Overall Study|Never started therapy|7
346714|NCT01142388|1170179|P2|Overall Study|Other|1
346715|NCT01142388|1170180|P1|Overall Study|Other|1
346716|NCT01142388|1170179|P2|Overall Study|Other complications|2
346717|NCT01142388|1170180|P1|Overall Study|Other complications|0
346718|NCT01142388|1170179|P2|Overall Study|Alternative therapy|0
346719|NCT01142388|1170180|P1|Overall Study|Alternative therapy|1
346720|NCT01142388|1170179|P2|Overall Study|Withdrawal by Subject|3
346721|NCT01142388|1170180|P1|Overall Study|Withdrawal by Subject|5
346722|NCT01142388|1170179|P2|Overall Study|Death|2
346723|NCT01142388|1170180|P1|Overall Study|Death|3
346724|NCT01142388|1170179|P2|Overall Study|Adverse Event|5
346725|NCT01142388|1170180|P1|Overall Study|Adverse Event|9
346726|NCT01142388|1170179|P2|Overall Study|Lack of Efficacy|31
346727|NCT01142388|1170180|P1|Overall Study|Lack of Efficacy|21
346728|NCT01142336|1170192|P2|Overall Study|Lost to Follow-up|1
346729|NCT01142336|1170193|P1|Overall Study|Lost to Follow-up|0
346730|NCT01142336|1170192|P2|Overall Study|Adverse Event|1
346731|NCT01142336|1170193|P1|Overall Study|Adverse Event|1
346732|NCT01142193|1170218|P2|Overall Study|Other|2
346733|NCT01142193|1170219|P1|Overall Study|Other|1
346734|NCT01142193|1170218|P2|Overall Study|Protocol Discontinuation Criterion Met|0
346735|NCT01142193|1170219|P1|Overall Study|Protocol Discontinuation Criterion Met|1
346736|NCT01142193|1170218|P2|Overall Study|Withdrawal by Subject|3
346737|NCT01142193|1170219|P1|Overall Study|Withdrawal by Subject|4
346738|NCT01142193|1170218|P2|Overall Study|Physician Decision|1
346739|NCT01142193|1170219|P1|Overall Study|Physician Decision|1
346740|NCT01142193|1170218|P2|Overall Study|Lack of Efficacy|1
346741|NCT01142193|1170219|P1|Overall Study|Lack of Efficacy|2
346742|NCT01142193|1170218|P2|Overall Study|Adverse Event|4
346743|NCT01142193|1170219|P1|Overall Study|Adverse Event|12
346744|NCT01142128|1170247|P1|Overall Study|Withdrawal by Subject|2
346745|NCT01142128|1170247|P1|Overall Study|Lost to Follow-up|1
346746|NCT01142128|1170247|P1|Overall Study|Physician Decision|1
346747|NCT01142115|1170257|P2|First Intervention|Adverse Event|0
346748|NCT01142115|1170258|P1|First Intervention|Adverse Event|1
346749|NCT01142115|1170257|P2|First Intervention|Lack of Efficacy|1
346750|NCT01142115|1170258|P1|First Intervention|Lack of Efficacy|1
346751|NCT01142089|1170275|P2|Overall Study|Patient required rescue medication|17
346752|NCT01142089|1170276|P1|Overall Study|Patient required rescue medication|8
346753|NCT01142089|1170275|P2|Overall Study|Noncompliance with study procedures|1
346754|NCT01142089|1170276|P1|Overall Study|Noncompliance with study procedures|2
346755|NCT01142089|1170275|P2|Overall Study|Use of prohibited medications|1
346756|NCT01142089|1170276|P1|Overall Study|Use of prohibited medications|0
346757|NCT01142089|1170275|P2|Overall Study|Withdrawal by Subject|2
346758|NCT01142089|1170276|P1|Overall Study|Withdrawal by Subject|1
346759|NCT01142089|1170275|P2|Overall Study|Physician Decision|0
346760|NCT01142089|1170276|P1|Overall Study|Physician Decision|1
346761|NCT01141712|1170298|P1|Overall Study|Disease progression|3
346762|NCT01141660|1170319|P2|Overall Study|Physician Decision|12
346763|NCT01141660|1170320|P1|Overall Study|Physician Decision|0
346764|NCT01141283|1170379|P1|Overall Study|Lack of Efficacy|10
346765|NCT01141283|1170379|P1|Overall Study|Administrative|4
346766|NCT01141283|1170379|P1|Overall Study|Withdrawal by Subject|14
346767|NCT01141283|1170379|P1|Overall Study|Lost to Follow-up|4
346768|NCT01141283|1170379|P1|Overall Study|Adverse Event|56
346769|NCT01141205|1170385|P2|Overall Study|Withdrawal by Subject|1
346770|NCT01141205|1170386|P1|Overall Study|Withdrawal by Subject|1
346771|NCT01141205|1170385|P2|Overall Study|Lost to Follow-up|0
346772|NCT01141205|1170386|P1|Overall Study|Lost to Follow-up|1
346773|NCT01141205|1170385|P2|Overall Study|Physician Decision|1
346774|NCT01141205|1170386|P1|Overall Study|Physician Decision|1
346775|NCT01140906|1170402|P4|Overall Study|Administrative or other reason|2
346776|NCT01140906|1170403|P3|Overall Study|Administrative or other reason|3
346777|NCT01140906|1170404|P2|Overall Study|Administrative or other reason|5
346778|NCT01140906|1170405|P1|Overall Study|Administrative or other reason|0
346779|NCT01140906|1170402|P4|Overall Study|Lost to Follow-up|2
346780|NCT01140906|1170403|P3|Overall Study|Lost to Follow-up|0
346781|NCT01140906|1170404|P2|Overall Study|Lost to Follow-up|1
346782|NCT01140906|1170405|P1|Overall Study|Lost to Follow-up|1
346783|NCT01140906|1170402|P4|Overall Study|Withdrawal of consent|2
346784|NCT01140906|1170403|P3|Overall Study|Withdrawal of consent|2
346785|NCT01140906|1170404|P2|Overall Study|Withdrawal of consent|6
346786|NCT01140906|1170405|P1|Overall Study|Withdrawal of consent|6
346787|NCT01140906|1170402|P4|Overall Study|Protocol Violation|1
346788|NCT01140906|1170403|P3|Overall Study|Protocol Violation|2
346789|NCT01140906|1170404|P2|Overall Study|Protocol Violation|3
346790|NCT01140906|1170405|P1|Overall Study|Protocol Violation|5
346791|NCT01140906|1170402|P4|Overall Study|Non-compliance|1
346792|NCT01140906|1170403|P3|Overall Study|Non-compliance|0
346793|NCT01140906|1170404|P2|Overall Study|Non-compliance|1
346794|NCT01140906|1170405|P1|Overall Study|Non-compliance|0
346795|NCT01140906|1170402|P4|Overall Study|Lack of Efficacy|1
346796|NCT01140906|1170403|P3|Overall Study|Lack of Efficacy|2
346797|NCT01140906|1170404|P2|Overall Study|Lack of Efficacy|8
346798|NCT01140906|1170405|P1|Overall Study|Lack of Efficacy|6
346799|NCT01140906|1170402|P4|Overall Study|Adverse Event|7
346800|NCT01140906|1170403|P3|Overall Study|Adverse Event|17
346801|NCT01140906|1170404|P2|Overall Study|Adverse Event|10
346802|NCT01140906|1170405|P1|Overall Study|Adverse Event|7
346803|NCT01140880|1170445|P2|Overall Study|Protocol Violation|30
346804|NCT01140880|1170446|P1|Overall Study|Protocol Violation|0
346805|NCT01140880|1170445|P2|Overall Study|Lost to Follow-up|10
346806|NCT01140880|1170446|P1|Overall Study|Lost to Follow-up|8
346807|NCT01140880|1170445|P2|Overall Study|Withdrawal by Subject|3
346808|NCT01140880|1170446|P1|Overall Study|Withdrawal by Subject|6
346809|NCT01140880|1170445|P2|Overall Study|Death|1
346810|NCT01140880|1170446|P1|Overall Study|Death|0
346811|NCT01140867|1170458|P1|Overall Study|Medication Noncompliance|2
346812|NCT01140867|1170458|P1|Overall Study|Uncooperative patient|2
346813|NCT01140867|1170458|P1|Overall Study|Protocol Violation|1
346814|NCT01140867|1170458|P1|Overall Study|Withdrawal by Subject|1
346815|NCT01140867|1170458|P1|Overall Study|Lost to Follow-up|2
346816|NCT01140867|1170458|P1|Overall Study|Lack of Efficacy|3
346817|NCT01140867|1170458|P1|Overall Study|Adverse Event|22
346818|NCT01140646|1170498|P1|Overall Study|Refused Further Treatment|5
346819|NCT01140646|1170498|P1|Overall Study|Adverse Event|4
346820|NCT01140503|1170502|P1|Overall Study|Withdrawal by Subject|1
346821|NCT01140477|1170510|P2|Overall Study|Subject explanted|1
346822|NCT01140477|1170511|P1|Overall Study|Subject explanted|0
346823|NCT01140477|1170510|P2|Overall Study|Death|1
346824|NCT01140477|1170511|P1|Overall Study|Death|1
346825|NCT01140477|1170510|P2|Overall Study|Surgical complication preventing implant|0
346826|NCT01140477|1170511|P1|Overall Study|Surgical complication preventing implant|2
346827|NCT01140477|1170510|P2|Overall Study|Withdrawal by Subject|4
346828|NCT01140477|1170511|P1|Overall Study|Withdrawal by Subject|1
346829|NCT01140477|1170510|P2|Overall Study|Lost to Follow-up|0
346830|NCT01140477|1170511|P1|Overall Study|Lost to Follow-up|4
346831|NCT01140347|1170526|P2|Overall Study|Withdrawal by Subject|8
346832|NCT01140347|1170527|P1|Overall Study|Withdrawal by Subject|13
346833|NCT01140347|1170526|P2|Overall Study|Lost to Follow-up|6
346834|NCT01140347|1170527|P1|Overall Study|Lost to Follow-up|5
346835|NCT01140061|1170580|P10|Extension|Laboratory Adverse Event|1
346836|NCT01140061|1170581|P9|Extension|Laboratory Adverse Event|0
346837|NCT01140061|1170582|P8|Extension|Laboratory Adverse Event|0
346838|NCT01140061|1170583|P7|Extension|Laboratory Adverse Event|0
346839|NCT01140061|1170584|P6|Extension|Laboratory Adverse Event|0
346840|NCT01140061|1170585|P5|Extension|Laboratory Adverse Event|0
346841|NCT01140061|1170586|P4|Extension|Laboratory Adverse Event|0
346842|NCT01140061|1170587|P3|Extension|Laboratory Adverse Event|0
346843|NCT01140061|1170588|P2|Extension|Laboratory Adverse Event|0
346844|NCT01140061|1170589|P1|Extension|Laboratory Adverse Event|0
346845|NCT01140061|1170580|P10|Part I|Adverse Event|0
346846|NCT01140061|1170581|P9|Part I|Adverse Event|0
346847|NCT01140061|1170582|P8|Part I|Adverse Event|0
346848|NCT01140061|1170583|P7|Part I|Adverse Event|0
346849|NCT01140061|1170584|P6|Part I|Adverse Event|0
346850|NCT01140061|1170585|P5|Part I|Adverse Event|0
346851|NCT01140061|1170586|P4|Part I|Adverse Event|0
346852|NCT01140061|1170587|P3|Part I|Adverse Event|0
346853|NCT01140061|1170588|P2|Part I|Adverse Event|0
346854|NCT01140061|1170589|P1|Part I|Adverse Event|1
346855|NCT01140048|1170616|P1|Overall Study|Lost to Follow-up|31
346856|NCT01140048|1170616|P1|Overall Study|Withdrawal by Subject|13
346857|NCT01140048|1170616|P1|Overall Study|Physician Decision|1
346858|NCT01139775|1170645|P3|Overall Study|Physician Decision|2
346859|NCT01139775|1170646|P2|Overall Study|Physician Decision|2
346860|NCT01139775|1170647|P1|Overall Study|Physician Decision|0
346861|NCT01139775|1170645|P3|Overall Study|Withdrawal by Subject|2
346862|NCT01139775|1170646|P2|Overall Study|Withdrawal by Subject|0
346863|NCT01139775|1170647|P1|Overall Study|Withdrawal by Subject|1
346864|NCT01139775|1170645|P3|Overall Study|Protocol Violation|0
346865|NCT01139775|1170646|P2|Overall Study|Protocol Violation|5
346866|NCT01139775|1170647|P1|Overall Study|Protocol Violation|0
346867|NCT01139775|1170645|P3|Overall Study|Adverse Event|2
346868|NCT01139775|1170646|P2|Overall Study|Adverse Event|6
346869|NCT01139775|1170647|P1|Overall Study|Adverse Event|0
346870|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
346871|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
346872|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
346873|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
346874|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
346875|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
346876|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
346877|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
346878|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
346879|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
346880|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
346881|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
346882|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
346883|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
346884|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
346885|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
346886|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
346887|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
346888|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
346889|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
346890|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
346891|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Death|1
346892|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Death|1
346893|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Death|0
346894|NCT01139762|1170679|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
346895|NCT01139762|1170680|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
346896|NCT01139762|1170681|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
346897|NCT01139762|1170679|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
346898|NCT01139762|1170680|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
346899|NCT01139762|1170681|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
346900|NCT01139762|1170679|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
346901|NCT01139762|1170680|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
346902|NCT01139762|1170681|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
346903|NCT01139762|1170679|P3|Washout and Placebo Lead-In Period|Physician Decision|0
346904|NCT01139762|1170680|P2|Washout and Placebo Lead-In Period|Physician Decision|0
346905|NCT01139762|1170681|P1|Washout and Placebo Lead-In Period|Physician Decision|12
346906|NCT01139762|1170679|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
346907|NCT01139762|1170680|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
346908|NCT01139762|1170681|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
346909|NCT01139762|1170679|P3|Washout and Placebo Lead-In Period|Adverse Event|0
346910|NCT01139762|1170680|P2|Washout and Placebo Lead-In Period|Adverse Event|0
346911|NCT01139762|1170681|P1|Washout and Placebo Lead-In Period|Adverse Event|1
346912|NCT01139762|1170679|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
346913|NCT01139762|1170680|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
346914|NCT01139762|1170681|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
346915|NCT01139658|1170716|P2|Overall Study|Not specified|75
346916|NCT01139658|1170717|P1|Overall Study|Not specified|28
346917|NCT01139658|1170716|P2|Overall Study|No documentation of treatment|0
346918|NCT01139658|1170717|P1|Overall Study|No documentation of treatment|1
346919|NCT01139658|1170716|P2|Overall Study|Withdrawal by Subject|4
346920|NCT01139658|1170717|P1|Overall Study|Withdrawal by Subject|2
346921|NCT01139658|1170716|P2|Overall Study|Lack of Efficacy|7
346922|NCT01139658|1170717|P1|Overall Study|Lack of Efficacy|15
346923|NCT01139658|1170716|P2|Overall Study|Adverse Event|27
346924|NCT01139658|1170717|P1|Overall Study|Adverse Event|10
346925|NCT01139580|1170755|P2|Overall Study|Participant Randomization in Error|1
346926|NCT01139580|1170756|P1|Overall Study|Participant Randomization in Error|0
346927|NCT01139580|1170755|P2|Overall Study|Beginning Study Exclusion Treatment|1
346928|NCT01139580|1170756|P1|Overall Study|Beginning Study Exclusion Treatment|0
346929|NCT01139580|1170755|P2|Overall Study|Misrandomized|0
346930|NCT01139580|1170756|P1|Overall Study|Misrandomized|1
346931|NCT01139580|1170755|P2|Overall Study|Did Not Meet Exclusion Criteria|0
346932|NCT01139580|1170756|P1|Overall Study|Did Not Meet Exclusion Criteria|1
346933|NCT01139580|1170755|P2|Overall Study|Used Excluded Medicine After Enrollment|0
346934|NCT01139580|1170756|P1|Overall Study|Used Excluded Medicine After Enrollment|1
346935|NCT01139580|1170755|P2|Overall Study|Withdrawal by Subject|9
346936|NCT01139580|1170756|P1|Overall Study|Withdrawal by Subject|6
346937|NCT01139580|1170755|P2|Overall Study|Lack of Efficacy|2
346938|NCT01139580|1170756|P1|Overall Study|Lack of Efficacy|0
346939|NCT01139580|1170755|P2|Overall Study|Lost to Follow-up|1
346940|NCT01139580|1170756|P1|Overall Study|Lost to Follow-up|9
346941|NCT01139580|1170755|P2|Overall Study|Adverse Event|4
346942|NCT01139580|1170756|P1|Overall Study|Adverse Event|5
346943|NCT01139450|1170804|P3|Overall Study|Adverse Event|3
346944|NCT01139450|1170805|P2|Overall Study|Adverse Event|2
346945|NCT01139450|1170806|P1|Overall Study|Adverse Event|2
346946|NCT01139450|1170804|P3|Overall Study|Administrative|1
346947|NCT01139450|1170805|P2|Overall Study|Administrative|0
346948|NCT01139450|1170806|P1|Overall Study|Administrative|0
346949|NCT01139450|1170804|P3|Overall Study|Lost to Follow-up|11
346950|NCT01139450|1170805|P2|Overall Study|Lost to Follow-up|7
346951|NCT01139450|1170806|P1|Overall Study|Lost to Follow-up|9
346952|NCT01139450|1170804|P3|Overall Study|Protocol Violation|2
346953|NCT01139450|1170805|P2|Overall Study|Protocol Violation|5
346954|NCT01139450|1170806|P1|Overall Study|Protocol Violation|6
346955|NCT01139450|1170804|P3|Overall Study|Lack of Efficacy|8
346956|NCT01139450|1170805|P2|Overall Study|Lack of Efficacy|1
346957|NCT01139450|1170806|P1|Overall Study|Lack of Efficacy|3
346958|NCT01139450|1170804|P3|Overall Study|Withdrawal by Subject|13
346959|NCT01139450|1170805|P2|Overall Study|Withdrawal by Subject|10
346960|NCT01139450|1170806|P1|Overall Study|Withdrawal by Subject|7
346961|NCT01139164|1170858|P3|Overall Study|Withdrawn prior to study start|0
346962|NCT01139164|1170859|P2|Overall Study|Withdrawn prior to study start|2
346963|NCT01139164|1170860|P1|Overall Study|Withdrawn prior to study start|0
346964|NCT01139125|1170874|P1|Overall Study|Withdrawal by Subject|1
346965|NCT01139047|1170878|P1|Overall Study|Withdrawal by Subject|1
346966|NCT01139021|1170893|P6|Overall Study|Withdrawal by Subject|0
346967|NCT01139021|1170894|P5|Overall Study|Withdrawal by Subject|4
346968|NCT01139021|1170895|P4|Overall Study|Withdrawal by Subject|1
346969|NCT01139021|1170896|P3|Overall Study|Withdrawal by Subject|0
346970|NCT01139021|1170897|P2|Overall Study|Withdrawal by Subject|0
346971|NCT01139021|1170898|P1|Overall Study|Withdrawal by Subject|0
346972|NCT01139021|1170893|P6|Overall Study|Protocol Violation|0
346973|NCT01139021|1170894|P5|Overall Study|Protocol Violation|2
346974|NCT01139021|1170895|P4|Overall Study|Protocol Violation|0
346975|NCT01139021|1170896|P3|Overall Study|Protocol Violation|0
346976|NCT01139021|1170897|P2|Overall Study|Protocol Violation|0
346977|NCT01139021|1170898|P1|Overall Study|Protocol Violation|1
346978|NCT01139021|1170893|P6|Overall Study|Lost to Follow-up|0
346979|NCT01139021|1170894|P5|Overall Study|Lost to Follow-up|2
346980|NCT01139021|1170895|P4|Overall Study|Lost to Follow-up|0
346981|NCT01139021|1170896|P3|Overall Study|Lost to Follow-up|0
346982|NCT01139021|1170897|P2|Overall Study|Lost to Follow-up|0
346983|NCT01139021|1170898|P1|Overall Study|Lost to Follow-up|0
346984|NCT01139021|1170893|P6|Overall Study|Adverse Event|0
346985|NCT01139021|1170894|P5|Overall Study|Adverse Event|1
346986|NCT01139021|1170895|P4|Overall Study|Adverse Event|0
346987|NCT01139021|1170896|P3|Overall Study|Adverse Event|0
346988|NCT01139021|1170897|P2|Overall Study|Adverse Event|0
346989|NCT01139021|1170898|P1|Overall Study|Adverse Event|0
346990|NCT01139008|1170934|P1|Overall Study|Non-compliant, lost product|1
346991|NCT01139008|1170934|P1|Overall Study|Withdrawal by Subject|5
346992|NCT01138826|1170967|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
346993|NCT01138826|1170968|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
346994|NCT01138826|1170969|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
346995|NCT01138826|1170970|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
346996|NCT01138826|1170971|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
346997|NCT01138826|1170972|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
346998|NCT01138657|1171009|P2|Overall Study|Miscellaneous Reasons|4
346999|NCT01138657|1171010|P1|Overall Study|Miscellaneous Reasons|3
347000|NCT01138657|1171009|P2|Overall Study|Lost to Follow-up|3
347001|NCT01138657|1171010|P1|Overall Study|Lost to Follow-up|0
347002|NCT01138657|1171009|P2|Overall Study|Lack of Efficacy|1
347003|NCT01138657|1171010|P1|Overall Study|Lack of Efficacy|2
347004|NCT01138657|1171009|P2|Overall Study|Adverse Event|10
347005|NCT01138657|1171010|P1|Overall Study|Adverse Event|3
347006|NCT01138501|1171073|P1|Overall Study|Withdrawal by Subject|3
347007|NCT01138501|1171073|P1|Overall Study|Protocol Violation|2
347008|NCT01138150|1171117|P2|Overall Study|Physician Decision|0
347009|NCT01138150|1171118|P1|Overall Study|Physician Decision|1
347010|NCT01138150|1171117|P2|Overall Study|blood unable to be processed|1
347011|NCT01138150|1171118|P1|Overall Study|blood unable to be processed|0
347012|NCT01138111|1171199|P1|Overall Study|Lost to Follow-up|2
347013|NCT01138111|1171199|P1|Overall Study|Death|1
347014|NCT01138111|1171199|P1|Overall Study|Adverse Event|1
347015|NCT01138111|1171199|P1|Overall Study|Withdrawal by Subject|5
347016|NCT01138046|1171253|P1|Overall Study|Withdrawal due to death|6
347017|NCT01138007|1171273|P3|Overall Study|Withdrawal by Subject|15
347018|NCT01138007|1171274|P2|Overall Study|Withdrawal by Subject|6
347019|NCT01138007|1171275|P1|Overall Study|Withdrawal by Subject|5
347020|NCT01138007|1171273|P3|Overall Study|Physician Decision|3
347021|NCT01138007|1171274|P2|Overall Study|Physician Decision|5
347022|NCT01138007|1171275|P1|Overall Study|Physician Decision|0
347023|NCT01138007|1171273|P3|Overall Study|Lost to Follow-up|5
347024|NCT01138007|1171274|P2|Overall Study|Lost to Follow-up|3
347025|NCT01138007|1171275|P1|Overall Study|Lost to Follow-up|3
347026|NCT01138007|1171273|P3|Overall Study|Protocol-Defined Stopping Criteria|8
347027|NCT01138007|1171274|P2|Overall Study|Protocol-Defined Stopping Criteria|1
347028|NCT01138007|1171275|P1|Overall Study|Protocol-Defined Stopping Criteria|6
347029|NCT01138007|1171273|P3|Overall Study|Protocol Violation|2
347030|NCT01138007|1171274|P2|Overall Study|Protocol Violation|3
347031|NCT01138007|1171275|P1|Overall Study|Protocol Violation|2
347032|NCT01138007|1171273|P3|Overall Study|Lack of Efficacy|6
347033|NCT01138007|1171274|P2|Overall Study|Lack of Efficacy|0
347034|NCT01138007|1171275|P1|Overall Study|Lack of Efficacy|2
347035|NCT01138007|1171273|P3|Overall Study|Adverse Event|9
347036|NCT01138007|1171274|P2|Overall Study|Adverse Event|12
347037|NCT01138007|1171275|P1|Overall Study|Adverse Event|4
347038|NCT01137812|1171382|P2|Overall Study|Not specified|27
347039|NCT01137812|1171383|P1|Overall Study|Not specified|19
347040|NCT01137812|1171382|P2|Overall Study|Patient met glycemic withdrawal criteria|85
347041|NCT01137812|1171383|P1|Overall Study|Patient met glycemic withdrawal criteria|40
347042|NCT01137812|1171382|P2|Overall Study|Death|0
347043|NCT01137812|1171383|P1|Overall Study|Death|2
347044|NCT01137812|1171382|P2|Overall Study|Withdrawal by Subject|13
347045|NCT01137812|1171383|P1|Overall Study|Withdrawal by Subject|5
347046|NCT01137812|1171382|P2|Overall Study|Protocol Violation|4
347047|NCT01137812|1171383|P1|Overall Study|Protocol Violation|5
347048|NCT01137812|1171382|P2|Overall Study|Physician Decision|17
347049|NCT01137812|1171383|P1|Overall Study|Physician Decision|25
347050|NCT01137812|1171382|P2|Overall Study|Lost to Follow-up|8
347051|NCT01137812|1171383|P1|Overall Study|Lost to Follow-up|6
347052|NCT01137812|1171382|P2|Overall Study|Adverse Event|14
347053|NCT01137812|1171383|P1|Overall Study|Adverse Event|21
347054|NCT01137786|1171403|P2|Overall Study|Withdrawal by Subject|1
347055|NCT01137786|1171404|P1|Overall Study|Withdrawal by Subject|1
347056|NCT01137786|1171403|P2|Overall Study|Lost to Follow-up|2
347057|NCT01137786|1171404|P1|Overall Study|Lost to Follow-up|0
347058|NCT01137773|1171414|P2|Overall Study|Lost to Follow-up|0
347059|NCT01137773|1171415|P1|Overall Study|Lost to Follow-up|6
347060|NCT01137773|1171414|P2|Overall Study|Death|3
347061|NCT01137773|1171415|P1|Overall Study|Death|3
347062|NCT01137682|1171426|P3|Overall Study|Did not receive treatment in extension|1
347063|NCT01137682|1171427|P2|Overall Study|Did not receive treatment in extension|0
347064|NCT01137682|1171428|P1|Overall Study|Did not receive treatment in extension|0
347065|NCT01137682|1171426|P3|Overall Study|Did not enter extension|2
347066|NCT01137682|1171427|P2|Overall Study|Did not enter extension|3
347067|NCT01137682|1171428|P1|Overall Study|Did not enter extension|2
347068|NCT01137682|1171426|P3|Overall Study|Protocol Violation-Extension|0
347069|NCT01137682|1171427|P2|Overall Study|Protocol Violation-Extension|1
347070|NCT01137682|1171428|P1|Overall Study|Protocol Violation-Extension|2
347071|NCT01137682|1171426|P3|Overall Study|Death-Extension|0
347072|NCT01137682|1171427|P2|Overall Study|Death-Extension|0
347073|NCT01137682|1171428|P1|Overall Study|Death-Extension|2
347074|NCT01137682|1171426|P3|Overall Study|Administrative problems-Extension|0
347075|NCT01137682|1171427|P2|Overall Study|Administrative problems-Extension|2
347076|NCT01137682|1171428|P1|Overall Study|Administrative problems-Extension|0
347077|NCT01137682|1171426|P3|Overall Study|Lost to Follow Up-Extension|0
347078|NCT01137682|1171427|P2|Overall Study|Lost to Follow Up-Extension|1
347079|NCT01137682|1171428|P1|Overall Study|Lost to Follow Up-Extension|0
347080|NCT01137682|1171426|P3|Overall Study|Withdrawal by Subject-Extension|8
347081|NCT01137682|1171427|P2|Overall Study|Withdrawal by Subject-Extension|8
347082|NCT01137682|1171428|P1|Overall Study|Withdrawal by Subject-Extension|6
347083|NCT01137682|1171426|P3|Overall Study|Lack of Efficacy-Extension|13
347084|NCT01137682|1171427|P2|Overall Study|Lack of Efficacy-Extension|9
347085|NCT01137682|1171428|P1|Overall Study|Lack of Efficacy-Extension|15
347086|NCT01137682|1171426|P3|Overall Study|Adverse Event-Extension|7
347087|NCT01137682|1171427|P2|Overall Study|Adverse Event-Extension|8
347088|NCT01137682|1171428|P1|Overall Study|Adverse Event-Extension|4
347089|NCT01137682|1171426|P3|Overall Study|Protocol Violation-CORE|1
347090|NCT01137682|1171427|P2|Overall Study|Protocol Violation-CORE|1
347091|NCT01137682|1171428|P1|Overall Study|Protocol Violation-CORE|0
347092|NCT01137682|1171426|P3|Overall Study|Administrative problems-CORE|0
347093|NCT01137682|1171427|P2|Overall Study|Administrative problems-CORE|1
347094|NCT01137682|1171428|P1|Overall Study|Administrative problems-CORE|2
347095|NCT01137682|1171426|P3|Overall Study|Withdrawal by Subject-CORE|2
347096|NCT01137682|1171427|P2|Overall Study|Withdrawal by Subject-CORE|2
347097|NCT01137682|1171428|P1|Overall Study|Withdrawal by Subject-CORE|2
347098|NCT01137682|1171426|P3|Overall Study|Adverse Event-CORE|0
347099|NCT01137682|1171427|P2|Overall Study|Adverse Event-CORE|4
347100|NCT01137682|1171428|P1|Overall Study|Adverse Event-CORE|2
347101|NCT01137604|1171478|P4|Overall Study|Clinical Decline|1
347102|NCT01137604|1171479|P3|Overall Study|Clinical Decline|1
347103|NCT01137604|1171480|P2|Overall Study|Clinical Decline|0
347104|NCT01137604|1171481|P1|Overall Study|Clinical Decline|0
347105|NCT01137604|1171478|P4|Overall Study|Participant's Decision|0
347106|NCT01137604|1171479|P3|Overall Study|Participant's Decision|0
347107|NCT01137604|1171480|P2|Overall Study|Participant's Decision|0
347108|NCT01137604|1171481|P1|Overall Study|Participant's Decision|1
347109|NCT01137604|1171478|P4|Overall Study|Clinical Progression|0
347110|NCT01137604|1171479|P3|Overall Study|Clinical Progression|1
347111|NCT01137604|1171480|P2|Overall Study|Clinical Progression|2
347112|NCT01137604|1171481|P1|Overall Study|Clinical Progression|0
347113|NCT01137604|1171478|P4|Overall Study|Withdrawal by Subject|1
347114|NCT01137604|1171479|P3|Overall Study|Withdrawal by Subject|2
347115|NCT01137604|1171480|P2|Overall Study|Withdrawal by Subject|2
347116|NCT01137604|1171481|P1|Overall Study|Withdrawal by Subject|0
347117|NCT01137604|1171478|P4|Overall Study|Adverse Event|9
347118|NCT01137604|1171479|P3|Overall Study|Adverse Event|9
347119|NCT01137604|1171480|P2|Overall Study|Adverse Event|6
347120|NCT01137604|1171481|P1|Overall Study|Adverse Event|1
347121|NCT01137578|1171515|P3|Overall Study|Not Specified|6
347122|NCT01137578|1171516|P2|Overall Study|Not Specified|2
347123|NCT01137578|1171517|P1|Overall Study|Not Specified|12
347124|NCT01137578|1171515|P3|Overall Study|Withdrawal by Subject|0
347125|NCT01137578|1171516|P2|Overall Study|Withdrawal by Subject|0
347126|NCT01137578|1171517|P1|Overall Study|Withdrawal by Subject|1
347127|NCT01137578|1171515|P3|Overall Study|Participant requested to Discontinue|0
347128|NCT01137578|1171516|P2|Overall Study|Participant requested to Discontinue|0
347129|NCT01137578|1171517|P1|Overall Study|Participant requested to Discontinue|3
347130|NCT01137474|1171566|P4|Overall Study|Administrative reason by sponsor|0
347131|NCT01137474|1171567|P3|Overall Study|Administrative reason by sponsor|0
347132|NCT01137474|1171568|P2|Overall Study|Administrative reason by sponsor|1
347133|NCT01137474|1171569|P1|Overall Study|Administrative reason by sponsor|0
347134|NCT01137474|1171566|P4|Overall Study|Pregnancy|0
347135|NCT01137474|1171567|P3|Overall Study|Pregnancy|0
347136|NCT01137474|1171568|P2|Overall Study|Pregnancy|1
347137|NCT01137474|1171569|P1|Overall Study|Pregnancy|0
347138|NCT01137474|1171566|P4|Overall Study|Not specified|0
347139|NCT01137474|1171567|P3|Overall Study|Not specified|0
347140|NCT01137474|1171568|P2|Overall Study|Not specified|1
347141|NCT01137474|1171569|P1|Overall Study|Not specified|3
347142|NCT01137474|1171566|P4|Overall Study|Lack of Efficacy|2
347143|NCT01137474|1171567|P3|Overall Study|Lack of Efficacy|0
347144|NCT01137474|1171568|P2|Overall Study|Lack of Efficacy|0
347145|NCT01137474|1171569|P1|Overall Study|Lack of Efficacy|0
347146|NCT01137474|1171566|P4|Overall Study|Lost to Follow-up|2
347147|NCT01137474|1171567|P3|Overall Study|Lost to Follow-up|0
347148|NCT01137474|1171568|P2|Overall Study|Lost to Follow-up|1
347149|NCT01137474|1171569|P1|Overall Study|Lost to Follow-up|5
347150|NCT01137474|1171566|P4|Overall Study|No longer met study criteria|5
347151|NCT01137474|1171567|P3|Overall Study|No longer met study criteria|0
347152|NCT01137474|1171568|P2|Overall Study|No longer met study criteria|1
347153|NCT01137474|1171569|P1|Overall Study|No longer met study criteria|6
347154|NCT01137474|1171566|P4|Overall Study|Withdrawal by Subject|9
347155|NCT01137474|1171567|P3|Overall Study|Withdrawal by Subject|6
347156|NCT01137474|1171568|P2|Overall Study|Withdrawal by Subject|2
347157|NCT01137474|1171569|P1|Overall Study|Withdrawal by Subject|7
347158|NCT01137474|1171566|P4|Overall Study|Adverse Event|3
347159|NCT01137474|1171567|P3|Overall Study|Adverse Event|1
347160|NCT01137474|1171568|P2|Overall Study|Adverse Event|5
347161|NCT01137474|1171569|P1|Overall Study|Adverse Event|3
347162|NCT01137435|1171587|P1|Overall Study|Off label usage|4
347163|NCT01137435|1171587|P1|Overall Study|Lost to Follow-up|24
347164|NCT01137292|1171614|P1|Overall Study|Other|7
347165|NCT01137292|1171614|P1|Overall Study|Lost to Follow-up|1
347166|NCT01137292|1171614|P1|Overall Study|Lack of Efficacy|13
347167|NCT01137292|1171614|P1|Overall Study|Adverse Event|3
347168|NCT01137292|1171614|P1|Overall Study|Death|30
347169|NCT01137071|1171621|P1|Overall Study|Wrongly Included|1
347170|NCT01137071|1171621|P1|Overall Study|Withdrawal by Subject|2
347171|NCT01137071|1171621|P1|Overall Study|Disease Progression|11
347172|NCT01136967|1171690|P2|Overall Study|Diagnosis of Second Primary Cancer|1
347173|NCT01136967|1171691|P1|Overall Study|Diagnosis of Second Primary Cancer|0
347174|NCT01136967|1171690|P2|Overall Study|Increase in Lesion Size|2
347175|NCT01136967|1171691|P1|Overall Study|Increase in Lesion Size|0
347176|NCT01136967|1171690|P2|Overall Study|Investigator's Choice|1
347177|NCT01136967|1171691|P1|Overall Study|Investigator's Choice|1
347178|NCT01136967|1171690|P2|Overall Study|Non Compliance|0
347179|NCT01136967|1171691|P1|Overall Study|Non Compliance|1
347180|NCT01136967|1171690|P2|Overall Study|Radiation|0
347181|NCT01136967|1171691|P1|Overall Study|Radiation|1
347182|NCT01136967|1171690|P2|Overall Study|Clinical Progression|5
347183|NCT01136967|1171691|P1|Overall Study|Clinical Progression|3
347184|NCT01136967|1171690|P2|Overall Study|Withdrawal by Subject|2
347185|NCT01136967|1171691|P1|Overall Study|Withdrawal by Subject|1
347186|NCT01136967|1171690|P2|Overall Study|Lost to Follow-up|1
347187|NCT01136967|1171691|P1|Overall Study|Lost to Follow-up|0
347188|NCT01136967|1171690|P2|Overall Study|Participant Choice|3
347189|NCT01136967|1171691|P1|Overall Study|Participant Choice|8
347190|NCT01136967|1171690|P2|Overall Study|Adverse Event|12
347191|NCT01136967|1171691|P1|Overall Study|Adverse Event|9
347192|NCT01136954|1171709|P2|Overall Study|Not Specified|3
347193|NCT01136954|1171710|P1|Overall Study|Not Specified|1
347194|NCT01136954|1171709|P2|Overall Study|Physician Decision|1
347195|NCT01136954|1171710|P1|Overall Study|Physician Decision|0
347196|NCT01136954|1171709|P2|Overall Study|Lack of Efficacy|13
347197|NCT01136954|1171710|P1|Overall Study|Lack of Efficacy|14
347198|NCT01136954|1171709|P2|Overall Study|Withdrawal by Subject|2
347199|NCT01136954|1171710|P1|Overall Study|Withdrawal by Subject|6
347200|NCT01136954|1171709|P2|Overall Study|Adverse Event|2
347201|NCT01136954|1171710|P1|Overall Study|Adverse Event|3
347202|NCT01136915|1171724|P2|Overall Study|Exclusion criterion met|1
347203|NCT01136915|1171725|P1|Overall Study|Exclusion criterion met|0
347204|NCT01136915|1171724|P2|Overall Study|Lost to Follow-up|0
347205|NCT01136915|1171725|P1|Overall Study|Lost to Follow-up|2
347206|NCT01136876|1171735|P2|Overall Study|Physician Decision|5
347207|NCT01136876|1171736|P1|Overall Study|Physician Decision|3
347208|NCT01136876|1171735|P2|Overall Study|Lost to Follow-up|1
347209|NCT01136876|1171736|P1|Overall Study|Lost to Follow-up|0
347210|NCT01136785|1171746|P2|Overall Study|Protocol Violation|1
347211|NCT01136785|1171747|P1|Overall Study|Protocol Violation|2
347212|NCT01136772|1171762|P2|Overall Study|Did not follow up after first injection|2
347213|NCT01136772|1171763|P1|Overall Study|Did not follow up after first injection|2
347214|NCT01136772|1171762|P2|Overall Study|Did not receive injection|7
347215|NCT01136772|1171763|P1|Overall Study|Did not receive injection|10
347216|NCT01136772|1171762|P2|Overall Study|Withdrawal by Subject|36
347217|NCT01136772|1171763|P1|Overall Study|Withdrawal by Subject|33
347218|NCT01136772|1171762|P2|Overall Study|Administrative|12
347219|NCT01136772|1171763|P1|Overall Study|Administrative|14
347220|NCT01136772|1171762|P2|Overall Study|Lack of Efficacy|39
347221|NCT01136772|1171763|P1|Overall Study|Lack of Efficacy|42
347222|NCT01136772|1171762|P2|Overall Study|Adverse Event|14
347223|NCT01136772|1171763|P1|Overall Study|Adverse Event|15
347224|NCT01136746|1171773|P2|Overall Study|Death|0
347225|NCT01136746|1171774|P1|Overall Study|Death|1
347226|NCT01136746|1171773|P2|Overall Study|Protocol Violation|1
347227|NCT01136746|1171774|P1|Overall Study|Protocol Violation|2
347228|NCT01136746|1171773|P2|Overall Study|Lost to Follow-up|2
347229|NCT01136746|1171774|P1|Overall Study|Lost to Follow-up|0
347230|NCT01136655|1171834|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
347231|NCT01136655|1171834|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
347232|NCT01136655|1171834|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
347233|NCT01136655|1171834|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
347234|NCT01136408|1171867|P3|Overall Study|Protocol Violation|1
347235|NCT01136408|1171868|P2|Overall Study|Protocol Violation|1
347236|NCT01136408|1171869|P1|Overall Study|Protocol Violation|1
347237|NCT01136408|1171867|P3|Overall Study|Adverse Event|4
347238|NCT01136408|1171868|P2|Overall Study|Adverse Event|8
347239|NCT01136408|1171869|P1|Overall Study|Adverse Event|4
347240|NCT01136382|1171926|P2|Overall Study|Withdrawal by Subject|1
347241|NCT01136382|1171927|P1|Overall Study|Withdrawal by Subject|4
347242|NCT01136382|1171926|P2|Overall Study|Severe Non-Compliance to Protocol|2
347243|NCT01136382|1171927|P1|Overall Study|Severe Non-Compliance to Protocol|0
347244|NCT01136382|1171926|P2|Overall Study|Study-Specific Withdrawal Criteria|25
347245|NCT01136382|1171927|P1|Overall Study|Study-Specific Withdrawal Criteria|48
347246|NCT01136382|1171926|P2|Overall Study|Not Specified|3
347247|NCT01136382|1171927|P1|Overall Study|Not Specified|8
347248|NCT01136356|1171953|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
347249|NCT01136356|1171954|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
347250|NCT01136356|1171953|P2|First 18-day Withdrawal|Physician Decision|0
347251|NCT01136356|1171954|P1|First 18-day Withdrawal|Physician Decision|1
347252|NCT01136356|1171953|P2|First 18-day Withdrawal|Withdrawal by Subject|0
347253|NCT01136356|1171954|P1|First 18-day Withdrawal|Withdrawal by Subject|3
347254|NCT01136291|1171965|P2|Overall Study|Lost to Follow-up|1
347255|NCT01136291|1171966|P1|Overall Study|Lost to Follow-up|1
347256|NCT01136174|1171984|P4|Overall Study|Adverse Event|4
347257|NCT01136174|1171985|P3|Overall Study|Adverse Event|0
347258|NCT01136174|1171986|P2|Overall Study|Adverse Event|0
347259|NCT01136174|1171987|P1|Overall Study|Adverse Event|0
347260|NCT01135992|1172067|P1|Overall Study|Unclassified|7
347261|NCT01135992|1172067|P1|Overall Study|Withdrawal criteria|10
347262|NCT01135992|1172067|P1|Overall Study|Protocol Violation|2
347263|NCT01135992|1172067|P1|Overall Study|Lack of Efficacy|1
347264|NCT01135992|1172067|P1|Overall Study|Adverse Event|1
347265|NCT01135914|1172079|P3|Overall Study|Adverse Event|2
347266|NCT01135914|1172080|P2|Overall Study|Adverse Event|1
347267|NCT01135914|1172081|P1|Overall Study|Adverse Event|0
347268|NCT01135914|1172079|P3|Overall Study|Lack of Efficacy|10
347269|NCT01135914|1172080|P2|Overall Study|Lack of Efficacy|1
347270|NCT01135914|1172081|P1|Overall Study|Lack of Efficacy|2
347271|NCT01135914|1172079|P3|Overall Study|Protocol Violation|3
347272|NCT01135914|1172080|P2|Overall Study|Protocol Violation|0
347273|NCT01135914|1172081|P1|Overall Study|Protocol Violation|0
347274|NCT01135914|1172079|P3|Overall Study|Lost to Follow-up|1
347275|NCT01135914|1172080|P2|Overall Study|Lost to Follow-up|0
347276|NCT01135914|1172081|P1|Overall Study|Lost to Follow-up|1
347277|NCT01135914|1172079|P3|Overall Study|Withdrawal by Subject|6
347278|NCT01135914|1172080|P2|Overall Study|Withdrawal by Subject|3
347279|NCT01135914|1172081|P1|Overall Study|Withdrawal by Subject|1
347280|NCT01135524|1172110|P1|Overall Study|Lack of Efficacy|8
347281|NCT01135524|1172110|P1|Overall Study|Administrative|151
347282|NCT01135524|1172110|P1|Overall Study|Lost to Follow-up|3
347283|NCT01135524|1172110|P1|Overall Study|Adverse Event|20
347284|NCT01135524|1172110|P1|Overall Study|Withdrawal by Subject|14
347285|NCT01135511|1172123|P9|Overall Study|Withdrawal by Subject|1
347286|NCT01135511|1172124|P8|Overall Study|Withdrawal by Subject|0
347287|NCT01135511|1172125|P7|Overall Study|Withdrawal by Subject|1
347288|NCT01135511|1172126|P6|Overall Study|Withdrawal by Subject|0
347289|NCT01135511|1172127|P5|Overall Study|Withdrawal by Subject|0
347290|NCT01135511|1172128|P4|Overall Study|Withdrawal by Subject|0
347291|NCT01135511|1172129|P3|Overall Study|Withdrawal by Subject|0
347292|NCT01135511|1172130|P2|Overall Study|Withdrawal by Subject|0
347293|NCT01135511|1172131|P1|Overall Study|Withdrawal by Subject|0
347294|NCT01135511|1172123|P9|Overall Study|noncompliance with study drug taken|0
347295|NCT01135511|1172124|P8|Overall Study|noncompliance with study drug taken|0
347296|NCT01135511|1172125|P7|Overall Study|noncompliance with study drug taken|0
347297|NCT01135511|1172126|P6|Overall Study|noncompliance with study drug taken|0
347298|NCT01135511|1172127|P5|Overall Study|noncompliance with study drug taken|1
347299|NCT01135511|1172128|P4|Overall Study|noncompliance with study drug taken|0
347300|NCT01135511|1172129|P3|Overall Study|noncompliance with study drug taken|0
347301|NCT01135511|1172130|P2|Overall Study|noncompliance with study drug taken|0
347302|NCT01135511|1172131|P1|Overall Study|noncompliance with study drug taken|0
347303|NCT01135511|1172123|P9|Overall Study|could not visit the clinic|0
347304|NCT01135511|1172124|P8|Overall Study|could not visit the clinic|0
347305|NCT01135511|1172125|P7|Overall Study|could not visit the clinic|0
347306|NCT01135511|1172126|P6|Overall Study|could not visit the clinic|0
347307|NCT01135511|1172127|P5|Overall Study|could not visit the clinic|0
347308|NCT01135511|1172128|P4|Overall Study|could not visit the clinic|0
347309|NCT01135511|1172129|P3|Overall Study|could not visit the clinic|2
347310|NCT01135511|1172130|P2|Overall Study|could not visit the clinic|1
347311|NCT01135511|1172131|P1|Overall Study|could not visit the clinic|0
347312|NCT01135511|1172123|P9|Overall Study|Pregnancy|0
347313|NCT01135511|1172124|P8|Overall Study|Pregnancy|0
347314|NCT01135511|1172125|P7|Overall Study|Pregnancy|0
347315|NCT01135511|1172126|P6|Overall Study|Pregnancy|0
347316|NCT01135511|1172127|P5|Overall Study|Pregnancy|0
347317|NCT01135511|1172128|P4|Overall Study|Pregnancy|1
347318|NCT01135511|1172129|P3|Overall Study|Pregnancy|0
347319|NCT01135511|1172130|P2|Overall Study|Pregnancy|0
347320|NCT01135511|1172131|P1|Overall Study|Pregnancy|0
347321|NCT01135511|1172123|P9|Overall Study|Protocol Violation|0
347322|NCT01135511|1172124|P8|Overall Study|Protocol Violation|0
347323|NCT01135511|1172125|P7|Overall Study|Protocol Violation|0
347324|NCT01135511|1172126|P6|Overall Study|Protocol Violation|0
347325|NCT01135511|1172127|P5|Overall Study|Protocol Violation|0
347326|NCT01135511|1172128|P4|Overall Study|Protocol Violation|0
347327|NCT01135511|1172129|P3|Overall Study|Protocol Violation|3
347328|NCT01135511|1172130|P2|Overall Study|Protocol Violation|0
347329|NCT01135511|1172131|P1|Overall Study|Protocol Violation|0
347330|NCT01135511|1172123|P9|Overall Study|Lack of Efficacy|0
347331|NCT01135511|1172124|P8|Overall Study|Lack of Efficacy|0
347332|NCT01135511|1172125|P7|Overall Study|Lack of Efficacy|0
347333|NCT01135511|1172126|P6|Overall Study|Lack of Efficacy|0
347334|NCT01135511|1172127|P5|Overall Study|Lack of Efficacy|0
347335|NCT01135511|1172128|P4|Overall Study|Lack of Efficacy|2
347336|NCT01135511|1172129|P3|Overall Study|Lack of Efficacy|1
347337|NCT01135511|1172130|P2|Overall Study|Lack of Efficacy|1
347338|NCT01135511|1172131|P1|Overall Study|Lack of Efficacy|0
347339|NCT01135511|1172123|P9|Overall Study|Adverse Event|0
347340|NCT01135511|1172124|P8|Overall Study|Adverse Event|1
347341|NCT01135511|1172125|P7|Overall Study|Adverse Event|0
347342|NCT01135511|1172126|P6|Overall Study|Adverse Event|1
347343|NCT01135511|1172127|P5|Overall Study|Adverse Event|0
347344|NCT01135511|1172128|P4|Overall Study|Adverse Event|0
347345|NCT01135511|1172129|P3|Overall Study|Adverse Event|2
347346|NCT01135511|1172130|P2|Overall Study|Adverse Event|1
347347|NCT01135511|1172131|P1|Overall Study|Adverse Event|0
347348|NCT01135498|1172413|P1|Overall Study|Ongoing at time of analysis|2
347349|NCT01135498|1172413|P1|Overall Study|Death|1
347350|NCT01135498|1172413|P1|Overall Study|Withdrawal by Subject|4
347351|NCT01135498|1172413|P1|Overall Study|Investigator judgement|25
347352|NCT01135498|1172413|P1|Overall Study|Progressive disease|38
347353|NCT01135498|1172413|P1|Overall Study|Adverse Event|20
347354|NCT01135134|1172581|P2|Overall Study|Did not meet protocol eligibility|0
347355|NCT01135134|1172582|P1|Overall Study|Did not meet protocol eligibility|1
347356|NCT01135134|1172581|P2|Overall Study|Adverse Event|1
347357|NCT01135134|1172582|P1|Overall Study|Adverse Event|1
347358|NCT01135017|1172605|P2|Overall Study|Other than above|4
347359|NCT01135017|1172606|P1|Overall Study|Other than above|3
347360|NCT01135017|1172605|P2|Overall Study|Adverse Event|8
347361|NCT01135017|1172606|P1|Overall Study|Adverse Event|3
347362|NCT01134939|1172644|P8|Overall Study|Termination page not available|0
347363|NCT01134939|1172645|P7|Overall Study|Termination page not available|7
347364|NCT01134939|1172646|P6|Overall Study|Termination page not available|3
347365|NCT01134939|1172647|P5|Overall Study|Termination page not available|0
347366|NCT01134939|1172648|P4|Overall Study|Termination page not available|8
347367|NCT01134939|1172649|P3|Overall Study|Termination page not available|5
347368|NCT01134939|1172650|P2|Overall Study|Termination page not available|6
347369|NCT01134939|1172651|P1|Overall Study|Termination page not available|4
347370|NCT01134939|1172644|P8|Overall Study|Death|0
347371|NCT01134939|1172645|P7|Overall Study|Death|0
347372|NCT01134939|1172646|P6|Overall Study|Death|0
347373|NCT01134939|1172647|P5|Overall Study|Death|0
347374|NCT01134939|1172648|P4|Overall Study|Death|0
347375|NCT01134939|1172649|P3|Overall Study|Death|0
347376|NCT01134939|1172650|P2|Overall Study|Death|1
347377|NCT01134939|1172651|P1|Overall Study|Death|0
347378|NCT01134939|1172644|P8|Overall Study|Lost to Follow-up|0
347379|NCT01134939|1172645|P7|Overall Study|Lost to Follow-up|0
347380|NCT01134939|1172646|P6|Overall Study|Lost to Follow-up|1
347381|NCT01134939|1172647|P5|Overall Study|Lost to Follow-up|2
347382|NCT01134939|1172648|P4|Overall Study|Lost to Follow-up|1
347383|NCT01134939|1172649|P3|Overall Study|Lost to Follow-up|0
347384|NCT01134939|1172650|P2|Overall Study|Lost to Follow-up|3
347385|NCT01134939|1172651|P1|Overall Study|Lost to Follow-up|2
347386|NCT01134939|1172644|P8|Overall Study|Lack of Efficacy|0
347387|NCT01134939|1172645|P7|Overall Study|Lack of Efficacy|1
347388|NCT01134939|1172646|P6|Overall Study|Lack of Efficacy|0
347389|NCT01134939|1172647|P5|Overall Study|Lack of Efficacy|3
347390|NCT01134939|1172648|P4|Overall Study|Lack of Efficacy|0
347391|NCT01134939|1172649|P3|Overall Study|Lack of Efficacy|1
347392|NCT01134939|1172650|P2|Overall Study|Lack of Efficacy|5
347393|NCT01134939|1172651|P1|Overall Study|Lack of Efficacy|2
347394|NCT01134939|1172644|P8|Overall Study|Adverse Event|0
347395|NCT01134939|1172645|P7|Overall Study|Adverse Event|1
347396|NCT01134939|1172646|P6|Overall Study|Adverse Event|5
347397|NCT01134939|1172647|P5|Overall Study|Adverse Event|5
347398|NCT01134939|1172648|P4|Overall Study|Adverse Event|5
347399|NCT01134939|1172649|P3|Overall Study|Adverse Event|4
347400|NCT01134939|1172650|P2|Overall Study|Adverse Event|3
347401|NCT01134939|1172651|P1|Overall Study|Adverse Event|9
347402|NCT01134783|1172789|P2|Overall Study|Lost to Follow-up|20
347403|NCT01134783|1172790|P1|Overall Study|Lost to Follow-up|5
347404|NCT01134783|1172789|P2|Overall Study|Withdrawal by Subject|9
347405|NCT01134783|1172790|P1|Overall Study|Withdrawal by Subject|15
347406|NCT01134783|1172789|P2|Overall Study|Pregnancy|8
347407|NCT01134783|1172790|P1|Overall Study|Pregnancy|16
347408|NCT01134731|1172809|P3|Overall Study|Lost to Follow-up|3
347409|NCT01134731|1172810|P2|Overall Study|Lost to Follow-up|4
347410|NCT01134731|1172811|P1|Overall Study|Lost to Follow-up|5
347411|NCT01134731|1172809|P3|Overall Study|Withdrawal by Subject|1
347412|NCT01134731|1172810|P2|Overall Study|Withdrawal by Subject|3
347413|NCT01134731|1172811|P1|Overall Study|Withdrawal by Subject|3
347414|NCT01134731|1172809|P3|Overall Study|Lack of Efficacy|1
347415|NCT01134731|1172810|P2|Overall Study|Lack of Efficacy|0
347416|NCT01134731|1172811|P1|Overall Study|Lack of Efficacy|0
347417|NCT01134731|1172809|P3|Overall Study|Physician Decision|2
347418|NCT01134731|1172810|P2|Overall Study|Physician Decision|2
347419|NCT01134731|1172811|P1|Overall Study|Physician Decision|2
347420|NCT01134731|1172809|P3|Overall Study|Adverse Event|1
347421|NCT01134731|1172810|P2|Overall Study|Adverse Event|2
347422|NCT01134731|1172811|P1|Overall Study|Adverse Event|3
347423|NCT01134705|1172824|P2|Overall Study|Other|6
347424|NCT01134705|1172825|P1|Overall Study|Other|1
347425|NCT01134705|1172824|P2|Overall Study|Protocol Violation|1
347426|NCT01134705|1172825|P1|Overall Study|Protocol Violation|1
347427|NCT01134705|1172824|P2|Overall Study|Lost to Follow-up|2
347428|NCT01134705|1172825|P1|Overall Study|Lost to Follow-up|5
347429|NCT01134705|1172824|P2|Overall Study|Pregnancy|0
347430|NCT01134705|1172825|P1|Overall Study|Pregnancy|1
347431|NCT01134705|1172824|P2|Overall Study|Withdrawal by Subject|6
347432|NCT01134705|1172825|P1|Overall Study|Withdrawal by Subject|6
347433|NCT01134705|1172824|P2|Overall Study|Adverse Event|7
347434|NCT01134705|1172825|P1|Overall Study|Adverse Event|1
347435|NCT01134627|1172837|P2|Overall Study|Other|14
347436|NCT01134627|1172838|P1|Overall Study|Other|11
347437|NCT01134627|1172837|P2|Overall Study|Planning to become pregnant/pregnancy|0
347438|NCT01134627|1172838|P1|Overall Study|Planning to become pregnant/pregnancy|1
347439|NCT01134627|1172837|P2|Overall Study|Withdrawal by Subject|3
347440|NCT01134627|1172838|P1|Overall Study|Withdrawal by Subject|4
347441|NCT01134627|1172837|P2|Overall Study|Lack of Efficacy|12
347442|NCT01134627|1172838|P1|Overall Study|Lack of Efficacy|2
347443|NCT01134627|1172837|P2|Overall Study|Protocol Violation|5
347444|NCT01134627|1172838|P1|Overall Study|Protocol Violation|3
347445|NCT01134627|1172837|P2|Overall Study|Lost to Follow-up|2
347446|NCT01134627|1172838|P1|Overall Study|Lost to Follow-up|1
347447|NCT01134627|1172837|P2|Overall Study|Adverse Event|31
347448|NCT01134627|1172838|P1|Overall Study|Adverse Event|47
347449|NCT01134614|1172868|P2|Overall Study|Patient in hospice care|1
347450|NCT01134614|1172869|P1|Overall Study|Patient in hospice care|0
347451|NCT01134614|1172868|P2|Overall Study|Symptomatic deterioration|1
347452|NCT01134614|1172869|P1|Overall Study|Symptomatic deterioration|0
347453|NCT01134614|1172868|P2|Overall Study|Pt received tx not allowed on study|1
347454|NCT01134614|1172869|P1|Overall Study|Pt received tx not allowed on study|0
347455|NCT01134614|1172868|P2|Overall Study|Never started treatment|1
347456|NCT01134614|1172869|P1|Overall Study|Never started treatment|4
347457|NCT01134614|1172868|P2|Overall Study|Physician's decision|1
347458|NCT01134614|1172869|P1|Overall Study|Physician's decision|0
347459|NCT01134614|1172868|P2|Overall Study|Complicating disease|1
347460|NCT01134614|1172869|P1|Overall Study|Complicating disease|2
347461|NCT01134614|1172868|P2|Overall Study|Alternative therapy|0
347462|NCT01134614|1172869|P1|Overall Study|Alternative therapy|2
347463|NCT01134614|1172868|P2|Overall Study|Withdrawal by Subject|2
347464|NCT01134614|1172869|P1|Overall Study|Withdrawal by Subject|3
347465|NCT01134614|1172868|P2|Overall Study|Death|8
347466|NCT01134614|1172869|P1|Overall Study|Death|5
347467|NCT01134614|1172868|P2|Overall Study|Adverse Event|39
347468|NCT01134614|1172869|P1|Overall Study|Adverse Event|26
347469|NCT01134614|1172868|P2|Overall Study|Progressive disease|54
347470|NCT01134614|1172869|P1|Overall Study|Progressive disease|60
347471|NCT01134614|1172868|P2|Overall Study|Still on treatment as of March 2013|13
347472|NCT01134614|1172869|P1|Overall Study|Still on treatment as of March 2013|21
347473|NCT01134562|1172884|P5|Overall Study|Adverse Event|0
347474|NCT01134562|1172885|P4|Overall Study|Adverse Event|0
347475|NCT01134562|1172886|P3|Overall Study|Adverse Event|0
347476|NCT01134562|1172887|P2|Overall Study|Adverse Event|1
347477|NCT01134562|1172888|P1|Overall Study|Adverse Event|0
347478|NCT01134393|1173060|P1|Overall Study|Other|6
347479|NCT01134393|1173060|P1|Overall Study|Withdrawal by Subject|11
347480|NCT01134393|1173060|P1|Overall Study|Lost to Follow-up|3
347481|NCT01134393|1173060|P1|Overall Study|Protocol Violation|12
347482|NCT01134393|1173060|P1|Overall Study|Lack of Efficacy|2
347483|NCT01134393|1173060|P1|Overall Study|Adverse Event|18
347484|NCT01134315|1173181|P2|Overall Study|Other Reason|17
347485|NCT01134315|1173182|P1|Overall Study|Other Reason|8
347486|NCT01134315|1173181|P2|Overall Study|Adverse Event|2
347487|NCT01134315|1173182|P1|Overall Study|Adverse Event|1
347488|NCT01134107|1173217|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
347489|NCT01134107|1173218|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
347490|NCT01134107|1173217|P2|Period 2-Second Treatment Intervention|Physician Decision|0
347491|NCT01134107|1173218|P1|Period 2-Second Treatment Intervention|Physician Decision|1
347492|NCT01134107|1173217|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
347493|NCT01134107|1173218|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
347494|NCT01134107|1173217|P2|Period 1-First Treatment Intervention|Physician Decision|0
347495|NCT01134107|1173218|P1|Period 1-First Treatment Intervention|Physician Decision|1
347496|NCT01134107|1173217|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
347497|NCT01134107|1173218|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
347498|NCT01134107|1173217|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
347499|NCT01134107|1173218|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
347500|NCT01134107|1173217|P2|Period 1-First Treatment Intervention|Adverse Event|0
347501|NCT01134107|1173218|P1|Period 1-First Treatment Intervention|Adverse Event|1
347502|NCT01134055|1173265|P7|Overall Study|Physician Decision|1
347503|NCT01134055|1173266|P6|Overall Study|Physician Decision|0
347504|NCT01134055|1173267|P5|Overall Study|Physician Decision|0
347505|NCT01134055|1173268|P4|Overall Study|Physician Decision|0
347506|NCT01134055|1173269|P3|Overall Study|Physician Decision|0
347507|NCT01134055|1173270|P2|Overall Study|Physician Decision|0
347508|NCT01134055|1173271|P1|Overall Study|Physician Decision|0
347509|NCT01134055|1173265|P7|Overall Study|Protocol Violation|0
347510|NCT01134055|1173266|P6|Overall Study|Protocol Violation|0
347511|NCT01134055|1173267|P5|Overall Study|Protocol Violation|1
347512|NCT01134055|1173268|P4|Overall Study|Protocol Violation|1
347513|NCT01134055|1173269|P3|Overall Study|Protocol Violation|0
347514|NCT01134055|1173270|P2|Overall Study|Protocol Violation|0
347515|NCT01134055|1173271|P1|Overall Study|Protocol Violation|0
347516|NCT01134055|1173265|P7|Overall Study|Withdrawal by Subject|8
347517|NCT01134055|1173266|P6|Overall Study|Withdrawal by Subject|0
347518|NCT01134055|1173267|P5|Overall Study|Withdrawal by Subject|0
347519|NCT01134055|1173268|P4|Overall Study|Withdrawal by Subject|2
347520|NCT01134055|1173269|P3|Overall Study|Withdrawal by Subject|1
347521|NCT01134055|1173270|P2|Overall Study|Withdrawal by Subject|3
347522|NCT01134055|1173271|P1|Overall Study|Withdrawal by Subject|3
347523|NCT01134055|1173265|P7|Overall Study|Lost to Follow-up|0
347524|NCT01134055|1173266|P6|Overall Study|Lost to Follow-up|0
347525|NCT01134055|1173267|P5|Overall Study|Lost to Follow-up|0
347526|NCT01134055|1173268|P4|Overall Study|Lost to Follow-up|1
347527|NCT01134055|1173269|P3|Overall Study|Lost to Follow-up|0
347528|NCT01134055|1173270|P2|Overall Study|Lost to Follow-up|1
347529|NCT01134055|1173271|P1|Overall Study|Lost to Follow-up|0
347530|NCT01134055|1173265|P7|Overall Study|Adverse Event|2
347531|NCT01134055|1173266|P6|Overall Study|Adverse Event|7
347532|NCT01134055|1173267|P5|Overall Study|Adverse Event|5
347533|NCT01134055|1173268|P4|Overall Study|Adverse Event|2
347534|NCT01134055|1173269|P3|Overall Study|Adverse Event|2
347535|NCT01134055|1173270|P2|Overall Study|Adverse Event|2
347536|NCT01134055|1173271|P1|Overall Study|Adverse Event|5
347537|NCT01134042|1173405|P3|Overall Study|Withdrawal by Subject|7
347538|NCT01134042|1173406|P2|Overall Study|Withdrawal by Subject|4
347539|NCT01134042|1173407|P1|Overall Study|Withdrawal by Subject|13
347540|NCT01134042|1173405|P3|Overall Study|Physician Decision|1
347541|NCT01134042|1173406|P2|Overall Study|Physician Decision|8
347542|NCT01134042|1173407|P1|Overall Study|Physician Decision|4
347543|NCT01134042|1173405|P3|Overall Study|Lost to Follow-up|1
347544|NCT01134042|1173406|P2|Overall Study|Lost to Follow-up|0
347545|NCT01134042|1173407|P1|Overall Study|Lost to Follow-up|2
347546|NCT01134042|1173405|P3|Overall Study|Protocol Violation|5
347547|NCT01134042|1173406|P2|Overall Study|Protocol Violation|3
347548|NCT01134042|1173407|P1|Overall Study|Protocol Violation|5
347549|NCT01134042|1173405|P3|Overall Study|Lack of Efficacy|18
347550|NCT01134042|1173406|P2|Overall Study|Lack of Efficacy|6
347551|NCT01134042|1173407|P1|Overall Study|Lack of Efficacy|21
347552|NCT01134042|1173405|P3|Overall Study|Adverse Event|2
347553|NCT01134042|1173406|P2|Overall Study|Adverse Event|7
347554|NCT01134042|1173407|P1|Overall Study|Adverse Event|3
347555|NCT01133977|1173483|P5|Overall Study|Withdrawal by Subject|1
347556|NCT01133977|1173484|P4|Overall Study|Withdrawal by Subject|5
347557|NCT01133977|1173485|P3|Overall Study|Withdrawal by Subject|0
347558|NCT01133977|1173486|P2|Overall Study|Withdrawal by Subject|0
347559|NCT01133977|1173487|P1|Overall Study|Withdrawal by Subject|0
347560|NCT01133977|1173483|P5|Overall Study|Lost to Follow-up|1
347561|NCT01133977|1173484|P4|Overall Study|Lost to Follow-up|2
347562|NCT01133977|1173485|P3|Overall Study|Lost to Follow-up|0
347563|NCT01133977|1173486|P2|Overall Study|Lost to Follow-up|0
347564|NCT01133977|1173487|P1|Overall Study|Lost to Follow-up|0
347565|NCT01133977|1173483|P5|Overall Study|Started a New Line of Therapy|33
347566|NCT01133977|1173484|P4|Overall Study|Started a New Line of Therapy|25
347567|NCT01133977|1173485|P3|Overall Study|Started a New Line of Therapy|4
347568|NCT01133977|1173486|P2|Overall Study|Started a New Line of Therapy|6
347569|NCT01133977|1173487|P1|Overall Study|Started a New Line of Therapy|2
347570|NCT01133977|1173483|P5|Overall Study|Death|3
347571|NCT01133977|1173484|P4|Overall Study|Death|7
347572|NCT01133977|1173485|P3|Overall Study|Death|1
347573|NCT01133977|1173486|P2|Overall Study|Death|1
347574|NCT01133977|1173487|P1|Overall Study|Death|1
347575|NCT01133977|1173483|P5|Overall Study|Adverse Event|0
347576|NCT01133977|1173484|P4|Overall Study|Adverse Event|0
347577|NCT01133977|1173485|P3|Overall Study|Adverse Event|1
347578|NCT01133977|1173486|P2|Overall Study|Adverse Event|0
347579|NCT01133977|1173487|P1|Overall Study|Adverse Event|0
347580|NCT01133847|1173514|P3|Follow-Up Phase|Lost to Follow-up|7
347581|NCT01133847|1173515|P2|Follow-Up Phase|Lost to Follow-up|3
347582|NCT01133847|1173516|P1|Follow-Up Phase|Lost to Follow-up|1
347583|NCT01133847|1173514|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
347584|NCT01133847|1173515|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
347585|NCT01133847|1173516|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
347586|NCT01133821|1173556|P2|Overall Study|Refused participation|3
347587|NCT01133821|1173557|P1|Overall Study|Refused participation|1
347588|NCT01133821|1173556|P2|Overall Study|Protocol Violation|1
347589|NCT01133821|1173557|P1|Overall Study|Protocol Violation|0
347590|NCT01133821|1173556|P2|Overall Study|preferred other treatment|1
347591|NCT01133821|1173557|P1|Overall Study|preferred other treatment|1
347592|NCT01133821|1173556|P2|Overall Study|Withdrawal by Subject|3
347593|NCT01133821|1173557|P1|Overall Study|Withdrawal by Subject|8
347594|NCT01133821|1173556|P2|Overall Study|Lost to Follow-up|11
347595|NCT01133821|1173557|P1|Overall Study|Lost to Follow-up|8
347596|NCT01133756|1173568|P3|Overall Study|Progression of Disease|1
347597|NCT01133756|1173569|P2|Overall Study|Progression of Disease|0
347598|NCT01133756|1173570|P1|Overall Study|Progression of Disease|0
347599|NCT01133756|1173568|P3|Overall Study|Withdrawal by Subject|0
347600|NCT01133756|1173569|P2|Overall Study|Withdrawal by Subject|1
347601|NCT01133756|1173570|P1|Overall Study|Withdrawal by Subject|0
347602|NCT01133756|1173568|P3|Overall Study|Investigator Decision|0
347603|NCT01133756|1173569|P2|Overall Study|Investigator Decision|0
347604|NCT01133756|1173570|P1|Overall Study|Investigator Decision|1
347605|NCT01133756|1173568|P3|Overall Study|Adverse Event|1
347606|NCT01133756|1173569|P2|Overall Study|Adverse Event|2
347607|NCT01133756|1173570|P1|Overall Study|Adverse Event|1
347608|NCT01133704|1173586|P2|Overall Study|Study Closure|0
347609|NCT01133704|1173587|P1|Overall Study|Study Closure|1
347610|NCT01133704|1173586|P2|Overall Study|Patient refused to continue|0
347611|NCT01133704|1173587|P1|Overall Study|Patient refused to continue|4
347612|NCT01133704|1173586|P2|Overall Study|Death|26
347613|NCT01133704|1173587|P1|Overall Study|Death|44
347614|NCT01133665|1173595|P1|Overall Study|Physician Decision|2
347615|NCT01133626|1173639|P3|Overall Study|Not specified|0
347616|NCT01133626|1173640|P2|Overall Study|Not specified|2
347617|NCT01133626|1173641|P1|Overall Study|Not specified|0
347618|NCT01133626|1173639|P3|Overall Study|Withdrawal by Subject|2
347619|NCT01133626|1173640|P2|Overall Study|Withdrawal by Subject|2
347620|NCT01133626|1173641|P1|Overall Study|Withdrawal by Subject|1
347621|NCT01133626|1173639|P3|Overall Study|Adverse Event|0
347622|NCT01133626|1173640|P2|Overall Study|Adverse Event|1
347623|NCT01133626|1173641|P1|Overall Study|Adverse Event|0
347624|NCT01133522|1173659|P10|Overall Study|Physician Decision|0
347625|NCT01133522|1173660|P9|Overall Study|Physician Decision|0
347626|NCT01133522|1173661|P8|Overall Study|Physician Decision|0
347627|NCT01133522|1173662|P7|Overall Study|Physician Decision|0
347628|NCT01133522|1173663|P6|Overall Study|Physician Decision|0
347629|NCT01133522|1173664|P5|Overall Study|Physician Decision|1
347630|NCT01133522|1173665|P4|Overall Study|Physician Decision|0
347631|NCT01133522|1173666|P3|Overall Study|Physician Decision|0
347632|NCT01133522|1173667|P2|Overall Study|Physician Decision|0
347633|NCT01133522|1173668|P1|Overall Study|Physician Decision|0
347634|NCT01133522|1173659|P10|Overall Study|Withdrawal by Subject|0
347635|NCT01133522|1173660|P9|Overall Study|Withdrawal by Subject|0
347636|NCT01133522|1173661|P8|Overall Study|Withdrawal by Subject|0
347637|NCT01133522|1173662|P7|Overall Study|Withdrawal by Subject|0
347638|NCT01133522|1173663|P6|Overall Study|Withdrawal by Subject|0
347639|NCT01133522|1173664|P5|Overall Study|Withdrawal by Subject|0
347640|NCT01133522|1173665|P4|Overall Study|Withdrawal by Subject|1
347641|NCT01133522|1173666|P3|Overall Study|Withdrawal by Subject|0
347642|NCT01133522|1173667|P2|Overall Study|Withdrawal by Subject|1
347643|NCT01133522|1173668|P1|Overall Study|Withdrawal by Subject|0
347644|NCT01133418|1173736|P2|Overall Study|Lost to Follow-up|6
347645|NCT01133418|1173737|P1|Overall Study|Lost to Follow-up|5
347646|NCT01133392|1173751|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
347647|NCT01133392|1173752|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
347648|NCT01133392|1173751|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
347649|NCT01133392|1173752|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
347650|NCT01133379|1173769|P3|Overall Study|Lost to Follow-up|1
347651|NCT01133379|1173770|P2|Overall Study|Lost to Follow-up|1
347652|NCT01133379|1173771|P1|Overall Study|Lost to Follow-up|1
347653|NCT01133379|1173769|P3|Overall Study|Withdrawal by Subject|1
347654|NCT01133379|1173770|P2|Overall Study|Withdrawal by Subject|1
347655|NCT01133379|1173771|P1|Overall Study|Withdrawal by Subject|0
347656|NCT01133288|1173824|P1|Intervention Allocation|study terminated|2
347657|NCT01133288|1173824|P1|Eligibility Assessment|met exclusion criteria|5
347658|NCT01133275|1173829|P1|Overall Study|Cerebrovascular accident (CVA)|1
347659|NCT01133275|1173829|P1|Overall Study|Withdrawal by Subject|1
347660|NCT01133171|1173837|P3|Overall Study|Withdrawal by Subject|0
347661|NCT01133171|1173838|P2|Overall Study|Withdrawal by Subject|2
347662|NCT01133171|1173839|P1|Overall Study|Withdrawal by Subject|1
347663|NCT01132820|1173904|P1|Overall Study|Inadequate data|1
347664|NCT01132820|1173904|P1|Overall Study|Never treated|1
347665|NCT01132820|1173904|P1|Overall Study|Ineligible:Inadequate pathology|1
347666|NCT01132820|1173904|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
347667|NCT01132820|1173904|P1|Overall Study|Ineligible: wrong cell type|1
347668|NCT01132664|1173937|P5|BM Cohort|Withdrawal by Subject|1
347669|NCT01132664|1173938|P4|BM Cohort|Withdrawal by Subject|0
347670|NCT01132664|1173939|P3|BM Cohort|Withdrawal by Subject|0
347671|NCT01132664|1173940|P2|BM Cohort|Withdrawal by Subject|0
347672|NCT01132664|1173941|P1|BM Cohort|Withdrawal by Subject|0
347673|NCT01132664|1173937|P5|BM Cohort|Adverse Event|1
347674|NCT01132664|1173938|P4|BM Cohort|Adverse Event|0
347675|NCT01132664|1173939|P3|BM Cohort|Adverse Event|0
347676|NCT01132664|1173940|P2|BM Cohort|Adverse Event|0
347677|NCT01132664|1173941|P1|BM Cohort|Adverse Event|0
347678|NCT01132664|1173937|P5|BM Cohort|Disease progression|4
347679|NCT01132664|1173938|P4|BM Cohort|Disease progression|3
347680|NCT01132664|1173939|P3|BM Cohort|Disease progression|0
347681|NCT01132664|1173940|P2|BM Cohort|Disease progression|0
347682|NCT01132664|1173941|P1|BM Cohort|Disease progression|0
347683|NCT01132664|1173937|P5|Phase ll|Disease progression|0
347684|NCT01132664|1173938|P4|Phase ll|Disease progression|0
347685|NCT01132664|1173939|P3|Phase ll|Disease progression|35
347686|NCT01132664|1173940|P2|Phase ll|Disease progression|0
347687|NCT01132664|1173941|P1|Phase ll|Disease progression|0
347688|NCT01132664|1173937|P5|Phase ll|Withdrawal by Subject|0
347689|NCT01132664|1173938|P4|Phase ll|Withdrawal by Subject|0
347690|NCT01132664|1173939|P3|Phase ll|Withdrawal by Subject|3
347691|NCT01132664|1173940|P2|Phase ll|Withdrawal by Subject|0
347692|NCT01132664|1173941|P1|Phase ll|Withdrawal by Subject|0
347693|NCT01132664|1173937|P5|Phase ll|Adverse Event|0
347694|NCT01132664|1173938|P4|Phase ll|Adverse Event|0
347695|NCT01132664|1173939|P3|Phase ll|Adverse Event|10
347696|NCT01132664|1173940|P2|Phase ll|Adverse Event|0
347697|NCT01132664|1173941|P1|Phase ll|Adverse Event|0
347698|NCT01132664|1173937|P5|Phase ll|Death|0
347699|NCT01132664|1173938|P4|Phase ll|Death|0
347700|NCT01132664|1173939|P3|Phase ll|Death|2
347701|NCT01132664|1173940|P2|Phase ll|Death|0
347702|NCT01132664|1173941|P1|Phase ll|Death|0
347703|NCT01132664|1173937|P5|Phase lb|Disease Progression|0
347704|NCT01132664|1173938|P4|Phase lb|Disease Progression|0
347705|NCT01132664|1173939|P3|Phase lb|Disease Progression|0
347706|NCT01132664|1173940|P2|Phase lb|Disease Progression|9
347707|NCT01132664|1173941|P1|Phase lb|Disease Progression|4
347708|NCT01132664|1173937|P5|Phase lb|Withdrawal by Subject|0
347709|NCT01132664|1173938|P4|Phase lb|Withdrawal by Subject|0
347710|NCT01132664|1173939|P3|Phase lb|Withdrawal by Subject|0
347711|NCT01132664|1173940|P2|Phase lb|Withdrawal by Subject|2
347712|NCT01132664|1173941|P1|Phase lb|Withdrawal by Subject|1
347713|NCT01132664|1173937|P5|Phase lb|Adverse Event|0
347714|NCT01132664|1173938|P4|Phase lb|Adverse Event|0
347715|NCT01132664|1173939|P3|Phase lb|Adverse Event|0
347716|NCT01132664|1173940|P2|Phase lb|Adverse Event|1
347717|NCT01132664|1173941|P1|Phase lb|Adverse Event|0
347718|NCT01132651|1173975|P2|Overall Study|Lost to Follow-up|1
347719|NCT01132651|1173976|P1|Overall Study|Lost to Follow-up|1
347720|NCT01132612|1173987|P3|Overall Study|Lack of Efficacy|73
347721|NCT01132612|1173988|P2|Overall Study|Lack of Efficacy|22
347722|NCT01132612|1173989|P1|Overall Study|Lack of Efficacy|23
347723|NCT01132612|1173987|P3|Overall Study|Administrative problems|52
347724|NCT01132612|1173988|P2|Overall Study|Administrative problems|1
347725|NCT01132612|1173989|P1|Overall Study|Administrative problems|5
347726|NCT01132612|1173987|P3|Overall Study|Withdrawal by Subject|19
347727|NCT01132612|1173988|P2|Overall Study|Withdrawal by Subject|8
347728|NCT01132612|1173989|P1|Overall Study|Withdrawal by Subject|5
347729|NCT01132612|1173987|P3|Overall Study|Adverse Event|15
347730|NCT01132612|1173988|P2|Overall Study|Adverse Event|2
347731|NCT01132612|1173989|P1|Overall Study|Adverse Event|5
347732|NCT01132612|1173987|P3|Overall Study|Lost to Follow-up|7
347733|NCT01132612|1173988|P2|Overall Study|Lost to Follow-up|2
347734|NCT01132612|1173989|P1|Overall Study|Lost to Follow-up|2
347735|NCT01132612|1173987|P3|Overall Study|Protocol deviation|3
347736|NCT01132612|1173988|P2|Overall Study|Protocol deviation|0
347737|NCT01132612|1173989|P1|Overall Study|Protocol deviation|0
347738|NCT01132612|1173987|P3|Overall Study|Death|1
347739|NCT01132612|1173988|P2|Overall Study|Death|0
347740|NCT01132612|1173989|P1|Overall Study|Death|0
347741|NCT01132547|1174005|P2|Overall Study|Death|0
347742|NCT01132547|1174006|P1|Overall Study|Death|1
347743|NCT01132547|1174005|P2|Overall Study|Withdrawal by Subject|1
347744|NCT01132547|1174006|P1|Overall Study|Withdrawal by Subject|3
347745|NCT01132495|1174076|P4|Overall Study|Various reasons|12
347746|NCT01132495|1174077|P3|Overall Study|Various reasons|20
347747|NCT01132495|1174078|P2|Overall Study|Various reasons|38
347748|NCT01132495|1174079|P1|Overall Study|Various reasons|40
347749|NCT01132326|1174092|P1|Overall Study|Subject Unable to Come To Visits|1
347750|NCT01132326|1174092|P1|Overall Study|Death|5
347751|NCT01132326|1174092|P1|Overall Study|Caregiver Withdrew Consent|1
347752|NCT01132326|1174092|P1|Overall Study|Pregnancy|1
347753|NCT01132326|1174092|P1|Overall Study|Declining Health|1
347754|NCT01132326|1174092|P1|Overall Study|Study Termination|80
347755|NCT01132326|1174092|P1|Overall Study|Physician Decision|10
347756|NCT01132326|1174092|P1|Overall Study|Withdrawal by Subject|40
347757|NCT01132326|1174092|P1|Overall Study|Lost to Follow-up|16
347758|NCT01132326|1174092|P1|Overall Study|Protocol Violation|1
347759|NCT01132326|1174092|P1|Overall Study|Adverse Event|37
347760|NCT01132326|1174092|P1|Overall Study|Lack of Efficacy|25
347761|NCT01132313|1174108|P12|Overall Study|Other reason not defined above|0
347762|NCT01132313|1174109|P11|Overall Study|Other reason not defined above|0
347763|NCT01132313|1174110|P10|Overall Study|Other reason not defined above|0
347764|NCT01132313|1174111|P9|Overall Study|Other reason not defined above|0
347765|NCT01132313|1174112|P8|Overall Study|Other reason not defined above|1
347766|NCT01132313|1174113|P7|Overall Study|Other reason not defined above|0
347767|NCT01132313|1174114|P6|Overall Study|Other reason not defined above|0
347768|NCT01132313|1174115|P5|Overall Study|Other reason not defined above|0
347769|NCT01132313|1174116|P4|Overall Study|Other reason not defined above|0
347770|NCT01132313|1174117|P3|Overall Study|Other reason not defined above|0
347771|NCT01132313|1174118|P2|Overall Study|Other reason not defined above|0
347772|NCT01132313|1174119|P1|Overall Study|Other reason not defined above|0
347773|NCT01132313|1174108|P12|Overall Study|Lack of antiviral response|0
347774|NCT01132313|1174109|P11|Overall Study|Lack of antiviral response|1
347775|NCT01132313|1174110|P10|Overall Study|Lack of antiviral response|0
347776|NCT01132313|1174111|P9|Overall Study|Lack of antiviral response|0
347777|NCT01132313|1174112|P8|Overall Study|Lack of antiviral response|0
347778|NCT01132313|1174113|P7|Overall Study|Lack of antiviral response|21
347779|NCT01132313|1174114|P6|Overall Study|Lack of antiviral response|18
347780|NCT01132313|1174115|P5|Overall Study|Lack of antiviral response|18
347781|NCT01132313|1174116|P4|Overall Study|Lack of antiviral response|18
347782|NCT01132313|1174117|P3|Overall Study|Lack of antiviral response|12
347783|NCT01132313|1174118|P2|Overall Study|Lack of antiviral response|0
347784|NCT01132313|1174119|P1|Overall Study|Lack of antiviral response|0
347785|NCT01132313|1174108|P12|Overall Study|Withdrawal by Subject|0
347786|NCT01132313|1174109|P11|Overall Study|Withdrawal by Subject|0
347787|NCT01132313|1174110|P10|Overall Study|Withdrawal by Subject|2
347788|NCT01132313|1174111|P9|Overall Study|Withdrawal by Subject|0
347789|NCT01132313|1174112|P8|Overall Study|Withdrawal by Subject|0
347790|NCT01132313|1174113|P7|Overall Study|Withdrawal by Subject|1
347791|NCT01132313|1174114|P6|Overall Study|Withdrawal by Subject|0
347792|NCT01132313|1174115|P5|Overall Study|Withdrawal by Subject|6
347793|NCT01132313|1174116|P4|Overall Study|Withdrawal by Subject|3
347794|NCT01132313|1174117|P3|Overall Study|Withdrawal by Subject|3
347795|NCT01132313|1174118|P2|Overall Study|Withdrawal by Subject|0
347796|NCT01132313|1174119|P1|Overall Study|Withdrawal by Subject|0
347797|NCT01132313|1174108|P12|Overall Study|Lost to Follow-up|0
347798|NCT01132313|1174109|P11|Overall Study|Lost to Follow-up|0
347799|NCT01132313|1174110|P10|Overall Study|Lost to Follow-up|0
347800|NCT01132313|1174111|P9|Overall Study|Lost to Follow-up|0
347801|NCT01132313|1174112|P8|Overall Study|Lost to Follow-up|1
347802|NCT01132313|1174113|P7|Overall Study|Lost to Follow-up|0
347803|NCT01132313|1174114|P6|Overall Study|Lost to Follow-up|0
347804|NCT01132313|1174115|P5|Overall Study|Lost to Follow-up|0
347805|NCT01132313|1174116|P4|Overall Study|Lost to Follow-up|0
347806|NCT01132313|1174117|P3|Overall Study|Lost to Follow-up|1
347807|NCT01132313|1174118|P2|Overall Study|Lost to Follow-up|0
347808|NCT01132313|1174119|P1|Overall Study|Lost to Follow-up|0
347809|NCT01132313|1174108|P12|Overall Study|Protocol Violation|0
347810|NCT01132313|1174109|P11|Overall Study|Protocol Violation|0
347811|NCT01132313|1174110|P10|Overall Study|Protocol Violation|0
347812|NCT01132313|1174111|P9|Overall Study|Protocol Violation|0
347813|NCT01132313|1174112|P8|Overall Study|Protocol Violation|0
347814|NCT01132313|1174113|P7|Overall Study|Protocol Violation|0
347815|NCT01132313|1174114|P6|Overall Study|Protocol Violation|0
347816|NCT01132313|1174115|P5|Overall Study|Protocol Violation|0
347817|NCT01132313|1174116|P4|Overall Study|Protocol Violation|1
347818|NCT01132313|1174117|P3|Overall Study|Protocol Violation|0
347819|NCT01132313|1174118|P2|Overall Study|Protocol Violation|0
347820|NCT01132313|1174119|P1|Overall Study|Protocol Violation|0
347821|NCT01132313|1174108|P12|Overall Study|Adverse Event|0
347822|NCT01132313|1174109|P11|Overall Study|Adverse Event|0
347823|NCT01132313|1174110|P10|Overall Study|Adverse Event|2
347824|NCT01132313|1174111|P9|Overall Study|Adverse Event|7
347825|NCT01132313|1174112|P8|Overall Study|Adverse Event|3
347826|NCT01132313|1174113|P7|Overall Study|Adverse Event|5
347827|NCT01132313|1174114|P6|Overall Study|Adverse Event|6
347828|NCT01132313|1174115|P5|Overall Study|Adverse Event|19
347829|NCT01132313|1174116|P4|Overall Study|Adverse Event|10
347830|NCT01132313|1174117|P3|Overall Study|Adverse Event|4
347831|NCT01132313|1174118|P2|Overall Study|Adverse Event|0
347832|NCT01132313|1174119|P1|Overall Study|Adverse Event|0
347833|NCT01132313|1174108|P12|Overall Study|Not treated|0
347834|NCT01132313|1174109|P11|Overall Study|Not treated|0
347835|NCT01132313|1174110|P10|Overall Study|Not treated|0
347836|NCT01132313|1174111|P9|Overall Study|Not treated|0
347837|NCT01132313|1174112|P8|Overall Study|Not treated|0
347838|NCT01132313|1174113|P7|Overall Study|Not treated|3
347839|NCT01132313|1174114|P6|Overall Study|Not treated|1
347840|NCT01132313|1174115|P5|Overall Study|Not treated|2
347841|NCT01132313|1174116|P4|Overall Study|Not treated|0
347842|NCT01132313|1174117|P3|Overall Study|Not treated|0
347843|NCT01132313|1174118|P2|Overall Study|Not treated|0
347844|NCT01132313|1174119|P1|Overall Study|Not treated|2
347845|NCT01132313|1174108|P12|Overall Study|Lack of Efficacy|0
347846|NCT01132313|1174109|P11|Overall Study|Lack of Efficacy|0
347847|NCT01132313|1174110|P10|Overall Study|Lack of Efficacy|16
347848|NCT01132313|1174111|P9|Overall Study|Lack of Efficacy|14
347849|NCT01132313|1174112|P8|Overall Study|Lack of Efficacy|3
347850|NCT01132313|1174113|P7|Overall Study|Lack of Efficacy|0
347851|NCT01132313|1174114|P6|Overall Study|Lack of Efficacy|0
347852|NCT01132313|1174115|P5|Overall Study|Lack of Efficacy|0
347853|NCT01132313|1174116|P4|Overall Study|Lack of Efficacy|0
347854|NCT01132313|1174117|P3|Overall Study|Lack of Efficacy|0
347855|NCT01132313|1174118|P2|Overall Study|Lack of Efficacy|0
347856|NCT01132313|1174119|P1|Overall Study|Lack of Efficacy|1
347857|NCT01132118|1174199|P2|Second Intervention (8 Weeks)|Adverse Event|1
347858|NCT01132118|1174200|P1|Second Intervention (8 Weeks)|Adverse Event|0
347859|NCT01132118|1174199|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
347860|NCT01132118|1174200|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
347861|NCT01132118|1174199|P2|First Intervention (8 Weeks)|Adverse Event|0
347862|NCT01132118|1174200|P1|First Intervention (8 Weeks)|Adverse Event|1
347863|NCT01131676|1174230|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
347864|NCT01131676|1174231|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
347865|NCT01131676|1174232|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
347866|NCT01131676|1174230|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
347867|NCT01131676|1174231|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
347868|NCT01131676|1174232|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
347869|NCT01131676|1174230|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
347870|NCT01131676|1174231|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
347871|NCT01131676|1174232|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
347872|NCT01131676|1174230|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
347873|NCT01131676|1174231|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
347874|NCT01131676|1174232|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
347875|NCT01131676|1174230|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
347876|NCT01131676|1174231|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
347877|NCT01131676|1174232|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
347878|NCT01131676|1174230|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
347879|NCT01131676|1174231|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
347880|NCT01131676|1174232|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
347881|NCT01131676|1174230|P3|Discontinuation From Treatment|Adverse Event|273
347882|NCT01131676|1174231|P2|Discontinuation From Treatment|Adverse Event|267
347883|NCT01131676|1174232|P1|Discontinuation From Treatment|Adverse Event|303
347884|NCT01131676|1174230|P3|Discontinuation From Treatment|Other than those specified|125
347885|NCT01131676|1174231|P2|Discontinuation From Treatment|Other than those specified|142
347886|NCT01131676|1174232|P1|Discontinuation From Treatment|Other than those specified|162
347887|NCT01131676|1174230|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
347888|NCT01131676|1174231|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
347889|NCT01131676|1174232|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
347890|NCT01131676|1174230|P3|Discontinuation From Treatment|Lost to Follow-up|6
347891|NCT01131676|1174231|P2|Discontinuation From Treatment|Lost to Follow-up|9
347892|NCT01131676|1174232|P1|Discontinuation From Treatment|Lost to Follow-up|15
347893|NCT01131676|1174230|P3|Discontinuation From Treatment|Non compliant with protocol|12
347894|NCT01131676|1174231|P2|Discontinuation From Treatment|Non compliant with protocol|15
347895|NCT01131676|1174232|P1|Discontinuation From Treatment|Non compliant with protocol|15
347896|NCT01131676|1174230|P3|Discontinuation From Treatment|Lack of Efficacy|0
347897|NCT01131676|1174231|P2|Discontinuation From Treatment|Lack of Efficacy|1
347898|NCT01131676|1174232|P1|Discontinuation From Treatment|Lack of Efficacy|11
347899|NCT01131676|1174230|P3|Discontinuation From Treatment|Not treated|2
347900|NCT01131676|1174231|P2|Discontinuation From Treatment|Not treated|2
347901|NCT01131676|1174232|P1|Discontinuation From Treatment|Not treated|4
347902|NCT01131676|1174230|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
347903|NCT01131676|1174231|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
347904|NCT01131676|1174232|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
347905|NCT01131585|1174267|P2|Overall Study|Study termination|32
347906|NCT01131585|1174268|P1|Overall Study|Study termination|78
347907|NCT01131585|1174267|P2|Overall Study|Administrative problems|1
347908|NCT01131585|1174268|P1|Overall Study|Administrative problems|1
347909|NCT01131585|1174267|P2|Overall Study|Lost to Follow-up|1
347910|NCT01131585|1174268|P1|Overall Study|Lost to Follow-up|0
347911|NCT01131585|1174267|P2|Overall Study|Withdrawal by Subject|3
347912|NCT01131585|1174268|P1|Overall Study|Withdrawal by Subject|3
347913|NCT01131585|1174267|P2|Overall Study|Protocol Violation|1
347914|NCT01131585|1174268|P1|Overall Study|Protocol Violation|2
347915|NCT01131585|1174267|P2|Overall Study|Unsatisfactory therapeutic effect|3
347916|NCT01131585|1174268|P1|Overall Study|Unsatisfactory therapeutic effect|0
347917|NCT01131585|1174267|P2|Overall Study|Abnormal laboratory value|0
347918|NCT01131585|1174268|P1|Overall Study|Abnormal laboratory value|1
347919|NCT01131585|1174267|P2|Overall Study|Adverse Event|2
347920|NCT01131585|1174268|P1|Overall Study|Adverse Event|0
347921|NCT01131520|1174276|P2|Overall Study|Subject changed history after enrollment|1
347922|NCT01131520|1174277|P1|Overall Study|Subject changed history after enrollment|0
347923|NCT01131520|1174276|P2|Overall Study|Counselor not available|3
347924|NCT01131520|1174277|P1|Overall Study|Counselor not available|0
347925|NCT01131520|1174276|P2|Overall Study|Computer problem|0
347926|NCT01131520|1174277|P1|Overall Study|Computer problem|1
347927|NCT01131507|1174299|P1|Overall Study|Withdrawal by Subject|1
347928|NCT01131507|1174299|P1|Overall Study|Lost to Follow-up|1
347929|NCT01131507|1174299|P1|Overall Study|Adverse Event|1
347930|NCT01131494|1174304|P1|Overall Study|Withdrawal by Subject|2
347931|NCT01131455|1174314|P3|Overall Study|Death of PI|0
347932|NCT01131455|1174315|P2|Overall Study|Death of PI|4
347933|NCT01131455|1174316|P1|Overall Study|Death of PI|6
347934|NCT01131299|1174324|P2|Overall Study|Withdrawal by Subject|7
347935|NCT01131299|1174325|P1|Overall Study|Withdrawal by Subject|4
347936|NCT01131182|1174338|P2|Overall Study|Other Reason|0
347937|NCT01131182|1174339|P1|Overall Study|Other Reason|1
347938|NCT01131182|1174338|P2|Overall Study|Lost to Follow-up|15
347939|NCT01131182|1174339|P1|Overall Study|Lost to Follow-up|14
347940|NCT01131182|1174338|P2|Overall Study|Withdrawal by Subject|1
347941|NCT01131182|1174339|P1|Overall Study|Withdrawal by Subject|1
347942|NCT01131130|1174347|P1|Period 3- Crossover|+ Slit lamp finding|1
347943|NCT01131130|1174347|P1|Period 1 - Baseline|Pregnancy|1
347944|NCT01131104|1174360|P1|Overall Study|No Information on Index Date of Onset|1
347945|NCT01131104|1174360|P1|Overall Study|Information Not Available|5
347946|NCT01131104|1174360|P1|Overall Study|Physician Decision|4
347947|NCT01131104|1174360|P1|Overall Study|Withdrawal by Subject|3
347948|NCT01131078|1174367|P3|Overall Study|Other|0
347949|NCT01131078|1174368|P2|Overall Study|Other|1
347950|NCT01131078|1174369|P1|Overall Study|Other|0
347951|NCT01131078|1174367|P3|Overall Study|Death|2
347952|NCT01131078|1174368|P2|Overall Study|Death|0
347953|NCT01131078|1174369|P1|Overall Study|Death|4
347954|NCT01131078|1174367|P3|Overall Study|Physician Decision|8
347955|NCT01131078|1174368|P2|Overall Study|Physician Decision|6
347956|NCT01131078|1174369|P1|Overall Study|Physician Decision|10
347957|NCT01131078|1174367|P3|Overall Study|Non-compliance|0
347958|NCT01131078|1174368|P2|Overall Study|Non-compliance|0
347959|NCT01131078|1174369|P1|Overall Study|Non-compliance|3
347960|NCT01131078|1174367|P3|Overall Study|Withdrawal by Subject|3
347961|NCT01131078|1174368|P2|Overall Study|Withdrawal by Subject|4
347962|NCT01131078|1174369|P1|Overall Study|Withdrawal by Subject|2
347963|NCT01131078|1174367|P3|Overall Study|Lost to Follow-up|1
347964|NCT01131078|1174368|P2|Overall Study|Lost to Follow-up|1
347965|NCT01131078|1174369|P1|Overall Study|Lost to Follow-up|1
347966|NCT01131078|1174367|P3|Overall Study|Protocol Violation|0
347967|NCT01131078|1174368|P2|Overall Study|Protocol Violation|0
347968|NCT01131078|1174369|P1|Overall Study|Protocol Violation|1
347969|NCT01131078|1174367|P3|Overall Study|Progressive Disease|71
347970|NCT01131078|1174368|P2|Overall Study|Progressive Disease|77
347971|NCT01131078|1174369|P1|Overall Study|Progressive Disease|58
347972|NCT01131078|1174367|P3|Overall Study|Adverse Event|17
347973|NCT01131078|1174368|P2|Overall Study|Adverse Event|12
347974|NCT01131078|1174369|P1|Overall Study|Adverse Event|22
347975|NCT01130974|1174456|P2|Overall Study|Ineligibility criteria|2
347976|NCT01130974|1174457|P1|Overall Study|Ineligibility criteria|5
347977|NCT01130974|1174456|P2|Overall Study|Withdrawal by Subject|1
347978|NCT01130974|1174457|P1|Overall Study|Withdrawal by Subject|0
347979|NCT01130974|1174456|P2|Overall Study|Protocol Violation|10
347980|NCT01130974|1174457|P1|Overall Study|Protocol Violation|10
347981|NCT01130883|1174477|P1|Overall Study|Adverse Event|3
347982|NCT01130883|1174477|P1|Overall Study|Reason Unknown|1
347983|NCT01130883|1174477|P1|Overall Study|Patient Noncompliance|6
347984|NCT01130831|1174534|P1|Overall Study|Information was missing|3
347985|NCT01130831|1174534|P1|Overall Study|Death|4
347986|NCT01130831|1174534|P1|Overall Study|Withdrawal by Subject|7
347987|NCT01130597|1174573|P1|Overall Study|Protocol Violation|1
347988|NCT01130597|1174573|P1|Overall Study|Death|1
347989|NCT01130597|1174573|P1|Overall Study|Adverse Event|4
347990|NCT01130597|1174573|P1|Overall Study|Protocol-specified (High K+)|1
347991|NCT01130532|1174598|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
347992|NCT01130532|1174599|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
347993|NCT01130532|1174600|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
347994|NCT01130532|1174601|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
347995|NCT01130532|1174598|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
347996|NCT01130532|1174599|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
347997|NCT01130532|1174600|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
347998|NCT01130532|1174601|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
347999|NCT01130532|1174598|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
348000|NCT01130532|1174599|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
348001|NCT01130532|1174600|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
348002|NCT01130532|1174601|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
348003|NCT01130532|1174598|P4|Period IV (Weeks 13-16)|Adverse Event|1
348004|NCT01130532|1174599|P3|Period IV (Weeks 13-16)|Adverse Event|0
348005|NCT01130532|1174600|P2|Period IV (Weeks 13-16)|Adverse Event|0
348006|NCT01130532|1174601|P1|Period IV (Weeks 13-16)|Adverse Event|0
348007|NCT01130532|1174598|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
348008|NCT01130532|1174599|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
348009|NCT01130532|1174600|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
348010|NCT01130532|1174601|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
348011|NCT01130532|1174598|P4|Period III (Weeks 0-12)|Sponsor Decision|0
348012|NCT01130532|1174599|P3|Period III (Weeks 0-12)|Sponsor Decision|2
348013|NCT01130532|1174600|P2|Period III (Weeks 0-12)|Sponsor Decision|4
348014|NCT01130532|1174601|P1|Period III (Weeks 0-12)|Sponsor Decision|3
348015|NCT01130532|1174598|P4|Period III (Weeks 0-12)|Protocol Violation|0
348016|NCT01130532|1174599|P3|Period III (Weeks 0-12)|Protocol Violation|1
348017|NCT01130532|1174600|P2|Period III (Weeks 0-12)|Protocol Violation|0
348018|NCT01130532|1174601|P1|Period III (Weeks 0-12)|Protocol Violation|0
348019|NCT01130532|1174598|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
348020|NCT01130532|1174599|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
348021|NCT01130532|1174600|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
348022|NCT01130532|1174601|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
348023|NCT01130532|1174598|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
348024|NCT01130532|1174599|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
348025|NCT01130532|1174600|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
348026|NCT01130532|1174601|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
348027|NCT01130532|1174598|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
348028|NCT01130532|1174599|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
348029|NCT01130532|1174600|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
348030|NCT01130532|1174601|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
348031|NCT01130532|1174598|P4|Period III (Weeks 0-12)|Adverse Event|0
348032|NCT01130532|1174599|P3|Period III (Weeks 0-12)|Adverse Event|2
348033|NCT01130532|1174600|P2|Period III (Weeks 0-12)|Adverse Event|3
348034|NCT01130532|1174601|P1|Period III (Weeks 0-12)|Adverse Event|3
348035|NCT01130493|1174646|P3|Part 2: OLE|Withdrawal by Subject|4
348036|NCT01130493|1174647|P2|Part 2: OLE|Withdrawal by Subject|1
348037|NCT01130493|1174648|P1|Part 2: OLE|Withdrawal by Subject|0
348038|NCT01130493|1174646|P3|Part 2: OLE|Adverse Event|1
348039|NCT01130493|1174647|P2|Part 2: OLE|Adverse Event|2
348040|NCT01130493|1174648|P1|Part 2: OLE|Adverse Event|0
348041|NCT01130493|1174646|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
348042|NCT01130493|1174647|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
348043|NCT01130493|1174648|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
348044|NCT01130493|1174646|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
348045|NCT01130493|1174647|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
348046|NCT01130493|1174648|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
348047|NCT01130493|1174646|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
348048|NCT01130493|1174647|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
348049|NCT01130493|1174648|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
348050|NCT01130493|1174646|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
348051|NCT01130493|1174647|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
348052|NCT01130493|1174648|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
348053|NCT01130493|1174646|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
348054|NCT01130493|1174647|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
348055|NCT01130493|1174648|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
348056|NCT01130493|1174646|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
348057|NCT01130493|1174647|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
348058|NCT01130493|1174648|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
348059|NCT01130493|1174646|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
348060|NCT01130493|1174647|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
348061|NCT01130493|1174648|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
348062|NCT01130493|1174646|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
348063|NCT01130493|1174647|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
348064|NCT01130493|1174648|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
348065|NCT01130493|1174646|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
348066|NCT01130493|1174647|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
348067|NCT01130493|1174648|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
348068|NCT01130493|1174646|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
348069|NCT01130493|1174647|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
348070|NCT01130493|1174648|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
348071|NCT01130493|1174646|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
348072|NCT01130493|1174647|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
348073|NCT01130493|1174648|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
348074|NCT01130493|1174646|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
348075|NCT01130493|1174647|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
348076|NCT01130493|1174648|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
348077|NCT01130337|1174665|P1|Overall Study|Surgical resection (R2)|1
348078|NCT01130337|1174665|P1|Overall Study|Toxicity, AE/intercurrent disease|7
348079|NCT01130337|1174665|P1|Overall Study|Disease progression|1
348080|NCT01130337|1174665|P1|Overall Study|Death|1
348081|NCT01130337|1174665|P1|Overall Study|Principal investigator decision|1
348082|NCT01130337|1174665|P1|Overall Study|Withdrawal by Subject|3
348083|NCT01130168|1174672|P6|Period 1|Adverse Event|0
348084|NCT01130168|1174673|P5|Period 1|Adverse Event|0
348085|NCT01130168|1174674|P4|Period 1|Adverse Event|1
348086|NCT01130168|1174675|P3|Period 1|Adverse Event|0
348087|NCT01130168|1174676|P2|Period 1|Adverse Event|0
348088|NCT01130168|1174677|P1|Period 1|Adverse Event|0
348089|NCT01130168|1174672|P6|Period 1|Discontinued For Other Reason|0
348090|NCT01130168|1174673|P5|Period 1|Discontinued For Other Reason|0
348091|NCT01130168|1174674|P4|Period 1|Discontinued For Other Reason|1
348092|NCT01130168|1174675|P3|Period 1|Discontinued For Other Reason|1
348093|NCT01130168|1174676|P2|Period 1|Discontinued For Other Reason|0
348094|NCT01130168|1174677|P1|Period 1|Discontinued For Other Reason|0
348095|NCT01130168|1174672|P6|Period 1|Withdrawal by Subject|0
348096|NCT01130168|1174673|P5|Period 1|Withdrawal by Subject|0
348097|NCT01130168|1174674|P4|Period 1|Withdrawal by Subject|1
348098|NCT01130168|1174675|P3|Period 1|Withdrawal by Subject|0
348099|NCT01130168|1174676|P2|Period 1|Withdrawal by Subject|1
348100|NCT01130168|1174677|P1|Period 1|Withdrawal by Subject|0
348101|NCT01130103|1174714|P2|Maintenance Treatment|Withdrawal by Subject|0
348102|NCT01130103|1174715|P1|Maintenance Treatment|Withdrawal by Subject|1
348103|NCT01130103|1174714|P2|Maintenance Treatment|Lost to Follow-up|1
348104|NCT01130103|1174715|P1|Maintenance Treatment|Lost to Follow-up|1
348105|NCT01130103|1174714|P2|Maintenance Treatment|Lack of Efficacy|1
348106|NCT01130103|1174715|P1|Maintenance Treatment|Lack of Efficacy|0
348107|NCT01130103|1174714|P2|Randomized Treatment|Withdrawal by Subject|2
348108|NCT01130103|1174715|P1|Randomized Treatment|Withdrawal by Subject|1
348109|NCT01130103|1174714|P2|Randomized Treatment|Protocol Violation|2
348110|NCT01130103|1174715|P1|Randomized Treatment|Protocol Violation|3
348111|NCT01130103|1174714|P2|Randomized Treatment|Lost to Follow-up|0
348112|NCT01130103|1174715|P1|Randomized Treatment|Lost to Follow-up|1
348113|NCT01130103|1174714|P2|Randomized Treatment|Adverse Event|1
348114|NCT01130103|1174715|P1|Randomized Treatment|Adverse Event|1
348115|NCT01130051|1174729|P2|Washout Period of 14 Days|Protocol Violation|1
348116|NCT01130051|1174730|P1|Washout Period of 14 Days|Protocol Violation|1
348117|NCT01130051|1174729|P2|Washout Period of 14 Days|Withdrawal by Subject|1
348118|NCT01130051|1174730|P1|Washout Period of 14 Days|Withdrawal by Subject|0
348119|NCT01129960|1174744|P4|Overall Study|Pregnancy|0
348120|NCT01129960|1174745|P3|Overall Study|Pregnancy|0
348121|NCT01129960|1174746|P2|Overall Study|Pregnancy|0
348122|NCT01129960|1174747|P1|Overall Study|Pregnancy|1
348123|NCT01129960|1174744|P4|Overall Study|Physician Decision|0
348124|NCT01129960|1174745|P3|Overall Study|Physician Decision|0
348125|NCT01129960|1174746|P2|Overall Study|Physician Decision|0
348126|NCT01129960|1174747|P1|Overall Study|Physician Decision|1
348127|NCT01129960|1174744|P4|Overall Study|Discontinuation of the study by Sponsor|0
348128|NCT01129960|1174745|P3|Overall Study|Discontinuation of the study by Sponsor|0
348129|NCT01129960|1174746|P2|Overall Study|Discontinuation of the study by Sponsor|1
348130|NCT01129960|1174747|P1|Overall Study|Discontinuation of the study by Sponsor|0
348131|NCT01129960|1174744|P4|Overall Study|Lost to Follow-up|3
348132|NCT01129960|1174745|P3|Overall Study|Lost to Follow-up|3
348133|NCT01129960|1174746|P2|Overall Study|Lost to Follow-up|2
348134|NCT01129960|1174747|P1|Overall Study|Lost to Follow-up|0
348135|NCT01129960|1174744|P4|Overall Study|Protocol Violation|0
348136|NCT01129960|1174745|P3|Overall Study|Protocol Violation|3
348137|NCT01129960|1174746|P2|Overall Study|Protocol Violation|2
348138|NCT01129960|1174747|P1|Overall Study|Protocol Violation|1
348139|NCT01129960|1174744|P4|Overall Study|Adverse Event|7
348140|NCT01129960|1174745|P3|Overall Study|Adverse Event|16
348141|NCT01129960|1174746|P2|Overall Study|Adverse Event|16
348142|NCT01129960|1174747|P1|Overall Study|Adverse Event|23
348143|NCT01129960|1174744|P4|Overall Study|Lack of Efficacy|1
348144|NCT01129960|1174745|P3|Overall Study|Lack of Efficacy|1
348145|NCT01129960|1174746|P2|Overall Study|Lack of Efficacy|1
348146|NCT01129960|1174747|P1|Overall Study|Lack of Efficacy|1
348147|NCT01129960|1174744|P4|Overall Study|Withdrawal by Subject|2
348148|NCT01129960|1174745|P3|Overall Study|Withdrawal by Subject|3
348149|NCT01129960|1174746|P2|Overall Study|Withdrawal by Subject|0
348150|NCT01129960|1174747|P1|Overall Study|Withdrawal by Subject|3
348151|NCT01129921|1174759|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
348152|NCT01129921|1174760|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
348153|NCT01129921|1174759|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
348154|NCT01129921|1174760|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
348155|NCT01129921|1174759|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
348156|NCT01129921|1174760|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
348157|NCT01129921|1174759|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
348158|NCT01129921|1174760|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
348159|NCT01129622|1174784|P1|Overall Study|Withdrawal by Subject|2
348160|NCT01129583|1174791|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
348161|NCT01129583|1174792|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
348162|NCT01129583|1174791|P2|Overall Study|Lost to Follow-up|1
348163|NCT01129583|1174792|P1|Overall Study|Lost to Follow-up|1
348164|NCT01129583|1174791|P2|Overall Study|Death|0
348165|NCT01129583|1174792|P1|Overall Study|Death|1
348166|NCT01129557|1174805|P3|Overall Study|Novartis terminated study early|2
348167|NCT01129557|1174806|P2|Overall Study|Novartis terminated study early|3
348168|NCT01129557|1174807|P1|Overall Study|Novartis terminated study early|3
348169|NCT01129557|1174805|P3|Overall Study|Adverse Event|2
348170|NCT01129557|1174806|P2|Overall Study|Adverse Event|2
348171|NCT01129557|1174807|P1|Overall Study|Adverse Event|1
348172|NCT01129336|1174902|P2|Overall Study|Death|4
348173|NCT01129336|1174903|P1|Overall Study|Death|0
348174|NCT01129336|1174902|P2|Overall Study|Missing Study Completion Status|3
348175|NCT01129336|1174903|P1|Overall Study|Missing Study Completion Status|2
348176|NCT01129336|1174902|P2|Overall Study|Adverse Event|1
348177|NCT01129336|1174903|P1|Overall Study|Adverse Event|0
348178|NCT01129336|1174902|P2|Overall Study|Withdrawal by Subject|4
348179|NCT01129336|1174903|P1|Overall Study|Withdrawal by Subject|7
348180|NCT01129336|1174902|P2|Overall Study|Lost to Follow-up|0
348181|NCT01129336|1174903|P1|Overall Study|Lost to Follow-up|1
348182|NCT01129336|1174902|P2|Overall Study|Disease Progression|4
348183|NCT01129336|1174903|P1|Overall Study|Disease Progression|1
348184|NCT01129336|1174902|P2|Overall Study|Protocol Violation|0
348185|NCT01129336|1174903|P1|Overall Study|Protocol Violation|1
348186|NCT01129284|1174918|P3|Overall Study|Adverse Event|1
348187|NCT01129284|1174919|P2|Overall Study|Adverse Event|0
348188|NCT01129284|1174920|P1|Overall Study|Adverse Event|2
348189|NCT01129128|1174960|P3|Overall Study|Physician Decision|0
348190|NCT01129128|1174961|P2|Overall Study|Physician Decision|0
348191|NCT01129128|1174962|P1|Overall Study|Physician Decision|1
348192|NCT01129128|1174960|P3|Overall Study|Withdrawal by Subject|3
348193|NCT01129128|1174961|P2|Overall Study|Withdrawal by Subject|1
348194|NCT01129128|1174962|P1|Overall Study|Withdrawal by Subject|0
348195|NCT01129128|1174960|P3|Overall Study|Protocol Violation|0
348196|NCT01129128|1174961|P2|Overall Study|Protocol Violation|1
348197|NCT01129128|1174962|P1|Overall Study|Protocol Violation|0
348198|NCT01129128|1174960|P3|Overall Study|Lost to Follow-up|1
348199|NCT01129128|1174961|P2|Overall Study|Lost to Follow-up|2
348200|NCT01129128|1174962|P1|Overall Study|Lost to Follow-up|2
348201|NCT01129115|1174986|P4|Overall Study|Protocol Violation|2
348202|NCT01129115|1174987|P3|Overall Study|Protocol Violation|2
348203|NCT01129115|1174988|P2|Overall Study|Protocol Violation|2
348204|NCT01129115|1174989|P1|Overall Study|Protocol Violation|0
348205|NCT01129115|1174986|P4|Overall Study|Withdrawal by Subject|4
348206|NCT01129115|1174987|P3|Overall Study|Withdrawal by Subject|1
348207|NCT01129115|1174988|P2|Overall Study|Withdrawal by Subject|3
348208|NCT01129115|1174989|P1|Overall Study|Withdrawal by Subject|1
348209|NCT01129115|1174986|P4|Overall Study|Adverse Event|3
348210|NCT01129115|1174987|P3|Overall Study|Adverse Event|3
348211|NCT01129115|1174988|P2|Overall Study|Adverse Event|2
348212|NCT01129115|1174989|P1|Overall Study|Adverse Event|1
348213|NCT01129102|1175026|P3|Overall Study|Lost to Follow-up|0
348214|NCT01129102|1175027|P2|Overall Study|Lost to Follow-up|0
348215|NCT01129102|1175028|P1|Overall Study|Lost to Follow-up|2
348216|NCT01129102|1175026|P3|Overall Study|Adverse Event|1
348217|NCT01129102|1175027|P2|Overall Study|Adverse Event|2
348218|NCT01129102|1175028|P1|Overall Study|Adverse Event|2
348219|NCT01129102|1175026|P3|Overall Study|Pregnancy|1
348220|NCT01129102|1175027|P2|Overall Study|Pregnancy|0
348221|NCT01129102|1175028|P1|Overall Study|Pregnancy|0
348222|NCT01129102|1175026|P3|Overall Study|Protocol Violation|1
348223|NCT01129102|1175027|P2|Overall Study|Protocol Violation|1
348224|NCT01129102|1175028|P1|Overall Study|Protocol Violation|0
348225|NCT01129102|1175026|P3|Overall Study|Withdrawal by Subject|3
348226|NCT01129102|1175027|P2|Overall Study|Withdrawal by Subject|0
348227|NCT01129102|1175028|P1|Overall Study|Withdrawal by Subject|2
348228|NCT01129102|1175026|P3|Overall Study|No study drug treatment|1
348229|NCT01129102|1175027|P2|Overall Study|No study drug treatment|3
348230|NCT01129102|1175028|P1|Overall Study|No study drug treatment|2
348231|NCT01129011|1175039|P2|Overall Study|misc|4
348232|NCT01129011|1175040|P1|Overall Study|misc|7
348233|NCT01129011|1175039|P2|Overall Study|Duodenal Ulcer|8
348234|NCT01129011|1175040|P1|Overall Study|Duodenal Ulcer|2
348235|NCT01129011|1175039|P2|Overall Study|Lost to Follow-up|7
348236|NCT01129011|1175040|P1|Overall Study|Lost to Follow-up|6
348237|NCT01129011|1175039|P2|Overall Study|Withdrawal by Subject|8
348238|NCT01129011|1175040|P1|Overall Study|Withdrawal by Subject|24
348239|NCT01129011|1175039|P2|Overall Study|Adverse Event|30
348240|NCT01129011|1175040|P1|Overall Study|Adverse Event|20
348241|NCT01128959|1175095|P1|Treatment Period|Withdrawal by Subject|1
348242|NCT01128959|1175095|P1|Treatment Period|Adverse Event|3
348243|NCT01128959|1175095|P1|Lead in Period|Adverse Event|3
348244|NCT01128946|1175101|P4|Period III|Protocol Violation|0
348245|NCT01128946|1175102|P3|Period III|Protocol Violation|0
348246|NCT01128946|1175103|P2|Period III|Protocol Violation|0
348247|NCT01128946|1175104|P1|Period III|Protocol Violation|1
348248|NCT01128946|1175101|P4|Period II|Withdrawal by Subject|1
348249|NCT01128946|1175102|P3|Period II|Withdrawal by Subject|0
348250|NCT01128946|1175103|P2|Period II|Withdrawal by Subject|0
348251|NCT01128946|1175104|P1|Period II|Withdrawal by Subject|0
348252|NCT01128946|1175101|P4|Period II|Protocol Violation|0
348253|NCT01128946|1175102|P3|Period II|Protocol Violation|0
348254|NCT01128946|1175103|P2|Period II|Protocol Violation|1
348255|NCT01128946|1175104|P1|Period II|Protocol Violation|0
348256|NCT01128946|1175101|P4|Period I|Withdrawal by Subject|1
348257|NCT01128946|1175102|P3|Period I|Withdrawal by Subject|1
348258|NCT01128946|1175103|P2|Period I|Withdrawal by Subject|0
348259|NCT01128946|1175104|P1|Period I|Withdrawal by Subject|0
348260|NCT01128946|1175101|P4|Period I|Protocol Violation|0
348261|NCT01128946|1175102|P3|Period I|Protocol Violation|0
348262|NCT01128946|1175103|P2|Period I|Protocol Violation|1
348263|NCT01128946|1175104|P1|Period I|Protocol Violation|0
348264|NCT01128894|1175122|P2|Overall Study|Conflicting HbA1c Results at Screening|0
348265|NCT01128894|1175123|P1|Overall Study|Conflicting HbA1c Results at Screening|1
348266|NCT01128894|1175122|P2|Overall Study|Physician Decision|1
348267|NCT01128894|1175123|P1|Overall Study|Physician Decision|2
348268|NCT01128894|1175122|P2|Overall Study|Withdrawal by Subject|12
348269|NCT01128894|1175123|P1|Overall Study|Withdrawal by Subject|10
348270|NCT01128894|1175122|P2|Overall Study|Lost to Follow-up|8
348271|NCT01128894|1175123|P1|Overall Study|Lost to Follow-up|8
348272|NCT01128894|1175122|P2|Overall Study|Noncompliance|5
348273|NCT01128894|1175123|P1|Overall Study|Noncompliance|4
348274|NCT01128894|1175122|P2|Overall Study|Protocol Violation|1
348275|NCT01128894|1175123|P1|Overall Study|Protocol Violation|2
348276|NCT01128894|1175122|P2|Overall Study|Adverse Event|41
348277|NCT01128894|1175123|P1|Overall Study|Adverse Event|31
348278|NCT01128738|1175148|P2|Second TP|Withdrawal by Subject|2
348279|NCT01128738|1175149|P1|Second TP|Withdrawal by Subject|0
348280|NCT01128738|1175148|P2|Second TP|Lost to Follow-up|1
348281|NCT01128738|1175149|P1|Second TP|Lost to Follow-up|0
348282|NCT01128738|1175148|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
348283|NCT01128738|1175149|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
348284|NCT01128738|1175148|P2|First Treatment Phase (TP)|Lost to Follow-up|0
348285|NCT01128738|1175149|P1|First Treatment Phase (TP)|Lost to Follow-up|1
348286|NCT01128621|1175274|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
348287|NCT01128621|1175275|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
348288|NCT01128595|1175396|P4|Treatment Period 3|Withdrawal by Subject|0
348289|NCT01128595|1175397|P3|Treatment Period 3|Withdrawal by Subject|0
348290|NCT01128595|1175398|P2|Treatment Period 3|Withdrawal by Subject|1
348291|NCT01128595|1175399|P1|Treatment Period 3|Withdrawal by Subject|0
348292|NCT01128569|1175429|P6|Treatment Period 2|Withdrawal by Subject|0
348293|NCT01128569|1175430|P5|Treatment Period 2|Withdrawal by Subject|0
348294|NCT01128569|1175431|P4|Treatment Period 2|Withdrawal by Subject|0
348295|NCT01128569|1175432|P3|Treatment Period 2|Withdrawal by Subject|0
348296|NCT01128569|1175433|P2|Treatment Period 2|Withdrawal by Subject|1
348297|NCT01128569|1175434|P1|Treatment Period 2|Withdrawal by Subject|0
348298|NCT01128569|1175429|P6|Washout Period 1|Adverse Event|0
348299|NCT01128569|1175430|P5|Washout Period 1|Adverse Event|0
348300|NCT01128569|1175431|P4|Washout Period 1|Adverse Event|0
348301|NCT01128569|1175432|P3|Washout Period 1|Adverse Event|1
348302|NCT01128569|1175433|P2|Washout Period 1|Adverse Event|0
348303|NCT01128569|1175434|P1|Washout Period 1|Adverse Event|0
348304|NCT01128543|1175451|P1|Overall Study|Protocol Violation|1
348305|NCT01128543|1175451|P1|Overall Study|Withdrawal by Subject|3
348306|NCT01128413|1175477|P2|Overall Study|Pt made DNR|0
348307|NCT01128413|1175478|P1|Overall Study|Pt made DNR|1
348308|NCT01128413|1175477|P2|Overall Study|NICOM Monitor Problems|1
348309|NCT01128413|1175478|P1|Overall Study|NICOM Monitor Problems|2
348310|NCT01128413|1175477|P2|Overall Study|Withdrawal by Subject|0
348311|NCT01128413|1175478|P1|Overall Study|Withdrawal by Subject|1
348312|NCT01128400|1175487|P3|Overall Study|were not invited to participate on taste|15
348313|NCT01128400|1175488|P2|Overall Study|were not invited to participate on taste|0
348314|NCT01128400|1175489|P1|Overall Study|were not invited to participate on taste|0
348315|NCT01128400|1175487|P3|Overall Study|Screening failure|0
348316|NCT01128400|1175488|P2|Overall Study|Screening failure|0
348317|NCT01128400|1175489|P1|Overall Study|Screening failure|1
348318|NCT01128400|1175487|P3|Overall Study|Lost to Follow-up|1
348319|NCT01128400|1175488|P2|Overall Study|Lost to Follow-up|0
348320|NCT01128400|1175489|P1|Overall Study|Lost to Follow-up|1
348321|NCT01128387|1175502|P2|Overall Study|Physician Decision|1
348322|NCT01128387|1175503|P1|Overall Study|Physician Decision|0
348323|NCT01128361|1175513|P2|Overall Study|Withdrawal by Subject|2
348324|NCT01128361|1175514|P1|Overall Study|Withdrawal by Subject|5
348325|NCT01128361|1175513|P2|Overall Study|Lost to Follow-up|1
348326|NCT01128361|1175514|P1|Overall Study|Lost to Follow-up|0
348327|NCT01128296|1175526|P6|Overall Study|Withdrawal by Subject|2
348328|NCT01128296|1175527|P5|Overall Study|Withdrawal by Subject|0
348329|NCT01128296|1175528|P4|Overall Study|Withdrawal by Subject|0
348330|NCT01128296|1175529|P3|Overall Study|Withdrawal by Subject|0
348331|NCT01128296|1175530|P2|Overall Study|Withdrawal by Subject|0
348332|NCT01128296|1175531|P1|Overall Study|Withdrawal by Subject|0
348333|NCT01128296|1175526|P6|Overall Study|Physician Decision|3
348334|NCT01128296|1175527|P5|Overall Study|Physician Decision|0
348335|NCT01128296|1175528|P4|Overall Study|Physician Decision|0
348336|NCT01128296|1175529|P3|Overall Study|Physician Decision|0
348337|NCT01128296|1175530|P2|Overall Study|Physician Decision|0
348338|NCT01128296|1175531|P1|Overall Study|Physician Decision|0
348339|NCT01128244|1175562|P1|Overall Study|Scheduling conflict|2
348340|NCT01128244|1175562|P1|Overall Study|Adverse Event|1
348341|NCT01128179|1175603|P2|Overall Study|Protocol Violation|0
348342|NCT01128179|1175604|P1|Overall Study|Protocol Violation|1
348343|NCT01128179|1175603|P2|Overall Study|Death|0
348344|NCT01128179|1175604|P1|Overall Study|Death|1
348345|NCT01128153|1175624|P2|Overall Study|Developed discontinuation criteria|1
348346|NCT01128153|1175625|P1|Overall Study|Developed discontinuation criteria|1
348347|NCT01128153|1175624|P2|Overall Study|Protocol Violation|0
348348|NCT01128153|1175625|P1|Overall Study|Protocol Violation|2
348349|NCT01128153|1175624|P2|Overall Study|Incorrect enrolment to study|1
348350|NCT01128153|1175625|P1|Overall Study|Incorrect enrolment to study|2
348351|NCT01128153|1175624|P2|Overall Study|Withdrawal by Subject|3
348352|NCT01128153|1175625|P1|Overall Study|Withdrawal by Subject|2
348353|NCT01128153|1175624|P2|Overall Study|Condition under investigation worsened|7
348354|NCT01128153|1175625|P1|Overall Study|Condition under investigation worsened|8
348355|NCT01128153|1175624|P2|Overall Study|Adverse Event|3
348356|NCT01128153|1175625|P1|Overall Study|Adverse Event|1
348357|NCT01128114|1175641|P1|Overall Study|Screening Failed|2
348358|NCT01128114|1175641|P1|Overall Study|Treatment Withdrawn|6
348359|NCT01127763|1175658|P1|Overall Study|Physician Decision|2
348360|NCT01127763|1175658|P1|Overall Study|Withdrawal by Subject|1
348361|NCT01127763|1175658|P1|Overall Study|Adverse Event|2
348362|NCT01127646|1175703|P2|Overall Study|Protocol Violation|1
348363|NCT01127646|1175704|P1|Overall Study|Protocol Violation|0
348364|NCT01127646|1175703|P2|Overall Study|Entry Criteria Not Met|0
348365|NCT01127646|1175704|P1|Overall Study|Entry Criteria Not Met|1
348366|NCT01127633|1175738|P2|Overall Study|Not treated|0
348367|NCT01127633|1175739|P1|Overall Study|Not treated|1
348368|NCT01127633|1175738|P2|Overall Study|Abnormal Lab/ECG Result|1
348369|NCT01127633|1175739|P1|Overall Study|Abnormal Lab/ECG Result|0
348370|NCT01127633|1175738|P2|Overall Study|Protocol Violation|16
348371|NCT01127633|1175739|P1|Overall Study|Protocol Violation|8
348372|NCT01127633|1175738|P2|Overall Study|Sponsor Decision|195
348373|NCT01127633|1175739|P1|Overall Study|Sponsor Decision|163
348374|NCT01127633|1175738|P2|Overall Study|Withdrawal by Subject|72
348375|NCT01127633|1175739|P1|Overall Study|Withdrawal by Subject|57
348376|NCT01127633|1175738|P2|Overall Study|Physician Decision|45
348377|NCT01127633|1175739|P1|Overall Study|Physician Decision|60
348378|NCT01127633|1175738|P2|Overall Study|Parent/Caregiver Decision|228
348379|NCT01127633|1175739|P1|Overall Study|Parent/Caregiver Decision|246
348380|NCT01127633|1175738|P2|Overall Study|Lost to Follow-up|0
348381|NCT01127633|1175739|P1|Overall Study|Lost to Follow-up|4
348382|NCT01127633|1175738|P2|Overall Study|Death|43
348383|NCT01127633|1175739|P1|Overall Study|Death|40
348384|NCT01127633|1175738|P2|Overall Study|Adverse Event|73
348385|NCT01127633|1175739|P1|Overall Study|Adverse Event|74
348386|NCT01127607|1175771|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
348387|NCT01127607|1175772|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
348388|NCT01127607|1175771|P2|Phase II (Between Subjects)|Lost to Follow-up|2
348389|NCT01127607|1175772|P1|Phase II (Between Subjects)|Lost to Follow-up|0
348390|NCT01127256|1175947|P2|Overall Study|Protocol Violation|0
348391|NCT01127256|1175948|P1|Overall Study|Protocol Violation|1
348392|NCT01127256|1175947|P2|Overall Study|Withdrawal by Subject|9
348393|NCT01127256|1175948|P1|Overall Study|Withdrawal by Subject|5
348394|NCT01127256|1175947|P2|Overall Study|Lost to Follow-up|17
348395|NCT01127256|1175948|P1|Overall Study|Lost to Follow-up|16
348396|NCT01127256|1175947|P2|Overall Study|Lack of Efficacy|0
348397|NCT01127256|1175948|P1|Overall Study|Lack of Efficacy|4
348398|NCT01127256|1175947|P2|Overall Study|Adverse Event|13
348399|NCT01127256|1175948|P1|Overall Study|Adverse Event|13
348400|NCT01127165|1175960|P2|Overall Study|Protocol Violation|1
348401|NCT01127165|1175961|P1|Overall Study|Protocol Violation|0
348402|NCT01127165|1175960|P2|Overall Study|Withdrawal by Subject|3
348403|NCT01127165|1175961|P1|Overall Study|Withdrawal by Subject|1
348404|NCT01127165|1175960|P2|Overall Study|Lost to Follow-up|5
348405|NCT01127165|1175961|P1|Overall Study|Lost to Follow-up|3
348406|NCT01127165|1175960|P2|Overall Study|Lack of Efficacy|8
348407|NCT01127165|1175961|P1|Overall Study|Lack of Efficacy|10
348408|NCT01127165|1175960|P2|Overall Study|Adverse Event|2
348409|NCT01127165|1175961|P1|Overall Study|Adverse Event|2
348410|NCT01127139|1175973|P1|Overall Study|Reason not specified|1
348411|NCT01127139|1175973|P1|Overall Study|Lack of Efficacy|4
348412|NCT01127139|1175973|P1|Overall Study|Incompliance|12
348413|NCT01127139|1175973|P1|Overall Study|Adverse Event|40
348414|NCT01126619|1176039|P1|Overall Study|Non-compliance|1
348415|NCT01126619|1176039|P1|Overall Study|Withdrawal by Subject|9
348416|NCT01126619|1176039|P1|Overall Study|Serious adverse event|1
348417|NCT01126619|1176039|P1|Overall Study|Investigator decision|4
348418|NCT01126619|1176039|P1|Overall Study|Not eligible for the study|2
348419|NCT01126580|1176067|P3|Overall Study|Treatment Non-compliance|3
348420|NCT01126580|1176068|P2|Overall Study|Treatment Non-compliance|2
348421|NCT01126580|1176069|P1|Overall Study|Treatment Non-compliance|0
348422|NCT01126580|1176067|P3|Overall Study|Lost to Follow-up|9
348423|NCT01126580|1176068|P2|Overall Study|Lost to Follow-up|13
348424|NCT01126580|1176069|P1|Overall Study|Lost to Follow-up|15
348425|NCT01126580|1176067|P3|Overall Study|Protocol Violation|2
348426|NCT01126580|1176068|P2|Overall Study|Protocol Violation|1
348427|NCT01126580|1176069|P1|Overall Study|Protocol Violation|0
348428|NCT01126580|1176067|P3|Overall Study|Lack of Efficacy|4
348429|NCT01126580|1176068|P2|Overall Study|Lack of Efficacy|3
348430|NCT01126580|1176069|P1|Overall Study|Lack of Efficacy|2
348431|NCT01126580|1176067|P3|Overall Study|Entry Criteria Not Met|2
348432|NCT01126580|1176068|P2|Overall Study|Entry Criteria Not Met|1
348433|NCT01126580|1176069|P1|Overall Study|Entry Criteria Not Met|1
348434|NCT01126580|1176067|P3|Overall Study|Physician Decision|2
348435|NCT01126580|1176068|P2|Overall Study|Physician Decision|1
348436|NCT01126580|1176069|P1|Overall Study|Physician Decision|1
348437|NCT01126580|1176067|P3|Overall Study|Sponsor Decision|7
348438|NCT01126580|1176068|P2|Overall Study|Sponsor Decision|4
348439|NCT01126580|1176069|P1|Overall Study|Sponsor Decision|5
348440|NCT01126580|1176067|P3|Overall Study|Withdrawal by Subject|14
348441|NCT01126580|1176068|P2|Overall Study|Withdrawal by Subject|19
348442|NCT01126580|1176069|P1|Overall Study|Withdrawal by Subject|11
348443|NCT01126580|1176067|P3|Overall Study|Adverse Event|12
348444|NCT01126580|1176068|P2|Overall Study|Adverse Event|8
348445|NCT01126580|1176069|P1|Overall Study|Adverse Event|14
348446|NCT01126541|1176164|P3|Overall Study|Administrative reason or other|2
348447|NCT01126541|1176165|P2|Overall Study|Administrative reason or other|1
348448|NCT01126541|1176166|P1|Overall Study|Administrative reason or other|1
348449|NCT01126541|1176164|P3|Overall Study|Protocol Violation|1
348450|NCT01126541|1176165|P2|Overall Study|Protocol Violation|0
348451|NCT01126541|1176166|P1|Overall Study|Protocol Violation|0
348452|NCT01126541|1176164|P3|Overall Study|Withdrawal by Subject|6
348453|NCT01126541|1176165|P2|Overall Study|Withdrawal by Subject|5
348454|NCT01126541|1176166|P1|Overall Study|Withdrawal by Subject|2
348455|NCT01126541|1176164|P3|Overall Study|Lost to Follow-up|2
348456|NCT01126541|1176165|P2|Overall Study|Lost to Follow-up|2
348457|NCT01126541|1176166|P1|Overall Study|Lost to Follow-up|1
348458|NCT01126541|1176164|P3|Overall Study|Lack of Efficacy|11
348459|NCT01126541|1176165|P2|Overall Study|Lack of Efficacy|1
348460|NCT01126541|1176166|P1|Overall Study|Lack of Efficacy|6
348461|NCT01126541|1176164|P3|Overall Study|Death|0
348462|NCT01126541|1176165|P2|Overall Study|Death|1
348463|NCT01126541|1176166|P1|Overall Study|Death|0
348464|NCT01126541|1176164|P3|Overall Study|Adverse Event|4
348465|NCT01126541|1176165|P2|Overall Study|Adverse Event|2
348466|NCT01126541|1176166|P1|Overall Study|Adverse Event|0
348467|NCT01126437|1176250|P3|Overall Study|Other reason not specified|178
348468|NCT01126437|1176251|P2|Overall Study|Other reason not specified|176
348469|NCT01126437|1176252|P1|Overall Study|Other reason not specified|210
348470|NCT01126437|1176250|P3|Overall Study|Withdrawal by Subject|319
348471|NCT01126437|1176251|P2|Overall Study|Withdrawal by Subject|335
348472|NCT01126437|1176252|P1|Overall Study|Withdrawal by Subject|331
348473|NCT01126437|1176250|P3|Overall Study|Lost to Follow-up|55
348474|NCT01126437|1176251|P2|Overall Study|Lost to Follow-up|63
348475|NCT01126437|1176252|P1|Overall Study|Lost to Follow-up|52
348476|NCT01126437|1176250|P3|Overall Study|Protocol Violation|41
348477|NCT01126437|1176251|P2|Overall Study|Protocol Violation|66
348478|NCT01126437|1176252|P1|Overall Study|Protocol Violation|64
348479|NCT01126437|1176250|P3|Overall Study|Lack of Efficacy|59
348480|NCT01126437|1176251|P2|Overall Study|Lack of Efficacy|60
348481|NCT01126437|1176252|P1|Overall Study|Lack of Efficacy|65
348482|NCT01126437|1176250|P3|Overall Study|Adverse Event|635
348483|NCT01126437|1176251|P2|Overall Study|Adverse Event|606
348484|NCT01126437|1176252|P1|Overall Study|Adverse Event|602
348485|NCT01126437|1176250|P3|Overall Study|Sites with data irregularities/fraud|7
348486|NCT01126437|1176251|P2|Overall Study|Sites with data irregularities/fraud|6
348487|NCT01126437|1176252|P1|Overall Study|Sites with data irregularities/fraud|6
348488|NCT01126437|1176250|P3|Overall Study|Not treated|19
348489|NCT01126437|1176251|P2|Overall Study|Not treated|18
348490|NCT01126437|1176252|P1|Overall Study|Not treated|11
348491|NCT01126424|1176290|P6|Overall Study|Withdrawal by Subject|0
348492|NCT01126424|1176291|P5|Overall Study|Withdrawal by Subject|1
348493|NCT01126424|1176292|P4|Overall Study|Withdrawal by Subject|3
348494|NCT01126424|1176293|P3|Overall Study|Withdrawal by Subject|1
348495|NCT01126424|1176294|P2|Overall Study|Withdrawal by Subject|0
348496|NCT01126424|1176295|P1|Overall Study|Withdrawal by Subject|0
348497|NCT01126424|1176290|P6|Overall Study|Adverse Event|0
348498|NCT01126424|1176291|P5|Overall Study|Adverse Event|1
348499|NCT01126424|1176292|P4|Overall Study|Adverse Event|0
348500|NCT01126424|1176293|P3|Overall Study|Adverse Event|0
348501|NCT01126424|1176294|P2|Overall Study|Adverse Event|0
348502|NCT01126424|1176295|P1|Overall Study|Adverse Event|0
348503|NCT01126359|1176318|P2|First Intervention (20-minutes)|Physician Decision|1
348504|NCT01126359|1176319|P1|First Intervention (20-minutes)|Physician Decision|0
348505|NCT01126268|1176331|P1|Overall Study|Adverse Event|1
348506|NCT01126060|1176370|P2|Overall Study|Protocol Violation|2
348507|NCT01126060|1176371|P1|Overall Study|Protocol Violation|0
348508|NCT01125930|1176379|P2|Overall Study|Lost to Follow-up|2
348509|NCT01125930|1176380|P1|Overall Study|Lost to Follow-up|0
348510|NCT01125930|1176379|P2|Overall Study|Protocol Violation|1
348511|NCT01125930|1176380|P1|Overall Study|Protocol Violation|0
348512|NCT01125930|1176379|P2|Overall Study|Withdrawal by Subject|6
348513|NCT01125930|1176380|P1|Overall Study|Withdrawal by Subject|1
348514|NCT01125930|1176379|P2|Overall Study|Adverse Event|1
348515|NCT01125930|1176380|P1|Overall Study|Adverse Event|0
348516|NCT01125917|1176534|P1|Overall Study|Lack of Efficacy|19
348517|NCT01125917|1176534|P1|Overall Study|Administrative|223
348518|NCT01125917|1176534|P1|Overall Study|Withdrawal by Subject|31
348519|NCT01125917|1176534|P1|Overall Study|Lost to Follow-up|23
348520|NCT01125917|1176534|P1|Overall Study|Adverse Event|43
348521|NCT01125813|1176538|P1|Overall Study|Screen Failures|4
348522|NCT01125813|1176538|P1|Overall Study|Withdrawal by Subject|1
348523|NCT01125813|1176538|P1|Overall Study|Death|1
348524|NCT01125800|1176548|P5|Phase II|Disease progression|8
348525|NCT01125800|1176549|P4|Phase II|Disease progression|1
348526|NCT01125800|1176550|P3|Phase II|Disease progression|0
348527|NCT01125800|1176551|P2|Phase II|Disease progression|0
348528|NCT01125800|1176552|P1|Phase II|Disease progression|0
348529|NCT01125800|1176548|P5|Phase II|Adverse Event|2
348530|NCT01125800|1176549|P4|Phase II|Adverse Event|0
348531|NCT01125800|1176550|P3|Phase II|Adverse Event|0
348532|NCT01125800|1176551|P2|Phase II|Adverse Event|0
348533|NCT01125800|1176552|P1|Phase II|Adverse Event|0
348534|NCT01125800|1176548|P5|Phase II|Protocol Violation|1
348535|NCT01125800|1176549|P4|Phase II|Protocol Violation|0
348536|NCT01125800|1176550|P3|Phase II|Protocol Violation|0
348537|NCT01125800|1176551|P2|Phase II|Protocol Violation|0
348538|NCT01125800|1176552|P1|Phase II|Protocol Violation|0
348539|NCT01125800|1176548|P5|Phase I|Disease progression|0
348540|NCT01125800|1176549|P4|Phase I|Disease progression|3
348541|NCT01125800|1176550|P3|Phase I|Disease progression|1
348542|NCT01125800|1176551|P2|Phase I|Disease progression|4
348543|NCT01125800|1176552|P1|Phase I|Disease progression|5
348544|NCT01125800|1176548|P5|Phase I|Withdrawal by Subject|0
348545|NCT01125800|1176549|P4|Phase I|Withdrawal by Subject|0
348546|NCT01125800|1176550|P3|Phase I|Withdrawal by Subject|1
348547|NCT01125800|1176551|P2|Phase I|Withdrawal by Subject|0
348548|NCT01125800|1176552|P1|Phase I|Withdrawal by Subject|0
348549|NCT01125800|1176548|P5|Phase I|Administrative problems|0
348550|NCT01125800|1176549|P4|Phase I|Administrative problems|0
348551|NCT01125800|1176550|P3|Phase I|Administrative problems|0
348552|NCT01125800|1176551|P2|Phase I|Administrative problems|0
348553|NCT01125800|1176552|P1|Phase I|Administrative problems|1
348554|NCT01125800|1176548|P5|Phase I|Adverse Event|0
348555|NCT01125800|1176549|P4|Phase I|Adverse Event|7
348556|NCT01125800|1176550|P3|Phase I|Adverse Event|1
348557|NCT01125800|1176551|P2|Phase I|Adverse Event|2
348558|NCT01125800|1176552|P1|Phase I|Adverse Event|2
348559|NCT01125800|1176548|P5|Phase I|Protocol Violation|0
348560|NCT01125800|1176549|P4|Phase I|Protocol Violation|1
348561|NCT01125800|1176550|P3|Phase I|Protocol Violation|1
348562|NCT01125800|1176551|P2|Phase I|Protocol Violation|3
348563|NCT01125800|1176552|P1|Phase I|Protocol Violation|0
348564|NCT01125748|1176618|P2|Overall Study|Patient Decision to Withdraw|4
348565|NCT01125748|1176619|P1|Overall Study|Patient Decision to Withdraw|2
348566|NCT01125748|1176618|P2|Overall Study|Physician Decision|7
348567|NCT01125748|1176619|P1|Overall Study|Physician Decision|8
348568|NCT01125748|1176618|P2|Overall Study|Lost to Follow-up|1
348569|NCT01125748|1176619|P1|Overall Study|Lost to Follow-up|0
348570|NCT01125748|1176618|P2|Overall Study|Adverse Event|2
348571|NCT01125748|1176619|P1|Overall Study|Adverse Event|0
348572|NCT01125722|1176629|P2|Overall Study|Lost to Follow-up|0
348573|NCT01125722|1176630|P1|Overall Study|Lost to Follow-up|1
348574|NCT01125722|1176629|P2|Overall Study|Withdrawal by Subject|1
348575|NCT01125722|1176630|P1|Overall Study|Withdrawal by Subject|2
348576|NCT01125566|1176677|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
348577|NCT01125566|1176678|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
348578|NCT01125566|1176679|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
348579|NCT01125566|1176677|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
348580|NCT01125566|1176678|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
348581|NCT01125566|1176679|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
348582|NCT01125566|1176677|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
348661|NCT01124864|1176868|P1|Overall Study|Lost to Follow-up|1
348583|NCT01125566|1176678|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
348584|NCT01125566|1176679|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
348585|NCT01125566|1176677|P3|Patients Before the Switch (26Apr2013)|Not treated|0
348586|NCT01125566|1176678|P2|Patients Before the Switch (26Apr2013)|Not treated|0
348587|NCT01125566|1176679|P1|Patients Before the Switch (26Apr2013)|Not treated|2
348588|NCT01125566|1176677|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
348589|NCT01125566|1176678|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
348590|NCT01125566|1176679|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
348591|NCT01125566|1176677|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
348592|NCT01125566|1176678|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
348593|NCT01125566|1176679|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
348594|NCT01125566|1176677|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
348595|NCT01125566|1176678|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
348596|NCT01125566|1176679|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
348597|NCT01125566|1176677|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
348598|NCT01125566|1176678|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
348599|NCT01125566|1176679|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
348600|NCT01125566|1176677|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
348601|NCT01125566|1176678|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
348602|NCT01125566|1176679|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
348603|NCT01125514|1176692|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
348604|NCT01125514|1176692|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
348605|NCT01125514|1176692|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
348606|NCT01125514|1176692|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
348607|NCT01125514|1176692|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
348608|NCT01125514|1176692|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
348609|NCT01125189|1176792|P3|Follow up Period|Other reasons|5
348610|NCT01125189|1176793|P2|Follow up Period|Other reasons|4
348611|NCT01125189|1176794|P1|Follow up Period|Other reasons|4
348612|NCT01125189|1176792|P3|Follow up Period|Lost to Follow-up|6
348613|NCT01125189|1176793|P2|Follow up Period|Lost to Follow-up|9
348614|NCT01125189|1176794|P1|Follow up Period|Lost to Follow-up|12
348615|NCT01125189|1176792|P3|Follow up Period|Death|0
348616|NCT01125189|1176793|P2|Follow up Period|Death|0
348617|NCT01125189|1176794|P1|Follow up Period|Death|1
348618|NCT01125189|1176792|P3|Follow up Period|Withdrawal by Subject|5
348619|NCT01125189|1176793|P2|Follow up Period|Withdrawal by Subject|2
348620|NCT01125189|1176794|P1|Follow up Period|Withdrawal by Subject|3
348621|NCT01125189|1176792|P3|Treatment Period|Completed 24 week treatment period only|2
348622|NCT01125189|1176793|P2|Treatment Period|Completed 24 week treatment period only|1
348623|NCT01125189|1176794|P1|Treatment Period|Completed 24 week treatment period only|2
348624|NCT01125189|1176792|P3|Treatment Period|Other reasons|0
348625|NCT01125189|1176793|P2|Treatment Period|Other reasons|1
348626|NCT01125189|1176794|P1|Treatment Period|Other reasons|1
348627|NCT01125189|1176792|P3|Treatment Period|Participants requested to discontinue|4
348628|NCT01125189|1176793|P2|Treatment Period|Participants requested to discontinue|3
348629|NCT01125189|1176794|P1|Treatment Period|Participants requested to discontinue|1
348630|NCT01125189|1176792|P3|Treatment Period|Poor compliance/noncompliance|0
348631|NCT01125189|1176793|P2|Treatment Period|Poor compliance/noncompliance|1
348632|NCT01125189|1176794|P1|Treatment Period|Poor compliance/noncompliance|0
348633|NCT01125189|1176792|P3|Treatment Period|Lost to Follow-up|1
348634|NCT01125189|1176793|P2|Treatment Period|Lost to Follow-up|2
348635|NCT01125189|1176794|P1|Treatment Period|Lost to Follow-up|1
348636|NCT01125189|1176792|P3|Treatment Period|Death|0
348637|NCT01125189|1176793|P2|Treatment Period|Death|0
348638|NCT01125189|1176794|P1|Treatment Period|Death|1
348639|NCT01125189|1176792|P3|Treatment Period|Withdrawal by Subject|1
348640|NCT01125189|1176793|P2|Treatment Period|Withdrawal by Subject|1
348641|NCT01125189|1176794|P1|Treatment Period|Withdrawal by Subject|3
348642|NCT01125189|1176792|P3|Treatment Period|Adverse Event|8
348643|NCT01125189|1176793|P2|Treatment Period|Adverse Event|8
348644|NCT01125189|1176794|P1|Treatment Period|Adverse Event|7
348645|NCT01125189|1176792|P3|Treatment Period|Lack of Efficacy|25
348646|NCT01125189|1176793|P2|Treatment Period|Lack of Efficacy|18
348647|NCT01125189|1176794|P1|Treatment Period|Lack of Efficacy|15
348648|NCT01124916|1176848|P2|Overall Study|Lost to Follow-up|2
348649|NCT01124916|1176849|P1|Overall Study|Lost to Follow-up|3
348650|NCT01124864|1176863|P6|Overall Study|Protocol Violation|0
348651|NCT01124864|1176864|P5|Overall Study|Protocol Violation|1
348652|NCT01124864|1176865|P4|Overall Study|Protocol Violation|0
348653|NCT01124864|1176866|P3|Overall Study|Protocol Violation|0
348654|NCT01124864|1176867|P2|Overall Study|Protocol Violation|0
348655|NCT01124864|1176868|P1|Overall Study|Protocol Violation|1
348656|NCT01124864|1176863|P6|Overall Study|Lost to Follow-up|0
348657|NCT01124864|1176864|P5|Overall Study|Lost to Follow-up|0
348658|NCT01124864|1176865|P4|Overall Study|Lost to Follow-up|1
348659|NCT01124864|1176866|P3|Overall Study|Lost to Follow-up|0
348660|NCT01124864|1176867|P2|Overall Study|Lost to Follow-up|1
348662|NCT01124864|1176863|P6|Overall Study|Withdrawal by Subject|1
348663|NCT01124864|1176864|P5|Overall Study|Withdrawal by Subject|2
348664|NCT01124864|1176865|P4|Overall Study|Withdrawal by Subject|0
348665|NCT01124864|1176866|P3|Overall Study|Withdrawal by Subject|4
348666|NCT01124864|1176867|P2|Overall Study|Withdrawal by Subject|3
348667|NCT01124864|1176868|P1|Overall Study|Withdrawal by Subject|2
348668|NCT01124864|1176863|P6|Overall Study|Death|0
348669|NCT01124864|1176864|P5|Overall Study|Death|1
348670|NCT01124864|1176865|P4|Overall Study|Death|2
348671|NCT01124864|1176866|P3|Overall Study|Death|6
348672|NCT01124864|1176867|P2|Overall Study|Death|9
348673|NCT01124864|1176868|P1|Overall Study|Death|6
348674|NCT01124864|1176863|P6|Overall Study|Follow up phase competed as per protocol|2
348675|NCT01124864|1176864|P5|Overall Study|Follow up phase competed as per protocol|26
348676|NCT01124864|1176865|P4|Overall Study|Follow up phase competed as per protocol|18
348677|NCT01124864|1176866|P3|Overall Study|Follow up phase competed as per protocol|24
348678|NCT01124864|1176867|P2|Overall Study|Follow up phase competed as per protocol|22
348679|NCT01124864|1176868|P1|Overall Study|Follow up phase competed as per protocol|18
348680|NCT01124838|1176902|P2|Overall Study|Lost to Follow-up|0
348681|NCT01124838|1176903|P1|Overall Study|Lost to Follow-up|2
348682|NCT01124838|1176902|P2|Overall Study|Withdrawal by Subject|2
348683|NCT01124838|1176903|P1|Overall Study|Withdrawal by Subject|3
348684|NCT01124838|1176902|P2|Overall Study|Lack of Efficacy|0
348685|NCT01124838|1176903|P1|Overall Study|Lack of Efficacy|2
348686|NCT01124838|1176902|P2|Overall Study|Adverse Event|11
348687|NCT01124838|1176903|P1|Overall Study|Adverse Event|7
348688|NCT01124838|1176902|P2|Overall Study|Miscellaneous|2
348689|NCT01124838|1176903|P1|Overall Study|Miscellaneous|4
348690|NCT01124643|1176970|P1|Overall Study|Death|1
348691|NCT01124617|1176984|P2|Overall Study|Other|1
348692|NCT01124617|1176985|P1|Overall Study|Other|2
348693|NCT01124617|1176984|P2|Overall Study|Withdrawal by Subject|1
348694|NCT01124617|1176985|P1|Overall Study|Withdrawal by Subject|9
348695|NCT01124617|1176984|P2|Overall Study|Protocol Violation|1
348696|NCT01124617|1176985|P1|Overall Study|Protocol Violation|1
348697|NCT01124617|1176984|P2|Overall Study|Lack of Efficacy|1
348698|NCT01124617|1176985|P1|Overall Study|Lack of Efficacy|2
348699|NCT01124617|1176984|P2|Overall Study|Adverse Event|2
348700|NCT01124617|1176985|P1|Overall Study|Adverse Event|5
348701|NCT01124604|1177017|P2|Overall Study|Disease Progression|1
348702|NCT01124604|1177018|P1|Overall Study|Disease Progression|0
348703|NCT01124604|1177017|P2|Overall Study|Withdrawal by Subject|0
348704|NCT01124604|1177018|P1|Overall Study|Withdrawal by Subject|4
348705|NCT01124604|1177017|P2|Overall Study|Lack of Efficacy|0
348706|NCT01124604|1177018|P1|Overall Study|Lack of Efficacy|1
348707|NCT01124604|1177017|P2|Overall Study|Adverse Event|1
348708|NCT01124604|1177018|P1|Overall Study|Adverse Event|10
348709|NCT01124448|1177057|P2|Overall Study|Protocol Violation|0
348710|NCT01124448|1177058|P1|Overall Study|Protocol Violation|2
348711|NCT01124448|1177057|P2|Overall Study|Lost to Follow-up|3
348712|NCT01124448|1177058|P1|Overall Study|Lost to Follow-up|0
348713|NCT01124422|1177066|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
348714|NCT01124422|1177067|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
348715|NCT01124422|1177068|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
348716|NCT01124422|1177066|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
348717|NCT01124422|1177067|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
348718|NCT01124422|1177068|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
348719|NCT01124422|1177066|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
348720|NCT01124422|1177067|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
348721|NCT01124422|1177068|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
348722|NCT01124422|1177066|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
348723|NCT01124422|1177067|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
348724|NCT01124422|1177068|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
348725|NCT01124422|1177066|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
348726|NCT01124422|1177067|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
348727|NCT01124422|1177068|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
348728|NCT01124422|1177066|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
348729|NCT01124422|1177067|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
348730|NCT01124422|1177068|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
348731|NCT01124422|1177066|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
348732|NCT01124422|1177067|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
348733|NCT01124422|1177068|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
348734|NCT01124422|1177066|P3|4-Week Open-label Run-in Phase|Physician Decision|0
348735|NCT01124422|1177067|P2|4-Week Open-label Run-in Phase|Physician Decision|0
348736|NCT01124422|1177068|P1|4-Week Open-label Run-in Phase|Physician Decision|4
348737|NCT01124422|1177066|P3|4-Week Open-label Run-in Phase|Adverse Event|0
348738|NCT01124422|1177067|P2|4-Week Open-label Run-in Phase|Adverse Event|0
348739|NCT01124422|1177068|P1|4-Week Open-label Run-in Phase|Adverse Event|7
348740|NCT01124422|1177066|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
348741|NCT01124422|1177067|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
348742|NCT01124422|1177068|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
348743|NCT01124292|1177138|P3|Overall Study|piercing track closed|1
348744|NCT01124292|1177139|P2|Overall Study|piercing track closed|2
348745|NCT01124292|1177140|P1|Overall Study|piercing track closed|0
348746|NCT01124292|1177138|P3|Overall Study|medical issue unrelated to the study|2
348747|NCT01124292|1177139|P2|Overall Study|medical issue unrelated to the study|0
348748|NCT01124292|1177140|P1|Overall Study|medical issue unrelated to the study|0
348749|NCT01124292|1177138|P3|Overall Study|Withdrawal by Subject|2
348750|NCT01124292|1177139|P2|Overall Study|Withdrawal by Subject|6
348751|NCT01124292|1177140|P1|Overall Study|Withdrawal by Subject|0
348752|NCT01124292|1177138|P3|Overall Study|Physician Decision|2
348753|NCT01124292|1177139|P2|Overall Study|Physician Decision|3
348754|NCT01124292|1177140|P1|Overall Study|Physician Decision|0
348755|NCT01124292|1177138|P3|Overall Study|Lost to Follow-up|3
348756|NCT01124292|1177139|P2|Overall Study|Lost to Follow-up|4
348757|NCT01124292|1177140|P1|Overall Study|Lost to Follow-up|2
348758|NCT01124175|1177211|P2|Washout of 7 Days|Withdrawal by Subject|2
348759|NCT01124175|1177212|P1|Washout of 7 Days|Withdrawal by Subject|0
348760|NCT01124162|1177230|P2|Washout of 7 Days|Withdrawal by Subject|0
348761|NCT01124162|1177231|P1|Washout of 7 Days|Withdrawal by Subject|1
348762|NCT01124162|1177230|P2|First Intervention|Adverse Event|0
348763|NCT01124162|1177231|P1|First Intervention|Adverse Event|2
348764|NCT01124149|1177247|P1|Maintenance Phase|Non-compliance|1
348765|NCT01124149|1177247|P1|Maintenance Phase|Coordinator error|1
348766|NCT01124149|1177247|P1|Maintenance Phase|Protocol Violation|5
348767|NCT01124149|1177247|P1|Maintenance Phase|Withdrawal by Subject|10
348768|NCT01124149|1177247|P1|Maintenance Phase|Lost to Follow-up|15
348769|NCT01124149|1177247|P1|Maintenance Phase|Adverse Event|24
348770|NCT01124149|1177247|P1|Maintenance Phase|Lack of Efficacy|40
348771|NCT01124149|1177247|P1|Acute Phase|Sponsor decision|1
348772|NCT01124149|1177247|P1|Acute Phase|Travelling to another country|1
348773|NCT01124149|1177247|P1|Acute Phase|Low hemoglobin|1
348774|NCT01124149|1177247|P1|Acute Phase|Non-compliance|1
348775|NCT01124149|1177247|P1|Acute Phase|UC symptoms not ameliorated|1
348776|NCT01124149|1177247|P1|Acute Phase|Sponsor request|1
348777|NCT01124149|1177247|P1|Acute Phase|Prolonged antibiotic therapy|1
348778|NCT01124149|1177247|P1|Acute Phase|Lost to Follow-up|2
348779|NCT01124149|1177247|P1|Acute Phase|Protocol Violation|14
348780|NCT01124149|1177247|P1|Acute Phase|Lack of Efficacy|17
348781|NCT01124149|1177247|P1|Acute Phase|Adverse Event|21
348782|NCT01124149|1177247|P1|Acute Phase|Withdrawal by Subject|22
348783|NCT01124097|1177267|P4|Overall Study|Physician Decision|0
348784|NCT01124097|1177268|P3|Overall Study|Physician Decision|0
348785|NCT01124097|1177269|P2|Overall Study|Physician Decision|1
348786|NCT01124097|1177270|P1|Overall Study|Physician Decision|2
348787|NCT01124097|1177267|P4|Overall Study|Protocol Violation|1
348788|NCT01124097|1177268|P3|Overall Study|Protocol Violation|2
348789|NCT01124097|1177269|P2|Overall Study|Protocol Violation|0
348790|NCT01124097|1177270|P1|Overall Study|Protocol Violation|2
348791|NCT01124097|1177267|P4|Overall Study|Adverse Event|7
348792|NCT01124097|1177268|P3|Overall Study|Adverse Event|15
348793|NCT01124097|1177269|P2|Overall Study|Adverse Event|15
348794|NCT01124097|1177270|P1|Overall Study|Adverse Event|24
348795|NCT01124097|1177267|P4|Overall Study|Lack of Efficacy|3
348796|NCT01124097|1177268|P3|Overall Study|Lack of Efficacy|1
348797|NCT01124097|1177269|P2|Overall Study|Lack of Efficacy|3
348798|NCT01124097|1177270|P1|Overall Study|Lack of Efficacy|2
348799|NCT01124097|1177267|P4|Overall Study|Withdrawal by Subject|3
348800|NCT01124097|1177268|P3|Overall Study|Withdrawal by Subject|2
348801|NCT01124097|1177269|P2|Overall Study|Withdrawal by Subject|3
348802|NCT01124097|1177270|P1|Overall Study|Withdrawal by Subject|4
348803|NCT01124045|1177282|P2|Overall Study|Physician Decision|2
348804|NCT01124045|1177283|P1|Overall Study|Physician Decision|0
348805|NCT01124045|1177282|P2|Overall Study|Lost to Follow-up|1
348806|NCT01124045|1177283|P1|Overall Study|Lost to Follow-up|0
348807|NCT01124006|1177316|P3|Overall Study|Other|1
348808|NCT01124006|1177317|P2|Overall Study|Other|0
348809|NCT01124006|1177318|P1|Overall Study|Other|0
348810|NCT01124006|1177316|P3|Overall Study|Lost to Follow-up|1
348811|NCT01124006|1177317|P2|Overall Study|Lost to Follow-up|0
348812|NCT01124006|1177318|P1|Overall Study|Lost to Follow-up|1
348813|NCT01124006|1177316|P3|Overall Study|Withdrawal by Subject|0
348814|NCT01124006|1177317|P2|Overall Study|Withdrawal by Subject|2
348815|NCT01124006|1177318|P1|Overall Study|Withdrawal by Subject|2
348816|NCT01123980|1177346|P2|Overall Study|Unclassified|7
348817|NCT01123980|1177347|P1|Overall Study|Unclassified|6
348818|NCT01123980|1177346|P2|Overall Study|Withdrawal by Subject|3
348819|NCT01123980|1177347|P1|Overall Study|Withdrawal by Subject|5
348820|NCT01123980|1177346|P2|Overall Study|Protocol Violation|6
348821|NCT01123980|1177347|P1|Overall Study|Protocol Violation|6
348822|NCT01123980|1177346|P2|Overall Study|Lost to Follow-up|6
348823|NCT01123980|1177347|P1|Overall Study|Lost to Follow-up|0
348824|NCT01123980|1177346|P2|Overall Study|Physician Decision|1
348825|NCT01123980|1177347|P1|Overall Study|Physician Decision|0
348826|NCT01123980|1177346|P2|Overall Study|Lack of Efficacy|0
348827|NCT01123980|1177347|P1|Overall Study|Lack of Efficacy|1
348828|NCT01123980|1177346|P2|Overall Study|Adverse Event|1
348829|NCT01123980|1177347|P1|Overall Study|Adverse Event|1
348830|NCT01123941|1177367|P2|Overall Study|Lost to Follow-up|1
348831|NCT01123941|1177368|P1|Overall Study|Lost to Follow-up|2
348832|NCT01123889|1177403|P2|Overall Study|Lost to Follow-up|1
348833|NCT01123889|1177404|P1|Overall Study|Lost to Follow-up|3
348834|NCT01123850|1177414|P1|Overall Study|Slow enrollment|45
348835|NCT01123642|1177419|P1|Overall Study|ineligible at baseline assessment|36
348836|NCT01123642|1177419|P1|Overall Study|Withdrawal by Subject|9
348837|NCT01123642|1177419|P1|Overall Study|Lost to Follow-up|23
348838|NCT01123395|1177432|P2|Washout Period of 14 Days|Withdrawal by Subject|1
348839|NCT01123395|1177433|P1|Washout Period of 14 Days|Withdrawal by Subject|0
348840|NCT01123382|1177445|P2|Overall Study|Lost to Follow-up|2
348841|NCT01123382|1177446|P1|Overall Study|Lost to Follow-up|1
348842|NCT01123382|1177445|P2|Overall Study|Withdrawal by Subject|4
348843|NCT01123382|1177446|P1|Overall Study|Withdrawal by Subject|1
348844|NCT01123356|1177468|P1|Overall Study|Withdrawal by Subject|1
348845|NCT01123356|1177468|P1|Overall Study|Lack of Efficacy|4
348846|NCT01123356|1177468|P1|Overall Study|Adverse Event|2
348847|NCT01123200|1177476|P1|Overall Study|Withdrawal by Subject|1
348848|NCT01123161|1177483|P2|Overall Study|Withdrawal by Subject|0
348849|NCT01123161|1177484|P1|Overall Study|Withdrawal by Subject|1
348850|NCT01123161|1177483|P2|Overall Study|Lost to Follow-up|0
348851|NCT01123161|1177484|P1|Overall Study|Lost to Follow-up|1
348852|NCT01123148|1177502|P1|Overall Study|Didn't meet milestone criteria|1
348853|NCT01123148|1177502|P1|Overall Study|Coughing caused unacceptable EEG quality|1
348854|NCT01123083|1177508|P2|Overall Study|Participant/legal representative request|3
348855|NCT01123083|1177509|P1|Overall Study|Participant/legal representative request|7
348856|NCT01123083|1177508|P2|Overall Study|Withdrew for another reason not covered|1
348857|NCT01123083|1177509|P1|Overall Study|Withdrew for another reason not covered|0
348858|NCT01123083|1177508|P2|Overall Study|Adverse Event|0
348859|NCT01123083|1177509|P1|Overall Study|Adverse Event|1
348860|NCT01123083|1177508|P2|Overall Study|Lost to Follow-up|6
348861|NCT01123083|1177509|P1|Overall Study|Lost to Follow-up|2
348862|NCT01123083|1177508|P2|Overall Study|Administrative reasons|4
348863|NCT01123083|1177509|P1|Overall Study|Administrative reasons|0
348864|NCT01123083|1177508|P2|Overall Study|Investigator recommendation|1
348865|NCT01123083|1177509|P1|Overall Study|Investigator recommendation|1
348866|NCT01122927|1177533|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
348867|NCT01122927|1177534|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
348868|NCT01122927|1177533|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
348869|NCT01122927|1177534|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
348870|NCT01122927|1177533|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
348871|NCT01122927|1177534|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
348872|NCT01122927|1177533|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
348873|NCT01122927|1177534|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
348874|NCT01122927|1177533|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
348875|NCT01122927|1177534|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
348876|NCT01122927|1177533|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
348877|NCT01122927|1177534|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
348878|NCT01122927|1177533|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
348879|NCT01122927|1177534|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
348880|NCT01122927|1177533|P2|Period 1 - Conversion Phase|Protocol Deviation|0
348881|NCT01122927|1177534|P1|Period 1 - Conversion Phase|Protocol Deviation|1
348882|NCT01122927|1177533|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
348883|NCT01122927|1177534|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
348884|NCT01122927|1177533|P2|Period 1 - Conversion Phase|Physician Decision|0
348885|NCT01122927|1177534|P1|Period 1 - Conversion Phase|Physician Decision|2
348886|NCT01122927|1177533|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
348887|NCT01122927|1177534|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
348888|NCT01122927|1177533|P2|Period 1 - Conversion Phase|Adverse Event|0
348889|NCT01122927|1177534|P1|Period 1 - Conversion Phase|Adverse Event|3
348890|NCT01122862|1177586|P3|Period 2|Adverse Event|1
348891|NCT01122862|1177587|P2|Period 2|Adverse Event|0
348892|NCT01122862|1177588|P1|Period 2|Adverse Event|0
348893|NCT01122862|1177586|P3|Period 1|Protocol Violation|0
348894|NCT01122862|1177587|P2|Period 1|Protocol Violation|1
348895|NCT01122862|1177588|P1|Period 1|Protocol Violation|0
348896|NCT01122680|1177694|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
348897|NCT01122680|1177695|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
348898|NCT01122680|1177696|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
348899|NCT01122680|1177697|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
348900|NCT01122680|1177694|P4|Period 3 (4 Weeks)|Adverse Event|0
348901|NCT01122680|1177695|P3|Period 3 (4 Weeks)|Adverse Event|0
348902|NCT01122680|1177696|P2|Period 3 (4 Weeks)|Adverse Event|0
348903|NCT01122680|1177697|P1|Period 3 (4 Weeks)|Adverse Event|1
348904|NCT01122680|1177694|P4|Period 2 (4 Weeks)|Other|0
348905|NCT01122680|1177695|P3|Period 2 (4 Weeks)|Other|0
348906|NCT01122680|1177696|P2|Period 2 (4 Weeks)|Other|0
348907|NCT01122680|1177697|P1|Period 2 (4 Weeks)|Other|1
348908|NCT01122680|1177694|P4|Period 2 (4 Weeks)|Protocol Violation|1
348909|NCT01122680|1177695|P3|Period 2 (4 Weeks)|Protocol Violation|0
348910|NCT01122680|1177696|P2|Period 2 (4 Weeks)|Protocol Violation|0
348911|NCT01122680|1177697|P1|Period 2 (4 Weeks)|Protocol Violation|0
348912|NCT01122680|1177694|P4|Period 1 (4 Weeks)|Other|0
348913|NCT01122680|1177695|P3|Period 1 (4 Weeks)|Other|0
348914|NCT01122680|1177696|P2|Period 1 (4 Weeks)|Other|1
348915|NCT01122680|1177697|P1|Period 1 (4 Weeks)|Other|1
348916|NCT01122680|1177694|P4|Period 1 (4 Weeks)|Protocol Violation|0
348917|NCT01122680|1177695|P3|Period 1 (4 Weeks)|Protocol Violation|0
348918|NCT01122680|1177696|P2|Period 1 (4 Weeks)|Protocol Violation|0
348919|NCT01122680|1177697|P1|Period 1 (4 Weeks)|Protocol Violation|1
348920|NCT01122680|1177694|P4|Period 1 (4 Weeks)|Adverse Event|0
348921|NCT01122680|1177695|P3|Period 1 (4 Weeks)|Adverse Event|0
348922|NCT01122680|1177696|P2|Period 1 (4 Weeks)|Adverse Event|0
348923|NCT01122680|1177697|P1|Period 1 (4 Weeks)|Adverse Event|1
348924|NCT01122576|1177762|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
348925|NCT01122576|1177763|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
348926|NCT01122576|1177764|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
348927|NCT01122576|1177762|P3|Post-Cataract Surgery|Central Macular Edema|1
348928|NCT01122576|1177763|P2|Post-Cataract Surgery|Central Macular Edema|0
348929|NCT01122576|1177764|P1|Post-Cataract Surgery|Central Macular Edema|0
348930|NCT01122576|1177762|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
348931|NCT01122576|1177763|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
348932|NCT01122576|1177764|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
348933|NCT01122394|1177918|P2|Overall Study|Adverse Event|1
348934|NCT01122394|1177919|P1|Overall Study|Adverse Event|0
348935|NCT01122394|1177918|P2|Overall Study|Lost to Follow-up|2
348936|NCT01122394|1177919|P1|Overall Study|Lost to Follow-up|2
348937|NCT01122394|1177918|P2|Overall Study|Withdrawal by Subject|1
348938|NCT01122394|1177919|P1|Overall Study|Withdrawal by Subject|1
348939|NCT01122381|1177935|P2|Overall Study|study terminated early|1
348940|NCT01122381|1177936|P1|Overall Study|study terminated early|0
348941|NCT01122264|1177945|P3|Overall Study|Lack of Efficacy|1
348942|NCT01122264|1177946|P2|Overall Study|Lack of Efficacy|1
348943|NCT01122264|1177947|P1|Overall Study|Lack of Efficacy|3
348944|NCT01122264|1177945|P3|Overall Study|Physician Decision|1
348945|NCT01122264|1177946|P2|Overall Study|Physician Decision|1
348946|NCT01122264|1177947|P1|Overall Study|Physician Decision|3
348947|NCT01122264|1177945|P3|Overall Study|Withdrawal by Subject|16
348948|NCT01122264|1177946|P2|Overall Study|Withdrawal by Subject|6
348949|NCT01122264|1177947|P1|Overall Study|Withdrawal by Subject|6
348950|NCT01122264|1177945|P3|Overall Study|Protocol Violation|9
348951|NCT01122264|1177946|P2|Overall Study|Protocol Violation|7
348952|NCT01122264|1177947|P1|Overall Study|Protocol Violation|7
348953|NCT01122264|1177945|P3|Overall Study|Entry Criteria Not Met|0
348954|NCT01122264|1177946|P2|Overall Study|Entry Criteria Not Met|0
348955|NCT01122264|1177947|P1|Overall Study|Entry Criteria Not Met|1
348956|NCT01122264|1177945|P3|Overall Study|Lost to Follow-up|13
348957|NCT01122264|1177946|P2|Overall Study|Lost to Follow-up|9
348958|NCT01122264|1177947|P1|Overall Study|Lost to Follow-up|5
348959|NCT01122264|1177945|P3|Overall Study|Death|0
348960|NCT01122264|1177946|P2|Overall Study|Death|0
348961|NCT01122264|1177947|P1|Overall Study|Death|1
348962|NCT01122264|1177945|P3|Overall Study|Adverse Event|7
348963|NCT01122264|1177946|P2|Overall Study|Adverse Event|5
348964|NCT01122264|1177947|P1|Overall Study|Adverse Event|6
348965|NCT01121991|1178273|P1|Overall Study|No Fertilization|1
348966|NCT01121991|1178273|P1|Overall Study|No Oocytes Retrieved|3
348967|NCT01121991|1178273|P1|Overall Study|Lack of Ovarian Response|2
348968|NCT01121926|1178298|P2|Washout Period|Positive pregnancy test|1
348969|NCT01121926|1178299|P1|Washout Period|Positive pregnancy test|0
348970|NCT01121926|1178298|P2|Washout Period|Adverse Event|1
348971|NCT01121926|1178299|P1|Washout Period|Adverse Event|0
348972|NCT01121926|1178298|P2|First Intervention Period|Adverse Event|0
348973|NCT01121926|1178299|P1|First Intervention Period|Adverse Event|1
348974|NCT01121913|1178317|P4|Third Washout Period|Adverse Event|0
348975|NCT01121913|1178318|P3|Third Washout Period|Adverse Event|0
348976|NCT01121913|1178319|P2|Third Washout Period|Adverse Event|0
348977|NCT01121913|1178320|P1|Third Washout Period|Adverse Event|1
348978|NCT01121913|1178317|P4|Second Washout Period|Withdrawal by Subject|0
348979|NCT01121913|1178318|P3|Second Washout Period|Withdrawal by Subject|1
348980|NCT01121913|1178319|P2|Second Washout Period|Withdrawal by Subject|0
348981|NCT01121913|1178320|P1|Second Washout Period|Withdrawal by Subject|0
348982|NCT01121913|1178317|P4|Second Intervention Period|Adverse Event|0
348983|NCT01121913|1178318|P3|Second Intervention Period|Adverse Event|1
348984|NCT01121913|1178319|P2|Second Intervention Period|Adverse Event|0
348985|NCT01121913|1178320|P1|Second Intervention Period|Adverse Event|0
348986|NCT01121913|1178317|P4|First Washout Period|Withdrawal by Subject|0
348987|NCT01121913|1178318|P3|First Washout Period|Withdrawal by Subject|0
348988|NCT01121913|1178319|P2|First Washout Period|Withdrawal by Subject|0
348989|NCT01121913|1178320|P1|First Washout Period|Withdrawal by Subject|1
348990|NCT01121913|1178317|P4|First Intervention Period|Adverse Event|0
348991|NCT01121913|1178318|P3|First Intervention Period|Adverse Event|1
348992|NCT01121913|1178319|P2|First Intervention Period|Adverse Event|0
348993|NCT01121913|1178320|P1|First Intervention Period|Adverse Event|0
348994|NCT01121900|1178350|P2|Washout Period of 7 Days|Withdrawal by Subject|1
348995|NCT01121900|1178351|P1|Washout Period of 7 Days|Withdrawal by Subject|0
348996|NCT01121900|1178350|P2|First Intervention Period|Adverse Event|1
348997|NCT01121900|1178351|P1|First Intervention Period|Adverse Event|1
348998|NCT01121757|1178371|P2|Combination|Disease Progression|0
348999|NCT01121757|1178372|P1|Combination|Disease Progression|2
349000|NCT01121757|1178371|P2|Combination|Physician Decision|1
349001|NCT01121757|1178372|P1|Combination|Physician Decision|0
349002|NCT01121757|1178371|P2|First Drug|Disease Progression|2
349003|NCT01121757|1178372|P1|First Drug|Disease Progression|0
349004|NCT01121757|1178371|P2|First Drug|Death|0
349005|NCT01121757|1178372|P1|First Drug|Death|1
349006|NCT01121666|1178388|P2|Overall Study|Protocol Violation|10
349007|NCT01121666|1178389|P1|Overall Study|Protocol Violation|29
349008|NCT01121575|1178445|P6|Overall Study|Death|1
349009|NCT01121575|1178446|P5|Overall Study|Death|7
349010|NCT01121575|1178447|P4|Overall Study|Death|1
349011|NCT01121575|1178448|P3|Overall Study|Death|0
349012|NCT01121575|1178449|P2|Overall Study|Death|0
349013|NCT01121575|1178450|P1|Overall Study|Death|6
349014|NCT01121575|1178445|P6|Overall Study|Unspecified Reasons|10
349015|NCT01121575|1178446|P5|Overall Study|Unspecified Reasons|13
349016|NCT01121575|1178447|P4|Overall Study|Unspecified Reasons|5
349017|NCT01121575|1178448|P3|Overall Study|Unspecified Reasons|7
349018|NCT01121575|1178449|P2|Overall Study|Unspecified Reasons|6
349019|NCT01121575|1178450|P1|Overall Study|Unspecified Reasons|8
349020|NCT01121575|1178445|P6|Overall Study|Participant Refused Further Follow-Up|1
349021|NCT01121575|1178446|P5|Overall Study|Participant Refused Further Follow-Up|5
349022|NCT01121575|1178447|P4|Overall Study|Participant Refused Further Follow-Up|0
349023|NCT01121575|1178448|P3|Overall Study|Participant Refused Further Follow-Up|0
349024|NCT01121575|1178449|P2|Overall Study|Participant Refused Further Follow-Up|0
349025|NCT01121575|1178450|P1|Overall Study|Participant Refused Further Follow-Up|0
349026|NCT01121562|1178574|P1|Overall Study|Met study discontinuation criteria|1
349027|NCT01121562|1178574|P1|Overall Study|Sponsor Decision|1
349028|NCT01121562|1178574|P1|Overall Study|Adverse Event|1
349029|NCT01121562|1178574|P1|Overall Study|Withdrawal by Subject|1
349030|NCT01121562|1178574|P1|Overall Study|Objective progression or relapse|8
349031|NCT01121549|1178583|P1|Overall Study|Other|58
349032|NCT01121549|1178583|P1|Overall Study|Withdrawal by Subject|16
349033|NCT01121549|1178583|P1|Overall Study|Protocol Violation|33
349034|NCT01121549|1178583|P1|Overall Study|Pregnancy|1
349035|NCT01121549|1178583|P1|Overall Study|Study terminated by sponsor|197
349036|NCT01121549|1178583|P1|Overall Study|Did not meet entrance criteria|9
349037|NCT01121549|1178583|P1|Overall Study|Lost to Follow-up|12
349038|NCT01121549|1178583|P1|Overall Study|Lack of Efficacy|11
349039|NCT01121549|1178583|P1|Overall Study|Adverse Event|10
349040|NCT01121536|1178594|P1|Overall Study|Not specified|118
349041|NCT01121536|1178594|P1|Overall Study|Lost to Follow-up|39
349042|NCT01121536|1178594|P1|Overall Study|Noncompliance with study procedures|9
349043|NCT01121536|1178594|P1|Overall Study|Noncompliance with study medication|12
349044|NCT01121536|1178594|P1|Overall Study|Protocol Violation|20
349045|NCT01121536|1178594|P1|Overall Study|Withdrawal by Subject|65
349046|NCT01121536|1178594|P1|Overall Study|Lack of Efficacy|35
349047|NCT01121536|1178594|P1|Overall Study|Adverse Event|63
349048|NCT01121484|1178615|P2|Overall Study|Randomized, not treated|4
349049|NCT01121484|1178616|P1|Overall Study|Randomized, not treated|1
349050|NCT01121484|1178615|P2|Overall Study|Other|3
349051|NCT01121484|1178616|P1|Overall Study|Other|3
349052|NCT01121484|1178615|P2|Overall Study|Discontinuation of study by sponsor|1
349053|NCT01121484|1178616|P1|Overall Study|Discontinuation of study by sponsor|0
349054|NCT01121484|1178615|P2|Overall Study|Withdrawal by Subject|7
349055|NCT01121484|1178616|P1|Overall Study|Withdrawal by Subject|8
349056|NCT01121484|1178615|P2|Overall Study|Protocol Violation|0
349057|NCT01121484|1178616|P1|Overall Study|Protocol Violation|1
349058|NCT01121484|1178615|P2|Overall Study|Physician Decision|3
349059|NCT01121484|1178616|P1|Overall Study|Physician Decision|0
349060|NCT01121484|1178615|P2|Overall Study|Lost to Follow-up|9
349061|NCT01121484|1178616|P1|Overall Study|Lost to Follow-up|5
349062|NCT01121484|1178615|P2|Overall Study|Lack of Efficacy|11
349063|NCT01121484|1178616|P1|Overall Study|Lack of Efficacy|3
349064|NCT01121484|1178615|P2|Overall Study|Adverse Event|5
349065|NCT01121484|1178616|P1|Overall Study|Adverse Event|12
349066|NCT01121406|1178634|P2|Overall Study|Not treated|0
349067|NCT01121406|1178635|P1|Overall Study|Not treated|1
349068|NCT01121406|1178634|P2|Overall Study|Reason other than specified above|6
349069|NCT01121406|1178635|P1|Overall Study|Reason other than specified above|2
349070|NCT01121406|1178634|P2|Overall Study|Refused continuation of study med.|2
349071|NCT01121406|1178635|P1|Overall Study|Refused continuation of study med.|1
349072|NCT01121406|1178634|P2|Overall Study|Lost to Follow-up|1
349073|NCT01121406|1178635|P1|Overall Study|Lost to Follow-up|0
349074|NCT01121406|1178634|P2|Overall Study|Non−compliant with protocol|2
349075|NCT01121406|1178635|P1|Overall Study|Non−compliant with protocol|0
349076|NCT01121406|1178634|P2|Overall Study|Other AE|10
349077|NCT01121406|1178635|P1|Overall Study|Other AE|3
349078|NCT01121406|1178634|P2|Overall Study|Wors. or AE of underlying cancer disease|6
349079|NCT01121406|1178635|P1|Overall Study|Wors. or AE of underlying cancer disease|4
349080|NCT01121406|1178634|P2|Overall Study|Progressive disease RECIST|28
349081|NCT01121406|1178635|P1|Overall Study|Progressive disease RECIST|44
349082|NCT01121393|1178685|P2|Overall Study|Not treated|9
349083|NCT01121393|1178686|P1|Overall Study|Not treated|3
349084|NCT01121393|1178685|P2|Overall Study|Refused cont. medication|7
349085|NCT01121393|1178686|P1|Overall Study|Refused cont. medication|7
349086|NCT01121393|1178685|P2|Overall Study|Lost to Follow-up|0
349087|NCT01121393|1178686|P1|Overall Study|Lost to Follow-up|1
349088|NCT01121393|1178685|P2|Overall Study|Non-compliant with protocol|3
349089|NCT01121393|1178686|P1|Overall Study|Non-compliant with protocol|0
349090|NCT01121393|1178685|P2|Overall Study|Other Adverse events|45
349091|NCT01121393|1178686|P1|Overall Study|Other Adverse events|22
349092|NCT01121393|1178685|P2|Overall Study|Progressive disease|20
349093|NCT01121393|1178686|P1|Overall Study|Progressive disease|186
349094|NCT01121263|1178731|P2|Overall Study|Withdrawal by Subject|1
349095|NCT01121263|1178732|P1|Overall Study|Withdrawal by Subject|0
349096|NCT01121263|1178731|P2|Overall Study|Lost to Follow-up|12
349097|NCT01121263|1178732|P1|Overall Study|Lost to Follow-up|22
349098|NCT01121263|1178731|P2|Overall Study|Death|2
349099|NCT01121263|1178732|P1|Overall Study|Death|3
349100|NCT01121185|1178778|P2|Overall Study|Not transplanted|0
349101|NCT01121185|1178779|P1|Overall Study|Not transplanted|1
349102|NCT01121185|1178778|P2|Overall Study|Not infused|1
349103|NCT01121185|1178779|P1|Overall Study|Not infused|0
349104|NCT01121146|1178813|P2|Overall Study|Lost to Follow-up|16
349105|NCT01121146|1178814|P1|Overall Study|Lost to Follow-up|7
349106|NCT01121146|1178813|P2|Overall Study|Adverse Event|11
349107|NCT01121146|1178814|P1|Overall Study|Adverse Event|2
349108|NCT01121146|1178813|P2|Overall Study|Death|15
349109|NCT01121146|1178814|P1|Overall Study|Death|17
349110|NCT01120899|1178835|P1|Overall Study|Withdrawal by Subject|3
349111|NCT01120782|1178863|P1|Overall Study|Test article shipping error|11
349112|NCT01120717|1178869|P2|Overall Study|Abnormal Test Procedure Result(s)|0
349113|NCT01120717|1178870|P1|Overall Study|Abnormal Test Procedure Result(s)|1
349114|NCT01120717|1178869|P2|Overall Study|Death|1
349115|NCT01120717|1178870|P1|Overall Study|Death|3
349116|NCT01120717|1178869|P2|Overall Study|Lost to Follow-up|3
349117|NCT01120717|1178870|P1|Overall Study|Lost to Follow-up|2
349118|NCT01120717|1178869|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
349119|NCT01120717|1178870|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
349120|NCT01120717|1178869|P2|Overall Study|Protocol Deviation|5
349121|NCT01120717|1178870|P1|Overall Study|Protocol Deviation|2
349122|NCT01120717|1178869|P2|Overall Study|Adverse Event|6
349123|NCT01120717|1178870|P1|Overall Study|Adverse Event|10
349124|NCT01120717|1178869|P2|Overall Study|Withdrawal by Subject|6
349125|NCT01120717|1178870|P1|Overall Study|Withdrawal by Subject|11
349126|NCT01120691|1178976|P3|Overall Study|Abnormal laboratory value(s)|4
349127|NCT01120691|1178977|P2|Overall Study|Abnormal laboratory value(s)|3
349128|NCT01120691|1178978|P1|Overall Study|Abnormal laboratory value(s)|1
349129|NCT01120691|1178976|P3|Overall Study|Patient's inability to use the device|0
349130|NCT01120691|1178977|P2|Overall Study|Patient's inability to use the device|1
349131|NCT01120691|1178978|P1|Overall Study|Patient's inability to use the device|3
349132|NCT01120691|1178976|P3|Overall Study|Abnormal test procedure result(s)|1
349133|NCT01120691|1178977|P2|Overall Study|Abnormal test procedure result(s)|2
349134|NCT01120691|1178978|P1|Overall Study|Abnormal test procedure result(s)|3
349135|NCT01120691|1178976|P3|Overall Study|Lost to Follow-up|4
349136|NCT01120691|1178977|P2|Overall Study|Lost to Follow-up|6
349137|NCT01120691|1178978|P1|Overall Study|Lost to Follow-up|5
349138|NCT01120691|1178976|P3|Overall Study|Protocol deviation|12
349139|NCT01120691|1178977|P2|Overall Study|Protocol deviation|12
349140|NCT01120691|1178978|P1|Overall Study|Protocol deviation|13
349141|NCT01120691|1178976|P3|Overall Study|Administrative problems|9
349142|NCT01120691|1178977|P2|Overall Study|Administrative problems|8
349143|NCT01120691|1178978|P1|Overall Study|Administrative problems|15
349144|NCT01120691|1178976|P3|Overall Study|Unsatisfactory therapeutic effect|38
349145|NCT01120691|1178977|P2|Overall Study|Unsatisfactory therapeutic effect|32
349146|NCT01120691|1178978|P1|Overall Study|Unsatisfactory therapeutic effect|18
349147|NCT01120691|1178976|P3|Overall Study|Death|24
349148|NCT01120691|1178977|P2|Overall Study|Death|22
349149|NCT01120691|1178978|P1|Overall Study|Death|21
349150|NCT01120691|1178976|P3|Overall Study|Subject withdrew consent|44
349151|NCT01120691|1178977|P2|Overall Study|Subject withdrew consent|50
349152|NCT01120691|1178978|P1|Overall Study|Subject withdrew consent|33
349153|NCT01120691|1178976|P3|Overall Study|Adverse Event|47
349154|NCT01120691|1178977|P2|Overall Study|Adverse Event|67
349155|NCT01120691|1178978|P1|Overall Study|Adverse Event|59
349156|NCT01120626|1179022|P2|Overall Study|Withdrawal by Subject|0
349157|NCT01120626|1179023|P1|Overall Study|Withdrawal by Subject|1
349158|NCT01120600|1179033|P2|Overall Study|Withdrawal by Subject|11
349159|NCT01120600|1179034|P1|Overall Study|Withdrawal by Subject|10
349160|NCT01120600|1179033|P2|Overall Study|Protocol Violation|4
349161|NCT01120600|1179034|P1|Overall Study|Protocol Violation|0
349162|NCT01120600|1179033|P2|Overall Study|Physician Decision|3
349163|NCT01120600|1179034|P1|Overall Study|Physician Decision|1
349164|NCT01120600|1179033|P2|Overall Study|Lost to Follow-up|3
349165|NCT01120600|1179034|P1|Overall Study|Lost to Follow-up|1
349166|NCT01120600|1179033|P2|Overall Study|Excessive Bone Loss|4
349167|NCT01120600|1179034|P1|Overall Study|Excessive Bone Loss|0
349168|NCT01120600|1179033|P2|Overall Study|Adverse Event|7
349169|NCT01120600|1179034|P1|Overall Study|Adverse Event|7
349170|NCT01120379|1179089|P1|Four Year Timepoint|Any other reason for early termination|217
349171|NCT01120379|1179089|P1|Four Year Timepoint|Physician Decision|5
349172|NCT01120379|1179089|P1|Four Year Timepoint|Death|131
349173|NCT01120379|1179089|P1|Four Year Timepoint|Lost to Follow-up|10
349174|NCT01120379|1179089|P1|Four Year Timepoint|Withdrawal by Subject|5
349175|NCT01120379|1179089|P1|Three Year Timepoint|Any other reason for early termination|17
349176|NCT01120379|1179089|P1|Three Year Timepoint|Physician Decision|9
349177|NCT01120379|1179089|P1|Three Year Timepoint|Death|120
349178|NCT01120379|1179089|P1|Three Year Timepoint|Lost to Follow-up|43
349179|NCT01120379|1179089|P1|Three Year Timepoint|Withdrawal by Subject|25
349180|NCT01120379|1179089|P1|Two Year Timepoint|Any other reason for early termination|4
349181|NCT01120379|1179089|P1|Two Year Timepoint|Physician Decision|12
349182|NCT01120379|1179089|P1|Two Year Timepoint|Death|123
349183|NCT01120379|1179089|P1|Two Year Timepoint|Lost to Follow-up|87
349184|NCT01120379|1179089|P1|Two Year Timepoint|Withdrawal by Subject|11
349185|NCT01120379|1179089|P1|One Year Timepoint|Any other reason for early termination|5
349186|NCT01120379|1179089|P1|One Year Timepoint|Physician Decision|9
349187|NCT01120379|1179089|P1|One Year Timepoint|Death|108
349188|NCT01120379|1179089|P1|One Year Timepoint|Lost to Follow-up|115
349189|NCT01120379|1179089|P1|One Year Timepoint|Withdrawal by Subject|41
349190|NCT01120275|1179125|P1|Overall Study|Not specific|1
349191|NCT01120275|1179125|P1|Overall Study|Refusal|1
349192|NCT01120275|1179125|P1|Overall Study|Withdrawal by Subject|1
349193|NCT01120275|1179125|P1|Overall Study|Ineligible|3
349194|NCT01120275|1179125|P1|Overall Study|Progression|27
349195|NCT01120275|1179125|P1|Overall Study|Adverse Event|3
349196|NCT01120210|1179192|P2|MAIN INFUSION|Withdrawal by Subject|1
349197|NCT01120210|1179193|P1|MAIN INFUSION|Withdrawal by Subject|0
349198|NCT01120210|1179192|P2|MAIN INFUSION|Adverse Event|0
349199|NCT01120210|1179193|P1|MAIN INFUSION|Adverse Event|1
349200|NCT01120184|1179243|P3|Overall Study|Death|169
349201|NCT01120184|1179244|P2|Overall Study|Death|176
349202|NCT01120184|1179245|P1|Overall Study|Death|170
349203|NCT01120184|1179243|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
349204|NCT01120184|1179244|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
349205|NCT01120184|1179245|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
349206|NCT01120184|1179243|P3|Overall Study|Sponsor Decision to Terminate Study|143
349207|NCT01120184|1179244|P2|Overall Study|Sponsor Decision to Terminate Study|144
349208|NCT01120184|1179245|P1|Overall Study|Sponsor Decision to Terminate Study|133
349209|NCT01120184|1179243|P3|Overall Study|Reason not Specified|12
349210|NCT01120184|1179244|P2|Overall Study|Reason not Specified|3
349211|NCT01120184|1179245|P1|Overall Study|Reason not Specified|8
349212|NCT01120184|1179243|P3|Overall Study|Physician Decision|3
349213|NCT01120184|1179244|P2|Overall Study|Physician Decision|1
349214|NCT01120184|1179245|P1|Overall Study|Physician Decision|9
349215|NCT01120184|1179243|P3|Overall Study|Lost to Follow-up|11
349216|NCT01120184|1179244|P2|Overall Study|Lost to Follow-up|13
349217|NCT01120184|1179245|P1|Overall Study|Lost to Follow-up|13
349218|NCT01120184|1179243|P3|Overall Study|Adverse Event|0
349219|NCT01120184|1179244|P2|Overall Study|Adverse Event|1
349220|NCT01120184|1179245|P1|Overall Study|Adverse Event|0
349221|NCT01120093|1179367|P5|Treatment Period 5|Adverse Event|0
349222|NCT01120093|1179368|P4|Treatment Period 5|Adverse Event|1
349223|NCT01120093|1179369|P3|Treatment Period 5|Adverse Event|0
349224|NCT01120093|1179370|P2|Treatment Period 5|Adverse Event|1
349225|NCT01120093|1179371|P1|Treatment Period 5|Adverse Event|0
349226|NCT01120093|1179367|P5|Treatment Period 4|Adverse Event|0
349227|NCT01120093|1179368|P4|Treatment Period 4|Adverse Event|0
349228|NCT01120093|1179369|P3|Treatment Period 4|Adverse Event|0
349229|NCT01120093|1179370|P2|Treatment Period 4|Adverse Event|0
349230|NCT01120093|1179371|P1|Treatment Period 4|Adverse Event|1
349231|NCT01120093|1179367|P5|Treatment Period 3|Withdrawal by Subject|0
349232|NCT01120093|1179368|P4|Treatment Period 3|Withdrawal by Subject|0
349233|NCT01120093|1179369|P3|Treatment Period 3|Withdrawal by Subject|1
349234|NCT01120093|1179370|P2|Treatment Period 3|Withdrawal by Subject|0
349235|NCT01120093|1179371|P1|Treatment Period 3|Withdrawal by Subject|0
349236|NCT01120093|1179367|P5|Treatment Period 3|Adverse Event|1
349237|NCT01120093|1179368|P4|Treatment Period 3|Adverse Event|0
349238|NCT01120093|1179369|P3|Treatment Period 3|Adverse Event|0
349239|NCT01120093|1179370|P2|Treatment Period 3|Adverse Event|0
349240|NCT01120093|1179371|P1|Treatment Period 3|Adverse Event|0
349241|NCT01120093|1179367|P5|Treatment Period 3|Lack of Efficacy|0
349242|NCT01120093|1179368|P4|Treatment Period 3|Lack of Efficacy|1
349243|NCT01120093|1179369|P3|Treatment Period 3|Lack of Efficacy|0
349244|NCT01120093|1179370|P2|Treatment Period 3|Lack of Efficacy|0
349245|NCT01120093|1179371|P1|Treatment Period 3|Lack of Efficacy|0
349246|NCT01120093|1179367|P5|Treatment Period 2|Withdrawal by Subject|1
349247|NCT01120093|1179368|P4|Treatment Period 2|Withdrawal by Subject|0
349248|NCT01120093|1179369|P3|Treatment Period 2|Withdrawal by Subject|0
349249|NCT01120093|1179370|P2|Treatment Period 2|Withdrawal by Subject|0
349250|NCT01120093|1179371|P1|Treatment Period 2|Withdrawal by Subject|0
349251|NCT01120093|1179367|P5|Treatment Period 2|Adverse Event|0
349252|NCT01120093|1179368|P4|Treatment Period 2|Adverse Event|1
349253|NCT01120093|1179369|P3|Treatment Period 2|Adverse Event|0
349254|NCT01120093|1179370|P2|Treatment Period 2|Adverse Event|0
349255|NCT01120093|1179371|P1|Treatment Period 2|Adverse Event|0
349256|NCT01120093|1179367|P5|Treatment Period 1|Withdrawal by Subject|0
349257|NCT01120093|1179368|P4|Treatment Period 1|Withdrawal by Subject|0
349258|NCT01120093|1179369|P3|Treatment Period 1|Withdrawal by Subject|0
349259|NCT01120093|1179370|P2|Treatment Period 1|Withdrawal by Subject|1
349260|NCT01120093|1179371|P1|Treatment Period 1|Withdrawal by Subject|0
349261|NCT01120093|1179367|P5|Treatment Period 1|Adverse Event|1
349262|NCT01120093|1179368|P4|Treatment Period 1|Adverse Event|0
349263|NCT01120093|1179369|P3|Treatment Period 1|Adverse Event|1
349264|NCT01120093|1179370|P2|Treatment Period 1|Adverse Event|0
349265|NCT01120093|1179371|P1|Treatment Period 1|Adverse Event|0
349266|NCT01120067|1179400|P2|Overall Study|fail to engage >3 sessions|0
349267|NCT01120067|1179401|P1|Overall Study|fail to engage >3 sessions|2
349268|NCT01120067|1179400|P2|Overall Study|Lost to Follow-up|1
349269|NCT01120067|1179401|P1|Overall Study|Lost to Follow-up|3
349270|NCT01119963|1179409|P2|Overall Study|Lost to Follow-up|1
349271|NCT01119963|1179410|P1|Overall Study|Lost to Follow-up|1
349272|NCT01119950|1179420|P1|Overall Study|Death|1
349273|NCT01119950|1179420|P1|Overall Study|Abnormal lab value|1
349274|NCT01119950|1179420|P1|Overall Study|Administrative|2
349275|NCT01119950|1179420|P1|Overall Study|Lost to Follow-up|4
349276|NCT01119950|1179420|P1|Overall Study|Protocol Violation|5
349277|NCT01119950|1179420|P1|Overall Study|Withdrawal by Subject|9
349278|NCT01119950|1179420|P1|Overall Study|Adverse Event|25
349279|NCT01119937|1179667|P2|Overall Study|Withdrawal by Subject|1
349280|NCT01119937|1179668|P1|Overall Study|Withdrawal by Subject|2
349281|NCT01119937|1179667|P2|Overall Study|Unsatisfactory therapeutic effect|0
349282|NCT01119937|1179668|P1|Overall Study|Unsatisfactory therapeutic effect|3
349283|NCT01119937|1179667|P2|Overall Study|Protocol deviation|1
349284|NCT01119937|1179668|P1|Overall Study|Protocol deviation|3
349285|NCT01119937|1179667|P2|Overall Study|Adverse Event|5
349286|NCT01119937|1179668|P1|Overall Study|Adverse Event|11
349287|NCT01119859|1179696|P2|Overall Study|Failure to return|0
349288|NCT01119859|1179697|P1|Overall Study|Failure to return|3
349289|NCT01119859|1179696|P2|Overall Study|Refused treatment|6
349290|NCT01119859|1179697|P1|Overall Study|Refused treatment|3
349291|NCT01119859|1179696|P2|Overall Study|Insufficient therapeutic response|14
349292|NCT01119859|1179697|P1|Overall Study|Insufficient therapeutic response|7
349293|NCT01119859|1179696|P2|Overall Study|Death|0
349294|NCT01119859|1179697|P1|Overall Study|Death|2
349295|NCT01119859|1179696|P2|Overall Study|Adverse Event|10
349296|NCT01119859|1179697|P1|Overall Study|Adverse Event|9
349297|NCT01119846|1179716|P3|Overall Study|Withdrawal by Subject|4
349298|NCT01119846|1179717|P2|Overall Study|Withdrawal by Subject|0
349299|NCT01119846|1179718|P1|Overall Study|Withdrawal by Subject|0
349300|NCT01119846|1179716|P3|Overall Study|Protocol Violation|1
349301|NCT01119846|1179717|P2|Overall Study|Protocol Violation|0
349302|NCT01119846|1179718|P1|Overall Study|Protocol Violation|0
349303|NCT01119846|1179716|P3|Overall Study|Physician Decision|0
349304|NCT01119846|1179717|P2|Overall Study|Physician Decision|0
349305|NCT01119846|1179718|P1|Overall Study|Physician Decision|1
349306|NCT01119846|1179716|P3|Overall Study|Adverse Event|6
349307|NCT01119846|1179717|P2|Overall Study|Adverse Event|0
349308|NCT01119846|1179718|P1|Overall Study|Adverse Event|1
349309|NCT01119768|1179932|P2|Treatment Period|Lack of Efficacy|25
349310|NCT01119768|1179933|P1|Treatment Period|Lack of Efficacy|18
349311|NCT01119703|1179989|P2|Overall Study|Adverse Event|1
349312|NCT01119703|1179990|P1|Overall Study|Adverse Event|0
349313|NCT01119625|1180004|P2|Overall Study|Other|1
349314|NCT01119625|1180005|P1|Overall Study|Other|0
349315|NCT01119625|1180004|P2|Overall Study|Withdrawal by Subject|1
349316|NCT01119625|1180005|P1|Overall Study|Withdrawal by Subject|2
349317|NCT01119625|1180004|P2|Overall Study|Lost to Follow-up|2
349318|NCT01119625|1180005|P1|Overall Study|Lost to Follow-up|1
349319|NCT01119443|1180047|P2|Crossover Period 1 (5 Days)|Adverse Event|1
349320|NCT01119443|1180048|P1|Crossover Period 1 (5 Days)|Adverse Event|0
349321|NCT01119287|1180091|P6|Overall Study|Patient Decision, not related to AE|0
349322|NCT01119287|1180092|P5|Overall Study|Patient Decision, not related to AE|1
349323|NCT01119287|1180093|P4|Overall Study|Patient Decision, not related to AE|2
349324|NCT01119287|1180094|P3|Overall Study|Patient Decision, not related to AE|2
349325|NCT01119287|1180095|P2|Overall Study|Patient Decision, not related to AE|0
349326|NCT01119287|1180096|P1|Overall Study|Patient Decision, not related to AE|0
349327|NCT01119248|1180109|P1|Overall Study|Physician Decision|5
349328|NCT01119131|1180159|P3|Overall Study|Physician Decision|1
349329|NCT01119131|1180160|P2|Overall Study|Physician Decision|0
349330|NCT01119131|1180161|P1|Overall Study|Physician Decision|0
349331|NCT01119131|1180159|P3|Overall Study|Non-Compliance|4
349332|NCT01119131|1180160|P2|Overall Study|Non-Compliance|0
349333|NCT01119131|1180161|P1|Overall Study|Non-Compliance|1
349334|NCT01119131|1180159|P3|Overall Study|Adverse Event|1
349335|NCT01119131|1180160|P2|Overall Study|Adverse Event|1
349336|NCT01119131|1180161|P1|Overall Study|Adverse Event|1
349337|NCT01119118|1180190|P1|Overall Study|Adverse Event|1
349338|NCT01119001|1180202|P1|Overall Study|Withdrawal by Subject|2
349339|NCT01118975|1180246|P2|Overall Study|Adverse Event|1
349340|NCT01118975|1180247|P1|Overall Study|Adverse Event|0
349341|NCT01118962|1180253|P1|Overall Study|Non-compliance with Medicinal Product|1
349342|NCT01118962|1180253|P1|Overall Study|Pregnancy|1
349343|NCT01118962|1180253|P1|Overall Study|Withdrawal by Subject|4
349344|NCT01118962|1180253|P1|Overall Study|Protocol Violation|1
349345|NCT01118962|1180253|P1|Overall Study|Lack of Efficacy|1
349346|NCT01118962|1180253|P1|Overall Study|Adverse Event|2
349347|NCT01118949|1180258|P1|Overall Study|Withdrawal by Subject|4
349348|NCT01118949|1180258|P1|Overall Study|Adverse Event|5
349349|NCT01118780|1180288|P2|Overall Study|Withdrawal by Subject|8
349350|NCT01118780|1180289|P1|Overall Study|Withdrawal by Subject|13
349351|NCT01118780|1180288|P2|Overall Study|Protocol Violation|6
349352|NCT01118780|1180289|P1|Overall Study|Protocol Violation|3
349353|NCT01118780|1180288|P2|Overall Study|Physician Decision|0
349354|NCT01118780|1180289|P1|Overall Study|Physician Decision|2
349355|NCT01118780|1180288|P2|Overall Study|Lack of Efficacy|6
349356|NCT01118780|1180289|P1|Overall Study|Lack of Efficacy|2
349357|NCT01118780|1180288|P2|Overall Study|Death|0
349358|NCT01118780|1180289|P1|Overall Study|Death|1
349359|NCT01118780|1180288|P2|Overall Study|Adverse Event|15
349360|NCT01118780|1180289|P1|Overall Study|Adverse Event|15
349361|NCT01118728|1180347|P1|Overall Study|Lost to Follow-up|4
349362|NCT01118728|1180347|P1|Overall Study|Withdrawal by Subject|3
349363|NCT01118728|1180347|P1|Overall Study|Sponsor's decision to discontinue study|172
349364|NCT01118728|1180347|P1|Overall Study|Lack of Efficacy|27
349365|NCT01118728|1180347|P1|Overall Study|Adverse Event|17
349366|NCT01118663|1180354|P2|Overall Study|Withdrawal by Subject|1
349367|NCT01118663|1180355|P1|Overall Study|Withdrawal by Subject|0
349368|NCT01118663|1180354|P2|Overall Study|Adverse Event|1
349369|NCT01118663|1180355|P1|Overall Study|Adverse Event|2
349370|NCT01118455|1180378|P2|Baseline [Visits 1 & 2]|Adverse Event|0
349371|NCT01118455|1180379|P1|Baseline [Visits 1 & 2]|Adverse Event|1
349372|NCT01118377|1180407|P1|Overall Study|Failure to Return|3
349373|NCT01118377|1180407|P1|Overall Study|Death|38
349374|NCT01118377|1180407|P1|Overall Study|Did Not Receive Study Medication|1
349375|NCT01118325|1180416|P3|Overall Study|Adverse Event|1
349376|NCT01118325|1180417|P2|Overall Study|Adverse Event|0
349377|NCT01118325|1180418|P1|Overall Study|Adverse Event|1
349378|NCT01118312|1180464|P2|Overall Study|Withdrawal by Subject|3
349379|NCT01118312|1180465|P1|Overall Study|Withdrawal by Subject|1
349380|NCT01118312|1180464|P2|Overall Study|Lost to Follow-up|32
349381|NCT01118312|1180465|P1|Overall Study|Lost to Follow-up|33
349382|NCT01118143|1180663|P2|Overall Study|Withdrawal by Subject|5
349383|NCT01118143|1180664|P1|Overall Study|Withdrawal by Subject|2
349384|NCT01118117|1180674|P2|Overall Study|Missed 12 Month Visit|0
349385|NCT01118117|1180675|P1|Overall Study|Missed 12 Month Visit|7
349386|NCT01118117|1180674|P2|Overall Study|Lost to Follow-up|0
349387|NCT01118117|1180675|P1|Overall Study|Lost to Follow-up|6
349388|NCT01118117|1180674|P2|Overall Study|Death|0
349389|NCT01118117|1180675|P1|Overall Study|Death|8
349390|NCT01118052|1180707|P1|Overall Study|Never treated|2
349391|NCT01117987|1180730|P2|Overall Study|Administrative problems|22
349392|NCT01117987|1180731|P1|Overall Study|Administrative problems|25
349393|NCT01117987|1180730|P2|Overall Study|Adverse Event|26
349394|NCT01117987|1180731|P1|Overall Study|Adverse Event|19
349395|NCT01117987|1180730|P2|Overall Study|Withdrawal by Subject|10
349396|NCT01117987|1180731|P1|Overall Study|Withdrawal by Subject|5
349397|NCT01117987|1180730|P2|Overall Study|Death|10
349398|NCT01117987|1180731|P1|Overall Study|Death|5
349399|NCT01117987|1180730|P2|Overall Study|Lack of Efficacy|4
349400|NCT01117987|1180731|P1|Overall Study|Lack of Efficacy|3
349401|NCT01117987|1180730|P2|Overall Study|Abnormal test procedure result|0
349402|NCT01117987|1180731|P1|Overall Study|Abnormal test procedure result|2
349403|NCT01117987|1180730|P2|Overall Study|Lost to Follow-up|1
349404|NCT01117987|1180731|P1|Overall Study|Lost to Follow-up|1
349405|NCT01117987|1180730|P2|Overall Study|Subject no longer requires study drug|0
349406|NCT01117987|1180731|P1|Overall Study|Subject no longer requires study drug|1
349407|NCT01117987|1180730|P2|Overall Study|Protocol deviation|1
349408|NCT01117987|1180731|P1|Overall Study|Protocol deviation|0
349409|NCT01117870|1180752|P2|Overall Study|Inability to place needle|0
349410|NCT01117870|1180753|P1|Overall Study|Inability to place needle|1
349411|NCT01117857|1180767|P1|Overall Study|Physician Decision|1
349412|NCT01117857|1180767|P1|Overall Study|Withdrawal by Subject|4
349413|NCT01117857|1180767|P1|Overall Study|Lost to Follow-up|4
349414|NCT01117766|1180775|P2|Second Intervention|Withdrawal by Subject|1
349415|NCT01117766|1180776|P1|Second Intervention|Withdrawal by Subject|0
349416|NCT01117766|1180775|P2|Second Intervention|Adverse Event|2
349417|NCT01117766|1180776|P1|Second Intervention|Adverse Event|0
349418|NCT01117766|1180775|P2|Second Intervention|Other|2
349419|NCT01117766|1180776|P1|Second Intervention|Other|1
349420|NCT01117766|1180775|P2|Second Intervention|Lost to Follow-up|0
349421|NCT01117766|1180776|P1|Second Intervention|Lost to Follow-up|1
349422|NCT01117766|1180775|P2|Washout Period|Protocol Violation|2
349423|NCT01117766|1180776|P1|Washout Period|Protocol Violation|0
349424|NCT01117766|1180775|P2|First Intervention|Protocol Violation|0
349425|NCT01117766|1180776|P1|First Intervention|Protocol Violation|1
349426|NCT01117766|1180775|P2|First Intervention|Other|0
349427|NCT01117766|1180776|P1|First Intervention|Other|0
349428|NCT01117766|1180775|P2|First Intervention|Adverse Event|1
349429|NCT01117766|1180776|P1|First Intervention|Adverse Event|0
349430|NCT01117623|1180813|P8|Overall Study|Invest. text: completed all planned txs|0
349431|NCT01117623|1180814|P7|Overall Study|Invest. text: completed all planned txs|0
349432|NCT01117623|1180815|P6|Overall Study|Invest. text: completed all planned txs|1
349433|NCT01117623|1180816|P5|Overall Study|Invest. text: completed all planned txs|0
349434|NCT01117623|1180817|P4|Overall Study|Invest. text: completed all planned txs|0
349435|NCT01117623|1180818|P3|Overall Study|Invest. text: completed all planned txs|0
349436|NCT01117623|1180819|P2|Overall Study|Invest. text: completed all planned txs|0
349437|NCT01117623|1180820|P1|Overall Study|Invest. text: completed all planned txs|0
349438|NCT01117623|1180813|P8|Overall Study|Non-compliance with study medication|1
349439|NCT01117623|1180814|P7|Overall Study|Non-compliance with study medication|0
349440|NCT01117623|1180815|P6|Overall Study|Non-compliance with study medication|0
349441|NCT01117623|1180816|P5|Overall Study|Non-compliance with study medication|0
349442|NCT01117623|1180817|P4|Overall Study|Non-compliance with study medication|0
349443|NCT01117623|1180818|P3|Overall Study|Non-compliance with study medication|0
349444|NCT01117623|1180819|P2|Overall Study|Non-compliance with study medication|0
349445|NCT01117623|1180820|P1|Overall Study|Non-compliance with study medication|0
349446|NCT01117623|1180813|P8|Overall Study|Withdrawal by Subject|1
349447|NCT01117623|1180814|P7|Overall Study|Withdrawal by Subject|1
349448|NCT01117623|1180815|P6|Overall Study|Withdrawal by Subject|1
349449|NCT01117623|1180816|P5|Overall Study|Withdrawal by Subject|0
349450|NCT01117623|1180817|P4|Overall Study|Withdrawal by Subject|0
349451|NCT01117623|1180818|P3|Overall Study|Withdrawal by Subject|2
349452|NCT01117623|1180819|P2|Overall Study|Withdrawal by Subject|0
349453|NCT01117623|1180820|P1|Overall Study|Withdrawal by Subject|0
349454|NCT01117623|1180813|P8|Overall Study|Disease progression, recurrence, relapse|22
349455|NCT01117623|1180814|P7|Overall Study|Disease progression, recurrence, relapse|5
349456|NCT01117623|1180815|P6|Overall Study|Disease progression, recurrence, relapse|14
349457|NCT01117623|1180816|P5|Overall Study|Disease progression, recurrence, relapse|8
349458|NCT01117623|1180817|P4|Overall Study|Disease progression, recurrence, relapse|6
349459|NCT01117623|1180818|P3|Overall Study|Disease progression, recurrence, relapse|5
349460|NCT01117623|1180819|P2|Overall Study|Disease progression, recurrence, relapse|6
349461|NCT01117623|1180820|P1|Overall Study|Disease progression, recurrence, relapse|3
349462|NCT01117623|1180813|P8|Overall Study|Adverse Event|2
349463|NCT01117623|1180814|P7|Overall Study|Adverse Event|0
349464|NCT01117623|1180815|P6|Overall Study|Adverse Event|0
349465|NCT01117623|1180816|P5|Overall Study|Adverse Event|2
349466|NCT01117623|1180817|P4|Overall Study|Adverse Event|0
349467|NCT01117623|1180818|P3|Overall Study|Adverse Event|4
349468|NCT01117623|1180819|P2|Overall Study|Adverse Event|2
349469|NCT01117623|1180820|P1|Overall Study|Adverse Event|0
349470|NCT01117480|1180972|P1|Overall Study|Did Not Start Adalimumab Therapy|20
349471|NCT01117480|1180972|P1|Overall Study|Protocol Violation|8
349472|NCT01117454|1180980|P2|Overall Study|Pregnancy|1
349473|NCT01117454|1180981|P1|Overall Study|Pregnancy|0
349474|NCT01117428|1180993|P6|Overall Study|Progressive disease|17
349475|NCT01117428|1180994|P5|Overall Study|Progressive disease|16
349476|NCT01117428|1180995|P4|Overall Study|Progressive disease|12
349477|NCT01117428|1180996|P3|Overall Study|Progressive disease|10
349478|NCT01117428|1180997|P2|Overall Study|Progressive disease|27
349479|NCT01117428|1180998|P1|Overall Study|Progressive disease|15
349480|NCT01117428|1180993|P6|Overall Study|Withdrawal by Subject|0
349481|NCT01117428|1180994|P5|Overall Study|Withdrawal by Subject|0
349482|NCT01117428|1180995|P4|Overall Study|Withdrawal by Subject|0
349483|NCT01117428|1180996|P3|Overall Study|Withdrawal by Subject|1
349484|NCT01117428|1180997|P2|Overall Study|Withdrawal by Subject|0
349485|NCT01117428|1180998|P1|Overall Study|Withdrawal by Subject|0
349486|NCT01117428|1180993|P6|Overall Study|Physician Decision|0
349487|NCT01117428|1180994|P5|Overall Study|Physician Decision|0
349488|NCT01117428|1180995|P4|Overall Study|Physician Decision|0
349489|NCT01117428|1180996|P3|Overall Study|Physician Decision|0
349490|NCT01117428|1180997|P2|Overall Study|Physician Decision|1
349491|NCT01117428|1180998|P1|Overall Study|Physician Decision|0
349492|NCT01117428|1180993|P6|Overall Study|Death|1
349493|NCT01117428|1180994|P5|Overall Study|Death|0
349494|NCT01117428|1180995|P4|Overall Study|Death|0
349495|NCT01117428|1180996|P3|Overall Study|Death|2
349496|NCT01117428|1180997|P2|Overall Study|Death|1
349497|NCT01117428|1180998|P1|Overall Study|Death|0
349498|NCT01117428|1180993|P6|Overall Study|Adverse Event|2
349499|NCT01117428|1180994|P5|Overall Study|Adverse Event|1
349500|NCT01117428|1180995|P4|Overall Study|Adverse Event|0
349501|NCT01117428|1180996|P3|Overall Study|Adverse Event|0
349502|NCT01117428|1180997|P2|Overall Study|Adverse Event|0
349503|NCT01117428|1180998|P1|Overall Study|Adverse Event|4
349504|NCT01117428|1180993|P6|Overall Study|Lack of Efficacy|0
349505|NCT01117428|1180994|P5|Overall Study|Lack of Efficacy|0
349506|NCT01117428|1180995|P4|Overall Study|Lack of Efficacy|0
349507|NCT01117428|1180996|P3|Overall Study|Lack of Efficacy|0
349508|NCT01117428|1180997|P2|Overall Study|Lack of Efficacy|0
349509|NCT01117428|1180998|P1|Overall Study|Lack of Efficacy|1
349510|NCT01117350|1181032|P2|Extension Period|Prohibited medication|1
349511|NCT01117350|1181033|P1|Extension Period|Prohibited medication|0
349512|NCT01117350|1181032|P2|Extension Period|Inclusion criteria not respected|1
349513|NCT01117350|1181033|P1|Extension Period|Inclusion criteria not respected|0
349514|NCT01117350|1181032|P2|Extension Period|Lack of Efficacy|2
349515|NCT01117350|1181033|P1|Extension Period|Lack of Efficacy|0
349516|NCT01117350|1181032|P2|Extension Period|Withdrawal by Subject|3
349517|NCT01117350|1181033|P1|Extension Period|Withdrawal by Subject|0
349518|NCT01117350|1181032|P2|Extension Period|Lost to Follow-up|2
349519|NCT01117350|1181033|P1|Extension Period|Lost to Follow-up|0
349520|NCT01117350|1181032|P2|Extension Period|Protocol Violation|2
349521|NCT01117350|1181033|P1|Extension Period|Protocol Violation|0
349522|NCT01117350|1181032|P2|Extension Period|Adverse Event|2
349523|NCT01117350|1181033|P1|Extension Period|Adverse Event|0
349524|NCT01117350|1181032|P2|Extension Period|Not included in extension, not treated|50
349525|NCT01117350|1181033|P1|Extension Period|Not included in extension, not treated|0
349526|NCT01117350|1181032|P2|Comparative Period|Move to another city/country|1
349527|NCT01117350|1181033|P1|Comparative Period|Move to another city/country|2
349528|NCT01117350|1181032|P2|Comparative Period|Physician Decision|1
349529|NCT01117350|1181033|P1|Comparative Period|Physician Decision|0
349530|NCT01117350|1181032|P2|Comparative Period|Lack of Efficacy|0
349531|NCT01117350|1181033|P1|Comparative Period|Lack of Efficacy|1
349532|NCT01117350|1181032|P2|Comparative Period|Protocol Violation|12
349533|NCT01117350|1181033|P1|Comparative Period|Protocol Violation|8
349534|NCT01117350|1181032|P2|Comparative Period|Withdrawal by Subject|13
349535|NCT01117350|1181033|P1|Comparative Period|Withdrawal by Subject|9
349536|NCT01117350|1181032|P2|Comparative Period|Lost to Follow-up|7
349537|NCT01117350|1181033|P1|Comparative Period|Lost to Follow-up|11
349538|NCT01117350|1181032|P2|Comparative Period|Adverse Event|33
349539|NCT01117350|1181033|P1|Comparative Period|Adverse Event|6
349540|NCT01117350|1181032|P2|Comparative Period|Not Treated|8
349541|NCT01117350|1181033|P1|Comparative Period|Not Treated|5
349542|NCT01117337|1181065|P2|Overall Study|Lost to Follow-up|0
349543|NCT01117337|1181066|P1|Overall Study|Lost to Follow-up|4
349544|NCT01117181|1181087|P2|Overall Study|Withdrawal by Subject|2
349545|NCT01117181|1181088|P1|Overall Study|Withdrawal by Subject|0
349546|NCT01117181|1181087|P2|Overall Study|Lost to Follow-up|0
349547|NCT01117181|1181088|P1|Overall Study|Lost to Follow-up|1
349548|NCT01117051|1181121|P2|Overall Study|Convenience issue|0
349549|NCT01117051|1181122|P1|Overall Study|Convenience issue|1
349550|NCT01117051|1181121|P2|Overall Study|Randomized by mistake|1
349551|NCT01117051|1181122|P1|Overall Study|Randomized by mistake|0
349552|NCT01117051|1181121|P2|Overall Study|Surgical procedure|1
349553|NCT01117051|1181122|P1|Overall Study|Surgical procedure|0
349554|NCT01117051|1181121|P2|Overall Study|Sponsor's decision|1
349555|NCT01117051|1181122|P1|Overall Study|Sponsor's decision|3
349556|NCT01117051|1181121|P2|Overall Study|Did not meet in-/exclusion criteria|1
349557|NCT01117051|1181122|P1|Overall Study|Did not meet in-/exclusion criteria|0
349558|NCT01117051|1181121|P2|Overall Study|Lost to Follow-up|1
349559|NCT01117051|1181122|P1|Overall Study|Lost to Follow-up|0
349560|NCT01117051|1181121|P2|Overall Study|Adverse Event|3
349561|NCT01117051|1181122|P1|Overall Study|Adverse Event|4
349562|NCT01117051|1181121|P2|Overall Study|Withdrawal by Subject|3
349563|NCT01117051|1181122|P1|Overall Study|Withdrawal by Subject|5
349564|NCT01117012|1181132|P2|Overall Study|Undefined|3
349565|NCT01117012|1181133|P1|Overall Study|Undefined|4
349566|NCT01117012|1181132|P2|Overall Study|Withdrawal by Subject|0
349567|NCT01117012|1181133|P1|Overall Study|Withdrawal by Subject|3
349568|NCT01117012|1181132|P2|Overall Study|Death|1
349569|NCT01117012|1181133|P1|Overall Study|Death|1
349570|NCT01117012|1181132|P2|Overall Study|Adverse Event|1
349571|NCT01117012|1181133|P1|Overall Study|Adverse Event|0
349572|NCT01116882|1181274|P2|12-month|Withdrawal by Subject|8
349573|NCT01116882|1181275|P1|12-month|Withdrawal by Subject|5
349574|NCT01116882|1181274|P2|12-month|Other Reasons|49
349575|NCT01116882|1181275|P1|12-month|Other Reasons|151
349576|NCT01116882|1181274|P2|12-month|Lost to Follow-up|42
349577|NCT01116882|1181275|P1|12-month|Lost to Follow-up|111
349578|NCT01116882|1181274|P2|30-day|Other Reasons|6
349579|NCT01116882|1181275|P1|30-day|Other Reasons|16
349580|NCT01116882|1181274|P2|30-day|Withdrawal by Subject|4
349581|NCT01116882|1181275|P1|30-day|Withdrawal by Subject|2
349582|NCT01116882|1181274|P2|30-day|Lost to Follow-up|21
349583|NCT01116882|1181275|P1|30-day|Lost to Follow-up|50
349584|NCT01116687|1181313|P1|Overall Study|Withdrawal by Subject|4
349585|NCT01116427|1181330|P2|Extension Phase|Not using appropriate birth control|0
349586|NCT01116427|1181331|P1|Extension Phase|Not using appropriate birth control|1
349587|NCT01116427|1181330|P2|Extension Phase|Withdrawal by Subject|1
349588|NCT01116427|1181331|P1|Extension Phase|Withdrawal by Subject|5
349589|NCT01116427|1181330|P2|Extension Phase|Lost to Follow-up|0
349590|NCT01116427|1181331|P1|Extension Phase|Lost to Follow-up|2
349591|NCT01116427|1181330|P2|Extension Phase|Adverse Event|1
349592|NCT01116427|1181331|P1|Extension Phase|Adverse Event|1
349593|NCT01116427|1181330|P2|Core Phase|Worsening Multiple Sclerosis|0
349594|NCT01116427|1181331|P1|Core Phase|Worsening Multiple Sclerosis|1
349595|NCT01116427|1181330|P2|Core Phase|Withdrawal by Subject|0
349596|NCT01116427|1181331|P1|Core Phase|Withdrawal by Subject|3
349597|NCT01116427|1181330|P2|Core Phase|Lost to Follow-up|0
349598|NCT01116427|1181331|P1|Core Phase|Lost to Follow-up|1
349599|NCT01116427|1181330|P2|Core Phase|Adverse Event|1
349600|NCT01116427|1181331|P1|Core Phase|Adverse Event|0
349601|NCT01116232|1181372|P1|Overall Study|Progressive diease|4
349602|NCT01115998|1181480|P2|Overall Study|Lost to Follow-up|6
349603|NCT01115998|1181481|P1|Overall Study|Lost to Follow-up|6
349604|NCT01115933|1181491|P1|Overall Study|Did not receive XIENCE PRIME SV|1
349605|NCT01115855|1181588|P2|Overall Study|Other|6
349606|NCT01115855|1181589|P1|Overall Study|Other|8
349607|NCT01115855|1181588|P2|Overall Study|Withdrawal by Subject|5
349608|NCT01115855|1181589|P1|Overall Study|Withdrawal by Subject|5
349609|NCT01115855|1181588|P2|Overall Study|Protocol Violation|1
349610|NCT01115855|1181589|P1|Overall Study|Protocol Violation|0
349611|NCT01115855|1181588|P2|Overall Study|Lab Abnormality|1
349612|NCT01115855|1181589|P1|Overall Study|Lab Abnormality|1
349613|NCT01115855|1181588|P2|Overall Study|Death|5
349614|NCT01115855|1181589|P1|Overall Study|Death|6
349615|NCT01115855|1181588|P2|Overall Study|Adverse Event|18
349616|NCT01115855|1181589|P1|Overall Study|Adverse Event|16
349617|NCT01115738|1181640|P3|Overall Study|Withdrawal by Subject|9
349618|NCT01115738|1181641|P2|Overall Study|Withdrawal by Subject|6
349619|NCT01115738|1181642|P1|Overall Study|Withdrawal by Subject|6
349620|NCT01115738|1181640|P3|Overall Study|Physician Decision|17
349621|NCT01115738|1181641|P2|Overall Study|Physician Decision|15
349622|NCT01115738|1181642|P1|Overall Study|Physician Decision|18
349623|NCT01115738|1181640|P3|Overall Study|Lost to Follow-up|1
349624|NCT01115738|1181641|P2|Overall Study|Lost to Follow-up|0
349625|NCT01115738|1181642|P1|Overall Study|Lost to Follow-up|0
349626|NCT01115738|1181640|P3|Overall Study|Death|0
349627|NCT01115738|1181641|P2|Overall Study|Death|0
349628|NCT01115738|1181642|P1|Overall Study|Death|1
349629|NCT01115569|1181840|P2|Maintenance Phase|Administrative|1
349630|NCT01115569|1181841|P1|Maintenance Phase|Administrative|0
349631|NCT01115569|1181840|P2|Maintenance Phase|Non-Compliance with Study Drug|48
349632|NCT01115569|1181841|P1|Maintenance Phase|Non-Compliance with Study Drug|0
349633|NCT01115569|1181840|P2|Maintenance Phase|Withdrawal by Subject|27
349634|NCT01115569|1181841|P1|Maintenance Phase|Withdrawal by Subject|0
349635|NCT01115569|1181840|P2|Maintenance Phase|Protocol Violation|9
349636|NCT01115569|1181841|P1|Maintenance Phase|Protocol Violation|0
349637|NCT01115569|1181840|P2|Maintenance Phase|Physician Decision|3
349638|NCT01115569|1181841|P1|Maintenance Phase|Physician Decision|0
349639|NCT01115569|1181840|P2|Maintenance Phase|Lost to Follow-up|8
349640|NCT01115569|1181841|P1|Maintenance Phase|Lost to Follow-up|0
349641|NCT01115569|1181840|P2|Maintenance Phase|Adverse Event|43
349642|NCT01115569|1181841|P1|Maintenance Phase|Adverse Event|0
349643|NCT01115569|1181840|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
349644|NCT01115569|1181841|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
349645|NCT01115569|1181840|P2|Conversion/Titration Phase|Withdrawal by Subject|0
349646|NCT01115569|1181841|P1|Conversion/Titration Phase|Withdrawal by Subject|26
349647|NCT01115569|1181840|P2|Conversion/Titration Phase|Protocol Violation|0
349648|NCT01115569|1181841|P1|Conversion/Titration Phase|Protocol Violation|68
349649|NCT01115569|1181840|P2|Conversion/Titration Phase|Physician Decision|0
349650|NCT01115569|1181841|P1|Conversion/Titration Phase|Physician Decision|5
349651|NCT01115569|1181840|P2|Conversion/Titration Phase|Lost to Follow-up|0
349652|NCT01115569|1181841|P1|Conversion/Titration Phase|Lost to Follow-up|3
349653|NCT01115569|1181840|P2|Conversion/Titration Phase|Adverse Event|0
349654|NCT01115569|1181841|P1|Conversion/Titration Phase|Adverse Event|59
349655|NCT01115491|1181870|P1|Overall Study|Physician Decision|1
349656|NCT01115491|1181870|P1|Overall Study|Withdrawal by Subject|1
349657|NCT01115491|1181870|P1|Overall Study|Lost to Follow-up|3
349658|NCT01115491|1181870|P1|Overall Study|Adverse Event|3
349659|NCT01115491|1181870|P1|Overall Study|Death|22
349660|NCT01114880|1182045|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
349661|NCT01114880|1182046|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
349662|NCT01114880|1182045|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
349663|NCT01114880|1182046|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
349664|NCT01114880|1182045|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
349665|NCT01114880|1182046|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
349666|NCT01114880|1182045|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
349667|NCT01114880|1182046|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
349668|NCT01114880|1182045|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
349669|NCT01114880|1182046|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
349670|NCT01114880|1182045|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
349671|NCT01114880|1182046|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
349672|NCT01114828|1182098|P2|Overall Study|Withdrawal by Subject|1
349673|NCT01114828|1182099|P1|Overall Study|Withdrawal by Subject|0
349674|NCT01114828|1182098|P2|Overall Study|Protocol Violation|0
349675|NCT01114828|1182099|P1|Overall Study|Protocol Violation|2
349676|NCT01114828|1182098|P2|Overall Study|Lack of Efficacy|2
349677|NCT01114828|1182099|P1|Overall Study|Lack of Efficacy|0
349678|NCT01114828|1182098|P2|Overall Study|Adverse Event|1
349679|NCT01114828|1182099|P1|Overall Study|Adverse Event|1
349680|NCT01114737|1182109|P2|Open-Label Treatment Period|Difficult Personal Events|0
349681|NCT01114737|1182110|P1|Open-Label Treatment Period|Difficult Personal Events|1
349682|NCT01114737|1182109|P2|Open-Label Treatment Period|Lost to Follow-up|1
349683|NCT01114737|1182110|P1|Open-Label Treatment Period|Lost to Follow-up|3
349684|NCT01114737|1182109|P2|Open-Label Treatment Period|Withdrawal by Subject|1
349685|NCT01114737|1182110|P1|Open-Label Treatment Period|Withdrawal by Subject|1
349686|NCT01114737|1182109|P2|Randomized Treatment Period|Pregnancy|0
349687|NCT01114737|1182110|P1|Randomized Treatment Period|Pregnancy|1
349688|NCT01114737|1182109|P2|Randomized Treatment Period|Lost to Follow-up|1
349689|NCT01114737|1182110|P1|Randomized Treatment Period|Lost to Follow-up|1
349690|NCT01114737|1182109|P2|Randomized Treatment Period|Withdrawal by Subject|0
349691|NCT01114737|1182110|P1|Randomized Treatment Period|Withdrawal by Subject|1
349692|NCT01114724|1182158|P1|Overall Study|Withdrawal by Subject|1
349693|NCT01114724|1182158|P1|Overall Study|Lost to Follow-up|1
349694|NCT01114724|1182158|P1|Overall Study|Death|8
349695|NCT01114672|1182178|P2|Overall Study|transplanted|0
349696|NCT01114672|1182179|P1|Overall Study|transplanted|1
349697|NCT01114672|1182178|P2|Overall Study|Lost to Follow-up|0
349698|NCT01114672|1182179|P1|Overall Study|Lost to Follow-up|1
349699|NCT01114672|1182178|P2|Overall Study|Withdrawal by Subject|1
349700|NCT01114672|1182179|P1|Overall Study|Withdrawal by Subject|2
349701|NCT01114672|1182178|P2|Overall Study|Death|1
349702|NCT01114672|1182179|P1|Overall Study|Death|0
349703|NCT01114529|1182230|P3|Completed Study Phase at Month 24|Missing|0
349704|NCT01114529|1182231|P2|Completed Study Phase at Month 24|Missing|0
349705|NCT01114529|1182232|P1|Completed Study Phase at Month 24|Missing|2
349706|NCT01114529|1182230|P3|Completed Study Phase at Month 24|Other|0
349707|NCT01114529|1182231|P2|Completed Study Phase at Month 24|Other|0
349708|NCT01114529|1182232|P1|Completed Study Phase at Month 24|Other|2
349709|NCT01114529|1182230|P3|Completed Study Phase at Month 24|Death|4
349710|NCT01114529|1182231|P2|Completed Study Phase at Month 24|Death|5
349711|NCT01114529|1182232|P1|Completed Study Phase at Month 24|Death|8
349712|NCT01114529|1182230|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
349713|NCT01114529|1182231|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
349714|NCT01114529|1182232|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
349715|NCT01114529|1182230|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
349716|NCT01114529|1182231|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
349717|NCT01114529|1182232|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
349718|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Missing|0
349719|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Missing|0
349720|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Missing|2
349721|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Protocol Violation|2
349722|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Protocol Violation|5
349723|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Protocol Violation|0
349724|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Graft loss|0
349725|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Graft loss|2
349726|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Graft loss|0
349727|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Death|2
349728|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Death|1
349729|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Death|2
349730|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Administrative problems|2
349731|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Administrative problems|1
349732|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Administrative problems|2
349733|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
349734|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
349735|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
349736|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
349737|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
349738|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
349739|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
349740|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
349741|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
349742|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
349743|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
349744|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
349745|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
349746|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
349747|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
349748|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
349749|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
349750|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
349751|NCT01114529|1182230|P3|Completed Study Medication at Month 24|Adverse Event|17
349752|NCT01114529|1182231|P2|Completed Study Medication at Month 24|Adverse Event|18
349753|NCT01114529|1182232|P1|Completed Study Medication at Month 24|Adverse Event|87
349754|NCT01114516|1182251|P2|Overall Study|Lost to Follow-up|1
349755|NCT01114516|1182252|P1|Overall Study|Lost to Follow-up|2
349756|NCT01114438|1182287|P1|Overall Study|Withdrawal by Subject|2
349757|NCT01114438|1182287|P1|Overall Study|Physician Decision|1
349758|NCT01114438|1182287|P1|Overall Study|concomitant medication|1
349759|NCT01114438|1182287|P1|Overall Study|Adverse Event|10
349760|NCT01114373|1182297|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
349761|NCT01114373|1182298|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
349762|NCT01114373|1182297|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
349763|NCT01114373|1182298|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
349764|NCT01114373|1182297|P2|Intervention 1 (4 Weeks)|Incarceration|0
349765|NCT01114373|1182298|P1|Intervention 1 (4 Weeks)|Incarceration|1
349766|NCT01114373|1182297|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
349767|NCT01114373|1182298|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
349768|NCT01114360|1182330|P2|Intervention 1 (4 Weeks)|Physician Decision|1
349769|NCT01114360|1182331|P1|Intervention 1 (4 Weeks)|Physician Decision|0
349770|NCT01114217|1182382|P2|Overall Study|Other-Withdrawal by Subject|1
349771|NCT01114217|1182383|P1|Overall Study|Other-Withdrawal by Subject|1
349772|NCT01114217|1182382|P2|Overall Study|Other-Lost to Follow-up|0
349773|NCT01114217|1182383|P1|Overall Study|Other-Lost to Follow-up|1
349774|NCT01114217|1182382|P2|Overall Study|Other-Site Stopped Communicating|0
349775|NCT01114217|1182383|P1|Overall Study|Other-Site Stopped Communicating|2
349776|NCT01114217|1182382|P2|Overall Study|Other-Study Withdrawn|1
349777|NCT01114217|1182383|P1|Overall Study|Other-Study Withdrawn|1
349778|NCT01114217|1182382|P2|Overall Study|Other-Study Termination|1
349779|NCT01114217|1182383|P1|Overall Study|Other-Study Termination|0
349780|NCT01114217|1182382|P2|Overall Study|Other-Sponsor Decision|12
349781|NCT01114217|1182383|P1|Overall Study|Other-Sponsor Decision|10
349782|NCT01114217|1182382|P2|Overall Study|Other-Physician Decision|1
349783|NCT01114217|1182383|P1|Overall Study|Other-Physician Decision|1
349784|NCT01114217|1182382|P2|Overall Study|Other-Non Compliance|0
349785|NCT01114217|1182383|P1|Overall Study|Other-Non Compliance|2
349786|NCT01114217|1182382|P2|Overall Study|Other-Lack of Efficacy|0
349787|NCT01114217|1182383|P1|Overall Study|Other-Lack of Efficacy|1
349788|NCT01114217|1182382|P2|Overall Study|Other-Protocol Violation|3
349789|NCT01114217|1182383|P1|Overall Study|Other-Protocol Violation|1
349790|NCT01114217|1182382|P2|Overall Study|Other-Pregnancy|4
349791|NCT01114217|1182383|P1|Overall Study|Other-Pregnancy|2
349792|NCT01114217|1182382|P2|Overall Study|Other-Procedure|1
349793|NCT01114217|1182383|P1|Overall Study|Other-Procedure|1
349794|NCT01114217|1182382|P2|Overall Study|Other-Early termination|10
349795|NCT01114217|1182383|P1|Overall Study|Other-Early termination|6
349796|NCT01114217|1182382|P2|Overall Study|Other-Clerical Error|0
349797|NCT01114217|1182383|P1|Overall Study|Other-Clerical Error|3
349798|NCT01114217|1182382|P2|Overall Study|Withdrawal by Subject|28
349799|NCT01114217|1182383|P1|Overall Study|Withdrawal by Subject|21
349800|NCT01114217|1182382|P2|Overall Study|Lost to Follow-up|33
349801|NCT01114217|1182383|P1|Overall Study|Lost to Follow-up|17
349802|NCT01114217|1182382|P2|Overall Study|Adverse Event|3
349803|NCT01114217|1182383|P1|Overall Study|Adverse Event|5
349804|NCT01114204|1182395|P2|Overall Study|Other-Protocol Violation|0
349805|NCT01114204|1182396|P1|Overall Study|Other-Protocol Violation|1
349806|NCT01114204|1182395|P2|Overall Study|Other-Participant request|0
349807|NCT01114204|1182396|P1|Overall Study|Other-Participant request|2
349808|NCT01114204|1182395|P2|Overall Study|Other-Medical monitor request|0
349809|NCT01114204|1182396|P1|Overall Study|Other-Medical monitor request|1
349810|NCT01114204|1182395|P2|Overall Study|Other-Personal reasons|0
349811|NCT01114204|1182396|P1|Overall Study|Other-Personal reasons|2
349812|NCT01114204|1182395|P2|Overall Study|Death|0
349813|NCT01114204|1182396|P1|Overall Study|Death|1
349814|NCT01114204|1182395|P2|Overall Study|Withdrawal by Subject|6
349815|NCT01114204|1182396|P1|Overall Study|Withdrawal by Subject|10
349816|NCT01114204|1182395|P2|Overall Study|Lost to Follow-up|0
349817|NCT01114204|1182396|P1|Overall Study|Lost to Follow-up|1
349818|NCT01114204|1182395|P2|Overall Study|Adverse Event|2
349819|NCT01114204|1182396|P1|Overall Study|Adverse Event|3
349820|NCT01114139|1182414|P2|Overall Study|Other-Withdrew prior to receiving dose|3
349821|NCT01114139|1182415|P1|Overall Study|Other-Withdrew prior to receiving dose|1
349822|NCT01114139|1182414|P2|Overall Study|Other-Physician changed treatment|0
349823|NCT01114139|1182415|P1|Overall Study|Other-Physician changed treatment|1
349824|NCT01114139|1182414|P2|Overall Study|Other-Participant went on hospice|1
349825|NCT01114139|1182415|P1|Overall Study|Other-Participant went on hospice|0
349826|NCT01114139|1182414|P2|Overall Study|Other-Participant falsified records|1
349827|NCT01114139|1182415|P1|Overall Study|Other-Participant falsified records|0
349828|NCT01114139|1182414|P2|Overall Study|Other-Out of window for study drug dose|0
349829|NCT01114139|1182415|P1|Overall Study|Other-Out of window for study drug dose|1
349830|NCT01114139|1182414|P2|Overall Study|Other-Protocol Violation|0
349831|NCT01114139|1182415|P1|Overall Study|Other-Protocol Violation|1
349832|NCT01114139|1182414|P2|Overall Study|Other-Missed 1 visit|0
349833|NCT01114139|1182415|P1|Overall Study|Other-Missed 1 visit|1
349834|NCT01114139|1182414|P2|Overall Study|Withdrawal by Subject|6
349835|NCT01114139|1182415|P1|Overall Study|Withdrawal by Subject|17
349836|NCT01114139|1182414|P2|Overall Study|Lost to Follow-up|3
349837|NCT01114139|1182415|P1|Overall Study|Lost to Follow-up|15
349838|NCT01114139|1182414|P2|Overall Study|Adverse Event|2
349839|NCT01114139|1182415|P1|Overall Study|Adverse Event|3
349840|NCT01113931|1182433|P2|Overall Study|Withdrawal by Subject|0
349841|NCT01113931|1182434|P1|Overall Study|Withdrawal by Subject|3
349842|NCT01113931|1182433|P2|Overall Study|Various|4
349843|NCT01113931|1182434|P1|Overall Study|Various|2
349844|NCT01113931|1182433|P2|Overall Study|Lost to Follow-up|9
349845|NCT01113931|1182434|P1|Overall Study|Lost to Follow-up|12
349846|NCT01113931|1182433|P2|Overall Study|Physician Decision|2
349847|NCT01113931|1182434|P1|Overall Study|Physician Decision|0
349848|NCT01113931|1182433|P2|Overall Study|Adverse Event|2
349849|NCT01113931|1182434|P1|Overall Study|Adverse Event|2
349850|NCT01113801|1182450|P4|Overall Study|Clinical Endpoint (ESRD)|5
349851|NCT01113801|1182451|P3|Overall Study|Clinical Endpoint (ESRD)|2
349852|NCT01113801|1182452|P2|Overall Study|Clinical Endpoint (ESRD)|4
349853|NCT01113801|1182453|P1|Overall Study|Clinical Endpoint (ESRD)|7
349854|NCT01113801|1182450|P4|Overall Study|Sponsor Decision|15
349855|NCT01113801|1182451|P3|Overall Study|Sponsor Decision|20
349856|NCT01113801|1182452|P2|Overall Study|Sponsor Decision|21
349857|NCT01113801|1182453|P1|Overall Study|Sponsor Decision|15
349858|NCT01113801|1182450|P4|Overall Study|Physician Decision|3
349859|NCT01113801|1182451|P3|Overall Study|Physician Decision|3
349860|NCT01113801|1182452|P2|Overall Study|Physician Decision|2
349861|NCT01113801|1182453|P1|Overall Study|Physician Decision|2
349862|NCT01113801|1182450|P4|Overall Study|Withdrawal by Subject|8
349863|NCT01113801|1182451|P3|Overall Study|Withdrawal by Subject|7
349864|NCT01113801|1182452|P2|Overall Study|Withdrawal by Subject|7
349865|NCT01113801|1182453|P1|Overall Study|Withdrawal by Subject|9
349866|NCT01113801|1182450|P4|Overall Study|Protocol Violation|0
349867|NCT01113801|1182451|P3|Overall Study|Protocol Violation|0
349868|NCT01113801|1182452|P2|Overall Study|Protocol Violation|1
349869|NCT01113801|1182453|P1|Overall Study|Protocol Violation|0
349870|NCT01113801|1182450|P4|Overall Study|Death|4
349871|NCT01113801|1182451|P3|Overall Study|Death|3
349872|NCT01113801|1182452|P2|Overall Study|Death|5
349873|NCT01113801|1182453|P1|Overall Study|Death|4
349874|NCT01113801|1182450|P4|Overall Study|Adverse Event|6
349875|NCT01113801|1182451|P3|Overall Study|Adverse Event|2
349876|NCT01113801|1182452|P2|Overall Study|Adverse Event|0
349877|NCT01113801|1182453|P1|Overall Study|Adverse Event|4
349878|NCT01113749|1182481|P2|Overall Study|Lost to Follow-up|2
349879|NCT01113749|1182482|P1|Overall Study|Lost to Follow-up|1
349880|NCT01113710|1182505|P1|Overall Study|Subject Did Not Receive Neupro|3
349881|NCT01113710|1182505|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
349882|NCT01113710|1182505|P1|Overall Study|Lack of Patient's Compliance/Other|1
349883|NCT01113710|1182505|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
349884|NCT01113710|1182505|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
349885|NCT01113710|1182505|P1|Overall Study|Compliance/Efficacy/AE/Other|1
349886|NCT01113710|1182505|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
349887|NCT01113710|1182505|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
349888|NCT01113710|1182505|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
349889|NCT01113710|1182505|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
349890|NCT01113710|1182505|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
349891|NCT01113710|1182505|P1|Overall Study|Lack of Efficacy/Adverse Event|3
349892|NCT01113710|1182505|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
349893|NCT01113710|1182505|P1|Overall Study|Lack of Efficacy/Other|4
349894|NCT01113710|1182505|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
349895|NCT01113710|1182505|P1|Overall Study|Adverse Event/Other|5
349896|NCT01113710|1182505|P1|Overall Study|Other|7
349897|NCT01113710|1182505|P1|Overall Study|Lack of Patient's Compliance|8
349898|NCT01113710|1182505|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
349899|NCT01113710|1182505|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
349900|NCT01113710|1182505|P1|Overall Study|Lost to Follow-up|20
349901|NCT01113710|1182505|P1|Overall Study|Withdrawal by Subject|28
349902|NCT01113710|1182505|P1|Overall Study|No Information Available|40
349903|NCT01113710|1182505|P1|Overall Study|Lack of Efficacy|41
349904|NCT01113710|1182505|P1|Overall Study|Adverse Event|64
349905|NCT01113580|1182533|P2|Overall Study|Protocol Violation|0
349906|NCT01113580|1182534|P1|Overall Study|Protocol Violation|1
349907|NCT01113541|1182548|P1|Overall Study|Adverse Event|4
349908|NCT01113541|1182548|P1|Overall Study|Study Terminated by Sponsor|7
349909|NCT01113541|1182548|P1|Overall Study|Protocol Violation|1
349910|NCT01113541|1182548|P1|Overall Study|Withdrawal by Subject|1
349911|NCT01113463|1182581|P1|Overall Study|Physician Decision|5
349912|NCT01112917|1182611|P2|Overall Study|Unable to Convert Filter|0
349913|NCT01112917|1182612|P1|Overall Study|Unable to Convert Filter|3
349914|NCT01112917|1182611|P2|Overall Study|Withdrawal by Subject|3
349915|NCT01112917|1182612|P1|Overall Study|Withdrawal by Subject|1
349916|NCT01112917|1182611|P2|Overall Study|Lost to Follow-up|1
349917|NCT01112917|1182612|P1|Overall Study|Lost to Follow-up|1
349918|NCT01112917|1182611|P2|Overall Study|Death|11
349919|NCT01112917|1182612|P1|Overall Study|Death|2
349920|NCT01112579|1182689|P2|Overall Study|Death|2
349921|NCT01112579|1182690|P1|Overall Study|Death|0
349922|NCT01112579|1182689|P2|Overall Study|Missed Visit|1
349923|NCT01112579|1182690|P1|Overall Study|Missed Visit|1
349924|NCT01112514|1182700|P1|Overall Study|Lost to Follow-up|1
349925|NCT01112267|1182706|P2|Overall Study|Participants not receive any study drug|2
349926|NCT01112267|1182707|P1|Overall Study|Participants not receive any study drug|1
349927|NCT01112267|1182706|P2|Overall Study|Participants not compliant|2
349928|NCT01112267|1182707|P1|Overall Study|Participants not compliant|1
349929|NCT01112267|1182706|P2|Overall Study|Protocol Violation|3
349930|NCT01112267|1182707|P1|Overall Study|Protocol Violation|5
349931|NCT01112267|1182706|P2|Overall Study|Withdrawal by Subject|5
349932|NCT01112267|1182707|P1|Overall Study|Withdrawal by Subject|3
349933|NCT01112267|1182706|P2|Overall Study|Adverse Event|6
349934|NCT01112267|1182707|P1|Overall Study|Adverse Event|24
349935|NCT01112059|1182740|P2|Overall Study|Withdrawal by Subject|0
349936|NCT01112059|1182741|P1|Overall Study|Withdrawal by Subject|1
349937|NCT01111851|1182755|P2|Overall Study|All planned PET scans were not obtained.|0
349938|NCT01111851|1182756|P1|Overall Study|All planned PET scans were not obtained.|2
349939|NCT01111838|1182768|P1|Overall Study|Other Complicating Disease|1
349940|NCT01111838|1182768|P1|Overall Study|Clinical deterioration|1
349941|NCT01111838|1182768|P1|Overall Study|Not Treated|3
349942|NCT01111838|1182768|P1|Overall Study|Patient Ineligible|2
349943|NCT01111825|1182776|P4|Overall Study|Discontinuation by Sponsor|20
349944|NCT01111825|1182777|P3|Overall Study|Discontinuation by Sponsor|0
349945|NCT01111825|1182778|P2|Overall Study|Discontinuation by Sponsor|0
349946|NCT01111825|1182779|P1|Overall Study|Discontinuation by Sponsor|0
349947|NCT01111825|1182776|P4|Overall Study|Disease Progression|0
349948|NCT01111825|1182777|P3|Overall Study|Disease Progression|0
349949|NCT01111825|1182778|P2|Overall Study|Disease Progression|0
349950|NCT01111825|1182779|P1|Overall Study|Disease Progression|1
349951|NCT01111825|1182776|P4|Overall Study|Adverse Event|0
349952|NCT01111825|1182777|P3|Overall Study|Adverse Event|4
349953|NCT01111825|1182778|P2|Overall Study|Adverse Event|1
349954|NCT01111825|1182779|P1|Overall Study|Adverse Event|2
349955|NCT01111825|1182776|P4|Overall Study|Lost to Follow-up|1
349956|NCT01111825|1182777|P3|Overall Study|Lost to Follow-up|3
349957|NCT01111825|1182778|P2|Overall Study|Lost to Follow-up|0
349958|NCT01111825|1182779|P1|Overall Study|Lost to Follow-up|0
349959|NCT01111825|1182776|P4|Overall Study|Withdrawal by Subject|0
349960|NCT01111825|1182777|P3|Overall Study|Withdrawal by Subject|1
349961|NCT01111825|1182778|P2|Overall Study|Withdrawal by Subject|0
349962|NCT01111825|1182779|P1|Overall Study|Withdrawal by Subject|0
349963|NCT01111526|1182798|P3|Overall Study|GVHD Disease Progression|2
349964|NCT01111526|1182799|P2|Overall Study|GVHD Disease Progression|1
349965|NCT01111526|1182800|P1|Overall Study|GVHD Disease Progression|0
349966|NCT01111461|1182812|P1|Overall Study|Not specified|6
349967|NCT01111461|1182812|P1|Overall Study|Withdrawal by Subject|1
349968|NCT01111461|1182812|P1|Overall Study|Lost to Follow-up|1
349969|NCT01111461|1182812|P1|Overall Study|Participant choice|11
349970|NCT01111461|1182812|P1|Overall Study|Adverse Event|32
349971|NCT01111292|1182992|P2|Treatment|Physician Decision|1
349972|NCT01111292|1182993|P1|Treatment|Physician Decision|1
349973|NCT01111240|1182999|P1|Overall Study|Not Specified|312
349974|NCT01111240|1182999|P1|Overall Study|Lack of Efficacy and Adverse Event|19
349975|NCT01111240|1182999|P1|Overall Study|Lack of Efficacy|545
349976|NCT01111240|1182999|P1|Overall Study|Adverse Event|190
349977|NCT01111149|1183029|P3|Overall Study|Withdrawal by Subject|2
349978|NCT01111149|1183030|P2|Overall Study|Withdrawal by Subject|0
349979|NCT01111149|1183031|P1|Overall Study|Withdrawal by Subject|1
349980|NCT01111149|1183029|P3|Overall Study|Protocol Violation|2
349981|NCT01111149|1183030|P2|Overall Study|Protocol Violation|1
349982|NCT01111149|1183031|P1|Overall Study|Protocol Violation|1
349983|NCT01111123|1183107|P2|Maintenance Phase|Lost to Follow-up|2
349984|NCT01111123|1183108|P1|Maintenance Phase|Lost to Follow-up|0
349985|NCT01111123|1183107|P2|Open- Label Phase|Failed to be clear or almost cleared|0
349986|NCT01111123|1183108|P1|Open- Label Phase|Failed to be clear or almost cleared|14
349987|NCT01110915|1183142|P2|Overall Study|Withdrawal by Subject|1
349988|NCT01110915|1183143|P1|Overall Study|Withdrawal by Subject|7
349989|NCT01110915|1183142|P2|Overall Study|Lost to Follow-up|0
349990|NCT01110915|1183143|P1|Overall Study|Lost to Follow-up|1
349991|NCT01110915|1183142|P2|Overall Study|Death|1
349992|NCT01110915|1183143|P1|Overall Study|Death|2
349993|NCT01110707|1183160|P2|Overall Study|Protocol Violation|3
349994|NCT01110707|1183161|P1|Overall Study|Protocol Violation|0
349995|NCT01110408|1183241|P2|Overall Study|Protocol Violation|0
349996|NCT01110408|1183242|P1|Overall Study|Protocol Violation|1
349997|NCT01110382|1183262|P2|Overall Study|Protocol Violation|1
349998|NCT01110382|1183263|P1|Overall Study|Protocol Violation|0
349999|NCT01110382|1183262|P2|Overall Study|Withdrawal by Subject|1
350000|NCT01110382|1183263|P1|Overall Study|Withdrawal by Subject|0
350001|NCT01110330|1183284|P3|Overall Study|Not specified|1
350002|NCT01110330|1183285|P2|Overall Study|Not specified|1
350003|NCT01110330|1183286|P1|Overall Study|Not specified|1
350004|NCT01110330|1183284|P3|Overall Study|Withdrawal by Subject|2
350005|NCT01110330|1183285|P2|Overall Study|Withdrawal by Subject|6
350006|NCT01110330|1183286|P1|Overall Study|Withdrawal by Subject|0
350007|NCT01110330|1183284|P3|Overall Study|Protocol Violation|4
350008|NCT01110330|1183285|P2|Overall Study|Protocol Violation|0
350009|NCT01110330|1183286|P1|Overall Study|Protocol Violation|2
350010|NCT01110330|1183284|P3|Overall Study|Physician Decision|0
350011|NCT01110330|1183285|P2|Overall Study|Physician Decision|1
350012|NCT01110330|1183286|P1|Overall Study|Physician Decision|0
350013|NCT01110330|1183284|P3|Overall Study|Lost to Follow-up|15
350014|NCT01110330|1183285|P2|Overall Study|Lost to Follow-up|10
350015|NCT01110330|1183286|P1|Overall Study|Lost to Follow-up|9
350016|NCT01110330|1183284|P3|Overall Study|Lack of Efficacy|1
350017|NCT01110330|1183285|P2|Overall Study|Lack of Efficacy|1
350018|NCT01110330|1183286|P1|Overall Study|Lack of Efficacy|3
350019|NCT01110330|1183284|P3|Overall Study|Adverse Event|3
350020|NCT01110330|1183285|P2|Overall Study|Adverse Event|4
350021|NCT01110330|1183286|P1|Overall Study|Adverse Event|0
350022|NCT01110239|1183314|P4|7.5 Min Ischemia|Withdrawal by Subject|0
350023|NCT01110239|1183315|P3|7.5 Min Ischemia|Withdrawal by Subject|1
350024|NCT01110239|1183316|P2|7.5 Min Ischemia|Withdrawal by Subject|0
350025|NCT01110239|1183317|P1|7.5 Min Ischemia|Withdrawal by Subject|0
350026|NCT01110239|1183314|P4|Sham Preconditioning|Withdrawal by Subject|0
350027|NCT01110239|1183315|P3|Sham Preconditioning|Withdrawal by Subject|1
350028|NCT01110239|1183316|P2|Sham Preconditioning|Withdrawal by Subject|0
350029|NCT01110239|1183317|P1|Sham Preconditioning|Withdrawal by Subject|0
350030|NCT01110200|1183333|P2|Overall Study|Lost to Follow-up|7
350031|NCT01110200|1183334|P1|Overall Study|Lost to Follow-up|10
350032|NCT01110200|1183333|P2|Overall Study|Physician Decision|17
350033|NCT01110200|1183334|P1|Overall Study|Physician Decision|13
350034|NCT01110200|1183333|P2|Overall Study|Protocol Violation|12
350035|NCT01110200|1183334|P1|Overall Study|Protocol Violation|14
350036|NCT01110200|1183333|P2|Overall Study|Lack of Efficacy|25
350037|NCT01110200|1183334|P1|Overall Study|Lack of Efficacy|16
350038|NCT01110200|1183333|P2|Overall Study|Withdrawal by Subject|32
350039|NCT01110200|1183334|P1|Overall Study|Withdrawal by Subject|25
350040|NCT01110200|1183333|P2|Overall Study|Adverse Event|28
350041|NCT01110200|1183334|P1|Overall Study|Adverse Event|28
350042|NCT01110005|1183365|P2|Overall Study|Withdrawal by Subject|1
350043|NCT01110005|1183366|P1|Overall Study|Withdrawal by Subject|0
350044|NCT01110005|1183365|P2|Overall Study|missing consent|2
350045|NCT01110005|1183366|P1|Overall Study|missing consent|3
350046|NCT01110005|1183365|P2|Overall Study|ineligible|2
350047|NCT01110005|1183366|P1|Overall Study|ineligible|1
350048|NCT01109979|1183378|P2|Overall Study|Withdrawal by Subject|1
350049|NCT01109979|1183379|P1|Overall Study|Withdrawal by Subject|0
350050|NCT01109979|1183378|P2|Overall Study|Physician Decision|0
350051|NCT01109979|1183379|P1|Overall Study|Physician Decision|2
350052|NCT01109849|1183387|P5|Adaptive Randomization: Weight Recovery|moved away|0
350053|NCT01109849|1183388|P4|Adaptive Randomization: Weight Recovery|moved away|2
350054|NCT01109849|1183389|P3|Adaptive Randomization: Weight Recovery|moved away|0
350055|NCT01109849|1183390|P2|Adaptive Randomization: Weight Recovery|moved away|0
350056|NCT01109849|1183391|P1|Adaptive Randomization: Weight Recovery|moved away|0
350057|NCT01109849|1183387|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
350058|NCT01109849|1183388|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
350059|NCT01109849|1183389|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
350060|NCT01109849|1183390|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
350061|NCT01109849|1183391|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
350062|NCT01109849|1183387|P5|Initial Randomization: ADHD Treatment|move away|0
350063|NCT01109849|1183388|P4|Initial Randomization: ADHD Treatment|move away|0
350064|NCT01109849|1183389|P3|Initial Randomization: ADHD Treatment|move away|0
350065|NCT01109849|1183390|P2|Initial Randomization: ADHD Treatment|move away|7
350066|NCT01109849|1183391|P1|Initial Randomization: ADHD Treatment|move away|2
350067|NCT01109849|1183387|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
350068|NCT01109849|1183388|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
350069|NCT01109849|1183389|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
350070|NCT01109849|1183390|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
350071|NCT01109849|1183391|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
350072|NCT01109849|1183387|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
350073|NCT01109849|1183388|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
350074|NCT01109849|1183389|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
350075|NCT01109849|1183390|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
350076|NCT01109849|1183391|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
350077|NCT01109849|1183387|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
350078|NCT01109849|1183388|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
350079|NCT01109849|1183389|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
350080|NCT01109849|1183390|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
350081|NCT01109849|1183391|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
350082|NCT01109524|1183460|P1|Overall Study|Not specified|5
350083|NCT01109524|1183460|P1|Overall Study|Participant requested to end treatment|4
350084|NCT01109524|1183460|P1|Overall Study|No longer meets criteria|2
350085|NCT01109524|1183460|P1|Overall Study|Death|2
350086|NCT01109524|1183460|P1|Overall Study|Maximum clinical benefit|3
350087|NCT01109524|1183460|P1|Overall Study|Withdrawal by Subject|2
350088|NCT01109524|1183460|P1|Overall Study|Adverse Event|4
350089|NCT01109524|1183460|P1|Overall Study|Study Drug toxicity|6
350090|NCT01109524|1183460|P1|Overall Study|Disease Progression|29
350091|NCT01109316|1183482|P3|Study Period 3|Withdrawal by Subject|1
350092|NCT01109316|1183483|P2|Study Period 3|Withdrawal by Subject|1
350093|NCT01109316|1183484|P1|Study Period 3|Withdrawal by Subject|0
350094|NCT01109316|1183482|P3|Study Period 3|Lost to Follow-up|0
350095|NCT01109316|1183483|P2|Study Period 3|Lost to Follow-up|1
350096|NCT01109316|1183484|P1|Study Period 3|Lost to Follow-up|0
350097|NCT01109316|1183482|P3|Study Period 2|Withdrawal by Subject|0
350098|NCT01109316|1183483|P2|Study Period 2|Withdrawal by Subject|1
350099|NCT01109316|1183484|P1|Study Period 2|Withdrawal by Subject|1
350100|NCT01109316|1183482|P3|Study Period 2|Protocol Violation|0
350101|NCT01109316|1183483|P2|Study Period 2|Protocol Violation|1
350102|NCT01109316|1183484|P1|Study Period 2|Protocol Violation|0
350103|NCT01109316|1183482|P3|Study Period 2|Physician Decision|1
350104|NCT01109316|1183483|P2|Study Period 2|Physician Decision|0
350105|NCT01109316|1183484|P1|Study Period 2|Physician Decision|0
350106|NCT01109316|1183482|P3|Study Period 2|Entry Criteria Not Met|1
350107|NCT01109316|1183483|P2|Study Period 2|Entry Criteria Not Met|0
350108|NCT01109316|1183484|P1|Study Period 2|Entry Criteria Not Met|0
350109|NCT01109316|1183482|P3|Study Period 1|Sponsor Decision|2
350110|NCT01109316|1183483|P2|Study Period 1|Sponsor Decision|0
350111|NCT01109316|1183484|P1|Study Period 1|Sponsor Decision|0
350112|NCT01109316|1183482|P3|Study Period 1|Withdrawal by Subject|2
350113|NCT01109316|1183483|P2|Study Period 1|Withdrawal by Subject|1
350114|NCT01109316|1183484|P1|Study Period 1|Withdrawal by Subject|0
350115|NCT01109316|1183482|P3|Study Period 1|Lost to Follow-up|0
350116|NCT01109316|1183483|P2|Study Period 1|Lost to Follow-up|2
350117|NCT01109316|1183484|P1|Study Period 1|Lost to Follow-up|0
350118|NCT01109316|1183482|P3|Study Period 1|Adverse Event|0
350119|NCT01109316|1183483|P2|Study Period 1|Adverse Event|1
350120|NCT01109316|1183484|P1|Study Period 1|Adverse Event|0
350121|NCT01109173|1183532|P4|Overall Study|Not Specifiied|14
350122|NCT01109173|1183533|P3|Overall Study|Not Specifiied|9
350123|NCT01109173|1183534|P2|Overall Study|Not Specifiied|4
350124|NCT01109173|1183535|P1|Overall Study|Not Specifiied|5
350125|NCT01109173|1183532|P4|Overall Study|Patient Did Not Use Study Medication|7
350126|NCT01109173|1183533|P3|Overall Study|Patient Did Not Use Study Medication|11
350127|NCT01109173|1183534|P2|Overall Study|Patient Did Not Use Study Medication|26
350128|NCT01109173|1183535|P1|Overall Study|Patient Did Not Use Study Medication|34
350129|NCT01109173|1183532|P4|Overall Study|Protocol Violation|2
350130|NCT01109173|1183533|P3|Overall Study|Protocol Violation|1
350131|NCT01109173|1183534|P2|Overall Study|Protocol Violation|5
350132|NCT01109173|1183535|P1|Overall Study|Protocol Violation|4
350133|NCT01109173|1183532|P4|Overall Study|Treatment Failure|64
350134|NCT01109173|1183533|P3|Overall Study|Treatment Failure|69
350135|NCT01109173|1183534|P2|Overall Study|Treatment Failure|32
350136|NCT01109173|1183535|P1|Overall Study|Treatment Failure|25
350137|NCT01109173|1183532|P4|Overall Study|Noncompliance|0
350138|NCT01109173|1183533|P3|Overall Study|Noncompliance|0
350139|NCT01109173|1183534|P2|Overall Study|Noncompliance|1
350140|NCT01109173|1183535|P1|Overall Study|Noncompliance|0
350141|NCT01109173|1183532|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
350142|NCT01109173|1183533|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
350143|NCT01109173|1183534|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
350144|NCT01109173|1183535|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
350145|NCT01109173|1183532|P4|Overall Study|Lost to Follow-up|0
350146|NCT01109173|1183533|P3|Overall Study|Lost to Follow-up|0
350147|NCT01109173|1183534|P2|Overall Study|Lost to Follow-up|1
350148|NCT01109173|1183535|P1|Overall Study|Lost to Follow-up|0
350149|NCT01109173|1183532|P4|Overall Study|Adverse Event|6
350150|NCT01109173|1183533|P3|Overall Study|Adverse Event|9
350151|NCT01109173|1183534|P2|Overall Study|Adverse Event|17
350152|NCT01109173|1183535|P1|Overall Study|Adverse Event|15
350153|NCT01108809|1183614|P1|Overall Study|Lost to Follow-up|1
350154|NCT01108809|1183614|P1|Overall Study|Adverse Event|3
350155|NCT01108796|1183631|P2|Overall Study|Lost to Follow-up|6
350156|NCT01108796|1183632|P1|Overall Study|Lost to Follow-up|7
350157|NCT01108796|1183631|P2|Overall Study|Adverse Event|1
350158|NCT01108796|1183632|P1|Overall Study|Adverse Event|0
350159|NCT01108731|1183675|P2|Overall Study|Adverse Event|3
350160|NCT01108731|1183676|P1|Overall Study|Adverse Event|3
350161|NCT01108731|1183675|P2|Overall Study|Withdrawal by Subject|1
350162|NCT01108731|1183676|P1|Overall Study|Withdrawal by Subject|1
350163|NCT01108718|1183688|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
350164|NCT01108718|1183689|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
350165|NCT01108523|1183694|P1|Overall Study|Protocol Violation|4
350166|NCT01108510|1183701|P2|Overall Study|Death|1
350167|NCT01108510|1183702|P1|Overall Study|Death|1
350168|NCT01108510|1183701|P2|Overall Study|Pregnancy|3
350169|NCT01108510|1183702|P1|Overall Study|Pregnancy|0
350170|NCT01108510|1183701|P2|Overall Study|Lack of Efficacy|0
350171|NCT01108510|1183702|P1|Overall Study|Lack of Efficacy|3
350172|NCT01108510|1183701|P2|Overall Study|Participant Noncompliance|7
350173|NCT01108510|1183702|P1|Overall Study|Participant Noncompliance|5
350174|NCT01108510|1183701|P2|Overall Study|Investigator’s Discretion|10
350175|NCT01108510|1183702|P1|Overall Study|Investigator’s Discretion|12
350176|NCT01108510|1183701|P2|Overall Study|Withdrew Consent|15
350177|NCT01108510|1183702|P1|Overall Study|Withdrew Consent|21
350178|NCT01108510|1183701|P2|Overall Study|Lost to Follow-up|17
350179|NCT01108510|1183702|P1|Overall Study|Lost to Follow-up|20
350180|NCT01108510|1183701|P2|Overall Study|Adverse Event|19
350181|NCT01108510|1183702|P1|Overall Study|Adverse Event|26
350182|NCT01108510|1183701|P2|Overall Study|Joined Another Gilead-sponsored Study|195
350183|NCT01108510|1183702|P1|Overall Study|Joined Another Gilead-sponsored Study|186
350184|NCT01108510|1183701|P2|Overall Study|Randomized but Not Treated|1
350185|NCT01108510|1183702|P1|Overall Study|Randomized but Not Treated|5
350186|NCT01108458|1183722|P1|Overall Study|Withdrawal by Subject|1
350187|NCT01108341|1183774|P1|Overall Study|not specified|1
350188|NCT01108341|1183774|P1|Overall Study|Lost to Follow-up|1
350189|NCT01108341|1183774|P1|Overall Study|Withdrawal by Subject|1
350190|NCT01108341|1183774|P1|Overall Study|Death|2
350191|NCT01108263|1183781|P2|Overall Study|Adverse Event|1
350192|NCT01108263|1183782|P1|Overall Study|Adverse Event|0
350193|NCT01108237|1183792|P2|Overall Study|Did not meet criteria for analysis|0
350194|NCT01108237|1183793|P1|Overall Study|Did not meet criteria for analysis|7
350195|NCT01108237|1183792|P2|Overall Study|No alignment data|17
350196|NCT01108237|1183793|P1|Overall Study|No alignment data|2
350197|NCT01108185|1183799|P1|Overall Study|Lost to Follow-up|12
350198|NCT01108185|1183799|P1|Overall Study|Non-compliance|15
350286|NCT01107457|1184159|P3|Part B and C|Protocol Violation|0
350199|NCT01108068|1183835|P2|Overall Study|5 not started, 1 stop due to side effect|0
350200|NCT01108068|1183836|P1|Overall Study|5 not started, 1 stop due to side effect|6
350201|NCT01108055|1183843|P1|Overall Study|Not evaluable- didn't complete treatment|4
350202|NCT01108055|1183843|P1|Overall Study|Ineligible|11
350203|NCT01107925|1183881|P6|Period 2|Withdrawal by Subject|1
350204|NCT01107925|1183882|P5|Period 2|Withdrawal by Subject|0
350205|NCT01107925|1183883|P4|Period 2|Withdrawal by Subject|0
350206|NCT01107925|1183884|P3|Period 2|Withdrawal by Subject|0
350207|NCT01107925|1183885|P2|Period 2|Withdrawal by Subject|1
350208|NCT01107925|1183886|P1|Period 2|Withdrawal by Subject|0
350209|NCT01107925|1183881|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
350210|NCT01107925|1183882|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
350211|NCT01107925|1183883|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
350212|NCT01107925|1183884|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
350213|NCT01107925|1183885|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
350214|NCT01107925|1183886|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
350215|NCT01107912|1183924|P6|Period 3|Withdrawal by Subject|0
350216|NCT01107912|1183925|P5|Period 3|Withdrawal by Subject|0
350217|NCT01107912|1183926|P4|Period 3|Withdrawal by Subject|1
350218|NCT01107912|1183927|P3|Period 3|Withdrawal by Subject|0
350219|NCT01107912|1183928|P2|Period 3|Withdrawal by Subject|0
350220|NCT01107912|1183929|P1|Period 3|Withdrawal by Subject|0
350221|NCT01107912|1183924|P6|Period 3|Adverse Event|0
350222|NCT01107912|1183925|P5|Period 3|Adverse Event|0
350223|NCT01107912|1183926|P4|Period 3|Adverse Event|0
350224|NCT01107912|1183927|P3|Period 3|Adverse Event|1
350225|NCT01107912|1183928|P2|Period 3|Adverse Event|1
350226|NCT01107912|1183929|P1|Period 3|Adverse Event|0
350227|NCT01107912|1183924|P6|Period 2|Physician Decision|0
350228|NCT01107912|1183925|P5|Period 2|Physician Decision|0
350229|NCT01107912|1183926|P4|Period 2|Physician Decision|0
350230|NCT01107912|1183927|P3|Period 2|Physician Decision|1
350231|NCT01107912|1183928|P2|Period 2|Physician Decision|0
350232|NCT01107912|1183929|P1|Period 2|Physician Decision|0
350233|NCT01107912|1183924|P6|Period 1|Withdrawal by Subject|0
350234|NCT01107912|1183925|P5|Period 1|Withdrawal by Subject|0
350235|NCT01107912|1183926|P4|Period 1|Withdrawal by Subject|0
350236|NCT01107912|1183927|P3|Period 1|Withdrawal by Subject|0
350237|NCT01107912|1183928|P2|Period 1|Withdrawal by Subject|0
350238|NCT01107912|1183929|P1|Period 1|Withdrawal by Subject|1
350239|NCT01107912|1183924|P6|Period 1|Physician Decision|0
350240|NCT01107912|1183925|P5|Period 1|Physician Decision|1
350241|NCT01107912|1183926|P4|Period 1|Physician Decision|0
350242|NCT01107912|1183927|P3|Period 1|Physician Decision|0
350243|NCT01107912|1183928|P2|Period 1|Physician Decision|0
350244|NCT01107912|1183929|P1|Period 1|Physician Decision|0
350245|NCT01107912|1183924|P6|Period 1|Adverse Event|0
350246|NCT01107912|1183925|P5|Period 1|Adverse Event|2
350247|NCT01107912|1183926|P4|Period 1|Adverse Event|0
350248|NCT01107912|1183927|P3|Period 1|Adverse Event|0
350249|NCT01107912|1183928|P2|Period 1|Adverse Event|0
350250|NCT01107912|1183929|P1|Period 1|Adverse Event|0
350251|NCT01107899|1183966|P3|Overall Study|Withdrawal by Subject|1
350252|NCT01107899|1183967|P2|Overall Study|Withdrawal by Subject|0
350253|NCT01107899|1183968|P1|Overall Study|Withdrawal by Subject|0
350254|NCT01107899|1183966|P3|Overall Study|Physician Decision|3
350255|NCT01107899|1183967|P2|Overall Study|Physician Decision|0
350256|NCT01107899|1183968|P1|Overall Study|Physician Decision|5
350257|NCT01107886|1184014|P2|Overall Study|Administrative withdrawal of consent|5
350258|NCT01107886|1184015|P1|Overall Study|Administrative withdrawal of consent|7
350259|NCT01107886|1184014|P2|Overall Study|Withdrawal by Subject|196
350260|NCT01107886|1184015|P1|Overall Study|Withdrawal by Subject|180
350261|NCT01107886|1184014|P2|Overall Study|Lost to Follow-up|13
350262|NCT01107886|1184015|P1|Overall Study|Lost to Follow-up|15
350263|NCT01107743|1184044|P1|Overall Study|Protocol Violation|46
350264|NCT01107535|1184143|P1|Overall Study|Death|5
350265|NCT01107457|1184156|P6|Part B and C|Clinical Relapse|4
350266|NCT01107457|1184157|P5|Part B and C|Clinical Relapse|0
350267|NCT01107457|1184158|P4|Part B and C|Clinical Relapse|0
350268|NCT01107457|1184159|P3|Part B and C|Clinical Relapse|0
350269|NCT01107457|1184160|P2|Part B and C|Clinical Relapse|0
350270|NCT01107457|1184161|P1|Part B and C|Clinical Relapse|0
350271|NCT01107457|1184156|P6|Part B and C|Withdrawal by Subject|16
350272|NCT01107457|1184157|P5|Part B and C|Withdrawal by Subject|0
350273|NCT01107457|1184158|P4|Part B and C|Withdrawal by Subject|0
350274|NCT01107457|1184159|P3|Part B and C|Withdrawal by Subject|0
350275|NCT01107457|1184160|P2|Part B and C|Withdrawal by Subject|0
350276|NCT01107457|1184161|P1|Part B and C|Withdrawal by Subject|0
350277|NCT01107457|1184156|P6|Part B and C|Sponsor Decision|66
350278|NCT01107457|1184157|P5|Part B and C|Sponsor Decision|0
350279|NCT01107457|1184158|P4|Part B and C|Sponsor Decision|0
350280|NCT01107457|1184159|P3|Part B and C|Sponsor Decision|0
350281|NCT01107457|1184160|P2|Part B and C|Sponsor Decision|0
350282|NCT01107457|1184161|P1|Part B and C|Sponsor Decision|0
350283|NCT01107457|1184156|P6|Part B and C|Protocol Violation|1
350284|NCT01107457|1184157|P5|Part B and C|Protocol Violation|0
350285|NCT01107457|1184158|P4|Part B and C|Protocol Violation|0
350287|NCT01107457|1184160|P2|Part B and C|Protocol Violation|0
350288|NCT01107457|1184161|P1|Part B and C|Protocol Violation|0
350289|NCT01107457|1184156|P6|Part B and C|Lost to Follow-up|10
350290|NCT01107457|1184157|P5|Part B and C|Lost to Follow-up|0
350291|NCT01107457|1184158|P4|Part B and C|Lost to Follow-up|0
350292|NCT01107457|1184159|P3|Part B and C|Lost to Follow-up|0
350293|NCT01107457|1184160|P2|Part B and C|Lost to Follow-up|0
350294|NCT01107457|1184161|P1|Part B and C|Lost to Follow-up|0
350295|NCT01107457|1184156|P6|Part B and C|Lack of Efficacy|7
350296|NCT01107457|1184157|P5|Part B and C|Lack of Efficacy|0
350297|NCT01107457|1184158|P4|Part B and C|Lack of Efficacy|0
350298|NCT01107457|1184159|P3|Part B and C|Lack of Efficacy|0
350299|NCT01107457|1184160|P2|Part B and C|Lack of Efficacy|0
350300|NCT01107457|1184161|P1|Part B and C|Lack of Efficacy|0
350301|NCT01107457|1184156|P6|Part B and C|Physician Decision|3
350302|NCT01107457|1184157|P5|Part B and C|Physician Decision|0
350303|NCT01107457|1184158|P4|Part B and C|Physician Decision|0
350304|NCT01107457|1184159|P3|Part B and C|Physician Decision|0
350305|NCT01107457|1184160|P2|Part B and C|Physician Decision|0
350306|NCT01107457|1184161|P1|Part B and C|Physician Decision|0
350307|NCT01107457|1184156|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
350308|NCT01107457|1184157|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
350309|NCT01107457|1184158|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
350310|NCT01107457|1184159|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
350311|NCT01107457|1184160|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
350312|NCT01107457|1184161|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
350313|NCT01107457|1184156|P6|Part B and C|Adverse Event|12
350314|NCT01107457|1184157|P5|Part B and C|Adverse Event|0
350315|NCT01107457|1184158|P4|Part B and C|Adverse Event|0
350316|NCT01107457|1184159|P3|Part B and C|Adverse Event|0
350317|NCT01107457|1184160|P2|Part B and C|Adverse Event|0
350318|NCT01107457|1184161|P1|Part B and C|Adverse Event|0
350319|NCT01107457|1184156|P6|Part A|Protocol Violation|0
350320|NCT01107457|1184157|P5|Part A|Protocol Violation|0
350321|NCT01107457|1184158|P4|Part A|Protocol Violation|0
350322|NCT01107457|1184159|P3|Part A|Protocol Violation|0
350323|NCT01107457|1184160|P2|Part A|Protocol Violation|1
350324|NCT01107457|1184161|P1|Part A|Protocol Violation|0
350325|NCT01107457|1184156|P6|Part A|Lack of Efficacy|0
350326|NCT01107457|1184157|P5|Part A|Lack of Efficacy|0
350327|NCT01107457|1184158|P4|Part A|Lack of Efficacy|0
350328|NCT01107457|1184159|P3|Part A|Lack of Efficacy|0
350329|NCT01107457|1184160|P2|Part A|Lack of Efficacy|0
350330|NCT01107457|1184161|P1|Part A|Lack of Efficacy|1
350331|NCT01107457|1184156|P6|Part A|Lost to Follow-up|0
350332|NCT01107457|1184157|P5|Part A|Lost to Follow-up|0
350333|NCT01107457|1184158|P4|Part A|Lost to Follow-up|0
350334|NCT01107457|1184159|P3|Part A|Lost to Follow-up|0
350335|NCT01107457|1184160|P2|Part A|Lost to Follow-up|1
350336|NCT01107457|1184161|P1|Part A|Lost to Follow-up|0
350337|NCT01107457|1184156|P6|Part A|Withdrawal by Subject|0
350338|NCT01107457|1184157|P5|Part A|Withdrawal by Subject|1
350339|NCT01107457|1184158|P4|Part A|Withdrawal by Subject|3
350340|NCT01107457|1184159|P3|Part A|Withdrawal by Subject|0
350341|NCT01107457|1184160|P2|Part A|Withdrawal by Subject|3
350342|NCT01107457|1184161|P1|Part A|Withdrawal by Subject|3
350343|NCT01107457|1184156|P6|Part A|Adverse Event|0
350344|NCT01107457|1184157|P5|Part A|Adverse Event|0
350345|NCT01107457|1184158|P4|Part A|Adverse Event|0
350346|NCT01107457|1184159|P3|Part A|Adverse Event|1
350347|NCT01107457|1184160|P2|Part A|Adverse Event|2
350348|NCT01107457|1184161|P1|Part A|Adverse Event|1
350349|NCT01107418|1184291|P1|Overall Study|Entered Extension Study|1
350350|NCT01107418|1184291|P1|Overall Study|Started Other Therapy|1
350351|NCT01107418|1184291|P1|Overall Study|Study Closing|1
350352|NCT01107418|1184291|P1|Overall Study|Withdrawal by Subject|1
350353|NCT01107418|1184291|P1|Overall Study|Adverse Event|3
350354|NCT01107418|1184291|P1|Overall Study|Disease Progression|45
350355|NCT01107405|1184364|P5|Overall Study|Protocol Violation|0
350356|NCT01107405|1184365|P4|Overall Study|Protocol Violation|1
350357|NCT01107405|1184366|P3|Overall Study|Protocol Violation|1
350358|NCT01107405|1184367|P2|Overall Study|Protocol Violation|0
350359|NCT01107405|1184368|P1|Overall Study|Protocol Violation|0
350360|NCT01107405|1184364|P5|Overall Study|Withdrawal by Subject|1
350361|NCT01107405|1184365|P4|Overall Study|Withdrawal by Subject|2
350362|NCT01107405|1184366|P3|Overall Study|Withdrawal by Subject|1
350363|NCT01107405|1184367|P2|Overall Study|Withdrawal by Subject|0
350364|NCT01107405|1184368|P1|Overall Study|Withdrawal by Subject|1
350365|NCT01107405|1184364|P5|Overall Study|Adverse Event|2
350366|NCT01107405|1184365|P4|Overall Study|Adverse Event|0
350367|NCT01107405|1184366|P3|Overall Study|Adverse Event|0
350368|NCT01107405|1184367|P2|Overall Study|Adverse Event|1
350369|NCT01107405|1184368|P1|Overall Study|Adverse Event|1
350370|NCT01107392|1184407|P2|Overall Study|Administrative decision|0
350371|NCT01107392|1184408|P1|Overall Study|Administrative decision|1
350372|NCT01107392|1184407|P2|Overall Study|Personal Reasons|3
350373|NCT01107392|1184408|P1|Overall Study|Personal Reasons|2
350374|NCT01107392|1184407|P2|Overall Study|Adverse Event|0
350375|NCT01107392|1184408|P1|Overall Study|Adverse Event|2
350376|NCT01107379|1184420|P1|Overall Study|Lost to Follow-up|3
350377|NCT01107379|1184420|P1|Overall Study|Withdrawal by Subject|18
350378|NCT01107353|1184431|P2|Overall Study|Positive Drug Screen|0
350379|NCT01107353|1184432|P1|Overall Study|Positive Drug Screen|1
350380|NCT01107197|1184440|P2|Overall Study|Withdrawal by Subject|5
350381|NCT01107197|1184441|P1|Overall Study|Withdrawal by Subject|3
350382|NCT01107197|1184440|P2|Overall Study|Lost to Follow-up|8
350383|NCT01107197|1184441|P1|Overall Study|Lost to Follow-up|5
350384|NCT01107197|1184440|P2|Overall Study|Death|10
350385|NCT01107197|1184441|P1|Overall Study|Death|12
350386|NCT01106976|1184476|P1|Overall Study|Lost to Follow-up|8
350387|NCT01106911|1184490|P1|Overall Study|deemed ineligible after screening|3
350388|NCT01106911|1184490|P1|Overall Study|Physician Decision|2
350389|NCT01106898|1184494|P1|Overall Study|Adverse Event|6
350390|NCT01106846|1184539|P2|Overall Study|Change in surgical procedure|1
350391|NCT01106846|1184540|P1|Overall Study|Change in surgical procedure|0
350392|NCT01106690|1184549|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
350393|NCT01106690|1184550|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
350394|NCT01106690|1184551|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
350395|NCT01106690|1184549|P3|Extension Period: Week 26 to Week 52|Not specified|4
350396|NCT01106690|1184550|P2|Extension Period: Week 26 to Week 52|Not specified|3
350397|NCT01106690|1184551|P1|Extension Period: Week 26 to Week 52|Not specified|8
350398|NCT01106690|1184549|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
350399|NCT01106690|1184550|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
350400|NCT01106690|1184551|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
350401|NCT01106690|1184549|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
350402|NCT01106690|1184550|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
350403|NCT01106690|1184551|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
350404|NCT01106690|1184549|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
350405|NCT01106690|1184550|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
350406|NCT01106690|1184551|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
350407|NCT01106690|1184549|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
350408|NCT01106690|1184550|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
350409|NCT01106690|1184551|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
350410|NCT01106690|1184549|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
350411|NCT01106690|1184550|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
350412|NCT01106690|1184551|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
350413|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Not specified|6
350414|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Not specified|2
350415|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Not specified|10
350416|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
350417|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
350418|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
350419|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
350420|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
350421|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
350422|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
350423|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
350424|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
350425|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
350426|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
350427|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
350428|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
350429|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
350430|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
350431|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Protocol Violation|0
350432|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Protocol Violation|0
350433|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Protocol Violation|1
350434|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
350435|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
350436|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
350437|NCT01106690|1184549|P3|Core Period: Baseline to Week 26|Adverse Event|4
350438|NCT01106690|1184550|P2|Core Period: Baseline to Week 26|Adverse Event|1
350439|NCT01106690|1184551|P1|Core Period: Baseline to Week 26|Adverse Event|6
350440|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Not specified|5
350441|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Not specified|8
350442|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Not specified|5
350443|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Not specified|6
350444|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
350445|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
350446|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
350447|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
350448|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
350449|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
350681|NCT01106352|1184839|P5|Overall Study|Disease progression|0
350450|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
350451|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
350452|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
350453|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
350454|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
350455|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
350456|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
350457|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
350458|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
350459|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
350460|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
350461|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
350462|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
350463|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
350464|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
350465|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
350466|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
350467|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
350468|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
350469|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
350470|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
350471|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
350472|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Death|1
350473|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Death|0
350474|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Death|0
350475|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Death|0
350476|NCT01106677|1184587|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
350477|NCT01106677|1184588|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
350478|NCT01106677|1184589|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
350479|NCT01106677|1184590|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
350480|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Pregnancy|0
350481|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Pregnancy|0
350482|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Pregnancy|1
350483|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Pregnancy|0
350484|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Not specified|23
350485|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Not specified|8
350486|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Not specified|14
350487|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Not specified|8
350488|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Product quality complaint|0
350489|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Product quality complaint|1
350490|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Product quality complaint|1
350491|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Product quality complaint|0
350492|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
350493|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
350494|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
350495|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
350496|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
350497|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
350498|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
350499|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
350500|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
350501|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
350502|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
350503|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
350504|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
350505|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
350506|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
350507|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
350508|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Protocol Violation|3
350509|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Protocol Violation|0
350510|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Protocol Violation|1
350511|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Protocol Violation|0
350512|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Physician Decision|1
350513|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Physician Decision|3
350514|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Physician Decision|1
350515|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Physician Decision|2
350516|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
350517|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
350518|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
350519|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
350520|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
350682|NCT01106352|1184840|P4|Overall Study|Disease progression|1
350521|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
350522|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
350523|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
350524|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Death|0
350525|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Death|1
350526|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Death|0
350527|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Death|0
350528|NCT01106677|1184587|P4|Core Period: Baseline to Week 26|Adverse Event|8
350529|NCT01106677|1184588|P3|Core Period: Baseline to Week 26|Adverse Event|6
350530|NCT01106677|1184589|P2|Core Period: Baseline to Week 26|Adverse Event|18
350531|NCT01106677|1184590|P1|Core Period: Baseline to Week 26|Adverse Event|7
350532|NCT01106651|1184653|P3|Overall Study|Death|0
350533|NCT01106651|1184654|P2|Overall Study|Death|3
350534|NCT01106651|1184655|P1|Overall Study|Death|0
350535|NCT01106651|1184653|P3|Overall Study|Not specified|21
350536|NCT01106651|1184654|P2|Overall Study|Not specified|31
350537|NCT01106651|1184655|P1|Overall Study|Not specified|34
350538|NCT01106651|1184653|P3|Overall Study|Noncompliance with study drug|2
350539|NCT01106651|1184654|P2|Overall Study|Noncompliance with study drug|0
350540|NCT01106651|1184655|P1|Overall Study|Noncompliance with study drug|1
350541|NCT01106651|1184653|P3|Overall Study|Withdrawal by Subject|4
350542|NCT01106651|1184654|P2|Overall Study|Withdrawal by Subject|7
350543|NCT01106651|1184655|P1|Overall Study|Withdrawal by Subject|14
350544|NCT01106651|1184653|P3|Overall Study|Protocol Violation|1
350545|NCT01106651|1184654|P2|Overall Study|Protocol Violation|2
350546|NCT01106651|1184655|P1|Overall Study|Protocol Violation|1
350547|NCT01106651|1184653|P3|Overall Study|Physician Decision|1
350548|NCT01106651|1184654|P2|Overall Study|Physician Decision|3
350549|NCT01106651|1184655|P1|Overall Study|Physician Decision|4
350550|NCT01106651|1184653|P3|Overall Study|Lost to Follow-up|6
350551|NCT01106651|1184654|P2|Overall Study|Lost to Follow-up|2
350552|NCT01106651|1184655|P1|Overall Study|Lost to Follow-up|8
350553|NCT01106651|1184653|P3|Overall Study|Adverse Event|23
350554|NCT01106651|1184654|P2|Overall Study|Adverse Event|9
350555|NCT01106651|1184655|P1|Overall Study|Adverse Event|17
350556|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Not specified|4
350557|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Not specified|5
350558|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Not specified|5
350559|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
350560|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
350561|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
350562|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
350563|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
350564|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
350565|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
350566|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
350567|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
350568|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
350569|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
350570|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
350571|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
350572|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
350573|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
350574|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
350575|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
350576|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
350577|NCT01106625|1184708|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
350578|NCT01106625|1184709|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
350579|NCT01106625|1184710|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
350580|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Not specified|4
350581|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Not specified|7
350582|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Not specified|8
350583|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
350584|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
350585|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
350586|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
350587|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
350588|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
350589|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
350590|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
350591|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
350592|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
350593|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
350594|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
350595|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Protocol Violation|3
350596|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Protocol Violation|1
350597|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Protocol Violation|2
350598|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Physician Decision|0
350599|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Physician Decision|0
350600|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Physician Decision|1
350601|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
350602|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
350603|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
350604|NCT01106625|1184708|P3|Core Period: Baseline to Week 26|Adverse Event|8
350605|NCT01106625|1184709|P2|Core Period: Baseline to Week 26|Adverse Event|8
350606|NCT01106625|1184710|P1|Core Period: Baseline to Week 26|Adverse Event|6
350607|NCT01106586|1184741|P2|Overall Study|Participant Transferred to Another Study|197
350608|NCT01106586|1184742|P1|Overall Study|Participant Transferred to Another Study|212
350609|NCT01106586|1184741|P2|Overall Study|Protocol Violation|0
350610|NCT01106586|1184742|P1|Overall Study|Protocol Violation|1
350611|NCT01106586|1184741|P2|Overall Study|Participant Noncompliance|10
350612|NCT01106586|1184742|P1|Overall Study|Participant Noncompliance|12
350613|NCT01106586|1184741|P2|Overall Study|Lost to Follow-up|20
350614|NCT01106586|1184742|P1|Overall Study|Lost to Follow-up|24
350615|NCT01106586|1184741|P2|Overall Study|Withdrew Consent|30
350616|NCT01106586|1184742|P1|Overall Study|Withdrew Consent|18
350617|NCT01106586|1184741|P2|Overall Study|Investigator's Discretion|8
350618|NCT01106586|1184742|P1|Overall Study|Investigator's Discretion|5
350619|NCT01106586|1184741|P2|Overall Study|Lack of Efficacy|0
350620|NCT01106586|1184742|P1|Overall Study|Lack of Efficacy|1
350621|NCT01106586|1184741|P2|Overall Study|Pregnancy|2
350622|NCT01106586|1184742|P1|Overall Study|Pregnancy|2
350623|NCT01106586|1184741|P2|Overall Study|Death|3
350624|NCT01106586|1184742|P1|Overall Study|Death|1
350625|NCT01106586|1184741|P2|Overall Study|Adverse Event|15
350626|NCT01106586|1184742|P1|Overall Study|Adverse Event|9
350627|NCT01106534|1184760|P1|Overall Study|Physician Decision|1
350628|NCT01106534|1184760|P1|Overall Study|Death|16
350629|NCT01106534|1184760|P1|Overall Study|Lost to Follow-up|2
350630|NCT01106534|1184760|P1|Overall Study|Withdrawal by Subject|18
350631|NCT01106430|1184792|P2|Overall Study|Withdrawal by Subject|4
350632|NCT01106430|1184793|P1|Overall Study|Withdrawal by Subject|8
350633|NCT01106430|1184792|P2|Overall Study|Protocol Violation|2
350634|NCT01106430|1184793|P1|Overall Study|Protocol Violation|7
350635|NCT01106430|1184792|P2|Overall Study|Previous Use Of Marijuana|0
350636|NCT01106430|1184793|P1|Overall Study|Previous Use Of Marijuana|1
350637|NCT01106430|1184792|P2|Overall Study|Hard Time Swallowing The Pills|0
350638|NCT01106430|1184793|P1|Overall Study|Hard Time Swallowing The Pills|1
350639|NCT01106430|1184792|P2|Overall Study|Noncompliance|1
350640|NCT01106430|1184793|P1|Overall Study|Noncompliance|0
350641|NCT01106430|1184792|P2|Overall Study|Refused To Take Medication|1
350642|NCT01106430|1184793|P1|Overall Study|Refused To Take Medication|0
350643|NCT01106430|1184792|P2|Overall Study|Moved Out Of State|1
350644|NCT01106430|1184793|P1|Overall Study|Moved Out Of State|0
350645|NCT01106430|1184792|P2|Overall Study|Early Termination Requested By Sponsor|0
350646|NCT01106430|1184793|P1|Overall Study|Early Termination Requested By Sponsor|1
350647|NCT01106430|1184792|P2|Overall Study|Lost to Follow-up|1
350648|NCT01106430|1184793|P1|Overall Study|Lost to Follow-up|5
350649|NCT01106430|1184792|P2|Overall Study|Lack of Efficacy|13
350650|NCT01106430|1184793|P1|Overall Study|Lack of Efficacy|2
350651|NCT01106430|1184792|P2|Overall Study|Adverse Event|10
350652|NCT01106430|1184793|P1|Overall Study|Adverse Event|8
350653|NCT01106404|1184815|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
350654|NCT01106404|1184816|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
350655|NCT01106404|1184815|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
350656|NCT01106404|1184816|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
350657|NCT01106404|1184815|P2|Period I (First 6 Weeks)|Physician Decision|0
350658|NCT01106404|1184816|P1|Period I (First 6 Weeks)|Physician Decision|1
350659|NCT01106404|1184815|P2|Period I (First 6 Weeks)|Adverse Event|0
350660|NCT01106404|1184816|P1|Period I (First 6 Weeks)|Adverse Event|2
350661|NCT01106352|1184839|P5|Overall Study|Home hospice since July 2013|0
350662|NCT01106352|1184840|P4|Overall Study|Home hospice since July 2013|1
350663|NCT01106352|1184841|P3|Overall Study|Home hospice since July 2013|0
350664|NCT01106352|1184842|P2|Overall Study|Home hospice since July 2013|0
350665|NCT01106352|1184843|P1|Overall Study|Home hospice since July 2013|0
350666|NCT01106352|1184839|P5|Overall Study|Subject entered hospice|0
350667|NCT01106352|1184840|P4|Overall Study|Subject entered hospice|1
350668|NCT01106352|1184841|P3|Overall Study|Subject entered hospice|0
350669|NCT01106352|1184842|P2|Overall Study|Subject entered hospice|0
350670|NCT01106352|1184843|P1|Overall Study|Subject entered hospice|0
350671|NCT01106352|1184839|P5|Overall Study|Went on hospice|0
350672|NCT01106352|1184840|P4|Overall Study|Went on hospice|1
350673|NCT01106352|1184841|P3|Overall Study|Went on hospice|0
350674|NCT01106352|1184842|P2|Overall Study|Went on hospice|0
350675|NCT01106352|1184843|P1|Overall Study|Went on hospice|0
350676|NCT01106352|1184839|P5|Overall Study|Withdrawal by Subject|2
350677|NCT01106352|1184840|P4|Overall Study|Withdrawal by Subject|3
350678|NCT01106352|1184841|P3|Overall Study|Withdrawal by Subject|0
350679|NCT01106352|1184842|P2|Overall Study|Withdrawal by Subject|0
350680|NCT01106352|1184843|P1|Overall Study|Withdrawal by Subject|0
350683|NCT01106352|1184841|P3|Overall Study|Disease progression|0
350684|NCT01106352|1184842|P2|Overall Study|Disease progression|0
350685|NCT01106352|1184843|P1|Overall Study|Disease progression|0
350686|NCT01106352|1184839|P5|Overall Study|Death|1
350687|NCT01106352|1184840|P4|Overall Study|Death|3
350688|NCT01106352|1184841|P3|Overall Study|Death|1
350689|NCT01106352|1184842|P2|Overall Study|Death|0
350690|NCT01106352|1184843|P1|Overall Study|Death|0
350691|NCT01106352|1184839|P5|Overall Study|Lost to Follow-up|1
350692|NCT01106352|1184840|P4|Overall Study|Lost to Follow-up|0
350693|NCT01106352|1184841|P3|Overall Study|Lost to Follow-up|0
350694|NCT01106352|1184842|P2|Overall Study|Lost to Follow-up|0
350695|NCT01106352|1184843|P1|Overall Study|Lost to Follow-up|0
350696|NCT01106352|1184839|P5|Overall Study|Too ill to come in for the visit|0
350697|NCT01106352|1184840|P4|Overall Study|Too ill to come in for the visit|0
350698|NCT01106352|1184841|P3|Overall Study|Too ill to come in for the visit|1
350699|NCT01106352|1184842|P2|Overall Study|Too ill to come in for the visit|0
350700|NCT01106352|1184843|P1|Overall Study|Too ill to come in for the visit|0
350701|NCT01106352|1184839|P5|Overall Study|Sponsor Decision|0
350702|NCT01106352|1184840|P4|Overall Study|Sponsor Decision|0
350703|NCT01106352|1184841|P3|Overall Study|Sponsor Decision|0
350704|NCT01106352|1184842|P2|Overall Study|Sponsor Decision|0
350705|NCT01106352|1184843|P1|Overall Study|Sponsor Decision|1
350706|NCT01106352|1184839|P5|Overall Study|Subjects untreated|4
350707|NCT01106352|1184840|P4|Overall Study|Subjects untreated|3
350708|NCT01106352|1184841|P3|Overall Study|Subjects untreated|0
350709|NCT01106352|1184842|P2|Overall Study|Subjects untreated|0
350710|NCT01106352|1184843|P1|Overall Study|Subjects untreated|0
350711|NCT01106287|1184939|P4|Overall Study|Adverse Event|0
350712|NCT01106287|1184940|P3|Overall Study|Adverse Event|0
350713|NCT01106287|1184941|P2|Overall Study|Adverse Event|0
350714|NCT01106287|1184942|P1|Overall Study|Adverse Event|1
350715|NCT01106248|1184962|P1|Overall Study|Administrative|2
350716|NCT01106248|1184962|P1|Overall Study|Adverse Event|1
350717|NCT01106157|1184970|P2|Overall Study|Withdrawal by Subject|0
350718|NCT01106157|1184971|P1|Overall Study|Withdrawal by Subject|1
350719|NCT01106092|1184999|P4|Overall Study|Withdrawal by Subject|1
350720|NCT01106092|1185000|P3|Overall Study|Withdrawal by Subject|0
350721|NCT01106092|1185001|P2|Overall Study|Withdrawal by Subject|0
350722|NCT01106092|1185002|P1|Overall Study|Withdrawal by Subject|0
350723|NCT01106027|1185085|P1|Overall Study|Lost graft early, discontinued|1
350724|NCT01106014|1185091|P2|Overall Study|Lost to Follow-up|3
350725|NCT01106014|1185092|P1|Overall Study|Lost to Follow-up|2
350726|NCT01106014|1185091|P2|Overall Study|Administrative reason|6
350727|NCT01106014|1185092|P1|Overall Study|Administrative reason|7
350728|NCT01106014|1185091|P2|Overall Study|Withdrawal by Subject|37
350729|NCT01106014|1185092|P1|Overall Study|Withdrawal by Subject|43
350730|NCT01106014|1185091|P2|Overall Study|Adverse Event|42
350731|NCT01106014|1185092|P1|Overall Study|Adverse Event|78
350732|NCT01106014|1185091|P2|Overall Study|Morbidity or Mortality primary endpoint|242
350733|NCT01106014|1185092|P1|Overall Study|Morbidity or Mortality primary endpoint|155
350734|NCT01105975|1185112|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
350735|NCT01105975|1185113|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
350736|NCT01105975|1185114|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
350737|NCT01105975|1185115|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
350738|NCT01105975|1185116|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
350739|NCT01105975|1185117|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
350740|NCT01105975|1185118|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
350741|NCT01105975|1185119|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
350742|NCT01105975|1185120|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
350743|NCT01105975|1185121|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
350744|NCT01105975|1185112|P10|Overall Study|Protocol Violation|2
350745|NCT01105975|1185113|P9|Overall Study|Protocol Violation|2
350746|NCT01105975|1185114|P8|Overall Study|Protocol Violation|1
350747|NCT01105975|1185115|P7|Overall Study|Protocol Violation|1
350748|NCT01105975|1185116|P6|Overall Study|Protocol Violation|1
350749|NCT01105975|1185117|P5|Overall Study|Protocol Violation|1
350750|NCT01105975|1185118|P4|Overall Study|Protocol Violation|0
350751|NCT01105975|1185119|P3|Overall Study|Protocol Violation|2
350752|NCT01105975|1185120|P2|Overall Study|Protocol Violation|2
350753|NCT01105975|1185121|P1|Overall Study|Protocol Violation|0
350754|NCT01105975|1185112|P10|Overall Study|Physician Decision|0
350755|NCT01105975|1185113|P9|Overall Study|Physician Decision|0
350756|NCT01105975|1185114|P8|Overall Study|Physician Decision|0
350757|NCT01105975|1185115|P7|Overall Study|Physician Decision|2
350758|NCT01105975|1185116|P6|Overall Study|Physician Decision|0
350759|NCT01105975|1185117|P5|Overall Study|Physician Decision|0
350760|NCT01105975|1185118|P4|Overall Study|Physician Decision|0
350761|NCT01105975|1185119|P3|Overall Study|Physician Decision|0
350762|NCT01105975|1185120|P2|Overall Study|Physician Decision|0
350763|NCT01105975|1185121|P1|Overall Study|Physician Decision|0
350764|NCT01105975|1185112|P10|Overall Study|Lost to Follow-up|0
350765|NCT01105975|1185113|P9|Overall Study|Lost to Follow-up|1
350766|NCT01105975|1185114|P8|Overall Study|Lost to Follow-up|0
350767|NCT01105975|1185115|P7|Overall Study|Lost to Follow-up|0
350768|NCT01105975|1185116|P6|Overall Study|Lost to Follow-up|0
350769|NCT01105975|1185117|P5|Overall Study|Lost to Follow-up|1
350770|NCT01105975|1185118|P4|Overall Study|Lost to Follow-up|1
350771|NCT01105975|1185119|P3|Overall Study|Lost to Follow-up|0
350772|NCT01105975|1185120|P2|Overall Study|Lost to Follow-up|0
350773|NCT01105975|1185121|P1|Overall Study|Lost to Follow-up|1
350774|NCT01105975|1185112|P10|Overall Study|Withdrawal by Subject|3
350775|NCT01105975|1185113|P9|Overall Study|Withdrawal by Subject|0
350776|NCT01105975|1185114|P8|Overall Study|Withdrawal by Subject|1
350777|NCT01105975|1185115|P7|Overall Study|Withdrawal by Subject|2
350778|NCT01105975|1185116|P6|Overall Study|Withdrawal by Subject|1
350779|NCT01105975|1185117|P5|Overall Study|Withdrawal by Subject|4
350780|NCT01105975|1185118|P4|Overall Study|Withdrawal by Subject|0
350781|NCT01105975|1185119|P3|Overall Study|Withdrawal by Subject|2
350782|NCT01105975|1185120|P2|Overall Study|Withdrawal by Subject|2
350783|NCT01105975|1185121|P1|Overall Study|Withdrawal by Subject|2
350784|NCT01105975|1185112|P10|Overall Study|Adverse Event|4
350785|NCT01105975|1185113|P9|Overall Study|Adverse Event|1
350786|NCT01105975|1185114|P8|Overall Study|Adverse Event|4
350787|NCT01105975|1185115|P7|Overall Study|Adverse Event|2
350788|NCT01105975|1185116|P6|Overall Study|Adverse Event|1
350789|NCT01105975|1185117|P5|Overall Study|Adverse Event|0
350790|NCT01105975|1185118|P4|Overall Study|Adverse Event|1
350791|NCT01105975|1185119|P3|Overall Study|Adverse Event|5
350792|NCT01105975|1185120|P2|Overall Study|Adverse Event|1
350793|NCT01105975|1185121|P1|Overall Study|Adverse Event|2
350794|NCT01105936|1185269|P4|Period 3|Protocol Violation|0
350795|NCT01105936|1185270|P3|Period 3|Protocol Violation|0
350796|NCT01105936|1185271|P2|Period 3|Protocol Violation|2
350797|NCT01105936|1185272|P1|Period 3|Protocol Violation|0
350798|NCT01105936|1185269|P4|Period 2|Adverse Event|0
350799|NCT01105936|1185270|P3|Period 2|Adverse Event|0
350800|NCT01105936|1185271|P2|Period 2|Adverse Event|0
350801|NCT01105936|1185272|P1|Period 2|Adverse Event|1
350802|NCT01105936|1185269|P4|Period 1|Adverse Event|1
350803|NCT01105936|1185270|P3|Period 1|Adverse Event|0
350804|NCT01105936|1185271|P2|Period 1|Adverse Event|0
350805|NCT01105936|1185272|P1|Period 1|Adverse Event|0
350806|NCT01105767|1185301|P3|Overall Study|Lost to Follow-up|1184
350807|NCT01105767|1185302|P2|Overall Study|Lost to Follow-up|1614
350808|NCT01105767|1185303|P1|Overall Study|Lost to Follow-up|1160
350809|NCT01105533|1185355|P9|Overall Study|Physician Decision|0
350810|NCT01105533|1185356|P8|Overall Study|Physician Decision|1
350811|NCT01105533|1185357|P7|Overall Study|Physician Decision|0
350812|NCT01105533|1185358|P6|Overall Study|Physician Decision|0
350813|NCT01105533|1185359|P5|Overall Study|Physician Decision|0
350814|NCT01105533|1185360|P4|Overall Study|Physician Decision|0
350815|NCT01105533|1185361|P3|Overall Study|Physician Decision|0
350816|NCT01105533|1185362|P2|Overall Study|Physician Decision|0
350817|NCT01105533|1185363|P1|Overall Study|Physician Decision|0
350818|NCT01105533|1185355|P9|Overall Study|Other|2
350819|NCT01105533|1185356|P8|Overall Study|Other|1
350820|NCT01105533|1185357|P7|Overall Study|Other|3
350821|NCT01105533|1185358|P6|Overall Study|Other|0
350822|NCT01105533|1185359|P5|Overall Study|Other|1
350823|NCT01105533|1185360|P4|Overall Study|Other|0
350824|NCT01105533|1185361|P3|Overall Study|Other|0
350825|NCT01105533|1185362|P2|Overall Study|Other|0
350826|NCT01105533|1185363|P1|Overall Study|Other|0
350827|NCT01105533|1185355|P9|Overall Study|Adverse Event|1
350828|NCT01105533|1185356|P8|Overall Study|Adverse Event|0
350829|NCT01105533|1185357|P7|Overall Study|Adverse Event|2
350830|NCT01105533|1185358|P6|Overall Study|Adverse Event|2
350831|NCT01105533|1185359|P5|Overall Study|Adverse Event|1
350832|NCT01105533|1185360|P4|Overall Study|Adverse Event|0
350833|NCT01105533|1185361|P3|Overall Study|Adverse Event|0
350834|NCT01105533|1185362|P2|Overall Study|Adverse Event|0
350835|NCT01105533|1185363|P1|Overall Study|Adverse Event|0
350836|NCT01105533|1185355|P9|Overall Study|Lack of Efficacy|9
350837|NCT01105533|1185356|P8|Overall Study|Lack of Efficacy|2
350838|NCT01105533|1185357|P7|Overall Study|Lack of Efficacy|3
350839|NCT01105533|1185358|P6|Overall Study|Lack of Efficacy|5
350840|NCT01105533|1185359|P5|Overall Study|Lack of Efficacy|4
350841|NCT01105533|1185360|P4|Overall Study|Lack of Efficacy|3
350842|NCT01105533|1185361|P3|Overall Study|Lack of Efficacy|3
350843|NCT01105533|1185362|P2|Overall Study|Lack of Efficacy|1
350844|NCT01105533|1185363|P1|Overall Study|Lack of Efficacy|1
350845|NCT01105533|1185355|P9|Overall Study|Death|0
350846|NCT01105533|1185356|P8|Overall Study|Death|0
350847|NCT01105533|1185357|P7|Overall Study|Death|0
350848|NCT01105533|1185358|P6|Overall Study|Death|0
350849|NCT01105533|1185359|P5|Overall Study|Death|1
350850|NCT01105533|1185360|P4|Overall Study|Death|0
350851|NCT01105533|1185361|P3|Overall Study|Death|0
350852|NCT01105533|1185362|P2|Overall Study|Death|0
350853|NCT01105533|1185363|P1|Overall Study|Death|0
350854|NCT01105377|1185453|P2|Overall Study|Withdrawal by Subject|1
350855|NCT01105377|1185454|P1|Overall Study|Withdrawal by Subject|0
350856|NCT01105130|1185502|P3|Overall Study|Multiple Reasons|2
350857|NCT01105130|1185503|P2|Overall Study|Multiple Reasons|0
350858|NCT01105130|1185504|P1|Overall Study|Multiple Reasons|3
350859|NCT01105130|1185502|P3|Overall Study|Toxicity|2
350860|NCT01105130|1185503|P2|Overall Study|Toxicity|3
350861|NCT01105130|1185504|P1|Overall Study|Toxicity|1
350862|NCT01105130|1185502|P3|Overall Study|Never Started|4
350863|NCT01105130|1185503|P2|Overall Study|Never Started|2
350864|NCT01105130|1185504|P1|Overall Study|Never Started|2
350865|NCT01105130|1185502|P3|Overall Study|Withdrawal by Subject|2
350866|NCT01105130|1185503|P2|Overall Study|Withdrawal by Subject|6
350867|NCT01105130|1185504|P1|Overall Study|Withdrawal by Subject|4
350868|NCT01105091|1185534|P2|Overall Study|Death|0
350869|NCT01105091|1185535|P1|Overall Study|Death|2
350870|NCT01105065|1185559|P1|Overall Study|Technical Problems|1
350871|NCT01105065|1185559|P1|Overall Study|Adverse Event|5
350872|NCT01104870|1185568|P3|Overall Study|Withdrawal by Subject|1
350873|NCT01104870|1185569|P2|Overall Study|Withdrawal by Subject|0
350874|NCT01104870|1185570|P1|Overall Study|Withdrawal by Subject|0
350875|NCT01104870|1185568|P3|Overall Study|Death|1
350876|NCT01104870|1185569|P2|Overall Study|Death|0
350877|NCT01104870|1185570|P1|Overall Study|Death|0
350878|NCT01104870|1185568|P3|Overall Study|Adverse Event|0
350879|NCT01104870|1185569|P2|Overall Study|Adverse Event|1
350880|NCT01104870|1185570|P1|Overall Study|Adverse Event|1
350881|NCT01104701|1185603|P4|Overall Study|Physician Decision|0
350882|NCT01104701|1185604|P3|Overall Study|Physician Decision|0
350883|NCT01104701|1185605|P2|Overall Study|Physician Decision|2
350884|NCT01104701|1185606|P1|Overall Study|Physician Decision|0
350885|NCT01104701|1185603|P4|Overall Study|Adverse Event|1
350886|NCT01104701|1185604|P3|Overall Study|Adverse Event|0
350887|NCT01104701|1185605|P2|Overall Study|Adverse Event|0
350888|NCT01104701|1185606|P1|Overall Study|Adverse Event|0
350889|NCT01104701|1185603|P4|Overall Study|Withdrawal by Subject|1
350890|NCT01104701|1185604|P3|Overall Study|Withdrawal by Subject|2
350891|NCT01104701|1185605|P2|Overall Study|Withdrawal by Subject|1
350892|NCT01104701|1185606|P1|Overall Study|Withdrawal by Subject|0
350893|NCT01104662|1185668|P8|Overall Study|Randomized but not treated|0
350894|NCT01104662|1185669|P7|Overall Study|Randomized but not treated|0
350895|NCT01104662|1185670|P6|Overall Study|Randomized but not treated|1
350896|NCT01104662|1185671|P5|Overall Study|Randomized but not treated|0
350897|NCT01104662|1185672|P4|Overall Study|Randomized but not treated|0
350898|NCT01104662|1185673|P3|Overall Study|Randomized but not treated|1
350899|NCT01104662|1185674|P2|Overall Study|Randomized but not treated|4
350900|NCT01104662|1185675|P1|Overall Study|Randomized but not treated|3
350901|NCT01104662|1185668|P8|Overall Study|Reason not specified|0
350902|NCT01104662|1185669|P7|Overall Study|Reason not specified|0
350903|NCT01104662|1185670|P6|Overall Study|Reason not specified|1
350904|NCT01104662|1185671|P5|Overall Study|Reason not specified|0
350905|NCT01104662|1185672|P4|Overall Study|Reason not specified|0
350906|NCT01104662|1185673|P3|Overall Study|Reason not specified|0
350907|NCT01104662|1185674|P2|Overall Study|Reason not specified|3
350908|NCT01104662|1185675|P1|Overall Study|Reason not specified|3
350909|NCT01104662|1185668|P8|Overall Study|Participant left investigator’s care|0
350910|NCT01104662|1185669|P7|Overall Study|Participant left investigator’s care|0
350911|NCT01104662|1185670|P6|Overall Study|Participant left investigator’s care|0
350912|NCT01104662|1185671|P5|Overall Study|Participant left investigator’s care|0
350913|NCT01104662|1185672|P4|Overall Study|Participant left investigator’s care|0
350914|NCT01104662|1185673|P3|Overall Study|Participant left investigator’s care|0
350915|NCT01104662|1185674|P2|Overall Study|Participant left investigator’s care|1
350916|NCT01104662|1185675|P1|Overall Study|Participant left investigator’s care|1
350917|NCT01104662|1185668|P8|Overall Study|Clinical Failure|0
350918|NCT01104662|1185669|P7|Overall Study|Clinical Failure|0
350919|NCT01104662|1185670|P6|Overall Study|Clinical Failure|1
350920|NCT01104662|1185671|P5|Overall Study|Clinical Failure|0
350921|NCT01104662|1185672|P4|Overall Study|Clinical Failure|0
350922|NCT01104662|1185673|P3|Overall Study|Clinical Failure|0
350923|NCT01104662|1185674|P2|Overall Study|Clinical Failure|0
350924|NCT01104662|1185675|P1|Overall Study|Clinical Failure|1
350925|NCT01104662|1185668|P8|Overall Study|Adverse Event|0
350926|NCT01104662|1185669|P7|Overall Study|Adverse Event|0
350927|NCT01104662|1185670|P6|Overall Study|Adverse Event|1
350928|NCT01104662|1185671|P5|Overall Study|Adverse Event|1
350929|NCT01104662|1185672|P4|Overall Study|Adverse Event|1
350930|NCT01104662|1185673|P3|Overall Study|Adverse Event|0
350931|NCT01104662|1185674|P2|Overall Study|Adverse Event|2
350932|NCT01104662|1185675|P1|Overall Study|Adverse Event|2
350933|NCT01104636|1185701|P1|Overall Study|Ongoing|21
350934|NCT01104636|1185701|P1|Overall Study|Adverse Event|40
350935|NCT01104636|1185701|P1|Overall Study|Pregnancy|2
350936|NCT01104636|1185701|P1|Overall Study|Study terminated by sponsor|1
350937|NCT01104636|1185701|P1|Overall Study|Other|43
350938|NCT01104636|1185701|P1|Overall Study|Withdrawal by Subject|4
350939|NCT01104636|1185701|P1|Overall Study|Lost to Follow-up|24
350940|NCT01104636|1185701|P1|Overall Study|Lack of Efficacy|43
350941|NCT01104584|1185706|P1|Overall Study|Study prematurely discontinued|2
350942|NCT01104584|1185706|P1|Overall Study|Study drug never administered|21
350943|NCT01104558|1185776|P1|Overall Study|Missing of genetic analysis results|1
350944|NCT01104558|1185776|P1|Overall Study|Missing of primary efficacy assessment|10
350945|NCT01104558|1185776|P1|Overall Study|Protocol Violation|6
350946|NCT01104493|1185819|P2|Overall Study|Lost to Follow-up|2
350947|NCT01104493|1185820|P1|Overall Study|Lost to Follow-up|0
350948|NCT01104415|1185838|P1|Overall Study|Withdrawal by Subject|1
350949|NCT01104376|1185881|P1|Overall Study|Consented but excluded after labs|13
350950|NCT01104376|1185881|P1|Overall Study|Withdrawal by Subject|15
350951|NCT01104311|1185887|P2|Overall Study|Adverse Event|2
350952|NCT01104311|1185888|P1|Overall Study|Adverse Event|1
350953|NCT01104311|1185887|P2|Overall Study|low compliance|1
350954|NCT01104311|1185888|P1|Overall Study|low compliance|1
350955|NCT01104311|1185887|P2|Overall Study|Physician Decision|2
350956|NCT01104311|1185888|P1|Overall Study|Physician Decision|2
350957|NCT01104311|1185887|P2|Overall Study|Protocol Violation|1
350958|NCT01104311|1185888|P1|Overall Study|Protocol Violation|0
350959|NCT01104311|1185887|P2|Overall Study|Withdrawal by Subject|6
350960|NCT01104311|1185888|P1|Overall Study|Withdrawal by Subject|6
350961|NCT01104246|1185915|P1|Overall Study|did not meet inclusion criteria|4
350962|NCT01104246|1185915|P1|Overall Study|Withdrawal by Subject|1
350963|NCT01104155|1185930|P2|Overall Study|Not specified|4
350964|NCT01104155|1185931|P1|Overall Study|Not specified|3
350965|NCT01104155|1185930|P2|Overall Study|Withdrawal of consent|1
350966|NCT01104155|1185931|P1|Overall Study|Withdrawal of consent|1
350967|NCT01104155|1185930|P2|Overall Study|Participant choice|5
350968|NCT01104155|1185931|P1|Overall Study|Participant choice|6
350969|NCT01104155|1185930|P2|Overall Study|Adverse Event|8
350970|NCT01104155|1185931|P1|Overall Study|Adverse Event|15
350971|NCT01103960|1185974|P2|Overall Study|Other|0
350972|NCT01103960|1185975|P1|Overall Study|Other|1
350973|NCT01103960|1185974|P2|Overall Study|Withdrawal by Subject|1
350974|NCT01103960|1185975|P1|Overall Study|Withdrawal by Subject|2
350975|NCT01103960|1185974|P2|Overall Study|Adverse Event|1
350976|NCT01103960|1185975|P1|Overall Study|Adverse Event|2
350977|NCT01103713|1186010|P1|Overall Study|Not specified|1
350978|NCT01103713|1186010|P1|Overall Study|Study terminated by sponsor|2
350979|NCT01103713|1186010|P1|Overall Study|Withdrawal by Subject|8
350980|NCT01103713|1186010|P1|Overall Study|Lost to Follow-up|2
350981|NCT01103479|1186043|P3|Overall Study|Saw non-study physician|0
350982|NCT01103479|1186044|P2|Overall Study|Saw non-study physician|0
350983|NCT01103479|1186045|P1|Overall Study|Saw non-study physician|2
350984|NCT01103479|1186043|P3|Overall Study|Active cancer|0
350985|NCT01103479|1186044|P2|Overall Study|Active cancer|0
350986|NCT01103479|1186045|P1|Overall Study|Active cancer|1
350987|NCT01103479|1186043|P3|Overall Study|Family history of CRC|2
350988|NCT01103479|1186044|P2|Overall Study|Family history of CRC|0
350989|NCT01103479|1186045|P1|Overall Study|Family history of CRC|1
350990|NCT01103479|1186043|P3|Overall Study|Up to date with CRC screening|12
350991|NCT01103479|1186044|P2|Overall Study|Up to date with CRC screening|9
350992|NCT01103479|1186045|P1|Overall Study|Up to date with CRC screening|1
350993|NCT01103466|1186058|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
350994|NCT01103466|1186059|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
350995|NCT01103466|1186060|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
350996|NCT01103466|1186058|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
350997|NCT01103466|1186059|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
350998|NCT01103466|1186060|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
350999|NCT01103466|1186058|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
351000|NCT01103466|1186059|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
351001|NCT01103466|1186060|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
351002|NCT01103466|1186058|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
351003|NCT01103466|1186059|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
351004|NCT01103466|1186060|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
351005|NCT01103466|1186058|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
351006|NCT01103466|1186059|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
351007|NCT01103466|1186060|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
351008|NCT01103466|1186058|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
351009|NCT01103466|1186059|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
351010|NCT01103466|1186060|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
351011|NCT01103362|1186150|P1|Overall Study|study terminated|596
351012|NCT01103323|1186156|P2|Switched From Placebo to Regorafenib|Adverse Event|1
351013|NCT01103323|1186157|P1|Switched From Placebo to Regorafenib|Adverse Event|0
351014|NCT01103323|1186156|P2|Without/Before Drug Switch|Switch to Regorafenib|4
351015|NCT01103323|1186157|P1|Without/Before Drug Switch|Switch to Regorafenib|0
351016|NCT01103323|1186156|P2|Without/Before Drug Switch|did not receive study treatment|2
351017|NCT01103323|1186157|P1|Without/Before Drug Switch|did not receive study treatment|5
351018|NCT01103323|1186156|P2|Without/Before Drug Switch|Physician Decision|0
351019|NCT01103323|1186157|P1|Without/Before Drug Switch|Physician Decision|2
351020|NCT01103323|1186156|P2|Without/Before Drug Switch|Protocol Violation|0
351021|NCT01103323|1186157|P1|Without/Before Drug Switch|Protocol Violation|2
351022|NCT01103323|1186156|P2|Without/Before Drug Switch|Withdrawal by Subject|5
351023|NCT01103323|1186157|P1|Without/Before Drug Switch|Withdrawal by Subject|17
351024|NCT01103323|1186156|P2|Without/Before Drug Switch|Adverse Event|7
351025|NCT01103323|1186157|P1|Without/Before Drug Switch|Adverse Event|50
351026|NCT01103284|1186174|P2|Overall Study|Missing CRF entries for study completion|2
351027|NCT01103284|1186175|P1|Overall Study|Missing CRF entries for study completion|0
351028|NCT01103284|1186174|P2|Overall Study|Not described|1
351029|NCT01103284|1186175|P1|Overall Study|Not described|2
351030|NCT01103284|1186174|P2|Overall Study|Termination by the Sponsor|1
351031|NCT01103284|1186175|P1|Overall Study|Termination by the Sponsor|0
351032|NCT01103284|1186174|P2|Overall Study|Dermal Hypersensitivity|1
351033|NCT01103284|1186175|P1|Overall Study|Dermal Hypersensitivity|0
351034|NCT01103284|1186174|P2|Overall Study|Withdrawal by Subject|18
351035|NCT01103284|1186175|P1|Overall Study|Withdrawal by Subject|14
351036|NCT01103284|1186174|P2|Overall Study|Adverse Event|5
351037|NCT01103284|1186175|P1|Overall Study|Adverse Event|0
351038|NCT01103284|1186174|P2|Overall Study|Protocol Violation|5
351039|NCT01103284|1186175|P1|Overall Study|Protocol Violation|12
351040|NCT01103284|1186174|P2|Overall Study|Pregnancy|1
351041|NCT01103284|1186175|P1|Overall Study|Pregnancy|3
351042|NCT01103284|1186174|P2|Overall Study|Lost to Follow-up|10
351043|NCT01103284|1186175|P1|Overall Study|Lost to Follow-up|9
351044|NCT01103284|1186174|P2|Overall Study|Death|0
351045|NCT01103284|1186175|P1|Overall Study|Death|2
351046|NCT01103232|1186201|P2|Overall Study|Protocol Violation|1
351047|NCT01103232|1186202|P1|Overall Study|Protocol Violation|0
351048|NCT01103232|1186201|P2|Overall Study|Withdrawal by Subject|1
351049|NCT01103232|1186202|P1|Overall Study|Withdrawal by Subject|1
351050|NCT01103141|1186210|P2|Overall Study|Lost to Follow-up|1
351051|NCT01103141|1186211|P1|Overall Study|Lost to Follow-up|2
351052|NCT01103141|1186210|P2|Overall Study|Death|1
351053|NCT01103141|1186211|P1|Overall Study|Death|0
351054|NCT01103063|1186219|P2|Overall Study|Death|1
351055|NCT01103063|1186220|P1|Overall Study|Death|3
351056|NCT01103063|1186219|P2|Overall Study|Study terminated by Sponsor|342
351057|NCT01103063|1186220|P1|Overall Study|Study terminated by Sponsor|326
351058|NCT01103063|1186219|P2|Overall Study|Protocol Violation|0
351059|NCT01103063|1186220|P1|Overall Study|Protocol Violation|1
351060|NCT01103063|1186219|P2|Overall Study|Not specified|11
351061|NCT01103063|1186220|P1|Overall Study|Not specified|16
351062|NCT01103063|1186219|P2|Overall Study|Withdrawal by Subject|15
351063|NCT01103063|1186220|P1|Overall Study|Withdrawal by Subject|60
351064|NCT01103063|1186219|P2|Overall Study|Lost to Follow-up|51
351065|NCT01103063|1186220|P1|Overall Study|Lost to Follow-up|68
351066|NCT01103063|1186219|P2|Overall Study|Adverse Event|1
351067|NCT01103063|1186220|P1|Overall Study|Adverse Event|3
351068|NCT01102972|1186288|P2|Overall Study|Withdrawal by Subject|6
351069|NCT01102972|1186289|P1|Overall Study|Withdrawal by Subject|6
351070|NCT01102972|1186288|P2|Overall Study|Investigator Discretion|0
351071|NCT01102972|1186289|P1|Overall Study|Investigator Discretion|2
351072|NCT01102972|1186288|P2|Overall Study|Lost to Follow-up|5
351073|NCT01102972|1186289|P1|Overall Study|Lost to Follow-up|10
351074|NCT01102972|1186288|P2|Overall Study|Protocol Violation|0
351075|NCT01102972|1186289|P1|Overall Study|Protocol Violation|1
351076|NCT01102972|1186288|P2|Overall Study|Lack of Efficacy|1
351077|NCT01102972|1186289|P1|Overall Study|Lack of Efficacy|2
351078|NCT01102972|1186288|P2|Overall Study|Adverse Event|2
351079|NCT01102972|1186289|P1|Overall Study|Adverse Event|8
351080|NCT01102803|1186353|P2|Post to Follow-Up|Lost to Follow-up|3
351081|NCT01102803|1186354|P1|Post to Follow-Up|Lost to Follow-up|1
351082|NCT01102803|1186353|P2|Baseline to Post-Treatment|Lost to Follow-up|0
351083|NCT01102803|1186354|P1|Baseline to Post-Treatment|Lost to Follow-up|3
351084|NCT01102777|1186368|P2|Overall Study|Lost to Follow-up|10
351085|NCT01102777|1186369|P1|Overall Study|Lost to Follow-up|7
351086|NCT01102777|1186368|P2|Overall Study|Death|6
351087|NCT01102777|1186369|P1|Overall Study|Death|2
351088|NCT01102491|1186408|P2|Overall Study|Protocol Violation|12
351089|NCT01102491|1186409|P1|Overall Study|Protocol Violation|11
351090|NCT01102374|1186428|P2|Overall Study|Lost to Follow-up|6
351091|NCT01102374|1186429|P1|Overall Study|Lost to Follow-up|7
351092|NCT01102374|1186428|P2|Overall Study|Death|13
351093|NCT01102374|1186429|P1|Overall Study|Death|9
351094|NCT01102257|1186478|P2|Overall Study|Adverse Event|0
351095|NCT01102257|1186479|P1|Overall Study|Adverse Event|1
351096|NCT01102257|1186478|P2|Overall Study|Adverse Event|0
351097|NCT01102257|1186479|P1|Overall Study|Adverse Event|1
351098|NCT01102140|1186496|P2|Overall Study|Investigator terminated study|2
351099|NCT01102140|1186497|P1|Overall Study|Investigator terminated study|2
351100|NCT01102140|1186496|P2|Overall Study|Lost to Follow-up|0
351101|NCT01102140|1186497|P1|Overall Study|Lost to Follow-up|1
351102|NCT01101841|1186552|P2|Overall Study|Eligibility Criteria|2
351103|NCT01101841|1186553|P1|Overall Study|Eligibility Criteria|1
351104|NCT01101841|1186552|P2|Overall Study|Suicidality Tracking Scale|1
351105|NCT01101841|1186553|P1|Overall Study|Suicidality Tracking Scale|3
351106|NCT01101841|1186552|P2|Overall Study|Not Specified|1
351107|NCT01101841|1186553|P1|Overall Study|Not Specified|0
351108|NCT01101841|1186552|P2|Overall Study|Lack of Efficacy|2
351109|NCT01101841|1186553|P1|Overall Study|Lack of Efficacy|0
351110|NCT01101841|1186552|P2|Overall Study|Physician Decision|2
351111|NCT01101841|1186553|P1|Overall Study|Physician Decision|0
351112|NCT01101841|1186552|P2|Overall Study|Protocol Violation|1
351113|NCT01101841|1186553|P1|Overall Study|Protocol Violation|1
351114|NCT01101841|1186552|P2|Overall Study|Withdrawal by Subject|40
351115|NCT01101841|1186553|P1|Overall Study|Withdrawal by Subject|21
351116|NCT01101841|1186552|P2|Overall Study|Lost to Follow-up|3
351117|NCT01101841|1186553|P1|Overall Study|Lost to Follow-up|9
351118|NCT01101841|1186552|P2|Overall Study|Adverse Event|15
351119|NCT01101841|1186553|P1|Overall Study|Adverse Event|15
351120|NCT01101542|1186591|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
351121|NCT01101542|1186591|P1|Year 6 Surveillance Period|Pregnancy|1
351122|NCT01101542|1186591|P1|Year 6 Surveillance Period|Lost to Follow-up|986
351123|NCT01101542|1186591|P1|Year 5 Surveillance Period|Pregnancy|1
351124|NCT01101542|1186591|P1|Year 5 Surveillance Period|Lost to Follow-up|140
351125|NCT01101542|1186591|P1|Year 4 Surveillance Period|Other|287
351126|NCT01101542|1186591|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
351127|NCT01101542|1186591|P1|Year 3 Surveillance Period|Lost to Follow-up|7
351128|NCT01101477|1186610|P3|Overall Study|Protocol Violation|1
351129|NCT01101477|1186611|P2|Overall Study|Protocol Violation|3
351130|NCT01101477|1186612|P1|Overall Study|Protocol Violation|5
351131|NCT01101321|1186633|P2|Period 1|Adverse Event|3
351132|NCT01101321|1186634|P1|Period 1|Adverse Event|3
351133|NCT01101321|1186633|P2|Period 1|Withdrawal by Subject|1
351134|NCT01101321|1186634|P1|Period 1|Withdrawal by Subject|1
351135|NCT01101308|1186644|P2|Period 1|Positive for cotinine|0
351136|NCT01101308|1186645|P1|Period 1|Positive for cotinine|1
351137|NCT01101308|1186644|P2|Period 1|Adverse Event|1
351138|NCT01101308|1186645|P1|Period 1|Adverse Event|2
351139|NCT01101191|1186656|P2|Period 1|Adverse Event|2
351140|NCT01101191|1186657|P1|Period 1|Adverse Event|1
351141|NCT01101191|1186656|P2|Period 1|Withdrawal by Subject|0
351142|NCT01101191|1186657|P1|Period 1|Withdrawal by Subject|1
351143|NCT01101178|1186668|P2|Period 2|Withdrawal by Subject|1
351144|NCT01101178|1186669|P1|Period 2|Withdrawal by Subject|0
351145|NCT01101178|1186668|P2|Period 1|Adverse Event|1
351146|NCT01101178|1186669|P1|Period 1|Adverse Event|2
351147|NCT01101178|1186668|P2|Period 1|Positive drug screen|1
351148|NCT01101178|1186669|P1|Period 1|Positive drug screen|1
351149|NCT01101178|1186668|P2|Period 1|Withdrawal by Subject|2
351150|NCT01101178|1186669|P1|Period 1|Withdrawal by Subject|1
351151|NCT01101165|1186680|P2|Period 2|Adverse Event|0
351152|NCT01101165|1186681|P1|Period 2|Adverse Event|1
351153|NCT01101165|1186680|P2|Period 2|Withdrawal by Subject|1
351154|NCT01101165|1186681|P1|Period 2|Withdrawal by Subject|3
351155|NCT01101165|1186680|P2|Period 1|Lost to Follow-up|0
351156|NCT01101165|1186681|P1|Period 1|Lost to Follow-up|1
351157|NCT01101165|1186680|P2|Period 1|Positive Drug Screen|1
351158|NCT01101165|1186681|P1|Period 1|Positive Drug Screen|0
351159|NCT01101165|1186680|P2|Period 1|Withdrawal by Subject|2
351160|NCT01101165|1186681|P1|Period 1|Withdrawal by Subject|0
351161|NCT01101165|1186680|P2|Period 1|Adverse Event|2
351162|NCT01101165|1186681|P1|Period 1|Adverse Event|1
351163|NCT01101035|1186693|P2|Overall Study|Reason not Specified|363
351164|NCT01101035|1186694|P1|Overall Study|Reason not Specified|333
351165|NCT01101035|1186693|P2|Overall Study|Voluntary Withdrawal|587
351166|NCT01101035|1186694|P1|Overall Study|Voluntary Withdrawal|595
351167|NCT01101035|1186693|P2|Overall Study|Lost to Follow-up|223
351168|NCT01101035|1186694|P1|Overall Study|Lost to Follow-up|226
351169|NCT01101035|1186693|P2|Overall Study|Major Protocol Deviation|46
351170|NCT01101035|1186694|P1|Overall Study|Major Protocol Deviation|52
351171|NCT01101035|1186693|P2|Overall Study|Adverse Event|172
351172|NCT01101035|1186694|P1|Overall Study|Adverse Event|191
351173|NCT01101022|1186714|P2|Overall Study|Vacation|1
351174|NCT01101022|1186715|P1|Overall Study|Vacation|0
351175|NCT01101022|1186714|P2|Overall Study|Work schedule|1
351176|NCT01101022|1186715|P1|Overall Study|Work schedule|1
351177|NCT01101022|1186714|P2|Overall Study|Non-compliance|0
351178|NCT01101022|1186715|P1|Overall Study|Non-compliance|1
351179|NCT01101022|1186714|P2|Overall Study|Sponsor decision|1
351180|NCT01101022|1186715|P1|Overall Study|Sponsor decision|1
351181|NCT01101022|1186714|P2|Overall Study|Lack of Efficacy|7
351182|NCT01101022|1186715|P1|Overall Study|Lack of Efficacy|0
351183|NCT01101022|1186714|P2|Overall Study|Lost to Follow-up|4
351184|NCT01101022|1186715|P1|Overall Study|Lost to Follow-up|1
351185|NCT01101022|1186714|P2|Overall Study|Withdrawal by Subject|8
351186|NCT01101022|1186715|P1|Overall Study|Withdrawal by Subject|3
351187|NCT01101022|1186714|P2|Overall Study|Protocol Violation|3
351188|NCT01101022|1186715|P1|Overall Study|Protocol Violation|4
351189|NCT01101022|1186714|P2|Overall Study|Adverse Event|2
351190|NCT01101022|1186715|P1|Overall Study|Adverse Event|6
351191|NCT01100944|1186749|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
351192|NCT01100944|1186750|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
351193|NCT01100944|1186751|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
351194|NCT01100944|1186749|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
351195|NCT01100944|1186750|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
351196|NCT01100944|1186751|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
351197|NCT01100944|1186749|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
351198|NCT01100944|1186750|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
351199|NCT01100944|1186751|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
351200|NCT01100944|1186749|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
351201|NCT01100944|1186750|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
351202|NCT01100944|1186751|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
351203|NCT01100853|1186809|P2|Overall Study|Withdrawal by Subject|4
351204|NCT01100853|1186810|P1|Overall Study|Withdrawal by Subject|6
351205|NCT01100853|1186809|P2|Overall Study|Received <4 study injections|13
351206|NCT01100853|1186810|P1|Overall Study|Received <4 study injections|10
351207|NCT01100853|1186809|P2|Overall Study|Lost to Follow-up|6
351208|NCT01100853|1186810|P1|Overall Study|Lost to Follow-up|11
351209|NCT01100658|1186856|P1|Overall Study|Withdrawal by Subject|1
351210|NCT01100567|1186888|P2|Overall Study|Deemed ineligible after consent|1
351211|NCT01100567|1186889|P1|Overall Study|Deemed ineligible after consent|0
351212|NCT01100567|1186888|P2|Overall Study|Physician Decision|1
351213|NCT01100567|1186889|P1|Overall Study|Physician Decision|0
351214|NCT01100567|1186888|P2|Overall Study|Lost to Follow-up|2
351215|NCT01100567|1186889|P1|Overall Study|Lost to Follow-up|1
351216|NCT01100567|1186888|P2|Overall Study|Early Hospital Discharge|4
351217|NCT01100567|1186889|P1|Overall Study|Early Hospital Discharge|6
351218|NCT01100567|1186888|P2|Overall Study|Withdrawal by Subject|8
351219|NCT01100567|1186889|P1|Overall Study|Withdrawal by Subject|5
351220|NCT01100502|1186899|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
351221|NCT01100502|1186900|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
351222|NCT01100502|1186899|P2|Long-Term Follow-up|Lost to Follow-up|2
351223|NCT01100502|1186900|P1|Long-Term Follow-up|Lost to Follow-up|5
351224|NCT01100502|1186899|P2|Long-Term Follow-up|Withdrawal by Subject|8
351225|NCT01100502|1186900|P1|Long-Term Follow-up|Withdrawal by Subject|10
351226|NCT01100502|1186899|P2|Treatment Period|Progressive Disease|69
351227|NCT01100502|1186900|P1|Treatment Period|Progressive Disease|24
351228|NCT01100502|1186899|P2|Treatment Period|Withdrawal by Subject|4
351229|NCT01100502|1186900|P1|Treatment Period|Withdrawal by Subject|9
351230|NCT01100502|1186899|P2|Treatment Period|Adverse Event|10
351231|NCT01100502|1186900|P1|Treatment Period|Adverse Event|54
351232|NCT01100437|1186910|P3|Maintenance|Sponsor termination of study|1
351233|NCT01100437|1186911|P2|Maintenance|Sponsor termination of study|0
351234|NCT01100437|1186912|P1|Maintenance|Sponsor termination of study|0
351235|NCT01100437|1186910|P3|Maintenance|Withdrawal by Subject|1
351236|NCT01100437|1186911|P2|Maintenance|Withdrawal by Subject|0
351237|NCT01100437|1186912|P1|Maintenance|Withdrawal by Subject|0
351238|NCT01100437|1186910|P3|Titration/Stabilization|Sponsor canceled study|1
351239|NCT01100437|1186911|P2|Titration/Stabilization|Sponsor canceled study|0
351240|NCT01100437|1186912|P1|Titration/Stabilization|Sponsor canceled study|0
351241|NCT01100437|1186910|P3|Titration/Stabilization|Non-compliance|1
351242|NCT01100437|1186911|P2|Titration/Stabilization|Non-compliance|0
351243|NCT01100437|1186912|P1|Titration/Stabilization|Non-compliance|0
351244|NCT01100437|1186910|P3|Titration/Stabilization|Adverse Event|4
351245|NCT01100437|1186911|P2|Titration/Stabilization|Adverse Event|0
351246|NCT01100437|1186912|P1|Titration/Stabilization|Adverse Event|0
351247|NCT01100320|1186949|P2|Period 2|Withdrawal by Subject|1
351248|NCT01100320|1186950|P1|Period 2|Withdrawal by Subject|1
351249|NCT01100320|1186949|P2|Period 1|Adverse Event|2
351250|NCT01100320|1186950|P1|Period 1|Adverse Event|2
351251|NCT01100320|1186949|P2|Period 1|Positive Drug Screen|1
351252|NCT01100320|1186950|P1|Period 1|Positive Drug Screen|1
351253|NCT01100320|1186949|P2|Period 1|Withdrawal by Subject|4
351254|NCT01100320|1186950|P1|Period 1|Withdrawal by Subject|2
351255|NCT01100307|1186962|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
351256|NCT01100307|1186963|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
351257|NCT01100307|1186962|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
351258|NCT01100307|1186963|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
351259|NCT01100307|1186962|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
351260|NCT01100307|1186963|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
351261|NCT01100307|1186962|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
351262|NCT01100307|1186963|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
351263|NCT01100307|1186962|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
351264|NCT01100307|1186963|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
351265|NCT01100307|1186962|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
351266|NCT01100307|1186963|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
351267|NCT01100086|1187032|P2|Period 1|Withdrawal by Subject|0
351268|NCT01100086|1187033|P1|Period 1|Withdrawal by Subject|1
351269|NCT01100073|1187043|P1|Overall Study|Missing|5
351270|NCT01100073|1187043|P1|Overall Study|Other|8
351271|NCT01100073|1187043|P1|Overall Study|Insufficient tolerability +patients wish|8
351272|NCT01100073|1187043|P1|Overall Study|Lack of effect + patient's wish|2
351273|NCT01100073|1187043|P1|Overall Study|Lost to Follow-up|39
351274|NCT01100073|1187043|P1|Overall Study|Withdrawal by Subject|13
351275|NCT01100073|1187043|P1|Overall Study|Insufficient Tolerability|21
351276|NCT01100073|1187043|P1|Overall Study|Lack of Efficacy|4
351277|NCT01099917|1187087|P1|Overall Study|Not Treated|24
351278|NCT01099917|1187087|P1|Overall Study|Adverse Event|3
351279|NCT01099709|1187149|P2|Period 1|Adverse Event|0
351280|NCT01099709|1187150|P1|Period 1|Adverse Event|1
351281|NCT01099709|1187149|P2|Period 1|Positive cotinine test|1
351282|NCT01099709|1187150|P1|Period 1|Positive cotinine test|0
351283|NCT01099709|1187149|P2|Period 1|Withdrawal by Subject|1
351284|NCT01099709|1187150|P1|Period 1|Withdrawal by Subject|0
351285|NCT01099579|1187176|P3|Stage 2 (ATV Capsule)|Adverse Event|0
351286|NCT01099579|1187177|P2|Stage 2 (ATV Capsule)|Adverse Event|1
351287|NCT01099579|1187178|P1|Stage 2 (ATV Capsule)|Adverse Event|0
351288|NCT01099579|1187176|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
351289|NCT01099579|1187177|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
351290|NCT01099579|1187178|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
351291|NCT01099579|1187176|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
351292|NCT01099579|1187177|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
351293|NCT01099579|1187178|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
351294|NCT01099579|1187176|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
351295|NCT01099579|1187177|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
351296|NCT01099579|1187178|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
351297|NCT01099579|1187176|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
351298|NCT01099579|1187177|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
351299|NCT01099579|1187178|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
351300|NCT01099579|1187176|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
351301|NCT01099579|1187177|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
351302|NCT01099579|1187178|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
351303|NCT01099579|1187176|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
351304|NCT01099579|1187177|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
351305|NCT01099579|1187178|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
351306|NCT01099579|1187176|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
351307|NCT01099579|1187177|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
351308|NCT01099579|1187178|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
351309|NCT01099579|1187176|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
351310|NCT01099579|1187177|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
351311|NCT01099579|1187178|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
351312|NCT01099579|1187176|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
351313|NCT01099579|1187177|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
351314|NCT01099579|1187178|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
351315|NCT01099397|1187247|P1|Overall Study|Withdrawal by Subject|5
351316|NCT01099397|1187247|P1|Overall Study|Protocol Violation|4
351317|NCT01099397|1187247|P1|Overall Study|Lost to Follow-up|4
351318|NCT01099267|1187274|P1|MDS-003 Study|Secondary Malign Disease|1
351319|NCT01099267|1187274|P1|MDS-003 Study|Loss of Response|1
351320|NCT01099267|1187274|P1|MDS-003 Study|Non-Compliance|2
351321|NCT01099267|1187274|P1|MDS-003 Study|Investigator Decision|2
351322|NCT01099267|1187274|P1|MDS-003 Study|Disease Progression|7
351323|NCT01099267|1187274|P1|MDS-003 Study|Study Closed by Sponsor|2
351324|NCT01099267|1187274|P1|MDS-003 Study|Death|11
351325|NCT01099267|1187274|P1|MDS-003 Study|Lost to Follow-up|1
351326|NCT01099267|1187274|P1|MDS-003 Study|Withdrawal by Subject|8
351327|NCT01099267|1187274|P1|MDS-003 Study|Lack of Efficacy|52
351328|NCT01099267|1187274|P1|MDS-003 Study|Adverse Event|37
351329|NCT01099215|1187284|P2|Overall Study|Adverse Event|1
351330|NCT01099215|1187285|P1|Overall Study|Adverse Event|0
351331|NCT01099215|1187284|P2|Overall Study|Withdrawal by Subject|0
351332|NCT01099215|1187285|P1|Overall Study|Withdrawal by Subject|1
351333|NCT01098851|1187355|P2|Overall Study|Equipment failure|0
351334|NCT01098851|1187356|P1|Overall Study|Equipment failure|1
351335|NCT01098812|1187367|P3|Overall Study|Lost to Follow-up|0
351336|NCT01098812|1187368|P2|Overall Study|Lost to Follow-up|1
351337|NCT01098812|1187369|P1|Overall Study|Lost to Follow-up|0
351338|NCT01098812|1187367|P3|Overall Study|Death|1
351339|NCT01098812|1187368|P2|Overall Study|Death|0
351340|NCT01098812|1187369|P1|Overall Study|Death|2
351341|NCT01098539|1187445|P2|Overall Study|Physician Decision|3
351342|NCT01098539|1187446|P1|Overall Study|Physician Decision|5
351343|NCT01098539|1187445|P2|Overall Study|Withdrawal by Subject|26
351344|NCT01098539|1187446|P1|Overall Study|Withdrawal by Subject|12
351345|NCT01098539|1187445|P2|Overall Study|Lost to Follow-up|4
351346|NCT01098539|1187446|P1|Overall Study|Lost to Follow-up|4
351347|NCT01098539|1187445|P2|Overall Study|Noncompliance|5
351348|NCT01098539|1187446|P1|Overall Study|Noncompliance|3
351349|NCT01098539|1187445|P2|Overall Study|Protocol Violation|4
351350|NCT01098539|1187446|P1|Overall Study|Protocol Violation|1
351351|NCT01098539|1187445|P2|Overall Study|Adverse Event|26
351352|NCT01098539|1187446|P1|Overall Study|Adverse Event|26
351353|NCT01098487|1187497|P1|Overall Study|Physician Decision|1
351354|NCT01098487|1187497|P1|Overall Study|Lost to Follow-up|3
351355|NCT01098487|1187497|P1|Overall Study|Withdrawal by Subject|7
351356|NCT01098487|1187497|P1|Overall Study|Lack of Efficacy|11
351357|NCT01098487|1187497|P1|Overall Study|Adverse Event|22
351358|NCT01098461|1187513|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
351359|NCT01098461|1187514|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
351360|NCT01098461|1187515|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
351361|NCT01098461|1187516|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
351362|NCT01098461|1187513|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
351363|NCT01098461|1187514|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
351364|NCT01098461|1187515|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
351365|NCT01098461|1187516|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
351366|NCT01098461|1187513|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
351367|NCT01098461|1187514|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
351368|NCT01098461|1187515|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
351369|NCT01098461|1187516|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
351370|NCT01098461|1187513|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
351371|NCT01098461|1187514|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
351372|NCT01098461|1187515|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
351373|NCT01098461|1187516|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
351374|NCT01098461|1187513|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
351458|NCT01098110|1187641|P2|Overall Study|Adverse Event|32
351375|NCT01098461|1187514|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
351376|NCT01098461|1187515|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
351377|NCT01098461|1187516|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
351378|NCT01098461|1187513|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
351379|NCT01098461|1187514|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
351380|NCT01098461|1187515|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
351381|NCT01098461|1187516|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
351382|NCT01098461|1187513|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
351383|NCT01098461|1187514|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
351384|NCT01098461|1187515|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
351385|NCT01098461|1187516|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
351386|NCT01098305|1187576|P2|Overall Study|Lost to Follow-up|33
351387|NCT01098305|1187577|P1|Overall Study|Lost to Follow-up|31
351388|NCT01098240|1187596|P3|Double-Blind Phase|Adverse Event|3
351389|NCT01098240|1187597|P2|Double-Blind Phase|Adverse Event|3
351390|NCT01098240|1187598|P1|Double-Blind Phase|Adverse Event|0
351391|NCT01098240|1187596|P3|Double-Blind Phase|Withdrawal by Subject|3
351392|NCT01098240|1187597|P2|Double-Blind Phase|Withdrawal by Subject|1
351393|NCT01098240|1187598|P1|Double-Blind Phase|Withdrawal by Subject|0
351394|NCT01098240|1187596|P3|Double-Blind Phase|Insufficient Clinical Response|2
351395|NCT01098240|1187597|P2|Double-Blind Phase|Insufficient Clinical Response|1
351396|NCT01098240|1187598|P1|Double-Blind Phase|Insufficient Clinical Response|0
351397|NCT01098240|1187596|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
351398|NCT01098240|1187597|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
351399|NCT01098240|1187598|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
351400|NCT01098240|1187596|P3|Double-Blind Phase|Other|2
351401|NCT01098240|1187597|P2|Double-Blind Phase|Other|2
351402|NCT01098240|1187598|P1|Double-Blind Phase|Other|0
351403|NCT01098240|1187596|P3|Double-Blind Phase|Lost to Follow-up|0
351404|NCT01098240|1187597|P2|Double-Blind Phase|Lost to Follow-up|2
351405|NCT01098240|1187598|P1|Double-Blind Phase|Lost to Follow-up|0
351406|NCT01098240|1187596|P3|Double-Blind Phase|Protocol Violation|4
351407|NCT01098240|1187597|P2|Double-Blind Phase|Protocol Violation|2
351408|NCT01098240|1187598|P1|Double-Blind Phase|Protocol Violation|0
351409|NCT01098240|1187596|P3|Double-Blind Phase|Study Terminated by Sponsor|8
351410|NCT01098240|1187597|P2|Double-Blind Phase|Study Terminated by Sponsor|5
351411|NCT01098240|1187598|P1|Double-Blind Phase|Study Terminated by Sponsor|0
351412|NCT01098240|1187596|P3|Open-Label Phase|Adverse Event|0
351413|NCT01098240|1187597|P2|Open-Label Phase|Adverse Event|0
351414|NCT01098240|1187598|P1|Open-Label Phase|Adverse Event|12
351415|NCT01098240|1187596|P3|Open-Label Phase|Withdrawal by Subject|0
351416|NCT01098240|1187597|P2|Open-Label Phase|Withdrawal by Subject|0
351417|NCT01098240|1187598|P1|Open-Label Phase|Withdrawal by Subject|9
351418|NCT01098240|1187596|P3|Open-Label Phase|Pregnancy|0
351419|NCT01098240|1187597|P2|Open-Label Phase|Pregnancy|0
351420|NCT01098240|1187598|P1|Open-Label Phase|Pregnancy|1
351421|NCT01098240|1187596|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
351422|NCT01098240|1187597|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
351423|NCT01098240|1187598|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
351424|NCT01098240|1187596|P3|Open-Label Phase|Other|0
351425|NCT01098240|1187597|P2|Open-Label Phase|Other|0
351426|NCT01098240|1187598|P1|Open-Label Phase|Other|19
351427|NCT01098240|1187596|P3|Open-Label Phase|Lost to Follow-up|0
351428|NCT01098240|1187597|P2|Open-Label Phase|Lost to Follow-up|0
351429|NCT01098240|1187598|P1|Open-Label Phase|Lost to Follow-up|13
351430|NCT01098240|1187596|P3|Open-Label Phase|Protocol Violation|0
351431|NCT01098240|1187597|P2|Open-Label Phase|Protocol Violation|0
351432|NCT01098240|1187598|P1|Open-Label Phase|Protocol Violation|4
351433|NCT01098240|1187596|P3|Open-Label Phase|Study Terminated by Sponsor|0
351434|NCT01098240|1187597|P2|Open-Label Phase|Study Terminated by Sponsor|0
351435|NCT01098240|1187598|P1|Open-Label Phase|Study Terminated by Sponsor|27
351436|NCT01098162|1187628|P1|Overall Study|Reason Unknown|26
351437|NCT01098162|1187628|P1|Overall Study|Other Reason|1
351438|NCT01098162|1187628|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
351439|NCT01098162|1187628|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
351440|NCT01098162|1187628|P1|Overall Study|Adverse Event & Lost to Follow-up|2
351441|NCT01098162|1187628|P1|Overall Study|Adverse Event & Wish of Patient|13
351442|NCT01098162|1187628|P1|Overall Study|Adverse Event & Lack of Efficacy|6
351443|NCT01098162|1187628|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
351444|NCT01098162|1187628|P1|Overall Study|Lost to Follow-up|9
351445|NCT01098162|1187628|P1|Overall Study|Wish of Patient|7
351446|NCT01098162|1187628|P1|Overall Study|Lack of Efficacy|4
351447|NCT01098162|1187628|P1|Overall Study|Adverse Event|37
351448|NCT01098110|1187640|P3|Overall Study|Untreated|0
351449|NCT01098110|1187641|P2|Overall Study|Untreated|1
351450|NCT01098110|1187642|P1|Overall Study|Untreated|1
351451|NCT01098110|1187640|P3|Overall Study|Not Specified|5
351452|NCT01098110|1187641|P2|Overall Study|Not Specified|7
351453|NCT01098110|1187642|P1|Overall Study|Not Specified|4
351454|NCT01098110|1187640|P3|Overall Study|Lack of Efficacy|27
351455|NCT01098110|1187641|P2|Overall Study|Lack of Efficacy|9
351456|NCT01098110|1187642|P1|Overall Study|Lack of Efficacy|13
351457|NCT01098110|1187640|P3|Overall Study|Adverse Event|43
351459|NCT01098110|1187642|P1|Overall Study|Adverse Event|30
351460|NCT01098110|1187640|P3|Overall Study|Withdrawal by Subject|19
351461|NCT01098110|1187641|P2|Overall Study|Withdrawal by Subject|24
351462|NCT01098110|1187642|P1|Overall Study|Withdrawal by Subject|14
351463|NCT01098097|1187683|P1|Overall Study|No reason reported|31
351464|NCT01098097|1187683|P1|Overall Study|Status unknown|16
351465|NCT01098097|1187683|P1|Overall Study|Lost to Follow-up|18
351466|NCT01098097|1187683|P1|Overall Study|Adverse Event|17
351467|NCT01098071|1187692|P1|Overall Study|Lost to Follow-up|13
351468|NCT01098071|1187692|P1|Overall Study|Surgery (adenoidectomy)|2
351469|NCT01098032|1187705|P2|Overall Study|Withdrawal by Subject|1
351470|NCT01098032|1187706|P1|Overall Study|Withdrawal by Subject|1
351471|NCT01097863|1187815|P3|Overall Study|Did not return for final visit|1
351472|NCT01097863|1187816|P2|Overall Study|Did not return for final visit|0
351473|NCT01097863|1187817|P1|Overall Study|Did not return for final visit|0
351474|NCT01097863|1187815|P3|Overall Study|Discomfort|1
351475|NCT01097863|1187816|P2|Overall Study|Discomfort|0
351476|NCT01097863|1187817|P1|Overall Study|Discomfort|1
351477|NCT01097694|1187838|P2|Overall Study|Withdrawal by Subject|1
351478|NCT01097694|1187839|P1|Overall Study|Withdrawal by Subject|3
351479|NCT01097694|1187838|P2|Overall Study|Lost to Follow-up|3
351480|NCT01097694|1187839|P1|Overall Study|Lost to Follow-up|0
351481|NCT01097694|1187838|P2|Overall Study|Adverse Event|0
351482|NCT01097694|1187839|P1|Overall Study|Adverse Event|5
351483|NCT01097668|1187901|P2|Overall Study|Lost to Follow-up|0
351484|NCT01097668|1187902|P1|Overall Study|Lost to Follow-up|1
351485|NCT01097668|1187901|P2|Overall Study|Withdrawal by Subject|2
351486|NCT01097668|1187902|P1|Overall Study|Withdrawal by Subject|1
351487|NCT01097655|1187912|P1|Overall Study|Did Not Meet Inclusion Criteria|8
351488|NCT01097655|1187912|P1|Overall Study|Subject Documented Twice|1
351489|NCT01097655|1187912|P1|Overall Study|Withdrawal by Subject|1
351490|NCT01097629|1187922|P8|DB RO Phase|Lost to Follow-up|0
351491|NCT01097629|1187923|P7|DB RO Phase|Lost to Follow-up|2
351492|NCT01097629|1187924|P6|DB RO Phase|Lost to Follow-up|0
351493|NCT01097629|1187925|P5|DB RO Phase|Lost to Follow-up|0
351494|NCT01097629|1187926|P4|DB RO Phase|Lost to Follow-up|0
351495|NCT01097629|1187927|P3|DB RO Phase|Lost to Follow-up|0
351496|NCT01097629|1187928|P2|DB RO Phase|Lost to Follow-up|0
351497|NCT01097629|1187929|P1|DB RO Phase|Lost to Follow-up|0
351498|NCT01097629|1187922|P8|DB RO Phase|Protocol Violation|0
351499|NCT01097629|1187923|P7|DB RO Phase|Protocol Violation|1
351500|NCT01097629|1187924|P6|DB RO Phase|Protocol Violation|1
351501|NCT01097629|1187925|P5|DB RO Phase|Protocol Violation|0
351502|NCT01097629|1187926|P4|DB RO Phase|Protocol Violation|1
351503|NCT01097629|1187927|P3|DB RO Phase|Protocol Violation|0
351504|NCT01097629|1187928|P2|DB RO Phase|Protocol Violation|0
351505|NCT01097629|1187929|P1|DB RO Phase|Protocol Violation|0
351506|NCT01097629|1187922|P8|DB RO Phase|Withdrawal by Subject|1
351507|NCT01097629|1187923|P7|DB RO Phase|Withdrawal by Subject|0
351508|NCT01097629|1187924|P6|DB RO Phase|Withdrawal by Subject|0
351509|NCT01097629|1187925|P5|DB RO Phase|Withdrawal by Subject|0
351510|NCT01097629|1187926|P4|DB RO Phase|Withdrawal by Subject|0
351511|NCT01097629|1187927|P3|DB RO Phase|Withdrawal by Subject|0
351512|NCT01097629|1187928|P2|DB RO Phase|Withdrawal by Subject|0
351513|NCT01097629|1187929|P1|DB RO Phase|Withdrawal by Subject|0
351514|NCT01097629|1187922|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351515|NCT01097629|1187923|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351516|NCT01097629|1187924|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351517|NCT01097629|1187925|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351518|NCT01097629|1187926|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351519|NCT01097629|1187927|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
351520|NCT01097629|1187928|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
351521|NCT01097629|1187929|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
351522|NCT01097629|1187922|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351523|NCT01097629|1187923|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351524|NCT01097629|1187924|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351525|NCT01097629|1187925|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351526|NCT01097629|1187926|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351527|NCT01097629|1187927|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351528|NCT01097629|1187928|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
351529|NCT01097629|1187929|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
351530|NCT01097629|1187922|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351531|NCT01097629|1187923|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351532|NCT01097629|1187924|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351533|NCT01097629|1187925|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351534|NCT01097629|1187926|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351535|NCT01097629|1187927|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
351536|NCT01097629|1187928|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
351537|NCT01097629|1187929|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
351538|NCT01097629|1187922|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351539|NCT01097629|1187923|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351540|NCT01097629|1187924|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351541|NCT01097629|1187925|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351542|NCT01097629|1187926|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351543|NCT01097629|1187927|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
351544|NCT01097629|1187928|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
351545|NCT01097629|1187929|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
351546|NCT01097629|1187922|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351547|NCT01097629|1187923|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351548|NCT01097629|1187924|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351549|NCT01097629|1187925|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351550|NCT01097629|1187926|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351551|NCT01097629|1187927|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
351552|NCT01097629|1187928|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
351553|NCT01097629|1187929|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
351554|NCT01097629|1187922|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351555|NCT01097629|1187923|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351556|NCT01097629|1187924|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351557|NCT01097629|1187925|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351558|NCT01097629|1187926|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351559|NCT01097629|1187927|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
351560|NCT01097629|1187928|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
351561|NCT01097629|1187929|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
351562|NCT01097629|1187922|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351563|NCT01097629|1187923|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351564|NCT01097629|1187924|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351565|NCT01097629|1187925|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351566|NCT01097629|1187926|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351567|NCT01097629|1187927|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
351568|NCT01097629|1187928|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
351569|NCT01097629|1187929|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
351570|NCT01097616|1187980|P8|DB RO Phase|Not Treated in RO|0
351571|NCT01097616|1187981|P7|DB RO Phase|Not Treated in RO|0
351572|NCT01097616|1187982|P6|DB RO Phase|Not Treated in RO|1
351573|NCT01097616|1187983|P5|DB RO Phase|Not Treated in RO|0
351574|NCT01097616|1187984|P4|DB RO Phase|Not Treated in RO|0
351575|NCT01097616|1187985|P3|DB RO Phase|Not Treated in RO|0
351576|NCT01097616|1187986|P2|DB RO Phase|Not Treated in RO|0
351577|NCT01097616|1187987|P1|DB RO Phase|Not Treated in RO|0
351578|NCT01097616|1187980|P8|DB RO Phase|Lost to Follow-up|1
351579|NCT01097616|1187981|P7|DB RO Phase|Lost to Follow-up|0
351580|NCT01097616|1187982|P6|DB RO Phase|Lost to Follow-up|0
351581|NCT01097616|1187983|P5|DB RO Phase|Lost to Follow-up|1
351582|NCT01097616|1187984|P4|DB RO Phase|Lost to Follow-up|1
351583|NCT01097616|1187985|P3|DB RO Phase|Lost to Follow-up|0
351584|NCT01097616|1187986|P2|DB RO Phase|Lost to Follow-up|0
351585|NCT01097616|1187987|P1|DB RO Phase|Lost to Follow-up|0
351586|NCT01097616|1187980|P8|DB RO Phase|Withdrawal by Subject|0
351587|NCT01097616|1187981|P7|DB RO Phase|Withdrawal by Subject|0
351588|NCT01097616|1187982|P6|DB RO Phase|Withdrawal by Subject|1
351589|NCT01097616|1187983|P5|DB RO Phase|Withdrawal by Subject|0
351590|NCT01097616|1187984|P4|DB RO Phase|Withdrawal by Subject|0
351591|NCT01097616|1187985|P3|DB RO Phase|Withdrawal by Subject|0
351592|NCT01097616|1187986|P2|DB RO Phase|Withdrawal by Subject|0
351593|NCT01097616|1187987|P1|DB RO Phase|Withdrawal by Subject|0
351594|NCT01097616|1187980|P8|DB RO Phase|Adverse Event|0
351595|NCT01097616|1187981|P7|DB RO Phase|Adverse Event|1
351596|NCT01097616|1187982|P6|DB RO Phase|Adverse Event|0
351597|NCT01097616|1187983|P5|DB RO Phase|Adverse Event|0
351598|NCT01097616|1187984|P4|DB RO Phase|Adverse Event|0
351599|NCT01097616|1187985|P3|DB RO Phase|Adverse Event|0
351600|NCT01097616|1187986|P2|DB RO Phase|Adverse Event|0
351601|NCT01097616|1187987|P1|DB RO Phase|Adverse Event|0
351602|NCT01097616|1187980|P8|Optional DB EXT Phase|Physician Decision|0
351603|NCT01097616|1187981|P7|Optional DB EXT Phase|Physician Decision|0
351604|NCT01097616|1187982|P6|Optional DB EXT Phase|Physician Decision|0
351605|NCT01097616|1187983|P5|Optional DB EXT Phase|Physician Decision|0
351606|NCT01097616|1187984|P4|Optional DB EXT Phase|Physician Decision|0
351607|NCT01097616|1187985|P3|Optional DB EXT Phase|Physician Decision|0
351608|NCT01097616|1187986|P2|Optional DB EXT Phase|Physician Decision|0
351609|NCT01097616|1187987|P1|Optional DB EXT Phase|Physician Decision|1
351610|NCT01097616|1187980|P8|Optional DB EXT Phase|Lack of Efficacy|0
351611|NCT01097616|1187981|P7|Optional DB EXT Phase|Lack of Efficacy|0
351612|NCT01097616|1187982|P6|Optional DB EXT Phase|Lack of Efficacy|0
351613|NCT01097616|1187983|P5|Optional DB EXT Phase|Lack of Efficacy|0
351614|NCT01097616|1187984|P4|Optional DB EXT Phase|Lack of Efficacy|0
351615|NCT01097616|1187985|P3|Optional DB EXT Phase|Lack of Efficacy|1
351616|NCT01097616|1187986|P2|Optional DB EXT Phase|Lack of Efficacy|1
351617|NCT01097616|1187987|P1|Optional DB EXT Phase|Lack of Efficacy|1
351618|NCT01097616|1187980|P8|Optional DB EXT Phase|Lost to Follow-up|0
351619|NCT01097616|1187981|P7|Optional DB EXT Phase|Lost to Follow-up|0
351620|NCT01097616|1187982|P6|Optional DB EXT Phase|Lost to Follow-up|0
351621|NCT01097616|1187983|P5|Optional DB EXT Phase|Lost to Follow-up|0
351622|NCT01097616|1187984|P4|Optional DB EXT Phase|Lost to Follow-up|0
351623|NCT01097616|1187985|P3|Optional DB EXT Phase|Lost to Follow-up|1
351624|NCT01097616|1187986|P2|Optional DB EXT Phase|Lost to Follow-up|5
351625|NCT01097616|1187987|P1|Optional DB EXT Phase|Lost to Follow-up|1
351626|NCT01097616|1187980|P8|Optional DB EXT Phase|Protocol Violation|0
351627|NCT01097616|1187981|P7|Optional DB EXT Phase|Protocol Violation|0
351628|NCT01097616|1187982|P6|Optional DB EXT Phase|Protocol Violation|0
351629|NCT01097616|1187983|P5|Optional DB EXT Phase|Protocol Violation|0
351630|NCT01097616|1187984|P4|Optional DB EXT Phase|Protocol Violation|0
351631|NCT01097616|1187985|P3|Optional DB EXT Phase|Protocol Violation|3
351632|NCT01097616|1187986|P2|Optional DB EXT Phase|Protocol Violation|2
351633|NCT01097616|1187987|P1|Optional DB EXT Phase|Protocol Violation|0
351634|NCT01097616|1187980|P8|Optional DB EXT Phase|Withdrawal by Subject|0
351635|NCT01097616|1187981|P7|Optional DB EXT Phase|Withdrawal by Subject|0
351636|NCT01097616|1187982|P6|Optional DB EXT Phase|Withdrawal by Subject|0
351637|NCT01097616|1187983|P5|Optional DB EXT Phase|Withdrawal by Subject|0
351638|NCT01097616|1187984|P4|Optional DB EXT Phase|Withdrawal by Subject|0
351639|NCT01097616|1187985|P3|Optional DB EXT Phase|Withdrawal by Subject|3
351640|NCT01097616|1187986|P2|Optional DB EXT Phase|Withdrawal by Subject|6
351641|NCT01097616|1187987|P1|Optional DB EXT Phase|Withdrawal by Subject|12
351642|NCT01097616|1187980|P8|Optional DB EXT Phase|Adverse Event|0
351643|NCT01097616|1187981|P7|Optional DB EXT Phase|Adverse Event|0
351644|NCT01097616|1187982|P6|Optional DB EXT Phase|Adverse Event|0
351645|NCT01097616|1187983|P5|Optional DB EXT Phase|Adverse Event|0
351646|NCT01097616|1187984|P4|Optional DB EXT Phase|Adverse Event|0
351647|NCT01097616|1187985|P3|Optional DB EXT Phase|Adverse Event|2
351648|NCT01097616|1187986|P2|Optional DB EXT Phase|Adverse Event|7
351649|NCT01097616|1187987|P1|Optional DB EXT Phase|Adverse Event|0
351650|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351651|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351652|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351653|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351654|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351655|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
351656|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351657|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
351658|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351659|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351660|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351661|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351662|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351663|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
351664|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
351665|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
351666|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
351667|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
351668|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
351669|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
351670|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
351671|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
351672|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
351673|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
351674|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351675|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351676|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351677|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351678|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
351679|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
351680|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
351681|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
351682|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351683|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351684|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351685|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351686|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351687|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
351688|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
351689|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
351690|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351691|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351692|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351693|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351694|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
351695|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
351696|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
351697|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
351698|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351699|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351700|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351701|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351702|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
351703|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
351704|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
351705|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
351706|NCT01097616|1187980|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351707|NCT01097616|1187981|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351708|NCT01097616|1187982|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351709|NCT01097616|1187983|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351710|NCT01097616|1187984|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
351711|NCT01097616|1187985|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
351712|NCT01097616|1187986|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
351713|NCT01097616|1187987|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
351714|NCT01097421|1188062|P1|Overall Study|Withdrawal by Subject|3
351715|NCT01097421|1188062|P1|Overall Study|Lost to Follow-up|1
351716|NCT01097421|1188062|P1|Overall Study|Protocol Violation|2
351717|NCT01097421|1188062|P1|Overall Study|Adverse Event|8
351718|NCT01097057|1188086|P1|Overall Study|Physician Decision|3
351719|NCT01097005|1188093|P1|Overall Study|Discontinuance by complication|50
351720|NCT01097005|1188093|P1|Overall Study|Adverse Event|14
351721|NCT01097005|1188093|P1|Overall Study|Deviation from exclusion criteria|37
351722|NCT01097005|1188093|P1|Overall Study|No examination data available|244
351723|NCT01097005|1188093|P1|Overall Study|Poor medication compliance|1
351724|NCT01097005|1188093|P1|Overall Study|Subjects cannot visit the hospital|1
351725|NCT01097005|1188093|P1|Overall Study|Case Report Form not collected|18
351726|NCT01096784|1188137|P2|Overall Study|Other Unspecified|1
351727|NCT01096784|1188138|P1|Overall Study|Other Unspecified|0
351728|NCT01096784|1188137|P2|Overall Study|Administrative Decision|1
351729|NCT01096784|1188138|P1|Overall Study|Administrative Decision|0
351730|NCT01096784|1188137|P2|Overall Study|Protocol Deviation|2
351731|NCT01096784|1188138|P1|Overall Study|Protocol Deviation|2
351732|NCT01096784|1188137|P2|Overall Study|Adverse Event|9
351733|NCT01096784|1188138|P1|Overall Study|Adverse Event|11
351734|NCT01096784|1188137|P2|Overall Study|Withdrawal by Subject|1
351735|NCT01096784|1188138|P1|Overall Study|Withdrawal by Subject|2
351736|NCT01096667|1188243|P5|Overall Study|Not treated|0
351737|NCT01096667|1188244|P4|Overall Study|Not treated|0
351738|NCT01096667|1188245|P3|Overall Study|Not treated|0
351739|NCT01096667|1188246|P2|Overall Study|Not treated|0
351740|NCT01096667|1188247|P1|Overall Study|Not treated|1
351741|NCT01096667|1188243|P5|Overall Study|Protocol Violation|0
351742|NCT01096667|1188244|P4|Overall Study|Protocol Violation|1
351743|NCT01096667|1188245|P3|Overall Study|Protocol Violation|0
351744|NCT01096667|1188246|P2|Overall Study|Protocol Violation|0
351745|NCT01096667|1188247|P1|Overall Study|Protocol Violation|0
351746|NCT01096667|1188243|P5|Overall Study|Reason not available|0
351747|NCT01096667|1188244|P4|Overall Study|Reason not available|1
351748|NCT01096667|1188245|P3|Overall Study|Reason not available|1
351749|NCT01096667|1188246|P2|Overall Study|Reason not available|1
351750|NCT01096667|1188247|P1|Overall Study|Reason not available|0
351751|NCT01096667|1188243|P5|Overall Study|Withdrawal by Subject|0
351752|NCT01096667|1188244|P4|Overall Study|Withdrawal by Subject|1
351753|NCT01096667|1188245|P3|Overall Study|Withdrawal by Subject|0
351754|NCT01096667|1188246|P2|Overall Study|Withdrawal by Subject|0
351755|NCT01096667|1188247|P1|Overall Study|Withdrawal by Subject|1
351756|NCT01096667|1188243|P5|Overall Study|Lost to Follow-up|0
351757|NCT01096667|1188244|P4|Overall Study|Lost to Follow-up|0
351758|NCT01096667|1188245|P3|Overall Study|Lost to Follow-up|1
351759|NCT01096667|1188246|P2|Overall Study|Lost to Follow-up|1
351760|NCT01096667|1188247|P1|Overall Study|Lost to Follow-up|1
351761|NCT01096589|1188389|P4|Overall Study|found treatment exhausting|1
351762|NCT01096589|1188390|P3|Overall Study|found treatment exhausting|0
351763|NCT01096589|1188391|P2|Overall Study|found treatment exhausting|0
351764|NCT01096589|1188392|P1|Overall Study|found treatment exhausting|0
351765|NCT01096589|1188389|P4|Overall Study|Compliance with protocol|0
351766|NCT01096589|1188390|P3|Overall Study|Compliance with protocol|1
351767|NCT01096589|1188391|P2|Overall Study|Compliance with protocol|0
351768|NCT01096589|1188392|P1|Overall Study|Compliance with protocol|0
351769|NCT01096589|1188389|P4|Overall Study|Withdrawal by Subject|1
351770|NCT01096589|1188390|P3|Overall Study|Withdrawal by Subject|1
351771|NCT01096589|1188391|P2|Overall Study|Withdrawal by Subject|1
351772|NCT01096589|1188392|P1|Overall Study|Withdrawal by Subject|2
351773|NCT01096589|1188389|P4|Overall Study|Adverse Event|1
351774|NCT01096589|1188390|P3|Overall Study|Adverse Event|2
351775|NCT01096589|1188391|P2|Overall Study|Adverse Event|1
351776|NCT01096589|1188392|P1|Overall Study|Adverse Event|2
351777|NCT01096550|1188404|P2|Overall Study|Lost to Follow-up|9
351778|NCT01096550|1188405|P1|Overall Study|Lost to Follow-up|12
351779|NCT01096550|1188404|P2|Overall Study|non-African American participant|6
351780|NCT01096550|1188405|P1|Overall Study|non-African American participant|13
351781|NCT01096550|1188404|P2|Overall Study|Withdrawal by Subject|1
351782|NCT01096550|1188405|P1|Overall Study|Withdrawal by Subject|0
351783|NCT01096550|1188404|P2|Overall Study|clinic readmission|1
351784|NCT01096550|1188405|P1|Overall Study|clinic readmission|1
351785|NCT01096550|1188404|P2|Overall Study|non-regular treatment track at clinic|1
351786|NCT01096550|1188405|P1|Overall Study|non-regular treatment track at clinic|1
351787|NCT01096550|1188404|P2|Overall Study|discontinued site|11
351788|NCT01096550|1188405|P1|Overall Study|discontinued site|10
351789|NCT01096446|1188413|P2|Overall Study|Protocol Violation|0
351790|NCT01096446|1188414|P1|Overall Study|Protocol Violation|2
351791|NCT01096446|1188413|P2|Overall Study|Death|0
351792|NCT01096446|1188414|P1|Overall Study|Death|1
351793|NCT01096342|1188419|P1|Overall Study|Protocol Violation|1
351794|NCT01096316|1188427|P2|Overall Study|Lost to Follow-up|9
351795|NCT01096316|1188428|P1|Overall Study|Lost to Follow-up|15
351796|NCT01096186|1188438|P1|Overall Study|Noncompliance with study drug|1
351797|NCT01096186|1188438|P1|Overall Study|Physician Decision|1
351798|NCT01096186|1188438|P1|Overall Study|Withdrawal by Subject|22
351799|NCT01096186|1188438|P1|Overall Study|Lost to Follow-up|2
351800|NCT01096186|1188438|P1|Overall Study|Lack of Efficacy|4
351801|NCT01096186|1188438|P1|Overall Study|Death|4
351802|NCT01096186|1188438|P1|Overall Study|Adverse Event|16
351803|NCT01096056|1188446|P2|Overall Study|Lost to Follow-up|1
351804|NCT01096056|1188447|P1|Overall Study|Lost to Follow-up|0
351805|NCT01096017|1188479|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
351806|NCT01096017|1188480|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
351807|NCT01095978|1188508|P1|Overall Study|Adverse Event|1
351808|NCT01095978|1188508|P1|Overall Study|Did not take Klacid SR|2
351809|NCT01095835|1188542|P3|Overall Study|Protocol Violation|0
351810|NCT01095835|1188543|P2|Overall Study|Protocol Violation|2
351811|NCT01095835|1188544|P1|Overall Study|Protocol Violation|1
351812|NCT01095835|1188542|P3|Overall Study|Non study compliance|1
351813|NCT01095835|1188543|P2|Overall Study|Non study compliance|0
351814|NCT01095835|1188544|P1|Overall Study|Non study compliance|0
351815|NCT01095835|1188542|P3|Overall Study|Withdrawal by Subject|0
351816|NCT01095835|1188543|P2|Overall Study|Withdrawal by Subject|3
351817|NCT01095835|1188544|P1|Overall Study|Withdrawal by Subject|1
351818|NCT01095835|1188542|P3|Overall Study|Physician Decision|1
351819|NCT01095835|1188543|P2|Overall Study|Physician Decision|0
351820|NCT01095835|1188544|P1|Overall Study|Physician Decision|0
351821|NCT01095835|1188542|P3|Overall Study|Lack of Efficacy|0
351822|NCT01095835|1188543|P2|Overall Study|Lack of Efficacy|1
351823|NCT01095835|1188544|P1|Overall Study|Lack of Efficacy|0
351824|NCT01095835|1188542|P3|Overall Study|Adverse Event|6
351825|NCT01095835|1188543|P2|Overall Study|Adverse Event|6
351826|NCT01095835|1188544|P1|Overall Study|Adverse Event|8
351827|NCT01095796|1188582|P2|Overall Study|Participant Transferred to Another Study|200
351828|NCT01095796|1188583|P1|Overall Study|Participant Transferred to Another Study|215
351829|NCT01095796|1188582|P2|Overall Study|Protocol Violation|0
351830|NCT01095796|1188583|P1|Overall Study|Protocol Violation|1
351831|NCT01095796|1188582|P2|Overall Study|Participant Noncompliance|10
351832|NCT01095796|1188583|P1|Overall Study|Participant Noncompliance|5
351833|NCT01095796|1188582|P2|Overall Study|Lost to Follow-up|29
351834|NCT01095796|1188583|P1|Overall Study|Lost to Follow-up|27
351835|NCT01095796|1188582|P2|Overall Study|Withdrew Consent|22
351836|NCT01095796|1188583|P1|Overall Study|Withdrew Consent|16
351837|NCT01095796|1188582|P2|Overall Study|Investigator's Discretion|2
351838|NCT01095796|1188583|P1|Overall Study|Investigator's Discretion|7
351839|NCT01095796|1188582|P2|Overall Study|Lack of Efficacy|3
351840|NCT01095796|1188583|P1|Overall Study|Lack of Efficacy|5
351841|NCT01095796|1188582|P2|Overall Study|Pregnancy|0
351842|NCT01095796|1188583|P1|Overall Study|Pregnancy|2
351843|NCT01095796|1188582|P2|Overall Study|Death|2
351844|NCT01095796|1188583|P1|Overall Study|Death|3
351845|NCT01095796|1188582|P2|Overall Study|Adverse Event|19
351846|NCT01095796|1188583|P1|Overall Study|Adverse Event|9
351847|NCT01095796|1188582|P2|Overall Study|Randomized but Not Treated|2
351848|NCT01095796|1188583|P1|Overall Study|Randomized but Not Treated|5
351849|NCT01095666|1188613|P3|Overall Study|Non-compliance, not met criteria etc.|2
351850|NCT01095666|1188614|P2|Overall Study|Non-compliance, not met criteria etc.|2
351851|NCT01095666|1188615|P1|Overall Study|Non-compliance, not met criteria etc.|7
351852|NCT01095666|1188613|P3|Overall Study|Withdrawal by Subject|1
351853|NCT01095666|1188614|P2|Overall Study|Withdrawal by Subject|6
351854|NCT01095666|1188615|P1|Overall Study|Withdrawal by Subject|6
351855|NCT01095666|1188613|P3|Overall Study|Lost to Follow-up|0
351856|NCT01095666|1188614|P2|Overall Study|Lost to Follow-up|2
351857|NCT01095666|1188615|P1|Overall Study|Lost to Follow-up|2
351858|NCT01095666|1188613|P3|Overall Study|Adverse Event|3
351859|NCT01095666|1188614|P2|Overall Study|Adverse Event|1
351860|NCT01095666|1188615|P1|Overall Study|Adverse Event|2
351861|NCT01095666|1188613|P3|Overall Study|Lack of Efficacy|1
351862|NCT01095666|1188614|P2|Overall Study|Lack of Efficacy|0
351863|NCT01095666|1188615|P1|Overall Study|Lack of Efficacy|0
351864|NCT01095653|1188638|P3|Overall Study|non-compliance, not met criteria, etc.|5
351865|NCT01095653|1188639|P2|Overall Study|non-compliance, not met criteria, etc.|6
351866|NCT01095653|1188640|P1|Overall Study|non-compliance, not met criteria, etc.|10
351867|NCT01095653|1188638|P3|Overall Study|Withdrawal by Subject|3
351868|NCT01095653|1188639|P2|Overall Study|Withdrawal by Subject|5
351869|NCT01095653|1188640|P1|Overall Study|Withdrawal by Subject|4
351870|NCT01095653|1188638|P3|Overall Study|Lost to Follow-up|4
351871|NCT01095653|1188639|P2|Overall Study|Lost to Follow-up|0
351872|NCT01095653|1188640|P1|Overall Study|Lost to Follow-up|1
351873|NCT01095653|1188638|P3|Overall Study|Adverse Event|4
351874|NCT01095653|1188639|P2|Overall Study|Adverse Event|4
351875|NCT01095653|1188640|P1|Overall Study|Adverse Event|1
351876|NCT01095653|1188638|P3|Overall Study|Lack of Efficacy|0
351877|NCT01095653|1188639|P2|Overall Study|Lack of Efficacy|0
351878|NCT01095653|1188640|P1|Overall Study|Lack of Efficacy|3
351879|NCT01095250|1188698|P4|Overall Study|Withdrawal by Subject|0
351880|NCT01095250|1188699|P3|Overall Study|Withdrawal by Subject|1
351881|NCT01095250|1188700|P2|Overall Study|Withdrawal by Subject|0
351882|NCT01095250|1188701|P1|Overall Study|Withdrawal by Subject|0
351883|NCT01095250|1188698|P4|Overall Study|administrative reasons|5
351884|NCT01095250|1188699|P3|Overall Study|administrative reasons|7
351885|NCT01095250|1188700|P2|Overall Study|administrative reasons|10
351886|NCT01095250|1188701|P1|Overall Study|administrative reasons|8
351887|NCT01095094|1188731|P1|Overall Study|Physician Decision|1
351888|NCT01095094|1188731|P1|Overall Study|Death|1
351889|NCT01095094|1188731|P1|Overall Study|Withdrawal by Subject|1
351890|NCT01094886|1188736|P1|Overall Study|Withdrawal by Subject|5
351891|NCT01094886|1188736|P1|Overall Study|Adverse Event|2
351892|NCT01094808|1188746|P3|Overall Study|Withdrawal by Subject|0
351893|NCT01094808|1188747|P2|Overall Study|Withdrawal by Subject|1
351894|NCT01094808|1188748|P1|Overall Study|Withdrawal by Subject|1
351895|NCT01094743|1188783|P1|Period 1|Unsatisfactory comfort at lens fitting|2
351896|NCT01094730|1188800|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
351897|NCT01094730|1188801|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
351898|NCT01094730|1188800|P2|Period 2 (14 Days)|Adverse Event|1
351899|NCT01094730|1188801|P1|Period 2 (14 Days)|Adverse Event|0
351900|NCT01094730|1188800|P2|Period 2 (14 Days)|No time for the follow-up visit|0
351901|NCT01094730|1188801|P1|Period 2 (14 Days)|No time for the follow-up visit|1
351902|NCT01094730|1188800|P2|Period 2 (14 Days)|Protocol Violation|0
351903|NCT01094730|1188801|P1|Period 2 (14 Days)|Protocol Violation|2
351904|NCT01094730|1188800|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
351905|NCT01094730|1188801|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
351906|NCT01094730|1188800|P2|Period 1 (14 Days)|No time for the follow-up visit|0
351907|NCT01094730|1188801|P1|Period 1 (14 Days)|No time for the follow-up visit|1
351908|NCT01094730|1188800|P2|Period 1 (14 Days)|Withdrawal by Subject|1
351909|NCT01094730|1188801|P1|Period 1 (14 Days)|Withdrawal by Subject|0
351910|NCT01094730|1188800|P2|Period 1 (14 Days)|Lost to Follow-up|1
351911|NCT01094730|1188801|P1|Period 1 (14 Days)|Lost to Follow-up|0
351912|NCT01094184|1188920|P2|Overall Study|Death|11
351913|NCT01094184|1188921|P1|Overall Study|Death|35
351914|NCT01094171|1189155|P1|Overall Study|Other|1
351915|NCT01094171|1189155|P1|Overall Study|Migration from the study area|3
351916|NCT01094171|1189155|P1|Overall Study|Informed consent withdrawal|4
351917|NCT01094171|1189155|P1|Overall Study|Lost to Follow-up|2
351918|NCT01094119|1189164|P2|Overall Study|Lack of Efficacy|4
351919|NCT01094119|1189165|P1|Overall Study|Lack of Efficacy|2
351920|NCT01093846|1189180|P3|Overall Study|Administrative Problems|15
351921|NCT01093846|1189181|P2|Overall Study|Administrative Problems|17
351922|NCT01093846|1189182|P1|Overall Study|Administrative Problems|18
351923|NCT01093846|1189180|P3|Overall Study|Condition no longer required study drug|1
351924|NCT01093846|1189181|P2|Overall Study|Condition no longer required study drug|1
351925|NCT01093846|1189182|P1|Overall Study|Condition no longer required study drug|1
351926|NCT01093846|1189180|P3|Overall Study|Lack of Efficacy|4
351927|NCT01093846|1189181|P2|Overall Study|Lack of Efficacy|0
351928|NCT01093846|1189182|P1|Overall Study|Lack of Efficacy|0
351929|NCT01093846|1189180|P3|Overall Study|Adverse Event|1
351930|NCT01093846|1189181|P2|Overall Study|Adverse Event|0
351931|NCT01093846|1189182|P1|Overall Study|Adverse Event|0
351932|NCT01093755|1189207|P2|Overall Study|Withdrawal by Subject|4
351933|NCT01093755|1189208|P1|Overall Study|Withdrawal by Subject|3
351934|NCT01093625|1189248|P2|1-Year Visit|Lost to Follow-up|3
351935|NCT01093625|1189249|P1|1-Year Visit|Lost to Follow-up|5
351936|NCT01093625|1189248|P2|6-Month Visit|Lost to Follow-up|2
351937|NCT01093625|1189249|P1|6-Month Visit|Lost to Follow-up|2
351938|NCT01093625|1189248|P2|6-Month Visit|Withdrawal by Subject|7
351939|NCT01093625|1189249|P1|6-Month Visit|Withdrawal by Subject|6
351940|NCT01093625|1189248|P2|3-Month Visit|Lost to Follow-up|0
351941|NCT01093625|1189249|P1|3-Month Visit|Lost to Follow-up|2
351942|NCT01093625|1189248|P2|1-Month Visit|Lost to Follow-up|0
351943|NCT01093625|1189249|P1|1-Month Visit|Lost to Follow-up|2
351944|NCT01093625|1189248|P2|2-Week Visit|Withdrawal by Subject|0
351945|NCT01093625|1189249|P1|2-Week Visit|Withdrawal by Subject|1
351946|NCT01093625|1189248|P2|Baseline and Dispensed|Withdrawal by Subject|0
351947|NCT01093625|1189249|P1|Baseline and Dispensed|Withdrawal by Subject|2
351948|NCT01093599|1189269|P2|Overall Study|Lost to Follow-up|46
351949|NCT01093599|1189270|P1|Overall Study|Lost to Follow-up|32
351950|NCT01093534|1189279|P3|Overall Study|Other|4
351951|NCT01093534|1189280|P2|Overall Study|Other|3
351952|NCT01093534|1189281|P1|Overall Study|Other|1
351953|NCT01093534|1189279|P3|Overall Study|Withdrawal by Subject|2
351954|NCT01093534|1189280|P2|Overall Study|Withdrawal by Subject|7
351955|NCT01093534|1189281|P1|Overall Study|Withdrawal by Subject|5
351956|NCT01093534|1189279|P3|Overall Study|Lack of Efficacy|1
351957|NCT01093534|1189280|P2|Overall Study|Lack of Efficacy|1
351958|NCT01093534|1189281|P1|Overall Study|Lack of Efficacy|2
351959|NCT01093534|1189279|P3|Overall Study|Adverse Event|2
351960|NCT01093534|1189280|P2|Overall Study|Adverse Event|5
351961|NCT01093534|1189281|P1|Overall Study|Adverse Event|2
351962|NCT01093222|1189429|P1|Overall Study|Not protocol specified|1
351963|NCT01093222|1189429|P1|Overall Study|Death|2
351964|NCT01093222|1189429|P1|Overall Study|Progression/relapse|24
351965|NCT01093222|1189429|P1|Overall Study|Adverse Event|7
351966|NCT01093222|1189429|P1|Overall Study|Ineligible|6
351967|NCT01092832|1189502|P2|Overall Study|Not specified|0
351968|NCT01092832|1189503|P1|Overall Study|Not specified|1
351969|NCT01092780|1189515|P4|Washout Period 2|Adverse Event|0
351970|NCT01092780|1189516|P3|Washout Period 2|Adverse Event|1
351971|NCT01092780|1189517|P2|Washout Period 2|Adverse Event|1
351972|NCT01092780|1189518|P1|Washout Period 2|Adverse Event|0
351973|NCT01092780|1189515|P4|Washout Period 1|Noncompliance with nCPAP|0
351974|NCT01092780|1189516|P3|Washout Period 1|Noncompliance with nCPAP|0
351975|NCT01092780|1189517|P2|Washout Period 1|Noncompliance with nCPAP|0
351976|NCT01092780|1189518|P1|Washout Period 1|Noncompliance with nCPAP|1
351977|NCT01092780|1189515|P4|Washout Period 1|Adverse Event|0
351978|NCT01092780|1189516|P3|Washout Period 1|Adverse Event|0
351979|NCT01092780|1189517|P2|Washout Period 1|Adverse Event|1
351980|NCT01092780|1189518|P1|Washout Period 1|Adverse Event|0
351981|NCT01092728|1189554|P2|Overall Study|Prohibited Concomitant Medications|0
351982|NCT01092728|1189555|P1|Overall Study|Prohibited Concomitant Medications|1
351983|NCT01092728|1189554|P2|Overall Study|Disease Progression|13
351984|NCT01092728|1189555|P1|Overall Study|Disease Progression|1
351985|NCT01092728|1189554|P2|Overall Study|Adverse Event|1
351986|NCT01092728|1189555|P1|Overall Study|Adverse Event|0
351987|NCT01092728|1189554|P2|Overall Study|Withdrawal by Subject|0
351988|NCT01092728|1189555|P1|Overall Study|Withdrawal by Subject|2
351989|NCT01092702|1189563|P1|Overall Study|Lost to Follow-up|2
351990|NCT01092702|1189563|P1|Overall Study|Withdrawal by Subject|7
351991|NCT01092663|1189569|P2|Overall Study|Protocol Violation|1
351992|NCT01092663|1189570|P1|Overall Study|Protocol Violation|0
351993|NCT01092663|1189569|P2|Overall Study|Adverse Event|1
351994|NCT01092663|1189570|P1|Overall Study|Adverse Event|1
351995|NCT01092663|1189569|P2|Overall Study|High fasting triglyceride|0
351996|NCT01092663|1189570|P1|Overall Study|High fasting triglyceride|2
351997|NCT01092663|1189569|P2|Overall Study|Glucose >300mg/dL|0
351998|NCT01092663|1189570|P1|Overall Study|Glucose >300mg/dL|1
351999|NCT01092663|1189569|P2|Overall Study|Withdrawal by Subject|2
352000|NCT01092663|1189570|P1|Overall Study|Withdrawal by Subject|3
352001|NCT01092637|1189618|P2|Overall Study|Death|49
352002|NCT01092637|1189619|P1|Overall Study|Death|47
352003|NCT01092546|1189634|P1|Overall Study|Subjects withdrawn prior to dosing|4
352004|NCT01092507|1189641|P2|Overall Study|Withdrawal by Subject|0
352005|NCT01092507|1189642|P1|Overall Study|Withdrawal by Subject|2
352006|NCT01092416|1189677|P1|12-Month Follow-up|Data collected after close of 1Y window|2
352007|NCT01092416|1189677|P1|12-Month Follow-up|Missed 1-year follow-up|1
352008|NCT01092416|1189677|P1|12-Month Follow-up|Withdrawal by Subject|2
352009|NCT01092416|1189677|P1|12-Month Follow-up|Lost to Follow-up|4
352010|NCT01092416|1189677|P1|12-Month Follow-up|Death|16
352011|NCT01092416|1189677|P1|30-Day Follow-up|Data collected after close of 30D window|5
352012|NCT01092416|1189677|P1|30-Day Follow-up|Missed 30-day follow-up|3
352013|NCT01092416|1189677|P1|30-Day Follow-up|Death|2
352014|NCT01092416|1189677|P1|Enrollment|Atherectomy device not inserted|3
352015|NCT01091974|1189714|P4|Overall Study|side-effects|2
352016|NCT01091974|1189715|P3|Overall Study|side-effects|0
352017|NCT01091974|1189716|P2|Overall Study|side-effects|1
352018|NCT01091974|1189717|P1|Overall Study|side-effects|1
352019|NCT01091974|1189714|P4|Overall Study|Withdrawal by Subject|2
352020|NCT01091974|1189715|P3|Overall Study|Withdrawal by Subject|2
352021|NCT01091974|1189716|P2|Overall Study|Withdrawal by Subject|3
352022|NCT01091974|1189717|P1|Overall Study|Withdrawal by Subject|1
352023|NCT01091974|1189714|P4|Overall Study|resumed sleep medication|2
352024|NCT01091974|1189715|P3|Overall Study|resumed sleep medication|1
352025|NCT01091974|1189716|P2|Overall Study|resumed sleep medication|0
352026|NCT01091974|1189717|P1|Overall Study|resumed sleep medication|0
352027|NCT01091974|1189714|P4|Overall Study|Did not start intervention|1
352028|NCT01091974|1189715|P3|Overall Study|Did not start intervention|3
352029|NCT01091974|1189716|P2|Overall Study|Did not start intervention|1
352030|NCT01091974|1189717|P1|Overall Study|Did not start intervention|3
352031|NCT01091675|1189752|P1|Overall Study|Lack of Efficacy|27
352032|NCT01091675|1189752|P1|Overall Study|Adverse Event|7
352033|NCT01091662|1189758|P2|Overall Study|unable to swallow capsule|1
352034|NCT01091662|1189759|P1|Overall Study|unable to swallow capsule|0
352035|NCT01091662|1189758|P2|Overall Study|Protocol Violation|2
352036|NCT01091662|1189759|P1|Overall Study|Protocol Violation|0
352037|NCT01091662|1189758|P2|Overall Study|Pregnancy|1
352038|NCT01091662|1189759|P1|Overall Study|Pregnancy|0
352039|NCT01091662|1189758|P2|Overall Study|Lost to Follow-up|1
352040|NCT01091662|1189759|P1|Overall Study|Lost to Follow-up|0
352041|NCT01091662|1189758|P2|Overall Study|met exclusion criteria|0
352042|NCT01091662|1189759|P1|Overall Study|met exclusion criteria|1
352043|NCT01091662|1189758|P2|Overall Study|met exit criteria|13
352044|NCT01091662|1189759|P1|Overall Study|met exit criteria|7
352045|NCT01091662|1189758|P2|Overall Study|Withdrawal by Subject|6
352046|NCT01091662|1189759|P1|Overall Study|Withdrawal by Subject|7
352047|NCT01091662|1189758|P2|Overall Study|Physician Decision|1
352048|NCT01091662|1189759|P1|Overall Study|Physician Decision|1
352049|NCT01091662|1189758|P2|Overall Study|Adverse Event|9
352050|NCT01091662|1189759|P1|Overall Study|Adverse Event|1
352051|NCT01091519|1189797|P2|Overall Study|Randomized not treated|4
352052|NCT01091519|1189798|P1|Overall Study|Randomized not treated|4
352053|NCT01091519|1189797|P2|Overall Study|Other|8
352054|NCT01091519|1189798|P1|Overall Study|Other|6
352055|NCT01091519|1189797|P2|Overall Study|Withdrawal by Subject|2
352056|NCT01091519|1189798|P1|Overall Study|Withdrawal by Subject|2
352057|NCT01091519|1189797|P2|Overall Study|Lost to Follow-up|24
352058|NCT01091519|1189798|P1|Overall Study|Lost to Follow-up|14
352059|NCT01091519|1189797|P2|Overall Study|Lack of Efficacy|19
352060|NCT01091519|1189798|P1|Overall Study|Lack of Efficacy|16
352061|NCT01091519|1189797|P2|Overall Study|Death|0
352062|NCT01091519|1189798|P1|Overall Study|Death|1
352063|NCT01091519|1189797|P2|Overall Study|Adverse Event|16
352064|NCT01091519|1189798|P1|Overall Study|Adverse Event|12
352065|NCT01091454|1189810|P1|Overall Study|Ineligible|1
352066|NCT01091428|1189823|P4|Phase 2|Physician Decision|0
352067|NCT01091428|1189824|P3|Phase 2|Physician Decision|2
352068|NCT01091428|1189825|P2|Phase 2|Physician Decision|0
352069|NCT01091428|1189826|P1|Phase 2|Physician Decision|0
352070|NCT01091428|1189823|P4|Phase 2|Reason not specified|3
352071|NCT01091428|1189824|P3|Phase 2|Reason not specified|4
352072|NCT01091428|1189825|P2|Phase 2|Reason not specified|0
352073|NCT01091428|1189826|P1|Phase 2|Reason not specified|0
352074|NCT01091428|1189823|P4|Phase 2|Unsatisfactory Therapeutic Response|1
352075|NCT01091428|1189824|P3|Phase 2|Unsatisfactory Therapeutic Response|1
352076|NCT01091428|1189825|P2|Phase 2|Unsatisfactory Therapeutic Response|0
352077|NCT01091428|1189826|P1|Phase 2|Unsatisfactory Therapeutic Response|0
352078|NCT01091428|1189823|P4|Phase 2|Withdrawal by Subject|8
352079|NCT01091428|1189824|P3|Phase 2|Withdrawal by Subject|9
352080|NCT01091428|1189825|P2|Phase 2|Withdrawal by Subject|0
352081|NCT01091428|1189826|P1|Phase 2|Withdrawal by Subject|0
352082|NCT01091428|1189823|P4|Phase 2|Adverse Event|5
352083|NCT01091428|1189824|P3|Phase 2|Adverse Event|12
352084|NCT01091428|1189825|P2|Phase 2|Adverse Event|0
352085|NCT01091428|1189826|P1|Phase 2|Adverse Event|0
352086|NCT01091428|1189823|P4|Phase 2|Symptomatic Deterioration|6
352087|NCT01091428|1189824|P3|Phase 2|Symptomatic Deterioration|1
352088|NCT01091428|1189825|P2|Phase 2|Symptomatic Deterioration|0
352089|NCT01091428|1189826|P1|Phase 2|Symptomatic Deterioration|0
352090|NCT01091428|1189823|P4|Phase 2|Progressive Disease|46
352091|NCT01091428|1189824|P3|Phase 2|Progressive Disease|44
352092|NCT01091428|1189825|P2|Phase 2|Progressive Disease|0
352093|NCT01091428|1189826|P1|Phase 2|Progressive Disease|0
352094|NCT01091428|1189823|P4|Phase 1|Single-Patient IND|0
352095|NCT01091428|1189824|P3|Phase 1|Single-Patient IND|0
352096|NCT01091428|1189825|P2|Phase 1|Single-Patient IND|0
352097|NCT01091428|1189826|P1|Phase 1|Single-Patient IND|2
352098|NCT01091428|1189823|P4|Phase 1|Reason not specified|0
352099|NCT01091428|1189824|P3|Phase 1|Reason not specified|0
352100|NCT01091428|1189825|P2|Phase 1|Reason not specified|1
352101|NCT01091428|1189826|P1|Phase 1|Reason not specified|0
352102|NCT01091428|1189823|P4|Phase 1|Withdrawal by Subject|0
352103|NCT01091428|1189824|P3|Phase 1|Withdrawal by Subject|0
352104|NCT01091428|1189825|P2|Phase 1|Withdrawal by Subject|0
352105|NCT01091428|1189826|P1|Phase 1|Withdrawal by Subject|7
352106|NCT01091428|1189823|P4|Phase 1|Adverse Event|0
352107|NCT01091428|1189824|P3|Phase 1|Adverse Event|0
352108|NCT01091428|1189825|P2|Phase 1|Adverse Event|0
352109|NCT01091428|1189826|P1|Phase 1|Adverse Event|2
352110|NCT01091428|1189823|P4|Phase 1|Symptomatic Deterioration|0
352111|NCT01091428|1189824|P3|Phase 1|Symptomatic Deterioration|0
352112|NCT01091428|1189825|P2|Phase 1|Symptomatic Deterioration|2
352113|NCT01091428|1189826|P1|Phase 1|Symptomatic Deterioration|3
352114|NCT01091428|1189823|P4|Phase 1|Progressive Disease|0
352115|NCT01091428|1189824|P3|Phase 1|Progressive Disease|0
352116|NCT01091428|1189825|P2|Phase 1|Progressive Disease|8
352117|NCT01091428|1189826|P1|Phase 1|Progressive Disease|24
352118|NCT01091259|1189927|P1|Overall Study|Lack of Efficacy|2
352119|NCT01091259|1189927|P1|Overall Study|Adverse Event|3
352120|NCT01091246|1189938|P3|Overall Study|Subject not dosed|1
352121|NCT01091246|1189939|P2|Overall Study|Subject not dosed|0
352122|NCT01091246|1189940|P1|Overall Study|Subject not dosed|2
352123|NCT01091246|1189938|P3|Overall Study|Withdrawal by Subject|4
352124|NCT01091246|1189939|P2|Overall Study|Withdrawal by Subject|5
352125|NCT01091246|1189940|P1|Overall Study|Withdrawal by Subject|9
352126|NCT01091246|1189938|P3|Overall Study|Adverse Event|1
352127|NCT01091246|1189939|P2|Overall Study|Adverse Event|0
352128|NCT01091246|1189940|P1|Overall Study|Adverse Event|1
352129|NCT01091246|1189938|P3|Overall Study|Lost to Follow-up|7
352130|NCT01091246|1189939|P2|Overall Study|Lost to Follow-up|11
352131|NCT01091246|1189940|P1|Overall Study|Lost to Follow-up|23
352132|NCT01091103|1190079|P1|Overall Study|Progressive Disease|3
352133|NCT01091103|1190079|P1|Overall Study|Adverse Event|1
352134|NCT01090973|1190099|P1|Overall Study|Disease progression|1
352135|NCT01090765|1190115|P6|Overall Study|Vasovagal reaction with first infusion|0
352136|NCT01090765|1190116|P5|Overall Study|Vasovagal reaction with first infusion|1
352137|NCT01090765|1190117|P4|Overall Study|Vasovagal reaction with first infusion|0
352138|NCT01090765|1190118|P3|Overall Study|Vasovagal reaction with first infusion|0
352139|NCT01090765|1190119|P2|Overall Study|Vasovagal reaction with first infusion|0
352140|NCT01090765|1190120|P1|Overall Study|Vasovagal reaction with first infusion|0
352141|NCT01090765|1190115|P6|Overall Study|Developed a DVT, needed anticoagulation|0
352142|NCT01090765|1190116|P5|Overall Study|Developed a DVT, needed anticoagulation|0
352143|NCT01090765|1190117|P4|Overall Study|Developed a DVT, needed anticoagulation|1
352144|NCT01090765|1190118|P3|Overall Study|Developed a DVT, needed anticoagulation|0
352145|NCT01090765|1190119|P2|Overall Study|Developed a DVT, needed anticoagulation|0
352146|NCT01090765|1190120|P1|Overall Study|Developed a DVT, needed anticoagulation|0
352147|NCT01090765|1190115|P6|Overall Study|Patient withdrew consent|1
352148|NCT01090765|1190116|P5|Overall Study|Patient withdrew consent|1
352149|NCT01090765|1190117|P4|Overall Study|Patient withdrew consent|0
352150|NCT01090765|1190118|P3|Overall Study|Patient withdrew consent|0
352151|NCT01090765|1190119|P2|Overall Study|Patient withdrew consent|0
352152|NCT01090765|1190120|P1|Overall Study|Patient withdrew consent|0
352153|NCT01090739|1190166|P1|36 Month Follow-up|Visit still pending|17
352154|NCT01090739|1190166|P1|36 Month Follow-up|Withdrawal by Subject|6
352155|NCT01090739|1190166|P1|24 Month Follow-up|Death|1
352156|NCT01090739|1190166|P1|24 Month Follow-up|Lost to Follow-up|1
352157|NCT01090739|1190166|P1|24 Month Follow-up|Withdrawal by Subject|7
352158|NCT01090739|1190166|P1|12 Month Follow-up|Death|1
352159|NCT01090739|1190166|P1|12 Month Follow-up|Physician Decision|1
352160|NCT01090739|1190166|P1|12 Month Follow-up|Lost to Follow-up|1
352161|NCT01090739|1190166|P1|12 Month Follow-up|Withdrawal by Subject|2
352162|NCT01090739|1190166|P1|Enrollment|Adverse Event|1
352163|NCT01090739|1190166|P1|Enrollment|Study implant limit reached|2
352164|NCT01090739|1190166|P1|Enrollment|Sponsor termination of site|4
352165|NCT01090739|1190166|P1|Enrollment|Physician Decision|5
352166|NCT01090739|1190166|P1|Enrollment|Lost to Follow-up|5
352167|NCT01090739|1190166|P1|Enrollment|Protocol Violation|14
352168|NCT01090739|1190166|P1|Enrollment|Withdrawal by Subject|24
352169|NCT01090492|1190191|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
352170|NCT01090492|1190192|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
352171|NCT01090492|1190193|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
352172|NCT01090492|1190194|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
352173|NCT01090492|1190195|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
352174|NCT01090492|1190196|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
352175|NCT01090492|1190197|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
352176|NCT01090492|1190198|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
352177|NCT01090492|1190191|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
352178|NCT01090492|1190192|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
352179|NCT01090492|1190193|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
352180|NCT01090492|1190194|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
352181|NCT01090492|1190195|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
352182|NCT01090492|1190196|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
352183|NCT01090492|1190197|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
352184|NCT01090492|1190198|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
352185|NCT01090492|1190191|P8|Second Intervention Period (4 Weeks)|Other|0
352186|NCT01090492|1190192|P7|Second Intervention Period (4 Weeks)|Other|0
352187|NCT01090492|1190193|P6|Second Intervention Period (4 Weeks)|Other|0
352188|NCT01090492|1190194|P5|Second Intervention Period (4 Weeks)|Other|0
352189|NCT01090492|1190195|P4|Second Intervention Period (4 Weeks)|Other|0
352190|NCT01090492|1190196|P3|Second Intervention Period (4 Weeks)|Other|1
352191|NCT01090492|1190197|P2|Second Intervention Period (4 Weeks)|Other|1
352192|NCT01090492|1190198|P1|Second Intervention Period (4 Weeks)|Other|0
352193|NCT01090492|1190191|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
352194|NCT01090492|1190192|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
352195|NCT01090492|1190193|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
352196|NCT01090492|1190194|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
352197|NCT01090492|1190195|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
352198|NCT01090492|1190196|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
352199|NCT01090492|1190197|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
352200|NCT01090492|1190198|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
352201|NCT01090492|1190191|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
352202|NCT01090492|1190192|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
352203|NCT01090492|1190193|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
352204|NCT01090492|1190194|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
352205|NCT01090492|1190195|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
352206|NCT01090492|1190196|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
352207|NCT01090492|1190197|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
352285|NCT01090427|1190316|P5|After Controlled Period|Death|0
352208|NCT01090492|1190198|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
352209|NCT01090492|1190191|P8|First Intervention Period (4 Weeks)|Adverse Event|5
352210|NCT01090492|1190192|P7|First Intervention Period (4 Weeks)|Adverse Event|0
352211|NCT01090492|1190193|P6|First Intervention Period (4 Weeks)|Adverse Event|2
352212|NCT01090492|1190194|P5|First Intervention Period (4 Weeks)|Adverse Event|1
352213|NCT01090492|1190195|P4|First Intervention Period (4 Weeks)|Adverse Event|3
352214|NCT01090492|1190196|P3|First Intervention Period (4 Weeks)|Adverse Event|0
352215|NCT01090492|1190197|P2|First Intervention Period (4 Weeks)|Adverse Event|2
352216|NCT01090492|1190198|P1|First Intervention Period (4 Weeks)|Adverse Event|0
352217|NCT01090492|1190191|P8|First Intervention Period (4 Weeks)|Pregnancy|0
352218|NCT01090492|1190192|P7|First Intervention Period (4 Weeks)|Pregnancy|0
352219|NCT01090492|1190193|P6|First Intervention Period (4 Weeks)|Pregnancy|0
352220|NCT01090492|1190194|P5|First Intervention Period (4 Weeks)|Pregnancy|1
352221|NCT01090492|1190195|P4|First Intervention Period (4 Weeks)|Pregnancy|0
352222|NCT01090492|1190196|P3|First Intervention Period (4 Weeks)|Pregnancy|0
352223|NCT01090492|1190197|P2|First Intervention Period (4 Weeks)|Pregnancy|0
352224|NCT01090492|1190198|P1|First Intervention Period (4 Weeks)|Pregnancy|0
352225|NCT01090492|1190191|P8|First Intervention Period (4 Weeks)|Other|0
352226|NCT01090492|1190192|P7|First Intervention Period (4 Weeks)|Other|0
352227|NCT01090492|1190193|P6|First Intervention Period (4 Weeks)|Other|0
352228|NCT01090492|1190194|P5|First Intervention Period (4 Weeks)|Other|2
352229|NCT01090492|1190195|P4|First Intervention Period (4 Weeks)|Other|1
352230|NCT01090492|1190196|P3|First Intervention Period (4 Weeks)|Other|1
352231|NCT01090492|1190197|P2|First Intervention Period (4 Weeks)|Other|0
352232|NCT01090492|1190198|P1|First Intervention Period (4 Weeks)|Other|0
352233|NCT01090492|1190191|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
352234|NCT01090492|1190192|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
352235|NCT01090492|1190193|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
352236|NCT01090492|1190194|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
352237|NCT01090492|1190195|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
352238|NCT01090492|1190196|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
352239|NCT01090492|1190197|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
352240|NCT01090492|1190198|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
352241|NCT01090492|1190191|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
352242|NCT01090492|1190192|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
352243|NCT01090492|1190193|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
352244|NCT01090492|1190194|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
352245|NCT01090492|1190195|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
352246|NCT01090492|1190196|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
352247|NCT01090492|1190197|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
352248|NCT01090492|1190198|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
352249|NCT01090492|1190191|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
352250|NCT01090492|1190192|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
352251|NCT01090492|1190193|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
352252|NCT01090492|1190194|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
352253|NCT01090492|1190195|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
352254|NCT01090492|1190196|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
352255|NCT01090492|1190197|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
352256|NCT01090492|1190198|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
352257|NCT01090453|1190266|P2|Overall Study|Eligibility Criteria|1
352258|NCT01090453|1190267|P1|Overall Study|Eligibility Criteria|0
352259|NCT01090453|1190266|P2|Overall Study|Other|4
352260|NCT01090453|1190267|P1|Overall Study|Other|2
352261|NCT01090453|1190266|P2|Overall Study|Protocol Violation|0
352262|NCT01090453|1190267|P1|Overall Study|Protocol Violation|2
352263|NCT01090453|1190266|P2|Overall Study|Non serious AEs|0
352264|NCT01090453|1190267|P1|Overall Study|Non serious AEs|1
352265|NCT01090453|1190266|P2|Overall Study|Lost to Follow-up|7
352266|NCT01090453|1190267|P1|Overall Study|Lost to Follow-up|7
352267|NCT01090453|1190266|P2|Overall Study|Withdrawal by Subject|2
352268|NCT01090453|1190267|P1|Overall Study|Withdrawal by Subject|1
352269|NCT01090427|1190314|P7|After Controlled Period|Adverse Event|0
352270|NCT01090427|1190315|P6|After Controlled Period|Adverse Event|1
352271|NCT01090427|1190316|P5|After Controlled Period|Adverse Event|0
352272|NCT01090427|1190317|P4|After Controlled Period|Adverse Event|2
352273|NCT01090427|1190318|P3|After Controlled Period|Adverse Event|0
352274|NCT01090427|1190319|P2|After Controlled Period|Adverse Event|0
352275|NCT01090427|1190320|P1|After Controlled Period|Adverse Event|0
352276|NCT01090427|1190314|P7|After Controlled Period|Lack of Efficacy|2
352277|NCT01090427|1190315|P6|After Controlled Period|Lack of Efficacy|3
352278|NCT01090427|1190316|P5|After Controlled Period|Lack of Efficacy|0
352279|NCT01090427|1190317|P4|After Controlled Period|Lack of Efficacy|0
352280|NCT01090427|1190318|P3|After Controlled Period|Lack of Efficacy|0
352281|NCT01090427|1190319|P2|After Controlled Period|Lack of Efficacy|0
352282|NCT01090427|1190320|P1|After Controlled Period|Lack of Efficacy|0
352283|NCT01090427|1190314|P7|After Controlled Period|Death|0
352284|NCT01090427|1190315|P6|After Controlled Period|Death|1
352286|NCT01090427|1190317|P4|After Controlled Period|Death|0
352287|NCT01090427|1190318|P3|After Controlled Period|Death|0
352288|NCT01090427|1190319|P2|After Controlled Period|Death|0
352289|NCT01090427|1190320|P1|After Controlled Period|Death|0
352290|NCT01090323|1190355|P2|Overall Study|Stopped end of extension 1#|1
352291|NCT01090323|1190356|P1|Overall Study|Stopped end of extension 1#|3
352292|NCT01090323|1190355|P2|Overall Study|Stopped end of core|0
352293|NCT01090323|1190356|P1|Overall Study|Stopped end of core|7
352294|NCT01090323|1190355|P2|Overall Study|Death|2
352295|NCT01090323|1190356|P1|Overall Study|Death|1
352296|NCT01090323|1190355|P2|Overall Study|Administrative problems|4
352297|NCT01090323|1190356|P1|Overall Study|Administrative problems|6
352298|NCT01090323|1190355|P2|Overall Study|Lost to Follow-up|6
352299|NCT01090323|1190356|P1|Overall Study|Lost to Follow-up|11
352300|NCT01090323|1190355|P2|Overall Study|Withdrew consent|11
352301|NCT01090323|1190356|P1|Overall Study|Withdrew consent|33
352302|NCT01090323|1190355|P2|Overall Study|Protocol Violation|1
352303|NCT01090323|1190356|P1|Overall Study|Protocol Violation|2
352304|NCT01090323|1190355|P2|Overall Study|Condition no longer requires drug|4
352305|NCT01090323|1190356|P1|Overall Study|Condition no longer requires drug|5
352306|NCT01090323|1190355|P2|Overall Study|Unsatisfactory therapeutic effect|2
352307|NCT01090323|1190356|P1|Overall Study|Unsatisfactory therapeutic effect|4
352308|NCT01090323|1190355|P2|Overall Study|Abnormal Test Procedure Results|0
352309|NCT01090323|1190356|P1|Overall Study|Abnormal Test Procedure Results|2
352310|NCT01090323|1190355|P2|Overall Study|Abnormal Lab Values|1
352311|NCT01090323|1190356|P1|Overall Study|Abnormal Lab Values|3
352312|NCT01090323|1190355|P2|Overall Study|Adverse Event|2
352313|NCT01090323|1190356|P1|Overall Study|Adverse Event|12
352314|NCT01090310|1190368|P4|Extension Study|Subject withdrew consent|0
352315|NCT01090310|1190369|P3|Extension Study|Subject withdrew consent|0
352316|NCT01090310|1190370|P2|Extension Study|Subject withdrew consent|1
352317|NCT01090310|1190371|P1|Extension Study|Subject withdrew consent|0
352318|NCT01090310|1190368|P4|Extension Study|Unsatisfactory therapeutic effect|1
352319|NCT01090310|1190369|P3|Extension Study|Unsatisfactory therapeutic effect|1
352320|NCT01090310|1190370|P2|Extension Study|Unsatisfactory therapeutic effect|0
352321|NCT01090310|1190371|P1|Extension Study|Unsatisfactory therapeutic effect|1
352322|NCT01090310|1190368|P4|Extension Study|Adverse Event|1
352323|NCT01090310|1190369|P3|Extension Study|Adverse Event|0
352324|NCT01090310|1190370|P2|Extension Study|Adverse Event|0
352325|NCT01090310|1190371|P1|Extension Study|Adverse Event|0
352326|NCT01090310|1190368|P4|Extension Study|Aministrative problems|18
352327|NCT01090310|1190369|P3|Extension Study|Aministrative problems|14
352328|NCT01090310|1190370|P2|Extension Study|Aministrative problems|15
352329|NCT01090310|1190371|P1|Extension Study|Aministrative problems|13
352330|NCT01090310|1190368|P4|Core Study|Protocol deviation|1
352331|NCT01090310|1190369|P3|Core Study|Protocol deviation|0
352332|NCT01090310|1190370|P2|Core Study|Protocol deviation|0
352333|NCT01090310|1190371|P1|Core Study|Protocol deviation|1
352334|NCT01090310|1190368|P4|Core Study|Administrative reasons|4
352335|NCT01090310|1190369|P3|Core Study|Administrative reasons|4
352336|NCT01090310|1190370|P2|Core Study|Administrative reasons|6
352337|NCT01090310|1190371|P1|Core Study|Administrative reasons|5
352338|NCT01090310|1190368|P4|Core Study|Abnormal test procedure result|0
352339|NCT01090310|1190369|P3|Core Study|Abnormal test procedure result|1
352340|NCT01090310|1190370|P2|Core Study|Abnormal test procedure result|0
352341|NCT01090310|1190371|P1|Core Study|Abnormal test procedure result|0
352342|NCT01090310|1190368|P4|Core Study|Subject withdrew consent|1
352343|NCT01090310|1190369|P3|Core Study|Subject withdrew consent|1
352344|NCT01090310|1190370|P2|Core Study|Subject withdrew consent|3
352345|NCT01090310|1190371|P1|Core Study|Subject withdrew consent|0
352346|NCT01090310|1190368|P4|Core Study|Adverse Event|1
352347|NCT01090310|1190369|P3|Core Study|Adverse Event|1
352348|NCT01090310|1190370|P2|Core Study|Adverse Event|2
352349|NCT01090310|1190371|P1|Core Study|Adverse Event|2
352350|NCT01090102|1190410|P2|Second 12 Weeks|Withdrawal by Subject|1
352351|NCT01090102|1190411|P1|Second 12 Weeks|Withdrawal by Subject|0
352352|NCT01090102|1190410|P2|First 12 Weeks|Death|1
352353|NCT01090102|1190411|P1|First 12 Weeks|Death|1
352354|NCT01090102|1190410|P2|First 12 Weeks|Adverse Event|0
352355|NCT01090102|1190411|P1|First 12 Weeks|Adverse Event|2
352356|NCT01090102|1190410|P2|First 12 Weeks|Withdrawal by Subject|1
352357|NCT01090102|1190411|P1|First 12 Weeks|Withdrawal by Subject|1
352358|NCT01090076|1190421|P2|Overall Study|Withdrawal by Subject|1
352359|NCT01090076|1190422|P1|Overall Study|Withdrawal by Subject|0
352360|NCT01090076|1190421|P2|Overall Study|Death|1
352361|NCT01090076|1190422|P1|Overall Study|Death|1
352362|NCT01090063|1190432|P1|Treatment|Withdrawal by Subject|4
352363|NCT01090063|1190432|P1|Screen|Screen Failed|4
352364|NCT01090050|1190448|P2|Overall Study|Physician Decision|1
352365|NCT01090050|1190449|P1|Overall Study|Physician Decision|0
352366|NCT01090050|1190448|P2|Overall Study|Lack of Efficacy|5
352367|NCT01090050|1190449|P1|Overall Study|Lack of Efficacy|1
352368|NCT01090050|1190448|P2|Overall Study|Lost to Follow-up|1
352369|NCT01090050|1190449|P1|Overall Study|Lost to Follow-up|0
352370|NCT01090011|1190469|P1|Overall Study|Other reason not defined above|5
352371|NCT01090011|1190469|P1|Overall Study|Refusal to start/continue medication|5
352372|NCT01090011|1190469|P1|Overall Study|Protocol Violation|1
352373|NCT01090011|1190469|P1|Overall Study|Adverse Event|32
352374|NCT01090011|1190469|P1|Overall Study|Progressive disease|128
352375|NCT01089608|1190562|P2|Overall Study|Lost to Follow-up|2
352376|NCT01089608|1190563|P1|Overall Study|Lost to Follow-up|0
352377|NCT01089608|1190562|P2|Overall Study|Adverse Event|4
352378|NCT01089608|1190563|P1|Overall Study|Adverse Event|0
352379|NCT01089582|1190580|P1|Overall Study|Withdrawal by Subject|1
352380|NCT01089582|1190580|P1|Overall Study|Other|4
352381|NCT01089582|1190580|P1|Overall Study|Lost to Follow-up|8
352382|NCT01089582|1190580|P1|Overall Study|Adverse Event|15
352383|NCT01089582|1190580|P1|Overall Study|Death|2
352384|NCT01089556|1190623|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
352385|NCT01089556|1190624|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
352386|NCT01089556|1190625|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
352387|NCT01089556|1190626|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
352388|NCT01089556|1190627|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
352389|NCT01089556|1190628|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
352390|NCT01089556|1190623|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
352391|NCT01089556|1190624|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
352392|NCT01089556|1190625|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
352393|NCT01089556|1190626|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
352394|NCT01089556|1190627|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
352395|NCT01089556|1190628|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
352396|NCT01089556|1190623|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
352397|NCT01089556|1190624|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
352398|NCT01089556|1190625|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
352399|NCT01089556|1190626|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
352400|NCT01089556|1190627|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
352401|NCT01089556|1190628|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
352402|NCT01089556|1190623|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
352403|NCT01089556|1190624|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
352404|NCT01089556|1190625|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
352405|NCT01089556|1190626|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
352406|NCT01089556|1190627|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
352407|NCT01089556|1190628|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
352408|NCT01089556|1190623|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
352409|NCT01089556|1190624|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
352410|NCT01089556|1190625|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
352411|NCT01089556|1190626|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
352412|NCT01089556|1190627|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
352413|NCT01089556|1190628|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
352414|NCT01089556|1190623|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
352415|NCT01089556|1190624|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
352416|NCT01089556|1190625|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
352417|NCT01089556|1190626|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
352418|NCT01089556|1190627|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
352419|NCT01089556|1190628|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
352420|NCT01089556|1190623|P6|Study Period III (Weeks 9-16)|Adverse Event|3
352421|NCT01089556|1190624|P5|Study Period III (Weeks 9-16)|Adverse Event|4
352422|NCT01089556|1190625|P4|Study Period III (Weeks 9-16)|Adverse Event|2
352423|NCT01089556|1190626|P3|Study Period III (Weeks 9-16)|Adverse Event|4
352424|NCT01089556|1190627|P2|Study Period III (Weeks 9-16)|Adverse Event|0
352425|NCT01089556|1190628|P1|Study Period III (Weeks 9-16)|Adverse Event|0
352426|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
352427|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
352428|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
352429|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
352430|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
352431|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
352432|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
352433|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
352434|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
352435|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
352436|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
352437|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
352438|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
352439|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
352440|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
352441|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
352442|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
352443|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
352444|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Physician Decision|0
352445|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Physician Decision|0
352446|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Physician Decision|0
352447|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Physician Decision|0
352448|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Physician Decision|0
352449|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Physician Decision|4
352450|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
352451|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
352452|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
352453|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
352454|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
352455|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
352456|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
352457|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
352458|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
352459|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
352460|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
352461|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
352462|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
352463|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
352464|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
352465|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
352466|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
352467|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
352468|NCT01089556|1190623|P6|Study Period II (Weeks 1-8)|Adverse Event|0
352469|NCT01089556|1190624|P5|Study Period II (Weeks 1-8)|Adverse Event|0
352470|NCT01089556|1190625|P4|Study Period II (Weeks 1-8)|Adverse Event|0
352471|NCT01089556|1190626|P3|Study Period II (Weeks 1-8)|Adverse Event|0
352472|NCT01089556|1190627|P2|Study Period II (Weeks 1-8)|Adverse Event|39
352473|NCT01089556|1190628|P1|Study Period II (Weeks 1-8)|Adverse Event|35
352474|NCT01089543|1190702|P4|Overall Study|Adverse Event|0
352475|NCT01089543|1190703|P3|Overall Study|Adverse Event|0
352476|NCT01089543|1190704|P2|Overall Study|Adverse Event|1
352477|NCT01089543|1190705|P1|Overall Study|Adverse Event|0
352478|NCT01089543|1190702|P4|Overall Study|Physician Decision|1
352479|NCT01089543|1190703|P3|Overall Study|Physician Decision|0
352480|NCT01089543|1190704|P2|Overall Study|Physician Decision|0
352481|NCT01089543|1190705|P1|Overall Study|Physician Decision|1
352482|NCT01089543|1190702|P4|Overall Study|Withdrawal by Subject|1
352483|NCT01089543|1190703|P3|Overall Study|Withdrawal by Subject|3
352484|NCT01089543|1190704|P2|Overall Study|Withdrawal by Subject|3
352485|NCT01089543|1190705|P1|Overall Study|Withdrawal by Subject|2
352486|NCT01089504|1190740|P2|Overall Study|Withdrawal by Subject|0
352487|NCT01089504|1190741|P1|Overall Study|Withdrawal by Subject|2
352488|NCT01089504|1190740|P2|Overall Study|Lost to Follow-up|1
352489|NCT01089504|1190741|P1|Overall Study|Lost to Follow-up|1
352490|NCT01089413|1190754|P1|Overall Study|Other|71
352491|NCT01089413|1190754|P1|Overall Study|Metastasectomy|13
352492|NCT01089413|1190754|P1|Overall Study|Death|10
352493|NCT01089413|1190754|P1|Overall Study|Unacceptable Toxicity|12
352494|NCT01089413|1190754|P1|Overall Study|Participant Withdrew Consent|1
352495|NCT01089413|1190754|P1|Overall Study|Progressive Disease|93
352496|NCT01089413|1190754|P1|Overall Study|Lost to Follow-up|1
352497|NCT01089361|1190773|P2|Overall Study|Death|0
352498|NCT01089361|1190774|P1|Overall Study|Death|1
352499|NCT01089127|1190823|P6|Overall Study|Protocol deviation|0
352500|NCT01089127|1190824|P5|Overall Study|Protocol deviation|1
352501|NCT01089127|1190825|P4|Overall Study|Protocol deviation|0
352502|NCT01089127|1190826|P3|Overall Study|Protocol deviation|0
352503|NCT01089127|1190827|P2|Overall Study|Protocol deviation|1
352504|NCT01089127|1190828|P1|Overall Study|Protocol deviation|0
352505|NCT01089127|1190823|P6|Overall Study|Lost to Follow-up|0
352506|NCT01089127|1190824|P5|Overall Study|Lost to Follow-up|1
352507|NCT01089127|1190825|P4|Overall Study|Lost to Follow-up|0
352508|NCT01089127|1190826|P3|Overall Study|Lost to Follow-up|0
352509|NCT01089127|1190827|P2|Overall Study|Lost to Follow-up|1
352510|NCT01089127|1190828|P1|Overall Study|Lost to Follow-up|1
352511|NCT01089127|1190823|P6|Overall Study|Abnormal test procedure result(s)|0
352512|NCT01089127|1190824|P5|Overall Study|Abnormal test procedure result(s)|0
352513|NCT01089127|1190825|P4|Overall Study|Abnormal test procedure result(s)|0
352514|NCT01089127|1190826|P3|Overall Study|Abnormal test procedure result(s)|0
352515|NCT01089127|1190827|P2|Overall Study|Abnormal test procedure result(s)|1
352516|NCT01089127|1190828|P1|Overall Study|Abnormal test procedure result(s)|2
352517|NCT01089127|1190823|P6|Overall Study|Subject withdrew consent|2
352518|NCT01089127|1190824|P5|Overall Study|Subject withdrew consent|0
352519|NCT01089127|1190825|P4|Overall Study|Subject withdrew consent|1
352520|NCT01089127|1190826|P3|Overall Study|Subject withdrew consent|1
352521|NCT01089127|1190827|P2|Overall Study|Subject withdrew consent|1
352522|NCT01089127|1190828|P1|Overall Study|Subject withdrew consent|0
352523|NCT01089127|1190823|P6|Overall Study|Adverse Event|1
352524|NCT01089127|1190824|P5|Overall Study|Adverse Event|0
352525|NCT01089127|1190825|P4|Overall Study|Adverse Event|0
352526|NCT01089127|1190826|P3|Overall Study|Adverse Event|1
352527|NCT01089127|1190827|P2|Overall Study|Adverse Event|1
352528|NCT01089127|1190828|P1|Overall Study|Adverse Event|5
352529|NCT01089023|1190882|P1|Overall Study|Lack of Efficacy|1
352530|NCT01089023|1190882|P1|Overall Study|Protocol Violation|1
352531|NCT01089023|1190882|P1|Overall Study|Withdrawal by Subject|1
352532|NCT01089023|1190882|P1|Overall Study|Adverse Event|1
352533|NCT01089023|1190882|P1|Overall Study|Lost to Follow-up|3
352534|NCT01088997|1190896|P2|Overall Study|Excluded prior to receiving drug|1
352535|NCT01088997|1190897|P1|Overall Study|Excluded prior to receiving drug|1
352536|NCT01088997|1190896|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
352537|NCT01088997|1190897|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
352538|NCT01088997|1190896|P2|Overall Study|Physician Decision|1
352539|NCT01088997|1190897|P1|Overall Study|Physician Decision|1
352540|NCT01088984|1190908|P2|Phase 2|Not Specified|1
352541|NCT01088984|1190909|P1|Phase 2|Not Specified|0
352542|NCT01088984|1190908|P2|Phase 2|DIsease Progression|25
352543|NCT01088984|1190909|P1|Phase 2|DIsease Progression|0
352544|NCT01088984|1190908|P2|Phase 2|Withdrawal by Subject|1
352545|NCT01088984|1190909|P1|Phase 2|Withdrawal by Subject|0
352546|NCT01088984|1190908|P2|Phase 2|Death|5
352547|NCT01088984|1190909|P1|Phase 2|Death|0
352548|NCT01088984|1190908|P2|Phase 1|Not Specified|1
352549|NCT01088984|1190909|P1|Phase 1|Not Specified|1
352550|NCT01088984|1190908|P2|Phase 1|Disease Progression|4
352551|NCT01088984|1190909|P1|Phase 1|Disease Progression|2
352552|NCT01088984|1190908|P2|Phase 1|Death|1
352553|NCT01088984|1190909|P1|Phase 1|Death|2
352554|NCT01088529|1190970|P2|Overall Study|Did not receive study treatment|1
352555|NCT01088529|1190971|P1|Overall Study|Did not receive study treatment|0
352556|NCT01088503|1190984|P3|Overall Study|Death|7
352557|NCT01088503|1190985|P2|Overall Study|Death|358
352558|NCT01088503|1190986|P1|Overall Study|Death|64
352559|NCT01088503|1190984|P3|Overall Study|Withdrawal by Subject|10
352560|NCT01088503|1190985|P2|Overall Study|Withdrawal by Subject|327
352561|NCT01088503|1190986|P1|Overall Study|Withdrawal by Subject|118
352562|NCT01088438|1191064|P2|Overall Study|Lost to Follow-up|30
352563|NCT01088438|1191065|P1|Overall Study|Lost to Follow-up|18
352564|NCT01088438|1191064|P2|Overall Study|Withdrawal by Subject|6
352565|NCT01088438|1191065|P1|Overall Study|Withdrawal by Subject|11
352566|NCT01088399|1191078|P3|Overall Study|Study summary visit not completed|80
352567|NCT01088399|1191079|P2|Overall Study|Study summary visit not completed|283
352568|NCT01088399|1191080|P1|Overall Study|Study summary visit not completed|2398
352569|NCT01088399|1191078|P3|Overall Study|Enrollment criteria not met|70
352570|NCT01088399|1191079|P2|Overall Study|Enrollment criteria not met|119
352571|NCT01088399|1191080|P1|Overall Study|Enrollment criteria not met|48
352572|NCT01088399|1191078|P3|Overall Study|Protocol Violation|0
352573|NCT01088399|1191079|P2|Overall Study|Protocol Violation|1
352574|NCT01088399|1191080|P1|Overall Study|Protocol Violation|10
352575|NCT01088399|1191078|P3|Overall Study|Sponsor decision|7
352576|NCT01088399|1191079|P2|Overall Study|Sponsor decision|298
352577|NCT01088399|1191080|P1|Overall Study|Sponsor decision|1573
352578|NCT01088399|1191078|P3|Overall Study|Change to or start of somatropin therapy|12
352579|NCT01088399|1191079|P2|Overall Study|Change to or start of somatropin therapy|17
352580|NCT01088399|1191080|P1|Overall Study|Change to or start of somatropin therapy|234
352581|NCT01088399|1191078|P3|Overall Study|Withdrawal by Subject|33
352582|NCT01088399|1191079|P2|Overall Study|Withdrawal by Subject|195
352583|NCT01088399|1191080|P1|Overall Study|Withdrawal by Subject|544
352584|NCT01088399|1191078|P3|Overall Study|Physician Decision|16
352585|NCT01088399|1191079|P2|Overall Study|Physician Decision|88
352586|NCT01088399|1191080|P1|Overall Study|Physician Decision|531
352587|NCT01088399|1191078|P3|Overall Study|Lost to Follow-up|58
352588|NCT01088399|1191079|P2|Overall Study|Lost to Follow-up|278
352589|NCT01088399|1191080|P1|Overall Study|Lost to Follow-up|1070
352590|NCT01088399|1191078|P3|Overall Study|Lack of Efficacy|5
352591|NCT01088399|1191079|P2|Overall Study|Lack of Efficacy|7
352592|NCT01088399|1191080|P1|Overall Study|Lack of Efficacy|298
352593|NCT01088399|1191078|P3|Overall Study|Death|0
352594|NCT01088399|1191079|P2|Overall Study|Death|45
352595|NCT01088399|1191080|P1|Overall Study|Death|204
352596|NCT01088399|1191078|P3|Overall Study|Adverse Event|0
352597|NCT01088399|1191079|P2|Overall Study|Adverse Event|16
352598|NCT01088399|1191080|P1|Overall Study|Adverse Event|211
352599|NCT01088243|1191109|P2|Overall Study|Adverse Event|0
352600|NCT01088243|1191110|P1|Overall Study|Adverse Event|1
352601|NCT01087970|1191151|P1|Overall Study|Protocol Violation|2
352602|NCT01087957|1191163|P2|Overall Study|Physician Decision|9
352603|NCT01087957|1191164|P1|Overall Study|Physician Decision|5
352604|NCT01087957|1191163|P2|Overall Study|Withdrawal by Subject|15
352605|NCT01087957|1191164|P1|Overall Study|Withdrawal by Subject|18
352606|NCT01087957|1191163|P2|Overall Study|Protocol Violation|25
352607|NCT01087957|1191164|P1|Overall Study|Protocol Violation|13
352608|NCT01087957|1191163|P2|Overall Study|Lost to Follow-up|4
352609|NCT01087957|1191164|P1|Overall Study|Lost to Follow-up|3
352610|NCT01087957|1191163|P2|Overall Study|Death|2
352611|NCT01087957|1191164|P1|Overall Study|Death|2
352612|NCT01087944|1191190|P2|Period 2 (Week 4-6)|Adverse Event|2
352613|NCT01087944|1191191|P1|Period 2 (Week 4-6)|Adverse Event|0
352614|NCT01087944|1191190|P2|Period 1 (Week 1-3)|Adverse Event|0
352615|NCT01087944|1191191|P1|Period 1 (Week 1-3)|Adverse Event|1
352616|NCT01087905|1191271|P8|Overall Study|Withdrawal by Subject|5
352617|NCT01087905|1191272|P7|Overall Study|Withdrawal by Subject|3
352618|NCT01087905|1191273|P6|Overall Study|Withdrawal by Subject|3
352619|NCT01087905|1191274|P5|Overall Study|Withdrawal by Subject|4
352620|NCT01087905|1191275|P4|Overall Study|Withdrawal by Subject|5
352621|NCT01087905|1191276|P3|Overall Study|Withdrawal by Subject|4
352622|NCT01087905|1191277|P2|Overall Study|Withdrawal by Subject|4
352623|NCT01087905|1191278|P1|Overall Study|Withdrawal by Subject|5
352624|NCT01087905|1191271|P8|Overall Study|Lost to Follow-up|24
352625|NCT01087905|1191272|P7|Overall Study|Lost to Follow-up|20
352626|NCT01087905|1191273|P6|Overall Study|Lost to Follow-up|25
352627|NCT01087905|1191274|P5|Overall Study|Lost to Follow-up|27
352628|NCT01087905|1191275|P4|Overall Study|Lost to Follow-up|31
352629|NCT01087905|1191276|P3|Overall Study|Lost to Follow-up|18
352630|NCT01087905|1191277|P2|Overall Study|Lost to Follow-up|28
352631|NCT01087905|1191278|P1|Overall Study|Lost to Follow-up|24
352632|NCT01087814|1191300|P2|Second Intervention (5 Days)|Physician Decision|0
352633|NCT01087814|1191301|P1|Second Intervention (5 Days)|Physician Decision|1
352634|NCT01087814|1191300|P2|First Intervention (5 Days)|Withdrawal by Subject|1
352635|NCT01087814|1191301|P1|First Intervention (5 Days)|Withdrawal by Subject|3
352636|NCT01087788|1191319|P3|Open-Label Period (OL-P)|Personal reasons|1
352637|NCT01087788|1191320|P2|Open-Label Period (OL-P)|Personal reasons|0
352638|NCT01087788|1191321|P1|Open-Label Period (OL-P)|Personal reasons|0
352639|NCT01087788|1191319|P3|Open-Label Period (OL-P)|No participation in study extension|1
352640|NCT01087788|1191320|P2|Open-Label Period (OL-P)|No participation in study extension|0
352641|NCT01087788|1191321|P1|Open-Label Period (OL-P)|No participation in study extension|0
352642|NCT01087788|1191319|P3|Open-Label Period (OL-P)|Principal investigator decision|2
352643|NCT01087788|1191320|P2|Open-Label Period (OL-P)|Principal investigator decision|1
352644|NCT01087788|1191321|P1|Open-Label Period (OL-P)|Principal investigator decision|0
352645|NCT01087788|1191319|P3|Open-Label Period (OL-P)|Sponsor request|0
352646|NCT01087788|1191320|P2|Open-Label Period (OL-P)|Sponsor request|0
352647|NCT01087788|1191321|P1|Open-Label Period (OL-P)|Sponsor request|1
352648|NCT01087788|1191319|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
352649|NCT01087788|1191320|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
352650|NCT01087788|1191321|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
352651|NCT01087788|1191319|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
352652|NCT01087788|1191320|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
352653|NCT01087788|1191321|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
352654|NCT01087788|1191319|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
352655|NCT01087788|1191320|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
352656|NCT01087788|1191321|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
352657|NCT01087788|1191319|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
352658|NCT01087788|1191320|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
352659|NCT01087788|1191321|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
352660|NCT01087788|1191319|P3|Open-Label Period (OL-P)|AE, serious fatal|1
352661|NCT01087788|1191320|P2|Open-Label Period (OL-P)|AE, serious fatal|0
352662|NCT01087788|1191321|P1|Open-Label Period (OL-P)|AE, serious fatal|2
352663|NCT01087788|1191319|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
352664|NCT01087788|1191320|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
352665|NCT01087788|1191321|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
352666|NCT01087788|1191319|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
352667|NCT01087788|1191320|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
352668|NCT01087788|1191321|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
352669|NCT01087788|1191319|P3|Open-Label Period (OL-P)|Protocol Violation|0
352670|NCT01087788|1191320|P2|Open-Label Period (OL-P)|Protocol Violation|1
352671|NCT01087788|1191321|P1|Open-Label Period (OL-P)|Protocol Violation|2
352672|NCT01087788|1191319|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
352673|NCT01087788|1191320|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
352674|NCT01087788|1191321|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
352675|NCT01087788|1191319|P3|24-weeks Dose-blind Period|Patient moved|1
352676|NCT01087788|1191320|P2|24-weeks Dose-blind Period|Patient moved|0
352677|NCT01087788|1191321|P1|24-weeks Dose-blind Period|Patient moved|0
352678|NCT01087788|1191319|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
352679|NCT01087788|1191320|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
352680|NCT01087788|1191321|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
352681|NCT01087788|1191319|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
352682|NCT01087788|1191320|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
352683|NCT01087788|1191321|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
352684|NCT01087788|1191319|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
352685|NCT01087788|1191320|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
352686|NCT01087788|1191321|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
352687|NCT01087788|1191319|P3|24-weeks Dose-blind Period|AE, serious fatal|0
352688|NCT01087788|1191320|P2|24-weeks Dose-blind Period|AE, serious fatal|1
352689|NCT01087788|1191321|P1|24-weeks Dose-blind Period|AE, serious fatal|0
352690|NCT01087788|1191319|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
352691|NCT01087788|1191320|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
352692|NCT01087788|1191321|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
352693|NCT01087788|1191319|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
352694|NCT01087788|1191320|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
352695|NCT01087788|1191321|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
352696|NCT01087788|1191319|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
352697|NCT01087788|1191320|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
352698|NCT01087788|1191321|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
352699|NCT01087788|1191319|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
352700|NCT01087788|1191320|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
352701|NCT01087788|1191321|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
352702|NCT01087788|1191319|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
352703|NCT01087788|1191320|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
352704|NCT01087788|1191321|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
352705|NCT01087788|1191319|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
352706|NCT01087788|1191320|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
352707|NCT01087788|1191321|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
352708|NCT01087788|1191319|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
352709|NCT01087788|1191320|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
352710|NCT01087788|1191321|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
352711|NCT01087788|1191319|P3|24-weeks Double-blind Period|AE, unknown type|1
352712|NCT01087788|1191320|P2|24-weeks Double-blind Period|AE, unknown type|0
352713|NCT01087788|1191321|P1|24-weeks Double-blind Period|AE, unknown type|0
352714|NCT01087788|1191319|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
352715|NCT01087788|1191320|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
352716|NCT01087788|1191321|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
352717|NCT01087788|1191319|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
352718|NCT01087788|1191320|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
352719|NCT01087788|1191321|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
352720|NCT01087788|1191319|P3|24-weeks Double-blind Period|AE, serious fatal|1
352721|NCT01087788|1191320|P2|24-weeks Double-blind Period|AE, serious fatal|1
352722|NCT01087788|1191321|P1|24-weeks Double-blind Period|AE, serious fatal|0
352723|NCT01087788|1191319|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
352724|NCT01087788|1191320|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
352725|NCT01087788|1191321|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
352726|NCT01087788|1191319|P3|24-weeks Double-blind Period|Lost to Follow-up|1
352727|NCT01087788|1191320|P2|24-weeks Double-blind Period|Lost to Follow-up|1
352728|NCT01087788|1191321|P1|24-weeks Double-blind Period|Lost to Follow-up|4
352729|NCT01087788|1191319|P3|24-weeks Double-blind Period|Protocol Violation|0
352730|NCT01087788|1191320|P2|24-weeks Double-blind Period|Protocol Violation|1
352731|NCT01087788|1191321|P1|24-weeks Double-blind Period|Protocol Violation|0
352732|NCT01087788|1191319|P3|24-weeks Double-blind Period|Lack of Efficacy|1
352733|NCT01087788|1191320|P2|24-weeks Double-blind Period|Lack of Efficacy|0
352734|NCT01087788|1191321|P1|24-weeks Double-blind Period|Lack of Efficacy|2
352735|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
352736|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
352737|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
352738|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
352739|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
352740|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
352741|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
352742|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
352743|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
352744|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
352745|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
352746|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
352747|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
352748|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
352749|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
352750|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|Other|4
352751|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|Other|2
352752|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|Other|0
352753|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|Other|0
352754|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|Other|0
352755|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
352756|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
352757|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
352758|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
352759|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
352760|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
352761|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
352762|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
352763|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
352764|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
352765|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
352766|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
352767|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
352768|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
352769|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
352770|NCT01087762|1191351|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
352771|NCT01087762|1191352|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
352772|NCT01087762|1191353|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
352773|NCT01087762|1191354|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
352774|NCT01087762|1191355|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
352775|NCT01087762|1191351|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
352776|NCT01087762|1191352|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
352777|NCT01087762|1191353|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
352778|NCT01087762|1191354|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
352779|NCT01087762|1191355|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
352780|NCT01087762|1191351|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
352781|NCT01087762|1191352|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
352782|NCT01087762|1191353|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
352783|NCT01087762|1191354|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
352784|NCT01087762|1191355|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
352785|NCT01087762|1191351|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
352786|NCT01087762|1191352|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
352787|NCT01087762|1191353|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
352788|NCT01087762|1191354|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
352789|NCT01087762|1191355|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
352790|NCT01087762|1191351|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
352791|NCT01087762|1191352|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
352792|NCT01087762|1191353|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
352793|NCT01087762|1191354|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
352794|NCT01087762|1191355|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
352795|NCT01087762|1191351|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
352796|NCT01087762|1191352|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
352797|NCT01087762|1191353|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
352798|NCT01087762|1191354|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
352799|NCT01087762|1191355|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
352800|NCT01087736|1191403|P2|Overall Study|Withdrawal by Subject|1
352801|NCT01087736|1191404|P1|Overall Study|Withdrawal by Subject|0
352802|NCT01087736|1191403|P2|Overall Study|Death|1
352803|NCT01087736|1191404|P1|Overall Study|Death|0
352804|NCT01087736|1191403|P2|Overall Study|Lost to Follow-up|0
352805|NCT01087736|1191404|P1|Overall Study|Lost to Follow-up|1
352806|NCT01087723|1191414|P2|Overall Study|Reason Not Specified|2
352807|NCT01087723|1191415|P1|Overall Study|Reason Not Specified|1
352808|NCT01087723|1191414|P2|Overall Study|Lost to Follow-up|4
352809|NCT01087723|1191415|P1|Overall Study|Lost to Follow-up|1
352810|NCT01087723|1191414|P2|Overall Study|Physician Decision|0
352811|NCT01087723|1191415|P1|Overall Study|Physician Decision|2
352812|NCT01087723|1191414|P2|Overall Study|Withdrawal by Subject|13
352813|NCT01087723|1191415|P1|Overall Study|Withdrawal by Subject|10
352814|NCT01087723|1191414|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
352815|NCT01087723|1191415|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
352816|NCT01087528|1191456|P1|Overall Study|Incomplete CE procedure|6
352817|NCT01087528|1191456|P1|Overall Study|Withdrawal by Subject|1
352818|NCT01087502|1191462|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
352819|NCT01087502|1191463|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
352820|NCT01087502|1191462|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
352821|NCT01087502|1191463|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
352822|NCT01087502|1191462|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
352823|NCT01087502|1191463|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
352824|NCT01087502|1191462|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
352825|NCT01087502|1191463|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
352826|NCT01087502|1191462|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
352827|NCT01087502|1191463|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
352828|NCT01087502|1191462|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
352829|NCT01087502|1191463|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
352830|NCT01087502|1191462|P2|Up to Final Analysis (Week 52)|Adverse Event|10
352831|NCT01087502|1191463|P1|Up to Final Analysis (Week 52)|Adverse Event|17
352832|NCT01087502|1191462|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
352833|NCT01087502|1191463|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
352834|NCT01087502|1191462|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
352835|NCT01087502|1191463|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
352836|NCT01087502|1191462|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
352837|NCT01087502|1191463|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
352838|NCT01087502|1191462|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
352839|NCT01087502|1191463|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
352840|NCT01087502|1191462|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
352841|NCT01087502|1191463|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
352842|NCT01087489|1191482|P2|Overall Study|unable to survey by telephone|1
352843|NCT01087489|1191483|P1|Overall Study|unable to survey by telephone|0
352844|NCT01087489|1191482|P2|Overall Study|Death|1
352845|NCT01087489|1191483|P1|Overall Study|Death|0
352846|NCT01087489|1191482|P2|Overall Study|enrolled in another VA study|1
352847|NCT01087489|1191483|P1|Overall Study|enrolled in another VA study|0
352848|NCT01086969|1191496|P3|Overall Study|Withdrawal by Subject|0
352849|NCT01086969|1191497|P2|Overall Study|Withdrawal by Subject|2
352850|NCT01086969|1191498|P1|Overall Study|Withdrawal by Subject|1
352851|NCT01086423|1191608|P3|Overall Study|Lost to Follow-up|1
352852|NCT01086423|1191609|P2|Overall Study|Lost to Follow-up|0
352853|NCT01086423|1191610|P1|Overall Study|Lost to Follow-up|0
352854|NCT01086423|1191608|P3|Overall Study|Withdrawal by Subject|3
352855|NCT01086423|1191609|P2|Overall Study|Withdrawal by Subject|1
352856|NCT01086423|1191610|P1|Overall Study|Withdrawal by Subject|5
352857|NCT01086423|1191608|P3|Overall Study|Adverse event, non-fatal|0
352858|NCT01086423|1191609|P2|Overall Study|Adverse event, non-fatal|1
352859|NCT01086423|1191610|P1|Overall Study|Adverse event, non-fatal|2
352860|NCT01086423|1191608|P3|Overall Study|Adverse event, fatal|0
352861|NCT01086423|1191609|P2|Overall Study|Adverse event, fatal|1
352862|NCT01086423|1191610|P1|Overall Study|Adverse event, fatal|1
352863|NCT01086423|1191608|P3|Overall Study|Migrated/moved from study area|4
352864|NCT01086423|1191609|P2|Overall Study|Migrated/moved from study area|0
352865|NCT01086423|1191610|P1|Overall Study|Migrated/moved from study area|2
352866|NCT01086423|1191608|P3|Overall Study|Protocol Violation|1
352867|NCT01086423|1191609|P2|Overall Study|Protocol Violation|0
352868|NCT01086423|1191610|P1|Overall Study|Protocol Violation|0
352869|NCT01086410|1191655|P4|Overall Study|Lost to Follow-up|0
352870|NCT01086410|1191656|P3|Overall Study|Lost to Follow-up|1
352871|NCT01086410|1191657|P2|Overall Study|Lost to Follow-up|0
352872|NCT01086410|1191658|P1|Overall Study|Lost to Follow-up|0
352873|NCT01086410|1191655|P4|Overall Study|Protocol Violation|0
352874|NCT01086410|1191656|P3|Overall Study|Protocol Violation|0
352875|NCT01086410|1191657|P2|Overall Study|Protocol Violation|1
352876|NCT01086410|1191658|P1|Overall Study|Protocol Violation|1
352877|NCT01086410|1191655|P4|Overall Study|Lack of Efficacy|0
352878|NCT01086410|1191656|P3|Overall Study|Lack of Efficacy|0
352879|NCT01086410|1191657|P2|Overall Study|Lack of Efficacy|1
352880|NCT01086410|1191658|P1|Overall Study|Lack of Efficacy|1
352881|NCT01086410|1191655|P4|Overall Study|Adverse Event|2
352882|NCT01086410|1191656|P3|Overall Study|Adverse Event|0
352883|NCT01086410|1191657|P2|Overall Study|Adverse Event|0
352884|NCT01086410|1191658|P1|Overall Study|Adverse Event|1
352885|NCT01086384|1191754|P3|Treatment Period|Received Treatment in Error|0
352886|NCT01086384|1191755|P2|Treatment Period|Received Treatment in Error|1
352887|NCT01086384|1191756|P1|Treatment Period|Received Treatment in Error|0
352888|NCT01086384|1191754|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
352889|NCT01086384|1191755|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
352890|NCT01086384|1191756|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
352891|NCT01086384|1191754|P3|Treatment Period|Study Closed/Terminated|8
352892|NCT01086384|1191755|P2|Treatment Period|Study Closed/Terminated|7
352893|NCT01086384|1191756|P1|Treatment Period|Study Closed/Terminated|0
352894|NCT01086384|1191754|P3|Treatment Period|Physician Decision|6
352895|NCT01086384|1191755|P2|Treatment Period|Physician Decision|9
352896|NCT01086384|1191756|P1|Treatment Period|Physician Decision|0
352897|NCT01086384|1191754|P3|Treatment Period|Lost to Follow-up|9
352898|NCT01086384|1191755|P2|Treatment Period|Lost to Follow-up|11
352899|NCT01086384|1191756|P1|Treatment Period|Lost to Follow-up|0
352900|NCT01086384|1191754|P3|Treatment Period|Adverse Event|15
352901|NCT01086384|1191755|P2|Treatment Period|Adverse Event|19
352902|NCT01086384|1191756|P1|Treatment Period|Adverse Event|0
352903|NCT01086384|1191754|P3|Treatment Period|Lack of Efficacy|13
352904|NCT01086384|1191755|P2|Treatment Period|Lack of Efficacy|22
352905|NCT01086384|1191756|P1|Treatment Period|Lack of Efficacy|0
352906|NCT01086384|1191754|P3|Treatment Period|Protocol Violation|17
352907|NCT01086384|1191755|P2|Treatment Period|Protocol Violation|26
352908|NCT01086384|1191756|P1|Treatment Period|Protocol Violation|0
352909|NCT01086384|1191754|P3|Treatment Period|Withdrawal by Subject|55
352910|NCT01086384|1191755|P2|Treatment Period|Withdrawal by Subject|53
352911|NCT01086384|1191756|P1|Treatment Period|Withdrawal by Subject|0
352912|NCT01086384|1191754|P3|2-week Run-in Period|Randomized in Error|0
352913|NCT01086384|1191755|P2|2-week Run-in Period|Randomized in Error|0
352914|NCT01086384|1191756|P1|2-week Run-in Period|Randomized in Error|1
352915|NCT01086384|1191754|P3|2-week Run-in Period|Continuation Criteria Not Met|0
352916|NCT01086384|1191755|P2|2-week Run-in Period|Continuation Criteria Not Met|0
352917|NCT01086384|1191756|P1|2-week Run-in Period|Continuation Criteria Not Met|92
352918|NCT01086384|1191754|P3|2-week Run-in Period|Study Closed/Terminated|0
352919|NCT01086384|1191755|P2|2-week Run-in Period|Study Closed/Terminated|0
352920|NCT01086384|1191756|P1|2-week Run-in Period|Study Closed/Terminated|42
352921|NCT01086384|1191754|P3|2-week Run-in Period|Withdrawal by Subject|0
352922|NCT01086384|1191755|P2|2-week Run-in Period|Withdrawal by Subject|0
352923|NCT01086384|1191756|P1|2-week Run-in Period|Withdrawal by Subject|19
352924|NCT01086384|1191754|P3|2-week Run-in Period|Physician Decision|0
352925|NCT01086384|1191755|P2|2-week Run-in Period|Physician Decision|0
352926|NCT01086384|1191756|P1|2-week Run-in Period|Physician Decision|6
352927|NCT01086384|1191754|P3|2-week Run-in Period|Lost to Follow-up|0
352928|NCT01086384|1191755|P2|2-week Run-in Period|Lost to Follow-up|0
352929|NCT01086384|1191756|P1|2-week Run-in Period|Lost to Follow-up|1
352930|NCT01086384|1191754|P3|2-week Run-in Period|Protocol Violation|0
352931|NCT01086384|1191755|P2|2-week Run-in Period|Protocol Violation|0
352932|NCT01086384|1191756|P1|2-week Run-in Period|Protocol Violation|1
352933|NCT01086384|1191754|P3|2-week Run-in Period|Adverse Event|0
352934|NCT01086384|1191755|P2|2-week Run-in Period|Adverse Event|0
352935|NCT01086384|1191756|P1|2-week Run-in Period|Adverse Event|1
352936|NCT01086358|1191766|P2|Second Intervention|Lost to Follow-up|4
352937|NCT01086358|1191767|P1|Second Intervention|Lost to Follow-up|4
352938|NCT01086358|1191766|P2|First Intervention|Withdrawal by Subject|1
352939|NCT01086358|1191767|P1|First Intervention|Withdrawal by Subject|0
352940|NCT01086358|1191766|P2|First Intervention|Lost to Follow-up|4
352941|NCT01086358|1191767|P1|First Intervention|Lost to Follow-up|9
352942|NCT01086215|1191837|P4|Overall Study|Lost to Follow-up|2
352943|NCT01086215|1191838|P3|Overall Study|Lost to Follow-up|18
352944|NCT01086215|1191839|P2|Overall Study|Lost to Follow-up|39
352945|NCT01086215|1191840|P1|Overall Study|Lost to Follow-up|22
352946|NCT01086215|1191837|P4|Overall Study|Death|1
352947|NCT01086215|1191838|P3|Overall Study|Death|8
352948|NCT01086215|1191839|P2|Overall Study|Death|8
352949|NCT01086215|1191840|P1|Overall Study|Death|14
352950|NCT01086033|1191858|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
352951|NCT01086033|1191858|P1|Overall Study|AE and Other Reason|1
352952|NCT01086033|1191858|P1|Overall Study|AE and Lost to Follow-up|1
352953|NCT01086033|1191858|P1|Overall Study|Death|1
352954|NCT01086033|1191858|P1|Overall Study|AE and Lack of Efficacy|4
352955|NCT01086033|1191858|P1|Overall Study|Withdrew consent and Other Reason|4
352956|NCT01086033|1191858|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
352957|NCT01086033|1191858|P1|Overall Study|AE and Withdrew Consent|5
352958|NCT01086033|1191858|P1|Overall Study|Other|13
352959|NCT01086033|1191858|P1|Overall Study|Other|14
352960|NCT01086033|1191858|P1|Overall Study|Withdrawal by Subject|41
352961|NCT01086033|1191858|P1|Overall Study|Adverse Event|42
352962|NCT01086033|1191858|P1|Overall Study|Lost to Follow-up|86
352963|NCT01086033|1191858|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
352964|NCT01085734|1191964|P2|Overall Study|Withdrawal by Subject|1
352965|NCT01085734|1191965|P1|Overall Study|Withdrawal by Subject|0
352966|NCT01085734|1191964|P2|Overall Study|Lost to Follow-up|1
352967|NCT01085734|1191965|P1|Overall Study|Lost to Follow-up|0
352968|NCT01085734|1191964|P2|Overall Study|Death|0
352969|NCT01085734|1191965|P1|Overall Study|Death|1
352970|NCT01085734|1191964|P2|Overall Study|Adverse Event|2
352971|NCT01085734|1191965|P1|Overall Study|Adverse Event|0
352972|NCT01085682|1191977|P2|Overall Study|Withdrawal by Subject|25
352973|NCT01085682|1191978|P1|Overall Study|Withdrawal by Subject|25
352974|NCT01085591|1191996|P3|Overall Study|Not Properly Consented|0
352975|NCT01085591|1191997|P2|Overall Study|Not Properly Consented|0
352976|NCT01085591|1191998|P1|Overall Study|Not Properly Consented|1
352977|NCT01085591|1191996|P3|Overall Study|Other|0
352978|NCT01085591|1191997|P2|Overall Study|Other|1
352979|NCT01085591|1191998|P1|Overall Study|Other|0
352980|NCT01085591|1191996|P3|Overall Study|Protocol Violation|1
352981|NCT01085591|1191997|P2|Overall Study|Protocol Violation|1
352982|NCT01085591|1191998|P1|Overall Study|Protocol Violation|1
352983|NCT01085591|1191996|P3|Overall Study|Lost to Follow-up|1
352984|NCT01085591|1191997|P2|Overall Study|Lost to Follow-up|1
352985|NCT01085591|1191998|P1|Overall Study|Lost to Follow-up|0
352986|NCT01085591|1191996|P3|Overall Study|Withdrawal by Subject|1
352987|NCT01085591|1191997|P2|Overall Study|Withdrawal by Subject|2
352988|NCT01085591|1191998|P1|Overall Study|Withdrawal by Subject|0
352989|NCT01085591|1191996|P3|Overall Study|Physician Decision|1
352990|NCT01085591|1191997|P2|Overall Study|Physician Decision|0
352991|NCT01085591|1191998|P1|Overall Study|Physician Decision|1
352992|NCT01085591|1191996|P3|Overall Study|Adverse Event|3
352993|NCT01085591|1191997|P2|Overall Study|Adverse Event|1
352994|NCT01085591|1191998|P1|Overall Study|Adverse Event|0
352995|NCT01085357|1192049|P2|Overall Study|Lost to Follow-up|0
352996|NCT01085357|1192050|P1|Overall Study|Lost to Follow-up|2
352997|NCT01085357|1192049|P2|Overall Study|Death|1
352998|NCT01085357|1192050|P1|Overall Study|Death|11
352999|NCT01085357|1192049|P2|Overall Study|Investigator Decision|1
353000|NCT01085357|1192050|P1|Overall Study|Investigator Decision|1
353001|NCT01085357|1192049|P2|Overall Study|Subject Decision|3
353002|NCT01085357|1192050|P1|Overall Study|Subject Decision|4
353003|NCT01085357|1192049|P2|Overall Study|Adverse Event|1
353004|NCT01085357|1192050|P1|Overall Study|Adverse Event|1
353005|NCT01085214|1192113|P1|Overall Study|Alternate treatment required|1
353006|NCT01085201|1192125|P5|Overall Study|Fond ineligible after consent|0
353007|NCT01085201|1192126|P4|Overall Study|Fond ineligible after consent|0
353008|NCT01085201|1192127|P3|Overall Study|Fond ineligible after consent|1
353009|NCT01085201|1192128|P2|Overall Study|Fond ineligible after consent|1
353010|NCT01085201|1192129|P1|Overall Study|Fond ineligible after consent|0
353011|NCT01085201|1192125|P5|Overall Study|Unknown- no study drug|0
353012|NCT01085201|1192126|P4|Overall Study|Unknown- no study drug|0
353013|NCT01085201|1192127|P3|Overall Study|Unknown- no study drug|0
353014|NCT01085201|1192128|P2|Overall Study|Unknown- no study drug|0
353015|NCT01085201|1192129|P1|Overall Study|Unknown- no study drug|2
353016|NCT01085201|1192125|P5|Overall Study|Scheduling conflict|0
353017|NCT01085201|1192126|P4|Overall Study|Scheduling conflict|0
353018|NCT01085201|1192127|P3|Overall Study|Scheduling conflict|1
353019|NCT01085201|1192128|P2|Overall Study|Scheduling conflict|0
353020|NCT01085201|1192129|P1|Overall Study|Scheduling conflict|1
353021|NCT01085136|1192151|P3|Part B|Other reason not defined above|3
353022|NCT01085136|1192152|P2|Part B|Other reason not defined above|6
353023|NCT01085136|1192153|P1|Part B|Other reason not defined above|0
353024|NCT01085136|1192151|P3|Part B|Not treated|8
353025|NCT01085136|1192152|P2|Part B|Not treated|4
353026|NCT01085136|1192153|P1|Part B|Not treated|0
353027|NCT01085136|1192151|P3|Part B|Refusal to continue trial medication|7
353028|NCT01085136|1192152|P2|Part B|Refusal to continue trial medication|12
353029|NCT01085136|1192153|P1|Part B|Refusal to continue trial medication|0
353030|NCT01085136|1192151|P3|Part B|Other AE|8
353031|NCT01085136|1192152|P2|Part B|Other AE|29
353032|NCT01085136|1192153|P1|Part B|Other AE|0
353033|NCT01085136|1192151|P3|Part A|Other reason not defined above|0
353034|NCT01085136|1192152|P2|Part A|Other reason not defined above|0
353035|NCT01085136|1192153|P1|Part A|Other reason not defined above|30
353036|NCT01085136|1192151|P3|Part A|Refusal to continue trial medication|0
353037|NCT01085136|1192152|P2|Part A|Refusal to continue trial medication|0
353038|NCT01085136|1192153|P1|Part A|Refusal to continue trial medication|64
353039|NCT01085136|1192151|P3|Part A|Lost to Follow-up|0
353040|NCT01085136|1192152|P2|Part A|Lost to Follow-up|0
353041|NCT01085136|1192153|P1|Part A|Lost to Follow-up|3
353042|NCT01085136|1192151|P3|Part A|Protocol Violation|0
353043|NCT01085136|1192152|P2|Part A|Protocol Violation|0
353044|NCT01085136|1192153|P1|Part A|Protocol Violation|3
353045|NCT01085136|1192151|P3|Part A|Other Adverse event|0
353046|NCT01085136|1192152|P2|Part A|Other Adverse event|0
353047|NCT01085136|1192153|P1|Part A|Other Adverse event|223
353048|NCT01085045|1192169|P1|Part B|Adverse Event|6
353049|NCT01085045|1192169|P1|Part B|Lost to Follow-up|1
353050|NCT01085045|1192169|P1|Part B|Protocol Specified Criteria|6
353051|NCT01085045|1192169|P1|Part B|Withdrawal by Subject|2
353052|NCT01085045|1192169|P1|Part A|Protocol Specified Criteria|7
353053|NCT01085045|1192169|P1|Part A|Protocol Violation|1
353054|NCT01085045|1192169|P1|Part A|Adverse Event|6
353055|NCT01085045|1192169|P1|Part A|Withdrawal by Subject|4
353056|NCT01084707|1192284|P1|Overall Study|Withdrawal by Subject|6
353057|NCT01084668|1192318|P1|Overall Study|Non-compliance|1
353058|NCT01084668|1192318|P1|Overall Study|Pregnancy|1
353059|NCT01084668|1192318|P1|Overall Study|Withdrawal by Subject|2
353060|NCT01084668|1192318|P1|Overall Study|Lack of Efficacy|5
353061|NCT01084603|1192327|P1|Washout Period 4|Adverse Event|1
353062|NCT01084603|1192327|P1|Oral Nicotine 1|Withdrawal by Subject|1
353063|NCT01084603|1192327|P1|Nicorette® Gum|Withdrawal by Subject|1
353064|NCT01084603|1192327|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
353065|NCT01084603|1192327|P1|Baseline|Withdrawal by Subject|2
353066|NCT01084551|1192363|P3|Overall Study|Physician Decision|0
353067|NCT01084551|1192364|P2|Overall Study|Physician Decision|0
353068|NCT01084551|1192365|P1|Overall Study|Physician Decision|1
353069|NCT01084551|1192363|P3|Overall Study|Lost to Follow-up|3
353070|NCT01084551|1192364|P2|Overall Study|Lost to Follow-up|0
353071|NCT01084551|1192365|P1|Overall Study|Lost to Follow-up|0
353072|NCT01084551|1192363|P3|Overall Study|Protocol Violation|0
353073|NCT01084551|1192364|P2|Overall Study|Protocol Violation|4
353074|NCT01084551|1192365|P1|Overall Study|Protocol Violation|2
353075|NCT01084551|1192363|P3|Overall Study|Withdrawal by Subject|0
353076|NCT01084551|1192364|P2|Overall Study|Withdrawal by Subject|1
353077|NCT01084551|1192365|P1|Overall Study|Withdrawal by Subject|2
353078|NCT01084551|1192363|P3|Overall Study|Lack of Efficacy|1
353079|NCT01084551|1192364|P2|Overall Study|Lack of Efficacy|0
353080|NCT01084551|1192365|P1|Overall Study|Lack of Efficacy|2
353081|NCT01084551|1192363|P3|Overall Study|Adverse Event|4
353082|NCT01084551|1192364|P2|Overall Study|Adverse Event|9
353083|NCT01084551|1192365|P1|Overall Study|Adverse Event|2
353084|NCT01084538|1192403|P1|Overall Study|Reason unknown|8
353085|NCT01084538|1192403|P1|Overall Study|Over-suppression of parathyroid gland|2
353086|NCT01084538|1192403|P1|Overall Study|Change of residence|2
353087|NCT01084538|1192403|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
353088|NCT01084538|1192403|P1|Overall Study|Hyperphosphatemia|2
353089|NCT01084538|1192403|P1|Overall Study|Patient noncompliance|2
353090|NCT01084538|1192403|P1|Overall Study|Lack of effectiveness|2
353091|NCT01084538|1192403|P1|Overall Study|Serious Adverse Event|3
353092|NCT01084538|1192403|P1|Overall Study|Kidney transplant|6
353093|NCT01084538|1192403|P1|Overall Study|Adverse Event|9
353094|NCT01084538|1192403|P1|Overall Study|Drug not available|30
353095|NCT01084239|1192514|P2|28-Day Follow-up|Lost to Follow-up|9
353096|NCT01084239|1192515|P1|28-Day Follow-up|Lost to Follow-up|4
353097|NCT01084174|1192533|P2|Overall Study|Participant noncompliance|1
353098|NCT01084174|1192534|P1|Overall Study|Participant noncompliance|0
353099|NCT01084174|1192533|P2|Overall Study|Anaphylaxis|1
353100|NCT01084174|1192534|P1|Overall Study|Anaphylaxis|0
353101|NCT01084174|1192533|P2|Overall Study|Eosinophilic esophagitis|1
353102|NCT01084174|1192534|P1|Overall Study|Eosinophilic esophagitis|0
353103|NCT01084174|1192533|P2|Overall Study|gastrointestinal symptoms|1
353104|NCT01084174|1192534|P1|Overall Study|gastrointestinal symptoms|1
353105|NCT01084135|1192567|P2|20 Week|Physician Decision|1
353106|NCT01084135|1192568|P1|20 Week|Physician Decision|0
353107|NCT01084083|1192578|P1|Overall Study|Never started assigned therapy|1
353108|NCT01084083|1192578|P1|Overall Study|Other|2
353109|NCT01084083|1192578|P1|Overall Study|Complicating disease|1
353110|NCT01084083|1192578|P1|Overall Study|Withdrawal by Subject|2
353111|NCT01084083|1192578|P1|Overall Study|Death|1
353112|NCT01084083|1192578|P1|Overall Study|Adverse Event|5
353113|NCT01084005|1192586|P2|Overall Study|Withdrawal by Subject|1
353114|NCT01084005|1192587|P1|Overall Study|Withdrawal by Subject|1
353115|NCT01084005|1192586|P2|Overall Study|Protocol Violation|7
353116|NCT01084005|1192587|P1|Overall Study|Protocol Violation|3
353117|NCT01084005|1192586|P2|Overall Study|Adverse Event|8
353118|NCT01084005|1192587|P1|Overall Study|Adverse Event|1
353119|NCT01083810|1192668|P3|Overall Study|Virologic failure|0
353120|NCT01083810|1192669|P2|Overall Study|Virologic failure|8
353121|NCT01083810|1192670|P1|Overall Study|Virologic failure|1
353122|NCT01083810|1192668|P3|Overall Study|Therapy break|2
353123|NCT01083810|1192669|P2|Overall Study|Therapy break|2
353124|NCT01083810|1192670|P1|Overall Study|Therapy break|1
353125|NCT01083810|1192668|P3|Overall Study|Participation in study|0
353126|NCT01083810|1192669|P2|Overall Study|Participation in study|0
353127|NCT01083810|1192670|P1|Overall Study|Participation in study|1
353128|NCT01083810|1192668|P3|Overall Study|Co-morbidities|0
353129|NCT01083810|1192669|P2|Overall Study|Co-morbidities|0
353130|NCT01083810|1192670|P1|Overall Study|Co-morbidities|1
353131|NCT01083810|1192668|P3|Overall Study|Death|3
353132|NCT01083810|1192669|P2|Overall Study|Death|2
353133|NCT01083810|1192670|P1|Overall Study|Death|2
353134|NCT01083810|1192668|P3|Overall Study|Simplification|0
353135|NCT01083810|1192669|P2|Overall Study|Simplification|1
353136|NCT01083810|1192670|P1|Overall Study|Simplification|4
353137|NCT01083810|1192668|P3|Overall Study|Non-compliance|2
353138|NCT01083810|1192669|P2|Overall Study|Non-compliance|7
353139|NCT01083810|1192670|P1|Overall Study|Non-compliance|4
353140|NCT01083810|1192668|P3|Overall Study|Reason not reported|1
353141|NCT01083810|1192669|P2|Overall Study|Reason not reported|1
353142|NCT01083810|1192670|P1|Overall Study|Reason not reported|6
353143|NCT01083810|1192668|P3|Overall Study|Withdrawal by Subject|4
353144|NCT01083810|1192669|P2|Overall Study|Withdrawal by Subject|2
353145|NCT01083810|1192670|P1|Overall Study|Withdrawal by Subject|7
353146|NCT01083810|1192668|P3|Overall Study|Adverse Event|4
353147|NCT01083810|1192669|P2|Overall Study|Adverse Event|11
353148|NCT01083810|1192670|P1|Overall Study|Adverse Event|15
353149|NCT01083810|1192668|P3|Overall Study|Lost to Follow-up|4
353150|NCT01083810|1192669|P2|Overall Study|Lost to Follow-up|11
353151|NCT01083810|1192670|P1|Overall Study|Lost to Follow-up|23
353152|NCT01083771|1192691|P1|Overall Study|Withdrawal by Subject|3
353153|NCT01083771|1192691|P1|Overall Study|non-compliant|2
353154|NCT01083693|1192792|P3|Overall Study|Reason unknown|1
353155|NCT01083693|1192793|P2|Overall Study|Reason unknown|0
353156|NCT01083693|1192794|P1|Overall Study|Reason unknown|0
353157|NCT01083693|1192792|P3|Overall Study|Withdrawal by Subject|2
353158|NCT01083693|1192793|P2|Overall Study|Withdrawal by Subject|0
353159|NCT01083693|1192794|P1|Overall Study|Withdrawal by Subject|3
353160|NCT01083693|1192792|P3|Overall Study|Other medical condition/surgery|0
353161|NCT01083693|1192793|P2|Overall Study|Other medical condition/surgery|1
353162|NCT01083693|1192794|P1|Overall Study|Other medical condition/surgery|1
353163|NCT01083693|1192792|P3|Overall Study|Complete remission|0
353164|NCT01083693|1192793|P2|Overall Study|Complete remission|1
353165|NCT01083693|1192794|P1|Overall Study|Complete remission|0
353166|NCT01083693|1192792|P3|Overall Study|Patient Moved|0
353167|NCT01083693|1192793|P2|Overall Study|Patient Moved|1
353168|NCT01083693|1192794|P1|Overall Study|Patient Moved|0
353169|NCT01083693|1192792|P3|Overall Study|Lack of effectiveness|2
353170|NCT01083693|1192793|P2|Overall Study|Lack of effectiveness|2
353171|NCT01083693|1192794|P1|Overall Study|Lack of effectiveness|13
353172|NCT01083693|1192792|P3|Overall Study|Lost to Follow-up|2
353173|NCT01083693|1192793|P2|Overall Study|Lost to Follow-up|0
353174|NCT01083693|1192794|P1|Overall Study|Lost to Follow-up|2
353175|NCT01083693|1192792|P3|Overall Study|Adverse Event|0
353176|NCT01083693|1192793|P2|Overall Study|Adverse Event|1
353177|NCT01083693|1192794|P1|Overall Study|Adverse Event|1
353178|NCT01083680|1192829|P1|Overall Study|Withdrawal by Subject|1086
353179|NCT01083680|1192829|P1|Overall Study|Lost to Follow-up|2758
353180|NCT01083641|1192852|P1|Overall Study|Withdrawal by Subject|2
353181|NCT01083602|1192859|P1|Overall Study|Lack of Efficacy|36
353182|NCT01083602|1192859|P1|Overall Study|Withdrawal by Subject|5
353183|NCT01083602|1192859|P1|Overall Study|Death|1
353184|NCT01083602|1192859|P1|Overall Study|New Cancer Therapy|2
353185|NCT01083602|1192859|P1|Overall Study|Adverse Event|11
353186|NCT01083576|1192870|P2|Overall Study|Treatment Failure|1
353187|NCT01083576|1192871|P1|Overall Study|Treatment Failure|6
353188|NCT01083485|1192901|P2|Overall Study|Other|0
353189|NCT01083485|1192902|P1|Overall Study|Other|1
353190|NCT01083485|1192901|P2|Overall Study|Withdrawal by Subject|2
353191|NCT01083485|1192902|P1|Overall Study|Withdrawal by Subject|5
353192|NCT01083485|1192901|P2|Overall Study|Protocol Violation|0
353193|NCT01083485|1192902|P1|Overall Study|Protocol Violation|1
353194|NCT01083485|1192901|P2|Overall Study|Adverse Event|1
353195|NCT01083485|1192902|P1|Overall Study|Adverse Event|0
353196|NCT01083316|1192919|P1|Overall Study|Withdrawal by Subject|1
353197|NCT01083316|1192919|P1|Overall Study|Adverse Event|2
353198|NCT01083186|1192930|P1|Overall Study|Non-compliance to Study Treatment|1
353199|NCT01083186|1192930|P1|Overall Study|Administrative Reasons|2
353200|NCT01083186|1192930|P1|Overall Study|Hemodialysis Initiation|28
353201|NCT01083186|1192930|P1|Overall Study|Lack of Efficacy|2
353202|NCT01083186|1192930|P1|Overall Study|Adverse Event|3
353203|NCT01083186|1192930|P1|Overall Study|Death|3
353204|NCT01083186|1192930|P1|Overall Study|Consent Withdrawal|7
353205|NCT01083186|1192930|P1|Overall Study|Lost to Follow-up|48
353206|NCT01083173|1192971|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
353207|NCT01083173|1192972|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
353208|NCT01083173|1192971|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
353209|NCT01083173|1192972|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
353210|NCT01083173|1192971|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
353211|NCT01083173|1192972|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
353212|NCT01083173|1192971|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
353213|NCT01083173|1192972|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
353214|NCT01083173|1192971|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
353215|NCT01083173|1192972|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
353216|NCT01083173|1192971|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
353217|NCT01083173|1192972|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
353218|NCT01083173|1192971|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
353219|NCT01083173|1192972|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
353220|NCT01083173|1192971|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
353221|NCT01083173|1192972|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
353222|NCT01083173|1192971|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
353223|NCT01083173|1192972|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
353224|NCT01083173|1192971|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
353225|NCT01083173|1192972|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
353226|NCT01083173|1192971|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
353227|NCT01083173|1192972|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
353228|NCT01083160|1192990|P1|Overall Study|Adverse Event|1
353229|NCT01083121|1192997|P1|Overall Study|Use of Humira outside the approved label|81
353230|NCT01082965|1193007|P2|Overall Study|Other|1
353231|NCT01082965|1193008|P1|Overall Study|Other|1
353232|NCT01082965|1193007|P2|Overall Study|Protocol Violation|1
353233|NCT01082965|1193008|P1|Overall Study|Protocol Violation|0
353234|NCT01082874|1193045|P4|Overall Study|Withdrawal by Subject|3
353235|NCT01082874|1193046|P3|Overall Study|Withdrawal by Subject|5
353236|NCT01082874|1193047|P2|Overall Study|Withdrawal by Subject|2
353237|NCT01082874|1193048|P1|Overall Study|Withdrawal by Subject|1
353238|NCT01082874|1193045|P4|Overall Study|Lost to Follow-up|10
353239|NCT01082874|1193046|P3|Overall Study|Lost to Follow-up|6
353240|NCT01082874|1193047|P2|Overall Study|Lost to Follow-up|10
353241|NCT01082874|1193048|P1|Overall Study|Lost to Follow-up|10
353242|NCT01082640|1193061|P3|Overall Study|Other|3
353243|NCT01082640|1193062|P2|Overall Study|Other|1
353244|NCT01082640|1193063|P1|Overall Study|Other|2
353245|NCT01082640|1193061|P3|Overall Study|Lost to Follow-up|0
353246|NCT01082640|1193062|P2|Overall Study|Lost to Follow-up|3
353247|NCT01082640|1193063|P1|Overall Study|Lost to Follow-up|0
353248|NCT01082640|1193061|P3|Overall Study|Major protocol deviation|0
353249|NCT01082640|1193062|P2|Overall Study|Major protocol deviation|3
353250|NCT01082640|1193063|P1|Overall Study|Major protocol deviation|3
353251|NCT01082640|1193061|P3|Overall Study|Withdrawal by Subject|2
353252|NCT01082640|1193062|P2|Overall Study|Withdrawal by Subject|3
353253|NCT01082640|1193063|P1|Overall Study|Withdrawal by Subject|3
353254|NCT01082640|1193061|P3|Overall Study|Adverse Event|3
353255|NCT01082640|1193062|P2|Overall Study|Adverse Event|5
353256|NCT01082640|1193063|P1|Overall Study|Adverse Event|9
353257|NCT01082614|1193085|P2|Overall Study|Physician Decision|0
353258|NCT01082614|1193086|P1|Overall Study|Physician Decision|2
353259|NCT01082614|1193085|P2|Overall Study|Equipment Malfunction|1
353260|NCT01082614|1193086|P1|Overall Study|Equipment Malfunction|0
353261|NCT01082614|1193085|P2|Overall Study|Adverse Event|4
353262|NCT01082614|1193086|P1|Overall Study|Adverse Event|1
353263|NCT01082367|1193157|P2|Follow-up (F-U) Period|Adverse Event|1
353264|NCT01082367|1193158|P1|Follow-up (F-U) Period|Adverse Event|0
353265|NCT01082367|1193157|P2|Follow-up (F-U) Period|Abnormal lab values|0
353266|NCT01082367|1193158|P1|Follow-up (F-U) Period|Abnormal lab values|1
353267|NCT01082367|1193157|P2|Follow-up (F-U) Period|Administrative problems|0
353268|NCT01082367|1193158|P1|Follow-up (F-U) Period|Administrative problems|1
353269|NCT01082367|1193157|P2|Double-blind Period|Adverse Event|1
353270|NCT01082367|1193158|P1|Double-blind Period|Adverse Event|0
353271|NCT01082367|1193157|P2|Double-blind Period|Lack of Efficacy|11
353272|NCT01082367|1193158|P1|Double-blind Period|Lack of Efficacy|5
353273|NCT01082367|1193157|P2|Double-blind Period|Administrative problems|1
353274|NCT01082367|1193158|P1|Double-blind Period|Administrative problems|0
353275|NCT01082328|1193172|P1|Overall Study|Adverse Event|1
353276|NCT01082211|1193181|P1|Overall Study|No protocol treatment received|3
353277|NCT01082211|1193181|P1|Overall Study|Protocol Violation|4
353278|NCT01082081|1193202|P3|Overall Study|Other Reason|0
353279|NCT01082081|1193203|P2|Overall Study|Other Reason|1
353280|NCT01082081|1193204|P1|Overall Study|Other Reason|0
353281|NCT01082081|1193202|P3|Overall Study|Withdrawal by Subject|1
353282|NCT01082081|1193203|P2|Overall Study|Withdrawal by Subject|0
353283|NCT01082081|1193204|P1|Overall Study|Withdrawal by Subject|0
353284|NCT01082081|1193202|P3|Overall Study|Lost to Follow-up|1
353285|NCT01082081|1193203|P2|Overall Study|Lost to Follow-up|0
353286|NCT01082081|1193204|P1|Overall Study|Lost to Follow-up|0
353287|NCT01081951|1193256|P2|Overall Study|Lost to Follow-up|1
353288|NCT01081951|1193257|P1|Overall Study|Lost to Follow-up|0
353289|NCT01081951|1193256|P2|Overall Study|Allocated treatment but did not take it|1
353290|NCT01081951|1193257|P1|Overall Study|Allocated treatment but did not take it|0
353291|NCT01081951|1193256|P2|Overall Study|Withdrawal by Subject|6
353292|NCT01081951|1193257|P1|Overall Study|Withdrawal by Subject|2
353293|NCT01081951|1193256|P2|Overall Study|Death|47
353294|NCT01081951|1193257|P1|Overall Study|Death|54
353295|NCT01081912|1193267|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
353296|NCT01081912|1193268|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
353297|NCT01081912|1193269|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
353298|NCT01081912|1193267|P3|Maintenance Treatment|Non-Compliance|7
353299|NCT01081912|1193268|P2|Maintenance Treatment|Non-Compliance|4
353300|NCT01081912|1193269|P1|Maintenance Treatment|Non-Compliance|0
353301|NCT01081912|1193267|P3|Maintenance Treatment|Withdrawal by Subject|5
353302|NCT01081912|1193268|P2|Maintenance Treatment|Withdrawal by Subject|5
353303|NCT01081912|1193269|P1|Maintenance Treatment|Withdrawal by Subject|0
353304|NCT01081912|1193267|P3|Maintenance Treatment|Protocol Violation|2
353305|NCT01081912|1193268|P2|Maintenance Treatment|Protocol Violation|1
353306|NCT01081912|1193269|P1|Maintenance Treatment|Protocol Violation|0
353307|NCT01081912|1193267|P3|Maintenance Treatment|Physician Decision|1
353308|NCT01081912|1193268|P2|Maintenance Treatment|Physician Decision|0
353309|NCT01081912|1193269|P1|Maintenance Treatment|Physician Decision|0
353310|NCT01081912|1193267|P3|Maintenance Treatment|Lost to Follow-up|0
353311|NCT01081912|1193268|P2|Maintenance Treatment|Lost to Follow-up|1
353312|NCT01081912|1193269|P1|Maintenance Treatment|Lost to Follow-up|0
353313|NCT01081912|1193267|P3|Maintenance Treatment|Lack of Efficacy|64
353314|NCT01081912|1193268|P2|Maintenance Treatment|Lack of Efficacy|14
353315|NCT01081912|1193269|P1|Maintenance Treatment|Lack of Efficacy|0
353316|NCT01081912|1193267|P3|Maintenance Treatment|Adverse Event|12
353317|NCT01081912|1193268|P2|Maintenance Treatment|Adverse Event|2
353318|NCT01081912|1193269|P1|Maintenance Treatment|Adverse Event|0
353319|NCT01081912|1193267|P3|Conversion/Titration|Non-Compliance|0
353320|NCT01081912|1193268|P2|Conversion/Titration|Non-Compliance|0
353321|NCT01081912|1193269|P1|Conversion/Titration|Non-Compliance|47
353322|NCT01081912|1193267|P3|Conversion/Titration|Withdrawal by Subject|0
353323|NCT01081912|1193268|P2|Conversion/Titration|Withdrawal by Subject|0
353324|NCT01081912|1193269|P1|Conversion/Titration|Withdrawal by Subject|23
353325|NCT01081912|1193267|P3|Conversion/Titration|Protocol Violation|0
353326|NCT01081912|1193268|P2|Conversion/Titration|Protocol Violation|0
353327|NCT01081912|1193269|P1|Conversion/Titration|Protocol Violation|67
353328|NCT01081912|1193267|P3|Conversion/Titration|Physician Decision|0
353329|NCT01081912|1193268|P2|Conversion/Titration|Physician Decision|0
353330|NCT01081912|1193269|P1|Conversion/Titration|Physician Decision|2
353331|NCT01081912|1193267|P3|Conversion/Titration|Lost to Follow-up|0
353332|NCT01081912|1193268|P2|Conversion/Titration|Lost to Follow-up|0
353333|NCT01081912|1193269|P1|Conversion/Titration|Lost to Follow-up|5
353334|NCT01081912|1193267|P3|Conversion/Titration|Lack of Efficacy|0
353335|NCT01081912|1193268|P2|Conversion/Titration|Lack of Efficacy|0
353336|NCT01081912|1193269|P1|Conversion/Titration|Lack of Efficacy|17
353337|NCT01081912|1193267|P3|Conversion/Titration|Adverse Event|0
353338|NCT01081912|1193268|P2|Conversion/Titration|Adverse Event|0
353339|NCT01081912|1193269|P1|Conversion/Titration|Adverse Event|47
353340|NCT01081886|1193278|P2|Overall Study|Study termination|13
353341|NCT01081886|1193279|P1|Overall Study|Study termination|11
353342|NCT01081873|1193287|P1|Overall Study|Other|47
353343|NCT01081873|1193287|P1|Overall Study|Progression of prostate cancer|13
353344|NCT01081873|1193287|P1|Overall Study|Lost to Follow-up|142
353345|NCT01081873|1193287|P1|Overall Study|Withdrawal by Subject|10
353346|NCT01081873|1193287|P1|Overall Study|Death|86
353347|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
353348|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
353349|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
353350|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
353351|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
353352|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
353353|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
353354|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
353355|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
353356|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
353357|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Not specified|0
353358|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Not specified|0
353359|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Not specified|4
353360|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Not specified|5
353361|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Not specified|4
353362|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
353363|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
353364|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
353365|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
353366|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
353367|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
353368|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
353369|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
353370|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
353371|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
353372|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
353373|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
353374|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
353375|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
353376|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
353377|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
353378|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
353379|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
353380|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
353381|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
353382|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
353383|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
353384|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
353385|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
353386|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
353387|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Death|0
353388|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Death|0
353389|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Death|0
353390|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Death|0
353391|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Death|1
353392|NCT01081834|1193359|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
353393|NCT01081834|1193360|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
353394|NCT01081834|1193361|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
353395|NCT01081834|1193362|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
353396|NCT01081834|1193363|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
353397|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
353398|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
353399|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
353400|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
353401|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
353402|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Not specified|0
353403|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Not specified|1
353404|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Not specified|3
353405|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Not specified|4
353406|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Not specified|4
353407|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
353408|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
353409|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
353410|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
353411|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
353412|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
353413|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
353414|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
353415|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
353416|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
353417|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
353418|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
353419|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
353420|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
353421|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
353422|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Protocol Violation|2
353423|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Protocol Violation|0
353424|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Protocol Violation|0
353425|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Protocol Violation|4
353426|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Protocol Violation|0
353427|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
353428|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
353429|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
353430|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
353431|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
353432|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Death|0
353433|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Death|0
353434|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Death|0
353435|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Death|0
353436|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Death|1
353437|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Adverse Event|1
353522|NCT01081301|1193537|P1|Overall Study|Patient too ill|2
353438|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Adverse Event|1
353439|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Adverse Event|3
353440|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Adverse Event|5
353441|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Adverse Event|2
353442|NCT01081834|1193359|P5|Core Period: Baseline to Week 26|Pregnancy|0
353443|NCT01081834|1193360|P4|Core Period: Baseline to Week 26|Pregnancy|0
353444|NCT01081834|1193361|P3|Core Period: Baseline to Week 26|Pregnancy|0
353445|NCT01081834|1193362|P2|Core Period: Baseline to Week 26|Pregnancy|0
353446|NCT01081834|1193363|P1|Core Period: Baseline to Week 26|Pregnancy|1
353447|NCT01081795|1193424|P3|Overall Study|Other|0
353448|NCT01081795|1193425|P2|Overall Study|Other|2
353449|NCT01081795|1193426|P1|Overall Study|Other|1
353450|NCT01081795|1193424|P3|Overall Study|Using drug with restricted days of use|2
353451|NCT01081795|1193425|P2|Overall Study|Using drug with restricted days of use|3
353452|NCT01081795|1193426|P1|Overall Study|Using drug with restricted days of use|2
353453|NCT01081795|1193424|P3|Overall Study|Use of a prohibited concomitant drug|1
353454|NCT01081795|1193425|P2|Overall Study|Use of a prohibited concomitant drug|1
353455|NCT01081795|1193426|P1|Overall Study|Use of a prohibited concomitant drug|1
353456|NCT01081795|1193424|P3|Overall Study|Ineligible for participation|0
353457|NCT01081795|1193425|P2|Overall Study|Ineligible for participation|0
353458|NCT01081795|1193426|P1|Overall Study|Ineligible for participation|1
353459|NCT01081795|1193424|P3|Overall Study|Revocation of informed consent|0
353460|NCT01081795|1193425|P2|Overall Study|Revocation of informed consent|0
353461|NCT01081795|1193426|P1|Overall Study|Revocation of informed consent|2
353462|NCT01081795|1193424|P3|Overall Study|Subject’s schedule|2
353463|NCT01081795|1193425|P2|Overall Study|Subject’s schedule|1
353464|NCT01081795|1193426|P1|Overall Study|Subject’s schedule|1
353465|NCT01081795|1193424|P3|Overall Study|Lack of Efficacy|19
353466|NCT01081795|1193425|P2|Overall Study|Lack of Efficacy|5
353467|NCT01081795|1193426|P1|Overall Study|Lack of Efficacy|7
353468|NCT01081795|1193424|P3|Overall Study|Adverse Event|6
353469|NCT01081795|1193425|P2|Overall Study|Adverse Event|23
353470|NCT01081795|1193426|P1|Overall Study|Adverse Event|18
353471|NCT01081769|1193463|P2|CORE Intent-To-Treat|Patient Moved|2
353472|NCT01081769|1193464|P1|CORE Intent-To-Treat|Patient Moved|2
353473|NCT01081769|1193463|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
353474|NCT01081769|1193464|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
353475|NCT01081769|1193463|P2|CORE Intent-To-Treat|Ineligibility|4
353476|NCT01081769|1193464|P1|CORE Intent-To-Treat|Ineligibility|3
353477|NCT01081769|1193463|P2|CORE Intent-To-Treat|Other|1
353478|NCT01081769|1193464|P1|CORE Intent-To-Treat|Other|0
353479|NCT01081769|1193463|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
353480|NCT01081769|1193464|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
353481|NCT01081769|1193463|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
353482|NCT01081769|1193464|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
353483|NCT01081769|1193463|P2|CORE Intent-To-Treat|Pregnancy|0
353484|NCT01081769|1193464|P1|CORE Intent-To-Treat|Pregnancy|1
353485|NCT01081769|1193463|P2|CORE Intent-To-Treat|Lost to Follow-up|5
353486|NCT01081769|1193464|P1|CORE Intent-To-Treat|Lost to Follow-up|4
353487|NCT01081769|1193463|P2|CORE Intent-To-Treat|Lack of Efficacy|6
353488|NCT01081769|1193464|P1|CORE Intent-To-Treat|Lack of Efficacy|2
353489|NCT01081769|1193463|P2|CORE Intent-To-Treat|Death|1
353490|NCT01081769|1193464|P1|CORE Intent-To-Treat|Death|1
353491|NCT01081769|1193463|P2|CORE Intent-To-Treat|Adverse Event|11
353492|NCT01081769|1193464|P1|CORE Intent-To-Treat|Adverse Event|14
353493|NCT01081769|1193463|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
353494|NCT01081769|1193464|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
353495|NCT01081769|1193463|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
353496|NCT01081769|1193464|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
353497|NCT01081769|1193463|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
353498|NCT01081769|1193464|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
353499|NCT01081769|1193463|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
353500|NCT01081769|1193464|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
353501|NCT01081665|1193498|P1|Overall Study|Lack of Efficacy|1
353502|NCT01081665|1193498|P1|Overall Study|Adverse Event|1
353503|NCT01081665|1193498|P1|Overall Study|Change in renal replacement therapy|2
353504|NCT01081665|1193498|P1|Overall Study|Regulation of iPTH|5
353505|NCT01081665|1193498|P1|Overall Study|Change of dialysis unit|10
353506|NCT01081665|1193498|P1|Overall Study|Withdrawal by Subject|17
353507|NCT01081665|1193498|P1|Overall Study|Lost to Follow-up|18
353508|NCT01081665|1193498|P1|Overall Study|Death|41
353509|NCT01081626|1193510|P2|Overall Study|Other|30
353510|NCT01081626|1193511|P1|Overall Study|Other|33
353511|NCT01081626|1193510|P2|Overall Study|Lost to Follow-up|1
353512|NCT01081626|1193511|P1|Overall Study|Lost to Follow-up|0
353513|NCT01081626|1193510|P2|Overall Study|Overstimulation|1
353514|NCT01081626|1193511|P1|Overall Study|Overstimulation|0
353515|NCT01081626|1193510|P2|Overall Study|Low antral follicle count|0
353516|NCT01081626|1193511|P1|Overall Study|Low antral follicle count|1
353517|NCT01081626|1193510|P2|Overall Study|Missing Estradiol|28
353518|NCT01081626|1193511|P1|Overall Study|Missing Estradiol|25
353519|NCT01081626|1193510|P2|Overall Study|Dosing error|1
353520|NCT01081626|1193511|P1|Overall Study|Dosing error|1
353521|NCT01081301|1193537|P1|Overall Study|Lost to Follow-up|4
353523|NCT01081301|1193537|P1|Overall Study|Too busy|5
353524|NCT01081301|1193537|P1|Overall Study|Bereaved|3
353525|NCT01081249|1193575|P2|Overall Study|Diagnosed with Bipolar Disorder|1
353526|NCT01081249|1193576|P1|Overall Study|Diagnosed with Bipolar Disorder|0
353527|NCT01081145|1193582|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
353528|NCT01081145|1193583|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
353529|NCT01081145|1193582|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
353530|NCT01081145|1193583|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
353531|NCT01081145|1193582|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
353532|NCT01081145|1193583|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
353533|NCT01081145|1193582|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
353534|NCT01081145|1193583|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
353535|NCT01081145|1193582|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
353536|NCT01081145|1193583|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
353537|NCT01081145|1193582|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
353538|NCT01081145|1193583|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
353539|NCT01081145|1193582|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
353540|NCT01081145|1193583|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
353541|NCT01081145|1193582|P2|Open-Label Phase|Protocol Violation|0
353542|NCT01081145|1193583|P1|Open-Label Phase|Protocol Violation|4
353543|NCT01081145|1193582|P2|Open-Label Phase|Lost to Follow-up|0
353544|NCT01081145|1193583|P1|Open-Label Phase|Lost to Follow-up|11
353545|NCT01081145|1193582|P2|Open-Label Phase|Not specified|0
353546|NCT01081145|1193583|P1|Open-Label Phase|Not specified|12
353547|NCT01081145|1193582|P2|Open-Label Phase|Withdrawal by Subject|0
353548|NCT01081145|1193583|P1|Open-Label Phase|Withdrawal by Subject|41
353549|NCT01081145|1193582|P2|Open-Label Phase|Adverse Event|0
353550|NCT01081145|1193583|P1|Open-Label Phase|Adverse Event|42
353551|NCT01081145|1193582|P2|Open-Label Phase|Response criteria not met|0
353552|NCT01081145|1193583|P1|Open-Label Phase|Response criteria not met|46
353553|NCT01081145|1193582|P2|Open-Label Phase|Lack of Efficacy|0
353554|NCT01081145|1193583|P1|Open-Label Phase|Lack of Efficacy|56
353555|NCT01081132|1193611|P2|Overall Study|Protocol Violation|1
353556|NCT01081132|1193612|P1|Overall Study|Protocol Violation|3
353557|NCT01081132|1193611|P2|Overall Study|Declined Taper Phase|1
353558|NCT01081132|1193612|P1|Overall Study|Declined Taper Phase|0
353559|NCT01081132|1193611|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
353560|NCT01081132|1193612|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
353561|NCT01081132|1193611|P2|Overall Study|Stopped Taking Meds|0
353562|NCT01081132|1193612|P1|Overall Study|Stopped Taking Meds|2
353563|NCT01081132|1193611|P2|Overall Study|Missed Visits|1
353564|NCT01081132|1193612|P1|Overall Study|Missed Visits|1
353565|NCT01081132|1193611|P2|Overall Study|Lack Of Compliance|1
353566|NCT01081132|1193612|P1|Overall Study|Lack Of Compliance|0
353567|NCT01081132|1193611|P2|Overall Study|Non Compliance|2
353568|NCT01081132|1193612|P1|Overall Study|Non Compliance|4
353569|NCT01081132|1193611|P2|Overall Study|Adverse Event|9
353570|NCT01081132|1193612|P1|Overall Study|Adverse Event|3
353571|NCT01081132|1193611|P2|Overall Study|Lost to Follow-up|11
353572|NCT01081132|1193612|P1|Overall Study|Lost to Follow-up|4
353573|NCT01081132|1193611|P2|Overall Study|Withdrawal by Subject|16
353574|NCT01081132|1193612|P1|Overall Study|Withdrawal by Subject|13
353575|NCT01081132|1193611|P2|Overall Study|Lack of Efficacy|9
353576|NCT01081132|1193612|P1|Overall Study|Lack of Efficacy|25
353577|NCT01080807|1193696|P2|Overall Study|Moved away without notifying center|0
353578|NCT01080807|1193697|P1|Overall Study|Moved away without notifying center|1
353579|NCT01080807|1193696|P2|Overall Study|Switched to first shift|0
353580|NCT01080807|1193697|P1|Overall Study|Switched to first shift|1
353581|NCT01080807|1193696|P2|Overall Study|Work schedule and travel|1
353582|NCT01080807|1193697|P1|Overall Study|Work schedule and travel|0
353583|NCT01080807|1193696|P2|Overall Study|Work schedule changing|1
353584|NCT01080807|1193697|P1|Overall Study|Work schedule changing|1
353585|NCT01080807|1193696|P2|Overall Study|Stopped working consistent night shifts|1
353586|NCT01080807|1193697|P1|Overall Study|Stopped working consistent night shifts|0
353587|NCT01080807|1193696|P2|Overall Study|Laid off or terminated from job|2
353588|NCT01080807|1193697|P1|Overall Study|Laid off or terminated from job|1
353589|NCT01080807|1193696|P2|Overall Study|Began working day shift|2
353590|NCT01080807|1193697|P1|Overall Study|Began working day shift|0
353591|NCT01080807|1193696|P2|Overall Study|Noncompliance to study procedures|1
353592|NCT01080807|1193697|P1|Overall Study|Noncompliance to study procedures|1
353593|NCT01080807|1193696|P2|Overall Study|Noncompliance with drug administration|1
353594|NCT01080807|1193697|P1|Overall Study|Noncompliance with drug administration|1
353595|NCT01080807|1193696|P2|Overall Study|Lost to Follow-up|4
353596|NCT01080807|1193697|P1|Overall Study|Lost to Follow-up|6
353597|NCT01080807|1193696|P2|Overall Study|Protocol Violation|6
353598|NCT01080807|1193697|P1|Overall Study|Protocol Violation|7
353599|NCT01080807|1193696|P2|Overall Study|Withdrawal by Subject|2
353600|NCT01080807|1193697|P1|Overall Study|Withdrawal by Subject|7
353601|NCT01080807|1193696|P2|Overall Study|Lack of Efficacy|1
353602|NCT01080807|1193697|P1|Overall Study|Lack of Efficacy|0
353603|NCT01080807|1193696|P2|Overall Study|Adverse Event|1
353604|NCT01080807|1193697|P1|Overall Study|Adverse Event|9
353605|NCT01080768|1193806|P2|Overall Study|Protocol Deviation|1
353606|NCT01080768|1193807|P1|Overall Study|Protocol Deviation|2
353607|NCT01080625|1193838|P3|Overall Study|Physician Decision|1
353608|NCT01080625|1193839|P2|Overall Study|Physician Decision|2
353609|NCT01080625|1193840|P1|Overall Study|Physician Decision|0
353610|NCT01080391|1193850|P2|Overall Study|Withdrawal by Subject|10
353611|NCT01080391|1193851|P1|Overall Study|Withdrawal by Subject|19
353612|NCT01080391|1193850|P2|Overall Study|Lost to Follow-up|3
353613|NCT01080391|1193851|P1|Overall Study|Lost to Follow-up|4
353614|NCT01080326|1193869|P1|Overall Study|Surgeon decision|1
353615|NCT01080326|1193869|P1|Overall Study|Patient deterioration prior to procedure|3
353616|NCT01080300|1193875|P2|Overall Study|Reasons not specified|6
353617|NCT01080300|1193876|P1|Overall Study|Reasons not specified|4
353618|NCT01080300|1193875|P2|Overall Study|Withdrawal by Subject|28
353619|NCT01080300|1193876|P1|Overall Study|Withdrawal by Subject|12
353620|NCT01080300|1193875|P2|Overall Study|Death|1
353621|NCT01080300|1193876|P1|Overall Study|Death|0
353622|NCT01080300|1193875|P2|Overall Study|Lost to Follow-up|6
353623|NCT01080300|1193876|P1|Overall Study|Lost to Follow-up|10
353624|NCT01080300|1193875|P2|Overall Study|Protocol Violation|13
353625|NCT01080300|1193876|P1|Overall Study|Protocol Violation|7
353626|NCT01080300|1193875|P2|Overall Study|Lack of Efficacy|15
353627|NCT01080300|1193876|P1|Overall Study|Lack of Efficacy|12
353628|NCT01080300|1193875|P2|Overall Study|Adverse Event|35
353629|NCT01080300|1193876|P1|Overall Study|Adverse Event|49
353630|NCT01080131|1193961|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
353631|NCT01080131|1193962|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
353632|NCT01080131|1193961|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
353633|NCT01080131|1193962|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
353634|NCT01080131|1193961|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
353635|NCT01080131|1193962|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
353636|NCT01080131|1193961|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
353637|NCT01080131|1193962|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
353638|NCT01080131|1193961|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
353639|NCT01080131|1193962|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
353640|NCT01080131|1193961|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
353641|NCT01080131|1193962|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
353642|NCT01080131|1193961|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
353643|NCT01080131|1193962|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
353644|NCT01080131|1193961|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
353645|NCT01080131|1193962|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
353646|NCT01080131|1193961|P2|Core Study (0- 12 Weeks)|Death|0
353647|NCT01080131|1193962|P1|Core Study (0- 12 Weeks)|Death|1
353648|NCT01080131|1193961|P2|Core Study (0- 12 Weeks)|Administrative problems|1
353649|NCT01080131|1193962|P1|Core Study (0- 12 Weeks)|Administrative problems|0
353650|NCT01080131|1193961|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
353651|NCT01080131|1193962|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
353652|NCT01080131|1193961|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
353653|NCT01080131|1193962|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
353654|NCT01080131|1193961|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
353655|NCT01080131|1193962|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
353656|NCT01079988|1194057|P5|Overall Study|Other|1
353657|NCT01079988|1194058|P4|Overall Study|Other|2
353658|NCT01079988|1194059|P3|Overall Study|Other|0
353659|NCT01079988|1194060|P2|Overall Study|Other|0
353660|NCT01079988|1194061|P1|Overall Study|Other|0
353661|NCT01079988|1194057|P5|Overall Study|Lack of Efficacy|0
353662|NCT01079988|1194058|P4|Overall Study|Lack of Efficacy|0
353663|NCT01079988|1194059|P3|Overall Study|Lack of Efficacy|0
353664|NCT01079988|1194060|P2|Overall Study|Lack of Efficacy|0
353665|NCT01079988|1194061|P1|Overall Study|Lack of Efficacy|1
353666|NCT01079988|1194057|P5|Overall Study|Lost to Follow-up|0
353667|NCT01079988|1194058|P4|Overall Study|Lost to Follow-up|1
353668|NCT01079988|1194059|P3|Overall Study|Lost to Follow-up|0
353669|NCT01079988|1194060|P2|Overall Study|Lost to Follow-up|0
353670|NCT01079988|1194061|P1|Overall Study|Lost to Follow-up|0
353671|NCT01079962|1194080|P2|Overall Study|Due to arrhythmia/bradycardia|1
353672|NCT01079962|1194081|P1|Overall Study|Due to arrhythmia/bradycardia|1
353673|NCT01079962|1194080|P2|Overall Study|Participant not returning for next visit|0
353674|NCT01079962|1194081|P1|Overall Study|Participant not returning for next visit|1
353675|NCT01079962|1194080|P2|Overall Study|Inclusion/exclusion criteria|3
353676|NCT01079962|1194081|P1|Overall Study|Inclusion/exclusion criteria|1
353677|NCT01079962|1194080|P2|Overall Study|No blood pressure (BP) control|0
353678|NCT01079962|1194081|P1|Overall Study|No blood pressure (BP) control|3
353679|NCT01079962|1194080|P2|Overall Study|Protocol Violation|2
353680|NCT01079962|1194081|P1|Overall Study|Protocol Violation|2
353681|NCT01079962|1194080|P2|Overall Study|Withdrawal by Subject|7
353682|NCT01079962|1194081|P1|Overall Study|Withdrawal by Subject|5
353683|NCT01079962|1194080|P2|Overall Study|Adverse Event|2
353684|NCT01079962|1194081|P1|Overall Study|Adverse Event|2
353685|NCT01079949|1194109|P2|Overall Study|Randomized but not treated|0
353686|NCT01079949|1194110|P1|Overall Study|Randomized but not treated|1
353687|NCT01079949|1194109|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
353688|NCT01079949|1194110|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
353689|NCT01079949|1194109|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
353690|NCT01079949|1194110|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
353691|NCT01079949|1194109|P2|Overall Study|Withdrawal before r-hCG administration|3
353692|NCT01079949|1194110|P1|Overall Study|Withdrawal before r-hCG administration|2
353693|NCT01079936|1194156|P5|Phase II|Insurance Issue|1
353694|NCT01079936|1194157|P4|Phase II|Insurance Issue|0
353695|NCT01079936|1194158|P3|Phase II|Insurance Issue|0
353696|NCT01079936|1194159|P2|Phase II|Insurance Issue|0
353697|NCT01079936|1194160|P1|Phase II|Insurance Issue|0
353698|NCT01079936|1194156|P5|Phase II|Adverse Event|0
353699|NCT01079936|1194157|P4|Phase II|Adverse Event|0
353700|NCT01079936|1194158|P3|Phase II|Adverse Event|1
353701|NCT01079936|1194159|P2|Phase II|Adverse Event|0
353702|NCT01079936|1194160|P1|Phase II|Adverse Event|0
353703|NCT01079936|1194156|P5|Phase I: MTD|No Stem Cell Transplantation|0
353704|NCT01079936|1194157|P4|Phase I: MTD|No Stem Cell Transplantation|0
353705|NCT01079936|1194158|P3|Phase I: MTD|No Stem Cell Transplantation|0
353706|NCT01079936|1194159|P2|Phase I: MTD|No Stem Cell Transplantation|0
353707|NCT01079936|1194160|P1|Phase I: MTD|No Stem Cell Transplantation|2
353708|NCT01079936|1194156|P5|Phase I: MTD|First Remission Status|0
353709|NCT01079936|1194157|P4|Phase I: MTD|First Remission Status|0
353710|NCT01079936|1194158|P3|Phase I: MTD|First Remission Status|0
353711|NCT01079936|1194159|P2|Phase I: MTD|First Remission Status|0
353712|NCT01079936|1194160|P1|Phase I: MTD|First Remission Status|2
353713|NCT01079832|1194179|P1|Overall Study|Withdrawal by Subject|1
353714|NCT01079806|1194189|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
353715|NCT01079806|1194190|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
353716|NCT01079806|1194189|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
353717|NCT01079806|1194190|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
353718|NCT01079806|1194189|P2|Day 1 to Week 96|Pregnancy|1
353719|NCT01079806|1194190|P1|Day 1 to Week 96|Pregnancy|0
353720|NCT01079806|1194189|P2|Day 1 to Week 96|Withdrawal by Subject|1
353721|NCT01079806|1194190|P1|Day 1 to Week 96|Withdrawal by Subject|3
353722|NCT01079806|1194189|P2|Day 1 to Week 96|Adverse Event|2
353723|NCT01079806|1194190|P1|Day 1 to Week 96|Adverse Event|0
353724|NCT01079741|1194215|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
353725|NCT01079741|1194216|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
353726|NCT01079741|1194217|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
353727|NCT01079741|1194218|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
353728|NCT01079741|1194219|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
353729|NCT01079741|1194215|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
353730|NCT01079741|1194216|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
353731|NCT01079741|1194217|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
353732|NCT01079741|1194218|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
353733|NCT01079741|1194219|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
353734|NCT01079234|1194267|P4|Extension: Week 27 to 52|Unclassified|7
353735|NCT01079234|1194268|P3|Extension: Week 27 to 52|Unclassified|4
353736|NCT01079234|1194269|P2|Extension: Week 27 to 52|Unclassified|0
353737|NCT01079234|1194270|P1|Extension: Week 27 to 52|Unclassified|0
353738|NCT01079234|1194267|P4|Extension: Week 27 to 52|Withdrawal criteria|2
353739|NCT01079234|1194268|P3|Extension: Week 27 to 52|Withdrawal criteria|4
353740|NCT01079234|1194269|P2|Extension: Week 27 to 52|Withdrawal criteria|0
353741|NCT01079234|1194270|P1|Extension: Week 27 to 52|Withdrawal criteria|0
353742|NCT01079234|1194267|P4|Extension: Week 27 to 52|Protocol Violation|5
353743|NCT01079234|1194268|P3|Extension: Week 27 to 52|Protocol Violation|2
353744|NCT01079234|1194269|P2|Extension: Week 27 to 52|Protocol Violation|0
353745|NCT01079234|1194270|P1|Extension: Week 27 to 52|Protocol Violation|0
353746|NCT01079234|1194267|P4|Extension: Week 27 to 52|Lack of Efficacy|2
353747|NCT01079234|1194268|P3|Extension: Week 27 to 52|Lack of Efficacy|0
353748|NCT01079234|1194269|P2|Extension: Week 27 to 52|Lack of Efficacy|0
353749|NCT01079234|1194270|P1|Extension: Week 27 to 52|Lack of Efficacy|0
353750|NCT01079234|1194267|P4|Extension: Week 27 to 52|Adverse Event|0
353751|NCT01079234|1194268|P3|Extension: Week 27 to 52|Adverse Event|1
353752|NCT01079234|1194269|P2|Extension: Week 27 to 52|Adverse Event|0
353753|NCT01079234|1194270|P1|Extension: Week 27 to 52|Adverse Event|0
353754|NCT01079234|1194267|P4|Main: Week 0 to 26|Unclassified|0
353755|NCT01079234|1194268|P3|Main: Week 0 to 26|Unclassified|4
353756|NCT01079234|1194269|P2|Main: Week 0 to 26|Unclassified|13
353757|NCT01079234|1194270|P1|Main: Week 0 to 26|Unclassified|7
353758|NCT01079234|1194267|P4|Main: Week 0 to 26|Withdrawal criteria|0
353759|NCT01079234|1194268|P3|Main: Week 0 to 26|Withdrawal criteria|2
353760|NCT01079234|1194269|P2|Main: Week 0 to 26|Withdrawal criteria|6
353761|NCT01079234|1194270|P1|Main: Week 0 to 26|Withdrawal criteria|6
353762|NCT01079234|1194267|P4|Main: Week 0 to 26|Protocol Violation|0
353763|NCT01079234|1194268|P3|Main: Week 0 to 26|Protocol Violation|4
353764|NCT01079234|1194269|P2|Main: Week 0 to 26|Protocol Violation|2
353765|NCT01079234|1194270|P1|Main: Week 0 to 26|Protocol Violation|6
353766|NCT01079234|1194267|P4|Main: Week 0 to 26|Lack of Efficacy|0
353767|NCT01079234|1194268|P3|Main: Week 0 to 26|Lack of Efficacy|1
353768|NCT01079234|1194269|P2|Main: Week 0 to 26|Lack of Efficacy|1
353769|NCT01079234|1194270|P1|Main: Week 0 to 26|Lack of Efficacy|2
353770|NCT01079234|1194267|P4|Main: Week 0 to 26|Adverse Event|0
353771|NCT01079234|1194268|P3|Main: Week 0 to 26|Adverse Event|1
353772|NCT01079234|1194269|P2|Main: Week 0 to 26|Adverse Event|4
353773|NCT01079234|1194270|P1|Main: Week 0 to 26|Adverse Event|5
353774|NCT01079195|1194288|P1|Overall Study|Non-compliance|2
353775|NCT01079195|1194288|P1|Overall Study|No Follow-up Documentation Available|4
353776|NCT01079195|1194288|P1|Overall Study|Improved Status of Participant|4
353777|NCT01079195|1194288|P1|Overall Study|Physician Decision|4
353778|NCT01079195|1194288|P1|Overall Study|Lack of Effectiveness|12
353779|NCT01079195|1194288|P1|Overall Study|Financial Reasons|15
353780|NCT01079195|1194288|P1|Overall Study|Withdrawal by Subject|18
353781|NCT01079195|1194288|P1|Overall Study|Reason Unknown|39
353782|NCT01079195|1194288|P1|Overall Study|Adverse Event|157
353783|NCT01079195|1194288|P1|Overall Study|No Documentation Available|437
353784|NCT01079195|1194288|P1|Overall Study|No Documentation of Tarka Therapy|739
353785|NCT01079182|1194294|P1|Overall Study|Reasons not Evaluated|271
353786|NCT01079182|1194294|P1|Overall Study|ADR and Lack of Effectiveness|39
353787|NCT01079182|1194294|P1|Overall Study|Lack of Efficacy|514
353788|NCT01079182|1194294|P1|Overall Study|Adverse Drug Reaction (ADR)|261
353789|NCT01079182|1194294|P1|Overall Study|Lost to Follow-up|1634
353790|NCT01079130|1194402|P6|Overall Study|Lost to Follow-up|0
353791|NCT01079130|1194403|P5|Overall Study|Lost to Follow-up|1
353792|NCT01079130|1194404|P4|Overall Study|Lost to Follow-up|0
353793|NCT01079130|1194405|P3|Overall Study|Lost to Follow-up|0
353794|NCT01079130|1194406|P2|Overall Study|Lost to Follow-up|0
353795|NCT01079130|1194407|P1|Overall Study|Lost to Follow-up|0
353796|NCT01079130|1194402|P6|Overall Study|Unsatisfactory therapeutic effect|0
353797|NCT01079130|1194403|P5|Overall Study|Unsatisfactory therapeutic effect|0
353798|NCT01079130|1194404|P4|Overall Study|Unsatisfactory therapeutic effect|2
353799|NCT01079130|1194405|P3|Overall Study|Unsatisfactory therapeutic effect|0
353800|NCT01079130|1194406|P2|Overall Study|Unsatisfactory therapeutic effect|0
353801|NCT01079130|1194407|P1|Overall Study|Unsatisfactory therapeutic effect|0
353802|NCT01079130|1194402|P6|Overall Study|Abnormal test procedure result(s)|0
353803|NCT01079130|1194403|P5|Overall Study|Abnormal test procedure result(s)|1
353804|NCT01079130|1194404|P4|Overall Study|Abnormal test procedure result(s)|0
353805|NCT01079130|1194405|P3|Overall Study|Abnormal test procedure result(s)|0
353806|NCT01079130|1194406|P2|Overall Study|Abnormal test procedure result(s)|0
353807|NCT01079130|1194407|P1|Overall Study|Abnormal test procedure result(s)|0
353808|NCT01079130|1194402|P6|Overall Study|Protocol deviation|0
353809|NCT01079130|1194403|P5|Overall Study|Protocol deviation|0
353810|NCT01079130|1194404|P4|Overall Study|Protocol deviation|2
353811|NCT01079130|1194405|P3|Overall Study|Protocol deviation|1
353812|NCT01079130|1194406|P2|Overall Study|Protocol deviation|2
353813|NCT01079130|1194407|P1|Overall Study|Protocol deviation|0
353814|NCT01079130|1194402|P6|Overall Study|Withdrawal by Subject|3
353815|NCT01079130|1194403|P5|Overall Study|Withdrawal by Subject|1
353816|NCT01079130|1194404|P4|Overall Study|Withdrawal by Subject|0
353817|NCT01079130|1194405|P3|Overall Study|Withdrawal by Subject|0
353818|NCT01079130|1194406|P2|Overall Study|Withdrawal by Subject|1
353819|NCT01079130|1194407|P1|Overall Study|Withdrawal by Subject|0
353820|NCT01079130|1194402|P6|Overall Study|Administrative problems|1
353821|NCT01079130|1194403|P5|Overall Study|Administrative problems|0
353822|NCT01079130|1194404|P4|Overall Study|Administrative problems|0
353823|NCT01079130|1194405|P3|Overall Study|Administrative problems|0
353824|NCT01079130|1194406|P2|Overall Study|Administrative problems|3
353825|NCT01079130|1194407|P1|Overall Study|Administrative problems|1
353826|NCT01079130|1194402|P6|Overall Study|Adverse Event|1
353827|NCT01079130|1194403|P5|Overall Study|Adverse Event|5
353828|NCT01079130|1194404|P4|Overall Study|Adverse Event|1
353829|NCT01079130|1194405|P3|Overall Study|Adverse Event|0
353830|NCT01079130|1194406|P2|Overall Study|Adverse Event|1
353831|NCT01079130|1194407|P1|Overall Study|Adverse Event|1
353832|NCT01078974|1194427|P1|Overall Study|Adverse Event|3
353833|NCT01078922|1194432|P1|Overall Study|Adverse Event|1
353834|NCT01078805|1194473|P1|Overall Study|Didn't take study drug|82
353835|NCT01078805|1194473|P1|Overall Study|Other|173
353836|NCT01078805|1194473|P1|Overall Study|Withdrawal by Subject|739
353837|NCT01078805|1194473|P1|Overall Study|Sponsor decision|46
353838|NCT01078805|1194473|P1|Overall Study|Serious adverse event|26
353839|NCT01078805|1194473|P1|Overall Study|Physician Decision|169
353840|NCT01078805|1194473|P1|Overall Study|Lost to Follow-up|676
353841|NCT01078805|1194473|P1|Overall Study|Death|134
353842|NCT01078805|1194473|P1|Overall Study|Clinically significant abnormal lab|5
353843|NCT01078675|1194500|P2|Overall Study|Adverse Event|0
353844|NCT01078675|1194501|P1|Overall Study|Adverse Event|3
353845|NCT01078675|1194500|P2|Overall Study|Provided in CRF for specific reasons|3
353846|NCT01078675|1194501|P1|Overall Study|Provided in CRF for specific reasons|2
353847|NCT01078675|1194500|P2|Overall Study|Protocol Violation|0
353848|NCT01078675|1194501|P1|Overall Study|Protocol Violation|56
353849|NCT01078675|1194500|P2|Overall Study|Withdrawal by Subject|3
353850|NCT01078675|1194501|P1|Overall Study|Withdrawal by Subject|7
353851|NCT01078662|1194523|P5|Overall Study|Lost to Follow-up|0
353852|NCT01078662|1194524|P4|Overall Study|Lost to Follow-up|0
353853|NCT01078662|1194525|P3|Overall Study|Lost to Follow-up|0
353854|NCT01078662|1194526|P2|Overall Study|Lost to Follow-up|0
353855|NCT01078662|1194527|P1|Overall Study|Lost to Follow-up|1
353856|NCT01078662|1194523|P5|Overall Study|Protocol Violation|0
353857|NCT01078662|1194524|P4|Overall Study|Protocol Violation|0
353858|NCT01078662|1194525|P3|Overall Study|Protocol Violation|0
353859|NCT01078662|1194526|P2|Overall Study|Protocol Violation|1
353860|NCT01078662|1194527|P1|Overall Study|Protocol Violation|0
353861|NCT01078662|1194523|P5|Overall Study|Withdrawal by Subject|0
353862|NCT01078662|1194524|P4|Overall Study|Withdrawal by Subject|0
353863|NCT01078662|1194525|P3|Overall Study|Withdrawal by Subject|1
353864|NCT01078662|1194526|P2|Overall Study|Withdrawal by Subject|11
353865|NCT01078662|1194527|P1|Overall Study|Withdrawal by Subject|4
353866|NCT01078662|1194523|P5|Overall Study|Patients reached data cut-off|3
353867|NCT01078662|1194524|P4|Overall Study|Patients reached data cut-off|2
353868|NCT01078662|1194525|P3|Overall Study|Patients reached data cut-off|2
353869|NCT01078662|1194526|P2|Overall Study|Patients reached data cut-off|53
353870|NCT01078662|1194527|P1|Overall Study|Patients reached data cut-off|12
353871|NCT01078662|1194523|P5|Overall Study|Death|8
353872|NCT01078662|1194524|P4|Overall Study|Death|5
353873|NCT01078662|1194525|P3|Overall Study|Death|18
353874|NCT01078662|1194526|P2|Overall Study|Death|103
353875|NCT01078662|1194527|P1|Overall Study|Death|41
353876|NCT01078623|1194566|P20|Treatment Period 4|Withdrawal by Subject|0
353877|NCT01078623|1194567|P19|Treatment Period 4|Withdrawal by Subject|0
353878|NCT01078623|1194568|P18|Treatment Period 4|Withdrawal by Subject|0
353879|NCT01078623|1194569|P17|Treatment Period 4|Withdrawal by Subject|0
353880|NCT01078623|1194570|P16|Treatment Period 4|Withdrawal by Subject|1
353881|NCT01078623|1194571|P15|Treatment Period 4|Withdrawal by Subject|0
353882|NCT01078623|1194572|P14|Treatment Period 4|Withdrawal by Subject|0
353883|NCT01078623|1194573|P13|Treatment Period 4|Withdrawal by Subject|0
353884|NCT01078623|1194574|P12|Treatment Period 4|Withdrawal by Subject|0
353885|NCT01078623|1194575|P11|Treatment Period 4|Withdrawal by Subject|0
353886|NCT01078623|1194576|P10|Treatment Period 4|Withdrawal by Subject|0
353887|NCT01078623|1194577|P9|Treatment Period 4|Withdrawal by Subject|0
353888|NCT01078623|1194578|P8|Treatment Period 4|Withdrawal by Subject|0
353889|NCT01078623|1194579|P7|Treatment Period 4|Withdrawal by Subject|0
353890|NCT01078623|1194580|P6|Treatment Period 4|Withdrawal by Subject|0
353891|NCT01078623|1194581|P5|Treatment Period 4|Withdrawal by Subject|0
353892|NCT01078623|1194582|P4|Treatment Period 4|Withdrawal by Subject|0
353893|NCT01078623|1194583|P3|Treatment Period 4|Withdrawal by Subject|0
353894|NCT01078623|1194584|P2|Treatment Period 4|Withdrawal by Subject|0
353895|NCT01078623|1194585|P1|Treatment Period 4|Withdrawal by Subject|0
353896|NCT01078623|1194566|P20|Treatment Period 4|Adverse Event|0
353897|NCT01078623|1194567|P19|Treatment Period 4|Adverse Event|0
353898|NCT01078623|1194568|P18|Treatment Period 4|Adverse Event|0
353899|NCT01078623|1194569|P17|Treatment Period 4|Adverse Event|0
353900|NCT01078623|1194570|P16|Treatment Period 4|Adverse Event|0
353901|NCT01078623|1194571|P15|Treatment Period 4|Adverse Event|0
353902|NCT01078623|1194572|P14|Treatment Period 4|Adverse Event|0
353903|NCT01078623|1194573|P13|Treatment Period 4|Adverse Event|0
353904|NCT01078623|1194574|P12|Treatment Period 4|Adverse Event|0
353905|NCT01078623|1194575|P11|Treatment Period 4|Adverse Event|0
353906|NCT01078623|1194576|P10|Treatment Period 4|Adverse Event|0
353907|NCT01078623|1194577|P9|Treatment Period 4|Adverse Event|0
353908|NCT01078623|1194578|P8|Treatment Period 4|Adverse Event|0
353909|NCT01078623|1194579|P7|Treatment Period 4|Adverse Event|0
353910|NCT01078623|1194580|P6|Treatment Period 4|Adverse Event|0
353911|NCT01078623|1194581|P5|Treatment Period 4|Adverse Event|0
353912|NCT01078623|1194582|P4|Treatment Period 4|Adverse Event|0
353913|NCT01078623|1194583|P3|Treatment Period 4|Adverse Event|1
353914|NCT01078623|1194584|P2|Treatment Period 4|Adverse Event|0
353915|NCT01078623|1194585|P1|Treatment Period 4|Adverse Event|0
353916|NCT01078623|1194566|P20|Treatment Period 3|Adverse Event|0
353917|NCT01078623|1194567|P19|Treatment Period 3|Adverse Event|0
353918|NCT01078623|1194568|P18|Treatment Period 3|Adverse Event|0
353919|NCT01078623|1194569|P17|Treatment Period 3|Adverse Event|0
353920|NCT01078623|1194570|P16|Treatment Period 3|Adverse Event|0
353921|NCT01078623|1194571|P15|Treatment Period 3|Adverse Event|0
353922|NCT01078623|1194572|P14|Treatment Period 3|Adverse Event|1
353923|NCT01078623|1194573|P13|Treatment Period 3|Adverse Event|0
353924|NCT01078623|1194574|P12|Treatment Period 3|Adverse Event|0
353925|NCT01078623|1194575|P11|Treatment Period 3|Adverse Event|0
353926|NCT01078623|1194576|P10|Treatment Period 3|Adverse Event|0
353927|NCT01078623|1194577|P9|Treatment Period 3|Adverse Event|0
353928|NCT01078623|1194578|P8|Treatment Period 3|Adverse Event|0
353929|NCT01078623|1194579|P7|Treatment Period 3|Adverse Event|0
353930|NCT01078623|1194580|P6|Treatment Period 3|Adverse Event|0
353931|NCT01078623|1194581|P5|Treatment Period 3|Adverse Event|1
353932|NCT01078623|1194582|P4|Treatment Period 3|Adverse Event|0
353933|NCT01078623|1194583|P3|Treatment Period 3|Adverse Event|0
353934|NCT01078623|1194584|P2|Treatment Period 3|Adverse Event|0
353935|NCT01078623|1194585|P1|Treatment Period 3|Adverse Event|0
353936|NCT01078623|1194566|P20|Treatment Period 2|Withdrawal by Subject|0
353937|NCT01078623|1194567|P19|Treatment Period 2|Withdrawal by Subject|0
353938|NCT01078623|1194568|P18|Treatment Period 2|Withdrawal by Subject|0
353939|NCT01078623|1194569|P17|Treatment Period 2|Withdrawal by Subject|0
353940|NCT01078623|1194570|P16|Treatment Period 2|Withdrawal by Subject|0
353941|NCT01078623|1194571|P15|Treatment Period 2|Withdrawal by Subject|0
353942|NCT01078623|1194572|P14|Treatment Period 2|Withdrawal by Subject|0
353943|NCT01078623|1194573|P13|Treatment Period 2|Withdrawal by Subject|0
353944|NCT01078623|1194574|P12|Treatment Period 2|Withdrawal by Subject|0
353945|NCT01078623|1194575|P11|Treatment Period 2|Withdrawal by Subject|0
353946|NCT01078623|1194576|P10|Treatment Period 2|Withdrawal by Subject|0
353947|NCT01078623|1194577|P9|Treatment Period 2|Withdrawal by Subject|0
353948|NCT01078623|1194578|P8|Treatment Period 2|Withdrawal by Subject|0
353949|NCT01078623|1194579|P7|Treatment Period 2|Withdrawal by Subject|0
353950|NCT01078623|1194580|P6|Treatment Period 2|Withdrawal by Subject|1
353951|NCT01078623|1194581|P5|Treatment Period 2|Withdrawal by Subject|0
353952|NCT01078623|1194582|P4|Treatment Period 2|Withdrawal by Subject|0
353953|NCT01078623|1194583|P3|Treatment Period 2|Withdrawal by Subject|0
353954|NCT01078623|1194584|P2|Treatment Period 2|Withdrawal by Subject|0
353955|NCT01078623|1194585|P1|Treatment Period 2|Withdrawal by Subject|0
353956|NCT01078623|1194566|P20|Treatment Period 2|Adverse Event|0
353957|NCT01078623|1194567|P19|Treatment Period 2|Adverse Event|1
353958|NCT01078623|1194568|P18|Treatment Period 2|Adverse Event|0
353959|NCT01078623|1194569|P17|Treatment Period 2|Adverse Event|0
353960|NCT01078623|1194570|P16|Treatment Period 2|Adverse Event|0
353961|NCT01078623|1194571|P15|Treatment Period 2|Adverse Event|0
353962|NCT01078623|1194572|P14|Treatment Period 2|Adverse Event|0
353963|NCT01078623|1194573|P13|Treatment Period 2|Adverse Event|0
353964|NCT01078623|1194574|P12|Treatment Period 2|Adverse Event|0
353965|NCT01078623|1194575|P11|Treatment Period 2|Adverse Event|0
353966|NCT01078623|1194576|P10|Treatment Period 2|Adverse Event|0
353967|NCT01078623|1194577|P9|Treatment Period 2|Adverse Event|0
353968|NCT01078623|1194578|P8|Treatment Period 2|Adverse Event|0
353969|NCT01078623|1194579|P7|Treatment Period 2|Adverse Event|1
353970|NCT01078623|1194580|P6|Treatment Period 2|Adverse Event|0
353971|NCT01078623|1194581|P5|Treatment Period 2|Adverse Event|0
353972|NCT01078623|1194582|P4|Treatment Period 2|Adverse Event|0
353973|NCT01078623|1194583|P3|Treatment Period 2|Adverse Event|0
353974|NCT01078623|1194584|P2|Treatment Period 2|Adverse Event|0
353975|NCT01078623|1194585|P1|Treatment Period 2|Adverse Event|0
353976|NCT01078623|1194566|P20|Treatment Period 1|Protocol Violation|0
353977|NCT01078623|1194567|P19|Treatment Period 1|Protocol Violation|0
353978|NCT01078623|1194568|P18|Treatment Period 1|Protocol Violation|0
353979|NCT01078623|1194569|P17|Treatment Period 1|Protocol Violation|0
353980|NCT01078623|1194570|P16|Treatment Period 1|Protocol Violation|0
353981|NCT01078623|1194571|P15|Treatment Period 1|Protocol Violation|0
353982|NCT01078623|1194572|P14|Treatment Period 1|Protocol Violation|0
353983|NCT01078623|1194573|P13|Treatment Period 1|Protocol Violation|0
353984|NCT01078623|1194574|P12|Treatment Period 1|Protocol Violation|0
353985|NCT01078623|1194575|P11|Treatment Period 1|Protocol Violation|0
353986|NCT01078623|1194576|P10|Treatment Period 1|Protocol Violation|0
353987|NCT01078623|1194577|P9|Treatment Period 1|Protocol Violation|0
353988|NCT01078623|1194578|P8|Treatment Period 1|Protocol Violation|0
353989|NCT01078623|1194579|P7|Treatment Period 1|Protocol Violation|0
353990|NCT01078623|1194580|P6|Treatment Period 1|Protocol Violation|1
353991|NCT01078623|1194581|P5|Treatment Period 1|Protocol Violation|0
353992|NCT01078623|1194582|P4|Treatment Period 1|Protocol Violation|0
353993|NCT01078623|1194583|P3|Treatment Period 1|Protocol Violation|0
353994|NCT01078623|1194584|P2|Treatment Period 1|Protocol Violation|0
353995|NCT01078623|1194585|P1|Treatment Period 1|Protocol Violation|0
353996|NCT01078623|1194566|P20|Treatment Period 1|Withdrawal by Subject|0
353997|NCT01078623|1194567|P19|Treatment Period 1|Withdrawal by Subject|0
353998|NCT01078623|1194568|P18|Treatment Period 1|Withdrawal by Subject|0
353999|NCT01078623|1194569|P17|Treatment Period 1|Withdrawal by Subject|0
354000|NCT01078623|1194570|P16|Treatment Period 1|Withdrawal by Subject|0
354001|NCT01078623|1194571|P15|Treatment Period 1|Withdrawal by Subject|0
354002|NCT01078623|1194572|P14|Treatment Period 1|Withdrawal by Subject|0
354003|NCT01078623|1194573|P13|Treatment Period 1|Withdrawal by Subject|0
354004|NCT01078623|1194574|P12|Treatment Period 1|Withdrawal by Subject|0
354005|NCT01078623|1194575|P11|Treatment Period 1|Withdrawal by Subject|1
354006|NCT01078623|1194576|P10|Treatment Period 1|Withdrawal by Subject|0
354007|NCT01078623|1194577|P9|Treatment Period 1|Withdrawal by Subject|0
354008|NCT01078623|1194578|P8|Treatment Period 1|Withdrawal by Subject|1
354009|NCT01078623|1194579|P7|Treatment Period 1|Withdrawal by Subject|0
354010|NCT01078623|1194580|P6|Treatment Period 1|Withdrawal by Subject|0
354011|NCT01078623|1194581|P5|Treatment Period 1|Withdrawal by Subject|0
354012|NCT01078623|1194582|P4|Treatment Period 1|Withdrawal by Subject|0
354013|NCT01078623|1194583|P3|Treatment Period 1|Withdrawal by Subject|0
354014|NCT01078623|1194584|P2|Treatment Period 1|Withdrawal by Subject|0
354015|NCT01078623|1194585|P1|Treatment Period 1|Withdrawal by Subject|0
354016|NCT01078623|1194566|P20|Treatment Period 1|Adverse Event|0
354017|NCT01078623|1194567|P19|Treatment Period 1|Adverse Event|0
354018|NCT01078623|1194568|P18|Treatment Period 1|Adverse Event|0
354019|NCT01078623|1194569|P17|Treatment Period 1|Adverse Event|0
354020|NCT01078623|1194570|P16|Treatment Period 1|Adverse Event|0
354021|NCT01078623|1194571|P15|Treatment Period 1|Adverse Event|0
354022|NCT01078623|1194572|P14|Treatment Period 1|Adverse Event|0
354023|NCT01078623|1194573|P13|Treatment Period 1|Adverse Event|0
354024|NCT01078623|1194574|P12|Treatment Period 1|Adverse Event|0
354025|NCT01078623|1194575|P11|Treatment Period 1|Adverse Event|0
354026|NCT01078623|1194576|P10|Treatment Period 1|Adverse Event|1
354027|NCT01078623|1194577|P9|Treatment Period 1|Adverse Event|1
354028|NCT01078623|1194578|P8|Treatment Period 1|Adverse Event|0
354029|NCT01078623|1194579|P7|Treatment Period 1|Adverse Event|1
354030|NCT01078623|1194580|P6|Treatment Period 1|Adverse Event|0
354031|NCT01078623|1194581|P5|Treatment Period 1|Adverse Event|0
354032|NCT01078623|1194582|P4|Treatment Period 1|Adverse Event|0
354033|NCT01078623|1194583|P3|Treatment Period 1|Adverse Event|1
354034|NCT01078623|1194584|P2|Treatment Period 1|Adverse Event|1
354035|NCT01078623|1194585|P1|Treatment Period 1|Adverse Event|1
354036|NCT01078584|1194607|P1|Overall Study|Multiple Reasons|2
354037|NCT01078584|1194607|P1|Overall Study|Serious Adverse Event|27
354038|NCT01078584|1194607|P1|Overall Study|Protocol Violation|75
354039|NCT01078584|1194607|P1|Overall Study|Lack of Efficacy|98
354040|NCT01078584|1194607|P1|Overall Study|Physician Discontinued Patient|12
354041|NCT01078584|1194607|P1|Overall Study|Physician Switched Medication|26
354042|NCT01078584|1194607|P1|Overall Study|Blood Pressure Controlled|49
354043|NCT01078584|1194607|P1|Overall Study|Non-compliance|67
354044|NCT01078584|1194607|P1|Overall Study|Physician Withdrew from Study|90
354045|NCT01078584|1194607|P1|Overall Study|Withdrawal of Consent|244
354046|NCT01078584|1194607|P1|Overall Study|Non-serious Adverse Event|577
354047|NCT01078584|1194607|P1|Overall Study|Lost to Follow-up|670
354048|NCT01078584|1194607|P1|Overall Study|Final Status Unknown|1073
354049|NCT01078571|1194688|P1|Overall Study|Protocol Violation|2
354050|NCT01078571|1194688|P1|Overall Study|Lost to Follow-up|8
354051|NCT01078571|1194688|P1|Overall Study|Withdrawal by Subject|12
354052|NCT01078571|1194688|P1|Overall Study|Reason not reported|21
354053|NCT01078571|1194688|P1|Overall Study|Lack of effectiveness|36
354054|NCT01078571|1194688|P1|Overall Study|Adverse Event|36
354055|NCT01078545|1194704|P1|Overall Study|Participant moved to another physician|1
354056|NCT01078545|1194704|P1|Overall Study|Death|3
354057|NCT01078545|1194704|P1|Overall Study|Withdrawal by Subject|3
354058|NCT01078545|1194704|P1|Overall Study|Physician Decision|6
354059|NCT01078545|1194704|P1|Overall Study|Lost to Follow-up|13
354060|NCT01078454|1194714|P2|Overall Study|Death|1
354061|NCT01078454|1194715|P1|Overall Study|Death|0
354062|NCT01078454|1194714|P2|Overall Study|Adverse Event|1
354063|NCT01078454|1194715|P1|Overall Study|Adverse Event|1
354064|NCT01078441|1194721|P1|Overall Study|Withdrawal by Subject|1
354065|NCT01078389|1194761|P2|Overall Study|Other|2
354066|NCT01078389|1194762|P1|Overall Study|Other|9
354067|NCT01078389|1194761|P2|Overall Study|Voluntary Withdrawal|36
354068|NCT01078389|1194762|P1|Overall Study|Voluntary Withdrawal|20
354069|NCT01078389|1194761|P2|Overall Study|Lost to Follow-up|23
354070|NCT01078389|1194762|P1|Overall Study|Lost to Follow-up|23
354071|NCT01078389|1194761|P2|Overall Study|Major Protocol Deviation|0
354072|NCT01078389|1194762|P1|Overall Study|Major Protocol Deviation|2
354073|NCT01078389|1194761|P2|Overall Study|Adverse Event|6
354074|NCT01078389|1194762|P1|Overall Study|Adverse Event|10
354075|NCT01078298|1194923|P2|Overall Study|Other|32
354076|NCT01078298|1194924|P1|Overall Study|Other|24
354077|NCT01078298|1194923|P2|Overall Study|Did not meet entrance criteria|1
354078|NCT01078298|1194924|P1|Overall Study|Did not meet entrance criteria|0
354079|NCT01078298|1194923|P2|Overall Study|Death|0
354080|NCT01078298|1194924|P1|Overall Study|Death|2
354081|NCT01078298|1194923|P2|Overall Study|Adverse Event|5
354082|NCT01078298|1194924|P1|Overall Study|Adverse Event|6
354083|NCT01078298|1194923|P2|Overall Study|Protocol Violation|6
354084|NCT01078298|1194924|P1|Overall Study|Protocol Violation|6
354085|NCT01078298|1194923|P2|Overall Study|Withdrawal by Subject|33
354086|NCT01078298|1194924|P1|Overall Study|Withdrawal by Subject|31
354087|NCT01078298|1194923|P2|Overall Study|Lost to Follow-up|13
354088|NCT01078298|1194924|P1|Overall Study|Lost to Follow-up|12
354089|NCT01078168|1195034|P2|Overall Study|Physician Decision|1
354090|NCT01078168|1195035|P1|Overall Study|Physician Decision|0
354091|NCT01078155|1195041|P1|Overall Study|Lost to Follow-up|15
354092|NCT01078155|1195041|P1|Overall Study|Participant's Decision|6
354093|NCT01078155|1195041|P1|Overall Study|Lack of Efficacy|16
354094|NCT01078155|1195041|P1|Overall Study|Adverse Event|7
354095|NCT01078116|1195057|P1|Overall Study|Case report form not completed|3
354096|NCT01078116|1195057|P1|Overall Study|Lack of effectiveness|15
354097|NCT01078116|1195057|P1|Overall Study|Withdrawal by Subject|8
354098|NCT01078116|1195057|P1|Overall Study|Adverse Event|5
354099|NCT01078116|1195057|P1|Overall Study|Lost to Follow-up|17
354100|NCT01078090|1195065|P1|Overall Study|Other|523
354101|NCT01078090|1195065|P1|Overall Study|ADR and lack of efficacy|61
354102|NCT01078090|1195065|P1|Overall Study|Lack of Efficacy|1193
354103|NCT01078090|1195065|P1|Overall Study|Adverse drug reaction (ADR)|453
354104|NCT01078090|1195065|P1|Overall Study|Lost to Follow-up|2363
354105|NCT01077960|1195159|P1|Overall Study|Reason unspecified|1
354106|NCT01077960|1195159|P1|Overall Study|Subject decision|1
354107|NCT01077960|1195159|P1|Overall Study|Lost to Follow-up|5
354108|NCT01077960|1195159|P1|Overall Study|Protocol Violation|3
354109|NCT01077960|1195159|P1|Overall Study|Adverse Event|6
354110|NCT01077804|1195409|P1|Overall Study|Other|18
354111|NCT01077804|1195409|P1|Overall Study|Refused to continue|79
354112|NCT01077804|1195409|P1|Overall Study|Unreachable|102
354113|NCT01077739|1195418|P2|Overall Study|Not specified|2
354114|NCT01077739|1195419|P1|Overall Study|Not specified|2
354115|NCT01077739|1195418|P2|Overall Study|Unacceptable toxicity|2
354116|NCT01077739|1195419|P1|Overall Study|Unacceptable toxicity|1
354117|NCT01077739|1195418|P2|Overall Study|Death|3
354118|NCT01077739|1195419|P1|Overall Study|Death|0
354119|NCT01077739|1195418|P2|Overall Study|Withdrawal by Subject|0
354120|NCT01077739|1195419|P1|Overall Study|Withdrawal by Subject|1
354121|NCT01077739|1195418|P2|Overall Study|Premature withdrawal|3
354122|NCT01077739|1195419|P1|Overall Study|Premature withdrawal|1
354123|NCT01077713|1195433|P2|Overall Study|Other|2
354124|NCT01077713|1195434|P1|Overall Study|Other|4
354125|NCT01077713|1195433|P2|Overall Study|Adverse Event|1
354126|NCT01077713|1195434|P1|Overall Study|Adverse Event|2
354127|NCT01077713|1195433|P2|Overall Study|Lost to Follow-up|1
354128|NCT01077713|1195434|P1|Overall Study|Lost to Follow-up|1
354129|NCT01077713|1195433|P2|Overall Study|Death|29
354130|NCT01077713|1195434|P1|Overall Study|Death|28
354131|NCT01077713|1195433|P2|Overall Study|Progressive Disease (PD)|1
354132|NCT01077713|1195434|P1|Overall Study|Progressive Disease (PD)|0
354133|NCT01077713|1195433|P2|Overall Study|Withdrawal by Subject|2
354134|NCT01077713|1195434|P1|Overall Study|Withdrawal by Subject|1
354135|NCT01077622|1195458|P1|Overall Study|Withdrawal by Subject|1
354136|NCT01077622|1195458|P1|Overall Study|Physician Decision|2
354137|NCT01077544|1195578|P2|Overall Study|Disease Progression|1
354138|NCT01077544|1195579|P1|Overall Study|Disease Progression|0
354139|NCT01077544|1195578|P2|Overall Study|Adverse Event|1
354140|NCT01077544|1195579|P1|Overall Study|Adverse Event|0
354141|NCT01077544|1195578|P2|Overall Study|New Cancer Therapy|3
354142|NCT01077544|1195579|P1|Overall Study|New Cancer Therapy|3
354143|NCT01077375|1195620|P2|Overall Study|Other Reason|1
354144|NCT01077375|1195621|P1|Overall Study|Other Reason|0
354145|NCT01077375|1195620|P2|Overall Study|Lost to Follow-up|5
354146|NCT01077375|1195621|P1|Overall Study|Lost to Follow-up|2
354147|NCT01077375|1195620|P2|Overall Study|Withdrawal by Subject|6
354148|NCT01077375|1195621|P1|Overall Study|Withdrawal by Subject|0
354149|NCT01077375|1195620|P2|Overall Study|Lack of Efficacy|8
354150|NCT01077375|1195621|P1|Overall Study|Lack of Efficacy|6
354151|NCT01077375|1195620|P2|Overall Study|Adverse Event|15
354152|NCT01077375|1195621|P1|Overall Study|Adverse Event|2
354153|NCT01077362|1195632|P3|Overall Study|Not Specified|2
354154|NCT01077362|1195633|P2|Overall Study|Not Specified|1
354155|NCT01077362|1195634|P1|Overall Study|Not Specified|0
354156|NCT01077362|1195632|P3|Overall Study|Withdrawal by Subject|5
354157|NCT01077362|1195633|P2|Overall Study|Withdrawal by Subject|3
354158|NCT01077362|1195634|P1|Overall Study|Withdrawal by Subject|5
354159|NCT01077362|1195632|P3|Overall Study|Adverse Event|4
354160|NCT01077362|1195633|P2|Overall Study|Adverse Event|7
354161|NCT01077362|1195634|P1|Overall Study|Adverse Event|12
354162|NCT01077362|1195632|P3|Overall Study|Lost to Follow-up|3
354163|NCT01077362|1195633|P2|Overall Study|Lost to Follow-up|0
354164|NCT01077362|1195634|P1|Overall Study|Lost to Follow-up|1
354165|NCT01077362|1195632|P3|Overall Study|Lack of Efficacy|10
354166|NCT01077362|1195633|P2|Overall Study|Lack of Efficacy|8
354167|NCT01077362|1195634|P1|Overall Study|Lack of Efficacy|13
354168|NCT01077323|1195670|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
354169|NCT01077323|1195671|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
354170|NCT01077323|1195672|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
354171|NCT01077323|1195670|P3|Overall Study|Dispensing of drug in baseline period|256446
354172|NCT01077323|1195671|P2|Overall Study|Dispensing of drug in baseline period|120229
354173|NCT01077323|1195672|P1|Overall Study|Dispensing of drug in baseline period|0
354174|NCT01077323|1195670|P3|Overall Study|<9 months enroll before drug dispensed|11655523
354175|NCT01077323|1195671|P2|Overall Study|<9 months enroll before drug dispensed|263954
354176|NCT01077323|1195672|P1|Overall Study|<9 months enroll before drug dispensed|11226
354177|NCT01077284|1195715|P3|Overall Study|Other|1
354178|NCT01077284|1195716|P2|Overall Study|Other|0
354179|NCT01077284|1195717|P1|Overall Study|Other|0
354180|NCT01077284|1195715|P3|Overall Study|Withdrawal by Subject|1
354181|NCT01077284|1195716|P2|Overall Study|Withdrawal by Subject|3
354182|NCT01077284|1195717|P1|Overall Study|Withdrawal by Subject|2
354183|NCT01077284|1195715|P3|Overall Study|Lost to Follow-up|0
354184|NCT01077284|1195716|P2|Overall Study|Lost to Follow-up|2
354185|NCT01077284|1195717|P1|Overall Study|Lost to Follow-up|1
354186|NCT01077284|1195715|P3|Overall Study|Adverse Event|1
354187|NCT01077284|1195716|P2|Overall Study|Adverse Event|0
354188|NCT01077284|1195717|P1|Overall Study|Adverse Event|2
354189|NCT01077271|1195738|P1|Overall Study|Mother unconvinced of the necessity|1
354190|NCT01077271|1195738|P1|Overall Study|End of RSV season nearly reached|1
354191|NCT01077271|1195738|P1|Overall Study|Parents thought too many injections|2
354192|NCT01077271|1195738|P1|Overall Study|Changed doctors|2
354193|NCT01077271|1195738|P1|Overall Study|Quota used up (insurance reimb issue)|2
354194|NCT01077271|1195738|P1|Overall Study|Noncompliance|2
354195|NCT01077271|1195738|P1|Overall Study|Screen failure, did not take palivizumab|4
354196|NCT01077271|1195738|P1|Overall Study|Parental desire|8
354197|NCT01077258|1195776|P1|Overall Study|Other reasons|260
354198|NCT01077258|1195776|P1|Overall Study|Clinical remission|37
354199|NCT01077258|1195776|P1|Overall Study|Lack of Efficacy|663
354200|NCT01077258|1195776|P1|Overall Study|Adverse drug reaction|218
354201|NCT01077258|1195776|P1|Overall Study|Lost to Follow-up|1390
354202|NCT01077193|1195812|P1|Overall Study|Study Terminated by Sponsor|40
354203|NCT01077193|1195812|P1|Overall Study|Lack of Efficacy|1
354204|NCT01077193|1195812|P1|Overall Study|Withdrawal by Subject|2
354205|NCT01077193|1195812|P1|Overall Study|Lost to Follow-up|1
354206|NCT01077128|1195816|P1|Overall Study|Not available|54
354207|NCT01077128|1195816|P1|Overall Study|Lack of efficacy/disease exacerbation|1
354208|NCT01077128|1195816|P1|Overall Study|Adverse event and disease exacerbation|1
354209|NCT01077128|1195816|P1|Overall Study|Adverse event and consent withdrawal|1
354210|NCT01077128|1195816|P1|Overall Study|Disease exacerbation|1
354211|NCT01077128|1195816|P1|Overall Study|Lack of Efficacy|1
354212|NCT01077128|1195816|P1|Overall Study|Adverse Event|8
354213|NCT01077076|1195874|P6|Third Intervention|Death in the participant's family|1
354214|NCT01077076|1195875|P5|Third Intervention|Death in the participant's family|0
354215|NCT01077076|1195876|P4|Third Intervention|Death in the participant's family|0
354216|NCT01077076|1195877|P3|Third Intervention|Death in the participant's family|0
354217|NCT01077076|1195878|P2|Third Intervention|Death in the participant's family|0
354218|NCT01077076|1195879|P1|Third Intervention|Death in the participant's family|0
354219|NCT01077076|1195874|P6|First Intervention|Withdrawal by Subject|0
354220|NCT01077076|1195875|P5|First Intervention|Withdrawal by Subject|0
354221|NCT01077076|1195876|P4|First Intervention|Withdrawal by Subject|0
354222|NCT01077076|1195877|P3|First Intervention|Withdrawal by Subject|0
354223|NCT01077076|1195878|P2|First Intervention|Withdrawal by Subject|0
354224|NCT01077076|1195879|P1|First Intervention|Withdrawal by Subject|1
354225|NCT01077063|1195889|P2|Overall Study|Withdrawal by Subject|2
354226|NCT01077063|1195890|P1|Overall Study|Withdrawal by Subject|0
354227|NCT01077063|1195889|P2|Overall Study|Death|1
354228|NCT01077063|1195890|P1|Overall Study|Death|1
354229|NCT01077063|1195889|P2|Overall Study|Adverse Event|0
354230|NCT01077063|1195890|P1|Overall Study|Adverse Event|3
354231|NCT01077050|1195896|P1|Overall Study|Screen failure|8
354232|NCT01077050|1195896|P1|Overall Study|Subjects signed ICF could not be located|1
354233|NCT01077024|1195902|P2|Overall Study|Other|4
354234|NCT01077024|1195903|P1|Overall Study|Other|4
354235|NCT01077024|1195902|P2|Overall Study|Incarcerated|8
354236|NCT01077024|1195903|P1|Overall Study|Incarcerated|7
354237|NCT01077024|1195902|P2|Overall Study|Withdrawal by Subject|2
354238|NCT01077024|1195903|P1|Overall Study|Withdrawal by Subject|0
354239|NCT01077024|1195902|P2|Overall Study|Lost to Follow-up|14
354240|NCT01077024|1195903|P1|Overall Study|Lost to Follow-up|20
354241|NCT01076959|1195942|P1|Overall Study|Other|119
354242|NCT01076959|1195942|P1|Overall Study|Lost to Follow-up|241
354243|NCT01076959|1195942|P1|Overall Study|Non-compliance|274
354244|NCT01076959|1195942|P1|Overall Study|Lack of Efficacy|849
354245|NCT01076959|1195942|P1|Overall Study|Adverse Event|767
354246|NCT01076647|1195978|P2|Overall Study|Unclassified|12
354247|NCT01076647|1195979|P1|Overall Study|Unclassified|12
354248|NCT01076647|1195978|P2|Overall Study|Withdrawal criteria|2
354249|NCT01076647|1195979|P1|Overall Study|Withdrawal criteria|2
354250|NCT01076647|1195978|P2|Overall Study|Protocol Violation|9
354251|NCT01076647|1195979|P1|Overall Study|Protocol Violation|7
354252|NCT01076647|1195978|P2|Overall Study|Lack of Efficacy|1
354253|NCT01076647|1195979|P1|Overall Study|Lack of Efficacy|0
354254|NCT01076647|1195978|P2|Overall Study|Adverse Event|1
354255|NCT01076647|1195979|P1|Overall Study|Adverse Event|4
354256|NCT01076400|1196010|P3|Overall Study|Progressive Disease|0
354257|NCT01076400|1196011|P2|Overall Study|Progressive Disease|0
354258|NCT01076400|1196012|P1|Overall Study|Progressive Disease|5
354259|NCT01076400|1196010|P3|Overall Study|Adverse Event|0
354260|NCT01076400|1196011|P2|Overall Study|Adverse Event|0
354261|NCT01076400|1196012|P1|Overall Study|Adverse Event|2
354262|NCT01076361|1196018|P1|Overall Study|22 leads were excluded from analysis|21
354263|NCT01076335|1196026|P1|Overall Study|Withdrawal without treatment|1
354264|NCT01076335|1196026|P1|Overall Study|Withdrawal by Subject|3
354265|NCT01076192|1196078|P1|Overall Study|Not specified|197
354266|NCT01076179|1196093|P1|Overall Study|Withdrawal by Subject|1
354267|NCT01076166|1196116|P1|Overall Study|Symptoms improved/resolved|6
354268|NCT01076166|1196116|P1|Overall Study|Adverse Event|3
354269|NCT01076153|1196123|P1|Overall Study|Adverse Event|1
354270|NCT01076153|1196123|P1|Overall Study|Symptoms improved/resolved|10
354271|NCT01076088|1196137|P6|Overall Study|Other protocol specified criteria|1
354272|NCT01076088|1196138|P5|Overall Study|Other protocol specified criteria|0
354273|NCT01076088|1196139|P4|Overall Study|Other protocol specified criteria|0
354274|NCT01076088|1196140|P3|Overall Study|Other protocol specified criteria|0
354275|NCT01076088|1196141|P2|Overall Study|Other protocol specified criteria|0
354276|NCT01076088|1196142|P1|Overall Study|Other protocol specified criteria|0
354277|NCT01076088|1196137|P6|Overall Study|Withdrawal by Subject|17
354278|NCT01076088|1196138|P5|Overall Study|Withdrawal by Subject|11
354279|NCT01076088|1196139|P4|Overall Study|Withdrawal by Subject|10
354280|NCT01076088|1196140|P3|Overall Study|Withdrawal by Subject|14
354281|NCT01076088|1196141|P2|Overall Study|Withdrawal by Subject|8
354282|NCT01076088|1196142|P1|Overall Study|Withdrawal by Subject|8
354283|NCT01076088|1196137|P6|Overall Study|Physician Decision|0
354284|NCT01076088|1196138|P5|Overall Study|Physician Decision|1
354285|NCT01076088|1196139|P4|Overall Study|Physician Decision|1
354286|NCT01076088|1196140|P3|Overall Study|Physician Decision|0
354287|NCT01076088|1196141|P2|Overall Study|Physician Decision|3
354288|NCT01076088|1196142|P1|Overall Study|Physician Decision|1
354289|NCT01076088|1196137|P6|Overall Study|Non-compliance with study drug|0
354290|NCT01076088|1196138|P5|Overall Study|Non-compliance with study drug|0
354291|NCT01076088|1196139|P4|Overall Study|Non-compliance with study drug|1
354292|NCT01076088|1196140|P3|Overall Study|Non-compliance with study drug|0
354293|NCT01076088|1196141|P2|Overall Study|Non-compliance with study drug|0
354294|NCT01076088|1196142|P1|Overall Study|Non-compliance with study drug|0
354295|NCT01076088|1196137|P6|Overall Study|Lost to Follow-up|2
354296|NCT01076088|1196138|P5|Overall Study|Lost to Follow-up|1
354297|NCT01076088|1196139|P4|Overall Study|Lost to Follow-up|1
354298|NCT01076088|1196140|P3|Overall Study|Lost to Follow-up|0
354299|NCT01076088|1196141|P2|Overall Study|Lost to Follow-up|1
354300|NCT01076088|1196142|P1|Overall Study|Lost to Follow-up|1
354301|NCT01076088|1196137|P6|Overall Study|Adverse Event|3
354302|NCT01076088|1196138|P5|Overall Study|Adverse Event|3
354303|NCT01076088|1196139|P4|Overall Study|Adverse Event|2
354304|NCT01076088|1196140|P3|Overall Study|Adverse Event|3
354305|NCT01076088|1196141|P2|Overall Study|Adverse Event|6
354306|NCT01076088|1196142|P1|Overall Study|Adverse Event|1
354307|NCT01076075|1196170|P2|Overall Study|Withdrawal by Subject|19
354308|NCT01076075|1196171|P1|Overall Study|Withdrawal by Subject|8
354309|NCT01076075|1196170|P2|Overall Study|Protocol Violation|1
354310|NCT01076075|1196171|P1|Overall Study|Protocol Violation|0
354311|NCT01076075|1196170|P2|Overall Study|other|9
354312|NCT01076075|1196171|P1|Overall Study|other|19
354313|NCT01076075|1196170|P2|Overall Study|Lost to Follow-up|5
354314|NCT01076075|1196171|P1|Overall Study|Lost to Follow-up|6
354315|NCT01076075|1196170|P2|Overall Study|Lack of Efficacy|4
354316|NCT01076075|1196171|P1|Overall Study|Lack of Efficacy|5
354317|NCT01076075|1196170|P2|Overall Study|Adverse Event|9
354318|NCT01076075|1196171|P1|Overall Study|Adverse Event|3
354319|NCT01076036|1196185|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
354320|NCT01075984|1196195|P5|Follow-up Phase|Treatment failure|4
354321|NCT01075984|1196196|P4|Follow-up Phase|Treatment failure|0
354322|NCT01075984|1196197|P3|Follow-up Phase|Treatment failure|0
354323|NCT01075984|1196198|P2|Follow-up Phase|Treatment failure|0
354324|NCT01075984|1196199|P1|Follow-up Phase|Treatment failure|0
354325|NCT01075984|1196195|P5|Follow-up Phase|Progression of disease|2
354326|NCT01075984|1196196|P4|Follow-up Phase|Progression of disease|0
354327|NCT01075984|1196197|P3|Follow-up Phase|Progression of disease|0
354328|NCT01075984|1196198|P2|Follow-up Phase|Progression of disease|0
354329|NCT01075984|1196199|P1|Follow-up Phase|Progression of disease|0
354330|NCT01075984|1196195|P5|Follow-up Phase|Withdrawal by Subject|10
354331|NCT01075984|1196196|P4|Follow-up Phase|Withdrawal by Subject|0
354332|NCT01075984|1196197|P3|Follow-up Phase|Withdrawal by Subject|0
354333|NCT01075984|1196198|P2|Follow-up Phase|Withdrawal by Subject|0
354334|NCT01075984|1196199|P1|Follow-up Phase|Withdrawal by Subject|0
354335|NCT01075984|1196195|P5|Follow-up Phase|Administrative|1
354336|NCT01075984|1196196|P4|Follow-up Phase|Administrative|0
354337|NCT01075984|1196197|P3|Follow-up Phase|Administrative|0
354338|NCT01075984|1196198|P2|Follow-up Phase|Administrative|0
354339|NCT01075984|1196199|P1|Follow-up Phase|Administrative|0
354340|NCT01075984|1196195|P5|Follow-up Phase|Adverse Event|27
354341|NCT01075984|1196196|P4|Follow-up Phase|Adverse Event|2
354342|NCT01075984|1196197|P3|Follow-up Phase|Adverse Event|0
354343|NCT01075984|1196198|P2|Follow-up Phase|Adverse Event|0
354344|NCT01075984|1196199|P1|Follow-up Phase|Adverse Event|0
354345|NCT01075984|1196195|P5|Follow-up Phase|Protocol Violation|3
354346|NCT01075984|1196196|P4|Follow-up Phase|Protocol Violation|0
354347|NCT01075984|1196197|P3|Follow-up Phase|Protocol Violation|1
354348|NCT01075984|1196198|P2|Follow-up Phase|Protocol Violation|0
354349|NCT01075984|1196199|P1|Follow-up Phase|Protocol Violation|0
354350|NCT01075984|1196195|P5|Treatment Phase|Progression of disease|2
354351|NCT01075984|1196196|P4|Treatment Phase|Progression of disease|0
354352|NCT01075984|1196197|P3|Treatment Phase|Progression of disease|0
354353|NCT01075984|1196198|P2|Treatment Phase|Progression of disease|0
354354|NCT01075984|1196199|P1|Treatment Phase|Progression of disease|0
354355|NCT01075984|1196195|P5|Treatment Phase|Treatment Failure|5
354356|NCT01075984|1196196|P4|Treatment Phase|Treatment Failure|0
354357|NCT01075984|1196197|P3|Treatment Phase|Treatment Failure|1
354358|NCT01075984|1196198|P2|Treatment Phase|Treatment Failure|0
354359|NCT01075984|1196199|P1|Treatment Phase|Treatment Failure|0
354360|NCT01075984|1196195|P5|Treatment Phase|Withdrawal by Subject|15
354361|NCT01075984|1196196|P4|Treatment Phase|Withdrawal by Subject|0
354362|NCT01075984|1196197|P3|Treatment Phase|Withdrawal by Subject|2
354363|NCT01075984|1196198|P2|Treatment Phase|Withdrawal by Subject|0
354364|NCT01075984|1196199|P1|Treatment Phase|Withdrawal by Subject|0
354365|NCT01075984|1196195|P5|Treatment Phase|Protocol Violation|3
354366|NCT01075984|1196196|P4|Treatment Phase|Protocol Violation|0
354367|NCT01075984|1196197|P3|Treatment Phase|Protocol Violation|1
354368|NCT01075984|1196198|P2|Treatment Phase|Protocol Violation|0
354369|NCT01075984|1196199|P1|Treatment Phase|Protocol Violation|0
354370|NCT01075984|1196195|P5|Treatment Phase|Adverse Event|35
354371|NCT01075984|1196196|P4|Treatment Phase|Adverse Event|7
354372|NCT01075984|1196197|P3|Treatment Phase|Adverse Event|3
354373|NCT01075984|1196198|P2|Treatment Phase|Adverse Event|1
354374|NCT01075984|1196199|P1|Treatment Phase|Adverse Event|0
354375|NCT01075958|1196257|P1|Overall Study|Blood sample could not be obtained|44
354376|NCT01075815|1196273|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
354377|NCT01075815|1196274|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
354378|NCT01075815|1196273|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
354379|NCT01075815|1196274|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
354380|NCT01075815|1196273|P2|Overall Study|Withdrawal before r-hCG administration|1
354381|NCT01075815|1196274|P1|Overall Study|Withdrawal before r-hCG administration|6
354382|NCT01075763|1196312|P2|Overall Study|Withdrawal by Subject|2
354383|NCT01075763|1196313|P1|Overall Study|Withdrawal by Subject|2
354384|NCT01075763|1196312|P2|Overall Study|Lack of Efficacy|1
354385|NCT01075763|1196313|P1|Overall Study|Lack of Efficacy|0
354386|NCT01075763|1196312|P2|Overall Study|Lost to Follow-up|1
354387|NCT01075763|1196313|P1|Overall Study|Lost to Follow-up|2
354388|NCT01075685|1196337|P2|Overall Study|Lost to Follow-up|220
354389|NCT01075685|1196338|P1|Overall Study|Lost to Follow-up|563
354390|NCT01075685|1196337|P2|Overall Study|Withdrawal by Subject|5
354391|NCT01075685|1196338|P1|Overall Study|Withdrawal by Subject|20
354392|NCT01075685|1196337|P2|Overall Study|Protocol Violation|1
354393|NCT01075685|1196338|P1|Overall Study|Protocol Violation|9
354394|NCT01075646|1196354|P4|Overall Study|Lost to Follow-up|2
354395|NCT01075646|1196355|P3|Overall Study|Lost to Follow-up|1
354396|NCT01075646|1196356|P2|Overall Study|Lost to Follow-up|3
354397|NCT01075646|1196357|P1|Overall Study|Lost to Follow-up|4
354398|NCT01075412|1196389|P2|Overall Study|Withdrawal by Subject|1
354399|NCT01075412|1196390|P1|Overall Study|Withdrawal by Subject|0
354400|NCT01075282|1196418|P3|Overall Study|Death|2
354401|NCT01075282|1196419|P2|Overall Study|Death|1
354402|NCT01075282|1196420|P1|Overall Study|Death|0
354403|NCT01075282|1196418|P3|Overall Study|Protocol Violation|1
354404|NCT01075282|1196419|P2|Overall Study|Protocol Violation|2
354405|NCT01075282|1196420|P1|Overall Study|Protocol Violation|0
354406|NCT01075282|1196418|P3|Overall Study|Treatment Non-compliance|2
354407|NCT01075282|1196419|P2|Overall Study|Treatment Non-compliance|2
354408|NCT01075282|1196420|P1|Overall Study|Treatment Non-compliance|1
354409|NCT01075282|1196418|P3|Overall Study|Lack of Efficacy|0
354410|NCT01075282|1196419|P2|Overall Study|Lack of Efficacy|1
354411|NCT01075282|1196420|P1|Overall Study|Lack of Efficacy|1
354412|NCT01075282|1196418|P3|Overall Study|Physician Decision|3
354413|NCT01075282|1196419|P2|Overall Study|Physician Decision|3
354414|NCT01075282|1196420|P1|Overall Study|Physician Decision|3
354415|NCT01075282|1196418|P3|Overall Study|Lost to Follow-up|3
354416|NCT01075282|1196419|P2|Overall Study|Lost to Follow-up|3
354417|NCT01075282|1196420|P1|Overall Study|Lost to Follow-up|3
354418|NCT01075282|1196418|P3|Overall Study|Entry Criteria Not Met|0
354419|NCT01075282|1196419|P2|Overall Study|Entry Criteria Not Met|2
354420|NCT01075282|1196420|P1|Overall Study|Entry Criteria Not Met|3
354421|NCT01075282|1196418|P3|Overall Study|Adverse Event|5
354422|NCT01075282|1196419|P2|Overall Study|Adverse Event|8
354423|NCT01075282|1196420|P1|Overall Study|Adverse Event|9
354424|NCT01075282|1196418|P3|Overall Study|Withdrawal by Subject|11
354425|NCT01075282|1196419|P2|Overall Study|Withdrawal by Subject|7
354426|NCT01075282|1196420|P1|Overall Study|Withdrawal by Subject|11
354427|NCT01075256|1196503|P3|Overall Study|Withdrawal by Subject|0
354428|NCT01075256|1196504|P2|Overall Study|Withdrawal by Subject|0
354429|NCT01075256|1196505|P1|Overall Study|Withdrawal by Subject|1
354430|NCT01075243|1196537|P3|Overall Study|Withdrawal by Subject|0
354431|NCT01075243|1196538|P2|Overall Study|Withdrawal by Subject|1
354432|NCT01075243|1196539|P1|Overall Study|Withdrawal by Subject|1
354433|NCT01075243|1196537|P3|Overall Study|Lost to Follow-up|0
354434|NCT01075243|1196538|P2|Overall Study|Lost to Follow-up|2
354435|NCT01075243|1196539|P1|Overall Study|Lost to Follow-up|5
354436|NCT01075217|1196591|P2|Overall Study|Physician Decision|0
354437|NCT01075217|1196592|P1|Overall Study|Physician Decision|1
354438|NCT01075217|1196591|P2|Overall Study|Adverse Event|1
354439|NCT01075217|1196592|P1|Overall Study|Adverse Event|1
354440|NCT01075191|1196625|P1|Overall Study|Unknown Reasons|1
354441|NCT01075191|1196625|P1|Overall Study|Patient's Wish|2
354442|NCT01075191|1196625|P1|Overall Study|Therapy Break|3
354443|NCT01075191|1196625|P1|Overall Study|Noncompliance|3
354444|NCT01075191|1196625|P1|Overall Study|Adverse Event|4
354445|NCT01075191|1196625|P1|Overall Study|Co-morbidities|1
354446|NCT01075191|1196625|P1|Overall Study|Intensification|3
354447|NCT01075191|1196625|P1|Overall Study|Death|1
354448|NCT01075178|1196636|P2|Subject Chart Review|matched partner excluded (reasons above)|3
354449|NCT01075178|1196637|P1|Subject Chart Review|matched partner excluded (reasons above)|6
354450|NCT01075178|1196636|P2|Subject Chart Review|no data collected due to site closure|4
354451|NCT01075178|1196637|P1|Subject Chart Review|no data collected due to site closure|3
354452|NCT01075178|1196636|P2|Subject Chart Review|died before chart review period|2
354453|NCT01075178|1196637|P1|Subject Chart Review|died before chart review period|0
354454|NCT01075178|1196636|P2|Subject Matching|eligible but not matched|403
354455|NCT01075178|1196637|P1|Subject Matching|eligible but not matched|130
354456|NCT01075152|1196651|P2|Overall Study|Withdrawal by Subject|0
354457|NCT01075152|1196652|P1|Overall Study|Withdrawal by Subject|1
354458|NCT01075100|1196678|P2|Overall Study|Other|1
354459|NCT01075100|1196679|P1|Overall Study|Other|3
354460|NCT01075100|1196678|P2|Overall Study|Disease Progression|29
354461|NCT01075100|1196679|P1|Overall Study|Disease Progression|25
354462|NCT01075100|1196678|P2|Overall Study|Investigator Request|1
354463|NCT01075100|1196679|P1|Overall Study|Investigator Request|2
354464|NCT01075100|1196678|P2|Overall Study|Patient Request|4
354465|NCT01075100|1196679|P1|Overall Study|Patient Request|4
354466|NCT01075100|1196678|P2|Overall Study|Adverse Event|18
354467|NCT01075100|1196679|P1|Overall Study|Adverse Event|15
354468|NCT01075074|1196709|P3|Overall Study|Surgeon changed to open incisional case|2
354469|NCT01075074|1196710|P2|Overall Study|Surgeon changed to open incisional case|2
354470|NCT01075074|1196711|P1|Overall Study|Surgeon changed to open incisional case|1
354471|NCT01074944|1196728|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
354472|NCT01074944|1196729|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
354473|NCT01074944|1196730|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
354474|NCT01074944|1196731|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
354475|NCT01074944|1196732|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
354476|NCT01074944|1196728|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
354477|NCT01074944|1196729|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
354478|NCT01074944|1196730|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
354479|NCT01074944|1196731|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
354480|NCT01074944|1196732|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
354481|NCT01074944|1196728|P5|Long Term Treatment|Withdrawal by Subject|0
354482|NCT01074944|1196729|P4|Long Term Treatment|Withdrawal by Subject|2
354483|NCT01074944|1196730|P3|Long Term Treatment|Withdrawal by Subject|0
354484|NCT01074944|1196731|P2|Long Term Treatment|Withdrawal by Subject|0
354485|NCT01074944|1196732|P1|Long Term Treatment|Withdrawal by Subject|0
354486|NCT01074944|1196728|P5|Long Term Treatment|Entered in Period, But Not Treated|0
354487|NCT01074944|1196729|P4|Long Term Treatment|Entered in Period, But Not Treated|1
354488|NCT01074944|1196730|P3|Long Term Treatment|Entered in Period, But Not Treated|0
354489|NCT01074944|1196731|P2|Long Term Treatment|Entered in Period, But Not Treated|0
354490|NCT01074944|1196732|P1|Long Term Treatment|Entered in Period, But Not Treated|0
354491|NCT01074944|1196728|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
354492|NCT01074944|1196729|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
354493|NCT01074944|1196730|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
354494|NCT01074944|1196731|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
354495|NCT01074944|1196732|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
354496|NCT01074944|1196728|P5|Long Term Treatment|Lost to Follow-up|0
354497|NCT01074944|1196729|P4|Long Term Treatment|Lost to Follow-up|2
354498|NCT01074944|1196730|P3|Long Term Treatment|Lost to Follow-up|0
354499|NCT01074944|1196731|P2|Long Term Treatment|Lost to Follow-up|0
354500|NCT01074944|1196732|P1|Long Term Treatment|Lost to Follow-up|0
354501|NCT01074944|1196728|P5|Long Term Treatment|Adverse Event|0
354502|NCT01074944|1196729|P4|Long Term Treatment|Adverse Event|3
354503|NCT01074944|1196730|P3|Long Term Treatment|Adverse Event|0
354504|NCT01074944|1196731|P2|Long Term Treatment|Adverse Event|0
354505|NCT01074944|1196732|P1|Long Term Treatment|Adverse Event|0
354506|NCT01074944|1196728|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
354507|NCT01074944|1196729|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
354508|NCT01074944|1196730|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
354509|NCT01074944|1196731|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
354510|NCT01074944|1196732|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
354511|NCT01074944|1196728|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
354512|NCT01074944|1196729|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
354513|NCT01074944|1196730|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
354514|NCT01074944|1196731|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
354515|NCT01074944|1196732|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
354516|NCT01074944|1196728|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
354517|NCT01074944|1196729|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
354518|NCT01074944|1196730|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
354519|NCT01074944|1196731|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
354520|NCT01074944|1196732|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
354521|NCT01074944|1196728|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
354522|NCT01074944|1196729|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
354523|NCT01074944|1196730|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
354524|NCT01074944|1196731|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
354525|NCT01074944|1196732|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
354526|NCT01074944|1196728|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
354527|NCT01074944|1196729|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
354528|NCT01074944|1196730|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
354529|NCT01074944|1196731|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
354530|NCT01074944|1196732|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
354531|NCT01074944|1196728|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
354532|NCT01074944|1196729|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
354533|NCT01074944|1196730|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
354534|NCT01074944|1196731|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
354535|NCT01074944|1196732|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
354536|NCT01074944|1196728|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
354537|NCT01074944|1196729|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
354538|NCT01074944|1196730|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
354539|NCT01074944|1196731|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
354540|NCT01074944|1196732|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
354541|NCT01074944|1196728|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
354542|NCT01074944|1196729|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
354543|NCT01074944|1196730|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
354544|NCT01074944|1196731|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
354545|NCT01074944|1196732|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
354546|NCT01074944|1196728|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
354547|NCT01074944|1196729|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
354548|NCT01074944|1196730|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
354549|NCT01074944|1196731|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
354550|NCT01074944|1196732|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
354551|NCT01074931|1196786|P1|Overall Study|Death|5
354552|NCT01074931|1196786|P1|Overall Study|Economic reasons|1
354553|NCT01074658|1196798|P1|Overall Study|No implant attempted|19
354554|NCT01074554|1196806|P2|Overall Study|Lost to Follow-up|1
354555|NCT01074554|1196807|P1|Overall Study|Lost to Follow-up|0
354556|NCT01074554|1196806|P2|Overall Study|Adverse Event|3
354557|NCT01074554|1196807|P1|Overall Study|Adverse Event|3
354558|NCT01074502|1196817|P1|Overall Study|Withdrawal by Subject|1
354559|NCT01074450|1196841|P2|Second Intervention|Physician Decision|1
354560|NCT01074450|1196842|P1|Second Intervention|Physician Decision|0
354561|NCT01074450|1196841|P2|Second Intervention|Protocol Violation|0
354562|NCT01074450|1196842|P1|Second Intervention|Protocol Violation|1
354563|NCT01074450|1196841|P2|First Intervention|Emesis in Dosing Interval|2
354564|NCT01074450|1196842|P1|First Intervention|Emesis in Dosing Interval|0
354565|NCT01074307|1196863|P2|Overall Study|Protocol Violation|5
354566|NCT01074307|1196864|P1|Overall Study|Protocol Violation|8
354567|NCT01074307|1196863|P2|Overall Study|Exclusion criterion|1
354568|NCT01074307|1196864|P1|Overall Study|Exclusion criterion|0
354569|NCT01074307|1196863|P2|Overall Study|No primary endpoint evaluation|6
354570|NCT01074307|1196864|P1|Overall Study|No primary endpoint evaluation|14
354571|NCT01074268|1196886|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
354572|NCT01074268|1196887|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
354573|NCT01074268|1196886|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
354574|NCT01074268|1196887|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
354575|NCT01074268|1196886|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
354576|NCT01074268|1196887|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
354577|NCT01074268|1196886|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
354578|NCT01074268|1196887|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
354579|NCT01074268|1196886|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
354580|NCT01074268|1196887|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
354581|NCT01074268|1196886|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
354582|NCT01074268|1196887|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
354583|NCT01074268|1196886|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
354584|NCT01074268|1196887|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
354585|NCT01074268|1196886|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
354586|NCT01074268|1196887|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
354587|NCT01074268|1196886|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
354588|NCT01074268|1196887|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
354589|NCT01074255|1196913|P1|Overall Study|Did not receive EMEND|2
354590|NCT01074242|1196917|P1|Overall Study|Duplicate Case Report Form|5
354591|NCT01074242|1196917|P1|Overall Study|Violation of vaccine dose or dosage|351
354592|NCT01074242|1196917|P1|Overall Study|Case report unclear|6
354593|NCT01074242|1196917|P1|Overall Study|Lost to Follow-up|1
354594|NCT01074242|1196917|P1|Overall Study|Case report before date of contract|40
354595|NCT01074229|1196925|P3|Overall Study|Change to open surgical procedure|4
354596|NCT01074229|1196926|P2|Overall Study|Change to open surgical procedure|3
354597|NCT01074229|1196927|P1|Overall Study|Change to open surgical procedure|1
354598|NCT01074229|1196925|P3|Overall Study|Lost to Follow-up|0
354599|NCT01074229|1196926|P2|Overall Study|Lost to Follow-up|0
354600|NCT01074229|1196927|P1|Overall Study|Lost to Follow-up|1
354601|NCT01074216|1196938|P1|Overall Study|Not Treated|12
354602|NCT01074216|1196938|P1|Overall Study|Physician Decision|1
354603|NCT01074047|1197002|P2|Extension Phase|Death|0
354604|NCT01074047|1197003|P1|Extension Phase|Death|5
354605|NCT01074047|1197002|P2|Extension Phase|Withdrawal by Subject|0
354606|NCT01074047|1197003|P1|Extension Phase|Withdrawal by Subject|2
354607|NCT01074047|1197002|P2|Extension Phase|Disease Progression|0
354608|NCT01074047|1197003|P1|Extension Phase|Disease Progression|9
354609|NCT01074047|1197002|P2|Extension Phase|Adverse Event|0
354610|NCT01074047|1197003|P1|Extension Phase|Adverse Event|5
354611|NCT01074047|1197002|P2|Extension Phase|Physician Decision|0
354612|NCT01074047|1197003|P1|Extension Phase|Physician Decision|1
354613|NCT01074047|1197002|P2|Survival Follow-Up Phase|Alive at study closure|3
354614|NCT01074047|1197003|P1|Survival Follow-Up Phase|Alive at study closure|1
354615|NCT01074047|1197002|P2|Survival Follow-Up Phase|Death|124
354616|NCT01074047|1197003|P1|Survival Follow-Up Phase|Death|116
354617|NCT01074047|1197002|P2|Survival Follow-Up Phase|Lost to Follow-up|1
354618|NCT01074047|1197003|P1|Survival Follow-Up Phase|Lost to Follow-up|2
354619|NCT01074047|1197002|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
354620|NCT01074047|1197003|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
354621|NCT01074047|1197002|P2|Treatment Phase|Miscellaneous|39
354622|NCT01074047|1197003|P1|Treatment Phase|Miscellaneous|32
354623|NCT01074047|1197002|P2|Treatment Phase|Protocol Violation|1
354624|NCT01074047|1197003|P1|Treatment Phase|Protocol Violation|0
354625|NCT01074047|1197002|P2|Treatment Phase|Lost to Follow-up|1
354626|NCT01074047|1197003|P1|Treatment Phase|Lost to Follow-up|0
354627|NCT01074047|1197002|P2|Treatment Phase|Death|58
354628|NCT01074047|1197003|P1|Treatment Phase|Death|53
354629|NCT01074047|1197002|P2|Treatment Phase|Withdrawal by Subject|48
354630|NCT01074047|1197003|P1|Treatment Phase|Withdrawal by Subject|27
354631|NCT01074047|1197002|P2|Treatment Phase|Disease Progression|21
354632|NCT01074047|1197003|P1|Treatment Phase|Disease Progression|16
354633|NCT01074047|1197002|P2|Treatment Phase|Adverse Event|66
354634|NCT01074047|1197003|P1|Treatment Phase|Adverse Event|89
354635|NCT01074008|1197091|P9|Overall Study|Lost to Follow-up|4
354636|NCT01074008|1197092|P8|Overall Study|Lost to Follow-up|0
354637|NCT01074008|1197093|P7|Overall Study|Lost to Follow-up|1
354638|NCT01074008|1197094|P6|Overall Study|Lost to Follow-up|0
354639|NCT01074008|1197095|P5|Overall Study|Lost to Follow-up|1
354640|NCT01074008|1197096|P4|Overall Study|Lost to Follow-up|1
354641|NCT01074008|1197097|P3|Overall Study|Lost to Follow-up|1
354642|NCT01074008|1197098|P2|Overall Study|Lost to Follow-up|1
354643|NCT01074008|1197099|P1|Overall Study|Lost to Follow-up|0
354644|NCT01074008|1197091|P9|Overall Study|Withdrawal by Subject|0
354645|NCT01074008|1197092|P8|Overall Study|Withdrawal by Subject|0
354646|NCT01074008|1197093|P7|Overall Study|Withdrawal by Subject|0
354647|NCT01074008|1197094|P6|Overall Study|Withdrawal by Subject|0
354648|NCT01074008|1197095|P5|Overall Study|Withdrawal by Subject|1
354649|NCT01074008|1197096|P4|Overall Study|Withdrawal by Subject|0
354650|NCT01074008|1197097|P3|Overall Study|Withdrawal by Subject|1
354651|NCT01074008|1197098|P2|Overall Study|Withdrawal by Subject|1
354652|NCT01074008|1197099|P1|Overall Study|Withdrawal by Subject|1
354653|NCT01074008|1197091|P9|Overall Study|Adverse Event|0
354654|NCT01074008|1197092|P8|Overall Study|Adverse Event|0
354655|NCT01074008|1197093|P7|Overall Study|Adverse Event|0
354656|NCT01074008|1197094|P6|Overall Study|Adverse Event|0
354657|NCT01074008|1197095|P5|Overall Study|Adverse Event|0
354658|NCT01074008|1197096|P4|Overall Study|Adverse Event|0
354659|NCT01074008|1197097|P3|Overall Study|Adverse Event|0
354660|NCT01074008|1197098|P2|Overall Study|Adverse Event|1
354661|NCT01074008|1197099|P1|Overall Study|Adverse Event|0
354662|NCT01073943|1197209|P2|Overall Study|Could not tolerate prep|0
354663|NCT01073943|1197210|P1|Overall Study|Could not tolerate prep|1
354664|NCT01073943|1197209|P2|Overall Study|Unable to return for follow-up|1
354665|NCT01073943|1197210|P1|Overall Study|Unable to return for follow-up|0
354666|NCT01073943|1197209|P2|Overall Study|Subject forgot|1
354667|NCT01073943|1197210|P1|Overall Study|Subject forgot|0
354668|NCT01073943|1197209|P2|Overall Study|Power outage; colonoscopy not done|0
354669|NCT01073943|1197210|P1|Overall Study|Power outage; colonoscopy not done|1
354670|NCT01073943|1197209|P2|Overall Study|Lost to Follow-up|2
354671|NCT01073943|1197210|P1|Overall Study|Lost to Follow-up|0
354672|NCT01073943|1197209|P2|Overall Study|Adverse Event|1
354673|NCT01073943|1197210|P1|Overall Study|Adverse Event|1
354674|NCT01073943|1197209|P2|Overall Study|Protocol Violation|1
354675|NCT01073943|1197210|P1|Overall Study|Protocol Violation|2
354676|NCT01073943|1197209|P2|Overall Study|Withdrawal by Subject|2
354677|NCT01073943|1197210|P1|Overall Study|Withdrawal by Subject|8
354678|NCT01073930|1197236|P2|Overall Study|Inadequate prep; unable to do procedure|1
354679|NCT01073930|1197237|P1|Overall Study|Inadequate prep; unable to do procedure|0
354680|NCT01073930|1197236|P2|Overall Study|Noncompliance with study drug|1
354681|NCT01073930|1197237|P1|Overall Study|Noncompliance with study drug|0
354682|NCT01073930|1197236|P2|Overall Study|Adverse Event|1
354683|NCT01073930|1197237|P1|Overall Study|Adverse Event|0
354684|NCT01073930|1197236|P2|Overall Study|Lost to Follow-up|1
354685|NCT01073930|1197237|P1|Overall Study|Lost to Follow-up|0
354686|NCT01073930|1197236|P2|Overall Study|Withdrawal by Subject|2
354687|NCT01073930|1197237|P1|Overall Study|Withdrawal by Subject|3
354688|NCT01073865|1197261|P2|Overall Study|Withdrawal by Subject|5
354689|NCT01073865|1197262|P1|Overall Study|Withdrawal by Subject|5
354690|NCT01073865|1197261|P2|Overall Study|Death|2
354691|NCT01073865|1197262|P1|Overall Study|Death|3
354692|NCT01073865|1197261|P2|Overall Study|Lost to Follow-up|1
354693|NCT01073865|1197262|P1|Overall Study|Lost to Follow-up|1
354694|NCT01073865|1197261|P2|Overall Study|Reasons other than below|31
354695|NCT01073865|1197262|P1|Overall Study|Reasons other than below|19
354696|NCT01073631|1197281|P1|Overall Study|Other|63
354697|NCT01073631|1197281|P1|Overall Study|Adverse Event|24
354698|NCT01073631|1197281|P1|Overall Study|Death|82
354699|NCT01073618|1197286|P1|Overall Study|Other|80
354700|NCT01073618|1197286|P1|Overall Study|Adverse Event|19
354701|NCT01073618|1197286|P1|Overall Study|Death|208
354702|NCT01073605|1197294|P3|Overall Study|Randomized But Not Treated|1
354703|NCT01073605|1197295|P2|Overall Study|Randomized But Not Treated|1
354704|NCT01073605|1197296|P1|Overall Study|Randomized But Not Treated|0
354705|NCT01073605|1197294|P3|Overall Study|Withdrawal by Subject|22
354706|NCT01073605|1197295|P2|Overall Study|Withdrawal by Subject|39
354707|NCT01073605|1197296|P1|Overall Study|Withdrawal by Subject|31
354708|NCT01073605|1197294|P3|Overall Study|Other|29
354709|NCT01073605|1197295|P2|Overall Study|Other|21
354710|NCT01073605|1197296|P1|Overall Study|Other|25
354711|NCT01073605|1197294|P3|Overall Study|Lost to Follow-up|9
354712|NCT01073605|1197295|P2|Overall Study|Lost to Follow-up|4
354713|NCT01073605|1197296|P1|Overall Study|Lost to Follow-up|3
354714|NCT01073605|1197294|P3|Overall Study|Adverse Event|0
354715|NCT01073605|1197295|P2|Overall Study|Adverse Event|1
354716|NCT01073605|1197296|P1|Overall Study|Adverse Event|2
354717|NCT01073605|1197294|P3|Overall Study|Ongoing at Cutoff Date|0
354718|NCT01073605|1197295|P2|Overall Study|Ongoing at Cutoff Date|1
354719|NCT01073605|1197296|P1|Overall Study|Ongoing at Cutoff Date|1
354720|NCT01073566|1197342|P2|Period 2 (6 Weeks)|Adverse Event|0
354721|NCT01073566|1197343|P1|Period 2 (6 Weeks)|Adverse Event|1
354722|NCT01073462|1197355|P1|Overall Study|Lost to Follow-up|7
354723|NCT01073462|1197355|P1|Overall Study|Serious adverse event|2
354724|NCT01073462|1197355|P1|Overall Study|Low parathyroid hormone levels|8
354725|NCT01073462|1197355|P1|Overall Study|Kidney transplant|10
354726|NCT01073462|1197355|P1|Overall Study|Death|14
354727|NCT01073293|1197374|P2|Overall Study|Withdrawal by Subject|10
354728|NCT01073293|1197375|P1|Overall Study|Withdrawal by Subject|5
354729|NCT01073293|1197374|P2|Overall Study|Lost to Follow-up|1
354730|NCT01073293|1197375|P1|Overall Study|Lost to Follow-up|0
354731|NCT01073267|1197397|P1|Overall Study|Disease Progression|3
354732|NCT01073163|1197401|P1|Overall Study|Early termination|1
354733|NCT01073163|1197401|P1|Overall Study|Disease Progression|1
354734|NCT01073163|1197401|P1|Overall Study|Adverse Event|1
354735|NCT01072929|1197424|P3|Overall Study|Not specified|0
354736|NCT01072929|1197425|P2|Overall Study|Not specified|3
354737|NCT01072929|1197426|P1|Overall Study|Not specified|0
354738|NCT01072929|1197424|P3|Overall Study|Noncompliance with study procedures|1
354739|NCT01072929|1197425|P2|Overall Study|Noncompliance with study procedures|0
354740|NCT01072929|1197426|P1|Overall Study|Noncompliance with study procedures|1
354741|NCT01072929|1197424|P3|Overall Study|Noncompliance with study medication|0
354742|NCT01072929|1197425|P2|Overall Study|Noncompliance with study medication|3
354743|NCT01072929|1197426|P1|Overall Study|Noncompliance with study medication|0
354744|NCT01072929|1197424|P3|Overall Study|Lost to Follow-up|1
354745|NCT01072929|1197425|P2|Overall Study|Lost to Follow-up|4
354746|NCT01072929|1197426|P1|Overall Study|Lost to Follow-up|8
354747|NCT01072929|1197424|P3|Overall Study|Protocol Violation|2
354748|NCT01072929|1197425|P2|Overall Study|Protocol Violation|11
354749|NCT01072929|1197426|P1|Overall Study|Protocol Violation|13
354750|NCT01072929|1197424|P3|Overall Study|Withdrawal by Subject|3
354751|NCT01072929|1197425|P2|Overall Study|Withdrawal by Subject|15
354752|NCT01072929|1197426|P1|Overall Study|Withdrawal by Subject|7
354753|NCT01072929|1197424|P3|Overall Study|Lack of Efficacy|0
354754|NCT01072929|1197425|P2|Overall Study|Lack of Efficacy|4
354755|NCT01072929|1197426|P1|Overall Study|Lack of Efficacy|7
354756|NCT01072929|1197424|P3|Overall Study|Adverse Event|2
354757|NCT01072929|1197425|P2|Overall Study|Adverse Event|11
354758|NCT01072929|1197426|P1|Overall Study|Adverse Event|8
354759|NCT01072877|1197505|P5|Overall Study|Lost to Follow-up|0
354760|NCT01072877|1197506|P4|Overall Study|Lost to Follow-up|2
354761|NCT01072877|1197507|P3|Overall Study|Lost to Follow-up|0
354762|NCT01072877|1197508|P2|Overall Study|Lost to Follow-up|1
354763|NCT01072877|1197509|P1|Overall Study|Lost to Follow-up|1
354764|NCT01072630|1197572|P3|Overall Study|Not specified|1
354765|NCT01072630|1197573|P2|Overall Study|Not specified|2
354766|NCT01072630|1197574|P1|Overall Study|Not specified|3
354767|NCT01072630|1197572|P3|Overall Study|Noncompliance with study procedures|1
354768|NCT01072630|1197573|P2|Overall Study|Noncompliance with study procedures|2
354769|NCT01072630|1197574|P1|Overall Study|Noncompliance with study procedures|1
354770|NCT01072630|1197572|P3|Overall Study|Noncompliance with study medication|1
354771|NCT01072630|1197573|P2|Overall Study|Noncompliance with study medication|1
354772|NCT01072630|1197574|P1|Overall Study|Noncompliance with study medication|1
354773|NCT01072630|1197572|P3|Overall Study|Lost to Follow-up|1
354774|NCT01072630|1197573|P2|Overall Study|Lost to Follow-up|11
354775|NCT01072630|1197574|P1|Overall Study|Lost to Follow-up|11
354776|NCT01072630|1197572|P3|Overall Study|Protocol Violation|4
354777|NCT01072630|1197573|P2|Overall Study|Protocol Violation|8
354778|NCT01072630|1197574|P1|Overall Study|Protocol Violation|10
354779|NCT01072630|1197572|P3|Overall Study|Withdrawal by Subject|2
354780|NCT01072630|1197573|P2|Overall Study|Withdrawal by Subject|7
354781|NCT01072630|1197574|P1|Overall Study|Withdrawal by Subject|8
354782|NCT01072630|1197572|P3|Overall Study|Lack of Efficacy|1
354783|NCT01072630|1197573|P2|Overall Study|Lack of Efficacy|10
354784|NCT01072630|1197574|P1|Overall Study|Lack of Efficacy|10
354785|NCT01072630|1197572|P3|Overall Study|Adverse Event|2
354786|NCT01072630|1197573|P2|Overall Study|Adverse Event|19
354787|NCT01072630|1197574|P1|Overall Study|Adverse Event|11
354788|NCT01072539|1197655|P1|Overall Study|Protocol Violation|2
354789|NCT01072539|1197655|P1|Overall Study|Treated prior to the Site Initiation|1
354790|NCT01072500|1197679|P2|Overall Study|Withdrawal by Subject|10
354791|NCT01072500|1197680|P1|Overall Study|Withdrawal by Subject|17
354792|NCT01072500|1197679|P2|Overall Study|Lost to Follow-up|2
354793|NCT01072500|1197680|P1|Overall Study|Lost to Follow-up|5
354794|NCT01072500|1197679|P2|Overall Study|Death|2
354795|NCT01072500|1197680|P1|Overall Study|Death|2
354796|NCT01072448|1197690|P2|Overall Study|Death|2
354797|NCT01072448|1197691|P1|Overall Study|Death|0
354798|NCT01072448|1197690|P2|Overall Study|Abnormal laboratory value(s)|1
354799|NCT01072448|1197691|P1|Overall Study|Abnormal laboratory value(s)|0
354800|NCT01072448|1197690|P2|Overall Study|Lost to Follow-up|1
354801|NCT01072448|1197691|P1|Overall Study|Lost to Follow-up|1
354802|NCT01072448|1197690|P2|Overall Study|Unsatisfactory therapeutic effect|3
354803|NCT01072448|1197691|P1|Overall Study|Unsatisfactory therapeutic effect|1
354804|NCT01072448|1197690|P2|Overall Study|Abnormal test procedure result(s)|0
354805|NCT01072448|1197691|P1|Overall Study|Abnormal test procedure result(s)|1
354806|NCT01072448|1197690|P2|Overall Study|Protocol deviation|4
354807|NCT01072448|1197691|P1|Overall Study|Protocol deviation|3
354808|NCT01072448|1197690|P2|Overall Study|Subject withdrew consent|9
354809|NCT01072448|1197691|P1|Overall Study|Subject withdrew consent|4
354810|NCT01072448|1197690|P2|Overall Study|Adverse Event|10
354811|NCT01072448|1197691|P1|Overall Study|Adverse Event|9
354812|NCT01072396|1197705|P2|Period Two|Lost to Follow-up|0
354813|NCT01072396|1197706|P1|Period Two|Lost to Follow-up|1
354814|NCT01072396|1197705|P2|Period Two|Adverse Event|3
354815|NCT01072396|1197706|P1|Period Two|Adverse Event|0
354816|NCT01072396|1197705|P2|Washout Period|Missing termination information|1
354817|NCT01072396|1197706|P1|Washout Period|Missing termination information|0
354818|NCT01072396|1197705|P2|Period One|Withdrawal by Subject|0
354819|NCT01072396|1197706|P1|Period One|Withdrawal by Subject|2
354820|NCT01072396|1197705|P2|Period One|Protocol Violation|1
354821|NCT01072396|1197706|P1|Period One|Protocol Violation|2
354822|NCT01072396|1197705|P2|Period One|Adverse Event|1
354823|NCT01072396|1197706|P1|Period One|Adverse Event|1
354824|NCT01072357|1197718|P2|Overall Study|Lost to Follow-up|1
354825|NCT01072357|1197719|P1|Overall Study|Lost to Follow-up|0
354826|NCT01072344|1197729|P2|Overall Study|Lost to Follow-up|4
354827|NCT01072344|1197730|P1|Overall Study|Lost to Follow-up|3
354828|NCT01072344|1197729|P2|Overall Study|Protocol Violation|2
354829|NCT01072344|1197730|P1|Overall Study|Protocol Violation|1
354830|NCT01072344|1197729|P2|Overall Study|Relasped-reached end point|12
354831|NCT01072344|1197730|P1|Overall Study|Relasped-reached end point|7
354832|NCT01072201|1197768|P2|Overall Study|Lost to Follow-up|1
354833|NCT01072201|1197769|P1|Overall Study|Lost to Follow-up|0
354834|NCT01072175|1197802|P13|Part D (HPMC Capsules)|Ongoing|34
354835|NCT01072175|1197803|P12|Part D (HPMC Capsules)|Ongoing|34
354836|NCT01072175|1197804|P11|Part D (HPMC Capsules)|Ongoing|12
354837|NCT01072175|1197805|P10|Part D (HPMC Capsules)|Ongoing|10
354838|NCT01072175|1197806|P9|Part D (HPMC Capsules)|Ongoing|0
354839|NCT01072175|1197807|P8|Part D (HPMC Capsules)|Ongoing|0
354840|NCT01072175|1197808|P7|Part D (HPMC Capsules)|Ongoing|0
354841|NCT01072175|1197809|P6|Part D (HPMC Capsules)|Ongoing|0
354842|NCT01072175|1197810|P5|Part D (HPMC Capsules)|Ongoing|0
354843|NCT01072175|1197811|P4|Part D (HPMC Capsules)|Ongoing|0
354844|NCT01072175|1197812|P3|Part D (HPMC Capsules)|Ongoing|0
354845|NCT01072175|1197813|P2|Part D (HPMC Capsules)|Ongoing|0
354846|NCT01072175|1197814|P1|Part D (HPMC Capsules)|Ongoing|0
354847|NCT01072175|1197802|P13|Part D (HPMC Capsules)|Death|5
354848|NCT01072175|1197803|P12|Part D (HPMC Capsules)|Death|6
354849|NCT01072175|1197804|P11|Part D (HPMC Capsules)|Death|4
354850|NCT01072175|1197805|P10|Part D (HPMC Capsules)|Death|2
354851|NCT01072175|1197806|P9|Part D (HPMC Capsules)|Death|0
354852|NCT01072175|1197807|P8|Part D (HPMC Capsules)|Death|0
354853|NCT01072175|1197808|P7|Part D (HPMC Capsules)|Death|0
354854|NCT01072175|1197809|P6|Part D (HPMC Capsules)|Death|0
354855|NCT01072175|1197810|P5|Part D (HPMC Capsules)|Death|0
354856|NCT01072175|1197811|P4|Part D (HPMC Capsules)|Death|0
354857|NCT01072175|1197812|P3|Part D (HPMC Capsules)|Death|0
354858|NCT01072175|1197813|P2|Part D (HPMC Capsules)|Death|0
354859|NCT01072175|1197814|P1|Part D (HPMC Capsules)|Death|0
354860|NCT01072175|1197802|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
354861|NCT01072175|1197803|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
354862|NCT01072175|1197804|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
354863|NCT01072175|1197805|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
354864|NCT01072175|1197806|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
354865|NCT01072175|1197807|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
354866|NCT01072175|1197808|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
354867|NCT01072175|1197809|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
354868|NCT01072175|1197810|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
354869|NCT01072175|1197811|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
354870|NCT01072175|1197812|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
354871|NCT01072175|1197813|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
354872|NCT01072175|1197814|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
354873|NCT01072175|1197802|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
354874|NCT01072175|1197803|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
354875|NCT01072175|1197804|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
354876|NCT01072175|1197805|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
354877|NCT01072175|1197806|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
354878|NCT01072175|1197807|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
354879|NCT01072175|1197808|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
354880|NCT01072175|1197809|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
354881|NCT01072175|1197810|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
354882|NCT01072175|1197811|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
354883|NCT01072175|1197812|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
354884|NCT01072175|1197813|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
354885|NCT01072175|1197814|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
354886|NCT01072175|1197802|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354887|NCT01072175|1197803|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354888|NCT01072175|1197804|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354889|NCT01072175|1197805|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354890|NCT01072175|1197806|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
354891|NCT01072175|1197807|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354892|NCT01072175|1197808|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354893|NCT01072175|1197809|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354894|NCT01072175|1197810|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354895|NCT01072175|1197811|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354896|NCT01072175|1197812|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354897|NCT01072175|1197813|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354898|NCT01072175|1197814|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
354899|NCT01072175|1197802|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
354900|NCT01072175|1197803|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
354901|NCT01072175|1197804|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
354902|NCT01072175|1197805|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
354903|NCT01072175|1197806|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
354904|NCT01072175|1197807|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
354905|NCT01072175|1197808|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
354906|NCT01072175|1197809|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
354907|NCT01072175|1197810|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
354908|NCT01072175|1197811|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
354909|NCT01072175|1197812|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
354910|NCT01072175|1197813|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
354911|NCT01072175|1197814|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
354912|NCT01072175|1197802|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
354913|NCT01072175|1197803|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
354914|NCT01072175|1197804|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
354915|NCT01072175|1197805|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
354916|NCT01072175|1197806|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
354917|NCT01072175|1197807|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
354918|NCT01072175|1197808|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
354919|NCT01072175|1197809|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
354920|NCT01072175|1197810|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
354921|NCT01072175|1197811|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
354922|NCT01072175|1197812|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
354923|NCT01072175|1197813|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
354924|NCT01072175|1197814|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
354925|NCT01072175|1197802|P13|Part C (Phase II: Randomized Phase)|Death|0
354926|NCT01072175|1197803|P12|Part C (Phase II: Randomized Phase)|Death|0
354927|NCT01072175|1197804|P11|Part C (Phase II: Randomized Phase)|Death|0
354928|NCT01072175|1197805|P10|Part C (Phase II: Randomized Phase)|Death|0
354929|NCT01072175|1197806|P9|Part C (Phase II: Randomized Phase)|Death|0
354930|NCT01072175|1197807|P8|Part C (Phase II: Randomized Phase)|Death|14
354931|NCT01072175|1197808|P7|Part C (Phase II: Randomized Phase)|Death|18
354932|NCT01072175|1197809|P6|Part C (Phase II: Randomized Phase)|Death|19
354933|NCT01072175|1197810|P5|Part C (Phase II: Randomized Phase)|Death|0
354934|NCT01072175|1197811|P4|Part C (Phase II: Randomized Phase)|Death|0
354935|NCT01072175|1197812|P3|Part C (Phase II: Randomized Phase)|Death|0
354936|NCT01072175|1197813|P2|Part C (Phase II: Randomized Phase)|Death|0
354937|NCT01072175|1197814|P1|Part C (Phase II: Randomized Phase)|Death|0
354938|NCT01072175|1197802|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354939|NCT01072175|1197803|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354940|NCT01072175|1197804|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354941|NCT01072175|1197805|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354942|NCT01072175|1197806|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354943|NCT01072175|1197807|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354944|NCT01072175|1197808|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
354945|NCT01072175|1197809|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354946|NCT01072175|1197810|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354947|NCT01072175|1197811|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354948|NCT01072175|1197812|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354949|NCT01072175|1197813|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354950|NCT01072175|1197814|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
354951|NCT01072175|1197802|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
354952|NCT01072175|1197803|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
354953|NCT01072175|1197804|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
354954|NCT01072175|1197805|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
354955|NCT01072175|1197806|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
354956|NCT01072175|1197807|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
355261|NCT01071278|1198171|P1|Overall Study|Completion Status Unknown|459
354957|NCT01072175|1197808|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
354958|NCT01072175|1197809|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
354959|NCT01072175|1197810|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
354960|NCT01072175|1197811|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
354961|NCT01072175|1197812|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
354962|NCT01072175|1197813|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
354963|NCT01072175|1197814|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
354964|NCT01072175|1197802|P13|Part B (Dose Escalation and Expansion)|Death|0
354965|NCT01072175|1197803|P12|Part B (Dose Escalation and Expansion)|Death|0
354966|NCT01072175|1197804|P11|Part B (Dose Escalation and Expansion)|Death|0
354967|NCT01072175|1197805|P10|Part B (Dose Escalation and Expansion)|Death|0
354968|NCT01072175|1197806|P9|Part B (Dose Escalation and Expansion)|Death|0
354969|NCT01072175|1197807|P8|Part B (Dose Escalation and Expansion)|Death|0
354970|NCT01072175|1197808|P7|Part B (Dose Escalation and Expansion)|Death|0
354971|NCT01072175|1197809|P6|Part B (Dose Escalation and Expansion)|Death|0
354972|NCT01072175|1197810|P5|Part B (Dose Escalation and Expansion)|Death|36
354973|NCT01072175|1197811|P4|Part B (Dose Escalation and Expansion)|Death|12
354974|NCT01072175|1197812|P3|Part B (Dose Escalation and Expansion)|Death|10
354975|NCT01072175|1197813|P2|Part B (Dose Escalation and Expansion)|Death|3
354976|NCT01072175|1197814|P1|Part B (Dose Escalation and Expansion)|Death|0
354977|NCT01072175|1197802|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354978|NCT01072175|1197803|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354979|NCT01072175|1197804|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354980|NCT01072175|1197805|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354981|NCT01072175|1197806|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354982|NCT01072175|1197807|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354983|NCT01072175|1197808|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354984|NCT01072175|1197809|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354985|NCT01072175|1197810|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
354986|NCT01072175|1197811|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
354987|NCT01072175|1197812|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354988|NCT01072175|1197813|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354989|NCT01072175|1197814|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
354990|NCT01072175|1197802|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
354991|NCT01072175|1197803|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
354992|NCT01072175|1197804|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
354993|NCT01072175|1197805|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
354994|NCT01072175|1197806|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
354995|NCT01072175|1197807|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
354996|NCT01072175|1197808|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
354997|NCT01072175|1197809|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
354998|NCT01072175|1197810|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
354999|NCT01072175|1197811|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
355000|NCT01072175|1197812|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
355001|NCT01072175|1197813|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
355002|NCT01072175|1197814|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
355003|NCT01072175|1197802|P13|Part A (Drug-Drug Interaction)|Death|0
355004|NCT01072175|1197803|P12|Part A (Drug-Drug Interaction)|Death|0
355005|NCT01072175|1197804|P11|Part A (Drug-Drug Interaction)|Death|0
355006|NCT01072175|1197805|P10|Part A (Drug-Drug Interaction)|Death|0
355007|NCT01072175|1197806|P9|Part A (Drug-Drug Interaction)|Death|0
355008|NCT01072175|1197807|P8|Part A (Drug-Drug Interaction)|Death|0
355009|NCT01072175|1197808|P7|Part A (Drug-Drug Interaction)|Death|0
355010|NCT01072175|1197809|P6|Part A (Drug-Drug Interaction)|Death|0
355011|NCT01072175|1197810|P5|Part A (Drug-Drug Interaction)|Death|0
355012|NCT01072175|1197811|P4|Part A (Drug-Drug Interaction)|Death|0
355013|NCT01072175|1197812|P3|Part A (Drug-Drug Interaction)|Death|0
355014|NCT01072175|1197813|P2|Part A (Drug-Drug Interaction)|Death|0
355015|NCT01072175|1197814|P1|Part A (Drug-Drug Interaction)|Death|1
355016|NCT01072175|1197802|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355017|NCT01072175|1197803|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355018|NCT01072175|1197804|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355019|NCT01072175|1197805|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355020|NCT01072175|1197806|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355021|NCT01072175|1197807|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355022|NCT01072175|1197808|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355023|NCT01072175|1197809|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355024|NCT01072175|1197810|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355025|NCT01072175|1197811|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355026|NCT01072175|1197812|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355027|NCT01072175|1197813|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
355028|NCT01072175|1197814|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
355029|NCT01072175|1197802|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
355030|NCT01072175|1197803|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
355031|NCT01072175|1197804|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
355032|NCT01072175|1197805|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
355033|NCT01072175|1197806|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
355034|NCT01072175|1197807|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
355035|NCT01072175|1197808|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
355036|NCT01072175|1197809|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
355037|NCT01072175|1197810|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
355038|NCT01072175|1197811|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
355039|NCT01072175|1197812|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
355040|NCT01072175|1197813|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
355041|NCT01072175|1197814|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
355042|NCT01072149|1197997|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355043|NCT01072149|1197998|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355044|NCT01072149|1197999|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355045|NCT01072149|1198000|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355046|NCT01072149|1198001|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
355047|NCT01072149|1198002|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355048|NCT01072149|1198003|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355049|NCT01072149|1198004|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355050|NCT01072149|1198005|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355051|NCT01072149|1198006|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355052|NCT01072149|1198007|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355053|NCT01072149|1198008|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355054|NCT01072149|1198009|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355055|NCT01072149|1198010|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355056|NCT01072149|1198011|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355057|NCT01072149|1198012|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
355058|NCT01072149|1198013|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355059|NCT01072149|1198014|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
355060|NCT01072149|1197997|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
355061|NCT01072149|1197998|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
355062|NCT01072149|1197999|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
355063|NCT01072149|1198000|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
355064|NCT01072149|1198001|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
355065|NCT01072149|1198002|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
355066|NCT01072149|1198003|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
355067|NCT01072149|1198004|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
355068|NCT01072149|1198005|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
355069|NCT01072149|1198006|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
355070|NCT01072149|1198007|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
355071|NCT01072149|1198008|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
355072|NCT01072149|1198009|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
355073|NCT01072149|1198010|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
355074|NCT01072149|1198011|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
355075|NCT01072149|1198012|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
355076|NCT01072149|1198013|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
355077|NCT01072149|1198014|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
355078|NCT01072149|1197997|P18|Washout Period 2 (14 Days)|Adverse Event|0
355079|NCT01072149|1197998|P17|Washout Period 2 (14 Days)|Adverse Event|0
355080|NCT01072149|1197999|P16|Washout Period 2 (14 Days)|Adverse Event|1
355081|NCT01072149|1198000|P15|Washout Period 2 (14 Days)|Adverse Event|0
355082|NCT01072149|1198001|P14|Washout Period 2 (14 Days)|Adverse Event|0
355083|NCT01072149|1198002|P13|Washout Period 2 (14 Days)|Adverse Event|0
355084|NCT01072149|1198003|P12|Washout Period 2 (14 Days)|Adverse Event|0
355085|NCT01072149|1198004|P11|Washout Period 2 (14 Days)|Adverse Event|0
355086|NCT01072149|1198005|P10|Washout Period 2 (14 Days)|Adverse Event|0
355087|NCT01072149|1198006|P9|Washout Period 2 (14 Days)|Adverse Event|0
355088|NCT01072149|1198007|P8|Washout Period 2 (14 Days)|Adverse Event|0
355089|NCT01072149|1198008|P7|Washout Period 2 (14 Days)|Adverse Event|0
355090|NCT01072149|1198009|P6|Washout Period 2 (14 Days)|Adverse Event|0
355091|NCT01072149|1198010|P5|Washout Period 2 (14 Days)|Adverse Event|0
355092|NCT01072149|1198011|P4|Washout Period 2 (14 Days)|Adverse Event|0
355093|NCT01072149|1198012|P3|Washout Period 2 (14 Days)|Adverse Event|0
355094|NCT01072149|1198013|P2|Washout Period 2 (14 Days)|Adverse Event|0
355095|NCT01072149|1198014|P1|Washout Period 2 (14 Days)|Adverse Event|0
355096|NCT01072149|1197997|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355097|NCT01072149|1197998|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355098|NCT01072149|1197999|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
355099|NCT01072149|1198000|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355100|NCT01072149|1198001|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355101|NCT01072149|1198002|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355102|NCT01072149|1198003|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355103|NCT01072149|1198004|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355104|NCT01072149|1198005|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355105|NCT01072149|1198006|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355106|NCT01072149|1198007|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355107|NCT01072149|1198008|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355108|NCT01072149|1198009|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355109|NCT01072149|1198010|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355110|NCT01072149|1198011|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355111|NCT01072149|1198012|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355112|NCT01072149|1198013|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355113|NCT01072149|1198014|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
355114|NCT01072149|1197997|P18|Washout Period 2 (14 Days)|Physician Decision|0
355115|NCT01072149|1197998|P17|Washout Period 2 (14 Days)|Physician Decision|0
355116|NCT01072149|1197999|P16|Washout Period 2 (14 Days)|Physician Decision|0
355117|NCT01072149|1198000|P15|Washout Period 2 (14 Days)|Physician Decision|0
355118|NCT01072149|1198001|P14|Washout Period 2 (14 Days)|Physician Decision|0
355119|NCT01072149|1198002|P13|Washout Period 2 (14 Days)|Physician Decision|0
355120|NCT01072149|1198003|P12|Washout Period 2 (14 Days)|Physician Decision|0
355121|NCT01072149|1198004|P11|Washout Period 2 (14 Days)|Physician Decision|0
355122|NCT01072149|1198005|P10|Washout Period 2 (14 Days)|Physician Decision|0
355123|NCT01072149|1198006|P9|Washout Period 2 (14 Days)|Physician Decision|0
355124|NCT01072149|1198007|P8|Washout Period 2 (14 Days)|Physician Decision|0
355125|NCT01072149|1198008|P7|Washout Period 2 (14 Days)|Physician Decision|0
355126|NCT01072149|1198009|P6|Washout Period 2 (14 Days)|Physician Decision|0
355127|NCT01072149|1198010|P5|Washout Period 2 (14 Days)|Physician Decision|0
355128|NCT01072149|1198011|P4|Washout Period 2 (14 Days)|Physician Decision|0
355129|NCT01072149|1198012|P3|Washout Period 2 (14 Days)|Physician Decision|0
355130|NCT01072149|1198013|P2|Washout Period 2 (14 Days)|Physician Decision|0
355131|NCT01072149|1198014|P1|Washout Period 2 (14 Days)|Physician Decision|1
355132|NCT01072149|1197997|P18|Treatment Period 2 (28 Days)|Physician Decision|0
355133|NCT01072149|1197998|P17|Treatment Period 2 (28 Days)|Physician Decision|0
355134|NCT01072149|1197999|P16|Treatment Period 2 (28 Days)|Physician Decision|0
355135|NCT01072149|1198000|P15|Treatment Period 2 (28 Days)|Physician Decision|0
355136|NCT01072149|1198001|P14|Treatment Period 2 (28 Days)|Physician Decision|0
355137|NCT01072149|1198002|P13|Treatment Period 2 (28 Days)|Physician Decision|0
355138|NCT01072149|1198003|P12|Treatment Period 2 (28 Days)|Physician Decision|0
355139|NCT01072149|1198004|P11|Treatment Period 2 (28 Days)|Physician Decision|0
355140|NCT01072149|1198005|P10|Treatment Period 2 (28 Days)|Physician Decision|0
355141|NCT01072149|1198006|P9|Treatment Period 2 (28 Days)|Physician Decision|0
355142|NCT01072149|1198007|P8|Treatment Period 2 (28 Days)|Physician Decision|1
355143|NCT01072149|1198008|P7|Treatment Period 2 (28 Days)|Physician Decision|0
355144|NCT01072149|1198009|P6|Treatment Period 2 (28 Days)|Physician Decision|0
355145|NCT01072149|1198010|P5|Treatment Period 2 (28 Days)|Physician Decision|0
355146|NCT01072149|1198011|P4|Treatment Period 2 (28 Days)|Physician Decision|0
355147|NCT01072149|1198012|P3|Treatment Period 2 (28 Days)|Physician Decision|0
355148|NCT01072149|1198013|P2|Treatment Period 2 (28 Days)|Physician Decision|0
355149|NCT01072149|1198014|P1|Treatment Period 2 (28 Days)|Physician Decision|0
355150|NCT01072149|1197997|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355151|NCT01072149|1197998|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355152|NCT01072149|1197999|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355153|NCT01072149|1198000|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355154|NCT01072149|1198001|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355155|NCT01072149|1198002|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355156|NCT01072149|1198003|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355157|NCT01072149|1198004|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355158|NCT01072149|1198005|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355159|NCT01072149|1198006|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355160|NCT01072149|1198007|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355161|NCT01072149|1198008|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355162|NCT01072149|1198009|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355163|NCT01072149|1198010|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355164|NCT01072149|1198011|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355165|NCT01072149|1198012|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
355166|NCT01072149|1198013|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355167|NCT01072149|1198014|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
355168|NCT01072149|1197997|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355169|NCT01072149|1197998|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355170|NCT01072149|1197999|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355171|NCT01072149|1198000|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355172|NCT01072149|1198001|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355173|NCT01072149|1198002|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355174|NCT01072149|1198003|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355175|NCT01072149|1198004|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355176|NCT01072149|1198005|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355177|NCT01072149|1198006|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355178|NCT01072149|1198007|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355179|NCT01072149|1198008|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355180|NCT01072149|1198009|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355181|NCT01072149|1198010|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355182|NCT01072149|1198011|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355183|NCT01072149|1198012|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355184|NCT01072149|1198013|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
355185|NCT01072149|1198014|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
355186|NCT01072149|1197997|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355187|NCT01072149|1197998|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355188|NCT01072149|1197999|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355189|NCT01072149|1198000|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355190|NCT01072149|1198001|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355191|NCT01072149|1198002|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355192|NCT01072149|1198003|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355193|NCT01072149|1198004|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
355194|NCT01072149|1198005|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355195|NCT01072149|1198006|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355196|NCT01072149|1198007|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355197|NCT01072149|1198008|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355198|NCT01072149|1198009|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355199|NCT01072149|1198010|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355200|NCT01072149|1198011|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355201|NCT01072149|1198012|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355202|NCT01072149|1198013|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355203|NCT01072149|1198014|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
355204|NCT01072149|1197997|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
355205|NCT01072149|1197998|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
355206|NCT01072149|1197999|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
355207|NCT01072149|1198000|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
355208|NCT01072149|1198001|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
355209|NCT01072149|1198002|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
355210|NCT01072149|1198003|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
355211|NCT01072149|1198004|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
355212|NCT01072149|1198005|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
355213|NCT01072149|1198006|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
355214|NCT01072149|1198007|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
355215|NCT01072149|1198008|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
355216|NCT01072149|1198009|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
355217|NCT01072149|1198010|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
355218|NCT01072149|1198011|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
355219|NCT01072149|1198012|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
355220|NCT01072149|1198013|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
355221|NCT01072149|1198014|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
355222|NCT01072149|1197997|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355223|NCT01072149|1197998|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355224|NCT01072149|1197999|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355225|NCT01072149|1198000|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355226|NCT01072149|1198001|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355227|NCT01072149|1198002|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355228|NCT01072149|1198003|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355229|NCT01072149|1198004|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355230|NCT01072149|1198005|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355231|NCT01072149|1198006|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355232|NCT01072149|1198007|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355233|NCT01072149|1198008|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355234|NCT01072149|1198009|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355235|NCT01072149|1198010|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355236|NCT01072149|1198011|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355237|NCT01072149|1198012|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
355238|NCT01072149|1198013|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355239|NCT01072149|1198014|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
355240|NCT01071915|1198103|P1|Overall Study|Miscellaneous Reasons|2
355241|NCT01071915|1198103|P1|Overall Study|Withdrawal by Subject|2
355242|NCT01071915|1198103|P1|Overall Study|Physician Decision|2
355243|NCT01071915|1198103|P1|Overall Study|Adverse Event|3
355244|NCT01071798|1198113|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
355245|NCT01071798|1198113|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
355246|NCT01071798|1198113|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
355247|NCT01071798|1198113|P1|Subpopulation Who Received Two Cycles|Remission|1
355248|NCT01071798|1198113|P1|Participants Who Received One Cycle|Severe concomitant disease|2
355249|NCT01071798|1198113|P1|Participants Who Received One Cycle|Change of therapy|6
355250|NCT01071798|1198113|P1|Participants Who Received One Cycle|Death|5
355251|NCT01071798|1198113|P1|Participants Who Received One Cycle|Patient requirement|20
355252|NCT01071798|1198113|P1|Participants Who Received One Cycle|Lack of tolerability|14
355253|NCT01071798|1198113|P1|Participants Who Received One Cycle|Lack of Efficacy|18
355254|NCT01071512|1198143|P1|Overall Study|positive anti-JC virus antibody test|2
355255|NCT01071512|1198143|P1|Overall Study|Development of antibodies to drug|2
355256|NCT01071512|1198143|P1|Overall Study|Adverse Event|1
355257|NCT01071395|1198153|P2|Overall Study|Adverse Event|1
355258|NCT01071395|1198154|P1|Overall Study|Adverse Event|3
355259|NCT01071395|1198153|P2|Overall Study|Withdrawal by Subject|1
355260|NCT01071395|1198154|P1|Overall Study|Withdrawal by Subject|2
355262|NCT01071278|1198171|P1|Overall Study|Premature Discontinuation|254
355263|NCT01071252|1198182|P5|Overall Study|Death|1
355264|NCT01071252|1198183|P4|Overall Study|Death|0
355265|NCT01071252|1198184|P3|Overall Study|Death|0
355266|NCT01071252|1198185|P2|Overall Study|Death|0
355267|NCT01071252|1198186|P1|Overall Study|Death|0
355268|NCT01071252|1198182|P5|Overall Study|Adverse Event|0
355269|NCT01071252|1198183|P4|Overall Study|Adverse Event|1
355270|NCT01071252|1198184|P3|Overall Study|Adverse Event|0
355271|NCT01071252|1198185|P2|Overall Study|Adverse Event|1
355272|NCT01071252|1198186|P1|Overall Study|Adverse Event|1
355273|NCT01071252|1198182|P5|Overall Study|Lost to Follow-up|0
355274|NCT01071252|1198183|P4|Overall Study|Lost to Follow-up|2
355275|NCT01071252|1198184|P3|Overall Study|Lost to Follow-up|1
355276|NCT01071252|1198185|P2|Overall Study|Lost to Follow-up|0
355277|NCT01071252|1198186|P1|Overall Study|Lost to Follow-up|1
355278|NCT01071252|1198182|P5|Overall Study|administrative problems|1
355279|NCT01071252|1198183|P4|Overall Study|administrative problems|2
355280|NCT01071252|1198184|P3|Overall Study|administrative problems|0
355281|NCT01071252|1198185|P2|Overall Study|administrative problems|1
355282|NCT01071252|1198186|P1|Overall Study|administrative problems|1
355283|NCT01071252|1198182|P5|Overall Study|Withdrawal by Subject|3
355284|NCT01071252|1198183|P4|Overall Study|Withdrawal by Subject|2
355285|NCT01071252|1198184|P3|Overall Study|Withdrawal by Subject|1
355286|NCT01071252|1198185|P2|Overall Study|Withdrawal by Subject|2
355287|NCT01071252|1198186|P1|Overall Study|Withdrawal by Subject|8
355288|NCT01071252|1198182|P5|Overall Study|unsatisfactory therapeutic effect|6
355289|NCT01071252|1198183|P4|Overall Study|unsatisfactory therapeutic effect|0
355290|NCT01071252|1198184|P3|Overall Study|unsatisfactory therapeutic effect|2
355291|NCT01071252|1198185|P2|Overall Study|unsatisfactory therapeutic effect|6
355292|NCT01071252|1198186|P1|Overall Study|unsatisfactory therapeutic effect|4
355293|NCT01071200|1198214|P2|Overall Study|No viable embryos|1
355294|NCT01071200|1198215|P1|Overall Study|No viable embryos|0
355295|NCT01071200|1198214|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
355296|NCT01071200|1198215|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
355297|NCT01071200|1198214|P2|Overall Study|No oocytes retrieved|1
355298|NCT01071200|1198215|P1|Overall Study|No oocytes retrieved|1
355299|NCT01071200|1198214|P2|Overall Study|No fertilization|0
355300|NCT01071200|1198215|P1|Overall Study|No fertilization|4
355301|NCT01071200|1198214|P2|Overall Study|Lack of ovarian response|1
355302|NCT01071200|1198215|P1|Overall Study|Lack of ovarian response|1
355303|NCT01071096|1198247|P2|First Intervention (90 Days)|Lost to Follow-up|0
355304|NCT01071096|1198248|P1|First Intervention (90 Days)|Lost to Follow-up|1
355305|NCT01071083|1198272|P5|Overall Study|Subject Refused to Continue|0
355306|NCT01071083|1198273|P4|Overall Study|Subject Refused to Continue|0
355307|NCT01071083|1198274|P3|Overall Study|Subject Refused to Continue|0
355308|NCT01071083|1198275|P2|Overall Study|Subject Refused to Continue|0
355309|NCT01071083|1198276|P1|Overall Study|Subject Refused to Continue|1
355310|NCT01071083|1198272|P5|Overall Study|Did Not Want Per Protocol Treatment|1
355311|NCT01071083|1198273|P4|Overall Study|Did Not Want Per Protocol Treatment|0
355312|NCT01071083|1198274|P3|Overall Study|Did Not Want Per Protocol Treatment|1
355313|NCT01071083|1198275|P2|Overall Study|Did Not Want Per Protocol Treatment|0
355314|NCT01071083|1198276|P1|Overall Study|Did Not Want Per Protocol Treatment|0
355315|NCT01071083|1198272|P5|Overall Study|Did Not Meet Eligibility Criteria|1
355316|NCT01071083|1198273|P4|Overall Study|Did Not Meet Eligibility Criteria|1
355317|NCT01071083|1198274|P3|Overall Study|Did Not Meet Eligibility Criteria|1
355318|NCT01071083|1198275|P2|Overall Study|Did Not Meet Eligibility Criteria|0
355319|NCT01071083|1198276|P1|Overall Study|Did Not Meet Eligibility Criteria|0
355320|NCT01071083|1198272|P5|Overall Study|Images Not Usable (Motion)|0
355321|NCT01071083|1198273|P4|Overall Study|Images Not Usable (Motion)|0
355322|NCT01071083|1198274|P3|Overall Study|Images Not Usable (Motion)|0
355323|NCT01071083|1198275|P2|Overall Study|Images Not Usable (Motion)|1
355324|NCT01071083|1198276|P1|Overall Study|Images Not Usable (Motion)|0
355325|NCT01071083|1198272|P5|Overall Study|Subject Moved|0
355326|NCT01071083|1198273|P4|Overall Study|Subject Moved|0
355327|NCT01071083|1198274|P3|Overall Study|Subject Moved|0
355328|NCT01071083|1198275|P2|Overall Study|Subject Moved|1
355329|NCT01071083|1198276|P1|Overall Study|Subject Moved|0
355330|NCT01071083|1198272|P5|Overall Study|Early Rescue|1
355331|NCT01071083|1198273|P4|Overall Study|Early Rescue|0
355332|NCT01071083|1198274|P3|Overall Study|Early Rescue|0
355333|NCT01071083|1198275|P2|Overall Study|Early Rescue|0
355334|NCT01071083|1198276|P1|Overall Study|Early Rescue|1
355335|NCT01071083|1198272|P5|Overall Study|Physician Decision|1
355336|NCT01071083|1198273|P4|Overall Study|Physician Decision|1
355337|NCT01071083|1198274|P3|Overall Study|Physician Decision|0
355338|NCT01071083|1198275|P2|Overall Study|Physician Decision|0
355339|NCT01071083|1198276|P1|Overall Study|Physician Decision|1
355340|NCT01071083|1198272|P5|Overall Study|Withdrawal by Subject|3
355341|NCT01071083|1198273|P4|Overall Study|Withdrawal by Subject|0
355342|NCT01071083|1198274|P3|Overall Study|Withdrawal by Subject|2
355343|NCT01071083|1198275|P2|Overall Study|Withdrawal by Subject|0
355344|NCT01071083|1198276|P1|Overall Study|Withdrawal by Subject|3
355345|NCT01071083|1198272|P5|Overall Study|Adverse Event|1
355346|NCT01071083|1198273|P4|Overall Study|Adverse Event|0
355347|NCT01071083|1198274|P3|Overall Study|Adverse Event|1
355348|NCT01071083|1198275|P2|Overall Study|Adverse Event|0
355349|NCT01071083|1198276|P1|Overall Study|Adverse Event|1
355350|NCT01071070|1198295|P2|Overall Study|Hypercalcemia|0
355351|NCT01071070|1198296|P1|Overall Study|Hypercalcemia|1
355352|NCT01071070|1198295|P2|Overall Study|Missed 3 consecutive doses of study drug|0
355353|NCT01071070|1198296|P1|Overall Study|Missed 3 consecutive doses of study drug|2
355354|NCT01071070|1198295|P2|Overall Study|Withdrawal by Subject|0
355355|NCT01071070|1198296|P1|Overall Study|Withdrawal by Subject|1
355356|NCT01071070|1198295|P2|Overall Study|Adverse Event|3
355357|NCT01071070|1198296|P1|Overall Study|Adverse Event|0
355358|NCT01070979|1198342|P3|Overall Study|No study drug taken|0
355359|NCT01070979|1198343|P2|Overall Study|No study drug taken|1
355360|NCT01070979|1198344|P1|Overall Study|No study drug taken|0
355361|NCT01070979|1198342|P3|Overall Study|Withdrawal by Subject|1
355362|NCT01070979|1198343|P2|Overall Study|Withdrawal by Subject|1
355363|NCT01070979|1198344|P1|Overall Study|Withdrawal by Subject|3
355364|NCT01070979|1198342|P3|Overall Study|Surgery, moving, personal, abn. labs|2
355365|NCT01070979|1198343|P2|Overall Study|Surgery, moving, personal, abn. labs|4
355366|NCT01070979|1198344|P1|Overall Study|Surgery, moving, personal, abn. labs|4
355367|NCT01070979|1198342|P3|Overall Study|Protocol Violation|6
355368|NCT01070979|1198343|P2|Overall Study|Protocol Violation|2
355369|NCT01070979|1198344|P1|Overall Study|Protocol Violation|0
355370|NCT01070979|1198342|P3|Overall Study|Lost to Follow-up|1
355371|NCT01070979|1198343|P2|Overall Study|Lost to Follow-up|1
355372|NCT01070979|1198344|P1|Overall Study|Lost to Follow-up|2
355373|NCT01070979|1198342|P3|Overall Study|Adverse Event|3
355374|NCT01070979|1198343|P2|Overall Study|Adverse Event|3
355375|NCT01070979|1198344|P1|Overall Study|Adverse Event|2
355376|NCT01070966|1198370|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
355377|NCT01070966|1198370|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
355378|NCT01070966|1198370|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
355379|NCT01070966|1198370|P1|Participants for Safety Evaluation|TMT given before date of contract|3
355380|NCT01070966|1198370|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
355381|NCT01070966|1198370|P1|Participants for Safety Evaluation|Duplicate Participants|4
355382|NCT01070966|1198370|P1|Participants for Safety Evaluation|Off-label use|9
355383|NCT01070966|1198370|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
355384|NCT01070953|1198381|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
355385|NCT01070953|1198381|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
355386|NCT01070953|1198381|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
355387|NCT01070953|1198381|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
355388|NCT01070953|1198381|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
355389|NCT01070953|1198381|P1|Participants for Safety Evaluation|Uncontracted participants|4
355390|NCT01070953|1198381|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
355391|NCT01070953|1198381|P1|Participants for Safety Evaluation|Duplicated participants|22
355392|NCT01070953|1198381|P1|Participants for Safety Evaluation|Off-label use|283
355393|NCT01070953|1198381|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
355394|NCT01070888|1198394|P2|Washout (14 Days)|Physician Decision|0
355395|NCT01070888|1198395|P1|Washout (14 Days)|Physician Decision|1
355396|NCT01070888|1198394|P2|First Intervention (14 Days)|Lost to Follow-up|1
355397|NCT01070888|1198395|P1|First Intervention (14 Days)|Lost to Follow-up|0
355398|NCT01070888|1198394|P2|First Intervention (14 Days)|Adverse Event|1
355399|NCT01070888|1198395|P1|First Intervention (14 Days)|Adverse Event|0
355400|NCT01070784|1198420|P2|Overall Study|Adverse Event|9
355401|NCT01070784|1198421|P1|Overall Study|Adverse Event|14
355402|NCT01070784|1198420|P2|Overall Study|Withdrawal by Subject|9
355403|NCT01070784|1198421|P1|Overall Study|Withdrawal by Subject|6
355404|NCT01070771|1198509|P1|Overall Study|Protocol Violation|1
355405|NCT01070771|1198509|P1|Overall Study|Adverse Event|2
355406|NCT01070550|1198529|P6|Overall Study|Withdrawal by Subject|0
355407|NCT01070550|1198530|P5|Overall Study|Withdrawal by Subject|0
355408|NCT01070550|1198531|P4|Overall Study|Withdrawal by Subject|0
355409|NCT01070550|1198532|P3|Overall Study|Withdrawal by Subject|3
355410|NCT01070550|1198533|P2|Overall Study|Withdrawal by Subject|0
355411|NCT01070550|1198534|P1|Overall Study|Withdrawal by Subject|35
355412|NCT01070550|1198529|P6|Overall Study|Other|0
355413|NCT01070550|1198530|P5|Overall Study|Other|0
355414|NCT01070550|1198531|P4|Overall Study|Other|1
355415|NCT01070550|1198532|P3|Overall Study|Other|0
355416|NCT01070550|1198533|P2|Overall Study|Other|0
355417|NCT01070550|1198534|P1|Overall Study|Other|5
355418|NCT01070550|1198529|P6|Overall Study|Treatment was stopped early|0
355419|NCT01070550|1198530|P5|Overall Study|Treatment was stopped early|0
355420|NCT01070550|1198531|P4|Overall Study|Treatment was stopped early|0
355421|NCT01070550|1198532|P3|Overall Study|Treatment was stopped early|0
355422|NCT01070550|1198533|P2|Overall Study|Treatment was stopped early|0
355423|NCT01070550|1198534|P1|Overall Study|Treatment was stopped early|7
355424|NCT01070550|1198529|P6|Overall Study|Treatment unavailable|0
355425|NCT01070550|1198530|P5|Overall Study|Treatment unavailable|0
355426|NCT01070550|1198531|P4|Overall Study|Treatment unavailable|0
355427|NCT01070550|1198532|P3|Overall Study|Treatment unavailable|0
355428|NCT01070550|1198533|P2|Overall Study|Treatment unavailable|0
355429|NCT01070550|1198534|P1|Overall Study|Treatment unavailable|1
355430|NCT01070550|1198529|P6|Overall Study|Treatment stopped|0
355431|NCT01070550|1198530|P5|Overall Study|Treatment stopped|0
355432|NCT01070550|1198531|P4|Overall Study|Treatment stopped|0
355433|NCT01070550|1198532|P3|Overall Study|Treatment stopped|0
355434|NCT01070550|1198533|P2|Overall Study|Treatment stopped|0
355435|NCT01070550|1198534|P1|Overall Study|Treatment stopped|3
355436|NCT01070550|1198529|P6|Overall Study|Treatment restarted|0
355437|NCT01070550|1198530|P5|Overall Study|Treatment restarted|0
355438|NCT01070550|1198531|P4|Overall Study|Treatment restarted|0
355439|NCT01070550|1198532|P3|Overall Study|Treatment restarted|0
355440|NCT01070550|1198533|P2|Overall Study|Treatment restarted|1
355441|NCT01070550|1198534|P1|Overall Study|Treatment restarted|0
355442|NCT01070550|1198529|P6|Overall Study|Treatment not started|0
355443|NCT01070550|1198530|P5|Overall Study|Treatment not started|0
355444|NCT01070550|1198531|P4|Overall Study|Treatment not started|0
355445|NCT01070550|1198532|P3|Overall Study|Treatment not started|4
355446|NCT01070550|1198533|P2|Overall Study|Treatment not started|2
355447|NCT01070550|1198534|P1|Overall Study|Treatment not started|14
355448|NCT01070550|1198529|P6|Overall Study|Treatment interrupted|0
355449|NCT01070550|1198530|P5|Overall Study|Treatment interrupted|0
355450|NCT01070550|1198531|P4|Overall Study|Treatment interrupted|1
355451|NCT01070550|1198532|P3|Overall Study|Treatment interrupted|1
355452|NCT01070550|1198533|P2|Overall Study|Treatment interrupted|0
355453|NCT01070550|1198534|P1|Overall Study|Treatment interrupted|7
355454|NCT01070550|1198529|P6|Overall Study|Treatment duration shortened|0
355455|NCT01070550|1198530|P5|Overall Study|Treatment duration shortened|0
355456|NCT01070550|1198531|P4|Overall Study|Treatment duration shortened|0
355457|NCT01070550|1198532|P3|Overall Study|Treatment duration shortened|0
355458|NCT01070550|1198533|P2|Overall Study|Treatment duration shortened|0
355459|NCT01070550|1198534|P1|Overall Study|Treatment duration shortened|1
355460|NCT01070550|1198529|P6|Overall Study|Sponsor decision|0
355461|NCT01070550|1198530|P5|Overall Study|Sponsor decision|0
355462|NCT01070550|1198531|P4|Overall Study|Sponsor decision|0
355463|NCT01070550|1198532|P3|Overall Study|Sponsor decision|0
355464|NCT01070550|1198533|P2|Overall Study|Sponsor decision|0
355465|NCT01070550|1198534|P1|Overall Study|Sponsor decision|1
355466|NCT01070550|1198529|P6|Overall Study|Screen failure|0
355467|NCT01070550|1198530|P5|Overall Study|Screen failure|0
355468|NCT01070550|1198531|P4|Overall Study|Screen failure|0
355469|NCT01070550|1198532|P3|Overall Study|Screen failure|0
355470|NCT01070550|1198533|P2|Overall Study|Screen failure|0
355471|NCT01070550|1198534|P1|Overall Study|Screen failure|1
355472|NCT01070550|1198529|P6|Overall Study|Result not available|0
355473|NCT01070550|1198530|P5|Overall Study|Result not available|0
355474|NCT01070550|1198531|P4|Overall Study|Result not available|0
355475|NCT01070550|1198532|P3|Overall Study|Result not available|3
355476|NCT01070550|1198533|P2|Overall Study|Result not available|1
355477|NCT01070550|1198534|P1|Overall Study|Result not available|3
355478|NCT01070550|1198529|P6|Overall Study|Relapse|0
355479|NCT01070550|1198530|P5|Overall Study|Relapse|0
355480|NCT01070550|1198531|P4|Overall Study|Relapse|4
355481|NCT01070550|1198532|P3|Overall Study|Relapse|14
355482|NCT01070550|1198533|P2|Overall Study|Relapse|5
355483|NCT01070550|1198534|P1|Overall Study|Relapse|44
355484|NCT01070550|1198529|P6|Overall Study|Protocol Violation|0
355485|NCT01070550|1198530|P5|Overall Study|Protocol Violation|0
355486|NCT01070550|1198531|P4|Overall Study|Protocol Violation|1
355487|NCT01070550|1198532|P3|Overall Study|Protocol Violation|1
355488|NCT01070550|1198533|P2|Overall Study|Protocol Violation|1
355489|NCT01070550|1198534|P1|Overall Study|Protocol Violation|15
355490|NCT01070550|1198529|P6|Overall Study|Not categorized|1
355491|NCT01070550|1198530|P5|Overall Study|Not categorized|0
355492|NCT01070550|1198531|P4|Overall Study|Not categorized|1
355493|NCT01070550|1198532|P3|Overall Study|Not categorized|6
355494|NCT01070550|1198533|P2|Overall Study|Not categorized|2
355495|NCT01070550|1198534|P1|Overall Study|Not categorized|33
355496|NCT01070550|1198529|P6|Overall Study|Non-responders|2
355497|NCT01070550|1198530|P5|Overall Study|Non-responders|0
355498|NCT01070550|1198531|P4|Overall Study|Non-responders|20
355499|NCT01070550|1198532|P3|Overall Study|Non-responders|21
355500|NCT01070550|1198533|P2|Overall Study|Non-responders|4
355501|NCT01070550|1198534|P1|Overall Study|Non-responders|493
355502|NCT01070550|1198529|P6|Overall Study|New treatment started|0
355503|NCT01070550|1198530|P5|Overall Study|New treatment started|0
355504|NCT01070550|1198531|P4|Overall Study|New treatment started|2
355505|NCT01070550|1198532|P3|Overall Study|New treatment started|0
355506|NCT01070550|1198533|P2|Overall Study|New treatment started|1
355507|NCT01070550|1198534|P1|Overall Study|New treatment started|3
355508|NCT01070550|1198529|P6|Overall Study|Miscellaneous|0
355509|NCT01070550|1198530|P5|Overall Study|Miscellaneous|0
355510|NCT01070550|1198531|P4|Overall Study|Miscellaneous|1
355511|NCT01070550|1198532|P3|Overall Study|Miscellaneous|3
355512|NCT01070550|1198533|P2|Overall Study|Miscellaneous|2
355513|NCT01070550|1198534|P1|Overall Study|Miscellaneous|12
355514|NCT01070550|1198529|P6|Overall Study|Lack of Efficacy|1
355515|NCT01070550|1198530|P5|Overall Study|Lack of Efficacy|0
355516|NCT01070550|1198531|P4|Overall Study|Lack of Efficacy|5
355517|NCT01070550|1198532|P3|Overall Study|Lack of Efficacy|5
355518|NCT01070550|1198533|P2|Overall Study|Lack of Efficacy|1
355519|NCT01070550|1198534|P1|Overall Study|Lack of Efficacy|65
355520|NCT01070550|1198529|P6|Overall Study|Lab test not done|1
355521|NCT01070550|1198530|P5|Overall Study|Lab test not done|0
355522|NCT01070550|1198531|P4|Overall Study|Lab test not done|1
355523|NCT01070550|1198532|P3|Overall Study|Lab test not done|4
355524|NCT01070550|1198533|P2|Overall Study|Lab test not done|3
355525|NCT01070550|1198534|P1|Overall Study|Lab test not done|22
355526|NCT01070550|1198529|P6|Overall Study|Incomplete treatment|0
355527|NCT01070550|1198530|P5|Overall Study|Incomplete treatment|0
355528|NCT01070550|1198531|P4|Overall Study|Incomplete treatment|0
355529|NCT01070550|1198532|P3|Overall Study|Incomplete treatment|0
355530|NCT01070550|1198533|P2|Overall Study|Incomplete treatment|0
355531|NCT01070550|1198534|P1|Overall Study|Incomplete treatment|2
355532|NCT01070550|1198529|P6|Overall Study|Failed to return|2
355533|NCT01070550|1198530|P5|Overall Study|Failed to return|1
355534|NCT01070550|1198531|P4|Overall Study|Failed to return|40
355535|NCT01070550|1198532|P3|Overall Study|Failed to return|144
355536|NCT01070550|1198533|P2|Overall Study|Failed to return|33
355537|NCT01070550|1198534|P1|Overall Study|Failed to return|450
355538|NCT01070550|1198529|P6|Overall Study|Early termination|0
355539|NCT01070550|1198530|P5|Overall Study|Early termination|0
355540|NCT01070550|1198531|P4|Overall Study|Early termination|0
355541|NCT01070550|1198532|P3|Overall Study|Early termination|0
355542|NCT01070550|1198533|P2|Overall Study|Early termination|0
355543|NCT01070550|1198534|P1|Overall Study|Early termination|3
355544|NCT01070550|1198529|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
355545|NCT01070550|1198530|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
355546|NCT01070550|1198531|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
355547|NCT01070550|1198532|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
355548|NCT01070550|1198533|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
355549|NCT01070550|1198534|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
355550|NCT01070550|1198529|P6|Overall Study|Death|0
355551|NCT01070550|1198530|P5|Overall Study|Death|0
355552|NCT01070550|1198531|P4|Overall Study|Death|0
355553|NCT01070550|1198532|P3|Overall Study|Death|3
355554|NCT01070550|1198533|P2|Overall Study|Death|4
355555|NCT01070550|1198534|P1|Overall Study|Death|20
355556|NCT01070550|1198529|P6|Overall Study|Adverse Event|0
355557|NCT01070550|1198530|P5|Overall Study|Adverse Event|0
355558|NCT01070550|1198531|P4|Overall Study|Adverse Event|0
355559|NCT01070550|1198532|P3|Overall Study|Adverse Event|3
355560|NCT01070550|1198533|P2|Overall Study|Adverse Event|1
355561|NCT01070550|1198534|P1|Overall Study|Adverse Event|43
355562|NCT01070394|1198674|P1|Overall Study|Withdrawal by Subject|1
355563|NCT01070394|1198674|P1|Overall Study|Adverse Event|6
355564|NCT01070381|1198685|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
355565|NCT01070381|1198686|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
355566|NCT01070381|1198685|P2|Period 2, 1 Week of Wear|Handling|1
355567|NCT01070381|1198686|P1|Period 2, 1 Week of Wear|Handling|0
355568|NCT01070329|1198694|P2|Overall Study|Sponsor Decision|1
355569|NCT01070329|1198695|P1|Overall Study|Sponsor Decision|0
355570|NCT01070329|1198694|P2|Overall Study|Entry Criteria Not Met|0
355571|NCT01070329|1198695|P1|Overall Study|Entry Criteria Not Met|1
355572|NCT01070329|1198694|P2|Overall Study|Physician Decision|1
355573|NCT01070329|1198695|P1|Overall Study|Physician Decision|2
355574|NCT01070329|1198694|P2|Overall Study|Lack of Efficacy|6
355575|NCT01070329|1198695|P1|Overall Study|Lack of Efficacy|2
355576|NCT01070329|1198694|P2|Overall Study|Protocol Violation|8
355577|NCT01070329|1198695|P1|Overall Study|Protocol Violation|3
355578|NCT01070329|1198694|P2|Overall Study|Withdrawal by Subject|11
355579|NCT01070329|1198695|P1|Overall Study|Withdrawal by Subject|9
355580|NCT01070329|1198694|P2|Overall Study|Lost to Follow-up|12
355581|NCT01070329|1198695|P1|Overall Study|Lost to Follow-up|22
355582|NCT01070329|1198694|P2|Overall Study|Adverse Event|10
355583|NCT01070329|1198695|P1|Overall Study|Adverse Event|13
355584|NCT01070316|1198727|P1|Extension Phase|Withdrawal by Subject|1
355585|NCT01070316|1198727|P1|Extension Phase|Lack of Efficacy|3
355586|NCT01070303|1198734|P1|Overall Study|Other|18
355587|NCT01070303|1198734|P1|Overall Study|Administrative Reason|1
355588|NCT01070303|1198734|P1|Overall Study|Lack of Efficacy|2
355589|NCT01070303|1198734|P1|Overall Study|Protocol Violation|0
355590|NCT01070303|1198734|P1|Overall Study|Lost to Follow-up|9
355591|NCT01070303|1198734|P1|Overall Study|Withdrawal by Subject|20
355592|NCT01070303|1198734|P1|Overall Study|Adverse Event|39
355593|NCT01070043|1198808|P3|Double-Blind Treatment|Adverse Event|2
355594|NCT01070043|1198809|P2|Double-Blind Treatment|Adverse Event|0
355595|NCT01070043|1198810|P1|Double-Blind Treatment|Adverse Event|0
355596|NCT01070043|1198808|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
355597|NCT01070043|1198809|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
355598|NCT01070043|1198810|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
355599|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Removal|0
355600|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Removal|1
355601|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Physician Decision|2
355602|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Physician Decision|0
355603|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
355604|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
355605|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
355606|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
355607|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
355608|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
355609|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
355610|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
355611|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Protocol Violation|1
355612|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Protocol Violation|0
355613|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
355614|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
355615|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
355616|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
355617|NCT01069939|1198826|P2|Randomised and Included in the Analyses|Adverse Event|22
355618|NCT01069939|1198827|P1|Randomised and Included in the Analyses|Adverse Event|17
355619|NCT01069900|1198853|P2|Overall Study|Insufficient Therapeutic effect|0
355620|NCT01069900|1198854|P1|Overall Study|Insufficient Therapeutic effect|1
355621|NCT01069900|1198853|P2|Overall Study|Protocol Violation|1
355622|NCT01069900|1198854|P1|Overall Study|Protocol Violation|4
355623|NCT01069900|1198853|P2|Overall Study|Withdrawal by Subject|1
355624|NCT01069900|1198854|P1|Overall Study|Withdrawal by Subject|6
355625|NCT01069900|1198853|P2|Overall Study|Lost to Follow-up|1
355626|NCT01069900|1198854|P1|Overall Study|Lost to Follow-up|7
355627|NCT01069900|1198853|P2|Overall Study|Technical problems|1
355628|NCT01069900|1198854|P1|Overall Study|Technical problems|0
355629|NCT01069861|1198898|P1|Overall Study|Did not meet entrance criteria|1
355630|NCT01069861|1198898|P1|Overall Study|Adverse Event|1
355631|NCT01069861|1198898|P1|Overall Study|Death|1
355632|NCT01069627|1198911|P1|Overall Study|Protocol Violation|1
355633|NCT01069627|1198911|P1|Overall Study|Adverse Event|12
355634|NCT01069627|1198911|P1|Overall Study|Disease progression|7
355635|NCT01069523|1198961|P2|Overall Study|Withdrawal by Subject|7
355636|NCT01069523|1198962|P1|Overall Study|Withdrawal by Subject|4
355637|NCT01069484|1198972|P2|Overall Study|Illness mother or child|1
355638|NCT01069484|1198973|P1|Overall Study|Illness mother or child|3
355639|NCT01069484|1198972|P2|Overall Study|No specific reason|2
355640|NCT01069484|1198973|P1|Overall Study|No specific reason|8
355641|NCT01069484|1198972|P2|Overall Study|Death-in-near-family|0
355642|NCT01069484|1198973|P1|Overall Study|Death-in-near-family|1
355643|NCT01069419|1198981|P1|Overall Study|Missing termination information|13
355644|NCT01069419|1198981|P1|Overall Study|Other Reason|43
355645|NCT01069419|1198981|P1|Overall Study|Withdrawal by Subject|34
355646|NCT01069419|1198981|P1|Overall Study|Remission of disease|11
355647|NCT01069419|1198981|P1|Overall Study|Lost to Follow-up|49
355648|NCT01069419|1198981|P1|Overall Study|Lack of Efficacy|332
355649|NCT01069419|1198981|P1|Overall Study|Adverse Event|233
355650|NCT01069341|1199010|P1|Overall Study|Lost to Follow-up|1
355651|NCT01069289|1199023|P2|Overall Study|Due to deteriorating health condition|0
355652|NCT01069289|1199024|P1|Overall Study|Due to deteriorating health condition|1
355653|NCT01069289|1199023|P2|Overall Study|Severe non-compliance to protocol|2
355654|NCT01069289|1199024|P1|Overall Study|Severe non-compliance to protocol|3
355655|NCT01069289|1199023|P2|Overall Study|Eligibility criteria not fulfilled|0
355656|NCT01069289|1199024|P1|Overall Study|Eligibility criteria not fulfilled|2
355657|NCT01069289|1199023|P2|Overall Study|Adverse Event|28
355658|NCT01069289|1199024|P1|Overall Study|Adverse Event|21
355659|NCT01069289|1199023|P2|Overall Study|Withdrawal by Subject|26
355660|NCT01069289|1199024|P1|Overall Study|Withdrawal by Subject|15
355661|NCT01069172|1199073|P2|Overall Study|Withdrawal by Subject|0
355662|NCT01069172|1199074|P1|Overall Study|Withdrawal by Subject|1
355663|NCT01069120|1199084|P1|Overall Study|Study prematurely terminated|27
355664|NCT01068912|1199121|P3|Overall Study|other underlying illness|3
355665|NCT01068912|1199122|P2|Overall Study|other underlying illness|3
355666|NCT01068912|1199123|P1|Overall Study|other underlying illness|0
355667|NCT01068912|1199121|P3|Overall Study|aggravation influenza|1
355668|NCT01068912|1199122|P2|Overall Study|aggravation influenza|1
355669|NCT01068912|1199123|P1|Overall Study|aggravation influenza|1
355670|NCT01068912|1199121|P3|Overall Study|Protocol Violation|0
355671|NCT01068912|1199122|P2|Overall Study|Protocol Violation|2
355672|NCT01068912|1199123|P1|Overall Study|Protocol Violation|0
355673|NCT01068912|1199121|P3|Overall Study|Lost to Follow-up|3
355674|NCT01068912|1199122|P2|Overall Study|Lost to Follow-up|7
355675|NCT01068912|1199123|P1|Overall Study|Lost to Follow-up|3
355676|NCT01068912|1199121|P3|Overall Study|Withdrawal by Subject|6
355677|NCT01068912|1199122|P2|Overall Study|Withdrawal by Subject|6
355678|NCT01068912|1199123|P1|Overall Study|Withdrawal by Subject|5
355679|NCT01068912|1199121|P3|Overall Study|Adverse Event|2
355680|NCT01068912|1199122|P2|Overall Study|Adverse Event|3
355681|NCT01068912|1199123|P1|Overall Study|Adverse Event|2
355682|NCT01068860|1199141|P10|Overall Study|Lost to Follow-up|0
355683|NCT01068860|1199142|P9|Overall Study|Lost to Follow-up|0
355684|NCT01068860|1199143|P8|Overall Study|Lost to Follow-up|0
355685|NCT01068860|1199144|P7|Overall Study|Lost to Follow-up|0
355686|NCT01068860|1199145|P6|Overall Study|Lost to Follow-up|0
355687|NCT01068860|1199146|P5|Overall Study|Lost to Follow-up|0
355688|NCT01068860|1199147|P4|Overall Study|Lost to Follow-up|0
355689|NCT01068860|1199148|P3|Overall Study|Lost to Follow-up|0
355690|NCT01068860|1199149|P2|Overall Study|Lost to Follow-up|1
355691|NCT01068860|1199150|P1|Overall Study|Lost to Follow-up|0
355692|NCT01068860|1199141|P10|Overall Study|Administrative problems; misrandomized|1
355693|NCT01068860|1199142|P9|Overall Study|Administrative problems; misrandomized|0
355694|NCT01068860|1199143|P8|Overall Study|Administrative problems; misrandomized|0
355695|NCT01068860|1199144|P7|Overall Study|Administrative problems; misrandomized|0
355696|NCT01068860|1199145|P6|Overall Study|Administrative problems; misrandomized|0
355697|NCT01068860|1199146|P5|Overall Study|Administrative problems; misrandomized|0
355698|NCT01068860|1199147|P4|Overall Study|Administrative problems; misrandomized|1
355699|NCT01068860|1199148|P3|Overall Study|Administrative problems; misrandomized|0
355700|NCT01068860|1199149|P2|Overall Study|Administrative problems; misrandomized|0
355701|NCT01068860|1199150|P1|Overall Study|Administrative problems; misrandomized|0
355702|NCT01068860|1199141|P10|Overall Study|Withdrawal by Subject|3
355703|NCT01068860|1199142|P9|Overall Study|Withdrawal by Subject|0
355704|NCT01068860|1199143|P8|Overall Study|Withdrawal by Subject|0
355705|NCT01068860|1199144|P7|Overall Study|Withdrawal by Subject|0
355706|NCT01068860|1199145|P6|Overall Study|Withdrawal by Subject|2
355707|NCT01068860|1199146|P5|Overall Study|Withdrawal by Subject|0
355708|NCT01068860|1199147|P4|Overall Study|Withdrawal by Subject|0
355709|NCT01068860|1199148|P3|Overall Study|Withdrawal by Subject|0
355710|NCT01068860|1199149|P2|Overall Study|Withdrawal by Subject|0
355711|NCT01068860|1199150|P1|Overall Study|Withdrawal by Subject|0
355712|NCT01068769|1199333|P1|Overall Study|Ineligible|1
355713|NCT01068743|1199338|P4|Period 3|Adverse Event|0
355714|NCT01068743|1199339|P3|Period 3|Adverse Event|0
355715|NCT01068743|1199340|P2|Period 3|Adverse Event|1
355716|NCT01068743|1199341|P1|Period 3|Adverse Event|0
355717|NCT01068730|1199415|P4|Period 4|Family emergency|0
355718|NCT01068730|1199416|P3|Period 4|Family emergency|0
355719|NCT01068730|1199417|P2|Period 4|Family emergency|1
355720|NCT01068730|1199418|P1|Period 4|Family emergency|0
355721|NCT01068730|1199415|P4|Period 3|Personal reason|0
355722|NCT01068730|1199416|P3|Period 3|Personal reason|0
355723|NCT01068730|1199417|P2|Period 3|Personal reason|0
355724|NCT01068730|1199418|P1|Period 3|Personal reason|1
355725|NCT01068717|1199472|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
355726|NCT01068717|1199473|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
355727|NCT01068717|1199474|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
355728|NCT01068717|1199475|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
355729|NCT01068678|1199531|P2|Overall Study|Unclassified|15
355730|NCT01068678|1199532|P1|Overall Study|Unclassified|18
355731|NCT01068678|1199531|P2|Overall Study|Withdrawal criteria|6
355732|NCT01068678|1199532|P1|Overall Study|Withdrawal criteria|12
355733|NCT01068678|1199531|P2|Overall Study|Protocol Violation|1
355734|NCT01068678|1199532|P1|Overall Study|Protocol Violation|5
355735|NCT01068678|1199531|P2|Overall Study|Lack of Efficacy|2
355736|NCT01068678|1199532|P1|Overall Study|Lack of Efficacy|3
355737|NCT01068665|1199542|P2|Overall Study|Other|12
355738|NCT01068665|1199543|P1|Overall Study|Other|17
355739|NCT01068665|1199542|P2|Overall Study|Withdrawal Criteria|9
355740|NCT01068665|1199543|P1|Overall Study|Withdrawal Criteria|3
355741|NCT01068665|1199542|P2|Overall Study|Protocol Violation|2
355742|NCT01068665|1199543|P1|Overall Study|Protocol Violation|5
355743|NCT01068665|1199542|P2|Overall Study|Lack of Efficacy|2
355744|NCT01068665|1199543|P1|Overall Study|Lack of Efficacy|0
355745|NCT01068665|1199542|P2|Overall Study|Adverse Event|4
355746|NCT01068665|1199543|P1|Overall Study|Adverse Event|5
355747|NCT01068652|1199553|P2|Overall Study|Unclassified|4
355748|NCT01068652|1199554|P1|Overall Study|Unclassified|7
355749|NCT01068652|1199553|P2|Overall Study|Patient was not eligible|0
355750|NCT01068652|1199554|P1|Overall Study|Patient was not eligible|1
355751|NCT01068652|1199553|P2|Overall Study|Withdrawal criteria|2
355752|NCT01068652|1199554|P1|Overall Study|Withdrawal criteria|1
355753|NCT01068652|1199553|P2|Overall Study|Protocol Violation|6
355754|NCT01068652|1199554|P1|Overall Study|Protocol Violation|3
355755|NCT01068652|1199553|P2|Overall Study|Lost to Follow-up|1
355756|NCT01068652|1199554|P1|Overall Study|Lost to Follow-up|2
355757|NCT01068652|1199553|P2|Overall Study|Lack of Efficacy|2
355758|NCT01068652|1199554|P1|Overall Study|Lack of Efficacy|0
355759|NCT01068652|1199553|P2|Overall Study|Adverse Event|0
355760|NCT01068652|1199554|P1|Overall Study|Adverse Event|4
355761|NCT01068626|1199594|P2|Overall Study|Withdrawal by Subject|2
355762|NCT01068626|1199595|P1|Overall Study|Withdrawal by Subject|0
355763|NCT01068626|1199594|P2|Overall Study|Adverse Event|0
355764|NCT01068626|1199595|P1|Overall Study|Adverse Event|3
355765|NCT01068600|1199613|P2|Overall Study|Administrative problems|1
355766|NCT01068600|1199614|P1|Overall Study|Administrative problems|0
355767|NCT01068600|1199613|P2|Overall Study|Unsatisfactory therapeutic effect|4
355768|NCT01068600|1199614|P1|Overall Study|Unsatisfactory therapeutic effect|0
355769|NCT01068600|1199613|P2|Overall Study|Protocol deviation|1
355770|NCT01068600|1199614|P1|Overall Study|Protocol deviation|1
355771|NCT01068600|1199613|P2|Overall Study|Lost to Follow-up|2
355772|NCT01068600|1199614|P1|Overall Study|Lost to Follow-up|1
355773|NCT01068600|1199613|P2|Overall Study|Abnormal laboratory value(s)|0
355774|NCT01068600|1199614|P1|Overall Study|Abnormal laboratory value(s)|1
355775|NCT01068600|1199613|P2|Overall Study|Adverse Event|3
355776|NCT01068600|1199614|P1|Overall Study|Adverse Event|3
355777|NCT01068600|1199613|P2|Overall Study|Withdrawal by Subject|6
355778|NCT01068600|1199614|P1|Overall Study|Withdrawal by Subject|5
355779|NCT01068509|1199634|P3|Overall Study|Reason Not Specified|0
355780|NCT01068509|1199635|P2|Overall Study|Reason Not Specified|1
355781|NCT01068509|1199636|P1|Overall Study|Reason Not Specified|0
355782|NCT01068509|1199634|P3|Overall Study|Withdrew Consent|2
355783|NCT01068509|1199635|P2|Overall Study|Withdrew Consent|1
355784|NCT01068509|1199636|P1|Overall Study|Withdrew Consent|0
355785|NCT01068509|1199634|P3|Overall Study|Lost to Follow-up|0
355786|NCT01068509|1199635|P2|Overall Study|Lost to Follow-up|0
355787|NCT01068509|1199636|P1|Overall Study|Lost to Follow-up|1
355788|NCT01068509|1199634|P3|Overall Study|Disease Progression|18
355789|NCT01068509|1199635|P2|Overall Study|Disease Progression|20
355790|NCT01068509|1199636|P1|Overall Study|Disease Progression|5
355791|NCT01068509|1199634|P3|Overall Study|Death|1
355792|NCT01068509|1199635|P2|Overall Study|Death|0
355793|NCT01068509|1199636|P1|Overall Study|Death|0
355794|NCT01068418|1199649|P1|Overall Study|Physician Decision|12
355795|NCT01068262|1199658|P4|Overall Study|Withdrawal by Subject|0
355796|NCT01068262|1199659|P3|Overall Study|Withdrawal by Subject|0
355797|NCT01068262|1199660|P2|Overall Study|Withdrawal by Subject|1
355798|NCT01068262|1199661|P1|Overall Study|Withdrawal by Subject|0
355799|NCT01068262|1199658|P4|Overall Study|Protocol Violation|0
355800|NCT01068262|1199659|P3|Overall Study|Protocol Violation|0
355801|NCT01068262|1199660|P2|Overall Study|Protocol Violation|0
355802|NCT01068262|1199661|P1|Overall Study|Protocol Violation|1
355803|NCT01068262|1199658|P4|Overall Study|Adverse Event|0
355804|NCT01068262|1199659|P3|Overall Study|Adverse Event|1
355805|NCT01068262|1199660|P2|Overall Study|Adverse Event|0
355806|NCT01068262|1199661|P1|Overall Study|Adverse Event|2
355807|NCT01068158|1199691|P2|Overall Study|Protocol Violation|2
355808|NCT01068158|1199692|P1|Overall Study|Protocol Violation|0
355809|NCT01068158|1199691|P2|Overall Study|Lost to Follow-up|0
355810|NCT01068158|1199692|P1|Overall Study|Lost to Follow-up|7
355811|NCT01068158|1199691|P2|Overall Study|Withdrawal by Subject|2
355812|NCT01068158|1199692|P1|Overall Study|Withdrawal by Subject|1
355813|NCT01067976|1199704|P1|Overall Study|Study prematurely discontinued|2
355814|NCT01067976|1199704|P1|Overall Study|Study drug never administered|20
355815|NCT01067846|1199765|P2|Overall Study|participation in other tx study|0
355816|NCT01067846|1199766|P1|Overall Study|participation in other tx study|1
355817|NCT01067846|1199765|P2|Overall Study|Withdrawal by Subject|0
355818|NCT01067846|1199766|P1|Overall Study|Withdrawal by Subject|1
355819|NCT01067846|1199765|P2|Overall Study|Lost to Follow-up|19
355820|NCT01067846|1199766|P1|Overall Study|Lost to Follow-up|17
355821|NCT01067352|1199838|P3|Overall Study|Physician Decision|0
355822|NCT01067352|1199839|P2|Overall Study|Physician Decision|1
355823|NCT01067352|1199840|P1|Overall Study|Physician Decision|0
355824|NCT01067352|1199838|P3|Overall Study|Withdrawal by Subject|1
355825|NCT01067352|1199839|P2|Overall Study|Withdrawal by Subject|2
355826|NCT01067352|1199840|P1|Overall Study|Withdrawal by Subject|1
355827|NCT01067339|1199856|P2|Overall Study|Withdrawal by Subject|5
355828|NCT01067339|1199857|P1|Overall Study|Withdrawal by Subject|6
355829|NCT01067326|1199867|P2|Overall Study|Early Study Termination|1
355830|NCT01067326|1199868|P1|Overall Study|Early Study Termination|1
355831|NCT01067326|1199867|P2|Overall Study|Withdrawal by Subject|0
355832|NCT01067326|1199868|P1|Overall Study|Withdrawal by Subject|1
355833|NCT01067326|1199867|P2|Overall Study|Adverse Event|2
355834|NCT01067326|1199868|P1|Overall Study|Adverse Event|0
355835|NCT01067144|1199882|P2|Follow-up|Death|1
355836|NCT01067144|1199883|P1|Follow-up|Death|0
355837|NCT01067144|1199882|P2|Follow-up|Surgery cancelled|1
355838|NCT01067144|1199883|P1|Follow-up|Surgery cancelled|0
355839|NCT01067144|1199882|P2|Follow-up|Withdrawal by Subject|14
355840|NCT01067144|1199883|P1|Follow-up|Withdrawal by Subject|18
355841|NCT01067144|1199882|P2|Follow-up|Censored owing to second surgery|28
355842|NCT01067144|1199883|P1|Follow-up|Censored owing to second surgery|19
355843|NCT01067144|1199882|P2|Follow-up|Lost to Follow-up|12
355844|NCT01067144|1199883|P1|Follow-up|Lost to Follow-up|22
355845|NCT01067144|1199882|P2|Treatment|Did not receive allocated intervention|7
355846|NCT01067144|1199883|P1|Treatment|Did not receive allocated intervention|4
355847|NCT01067105|1199891|P1|Overall Study|Other|31
355848|NCT01067105|1199891|P1|Overall Study|Physician Decision|6
355849|NCT01067105|1199891|P1|Overall Study|Lost to Follow-up|6
355850|NCT01067105|1199891|P1|Overall Study|Withdrawal by Subject|36
355851|NCT01067105|1199891|P1|Overall Study|Protocol Violation|48
355852|NCT01067105|1199891|P1|Overall Study|Adverse Event|14
355853|NCT01066923|1199912|P4|Overall Study|Withdrawal by Subject|8
355854|NCT01066923|1199913|P3|Overall Study|Withdrawal by Subject|8
355855|NCT01066923|1199914|P2|Overall Study|Withdrawal by Subject|3
355856|NCT01066923|1199915|P1|Overall Study|Withdrawal by Subject|3
355857|NCT01066897|1199939|P2|Overall Study|stopped study after developing the flu.|0
355858|NCT01066897|1199940|P1|Overall Study|stopped study after developing the flu.|1
355859|NCT01066897|1199939|P2|Overall Study|Withdrawal by Subject|0
355860|NCT01066897|1199940|P1|Overall Study|Withdrawal by Subject|1
355861|NCT01066871|1199954|P4|Overall Study|Other|2
355862|NCT01066871|1199955|P3|Overall Study|Other|1
355863|NCT01066871|1199956|P2|Overall Study|Other|2
355864|NCT01066871|1199957|P1|Overall Study|Other|0
355865|NCT01066871|1199954|P4|Overall Study|Withdrawal by Subject|0
355866|NCT01066871|1199955|P3|Overall Study|Withdrawal by Subject|0
355867|NCT01066871|1199956|P2|Overall Study|Withdrawal by Subject|1
355868|NCT01066871|1199957|P1|Overall Study|Withdrawal by Subject|3
355869|NCT01066871|1199954|P4|Overall Study|Lack of Efficacy|1
355870|NCT01066871|1199955|P3|Overall Study|Lack of Efficacy|0
355871|NCT01066871|1199956|P2|Overall Study|Lack of Efficacy|0
355872|NCT01066871|1199957|P1|Overall Study|Lack of Efficacy|0
355873|NCT01066871|1199954|P4|Overall Study|Protocol Violation|2
355874|NCT01066871|1199955|P3|Overall Study|Protocol Violation|3
355875|NCT01066871|1199956|P2|Overall Study|Protocol Violation|0
355876|NCT01066871|1199957|P1|Overall Study|Protocol Violation|1
355877|NCT01066871|1199954|P4|Overall Study|Lost to Follow-up|0
355878|NCT01066871|1199955|P3|Overall Study|Lost to Follow-up|2
355879|NCT01066871|1199956|P2|Overall Study|Lost to Follow-up|2
355880|NCT01066871|1199957|P1|Overall Study|Lost to Follow-up|0
355881|NCT01066819|1200021|P6|Overall Study|Other|0
355882|NCT01066819|1200022|P5|Overall Study|Other|0
355883|NCT01066819|1200023|P4|Overall Study|Other|0
355884|NCT01066819|1200024|P3|Overall Study|Other|1
355885|NCT01066819|1200025|P2|Overall Study|Other|1
355886|NCT01066819|1200026|P1|Overall Study|Other|5
355887|NCT01066819|1200021|P6|Overall Study|Treatment stopped|0
355888|NCT01066819|1200022|P5|Overall Study|Treatment stopped|0
355889|NCT01066819|1200023|P4|Overall Study|Treatment stopped|1
355890|NCT01066819|1200024|P3|Overall Study|Treatment stopped|2
355891|NCT01066819|1200025|P2|Overall Study|Treatment stopped|1
355892|NCT01066819|1200026|P1|Overall Study|Treatment stopped|12
355893|NCT01066819|1200021|P6|Overall Study|Treatment never started|2
355894|NCT01066819|1200022|P5|Overall Study|Treatment never started|2
355895|NCT01066819|1200023|P4|Overall Study|Treatment never started|3
355896|NCT01066819|1200024|P3|Overall Study|Treatment never started|19
355897|NCT01066819|1200025|P2|Overall Study|Treatment never started|19
355898|NCT01066819|1200026|P1|Overall Study|Treatment never started|85
355899|NCT01066819|1200021|P6|Overall Study|Spontaneous cure|0
355900|NCT01066819|1200022|P5|Overall Study|Spontaneous cure|0
355901|NCT01066819|1200023|P4|Overall Study|Spontaneous cure|0
355902|NCT01066819|1200024|P3|Overall Study|Spontaneous cure|0
355903|NCT01066819|1200025|P2|Overall Study|Spontaneous cure|0
355904|NCT01066819|1200026|P1|Overall Study|Spontaneous cure|1
355905|NCT01066819|1200021|P6|Overall Study|Screen failure|0
355906|NCT01066819|1200022|P5|Overall Study|Screen failure|0
355907|NCT01066819|1200023|P4|Overall Study|Screen failure|0
355908|NCT01066819|1200024|P3|Overall Study|Screen failure|0
355909|NCT01066819|1200025|P2|Overall Study|Screen failure|0
355910|NCT01066819|1200026|P1|Overall Study|Screen failure|1
355911|NCT01066819|1200021|P6|Overall Study|Results not available|0
355912|NCT01066819|1200022|P5|Overall Study|Results not available|0
355913|NCT01066819|1200023|P4|Overall Study|Results not available|0
355914|NCT01066819|1200024|P3|Overall Study|Results not available|0
355915|NCT01066819|1200025|P2|Overall Study|Results not available|0
355916|NCT01066819|1200026|P1|Overall Study|Results not available|1
355917|NCT01066819|1200021|P6|Overall Study|Relapse|0
355918|NCT01066819|1200022|P5|Overall Study|Relapse|0
355919|NCT01066819|1200023|P4|Overall Study|Relapse|0
355920|NCT01066819|1200024|P3|Overall Study|Relapse|3
355921|NCT01066819|1200025|P2|Overall Study|Relapse|4
355922|NCT01066819|1200026|P1|Overall Study|Relapse|16
355923|NCT01066819|1200021|P6|Overall Study|Not categorised|0
355924|NCT01066819|1200022|P5|Overall Study|Not categorised|0
355925|NCT01066819|1200023|P4|Overall Study|Not categorised|1
355926|NCT01066819|1200024|P3|Overall Study|Not categorised|6
355927|NCT01066819|1200025|P2|Overall Study|Not categorised|2
355928|NCT01066819|1200026|P1|Overall Study|Not categorised|9
355929|NCT01066819|1200021|P6|Overall Study|Non responders|1
355930|NCT01066819|1200022|P5|Overall Study|Non responders|0
355931|NCT01066819|1200023|P4|Overall Study|Non responders|2
355932|NCT01066819|1200024|P3|Overall Study|Non responders|7
355933|NCT01066819|1200025|P2|Overall Study|Non responders|2
355934|NCT01066819|1200026|P1|Overall Study|Non responders|123
355935|NCT01066819|1200021|P6|Overall Study|Miscellaneous|0
355936|NCT01066819|1200022|P5|Overall Study|Miscellaneous|0
355937|NCT01066819|1200023|P4|Overall Study|Miscellaneous|1
355938|NCT01066819|1200024|P3|Overall Study|Miscellaneous|18
355939|NCT01066819|1200025|P2|Overall Study|Miscellaneous|10
355940|NCT01066819|1200026|P1|Overall Study|Miscellaneous|28
355941|NCT01066819|1200021|P6|Overall Study|Lab test not done|0
355942|NCT01066819|1200022|P5|Overall Study|Lab test not done|0
355943|NCT01066819|1200023|P4|Overall Study|Lab test not done|1
355944|NCT01066819|1200024|P3|Overall Study|Lab test not done|2
355945|NCT01066819|1200025|P2|Overall Study|Lab test not done|0
355946|NCT01066819|1200026|P1|Overall Study|Lab test not done|9
355947|NCT01066819|1200021|P6|Overall Study|Failed to return|3
355948|NCT01066819|1200022|P5|Overall Study|Failed to return|2
355949|NCT01066819|1200023|P4|Overall Study|Failed to return|7
355950|NCT01066819|1200024|P3|Overall Study|Failed to return|68
355951|NCT01066819|1200025|P2|Overall Study|Failed to return|107
355952|NCT01066819|1200026|P1|Overall Study|Failed to return|298
355953|NCT01066819|1200021|P6|Overall Study|Early termination|0
355954|NCT01066819|1200022|P5|Overall Study|Early termination|0
355955|NCT01066819|1200023|P4|Overall Study|Early termination|0
355956|NCT01066819|1200024|P3|Overall Study|Early termination|0
355957|NCT01066819|1200025|P2|Overall Study|Early termination|0
355958|NCT01066819|1200026|P1|Overall Study|Early termination|2
355959|NCT01066819|1200021|P6|Overall Study|Not met inclusion/exclusion criteria|0
355960|NCT01066819|1200022|P5|Overall Study|Not met inclusion/exclusion criteria|0
355961|NCT01066819|1200023|P4|Overall Study|Not met inclusion/exclusion criteria|0
355962|NCT01066819|1200024|P3|Overall Study|Not met inclusion/exclusion criteria|0
355963|NCT01066819|1200025|P2|Overall Study|Not met inclusion/exclusion criteria|0
355964|NCT01066819|1200026|P1|Overall Study|Not met inclusion/exclusion criteria|1
355965|NCT01066819|1200021|P6|Overall Study|Administrative|0
355966|NCT01066819|1200022|P5|Overall Study|Administrative|0
355967|NCT01066819|1200023|P4|Overall Study|Administrative|0
355968|NCT01066819|1200024|P3|Overall Study|Administrative|2
355969|NCT01066819|1200025|P2|Overall Study|Administrative|4
355970|NCT01066819|1200026|P1|Overall Study|Administrative|6
355971|NCT01066819|1200021|P6|Overall Study|Withdrawal by Subject|0
355972|NCT01066819|1200022|P5|Overall Study|Withdrawal by Subject|0
355973|NCT01066819|1200023|P4|Overall Study|Withdrawal by Subject|0
355974|NCT01066819|1200024|P3|Overall Study|Withdrawal by Subject|6
355975|NCT01066819|1200025|P2|Overall Study|Withdrawal by Subject|11
355976|NCT01066819|1200026|P1|Overall Study|Withdrawal by Subject|29
355977|NCT01066819|1200021|P6|Overall Study|Protocol Violation|0
355978|NCT01066819|1200022|P5|Overall Study|Protocol Violation|0
355979|NCT01066819|1200023|P4|Overall Study|Protocol Violation|0
355980|NCT01066819|1200024|P3|Overall Study|Protocol Violation|0
355981|NCT01066819|1200025|P2|Overall Study|Protocol Violation|6
355982|NCT01066819|1200026|P1|Overall Study|Protocol Violation|12
355983|NCT01066819|1200021|P6|Overall Study|Physician Decision|0
355984|NCT01066819|1200022|P5|Overall Study|Physician Decision|0
355985|NCT01066819|1200023|P4|Overall Study|Physician Decision|0
355986|NCT01066819|1200024|P3|Overall Study|Physician Decision|3
355987|NCT01066819|1200025|P2|Overall Study|Physician Decision|2
355988|NCT01066819|1200026|P1|Overall Study|Physician Decision|6
355989|NCT01066819|1200021|P6|Overall Study|Lack of Efficacy|0
355990|NCT01066819|1200022|P5|Overall Study|Lack of Efficacy|0
355991|NCT01066819|1200023|P4|Overall Study|Lack of Efficacy|1
355992|NCT01066819|1200024|P3|Overall Study|Lack of Efficacy|2
355993|NCT01066819|1200025|P2|Overall Study|Lack of Efficacy|1
355994|NCT01066819|1200026|P1|Overall Study|Lack of Efficacy|22
355995|NCT01066819|1200021|P6|Overall Study|Death|0
355996|NCT01066819|1200022|P5|Overall Study|Death|0
355997|NCT01066819|1200023|P4|Overall Study|Death|0
355998|NCT01066819|1200024|P3|Overall Study|Death|1
355999|NCT01066819|1200025|P2|Overall Study|Death|0
356000|NCT01066819|1200026|P1|Overall Study|Death|5
356001|NCT01066819|1200021|P6|Overall Study|Adverse Event|0
356002|NCT01066819|1200022|P5|Overall Study|Adverse Event|0
356003|NCT01066819|1200023|P4|Overall Study|Adverse Event|0
356004|NCT01066819|1200024|P3|Overall Study|Adverse Event|6
356005|NCT01066819|1200025|P2|Overall Study|Adverse Event|1
356006|NCT01066819|1200026|P1|Overall Study|Adverse Event|18
356007|NCT01066793|1200167|P6|Overall Study|Treatment Stopped|0
356008|NCT01066793|1200168|P5|Overall Study|Treatment Stopped|0
356009|NCT01066793|1200169|P4|Overall Study|Treatment Stopped|1
356010|NCT01066793|1200170|P3|Overall Study|Treatment Stopped|0
356011|NCT01066793|1200171|P2|Overall Study|Treatment Stopped|1
356012|NCT01066793|1200172|P1|Overall Study|Treatment Stopped|2
356013|NCT01066793|1200167|P6|Overall Study|Treatment Never Started|0
356014|NCT01066793|1200168|P5|Overall Study|Treatment Never Started|0
356015|NCT01066793|1200169|P4|Overall Study|Treatment Never Started|1
356016|NCT01066793|1200170|P3|Overall Study|Treatment Never Started|4
356017|NCT01066793|1200171|P2|Overall Study|Treatment Never Started|5
356018|NCT01066793|1200172|P1|Overall Study|Treatment Never Started|18
356019|NCT01066793|1200167|P6|Overall Study|Treatment Interrupted|0
356020|NCT01066793|1200168|P5|Overall Study|Treatment Interrupted|0
356021|NCT01066793|1200169|P4|Overall Study|Treatment Interrupted|0
356022|NCT01066793|1200170|P3|Overall Study|Treatment Interrupted|0
356023|NCT01066793|1200171|P2|Overall Study|Treatment Interrupted|1
356024|NCT01066793|1200172|P1|Overall Study|Treatment Interrupted|1
356025|NCT01066793|1200167|P6|Overall Study|Result Not Available|0
356026|NCT01066793|1200168|P5|Overall Study|Result Not Available|0
356027|NCT01066793|1200169|P4|Overall Study|Result Not Available|0
356028|NCT01066793|1200170|P3|Overall Study|Result Not Available|0
356029|NCT01066793|1200171|P2|Overall Study|Result Not Available|0
356030|NCT01066793|1200172|P1|Overall Study|Result Not Available|1
356031|NCT01066793|1200167|P6|Overall Study|Relapse|0
356032|NCT01066793|1200168|P5|Overall Study|Relapse|0
356033|NCT01066793|1200169|P4|Overall Study|Relapse|3
356034|NCT01066793|1200170|P3|Overall Study|Relapse|2
356035|NCT01066793|1200171|P2|Overall Study|Relapse|8
356036|NCT01066793|1200172|P1|Overall Study|Relapse|20
356037|NCT01066793|1200167|P6|Overall Study|Other|0
356038|NCT01066793|1200168|P5|Overall Study|Other|0
356039|NCT01066793|1200169|P4|Overall Study|Other|2
356040|NCT01066793|1200170|P3|Overall Study|Other|6
356041|NCT01066793|1200171|P2|Overall Study|Other|5
356042|NCT01066793|1200172|P1|Overall Study|Other|15
356043|NCT01066793|1200167|P6|Overall Study|Non-responders|0
356044|NCT01066793|1200168|P5|Overall Study|Non-responders|0
356045|NCT01066793|1200169|P4|Overall Study|Non-responders|25
356046|NCT01066793|1200170|P3|Overall Study|Non-responders|11
356047|NCT01066793|1200171|P2|Overall Study|Non-responders|5
356048|NCT01066793|1200172|P1|Overall Study|Non-responders|104
356049|NCT01066793|1200167|P6|Overall Study|Miscellaneous|0
356050|NCT01066793|1200168|P5|Overall Study|Miscellaneous|0
356051|NCT01066793|1200169|P4|Overall Study|Miscellaneous|0
356052|NCT01066793|1200170|P3|Overall Study|Miscellaneous|6
356053|NCT01066793|1200171|P2|Overall Study|Miscellaneous|5
356054|NCT01066793|1200172|P1|Overall Study|Miscellaneous|4
356055|NCT01066793|1200167|P6|Overall Study|Lab test not done|0
356056|NCT01066793|1200168|P5|Overall Study|Lab test not done|0
356057|NCT01066793|1200169|P4|Overall Study|Lab test not done|1
356058|NCT01066793|1200170|P3|Overall Study|Lab test not done|0
356059|NCT01066793|1200171|P2|Overall Study|Lab test not done|0
356060|NCT01066793|1200172|P1|Overall Study|Lab test not done|7
356061|NCT01066793|1200167|P6|Overall Study|Early Termination|0
356062|NCT01066793|1200168|P5|Overall Study|Early Termination|0
356063|NCT01066793|1200169|P4|Overall Study|Early Termination|0
356064|NCT01066793|1200170|P3|Overall Study|Early Termination|0
356065|NCT01066793|1200171|P2|Overall Study|Early Termination|0
356066|NCT01066793|1200172|P1|Overall Study|Early Termination|3
356067|NCT01066793|1200167|P6|Overall Study|Withdrawal by Subject|0
356068|NCT01066793|1200168|P5|Overall Study|Withdrawal by Subject|0
356069|NCT01066793|1200169|P4|Overall Study|Withdrawal by Subject|0
356070|NCT01066793|1200170|P3|Overall Study|Withdrawal by Subject|1
356071|NCT01066793|1200171|P2|Overall Study|Withdrawal by Subject|4
356072|NCT01066793|1200172|P1|Overall Study|Withdrawal by Subject|7
356073|NCT01066793|1200167|P6|Overall Study|Protocol Violation|0
356074|NCT01066793|1200168|P5|Overall Study|Protocol Violation|0
356075|NCT01066793|1200169|P4|Overall Study|Protocol Violation|0
356076|NCT01066793|1200170|P3|Overall Study|Protocol Violation|2
356077|NCT01066793|1200171|P2|Overall Study|Protocol Violation|2
356078|NCT01066793|1200172|P1|Overall Study|Protocol Violation|3
356079|NCT01066793|1200167|P6|Overall Study|Physician Decision|0
356080|NCT01066793|1200168|P5|Overall Study|Physician Decision|0
356081|NCT01066793|1200169|P4|Overall Study|Physician Decision|0
356082|NCT01066793|1200170|P3|Overall Study|Physician Decision|0
356083|NCT01066793|1200171|P2|Overall Study|Physician Decision|0
356084|NCT01066793|1200172|P1|Overall Study|Physician Decision|3
356085|NCT01066793|1200167|P6|Overall Study|Lost to Follow-up|1
356086|NCT01066793|1200168|P5|Overall Study|Lost to Follow-up|0
356087|NCT01066793|1200169|P4|Overall Study|Lost to Follow-up|16
356088|NCT01066793|1200170|P3|Overall Study|Lost to Follow-up|82
356089|NCT01066793|1200171|P2|Overall Study|Lost to Follow-up|39
356090|NCT01066793|1200172|P1|Overall Study|Lost to Follow-up|180
356091|NCT01066793|1200167|P6|Overall Study|Lack of Efficacy|0
356092|NCT01066793|1200168|P5|Overall Study|Lack of Efficacy|0
356093|NCT01066793|1200169|P4|Overall Study|Lack of Efficacy|0
356094|NCT01066793|1200170|P3|Overall Study|Lack of Efficacy|0
356095|NCT01066793|1200171|P2|Overall Study|Lack of Efficacy|1
356096|NCT01066793|1200172|P1|Overall Study|Lack of Efficacy|2
356097|NCT01066793|1200167|P6|Overall Study|Death|0
356098|NCT01066793|1200168|P5|Overall Study|Death|0
356099|NCT01066793|1200169|P4|Overall Study|Death|0
356100|NCT01066793|1200170|P3|Overall Study|Death|1
356101|NCT01066793|1200171|P2|Overall Study|Death|1
356102|NCT01066793|1200172|P1|Overall Study|Death|4
356103|NCT01066780|1200312|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
356104|NCT01066780|1200313|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
356105|NCT01066585|1200332|P2|Overall Study|Withdrawal by Subject|3
356106|NCT01066585|1200333|P1|Overall Study|Withdrawal by Subject|0
356107|NCT01066585|1200332|P2|Overall Study|Protocol Violation|0
356108|NCT01066585|1200333|P1|Overall Study|Protocol Violation|1
356109|NCT01066546|1200345|P1|Overall Study|Study terminated by sponsor|5
356110|NCT01066156|1200375|P1|Overall Study|Withdrawal by Subject|1
356111|NCT01066156|1200375|P1|Overall Study|Lost to Follow-up|7
356112|NCT01066156|1200375|P1|Overall Study|ineligible|2
356113|NCT01066143|1200379|P1|Overall Study|ineligible for the study|8
356114|NCT01066104|1200385|P2|Overall Study|Protocol Violation|0
356115|NCT01066104|1200386|P1|Overall Study|Protocol Violation|1
356116|NCT01066104|1200385|P2|Overall Study|Adverse Event|1
356117|NCT01066104|1200386|P1|Overall Study|Adverse Event|1
356118|NCT01066039|1200394|P1|Overall Study|Drug/Dose Adjustment Required|1
356119|NCT01066039|1200394|P1|Overall Study|Failure to Control Blood Pressure|1
356120|NCT01066039|1200394|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
356121|NCT01066039|1200394|P1|Overall Study|Additional Antihypertensive Required|4
356122|NCT01066039|1200394|P1|Overall Study|Dropout due to Insulin Administration|1
356123|NCT01066039|1200394|P1|Overall Study|Investigator’s Request|1
356124|NCT01066039|1200394|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
356125|NCT01066039|1200394|P1|Overall Study|Protocol Violation|2
356126|NCT01066039|1200394|P1|Overall Study|Withdrawal by Subject|17
356127|NCT01066039|1200394|P1|Overall Study|Adverse Event|6
356128|NCT01066000|1200407|P1|Overall Study|Adverse Event|1
356129|NCT01066000|1200407|P1|Overall Study|Withdrawal by Subject|1
356130|NCT01066000|1200407|P1|Overall Study|Death|3
356131|NCT01066000|1200407|P1|Overall Study|Protocol Violation|4
356132|NCT01065844|1200418|P1|Overall Study|Adverse Event|5
356133|NCT01065818|1200422|P1|Overall Study|Not a candidate for surgery|1
356134|NCT01065818|1200422|P1|Overall Study|Withdrawal by Subject|1
356135|NCT01065779|1200426|P1|Overall Study|Inclusion Criteria Violation|7
356136|NCT01065779|1200426|P1|Overall Study|Failed to Follow-up|10
356137|NCT01065779|1200426|P1|Overall Study|Not Administered With Study Drug|17
356138|NCT01065779|1200426|P1|Overall Study|Non-enrollment Period Administration|10
356139|NCT01065779|1200426|P1|Overall Study|Investigation Before Contract Date|37
356140|NCT01065779|1200426|P1|Overall Study|Duplicate Investigation|1
356141|NCT01065766|1200437|P1|Overall Study|Violated dosage/administration|25
356142|NCT01065766|1200437|P1|Overall Study|Contraindication to administration|6
356143|NCT01065766|1200437|P1|Overall Study|Assessed before the contracted date|1
356144|NCT01065597|1200456|P1|Overall Study|Adverse Event|1
356145|NCT01065454|1200490|P4|Follow up|study ongoing|41
356146|NCT01065454|1200491|P3|Follow up|study ongoing|15
356147|NCT01065454|1200492|P2|Follow up|study ongoing|22
356148|NCT01065454|1200493|P1|Follow up|study ongoing|37
356149|NCT01065454|1200490|P4|Follow up|Withdrawal by Subject|0
356150|NCT01065454|1200491|P3|Follow up|Withdrawal by Subject|1
356151|NCT01065454|1200492|P2|Follow up|Withdrawal by Subject|1
356152|NCT01065454|1200493|P1|Follow up|Withdrawal by Subject|1
356153|NCT01065454|1200490|P4|Follow up|Progressive disease|1
356154|NCT01065454|1200491|P3|Follow up|Progressive disease|0
356155|NCT01065454|1200492|P2|Follow up|Progressive disease|0
356156|NCT01065454|1200493|P1|Follow up|Progressive disease|0
356157|NCT01065454|1200490|P4|Follow up|Lost to Follow-up|1
356158|NCT01065454|1200491|P3|Follow up|Lost to Follow-up|0
356159|NCT01065454|1200492|P2|Follow up|Lost to Follow-up|0
356160|NCT01065454|1200493|P1|Follow up|Lost to Follow-up|0
356161|NCT01065454|1200490|P4|Follow up|Death|0
356162|NCT01065454|1200491|P3|Follow up|Death|1
356163|NCT01065454|1200492|P2|Follow up|Death|1
356164|NCT01065454|1200493|P1|Follow up|Death|0
356165|NCT01065454|1200490|P4|Follow up|Adverse Event|1
356166|NCT01065454|1200491|P3|Follow up|Adverse Event|0
356167|NCT01065454|1200492|P2|Follow up|Adverse Event|0
356168|NCT01065454|1200493|P1|Follow up|Adverse Event|1
356169|NCT01065454|1200490|P4|Treatment|Withdrawal by Subject|3
356170|NCT01065454|1200491|P3|Treatment|Withdrawal by Subject|2
356171|NCT01065454|1200492|P2|Treatment|Withdrawal by Subject|1
356172|NCT01065454|1200493|P1|Treatment|Withdrawal by Subject|3
356173|NCT01065454|1200490|P4|Treatment|Protocol Violation|0
356174|NCT01065454|1200491|P3|Treatment|Protocol Violation|1
356175|NCT01065454|1200492|P2|Treatment|Protocol Violation|0
356176|NCT01065454|1200493|P1|Treatment|Protocol Violation|1
356177|NCT01065454|1200490|P4|Treatment|Protocol Decision|2
356178|NCT01065454|1200491|P3|Treatment|Protocol Decision|3
356179|NCT01065454|1200492|P2|Treatment|Protocol Decision|0
356180|NCT01065454|1200493|P1|Treatment|Protocol Decision|0
356181|NCT01065454|1200490|P4|Treatment|Non-compliance|1
356182|NCT01065454|1200491|P3|Treatment|Non-compliance|0
356183|NCT01065454|1200492|P2|Treatment|Non-compliance|0
356184|NCT01065454|1200493|P1|Treatment|Non-compliance|1
356185|NCT01065454|1200490|P4|Treatment|Death|0
356186|NCT01065454|1200491|P3|Treatment|Death|0
356187|NCT01065454|1200492|P2|Treatment|Death|0
356188|NCT01065454|1200493|P1|Treatment|Death|1
356189|NCT01065454|1200490|P4|Treatment|Adverse Event|6
356190|NCT01065454|1200491|P3|Treatment|Adverse Event|3
356191|NCT01065454|1200492|P2|Treatment|Adverse Event|4
356192|NCT01065454|1200493|P1|Treatment|Adverse Event|7
356193|NCT01065350|1200616|P2|Overall Study|Received incorrect drug allocation|1
356194|NCT01065350|1200617|P1|Overall Study|Received incorrect drug allocation|0
356195|NCT01064947|1200678|P1|Overall Study|negative culture|41
356196|NCT01064856|1200719|P4|Open-label (OL) Period|Not specified|7
356197|NCT01064856|1200720|P3|Open-label (OL) Period|Not specified|7
356198|NCT01064856|1200721|P2|Open-label (OL) Period|Not specified|0
356199|NCT01064856|1200722|P1|Open-label (OL) Period|Not specified|0
356200|NCT01064856|1200719|P4|Open-label (OL) Period|Lost to Follow-up|1
356201|NCT01064856|1200720|P3|Open-label (OL) Period|Lost to Follow-up|2
356202|NCT01064856|1200721|P2|Open-label (OL) Period|Lost to Follow-up|0
356203|NCT01064856|1200722|P1|Open-label (OL) Period|Lost to Follow-up|0
356204|NCT01064856|1200719|P4|Open-label (OL) Period|Consent withdrawn by participant|6
356205|NCT01064856|1200720|P3|Open-label (OL) Period|Consent withdrawn by participant|5
356206|NCT01064856|1200721|P2|Open-label (OL) Period|Consent withdrawn by participant|0
356207|NCT01064856|1200722|P1|Open-label (OL) Period|Consent withdrawn by participant|0
356208|NCT01064856|1200719|P4|Open-label (OL) Period|Adverse Event|6
356209|NCT01064856|1200720|P3|Open-label (OL) Period|Adverse Event|12
356210|NCT01064856|1200721|P2|Open-label (OL) Period|Adverse Event|0
356211|NCT01064856|1200722|P1|Open-label (OL) Period|Adverse Event|0
356212|NCT01064856|1200719|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
356213|NCT01064856|1200720|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
356214|NCT01064856|1200721|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
356215|NCT01064856|1200722|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
356216|NCT01064856|1200719|P4|Double-blind (DB) Period|Adverse Event|0
356217|NCT01064856|1200720|P3|Double-blind (DB) Period|Adverse Event|0
356218|NCT01064856|1200721|P2|Double-blind (DB) Period|Adverse Event|0
356219|NCT01064856|1200722|P1|Double-blind (DB) Period|Adverse Event|1
356220|NCT01064817|1200766|P2|Study Completion|Withdrawal by Subject|0
356221|NCT01064817|1200767|P1|Study Completion|Withdrawal by Subject|1
356222|NCT01064817|1200766|P2|Study Completion|Physician Decision|0
356223|NCT01064817|1200767|P1|Study Completion|Physician Decision|1
356224|NCT01064739|1200779|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
356225|NCT01064687|1200839|P4|Overall Study|Treatment Noncompliance|0
356226|NCT01064687|1200840|P3|Overall Study|Treatment Noncompliance|1
356227|NCT01064687|1200841|P2|Overall Study|Treatment Noncompliance|1
356228|NCT01064687|1200842|P1|Overall Study|Treatment Noncompliance|1
356229|NCT01064687|1200839|P4|Overall Study|Withdrawal by Subject|5
356230|NCT01064687|1200840|P3|Overall Study|Withdrawal by Subject|12
356231|NCT01064687|1200841|P2|Overall Study|Withdrawal by Subject|7
356232|NCT01064687|1200842|P1|Overall Study|Withdrawal by Subject|9
356233|NCT01064687|1200839|P4|Overall Study|Sponsor Decision|0
356234|NCT01064687|1200840|P3|Overall Study|Sponsor Decision|3
356235|NCT01064687|1200841|P2|Overall Study|Sponsor Decision|0
356236|NCT01064687|1200842|P1|Overall Study|Sponsor Decision|0
356237|NCT01064687|1200839|P4|Overall Study|Protocol Violation|1
356238|NCT01064687|1200840|P3|Overall Study|Protocol Violation|0
356239|NCT01064687|1200841|P2|Overall Study|Protocol Violation|1
356240|NCT01064687|1200842|P1|Overall Study|Protocol Violation|1
356241|NCT01064687|1200839|P4|Overall Study|Physician Decision|0
356242|NCT01064687|1200840|P3|Overall Study|Physician Decision|0
356243|NCT01064687|1200841|P2|Overall Study|Physician Decision|2
356244|NCT01064687|1200842|P1|Overall Study|Physician Decision|2
356245|NCT01064687|1200839|P4|Overall Study|Lost to Follow-up|5
356246|NCT01064687|1200840|P3|Overall Study|Lost to Follow-up|13
356247|NCT01064687|1200841|P2|Overall Study|Lost to Follow-up|10
356248|NCT01064687|1200842|P1|Overall Study|Lost to Follow-up|7
356249|NCT01064687|1200839|P4|Overall Study|Lack of Efficacy|3
356250|NCT01064687|1200840|P3|Overall Study|Lack of Efficacy|2
356251|NCT01064687|1200841|P2|Overall Study|Lack of Efficacy|0
356252|NCT01064687|1200842|P1|Overall Study|Lack of Efficacy|1
356253|NCT01064687|1200839|P4|Overall Study|Entry Criteria Not Met|0
356254|NCT01064687|1200840|P3|Overall Study|Entry Criteria Not Met|0
356255|NCT01064687|1200841|P2|Overall Study|Entry Criteria Not Met|0
356256|NCT01064687|1200842|P1|Overall Study|Entry Criteria Not Met|3
356257|NCT01064687|1200839|P4|Overall Study|Death|0
356258|NCT01064687|1200840|P3|Overall Study|Death|0
356259|NCT01064687|1200841|P2|Overall Study|Death|1
356260|NCT01064687|1200842|P1|Overall Study|Death|1
356261|NCT01064687|1200839|P4|Overall Study|Adverse Event|3
356262|NCT01064687|1200840|P3|Overall Study|Adverse Event|10
356263|NCT01064687|1200841|P2|Overall Study|Adverse Event|4
356264|NCT01064687|1200842|P1|Overall Study|Adverse Event|9
356265|NCT01064622|1201022|P2|Randomized Phase II|Protocol Violation|1
356266|NCT01064622|1201023|P1|Randomized Phase II|Protocol Violation|0
356267|NCT01064622|1201022|P2|Randomized Phase II|Withdrawal by Subject|2
356268|NCT01064622|1201023|P1|Randomized Phase II|Withdrawal by Subject|2
356269|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Not specified|1
356270|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Not specified|2
356271|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Not specified|5
356272|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
356273|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
356274|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
356275|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
356276|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
356277|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
356278|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
356279|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
356280|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
356281|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
356282|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
356283|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
356284|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
356285|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
356286|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
356287|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Death|0
356288|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Death|1
356289|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Death|0
356290|NCT01064414|1201047|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
356291|NCT01064414|1201048|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
356292|NCT01064414|1201049|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
356293|NCT01064414|1201047|P3|Core Period: Baseline to Week 26|Not specified|2
356294|NCT01064414|1201048|P2|Core Period: Baseline to Week 26|Not specified|7
356295|NCT01064414|1201049|P1|Core Period: Baseline to Week 26|Not specified|4
356296|NCT01064414|1201047|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
356297|NCT01064414|1201048|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
356298|NCT01064414|1201049|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
356299|NCT01064414|1201047|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
356300|NCT01064414|1201048|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
356301|NCT01064414|1201049|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
356302|NCT01064414|1201047|P3|Core Period: Baseline to Week 26|Protocol Violation|1
356303|NCT01064414|1201048|P2|Core Period: Baseline to Week 26|Protocol Violation|0
356304|NCT01064414|1201049|P1|Core Period: Baseline to Week 26|Protocol Violation|1
356305|NCT01064414|1201047|P3|Core Period: Baseline to Week 26|Death|0
356306|NCT01064414|1201048|P2|Core Period: Baseline to Week 26|Death|1
356307|NCT01064414|1201049|P1|Core Period: Baseline to Week 26|Death|0
356308|NCT01064414|1201047|P3|Core Period: Baseline to Week 26|Adverse Event|2
356309|NCT01064414|1201048|P2|Core Period: Baseline to Week 26|Adverse Event|4
356310|NCT01064414|1201049|P1|Core Period: Baseline to Week 26|Adverse Event|4
356311|NCT01064401|1201068|P2|Overall Study|Not Specified|1
356312|NCT01064401|1201069|P1|Overall Study|Not Specified|2
356313|NCT01064401|1201068|P2|Overall Study|Site Closure|5
356314|NCT01064401|1201069|P1|Overall Study|Site Closure|4
356315|NCT01064401|1201068|P2|Overall Study|Noncompliance|8
356316|NCT01064401|1201069|P1|Overall Study|Noncompliance|7
356317|NCT01064401|1201068|P2|Overall Study|Pregnancy|7
356318|NCT01064401|1201069|P1|Overall Study|Pregnancy|4
356319|NCT01064401|1201068|P2|Overall Study|Death|0
356320|NCT01064401|1201069|P1|Overall Study|Death|4
356321|NCT01064401|1201068|P2|Overall Study|Investigator Decision|6
356322|NCT01064401|1201069|P1|Overall Study|Investigator Decision|4
356323|NCT01064401|1201068|P2|Overall Study|Consent Withdrawn|80
356324|NCT01064401|1201069|P1|Overall Study|Consent Withdrawn|98
356325|NCT01064401|1201068|P2|Overall Study|Lost to Follow-up|9
356326|NCT01064401|1201069|P1|Overall Study|Lost to Follow-up|12
356327|NCT01064401|1201068|P2|Overall Study|Lack of Efficacy|23
356328|NCT01064401|1201069|P1|Overall Study|Lack of Efficacy|46
356329|NCT01064401|1201068|P2|Overall Study|Adverse Event|56
356330|NCT01064401|1201069|P1|Overall Study|Adverse Event|47
356331|NCT01064310|1201118|P3|Open Label Pazopinib|Physician Decision|20
356332|NCT01064310|1201119|P2|Open Label Pazopinib|Physician Decision|0
356333|NCT01064310|1201120|P1|Open Label Pazopinib|Physician Decision|0
356334|NCT01064310|1201118|P3|Open Label Pazopinib|Lack of Efficacy|51
356335|NCT01064310|1201119|P2|Open Label Pazopinib|Lack of Efficacy|0
356336|NCT01064310|1201120|P1|Open Label Pazopinib|Lack of Efficacy|0
356337|NCT01064310|1201118|P3|Open Label Pazopinib|Adverse Event|12
356338|NCT01064310|1201119|P2|Open Label Pazopinib|Adverse Event|0
356339|NCT01064310|1201120|P1|Open Label Pazopinib|Adverse Event|0
356340|NCT01064310|1201118|P3|Open Label Pazopinib|Withdrawal by Subject|1
356341|NCT01064310|1201119|P2|Open Label Pazopinib|Withdrawal by Subject|0
356342|NCT01064310|1201120|P1|Open Label Pazopinib|Withdrawal by Subject|0
356343|NCT01064310|1201118|P3|Period 2|Lack of Efficacy|0
356344|NCT01064310|1201119|P2|Period 2|Lack of Efficacy|4
356345|NCT01064310|1201120|P1|Period 2|Lack of Efficacy|1
356346|NCT01064310|1201118|P3|Period 2|Entered Open-label Period|0
356347|NCT01064310|1201119|P2|Period 2|Entered Open-label Period|0
356348|NCT01064310|1201120|P1|Period 2|Entered Open-label Period|1
356349|NCT01064310|1201118|P3|Period 2|Physician Decision|0
356350|NCT01064310|1201119|P2|Period 2|Physician Decision|1
356351|NCT01064310|1201120|P1|Period 2|Physician Decision|0
356352|NCT01064310|1201118|P3|Period 2|Adverse Event|0
356353|NCT01064310|1201119|P2|Period 2|Adverse Event|1
356354|NCT01064310|1201120|P1|Period 2|Adverse Event|2
356355|NCT01064310|1201118|P3|Period 1|Entered Open-label Period|0
356356|NCT01064310|1201119|P2|Period 1|Entered Open-label Period|1
356357|NCT01064310|1201120|P1|Period 1|Entered Open-label Period|1
356358|NCT01064310|1201118|P3|Period 1|Lack of Efficacy|0
356359|NCT01064310|1201119|P2|Period 1|Lack of Efficacy|5
356360|NCT01064310|1201120|P1|Period 1|Lack of Efficacy|3
356361|NCT01064310|1201118|P3|Period 1|Withdrawal by Subject|0
356362|NCT01064310|1201119|P2|Period 1|Withdrawal by Subject|2
356363|NCT01064310|1201120|P1|Period 1|Withdrawal by Subject|2
356364|NCT01064310|1201118|P3|Period 1|Physician Decision|0
356365|NCT01064310|1201119|P2|Period 1|Physician Decision|0
356366|NCT01064310|1201120|P1|Period 1|Physician Decision|1
356367|NCT01064310|1201118|P3|Period 1|Adverse Event|0
356368|NCT01064310|1201119|P2|Period 1|Adverse Event|10
356369|NCT01064310|1201120|P1|Period 1|Adverse Event|7
356370|NCT01064297|1201150|P3|Overall Study|Lost to Follow-up|133
356371|NCT01064297|1201151|P2|Overall Study|Lost to Follow-up|48
356372|NCT01064297|1201152|P1|Overall Study|Lost to Follow-up|791
356373|NCT01064167|1201221|P2|Overall Study|Protocol Violation|15
356374|NCT01064167|1201222|P1|Overall Study|Protocol Violation|14
356375|NCT01063881|1201269|P3|Overall Study|Reason for not completed not specified|0
356376|NCT01063881|1201270|P2|Overall Study|Reason for not completed not specified|1
356377|NCT01063881|1201271|P1|Overall Study|Reason for not completed not specified|5
356378|NCT01063881|1201269|P3|Overall Study|Withdrawal by Subject|0
356379|NCT01063881|1201270|P2|Overall Study|Withdrawal by Subject|1
356380|NCT01063881|1201271|P1|Overall Study|Withdrawal by Subject|25
356381|NCT01063881|1201269|P3|Overall Study|Lost to Follow-up|1
356382|NCT01063881|1201270|P2|Overall Study|Lost to Follow-up|7
356383|NCT01063881|1201271|P1|Overall Study|Lost to Follow-up|13
356384|NCT01063881|1201269|P3|Overall Study|Adverse Event|0
356385|NCT01063881|1201270|P2|Overall Study|Adverse Event|2
356386|NCT01063881|1201271|P1|Overall Study|Adverse Event|12
356387|NCT01063868|1201295|P2|Overall Study|Study Terminated By Sponsor|4
356388|NCT01063868|1201296|P1|Overall Study|Study Terminated By Sponsor|23
356389|NCT01063868|1201295|P2|Overall Study|Withdrawal by Subject|1
356390|NCT01063868|1201296|P1|Overall Study|Withdrawal by Subject|3
356391|NCT01063868|1201295|P2|Overall Study|Adverse Event|7
356392|NCT01063868|1201296|P1|Overall Study|Adverse Event|9
356393|NCT01063855|1201304|P2|Overall Study|Reason not specified|11
356394|NCT01063855|1201305|P1|Overall Study|Reason not specified|13
356395|NCT01063855|1201304|P2|Overall Study|Withdrawal by Subject|8
356396|NCT01063855|1201305|P1|Overall Study|Withdrawal by Subject|11
356397|NCT01063855|1201304|P2|Overall Study|Lack of Efficacy|1
356398|NCT01063855|1201305|P1|Overall Study|Lack of Efficacy|0
356399|NCT01063855|1201304|P2|Overall Study|Pregnancy|0
356400|NCT01063855|1201305|P1|Overall Study|Pregnancy|1
356401|NCT01063855|1201304|P2|Overall Study|Lost to Follow-up|4
356402|NCT01063855|1201305|P1|Overall Study|Lost to Follow-up|8
356403|NCT01063855|1201304|P2|Overall Study|Death|1
356404|NCT01063855|1201305|P1|Overall Study|Death|0
356405|NCT01063855|1201304|P2|Overall Study|Adverse Event|4
356406|NCT01063855|1201305|P1|Overall Study|Adverse Event|4
356407|NCT01063764|1201352|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
356408|NCT01063764|1201352|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
356409|NCT01063764|1201352|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
356410|NCT01063764|1201352|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
356411|NCT01063764|1201352|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
356412|NCT01063764|1201352|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
356413|NCT01063764|1201352|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
356414|NCT01063595|1201371|P2|First Intervention|Reason not Specified|1
356415|NCT01063595|1201372|P1|First Intervention|Reason not Specified|0
356416|NCT01063595|1201371|P2|First Intervention|Withdrawal by Subject|0
356417|NCT01063595|1201372|P1|First Intervention|Withdrawal by Subject|1
356418|NCT01063595|1201371|P2|First Intervention|Adverse Event|4
356419|NCT01063595|1201372|P1|First Intervention|Adverse Event|1
356420|NCT01063595|1201371|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
356421|NCT01063595|1201372|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
356422|NCT01063595|1201371|P2|Enrolled in Study and Randomized|Adverse Event|1
356423|NCT01063595|1201372|P1|Enrolled in Study and Randomized|Adverse Event|0
356424|NCT01063595|1201371|P2|Enrolled in Study and Randomized|Reason not Specified|0
356425|NCT01063595|1201372|P1|Enrolled in Study and Randomized|Reason not Specified|1
356426|NCT01063517|1201384|P2|Overall Study|Death|48
356427|NCT01063517|1201385|P1|Overall Study|Death|33
356428|NCT01063517|1201384|P2|Overall Study|Withdrawal by Subject|2
356429|NCT01063517|1201385|P1|Overall Study|Withdrawal by Subject|1
356430|NCT01063517|1201384|P2|Overall Study|Lost to Follow-up|3
356431|NCT01063517|1201385|P1|Overall Study|Lost to Follow-up|4
356432|NCT01063517|1201384|P2|Overall Study|Study reached data cut-off|7
356433|NCT01063517|1201385|P1|Overall Study|Study reached data cut-off|19
356434|NCT01063517|1201384|P2|Overall Study|Consent withdrawal|0
356435|NCT01063517|1201385|P1|Overall Study|Consent withdrawal|1
356436|NCT01063348|1201425|P2|Overall Study|Lost to Follow-up|10
356437|NCT01063348|1201426|P1|Overall Study|Lost to Follow-up|3
356438|NCT01063153|1201436|P2|Overall Study|Physician Decision|4
356439|NCT01063153|1201437|P1|Overall Study|Physician Decision|0
356440|NCT01063153|1201436|P2|Overall Study|Withdrawal by Subject|1
356441|NCT01063153|1201437|P1|Overall Study|Withdrawal by Subject|0
356442|NCT01063153|1201436|P2|Overall Study|Lost to Follow-up|7
356443|NCT01063153|1201437|P1|Overall Study|Lost to Follow-up|0
356444|NCT01063153|1201436|P2|Overall Study|Found Ineligible During Screening|0
356445|NCT01063153|1201437|P1|Overall Study|Found Ineligible During Screening|2
356446|NCT01063062|1201468|P2|Overall Study|Miscellaneous reason|1
356447|NCT01063062|1201469|P1|Overall Study|Miscellaneous reason|0
356448|NCT01063062|1201468|P2|Overall Study|Lost to Follow-up|2
356449|NCT01063062|1201469|P1|Overall Study|Lost to Follow-up|0
356450|NCT01063062|1201468|P2|Overall Study|Investigator's request|0
356451|NCT01063062|1201469|P1|Overall Study|Investigator's request|1
356452|NCT01063062|1201468|P2|Overall Study|Protocol Violation|4
356453|NCT01063062|1201469|P1|Overall Study|Protocol Violation|5
356454|NCT01063062|1201468|P2|Overall Study|Adverse Event|4
356455|NCT01063062|1201469|P1|Overall Study|Adverse Event|2
356456|NCT01063062|1201468|P2|Overall Study|Patient withdrew consent|1
356457|NCT01063062|1201469|P1|Overall Study|Patient withdrew consent|0
356458|NCT01063036|1201523|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
356459|NCT01063036|1201523|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
356460|NCT01063036|1201523|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
356461|NCT01063036|1201523|P1|Participants Treated With Study Drug|Pregnancy|1
356462|NCT01063036|1201523|P1|Participants Treated With Study Drug|Lost to Follow-up|1
356463|NCT01063036|1201523|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
356464|NCT01063036|1201523|P1|Participants Treated With Study Drug|Protocol Violation|1
356465|NCT01063036|1201523|P1|Participants Treated With Study Drug|Adverse Event|1
356466|NCT01062841|1201539|P2|Overall Study|Withdrawal by Study|0
356467|NCT01062841|1201540|P1|Overall Study|Withdrawal by Study|3
356468|NCT01062841|1201539|P2|Overall Study|Withdrawal by Subject|0
356469|NCT01062841|1201540|P1|Overall Study|Withdrawal by Subject|2
356470|NCT01062841|1201539|P2|Overall Study|Death|5
356471|NCT01062841|1201540|P1|Overall Study|Death|3
356472|NCT01062841|1201539|P2|Overall Study|Indwelling Device Removed|48
356473|NCT01062841|1201540|P1|Overall Study|Indwelling Device Removed|41
356474|NCT01062763|1201570|P2|Overall Study|Adverse Event|4
356475|NCT01062763|1201571|P1|Overall Study|Adverse Event|3
356476|NCT01062425|1201583|P2|Overall Study|Protocol Violation|6
356477|NCT01062425|1201584|P1|Overall Study|Protocol Violation|3
356478|NCT01062399|1201601|P5|Overall Study|Protocol Violation|4
356479|NCT01062399|1201602|P4|Overall Study|Protocol Violation|6
356480|NCT01062399|1201603|P3|Overall Study|Protocol Violation|0
356481|NCT01062399|1201604|P2|Overall Study|Protocol Violation|1
356482|NCT01062399|1201605|P1|Overall Study|Protocol Violation|0
356483|NCT01062256|1201649|P3|Overall Study|Administrative|0
356484|NCT01062256|1201650|P2|Overall Study|Administrative|2
356485|NCT01062256|1201651|P1|Overall Study|Administrative|0
356486|NCT01062256|1201649|P3|Overall Study|Ineligible|3
356487|NCT01062256|1201650|P2|Overall Study|Ineligible|4
356488|NCT01062256|1201651|P1|Overall Study|Ineligible|1
356489|NCT01062256|1201649|P3|Overall Study|Withdrawal by Subject|1
356490|NCT01062256|1201650|P2|Overall Study|Withdrawal by Subject|1
356491|NCT01062256|1201651|P1|Overall Study|Withdrawal by Subject|1
356492|NCT01062256|1201649|P3|Overall Study|Adverse Event|0
356493|NCT01062256|1201650|P2|Overall Study|Adverse Event|0
356494|NCT01062256|1201651|P1|Overall Study|Adverse Event|1
356495|NCT01062113|1201685|P3|Overall Study|Withdrawal by Subject|0
356496|NCT01062113|1201686|P2|Overall Study|Withdrawal by Subject|0
356497|NCT01062113|1201687|P1|Overall Study|Withdrawal by Subject|1
356498|NCT01062113|1201685|P3|Overall Study|Lack of Efficacy|31
356499|NCT01062113|1201686|P2|Overall Study|Lack of Efficacy|22
356500|NCT01062113|1201687|P1|Overall Study|Lack of Efficacy|38
356501|NCT01062113|1201685|P3|Overall Study|Adverse Event|0
356502|NCT01062113|1201686|P2|Overall Study|Adverse Event|0
356503|NCT01062113|1201687|P1|Overall Study|Adverse Event|1
356504|NCT01062061|1201705|P1|Overall Study|Failed to meet inclusion criteria|2
356505|NCT01062061|1201705|P1|Overall Study|Outside chief indications|10
356506|NCT01062061|1201705|P1|Overall Study|Investigated before study start|13
356507|NCT01062061|1201705|P1|Overall Study|Enrolled more than once|2
356508|NCT01061866|1201719|P1|Overall Study|Adverse Event|2
356509|NCT01061775|1201723|P1|Overall Study|Lost to Follow-up|1
356510|NCT01061775|1201723|P1|Overall Study|Physician Decision|2
356511|NCT01061736|1201740|P10|Overall Study|Other than specified above|21
356512|NCT01061736|1201741|P9|Overall Study|Other than specified above|15
356513|NCT01061736|1201742|P8|Overall Study|Other than specified above|18
356514|NCT01061736|1201743|P7|Overall Study|Other than specified above|0
356515|NCT01061736|1201744|P6|Overall Study|Other than specified above|0
356516|NCT01061736|1201745|P5|Overall Study|Other than specified above|1
356517|NCT01061736|1201746|P4|Overall Study|Other than specified above|0
356518|NCT01061736|1201747|P3|Overall Study|Other than specified above|2
356519|NCT01061736|1201748|P2|Overall Study|Other than specified above|1
356520|NCT01061736|1201749|P1|Overall Study|Other than specified above|0
356521|NCT01061736|1201740|P10|Overall Study|Not treated|0
356522|NCT01061736|1201741|P9|Overall Study|Not treated|1
356523|NCT01061736|1201742|P8|Overall Study|Not treated|2
356524|NCT01061736|1201743|P7|Overall Study|Not treated|0
356525|NCT01061736|1201744|P6|Overall Study|Not treated|0
356526|NCT01061736|1201745|P5|Overall Study|Not treated|1
356527|NCT01061736|1201746|P4|Overall Study|Not treated|0
356528|NCT01061736|1201747|P3|Overall Study|Not treated|0
356529|NCT01061736|1201748|P2|Overall Study|Not treated|0
356530|NCT01061736|1201749|P1|Overall Study|Not treated|0
356531|NCT01061736|1201740|P10|Overall Study|Poor compliance to protocol|9
356532|NCT01061736|1201741|P9|Overall Study|Poor compliance to protocol|5
356533|NCT01061736|1201742|P8|Overall Study|Poor compliance to protocol|2
356534|NCT01061736|1201743|P7|Overall Study|Poor compliance to protocol|0
356535|NCT01061736|1201744|P6|Overall Study|Poor compliance to protocol|0
356536|NCT01061736|1201745|P5|Overall Study|Poor compliance to protocol|0
356537|NCT01061736|1201746|P4|Overall Study|Poor compliance to protocol|0
356538|NCT01061736|1201747|P3|Overall Study|Poor compliance to protocol|0
356539|NCT01061736|1201748|P2|Overall Study|Poor compliance to protocol|0
356540|NCT01061736|1201749|P1|Overall Study|Poor compliance to protocol|0
356541|NCT01061736|1201740|P10|Overall Study|Lack of Efficacy|10
356542|NCT01061736|1201741|P9|Overall Study|Lack of Efficacy|9
356543|NCT01061736|1201742|P8|Overall Study|Lack of Efficacy|9
356544|NCT01061736|1201743|P7|Overall Study|Lack of Efficacy|1
356545|NCT01061736|1201744|P6|Overall Study|Lack of Efficacy|2
356546|NCT01061736|1201745|P5|Overall Study|Lack of Efficacy|1
356547|NCT01061736|1201746|P4|Overall Study|Lack of Efficacy|1
356548|NCT01061736|1201747|P3|Overall Study|Lack of Efficacy|1
356549|NCT01061736|1201748|P2|Overall Study|Lack of Efficacy|2
356550|NCT01061736|1201749|P1|Overall Study|Lack of Efficacy|0
356551|NCT01061736|1201740|P10|Overall Study|Adverse Event|34
356552|NCT01061736|1201741|P9|Overall Study|Adverse Event|67
356553|NCT01061736|1201742|P8|Overall Study|Adverse Event|63
356554|NCT01061736|1201743|P7|Overall Study|Adverse Event|4
356555|NCT01061736|1201744|P6|Overall Study|Adverse Event|1
356556|NCT01061736|1201745|P5|Overall Study|Adverse Event|4
356557|NCT01061736|1201746|P4|Overall Study|Adverse Event|2
356558|NCT01061736|1201747|P3|Overall Study|Adverse Event|3
356559|NCT01061736|1201748|P2|Overall Study|Adverse Event|1
356560|NCT01061736|1201749|P1|Overall Study|Adverse Event|13
356561|NCT01061736|1201740|P10|Overall Study|Dose regimen not selected|0
356562|NCT01061736|1201741|P9|Overall Study|Dose regimen not selected|0
356563|NCT01061736|1201742|P8|Overall Study|Dose regimen not selected|0
356564|NCT01061736|1201743|P7|Overall Study|Dose regimen not selected|79
356565|NCT01061736|1201744|P6|Overall Study|Dose regimen not selected|0
356566|NCT01061736|1201745|P5|Overall Study|Dose regimen not selected|0
356567|NCT01061736|1201746|P4|Overall Study|Dose regimen not selected|0
356568|NCT01061736|1201747|P3|Overall Study|Dose regimen not selected|0
356569|NCT01061736|1201748|P2|Overall Study|Dose regimen not selected|0
356570|NCT01061736|1201749|P1|Overall Study|Dose regimen not selected|0
356571|NCT01061723|1201788|P6|Overall Study|Other than specified above|1
356572|NCT01061723|1201789|P5|Overall Study|Other than specified above|0
356573|NCT01061723|1201790|P4|Overall Study|Other than specified above|1
356574|NCT01061723|1201791|P3|Overall Study|Other than specified above|1
356575|NCT01061723|1201792|P2|Overall Study|Other than specified above|1
356576|NCT01061723|1201793|P1|Overall Study|Other than specified above|2
356577|NCT01061723|1201788|P6|Overall Study|Randomized but not treated|1
356578|NCT01061723|1201789|P5|Overall Study|Randomized but not treated|0
356579|NCT01061723|1201790|P4|Overall Study|Randomized but not treated|0
356580|NCT01061723|1201791|P3|Overall Study|Randomized but not treated|0
356581|NCT01061723|1201792|P2|Overall Study|Randomized but not treated|0
356582|NCT01061723|1201793|P1|Overall Study|Randomized but not treated|0
356583|NCT01061723|1201788|P6|Overall Study|Lack of Efficacy|1
356584|NCT01061723|1201789|P5|Overall Study|Lack of Efficacy|1
356585|NCT01061723|1201790|P4|Overall Study|Lack of Efficacy|2
356586|NCT01061723|1201791|P3|Overall Study|Lack of Efficacy|4
356587|NCT01061723|1201792|P2|Overall Study|Lack of Efficacy|3
356588|NCT01061723|1201793|P1|Overall Study|Lack of Efficacy|2
356589|NCT01061723|1201788|P6|Overall Study|Adverse Event|6
356590|NCT01061723|1201789|P5|Overall Study|Adverse Event|2
356591|NCT01061723|1201790|P4|Overall Study|Adverse Event|5
356592|NCT01061723|1201791|P3|Overall Study|Adverse Event|5
356593|NCT01061723|1201792|P2|Overall Study|Adverse Event|2
356594|NCT01061723|1201793|P1|Overall Study|Adverse Event|0
356595|NCT01061710|1201873|P1|Overall Study|Protocol Violation|14
356596|NCT01061671|1201883|P2|Overall Study|Death|30
356597|NCT01061671|1201884|P1|Overall Study|Death|28
356598|NCT01061671|1201883|P2|Overall Study|Lost to Follow-up|5
356599|NCT01061671|1201884|P1|Overall Study|Lost to Follow-up|3
356600|NCT01061671|1201883|P2|Overall Study|Withdrawal by Subject|20
356601|NCT01061671|1201884|P1|Overall Study|Withdrawal by Subject|16
356602|NCT01061606|1201896|P1|Overall Study|alternative therapy|2
356603|NCT01061606|1201896|P1|Overall Study|Disease Progression|4
356604|NCT01061606|1201896|P1|Overall Study|Death|1
356605|NCT01061606|1201896|P1|Overall Study|Adverse Event|1
356606|NCT01061567|1201905|P1|Overall Study|Other reason than stated above|3
356607|NCT01061567|1201905|P1|Overall Study|Withdrawal by Subject|11
356608|NCT01061567|1201905|P1|Overall Study|Protocol Violation|1
356609|NCT01061567|1201905|P1|Overall Study|Lost to Follow-up|24
356610|NCT01061567|1201905|P1|Overall Study|Lack of Efficacy|3
356611|NCT01061567|1201905|P1|Overall Study|Death|2
356612|NCT01061567|1201905|P1|Overall Study|Adverse Event|32
356613|NCT01061385|1201929|P2|Overall Study|subject decision not related to AE|1
356614|NCT01061385|1201930|P1|Overall Study|subject decision not related to AE|0
356615|NCT01061385|1201929|P2|Overall Study|Lost to Follow-up|0
356616|NCT01061385|1201930|P1|Overall Study|Lost to Follow-up|1
356617|NCT01061359|1201938|P1|Overall Study|Secondary neoplasm|11
356618|NCT01061359|1201938|P1|Overall Study|Relapse|187
356619|NCT01061359|1201938|P1|Overall Study|Lost to Follow-up|1072
356620|NCT01061359|1201938|P1|Overall Study|Death|32
356621|NCT01061333|1201944|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
356622|NCT01061333|1201945|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
356623|NCT01061177|1201983|P1|Overall Study|Death|4
356624|NCT01061177|1201983|P1|Overall Study|Administratie problems|4
356625|NCT01061177|1201983|P1|Overall Study|Abnormal test procedure results|4
356626|NCT01061177|1201983|P1|Overall Study|Abnormal laboratory values|6
356627|NCT01061177|1201983|P1|Overall Study|New cancer therapy|9
356628|NCT01061177|1201983|P1|Overall Study|Lost to Follow-up|9
356629|NCT01061177|1201983|P1|Overall Study|Protocol Violation|11
356630|NCT01061177|1201983|P1|Overall Study|Disease progression|17
356631|NCT01061177|1201983|P1|Overall Study|Withdrawal by Subject|27
356632|NCT01061177|1201983|P1|Overall Study|Adverse Event|117
356633|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
356634|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
356635|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
356636|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
356637|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
356638|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
356639|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
356640|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
356641|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
356642|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
356643|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
356644|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
356645|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
356646|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
356647|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
356727|NCT01060111|1202162|P3|Overall Study|Other|4
356648|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
356649|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
356650|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
356651|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
356652|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
356653|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
356654|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
356655|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
356656|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
356657|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
356658|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
356659|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
356660|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
356661|NCT01061151|1202006|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
356662|NCT01061151|1202007|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
356663|NCT01061151|1202008|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
356664|NCT01061151|1202009|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
356665|NCT01061151|1202006|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
356666|NCT01061151|1202007|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
356667|NCT01061151|1202008|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
356668|NCT01061151|1202009|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
356669|NCT01061151|1202006|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
356670|NCT01061151|1202007|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
356671|NCT01061151|1202008|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
356672|NCT01061151|1202009|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
356673|NCT01061151|1202006|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
356674|NCT01061151|1202007|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
356675|NCT01061151|1202008|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
356676|NCT01061151|1202009|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
356677|NCT01061151|1202006|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
356678|NCT01061151|1202007|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
356679|NCT01061151|1202008|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
356680|NCT01061151|1202009|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
356681|NCT01061151|1202006|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
356682|NCT01061151|1202007|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
356683|NCT01061151|1202008|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
356684|NCT01061151|1202009|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
356685|NCT01061151|1202006|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
356686|NCT01061151|1202007|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
356687|NCT01061151|1202008|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
356688|NCT01061151|1202009|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
356689|NCT01061151|1202006|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
356690|NCT01061151|1202007|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
356691|NCT01061151|1202008|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
356692|NCT01061151|1202009|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
356693|NCT01061008|1202068|P2|Overall Study|Adverse Event|1
356694|NCT01061008|1202069|P1|Overall Study|Adverse Event|0
356695|NCT01061008|1202068|P2|Overall Study|Unable to exercise following surgery|0
356696|NCT01061008|1202069|P1|Overall Study|Unable to exercise following surgery|1
356697|NCT01061008|1202068|P2|Overall Study|Withdrawal by Subject|3
356698|NCT01061008|1202069|P1|Overall Study|Withdrawal by Subject|1
356699|NCT01061008|1202068|P2|Overall Study|Death|0
356700|NCT01061008|1202069|P1|Overall Study|Death|1
356701|NCT01061008|1202068|P2|Overall Study|Badiocephalic fistula failed|2
356702|NCT01061008|1202069|P1|Overall Study|Badiocephalic fistula failed|3
356703|NCT01060670|1202077|P2|Run In|screen failure|238
356704|NCT01060670|1202078|P1|Run In|screen failure|0
356705|NCT01060553|1202113|P2|Overall Study|Lack of Efficacy|0
356706|NCT01060553|1202114|P1|Overall Study|Lack of Efficacy|1
356707|NCT01060553|1202113|P2|Overall Study|Withdrawal by Subject|5
356708|NCT01060553|1202114|P1|Overall Study|Withdrawal by Subject|5
356709|NCT01060553|1202113|P2|Overall Study|Lost to Follow-up|5
356710|NCT01060553|1202114|P1|Overall Study|Lost to Follow-up|3
356711|NCT01060540|1202121|P2|Overall Study|Physician Decision|1
356712|NCT01060540|1202122|P1|Overall Study|Physician Decision|0
356713|NCT01060540|1202121|P2|Overall Study|Death|1
356714|NCT01060540|1202122|P1|Overall Study|Death|2
356715|NCT01060540|1202121|P2|Overall Study|Lost to Follow-up|43
356716|NCT01060540|1202122|P1|Overall Study|Lost to Follow-up|52
356717|NCT01060540|1202121|P2|Overall Study|Withdrawal by Subject|20
356718|NCT01060540|1202122|P1|Overall Study|Withdrawal by Subject|10
356719|NCT01060150|1202136|P1|Overall Study|Enrolled, but not treated|2
356720|NCT01060150|1202136|P1|Overall Study|Withdrawal by Subject|8
356721|NCT01060150|1202136|P1|Overall Study|Protocol Violation|6
356722|NCT01060150|1202136|P1|Overall Study|Lost to Follow-up|1
356723|NCT01060150|1202136|P1|Overall Study|Adverse Event|6
356724|NCT01060124|1202151|P1|Overall Study|Withdrawal by Subject|7
356725|NCT01060124|1202151|P1|Overall Study|Adverse Event|14
356726|NCT01060124|1202151|P1|Overall Study|Other|16
356728|NCT01060111|1202163|P2|Overall Study|Other|3
356729|NCT01060111|1202164|P1|Overall Study|Other|2
356730|NCT01060111|1202162|P3|Overall Study|Participants' non-cooperation|0
356731|NCT01060111|1202163|P2|Overall Study|Participants' non-cooperation|0
356732|NCT01060111|1202164|P1|Overall Study|Participants' non-cooperation|1
356733|NCT01060111|1202162|P3|Overall Study|Adverse event and insufficient effect|0
356734|NCT01060111|1202163|P2|Overall Study|Adverse event and insufficient effect|1
356735|NCT01060111|1202164|P1|Overall Study|Adverse event and insufficient effect|0
356736|NCT01060111|1202162|P3|Overall Study|Participants' non-cooperation|6
356737|NCT01060111|1202163|P2|Overall Study|Participants' non-cooperation|6
356738|NCT01060111|1202164|P1|Overall Study|Participants' non-cooperation|8
356739|NCT01060111|1202162|P3|Overall Study|Participants' evasion for hospital visit|2
356740|NCT01060111|1202163|P2|Overall Study|Participants' evasion for hospital visit|3
356741|NCT01060111|1202164|P1|Overall Study|Participants' evasion for hospital visit|0
356742|NCT01060111|1202162|P3|Overall Study|Inappropriate participant|5
356743|NCT01060111|1202163|P2|Overall Study|Inappropriate participant|4
356744|NCT01060111|1202164|P1|Overall Study|Inappropriate participant|5
356745|NCT01060111|1202162|P3|Overall Study|Lack of Efficacy|0
356746|NCT01060111|1202163|P2|Overall Study|Lack of Efficacy|1
356747|NCT01060111|1202164|P1|Overall Study|Lack of Efficacy|2
356748|NCT01060111|1202162|P3|Overall Study|Adverse Event|18
356749|NCT01060111|1202163|P2|Overall Study|Adverse Event|5
356750|NCT01060111|1202164|P1|Overall Study|Adverse Event|9
356751|NCT01060072|1202183|P2|Overall Study|Excluded Medications|1
356752|NCT01060072|1202184|P1|Overall Study|Excluded Medications|0
356753|NCT01060072|1202183|P2|Overall Study|Acute cholecystitis|0
356754|NCT01060072|1202184|P1|Overall Study|Acute cholecystitis|1
356755|NCT01060072|1202183|P2|Overall Study|Protocol Violation|1
356756|NCT01060072|1202184|P1|Overall Study|Protocol Violation|0
356757|NCT01060072|1202183|P2|Overall Study|Physician Decision|2
356758|NCT01060072|1202184|P1|Overall Study|Physician Decision|0
356759|NCT01060072|1202183|P2|Overall Study|Adverse Event|1
356760|NCT01060072|1202184|P1|Overall Study|Adverse Event|1
356761|NCT01060059|1202200|P2|Overall Study|lack of compliance|2
356762|NCT01060059|1202201|P1|Overall Study|lack of compliance|5
356763|NCT01060059|1202200|P2|Overall Study|lack of glycemic control|1
356764|NCT01060059|1202201|P1|Overall Study|lack of glycemic control|2
356765|NCT01060059|1202200|P2|Overall Study|Withdrawal by Subject|23
356766|NCT01060059|1202201|P1|Overall Study|Withdrawal by Subject|35
356767|NCT01060059|1202200|P2|Overall Study|entry criteria not met|3
356768|NCT01060059|1202201|P1|Overall Study|entry criteria not met|4
356769|NCT01060059|1202200|P2|Overall Study|Lost to Follow-up|34
356770|NCT01060059|1202201|P1|Overall Study|Lost to Follow-up|18
356771|NCT01060059|1202200|P2|Overall Study|Death|3
356772|NCT01060059|1202201|P1|Overall Study|Death|2
356773|NCT01060059|1202200|P2|Overall Study|Adverse Event|1
356774|NCT01060059|1202201|P1|Overall Study|Adverse Event|1
356775|NCT01060007|1202259|P1|Overall Study|Inevaluable for response at surgery|3
356776|NCT01060007|1202259|P1|Overall Study|Withdrawal by Subject|1
356777|NCT01059903|1202296|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
356778|NCT01059903|1202297|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
356779|NCT01059864|1202331|P3|Double-Blind Treatment Phase|Adverse Event|3
356780|NCT01059864|1202332|P2|Double-Blind Treatment Phase|Adverse Event|3
356781|NCT01059864|1202333|P1|Double-Blind Treatment Phase|Adverse Event|0
356782|NCT01059864|1202331|P3|Open-Label Run-In Phase|Protocol Violation|0
356783|NCT01059864|1202332|P2|Open-Label Run-In Phase|Protocol Violation|0
356784|NCT01059864|1202333|P1|Open-Label Run-In Phase|Protocol Violation|2
356785|NCT01059864|1202331|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
356786|NCT01059864|1202332|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
356787|NCT01059864|1202333|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
356788|NCT01059864|1202331|P3|Open-Label Run-In Phase|Lost to Follow-up|0
356789|NCT01059864|1202332|P2|Open-Label Run-In Phase|Lost to Follow-up|0
356790|NCT01059864|1202333|P1|Open-Label Run-In Phase|Lost to Follow-up|2
356791|NCT01059864|1202331|P3|Open-Label Run-In Phase|Lack of Efficacy|0
356792|NCT01059864|1202332|P2|Open-Label Run-In Phase|Lack of Efficacy|0
356793|NCT01059864|1202333|P1|Open-Label Run-In Phase|Lack of Efficacy|1
356794|NCT01059864|1202331|P3|Open-Label Run-In Phase|Adverse Event|0
356795|NCT01059864|1202332|P2|Open-Label Run-In Phase|Adverse Event|0
356796|NCT01059864|1202333|P1|Open-Label Run-In Phase|Adverse Event|7
356797|NCT01059825|1202407|P7|Treatment Period|Adverse event not related to study drug|0
356798|NCT01059825|1202408|P6|Treatment Period|Adverse event not related to study drug|1
356799|NCT01059825|1202409|P5|Treatment Period|Adverse event not related to study drug|1
356800|NCT01059825|1202410|P4|Treatment Period|Adverse event not related to study drug|1
356801|NCT01059825|1202411|P3|Treatment Period|Adverse event not related to study drug|2
356802|NCT01059825|1202412|P2|Treatment Period|Adverse event not related to study drug|1
356803|NCT01059825|1202413|P1|Treatment Period|Adverse event not related to study drug|0
356804|NCT01059825|1202407|P7|Treatment Period|Insufficient clinical response|0
356805|NCT01059825|1202408|P6|Treatment Period|Insufficient clinical response|0
356806|NCT01059825|1202409|P5|Treatment Period|Insufficient clinical response|0
356807|NCT01059825|1202410|P4|Treatment Period|Insufficient clinical response|0
356808|NCT01059825|1202411|P3|Treatment Period|Insufficient clinical response|0
356809|NCT01059825|1202412|P2|Treatment Period|Insufficient clinical response|0
356810|NCT01059825|1202413|P1|Treatment Period|Insufficient clinical response|3
356811|NCT01059825|1202407|P7|Treatment Period|Adverse event related to study drug|0
356812|NCT01059825|1202408|P6|Treatment Period|Adverse event related to study drug|0
356813|NCT01059825|1202409|P5|Treatment Period|Adverse event related to study drug|0
356814|NCT01059825|1202410|P4|Treatment Period|Adverse event related to study drug|1
356815|NCT01059825|1202411|P3|Treatment Period|Adverse event related to study drug|1
356816|NCT01059825|1202412|P2|Treatment Period|Adverse event related to study drug|0
356817|NCT01059825|1202413|P1|Treatment Period|Adverse event related to study drug|1
356818|NCT01059825|1202407|P7|Treatment Period|Protocol Violation|0
356819|NCT01059825|1202408|P6|Treatment Period|Protocol Violation|1
356820|NCT01059825|1202409|P5|Treatment Period|Protocol Violation|1
356821|NCT01059825|1202410|P4|Treatment Period|Protocol Violation|1
356822|NCT01059825|1202411|P3|Treatment Period|Protocol Violation|1
356823|NCT01059825|1202412|P2|Treatment Period|Protocol Violation|0
356824|NCT01059825|1202413|P1|Treatment Period|Protocol Violation|0
356825|NCT01059825|1202407|P7|Treatment Period|Other reason not specified|0
356826|NCT01059825|1202408|P6|Treatment Period|Other reason not specified|0
356827|NCT01059825|1202409|P5|Treatment Period|Other reason not specified|0
356828|NCT01059825|1202410|P4|Treatment Period|Other reason not specified|2
356829|NCT01059825|1202411|P3|Treatment Period|Other reason not specified|1
356830|NCT01059825|1202412|P2|Treatment Period|Other reason not specified|2
356831|NCT01059825|1202413|P1|Treatment Period|Other reason not specified|1
356832|NCT01059825|1202407|P7|Treatment Period|Withdrawal by Subject|0
356833|NCT01059825|1202408|P6|Treatment Period|Withdrawal by Subject|1
356834|NCT01059825|1202409|P5|Treatment Period|Withdrawal by Subject|4
356835|NCT01059825|1202410|P4|Treatment Period|Withdrawal by Subject|5
356836|NCT01059825|1202411|P3|Treatment Period|Withdrawal by Subject|1
356837|NCT01059825|1202412|P2|Treatment Period|Withdrawal by Subject|0
356838|NCT01059825|1202413|P1|Treatment Period|Withdrawal by Subject|3
356839|NCT01059825|1202407|P7|Treatment Period|Lost to Follow-up|0
356840|NCT01059825|1202408|P6|Treatment Period|Lost to Follow-up|0
356841|NCT01059825|1202409|P5|Treatment Period|Lost to Follow-up|2
356842|NCT01059825|1202410|P4|Treatment Period|Lost to Follow-up|1
356843|NCT01059825|1202411|P3|Treatment Period|Lost to Follow-up|0
356844|NCT01059825|1202412|P2|Treatment Period|Lost to Follow-up|1
356845|NCT01059825|1202413|P1|Treatment Period|Lost to Follow-up|2
356846|NCT01059825|1202407|P7|Enrolled, Run-in Period|Protocol Violation|5
356847|NCT01059825|1202408|P6|Enrolled, Run-in Period|Protocol Violation|0
356848|NCT01059825|1202409|P5|Enrolled, Run-in Period|Protocol Violation|0
356849|NCT01059825|1202410|P4|Enrolled, Run-in Period|Protocol Violation|0
356850|NCT01059825|1202411|P3|Enrolled, Run-in Period|Protocol Violation|0
356851|NCT01059825|1202412|P2|Enrolled, Run-in Period|Protocol Violation|0
356852|NCT01059825|1202413|P1|Enrolled, Run-in Period|Protocol Violation|0
356853|NCT01059825|1202407|P7|Enrolled, Run-in Period|Other reason not specified|7
356854|NCT01059825|1202408|P6|Enrolled, Run-in Period|Other reason not specified|0
356855|NCT01059825|1202409|P5|Enrolled, Run-in Period|Other reason not specified|0
356856|NCT01059825|1202410|P4|Enrolled, Run-in Period|Other reason not specified|0
356857|NCT01059825|1202411|P3|Enrolled, Run-in Period|Other reason not specified|0
356858|NCT01059825|1202412|P2|Enrolled, Run-in Period|Other reason not specified|0
356859|NCT01059825|1202413|P1|Enrolled, Run-in Period|Other reason not specified|0
356860|NCT01059825|1202407|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
356861|NCT01059825|1202408|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
356862|NCT01059825|1202409|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
356863|NCT01059825|1202410|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
356864|NCT01059825|1202411|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
356865|NCT01059825|1202412|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
356866|NCT01059825|1202413|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
356867|NCT01059825|1202407|P7|Enrolled, Run-in Period|Lost to Follow-up|5
356868|NCT01059825|1202408|P6|Enrolled, Run-in Period|Lost to Follow-up|0
356869|NCT01059825|1202409|P5|Enrolled, Run-in Period|Lost to Follow-up|0
356870|NCT01059825|1202410|P4|Enrolled, Run-in Period|Lost to Follow-up|0
356871|NCT01059825|1202411|P3|Enrolled, Run-in Period|Lost to Follow-up|0
356872|NCT01059825|1202412|P2|Enrolled, Run-in Period|Lost to Follow-up|0
356873|NCT01059825|1202413|P1|Enrolled, Run-in Period|Lost to Follow-up|0
356874|NCT01059825|1202407|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
356875|NCT01059825|1202408|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
356876|NCT01059825|1202409|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
356877|NCT01059825|1202410|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
356878|NCT01059825|1202411|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
356879|NCT01059825|1202412|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
356880|NCT01059825|1202413|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
356881|NCT01059825|1202407|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
356882|NCT01059825|1202408|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
356883|NCT01059825|1202409|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
356884|NCT01059825|1202410|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
356885|NCT01059825|1202411|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
356886|NCT01059825|1202412|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
356887|NCT01059825|1202413|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
356888|NCT01059812|1202600|P2|Overall Study|Unclassified|4
356889|NCT01059812|1202601|P1|Overall Study|Unclassified|14
356890|NCT01059812|1202600|P2|Overall Study|Withdrawal Criteria|4
356891|NCT01059812|1202601|P1|Overall Study|Withdrawal Criteria|9
356892|NCT01059812|1202600|P2|Overall Study|Protocol Violation|1
356893|NCT01059812|1202601|P1|Overall Study|Protocol Violation|3
356894|NCT01059812|1202600|P2|Overall Study|Lack of Efficacy|2
356895|NCT01059812|1202601|P1|Overall Study|Lack of Efficacy|2
356896|NCT01059812|1202600|P2|Overall Study|Adverse Event|5
356897|NCT01059812|1202601|P1|Overall Study|Adverse Event|9
356898|NCT01059799|1202617|P2|Overall Study|Other|3
356899|NCT01059799|1202618|P1|Overall Study|Other|12
356900|NCT01059799|1202617|P2|Overall Study|Withdrawal criteria|2
356901|NCT01059799|1202618|P1|Overall Study|Withdrawal criteria|13
356902|NCT01059799|1202617|P2|Overall Study|Protocol Violation|2
356903|NCT01059799|1202618|P1|Overall Study|Protocol Violation|3
356904|NCT01059799|1202617|P2|Overall Study|Lack of Efficacy|0
356905|NCT01059799|1202618|P1|Overall Study|Lack of Efficacy|1
356906|NCT01059799|1202617|P2|Overall Study|Adverse Event|3
356907|NCT01059799|1202618|P1|Overall Study|Adverse Event|2
356908|NCT01059773|1202632|P2|Overall Study|Other|3
356909|NCT01059773|1202633|P1|Overall Study|Other|1
356910|NCT01059773|1202632|P2|Overall Study|Ineligible follow TB screening criteria|1
356911|NCT01059773|1202633|P1|Overall Study|Ineligible follow TB screening criteria|0
356912|NCT01059773|1202632|P2|Overall Study|Malignancy including squamous cell skin|1
356913|NCT01059773|1202633|P1|Overall Study|Malignancy including squamous cell skin|0
356914|NCT01059773|1202632|P2|Overall Study|Death|1
356915|NCT01059773|1202633|P1|Overall Study|Death|0
356916|NCT01059773|1202632|P2|Overall Study|Lack of Efficacy|3
356917|NCT01059773|1202633|P1|Overall Study|Lack of Efficacy|3
356918|NCT01059773|1202632|P2|Overall Study|Physician Decision|4
356919|NCT01059773|1202633|P1|Overall Study|Physician Decision|5
356920|NCT01059773|1202632|P2|Overall Study|Protocol Violation|2
356921|NCT01059773|1202633|P1|Overall Study|Protocol Violation|6
356922|NCT01059773|1202632|P2|Overall Study|Pregnancy|1
356923|NCT01059773|1202633|P1|Overall Study|Pregnancy|1
356924|NCT01059773|1202632|P2|Overall Study|Lost to Follow-up|1
356925|NCT01059773|1202633|P1|Overall Study|Lost to Follow-up|1
356926|NCT01059773|1202632|P2|Overall Study|Withdrawal by Subject|5
356927|NCT01059773|1202633|P1|Overall Study|Withdrawal by Subject|1
356928|NCT01059773|1202632|P2|Overall Study|Adverse Event|2
356929|NCT01059773|1202633|P1|Overall Study|Adverse Event|2
356930|NCT01059643|1202772|P1|Overall Study|Physician Decision|1
356931|NCT01059643|1202772|P1|Overall Study|Withdrawal by Subject|2
356932|NCT01059643|1202772|P1|Overall Study|Adverse Event|3
356933|NCT01059630|1202787|P2|Maintenance Period (up to 2 Years)|Other|3
356934|NCT01059630|1202788|P1|Maintenance Period (up to 2 Years)|Other|0
356935|NCT01059630|1202787|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
356936|NCT01059630|1202788|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
356937|NCT01059630|1202787|P2|Maintenance Period (up to 2 Years)|Death|2
356938|NCT01059630|1202788|P1|Maintenance Period (up to 2 Years)|Death|0
356939|NCT01059630|1202787|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
356940|NCT01059630|1202788|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
356941|NCT01059630|1202787|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
356942|NCT01059630|1202788|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
356943|NCT01059630|1202787|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
356944|NCT01059630|1202788|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
356945|NCT01059630|1202787|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
356946|NCT01059630|1202788|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
356947|NCT01059630|1202787|P2|Induction Period (6 Months)|Randomized but not Treated|0
356948|NCT01059630|1202788|P1|Induction Period (6 Months)|Randomized but not Treated|4
356949|NCT01059630|1202787|P2|Induction Period (6 Months)|Other|0
356950|NCT01059630|1202788|P1|Induction Period (6 Months)|Other|1
356951|NCT01059630|1202787|P2|Induction Period (6 Months)|Physician Decision|4
356952|NCT01059630|1202788|P1|Induction Period (6 Months)|Physician Decision|2
356953|NCT01059630|1202787|P2|Induction Period (6 Months)|Death|2
356954|NCT01059630|1202788|P1|Induction Period (6 Months)|Death|2
356955|NCT01059630|1202787|P2|Induction Period (6 Months)|Withdrawal by Subject|2
356956|NCT01059630|1202788|P1|Induction Period (6 Months)|Withdrawal by Subject|7
356957|NCT01059630|1202787|P2|Induction Period (6 Months)|Progressive Disease|9
356958|NCT01059630|1202788|P1|Induction Period (6 Months)|Progressive Disease|14
356959|NCT01059630|1202787|P2|Induction Period (6 Months)|Adverse Event|15
356960|NCT01059630|1202788|P1|Induction Period (6 Months)|Adverse Event|30
356961|NCT01059630|1202787|P2|Induction Period (6 Months)|Induction ongoing|6
356962|NCT01059630|1202788|P1|Induction Period (6 Months)|Induction ongoing|13
356963|NCT01059617|1202848|P4|Overall Study|Other|6
356964|NCT01059617|1202849|P3|Overall Study|Other|8
356965|NCT01059617|1202850|P2|Overall Study|Other|1
356966|NCT01059617|1202851|P1|Overall Study|Other|7
356967|NCT01059565|1203021|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
356968|NCT01059565|1203022|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
356969|NCT01059565|1203021|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
356970|NCT01059565|1203022|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
356971|NCT01059565|1203021|P2|24-Week Open-Label Phase|Subject noncompliance|0
356972|NCT01059565|1203022|P1|24-Week Open-Label Phase|Subject noncompliance|1
356973|NCT01059565|1203021|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
356974|NCT01059565|1203022|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
356975|NCT01059565|1203021|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
356976|NCT01059565|1203022|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
356977|NCT01059565|1203021|P2|24-Week Open-Label Phase|Adverse Event|0
356978|NCT01059565|1203022|P1|24-Week Open-Label Phase|Adverse Event|2
356979|NCT01059565|1203021|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
356980|NCT01059565|1203022|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
356981|NCT01059565|1203021|P2|24-Week Randomized Phase|Lost to Follow-up|1
356982|NCT01059565|1203022|P1|24-Week Randomized Phase|Lost to Follow-up|0
356983|NCT01059565|1203021|P2|24-Week Randomized Phase|Withdrawal by Subject|1
356984|NCT01059565|1203022|P1|24-Week Randomized Phase|Withdrawal by Subject|3
356985|NCT01059565|1203021|P2|24-Week Randomized Phase|Adverse Event|0
356986|NCT01059565|1203022|P1|24-Week Randomized Phase|Adverse Event|5
356987|NCT01059565|1203021|P2|24-Week Randomized Phase|Randomized but not treated|0
356988|NCT01059565|1203022|P1|24-Week Randomized Phase|Randomized but not treated|1
356989|NCT01059526|1203058|P2|Overall Study|Patient found to be dermatographic|0
356990|NCT01059526|1203059|P1|Overall Study|Patient found to be dermatographic|1
356991|NCT01059526|1203058|P2|Overall Study|Lost to Follow-up|1
356992|NCT01059526|1203059|P1|Overall Study|Lost to Follow-up|4
356993|NCT01059526|1203058|P2|Overall Study|Withdrawal by Subject|1
356994|NCT01059526|1203059|P1|Overall Study|Withdrawal by Subject|3
356995|NCT01059526|1203058|P2|Overall Study|Protocol Violation|1
356996|NCT01059526|1203059|P1|Overall Study|Protocol Violation|0
356997|NCT01059526|1203058|P2|Overall Study|Adverse Event|2
356998|NCT01059526|1203059|P1|Overall Study|Adverse Event|2
356999|NCT01059526|1203058|P2|Overall Study|Patient enrolled but not treated|17
357000|NCT01059526|1203059|P1|Overall Study|Patient enrolled but not treated|20
357001|NCT01059344|1203069|P2|Overall Study|Other|6
357002|NCT01059344|1203070|P1|Overall Study|Other|3
357003|NCT01059344|1203069|P2|Overall Study|Lost to Follow-up|1
357004|NCT01059344|1203070|P1|Overall Study|Lost to Follow-up|1
357005|NCT01059344|1203069|P2|Overall Study|Withdrawal by Subject|9
357006|NCT01059344|1203070|P1|Overall Study|Withdrawal by Subject|6
357007|NCT01059344|1203069|P2|Overall Study|Adverse Event|30
357008|NCT01059344|1203070|P1|Overall Study|Adverse Event|12
357009|NCT01059175|1203094|P2|Overall Study|Lost to Follow-up|1
357010|NCT01059175|1203095|P1|Overall Study|Lost to Follow-up|0
357011|NCT01059175|1203094|P2|Overall Study|Adverse Event|2
357012|NCT01059175|1203095|P1|Overall Study|Adverse Event|4
357013|NCT01059175|1203094|P2|Overall Study|Death|17
357014|NCT01059175|1203095|P1|Overall Study|Death|17
357015|NCT01059071|1203117|P4|Overall Study|Physician Decision|1
357016|NCT01059071|1203118|P3|Overall Study|Physician Decision|0
357017|NCT01059071|1203119|P2|Overall Study|Physician Decision|0
357018|NCT01059071|1203120|P1|Overall Study|Physician Decision|0
357019|NCT01059071|1203117|P4|Overall Study|Withdrawal by Subject|2
357020|NCT01059071|1203118|P3|Overall Study|Withdrawal by Subject|0
357021|NCT01059071|1203119|P2|Overall Study|Withdrawal by Subject|0
357022|NCT01059071|1203120|P1|Overall Study|Withdrawal by Subject|1
357023|NCT01059071|1203117|P4|Overall Study|Lack of Efficacy|3
357024|NCT01059071|1203118|P3|Overall Study|Lack of Efficacy|2
357025|NCT01059071|1203119|P2|Overall Study|Lack of Efficacy|4
357026|NCT01059071|1203120|P1|Overall Study|Lack of Efficacy|1
357027|NCT01058863|1203147|P1|Overall Study|Randomized in error|1
357028|NCT01058863|1203147|P1|Overall Study|Sponsor requested withdrawal|1
357029|NCT01058863|1203147|P1|Overall Study|Withdrawal by Subject|1
357030|NCT01058863|1203147|P1|Overall Study|Lost to Follow-up|1
357031|NCT01058668|1203168|P3|Double-blind Treatment Phase|Other Unspecified|0
357032|NCT01058668|1203169|P2|Double-blind Treatment Phase|Other Unspecified|1
357033|NCT01058668|1203170|P1|Double-blind Treatment Phase|Other Unspecified|1
357034|NCT01058668|1203168|P3|Double-blind Treatment Phase|Lost to Follow-up|1
357035|NCT01058668|1203169|P2|Double-blind Treatment Phase|Lost to Follow-up|1
357036|NCT01058668|1203170|P1|Double-blind Treatment Phase|Lost to Follow-up|0
357037|NCT01058668|1203168|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
357038|NCT01058668|1203169|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
357039|NCT01058668|1203170|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
357040|NCT01058668|1203168|P3|Double-blind Treatment Phase|Protocol Violation|2
357041|NCT01058668|1203169|P2|Double-blind Treatment Phase|Protocol Violation|1
357042|NCT01058668|1203170|P1|Double-blind Treatment Phase|Protocol Violation|1
357043|NCT01058668|1203168|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
357044|NCT01058668|1203169|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
357045|NCT01058668|1203170|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
357046|NCT01058668|1203168|P3|Double-blind Treatment Phase|Adverse Event|25
357047|NCT01058668|1203169|P2|Double-blind Treatment Phase|Adverse Event|15
357048|NCT01058668|1203170|P1|Double-blind Treatment Phase|Adverse Event|8
357049|NCT01058655|1203185|P4|Overall Study|Other|4
357050|NCT01058655|1203186|P3|Overall Study|Other|0
357051|NCT01058655|1203187|P2|Overall Study|Other|0
357052|NCT01058655|1203188|P1|Overall Study|Other|0
357053|NCT01058655|1203185|P4|Overall Study|Disease Progression|24
357054|NCT01058655|1203186|P3|Overall Study|Disease Progression|4
357055|NCT01058655|1203187|P2|Overall Study|Disease Progression|2
357056|NCT01058655|1203188|P1|Overall Study|Disease Progression|1
357057|NCT01058655|1203185|P4|Overall Study|Death|0
357058|NCT01058655|1203186|P3|Overall Study|Death|1
357059|NCT01058655|1203187|P2|Overall Study|Death|1
357060|NCT01058655|1203188|P1|Overall Study|Death|0
357061|NCT01058655|1203185|P4|Overall Study|Clinical Progression (non-RECIST)|7
357062|NCT01058655|1203186|P3|Overall Study|Clinical Progression (non-RECIST)|0
357063|NCT01058655|1203187|P2|Overall Study|Clinical Progression (non-RECIST)|0
357064|NCT01058655|1203188|P1|Overall Study|Clinical Progression (non-RECIST)|1
357065|NCT01058655|1203185|P4|Overall Study|Symptomatic Deterioration|1
357066|NCT01058655|1203186|P3|Overall Study|Symptomatic Deterioration|0
357067|NCT01058655|1203187|P2|Overall Study|Symptomatic Deterioration|0
357068|NCT01058655|1203188|P1|Overall Study|Symptomatic Deterioration|0
357069|NCT01058655|1203185|P4|Overall Study|Prolonged Treatment Delay|2
357070|NCT01058655|1203186|P3|Overall Study|Prolonged Treatment Delay|0
357071|NCT01058655|1203187|P2|Overall Study|Prolonged Treatment Delay|0
357072|NCT01058655|1203188|P1|Overall Study|Prolonged Treatment Delay|0
357073|NCT01058655|1203185|P4|Overall Study|Withdrawal by Subject|4
357074|NCT01058655|1203186|P3|Overall Study|Withdrawal by Subject|3
357075|NCT01058655|1203187|P2|Overall Study|Withdrawal by Subject|0
357076|NCT01058655|1203188|P1|Overall Study|Withdrawal by Subject|1
357077|NCT01058642|1203206|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
357078|NCT01058642|1203207|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
357079|NCT01058642|1203208|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
357080|NCT01058642|1203209|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
357081|NCT01058642|1203206|P4|Treatment Period 1|Protocol Violation|1
357082|NCT01058642|1203207|P3|Treatment Period 1|Protocol Violation|0
357083|NCT01058642|1203208|P2|Treatment Period 1|Protocol Violation|0
357084|NCT01058642|1203209|P1|Treatment Period 1|Protocol Violation|0
357085|NCT01058642|1203206|P4|Treatment Period 1|Lack of Efficacy|1
357086|NCT01058642|1203207|P3|Treatment Period 1|Lack of Efficacy|0
357087|NCT01058642|1203208|P2|Treatment Period 1|Lack of Efficacy|0
357088|NCT01058642|1203209|P1|Treatment Period 1|Lack of Efficacy|0
357089|NCT01058642|1203206|P4|Treatment Period 1|Withdrawal by Subject|0
357090|NCT01058642|1203207|P3|Treatment Period 1|Withdrawal by Subject|0
357091|NCT01058642|1203208|P2|Treatment Period 1|Withdrawal by Subject|0
357092|NCT01058642|1203209|P1|Treatment Period 1|Withdrawal by Subject|1
357093|NCT01058642|1203206|P4|Treatment Period 1|Physician Decision|0
357094|NCT01058642|1203207|P3|Treatment Period 1|Physician Decision|1
357095|NCT01058642|1203208|P2|Treatment Period 1|Physician Decision|0
357096|NCT01058642|1203209|P1|Treatment Period 1|Physician Decision|0
357097|NCT01058642|1203206|P4|Treatment Period 1|Adverse Event|0
357098|NCT01058642|1203207|P3|Treatment Period 1|Adverse Event|1
357099|NCT01058642|1203208|P2|Treatment Period 1|Adverse Event|1
357100|NCT01058642|1203209|P1|Treatment Period 1|Adverse Event|0
357101|NCT01058421|1203219|P2|6 Month Outcomes|Remained in Other Facility|3
357102|NCT01058421|1203220|P1|6 Month Outcomes|Remained in Other Facility|1
357103|NCT01058421|1203219|P2|6 Month Outcomes|Lost to Follow-up|21
357104|NCT01058421|1203220|P1|6 Month Outcomes|Lost to Follow-up|16
357105|NCT01058421|1203219|P2|6 Month Outcomes|Death|2
357106|NCT01058421|1203220|P1|6 Month Outcomes|Death|2
357107|NCT01058421|1203219|P2|3 Month Outcomes|Remained in Other Facility|8
357108|NCT01058421|1203220|P1|3 Month Outcomes|Remained in Other Facility|5
357109|NCT01058421|1203219|P2|3 Month Outcomes|Remained in Hospital|2
357110|NCT01058421|1203220|P1|3 Month Outcomes|Remained in Hospital|0
357111|NCT01058421|1203219|P2|3 Month Outcomes|Lost to Follow-up|11
357112|NCT01058421|1203220|P1|3 Month Outcomes|Lost to Follow-up|12
357113|NCT01058421|1203219|P2|3 Month Outcomes|Death|5
357114|NCT01058421|1203220|P1|3 Month Outcomes|Death|3
357115|NCT01058421|1203219|P2|1 Month Outcomes|Remained in Other Facility|17
357116|NCT01058421|1203220|P1|1 Month Outcomes|Remained in Other Facility|16
357117|NCT01058421|1203219|P2|1 Month Outcomes|Remained in Hospital|12
357118|NCT01058421|1203220|P1|1 Month Outcomes|Remained in Hospital|5
357119|NCT01058421|1203219|P2|1 Month Outcomes|Lost to Follow-up|7
357120|NCT01058421|1203220|P1|1 Month Outcomes|Lost to Follow-up|8
357121|NCT01058421|1203219|P2|1 Month Outcomes|Death|6
357122|NCT01058421|1203220|P1|1 Month Outcomes|Death|10
357123|NCT01058356|1203242|P1|Overall Study|Lost to Follow-up|4
357124|NCT01058356|1203242|P1|Overall Study|Withdrawal by Subject|21
357125|NCT01058356|1203242|P1|Overall Study|Administration of contraindicated drugs|12
357126|NCT01058356|1203242|P1|Overall Study|Adverse Event|5
357127|NCT01058304|1203249|P2|Overall Study|Developed exclusion criterion|12
357128|NCT01058304|1203250|P1|Overall Study|Developed exclusion criterion|6
357129|NCT01058304|1203249|P2|Overall Study|Lost to Follow-up|16
357130|NCT01058304|1203250|P1|Overall Study|Lost to Follow-up|13
357131|NCT01058304|1203249|P2|Overall Study|Withdrawal by Subject|5
357132|NCT01058304|1203250|P1|Overall Study|Withdrawal by Subject|8
357133|NCT01058265|1203260|P2|Overall Study|Lost to Follow-up|12
357134|NCT01058265|1203261|P1|Overall Study|Lost to Follow-up|11
357135|NCT01058096|1203280|P2|Double-blind Treatment Phase|Other Unspecified|0
357136|NCT01058096|1203281|P1|Double-blind Treatment Phase|Other Unspecified|2
357137|NCT01058096|1203280|P2|Double-blind Treatment Phase|Lost to Follow-up|1
357138|NCT01058096|1203281|P1|Double-blind Treatment Phase|Lost to Follow-up|0
357139|NCT01058096|1203280|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
357140|NCT01058096|1203281|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
357141|NCT01058096|1203280|P2|Double-blind Treatment Phase|Protocol Violation|1
357142|NCT01058096|1203281|P1|Double-blind Treatment Phase|Protocol Violation|2
357143|NCT01058096|1203280|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
357144|NCT01058096|1203281|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
357145|NCT01058096|1203280|P2|Double-blind Treatment Phase|Adverse Event|15
357146|NCT01058096|1203281|P1|Double-blind Treatment Phase|Adverse Event|11
357147|NCT01058005|1203297|P3|Overall Study|Reason Missing|1
357148|NCT01058005|1203298|P2|Overall Study|Reason Missing|3
357149|NCT01058005|1203299|P1|Overall Study|Reason Missing|5
357150|NCT01058005|1203297|P3|Overall Study|Withdrawn Due to Study Termination|7
357151|NCT01058005|1203298|P2|Overall Study|Withdrawn Due to Study Termination|13
357152|NCT01058005|1203299|P1|Overall Study|Withdrawn Due to Study Termination|27
357153|NCT01058005|1203297|P3|Overall Study|Withdrawal by Subject|11
357154|NCT01058005|1203298|P2|Overall Study|Withdrawal by Subject|5
357155|NCT01058005|1203299|P1|Overall Study|Withdrawal by Subject|4
357156|NCT01058005|1203297|P3|Overall Study|Physician Decision|0
357157|NCT01058005|1203298|P2|Overall Study|Physician Decision|2
357158|NCT01058005|1203299|P1|Overall Study|Physician Decision|2
357159|NCT01058005|1203297|P3|Overall Study|Adverse Event|1
357160|NCT01058005|1203298|P2|Overall Study|Adverse Event|2
357161|NCT01058005|1203299|P1|Overall Study|Adverse Event|0
357162|NCT01057862|1203334|P2|Overall Study|Withdrawal by Subject|2
357163|NCT01057862|1203335|P1|Overall Study|Withdrawal by Subject|1
357164|NCT01057810|1203345|P2|Overall Study|Other|14
357165|NCT01057810|1203346|P1|Overall Study|Other|7
357166|NCT01057810|1203345|P2|Overall Study|No longer met study criteria|1
357167|NCT01057810|1203346|P1|Overall Study|No longer met study criteria|0
357168|NCT01057810|1203345|P2|Overall Study|Poor/non-compliance|1
357169|NCT01057810|1203346|P1|Overall Study|Poor/non-compliance|0
357170|NCT01057810|1203345|P2|Overall Study|Maximum clinical benefit|5
357171|NCT01057810|1203346|P1|Overall Study|Maximum clinical benefit|5
357172|NCT01057810|1203345|P2|Overall Study|Death|12
357173|NCT01057810|1203346|P1|Overall Study|Death|2
357174|NCT01057810|1203345|P2|Overall Study|Withdrawal by Subject|25
357175|NCT01057810|1203346|P1|Overall Study|Withdrawal by Subject|10
357176|NCT01057810|1203345|P2|Overall Study|Adverse event unrelated to study drug|29
357177|NCT01057810|1203346|P1|Overall Study|Adverse event unrelated to study drug|13
357178|NCT01057810|1203345|P2|Overall Study|Study drug toxicity|114
357179|NCT01057810|1203346|P1|Overall Study|Study drug toxicity|5
357180|NCT01057810|1203345|P2|Overall Study|Disease progression|197
357181|NCT01057810|1203346|P1|Overall Study|Disease progression|156
357182|NCT01057693|1203362|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
357183|NCT01057693|1203363|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
357184|NCT01057693|1203364|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
357185|NCT01057693|1203362|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
357186|NCT01057693|1203363|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
357187|NCT01057693|1203364|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
357188|NCT01057693|1203362|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
357189|NCT01057693|1203363|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
357190|NCT01057693|1203364|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
357191|NCT01057693|1203362|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
357192|NCT01057693|1203363|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
357193|NCT01057693|1203364|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
357194|NCT01057693|1203362|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
357195|NCT01057693|1203363|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
357196|NCT01057693|1203364|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
357197|NCT01057693|1203362|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
357198|NCT01057693|1203363|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
357199|NCT01057693|1203364|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
357200|NCT01057693|1203362|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
357201|NCT01057693|1203363|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
357202|NCT01057693|1203364|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
357203|NCT01057693|1203362|P3|Between Single-Blind and Double-Blind|Other|0
357204|NCT01057693|1203363|P2|Between Single-Blind and Double-Blind|Other|0
357205|NCT01057693|1203364|P1|Between Single-Blind and Double-Blind|Other|6
357206|NCT01057693|1203362|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
357207|NCT01057693|1203363|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
357208|NCT01057693|1203364|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
357209|NCT01057693|1203362|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
357210|NCT01057693|1203363|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
357211|NCT01057693|1203364|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
357212|NCT01057693|1203362|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
357213|NCT01057693|1203363|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
357214|NCT01057693|1203364|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
357215|NCT01057693|1203362|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
357216|NCT01057693|1203363|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
357389|NCT01056276|1203833|P1|Maintenance Therapy|Physician Decision|0
357217|NCT01057693|1203364|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
357218|NCT01057693|1203362|P3|Between Single-Blind and Double-Blind|Adverse Event|0
357219|NCT01057693|1203363|P2|Between Single-Blind and Double-Blind|Adverse Event|0
357220|NCT01057693|1203364|P1|Between Single-Blind and Double-Blind|Adverse Event|5
357221|NCT01057693|1203362|P3|Single-Blind Phase (Up to Week 6)|Other|0
357222|NCT01057693|1203363|P2|Single-Blind Phase (Up to Week 6)|Other|0
357223|NCT01057693|1203364|P1|Single-Blind Phase (Up to Week 6)|Other|2
357224|NCT01057693|1203362|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
357225|NCT01057693|1203363|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
357226|NCT01057693|1203364|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
357227|NCT01057693|1203362|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
357228|NCT01057693|1203363|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
357229|NCT01057693|1203364|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
357230|NCT01057693|1203362|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
357231|NCT01057693|1203363|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
357232|NCT01057693|1203364|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
357233|NCT01057693|1203362|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
357234|NCT01057693|1203363|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
357235|NCT01057693|1203364|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
357236|NCT01057693|1203362|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
357237|NCT01057693|1203363|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
357238|NCT01057693|1203364|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
357239|NCT01057589|1203410|P1|Overall Study|Lost to Follow-up|1
357240|NCT01057589|1203410|P1|Overall Study|Death|8
357241|NCT01057589|1203410|P1|Overall Study|Sponsor Decision|1
357242|NCT01057589|1203410|P1|Overall Study|Withdrawal by Subject|3
357243|NCT01057589|1203410|P1|Overall Study|Physician Decision|8
357244|NCT01057589|1203410|P1|Overall Study|Adverse Event|10
357245|NCT01057589|1203410|P1|Overall Study|Disease Progression|35
357246|NCT01057433|1203419|P1|Overall Study|Adverse Event|1
357247|NCT01057394|1203423|P2|Overall Study|Not eligible|2
357248|NCT01057394|1203424|P1|Overall Study|Not eligible|0
357249|NCT01057251|1203434|P2|Overall Study|Other Reason|1
357250|NCT01057251|1203435|P1|Overall Study|Other Reason|1
357251|NCT01057251|1203434|P2|Overall Study|Lost to Follow-up|6
357252|NCT01057251|1203435|P1|Overall Study|Lost to Follow-up|7
357253|NCT01057251|1203434|P2|Overall Study|Withdrawal by Subject|5
357254|NCT01057251|1203435|P1|Overall Study|Withdrawal by Subject|4
357255|NCT01057251|1203434|P2|Overall Study|Protocol Violation|2
357256|NCT01057251|1203435|P1|Overall Study|Protocol Violation|6
357257|NCT01057251|1203434|P2|Overall Study|Lack of Efficacy|11
357258|NCT01057251|1203435|P1|Overall Study|Lack of Efficacy|2
357259|NCT01057251|1203434|P2|Overall Study|Adverse Event|2
357260|NCT01057251|1203435|P1|Overall Study|Adverse Event|4
357261|NCT01057251|1203434|P2|Overall Study|Did not meet InclusionExclusion criteria|2
357262|NCT01057251|1203435|P1|Overall Study|Did not meet InclusionExclusion criteria|4
357263|NCT01056822|1203513|P2|Overall Study|Lost to Follow-up|0
357264|NCT01056822|1203514|P1|Overall Study|Lost to Follow-up|1
357265|NCT01056822|1203513|P2|Overall Study|Withdrawal by Subject|1
357266|NCT01056822|1203514|P1|Overall Study|Withdrawal by Subject|1
357267|NCT01056822|1203513|P2|Overall Study|Protocol Violation|5
357268|NCT01056822|1203514|P1|Overall Study|Protocol Violation|6
357269|NCT01056822|1203513|P2|Overall Study|Adverse Event|1
357270|NCT01056822|1203514|P1|Overall Study|Adverse Event|0
357271|NCT01056718|1203563|P1|Overall Study|Ischemia on baseline stress test|1
357272|NCT01056718|1203563|P1|Overall Study|Withdrawal by Subject|2
357273|NCT01056653|1203596|P3|Overall Study|Lost to Follow-up|2
357274|NCT01056653|1203597|P2|Overall Study|Lost to Follow-up|0
357275|NCT01056653|1203598|P1|Overall Study|Lost to Follow-up|0
357276|NCT01056640|1203614|P2|Overall Study|Death|4
357277|NCT01056640|1203615|P1|Overall Study|Death|15
357278|NCT01056640|1203614|P2|Overall Study|Withdrawal by Subject|8
357279|NCT01056640|1203615|P1|Overall Study|Withdrawal by Subject|11
357280|NCT01056523|1203627|P7|Overall Study|Death|1
357281|NCT01056523|1203628|P6|Overall Study|Death|0
357282|NCT01056523|1203629|P5|Overall Study|Death|0
357283|NCT01056523|1203630|P4|Overall Study|Death|3
357284|NCT01056523|1203631|P3|Overall Study|Death|2
357285|NCT01056523|1203632|P2|Overall Study|Death|0
357286|NCT01056523|1203633|P1|Overall Study|Death|1
357287|NCT01056510|1203643|P2|Overall Study|Missing|1
357288|NCT01056510|1203644|P1|Overall Study|Missing|0
357289|NCT01056510|1203643|P2|Overall Study|Not Specified|12
357290|NCT01056510|1203644|P1|Overall Study|Not Specified|10
357291|NCT01056510|1203643|P2|Overall Study|Lost to Follow-up|6
357292|NCT01056510|1203644|P1|Overall Study|Lost to Follow-up|5
357293|NCT01056510|1203643|P2|Overall Study|Physician Decision|5
357294|NCT01056510|1203644|P1|Overall Study|Physician Decision|4
357295|NCT01056510|1203643|P2|Overall Study|Noncompliance|3
357296|NCT01056510|1203644|P1|Overall Study|Noncompliance|1
357297|NCT01056510|1203643|P2|Overall Study|Death|34
357298|NCT01056510|1203644|P1|Overall Study|Death|29
357299|NCT01056510|1203643|P2|Overall Study|Withdrawal by Subject|2
357300|NCT01056510|1203644|P1|Overall Study|Withdrawal by Subject|4
357301|NCT01056510|1203643|P2|Overall Study|Dropout Before Start of Treatment|1
357302|NCT01056510|1203644|P1|Overall Study|Dropout Before Start of Treatment|1
357303|NCT01056484|1203690|P2|Follow up - Non-randomized|Withdrawal by Subject|2
357304|NCT01056484|1203691|P1|Follow up - Non-randomized|Withdrawal by Subject|0
357305|NCT01056484|1203690|P2|Randomized Controlled Trial|Physician Decision|0
357306|NCT01056484|1203691|P1|Randomized Controlled Trial|Physician Decision|1
357307|NCT01056484|1203690|P2|Randomized Controlled Trial|Withdrawal by Subject|1
357308|NCT01056484|1203691|P1|Randomized Controlled Trial|Withdrawal by Subject|6
357309|NCT01056380|1203707|P2|Overall Study|Lost to Follow-up|3
357310|NCT01056380|1203708|P1|Overall Study|Lost to Follow-up|2
357311|NCT01056341|1203735|P5|Overall Study|Other reasons|5
357312|NCT01056341|1203736|P4|Overall Study|Other reasons|9
357313|NCT01056341|1203737|P3|Overall Study|Other reasons|8
357314|NCT01056341|1203738|P2|Overall Study|Other reasons|4
357315|NCT01056341|1203739|P1|Overall Study|Other reasons|4
357316|NCT01056341|1203735|P5|Overall Study|Lack of Efficacy|9
357317|NCT01056341|1203736|P4|Overall Study|Lack of Efficacy|25
357318|NCT01056341|1203737|P3|Overall Study|Lack of Efficacy|7
357319|NCT01056341|1203738|P2|Overall Study|Lack of Efficacy|30
357320|NCT01056341|1203739|P1|Overall Study|Lack of Efficacy|32
357321|NCT01056341|1203735|P5|Overall Study|Treatment Intolerance|0
357322|NCT01056341|1203736|P4|Overall Study|Treatment Intolerance|2
357323|NCT01056341|1203737|P3|Overall Study|Treatment Intolerance|0
357324|NCT01056341|1203738|P2|Overall Study|Treatment Intolerance|2
357325|NCT01056341|1203739|P1|Overall Study|Treatment Intolerance|0
357326|NCT01056289|1203812|P4|Double-blind Phase|Physician Decision|0
357327|NCT01056289|1203813|P3|Double-blind Phase|Physician Decision|1
357328|NCT01056289|1203814|P2|Double-blind Phase|Physician Decision|0
357329|NCT01056289|1203815|P1|Double-blind Phase|Physician Decision|0
357330|NCT01056289|1203812|P4|Double-blind Phase|Discontinuation symptom|2
357331|NCT01056289|1203813|P3|Double-blind Phase|Discontinuation symptom|2
357332|NCT01056289|1203814|P2|Double-blind Phase|Discontinuation symptom|1
357333|NCT01056289|1203815|P1|Double-blind Phase|Discontinuation symptom|0
357334|NCT01056289|1203812|P4|Double-blind Phase|Withdrawal by Subject|2
357335|NCT01056289|1203813|P3|Double-blind Phase|Withdrawal by Subject|4
357336|NCT01056289|1203814|P2|Double-blind Phase|Withdrawal by Subject|0
357337|NCT01056289|1203815|P1|Double-blind Phase|Withdrawal by Subject|0
357338|NCT01056289|1203812|P4|Double-blind Phase|Protocol Violation|1
357339|NCT01056289|1203813|P3|Double-blind Phase|Protocol Violation|1
357340|NCT01056289|1203814|P2|Double-blind Phase|Protocol Violation|0
357341|NCT01056289|1203815|P1|Double-blind Phase|Protocol Violation|0
357342|NCT01056289|1203812|P4|Double-blind Phase|Other|2
357343|NCT01056289|1203813|P3|Double-blind Phase|Other|1
357344|NCT01056289|1203814|P2|Double-blind Phase|Other|0
357345|NCT01056289|1203815|P1|Double-blind Phase|Other|0
357346|NCT01056289|1203812|P4|Double-blind Phase|Lost to Follow-up|2
357347|NCT01056289|1203813|P3|Double-blind Phase|Lost to Follow-up|2
357348|NCT01056289|1203814|P2|Double-blind Phase|Lost to Follow-up|2
357349|NCT01056289|1203815|P1|Double-blind Phase|Lost to Follow-up|0
357350|NCT01056289|1203812|P4|Double-blind Phase|Adverse Event|1
357351|NCT01056289|1203813|P3|Double-blind Phase|Adverse Event|2
357352|NCT01056289|1203814|P2|Double-blind Phase|Adverse Event|1
357353|NCT01056289|1203815|P1|Double-blind Phase|Adverse Event|0
357354|NCT01056289|1203812|P4|Open-label Phase|Not randomized to Double-blind phase|0
357355|NCT01056289|1203813|P3|Open-label Phase|Not randomized to Double-blind phase|0
357356|NCT01056289|1203814|P2|Open-label Phase|Not randomized to Double-blind phase|0
357357|NCT01056289|1203815|P1|Open-label Phase|Not randomized to Double-blind phase|1
357358|NCT01056289|1203812|P4|Open-label Phase|Lack of Efficacy|0
357359|NCT01056289|1203813|P3|Open-label Phase|Lack of Efficacy|0
357360|NCT01056289|1203814|P2|Open-label Phase|Lack of Efficacy|0
357361|NCT01056289|1203815|P1|Open-label Phase|Lack of Efficacy|18
357362|NCT01056289|1203812|P4|Open-label Phase|Withdrawal by Subject|0
357363|NCT01056289|1203813|P3|Open-label Phase|Withdrawal by Subject|0
357364|NCT01056289|1203814|P2|Open-label Phase|Withdrawal by Subject|0
357365|NCT01056289|1203815|P1|Open-label Phase|Withdrawal by Subject|26
357366|NCT01056289|1203812|P4|Open-label Phase|Protocol Violation|0
357367|NCT01056289|1203813|P3|Open-label Phase|Protocol Violation|0
357368|NCT01056289|1203814|P2|Open-label Phase|Protocol Violation|0
357369|NCT01056289|1203815|P1|Open-label Phase|Protocol Violation|6
357370|NCT01056289|1203812|P4|Open-label Phase|Other|0
357371|NCT01056289|1203813|P3|Open-label Phase|Other|0
357372|NCT01056289|1203814|P2|Open-label Phase|Other|0
357373|NCT01056289|1203815|P1|Open-label Phase|Other|9
357374|NCT01056289|1203812|P4|Open-label Phase|Lost to Follow-up|0
357375|NCT01056289|1203813|P3|Open-label Phase|Lost to Follow-up|0
357376|NCT01056289|1203814|P2|Open-label Phase|Lost to Follow-up|0
357377|NCT01056289|1203815|P1|Open-label Phase|Lost to Follow-up|30
357378|NCT01056289|1203812|P4|Open-label Phase|Adverse Event|0
357379|NCT01056289|1203813|P3|Open-label Phase|Adverse Event|0
357380|NCT01056289|1203814|P2|Open-label Phase|Adverse Event|0
357381|NCT01056289|1203815|P1|Open-label Phase|Adverse Event|29
357382|NCT01056276|1203832|P2|Maintenance Therapy|Continuing maintenance therapy|14
357383|NCT01056276|1203833|P1|Maintenance Therapy|Continuing maintenance therapy|0
357384|NCT01056276|1203832|P2|Maintenance Therapy|Intercurrent Illness|1
357385|NCT01056276|1203833|P1|Maintenance Therapy|Intercurrent Illness|0
357386|NCT01056276|1203832|P2|Maintenance Therapy|Withdrawal by Subject|1
357387|NCT01056276|1203833|P1|Maintenance Therapy|Withdrawal by Subject|0
357388|NCT01056276|1203832|P2|Maintenance Therapy|Physician Decision|1
357390|NCT01056276|1203832|P2|Maintenance Therapy|Progressive Disease|9
357391|NCT01056276|1203833|P1|Maintenance Therapy|Progressive Disease|0
357392|NCT01056276|1203832|P2|Maintenance Therapy|Toxicity|2
357393|NCT01056276|1203833|P1|Maintenance Therapy|Toxicity|0
357394|NCT01056276|1203832|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
357395|NCT01056276|1203833|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
357396|NCT01056276|1203832|P2|Treatment Period-Cycles 1-8|Death|1
357397|NCT01056276|1203833|P1|Treatment Period-Cycles 1-8|Death|3
357398|NCT01056276|1203832|P2|Treatment Period-Cycles 1-8|Physician Decision|0
357399|NCT01056276|1203833|P1|Treatment Period-Cycles 1-8|Physician Decision|3
357400|NCT01056276|1203832|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
357401|NCT01056276|1203833|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
357402|NCT01056276|1203832|P2|Treatment Period-Cycles 1-8|Disease Progression|2
357403|NCT01056276|1203833|P1|Treatment Period-Cycles 1-8|Disease Progression|2
357404|NCT01056276|1203832|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
357405|NCT01056276|1203833|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
357406|NCT01056276|1203832|P2|Treatment Period-Cycles 1-8|Toxicity|1
357407|NCT01056276|1203833|P1|Treatment Period-Cycles 1-8|Toxicity|2
357408|NCT01056263|1203847|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
357409|NCT01056263|1203847|P1|Overall Study|Objective progression or relapse|1
357410|NCT01056263|1203847|P1|Overall Study|Neoplasm progression|1
357411|NCT01056263|1203847|P1|Overall Study|Progressive disease|2
357412|NCT01056263|1203847|P1|Overall Study|Lack of Efficacy|29
357413|NCT01056263|1203847|P1|Overall Study|Withdrawal by Subject|1
357414|NCT01056263|1203847|P1|Overall Study|Death|1
357415|NCT01056263|1203847|P1|Overall Study|Adverse Event|12
357416|NCT01056107|1203870|P4|Overall Study|Withdrawal by Subject|0
357417|NCT01056107|1203871|P3|Overall Study|Withdrawal by Subject|3
357418|NCT01056107|1203872|P2|Overall Study|Withdrawal by Subject|1
357419|NCT01056107|1203873|P1|Overall Study|Withdrawal by Subject|0
357420|NCT01055886|1203930|P2|Overall Study|Withdrawal by PI|1
357421|NCT01055886|1203931|P1|Overall Study|Withdrawal by PI|0
357422|NCT01055886|1203930|P2|Overall Study|Lost to Follow-up|1
357423|NCT01055886|1203931|P1|Overall Study|Lost to Follow-up|1
357424|NCT01055886|1203930|P2|Overall Study|Withdrawal by Subject|9
357425|NCT01055886|1203931|P1|Overall Study|Withdrawal by Subject|4
357426|NCT01055834|1203943|P2|Treatment Period I|Adverse Event|0
357427|NCT01055834|1203944|P1|Treatment Period I|Adverse Event|1
357428|NCT01055639|1204029|P2|Overall Study|Withdrawal by Subject|11
357429|NCT01055639|1204030|P1|Overall Study|Withdrawal by Subject|8
357430|NCT01055639|1204029|P2|Overall Study|Protocol Violation|5
357431|NCT01055639|1204030|P1|Overall Study|Protocol Violation|5
357432|NCT01055639|1204029|P2|Overall Study|Lost to Follow-up|11
357433|NCT01055639|1204030|P1|Overall Study|Lost to Follow-up|8
357434|NCT01055639|1204029|P2|Overall Study|Lack of Efficacy|1
357435|NCT01055639|1204030|P1|Overall Study|Lack of Efficacy|0
357436|NCT01055639|1204029|P2|Overall Study|Adverse Event|1
357437|NCT01055639|1204030|P1|Overall Study|Adverse Event|0
357438|NCT01055613|1204054|P2|Overall Study|Subject Disinterest|1
357439|NCT01055613|1204055|P1|Overall Study|Subject Disinterest|1
357440|NCT01055613|1204054|P2|Overall Study|Protocol Violation|1
357441|NCT01055613|1204055|P1|Overall Study|Protocol Violation|1
357442|NCT01055613|1204054|P2|Overall Study|Lost to Follow-up|1
357443|NCT01055613|1204055|P1|Overall Study|Lost to Follow-up|1
357444|NCT01055613|1204054|P2|Overall Study|Discomfort|1
357445|NCT01055613|1204055|P1|Overall Study|Discomfort|2
357446|NCT01055613|1204054|P2|Overall Study|Unacceptable lens fit|0
357447|NCT01055613|1204055|P1|Overall Study|Unacceptable lens fit|1
357448|NCT01055613|1204054|P2|Overall Study|No Longer Meets Eligibility Criteria|0
357449|NCT01055613|1204055|P1|Overall Study|No Longer Meets Eligibility Criteria|3
357450|NCT01055457|1204073|P10|Overall Study|Adverse Event|0
357451|NCT01055457|1204074|P9|Overall Study|Adverse Event|0
357452|NCT01055457|1204075|P8|Overall Study|Adverse Event|0
357453|NCT01055457|1204076|P7|Overall Study|Adverse Event|0
357454|NCT01055457|1204077|P6|Overall Study|Adverse Event|0
357455|NCT01055457|1204078|P5|Overall Study|Adverse Event|0
357456|NCT01055457|1204079|P4|Overall Study|Adverse Event|1
357457|NCT01055457|1204080|P3|Overall Study|Adverse Event|0
357458|NCT01055457|1204081|P2|Overall Study|Adverse Event|0
357459|NCT01055457|1204082|P1|Overall Study|Adverse Event|0
357460|NCT01055457|1204073|P10|Overall Study|Pregnancy|0
357461|NCT01055457|1204074|P9|Overall Study|Pregnancy|0
357462|NCT01055457|1204075|P8|Overall Study|Pregnancy|0
357463|NCT01055457|1204076|P7|Overall Study|Pregnancy|0
357464|NCT01055457|1204077|P6|Overall Study|Pregnancy|0
357465|NCT01055457|1204078|P5|Overall Study|Pregnancy|0
357466|NCT01055457|1204079|P4|Overall Study|Pregnancy|1
357467|NCT01055457|1204080|P3|Overall Study|Pregnancy|0
357468|NCT01055457|1204081|P2|Overall Study|Pregnancy|0
357469|NCT01055457|1204082|P1|Overall Study|Pregnancy|0
357470|NCT01055457|1204073|P10|Overall Study|Discomfort|0
357471|NCT01055457|1204074|P9|Overall Study|Discomfort|0
357472|NCT01055457|1204075|P8|Overall Study|Discomfort|0
357473|NCT01055457|1204076|P7|Overall Study|Discomfort|0
357474|NCT01055457|1204077|P6|Overall Study|Discomfort|0
357475|NCT01055457|1204078|P5|Overall Study|Discomfort|1
357476|NCT01055457|1204079|P4|Overall Study|Discomfort|0
357477|NCT01055457|1204080|P3|Overall Study|Discomfort|0
357478|NCT01055457|1204081|P2|Overall Study|Discomfort|0
357479|NCT01055457|1204082|P1|Overall Study|Discomfort|0
357480|NCT01055457|1204073|P10|Overall Study|Subject Ineligible|0
357481|NCT01055457|1204074|P9|Overall Study|Subject Ineligible|0
357482|NCT01055457|1204075|P8|Overall Study|Subject Ineligible|0
357483|NCT01055457|1204076|P7|Overall Study|Subject Ineligible|0
357484|NCT01055457|1204077|P6|Overall Study|Subject Ineligible|0
357485|NCT01055457|1204078|P5|Overall Study|Subject Ineligible|1
357486|NCT01055457|1204079|P4|Overall Study|Subject Ineligible|0
357487|NCT01055457|1204080|P3|Overall Study|Subject Ineligible|1
357488|NCT01055457|1204081|P2|Overall Study|Subject Ineligible|0
357489|NCT01055457|1204082|P1|Overall Study|Subject Ineligible|1
357490|NCT01055457|1204073|P10|Overall Study|Subject Disinterest|0
357491|NCT01055457|1204074|P9|Overall Study|Subject Disinterest|0
357492|NCT01055457|1204075|P8|Overall Study|Subject Disinterest|1
357493|NCT01055457|1204076|P7|Overall Study|Subject Disinterest|0
357494|NCT01055457|1204077|P6|Overall Study|Subject Disinterest|0
357495|NCT01055457|1204078|P5|Overall Study|Subject Disinterest|0
357496|NCT01055457|1204079|P4|Overall Study|Subject Disinterest|0
357497|NCT01055457|1204080|P3|Overall Study|Subject Disinterest|0
357498|NCT01055457|1204081|P2|Overall Study|Subject Disinterest|0
357499|NCT01055457|1204082|P1|Overall Study|Subject Disinterest|0
357500|NCT01055457|1204073|P10|Overall Study|Protocol Violation|1
357501|NCT01055457|1204074|P9|Overall Study|Protocol Violation|0
357502|NCT01055457|1204075|P8|Overall Study|Protocol Violation|0
357503|NCT01055457|1204076|P7|Overall Study|Protocol Violation|1
357504|NCT01055457|1204077|P6|Overall Study|Protocol Violation|2
357505|NCT01055457|1204078|P5|Overall Study|Protocol Violation|1
357506|NCT01055457|1204079|P4|Overall Study|Protocol Violation|1
357507|NCT01055457|1204080|P3|Overall Study|Protocol Violation|1
357508|NCT01055457|1204081|P2|Overall Study|Protocol Violation|0
357509|NCT01055457|1204082|P1|Overall Study|Protocol Violation|0
357510|NCT01055457|1204073|P10|Overall Study|Lost to Follow-up|0
357511|NCT01055457|1204074|P9|Overall Study|Lost to Follow-up|0
357512|NCT01055457|1204075|P8|Overall Study|Lost to Follow-up|0
357513|NCT01055457|1204076|P7|Overall Study|Lost to Follow-up|0
357514|NCT01055457|1204077|P6|Overall Study|Lost to Follow-up|1
357515|NCT01055457|1204078|P5|Overall Study|Lost to Follow-up|0
357516|NCT01055457|1204079|P4|Overall Study|Lost to Follow-up|0
357517|NCT01055457|1204080|P3|Overall Study|Lost to Follow-up|0
357518|NCT01055457|1204081|P2|Overall Study|Lost to Follow-up|1
357519|NCT01055457|1204082|P1|Overall Study|Lost to Follow-up|0
357520|NCT01055314|1204116|P2|Overall Study|No treatment|0
357521|NCT01055314|1204117|P1|Overall Study|No treatment|1
357522|NCT01055314|1204116|P2|Overall Study|Refusal of further protocol therapy|4
357523|NCT01055314|1204117|P1|Overall Study|Refusal of further protocol therapy|10
357524|NCT01055314|1204116|P2|Overall Study|Ineligible|5
357525|NCT01055314|1204117|P1|Overall Study|Ineligible|3
357526|NCT01055314|1204116|P2|Overall Study|Withdrawal by Subject|0
357527|NCT01055314|1204117|P1|Overall Study|Withdrawal by Subject|1
357528|NCT01055314|1204116|P2|Overall Study|Physician Decision|5
357529|NCT01055314|1204117|P1|Overall Study|Physician Decision|10
357530|NCT01055314|1204116|P2|Overall Study|Lack of Efficacy|19
357531|NCT01055314|1204117|P1|Overall Study|Lack of Efficacy|11
357532|NCT01055314|1204116|P2|Overall Study|Death|1
357533|NCT01055314|1204117|P1|Overall Study|Death|2
357534|NCT01055314|1204116|P2|Overall Study|Adverse Event|4
357535|NCT01055314|1204117|P1|Overall Study|Adverse Event|7
357536|NCT01055262|1204129|P1|Overall Study|Uncooperativeness|1
357537|NCT01055262|1204129|P1|Overall Study|Protocol Violation|3
357538|NCT01055262|1204129|P1|Overall Study|Adverse Event|5
357539|NCT01055197|1204170|P2|Overall Study|Withdrawal by Subject|0
357540|NCT01055197|1204171|P1|Overall Study|Withdrawal by Subject|2
357541|NCT01055197|1204170|P2|Overall Study|Protocol Violation|2
357542|NCT01055197|1204171|P1|Overall Study|Protocol Violation|7
357543|NCT01055132|1204198|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
357544|NCT01055132|1204199|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
357545|NCT01055132|1204198|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
357546|NCT01055132|1204199|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
357547|NCT01055028|1204212|P2|Inter-treatment Period|Did not start Cycle 4|3
357548|NCT01055028|1204213|P1|Inter-treatment Period|Did not start Cycle 4|0
357549|NCT01055028|1204212|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
357550|NCT01055028|1204213|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
357551|NCT01055028|1204212|P2|Treatment Cycles 1 to 3|Adverse Event|1
357552|NCT01055028|1204213|P1|Treatment Cycles 1 to 3|Adverse Event|0
357553|NCT01055028|1204212|P2|Screening|Screen Failure|1
357554|NCT01055028|1204213|P1|Screening|Screen Failure|1
357555|NCT01054976|1204227|P1|Overall Study|Not specified|8
357556|NCT01054976|1204227|P1|Overall Study|Withdrawal by Subject|4
357557|NCT01054976|1204227|P1|Overall Study|Uncooperative participations to study|7
357558|NCT01054976|1204227|P1|Overall Study|Adverse Event|16
357559|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
357560|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
357561|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
357562|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
357563|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
357564|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
357565|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
357566|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Physician Decision|1
357567|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Physician Decision|1
357568|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Physician Decision|3
357569|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Physician Decision|6
357570|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Physician Decision|1
357571|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Physician Decision|4
357572|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Physician Decision|0
357573|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
357574|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
357575|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
357576|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
357577|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
357578|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
357579|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
357580|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
357581|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
357582|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
357583|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
357584|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
357585|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
357586|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
357587|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
357588|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
357589|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
357590|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
357591|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
357592|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
357593|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
357594|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
357595|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
357596|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
357597|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
357598|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
357599|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
357600|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
357601|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
357602|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
357603|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
357604|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
357605|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
357606|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
357607|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
357608|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
357609|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
357610|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
357611|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
357612|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
357613|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
357614|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
357615|NCT01054885|1204248|P7|24-week, Double-blind Treatment Period|Adverse Event|19
357616|NCT01054885|1204249|P6|24-week, Double-blind Treatment Period|Adverse Event|17
357617|NCT01054885|1204250|P5|24-week, Double-blind Treatment Period|Adverse Event|15
357618|NCT01054885|1204251|P4|24-week, Double-blind Treatment Period|Adverse Event|15
357619|NCT01054885|1204252|P3|24-week, Double-blind Treatment Period|Adverse Event|12
357620|NCT01054885|1204253|P2|24-week, Double-blind Treatment Period|Adverse Event|18
357621|NCT01054885|1204254|P1|24-week, Double-blind Treatment Period|Adverse Event|0
357622|NCT01054885|1204248|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357623|NCT01054885|1204249|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357624|NCT01054885|1204250|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357625|NCT01054885|1204251|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357626|NCT01054885|1204252|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357627|NCT01054885|1204253|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357628|NCT01054885|1204254|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
357629|NCT01054885|1204248|P7|2-week, Single-blind Run-In Period|Adverse Event|0
357630|NCT01054885|1204249|P6|2-week, Single-blind Run-In Period|Adverse Event|0
357631|NCT01054885|1204250|P5|2-week, Single-blind Run-In Period|Adverse Event|0
357632|NCT01054885|1204251|P4|2-week, Single-blind Run-In Period|Adverse Event|0
357633|NCT01054885|1204252|P3|2-week, Single-blind Run-In Period|Adverse Event|0
357634|NCT01054885|1204253|P2|2-week, Single-blind Run-In Period|Adverse Event|0
357635|NCT01054885|1204254|P1|2-week, Single-blind Run-In Period|Adverse Event|7
357636|NCT01054885|1204248|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357637|NCT01054885|1204249|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357638|NCT01054885|1204250|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357639|NCT01054885|1204251|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357640|NCT01054885|1204252|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357641|NCT01054885|1204253|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357642|NCT01054885|1204254|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
357643|NCT01054885|1204248|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357644|NCT01054885|1204249|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357645|NCT01054885|1204250|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357646|NCT01054885|1204251|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357647|NCT01054885|1204252|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357648|NCT01054885|1204253|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357649|NCT01054885|1204254|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
357650|NCT01054885|1204248|P7|2-week, Single-blind Run-In Period|Physician Decision|0
357651|NCT01054885|1204249|P6|2-week, Single-blind Run-In Period|Physician Decision|0
357652|NCT01054885|1204250|P5|2-week, Single-blind Run-In Period|Physician Decision|0
357653|NCT01054885|1204251|P4|2-week, Single-blind Run-In Period|Physician Decision|0
357654|NCT01054885|1204252|P3|2-week, Single-blind Run-In Period|Physician Decision|0
357655|NCT01054885|1204253|P2|2-week, Single-blind Run-In Period|Physician Decision|0
357656|NCT01054885|1204254|P1|2-week, Single-blind Run-In Period|Physician Decision|6
357657|NCT01054885|1204248|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357658|NCT01054885|1204249|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357659|NCT01054885|1204250|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357660|NCT01054885|1204251|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357661|NCT01054885|1204252|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357662|NCT01054885|1204253|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357663|NCT01054885|1204254|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
357664|NCT01054846|1204294|P2|Overall Study|Lost to Follow-up|17
357665|NCT01054846|1204295|P1|Overall Study|Lost to Follow-up|76
357666|NCT01054820|1204302|P1|Overall Study|Withdrawal by Subject|2
357667|NCT01054729|1204324|P4|Overall Study|Lack of Efficacy|1
357668|NCT01054729|1204325|P3|Overall Study|Lack of Efficacy|0
357669|NCT01054729|1204326|P2|Overall Study|Lack of Efficacy|0
357670|NCT01054729|1204327|P1|Overall Study|Lack of Efficacy|0
357671|NCT01054729|1204324|P4|Overall Study|Subject moved|0
357672|NCT01054729|1204325|P3|Overall Study|Subject moved|1
357673|NCT01054729|1204326|P2|Overall Study|Subject moved|0
357674|NCT01054729|1204327|P1|Overall Study|Subject moved|0
357675|NCT01054729|1204324|P4|Overall Study|Personal/Obligations|0
357676|NCT01054729|1204325|P3|Overall Study|Personal/Obligations|0
357677|NCT01054729|1204326|P2|Overall Study|Personal/Obligations|1
357678|NCT01054729|1204327|P1|Overall Study|Personal/Obligations|0
357679|NCT01054729|1204324|P4|Overall Study|PEG/RBV Non-responder|0
357680|NCT01054729|1204325|P3|Overall Study|PEG/RBV Non-responder|1
357681|NCT01054729|1204326|P2|Overall Study|PEG/RBV Non-responder|0
357682|NCT01054729|1204327|P1|Overall Study|PEG/RBV Non-responder|1
357683|NCT01054729|1204324|P4|Overall Study|Non-responder|1
357684|NCT01054729|1204325|P3|Overall Study|Non-responder|1
357685|NCT01054729|1204326|P2|Overall Study|Non-responder|0
357686|NCT01054729|1204327|P1|Overall Study|Non-responder|1
357687|NCT01054729|1204324|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
357688|NCT01054729|1204325|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
357689|NCT01054729|1204326|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
357690|NCT01054729|1204327|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
357691|NCT01054729|1204324|P4|Overall Study|Lost to Follow-up|0
357692|NCT01054729|1204325|P3|Overall Study|Lost to Follow-up|0
357693|NCT01054729|1204326|P2|Overall Study|Lost to Follow-up|1
357694|NCT01054729|1204327|P1|Overall Study|Lost to Follow-up|0
357695|NCT01054729|1204324|P4|Overall Study|Withdrawal by Subject|0
357696|NCT01054729|1204325|P3|Overall Study|Withdrawal by Subject|1
357697|NCT01054729|1204326|P2|Overall Study|Withdrawal by Subject|0
357698|NCT01054729|1204327|P1|Overall Study|Withdrawal by Subject|1
357699|NCT01054729|1204324|P4|Overall Study|Adverse Event|1
357700|NCT01054729|1204325|P3|Overall Study|Adverse Event|2
357701|NCT01054729|1204326|P2|Overall Study|Adverse Event|1
357702|NCT01054729|1204327|P1|Overall Study|Adverse Event|1
357703|NCT01054729|1204324|P4|Overall Study|Randomized but Not Treated|0
357704|NCT01054729|1204325|P3|Overall Study|Randomized but Not Treated|0
357705|NCT01054729|1204326|P2|Overall Study|Randomized but Not Treated|1
357706|NCT01054729|1204327|P1|Overall Study|Randomized but Not Treated|0
357707|NCT01054599|1204425|P2|Overall Study|Withdrawal by Subject|1
357708|NCT01054599|1204426|P1|Overall Study|Withdrawal by Subject|0
357709|NCT01054599|1204425|P2|Overall Study|Adverse Event|1
357710|NCT01054599|1204426|P1|Overall Study|Adverse Event|0
357711|NCT01054599|1204425|P2|Overall Study|Lost to Follow-up|2
357712|NCT01054599|1204426|P1|Overall Study|Lost to Follow-up|0
357713|NCT01054599|1204425|P2|Overall Study|Visual impairment, WTAR <80|1
357714|NCT01054599|1204426|P1|Overall Study|Visual impairment, WTAR <80|0
357715|NCT01054599|1204425|P2|Overall Study|Timing/scheduling difficulties|1
357716|NCT01054599|1204426|P1|Overall Study|Timing/scheduling difficulties|1
357717|NCT01054599|1204425|P2|Overall Study|Spells/seizure-like episodes|1
357718|NCT01054599|1204426|P1|Overall Study|Spells/seizure-like episodes|1
357719|NCT01054599|1204425|P2|Overall Study|Protocol Violation|0
357720|NCT01054599|1204426|P1|Overall Study|Protocol Violation|1
357721|NCT01054599|1204425|P2|Overall Study|Dizziness due to phenytoin toxicity|0
357722|NCT01054599|1204426|P1|Overall Study|Dizziness due to phenytoin toxicity|1
357723|NCT01054573|1204533|P4|Overall Study|Withdrawal by Subject|1
357724|NCT01054573|1204534|P3|Overall Study|Withdrawal by Subject|2
357725|NCT01054573|1204535|P2|Overall Study|Withdrawal by Subject|2
357726|NCT01054573|1204536|P1|Overall Study|Withdrawal by Subject|0
357727|NCT01054573|1204533|P4|Overall Study|Lost to Follow-up|0
357728|NCT01054573|1204534|P3|Overall Study|Lost to Follow-up|0
357729|NCT01054573|1204535|P2|Overall Study|Lost to Follow-up|2
357730|NCT01054573|1204536|P1|Overall Study|Lost to Follow-up|0
357731|NCT01054573|1204533|P4|Overall Study|Adverse Event|1
357732|NCT01054573|1204534|P3|Overall Study|Adverse Event|1
357733|NCT01054573|1204535|P2|Overall Study|Adverse Event|0
357734|NCT01054573|1204536|P1|Overall Study|Adverse Event|1
357735|NCT01054560|1204582|P2|Overall Study|Physician Decision|0
357736|NCT01054560|1204583|P1|Overall Study|Physician Decision|1
357737|NCT01054560|1204582|P2|Overall Study|Withdrawal by Subject|2
357738|NCT01054560|1204583|P1|Overall Study|Withdrawal by Subject|0
357739|NCT01054560|1204582|P2|Overall Study|Lost to Follow-up|5
357740|NCT01054560|1204583|P1|Overall Study|Lost to Follow-up|2
357741|NCT01054560|1204582|P2|Overall Study|Death|21
357742|NCT01054560|1204583|P1|Overall Study|Death|10
357743|NCT01054222|1204633|P1|Overall Study|Withdrawal by Subject|6
357744|NCT01054222|1204633|P1|Overall Study|Lost to Follow-up|4
357745|NCT01054222|1204633|P1|Overall Study|Lack of Efficacy|1
357746|NCT01054170|1204665|P2|Overall Study|Adverse Event|4
357747|NCT01054170|1204666|P1|Overall Study|Adverse Event|0
357748|NCT01054170|1204665|P2|Overall Study|Withdrawal by Subject|2
357749|NCT01054170|1204666|P1|Overall Study|Withdrawal by Subject|3
357750|NCT01054170|1204665|P2|Overall Study|Protocol Violation|0
357751|NCT01054170|1204666|P1|Overall Study|Protocol Violation|1
357752|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
357753|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
357754|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
357755|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
357756|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
357757|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
357758|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Physician Decision|4
357759|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Physician Decision|5
357760|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Physician Decision|5
357761|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Physician Decision|2
357762|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Physician Decision|5
357763|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Physician Decision|0
357764|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
357765|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
357766|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
357767|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
357768|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
357769|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
357770|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
357771|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
357772|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
357773|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
357774|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
357775|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
357776|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
357777|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
357778|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
357779|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
357780|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
357781|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
357782|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
357783|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
357784|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
357785|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
357786|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
357787|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
357788|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
357789|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
357790|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
357791|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
357792|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
357793|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
357794|NCT01053988|1204731|P6|24-week, Double-blind Treatment Period|Adverse Event|14
357795|NCT01053988|1204732|P5|24-week, Double-blind Treatment Period|Adverse Event|17
357796|NCT01053988|1204733|P4|24-week, Double-blind Treatment Period|Adverse Event|24
357797|NCT01053988|1204734|P3|24-week, Double-blind Treatment Period|Adverse Event|23
357798|NCT01053988|1204735|P2|24-week, Double-blind Treatment Period|Adverse Event|15
357799|NCT01053988|1204736|P1|24-week, Double-blind Treatment Period|Adverse Event|0
357800|NCT01053988|1204731|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357801|NCT01053988|1204732|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357802|NCT01053988|1204733|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357803|NCT01053988|1204734|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357804|NCT01053988|1204735|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
357805|NCT01053988|1204736|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
357806|NCT01053988|1204731|P6|2-week, Single-blind Run-In Period|Physician Decision|0
357807|NCT01053988|1204732|P5|2-week, Single-blind Run-In Period|Physician Decision|0
357808|NCT01053988|1204733|P4|2-week, Single-blind Run-In Period|Physician Decision|0
357809|NCT01053988|1204734|P3|2-week, Single-blind Run-In Period|Physician Decision|0
357810|NCT01053988|1204735|P2|2-week, Single-blind Run-In Period|Physician Decision|0
357811|NCT01053988|1204736|P1|2-week, Single-blind Run-In Period|Physician Decision|5
357812|NCT01053988|1204731|P6|2-week, Single-blind Run-In Period|Adverse Event|0
357813|NCT01053988|1204732|P5|2-week, Single-blind Run-In Period|Adverse Event|0
357814|NCT01053988|1204733|P4|2-week, Single-blind Run-In Period|Adverse Event|0
357815|NCT01053988|1204734|P3|2-week, Single-blind Run-In Period|Adverse Event|0
357816|NCT01053988|1204735|P2|2-week, Single-blind Run-In Period|Adverse Event|0
357817|NCT01053988|1204736|P1|2-week, Single-blind Run-In Period|Adverse Event|6
357818|NCT01053988|1204731|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357819|NCT01053988|1204732|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357820|NCT01053988|1204733|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357821|NCT01053988|1204734|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357822|NCT01053988|1204735|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
357823|NCT01053988|1204736|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
357824|NCT01053988|1204731|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357825|NCT01053988|1204732|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357826|NCT01053988|1204733|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357827|NCT01053988|1204734|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357828|NCT01053988|1204735|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
357829|NCT01053988|1204736|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
357830|NCT01053988|1204731|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357831|NCT01053988|1204732|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357832|NCT01053988|1204733|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357833|NCT01053988|1204734|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357834|NCT01053988|1204735|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
357835|NCT01053988|1204736|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
357836|NCT01053741|1204787|P2|2nd Study Intervention|Physician Decision|1
357837|NCT01053741|1204788|P1|2nd Study Intervention|Physician Decision|0
357838|NCT01053663|1204797|P1|Overall Study|Negative Influenza Diagnosis|1
357839|NCT01053663|1204797|P1|Overall Study|Transferred to Another Hospital|1
357840|NCT01053663|1204797|P1|Overall Study|Poor IV Access|1
357841|NCT01053663|1204797|P1|Overall Study|Lost to Follow-up|1
357842|NCT01053663|1204797|P1|Overall Study|Death|2
357843|NCT01053429|1204855|P1|Overall Study|Other|309
357844|NCT01053429|1204855|P1|Overall Study|Adverse Event|64
357845|NCT01053247|1204885|P3|Overall Study|Adverse Event|3
357846|NCT01053247|1204886|P2|Overall Study|Adverse Event|9
357847|NCT01053247|1204887|P1|Overall Study|Adverse Event|0
357848|NCT01053247|1204885|P3|Overall Study|Lost to Follow-up|7
357849|NCT01053247|1204886|P2|Overall Study|Lost to Follow-up|5
357850|NCT01053247|1204887|P1|Overall Study|Lost to Follow-up|8
357851|NCT01053247|1204885|P3|Overall Study|Protocol Violation|2
357852|NCT01053247|1204886|P2|Overall Study|Protocol Violation|1
357853|NCT01053247|1204887|P1|Overall Study|Protocol Violation|2
357854|NCT01053247|1204885|P3|Overall Study|Lack of Efficacy|1
357855|NCT01053247|1204886|P2|Overall Study|Lack of Efficacy|0
357856|NCT01053247|1204887|P1|Overall Study|Lack of Efficacy|1
357857|NCT01053247|1204885|P3|Overall Study|Withdrawal by Subject|15
357858|NCT01053247|1204886|P2|Overall Study|Withdrawal by Subject|4
357859|NCT01053247|1204887|P1|Overall Study|Withdrawal by Subject|9
357860|NCT01052844|1204981|P2|Overall Study|Adverse Event|1
357861|NCT01052844|1204982|P1|Overall Study|Adverse Event|0
357862|NCT01052779|1205003|P2|Overall Study|Other-Missed Week 5 Visit|0
357863|NCT01052779|1205004|P1|Overall Study|Other-Missed Week 5 Visit|2
357864|NCT01052779|1205003|P2|Overall Study|Other-Surgery|2
357865|NCT01052779|1205004|P1|Overall Study|Other-Surgery|0
357866|NCT01052779|1205003|P2|Overall Study|Other-Protocol Violation|1
357867|NCT01052779|1205004|P1|Overall Study|Other-Protocol Violation|1
357868|NCT01052779|1205003|P2|Overall Study|Withdrawal by Subject|2
357869|NCT01052779|1205004|P1|Overall Study|Withdrawal by Subject|1
357870|NCT01052779|1205003|P2|Overall Study|Adverse Event|4
357871|NCT01052779|1205004|P1|Overall Study|Adverse Event|1
357872|NCT01052714|1205014|P3|Overall Study|Withdrawal by Subject|1
357873|NCT01052714|1205015|P2|Overall Study|Withdrawal by Subject|12
357874|NCT01052714|1205016|P1|Overall Study|Withdrawal by Subject|7
357875|NCT01052714|1205014|P3|Overall Study|Physician Decision|1
357876|NCT01052714|1205015|P2|Overall Study|Physician Decision|9
357877|NCT01052714|1205016|P1|Overall Study|Physician Decision|9
357878|NCT01052714|1205014|P3|Overall Study|Lost to Follow-up|0
357879|NCT01052714|1205015|P2|Overall Study|Lost to Follow-up|3
357880|NCT01052714|1205016|P1|Overall Study|Lost to Follow-up|2
357881|NCT01052714|1205014|P3|Overall Study|Death|0
357882|NCT01052714|1205015|P2|Overall Study|Death|2
357883|NCT01052714|1205016|P1|Overall Study|Death|1
357884|NCT01052714|1205014|P3|Overall Study|Adverse Event|0
357885|NCT01052714|1205015|P2|Overall Study|Adverse Event|3
357886|NCT01052714|1205016|P1|Overall Study|Adverse Event|6
357887|NCT01052662|1205070|P3|Overall Study|Administrative|0
357888|NCT01052662|1205071|P2|Overall Study|Administrative|3
357889|NCT01052662|1205072|P1|Overall Study|Administrative|0
357890|NCT01052662|1205070|P3|Overall Study|Legal Problem|0
357891|NCT01052662|1205071|P2|Overall Study|Legal Problem|0
357892|NCT01052662|1205072|P1|Overall Study|Legal Problem|2
357893|NCT01052662|1205070|P3|Overall Study|Adverse Event|0
357894|NCT01052662|1205071|P2|Overall Study|Adverse Event|1
357895|NCT01052662|1205072|P1|Overall Study|Adverse Event|1
357896|NCT01052662|1205070|P3|Overall Study|Pharmacy issue|3
357897|NCT01052662|1205071|P2|Overall Study|Pharmacy issue|3
357898|NCT01052662|1205072|P1|Overall Study|Pharmacy issue|1
357899|NCT01052662|1205070|P3|Overall Study|Withdrawal by Subject|1
357900|NCT01052662|1205071|P2|Overall Study|Withdrawal by Subject|2
357901|NCT01052662|1205072|P1|Overall Study|Withdrawal by Subject|3
357902|NCT01052662|1205070|P3|Overall Study|Lost to Follow-up|18
357903|NCT01052662|1205071|P2|Overall Study|Lost to Follow-up|13
357904|NCT01052662|1205072|P1|Overall Study|Lost to Follow-up|15
357905|NCT01052480|1205103|P2|Overall Study|Death|5
357906|NCT01052480|1205104|P1|Overall Study|Death|1
357907|NCT01052480|1205103|P2|Overall Study|Physician Decision|2
357908|NCT01052480|1205104|P1|Overall Study|Physician Decision|0
357909|NCT01052480|1205103|P2|Overall Study|Withdrawal by Subject|7
357910|NCT01052480|1205104|P1|Overall Study|Withdrawal by Subject|3
357911|NCT01052480|1205103|P2|Overall Study|Protocol Violation|0
357912|NCT01052480|1205104|P1|Overall Study|Protocol Violation|1
357913|NCT01052480|1205103|P2|Overall Study|Lost to Follow-up|3
357914|NCT01052480|1205104|P1|Overall Study|Lost to Follow-up|3
357915|NCT01052428|1205154|P2|Overall Study|Withdrawal by Subject|1
357916|NCT01052428|1205155|P1|Overall Study|Withdrawal by Subject|0
357917|NCT01052428|1205154|P2|Overall Study|Death|0
357918|NCT01052428|1205155|P1|Overall Study|Death|1
357919|NCT01052272|1205177|P4|Overall Study|decline in health|0
357920|NCT01052272|1205178|P3|Overall Study|decline in health|1
357921|NCT01052272|1205179|P2|Overall Study|decline in health|0
357922|NCT01052272|1205180|P1|Overall Study|decline in health|0
357923|NCT01052272|1205177|P4|Overall Study|placed in long-term care|0
357924|NCT01052272|1205178|P3|Overall Study|placed in long-term care|1
357925|NCT01052272|1205179|P2|Overall Study|placed in long-term care|0
357926|NCT01052272|1205180|P1|Overall Study|placed in long-term care|0
357927|NCT01052272|1205177|P4|Overall Study|Withdrawal by Subject|2
357928|NCT01052272|1205178|P3|Overall Study|Withdrawal by Subject|3
357929|NCT01052272|1205179|P2|Overall Study|Withdrawal by Subject|2
357930|NCT01052272|1205180|P1|Overall Study|Withdrawal by Subject|0
357931|NCT01052272|1205177|P4|Overall Study|patient refuses follow-up|4
357932|NCT01052272|1205178|P3|Overall Study|patient refuses follow-up|2
357933|NCT01052272|1205179|P2|Overall Study|patient refuses follow-up|4
357934|NCT01052272|1205180|P1|Overall Study|patient refuses follow-up|5
357935|NCT01052272|1205177|P4|Overall Study|Physician Decision|0
357936|NCT01052272|1205178|P3|Overall Study|Physician Decision|0
357937|NCT01052272|1205179|P2|Overall Study|Physician Decision|1
357938|NCT01052272|1205180|P1|Overall Study|Physician Decision|0
357939|NCT01052272|1205177|P4|Overall Study|Death|1
357940|NCT01052272|1205178|P3|Overall Study|Death|1
357941|NCT01052272|1205179|P2|Overall Study|Death|0
357942|NCT01052272|1205180|P1|Overall Study|Death|0
357943|NCT01052116|1205225|P2|Overall Study|Spirometry not performed|4
357944|NCT01052116|1205226|P1|Overall Study|Spirometry not performed|0
357945|NCT01052116|1205225|P2|Overall Study|Withdrawal by Subject|6
357946|NCT01052116|1205226|P1|Overall Study|Withdrawal by Subject|3
357947|NCT01052116|1205225|P2|Overall Study|Lost to Follow-up|17
357948|NCT01052116|1205226|P1|Overall Study|Lost to Follow-up|11
357949|NCT01052077|1205234|P4|Phase A+|Withdrawal by Subject|7
357950|NCT01052077|1205235|P3|Phase A+|Withdrawal by Subject|0
357951|NCT01052077|1205236|P2|Phase A+|Withdrawal by Subject|0
357952|NCT01052077|1205237|P1|Phase A+|Withdrawal by Subject|0
357953|NCT01052077|1205234|P4|Phase A+|Met Withdrawal Criteria|2
357954|NCT01052077|1205235|P3|Phase A+|Met Withdrawal Criteria|0
357955|NCT01052077|1205236|P2|Phase A+|Met Withdrawal Criteria|0
357956|NCT01052077|1205237|P1|Phase A+|Met Withdrawal Criteria|0
357957|NCT01052077|1205234|P4|Phase A+|Adverse Event|4
357958|NCT01052077|1205235|P3|Phase A+|Adverse Event|0
357959|NCT01052077|1205236|P2|Phase A+|Adverse Event|0
357960|NCT01052077|1205237|P1|Phase A+|Adverse Event|0
357961|NCT01052077|1205234|P4|Phase A+|Lost to Follow-up|8
357962|NCT01052077|1205235|P3|Phase A+|Lost to Follow-up|0
357963|NCT01052077|1205236|P2|Phase A+|Lost to Follow-up|0
357964|NCT01052077|1205237|P1|Phase A+|Lost to Follow-up|0
357965|NCT01052077|1205234|P4|Phase B|Lack of Efficacy|0
357966|NCT01052077|1205235|P3|Phase B|Lack of Efficacy|0
357967|NCT01052077|1205236|P2|Phase B|Lack of Efficacy|1
357968|NCT01052077|1205237|P1|Phase B|Lack of Efficacy|0
357969|NCT01052077|1205234|P4|Phase B|Protocol Deviation|0
357970|NCT01052077|1205235|P3|Phase B|Protocol Deviation|4
357971|NCT01052077|1205236|P2|Phase B|Protocol Deviation|3
357972|NCT01052077|1205237|P1|Phase B|Protocol Deviation|0
357973|NCT01052077|1205234|P4|Phase B|Withdrawal by Subject|0
357974|NCT01052077|1205235|P3|Phase B|Withdrawal by Subject|5
357975|NCT01052077|1205236|P2|Phase B|Withdrawal by Subject|0
357976|NCT01052077|1205237|P1|Phase B|Withdrawal by Subject|0
357977|NCT01052077|1205234|P4|Phase B|Physician Decision|0
357978|NCT01052077|1205235|P3|Phase B|Physician Decision|1
357979|NCT01052077|1205236|P2|Phase B|Physician Decision|1
357980|NCT01052077|1205237|P1|Phase B|Physician Decision|0
357981|NCT01052077|1205234|P4|Phase B|Met Withdrawal Criteria|0
357982|NCT01052077|1205235|P3|Phase B|Met Withdrawal Criteria|1
357983|NCT01052077|1205236|P2|Phase B|Met Withdrawal Criteria|2
357984|NCT01052077|1205237|P1|Phase B|Met Withdrawal Criteria|0
357985|NCT01052077|1205234|P4|Phase B|Adverse Event|0
357986|NCT01052077|1205235|P3|Phase B|Adverse Event|2
357987|NCT01052077|1205236|P2|Phase B|Adverse Event|9
357988|NCT01052077|1205237|P1|Phase B|Adverse Event|0
357989|NCT01052077|1205234|P4|Phase B|Lost to Follow-up|0
357990|NCT01052077|1205235|P3|Phase B|Lost to Follow-up|3
357991|NCT01052077|1205236|P2|Phase B|Lost to Follow-up|2
357992|NCT01052077|1205237|P1|Phase B|Lost to Follow-up|0
357993|NCT01052077|1205234|P4|Phase A|Protocol Deviation|0
357994|NCT01052077|1205235|P3|Phase A|Protocol Deviation|0
357995|NCT01052077|1205236|P2|Phase A|Protocol Deviation|0
357996|NCT01052077|1205237|P1|Phase A|Protocol Deviation|27
357997|NCT01052077|1205234|P4|Phase A|Withdrawal by Subject|0
357998|NCT01052077|1205235|P3|Phase A|Withdrawal by Subject|0
357999|NCT01052077|1205236|P2|Phase A|Withdrawal by Subject|0
358000|NCT01052077|1205237|P1|Phase A|Withdrawal by Subject|29
358001|NCT01052077|1205234|P4|Phase A|Physician Decision|0
358002|NCT01052077|1205235|P3|Phase A|Physician Decision|0
358003|NCT01052077|1205236|P2|Phase A|Physician Decision|0
358004|NCT01052077|1205237|P1|Phase A|Physician Decision|10
358005|NCT01052077|1205234|P4|Phase A|Met Withdrawal Criteria|0
358006|NCT01052077|1205235|P3|Phase A|Met Withdrawal Criteria|0
358007|NCT01052077|1205236|P2|Phase A|Met Withdrawal Criteria|0
358008|NCT01052077|1205237|P1|Phase A|Met Withdrawal Criteria|26
358009|NCT01052077|1205234|P4|Phase A|Adverse Event|0
358010|NCT01052077|1205235|P3|Phase A|Adverse Event|0
358011|NCT01052077|1205236|P2|Phase A|Adverse Event|0
358012|NCT01052077|1205237|P1|Phase A|Adverse Event|32
358013|NCT01052077|1205234|P4|Phase A|Lost to Follow-up|0
358014|NCT01052077|1205235|P3|Phase A|Lost to Follow-up|0
358015|NCT01052077|1205236|P2|Phase A|Lost to Follow-up|0
358016|NCT01052077|1205237|P1|Phase A|Lost to Follow-up|22
358017|NCT01052038|1205264|P3|Overall Study|Protocol Violation|3
358018|NCT01052038|1205265|P2|Overall Study|Protocol Violation|3
358019|NCT01052038|1205266|P1|Overall Study|Protocol Violation|2
358020|NCT01052038|1205264|P3|Overall Study|Lost to Follow-up|1
358021|NCT01052038|1205265|P2|Overall Study|Lost to Follow-up|3
358022|NCT01052038|1205266|P1|Overall Study|Lost to Follow-up|2
358023|NCT01051986|1205288|P2|Overall Study|Protocol Violation|3
358024|NCT01051986|1205289|P1|Overall Study|Protocol Violation|2
358025|NCT01051986|1205288|P2|Overall Study|Withdrawal by Subject|1
358026|NCT01051986|1205289|P1|Overall Study|Withdrawal by Subject|2
358027|NCT01051986|1205288|P2|Overall Study|Death|0
358028|NCT01051986|1205289|P1|Overall Study|Death|1
358029|NCT01051921|1205303|P1|Overall Study|patient moved|1
358030|NCT01051921|1205303|P1|Overall Study|virological failure|1
358031|NCT01051921|1205303|P1|Overall Study|Lost to Follow-up|4
358032|NCT01051921|1205303|P1|Overall Study|Withdrawal by Subject|7
358033|NCT01051921|1205303|P1|Overall Study|Adverse Event|8
358034|NCT01051921|1205303|P1|Overall Study|Physician Decision|9
358035|NCT01051856|1205310|P2|Overall Study|Withdrawal by Subject|0
358036|NCT01051856|1205311|P1|Overall Study|Withdrawal by Subject|1
358037|NCT01051817|1205321|P2|Overall Study|Protocol Violation|1
358038|NCT01051817|1205322|P1|Overall Study|Protocol Violation|0
358039|NCT01051817|1205321|P2|Overall Study|Withdrawal by Subject|5
358040|NCT01051817|1205322|P1|Overall Study|Withdrawal by Subject|3
358041|NCT01051817|1205321|P2|Overall Study|Abnormal Test Proceedure reults|1
358042|NCT01051817|1205322|P1|Overall Study|Abnormal Test Proceedure reults|0
358043|NCT01051817|1205321|P2|Overall Study|Adverse Event|2
358044|NCT01051817|1205322|P1|Overall Study|Adverse Event|0
358045|NCT01051791|1205332|P1|Overall Study|Withdrawal by Subject|1
358046|NCT01051791|1205332|P1|Overall Study|Failed screening|3
358047|NCT01051739|1205350|P2|Overall Study|Withdrawal by Subject|10
358048|NCT01051739|1205351|P1|Overall Study|Withdrawal by Subject|25
358049|NCT01051739|1205350|P2|Overall Study|Death|3
358050|NCT01051739|1205351|P1|Overall Study|Death|3
358051|NCT01051557|1205368|P7|Overall Study|Adverse Event|4
358052|NCT01051557|1205369|P6|Overall Study|Adverse Event|3
358053|NCT01051557|1205370|P5|Overall Study|Adverse Event|1
358054|NCT01051557|1205371|P4|Overall Study|Adverse Event|1
358055|NCT01051557|1205372|P3|Overall Study|Adverse Event|0
358056|NCT01051557|1205373|P2|Overall Study|Adverse Event|0
358057|NCT01051557|1205374|P1|Overall Study|Adverse Event|0
358058|NCT01051557|1205368|P7|Overall Study|Withdrawal by Subject|1
358059|NCT01051557|1205369|P6|Overall Study|Withdrawal by Subject|0
358060|NCT01051557|1205370|P5|Overall Study|Withdrawal by Subject|2
358061|NCT01051557|1205371|P4|Overall Study|Withdrawal by Subject|0
358062|NCT01051557|1205372|P3|Overall Study|Withdrawal by Subject|1
358063|NCT01051557|1205373|P2|Overall Study|Withdrawal by Subject|0
358064|NCT01051557|1205374|P1|Overall Study|Withdrawal by Subject|0
358065|NCT01051557|1205368|P7|Overall Study|disease progression|1
358066|NCT01051557|1205369|P6|Overall Study|disease progression|3
358067|NCT01051557|1205370|P5|Overall Study|disease progression|4
358068|NCT01051557|1205371|P4|Overall Study|disease progression|2
358069|NCT01051557|1205372|P3|Overall Study|disease progression|5
358070|NCT01051557|1205373|P2|Overall Study|disease progression|3
358071|NCT01051557|1205374|P1|Overall Study|disease progression|3
358072|NCT01051557|1205368|P7|Overall Study|Physician Decision|0
358073|NCT01051557|1205369|P6|Overall Study|Physician Decision|0
358074|NCT01051557|1205370|P5|Overall Study|Physician Decision|0
358075|NCT01051557|1205371|P4|Overall Study|Physician Decision|0
358076|NCT01051557|1205372|P3|Overall Study|Physician Decision|0
358077|NCT01051557|1205373|P2|Overall Study|Physician Decision|0
358078|NCT01051557|1205374|P1|Overall Study|Physician Decision|1
358079|NCT01051466|1205393|P2|Overall Study|Physician Decision|0
358080|NCT01051466|1205394|P1|Overall Study|Physician Decision|1
358081|NCT01051466|1205393|P2|Overall Study|Entry Criteria Not Met|3
358082|NCT01051466|1205394|P1|Overall Study|Entry Criteria Not Met|0
358083|NCT01051466|1205393|P2|Overall Study|Withdrawal by Subject|1
358084|NCT01051466|1205394|P1|Overall Study|Withdrawal by Subject|5
358085|NCT01051466|1205393|P2|Overall Study|Lost to Follow-up|1
358086|NCT01051466|1205394|P1|Overall Study|Lost to Follow-up|1
358087|NCT01051466|1205393|P2|Overall Study|Adverse Event|0
358088|NCT01051466|1205394|P1|Overall Study|Adverse Event|1
358089|NCT01051323|1205441|P1|Overall Study|Missing|37
358090|NCT01051323|1205441|P1|Overall Study|Other|148
358091|NCT01051323|1205441|P1|Overall Study|Hospitalization|28
358092|NCT01051323|1205441|P1|Overall Study|Death|129
358093|NCT01051323|1205441|P1|Overall Study|Lost to Follow-up|31
358094|NCT01051323|1205441|P1|Overall Study|Withdrawal by Subject|13
358095|NCT01051323|1205441|P1|Overall Study|Dialysis dependency|22
358096|NCT01051323|1205441|P1|Overall Study|Transplantation|28
358097|NCT01051323|1205441|P1|Overall Study|Discontinuation of treatment|103
358098|NCT01050998|1205468|P5|Overall Study|Data integrity issues|4
358099|NCT01050998|1205469|P4|Overall Study|Data integrity issues|1
358100|NCT01050998|1205470|P3|Overall Study|Data integrity issues|1
358101|NCT01050998|1205471|P2|Overall Study|Data integrity issues|0
358102|NCT01050998|1205472|P1|Overall Study|Data integrity issues|0
358103|NCT01050998|1205468|P5|Overall Study|Other|5
358104|NCT01050998|1205469|P4|Overall Study|Other|1
358105|NCT01050998|1205470|P3|Overall Study|Other|1
358106|NCT01050998|1205471|P2|Overall Study|Other|2
358107|NCT01050998|1205472|P1|Overall Study|Other|3
358108|NCT01050998|1205468|P5|Overall Study|Withdrawal by Subject|3
358109|NCT01050998|1205469|P4|Overall Study|Withdrawal by Subject|1
358110|NCT01050998|1205470|P3|Overall Study|Withdrawal by Subject|0
358111|NCT01050998|1205471|P2|Overall Study|Withdrawal by Subject|0
358112|NCT01050998|1205472|P1|Overall Study|Withdrawal by Subject|0
358113|NCT01050998|1205468|P5|Overall Study|Adverse Event|2
358114|NCT01050998|1205469|P4|Overall Study|Adverse Event|0
358115|NCT01050998|1205470|P3|Overall Study|Adverse Event|1
358116|NCT01050998|1205471|P2|Overall Study|Adverse Event|0
358117|NCT01050998|1205472|P1|Overall Study|Adverse Event|1
358118|NCT01050816|1205806|P1|Overall Study|patient's refusal|2
358119|NCT01050816|1205806|P1|Overall Study|Lost to Follow-up|2
358120|NCT01050790|1205812|P1|Overall Study|Adverse Event|1
358121|NCT01050764|1205822|P1|Overall Study|Death after HSCT, before T-cell infusion|1
358122|NCT01050764|1205822|P1|Overall Study|Donor mobilization failure, death|1
358123|NCT01050764|1205822|P1|Overall Study|Death, before HSCT|1
358124|NCT01050673|1205833|P2|Overall Study|Physician Decision|5
358125|NCT01050673|1205834|P1|Overall Study|Physician Decision|4
358126|NCT01050634|1205902|P1|Overall Study|Ongoing at Date of Cut-Off|5
358127|NCT01050634|1205902|P1|Overall Study|Other|21
358128|NCT01050634|1205902|P1|Overall Study|Lost to Follow-up|2
358129|NCT01050634|1205902|P1|Overall Study|Adverse Event|42
358130|NCT01050634|1205902|P1|Overall Study|Death|2
358131|NCT01050634|1205902|P1|Overall Study|Enrolled, but Not Treated|56
358132|NCT01050569|1205926|P3|Overall Study|Physician Decision|3
358133|NCT01050569|1205927|P2|Overall Study|Physician Decision|3
358134|NCT01050569|1205928|P1|Overall Study|Physician Decision|3
358135|NCT01050569|1205926|P3|Overall Study|Adverse Event|0
358136|NCT01050569|1205927|P2|Overall Study|Adverse Event|0
358137|NCT01050569|1205928|P1|Overall Study|Adverse Event|1
358138|NCT01050569|1205926|P3|Overall Study|Lack of Efficacy|3
358139|NCT01050569|1205927|P2|Overall Study|Lack of Efficacy|4
358140|NCT01050569|1205928|P1|Overall Study|Lack of Efficacy|5
358141|NCT01050569|1205926|P3|Overall Study|Withdrawal by Subject|11
358142|NCT01050569|1205927|P2|Overall Study|Withdrawal by Subject|3
358143|NCT01050569|1205928|P1|Overall Study|Withdrawal by Subject|9
358144|NCT01050569|1205926|P3|Overall Study|Lost to Follow-up|16
358145|NCT01050569|1205927|P2|Overall Study|Lost to Follow-up|14
358146|NCT01050569|1205928|P1|Overall Study|Lost to Follow-up|20
358147|NCT01050543|1205947|P2|Overall Study|Administrative|1
358148|NCT01050543|1205948|P1|Overall Study|Administrative|4
358149|NCT01050543|1205947|P2|Overall Study|Protocol Violation|1
358150|NCT01050543|1205948|P1|Overall Study|Protocol Violation|0
358151|NCT01050543|1205947|P2|Overall Study|Withdrawal by Subject|2
358152|NCT01050543|1205948|P1|Overall Study|Withdrawal by Subject|0
358153|NCT01050530|1205956|P2|Overall Study|Protocol Violation|0
358154|NCT01050530|1205957|P1|Overall Study|Protocol Violation|1
358155|NCT01050530|1205956|P2|Overall Study|Withdrawal by Subject|3
358156|NCT01050530|1205957|P1|Overall Study|Withdrawal by Subject|0
358157|NCT01050530|1205956|P2|Overall Study|Lack of Efficacy|4
358158|NCT01050530|1205957|P1|Overall Study|Lack of Efficacy|1
358159|NCT01050530|1205956|P2|Overall Study|Adverse Event|3
358160|NCT01050530|1205957|P1|Overall Study|Adverse Event|6
358161|NCT01050257|1205968|P3|Overall Study|Death|1
358162|NCT01050257|1205969|P2|Overall Study|Death|0
358163|NCT01050257|1205970|P1|Overall Study|Death|0
358164|NCT01050257|1205968|P3|Overall Study|Failure to return|0
358165|NCT01050257|1205969|P2|Overall Study|Failure to return|2
358166|NCT01050257|1205970|P1|Overall Study|Failure to return|0
358167|NCT01050257|1205968|P3|Overall Study|Violation criteria|0
358168|NCT01050257|1205969|P2|Overall Study|Violation criteria|1
358169|NCT01050257|1205970|P1|Overall Study|Violation criteria|0
358170|NCT01050257|1205968|P3|Overall Study|Refused treatment/ Did not Cooperate|0
358171|NCT01050257|1205969|P2|Overall Study|Refused treatment/ Did not Cooperate|1
358172|NCT01050257|1205970|P1|Overall Study|Refused treatment/ Did not Cooperate|1
358173|NCT01050257|1205968|P3|Overall Study|No reason specified|2
358174|NCT01050257|1205969|P2|Overall Study|No reason specified|0
358175|NCT01050257|1205970|P1|Overall Study|No reason specified|0
358176|NCT01050257|1205968|P3|Overall Study|Withdrawal by Subject|0
358177|NCT01050257|1205969|P2|Overall Study|Withdrawal by Subject|3
358178|NCT01050257|1205970|P1|Overall Study|Withdrawal by Subject|0
358179|NCT01050257|1205968|P3|Overall Study|Admin/Other (did not switch to oral)|2
358180|NCT01050257|1205969|P2|Overall Study|Admin/Other (did not switch to oral)|2
358181|NCT01050257|1205970|P1|Overall Study|Admin/Other (did not switch to oral)|6
358182|NCT01050257|1205968|P3|Overall Study|Adverse Event|2
358183|NCT01050257|1205969|P2|Overall Study|Adverse Event|4
358184|NCT01050257|1205970|P1|Overall Study|Adverse Event|4
358185|NCT01050218|1206005|P1|Overall Study|Family emergency|1
358186|NCT01050218|1206005|P1|Overall Study|Serious Adverse Event|1
358187|NCT01050218|1206005|P1|Overall Study|Failed to return|7
358188|NCT01050218|1206005|P1|Overall Study|Compliance|2
358189|NCT01050218|1206005|P1|Overall Study|Discontinued by sponsor|18
358190|NCT01050218|1206005|P1|Overall Study|Withdrawal by Subject|18
358191|NCT01050218|1206005|P1|Overall Study|Protocol Violation|3
358192|NCT01050218|1206005|P1|Overall Study|Lack of Efficacy|8
358193|NCT01050218|1206005|P1|Overall Study|Adverse Event|37
358194|NCT01050205|1206011|P2|Overall Study|Discontinued Intervention|0
358195|NCT01050205|1206012|P1|Overall Study|Discontinued Intervention|2
358196|NCT01050205|1206011|P2|Overall Study|Relocated from area|2
358197|NCT01050205|1206012|P1|Overall Study|Relocated from area|1
358198|NCT01050205|1206011|P2|Overall Study|Withdrawal by Subject|1
358199|NCT01050205|1206012|P1|Overall Study|Withdrawal by Subject|1
358200|NCT01050205|1206011|P2|Overall Study|Lost to Follow-up|1
358201|NCT01050205|1206012|P1|Overall Study|Lost to Follow-up|7
358202|NCT01050062|1206069|P2|Overall Study|Others|11
358203|NCT01050062|1206070|P1|Overall Study|Others|17
358204|NCT01050062|1206069|P2|Overall Study|Physician Decision|9
358205|NCT01050062|1206070|P1|Overall Study|Physician Decision|74
358206|NCT01050062|1206069|P2|Overall Study|Lack of Efficacy|35
358207|NCT01050062|1206070|P1|Overall Study|Lack of Efficacy|22
358208|NCT01050062|1206069|P2|Overall Study|Lost to Follow-up|35
358209|NCT01050062|1206070|P1|Overall Study|Lost to Follow-up|83
358210|NCT01050062|1206069|P2|Overall Study|Adverse Event|22
358211|NCT01050062|1206070|P1|Overall Study|Adverse Event|75
358212|NCT01049984|1206092|P2|Overall Study|Treatment failure|2
358213|NCT01049984|1206093|P1|Overall Study|Treatment failure|0
358214|NCT01049984|1206092|P2|Overall Study|Adverse Event|7
358215|NCT01049984|1206093|P1|Overall Study|Adverse Event|13
358216|NCT01049984|1206092|P2|Overall Study|Lost to Follow-up|1
358217|NCT01049984|1206093|P1|Overall Study|Lost to Follow-up|2
358218|NCT01049984|1206092|P2|Overall Study|Protocol Violation|4
358219|NCT01049984|1206093|P1|Overall Study|Protocol Violation|3
358220|NCT01049984|1206092|P2|Overall Study|Withdrawal by Subject|5
358221|NCT01049984|1206093|P1|Overall Study|Withdrawal by Subject|1
358222|NCT01049581|1206153|P2|Overall Study|Lost to Follow-up|1
358223|NCT01049581|1206154|P1|Overall Study|Lost to Follow-up|2
358224|NCT01049503|1206169|P6|Overall Study|Lost to Follow-up|8
358225|NCT01049503|1206170|P5|Overall Study|Lost to Follow-up|27
358226|NCT01049503|1206171|P4|Overall Study|Lost to Follow-up|26
358227|NCT01049503|1206172|P3|Overall Study|Lost to Follow-up|24
358228|NCT01049503|1206173|P2|Overall Study|Lost to Follow-up|12
358229|NCT01049503|1206174|P1|Overall Study|Lost to Follow-up|11
358230|NCT01049412|1206205|P2|Period II|Lost to Follow-up|0
358231|NCT01049412|1206206|P1|Period II|Lost to Follow-up|1
358232|NCT01049412|1206205|P2|Period II|Adverse Event|0
358233|NCT01049412|1206206|P1|Period II|Adverse Event|1
358234|NCT01049412|1206205|P2|Period II|Withdrawal by Subject|3
358235|NCT01049412|1206206|P1|Period II|Withdrawal by Subject|2
358236|NCT01049412|1206205|P2|Period I|Adverse Event|0
358237|NCT01049412|1206206|P1|Period I|Adverse Event|1
358238|NCT01049412|1206205|P2|Period I|Protocol Violation|2
358239|NCT01049412|1206206|P1|Period I|Protocol Violation|1
358240|NCT01049412|1206205|P2|Period I|Physician Decision|3
358241|NCT01049412|1206206|P1|Period I|Physician Decision|0
358242|NCT01049412|1206205|P2|Period I|Lost to Follow-up|2
358243|NCT01049412|1206206|P1|Period I|Lost to Follow-up|2
358244|NCT01049412|1206205|P2|Period I|Withdrawal by Subject|6
358245|NCT01049412|1206206|P1|Period I|Withdrawal by Subject|4
358246|NCT01049373|1206235|P2|Overall Study|Non-cooperation|1
358247|NCT01049373|1206236|P1|Overall Study|Non-cooperation|0
358248|NCT01049373|1206235|P2|Overall Study|Not specified|1
358249|NCT01049373|1206236|P1|Overall Study|Not specified|1
358250|NCT01049373|1206235|P2|Overall Study|no evaluable study values|21
358251|NCT01049373|1206236|P1|Overall Study|no evaluable study values|9
358252|NCT01049373|1206235|P2|Overall Study|Lost to Follow-up|4
358253|NCT01049373|1206236|P1|Overall Study|Lost to Follow-up|9
358254|NCT01049373|1206235|P2|Overall Study|Adverse Event|3
358255|NCT01049373|1206236|P1|Overall Study|Adverse Event|3
358256|NCT01049373|1206235|P2|Overall Study|Withdrawal by Subject|5
358257|NCT01049373|1206236|P1|Overall Study|Withdrawal by Subject|8
358258|NCT01049373|1206235|P2|Overall Study|Protocol Violation|9
358259|NCT01049373|1206236|P1|Overall Study|Protocol Violation|9
358260|NCT01049360|1206250|P20|Period 4|Withdrawal by Subject|0
358261|NCT01049360|1206251|P19|Period 4|Withdrawal by Subject|0
358262|NCT01049360|1206252|P18|Period 4|Withdrawal by Subject|0
358263|NCT01049360|1206253|P17|Period 4|Withdrawal by Subject|0
358264|NCT01049360|1206254|P16|Period 4|Withdrawal by Subject|0
358265|NCT01049360|1206255|P15|Period 4|Withdrawal by Subject|0
358266|NCT01049360|1206256|P14|Period 4|Withdrawal by Subject|0
358267|NCT01049360|1206257|P13|Period 4|Withdrawal by Subject|0
358268|NCT01049360|1206258|P12|Period 4|Withdrawal by Subject|0
358269|NCT01049360|1206259|P11|Period 4|Withdrawal by Subject|0
358270|NCT01049360|1206260|P10|Period 4|Withdrawal by Subject|0
358271|NCT01049360|1206261|P9|Period 4|Withdrawal by Subject|0
358272|NCT01049360|1206262|P8|Period 4|Withdrawal by Subject|0
358273|NCT01049360|1206263|P7|Period 4|Withdrawal by Subject|0
358274|NCT01049360|1206264|P6|Period 4|Withdrawal by Subject|0
358275|NCT01049360|1206265|P5|Period 4|Withdrawal by Subject|0
358276|NCT01049360|1206266|P4|Period 4|Withdrawal by Subject|1
358277|NCT01049360|1206267|P3|Period 4|Withdrawal by Subject|0
358278|NCT01049360|1206268|P2|Period 4|Withdrawal by Subject|0
358279|NCT01049360|1206269|P1|Period 4|Withdrawal by Subject|0
358280|NCT01049360|1206250|P20|Period 4|Protocol Violation|0
358281|NCT01049360|1206251|P19|Period 4|Protocol Violation|0
358282|NCT01049360|1206252|P18|Period 4|Protocol Violation|1
358283|NCT01049360|1206253|P17|Period 4|Protocol Violation|0
358284|NCT01049360|1206254|P16|Period 4|Protocol Violation|0
358285|NCT01049360|1206255|P15|Period 4|Protocol Violation|0
358286|NCT01049360|1206256|P14|Period 4|Protocol Violation|0
358287|NCT01049360|1206257|P13|Period 4|Protocol Violation|0
358288|NCT01049360|1206258|P12|Period 4|Protocol Violation|0
358289|NCT01049360|1206259|P11|Period 4|Protocol Violation|0
358290|NCT01049360|1206260|P10|Period 4|Protocol Violation|0
358291|NCT01049360|1206261|P9|Period 4|Protocol Violation|0
358292|NCT01049360|1206262|P8|Period 4|Protocol Violation|0
358293|NCT01049360|1206263|P7|Period 4|Protocol Violation|0
358294|NCT01049360|1206264|P6|Period 4|Protocol Violation|0
358295|NCT01049360|1206265|P5|Period 4|Protocol Violation|0
358296|NCT01049360|1206266|P4|Period 4|Protocol Violation|0
358297|NCT01049360|1206267|P3|Period 4|Protocol Violation|0
358298|NCT01049360|1206268|P2|Period 4|Protocol Violation|0
358299|NCT01049360|1206269|P1|Period 4|Protocol Violation|0
358300|NCT01049360|1206250|P20|Period 2|Lack of Efficacy|0
358301|NCT01049360|1206251|P19|Period 2|Lack of Efficacy|0
358302|NCT01049360|1206252|P18|Period 2|Lack of Efficacy|0
358303|NCT01049360|1206253|P17|Period 2|Lack of Efficacy|0
358304|NCT01049360|1206254|P16|Period 2|Lack of Efficacy|0
358305|NCT01049360|1206255|P15|Period 2|Lack of Efficacy|0
358306|NCT01049360|1206256|P14|Period 2|Lack of Efficacy|0
358307|NCT01049360|1206257|P13|Period 2|Lack of Efficacy|0
358308|NCT01049360|1206258|P12|Period 2|Lack of Efficacy|0
358309|NCT01049360|1206259|P11|Period 2|Lack of Efficacy|0
358310|NCT01049360|1206260|P10|Period 2|Lack of Efficacy|0
358311|NCT01049360|1206261|P9|Period 2|Lack of Efficacy|0
358312|NCT01049360|1206262|P8|Period 2|Lack of Efficacy|0
358313|NCT01049360|1206263|P7|Period 2|Lack of Efficacy|0
358314|NCT01049360|1206264|P6|Period 2|Lack of Efficacy|1
358315|NCT01049360|1206265|P5|Period 2|Lack of Efficacy|0
358316|NCT01049360|1206266|P4|Period 2|Lack of Efficacy|0
358317|NCT01049360|1206267|P3|Period 2|Lack of Efficacy|0
358318|NCT01049360|1206268|P2|Period 2|Lack of Efficacy|0
358319|NCT01049360|1206269|P1|Period 2|Lack of Efficacy|0
358320|NCT01049360|1206250|P20|Period 2|Withdrawal by Subject|1
358321|NCT01049360|1206251|P19|Period 2|Withdrawal by Subject|0
358322|NCT01049360|1206252|P18|Period 2|Withdrawal by Subject|0
358323|NCT01049360|1206253|P17|Period 2|Withdrawal by Subject|0
358324|NCT01049360|1206254|P16|Period 2|Withdrawal by Subject|0
358325|NCT01049360|1206255|P15|Period 2|Withdrawal by Subject|1
358326|NCT01049360|1206256|P14|Period 2|Withdrawal by Subject|0
358327|NCT01049360|1206257|P13|Period 2|Withdrawal by Subject|0
358328|NCT01049360|1206258|P12|Period 2|Withdrawal by Subject|0
358329|NCT01049360|1206259|P11|Period 2|Withdrawal by Subject|0
358330|NCT01049360|1206260|P10|Period 2|Withdrawal by Subject|0
358331|NCT01049360|1206261|P9|Period 2|Withdrawal by Subject|0
358332|NCT01049360|1206262|P8|Period 2|Withdrawal by Subject|0
358333|NCT01049360|1206263|P7|Period 2|Withdrawal by Subject|0
358334|NCT01049360|1206264|P6|Period 2|Withdrawal by Subject|0
358335|NCT01049360|1206265|P5|Period 2|Withdrawal by Subject|0
358336|NCT01049360|1206266|P4|Period 2|Withdrawal by Subject|1
358337|NCT01049360|1206267|P3|Period 2|Withdrawal by Subject|0
358338|NCT01049360|1206268|P2|Period 2|Withdrawal by Subject|0
358339|NCT01049360|1206269|P1|Period 2|Withdrawal by Subject|0
358340|NCT01049360|1206250|P20|Period 2|Adverse Event|1
358341|NCT01049360|1206251|P19|Period 2|Adverse Event|0
358342|NCT01049360|1206252|P18|Period 2|Adverse Event|0
358343|NCT01049360|1206253|P17|Period 2|Adverse Event|0
358344|NCT01049360|1206254|P16|Period 2|Adverse Event|0
358345|NCT01049360|1206255|P15|Period 2|Adverse Event|0
358346|NCT01049360|1206256|P14|Period 2|Adverse Event|0
358347|NCT01049360|1206257|P13|Period 2|Adverse Event|0
358348|NCT01049360|1206258|P12|Period 2|Adverse Event|0
358349|NCT01049360|1206259|P11|Period 2|Adverse Event|0
358350|NCT01049360|1206260|P10|Period 2|Adverse Event|0
358351|NCT01049360|1206261|P9|Period 2|Adverse Event|1
358352|NCT01049360|1206262|P8|Period 2|Adverse Event|0
358353|NCT01049360|1206263|P7|Period 2|Adverse Event|0
358354|NCT01049360|1206264|P6|Period 2|Adverse Event|0
358355|NCT01049360|1206265|P5|Period 2|Adverse Event|0
358356|NCT01049360|1206266|P4|Period 2|Adverse Event|0
358357|NCT01049360|1206267|P3|Period 2|Adverse Event|0
358358|NCT01049360|1206268|P2|Period 2|Adverse Event|1
358359|NCT01049360|1206269|P1|Period 2|Adverse Event|0
358360|NCT01049360|1206250|P20|Period 2|Protocol Violation|0
358361|NCT01049360|1206251|P19|Period 2|Protocol Violation|0
358362|NCT01049360|1206252|P18|Period 2|Protocol Violation|0
358363|NCT01049360|1206253|P17|Period 2|Protocol Violation|0
358364|NCT01049360|1206254|P16|Period 2|Protocol Violation|1
358365|NCT01049360|1206255|P15|Period 2|Protocol Violation|1
358366|NCT01049360|1206256|P14|Period 2|Protocol Violation|0
358367|NCT01049360|1206257|P13|Period 2|Protocol Violation|0
358368|NCT01049360|1206258|P12|Period 2|Protocol Violation|0
358369|NCT01049360|1206259|P11|Period 2|Protocol Violation|0
358370|NCT01049360|1206260|P10|Period 2|Protocol Violation|0
358371|NCT01049360|1206261|P9|Period 2|Protocol Violation|0
358372|NCT01049360|1206262|P8|Period 2|Protocol Violation|0
358373|NCT01049360|1206263|P7|Period 2|Protocol Violation|0
358374|NCT01049360|1206264|P6|Period 2|Protocol Violation|0
358375|NCT01049360|1206265|P5|Period 2|Protocol Violation|0
358376|NCT01049360|1206266|P4|Period 2|Protocol Violation|1
358377|NCT01049360|1206267|P3|Period 2|Protocol Violation|0
358378|NCT01049360|1206268|P2|Period 2|Protocol Violation|0
358379|NCT01049360|1206269|P1|Period 2|Protocol Violation|0
358380|NCT01049360|1206250|P20|Period 1|Withdrawal by Subject|0
358381|NCT01049360|1206251|P19|Period 1|Withdrawal by Subject|0
358382|NCT01049360|1206252|P18|Period 1|Withdrawal by Subject|0
358383|NCT01049360|1206253|P17|Period 1|Withdrawal by Subject|0
358384|NCT01049360|1206254|P16|Period 1|Withdrawal by Subject|0
358385|NCT01049360|1206255|P15|Period 1|Withdrawal by Subject|0
358386|NCT01049360|1206256|P14|Period 1|Withdrawal by Subject|0
358387|NCT01049360|1206257|P13|Period 1|Withdrawal by Subject|1
358388|NCT01049360|1206258|P12|Period 1|Withdrawal by Subject|0
358389|NCT01049360|1206259|P11|Period 1|Withdrawal by Subject|1
358390|NCT01049360|1206260|P10|Period 1|Withdrawal by Subject|0
358391|NCT01049360|1206261|P9|Period 1|Withdrawal by Subject|1
358392|NCT01049360|1206262|P8|Period 1|Withdrawal by Subject|0
358393|NCT01049360|1206263|P7|Period 1|Withdrawal by Subject|0
358394|NCT01049360|1206264|P6|Period 1|Withdrawal by Subject|0
358395|NCT01049360|1206265|P5|Period 1|Withdrawal by Subject|0
358396|NCT01049360|1206266|P4|Period 1|Withdrawal by Subject|0
358397|NCT01049360|1206267|P3|Period 1|Withdrawal by Subject|0
358398|NCT01049360|1206268|P2|Period 1|Withdrawal by Subject|0
358399|NCT01049360|1206269|P1|Period 1|Withdrawal by Subject|0
358400|NCT01049360|1206250|P20|Period 1|Did not meet inc/exc criteria|0
358401|NCT01049360|1206251|P19|Period 1|Did not meet inc/exc criteria|0
358402|NCT01049360|1206252|P18|Period 1|Did not meet inc/exc criteria|0
358403|NCT01049360|1206253|P17|Period 1|Did not meet inc/exc criteria|0
358404|NCT01049360|1206254|P16|Period 1|Did not meet inc/exc criteria|0
358405|NCT01049360|1206255|P15|Period 1|Did not meet inc/exc criteria|0
358406|NCT01049360|1206256|P14|Period 1|Did not meet inc/exc criteria|0
358407|NCT01049360|1206257|P13|Period 1|Did not meet inc/exc criteria|0
358408|NCT01049360|1206258|P12|Period 1|Did not meet inc/exc criteria|0
358409|NCT01049360|1206259|P11|Period 1|Did not meet inc/exc criteria|0
358410|NCT01049360|1206260|P10|Period 1|Did not meet inc/exc criteria|0
358411|NCT01049360|1206261|P9|Period 1|Did not meet inc/exc criteria|1
358412|NCT01049360|1206262|P8|Period 1|Did not meet inc/exc criteria|1
358413|NCT01049360|1206263|P7|Period 1|Did not meet inc/exc criteria|0
358414|NCT01049360|1206264|P6|Period 1|Did not meet inc/exc criteria|0
358415|NCT01049360|1206265|P5|Period 1|Did not meet inc/exc criteria|0
358416|NCT01049360|1206266|P4|Period 1|Did not meet inc/exc criteria|0
358417|NCT01049360|1206267|P3|Period 1|Did not meet inc/exc criteria|0
358418|NCT01049360|1206268|P2|Period 1|Did not meet inc/exc criteria|0
358419|NCT01049360|1206269|P1|Period 1|Did not meet inc/exc criteria|0
358420|NCT01049360|1206250|P20|Period 1|Adverse Event|0
358421|NCT01049360|1206251|P19|Period 1|Adverse Event|1
358422|NCT01049360|1206252|P18|Period 1|Adverse Event|0
358423|NCT01049360|1206253|P17|Period 1|Adverse Event|1
358424|NCT01049360|1206254|P16|Period 1|Adverse Event|0
358425|NCT01049360|1206255|P15|Period 1|Adverse Event|0
358426|NCT01049360|1206256|P14|Period 1|Adverse Event|1
358427|NCT01049360|1206257|P13|Period 1|Adverse Event|1
358428|NCT01049360|1206258|P12|Period 1|Adverse Event|0
358429|NCT01049360|1206259|P11|Period 1|Adverse Event|0
358430|NCT01049360|1206260|P10|Period 1|Adverse Event|0
358431|NCT01049360|1206261|P9|Period 1|Adverse Event|0
358432|NCT01049360|1206262|P8|Period 1|Adverse Event|1
358433|NCT01049360|1206263|P7|Period 1|Adverse Event|0
358434|NCT01049360|1206264|P6|Period 1|Adverse Event|0
358435|NCT01049360|1206265|P5|Period 1|Adverse Event|0
358436|NCT01049360|1206266|P4|Period 1|Adverse Event|1
358437|NCT01049360|1206267|P3|Period 1|Adverse Event|0
358438|NCT01049360|1206268|P2|Period 1|Adverse Event|1
358439|NCT01049360|1206269|P1|Period 1|Adverse Event|0
358440|NCT01049334|1206293|P2|Overall Study|Protocol Violation|1
358441|NCT01049334|1206294|P1|Overall Study|Protocol Violation|0
358442|NCT01049334|1206293|P2|Overall Study|Physician Decision|0
358443|NCT01049334|1206294|P1|Overall Study|Physician Decision|2
358444|NCT01049334|1206293|P2|Overall Study|Adverse Event|3
358445|NCT01049334|1206294|P1|Overall Study|Adverse Event|2
358446|NCT01049334|1206293|P2|Overall Study|Withdrawal by Subject|3
358447|NCT01049334|1206294|P1|Overall Study|Withdrawal by Subject|5
358448|NCT01049308|1206330|P1|Pill Counts|Withdrawal by Subject|83
358449|NCT01049217|1206344|P2|Overall Study|Randomized but not Treated|2
358450|NCT01049217|1206345|P1|Overall Study|Randomized but not Treated|0
358451|NCT01049217|1206344|P2|Overall Study|Other|2
358452|NCT01049217|1206345|P1|Overall Study|Other|1
358453|NCT01049217|1206344|P2|Overall Study|Study Terminated by Sponsor|43
358454|NCT01049217|1206345|P1|Overall Study|Study Terminated by Sponsor|43
358455|NCT01049217|1206344|P2|Overall Study|Pregnancy|0
358456|NCT01049217|1206345|P1|Overall Study|Pregnancy|1
358457|NCT01049217|1206344|P2|Overall Study|Protocol Violation|3
358458|NCT01049217|1206345|P1|Overall Study|Protocol Violation|1
358459|NCT01049217|1206344|P2|Overall Study|Withdrawal by Subject|3
358460|NCT01049217|1206345|P1|Overall Study|Withdrawal by Subject|4
358461|NCT01049217|1206344|P2|Overall Study|Lost to Follow-up|8
358462|NCT01049217|1206345|P1|Overall Study|Lost to Follow-up|3
358463|NCT01049217|1206344|P2|Overall Study|Lack of Efficacy|1
358464|NCT01049217|1206345|P1|Overall Study|Lack of Efficacy|1
358465|NCT01049217|1206344|P2|Overall Study|Adverse Event|1
358466|NCT01049217|1206345|P1|Overall Study|Adverse Event|2
358467|NCT01049009|1206417|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
358468|NCT01049009|1206418|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
358469|NCT01049009|1206417|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
358470|NCT01049009|1206418|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
358471|NCT01049009|1206417|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
358472|NCT01049009|1206418|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
358473|NCT01049009|1206417|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
358474|NCT01049009|1206418|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
358475|NCT01048944|1206430|P4|Overall Study|Protocol Violation|2
358476|NCT01048944|1206431|P3|Overall Study|Protocol Violation|10
358477|NCT01048944|1206432|P2|Overall Study|Protocol Violation|10
358478|NCT01048944|1206433|P1|Overall Study|Protocol Violation|8
358479|NCT01048866|1206465|P2|Overall Study|not specified|1
358480|NCT01048866|1206466|P1|Overall Study|not specified|1
358481|NCT01048866|1206465|P2|Overall Study|Lost to Follow-up|2
358482|NCT01048866|1206466|P1|Overall Study|Lost to Follow-up|0
358483|NCT01048866|1206465|P2|Overall Study|Withdrawal by Subject|2
358484|NCT01048866|1206466|P1|Overall Study|Withdrawal by Subject|0
358485|NCT01048866|1206465|P2|Overall Study|Physician Decision|0
358486|NCT01048866|1206466|P1|Overall Study|Physician Decision|1
358487|NCT01048866|1206465|P2|Overall Study|Protocol Violation|0
358488|NCT01048866|1206466|P1|Overall Study|Protocol Violation|1
358489|NCT01048866|1206465|P2|Overall Study|Adverse Event|0
358490|NCT01048866|1206466|P1|Overall Study|Adverse Event|1
358491|NCT01048788|1206511|P3|Overall Study|Withdrawal by Subject|0
358492|NCT01048788|1206512|P2|Overall Study|Withdrawal by Subject|1
358493|NCT01048788|1206513|P1|Overall Study|Withdrawal by Subject|0
358494|NCT01048788|1206511|P3|Overall Study|Lack of Efficacy|1
358495|NCT01048788|1206512|P2|Overall Study|Lack of Efficacy|0
358496|NCT01048788|1206513|P1|Overall Study|Lack of Efficacy|0
358497|NCT01048788|1206511|P3|Overall Study|Adverse Event|1
358498|NCT01048788|1206512|P2|Overall Study|Adverse Event|1
358499|NCT01048788|1206513|P1|Overall Study|Adverse Event|5
358500|NCT01048671|1206535|P3|Overall Study|Protocol Violation|1
358501|NCT01048671|1206536|P2|Overall Study|Protocol Violation|1
358502|NCT01048671|1206537|P1|Overall Study|Protocol Violation|0
358503|NCT01048541|1206605|P2|Overall Study|Withdrawal by Subject|0
358504|NCT01048541|1206606|P1|Overall Study|Withdrawal by Subject|1
358505|NCT01048502|1206616|P4|Overall Study|Physician Decision|1
358506|NCT01048502|1206617|P3|Overall Study|Physician Decision|0
358507|NCT01048502|1206618|P2|Overall Study|Physician Decision|3
358508|NCT01048502|1206619|P1|Overall Study|Physician Decision|0
358509|NCT01048502|1206616|P4|Overall Study|Withdrawal by Subject|3
358510|NCT01048502|1206617|P3|Overall Study|Withdrawal by Subject|5
358511|NCT01048502|1206618|P2|Overall Study|Withdrawal by Subject|4
358512|NCT01048502|1206619|P1|Overall Study|Withdrawal by Subject|1
358513|NCT01048502|1206616|P4|Overall Study|Adverse Event|0
358514|NCT01048502|1206617|P3|Overall Study|Adverse Event|0
358515|NCT01048502|1206618|P2|Overall Study|Adverse Event|0
358516|NCT01048502|1206619|P1|Overall Study|Adverse Event|1
358517|NCT01048502|1206616|P4|Overall Study|Lost to Follow-up|0
358518|NCT01048502|1206617|P3|Overall Study|Lost to Follow-up|0
358519|NCT01048502|1206618|P2|Overall Study|Lost to Follow-up|0
358520|NCT01048502|1206619|P1|Overall Study|Lost to Follow-up|2
358521|NCT01048333|1206655|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
358522|NCT01048333|1206656|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
358523|NCT01048333|1206657|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
358524|NCT01048333|1206658|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
358525|NCT01048333|1206659|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
358526|NCT01048333|1206660|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
358527|NCT01048242|1206682|P2|Overall Study|See study flow chart|2
358528|NCT01048242|1206683|P1|Overall Study|See study flow chart|4
358529|NCT01048099|1206698|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
358530|NCT01048099|1206698|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
358531|NCT01047553|1206728|P2|Overall Study|PI's decision|1
358532|NCT01047553|1206729|P1|Overall Study|PI's decision|0
358533|NCT01047553|1206728|P2|Overall Study|Sever Non-Compliance to Protocol|0
358534|NCT01047553|1206729|P1|Overall Study|Sever Non-Compliance to Protocol|1
358535|NCT01047553|1206728|P2|Overall Study|Lost to Follow-up|0
358536|NCT01047553|1206729|P1|Overall Study|Lost to Follow-up|1
358537|NCT01047553|1206728|P2|Overall Study|Development of Study-Specific Withdrawal|1
358538|NCT01047553|1206729|P1|Overall Study|Development of Study-Specific Withdrawal|1
358539|NCT01047553|1206728|P2|Overall Study|Withdrawal by Subject|2
358540|NCT01047553|1206729|P1|Overall Study|Withdrawal by Subject|4
358541|NCT01047553|1206728|P2|Overall Study|Adverse Event|5
358542|NCT01047553|1206729|P1|Overall Study|Adverse Event|10
358543|NCT01047436|1206836|P2|Overall Study|Protocol Violation|0
358544|NCT01047436|1206837|P1|Overall Study|Protocol Violation|1
358545|NCT01047345|1206862|P3|Extension|Lost to Follow-up|5
358546|NCT01047345|1206863|P2|Extension|Lost to Follow-up|0
358547|NCT01047345|1206864|P1|Extension|Lost to Follow-up|0
358548|NCT01047345|1206862|P3|Extension|Withdrawal by Subject|1
358549|NCT01047345|1206863|P2|Extension|Withdrawal by Subject|0
358550|NCT01047345|1206864|P1|Extension|Withdrawal by Subject|0
358551|NCT01047345|1206862|P3|Base Study|Withdrawal by Subject|0
358552|NCT01047345|1206863|P2|Base Study|Withdrawal by Subject|4
358553|NCT01047345|1206864|P1|Base Study|Withdrawal by Subject|12
358554|NCT01047345|1206862|P3|Base Study|Protocol Violation|0
358555|NCT01047345|1206863|P2|Base Study|Protocol Violation|1
358556|NCT01047345|1206864|P1|Base Study|Protocol Violation|3
358557|NCT01047345|1206862|P3|Base Study|Lost to Follow-up|0
358558|NCT01047345|1206863|P2|Base Study|Lost to Follow-up|1
358559|NCT01047345|1206864|P1|Base Study|Lost to Follow-up|4
358560|NCT01047345|1206862|P3|Base Study|Adverse Event|0
358561|NCT01047345|1206863|P2|Base Study|Adverse Event|0
358562|NCT01047345|1206864|P1|Base Study|Adverse Event|3
358563|NCT01047332|1206886|P2|Overall Study|Lost to Follow-up|3
358564|NCT01047332|1206887|P1|Overall Study|Lost to Follow-up|8
358565|NCT01047332|1206886|P2|Overall Study|Died Unobstructed|41
358566|NCT01047332|1206887|P1|Overall Study|Died Unobstructed|38
358567|NCT01047332|1206886|P2|Overall Study|SEMS Obstruction|20
358568|NCT01047332|1206887|P1|Overall Study|SEMS Obstruction|11
358569|NCT01047306|1206901|P2|Overall Study|Lost to Follow-up|0
358570|NCT01047306|1206902|P1|Overall Study|Lost to Follow-up|1
358571|NCT01047306|1206901|P2|Overall Study|Withdrawal by Subject|0
358572|NCT01047306|1206902|P1|Overall Study|Withdrawal by Subject|2
358573|NCT01047293|1206976|P4|Overall Study|DLT criteria not fulfilled|0
358574|NCT01047293|1206977|P3|Overall Study|DLT criteria not fulfilled|0
358575|NCT01047293|1206978|P2|Overall Study|DLT criteria not fulfilled|1
358576|NCT01047293|1206979|P1|Overall Study|DLT criteria not fulfilled|1
358577|NCT01046903|1207006|P1|Overall Study|Other|5
358578|NCT01046903|1207006|P1|Overall Study|Withdrawal by Subject|3
358579|NCT01046903|1207006|P1|Overall Study|Adverse Event|4
358580|NCT01046903|1207006|P1|Overall Study|Lost to Follow-up|16
358581|NCT01046877|1207019|P1|Overall Study|Exited voluntarily after tube extrusion|11
358582|NCT01046877|1207019|P1|Overall Study|Exited voluntarily before tube extrusion|7
358583|NCT01046695|1207035|P2|Overall Study|TENS interfered with the cardiac monitor|1
358584|NCT01046695|1207036|P1|Overall Study|TENS interfered with the cardiac monitor|0
358585|NCT01046695|1207035|P2|Overall Study|Subject had a pacemaker|1
358586|NCT01046695|1207036|P1|Overall Study|Subject had a pacemaker|0
358587|NCT01046682|1207048|P2|Overall Study|Adverse Event|0
358588|NCT01046682|1207049|P1|Overall Study|Adverse Event|2
358589|NCT01046643|1207057|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
358590|NCT01046643|1207058|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
358591|NCT01046643|1207059|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
358592|NCT01046643|1207060|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
358593|NCT01046565|1207082|P1|Overall Study|Withdrawal by Subject|7
358594|NCT01046565|1207082|P1|Overall Study|Adverse Event|2
358595|NCT01046396|1207091|P1|Overall Study|Withdrawal by Subject|5
358596|NCT01046253|1207102|P2|Second Intervention|Protocol Violation|1
358597|NCT01046253|1207103|P1|Second Intervention|Protocol Violation|0
358598|NCT01046253|1207102|P2|Second Intervention|Adverse Event|1
358599|NCT01046253|1207103|P1|Second Intervention|Adverse Event|0
358600|NCT01046136|1207115|P2|Overall Study|Lost to Follow-up|3
358601|NCT01046136|1207116|P1|Overall Study|Lost to Follow-up|3
358602|NCT01046136|1207115|P2|Overall Study|Physician Decision|1
358603|NCT01046136|1207116|P1|Overall Study|Physician Decision|1
358604|NCT01046136|1207115|P2|Overall Study|Withdrawal by Subject|4
358605|NCT01046136|1207116|P1|Overall Study|Withdrawal by Subject|0
358606|NCT01046110|1207128|P2|Overall Study|Unclassified|35
358607|NCT01046110|1207129|P1|Overall Study|Unclassified|36
358608|NCT01046110|1207128|P2|Overall Study|Withdrawal Criteria|5
358609|NCT01046110|1207129|P1|Overall Study|Withdrawal Criteria|3
358610|NCT01046110|1207128|P2|Overall Study|Protocol Violation|12
358611|NCT01046110|1207129|P1|Overall Study|Protocol Violation|7
358612|NCT01046110|1207128|P2|Overall Study|Lack of Efficacy|1
358613|NCT01046110|1207129|P1|Overall Study|Lack of Efficacy|0
358614|NCT01046110|1207128|P2|Overall Study|Adverse Event|2
358615|NCT01046110|1207129|P1|Overall Study|Adverse Event|9
358616|NCT01046084|1207139|P2|Third Washout of 7 Days|Withdrawal by Subject|0
358617|NCT01046084|1207140|P1|Third Washout of 7 Days|Withdrawal by Subject|2
358618|NCT01045993|1207154|P4|Overall Study|Treated-later found eligibility not met|0
358619|NCT01045993|1207155|P3|Overall Study|Treated-later found eligibility not met|0
358620|NCT01045993|1207156|P2|Overall Study|Treated-later found eligibility not met|1
358621|NCT01045993|1207157|P1|Overall Study|Treated-later found eligibility not met|0
358622|NCT01045967|1207233|P2|Second Intervention|Protocol Violation|1
358623|NCT01045967|1207234|P1|Second Intervention|Protocol Violation|0
358624|NCT01045798|1207246|P2|Overall Study|Received Systemic Antifungal Prestudy|1
358625|NCT01045798|1207247|P1|Overall Study|Received Systemic Antifungal Prestudy|0
358626|NCT01045798|1207246|P2|Overall Study|Changed to Other Antifungal Therapy|2
358627|NCT01045798|1207247|P1|Overall Study|Changed to Other Antifungal Therapy|1
358628|NCT01045798|1207246|P2|Overall Study|Invasive Fungal Infection at Baseline|1
358629|NCT01045798|1207247|P1|Overall Study|Invasive Fungal Infection at Baseline|0
358630|NCT01045798|1207246|P2|Overall Study|Changed to Open-Label Caspofungin|0
358631|NCT01045798|1207247|P1|Overall Study|Changed to Open-Label Caspofungin|1
358632|NCT01045707|1207255|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
358633|NCT01045707|1207256|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
358634|NCT01045707|1207255|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
358635|NCT01045707|1207256|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
358636|NCT01045707|1207255|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
358637|NCT01045707|1207256|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
358638|NCT01045707|1207255|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
358639|NCT01045707|1207256|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
358640|NCT01045707|1207255|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
358641|NCT01045707|1207256|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
358642|NCT01045707|1207255|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
358643|NCT01045707|1207256|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
358644|NCT01045707|1207255|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
358645|NCT01045707|1207256|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
358646|NCT01045707|1207255|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
358647|NCT01045707|1207256|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
358648|NCT01045707|1207255|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
358649|NCT01045707|1207256|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
358650|NCT01045694|1207272|P1|Overall Study|Withdrawal by Subject|2
358651|NCT01045447|1207288|P2|Overall Study|Unclassified|13
358652|NCT01045447|1207289|P1|Overall Study|Unclassified|17
358653|NCT01045447|1207288|P2|Overall Study|Withdrawal Criteria|10
358654|NCT01045447|1207289|P1|Overall Study|Withdrawal Criteria|10
358655|NCT01045447|1207288|P2|Overall Study|Protocol Violation|3
358656|NCT01045447|1207289|P1|Overall Study|Protocol Violation|6
358657|NCT01045447|1207288|P2|Overall Study|Lack of Efficacy|1
358658|NCT01045447|1207289|P1|Overall Study|Lack of Efficacy|3
358659|NCT01045447|1207288|P2|Overall Study|Adverse Event|1
358660|NCT01045447|1207289|P1|Overall Study|Adverse Event|0
358661|NCT01045421|1207303|P11|Phase 2|Other|1
358662|NCT01045421|1207304|P10|Phase 2|Other|0
358663|NCT01045421|1207305|P9|Phase 2|Other|0
358664|NCT01045421|1207306|P8|Phase 2|Other|3
358665|NCT01045421|1207307|P7|Phase 2|Other|0
358666|NCT01045421|1207308|P6|Phase 2|Other|0
358667|NCT01045421|1207309|P5|Phase 2|Other|0
358668|NCT01045421|1207310|P4|Phase 2|Other|0
358669|NCT01045421|1207311|P3|Phase 2|Other|0
358670|NCT01045421|1207312|P2|Phase 2|Other|0
358671|NCT01045421|1207313|P1|Phase 2|Other|0
358672|NCT01045421|1207303|P11|Phase 2|Death|0
358673|NCT01045421|1207304|P10|Phase 2|Death|2
358674|NCT01045421|1207305|P9|Phase 2|Death|1
358675|NCT01045421|1207306|P8|Phase 2|Death|1
358676|NCT01045421|1207307|P7|Phase 2|Death|0
358677|NCT01045421|1207308|P6|Phase 2|Death|0
358678|NCT01045421|1207309|P5|Phase 2|Death|0
358679|NCT01045421|1207310|P4|Phase 2|Death|0
358680|NCT01045421|1207311|P3|Phase 2|Death|0
358681|NCT01045421|1207312|P2|Phase 2|Death|0
358682|NCT01045421|1207313|P1|Phase 2|Death|0
358683|NCT01045421|1207303|P11|Phase 2|Progressive Disease|1
358684|NCT01045421|1207304|P10|Phase 2|Progressive Disease|1
358685|NCT01045421|1207305|P9|Phase 2|Progressive Disease|1
358686|NCT01045421|1207306|P8|Phase 2|Progressive Disease|1
358687|NCT01045421|1207307|P7|Phase 2|Progressive Disease|0
358688|NCT01045421|1207308|P6|Phase 2|Progressive Disease|0
358689|NCT01045421|1207309|P5|Phase 2|Progressive Disease|0
358690|NCT01045421|1207310|P4|Phase 2|Progressive Disease|0
358691|NCT01045421|1207311|P3|Phase 2|Progressive Disease|0
358692|NCT01045421|1207312|P2|Phase 2|Progressive Disease|0
358693|NCT01045421|1207313|P1|Phase 2|Progressive Disease|0
358694|NCT01045421|1207303|P11|Phase 1|Withdrawal by Subject|0
358695|NCT01045421|1207304|P10|Phase 1|Withdrawal by Subject|0
358696|NCT01045421|1207305|P9|Phase 1|Withdrawal by Subject|0
358697|NCT01045421|1207306|P8|Phase 1|Withdrawal by Subject|0
358698|NCT01045421|1207307|P7|Phase 1|Withdrawal by Subject|0
358699|NCT01045421|1207308|P6|Phase 1|Withdrawal by Subject|0
358700|NCT01045421|1207309|P5|Phase 1|Withdrawal by Subject|0
358701|NCT01045421|1207310|P4|Phase 1|Withdrawal by Subject|1
358702|NCT01045421|1207311|P3|Phase 1|Withdrawal by Subject|0
358703|NCT01045421|1207312|P2|Phase 1|Withdrawal by Subject|0
358704|NCT01045421|1207313|P1|Phase 1|Withdrawal by Subject|0
358705|NCT01045421|1207303|P11|Phase 1|Progressive Disease|0
358706|NCT01045421|1207304|P10|Phase 1|Progressive Disease|0
358707|NCT01045421|1207305|P9|Phase 1|Progressive Disease|0
358708|NCT01045421|1207306|P8|Phase 1|Progressive Disease|0
358709|NCT01045421|1207307|P7|Phase 1|Progressive Disease|0
358710|NCT01045421|1207308|P6|Phase 1|Progressive Disease|0
358711|NCT01045421|1207309|P5|Phase 1|Progressive Disease|1
358712|NCT01045421|1207310|P4|Phase 1|Progressive Disease|0
358713|NCT01045421|1207311|P3|Phase 1|Progressive Disease|0
358714|NCT01045421|1207312|P2|Phase 1|Progressive Disease|0
358715|NCT01045421|1207313|P1|Phase 1|Progressive Disease|0
358716|NCT01045161|1207407|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
358717|NCT01045161|1207408|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
358718|NCT01045161|1207409|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
358719|NCT01045161|1207407|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
358720|NCT01045161|1207408|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
358721|NCT01045161|1207409|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
358722|NCT01045161|1207407|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
358723|NCT01045161|1207408|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
358724|NCT01045161|1207409|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
358725|NCT01045161|1207407|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
358726|NCT01045161|1207408|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
358727|NCT01045161|1207409|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
358728|NCT01045161|1207407|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
358729|NCT01045161|1207408|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
358730|NCT01045161|1207409|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
358731|NCT01045161|1207407|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
358732|NCT01045161|1207408|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
358733|NCT01045161|1207409|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
358734|NCT01045161|1207407|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
358735|NCT01045161|1207408|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
358736|NCT01045161|1207409|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
358737|NCT01045161|1207407|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
358738|NCT01045161|1207408|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
358739|NCT01045161|1207409|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
358740|NCT01045161|1207407|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
358741|NCT01045161|1207408|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
358742|NCT01045161|1207409|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
358743|NCT01045161|1207407|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
358744|NCT01045161|1207408|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
358745|NCT01045161|1207409|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
358746|NCT01045161|1207407|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
358747|NCT01045161|1207408|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
358748|NCT01045161|1207409|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
358749|NCT01045161|1207407|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
358750|NCT01045161|1207408|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
358751|NCT01045161|1207409|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
358752|NCT01045161|1207407|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
358753|NCT01045161|1207408|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
358754|NCT01045161|1207409|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
358755|NCT01045161|1207407|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
358756|NCT01045161|1207408|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
358757|NCT01045161|1207409|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
358758|NCT01045096|1207439|P3|Overall Study|Other|0
358759|NCT01045096|1207440|P2|Overall Study|Other|0
358760|NCT01045096|1207441|P1|Overall Study|Other|1
358761|NCT01045096|1207439|P3|Overall Study|Withdrawal by Subject|0
358762|NCT01045096|1207440|P2|Overall Study|Withdrawal by Subject|0
358763|NCT01045096|1207441|P1|Overall Study|Withdrawal by Subject|2
358764|NCT01044732|1207552|P2|Overall Study|Technical error or malfunction|14
358765|NCT01044732|1207553|P1|Overall Study|Technical error or malfunction|15
358766|NCT01044732|1207552|P2|Overall Study|Inability to reach cecum|2
358767|NCT01044732|1207553|P1|Overall Study|Inability to reach cecum|5
358768|NCT01044732|1207552|P2|Overall Study|Inadequate bowel preparation|17
358769|NCT01044732|1207553|P1|Overall Study|Inadequate bowel preparation|11
358770|NCT01044732|1207552|P2|Overall Study|Withdrawal by Subject|1
358771|NCT01044732|1207553|P1|Overall Study|Withdrawal by Subject|0
358772|NCT01044732|1207552|P2|Overall Study|Protocol Violation|12
358773|NCT01044732|1207553|P1|Overall Study|Protocol Violation|11
358774|NCT01044732|1207552|P2|Overall Study|Physician Decision|3
358775|NCT01044732|1207553|P1|Overall Study|Physician Decision|5
358776|NCT01044732|1207552|P2|Overall Study|Lost to Follow-up|1
358777|NCT01044732|1207553|P1|Overall Study|Lost to Follow-up|2
358778|NCT01044498|1207742|P2|Overall Study|Not specified|0
358779|NCT01044498|1207743|P1|Overall Study|Not specified|1
358780|NCT01044498|1207742|P2|Overall Study|Adverse Event|1
358781|NCT01044498|1207743|P1|Overall Study|Adverse Event|1
358782|NCT01044498|1207742|P2|Overall Study|Withdrew consent|1
358783|NCT01044498|1207743|P1|Overall Study|Withdrew consent|1
358784|NCT01044459|1207769|P2|Overall Study|Lost to Follow-up|12
358785|NCT01044459|1207770|P1|Overall Study|Lost to Follow-up|18
358786|NCT01044459|1207769|P2|Overall Study|COPD exacerbation|8
358787|NCT01044459|1207770|P1|Overall Study|COPD exacerbation|9
358788|NCT01044459|1207769|P2|Overall Study|Other Reason|14
358789|NCT01044459|1207770|P1|Overall Study|Other Reason|7
358790|NCT01044459|1207769|P2|Overall Study|Protocol Violation|16
358791|NCT01044459|1207770|P1|Overall Study|Protocol Violation|11
358792|NCT01044459|1207769|P2|Overall Study|Lack of Efficacy|12
358793|NCT01044459|1207770|P1|Overall Study|Lack of Efficacy|23
358794|NCT01044459|1207769|P2|Overall Study|Adverse Event|20
358795|NCT01044459|1207770|P1|Overall Study|Adverse Event|22
358796|NCT01044459|1207769|P2|Overall Study|Terminated by Sponsor|21
358797|NCT01044459|1207770|P1|Overall Study|Terminated by Sponsor|22
358798|NCT01044459|1207769|P2|Overall Study|Withdrawal by Subject|28
358799|NCT01044459|1207770|P1|Overall Study|Withdrawal by Subject|21
358800|NCT01044303|1207778|P1|Overall Study|Lost to Follow-up|2
358801|NCT01044290|1207788|P3|Follow-Up 2|Withdrawal by Subject|1
358802|NCT01044290|1207789|P2|Follow-Up 2|Withdrawal by Subject|1
358803|NCT01044290|1207790|P1|Follow-Up 2|Withdrawal by Subject|0
358804|NCT01044290|1207788|P3|Follow-Up 2|Death|1
358805|NCT01044290|1207789|P2|Follow-Up 2|Death|1
358806|NCT01044290|1207790|P1|Follow-Up 2|Death|0
358807|NCT01044290|1207788|P3|Follow-up 1|Withdrawal by Subject|0
358808|NCT01044290|1207789|P2|Follow-up 1|Withdrawal by Subject|2
358809|NCT01044290|1207790|P1|Follow-up 1|Withdrawal by Subject|2
358810|NCT01044290|1207788|P3|Follow-up 1|Death|1
358811|NCT01044290|1207789|P2|Follow-up 1|Death|3
358812|NCT01044290|1207790|P1|Follow-up 1|Death|3
358813|NCT01043874|1207910|P1|Overall Study|Administrative Problems|1
358814|NCT01043874|1207910|P1|Overall Study|Lack of Efficacy|1
358815|NCT01043874|1207910|P1|Overall Study|Withdrawal by Subject|1
358816|NCT01043874|1207910|P1|Overall Study|Adverse Event|3
358817|NCT01043705|1207920|P3|Overall Study|Other|25
358818|NCT01043705|1207921|P2|Overall Study|Other|19
358819|NCT01043705|1207922|P1|Overall Study|Other|0
358820|NCT01043705|1207920|P3|Overall Study|Screen Fail|0
358821|NCT01043705|1207921|P2|Overall Study|Screen Fail|0
358822|NCT01043705|1207922|P1|Overall Study|Screen Fail|21
358823|NCT01043705|1207920|P3|Overall Study|Adverse Event|0
358824|NCT01043705|1207921|P2|Overall Study|Adverse Event|2
358825|NCT01043705|1207922|P1|Overall Study|Adverse Event|0
358826|NCT01043705|1207920|P3|Overall Study|Subsequent Procedure|29
358827|NCT01043705|1207921|P2|Overall Study|Subsequent Procedure|24
358828|NCT01043705|1207922|P1|Overall Study|Subsequent Procedure|9
358829|NCT01043705|1207920|P3|Overall Study|Site Closure|0
358830|NCT01043705|1207921|P2|Overall Study|Site Closure|0
358831|NCT01043705|1207922|P1|Overall Study|Site Closure|8
358832|NCT01043705|1207920|P3|Overall Study|Withdrawal by Subject|0
358833|NCT01043705|1207921|P2|Overall Study|Withdrawal by Subject|6
358834|NCT01043705|1207922|P1|Overall Study|Withdrawal by Subject|8
358835|NCT01043705|1207920|P3|Overall Study|Protocol Violation|0
358836|NCT01043705|1207921|P2|Overall Study|Protocol Violation|1
358837|NCT01043705|1207922|P1|Overall Study|Protocol Violation|2
358838|NCT01043705|1207920|P3|Overall Study|Multiple Reasons|0
358839|NCT01043705|1207921|P2|Overall Study|Multiple Reasons|7
358840|NCT01043705|1207922|P1|Overall Study|Multiple Reasons|4
358841|NCT01043705|1207920|P3|Overall Study|Lost to Follow-up|0
358842|NCT01043705|1207921|P2|Overall Study|Lost to Follow-up|12
358843|NCT01043705|1207922|P1|Overall Study|Lost to Follow-up|27
358844|NCT01043705|1207920|P3|Overall Study|Death|26
358845|NCT01043705|1207921|P2|Overall Study|Death|60
358846|NCT01043705|1207922|P1|Overall Study|Death|28
358847|NCT01043185|1208011|P10|Period 6 - Third Washout Period|Protocol Violation|0
358848|NCT01043185|1208012|P9|Period 6 - Third Washout Period|Protocol Violation|1
358849|NCT01043185|1208013|P8|Period 6 - Third Washout Period|Protocol Violation|0
358850|NCT01043185|1208014|P7|Period 6 - Third Washout Period|Protocol Violation|0
358851|NCT01043185|1208015|P6|Period 6 - Third Washout Period|Protocol Violation|0
358852|NCT01043185|1208016|P5|Period 6 - Third Washout Period|Protocol Violation|0
358853|NCT01043185|1208017|P4|Period 6 - Third Washout Period|Protocol Violation|0
358854|NCT01043185|1208018|P3|Period 6 - Third Washout Period|Protocol Violation|0
358855|NCT01043185|1208019|P2|Period 6 - Third Washout Period|Protocol Violation|0
358856|NCT01043185|1208020|P1|Period 6 - Third Washout Period|Protocol Violation|0
358857|NCT01042977|1208096|P2|Overall Study|Various|0
358858|NCT01042977|1208097|P1|Overall Study|Various|3
358859|NCT01042977|1208096|P2|Overall Study|Administrative reason by sponsor|1
358860|NCT01042977|1208097|P1|Overall Study|Administrative reason by sponsor|0
358861|NCT01042977|1208096|P2|Overall Study|Safety|2
358862|NCT01042977|1208097|P1|Overall Study|Safety|0
358863|NCT01042977|1208096|P2|Overall Study|Incorrect enrollment|4
358864|NCT01042977|1208097|P1|Overall Study|Incorrect enrollment|6
358865|NCT01042977|1208096|P2|Overall Study|Subject no longer meets study criteria|13
358866|NCT01042977|1208097|P1|Overall Study|Subject no longer meets study criteria|15
358867|NCT01042977|1208096|P2|Overall Study|Poor/non-compliance|4
358868|NCT01042977|1208097|P1|Overall Study|Poor/non-compliance|3
358869|NCT01042977|1208096|P2|Overall Study|Lost to Follow-up|2
358870|NCT01042977|1208097|P1|Overall Study|Lost to Follow-up|0
358871|NCT01042977|1208096|P2|Overall Study|Withdrawal by Subject|16
358872|NCT01042977|1208097|P1|Overall Study|Withdrawal by Subject|8
358873|NCT01042977|1208096|P2|Overall Study|Death|1
358874|NCT01042977|1208097|P1|Overall Study|Death|2
358875|NCT01042977|1208096|P2|Overall Study|Adverse Event|12
358876|NCT01042977|1208097|P1|Overall Study|Adverse Event|4
358877|NCT01042938|1208117|P2|Overall Study|Ineligible: RTOG study conflict|0
358878|NCT01042938|1208118|P1|Overall Study|Ineligible: RTOG study conflict|1
358879|NCT01042938|1208117|P2|Overall Study|Protocol Violation|1
358880|NCT01042938|1208118|P1|Overall Study|Protocol Violation|1
358881|NCT01042938|1208117|P2|Overall Study|Withdrawal by Subject|1
358882|NCT01042938|1208118|P1|Overall Study|Withdrawal by Subject|1
358883|NCT01042678|1208137|P6|Overall Study|Physician Decision|0
358884|NCT01042678|1208138|P5|Overall Study|Physician Decision|0
358885|NCT01042678|1208139|P4|Overall Study|Physician Decision|0
358886|NCT01042678|1208140|P3|Overall Study|Physician Decision|0
358887|NCT01042678|1208141|P2|Overall Study|Physician Decision|0
358888|NCT01042678|1208142|P1|Overall Study|Physician Decision|1
358889|NCT01042600|1208180|P2|Overall Study|Ineligible|0
358890|NCT01042600|1208181|P1|Overall Study|Ineligible|1
358891|NCT01042535|1208189|P1|Overall Study|complications from other disease|2
358892|NCT01042535|1208189|P1|Overall Study|disease progression during treatment|3
358893|NCT01042535|1208189|P1|Overall Study|disease progression prior to treatment|3
358894|NCT01042392|1208223|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
358895|NCT01042392|1208224|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
358896|NCT01042392|1208225|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
358897|NCT01042392|1208226|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
358898|NCT01042392|1208223|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
358899|NCT01042392|1208224|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
358900|NCT01042392|1208225|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
358901|NCT01042392|1208226|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
358902|NCT01042392|1208223|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
358903|NCT01042392|1208224|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
358904|NCT01042392|1208225|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
358905|NCT01042392|1208226|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
358906|NCT01042392|1208223|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
358907|NCT01042392|1208224|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
358908|NCT01042392|1208225|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
358909|NCT01042392|1208226|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
358910|NCT01042392|1208223|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
358911|NCT01042392|1208224|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
358912|NCT01042392|1208225|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
358913|NCT01042392|1208226|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
358914|NCT01042392|1208223|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
358915|NCT01042392|1208224|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
358916|NCT01042392|1208225|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
358917|NCT01042392|1208226|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
358918|NCT01042392|1208223|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
358919|NCT01042392|1208224|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
359001|NCT01041859|1208382|P1|Open-Label Titration|Physician Decision|1
358920|NCT01042392|1208225|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
358921|NCT01042392|1208226|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
358922|NCT01042392|1208223|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
358923|NCT01042392|1208224|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
358924|NCT01042392|1208225|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
358925|NCT01042392|1208226|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
358926|NCT01042392|1208223|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
358927|NCT01042392|1208224|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
358928|NCT01042392|1208225|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
358929|NCT01042392|1208226|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
358930|NCT01042236|1208274|P6|Treatment Period 3|Protocol Violation|0
358931|NCT01042236|1208275|P5|Treatment Period 3|Protocol Violation|0
358932|NCT01042236|1208276|P4|Treatment Period 3|Protocol Violation|1
358933|NCT01042236|1208277|P3|Treatment Period 3|Protocol Violation|0
358934|NCT01042236|1208278|P2|Treatment Period 3|Protocol Violation|0
358935|NCT01042236|1208279|P1|Treatment Period 3|Protocol Violation|0
358936|NCT01042236|1208274|P6|Treatment Period 3|Adverse Event|0
358937|NCT01042236|1208275|P5|Treatment Period 3|Adverse Event|0
358938|NCT01042236|1208276|P4|Treatment Period 3|Adverse Event|1
358939|NCT01042236|1208277|P3|Treatment Period 3|Adverse Event|0
358940|NCT01042236|1208278|P2|Treatment Period 3|Adverse Event|0
358941|NCT01042236|1208279|P1|Treatment Period 3|Adverse Event|0
358942|NCT01042236|1208274|P6|Treatment Period 1|Adverse Event|0
358943|NCT01042236|1208275|P5|Treatment Period 1|Adverse Event|1
358944|NCT01042236|1208276|P4|Treatment Period 1|Adverse Event|0
358945|NCT01042236|1208277|P3|Treatment Period 1|Adverse Event|0
358946|NCT01042236|1208278|P2|Treatment Period 1|Adverse Event|1
358947|NCT01042236|1208279|P1|Treatment Period 1|Adverse Event|0
358948|NCT01042158|1208316|P1|Overall Study|Physician Decision|1
358949|NCT01042093|1208346|P4|Overall Study|Withdrawal by Subject|1
358950|NCT01042093|1208347|P3|Overall Study|Withdrawal by Subject|0
358951|NCT01042093|1208348|P2|Overall Study|Withdrawal by Subject|0
358952|NCT01042093|1208349|P1|Overall Study|Withdrawal by Subject|0
358953|NCT01042093|1208346|P4|Overall Study|Protocol Violation|3
358954|NCT01042093|1208347|P3|Overall Study|Protocol Violation|2
358955|NCT01042093|1208348|P2|Overall Study|Protocol Violation|2
358956|NCT01042093|1208349|P1|Overall Study|Protocol Violation|2
358957|NCT01041976|1208369|P2|Overall Study|Death|4
358958|NCT01041976|1208370|P1|Overall Study|Death|0
358959|NCT01041976|1208369|P2|Overall Study|Incarceration|0
358960|NCT01041976|1208370|P1|Overall Study|Incarceration|2
358961|NCT01041976|1208369|P2|Overall Study|Withdrawal by Subject|0
358962|NCT01041976|1208370|P1|Overall Study|Withdrawal by Subject|3
358963|NCT01041859|1208380|P3|Double-Blind Maintenance|Withdrawal by Subject|9
358964|NCT01041859|1208381|P2|Double-Blind Maintenance|Withdrawal by Subject|8
358965|NCT01041859|1208382|P1|Double-Blind Maintenance|Withdrawal by Subject|0
358966|NCT01041859|1208380|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
358967|NCT01041859|1208381|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
358968|NCT01041859|1208382|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
358969|NCT01041859|1208380|P3|Double-Blind Maintenance|Other|2
358970|NCT01041859|1208381|P2|Double-Blind Maintenance|Other|6
358971|NCT01041859|1208382|P1|Double-Blind Maintenance|Other|0
358972|NCT01041859|1208380|P3|Double-Blind Maintenance|Protocol Violation|3
358973|NCT01041859|1208381|P2|Double-Blind Maintenance|Protocol Violation|1
358974|NCT01041859|1208382|P1|Double-Blind Maintenance|Protocol Violation|0
358975|NCT01041859|1208380|P3|Double-Blind Maintenance|Physician Decision|1
358976|NCT01041859|1208381|P2|Double-Blind Maintenance|Physician Decision|2
358977|NCT01041859|1208382|P1|Double-Blind Maintenance|Physician Decision|0
358978|NCT01041859|1208380|P3|Double-Blind Maintenance|Lost to Follow-up|0
358979|NCT01041859|1208381|P2|Double-Blind Maintenance|Lost to Follow-up|1
358980|NCT01041859|1208382|P1|Double-Blind Maintenance|Lost to Follow-up|0
358981|NCT01041859|1208380|P3|Double-Blind Maintenance|Lack of Efficacy|11
358982|NCT01041859|1208381|P2|Double-Blind Maintenance|Lack of Efficacy|3
358983|NCT01041859|1208382|P1|Double-Blind Maintenance|Lack of Efficacy|0
358984|NCT01041859|1208380|P3|Double-Blind Maintenance|Adverse Event|13
358985|NCT01041859|1208381|P2|Double-Blind Maintenance|Adverse Event|23
358986|NCT01041859|1208382|P1|Double-Blind Maintenance|Adverse Event|0
358987|NCT01041859|1208380|P3|Open-Label Titration|Withdrawal by Subject|0
358988|NCT01041859|1208381|P2|Open-Label Titration|Withdrawal by Subject|0
358989|NCT01041859|1208382|P1|Open-Label Titration|Withdrawal by Subject|11
358990|NCT01041859|1208380|P3|Open-Label Titration|Noncompliance With Study Drug|0
358991|NCT01041859|1208381|P2|Open-Label Titration|Noncompliance With Study Drug|0
358992|NCT01041859|1208382|P1|Open-Label Titration|Noncompliance With Study Drug|8
358993|NCT01041859|1208380|P3|Open-Label Titration|Other|0
358994|NCT01041859|1208381|P2|Open-Label Titration|Other|0
358995|NCT01041859|1208382|P1|Open-Label Titration|Other|7
358996|NCT01041859|1208380|P3|Open-Label Titration|Protocol Violation|0
358997|NCT01041859|1208381|P2|Open-Label Titration|Protocol Violation|0
358998|NCT01041859|1208382|P1|Open-Label Titration|Protocol Violation|1
358999|NCT01041859|1208380|P3|Open-Label Titration|Physician Decision|0
359000|NCT01041859|1208381|P2|Open-Label Titration|Physician Decision|0
359002|NCT01041859|1208380|P3|Open-Label Titration|Lost to Follow-up|0
359003|NCT01041859|1208381|P2|Open-Label Titration|Lost to Follow-up|0
359004|NCT01041859|1208382|P1|Open-Label Titration|Lost to Follow-up|1
359005|NCT01041859|1208380|P3|Open-Label Titration|Lack of Efficacy|0
359006|NCT01041859|1208381|P2|Open-Label Titration|Lack of Efficacy|0
359007|NCT01041859|1208382|P1|Open-Label Titration|Lack of Efficacy|3
359008|NCT01041859|1208380|P3|Open-Label Titration|Adverse Event|0
359009|NCT01041859|1208381|P2|Open-Label Titration|Adverse Event|0
359010|NCT01041859|1208382|P1|Open-Label Titration|Adverse Event|69
359011|NCT01041638|1208397|P1|Overall Study|Withdrawal by Subject|11
359012|NCT01041638|1208397|P1|Overall Study|Physician Decision|4
359013|NCT01041638|1208397|P1|Overall Study|Lack of Efficacy|7
359014|NCT01041638|1208397|P1|Overall Study|Death|1
359015|NCT01041638|1208397|P1|Overall Study|Adverse Event|4
359016|NCT01041573|1208405|P4|Overall Study|positive to anti-HCV|0
359017|NCT01041573|1208406|P3|Overall Study|positive to anti-HCV|0
359018|NCT01041573|1208407|P2|Overall Study|positive to anti-HCV|0
359019|NCT01041573|1208408|P1|Overall Study|positive to anti-HCV|1
359020|NCT01041573|1208405|P4|Overall Study|further blood extraction|0
359021|NCT01041573|1208406|P3|Overall Study|further blood extraction|0
359022|NCT01041573|1208407|P2|Overall Study|further blood extraction|1
359023|NCT01041573|1208408|P1|Overall Study|further blood extraction|0
359024|NCT01041573|1208405|P4|Overall Study|relocation|1
359025|NCT01041573|1208406|P3|Overall Study|relocation|3
359026|NCT01041573|1208407|P2|Overall Study|relocation|4
359027|NCT01041573|1208408|P1|Overall Study|relocation|1
359028|NCT01041573|1208405|P4|Overall Study|Adverse Event|0
359029|NCT01041573|1208406|P3|Overall Study|Adverse Event|0
359030|NCT01041573|1208407|P2|Overall Study|Adverse Event|2
359031|NCT01041573|1208408|P1|Overall Study|Adverse Event|0
359032|NCT01041573|1208405|P4|Overall Study|Lost to Follow-up|1
359033|NCT01041573|1208406|P3|Overall Study|Lost to Follow-up|2
359034|NCT01041573|1208407|P2|Overall Study|Lost to Follow-up|1
359035|NCT01041573|1208408|P1|Overall Study|Lost to Follow-up|0
359036|NCT01041573|1208405|P4|Overall Study|Death|0
359037|NCT01041573|1208406|P3|Overall Study|Death|0
359038|NCT01041573|1208407|P2|Overall Study|Death|0
359039|NCT01041573|1208408|P1|Overall Study|Death|1
359040|NCT01041573|1208405|P4|Overall Study|Withdrawal by Subject|0
359041|NCT01041573|1208406|P3|Overall Study|Withdrawal by Subject|2
359042|NCT01041573|1208407|P2|Overall Study|Withdrawal by Subject|5
359043|NCT01041573|1208408|P1|Overall Study|Withdrawal by Subject|2
359044|NCT01041417|1208420|P2|Overall Study|Death|0
359045|NCT01041417|1208421|P1|Overall Study|Death|1
359046|NCT01041417|1208420|P2|Overall Study|Lost to Follow-up|1
359047|NCT01041417|1208421|P1|Overall Study|Lost to Follow-up|1
359048|NCT01041417|1208420|P2|Overall Study|Adverse Event|2
359049|NCT01041417|1208421|P1|Overall Study|Adverse Event|5
359050|NCT01041404|1208459|P2|Overall Study|Not Specified|23
359051|NCT01041404|1208460|P1|Overall Study|Not Specified|11
359052|NCT01041404|1208459|P2|Overall Study|Failure to Return|2
359053|NCT01041404|1208460|P1|Overall Study|Failure to Return|1
359054|NCT01041404|1208459|P2|Overall Study|Withdrawal by Subject|23
359055|NCT01041404|1208460|P1|Overall Study|Withdrawal by Subject|29
359056|NCT01041404|1208459|P2|Overall Study|Protocol Violation|0
359057|NCT01041404|1208460|P1|Overall Study|Protocol Violation|4
359058|NCT01041404|1208459|P2|Overall Study|Violation of Selection Criteria|1
359059|NCT01041404|1208460|P1|Overall Study|Violation of Selection Criteria|0
359060|NCT01041404|1208459|P2|Overall Study|Lack of Efficacy|210
359061|NCT01041404|1208460|P1|Overall Study|Lack of Efficacy|200
359062|NCT01041404|1208459|P2|Overall Study|Adverse Event|35
359063|NCT01041404|1208460|P1|Overall Study|Adverse Event|45
359064|NCT01041287|1208501|P2|Treatment Period 2 (3 Months)|Adverse Event|2
359065|NCT01041287|1208502|P1|Treatment Period 2 (3 Months)|Adverse Event|0
359066|NCT01041287|1208501|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
359067|NCT01041287|1208502|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
359068|NCT01040871|1208525|P2|Overall Study|Randomized and Not Treated|1
359069|NCT01040871|1208526|P1|Overall Study|Randomized and Not Treated|2
359070|NCT01040871|1208525|P2|Overall Study|drug supply issue|0
359071|NCT01040871|1208526|P1|Overall Study|drug supply issue|1
359072|NCT01040871|1208525|P2|Overall Study|Lack of Efficacy|1
359073|NCT01040871|1208526|P1|Overall Study|Lack of Efficacy|1
359074|NCT01040871|1208525|P2|Overall Study|Death|3
359075|NCT01040871|1208526|P1|Overall Study|Death|1
359076|NCT01040871|1208525|P2|Overall Study|Withdrawal by Subject|0
359077|NCT01040871|1208526|P1|Overall Study|Withdrawal by Subject|2
359078|NCT01040871|1208525|P2|Overall Study|Adverse Event|2
359079|NCT01040871|1208526|P1|Overall Study|Adverse Event|6
359080|NCT01040845|1208577|P2|Overall Study|Physician Decision|0
359081|NCT01040845|1208578|P1|Overall Study|Physician Decision|1
359082|NCT01040845|1208577|P2|Overall Study|Withdrawal by Subject|1
359083|NCT01040845|1208578|P1|Overall Study|Withdrawal by Subject|1
359084|NCT01040832|1208593|P2|Overall Study|Other|1
359085|NCT01040832|1208594|P1|Overall Study|Other|2
359086|NCT01040832|1208593|P2|Overall Study|Symptomatic deterioration|5
359087|NCT01040832|1208594|P1|Overall Study|Symptomatic deterioration|2
359088|NCT01040832|1208593|P2|Overall Study|Progressive disease|17
359089|NCT01040832|1208594|P1|Overall Study|Progressive disease|32
359090|NCT01040832|1208593|P2|Overall Study|Withdrawal by Subject|3
359091|NCT01040832|1208594|P1|Overall Study|Withdrawal by Subject|2
359092|NCT01040832|1208593|P2|Overall Study|Death|6
359093|NCT01040832|1208594|P1|Overall Study|Death|4
359094|NCT01040832|1208593|P2|Overall Study|Adverse Event|5
359095|NCT01040832|1208594|P1|Overall Study|Adverse Event|4
359096|NCT01040793|1208617|P6|Overall Study|Other reasons not listed above|0
359097|NCT01040793|1208618|P5|Overall Study|Other reasons not listed above|1
359098|NCT01040793|1208619|P4|Overall Study|Other reasons not listed above|0
359099|NCT01040793|1208620|P3|Overall Study|Other reasons not listed above|1
359100|NCT01040793|1208621|P2|Overall Study|Other reasons not listed above|0
359101|NCT01040793|1208622|P1|Overall Study|Other reasons not listed above|0
359102|NCT01040793|1208617|P6|Overall Study|Withdrawal by Subject|0
359103|NCT01040793|1208618|P5|Overall Study|Withdrawal by Subject|0
359104|NCT01040793|1208619|P4|Overall Study|Withdrawal by Subject|2
359105|NCT01040793|1208620|P3|Overall Study|Withdrawal by Subject|0
359106|NCT01040793|1208621|P2|Overall Study|Withdrawal by Subject|0
359107|NCT01040793|1208622|P1|Overall Study|Withdrawal by Subject|0
359108|NCT01040793|1208617|P6|Overall Study|Lost to Follow-up|0
359109|NCT01040793|1208618|P5|Overall Study|Lost to Follow-up|0
359110|NCT01040793|1208619|P4|Overall Study|Lost to Follow-up|0
359111|NCT01040793|1208620|P3|Overall Study|Lost to Follow-up|1
359112|NCT01040793|1208621|P2|Overall Study|Lost to Follow-up|1
359113|NCT01040793|1208622|P1|Overall Study|Lost to Follow-up|0
359114|NCT01040793|1208617|P6|Overall Study|Protocol Violation|0
359115|NCT01040793|1208618|P5|Overall Study|Protocol Violation|1
359116|NCT01040793|1208619|P4|Overall Study|Protocol Violation|0
359117|NCT01040793|1208620|P3|Overall Study|Protocol Violation|1
359118|NCT01040793|1208621|P2|Overall Study|Protocol Violation|1
359119|NCT01040793|1208622|P1|Overall Study|Protocol Violation|1
359120|NCT01040793|1208617|P6|Overall Study|Adverse Event|1
359121|NCT01040793|1208618|P5|Overall Study|Adverse Event|2
359122|NCT01040793|1208619|P4|Overall Study|Adverse Event|2
359123|NCT01040793|1208620|P3|Overall Study|Adverse Event|0
359124|NCT01040793|1208621|P2|Overall Study|Adverse Event|3
359125|NCT01040793|1208622|P1|Overall Study|Adverse Event|5
359126|NCT01040780|1208701|P2|Overall Study|Protocol Violation|3
359127|NCT01040780|1208702|P1|Overall Study|Protocol Violation|1
359128|NCT01040728|1208716|P4|Overall Study|Other reasons not listed above|0
359129|NCT01040728|1208717|P3|Overall Study|Other reasons not listed above|0
359130|NCT01040728|1208718|P2|Overall Study|Other reasons not listed above|1
359131|NCT01040728|1208719|P1|Overall Study|Other reasons not listed above|0
359132|NCT01040728|1208716|P4|Overall Study|Lack of Efficacy|1
359133|NCT01040728|1208717|P3|Overall Study|Lack of Efficacy|0
359134|NCT01040728|1208718|P2|Overall Study|Lack of Efficacy|1
359135|NCT01040728|1208719|P1|Overall Study|Lack of Efficacy|0
359136|NCT01040728|1208716|P4|Overall Study|Protocol Violation|1
359137|NCT01040728|1208717|P3|Overall Study|Protocol Violation|0
359138|NCT01040728|1208718|P2|Overall Study|Protocol Violation|0
359139|NCT01040728|1208719|P1|Overall Study|Protocol Violation|0
359140|NCT01040728|1208716|P4|Overall Study|Withdrawal by Subject|0
359141|NCT01040728|1208717|P3|Overall Study|Withdrawal by Subject|1
359142|NCT01040728|1208718|P2|Overall Study|Withdrawal by Subject|1
359143|NCT01040728|1208719|P1|Overall Study|Withdrawal by Subject|0
359144|NCT01040728|1208716|P4|Overall Study|Adverse Event|4
359145|NCT01040728|1208717|P3|Overall Study|Adverse Event|0
359146|NCT01040728|1208718|P2|Overall Study|Adverse Event|8
359147|NCT01040728|1208719|P1|Overall Study|Adverse Event|4
359148|NCT01040689|1208789|P4|Overall Study|Other reasons not listed above|0
359149|NCT01040689|1208790|P3|Overall Study|Other reasons not listed above|0
359150|NCT01040689|1208791|P2|Overall Study|Other reasons not listed above|1
359151|NCT01040689|1208792|P1|Overall Study|Other reasons not listed above|0
359152|NCT01040689|1208789|P4|Overall Study|Withdrawal by Subject|0
359153|NCT01040689|1208790|P3|Overall Study|Withdrawal by Subject|1
359154|NCT01040689|1208791|P2|Overall Study|Withdrawal by Subject|1
359155|NCT01040689|1208792|P1|Overall Study|Withdrawal by Subject|2
359156|NCT01040689|1208789|P4|Overall Study|Lost to Follow-up|0
359157|NCT01040689|1208790|P3|Overall Study|Lost to Follow-up|0
359158|NCT01040689|1208791|P2|Overall Study|Lost to Follow-up|0
359159|NCT01040689|1208792|P1|Overall Study|Lost to Follow-up|1
359160|NCT01040689|1208789|P4|Overall Study|Lack of Efficacy|0
359161|NCT01040689|1208790|P3|Overall Study|Lack of Efficacy|1
359162|NCT01040689|1208791|P2|Overall Study|Lack of Efficacy|0
359163|NCT01040689|1208792|P1|Overall Study|Lack of Efficacy|0
359164|NCT01040689|1208789|P4|Overall Study|Adverse Event|4
359165|NCT01040689|1208790|P3|Overall Study|Adverse Event|2
359166|NCT01040689|1208791|P2|Overall Study|Adverse Event|0
359167|NCT01040689|1208792|P1|Overall Study|Adverse Event|0
359168|NCT01040403|1208871|P1|Overall Study|Other reason not defined above|6
359169|NCT01040403|1208871|P1|Overall Study|Not treated|1
359170|NCT01040403|1208871|P1|Overall Study|Lost to Follow-up|1
359171|NCT01040403|1208871|P1|Overall Study|Protocol Violation|2
359172|NCT01040403|1208871|P1|Overall Study|Adverse Event|10
359173|NCT01040351|1209059|P2|Overall Study|poor ovarian response|2
359174|NCT01040351|1209060|P1|Overall Study|poor ovarian response|1
359175|NCT01040260|1209070|P2|Overall Study|Lost to Follow-up|5
359176|NCT01040260|1209071|P1|Overall Study|Lost to Follow-up|3
359177|NCT01040260|1209070|P2|Overall Study|Withdrawal by Subject|6
359178|NCT01040260|1209071|P1|Overall Study|Withdrawal by Subject|12
359179|NCT01040169|1209098|P2|Overall Study|Lost to Follow-up|8
359180|NCT01040169|1209099|P1|Overall Study|Lost to Follow-up|3
359181|NCT01040130|1209107|P6|Overall Study|Other reasons not listed above|0
359182|NCT01040130|1209108|P5|Overall Study|Other reasons not listed above|0
359183|NCT01040130|1209109|P4|Overall Study|Other reasons not listed above|0
359184|NCT01040130|1209110|P3|Overall Study|Other reasons not listed above|0
359185|NCT01040130|1209111|P2|Overall Study|Other reasons not listed above|0
359186|NCT01040130|1209112|P1|Overall Study|Other reasons not listed above|2
359187|NCT01040130|1209107|P6|Overall Study|Withdrawal by Subject|1
359188|NCT01040130|1209108|P5|Overall Study|Withdrawal by Subject|0
359189|NCT01040130|1209109|P4|Overall Study|Withdrawal by Subject|0
359190|NCT01040130|1209110|P3|Overall Study|Withdrawal by Subject|0
359191|NCT01040130|1209111|P2|Overall Study|Withdrawal by Subject|2
359192|NCT01040130|1209112|P1|Overall Study|Withdrawal by Subject|0
359193|NCT01040130|1209107|P6|Overall Study|Protocol Violation|0
359194|NCT01040130|1209108|P5|Overall Study|Protocol Violation|0
359195|NCT01040130|1209109|P4|Overall Study|Protocol Violation|0
359196|NCT01040130|1209110|P3|Overall Study|Protocol Violation|2
359197|NCT01040130|1209111|P2|Overall Study|Protocol Violation|0
359198|NCT01040130|1209112|P1|Overall Study|Protocol Violation|0
359199|NCT01040130|1209107|P6|Overall Study|Adverse Event|3
359200|NCT01040130|1209108|P5|Overall Study|Adverse Event|0
359201|NCT01040130|1209109|P4|Overall Study|Adverse Event|5
359202|NCT01040130|1209110|P3|Overall Study|Adverse Event|0
359203|NCT01040130|1209111|P2|Overall Study|Adverse Event|1
359204|NCT01040130|1209112|P1|Overall Study|Adverse Event|1
359205|NCT01039688|1209205|P3|Overall Study|Death|0
359206|NCT01039688|1209206|P2|Overall Study|Death|0
359207|NCT01039688|1209207|P1|Overall Study|Death|2
359208|NCT01039688|1209205|P3|Overall Study|Withdrawal by Subject|13
359209|NCT01039688|1209206|P2|Overall Study|Withdrawal by Subject|27
359210|NCT01039688|1209207|P1|Overall Study|Withdrawal by Subject|23
359211|NCT01039688|1209205|P3|Overall Study|Not specified|12
359212|NCT01039688|1209206|P2|Overall Study|Not specified|25
359213|NCT01039688|1209207|P1|Overall Study|Not specified|13
359214|NCT01039688|1209205|P3|Overall Study|Lost to Follow-up|5
359215|NCT01039688|1209206|P2|Overall Study|Lost to Follow-up|9
359216|NCT01039688|1209207|P1|Overall Study|Lost to Follow-up|11
359217|NCT01039688|1209205|P3|Overall Study|Lack of Efficacy|26
359218|NCT01039688|1209206|P2|Overall Study|Lack of Efficacy|11
359219|NCT01039688|1209207|P1|Overall Study|Lack of Efficacy|20
359220|NCT01039688|1209205|P3|Overall Study|Adverse Event|24
359221|NCT01039688|1209206|P2|Overall Study|Adverse Event|39
359222|NCT01039688|1209207|P1|Overall Study|Adverse Event|38
359223|NCT01039675|1209478|P2|Overall Study|Physician Decision|1
359224|NCT01039675|1209479|P1|Overall Study|Physician Decision|0
359225|NCT01039675|1209478|P2|Overall Study|Lost to Follow-up|1
359226|NCT01039675|1209479|P1|Overall Study|Lost to Follow-up|0
359227|NCT01039675|1209478|P2|Overall Study|Withdrawal by Subject|1
359228|NCT01039675|1209479|P1|Overall Study|Withdrawal by Subject|0
359229|NCT01039675|1209478|P2|Overall Study|Lack of Efficacy|2
359230|NCT01039675|1209479|P1|Overall Study|Lack of Efficacy|0
359231|NCT01039675|1209478|P2|Overall Study|Adverse Event|2
359232|NCT01039675|1209479|P1|Overall Study|Adverse Event|0
359233|NCT01039584|1209492|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
359234|NCT01039584|1209493|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
359235|NCT01039584|1209494|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
359236|NCT01039584|1209492|P3|Overall Study|Pap smear with significant pathology|3
359237|NCT01039584|1209493|P2|Overall Study|Pap smear with significant pathology|10
359238|NCT01039584|1209494|P1|Overall Study|Pap smear with significant pathology|10
359239|NCT01039584|1209492|P3|Overall Study|other|1
359240|NCT01039584|1209493|P2|Overall Study|other|3
359241|NCT01039584|1209494|P1|Overall Study|other|1
359242|NCT01039584|1209492|P3|Overall Study|Lack of Efficacy|10
359243|NCT01039584|1209493|P2|Overall Study|Lack of Efficacy|6
359244|NCT01039584|1209494|P1|Overall Study|Lack of Efficacy|7
359245|NCT01039584|1209492|P3|Overall Study|Negative Baseline culture for Candida|24
359246|NCT01039584|1209493|P2|Overall Study|Negative Baseline culture for Candida|59
359247|NCT01039584|1209494|P1|Overall Study|Negative Baseline culture for Candida|59
359248|NCT01039584|1209492|P3|Overall Study|Lost to Follow-up|4
359249|NCT01039584|1209493|P2|Overall Study|Lost to Follow-up|3
359250|NCT01039584|1209494|P1|Overall Study|Lost to Follow-up|5
359251|NCT01039584|1209492|P3|Overall Study|Protocol Violation|6
359252|NCT01039584|1209493|P2|Overall Study|Protocol Violation|4
359253|NCT01039584|1209494|P1|Overall Study|Protocol Violation|10
359254|NCT01039584|1209492|P3|Overall Study|Withdrawal by Subject|1
359255|NCT01039584|1209493|P2|Overall Study|Withdrawal by Subject|2
359256|NCT01039584|1209494|P1|Overall Study|Withdrawal by Subject|4
359257|NCT01039519|1209508|P1|Survival Follow-up|Sponsor decision|4
359258|NCT01039519|1209508|P1|Survival Follow-up|Death|23
359259|NCT01039519|1209508|P1|Treatment|Physician Decision|2
359260|NCT01039519|1209508|P1|Treatment|Adverse Event|3
359261|NCT01039519|1209508|P1|Treatment|Treatment failure|2
359262|NCT01039519|1209508|P1|Treatment|Progressive disease|20
359263|NCT01039428|1209519|P2|Overall Study|Withdrawal by Subject|0
359264|NCT01039428|1209520|P1|Overall Study|Withdrawal by Subject|1
359265|NCT01039428|1209519|P2|Overall Study|Protocol Violation|0
359266|NCT01039428|1209520|P1|Overall Study|Protocol Violation|1
359267|NCT01039376|1209544|P2|Overall Study|Ongoing|182
359268|NCT01039376|1209545|P1|Overall Study|Ongoing|189
359269|NCT01039376|1209544|P2|Overall Study|Withdrawal by Subject|17
359270|NCT01039376|1209545|P1|Overall Study|Withdrawal by Subject|11
359271|NCT01039376|1209544|P2|Overall Study|Physician Decision|2
359272|NCT01039376|1209545|P1|Overall Study|Physician Decision|4
359273|NCT01039376|1209544|P2|Overall Study|Lost to Follow-up|1
359274|NCT01039376|1209545|P1|Overall Study|Lost to Follow-up|2
359275|NCT01038921|1209613|P2|Overall Study|Physician Decision|0
359276|NCT01038921|1209614|P1|Overall Study|Physician Decision|1
359277|NCT01038921|1209613|P2|Overall Study|Withdrawal by Subject|0
359278|NCT01038921|1209614|P1|Overall Study|Withdrawal by Subject|1
359279|NCT01038869|1209620|P1|Overall Study|Lost to Follow-up|6
359280|NCT01038869|1209620|P1|Overall Study|Withdrawal by Subject|1
359281|NCT01038856|1209628|P1|Overall Study|Adverse Event|2
359282|NCT01038752|1209637|P2|Overall Study|Lost to Follow-up|3
359283|NCT01038752|1209638|P1|Overall Study|Lost to Follow-up|3
359284|NCT01038752|1209637|P2|Overall Study|Tumor Progression|2
359285|NCT01038752|1209638|P1|Overall Study|Tumor Progression|2
359286|NCT01038713|1209661|P3|Overall Study|Autoimmune Pancreatitis|0
359287|NCT01038713|1209662|P2|Overall Study|Autoimmune Pancreatitis|0
359288|NCT01038713|1209663|P1|Overall Study|Autoimmune Pancreatitis|1
359289|NCT01038713|1209661|P3|Overall Study|died from PEP|0
359290|NCT01038713|1209662|P2|Overall Study|died from PEP|1
359291|NCT01038713|1209663|P1|Overall Study|died from PEP|0
359292|NCT01038713|1209661|P3|Overall Study|Neuroendocrine Tumor|0
359293|NCT01038713|1209662|P2|Overall Study|Neuroendocrine Tumor|1
359294|NCT01038713|1209663|P1|Overall Study|Neuroendocrine Tumor|0
359295|NCT01038713|1209661|P3|Overall Study|Lost to Follow-up|0
359296|NCT01038713|1209662|P2|Overall Study|Lost to Follow-up|0
359297|NCT01038713|1209663|P1|Overall Study|Lost to Follow-up|3
359298|NCT01038713|1209661|P3|Overall Study|Patient to hospice|1
359299|NCT01038713|1209662|P2|Overall Study|Patient to hospice|1
359300|NCT01038713|1209663|P1|Overall Study|Patient to hospice|1
359301|NCT01038635|1209692|P9|Overall Study|Death|2
359302|NCT01038635|1209693|P8|Overall Study|Death|1
359303|NCT01038635|1209694|P7|Overall Study|Death|1
359304|NCT01038635|1209695|P6|Overall Study|Death|0
359305|NCT01038635|1209696|P5|Overall Study|Death|1
359306|NCT01038635|1209697|P4|Overall Study|Death|0
359307|NCT01038635|1209698|P3|Overall Study|Death|0
359308|NCT01038635|1209699|P2|Overall Study|Death|0
359309|NCT01038635|1209700|P1|Overall Study|Death|0
359310|NCT01038635|1209692|P9|Overall Study|Disease Progression|0
359311|NCT01038635|1209693|P8|Overall Study|Disease Progression|4
359312|NCT01038635|1209694|P7|Overall Study|Disease Progression|1
359313|NCT01038635|1209695|P6|Overall Study|Disease Progression|0
359314|NCT01038635|1209696|P5|Overall Study|Disease Progression|0
359315|NCT01038635|1209697|P4|Overall Study|Disease Progression|0
359316|NCT01038635|1209698|P3|Overall Study|Disease Progression|0
359317|NCT01038635|1209699|P2|Overall Study|Disease Progression|0
359318|NCT01038635|1209700|P1|Overall Study|Disease Progression|2
359319|NCT01038609|1209726|P5|Overall Study|Refusal of Blood Draws|0
359320|NCT01038609|1209727|P4|Overall Study|Refusal of Blood Draws|0
359321|NCT01038609|1209728|P3|Overall Study|Refusal of Blood Draws|0
359322|NCT01038609|1209729|P2|Overall Study|Refusal of Blood Draws|1
359323|NCT01038609|1209730|P1|Overall Study|Refusal of Blood Draws|0
359324|NCT01038609|1209726|P5|Overall Study|Death in the Family|0
359325|NCT01038609|1209727|P4|Overall Study|Death in the Family|0
359326|NCT01038609|1209728|P3|Overall Study|Death in the Family|0
359327|NCT01038609|1209729|P2|Overall Study|Death in the Family|0
359328|NCT01038609|1209730|P1|Overall Study|Death in the Family|1
359329|NCT01038609|1209726|P5|Overall Study|Dosing Error|1
359330|NCT01038609|1209727|P4|Overall Study|Dosing Error|1
359331|NCT01038609|1209728|P3|Overall Study|Dosing Error|0
359332|NCT01038609|1209729|P2|Overall Study|Dosing Error|0
359333|NCT01038609|1209730|P1|Overall Study|Dosing Error|0
359334|NCT01038609|1209726|P5|Overall Study|Adverse Event|0
359335|NCT01038609|1209727|P4|Overall Study|Adverse Event|0
359336|NCT01038609|1209728|P3|Overall Study|Adverse Event|1
359337|NCT01038609|1209729|P2|Overall Study|Adverse Event|0
359338|NCT01038609|1209730|P1|Overall Study|Adverse Event|0
359339|NCT01038323|1209809|P3|Overall Study|Withdrawal by Subject|4
359340|NCT01038323|1209810|P2|Overall Study|Withdrawal by Subject|2
359341|NCT01038323|1209811|P1|Overall Study|Withdrawal by Subject|3
359342|NCT01038128|1209825|P1|Overall Study|Withdrawal by Subject|2
359343|NCT01038128|1209825|P1|Overall Study|Lost to Follow-up|1
359344|NCT01038128|1209825|P1|Overall Study|Lack of Efficacy|1
359345|NCT01037244|1209909|P4|Overall Study|Various|1
359346|NCT01037244|1209910|P3|Overall Study|Various|1
359347|NCT01037244|1209911|P2|Overall Study|Various|2
359348|NCT01037244|1209912|P1|Overall Study|Various|3
359349|NCT01037244|1209909|P4|Overall Study|Partner Withdrew Consent|0
359350|NCT01037244|1209910|P3|Overall Study|Partner Withdrew Consent|0
359351|NCT01037244|1209911|P2|Overall Study|Partner Withdrew Consent|1
359352|NCT01037244|1209912|P1|Overall Study|Partner Withdrew Consent|2
359353|NCT01037244|1209909|P4|Overall Study|Withdrawal by Subject|5
359354|NCT01037244|1209910|P3|Overall Study|Withdrawal by Subject|3
359355|NCT01037244|1209911|P2|Overall Study|Withdrawal by Subject|5
359356|NCT01037244|1209912|P1|Overall Study|Withdrawal by Subject|1
359357|NCT01037244|1209909|P4|Overall Study|Lost to Follow-up|4
359358|NCT01037244|1209910|P3|Overall Study|Lost to Follow-up|4
359359|NCT01037244|1209911|P2|Overall Study|Lost to Follow-up|3
359360|NCT01037244|1209912|P1|Overall Study|Lost to Follow-up|3
359361|NCT01037244|1209909|P4|Overall Study|Lack of Efficacy|1
359362|NCT01037244|1209910|P3|Overall Study|Lack of Efficacy|0
359363|NCT01037244|1209911|P2|Overall Study|Lack of Efficacy|1
359364|NCT01037244|1209912|P1|Overall Study|Lack of Efficacy|1
359365|NCT01037244|1209909|P4|Overall Study|Adverse Event|3
359366|NCT01037244|1209910|P3|Overall Study|Adverse Event|6
359367|NCT01037244|1209911|P2|Overall Study|Adverse Event|2
359368|NCT01037244|1209912|P1|Overall Study|Adverse Event|3
359369|NCT01037218|1209974|P4|Overall Study|Various|1
359370|NCT01037218|1209975|P3|Overall Study|Various|3
359371|NCT01037218|1209976|P2|Overall Study|Various|2
359372|NCT01037218|1209977|P1|Overall Study|Various|3
359373|NCT01037218|1209974|P4|Overall Study|Protocol Violation|2
359374|NCT01037218|1209975|P3|Overall Study|Protocol Violation|2
359375|NCT01037218|1209976|P2|Overall Study|Protocol Violation|0
359376|NCT01037218|1209977|P1|Overall Study|Protocol Violation|0
359377|NCT01037218|1209974|P4|Overall Study|Partner Withdrew Consent|1
359378|NCT01037218|1209975|P3|Overall Study|Partner Withdrew Consent|2
359379|NCT01037218|1209976|P2|Overall Study|Partner Withdrew Consent|3
359380|NCT01037218|1209977|P1|Overall Study|Partner Withdrew Consent|0
359381|NCT01037218|1209974|P4|Overall Study|Withdrawal by Subject|4
359382|NCT01037218|1209975|P3|Overall Study|Withdrawal by Subject|7
359383|NCT01037218|1209976|P2|Overall Study|Withdrawal by Subject|7
359384|NCT01037218|1209977|P1|Overall Study|Withdrawal by Subject|6
359385|NCT01037218|1209974|P4|Overall Study|Lost to Follow-up|2
359386|NCT01037218|1209975|P3|Overall Study|Lost to Follow-up|4
359387|NCT01037218|1209976|P2|Overall Study|Lost to Follow-up|5
359388|NCT01037218|1209977|P1|Overall Study|Lost to Follow-up|3
359389|NCT01037218|1209974|P4|Overall Study|Lack of Efficacy|5
359390|NCT01037218|1209975|P3|Overall Study|Lack of Efficacy|1
359391|NCT01037218|1209976|P2|Overall Study|Lack of Efficacy|2
359392|NCT01037218|1209977|P1|Overall Study|Lack of Efficacy|0
359393|NCT01037218|1209974|P4|Overall Study|Adverse Event|1
359394|NCT01037218|1209975|P3|Overall Study|Adverse Event|2
359395|NCT01037218|1209976|P2|Overall Study|Adverse Event|2
359396|NCT01037218|1209977|P1|Overall Study|Adverse Event|4
359397|NCT01037127|1210048|P2|Overall Study|Study Closed Terminated|17
359398|NCT01037127|1210049|P1|Overall Study|Study Closed Terminated|2
359399|NCT01037127|1210048|P2|Overall Study|Physician Decision|0
359400|NCT01037127|1210049|P1|Overall Study|Physician Decision|1
359401|NCT01037127|1210048|P2|Overall Study|Lost to Follow-up|4
359402|NCT01037127|1210049|P1|Overall Study|Lost to Follow-up|2
359403|NCT01037114|1210081|P1|Year 20|Others|1
359404|NCT01037088|1210094|P1|Overall Study|Withdrawal by Subject|3
359405|NCT01036763|1210126|P1|Overall Study|Other reason (not specified)|40
359406|NCT01036763|1210126|P1|Overall Study|Lost to Follow-up|28
359407|NCT01036763|1210126|P1|Overall Study|Adverse Event|25
359408|NCT01036724|1210138|P2|Overall Study|Protocol Violation|5
359409|NCT01036724|1210139|P1|Overall Study|Protocol Violation|4
359410|NCT01036724|1210138|P2|Overall Study|Lack of Efficacy|1
359411|NCT01036724|1210139|P1|Overall Study|Lack of Efficacy|1
359412|NCT01036724|1210138|P2|Overall Study|Adverse Event|2
359413|NCT01036724|1210139|P1|Overall Study|Adverse Event|1
359414|NCT01036529|1210149|P2|Overall Study|Sponsor study termination|12
359415|NCT01036529|1210150|P1|Overall Study|Sponsor study termination|11
359416|NCT01036529|1210149|P2|Overall Study|Withdrawal by Subject|1
359417|NCT01036529|1210150|P1|Overall Study|Withdrawal by Subject|1
359418|NCT01036529|1210149|P2|Overall Study|Physician Decision|0
359419|NCT01036529|1210150|P1|Overall Study|Physician Decision|1
359420|NCT01036529|1210149|P2|Overall Study|Lost to Follow-up|1
359421|NCT01036529|1210150|P1|Overall Study|Lost to Follow-up|0
359422|NCT01036529|1210149|P2|Overall Study|Adverse Event|1
359423|NCT01036529|1210150|P1|Overall Study|Adverse Event|0
359424|NCT01036438|1210177|P2|Overall Study|No effect of study treatment|1
359425|NCT01036438|1210178|P1|Overall Study|No effect of study treatment|3
359426|NCT01036438|1210177|P2|Overall Study|Death|1
359427|NCT01036438|1210178|P1|Overall Study|Death|0
359428|NCT01036438|1210177|P2|Overall Study|Adverse Event|8
359429|NCT01036438|1210178|P1|Overall Study|Adverse Event|7
359430|NCT01036321|1210186|P2|Overall Study|Adverse Event|1
359431|NCT01036321|1210187|P1|Overall Study|Adverse Event|2
359432|NCT01036321|1210186|P2|Overall Study|Withdrawal by Subject|2
359433|NCT01036321|1210187|P1|Overall Study|Withdrawal by Subject|3
359434|NCT01036321|1210186|P2|Overall Study|Ineligible after randomization|1
359435|NCT01036321|1210187|P1|Overall Study|Ineligible after randomization|0
359436|NCT01036165|1210211|P1|Overall Study|Problems finding proper area to inject|1
359437|NCT01036165|1210211|P1|Overall Study|Device Related Issues|3
359438|NCT01036165|1210211|P1|Overall Study|Withdrawal by Subject|3
359439|NCT01036165|1210211|P1|Overall Study|Lost to Follow-up|2
359440|NCT01036165|1210211|P1|Overall Study|Adverse Event|6
359441|NCT01036022|1210222|P6|Overall Study|Withdrawal by Subject|0
359442|NCT01036022|1210223|P5|Overall Study|Withdrawal by Subject|2
359443|NCT01036022|1210224|P4|Overall Study|Withdrawal by Subject|1
359444|NCT01036022|1210225|P3|Overall Study|Withdrawal by Subject|0
359445|NCT01036022|1210226|P2|Overall Study|Withdrawal by Subject|0
359446|NCT01036022|1210227|P1|Overall Study|Withdrawal by Subject|0
359447|NCT01036022|1210222|P6|Overall Study|Physician Decision|0
359448|NCT01036022|1210223|P5|Overall Study|Physician Decision|0
359449|NCT01036022|1210224|P4|Overall Study|Physician Decision|0
359450|NCT01036022|1210225|P3|Overall Study|Physician Decision|1
359451|NCT01036022|1210226|P2|Overall Study|Physician Decision|0
359452|NCT01036022|1210227|P1|Overall Study|Physician Decision|0
359453|NCT01036022|1210222|P6|Overall Study|Lack of Efficacy|1
359454|NCT01036022|1210223|P5|Overall Study|Lack of Efficacy|1
359455|NCT01036022|1210224|P4|Overall Study|Lack of Efficacy|0
359456|NCT01036022|1210225|P3|Overall Study|Lack of Efficacy|1
359457|NCT01036022|1210226|P2|Overall Study|Lack of Efficacy|1
359458|NCT01036022|1210227|P1|Overall Study|Lack of Efficacy|1
359459|NCT01036022|1210222|P6|Overall Study|Adverse Event|2
359460|NCT01036022|1210223|P5|Overall Study|Adverse Event|0
359461|NCT01036022|1210224|P4|Overall Study|Adverse Event|1
359462|NCT01036022|1210225|P3|Overall Study|Adverse Event|2
359463|NCT01036022|1210226|P2|Overall Study|Adverse Event|3
359464|NCT01036022|1210227|P1|Overall Study|Adverse Event|1
359465|NCT01035905|1210363|P2|Overall Study|Lack of Efficacy|1
359466|NCT01035905|1210364|P1|Overall Study|Lack of Efficacy|1
359467|NCT01035606|1210537|P3|Overall Study|change in health, job demands,family|4
359468|NCT01035606|1210538|P2|Overall Study|change in health, job demands,family|3
359469|NCT01035606|1210539|P1|Overall Study|change in health, job demands,family|3
359470|NCT01035255|1210581|P2|Overall Study|patient's request|13
359471|NCT01035255|1210582|P1|Overall Study|patient's request|15
359472|NCT01035255|1210581|P2|Overall Study|Lost to Follow-up|5
359473|NCT01035255|1210582|P1|Overall Study|Lost to Follow-up|2
359474|NCT01035255|1210581|P2|Overall Study|Death|844
359475|NCT01035255|1210582|P1|Overall Study|Death|724
359476|NCT01035229|1210600|P2|Overall Study|Disease Progression|152
359477|NCT01035229|1210601|P1|Overall Study|Disease Progression|261
359478|NCT01035229|1210600|P2|Overall Study|Sponsor's decision to end study|3
359479|NCT01035229|1210601|P1|Overall Study|Sponsor's decision to end study|3
359480|NCT01035229|1210600|P2|Overall Study|Protocol Violation|2
359481|NCT01035229|1210601|P1|Overall Study|Protocol Violation|0
359482|NCT01035229|1210600|P2|Overall Study|New cancer therapy|0
359483|NCT01035229|1210601|P1|Overall Study|New cancer therapy|2
359484|NCT01035229|1210600|P2|Overall Study|Death|5
359485|NCT01035229|1210601|P1|Overall Study|Death|13
359486|NCT01035229|1210600|P2|Overall Study|Administrative problems|1
359487|NCT01035229|1210601|P1|Overall Study|Administrative problems|1
359488|NCT01035229|1210600|P2|Overall Study|Lost to Follow-up|0
359489|NCT01035229|1210601|P1|Overall Study|Lost to Follow-up|1
359490|NCT01035229|1210600|P2|Overall Study|Withdrawal by Subject|7
359491|NCT01035229|1210601|P1|Overall Study|Withdrawal by Subject|20
359492|NCT01035229|1210600|P2|Overall Study|Adverse Event|14
359493|NCT01035229|1210601|P1|Overall Study|Adverse Event|61
359494|NCT01035138|1210622|P3|Overall Study|Lost to Follow-up|1
359495|NCT01035138|1210623|P2|Overall Study|Lost to Follow-up|0
359496|NCT01035138|1210624|P1|Overall Study|Lost to Follow-up|0
359497|NCT01035138|1210622|P3|Overall Study|Sponsor Decision|42
359498|NCT01035138|1210623|P2|Overall Study|Sponsor Decision|60
359499|NCT01035138|1210624|P1|Overall Study|Sponsor Decision|66
359500|NCT01035138|1210622|P3|Overall Study|Physician Decision|1
359501|NCT01035138|1210623|P2|Overall Study|Physician Decision|0
359502|NCT01035138|1210624|P1|Overall Study|Physician Decision|0
359503|NCT01035138|1210622|P3|Overall Study|Withdrawal by Subject|0
359504|NCT01035138|1210623|P2|Overall Study|Withdrawal by Subject|0
359505|NCT01035138|1210624|P1|Overall Study|Withdrawal by Subject|1
359506|NCT01035138|1210622|P3|Overall Study|Caregiver Decision|1
359507|NCT01035138|1210623|P2|Overall Study|Caregiver Decision|0
359508|NCT01035138|1210624|P1|Overall Study|Caregiver Decision|2
359509|NCT01035138|1210622|P3|Overall Study|Adverse Event|2
359510|NCT01035138|1210623|P2|Overall Study|Adverse Event|0
359511|NCT01035138|1210624|P1|Overall Study|Adverse Event|4
359512|NCT01035060|1210680|P2|Overall Study|Physician Decision|0
359513|NCT01035060|1210681|P1|Overall Study|Physician Decision|2
359514|NCT01035060|1210680|P2|Overall Study|Withdrawal by Subject|6
359515|NCT01035060|1210681|P1|Overall Study|Withdrawal by Subject|8
359516|NCT01035060|1210680|P2|Overall Study|Did not quality after 2nd screening|1
359517|NCT01035060|1210681|P1|Overall Study|Did not quality after 2nd screening|14
359518|NCT01035060|1210680|P2|Overall Study|Lost to Follow-up|7
359519|NCT01035060|1210681|P1|Overall Study|Lost to Follow-up|0
359520|NCT01034709|1210706|P2|Overall Study|Protocol Violation|16
359521|NCT01034709|1210707|P1|Overall Study|Protocol Violation|9
359522|NCT01034657|1210713|P3|Randomized Phase|Adverse Event|1
359523|NCT01034657|1210714|P2|Randomized Phase|Adverse Event|2
359524|NCT01034657|1210715|P1|Randomized Phase|Adverse Event|0
359525|NCT01034657|1210713|P3|Randomized Phase|Abnormal laboratory value|0
359526|NCT01034657|1210714|P2|Randomized Phase|Abnormal laboratory value|1
359527|NCT01034657|1210715|P1|Randomized Phase|Abnormal laboratory value|0
359528|NCT01034657|1210713|P3|Randomized Phase|Lack of Efficacy|0
359529|NCT01034657|1210714|P2|Randomized Phase|Lack of Efficacy|1
359530|NCT01034657|1210715|P1|Randomized Phase|Lack of Efficacy|5
359531|NCT01034657|1210713|P3|Randomized Phase|Withdrawal by Subject|0
359532|NCT01034657|1210714|P2|Randomized Phase|Withdrawal by Subject|2
359533|NCT01034657|1210715|P1|Randomized Phase|Withdrawal by Subject|0
359534|NCT01034657|1210713|P3|Core Phase|Protocol Violation|0
359535|NCT01034657|1210714|P2|Core Phase|Protocol Violation|0
359536|NCT01034657|1210715|P1|Core Phase|Protocol Violation|2
359537|NCT01034657|1210713|P3|Core Phase|Adverse Event|0
359538|NCT01034657|1210714|P2|Core Phase|Adverse Event|0
359539|NCT01034657|1210715|P1|Core Phase|Adverse Event|8
359540|NCT01034657|1210713|P3|Core Phase|Abnormal laboratory value|0
359541|NCT01034657|1210714|P2|Core Phase|Abnormal laboratory value|0
359542|NCT01034657|1210715|P1|Core Phase|Abnormal laboratory value|1
359543|NCT01034657|1210713|P3|Core Phase|Lack of Efficacy|0
359544|NCT01034657|1210714|P2|Core Phase|Lack of Efficacy|0
359545|NCT01034657|1210715|P1|Core Phase|Lack of Efficacy|2
359546|NCT01034657|1210713|P3|Core Phase|Withdrawal by Subject|0
359547|NCT01034657|1210714|P2|Core Phase|Withdrawal by Subject|0
359548|NCT01034657|1210715|P1|Core Phase|Withdrawal by Subject|1
359549|NCT01034631|1210756|P3|Phase II|Determined Ineligible per protocol|0
359550|NCT01034631|1210757|P2|Phase II|Determined Ineligible per protocol|1
359551|NCT01034631|1210758|P1|Phase II|Determined Ineligible per protocol|0
359552|NCT01034631|1210756|P3|Phase II|Not Evaluable per protocol|2
359553|NCT01034631|1210757|P2|Phase II|Not Evaluable per protocol|0
359554|NCT01034631|1210758|P1|Phase II|Not Evaluable per protocol|0
359555|NCT01034631|1210756|P3|Phase I|Symptomatic Deterioration before Treatme|0
359556|NCT01034631|1210757|P2|Phase I|Symptomatic Deterioration before Treatme|0
359557|NCT01034631|1210758|P1|Phase I|Symptomatic Deterioration before Treatme|3
359558|NCT01034540|1210825|P2|Overall Study|Adverse Event|1
359559|NCT01034540|1210826|P1|Overall Study|Adverse Event|0
359560|NCT01034462|1210836|P2|Overall Study|Other reasons|2
359561|NCT01034462|1210837|P1|Overall Study|Other reasons|1
359562|NCT01034462|1210836|P2|Overall Study|Lost to Follow-up|16
359563|NCT01034462|1210837|P1|Overall Study|Lost to Follow-up|14
359564|NCT01034462|1210836|P2|Overall Study|Withdrawal by Subject|8
359565|NCT01034462|1210837|P1|Overall Study|Withdrawal by Subject|9
359566|NCT01034462|1210836|P2|Overall Study|Protocol Violation|7
359567|NCT01034462|1210837|P1|Overall Study|Protocol Violation|10
359568|NCT01034462|1210836|P2|Overall Study|Lack of Efficacy|4
359569|NCT01034462|1210837|P1|Overall Study|Lack of Efficacy|4
359570|NCT01034462|1210836|P2|Overall Study|Adverse Event|17
359571|NCT01034462|1210837|P1|Overall Study|Adverse Event|7
359572|NCT01034397|1210847|P2|Overall Study|Not specified|1
359573|NCT01034397|1210848|P1|Overall Study|Not specified|0
359574|NCT01034397|1210847|P2|Overall Study|Adverse Event|0
359575|NCT01034397|1210848|P1|Overall Study|Adverse Event|4
359576|NCT01034397|1210847|P2|Overall Study|Lack of Efficacy|0
359577|NCT01034397|1210848|P1|Overall Study|Lack of Efficacy|3
359578|NCT01034397|1210847|P2|Overall Study|Lack of compliance|1
359579|NCT01034397|1210848|P1|Overall Study|Lack of compliance|0
359580|NCT01034358|1210997|P1|Overall Study|Protocol Violation|1
359581|NCT01034358|1210997|P1|Overall Study|Withdrawal by Subject|1
359582|NCT01034306|1211003|P2|Overall Study|Noncomplience|0
359583|NCT01034306|1211004|P1|Overall Study|Noncomplience|1
359584|NCT01034306|1211003|P2|Overall Study|hospitalized and decided to stop|0
359585|NCT01034306|1211004|P1|Overall Study|hospitalized and decided to stop|1
359586|NCT01034306|1211003|P2|Overall Study|Withdrawal by Subject|2
359587|NCT01034306|1211004|P1|Overall Study|Withdrawal by Subject|2
359588|NCT01034306|1211003|P2|Overall Study|Lost to Follow-up|1
359589|NCT01034306|1211004|P1|Overall Study|Lost to Follow-up|0
359590|NCT01034306|1211003|P2|Overall Study|Adverse Event|0
359591|NCT01034306|1211004|P1|Overall Study|Adverse Event|1
359592|NCT01034176|1211012|P2|Overall Study|Lost to Follow-up|1
359593|NCT01034176|1211013|P1|Overall Study|Lost to Follow-up|0
359594|NCT01034176|1211012|P2|Overall Study|Withdrawal by Subject|1
359595|NCT01034176|1211013|P1|Overall Study|Withdrawal by Subject|0
359596|NCT01034176|1211012|P2|Overall Study|Physician Decision|0
359597|NCT01034176|1211013|P1|Overall Study|Physician Decision|2
359598|NCT01034163|1211023|P2|Overall Study|Abnormal laboratory value|0
359599|NCT01034163|1211024|P1|Overall Study|Abnormal laboratory value|1
359600|NCT01034163|1211023|P2|Overall Study|Administrative problems|1
359601|NCT01034163|1211024|P1|Overall Study|Administrative problems|0
359602|NCT01034163|1211023|P2|Overall Study|Adverse Event|0
359603|NCT01034163|1211024|P1|Overall Study|Adverse Event|6
359604|NCT01034163|1211023|P2|Overall Study|Disease progression|4
359605|NCT01034163|1211024|P1|Overall Study|Disease progression|3
359606|NCT01034163|1211023|P2|Overall Study|Protocol deviation|0
359607|NCT01034163|1211024|P1|Overall Study|Protocol deviation|1
359608|NCT01034163|1211023|P2|Overall Study|Withdrawal by Subject|2
359609|NCT01034163|1211024|P1|Overall Study|Withdrawal by Subject|8
359610|NCT01034163|1211023|P2|Overall Study|Treatment completed as per protocol|7
359611|NCT01034163|1211024|P1|Overall Study|Treatment completed as per protocol|8
359612|NCT01034137|1211033|P3|Overall Study|Administrative or other|4
359613|NCT01034137|1211034|P2|Overall Study|Administrative or other|3
359614|NCT01034137|1211035|P1|Overall Study|Administrative or other|2
359615|NCT01034137|1211033|P3|Overall Study|Refused treatment or did not cooperate|1
359616|NCT01034137|1211034|P2|Overall Study|Refused treatment or did not cooperate|0
359617|NCT01034137|1211035|P1|Overall Study|Refused treatment or did not cooperate|2
359618|NCT01034137|1211033|P3|Overall Study|Protocol Violation|1
359619|NCT01034137|1211034|P2|Overall Study|Protocol Violation|2
359620|NCT01034137|1211035|P1|Overall Study|Protocol Violation|2
359621|NCT01034137|1211033|P3|Overall Study|Lack of Efficacy|13
359622|NCT01034137|1211034|P2|Overall Study|Lack of Efficacy|4
359623|NCT01034137|1211035|P1|Overall Study|Lack of Efficacy|9
359624|NCT01034137|1211033|P3|Overall Study|Withdrawal by Subject|3
359625|NCT01034137|1211034|P2|Overall Study|Withdrawal by Subject|3
359626|NCT01034137|1211035|P1|Overall Study|Withdrawal by Subject|4
359627|NCT01034137|1211033|P3|Overall Study|Adverse Event|8
359628|NCT01034137|1211034|P2|Overall Study|Adverse Event|10
359629|NCT01034137|1211035|P1|Overall Study|Adverse Event|9
359630|NCT01033942|1211174|P3|Overall Study|Enrolled in Extension Study|0
359631|NCT01033942|1211175|P2|Overall Study|Enrolled in Extension Study|3
359632|NCT01033942|1211176|P1|Overall Study|Enrolled in Extension Study|0
359633|NCT01033942|1211174|P3|Overall Study|Lost to Follow-up|0
359634|NCT01033942|1211175|P2|Overall Study|Lost to Follow-up|0
359635|NCT01033942|1211176|P1|Overall Study|Lost to Follow-up|1
359636|NCT01033942|1211174|P3|Overall Study|Withdrawal by Subject|1
359637|NCT01033942|1211175|P2|Overall Study|Withdrawal by Subject|1
359638|NCT01033942|1211176|P1|Overall Study|Withdrawal by Subject|1
359639|NCT01033851|1211474|P2|Overall Study|Withdrawal by Subject|7
359640|NCT01033851|1211475|P1|Overall Study|Withdrawal by Subject|3
359641|NCT01033825|1211490|P7|Overall Study|Other|0
359642|NCT01033825|1211491|P6|Overall Study|Other|0
359643|NCT01033825|1211492|P5|Overall Study|Other|1
359644|NCT01033825|1211493|P4|Overall Study|Other|0
359645|NCT01033825|1211494|P3|Overall Study|Other|0
359646|NCT01033825|1211495|P2|Overall Study|Other|0
359647|NCT01033825|1211496|P1|Overall Study|Other|0
359648|NCT01033825|1211490|P7|Overall Study|Protocol Violation|0
359649|NCT01033825|1211491|P6|Overall Study|Protocol Violation|0
359650|NCT01033825|1211492|P5|Overall Study|Protocol Violation|0
359651|NCT01033825|1211493|P4|Overall Study|Protocol Violation|0
359652|NCT01033825|1211494|P3|Overall Study|Protocol Violation|0
359653|NCT01033825|1211495|P2|Overall Study|Protocol Violation|0
359654|NCT01033825|1211496|P1|Overall Study|Protocol Violation|1
359655|NCT01033825|1211490|P7|Overall Study|Adverse Event|0
359656|NCT01033825|1211491|P6|Overall Study|Adverse Event|0
359657|NCT01033825|1211492|P5|Overall Study|Adverse Event|0
359658|NCT01033825|1211493|P4|Overall Study|Adverse Event|1
359659|NCT01033825|1211494|P3|Overall Study|Adverse Event|0
359660|NCT01033825|1211495|P2|Overall Study|Adverse Event|0
359661|NCT01033825|1211496|P1|Overall Study|Adverse Event|0
359662|NCT01033825|1211490|P7|Overall Study|Withdrawal by Subject|0
359663|NCT01033825|1211491|P6|Overall Study|Withdrawal by Subject|0
359664|NCT01033825|1211492|P5|Overall Study|Withdrawal by Subject|1
359665|NCT01033825|1211493|P4|Overall Study|Withdrawal by Subject|1
359666|NCT01033825|1211494|P3|Overall Study|Withdrawal by Subject|2
359667|NCT01033825|1211495|P2|Overall Study|Withdrawal by Subject|3
359668|NCT01033825|1211496|P1|Overall Study|Withdrawal by Subject|2
359669|NCT01033747|1211717|P2|Overall Study|Stopped at end of Extension 1|0
359670|NCT01033747|1211718|P1|Overall Study|Stopped at end of Extension 1|2
359671|NCT01033747|1211717|P2|Overall Study|Stopped at end of prolongation visit 1|0
359672|NCT01033747|1211718|P1|Overall Study|Stopped at end of prolongation visit 1|1
359673|NCT01033747|1211717|P2|Overall Study|Withdrawal by Subject|6
359674|NCT01033747|1211718|P1|Overall Study|Withdrawal by Subject|9
359675|NCT01033747|1211717|P2|Overall Study|Protocol Violation|0
359676|NCT01033747|1211718|P1|Overall Study|Protocol Violation|1
359677|NCT01033747|1211717|P2|Overall Study|Unsatisfactory therapeutic effect|4
359678|NCT01033747|1211718|P1|Overall Study|Unsatisfactory therapeutic effect|14
359679|NCT01033747|1211717|P2|Overall Study|Abnormal test procedure|1
359680|NCT01033747|1211718|P1|Overall Study|Abnormal test procedure|0
359681|NCT01033747|1211717|P2|Overall Study|Abnormal Laboratory Value|0
359682|NCT01033747|1211718|P1|Overall Study|Abnormal Laboratory Value|1
359683|NCT01033747|1211717|P2|Overall Study|Adverse Event|4
359684|NCT01033747|1211718|P1|Overall Study|Adverse Event|9
359685|NCT01033734|1211726|P1|Overall Study|Withdrawal by Subject|1
359686|NCT01033487|1211782|P10|Fourth Intervention Period|Adverse Event|0
359687|NCT01033487|1211783|P9|Fourth Intervention Period|Adverse Event|1
359688|NCT01033487|1211784|P8|Fourth Intervention Period|Adverse Event|0
359689|NCT01033487|1211785|P7|Fourth Intervention Period|Adverse Event|0
359690|NCT01033487|1211786|P6|Fourth Intervention Period|Adverse Event|0
359691|NCT01033487|1211787|P5|Fourth Intervention Period|Adverse Event|0
359692|NCT01033487|1211788|P4|Fourth Intervention Period|Adverse Event|0
359693|NCT01033487|1211789|P3|Fourth Intervention Period|Adverse Event|0
359694|NCT01033487|1211790|P2|Fourth Intervention Period|Adverse Event|0
359695|NCT01033487|1211791|P1|Fourth Intervention Period|Adverse Event|0
359696|NCT01033448|1211845|P1|Overall Study|Unknown disposition|1
359697|NCT01033448|1211845|P1|Overall Study|Withdrew due to other reasons|3
359698|NCT01033448|1211845|P1|Overall Study|Lost to Follow-up|3
359699|NCT01033448|1211845|P1|Overall Study|Positive HCV-RNA at week 48|1
359700|NCT01033448|1211845|P1|Overall Study|Withdrawal by Subject|4
359701|NCT01033071|1211892|P3|Overall Study|Other|3
359702|NCT01033071|1211893|P2|Overall Study|Other|4
359703|NCT01033071|1211894|P1|Overall Study|Other|6
359704|NCT01033071|1211892|P3|Overall Study|Lack of Efficacy|1
359705|NCT01033071|1211893|P2|Overall Study|Lack of Efficacy|1
359706|NCT01033071|1211894|P1|Overall Study|Lack of Efficacy|0
359707|NCT01033071|1211892|P3|Overall Study|Withdrawal by Subject|11
359708|NCT01033071|1211893|P2|Overall Study|Withdrawal by Subject|14
359709|NCT01033071|1211894|P1|Overall Study|Withdrawal by Subject|17
359710|NCT01033071|1211892|P3|Overall Study|Lost to Follow-up|5
359711|NCT01033071|1211893|P2|Overall Study|Lost to Follow-up|5
359712|NCT01033071|1211894|P1|Overall Study|Lost to Follow-up|4
359713|NCT01033071|1211892|P3|Overall Study|Protocol Violation|1
359714|NCT01033071|1211893|P2|Overall Study|Protocol Violation|2
359715|NCT01033071|1211894|P1|Overall Study|Protocol Violation|0
359716|NCT01033071|1211892|P3|Overall Study|Adverse Event|26
359717|NCT01033071|1211893|P2|Overall Study|Adverse Event|51
359718|NCT01033071|1211894|P1|Overall Study|Adverse Event|28
359719|NCT01033019|1211965|P2|Overall Study|Withdrawal by Subject|0
359720|NCT01033019|1211966|P1|Overall Study|Withdrawal by Subject|1
359721|NCT01032915|1212004|P4|Overall Study|Protocol Violation|1
359722|NCT01032915|1212005|P3|Overall Study|Protocol Violation|0
359723|NCT01032915|1212006|P2|Overall Study|Protocol Violation|0
359724|NCT01032915|1212007|P1|Overall Study|Protocol Violation|1
359725|NCT01032915|1212004|P4|Overall Study|Administrative reasons|4
359726|NCT01032915|1212005|P3|Overall Study|Administrative reasons|4
359727|NCT01032915|1212006|P2|Overall Study|Administrative reasons|6
359728|NCT01032915|1212007|P1|Overall Study|Administrative reasons|5
359729|NCT01032915|1212004|P4|Overall Study|Withdrawal by Subject|1
359730|NCT01032915|1212005|P3|Overall Study|Withdrawal by Subject|1
359731|NCT01032915|1212006|P2|Overall Study|Withdrawal by Subject|3
359732|NCT01032915|1212007|P1|Overall Study|Withdrawal by Subject|0
359733|NCT01032915|1212004|P4|Overall Study|Abnormal test procedure result|0
359734|NCT01032915|1212005|P3|Overall Study|Abnormal test procedure result|1
359735|NCT01032915|1212006|P2|Overall Study|Abnormal test procedure result|0
359736|NCT01032915|1212007|P1|Overall Study|Abnormal test procedure result|0
359737|NCT01032915|1212004|P4|Overall Study|Adverse Event|1
359738|NCT01032915|1212005|P3|Overall Study|Adverse Event|1
359739|NCT01032915|1212006|P2|Overall Study|Adverse Event|2
359740|NCT01032915|1212007|P1|Overall Study|Adverse Event|2
359741|NCT01032889|1212032|P3|Overall Study|Miscellaneous Reasons|1
359742|NCT01032889|1212033|P2|Overall Study|Miscellaneous Reasons|1
359743|NCT01032889|1212034|P1|Overall Study|Miscellaneous Reasons|2
359744|NCT01032889|1212032|P3|Overall Study|Lack of Submental Fat|1
359745|NCT01032889|1212033|P2|Overall Study|Lack of Submental Fat|8
359746|NCT01032889|1212034|P1|Overall Study|Lack of Submental Fat|2
359747|NCT01032889|1212032|P3|Overall Study|Lost to Follow-up|0
359748|NCT01032889|1212033|P2|Overall Study|Lost to Follow-up|1
359749|NCT01032889|1212034|P1|Overall Study|Lost to Follow-up|1
359750|NCT01032889|1212032|P3|Overall Study|Patient Request|0
359751|NCT01032889|1212033|P2|Overall Study|Patient Request|1
359752|NCT01032889|1212034|P1|Overall Study|Patient Request|0
359753|NCT01032889|1212032|P3|Overall Study|Withdrawal of Consent|1
359754|NCT01032889|1212033|P2|Overall Study|Withdrawal of Consent|2
359755|NCT01032889|1212034|P1|Overall Study|Withdrawal of Consent|1
359756|NCT01032889|1212032|P3|Overall Study|Adverse Event|0
359757|NCT01032889|1212033|P2|Overall Study|Adverse Event|2
359758|NCT01032889|1212034|P1|Overall Study|Adverse Event|2
359759|NCT01032837|1212065|P4|Overall Study|Refused treatment|1
359760|NCT01032837|1212066|P3|Overall Study|Refused treatment|0
359761|NCT01032837|1212067|P2|Overall Study|Refused treatment|0
359762|NCT01032837|1212068|P1|Overall Study|Refused treatment|0
359763|NCT01032837|1212065|P4|Overall Study|Failed to return|0
359764|NCT01032837|1212066|P3|Overall Study|Failed to return|1
359765|NCT01032837|1212067|P2|Overall Study|Failed to return|0
359766|NCT01032837|1212068|P1|Overall Study|Failed to return|0
359767|NCT01032837|1212065|P4|Overall Study|Withdrew consent|1
359768|NCT01032837|1212066|P3|Overall Study|Withdrew consent|0
359769|NCT01032837|1212067|P2|Overall Study|Withdrew consent|2
359770|NCT01032837|1212068|P1|Overall Study|Withdrew consent|0
359771|NCT01032837|1212065|P4|Overall Study|Adverse event/internal illness|1
359772|NCT01032837|1212066|P3|Overall Study|Adverse event/internal illness|0
359773|NCT01032837|1212067|P2|Overall Study|Adverse event/internal illness|1
359774|NCT01032837|1212068|P1|Overall Study|Adverse event/internal illness|0
359775|NCT01032382|1212173|P2|Overall Study|Index lesion relapse|3
359776|NCT01032382|1212174|P1|Overall Study|Index lesion relapse|1
359777|NCT01032382|1212173|P2|Overall Study|Treatment failure|1
359778|NCT01032382|1212174|P1|Overall Study|Treatment failure|3
359779|NCT01032382|1212173|P2|Overall Study|Disease dissemination|1
359780|NCT01032382|1212174|P1|Overall Study|Disease dissemination|1
359781|NCT01032291|1212203|P3|Proof of Concept|Never Received Study Drug|0
359782|NCT01032291|1212204|P2|Proof of Concept|Never Received Study Drug|1
359783|NCT01032291|1212205|P1|Proof of Concept|Never Received Study Drug|0
359784|NCT01032291|1212203|P3|Proof of Concept|Lack of Efficacy|0
359785|NCT01032291|1212204|P2|Proof of Concept|Lack of Efficacy|1
359786|NCT01032291|1212205|P1|Proof of Concept|Lack of Efficacy|0
359787|NCT01032291|1212203|P3|Proof of Concept|Death|2
359788|NCT01032291|1212204|P2|Proof of Concept|Death|1
359789|NCT01032291|1212205|P1|Proof of Concept|Death|0
359790|NCT01032291|1212203|P3|Proof of Concept|Adverse Event|1
359791|NCT01032291|1212204|P2|Proof of Concept|Adverse Event|5
359792|NCT01032291|1212205|P1|Proof of Concept|Adverse Event|0
359793|NCT01032291|1212203|P3|Safety Lead-in|Death|0
359794|NCT01032291|1212204|P2|Safety Lead-in|Death|0
359795|NCT01032291|1212205|P1|Safety Lead-in|Death|1
359796|NCT01032291|1212203|P3|Safety Lead-in|Adverse Event|0
359797|NCT01032291|1212204|P2|Safety Lead-in|Adverse Event|0
359798|NCT01032291|1212205|P1|Safety Lead-in|Adverse Event|1
359799|NCT01032239|1212252|P2|Overall Study|Protocol Violation|0
359800|NCT01032239|1212253|P1|Overall Study|Protocol Violation|1
359801|NCT01032239|1212252|P2|Overall Study|Death|0
359802|NCT01032239|1212253|P1|Overall Study|Death|1
359803|NCT01032239|1212252|P2|Overall Study|Withdrawal by Subject|3
359804|NCT01032239|1212253|P1|Overall Study|Withdrawal by Subject|2
359805|NCT01032239|1212252|P2|Overall Study|Lost to Follow-up|2
359806|NCT01032239|1212253|P1|Overall Study|Lost to Follow-up|3
359807|NCT01032200|1212283|P2|Overall Study|Multiple|1
359808|NCT01032200|1212284|P1|Overall Study|Multiple|1
359809|NCT01032200|1212283|P2|Overall Study|Progression|0
359810|NCT01032200|1212284|P1|Overall Study|Progression|1
359811|NCT01032200|1212283|P2|Overall Study|Toxicity|2
359812|NCT01032200|1212284|P1|Overall Study|Toxicity|0
359813|NCT01032200|1212283|P2|Overall Study|Withdrawal by Subject|3
359814|NCT01032200|1212284|P1|Overall Study|Withdrawal by Subject|1
359815|NCT01032200|1212283|P2|Overall Study|Death|1
359816|NCT01032200|1212284|P1|Overall Study|Death|1
359817|NCT01032174|1212300|P2|Overall Study|Adverse Event|1
359818|NCT01032174|1212301|P1|Overall Study|Adverse Event|0
359819|NCT01032070|1212541|P2|Overall Study|Withdrawal by Subject|2
359820|NCT01032070|1212542|P1|Overall Study|Withdrawal by Subject|0
359821|NCT01032070|1212541|P2|Overall Study|Medical or ethical reasons|2
359822|NCT01032070|1212542|P1|Overall Study|Medical or ethical reasons|0
359823|NCT01032070|1212541|P2|Overall Study|Disease progression|8
359824|NCT01032070|1212542|P1|Overall Study|Disease progression|13
359825|NCT01032044|1212571|P2|Overall Study|Lost to Follow-up|11
359826|NCT01032044|1212572|P1|Overall Study|Lost to Follow-up|11
359827|NCT01032044|1212571|P2|Overall Study|Adverse Event|1
359828|NCT01032044|1212572|P1|Overall Study|Adverse Event|0
359829|NCT01032044|1212571|P2|Overall Study|Protocol Violation|8
359830|NCT01032044|1212572|P1|Overall Study|Protocol Violation|14
359831|NCT01032018|1212580|P2|Overall Study|Death|1
359832|NCT01032018|1212581|P1|Overall Study|Death|0
359833|NCT01032018|1212580|P2|Overall Study|Lost to Follow-up|5
359834|NCT01032018|1212581|P1|Overall Study|Lost to Follow-up|6
359835|NCT01031979|1212591|P2|Overall Study|Lost to Follow-up|4
359836|NCT01031979|1212592|P1|Overall Study|Lost to Follow-up|5
359837|NCT01031706|1212630|P2|Overall Study|Withdrawal by Subject|1
359838|NCT01031706|1212631|P1|Overall Study|Withdrawal by Subject|1
359839|NCT01031706|1212630|P2|Overall Study|Adverse Event|0
359840|NCT01031706|1212631|P1|Overall Study|Adverse Event|1
359841|NCT01031680|1212641|P2|Overall Study|Various|2
359842|NCT01031680|1212642|P1|Overall Study|Various|0
359843|NCT01031680|1212641|P2|Overall Study|Administrative Reason by Sponsor|1
359844|NCT01031680|1212642|P1|Overall Study|Administrative Reason by Sponsor|0
359845|NCT01031680|1212641|P2|Overall Study|Incorrect Enrolment|2
359846|NCT01031680|1212642|P1|Overall Study|Incorrect Enrolment|1
359847|NCT01031680|1212641|P2|Overall Study|Safety|0
359848|NCT01031680|1212642|P1|Overall Study|Safety|1
359849|NCT01031680|1212641|P2|Overall Study|Poor/Non-compliance|6
359850|NCT01031680|1212642|P1|Overall Study|Poor/Non-compliance|5
359851|NCT01031680|1212641|P2|Overall Study|Subject No Longer Meets Study Criteria|17
359852|NCT01031680|1212642|P1|Overall Study|Subject No Longer Meets Study Criteria|26
359853|NCT01031680|1212641|P2|Overall Study|Death|1
359854|NCT01031680|1212642|P1|Overall Study|Death|2
359855|NCT01031680|1212641|P2|Overall Study|Withdrawal by Subject|16
359856|NCT01031680|1212642|P1|Overall Study|Withdrawal by Subject|12
359857|NCT01031680|1212641|P2|Overall Study|Lost to Follow-up|10
359858|NCT01031680|1212642|P1|Overall Study|Lost to Follow-up|2
359859|NCT01031680|1212641|P2|Overall Study|Adverse Event|3
359860|NCT01031680|1212642|P1|Overall Study|Adverse Event|8
359861|NCT01031628|1212662|P4|Overall Study|Study terminated early|0
359862|NCT01031628|1212663|P3|Overall Study|Study terminated early|3
359863|NCT01031628|1212664|P2|Overall Study|Study terminated early|1
359864|NCT01031628|1212665|P1|Overall Study|Study terminated early|0
359865|NCT01031446|1212703|P1|Overall Study|Still on treatment|1
359866|NCT01031446|1212703|P1|Overall Study|Withdrawal by Subject|3
359867|NCT01031446|1212703|P1|Overall Study|Physician Decision|4
359868|NCT01031446|1212703|P1|Overall Study|Adverse Event|9
359869|NCT01031446|1212703|P1|Overall Study|Disease Progression|38
359870|NCT01031381|1212712|P1|Overall Study|Withdrawal by Subject|6
359871|NCT01031381|1212712|P1|Overall Study|Physician Decision|3
359872|NCT01031004|1212743|P2|Overall Study|Lost to Follow-up|0
359873|NCT01031004|1212744|P1|Overall Study|Lost to Follow-up|1
359874|NCT01031004|1212743|P2|Overall Study|Protocol Violation|1
359875|NCT01031004|1212744|P1|Overall Study|Protocol Violation|0
359876|NCT01030965|1212788|P4|Overall Study|Withdrawal by Subject|2
359877|NCT01030965|1212789|P3|Overall Study|Withdrawal by Subject|0
359878|NCT01030965|1212790|P2|Overall Study|Withdrawal by Subject|1
359879|NCT01030965|1212791|P1|Overall Study|Withdrawal by Subject|0
359880|NCT01030965|1212788|P4|Overall Study|Protocol-defined Stopping Criteria|0
359881|NCT01030965|1212789|P3|Overall Study|Protocol-defined Stopping Criteria|1
359882|NCT01030965|1212790|P2|Overall Study|Protocol-defined Stopping Criteria|1
359883|NCT01030965|1212791|P1|Overall Study|Protocol-defined Stopping Criteria|0
359884|NCT01030965|1212788|P4|Overall Study|Adverse Event|1
359885|NCT01030965|1212789|P3|Overall Study|Adverse Event|2
359886|NCT01030965|1212790|P2|Overall Study|Adverse Event|1
359887|NCT01030965|1212791|P1|Overall Study|Adverse Event|0
359888|NCT01030965|1212788|P4|Overall Study|Protocol Violation|1
359889|NCT01030965|1212789|P3|Overall Study|Protocol Violation|1
359890|NCT01030965|1212790|P2|Overall Study|Protocol Violation|1
359891|NCT01030965|1212791|P1|Overall Study|Protocol Violation|1
359892|NCT01030965|1212788|P4|Overall Study|Lack of Efficacy|3
359893|NCT01030965|1212789|P3|Overall Study|Lack of Efficacy|0
359894|NCT01030965|1212790|P2|Overall Study|Lack of Efficacy|2
359895|NCT01030965|1212791|P1|Overall Study|Lack of Efficacy|3
359896|NCT01030952|1212811|P2|Overall Study|Unexplained|1
359897|NCT01030952|1212812|P1|Overall Study|Unexplained|1
359898|NCT01030952|1212811|P2|Overall Study|Lost to Follow-up|1
359899|NCT01030952|1212812|P1|Overall Study|Lost to Follow-up|0
359900|NCT01030952|1212811|P2|Overall Study|Informed consent withdrawal|0
359901|NCT01030952|1212812|P1|Overall Study|Informed consent withdrawal|1
359902|NCT01030952|1212811|P2|Overall Study|Protocol Violation|1
359903|NCT01030952|1212812|P1|Overall Study|Protocol Violation|0
359904|NCT01030822|1212849|P3|Overall Study|Lost to Follow-up|7
359905|NCT01030822|1212850|P2|Overall Study|Lost to Follow-up|4
359906|NCT01030822|1212851|P1|Overall Study|Lost to Follow-up|9
359907|NCT01030822|1212849|P3|Overall Study|Withdrawal by Subject|16
359908|NCT01030822|1212850|P2|Overall Study|Withdrawal by Subject|13
359909|NCT01030822|1212851|P1|Overall Study|Withdrawal by Subject|16
359910|NCT01030822|1212849|P3|Overall Study|Moved/migrated from study area|3
359911|NCT01030822|1212850|P2|Overall Study|Moved/migrated from study area|7
359912|NCT01030822|1212851|P1|Overall Study|Moved/migrated from study area|6
359913|NCT01030718|1212906|P3|Study CA180-036 Only|Other Reasons|0
359914|NCT01030718|1212907|P2|Study CA180-036 Only|Other Reasons|2
359915|NCT01030718|1212908|P1|Study CA180-036 Only|Other Reasons|0
359916|NCT01030718|1212906|P3|Study CA180-036 Only|Death|0
359917|NCT01030718|1212907|P2|Study CA180-036 Only|Death|1
359918|NCT01030718|1212908|P1|Study CA180-036 Only|Death|0
359919|NCT01030718|1212906|P3|Study CA180-036 Only|Adverse Event|0
359920|NCT01030718|1212907|P2|Study CA180-036 Only|Adverse Event|3
359921|NCT01030718|1212908|P1|Study CA180-036 Only|Adverse Event|2
359922|NCT01030718|1212906|P3|Study CA180-036 Only|insufficient effect|5
359923|NCT01030718|1212907|P2|Study CA180-036 Only|insufficient effect|1
359924|NCT01030718|1212908|P1|Study CA180-036 Only|insufficient effect|1
359925|NCT01030718|1212906|P3|Studies CA180-031 and -036 Combined|other reasons|0
359926|NCT01030718|1212907|P2|Studies CA180-031 and -036 Combined|other reasons|2
359927|NCT01030718|1212908|P1|Studies CA180-031 and -036 Combined|other reasons|0
359928|NCT01030718|1212906|P3|Studies CA180-031 and -036 Combined|Death|0
359929|NCT01030718|1212907|P2|Studies CA180-031 and -036 Combined|Death|1
359930|NCT01030718|1212908|P1|Studies CA180-031 and -036 Combined|Death|0
359931|NCT01030718|1212906|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
359932|NCT01030718|1212907|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
359933|NCT01030718|1212908|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
359934|NCT01030718|1212906|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
359935|NCT01030718|1212907|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
359936|NCT01030718|1212908|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
359937|NCT01030666|1212969|P2|Overall Study|Lost to Follow-up|2
359938|NCT01030666|1212970|P1|Overall Study|Lost to Follow-up|3
359939|NCT01030536|1212995|P5|Overall Study|Death|0
359940|NCT01030536|1212996|P4|Overall Study|Death|0
359941|NCT01030536|1212997|P3|Overall Study|Death|0
359942|NCT01030536|1212998|P2|Overall Study|Death|1
359943|NCT01030536|1212999|P1|Overall Study|Death|0
359944|NCT01030536|1212995|P5|Overall Study|Progressive disease|0
359945|NCT01030536|1212996|P4|Overall Study|Progressive disease|2
359946|NCT01030536|1212997|P3|Overall Study|Progressive disease|3
359947|NCT01030536|1212998|P2|Overall Study|Progressive disease|2
359948|NCT01030536|1212999|P1|Overall Study|Progressive disease|6
359949|NCT01030536|1212995|P5|Overall Study|Adverse Event|1
359950|NCT01030536|1212996|P4|Overall Study|Adverse Event|0
359951|NCT01030536|1212997|P3|Overall Study|Adverse Event|1
359952|NCT01030536|1212998|P2|Overall Study|Adverse Event|3
359953|NCT01030536|1212999|P1|Overall Study|Adverse Event|0
359954|NCT01030536|1212995|P5|Overall Study|undefined|0
359955|NCT01030536|1212996|P4|Overall Study|undefined|1
359956|NCT01030536|1212997|P3|Overall Study|undefined|1
359957|NCT01030536|1212998|P2|Overall Study|undefined|0
359958|NCT01030536|1212999|P1|Overall Study|undefined|1
359959|NCT01030536|1212995|P5|Overall Study|Withdrawal by Subject|0
359960|NCT01030536|1212996|P4|Overall Study|Withdrawal by Subject|0
359961|NCT01030536|1212997|P3|Overall Study|Withdrawal by Subject|1
359962|NCT01030536|1212998|P2|Overall Study|Withdrawal by Subject|0
359963|NCT01030536|1212999|P1|Overall Study|Withdrawal by Subject|0
359964|NCT01030458|1213104|P2|Overall Study|Side effect of medication|1
359965|NCT01030458|1213105|P1|Overall Study|Side effect of medication|1
359966|NCT01030458|1213104|P2|Overall Study|Moved or changed job|13
359967|NCT01030458|1213105|P1|Overall Study|Moved or changed job|6
359968|NCT01030458|1213104|P2|Overall Study|Logistical reasons|5
359969|NCT01030458|1213105|P1|Overall Study|Logistical reasons|9
359970|NCT01030458|1213104|P2|Overall Study|Withdrawal by Subject|3
359971|NCT01030458|1213105|P1|Overall Study|Withdrawal by Subject|2
359972|NCT01030458|1213104|P2|Overall Study|Lost to Follow-up|10
359973|NCT01030458|1213105|P1|Overall Study|Lost to Follow-up|9
359974|NCT01029925|1213133|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
359975|NCT01029925|1213133|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
359976|NCT01029925|1213133|P1|Completion of Cycle 1 (28 Days)|Death|2
359977|NCT01029886|1213152|P2|Overall Study|Loss Glucose Control|1
359978|NCT01029886|1213153|P1|Overall Study|Loss Glucose Control|7
359979|NCT01029886|1213152|P2|Overall Study|Sponsor Decision|0
359980|NCT01029886|1213153|P1|Overall Study|Sponsor Decision|1
359981|NCT01029886|1213152|P2|Overall Study|Entry Criteria Not Met|5
359982|NCT01029886|1213153|P1|Overall Study|Entry Criteria Not Met|13
359983|NCT01029886|1213152|P2|Overall Study|Withdrawal by Subject|18
359984|NCT01029886|1213153|P1|Overall Study|Withdrawal by Subject|8
359985|NCT01029886|1213152|P2|Overall Study|Protocol Violation|5
359986|NCT01029886|1213153|P1|Overall Study|Protocol Violation|17
359987|NCT01029886|1213152|P2|Overall Study|Physician Decision|6
359988|NCT01029886|1213153|P1|Overall Study|Physician Decision|2
359989|NCT01029886|1213152|P2|Overall Study|Lost to Follow-up|0
359990|NCT01029886|1213153|P1|Overall Study|Lost to Follow-up|1
359991|NCT01029886|1213152|P2|Overall Study|Adverse Event|25
359992|NCT01029886|1213153|P1|Overall Study|Adverse Event|12
359993|NCT01029795|1213181|P2|Overall Study|Withdrawal by Subject|3
359994|NCT01029795|1213182|P1|Overall Study|Withdrawal by Subject|1
359995|NCT01029795|1213181|P2|Overall Study|Sponsor Decision|17
359996|NCT01029795|1213182|P1|Overall Study|Sponsor Decision|11
359997|NCT01029795|1213181|P2|Overall Study|Physician Decision|1
359998|NCT01029795|1213182|P1|Overall Study|Physician Decision|2
359999|NCT01029795|1213181|P2|Overall Study|Entry Criteria Not Met|1
360000|NCT01029795|1213182|P1|Overall Study|Entry Criteria Not Met|2
360001|NCT01029691|1213280|P3|Continued APAP to Delivery|Death|1
360002|NCT01029691|1213281|P2|Continued APAP to Delivery|Death|0
360003|NCT01029691|1213282|P1|Continued APAP to Delivery|Death|0
360004|NCT01029652|1213307|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
360005|NCT01029652|1213308|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
360006|NCT01029652|1213307|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
360007|NCT01029652|1213308|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
360008|NCT01029652|1213307|P2|Extension Study 2 (25-72 Weeks)|Death|1
360009|NCT01029652|1213308|P1|Extension Study 2 (25-72 Weeks)|Death|1
360010|NCT01029652|1213307|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
360011|NCT01029652|1213308|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
360012|NCT01029652|1213307|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
360013|NCT01029652|1213308|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
360014|NCT01029652|1213307|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
360015|NCT01029652|1213308|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
360016|NCT01029652|1213307|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
360017|NCT01029652|1213308|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
360018|NCT01029652|1213307|P2|Core Study (0-12 Weeks)|Death|1
360019|NCT01029652|1213308|P1|Core Study (0-12 Weeks)|Death|0
360020|NCT01029652|1213307|P2|Core Study (0-12 Weeks)|Administrative problems|1
360021|NCT01029652|1213308|P1|Core Study (0-12 Weeks)|Administrative problems|2
360022|NCT01029652|1213307|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
360023|NCT01029652|1213308|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
360024|NCT01029652|1213307|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
360025|NCT01029652|1213308|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
360026|NCT01029652|1213307|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
360027|NCT01029652|1213308|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
360028|NCT01029535|1213386|P1|Overall Study|Death|1
360029|NCT01029535|1213386|P1|Overall Study|Use of Another Treatment|1
360030|NCT01029535|1213386|P1|Overall Study|Adverse Event|1
360031|NCT01029535|1213386|P1|Overall Study|Participant Withdrew Consent|2
360032|NCT01029535|1213386|P1|Overall Study|Protocol Violation|2
360033|NCT01029535|1213386|P1|Overall Study|Lost to Follow-up|24
360034|NCT01029405|1213415|P4|Overall Study|Other|1
360035|NCT01029405|1213416|P3|Overall Study|Other|0
360036|NCT01029405|1213417|P2|Overall Study|Other|1
360037|NCT01029405|1213418|P1|Overall Study|Other|0
360038|NCT01029405|1213415|P4|Overall Study|Lost to Follow-up|2
360039|NCT01029405|1213416|P3|Overall Study|Lost to Follow-up|1
360040|NCT01029405|1213417|P2|Overall Study|Lost to Follow-up|1
360041|NCT01029405|1213418|P1|Overall Study|Lost to Follow-up|2
360042|NCT01029405|1213415|P4|Overall Study|Adverse Event|1
360043|NCT01029405|1213416|P3|Overall Study|Adverse Event|1
360044|NCT01029405|1213417|P2|Overall Study|Adverse Event|0
360045|NCT01029405|1213418|P1|Overall Study|Adverse Event|0
360046|NCT01029405|1213415|P4|Overall Study|Protocol Violation|1
360047|NCT01029405|1213416|P3|Overall Study|Protocol Violation|0
360048|NCT01029405|1213417|P2|Overall Study|Protocol Violation|0
360049|NCT01029405|1213418|P1|Overall Study|Protocol Violation|0
360050|NCT01029405|1213415|P4|Overall Study|Withdrawal by Subject|0
360051|NCT01029405|1213416|P3|Overall Study|Withdrawal by Subject|2
360052|NCT01029405|1213417|P2|Overall Study|Withdrawal by Subject|1
360053|NCT01029405|1213418|P1|Overall Study|Withdrawal by Subject|0
360054|NCT01029392|1213430|P2|Overall Study|Physician Decision|0
360055|NCT01029392|1213431|P1|Overall Study|Physician Decision|2
360056|NCT01029392|1213430|P2|Overall Study|Withdrawal by Subject|11
360057|NCT01029392|1213431|P1|Overall Study|Withdrawal by Subject|18
360058|NCT01029366|1213441|P2|Overall Study|manufacturing failure|1
360059|NCT01029366|1213442|P1|Overall Study|manufacturing failure|0
360060|NCT01029366|1213441|P2|Overall Study|disease progression|0
360061|NCT01029366|1213442|P1|Overall Study|disease progression|2
360062|NCT01029366|1213441|P2|Overall Study|Death|1
360063|NCT01029366|1213442|P1|Overall Study|Death|1
360064|NCT01029366|1213441|P2|Overall Study|Withdrawal by Subject|0
360065|NCT01029366|1213442|P1|Overall Study|Withdrawal by Subject|1
360066|NCT01029340|1213454|P6|Extension Period|Physician Decision|1
360067|NCT01029340|1213455|P5|Extension Period|Physician Decision|0
360068|NCT01029340|1213456|P4|Extension Period|Physician Decision|0
360069|NCT01029340|1213457|P3|Extension Period|Physician Decision|0
360070|NCT01029340|1213458|P2|Extension Period|Physician Decision|0
360071|NCT01029340|1213459|P1|Extension Period|Physician Decision|0
360072|NCT01029340|1213454|P6|Extension Period|Withdrawal by Subject|1
360073|NCT01029340|1213455|P5|Extension Period|Withdrawal by Subject|0
360074|NCT01029340|1213456|P4|Extension Period|Withdrawal by Subject|0
360075|NCT01029340|1213457|P3|Extension Period|Withdrawal by Subject|0
360076|NCT01029340|1213458|P2|Extension Period|Withdrawal by Subject|0
360077|NCT01029340|1213459|P1|Extension Period|Withdrawal by Subject|0
360078|NCT01029340|1213454|P6|Extension Period|non-compliance|1
360079|NCT01029340|1213455|P5|Extension Period|non-compliance|0
360080|NCT01029340|1213456|P4|Extension Period|non-compliance|0
360081|NCT01029340|1213457|P3|Extension Period|non-compliance|0
360082|NCT01029340|1213458|P2|Extension Period|non-compliance|0
360083|NCT01029340|1213459|P1|Extension Period|non-compliance|0
360084|NCT01029340|1213454|P6|Extension Period|starting another study|8
360085|NCT01029340|1213455|P5|Extension Period|starting another study|0
360086|NCT01029340|1213456|P4|Extension Period|starting another study|0
360087|NCT01029340|1213457|P3|Extension Period|starting another study|0
360088|NCT01029340|1213458|P2|Extension Period|starting another study|0
360089|NCT01029340|1213459|P1|Extension Period|starting another study|0
360090|NCT01029340|1213454|P6|Extension Period|Adverse Event|1
360091|NCT01029340|1213455|P5|Extension Period|Adverse Event|0
360092|NCT01029340|1213456|P4|Extension Period|Adverse Event|0
360093|NCT01029340|1213457|P3|Extension Period|Adverse Event|0
360094|NCT01029340|1213458|P2|Extension Period|Adverse Event|0
360095|NCT01029340|1213459|P1|Extension Period|Adverse Event|0
360096|NCT01029340|1213454|P6|Part B Treatment Period|Protocol Violation|0
360097|NCT01029340|1213455|P5|Part B Treatment Period|Protocol Violation|0
360098|NCT01029340|1213456|P4|Part B Treatment Period|Protocol Violation|0
360099|NCT01029340|1213457|P3|Part B Treatment Period|Protocol Violation|1
360100|NCT01029340|1213458|P2|Part B Treatment Period|Protocol Violation|0
360101|NCT01029340|1213459|P1|Part B Treatment Period|Protocol Violation|0
360102|NCT01029340|1213454|P6|Part B Treatment Period|Withdrawal by Subject|0
360103|NCT01029340|1213455|P5|Part B Treatment Period|Withdrawal by Subject|0
360104|NCT01029340|1213456|P4|Part B Treatment Period|Withdrawal by Subject|0
360105|NCT01029340|1213457|P3|Part B Treatment Period|Withdrawal by Subject|1
360106|NCT01029340|1213458|P2|Part B Treatment Period|Withdrawal by Subject|0
360107|NCT01029340|1213459|P1|Part B Treatment Period|Withdrawal by Subject|0
360108|NCT01029262|1213490|P2|Overall Study|Other|5
360109|NCT01029262|1213491|P1|Overall Study|Other|1
360110|NCT01029262|1213490|P2|Overall Study|Protocol Violation|3
360111|NCT01029262|1213491|P1|Overall Study|Protocol Violation|2
360112|NCT01029262|1213490|P2|Overall Study|Withdrawal by Subject|16
360113|NCT01029262|1213491|P1|Overall Study|Withdrawal by Subject|10
360114|NCT01029262|1213490|P2|Overall Study|Lack of therapeutic effect|69
360115|NCT01029262|1213491|P1|Overall Study|Lack of therapeutic effect|56
360116|NCT01029262|1213490|P2|Overall Study|Adverse Event|52
360117|NCT01029262|1213491|P1|Overall Study|Adverse Event|9
360118|NCT01028651|1213649|P1|Overall Study|Adverse Event|1
360119|NCT01028651|1213649|P1|Overall Study|Death|2
360120|NCT01028391|1213672|P2|Overall Study|Needed excluded medication|1
360121|NCT01028391|1213673|P1|Overall Study|Needed excluded medication|1
360122|NCT01028391|1213672|P2|Overall Study|Withdrawal by Subject|3
360123|NCT01028391|1213673|P1|Overall Study|Withdrawal by Subject|6
360124|NCT01028391|1213672|P2|Overall Study|Physician Decision|1
360125|NCT01028391|1213673|P1|Overall Study|Physician Decision|0
360126|NCT01028391|1213672|P2|Overall Study|Lost to Follow-up|4
360127|NCT01028391|1213673|P1|Overall Study|Lost to Follow-up|3
360128|NCT01028391|1213672|P2|Overall Study|Lack of Efficacy|2
360129|NCT01028391|1213673|P1|Overall Study|Lack of Efficacy|0
360130|NCT01028391|1213672|P2|Overall Study|Adverse Event|0
360131|NCT01028391|1213673|P1|Overall Study|Adverse Event|4
360132|NCT01028378|1213681|P1|Overall Study|Adminstrative Reasons|4
360133|NCT01028378|1213681|P1|Overall Study|Withdrawal by Subject|1
360134|NCT01028378|1213681|P1|Overall Study|Lost to Follow-up|12
360135|NCT01028352|1213693|P1|Overall Study|Withdrawal by Subject|1
360136|NCT01028352|1213693|P1|Overall Study|Ineligible due to baseline average pain|5
360137|NCT01028300|1213698|P1|Overall Study|Study Terminated|4
360138|NCT01028222|1213707|P2|Overall Study|Adverse Event|0
360139|NCT01028222|1213708|P1|Overall Study|Adverse Event|2
360140|NCT01028222|1213707|P2|Overall Study|Crossover to nilotinib w/out progression|2
360141|NCT01028222|1213708|P1|Overall Study|Crossover to nilotinib w/out progression|0
360142|NCT01028222|1213707|P2|Overall Study|Withdrawal by Subject|0
360143|NCT01028222|1213708|P1|Overall Study|Withdrawal by Subject|1
360144|NCT01028222|1213707|P2|Overall Study|Lost to Follow-up|1
360145|NCT01028222|1213708|P1|Overall Study|Lost to Follow-up|0
360146|NCT01028222|1213707|P2|Overall Study|Administrative problems|1
360147|NCT01028222|1213708|P1|Overall Study|Administrative problems|1
360148|NCT01028222|1213707|P2|Overall Study|Disease progression|9
360149|NCT01028222|1213708|P1|Overall Study|Disease progression|33
360150|NCT01028222|1213707|P2|Overall Study|Protocol deviation|0
360151|NCT01028222|1213708|P1|Overall Study|Protocol deviation|1
360152|NCT01028053|1213750|P1|Overall Study|Various reasons|4
360153|NCT01028053|1213750|P1|Overall Study|Terminated by Sponsor|1
360154|NCT01028053|1213750|P1|Overall Study|Technical Problem|1
360155|NCT01028053|1213750|P1|Overall Study|Physician Decision|2
360156|NCT01028053|1213750|P1|Overall Study|Protocol Violation|1
360157|NCT01028053|1213750|P1|Overall Study|Patient Request|11
360158|NCT01028053|1213750|P1|Overall Study|Screen Failure|113
360159|NCT01028027|1213758|P2|Overall Study|Lack of Efficacy|1
360160|NCT01028027|1213759|P1|Overall Study|Lack of Efficacy|0
360161|NCT01028027|1213758|P2|Overall Study|Protocol Violation|1
360162|NCT01028027|1213759|P1|Overall Study|Protocol Violation|3
360163|NCT01028027|1213758|P2|Overall Study|Adverse Event|7
360164|NCT01028027|1213759|P1|Overall Study|Adverse Event|4
360165|NCT01028027|1213758|P2|Overall Study|Withdrawal by Subject|3
360166|NCT01028027|1213759|P1|Overall Study|Withdrawal by Subject|5
360167|NCT01028027|1213758|P2|Overall Study|Lost to Follow-up|1
360168|NCT01028027|1213759|P1|Overall Study|Lost to Follow-up|4
360169|NCT01028014|1213781|P6|Overall Study|Lost to Follow-up|2
360170|NCT01028014|1213782|P5|Overall Study|Lost to Follow-up|1
360171|NCT01028014|1213783|P4|Overall Study|Lost to Follow-up|1
360172|NCT01028014|1213784|P3|Overall Study|Lost to Follow-up|0
360173|NCT01028014|1213785|P2|Overall Study|Lost to Follow-up|2
360174|NCT01028014|1213786|P1|Overall Study|Lost to Follow-up|1
360175|NCT01027897|1213827|P1|Overall Study|Withdrawal by Subject|1
360176|NCT01027897|1213827|P1|Overall Study|Protocol Violation|1
360177|NCT01027884|1213835|P2|Overall Study|Spinal fixation surgery|3
360178|NCT01027884|1213836|P1|Overall Study|Spinal fixation surgery|0
360179|NCT01027884|1213835|P2|Overall Study|Lost to Follow-up|1
360180|NCT01027884|1213836|P1|Overall Study|Lost to Follow-up|0
360181|NCT01027884|1213835|P2|Overall Study|Withdrawal by Subject|1
360182|NCT01027884|1213836|P1|Overall Study|Withdrawal by Subject|0
360183|NCT01027884|1213835|P2|Overall Study|Non-compliance|1
360184|NCT01027884|1213836|P1|Overall Study|Non-compliance|1
360185|NCT01027884|1213835|P2|Overall Study|Protocol Violation|0
360186|NCT01027884|1213836|P1|Overall Study|Protocol Violation|1
360187|NCT01027884|1213835|P2|Overall Study|Adverse Event|1
360188|NCT01027884|1213836|P1|Overall Study|Adverse Event|2
360189|NCT01027871|1213853|P3|Overall Study|Discontinued Prior to Treatment|1
360190|NCT01027871|1213854|P2|Overall Study|Discontinued Prior to Treatment|0
360191|NCT01027871|1213855|P1|Overall Study|Discontinued Prior to Treatment|0
360192|NCT01027871|1213853|P3|Overall Study|Sponsor Decision|0
360193|NCT01027871|1213854|P2|Overall Study|Sponsor Decision|2
360194|NCT01027871|1213855|P1|Overall Study|Sponsor Decision|0
360195|NCT01027871|1213853|P3|Overall Study|Adverse Event|2
360196|NCT01027871|1213854|P2|Overall Study|Adverse Event|2
360197|NCT01027871|1213855|P1|Overall Study|Adverse Event|0
360198|NCT01027871|1213853|P3|Overall Study|Withdrawal by Subject|2
360199|NCT01027871|1213854|P2|Overall Study|Withdrawal by Subject|2
360200|NCT01027871|1213855|P1|Overall Study|Withdrawal by Subject|1
360201|NCT01027871|1213853|P3|Overall Study|Protocol Violation|2
360202|NCT01027871|1213854|P2|Overall Study|Protocol Violation|2
360203|NCT01027871|1213855|P1|Overall Study|Protocol Violation|0
360204|NCT01027871|1213853|P3|Overall Study|Physician Decision|0
360205|NCT01027871|1213854|P2|Overall Study|Physician Decision|5
360206|NCT01027871|1213855|P1|Overall Study|Physician Decision|1
360207|NCT01027702|1213934|P7|Overall Study|Death|0
360208|NCT01027702|1213935|P6|Overall Study|Death|0
360209|NCT01027702|1213936|P5|Overall Study|Death|0
360210|NCT01027702|1213937|P4|Overall Study|Death|0
360211|NCT01027702|1213938|P3|Overall Study|Death|1
360212|NCT01027702|1213939|P2|Overall Study|Death|0
360213|NCT01027702|1213940|P1|Overall Study|Death|0
360214|NCT01027702|1213934|P7|Overall Study|Received subsequent therapy|1
360215|NCT01027702|1213935|P6|Overall Study|Received subsequent therapy|0
360216|NCT01027702|1213936|P5|Overall Study|Received subsequent therapy|1
360217|NCT01027702|1213937|P4|Overall Study|Received subsequent therapy|4
360218|NCT01027702|1213938|P3|Overall Study|Received subsequent therapy|0
360219|NCT01027702|1213939|P2|Overall Study|Received subsequent therapy|2
360220|NCT01027702|1213940|P1|Overall Study|Received subsequent therapy|1
360221|NCT01027650|1213966|P8|Overall Study|Lack of Efficacy|0
360222|NCT01027650|1213967|P7|Overall Study|Lack of Efficacy|0
360223|NCT01027650|1213968|P6|Overall Study|Lack of Efficacy|1
360224|NCT01027650|1213969|P5|Overall Study|Lack of Efficacy|0
360225|NCT01027650|1213970|P4|Overall Study|Lack of Efficacy|0
360226|NCT01027650|1213971|P3|Overall Study|Lack of Efficacy|0
360227|NCT01027650|1213972|P2|Overall Study|Lack of Efficacy|0
360228|NCT01027650|1213973|P1|Overall Study|Lack of Efficacy|0
360229|NCT01027650|1213966|P8|Overall Study|Lost to Follow-up|0
360230|NCT01027650|1213967|P7|Overall Study|Lost to Follow-up|1
360231|NCT01027650|1213968|P6|Overall Study|Lost to Follow-up|0
360232|NCT01027650|1213969|P5|Overall Study|Lost to Follow-up|0
360233|NCT01027650|1213970|P4|Overall Study|Lost to Follow-up|0
360234|NCT01027650|1213971|P3|Overall Study|Lost to Follow-up|0
360235|NCT01027650|1213972|P2|Overall Study|Lost to Follow-up|0
360236|NCT01027650|1213973|P1|Overall Study|Lost to Follow-up|0
360237|NCT01027650|1213966|P8|Overall Study|Personal Reasons|0
360238|NCT01027650|1213967|P7|Overall Study|Personal Reasons|0
360239|NCT01027650|1213968|P6|Overall Study|Personal Reasons|1
360240|NCT01027650|1213969|P5|Overall Study|Personal Reasons|2
360241|NCT01027650|1213970|P4|Overall Study|Personal Reasons|0
360242|NCT01027650|1213971|P3|Overall Study|Personal Reasons|0
360243|NCT01027650|1213972|P2|Overall Study|Personal Reasons|0
360244|NCT01027650|1213973|P1|Overall Study|Personal Reasons|0
360245|NCT01027416|1214049|P2|Overall Study|Physician Decision|4
360246|NCT01027416|1214050|P1|Overall Study|Physician Decision|1
360247|NCT01027416|1214049|P2|Overall Study|Withdrawal by Subject|1
360248|NCT01027416|1214050|P1|Overall Study|Withdrawal by Subject|0
360249|NCT01027364|1214062|P4|Overall Study|Withdrawal by Subject|0
360250|NCT01027364|1214063|P3|Overall Study|Withdrawal by Subject|0
360251|NCT01027364|1214064|P2|Overall Study|Withdrawal by Subject|2
360252|NCT01027364|1214065|P1|Overall Study|Withdrawal by Subject|1
360253|NCT01027364|1214062|P4|Overall Study|Protocol Violation|1
360254|NCT01027364|1214063|P3|Overall Study|Protocol Violation|0
360255|NCT01027364|1214064|P2|Overall Study|Protocol Violation|0
360256|NCT01027364|1214065|P1|Overall Study|Protocol Violation|1
360257|NCT01027364|1214062|P4|Overall Study|Lost to Follow-up|0
360258|NCT01027364|1214063|P3|Overall Study|Lost to Follow-up|0
360259|NCT01027364|1214064|P2|Overall Study|Lost to Follow-up|0
360260|NCT01027364|1214065|P1|Overall Study|Lost to Follow-up|1
360261|NCT01027364|1214062|P4|Overall Study|Adverse Event|0
360262|NCT01027364|1214063|P3|Overall Study|Adverse Event|1
360263|NCT01027364|1214064|P2|Overall Study|Adverse Event|0
360264|NCT01027364|1214065|P1|Overall Study|Adverse Event|1
360265|NCT01027351|1214160|P6|Overall Study|Protocol Violation|0
360266|NCT01027351|1214161|P5|Overall Study|Protocol Violation|1
360267|NCT01027351|1214162|P4|Overall Study|Protocol Violation|1
360268|NCT01027351|1214163|P3|Overall Study|Protocol Violation|0
360269|NCT01027351|1214164|P2|Overall Study|Protocol Violation|0
360270|NCT01027351|1214165|P1|Overall Study|Protocol Violation|1
360271|NCT01027351|1214160|P6|Overall Study|Inappropriate enrollment|0
360272|NCT01027351|1214161|P5|Overall Study|Inappropriate enrollment|1
360273|NCT01027351|1214162|P4|Overall Study|Inappropriate enrollment|0
360274|NCT01027351|1214163|P3|Overall Study|Inappropriate enrollment|0
360275|NCT01027351|1214164|P2|Overall Study|Inappropriate enrollment|0
360276|NCT01027351|1214165|P1|Overall Study|Inappropriate enrollment|0
360277|NCT01027351|1214160|P6|Overall Study|Lost to Follow-up|0
360278|NCT01027351|1214161|P5|Overall Study|Lost to Follow-up|6
360279|NCT01027351|1214162|P4|Overall Study|Lost to Follow-up|1
360280|NCT01027351|1214163|P3|Overall Study|Lost to Follow-up|0
360281|NCT01027351|1214164|P2|Overall Study|Lost to Follow-up|1
360282|NCT01027351|1214165|P1|Overall Study|Lost to Follow-up|1
360283|NCT01027351|1214160|P6|Overall Study|Withdrawal by Subject|5
360284|NCT01027351|1214161|P5|Overall Study|Withdrawal by Subject|3
360285|NCT01027351|1214162|P4|Overall Study|Withdrawal by Subject|0
360286|NCT01027351|1214163|P3|Overall Study|Withdrawal by Subject|1
360287|NCT01027351|1214164|P2|Overall Study|Withdrawal by Subject|0
360288|NCT01027351|1214165|P1|Overall Study|Withdrawal by Subject|1
360289|NCT01027286|1214249|P2|Overall Study|Lost to Follow-up|1
360290|NCT01027286|1214250|P1|Overall Study|Lost to Follow-up|0
360291|NCT01027286|1214249|P2|Overall Study|Unable to Obtain Required Blood Volume|0
360292|NCT01027286|1214250|P1|Overall Study|Unable to Obtain Required Blood Volume|1
360293|NCT01027273|1214270|P2|Overall Study|Death|2
360294|NCT01027273|1214271|P1|Overall Study|Death|2
360295|NCT01027273|1214270|P2|Overall Study|Lost to Follow-up|31
360296|NCT01027273|1214271|P1|Overall Study|Lost to Follow-up|57
360297|NCT01026974|1214318|P4|Overall Study|Inappropriate enrollment|0
360298|NCT01026974|1214319|P3|Overall Study|Inappropriate enrollment|1
360299|NCT01026974|1214320|P2|Overall Study|Inappropriate enrollment|0
360300|NCT01026974|1214321|P1|Overall Study|Inappropriate enrollment|0
360301|NCT01026974|1214318|P4|Overall Study|Adverse Event|1
360302|NCT01026974|1214319|P3|Overall Study|Adverse Event|0
360303|NCT01026974|1214320|P2|Overall Study|Adverse Event|0
360304|NCT01026974|1214321|P1|Overall Study|Adverse Event|0
360305|NCT01026974|1214318|P4|Overall Study|Lost to Follow-up|0
360306|NCT01026974|1214319|P3|Overall Study|Lost to Follow-up|4
360307|NCT01026974|1214320|P2|Overall Study|Lost to Follow-up|1
360308|NCT01026974|1214321|P1|Overall Study|Lost to Follow-up|1
360309|NCT01026974|1214318|P4|Overall Study|Withdrawal by Subject|2
360310|NCT01026974|1214319|P3|Overall Study|Withdrawal by Subject|7
360311|NCT01026974|1214320|P2|Overall Study|Withdrawal by Subject|1
360312|NCT01026974|1214321|P1|Overall Study|Withdrawal by Subject|0
360313|NCT01026948|1214378|P1|Overall Study|Physician Decision|8
360314|NCT01026831|1214411|P2|Overall Study|Withdrawal by Subject|5
360315|NCT01026831|1214412|P1|Overall Study|Withdrawal by Subject|7
360316|NCT01026831|1214411|P2|Overall Study|Protocol Violation|2
360317|NCT01026831|1214412|P1|Overall Study|Protocol Violation|0
360318|NCT01026831|1214411|P2|Overall Study|Physician Decision|1
360319|NCT01026831|1214412|P1|Overall Study|Physician Decision|1
360320|NCT01026831|1214411|P2|Overall Study|Lost to Follow-up|0
360321|NCT01026831|1214412|P1|Overall Study|Lost to Follow-up|2
360322|NCT01026831|1214411|P2|Overall Study|Adverse Event|3
360323|NCT01026831|1214412|P1|Overall Study|Adverse Event|4
360324|NCT01026818|1214423|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
360325|NCT01026818|1214424|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
360326|NCT01026818|1214425|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
360327|NCT01026818|1214426|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
360328|NCT01026818|1214423|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
360329|NCT01026818|1214424|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
360330|NCT01026818|1214425|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
360331|NCT01026818|1214426|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
360332|NCT01026818|1214423|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
360333|NCT01026818|1214424|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
360334|NCT01026818|1214425|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
360335|NCT01026818|1214426|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
360336|NCT01026818|1214423|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
360337|NCT01026818|1214424|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
360338|NCT01026818|1214425|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
360339|NCT01026818|1214426|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
360340|NCT01026818|1214423|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
360341|NCT01026818|1214424|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
360342|NCT01026818|1214425|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
360343|NCT01026818|1214426|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
360344|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
360345|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
360346|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
360347|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
360348|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
360349|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
360350|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
360351|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
360352|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
360353|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
360354|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
360355|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
360356|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
360357|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
360358|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
360359|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
360360|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
360361|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
360362|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
360363|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
360364|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
360365|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
360366|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
360367|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
360368|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
360369|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
360370|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
360371|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
360372|NCT01026818|1214423|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
360373|NCT01026818|1214424|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
360374|NCT01026818|1214425|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
360375|NCT01026818|1214426|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
360376|NCT01026818|1214423|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
360377|NCT01026818|1214424|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
360378|NCT01026818|1214425|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
360379|NCT01026818|1214426|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
360380|NCT01026818|1214423|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
360381|NCT01026818|1214424|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
360382|NCT01026818|1214425|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
360383|NCT01026818|1214426|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
360384|NCT01026818|1214423|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
360385|NCT01026818|1214424|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
360386|NCT01026818|1214425|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
360387|NCT01026818|1214426|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
360388|NCT01026818|1214423|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
360389|NCT01026818|1214424|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
360390|NCT01026818|1214425|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
360391|NCT01026818|1214426|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
360392|NCT01026818|1214423|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
360393|NCT01026818|1214424|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
360394|NCT01026818|1214425|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
360395|NCT01026818|1214426|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
360396|NCT01026818|1214423|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
360397|NCT01026818|1214424|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
360398|NCT01026818|1214425|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
360399|NCT01026818|1214426|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
360400|NCT01026818|1214423|P4|Screening Period|Physician Decision|0
360401|NCT01026818|1214424|P3|Screening Period|Physician Decision|0
360402|NCT01026818|1214425|P2|Screening Period|Physician Decision|0
360403|NCT01026818|1214426|P1|Screening Period|Physician Decision|1
360404|NCT01026818|1214423|P4|Screening Period|Adverse Event|0
360405|NCT01026818|1214424|P3|Screening Period|Adverse Event|0
360406|NCT01026818|1214425|P2|Screening Period|Adverse Event|0
360407|NCT01026818|1214426|P1|Screening Period|Adverse Event|2
360408|NCT01026818|1214423|P4|Screening Period|Protocol Deviation|0
360409|NCT01026818|1214424|P3|Screening Period|Protocol Deviation|0
360410|NCT01026818|1214425|P2|Screening Period|Protocol Deviation|0
360411|NCT01026818|1214426|P1|Screening Period|Protocol Deviation|3
360412|NCT01026818|1214423|P4|Screening Period|Withdrawal by Subject|0
360413|NCT01026818|1214424|P3|Screening Period|Withdrawal by Subject|0
360414|NCT01026818|1214425|P2|Screening Period|Withdrawal by Subject|0
360415|NCT01026818|1214426|P1|Screening Period|Withdrawal by Subject|49
360416|NCT01026818|1214423|P4|Screening Period|Entry Criteria Not Met|0
360417|NCT01026818|1214424|P3|Screening Period|Entry Criteria Not Met|0
360418|NCT01026818|1214425|P2|Screening Period|Entry Criteria Not Met|0
360419|NCT01026818|1214426|P1|Screening Period|Entry Criteria Not Met|105
360420|NCT01026792|1214514|P1|Overall Study|Protocol Violation|1
360421|NCT01026493|1214526|P8|Overall Study|Protocol Violation|1
360422|NCT01026493|1214527|P7|Overall Study|Protocol Violation|4
360423|NCT01026493|1214528|P6|Overall Study|Protocol Violation|3
360424|NCT01026493|1214529|P5|Overall Study|Protocol Violation|2
360425|NCT01026493|1214530|P4|Overall Study|Protocol Violation|0
360426|NCT01026493|1214531|P3|Overall Study|Protocol Violation|0
360427|NCT01026493|1214532|P2|Overall Study|Protocol Violation|1
360428|NCT01026493|1214533|P1|Overall Study|Protocol Violation|0
360429|NCT01026454|1214561|P2|Second Intervention|Pregnancy|1
360430|NCT01026454|1214562|P1|Second Intervention|Pregnancy|1
360431|NCT01026389|1214911|P2|Overall Study|change of treatment, patient moved|2
360432|NCT01026389|1214912|P1|Overall Study|change of treatment, patient moved|4
360433|NCT01026389|1214911|P2|Overall Study|Withdrawal by Subject|3
360434|NCT01026389|1214912|P1|Overall Study|Withdrawal by Subject|1
360435|NCT01026324|1214927|P3|Follow up/Survival|Withdrawal by Subject|0
360436|NCT01026324|1214928|P2|Follow up/Survival|Withdrawal by Subject|0
360437|NCT01026324|1214929|P1|Follow up/Survival|Withdrawal by Subject|1
360438|NCT01026220|1214939|P3|Consolidation Maintenance|Withdrawal by Subject|6
360439|NCT01026220|1214940|P2|Consolidation Maintenance|Withdrawal by Subject|2
360440|NCT01026220|1214941|P1|Consolidation Maintenance|Withdrawal by Subject|0
360441|NCT01026220|1214939|P3|Consolidation Maintenance|Physician Decision|7
360442|NCT01026220|1214940|P2|Consolidation Maintenance|Physician Decision|2
360443|NCT01026220|1214941|P1|Consolidation Maintenance|Physician Decision|0
360444|NCT01026220|1214939|P3|Consolidation Maintenance|Lack of Efficacy|1
360445|NCT01026220|1214940|P2|Consolidation Maintenance|Lack of Efficacy|1
360446|NCT01026220|1214941|P1|Consolidation Maintenance|Lack of Efficacy|0
360447|NCT01026220|1214939|P3|Consolidation Maintenance|Death|0
360448|NCT01026220|1214940|P2|Consolidation Maintenance|Death|1
360449|NCT01026220|1214941|P1|Consolidation Maintenance|Death|0
360450|NCT01026220|1214939|P3|Induction|Ineligible|0
360451|NCT01026220|1214940|P2|Induction|Ineligible|0
360452|NCT01026220|1214941|P1|Induction|Ineligible|1
360453|NCT01026220|1214939|P3|Induction|Withdrawal by Subject|0
360454|NCT01026220|1214940|P2|Induction|Withdrawal by Subject|0
360455|NCT01026220|1214941|P1|Induction|Withdrawal by Subject|9
360456|NCT01026220|1214939|P3|Induction|Physician Decision|0
360457|NCT01026220|1214940|P2|Induction|Physician Decision|0
360458|NCT01026220|1214941|P1|Induction|Physician Decision|12
360459|NCT01026220|1214939|P3|Induction|Lack of Efficacy|0
360460|NCT01026220|1214940|P2|Induction|Lack of Efficacy|0
360461|NCT01026220|1214941|P1|Induction|Lack of Efficacy|2
360462|NCT01026220|1214939|P3|Induction|Death|0
360463|NCT01026220|1214940|P2|Induction|Death|0
360464|NCT01026220|1214941|P1|Induction|Death|1
360465|NCT01026194|1214965|P2|Period 2：Open-label Period|Withdrawal by Subject|4
360466|NCT01026194|1214966|P1|Period 2：Open-label Period|Withdrawal by Subject|0
360467|NCT01026194|1214965|P2|Period 2：Open-label Period|Physician Decision|1
360468|NCT01026194|1214966|P1|Period 2：Open-label Period|Physician Decision|3
360469|NCT01026194|1214965|P2|Period 2：Open-label Period|Adverse Event|5
360470|NCT01026194|1214966|P1|Period 2：Open-label Period|Adverse Event|4
360471|NCT01026194|1214965|P2|Period 1：Double Blind Period|Physician Decision|4
360472|NCT01026194|1214966|P1|Period 1：Double Blind Period|Physician Decision|0
360473|NCT01026194|1214965|P2|Period 1：Double Blind Period|Lack of Efficacy|0
360474|NCT01026194|1214966|P1|Period 1：Double Blind Period|Lack of Efficacy|1
360475|NCT01026194|1214965|P2|Period 1：Double Blind Period|Adverse Event|1
360476|NCT01026194|1214966|P1|Period 1：Double Blind Period|Adverse Event|2
360477|NCT01026142|1214998|P2|Overall Study|Reasons not specified|23
360478|NCT01026142|1214999|P1|Overall Study|Reasons not specified|25
360479|NCT01026142|1214998|P2|Overall Study|Death|98
360480|NCT01026142|1214999|P1|Overall Study|Death|114
360481|NCT01026103|1215021|P1|Overall Study|did not receive study device bc of error|1
360482|NCT01026103|1215021|P1|Overall Study|Physician Decision|1
360483|NCT01026038|1215031|P3|Overall Study|Lost to Follow-up|0
360484|NCT01026038|1215032|P2|Overall Study|Lost to Follow-up|1
360485|NCT01026038|1215033|P1|Overall Study|Lost to Follow-up|1
360486|NCT01025843|1215082|P10|Washout 4|Withdrawal by Subject|0
360487|NCT01025843|1215083|P9|Washout 4|Withdrawal by Subject|0
360488|NCT01025843|1215084|P8|Washout 4|Withdrawal by Subject|0
360489|NCT01025843|1215085|P7|Washout 4|Withdrawal by Subject|0
360490|NCT01025843|1215086|P6|Washout 4|Withdrawal by Subject|0
360491|NCT01025843|1215087|P5|Washout 4|Withdrawal by Subject|0
360492|NCT01025843|1215088|P4|Washout 4|Withdrawal by Subject|1
360493|NCT01025843|1215089|P3|Washout 4|Withdrawal by Subject|1
360494|NCT01025843|1215090|P2|Washout 4|Withdrawal by Subject|0
360495|NCT01025843|1215091|P1|Washout 4|Withdrawal by Subject|0
360496|NCT01025817|1215185|P2|Completed Study|Lost to Follow-up|1
360497|NCT01025817|1215186|P1|Completed Study|Lost to Follow-up|0
360498|NCT01025817|1215185|P2|Completed Study|Missing|0
360499|NCT01025817|1215186|P1|Completed Study|Missing|2
360500|NCT01025817|1215185|P2|Completed Study|Death|5
360501|NCT01025817|1215186|P1|Completed Study|Death|6
360502|NCT01025817|1215185|P2|Completed Study|Withdrawal by Subject|16
360503|NCT01025817|1215186|P1|Completed Study|Withdrawal by Subject|8
360504|NCT01025817|1215185|P2|Completed Study Medication|Lost to Follow-up|1
360505|NCT01025817|1215186|P1|Completed Study Medication|Lost to Follow-up|0
360506|NCT01025817|1215185|P2|Completed Study Medication|Subject no longer required study drug|1
360507|NCT01025817|1215186|P1|Completed Study Medication|Subject no longer required study drug|0
360508|NCT01025817|1215185|P2|Completed Study Medication|Abnormal lab values|2
360509|NCT01025817|1215186|P1|Completed Study Medication|Abnormal lab values|0
360510|NCT01025817|1215185|P2|Completed Study Medication|Death|2
360511|NCT01025817|1215186|P1|Completed Study Medication|Death|2
360512|NCT01025817|1215185|P2|Completed Study Medication|Graft loss|5
360513|NCT01025817|1215186|P1|Completed Study Medication|Graft loss|2
360514|NCT01025817|1215185|P2|Completed Study Medication|Abnormal test procedure|0
360515|NCT01025817|1215186|P1|Completed Study Medication|Abnormal test procedure|4
360516|NCT01025817|1215185|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
360517|NCT01025817|1215186|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
360518|NCT01025817|1215185|P2|Completed Study Medication|Administrative problems|5
360519|NCT01025817|1215186|P1|Completed Study Medication|Administrative problems|7
360520|NCT01025817|1215185|P2|Completed Study Medication|Withdrawal by Subject|9
360521|NCT01025817|1215186|P1|Completed Study Medication|Withdrawal by Subject|8
360522|NCT01025817|1215185|P2|Completed Study Medication|Protocol Deviation|8
360523|NCT01025817|1215186|P1|Completed Study Medication|Protocol Deviation|9
360524|NCT01025817|1215185|P2|Completed Study Medication|Adverse Event|39
360525|NCT01025817|1215186|P1|Completed Study Medication|Adverse Event|66
360526|NCT01025635|1215206|P2|Overall Study|Reason not known|2
360527|NCT01025635|1215207|P1|Overall Study|Reason not known|4
360528|NCT01025635|1215206|P2|Overall Study|Lost to Follow-up|13
360529|NCT01025635|1215207|P1|Overall Study|Lost to Follow-up|9
360530|NCT01025635|1215206|P2|Overall Study|Lack of Efficacy|1
360531|NCT01025635|1215207|P1|Overall Study|Lack of Efficacy|0
360532|NCT01025635|1215206|P2|Overall Study|Protocol Violation|2
360533|NCT01025635|1215207|P1|Overall Study|Protocol Violation|4
360534|NCT01025635|1215206|P2|Overall Study|Withdrawal by Subject|7
360535|NCT01025635|1215207|P1|Overall Study|Withdrawal by Subject|6
360536|NCT01025336|1215228|P5|Overall Study|Protocol Violation|0
360537|NCT01025336|1215229|P4|Overall Study|Protocol Violation|2
360538|NCT01025336|1215230|P3|Overall Study|Protocol Violation|0
360539|NCT01025336|1215231|P2|Overall Study|Protocol Violation|0
360540|NCT01025336|1215232|P1|Overall Study|Protocol Violation|0
360541|NCT01025284|1215287|P3|Overall Study|Withdrawal by Subject|0
360542|NCT01025284|1215288|P2|Overall Study|Withdrawal by Subject|1
360543|NCT01025284|1215289|P1|Overall Study|Withdrawal by Subject|0
360544|NCT01025284|1215287|P3|Overall Study|Investigator Decision|0
360545|NCT01025284|1215288|P2|Overall Study|Investigator Decision|1
360546|NCT01025284|1215289|P1|Overall Study|Investigator Decision|0
360547|NCT01025232|1215314|P2|Overall Study|Study drug no longer available|6
360548|NCT01025232|1215315|P1|Overall Study|Study drug no longer available|3
360549|NCT01025193|1215333|P1|Overall Study|Adverse Event|3
360550|NCT01025193|1215333|P1|Overall Study|Protocol Violation|1
360551|NCT01025154|1215343|P1|Overall Study|Withdrawal by Subject|1
360552|NCT01025154|1215343|P1|Overall Study|Lost to Follow-up|1
360553|NCT01025037|1215352|P1|Overall Study|Withdrawal by Subject|1
360554|NCT01025037|1215352|P1|Overall Study|Lost to Follow-up|7
360555|NCT01025037|1215352|P1|Overall Study|Adverse Event|3
360556|NCT01024959|1215374|P1|Overall Study|missing results required for analysis|17
360557|NCT01024959|1215374|P1|Overall Study|results not evaluable|12
360558|NCT01024959|1215374|P1|Overall Study|ineligible|12
360559|NCT01024946|1215383|P1|Overall Study|Adverse Event|1
360560|NCT01024946|1215383|P1|Overall Study|Withdrawal by Subject|1
360561|NCT01024946|1215383|P1|Overall Study|Screen Failure|3
360562|NCT01024855|1215387|P1|Overall Study|Inclusion/exclusion criteria|1
360563|NCT01024751|1215394|P2|Eligible Participants|Ineligible|1
360564|NCT01024751|1215395|P1|Eligible Participants|Ineligible|0
360565|NCT01024751|1215394|P2|Eligible Participants|Lost to Follow-up|1
360566|NCT01024751|1215395|P1|Eligible Participants|Lost to Follow-up|0
360567|NCT01024751|1215394|P2|Eligible Participants|Withdrawal by Subject|1
360568|NCT01024751|1215395|P1|Eligible Participants|Withdrawal by Subject|0
360569|NCT01024751|1215394|P2|Enrolled Participants|Ineligible at baseline|4
360570|NCT01024751|1215395|P1|Enrolled Participants|Ineligible at baseline|3
360571|NCT01024608|1215418|P2|Overall Study|Never received study treatment|0
360572|NCT01024608|1215419|P1|Overall Study|Never received study treatment|2
360573|NCT01024608|1215418|P2|Overall Study|Protocol Violation|3
360574|NCT01024608|1215419|P1|Overall Study|Protocol Violation|0
360575|NCT01024608|1215418|P2|Overall Study|Lost to Follow-up|1
360576|NCT01024608|1215419|P1|Overall Study|Lost to Follow-up|0
360577|NCT01024608|1215418|P2|Overall Study|Withdrawal by Subject|0
360578|NCT01024608|1215419|P1|Overall Study|Withdrawal by Subject|1
360579|NCT01024608|1215418|P2|Overall Study|Adverse Event|0
360580|NCT01024608|1215419|P1|Overall Study|Adverse Event|1
360581|NCT01024465|1215431|P1|Overall Study|Physician Decision|1
360582|NCT01024465|1215431|P1|Overall Study|Adverse Event|2
360583|NCT01024387|1215435|P1|Overall Study|Other|5
360584|NCT01024387|1215435|P1|Overall Study|Adverse Event|3
360585|NCT01024387|1215435|P1|Overall Study|Prolonged Treatment Delay|1
360586|NCT01024387|1215435|P1|Overall Study|Death|2
360587|NCT01024387|1215435|P1|Overall Study|Withdrawal by Subject|5
360588|NCT01024387|1215435|P1|Overall Study|Physician Decision|5
360589|NCT01024387|1215435|P1|Overall Study|Symptomatic Progression|10
360590|NCT01024387|1215435|P1|Overall Study|Radiographic Progression|29
360591|NCT01024309|1215456|P2|Overall Study|Withdrawal by Subject|4
360592|NCT01024309|1215457|P1|Overall Study|Withdrawal by Subject|4
360593|NCT01024309|1215456|P2|Overall Study|Physician Decision|0
360594|NCT01024309|1215457|P1|Overall Study|Physician Decision|4
360595|NCT01024244|1215489|P5|Overall Study|Withdrawal by Subject|0
360596|NCT01024244|1215490|P4|Overall Study|Withdrawal by Subject|0
360597|NCT01024244|1215491|P3|Overall Study|Withdrawal by Subject|0
360598|NCT01024244|1215492|P2|Overall Study|Withdrawal by Subject|1
360599|NCT01024244|1215493|P1|Overall Study|Withdrawal by Subject|0
360600|NCT01024244|1215489|P5|Overall Study|Sponsor Decision|10
360601|NCT01024244|1215490|P4|Overall Study|Sponsor Decision|12
360602|NCT01024244|1215491|P3|Overall Study|Sponsor Decision|14
360603|NCT01024244|1215492|P2|Overall Study|Sponsor Decision|7
360604|NCT01024244|1215493|P1|Overall Study|Sponsor Decision|14
360605|NCT01024244|1215489|P5|Overall Study|Protocol Violation|2
360606|NCT01024244|1215490|P4|Overall Study|Protocol Violation|0
360607|NCT01024244|1215491|P3|Overall Study|Protocol Violation|0
360608|NCT01024244|1215492|P2|Overall Study|Protocol Violation|0
360609|NCT01024244|1215493|P1|Overall Study|Protocol Violation|1
360610|NCT01024244|1215489|P5|Overall Study|Lack of Efficacy|0
360611|NCT01024244|1215490|P4|Overall Study|Lack of Efficacy|0
360612|NCT01024244|1215491|P3|Overall Study|Lack of Efficacy|0
360613|NCT01024244|1215492|P2|Overall Study|Lack of Efficacy|0
360614|NCT01024244|1215493|P1|Overall Study|Lack of Efficacy|1
360615|NCT01024244|1215489|P5|Overall Study|Entry Criteria Not Met|0
360616|NCT01024244|1215490|P4|Overall Study|Entry Criteria Not Met|0
360617|NCT01024244|1215491|P3|Overall Study|Entry Criteria Not Met|0
360618|NCT01024244|1215492|P2|Overall Study|Entry Criteria Not Met|1
360619|NCT01024244|1215493|P1|Overall Study|Entry Criteria Not Met|0
360620|NCT01024244|1215489|P5|Overall Study|Adverse Event|2
360621|NCT01024244|1215490|P4|Overall Study|Adverse Event|1
360622|NCT01024244|1215491|P3|Overall Study|Adverse Event|0
360623|NCT01024244|1215492|P2|Overall Study|Adverse Event|2
360624|NCT01024244|1215493|P1|Overall Study|Adverse Event|1
360625|NCT01024036|1215607|P2|Follow-Up Period|Adverse Event|1
360626|NCT01024036|1215608|P1|Follow-Up Period|Adverse Event|4
360627|NCT01024036|1215607|P2|Follow-Up Period|Withdrawal by Subject|1
360628|NCT01024036|1215608|P1|Follow-Up Period|Withdrawal by Subject|0
360629|NCT01024036|1215607|P2|Follow-Up Period|Lost to Follow-up|1
360630|NCT01024036|1215608|P1|Follow-Up Period|Lost to Follow-up|1
360631|NCT01024036|1215607|P2|Unblinded Treatment|Lack of Efficacy|2
360632|NCT01024036|1215608|P1|Unblinded Treatment|Lack of Efficacy|0
360633|NCT01024036|1215607|P2|Unblinded Treatment|Adverse Event|1
360634|NCT01024036|1215608|P1|Unblinded Treatment|Adverse Event|0
360635|NCT01024036|1215607|P2|Blinded Treatment|Withdrawal by Subject|3
360636|NCT01024036|1215608|P1|Blinded Treatment|Withdrawal by Subject|4
360637|NCT01024036|1215607|P2|Blinded Treatment|Death|2
360638|NCT01024036|1215608|P1|Blinded Treatment|Death|0
360639|NCT01024036|1215607|P2|Blinded Treatment|Physician Decision|0
360640|NCT01024036|1215608|P1|Blinded Treatment|Physician Decision|1
360641|NCT01024036|1215607|P2|Blinded Treatment|Lack of Efficacy|14
360642|NCT01024036|1215608|P1|Blinded Treatment|Lack of Efficacy|16
360643|NCT01024036|1215607|P2|Blinded Treatment|Adverse Event|1
360644|NCT01024036|1215608|P1|Blinded Treatment|Adverse Event|1
360645|NCT01023958|1215639|P1|Overall Study|Refused to continue medication|1
360646|NCT01023958|1215639|P1|Overall Study|Other adverse event|1
360647|NCT01023958|1215639|P1|Overall Study|Progressive disease|48
360648|NCT01023815|1215687|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
360649|NCT01023815|1215688|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
360650|NCT01023815|1215689|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
360651|NCT01023815|1215690|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
360652|NCT01023815|1215687|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
360653|NCT01023815|1215688|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
360654|NCT01023815|1215689|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
360655|NCT01023815|1215690|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
360656|NCT01023815|1215687|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
360657|NCT01023815|1215688|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
360658|NCT01023815|1215689|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
360659|NCT01023815|1215690|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
360660|NCT01023815|1215687|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
360661|NCT01023815|1215688|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
360662|NCT01023815|1215689|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
360663|NCT01023815|1215690|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
360664|NCT01023815|1215687|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
360665|NCT01023815|1215688|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
360666|NCT01023815|1215689|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
360667|NCT01023815|1215690|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
360668|NCT01023789|1215709|P1|3 - Year Visit|Lost to Follow-up|13
360669|NCT01023789|1215709|P1|3 - Year Visit|Withdrawal of consent|1
360670|NCT01023789|1215709|P1|3 - Year Visit|Death|29
360671|NCT01023672|1215795|P1|Overall Study|Death|1
360672|NCT01023672|1215795|P1|Overall Study|Worsening disease|2
360673|NCT01023659|1215802|P3|Overall Study|Lost to Follow-up|99
360674|NCT01023659|1215803|P2|Overall Study|Lost to Follow-up|228
360675|NCT01023659|1215804|P1|Overall Study|Lost to Follow-up|73
360676|NCT01023581|1215820|P7|Overall Study|Other|0
360677|NCT01023581|1215821|P6|Overall Study|Other|0
360678|NCT01023581|1215822|P5|Overall Study|Other|1
360679|NCT01023581|1215823|P4|Overall Study|Other|0
360680|NCT01023581|1215824|P3|Overall Study|Other|1
360681|NCT01023581|1215825|P2|Overall Study|Other|0
360682|NCT01023581|1215826|P1|Overall Study|Other|1
360683|NCT01023581|1215820|P7|Overall Study|Physician Decision|1
360684|NCT01023581|1215821|P6|Overall Study|Physician Decision|1
360685|NCT01023581|1215822|P5|Overall Study|Physician Decision|1
360686|NCT01023581|1215823|P4|Overall Study|Physician Decision|1
360687|NCT01023581|1215824|P3|Overall Study|Physician Decision|2
360688|NCT01023581|1215825|P2|Overall Study|Physician Decision|0
360689|NCT01023581|1215826|P1|Overall Study|Physician Decision|2
360690|NCT01023581|1215820|P7|Overall Study|Lack of Efficacy|1
360691|NCT01023581|1215821|P6|Overall Study|Lack of Efficacy|2
360692|NCT01023581|1215822|P5|Overall Study|Lack of Efficacy|1
360693|NCT01023581|1215823|P4|Overall Study|Lack of Efficacy|2
360694|NCT01023581|1215824|P3|Overall Study|Lack of Efficacy|6
360695|NCT01023581|1215825|P2|Overall Study|Lack of Efficacy|3
360696|NCT01023581|1215826|P1|Overall Study|Lack of Efficacy|9
360697|NCT01023581|1215820|P7|Overall Study|Pregnancy|0
360698|NCT01023581|1215821|P6|Overall Study|Pregnancy|1
360699|NCT01023581|1215822|P5|Overall Study|Pregnancy|0
360700|NCT01023581|1215823|P4|Overall Study|Pregnancy|2
360701|NCT01023581|1215824|P3|Overall Study|Pregnancy|0
360702|NCT01023581|1215825|P2|Overall Study|Pregnancy|0
360703|NCT01023581|1215826|P1|Overall Study|Pregnancy|0
360704|NCT01023581|1215820|P7|Overall Study|Withdrawal by Subject|5
360705|NCT01023581|1215821|P6|Overall Study|Withdrawal by Subject|8
360706|NCT01023581|1215822|P5|Overall Study|Withdrawal by Subject|6
360707|NCT01023581|1215823|P4|Overall Study|Withdrawal by Subject|10
360708|NCT01023581|1215824|P3|Overall Study|Withdrawal by Subject|16
360709|NCT01023581|1215825|P2|Overall Study|Withdrawal by Subject|8
360710|NCT01023581|1215826|P1|Overall Study|Withdrawal by Subject|13
360711|NCT01023581|1215820|P7|Overall Study|Lost to Follow-up|2
360712|NCT01023581|1215821|P6|Overall Study|Lost to Follow-up|2
360713|NCT01023581|1215822|P5|Overall Study|Lost to Follow-up|5
360714|NCT01023581|1215823|P4|Overall Study|Lost to Follow-up|2
360715|NCT01023581|1215824|P3|Overall Study|Lost to Follow-up|7
360716|NCT01023581|1215825|P2|Overall Study|Lost to Follow-up|8
360717|NCT01023581|1215826|P1|Overall Study|Lost to Follow-up|4
360718|NCT01023581|1215820|P7|Overall Study|Major protocol deviation|0
360719|NCT01023581|1215821|P6|Overall Study|Major protocol deviation|0
360720|NCT01023581|1215822|P5|Overall Study|Major protocol deviation|0
360721|NCT01023581|1215823|P4|Overall Study|Major protocol deviation|0
360722|NCT01023581|1215824|P3|Overall Study|Major protocol deviation|3
360723|NCT01023581|1215825|P2|Overall Study|Major protocol deviation|0
360724|NCT01023581|1215826|P1|Overall Study|Major protocol deviation|2
360725|NCT01023581|1215820|P7|Overall Study|Adverse Event|11
360726|NCT01023581|1215821|P6|Overall Study|Adverse Event|5
360727|NCT01023581|1215822|P5|Overall Study|Adverse Event|2
360728|NCT01023581|1215823|P4|Overall Study|Adverse Event|3
360729|NCT01023581|1215824|P3|Overall Study|Adverse Event|7
360730|NCT01023581|1215825|P2|Overall Study|Adverse Event|4
360731|NCT01023581|1215826|P1|Overall Study|Adverse Event|4
360732|NCT01023516|1215883|P2|Overall Study|Incorrect enrolment|2
360733|NCT01023516|1215884|P1|Overall Study|Incorrect enrolment|4
360734|NCT01023516|1215883|P2|Overall Study|Study-specific criteria|2
360735|NCT01023516|1215884|P1|Overall Study|Study-specific criteria|4
360736|NCT01023516|1215883|P2|Overall Study|Safety reason|3
360737|NCT01023516|1215884|P1|Overall Study|Safety reason|0
360738|NCT01023516|1215883|P2|Overall Study|Adverse Event|6
360739|NCT01023516|1215884|P1|Overall Study|Adverse Event|9
360740|NCT01023516|1215883|P2|Overall Study|Voluntary discontinuation|5
360741|NCT01023516|1215884|P1|Overall Study|Voluntary discontinuation|7
360742|NCT01023308|1215966|P2|Overall Study|Withdrawal by Subject|18
360743|NCT01023308|1215967|P1|Overall Study|Withdrawal by Subject|34
360744|NCT01023308|1215966|P2|Overall Study|Lost to Follow-up|0
360745|NCT01023308|1215967|P1|Overall Study|Lost to Follow-up|1
360746|NCT01023308|1215966|P2|Overall Study|Untreated|5
360747|NCT01023308|1215967|P1|Overall Study|Untreated|5
360748|NCT01023308|1215966|P2|Overall Study|Protocol Violation|4
360749|NCT01023308|1215967|P1|Overall Study|Protocol Violation|3
360750|NCT01023308|1215966|P2|Overall Study|New Cancer therapy|7
360751|NCT01023308|1215967|P1|Overall Study|New Cancer therapy|4
360752|NCT01023308|1215966|P2|Overall Study|Disease progression|153
360753|NCT01023308|1215967|P1|Overall Study|Disease progression|82
360754|NCT01023308|1215966|P2|Overall Study|Death|17
360755|NCT01023308|1215967|P1|Overall Study|Death|21
360756|NCT01023308|1215966|P2|Overall Study|Adverse Event|66
360757|NCT01023308|1215967|P1|Overall Study|Adverse Event|130
360758|NCT01023308|1215966|P2|Overall Study|Administrative problems|1
360759|NCT01023308|1215967|P1|Overall Study|Administrative problems|2
360760|NCT01023308|1215966|P2|Overall Study|Abnormal test proceedure results|8
360761|NCT01023308|1215967|P1|Overall Study|Abnormal test proceedure results|3
360762|NCT01023256|1215997|P4|Overall Study|Withdrawal by Subject|2
360763|NCT01023256|1215998|P3|Overall Study|Withdrawal by Subject|0
360764|NCT01023256|1215999|P2|Overall Study|Withdrawal by Subject|0
360765|NCT01023256|1216000|P1|Overall Study|Withdrawal by Subject|0
360766|NCT01023256|1215997|P4|Overall Study|Adverse Event|1
360767|NCT01023256|1215998|P3|Overall Study|Adverse Event|0
360768|NCT01023256|1215999|P2|Overall Study|Adverse Event|0
360769|NCT01023256|1216000|P1|Overall Study|Adverse Event|0
360770|NCT01023256|1215997|P4|Overall Study|Not specified|2
360771|NCT01023256|1215998|P3|Overall Study|Not specified|0
360772|NCT01023256|1215999|P2|Overall Study|Not specified|0
360773|NCT01023256|1216000|P1|Overall Study|Not specified|1
360774|NCT01023256|1215997|P4|Overall Study|Randomized but not treated|0
360775|NCT01023256|1215998|P3|Overall Study|Randomized but not treated|1
360776|NCT01023256|1215999|P2|Overall Study|Randomized but not treated|0
360777|NCT01023256|1216000|P1|Overall Study|Randomized but not treated|1
360778|NCT01023256|1215997|P4|Overall Study|Protocol Violation|0
360779|NCT01023256|1215998|P3|Overall Study|Protocol Violation|0
360780|NCT01023256|1215999|P2|Overall Study|Protocol Violation|3
360781|NCT01023256|1216000|P1|Overall Study|Protocol Violation|2
360782|NCT01023217|1216042|P2|Overall Study|Withdrawal by Subject|0
360783|NCT01023217|1216043|P1|Overall Study|Withdrawal by Subject|1
360784|NCT01023061|1216081|P1|Overall Study|Withdrawal prior to treatment|2
360785|NCT01023035|1216090|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
360786|NCT01023035|1216091|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
360787|NCT01023035|1216092|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
360788|NCT01023035|1216090|P3|Follow-up Period (up to Week 72)|Adverse Event|1
360789|NCT01023035|1216091|P2|Follow-up Period (up to Week 72)|Adverse Event|0
360790|NCT01023035|1216092|P1|Follow-up Period (up to Week 72)|Adverse Event|2
360791|NCT01023035|1216090|P3|Treatment Period|Treatment Failure|24
360792|NCT01023035|1216091|P2|Treatment Period|Treatment Failure|31
360793|NCT01023035|1216092|P1|Treatment Period|Treatment Failure|26
360794|NCT01023035|1216090|P3|Treatment Period|Non-Medical Reasons|44
360795|NCT01023035|1216091|P2|Treatment Period|Non-Medical Reasons|22
360796|NCT01023035|1216092|P1|Treatment Period|Non-Medical Reasons|19
360797|NCT01023035|1216090|P3|Treatment Period|Adverse Event|50
360798|NCT01023035|1216091|P2|Treatment Period|Adverse Event|32
360799|NCT01023035|1216092|P1|Treatment Period|Adverse Event|27
360800|NCT01023022|1216102|P1|Overall Study|due to technical issues|2
360801|NCT01023022|1216102|P1|Overall Study|Lost to Follow-up|7
360802|NCT01023022|1216102|P1|Overall Study|Death|5
360803|NCT01022996|1216108|P1|Overall Study|Protocol Violation|1
360804|NCT01022996|1216108|P1|Overall Study|Disease Progression|32
360805|NCT01022996|1216108|P1|Overall Study|Administrative problems|6
360806|NCT01022996|1216108|P1|Overall Study|Lost to Follow-up|1
360807|NCT01022996|1216108|P1|Overall Study|Withdrawal by Subject|3
360808|NCT01022996|1216108|P1|Overall Study|Adverse Event|14
360809|NCT01022762|1216119|P2|Overall Study|Unclassified|20
360810|NCT01022762|1216120|P1|Overall Study|Unclassified|12
360811|NCT01022762|1216119|P2|Overall Study|Protocol Violation|6
360812|NCT01022762|1216120|P1|Overall Study|Protocol Violation|7
360813|NCT01022762|1216119|P2|Overall Study|Lack of Efficacy|1
360814|NCT01022762|1216120|P1|Overall Study|Lack of Efficacy|0
360815|NCT01022762|1216119|P2|Overall Study|Adverse Event|1
360816|NCT01022762|1216120|P1|Overall Study|Adverse Event|3
360817|NCT01022502|1216155|P1|Overall Study|Withdrawal by Subject|1
360818|NCT01022502|1216155|P1|Overall Study|employment related reasons|1
360819|NCT01022502|1216155|P1|Overall Study|Adverse Event|1
360820|NCT01022398|1216171|P2|Overall Study|Study terminated|2
360821|NCT01022398|1216172|P1|Overall Study|Study terminated|2
360822|NCT01022203|1216197|P2|Follow-Up Assessment|Lost to Follow-up|2
360823|NCT01022203|1216198|P1|Follow-Up Assessment|Lost to Follow-up|2
360824|NCT01022203|1216197|P2|Post Treatment Assessment|Adverse Event|2
360825|NCT01022203|1216198|P1|Post Treatment Assessment|Adverse Event|0
360826|NCT01022203|1216197|P2|Post Treatment Assessment|Physician Decision|0
360827|NCT01022203|1216198|P1|Post Treatment Assessment|Physician Decision|2
360828|NCT01022203|1216197|P2|Post Treatment Assessment|Withdrawal by Subject|12
360829|NCT01022203|1216198|P1|Post Treatment Assessment|Withdrawal by Subject|12
360830|NCT01022112|1216217|P5|Overall Study|Fasting plasma glucose level increased|7
360831|NCT01022112|1216218|P4|Overall Study|Fasting plasma glucose level increased|0
360832|NCT01022112|1216219|P3|Overall Study|Fasting plasma glucose level increased|0
360833|NCT01022112|1216220|P2|Overall Study|Fasting plasma glucose level increased|0
360834|NCT01022112|1216221|P1|Overall Study|Fasting plasma glucose level increased|1
360835|NCT01022112|1216217|P5|Overall Study|Withdrawal by Subject|1
360836|NCT01022112|1216218|P4|Overall Study|Withdrawal by Subject|2
360837|NCT01022112|1216219|P3|Overall Study|Withdrawal by Subject|2
360838|NCT01022112|1216220|P2|Overall Study|Withdrawal by Subject|1
360839|NCT01022112|1216221|P1|Overall Study|Withdrawal by Subject|0
360840|NCT01022112|1216217|P5|Overall Study|Physician Decision|1
360841|NCT01022112|1216218|P4|Overall Study|Physician Decision|0
360842|NCT01022112|1216219|P3|Overall Study|Physician Decision|1
360843|NCT01022112|1216220|P2|Overall Study|Physician Decision|0
360844|NCT01022112|1216221|P1|Overall Study|Physician Decision|0
360845|NCT01022112|1216217|P5|Overall Study|Lack of Efficacy|1
360846|NCT01022112|1216218|P4|Overall Study|Lack of Efficacy|0
360847|NCT01022112|1216219|P3|Overall Study|Lack of Efficacy|0
360848|NCT01022112|1216220|P2|Overall Study|Lack of Efficacy|0
360849|NCT01022112|1216221|P1|Overall Study|Lack of Efficacy|1
360850|NCT01022112|1216217|P5|Overall Study|Adverse Event|0
360851|NCT01022112|1216218|P4|Overall Study|Adverse Event|1
360852|NCT01022112|1216219|P3|Overall Study|Adverse Event|0
360853|NCT01022112|1216220|P2|Overall Study|Adverse Event|2
360854|NCT01022112|1216221|P1|Overall Study|Adverse Event|1
360855|NCT01021878|1216244|P2|Overall Study|Transplantation|1
360856|NCT01021878|1216245|P1|Overall Study|Transplantation|6
360857|NCT01021878|1216244|P2|Overall Study|Adverse Event|5
360858|NCT01021878|1216245|P1|Overall Study|Adverse Event|6
360859|NCT01021878|1216244|P2|Overall Study|Death|1
360860|NCT01021878|1216245|P1|Overall Study|Death|0
360861|NCT01021878|1216244|P2|Overall Study|Lost to Follow-up|3
360862|NCT01021878|1216245|P1|Overall Study|Lost to Follow-up|4
360863|NCT01021852|1216267|P8|Treatment Period 2|Withdrawal by Subject|2
360864|NCT01021852|1216268|P7|Treatment Period 2|Withdrawal by Subject|1
360865|NCT01021852|1216269|P6|Treatment Period 2|Withdrawal by Subject|0
360866|NCT01021852|1216270|P5|Treatment Period 2|Withdrawal by Subject|0
360867|NCT01021852|1216271|P4|Treatment Period 2|Withdrawal by Subject|0
360868|NCT01021852|1216272|P3|Treatment Period 2|Withdrawal by Subject|0
360869|NCT01021852|1216273|P2|Treatment Period 2|Withdrawal by Subject|0
360870|NCT01021852|1216274|P1|Treatment Period 2|Withdrawal by Subject|0
360871|NCT01021852|1216267|P8|Treatment Period 2|Protocol Violation|0
360872|NCT01021852|1216268|P7|Treatment Period 2|Protocol Violation|1
360873|NCT01021852|1216269|P6|Treatment Period 2|Protocol Violation|0
360874|NCT01021852|1216270|P5|Treatment Period 2|Protocol Violation|1
360875|NCT01021852|1216271|P4|Treatment Period 2|Protocol Violation|0
360876|NCT01021852|1216272|P3|Treatment Period 2|Protocol Violation|0
360877|NCT01021852|1216273|P2|Treatment Period 2|Protocol Violation|0
360878|NCT01021852|1216274|P1|Treatment Period 2|Protocol Violation|0
360879|NCT01021852|1216267|P8|Treatment Period 2|Physician Decision|0
360880|NCT01021852|1216268|P7|Treatment Period 2|Physician Decision|0
360881|NCT01021852|1216269|P6|Treatment Period 2|Physician Decision|0
360882|NCT01021852|1216270|P5|Treatment Period 2|Physician Decision|0
360883|NCT01021852|1216271|P4|Treatment Period 2|Physician Decision|0
360884|NCT01021852|1216272|P3|Treatment Period 2|Physician Decision|1
360885|NCT01021852|1216273|P2|Treatment Period 2|Physician Decision|0
360886|NCT01021852|1216274|P1|Treatment Period 2|Physician Decision|0
360887|NCT01021852|1216267|P8|Treatment Period 2|Lack of Efficacy|0
360888|NCT01021852|1216268|P7|Treatment Period 2|Lack of Efficacy|0
360889|NCT01021852|1216269|P6|Treatment Period 2|Lack of Efficacy|1
360890|NCT01021852|1216270|P5|Treatment Period 2|Lack of Efficacy|0
360891|NCT01021852|1216271|P4|Treatment Period 2|Lack of Efficacy|0
360892|NCT01021852|1216272|P3|Treatment Period 2|Lack of Efficacy|0
360893|NCT01021852|1216273|P2|Treatment Period 2|Lack of Efficacy|0
360894|NCT01021852|1216274|P1|Treatment Period 2|Lack of Efficacy|0
360895|NCT01021852|1216267|P8|Treatment Period 2|Adverse Event|0
360896|NCT01021852|1216268|P7|Treatment Period 2|Adverse Event|1
360897|NCT01021852|1216269|P6|Treatment Period 2|Adverse Event|0
360898|NCT01021852|1216270|P5|Treatment Period 2|Adverse Event|1
360899|NCT01021852|1216271|P4|Treatment Period 2|Adverse Event|0
360900|NCT01021852|1216272|P3|Treatment Period 2|Adverse Event|0
360901|NCT01021852|1216273|P2|Treatment Period 2|Adverse Event|1
360902|NCT01021852|1216274|P1|Treatment Period 2|Adverse Event|0
360903|NCT01021852|1216267|P8|Washout Period-No Drug|Adverse Event|0
360904|NCT01021852|1216268|P7|Washout Period-No Drug|Adverse Event|0
360905|NCT01021852|1216269|P6|Washout Period-No Drug|Adverse Event|1
360906|NCT01021852|1216270|P5|Washout Period-No Drug|Adverse Event|0
360907|NCT01021852|1216271|P4|Washout Period-No Drug|Adverse Event|0
360908|NCT01021852|1216272|P3|Washout Period-No Drug|Adverse Event|0
360909|NCT01021852|1216273|P2|Washout Period-No Drug|Adverse Event|0
360910|NCT01021852|1216274|P1|Washout Period-No Drug|Adverse Event|1
360911|NCT01021852|1216267|P8|Washout Period-Placebo|Protocol Violation|0
360912|NCT01021852|1216268|P7|Washout Period-Placebo|Protocol Violation|1
360913|NCT01021852|1216269|P6|Washout Period-Placebo|Protocol Violation|0
360914|NCT01021852|1216270|P5|Washout Period-Placebo|Protocol Violation|0
360915|NCT01021852|1216271|P4|Washout Period-Placebo|Protocol Violation|0
360916|NCT01021852|1216272|P3|Washout Period-Placebo|Protocol Violation|0
360917|NCT01021852|1216273|P2|Washout Period-Placebo|Protocol Violation|0
360918|NCT01021852|1216274|P1|Washout Period-Placebo|Protocol Violation|0
360919|NCT01021852|1216267|P8|Washout Period-Placebo|Lost to Follow-up|0
360920|NCT01021852|1216268|P7|Washout Period-Placebo|Lost to Follow-up|0
360921|NCT01021852|1216269|P6|Washout Period-Placebo|Lost to Follow-up|0
360922|NCT01021852|1216270|P5|Washout Period-Placebo|Lost to Follow-up|1
360923|NCT01021852|1216271|P4|Washout Period-Placebo|Lost to Follow-up|0
360924|NCT01021852|1216272|P3|Washout Period-Placebo|Lost to Follow-up|0
360925|NCT01021852|1216273|P2|Washout Period-Placebo|Lost to Follow-up|0
360926|NCT01021852|1216274|P1|Washout Period-Placebo|Lost to Follow-up|0
360927|NCT01021852|1216267|P8|Washout Period-Placebo|Adverse Event|0
360928|NCT01021852|1216268|P7|Washout Period-Placebo|Adverse Event|0
360929|NCT01021852|1216269|P6|Washout Period-Placebo|Adverse Event|1
360930|NCT01021852|1216270|P5|Washout Period-Placebo|Adverse Event|0
360931|NCT01021852|1216271|P4|Washout Period-Placebo|Adverse Event|1
360932|NCT01021852|1216272|P3|Washout Period-Placebo|Adverse Event|0
360933|NCT01021852|1216273|P2|Washout Period-Placebo|Adverse Event|0
360934|NCT01021852|1216274|P1|Washout Period-Placebo|Adverse Event|0
360935|NCT01021852|1216267|P8|Treatment Period 1|Not Treated|0
360936|NCT01021852|1216268|P7|Treatment Period 1|Not Treated|0
360937|NCT01021852|1216269|P6|Treatment Period 1|Not Treated|0
360938|NCT01021852|1216270|P5|Treatment Period 1|Not Treated|0
360939|NCT01021852|1216271|P4|Treatment Period 1|Not Treated|2
360940|NCT01021852|1216272|P3|Treatment Period 1|Not Treated|0
360941|NCT01021852|1216273|P2|Treatment Period 1|Not Treated|0
360942|NCT01021852|1216274|P1|Treatment Period 1|Not Treated|0
360943|NCT01021852|1216267|P8|Treatment Period 1|Withdrawal by Subject|1
360944|NCT01021852|1216268|P7|Treatment Period 1|Withdrawal by Subject|0
360945|NCT01021852|1216269|P6|Treatment Period 1|Withdrawal by Subject|0
360946|NCT01021852|1216270|P5|Treatment Period 1|Withdrawal by Subject|1
360947|NCT01021852|1216271|P4|Treatment Period 1|Withdrawal by Subject|0
360948|NCT01021852|1216272|P3|Treatment Period 1|Withdrawal by Subject|0
360949|NCT01021852|1216273|P2|Treatment Period 1|Withdrawal by Subject|0
360950|NCT01021852|1216274|P1|Treatment Period 1|Withdrawal by Subject|0
360951|NCT01021852|1216267|P8|Treatment Period 1|Pregnancy|0
360952|NCT01021852|1216268|P7|Treatment Period 1|Pregnancy|0
360953|NCT01021852|1216269|P6|Treatment Period 1|Pregnancy|0
360954|NCT01021852|1216270|P5|Treatment Period 1|Pregnancy|0
360955|NCT01021852|1216271|P4|Treatment Period 1|Pregnancy|0
360956|NCT01021852|1216272|P3|Treatment Period 1|Pregnancy|1
360957|NCT01021852|1216273|P2|Treatment Period 1|Pregnancy|0
360958|NCT01021852|1216274|P1|Treatment Period 1|Pregnancy|0
360959|NCT01021852|1216267|P8|Treatment Period 1|Adverse Event|0
360960|NCT01021852|1216268|P7|Treatment Period 1|Adverse Event|0
360961|NCT01021852|1216269|P6|Treatment Period 1|Adverse Event|2
360962|NCT01021852|1216270|P5|Treatment Period 1|Adverse Event|2
360963|NCT01021852|1216271|P4|Treatment Period 1|Adverse Event|0
360964|NCT01021852|1216272|P3|Treatment Period 1|Adverse Event|1
360965|NCT01021852|1216273|P2|Treatment Period 1|Adverse Event|1
360966|NCT01021852|1216274|P1|Treatment Period 1|Adverse Event|3
360967|NCT01021813|1216310|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
360968|NCT01021813|1216311|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
360969|NCT01021813|1216312|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
360970|NCT01021813|1216313|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
360971|NCT01021813|1216314|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
360972|NCT01021813|1216310|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
360973|NCT01021813|1216311|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
360974|NCT01021813|1216312|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
360975|NCT01021813|1216313|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
360976|NCT01021813|1216314|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
360977|NCT01021813|1216310|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
360978|NCT01021813|1216311|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
360979|NCT01021813|1216312|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
360980|NCT01021813|1216313|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
360981|NCT01021813|1216314|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
360982|NCT01021813|1216310|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
360983|NCT01021813|1216311|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
360984|NCT01021813|1216312|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
360985|NCT01021813|1216313|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
360986|NCT01021813|1216314|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
360987|NCT01021813|1216310|P5|DB Randomized Discontinuation Phase|Adverse Event|1
360988|NCT01021813|1216311|P4|DB Randomized Discontinuation Phase|Adverse Event|3
360989|NCT01021813|1216312|P3|DB Randomized Discontinuation Phase|Adverse Event|0
360990|NCT01021813|1216313|P2|DB Randomized Discontinuation Phase|Adverse Event|0
360991|NCT01021813|1216314|P1|DB Randomized Discontinuation Phase|Adverse Event|0
360992|NCT01021813|1216310|P5|DB Treatment Phase|Withdrawal by Subject|0
360993|NCT01021813|1216311|P4|DB Treatment Phase|Withdrawal by Subject|0
360994|NCT01021813|1216312|P3|DB Treatment Phase|Withdrawal by Subject|0
360995|NCT01021813|1216313|P2|DB Treatment Phase|Withdrawal by Subject|24
360996|NCT01021813|1216314|P1|DB Treatment Phase|Withdrawal by Subject|60
360997|NCT01021813|1216310|P5|DB Treatment Phase|Protocol Violation|0
360998|NCT01021813|1216311|P4|DB Treatment Phase|Protocol Violation|0
360999|NCT01021813|1216312|P3|DB Treatment Phase|Protocol Violation|0
361000|NCT01021813|1216313|P2|DB Treatment Phase|Protocol Violation|3
361001|NCT01021813|1216314|P1|DB Treatment Phase|Protocol Violation|4
361002|NCT01021813|1216310|P5|DB Treatment Phase|Pregnancy|0
361003|NCT01021813|1216311|P4|DB Treatment Phase|Pregnancy|0
361004|NCT01021813|1216312|P3|DB Treatment Phase|Pregnancy|0
361005|NCT01021813|1216313|P2|DB Treatment Phase|Pregnancy|0
361006|NCT01021813|1216314|P1|DB Treatment Phase|Pregnancy|1
361007|NCT01021813|1216310|P5|DB Treatment Phase|Physician Decision|0
361008|NCT01021813|1216311|P4|DB Treatment Phase|Physician Decision|0
361009|NCT01021813|1216312|P3|DB Treatment Phase|Physician Decision|0
361010|NCT01021813|1216313|P2|DB Treatment Phase|Physician Decision|8
361011|NCT01021813|1216314|P1|DB Treatment Phase|Physician Decision|17
361012|NCT01021813|1216310|P5|DB Treatment Phase|Lost to Follow-up|0
361013|NCT01021813|1216311|P4|DB Treatment Phase|Lost to Follow-up|0
361014|NCT01021813|1216312|P3|DB Treatment Phase|Lost to Follow-up|0
361015|NCT01021813|1216313|P2|DB Treatment Phase|Lost to Follow-up|12
361016|NCT01021813|1216314|P1|DB Treatment Phase|Lost to Follow-up|14
361017|NCT01021813|1216310|P5|DB Treatment Phase|Lack of Efficacy|0
361018|NCT01021813|1216311|P4|DB Treatment Phase|Lack of Efficacy|0
361019|NCT01021813|1216312|P3|DB Treatment Phase|Lack of Efficacy|0
361020|NCT01021813|1216313|P2|DB Treatment Phase|Lack of Efficacy|28
361021|NCT01021813|1216314|P1|DB Treatment Phase|Lack of Efficacy|44
361022|NCT01021813|1216310|P5|DB Treatment Phase|Adverse Event|0
361023|NCT01021813|1216311|P4|DB Treatment Phase|Adverse Event|0
361024|NCT01021813|1216312|P3|DB Treatment Phase|Adverse Event|0
361025|NCT01021813|1216313|P2|DB Treatment Phase|Adverse Event|22
361026|NCT01021813|1216314|P1|DB Treatment Phase|Adverse Event|60
361027|NCT01021683|1216366|P1|Overall Study|Other|8
361028|NCT01021683|1216366|P1|Overall Study|Recovery of neutrophil count|51
361029|NCT01021683|1216366|P1|Overall Study|Lack of Efficacy|12
361030|NCT01021553|1216392|P3|Overall Study|Withdrawal by Subject|0
361031|NCT01021553|1216393|P2|Overall Study|Withdrawal by Subject|1
361032|NCT01021553|1216394|P1|Overall Study|Withdrawal by Subject|1
361033|NCT01021553|1216392|P3|Overall Study|Lost to Follow-up|1
361034|NCT01021553|1216393|P2|Overall Study|Lost to Follow-up|0
361035|NCT01021553|1216394|P1|Overall Study|Lost to Follow-up|0
361036|NCT01021553|1216392|P3|Overall Study|Protocol Violation|2
361037|NCT01021553|1216393|P2|Overall Study|Protocol Violation|2
361038|NCT01021553|1216394|P1|Overall Study|Protocol Violation|0
361039|NCT01021553|1216392|P3|Overall Study|Lack of Efficacy|0
361040|NCT01021553|1216393|P2|Overall Study|Lack of Efficacy|2
361041|NCT01021553|1216394|P1|Overall Study|Lack of Efficacy|2
361042|NCT01021553|1216392|P3|Overall Study|Adverse Event|0
361043|NCT01021553|1216393|P2|Overall Study|Adverse Event|0
361044|NCT01021553|1216394|P1|Overall Study|Adverse Event|1
361045|NCT01021423|1216448|P2|Overall Study|Study terminated|5
361046|NCT01021423|1216449|P1|Overall Study|Study terminated|4
361047|NCT01021332|1216465|P1|Overall Study|Miscellaneous|3
361048|NCT01021332|1216465|P1|Overall Study|Protocol Violation|9
361049|NCT01021332|1216465|P1|Overall Study|Lost to Follow-up|4
361050|NCT01021332|1216465|P1|Overall Study|Withdrawal of Consent|23
361051|NCT01021332|1216465|P1|Overall Study|Lack of Efficacy|19
361052|NCT01021332|1216465|P1|Overall Study|Adverse Event|43
361053|NCT01021332|1216465|P1|Overall Study|Not fulfilling incl./excl.criteria|5
361054|NCT01021293|1216526|P2|Overall Study|Lost to Follow-up|1
361055|NCT01021293|1216527|P1|Overall Study|Lost to Follow-up|1
361056|NCT01021293|1216526|P2|Overall Study|Migrated/moved from study area|18
361057|NCT01021293|1216527|P1|Overall Study|Migrated/moved from study area|6
361058|NCT01021293|1216526|P2|Overall Study|Withdrawal by Subject|3
361059|NCT01021293|1216527|P1|Overall Study|Withdrawal by Subject|1
361060|NCT01021293|1216526|P2|Overall Study|Adverse Event|1
361061|NCT01021293|1216527|P1|Overall Study|Adverse Event|2
361062|NCT01021293|1216526|P2|Overall Study|Serious Adverse Event|1
361063|NCT01021293|1216527|P1|Overall Study|Serious Adverse Event|2
361064|NCT01021215|1216546|P2|Overall Study|Lost to Follow-up|0
361065|NCT01021215|1216547|P1|Overall Study|Lost to Follow-up|3
361066|NCT01021020|1216562|P1|14 Day Washout Period A|Physician Decision|1
361067|NCT01021020|1216562|P1|Period I|Withdrawal by Subject|1
361068|NCT01021020|1216562|P1|Period I|Protocol Violation|1
361069|NCT01021007|1216578|P2|Overall Study|Adverse Event|3
361070|NCT01021007|1216579|P1|Overall Study|Adverse Event|1
361071|NCT01021007|1216578|P2|Overall Study|Lost to Follow-up|1
361072|NCT01021007|1216579|P1|Overall Study|Lost to Follow-up|1
361073|NCT01020981|1216591|P2|Overall Study|Participant declined to complete survey|0
361074|NCT01020981|1216592|P1|Overall Study|Participant declined to complete survey|2
361075|NCT01020981|1216591|P2|Overall Study|Survey returned undeliverable|32
361076|NCT01020981|1216592|P1|Overall Study|Survey returned undeliverable|8
361077|NCT01020981|1216591|P2|Overall Study|Did not return mailed survey|58
361078|NCT01020981|1216592|P1|Overall Study|Did not return mailed survey|74
361079|NCT01020877|1216613|P2|Second Intervention|Withdrawal by Subject|0
361080|NCT01020877|1216614|P1|Second Intervention|Withdrawal by Subject|1
361081|NCT01020838|1216624|P1|Overall Study|Most common: Study ended by sponsor|77
361082|NCT01020838|1216624|P1|Overall Study|Lost to Follow-up|6
361083|NCT01020838|1216624|P1|Overall Study|Withdrawal by Subject|9
361084|NCT01020838|1216624|P1|Overall Study|Adverse Event|1
361085|NCT01020838|1216624|P1|Overall Study|Death|90
361086|NCT01020812|1216639|P1|Overall Study|Protocol Violation|1
361087|NCT01020812|1216639|P1|Overall Study|Withdrawal by Subject|1
361088|NCT01020812|1216639|P1|Overall Study|Physician Decision|1
361089|NCT01020799|1216649|P3|Overall Study|Lost to Follow-up|2
361090|NCT01020799|1216650|P2|Overall Study|Lost to Follow-up|4
361091|NCT01020799|1216651|P1|Overall Study|Lost to Follow-up|6
361092|NCT01020799|1216649|P3|Overall Study|Withdrawal by Subject|3
361093|NCT01020799|1216650|P2|Overall Study|Withdrawal by Subject|2
361094|NCT01020799|1216651|P1|Overall Study|Withdrawal by Subject|2
361095|NCT01020799|1216649|P3|Overall Study|Protocol Violation|0
361096|NCT01020799|1216650|P2|Overall Study|Protocol Violation|2
361097|NCT01020799|1216651|P1|Overall Study|Protocol Violation|3
361098|NCT01020799|1216649|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
361099|NCT01020799|1216650|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
361100|NCT01020799|1216651|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
361101|NCT01020799|1216649|P3|Overall Study|Adverse Event|2
361102|NCT01020799|1216650|P2|Overall Study|Adverse Event|3
361103|NCT01020799|1216651|P1|Overall Study|Adverse Event|4
361104|NCT01020786|1216674|P1|Maintenance Period|Sponsor Decision|1
361105|NCT01020786|1216674|P1|Maintenance Period|Withdrawal by Subject|8
361106|NCT01020786|1216674|P1|Maintenance Period|Progressive Disease|43
361107|NCT01020786|1216674|P1|Maintenance Period|Adverse Event|8
361108|NCT01020786|1216674|P1|Induction Period|Withdrawal by Subject|3
361109|NCT01020786|1216674|P1|Induction Period|Investigator Decision|3
361110|NCT01020786|1216674|P1|Induction Period|Progressive Disease|31
361111|NCT01020786|1216674|P1|Induction Period|Adverse Event|10
361112|NCT01020786|1216674|P1|Induction Period|Entry Criteria Not Met|2
361113|NCT01020773|1216688|P2|Overall Study|Withdrawal by Subject|3
361114|NCT01020773|1216689|P1|Overall Study|Withdrawal by Subject|4
361115|NCT01020747|1216695|P1|Overall Study|Withdrawal by Subject|1
361116|NCT01020526|1216711|P1|Overall Study|Adverse Event|2
361117|NCT01020526|1216711|P1|Overall Study|Lost to Follow-up|1
361118|NCT01020526|1216711|P1|Overall Study|Insufficient clinical response|3
361119|NCT01020526|1216711|P1|Overall Study|Other reasons|3
361120|NCT01020526|1216711|P1|Overall Study|Withdrawal by Subject|5
361121|NCT01020474|1216717|P2|Overall Study|Insufficient Clinical Response|3
361122|NCT01020474|1216718|P1|Overall Study|Insufficient Clinical Response|0
361123|NCT01020474|1216717|P2|Overall Study|Other Reasons|1
361124|NCT01020474|1216718|P1|Overall Study|Other Reasons|1
361125|NCT01020474|1216717|P2|Overall Study|Withdrawal by Subject|7
361126|NCT01020474|1216718|P1|Overall Study|Withdrawal by Subject|5
361127|NCT01020474|1216717|P2|Overall Study|Protocol Violation|2
361128|NCT01020474|1216718|P1|Overall Study|Protocol Violation|0
361129|NCT01020474|1216717|P2|Overall Study|Adverse Event|4
361130|NCT01020474|1216718|P1|Overall Study|Adverse Event|4
361131|NCT01020448|1216738|P1|Treatment|Lost to Follow-up|2
361132|NCT01020448|1216738|P1|Treatment|Lack of Efficacy|8
361133|NCT01020448|1216738|P1|Treatment|Disease Progression|2
361134|NCT01020448|1216738|P1|Treatment|Consent Withdrawn|3
361135|NCT01020448|1216738|P1|Treatment|Adverse Event|11
361136|NCT01020448|1216738|P1|Pre-assignment|Does Not Meet Entry Criteria|2
361137|NCT01020448|1216738|P1|Pre-assignment|Withdrawal by Subject|5
361138|NCT01020448|1216738|P1|Pre-assignment|Adverse Event|6
361139|NCT01020435|1216749|P2|Overall Study|Lost to Follow-up|1
361140|NCT01020435|1216750|P1|Overall Study|Lost to Follow-up|0
361141|NCT01020305|1216758|P1|Overall Study|Adverse Event|2
361142|NCT01020123|1216769|P7|Extention Period|Lost to Follow-up|0
361143|NCT01020123|1216770|P6|Extention Period|Lost to Follow-up|2
361144|NCT01020123|1216771|P5|Extention Period|Lost to Follow-up|0
361145|NCT01020123|1216772|P4|Extention Period|Lost to Follow-up|0
361146|NCT01020123|1216773|P3|Extention Period|Lost to Follow-up|0
361147|NCT01020123|1216774|P2|Extention Period|Lost to Follow-up|0
361148|NCT01020123|1216775|P1|Extention Period|Lost to Follow-up|0
361149|NCT01020123|1216769|P7|Extention Period|Protocol Violation|1
361150|NCT01020123|1216770|P6|Extention Period|Protocol Violation|0
361151|NCT01020123|1216771|P5|Extention Period|Protocol Violation|0
361152|NCT01020123|1216772|P4|Extention Period|Protocol Violation|0
361153|NCT01020123|1216773|P3|Extention Period|Protocol Violation|1
361154|NCT01020123|1216774|P2|Extention Period|Protocol Violation|1
361155|NCT01020123|1216775|P1|Extention Period|Protocol Violation|1
361156|NCT01020123|1216769|P7|Extention Period|Adverse Event|0
361157|NCT01020123|1216770|P6|Extention Period|Adverse Event|0
361158|NCT01020123|1216771|P5|Extention Period|Adverse Event|0
361159|NCT01020123|1216772|P4|Extention Period|Adverse Event|1
361160|NCT01020123|1216773|P3|Extention Period|Adverse Event|0
361161|NCT01020123|1216774|P2|Extention Period|Adverse Event|0
361162|NCT01020123|1216775|P1|Extention Period|Adverse Event|0
361163|NCT01020123|1216769|P7|Extention Period|Withdrawal by Subject|0
361164|NCT01020123|1216770|P6|Extention Period|Withdrawal by Subject|0
361165|NCT01020123|1216771|P5|Extention Period|Withdrawal by Subject|0
361166|NCT01020123|1216772|P4|Extention Period|Withdrawal by Subject|0
361167|NCT01020123|1216773|P3|Extention Period|Withdrawal by Subject|1
361168|NCT01020123|1216774|P2|Extention Period|Withdrawal by Subject|1
361169|NCT01020123|1216775|P1|Extention Period|Withdrawal by Subject|2
361170|NCT01020123|1216769|P7|Main Period|Unclasified|6
361171|NCT01020123|1216770|P6|Main Period|Unclasified|3
361172|NCT01020123|1216771|P5|Main Period|Unclasified|1
361173|NCT01020123|1216772|P4|Main Period|Unclasified|0
361174|NCT01020123|1216773|P3|Main Period|Unclasified|1
361175|NCT01020123|1216774|P2|Main Period|Unclasified|0
361176|NCT01020123|1216775|P1|Main Period|Unclasified|2
361177|NCT01020123|1216769|P7|Main Period|Lost to Follow-up|0
361178|NCT01020123|1216770|P6|Main Period|Lost to Follow-up|0
361179|NCT01020123|1216771|P5|Main Period|Lost to Follow-up|0
361180|NCT01020123|1216772|P4|Main Period|Lost to Follow-up|0
361181|NCT01020123|1216773|P3|Main Period|Lost to Follow-up|0
361182|NCT01020123|1216774|P2|Main Period|Lost to Follow-up|2
361183|NCT01020123|1216775|P1|Main Period|Lost to Follow-up|0
361184|NCT01020123|1216769|P7|Main Period|Protocol Violation|2
361185|NCT01020123|1216770|P6|Main Period|Protocol Violation|3
361186|NCT01020123|1216771|P5|Main Period|Protocol Violation|2
361187|NCT01020123|1216772|P4|Main Period|Protocol Violation|5
361188|NCT01020123|1216773|P3|Main Period|Protocol Violation|2
361189|NCT01020123|1216774|P2|Main Period|Protocol Violation|4
361190|NCT01020123|1216775|P1|Main Period|Protocol Violation|4
361191|NCT01020123|1216769|P7|Main Period|Adverse Event|1
361192|NCT01020123|1216770|P6|Main Period|Adverse Event|2
361193|NCT01020123|1216771|P5|Main Period|Adverse Event|1
361194|NCT01020123|1216772|P4|Main Period|Adverse Event|1
361195|NCT01020123|1216773|P3|Main Period|Adverse Event|2
361196|NCT01020123|1216774|P2|Main Period|Adverse Event|2
361197|NCT01020123|1216775|P1|Main Period|Adverse Event|5
361198|NCT01020123|1216769|P7|Main Period|Eligibility Criteria not fullfilled|0
361199|NCT01020123|1216770|P6|Main Period|Eligibility Criteria not fullfilled|0
361200|NCT01020123|1216771|P5|Main Period|Eligibility Criteria not fullfilled|1
361201|NCT01020123|1216772|P4|Main Period|Eligibility Criteria not fullfilled|0
361202|NCT01020123|1216773|P3|Main Period|Eligibility Criteria not fullfilled|0
361203|NCT01020123|1216774|P2|Main Period|Eligibility Criteria not fullfilled|1
361204|NCT01020123|1216775|P1|Main Period|Eligibility Criteria not fullfilled|0
361205|NCT01020123|1216769|P7|Main Period|Withdrawal by Subject|2
361206|NCT01020123|1216770|P6|Main Period|Withdrawal by Subject|3
361207|NCT01020123|1216771|P5|Main Period|Withdrawal by Subject|6
361208|NCT01020123|1216772|P4|Main Period|Withdrawal by Subject|1
361209|NCT01020123|1216773|P3|Main Period|Withdrawal by Subject|3
361210|NCT01020123|1216774|P2|Main Period|Withdrawal by Subject|5
361211|NCT01020123|1216775|P1|Main Period|Withdrawal by Subject|6
361212|NCT01020019|1216970|P2|Overall Study|moving|2
361213|NCT01020019|1216971|P1|Overall Study|moving|0
361214|NCT01020019|1216970|P2|Overall Study|not interested in treatment|4
361215|NCT01020019|1216971|P1|Overall Study|not interested in treatment|4
361216|NCT01020019|1216970|P2|Overall Study|Adverse Event|5
361217|NCT01020019|1216971|P1|Overall Study|Adverse Event|1
361218|NCT01020019|1216970|P2|Overall Study|Lost to Follow-up|18
361219|NCT01020019|1216971|P1|Overall Study|Lost to Follow-up|21
361220|NCT01019980|1216992|P2|Overall Study|Drug not available.|0
361221|NCT01019980|1216993|P1|Overall Study|Drug not available.|2
361222|NCT01019694|1217056|P3|Overall Study|Other reason (not specified)|6
361223|NCT01019694|1217057|P2|Overall Study|Other reason (not specified)|5
361224|NCT01019694|1217058|P1|Overall Study|Other reason (not specified)|1
361225|NCT01019694|1217056|P3|Overall Study|Not treated|3
361226|NCT01019694|1217057|P2|Overall Study|Not treated|2
361227|NCT01019694|1217058|P1|Overall Study|Not treated|0
361228|NCT01019694|1217056|P3|Overall Study|Withdrawal by Subject|12
361229|NCT01019694|1217057|P2|Overall Study|Withdrawal by Subject|6
361230|NCT01019694|1217058|P1|Overall Study|Withdrawal by Subject|4
361231|NCT01019694|1217056|P3|Overall Study|Lost to Follow-up|3
361232|NCT01019694|1217057|P2|Overall Study|Lost to Follow-up|3
361233|NCT01019694|1217058|P1|Overall Study|Lost to Follow-up|5
361234|NCT01019694|1217056|P3|Overall Study|Protocol Violation|4
361235|NCT01019694|1217057|P2|Overall Study|Protocol Violation|6
361236|NCT01019694|1217058|P1|Overall Study|Protocol Violation|2
361237|NCT01019694|1217056|P3|Overall Study|Adverse Event|19
361238|NCT01019694|1217057|P2|Overall Study|Adverse Event|16
361239|NCT01019694|1217058|P1|Overall Study|Adverse Event|12
361240|NCT01019486|1217183|P3|Overall Study|Withdrawal by Subject|1
361241|NCT01019486|1217184|P2|Overall Study|Withdrawal by Subject|1
361242|NCT01019486|1217185|P1|Overall Study|Withdrawal by Subject|1
361243|NCT01019369|1217199|P2|Overall Study|Withdrawal by Subject|1
361244|NCT01019369|1217200|P1|Overall Study|Withdrawal by Subject|0
361245|NCT01019369|1217199|P2|Overall Study|Lost to Follow-up|6
361246|NCT01019369|1217200|P1|Overall Study|Lost to Follow-up|10
361247|NCT01019317|1217206|P1|Overall Study|Not Eligible|4
361248|NCT01019135|1217213|P3|Overall Study|Did not attend CR|6
361249|NCT01019135|1217214|P2|Overall Study|Did not attend CR|13
361250|NCT01019135|1217215|P1|Overall Study|Did not attend CR|8
361251|NCT01019135|1217213|P3|Overall Study|Did not receive allocated intervention|25
361252|NCT01019135|1217214|P2|Overall Study|Did not receive allocated intervention|6
361253|NCT01019135|1217215|P1|Overall Study|Did not receive allocated intervention|12
361254|NCT01018992|1217243|P2|Overall Study|Lost to Follow-up|1
361255|NCT01018992|1217244|P1|Overall Study|Lost to Follow-up|5
361256|NCT01018992|1217243|P2|Overall Study|Protocol Violation|4
361257|NCT01018992|1217244|P1|Overall Study|Protocol Violation|0
361258|NCT01018992|1217243|P2|Overall Study|Withdrawal by Subject|8
361259|NCT01018992|1217244|P1|Overall Study|Withdrawal by Subject|3
361260|NCT01018992|1217243|P2|Overall Study|Adverse Event|3
361261|NCT01018992|1217244|P1|Overall Study|Adverse Event|8
361262|NCT01018979|1217258|P2|Overall Study|Not received at least one dose|1
361263|NCT01018979|1217259|P1|Overall Study|Not received at least one dose|0
361264|NCT01018979|1217258|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
361265|NCT01018979|1217259|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
361266|NCT01018953|1217289|P1|Overall Study|Study termination by sponsor|5
361267|NCT01018953|1217289|P1|Overall Study|Withdrawal by Subject|1
361268|NCT01018953|1217289|P1|Overall Study|Adverse Event|2
361269|NCT01018862|1217302|P3|Overall Study|administrative problems|4
361270|NCT01018862|1217303|P2|Overall Study|administrative problems|4
361271|NCT01018862|1217304|P1|Overall Study|administrative problems|5
361272|NCT01018862|1217302|P3|Overall Study|Withdrawal by Subject|1
361273|NCT01018862|1217303|P2|Overall Study|Withdrawal by Subject|2
361274|NCT01018862|1217304|P1|Overall Study|Withdrawal by Subject|1
361275|NCT01018862|1217302|P3|Overall Study|Protocol Violation|3
361276|NCT01018862|1217303|P2|Overall Study|Protocol Violation|3
361277|NCT01018862|1217304|P1|Overall Study|Protocol Violation|1
361278|NCT01018862|1217302|P3|Overall Study|Lost to Follow-up|0
361279|NCT01018862|1217303|P2|Overall Study|Lost to Follow-up|1
361280|NCT01018862|1217304|P1|Overall Study|Lost to Follow-up|3
361281|NCT01018862|1217302|P3|Overall Study|Lack of Efficacy|2
361282|NCT01018862|1217303|P2|Overall Study|Lack of Efficacy|0
361283|NCT01018862|1217304|P1|Overall Study|Lack of Efficacy|1
361284|NCT01018862|1217302|P3|Overall Study|Adverse Event|6
361285|NCT01018862|1217303|P2|Overall Study|Adverse Event|0
361286|NCT01018862|1217304|P1|Overall Study|Adverse Event|2
361287|NCT01018810|1217326|P5|Overall Study|Sponsor Decision|1
361288|NCT01018810|1217327|P4|Overall Study|Sponsor Decision|1
361289|NCT01018810|1217328|P3|Overall Study|Sponsor Decision|1
361290|NCT01018810|1217329|P2|Overall Study|Sponsor Decision|0
361291|NCT01018810|1217330|P1|Overall Study|Sponsor Decision|2
361292|NCT01018810|1217326|P5|Overall Study|Withdrawal by Subject|0
361293|NCT01018810|1217327|P4|Overall Study|Withdrawal by Subject|0
361294|NCT01018810|1217328|P3|Overall Study|Withdrawal by Subject|0
361295|NCT01018810|1217329|P2|Overall Study|Withdrawal by Subject|1
361296|NCT01018810|1217330|P1|Overall Study|Withdrawal by Subject|0
361297|NCT01018732|1217390|P3|Overall Study|Unable to Classify|1
361298|NCT01018732|1217391|P2|Overall Study|Unable to Classify|0
361299|NCT01018732|1217392|P1|Overall Study|Unable to Classify|0
361300|NCT01018732|1217390|P3|Overall Study|Inappropriate Enrollment|0
361301|NCT01018732|1217391|P2|Overall Study|Inappropriate Enrollment|1
361302|NCT01018732|1217392|P1|Overall Study|Inappropriate Enrollment|0
361303|NCT01018732|1217390|P3|Overall Study|Protocol Violation|0
361304|NCT01018732|1217391|P2|Overall Study|Protocol Violation|1
361305|NCT01018732|1217392|P1|Overall Study|Protocol Violation|1
361306|NCT01018732|1217390|P3|Overall Study|Lost to Follow-up|3
361307|NCT01018732|1217391|P2|Overall Study|Lost to Follow-up|0
361308|NCT01018732|1217392|P1|Overall Study|Lost to Follow-up|0
361309|NCT01018680|1217426|P2|Overall Study|Physician Decision|1
361310|NCT01018680|1217427|P1|Overall Study|Physician Decision|3
361311|NCT01018680|1217426|P2|Overall Study|Entry Criteria Not Met|4
361312|NCT01018680|1217427|P1|Overall Study|Entry Criteria Not Met|1
361313|NCT01018680|1217426|P2|Overall Study|Lost to Follow-up|3
361314|NCT01018680|1217427|P1|Overall Study|Lost to Follow-up|5
361315|NCT01018680|1217426|P2|Overall Study|Lack of Efficacy|2
361316|NCT01018680|1217427|P1|Overall Study|Lack of Efficacy|8
361317|NCT01018680|1217426|P2|Overall Study|Sponsor Decision|7
361318|NCT01018680|1217427|P1|Overall Study|Sponsor Decision|6
361319|NCT01018680|1217426|P2|Overall Study|Protocol Violation|8
361320|NCT01018680|1217427|P1|Overall Study|Protocol Violation|5
361321|NCT01018680|1217426|P2|Overall Study|Withdrawal by Subject|10
361322|NCT01018680|1217427|P1|Overall Study|Withdrawal by Subject|10
361323|NCT01018680|1217426|P2|Overall Study|Adverse Event|40
361324|NCT01018680|1217427|P1|Overall Study|Adverse Event|23
361325|NCT01020487|1217470|P3|Part 2 Open-label Period|Adverse Event|1
361326|NCT01020487|1217471|P2|Part 2 Open-label Period|Adverse Event|4
361327|NCT01020487|1217472|P1|Part 2 Open-label Period|Adverse Event|0
361328|NCT01020487|1217470|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
361329|NCT01020487|1217471|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
361330|NCT01020487|1217472|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
361331|NCT01020487|1217470|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
361332|NCT01020487|1217471|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
361333|NCT01020487|1217472|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
361334|NCT01020487|1217470|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
361335|NCT01020487|1217471|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
361336|NCT01020487|1217472|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
361337|NCT01020487|1217470|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
361338|NCT01020487|1217471|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
361339|NCT01020487|1217472|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
361340|NCT01018511|1217497|P4|Overall Study|Miscellaneous|0
361341|NCT01018511|1217498|P3|Overall Study|Miscellaneous|0
361342|NCT01018511|1217499|P2|Overall Study|Miscellaneous|2
361343|NCT01018511|1217500|P1|Overall Study|Miscellaneous|0
361344|NCT01018511|1217497|P4|Overall Study|Protocol Violation|9
361345|NCT01018511|1217498|P3|Overall Study|Protocol Violation|7
361346|NCT01018511|1217499|P2|Overall Study|Protocol Violation|8
361347|NCT01018511|1217500|P1|Overall Study|Protocol Violation|5
361348|NCT01018511|1217497|P4|Overall Study|Lost to Follow-up|0
361349|NCT01018511|1217498|P3|Overall Study|Lost to Follow-up|1
361350|NCT01018511|1217499|P2|Overall Study|Lost to Follow-up|0
361351|NCT01018511|1217500|P1|Overall Study|Lost to Follow-up|0
361352|NCT01018511|1217497|P4|Overall Study|Withdrawal by Subject|9
361353|NCT01018511|1217498|P3|Overall Study|Withdrawal by Subject|11
361354|NCT01018511|1217499|P2|Overall Study|Withdrawal by Subject|5
361355|NCT01018511|1217500|P1|Overall Study|Withdrawal by Subject|6
361356|NCT01018511|1217497|P4|Overall Study|Lack of Efficacy|2
361357|NCT01018511|1217498|P3|Overall Study|Lack of Efficacy|1
361358|NCT01018511|1217499|P2|Overall Study|Lack of Efficacy|1
361359|NCT01018511|1217500|P1|Overall Study|Lack of Efficacy|4
361360|NCT01018511|1217497|P4|Overall Study|Adverse Event|10
361361|NCT01018511|1217498|P3|Overall Study|Adverse Event|13
361362|NCT01018511|1217499|P2|Overall Study|Adverse Event|9
361363|NCT01018511|1217500|P1|Overall Study|Adverse Event|5
361364|NCT01018511|1217497|P4|Overall Study|Not fulfilling eligibility criteria|3
361365|NCT01018511|1217498|P3|Overall Study|Not fulfilling eligibility criteria|7
361366|NCT01018511|1217499|P2|Overall Study|Not fulfilling eligibility criteria|7
361367|NCT01018511|1217500|P1|Overall Study|Not fulfilling eligibility criteria|6
361368|NCT01018394|1217697|P2|Overall Study|Lost to Follow-up|3
361369|NCT01018394|1217698|P1|Overall Study|Lost to Follow-up|4
361370|NCT01018394|1217697|P2|Overall Study|Withdrawal by Subject|5
361371|NCT01018394|1217698|P1|Overall Study|Withdrawal by Subject|5
361372|NCT01018264|1217708|P2|Overall Study|Lost to Follow-up|1
361373|NCT01018264|1217709|P1|Overall Study|Lost to Follow-up|0
361374|NCT01018264|1217708|P2|Overall Study|Withdrawal by Subject|0
361375|NCT01018264|1217709|P1|Overall Study|Withdrawal by Subject|1
361376|NCT01018186|1217726|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
361377|NCT01018186|1217727|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
361378|NCT01018186|1217728|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
361379|NCT01018186|1217729|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
361380|NCT01018186|1217726|P4|52-week Double-blind Treatment Period|Physician Decision|3
361381|NCT01018186|1217727|P3|52-week Double-blind Treatment Period|Physician Decision|0
361382|NCT01018186|1217728|P2|52-week Double-blind Treatment Period|Physician Decision|1
361383|NCT01018186|1217729|P1|52-week Double-blind Treatment Period|Physician Decision|0
361384|NCT01018186|1217726|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
361385|NCT01018186|1217727|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
361386|NCT01018186|1217728|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
361387|NCT01018186|1217729|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
361388|NCT01018186|1217726|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
361389|NCT01018186|1217727|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
361390|NCT01018186|1217728|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
361391|NCT01018186|1217729|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
361392|NCT01018186|1217726|P4|52-week Double-blind Treatment Period|Protocol Violation|2
361393|NCT01018186|1217727|P3|52-week Double-blind Treatment Period|Protocol Violation|8
361394|NCT01018186|1217728|P2|52-week Double-blind Treatment Period|Protocol Violation|8
361395|NCT01018186|1217729|P1|52-week Double-blind Treatment Period|Protocol Violation|0
361396|NCT01018186|1217726|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
361397|NCT01018186|1217727|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
361398|NCT01018186|1217728|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
361399|NCT01018186|1217729|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
361400|NCT01018186|1217726|P4|52-week Double-blind Treatment Period|Adverse Event|6
361401|NCT01018186|1217727|P3|52-week Double-blind Treatment Period|Adverse Event|3
361402|NCT01018186|1217728|P2|52-week Double-blind Treatment Period|Adverse Event|5
361403|NCT01018186|1217729|P1|52-week Double-blind Treatment Period|Adverse Event|0
361404|NCT01018186|1217726|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
361405|NCT01018186|1217727|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
361406|NCT01018186|1217728|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
361407|NCT01018186|1217729|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
361408|NCT01018186|1217726|P4|2-week Run-in Period|Withdrawal by Subject|0
361409|NCT01018186|1217727|P3|2-week Run-in Period|Withdrawal by Subject|0
361410|NCT01018186|1217728|P2|2-week Run-in Period|Withdrawal by Subject|0
361411|NCT01018186|1217729|P1|2-week Run-in Period|Withdrawal by Subject|11
361412|NCT01018186|1217726|P4|2-week Run-in Period|Physician Decision|0
361413|NCT01018186|1217727|P3|2-week Run-in Period|Physician Decision|0
361414|NCT01018186|1217728|P2|2-week Run-in Period|Physician Decision|0
361415|NCT01018186|1217729|P1|2-week Run-in Period|Physician Decision|3
361416|NCT01018186|1217726|P4|2-week Run-in Period|Lost to Follow-up|0
361417|NCT01018186|1217727|P3|2-week Run-in Period|Lost to Follow-up|0
361418|NCT01018186|1217728|P2|2-week Run-in Period|Lost to Follow-up|0
361419|NCT01018186|1217729|P1|2-week Run-in Period|Lost to Follow-up|2
361420|NCT01018186|1217726|P4|2-week Run-in Period|Protocol Violation|0
361421|NCT01018186|1217727|P3|2-week Run-in Period|Protocol Violation|0
361422|NCT01018186|1217728|P2|2-week Run-in Period|Protocol Violation|0
361423|NCT01018186|1217729|P1|2-week Run-in Period|Protocol Violation|1
361424|NCT01018030|1217930|P3|Overall Study|Did Not Receive Study Drug|0
361425|NCT01018030|1217931|P2|Overall Study|Did Not Receive Study Drug|3
361426|NCT01018030|1217932|P1|Overall Study|Did Not Receive Study Drug|1
361427|NCT01018030|1217930|P3|Overall Study|Lack of Efficacy|0
361428|NCT01018030|1217931|P2|Overall Study|Lack of Efficacy|0
361429|NCT01018030|1217932|P1|Overall Study|Lack of Efficacy|1
361430|NCT01018030|1217930|P3|Overall Study|Physician Decision|1
361431|NCT01018030|1217931|P2|Overall Study|Physician Decision|0
361432|NCT01018030|1217932|P1|Overall Study|Physician Decision|1
361433|NCT01018030|1217930|P3|Overall Study|Protocol Violation|0
361434|NCT01018030|1217931|P2|Overall Study|Protocol Violation|1
361435|NCT01018030|1217932|P1|Overall Study|Protocol Violation|2
361436|NCT01018030|1217930|P3|Overall Study|Lost to Follow-up|3
361437|NCT01018030|1217931|P2|Overall Study|Lost to Follow-up|0
361438|NCT01018030|1217932|P1|Overall Study|Lost to Follow-up|2
361439|NCT01018030|1217930|P3|Overall Study|Withdrawal by Subject|4
361440|NCT01018030|1217931|P2|Overall Study|Withdrawal by Subject|2
361441|NCT01018030|1217932|P1|Overall Study|Withdrawal by Subject|2
361442|NCT01018030|1217930|P3|Overall Study|Adverse Event|5
361443|NCT01018030|1217931|P2|Overall Study|Adverse Event|5
361444|NCT01018030|1217932|P1|Overall Study|Adverse Event|10
361445|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Physician Decision|7
361446|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Physician Decision|9
361447|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Physician Decision|8
361448|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Physician Decision|10
361449|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Physician Decision|0
361450|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
361451|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
361452|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
361453|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
361454|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
361455|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
361456|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
361457|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
361458|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
361459|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
361460|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
361461|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
361462|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
361463|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
361464|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
361465|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
361466|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
361467|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
361468|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
361469|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
361470|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
361471|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
361472|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
361473|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
361474|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
361475|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
361476|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
361477|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
361478|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
361479|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
361480|NCT01017952|1217983|P5|52-week, Double-blind Treatment Period|Adverse Event|30
361481|NCT01017952|1217984|P4|52-week, Double-blind Treatment Period|Adverse Event|35
361482|NCT01017952|1217985|P3|52-week, Double-blind Treatment Period|Adverse Event|32
361483|NCT01017952|1217986|P2|52-week, Double-blind Treatment Period|Adverse Event|25
361484|NCT01017952|1217987|P1|52-week, Double-blind Treatment Period|Adverse Event|0
361485|NCT01017952|1217983|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
361486|NCT01017952|1217984|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
361487|NCT01017952|1217985|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
361488|NCT01017952|1217986|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
361489|NCT01017952|1217987|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
361490|NCT01017952|1217983|P5|4-week, Open-label Run-In Period|Physician Decision|0
361491|NCT01017952|1217984|P4|4-week, Open-label Run-In Period|Physician Decision|0
361492|NCT01017952|1217985|P3|4-week, Open-label Run-In Period|Physician Decision|0
361493|NCT01017952|1217986|P2|4-week, Open-label Run-In Period|Physician Decision|0
361494|NCT01017952|1217987|P1|4-week, Open-label Run-In Period|Physician Decision|10
361495|NCT01017952|1217983|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
361496|NCT01017952|1217984|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
361497|NCT01017952|1217985|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
361498|NCT01017952|1217986|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
361499|NCT01017952|1217987|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
361500|NCT01017952|1217983|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
361501|NCT01017952|1217984|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
361502|NCT01017952|1217985|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
361503|NCT01017952|1217986|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
361504|NCT01017952|1217987|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
361505|NCT01017952|1217983|P5|4-week, Open-label Run-In Period|Adverse Event|0
361506|NCT01017952|1217984|P4|4-week, Open-label Run-In Period|Adverse Event|0
361507|NCT01017952|1217985|P3|4-week, Open-label Run-In Period|Adverse Event|0
361508|NCT01017952|1217986|P2|4-week, Open-label Run-In Period|Adverse Event|0
361509|NCT01017952|1217987|P1|4-week, Open-label Run-In Period|Adverse Event|23
361510|NCT01017952|1217983|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
361511|NCT01017952|1217984|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
361512|NCT01017952|1217985|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
361513|NCT01017952|1217986|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
361514|NCT01017952|1217987|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
361515|NCT01017874|1218011|P2|Overall Study|Physician Decision|3
361516|NCT01017874|1218012|P1|Overall Study|Physician Decision|1
361517|NCT01017874|1218011|P2|Overall Study|Lost to Follow-up|2
361518|NCT01017874|1218012|P1|Overall Study|Lost to Follow-up|3
361519|NCT01017874|1218011|P2|Overall Study|Sponsor decision|1
361520|NCT01017874|1218012|P1|Overall Study|Sponsor decision|3
361521|NCT01017874|1218011|P2|Overall Study|Withdrawal by Subject|20
361522|NCT01017874|1218012|P1|Overall Study|Withdrawal by Subject|23
361523|NCT01017731|1218030|P1|Overall Study|Adverse Event|1
361524|NCT01017731|1218030|P1|Overall Study|Physician Decision|2
361525|NCT01017731|1218030|P1|Overall Study|Withdrawal by Subject|3
361526|NCT01017731|1218030|P1|Overall Study|Lost to Follow-up|2
361527|NCT01017601|1218059|P2|Overall Study|Withdrawal by Subject|1
361528|NCT01017601|1218060|P1|Overall Study|Withdrawal by Subject|0
361529|NCT01017601|1218059|P2|Overall Study|Disease Progression|12
361530|NCT01017601|1218060|P1|Overall Study|Disease Progression|12
361531|NCT01017575|1218087|P5|Overall Study|Withdrawal by Subject|0
361532|NCT01017575|1218088|P4|Overall Study|Withdrawal by Subject|0
361533|NCT01017575|1218089|P3|Overall Study|Withdrawal by Subject|0
361534|NCT01017575|1218090|P2|Overall Study|Withdrawal by Subject|0
361535|NCT01017575|1218091|P1|Overall Study|Withdrawal by Subject|1
361536|NCT01017575|1218087|P5|Overall Study|Adverse Event|2
361537|NCT01017575|1218088|P4|Overall Study|Adverse Event|0
361538|NCT01017575|1218089|P3|Overall Study|Adverse Event|0
361539|NCT01017575|1218090|P2|Overall Study|Adverse Event|1
361540|NCT01017575|1218091|P1|Overall Study|Adverse Event|0
361541|NCT01017575|1218087|P5|Overall Study|Lack of Efficacy|1
361542|NCT01017575|1218088|P4|Overall Study|Lack of Efficacy|1
361543|NCT01017575|1218089|P3|Overall Study|Lack of Efficacy|0
361544|NCT01017575|1218090|P2|Overall Study|Lack of Efficacy|1
361545|NCT01017575|1218091|P1|Overall Study|Lack of Efficacy|0
361546|NCT01017549|1218128|P1|One-year Follow-up|Withdrawal by Subject|5
361547|NCT01017549|1218128|P1|One-year Follow-up|Lost to Follow-up|2
361548|NCT01017549|1218128|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
361549|NCT01017263|1218159|P1|Overall Study|not eligible|12
361550|NCT01017146|1218240|P2|Overall Study|Change in Work Situation|0
361551|NCT01017146|1218241|P1|Overall Study|Change in Work Situation|1
361552|NCT01017146|1218240|P2|Overall Study|Did Not Meet Eligibility Criteria|2
361553|NCT01017146|1218241|P1|Overall Study|Did Not Meet Eligibility Criteria|1
361554|NCT01017146|1218240|P2|Overall Study|Took Excluded Medication|0
361555|NCT01017146|1218241|P1|Overall Study|Took Excluded Medication|2
361556|NCT01017146|1218240|P2|Overall Study|Protocol Violation|0
361557|NCT01017146|1218241|P1|Overall Study|Protocol Violation|2
361558|NCT01017146|1218240|P2|Overall Study|Pregnancy|1
361559|NCT01017146|1218241|P1|Overall Study|Pregnancy|2
361560|NCT01017146|1218240|P2|Overall Study|Relocation|4
361561|NCT01017146|1218241|P1|Overall Study|Relocation|0
361562|NCT01017146|1218240|P2|Overall Study|Withdrawal by Subject|16
361563|NCT01017146|1218241|P1|Overall Study|Withdrawal by Subject|32
361564|NCT01017146|1218240|P2|Overall Study|Noncompliance with Study Product|1
361565|NCT01017146|1218241|P1|Overall Study|Noncompliance with Study Product|1
361566|NCT01017146|1218240|P2|Overall Study|Lost to Follow-up|14
361567|NCT01017146|1218241|P1|Overall Study|Lost to Follow-up|14
361568|NCT01017146|1218240|P2|Overall Study|Adverse Event|1
361569|NCT01017146|1218241|P1|Overall Study|Adverse Event|11
361570|NCT01017120|1218279|P2|Overall Study|Parent Unable to Provide Transportation|0
361571|NCT01017120|1218280|P1|Overall Study|Parent Unable to Provide Transportation|1
361572|NCT01017120|1218279|P2|Overall Study|Protocol Violation|0
361573|NCT01017120|1218280|P1|Overall Study|Protocol Violation|1
361574|NCT01017120|1218279|P2|Overall Study|Relocated Out of Town|2
361575|NCT01017120|1218280|P1|Overall Study|Relocated Out of Town|0
361576|NCT01017120|1218279|P2|Overall Study|Did Not Meet Eligibility Criteria|0
361577|NCT01017120|1218280|P1|Overall Study|Did Not Meet Eligibility Criteria|1
361578|NCT01017120|1218279|P2|Overall Study|Pregnancy|1
361579|NCT01017120|1218280|P1|Overall Study|Pregnancy|1
361580|NCT01017120|1218279|P2|Overall Study|Withdrawal by Subject|21
361581|NCT01017120|1218280|P1|Overall Study|Withdrawal by Subject|39
361582|NCT01017120|1218279|P2|Overall Study|Lack of Efficacy|0
361583|NCT01017120|1218280|P1|Overall Study|Lack of Efficacy|1
361584|NCT01017120|1218279|P2|Overall Study|Lost to Follow-up|11
361585|NCT01017120|1218280|P1|Overall Study|Lost to Follow-up|13
361586|NCT01017120|1218279|P2|Overall Study|Adverse Event|0
361587|NCT01017120|1218280|P1|Overall Study|Adverse Event|9
361588|NCT01017029|1218341|P2|Overall Study|Death|1
361589|NCT01017029|1218342|P1|Overall Study|Death|3
361590|NCT01017029|1218341|P2|Overall Study|Administrative problem|1
361591|NCT01017029|1218342|P1|Overall Study|Administrative problem|0
361592|NCT01017029|1218341|P2|Overall Study|Lost to Follow-up|0
361593|NCT01017029|1218342|P1|Overall Study|Lost to Follow-up|1
361594|NCT01016977|1218370|P2|Overall Study|Withdrawal by Subject|2
361595|NCT01016977|1218371|P1|Overall Study|Withdrawal by Subject|2
361596|NCT01016977|1218370|P2|Overall Study|Lost to Follow-up|0
361597|NCT01016977|1218371|P1|Overall Study|Lost to Follow-up|1
361598|NCT01016964|1218407|P2|Overall Study|Lost to Follow-up|3
361599|NCT01016964|1218408|P1|Overall Study|Lost to Follow-up|3
361600|NCT01016912|1218424|P5|Follow-up Period|Other reason|0
361601|NCT01016912|1218425|P4|Follow-up Period|Other reason|1
361602|NCT01016912|1218426|P3|Follow-up Period|Other reason|1
361603|NCT01016912|1218427|P2|Follow-up Period|Other reason|0
361604|NCT01016912|1218428|P1|Follow-up Period|Other reason|0
361605|NCT01016912|1218424|P5|End of Treatment Period|Completed double-blind period only|0
361606|NCT01016912|1218425|P4|End of Treatment Period|Completed double-blind period only|0
361607|NCT01016912|1218426|P3|End of Treatment Period|Completed double-blind period only|0
361608|NCT01016912|1218427|P2|End of Treatment Period|Completed double-blind period only|1
361609|NCT01016912|1218428|P1|End of Treatment Period|Completed double-blind period only|0
361610|NCT01016912|1218424|P5|End of Treatment Period|Adverse Event|0
361611|NCT01016912|1218425|P4|End of Treatment Period|Adverse Event|0
361612|NCT01016912|1218426|P3|End of Treatment Period|Adverse Event|1
361613|NCT01016912|1218427|P2|End of Treatment Period|Adverse Event|1
361614|NCT01016912|1218428|P1|End of Treatment Period|Adverse Event|0
361615|NCT01016912|1218424|P5|End of Treatment Period|Lack of Efficacy|4
361616|NCT01016912|1218425|P4|End of Treatment Period|Lack of Efficacy|4
361617|NCT01016912|1218426|P3|End of Treatment Period|Lack of Efficacy|0
361618|NCT01016912|1218427|P2|End of Treatment Period|Lack of Efficacy|1
361619|NCT01016912|1218428|P1|End of Treatment Period|Lack of Efficacy|0
361620|NCT01016600|1218589|P4|Overall Study|Did not start treatment|0
361621|NCT01016600|1218590|P3|Overall Study|Did not start treatment|0
361622|NCT01016600|1218591|P2|Overall Study|Did not start treatment|0
361623|NCT01016600|1218592|P1|Overall Study|Did not start treatment|1
361624|NCT01016132|1218777|P1|Overall Study|Discomfort|1
361625|NCT01016067|1218792|P2|Overall Study|Withdrew due to Relocation|1
361626|NCT01016067|1218793|P1|Overall Study|Withdrew due to Relocation|0
361627|NCT01016067|1218792|P2|Overall Study|Physician Decision|1
361628|NCT01016067|1218793|P1|Overall Study|Physician Decision|1
361629|NCT01016067|1218792|P2|Overall Study|Lost to Follow-up|2
361630|NCT01016067|1218793|P1|Overall Study|Lost to Follow-up|1
361631|NCT01016015|1218811|P1|Overall Study|Adverse Event|15
361632|NCT01016015|1218811|P1|Overall Study|Withdrawal by Subject|1
361633|NCT01016015|1218811|P1|Overall Study|Not Treated|3
361634|NCT01015833|1218822|P2|Overall Study|Did not start treatment|0
361635|NCT01015833|1218823|P1|Overall Study|Did not start treatment|1
361636|NCT01015833|1218822|P2|Overall Study|Motor Vehicle Accidents|0
361637|NCT01015833|1218823|P1|Overall Study|Motor Vehicle Accidents|1
361638|NCT01015833|1218822|P2|Overall Study|Other|1
361639|NCT01015833|1218823|P1|Overall Study|Other|5
361640|NCT01015833|1218822|P2|Overall Study|Symptomatic deterioration|1
361641|NCT01015833|1218823|P1|Overall Study|Symptomatic deterioration|0
361642|NCT01015833|1218822|P2|Overall Study|Physician Decision|0
361643|NCT01015833|1218823|P1|Overall Study|Physician Decision|2
361644|NCT01015833|1218822|P2|Overall Study|Adverse Event|1
361645|NCT01015833|1218823|P1|Overall Study|Adverse Event|0
361646|NCT01015833|1218822|P2|Overall Study|Withdrawal by Subject|2
361647|NCT01015833|1218823|P1|Overall Study|Withdrawal by Subject|3
361648|NCT01015833|1218822|P2|Overall Study|Death|0
361649|NCT01015833|1218823|P1|Overall Study|Death|1
361650|NCT01015820|1218839|P2|Overall Study|Suboptimal measurements|0
361651|NCT01015820|1218840|P1|Overall Study|Suboptimal measurements|1
361652|NCT01015703|1218875|P5|Overall Study|Protocol Violation|0
361653|NCT01015703|1218876|P4|Overall Study|Protocol Violation|0
361654|NCT01015703|1218877|P3|Overall Study|Protocol Violation|0
361655|NCT01015703|1218878|P2|Overall Study|Protocol Violation|0
361656|NCT01015703|1218879|P1|Overall Study|Protocol Violation|1
361657|NCT01015703|1218875|P5|Overall Study|Adverse Event|0
361658|NCT01015703|1218876|P4|Overall Study|Adverse Event|0
361659|NCT01015703|1218877|P3|Overall Study|Adverse Event|0
361660|NCT01015703|1218878|P2|Overall Study|Adverse Event|0
361661|NCT01015703|1218879|P1|Overall Study|Adverse Event|1
361662|NCT01015703|1218875|P5|Overall Study|Withdrawal by Subject|0
361663|NCT01015703|1218876|P4|Overall Study|Withdrawal by Subject|0
361664|NCT01015703|1218877|P3|Overall Study|Withdrawal by Subject|0
361665|NCT01015703|1218878|P2|Overall Study|Withdrawal by Subject|1
361666|NCT01015703|1218879|P1|Overall Study|Withdrawal by Subject|0
361667|NCT01015677|1218894|P3|Overall Study|Withdrawal by Subject|0
361668|NCT01015677|1218895|P2|Overall Study|Withdrawal by Subject|1
361669|NCT01015677|1218896|P1|Overall Study|Withdrawal by Subject|1
361670|NCT01015677|1218894|P3|Overall Study|Protocol Violation|0
361671|NCT01015677|1218895|P2|Overall Study|Protocol Violation|1
361672|NCT01015677|1218896|P1|Overall Study|Protocol Violation|0
361673|NCT01015677|1218894|P3|Overall Study|Lack of Efficacy|0
361674|NCT01015677|1218895|P2|Overall Study|Lack of Efficacy|1
361675|NCT01015677|1218896|P1|Overall Study|Lack of Efficacy|0
361676|NCT01015677|1218894|P3|Overall Study|Adverse Event|0
361677|NCT01015677|1218895|P2|Overall Study|Adverse Event|1
361678|NCT01015677|1218896|P1|Overall Study|Adverse Event|0
361679|NCT01015638|1218918|P2|Overall Study|Withdrawal by Subject|0
361680|NCT01015638|1218919|P1|Overall Study|Withdrawal by Subject|1
361681|NCT01015560|1218947|P1|Overall Study|Withdrawal by Subject|1
361682|NCT01015560|1218947|P1|Overall Study|Not protocol specified|1
361683|NCT01015560|1218947|P1|Overall Study|Adverse Event|1
361684|NCT01015287|1218996|P2|Overall Study|Protocol Violation|1
361685|NCT01015287|1218997|P1|Overall Study|Protocol Violation|1
361686|NCT01015287|1218996|P2|Overall Study|Lost to Follow-up|1
361687|NCT01015287|1218997|P1|Overall Study|Lost to Follow-up|2
361688|NCT01015287|1218996|P2|Overall Study|Entry Criteria not Met|14
361689|NCT01015287|1218997|P1|Overall Study|Entry Criteria not Met|11
361690|NCT01015287|1218996|P2|Overall Study|Withdrawal by Subject|19
361691|NCT01015287|1218997|P1|Overall Study|Withdrawal by Subject|14
361692|NCT01015287|1218996|P2|Overall Study|Physician Decision|21
361693|NCT01015287|1218997|P1|Overall Study|Physician Decision|19
361694|NCT01015287|1218996|P2|Overall Study|Sponsor Decision|7
361695|NCT01015287|1218997|P1|Overall Study|Sponsor Decision|3
361696|NCT01015287|1218996|P2|Overall Study|Adverse Event|0
361697|NCT01015287|1218997|P1|Overall Study|Adverse Event|1
361698|NCT01015287|1218996|P2|Overall Study|Death|16
361699|NCT01015287|1218997|P1|Overall Study|Death|21
361700|NCT01015131|1219029|P1|Overall Study|Other Protocol Specified Criteria|4
361701|NCT01015131|1219029|P1|Overall Study|Withdrawal by Subject|2
361702|NCT01015131|1219029|P1|Overall Study|Protocol Violation|1
361703|NCT01015131|1219029|P1|Overall Study|Physician Decision|1
361704|NCT01015118|1219045|P2|Overall Study|Other than stated above|23
361705|NCT01015118|1219046|P1|Overall Study|Other than stated above|42
361706|NCT01015118|1219045|P2|Overall Study|Not treated|5
361707|NCT01015118|1219046|P1|Overall Study|Not treated|9
361708|NCT01015118|1219045|P2|Overall Study|Progressive disease|229
361709|NCT01015118|1219046|P1|Overall Study|Progressive disease|364
361710|NCT01015118|1219045|P2|Overall Study|Worsening or AE of underlying disease|4
361711|NCT01015118|1219046|P1|Overall Study|Worsening or AE of underlying disease|5
361712|NCT01015118|1219045|P2|Overall Study|Other Adverse Event (AE)|33
361713|NCT01015118|1219046|P1|Overall Study|Other Adverse Event (AE)|141
361714|NCT01015118|1219045|P2|Overall Study|Withdrawal by Subject|27
361715|NCT01015118|1219046|P1|Overall Study|Withdrawal by Subject|103
361716|NCT01015118|1219045|P2|Overall Study|Protocol Violation|6
361717|NCT01015118|1219046|P1|Overall Study|Protocol Violation|5
361718|NCT01014988|1219074|P6|Overall Study|Withdrawal by Subject|0
361719|NCT01014988|1219075|P5|Overall Study|Withdrawal by Subject|0
361720|NCT01014988|1219076|P4|Overall Study|Withdrawal by Subject|0
361721|NCT01014988|1219077|P3|Overall Study|Withdrawal by Subject|0
361722|NCT01014988|1219078|P2|Overall Study|Withdrawal by Subject|0
361723|NCT01014988|1219079|P1|Overall Study|Withdrawal by Subject|1
361724|NCT01014988|1219074|P6|Overall Study|Physician Decision|0
361725|NCT01014988|1219075|P5|Overall Study|Physician Decision|0
361726|NCT01014988|1219076|P4|Overall Study|Physician Decision|0
361727|NCT01014988|1219077|P3|Overall Study|Physician Decision|0
361728|NCT01014988|1219078|P2|Overall Study|Physician Decision|0
361729|NCT01014988|1219079|P1|Overall Study|Physician Decision|1
361730|NCT01014988|1219074|P6|Overall Study|Lost to Follow-up|0
361731|NCT01014988|1219075|P5|Overall Study|Lost to Follow-up|0
361732|NCT01014988|1219076|P4|Overall Study|Lost to Follow-up|0
361733|NCT01014988|1219077|P3|Overall Study|Lost to Follow-up|1
361734|NCT01014988|1219078|P2|Overall Study|Lost to Follow-up|0
361735|NCT01014988|1219079|P1|Overall Study|Lost to Follow-up|1
361736|NCT01014988|1219074|P6|Overall Study|Adverse Event|3
361737|NCT01014988|1219075|P5|Overall Study|Adverse Event|1
361738|NCT01014988|1219076|P4|Overall Study|Adverse Event|0
361739|NCT01014988|1219077|P3|Overall Study|Adverse Event|1
361740|NCT01014988|1219078|P2|Overall Study|Adverse Event|0
361741|NCT01014988|1219079|P1|Overall Study|Adverse Event|20
361742|NCT01014975|1219251|P3|Overall Study|Lost to Follow-up|1
361743|NCT01014975|1219252|P2|Overall Study|Lost to Follow-up|0
361744|NCT01014975|1219253|P1|Overall Study|Lost to Follow-up|0
361745|NCT01014975|1219251|P3|Overall Study|Death|4
361746|NCT01014975|1219252|P2|Overall Study|Death|3
361747|NCT01014975|1219253|P1|Overall Study|Death|3
361748|NCT01014975|1219251|P3|Overall Study|Withdrawal by Subject|1
361749|NCT01014975|1219252|P2|Overall Study|Withdrawal by Subject|0
361750|NCT01014975|1219253|P1|Overall Study|Withdrawal by Subject|1
361751|NCT01014910|1219758|P2|Overall Study|Withdrawal by Subject|2
361752|NCT01014910|1219759|P1|Overall Study|Withdrawal by Subject|0
361753|NCT01014689|1219803|P2|Overall Study|Pregnancy|0
361754|NCT01014689|1219804|P1|Overall Study|Pregnancy|1
361755|NCT01014689|1219803|P2|Overall Study|Lost to Follow-up|7
361756|NCT01014689|1219804|P1|Overall Study|Lost to Follow-up|3
361757|NCT01014689|1219803|P2|Overall Study|Protocol Violation|1
361758|NCT01014689|1219804|P1|Overall Study|Protocol Violation|1
361759|NCT01014689|1219803|P2|Overall Study|Withdrawal by Subject|4
361760|NCT01014689|1219804|P1|Overall Study|Withdrawal by Subject|5
361761|NCT01014689|1219803|P2|Overall Study|Adverse Event|0
361762|NCT01014689|1219804|P1|Overall Study|Adverse Event|3
361763|NCT01014689|1219803|P2|Overall Study|Lack of Efficacy|1
361764|NCT01014689|1219804|P1|Overall Study|Lack of Efficacy|0
361765|NCT01014585|1219839|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
361766|NCT01014585|1219840|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
361767|NCT01014585|1219841|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
361768|NCT01014585|1219842|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
361769|NCT01014585|1219839|P4|Overall Study|Lost to Follow-up|2
361770|NCT01014585|1219840|P3|Overall Study|Lost to Follow-up|0
361771|NCT01014585|1219841|P2|Overall Study|Lost to Follow-up|0
361772|NCT01014585|1219842|P1|Overall Study|Lost to Follow-up|0
361773|NCT01014585|1219839|P4|Overall Study|Withdrawal by Subject|3
361774|NCT01014585|1219840|P3|Overall Study|Withdrawal by Subject|1
361775|NCT01014585|1219841|P2|Overall Study|Withdrawal by Subject|0
361776|NCT01014585|1219842|P1|Overall Study|Withdrawal by Subject|2
361777|NCT01014585|1219839|P4|Overall Study|Adverse Event|3
361778|NCT01014585|1219840|P3|Overall Study|Adverse Event|0
361779|NCT01014585|1219841|P2|Overall Study|Adverse Event|2
361780|NCT01014585|1219842|P1|Overall Study|Adverse Event|0
361781|NCT01014533|1219862|P2|Overall Study|unable to come to appointment|3
361782|NCT01014533|1219863|P1|Overall Study|unable to come to appointment|0
361783|NCT01014533|1219862|P2|Overall Study|Withdrawal by Subject|0
361784|NCT01014533|1219863|P1|Overall Study|Withdrawal by Subject|2
361785|NCT01014533|1219862|P2|Overall Study|Protocol Violation|2
361786|NCT01014533|1219863|P1|Overall Study|Protocol Violation|3
361787|NCT01014442|1219884|P2|Overall Study|Unspecified Reason|1
361788|NCT01014442|1219885|P1|Overall Study|Unspecified Reason|1
361789|NCT01014442|1219884|P2|Overall Study|Lack of Compliance|1
361790|NCT01014442|1219885|P1|Overall Study|Lack of Compliance|0
361791|NCT01014442|1219884|P2|Overall Study|Protocol Violation|5
361792|NCT01014442|1219885|P1|Overall Study|Protocol Violation|2
361793|NCT01014442|1219884|P2|Overall Study|Withdrawal by Subject|4
361794|NCT01014442|1219885|P1|Overall Study|Withdrawal by Subject|4
361795|NCT01014442|1219884|P2|Overall Study|Adverse Event|8
361796|NCT01014442|1219885|P1|Overall Study|Adverse Event|0
361797|NCT01014208|1220005|P2|Overall Study|Study Closed/terminated|83
361798|NCT01014208|1220006|P1|Overall Study|Study Closed/terminated|78
361799|NCT01014208|1220005|P2|Overall Study|Did Not Receive Study Drug|0
361800|NCT01014208|1220006|P1|Overall Study|Did Not Receive Study Drug|2
361801|NCT01014208|1220005|P2|Overall Study|Participant Withdrew Consent|12
361802|NCT01014208|1220006|P1|Overall Study|Participant Withdrew Consent|12
361803|NCT01014208|1220005|P2|Overall Study|Lost to Follow-up|5
361804|NCT01014208|1220006|P1|Overall Study|Lost to Follow-up|2
361805|NCT01014143|1220048|P3|Second Intervention|Lost to Follow-up|0
361806|NCT01014143|1220049|P2|Second Intervention|Lost to Follow-up|0
361807|NCT01014143|1220050|P1|Second Intervention|Lost to Follow-up|2
361808|NCT01014013|1220145|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
361809|NCT01014013|1220146|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
361810|NCT01014013|1220145|P2|Overall Study|Appendectomy|0
361811|NCT01014013|1220146|P1|Overall Study|Appendectomy|1
361812|NCT01014013|1220145|P2|Overall Study|Another antibiotic therapy required|1
361813|NCT01014013|1220146|P1|Overall Study|Another antibiotic therapy required|0
361814|NCT01014013|1220145|P2|Overall Study|Physician Decision|1
361815|NCT01014013|1220146|P1|Overall Study|Physician Decision|0
361816|NCT01014013|1220145|P2|Overall Study|Pathogen resistant|4
361817|NCT01014013|1220146|P1|Overall Study|Pathogen resistant|7
361818|NCT01014013|1220145|P2|Overall Study|Negative urine culture|0
361819|NCT01014013|1220146|P1|Overall Study|Negative urine culture|2
361820|NCT01014013|1220145|P2|Overall Study|Pathogen culture = no growth|34
361821|NCT01014013|1220146|P1|Overall Study|Pathogen culture = no growth|26
361822|NCT01014013|1220145|P2|Overall Study|Clinical/microbiologic failure|2
361823|NCT01014013|1220146|P1|Overall Study|Clinical/microbiologic failure|1
361824|NCT01014013|1220145|P2|Overall Study|Withdrawal by Subject|4
361825|NCT01014013|1220146|P1|Overall Study|Withdrawal by Subject|7
361826|NCT01014013|1220145|P2|Overall Study|Protocol Violation|3
361827|NCT01014013|1220146|P1|Overall Study|Protocol Violation|1
361828|NCT01014013|1220145|P2|Overall Study|Laboratory adverse experience|1
361829|NCT01014013|1220146|P1|Overall Study|Laboratory adverse experience|1
361830|NCT01014013|1220145|P2|Overall Study|Clinical adverse experience|2
361831|NCT01014013|1220146|P1|Overall Study|Clinical adverse experience|4
361832|NCT01014013|1220145|P2|Overall Study|Inclusion/Exclusion criteria not met|3
361833|NCT01014013|1220146|P1|Overall Study|Inclusion/Exclusion criteria not met|1
361834|NCT01013961|1220158|P2|Overall Study|Physician Decision|1
361835|NCT01013961|1220159|P1|Overall Study|Physician Decision|0
361836|NCT01013961|1220158|P2|Overall Study|Withdrawal by Subject|0
361837|NCT01013961|1220159|P1|Overall Study|Withdrawal by Subject|1
361838|NCT01013961|1220158|P2|Overall Study|Adverse Event|2
361839|NCT01013961|1220159|P1|Overall Study|Adverse Event|2
361840|NCT01013883|1220177|P2|Overall Study|Lost to Follow-up|2
361841|NCT01013883|1220178|P1|Overall Study|Lost to Follow-up|2
361842|NCT01013870|1220190|P2|Overall Study|Lost to Follow-up|3
361843|NCT01013870|1220191|P1|Overall Study|Lost to Follow-up|1
361844|NCT01013792|1220240|P2|Overall Study|Lost to Follow-up|1
361845|NCT01013792|1220241|P1|Overall Study|Lost to Follow-up|0
361846|NCT01013792|1220240|P2|Overall Study|Adverse Event|3
361847|NCT01013792|1220241|P1|Overall Study|Adverse Event|0
361848|NCT01013792|1220240|P2|Overall Study|Study suspended|1
361849|NCT01013792|1220241|P1|Overall Study|Study suspended|2
361850|NCT01013753|1220247|P1|Overall Study|Other|2
361851|NCT01013753|1220247|P1|Overall Study|Withdrawal by Subject|2
361852|NCT01013753|1220247|P1|Overall Study|Lost to Follow-up|1
361853|NCT01013753|1220247|P1|Overall Study|Protocol Violation|3
361854|NCT01013753|1220247|P1|Overall Study|Adverse Event|8
361855|NCT01013740|1220443|P2|Overall Study|Ongoing: Study records not completed|2
361856|NCT01013740|1220444|P1|Overall Study|Ongoing: Study records not completed|0
361857|NCT01013740|1220443|P2|Overall Study|Missing|1
361858|NCT01013740|1220444|P1|Overall Study|Missing|2
361859|NCT01013740|1220443|P2|Overall Study|study close / terminated : done in error|1
361860|NCT01013740|1220444|P1|Overall Study|study close / terminated : done in error|2
361861|NCT01013740|1220443|P2|Overall Study|Withdrawal by Subject|10
361862|NCT01013740|1220444|P1|Overall Study|Withdrawal by Subject|2
361863|NCT01013740|1220443|P2|Overall Study|Physician Decision|0
361864|NCT01013740|1220444|P1|Overall Study|Physician Decision|2
361865|NCT01013740|1220443|P2|Overall Study|Lost to Follow-up|5
361866|NCT01013740|1220444|P1|Overall Study|Lost to Follow-up|3
361867|NCT01013701|1220468|P1|Overall Study|study prematurely terminated|7
361868|NCT01013597|1220475|P1|Overall Study|Withdrawal by Subject|1
361869|NCT01013207|1220485|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
361870|NCT01012999|1220503|P1|Overall Study|Protocol Violation|1
361871|NCT01012973|1220509|P2|Overall Study|Withdrawal by Subject|6
361872|NCT01012973|1220510|P1|Overall Study|Withdrawal by Subject|4
361873|NCT01012973|1220509|P2|Overall Study|Protocol Violation|2
361874|NCT01012973|1220510|P1|Overall Study|Protocol Violation|5
361875|NCT01012973|1220509|P2|Overall Study|Increase in vis. acuity, never injected|1
361876|NCT01012973|1220510|P1|Overall Study|Increase in vis. acuity, never injected|0
361877|NCT01012973|1220509|P2|Overall Study|(Overseas travel - indefinite period)|0
361878|NCT01012973|1220510|P1|Overall Study|(Overseas travel - indefinite period)|1
361879|NCT01012973|1220509|P2|Overall Study|Lost to Follow-up|0
361880|NCT01012973|1220510|P1|Overall Study|Lost to Follow-up|1
361881|NCT01012973|1220509|P2|Overall Study|Lack of Efficacy|5
361882|NCT01012973|1220510|P1|Overall Study|Lack of Efficacy|0
361883|NCT01012973|1220509|P2|Overall Study|Adverse Event|5
361884|NCT01012973|1220510|P1|Overall Study|Adverse Event|5
361885|NCT01012947|1220535|P5|Overall Study|Lost to Follow-up|142
361886|NCT01012947|1220536|P4|Overall Study|Lost to Follow-up|118
361887|NCT01012947|1220537|P3|Overall Study|Lost to Follow-up|130
361888|NCT01012947|1220538|P2|Overall Study|Lost to Follow-up|135
361889|NCT01012947|1220539|P1|Overall Study|Lost to Follow-up|131
361890|NCT01012765|1220560|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
361891|NCT01012765|1220561|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
361892|NCT01012765|1220562|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
361893|NCT01012765|1220563|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
361894|NCT01012765|1220564|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
361895|NCT01012765|1220565|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
361896|NCT01012765|1220560|P6|Treatment Period 2|Adverse Event|0
361897|NCT01012765|1220561|P5|Treatment Period 2|Adverse Event|0
361898|NCT01012765|1220562|P4|Treatment Period 2|Adverse Event|0
361899|NCT01012765|1220563|P3|Treatment Period 2|Adverse Event|1
361900|NCT01012765|1220564|P2|Treatment Period 2|Adverse Event|1
361901|NCT01012765|1220565|P1|Treatment Period 2|Adverse Event|0
361902|NCT01012765|1220560|P6|Treatment Period 2|Abnormal laboratory value(s)|1
361903|NCT01012765|1220561|P5|Treatment Period 2|Abnormal laboratory value(s)|0
361904|NCT01012765|1220562|P4|Treatment Period 2|Abnormal laboratory value(s)|0
361905|NCT01012765|1220563|P3|Treatment Period 2|Abnormal laboratory value(s)|0
361906|NCT01012765|1220564|P2|Treatment Period 2|Abnormal laboratory value(s)|0
361907|NCT01012765|1220565|P1|Treatment Period 2|Abnormal laboratory value(s)|0
361908|NCT01012765|1220560|P6|Treatment Period 2|Withdrawal by Subject|0
361909|NCT01012765|1220561|P5|Treatment Period 2|Withdrawal by Subject|1
361910|NCT01012765|1220562|P4|Treatment Period 2|Withdrawal by Subject|0
361911|NCT01012765|1220563|P3|Treatment Period 2|Withdrawal by Subject|1
361912|NCT01012765|1220564|P2|Treatment Period 2|Withdrawal by Subject|0
361913|NCT01012765|1220565|P1|Treatment Period 2|Withdrawal by Subject|1
361914|NCT01012765|1220560|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
361915|NCT01012765|1220561|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
361916|NCT01012765|1220562|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
361917|NCT01012765|1220563|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
361918|NCT01012765|1220564|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
361919|NCT01012765|1220565|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
361920|NCT01012765|1220560|P6|Treatment Period 1|Protocol Violation|0
361921|NCT01012765|1220561|P5|Treatment Period 1|Protocol Violation|1
361922|NCT01012765|1220562|P4|Treatment Period 1|Protocol Violation|2
361923|NCT01012765|1220563|P3|Treatment Period 1|Protocol Violation|0
361924|NCT01012765|1220564|P2|Treatment Period 1|Protocol Violation|0
361925|NCT01012765|1220565|P1|Treatment Period 1|Protocol Violation|0
361926|NCT01012765|1220560|P6|Treatment Period 1|Administrative problems|0
361927|NCT01012765|1220561|P5|Treatment Period 1|Administrative problems|1
361928|NCT01012765|1220562|P4|Treatment Period 1|Administrative problems|1
361929|NCT01012765|1220563|P3|Treatment Period 1|Administrative problems|1
361930|NCT01012765|1220564|P2|Treatment Period 1|Administrative problems|0
361931|NCT01012765|1220565|P1|Treatment Period 1|Administrative problems|0
361932|NCT01012765|1220560|P6|Treatment Period 1|Withdrawal by Subject|0
361933|NCT01012765|1220561|P5|Treatment Period 1|Withdrawal by Subject|0
361934|NCT01012765|1220562|P4|Treatment Period 1|Withdrawal by Subject|0
361935|NCT01012765|1220563|P3|Treatment Period 1|Withdrawal by Subject|0
361936|NCT01012765|1220564|P2|Treatment Period 1|Withdrawal by Subject|0
361937|NCT01012765|1220565|P1|Treatment Period 1|Withdrawal by Subject|2
361938|NCT01012765|1220560|P6|Treatment Period 1|Adverse Event|0
361939|NCT01012765|1220561|P5|Treatment Period 1|Adverse Event|0
361940|NCT01012765|1220562|P4|Treatment Period 1|Adverse Event|0
361941|NCT01012765|1220563|P3|Treatment Period 1|Adverse Event|1
361942|NCT01012765|1220564|P2|Treatment Period 1|Adverse Event|0
361943|NCT01012765|1220565|P1|Treatment Period 1|Adverse Event|1
361944|NCT01012739|1220594|P4|Treatment Period 2|Abnormal test procedure results|1
361945|NCT01012739|1220595|P3|Treatment Period 2|Abnormal test procedure results|0
361946|NCT01012739|1220596|P2|Treatment Period 2|Abnormal test procedure results|0
361947|NCT01012739|1220597|P1|Treatment Period 2|Abnormal test procedure results|0
361948|NCT01012739|1220594|P4|Treatment Period 1|Adverse Event|1
361949|NCT01012739|1220595|P3|Treatment Period 1|Adverse Event|0
361950|NCT01012739|1220596|P2|Treatment Period 1|Adverse Event|0
361951|NCT01012739|1220597|P1|Treatment Period 1|Adverse Event|0
361952|NCT01012713|1220625|P1|Overall Study|Lack of Efficacy|3
361953|NCT01012622|1220651|P1|Overall Study|withdrawal of consent by a parent|2
361954|NCT01012622|1220651|P1|Overall Study|screening failure|1
361955|NCT01012622|1220651|P1|Overall Study|Other|1
361956|NCT01012622|1220651|P1|Overall Study|non-compliance with the drug|9
361957|NCT01012622|1220651|P1|Overall Study|Adverse Event|7
361958|NCT01012622|1220651|P1|Overall Study|Lost to Follow-up|5
361959|NCT01012622|1220651|P1|Overall Study|Withdrawal by Subject|6
361960|NCT01012440|1220675|P1|Overall Study|Withdrawal by Subject|2
361961|NCT01012414|1220679|P1|Overall Study|Trial was stopped before completed|7
361962|NCT01012414|1220679|P1|Overall Study|Lost to Follow-up|1
361963|NCT01012414|1220679|P1|Overall Study|Withdrawal by Subject|2
361964|NCT01012323|1220720|P1|Overall Study|Investigator Judgment|1
361965|NCT01012258|1220757|P1|Overall Study|Ongoing|29
361966|NCT01012258|1220757|P1|Overall Study|Another Tumor Discovered|1
361967|NCT01012258|1220757|P1|Overall Study|Another Anti-cancer Drug Received|1
361968|NCT01012258|1220757|P1|Overall Study|Symptomatic Deterioration|1
361969|NCT01012258|1220757|P1|Overall Study|Progressive Disease (PD)|18
361970|NCT01012258|1220757|P1|Overall Study|Adverse Event|1
361971|NCT01012258|1220757|P1|Overall Study|Lost to Follow-up|1
361972|NCT01012258|1220757|P1|Overall Study|Death|14
361973|NCT01012219|1220804|P1|Period 2|Withdrawal by Subject|1
361974|NCT01012219|1220804|P1|Period 1|Withdrawal by Subject|1
361975|NCT01012037|1221095|P3|Overall Study|Other reason (not specified)|1
361976|NCT01012037|1221096|P2|Overall Study|Other reason (not specified)|1
361977|NCT01012037|1221097|P1|Overall Study|Other reason (not specified)|1
361978|NCT01012037|1221095|P3|Overall Study|Withdrawal by Subject|1
361979|NCT01012037|1221096|P2|Overall Study|Withdrawal by Subject|4
361980|NCT01012037|1221097|P1|Overall Study|Withdrawal by Subject|0
361981|NCT01012037|1221095|P3|Overall Study|Protocol Violation|5
361982|NCT01012037|1221096|P2|Overall Study|Protocol Violation|3
361983|NCT01012037|1221097|P1|Overall Study|Protocol Violation|0
361984|NCT01012037|1221095|P3|Overall Study|Adverse Event|3
361985|NCT01012037|1221096|P2|Overall Study|Adverse Event|8
361986|NCT01012037|1221097|P1|Overall Study|Adverse Event|0
361987|NCT01011946|1221132|P1|Overall Study|No pathological lab value|1
361988|NCT01011946|1221132|P1|Overall Study|Transferred to another hospital|2
361989|NCT01011933|1221136|P1|Overall Study|Never treated|1
361990|NCT01011933|1221136|P1|Overall Study|Inadequate pathology|1
361991|NCT01011933|1221136|P1|Overall Study|Improper pre-protocol Rx|1
361992|NCT01011933|1221136|P1|Overall Study|Wrong cell type|1
361993|NCT01011907|1221153|P2|Overall Study|Adverse Event|4
361994|NCT01011907|1221154|P1|Overall Study|Adverse Event|1
361995|NCT01011907|1221153|P2|Overall Study|Withdrawal by Subject|11
361996|NCT01011907|1221154|P1|Overall Study|Withdrawal by Subject|13
361997|NCT01011868|1221171|P3|After Week 78 Follow-up|Other reason not defined above|16
361998|NCT01011868|1221172|P2|After Week 78 Follow-up|Other reason not defined above|5
361999|NCT01011868|1221173|P1|After Week 78 Follow-up|Other reason not defined above|5
362000|NCT01011868|1221171|P3|After Week 78 Follow-up|Withdrawal by Subject|1
362001|NCT01011868|1221172|P2|After Week 78 Follow-up|Withdrawal by Subject|8
362002|NCT01011868|1221173|P1|After Week 78 Follow-up|Withdrawal by Subject|9
362003|NCT01011868|1221171|P3|After Week 78 Follow-up|Lost to Follow-up|4
362004|NCT01011868|1221172|P2|After Week 78 Follow-up|Lost to Follow-up|6
362005|NCT01011868|1221173|P1|After Week 78 Follow-up|Lost to Follow-up|11
362006|NCT01011868|1221171|P3|After Week 78 Follow-up|Protocol Violation|2
362007|NCT01011868|1221172|P2|After Week 78 Follow-up|Protocol Violation|1
362008|NCT01011868|1221173|P1|After Week 78 Follow-up|Protocol Violation|9
362009|NCT01011868|1221171|P3|After Week 78 Follow-up|Lack of Efficacy|0
362010|NCT01011868|1221172|P2|After Week 78 Follow-up|Lack of Efficacy|0
362011|NCT01011868|1221173|P1|After Week 78 Follow-up|Lack of Efficacy|4
362012|NCT01011868|1221171|P3|After Week 78 Follow-up|Adverse Event|21
362013|NCT01011868|1221172|P2|After Week 78 Follow-up|Adverse Event|18
362014|NCT01011868|1221173|P1|After Week 78 Follow-up|Adverse Event|14
362015|NCT01011868|1221171|P3|After Week 18 Follow-up|Other reason not defined above|12
362016|NCT01011868|1221172|P2|After Week 18 Follow-up|Other reason not defined above|3
362017|NCT01011868|1221173|P1|After Week 18 Follow-up|Other reason not defined above|2
362018|NCT01011868|1221171|P3|After Week 18 Follow-up|Withdrawal by Subject|0
362019|NCT01011868|1221172|P2|After Week 18 Follow-up|Withdrawal by Subject|3
362020|NCT01011868|1221173|P1|After Week 18 Follow-up|Withdrawal by Subject|6
362021|NCT01011868|1221171|P3|After Week 18 Follow-up|Lost to Follow-up|0
362022|NCT01011868|1221172|P2|After Week 18 Follow-up|Lost to Follow-up|3
362023|NCT01011868|1221173|P1|After Week 18 Follow-up|Lost to Follow-up|5
362024|NCT01011868|1221171|P3|After Week 18 Follow-up|Protocol Violation|1
362025|NCT01011868|1221172|P2|After Week 18 Follow-up|Protocol Violation|1
362026|NCT01011868|1221173|P1|After Week 18 Follow-up|Protocol Violation|1
362027|NCT01011868|1221171|P3|After Week 18 Follow-up|Lack of Efficacy|0
362028|NCT01011868|1221172|P2|After Week 18 Follow-up|Lack of Efficacy|0
362029|NCT01011868|1221173|P1|After Week 18 Follow-up|Lack of Efficacy|1
362030|NCT01011868|1221171|P3|After Week 18 Follow-up|Adverse Event|13
362031|NCT01011868|1221172|P2|After Week 18 Follow-up|Adverse Event|6
362032|NCT01011868|1221173|P1|After Week 18 Follow-up|Adverse Event|8
362033|NCT01011738|1221235|P3|Overall Study|Unknown reasons|17
362034|NCT01011738|1221236|P2|Overall Study|Unknown reasons|291
362035|NCT01011738|1221237|P1|Overall Study|Unknown reasons|312
362036|NCT01011738|1221235|P3|Overall Study|Death|0
362037|NCT01011738|1221236|P2|Overall Study|Death|3
362038|NCT01011738|1221237|P1|Overall Study|Death|12
362039|NCT01011673|1221277|P2|24 Hour Follow-up|Lost to Follow-up|3
362040|NCT01011673|1221278|P1|24 Hour Follow-up|Lost to Follow-up|3
362041|NCT01011673|1221277|P2|Randomized|Secondary headache|1
362042|NCT01011673|1221278|P1|Randomized|Secondary headache|2
362043|NCT01011556|1221301|P4|Overall Study|Inclusion/exclusion criteria not met|5
362044|NCT01011556|1221302|P3|Overall Study|Inclusion/exclusion criteria not met|3
362045|NCT01011556|1221303|P2|Overall Study|Inclusion/exclusion criteria not met|1
362046|NCT01011556|1221304|P1|Overall Study|Inclusion/exclusion criteria not met|2
362047|NCT01011556|1221301|P4|Overall Study|Sponsor decision|2
362048|NCT01011556|1221302|P3|Overall Study|Sponsor decision|1
362049|NCT01011556|1221303|P2|Overall Study|Sponsor decision|1
362050|NCT01011556|1221304|P1|Overall Study|Sponsor decision|0
362051|NCT01011556|1221301|P4|Overall Study|Withdrawal by Subject|4
362052|NCT01011556|1221302|P3|Overall Study|Withdrawal by Subject|4
362053|NCT01011556|1221303|P2|Overall Study|Withdrawal by Subject|2
362054|NCT01011556|1221304|P1|Overall Study|Withdrawal by Subject|1
362055|NCT01011556|1221301|P4|Overall Study|Protocol Violation|0
362056|NCT01011556|1221302|P3|Overall Study|Protocol Violation|0
362057|NCT01011556|1221303|P2|Overall Study|Protocol Violation|1
362058|NCT01011556|1221304|P1|Overall Study|Protocol Violation|0
362059|NCT01011556|1221301|P4|Overall Study|Physician Decision|1
362060|NCT01011556|1221302|P3|Overall Study|Physician Decision|0
362061|NCT01011556|1221303|P2|Overall Study|Physician Decision|0
362062|NCT01011556|1221304|P1|Overall Study|Physician Decision|1
362063|NCT01011556|1221301|P4|Overall Study|Lost to Follow-up|0
362064|NCT01011556|1221302|P3|Overall Study|Lost to Follow-up|0
362065|NCT01011556|1221303|P2|Overall Study|Lost to Follow-up|0
362066|NCT01011556|1221304|P1|Overall Study|Lost to Follow-up|1
362067|NCT01011556|1221301|P4|Overall Study|Adverse Event|1
362068|NCT01011556|1221302|P3|Overall Study|Adverse Event|2
362069|NCT01011556|1221303|P2|Overall Study|Adverse Event|3
362070|NCT01011556|1221304|P1|Overall Study|Adverse Event|1
362071|NCT01011465|1221382|P8|Overall Study|Withdrawal by Subject|0
362072|NCT01011465|1221383|P7|Overall Study|Withdrawal by Subject|1
362073|NCT01011465|1221384|P6|Overall Study|Withdrawal by Subject|0
362074|NCT01011465|1221385|P5|Overall Study|Withdrawal by Subject|1
362075|NCT01011465|1221386|P4|Overall Study|Withdrawal by Subject|0
362076|NCT01011465|1221387|P3|Overall Study|Withdrawal by Subject|0
362077|NCT01011465|1221388|P2|Overall Study|Withdrawal by Subject|1
362078|NCT01011465|1221389|P1|Overall Study|Withdrawal by Subject|2
362079|NCT01011387|1221417|P1|Overall Study|Protocol Violation|1
362080|NCT01011387|1221417|P1|Overall Study|Adverse Event|2
362081|NCT01011387|1221417|P1|Overall Study|Withdrawal by Subject|3
362082|NCT01011335|1221425|P13|Overall Study|Adverse Event|1
362083|NCT01011335|1221426|P12|Overall Study|Adverse Event|0
362084|NCT01011335|1221427|P11|Overall Study|Adverse Event|4
362085|NCT01011335|1221428|P10|Overall Study|Adverse Event|0
362086|NCT01011335|1221429|P9|Overall Study|Adverse Event|0
362087|NCT01011335|1221430|P8|Overall Study|Adverse Event|0
362088|NCT01011335|1221431|P7|Overall Study|Adverse Event|0
362089|NCT01011335|1221432|P6|Overall Study|Adverse Event|0
362090|NCT01011335|1221433|P5|Overall Study|Adverse Event|0
362091|NCT01011335|1221434|P4|Overall Study|Adverse Event|0
362092|NCT01011335|1221435|P3|Overall Study|Adverse Event|0
362093|NCT01011335|1221436|P2|Overall Study|Adverse Event|0
362094|NCT01011335|1221437|P1|Overall Study|Adverse Event|0
362095|NCT01011335|1221425|P13|Overall Study|Moved/deployed or no booster|0
362096|NCT01011335|1221426|P12|Overall Study|Moved/deployed or no booster|0
362097|NCT01011335|1221427|P11|Overall Study|Moved/deployed or no booster|2
362098|NCT01011335|1221428|P10|Overall Study|Moved/deployed or no booster|0
362099|NCT01011335|1221429|P9|Overall Study|Moved/deployed or no booster|1
362100|NCT01011335|1221430|P8|Overall Study|Moved/deployed or no booster|0
362101|NCT01011335|1221431|P7|Overall Study|Moved/deployed or no booster|1
362102|NCT01011335|1221432|P6|Overall Study|Moved/deployed or no booster|0
362103|NCT01011335|1221433|P5|Overall Study|Moved/deployed or no booster|0
362104|NCT01011335|1221434|P4|Overall Study|Moved/deployed or no booster|1
362105|NCT01011335|1221435|P3|Overall Study|Moved/deployed or no booster|0
362106|NCT01011335|1221436|P2|Overall Study|Moved/deployed or no booster|0
362107|NCT01011335|1221437|P1|Overall Study|Moved/deployed or no booster|1
362108|NCT01011335|1221425|P13|Overall Study|Protocol Violation|0
362109|NCT01011335|1221426|P12|Overall Study|Protocol Violation|0
362110|NCT01011335|1221427|P11|Overall Study|Protocol Violation|0
362111|NCT01011335|1221428|P10|Overall Study|Protocol Violation|0
362112|NCT01011335|1221429|P9|Overall Study|Protocol Violation|0
362113|NCT01011335|1221430|P8|Overall Study|Protocol Violation|0
362114|NCT01011335|1221431|P7|Overall Study|Protocol Violation|0
362115|NCT01011335|1221432|P6|Overall Study|Protocol Violation|0
362116|NCT01011335|1221433|P5|Overall Study|Protocol Violation|0
362117|NCT01011335|1221434|P4|Overall Study|Protocol Violation|0
362118|NCT01011335|1221435|P3|Overall Study|Protocol Violation|0
362119|NCT01011335|1221436|P2|Overall Study|Protocol Violation|1
362120|NCT01011335|1221437|P1|Overall Study|Protocol Violation|0
362121|NCT01011335|1221425|P13|Overall Study|Lost to Follow-up|2
362122|NCT01011335|1221426|P12|Overall Study|Lost to Follow-up|1
362123|NCT01011335|1221427|P11|Overall Study|Lost to Follow-up|0
362124|NCT01011335|1221428|P10|Overall Study|Lost to Follow-up|0
362125|NCT01011335|1221429|P9|Overall Study|Lost to Follow-up|1
362126|NCT01011335|1221430|P8|Overall Study|Lost to Follow-up|2
362127|NCT01011335|1221431|P7|Overall Study|Lost to Follow-up|2
362128|NCT01011335|1221432|P6|Overall Study|Lost to Follow-up|1
362129|NCT01011335|1221433|P5|Overall Study|Lost to Follow-up|1
362130|NCT01011335|1221434|P4|Overall Study|Lost to Follow-up|1
362131|NCT01011335|1221435|P3|Overall Study|Lost to Follow-up|1
362132|NCT01011335|1221436|P2|Overall Study|Lost to Follow-up|0
362133|NCT01011335|1221437|P1|Overall Study|Lost to Follow-up|0
362134|NCT01011309|1221477|P3|Overall Study|Protocol Violation|3
362135|NCT01011309|1221478|P2|Overall Study|Protocol Violation|1
362136|NCT01011309|1221479|P1|Overall Study|Protocol Violation|0
362137|NCT01011309|1221477|P3|Overall Study|Lack of Efficacy|0
362138|NCT01011309|1221478|P2|Overall Study|Lack of Efficacy|1
362139|NCT01011309|1221479|P1|Overall Study|Lack of Efficacy|0
362140|NCT01011309|1221477|P3|Overall Study|Adverse Event|2
362141|NCT01011309|1221478|P2|Overall Study|Adverse Event|1
362142|NCT01011309|1221479|P1|Overall Study|Adverse Event|2
362143|NCT01011283|1221495|P2|Overall Study|Not Specified|2
362144|NCT01011283|1221496|P1|Overall Study|Not Specified|2
362145|NCT01011283|1221495|P2|Overall Study|Terminated by Sponsor|5
362146|NCT01011283|1221496|P1|Overall Study|Terminated by Sponsor|5
362147|NCT01011283|1221495|P2|Overall Study|Progressive Disease|2
362148|NCT01011283|1221496|P1|Overall Study|Progressive Disease|0
362149|NCT01011283|1221495|P2|Overall Study|Adverse Event|2
362150|NCT01011283|1221496|P1|Overall Study|Adverse Event|4
362151|NCT01011153|1221516|P3|Overall Study|Less than 78 cases completed|9
362152|NCT01011153|1221517|P2|Overall Study|Less than 78 cases completed|11
362153|NCT01011153|1221518|P1|Overall Study|Less than 78 cases completed|8
362154|NCT01011049|1221547|P4|Overall Study|Withdrawal by Subject|0
362155|NCT01011049|1221548|P3|Overall Study|Withdrawal by Subject|1
362156|NCT01011049|1221549|P2|Overall Study|Withdrawal by Subject|0
362157|NCT01011049|1221550|P1|Overall Study|Withdrawal by Subject|0
362158|NCT01011049|1221547|P4|Overall Study|Lost to Follow-up|0
362159|NCT01011049|1221548|P3|Overall Study|Lost to Follow-up|1
362160|NCT01011049|1221549|P2|Overall Study|Lost to Follow-up|2
362161|NCT01011049|1221550|P1|Overall Study|Lost to Follow-up|1
362162|NCT01011049|1221547|P4|Overall Study|Protocol Violation|0
362163|NCT01011049|1221548|P3|Overall Study|Protocol Violation|2
362164|NCT01011049|1221549|P2|Overall Study|Protocol Violation|0
362165|NCT01011049|1221550|P1|Overall Study|Protocol Violation|0
362166|NCT01010971|1221580|P3|Overall Study|Other|2
362167|NCT01010971|1221581|P2|Overall Study|Other|0
362168|NCT01010971|1221582|P1|Overall Study|Other|1
362169|NCT01010971|1221580|P3|Overall Study|Lost to Follow-up|3
362170|NCT01010971|1221581|P2|Overall Study|Lost to Follow-up|2
362171|NCT01010971|1221582|P1|Overall Study|Lost to Follow-up|0
362172|NCT01010971|1221580|P3|Overall Study|Withdrawal by Subject|5
362173|NCT01010971|1221581|P2|Overall Study|Withdrawal by Subject|2
362174|NCT01010971|1221582|P1|Overall Study|Withdrawal by Subject|0
362175|NCT01010971|1221580|P3|Overall Study|Adverse Event|3
362176|NCT01010971|1221581|P2|Overall Study|Adverse Event|4
362177|NCT01010971|1221582|P1|Overall Study|Adverse Event|2
362178|NCT01010867|1221710|P1|Overall Study|< 50% adherence to probiotic|1
362179|NCT01010776|1221722|P1|Extension Phase|Not specified|3
362180|NCT01010776|1221722|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
362181|NCT01010776|1221722|P1|Main Phase|Did not received study medication|5
362182|NCT01010776|1221722|P1|Main Phase|Not specified|1
362183|NCT01010776|1221722|P1|Main Phase|Inform consent withdrawal|1
362184|NCT01010776|1221722|P1|Main Phase|Selection failure|2
362185|NCT01010776|1221722|P1|Main Phase|Non-compliance to study medication|5
362186|NCT01010776|1221722|P1|Main Phase|Lost to Follow-up|6
362187|NCT01010776|1221722|P1|Main Phase|Adverse Event|7
362188|NCT01010776|1221722|P1|Main Phase|Lack of Efficacy|8
362189|NCT01010776|1221722|P1|Main Phase|Withdrawal by Subject|14
362190|NCT01010750|1221750|P6|Second Intervention|Adverse Event|0
362191|NCT01010750|1221751|P5|Second Intervention|Adverse Event|0
362192|NCT01010750|1221752|P4|Second Intervention|Adverse Event|0
362193|NCT01010750|1221753|P3|Second Intervention|Adverse Event|0
362194|NCT01010750|1221754|P2|Second Intervention|Adverse Event|1
362195|NCT01010750|1221755|P1|Second Intervention|Adverse Event|0
362196|NCT01010633|1221780|P2|Overall Study|Investigator decision|1
362197|NCT01010633|1221781|P1|Overall Study|Investigator decision|0
362198|NCT01010633|1221780|P2|Overall Study|Withdrawal by Subject|1
362199|NCT01010633|1221781|P1|Overall Study|Withdrawal by Subject|2
362200|NCT01010633|1221780|P2|Overall Study|Protocol Violation|2
362201|NCT01010633|1221781|P1|Overall Study|Protocol Violation|1
362202|NCT01010633|1221780|P2|Overall Study|Adverse Event|1
362203|NCT01010633|1221781|P1|Overall Study|Adverse Event|1
362204|NCT01010503|1221808|P1|Overall Study|Death|1
362205|NCT01010503|1221808|P1|Overall Study|Adverse Event|1
362206|NCT01010230|1221867|P2|Overall Study|Lost to Follow-up|2
362207|NCT01010230|1221868|P1|Overall Study|Lost to Follow-up|4
362208|NCT01010230|1221867|P2|Overall Study|Withdrawal by Subject|5
362209|NCT01010230|1221868|P1|Overall Study|Withdrawal by Subject|6
362210|NCT01010204|1221900|P2|Overall Study|psychiatric hospitalization|1
362211|NCT01010204|1221901|P1|Overall Study|psychiatric hospitalization|2
362212|NCT01010204|1221900|P2|Overall Study|Withdrawal by Subject|3
362213|NCT01010204|1221901|P1|Overall Study|Withdrawal by Subject|2
362214|NCT01010204|1221900|P2|Overall Study|Adverse Event|3
362215|NCT01010204|1221901|P1|Overall Study|Adverse Event|1
362216|NCT01010204|1221900|P2|Overall Study|Lost to Follow-up|2
362217|NCT01010204|1221901|P1|Overall Study|Lost to Follow-up|2
362218|NCT01010061|1221913|P2|Overall Study|Failure to Return|2
362219|NCT01010061|1221914|P1|Overall Study|Failure to Return|3
362220|NCT01010061|1221913|P2|Overall Study|Refused Treatment/Did Not Cooperate|1
362221|NCT01010061|1221914|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
362222|NCT01010061|1221913|P2|Overall Study|Administrative/Other|14
362223|NCT01010061|1221914|P1|Overall Study|Administrative/Other|19
362224|NCT01010061|1221913|P2|Overall Study|Death|7
362225|NCT01010061|1221914|P1|Overall Study|Death|23
362226|NCT01010061|1221913|P2|Overall Study|Withdrew Consent|4
362227|NCT01010061|1221914|P1|Overall Study|Withdrew Consent|9
362228|NCT01010061|1221913|P2|Overall Study|Progression of Disease|63
362229|NCT01010061|1221914|P1|Overall Study|Progression of Disease|71
362230|NCT01010061|1221913|P2|Overall Study|Adverse Events or Intercurrent Illness|4
362231|NCT01010061|1221914|P1|Overall Study|Adverse Events or Intercurrent Illness|7
362232|NCT01009983|1221964|P1|Overall Study|necessary scans not completed|1
362233|NCT01009840|1221977|P1|Overall Study|Subject Withdrew Consent to Participate|1
362234|NCT01009840|1221977|P1|Overall Study|Subject was Withdrawn by Investigator|1
362235|NCT01009840|1221977|P1|Overall Study|Subject Met Withdrawal Criteria|7
362236|NCT01009840|1221977|P1|Overall Study|Adverse Event|4
362237|NCT01009840|1221977|P1|Overall Study|Lost to Follow-up|1
362238|NCT01009645|1222007|P4|Overall Study|Lost to Follow-up|5
362239|NCT01009645|1222008|P3|Overall Study|Lost to Follow-up|4
362240|NCT01009645|1222009|P2|Overall Study|Lost to Follow-up|8
362241|NCT01009645|1222010|P1|Overall Study|Lost to Follow-up|2
362242|NCT01009580|1222047|P2|Overall Study|Unclassified|21
362243|NCT01009580|1222048|P1|Overall Study|Unclassified|17
362244|NCT01009580|1222047|P2|Overall Study|Withdrawal Criteria|6
362245|NCT01009580|1222048|P1|Overall Study|Withdrawal Criteria|4
362246|NCT01009580|1222047|P2|Overall Study|Protocol Violation|3
362247|NCT01009580|1222048|P1|Overall Study|Protocol Violation|2
362248|NCT01009580|1222047|P2|Overall Study|Lack of Efficacy|1
362249|NCT01009580|1222048|P1|Overall Study|Lack of Efficacy|0
362250|NCT01009580|1222047|P2|Overall Study|Adverse Event|4
362251|NCT01009580|1222048|P1|Overall Study|Adverse Event|4
362252|NCT01009554|1222062|P2|Overall Study|Noncompliant with Study Product|3
362253|NCT01009554|1222063|P1|Overall Study|Noncompliant with Study Product|0
362254|NCT01009554|1222062|P2|Overall Study|Withdrawal by Subject|3
362255|NCT01009554|1222063|P1|Overall Study|Withdrawal by Subject|1
362256|NCT01009554|1222062|P2|Overall Study|Adverse Event|1
362257|NCT01009554|1222063|P1|Overall Study|Adverse Event|1
362258|NCT01009515|1222195|P1|Overall Study|Withdrawal by Subject|3
362259|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Physician Decision|8
362260|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Physician Decision|6
362261|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Physician Decision|6
362262|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Physician Decision|4
362263|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Physician Decision|0
362264|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
362265|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
362266|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
362267|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
362268|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
362269|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
362270|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
362271|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
362272|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
362273|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
362274|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
362275|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
362276|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
362277|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
362278|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
362279|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
362280|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
362281|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
362282|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
362283|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
362284|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
362285|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
362286|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
362287|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
362288|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
362289|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
362290|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
362291|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
362292|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
362293|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
362294|NCT01009463|1222206|P5|52-week, Double-blind Treatment Period|Adverse Event|31
362295|NCT01009463|1222207|P4|52-week, Double-blind Treatment Period|Adverse Event|29
362296|NCT01009463|1222208|P3|52-week, Double-blind Treatment Period|Adverse Event|25
362297|NCT01009463|1222209|P2|52-week, Double-blind Treatment Period|Adverse Event|22
362298|NCT01009463|1222210|P1|52-week, Double-blind Treatment Period|Adverse Event|0
362299|NCT01009463|1222206|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
362300|NCT01009463|1222207|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
362301|NCT01009463|1222208|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
362302|NCT01009463|1222209|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
362303|NCT01009463|1222210|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
362304|NCT01009463|1222206|P5|4-week, Open-label Run-In Period|Physician Decision|0
362305|NCT01009463|1222207|P4|4-week, Open-label Run-In Period|Physician Decision|0
362306|NCT01009463|1222208|P3|4-week, Open-label Run-In Period|Physician Decision|0
362307|NCT01009463|1222209|P2|4-week, Open-label Run-In Period|Physician Decision|0
362308|NCT01009463|1222210|P1|4-week, Open-label Run-In Period|Physician Decision|10
362309|NCT01009463|1222206|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
362310|NCT01009463|1222207|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
362311|NCT01009463|1222208|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
362312|NCT01009463|1222209|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
362313|NCT01009463|1222210|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
362314|NCT01009463|1222206|P5|4-week, Open-label Run-In Period|Adverse Event|0
362315|NCT01009463|1222207|P4|4-week, Open-label Run-In Period|Adverse Event|0
362316|NCT01009463|1222208|P3|4-week, Open-label Run-In Period|Adverse Event|0
362317|NCT01009463|1222209|P2|4-week, Open-label Run-In Period|Adverse Event|0
362318|NCT01009463|1222210|P1|4-week, Open-label Run-In Period|Adverse Event|10
362319|NCT01009463|1222206|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
362320|NCT01009463|1222207|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
362321|NCT01009463|1222208|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
362322|NCT01009463|1222209|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
362323|NCT01009463|1222210|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
362324|NCT01009203|1222255|P1|Overall Study|Treatment-unrelated death|1
362325|NCT01009203|1222255|P1|Overall Study|Adverse Event|5
362326|NCT01009203|1222255|P1|Overall Study|Withdrawal by Subject|1
362327|NCT01009099|1222295|P2|Overall Study|Death|1
362328|NCT01009099|1222296|P1|Overall Study|Death|0
362329|NCT01009099|1222295|P2|Overall Study|Withdrawal by Subject|1
362330|NCT01009099|1222296|P1|Overall Study|Withdrawal by Subject|1
362331|NCT01009099|1222295|P2|Overall Study|Physician Decision|2
362332|NCT01009099|1222296|P1|Overall Study|Physician Decision|3
362333|NCT01009099|1222295|P2|Overall Study|Lost to Follow-up|0
362334|NCT01009099|1222296|P1|Overall Study|Lost to Follow-up|1
362335|NCT01009086|1222305|P3|Overall Study|Other|1
362336|NCT01009086|1222306|P2|Overall Study|Other|5
362337|NCT01009086|1222307|P1|Overall Study|Other|3
362338|NCT01009086|1222305|P3|Overall Study|Withdrawal by Subject|13
362339|NCT01009086|1222306|P2|Overall Study|Withdrawal by Subject|11
362340|NCT01009086|1222307|P1|Overall Study|Withdrawal by Subject|9
362341|NCT01009086|1222305|P3|Overall Study|Adverse Event|8
362342|NCT01009086|1222306|P2|Overall Study|Adverse Event|11
362343|NCT01009086|1222307|P1|Overall Study|Adverse Event|12
362344|NCT01009086|1222305|P3|Overall Study|Lost to Follow-up|3
362345|NCT01009086|1222306|P2|Overall Study|Lost to Follow-up|5
362346|NCT01009086|1222307|P1|Overall Study|Lost to Follow-up|4
362347|NCT01009086|1222305|P3|Overall Study|Lack of Efficacy|9
362348|NCT01009086|1222306|P2|Overall Study|Lack of Efficacy|15
362349|NCT01009086|1222307|P1|Overall Study|Lack of Efficacy|16
362350|NCT01009060|1222342|P2|Overall Study|Withdrawal by Subject|1
362351|NCT01009060|1222343|P1|Overall Study|Withdrawal by Subject|1
362352|NCT01009060|1222342|P2|Overall Study|Physician Decision|1
362353|NCT01009060|1222343|P1|Overall Study|Physician Decision|1
362354|NCT01009060|1222342|P2|Overall Study|Lost to Follow-up|0
362355|NCT01009060|1222343|P1|Overall Study|Lost to Follow-up|1
362356|NCT01009060|1222342|P2|Overall Study|Protocol Violation|1
362357|NCT01009060|1222343|P1|Overall Study|Protocol Violation|0
362358|NCT01009060|1222342|P2|Overall Study|Adverse Event|2
362359|NCT01009060|1222343|P1|Overall Study|Adverse Event|1
362360|NCT01009047|1222381|P2|Overall Study|Other|2
362361|NCT01009047|1222382|P1|Overall Study|Other|3
362362|NCT01009047|1222381|P2|Overall Study|Withdrawal by consent|11
362363|NCT01009047|1222382|P1|Overall Study|Withdrawal by consent|16
362364|NCT01009047|1222381|P2|Overall Study|Lack of Efficacy|11
362365|NCT01009047|1222382|P1|Overall Study|Lack of Efficacy|4
362366|NCT01009047|1222381|P2|Overall Study|Lost to Follow-up|2
362367|NCT01009047|1222382|P1|Overall Study|Lost to Follow-up|0
362368|NCT01009047|1222381|P2|Overall Study|Adverse Event|0
362369|NCT01009047|1222382|P1|Overall Study|Adverse Event|5
362370|NCT01009034|1222404|P1|Overall Study|Withdrawal by Subject|2
362371|NCT01009034|1222404|P1|Overall Study|Lost to Follow-up|2
362372|NCT01008995|1222412|P4|After Controlled Period|Not specified|0
362373|NCT01008995|1222413|P3|After Controlled Period|Not specified|1
362374|NCT01008995|1222414|P2|After Controlled Period|Not specified|0
362375|NCT01008995|1222415|P1|After Controlled Period|Not specified|0
362376|NCT01008995|1222412|P4|After Controlled Period|Adverse Event|1
362377|NCT01008995|1222413|P3|After Controlled Period|Adverse Event|1
362378|NCT01008995|1222414|P2|After Controlled Period|Adverse Event|0
362379|NCT01008995|1222415|P1|After Controlled Period|Adverse Event|0
362380|NCT01008995|1222412|P4|Controlled Period|Not specified|0
362381|NCT01008995|1222413|P3|Controlled Period|Not specified|0
362382|NCT01008995|1222414|P2|Controlled Period|Not specified|1
362383|NCT01008995|1222415|P1|Controlled Period|Not specified|2
362384|NCT01008995|1222412|P4|Controlled Period|Adverse Event|0
362385|NCT01008995|1222413|P3|Controlled Period|Adverse Event|0
362386|NCT01008995|1222414|P2|Controlled Period|Adverse Event|2
362387|NCT01008995|1222415|P1|Controlled Period|Adverse Event|1
362388|NCT01008943|1222432|P1|Overall Study|Withdrawal by Subject|1
362389|NCT01008904|1222439|P1|Overall Study|unexpected unrelated surgery|1
362390|NCT01008904|1222439|P1|Overall Study|Adverse Event|2
362391|NCT01008904|1222439|P1|Overall Study|Lost to Follow-up|1
362392|NCT01008696|1222457|P2|Overall Study|Other|2
362393|NCT01008696|1222458|P1|Overall Study|Other|0
362394|NCT01008696|1222457|P2|Overall Study|Other|3
362395|NCT01008696|1222458|P1|Overall Study|Other|2
362396|NCT01008696|1222457|P2|Overall Study|Participants' non-cooperation|3
362397|NCT01008696|1222458|P1|Overall Study|Participants' non-cooperation|2
362398|NCT01008696|1222457|P2|Overall Study|Adverse Event|0
362399|NCT01008696|1222458|P1|Overall Study|Adverse Event|1
362400|NCT01008696|1222457|P2|Overall Study|Physician Decision|1
362401|NCT01008696|1222458|P1|Overall Study|Physician Decision|5
362402|NCT01008696|1222457|P2|Overall Study|Withdrawal by Subject|4
362403|NCT01008696|1222458|P1|Overall Study|Withdrawal by Subject|2
362404|NCT01008696|1222457|P2|Overall Study|Participant's evasion of hospital visit|4
362405|NCT01008696|1222458|P1|Overall Study|Participant's evasion of hospital visit|5
362406|NCT01008618|1222468|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
362407|NCT01008618|1222469|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
362408|NCT01008618|1222470|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
362409|NCT01008618|1222468|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
362410|NCT01008618|1222469|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
362411|NCT01008618|1222470|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
362412|NCT01008618|1222468|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
362413|NCT01008618|1222469|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
362414|NCT01008618|1222470|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
362415|NCT01008618|1222468|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
362416|NCT01008618|1222469|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
362417|NCT01008618|1222470|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
362418|NCT01008618|1222468|P3|Period 2 (Double-Blind Period)|Physician Decision|0
362419|NCT01008618|1222469|P2|Period 2 (Double-Blind Period)|Physician Decision|1
362420|NCT01008618|1222470|P1|Period 2 (Double-Blind Period)|Physician Decision|0
362421|NCT01008618|1222468|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
362422|NCT01008618|1222469|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
362423|NCT01008618|1222470|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
362424|NCT01008618|1222468|P3|Period 2 (Double-Blind Period)|Adverse Event|2
362425|NCT01008618|1222469|P2|Period 2 (Double-Blind Period)|Adverse Event|11
362426|NCT01008618|1222470|P1|Period 2 (Double-Blind Period)|Adverse Event|0
362427|NCT01008618|1222468|P3|Period 1 (Titration Period)|Aggravated symptom|0
362428|NCT01008618|1222469|P2|Period 1 (Titration Period)|Aggravated symptom|0
362429|NCT01008618|1222470|P1|Period 1 (Titration Period)|Aggravated symptom|2
362430|NCT01008618|1222468|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
362431|NCT01008618|1222469|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
362432|NCT01008618|1222470|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
362433|NCT01008618|1222468|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
362434|NCT01008618|1222469|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
362435|NCT01008618|1222470|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
362436|NCT01008618|1222468|P3|Period 1 (Titration Period)|Adverse Event|0
362437|NCT01008618|1222469|P2|Period 1 (Titration Period)|Adverse Event|0
362438|NCT01008618|1222470|P1|Period 1 (Titration Period)|Adverse Event|33
362439|NCT01008618|1222468|P3|Period 1 (Titration Period)|Physician Decision|0
362440|NCT01008618|1222469|P2|Period 1 (Titration Period)|Physician Decision|0
362441|NCT01008618|1222470|P1|Period 1 (Titration Period)|Physician Decision|2
362442|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
362443|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
362444|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
362445|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
362446|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
362447|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
362448|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
362449|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
362450|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
362451|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
362452|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
362453|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
362454|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
362455|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
362456|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
362457|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
362458|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
362459|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
362460|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|Adverse Event|4
362461|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|Adverse Event|14
362462|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|Adverse Event|0
362463|NCT01008553|1222519|P3|Period 2 (Double-Blind Period)|Physician Decision|2
362464|NCT01008553|1222520|P2|Period 2 (Double-Blind Period)|Physician Decision|1
362465|NCT01008553|1222521|P1|Period 2 (Double-Blind Period)|Physician Decision|0
362466|NCT01008553|1222519|P3|Period 1 (Titration Period)|Not appropriate for this study|0
362467|NCT01008553|1222520|P2|Period 1 (Titration Period)|Not appropriate for this study|0
362468|NCT01008553|1222521|P1|Period 1 (Titration Period)|Not appropriate for this study|1
362469|NCT01008553|1222519|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
362470|NCT01008553|1222520|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
362471|NCT01008553|1222521|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
362472|NCT01008553|1222519|P3|Period 1 (Titration Period)|Determined to increase dosage|0
362473|NCT01008553|1222520|P2|Period 1 (Titration Period)|Determined to increase dosage|0
362474|NCT01008553|1222521|P1|Period 1 (Titration Period)|Determined to increase dosage|3
362475|NCT01008553|1222519|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
362476|NCT01008553|1222520|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
362477|NCT01008553|1222521|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
362478|NCT01008553|1222519|P3|Period 1 (Titration Period)|Adverse Event|0
362479|NCT01008553|1222520|P2|Period 1 (Titration Period)|Adverse Event|0
362480|NCT01008553|1222521|P1|Period 1 (Titration Period)|Adverse Event|33
362481|NCT01008553|1222519|P3|Period 1 (Titration Period)|Physician Decision|0
362482|NCT01008553|1222520|P2|Period 1 (Titration Period)|Physician Decision|0
362483|NCT01008553|1222521|P1|Period 1 (Titration Period)|Physician Decision|2
362484|NCT01008475|1222553|P7|Overall Study|Ongoing treatment at data cut-off date|4
362485|NCT01008475|1222554|P6|Overall Study|Ongoing treatment at data cut-off date|6
362486|NCT01008475|1222555|P5|Overall Study|Ongoing treatment at data cut-off date|5
362487|NCT01008475|1222556|P4|Overall Study|Ongoing treatment at data cut-off date|0
362488|NCT01008475|1222557|P3|Overall Study|Ongoing treatment at data cut-off date|0
362489|NCT01008475|1222558|P2|Overall Study|Ongoing treatment at data cut-off date|0
362490|NCT01008475|1222559|P1|Overall Study|Ongoing treatment at data cut-off date|0
362491|NCT01008449|1222589|P2|Overall Study|Lost to Follow-up|19
362492|NCT01008449|1222590|P1|Overall Study|Lost to Follow-up|29
362493|NCT01007916|1222636|P2|Period 2, 4 Weeks of Wear|Relocation|0
362494|NCT01007916|1222637|P1|Period 2, 4 Weeks of Wear|Relocation|1
362495|NCT01007916|1222636|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
362496|NCT01007916|1222637|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
362497|NCT01007942|1222645|P2|Overall Study|Patients untreated|3
362498|NCT01007942|1222646|P1|Overall Study|Patients untreated|4
362499|NCT01007942|1222645|P2|Overall Study|Death|2
362500|NCT01007942|1222646|P1|Overall Study|Death|3
362501|NCT01007942|1222645|P2|Overall Study|Administrative problems|0
362502|NCT01007942|1222646|P1|Overall Study|Administrative problems|2
362503|NCT01007942|1222645|P2|Overall Study|Lost to Follow-up|0
362504|NCT01007942|1222646|P1|Overall Study|Lost to Follow-up|1
362505|NCT01007942|1222645|P2|Overall Study|Withdrawal by Subject|14
362506|NCT01007942|1222646|P1|Overall Study|Withdrawal by Subject|19
362507|NCT01007942|1222645|P2|Overall Study|Protocol Violation|1
362508|NCT01007942|1222646|P1|Overall Study|Protocol Violation|1
362509|NCT01007942|1222645|P2|Overall Study|New cancer therapy|1
362510|NCT01007942|1222646|P1|Overall Study|New cancer therapy|5
362511|NCT01007942|1222645|P2|Overall Study|Disease progression|242
362512|NCT01007942|1222646|P1|Overall Study|Disease progression|217
362513|NCT01007942|1222645|P2|Overall Study|Abnormal test procedure|1
362514|NCT01007942|1222646|P1|Overall Study|Abnormal test procedure|0
362515|NCT01007942|1222645|P2|Overall Study|Adverse Event|14
362516|NCT01007942|1222646|P1|Overall Study|Adverse Event|29
362517|NCT01007838|1222672|P4|Overall Study|Started home haemodialysis|0
362518|NCT01007838|1222673|P3|Overall Study|Started home haemodialysis|0
362519|NCT01007838|1222674|P2|Overall Study|Started home haemodialysis|0
362520|NCT01007838|1222675|P1|Overall Study|Started home haemodialysis|1
362521|NCT01007838|1222672|P4|Overall Study|Physician Decision|0
362522|NCT01007838|1222673|P3|Overall Study|Physician Decision|0
362523|NCT01007838|1222674|P2|Overall Study|Physician Decision|0
362524|NCT01007838|1222675|P1|Overall Study|Physician Decision|1
362525|NCT01007838|1222672|P4|Overall Study|Withdrawal by Subject|0
362526|NCT01007838|1222673|P3|Overall Study|Withdrawal by Subject|0
362527|NCT01007838|1222674|P2|Overall Study|Withdrawal by Subject|0
362528|NCT01007838|1222675|P1|Overall Study|Withdrawal by Subject|1
362529|NCT01007812|1222685|P2|Period 1, One Week|Discomfort|0
362530|NCT01007812|1222686|P1|Period 1, One Week|Discomfort|1
362531|NCT01007812|1222685|P2|Period 1, One Week|Lost to Follow-up|1
362532|NCT01007812|1222686|P1|Period 1, One Week|Lost to Follow-up|0
362533|NCT01007552|1222719|P1|Overall Study|Withdrawal by Subject|1
362534|NCT01007435|1222733|P4|Overall Study|Reason not Specified|1
362535|NCT01007435|1222734|P3|Overall Study|Reason not Specified|2
362536|NCT01007435|1222735|P2|Overall Study|Reason not Specified|1
362537|NCT01007435|1222736|P1|Overall Study|Reason not Specified|1
362538|NCT01007435|1222733|P4|Overall Study|Failure to Return|6
362539|NCT01007435|1222734|P3|Overall Study|Failure to Return|3
362540|NCT01007435|1222735|P2|Overall Study|Failure to Return|4
362541|NCT01007435|1222736|P1|Overall Study|Failure to Return|5
362542|NCT01007435|1222733|P4|Overall Study|Refused Treatment|8
362543|NCT01007435|1222734|P3|Overall Study|Refused Treatment|5
362544|NCT01007435|1222735|P2|Overall Study|Refused Treatment|13
362545|NCT01007435|1222736|P1|Overall Study|Refused Treatment|13
362546|NCT01007435|1222733|P4|Overall Study|Other Protocol Violation|0
362547|NCT01007435|1222734|P3|Overall Study|Other Protocol Violation|1
362548|NCT01007435|1222735|P2|Overall Study|Other Protocol Violation|0
362549|NCT01007435|1222736|P1|Overall Study|Other Protocol Violation|2
362550|NCT01007435|1222733|P4|Overall Study|Violation of Selection Criteria at Entry|0
362551|NCT01007435|1222734|P3|Overall Study|Violation of Selection Criteria at Entry|2
362552|NCT01007435|1222735|P2|Overall Study|Violation of Selection Criteria at Entry|5
362553|NCT01007435|1222736|P1|Overall Study|Violation of Selection Criteria at Entry|3
362554|NCT01007435|1222733|P4|Overall Study|Insufficient Therapeutic Response|9
362555|NCT01007435|1222734|P3|Overall Study|Insufficient Therapeutic Response|2
362556|NCT01007435|1222735|P2|Overall Study|Insufficient Therapeutic Response|7
362557|NCT01007435|1222736|P1|Overall Study|Insufficient Therapeutic Response|21
362558|NCT01007435|1222733|P4|Overall Study|Death|1
362559|NCT01007435|1222734|P3|Overall Study|Death|2
362560|NCT01007435|1222735|P2|Overall Study|Death|4
362561|NCT01007435|1222736|P1|Overall Study|Death|2
362562|NCT01007435|1222733|P4|Overall Study|Adverse Event|31
362563|NCT01007435|1222734|P3|Overall Study|Adverse Event|47
362564|NCT01007435|1222735|P2|Overall Study|Adverse Event|25
362565|NCT01007435|1222736|P1|Overall Study|Adverse Event|16
362566|NCT01007396|1222778|P1|Overall Study|Lost to Follow-up|47
362567|NCT01007253|1222783|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
362568|NCT01007253|1222784|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
362569|NCT01007253|1222785|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
362570|NCT01007253|1222786|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
362571|NCT01007149|1222818|P2|Overall Study|Administrative problems|1
362572|NCT01007149|1222819|P1|Overall Study|Administrative problems|0
362573|NCT01007123|1222845|P4|Overall Study|Lost to Follow-up|0
362574|NCT01007123|1222846|P3|Overall Study|Lost to Follow-up|0
362575|NCT01007123|1222847|P2|Overall Study|Lost to Follow-up|1
362576|NCT01007123|1222848|P1|Overall Study|Lost to Follow-up|0
362577|NCT01007123|1222845|P4|Overall Study|Withdrawal by Subject|0
362578|NCT01007123|1222846|P3|Overall Study|Withdrawal by Subject|1
362579|NCT01007123|1222847|P2|Overall Study|Withdrawal by Subject|0
362580|NCT01007123|1222848|P1|Overall Study|Withdrawal by Subject|1
362581|NCT01007123|1222845|P4|Overall Study|Protocol Violation|1
362582|NCT01007123|1222846|P3|Overall Study|Protocol Violation|2
362583|NCT01007123|1222847|P2|Overall Study|Protocol Violation|1
362584|NCT01007123|1222848|P1|Overall Study|Protocol Violation|1
362585|NCT01007123|1222845|P4|Overall Study|Lack of Efficacy|4
362586|NCT01007123|1222846|P3|Overall Study|Lack of Efficacy|1
362587|NCT01007123|1222847|P2|Overall Study|Lack of Efficacy|0
362588|NCT01007123|1222848|P1|Overall Study|Lack of Efficacy|1
362589|NCT01007123|1222845|P4|Overall Study|Adverse Event|1
362590|NCT01007123|1222846|P3|Overall Study|Adverse Event|7
362591|NCT01007123|1222847|P2|Overall Study|Adverse Event|4
362592|NCT01007123|1222848|P1|Overall Study|Adverse Event|3
362593|NCT01006980|1222907|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
362594|NCT01006980|1222908|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
362595|NCT01006980|1222907|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
362596|NCT01006980|1222908|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
362597|NCT01006980|1222907|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
362598|NCT01006980|1222908|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
362599|NCT01006980|1222907|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
362600|NCT01006980|1222908|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
362601|NCT01006980|1222907|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
362602|NCT01006980|1222908|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
362603|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
362604|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
362605|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
362606|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
362607|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
362608|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
362609|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
362610|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
362611|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Progression|218
362612|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Progression|257
362613|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Death|12
362614|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Death|13
362615|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Adverse Event|5
362616|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Adverse Event|25
362617|NCT01006980|1222907|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
362618|NCT01006980|1222908|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
362619|NCT01006889|1222928|P1|Overall Study|Withdrawal by Subject|3
362620|NCT01006707|1222939|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
362621|NCT01006707|1222940|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
362622|NCT01006707|1222941|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
362623|NCT01006707|1222939|P3|Study Session 1|Lost to Follow-up|0
362624|NCT01006707|1222940|P2|Study Session 1|Lost to Follow-up|0
362625|NCT01006707|1222941|P1|Study Session 1|Lost to Follow-up|2
362626|NCT01006629|1222961|P1|Overall Study|Parent unable to perform site visit|4
362627|NCT01006629|1222961|P1|Overall Study|Parent refused to continue participation|1
362628|NCT01006629|1222961|P1|Overall Study|Adverse Event|1
362629|NCT01006616|1222976|P4|Period 2 (18 Months)|Study Terminated|70
362630|NCT01006616|1222977|P3|Period 2 (18 Months)|Study Terminated|44
362631|NCT01006616|1222978|P2|Period 2 (18 Months)|Study Terminated|46
362632|NCT01006616|1222979|P1|Period 2 (18 Months)|Study Terminated|63
362633|NCT01006616|1222976|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
362634|NCT01006616|1222977|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
362635|NCT01006616|1222978|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
362636|NCT01006616|1222979|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
362637|NCT01006616|1222976|P4|Period 2 (18 Months)|Withdrawal by Subject|1
362638|NCT01006616|1222977|P3|Period 2 (18 Months)|Withdrawal by Subject|0
362639|NCT01006616|1222978|P2|Period 2 (18 Months)|Withdrawal by Subject|4
362640|NCT01006616|1222979|P1|Period 2 (18 Months)|Withdrawal by Subject|1
362641|NCT01006616|1222976|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
362642|NCT01006616|1222977|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
362643|NCT01006616|1222978|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
362644|NCT01006616|1222979|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
362645|NCT01006616|1222976|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
362646|NCT01006616|1222977|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
362647|NCT01006616|1222978|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
362648|NCT01006616|1222979|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
362649|NCT01006616|1222976|P4|Period 2 (18 Months)|Lost to Follow-up|0
362650|NCT01006616|1222977|P3|Period 2 (18 Months)|Lost to Follow-up|0
362651|NCT01006616|1222978|P2|Period 2 (18 Months)|Lost to Follow-up|0
362652|NCT01006616|1222979|P1|Period 2 (18 Months)|Lost to Follow-up|2
362653|NCT01006616|1222976|P4|Period 2 (18 Months)|Lack of Efficacy|2
362654|NCT01006616|1222977|P3|Period 2 (18 Months)|Lack of Efficacy|1
362655|NCT01006616|1222978|P2|Period 2 (18 Months)|Lack of Efficacy|0
362656|NCT01006616|1222979|P1|Period 2 (18 Months)|Lack of Efficacy|0
362657|NCT01006616|1222976|P4|Period 2 (18 Months)|Adverse Event|4
362658|NCT01006616|1222977|P3|Period 2 (18 Months)|Adverse Event|6
362659|NCT01006616|1222978|P2|Period 2 (18 Months)|Adverse Event|6
362660|NCT01006616|1222979|P1|Period 2 (18 Months)|Adverse Event|6
362661|NCT01006616|1222976|P4|Period 1 (6 Months)|Not Treated|1
362662|NCT01006616|1222977|P3|Period 1 (6 Months)|Not Treated|1
362663|NCT01006616|1222978|P2|Period 1 (6 Months)|Not Treated|0
362664|NCT01006616|1222979|P1|Period 1 (6 Months)|Not Treated|0
362665|NCT01006616|1222976|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
362666|NCT01006616|1222977|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
362667|NCT01006616|1222978|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
362668|NCT01006616|1222979|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
362669|NCT01006616|1222976|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
362670|NCT01006616|1222977|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
362671|NCT01006616|1222978|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
362672|NCT01006616|1222979|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
362673|NCT01006616|1222976|P4|Period 1 (6 Months)|Withdrawal by Subject|0
362674|NCT01006616|1222977|P3|Period 1 (6 Months)|Withdrawal by Subject|2
362675|NCT01006616|1222978|P2|Period 1 (6 Months)|Withdrawal by Subject|2
362676|NCT01006616|1222979|P1|Period 1 (6 Months)|Withdrawal by Subject|2
362677|NCT01006616|1222976|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
362678|NCT01006616|1222977|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
362679|NCT01006616|1222978|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
362680|NCT01006616|1222979|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
362681|NCT01006616|1222976|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
362682|NCT01006616|1222977|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
362683|NCT01006616|1222978|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
362684|NCT01006616|1222979|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
362685|NCT01006616|1222976|P4|Period 1 (6 Months)|Lost to Follow-up|0
362686|NCT01006616|1222977|P3|Period 1 (6 Months)|Lost to Follow-up|1
362687|NCT01006616|1222978|P2|Period 1 (6 Months)|Lost to Follow-up|0
362688|NCT01006616|1222979|P1|Period 1 (6 Months)|Lost to Follow-up|0
362689|NCT01006616|1222976|P4|Period 1 (6 Months)|Lack of Efficacy|4
362690|NCT01006616|1222977|P3|Period 1 (6 Months)|Lack of Efficacy|0
362691|NCT01006616|1222978|P2|Period 1 (6 Months)|Lack of Efficacy|4
362692|NCT01006616|1222979|P1|Period 1 (6 Months)|Lack of Efficacy|3
362693|NCT01006616|1222976|P4|Period 1 (6 Months)|Adverse Event|9
362694|NCT01006616|1222977|P3|Period 1 (6 Months)|Adverse Event|37
362695|NCT01006616|1222978|P2|Period 1 (6 Months)|Adverse Event|31
362696|NCT01006616|1222979|P1|Period 1 (6 Months)|Adverse Event|10
362697|NCT01006603|1223115|P2|Overall Study|Other|7
362698|NCT01006603|1223116|P1|Overall Study|Other|3
362699|NCT01006603|1223115|P2|Overall Study|Study specific discontinuation criteria|34
362700|NCT01006603|1223116|P1|Overall Study|Study specific discontinuation criteria|33
362701|NCT01006603|1223115|P2|Overall Study|Death|1
362702|NCT01006603|1223116|P1|Overall Study|Death|1
362703|NCT01006603|1223115|P2|Overall Study|Adverse Event|7
362704|NCT01006603|1223116|P1|Overall Study|Adverse Event|15
362705|NCT01006603|1223115|P2|Overall Study|Incorrect enrolment|2
362706|NCT01006603|1223116|P1|Overall Study|Incorrect enrolment|0
362707|NCT01006603|1223115|P2|Overall Study|Protocol Violation|3
362708|NCT01006603|1223116|P1|Overall Study|Protocol Violation|1
362709|NCT01006603|1223115|P2|Overall Study|Safety reason|1
362710|NCT01006603|1223116|P1|Overall Study|Safety reason|1
362711|NCT01006603|1223115|P2|Overall Study|Lost to Follow-up|1
362712|NCT01006603|1223116|P1|Overall Study|Lost to Follow-up|0
362713|NCT01006603|1223115|P2|Overall Study|Withdrawal by Subject|19
362714|NCT01006603|1223116|P1|Overall Study|Withdrawal by Subject|17
362715|NCT01006590|1223136|P2|Overall Study|Not specified|2
362716|NCT01006590|1223137|P1|Overall Study|Not specified|3
362717|NCT01006590|1223136|P2|Overall Study|Study specific discontinuation criteria|23
362718|NCT01006590|1223137|P1|Overall Study|Study specific discontinuation criteria|16
362719|NCT01006590|1223136|P2|Overall Study|Withdrawal by Subject|2
362720|NCT01006590|1223137|P1|Overall Study|Withdrawal by Subject|4
362721|NCT01006590|1223136|P2|Overall Study|Protocol Violation|0
362722|NCT01006590|1223137|P1|Overall Study|Protocol Violation|1
362723|NCT01006590|1223136|P2|Overall Study|Lost to Follow-up|1
362724|NCT01006590|1223137|P1|Overall Study|Lost to Follow-up|1
362725|NCT01006590|1223136|P2|Overall Study|Death|1
362726|NCT01006590|1223137|P1|Overall Study|Death|1
362727|NCT01006590|1223136|P2|Overall Study|Adverse Event|3
362728|NCT01006590|1223137|P1|Overall Study|Adverse Event|2
362729|NCT01006356|1223153|P1|Overall Study|Other|23
362730|NCT01006356|1223153|P1|Overall Study|Protocol Violation|3
362731|NCT01006356|1223153|P1|Overall Study|Choice by participants|2
362732|NCT01006356|1223153|P1|Overall Study|Withdrawal by Subject|1
362733|NCT01006356|1223153|P1|Overall Study|Paticipants did not cooperate|6
362734|NCT01006356|1223153|P1|Overall Study|Physician Decision|1
362735|NCT01006356|1223153|P1|Overall Study|Adverse Event|6
362736|NCT01006291|1223168|P3|Overall Study|Other|17
362737|NCT01006291|1223169|P2|Overall Study|Other|14
362738|NCT01006291|1223170|P1|Overall Study|Other|14
362739|NCT01006291|1223168|P3|Overall Study|Withdrawal criteria|4
362740|NCT01006291|1223169|P2|Overall Study|Withdrawal criteria|4
362741|NCT01006291|1223170|P1|Overall Study|Withdrawal criteria|5
362742|NCT01006291|1223168|P3|Overall Study|Protocol Violation|3
362743|NCT01006291|1223169|P2|Overall Study|Protocol Violation|3
362744|NCT01006291|1223170|P1|Overall Study|Protocol Violation|3
362745|NCT01006291|1223168|P3|Overall Study|Lack of Efficacy|1
362746|NCT01006291|1223169|P2|Overall Study|Lack of Efficacy|2
362747|NCT01006291|1223170|P1|Overall Study|Lack of Efficacy|2
362748|NCT01006291|1223168|P3|Overall Study|Adverse Event|2
362749|NCT01006291|1223169|P2|Overall Study|Adverse Event|1
362750|NCT01006291|1223170|P1|Overall Study|Adverse Event|2
362751|NCT01006135|1223187|P1|Overall Study|Other|72
362752|NCT01006135|1223187|P1|Overall Study|Lost to Follow-up|32
362753|NCT01006135|1223187|P1|Overall Study|Protocol Violation|14
362754|NCT01006135|1223187|P1|Overall Study|Adverse Event|22
362755|NCT01006122|1223194|P2|Second Double-blind Intervention Period|Death|1
362756|NCT01006122|1223195|P1|Second Double-blind Intervention Period|Death|0
362757|NCT01006122|1223194|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
362758|NCT01006122|1223195|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
362759|NCT01006122|1223194|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
362760|NCT01006122|1223195|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
362761|NCT01006122|1223194|P2|Second Double-blind Intervention Period|Protocol Violation|0
362762|NCT01006122|1223195|P1|Second Double-blind Intervention Period|Protocol Violation|1
362763|NCT01006122|1223194|P2|Second Double-blind Intervention Period|Adverse Event|1
362764|NCT01006122|1223195|P1|Second Double-blind Intervention Period|Adverse Event|1
362765|NCT01006122|1223194|P2|First Double-blind Intervention Period|Adverse Event|4
362766|NCT01006122|1223195|P1|First Double-blind Intervention Period|Adverse Event|0
362767|NCT01006122|1223194|P2|First Double-blind Intervention Period|Other|0
362768|NCT01006122|1223195|P1|First Double-blind Intervention Period|Other|3
362769|NCT01006122|1223194|P2|First Double-blind Intervention Period|Lack of Efficacy|1
362770|NCT01006122|1223195|P1|First Double-blind Intervention Period|Lack of Efficacy|2
362771|NCT01006122|1223194|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
362772|NCT01006122|1223195|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
362773|NCT01006122|1223194|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
362774|NCT01006122|1223195|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
362775|NCT01006122|1223194|P2|First Double-blind Intervention Period|Pregnancy|1
362776|NCT01006122|1223195|P1|First Double-blind Intervention Period|Pregnancy|0
362777|NCT01006122|1223194|P2|First Double-blind Intervention Period|Protocol Violation|1
362778|NCT01006122|1223195|P1|First Double-blind Intervention Period|Protocol Violation|1
362779|NCT01006122|1223194|P2|First Double-blind Intervention Period|Lost to Follow-up|2
362780|NCT01006122|1223195|P1|First Double-blind Intervention Period|Lost to Follow-up|0
362781|NCT01005966|1223246|P5|Treatment Period 4 (14 Days)|Other Reason|1
362782|NCT01005966|1223247|P4|Treatment Period 4 (14 Days)|Other Reason|0
362783|NCT01005966|1223248|P3|Treatment Period 4 (14 Days)|Other Reason|0
362784|NCT01005966|1223249|P2|Treatment Period 4 (14 Days)|Other Reason|0
362785|NCT01005966|1223250|P1|Treatment Period 4 (14 Days)|Other Reason|0
362786|NCT01005966|1223246|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
362787|NCT01005966|1223247|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
362788|NCT01005966|1223248|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
362789|NCT01005966|1223249|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
362790|NCT01005966|1223250|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
362791|NCT01005966|1223246|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
362792|NCT01005966|1223247|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
362793|NCT01005966|1223248|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
362794|NCT01005966|1223249|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
362795|NCT01005966|1223250|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
362796|NCT01005966|1223246|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
362797|NCT01005966|1223247|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
362798|NCT01005966|1223248|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
362799|NCT01005966|1223249|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
362800|NCT01005966|1223250|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
362801|NCT01005966|1223246|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
362802|NCT01005966|1223247|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
362803|NCT01005966|1223248|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
362804|NCT01005966|1223249|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
362805|NCT01005966|1223250|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
362806|NCT01005966|1223246|P5|Treatment Period 2 (14 Days)|Adverse Event|0
362807|NCT01005966|1223247|P4|Treatment Period 2 (14 Days)|Adverse Event|0
362808|NCT01005966|1223248|P3|Treatment Period 2 (14 Days)|Adverse Event|1
362809|NCT01005966|1223249|P2|Treatment Period 2 (14 Days)|Adverse Event|1
362810|NCT01005966|1223250|P1|Treatment Period 2 (14 Days)|Adverse Event|0
362811|NCT01005966|1223246|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
362812|NCT01005966|1223247|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
362813|NCT01005966|1223248|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
362814|NCT01005966|1223249|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
362815|NCT01005966|1223250|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
362816|NCT01005966|1223246|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
362817|NCT01005966|1223247|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
362818|NCT01005966|1223248|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
362819|NCT01005966|1223249|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
362820|NCT01005966|1223250|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
362821|NCT01005966|1223246|P5|Treatment Period 1 (14 Days)|Adverse Event|0
362822|NCT01005966|1223247|P4|Treatment Period 1 (14 Days)|Adverse Event|0
362823|NCT01005966|1223248|P3|Treatment Period 1 (14 Days)|Adverse Event|0
362824|NCT01005966|1223249|P2|Treatment Period 1 (14 Days)|Adverse Event|0
362825|NCT01005966|1223250|P1|Treatment Period 1 (14 Days)|Adverse Event|1
362826|NCT01005914|1223270|P1|Overall Study|Withdrawal by Subject|1
362827|NCT01005914|1223270|P1|Overall Study|Lack of Efficacy|1
362828|NCT01005914|1223270|P1|Overall Study|Death|4
362829|NCT01005914|1223270|P1|Overall Study|Adverse Event|4
362830|NCT01005901|1223276|P2|Overall Study|No longer requires study drug|1
362831|NCT01005901|1223277|P1|Overall Study|No longer requires study drug|0
362832|NCT01005901|1223276|P2|Overall Study|Patient's inability to use the device|1
362833|NCT01005901|1223277|P1|Overall Study|Patient's inability to use the device|1
362834|NCT01005901|1223276|P2|Overall Study|Lost to Follow-up|2
362835|NCT01005901|1223277|P1|Overall Study|Lost to Follow-up|1
362836|NCT01005901|1223276|P2|Overall Study|Death|3
362837|NCT01005901|1223277|P1|Overall Study|Death|2
362838|NCT01005901|1223276|P2|Overall Study|Protocol Violation|3
362839|NCT01005901|1223277|P1|Overall Study|Protocol Violation|4
362840|NCT01005901|1223276|P2|Overall Study|Unsatisfactory therapeutic effect|5
362841|NCT01005901|1223277|P1|Overall Study|Unsatisfactory therapeutic effect|5
362842|NCT01005901|1223276|P2|Overall Study|Administrative problems|13
362843|NCT01005901|1223277|P1|Overall Study|Administrative problems|21
362844|NCT01005901|1223276|P2|Overall Study|Adverse Event|16
362845|NCT01005901|1223277|P1|Overall Study|Adverse Event|30
362846|NCT01005901|1223276|P2|Overall Study|Withdrawal by Subject|14
362847|NCT01005901|1223277|P1|Overall Study|Withdrawal by Subject|38
362848|NCT01005875|1223340|P1|Overall Study|Death|3
362849|NCT01005745|1223348|P1|Overall Study|Inappropriate antidiuretic hormone|1
362850|NCT01005745|1223348|P1|Overall Study|Death prior to treatment|1
362851|NCT01005745|1223348|P1|Overall Study|Disease progressed during TIL growth|3
362852|NCT01005745|1223348|P1|Overall Study|No TIL growth|1
362853|NCT01005732|1223353|P1|Overall Study|Death|1
362854|NCT01005732|1223353|P1|Overall Study|Lost to Follow-up|10
362855|NCT01005719|1223369|P6|Period 2|Adverse Event|1
362856|NCT01005719|1223370|P5|Period 2|Adverse Event|1
362857|NCT01005719|1223371|P4|Period 2|Adverse Event|0
362858|NCT01005719|1223372|P3|Period 2|Adverse Event|0
362859|NCT01005719|1223373|P2|Period 2|Adverse Event|0
362860|NCT01005719|1223374|P1|Period 2|Adverse Event|0
362861|NCT01005719|1223369|P6|Period 1|Delay in completing study procedures|1
362862|NCT01005719|1223370|P5|Period 1|Delay in completing study procedures|0
362863|NCT01005719|1223371|P4|Period 1|Delay in completing study procedures|0
362864|NCT01005719|1223372|P3|Period 1|Delay in completing study procedures|0
362865|NCT01005719|1223373|P2|Period 1|Delay in completing study procedures|0
362866|NCT01005719|1223374|P1|Period 1|Delay in completing study procedures|0
362867|NCT01005719|1223369|P6|Period 1|Adverse Event|0
362868|NCT01005719|1223370|P5|Period 1|Adverse Event|0
362869|NCT01005719|1223371|P4|Period 1|Adverse Event|1
362870|NCT01005719|1223372|P3|Period 1|Adverse Event|0
362871|NCT01005719|1223373|P2|Period 1|Adverse Event|0
362872|NCT01005719|1223374|P1|Period 1|Adverse Event|0
362873|NCT01005680|1223441|P2|Overall Study|Physician Decision|1
362874|NCT01005680|1223442|P1|Overall Study|Physician Decision|1
362875|NCT01005680|1223441|P2|Overall Study|Withdrawal by Subject|4
362876|NCT01005680|1223442|P1|Overall Study|Withdrawal by Subject|1
362877|NCT01005680|1223441|P2|Overall Study|Lost to Follow-up|6
362878|NCT01005680|1223442|P1|Overall Study|Lost to Follow-up|4
362879|NCT01005602|1223466|P2|Overall Study|Excluded due to unreliable clinical data|0
362880|NCT01005602|1223467|P1|Overall Study|Excluded due to unreliable clinical data|1
362881|NCT01005329|1223555|P1|Overall Study|Ineligible or received no protocol trt.|4
362882|NCT01005316|1223568|P4|Overall Study|Retransplanted|0
362883|NCT01005316|1223569|P3|Overall Study|Retransplanted|0
362884|NCT01005316|1223570|P2|Overall Study|Retransplanted|1
362885|NCT01005316|1223571|P1|Overall Study|Retransplanted|0
362886|NCT01005316|1223568|P4|Overall Study|Transferred Care|3
362887|NCT01005316|1223569|P3|Overall Study|Transferred Care|1
362888|NCT01005316|1223570|P2|Overall Study|Transferred Care|0
362889|NCT01005316|1223571|P1|Overall Study|Transferred Care|1
362890|NCT01005316|1223568|P4|Overall Study|Delisted|0
362891|NCT01005316|1223569|P3|Overall Study|Delisted|0
362892|NCT01005316|1223570|P2|Overall Study|Delisted|0
362893|NCT01005316|1223571|P1|Overall Study|Delisted|8
362894|NCT01005316|1223568|P4|Overall Study|Consented to Another Study|0
362895|NCT01005316|1223569|P3|Overall Study|Consented to Another Study|0
362896|NCT01005316|1223570|P2|Overall Study|Consented to Another Study|0
362897|NCT01005316|1223571|P1|Overall Study|Consented to Another Study|2
362898|NCT01005316|1223568|P4|Overall Study|Withdrawal by Subject|2
362899|NCT01005316|1223569|P3|Overall Study|Withdrawal by Subject|0
362900|NCT01005316|1223570|P2|Overall Study|Withdrawal by Subject|1
362901|NCT01005316|1223571|P1|Overall Study|Withdrawal by Subject|1
362902|NCT01005316|1223568|P4|Overall Study|Sponsor Decision|0
362903|NCT01005316|1223569|P3|Overall Study|Sponsor Decision|0
362904|NCT01005316|1223570|P2|Overall Study|Sponsor Decision|3
362905|NCT01005316|1223571|P1|Overall Study|Sponsor Decision|6
362906|NCT01005316|1223568|P4|Overall Study|Physician Decision|0
362907|NCT01005316|1223569|P3|Overall Study|Physician Decision|0
362908|NCT01005316|1223570|P2|Overall Study|Physician Decision|0
362909|NCT01005316|1223571|P1|Overall Study|Physician Decision|6
362910|NCT01005316|1223568|P4|Overall Study|Lost to Follow-up|2
362911|NCT01005316|1223569|P3|Overall Study|Lost to Follow-up|0
362912|NCT01005316|1223570|P2|Overall Study|Lost to Follow-up|3
362913|NCT01005316|1223571|P1|Overall Study|Lost to Follow-up|1
362914|NCT01005316|1223568|P4|Overall Study|Study Termination|85
362915|NCT01005316|1223569|P3|Overall Study|Study Termination|9
362916|NCT01005316|1223570|P2|Overall Study|Study Termination|63
362917|NCT01005316|1223571|P1|Overall Study|Study Termination|5
362918|NCT01005316|1223568|P4|Overall Study|Death|15
362919|NCT01005316|1223569|P3|Overall Study|Death|1
362920|NCT01005316|1223570|P2|Overall Study|Death|5
362921|NCT01005316|1223571|P1|Overall Study|Death|20
362922|NCT01005316|1223568|P4|Overall Study|Adverse Event|1
362923|NCT01005316|1223569|P3|Overall Study|Adverse Event|0
362924|NCT01005316|1223570|P2|Overall Study|Adverse Event|0
362925|NCT01005316|1223571|P1|Overall Study|Adverse Event|0
362926|NCT01005251|1223638|P5|Overall Study|Lack of Efficacy|0
362927|NCT01005251|1223639|P4|Overall Study|Lack of Efficacy|1
362928|NCT01005251|1223640|P3|Overall Study|Lack of Efficacy|1
362929|NCT01005251|1223641|P2|Overall Study|Lack of Efficacy|0
362930|NCT01005251|1223642|P1|Overall Study|Lack of Efficacy|0
362931|NCT01005251|1223638|P5|Overall Study|Randomized in error|0
362932|NCT01005251|1223639|P4|Overall Study|Randomized in error|1
362933|NCT01005251|1223640|P3|Overall Study|Randomized in error|1
362934|NCT01005251|1223641|P2|Overall Study|Randomized in error|0
362935|NCT01005251|1223642|P1|Overall Study|Randomized in error|0
362936|NCT01005251|1223638|P5|Overall Study|Wrong drug dispensed|0
362937|NCT01005251|1223639|P4|Overall Study|Wrong drug dispensed|0
362938|NCT01005251|1223640|P3|Overall Study|Wrong drug dispensed|0
362939|NCT01005251|1223641|P2|Overall Study|Wrong drug dispensed|1
362940|NCT01005251|1223642|P1|Overall Study|Wrong drug dispensed|0
362941|NCT01005251|1223638|P5|Overall Study|Patient moved|0
362942|NCT01005251|1223639|P4|Overall Study|Patient moved|0
362943|NCT01005251|1223640|P3|Overall Study|Patient moved|0
362944|NCT01005251|1223641|P2|Overall Study|Patient moved|0
362945|NCT01005251|1223642|P1|Overall Study|Patient moved|1
362946|NCT01005251|1223638|P5|Overall Study|Physician Decision|2
362947|NCT01005251|1223639|P4|Overall Study|Physician Decision|0
362948|NCT01005251|1223640|P3|Overall Study|Physician Decision|0
362949|NCT01005251|1223641|P2|Overall Study|Physician Decision|0
362950|NCT01005251|1223642|P1|Overall Study|Physician Decision|0
362951|NCT01005251|1223638|P5|Overall Study|Lost to Follow-up|0
362952|NCT01005251|1223639|P4|Overall Study|Lost to Follow-up|0
362953|NCT01005251|1223640|P3|Overall Study|Lost to Follow-up|2
362954|NCT01005251|1223641|P2|Overall Study|Lost to Follow-up|4
362955|NCT01005251|1223642|P1|Overall Study|Lost to Follow-up|1
362956|NCT01005251|1223638|P5|Overall Study|Developed study-specific withdrawal crit|1
362957|NCT01005251|1223639|P4|Overall Study|Developed study-specific withdrawal crit|0
362958|NCT01005251|1223640|P3|Overall Study|Developed study-specific withdrawal crit|3
362959|NCT01005251|1223641|P2|Overall Study|Developed study-specific withdrawal crit|0
362960|NCT01005251|1223642|P1|Overall Study|Developed study-specific withdrawal crit|2
362961|NCT01005251|1223638|P5|Overall Study|Protocol Violation|2
362962|NCT01005251|1223639|P4|Overall Study|Protocol Violation|0
362963|NCT01005251|1223640|P3|Overall Study|Protocol Violation|0
362964|NCT01005251|1223641|P2|Overall Study|Protocol Violation|0
362965|NCT01005251|1223642|P1|Overall Study|Protocol Violation|1
362966|NCT01005251|1223638|P5|Overall Study|Adverse Event|4
362967|NCT01005251|1223639|P4|Overall Study|Adverse Event|5
362968|NCT01005251|1223640|P3|Overall Study|Adverse Event|8
362969|NCT01005251|1223641|P2|Overall Study|Adverse Event|6
362970|NCT01005251|1223642|P1|Overall Study|Adverse Event|2
362971|NCT01005251|1223638|P5|Overall Study|Eligibility criteria not fulfilled|0
362972|NCT01005251|1223639|P4|Overall Study|Eligibility criteria not fulfilled|1
362973|NCT01005251|1223640|P3|Overall Study|Eligibility criteria not fulfilled|4
362974|NCT01005251|1223641|P2|Overall Study|Eligibility criteria not fulfilled|0
362975|NCT01005251|1223642|P1|Overall Study|Eligibility criteria not fulfilled|4
362976|NCT01005251|1223638|P5|Overall Study|Withdrawal by Subject|9
362977|NCT01005251|1223639|P4|Overall Study|Withdrawal by Subject|4
362978|NCT01005251|1223640|P3|Overall Study|Withdrawal by Subject|3
362979|NCT01005251|1223641|P2|Overall Study|Withdrawal by Subject|5
362980|NCT01005251|1223642|P1|Overall Study|Withdrawal by Subject|2
362981|NCT01004848|1223715|P2|Overall Study|Lost to Follow-up|45
362982|NCT01004848|1223716|P1|Overall Study|Lost to Follow-up|55
362983|NCT01004822|1223754|P8|Overall Study|Other|0
362984|NCT01004822|1223755|P7|Overall Study|Other|0
362985|NCT01004822|1223756|P6|Overall Study|Other|1
362986|NCT01004822|1223757|P5|Overall Study|Other|0
362987|NCT01004822|1223758|P4|Overall Study|Other|1
362988|NCT01004822|1223759|P3|Overall Study|Other|4
362989|NCT01004822|1223760|P2|Overall Study|Other|0
362990|NCT01004822|1223761|P1|Overall Study|Other|0
362991|NCT01004822|1223754|P8|Overall Study|Adverse Event|1
362992|NCT01004822|1223755|P7|Overall Study|Adverse Event|1
362993|NCT01004822|1223756|P6|Overall Study|Adverse Event|0
362994|NCT01004822|1223757|P5|Overall Study|Adverse Event|0
362995|NCT01004822|1223758|P4|Overall Study|Adverse Event|0
362996|NCT01004822|1223759|P3|Overall Study|Adverse Event|0
362997|NCT01004822|1223760|P2|Overall Study|Adverse Event|0
362998|NCT01004822|1223761|P1|Overall Study|Adverse Event|0
362999|NCT01004822|1223754|P8|Overall Study|No longer willing to continue|0
363000|NCT01004822|1223755|P7|Overall Study|No longer willing to continue|1
363001|NCT01004822|1223756|P6|Overall Study|No longer willing to continue|1
363002|NCT01004822|1223757|P5|Overall Study|No longer willing to continue|2
363003|NCT01004822|1223758|P4|Overall Study|No longer willing to continue|1
363004|NCT01004822|1223759|P3|Overall Study|No longer willing to continue|0
363005|NCT01004822|1223760|P2|Overall Study|No longer willing to continue|0
363006|NCT01004822|1223761|P1|Overall Study|No longer willing to continue|0
363007|NCT01004822|1223754|P8|Overall Study|Global deterioration of health status|0
363008|NCT01004822|1223755|P7|Overall Study|Global deterioration of health status|1
363009|NCT01004822|1223756|P6|Overall Study|Global deterioration of health status|0
363010|NCT01004822|1223757|P5|Overall Study|Global deterioration of health status|0
363011|NCT01004822|1223758|P4|Overall Study|Global deterioration of health status|1
363012|NCT01004822|1223759|P3|Overall Study|Global deterioration of health status|0
363013|NCT01004822|1223760|P2|Overall Study|Global deterioration of health status|0
363014|NCT01004822|1223761|P1|Overall Study|Global deterioration of health status|0
363015|NCT01004822|1223754|P8|Overall Study|Objective progression or relapse|4
363016|NCT01004822|1223755|P7|Overall Study|Objective progression or relapse|1
363017|NCT01004822|1223756|P6|Overall Study|Objective progression or relapse|2
363018|NCT01004822|1223757|P5|Overall Study|Objective progression or relapse|2
363019|NCT01004822|1223758|P4|Overall Study|Objective progression or relapse|1
363020|NCT01004822|1223759|P3|Overall Study|Objective progression or relapse|0
363021|NCT01004822|1223760|P2|Overall Study|Objective progression or relapse|3
363022|NCT01004822|1223761|P1|Overall Study|Objective progression or relapse|3
363023|NCT01004614|1223926|P4|Washout|Withdrawal by Subject|0
363024|NCT01004614|1223927|P3|Washout|Withdrawal by Subject|0
363025|NCT01004614|1223928|P2|Washout|Withdrawal by Subject|1
363026|NCT01004614|1223929|P1|Washout|Withdrawal by Subject|0
363027|NCT01004510|1223963|P1|Overall Study|Adverse Event|1
363028|NCT01004432|1223967|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
363029|NCT01004432|1223968|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
363030|NCT01004432|1223969|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
363031|NCT01004432|1223970|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
363032|NCT01004432|1223971|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
363033|NCT01004432|1223967|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
363034|NCT01004432|1223968|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
363035|NCT01004432|1223969|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
363036|NCT01004432|1223970|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
363037|NCT01004432|1223971|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
363038|NCT01004432|1223967|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
363039|NCT01004432|1223968|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
363040|NCT01004432|1223969|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
363041|NCT01004432|1223970|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
363042|NCT01004432|1223971|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
363043|NCT01004432|1223967|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
363044|NCT01004432|1223968|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
363045|NCT01004432|1223969|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
363046|NCT01004432|1223970|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
363047|NCT01004432|1223971|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
363048|NCT01004432|1223967|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
363049|NCT01004432|1223968|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
363050|NCT01004432|1223969|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
363051|NCT01004432|1223970|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
363052|NCT01004432|1223971|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
363053|NCT01004432|1223967|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
363054|NCT01004432|1223968|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
363055|NCT01004432|1223969|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
363056|NCT01004432|1223970|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
363057|NCT01004432|1223971|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
363058|NCT01004432|1223967|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
363059|NCT01004432|1223968|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
363060|NCT01004432|1223969|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
363061|NCT01004432|1223970|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
363062|NCT01004432|1223971|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
363063|NCT01004432|1223967|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
363064|NCT01004432|1223968|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
363065|NCT01004432|1223969|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
363066|NCT01004432|1223970|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
363067|NCT01004432|1223971|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
363068|NCT01004432|1223967|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
363069|NCT01004432|1223968|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
363070|NCT01004432|1223969|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
363071|NCT01004432|1223970|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
363072|NCT01004432|1223971|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
363073|NCT01004432|1223967|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
363074|NCT01004432|1223968|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
363075|NCT01004432|1223969|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
363076|NCT01004432|1223970|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
363077|NCT01004432|1223971|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
363159|NCT01004003|1224072|P9|Overall Study|Adverse Event|6
363078|NCT01004432|1223967|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
363079|NCT01004432|1223968|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
363080|NCT01004432|1223969|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
363081|NCT01004432|1223970|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
363082|NCT01004432|1223971|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
363083|NCT01004432|1223967|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
363084|NCT01004432|1223968|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
363085|NCT01004432|1223969|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
363086|NCT01004432|1223970|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
363087|NCT01004432|1223971|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
363088|NCT01004432|1223967|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
363089|NCT01004432|1223968|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
363090|NCT01004432|1223969|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
363091|NCT01004432|1223970|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
363092|NCT01004432|1223971|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
363093|NCT01004432|1223967|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
363094|NCT01004432|1223968|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
363095|NCT01004432|1223969|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
363096|NCT01004432|1223970|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
363097|NCT01004432|1223971|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
363098|NCT01004432|1223967|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
363099|NCT01004432|1223968|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
363100|NCT01004432|1223969|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
363101|NCT01004432|1223970|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
363102|NCT01004432|1223971|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
363103|NCT01004263|1224014|P1|Overall Study|Lack of Qualifying Event|2
363104|NCT01004263|1224014|P1|Overall Study|Physician Decision|15
363105|NCT01004263|1224014|P1|Overall Study|Pregnancy|2
363106|NCT01004263|1224014|P1|Overall Study|Lack of Efficacy|13
363107|NCT01004263|1224014|P1|Overall Study|Lost to Follow-up|64
363108|NCT01004263|1224014|P1|Overall Study|Protocol Violation|10
363109|NCT01004263|1224014|P1|Overall Study|Withdrawal by Subject|58
363110|NCT01004263|1224014|P1|Overall Study|Adverse Event|15
363111|NCT01004250|1224022|P1|Follow-Up (FU) Period|Lost to Follow-up|1
363112|NCT01004250|1224022|P1|Maintenance Therapy Period|Physician Decision|4
363113|NCT01004250|1224022|P1|Maintenance Therapy Period|Withdrawal by Subject|5
363114|NCT01004250|1224022|P1|Maintenance Therapy Period|Protocol Violation|1
363115|NCT01004250|1224022|P1|Maintenance Therapy Period|Lost to Follow-up|1
363116|NCT01004250|1224022|P1|Maintenance Therapy Period|Adverse Event|15
363117|NCT01004250|1224022|P1|Induction Therapy Period|Physician Decision|2
363118|NCT01004250|1224022|P1|Induction Therapy Period|Withdrawal by Subject|2
363119|NCT01004250|1224022|P1|Induction Therapy Period|Entry Criteria Not Met|1
363120|NCT01004250|1224022|P1|Induction Therapy Period|Adverse Event|10
363121|NCT01004185|1224034|P2|Overall Study|Withdrawal by Subject|1
363122|NCT01004185|1224035|P1|Overall Study|Withdrawal by Subject|2
363123|NCT01004185|1224034|P2|Overall Study|Sponsor Terminated Study|5
363124|NCT01004185|1224035|P1|Overall Study|Sponsor Terminated Study|4
363125|NCT01004185|1224034|P2|Overall Study|Lack of Efficacy|1
363126|NCT01004185|1224035|P1|Overall Study|Lack of Efficacy|2
363127|NCT01004185|1224034|P2|Overall Study|Lost to Follow-up|1
363128|NCT01004185|1224035|P1|Overall Study|Lost to Follow-up|0
363129|NCT01004185|1224034|P2|Overall Study|Adverse Event|1
363130|NCT01004185|1224035|P1|Overall Study|Adverse Event|1
363131|NCT01004172|1224043|P1|Overall Study|Symptomatic Deterioration|2
363132|NCT01004172|1224043|P1|Overall Study|Physician Decision|1
363133|NCT01004172|1224043|P1|Overall Study|Adverse Event|1
363134|NCT01004172|1224043|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
363135|NCT01004172|1224043|P1|Overall Study|Progressive Disease in Non-CNS Only|16
363136|NCT01004172|1224043|P1|Overall Study|Progressive Disease in CNS Only|16
363137|NCT01004159|1224049|P1|Overall Study|Disease Progression|18
363138|NCT01004159|1224049|P1|Overall Study|Adverse Event|2
363139|NCT01004146|1224056|P2|Overall Study|Withdrawal by Subject|5
363140|NCT01004146|1224057|P1|Overall Study|Withdrawal by Subject|4
363141|NCT01004003|1224072|P9|Overall Study|Other|0
363142|NCT01004003|1224073|P8|Overall Study|Other|0
363143|NCT01004003|1224074|P7|Overall Study|Other|0
363144|NCT01004003|1224075|P6|Overall Study|Other|1
363145|NCT01004003|1224076|P5|Overall Study|Other|0
363146|NCT01004003|1224077|P4|Overall Study|Other|0
363147|NCT01004003|1224078|P3|Overall Study|Other|0
363148|NCT01004003|1224079|P2|Overall Study|Other|0
363149|NCT01004003|1224080|P1|Overall Study|Other|0
363150|NCT01004003|1224072|P9|Overall Study|Refused to continue taking trial med.|2
363151|NCT01004003|1224073|P8|Overall Study|Refused to continue taking trial med.|0
363152|NCT01004003|1224074|P7|Overall Study|Refused to continue taking trial med.|0
363153|NCT01004003|1224075|P6|Overall Study|Refused to continue taking trial med.|0
363154|NCT01004003|1224076|P5|Overall Study|Refused to continue taking trial med.|0
363155|NCT01004003|1224077|P4|Overall Study|Refused to continue taking trial med.|0
363156|NCT01004003|1224078|P3|Overall Study|Refused to continue taking trial med.|0
363157|NCT01004003|1224079|P2|Overall Study|Refused to continue taking trial med.|0
363158|NCT01004003|1224080|P1|Overall Study|Refused to continue taking trial med.|0
363160|NCT01004003|1224073|P8|Overall Study|Adverse Event|21
363161|NCT01004003|1224074|P7|Overall Study|Adverse Event|7
363162|NCT01004003|1224075|P6|Overall Study|Adverse Event|2
363163|NCT01004003|1224076|P5|Overall Study|Adverse Event|2
363164|NCT01004003|1224077|P4|Overall Study|Adverse Event|3
363165|NCT01004003|1224078|P3|Overall Study|Adverse Event|3
363166|NCT01004003|1224079|P2|Overall Study|Adverse Event|2
363167|NCT01004003|1224080|P1|Overall Study|Adverse Event|4
363168|NCT01004003|1224072|P9|Overall Study|Progressive disease|22
363169|NCT01004003|1224073|P8|Overall Study|Progressive disease|39
363170|NCT01004003|1224074|P7|Overall Study|Progressive disease|1
363171|NCT01004003|1224075|P6|Overall Study|Progressive disease|1
363172|NCT01004003|1224076|P5|Overall Study|Progressive disease|2
363173|NCT01004003|1224077|P4|Overall Study|Progressive disease|0
363174|NCT01004003|1224078|P3|Overall Study|Progressive disease|1
363175|NCT01004003|1224079|P2|Overall Study|Progressive disease|1
363176|NCT01004003|1224080|P1|Overall Study|Progressive disease|2
363177|NCT01003990|1224111|P3|Overall Study|Subject Withdrew Consent|7
363178|NCT01003990|1224112|P2|Overall Study|Subject Withdrew Consent|5
363179|NCT01003990|1224113|P1|Overall Study|Subject Withdrew Consent|12
363180|NCT01003990|1224111|P3|Overall Study|No Longer Met Study Criteria|0
363181|NCT01003990|1224112|P2|Overall Study|No Longer Met Study Criteria|1
363182|NCT01003990|1224113|P1|Overall Study|No Longer Met Study Criteria|4
363183|NCT01003990|1224111|P3|Overall Study|Pregnancy|4
363184|NCT01003990|1224112|P2|Overall Study|Pregnancy|2
363185|NCT01003990|1224113|P1|Overall Study|Pregnancy|10
363186|NCT01003990|1224111|P3|Overall Study|Poor/Non-compliance|2
363187|NCT01003990|1224112|P2|Overall Study|Poor/Non-compliance|3
363188|NCT01003990|1224113|P1|Overall Study|Poor/Non-compliance|4
363189|NCT01003990|1224111|P3|Overall Study|Reasons Not Identified|8
363190|NCT01003990|1224112|P2|Overall Study|Reasons Not Identified|13
363191|NCT01003990|1224113|P1|Overall Study|Reasons Not Identified|14
363192|NCT01003990|1224111|P3|Overall Study|Lost to Follow-up|7
363193|NCT01003990|1224112|P2|Overall Study|Lost to Follow-up|12
363194|NCT01003990|1224113|P1|Overall Study|Lost to Follow-up|30
363195|NCT01003990|1224111|P3|Overall Study|Lack of Efficacy|3
363196|NCT01003990|1224112|P2|Overall Study|Lack of Efficacy|2
363197|NCT01003990|1224113|P1|Overall Study|Lack of Efficacy|10
363198|NCT01003990|1224111|P3|Overall Study|Death|1
363199|NCT01003990|1224112|P2|Overall Study|Death|8
363200|NCT01003990|1224113|P1|Overall Study|Death|0
363201|NCT01003990|1224111|P3|Overall Study|Adverse Event|11
363202|NCT01003990|1224112|P2|Overall Study|Adverse Event|5
363203|NCT01003990|1224113|P1|Overall Study|Adverse Event|8
363204|NCT01003899|1224130|P1|Overall Study|Progressive disease|34
363205|NCT01003899|1224130|P1|Overall Study|Not treated|1
363206|NCT01003899|1224130|P1|Overall Study|Not entered|4
363207|NCT01003899|1224130|P1|Overall Study|Other Adverse Event|8
363208|NCT01003886|1224139|P1|Overall Study|Adverse Event|3
363209|NCT01003886|1224139|P1|Overall Study|Other|14
363210|NCT01003886|1224139|P1|Overall Study|Withdrawal by Subject|39
363211|NCT01003886|1224139|P1|Overall Study|Lost to Follow-up|169
363212|NCT01003886|1224139|P1|Overall Study|Lack of Efficacy|5
363213|NCT01003249|1224173|P2|Second Intervention (4 Weeks)|Adverse Event|0
363214|NCT01003249|1224174|P1|Second Intervention (4 Weeks)|Adverse Event|1
363215|NCT01003249|1224173|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
363216|NCT01003249|1224174|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
363217|NCT01003249|1224173|P2|First Intervention (4 Weeks)|Non-Serious Event|1
363218|NCT01003249|1224174|P1|First Intervention (4 Weeks)|Non-Serious Event|1
363219|NCT01003249|1224173|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
363220|NCT01003249|1224174|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
363221|NCT01003210|1224192|P2|Overall Study|Lost to Follow-up|3
363222|NCT01003210|1224193|P1|Overall Study|Lost to Follow-up|1
363223|NCT01003184|1224205|P2|Overall Study|Physician Decision|0
363224|NCT01003184|1224206|P1|Overall Study|Physician Decision|1
363225|NCT01003184|1224205|P2|Overall Study|Withdrawal by Subject|6
363226|NCT01003184|1224206|P1|Overall Study|Withdrawal by Subject|1
363227|NCT01003184|1224205|P2|Overall Study|Protocol Violation|0
363228|NCT01003184|1224206|P1|Overall Study|Protocol Violation|3
363229|NCT01003184|1224205|P2|Overall Study|Loss of glucose control|1
363230|NCT01003184|1224206|P1|Overall Study|Loss of glucose control|1
363231|NCT01003184|1224205|P2|Overall Study|Lost to Follow-up|0
363232|NCT01003184|1224206|P1|Overall Study|Lost to Follow-up|1
363233|NCT01003184|1224205|P2|Overall Study|Adverse Event|5
363234|NCT01003184|1224206|P1|Overall Study|Adverse Event|12
363235|NCT01002989|1224289|P1|Overall Study|exclusion criteria, no consent|5
363236|NCT01002742|1224298|P2|Overall Study|Determined to be ineligible|1
363237|NCT01002742|1224299|P1|Overall Study|Determined to be ineligible|0
363238|NCT01002573|1224335|P2|Overall Study|Subject did not receive at least 1 dose|7
363239|NCT01002573|1224336|P1|Overall Study|Subject did not receive at least 1 dose|11
363240|NCT01002482|1224356|P2|Overall Study|Included twice|0
363241|NCT01002482|1224357|P1|Overall Study|Included twice|1
363242|NCT01002482|1224356|P2|Overall Study|Withdrawal by Subject|21
363243|NCT01002482|1224357|P1|Overall Study|Withdrawal by Subject|14
363244|NCT01002339|1224391|P3|Overall Study|Randomized. Not transplanted|1
363245|NCT01002339|1224392|P2|Overall Study|Randomized. Not transplanted|0
363246|NCT01002339|1224393|P1|Overall Study|Randomized. Not transplanted|0
363247|NCT01002339|1224391|P3|Overall Study|Lung cancer detected before transplant|1
363248|NCT01002339|1224392|P2|Overall Study|Lung cancer detected before transplant|0
363249|NCT01002339|1224393|P1|Overall Study|Lung cancer detected before transplant|0
363250|NCT01002339|1224391|P3|Overall Study|Protocol Violation|2
363251|NCT01002339|1224392|P2|Overall Study|Protocol Violation|0
363252|NCT01002339|1224393|P1|Overall Study|Protocol Violation|0
363253|NCT01002339|1224391|P3|Overall Study|Incorrect treatment assignment|1
363254|NCT01002339|1224392|P2|Overall Study|Incorrect treatment assignment|0
363255|NCT01002339|1224393|P1|Overall Study|Incorrect treatment assignment|0
363256|NCT01002339|1224391|P3|Overall Study|Withdrawal by Subject|0
363257|NCT01002339|1224392|P2|Overall Study|Withdrawal by Subject|1
363258|NCT01002339|1224393|P1|Overall Study|Withdrawal by Subject|0
363259|NCT01002105|1224469|P2|Overall Study|condition worsened|2
363260|NCT01002105|1224470|P1|Overall Study|condition worsened|4
363261|NCT01002105|1224469|P2|Overall Study|non compliance|3
363262|NCT01002105|1224470|P1|Overall Study|non compliance|5
363263|NCT01002105|1224469|P2|Overall Study|Lost to Follow-up|16
363264|NCT01002105|1224470|P1|Overall Study|Lost to Follow-up|10
363265|NCT01001988|1224486|P1|Overall Study|Lost to Follow-up|15
363266|NCT01001988|1224486|P1|Overall Study|Withdrawal by Subject|18
363267|NCT01001988|1224486|P1|Overall Study|Protocol Violation|84
363268|NCT01001832|1224504|P2|Follow-up Period|Not specified|1
363269|NCT01001832|1224505|P1|Follow-up Period|Not specified|2
363270|NCT01001832|1224504|P2|Follow-up Period|Follow-up no longer required /protocol|20
363271|NCT01001832|1224505|P1|Follow-up Period|Follow-up no longer required /protocol|15
363272|NCT01001832|1224504|P2|Follow-up Period|Withdrawal by Subject|0
363273|NCT01001832|1224505|P1|Follow-up Period|Withdrawal by Subject|1
363274|NCT01001832|1224504|P2|Long-term Period|Not specified|2
363275|NCT01001832|1224505|P1|Long-term Period|Not specified|1
363276|NCT01001832|1224504|P2|Long-term Period|Lack of Efficacy|2
363277|NCT01001832|1224505|P1|Long-term Period|Lack of Efficacy|0
363278|NCT01001832|1224504|P2|Long-term Period|Withdrawal by Subject|0
363279|NCT01001832|1224505|P1|Long-term Period|Withdrawal by Subject|1
363280|NCT01001832|1224504|P2|Long-term Period|Adverse Event|1
363281|NCT01001832|1224505|P1|Long-term Period|Adverse Event|2
363282|NCT01001832|1224504|P2|Short-term Period|Adverse Event|3
363283|NCT01001832|1224505|P1|Short-term Period|Adverse Event|2
363284|NCT01001767|1224563|P2|Overall Study|Physician Decision|0
363285|NCT01001767|1224564|P1|Overall Study|Physician Decision|1
363286|NCT01001767|1224563|P2|Overall Study|Lost to Follow-up|0
363287|NCT01001767|1224564|P1|Overall Study|Lost to Follow-up|1
363288|NCT01001767|1224563|P2|Overall Study|Protocol Violation|0
363289|NCT01001767|1224564|P1|Overall Study|Protocol Violation|1
363290|NCT01001767|1224563|P2|Overall Study|no baseline study performed|0
363291|NCT01001767|1224564|P1|Overall Study|no baseline study performed|1
363292|NCT01001702|1224570|P1|Overall Study|Lack of Efficacy per Investigator|3
363293|NCT01001702|1224570|P1|Overall Study|Withdrawal by Subject|19
363294|NCT01001702|1224570|P1|Overall Study|Investigator withdrew Subject|10
363295|NCT01001702|1224570|P1|Overall Study|Subject met Withdrawal Criteria|22
363296|NCT01001702|1224570|P1|Overall Study|Sponsor Discontinued Study|4
363297|NCT01001702|1224570|P1|Overall Study|Adverse Event|7
363298|NCT01001702|1224570|P1|Overall Study|Lost to Follow-up|7
363299|NCT01001572|1224583|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
363300|NCT01001572|1224584|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
363301|NCT01001572|1224585|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
363302|NCT01001572|1224583|P3|Double-Blind Treatment Phase|Protocol deviation|1
363303|NCT01001572|1224584|P2|Double-Blind Treatment Phase|Protocol deviation|0
363304|NCT01001572|1224585|P1|Double-Blind Treatment Phase|Protocol deviation|0
363305|NCT01001572|1224583|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
363306|NCT01001572|1224584|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
363307|NCT01001572|1224585|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
363308|NCT01001572|1224583|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
363309|NCT01001572|1224584|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
363310|NCT01001572|1224585|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
363311|NCT01001572|1224583|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
363312|NCT01001572|1224584|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
363313|NCT01001572|1224585|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
363314|NCT01001572|1224583|P3|Double-Blind Treatment Phase|Adverse Event|2
363315|NCT01001572|1224584|P2|Double-Blind Treatment Phase|Adverse Event|2
363316|NCT01001572|1224585|P1|Double-Blind Treatment Phase|Adverse Event|0
363317|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
363318|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
363319|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
363320|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
363321|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
363322|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
363323|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
363324|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
363325|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
363326|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
363409|NCT01001234|1224858|P1|Overall Study|Not Treated: Pregnancy|3
363327|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
363328|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
363329|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
363330|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
363331|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
363332|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
363333|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
363334|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
363335|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
363336|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
363337|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
363338|NCT01001572|1224583|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
363339|NCT01001572|1224584|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
363340|NCT01001572|1224585|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
363341|NCT01001520|1224623|P2|Medication Period 2|Withdrawal by Subject|3
363342|NCT01001520|1224624|P1|Medication Period 2|Withdrawal by Subject|0
363343|NCT01001520|1224623|P2|Washout Period|Withdrawal by Subject|1
363344|NCT01001520|1224624|P1|Washout Period|Withdrawal by Subject|2
363345|NCT01001520|1224623|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
363346|NCT01001520|1224624|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
363347|NCT01001520|1224623|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
363348|NCT01001520|1224624|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
363349|NCT01001520|1224623|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
363350|NCT01001520|1224624|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
363351|NCT01001520|1224623|P2|Medication Period 1|Withdrawal by Subject|2
363352|NCT01001520|1224624|P1|Medication Period 1|Withdrawal by Subject|2
363353|NCT01001494|1224651|P3|Overall Study|Other|3
363354|NCT01001494|1224652|P2|Overall Study|Other|1
363355|NCT01001494|1224653|P1|Overall Study|Other|0
363356|NCT01001494|1224651|P3|Overall Study|Lack of Efficacy|8
363357|NCT01001494|1224652|P2|Overall Study|Lack of Efficacy|0
363358|NCT01001494|1224653|P1|Overall Study|Lack of Efficacy|2
363359|NCT01001494|1224651|P3|Overall Study|COPD exacerbation|5
363360|NCT01001494|1224652|P2|Overall Study|COPD exacerbation|4
363361|NCT01001494|1224653|P1|Overall Study|COPD exacerbation|3
363362|NCT01001494|1224651|P3|Overall Study|Withdrawal by Subject|17
363363|NCT01001494|1224652|P2|Overall Study|Withdrawal by Subject|7
363364|NCT01001494|1224653|P1|Overall Study|Withdrawal by Subject|9
363365|NCT01001494|1224651|P3|Overall Study|Lost to Follow-up|1
363366|NCT01001494|1224652|P2|Overall Study|Lost to Follow-up|0
363367|NCT01001494|1224653|P1|Overall Study|Lost to Follow-up|2
363368|NCT01001494|1224651|P3|Overall Study|Protocol Violation|1
363369|NCT01001494|1224652|P2|Overall Study|Protocol Violation|1
363370|NCT01001494|1224653|P1|Overall Study|Protocol Violation|0
363371|NCT01001494|1224651|P3|Overall Study|Adverse Event|6
363372|NCT01001494|1224652|P2|Overall Study|Adverse Event|4
363373|NCT01001494|1224653|P1|Overall Study|Adverse Event|8
363374|NCT01001429|1224738|P2|Overall Study|surgery cancelled|1
363375|NCT01001429|1224739|P1|Overall Study|surgery cancelled|0
363376|NCT01001390|1224778|P2|Overall Study|Failure to wear AFO device|0
363377|NCT01001390|1224779|P1|Overall Study|Failure to wear AFO device|2
363378|NCT01001377|1224787|P2|Overall Study|Death|384
363379|NCT01001377|1224788|P1|Overall Study|Death|391
363380|NCT01001377|1224787|P2|Overall Study|Lost to Follow-up|17
363381|NCT01001377|1224788|P1|Overall Study|Lost to Follow-up|14
363382|NCT01001377|1224787|P2|Overall Study|Withdrawal by Subject|20
363383|NCT01001377|1224788|P1|Overall Study|Withdrawal by Subject|19
363384|NCT01001377|1224787|P2|Overall Study|Ineligibility determined|0
363385|NCT01001377|1224788|P1|Overall Study|Ineligibility determined|2
363386|NCT01001325|1224818|P2|Overall Study|Protocol Violation|0
363387|NCT01001325|1224819|P1|Overall Study|Protocol Violation|2
363388|NCT01001325|1224818|P2|Overall Study|Lost to Follow-up|10
363389|NCT01001325|1224819|P1|Overall Study|Lost to Follow-up|16
363390|NCT01001299|1224825|P1|Overall Study|Withdrew Consent|1
363391|NCT01001299|1224825|P1|Overall Study|Began Taking Commercially Available Drug|2
363392|NCT01001299|1224825|P1|Overall Study|Death|1
363393|NCT01001299|1224825|P1|Overall Study|Adverse event or Intercurrent Illness|1
363394|NCT01001299|1224825|P1|Overall Study|Insufficient Therapeutic Response|20
363395|NCT01001234|1224854|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
363396|NCT01001234|1224855|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
363397|NCT01001234|1224856|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
363398|NCT01001234|1224857|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
363399|NCT01001234|1224858|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
363400|NCT01001234|1224854|P5|Overall Study|Not Treated: Physician Decision|0
363401|NCT01001234|1224855|P4|Overall Study|Not Treated: Physician Decision|0
363402|NCT01001234|1224856|P3|Overall Study|Not Treated: Physician Decision|0
363403|NCT01001234|1224857|P2|Overall Study|Not Treated: Physician Decision|4
363404|NCT01001234|1224858|P1|Overall Study|Not Treated: Physician Decision|37
363405|NCT01001234|1224854|P5|Overall Study|Not Treated: Pregnancy|0
363406|NCT01001234|1224855|P4|Overall Study|Not Treated: Pregnancy|0
363407|NCT01001234|1224856|P3|Overall Study|Not Treated: Pregnancy|0
363408|NCT01001234|1224857|P2|Overall Study|Not Treated: Pregnancy|0
363410|NCT01001234|1224854|P5|Overall Study|Not Treated: Lost to Follow-up|0
363411|NCT01001234|1224855|P4|Overall Study|Not Treated: Lost to Follow-up|5
363412|NCT01001234|1224856|P3|Overall Study|Not Treated: Lost to Follow-up|7
363413|NCT01001234|1224857|P2|Overall Study|Not Treated: Lost to Follow-up|4
363414|NCT01001234|1224858|P1|Overall Study|Not Treated: Lost to Follow-up|53
363415|NCT01001234|1224854|P5|Overall Study|Not Treated: Protocol Violation|0
363416|NCT01001234|1224855|P4|Overall Study|Not Treated: Protocol Violation|0
363417|NCT01001234|1224856|P3|Overall Study|Not Treated: Protocol Violation|0
363418|NCT01001234|1224857|P2|Overall Study|Not Treated: Protocol Violation|0
363419|NCT01001234|1224858|P1|Overall Study|Not Treated: Protocol Violation|3
363420|NCT01001234|1224854|P5|Overall Study|Not Treated: Withdrawal by Subject|0
363421|NCT01001234|1224855|P4|Overall Study|Not Treated: Withdrawal by Subject|0
363422|NCT01001234|1224856|P3|Overall Study|Not Treated: Withdrawal by Subject|2
363423|NCT01001234|1224857|P2|Overall Study|Not Treated: Withdrawal by Subject|2
363424|NCT01001234|1224858|P1|Overall Study|Not Treated: Withdrawal by Subject|23
363425|NCT01001234|1224854|P5|Overall Study|Not Treated: Adverse Event|0
363426|NCT01001234|1224855|P4|Overall Study|Not Treated: Adverse Event|0
363427|NCT01001234|1224856|P3|Overall Study|Not Treated: Adverse Event|0
363428|NCT01001234|1224857|P2|Overall Study|Not Treated: Adverse Event|0
363429|NCT01001234|1224858|P1|Overall Study|Not Treated: Adverse Event|1
363430|NCT01001234|1224854|P5|Overall Study|Physician Decision|0
363431|NCT01001234|1224855|P4|Overall Study|Physician Decision|0
363432|NCT01001234|1224856|P3|Overall Study|Physician Decision|0
363433|NCT01001234|1224857|P2|Overall Study|Physician Decision|0
363434|NCT01001234|1224858|P1|Overall Study|Physician Decision|1
363435|NCT01001234|1224854|P5|Overall Study|Lost to Follow-up|0
363436|NCT01001234|1224855|P4|Overall Study|Lost to Follow-up|2
363437|NCT01001234|1224856|P3|Overall Study|Lost to Follow-up|1
363438|NCT01001234|1224857|P2|Overall Study|Lost to Follow-up|0
363439|NCT01001234|1224858|P1|Overall Study|Lost to Follow-up|0
363440|NCT01001234|1224854|P5|Overall Study|Protocol Violation|0
363441|NCT01001234|1224855|P4|Overall Study|Protocol Violation|18
363442|NCT01001234|1224856|P3|Overall Study|Protocol Violation|19
363443|NCT01001234|1224857|P2|Overall Study|Protocol Violation|3
363444|NCT01001234|1224858|P1|Overall Study|Protocol Violation|34
363445|NCT01001234|1224854|P5|Overall Study|Withdrawal by Subject|0
363446|NCT01001234|1224855|P4|Overall Study|Withdrawal by Subject|0
363447|NCT01001234|1224856|P3|Overall Study|Withdrawal by Subject|3
363448|NCT01001234|1224857|P2|Overall Study|Withdrawal by Subject|0
363449|NCT01001234|1224858|P1|Overall Study|Withdrawal by Subject|2
363450|NCT01001221|1224874|P5|Overall Study|Not treated; protocol exclusion|0
363451|NCT01001221|1224875|P4|Overall Study|Not treated; protocol exclusion|0
363452|NCT01001221|1224876|P3|Overall Study|Not treated; protocol exclusion|1
363453|NCT01001221|1224877|P2|Overall Study|Not treated; protocol exclusion|0
363454|NCT01001221|1224878|P1|Overall Study|Not treated; protocol exclusion|0
363455|NCT01001221|1224874|P5|Overall Study|Not specified|0
363456|NCT01001221|1224875|P4|Overall Study|Not specified|0
363457|NCT01001221|1224876|P3|Overall Study|Not specified|0
363458|NCT01001221|1224877|P2|Overall Study|Not specified|1
363459|NCT01001221|1224878|P1|Overall Study|Not specified|1
363460|NCT01001221|1224874|P5|Overall Study|Disease progression|0
363461|NCT01001221|1224875|P4|Overall Study|Disease progression|4
363462|NCT01001221|1224876|P3|Overall Study|Disease progression|2
363463|NCT01001221|1224877|P2|Overall Study|Disease progression|2
363464|NCT01001221|1224878|P1|Overall Study|Disease progression|3
363465|NCT01001221|1224874|P5|Overall Study|Adverse Event|0
363466|NCT01001221|1224875|P4|Overall Study|Adverse Event|2
363467|NCT01001221|1224876|P3|Overall Study|Adverse Event|0
363468|NCT01001221|1224877|P2|Overall Study|Adverse Event|2
363469|NCT01001221|1224878|P1|Overall Study|Adverse Event|1
363470|NCT01001208|1225053|P2|Overall Study|Other|2
363471|NCT01001208|1225054|P1|Overall Study|Other|0
363472|NCT01001208|1225053|P2|Overall Study|Disease Progression|3
363473|NCT01001208|1225054|P1|Overall Study|Disease Progression|0
363474|NCT01001208|1225053|P2|Overall Study|Noncompliance|7
363475|NCT01001208|1225054|P1|Overall Study|Noncompliance|4
363476|NCT01001208|1225053|P2|Overall Study|Ineligibility Determined|2
363477|NCT01001208|1225054|P1|Overall Study|Ineligibility Determined|4
363478|NCT01001208|1225053|P2|Overall Study|Withdrawal by Subject|5
363479|NCT01001208|1225054|P1|Overall Study|Withdrawal by Subject|4
363480|NCT01001208|1225053|P2|Overall Study|Physician Decision|0
363481|NCT01001208|1225054|P1|Overall Study|Physician Decision|1
363482|NCT01001208|1225053|P2|Overall Study|Lost to Follow-up|9
363483|NCT01001208|1225054|P1|Overall Study|Lost to Follow-up|5
363484|NCT01001208|1225053|P2|Overall Study|Adverse Event|5
363485|NCT01001208|1225054|P1|Overall Study|Adverse Event|10
363486|NCT01001169|1225097|P2|Overall Study|Withdrawal by Subject|1
363487|NCT01001169|1225098|P1|Overall Study|Withdrawal by Subject|2
363488|NCT01001104|1225206|P4|Overall Study|Withdrawal by Subject|2
363489|NCT01001104|1225207|P3|Overall Study|Withdrawal by Subject|0
363490|NCT01001104|1225208|P2|Overall Study|Withdrawal by Subject|0
363491|NCT01001104|1225209|P1|Overall Study|Withdrawal by Subject|0
363492|NCT01001104|1225206|P4|Overall Study|Entry Criteria Not Met|1
363493|NCT01001104|1225207|P3|Overall Study|Entry Criteria Not Met|0
363494|NCT01001104|1225208|P2|Overall Study|Entry Criteria Not Met|0
363495|NCT01001104|1225209|P1|Overall Study|Entry Criteria Not Met|0
363496|NCT01001104|1225206|P4|Overall Study|Lost to Follow-up|0
363497|NCT01001104|1225207|P3|Overall Study|Lost to Follow-up|1
363498|NCT01001104|1225208|P2|Overall Study|Lost to Follow-up|0
363499|NCT01001104|1225209|P1|Overall Study|Lost to Follow-up|0
363500|NCT01001104|1225206|P4|Overall Study|Adverse Event|0
363501|NCT01001104|1225207|P3|Overall Study|Adverse Event|0
363502|NCT01001104|1225208|P2|Overall Study|Adverse Event|1
363503|NCT01001104|1225209|P1|Overall Study|Adverse Event|2
363504|NCT01000974|1225300|P3|Booster Vaccination Phase|Other|4
363505|NCT01000974|1225301|P2|Booster Vaccination Phase|Other|6
363506|NCT01000974|1225302|P1|Booster Vaccination Phase|Other|24
363507|NCT01000974|1225300|P3|Booster Vaccination Phase|Lost to Follow-up|7
363508|NCT01000974|1225301|P2|Booster Vaccination Phase|Lost to Follow-up|5
363509|NCT01000974|1225302|P1|Booster Vaccination Phase|Lost to Follow-up|40
363510|NCT01000974|1225300|P3|Booster Vaccination Phase|Withdrawal by Subject|1
363511|NCT01000974|1225301|P2|Booster Vaccination Phase|Withdrawal by Subject|1
363512|NCT01000974|1225302|P1|Booster Vaccination Phase|Withdrawal by Subject|3
363513|NCT01000974|1225300|P3|Booster Vaccination Phase|Protocol Violation|2
363514|NCT01000974|1225301|P2|Booster Vaccination Phase|Protocol Violation|0
363515|NCT01000974|1225302|P1|Booster Vaccination Phase|Protocol Violation|0
363516|NCT01000974|1225300|P3|Primary Vaccination Phase|Other|12
363517|NCT01000974|1225301|P2|Primary Vaccination Phase|Other|9
363518|NCT01000974|1225302|P1|Primary Vaccination Phase|Other|4
363519|NCT01000974|1225300|P3|Primary Vaccination Phase|Adverse Event|2
363520|NCT01000974|1225301|P2|Primary Vaccination Phase|Adverse Event|2
363521|NCT01000974|1225302|P1|Primary Vaccination Phase|Adverse Event|14
363522|NCT01000974|1225300|P3|Primary Vaccination Phase|Protocol Violation|2
363523|NCT01000974|1225301|P2|Primary Vaccination Phase|Protocol Violation|3
363524|NCT01000974|1225302|P1|Primary Vaccination Phase|Protocol Violation|40
363525|NCT01000974|1225300|P3|Primary Vaccination Phase|Lost to Follow-up|26
363526|NCT01000974|1225301|P2|Primary Vaccination Phase|Lost to Follow-up|19
363527|NCT01000974|1225302|P1|Primary Vaccination Phase|Lost to Follow-up|171
363528|NCT01000974|1225300|P3|Primary Vaccination Phase|Withdrawal by Subject|21
363529|NCT01000974|1225301|P2|Primary Vaccination Phase|Withdrawal by Subject|17
363530|NCT01000974|1225302|P1|Primary Vaccination Phase|Withdrawal by Subject|109
363531|NCT01000961|1225409|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
363532|NCT01000961|1225410|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
363533|NCT01000961|1225409|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
363534|NCT01000961|1225410|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
363535|NCT01000805|1225433|P2|Overall Study|Sponsor Decision|1
363536|NCT01000805|1225434|P1|Overall Study|Sponsor Decision|0
363537|NCT01000805|1225433|P2|Overall Study|Withdrawal by Subject|6
363538|NCT01000805|1225434|P1|Overall Study|Withdrawal by Subject|16
363539|NCT01000805|1225433|P2|Overall Study|Protocol Violation|8
363540|NCT01000805|1225434|P1|Overall Study|Protocol Violation|12
363541|NCT01000805|1225433|P2|Overall Study|Physician Decision|1
363542|NCT01000805|1225434|P1|Overall Study|Physician Decision|0
363543|NCT01000805|1225433|P2|Overall Study|Lost to Follow-up|21
363544|NCT01000805|1225434|P1|Overall Study|Lost to Follow-up|16
363545|NCT01000805|1225433|P2|Overall Study|Lack of Efficacy|16
363546|NCT01000805|1225434|P1|Overall Study|Lack of Efficacy|5
363547|NCT01000805|1225433|P2|Overall Study|Adverse Event|9
363548|NCT01000805|1225434|P1|Overall Study|Adverse Event|21
363549|NCT01000727|1225468|P2|Overall Study|Study closed/terminated|24
363550|NCT01000727|1225469|P1|Overall Study|Study closed/terminated|23
363551|NCT01000727|1225468|P2|Overall Study|Withdrawal by Subject|109
363552|NCT01000727|1225469|P1|Overall Study|Withdrawal by Subject|111
363553|NCT01000727|1225468|P2|Overall Study|Lost to Follow-up|43
363554|NCT01000727|1225469|P1|Overall Study|Lost to Follow-up|41
363555|NCT01000649|1225510|P4|Overall Study|Lost to Follow-up|2
363556|NCT01000649|1225511|P3|Overall Study|Lost to Follow-up|0
363557|NCT01000649|1225512|P2|Overall Study|Lost to Follow-up|2
363558|NCT01000649|1225513|P1|Overall Study|Lost to Follow-up|0
363559|NCT01000649|1225510|P4|Overall Study|Adverse Event|4
363560|NCT01000649|1225511|P3|Overall Study|Adverse Event|2
363561|NCT01000649|1225512|P2|Overall Study|Adverse Event|1
363562|NCT01000649|1225513|P1|Overall Study|Adverse Event|5
363563|NCT01000610|1225594|P1|Overall Study|Treatment failure|1
363564|NCT01000610|1225594|P1|Overall Study|Lost to Follow-up|4
363565|NCT01000610|1225594|P1|Overall Study|Adverse Event|1
363566|NCT01000506|1225605|P4|Overall Study|Withdrawal by Subject|7
363567|NCT01000506|1225606|P3|Overall Study|Withdrawal by Subject|2
363568|NCT01000506|1225607|P2|Overall Study|Withdrawal by Subject|8
363569|NCT01000506|1225608|P1|Overall Study|Withdrawal by Subject|11
363570|NCT01000506|1225605|P4|Overall Study|Physician Decision|3
363571|NCT01000506|1225606|P3|Overall Study|Physician Decision|3
363572|NCT01000506|1225607|P2|Overall Study|Physician Decision|3
363573|NCT01000506|1225608|P1|Overall Study|Physician Decision|1
363574|NCT01000506|1225605|P4|Overall Study|Lost to Follow-up|0
363575|NCT01000506|1225606|P3|Overall Study|Lost to Follow-up|4
363576|NCT01000506|1225607|P2|Overall Study|Lost to Follow-up|1
363577|NCT01000506|1225608|P1|Overall Study|Lost to Follow-up|1
363578|NCT01000506|1225605|P4|Overall Study|Protocol Violation|0
363579|NCT01000506|1225606|P3|Overall Study|Protocol Violation|0
363580|NCT01000506|1225607|P2|Overall Study|Protocol Violation|1
363581|NCT01000506|1225608|P1|Overall Study|Protocol Violation|1
363582|NCT01000506|1225605|P4|Overall Study|Lack of Efficacy|4
363583|NCT01000506|1225606|P3|Overall Study|Lack of Efficacy|4
363584|NCT01000506|1225607|P2|Overall Study|Lack of Efficacy|6
363585|NCT01000506|1225608|P1|Overall Study|Lack of Efficacy|8
363586|NCT01000506|1225605|P4|Overall Study|Adverse Event|9
363587|NCT01000506|1225606|P3|Overall Study|Adverse Event|8
363588|NCT01000506|1225607|P2|Overall Study|Adverse Event|5
363589|NCT01000506|1225608|P1|Overall Study|Adverse Event|6
363590|NCT01000493|1225652|P2|Overall Study|Withdrawal by Subject|7
363591|NCT01000493|1225653|P1|Overall Study|Withdrawal by Subject|3
363592|NCT01000493|1225652|P2|Overall Study|Physician Decision|1
363593|NCT01000493|1225653|P1|Overall Study|Physician Decision|1
363594|NCT01000493|1225652|P2|Overall Study|Lost to Follow-up|9
363595|NCT01000493|1225653|P1|Overall Study|Lost to Follow-up|5
363596|NCT01000493|1225652|P2|Overall Study|Study closed/terminated|23
363597|NCT01000493|1225653|P1|Overall Study|Study closed/terminated|25
363598|NCT01000493|1225652|P2|Overall Study|Protocol Violation|8
363599|NCT01000493|1225653|P1|Overall Study|Protocol Violation|1
363600|NCT01000493|1225652|P2|Overall Study|Lack of Efficacy|1
363601|NCT01000493|1225653|P1|Overall Study|Lack of Efficacy|1
363602|NCT01000493|1225652|P2|Overall Study|Adverse Event|6
363603|NCT01000493|1225653|P1|Overall Study|Adverse Event|3
363604|NCT01000480|1225703|P1|Concurrent Therapy Phase|Physician Decision|1
363605|NCT01000480|1225703|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
363606|NCT01000480|1225703|P1|Concurrent Therapy Phase|Protocol Violation|2
363607|NCT01000480|1225703|P1|Concurrent Therapy Phase|Adverse Event|4
363608|NCT01000480|1225703|P1|Induction Phase|Entry Criteria Not Met|3
363609|NCT01000480|1225703|P1|Induction Phase|Physician Decision|1
363610|NCT01000480|1225703|P1|Induction Phase|Lost to Follow-up|1
363611|NCT01000480|1225703|P1|Induction Phase|Adverse Event|2
363612|NCT01000376|1225711|P2|Cycle 1 Day 1|Progressive Disease|0
363613|NCT01000376|1225712|P1|Cycle 1 Day 1|Progressive Disease|1
363614|NCT01000376|1225711|P2|Cycle 1 Day 1|Adverse Event|0
363615|NCT01000376|1225712|P1|Cycle 1 Day 1|Adverse Event|1
363616|NCT01000337|1225722|P2|Overall Study|Lost to Follow-up|3
363617|NCT01000337|1225723|P1|Overall Study|Lost to Follow-up|4
363618|NCT01000311|1225741|P2|Overall Study|Administrative reason|15
363619|NCT01000311|1225742|P1|Overall Study|Administrative reason|9
363620|NCT01000311|1225741|P2|Overall Study|Inappropriate enrollment|0
363621|NCT01000311|1225742|P1|Overall Study|Inappropriate enrollment|2
363622|NCT01000311|1225741|P2|Overall Study|Protocol Violation|2
363623|NCT01000311|1225742|P1|Overall Study|Protocol Violation|1
363624|NCT01000311|1225741|P2|Overall Study|Lost to Follow-up|24
363625|NCT01000311|1225742|P1|Overall Study|Lost to Follow-up|15
363626|NCT01000311|1225741|P2|Overall Study|Withdrawal by Subject|24
363627|NCT01000311|1225742|P1|Overall Study|Withdrawal by Subject|16
363628|NCT01000311|1225741|P2|Overall Study|Adverse Event|5
363629|NCT01000311|1225742|P1|Overall Study|Adverse Event|2
363630|NCT01000155|1225792|P1|Overall Study|Adverse Event|1
363631|NCT01000155|1225792|P1|Overall Study|Withdrawal by Subject|1
363632|NCT01000064|1225798|P2|Overall Study|Withdrawal by Subject|1
363633|NCT01000064|1225799|P1|Overall Study|Withdrawal by Subject|1
363634|NCT01000025|1225822|P2|Overall Study|Intercurrent Illness|7
363635|NCT01000025|1225823|P1|Overall Study|Intercurrent Illness|26
363636|NCT01000025|1225822|P2|Overall Study|Lack of Efficacy|208
363637|NCT01000025|1225823|P1|Overall Study|Lack of Efficacy|363
363638|NCT01000025|1225822|P2|Overall Study|Death|13
363639|NCT01000025|1225823|P1|Overall Study|Death|23
363640|NCT01000025|1225822|P2|Overall Study|Withdrawal by Subject|8
363641|NCT01000025|1225823|P1|Overall Study|Withdrawal by Subject|13
363642|NCT01000025|1225822|P2|Overall Study|Adverse Event|2
363643|NCT01000025|1225823|P1|Overall Study|Adverse Event|43
363644|NCT00999921|1225841|P2|Overall Study|Lost to Follow-up|19
363645|NCT00999921|1225842|P1|Overall Study|Lost to Follow-up|10
363646|NCT00999908|1225852|P3|Treatment Period 2|Protocol Violation|0
363647|NCT00999908|1225853|P2|Treatment Period 2|Protocol Violation|0
363648|NCT00999908|1225854|P1|Treatment Period 2|Protocol Violation|1
363649|NCT00999908|1225852|P3|Treatment Period 1|Subject withdrew consent|0
363650|NCT00999908|1225853|P2|Treatment Period 1|Subject withdrew consent|0
363651|NCT00999908|1225854|P1|Treatment Period 1|Subject withdrew consent|2
363652|NCT00999804|1225883|P2|Overall Study|Ineligible|0
363653|NCT00999804|1225884|P1|Overall Study|Ineligible|3
363654|NCT00999804|1225883|P2|Overall Study|Death|0
363655|NCT00999804|1225884|P1|Overall Study|Death|1
363656|NCT00999804|1225883|P2|Overall Study|Withdrawal by Subject|0
363657|NCT00999804|1225884|P1|Overall Study|Withdrawal by Subject|4
363658|NCT00999804|1225883|P2|Overall Study|Adverse Event|3
363659|NCT00999804|1225884|P1|Overall Study|Adverse Event|4
363660|NCT00999804|1225883|P2|Overall Study|Lack of Efficacy|2
363661|NCT00999804|1225884|P1|Overall Study|Lack of Efficacy|9
363662|NCT00999713|1225898|P2|Overall Study|Physician Decision|0
363663|NCT00999713|1225899|P1|Overall Study|Physician Decision|2
363664|NCT00999687|1225913|P1|Second Intervention|Lack of Efficacy|1
363665|NCT00999687|1225913|P1|Second Intervention|Withdrawal by Subject|2
363666|NCT00999687|1225913|P1|First Intervention|Withdrawal by Subject|1
363667|NCT00999661|1225920|P1|Overall Study|Not meeting eligibility criteria|9
363668|NCT00999661|1225920|P1|Overall Study|Withdrawal by Subject|1
363669|NCT00999661|1225920|P1|Overall Study|Adverse Event|1
363670|NCT00999661|1225920|P1|Overall Study|Lost to Follow-up|59
363671|NCT00999596|1225941|P1|Overall Study|Statistical population not required|101
363672|NCT00999544|1225946|P1|Overall Study|Withdrawal by Subject|1
363673|NCT00999466|1225982|P3|Main Part|Adverse Event|2
363674|NCT00999466|1225983|P2|Main Part|Adverse Event|4
363675|NCT00999466|1225984|P1|Main Part|Adverse Event|0
363676|NCT00999466|1225982|P3|Main Part|Withdrawal by Subject|2
363677|NCT00999466|1225983|P2|Main Part|Withdrawal by Subject|0
363678|NCT00999466|1225984|P1|Main Part|Withdrawal by Subject|0
363679|NCT00999167|1226261|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
363680|NCT00999167|1226262|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
363681|NCT00999167|1226263|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
363682|NCT00999167|1226261|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
363683|NCT00999167|1226262|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
363684|NCT00999167|1226263|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
363685|NCT00999167|1226261|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
363686|NCT00999167|1226262|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
363687|NCT00999167|1226263|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
363688|NCT00999167|1226261|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
363689|NCT00999167|1226262|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
363690|NCT00999167|1226263|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
363691|NCT00999167|1226261|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
363692|NCT00999167|1226262|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
363693|NCT00999167|1226263|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
363694|NCT00999167|1226261|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
363695|NCT00999167|1226262|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
363696|NCT00999167|1226263|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
363697|NCT00999167|1226261|P3|Part A: Open Label Safety run-in|Adverse Event|0
363698|NCT00999167|1226262|P2|Part A: Open Label Safety run-in|Adverse Event|0
363699|NCT00999167|1226263|P1|Part A: Open Label Safety run-in|Adverse Event|3
363700|NCT00999167|1226261|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
363701|NCT00999167|1226262|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
363702|NCT00999167|1226263|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
363703|NCT00998985|1226386|P14|Overall Study|Protocol Violation|0
363704|NCT00998985|1226387|P13|Overall Study|Protocol Violation|0
363705|NCT00998985|1226388|P12|Overall Study|Protocol Violation|0
363706|NCT00998985|1226389|P11|Overall Study|Protocol Violation|0
363707|NCT00998985|1226390|P10|Overall Study|Protocol Violation|0
363708|NCT00998985|1226391|P9|Overall Study|Protocol Violation|0
363709|NCT00998985|1226392|P8|Overall Study|Protocol Violation|0
363710|NCT00998985|1226393|P7|Overall Study|Protocol Violation|0
363711|NCT00998985|1226394|P6|Overall Study|Protocol Violation|1
363712|NCT00998985|1226395|P5|Overall Study|Protocol Violation|0
363713|NCT00998985|1226396|P4|Overall Study|Protocol Violation|0
363714|NCT00998985|1226397|P3|Overall Study|Protocol Violation|0
363715|NCT00998985|1226398|P2|Overall Study|Protocol Violation|0
363716|NCT00998985|1226399|P1|Overall Study|Protocol Violation|0
363717|NCT00998985|1226386|P14|Overall Study|Withdrawal by Subject|0
363718|NCT00998985|1226387|P13|Overall Study|Withdrawal by Subject|0
363719|NCT00998985|1226388|P12|Overall Study|Withdrawal by Subject|0
363720|NCT00998985|1226389|P11|Overall Study|Withdrawal by Subject|0
363721|NCT00998985|1226390|P10|Overall Study|Withdrawal by Subject|0
363722|NCT00998985|1226391|P9|Overall Study|Withdrawal by Subject|1
363723|NCT00998985|1226392|P8|Overall Study|Withdrawal by Subject|0
363724|NCT00998985|1226393|P7|Overall Study|Withdrawal by Subject|0
363725|NCT00998985|1226394|P6|Overall Study|Withdrawal by Subject|0
363726|NCT00998985|1226395|P5|Overall Study|Withdrawal by Subject|0
363727|NCT00998985|1226396|P4|Overall Study|Withdrawal by Subject|0
363728|NCT00998985|1226397|P3|Overall Study|Withdrawal by Subject|0
363729|NCT00998985|1226398|P2|Overall Study|Withdrawal by Subject|0
363730|NCT00998985|1226399|P1|Overall Study|Withdrawal by Subject|0
363731|NCT00998881|1226467|P2|Overall Study|Personal matter|0
363732|NCT00998881|1226468|P1|Overall Study|Personal matter|1
363733|NCT00998881|1226467|P2|Overall Study|Withdrawal by Subject|0
363734|NCT00998881|1226468|P1|Overall Study|Withdrawal by Subject|1
363735|NCT00998881|1226467|P2|Overall Study|Physician Decision|0
363736|NCT00998881|1226468|P1|Overall Study|Physician Decision|3
363737|NCT00998881|1226467|P2|Overall Study|Lack of Efficacy|0
363738|NCT00998881|1226468|P1|Overall Study|Lack of Efficacy|1
363739|NCT00998881|1226467|P2|Overall Study|Adverse Event|2
363740|NCT00998881|1226468|P1|Overall Study|Adverse Event|2
363741|NCT00998764|1226489|P2|Overall Study|Recurrent Episode of vasogenic edema|0
363742|NCT00998764|1226490|P1|Overall Study|Recurrent Episode of vasogenic edema|1
363743|NCT00998764|1226489|P2|Overall Study|Not specified|4
363744|NCT00998764|1226490|P1|Overall Study|Not specified|4
363745|NCT00998764|1226489|P2|Overall Study|Loss of Caregiver|3
363746|NCT00998764|1226490|P1|Overall Study|Loss of Caregiver|0
363747|NCT00998764|1226489|P2|Overall Study|Lost to Follow-up|1
363748|NCT00998764|1226490|P1|Overall Study|Lost to Follow-up|1
363749|NCT00998764|1226489|P2|Overall Study|Failed to Return|1
363750|NCT00998764|1226490|P1|Overall Study|Failed to Return|1
363751|NCT00998764|1226489|P2|Overall Study|Protocol Violation|1
363752|NCT00998764|1226490|P1|Overall Study|Protocol Violation|0
363753|NCT00998764|1226489|P2|Overall Study|Discontinuation of Study by Sponsor|217
363754|NCT00998764|1226490|P1|Overall Study|Discontinuation of Study by Sponsor|164
363755|NCT00998764|1226489|P2|Overall Study|Death|1
363756|NCT00998764|1226490|P1|Overall Study|Death|3
363757|NCT00998764|1226489|P2|Overall Study|Physician Decision|3
363758|NCT00998764|1226490|P1|Overall Study|Physician Decision|3
363759|NCT00998764|1226489|P2|Overall Study|Withdrawal by Subject|25
363760|NCT00998764|1226490|P1|Overall Study|Withdrawal by Subject|19
363761|NCT00998764|1226489|P2|Overall Study|Adverse Event|12
363762|NCT00998764|1226490|P1|Overall Study|Adverse Event|17
363763|NCT00998764|1226489|P2|Overall Study|Lack of Efficacy|6
363764|NCT00998764|1226490|P1|Overall Study|Lack of Efficacy|3
363765|NCT00998738|1226512|P1|Overall Study|Uknown|1
363766|NCT00998335|1226595|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
363767|NCT00998335|1226596|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
363768|NCT00998309|1226624|P1|Overall Study|Protocol Violation|4
363769|NCT00998296|1226691|P11|Overall Study|Reason other than those specified above|0
363770|NCT00998296|1226692|P10|Overall Study|Reason other than those specified above|1
363771|NCT00998296|1226693|P9|Overall Study|Reason other than those specified above|0
363772|NCT00998296|1226694|P8|Overall Study|Reason other than those specified above|0
363773|NCT00998296|1226695|P7|Overall Study|Reason other than those specified above|0
363774|NCT00998296|1226696|P6|Overall Study|Reason other than those specified above|0
363775|NCT00998296|1226697|P5|Overall Study|Reason other than those specified above|0
363776|NCT00998296|1226698|P4|Overall Study|Reason other than those specified above|0
363777|NCT00998296|1226699|P3|Overall Study|Reason other than those specified above|0
363778|NCT00998296|1226700|P2|Overall Study|Reason other than those specified above|0
363779|NCT00998296|1226701|P1|Overall Study|Reason other than those specified above|0
363780|NCT00998296|1226691|P11|Overall Study|Refused to continue taking trial med.|0
363781|NCT00998296|1226692|P10|Overall Study|Refused to continue taking trial med.|2
363782|NCT00998296|1226693|P9|Overall Study|Refused to continue taking trial med.|0
363783|NCT00998296|1226694|P8|Overall Study|Refused to continue taking trial med.|0
363784|NCT00998296|1226695|P7|Overall Study|Refused to continue taking trial med.|0
363785|NCT00998296|1226696|P6|Overall Study|Refused to continue taking trial med.|0
363786|NCT00998296|1226697|P5|Overall Study|Refused to continue taking trial med.|0
363787|NCT00998296|1226698|P4|Overall Study|Refused to continue taking trial med.|0
363788|NCT00998296|1226699|P3|Overall Study|Refused to continue taking trial med.|0
363789|NCT00998296|1226700|P2|Overall Study|Refused to continue taking trial med.|0
363790|NCT00998296|1226701|P1|Overall Study|Refused to continue taking trial med.|0
363791|NCT00998296|1226691|P11|Overall Study|Other adverse event|2
363792|NCT00998296|1226692|P10|Overall Study|Other adverse event|1
363793|NCT00998296|1226693|P9|Overall Study|Other adverse event|0
363794|NCT00998296|1226694|P8|Overall Study|Other adverse event|0
363795|NCT00998296|1226695|P7|Overall Study|Other adverse event|0
363796|NCT00998296|1226696|P6|Overall Study|Other adverse event|0
363797|NCT00998296|1226697|P5|Overall Study|Other adverse event|1
363798|NCT00998296|1226698|P4|Overall Study|Other adverse event|0
363799|NCT00998296|1226699|P3|Overall Study|Other adverse event|0
363800|NCT00998296|1226700|P2|Overall Study|Other adverse event|0
363801|NCT00998296|1226701|P1|Overall Study|Other adverse event|0
363802|NCT00998296|1226691|P11|Overall Study|Dose limiting or dose reducing toxicity|0
363803|NCT00998296|1226692|P10|Overall Study|Dose limiting or dose reducing toxicity|0
363804|NCT00998296|1226693|P9|Overall Study|Dose limiting or dose reducing toxicity|2
363805|NCT00998296|1226694|P8|Overall Study|Dose limiting or dose reducing toxicity|2
363806|NCT00998296|1226695|P7|Overall Study|Dose limiting or dose reducing toxicity|0
363807|NCT00998296|1226696|P6|Overall Study|Dose limiting or dose reducing toxicity|0
363808|NCT00998296|1226697|P5|Overall Study|Dose limiting or dose reducing toxicity|1
363809|NCT00998296|1226698|P4|Overall Study|Dose limiting or dose reducing toxicity|0
363810|NCT00998296|1226699|P3|Overall Study|Dose limiting or dose reducing toxicity|0
363811|NCT00998296|1226700|P2|Overall Study|Dose limiting or dose reducing toxicity|0
363812|NCT00998296|1226701|P1|Overall Study|Dose limiting or dose reducing toxicity|0
363813|NCT00998296|1226691|P11|Overall Study|Progressive disease|5
363814|NCT00998296|1226692|P10|Overall Study|Progressive disease|14
363815|NCT00998296|1226693|P9|Overall Study|Progressive disease|0
363816|NCT00998296|1226694|P8|Overall Study|Progressive disease|0
363817|NCT00998296|1226695|P7|Overall Study|Progressive disease|1
363818|NCT00998296|1226696|P6|Overall Study|Progressive disease|0
363819|NCT00998296|1226697|P5|Overall Study|Progressive disease|0
363820|NCT00998296|1226698|P4|Overall Study|Progressive disease|0
363821|NCT00998296|1226699|P3|Overall Study|Progressive disease|0
363822|NCT00998296|1226700|P2|Overall Study|Progressive disease|1
363823|NCT00998296|1226701|P1|Overall Study|Progressive disease|0
363824|NCT00997984|1226796|P3|Overall Study|Work schedule|2
363825|NCT00997984|1226797|P2|Overall Study|Work schedule|0
363826|NCT00997984|1226798|P1|Overall Study|Work schedule|0
363827|NCT00997984|1226796|P3|Overall Study|Suicidal ideation|1
363828|NCT00997984|1226797|P2|Overall Study|Suicidal ideation|0
363829|NCT00997984|1226798|P1|Overall Study|Suicidal ideation|0
363830|NCT00997984|1226796|P3|Overall Study|Wrong medication dispensed|0
363831|NCT00997984|1226797|P2|Overall Study|Wrong medication dispensed|1
363832|NCT00997984|1226798|P1|Overall Study|Wrong medication dispensed|0
363833|NCT00997984|1226796|P3|Overall Study|non-compliance|3
363834|NCT00997984|1226797|P2|Overall Study|non-compliance|2
363835|NCT00997984|1226798|P1|Overall Study|non-compliance|0
363836|NCT00997984|1226796|P3|Overall Study|Met exclusion criteria|0
363837|NCT00997984|1226797|P2|Overall Study|Met exclusion criteria|0
363838|NCT00997984|1226798|P1|Overall Study|Met exclusion criteria|1
363839|NCT00997984|1226796|P3|Overall Study|Lack of Efficacy|3
363840|NCT00997984|1226797|P2|Overall Study|Lack of Efficacy|6
363841|NCT00997984|1226798|P1|Overall Study|Lack of Efficacy|20
363842|NCT00997984|1226796|P3|Overall Study|Lost to Follow-up|4
363843|NCT00997984|1226797|P2|Overall Study|Lost to Follow-up|5
363844|NCT00997984|1226798|P1|Overall Study|Lost to Follow-up|8
363845|NCT00997984|1226796|P3|Overall Study|Withdrawal by Subject|5
363846|NCT00997984|1226797|P2|Overall Study|Withdrawal by Subject|9
363847|NCT00997984|1226798|P1|Overall Study|Withdrawal by Subject|6
363848|NCT00997984|1226796|P3|Overall Study|Protocol Violation|0
363849|NCT00997984|1226797|P2|Overall Study|Protocol Violation|3
363850|NCT00997984|1226798|P1|Overall Study|Protocol Violation|1
363851|NCT00997984|1226796|P3|Overall Study|Adverse Event|8
363852|NCT00997984|1226797|P2|Overall Study|Adverse Event|8
363853|NCT00997984|1226798|P1|Overall Study|Adverse Event|1
363854|NCT00997503|1226956|P1|Overall Study|Other reason|13
363855|NCT00997503|1226956|P1|Overall Study|Missed 12-month follow-up|85
363856|NCT00997503|1226956|P1|Overall Study|Physician Decision|10
363857|NCT00997503|1226956|P1|Overall Study|Adverse Event|3
363858|NCT00997503|1226956|P1|Overall Study|Lost to Follow-up|33
363859|NCT00997503|1226956|P1|Overall Study|Withdrawal by Subject|76
363860|NCT00997503|1226956|P1|Overall Study|Death|53
363861|NCT00997438|1226999|P3|Overall Study|Exclusion criteria at visit 1|3
363862|NCT00997438|1227000|P2|Overall Study|Exclusion criteria at visit 1|2
363863|NCT00997438|1227001|P1|Overall Study|Exclusion criteria at visit 1|2
363864|NCT00997438|1226999|P3|Overall Study|Withdrawal by Subject|0
363865|NCT00997438|1227000|P2|Overall Study|Withdrawal by Subject|1
363866|NCT00997438|1227001|P1|Overall Study|Withdrawal by Subject|1
363867|NCT00997438|1226999|P3|Overall Study|Blood draw difficulty|1
363868|NCT00997438|1227000|P2|Overall Study|Blood draw difficulty|0
363869|NCT00997438|1227001|P1|Overall Study|Blood draw difficulty|2
363870|NCT00997373|1227043|P2|Overall Study|could not have hysterectomy|0
363871|NCT00997373|1227044|P1|Overall Study|could not have hysterectomy|6
363872|NCT00997373|1227043|P2|Overall Study|wrong tumor type|0
363873|NCT00997373|1227044|P1|Overall Study|wrong tumor type|4
363874|NCT00997373|1227043|P2|Overall Study|Withdrawal by Subject|0
363875|NCT00997373|1227044|P1|Overall Study|Withdrawal by Subject|5
363876|NCT00997334|1227050|P1|Overall Study|Ineligible|1
363877|NCT00997334|1227050|P1|Overall Study|No lesion amenable|1
363878|NCT00997334|1227050|P1|Overall Study|Urgent Palliative Care|2
363879|NCT00997334|1227050|P1|Overall Study|Death|2
363880|NCT00997334|1227050|P1|Overall Study|Withdrawal by Subject|3
363881|NCT00997334|1227050|P1|Overall Study|Patient non-compliance|1
363882|NCT00997334|1227050|P1|Overall Study|Adverse Event|3
363883|NCT00997334|1227050|P1|Overall Study|still on therapy|12
363884|NCT00997321|1227059|P2|Overall Study|did not undergo sedation after enrollmen|3
363885|NCT00997321|1227060|P1|Overall Study|did not undergo sedation after enrollmen|0
363886|NCT00997243|1227072|P1|Overall Study|Early termination of study by sponsor|7
363887|NCT00997126|1227104|P2|Overall Study|Physician Decision|11
363888|NCT00997126|1227105|P1|Overall Study|Physician Decision|7
363889|NCT00997035|1227134|P2|3-month Follow-up Visit|Lost to Follow-up|6
363890|NCT00997035|1227135|P1|3-month Follow-up Visit|Lost to Follow-up|12
363891|NCT00997035|1227134|P2|3-week Followup Visit|Lost to Follow-up|6
363892|NCT00997035|1227135|P1|3-week Followup Visit|Lost to Follow-up|9
363893|NCT00996996|1227155|P1|Overall Study|Did Not Receive Study Medications|1
363894|NCT00996996|1227155|P1|Overall Study|Death|5
363895|NCT00996996|1227155|P1|Overall Study|Lost to Follow-up|9
363896|NCT00996996|1227155|P1|Overall Study|Non-compliance|8
363897|NCT00996996|1227155|P1|Overall Study|Progressive Disease|10
363898|NCT00996944|1227189|P2|Long-term Treatment Period|Study Closed/Terminated|5
363899|NCT00996944|1227190|P1|Long-term Treatment Period|Study Closed/Terminated|12
363900|NCT00996944|1227189|P2|Double-blind Treatment Period|Withdrawal by Subject|1
363901|NCT00996944|1227190|P1|Double-blind Treatment Period|Withdrawal by Subject|1
363902|NCT00996944|1227189|P2|Double-blind Treatment Period|Study Closed/Terminated|5
363903|NCT00996944|1227190|P1|Double-blind Treatment Period|Study Closed/Terminated|6
363904|NCT00996944|1227189|P2|Double-blind Treatment Period|Protocol Violation|0
363905|NCT00996944|1227190|P1|Double-blind Treatment Period|Protocol Violation|1
363906|NCT00996944|1227189|P2|Double-blind Treatment Period|Adverse Event|1
363907|NCT00996944|1227190|P1|Double-blind Treatment Period|Adverse Event|2
363908|NCT00996918|1227242|P5|Overall Study|Not Specified|0
363909|NCT00996918|1227243|P4|Overall Study|Not Specified|0
363910|NCT00996918|1227244|P3|Overall Study|Not Specified|0
363911|NCT00996918|1227245|P2|Overall Study|Not Specified|1
363912|NCT00996918|1227246|P1|Overall Study|Not Specified|3
363913|NCT00996918|1227242|P5|Overall Study|Loss of Caregiver|0
363914|NCT00996918|1227243|P4|Overall Study|Loss of Caregiver|0
363915|NCT00996918|1227244|P3|Overall Study|Loss of Caregiver|0
363916|NCT00996918|1227245|P2|Overall Study|Loss of Caregiver|1
363917|NCT00996918|1227246|P1|Overall Study|Loss of Caregiver|0
363918|NCT00996918|1227242|P5|Overall Study|Discontinuation of Study by Sponsor|2
363919|NCT00996918|1227243|P4|Overall Study|Discontinuation of Study by Sponsor|45
363920|NCT00996918|1227244|P3|Overall Study|Discontinuation of Study by Sponsor|30
363921|NCT00996918|1227245|P2|Overall Study|Discontinuation of Study by Sponsor|54
363922|NCT00996918|1227246|P1|Overall Study|Discontinuation of Study by Sponsor|31
363923|NCT00996918|1227242|P5|Overall Study|Physician Decision|0
363924|NCT00996918|1227243|P4|Overall Study|Physician Decision|0
363925|NCT00996918|1227244|P3|Overall Study|Physician Decision|0
363926|NCT00996918|1227245|P2|Overall Study|Physician Decision|0
363927|NCT00996918|1227246|P1|Overall Study|Physician Decision|1
363928|NCT00996918|1227242|P5|Overall Study|Withdrawal by Subject|2
363929|NCT00996918|1227243|P4|Overall Study|Withdrawal by Subject|3
363930|NCT00996918|1227244|P3|Overall Study|Withdrawal by Subject|3
363931|NCT00996918|1227245|P2|Overall Study|Withdrawal by Subject|4
363932|NCT00996918|1227246|P1|Overall Study|Withdrawal by Subject|1
363933|NCT00996918|1227242|P5|Overall Study|Adverse Event|0
363934|NCT00996918|1227243|P4|Overall Study|Adverse Event|6
363935|NCT00996918|1227244|P3|Overall Study|Adverse Event|2
363936|NCT00996918|1227245|P2|Overall Study|Adverse Event|5
363937|NCT00996918|1227246|P1|Overall Study|Adverse Event|2
363938|NCT00996918|1227242|P5|Overall Study|Lack of Efficacy|0
363939|NCT00996918|1227243|P4|Overall Study|Lack of Efficacy|2
363940|NCT00996918|1227244|P3|Overall Study|Lack of Efficacy|2
363941|NCT00996918|1227245|P2|Overall Study|Lack of Efficacy|1
363942|NCT00996918|1227246|P1|Overall Study|Lack of Efficacy|1
363943|NCT00996892|1227290|P20|Expansion Stage 2A|Disease Progression|31
363944|NCT00996892|1227291|P19|Expansion Stage 2A|Disease Progression|0
363945|NCT00996892|1227292|P18|Expansion Stage 2A|Disease Progression|0
363946|NCT00996892|1227293|P17|Expansion Stage 2A|Disease Progression|0
363947|NCT00996892|1227294|P16|Expansion Stage 2A|Disease Progression|0
363948|NCT00996892|1227295|P15|Expansion Stage 2A|Disease Progression|0
363949|NCT00996892|1227296|P14|Expansion Stage 2A|Disease Progression|0
363950|NCT00996892|1227297|P13|Expansion Stage 2A|Disease Progression|0
363951|NCT00996892|1227298|P12|Expansion Stage 2A|Disease Progression|0
363952|NCT00996892|1227299|P11|Expansion Stage 2A|Disease Progression|0
363953|NCT00996892|1227300|P10|Expansion Stage 2A|Disease Progression|0
363954|NCT00996892|1227301|P9|Expansion Stage 2A|Disease Progression|0
363955|NCT00996892|1227302|P8|Expansion Stage 2A|Disease Progression|0
363956|NCT00996892|1227303|P7|Expansion Stage 2A|Disease Progression|0
363957|NCT00996892|1227304|P6|Expansion Stage 2A|Disease Progression|0
363958|NCT00996892|1227305|P5|Expansion Stage 2A|Disease Progression|0
363959|NCT00996892|1227306|P4|Expansion Stage 2A|Disease Progression|0
363960|NCT00996892|1227307|P3|Expansion Stage 2A|Disease Progression|0
363961|NCT00996892|1227308|P2|Expansion Stage 2A|Disease Progression|0
363962|NCT00996892|1227309|P1|Expansion Stage 2A|Disease Progression|0
363963|NCT00996892|1227290|P20|Expansion Stage 2A|Withdrawal by Subject|4
363964|NCT00996892|1227291|P19|Expansion Stage 2A|Withdrawal by Subject|0
363965|NCT00996892|1227292|P18|Expansion Stage 2A|Withdrawal by Subject|0
363966|NCT00996892|1227293|P17|Expansion Stage 2A|Withdrawal by Subject|0
363967|NCT00996892|1227294|P16|Expansion Stage 2A|Withdrawal by Subject|0
363968|NCT00996892|1227295|P15|Expansion Stage 2A|Withdrawal by Subject|0
363969|NCT00996892|1227296|P14|Expansion Stage 2A|Withdrawal by Subject|0
363970|NCT00996892|1227297|P13|Expansion Stage 2A|Withdrawal by Subject|0
363971|NCT00996892|1227298|P12|Expansion Stage 2A|Withdrawal by Subject|0
363972|NCT00996892|1227299|P11|Expansion Stage 2A|Withdrawal by Subject|0
363973|NCT00996892|1227300|P10|Expansion Stage 2A|Withdrawal by Subject|0
363974|NCT00996892|1227301|P9|Expansion Stage 2A|Withdrawal by Subject|0
363975|NCT00996892|1227302|P8|Expansion Stage 2A|Withdrawal by Subject|0
363976|NCT00996892|1227303|P7|Expansion Stage 2A|Withdrawal by Subject|0
363977|NCT00996892|1227304|P6|Expansion Stage 2A|Withdrawal by Subject|0
363978|NCT00996892|1227305|P5|Expansion Stage 2A|Withdrawal by Subject|0
363979|NCT00996892|1227306|P4|Expansion Stage 2A|Withdrawal by Subject|0
363980|NCT00996892|1227307|P3|Expansion Stage 2A|Withdrawal by Subject|0
363981|NCT00996892|1227308|P2|Expansion Stage 2A|Withdrawal by Subject|0
363982|NCT00996892|1227309|P1|Expansion Stage 2A|Withdrawal by Subject|0
363983|NCT00996892|1227290|P20|Expansion Stage 2A|Physician Decision|2
363984|NCT00996892|1227291|P19|Expansion Stage 2A|Physician Decision|0
363985|NCT00996892|1227292|P18|Expansion Stage 2A|Physician Decision|0
363986|NCT00996892|1227293|P17|Expansion Stage 2A|Physician Decision|0
363987|NCT00996892|1227294|P16|Expansion Stage 2A|Physician Decision|0
363988|NCT00996892|1227295|P15|Expansion Stage 2A|Physician Decision|0
363989|NCT00996892|1227296|P14|Expansion Stage 2A|Physician Decision|0
363990|NCT00996892|1227297|P13|Expansion Stage 2A|Physician Decision|0
363991|NCT00996892|1227298|P12|Expansion Stage 2A|Physician Decision|0
363992|NCT00996892|1227299|P11|Expansion Stage 2A|Physician Decision|0
363993|NCT00996892|1227300|P10|Expansion Stage 2A|Physician Decision|0
363994|NCT00996892|1227301|P9|Expansion Stage 2A|Physician Decision|0
363995|NCT00996892|1227302|P8|Expansion Stage 2A|Physician Decision|0
363996|NCT00996892|1227303|P7|Expansion Stage 2A|Physician Decision|0
363997|NCT00996892|1227304|P6|Expansion Stage 2A|Physician Decision|0
363998|NCT00996892|1227305|P5|Expansion Stage 2A|Physician Decision|0
363999|NCT00996892|1227306|P4|Expansion Stage 2A|Physician Decision|0
364000|NCT00996892|1227307|P3|Expansion Stage 2A|Physician Decision|0
364001|NCT00996892|1227308|P2|Expansion Stage 2A|Physician Decision|0
364002|NCT00996892|1227309|P1|Expansion Stage 2A|Physician Decision|0
364003|NCT00996892|1227290|P20|Expansion Stage 2A|Adverse Event|8
364004|NCT00996892|1227291|P19|Expansion Stage 2A|Adverse Event|0
364005|NCT00996892|1227292|P18|Expansion Stage 2A|Adverse Event|0
364006|NCT00996892|1227293|P17|Expansion Stage 2A|Adverse Event|0
364007|NCT00996892|1227294|P16|Expansion Stage 2A|Adverse Event|0
364008|NCT00996892|1227295|P15|Expansion Stage 2A|Adverse Event|0
364009|NCT00996892|1227296|P14|Expansion Stage 2A|Adverse Event|0
364010|NCT00996892|1227297|P13|Expansion Stage 2A|Adverse Event|0
364011|NCT00996892|1227298|P12|Expansion Stage 2A|Adverse Event|0
364012|NCT00996892|1227299|P11|Expansion Stage 2A|Adverse Event|0
364013|NCT00996892|1227300|P10|Expansion Stage 2A|Adverse Event|0
364014|NCT00996892|1227301|P9|Expansion Stage 2A|Adverse Event|0
364015|NCT00996892|1227302|P8|Expansion Stage 2A|Adverse Event|0
364016|NCT00996892|1227303|P7|Expansion Stage 2A|Adverse Event|0
364017|NCT00996892|1227304|P6|Expansion Stage 2A|Adverse Event|0
364018|NCT00996892|1227305|P5|Expansion Stage 2A|Adverse Event|0
364019|NCT00996892|1227306|P4|Expansion Stage 2A|Adverse Event|0
364020|NCT00996892|1227307|P3|Expansion Stage 2A|Adverse Event|0
364021|NCT00996892|1227308|P2|Expansion Stage 2A|Adverse Event|0
364022|NCT00996892|1227309|P1|Expansion Stage 2A|Adverse Event|0
364023|NCT00996892|1227290|P20|Expansion Stage 2|Disease Progression|0
364024|NCT00996892|1227291|P19|Expansion Stage 2|Disease Progression|28
364025|NCT00996892|1227292|P18|Expansion Stage 2|Disease Progression|0
364026|NCT00996892|1227293|P17|Expansion Stage 2|Disease Progression|0
364027|NCT00996892|1227294|P16|Expansion Stage 2|Disease Progression|0
364028|NCT00996892|1227295|P15|Expansion Stage 2|Disease Progression|0
364029|NCT00996892|1227296|P14|Expansion Stage 2|Disease Progression|0
364030|NCT00996892|1227297|P13|Expansion Stage 2|Disease Progression|0
364031|NCT00996892|1227298|P12|Expansion Stage 2|Disease Progression|0
364032|NCT00996892|1227299|P11|Expansion Stage 2|Disease Progression|0
364033|NCT00996892|1227300|P10|Expansion Stage 2|Disease Progression|0
364034|NCT00996892|1227301|P9|Expansion Stage 2|Disease Progression|0
364035|NCT00996892|1227302|P8|Expansion Stage 2|Disease Progression|0
364036|NCT00996892|1227303|P7|Expansion Stage 2|Disease Progression|0
364037|NCT00996892|1227304|P6|Expansion Stage 2|Disease Progression|0
364038|NCT00996892|1227305|P5|Expansion Stage 2|Disease Progression|0
364039|NCT00996892|1227306|P4|Expansion Stage 2|Disease Progression|0
364040|NCT00996892|1227307|P3|Expansion Stage 2|Disease Progression|0
364041|NCT00996892|1227308|P2|Expansion Stage 2|Disease Progression|0
364042|NCT00996892|1227309|P1|Expansion Stage 2|Disease Progression|0
364043|NCT00996892|1227290|P20|Expansion Stage 2|Withdrawal by Subject|0
364044|NCT00996892|1227291|P19|Expansion Stage 2|Withdrawal by Subject|1
364045|NCT00996892|1227292|P18|Expansion Stage 2|Withdrawal by Subject|0
364046|NCT00996892|1227293|P17|Expansion Stage 2|Withdrawal by Subject|0
364047|NCT00996892|1227294|P16|Expansion Stage 2|Withdrawal by Subject|0
364048|NCT00996892|1227295|P15|Expansion Stage 2|Withdrawal by Subject|0
364049|NCT00996892|1227296|P14|Expansion Stage 2|Withdrawal by Subject|0
364050|NCT00996892|1227297|P13|Expansion Stage 2|Withdrawal by Subject|0
364051|NCT00996892|1227298|P12|Expansion Stage 2|Withdrawal by Subject|0
364052|NCT00996892|1227299|P11|Expansion Stage 2|Withdrawal by Subject|0
364053|NCT00996892|1227300|P10|Expansion Stage 2|Withdrawal by Subject|0
364054|NCT00996892|1227301|P9|Expansion Stage 2|Withdrawal by Subject|0
364055|NCT00996892|1227302|P8|Expansion Stage 2|Withdrawal by Subject|0
364056|NCT00996892|1227303|P7|Expansion Stage 2|Withdrawal by Subject|0
364057|NCT00996892|1227304|P6|Expansion Stage 2|Withdrawal by Subject|0
364058|NCT00996892|1227305|P5|Expansion Stage 2|Withdrawal by Subject|0
364059|NCT00996892|1227306|P4|Expansion Stage 2|Withdrawal by Subject|0
364060|NCT00996892|1227307|P3|Expansion Stage 2|Withdrawal by Subject|0
364061|NCT00996892|1227308|P2|Expansion Stage 2|Withdrawal by Subject|0
364062|NCT00996892|1227309|P1|Expansion Stage 2|Withdrawal by Subject|0
364063|NCT00996892|1227290|P20|Expansion Stage 2|Physician Decision|0
364064|NCT00996892|1227291|P19|Expansion Stage 2|Physician Decision|1
364065|NCT00996892|1227292|P18|Expansion Stage 2|Physician Decision|0
364066|NCT00996892|1227293|P17|Expansion Stage 2|Physician Decision|0
364067|NCT00996892|1227294|P16|Expansion Stage 2|Physician Decision|0
364068|NCT00996892|1227295|P15|Expansion Stage 2|Physician Decision|0
364069|NCT00996892|1227296|P14|Expansion Stage 2|Physician Decision|0
364070|NCT00996892|1227297|P13|Expansion Stage 2|Physician Decision|0
364071|NCT00996892|1227298|P12|Expansion Stage 2|Physician Decision|0
364072|NCT00996892|1227299|P11|Expansion Stage 2|Physician Decision|0
364073|NCT00996892|1227300|P10|Expansion Stage 2|Physician Decision|0
364074|NCT00996892|1227301|P9|Expansion Stage 2|Physician Decision|0
364075|NCT00996892|1227302|P8|Expansion Stage 2|Physician Decision|0
364076|NCT00996892|1227303|P7|Expansion Stage 2|Physician Decision|0
364077|NCT00996892|1227304|P6|Expansion Stage 2|Physician Decision|0
364078|NCT00996892|1227305|P5|Expansion Stage 2|Physician Decision|0
364079|NCT00996892|1227306|P4|Expansion Stage 2|Physician Decision|0
364080|NCT00996892|1227307|P3|Expansion Stage 2|Physician Decision|0
364081|NCT00996892|1227308|P2|Expansion Stage 2|Physician Decision|0
364082|NCT00996892|1227309|P1|Expansion Stage 2|Physician Decision|0
364083|NCT00996892|1227290|P20|Expansion Stage 2|Death|0
364084|NCT00996892|1227291|P19|Expansion Stage 2|Death|2
364085|NCT00996892|1227292|P18|Expansion Stage 2|Death|0
364086|NCT00996892|1227293|P17|Expansion Stage 2|Death|0
364087|NCT00996892|1227294|P16|Expansion Stage 2|Death|0
364088|NCT00996892|1227295|P15|Expansion Stage 2|Death|0
364089|NCT00996892|1227296|P14|Expansion Stage 2|Death|0
364090|NCT00996892|1227297|P13|Expansion Stage 2|Death|0
364091|NCT00996892|1227298|P12|Expansion Stage 2|Death|0
364092|NCT00996892|1227299|P11|Expansion Stage 2|Death|0
364093|NCT00996892|1227300|P10|Expansion Stage 2|Death|0
364094|NCT00996892|1227301|P9|Expansion Stage 2|Death|0
364095|NCT00996892|1227302|P8|Expansion Stage 2|Death|0
364096|NCT00996892|1227303|P7|Expansion Stage 2|Death|0
364097|NCT00996892|1227304|P6|Expansion Stage 2|Death|0
364098|NCT00996892|1227305|P5|Expansion Stage 2|Death|0
364099|NCT00996892|1227306|P4|Expansion Stage 2|Death|0
364100|NCT00996892|1227307|P3|Expansion Stage 2|Death|0
364101|NCT00996892|1227308|P2|Expansion Stage 2|Death|0
364102|NCT00996892|1227309|P1|Expansion Stage 2|Death|0
364103|NCT00996892|1227290|P20|Expansion Stage 2|Adverse Event|0
364104|NCT00996892|1227291|P19|Expansion Stage 2|Adverse Event|3
364105|NCT00996892|1227292|P18|Expansion Stage 2|Adverse Event|0
364106|NCT00996892|1227293|P17|Expansion Stage 2|Adverse Event|0
364107|NCT00996892|1227294|P16|Expansion Stage 2|Adverse Event|0
364108|NCT00996892|1227295|P15|Expansion Stage 2|Adverse Event|0
364109|NCT00996892|1227296|P14|Expansion Stage 2|Adverse Event|0
364110|NCT00996892|1227297|P13|Expansion Stage 2|Adverse Event|0
364111|NCT00996892|1227298|P12|Expansion Stage 2|Adverse Event|0
364112|NCT00996892|1227299|P11|Expansion Stage 2|Adverse Event|0
364113|NCT00996892|1227300|P10|Expansion Stage 2|Adverse Event|0
364114|NCT00996892|1227301|P9|Expansion Stage 2|Adverse Event|0
364115|NCT00996892|1227302|P8|Expansion Stage 2|Adverse Event|0
364116|NCT00996892|1227303|P7|Expansion Stage 2|Adverse Event|0
364117|NCT00996892|1227304|P6|Expansion Stage 2|Adverse Event|0
364118|NCT00996892|1227305|P5|Expansion Stage 2|Adverse Event|0
364119|NCT00996892|1227306|P4|Expansion Stage 2|Adverse Event|0
364120|NCT00996892|1227307|P3|Expansion Stage 2|Adverse Event|0
364121|NCT00996892|1227308|P2|Expansion Stage 2|Adverse Event|0
364122|NCT00996892|1227309|P1|Expansion Stage 2|Adverse Event|0
364123|NCT00996892|1227290|P20|Dose-Escalation Stage 1B|Disease Progression|0
364124|NCT00996892|1227291|P19|Dose-Escalation Stage 1B|Disease Progression|0
364125|NCT00996892|1227292|P18|Dose-Escalation Stage 1B|Disease Progression|3
364126|NCT00996892|1227293|P17|Dose-Escalation Stage 1B|Disease Progression|3
364127|NCT00996892|1227294|P16|Dose-Escalation Stage 1B|Disease Progression|3
364128|NCT00996892|1227295|P15|Dose-Escalation Stage 1B|Disease Progression|4
364129|NCT00996892|1227296|P14|Dose-Escalation Stage 1B|Disease Progression|0
364130|NCT00996892|1227297|P13|Dose-Escalation Stage 1B|Disease Progression|0
364131|NCT00996892|1227298|P12|Dose-Escalation Stage 1B|Disease Progression|0
364132|NCT00996892|1227299|P11|Dose-Escalation Stage 1B|Disease Progression|0
364133|NCT00996892|1227300|P10|Dose-Escalation Stage 1B|Disease Progression|0
364134|NCT00996892|1227301|P9|Dose-Escalation Stage 1B|Disease Progression|0
364135|NCT00996892|1227302|P8|Dose-Escalation Stage 1B|Disease Progression|0
364136|NCT00996892|1227303|P7|Dose-Escalation Stage 1B|Disease Progression|0
364137|NCT00996892|1227304|P6|Dose-Escalation Stage 1B|Disease Progression|0
364138|NCT00996892|1227305|P5|Dose-Escalation Stage 1B|Disease Progression|0
364139|NCT00996892|1227306|P4|Dose-Escalation Stage 1B|Disease Progression|0
364140|NCT00996892|1227307|P3|Dose-Escalation Stage 1B|Disease Progression|0
364141|NCT00996892|1227308|P2|Dose-Escalation Stage 1B|Disease Progression|0
364142|NCT00996892|1227309|P1|Dose-Escalation Stage 1B|Disease Progression|0
364143|NCT00996892|1227290|P20|Dose-Escalation Stage 1B|Physician Decision|0
364144|NCT00996892|1227291|P19|Dose-Escalation Stage 1B|Physician Decision|0
364145|NCT00996892|1227292|P18|Dose-Escalation Stage 1B|Physician Decision|2
364146|NCT00996892|1227293|P17|Dose-Escalation Stage 1B|Physician Decision|0
364147|NCT00996892|1227294|P16|Dose-Escalation Stage 1B|Physician Decision|0
364148|NCT00996892|1227295|P15|Dose-Escalation Stage 1B|Physician Decision|0
364149|NCT00996892|1227296|P14|Dose-Escalation Stage 1B|Physician Decision|0
364150|NCT00996892|1227297|P13|Dose-Escalation Stage 1B|Physician Decision|0
364151|NCT00996892|1227298|P12|Dose-Escalation Stage 1B|Physician Decision|0
364152|NCT00996892|1227299|P11|Dose-Escalation Stage 1B|Physician Decision|0
364153|NCT00996892|1227300|P10|Dose-Escalation Stage 1B|Physician Decision|0
364154|NCT00996892|1227301|P9|Dose-Escalation Stage 1B|Physician Decision|0
364155|NCT00996892|1227302|P8|Dose-Escalation Stage 1B|Physician Decision|0
364156|NCT00996892|1227303|P7|Dose-Escalation Stage 1B|Physician Decision|0
364157|NCT00996892|1227304|P6|Dose-Escalation Stage 1B|Physician Decision|0
364158|NCT00996892|1227305|P5|Dose-Escalation Stage 1B|Physician Decision|0
364159|NCT00996892|1227306|P4|Dose-Escalation Stage 1B|Physician Decision|0
364160|NCT00996892|1227307|P3|Dose-Escalation Stage 1B|Physician Decision|0
364161|NCT00996892|1227308|P2|Dose-Escalation Stage 1B|Physician Decision|0
364162|NCT00996892|1227309|P1|Dose-Escalation Stage 1B|Physician Decision|0
364163|NCT00996892|1227290|P20|Dose-Escalation Stage 1A|Disease Progression|0
364164|NCT00996892|1227291|P19|Dose-Escalation Stage 1A|Disease Progression|0
364165|NCT00996892|1227292|P18|Dose-Escalation Stage 1A|Disease Progression|0
364166|NCT00996892|1227293|P17|Dose-Escalation Stage 1A|Disease Progression|0
364167|NCT00996892|1227294|P16|Dose-Escalation Stage 1A|Disease Progression|0
364168|NCT00996892|1227295|P15|Dose-Escalation Stage 1A|Disease Progression|0
364169|NCT00996892|1227296|P14|Dose-Escalation Stage 1A|Disease Progression|4
364170|NCT00996892|1227297|P13|Dose-Escalation Stage 1A|Disease Progression|6
364171|NCT00996892|1227298|P12|Dose-Escalation Stage 1A|Disease Progression|7
364172|NCT00996892|1227299|P11|Dose-Escalation Stage 1A|Disease Progression|5
364173|NCT00996892|1227300|P10|Dose-Escalation Stage 1A|Disease Progression|1
364174|NCT00996892|1227301|P9|Dose-Escalation Stage 1A|Disease Progression|3
364175|NCT00996892|1227302|P8|Dose-Escalation Stage 1A|Disease Progression|2
364176|NCT00996892|1227303|P7|Dose-Escalation Stage 1A|Disease Progression|0
364177|NCT00996892|1227304|P6|Dose-Escalation Stage 1A|Disease Progression|0
364178|NCT00996892|1227305|P5|Dose-Escalation Stage 1A|Disease Progression|0
364179|NCT00996892|1227306|P4|Dose-Escalation Stage 1A|Disease Progression|0
364180|NCT00996892|1227307|P3|Dose-Escalation Stage 1A|Disease Progression|0
364181|NCT00996892|1227308|P2|Dose-Escalation Stage 1A|Disease Progression|0
364182|NCT00996892|1227309|P1|Dose-Escalation Stage 1A|Disease Progression|0
364183|NCT00996892|1227290|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364184|NCT00996892|1227291|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364185|NCT00996892|1227292|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364186|NCT00996892|1227293|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364187|NCT00996892|1227294|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364188|NCT00996892|1227295|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364189|NCT00996892|1227296|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364190|NCT00996892|1227297|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
364191|NCT00996892|1227298|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
364192|NCT00996892|1227299|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
364193|NCT00996892|1227300|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
364194|NCT00996892|1227301|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364195|NCT00996892|1227302|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364196|NCT00996892|1227303|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364197|NCT00996892|1227304|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364198|NCT00996892|1227305|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364199|NCT00996892|1227306|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364200|NCT00996892|1227307|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364201|NCT00996892|1227308|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364202|NCT00996892|1227309|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
364203|NCT00996892|1227290|P20|Dose-Escalation Stage 1A|Physician Decision|0
364204|NCT00996892|1227291|P19|Dose-Escalation Stage 1A|Physician Decision|0
364205|NCT00996892|1227292|P18|Dose-Escalation Stage 1A|Physician Decision|0
364206|NCT00996892|1227293|P17|Dose-Escalation Stage 1A|Physician Decision|0
364207|NCT00996892|1227294|P16|Dose-Escalation Stage 1A|Physician Decision|0
364208|NCT00996892|1227295|P15|Dose-Escalation Stage 1A|Physician Decision|0
364209|NCT00996892|1227296|P14|Dose-Escalation Stage 1A|Physician Decision|0
364210|NCT00996892|1227297|P13|Dose-Escalation Stage 1A|Physician Decision|0
364211|NCT00996892|1227298|P12|Dose-Escalation Stage 1A|Physician Decision|0
364212|NCT00996892|1227299|P11|Dose-Escalation Stage 1A|Physician Decision|0
364213|NCT00996892|1227300|P10|Dose-Escalation Stage 1A|Physician Decision|0
364214|NCT00996892|1227301|P9|Dose-Escalation Stage 1A|Physician Decision|0
364215|NCT00996892|1227302|P8|Dose-Escalation Stage 1A|Physician Decision|1
364216|NCT00996892|1227303|P7|Dose-Escalation Stage 1A|Physician Decision|0
364217|NCT00996892|1227304|P6|Dose-Escalation Stage 1A|Physician Decision|0
364218|NCT00996892|1227305|P5|Dose-Escalation Stage 1A|Physician Decision|0
364219|NCT00996892|1227306|P4|Dose-Escalation Stage 1A|Physician Decision|0
364220|NCT00996892|1227307|P3|Dose-Escalation Stage 1A|Physician Decision|0
364221|NCT00996892|1227308|P2|Dose-Escalation Stage 1A|Physician Decision|0
364222|NCT00996892|1227309|P1|Dose-Escalation Stage 1A|Physician Decision|0
364223|NCT00996892|1227290|P20|Dose-Escalation Stage 1A|Death|0
364224|NCT00996892|1227291|P19|Dose-Escalation Stage 1A|Death|0
364225|NCT00996892|1227292|P18|Dose-Escalation Stage 1A|Death|0
364226|NCT00996892|1227293|P17|Dose-Escalation Stage 1A|Death|0
364227|NCT00996892|1227294|P16|Dose-Escalation Stage 1A|Death|0
364228|NCT00996892|1227295|P15|Dose-Escalation Stage 1A|Death|0
364229|NCT00996892|1227296|P14|Dose-Escalation Stage 1A|Death|0
364230|NCT00996892|1227297|P13|Dose-Escalation Stage 1A|Death|1
364231|NCT00996892|1227298|P12|Dose-Escalation Stage 1A|Death|1
364232|NCT00996892|1227299|P11|Dose-Escalation Stage 1A|Death|0
364233|NCT00996892|1227300|P10|Dose-Escalation Stage 1A|Death|2
364234|NCT00996892|1227301|P9|Dose-Escalation Stage 1A|Death|0
364235|NCT00996892|1227302|P8|Dose-Escalation Stage 1A|Death|0
364236|NCT00996892|1227303|P7|Dose-Escalation Stage 1A|Death|0
364237|NCT00996892|1227304|P6|Dose-Escalation Stage 1A|Death|0
364238|NCT00996892|1227305|P5|Dose-Escalation Stage 1A|Death|0
364239|NCT00996892|1227306|P4|Dose-Escalation Stage 1A|Death|0
364240|NCT00996892|1227307|P3|Dose-Escalation Stage 1A|Death|0
364241|NCT00996892|1227308|P2|Dose-Escalation Stage 1A|Death|0
364242|NCT00996892|1227309|P1|Dose-Escalation Stage 1A|Death|0
364243|NCT00996892|1227290|P20|Dose-Escalation Stage 1A|Adverse Event|0
364244|NCT00996892|1227291|P19|Dose-Escalation Stage 1A|Adverse Event|0
364245|NCT00996892|1227292|P18|Dose-Escalation Stage 1A|Adverse Event|0
364246|NCT00996892|1227293|P17|Dose-Escalation Stage 1A|Adverse Event|0
364247|NCT00996892|1227294|P16|Dose-Escalation Stage 1A|Adverse Event|0
364248|NCT00996892|1227295|P15|Dose-Escalation Stage 1A|Adverse Event|0
364249|NCT00996892|1227296|P14|Dose-Escalation Stage 1A|Adverse Event|1
364250|NCT00996892|1227297|P13|Dose-Escalation Stage 1A|Adverse Event|0
364251|NCT00996892|1227298|P12|Dose-Escalation Stage 1A|Adverse Event|0
364252|NCT00996892|1227299|P11|Dose-Escalation Stage 1A|Adverse Event|1
364253|NCT00996892|1227300|P10|Dose-Escalation Stage 1A|Adverse Event|0
364254|NCT00996892|1227301|P9|Dose-Escalation Stage 1A|Adverse Event|0
364255|NCT00996892|1227302|P8|Dose-Escalation Stage 1A|Adverse Event|0
364256|NCT00996892|1227303|P7|Dose-Escalation Stage 1A|Adverse Event|0
364257|NCT00996892|1227304|P6|Dose-Escalation Stage 1A|Adverse Event|0
364258|NCT00996892|1227305|P5|Dose-Escalation Stage 1A|Adverse Event|0
364259|NCT00996892|1227306|P4|Dose-Escalation Stage 1A|Adverse Event|0
364260|NCT00996892|1227307|P3|Dose-Escalation Stage 1A|Adverse Event|0
364261|NCT00996892|1227308|P2|Dose-Escalation Stage 1A|Adverse Event|0
364262|NCT00996892|1227309|P1|Dose-Escalation Stage 1A|Adverse Event|0
364263|NCT00996892|1227290|P20|Dose-Escalation Stage 1|Disease Progression|0
364264|NCT00996892|1227291|P19|Dose-Escalation Stage 1|Disease Progression|0
364265|NCT00996892|1227292|P18|Dose-Escalation Stage 1|Disease Progression|0
364266|NCT00996892|1227293|P17|Dose-Escalation Stage 1|Disease Progression|0
364267|NCT00996892|1227294|P16|Dose-Escalation Stage 1|Disease Progression|0
364268|NCT00996892|1227295|P15|Dose-Escalation Stage 1|Disease Progression|0
364269|NCT00996892|1227296|P14|Dose-Escalation Stage 1|Disease Progression|0
364270|NCT00996892|1227297|P13|Dose-Escalation Stage 1|Disease Progression|0
364271|NCT00996892|1227298|P12|Dose-Escalation Stage 1|Disease Progression|0
364272|NCT00996892|1227299|P11|Dose-Escalation Stage 1|Disease Progression|0
364273|NCT00996892|1227300|P10|Dose-Escalation Stage 1|Disease Progression|0
364274|NCT00996892|1227301|P9|Dose-Escalation Stage 1|Disease Progression|0
364275|NCT00996892|1227302|P8|Dose-Escalation Stage 1|Disease Progression|0
364276|NCT00996892|1227303|P7|Dose-Escalation Stage 1|Disease Progression|0
364277|NCT00996892|1227304|P6|Dose-Escalation Stage 1|Disease Progression|7
364278|NCT00996892|1227305|P5|Dose-Escalation Stage 1|Disease Progression|10
364279|NCT00996892|1227306|P4|Dose-Escalation Stage 1|Disease Progression|4
364280|NCT00996892|1227307|P3|Dose-Escalation Stage 1|Disease Progression|3
364281|NCT00996892|1227308|P2|Dose-Escalation Stage 1|Disease Progression|2
364282|NCT00996892|1227309|P1|Dose-Escalation Stage 1|Disease Progression|2
364283|NCT00996892|1227290|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
364284|NCT00996892|1227291|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
364285|NCT00996892|1227292|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
364286|NCT00996892|1227293|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
364287|NCT00996892|1227294|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
364288|NCT00996892|1227295|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
364289|NCT00996892|1227296|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
364290|NCT00996892|1227297|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
364291|NCT00996892|1227298|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
364292|NCT00996892|1227299|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
364293|NCT00996892|1227300|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
364294|NCT00996892|1227301|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
364295|NCT00996892|1227302|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
364296|NCT00996892|1227303|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
364297|NCT00996892|1227304|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
364298|NCT00996892|1227305|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
364299|NCT00996892|1227306|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
364300|NCT00996892|1227307|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
364301|NCT00996892|1227308|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
364302|NCT00996892|1227309|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
364303|NCT00996892|1227290|P20|Dose-Escalation Stage 1|Physician Decision|0
364304|NCT00996892|1227291|P19|Dose-Escalation Stage 1|Physician Decision|0
364305|NCT00996892|1227292|P18|Dose-Escalation Stage 1|Physician Decision|0
364306|NCT00996892|1227293|P17|Dose-Escalation Stage 1|Physician Decision|0
364307|NCT00996892|1227294|P16|Dose-Escalation Stage 1|Physician Decision|0
364308|NCT00996892|1227295|P15|Dose-Escalation Stage 1|Physician Decision|0
364309|NCT00996892|1227296|P14|Dose-Escalation Stage 1|Physician Decision|0
364310|NCT00996892|1227297|P13|Dose-Escalation Stage 1|Physician Decision|0
364311|NCT00996892|1227298|P12|Dose-Escalation Stage 1|Physician Decision|0
364312|NCT00996892|1227299|P11|Dose-Escalation Stage 1|Physician Decision|0
364313|NCT00996892|1227300|P10|Dose-Escalation Stage 1|Physician Decision|0
364314|NCT00996892|1227301|P9|Dose-Escalation Stage 1|Physician Decision|0
364315|NCT00996892|1227302|P8|Dose-Escalation Stage 1|Physician Decision|0
364316|NCT00996892|1227303|P7|Dose-Escalation Stage 1|Physician Decision|2
364317|NCT00996892|1227304|P6|Dose-Escalation Stage 1|Physician Decision|1
364318|NCT00996892|1227305|P5|Dose-Escalation Stage 1|Physician Decision|0
364319|NCT00996892|1227306|P4|Dose-Escalation Stage 1|Physician Decision|1
364320|NCT00996892|1227307|P3|Dose-Escalation Stage 1|Physician Decision|0
364321|NCT00996892|1227308|P2|Dose-Escalation Stage 1|Physician Decision|0
364322|NCT00996892|1227309|P1|Dose-Escalation Stage 1|Physician Decision|1
364323|NCT00996892|1227290|P20|Dose-Escalation Stage 1|Death|0
364324|NCT00996892|1227291|P19|Dose-Escalation Stage 1|Death|0
364325|NCT00996892|1227292|P18|Dose-Escalation Stage 1|Death|0
364326|NCT00996892|1227293|P17|Dose-Escalation Stage 1|Death|0
364327|NCT00996892|1227294|P16|Dose-Escalation Stage 1|Death|0
364328|NCT00996892|1227295|P15|Dose-Escalation Stage 1|Death|0
364329|NCT00996892|1227296|P14|Dose-Escalation Stage 1|Death|0
364330|NCT00996892|1227297|P13|Dose-Escalation Stage 1|Death|0
364331|NCT00996892|1227298|P12|Dose-Escalation Stage 1|Death|0
364332|NCT00996892|1227299|P11|Dose-Escalation Stage 1|Death|0
364333|NCT00996892|1227300|P10|Dose-Escalation Stage 1|Death|0
364334|NCT00996892|1227301|P9|Dose-Escalation Stage 1|Death|0
364335|NCT00996892|1227302|P8|Dose-Escalation Stage 1|Death|0
364336|NCT00996892|1227303|P7|Dose-Escalation Stage 1|Death|0
364337|NCT00996892|1227304|P6|Dose-Escalation Stage 1|Death|1
364338|NCT00996892|1227305|P5|Dose-Escalation Stage 1|Death|0
364339|NCT00996892|1227306|P4|Dose-Escalation Stage 1|Death|0
364340|NCT00996892|1227307|P3|Dose-Escalation Stage 1|Death|0
364341|NCT00996892|1227308|P2|Dose-Escalation Stage 1|Death|0
364342|NCT00996892|1227309|P1|Dose-Escalation Stage 1|Death|1
364343|NCT00996892|1227290|P20|Dose-Escalation Stage 1|Adverse Event|0
364344|NCT00996892|1227291|P19|Dose-Escalation Stage 1|Adverse Event|0
364345|NCT00996892|1227292|P18|Dose-Escalation Stage 1|Adverse Event|0
364346|NCT00996892|1227293|P17|Dose-Escalation Stage 1|Adverse Event|0
364347|NCT00996892|1227294|P16|Dose-Escalation Stage 1|Adverse Event|0
364348|NCT00996892|1227295|P15|Dose-Escalation Stage 1|Adverse Event|0
364349|NCT00996892|1227296|P14|Dose-Escalation Stage 1|Adverse Event|0
364350|NCT00996892|1227297|P13|Dose-Escalation Stage 1|Adverse Event|0
364351|NCT00996892|1227298|P12|Dose-Escalation Stage 1|Adverse Event|0
364352|NCT00996892|1227299|P11|Dose-Escalation Stage 1|Adverse Event|0
364353|NCT00996892|1227300|P10|Dose-Escalation Stage 1|Adverse Event|0
364354|NCT00996892|1227301|P9|Dose-Escalation Stage 1|Adverse Event|0
364355|NCT00996892|1227302|P8|Dose-Escalation Stage 1|Adverse Event|0
364356|NCT00996892|1227303|P7|Dose-Escalation Stage 1|Adverse Event|1
364357|NCT00996892|1227304|P6|Dose-Escalation Stage 1|Adverse Event|0
364358|NCT00996892|1227305|P5|Dose-Escalation Stage 1|Adverse Event|0
364359|NCT00996892|1227306|P4|Dose-Escalation Stage 1|Adverse Event|2
364360|NCT00996892|1227307|P3|Dose-Escalation Stage 1|Adverse Event|0
364361|NCT00996892|1227308|P2|Dose-Escalation Stage 1|Adverse Event|0
364362|NCT00996892|1227309|P1|Dose-Escalation Stage 1|Adverse Event|0
364363|NCT00996840|1227903|P5|Overall Study|Withdrawal by Subject|0
364364|NCT00996840|1227904|P4|Overall Study|Withdrawal by Subject|0
364365|NCT00996840|1227905|P3|Overall Study|Withdrawal by Subject|0
364366|NCT00996840|1227906|P2|Overall Study|Withdrawal by Subject|1
364367|NCT00996840|1227907|P1|Overall Study|Withdrawal by Subject|1
364368|NCT00996840|1227903|P5|Overall Study|Physician Decision|2
364369|NCT00996840|1227904|P4|Overall Study|Physician Decision|1
364370|NCT00996840|1227905|P3|Overall Study|Physician Decision|1
364371|NCT00996840|1227906|P2|Overall Study|Physician Decision|0
364372|NCT00996840|1227907|P1|Overall Study|Physician Decision|0
364373|NCT00996840|1227903|P5|Overall Study|Adverse Event|0
364374|NCT00996840|1227904|P4|Overall Study|Adverse Event|0
364375|NCT00996840|1227905|P3|Overall Study|Adverse Event|0
364376|NCT00996840|1227906|P2|Overall Study|Adverse Event|1
364377|NCT00996840|1227907|P1|Overall Study|Adverse Event|0
364378|NCT00996801|1228057|P6|Overall Study|Withdrawal by Subject|9
364379|NCT00996801|1228058|P5|Overall Study|Withdrawal by Subject|5
364380|NCT00996801|1228059|P4|Overall Study|Withdrawal by Subject|5
364381|NCT00996801|1228060|P3|Overall Study|Withdrawal by Subject|9
364382|NCT00996801|1228061|P2|Overall Study|Withdrawal by Subject|6
364383|NCT00996801|1228062|P1|Overall Study|Withdrawal by Subject|8
364384|NCT00996801|1228057|P6|Overall Study|Study Terminated by Sponsor|0
364385|NCT00996801|1228058|P5|Overall Study|Study Terminated by Sponsor|46
364386|NCT00996801|1228059|P4|Overall Study|Study Terminated by Sponsor|0
364387|NCT00996801|1228060|P3|Overall Study|Study Terminated by Sponsor|0
364388|NCT00996801|1228061|P2|Overall Study|Study Terminated by Sponsor|1
364389|NCT00996801|1228062|P1|Overall Study|Study Terminated by Sponsor|0
364390|NCT00996801|1228057|P6|Overall Study|Protocol Violation|4
364391|NCT00996801|1228058|P5|Overall Study|Protocol Violation|3
364392|NCT00996801|1228059|P4|Overall Study|Protocol Violation|2
364393|NCT00996801|1228060|P3|Overall Study|Protocol Violation|1
364394|NCT00996801|1228061|P2|Overall Study|Protocol Violation|4
364395|NCT00996801|1228062|P1|Overall Study|Protocol Violation|3
364396|NCT00996801|1228057|P6|Overall Study|Progressive Disease|0
364397|NCT00996801|1228058|P5|Overall Study|Progressive Disease|0
364398|NCT00996801|1228059|P4|Overall Study|Progressive Disease|0
364399|NCT00996801|1228060|P3|Overall Study|Progressive Disease|0
364400|NCT00996801|1228061|P2|Overall Study|Progressive Disease|1
364401|NCT00996801|1228062|P1|Overall Study|Progressive Disease|0
364402|NCT00996801|1228057|P6|Overall Study|Physician Decision|0
364403|NCT00996801|1228058|P5|Overall Study|Physician Decision|0
364404|NCT00996801|1228059|P4|Overall Study|Physician Decision|1
364405|NCT00996801|1228060|P3|Overall Study|Physician Decision|0
364406|NCT00996801|1228061|P2|Overall Study|Physician Decision|0
364407|NCT00996801|1228062|P1|Overall Study|Physician Decision|0
364408|NCT00996801|1228057|P6|Overall Study|Lost to Follow-up|2
364409|NCT00996801|1228058|P5|Overall Study|Lost to Follow-up|3
364410|NCT00996801|1228059|P4|Overall Study|Lost to Follow-up|3
364411|NCT00996801|1228060|P3|Overall Study|Lost to Follow-up|0
364412|NCT00996801|1228061|P2|Overall Study|Lost to Follow-up|0
364413|NCT00996801|1228062|P1|Overall Study|Lost to Follow-up|0
364414|NCT00996801|1228057|P6|Overall Study|Lack of Efficacy|1
364415|NCT00996801|1228058|P5|Overall Study|Lack of Efficacy|0
364416|NCT00996801|1228059|P4|Overall Study|Lack of Efficacy|3
364417|NCT00996801|1228060|P3|Overall Study|Lack of Efficacy|1
364418|NCT00996801|1228061|P2|Overall Study|Lack of Efficacy|0
364419|NCT00996801|1228062|P1|Overall Study|Lack of Efficacy|3
364420|NCT00996801|1228057|P6|Overall Study|Adverse Event|3
364421|NCT00996801|1228058|P5|Overall Study|Adverse Event|31
364422|NCT00996801|1228059|P4|Overall Study|Adverse Event|17
364423|NCT00996801|1228060|P3|Overall Study|Adverse Event|12
364424|NCT00996801|1228061|P2|Overall Study|Adverse Event|4
364425|NCT00996801|1228062|P1|Overall Study|Adverse Event|6
364426|NCT00996736|1228174|P2|Overall Study|Visit not within 3-month window|3
364427|NCT00996736|1228175|P1|Overall Study|Visit not within 3-month window|5
364428|NCT00996736|1228174|P2|Overall Study|Lost to Follow-up|14
364429|NCT00996736|1228175|P1|Overall Study|Lost to Follow-up|15
364430|NCT00996736|1228174|P2|Overall Study|Death|1
364431|NCT00996736|1228175|P1|Overall Study|Death|1
364432|NCT00996658|1228195|P2|Overall Study|Other|7
364433|NCT00996658|1228196|P1|Overall Study|Other|9
364434|NCT00996658|1228195|P2|Overall Study|Non-compliance issues|3
364435|NCT00996658|1228196|P1|Overall Study|Non-compliance issues|3
364436|NCT00996658|1228195|P2|Overall Study|Lost to Follow-up|5
364437|NCT00996658|1228196|P1|Overall Study|Lost to Follow-up|2
364438|NCT00996658|1228195|P2|Overall Study|Protocol Violation|1
364439|NCT00996658|1228196|P1|Overall Study|Protocol Violation|0
364440|NCT00996658|1228195|P2|Overall Study|Adverse Event|5
364441|NCT00996658|1228196|P1|Overall Study|Adverse Event|2
364442|NCT00996632|1228224|P2|Overall Study|Physician Decision|0
364443|NCT00996632|1228225|P1|Overall Study|Physician Decision|0
364444|NCT00996606|1228233|P1|Overall Study|Withdrawal by Subject|3
364445|NCT00996606|1228233|P1|Overall Study|Protocol Violation|1
364446|NCT00996606|1228233|P1|Overall Study|Insufficient Therapeutic Response|2
364447|NCT00996606|1228233|P1|Overall Study|Adverse Event or Intercurrent Illness|2
364448|NCT00996593|1228327|P1|Long-Term Follow-Up|Site Closed|1
364449|NCT00996593|1228327|P1|Long-Term Follow-Up|Withdrawal by Subject|2
364450|NCT00996593|1228327|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
364451|NCT00996593|1228327|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
364452|NCT00996593|1228327|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
364453|NCT00996593|1228327|P1|Dosimetric and Therapeutic Treatment|Death|1
364454|NCT00996593|1228327|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
364455|NCT00996593|1228327|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
364456|NCT00996593|1228327|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
364457|NCT00996580|1228355|P1|Overall Study|Not specified|29
364458|NCT00996580|1228355|P1|Overall Study|Withdrawal by Subject|217
364459|NCT00996580|1228355|P1|Overall Study|Sponsor requested participant withdrawal|35
364460|NCT00996580|1228355|P1|Overall Study|Protocol Violation|16
364461|NCT00996580|1228355|P1|Overall Study|Pregnancy|68
364462|NCT00996580|1228355|P1|Overall Study|Physician Decision|5
364463|NCT00996580|1228355|P1|Overall Study|Noncompliance with the protocol|137
364464|NCT00996580|1228355|P1|Overall Study|Lost to Follow-up|480
364465|NCT00996580|1228355|P1|Overall Study|Adverse Event|466
364466|NCT00996476|1228392|P5|Overall Study|Adverse Event|1
364467|NCT00996476|1228393|P4|Overall Study|Adverse Event|0
364468|NCT00996476|1228394|P3|Overall Study|Adverse Event|0
364469|NCT00996476|1228395|P2|Overall Study|Adverse Event|1
364470|NCT00996476|1228396|P1|Overall Study|Adverse Event|0
364471|NCT00996476|1228392|P5|Overall Study|Withdrawal by Subject|1
364472|NCT00996476|1228393|P4|Overall Study|Withdrawal by Subject|0
364473|NCT00996476|1228394|P3|Overall Study|Withdrawal by Subject|1
364474|NCT00996476|1228395|P2|Overall Study|Withdrawal by Subject|2
364475|NCT00996476|1228396|P1|Overall Study|Withdrawal by Subject|1
364476|NCT00996437|1228464|P2|Overall Study|Missed|5
364477|NCT00996437|1228465|P1|Overall Study|Missed|2
364478|NCT00996437|1228464|P2|Overall Study|Dropped|2
364479|NCT00996437|1228465|P1|Overall Study|Dropped|2
364480|NCT00996437|1228464|P2|Overall Study|Death|0
364481|NCT00996437|1228465|P1|Overall Study|Death|1
364482|NCT00996333|1228510|P1|Overall Study|Other|5
364483|NCT00996333|1228510|P1|Overall Study|Physician Decision|1
364484|NCT00996333|1228510|P1|Overall Study|Adverse Event|1
364485|NCT00996333|1228510|P1|Overall Study|Death|4
364486|NCT00996333|1228510|P1|Overall Study|Withdrawal by Subject|1
364487|NCT00996333|1228510|P1|Overall Study|Screen failure|1
364488|NCT00996307|1228520|P4|Overall Study|Unable to classify|1
364489|NCT00996307|1228521|P3|Overall Study|Unable to classify|2
364490|NCT00996307|1228522|P2|Overall Study|Unable to classify|0
364491|NCT00996307|1228523|P1|Overall Study|Unable to classify|4
364492|NCT00996307|1228520|P4|Overall Study|Administrative reason|0
364493|NCT00996307|1228521|P3|Overall Study|Administrative reason|0
364494|NCT00996307|1228522|P2|Overall Study|Administrative reason|1
364495|NCT00996307|1228523|P1|Overall Study|Administrative reason|0
364496|NCT00996307|1228520|P4|Overall Study|Lost to Follow-up|15
364497|NCT00996307|1228521|P3|Overall Study|Lost to Follow-up|7
364498|NCT00996307|1228522|P2|Overall Study|Lost to Follow-up|13
364499|NCT00996307|1228523|P1|Overall Study|Lost to Follow-up|13
364500|NCT00996307|1228520|P4|Overall Study|Withdrawal by Subject|5
364501|NCT00996307|1228521|P3|Overall Study|Withdrawal by Subject|5
364502|NCT00996307|1228522|P2|Overall Study|Withdrawal by Subject|2
364503|NCT00996307|1228523|P1|Overall Study|Withdrawal by Subject|3
364504|NCT00996307|1228520|P4|Overall Study|Adverse Event|0
364505|NCT00996307|1228521|P3|Overall Study|Adverse Event|0
364506|NCT00996307|1228522|P2|Overall Study|Adverse Event|1
364507|NCT00996307|1228523|P1|Overall Study|Adverse Event|0
364508|NCT00996281|1228583|P2|Overall Study|Other|7
364509|NCT00996281|1228584|P1|Overall Study|Other|5
364510|NCT00996281|1228583|P2|Overall Study|Lack of Efficacy|2
364511|NCT00996281|1228584|P1|Overall Study|Lack of Efficacy|0
364512|NCT00996281|1228583|P2|Overall Study|Withdrawal by Subject|20
364513|NCT00996281|1228584|P1|Overall Study|Withdrawal by Subject|31
364514|NCT00996281|1228583|P2|Overall Study|Lost to Follow-up|16
364515|NCT00996281|1228584|P1|Overall Study|Lost to Follow-up|14
364516|NCT00996281|1228583|P2|Overall Study|Major Protocol Deviation|7
364517|NCT00996281|1228584|P1|Overall Study|Major Protocol Deviation|6
364518|NCT00996281|1228583|P2|Overall Study|Adverse Event|37
364519|NCT00996281|1228584|P1|Overall Study|Adverse Event|75
364520|NCT00996216|1228592|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
364521|NCT00996216|1228592|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
364522|NCT00996216|1228592|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
364523|NCT00996203|1228608|P1|Overall Study|Protocol Violation|2
364524|NCT00996203|1228608|P1|Overall Study|Lack of Efficacy|1
364525|NCT00996203|1228608|P1|Overall Study|Lost to Follow-up|1
364526|NCT00996203|1228608|P1|Overall Study|Adverse Event|3
364527|NCT00996125|1228640|P2|Overall Study|Withdrawal by Subject|3
364528|NCT00996125|1228641|P1|Overall Study|Withdrawal by Subject|4
364529|NCT00996125|1228640|P2|Overall Study|Lost to Follow-up|6
364530|NCT00996125|1228641|P1|Overall Study|Lost to Follow-up|1
364531|NCT00996125|1228640|P2|Overall Study|Adverse Event|2
364532|NCT00996125|1228641|P1|Overall Study|Adverse Event|0
364533|NCT00996034|1228661|P1|Overall Study|withdrawn by PI|1
364534|NCT00996034|1228661|P1|Overall Study|Lost to Follow-up|2
364535|NCT00995930|1228667|P2|Overall Study|Adverse Event|14
364536|NCT00995930|1228668|P1|Overall Study|Adverse Event|11
364537|NCT00995930|1228667|P2|Overall Study|Withdrawal by Subject|4
364538|NCT00995930|1228668|P1|Overall Study|Withdrawal by Subject|3
364539|NCT00995930|1228667|P2|Overall Study|Lost to Follow-up|2
364540|NCT00995930|1228668|P1|Overall Study|Lost to Follow-up|1
364541|NCT00995930|1228667|P2|Overall Study|Administrative problems|2
364542|NCT00995930|1228668|P1|Overall Study|Administrative problems|4
364543|NCT00995930|1228667|P2|Overall Study|Death|1
364544|NCT00995930|1228668|P1|Overall Study|Death|0
364545|NCT00995930|1228667|P2|Overall Study|Protocol deviation|5
364546|NCT00995930|1228668|P1|Overall Study|Protocol deviation|2
364547|NCT00995865|1228719|P3|Overall Study|Lost to Follow-up|1
364548|NCT00995865|1228720|P2|Overall Study|Lost to Follow-up|0
364549|NCT00995865|1228721|P1|Overall Study|Lost to Follow-up|0
364550|NCT00995865|1228719|P3|Overall Study|Protocol Violation|0
364551|NCT00995865|1228720|P2|Overall Study|Protocol Violation|0
364552|NCT00995865|1228721|P1|Overall Study|Protocol Violation|2
364553|NCT00995774|1228743|P2|Training Period 2|Withdrawal by Subject|0
364554|NCT00995774|1228744|P1|Training Period 2|Withdrawal by Subject|2
364555|NCT00995709|1228776|P3|Overall Study|Protocol Violation|0
364556|NCT00995709|1228777|P2|Overall Study|Protocol Violation|1
364557|NCT00995709|1228778|P1|Overall Study|Protocol Violation|2
364558|NCT00995709|1228776|P3|Overall Study|Death|0
364559|NCT00995709|1228777|P2|Overall Study|Death|1
364560|NCT00995709|1228778|P1|Overall Study|Death|0
364561|NCT00995709|1228776|P3|Overall Study|Lost to Follow-up|0
364562|NCT00995709|1228777|P2|Overall Study|Lost to Follow-up|0
364563|NCT00995709|1228778|P1|Overall Study|Lost to Follow-up|1
364564|NCT00995709|1228776|P3|Overall Study|Withdrawal by Subject|1
364565|NCT00995709|1228777|P2|Overall Study|Withdrawal by Subject|4
364566|NCT00995709|1228778|P1|Overall Study|Withdrawal by Subject|0
364567|NCT00995709|1228776|P3|Overall Study|Lack of Efficacy|4
364568|NCT00995709|1228777|P2|Overall Study|Lack of Efficacy|1
364569|NCT00995709|1228778|P1|Overall Study|Lack of Efficacy|0
364570|NCT00995709|1228776|P3|Overall Study|Adverse Event|0
364571|NCT00995709|1228777|P2|Overall Study|Adverse Event|2
364572|NCT00995709|1228778|P1|Overall Study|Adverse Event|4
364573|NCT00995670|1228804|P3|Overall Study|Failed arterial cannulation|3
364574|NCT00995670|1228805|P2|Overall Study|Failed arterial cannulation|0
364575|NCT00995670|1228806|P1|Overall Study|Failed arterial cannulation|1
364576|NCT00995566|1228814|P1|Overall Study|Early study termination|52
364577|NCT00995566|1228814|P1|Overall Study|Adverse Event|2
364578|NCT00995553|1228828|P2|Overall Study|Withdrawal by Subject|6
364579|NCT00995553|1228829|P1|Overall Study|Withdrawal by Subject|2
364580|NCT00995488|1228878|P1|Overall Study|Withdrawal by Subject|1
364581|NCT00995436|1228901|P3|Overall Study|Withdrawal by Subject|0
364582|NCT00995436|1228902|P2|Overall Study|Withdrawal by Subject|5
364583|NCT00995436|1228903|P1|Overall Study|Withdrawal by Subject|2
364584|NCT00995410|1228911|P1|Overall Study|Misc|28
364585|NCT00995410|1228911|P1|Overall Study|Lost to Follow-up|2
364586|NCT00995410|1228911|P1|Overall Study|Withdrawal by Subject|7
364587|NCT00995410|1228911|P1|Overall Study|Adverse Event|51
364588|NCT00995371|1228918|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
364589|NCT00995371|1228919|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
364590|NCT00995345|1228937|P5|Overall Study|all other reasons combined|3
364591|NCT00995345|1228938|P4|Overall Study|all other reasons combined|1
364592|NCT00995345|1228939|P3|Overall Study|all other reasons combined|2
364593|NCT00995345|1228940|P2|Overall Study|all other reasons combined|2
364594|NCT00995345|1228941|P1|Overall Study|all other reasons combined|2
364595|NCT00995345|1228937|P5|Overall Study|Lost to Follow-up|0
364596|NCT00995345|1228938|P4|Overall Study|Lost to Follow-up|1
364597|NCT00995345|1228939|P3|Overall Study|Lost to Follow-up|2
364598|NCT00995345|1228940|P2|Overall Study|Lost to Follow-up|2
364599|NCT00995345|1228941|P1|Overall Study|Lost to Follow-up|2
364600|NCT00995345|1228937|P5|Overall Study|Adverse Event|1
364601|NCT00995345|1228938|P4|Overall Study|Adverse Event|0
364602|NCT00995345|1228939|P3|Overall Study|Adverse Event|2
364603|NCT00995345|1228940|P2|Overall Study|Adverse Event|1
364604|NCT00995345|1228941|P1|Overall Study|Adverse Event|3
364605|NCT00995345|1228937|P5|Overall Study|Withdrawal by Subject|1
364606|NCT00995345|1228938|P4|Overall Study|Withdrawal by Subject|3
364607|NCT00995345|1228939|P3|Overall Study|Withdrawal by Subject|1
364608|NCT00995345|1228940|P2|Overall Study|Withdrawal by Subject|2
364609|NCT00995345|1228941|P1|Overall Study|Withdrawal by Subject|4
364610|NCT00995085|1228968|P1|Overall Study|Withdrawal by Subject|5
364611|NCT00995020|1228974|P2|Overall Study|specimen fragmentation, thermal damage|2
364612|NCT00995020|1228975|P1|Overall Study|specimen fragmentation, thermal damage|1
364613|NCT00995020|1228974|P2|Overall Study|margin analysis not performed|5
364614|NCT00995020|1228975|P1|Overall Study|margin analysis not performed|2
364615|NCT00995007|1228985|P2|Overall Study|Toxicity|0
364616|NCT00995007|1228986|P1|Overall Study|Toxicity|8
364617|NCT00995007|1228985|P2|Overall Study|Refused further treatment|2
364618|NCT00995007|1228986|P1|Overall Study|Refused further treatment|8
364619|NCT00995007|1228985|P2|Overall Study|Withdrew consent|0
364620|NCT00995007|1228986|P1|Overall Study|Withdrew consent|1
364621|NCT00994682|1229049|P2|Pioglitazone Open Label|Physician Decision|1
364622|NCT00994682|1229050|P1|Pioglitazone Open Label|Physician Decision|6
364623|NCT00994682|1229049|P2|Pioglitazone Open Label|Lost to Follow-up|2
364624|NCT00994682|1229050|P1|Pioglitazone Open Label|Lost to Follow-up|3
364625|NCT00994682|1229049|P2|Pioglitazone Open Label|Withdrawal by Subject|4
364626|NCT00994682|1229050|P1|Pioglitazone Open Label|Withdrawal by Subject|4
364627|NCT00994682|1229049|P2|Double Bilnd|Adverse Event|0
364628|NCT00994682|1229050|P1|Double Bilnd|Adverse Event|1
364629|NCT00994682|1229049|P2|Double Bilnd|Lost to Follow-up|3
364630|NCT00994682|1229050|P1|Double Bilnd|Lost to Follow-up|3
364631|NCT00994682|1229049|P2|Double Bilnd|Withdrawal by Subject|6
364632|NCT00994682|1229050|P1|Double Bilnd|Withdrawal by Subject|5
364633|NCT00994643|1229094|P1|Overall Study|Withdrawal by Subject|1
364634|NCT00994461|1229108|P3|Overall Study|Adverse Event|0
364635|NCT00994461|1229109|P2|Overall Study|Adverse Event|1
364636|NCT00994461|1229110|P1|Overall Study|Adverse Event|2
364637|NCT00994448|1229138|P2|Overall Study|Physician Decision|0
364638|NCT00994448|1229139|P1|Overall Study|Physician Decision|1
364639|NCT00994448|1229138|P2|Overall Study|Withdrawal by Subject|1
364640|NCT00994448|1229139|P1|Overall Study|Withdrawal by Subject|1
364641|NCT00994448|1229138|P2|Overall Study|Lost to Follow-up|1
364642|NCT00994448|1229139|P1|Overall Study|Lost to Follow-up|5
364643|NCT00994448|1229138|P2|Overall Study|Adverse Event|0
364644|NCT00994448|1229139|P1|Overall Study|Adverse Event|1
364645|NCT00994422|1229147|P2|Overall Study|Lost to Follow-up|1
364646|NCT00994422|1229148|P1|Overall Study|Lost to Follow-up|7
364647|NCT00994279|1229173|P2|Overall Study|Multiple reasons|3
364648|NCT00994279|1229174|P1|Overall Study|Multiple reasons|1
364649|NCT00994279|1229173|P2|Overall Study|Toxicity|0
364650|NCT00994279|1229174|P1|Overall Study|Toxicity|1
364651|NCT00994279|1229173|P2|Overall Study|Withdrawal by Subject|2
364652|NCT00994279|1229174|P1|Overall Study|Withdrawal by Subject|2
364653|NCT00994240|1229184|P2|Overall Study|study termination|3
364654|NCT00994240|1229185|P1|Overall Study|study termination|2
364655|NCT00994240|1229184|P2|Overall Study|Withdrawal by Subject|0
364656|NCT00994240|1229185|P1|Overall Study|Withdrawal by Subject|1
364657|NCT00994240|1229184|P2|Overall Study|Lost to Follow-up|2
364658|NCT00994240|1229185|P1|Overall Study|Lost to Follow-up|3
364659|NCT00994214|1229195|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
364660|NCT00994214|1229196|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
364661|NCT00994214|1229197|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
364662|NCT00994214|1229198|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
364663|NCT00994214|1229195|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
364664|NCT00994214|1229196|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
364665|NCT00994214|1229197|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
364666|NCT00994214|1229198|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
364667|NCT00994214|1229195|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
364668|NCT00994214|1229196|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
364669|NCT00994214|1229197|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
364670|NCT00994214|1229198|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
364671|NCT00994214|1229195|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
364672|NCT00994214|1229196|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
364673|NCT00994214|1229197|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
364674|NCT00994214|1229198|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
364675|NCT00994214|1229195|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
364676|NCT00994214|1229196|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
364677|NCT00994214|1229197|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
364678|NCT00994214|1229198|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
364679|NCT00994214|1229195|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
364680|NCT00994214|1229196|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
364681|NCT00994214|1229197|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
364682|NCT00994214|1229198|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
364683|NCT00994110|1229277|P2|Overall Study|Pt not eligible|5
364684|NCT00994110|1229278|P1|Overall Study|Pt not eligible|10
364685|NCT00994110|1229277|P2|Overall Study|Patient not resected|52
364686|NCT00994110|1229278|P1|Overall Study|Patient not resected|41
364687|NCT00994110|1229277|P2|Overall Study|Adverse Event|0
364688|NCT00994110|1229278|P1|Overall Study|Adverse Event|1
364689|NCT00994110|1229277|P2|Overall Study|Not Treated|8
364690|NCT00994110|1229278|P1|Overall Study|Not Treated|4
364691|NCT00994110|1229277|P2|Overall Study|Withdrawal by Subject|9
364692|NCT00994110|1229278|P1|Overall Study|Withdrawal by Subject|9
364693|NCT00993967|1229284|P1|Overall Study|Protocol Violation|2
364694|NCT00993967|1229284|P1|Overall Study|Withdrawal by Subject|36
364695|NCT00993967|1229284|P1|Overall Study|Lost to Follow-up|14
364696|NCT00993967|1229284|P1|Overall Study|Death|1
364697|NCT00993967|1229284|P1|Overall Study|Adverse Event|8
364698|NCT00993954|1229291|P2|Overall Study|Protocol Violation|2
364699|NCT00993954|1229292|P1|Overall Study|Protocol Violation|21
364700|NCT00993928|1229305|P2|Overall Study|ineligible|0
364701|NCT00993928|1229306|P1|Overall Study|ineligible|1
364702|NCT00993928|1229305|P2|Overall Study|Withdrawal by Subject|7
364703|NCT00993928|1229306|P1|Overall Study|Withdrawal by Subject|4
364704|NCT00993915|1229320|P1|Overall Study|Ongoing|3
364705|NCT00993915|1229320|P1|Overall Study|Not specified|1
364706|NCT00993915|1229320|P1|Overall Study|Withdrawal by Subject|2
364707|NCT00993915|1229320|P1|Overall Study|Insufficient clinical response|3
364708|NCT00993668|1229346|P2|Open-Label Period|Lost to Follow-up|1
364709|NCT00993668|1229347|P1|Open-Label Period|Lost to Follow-up|6
364710|NCT00993668|1229346|P2|Open-Label Period|Withdrawal by Subject|3
364711|NCT00993668|1229347|P1|Open-Label Period|Withdrawal by Subject|4
364712|NCT00993668|1229346|P2|Open-Label Period|Lack of Efficacy|3
364713|NCT00993668|1229347|P1|Open-Label Period|Lack of Efficacy|4
364714|NCT00993668|1229346|P2|Open-Label Period|Adverse Event|8
364715|NCT00993668|1229347|P1|Open-Label Period|Adverse Event|9
364716|NCT00993668|1229346|P2|Single-Blind Period|Lost to Follow-up|1
364717|NCT00993668|1229347|P1|Single-Blind Period|Lost to Follow-up|3
364718|NCT00993668|1229346|P2|Single-Blind Period|Lack of Efficacy|1
364719|NCT00993668|1229347|P1|Single-Blind Period|Lack of Efficacy|0
364720|NCT00993668|1229346|P2|Single-Blind Period|Adverse Event|1
364721|NCT00993668|1229347|P1|Single-Blind Period|Adverse Event|1
364722|NCT00993616|1229391|P1|Overall Study|Never treated|1
364723|NCT00993616|1229391|P1|Overall Study|No tumor at entry|1
364724|NCT00993499|1229409|P6|Discontinued After Starting Course 3|Other adverse event|0
364725|NCT00993499|1229410|P5|Discontinued After Starting Course 3|Other adverse event|0
364726|NCT00993499|1229411|P4|Discontinued After Starting Course 3|Other adverse event|0
364727|NCT00993499|1229412|P3|Discontinued After Starting Course 3|Other adverse event|1
364728|NCT00993499|1229413|P2|Discontinued After Starting Course 3|Other adverse event|0
364729|NCT00993499|1229414|P1|Discontinued After Starting Course 3|Other adverse event|1
364730|NCT00993499|1229409|P6|Discontinued After Starting Course 3|DLT|0
364731|NCT00993499|1229410|P5|Discontinued After Starting Course 3|DLT|0
364732|NCT00993499|1229411|P4|Discontinued After Starting Course 3|DLT|1
364733|NCT00993499|1229412|P3|Discontinued After Starting Course 3|DLT|2
364734|NCT00993499|1229413|P2|Discontinued After Starting Course 3|DLT|0
364735|NCT00993499|1229414|P1|Discontinued After Starting Course 3|DLT|1
364736|NCT00993499|1229409|P6|Discontinued After Starting Course 3|Progressive Disease|3
364737|NCT00993499|1229410|P5|Discontinued After Starting Course 3|Progressive Disease|3
364738|NCT00993499|1229411|P4|Discontinued After Starting Course 3|Progressive Disease|1
364739|NCT00993499|1229412|P3|Discontinued After Starting Course 3|Progressive Disease|3
364740|NCT00993499|1229413|P2|Discontinued After Starting Course 3|Progressive Disease|4
364741|NCT00993499|1229414|P1|Discontinued After Starting Course 3|Progressive Disease|6
364742|NCT00993499|1229409|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
364743|NCT00993499|1229410|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
364744|NCT00993499|1229411|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
364745|NCT00993499|1229412|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
364746|NCT00993499|1229413|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
364747|NCT00993499|1229414|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
364748|NCT00993499|1229409|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
364749|NCT00993499|1229410|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
364750|NCT00993499|1229411|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
364751|NCT00993499|1229412|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
364752|NCT00993499|1229413|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
364753|NCT00993499|1229414|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
364754|NCT00993499|1229409|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
364755|NCT00993499|1229410|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
364756|NCT00993499|1229411|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
364757|NCT00993499|1229412|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
364758|NCT00993499|1229413|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
364759|NCT00993499|1229414|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
364760|NCT00993499|1229409|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
364761|NCT00993499|1229410|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
364762|NCT00993499|1229411|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
364763|NCT00993499|1229412|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
364764|NCT00993499|1229413|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
364765|NCT00993499|1229414|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
364766|NCT00993499|1229409|P6|Discontinued Before Starting Course 3|Progressive Disease|0
364767|NCT00993499|1229410|P5|Discontinued Before Starting Course 3|Progressive Disease|0
364768|NCT00993499|1229411|P4|Discontinued Before Starting Course 3|Progressive Disease|0
364769|NCT00993499|1229412|P3|Discontinued Before Starting Course 3|Progressive Disease|0
364770|NCT00993499|1229413|P2|Discontinued Before Starting Course 3|Progressive Disease|2
364771|NCT00993499|1229414|P1|Discontinued Before Starting Course 3|Progressive Disease|2
364772|NCT00993499|1229409|P6|Run-in Period (8 Days)|Progressive disease|0
364773|NCT00993499|1229410|P5|Run-in Period (8 Days)|Progressive disease|0
364774|NCT00993499|1229411|P4|Run-in Period (8 Days)|Progressive disease|0
364775|NCT00993499|1229412|P3|Run-in Period (8 Days)|Progressive disease|1
364776|NCT00993499|1229413|P2|Run-in Period (8 Days)|Progressive disease|1
364777|NCT00993499|1229414|P1|Run-in Period (8 Days)|Progressive disease|0
364778|NCT00993499|1229409|P6|Run-in Period (8 Days)|Consent withdrawn|0
364779|NCT00993499|1229410|P5|Run-in Period (8 Days)|Consent withdrawn|0
364780|NCT00993499|1229411|P4|Run-in Period (8 Days)|Consent withdrawn|0
364781|NCT00993499|1229412|P3|Run-in Period (8 Days)|Consent withdrawn|0
364782|NCT00993499|1229413|P2|Run-in Period (8 Days)|Consent withdrawn|1
364783|NCT00993499|1229414|P1|Run-in Period (8 Days)|Consent withdrawn|0
364784|NCT00993499|1229409|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
364785|NCT00993499|1229410|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
364786|NCT00993499|1229411|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
364787|NCT00993499|1229412|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
364788|NCT00993499|1229413|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
364789|NCT00993499|1229414|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
364790|NCT00993499|1229409|P6|Run-in Period (8 Days)|Adverse Event|0
364791|NCT00993499|1229410|P5|Run-in Period (8 Days)|Adverse Event|0
364792|NCT00993499|1229411|P4|Run-in Period (8 Days)|Adverse Event|0
364793|NCT00993499|1229412|P3|Run-in Period (8 Days)|Adverse Event|0
364794|NCT00993499|1229413|P2|Run-in Period (8 Days)|Adverse Event|1
364795|NCT00993499|1229414|P1|Run-in Period (8 Days)|Adverse Event|0
364796|NCT00993473|1229496|P2|Overall Study|Family event|0
364797|NCT00993473|1229497|P1|Overall Study|Family event|1
364798|NCT00993473|1229496|P2|Overall Study|Technical problem with CGM device|1
364799|NCT00993473|1229497|P1|Overall Study|Technical problem with CGM device|0
364800|NCT00993473|1229496|P2|Overall Study|Withdrawal by Subject|5
364801|NCT00993473|1229497|P1|Overall Study|Withdrawal by Subject|1
364802|NCT00993473|1229496|P2|Overall Study|Lost to Follow-up|0
364803|NCT00993473|1229497|P1|Overall Study|Lost to Follow-up|1
364804|NCT00993473|1229496|P2|Overall Study|Protocol Violation|2
364805|NCT00993473|1229497|P1|Overall Study|Protocol Violation|1
364806|NCT00993473|1229496|P2|Overall Study|Adverse Event|2
364807|NCT00993473|1229497|P1|Overall Study|Adverse Event|0
364808|NCT00993447|1229535|P2|Overall Study|Adverse Event|0
364809|NCT00993447|1229536|P1|Overall Study|Adverse Event|1
364810|NCT00993447|1229535|P2|Overall Study|Lost to Follow-up|3
364811|NCT00993447|1229536|P1|Overall Study|Lost to Follow-up|1
364812|NCT00993447|1229535|P2|Overall Study|Protocol Violation|8
364813|NCT00993447|1229536|P1|Overall Study|Protocol Violation|12
364814|NCT00993447|1229535|P2|Overall Study|Withdrawal by Subject|8
364815|NCT00993447|1229536|P1|Overall Study|Withdrawal by Subject|23
364816|NCT00993421|1229573|P7|Overall Study|Protocol Violation|1
364817|NCT00993421|1229574|P6|Overall Study|Protocol Violation|2
364818|NCT00993421|1229575|P5|Overall Study|Protocol Violation|0
364819|NCT00993421|1229576|P4|Overall Study|Protocol Violation|0
364820|NCT00993421|1229577|P3|Overall Study|Protocol Violation|0
364821|NCT00993421|1229578|P2|Overall Study|Protocol Violation|0
364822|NCT00993421|1229579|P1|Overall Study|Protocol Violation|0
364823|NCT00993421|1229573|P7|Overall Study|Physician Decision|1
364824|NCT00993421|1229574|P6|Overall Study|Physician Decision|1
364825|NCT00993421|1229575|P5|Overall Study|Physician Decision|0
364826|NCT00993421|1229576|P4|Overall Study|Physician Decision|0
364827|NCT00993421|1229577|P3|Overall Study|Physician Decision|0
364828|NCT00993421|1229578|P2|Overall Study|Physician Decision|0
364829|NCT00993421|1229579|P1|Overall Study|Physician Decision|0
364830|NCT00993421|1229573|P7|Overall Study|Entry Criteria Exclusion|0
364831|NCT00993421|1229574|P6|Overall Study|Entry Criteria Exclusion|1
364832|NCT00993421|1229575|P5|Overall Study|Entry Criteria Exclusion|0
364833|NCT00993421|1229576|P4|Overall Study|Entry Criteria Exclusion|3
364834|NCT00993421|1229577|P3|Overall Study|Entry Criteria Exclusion|1
364835|NCT00993421|1229578|P2|Overall Study|Entry Criteria Exclusion|0
364836|NCT00993421|1229579|P1|Overall Study|Entry Criteria Exclusion|0
364837|NCT00993421|1229573|P7|Overall Study|Death|1
364838|NCT00993421|1229574|P6|Overall Study|Death|0
364839|NCT00993421|1229575|P5|Overall Study|Death|0
364840|NCT00993421|1229576|P4|Overall Study|Death|0
364841|NCT00993421|1229577|P3|Overall Study|Death|0
364842|NCT00993421|1229578|P2|Overall Study|Death|0
364843|NCT00993421|1229579|P1|Overall Study|Death|0
364844|NCT00993421|1229573|P7|Overall Study|Withdrawal by Subject|3
364845|NCT00993421|1229574|P6|Overall Study|Withdrawal by Subject|5
364846|NCT00993421|1229575|P5|Overall Study|Withdrawal by Subject|3
364847|NCT00993421|1229576|P4|Overall Study|Withdrawal by Subject|3
364848|NCT00993421|1229577|P3|Overall Study|Withdrawal by Subject|3
364849|NCT00993421|1229578|P2|Overall Study|Withdrawal by Subject|2
364850|NCT00993421|1229579|P1|Overall Study|Withdrawal by Subject|3
364851|NCT00993421|1229573|P7|Overall Study|Lost to Follow-up|6
364852|NCT00993421|1229574|P6|Overall Study|Lost to Follow-up|0
364853|NCT00993421|1229575|P5|Overall Study|Lost to Follow-up|0
364854|NCT00993421|1229576|P4|Overall Study|Lost to Follow-up|0
364855|NCT00993421|1229577|P3|Overall Study|Lost to Follow-up|5
364856|NCT00993421|1229578|P2|Overall Study|Lost to Follow-up|5
364857|NCT00993421|1229579|P1|Overall Study|Lost to Follow-up|3
364858|NCT00993421|1229573|P7|Overall Study|Sponsor Decision|29
364859|NCT00993421|1229574|P6|Overall Study|Sponsor Decision|30
364860|NCT00993421|1229575|P5|Overall Study|Sponsor Decision|38
364861|NCT00993421|1229576|P4|Overall Study|Sponsor Decision|30
364862|NCT00993421|1229577|P3|Overall Study|Sponsor Decision|28
364863|NCT00993421|1229578|P2|Overall Study|Sponsor Decision|31
364864|NCT00993421|1229579|P1|Overall Study|Sponsor Decision|36
364865|NCT00993421|1229573|P7|Overall Study|Adverse Event|1
364866|NCT00993421|1229574|P6|Overall Study|Adverse Event|7
364867|NCT00993421|1229575|P5|Overall Study|Adverse Event|5
364868|NCT00993421|1229576|P4|Overall Study|Adverse Event|9
364869|NCT00993421|1229577|P3|Overall Study|Adverse Event|6
364870|NCT00993421|1229578|P2|Overall Study|Adverse Event|7
364871|NCT00993421|1229579|P1|Overall Study|Adverse Event|2
364872|NCT00993317|1229730|P2|Overall Study|Early study termination at the site|0
364873|NCT00993317|1229731|P1|Overall Study|Early study termination at the site|1
364874|NCT00993317|1229730|P2|Overall Study|Investigator's opinion|1
364875|NCT00993317|1229731|P1|Overall Study|Investigator's opinion|0
364876|NCT00993317|1229730|P2|Overall Study|Withdrawal by Subject|2
364877|NCT00993317|1229731|P1|Overall Study|Withdrawal by Subject|0
364878|NCT00993317|1229730|P2|Overall Study|Lack of Efficacy|18
364879|NCT00993317|1229731|P1|Overall Study|Lack of Efficacy|18
364880|NCT00993317|1229730|P2|Overall Study|Adverse Event|4
364881|NCT00993317|1229731|P1|Overall Study|Adverse Event|2
364882|NCT00993291|1229749|P1|Overall Study|Withdrawal by Subject|1
364883|NCT00993265|1229755|P2|Overall Study|Non-compliant with study medication|0
364884|NCT00993265|1229756|P1|Overall Study|Non-compliant with study medication|1
364885|NCT00993265|1229755|P2|Overall Study|Changed dose of concomitant drug|0
364886|NCT00993265|1229756|P1|Overall Study|Changed dose of concomitant drug|2
364887|NCT00993265|1229755|P2|Overall Study|Adverse Event|0
364888|NCT00993265|1229756|P1|Overall Study|Adverse Event|1
364889|NCT00993148|1229808|P1|Overall Study|never initiated treatment|1
364890|NCT00993148|1229808|P1|Overall Study|Lost to Follow-up|2
364891|NCT00993044|1229820|P1|Irinotecan 50 mg|Physician Decision|1
364892|NCT00993031|1229827|P2|Overall Study|Lost to Follow-up|13
364893|NCT00993031|1229828|P1|Overall Study|Lost to Follow-up|19
364894|NCT00993031|1229827|P2|Overall Study|Withdrawal by Subject|3
364895|NCT00993031|1229828|P1|Overall Study|Withdrawal by Subject|3
364896|NCT00993031|1229827|P2|Overall Study|Physician Decision|2
364897|NCT00993031|1229828|P1|Overall Study|Physician Decision|0
364898|NCT00993031|1229827|P2|Overall Study|Death|1
364899|NCT00993031|1229828|P1|Overall Study|Death|0
364900|NCT00992992|1229846|P1|Overall Study|Sponsor Closed the Study|4
364901|NCT00992992|1229846|P1|Overall Study|GlaxoSmithKline Closed the Study|2
364902|NCT00992992|1229846|P1|Overall Study|Death|16
364903|NCT00992992|1229846|P1|Overall Study|Lost to Follow-up|3
364904|NCT00992836|1229877|P1|Overall Study|Protocol Violation|2
364905|NCT00992836|1229877|P1|Overall Study|Withdrawal by Subject|2
364906|NCT00992836|1229877|P1|Overall Study|Lost to Follow-up|1
364907|NCT00992784|1229892|P3|Overall Study|Withdrawal by Subject|1
364908|NCT00992784|1229893|P2|Overall Study|Withdrawal by Subject|1
364909|NCT00992784|1229894|P1|Overall Study|Withdrawal by Subject|1
364910|NCT00992784|1229892|P3|Overall Study|Adverse Event|0
364911|NCT00992784|1229893|P2|Overall Study|Adverse Event|1
364912|NCT00992784|1229894|P1|Overall Study|Adverse Event|2
364913|NCT00992589|1230006|P4|Double-Blind Phase|Not specified|3
364914|NCT00992589|1230007|P3|Double-Blind Phase|Not specified|6
364915|NCT00992589|1230008|P2|Double-Blind Phase|Not specified|1
364916|NCT00992589|1230009|P1|Double-Blind Phase|Not specified|0
364917|NCT00992589|1230006|P4|Double-Blind Phase|Lost to Follow-up|2
364918|NCT00992589|1230007|P3|Double-Blind Phase|Lost to Follow-up|0
364919|NCT00992589|1230008|P2|Double-Blind Phase|Lost to Follow-up|0
364920|NCT00992589|1230009|P1|Double-Blind Phase|Lost to Follow-up|0
364921|NCT00992589|1230006|P4|Double-Blind Phase|Withdrawal by Subject|2
364922|NCT00992589|1230007|P3|Double-Blind Phase|Withdrawal by Subject|5
364923|NCT00992589|1230008|P2|Double-Blind Phase|Withdrawal by Subject|6
364924|NCT00992589|1230009|P1|Double-Blind Phase|Withdrawal by Subject|0
364925|NCT00992589|1230006|P4|Double-Blind Phase|Adverse Event|3
364926|NCT00992589|1230007|P3|Double-Blind Phase|Adverse Event|2
364927|NCT00992589|1230008|P2|Double-Blind Phase|Adverse Event|6
364928|NCT00992589|1230009|P1|Double-Blind Phase|Adverse Event|0
364929|NCT00992589|1230006|P4|Open-Label Phase|Not specified|0
364930|NCT00992589|1230007|P3|Open-Label Phase|Not specified|0
364931|NCT00992589|1230008|P2|Open-Label Phase|Not specified|0
364932|NCT00992589|1230009|P1|Open-Label Phase|Not specified|45
364933|NCT00992589|1230006|P4|Open-Label Phase|Physician Decision|0
364934|NCT00992589|1230007|P3|Open-Label Phase|Physician Decision|0
364935|NCT00992589|1230008|P2|Open-Label Phase|Physician Decision|0
364936|NCT00992589|1230009|P1|Open-Label Phase|Physician Decision|4
364937|NCT00992589|1230006|P4|Open-Label Phase|Protocol Violation|0
364938|NCT00992589|1230007|P3|Open-Label Phase|Protocol Violation|0
364939|NCT00992589|1230008|P2|Open-Label Phase|Protocol Violation|0
364940|NCT00992589|1230009|P1|Open-Label Phase|Protocol Violation|3
364941|NCT00992589|1230006|P4|Open-Label Phase|Lost to Follow-up|0
364942|NCT00992589|1230007|P3|Open-Label Phase|Lost to Follow-up|0
364943|NCT00992589|1230008|P2|Open-Label Phase|Lost to Follow-up|0
364944|NCT00992589|1230009|P1|Open-Label Phase|Lost to Follow-up|1
364945|NCT00992589|1230006|P4|Open-Label Phase|Withdrawal by Subject|0
364946|NCT00992589|1230007|P3|Open-Label Phase|Withdrawal by Subject|0
364947|NCT00992589|1230008|P2|Open-Label Phase|Withdrawal by Subject|0
364948|NCT00992589|1230009|P1|Open-Label Phase|Withdrawal by Subject|20
364949|NCT00992589|1230006|P4|Open-Label Phase|Adverse Event|0
364950|NCT00992589|1230007|P3|Open-Label Phase|Adverse Event|0
364951|NCT00992589|1230008|P2|Open-Label Phase|Adverse Event|0
364952|NCT00992589|1230009|P1|Open-Label Phase|Adverse Event|4
364953|NCT00992459|1230053|P2|Overall Study|Adverse Event|0
364954|NCT00992459|1230054|P1|Overall Study|Adverse Event|1
364955|NCT00992459|1230053|P2|Overall Study|Withdrawal by Subject|1
364956|NCT00992459|1230054|P1|Overall Study|Withdrawal by Subject|0
364957|NCT00992446|1230078|P1|Overall Study|Maintenance Therapy Screen Fail|5
364958|NCT00992446|1230078|P1|Overall Study|Withdrawal by Subject|2
364959|NCT00992446|1230078|P1|Overall Study|Disease Progression|1
364960|NCT00992407|1230150|P2|Overall Study|Study medication not administered|13
364961|NCT00992407|1230151|P1|Overall Study|Study medication not administered|17
364962|NCT00992407|1230150|P2|Overall Study|Loss of follow-up & Adverse events|1
364963|NCT00992407|1230151|P1|Overall Study|Loss of follow-up & Adverse events|2
364964|NCT00992407|1230150|P2|Overall Study|Other|0
364965|NCT00992407|1230151|P1|Overall Study|Other|2
364966|NCT00992407|1230150|P2|Overall Study|protocol Violation & Adverse events|4
364967|NCT00992407|1230151|P1|Overall Study|protocol Violation & Adverse events|2
364968|NCT00992407|1230150|P2|Overall Study|Adverse Event|2
364969|NCT00992407|1230151|P1|Overall Study|Adverse Event|3
364970|NCT00992407|1230150|P2|Overall Study|Lost to Follow-up|3
364971|NCT00992407|1230151|P1|Overall Study|Lost to Follow-up|3
364972|NCT00992407|1230150|P2|Overall Study|Protocol Violation|1
364973|NCT00992407|1230151|P1|Overall Study|Protocol Violation|2
364974|NCT00992394|1230201|P2|Overall Study|Other event|0
364975|NCT00992394|1230202|P1|Overall Study|Other event|1
364976|NCT00992394|1230201|P2|Overall Study|Lost to Follow-up|0
364977|NCT00992394|1230202|P1|Overall Study|Lost to Follow-up|2
364978|NCT00992394|1230201|P2|Overall Study|Protocol Violation|4
364979|NCT00992394|1230202|P1|Overall Study|Protocol Violation|2
364980|NCT00992394|1230201|P2|Overall Study|Physician Decision|0
364981|NCT00992394|1230202|P1|Overall Study|Physician Decision|1
364982|NCT00992394|1230201|P2|Overall Study|Withdrawal by Subject|2
364983|NCT00992394|1230202|P1|Overall Study|Withdrawal by Subject|8
364984|NCT00992394|1230201|P2|Overall Study|Adverse Event|5
364985|NCT00992394|1230202|P1|Overall Study|Adverse Event|4
364986|NCT00992394|1230201|P2|Overall Study|Lack of Efficacy|3
364987|NCT00992394|1230202|P1|Overall Study|Lack of Efficacy|6
364988|NCT00992186|1230289|P1|Overall Study|Refusal To Receive Study Agent|3
364989|NCT00992186|1230289|P1|Overall Study|Progressive Disease|30
364990|NCT00992186|1230289|P1|Overall Study|Adverse Event|9
364991|NCT00992186|1230289|P1|Overall Study|Physician Decision|1
364992|NCT00992186|1230289|P1|Overall Study|Protocol Violation|1
364993|NCT00992186|1230289|P1|Overall Study|Withdrawal by Subject|2
364994|NCT00992108|1230308|P2|Overall Study|Lost to Follow-up|1
364995|NCT00992108|1230309|P1|Overall Study|Lost to Follow-up|0
364996|NCT00992056|1230323|P2|Washout Period (2 Weeks)|Physician Decision|0
364997|NCT00992056|1230324|P1|Washout Period (2 Weeks)|Physician Decision|1
364998|NCT00992056|1230323|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
364999|NCT00992056|1230324|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
365000|NCT00992017|1230330|P1|Overall Study|Not adhere to study requirements|1
365001|NCT00992017|1230330|P1|Overall Study|Unable to get to clinic|5
365002|NCT00992017|1230330|P1|Overall Study|Withdrawal by Subject|2
365003|NCT00992017|1230330|P1|Overall Study|Lost to Follow-up|2
365004|NCT00991952|1230345|P2|Overall Study|Adverse Event|1
365005|NCT00991952|1230346|P1|Overall Study|Adverse Event|0
365006|NCT00991939|1230354|P2|Overall Study|Entire study terminated|1
365007|NCT00991939|1230355|P1|Overall Study|Entire study terminated|4
365008|NCT00991939|1230354|P2|Overall Study|Withdrawal by Subject|0
365009|NCT00991939|1230355|P1|Overall Study|Withdrawal by Subject|1
365010|NCT00991939|1230354|P2|Overall Study|Lost to Follow-up|1
365011|NCT00991939|1230355|P1|Overall Study|Lost to Follow-up|0
365012|NCT00991887|1230389|P2|Overall Study|Lost to Follow-up|1
365013|NCT00991887|1230390|P1|Overall Study|Lost to Follow-up|2
365014|NCT00991510|1230409|P2|Period III (Days 29-112)|Adverse Event|1
365015|NCT00991510|1230410|P1|Period III (Days 29-112)|Adverse Event|1
365016|NCT00991510|1230409|P2|Period I (Days 1-14)|Adverse Event|0
365017|NCT00991510|1230410|P1|Period I (Days 1-14)|Adverse Event|1
365018|NCT00991341|1230456|P2|Overall Study|Withdrawal by Subject|4
365019|NCT00991341|1230457|P1|Overall Study|Withdrawal by Subject|3
365020|NCT00991341|1230456|P2|Overall Study|Physician Decision|2
365021|NCT00991341|1230457|P1|Overall Study|Physician Decision|1
365022|NCT00991341|1230456|P2|Overall Study|no RBCs received 96hrs after randomized|155
365023|NCT00991341|1230457|P1|Overall Study|no RBCs received 96hrs after randomized|186
365024|NCT00991341|1230456|P2|Overall Study|Death|0
365025|NCT00991341|1230457|P1|Overall Study|Death|3
365026|NCT00991341|1230456|P2|Overall Study|no surgery w/in 30 days of randomization|18
365027|NCT00991341|1230457|P1|Overall Study|no surgery w/in 30 days of randomization|11
365028|NCT00991302|1230495|P2|Overall Study|Lost to Follow-up|12
365029|NCT00991302|1230496|P1|Overall Study|Lost to Follow-up|14
365030|NCT00991302|1230495|P2|Overall Study|Death|1
365031|NCT00991302|1230496|P1|Overall Study|Death|0
365032|NCT00991289|1230512|P1|Overall Study|Protocol Violation|2
365033|NCT00991289|1230512|P1|Overall Study|Lost to Follow-up|4
365034|NCT00991289|1230512|P1|Overall Study|Withdrawal by Subject|3
365035|NCT00991289|1230512|P1|Overall Study|Physician Decision|2
365036|NCT00991289|1230512|P1|Overall Study|Adverse Event|1
365037|NCT00991276|1230532|P6|Third Intervention Period|Withdrawal by Subject|0
365038|NCT00991276|1230533|P5|Third Intervention Period|Withdrawal by Subject|0
365039|NCT00991276|1230534|P4|Third Intervention Period|Withdrawal by Subject|1
365040|NCT00991276|1230535|P3|Third Intervention Period|Withdrawal by Subject|0
365041|NCT00991276|1230536|P2|Third Intervention Period|Withdrawal by Subject|0
365042|NCT00991276|1230537|P1|Third Intervention Period|Withdrawal by Subject|0
365043|NCT00991276|1230532|P6|Third Intervention Period|Adverse Event|0
365044|NCT00991276|1230533|P5|Third Intervention Period|Adverse Event|0
365045|NCT00991276|1230534|P4|Third Intervention Period|Adverse Event|0
365046|NCT00991276|1230535|P3|Third Intervention Period|Adverse Event|1
365047|NCT00991276|1230536|P2|Third Intervention Period|Adverse Event|0
365048|NCT00991276|1230537|P1|Third Intervention Period|Adverse Event|0
365049|NCT00991276|1230532|P6|Third Intervention Period|Other|1
365050|NCT00991276|1230533|P5|Third Intervention Period|Other|0
365051|NCT00991276|1230534|P4|Third Intervention Period|Other|0
365052|NCT00991276|1230535|P3|Third Intervention Period|Other|0
365053|NCT00991276|1230536|P2|Third Intervention Period|Other|0
365054|NCT00991276|1230537|P1|Third Intervention Period|Other|0
365055|NCT00991276|1230532|P6|Third Intervention Period|Protocol Violation|0
365056|NCT00991276|1230533|P5|Third Intervention Period|Protocol Violation|0
365057|NCT00991276|1230534|P4|Third Intervention Period|Protocol Violation|0
365058|NCT00991276|1230535|P3|Third Intervention Period|Protocol Violation|0
365059|NCT00991276|1230536|P2|Third Intervention Period|Protocol Violation|0
365060|NCT00991276|1230537|P1|Third Intervention Period|Protocol Violation|1
365061|NCT00991276|1230532|P6|Second Intervention Period|Other|1
365062|NCT00991276|1230533|P5|Second Intervention Period|Other|0
365063|NCT00991276|1230534|P4|Second Intervention Period|Other|1
365064|NCT00991276|1230535|P3|Second Intervention Period|Other|0
365065|NCT00991276|1230536|P2|Second Intervention Period|Other|0
365066|NCT00991276|1230537|P1|Second Intervention Period|Other|0
365067|NCT00991276|1230532|P6|Second Intervention Period|Protocol Violation|0
365068|NCT00991276|1230533|P5|Second Intervention Period|Protocol Violation|0
365069|NCT00991276|1230534|P4|Second Intervention Period|Protocol Violation|0
365070|NCT00991276|1230535|P3|Second Intervention Period|Protocol Violation|0
365071|NCT00991276|1230536|P2|Second Intervention Period|Protocol Violation|0
365072|NCT00991276|1230537|P1|Second Intervention Period|Protocol Violation|1
365073|NCT00991276|1230532|P6|Second Intervention Period|Adverse Event|0
365074|NCT00991276|1230533|P5|Second Intervention Period|Adverse Event|1
365075|NCT00991276|1230534|P4|Second Intervention Period|Adverse Event|1
365076|NCT00991276|1230535|P3|Second Intervention Period|Adverse Event|0
365077|NCT00991276|1230536|P2|Second Intervention Period|Adverse Event|2
365078|NCT00991276|1230537|P1|Second Intervention Period|Adverse Event|0
365079|NCT00991276|1230532|P6|First Intervention Period|Lost to Follow-up|0
365080|NCT00991276|1230533|P5|First Intervention Period|Lost to Follow-up|0
365081|NCT00991276|1230534|P4|First Intervention Period|Lost to Follow-up|1
365082|NCT00991276|1230535|P3|First Intervention Period|Lost to Follow-up|0
365083|NCT00991276|1230536|P2|First Intervention Period|Lost to Follow-up|1
365084|NCT00991276|1230537|P1|First Intervention Period|Lost to Follow-up|0
365085|NCT00991276|1230532|P6|First Intervention Period|Withdrawal by Subject|1
365086|NCT00991276|1230533|P5|First Intervention Period|Withdrawal by Subject|0
365087|NCT00991276|1230534|P4|First Intervention Period|Withdrawal by Subject|1
365088|NCT00991276|1230535|P3|First Intervention Period|Withdrawal by Subject|0
365089|NCT00991276|1230536|P2|First Intervention Period|Withdrawal by Subject|1
365090|NCT00991276|1230537|P1|First Intervention Period|Withdrawal by Subject|0
365091|NCT00991276|1230532|P6|First Intervention Period|Other|0
365092|NCT00991276|1230533|P5|First Intervention Period|Other|1
365093|NCT00991276|1230534|P4|First Intervention Period|Other|1
365094|NCT00991276|1230535|P3|First Intervention Period|Other|0
365095|NCT00991276|1230536|P2|First Intervention Period|Other|0
365096|NCT00991276|1230537|P1|First Intervention Period|Other|0
365097|NCT00991276|1230532|P6|First Intervention Period|Insufficient clinical response|0
365098|NCT00991276|1230533|P5|First Intervention Period|Insufficient clinical response|1
365099|NCT00991276|1230534|P4|First Intervention Period|Insufficient clinical response|0
365100|NCT00991276|1230535|P3|First Intervention Period|Insufficient clinical response|0
365101|NCT00991276|1230536|P2|First Intervention Period|Insufficient clinical response|0
365102|NCT00991276|1230537|P1|First Intervention Period|Insufficient clinical response|0
365103|NCT00991276|1230532|P6|First Intervention Period|Protocol Violation|0
365104|NCT00991276|1230533|P5|First Intervention Period|Protocol Violation|2
365105|NCT00991276|1230534|P4|First Intervention Period|Protocol Violation|0
365106|NCT00991276|1230535|P3|First Intervention Period|Protocol Violation|0
365107|NCT00991276|1230536|P2|First Intervention Period|Protocol Violation|0
365108|NCT00991276|1230537|P1|First Intervention Period|Protocol Violation|0
365109|NCT00991276|1230532|P6|First Intervention Period|Adverse Event|0
365110|NCT00991276|1230533|P5|First Intervention Period|Adverse Event|0
365111|NCT00991276|1230534|P4|First Intervention Period|Adverse Event|1
365112|NCT00991276|1230535|P3|First Intervention Period|Adverse Event|0
365113|NCT00991276|1230536|P2|First Intervention Period|Adverse Event|1
365114|NCT00991276|1230537|P1|First Intervention Period|Adverse Event|0
365115|NCT00990821|1230694|P14|Overall Study|Withdrawal by Subject|1
365116|NCT00990821|1230695|P13|Overall Study|Withdrawal by Subject|2
365117|NCT00990821|1230696|P12|Overall Study|Withdrawal by Subject|5
365118|NCT00990821|1230697|P11|Overall Study|Withdrawal by Subject|3
365119|NCT00990821|1230698|P10|Overall Study|Withdrawal by Subject|1
365120|NCT00990821|1230699|P9|Overall Study|Withdrawal by Subject|0
365121|NCT00990821|1230700|P8|Overall Study|Withdrawal by Subject|0
365122|NCT00990821|1230701|P7|Overall Study|Withdrawal by Subject|1
365123|NCT00990821|1230702|P6|Overall Study|Withdrawal by Subject|3
365124|NCT00990821|1230703|P5|Overall Study|Withdrawal by Subject|3
365125|NCT00990821|1230704|P4|Overall Study|Withdrawal by Subject|0
365126|NCT00990821|1230705|P3|Overall Study|Withdrawal by Subject|0
365127|NCT00990821|1230706|P2|Overall Study|Withdrawal by Subject|2
365128|NCT00990821|1230707|P1|Overall Study|Withdrawal by Subject|0
365129|NCT00990704|1230744|P2|Overall Study|Physician Decision|1
365130|NCT00990704|1230745|P1|Overall Study|Physician Decision|0
365131|NCT00990704|1230744|P2|Overall Study|Adverse Event|1
365132|NCT00990704|1230745|P1|Overall Study|Adverse Event|1
365133|NCT00990652|1230765|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
365134|NCT00990652|1230765|P1|Pre-surgical Bortezomib|Adverse Event|1
365135|NCT00990340|1230799|P2|First 14-day Treatment|Protocol Violation|2
365136|NCT00990340|1230800|P1|First 14-day Treatment|Protocol Violation|2
365137|NCT00990340|1230799|P2|First 14-day Treatment|Lost to Follow-up|1
365138|NCT00990340|1230800|P1|First 14-day Treatment|Lost to Follow-up|2
365139|NCT00990340|1230799|P2|First 14-day Treatment|Not Compliant|1
365140|NCT00990340|1230800|P1|First 14-day Treatment|Not Compliant|2
365141|NCT00990184|1230847|P1|Overall Study|Physician Decision|1
365142|NCT00990106|1230855|P2|Overall Study|scheduling conflicts|2
365143|NCT00990106|1230856|P1|Overall Study|scheduling conflicts|0
365144|NCT00990106|1230855|P2|Overall Study|planned major surgery|1
365145|NCT00990106|1230856|P1|Overall Study|planned major surgery|0
365146|NCT00990106|1230855|P2|Overall Study|started exclusionary medication|1
365147|NCT00990106|1230856|P1|Overall Study|started exclusionary medication|0
365148|NCT00990106|1230855|P2|Overall Study|relocation/deployment|1
365149|NCT00990106|1230856|P1|Overall Study|relocation/deployment|4
365150|NCT00990106|1230855|P2|Overall Study|opted for open label prazosin|1
365151|NCT00990106|1230856|P1|Overall Study|opted for open label prazosin|1
365152|NCT00990106|1230855|P2|Overall Study|Withdrawal by Subject|1
365153|NCT00990106|1230856|P1|Overall Study|Withdrawal by Subject|2
365154|NCT00990106|1230855|P2|Overall Study|Lost to Follow-up|3
365155|NCT00990106|1230856|P1|Overall Study|Lost to Follow-up|1
365156|NCT00990106|1230855|P2|Overall Study|"too busy to continue"|2
365157|NCT00990106|1230856|P1|Overall Study|"too busy to continue"|1
365158|NCT00990093|1230866|P2|Test Period 2 (15-28 Days)|Not specified|1
365159|NCT00990093|1230867|P1|Test Period 2 (15-28 Days)|Not specified|0
365160|NCT00990093|1230866|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
365161|NCT00990093|1230867|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
365162|NCT00990093|1230866|P2|Test Period 2 (15-28 Days)|Adverse Event|0
365163|NCT00990093|1230867|P1|Test Period 2 (15-28 Days)|Adverse Event|1
365164|NCT00990093|1230866|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
365165|NCT00990093|1230867|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
365166|NCT00990093|1230866|P2|Test Period 1 (1-14 Days)|Not Specified|0
365167|NCT00990093|1230867|P1|Test Period 1 (1-14 Days)|Not Specified|1
365168|NCT00990093|1230866|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
365169|NCT00990093|1230867|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
365170|NCT00990093|1230866|P2|Test Period 1 (1-14 Days)|Adverse Event|0
365171|NCT00990093|1230867|P1|Test Period 1 (1-14 Days)|Adverse Event|1
365172|NCT00989950|1230920|P4|Randomized Phase|Adverse Event|0
365173|NCT00989950|1230921|P3|Randomized Phase|Adverse Event|0
365174|NCT00989950|1230922|P2|Randomized Phase|Adverse Event|1
365175|NCT00989950|1230923|P1|Randomized Phase|Adverse Event|0
365176|NCT00989950|1230920|P4|Randomized Phase|Protocol Violation|0
365177|NCT00989950|1230921|P3|Randomized Phase|Protocol Violation|0
365178|NCT00989950|1230922|P2|Randomized Phase|Protocol Violation|0
365179|NCT00989950|1230923|P1|Randomized Phase|Protocol Violation|1
365180|NCT00989833|1230940|P3|Overall Study|Incorrectly randomized|0
365181|NCT00989833|1230941|P2|Overall Study|Incorrectly randomized|0
365182|NCT00989833|1230942|P1|Overall Study|Incorrectly randomized|1
365183|NCT00989833|1230940|P3|Overall Study|Withdrawal by Subject|1
365184|NCT00989833|1230941|P2|Overall Study|Withdrawal by Subject|0
365185|NCT00989833|1230942|P1|Overall Study|Withdrawal by Subject|0
365186|NCT00989833|1230940|P3|Overall Study|Protocol Violation|1
365187|NCT00989833|1230941|P2|Overall Study|Protocol Violation|2
365188|NCT00989833|1230942|P1|Overall Study|Protocol Violation|1
365189|NCT00989833|1230940|P3|Overall Study|Lost to Follow-up|0
365190|NCT00989833|1230941|P2|Overall Study|Lost to Follow-up|1
365191|NCT00989833|1230942|P1|Overall Study|Lost to Follow-up|0
365192|NCT00989781|1230973|P2|Ovarian Response to hCG|Lost to Follow-up|2
365193|NCT00989781|1230974|P1|Ovarian Response to hCG|Lost to Follow-up|3
365194|NCT00989664|1231004|P1|Long-Term Follow-Up|Death|3
365195|NCT00989664|1231004|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
365196|NCT00989664|1231004|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
365197|NCT00989664|1231004|P1|Dosimetric and Therapeutic Treatment|Death|1
365198|NCT00989664|1231004|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
365199|NCT00989664|1231004|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
365200|NCT00989664|1231004|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
365201|NCT00989287|1231050|P2|Overall Study|Lost to Follow-up|1
365202|NCT00989287|1231051|P1|Overall Study|Lost to Follow-up|0
365203|NCT00989287|1231050|P2|Overall Study|Adverse Event|0
365204|NCT00989287|1231051|P1|Overall Study|Adverse Event|1
365205|NCT00989235|1231153|P2|Overall Study|Lost to Follow-up|1
365206|NCT00989235|1231154|P1|Overall Study|Lost to Follow-up|0
365207|NCT00989235|1231153|P2|Overall Study|Randomized by Mistake|2
365208|NCT00989235|1231154|P1|Overall Study|Randomized by Mistake|0
365209|NCT00989235|1231153|P2|Overall Study|Desire to Become Pregnant|0
365210|NCT00989235|1231154|P1|Overall Study|Desire to Become Pregnant|1
365211|NCT00989235|1231153|P2|Overall Study|Withdrawal of Consent|1
365212|NCT00989235|1231154|P1|Overall Study|Withdrawal of Consent|1
365213|NCT00989235|1231153|P2|Overall Study|Lack of Efficacy|0
365214|NCT00989235|1231154|P1|Overall Study|Lack of Efficacy|1
365215|NCT00989235|1231153|P2|Overall Study|Adverse Event|1
365216|NCT00989235|1231154|P1|Overall Study|Adverse Event|0
365217|NCT00989235|1231153|P2|Overall Study|Death|1
365218|NCT00989235|1231154|P1|Overall Study|Death|0
365219|NCT00989196|1231199|P2|Treatment Period|Lost to Follow-up|0
365220|NCT00989196|1231200|P1|Treatment Period|Lost to Follow-up|1
365221|NCT00989092|1231238|P2|Overall Study|Did not receive study drug|0
365222|NCT00989092|1231239|P1|Overall Study|Did not receive study drug|2
365223|NCT00989092|1231238|P2|Overall Study|Erythropoietin therapy initiated|0
365224|NCT00989092|1231239|P1|Overall Study|Erythropoietin therapy initiated|2
365225|NCT00989092|1231238|P2|Overall Study|Protocol deviation|0
365226|NCT00989092|1231239|P1|Overall Study|Protocol deviation|2
365227|NCT00989092|1231238|P2|Overall Study|Other|1
365228|NCT00989092|1231239|P1|Overall Study|Other|3
365229|NCT00989092|1231238|P2|Overall Study|Lost to Follow-up|2
365230|NCT00989092|1231239|P1|Overall Study|Lost to Follow-up|6
365231|NCT00989092|1231238|P2|Overall Study|Ineligibility determined|3
365232|NCT00989092|1231239|P1|Overall Study|Ineligibility determined|3
365233|NCT00989092|1231238|P2|Overall Study|Death|2
365234|NCT00989092|1231239|P1|Overall Study|Death|14
365235|NCT00989092|1231238|P2|Overall Study|Withdrawal by Subject|9
365236|NCT00989092|1231239|P1|Overall Study|Withdrawal by Subject|17
365237|NCT00989092|1231238|P2|Overall Study|Chemotherapy initiated|4
365238|NCT00989092|1231239|P1|Overall Study|Chemotherapy initiated|12
365239|NCT00989092|1231238|P2|Overall Study|Adverse Event|1
365240|NCT00989092|1231239|P1|Overall Study|Adverse Event|20
365241|NCT00989092|1231238|P2|Overall Study|Physician Decision|6
365242|NCT00989092|1231239|P1|Overall Study|Physician Decision|9
365243|NCT00988884|1231291|P2|Overall Study|Withdrawal by Subject|18
365244|NCT00988884|1231292|P1|Overall Study|Withdrawal by Subject|15
365245|NCT00988884|1231291|P2|Overall Study|Protocol Violation|1
365246|NCT00988884|1231292|P1|Overall Study|Protocol Violation|0
365247|NCT00988884|1231291|P2|Overall Study|Lost to Follow-up|16
365248|NCT00988884|1231292|P1|Overall Study|Lost to Follow-up|20
365249|NCT00988884|1231291|P2|Overall Study|Adverse Event|1
365250|NCT00988884|1231292|P1|Overall Study|Adverse Event|0
365251|NCT00988858|1231314|P1|Overall Study|Sponsor Decision|1
365252|NCT00988858|1231314|P1|Overall Study|Physician Decision|1
365253|NCT00988858|1231314|P1|Overall Study|Death|1
365254|NCT00988858|1231314|P1|Overall Study|Adverse Event|7
365255|NCT00988637|1231363|P2|Overall Study|non-compliance with study drug|1
365256|NCT00988637|1231364|P1|Overall Study|non-compliance with study drug|0
365257|NCT00988637|1231363|P2|Overall Study|Withdrawal by Subject|1
365258|NCT00988637|1231364|P1|Overall Study|Withdrawal by Subject|1
365259|NCT00988637|1231363|P2|Overall Study|Lost to Follow-up|1
365260|NCT00988637|1231364|P1|Overall Study|Lost to Follow-up|2
365261|NCT00988533|1231394|P1|Overall Study|Lost to Follow-up|3
365262|NCT00988442|1231408|P2|Overall Study|Early Study Closure|25
365263|NCT00988442|1231409|P1|Overall Study|Early Study Closure|29
365264|NCT00988442|1231408|P2|Overall Study|Lost to Follow-up|1
365265|NCT00988442|1231409|P1|Overall Study|Lost to Follow-up|0
365266|NCT00988442|1231408|P2|Overall Study|Death|2
365267|NCT00988442|1231409|P1|Overall Study|Death|1
365268|NCT00988429|1231472|P3|Overall Study|other reasons|1
365269|NCT00988429|1231473|P2|Overall Study|other reasons|8
365270|NCT00988429|1231474|P1|Overall Study|other reasons|8
365271|NCT00988429|1231472|P3|Overall Study|Administrative Reasons|1
365272|NCT00988429|1231473|P2|Overall Study|Administrative Reasons|2
365273|NCT00988429|1231474|P1|Overall Study|Administrative Reasons|1
365274|NCT00988429|1231472|P3|Overall Study|Withdrawal by Subject|12
365275|NCT00988429|1231473|P2|Overall Study|Withdrawal by Subject|7
365276|NCT00988429|1231474|P1|Overall Study|Withdrawal by Subject|7
365277|NCT00988429|1231472|P3|Overall Study|Protocol Violation|3
365278|NCT00988429|1231473|P2|Overall Study|Protocol Violation|3
365279|NCT00988429|1231474|P1|Overall Study|Protocol Violation|4
365280|NCT00988429|1231472|P3|Overall Study|Pregnancy|0
365281|NCT00988429|1231473|P2|Overall Study|Pregnancy|1
365282|NCT00988429|1231474|P1|Overall Study|Pregnancy|2
365283|NCT00988429|1231472|P3|Overall Study|Physician Decision|3
365284|NCT00988429|1231473|P2|Overall Study|Physician Decision|0
365285|NCT00988429|1231474|P1|Overall Study|Physician Decision|1
365286|NCT00988429|1231472|P3|Overall Study|Non-Compliance with Study Drug|3
365287|NCT00988429|1231473|P2|Overall Study|Non-Compliance with Study Drug|1
365288|NCT00988429|1231474|P1|Overall Study|Non-Compliance with Study Drug|5
365289|NCT00988429|1231472|P3|Overall Study|Lack of Efficacy|1
365290|NCT00988429|1231473|P2|Overall Study|Lack of Efficacy|0
365291|NCT00988429|1231474|P1|Overall Study|Lack of Efficacy|0
365292|NCT00988429|1231472|P3|Overall Study|Adverse Event|45
365293|NCT00988429|1231473|P2|Overall Study|Adverse Event|21
365294|NCT00988429|1231474|P1|Overall Study|Adverse Event|9
365295|NCT00988351|1231487|P2|Overall Study|not using CPAP|3
365296|NCT00988351|1231488|P1|Overall Study|not using CPAP|5
365297|NCT00988351|1231487|P2|Overall Study|Lost to Follow-up|9
365298|NCT00988351|1231488|P1|Overall Study|Lost to Follow-up|6
365299|NCT00988351|1231487|P2|Overall Study|Withdrawal by Subject|0
365300|NCT00988351|1231488|P1|Overall Study|Withdrawal by Subject|8
365301|NCT00988247|1231565|P2|Overall Study|Not specified|0
365302|NCT00988247|1231566|P1|Overall Study|Not specified|3
365303|NCT00988247|1231565|P2|Overall Study|Sponsor requested withdrawal|1
365304|NCT00988247|1231566|P1|Overall Study|Sponsor requested withdrawal|3
365305|NCT00988247|1231565|P2|Overall Study|Protocol Violation|5
365306|NCT00988247|1231566|P1|Overall Study|Protocol Violation|4
365307|NCT00988247|1231565|P2|Overall Study|Lost to Follow-up|2
365308|NCT00988247|1231566|P1|Overall Study|Lost to Follow-up|11
365309|NCT00988247|1231565|P2|Overall Study|Pregnancy|2
365310|NCT00988247|1231566|P1|Overall Study|Pregnancy|1
365311|NCT00988247|1231565|P2|Overall Study|Withdrawal by Subject|13
365312|NCT00988247|1231566|P1|Overall Study|Withdrawal by Subject|44
365313|NCT00988247|1231565|P2|Overall Study|Adverse Event|3
365314|NCT00988247|1231566|P1|Overall Study|Adverse Event|17
365315|NCT00988221|1231585|P4|Part III|Refused Treatment|0
365316|NCT00988221|1231586|P3|Part III|Refused Treatment|1
365317|NCT00988221|1231587|P2|Part III|Refused Treatment|0
365318|NCT00988221|1231588|P1|Part III|Refused Treatment|0
365319|NCT00988221|1231585|P4|Part III|Insufficient Therapeutic Response|0
365320|NCT00988221|1231586|P3|Part III|Insufficient Therapeutic Response|1
365321|NCT00988221|1231587|P2|Part III|Insufficient Therapeutic Response|1
365322|NCT00988221|1231588|P1|Part III|Insufficient Therapeutic Response|0
365323|NCT00988221|1231585|P4|Part III|Adverse Event|0
365324|NCT00988221|1231586|P3|Part III|Adverse Event|1
365325|NCT00988221|1231587|P2|Part III|Adverse Event|0
365326|NCT00988221|1231588|P1|Part III|Adverse Event|1
365327|NCT00988221|1231585|P4|Part II|Reason not Specified|0
365328|NCT00988221|1231586|P3|Part II|Reason not Specified|1
365329|NCT00988221|1231587|P2|Part II|Reason not Specified|0
365330|NCT00988221|1231588|P1|Part II|Reason not Specified|0
365331|NCT00988221|1231585|P4|Part II|Withdrawal by Subject|2
365332|NCT00988221|1231586|P3|Part II|Withdrawal by Subject|2
365333|NCT00988221|1231587|P2|Part II|Withdrawal by Subject|0
365334|NCT00988221|1231588|P1|Part II|Withdrawal by Subject|0
365335|NCT00988221|1231585|P4|Part II|Adverse Event|1
365336|NCT00988221|1231586|P3|Part II|Adverse Event|0
365337|NCT00988221|1231587|P2|Part II|Adverse Event|0
365338|NCT00988221|1231588|P1|Part II|Adverse Event|1
365339|NCT00988221|1231585|P4|Part I|Lost to Follow-up|0
365340|NCT00988221|1231586|P3|Part I|Lost to Follow-up|0
365341|NCT00988221|1231587|P2|Part I|Lost to Follow-up|1
365342|NCT00988221|1231588|P1|Part I|Lost to Follow-up|0
365343|NCT00988221|1231585|P4|Part I|Refused Treatment|0
365344|NCT00988221|1231586|P3|Part I|Refused Treatment|1
365345|NCT00988221|1231587|P2|Part I|Refused Treatment|2
365346|NCT00988221|1231588|P1|Part I|Refused Treatment|0
365347|NCT00988221|1231585|P4|Part I|Insufficient Therapeutic Response|0
365348|NCT00988221|1231586|P3|Part I|Insufficient Therapeutic Response|5
365349|NCT00988221|1231587|P2|Part I|Insufficient Therapeutic Response|6
365350|NCT00988221|1231588|P1|Part I|Insufficient Therapeutic Response|4
365351|NCT00988221|1231585|P4|Part I|Adverse Event|0
365352|NCT00988221|1231586|P3|Part I|Adverse Event|2
365353|NCT00988221|1231587|P2|Part I|Adverse Event|1
365354|NCT00988221|1231588|P1|Part I|Adverse Event|0
365355|NCT00988208|1231761|P2|Overall Study|Other|3
365356|NCT00988208|1231762|P1|Overall Study|Other|8
365357|NCT00988208|1231761|P2|Overall Study|Subject Decision/Investigator Discretion|32
365358|NCT00988208|1231762|P1|Overall Study|Subject Decision/Investigator Discretion|32
365359|NCT00988208|1231761|P2|Overall Study|Clinical Deterioration|14
365360|NCT00988208|1231762|P1|Overall Study|Clinical Deterioration|7
365361|NCT00988208|1231761|P2|Overall Study|Biochemical Progression|7
365362|NCT00988208|1231762|P1|Overall Study|Biochemical Progression|21
365363|NCT00988208|1231761|P2|Overall Study|Clinical Progression|16
365364|NCT00988208|1231762|P1|Overall Study|Clinical Progression|17
365365|NCT00988208|1231761|P2|Overall Study|Sponsor Decision|78
365366|NCT00988208|1231762|P1|Overall Study|Sponsor Decision|102
365367|NCT00988208|1231761|P2|Overall Study|Protocol Violation|2
365368|NCT00988208|1231762|P1|Overall Study|Protocol Violation|9
365369|NCT00988208|1231761|P2|Overall Study|Lost to Follow-up|3
365370|NCT00988208|1231762|P1|Overall Study|Lost to Follow-up|2
365371|NCT00988208|1231761|P2|Overall Study|Death|15
365372|NCT00988208|1231762|P1|Overall Study|Death|9
365373|NCT00988208|1231761|P2|Overall Study|Withdrawal by Subject|57
365374|NCT00988208|1231762|P1|Overall Study|Withdrawal by Subject|50
365375|NCT00988208|1231761|P2|Overall Study|Disease Progression|89
365376|NCT00988208|1231762|P1|Overall Study|Disease Progression|103
365377|NCT00988208|1231761|P2|Overall Study|Adverse Event|122
365378|NCT00988208|1231762|P1|Overall Study|Adverse Event|71
365379|NCT00988169|1231780|P1|Overall Study|Withdrawal by Subject|1
365380|NCT00988117|1231832|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
365381|NCT00988117|1231832|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
365382|NCT00988091|1231841|P2|Open-label Period|Not specified|3
365383|NCT00988091|1231842|P1|Open-label Period|Not specified|2
365384|NCT00988091|1231841|P2|Open-label Period|Lost to Follow-up|5
365385|NCT00988091|1231842|P1|Open-label Period|Lost to Follow-up|3
365386|NCT00988091|1231841|P2|Open-label Period|Withdrawal by Subject|16
365387|NCT00988091|1231842|P1|Open-label Period|Withdrawal by Subject|10
365388|NCT00988091|1231841|P2|Open-label Period|Protocol Violation|1
365389|NCT00988091|1231842|P1|Open-label Period|Protocol Violation|1
365390|NCT00988091|1231841|P2|Open-label Period|Use of exclusionary medication|1
365391|NCT00988091|1231842|P1|Open-label Period|Use of exclusionary medication|1
365392|NCT00988091|1231841|P2|Open-label Period|Adverse Event|7
365393|NCT00988091|1231842|P1|Open-label Period|Adverse Event|4
365394|NCT00988091|1231841|P2|Double-blind Period|Use of exclusionary medication|3
365395|NCT00988091|1231842|P1|Double-blind Period|Use of exclusionary medication|2
365396|NCT00988091|1231841|P2|Double-blind Period|Adverse Event|9
365397|NCT00988091|1231842|P1|Double-blind Period|Adverse Event|6
365398|NCT00988091|1231841|P2|Double-blind Period|Not specified|8
365399|NCT00988091|1231842|P1|Double-blind Period|Not specified|8
365400|NCT00988091|1231841|P2|Double-blind Period|Lost to Follow-up|14
365401|NCT00988091|1231842|P1|Double-blind Period|Lost to Follow-up|12
365402|NCT00988091|1231841|P2|Double-blind Period|Withdrawal by Subject|13
365403|NCT00988091|1231842|P1|Double-blind Period|Withdrawal by Subject|15
365404|NCT00988065|1231864|P3|Overall Study|Noncompliance with protocol|9
365405|NCT00988065|1231865|P2|Overall Study|Noncompliance with protocol|6
365406|NCT00988065|1231866|P1|Overall Study|Noncompliance with protocol|5
365407|NCT00988065|1231864|P3|Overall Study|Subject withdrew consent|2
365408|NCT00988065|1231865|P2|Overall Study|Subject withdrew consent|5
365409|NCT00988065|1231866|P1|Overall Study|Subject withdrew consent|3
365410|NCT00988065|1231864|P3|Overall Study|Lost to Follow-up|2
365411|NCT00988065|1231865|P2|Overall Study|Lost to Follow-up|2
365412|NCT00988065|1231866|P1|Overall Study|Lost to Follow-up|1
365413|NCT00988065|1231864|P3|Overall Study|Adverse Event|2
365414|NCT00988065|1231865|P2|Overall Study|Adverse Event|10
365415|NCT00988065|1231866|P1|Overall Study|Adverse Event|4
365416|NCT00987935|1231900|P9|Overall Study|Reason other than those specified above|1
365417|NCT00987935|1231901|P8|Overall Study|Reason other than those specified above|0
365418|NCT00987935|1231902|P7|Overall Study|Reason other than those specified above|0
365419|NCT00987935|1231903|P6|Overall Study|Reason other than those specified above|0
365420|NCT00987935|1231904|P5|Overall Study|Reason other than those specified above|0
365421|NCT00987935|1231905|P4|Overall Study|Reason other than those specified above|0
365422|NCT00987935|1231906|P3|Overall Study|Reason other than those specified above|0
365423|NCT00987935|1231907|P2|Overall Study|Reason other than those specified above|0
365424|NCT00987935|1231908|P1|Overall Study|Reason other than those specified above|0
365425|NCT00987935|1231900|P9|Overall Study|Refused to continue taking trial med.|2
365426|NCT00987935|1231901|P8|Overall Study|Refused to continue taking trial med.|4
365427|NCT00987935|1231902|P7|Overall Study|Refused to continue taking trial med.|4
365428|NCT00987935|1231903|P6|Overall Study|Refused to continue taking trial med.|0
365429|NCT00987935|1231904|P5|Overall Study|Refused to continue taking trial med.|1
365430|NCT00987935|1231905|P4|Overall Study|Refused to continue taking trial med.|0
365431|NCT00987935|1231906|P3|Overall Study|Refused to continue taking trial med.|0
365432|NCT00987935|1231907|P2|Overall Study|Refused to continue taking trial med.|0
365433|NCT00987935|1231908|P1|Overall Study|Refused to continue taking trial med.|1
365434|NCT00987935|1231900|P9|Overall Study|Adverse Event|6
365435|NCT00987935|1231901|P8|Overall Study|Adverse Event|10
365436|NCT00987935|1231902|P7|Overall Study|Adverse Event|2
365437|NCT00987935|1231903|P6|Overall Study|Adverse Event|0
365438|NCT00987935|1231904|P5|Overall Study|Adverse Event|1
365439|NCT00987935|1231905|P4|Overall Study|Adverse Event|1
365440|NCT00987935|1231906|P3|Overall Study|Adverse Event|0
365441|NCT00987935|1231907|P2|Overall Study|Adverse Event|1
365442|NCT00987935|1231908|P1|Overall Study|Adverse Event|0
365443|NCT00987935|1231900|P9|Overall Study|Progressive disease|23
365444|NCT00987935|1231901|P8|Overall Study|Progressive disease|48
365445|NCT00987935|1231902|P7|Overall Study|Progressive disease|9
365446|NCT00987935|1231903|P6|Overall Study|Progressive disease|3
365447|NCT00987935|1231904|P5|Overall Study|Progressive disease|5
365448|NCT00987935|1231905|P4|Overall Study|Progressive disease|2
365449|NCT00987935|1231906|P3|Overall Study|Progressive disease|3
365450|NCT00987935|1231907|P2|Overall Study|Progressive disease|2
365451|NCT00987935|1231908|P1|Overall Study|Progressive disease|3
365452|NCT00987831|1231964|P3|Overall Study|Lost to Follow-up|0
365453|NCT00987831|1231965|P2|Overall Study|Lost to Follow-up|3
365454|NCT00987831|1231966|P1|Overall Study|Lost to Follow-up|0
365455|NCT00987831|1231964|P3|Overall Study|Never flared in 12 months|0
365456|NCT00987831|1231965|P2|Overall Study|Never flared in 12 months|0
365457|NCT00987831|1231966|P1|Overall Study|Never flared in 12 months|1
365458|NCT00987623|1231988|P2|Overall Study|Influenza|1
365459|NCT00987623|1231989|P1|Overall Study|Influenza|0
365460|NCT00987623|1231988|P2|Overall Study|Biomicroscopy|1
365461|NCT00987623|1231989|P1|Overall Study|Biomicroscopy|0
365462|NCT00987623|1231988|P2|Overall Study|Discomfort|0
365463|NCT00987623|1231989|P1|Overall Study|Discomfort|1
365464|NCT00987623|1231988|P2|Overall Study|Time/job conflict|0
365465|NCT00987623|1231989|P1|Overall Study|Time/job conflict|2
365466|NCT00987623|1231988|P2|Overall Study|Lost to Follow-up|1
365467|NCT00987623|1231989|P1|Overall Study|Lost to Follow-up|2
365468|NCT00987467|1232009|P1|Overall Study|Lost to Follow-up|2
365469|NCT00987402|1232033|P2|Overall Study|Insufficient data entry|98
365470|NCT00987402|1232034|P1|Overall Study|Insufficient data entry|86
365471|NCT00987337|1232043|P3|Overall Study|Participant Relapsed|5
365472|NCT00987337|1232044|P2|Overall Study|Participant Relapsed|20
365473|NCT00987337|1232045|P1|Overall Study|Participant Relapsed|18
365474|NCT00987337|1232043|P3|Overall Study|Protocol Violation|2
365475|NCT00987337|1232044|P2|Overall Study|Protocol Violation|0
365476|NCT00987337|1232045|P1|Overall Study|Protocol Violation|1
365477|NCT00987337|1232043|P3|Overall Study|Other|5
365478|NCT00987337|1232044|P2|Overall Study|Other|2
365479|NCT00987337|1232045|P1|Overall Study|Other|0
365480|NCT00987337|1232043|P3|Overall Study|Withdrawal by Subject|9
365481|NCT00987337|1232044|P2|Overall Study|Withdrawal by Subject|9
365482|NCT00987337|1232045|P1|Overall Study|Withdrawal by Subject|6
365483|NCT00987337|1232043|P3|Overall Study|Lost to Follow-up|2
365484|NCT00987337|1232044|P2|Overall Study|Lost to Follow-up|6
365485|NCT00987337|1232045|P1|Overall Study|Lost to Follow-up|10
365486|NCT00987337|1232043|P3|Overall Study|Virologic Breakthrough|8
365487|NCT00987337|1232044|P2|Overall Study|Virologic Breakthrough|2
365488|NCT00987337|1232045|P1|Overall Study|Virologic Breakthrough|2
365489|NCT00987337|1232043|P3|Overall Study|Insufficient Virologic Response|12
365490|NCT00987337|1232044|P2|Overall Study|Insufficient Virologic Response|7
365491|NCT00987337|1232045|P1|Overall Study|Insufficient Virologic Response|10
365492|NCT00987337|1232043|P3|Overall Study|Adverse Event|8
365493|NCT00987337|1232044|P2|Overall Study|Adverse Event|9
365494|NCT00987337|1232045|P1|Overall Study|Adverse Event|10
365495|NCT00986986|1232100|P2|Overall Study|Lost to Follow-up|1
365496|NCT00986986|1232101|P1|Overall Study|Lost to Follow-up|0
365497|NCT00986973|1232111|P1|Overall Study|Withdrawn by study team|1
365498|NCT00986921|1232137|P2|Overall Study|Physician Decision|0
365499|NCT00986921|1232138|P1|Overall Study|Physician Decision|1
365500|NCT00986674|1232174|P3|Overall Study|unknown/not specify|9
365501|NCT00986674|1232175|P2|Overall Study|unknown/not specify|7
365502|NCT00986674|1232176|P1|Overall Study|unknown/not specify|0
365503|NCT00986674|1232174|P3|Overall Study|not start protocol therapy|1
365504|NCT00986674|1232175|P2|Overall Study|not start protocol therapy|3
365505|NCT00986674|1232176|P1|Overall Study|not start protocol therapy|4
365506|NCT00986674|1232174|P3|Overall Study|alternative therapy|1
365507|NCT00986674|1232175|P2|Overall Study|alternative therapy|0
365508|NCT00986674|1232176|P1|Overall Study|alternative therapy|0
365509|NCT00986674|1232174|P3|Overall Study|Withdrawal by Subject|1
365510|NCT00986674|1232175|P2|Overall Study|Withdrawal by Subject|2
365511|NCT00986674|1232176|P1|Overall Study|Withdrawal by Subject|6
365512|NCT00986674|1232174|P3|Overall Study|Death|4
365513|NCT00986674|1232175|P2|Overall Study|Death|0
365514|NCT00986674|1232176|P1|Overall Study|Death|5
365515|NCT00986674|1232174|P3|Overall Study|Adverse Event|9
365516|NCT00986674|1232175|P2|Overall Study|Adverse Event|8
365517|NCT00986674|1232176|P1|Overall Study|Adverse Event|4
365518|NCT00986674|1232174|P3|Overall Study|Lack of Efficacy|23
365519|NCT00986674|1232175|P2|Overall Study|Lack of Efficacy|25
365520|NCT00986674|1232176|P1|Overall Study|Lack of Efficacy|28
365521|NCT00986570|1232209|P1|Overall Study|Potential bias for objective assessment|1
365522|NCT00986570|1232209|P1|Overall Study|Lost to Follow-up|6
365523|NCT00986479|1232226|P2|Period 1|Administrative reasons|0
365524|NCT00986479|1232227|P1|Period 1|Administrative reasons|1
365525|NCT00986479|1232226|P2|Period 1|Improved mood|0
365526|NCT00986479|1232227|P1|Period 1|Improved mood|1
365527|NCT00986427|1232273|P2|Overall Study|Withdrawal by Subject|0
365528|NCT00986427|1232274|P1|Overall Study|Withdrawal by Subject|1
365529|NCT00986427|1232273|P2|Overall Study|Lack of Efficacy|0
365530|NCT00986427|1232274|P1|Overall Study|Lack of Efficacy|1
365531|NCT00986427|1232273|P2|Overall Study|Lost to Follow-up|0
365532|NCT00986427|1232274|P1|Overall Study|Lost to Follow-up|2
365533|NCT00986362|1232302|P2|Overall Study|Lost to Follow-up|1
365534|NCT00986362|1232303|P1|Overall Study|Lost to Follow-up|0
365535|NCT00986362|1232302|P2|Overall Study|Death|0
365536|NCT00986362|1232303|P1|Overall Study|Death|2
365537|NCT00986349|1232309|P1|Overall Study|device migration|1
365538|NCT00986349|1232309|P1|Overall Study|Physician Decision|1
365539|NCT00986349|1232309|P1|Overall Study|Adverse Event|2
365540|NCT00986349|1232309|P1|Overall Study|Unsuccessful implant procedure|3
365541|NCT00986258|1232322|P1|Maintenance Period|Withdrawal by Subject|2
365542|NCT00986258|1232322|P1|Maintenance Period|Lack of Efficacy|2
365543|NCT00986258|1232322|P1|Maintenance Period|Adverse Event|5
365544|NCT00986258|1232322|P1|Titration and Optimal Dose Period|Other|1
365545|NCT00986258|1232322|P1|Titration and Optimal Dose Period|Non-Compliance|1
365546|NCT00986258|1232322|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
365547|NCT00986258|1232322|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
365548|NCT00986258|1232322|P1|Titration and Optimal Dose Period|Adverse Event|15
365549|NCT00986258|1232322|P1|Observation Period|Not eligible to be dosed|11
365550|NCT00986245|1232350|P2|Second Intervention|Protocol Violation|1
365551|NCT00986245|1232351|P1|Second Intervention|Protocol Violation|0
365552|NCT00986245|1232350|P2|Second Intervention|Lost to Follow-up|0
365553|NCT00986245|1232351|P1|Second Intervention|Lost to Follow-up|1
365554|NCT00986245|1232350|P2|Second Intervention|Poor compliance|0
365555|NCT00986245|1232351|P1|Second Intervention|Poor compliance|1
365556|NCT00986245|1232350|P2|First Intervention|Out of indication|0
365557|NCT00986245|1232351|P1|First Intervention|Out of indication|1
365558|NCT00986245|1232350|P2|First Intervention|Protocol Violation|1
365559|NCT00986245|1232351|P1|First Intervention|Protocol Violation|0
365560|NCT00986245|1232350|P2|First Intervention|Withdrawal by Subject|1
365561|NCT00986245|1232351|P1|First Intervention|Withdrawal by Subject|0
365562|NCT00986245|1232350|P2|First Intervention|Lack of Efficacy|2
365563|NCT00986245|1232351|P1|First Intervention|Lack of Efficacy|1
365564|NCT00986245|1232350|P2|First Intervention|Poor compliance|4
365565|NCT00986245|1232351|P1|First Intervention|Poor compliance|8
365566|NCT00986232|1232388|P4|Overall Study|Incomplete safety follow-up|2
365567|NCT00986232|1232389|P3|Overall Study|Incomplete safety follow-up|2
365568|NCT00986232|1232390|P2|Overall Study|Incomplete safety follow-up|7
365569|NCT00986232|1232391|P1|Overall Study|Incomplete safety follow-up|3
365570|NCT00986232|1232388|P4|Overall Study|Missed one or more bleeds|7
365571|NCT00986232|1232389|P3|Overall Study|Missed one or more bleeds|6
365572|NCT00986232|1232390|P2|Overall Study|Missed one or more bleeds|10
365573|NCT00986232|1232391|P1|Overall Study|Missed one or more bleeds|13
365574|NCT00986232|1232388|P4|Overall Study|Withdrawal by Subject|3
365575|NCT00986232|1232389|P3|Overall Study|Withdrawal by Subject|12
365576|NCT00986232|1232390|P2|Overall Study|Withdrawal by Subject|16
365577|NCT00986232|1232391|P1|Overall Study|Withdrawal by Subject|13
365578|NCT00986232|1232388|P4|Overall Study|Protocol Violation|1
365579|NCT00986232|1232389|P3|Overall Study|Protocol Violation|0
365580|NCT00986232|1232390|P2|Overall Study|Protocol Violation|3
365581|NCT00986232|1232391|P1|Overall Study|Protocol Violation|2
365582|NCT00986232|1232388|P4|Overall Study|Lost to Follow-up|7
365583|NCT00986232|1232389|P3|Overall Study|Lost to Follow-up|12
365584|NCT00986232|1232390|P2|Overall Study|Lost to Follow-up|12
365585|NCT00986232|1232391|P1|Overall Study|Lost to Follow-up|19
365586|NCT00986232|1232388|P4|Overall Study|Adverse Event|0
365587|NCT00986232|1232389|P3|Overall Study|Adverse Event|3
365588|NCT00986232|1232390|P2|Overall Study|Adverse Event|2
365589|NCT00986232|1232391|P1|Overall Study|Adverse Event|1
365590|NCT00986180|1232465|P2|Overall Study|Miscellanies|11
365591|NCT00986180|1232466|P1|Overall Study|Miscellanies|10
365592|NCT00986180|1232465|P2|Overall Study|Withdrawal by Subject|9
365593|NCT00986180|1232466|P1|Overall Study|Withdrawal by Subject|1
365594|NCT00986180|1232465|P2|Overall Study|Protocol Violation|0
365595|NCT00986180|1232466|P1|Overall Study|Protocol Violation|2
365596|NCT00986180|1232465|P2|Overall Study|Physician Decision|3
365597|NCT00986180|1232466|P1|Overall Study|Physician Decision|1
365598|NCT00986180|1232465|P2|Overall Study|Lost to Follow-up|7
365599|NCT00986180|1232466|P1|Overall Study|Lost to Follow-up|5
365600|NCT00986180|1232465|P2|Overall Study|Lack of Efficacy|3
365601|NCT00986180|1232466|P1|Overall Study|Lack of Efficacy|4
365602|NCT00986180|1232465|P2|Overall Study|Adverse Event|23
365603|NCT00986180|1232466|P1|Overall Study|Adverse Event|21
365604|NCT00986154|1232544|P2|Overall Study|never received study drug|27
365605|NCT00986154|1232545|P1|Overall Study|never received study drug|25
365606|NCT00986154|1232544|P2|Overall Study|investigator/subject decide not continue|3
365607|NCT00986154|1232545|P1|Overall Study|investigator/subject decide not continue|6
365608|NCT00986154|1232544|P2|Overall Study|Withdrawal by Subject|33
365609|NCT00986154|1232545|P1|Overall Study|Withdrawal by Subject|32
365610|NCT00986154|1232544|P2|Overall Study|Lost to Follow-up|4
365611|NCT00986154|1232545|P1|Overall Study|Lost to Follow-up|7
365612|NCT00986154|1232544|P2|Overall Study|Death|127
365613|NCT00986154|1232545|P1|Overall Study|Death|136
365614|NCT00986102|1232559|P4|Overall Study|Withdrawal by Subject|0
365615|NCT00986102|1232560|P3|Overall Study|Withdrawal by Subject|0
365616|NCT00986102|1232561|P2|Overall Study|Withdrawal by Subject|1
365617|NCT00986102|1232562|P1|Overall Study|Withdrawal by Subject|1
365618|NCT00986102|1232559|P4|Overall Study|Lost to Follow-up|1
365619|NCT00986102|1232560|P3|Overall Study|Lost to Follow-up|0
365620|NCT00986102|1232561|P2|Overall Study|Lost to Follow-up|1
365621|NCT00986102|1232562|P1|Overall Study|Lost to Follow-up|0
365622|NCT00985985|1232612|P4|Overall Study|Other Reason|2
365623|NCT00985985|1232613|P3|Overall Study|Other Reason|4
365624|NCT00985985|1232614|P2|Overall Study|Other Reason|1
365625|NCT00985985|1232615|P1|Overall Study|Other Reason|6
365626|NCT00985985|1232612|P4|Overall Study|Withdrawal by Subject|2
365627|NCT00985985|1232613|P3|Overall Study|Withdrawal by Subject|2
365628|NCT00985985|1232614|P2|Overall Study|Withdrawal by Subject|2
365629|NCT00985985|1232615|P1|Overall Study|Withdrawal by Subject|4
365630|NCT00985985|1232612|P4|Overall Study|Lack of Efficacy|3
365631|NCT00985985|1232613|P3|Overall Study|Lack of Efficacy|1
365632|NCT00985985|1232614|P2|Overall Study|Lack of Efficacy|6
365633|NCT00985985|1232615|P1|Overall Study|Lack of Efficacy|5
365634|NCT00985985|1232612|P4|Overall Study|Protocol Violation|1
365635|NCT00985985|1232613|P3|Overall Study|Protocol Violation|0
365636|NCT00985985|1232614|P2|Overall Study|Protocol Violation|2
365637|NCT00985985|1232615|P1|Overall Study|Protocol Violation|1
365638|NCT00985985|1232612|P4|Overall Study|Lost to Follow-up|3
365639|NCT00985985|1232613|P3|Overall Study|Lost to Follow-up|2
365640|NCT00985985|1232614|P2|Overall Study|Lost to Follow-up|11
365641|NCT00985985|1232615|P1|Overall Study|Lost to Follow-up|4
365642|NCT00985985|1232612|P4|Overall Study|Adverse Event|2
365643|NCT00985985|1232613|P3|Overall Study|Adverse Event|2
365644|NCT00985985|1232614|P2|Overall Study|Adverse Event|2
365645|NCT00985985|1232615|P1|Overall Study|Adverse Event|4
365646|NCT00985959|1232656|P3|Overall Study|Other|11
365647|NCT00985959|1232657|P2|Overall Study|Other|0
365648|NCT00985959|1232658|P1|Overall Study|Other|0
365649|NCT00985959|1232656|P3|Overall Study|Complete response observed over 2 cycles|4
365650|NCT00985959|1232657|P2|Overall Study|Complete response observed over 2 cycles|1
365651|NCT00985959|1232658|P1|Overall Study|Complete response observed over 2 cycles|0
365652|NCT00985959|1232656|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
365653|NCT00985959|1232657|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
365654|NCT00985959|1232658|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
365655|NCT00985959|1232656|P3|Overall Study|Unrecovered toxicity|7
365656|NCT00985959|1232657|P2|Overall Study|Unrecovered toxicity|0
365657|NCT00985959|1232658|P1|Overall Study|Unrecovered toxicity|0
365658|NCT00985959|1232656|P3|Overall Study|Progressive disease|8
365659|NCT00985959|1232657|P2|Overall Study|Progressive disease|2
365660|NCT00985959|1232658|P1|Overall Study|Progressive disease|1
365661|NCT00985959|1232656|P3|Overall Study|Withdrawal by Subject|8
365662|NCT00985959|1232657|P2|Overall Study|Withdrawal by Subject|0
365663|NCT00985959|1232658|P1|Overall Study|Withdrawal by Subject|0
365664|NCT00985959|1232656|P3|Overall Study|Adverse Event|19
365665|NCT00985959|1232657|P2|Overall Study|Adverse Event|0
365666|NCT00985959|1232658|P1|Overall Study|Adverse Event|0
365667|NCT00985946|1232681|P1|Overall Study|Withdrawal by Subject|1
365668|NCT00985946|1232681|P1|Overall Study|Lost to Follow-up|6
365669|NCT00985790|1232700|P2|Overall Study|Lost to Follow-up|7
365670|NCT00985790|1232701|P1|Overall Study|Lost to Follow-up|6
365671|NCT00985790|1232700|P2|Overall Study|Withdrawal by Subject|1
365672|NCT00985790|1232701|P1|Overall Study|Withdrawal by Subject|1
365673|NCT00985751|1232742|P5|Overall Study|Adverse Event|1
365674|NCT00985751|1232743|P4|Overall Study|Adverse Event|0
365675|NCT00985751|1232744|P3|Overall Study|Adverse Event|0
365676|NCT00985751|1232745|P2|Overall Study|Adverse Event|0
365677|NCT00985751|1232746|P1|Overall Study|Adverse Event|0
365678|NCT00985738|1232809|P2|Overall Study|Study closed prematurely|8
365679|NCT00985738|1232810|P1|Overall Study|Study closed prematurely|8
365680|NCT00985725|1232818|P2|Overall Study|Out-of-window visits|1
365681|NCT00985725|1232819|P1|Overall Study|Out-of-window visits|0
365682|NCT00985725|1232818|P2|Overall Study|Non-compliance|2
365683|NCT00985725|1232819|P1|Overall Study|Non-compliance|1
365684|NCT00985725|1232818|P2|Overall Study|Lack of Efficacy|1
365685|NCT00985725|1232819|P1|Overall Study|Lack of Efficacy|0
365686|NCT00985725|1232818|P2|Overall Study|Lost to Follow-up|1
365687|NCT00985725|1232819|P1|Overall Study|Lost to Follow-up|1
365688|NCT00985725|1232818|P2|Overall Study|Withdrawal by Subject|4
365689|NCT00985725|1232819|P1|Overall Study|Withdrawal by Subject|4
365690|NCT00985725|1232818|P2|Overall Study|Protocol Violation|3
365691|NCT00985725|1232819|P1|Overall Study|Protocol Violation|1
365692|NCT00985725|1232818|P2|Overall Study|Adverse Event|1
365693|NCT00985725|1232819|P1|Overall Study|Adverse Event|4
365694|NCT00985712|1232855|P2|Overall Study|Sponsor decision|2
365695|NCT00985712|1232856|P1|Overall Study|Sponsor decision|0
365696|NCT00985712|1232855|P2|Overall Study|Withdrawal by Subject|1
365697|NCT00985712|1232856|P1|Overall Study|Withdrawal by Subject|4
365698|NCT00985712|1232855|P2|Overall Study|Protocol Violation|1
365699|NCT00985712|1232856|P1|Overall Study|Protocol Violation|0
365700|NCT00985712|1232855|P2|Overall Study|Lost to Follow-up|2
365701|NCT00985712|1232856|P1|Overall Study|Lost to Follow-up|2
365702|NCT00985712|1232855|P2|Overall Study|Adverse Event|1
365703|NCT00985712|1232856|P1|Overall Study|Adverse Event|0
365704|NCT00985686|1232874|P4|Overall Study|Lost to Follow-up|2
365705|NCT00985686|1232875|P3|Overall Study|Lost to Follow-up|0
365706|NCT00985686|1232876|P2|Overall Study|Lost to Follow-up|1
365707|NCT00985686|1232877|P1|Overall Study|Lost to Follow-up|1
365708|NCT00985673|1232891|P6|Overall Study|Other|0
365709|NCT00985673|1232892|P5|Overall Study|Other|1
365710|NCT00985673|1232893|P4|Overall Study|Other|0
365711|NCT00985673|1232894|P3|Overall Study|Other|1
365712|NCT00985673|1232895|P2|Overall Study|Other|0
365713|NCT00985673|1232896|P1|Overall Study|Other|1
365714|NCT00985673|1232891|P6|Overall Study|Withdrawal by Subject|3
365715|NCT00985673|1232892|P5|Overall Study|Withdrawal by Subject|2
365716|NCT00985673|1232893|P4|Overall Study|Withdrawal by Subject|2
365717|NCT00985673|1232894|P3|Overall Study|Withdrawal by Subject|5
365718|NCT00985673|1232895|P2|Overall Study|Withdrawal by Subject|4
365719|NCT00985673|1232896|P1|Overall Study|Withdrawal by Subject|0
365720|NCT00985673|1232891|P6|Overall Study|Lost to Follow-up|3
365721|NCT00985673|1232892|P5|Overall Study|Lost to Follow-up|5
365722|NCT00985673|1232893|P4|Overall Study|Lost to Follow-up|10
365723|NCT00985673|1232894|P3|Overall Study|Lost to Follow-up|6
365724|NCT00985673|1232895|P2|Overall Study|Lost to Follow-up|7
365725|NCT00985673|1232896|P1|Overall Study|Lost to Follow-up|6
365726|NCT00985504|1233158|P2|Optimization Period|Withdrawal by Subject|8
365727|NCT00985504|1233159|P1|Optimization Period|Withdrawal by Subject|10
365728|NCT00985504|1233158|P2|Optimization Period|Protocol Violation|1
365729|NCT00985504|1233159|P1|Optimization Period|Protocol Violation|3
365730|NCT00985504|1233158|P2|Optimization Period|Physician Decision|0
365731|NCT00985504|1233159|P1|Optimization Period|Physician Decision|1
365732|NCT00985504|1233158|P2|Optimization Period|Lost to Follow-up|1
365733|NCT00985504|1233159|P1|Optimization Period|Lost to Follow-up|0
365734|NCT00985504|1233158|P2|Optimization Period|Lack of Efficacy|3
365735|NCT00985504|1233159|P1|Optimization Period|Lack of Efficacy|5
365736|NCT00985504|1233158|P2|Optimization Period|Death|1
365737|NCT00985504|1233159|P1|Optimization Period|Death|0
365738|NCT00985504|1233158|P2|Optimization Period|Adverse Event|9
365739|NCT00985504|1233159|P1|Optimization Period|Adverse Event|7
365740|NCT00985504|1233158|P2|Acute Treatment Period|Withdrawal by Subject|5
365741|NCT00985504|1233159|P1|Acute Treatment Period|Withdrawal by Subject|9
365742|NCT00985504|1233158|P2|Acute Treatment Period|Sponsor Decision|1
365743|NCT00985504|1233159|P1|Acute Treatment Period|Sponsor Decision|0
365744|NCT00985504|1233158|P2|Acute Treatment Period|Protocol Violation|0
365745|NCT00985504|1233159|P1|Acute Treatment Period|Protocol Violation|2
365746|NCT00985504|1233158|P2|Acute Treatment Period|Entry Criteria Not Met|2
365747|NCT00985504|1233159|P1|Acute Treatment Period|Entry Criteria Not Met|1
365748|NCT00985504|1233158|P2|Acute Treatment Period|Adverse Event|4
365749|NCT00985504|1233159|P1|Acute Treatment Period|Adverse Event|3
365750|NCT00985491|1233185|P1|Overall Study|implant failure|3
365751|NCT00985491|1233185|P1|Overall Study|Withdrawal by Subject|1
365752|NCT00985491|1233185|P1|Overall Study|device migration|7
365753|NCT00985491|1233185|P1|Overall Study|Adverse Event|8
365754|NCT00985439|1233194|P4|Overall Study|Adverse Event|0
365755|NCT00985439|1233195|P3|Overall Study|Adverse Event|1
365756|NCT00985439|1233196|P2|Overall Study|Adverse Event|0
365757|NCT00985439|1233197|P1|Overall Study|Adverse Event|0
365758|NCT00985231|1233213|P2|Overall Study|Study related symptoms & complaints|2
365759|NCT00985231|1233214|P1|Overall Study|Study related symptoms & complaints|0
365760|NCT00985231|1233213|P2|Overall Study|Lost to Follow-up|1
365761|NCT00985231|1233214|P1|Overall Study|Lost to Follow-up|0
365762|NCT00985231|1233213|P2|Overall Study|Withdrawal by Subject|0
365763|NCT00985231|1233214|P1|Overall Study|Withdrawal by Subject|1
365764|NCT00985231|1233213|P2|Overall Study|Protocol Violation|0
365765|NCT00985231|1233214|P1|Overall Study|Protocol Violation|1
365766|NCT00985231|1233213|P2|Overall Study|ineligible|0
365767|NCT00985231|1233214|P1|Overall Study|ineligible|1
365768|NCT00985192|1233222|P1|Overall Study|Determined to be Ineligible During Trial|2
365769|NCT00985192|1233222|P1|Overall Study|Disease Progression|1
365770|NCT00985192|1233222|P1|Overall Study|Withdrawal by Subject|1
365771|NCT00985166|1233234|P3|Overall Study|Other|1
365772|NCT00985166|1233235|P2|Overall Study|Other|0
365773|NCT00985166|1233236|P1|Overall Study|Other|1
365774|NCT00985166|1233234|P3|Overall Study|Test not done|4
365775|NCT00985166|1233235|P2|Overall Study|Test not done|0
365776|NCT00985166|1233236|P1|Overall Study|Test not done|2
365777|NCT00985166|1233234|P3|Overall Study|Withdrawal by Subject|0
365778|NCT00985166|1233235|P2|Overall Study|Withdrawal by Subject|2
365779|NCT00985166|1233236|P1|Overall Study|Withdrawal by Subject|3
365780|NCT00985166|1233234|P3|Overall Study|Lost to Follow-up|2
365781|NCT00985166|1233235|P2|Overall Study|Lost to Follow-up|2
365782|NCT00985166|1233236|P1|Overall Study|Lost to Follow-up|3
365783|NCT00985153|1233256|P4|Overall Study|Incomplete Safety Follow-up|4
365784|NCT00985153|1233257|P3|Overall Study|Incomplete Safety Follow-up|4
365785|NCT00985153|1233258|P2|Overall Study|Incomplete Safety Follow-up|5
365786|NCT00985153|1233259|P1|Overall Study|Incomplete Safety Follow-up|3
365787|NCT00985153|1233256|P4|Overall Study|Missed One or More Bleeds|10
365788|NCT00985153|1233257|P3|Overall Study|Missed One or More Bleeds|8
365789|NCT00985153|1233258|P2|Overall Study|Missed One or More Bleeds|7
365790|NCT00985153|1233259|P1|Overall Study|Missed One or More Bleeds|7
365791|NCT00985153|1233256|P4|Overall Study|Withdrawal by Subject|10
365792|NCT00985153|1233257|P3|Overall Study|Withdrawal by Subject|11
365793|NCT00985153|1233258|P2|Overall Study|Withdrawal by Subject|11
365794|NCT00985153|1233259|P1|Overall Study|Withdrawal by Subject|6
365795|NCT00985153|1233256|P4|Overall Study|Protocol Violation|3
365796|NCT00985153|1233257|P3|Overall Study|Protocol Violation|4
365797|NCT00985153|1233258|P2|Overall Study|Protocol Violation|2
365798|NCT00985153|1233259|P1|Overall Study|Protocol Violation|3
365799|NCT00985153|1233256|P4|Overall Study|Lost to Follow-up|20
365800|NCT00985153|1233257|P3|Overall Study|Lost to Follow-up|17
365801|NCT00985153|1233258|P2|Overall Study|Lost to Follow-up|19
365802|NCT00985153|1233259|P1|Overall Study|Lost to Follow-up|16
365803|NCT00985114|1233307|P2|Overall Study|Withdrawal by Subject|2
365804|NCT00985114|1233308|P1|Overall Study|Withdrawal by Subject|0
365805|NCT00985114|1233307|P2|Overall Study|Adverse Event|0
365806|NCT00985114|1233308|P1|Overall Study|Adverse Event|1
365807|NCT00985088|1233322|P8|Overall Study|Lost to Follow-up|2
365808|NCT00985088|1233323|P7|Overall Study|Lost to Follow-up|3
365809|NCT00985088|1233324|P6|Overall Study|Lost to Follow-up|5
365810|NCT00985088|1233325|P5|Overall Study|Lost to Follow-up|6
365811|NCT00985088|1233326|P4|Overall Study|Lost to Follow-up|6
365812|NCT00985088|1233327|P3|Overall Study|Lost to Follow-up|2
365813|NCT00985088|1233328|P2|Overall Study|Lost to Follow-up|1
365814|NCT00985088|1233329|P1|Overall Study|Lost to Follow-up|6
365815|NCT00985088|1233322|P8|Overall Study|Migrated/moved from study area|1
365816|NCT00985088|1233323|P7|Overall Study|Migrated/moved from study area|0
365817|NCT00985088|1233324|P6|Overall Study|Migrated/moved from study area|0
365818|NCT00985088|1233325|P5|Overall Study|Migrated/moved from study area|0
365819|NCT00985088|1233326|P4|Overall Study|Migrated/moved from study area|0
365820|NCT00985088|1233327|P3|Overall Study|Migrated/moved from study area|1
365821|NCT00985088|1233328|P2|Overall Study|Migrated/moved from study area|0
365822|NCT00985088|1233329|P1|Overall Study|Migrated/moved from study area|0
365823|NCT00985088|1233322|P8|Overall Study|Withdrawal by Subject|2
365824|NCT00985088|1233323|P7|Overall Study|Withdrawal by Subject|1
365825|NCT00985088|1233324|P6|Overall Study|Withdrawal by Subject|2
365826|NCT00985088|1233325|P5|Overall Study|Withdrawal by Subject|3
365827|NCT00985088|1233326|P4|Overall Study|Withdrawal by Subject|1
365828|NCT00985088|1233327|P3|Overall Study|Withdrawal by Subject|0
365829|NCT00985088|1233328|P2|Overall Study|Withdrawal by Subject|0
365830|NCT00985088|1233329|P1|Overall Study|Withdrawal by Subject|4
365831|NCT00985088|1233322|P8|Overall Study|Adverse Event|0
365832|NCT00985088|1233323|P7|Overall Study|Adverse Event|0
365833|NCT00985088|1233324|P6|Overall Study|Adverse Event|0
365834|NCT00985088|1233325|P5|Overall Study|Adverse Event|0
365835|NCT00985088|1233326|P4|Overall Study|Adverse Event|0
365836|NCT00985088|1233327|P3|Overall Study|Adverse Event|1
365837|NCT00985088|1233328|P2|Overall Study|Adverse Event|0
365838|NCT00985088|1233329|P1|Overall Study|Adverse Event|0
365839|NCT00985088|1233322|P8|Overall Study|Serious Adverse Event|1
365840|NCT00985088|1233323|P7|Overall Study|Serious Adverse Event|0
365841|NCT00985088|1233324|P6|Overall Study|Serious Adverse Event|0
365842|NCT00985088|1233325|P5|Overall Study|Serious Adverse Event|0
365843|NCT00985088|1233326|P4|Overall Study|Serious Adverse Event|0
365844|NCT00985088|1233327|P3|Overall Study|Serious Adverse Event|0
365845|NCT00985088|1233328|P2|Overall Study|Serious Adverse Event|1
365846|NCT00985088|1233329|P1|Overall Study|Serious Adverse Event|1
365847|NCT00984867|1233598|P2|Overall Study|lack of efficacy and subject compliance|0
365848|NCT00984867|1233599|P1|Overall Study|lack of efficacy and subject compliance|1
365849|NCT00984867|1233598|P2|Overall Study|site closing|0
365850|NCT00984867|1233599|P1|Overall Study|site closing|1
365851|NCT00984867|1233598|P2|Overall Study|Subject no longer meets study criteria|1
365852|NCT00984867|1233599|P1|Overall Study|Subject no longer meets study criteria|1
365853|NCT00984867|1233598|P2|Overall Study|Poor/non-compliance|1
365854|NCT00984867|1233599|P1|Overall Study|Poor/non-compliance|0
365855|NCT00984867|1233598|P2|Overall Study|Lost to Follow-up|4
365856|NCT00984867|1233599|P1|Overall Study|Lost to Follow-up|3
365857|NCT00984867|1233598|P2|Overall Study|Withdrawal by Subject|4
365858|NCT00984867|1233599|P1|Overall Study|Withdrawal by Subject|13
365859|NCT00984867|1233598|P2|Overall Study|Death|0
365860|NCT00984867|1233599|P1|Overall Study|Death|1
365861|NCT00984867|1233598|P2|Overall Study|Adverse Event|7
365862|NCT00984867|1233599|P1|Overall Study|Adverse Event|3
365863|NCT00984659|1233639|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
365864|NCT00984659|1233640|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
365865|NCT00984659|1233641|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
365866|NCT00984659|1233642|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
365867|NCT00984659|1233639|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
365868|NCT00984659|1233640|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
365869|NCT00984659|1233641|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
365870|NCT00984659|1233642|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
365871|NCT00984659|1233639|P4|6-week Double-blind Treatment Period|Protocol Violation|4
365872|NCT00984659|1233640|P3|6-week Double-blind Treatment Period|Protocol Violation|0
365873|NCT00984659|1233641|P2|6-week Double-blind Treatment Period|Protocol Violation|0
365874|NCT00984659|1233642|P1|6-week Double-blind Treatment Period|Protocol Violation|0
365875|NCT00984659|1233639|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
365876|NCT00984659|1233640|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
365877|NCT00984659|1233641|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
365878|NCT00984659|1233642|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
365879|NCT00984659|1233639|P4|6-week Double-blind Treatment Period|Adverse Event|7
365880|NCT00984659|1233640|P3|6-week Double-blind Treatment Period|Adverse Event|3
365881|NCT00984659|1233641|P2|6-week Double-blind Treatment Period|Adverse Event|3
365882|NCT00984659|1233642|P1|6-week Double-blind Treatment Period|Adverse Event|0
365883|NCT00984659|1233639|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
365884|NCT00984659|1233640|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
365885|NCT00984659|1233641|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
365886|NCT00984659|1233642|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
365887|NCT00984659|1233639|P4|2-week Run-in Period|Withdrawal by Subject|0
365888|NCT00984659|1233640|P3|2-week Run-in Period|Withdrawal by Subject|0
365889|NCT00984659|1233641|P2|2-week Run-in Period|Withdrawal by Subject|0
365890|NCT00984659|1233642|P1|2-week Run-in Period|Withdrawal by Subject|10
365891|NCT00984659|1233639|P4|2-week Run-in Period|Physician Decision|0
365892|NCT00984659|1233640|P3|2-week Run-in Period|Physician Decision|0
365893|NCT00984659|1233641|P2|2-week Run-in Period|Physician Decision|0
365894|NCT00984659|1233642|P1|2-week Run-in Period|Physician Decision|10
365895|NCT00984659|1233639|P4|2-week Run-in Period|Lost to Follow-up|0
365896|NCT00984659|1233640|P3|2-week Run-in Period|Lost to Follow-up|0
365897|NCT00984659|1233641|P2|2-week Run-in Period|Lost to Follow-up|0
365898|NCT00984659|1233642|P1|2-week Run-in Period|Lost to Follow-up|3
365899|NCT00984659|1233639|P4|2-week Run-in Period|Study Closed/Terminated|0
365900|NCT00984659|1233640|P3|2-week Run-in Period|Study Closed/Terminated|0
365901|NCT00984659|1233641|P2|2-week Run-in Period|Study Closed/Terminated|0
365902|NCT00984659|1233642|P1|2-week Run-in Period|Study Closed/Terminated|2
365903|NCT00984659|1233639|P4|2-week Run-in Period|Protocol Violation|0
365904|NCT00984659|1233640|P3|2-week Run-in Period|Protocol Violation|0
365905|NCT00984659|1233641|P2|2-week Run-in Period|Protocol Violation|0
365906|NCT00984659|1233642|P1|2-week Run-in Period|Protocol Violation|5
365907|NCT00984659|1233639|P4|2-week Run-in Period|Adverse Event|0
365908|NCT00984659|1233640|P3|2-week Run-in Period|Adverse Event|0
365909|NCT00984659|1233641|P2|2-week Run-in Period|Adverse Event|0
365910|NCT00984659|1233642|P1|2-week Run-in Period|Adverse Event|8
365911|NCT00984620|1233669|P2|Overall Study|reason other than listed above|4
365912|NCT00984620|1233670|P1|Overall Study|reason other than listed above|0
365913|NCT00984620|1233669|P2|Overall Study|Withdrawal by Subject|2
365914|NCT00984620|1233670|P1|Overall Study|Withdrawal by Subject|0
365915|NCT00984620|1233669|P2|Overall Study|Lost to Follow-up|1
365916|NCT00984620|1233670|P1|Overall Study|Lost to Follow-up|1
365917|NCT00984620|1233669|P2|Overall Study|Adverse Event|5
365918|NCT00984620|1233670|P1|Overall Study|Adverse Event|5
365919|NCT00984594|1233708|P2|Overall Study|Withdrawal by Subject|1
365920|NCT00984594|1233709|P1|Overall Study|Withdrawal by Subject|0
365921|NCT00984594|1233708|P2|Overall Study|Lost to Follow-up|0
365922|NCT00984594|1233709|P1|Overall Study|Lost to Follow-up|1
365923|NCT00984568|1233725|P2|Overall Study|Unknown Reason|3
365924|NCT00984568|1233726|P1|Overall Study|Unknown Reason|1
365925|NCT00984568|1233725|P2|Overall Study|Opportunistic Infection|0
365926|NCT00984568|1233726|P1|Overall Study|Opportunistic Infection|1
365927|NCT00984568|1233725|P2|Overall Study|Lost to Follow-up|1
365928|NCT00984568|1233726|P1|Overall Study|Lost to Follow-up|0
365929|NCT00984568|1233725|P2|Overall Study|Did Not Meet Randomization Criteria|0
365930|NCT00984568|1233726|P1|Overall Study|Did Not Meet Randomization Criteria|1
365931|NCT00984568|1233725|P2|Overall Study|Adverse Event|0
365932|NCT00984568|1233726|P1|Overall Study|Adverse Event|2
365933|NCT00984568|1233725|P2|Overall Study|Lack of Efficacy|0
365934|NCT00984568|1233726|P1|Overall Study|Lack of Efficacy|2
365935|NCT00984568|1233725|P2|Overall Study|Withdrawal by Subject|2
365936|NCT00984568|1233726|P1|Overall Study|Withdrawal by Subject|1
365937|NCT00984542|1233734|P1|Overall Study|clinical deterioration|2
365938|NCT00984542|1233734|P1|Overall Study|Withdrawal by Subject|3
365939|NCT00984542|1233734|P1|Overall Study|complicating disease|3
365940|NCT00984542|1233734|P1|Overall Study|Death|7
365941|NCT00984542|1233734|P1|Overall Study|toxicity|7
365942|NCT00984542|1233734|P1|Overall Study|disease progression|19
365943|NCT00984295|1233784|P3|Overall Study|Incomplete safety follow-up|3
365944|NCT00984295|1233785|P2|Overall Study|Incomplete safety follow-up|2
365945|NCT00984295|1233786|P1|Overall Study|Incomplete safety follow-up|11
365946|NCT00984295|1233784|P3|Overall Study|Missed one or more blood samplings|2
365947|NCT00984295|1233785|P2|Overall Study|Missed one or more blood samplings|7
365948|NCT00984295|1233786|P1|Overall Study|Missed one or more blood samplings|3
365949|NCT00984295|1233784|P3|Overall Study|CAE – discontinued test vaccine|3
365950|NCT00984295|1233785|P2|Overall Study|CAE – discontinued test vaccine|1
365951|NCT00984295|1233786|P1|Overall Study|CAE – discontinued test vaccine|0
365952|NCT00984295|1233784|P3|Overall Study|Withdrawal by Subject|12
365953|NCT00984295|1233785|P2|Overall Study|Withdrawal by Subject|9
365954|NCT00984295|1233786|P1|Overall Study|Withdrawal by Subject|18
365955|NCT00984295|1233784|P3|Overall Study|Protocol Violation|4
365956|NCT00984295|1233785|P2|Overall Study|Protocol Violation|1
365957|NCT00984295|1233786|P1|Overall Study|Protocol Violation|2
365958|NCT00984295|1233784|P3|Overall Study|Lost to Follow-up|13
365959|NCT00984295|1233785|P2|Overall Study|Lost to Follow-up|12
365960|NCT00984295|1233786|P1|Overall Study|Lost to Follow-up|31
365961|NCT00984282|1233853|P2|Long Term Follow-up|Ongoing with treatment|26
365962|NCT00984282|1233854|P1|Long Term Follow-up|Ongoing with treatment|33
365963|NCT00984282|1233853|P2|Long Term Follow-up|Lost to Follow-up|4
365964|NCT00984282|1233854|P1|Long Term Follow-up|Lost to Follow-up|8
365965|NCT00984282|1233853|P2|Long Term Follow-up|Death|72
365966|NCT00984282|1233854|P1|Long Term Follow-up|Death|55
365967|NCT00984282|1233853|P2|Long Term Follow-up|Withdrawal by Subject|15
365968|NCT00984282|1233854|P1|Long Term Follow-up|Withdrawal by Subject|18
365969|NCT00984282|1233853|P2|Open-label Treatment|Target lesion removed|1
365970|NCT00984282|1233854|P1|Open-label Treatment|Target lesion removed|0
365971|NCT00984282|1233853|P2|Open-label Treatment|Non-compliant with study medication|0
365972|NCT00984282|1233854|P1|Open-label Treatment|Non-compliant with study medication|1
365973|NCT00984282|1233853|P2|Open-label Treatment|Ongoing with treatment|18
365974|NCT00984282|1233854|P1|Open-label Treatment|Ongoing with treatment|19
365975|NCT00984282|1233853|P2|Open-label Treatment|Lost to Follow-up|0
365976|NCT00984282|1233854|P1|Open-label Treatment|Lost to Follow-up|1
365977|NCT00984282|1233853|P2|Open-label Treatment|Progression, recurrence or relapse|77
365978|NCT00984282|1233854|P1|Open-label Treatment|Progression, recurrence or relapse|37
365979|NCT00984282|1233853|P2|Open-label Treatment|Death|15
365980|NCT00984282|1233854|P1|Open-label Treatment|Death|5
365981|NCT00984282|1233853|P2|Open-label Treatment|Withdrawal by Subject|21
365982|NCT00984282|1233854|P1|Open-label Treatment|Withdrawal by Subject|6
365983|NCT00984282|1233853|P2|Open-label Treatment|Adverse Event|29
365984|NCT00984282|1233854|P1|Open-label Treatment|Adverse Event|17
365985|NCT00984282|1233853|P2|Double Blind Treatment|Switched to follow-up|4
365986|NCT00984282|1233854|P1|Double Blind Treatment|Switched to follow-up|12
365987|NCT00984282|1233853|P2|Double Blind Treatment|Not treated|1
365988|NCT00984282|1233854|P1|Double Blind Treatment|Not treated|0
365989|NCT00984282|1233853|P2|Double Blind Treatment|Death|4
365990|NCT00984282|1233854|P1|Double Blind Treatment|Death|8
365991|NCT00984282|1233853|P2|Double Blind Treatment|Lost to Follow-up|0
365992|NCT00984282|1233854|P1|Double Blind Treatment|Lost to Follow-up|3
365993|NCT00984282|1233853|P2|Double Blind Treatment|Withdrawal by Subject|18
365994|NCT00984282|1233854|P1|Double Blind Treatment|Withdrawal by Subject|14
365995|NCT00984282|1233853|P2|Double Blind Treatment|Progression by clinical judgment|0
365996|NCT00984282|1233854|P1|Double Blind Treatment|Progression by clinical judgment|1
365997|NCT00984282|1233853|P2|Double Blind Treatment|Noncompliance with study medication|0
365998|NCT00984282|1233854|P1|Double Blind Treatment|Noncompliance with study medication|3
365999|NCT00984282|1233853|P2|Double Blind Treatment|Physician Decision|2
366000|NCT00984282|1233854|P1|Double Blind Treatment|Physician Decision|1
366001|NCT00984282|1233853|P2|Double Blind Treatment|Progression, recurrence or relapse|3
366002|NCT00984282|1233854|P1|Double Blind Treatment|Progression, recurrence or relapse|24
366003|NCT00984282|1233853|P2|Double Blind Treatment|Adverse Event|6
366004|NCT00984282|1233854|P1|Double Blind Treatment|Adverse Event|38
366005|NCT00984256|1233877|P2|Overall Study|Withdrawal by Subject|1
366006|NCT00984256|1233878|P1|Overall Study|Withdrawal by Subject|0
366007|NCT00984204|1233898|P1|Overall Study|Lack of Efficacy|10
366008|NCT00984204|1233898|P1|Overall Study|Lost to Follow-up|4
366009|NCT00984204|1233898|P1|Overall Study|Death|1
366010|NCT00984165|1233908|P4|Overall Study|removed with a pair recipient|1
366011|NCT00984165|1233909|P3|Overall Study|removed with a pair recipient|0
366012|NCT00984165|1233910|P2|Overall Study|removed with a pair recipient|0
366013|NCT00984165|1233911|P1|Overall Study|removed with a pair recipient|0
366014|NCT00984165|1233908|P4|Overall Study|P+/donor pair removed from protocol|1
366015|NCT00984165|1233909|P3|Overall Study|P+/donor pair removed from protocol|0
366016|NCT00984165|1233910|P2|Overall Study|P+/donor pair removed from protocol|0
366017|NCT00984165|1233911|P1|Overall Study|P+/donor pair removed from protocol|0
366018|NCT00984165|1233908|P4|Overall Study|New protocol|1
366019|NCT00984165|1233909|P3|Overall Study|New protocol|0
366020|NCT00984165|1233910|P2|Overall Study|New protocol|0
366021|NCT00984165|1233911|P1|Overall Study|New protocol|0
366022|NCT00984165|1233908|P4|Overall Study|Death of recipient|1
366023|NCT00984165|1233909|P3|Overall Study|Death of recipient|0
366024|NCT00984165|1233910|P2|Overall Study|Death of recipient|0
366025|NCT00984165|1233911|P1|Overall Study|Death of recipient|0
366026|NCT00984165|1233908|P4|Overall Study|Disease progression on study|0
366027|NCT00984165|1233909|P3|Overall Study|Disease progression on study|0
366028|NCT00984165|1233910|P2|Overall Study|Disease progression on study|1
366029|NCT00984165|1233911|P1|Overall Study|Disease progression on study|5
366030|NCT00984165|1233908|P4|Overall Study|Death on study|0
366031|NCT00984165|1233909|P3|Overall Study|Death on study|0
366032|NCT00984165|1233910|P2|Overall Study|Death on study|0
366033|NCT00984165|1233911|P1|Overall Study|Death on study|2
366034|NCT00984126|1233940|P4|Overall Study|Withdrawal criteria|9
366035|NCT00984126|1233941|P3|Overall Study|Withdrawal criteria|3
366036|NCT00984126|1233942|P2|Overall Study|Withdrawal criteria|1
366037|NCT00984126|1233943|P1|Overall Study|Withdrawal criteria|0
366038|NCT00984126|1233940|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
366039|NCT00984126|1233941|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
366040|NCT00984126|1233942|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
366041|NCT00984126|1233943|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
366042|NCT00984126|1233940|P4|Overall Study|Adverse Event|2
366043|NCT00984126|1233941|P3|Overall Study|Adverse Event|0
366044|NCT00984126|1233942|P2|Overall Study|Adverse Event|0
366045|NCT00984126|1233943|P1|Overall Study|Adverse Event|0
366046|NCT00984126|1233940|P4|Overall Study|Protocol Violation|2
366047|NCT00984126|1233941|P3|Overall Study|Protocol Violation|1
366048|NCT00984126|1233942|P2|Overall Study|Protocol Violation|0
366049|NCT00984126|1233943|P1|Overall Study|Protocol Violation|0
366050|NCT00984061|1233968|P1|Clarithromycin Alone|Protocol Violation|1
366051|NCT00984022|1233981|P2|Overall Study|Lost to Follow-up|14
366052|NCT00984022|1233982|P1|Overall Study|Lost to Follow-up|10
366053|NCT00984009|1233992|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
366054|NCT00983957|1234025|P1|Overall Study|Personal Reasons|1
366055|NCT00983957|1234025|P1|Overall Study|Adverse Event|1
366056|NCT00983931|1234059|P1|14 Day Washout Period|Physician Decision|1
366057|NCT00983918|1234073|P4|Overall Study|conversion to open cholecystectomy|2
366058|NCT00983918|1234074|P3|Overall Study|conversion to open cholecystectomy|2
366059|NCT00983918|1234075|P2|Overall Study|conversion to open cholecystectomy|2
366060|NCT00983918|1234076|P1|Overall Study|conversion to open cholecystectomy|0
366061|NCT00983905|1234086|P1|Colchicine Alone|Adverse Event|2
366062|NCT00983905|1234086|P1|Theophylline Alone|Adverse Event|1
366063|NCT00983892|1234099|P2|Overall Study|Withdrawal by Subject|12
366064|NCT00983892|1234100|P1|Overall Study|Withdrawal by Subject|10
366065|NCT00983853|1234112|P6|Overall Study|Unable to come to study follow-up visits|0
366066|NCT00983853|1234113|P5|Overall Study|Unable to come to study follow-up visits|0
366067|NCT00983853|1234114|P4|Overall Study|Unable to come to study follow-up visits|0
366068|NCT00983853|1234115|P3|Overall Study|Unable to come to study follow-up visits|0
366069|NCT00983853|1234116|P2|Overall Study|Unable to come to study follow-up visits|1
366070|NCT00983853|1234117|P1|Overall Study|Unable to come to study follow-up visits|0
366071|NCT00983853|1234112|P6|Overall Study|Withdrawal by Subject|0
366072|NCT00983853|1234113|P5|Overall Study|Withdrawal by Subject|1
366073|NCT00983853|1234114|P4|Overall Study|Withdrawal by Subject|0
366074|NCT00983853|1234115|P3|Overall Study|Withdrawal by Subject|1
366075|NCT00983853|1234116|P2|Overall Study|Withdrawal by Subject|0
366076|NCT00983853|1234117|P1|Overall Study|Withdrawal by Subject|0
366077|NCT00983853|1234112|P6|Overall Study|Lost to Follow-up|1
366078|NCT00983853|1234113|P5|Overall Study|Lost to Follow-up|2
366079|NCT00983853|1234114|P4|Overall Study|Lost to Follow-up|2
366080|NCT00983853|1234115|P3|Overall Study|Lost to Follow-up|2
366081|NCT00983853|1234116|P2|Overall Study|Lost to Follow-up|1
366082|NCT00983853|1234117|P1|Overall Study|Lost to Follow-up|1
366083|NCT00983827|1234145|P1|Overall Study|Withdrawal by Subject|1
366084|NCT00983749|1234163|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
366085|NCT00983749|1234164|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
366086|NCT00983580|1234189|P2|Overall Study|Ineligible|0
366087|NCT00983580|1234190|P1|Overall Study|Ineligible|3
366088|NCT00983580|1234189|P2|Overall Study|Protocol Violation|1
366089|NCT00983580|1234190|P1|Overall Study|Protocol Violation|1
366090|NCT00983580|1234189|P2|Overall Study|Cancel Prior to treatment|3
366091|NCT00983580|1234190|P1|Overall Study|Cancel Prior to treatment|1
366092|NCT00983515|1234216|P1|Colchicine With Ritonavir|Lost to Follow-up|1
366093|NCT00983515|1234216|P1|Ritonavir Alone|liver panel out of range|6
366094|NCT00983476|1234243|P3|Overall Study|Did not receive intervention|0
366095|NCT00983476|1234244|P2|Overall Study|Did not receive intervention|22
366096|NCT00983476|1234245|P1|Overall Study|Did not receive intervention|17
366097|NCT00983437|1234277|P1|Overall Study|Other Reason|26
366098|NCT00983437|1234277|P1|Overall Study|Lost to Follow-up|2
366099|NCT00983437|1234277|P1|Overall Study|Noncompliance to Study Procedures|1
366100|NCT00983437|1234277|P1|Overall Study|Withdrawal by Subject|8
366101|NCT00983437|1234277|P1|Overall Study|Lack of Efficacy|1
366102|NCT00983437|1234277|P1|Overall Study|Adverse Event|9
366103|NCT00983385|1234296|P1|Observation Period|Not Evaluable due to Non Compliance|12
366104|NCT00983385|1234296|P1|Observation Period|Not eligible to be dosed|20
366105|NCT00983372|1234341|P1|Diltiazem ER Alone|Adverse Event|1
366106|NCT00983372|1234341|P1|Diltiazem ER Alone|missed diltiazem dose|2
366107|NCT00983372|1234341|P1|14 Day Washout Period|Withdrawal by Subject|1
366108|NCT00983294|1234368|P1|Colchicine With Azithromycin|Adverse Event|1
366109|NCT00983294|1234368|P1|14 Day Washout Period|Withdrawal by Subject|2
366110|NCT00983073|1234410|P1|Maintenance Period|Other Reason|7
366111|NCT00983073|1234410|P1|Maintenance Period|Lack of Efficacy|2
366112|NCT00983073|1234410|P1|Maintenance Period|Withdrawal by Subject|2
366113|NCT00983073|1234410|P1|Maintenance Period|Adverse Event|5
366114|NCT00983073|1234410|P1|Titration and Optimal Dose Period|Other reason|4
366115|NCT00983073|1234410|P1|Titration and Optimal Dose Period|Non-Compliance|1
366116|NCT00983073|1234410|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
366117|NCT00983073|1234410|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
366118|NCT00983073|1234410|P1|Titration and Optimal Dose Period|Adverse Event|19
366119|NCT00982735|1234436|P1|Overall Study|Patient ineligible for trial|224
366120|NCT00982735|1234436|P1|Overall Study|Lost to Follow-up|6
366121|NCT00982657|1234446|P4|Overall Study|On going at date of cut-off|1
366122|NCT00982657|1234447|P3|Overall Study|On going at date of cut-off|0
366123|NCT00982657|1234448|P2|Overall Study|On going at date of cut-off|0
366124|NCT00982657|1234449|P1|Overall Study|On going at date of cut-off|0
366125|NCT00982657|1234446|P4|Overall Study|Other|4
366126|NCT00982657|1234447|P3|Overall Study|Other|0
366127|NCT00982657|1234448|P2|Overall Study|Other|0
366128|NCT00982657|1234449|P1|Overall Study|Other|0
366129|NCT00982657|1234446|P4|Overall Study|Withdrawal by Subject|3
366130|NCT00982657|1234447|P3|Overall Study|Withdrawal by Subject|1
366131|NCT00982657|1234448|P2|Overall Study|Withdrawal by Subject|0
366132|NCT00982657|1234449|P1|Overall Study|Withdrawal by Subject|0
366133|NCT00982657|1234446|P4|Overall Study|Death|1
366134|NCT00982657|1234447|P3|Overall Study|Death|1
366135|NCT00982657|1234448|P2|Overall Study|Death|0
366136|NCT00982657|1234449|P1|Overall Study|Death|1
366137|NCT00982644|1234490|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
366138|NCT00982644|1234491|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
366139|NCT00982644|1234490|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
366140|NCT00982644|1234491|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
366141|NCT00982644|1234490|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
366142|NCT00982644|1234491|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
366143|NCT00982644|1234490|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
366144|NCT00982644|1234491|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
366145|NCT00982644|1234490|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
366146|NCT00982644|1234491|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
366147|NCT00982644|1234490|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
366148|NCT00982644|1234491|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
366149|NCT00982644|1234490|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
366150|NCT00982644|1234491|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
366151|NCT00982644|1234490|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
366152|NCT00982644|1234491|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
366153|NCT00982644|1234490|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
366154|NCT00982644|1234491|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
366155|NCT00982644|1234490|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
366156|NCT00982644|1234491|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
366157|NCT00982488|1234542|P5|Overall Study|Withdrawal by Subject|0
366158|NCT00982488|1234543|P4|Overall Study|Withdrawal by Subject|0
366159|NCT00982488|1234544|P3|Overall Study|Withdrawal by Subject|1
366160|NCT00982488|1234545|P2|Overall Study|Withdrawal by Subject|1
366161|NCT00982488|1234546|P1|Overall Study|Withdrawal by Subject|5
366162|NCT00982488|1234542|P5|Overall Study|Study drug toxicity|0
366163|NCT00982488|1234543|P4|Overall Study|Study drug toxicity|0
366164|NCT00982488|1234544|P3|Overall Study|Study drug toxicity|6
366165|NCT00982488|1234545|P2|Overall Study|Study drug toxicity|1
366166|NCT00982488|1234546|P1|Overall Study|Study drug toxicity|34
366167|NCT00982488|1234542|P5|Overall Study|Stem cell transplant|0
366168|NCT00982488|1234543|P4|Overall Study|Stem cell transplant|1
366169|NCT00982488|1234544|P3|Overall Study|Stem cell transplant|0
366170|NCT00982488|1234545|P2|Overall Study|Stem cell transplant|0
366171|NCT00982488|1234546|P1|Overall Study|Stem cell transplant|2
366172|NCT00982488|1234542|P5|Overall Study|Poor compliance/noncompliance|0
366173|NCT00982488|1234543|P4|Overall Study|Poor compliance/noncompliance|0
366174|NCT00982488|1234544|P3|Overall Study|Poor compliance/noncompliance|0
366175|NCT00982488|1234545|P2|Overall Study|Poor compliance/noncompliance|1
366176|NCT00982488|1234546|P1|Overall Study|Poor compliance/noncompliance|0
366177|NCT00982488|1234542|P5|Overall Study|Not specified|0
366178|NCT00982488|1234543|P4|Overall Study|Not specified|1
366179|NCT00982488|1234544|P3|Overall Study|Not specified|3
366180|NCT00982488|1234545|P2|Overall Study|Not specified|1
366181|NCT00982488|1234546|P1|Overall Study|Not specified|15
366182|NCT00982488|1234542|P5|Overall Study|Maximum clinical benefit|0
366183|NCT00982488|1234543|P4|Overall Study|Maximum clinical benefit|0
366184|NCT00982488|1234544|P3|Overall Study|Maximum clinical benefit|1
366185|NCT00982488|1234545|P2|Overall Study|Maximum clinical benefit|1
366186|NCT00982488|1234546|P1|Overall Study|Maximum clinical benefit|1
366187|NCT00982488|1234542|P5|Overall Study|Lost to Follow-up|0
366188|NCT00982488|1234543|P4|Overall Study|Lost to Follow-up|0
366189|NCT00982488|1234544|P3|Overall Study|Lost to Follow-up|0
366190|NCT00982488|1234545|P2|Overall Study|Lost to Follow-up|0
366191|NCT00982488|1234546|P1|Overall Study|Lost to Follow-up|1
366192|NCT00982488|1234542|P5|Overall Study|Disease progression|1
366193|NCT00982488|1234543|P4|Overall Study|Disease progression|1
366194|NCT00982488|1234544|P3|Overall Study|Disease progression|10
366195|NCT00982488|1234545|P2|Overall Study|Disease progression|5
366196|NCT00982488|1234546|P1|Overall Study|Disease progression|30
366197|NCT00982488|1234542|P5|Overall Study|Death|0
366198|NCT00982488|1234543|P4|Overall Study|Death|0
366199|NCT00982488|1234544|P3|Overall Study|Death|2
366200|NCT00982488|1234545|P2|Overall Study|Death|0
366201|NCT00982488|1234546|P1|Overall Study|Death|11
366202|NCT00982488|1234542|P5|Overall Study|Adverse event unrelated to study drug|0
366203|NCT00982488|1234543|P4|Overall Study|Adverse event unrelated to study drug|0
366204|NCT00982488|1234544|P3|Overall Study|Adverse event unrelated to study drug|0
366205|NCT00982488|1234545|P2|Overall Study|Adverse event unrelated to study drug|1
366206|NCT00982488|1234546|P1|Overall Study|Adverse event unrelated to study drug|5
366207|NCT00982488|1234542|P5|Overall Study|Administrative reason by sponsor|0
366208|NCT00982488|1234543|P4|Overall Study|Administrative reason by sponsor|0
366209|NCT00982488|1234544|P3|Overall Study|Administrative reason by sponsor|11
366210|NCT00982488|1234545|P2|Overall Study|Administrative reason by sponsor|3
366211|NCT00982488|1234546|P1|Overall Study|Administrative reason by sponsor|81
366212|NCT00982410|1234579|P2|12-month Follow-up Assessment|scheduled, no-show|0
366213|NCT00982410|1234580|P1|12-month Follow-up Assessment|scheduled, no-show|1
366214|NCT00982410|1234579|P2|12-month Follow-up Assessment|incarceration|1
366215|NCT00982410|1234580|P1|12-month Follow-up Assessment|incarceration|2
366216|NCT00982410|1234579|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
366217|NCT00982410|1234580|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
366218|NCT00982410|1234579|P2|12-month Follow-up Assessment|could not reach to schedule|5
366219|NCT00982410|1234580|P1|12-month Follow-up Assessment|could not reach to schedule|6
366220|NCT00982410|1234579|P2|12-month Follow-up Assessment|Death|2
366221|NCT00982410|1234580|P1|12-month Follow-up Assessment|Death|0
366222|NCT00982410|1234579|P2|6-month Follow-up Assessment|scheduled, no-show|1
366223|NCT00982410|1234580|P1|6-month Follow-up Assessment|scheduled, no-show|0
366224|NCT00982410|1234579|P2|6-month Follow-up Assessment|patent surgery|1
366225|NCT00982410|1234580|P1|6-month Follow-up Assessment|patent surgery|0
366226|NCT00982410|1234579|P2|6-month Follow-up Assessment|incarceration|2
366227|NCT00982410|1234580|P1|6-month Follow-up Assessment|incarceration|0
366228|NCT00982410|1234579|P2|6-month Follow-up Assessment|participant no transportation|0
366229|NCT00982410|1234580|P1|6-month Follow-up Assessment|participant no transportation|1
366230|NCT00982410|1234579|P2|6-month Follow-up Assessment|Could not reach to schedule|7
366231|NCT00982410|1234580|P1|6-month Follow-up Assessment|Could not reach to schedule|5
366232|NCT00982410|1234579|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
366233|NCT00982410|1234580|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
366234|NCT00982410|1234579|P2|3-month Follow-up Assessment|Scheduled, no-show|2
366235|NCT00982410|1234580|P1|3-month Follow-up Assessment|Scheduled, no-show|1
366236|NCT00982410|1234579|P2|3-month Follow-up Assessment|Could not reach to schedule|9
366237|NCT00982410|1234580|P1|3-month Follow-up Assessment|Could not reach to schedule|8
366238|NCT00982280|1234619|P1|Maintenance Period|Adverse Event|1
366239|NCT00982280|1234619|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
366240|NCT00982280|1234619|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
366241|NCT00982280|1234619|P1|Titration and Optimal Dose Period|Adverse Event|5
366242|NCT00982280|1234619|P1|Observation Period|Not eligible to be dosed|19
366243|NCT00982228|1234644|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
366244|NCT00982228|1234645|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
366245|NCT00982228|1234644|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
366246|NCT00982228|1234645|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
366247|NCT00982228|1234644|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
366248|NCT00982228|1234645|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
366249|NCT00982228|1234644|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
366250|NCT00982228|1234645|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
366251|NCT00982228|1234644|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
366252|NCT00982228|1234645|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
366253|NCT00982228|1234644|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
366254|NCT00982228|1234645|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
366255|NCT00982228|1234644|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
366256|NCT00982228|1234645|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
366257|NCT00982228|1234644|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
366258|NCT00982228|1234645|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
366259|NCT00982228|1234644|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
366260|NCT00982228|1234645|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
366261|NCT00982228|1234644|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
366262|NCT00982228|1234645|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
366263|NCT00982137|1234704|P4|Overall Study|Withdrawal by Subject|0
366264|NCT00982137|1234705|P3|Overall Study|Withdrawal by Subject|0
366265|NCT00982137|1234706|P2|Overall Study|Withdrawal by Subject|1
366266|NCT00982137|1234707|P1|Overall Study|Withdrawal by Subject|0
366267|NCT00982137|1234704|P4|Overall Study|Lost to Follow-up|1
366268|NCT00982137|1234705|P3|Overall Study|Lost to Follow-up|0
366269|NCT00982137|1234706|P2|Overall Study|Lost to Follow-up|0
366270|NCT00982137|1234707|P1|Overall Study|Lost to Follow-up|0
366271|NCT00982111|1234739|P2|Overall Study|Withdrawal by Subject|17
366272|NCT00982111|1234740|P1|Overall Study|Withdrawal by Subject|16
366273|NCT00982111|1234739|P2|Overall Study|On Study Treatment at Conclusion|0
366274|NCT00982111|1234740|P1|Overall Study|On Study Treatment at Conclusion|7
366275|NCT00982111|1234739|P2|Overall Study|New Anti-Cancer Therapy|5
366276|NCT00982111|1234740|P1|Overall Study|New Anti-Cancer Therapy|5
366277|NCT00982111|1234739|P2|Overall Study|Lost to Follow-up|6
366278|NCT00982111|1234740|P1|Overall Study|Lost to Follow-up|9
366279|NCT00982111|1234739|P2|Overall Study|Progressive Disease|37
366280|NCT00982111|1234740|P1|Overall Study|Progressive Disease|37
366281|NCT00982111|1234739|P2|Overall Study|Adverse Event|1
366282|NCT00982111|1234740|P1|Overall Study|Adverse Event|1
366283|NCT00982020|1234773|P2|Overall Study|Clinical Relapse|1
366284|NCT00982020|1234774|P1|Overall Study|Clinical Relapse|0
366285|NCT00982020|1234773|P2|Overall Study|Protocol Violation|2
366286|NCT00982020|1234774|P1|Overall Study|Protocol Violation|0
366287|NCT00982020|1234773|P2|Overall Study|Entry Criteria Not Met|1
366288|NCT00982020|1234774|P1|Overall Study|Entry Criteria Not Met|2
366289|NCT00982020|1234773|P2|Overall Study|Physician Decision|5
366290|NCT00982020|1234774|P1|Overall Study|Physician Decision|2
366291|NCT00982020|1234773|P2|Overall Study|Treatment Non-compliance|6
366292|NCT00982020|1234774|P1|Overall Study|Treatment Non-compliance|3
366293|NCT00982020|1234773|P2|Overall Study|Parent/Caregiver Decision|5
366294|NCT00982020|1234774|P1|Overall Study|Parent/Caregiver Decision|5
366295|NCT00982020|1234773|P2|Overall Study|Lack of Efficacy|4
366296|NCT00982020|1234774|P1|Overall Study|Lack of Efficacy|10
366297|NCT00982020|1234773|P2|Overall Study|Lost to Follow-up|11
366298|NCT00982020|1234774|P1|Overall Study|Lost to Follow-up|5
366299|NCT00982020|1234773|P2|Overall Study|Withdrawal by Subject|14
366300|NCT00982020|1234774|P1|Overall Study|Withdrawal by Subject|11
366301|NCT00982020|1234773|P2|Overall Study|Adverse Event|15
366302|NCT00982020|1234774|P1|Overall Study|Adverse Event|19
366303|NCT00981526|1234874|P2|Overall Study|Physician Decision|4
366304|NCT00981526|1234875|P1|Overall Study|Physician Decision|4
366305|NCT00981526|1234874|P2|Overall Study|Withdrawal by Subject|2
366306|NCT00981526|1234875|P1|Overall Study|Withdrawal by Subject|0
366307|NCT00981461|1234893|P2|Overall Study|Lost to Follow-up|2
366308|NCT00981461|1234894|P1|Overall Study|Lost to Follow-up|5
366309|NCT00981409|1234918|P2|Overall Study|Prostate Cancer Treatment before Trial|0
366310|NCT00981409|1234919|P1|Overall Study|Prostate Cancer Treatment before Trial|2
366311|NCT00981409|1234918|P2|Overall Study|Protocol Violation|1
366312|NCT00981409|1234919|P1|Overall Study|Protocol Violation|0
366313|NCT00981409|1234918|P2|Overall Study|Adverse Event|0
366314|NCT00981409|1234919|P1|Overall Study|Adverse Event|4
366315|NCT00981292|1234958|P6|Day 3|Protocol Violation|1
366316|NCT00981292|1234959|P5|Day 3|Protocol Violation|0
366317|NCT00981292|1234960|P4|Day 3|Protocol Violation|0
366318|NCT00981292|1234961|P3|Day 3|Protocol Violation|0
366319|NCT00981292|1234962|P2|Day 3|Protocol Violation|0
366320|NCT00981292|1234963|P1|Day 3|Protocol Violation|0
366321|NCT00981292|1234958|P6|Day 2|Protocol Violation|0
366322|NCT00981292|1234959|P5|Day 2|Protocol Violation|0
366323|NCT00981292|1234960|P4|Day 2|Protocol Violation|0
366324|NCT00981292|1234961|P3|Day 2|Protocol Violation|0
366325|NCT00981292|1234962|P2|Day 2|Protocol Violation|0
366326|NCT00981292|1234963|P1|Day 2|Protocol Violation|2
366327|NCT00981292|1234958|P6|Day 1|Protocol Violation|2
366328|NCT00981292|1234959|P5|Day 1|Protocol Violation|0
366329|NCT00981292|1234960|P4|Day 1|Protocol Violation|0
366330|NCT00981292|1234961|P3|Day 1|Protocol Violation|0
366331|NCT00981292|1234962|P2|Day 1|Protocol Violation|0
366332|NCT00981292|1234963|P1|Day 1|Protocol Violation|1
366333|NCT00981175|1235047|P2|Booster Dose Vaccination|Lost to Follow-up|3
366334|NCT00981175|1235048|P1|Booster Dose Vaccination|Lost to Follow-up|2
366335|NCT00981175|1235047|P2|Primary Dose Vaccination|Lost to Follow-up|1
366336|NCT00981175|1235048|P1|Primary Dose Vaccination|Lost to Follow-up|2
366337|NCT00981175|1235047|P2|Primary Dose Vaccination|Protocol Violation|1
366338|NCT00981175|1235048|P1|Primary Dose Vaccination|Protocol Violation|0
366339|NCT00981175|1235047|P2|Primary Dose Vaccination|Adverse Event|0
366340|NCT00981175|1235048|P1|Primary Dose Vaccination|Adverse Event|1
366341|NCT00981149|1235073|P2|Overall Study|Withdrawal by Subject|1
366342|NCT00981149|1235074|P1|Overall Study|Withdrawal by Subject|1
366343|NCT00981149|1235073|P2|Overall Study|Lost to Follow-up|2
366344|NCT00981149|1235074|P1|Overall Study|Lost to Follow-up|1
366345|NCT00981084|1235084|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
366346|NCT00981084|1235085|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
366347|NCT00981084|1235084|P2|Post Intervention (Data Analysis)|poor effort|1
366348|NCT00981084|1235085|P1|Post Intervention (Data Analysis)|poor effort|1
366349|NCT00981058|1235101|P2|Overall Study|On study treatment at conclusion|0
366350|NCT00981058|1235102|P1|Overall Study|On study treatment at conclusion|9
366351|NCT00981058|1235101|P2|Overall Study|Withdrawal by Subject|23
366352|NCT00981058|1235102|P1|Overall Study|Withdrawal by Subject|25
366353|NCT00981058|1235101|P2|Overall Study|Randomization Error|2
366354|NCT00981058|1235102|P1|Overall Study|Randomization Error|1
366355|NCT00981058|1235101|P2|Overall Study|Radiologist Error|1
366356|NCT00981058|1235102|P1|Overall Study|Radiologist Error|0
366357|NCT00981058|1235101|P2|Overall Study|Noncompliance|0
366358|NCT00981058|1235102|P1|Overall Study|Noncompliance|1
366359|NCT00981058|1235101|P2|Overall Study|New Anticancer Therapy|6
366360|NCT00981058|1235102|P1|Overall Study|New Anticancer Therapy|6
366361|NCT00981058|1235101|P2|Overall Study|Lost to Follow-up|15
366362|NCT00981058|1235102|P1|Overall Study|Lost to Follow-up|16
366363|NCT00981058|1235101|P2|Overall Study|Progressive Disease|49
366364|NCT00981058|1235102|P1|Overall Study|Progressive Disease|61
366365|NCT00981058|1235101|P2|Overall Study|Adverse Event|1
366366|NCT00981058|1235102|P1|Overall Study|Adverse Event|1
366367|NCT00981019|1235133|P1|Overall Study|Hit the survey after closure|79
366368|NCT00981019|1235133|P1|Overall Study|Inadvertent exclusion|239
366369|NCT00981019|1235133|P1|Overall Study|Did not match target population|94
366370|NCT00981019|1235133|P1|Overall Study|Did not respond|65
366371|NCT00980980|1235140|P3|Overall Study|Withdrawal by Hospital|0
366372|NCT00980980|1235141|P2|Overall Study|Withdrawal by Hospital|1
366373|NCT00980980|1235142|P1|Overall Study|Withdrawal by Hospital|0
366374|NCT00980798|1235173|P2|Overall Study|Other|1
366375|NCT00980798|1235174|P1|Overall Study|Other|0
366376|NCT00980798|1235173|P2|Overall Study|Withdrawal by Subject|11
366377|NCT00980798|1235174|P1|Overall Study|Withdrawal by Subject|8
366378|NCT00980798|1235173|P2|Overall Study|Physician Decision|1
366379|NCT00980798|1235174|P1|Overall Study|Physician Decision|2
366380|NCT00980798|1235173|P2|Overall Study|Lost to Follow-up|1
366381|NCT00980798|1235174|P1|Overall Study|Lost to Follow-up|0
366382|NCT00980798|1235173|P2|Overall Study|Lack of Efficacy|5
366383|NCT00980798|1235174|P1|Overall Study|Lack of Efficacy|16
366384|NCT00980798|1235173|P2|Overall Study|Adverse Event|36
366385|NCT00980798|1235174|P1|Overall Study|Adverse Event|7
366386|NCT00980655|1235215|P2|Overall Study|Other|1
366387|NCT00980655|1235216|P1|Overall Study|Other|0
366388|NCT00980655|1235215|P2|Overall Study|Parent/legal guardian request|0
366389|NCT00980655|1235216|P1|Overall Study|Parent/legal guardian request|1
366390|NCT00980655|1235215|P2|Overall Study|Lost to Follow-up|1
366391|NCT00980655|1235216|P1|Overall Study|Lost to Follow-up|0
366392|NCT00980655|1235215|P2|Overall Study|Withdrawal by Subject|4
366393|NCT00980655|1235216|P1|Overall Study|Withdrawal by Subject|0
366394|NCT00980655|1235215|P2|Overall Study|Protocol Violation|7
366395|NCT00980655|1235216|P1|Overall Study|Protocol Violation|2
366396|NCT00980655|1235215|P2|Overall Study|Death|7
366397|NCT00980655|1235216|P1|Overall Study|Death|0
366398|NCT00980655|1235215|P2|Overall Study|Adverse Event|31
366399|NCT00980655|1235216|P1|Overall Study|Adverse Event|13
366400|NCT00980343|1235292|P2|Overall Study|no tumor at surgery - treatment effect|3
366401|NCT00980343|1235293|P1|Overall Study|no tumor at surgery - treatment effect|1
366402|NCT00980330|1235317|P7|Overall Study|(not specified)|0
366403|NCT00980330|1235318|P6|Overall Study|(not specified)|1
366404|NCT00980330|1235319|P5|Overall Study|(not specified)|1
366405|NCT00980330|1235320|P4|Overall Study|(not specified)|1
366406|NCT00980330|1235321|P3|Overall Study|(not specified)|0
366407|NCT00980330|1235322|P2|Overall Study|(not specified)|0
366408|NCT00980330|1235323|P1|Overall Study|(not specified)|2
366409|NCT00980330|1235317|P7|Overall Study|Withdrawal by Subject|5
366410|NCT00980330|1235318|P6|Overall Study|Withdrawal by Subject|2
366411|NCT00980330|1235319|P5|Overall Study|Withdrawal by Subject|3
366412|NCT00980330|1235320|P4|Overall Study|Withdrawal by Subject|1
366413|NCT00980330|1235321|P3|Overall Study|Withdrawal by Subject|4
366414|NCT00980330|1235322|P2|Overall Study|Withdrawal by Subject|4
366415|NCT00980330|1235323|P1|Overall Study|Withdrawal by Subject|2
366416|NCT00980330|1235317|P7|Overall Study|Lost to Follow-up|2
366417|NCT00980330|1235318|P6|Overall Study|Lost to Follow-up|1
366418|NCT00980330|1235319|P5|Overall Study|Lost to Follow-up|1
366419|NCT00980330|1235320|P4|Overall Study|Lost to Follow-up|2
366420|NCT00980330|1235321|P3|Overall Study|Lost to Follow-up|4
366421|NCT00980330|1235322|P2|Overall Study|Lost to Follow-up|1
366422|NCT00980330|1235323|P1|Overall Study|Lost to Follow-up|1
366423|NCT00980330|1235317|P7|Overall Study|Adverse Event|0
366424|NCT00980330|1235318|P6|Overall Study|Adverse Event|0
366425|NCT00980330|1235319|P5|Overall Study|Adverse Event|0
366426|NCT00980330|1235320|P4|Overall Study|Adverse Event|1
366427|NCT00980330|1235321|P3|Overall Study|Adverse Event|0
366428|NCT00980330|1235322|P2|Overall Study|Adverse Event|0
366429|NCT00980330|1235323|P1|Overall Study|Adverse Event|0
366430|NCT00980200|1235438|P5|7-day Treatment Period 3|Lack of Efficacy|1
366431|NCT00980200|1235439|P4|7-day Treatment Period 3|Lack of Efficacy|0
366432|NCT00980200|1235440|P3|7-day Treatment Period 3|Lack of Efficacy|0
366433|NCT00980200|1235441|P2|7-day Treatment Period 3|Lack of Efficacy|1
366434|NCT00980200|1235442|P1|7-day Treatment Period 3|Lack of Efficacy|0
366435|NCT00980200|1235438|P5|7-day Treatment Period 1|Withdrawal by Subject|0
366436|NCT00980200|1235439|P4|7-day Treatment Period 1|Withdrawal by Subject|0
366437|NCT00980200|1235440|P3|7-day Treatment Period 1|Withdrawal by Subject|0
366438|NCT00980200|1235441|P2|7-day Treatment Period 1|Withdrawal by Subject|1
366439|NCT00980200|1235442|P1|7-day Treatment Period 1|Withdrawal by Subject|0
366440|NCT00980174|1235461|P2|Overall Study|Other|1
366441|NCT00980174|1235462|P1|Overall Study|Other|0
366442|NCT00980174|1235461|P2|Overall Study|Death|1
366443|NCT00980174|1235462|P1|Overall Study|Death|1
366444|NCT00980174|1235461|P2|Overall Study|Ineligibility determined|1
366445|NCT00980174|1235462|P1|Overall Study|Ineligibility determined|2
366446|NCT00980174|1235461|P2|Overall Study|Adverse Event|3
366447|NCT00980174|1235462|P1|Overall Study|Adverse Event|0
366448|NCT00980174|1235461|P2|Overall Study|Withdrawal by Subject|4
366449|NCT00980174|1235462|P1|Overall Study|Withdrawal by Subject|1
366450|NCT00980148|1235480|P2|Overall Study|Various other reasons|9
366451|NCT00980148|1235481|P1|Overall Study|Various other reasons|8
366452|NCT00980148|1235480|P2|Overall Study|Negative for chlamydia at enrollment|9
366453|NCT00980148|1235481|P1|Overall Study|Negative for chlamydia at enrollment|12
366454|NCT00980148|1235480|P2|Overall Study|Received other antichlamydia treatment|14
366455|NCT00980148|1235481|P1|Overall Study|Received other antichlamydia treatment|20
366456|NCT00980148|1235480|P2|Overall Study|Discharged from facility|96
366457|NCT00980148|1235481|P1|Overall Study|Discharged from facility|89
366458|NCT00980044|1235490|P3|Overall Study|Protocol Violation|2
366459|NCT00980044|1235491|P2|Overall Study|Protocol Violation|0
366460|NCT00980044|1235492|P1|Overall Study|Protocol Violation|0
366461|NCT00980044|1235490|P3|Overall Study|Withdrawal by Subject|3
366462|NCT00980044|1235491|P2|Overall Study|Withdrawal by Subject|7
366463|NCT00980044|1235492|P1|Overall Study|Withdrawal by Subject|5
366464|NCT00980005|1235511|P2|Overall Study|Other|3
366465|NCT00980005|1235512|P1|Overall Study|Other|4
366466|NCT00980005|1235511|P2|Overall Study|Lost to Follow-up|43
366467|NCT00980005|1235512|P1|Overall Study|Lost to Follow-up|37
366468|NCT00980005|1235511|P2|Overall Study|Withdrawal by Subject|17
366469|NCT00980005|1235512|P1|Overall Study|Withdrawal by Subject|6
366470|NCT00979992|1235552|P1|Overall Study|Refused – Never Treated|2
366471|NCT00979992|1235552|P1|Overall Study|Ineligible - wrong cell type|2
366472|NCT00979992|1235552|P1|Overall Study|Ineligible - inadequate pathology|1
366473|NCT00979953|1235564|P4|Overall Study|Protocol Violation|2
366474|NCT00979953|1235565|P3|Overall Study|Protocol Violation|2
366475|NCT00979953|1235566|P2|Overall Study|Protocol Violation|0
366476|NCT00979953|1235567|P1|Overall Study|Protocol Violation|1
366477|NCT00979953|1235564|P4|Overall Study|Withdrawal by Subject|1
366478|NCT00979953|1235565|P3|Overall Study|Withdrawal by Subject|2
366479|NCT00979953|1235566|P2|Overall Study|Withdrawal by Subject|0
366480|NCT00979953|1235567|P1|Overall Study|Withdrawal by Subject|0
366481|NCT00979953|1235564|P4|Overall Study|Lost to Follow-up|0
366482|NCT00979953|1235565|P3|Overall Study|Lost to Follow-up|1
366483|NCT00979953|1235566|P2|Overall Study|Lost to Follow-up|1
366484|NCT00979953|1235567|P1|Overall Study|Lost to Follow-up|1
366485|NCT00979953|1235564|P4|Overall Study|Lack of Efficacy|0
366486|NCT00979953|1235565|P3|Overall Study|Lack of Efficacy|0
366487|NCT00979953|1235566|P2|Overall Study|Lack of Efficacy|2
366488|NCT00979953|1235567|P1|Overall Study|Lack of Efficacy|1
366489|NCT00979953|1235564|P4|Overall Study|Adverse Event|4
366490|NCT00979953|1235565|P3|Overall Study|Adverse Event|17
366491|NCT00979953|1235566|P2|Overall Study|Adverse Event|2
366492|NCT00979953|1235567|P1|Overall Study|Adverse Event|5
366493|NCT00979901|1235590|P4|Overall Study|Treatment Group Terminated by Sponsor|112
366494|NCT00979901|1235591|P3|Overall Study|Treatment Group Terminated by Sponsor|0
366495|NCT00979901|1235592|P2|Overall Study|Treatment Group Terminated by Sponsor|0
366496|NCT00979901|1235593|P1|Overall Study|Treatment Group Terminated by Sponsor|0
366497|NCT00979901|1235590|P4|Overall Study|Left Country|0
366498|NCT00979901|1235591|P3|Overall Study|Left Country|1
366499|NCT00979901|1235592|P2|Overall Study|Left Country|0
366500|NCT00979901|1235593|P1|Overall Study|Left Country|0
366501|NCT00979901|1235590|P4|Overall Study|Discontinued in Error|0
366502|NCT00979901|1235591|P3|Overall Study|Discontinued in Error|0
366503|NCT00979901|1235592|P2|Overall Study|Discontinued in Error|1
366504|NCT00979901|1235593|P1|Overall Study|Discontinued in Error|0
366505|NCT00979901|1235590|P4|Overall Study|elevated lab values pre-randomization|0
366506|NCT00979901|1235591|P3|Overall Study|elevated lab values pre-randomization|0
366507|NCT00979901|1235592|P2|Overall Study|elevated lab values pre-randomization|0
366508|NCT00979901|1235593|P1|Overall Study|elevated lab values pre-randomization|1
366509|NCT00979901|1235590|P4|Overall Study|vacation|0
366510|NCT00979901|1235591|P3|Overall Study|vacation|0
366511|NCT00979901|1235592|P2|Overall Study|vacation|0
366512|NCT00979901|1235593|P1|Overall Study|vacation|1
366513|NCT00979901|1235590|P4|Overall Study|out-of-state|0
366514|NCT00979901|1235591|P3|Overall Study|out-of-state|0
366515|NCT00979901|1235592|P2|Overall Study|out-of-state|0
366516|NCT00979901|1235593|P1|Overall Study|out-of-state|1
366517|NCT00979901|1235590|P4|Overall Study|Noncompliance|0
366518|NCT00979901|1235591|P3|Overall Study|Noncompliance|0
366519|NCT00979901|1235592|P2|Overall Study|Noncompliance|0
366520|NCT00979901|1235593|P1|Overall Study|Noncompliance|1
366521|NCT00979901|1235590|P4|Overall Study|Withdrawal by Subject|1
366522|NCT00979901|1235591|P3|Overall Study|Withdrawal by Subject|1
366523|NCT00979901|1235592|P2|Overall Study|Withdrawal by Subject|1
366524|NCT00979901|1235593|P1|Overall Study|Withdrawal by Subject|2
366525|NCT00979901|1235590|P4|Overall Study|Protocol Violation|1
366526|NCT00979901|1235591|P3|Overall Study|Protocol Violation|7
366527|NCT00979901|1235592|P2|Overall Study|Protocol Violation|2
366528|NCT00979901|1235593|P1|Overall Study|Protocol Violation|2
366529|NCT00979901|1235590|P4|Overall Study|Lost to Follow-up|0
366530|NCT00979901|1235591|P3|Overall Study|Lost to Follow-up|2
366531|NCT00979901|1235592|P2|Overall Study|Lost to Follow-up|1
366532|NCT00979901|1235593|P1|Overall Study|Lost to Follow-up|1
366533|NCT00979901|1235590|P4|Overall Study|Lack of Efficacy|0
366534|NCT00979901|1235591|P3|Overall Study|Lack of Efficacy|9
366535|NCT00979901|1235592|P2|Overall Study|Lack of Efficacy|4
366536|NCT00979901|1235593|P1|Overall Study|Lack of Efficacy|8
366537|NCT00979901|1235590|P4|Overall Study|Adverse Event|2
366538|NCT00979901|1235591|P3|Overall Study|Adverse Event|9
366539|NCT00979901|1235592|P2|Overall Study|Adverse Event|3
366540|NCT00979901|1235593|P1|Overall Study|Adverse Event|1
366541|NCT00979654|1235666|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
366542|NCT00979654|1235666|P1|Overall Study|Serious Adverse Event|1
366543|NCT00979654|1235666|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
366544|NCT00979654|1235666|P1|Overall Study|Per Principal Investigator’s Discretion|1
366545|NCT00979654|1235666|P1|Overall Study|Adverse Event of Diverticulitis|1
366546|NCT00979654|1235666|P1|Overall Study|Adverse Event|1
366547|NCT00979654|1235666|P1|Overall Study|Lack of Efficacy|6
366548|NCT00979654|1235666|P1|Overall Study|Death|1
366549|NCT00979654|1235666|P1|Overall Study|Withdrawal by Subject|22
366550|NCT00979654|1235666|P1|Overall Study|Lost to Follow-up|1
366551|NCT00979628|1235681|P3|Overall Study|transferred to ICU|1
366552|NCT00979628|1235682|P2|Overall Study|transferred to ICU|2
366553|NCT00979628|1235683|P1|Overall Study|transferred to ICU|1
366554|NCT00979628|1235681|P3|Overall Study|received steroids|0
366555|NCT00979628|1235682|P2|Overall Study|received steroids|1
366556|NCT00979628|1235683|P1|Overall Study|received steroids|1
366557|NCT00979628|1235681|P3|Overall Study|received regimen < 24 hours|5
366558|NCT00979628|1235682|P2|Overall Study|received regimen < 24 hours|6
366559|NCT00979628|1235683|P1|Overall Study|received regimen < 24 hours|7
366560|NCT00979602|1235710|P2|Overall Study|Others|3
366561|NCT00979602|1235711|P1|Overall Study|Others|3
366562|NCT00979602|1235710|P2|Overall Study|Migrated/moved from study area|6
366563|NCT00979602|1235711|P1|Overall Study|Migrated/moved from study area|3
366564|NCT00979602|1235710|P2|Overall Study|Lost to Follow-up|96
366565|NCT00979602|1235711|P1|Overall Study|Lost to Follow-up|100
366566|NCT00979602|1235710|P2|Overall Study|Withdrawal by Subject|25
366567|NCT00979602|1235711|P1|Overall Study|Withdrawal by Subject|31
366568|NCT00979602|1235710|P2|Overall Study|Protocol Violation|0
366569|NCT00979602|1235711|P1|Overall Study|Protocol Violation|3
366570|NCT00979602|1235710|P2|Overall Study|Serious Adverse Event|3
366571|NCT00979602|1235711|P1|Overall Study|Serious Adverse Event|5
366572|NCT00979576|1235882|P3|Combination Followed by Monotherapy|Progressive Disease|1
366573|NCT00979576|1235883|P2|Combination Followed by Monotherapy|Progressive Disease|2
366574|NCT00979576|1235884|P1|Combination Followed by Monotherapy|Progressive Disease|0
366575|NCT00979576|1235882|P3|Combination Treatment Phase|Adverse Event|2
366576|NCT00979576|1235883|P2|Combination Treatment Phase|Adverse Event|2
366577|NCT00979576|1235884|P1|Combination Treatment Phase|Adverse Event|0
366578|NCT00979576|1235882|P3|Combination Treatment Phase|Dose limiting toxicity|2
366579|NCT00979576|1235883|P2|Combination Treatment Phase|Dose limiting toxicity|3
366580|NCT00979576|1235884|P1|Combination Treatment Phase|Dose limiting toxicity|0
366581|NCT00979576|1235882|P3|Combination Treatment Phase|Progressive disease|5
366582|NCT00979576|1235883|P2|Combination Treatment Phase|Progressive disease|1
366583|NCT00979576|1235884|P1|Combination Treatment Phase|Progressive disease|3
366584|NCT00979420|1235941|P4|Overall Study|Other reasons not related to Viramune|1
366585|NCT00979420|1235942|P3|Overall Study|Other reasons not related to Viramune|0
366586|NCT00979420|1235943|P2|Overall Study|Other reasons not related to Viramune|0
366587|NCT00979420|1235944|P1|Overall Study|Other reasons not related to Viramune|3
366588|NCT00979420|1235941|P4|Overall Study|Lack of Efficacy|1
366589|NCT00979420|1235942|P3|Overall Study|Lack of Efficacy|1
366590|NCT00979420|1235943|P2|Overall Study|Lack of Efficacy|0
366591|NCT00979420|1235944|P1|Overall Study|Lack of Efficacy|3
366592|NCT00979420|1235941|P4|Overall Study|Adverse Event|0
366593|NCT00979420|1235942|P3|Overall Study|Adverse Event|0
366594|NCT00979420|1235943|P2|Overall Study|Adverse Event|0
366595|NCT00979420|1235944|P1|Overall Study|Adverse Event|1
366596|NCT00979212|1236025|P2|Overall Study|No protocol therapy received|0
366597|NCT00979212|1236026|P1|Overall Study|No protocol therapy received|1
366598|NCT00979212|1236025|P2|Overall Study|Protocol Violation|8
366599|NCT00979212|1236026|P1|Overall Study|Protocol Violation|1
366600|NCT00978757|1236086|P2|Overall Study|Physician Decision|3
366601|NCT00978757|1236087|P1|Overall Study|Physician Decision|1
366602|NCT00978731|1236097|P4|Overall Study|No response|0
366603|NCT00978731|1236098|P3|Overall Study|No response|0
366604|NCT00978731|1236099|P2|Overall Study|No response|0
366605|NCT00978731|1236100|P1|Overall Study|No response|1
366606|NCT00978731|1236097|P4|Overall Study|Study closure|1
366607|NCT00978731|1236098|P3|Overall Study|Study closure|1
366608|NCT00978731|1236099|P2|Overall Study|Study closure|4
366609|NCT00978731|1236100|P1|Overall Study|Study closure|3
366610|NCT00978731|1236097|P4|Overall Study|Disease progression/relapse|2
366611|NCT00978731|1236098|P3|Overall Study|Disease progression/relapse|2
366612|NCT00978731|1236099|P2|Overall Study|Disease progression/relapse|4
366613|NCT00978731|1236100|P1|Overall Study|Disease progression/relapse|5
366614|NCT00978731|1236097|P4|Overall Study|Deterioration without progression|0
366615|NCT00978731|1236098|P3|Overall Study|Deterioration without progression|0
366616|NCT00978731|1236099|P2|Overall Study|Deterioration without progression|1
366617|NCT00978731|1236100|P1|Overall Study|Deterioration without progression|0
366618|NCT00978731|1236097|P4|Overall Study|Administrative reason|0
366619|NCT00978731|1236098|P3|Overall Study|Administrative reason|1
366620|NCT00978731|1236099|P2|Overall Study|Administrative reason|3
366621|NCT00978731|1236100|P1|Overall Study|Administrative reason|3
366622|NCT00978731|1236097|P4|Overall Study|Participant's request|0
366623|NCT00978731|1236098|P3|Overall Study|Participant's request|0
366624|NCT00978731|1236099|P2|Overall Study|Participant's request|0
366625|NCT00978731|1236100|P1|Overall Study|Participant's request|1
366626|NCT00978731|1236097|P4|Overall Study|Adverse Event|0
366627|NCT00978731|1236098|P3|Overall Study|Adverse Event|0
366628|NCT00978731|1236099|P2|Overall Study|Adverse Event|2
366629|NCT00978731|1236100|P1|Overall Study|Adverse Event|5
366630|NCT00978731|1236097|P4|Overall Study|Lost to Follow-up|1
366631|NCT00978731|1236098|P3|Overall Study|Lost to Follow-up|0
366632|NCT00978731|1236099|P2|Overall Study|Lost to Follow-up|0
366633|NCT00978731|1236100|P1|Overall Study|Lost to Follow-up|0
366634|NCT00978731|1236097|P4|Overall Study|Death|0
366635|NCT00978731|1236098|P3|Overall Study|Death|1
366636|NCT00978731|1236099|P2|Overall Study|Death|1
366637|NCT00978731|1236100|P1|Overall Study|Death|4
366638|NCT00978627|1236140|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
366639|NCT00978627|1236141|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
366640|NCT00978627|1236140|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
366723|NCT00977938|1236361|P2|Treatment (12-30 mo. Post Procedure)|Other|18
366641|NCT00978627|1236141|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
366642|NCT00978627|1236140|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
366643|NCT00978627|1236141|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
366644|NCT00978627|1236140|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
366645|NCT00978627|1236141|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
366646|NCT00978627|1236140|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
366647|NCT00978627|1236141|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
366648|NCT00978627|1236140|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
366649|NCT00978627|1236141|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
366650|NCT00978627|1236140|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
366651|NCT00978627|1236141|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
366652|NCT00978627|1236140|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
366653|NCT00978627|1236141|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
366654|NCT00978627|1236140|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
366655|NCT00978627|1236141|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
366656|NCT00978432|1236179|P3|Overall Study|Adverse Event|1
366657|NCT00978432|1236180|P2|Overall Study|Adverse Event|0
366658|NCT00978432|1236181|P1|Overall Study|Adverse Event|2
366659|NCT00978432|1236179|P3|Overall Study|Lack of Efficacy|3
366660|NCT00978432|1236180|P2|Overall Study|Lack of Efficacy|1
366661|NCT00978432|1236181|P1|Overall Study|Lack of Efficacy|1
366662|NCT00978432|1236179|P3|Overall Study|Withdrawal by Subject|1
366663|NCT00978432|1236180|P2|Overall Study|Withdrawal by Subject|0
366664|NCT00978432|1236181|P1|Overall Study|Withdrawal by Subject|0
366665|NCT00978380|1236232|P1|Overall Study|Unclassified|8
366666|NCT00978380|1236232|P1|Overall Study|Withdrawal criteria|9
366667|NCT00978380|1236232|P1|Overall Study|Protocol Violation|2
366668|NCT00978341|1236238|P2|Washout Period of 2 Weeks|Adverse Event|0
366669|NCT00978341|1236239|P1|Washout Period of 2 Weeks|Adverse Event|1
366670|NCT00978120|1236261|P4|Overall Study|Moved out of state|1
366671|NCT00978120|1236262|P3|Overall Study|Moved out of state|0
366672|NCT00978120|1236263|P2|Overall Study|Moved out of state|0
366673|NCT00978120|1236264|P1|Overall Study|Moved out of state|0
366674|NCT00978120|1236261|P4|Overall Study|Withdrawal by Subject|0
366675|NCT00978120|1236262|P3|Overall Study|Withdrawal by Subject|0
366676|NCT00978120|1236263|P2|Overall Study|Withdrawal by Subject|0
366677|NCT00978120|1236264|P1|Overall Study|Withdrawal by Subject|2
366678|NCT00978120|1236261|P4|Overall Study|Lost to Follow-up|0
366679|NCT00978120|1236262|P3|Overall Study|Lost to Follow-up|3
366680|NCT00978120|1236263|P2|Overall Study|Lost to Follow-up|0
366681|NCT00978120|1236264|P1|Overall Study|Lost to Follow-up|0
366682|NCT00978120|1236261|P4|Overall Study|Death|1
366683|NCT00978120|1236262|P3|Overall Study|Death|0
366684|NCT00978120|1236263|P2|Overall Study|Death|0
366685|NCT00978120|1236264|P1|Overall Study|Death|0
366686|NCT00978042|1236316|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
366687|NCT00978042|1236317|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
366688|NCT00978042|1236316|P2|Initial Treatment Period|Consent withdrawn|9
366689|NCT00978042|1236317|P1|Initial Treatment Period|Consent withdrawn|22
366690|NCT00978042|1236316|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
366691|NCT00978042|1236317|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
366692|NCT00978042|1236316|P2|Initial Treatment Period|Adverse Event|0
366693|NCT00978042|1236317|P1|Initial Treatment Period|Adverse Event|2
366694|NCT00978042|1236316|P2|Initial Treatment Period|Lost to Follow-up|3
366695|NCT00978042|1236317|P1|Initial Treatment Period|Lost to Follow-up|21
366696|NCT00978042|1236316|P2|Initial Treatment Period|Ineligibility|0
366697|NCT00978042|1236317|P1|Initial Treatment Period|Ineligibility|1
366698|NCT00978042|1236316|P2|Initial Treatment Period|Treated in Error|3
366699|NCT00978042|1236317|P1|Initial Treatment Period|Treated in Error|0
366700|NCT00978029|1236330|P3|Overall Study|Protocol Violation|0
366701|NCT00978029|1236331|P2|Overall Study|Protocol Violation|1
366702|NCT00978029|1236332|P1|Overall Study|Protocol Violation|0
366703|NCT00978029|1236330|P3|Overall Study|Withdrawal by Subject|1
366704|NCT00978029|1236331|P2|Overall Study|Withdrawal by Subject|0
366705|NCT00978029|1236332|P1|Overall Study|Withdrawal by Subject|0
366706|NCT00978029|1236330|P3|Overall Study|Adverse Event|5
366707|NCT00978029|1236331|P2|Overall Study|Adverse Event|2
366708|NCT00978029|1236332|P1|Overall Study|Adverse Event|1
366709|NCT00977938|1236359|P4|Observation (30-33 mo. Post Procedure)|Other|0
366710|NCT00977938|1236360|P3|Observation (30-33 mo. Post Procedure)|Other|0
366711|NCT00977938|1236361|P2|Observation (30-33 mo. Post Procedure)|Other|4
366712|NCT00977938|1236362|P1|Observation (30-33 mo. Post Procedure)|Other|8
366713|NCT00977938|1236359|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
366714|NCT00977938|1236360|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
366715|NCT00977938|1236361|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
366716|NCT00977938|1236362|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
366717|NCT00977938|1236359|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
366718|NCT00977938|1236360|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
366719|NCT00977938|1236361|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
366720|NCT00977938|1236362|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
366721|NCT00977938|1236359|P4|Treatment (12-30 mo. Post Procedure)|Other|4
366722|NCT00977938|1236360|P3|Treatment (12-30 mo. Post Procedure)|Other|3
366724|NCT00977938|1236362|P1|Treatment (12-30 mo. Post Procedure)|Other|17
366725|NCT00977938|1236359|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
366726|NCT00977938|1236360|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
366727|NCT00977938|1236361|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
366728|NCT00977938|1236362|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
366729|NCT00977938|1236359|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
366730|NCT00977938|1236360|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
366731|NCT00977938|1236361|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
366732|NCT00977938|1236362|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
366733|NCT00977665|1236426|P2|Overall Study|Treatment failure|1
366734|NCT00977665|1236427|P1|Overall Study|Treatment failure|0
366735|NCT00977665|1236426|P2|Overall Study|Adverse Event|7
366736|NCT00977665|1236427|P1|Overall Study|Adverse Event|14
366737|NCT00977665|1236426|P2|Overall Study|Death|2
366738|NCT00977665|1236427|P1|Overall Study|Death|3
366739|NCT00977665|1236426|P2|Overall Study|Lost to Follow-up|0
366740|NCT00977665|1236427|P1|Overall Study|Lost to Follow-up|1
366741|NCT00977665|1236426|P2|Overall Study|Sponsor requested withdrawal|1
366742|NCT00977665|1236427|P1|Overall Study|Sponsor requested withdrawal|0
366743|NCT00977665|1236426|P2|Overall Study|Physician Decision|1
366744|NCT00977665|1236427|P1|Overall Study|Physician Decision|2
366745|NCT00977665|1236426|P2|Overall Study|Withdrawal by Subject|3
366746|NCT00977665|1236427|P1|Overall Study|Withdrawal by Subject|1
366747|NCT00977613|1236459|P1|Overall Study|Lost to Follow-up|16
366748|NCT00977574|1236466|P3|Overall Study|Never Treated|4
366749|NCT00977574|1236467|P2|Overall Study|Never Treated|2
366750|NCT00977574|1236468|P1|Overall Study|Never Treated|4
366751|NCT00977561|1236487|P2|Overall Study|Other|0
366752|NCT00977561|1236488|P1|Overall Study|Other|2
366753|NCT00977561|1236487|P2|Overall Study|Study terminated|2
366754|NCT00977561|1236488|P1|Overall Study|Study terminated|0
366755|NCT00977561|1236487|P2|Overall Study|Death|2
366756|NCT00977561|1236488|P1|Overall Study|Death|3
366757|NCT00977548|1236515|P1|Overall Study|Withdrawal by Subject|1
366758|NCT00977548|1236515|P1|Overall Study|Adverse Event|8
366759|NCT00977548|1236515|P1|Overall Study|Ineligible|4
366760|NCT00977470|1236524|P2|Overall Study|Still on-study|0
366761|NCT00977470|1236525|P1|Overall Study|Still on-study|2
366762|NCT00977470|1236524|P2|Overall Study|prolonged recovery post-surgery|1
366763|NCT00977470|1236525|P1|Overall Study|prolonged recovery post-surgery|0
366764|NCT00977470|1236524|P2|Overall Study|clinical decline|1
366765|NCT00977470|1236525|P1|Overall Study|clinical decline|0
366766|NCT00977470|1236524|P2|Overall Study|Death|2
366767|NCT00977470|1236525|P1|Overall Study|Death|0
366768|NCT00977470|1236524|P2|Overall Study|Withdrawal by Subject|2
366769|NCT00977470|1236525|P1|Overall Study|Withdrawal by Subject|0
366770|NCT00977470|1236524|P2|Overall Study|Protocol Violation|0
366771|NCT00977470|1236525|P1|Overall Study|Protocol Violation|1
366772|NCT00977470|1236524|P2|Overall Study|Adverse Event|2
366773|NCT00977470|1236525|P1|Overall Study|Adverse Event|1
366774|NCT00977470|1236524|P2|Overall Study|Physician Decision|0
366775|NCT00977470|1236525|P1|Overall Study|Physician Decision|2
366776|NCT00977470|1236524|P2|Overall Study|Lack of Efficacy|30
366777|NCT00977470|1236525|P1|Overall Study|Lack of Efficacy|32
366778|NCT00977379|1236545|P2|Overall Study|Randomization Error|1
366779|NCT00977379|1236546|P1|Overall Study|Randomization Error|0
366780|NCT00977379|1236545|P2|Overall Study|Participant Moving House|1
366781|NCT00977379|1236546|P1|Overall Study|Participant Moving House|0
366782|NCT00977379|1236545|P2|Overall Study|Premature Study Termination|0
366783|NCT00977379|1236546|P1|Overall Study|Premature Study Termination|4
366784|NCT00977379|1236545|P2|Overall Study|Death|9
366785|NCT00977379|1236546|P1|Overall Study|Death|7
366786|NCT00977379|1236545|P2|Overall Study|Withdrawal by Subject|1
366787|NCT00977379|1236546|P1|Overall Study|Withdrawal by Subject|1
366788|NCT00977314|1236582|P2|Overall Study|Physician Decision|0
366789|NCT00977314|1236583|P1|Overall Study|Physician Decision|1
366790|NCT00977314|1236582|P2|Overall Study|Withdrawal by Subject|0
366791|NCT00977314|1236583|P1|Overall Study|Withdrawal by Subject|1
366792|NCT00977197|1236591|P2|Overall Study|Nonadherence|1
366793|NCT00977197|1236592|P1|Overall Study|Nonadherence|1
366794|NCT00977197|1236591|P2|Overall Study|Lost to Follow-up|3
366795|NCT00977197|1236592|P1|Overall Study|Lost to Follow-up|1
366796|NCT00977197|1236591|P2|Overall Study|Lack of Efficacy|0
366797|NCT00977197|1236592|P1|Overall Study|Lack of Efficacy|1
366798|NCT00977197|1236591|P2|Overall Study|Adverse Event|1
366799|NCT00977197|1236592|P1|Overall Study|Adverse Event|3
366800|NCT00977197|1236591|P2|Overall Study|Withdrawal by Subject|4
366801|NCT00977197|1236592|P1|Overall Study|Withdrawal by Subject|3
366802|NCT00977106|1236655|P2|Overall Study|Not specified|0
366803|NCT00977106|1236656|P1|Overall Study|Not specified|1
366804|NCT00977106|1236655|P2|Overall Study|Protocol Violation|1
366805|NCT00977106|1236656|P1|Overall Study|Protocol Violation|0
366806|NCT00977106|1236655|P2|Overall Study|Lack of Efficacy|2
366807|NCT00977106|1236656|P1|Overall Study|Lack of Efficacy|2
366808|NCT00977106|1236655|P2|Overall Study|Withdrawal by Subject|2
366809|NCT00977106|1236656|P1|Overall Study|Withdrawal by Subject|2
366810|NCT00977106|1236655|P2|Overall Study|Adverse Event|6
366811|NCT00977106|1236656|P1|Overall Study|Adverse Event|5
366812|NCT00977080|1236748|P4|Overall Study|Travel for family reasons|0
366813|NCT00977080|1236749|P3|Overall Study|Travel for family reasons|0
366814|NCT00977080|1236750|P2|Overall Study|Travel for family reasons|0
366815|NCT00977080|1236751|P1|Overall Study|Travel for family reasons|1
366816|NCT00977080|1236748|P4|Overall Study|Required kidney transplantation|1
366817|NCT00977080|1236749|P3|Overall Study|Required kidney transplantation|3
366818|NCT00977080|1236750|P2|Overall Study|Required kidney transplantation|3
366819|NCT00977080|1236751|P1|Overall Study|Required kidney transplantation|1
366820|NCT00977080|1236748|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
366821|NCT00977080|1236749|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
366822|NCT00977080|1236750|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
366823|NCT00977080|1236751|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
366824|NCT00977080|1236748|P4|Overall Study|Noncompliance|0
366825|NCT00977080|1236749|P3|Overall Study|Noncompliance|1
366826|NCT00977080|1236750|P2|Overall Study|Noncompliance|2
366827|NCT00977080|1236751|P1|Overall Study|Noncompliance|0
366828|NCT00977080|1236748|P4|Overall Study|Protocol Violation|3
366829|NCT00977080|1236749|P3|Overall Study|Protocol Violation|4
366830|NCT00977080|1236750|P2|Overall Study|Protocol Violation|3
366831|NCT00977080|1236751|P1|Overall Study|Protocol Violation|7
366832|NCT00977080|1236748|P4|Overall Study|Withdrawal by Subject|5
366833|NCT00977080|1236749|P3|Overall Study|Withdrawal by Subject|1
366834|NCT00977080|1236750|P2|Overall Study|Withdrawal by Subject|5
366835|NCT00977080|1236751|P1|Overall Study|Withdrawal by Subject|1
366836|NCT00977080|1236748|P4|Overall Study|Adverse Event|7
366837|NCT00977080|1236749|P3|Overall Study|Adverse Event|7
366838|NCT00977080|1236750|P2|Overall Study|Adverse Event|7
366839|NCT00977080|1236751|P1|Overall Study|Adverse Event|2
366840|NCT00976989|1236784|P3|Overall Study|Other|1
366841|NCT00976989|1236785|P2|Overall Study|Other|0
366842|NCT00976989|1236786|P1|Overall Study|Other|1
366843|NCT00976989|1236784|P3|Overall Study|Recurrence of Disease|0
366844|NCT00976989|1236785|P2|Overall Study|Recurrence of Disease|1
366845|NCT00976989|1236786|P1|Overall Study|Recurrence of Disease|0
366846|NCT00976989|1236784|P3|Overall Study|Failure to Return|0
366847|NCT00976989|1236785|P2|Overall Study|Failure to Return|1
366848|NCT00976989|1236786|P1|Overall Study|Failure to Return|2
366849|NCT00976989|1236784|P3|Overall Study|Refused Treatment|5
366850|NCT00976989|1236785|P2|Overall Study|Refused Treatment|3
366851|NCT00976989|1236786|P1|Overall Study|Refused Treatment|4
366852|NCT00976989|1236784|P3|Overall Study|Death|10
366853|NCT00976989|1236785|P2|Overall Study|Death|7
366854|NCT00976989|1236786|P1|Overall Study|Death|5
366855|NCT00976989|1236784|P3|Overall Study|Violation of Selection Criteria at Entry|1
366856|NCT00976989|1236785|P2|Overall Study|Violation of Selection Criteria at Entry|0
366857|NCT00976989|1236786|P1|Overall Study|Violation of Selection Criteria at Entry|1
366858|NCT00976950|1236827|P1|Overall Study|Events with no relationship to Aptivus|3
366859|NCT00976950|1236827|P1|Overall Study|Adverse Event|3
366860|NCT00976937|1236835|P2|Overall Study|Personal and Familial Reason|2
366861|NCT00976937|1236836|P1|Overall Study|Personal and Familial Reason|2
366862|NCT00976937|1236835|P2|Overall Study|Poor compliance to protocol|0
366863|NCT00976937|1236836|P1|Overall Study|Poor compliance to protocol|3
366864|NCT00976937|1236835|P2|Overall Study|Withdrawal by Subject|3
366865|NCT00976937|1236836|P1|Overall Study|Withdrawal by Subject|5
366866|NCT00976937|1236835|P2|Overall Study|Lost to Follow-up|1
366867|NCT00976937|1236836|P1|Overall Study|Lost to Follow-up|2
366868|NCT00976937|1236835|P2|Overall Study|Adverse Event|5
366869|NCT00976937|1236836|P1|Overall Study|Adverse Event|4
366870|NCT00976911|1236878|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
366871|NCT00976911|1236879|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
366872|NCT00976911|1236878|P2|Overall Study|Not Specified|9
366873|NCT00976911|1236879|P1|Overall Study|Not Specified|8
366874|NCT00976911|1236878|P2|Overall Study|Protocol Violation|0
366875|NCT00976911|1236879|P1|Overall Study|Protocol Violation|2
366876|NCT00976911|1236878|P2|Overall Study|Adverse Event|1
366877|NCT00976911|1236879|P1|Overall Study|Adverse Event|0
366878|NCT00976911|1236878|P2|Overall Study|Death|126
366879|NCT00976911|1236879|P1|Overall Study|Death|138
366880|NCT00976911|1236878|P2|Overall Study|Withdrawal by Subject|6
366881|NCT00976911|1236879|P1|Overall Study|Withdrawal by Subject|4
366882|NCT00976898|1236897|P1|Overall Study|Progressive Disease|1
366883|NCT00976898|1236897|P1|Overall Study|Liver Transplant|1
366884|NCT00976898|1236897|P1|Overall Study|Physician Decision|1
366885|NCT00976898|1236897|P1|Overall Study|Adverse Event|1
366886|NCT00976898|1236897|P1|Overall Study|Protocol Violation|1
366887|NCT00976820|1236908|P4|Overall Study|Withdrawal by Subject|4
366888|NCT00976820|1236909|P3|Overall Study|Withdrawal by Subject|1
366889|NCT00976820|1236910|P2|Overall Study|Withdrawal by Subject|4
366890|NCT00976820|1236911|P1|Overall Study|Withdrawal by Subject|2
366891|NCT00976820|1236908|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
366892|NCT00976820|1236909|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
366893|NCT00976820|1236910|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
366894|NCT00976820|1236911|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
366895|NCT00976820|1236908|P4|Overall Study|Lost to Follow-up|3
366896|NCT00976820|1236909|P3|Overall Study|Lost to Follow-up|2
366897|NCT00976820|1236910|P2|Overall Study|Lost to Follow-up|16
366898|NCT00976820|1236911|P1|Overall Study|Lost to Follow-up|5
366899|NCT00976716|1237247|P1|Overall Study|Adverse Event|1
366900|NCT00976703|1237265|P2|Overall Study|ineligible for study|2
366901|NCT00976703|1237266|P1|Overall Study|ineligible for study|2
366902|NCT00976703|1237265|P2|Overall Study|Physician Decision|1
366903|NCT00976703|1237266|P1|Overall Study|Physician Decision|1
366904|NCT00976677|1237280|P2|Overall Study|Unknown/Missing|0
366905|NCT00976677|1237281|P1|Overall Study|Unknown/Missing|1
366906|NCT00976677|1237280|P2|Overall Study|Trial unblinded|2
366907|NCT00976677|1237281|P1|Overall Study|Trial unblinded|2
366908|NCT00976677|1237280|P2|Overall Study|Disease progression|1
366909|NCT00976677|1237281|P1|Overall Study|Disease progression|1
366910|NCT00976677|1237280|P2|Overall Study|Withdrawal by Subject|2
366911|NCT00976677|1237281|P1|Overall Study|Withdrawal by Subject|0
366912|NCT00976677|1237280|P2|Overall Study|Adverse Event|0
366913|NCT00976677|1237281|P1|Overall Study|Adverse Event|1
366914|NCT00976573|1237489|P2|Overall Study|Cancel prior to receiving treatment|2
366915|NCT00976573|1237490|P1|Overall Study|Cancel prior to receiving treatment|4
366916|NCT00976573|1237489|P2|Overall Study|Ineligible|1
366917|NCT00976573|1237490|P1|Overall Study|Ineligible|0
366918|NCT00976560|1237504|P2|Overall Study|Withdrawal by Subject|3
366919|NCT00976560|1237505|P1|Overall Study|Withdrawal by Subject|2
366920|NCT00976560|1237504|P2|Overall Study|Physician Decision|0
366921|NCT00976560|1237505|P1|Overall Study|Physician Decision|2
366922|NCT00976560|1237504|P2|Overall Study|Lost to Follow-up|0
366923|NCT00976560|1237505|P1|Overall Study|Lost to Follow-up|1
366924|NCT00976560|1237504|P2|Overall Study|Protocol Violation|0
366925|NCT00976560|1237505|P1|Overall Study|Protocol Violation|1
366926|NCT00976560|1237504|P2|Overall Study|Lack of Efficacy|5
366927|NCT00976560|1237505|P1|Overall Study|Lack of Efficacy|3
366928|NCT00976560|1237504|P2|Overall Study|Adverse Event|5
366929|NCT00976560|1237505|P1|Overall Study|Adverse Event|5
366930|NCT00976508|1237574|P2|Overall Study|Terminated by the Sponsor|1
366931|NCT00976508|1237575|P1|Overall Study|Terminated by the Sponsor|0
366932|NCT00976508|1237574|P2|Overall Study|Subject Enrolled in Hospice|0
366933|NCT00976508|1237575|P1|Overall Study|Subject Enrolled in Hospice|1
366934|NCT00976508|1237574|P2|Overall Study|Disease Progression|4
366935|NCT00976508|1237575|P1|Overall Study|Disease Progression|4
366936|NCT00976508|1237574|P2|Overall Study|Withdrawal by Subject|0
366937|NCT00976508|1237575|P1|Overall Study|Withdrawal by Subject|1
366938|NCT00976508|1237574|P2|Overall Study|Lost to Follow-up|0
366939|NCT00976508|1237575|P1|Overall Study|Lost to Follow-up|1
366940|NCT00976508|1237574|P2|Overall Study|Death|1
366941|NCT00976508|1237575|P1|Overall Study|Death|7
366942|NCT00976495|1237608|P3|Overall Study|Withdrawal by Subject|0
366943|NCT00976495|1237609|P2|Overall Study|Withdrawal by Subject|1
366944|NCT00976495|1237610|P1|Overall Study|Withdrawal by Subject|0
366945|NCT00976482|1237627|P1|Overall Study|Protocol Violation|5
366946|NCT00976482|1237627|P1|Overall Study|Center terminated|1
366947|NCT00976482|1237627|P1|Overall Study|Withdrawal by Subject|45
366948|NCT00976482|1237627|P1|Overall Study|Death|208
366949|NCT00976456|1237633|P2|Overall Study|screening failure, unknown|4
366950|NCT00976456|1237634|P1|Overall Study|screening failure, unknown|11
366951|NCT00976456|1237633|P2|Overall Study|Withdrawal by Subject|1
366952|NCT00976456|1237634|P1|Overall Study|Withdrawal by Subject|3
366953|NCT00976456|1237633|P2|Overall Study|Lack of Efficacy|2
366954|NCT00976456|1237634|P1|Overall Study|Lack of Efficacy|5
366955|NCT00976456|1237633|P2|Overall Study|Death|9
366956|NCT00976456|1237634|P1|Overall Study|Death|7
366957|NCT00976456|1237633|P2|Overall Study|Adverse Event|22
366958|NCT00976456|1237634|P1|Overall Study|Adverse Event|17
366959|NCT00976391|1237661|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
366960|NCT00976391|1237662|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
366961|NCT00976391|1237661|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
366962|NCT00976391|1237662|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
366963|NCT00976391|1237661|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
366964|NCT00976391|1237662|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
366965|NCT00976391|1237661|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
366966|NCT00976391|1237662|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
366967|NCT00976391|1237661|P2|Follow-up Period (8 Weeks)|Noncompliance|2
366968|NCT00976391|1237662|P1|Follow-up Period (8 Weeks)|Noncompliance|2
366969|NCT00976391|1237661|P2|Follow-up Period (8 Weeks)|Adverse Event|1
366970|NCT00976391|1237662|P1|Follow-up Period (8 Weeks)|Adverse Event|3
366971|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Pregnancy|0
366972|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Pregnancy|1
366973|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
366974|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
366975|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Physician Decision|1
366976|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Physician Decision|1
366977|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
366978|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
366979|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
366980|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
366981|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Noncompliance|4
366982|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Noncompliance|4
366983|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Protocol Violation|1
366984|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Protocol Violation|1
366985|NCT00976391|1237661|P2|Treatment Period (52 Weeks)|Adverse Event|2
366986|NCT00976391|1237662|P1|Treatment Period (52 Weeks)|Adverse Event|16
366987|NCT00976274|1237710|P2|Overall Study|Physician Decision|2
366988|NCT00976274|1237711|P1|Overall Study|Physician Decision|1
366989|NCT00976274|1237710|P2|Overall Study|Withdrawal by Subject|1
366990|NCT00976274|1237711|P1|Overall Study|Withdrawal by Subject|1
366991|NCT00976274|1237710|P2|Overall Study|Lost to Follow-up|5
366992|NCT00976274|1237711|P1|Overall Study|Lost to Follow-up|5
366993|NCT00976209|1237727|P2|Treatment Period 2|Lost to Follow-up|1
366994|NCT00976209|1237728|P1|Treatment Period 2|Lost to Follow-up|0
366995|NCT00976209|1237727|P2|Treatment Period 2|Withdrawal by Subject|1
366996|NCT00976209|1237728|P1|Treatment Period 2|Withdrawal by Subject|0
366997|NCT00976209|1237727|P2|Wash-out Period|Other|0
366998|NCT00976209|1237728|P1|Wash-out Period|Other|1
366999|NCT00976209|1237727|P2|Wash-out Period|Protocol Violation|0
367000|NCT00976209|1237728|P1|Wash-out Period|Protocol Violation|1
367001|NCT00976209|1237727|P2|Wash-out Period|Lost to Follow-up|0
367002|NCT00976209|1237728|P1|Wash-out Period|Lost to Follow-up|1
367003|NCT00976209|1237727|P2|Wash-out Period|Adverse Event|2
367004|NCT00976209|1237728|P1|Wash-out Period|Adverse Event|1
367005|NCT00976209|1237727|P2|Treatment Period 1|Other|1
367006|NCT00976209|1237728|P1|Treatment Period 1|Other|0
367007|NCT00976209|1237727|P2|Treatment Period 1|Lost to Follow-up|0
367008|NCT00976209|1237728|P1|Treatment Period 1|Lost to Follow-up|2
367009|NCT00976209|1237727|P2|Treatment Period 1|Protocol Violation|0
367010|NCT00976209|1237728|P1|Treatment Period 1|Protocol Violation|1
367011|NCT00976027|1237741|P2|Overall Study|Withdrawal by Subject|66
367012|NCT00976027|1237742|P1|Overall Study|Withdrawal by Subject|107
367013|NCT00976027|1237741|P2|Overall Study|Lost to Follow-up|103
367014|NCT00976027|1237742|P1|Overall Study|Lost to Follow-up|208
367015|NCT00976027|1237741|P2|Overall Study|Protocol Violation|27
367016|NCT00976027|1237742|P1|Overall Study|Protocol Violation|60
367017|NCT00976027|1237741|P2|Overall Study|Adverse Event|2
367018|NCT00976027|1237742|P1|Overall Study|Adverse Event|0
367019|NCT00976027|1237741|P2|Overall Study|Serious Adverse Event|17
367020|NCT00976027|1237742|P1|Overall Study|Serious Adverse Event|36
367021|NCT00975975|1237754|P1|Overall Study|Death|6
367022|NCT00975923|1237762|P2|Overall Study|Withdrawal by Subject|1
367023|NCT00975923|1237763|P1|Overall Study|Withdrawal by Subject|0
367024|NCT00975806|1237774|P3|Overall Study|Physician decision and disease related|1
367025|NCT00975806|1237775|P2|Overall Study|Physician decision and disease related|0
367026|NCT00975806|1237776|P1|Overall Study|Physician decision and disease related|1
367027|NCT00975806|1237774|P3|Overall Study|Death|0
367028|NCT00975806|1237775|P2|Overall Study|Death|1
367029|NCT00975806|1237776|P1|Overall Study|Death|0
367030|NCT00975806|1237774|P3|Overall Study|Withdrawal by Subject|0
367031|NCT00975806|1237775|P2|Overall Study|Withdrawal by Subject|0
367032|NCT00975806|1237776|P1|Overall Study|Withdrawal by Subject|1
367033|NCT00975806|1237774|P3|Overall Study|Disease Progression|1
367034|NCT00975806|1237775|P2|Overall Study|Disease Progression|5
367035|NCT00975806|1237776|P1|Overall Study|Disease Progression|1
367036|NCT00975806|1237774|P3|Overall Study|Adverse Event|2
367037|NCT00975806|1237775|P2|Overall Study|Adverse Event|1
367038|NCT00975806|1237776|P1|Overall Study|Adverse Event|2
367039|NCT00975780|1237800|P2|Follow Up|Discharged from Facility|12
367040|NCT00975780|1237801|P1|Follow Up|Discharged from Facility|7
367041|NCT00975780|1237800|P2|Follow Up|Facility Withdrawal|23
367042|NCT00975780|1237801|P1|Follow Up|Facility Withdrawal|7
367043|NCT00975780|1237800|P2|Follow Up|Death|122
367044|NCT00975780|1237801|P1|Follow Up|Death|88
367045|NCT00975715|1237811|P2|Maintenance Period|Adverse Event|1
367046|NCT00975715|1237812|P1|Maintenance Period|Adverse Event|2
367047|NCT00975715|1237811|P2|Titration Period|Protocol Violation|0
367048|NCT00975715|1237812|P1|Titration Period|Protocol Violation|1
367049|NCT00975715|1237811|P2|Titration Period|Adverse Event|0
367050|NCT00975715|1237812|P1|Titration Period|Adverse Event|6
367051|NCT00975689|1237828|P2|Overall Study|Physician Decision|0
367052|NCT00975689|1237829|P1|Overall Study|Physician Decision|1
367053|NCT00975689|1237828|P2|Overall Study|Withdrawal by Subject|0
367054|NCT00975689|1237829|P1|Overall Study|Withdrawal by Subject|1
367055|NCT00975689|1237828|P2|Overall Study|Adverse Event|3
367056|NCT00975689|1237829|P1|Overall Study|Adverse Event|0
367057|NCT00975611|1237861|P1|Overall Study|Physician Decision|1
367058|NCT00975611|1237861|P1|Overall Study|Screen Fail|16
367059|NCT00975585|1237867|P2|Overall Study|Lens issue|2
367060|NCT00975585|1237868|P1|Overall Study|Lens issue|2
367061|NCT00975585|1237867|P2|Overall Study|Withdrawal by Subject|1
367062|NCT00975585|1237868|P1|Overall Study|Withdrawal by Subject|2
367063|NCT00975585|1237867|P2|Overall Study|Lost to Follow-up|5
367064|NCT00975585|1237868|P1|Overall Study|Lost to Follow-up|3
367065|NCT00975585|1237867|P2|Overall Study|Adverse Event|4
367066|NCT00975585|1237868|P1|Overall Study|Adverse Event|0
367067|NCT00975507|1237888|P2|Overall Study|Withdrawal by Subject|3
367068|NCT00975507|1237889|P1|Overall Study|Withdrawal by Subject|10
367069|NCT00975507|1237888|P2|Overall Study|Protocol Violation|0
367070|NCT00975507|1237889|P1|Overall Study|Protocol Violation|2
367071|NCT00975507|1237888|P2|Overall Study|Lost to Follow-up|1
367072|NCT00975507|1237889|P1|Overall Study|Lost to Follow-up|7
367073|NCT00975507|1237888|P2|Overall Study|Adverse Event|0
367074|NCT00975507|1237889|P1|Overall Study|Adverse Event|1
367075|NCT00975481|1237909|P6|Fifth Intervention Period|Withdrawal by Subject|0
367076|NCT00975481|1237910|P5|Fifth Intervention Period|Withdrawal by Subject|1
367077|NCT00975481|1237911|P4|Fifth Intervention Period|Withdrawal by Subject|0
367078|NCT00975481|1237912|P3|Fifth Intervention Period|Withdrawal by Subject|0
367079|NCT00975481|1237913|P2|Fifth Intervention Period|Withdrawal by Subject|0
367080|NCT00975481|1237914|P1|Fifth Intervention Period|Withdrawal by Subject|0
367081|NCT00975481|1237909|P6|Fourth Intervention Period|Withdrawal by Subject|0
367082|NCT00975481|1237910|P5|Fourth Intervention Period|Withdrawal by Subject|0
367083|NCT00975481|1237911|P4|Fourth Intervention Period|Withdrawal by Subject|1
367084|NCT00975481|1237912|P3|Fourth Intervention Period|Withdrawal by Subject|1
367085|NCT00975481|1237913|P2|Fourth Intervention Period|Withdrawal by Subject|0
367086|NCT00975481|1237914|P1|Fourth Intervention Period|Withdrawal by Subject|0
367087|NCT00975481|1237909|P6|Second Intervention Period|Withdrawal by Subject|0
367088|NCT00975481|1237910|P5|Second Intervention Period|Withdrawal by Subject|0
367089|NCT00975481|1237911|P4|Second Intervention Period|Withdrawal by Subject|0
367090|NCT00975481|1237912|P3|Second Intervention Period|Withdrawal by Subject|1
367091|NCT00975481|1237913|P2|Second Intervention Period|Withdrawal by Subject|0
367092|NCT00975481|1237914|P1|Second Intervention Period|Withdrawal by Subject|0
367093|NCT00975481|1237909|P6|Second Intervention Period|Adverse Event|0
367094|NCT00975481|1237910|P5|Second Intervention Period|Adverse Event|0
367095|NCT00975481|1237911|P4|Second Intervention Period|Adverse Event|0
367096|NCT00975481|1237912|P3|Second Intervention Period|Adverse Event|0
367097|NCT00975481|1237913|P2|Second Intervention Period|Adverse Event|1
367098|NCT00975481|1237914|P1|Second Intervention Period|Adverse Event|2
367099|NCT00975416|1238014|P2|Overall Study|early discharge from tx|5
367100|NCT00975416|1238015|P1|Overall Study|early discharge from tx|3
367101|NCT00975286|1238024|P2|Overall Study|Sponsor Decision|2
367102|NCT00975286|1238025|P1|Overall Study|Sponsor Decision|0
367103|NCT00975286|1238024|P2|Overall Study|Poor Compliance to Protocol|2
367104|NCT00975286|1238025|P1|Overall Study|Poor Compliance to Protocol|0
367105|NCT00975286|1238024|P2|Overall Study|Familial and Personal Reasons|2
367106|NCT00975286|1238025|P1|Overall Study|Familial and Personal Reasons|2
367107|NCT00975286|1238024|P2|Overall Study|Withdrawal by Subject|2
367108|NCT00975286|1238025|P1|Overall Study|Withdrawal by Subject|0
367109|NCT00975286|1238024|P2|Overall Study|Protocol Violation|2
367110|NCT00975286|1238025|P1|Overall Study|Protocol Violation|1
367111|NCT00975286|1238024|P2|Overall Study|Adverse Event|19
367112|NCT00975286|1238025|P1|Overall Study|Adverse Event|9
367113|NCT00975221|1238057|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
367114|NCT00975221|1238058|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
367115|NCT00975221|1238057|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
367116|NCT00975221|1238058|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
367117|NCT00975221|1238057|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
367118|NCT00975221|1238058|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
367119|NCT00975221|1238057|P2|Titration Phase (Weeks 1-12)|Other|1
367120|NCT00975221|1238058|P1|Titration Phase (Weeks 1-12)|Other|0
367121|NCT00975221|1238057|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
367122|NCT00975221|1238058|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
367123|NCT00975221|1238057|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
367124|NCT00975221|1238058|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
367125|NCT00975195|1238074|P2|Overall Study|Not treated|2
367126|NCT00975195|1238075|P1|Overall Study|Not treated|1
367127|NCT00975195|1238074|P2|Overall Study|Other reason not defined above|33
367128|NCT00975195|1238075|P1|Overall Study|Other reason not defined above|29
367129|NCT00975195|1238074|P2|Overall Study|Withdrawal by Subject|61
367130|NCT00975195|1238075|P1|Overall Study|Withdrawal by Subject|48
367131|NCT00975195|1238074|P2|Overall Study|Lost to Follow-up|7
367132|NCT00975195|1238075|P1|Overall Study|Lost to Follow-up|9
367133|NCT00975195|1238074|P2|Overall Study|Protocol Violation|23
367134|NCT00975195|1238075|P1|Overall Study|Protocol Violation|27
367135|NCT00975195|1238074|P2|Overall Study|Lack of Efficacy|6
367136|NCT00975195|1238075|P1|Overall Study|Lack of Efficacy|6
367137|NCT00975195|1238074|P2|Overall Study|Adverse Event|101
367138|NCT00975195|1238075|P1|Overall Study|Adverse Event|108
367139|NCT00975156|1238135|P2|Overall Study|Protocol Violation|1
367140|NCT00975156|1238136|P1|Overall Study|Protocol Violation|0
367141|NCT00975143|1238148|P2|Overall Study|Details not available|4
367142|NCT00975143|1238149|P1|Overall Study|Details not available|10
367143|NCT00975143|1238148|P2|Overall Study|Physician Decision|2
367144|NCT00975143|1238149|P1|Overall Study|Physician Decision|1
367145|NCT00975143|1238148|P2|Overall Study|Non-compliance|8
367146|NCT00975143|1238149|P1|Overall Study|Non-compliance|5
367147|NCT00975143|1238148|P2|Overall Study|Lost to Follow-up|16
367148|NCT00975143|1238149|P1|Overall Study|Lost to Follow-up|20
367149|NCT00975143|1238148|P2|Overall Study|Withdrawal by Subject|15
367150|NCT00975143|1238149|P1|Overall Study|Withdrawal by Subject|15
367151|NCT00975143|1238148|P2|Overall Study|Adverse Event|15
367152|NCT00975143|1238149|P1|Overall Study|Adverse Event|19
367153|NCT00975130|1238159|P3|Study Part 2|Protocol Violation|1
367154|NCT00975130|1238160|P2|Study Part 2|Protocol Violation|0
367155|NCT00975130|1238161|P1|Study Part 2|Protocol Violation|0
367156|NCT00975130|1238159|P3|Study Part 2|Administrative|0
367157|NCT00975130|1238160|P2|Study Part 2|Administrative|1
367158|NCT00975130|1238161|P1|Study Part 2|Administrative|0
367159|NCT00975130|1238159|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
367160|NCT00975130|1238160|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
367161|NCT00975130|1238161|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
367162|NCT00975130|1238159|P3|Study Part 2|Withdrew Consent|2
367163|NCT00975130|1238160|P2|Study Part 2|Withdrew Consent|6
367164|NCT00975130|1238161|P1|Study Part 2|Withdrew Consent|0
367165|NCT00975130|1238159|P3|Study Part 2|Withdrawal by Subject|5
367166|NCT00975130|1238160|P2|Study Part 2|Withdrawal by Subject|13
367167|NCT00975130|1238161|P1|Study Part 2|Withdrawal by Subject|0
367168|NCT00975130|1238159|P3|Study Part 2|Lost to Follow-up|1
367169|NCT00975130|1238160|P2|Study Part 2|Lost to Follow-up|0
367170|NCT00975130|1238161|P1|Study Part 2|Lost to Follow-up|0
367171|NCT00975130|1238159|P3|Study Part 2|Adverse Event|7
367172|NCT00975130|1238160|P2|Study Part 2|Adverse Event|14
367173|NCT00975130|1238161|P1|Study Part 2|Adverse Event|0
367174|NCT00975130|1238159|P3|Study Part 1|Withdrew Consent|0
367175|NCT00975130|1238160|P2|Study Part 1|Withdrew Consent|0
367176|NCT00975130|1238161|P1|Study Part 1|Withdrew Consent|24
367177|NCT00975130|1238159|P3|Study Part 1|Administrative|0
367178|NCT00975130|1238160|P2|Study Part 1|Administrative|0
367179|NCT00975130|1238161|P1|Study Part 1|Administrative|4
367180|NCT00975130|1238159|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
367181|NCT00975130|1238160|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
367182|NCT00975130|1238161|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
367183|NCT00975130|1238159|P3|Study Part 1|Protocol Violation|0
367184|NCT00975130|1238160|P2|Study Part 1|Protocol Violation|0
367185|NCT00975130|1238161|P1|Study Part 1|Protocol Violation|13
367186|NCT00975130|1238159|P3|Study Part 1|Withdrawal by Subject|0
367187|NCT00975130|1238160|P2|Study Part 1|Withdrawal by Subject|0
367188|NCT00975130|1238161|P1|Study Part 1|Withdrawal by Subject|61
367189|NCT00975130|1238159|P3|Study Part 1|Lost to Follow-up|0
367190|NCT00975130|1238160|P2|Study Part 1|Lost to Follow-up|0
367191|NCT00975130|1238161|P1|Study Part 1|Lost to Follow-up|19
367192|NCT00975130|1238159|P3|Study Part 1|Adverse Event|0
367193|NCT00975130|1238160|P2|Study Part 1|Adverse Event|0
367194|NCT00975130|1238161|P1|Study Part 1|Adverse Event|150
367195|NCT00975000|1238345|P2|Overall Study|Non-compliance|1
367196|NCT00975000|1238346|P1|Overall Study|Non-compliance|0
367197|NCT00975000|1238345|P2|Overall Study|Protocol-specified Criteria|0
367198|NCT00975000|1238346|P1|Overall Study|Protocol-specified Criteria|1
367199|NCT00975000|1238345|P2|Overall Study|Lost to Follow-up|1
367200|NCT00975000|1238346|P1|Overall Study|Lost to Follow-up|0
367201|NCT00975000|1238345|P2|Overall Study|Withdrawal by Subject|2
367202|NCT00975000|1238346|P1|Overall Study|Withdrawal by Subject|2
367203|NCT00975000|1238345|P2|Overall Study|Adverse Event|1
367204|NCT00975000|1238346|P1|Overall Study|Adverse Event|1
367205|NCT00975000|1238345|P2|Overall Study|Other|0
367206|NCT00975000|1238346|P1|Overall Study|Other|1
367207|NCT00974974|1238370|P2|Maintenance - Double Blind Treatment|Various|0
367208|NCT00974974|1238371|P1|Maintenance - Double Blind Treatment|Various|4
367209|NCT00974974|1238370|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
367210|NCT00974974|1238371|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
367211|NCT00974974|1238370|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
367212|NCT00974974|1238371|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
367213|NCT00974974|1238370|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
367214|NCT00974974|1238371|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
367215|NCT00974974|1238370|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
367216|NCT00974974|1238371|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
367217|NCT00974974|1238370|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
367218|NCT00974974|1238371|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
367219|NCT00974974|1238370|P2|Maintenance - Double Blind Treatment|Adverse Event|3
367220|NCT00974974|1238371|P1|Maintenance - Double Blind Treatment|Adverse Event|3
367221|NCT00974974|1238370|P2|IPX066 Dose Conversion|Protocol Violation|0
367222|NCT00974974|1238371|P1|IPX066 Dose Conversion|Protocol Violation|4
367223|NCT00974974|1238370|P2|IPX066 Dose Conversion|Various|0
367224|NCT00974974|1238371|P1|IPX066 Dose Conversion|Various|3
367225|NCT00974974|1238370|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
367226|NCT00974974|1238371|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
367227|NCT00974974|1238370|P2|IPX066 Dose Conversion|Lack of Efficacy|0
367228|NCT00974974|1238371|P1|IPX066 Dose Conversion|Lack of Efficacy|13
367229|NCT00974974|1238370|P2|IPX066 Dose Conversion|Death|0
367230|NCT00974974|1238371|P1|IPX066 Dose Conversion|Death|2
367231|NCT00974974|1238370|P2|IPX066 Dose Conversion|Adverse Event|0
367232|NCT00974974|1238371|P1|IPX066 Dose Conversion|Adverse Event|23
367233|NCT00974974|1238370|P2|IR CD-LD Dose Adjustment|Various|9
367234|NCT00974974|1238371|P1|IR CD-LD Dose Adjustment|Various|0
367235|NCT00974974|1238370|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
367236|NCT00974974|1238371|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
367237|NCT00974974|1238370|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
367238|NCT00974974|1238371|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
367239|NCT00974974|1238370|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
367240|NCT00974974|1238371|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
367241|NCT00974974|1238370|P2|IR CD-LD Dose Adjustment|Adverse Event|3
367242|NCT00974974|1238371|P1|IR CD-LD Dose Adjustment|Adverse Event|0
367243|NCT00974922|1238381|P1|Overall Study|study terminated|24
367244|NCT00974675|1238399|P4|Overall Study|Participant on holiday; unable to attend|1
367245|NCT00974675|1238400|P3|Overall Study|Participant on holiday; unable to attend|0
367246|NCT00974675|1238401|P2|Overall Study|Participant on holiday; unable to attend|0
367247|NCT00974675|1238402|P1|Overall Study|Participant on holiday; unable to attend|0
367248|NCT00974675|1238399|P4|Overall Study|Physician Decision|0
367249|NCT00974675|1238400|P3|Overall Study|Physician Decision|1
367250|NCT00974675|1238401|P2|Overall Study|Physician Decision|0
367251|NCT00974675|1238402|P1|Overall Study|Physician Decision|0
367252|NCT00974675|1238399|P4|Overall Study|Adverse Event|1
367253|NCT00974675|1238400|P3|Overall Study|Adverse Event|1
367254|NCT00974675|1238401|P2|Overall Study|Adverse Event|1
367255|NCT00974675|1238402|P1|Overall Study|Adverse Event|2
367256|NCT00974571|1238451|P3|Overall Study|Other|10
367257|NCT00974571|1238452|P2|Overall Study|Other|0
367258|NCT00974571|1238453|P1|Overall Study|Other|4
367259|NCT00974571|1238451|P3|Overall Study|Patient Moved|1
367260|NCT00974571|1238452|P2|Overall Study|Patient Moved|0
367261|NCT00974571|1238453|P1|Overall Study|Patient Moved|1
367262|NCT00974571|1238451|P3|Overall Study|Withdrawal by Subject|16
367263|NCT00974571|1238452|P2|Overall Study|Withdrawal by Subject|5
367264|NCT00974571|1238453|P1|Overall Study|Withdrawal by Subject|14
367265|NCT00974571|1238451|P3|Overall Study|Protocol Violation|18
367266|NCT00974571|1238452|P2|Overall Study|Protocol Violation|4
367267|NCT00974571|1238453|P1|Overall Study|Protocol Violation|13
367268|NCT00974571|1238451|P3|Overall Study|Lost to Follow-up|2
367269|NCT00974571|1238452|P2|Overall Study|Lost to Follow-up|1
367270|NCT00974571|1238453|P1|Overall Study|Lost to Follow-up|2
367271|NCT00974571|1238451|P3|Overall Study|Lack of Efficacy|9
367272|NCT00974571|1238452|P2|Overall Study|Lack of Efficacy|2
367273|NCT00974571|1238453|P1|Overall Study|Lack of Efficacy|3
367274|NCT00974571|1238451|P3|Overall Study|Adverse Event|27
367275|NCT00974571|1238452|P2|Overall Study|Adverse Event|4
367276|NCT00974571|1238453|P1|Overall Study|Adverse Event|31
367277|NCT00974311|1238550|P2|Overall Study|Continuing Treatment|19
367278|NCT00974311|1238551|P1|Overall Study|Continuing Treatment|231
367279|NCT00974311|1238550|P2|Overall Study|Withdrawal of consent|5
367280|NCT00974311|1238551|P1|Overall Study|Withdrawal of consent|9
367281|NCT00974311|1238550|P2|Overall Study|Death|211
367282|NCT00974311|1238551|P1|Overall Study|Death|305
367283|NCT00974311|1238550|P2|Overall Study|Lost to Follow-up|1
367284|NCT00974311|1238551|P1|Overall Study|Lost to Follow-up|1
367285|NCT00974233|1238581|P1|Maintenance Lenalidomide|Adverse Event|8
367286|NCT00974233|1238581|P1|Maintenance Lenalidomide|Lack of Efficacy|5
367287|NCT00974233|1238581|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
367288|NCT00974233|1238581|P1|Induction Chemoimmunotherapy|Adverse Event|7
367289|NCT00974233|1238581|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
367290|NCT00974233|1238581|P1|Induction Chemoimmunotherapy|Death|2
367291|NCT00974220|1238596|P2|Treatment Period 1|noncompliant subjects|1
367292|NCT00974220|1238597|P1|Treatment Period 1|noncompliant subjects|0
367293|NCT00974220|1238596|P2|Treatment Period 1|Adverse Event|1
367294|NCT00974220|1238597|P1|Treatment Period 1|Adverse Event|2
367295|NCT00974090|1238642|P2|Period 2: Open-label Period|Withdrawal by Subject|0
367296|NCT00974090|1238643|P1|Period 2: Open-label Period|Withdrawal by Subject|1
367297|NCT00974090|1238642|P2|Period 2: Open-label Period|Physician Decision|3
367298|NCT00974090|1238643|P1|Period 2: Open-label Period|Physician Decision|0
367299|NCT00974090|1238642|P2|Period 2: Open-label Period|Lack of Efficacy|1
367300|NCT00974090|1238643|P1|Period 2: Open-label Period|Lack of Efficacy|3
367301|NCT00974090|1238642|P2|Period 2: Open-label Period|Adverse Event|6
367302|NCT00974090|1238643|P1|Period 2: Open-label Period|Adverse Event|4
367303|NCT00974090|1238642|P2|Period 1: Double Blind Period|Physician Decision|0
367304|NCT00974090|1238643|P1|Period 1: Double Blind Period|Physician Decision|1
367305|NCT00974090|1238642|P2|Period 1: Double Blind Period|Adverse Event|1
367306|NCT00974090|1238643|P1|Period 1: Double Blind Period|Adverse Event|2
367307|NCT00973921|1238677|P1|Overall Study|IVUS results were not available|9
367308|NCT00973765|1238686|P2|Overall Study|Lost to Follow-up|14
367309|NCT00973765|1238687|P1|Overall Study|Lost to Follow-up|8
367310|NCT00973700|1238709|P5|Overall Study|Unable to Classify|1
367311|NCT00973700|1238710|P4|Overall Study|Unable to Classify|2
367312|NCT00973700|1238711|P3|Overall Study|Unable to Classify|1
367313|NCT00973700|1238712|P2|Overall Study|Unable to Classify|0
367314|NCT00973700|1238713|P1|Overall Study|Unable to Classify|0
367315|NCT00973700|1238709|P5|Overall Study|Inappropriate enrolment|0
367316|NCT00973700|1238710|P4|Overall Study|Inappropriate enrolment|4
367317|NCT00973700|1238711|P3|Overall Study|Inappropriate enrolment|0
367318|NCT00973700|1238712|P2|Overall Study|Inappropriate enrolment|0
367319|NCT00973700|1238713|P1|Overall Study|Inappropriate enrolment|0
367320|NCT00973700|1238709|P5|Overall Study|Lost to Follow-up|5
367321|NCT00973700|1238710|P4|Overall Study|Lost to Follow-up|8
367322|NCT00973700|1238711|P3|Overall Study|Lost to Follow-up|1
367323|NCT00973700|1238712|P2|Overall Study|Lost to Follow-up|0
367324|NCT00973700|1238713|P1|Overall Study|Lost to Follow-up|5
367325|NCT00973700|1238709|P5|Overall Study|Withdrawal by Subject|4
367326|NCT00973700|1238710|P4|Overall Study|Withdrawal by Subject|4
367327|NCT00973700|1238711|P3|Overall Study|Withdrawal by Subject|8
367328|NCT00973700|1238712|P2|Overall Study|Withdrawal by Subject|2
367329|NCT00973700|1238713|P1|Overall Study|Withdrawal by Subject|2
367330|NCT00973622|1238762|P2|Overall Study|did not complete rTMS sessions|2
367331|NCT00973622|1238763|P1|Overall Study|did not complete rTMS sessions|11
367332|NCT00973622|1238762|P2|Overall Study|did not pass MRI screen|0
367333|NCT00973622|1238763|P1|Overall Study|did not pass MRI screen|6
367334|NCT00973622|1238762|P2|Overall Study|did not attend MRI|3
367335|NCT00973622|1238763|P1|Overall Study|did not attend MRI|14
367336|NCT00973479|1238771|P2|Overall Study|Not Specified|7
367337|NCT00973479|1238772|P1|Overall Study|Not Specified|1
367338|NCT00973479|1238771|P2|Overall Study|Protocol Violation|2
367339|NCT00973479|1238772|P1|Overall Study|Protocol Violation|2
367340|NCT00973479|1238771|P2|Overall Study|Adverse Event|32
367341|NCT00973479|1238772|P1|Overall Study|Adverse Event|12
367342|NCT00973479|1238771|P2|Overall Study|Lack of Efficacy|7
367343|NCT00973479|1238772|P1|Overall Study|Lack of Efficacy|5
367344|NCT00973479|1238771|P2|Overall Study|Withdrawal by Subject|16
367345|NCT00973479|1238772|P1|Overall Study|Withdrawal by Subject|15
367346|NCT00973479|1238771|P2|Overall Study|Death|2
367347|NCT00973479|1238772|P1|Overall Study|Death|2
367348|NCT00973479|1238771|P2|Overall Study|Lost to Follow-up|3
367349|NCT00973479|1238772|P1|Overall Study|Lost to Follow-up|0
367350|NCT00973362|1238790|P2|3-Year Follow-up|Lost to Follow-up|0
367351|NCT00973362|1238791|P1|3-Year Follow-up|Lost to Follow-up|17
367352|NCT00973362|1238790|P2|Baseline Evaluation|Inevaluable|223
367353|NCT00973362|1238791|P1|Baseline Evaluation|Inevaluable|686
367354|NCT00973362|1238790|P2|Baseline Evaluation|No colposcopy visit|0
367355|NCT00973362|1238791|P1|Baseline Evaluation|No colposcopy visit|62
367356|NCT00973362|1238790|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
367357|NCT00973362|1238791|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
367358|NCT00973349|1238816|P16|Overall Study|Unable to classify|0
367359|NCT00973349|1238817|P15|Overall Study|Unable to classify|0
367360|NCT00973349|1238818|P14|Overall Study|Unable to classify|0
367361|NCT00973349|1238819|P13|Overall Study|Unable to classify|0
367362|NCT00973349|1238820|P12|Overall Study|Unable to classify|0
367363|NCT00973349|1238821|P11|Overall Study|Unable to classify|0
367364|NCT00973349|1238822|P10|Overall Study|Unable to classify|1
367365|NCT00973349|1238823|P9|Overall Study|Unable to classify|0
367366|NCT00973349|1238824|P8|Overall Study|Unable to classify|0
367367|NCT00973349|1238825|P7|Overall Study|Unable to classify|0
367368|NCT00973349|1238826|P6|Overall Study|Unable to classify|1
367369|NCT00973349|1238827|P5|Overall Study|Unable to classify|1
367370|NCT00973349|1238828|P4|Overall Study|Unable to classify|0
367371|NCT00973349|1238829|P3|Overall Study|Unable to classify|0
367372|NCT00973349|1238830|P2|Overall Study|Unable to classify|0
367373|NCT00973349|1238831|P1|Overall Study|Unable to classify|0
367374|NCT00973349|1238816|P16|Overall Study|Protocol Violation|0
367375|NCT00973349|1238817|P15|Overall Study|Protocol Violation|0
367376|NCT00973349|1238818|P14|Overall Study|Protocol Violation|0
367377|NCT00973349|1238819|P13|Overall Study|Protocol Violation|0
367378|NCT00973349|1238820|P12|Overall Study|Protocol Violation|0
367379|NCT00973349|1238821|P11|Overall Study|Protocol Violation|0
367380|NCT00973349|1238822|P10|Overall Study|Protocol Violation|0
367381|NCT00973349|1238823|P9|Overall Study|Protocol Violation|1
367382|NCT00973349|1238824|P8|Overall Study|Protocol Violation|0
367383|NCT00973349|1238825|P7|Overall Study|Protocol Violation|0
367384|NCT00973349|1238826|P6|Overall Study|Protocol Violation|0
367385|NCT00973349|1238827|P5|Overall Study|Protocol Violation|0
367386|NCT00973349|1238828|P4|Overall Study|Protocol Violation|0
367387|NCT00973349|1238829|P3|Overall Study|Protocol Violation|0
367388|NCT00973349|1238830|P2|Overall Study|Protocol Violation|0
367389|NCT00973349|1238831|P1|Overall Study|Protocol Violation|0
367390|NCT00973349|1238816|P16|Overall Study|Inappropriate enrolment|1
367391|NCT00973349|1238817|P15|Overall Study|Inappropriate enrolment|1
367392|NCT00973349|1238818|P14|Overall Study|Inappropriate enrolment|0
367393|NCT00973349|1238819|P13|Overall Study|Inappropriate enrolment|1
367394|NCT00973349|1238820|P12|Overall Study|Inappropriate enrolment|0
367395|NCT00973349|1238821|P11|Overall Study|Inappropriate enrolment|0
367396|NCT00973349|1238822|P10|Overall Study|Inappropriate enrolment|2
367397|NCT00973349|1238823|P9|Overall Study|Inappropriate enrolment|0
367398|NCT00973349|1238824|P8|Overall Study|Inappropriate enrolment|0
367399|NCT00973349|1238825|P7|Overall Study|Inappropriate enrolment|0
367400|NCT00973349|1238826|P6|Overall Study|Inappropriate enrolment|0
367401|NCT00973349|1238827|P5|Overall Study|Inappropriate enrolment|0
367402|NCT00973349|1238828|P4|Overall Study|Inappropriate enrolment|0
367403|NCT00973349|1238829|P3|Overall Study|Inappropriate enrolment|1
367404|NCT00973349|1238830|P2|Overall Study|Inappropriate enrolment|0
367405|NCT00973349|1238831|P1|Overall Study|Inappropriate enrolment|0
367406|NCT00973349|1238816|P16|Overall Study|Lost to Follow-up|1
367407|NCT00973349|1238817|P15|Overall Study|Lost to Follow-up|0
367408|NCT00973349|1238818|P14|Overall Study|Lost to Follow-up|0
367409|NCT00973349|1238819|P13|Overall Study|Lost to Follow-up|0
367410|NCT00973349|1238820|P12|Overall Study|Lost to Follow-up|1
367411|NCT00973349|1238821|P11|Overall Study|Lost to Follow-up|0
367412|NCT00973349|1238822|P10|Overall Study|Lost to Follow-up|1
367413|NCT00973349|1238823|P9|Overall Study|Lost to Follow-up|2
367414|NCT00973349|1238824|P8|Overall Study|Lost to Follow-up|1
367415|NCT00973349|1238825|P7|Overall Study|Lost to Follow-up|0
367416|NCT00973349|1238826|P6|Overall Study|Lost to Follow-up|3
367417|NCT00973349|1238827|P5|Overall Study|Lost to Follow-up|1
367418|NCT00973349|1238828|P4|Overall Study|Lost to Follow-up|2
367419|NCT00973349|1238829|P3|Overall Study|Lost to Follow-up|2
367420|NCT00973349|1238830|P2|Overall Study|Lost to Follow-up|1
367421|NCT00973349|1238831|P1|Overall Study|Lost to Follow-up|3
367422|NCT00973349|1238816|P16|Overall Study|Withdrawal by Subject|0
367423|NCT00973349|1238817|P15|Overall Study|Withdrawal by Subject|0
367424|NCT00973349|1238818|P14|Overall Study|Withdrawal by Subject|0
367425|NCT00973349|1238819|P13|Overall Study|Withdrawal by Subject|0
367426|NCT00973349|1238820|P12|Overall Study|Withdrawal by Subject|1
367427|NCT00973349|1238821|P11|Overall Study|Withdrawal by Subject|0
367428|NCT00973349|1238822|P10|Overall Study|Withdrawal by Subject|2
367429|NCT00973349|1238823|P9|Overall Study|Withdrawal by Subject|0
367430|NCT00973349|1238824|P8|Overall Study|Withdrawal by Subject|2
367431|NCT00973349|1238825|P7|Overall Study|Withdrawal by Subject|2
367432|NCT00973349|1238826|P6|Overall Study|Withdrawal by Subject|0
367433|NCT00973349|1238827|P5|Overall Study|Withdrawal by Subject|2
367434|NCT00973349|1238828|P4|Overall Study|Withdrawal by Subject|3
367435|NCT00973349|1238829|P3|Overall Study|Withdrawal by Subject|2
367436|NCT00973349|1238830|P2|Overall Study|Withdrawal by Subject|2
367437|NCT00973349|1238831|P1|Overall Study|Withdrawal by Subject|1
367438|NCT00973349|1238816|P16|Overall Study|Adverse Event|0
367439|NCT00973349|1238817|P15|Overall Study|Adverse Event|1
367440|NCT00973349|1238818|P14|Overall Study|Adverse Event|0
367441|NCT00973349|1238819|P13|Overall Study|Adverse Event|0
367442|NCT00973349|1238820|P12|Overall Study|Adverse Event|0
367443|NCT00973349|1238821|P11|Overall Study|Adverse Event|0
367444|NCT00973349|1238822|P10|Overall Study|Adverse Event|0
367445|NCT00973349|1238823|P9|Overall Study|Adverse Event|1
367446|NCT00973349|1238824|P8|Overall Study|Adverse Event|0
367447|NCT00973349|1238825|P7|Overall Study|Adverse Event|0
367448|NCT00973349|1238826|P6|Overall Study|Adverse Event|0
367449|NCT00973349|1238827|P5|Overall Study|Adverse Event|1
367450|NCT00973349|1238828|P4|Overall Study|Adverse Event|0
367451|NCT00973349|1238829|P3|Overall Study|Adverse Event|0
367452|NCT00973349|1238830|P2|Overall Study|Adverse Event|0
367453|NCT00973349|1238831|P1|Overall Study|Adverse Event|0
367454|NCT00972816|1238952|P8|Overall Study|Unable to classify|0
367455|NCT00972816|1238953|P7|Overall Study|Unable to classify|0
367456|NCT00972816|1238954|P6|Overall Study|Unable to classify|0
367457|NCT00972816|1238955|P5|Overall Study|Unable to classify|1
367458|NCT00972816|1238956|P4|Overall Study|Unable to classify|0
367459|NCT00972816|1238957|P3|Overall Study|Unable to classify|0
367460|NCT00972816|1238958|P2|Overall Study|Unable to classify|0
367461|NCT00972816|1238959|P1|Overall Study|Unable to classify|2
367462|NCT00972816|1238952|P8|Overall Study|Inappropriate enrolment|0
367463|NCT00972816|1238953|P7|Overall Study|Inappropriate enrolment|2
367464|NCT00972816|1238954|P6|Overall Study|Inappropriate enrolment|0
367465|NCT00972816|1238955|P5|Overall Study|Inappropriate enrolment|0
367466|NCT00972816|1238956|P4|Overall Study|Inappropriate enrolment|0
367467|NCT00972816|1238957|P3|Overall Study|Inappropriate enrolment|0
367468|NCT00972816|1238958|P2|Overall Study|Inappropriate enrolment|0
367469|NCT00972816|1238959|P1|Overall Study|Inappropriate enrolment|0
367470|NCT00972816|1238952|P8|Overall Study|Lost to Follow-up|7
367471|NCT00972816|1238953|P7|Overall Study|Lost to Follow-up|7
367472|NCT00972816|1238954|P6|Overall Study|Lost to Follow-up|10
367473|NCT00972816|1238955|P5|Overall Study|Lost to Follow-up|11
367474|NCT00972816|1238956|P4|Overall Study|Lost to Follow-up|5
367475|NCT00972816|1238957|P3|Overall Study|Lost to Follow-up|7
367476|NCT00972816|1238958|P2|Overall Study|Lost to Follow-up|9
367477|NCT00972816|1238959|P1|Overall Study|Lost to Follow-up|11
367478|NCT00972816|1238952|P8|Overall Study|Withdrawal by Subject|2
367479|NCT00972816|1238953|P7|Overall Study|Withdrawal by Subject|1
367480|NCT00972816|1238954|P6|Overall Study|Withdrawal by Subject|1
367481|NCT00972816|1238955|P5|Overall Study|Withdrawal by Subject|0
367482|NCT00972816|1238956|P4|Overall Study|Withdrawal by Subject|3
367483|NCT00972816|1238957|P3|Overall Study|Withdrawal by Subject|1
367484|NCT00972816|1238958|P2|Overall Study|Withdrawal by Subject|2
367485|NCT00972816|1238959|P1|Overall Study|Withdrawal by Subject|4
367486|NCT00972816|1238952|P8|Overall Study|Adverse Event|0
367487|NCT00972816|1238953|P7|Overall Study|Adverse Event|0
367488|NCT00972816|1238954|P6|Overall Study|Adverse Event|0
367489|NCT00972816|1238955|P5|Overall Study|Adverse Event|0
367490|NCT00972816|1238956|P4|Overall Study|Adverse Event|0
367491|NCT00972816|1238957|P3|Overall Study|Adverse Event|1
367492|NCT00972816|1238958|P2|Overall Study|Adverse Event|0
367493|NCT00972816|1238959|P1|Overall Study|Adverse Event|0
367494|NCT00972777|1239043|P2|Overall Study|Missed visit|0
367495|NCT00972777|1239044|P1|Overall Study|Missed visit|1
367496|NCT00972777|1239043|P2|Overall Study|Screening Failure|1
367497|NCT00972777|1239044|P1|Overall Study|Screening Failure|2
367498|NCT00972777|1239043|P2|Overall Study|Protocol Violation|2
367499|NCT00972777|1239044|P1|Overall Study|Protocol Violation|0
367500|NCT00972777|1239043|P2|Overall Study|Physician Decision|0
367501|NCT00972777|1239044|P1|Overall Study|Physician Decision|4
367502|NCT00972777|1239043|P2|Overall Study|Withdrawal by Subject|5
367503|NCT00972777|1239044|P1|Overall Study|Withdrawal by Subject|4
367504|NCT00972777|1239043|P2|Overall Study|Lost to Follow-up|4
367505|NCT00972777|1239044|P1|Overall Study|Lost to Follow-up|0
367506|NCT00972777|1239043|P2|Overall Study|Adverse Event|2
367507|NCT00972777|1239044|P1|Overall Study|Adverse Event|3
367508|NCT00972738|1239059|P3|Overall Study|Other|1
367509|NCT00972738|1239060|P2|Overall Study|Other|2
367510|NCT00972738|1239061|P1|Overall Study|Other|1
367511|NCT00972738|1239059|P3|Overall Study|Moved|1
367512|NCT00972738|1239060|P2|Overall Study|Moved|0
367513|NCT00972738|1239061|P1|Overall Study|Moved|0
367514|NCT00972738|1239059|P3|Overall Study|Withdrawal by Subject|4
367515|NCT00972738|1239060|P2|Overall Study|Withdrawal by Subject|1
367516|NCT00972738|1239061|P1|Overall Study|Withdrawal by Subject|5
367517|NCT00972738|1239059|P3|Overall Study|Lack of Efficacy|11
367518|NCT00972738|1239060|P2|Overall Study|Lack of Efficacy|1
367519|NCT00972738|1239061|P1|Overall Study|Lack of Efficacy|5
367520|NCT00972738|1239059|P3|Overall Study|Lost to Follow-up|1
367521|NCT00972738|1239060|P2|Overall Study|Lost to Follow-up|0
367522|NCT00972738|1239061|P1|Overall Study|Lost to Follow-up|1
367523|NCT00972738|1239059|P3|Overall Study|Protocol Violation|3
367524|NCT00972738|1239060|P2|Overall Study|Protocol Violation|1
367525|NCT00972738|1239061|P1|Overall Study|Protocol Violation|2
367526|NCT00972738|1239059|P3|Overall Study|Adverse Event|8
367527|NCT00972738|1239060|P2|Overall Study|Adverse Event|1
367528|NCT00972738|1239061|P1|Overall Study|Adverse Event|7
367529|NCT00972595|1239178|P2|Period 1|Adverse Event|0
367530|NCT00972595|1239179|P1|Period 1|Adverse Event|1
367531|NCT00972543|1239189|P2|Overall Study|Early study termination by sponsor|1
367532|NCT00972543|1239190|P1|Overall Study|Early study termination by sponsor|4
367533|NCT00972543|1239189|P2|Overall Study|Adverse Event|0
367534|NCT00972543|1239190|P1|Overall Study|Adverse Event|1
367535|NCT00972504|1239273|P1|Overall Study|Investigator discretion|1
367536|NCT00972504|1239273|P1|Overall Study|Adverse Event|2
367537|NCT00972478|1239305|P2|Overall Study|Not start protocol treatment|2
367538|NCT00972478|1239306|P1|Overall Study|Not start protocol treatment|1
367539|NCT00972478|1239305|P2|Overall Study|Ineligible|7
367540|NCT00972478|1239306|P1|Overall Study|Ineligible|1
367541|NCT00972478|1239305|P2|Overall Study|Not protocol specified|1
367542|NCT00972478|1239306|P1|Overall Study|Not protocol specified|1
367543|NCT00972478|1239305|P2|Overall Study|Death|2
367544|NCT00972478|1239306|P1|Overall Study|Death|0
367545|NCT00972478|1239305|P2|Overall Study|Progression/Relapse|2
367546|NCT00972478|1239306|P1|Overall Study|Progression/Relapse|0
367547|NCT00972478|1239305|P2|Overall Study|Withdrawal by Subject|8
367548|NCT00972478|1239306|P1|Overall Study|Withdrawal by Subject|1
367549|NCT00972478|1239305|P2|Overall Study|Adverse Event|16
367550|NCT00972478|1239306|P1|Overall Study|Adverse Event|3
367551|NCT00972322|1239351|P2|Overall Study|Consistently high glucose values|0
367552|NCT00972322|1239352|P1|Overall Study|Consistently high glucose values|1
367553|NCT00972322|1239351|P2|Overall Study|Lost to Follow-up|1
367554|NCT00972322|1239352|P1|Overall Study|Lost to Follow-up|0
367555|NCT00972322|1239351|P2|Overall Study|Positive drug screen|1
367556|NCT00972322|1239352|P1|Overall Study|Positive drug screen|0
367557|NCT00972322|1239351|P2|Overall Study|Adverse Event|1
367558|NCT00972322|1239352|P1|Overall Study|Adverse Event|2
367559|NCT00972283|1239364|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
367560|NCT00972283|1239365|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
367561|NCT00972283|1239364|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
367562|NCT00972283|1239365|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
367563|NCT00972283|1239364|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
367564|NCT00972283|1239365|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
367565|NCT00972283|1239364|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
367566|NCT00972283|1239365|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
367567|NCT00972283|1239364|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
367568|NCT00972283|1239365|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
367569|NCT00972283|1239364|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
367570|NCT00972283|1239365|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
367571|NCT00972283|1239364|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
367572|NCT00972283|1239365|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
367573|NCT00972283|1239364|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
367574|NCT00972283|1239365|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
367575|NCT00972283|1239364|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
367576|NCT00972283|1239365|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
367577|NCT00972283|1239364|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
367578|NCT00972283|1239365|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
367579|NCT00972244|1239392|P5|Overall Study|Various|2
367580|NCT00972244|1239393|P4|Overall Study|Various|0
367581|NCT00972244|1239394|P3|Overall Study|Various|0
367582|NCT00972244|1239395|P2|Overall Study|Various|0
367583|NCT00972244|1239396|P1|Overall Study|Various|0
367584|NCT00972244|1239392|P5|Overall Study|Death|0
367585|NCT00972244|1239393|P4|Overall Study|Death|0
367586|NCT00972244|1239394|P3|Overall Study|Death|0
367587|NCT00972244|1239395|P2|Overall Study|Death|0
367588|NCT00972244|1239396|P1|Overall Study|Death|1
367589|NCT00972244|1239392|P5|Overall Study|Safety|1
367590|NCT00972244|1239393|P4|Overall Study|Safety|0
367591|NCT00972244|1239394|P3|Overall Study|Safety|0
367592|NCT00972244|1239395|P2|Overall Study|Safety|0
367593|NCT00972244|1239396|P1|Overall Study|Safety|0
367594|NCT00972244|1239392|P5|Overall Study|Withdrawal by Subject|1
367595|NCT00972244|1239393|P4|Overall Study|Withdrawal by Subject|0
367596|NCT00972244|1239394|P3|Overall Study|Withdrawal by Subject|1
367597|NCT00972244|1239395|P2|Overall Study|Withdrawal by Subject|2
367598|NCT00972244|1239396|P1|Overall Study|Withdrawal by Subject|1
367599|NCT00972244|1239392|P5|Overall Study|Subject No Longer Meets Study Criteria|5
367600|NCT00972244|1239393|P4|Overall Study|Subject No Longer Meets Study Criteria|0
367601|NCT00972244|1239394|P3|Overall Study|Subject No Longer Meets Study Criteria|0
367602|NCT00972244|1239395|P2|Overall Study|Subject No Longer Meets Study Criteria|2
367603|NCT00972244|1239396|P1|Overall Study|Subject No Longer Meets Study Criteria|2
367604|NCT00972244|1239392|P5|Overall Study|Adverse Event|0
367605|NCT00972244|1239393|P4|Overall Study|Adverse Event|0
367606|NCT00972244|1239394|P3|Overall Study|Adverse Event|1
367607|NCT00972244|1239395|P2|Overall Study|Adverse Event|1
367608|NCT00972244|1239396|P1|Overall Study|Adverse Event|0
367609|NCT00972244|1239392|P5|Overall Study|Incorrect Enrolment|0
367610|NCT00972244|1239393|P4|Overall Study|Incorrect Enrolment|0
367611|NCT00972244|1239394|P3|Overall Study|Incorrect Enrolment|0
367612|NCT00972244|1239395|P2|Overall Study|Incorrect Enrolment|0
367613|NCT00972244|1239396|P1|Overall Study|Incorrect Enrolment|1
367614|NCT00972153|1239428|P3|Overall Study|Equipment malfunction during case|0
367615|NCT00972153|1239429|P2|Overall Study|Equipment malfunction during case|1
367616|NCT00972153|1239430|P1|Overall Study|Equipment malfunction during case|0
367617|NCT00972023|1239445|P1|Overall Study|Withdrawal by Subject|1
367618|NCT00971997|1239452|P1|Overall Study|Physician Decision|7
367619|NCT00971997|1239452|P1|Overall Study|Withdrawal by Subject|5
367620|NCT00971997|1239452|P1|Overall Study|Protocol Violation|4
367621|NCT00971997|1239452|P1|Overall Study|Death|1
367622|NCT00971997|1239452|P1|Overall Study|Adverse Event|2
367623|NCT00971932|1239470|P1|Overall Study|Ongoing|4
367624|NCT00971932|1239470|P1|Overall Study|Investigator's decision|2
367625|NCT00971932|1239470|P1|Overall Study|Withdrawal by Subject|1
367626|NCT00971425|1239550|P2|Overall Study|Withdrawal by Subject|1
367627|NCT00971425|1239551|P1|Overall Study|Withdrawal by Subject|0
367628|NCT00971425|1239550|P2|Overall Study|Adverse Event|1
367629|NCT00971425|1239551|P1|Overall Study|Adverse Event|1
367630|NCT00971243|1239615|P5|Open-label Period|Other reason|2
367631|NCT00971243|1239616|P4|Open-label Period|Other reason|0
367632|NCT00971243|1239617|P3|Open-label Period|Other reason|0
367633|NCT00971243|1239618|P2|Open-label Period|Other reason|0
367634|NCT00971243|1239619|P1|Open-label Period|Other reason|0
367635|NCT00971243|1239615|P5|Open-label Period|Withdrawal by Subject|1
367636|NCT00971243|1239616|P4|Open-label Period|Withdrawal by Subject|2
367637|NCT00971243|1239617|P3|Open-label Period|Withdrawal by Subject|0
367638|NCT00971243|1239618|P2|Open-label Period|Withdrawal by Subject|0
367639|NCT00971243|1239619|P1|Open-label Period|Withdrawal by Subject|1
367640|NCT00971243|1239615|P5|Open-label Period|Protocol Violation|1
367641|NCT00971243|1239616|P4|Open-label Period|Protocol Violation|0
367642|NCT00971243|1239617|P3|Open-label Period|Protocol Violation|1
367643|NCT00971243|1239618|P2|Open-label Period|Protocol Violation|1
367644|NCT00971243|1239619|P1|Open-label Period|Protocol Violation|1
367645|NCT00971243|1239615|P5|Open-label Period|Physician Decision|2
367646|NCT00971243|1239616|P4|Open-label Period|Physician Decision|7
367647|NCT00971243|1239617|P3|Open-label Period|Physician Decision|3
367648|NCT00971243|1239618|P2|Open-label Period|Physician Decision|9
367649|NCT00971243|1239619|P1|Open-label Period|Physician Decision|5
367650|NCT00971243|1239615|P5|Open-label Period|Adverse Event|0
367651|NCT00971243|1239616|P4|Open-label Period|Adverse Event|1
367652|NCT00971243|1239617|P3|Open-label Period|Adverse Event|1
367653|NCT00971243|1239618|P2|Open-label Period|Adverse Event|0
367654|NCT00971243|1239619|P1|Open-label Period|Adverse Event|1
367655|NCT00971243|1239615|P5|Double Blind Period|Other reasons|1
367656|NCT00971243|1239616|P4|Double Blind Period|Other reasons|0
367657|NCT00971243|1239617|P3|Double Blind Period|Other reasons|2
367658|NCT00971243|1239618|P2|Double Blind Period|Other reasons|0
367659|NCT00971243|1239619|P1|Double Blind Period|Other reasons|1
367660|NCT00971243|1239615|P5|Double Blind Period|Withdrawal by Subject|4
367661|NCT00971243|1239616|P4|Double Blind Period|Withdrawal by Subject|4
367662|NCT00971243|1239617|P3|Double Blind Period|Withdrawal by Subject|4
367663|NCT00971243|1239618|P2|Double Blind Period|Withdrawal by Subject|1
367664|NCT00971243|1239619|P1|Double Blind Period|Withdrawal by Subject|4
367665|NCT00971243|1239615|P5|Double Blind Period|Protocol Violation|2
367666|NCT00971243|1239616|P4|Double Blind Period|Protocol Violation|2
367667|NCT00971243|1239617|P3|Double Blind Period|Protocol Violation|3
367668|NCT00971243|1239618|P2|Double Blind Period|Protocol Violation|0
367669|NCT00971243|1239619|P1|Double Blind Period|Protocol Violation|2
367670|NCT00971243|1239615|P5|Double Blind Period|Physician Decision|7
367671|NCT00971243|1239616|P4|Double Blind Period|Physician Decision|6
367672|NCT00971243|1239617|P3|Double Blind Period|Physician Decision|7
367673|NCT00971243|1239618|P2|Double Blind Period|Physician Decision|6
367674|NCT00971243|1239619|P1|Double Blind Period|Physician Decision|10
367675|NCT00971243|1239615|P5|Double Blind Period|Lost to Follow-up|1
367676|NCT00971243|1239616|P4|Double Blind Period|Lost to Follow-up|0
367677|NCT00971243|1239617|P3|Double Blind Period|Lost to Follow-up|1
367678|NCT00971243|1239618|P2|Double Blind Period|Lost to Follow-up|1
367679|NCT00971243|1239619|P1|Double Blind Period|Lost to Follow-up|0
367680|NCT00971243|1239615|P5|Double Blind Period|Adverse Event|3
367681|NCT00971243|1239616|P4|Double Blind Period|Adverse Event|2
367682|NCT00971243|1239617|P3|Double Blind Period|Adverse Event|2
367683|NCT00971243|1239618|P2|Double Blind Period|Adverse Event|3
367684|NCT00971243|1239619|P1|Double Blind Period|Adverse Event|2
367685|NCT00971204|1239636|P1|Overall Study|Lost to Follow-up|10
367686|NCT00971204|1239636|P1|Overall Study|Did not meet all criteria-not treated|14
367687|NCT00971048|1239644|P4|Overall Study|Physician Decision|1
367688|NCT00971048|1239645|P3|Overall Study|Physician Decision|0
367689|NCT00971048|1239646|P2|Overall Study|Physician Decision|0
367690|NCT00971048|1239647|P1|Overall Study|Physician Decision|0
367691|NCT00971048|1239644|P4|Overall Study|Adverse Event|0
367692|NCT00971048|1239645|P3|Overall Study|Adverse Event|1
367693|NCT00971048|1239646|P2|Overall Study|Adverse Event|0
367694|NCT00971048|1239647|P1|Overall Study|Adverse Event|0
367695|NCT00971048|1239644|P4|Overall Study|Protocol Violation|1
367696|NCT00971048|1239645|P3|Overall Study|Protocol Violation|0
367697|NCT00971048|1239646|P2|Overall Study|Protocol Violation|2
367698|NCT00971048|1239647|P1|Overall Study|Protocol Violation|1
367699|NCT00970944|1239671|P2|Overall Study|Physician Decision|2
367700|NCT00970944|1239672|P1|Overall Study|Physician Decision|0
367701|NCT00970944|1239671|P2|Overall Study|Death|0
367702|NCT00970944|1239672|P1|Overall Study|Death|1
367703|NCT00970684|1239724|P1|Overall Study|Withdrawal by Subject|1
367704|NCT00970684|1239724|P1|Overall Study|Adverse Event|4
367705|NCT00970684|1239724|P1|Overall Study|Lack of Efficacy|5
367706|NCT00970632|1239733|P3|Overall Study|Sponsor decision|1
367707|NCT00970632|1239734|P2|Overall Study|Sponsor decision|0
367708|NCT00970632|1239735|P1|Overall Study|Sponsor decision|1
367709|NCT00970632|1239733|P3|Overall Study|Entry criteria not met|2
367710|NCT00970632|1239734|P2|Overall Study|Entry criteria not met|2
367711|NCT00970632|1239735|P1|Overall Study|Entry criteria not met|0
367712|NCT00970632|1239733|P3|Overall Study|Withdrawal by Subject|4
367713|NCT00970632|1239734|P2|Overall Study|Withdrawal by Subject|6
367714|NCT00970632|1239735|P1|Overall Study|Withdrawal by Subject|7
367715|NCT00970632|1239733|P3|Overall Study|Protocol Violation|8
367716|NCT00970632|1239734|P2|Overall Study|Protocol Violation|5
367717|NCT00970632|1239735|P1|Overall Study|Protocol Violation|8
367718|NCT00970632|1239733|P3|Overall Study|Lost to Follow-up|2
367719|NCT00970632|1239734|P2|Overall Study|Lost to Follow-up|0
367720|NCT00970632|1239735|P1|Overall Study|Lost to Follow-up|3
367721|NCT00970632|1239733|P3|Overall Study|Lack of Efficacy|0
367722|NCT00970632|1239734|P2|Overall Study|Lack of Efficacy|0
367723|NCT00970632|1239735|P1|Overall Study|Lack of Efficacy|3
367724|NCT00970632|1239733|P3|Overall Study|Adverse Event|1
367725|NCT00970632|1239734|P2|Overall Study|Adverse Event|2
367726|NCT00970632|1239735|P1|Overall Study|Adverse Event|2
367727|NCT00970502|1239800|P1|Overall Study|Withdrawal by Subject|1
367728|NCT00970489|1239811|P2|Overall Study|Death/Withdrew/Criteria Violation|41
367729|NCT00970489|1239812|P1|Overall Study|Death/Withdrew/Criteria Violation|54
367730|NCT00970359|1239824|P1|Overall Study|Not Treated|4
367731|NCT00970307|1239854|P3|Overall Study|Withdrawal by Subject|2
367732|NCT00970307|1239855|P2|Overall Study|Withdrawal by Subject|3
367733|NCT00970307|1239856|P1|Overall Study|Withdrawal by Subject|2
367734|NCT00970307|1239854|P3|Overall Study|Serious Adverse Event|0
367735|NCT00970307|1239855|P2|Overall Study|Serious Adverse Event|0
367736|NCT00970307|1239856|P1|Overall Study|Serious Adverse Event|1
367737|NCT00970294|1239930|P1|Overall Study|Withdrawal by Subject|1
367738|NCT00970294|1239930|P1|Overall Study|Physician Decision|4
367739|NCT00970281|1239938|P2|Overall Study|Physician Decision|1
367740|NCT00970281|1239939|P1|Overall Study|Physician Decision|1
367741|NCT00970281|1239938|P2|Overall Study|Withdrawal by Subject|1
367742|NCT00970281|1239939|P1|Overall Study|Withdrawal by Subject|0
367743|NCT00970281|1239938|P2|Overall Study|Lack of Efficacy|14
367744|NCT00970281|1239939|P1|Overall Study|Lack of Efficacy|1
367745|NCT00970268|1239957|P2|Overall Study|Inclusion/Exclusion Criteria|0
367746|NCT00970268|1239958|P1|Overall Study|Inclusion/Exclusion Criteria|1
367747|NCT00970268|1239957|P2|Overall Study|Lost to Follow-up|2
367748|NCT00970268|1239958|P1|Overall Study|Lost to Follow-up|1
367749|NCT00970268|1239957|P2|Overall Study|COPD Exacerbation|2
367750|NCT00970268|1239958|P1|Overall Study|COPD Exacerbation|4
367751|NCT00970268|1239957|P2|Overall Study|Other Reason|1
367752|NCT00970268|1239958|P1|Overall Study|Other Reason|3
367753|NCT00970268|1239957|P2|Overall Study|Protocol Violation|7
367754|NCT00970268|1239958|P1|Overall Study|Protocol Violation|4
367755|NCT00970268|1239957|P2|Overall Study|Lack of Efficacy|6
367756|NCT00970268|1239958|P1|Overall Study|Lack of Efficacy|3
367757|NCT00970268|1239957|P2|Overall Study|Adverse Event|12
367758|NCT00970268|1239958|P1|Overall Study|Adverse Event|15
367759|NCT00970268|1239957|P2|Overall Study|Withdrawal by Subject|19
367760|NCT00970268|1239958|P1|Overall Study|Withdrawal by Subject|12
367761|NCT00969709|1239991|P4|Overall Study|Other reasons|0
367762|NCT00969709|1239992|P3|Overall Study|Other reasons|3
367763|NCT00969709|1239993|P2|Overall Study|Other reasons|0
367764|NCT00969709|1239994|P1|Overall Study|Other reasons|0
367765|NCT00969709|1239991|P4|Overall Study|Lost to Follow-up|15
367766|NCT00969709|1239992|P3|Overall Study|Lost to Follow-up|8
367767|NCT00969709|1239993|P2|Overall Study|Lost to Follow-up|14
367768|NCT00969709|1239994|P1|Overall Study|Lost to Follow-up|10
367769|NCT00969709|1239991|P4|Overall Study|Withdrawal by Subject|23
367770|NCT00969709|1239992|P3|Overall Study|Withdrawal by Subject|11
367771|NCT00969709|1239993|P2|Overall Study|Withdrawal by Subject|12
367772|NCT00969709|1239994|P1|Overall Study|Withdrawal by Subject|9
367773|NCT00969709|1239991|P4|Overall Study|Protocol Violation|10
367774|NCT00969709|1239992|P3|Overall Study|Protocol Violation|9
367775|NCT00969709|1239993|P2|Overall Study|Protocol Violation|5
367776|NCT00969709|1239994|P1|Overall Study|Protocol Violation|9
367777|NCT00969709|1239991|P4|Overall Study|Lack of Efficacy|3
367778|NCT00969709|1239992|P3|Overall Study|Lack of Efficacy|1
367779|NCT00969709|1239993|P2|Overall Study|Lack of Efficacy|4
367780|NCT00969709|1239994|P1|Overall Study|Lack of Efficacy|7
367781|NCT00969709|1239991|P4|Overall Study|Adverse Event|12
367782|NCT00969709|1239992|P3|Overall Study|Adverse Event|26
367783|NCT00969709|1239993|P2|Overall Study|Adverse Event|13
367784|NCT00969709|1239994|P1|Overall Study|Adverse Event|3
367785|NCT00969618|1240008|P1|Overall Study|Withdrawal by Subject|27
367786|NCT00969618|1240008|P1|Overall Study|Protocol Violation|9
367787|NCT00969618|1240008|P1|Overall Study|Physician Decision|1
367788|NCT00969618|1240008|P1|Overall Study|Lost to Follow-up|7
367789|NCT00969618|1240008|P1|Overall Study|Lack of Efficacy|2
367790|NCT00969618|1240008|P1|Overall Study|Entry Criteria Not Met|3
367791|NCT00969618|1240008|P1|Overall Study|Adverse Event|29
367792|NCT00969540|1240021|P2|Overall Study|Lost to Follow-up|1
367793|NCT00969540|1240022|P1|Overall Study|Lost to Follow-up|1
367794|NCT00969436|1240047|P3|Overall Study|Lost to Follow-up|5
367795|NCT00969436|1240048|P2|Overall Study|Lost to Follow-up|8
367796|NCT00969436|1240049|P1|Overall Study|Lost to Follow-up|8
367797|NCT00969436|1240047|P3|Overall Study|Withdrawal by Subject|2
367798|NCT00969436|1240048|P2|Overall Study|Withdrawal by Subject|0
367799|NCT00969436|1240049|P1|Overall Study|Withdrawal by Subject|3
367800|NCT00969436|1240047|P3|Overall Study|Subject eliminated (other vaccine)|0
367801|NCT00969436|1240048|P2|Overall Study|Subject eliminated (other vaccine)|0
367802|NCT00969436|1240049|P1|Overall Study|Subject eliminated (other vaccine)|1
367803|NCT00969436|1240047|P3|Overall Study|Parents personal problem|1
367804|NCT00969436|1240048|P2|Overall Study|Parents personal problem|0
367805|NCT00969436|1240049|P1|Overall Study|Parents personal problem|0
367806|NCT00969436|1240047|P3|Overall Study|Father - serious health problem|1
367807|NCT00969436|1240048|P2|Overall Study|Father - serious health problem|0
367808|NCT00969436|1240049|P1|Overall Study|Father - serious health problem|0
367809|NCT00969436|1240047|P3|Overall Study|Migrated/moved from study area|2
367810|NCT00969436|1240048|P2|Overall Study|Migrated/moved from study area|10
367811|NCT00969436|1240049|P1|Overall Study|Migrated/moved from study area|12
367812|NCT00969436|1240047|P3|Overall Study|Protocol Violation|0
367813|NCT00969436|1240048|P2|Overall Study|Protocol Violation|3
367814|NCT00969436|1240049|P1|Overall Study|Protocol Violation|1
367815|NCT00969280|1240083|P2|Overall Study|infection of influenza A(H1N1)|1
367816|NCT00969280|1240084|P1|Overall Study|infection of influenza A(H1N1)|0
367817|NCT00969280|1240083|P2|Overall Study|Withdrawal by Subject|1
367818|NCT00969280|1240084|P1|Overall Study|Withdrawal by Subject|0
367819|NCT00969280|1240083|P2|Overall Study|Protocol Violation|1
367820|NCT00969280|1240084|P1|Overall Study|Protocol Violation|2
367821|NCT00969228|1240092|P2|Overall Study|Porcine circovirus detection in vaccine|14
367822|NCT00969228|1240093|P1|Overall Study|Porcine circovirus detection in vaccine|38
367823|NCT00969228|1240092|P2|Overall Study|Withdrawal by Subject|0
367824|NCT00969228|1240093|P1|Overall Study|Withdrawal by Subject|4
367825|NCT00969228|1240092|P2|Overall Study|Adverse Event|0
367826|NCT00969228|1240093|P1|Overall Study|Adverse Event|1
367827|NCT00969150|1240111|P2|Overall Study|Other reasons|0
367828|NCT00969150|1240112|P1|Overall Study|Other reasons|1
367829|NCT00969150|1240111|P2|Overall Study|Lost to Follow-up|4
367830|NCT00969150|1240112|P1|Overall Study|Lost to Follow-up|5
367831|NCT00969150|1240111|P2|Overall Study|Withdrawal by Subject|9
367832|NCT00969150|1240112|P1|Overall Study|Withdrawal by Subject|13
367833|NCT00969150|1240111|P2|Overall Study|Protocol Violation|12
367834|NCT00969150|1240112|P1|Overall Study|Protocol Violation|9
367835|NCT00969150|1240111|P2|Overall Study|Lack of Efficacy|1
367836|NCT00969150|1240112|P1|Overall Study|Lack of Efficacy|1
367837|NCT00969150|1240111|P2|Overall Study|Adverse Event|14
367838|NCT00969150|1240112|P1|Overall Study|Adverse Event|4
367839|NCT00969124|1240120|P1|Overall Study|Technical error|1
367840|NCT00969124|1240120|P1|Overall Study|Previously unrecognized disease|3
367841|NCT00969124|1240120|P1|Overall Study|Inability to reach cecum|9
367842|NCT00969124|1240120|P1|Overall Study|Inadequate bowel preparation|15
367843|NCT00969124|1240120|P1|Overall Study|Protocol Violation|2
367844|NCT00968981|1240129|P3|Overall Study|Withdrawal by Subject|3
367845|NCT00968981|1240130|P2|Overall Study|Withdrawal by Subject|3
367846|NCT00968981|1240131|P1|Overall Study|Withdrawal by Subject|1
367847|NCT00968981|1240129|P3|Overall Study|Physician Decision|5
367848|NCT00968981|1240130|P2|Overall Study|Physician Decision|3
367849|NCT00968981|1240131|P1|Overall Study|Physician Decision|5
367850|NCT00968981|1240129|P3|Overall Study|Lost to Follow-up|1
367851|NCT00968981|1240130|P2|Overall Study|Lost to Follow-up|0
367852|NCT00968981|1240131|P1|Overall Study|Lost to Follow-up|0
367853|NCT00968981|1240129|P3|Overall Study|Disease Progression|13
367854|NCT00968981|1240130|P2|Overall Study|Disease Progression|16
367855|NCT00968981|1240131|P1|Overall Study|Disease Progression|14
367856|NCT00968981|1240129|P3|Overall Study|Adverse Event|0
367857|NCT00968981|1240130|P2|Overall Study|Adverse Event|0
367858|NCT00968981|1240131|P1|Overall Study|Adverse Event|2
367859|NCT00968864|1240198|P1|Overall Study|Protocol exception/ not evaluable|1
367860|NCT00968812|1240226|P3|Overall Study|Not specified|40
367861|NCT00968812|1240227|P2|Overall Study|Not specified|37
367862|NCT00968812|1240228|P1|Overall Study|Not specified|25
367863|NCT00968812|1240226|P3|Overall Study|Unable to take rescue therapy|17
367864|NCT00968812|1240227|P2|Overall Study|Unable to take rescue therapy|12
367865|NCT00968812|1240228|P1|Overall Study|Unable to take rescue therapy|12
367866|NCT00968812|1240226|P3|Overall Study|Noncompliance with study drug|6
367867|NCT00968812|1240227|P2|Overall Study|Noncompliance with study drug|1
367868|NCT00968812|1240228|P1|Overall Study|Noncompliance with study drug|4
367869|NCT00968812|1240226|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
367870|NCT00968812|1240227|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
367871|NCT00968812|1240228|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
367872|NCT00968812|1240226|P3|Overall Study|Withdrawal by Subject|25
367873|NCT00968812|1240227|P2|Overall Study|Withdrawal by Subject|23
367874|NCT00968812|1240228|P1|Overall Study|Withdrawal by Subject|17
367875|NCT00968812|1240226|P3|Overall Study|Protocol Violation|3
367876|NCT00968812|1240227|P2|Overall Study|Protocol Violation|4
367877|NCT00968812|1240228|P1|Overall Study|Protocol Violation|7
367878|NCT00968812|1240226|P3|Overall Study|Physician Decision|9
367879|NCT00968812|1240227|P2|Overall Study|Physician Decision|5
367880|NCT00968812|1240228|P1|Overall Study|Physician Decision|8
367881|NCT00968812|1240226|P3|Overall Study|Lost to Follow-up|11
367882|NCT00968812|1240227|P2|Overall Study|Lost to Follow-up|12
367883|NCT00968812|1240228|P1|Overall Study|Lost to Follow-up|17
367884|NCT00968812|1240226|P3|Overall Study|Lack of Efficacy|16
367885|NCT00968812|1240227|P2|Overall Study|Lack of Efficacy|7
367886|NCT00968812|1240228|P1|Overall Study|Lack of Efficacy|9
367887|NCT00968812|1240226|P3|Overall Study|Death|1
367888|NCT00968812|1240227|P2|Overall Study|Death|2
367889|NCT00968812|1240228|P1|Overall Study|Death|2
367890|NCT00968812|1240226|P3|Overall Study|Adverse Event|33
367891|NCT00968812|1240227|P2|Overall Study|Adverse Event|46
367892|NCT00968812|1240228|P1|Overall Study|Adverse Event|30
367893|NCT00968799|1240248|P1|Overall Study|Advanced disease, HIPEC not applicable|2
367894|NCT00968708|1240258|P2|Overall Study|Other|34
367895|NCT00968708|1240259|P1|Overall Study|Other|26
367896|NCT00968708|1240258|P2|Overall Study|Investigator Discretion|1
367897|NCT00968708|1240259|P1|Overall Study|Investigator Discretion|0
367898|NCT00968708|1240258|P2|Overall Study|Voluntary Withdrawal|101
367899|NCT00968708|1240259|P1|Overall Study|Voluntary Withdrawal|104
367900|NCT00968708|1240258|P2|Overall Study|Lost to Follow-up|11
367901|NCT00968708|1240259|P1|Overall Study|Lost to Follow-up|19
367902|NCT00968708|1240258|P2|Overall Study|Major Protocol Deviation|1
367903|NCT00968708|1240259|P1|Overall Study|Major Protocol Deviation|0
367904|NCT00968708|1240258|P2|Overall Study|Adverse Event|150
367905|NCT00968708|1240259|P1|Overall Study|Adverse Event|169
367906|NCT00968669|1240271|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
367907|NCT00968669|1240272|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
367908|NCT00968669|1240273|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
367909|NCT00968669|1240274|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
367910|NCT00968669|1240271|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
367911|NCT00968669|1240272|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
367912|NCT00968669|1240273|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
367913|NCT00968669|1240274|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
367914|NCT00968669|1240271|P4|Overall Study|SUBJECT INCARCERATED|0
367915|NCT00968669|1240272|P3|Overall Study|SUBJECT INCARCERATED|0
367916|NCT00968669|1240273|P2|Overall Study|SUBJECT INCARCERATED|1
367917|NCT00968669|1240274|P1|Overall Study|SUBJECT INCARCERATED|0
367918|NCT00968669|1240271|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
367919|NCT00968669|1240272|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
367920|NCT00968669|1240273|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
367921|NCT00968669|1240274|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
367922|NCT00968669|1240271|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
367923|NCT00968669|1240272|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
367924|NCT00968669|1240273|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
367925|NCT00968669|1240274|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
367926|NCT00968669|1240271|P4|Overall Study|SPONSOR DECISION|0
367927|NCT00968669|1240272|P3|Overall Study|SPONSOR DECISION|0
367928|NCT00968669|1240273|P2|Overall Study|SPONSOR DECISION|1
367929|NCT00968669|1240274|P1|Overall Study|SPONSOR DECISION|0
367930|NCT00968669|1240271|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
367931|NCT00968669|1240272|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
367932|NCT00968669|1240273|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
367933|NCT00968669|1240274|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
367934|NCT00968669|1240271|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
367935|NCT00968669|1240272|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
367936|NCT00968669|1240273|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
367937|NCT00968669|1240274|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
367938|NCT00968669|1240271|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
367939|NCT00968669|1240272|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
367940|NCT00968669|1240273|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
367941|NCT00968669|1240274|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
367942|NCT00968669|1240271|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
367943|NCT00968669|1240272|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
367944|NCT00968669|1240273|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
367945|NCT00968669|1240274|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
367946|NCT00968669|1240271|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
367947|NCT00968669|1240272|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
367948|NCT00968669|1240273|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
367949|NCT00968669|1240274|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
367950|NCT00968669|1240271|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
367951|NCT00968669|1240272|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
367952|NCT00968669|1240273|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
367953|NCT00968669|1240274|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
367954|NCT00968669|1240271|P4|Overall Study|EARLY WITHDRAWAL|0
367955|NCT00968669|1240272|P3|Overall Study|EARLY WITHDRAWAL|0
367956|NCT00968669|1240273|P2|Overall Study|EARLY WITHDRAWAL|1
367957|NCT00968669|1240274|P1|Overall Study|EARLY WITHDRAWAL|0
367958|NCT00968669|1240271|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
367959|NCT00968669|1240272|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
367960|NCT00968669|1240273|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
367961|NCT00968669|1240274|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
367962|NCT00968669|1240271|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
367963|NCT00968669|1240272|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
367964|NCT00968669|1240273|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
367965|NCT00968669|1240274|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
367966|NCT00968669|1240271|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
367967|NCT00968669|1240272|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
367968|NCT00968669|1240273|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
367969|NCT00968669|1240274|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
367970|NCT00968669|1240271|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
367971|NCT00968669|1240272|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
367972|NCT00968669|1240273|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
367973|NCT00968669|1240274|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
367974|NCT00968669|1240271|P4|Overall Study|AE|0
367975|NCT00968669|1240272|P3|Overall Study|AE|0
367976|NCT00968669|1240273|P2|Overall Study|AE|0
367977|NCT00968669|1240274|P1|Overall Study|AE|1
367978|NCT00968669|1240271|P4|Overall Study|Pregnancy|0
367979|NCT00968669|1240272|P3|Overall Study|Pregnancy|2
367980|NCT00968669|1240273|P2|Overall Study|Pregnancy|0
367981|NCT00968669|1240274|P1|Overall Study|Pregnancy|0
367982|NCT00968669|1240271|P4|Overall Study|Withdrawal by Subject|3
367983|NCT00968669|1240272|P3|Overall Study|Withdrawal by Subject|5
367984|NCT00968669|1240273|P2|Overall Study|Withdrawal by Subject|7
367985|NCT00968669|1240274|P1|Overall Study|Withdrawal by Subject|9
367986|NCT00968669|1240271|P4|Overall Study|Lost to Follow-up|4
367987|NCT00968669|1240272|P3|Overall Study|Lost to Follow-up|1
367988|NCT00968669|1240273|P2|Overall Study|Lost to Follow-up|2
367989|NCT00968669|1240274|P1|Overall Study|Lost to Follow-up|5
367990|NCT00968617|1240364|P1|Overall Study|Study terminated by sponsor|6
367991|NCT00968539|1240378|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
367992|NCT00968539|1240379|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
367993|NCT00968253|1240440|P3|Overall Study|Adverse Event|1
367994|NCT00968253|1240441|P2|Overall Study|Adverse Event|0
367995|NCT00968253|1240442|P1|Overall Study|Adverse Event|0
367996|NCT00968253|1240440|P3|Overall Study|Disease Progression|3
367997|NCT00968253|1240441|P2|Overall Study|Disease Progression|3
367998|NCT00968253|1240442|P1|Overall Study|Disease Progression|0
367999|NCT00968253|1240440|P3|Overall Study|Withdrawal by Subject|1
368000|NCT00968253|1240441|P2|Overall Study|Withdrawal by Subject|0
368001|NCT00968253|1240442|P1|Overall Study|Withdrawal by Subject|0
368002|NCT00968253|1240440|P3|Overall Study|Death|2
368003|NCT00968253|1240441|P2|Overall Study|Death|0
368004|NCT00968253|1240442|P1|Overall Study|Death|0
368005|NCT00968201|1240463|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
368006|NCT00968201|1240464|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
368007|NCT00968201|1240465|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
368008|NCT00968201|1240463|P3|Extension Study - (Period III)|Not Specified|2
368009|NCT00968201|1240464|P2|Extension Study - (Period III)|Not Specified|0
368010|NCT00968201|1240465|P1|Extension Study - (Period III)|Not Specified|0
368011|NCT00968201|1240463|P3|Extension Study - (Period III)|Noncompliance|3
368012|NCT00968201|1240464|P2|Extension Study - (Period III)|Noncompliance|0
368013|NCT00968201|1240465|P1|Extension Study - (Period III)|Noncompliance|0
368014|NCT00968201|1240463|P3|Extension Study - (Period III)|Patient Relocated|1
368015|NCT00968201|1240464|P2|Extension Study - (Period III)|Patient Relocated|1
368016|NCT00968201|1240465|P1|Extension Study - (Period III)|Patient Relocated|0
368017|NCT00968201|1240463|P3|Extension Study - (Period III)|Withdrawal by Subject|40
368018|NCT00968201|1240464|P2|Extension Study - (Period III)|Withdrawal by Subject|20
368019|NCT00968201|1240465|P1|Extension Study - (Period III)|Withdrawal by Subject|0
368020|NCT00968201|1240463|P3|Extension Study - (Period III)|Protocol Violation|14
368021|NCT00968201|1240464|P2|Extension Study - (Period III)|Protocol Violation|17
368022|NCT00968201|1240465|P1|Extension Study - (Period III)|Protocol Violation|0
368023|NCT00968201|1240463|P3|Extension Study - (Period III)|Lost to Follow-up|13
368024|NCT00968201|1240464|P2|Extension Study - (Period III)|Lost to Follow-up|7
368025|NCT00968201|1240465|P1|Extension Study - (Period III)|Lost to Follow-up|0
368026|NCT00968201|1240463|P3|Extension Study - (Period III)|Adverse Event|22
368027|NCT00968201|1240464|P2|Extension Study - (Period III)|Adverse Event|5
368028|NCT00968201|1240465|P1|Extension Study - (Period III)|Adverse Event|0
368029|NCT00968201|1240463|P3|Base Study - (Period II)|Site Error|1
368030|NCT00968201|1240464|P2|Base Study - (Period II)|Site Error|0
368031|NCT00968201|1240465|P1|Base Study - (Period II)|Site Error|0
368032|NCT00968201|1240463|P3|Base Study - (Period II)|Withdrawal by Subject|8
368033|NCT00968201|1240464|P2|Base Study - (Period II)|Withdrawal by Subject|0
368034|NCT00968201|1240465|P1|Base Study - (Period II)|Withdrawal by Subject|4
368035|NCT00968201|1240463|P3|Base Study - (Period II)|Protocol Violation|12
368036|NCT00968201|1240464|P2|Base Study - (Period II)|Protocol Violation|0
368037|NCT00968201|1240465|P1|Base Study - (Period II)|Protocol Violation|12
368038|NCT00968201|1240463|P3|Base Study - (Period II)|Lost to Follow-up|7
368039|NCT00968201|1240464|P2|Base Study - (Period II)|Lost to Follow-up|0
368040|NCT00968201|1240465|P1|Base Study - (Period II)|Lost to Follow-up|2
368041|NCT00968201|1240463|P3|Base Study - (Period II)|Lack of Efficacy|1
368042|NCT00968201|1240464|P2|Base Study - (Period II)|Lack of Efficacy|0
368043|NCT00968201|1240465|P1|Base Study - (Period II)|Lack of Efficacy|0
368044|NCT00968201|1240463|P3|Base Study - (Period II)|Adverse Event|16
368045|NCT00968201|1240464|P2|Base Study - (Period II)|Adverse Event|0
368046|NCT00968201|1240465|P1|Base Study - (Period II)|Adverse Event|8
368047|NCT00968149|1240526|P2|Overall Study|Withdrawal by Subject|0
368048|NCT00968149|1240527|P1|Overall Study|Withdrawal by Subject|2
368049|NCT00968149|1240526|P2|Overall Study|Protocol Violation|0
368050|NCT00968149|1240527|P1|Overall Study|Protocol Violation|4
368051|NCT00968149|1240526|P2|Overall Study|Lost to Follow-up|1
368052|NCT00968149|1240527|P1|Overall Study|Lost to Follow-up|0
368053|NCT00968149|1240526|P2|Overall Study|Lack of Efficacy|4
368054|NCT00968149|1240527|P1|Overall Study|Lack of Efficacy|0
368055|NCT00968149|1240526|P2|Overall Study|Adverse Event|1
368056|NCT00968149|1240527|P1|Overall Study|Adverse Event|5
368057|NCT00967798|1240582|P2|Overall Study|Lost to Follow-up|1
368058|NCT00967798|1240583|P1|Overall Study|Lost to Follow-up|4
368059|NCT00967798|1240582|P2|Overall Study|Withdrawal by Subject|2
368060|NCT00967798|1240583|P1|Overall Study|Withdrawal by Subject|5
368061|NCT00967694|1240597|P1|Overall Study|Withdrawal by Subject|6
368062|NCT00967668|1240604|P3|Overall Study|Pregnancy|0
368063|NCT00967668|1240605|P2|Overall Study|Pregnancy|0
368064|NCT00967668|1240606|P1|Overall Study|Pregnancy|1
368065|NCT00967668|1240604|P3|Overall Study|Refused 12-mo assessment|9
368066|NCT00967668|1240605|P2|Overall Study|Refused 12-mo assessment|1
368067|NCT00967668|1240606|P1|Overall Study|Refused 12-mo assessment|3
368068|NCT00967668|1240604|P3|Overall Study|Lost to Follow-up|16
368069|NCT00967668|1240605|P2|Overall Study|Lost to Follow-up|9
368070|NCT00967668|1240606|P1|Overall Study|Lost to Follow-up|15
368071|NCT00967668|1240604|P3|Overall Study|Lost to follow-up at 12-mo|26
368072|NCT00967668|1240605|P2|Overall Study|Lost to follow-up at 12-mo|29
368073|NCT00967668|1240606|P1|Overall Study|Lost to follow-up at 12-mo|27
368074|NCT00967668|1240604|P3|Overall Study|Refused Year 2|4
368075|NCT00967668|1240605|P2|Overall Study|Refused Year 2|6
368076|NCT00967668|1240606|P1|Overall Study|Refused Year 2|11
368077|NCT00967668|1240604|P3|Overall Study|Removed due to behavior|2
368078|NCT00967668|1240605|P2|Overall Study|Removed due to behavior|1
368079|NCT00967668|1240606|P1|Overall Study|Removed due to behavior|1
368080|NCT00967668|1240604|P3|Overall Study|Death|4
368081|NCT00967668|1240605|P2|Overall Study|Death|2
368082|NCT00967668|1240606|P1|Overall Study|Death|0
368083|NCT00967668|1240604|P3|Overall Study|Withdrawal by Subject|8
368084|NCT00967668|1240605|P2|Overall Study|Withdrawal by Subject|8
368085|NCT00967668|1240606|P1|Overall Study|Withdrawal by Subject|13
368086|NCT00967330|1240652|P2|Overall Study|Severe protocol deviation|1
368087|NCT00967330|1240653|P1|Overall Study|Severe protocol deviation|0
368088|NCT00967330|1240652|P2|Overall Study|Death|51
368089|NCT00967330|1240653|P1|Overall Study|Death|102
368090|NCT00967330|1240652|P2|Overall Study|Lost to Follow-up|1
368091|NCT00967330|1240653|P1|Overall Study|Lost to Follow-up|1
368092|NCT00967330|1240652|P2|Overall Study|Withdrawal by Subject|0
368093|NCT00967330|1240653|P1|Overall Study|Withdrawal by Subject|6
368094|NCT00967330|1240652|P2|Overall Study|Regular|3
368095|NCT00967330|1240653|P1|Overall Study|Regular|10
368096|NCT00967330|1240652|P2|Overall Study|Protocol Violation|4
368097|NCT00967330|1240653|P1|Overall Study|Protocol Violation|3
368098|NCT00967226|1240683|P2|Overall Study|Physician Decision|1
368099|NCT00967226|1240684|P1|Overall Study|Physician Decision|0
368100|NCT00967226|1240683|P2|Overall Study|Protocol Violation|0
368101|NCT00967226|1240684|P1|Overall Study|Protocol Violation|2
368102|NCT00967226|1240683|P2|Overall Study|Adverse Event|5
368103|NCT00967226|1240684|P1|Overall Study|Adverse Event|0
368104|NCT00967018|1240718|P1|Overall Study|Miscellaneous Reasons|9
368105|NCT00967018|1240718|P1|Overall Study|Withdrawal by Subject|1
368106|NCT00967018|1240718|P1|Overall Study|Lost to Follow-up|2
368107|NCT00967018|1240718|P1|Overall Study|Physician Decision|7
368108|NCT00967018|1240718|P1|Overall Study|Adverse Event|2
368109|NCT00967005|1240727|P2|Overall Study|Lost to Follow-up|10
368110|NCT00967005|1240728|P1|Overall Study|Lost to Follow-up|7
368111|NCT00966940|1240814|P2|Period 1, First 6 Weeks|Protocol Violation|0
368112|NCT00966940|1240815|P1|Period 1, First 6 Weeks|Protocol Violation|1
368113|NCT00966940|1240814|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
368114|NCT00966940|1240815|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
368115|NCT00966875|1240842|P9|Part B|Entry Criteria|1
368116|NCT00966875|1240843|P8|Part B|Entry Criteria|0
368117|NCT00966875|1240844|P7|Part B|Entry Criteria|1
368118|NCT00966875|1240845|P6|Part B|Entry Criteria|0
368119|NCT00966875|1240846|P5|Part B|Entry Criteria|0
368120|NCT00966875|1240847|P4|Part B|Entry Criteria|0
368121|NCT00966875|1240848|P3|Part B|Entry Criteria|0
368122|NCT00966875|1240849|P2|Part B|Entry Criteria|0
368123|NCT00966875|1240850|P1|Part B|Entry Criteria|0
368124|NCT00966875|1240842|P9|Part B|Withdrawal by Subject|5
368125|NCT00966875|1240843|P8|Part B|Withdrawal by Subject|5
368126|NCT00966875|1240844|P7|Part B|Withdrawal by Subject|4
368127|NCT00966875|1240845|P6|Part B|Withdrawal by Subject|1
368128|NCT00966875|1240846|P5|Part B|Withdrawal by Subject|2
368129|NCT00966875|1240847|P4|Part B|Withdrawal by Subject|1
368130|NCT00966875|1240848|P3|Part B|Withdrawal by Subject|2
368131|NCT00966875|1240849|P2|Part B|Withdrawal by Subject|1
368132|NCT00966875|1240850|P1|Part B|Withdrawal by Subject|2
368133|NCT00966875|1240842|P9|Part B|Sponsor Decision|1
368134|NCT00966875|1240843|P8|Part B|Sponsor Decision|2
368135|NCT00966875|1240844|P7|Part B|Sponsor Decision|0
368136|NCT00966875|1240845|P6|Part B|Sponsor Decision|1
368137|NCT00966875|1240846|P5|Part B|Sponsor Decision|0
368138|NCT00966875|1240847|P4|Part B|Sponsor Decision|0
368139|NCT00966875|1240848|P3|Part B|Sponsor Decision|0
368140|NCT00966875|1240849|P2|Part B|Sponsor Decision|0
368141|NCT00966875|1240850|P1|Part B|Sponsor Decision|1
368142|NCT00966875|1240842|P9|Part B|Physician Decision|2
368143|NCT00966875|1240843|P8|Part B|Physician Decision|0
368144|NCT00966875|1240844|P7|Part B|Physician Decision|0
368145|NCT00966875|1240845|P6|Part B|Physician Decision|1
368146|NCT00966875|1240846|P5|Part B|Physician Decision|2
368147|NCT00966875|1240847|P4|Part B|Physician Decision|0
368148|NCT00966875|1240848|P3|Part B|Physician Decision|1
368149|NCT00966875|1240849|P2|Part B|Physician Decision|0
368150|NCT00966875|1240850|P1|Part B|Physician Decision|0
368151|NCT00966875|1240842|P9|Part B|Lost to Follow-up|1
368152|NCT00966875|1240843|P8|Part B|Lost to Follow-up|0
368153|NCT00966875|1240844|P7|Part B|Lost to Follow-up|0
368154|NCT00966875|1240845|P6|Part B|Lost to Follow-up|0
368155|NCT00966875|1240846|P5|Part B|Lost to Follow-up|0
368156|NCT00966875|1240847|P4|Part B|Lost to Follow-up|1
368157|NCT00966875|1240848|P3|Part B|Lost to Follow-up|0
368158|NCT00966875|1240849|P2|Part B|Lost to Follow-up|0
368159|NCT00966875|1240850|P1|Part B|Lost to Follow-up|0
368160|NCT00966875|1240842|P9|Part B|Lack of Efficacy|6
368161|NCT00966875|1240843|P8|Part B|Lack of Efficacy|9
368162|NCT00966875|1240844|P7|Part B|Lack of Efficacy|12
368163|NCT00966875|1240845|P6|Part B|Lack of Efficacy|3
368164|NCT00966875|1240846|P5|Part B|Lack of Efficacy|2
368165|NCT00966875|1240847|P4|Part B|Lack of Efficacy|1
368166|NCT00966875|1240848|P3|Part B|Lack of Efficacy|1
368167|NCT00966875|1240849|P2|Part B|Lack of Efficacy|1
368168|NCT00966875|1240850|P1|Part B|Lack of Efficacy|2
368169|NCT00966875|1240842|P9|Part B|Death|0
368170|NCT00966875|1240843|P8|Part B|Death|1
368171|NCT00966875|1240844|P7|Part B|Death|0
368172|NCT00966875|1240845|P6|Part B|Death|0
368173|NCT00966875|1240846|P5|Part B|Death|0
368174|NCT00966875|1240847|P4|Part B|Death|0
368175|NCT00966875|1240848|P3|Part B|Death|1
368176|NCT00966875|1240849|P2|Part B|Death|0
368177|NCT00966875|1240850|P1|Part B|Death|0
368178|NCT00966875|1240842|P9|Part B|Adverse Event|2
368179|NCT00966875|1240843|P8|Part B|Adverse Event|2
368180|NCT00966875|1240844|P7|Part B|Adverse Event|5
368181|NCT00966875|1240845|P6|Part B|Adverse Event|0
368182|NCT00966875|1240846|P5|Part B|Adverse Event|1
368183|NCT00966875|1240847|P4|Part B|Adverse Event|0
368184|NCT00966875|1240848|P3|Part B|Adverse Event|1
368185|NCT00966875|1240849|P2|Part B|Adverse Event|1
368186|NCT00966875|1240850|P1|Part B|Adverse Event|0
368187|NCT00966875|1240842|P9|Part A|Protocol Violation|1
368188|NCT00966875|1240843|P8|Part A|Protocol Violation|1
368189|NCT00966875|1240844|P7|Part A|Protocol Violation|2
368190|NCT00966875|1240845|P6|Part A|Protocol Violation|0
368191|NCT00966875|1240846|P5|Part A|Protocol Violation|0
368192|NCT00966875|1240847|P4|Part A|Protocol Violation|0
368193|NCT00966875|1240848|P3|Part A|Protocol Violation|0
368194|NCT00966875|1240849|P2|Part A|Protocol Violation|0
368195|NCT00966875|1240850|P1|Part A|Protocol Violation|0
368196|NCT00966875|1240842|P9|Part A|Withdrawal by Subject|1
368197|NCT00966875|1240843|P8|Part A|Withdrawal by Subject|1
368198|NCT00966875|1240844|P7|Part A|Withdrawal by Subject|5
368199|NCT00966875|1240845|P6|Part A|Withdrawal by Subject|0
368200|NCT00966875|1240846|P5|Part A|Withdrawal by Subject|3
368201|NCT00966875|1240847|P4|Part A|Withdrawal by Subject|1
368202|NCT00966875|1240848|P3|Part A|Withdrawal by Subject|1
368203|NCT00966875|1240849|P2|Part A|Withdrawal by Subject|2
368204|NCT00966875|1240850|P1|Part A|Withdrawal by Subject|2
368205|NCT00966875|1240842|P9|Part A|Sponsor Decision|1
368206|NCT00966875|1240843|P8|Part A|Sponsor Decision|2
368207|NCT00966875|1240844|P7|Part A|Sponsor Decision|0
368208|NCT00966875|1240845|P6|Part A|Sponsor Decision|0
368209|NCT00966875|1240846|P5|Part A|Sponsor Decision|1
368210|NCT00966875|1240847|P4|Part A|Sponsor Decision|0
368211|NCT00966875|1240848|P3|Part A|Sponsor Decision|1
368212|NCT00966875|1240849|P2|Part A|Sponsor Decision|0
368213|NCT00966875|1240850|P1|Part A|Sponsor Decision|0
368214|NCT00966875|1240842|P9|Part A|Physician Decision|2
368215|NCT00966875|1240843|P8|Part A|Physician Decision|0
368216|NCT00966875|1240844|P7|Part A|Physician Decision|1
368217|NCT00966875|1240845|P6|Part A|Physician Decision|0
368218|NCT00966875|1240846|P5|Part A|Physician Decision|1
368219|NCT00966875|1240847|P4|Part A|Physician Decision|0
368220|NCT00966875|1240848|P3|Part A|Physician Decision|0
368221|NCT00966875|1240849|P2|Part A|Physician Decision|0
368222|NCT00966875|1240850|P1|Part A|Physician Decision|0
368223|NCT00966875|1240842|P9|Part A|Parent/Caregiver Decision|0
368224|NCT00966875|1240843|P8|Part A|Parent/Caregiver Decision|0
368225|NCT00966875|1240844|P7|Part A|Parent/Caregiver Decision|0
368226|NCT00966875|1240845|P6|Part A|Parent/Caregiver Decision|0
368227|NCT00966875|1240846|P5|Part A|Parent/Caregiver Decision|0
368228|NCT00966875|1240847|P4|Part A|Parent/Caregiver Decision|1
368229|NCT00966875|1240848|P3|Part A|Parent/Caregiver Decision|0
368230|NCT00966875|1240849|P2|Part A|Parent/Caregiver Decision|0
368231|NCT00966875|1240850|P1|Part A|Parent/Caregiver Decision|0
368232|NCT00966875|1240842|P9|Part A|Lost to Follow-up|0
368233|NCT00966875|1240843|P8|Part A|Lost to Follow-up|0
368234|NCT00966875|1240844|P7|Part A|Lost to Follow-up|0
368235|NCT00966875|1240845|P6|Part A|Lost to Follow-up|1
368236|NCT00966875|1240846|P5|Part A|Lost to Follow-up|0
368237|NCT00966875|1240847|P4|Part A|Lost to Follow-up|0
368238|NCT00966875|1240848|P3|Part A|Lost to Follow-up|0
368239|NCT00966875|1240849|P2|Part A|Lost to Follow-up|0
368240|NCT00966875|1240850|P1|Part A|Lost to Follow-up|2
368241|NCT00966875|1240842|P9|Part A|Lack of Efficacy|0
368242|NCT00966875|1240843|P8|Part A|Lack of Efficacy|0
368243|NCT00966875|1240844|P7|Part A|Lack of Efficacy|4
368244|NCT00966875|1240845|P6|Part A|Lack of Efficacy|0
368245|NCT00966875|1240846|P5|Part A|Lack of Efficacy|0
368246|NCT00966875|1240847|P4|Part A|Lack of Efficacy|0
368247|NCT00966875|1240848|P3|Part A|Lack of Efficacy|0
368248|NCT00966875|1240849|P2|Part A|Lack of Efficacy|1
368249|NCT00966875|1240850|P1|Part A|Lack of Efficacy|0
368250|NCT00966875|1240842|P9|Part A|Entry Criteria|0
368251|NCT00966875|1240843|P8|Part A|Entry Criteria|0
368252|NCT00966875|1240844|P7|Part A|Entry Criteria|0
368253|NCT00966875|1240845|P6|Part A|Entry Criteria|2
368254|NCT00966875|1240846|P5|Part A|Entry Criteria|0
368255|NCT00966875|1240847|P4|Part A|Entry Criteria|0
368256|NCT00966875|1240848|P3|Part A|Entry Criteria|0
368257|NCT00966875|1240849|P2|Part A|Entry Criteria|0
368258|NCT00966875|1240850|P1|Part A|Entry Criteria|0
368259|NCT00966875|1240842|P9|Part A|Adverse Event|3
368260|NCT00966875|1240843|P8|Part A|Adverse Event|3
368261|NCT00966875|1240844|P7|Part A|Adverse Event|0
368262|NCT00966875|1240845|P6|Part A|Adverse Event|1
368263|NCT00966875|1240846|P5|Part A|Adverse Event|0
368264|NCT00966875|1240847|P4|Part A|Adverse Event|1
368265|NCT00966875|1240848|P3|Part A|Adverse Event|0
368266|NCT00966875|1240849|P2|Part A|Adverse Event|1
368267|NCT00966875|1240850|P1|Part A|Adverse Event|2
368268|NCT00966654|1241177|P1|Overall Study|Study was terminated,PI left institution|12
368269|NCT00966355|1241223|P3|Overall Study|Lost to Follow-up|3
368270|NCT00966355|1241224|P2|Overall Study|Lost to Follow-up|4
368271|NCT00966355|1241225|P1|Overall Study|Lost to Follow-up|5
368272|NCT00966355|1241223|P3|Overall Study|newly diagnosed advanced HCC|10
368273|NCT00966355|1241224|P2|Overall Study|newly diagnosed advanced HCC|12
368274|NCT00966355|1241225|P1|Overall Study|newly diagnosed advanced HCC|11
368275|NCT00966355|1241223|P3|Overall Study|non-variceal bleeding on endoscopy|71
368276|NCT00966355|1241224|P2|Overall Study|non-variceal bleeding on endoscopy|70
368277|NCT00966355|1241225|P1|Overall Study|non-variceal bleeding on endoscopy|68
368278|NCT00966277|1241238|P2|Overall Study|Treatment Plan Changed|1
368279|NCT00966277|1241239|P1|Overall Study|Treatment Plan Changed|0
368280|NCT00966277|1241238|P2|Overall Study|Ineligible|3
368281|NCT00966277|1241239|P1|Overall Study|Ineligible|1
368282|NCT00966277|1241238|P2|Overall Study|Withdrawal by Subject|0
368283|NCT00966277|1241239|P1|Overall Study|Withdrawal by Subject|3
368284|NCT00966264|1241247|P2|Overall Study|Lost to Follow-up|3
368285|NCT00966264|1241248|P1|Overall Study|Lost to Follow-up|4
368286|NCT00965848|1241294|P3|Overall Study|Other|1
368287|NCT00965848|1241295|P2|Overall Study|Other|0
368288|NCT00965848|1241296|P1|Overall Study|Other|5
368289|NCT00965848|1241294|P3|Overall Study|Not Clinically Evaluable|1
368290|NCT00965848|1241295|P2|Overall Study|Not Clinically Evaluable|1
368291|NCT00965848|1241296|P1|Overall Study|Not Clinically Evaluable|7
368292|NCT00965848|1241294|P3|Overall Study|Indeterminate Clinical Outcome|1
368293|NCT00965848|1241295|P2|Overall Study|Indeterminate Clinical Outcome|0
368294|NCT00965848|1241296|P1|Overall Study|Indeterminate Clinical Outcome|2
368295|NCT00965848|1241294|P3|Overall Study|Withdrawal by Subject|0
368296|NCT00965848|1241295|P2|Overall Study|Withdrawal by Subject|0
368297|NCT00965848|1241296|P1|Overall Study|Withdrawal by Subject|1
368298|NCT00965848|1241294|P3|Overall Study|Lost to Follow-up|1
368299|NCT00965848|1241295|P2|Overall Study|Lost to Follow-up|0
368300|NCT00965848|1241296|P1|Overall Study|Lost to Follow-up|0
368301|NCT00965848|1241294|P3|Overall Study|Death|5
368302|NCT00965848|1241295|P2|Overall Study|Death|1
368303|NCT00965848|1241296|P1|Overall Study|Death|11
368304|NCT00965848|1241294|P3|Overall Study|Protocol Violation|1
368305|NCT00965848|1241295|P2|Overall Study|Protocol Violation|0
368306|NCT00965848|1241296|P1|Overall Study|Protocol Violation|3
368307|NCT00965757|1241315|P4|Extension Phase|Not Specified|1
368308|NCT00965757|1241316|P3|Extension Phase|Not Specified|2
368309|NCT00965757|1241317|P2|Extension Phase|Not Specified|0
368310|NCT00965757|1241318|P1|Extension Phase|Not Specified|0
368311|NCT00965757|1241315|P4|Extension Phase|Protocol Violation|1
368312|NCT00965757|1241316|P3|Extension Phase|Protocol Violation|0
368313|NCT00965757|1241317|P2|Extension Phase|Protocol Violation|0
368314|NCT00965757|1241318|P1|Extension Phase|Protocol Violation|0
368315|NCT00965757|1241315|P4|Extension Phase|Ineligible after Taking Study Drug|3
368316|NCT00965757|1241316|P3|Extension Phase|Ineligible after Taking Study Drug|3
368317|NCT00965757|1241317|P2|Extension Phase|Ineligible after Taking Study Drug|0
368318|NCT00965757|1241318|P1|Extension Phase|Ineligible after Taking Study Drug|0
368319|NCT00965757|1241315|P4|Extension Phase|Lost to Follow-up|1
368320|NCT00965757|1241316|P3|Extension Phase|Lost to Follow-up|0
368321|NCT00965757|1241317|P2|Extension Phase|Lost to Follow-up|0
368322|NCT00965757|1241318|P1|Extension Phase|Lost to Follow-up|0
368323|NCT00965757|1241315|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
368324|NCT00965757|1241316|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
368325|NCT00965757|1241317|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
368326|NCT00965757|1241318|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
368327|NCT00965757|1241315|P4|Extension Phase|Lack of Efficacy|12
368328|NCT00965757|1241316|P3|Extension Phase|Lack of Efficacy|8
368329|NCT00965757|1241317|P2|Extension Phase|Lack of Efficacy|0
368330|NCT00965757|1241318|P1|Extension Phase|Lack of Efficacy|0
368331|NCT00965757|1241315|P4|Extension Phase|Abnormal Laboratory Value|1
368332|NCT00965757|1241316|P3|Extension Phase|Abnormal Laboratory Value|6
368333|NCT00965757|1241317|P2|Extension Phase|Abnormal Laboratory Value|0
368334|NCT00965757|1241318|P1|Extension Phase|Abnormal Laboratory Value|0
368335|NCT00965757|1241315|P4|Extension Phase|Adverse drug reaction|3
368336|NCT00965757|1241316|P3|Extension Phase|Adverse drug reaction|6
368337|NCT00965757|1241317|P2|Extension Phase|Adverse drug reaction|0
368338|NCT00965757|1241318|P1|Extension Phase|Adverse drug reaction|0
368339|NCT00965757|1241315|P4|Extension Phase|Progression of concomitant disease|2
368340|NCT00965757|1241316|P3|Extension Phase|Progression of concomitant disease|4
368341|NCT00965757|1241317|P2|Extension Phase|Progression of concomitant disease|0
368342|NCT00965757|1241318|P1|Extension Phase|Progression of concomitant disease|0
368343|NCT00965757|1241315|P4|Double-blind Phase|Not specified|0
368344|NCT00965757|1241316|P3|Double-blind Phase|Not specified|0
368345|NCT00965757|1241317|P2|Double-blind Phase|Not specified|0
368346|NCT00965757|1241318|P1|Double-blind Phase|Not specified|1
368347|NCT00965757|1241315|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
368348|NCT00965757|1241316|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
368349|NCT00965757|1241317|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
368350|NCT00965757|1241318|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
368351|NCT00965757|1241315|P4|Double-blind Phase|Lost to Follow-up|0
368352|NCT00965757|1241316|P3|Double-blind Phase|Lost to Follow-up|0
368353|NCT00965757|1241317|P2|Double-blind Phase|Lost to Follow-up|1
368354|NCT00965757|1241318|P1|Double-blind Phase|Lost to Follow-up|0
368355|NCT00965757|1241315|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
368356|NCT00965757|1241316|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
368357|NCT00965757|1241317|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
368358|NCT00965757|1241318|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
368359|NCT00965757|1241315|P4|Double-blind Phase|Lack of Efficacy|0
368360|NCT00965757|1241316|P3|Double-blind Phase|Lack of Efficacy|0
368361|NCT00965757|1241317|P2|Double-blind Phase|Lack of Efficacy|11
368362|NCT00965757|1241318|P1|Double-blind Phase|Lack of Efficacy|7
368363|NCT00965757|1241315|P4|Double-blind Phase|Abnormal Laboratory Value|0
368364|NCT00965757|1241316|P3|Double-blind Phase|Abnormal Laboratory Value|0
368365|NCT00965757|1241317|P2|Double-blind Phase|Abnormal Laboratory Value|0
368366|NCT00965757|1241318|P1|Double-blind Phase|Abnormal Laboratory Value|2
368367|NCT00965757|1241315|P4|Double-blind Phase|Adverse drug reaction|0
368368|NCT00965757|1241316|P3|Double-blind Phase|Adverse drug reaction|0
368369|NCT00965757|1241317|P2|Double-blind Phase|Adverse drug reaction|1
368370|NCT00965757|1241318|P1|Double-blind Phase|Adverse drug reaction|2
368371|NCT00965757|1241315|P4|Double-blind Phase|Progression of concomitant disease|0
368372|NCT00965757|1241316|P3|Double-blind Phase|Progression of concomitant disease|0
368373|NCT00965757|1241317|P2|Double-blind Phase|Progression of concomitant disease|2
368374|NCT00965757|1241318|P1|Double-blind Phase|Progression of concomitant disease|1
368375|NCT00965731|1241352|P2|Overall Study|Not specified|15
368376|NCT00965731|1241353|P1|Overall Study|Not specified|7
368377|NCT00965731|1241352|P2|Overall Study|Withdrawal by Subject|1
368378|NCT00965731|1241353|P1|Overall Study|Withdrawal by Subject|0
368379|NCT00965731|1241352|P2|Overall Study|Death|4
368380|NCT00965731|1241353|P1|Overall Study|Death|0
368381|NCT00965718|1241417|P1|Overall Study|Withdrawal by Subject|4
368382|NCT00965562|1241430|P3|Overall Study|Withdrawal by Subject|0
368383|NCT00965562|1241431|P2|Overall Study|Withdrawal by Subject|2
368384|NCT00965562|1241432|P1|Overall Study|Withdrawal by Subject|2
368385|NCT00965562|1241430|P3|Overall Study|Lost to Follow-up|3
368386|NCT00965562|1241431|P2|Overall Study|Lost to Follow-up|2
368387|NCT00965562|1241432|P1|Overall Study|Lost to Follow-up|1
368388|NCT00965523|1241470|P1|Study 224|Physician Decision|1
368389|NCT00965523|1241470|P1|Study 224|Progressive Disease|5
368390|NCT00965523|1241470|P1|Study 221|Physician Decision|3
368391|NCT00965523|1241470|P1|Study 221|Progressive Disease|4
368392|NCT00965497|1241475|P1|Overall Study|Physician Decision|1
368393|NCT00965484|1241480|P1|Overall Study|Withdrawal by Subject|1
368394|NCT00965484|1241480|P1|Overall Study|Protocol Violation|1
368395|NCT00965458|1241489|P2|Overall Study|Withdrawal by Subject|1
368396|NCT00965458|1241490|P1|Overall Study|Withdrawal by Subject|0
368397|NCT00965458|1241489|P2|Overall Study|Lost to Follow-up|3
368398|NCT00965458|1241490|P1|Overall Study|Lost to Follow-up|1
368399|NCT00965458|1241489|P2|Overall Study|Adverse Event|0
368400|NCT00965458|1241490|P1|Overall Study|Adverse Event|1
368401|NCT00965419|1241506|P1|Follow-up Phase|Lack of Efficacy|28
368402|NCT00965419|1241506|P1|Follow-up Phase|Parent/Caregiver Decision|9
368403|NCT00965419|1241506|P1|Follow-up Phase|Physician Decision|4
368404|NCT00965419|1241506|P1|Follow-up Phase|Withdrawal by Subject|8
368405|NCT00965419|1241506|P1|Follow-up Phase|Protocol Violation|4
368406|NCT00965419|1241506|P1|Follow-up Phase|Adverse Event|9
368407|NCT00965419|1241506|P1|Open Label Treatment for Responders|Lost to Follow-up|46
368408|NCT00965419|1241506|P1|Open Label Treatment for Responders|Lack of Efficacy|67
368409|NCT00965419|1241506|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
368410|NCT00965419|1241506|P1|Open Label Treatment for Responders|Sponsor Decision|5
368411|NCT00965419|1241506|P1|Open Label Treatment for Responders|Physician Decision|6
368412|NCT00965419|1241506|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
368413|NCT00965419|1241506|P1|Open Label Treatment for Responders|Protocol Violation|21
368414|NCT00965419|1241506|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
368415|NCT00965419|1241506|P1|Open Label Treatment for Responders|Adverse Event|33
368416|NCT00965341|1241552|P2|Overall Study|Transportation issues|3
368417|NCT00965341|1241553|P1|Overall Study|Transportation issues|4
368418|NCT00965341|1241552|P2|Overall Study|Lost to Follow-up|0
368419|NCT00965341|1241553|P1|Overall Study|Lost to Follow-up|1
368420|NCT00965341|1241552|P2|Overall Study|Withdrew consent|5
368421|NCT00965341|1241553|P1|Overall Study|Withdrew consent|1
368422|NCT00965263|1241563|P2|Overall Study|Protocol Violation|2
368423|NCT00965263|1241564|P1|Overall Study|Protocol Violation|0
368424|NCT00965263|1241563|P2|Overall Study|Family emergency|1
368425|NCT00965263|1241564|P1|Overall Study|Family emergency|0
368426|NCT00965263|1241563|P2|Overall Study|Physician Decision|0
368427|NCT00965263|1241564|P1|Overall Study|Physician Decision|2
368428|NCT00965185|1241624|P2|Overall Study|Withdrawal by Subject|1
368429|NCT00965185|1241625|P1|Overall Study|Withdrawal by Subject|0
368430|NCT00965185|1241624|P2|Overall Study|Lost to Follow-up|0
368431|NCT00965185|1241625|P1|Overall Study|Lost to Follow-up|2
368432|NCT00965146|1241645|P1|Overall Study|Overall Study Termination|145
368433|NCT00965146|1241645|P1|Overall Study|Revision / Removal of Study Implant|6
368434|NCT00965146|1241645|P1|Overall Study|Intercurrent illness|1
368435|NCT00965146|1241645|P1|Overall Study|Unwilling to return|11
368436|NCT00965146|1241645|P1|Overall Study|Unable to return|1
368437|NCT00965146|1241645|P1|Overall Study|Withdrawal by Subject|17
368438|NCT00965146|1241645|P1|Overall Study|Lost to Follow-up|22
368439|NCT00965146|1241645|P1|Overall Study|Death|7
368440|NCT00965094|1241652|P2|Overall Study|Lost to Follow-up|1
368441|NCT00965094|1241653|P1|Overall Study|Lost to Follow-up|0
368442|NCT00965094|1241652|P2|Overall Study|Adverse Event|0
368443|NCT00965094|1241653|P1|Overall Study|Adverse Event|5
368444|NCT00965081|1241669|P2|Overall Study|Switched to Rescue Arm|12
368445|NCT00965081|1241670|P1|Overall Study|Switched to Rescue Arm|5
368446|NCT00965081|1241669|P2|Overall Study|Withdrawal by Subject|7
368447|NCT00965081|1241670|P1|Overall Study|Withdrawal by Subject|4
368448|NCT00965081|1241669|P2|Overall Study|Sponsor Decision|0
368449|NCT00965081|1241670|P1|Overall Study|Sponsor Decision|1
368450|NCT00965081|1241669|P2|Overall Study|Protocol Violation|5
368451|NCT00965081|1241670|P1|Overall Study|Protocol Violation|2
368452|NCT00965081|1241669|P2|Overall Study|Physician Decision|0
368453|NCT00965081|1241670|P1|Overall Study|Physician Decision|2
368454|NCT00965081|1241669|P2|Overall Study|Lost to Follow-up|5
368455|NCT00965081|1241670|P1|Overall Study|Lost to Follow-up|4
368456|NCT00965081|1241669|P2|Overall Study|Lack of Efficacy|5
368457|NCT00965081|1241670|P1|Overall Study|Lack of Efficacy|2
368458|NCT00965081|1241669|P2|Overall Study|Adverse Event|9
368459|NCT00965081|1241670|P1|Overall Study|Adverse Event|14
368460|NCT00964886|1241697|P4|Overall Study|Protocol Violation|0
368461|NCT00964886|1241698|P3|Overall Study|Protocol Violation|0
368462|NCT00964886|1241699|P2|Overall Study|Protocol Violation|2
368463|NCT00964886|1241700|P1|Overall Study|Protocol Violation|0
368464|NCT00964886|1241697|P4|Overall Study|Adverse Event|2
368465|NCT00964886|1241698|P3|Overall Study|Adverse Event|5
368466|NCT00964886|1241699|P2|Overall Study|Adverse Event|1
368467|NCT00964886|1241700|P1|Overall Study|Adverse Event|3
368468|NCT00964886|1241697|P4|Overall Study|Withdrawal by Subject|3
368469|NCT00964886|1241698|P3|Overall Study|Withdrawal by Subject|5
368470|NCT00964886|1241699|P2|Overall Study|Withdrawal by Subject|2
368471|NCT00964886|1241700|P1|Overall Study|Withdrawal by Subject|6
368472|NCT00964886|1241697|P4|Overall Study|Lost to Follow-up|4
368473|NCT00964886|1241698|P3|Overall Study|Lost to Follow-up|6
368474|NCT00964886|1241699|P2|Overall Study|Lost to Follow-up|2
368475|NCT00964886|1241700|P1|Overall Study|Lost to Follow-up|2
368476|NCT00964860|1241716|P2|Overall Study|Withdrawal by Subject|1
368477|NCT00964860|1241717|P1|Overall Study|Withdrawal by Subject|0
368478|NCT00964795|1241725|P1|Overall Study|Other|23
368479|NCT00964795|1241725|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
368480|NCT00964795|1241725|P1|Overall Study|Termination of Study by Sponsor|169
368481|NCT00964795|1241725|P1|Overall Study|Lost to Follow-up|7
368482|NCT00964795|1241725|P1|Overall Study|Death|14
368483|NCT00964795|1241725|P1|Overall Study|Adverse Event|12
368484|NCT00964795|1241725|P1|Overall Study|Withdrawal by Subject|79
368485|NCT00964743|1241732|P1|Overall Study|Neither patient completed 8 weeks of tre|2
368486|NCT00964678|1241740|P1|Overall Study|Physician Decision|4
368487|NCT00964392|1241804|P2|Overall Study|Not completed|168
368488|NCT00964392|1241805|P1|Overall Study|Not completed|44
368489|NCT00964392|1241804|P2|Overall Study|Early Termination, non-study arrhythmia|6
368490|NCT00964392|1241805|P1|Overall Study|Early Termination, non-study arrhythmia|1
368491|NCT00964392|1241804|P2|Overall Study|Lost to Follow-up|10
368492|NCT00964392|1241805|P1|Overall Study|Lost to Follow-up|4
368493|NCT00964392|1241804|P2|Overall Study|Withdrawal by Subject|6
368494|NCT00964392|1241805|P1|Overall Study|Withdrawal by Subject|4
368495|NCT00964366|1241815|P2|Overall Study|Withdrawal by Subject|1
368496|NCT00964366|1241816|P1|Overall Study|Withdrawal by Subject|0
368497|NCT00964366|1241815|P2|Overall Study|Did not qualify at Day 1|0
368498|NCT00964366|1241816|P1|Overall Study|Did not qualify at Day 1|1
368499|NCT00964223|1241830|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
368500|NCT00964158|1241898|P3|Overall Study|Withdrawal by Subject|6
368501|NCT00964158|1241899|P2|Overall Study|Withdrawal by Subject|0
368502|NCT00964158|1241900|P1|Overall Study|Withdrawal by Subject|0
368503|NCT00964158|1241898|P3|Overall Study|Lost to Follow-up|2
368504|NCT00964158|1241899|P2|Overall Study|Lost to Follow-up|1
368505|NCT00964158|1241900|P1|Overall Study|Lost to Follow-up|0
368506|NCT00964028|1241975|P2|Overall Study|Withdrawal by Subject|1
368507|NCT00964028|1241976|P1|Overall Study|Withdrawal by Subject|0
368508|NCT00963937|1241991|P3|Overall Study|Physician Decision|4
368509|NCT00963937|1241992|P2|Overall Study|Physician Decision|10
368510|NCT00963937|1241993|P1|Overall Study|Physician Decision|18
368511|NCT00963937|1241991|P3|Overall Study|Protocol Violation|0
368512|NCT00963937|1241992|P2|Overall Study|Protocol Violation|1
368513|NCT00963937|1241993|P1|Overall Study|Protocol Violation|1
368514|NCT00963924|1242031|P2|Overall Study|Lost to Follow-up|1
368515|NCT00963924|1242032|P1|Overall Study|Lost to Follow-up|0
368516|NCT00963924|1242031|P2|Overall Study|Changed antipsychotic|1
368517|NCT00963924|1242032|P1|Overall Study|Changed antipsychotic|0
368518|NCT00963924|1242031|P2|Overall Study|Withdrawal by Subject|1
368519|NCT00963924|1242032|P1|Overall Study|Withdrawal by Subject|0
368520|NCT00963924|1242031|P2|Overall Study|Adverse Event|0
368521|NCT00963924|1242032|P1|Overall Study|Adverse Event|1
368522|NCT00963820|1242106|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
368523|NCT00963820|1242107|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
368524|NCT00963820|1242108|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
368525|NCT00963820|1242109|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
368526|NCT00963820|1242110|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
368527|NCT00963820|1242111|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
368528|NCT00963820|1242112|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
368529|NCT00963820|1242113|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
368530|NCT00963820|1242114|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
368531|NCT00963820|1242115|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
368532|NCT00963820|1242116|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
368533|NCT00963820|1242117|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
368534|NCT00963820|1242106|P12|Expansion Phase|Withdrawal by Subject|1
368535|NCT00963820|1242107|P11|Expansion Phase|Withdrawal by Subject|1
368536|NCT00963820|1242108|P10|Expansion Phase|Withdrawal by Subject|0
368537|NCT00963820|1242109|P9|Expansion Phase|Withdrawal by Subject|1
368538|NCT00963820|1242110|P8|Expansion Phase|Withdrawal by Subject|0
368539|NCT00963820|1242111|P7|Expansion Phase|Withdrawal by Subject|0
368540|NCT00963820|1242112|P6|Expansion Phase|Withdrawal by Subject|0
368541|NCT00963820|1242113|P5|Expansion Phase|Withdrawal by Subject|0
368542|NCT00963820|1242114|P4|Expansion Phase|Withdrawal by Subject|0
368543|NCT00963820|1242115|P3|Expansion Phase|Withdrawal by Subject|0
368544|NCT00963820|1242116|P2|Expansion Phase|Withdrawal by Subject|0
368545|NCT00963820|1242117|P1|Expansion Phase|Withdrawal by Subject|0
368546|NCT00963820|1242106|P12|Expansion Phase|Adverse Event|0
368547|NCT00963820|1242107|P11|Expansion Phase|Adverse Event|0
368548|NCT00963820|1242108|P10|Expansion Phase|Adverse Event|3
368549|NCT00963820|1242109|P9|Expansion Phase|Adverse Event|1
368550|NCT00963820|1242110|P8|Expansion Phase|Adverse Event|0
368551|NCT00963820|1242111|P7|Expansion Phase|Adverse Event|0
368552|NCT00963820|1242112|P6|Expansion Phase|Adverse Event|0
368553|NCT00963820|1242113|P5|Expansion Phase|Adverse Event|0
368554|NCT00963820|1242114|P4|Expansion Phase|Adverse Event|0
368555|NCT00963820|1242115|P3|Expansion Phase|Adverse Event|0
368556|NCT00963820|1242116|P2|Expansion Phase|Adverse Event|0
368557|NCT00963820|1242117|P1|Expansion Phase|Adverse Event|0
368558|NCT00963820|1242106|P12|Expansion Phase|Progressive Disease|2
368559|NCT00963820|1242107|P11|Expansion Phase|Progressive Disease|4
368560|NCT00963820|1242108|P10|Expansion Phase|Progressive Disease|6
368561|NCT00963820|1242109|P9|Expansion Phase|Progressive Disease|8
368562|NCT00963820|1242110|P8|Expansion Phase|Progressive Disease|0
368563|NCT00963820|1242111|P7|Expansion Phase|Progressive Disease|0
368564|NCT00963820|1242112|P6|Expansion Phase|Progressive Disease|0
368565|NCT00963820|1242113|P5|Expansion Phase|Progressive Disease|0
368566|NCT00963820|1242114|P4|Expansion Phase|Progressive Disease|0
368567|NCT00963820|1242115|P3|Expansion Phase|Progressive Disease|0
368568|NCT00963820|1242116|P2|Expansion Phase|Progressive Disease|0
368569|NCT00963820|1242117|P1|Expansion Phase|Progressive Disease|0
368570|NCT00963820|1242106|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368571|NCT00963820|1242107|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368572|NCT00963820|1242108|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368573|NCT00963820|1242109|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368574|NCT00963820|1242110|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368575|NCT00963820|1242111|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
368576|NCT00963820|1242112|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368577|NCT00963820|1242113|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368578|NCT00963820|1242114|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368579|NCT00963820|1242115|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368580|NCT00963820|1242116|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368581|NCT00963820|1242117|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
368582|NCT00963820|1242106|P12|Dose Escalation Phase|Withdrawal by Subject|0
368583|NCT00963820|1242107|P11|Dose Escalation Phase|Withdrawal by Subject|0
368584|NCT00963820|1242108|P10|Dose Escalation Phase|Withdrawal by Subject|0
368585|NCT00963820|1242109|P9|Dose Escalation Phase|Withdrawal by Subject|0
368586|NCT00963820|1242110|P8|Dose Escalation Phase|Withdrawal by Subject|2
368587|NCT00963820|1242111|P7|Dose Escalation Phase|Withdrawal by Subject|1
368588|NCT00963820|1242112|P6|Dose Escalation Phase|Withdrawal by Subject|0
368589|NCT00963820|1242113|P5|Dose Escalation Phase|Withdrawal by Subject|0
368590|NCT00963820|1242114|P4|Dose Escalation Phase|Withdrawal by Subject|0
368591|NCT00963820|1242115|P3|Dose Escalation Phase|Withdrawal by Subject|0
368592|NCT00963820|1242116|P2|Dose Escalation Phase|Withdrawal by Subject|0
368593|NCT00963820|1242117|P1|Dose Escalation Phase|Withdrawal by Subject|0
368594|NCT00963820|1242106|P12|Dose Escalation Phase|Adverse Event|0
368595|NCT00963820|1242107|P11|Dose Escalation Phase|Adverse Event|0
368596|NCT00963820|1242108|P10|Dose Escalation Phase|Adverse Event|0
368597|NCT00963820|1242109|P9|Dose Escalation Phase|Adverse Event|0
368598|NCT00963820|1242110|P8|Dose Escalation Phase|Adverse Event|1
368599|NCT00963820|1242111|P7|Dose Escalation Phase|Adverse Event|3
368600|NCT00963820|1242112|P6|Dose Escalation Phase|Adverse Event|0
368601|NCT00963820|1242113|P5|Dose Escalation Phase|Adverse Event|0
368602|NCT00963820|1242114|P4|Dose Escalation Phase|Adverse Event|0
368603|NCT00963820|1242115|P3|Dose Escalation Phase|Adverse Event|0
368604|NCT00963820|1242116|P2|Dose Escalation Phase|Adverse Event|0
368605|NCT00963820|1242117|P1|Dose Escalation Phase|Adverse Event|0
368606|NCT00963820|1242106|P12|Dose Escalation Phase|Progressive Disease|0
368607|NCT00963820|1242107|P11|Dose Escalation Phase|Progressive Disease|0
368608|NCT00963820|1242108|P10|Dose Escalation Phase|Progressive Disease|0
368609|NCT00963820|1242109|P9|Dose Escalation Phase|Progressive Disease|0
368610|NCT00963820|1242110|P8|Dose Escalation Phase|Progressive Disease|2
368611|NCT00963820|1242111|P7|Dose Escalation Phase|Progressive Disease|3
368612|NCT00963820|1242112|P6|Dose Escalation Phase|Progressive Disease|3
368613|NCT00963820|1242113|P5|Dose Escalation Phase|Progressive Disease|4
368614|NCT00963820|1242114|P4|Dose Escalation Phase|Progressive Disease|3
368615|NCT00963820|1242115|P3|Dose Escalation Phase|Progressive Disease|3
368616|NCT00963820|1242116|P2|Dose Escalation Phase|Progressive Disease|3
368617|NCT00963820|1242117|P1|Dose Escalation Phase|Progressive Disease|3
368618|NCT00963807|1242253|P1|Overall Study|Disease progression|15
368619|NCT00963807|1242253|P1|Overall Study|Reaction to study chemotherapy regimen|1
368620|NCT00963807|1242253|P1|Overall Study|Physician Decision|2
368621|NCT00963599|1242286|P4|Overall Study|Withdrawal by Subject|3
368622|NCT00963599|1242287|P3|Overall Study|Withdrawal by Subject|3
368623|NCT00963599|1242288|P2|Overall Study|Withdrawal by Subject|1
368624|NCT00963599|1242289|P1|Overall Study|Withdrawal by Subject|2
368625|NCT00963599|1242286|P4|Overall Study|Protocol Violation|4
368626|NCT00963599|1242287|P3|Overall Study|Protocol Violation|3
368627|NCT00963599|1242288|P2|Overall Study|Protocol Violation|2
368628|NCT00963599|1242289|P1|Overall Study|Protocol Violation|2
368629|NCT00963599|1242286|P4|Overall Study|Lost to Follow-up|1
368630|NCT00963599|1242287|P3|Overall Study|Lost to Follow-up|1
368631|NCT00963599|1242288|P2|Overall Study|Lost to Follow-up|1
368632|NCT00963599|1242289|P1|Overall Study|Lost to Follow-up|0
368633|NCT00963599|1242286|P4|Overall Study|Lack of Efficacy|4
368634|NCT00963599|1242287|P3|Overall Study|Lack of Efficacy|1
368635|NCT00963599|1242288|P2|Overall Study|Lack of Efficacy|2
368636|NCT00963599|1242289|P1|Overall Study|Lack of Efficacy|0
368637|NCT00963599|1242286|P4|Overall Study|Adverse Event|2
368638|NCT00963599|1242287|P3|Overall Study|Adverse Event|1
368639|NCT00963599|1242288|P2|Overall Study|Adverse Event|0
368640|NCT00963599|1242289|P1|Overall Study|Adverse Event|2
368641|NCT00963469|1242379|P3|Overall Study|Site closed (local pollen Season ended)|3
368642|NCT00963469|1242380|P2|Overall Study|Site closed (local pollen Season ended)|1
368643|NCT00963469|1242381|P1|Overall Study|Site closed (local pollen Season ended)|4
368644|NCT00963469|1242379|P3|Overall Study|Moved|0
368645|NCT00963469|1242380|P2|Overall Study|Moved|0
368646|NCT00963469|1242381|P1|Overall Study|Moved|1
368647|NCT00963469|1242379|P3|Overall Study|Pre-randomization Adverse Event|0
368648|NCT00963469|1242380|P2|Overall Study|Pre-randomization Adverse Event|2
368649|NCT00963469|1242381|P1|Overall Study|Pre-randomization Adverse Event|1
368650|NCT00963469|1242379|P3|Overall Study|Withdrawal by Subject|1
368651|NCT00963469|1242380|P2|Overall Study|Withdrawal by Subject|1
368652|NCT00963469|1242381|P1|Overall Study|Withdrawal by Subject|4
368653|NCT00963469|1242379|P3|Overall Study|Protocol Violation|3
368654|NCT00963469|1242380|P2|Overall Study|Protocol Violation|5
368655|NCT00963469|1242381|P1|Overall Study|Protocol Violation|5
368656|NCT00963469|1242379|P3|Overall Study|Lost to Follow-up|0
368657|NCT00963469|1242380|P2|Overall Study|Lost to Follow-up|1
368658|NCT00963469|1242381|P1|Overall Study|Lost to Follow-up|1
368659|NCT00963469|1242379|P3|Overall Study|Lack of Efficacy|2
368660|NCT00963469|1242380|P2|Overall Study|Lack of Efficacy|7
368661|NCT00963469|1242381|P1|Overall Study|Lack of Efficacy|10
368662|NCT00963469|1242379|P3|Overall Study|Adverse Event|1
368663|NCT00963469|1242380|P2|Overall Study|Adverse Event|11
368664|NCT00963469|1242381|P1|Overall Study|Adverse Event|15
368665|NCT00963235|1242448|P1|Overall Study|Other|1
368666|NCT00963235|1242448|P1|Overall Study|Physician Decision|2
368667|NCT00963235|1242448|P1|Overall Study|Adverse Event|5
368668|NCT00963235|1242448|P1|Overall Study|Protocol Violation|7
368669|NCT00963235|1242448|P1|Overall Study|Failed to return|9
368670|NCT00963235|1242448|P1|Overall Study|Lost to Follow-up|14
368671|NCT00963235|1242448|P1|Overall Study|Withdrawal by Subject|22
368672|NCT00962780|1242691|P2|Overall Study|Other|1
368673|NCT00962780|1242692|P1|Overall Study|Other|0
368674|NCT00962780|1242691|P2|Overall Study|Withdrawal by Subject|8
368675|NCT00962780|1242692|P1|Overall Study|Withdrawal by Subject|1
368676|NCT00962780|1242691|P2|Overall Study|Protocol Violation|4
368677|NCT00962780|1242692|P1|Overall Study|Protocol Violation|9
368678|NCT00962780|1242691|P2|Overall Study|Death|1
368679|NCT00962780|1242692|P1|Overall Study|Death|0
368680|NCT00962741|1242767|P1|Overall Study|drug ineffective+prohibited drug taken|1
368681|NCT00962741|1242767|P1|Overall Study|Lack of Efficacy|1
368682|NCT00962741|1242767|P1|Overall Study|Withdrawal by Subject|1
368683|NCT00962741|1242767|P1|Overall Study|Lost to Follow-up|2
368684|NCT00962741|1242767|P1|Overall Study|Failed to return|3
368685|NCT00962650|1242858|P1|Overall Study|Transgastric DP was not completed|2
368686|NCT00962585|1242877|P4|Overall Study|Withdrew Consent|0
368687|NCT00962585|1242878|P3|Overall Study|Withdrew Consent|0
368688|NCT00962585|1242879|P2|Overall Study|Withdrew Consent|0
368689|NCT00962585|1242880|P1|Overall Study|Withdrew Consent|2
368690|NCT00962585|1242877|P4|Overall Study|Withdrawal by Subject|0
368691|NCT00962585|1242878|P3|Overall Study|Withdrawal by Subject|0
368692|NCT00962585|1242879|P2|Overall Study|Withdrawal by Subject|0
368693|NCT00962585|1242880|P1|Overall Study|Withdrawal by Subject|1
368694|NCT00962585|1242877|P4|Overall Study|Protocol Violation|0
368695|NCT00962585|1242878|P3|Overall Study|Protocol Violation|1
368696|NCT00962585|1242879|P2|Overall Study|Protocol Violation|0
368697|NCT00962585|1242880|P1|Overall Study|Protocol Violation|0
368698|NCT00962585|1242877|P4|Overall Study|Lost to Follow-up|0
368699|NCT00962585|1242878|P3|Overall Study|Lost to Follow-up|1
368700|NCT00962585|1242879|P2|Overall Study|Lost to Follow-up|0
368701|NCT00962585|1242880|P1|Overall Study|Lost to Follow-up|3
368702|NCT00962585|1242877|P4|Overall Study|Adverse Event|0
368703|NCT00962585|1242878|P3|Overall Study|Adverse Event|1
368704|NCT00962585|1242879|P2|Overall Study|Adverse Event|2
368705|NCT00962585|1242880|P1|Overall Study|Adverse Event|0
368706|NCT00962390|1242942|P4|Overall Study|Withdrawal by Subject|0
368707|NCT00962390|1242943|P3|Overall Study|Withdrawal by Subject|1
368708|NCT00962390|1242944|P2|Overall Study|Withdrawal by Subject|1
368709|NCT00962390|1242945|P1|Overall Study|Withdrawal by Subject|1
368710|NCT00962390|1242942|P4|Overall Study|Protocol Violation|0
368711|NCT00962390|1242943|P3|Overall Study|Protocol Violation|0
368712|NCT00962390|1242944|P2|Overall Study|Protocol Violation|0
368713|NCT00962390|1242945|P1|Overall Study|Protocol Violation|1
368714|NCT00962390|1242942|P4|Overall Study|Lost to Follow-up|0
368715|NCT00962390|1242943|P3|Overall Study|Lost to Follow-up|0
368716|NCT00962390|1242944|P2|Overall Study|Lost to Follow-up|2
368717|NCT00962390|1242945|P1|Overall Study|Lost to Follow-up|2
368718|NCT00962390|1242942|P4|Overall Study|Adverse Event|1
368719|NCT00962390|1242943|P3|Overall Study|Adverse Event|3
368720|NCT00962390|1242944|P2|Overall Study|Adverse Event|0
368721|NCT00962390|1242945|P1|Overall Study|Adverse Event|0
368722|NCT00962247|1243007|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
368723|NCT00962247|1243007|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
368724|NCT00962247|1243007|P1|Usual Sedentary|Withdrawal by Subject|5
368725|NCT00962247|1243007|P1|Usual Sedentary|Protocol Violation|13
368726|NCT00962208|1243018|P2|Overall Study|Lost to Follow-up|9
368727|NCT00962208|1243019|P1|Overall Study|Lost to Follow-up|0
368728|NCT00962208|1243018|P2|Overall Study|Contraindicated to continue study|1
368729|NCT00962208|1243019|P1|Overall Study|Contraindicated to continue study|5
368730|NCT00962208|1243018|P2|Overall Study|Could not achieve good vision|0
368731|NCT00962208|1243019|P1|Overall Study|Could not achieve good vision|9
368732|NCT00962104|1243027|P2|Overall Study|Other|0
368733|NCT00962104|1243028|P1|Overall Study|Other|2
368734|NCT00962104|1243027|P2|Overall Study|Withdrawal by Subject|6
368735|NCT00962104|1243028|P1|Overall Study|Withdrawal by Subject|10
368736|NCT00962104|1243027|P2|Overall Study|Sponsor Decision|1
368737|NCT00962104|1243028|P1|Overall Study|Sponsor Decision|0
368738|NCT00962104|1243027|P2|Overall Study|Protocol Violation|8
368739|NCT00962104|1243028|P1|Overall Study|Protocol Violation|6
368740|NCT00962104|1243027|P2|Overall Study|Physician Decision|0
368741|NCT00962104|1243028|P1|Overall Study|Physician Decision|1
368742|NCT00962104|1243027|P2|Overall Study|Lost to Follow-up|4
368743|NCT00962104|1243028|P1|Overall Study|Lost to Follow-up|10
368744|NCT00962104|1243027|P2|Overall Study|Lack of Efficacy|1
368745|NCT00962104|1243028|P1|Overall Study|Lack of Efficacy|0
368746|NCT00962104|1243027|P2|Overall Study|Entry Criteria Not Met|2
368747|NCT00962104|1243028|P1|Overall Study|Entry Criteria Not Met|1
368748|NCT00962104|1243027|P2|Overall Study|Adverse Event|3
368749|NCT00962104|1243028|P1|Overall Study|Adverse Event|10
368750|NCT00962013|1243082|P1|Overall Study|No 5 year evaluation|6
368751|NCT00962013|1243082|P1|Overall Study|Site Termination|24
368752|NCT00962013|1243082|P1|Overall Study|Removal of study device|3
368753|NCT00962013|1243082|P1|Overall Study|Withdrawal by Subject|8
368754|NCT00962013|1243082|P1|Overall Study|Unable/Unwilling to return|6
368755|NCT00962013|1243082|P1|Overall Study|Lost to Follow-up|12
368756|NCT00962013|1243082|P1|Overall Study|Death|8
368757|NCT00962013|1243082|P1|Overall Study|Did not have surgery|1
368758|NCT00961896|1243105|P3|Overall Study|Abnormal laboratory value|1
368759|NCT00961896|1243106|P2|Overall Study|Abnormal laboratory value|0
368760|NCT00961896|1243107|P1|Overall Study|Abnormal laboratory value|0
368761|NCT00961649|1243174|P4|Overall Study|Study terminated by sponsor|1
368762|NCT00961649|1243175|P3|Overall Study|Study terminated by sponsor|4
368763|NCT00961649|1243176|P2|Overall Study|Study terminated by sponsor|4
368764|NCT00961649|1243177|P1|Overall Study|Study terminated by sponsor|4
368765|NCT00961649|1243174|P4|Overall Study|Patient left to Mexico-family emergency|0
368766|NCT00961649|1243175|P3|Overall Study|Patient left to Mexico-family emergency|0
368767|NCT00961649|1243176|P2|Overall Study|Patient left to Mexico-family emergency|0
368768|NCT00961649|1243177|P1|Overall Study|Patient left to Mexico-family emergency|1
368769|NCT00961649|1243174|P4|Overall Study|Patient has travel plans during holidays|0
368770|NCT00961649|1243175|P3|Overall Study|Patient has travel plans during holidays|1
368771|NCT00961649|1243176|P2|Overall Study|Patient has travel plans during holidays|0
368772|NCT00961649|1243177|P1|Overall Study|Patient has travel plans during holidays|0
368773|NCT00961649|1243174|P4|Overall Study|Inadequate control of IOP|1
368774|NCT00961649|1243175|P3|Overall Study|Inadequate control of IOP|0
368775|NCT00961649|1243176|P2|Overall Study|Inadequate control of IOP|0
368776|NCT00961649|1243177|P1|Overall Study|Inadequate control of IOP|0
368777|NCT00961649|1243174|P4|Overall Study|Adverse Event|2
368778|NCT00961649|1243175|P3|Overall Study|Adverse Event|0
368779|NCT00961649|1243176|P2|Overall Study|Adverse Event|0
368780|NCT00961649|1243177|P1|Overall Study|Adverse Event|4
368781|NCT00961636|1243191|P3|Overall Study|Withdrawal by Subject|13
368782|NCT00961636|1243192|P2|Overall Study|Withdrawal by Subject|22
368783|NCT00961636|1243193|P1|Overall Study|Withdrawal by Subject|29
368784|NCT00961636|1243191|P3|Overall Study|Protocol Violation|1
368785|NCT00961636|1243192|P2|Overall Study|Protocol Violation|5
368786|NCT00961636|1243193|P1|Overall Study|Protocol Violation|9
368787|NCT00961636|1243191|P3|Overall Study|Physician Decision|1
368788|NCT00961636|1243192|P2|Overall Study|Physician Decision|1
368789|NCT00961636|1243193|P1|Overall Study|Physician Decision|3
368790|NCT00961636|1243191|P3|Overall Study|Lost to Follow-up|1
368791|NCT00961636|1243192|P2|Overall Study|Lost to Follow-up|3
368792|NCT00961636|1243193|P1|Overall Study|Lost to Follow-up|2
368793|NCT00961636|1243191|P3|Overall Study|Flushing Symptoms|3
368794|NCT00961636|1243192|P2|Overall Study|Flushing Symptoms|46
368795|NCT00961636|1243193|P1|Overall Study|Flushing Symptoms|29
368796|NCT00961636|1243191|P3|Overall Study|Adverse Event|13
368797|NCT00961636|1243192|P2|Overall Study|Adverse Event|54
368798|NCT00961636|1243193|P1|Overall Study|Adverse Event|35
368799|NCT00961571|1243204|P1|Overall Study|Physician Decision|39
368800|NCT00961415|1243232|P3|Maintenance Treatment Phase|Other reason|3
368801|NCT00961415|1243233|P2|Maintenance Treatment Phase|Other reason|1
368802|NCT00961415|1243234|P1|Maintenance Treatment Phase|Other reason|0
368803|NCT00961415|1243232|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
368804|NCT00961415|1243233|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
368805|NCT00961415|1243234|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
368806|NCT00961415|1243232|P3|Maintenance Treatment Phase|Investigators decision|0
368807|NCT00961415|1243233|P2|Maintenance Treatment Phase|Investigators decision|2
368808|NCT00961415|1243234|P1|Maintenance Treatment Phase|Investigators decision|0
368809|NCT00961415|1243232|P3|Maintenance Treatment Phase|Death|34
368810|NCT00961415|1243233|P2|Maintenance Treatment Phase|Death|42
368811|NCT00961415|1243234|P1|Maintenance Treatment Phase|Death|0
368812|NCT00961415|1243232|P3|Induction Treatment Phase|Other Reason|0
368813|NCT00961415|1243233|P2|Induction Treatment Phase|Other Reason|0
368814|NCT00961415|1243234|P1|Induction Treatment Phase|Other Reason|5
368815|NCT00961415|1243232|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
368816|NCT00961415|1243233|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
368817|NCT00961415|1243234|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
368818|NCT00961415|1243232|P3|Induction Treatment Phase|Physician Decision|0
368819|NCT00961415|1243233|P2|Induction Treatment Phase|Physician Decision|0
368820|NCT00961415|1243234|P1|Induction Treatment Phase|Physician Decision|2
368821|NCT00961415|1243232|P3|Induction Treatment Phase|Protocol Violation|0
368822|NCT00961415|1243233|P2|Induction Treatment Phase|Protocol Violation|0
368823|NCT00961415|1243234|P1|Induction Treatment Phase|Protocol Violation|1
368824|NCT00961415|1243232|P3|Induction Treatment Phase|Death|0
368825|NCT00961415|1243233|P2|Induction Treatment Phase|Death|0
368826|NCT00961415|1243234|P1|Induction Treatment Phase|Death|77
368827|NCT00961415|1243232|P3|Induction Treatment Phase|Withdrawal by Subject|0
368828|NCT00961415|1243233|P2|Induction Treatment Phase|Withdrawal by Subject|0
368829|NCT00961415|1243234|P1|Induction Treatment Phase|Withdrawal by Subject|11
368830|NCT00961350|1243274|P2|Overall Study|Misc|21
368831|NCT00961350|1243275|P1|Overall Study|Misc|16
368832|NCT00961350|1243274|P2|Overall Study|Lost to Follow-up|3
368833|NCT00961350|1243275|P1|Overall Study|Lost to Follow-up|3
368834|NCT00961350|1243274|P2|Overall Study|Withdrawal by Subject|10
368835|NCT00961350|1243275|P1|Overall Study|Withdrawal by Subject|10
368836|NCT00961350|1243274|P2|Overall Study|Adverse Event|33
368837|NCT00961350|1243275|P1|Overall Study|Adverse Event|18
368838|NCT00961298|1243296|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
368839|NCT00961298|1243296|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
368840|NCT00961298|1243296|P1|Two Week Placebo Run in|Withdrawal by Subject|1
368841|NCT00961259|1243303|P3|Washout Period of 7 Days|due to concomitant medication used|0
368842|NCT00961259|1243304|P2|Washout Period of 7 Days|due to concomitant medication used|1
368843|NCT00961259|1243305|P1|Washout Period of 7 Days|due to concomitant medication used|0
368844|NCT00961220|1243333|P1|Overall Study|Complete Response prior to 12 courses|1
368845|NCT00961220|1243333|P1|Overall Study|O6BG no longer supplied|1
368846|NCT00961220|1243333|P1|Overall Study|No IV access for O6BG|1
368847|NCT00961220|1243333|P1|Overall Study|Lack of Efficacy|1
368848|NCT00961220|1243333|P1|Overall Study|Adverse Event|3
368849|NCT00961181|1243349|P1|Overall Study|Lost to Follow-up|1
368850|NCT00961181|1243349|P1|Overall Study|Withdrawal by Subject|2
368851|NCT00961181|1243349|P1|Overall Study|Death|2
368852|NCT00961116|1243362|P2|Washout Period of 7 Days|Protocol Violation|1
368853|NCT00961116|1243363|P1|Washout Period of 7 Days|Protocol Violation|0
368854|NCT00961116|1243362|P2|Washout Period of 7 Days|Withdrawal by Subject|1
368855|NCT00961116|1243363|P1|Washout Period of 7 Days|Withdrawal by Subject|1
368856|NCT00961116|1243362|P2|Washout Period of 7 Days|Adverse Event|1
368857|NCT00961116|1243363|P1|Washout Period of 7 Days|Adverse Event|1
368858|NCT00960999|1243386|P2|Overall Study|RT dose constraints not met|0
368859|NCT00960999|1243387|P1|Overall Study|RT dose constraints not met|2
368860|NCT00960999|1243386|P2|Overall Study|Protocol Violation|2
368861|NCT00960999|1243387|P1|Overall Study|Protocol Violation|5
368862|NCT00960999|1243386|P2|Overall Study|Withdrawal by Subject|0
368863|NCT00960999|1243387|P1|Overall Study|Withdrawal by Subject|1
368864|NCT00960986|1243397|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
368865|NCT00960986|1243398|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
368866|NCT00960986|1243399|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
368867|NCT00960986|1243400|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
368868|NCT00960986|1243397|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
368869|NCT00960986|1243398|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
368870|NCT00960986|1243399|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
368871|NCT00960986|1243400|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
368872|NCT00960986|1243397|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
368873|NCT00960986|1243398|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
368874|NCT00960986|1243399|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
368875|NCT00960986|1243400|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
368876|NCT00960986|1243397|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
368877|NCT00960986|1243398|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
368878|NCT00960986|1243399|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
368879|NCT00960986|1243400|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
368880|NCT00960986|1243397|P4|Period 3 (7-week Therapy Period)|Death|0
368881|NCT00960986|1243398|P3|Period 3 (7-week Therapy Period)|Death|1
368882|NCT00960986|1243399|P2|Period 3 (7-week Therapy Period)|Death|0
368883|NCT00960986|1243400|P1|Period 3 (7-week Therapy Period)|Death|0
368884|NCT00960986|1243397|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
368885|NCT00960986|1243398|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
368886|NCT00960986|1243399|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
368887|NCT00960986|1243400|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
368888|NCT00960986|1243397|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
368889|NCT00960986|1243398|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
368890|NCT00960986|1243399|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
368891|NCT00960986|1243400|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
368892|NCT00960986|1243397|P4|Period 1 (Screening and Washout)|Protocol Violation|0
368893|NCT00960986|1243398|P3|Period 1 (Screening and Washout)|Protocol Violation|0
368894|NCT00960986|1243399|P2|Period 1 (Screening and Washout)|Protocol Violation|0
368895|NCT00960986|1243400|P1|Period 1 (Screening and Washout)|Protocol Violation|1
368896|NCT00960986|1243397|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
368897|NCT00960986|1243398|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
368898|NCT00960986|1243399|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
368899|NCT00960986|1243400|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
368900|NCT00960986|1243397|P4|Period 1 (Screening and Washout)|Adverse Event|1
368901|NCT00960986|1243398|P3|Period 1 (Screening and Washout)|Adverse Event|1
368902|NCT00960986|1243399|P2|Period 1 (Screening and Washout)|Adverse Event|2
368903|NCT00960986|1243400|P1|Period 1 (Screening and Washout)|Adverse Event|1
368904|NCT00960934|1243476|P6|Overall Study|Study Terminated by Sponsor|49
368905|NCT00960934|1243477|P5|Overall Study|Study Terminated by Sponsor|49
368906|NCT00960934|1243478|P4|Overall Study|Study Terminated by Sponsor|50
368907|NCT00960934|1243479|P3|Overall Study|Study Terminated by Sponsor|52
368908|NCT00960934|1243480|P2|Overall Study|Study Terminated by Sponsor|46
368909|NCT00960934|1243481|P1|Overall Study|Study Terminated by Sponsor|50
368910|NCT00960934|1243476|P6|Overall Study|Withdrawal by Subject|7
368911|NCT00960934|1243477|P5|Overall Study|Withdrawal by Subject|5
368912|NCT00960934|1243478|P4|Overall Study|Withdrawal by Subject|5
368913|NCT00960934|1243479|P3|Overall Study|Withdrawal by Subject|4
368914|NCT00960934|1243480|P2|Overall Study|Withdrawal by Subject|6
368915|NCT00960934|1243481|P1|Overall Study|Withdrawal by Subject|5
368916|NCT00960934|1243476|P6|Overall Study|Protocol Violation|2
368917|NCT00960934|1243477|P5|Overall Study|Protocol Violation|3
368918|NCT00960934|1243478|P4|Overall Study|Protocol Violation|3
368919|NCT00960934|1243479|P3|Overall Study|Protocol Violation|0
368920|NCT00960934|1243480|P2|Overall Study|Protocol Violation|4
368921|NCT00960934|1243481|P1|Overall Study|Protocol Violation|3
368922|NCT00960934|1243476|P6|Overall Study|Progressive Disease|1
368923|NCT00960934|1243477|P5|Overall Study|Progressive Disease|1
368924|NCT00960934|1243478|P4|Overall Study|Progressive Disease|0
368925|NCT00960934|1243479|P3|Overall Study|Progressive Disease|0
368926|NCT00960934|1243480|P2|Overall Study|Progressive Disease|1
368927|NCT00960934|1243481|P1|Overall Study|Progressive Disease|1
368928|NCT00960934|1243476|P6|Overall Study|Physician Decision|0
368929|NCT00960934|1243477|P5|Overall Study|Physician Decision|0
368930|NCT00960934|1243478|P4|Overall Study|Physician Decision|0
368931|NCT00960934|1243479|P3|Overall Study|Physician Decision|0
368932|NCT00960934|1243480|P2|Overall Study|Physician Decision|1
368933|NCT00960934|1243481|P1|Overall Study|Physician Decision|0
368934|NCT00960934|1243476|P6|Overall Study|Not Specified|2
368935|NCT00960934|1243477|P5|Overall Study|Not Specified|2
368936|NCT00960934|1243478|P4|Overall Study|Not Specified|4
368937|NCT00960934|1243479|P3|Overall Study|Not Specified|5
368938|NCT00960934|1243480|P2|Overall Study|Not Specified|1
368939|NCT00960934|1243481|P1|Overall Study|Not Specified|2
368940|NCT00960934|1243476|P6|Overall Study|Lost to Follow-up|0
368941|NCT00960934|1243477|P5|Overall Study|Lost to Follow-up|0
368942|NCT00960934|1243478|P4|Overall Study|Lost to Follow-up|0
368943|NCT00960934|1243479|P3|Overall Study|Lost to Follow-up|0
368944|NCT00960934|1243480|P2|Overall Study|Lost to Follow-up|1
368945|NCT00960934|1243481|P1|Overall Study|Lost to Follow-up|0
368946|NCT00960934|1243476|P6|Overall Study|Lack of Efficacy|0
368947|NCT00960934|1243477|P5|Overall Study|Lack of Efficacy|0
368948|NCT00960934|1243478|P4|Overall Study|Lack of Efficacy|0
368949|NCT00960934|1243479|P3|Overall Study|Lack of Efficacy|0
368950|NCT00960934|1243480|P2|Overall Study|Lack of Efficacy|0
368951|NCT00960934|1243481|P1|Overall Study|Lack of Efficacy|1
368952|NCT00960934|1243476|P6|Overall Study|Adverse Event|3
368953|NCT00960934|1243477|P5|Overall Study|Adverse Event|4
368954|NCT00960934|1243478|P4|Overall Study|Adverse Event|2
368955|NCT00960934|1243479|P3|Overall Study|Adverse Event|3
368956|NCT00960934|1243480|P2|Overall Study|Adverse Event|3
368957|NCT00960934|1243481|P1|Overall Study|Adverse Event|2
368958|NCT00960869|1243593|P2|Overall Study|Misc|18
368959|NCT00960869|1243594|P1|Overall Study|Misc|19
368960|NCT00960869|1243593|P2|Overall Study|Lost to Follow-up|4
368961|NCT00960869|1243594|P1|Overall Study|Lost to Follow-up|1
368962|NCT00960869|1243593|P2|Overall Study|Withdrawal by Subject|14
368963|NCT00960869|1243594|P1|Overall Study|Withdrawal by Subject|16
368964|NCT00960869|1243593|P2|Overall Study|Adverse Event|26
368965|NCT00960869|1243594|P1|Overall Study|Adverse Event|17
368966|NCT00960856|1243608|P4|Washout Period of 7 Days|Adverse Event|0
368967|NCT00960856|1243609|P3|Washout Period of 7 Days|Adverse Event|1
368968|NCT00960856|1243610|P2|Washout Period of 7 Days|Adverse Event|0
368969|NCT00960856|1243611|P1|Washout Period of 7 Days|Adverse Event|0
368970|NCT00960856|1243608|P4|Washout Period of 7 Days|Withdrawal by Subject|0
368971|NCT00960856|1243609|P3|Washout Period of 7 Days|Withdrawal by Subject|0
368972|NCT00960856|1243610|P2|Washout Period of 7 Days|Withdrawal by Subject|2
368973|NCT00960856|1243611|P1|Washout Period of 7 Days|Withdrawal by Subject|0
368974|NCT00960843|1243631|P2|Overall Study|Repeated needle dislodgment|1
368975|NCT00960843|1243632|P1|Overall Study|Repeated needle dislodgment|0
368976|NCT00960843|1243631|P2|Overall Study|Protocol Violation|4
368977|NCT00960843|1243632|P1|Overall Study|Protocol Violation|0
368978|NCT00960843|1243631|P2|Overall Study|Lost to Follow-up|0
368979|NCT00960843|1243632|P1|Overall Study|Lost to Follow-up|2
368980|NCT00960687|1243642|P2|Washout Period of 7 Days|Withdrawal by Subject|1
368981|NCT00960687|1243643|P1|Washout Period of 7 Days|Withdrawal by Subject|1
368982|NCT00960687|1243642|P2|Washout Period of 7 Days|Adverse Event|2
368983|NCT00960687|1243643|P1|Washout Period of 7 Days|Adverse Event|3
368984|NCT00960661|1243655|P3|Interventional Phase|Lack of Efficacy|0
368985|NCT00960661|1243656|P2|Interventional Phase|Lack of Efficacy|2
368986|NCT00960661|1243657|P1|Interventional Phase|Lack of Efficacy|0
368987|NCT00960661|1243655|P3|Interventional Phase|sponsor decision|0
368988|NCT00960661|1243656|P2|Interventional Phase|sponsor decision|1
368989|NCT00960661|1243657|P1|Interventional Phase|sponsor decision|0
368990|NCT00960661|1243655|P3|Interventional Phase|Physician Decision|5
368991|NCT00960661|1243656|P2|Interventional Phase|Physician Decision|3
368992|NCT00960661|1243657|P1|Interventional Phase|Physician Decision|0
368993|NCT00960661|1243655|P3|Interventional Phase|Withdrawal by Subject|29
368994|NCT00960661|1243656|P2|Interventional Phase|Withdrawal by Subject|18
368995|NCT00960661|1243657|P1|Interventional Phase|Withdrawal by Subject|0
368996|NCT00960661|1243655|P3|Interventional Phase|Protocol Violation|2
368997|NCT00960661|1243656|P2|Interventional Phase|Protocol Violation|7
368998|NCT00960661|1243657|P1|Interventional Phase|Protocol Violation|0
368999|NCT00960661|1243655|P3|Interventional Phase|entry criteria not met|0
369000|NCT00960661|1243656|P2|Interventional Phase|entry criteria not met|3
369001|NCT00960661|1243657|P1|Interventional Phase|entry criteria not met|0
369002|NCT00960661|1243655|P3|Interventional Phase|Lost to Follow-up|2
369003|NCT00960661|1243656|P2|Interventional Phase|Lost to Follow-up|0
369004|NCT00960661|1243657|P1|Interventional Phase|Lost to Follow-up|0
369005|NCT00960661|1243655|P3|Interventional Phase|Death|0
369006|NCT00960661|1243656|P2|Interventional Phase|Death|1
369007|NCT00960661|1243657|P1|Interventional Phase|Death|0
369008|NCT00960661|1243655|P3|Interventional Phase|Adverse Event|8
369009|NCT00960661|1243656|P2|Interventional Phase|Adverse Event|17
369010|NCT00960661|1243657|P1|Interventional Phase|Adverse Event|0
369011|NCT00960661|1243655|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
369012|NCT00960661|1243656|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
369013|NCT00960661|1243657|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
369014|NCT00960661|1243655|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
369015|NCT00960661|1243656|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
369016|NCT00960661|1243657|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
369017|NCT00960661|1243655|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
369018|NCT00960661|1243656|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
369019|NCT00960661|1243657|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
369020|NCT00960661|1243655|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
369021|NCT00960661|1243656|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
369022|NCT00960661|1243657|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
369023|NCT00960661|1243655|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
369024|NCT00960661|1243656|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
369025|NCT00960661|1243657|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
369026|NCT00960661|1243655|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
369027|NCT00960661|1243656|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
369028|NCT00960661|1243657|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
369029|NCT00960570|1243696|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
369030|NCT00960570|1243696|P1|1 Day Period Between Dosing|Adverse Event|2
369031|NCT00960570|1243696|P1|21 Day Washout Period|Withdrawal by Subject|1
369032|NCT00960570|1243696|P1|21 Day Washout Period|Adverse Event|1
369033|NCT00960531|1243717|P10|Overall Study|Reason not Specified|1
369034|NCT00960531|1243718|P9|Overall Study|Reason not Specified|8
369035|NCT00960531|1243719|P8|Overall Study|Reason not Specified|0
369036|NCT00960531|1243720|P7|Overall Study|Reason not Specified|16
369037|NCT00960531|1243721|P6|Overall Study|Reason not Specified|0
369038|NCT00960531|1243722|P5|Overall Study|Reason not Specified|2
369039|NCT00960531|1243723|P4|Overall Study|Reason not Specified|1
369040|NCT00960531|1243724|P3|Overall Study|Reason not Specified|13
369041|NCT00960531|1243725|P2|Overall Study|Reason not Specified|1
369042|NCT00960531|1243726|P1|Overall Study|Reason not Specified|2
369043|NCT00960531|1243717|P10|Overall Study|Adverse Event (AE)|0
369044|NCT00960531|1243718|P9|Overall Study|Adverse Event (AE)|2
369045|NCT00960531|1243719|P8|Overall Study|Adverse Event (AE)|0
369046|NCT00960531|1243720|P7|Overall Study|Adverse Event (AE)|2
369047|NCT00960531|1243721|P6|Overall Study|Adverse Event (AE)|1
369048|NCT00960531|1243722|P5|Overall Study|Adverse Event (AE)|0
369049|NCT00960531|1243723|P4|Overall Study|Adverse Event (AE)|0
369050|NCT00960531|1243724|P3|Overall Study|Adverse Event (AE)|0
369051|NCT00960531|1243725|P2|Overall Study|Adverse Event (AE)|0
369052|NCT00960531|1243726|P1|Overall Study|Adverse Event (AE)|2
369053|NCT00960531|1243717|P10|Overall Study|Failed to Return|0
369054|NCT00960531|1243718|P9|Overall Study|Failed to Return|0
369055|NCT00960531|1243719|P8|Overall Study|Failed to Return|2
369056|NCT00960531|1243720|P7|Overall Study|Failed to Return|0
369057|NCT00960531|1243721|P6|Overall Study|Failed to Return|0
369058|NCT00960531|1243722|P5|Overall Study|Failed to Return|0
369059|NCT00960531|1243723|P4|Overall Study|Failed to Return|0
369060|NCT00960531|1243724|P3|Overall Study|Failed to Return|0
369061|NCT00960531|1243725|P2|Overall Study|Failed to Return|0
369062|NCT00960531|1243726|P1|Overall Study|Failed to Return|2
369063|NCT00960531|1243717|P10|Overall Study|Lost to Follow-up|0
369064|NCT00960531|1243718|P9|Overall Study|Lost to Follow-up|0
369065|NCT00960531|1243719|P8|Overall Study|Lost to Follow-up|0
369066|NCT00960531|1243720|P7|Overall Study|Lost to Follow-up|1
369067|NCT00960531|1243721|P6|Overall Study|Lost to Follow-up|0
369068|NCT00960531|1243722|P5|Overall Study|Lost to Follow-up|0
369069|NCT00960531|1243723|P4|Overall Study|Lost to Follow-up|0
369070|NCT00960531|1243724|P3|Overall Study|Lost to Follow-up|1
369071|NCT00960531|1243725|P2|Overall Study|Lost to Follow-up|0
369072|NCT00960531|1243726|P1|Overall Study|Lost to Follow-up|0
369073|NCT00960531|1243717|P10|Overall Study|Discontinuation of Study by Sponsor|0
369074|NCT00960531|1243718|P9|Overall Study|Discontinuation of Study by Sponsor|0
369075|NCT00960531|1243719|P8|Overall Study|Discontinuation of Study by Sponsor|1
369076|NCT00960531|1243720|P7|Overall Study|Discontinuation of Study by Sponsor|0
369077|NCT00960531|1243721|P6|Overall Study|Discontinuation of Study by Sponsor|0
369078|NCT00960531|1243722|P5|Overall Study|Discontinuation of Study by Sponsor|0
369079|NCT00960531|1243723|P4|Overall Study|Discontinuation of Study by Sponsor|0
369080|NCT00960531|1243724|P3|Overall Study|Discontinuation of Study by Sponsor|0
369081|NCT00960531|1243725|P2|Overall Study|Discontinuation of Study by Sponsor|0
369082|NCT00960531|1243726|P1|Overall Study|Discontinuation of Study by Sponsor|0
369083|NCT00960531|1243717|P10|Overall Study|Investigator Request|0
369084|NCT00960531|1243718|P9|Overall Study|Investigator Request|0
369085|NCT00960531|1243719|P8|Overall Study|Investigator Request|0
369086|NCT00960531|1243720|P7|Overall Study|Investigator Request|0
369087|NCT00960531|1243721|P6|Overall Study|Investigator Request|0
369088|NCT00960531|1243722|P5|Overall Study|Investigator Request|0
369089|NCT00960531|1243723|P4|Overall Study|Investigator Request|0
369090|NCT00960531|1243724|P3|Overall Study|Investigator Request|1
369091|NCT00960531|1243725|P2|Overall Study|Investigator Request|0
369092|NCT00960531|1243726|P1|Overall Study|Investigator Request|0
369093|NCT00960531|1243717|P10|Overall Study|Caregiver Request|0
369094|NCT00960531|1243718|P9|Overall Study|Caregiver Request|3
369095|NCT00960531|1243719|P8|Overall Study|Caregiver Request|1
369096|NCT00960531|1243720|P7|Overall Study|Caregiver Request|3
369097|NCT00960531|1243721|P6|Overall Study|Caregiver Request|2
369098|NCT00960531|1243722|P5|Overall Study|Caregiver Request|0
369099|NCT00960531|1243723|P4|Overall Study|Caregiver Request|5
369100|NCT00960531|1243724|P3|Overall Study|Caregiver Request|6
369101|NCT00960531|1243725|P2|Overall Study|Caregiver Request|0
369102|NCT00960531|1243726|P1|Overall Study|Caregiver Request|2
369103|NCT00960531|1243717|P10|Overall Study|Withdrawal by Subject|0
369104|NCT00960531|1243718|P9|Overall Study|Withdrawal by Subject|1
369105|NCT00960531|1243719|P8|Overall Study|Withdrawal by Subject|0
369106|NCT00960531|1243720|P7|Overall Study|Withdrawal by Subject|2
369107|NCT00960531|1243721|P6|Overall Study|Withdrawal by Subject|0
369108|NCT00960531|1243722|P5|Overall Study|Withdrawal by Subject|0
369109|NCT00960531|1243723|P4|Overall Study|Withdrawal by Subject|2
369110|NCT00960531|1243724|P3|Overall Study|Withdrawal by Subject|5
369111|NCT00960531|1243725|P2|Overall Study|Withdrawal by Subject|0
369112|NCT00960531|1243726|P1|Overall Study|Withdrawal by Subject|1
369113|NCT00960531|1243717|P10|Overall Study|Lack of Efficacy|0
369114|NCT00960531|1243718|P9|Overall Study|Lack of Efficacy|0
369115|NCT00960531|1243719|P8|Overall Study|Lack of Efficacy|0
369116|NCT00960531|1243720|P7|Overall Study|Lack of Efficacy|0
369117|NCT00960531|1243721|P6|Overall Study|Lack of Efficacy|0
369118|NCT00960531|1243722|P5|Overall Study|Lack of Efficacy|0
369119|NCT00960531|1243723|P4|Overall Study|Lack of Efficacy|0
369120|NCT00960531|1243724|P3|Overall Study|Lack of Efficacy|0
369121|NCT00960531|1243725|P2|Overall Study|Lack of Efficacy|0
369122|NCT00960531|1243726|P1|Overall Study|Lack of Efficacy|1
369123|NCT00960440|1243774|P4|Overall Study|Other|0
369124|NCT00960440|1243775|P3|Overall Study|Other|1
369125|NCT00960440|1243776|P2|Overall Study|Other|1
369126|NCT00960440|1243777|P1|Overall Study|Other|1
369127|NCT00960440|1243774|P4|Overall Study|Withdrawal by Subject|1
369128|NCT00960440|1243775|P3|Overall Study|Withdrawal by Subject|2
369129|NCT00960440|1243776|P2|Overall Study|Withdrawal by Subject|5
369130|NCT00960440|1243777|P1|Overall Study|Withdrawal by Subject|9
369131|NCT00960440|1243774|P4|Overall Study|Protocol Violation|4
369132|NCT00960440|1243775|P3|Overall Study|Protocol Violation|3
369133|NCT00960440|1243776|P2|Overall Study|Protocol Violation|8
369134|NCT00960440|1243777|P1|Overall Study|Protocol Violation|2
369135|NCT00960440|1243774|P4|Overall Study|Lack of Efficacy|8
369136|NCT00960440|1243775|P3|Overall Study|Lack of Efficacy|3
369137|NCT00960440|1243776|P2|Overall Study|Lack of Efficacy|5
369138|NCT00960440|1243777|P1|Overall Study|Lack of Efficacy|2
369139|NCT00960440|1243774|P4|Overall Study|Adverse Event|4
369140|NCT00960440|1243775|P3|Overall Study|Adverse Event|4
369141|NCT00960440|1243776|P2|Overall Study|Adverse Event|12
369142|NCT00960440|1243777|P1|Overall Study|Adverse Event|12
369143|NCT00960440|1243774|P4|Overall Study|Death|1
369144|NCT00960440|1243775|P3|Overall Study|Death|0
369145|NCT00960440|1243776|P2|Overall Study|Death|0
369146|NCT00960440|1243777|P1|Overall Study|Death|0
369147|NCT00960375|1243949|P2|Overall Study|Lost to Follow-up|22
369148|NCT00960375|1243950|P1|Overall Study|Lost to Follow-up|20
369149|NCT00960323|1243958|P1|Atorvastatin Alone|Withdrawal by Subject|1
369150|NCT00960297|1243969|P1|Overall Study|Disease progression|1
369151|NCT00960297|1243969|P1|Overall Study|Venous port infection|1
369152|NCT00960297|1243969|P1|Overall Study|Physician Decision|1
369153|NCT00960206|1243976|P3|Overall Study|Missing 10 year data|1
369154|NCT00960206|1243977|P2|Overall Study|Missing 10 year data|1
369155|NCT00960206|1243978|P1|Overall Study|Missing 10 year data|20
369156|NCT00960206|1243976|P3|Overall Study|Revision of study component|2
369157|NCT00960206|1243977|P2|Overall Study|Revision of study component|2
369158|NCT00960206|1243978|P1|Overall Study|Revision of study component|2
369159|NCT00960206|1243976|P3|Overall Study|Withdrawal by Subject|0
369160|NCT00960206|1243977|P2|Overall Study|Withdrawal by Subject|4
369161|NCT00960206|1243978|P1|Overall Study|Withdrawal by Subject|2
369162|NCT00960206|1243976|P3|Overall Study|Lost to Follow-up|8
369163|NCT00960206|1243977|P2|Overall Study|Lost to Follow-up|14
369164|NCT00960206|1243978|P1|Overall Study|Lost to Follow-up|8
369165|NCT00960206|1243976|P3|Overall Study|Unwilling/Unable to return|0
369166|NCT00960206|1243977|P2|Overall Study|Unwilling/Unable to return|2
369167|NCT00960206|1243978|P1|Overall Study|Unwilling/Unable to return|1
369168|NCT00960206|1243976|P3|Overall Study|Death|1
369169|NCT00960206|1243977|P2|Overall Study|Death|4
369170|NCT00960206|1243978|P1|Overall Study|Death|7
369171|NCT00960193|1243996|P1|14 Day Washout Period|Withdrawal by Subject|1
369172|NCT00960154|1244009|P2|Overall Study|Study termination|25
369173|NCT00960154|1244010|P1|Overall Study|Study termination|25
369174|NCT00960141|1244021|P3|Overall Study|Withdrawal by Subject|1
369175|NCT00960141|1244022|P2|Overall Study|Withdrawal by Subject|2
369176|NCT00960141|1244023|P1|Overall Study|Withdrawal by Subject|1
369177|NCT00960141|1244021|P3|Overall Study|Protocol Violation|2
369178|NCT00960141|1244022|P2|Overall Study|Protocol Violation|3
369179|NCT00960141|1244023|P1|Overall Study|Protocol Violation|1
369180|NCT00960141|1244021|P3|Overall Study|Lost to Follow-up|0
369181|NCT00960141|1244022|P2|Overall Study|Lost to Follow-up|0
369182|NCT00960141|1244023|P1|Overall Study|Lost to Follow-up|1
369183|NCT00960141|1244021|P3|Overall Study|Lack of Efficacy|2
369184|NCT00960141|1244022|P2|Overall Study|Lack of Efficacy|4
369185|NCT00960141|1244023|P1|Overall Study|Lack of Efficacy|3
369186|NCT00960141|1244021|P3|Overall Study|Adverse Event|2
369187|NCT00960141|1244022|P2|Overall Study|Adverse Event|8
369188|NCT00960141|1244023|P1|Overall Study|Adverse Event|4
369189|NCT00960115|1244048|P2|Overall Study|Ongoing treatment at data cut-off date|15
369190|NCT00960115|1244049|P1|Overall Study|Ongoing treatment at data cut-off date|19
369191|NCT00960076|1244063|P2|Overall Study|Did not attend the termination visit|1
369192|NCT00960076|1244064|P1|Overall Study|Did not attend the termination visit|0
369193|NCT00960076|1244063|P2|Overall Study|Hyperglycemia|5
369194|NCT00960076|1244064|P1|Overall Study|Hyperglycemia|1
369195|NCT00960076|1244063|P2|Overall Study|Severe non-compliance to protocol|2
369196|NCT00960076|1244064|P1|Overall Study|Severe non-compliance to protocol|1
369197|NCT00960076|1244063|P2|Overall Study|Lost to Follow-up|3
369198|NCT00960076|1244064|P1|Overall Study|Lost to Follow-up|3
369199|NCT00960076|1244063|P2|Overall Study|Withdrawal by Subject|2
369200|NCT00960076|1244064|P1|Overall Study|Withdrawal by Subject|1
369201|NCT00960076|1244063|P2|Overall Study|No longer met study criteria|5
369202|NCT00960076|1244064|P1|Overall Study|No longer met study criteria|1
369203|NCT00960076|1244063|P2|Overall Study|Adverse Event|7
369204|NCT00960076|1244064|P1|Overall Study|Adverse Event|1
369205|NCT00960063|1244079|P3|Overall Study|Progression of Disease|3
369206|NCT00960063|1244080|P2|Overall Study|Progression of Disease|0
369207|NCT00960063|1244081|P1|Overall Study|Progression of Disease|0
369208|NCT00960063|1244079|P3|Overall Study|Adverse Event|0
369209|NCT00960063|1244080|P2|Overall Study|Adverse Event|0
369210|NCT00960063|1244081|P1|Overall Study|Adverse Event|1
369211|NCT00959946|1244172|P8|Overall Study|Withdrawal by Subject|0
369212|NCT00959946|1244173|P7|Overall Study|Withdrawal by Subject|0
369213|NCT00959946|1244174|P6|Overall Study|Withdrawal by Subject|1
369214|NCT00959946|1244175|P5|Overall Study|Withdrawal by Subject|0
369215|NCT00959946|1244176|P4|Overall Study|Withdrawal by Subject|0
369216|NCT00959946|1244177|P3|Overall Study|Withdrawal by Subject|0
369217|NCT00959946|1244178|P2|Overall Study|Withdrawal by Subject|0
369218|NCT00959946|1244179|P1|Overall Study|Withdrawal by Subject|0
369219|NCT00959946|1244172|P8|Overall Study|Disease Progression|2
369220|NCT00959946|1244173|P7|Overall Study|Disease Progression|2
369221|NCT00959946|1244174|P6|Overall Study|Disease Progression|6
369222|NCT00959946|1244175|P5|Overall Study|Disease Progression|4
369223|NCT00959946|1244176|P4|Overall Study|Disease Progression|4
369224|NCT00959946|1244177|P3|Overall Study|Disease Progression|2
369225|NCT00959946|1244178|P2|Overall Study|Disease Progression|4
369226|NCT00959946|1244179|P1|Overall Study|Disease Progression|2
369227|NCT00959946|1244172|P8|Overall Study|Death|0
369228|NCT00959946|1244173|P7|Overall Study|Death|0
369229|NCT00959946|1244174|P6|Overall Study|Death|1
369230|NCT00959946|1244175|P5|Overall Study|Death|0
369231|NCT00959946|1244176|P4|Overall Study|Death|0
369232|NCT00959946|1244177|P3|Overall Study|Death|0
369233|NCT00959946|1244178|P2|Overall Study|Death|0
369234|NCT00959946|1244179|P1|Overall Study|Death|0
369235|NCT00959946|1244172|P8|Overall Study|Adverse Event|0
369236|NCT00959946|1244173|P7|Overall Study|Adverse Event|0
369237|NCT00959946|1244174|P6|Overall Study|Adverse Event|1
369238|NCT00959946|1244175|P5|Overall Study|Adverse Event|0
369239|NCT00959946|1244176|P4|Overall Study|Adverse Event|1
369240|NCT00959946|1244177|P3|Overall Study|Adverse Event|2
369241|NCT00959946|1244178|P2|Overall Study|Adverse Event|0
369242|NCT00959946|1244179|P1|Overall Study|Adverse Event|0
369243|NCT00959907|1244243|P2|Overall Study|Withdrawal by Subject|0
369244|NCT00959907|1244244|P1|Overall Study|Withdrawal by Subject|2
369245|NCT00959907|1244243|P2|Overall Study|Adverse Event|0
369246|NCT00959907|1244244|P1|Overall Study|Adverse Event|1
369247|NCT00959907|1244243|P2|Overall Study|Protocol Violation|1
369248|NCT00959907|1244244|P1|Overall Study|Protocol Violation|0
369249|NCT00959894|1244254|P1|Overall Study|Subject moved out of town|1
369250|NCT00959894|1244254|P1|Overall Study|Need for contraindicated medication|1
369251|NCT00959894|1244254|P1|Overall Study|Withdrawal by Subject|1
369252|NCT00959894|1244254|P1|Overall Study|Adverse Event|3
369253|NCT00959894|1244254|P1|Overall Study|Lost to Follow-up|10
369254|NCT00959751|1244303|P2|Overall Study|No migraine headache without aura|7
369255|NCT00959751|1244304|P1|Overall Study|No migraine headache without aura|7
369256|NCT00959751|1244303|P2|Overall Study|Non-compliance to Study Procedures|1
369257|NCT00959751|1244304|P1|Overall Study|Non-compliance to Study Procedures|0
369258|NCT00959751|1244303|P2|Overall Study|Consent Withdrawn|1
369259|NCT00959751|1244304|P1|Overall Study|Consent Withdrawn|0
369260|NCT00959751|1244303|P2|Overall Study|Lost to Follow-up|3
369261|NCT00959751|1244304|P1|Overall Study|Lost to Follow-up|2
369262|NCT00959699|1244326|P2|Follow-up Period|Withdrawal by Subject|4
369263|NCT00959699|1244327|P1|Follow-up Period|Withdrawal by Subject|3
369264|NCT00959699|1244326|P2|Follow-up Period|Lost to Follow-up|2
369265|NCT00959699|1244327|P1|Follow-up Period|Lost to Follow-up|3
369266|NCT00959699|1244326|P2|Treatment Period|Futility/crossover to boceprevir|0
369267|NCT00959699|1244327|P1|Treatment Period|Futility/crossover to boceprevir|4
369268|NCT00959699|1244326|P2|Treatment Period|Did not receive treatment|1
369269|NCT00959699|1244327|P1|Treatment Period|Did not receive treatment|0
369270|NCT00959699|1244326|P2|Treatment Period|Non-Compliance with Protocol|1
369271|NCT00959699|1244327|P1|Treatment Period|Non-Compliance with Protocol|0
369272|NCT00959699|1244326|P2|Treatment Period|Withdrawal by Subject|3
369273|NCT00959699|1244327|P1|Treatment Period|Withdrawal by Subject|1
369274|NCT00959699|1244326|P2|Treatment Period|Lost to Follow-up|1
369275|NCT00959699|1244327|P1|Treatment Period|Lost to Follow-up|0
369276|NCT00959699|1244326|P2|Treatment Period|Lack of Efficacy|6
369277|NCT00959699|1244327|P1|Treatment Period|Lack of Efficacy|15
369278|NCT00959699|1244326|P2|Treatment Period|Adverse Event|13
369279|NCT00959699|1244327|P1|Treatment Period|Adverse Event|3
369280|NCT00959647|1244373|P1|Overall Study|Withdrawal by Subject|7
369281|NCT00959647|1244373|P1|Overall Study|Study terminated by sponsor|4
369282|NCT00959647|1244373|P1|Overall Study|Progressive disease|6
369283|NCT00959647|1244373|P1|Overall Study|Adverse Event|2
369284|NCT00959374|1244378|P1|Overall Study|Physician Decision|1
369285|NCT00959374|1244378|P1|Overall Study|Implant Removed/Not Replaced|4
369286|NCT00959374|1244378|P1|Overall Study|Protocol Violation|1
369287|NCT00959374|1244378|P1|Overall Study|Death|1
369288|NCT00959374|1244378|P1|Overall Study|Lost to Follow-up|14
369289|NCT00959374|1244378|P1|Overall Study|Withdrawal by Subject|2
369290|NCT00959192|1244392|P4|Overall Study|Caregiver Request|1
369291|NCT00959192|1244393|P3|Overall Study|Caregiver Request|2
369292|NCT00959192|1244394|P2|Overall Study|Caregiver Request|0
369293|NCT00959192|1244395|P1|Overall Study|Caregiver Request|0
369294|NCT00959192|1244392|P4|Overall Study|Investigator Request|0
369295|NCT00959192|1244393|P3|Overall Study|Investigator Request|0
369296|NCT00959192|1244394|P2|Overall Study|Investigator Request|0
369297|NCT00959192|1244395|P1|Overall Study|Investigator Request|1
369298|NCT00959192|1244392|P4|Overall Study|Adverse Event|0
369299|NCT00959192|1244393|P3|Overall Study|Adverse Event|1
369300|NCT00959192|1244394|P2|Overall Study|Adverse Event|1
369301|NCT00959192|1244395|P1|Overall Study|Adverse Event|1
369302|NCT00959049|1244443|P6|Overall Study|Withdrawal by Subject|0
369303|NCT00959049|1244444|P5|Overall Study|Withdrawal by Subject|0
369304|NCT00959049|1244445|P4|Overall Study|Withdrawal by Subject|0
369305|NCT00959049|1244446|P3|Overall Study|Withdrawal by Subject|0
369306|NCT00959049|1244447|P2|Overall Study|Withdrawal by Subject|2
369307|NCT00959049|1244448|P1|Overall Study|Withdrawal by Subject|0
369308|NCT00959049|1244443|P6|Overall Study|Contraindicated medication|0
369309|NCT00959049|1244444|P5|Overall Study|Contraindicated medication|0
369310|NCT00959049|1244445|P4|Overall Study|Contraindicated medication|1
369311|NCT00959049|1244446|P3|Overall Study|Contraindicated medication|0
369312|NCT00959049|1244447|P2|Overall Study|Contraindicated medication|0
369313|NCT00959049|1244448|P1|Overall Study|Contraindicated medication|0
369314|NCT00959049|1244443|P6|Overall Study|Lost to Follow-up|1
369315|NCT00959049|1244444|P5|Overall Study|Lost to Follow-up|9
369316|NCT00959049|1244445|P4|Overall Study|Lost to Follow-up|10
369317|NCT00959049|1244446|P3|Overall Study|Lost to Follow-up|1
369318|NCT00959049|1244447|P2|Overall Study|Lost to Follow-up|5
369319|NCT00959049|1244448|P1|Overall Study|Lost to Follow-up|17
369320|NCT00959049|1244443|P6|Overall Study|Adverse Event|0
369321|NCT00959049|1244444|P5|Overall Study|Adverse Event|0
369322|NCT00959049|1244445|P4|Overall Study|Adverse Event|0
369323|NCT00959049|1244446|P3|Overall Study|Adverse Event|0
369324|NCT00959049|1244447|P2|Overall Study|Adverse Event|0
369325|NCT00959049|1244448|P1|Overall Study|Adverse Event|1
369326|NCT00958893|1244513|P1|Overall Study|Study prematurely terminated|4
369327|NCT00958880|1244519|P2|Overall Study|Lost to Follow-up|2
369328|NCT00958880|1244520|P1|Overall Study|Lost to Follow-up|2
369329|NCT00958841|1244528|P1|Overall Study|Discontinued prior to M*|28
369330|NCT00958841|1244528|P1|Overall Study|Completed M6/did not enter extension|27
369331|NCT00958841|1244528|P1|Overall Study|Unsatisfactory therapeutic effect|22
369332|NCT00958841|1244528|P1|Overall Study|Withdrawal by Subject|1
369333|NCT00958841|1244528|P1|Overall Study|New cancer therapy|5
369334|NCT00958841|1244528|P1|Overall Study|Adverse Event|8
369335|NCT00958841|1244528|P1|Overall Study|Administrative problems|1
369336|NCT00958841|1244528|P1|Overall Study|Abnormal test procedure result(s)|3
369337|NCT00958841|1244528|P1|Overall Study|Abnormal laboratory value(s)|1
369338|NCT00958828|1244546|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
369339|NCT00958828|1244547|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
369340|NCT00958828|1244546|P2|Period 1, 1 Week of Wear|Randomization break|1
369341|NCT00958828|1244547|P1|Period 1, 1 Week of Wear|Randomization break|0
369342|NCT00958789|1244553|P1|Overall Study|Revision|7
369343|NCT00958789|1244553|P1|Overall Study|Subject terminated|3
369344|NCT00958789|1244553|P1|Overall Study|2 yr. Knee Society Score not calculable|2
369345|NCT00958789|1244553|P1|Overall Study|No 2 yr. Knee Society Score data|12
369346|NCT00958789|1244553|P1|Overall Study|Withdrawal by Subject|16
369347|NCT00958789|1244553|P1|Overall Study|Lost to Follow-up|7
369348|NCT00958789|1244553|P1|Overall Study|Death|3
369349|NCT00958776|1244560|P2|Overall Study|Missing|1
369350|NCT00958776|1244561|P1|Overall Study|Missing|1
369351|NCT00958776|1244560|P2|Overall Study|Noncompliance; Protocol Deviations|3
369352|NCT00958776|1244561|P1|Overall Study|Noncompliance; Protocol Deviations|2
369353|NCT00958776|1244560|P2|Overall Study|Death|1
369354|NCT00958776|1244561|P1|Overall Study|Death|2
369355|NCT00958776|1244560|P2|Overall Study|Protocol Violation|1
369356|NCT00958776|1244561|P1|Overall Study|Protocol Violation|1
369357|NCT00958776|1244560|P2|Overall Study|Withdrawal by Subject|16
369358|NCT00958776|1244561|P1|Overall Study|Withdrawal by Subject|7
369359|NCT00958776|1244560|P2|Overall Study|Lost to Follow-up|6
369360|NCT00958776|1244561|P1|Overall Study|Lost to Follow-up|2
369361|NCT00958776|1244560|P2|Overall Study|Physician Decision|0
369362|NCT00958776|1244561|P1|Overall Study|Physician Decision|1
369363|NCT00958776|1244560|P2|Overall Study|Adverse Event|1
369364|NCT00958776|1244561|P1|Overall Study|Adverse Event|0
369365|NCT00958724|1244591|P1|Overall Study|Disease Progression|6
369366|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
369367|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
369368|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
369369|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
369370|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
369371|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
369372|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
369373|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
369374|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
369375|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
369376|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
369377|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
369378|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
369379|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
369380|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
369381|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
369382|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
369383|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
369384|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
369385|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
369386|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
369387|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
369388|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
369389|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
369390|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
369391|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
369392|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
369393|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
369394|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
369395|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
369396|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
369397|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
369398|NCT00958568|1244620|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
369399|NCT00958568|1244621|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
369400|NCT00958568|1244622|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
369401|NCT00958568|1244623|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
369402|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
369403|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
369404|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
369405|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
369406|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
369407|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
369408|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
369409|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
369410|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
369411|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
369412|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
369413|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
369414|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
369415|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
369416|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
369417|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
369418|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
369419|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
369420|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
369421|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
369422|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
369423|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
369424|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
369425|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
369426|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
369427|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
369428|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
369429|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
369430|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
369431|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
369432|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
369433|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
369434|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
369435|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
369436|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
369437|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
369438|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
369439|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
369440|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
369441|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
369442|NCT00958568|1244620|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
369443|NCT00958568|1244621|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
369444|NCT00958568|1244622|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
369445|NCT00958568|1244623|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
369446|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
369447|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
369448|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
369449|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
369450|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
369451|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
369452|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
369453|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
369454|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
369455|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
369456|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
369457|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
369458|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
369459|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
369460|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
369461|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
369462|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
369463|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
369464|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
369465|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
369466|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
369467|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
369468|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
369469|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
369470|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
369471|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
369472|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
369473|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
369474|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
369475|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
369476|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
369477|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
369478|NCT00958568|1244620|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
369479|NCT00958568|1244621|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
369480|NCT00958568|1244622|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
369481|NCT00958568|1244623|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
369482|NCT00958438|1244860|P3|Overall Study|Other than specified above|2
369483|NCT00958438|1244861|P2|Overall Study|Other than specified above|3
369484|NCT00958438|1244862|P1|Overall Study|Other than specified above|2
369485|NCT00958438|1244860|P3|Overall Study|Physician Decision|1
369486|NCT00958438|1244861|P2|Overall Study|Physician Decision|0
369487|NCT00958438|1244862|P1|Overall Study|Physician Decision|1
369488|NCT00958438|1244860|P3|Overall Study|Adverse Event|0
369489|NCT00958438|1244861|P2|Overall Study|Adverse Event|3
369490|NCT00958438|1244862|P1|Overall Study|Adverse Event|0
369491|NCT00958438|1244860|P3|Overall Study|Withdrawal by Subject|1
369492|NCT00958438|1244861|P2|Overall Study|Withdrawal by Subject|2
369493|NCT00958438|1244862|P1|Overall Study|Withdrawal by Subject|4
369494|NCT00958438|1244860|P3|Overall Study|Protocol Violation|2
369495|NCT00958438|1244861|P2|Overall Study|Protocol Violation|2
369496|NCT00958438|1244862|P1|Overall Study|Protocol Violation|3
369497|NCT00958360|1244887|P2|Overall Study|Lost to Follow-up|1
369498|NCT00958360|1244888|P1|Overall Study|Lost to Follow-up|0
369499|NCT00958360|1244887|P2|Overall Study|Physician Decision|1
369500|NCT00958360|1244888|P1|Overall Study|Physician Decision|2
369501|NCT00958360|1244887|P2|Overall Study|Death|7
369502|NCT00958360|1244888|P1|Overall Study|Death|6
369503|NCT00958360|1244887|P2|Overall Study|Withdrawal by Subject|1
369504|NCT00958360|1244888|P1|Overall Study|Withdrawal by Subject|3
369505|NCT00958347|1244902|P1|Overall Study|study termination|135
369506|NCT00958347|1244902|P1|Overall Study|revision/removal|10
369507|NCT00958347|1244902|P1|Overall Study|Lost to Follow-up|15
369508|NCT00958347|1244902|P1|Overall Study|Withdrawal by Subject|23
369509|NCT00958347|1244902|P1|Overall Study|Death|43
369510|NCT00958256|1244943|P1|Overall Study|Adverse Event|3
369511|NCT00958243|1244953|P6|Overall Study|Lost to Follow-up|5
369512|NCT00958243|1244954|P5|Overall Study|Lost to Follow-up|8
369513|NCT00958243|1244955|P4|Overall Study|Lost to Follow-up|2
369514|NCT00958243|1244956|P3|Overall Study|Lost to Follow-up|11
369515|NCT00958243|1244957|P2|Overall Study|Lost to Follow-up|5
369516|NCT00958243|1244958|P1|Overall Study|Lost to Follow-up|2
369517|NCT00958243|1244953|P6|Overall Study|Withdrawal by Subject|5
369518|NCT00958243|1244954|P5|Overall Study|Withdrawal by Subject|1
369519|NCT00958243|1244955|P4|Overall Study|Withdrawal by Subject|1
369520|NCT00958243|1244956|P3|Overall Study|Withdrawal by Subject|3
369521|NCT00958243|1244957|P2|Overall Study|Withdrawal by Subject|1
369522|NCT00958243|1244958|P1|Overall Study|Withdrawal by Subject|0
369523|NCT00958217|1245016|P2|Overall Study|Inpatient hospitalization|1
369524|NCT00958217|1245017|P1|Overall Study|Inpatient hospitalization|0
369525|NCT00958217|1245016|P2|Overall Study|Moved out of area|1
369526|NCT00958217|1245017|P1|Overall Study|Moved out of area|1
369527|NCT00958217|1245016|P2|Overall Study|Lost to Follow-up|19
369528|NCT00958217|1245017|P1|Overall Study|Lost to Follow-up|17
369529|NCT00958217|1245016|P2|Overall Study|Withdrawal by Subject|3
369530|NCT00958217|1245017|P1|Overall Study|Withdrawal by Subject|4
369531|NCT00958217|1245016|P2|Overall Study|Death|1
369532|NCT00958217|1245017|P1|Overall Study|Death|2
369533|NCT00958191|1245028|P1|Overall Study|No 5 yr x-rays|56
369534|NCT00958191|1245028|P1|Overall Study|Site termination|11
369535|NCT00958191|1245028|P1|Overall Study|Revision of study device|4
369536|NCT00958191|1245028|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
369537|NCT00958191|1245028|P1|Overall Study|Inadequate 5 yr x-ray quality|10
369538|NCT00958191|1245028|P1|Overall Study|Lost to Follow-up|5
369539|NCT00958191|1245028|P1|Overall Study|Death|4
369540|NCT00958165|1245043|P1|Overall Study|Not eligible|9
369541|NCT00958165|1245043|P1|Overall Study|Lost to Follow-up|5
369542|NCT00958126|1245055|P8|Overall Study|Other Reason|0
369543|NCT00958126|1245056|P7|Overall Study|Other Reason|0
369544|NCT00958126|1245057|P6|Overall Study|Other Reason|1
369545|NCT00958126|1245058|P5|Overall Study|Other Reason|0
369546|NCT00958126|1245059|P4|Overall Study|Other Reason|1
369547|NCT00958126|1245060|P3|Overall Study|Other Reason|0
369548|NCT00958126|1245061|P2|Overall Study|Other Reason|0
369549|NCT00958126|1245062|P1|Overall Study|Other Reason|0
369550|NCT00958126|1245055|P8|Overall Study|Sponsor/Investigator decision|0
369551|NCT00958126|1245056|P7|Overall Study|Sponsor/Investigator decision|0
369552|NCT00958126|1245057|P6|Overall Study|Sponsor/Investigator decision|0
369553|NCT00958126|1245058|P5|Overall Study|Sponsor/Investigator decision|0
369554|NCT00958126|1245059|P4|Overall Study|Sponsor/Investigator decision|1
369555|NCT00958126|1245060|P3|Overall Study|Sponsor/Investigator decision|0
369556|NCT00958126|1245061|P2|Overall Study|Sponsor/Investigator decision|0
369557|NCT00958126|1245062|P1|Overall Study|Sponsor/Investigator decision|0
369558|NCT00958126|1245055|P8|Overall Study|Lost to Follow-up|0
369559|NCT00958126|1245056|P7|Overall Study|Lost to Follow-up|0
369560|NCT00958126|1245057|P6|Overall Study|Lost to Follow-up|0
369561|NCT00958126|1245058|P5|Overall Study|Lost to Follow-up|0
369562|NCT00958126|1245059|P4|Overall Study|Lost to Follow-up|8
369563|NCT00958126|1245060|P3|Overall Study|Lost to Follow-up|9
369564|NCT00958126|1245061|P2|Overall Study|Lost to Follow-up|5
369565|NCT00958126|1245062|P1|Overall Study|Lost to Follow-up|1
369566|NCT00958126|1245055|P8|Overall Study|Moved away from study area|0
369567|NCT00958126|1245056|P7|Overall Study|Moved away from study area|0
369568|NCT00958126|1245057|P6|Overall Study|Moved away from study area|0
369569|NCT00958126|1245058|P5|Overall Study|Moved away from study area|0
369570|NCT00958126|1245059|P4|Overall Study|Moved away from study area|1
369571|NCT00958126|1245060|P3|Overall Study|Moved away from study area|1
369572|NCT00958126|1245061|P2|Overall Study|Moved away from study area|0
369573|NCT00958126|1245062|P1|Overall Study|Moved away from study area|0
369574|NCT00958126|1245055|P8|Overall Study|Withdrawal by Subject|0
369575|NCT00958126|1245056|P7|Overall Study|Withdrawal by Subject|0
369576|NCT00958126|1245057|P6|Overall Study|Withdrawal by Subject|0
369577|NCT00958126|1245058|P5|Overall Study|Withdrawal by Subject|0
369578|NCT00958126|1245059|P4|Overall Study|Withdrawal by Subject|0
369579|NCT00958126|1245060|P3|Overall Study|Withdrawal by Subject|0
369580|NCT00958126|1245061|P2|Overall Study|Withdrawal by Subject|2
369581|NCT00958126|1245062|P1|Overall Study|Withdrawal by Subject|0
369582|NCT00958126|1245055|P8|Overall Study|Serious Adverse Event|0
369583|NCT00958126|1245056|P7|Overall Study|Serious Adverse Event|1
369584|NCT00958126|1245057|P6|Overall Study|Serious Adverse Event|0
369585|NCT00958126|1245058|P5|Overall Study|Serious Adverse Event|0
369586|NCT00958126|1245059|P4|Overall Study|Serious Adverse Event|0
369587|NCT00958126|1245060|P3|Overall Study|Serious Adverse Event|0
369588|NCT00958126|1245061|P2|Overall Study|Serious Adverse Event|2
369589|NCT00958126|1245062|P1|Overall Study|Serious Adverse Event|0
369590|NCT00958074|1245134|P2|Overall Study|Withdrawal by Subject|1
369591|NCT00958074|1245135|P1|Overall Study|Withdrawal by Subject|0
369592|NCT00958009|1245150|P1|Overall Study|Subject found device difficult to use|1
369593|NCT00958009|1245150|P1|Overall Study|Adverse Event|1
369594|NCT00957996|1245157|P2|Overall Study|Noncompliance; Protocol Deviations|6
369595|NCT00957996|1245158|P1|Overall Study|Noncompliance; Protocol Deviations|5
369596|NCT00957996|1245157|P2|Overall Study|Missing|0
369597|NCT00957996|1245158|P1|Overall Study|Missing|1
369598|NCT00957996|1245157|P2|Overall Study|Influenza-related complication|1
369599|NCT00957996|1245158|P1|Overall Study|Influenza-related complication|0
369600|NCT00957996|1245157|P2|Overall Study|Physician Decision|1
369601|NCT00957996|1245158|P1|Overall Study|Physician Decision|1
369602|NCT00957996|1245157|P2|Overall Study|Adverse Event|1
369603|NCT00957996|1245158|P1|Overall Study|Adverse Event|2
369604|NCT00957996|1245157|P2|Overall Study|Withdrawal by Subject|2
369605|NCT00957996|1245158|P1|Overall Study|Withdrawal by Subject|9
369606|NCT00957996|1245157|P2|Overall Study|Lost to Follow-up|7
369607|NCT00957996|1245158|P1|Overall Study|Lost to Follow-up|4
369608|NCT00957996|1245157|P2|Overall Study|Death|10
369609|NCT00957996|1245158|P1|Overall Study|Death|4
369610|NCT00957944|1245190|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
369611|NCT00957944|1245191|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
369612|NCT00957905|1245227|P2|Part B|Protocol Violation|1
369613|NCT00957905|1245228|P1|Part B|Protocol Violation|0
369614|NCT00957905|1245227|P2|Part B|Death|1
369615|NCT00957905|1245228|P1|Part B|Death|0
369616|NCT00957905|1245227|P2|Part B|Physician Decision|1
369617|NCT00957905|1245228|P1|Part B|Physician Decision|0
369618|NCT00957905|1245227|P2|Part B|Not Treated|1
369619|NCT00957905|1245228|P1|Part B|Not Treated|0
369620|NCT00957801|1245238|P4|Overall Study|Withdrawal by Subject|1
369621|NCT00957801|1245239|P3|Overall Study|Withdrawal by Subject|0
369622|NCT00957801|1245240|P2|Overall Study|Withdrawal by Subject|0
369623|NCT00957801|1245241|P1|Overall Study|Withdrawal by Subject|0
369624|NCT00957723|1245407|P1|Overall Study|2yr ROM Data Not Evaluable|25
369625|NCT00957723|1245407|P1|Overall Study|Intercurrent Illness|2
369626|NCT00957723|1245407|P1|Overall Study|Investigative Site Terminated|55
369627|NCT00957723|1245407|P1|Overall Study|Did not undergo surgery|3
369628|NCT00957723|1245407|P1|Overall Study|Withdrawal by Subject|23
369629|NCT00957723|1245407|P1|Overall Study|Lost to Follow-up|7
369630|NCT00957723|1245407|P1|Overall Study|Revision/ Removal of Study Implant|3
369631|NCT00957723|1245407|P1|Overall Study|Death|3
369632|NCT00957658|1245493|P1|Overall Study|Protocol Violation|5
369633|NCT00957658|1245493|P1|Overall Study|surgery cancelled|2
369634|NCT00957658|1245493|P1|Overall Study|unwilling/unable to return|2
369635|NCT00957658|1245493|P1|Overall Study|Site termination|10
369636|NCT00957658|1245493|P1|Overall Study|Incomplete 2 yr data|28
369637|NCT00957658|1245493|P1|Overall Study|Revision|1
369638|NCT00957658|1245493|P1|Overall Study|Withdrawal by Subject|12
369639|NCT00957658|1245493|P1|Overall Study|Lost to Follow-up|4
369640|NCT00957658|1245493|P1|Overall Study|Death|1
369641|NCT00957580|1245518|P3|Overall Study|Enrolled but not treated|0
369642|NCT00957580|1245519|P2|Overall Study|Enrolled but not treated|1
369643|NCT00957580|1245520|P1|Overall Study|Enrolled but not treated|0
369644|NCT00957580|1245518|P3|Overall Study|Ongoing at data cut-off|0
369645|NCT00957580|1245519|P2|Overall Study|Ongoing at data cut-off|1
369646|NCT00957580|1245520|P1|Overall Study|Ongoing at data cut-off|0
369647|NCT00957528|1245667|P3|Overall Study|Withdrawal by Subject|1
369648|NCT00957528|1245668|P2|Overall Study|Withdrawal by Subject|0
369649|NCT00957528|1245669|P1|Overall Study|Withdrawal by Subject|0
369650|NCT00957528|1245667|P3|Overall Study|Protocol Violation|0
369651|NCT00957528|1245668|P2|Overall Study|Protocol Violation|1
369652|NCT00957528|1245669|P1|Overall Study|Protocol Violation|0
369653|NCT00957424|1245692|P1|Overall Study|Withdrawal by Subject|1
369654|NCT00957424|1245692|P1|Overall Study|Protocol Violation|3
369655|NCT00957424|1245692|P1|Overall Study|Lost to Follow-up|19
369656|NCT00957372|1245702|P4|PART II|Patient non-compliance|4
369657|NCT00957372|1245703|P3|PART II|Patient non-compliance|0
369658|NCT00957372|1245704|P2|PART II|Patient non-compliance|0
369659|NCT00957372|1245705|P1|PART II|Patient non-compliance|0
369660|NCT00957372|1245702|P4|PART II|Adverse Event|10
369661|NCT00957372|1245703|P3|PART II|Adverse Event|0
369662|NCT00957372|1245704|P2|PART II|Adverse Event|0
369663|NCT00957372|1245705|P1|PART II|Adverse Event|0
369664|NCT00957372|1245702|P4|PART II|Not Know|20
369665|NCT00957372|1245703|P3|PART II|Not Know|0
369666|NCT00957372|1245704|P2|PART II|Not Know|0
369667|NCT00957372|1245705|P1|PART II|Not Know|0
369668|NCT00957372|1245702|P4|PART II|Pregnancy|1
369669|NCT00957372|1245703|P3|PART II|Pregnancy|0
369670|NCT00957372|1245704|P2|PART II|Pregnancy|0
369671|NCT00957372|1245705|P1|PART II|Pregnancy|0
369672|NCT00957372|1245702|P4|PART II|Physician Decision|1
369673|NCT00957372|1245703|P3|PART II|Physician Decision|0
369674|NCT00957372|1245704|P2|PART II|Physician Decision|0
369675|NCT00957372|1245705|P1|PART II|Physician Decision|0
369676|NCT00957372|1245702|P4|PART II|Withdrawal by Subject|8
369677|NCT00957372|1245703|P3|PART II|Withdrawal by Subject|0
369678|NCT00957372|1245704|P2|PART II|Withdrawal by Subject|0
369679|NCT00957372|1245705|P1|PART II|Withdrawal by Subject|0
369680|NCT00957372|1245702|P4|PART I|Lost to Follow-up|0
369681|NCT00957372|1245703|P3|PART I|Lost to Follow-up|1
369682|NCT00957372|1245704|P2|PART I|Lost to Follow-up|0
369683|NCT00957372|1245705|P1|PART I|Lost to Follow-up|0
369684|NCT00957268|1245730|P5|Overall Study|Voluntary Withdrawal|0
369685|NCT00957268|1245731|P4|Overall Study|Voluntary Withdrawal|0
369686|NCT00957268|1245732|P3|Overall Study|Voluntary Withdrawal|1
369687|NCT00957268|1245733|P2|Overall Study|Voluntary Withdrawal|0
369688|NCT00957268|1245734|P1|Overall Study|Voluntary Withdrawal|0
369689|NCT00957034|1245856|P3|Overall Study|Withdrawal by Subject|0
369690|NCT00957034|1245857|P2|Overall Study|Withdrawal by Subject|2
369691|NCT00957034|1245858|P1|Overall Study|Withdrawal by Subject|0
369692|NCT00957034|1245856|P3|Overall Study|Sponsor Terminated Study|5
369693|NCT00957034|1245857|P2|Overall Study|Sponsor Terminated Study|1
369694|NCT00957034|1245858|P1|Overall Study|Sponsor Terminated Study|6
369695|NCT00957034|1245856|P3|Overall Study|Adverse Event|1
369696|NCT00957034|1245857|P2|Overall Study|Adverse Event|1
369697|NCT00957034|1245858|P1|Overall Study|Adverse Event|0
369698|NCT00957021|1245881|P1|Overall Study|Termination due to language issue|2
369699|NCT00957021|1245881|P1|Overall Study|Surgery Cancelled|9
369700|NCT00957021|1245881|P1|Overall Study|Site Termination by the 2 yr visit|16
369701|NCT00957021|1245881|P1|Overall Study|Revised study component by 2 yr visit|8
369702|NCT00957021|1245881|P1|Overall Study|No 2 yr ROM data|35
369703|NCT00957021|1245881|P1|Overall Study|Withdrawal by Subject|34
369704|NCT00957021|1245881|P1|Overall Study|Lost to Follow-up|8
369705|NCT00957021|1245881|P1|Overall Study|Death|5
369706|NCT00957008|1245894|P4|Overall Study|Relocated; Family conflict|3
369707|NCT00957008|1245895|P3|Overall Study|Relocated; Family conflict|1
369708|NCT00957008|1245896|P2|Overall Study|Relocated; Family conflict|1
369709|NCT00957008|1245897|P1|Overall Study|Relocated; Family conflict|4
369710|NCT00957008|1245894|P4|Overall Study|Physician Decision|1
369711|NCT00957008|1245895|P3|Overall Study|Physician Decision|1
369712|NCT00957008|1245896|P2|Overall Study|Physician Decision|0
369713|NCT00957008|1245897|P1|Overall Study|Physician Decision|1
369714|NCT00957008|1245894|P4|Overall Study|Lost to Follow-up|4
369715|NCT00957008|1245895|P3|Overall Study|Lost to Follow-up|3
369716|NCT00957008|1245896|P2|Overall Study|Lost to Follow-up|1
369717|NCT00957008|1245897|P1|Overall Study|Lost to Follow-up|3
369718|NCT00957008|1245894|P4|Overall Study|Withdrawal by Subject|16
369719|NCT00957008|1245895|P3|Overall Study|Withdrawal by Subject|12
369720|NCT00957008|1245896|P2|Overall Study|Withdrawal by Subject|10
369721|NCT00957008|1245897|P1|Overall Study|Withdrawal by Subject|13
369722|NCT00956943|1245925|P2|Overall Study|Lost to Follow-up|10
369723|NCT00956943|1245926|P1|Overall Study|Lost to Follow-up|9
369724|NCT00956839|1245937|P3|Overall Study|Lost to Follow-up|3
369725|NCT00956839|1245938|P2|Overall Study|Lost to Follow-up|0
369726|NCT00956839|1245939|P1|Overall Study|Lost to Follow-up|3
369727|NCT00956813|1245952|P2|Flaxseed and Placebo|Ineligible|1
369728|NCT00956813|1245953|P1|Flaxseed and Placebo|Ineligible|3
369729|NCT00956813|1245952|P2|Flaxseed and Placebo|Withdrawal by Subject|4
369730|NCT00956813|1245953|P1|Flaxseed and Placebo|Withdrawal by Subject|5
369731|NCT00956592|1246005|P2|Overall Study|Protocol Violation|3
369732|NCT00956592|1246006|P1|Overall Study|Protocol Violation|1
369733|NCT00956293|1246041|P3|Follow-up Period|Follow-up period was terminated.|0
369734|NCT00956293|1246042|P2|Follow-up Period|Follow-up period was terminated.|32
369735|NCT00956293|1246043|P1|Follow-up Period|Follow-up period was terminated.|20
369736|NCT00956293|1246041|P3|Main Period (Randomization)|Adverse Event|0
369737|NCT00956293|1246042|P2|Main Period (Randomization)|Adverse Event|15
369738|NCT00956293|1246043|P1|Main Period (Randomization)|Adverse Event|0
369739|NCT00956293|1246041|P3|Main Period (Randomization)|Lack of Efficacy|0
369740|NCT00956293|1246042|P2|Main Period (Randomization)|Lack of Efficacy|10
369741|NCT00956293|1246043|P1|Main Period (Randomization)|Lack of Efficacy|1
369742|NCT00956293|1246041|P3|Main Period (Randomization)|Abnormal laboratory value|0
369743|NCT00956293|1246042|P2|Main Period (Randomization)|Abnormal laboratory value|2
369744|NCT00956293|1246043|P1|Main Period (Randomization)|Abnormal laboratory value|0
369745|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
369746|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
369747|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
369748|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Adverse Event|36
369749|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Adverse Event|0
369750|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Adverse Event|0
369751|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
369752|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
369753|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
369754|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
369755|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
369756|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
369757|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Graft loss|7
369758|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Graft loss|0
369759|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Graft loss|0
369760|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Administrative problems|6
369761|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Administrative problems|0
369762|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Administrative problems|0
369763|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
369764|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
369765|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
369766|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Protocol Violation|1
369767|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Protocol Violation|0
369768|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Protocol Violation|0
369769|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Death|1
369770|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Death|0
369771|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Death|0
369772|NCT00956293|1246041|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
369773|NCT00956293|1246042|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
369774|NCT00956293|1246043|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
369775|NCT00955968|1246098|P2|Overall Study|Site closed|52
369776|NCT00955968|1246099|P1|Overall Study|Site closed|55
369777|NCT00955968|1246098|P2|Overall Study|Lost to Follow-up|39
369778|NCT00955968|1246099|P1|Overall Study|Lost to Follow-up|45
369779|NCT00955968|1246098|P2|Overall Study|Withdrawal by Subject|31
369780|NCT00955968|1246099|P1|Overall Study|Withdrawal by Subject|35
369781|NCT00955968|1246098|P2|Overall Study|Death|4
369782|NCT00955968|1246099|P1|Overall Study|Death|2
369783|NCT00955955|1246133|P3|Overall Study|Lost to Follow-up|0
369784|NCT00955955|1246134|P2|Overall Study|Lost to Follow-up|0
369785|NCT00955955|1246135|P1|Overall Study|Lost to Follow-up|2
369786|NCT00955825|1246219|P2|Overall Study|Any other reason not above-mentioned|9
369787|NCT00955825|1246220|P1|Overall Study|Any other reason not above-mentioned|7
369788|NCT00955825|1246219|P2|Overall Study|Withdrawal by Subject|6
369789|NCT00955825|1246220|P1|Overall Study|Withdrawal by Subject|4
369790|NCT00955825|1246219|P2|Overall Study|Adverse Event|2
369791|NCT00955825|1246220|P1|Overall Study|Adverse Event|15
369792|NCT00955721|1246237|P2|Overall Study|Withdrawal by Subject|0
369793|NCT00955721|1246238|P1|Overall Study|Withdrawal by Subject|1
369794|NCT00955721|1246237|P2|Overall Study|Death|0
369795|NCT00955721|1246238|P1|Overall Study|Death|1
369796|NCT00955721|1246237|P2|Overall Study|Physician Decision|0
369797|NCT00955721|1246238|P1|Overall Study|Physician Decision|1
369798|NCT00955617|1246248|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
369799|NCT00955617|1246249|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
369800|NCT00955617|1246248|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
369801|NCT00955617|1246249|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
369802|NCT00955617|1246248|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
369803|NCT00955617|1246249|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
369804|NCT00955617|1246248|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
369805|NCT00955617|1246249|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
369806|NCT00955474|1246313|P2|Overall Study|Physician Decision|5
369807|NCT00955474|1246314|P1|Overall Study|Physician Decision|7
369808|NCT00955357|1246350|P2|Maintenance Phase|Non compliance to study procedures|0
369809|NCT00955357|1246351|P1|Maintenance Phase|Non compliance to study procedures|1
369810|NCT00955357|1246350|P2|Maintenance Phase|Patient moving out of area|1
369811|NCT00955357|1246351|P1|Maintenance Phase|Patient moving out of area|0
369812|NCT00955357|1246350|P2|Maintenance Phase|Withdrawal by Subject|4
369813|NCT00955357|1246351|P1|Maintenance Phase|Withdrawal by Subject|4
369814|NCT00955357|1246350|P2|Maintenance Phase|Lost to Follow-up|7
369815|NCT00955357|1246351|P1|Maintenance Phase|Lost to Follow-up|2
369816|NCT00955357|1246350|P2|Maintenance Phase|Protocol Violation|6
369817|NCT00955357|1246351|P1|Maintenance Phase|Protocol Violation|2
369818|NCT00955357|1246350|P2|Maintenance Phase|Lack of Efficacy|4
369819|NCT00955357|1246351|P1|Maintenance Phase|Lack of Efficacy|0
369820|NCT00955357|1246350|P2|Maintenance Phase|Adverse Event|23
369821|NCT00955357|1246351|P1|Maintenance Phase|Adverse Event|3
369822|NCT00955357|1246350|P2|Titration Phase|Non compliance to study procedures|1
369823|NCT00955357|1246351|P1|Titration Phase|Non compliance to study procedures|0
369824|NCT00955357|1246350|P2|Titration Phase|Study medication not tolerated|1
369825|NCT00955357|1246351|P1|Titration Phase|Study medication not tolerated|0
369826|NCT00955357|1246350|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
369827|NCT00955357|1246351|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
369828|NCT00955357|1246350|P2|Titration Phase|Withdrawal by Subject|5
369829|NCT00955357|1246351|P1|Titration Phase|Withdrawal by Subject|3
369830|NCT00955357|1246350|P2|Titration Phase|Lost to Follow-up|3
369831|NCT00955357|1246351|P1|Titration Phase|Lost to Follow-up|1
369832|NCT00955357|1246350|P2|Titration Phase|Protocol Violation|7
369833|NCT00955357|1246351|P1|Titration Phase|Protocol Violation|3
369834|NCT00955357|1246350|P2|Titration Phase|Lack of Efficacy|2
369835|NCT00955357|1246351|P1|Titration Phase|Lack of Efficacy|0
369836|NCT00955357|1246350|P2|Titration Phase|Adverse Event|46
369837|NCT00955357|1246351|P1|Titration Phase|Adverse Event|9
369838|NCT00955305|1246359|P2|Overall Study|Ineligible|7
369839|NCT00955305|1246360|P1|Overall Study|Ineligible|5
369840|NCT00955305|1246359|P2|Overall Study|Never started protocol treatment|5
369841|NCT00955305|1246360|P1|Overall Study|Never started protocol treatment|5
369842|NCT00955305|1246359|P2|Overall Study|No off-treatment reason submitted|0
369843|NCT00955305|1246360|P1|Overall Study|No off-treatment reason submitted|1
369844|NCT00955305|1246359|P2|Overall Study|Lost to Follow-up|1
369845|NCT00955305|1246360|P1|Overall Study|Lost to Follow-up|0
369846|NCT00955305|1246359|P2|Overall Study|Maximum response achieved|1
369847|NCT00955305|1246360|P1|Overall Study|Maximum response achieved|0
369848|NCT00955305|1246359|P2|Overall Study|Functional decline|0
369849|NCT00955305|1246360|P1|Overall Study|Functional decline|2
369850|NCT00955305|1246359|P2|Overall Study|Continued presence of residual disease|1
369851|NCT00955305|1246360|P1|Overall Study|Continued presence of residual disease|0
369852|NCT00955305|1246359|P2|Overall Study|Physician Decision|0
369853|NCT00955305|1246360|P1|Overall Study|Physician Decision|1
369854|NCT00955305|1246359|P2|Overall Study|Other complicating disease|4
369855|NCT00955305|1246360|P1|Overall Study|Other complicating disease|2
369856|NCT00955305|1246359|P2|Overall Study|Alternative therapy|0
369857|NCT00955305|1246360|P1|Overall Study|Alternative therapy|4
369858|NCT00955305|1246359|P2|Overall Study|Withdrawal by Subject|4
369859|NCT00955305|1246360|P1|Overall Study|Withdrawal by Subject|5
369860|NCT00955305|1246359|P2|Overall Study|Death|1
369861|NCT00955305|1246360|P1|Overall Study|Death|2
369862|NCT00955305|1246359|P2|Overall Study|Adverse Event|22
369863|NCT00955305|1246360|P1|Overall Study|Adverse Event|22
369864|NCT00955305|1246359|P2|Overall Study|Disease progression|41
369865|NCT00955305|1246360|P1|Overall Study|Disease progression|39
369866|NCT00955279|1246373|P3|Overall Study|Withdrawal by Subject|3
369867|NCT00955279|1246374|P2|Overall Study|Withdrawal by Subject|0
369868|NCT00955279|1246375|P1|Overall Study|Withdrawal by Subject|2
369869|NCT00955279|1246373|P3|Overall Study|Lost to Follow-up|1
369870|NCT00955279|1246374|P2|Overall Study|Lost to Follow-up|3
369871|NCT00955279|1246375|P1|Overall Study|Lost to Follow-up|0
369872|NCT00955279|1246373|P3|Overall Study|Death|1
369873|NCT00955279|1246374|P2|Overall Study|Death|1
369874|NCT00955279|1246375|P1|Overall Study|Death|1
369875|NCT00955279|1246373|P3|Overall Study|Other|3
369876|NCT00955279|1246374|P2|Overall Study|Other|0
369877|NCT00955279|1246375|P1|Overall Study|Other|0
369878|NCT00955110|1246412|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
369879|NCT00955110|1246412|P1|Treatment Phase|Non-compliance with study restrictions|1
369880|NCT00955110|1246412|P1|Treatment Phase|Administrative reasons|2
369881|NCT00955110|1246412|P1|Treatment Phase|Adverse Event|2
369882|NCT00955110|1246412|P1|Qualification Phase|Did not meet eligibility criteria|24
369883|NCT00954941|1246459|P2|Overall Study|Adverse Event|1
369884|NCT00954941|1246460|P1|Overall Study|Adverse Event|0
369885|NCT00954941|1246459|P2|Overall Study|Ineligible|2
369886|NCT00954941|1246460|P1|Overall Study|Ineligible|2
369887|NCT00954941|1246459|P2|Overall Study|Physician Decision|2
369888|NCT00954941|1246460|P1|Overall Study|Physician Decision|2
369889|NCT00954941|1246459|P2|Overall Study|Insurance Denial|2
369890|NCT00954941|1246460|P1|Overall Study|Insurance Denial|2
369891|NCT00954941|1246459|P2|Overall Study|Withdrawal by Subject|0
369892|NCT00954941|1246460|P1|Overall Study|Withdrawal by Subject|1
369893|NCT00954941|1246459|P2|Overall Study|Received treatment at home|0
369894|NCT00954941|1246460|P1|Overall Study|Received treatment at home|1
369895|NCT00954733|1246476|P1|Overall Study|blood gas machine did not work|1
369896|NCT00954707|1246480|P1|Overall Study|Lost to Follow-up|33
369897|NCT00954707|1246480|P1|Overall Study|Withdrawal by Subject|100
369898|NCT00954707|1246480|P1|Overall Study|Death|34
369899|NCT00954538|1246502|P6|Part III|Withdrawal by Subject|0
369900|NCT00954538|1246503|P5|Part III|Withdrawal by Subject|1
369901|NCT00954538|1246504|P4|Part III|Withdrawal by Subject|0
369902|NCT00954538|1246505|P3|Part III|Withdrawal by Subject|0
369903|NCT00954538|1246506|P2|Part III|Withdrawal by Subject|0
369904|NCT00954538|1246507|P1|Part III|Withdrawal by Subject|0
369905|NCT00954512|1246524|P6|Overall Study|Progression of Disease|1
369906|NCT00954512|1246525|P5|Overall Study|Progression of Disease|1
369907|NCT00954512|1246526|P4|Overall Study|Progression of Disease|1
369908|NCT00954512|1246527|P3|Overall Study|Progression of Disease|0
369909|NCT00954512|1246528|P2|Overall Study|Progression of Disease|1
369910|NCT00954512|1246529|P1|Overall Study|Progression of Disease|2
369911|NCT00954512|1246524|P6|Overall Study|Symptomatic Deterioration|0
369912|NCT00954512|1246525|P5|Overall Study|Symptomatic Deterioration|2
369913|NCT00954512|1246526|P4|Overall Study|Symptomatic Deterioration|0
369914|NCT00954512|1246527|P3|Overall Study|Symptomatic Deterioration|0
369915|NCT00954512|1246528|P2|Overall Study|Symptomatic Deterioration|1
369916|NCT00954512|1246529|P1|Overall Study|Symptomatic Deterioration|0
369917|NCT00954512|1246524|P6|Overall Study|Physician Decision|0
369918|NCT00954512|1246525|P5|Overall Study|Physician Decision|0
369919|NCT00954512|1246526|P4|Overall Study|Physician Decision|1
369920|NCT00954512|1246527|P3|Overall Study|Physician Decision|0
369921|NCT00954512|1246528|P2|Overall Study|Physician Decision|1
369922|NCT00954512|1246529|P1|Overall Study|Physician Decision|0
369923|NCT00954512|1246524|P6|Overall Study|Adverse Event|2
369924|NCT00954512|1246525|P5|Overall Study|Adverse Event|1
369925|NCT00954512|1246526|P4|Overall Study|Adverse Event|0
369926|NCT00954512|1246527|P3|Overall Study|Adverse Event|0
369927|NCT00954512|1246528|P2|Overall Study|Adverse Event|0
369928|NCT00954512|1246529|P1|Overall Study|Adverse Event|0
369929|NCT00954512|1246524|P6|Overall Study|Withdrawal by Subject|1
369930|NCT00954512|1246525|P5|Overall Study|Withdrawal by Subject|0
369931|NCT00954512|1246526|P4|Overall Study|Withdrawal by Subject|0
369932|NCT00954512|1246527|P3|Overall Study|Withdrawal by Subject|0
369933|NCT00954512|1246528|P2|Overall Study|Withdrawal by Subject|0
369934|NCT00954512|1246529|P1|Overall Study|Withdrawal by Subject|0
369935|NCT00954447|1246550|P2|Overall Study|Other|18
369936|NCT00954447|1246551|P1|Overall Study|Other|21
369937|NCT00954447|1246550|P2|Overall Study|Withdrawal by Subject|21
369938|NCT00954447|1246551|P1|Overall Study|Withdrawal by Subject|26
369939|NCT00954447|1246550|P2|Overall Study|Lost to Follow-up|14
369940|NCT00954447|1246551|P1|Overall Study|Lost to Follow-up|8
369941|NCT00954447|1246550|P2|Overall Study|Protocol Violation|7
369942|NCT00954447|1246551|P1|Overall Study|Protocol Violation|5
369943|NCT00954447|1246550|P2|Overall Study|Lack of Efficacy|3
369944|NCT00954447|1246551|P1|Overall Study|Lack of Efficacy|17
369945|NCT00954447|1246550|P2|Overall Study|Adverse Event|25
369946|NCT00954447|1246551|P1|Overall Study|Adverse Event|33
369947|NCT00954421|1246587|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
369948|NCT00954421|1246587|P1|6 Months of DBS|Withdrawal by Subject|1
369949|NCT00954421|1246587|P1|Screening|screen failures|3
369950|NCT00954122|1246633|P1|Overall Study|Safety Reason|1
369951|NCT00954122|1246633|P1|Overall Study|Adverse Event|1
369952|NCT00954122|1246633|P1|Overall Study|Withdrawal by Subject|5
369953|NCT00953927|1246650|P2|Overall Study|Other study discontinuation|1
369954|NCT00953927|1246651|P1|Overall Study|Other study discontinuation|1
369955|NCT00953927|1246650|P2|Overall Study|Death|4
369956|NCT00953927|1246651|P1|Overall Study|Death|7
369957|NCT00953927|1246650|P2|Overall Study|Withdrawal by Subject|25
369958|NCT00953927|1246651|P1|Overall Study|Withdrawal by Subject|36
369959|NCT00953927|1246650|P2|Overall Study|Lost to Follow-up|65
369960|NCT00953927|1246651|P1|Overall Study|Lost to Follow-up|61
369961|NCT00953745|1246706|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
369962|NCT00953745|1246707|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
369963|NCT00953745|1246706|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
369964|NCT00953745|1246707|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
369965|NCT00953745|1246706|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
369966|NCT00953745|1246707|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
369967|NCT00953745|1246706|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
369968|NCT00953745|1246707|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
369969|NCT00953745|1246706|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
369970|NCT00953745|1246707|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
369971|NCT00953745|1246706|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
369972|NCT00953745|1246707|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
369973|NCT00953706|1246740|P4|Part B (96-Week Open-Label Extension)|Other|2
369974|NCT00953706|1246741|P3|Part B (96-Week Open-Label Extension)|Other|0
369975|NCT00953706|1246742|P2|Part B (96-Week Open-Label Extension)|Other|0
369976|NCT00953706|1246743|P1|Part B (96-Week Open-Label Extension)|Other|0
369977|NCT00953706|1246740|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
369978|NCT00953706|1246741|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
369979|NCT00953706|1246742|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
369980|NCT00953706|1246743|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
369981|NCT00953706|1246740|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
369982|NCT00953706|1246741|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
369983|NCT00953706|1246742|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
369984|NCT00953706|1246743|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
369985|NCT00953706|1246740|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
369986|NCT00953706|1246741|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
369987|NCT00953706|1246742|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
369988|NCT00953706|1246743|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
369989|NCT00953706|1246740|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
369990|NCT00953706|1246741|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
369991|NCT00953706|1246742|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
369992|NCT00953706|1246743|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
369993|NCT00953706|1246740|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
369994|NCT00953706|1246741|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
369995|NCT00953706|1246742|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
369996|NCT00953706|1246743|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
369997|NCT00953706|1246740|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
369998|NCT00953706|1246741|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
369999|NCT00953706|1246742|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
370000|NCT00953706|1246743|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
370001|NCT00953706|1246740|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
370002|NCT00953706|1246741|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
370003|NCT00953706|1246742|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
370004|NCT00953706|1246743|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
370005|NCT00953706|1246740|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
370006|NCT00953706|1246741|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
370007|NCT00953706|1246742|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
370008|NCT00953706|1246743|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
370009|NCT00953706|1246740|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
370010|NCT00953706|1246741|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
370011|NCT00953706|1246742|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
370012|NCT00953706|1246743|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
370013|NCT00953706|1246740|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
370014|NCT00953706|1246741|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
370015|NCT00953706|1246742|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
370016|NCT00953706|1246743|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
370017|NCT00953680|1246775|P2|Period 1|Withdrawal by Subject|1
370018|NCT00953680|1246776|P1|Period 1|Withdrawal by Subject|0
370019|NCT00953667|1246788|P1|Overall Study|poor venous access,unable to draw blood|4
370020|NCT00953667|1246788|P1|Overall Study|Adverse Event|10
370021|NCT00953667|1246788|P1|Overall Study|Withdrawal by Subject|63
370022|NCT00953667|1246788|P1|Overall Study|Physician Decision|35
370023|NCT00953667|1246788|P1|Overall Study|Lost to Follow-up|11
370024|NCT00953615|1246809|P1|Overall Study|Adverse Event|1
370025|NCT00953524|1246820|P4|Overall Study|Withdrawal by Subject|0
370026|NCT00953524|1246821|P3|Overall Study|Withdrawal by Subject|1
370027|NCT00953524|1246822|P2|Overall Study|Withdrawal by Subject|4
370028|NCT00953524|1246823|P1|Overall Study|Withdrawal by Subject|2
370029|NCT00953524|1246820|P4|Overall Study|Lost to Follow-up|0
370030|NCT00953524|1246821|P3|Overall Study|Lost to Follow-up|1
370031|NCT00953524|1246822|P2|Overall Study|Lost to Follow-up|1
370032|NCT00953524|1246823|P1|Overall Study|Lost to Follow-up|0
370033|NCT00953524|1246820|P4|Overall Study|Protocol Violation|6
370034|NCT00953524|1246821|P3|Overall Study|Protocol Violation|11
370035|NCT00953524|1246822|P2|Overall Study|Protocol Violation|10
370036|NCT00953524|1246823|P1|Overall Study|Protocol Violation|18
370037|NCT00953524|1246820|P4|Overall Study|Adverse Event|2
370038|NCT00953524|1246821|P3|Overall Study|Adverse Event|1
370039|NCT00953524|1246822|P2|Overall Study|Adverse Event|0
370040|NCT00953524|1246823|P1|Overall Study|Adverse Event|2
370041|NCT00953407|1246866|P5|Overall Study|Lost to Follow-up|0
370042|NCT00953407|1246867|P4|Overall Study|Lost to Follow-up|1
370043|NCT00953407|1246868|P3|Overall Study|Lost to Follow-up|0
370044|NCT00953407|1246869|P2|Overall Study|Lost to Follow-up|0
370045|NCT00953407|1246870|P1|Overall Study|Lost to Follow-up|0
370046|NCT00953407|1246866|P5|Overall Study|Failed inclusion criteria|1
370047|NCT00953407|1246867|P4|Overall Study|Failed inclusion criteria|1
370048|NCT00953407|1246868|P3|Overall Study|Failed inclusion criteria|1
370049|NCT00953407|1246869|P2|Overall Study|Failed inclusion criteria|1
370050|NCT00953407|1246870|P1|Overall Study|Failed inclusion criteria|1
370051|NCT00953329|1246882|P1|Overall Study|Lack of Efficacy|1
370052|NCT00953225|1246895|P2|Overall Study|Withdrawal by Subject|0
370053|NCT00953225|1246896|P1|Overall Study|Withdrawal by Subject|2
370054|NCT00953160|1246980|P1|Overall Study|Withdrawal by Subject|4
370055|NCT00953160|1246980|P1|Overall Study|Lost to Follow-up|23
370056|NCT00953147|1246989|P3|Overall Study|Other|13
370057|NCT00953147|1246990|P2|Overall Study|Other|11
370058|NCT00953147|1246991|P1|Overall Study|Other|4
370059|NCT00953147|1246989|P3|Overall Study|Physician Decision|3
370060|NCT00953147|1246990|P2|Overall Study|Physician Decision|7
370061|NCT00953147|1246991|P1|Overall Study|Physician Decision|2
370062|NCT00953147|1246989|P3|Overall Study|Lost to Follow-up|4
370063|NCT00953147|1246990|P2|Overall Study|Lost to Follow-up|9
370064|NCT00953147|1246991|P1|Overall Study|Lost to Follow-up|8
370065|NCT00953147|1246989|P3|Overall Study|Withdrawal by Subject|12
370066|NCT00953147|1246990|P2|Overall Study|Withdrawal by Subject|15
370067|NCT00953147|1246991|P1|Overall Study|Withdrawal by Subject|13
370068|NCT00953147|1246989|P3|Overall Study|Protocol Violation|4
370069|NCT00953147|1246990|P2|Overall Study|Protocol Violation|8
370070|NCT00953147|1246991|P1|Overall Study|Protocol Violation|2
370071|NCT00953147|1246989|P3|Overall Study|Adverse Event|6
370072|NCT00953147|1246990|P2|Overall Study|Adverse Event|16
370073|NCT00953147|1246991|P1|Overall Study|Adverse Event|8
370074|NCT00953056|1247069|P6|Overall Study|Serious Adverse Event|1
370075|NCT00953056|1247070|P5|Overall Study|Serious Adverse Event|0
370076|NCT00953056|1247071|P4|Overall Study|Serious Adverse Event|0
370077|NCT00953056|1247072|P3|Overall Study|Serious Adverse Event|0
370078|NCT00953056|1247073|P2|Overall Study|Serious Adverse Event|0
370079|NCT00953056|1247074|P1|Overall Study|Serious Adverse Event|0
370080|NCT00953056|1247069|P6|Overall Study|Withdrew Consent|3
370081|NCT00953056|1247070|P5|Overall Study|Withdrew Consent|2
370082|NCT00953056|1247071|P4|Overall Study|Withdrew Consent|0
370083|NCT00953056|1247072|P3|Overall Study|Withdrew Consent|0
370084|NCT00953056|1247073|P2|Overall Study|Withdrew Consent|0
370085|NCT00953056|1247074|P1|Overall Study|Withdrew Consent|0
370086|NCT00953043|1247098|P2|Overall Study|Physician Decision|2
370087|NCT00953043|1247099|P1|Overall Study|Physician Decision|0
370088|NCT00953043|1247098|P2|Overall Study|Withdrawal by Subject|0
370089|NCT00953043|1247099|P1|Overall Study|Withdrawal by Subject|4
370090|NCT00953017|1247123|P4|Overall Study|Brown stool prior to procedure|0
370091|NCT00953017|1247124|P3|Overall Study|Brown stool prior to procedure|1
370092|NCT00953017|1247125|P2|Overall Study|Brown stool prior to procedure|0
370093|NCT00953017|1247126|P1|Overall Study|Brown stool prior to procedure|0
370094|NCT00953017|1247123|P4|Overall Study|Procedure incomplete due to pain/looping|1
370095|NCT00953017|1247124|P3|Overall Study|Procedure incomplete due to pain/looping|0
370096|NCT00953017|1247125|P2|Overall Study|Procedure incomplete due to pain/looping|1
370097|NCT00953017|1247126|P1|Overall Study|Procedure incomplete due to pain/looping|0
370098|NCT00953017|1247123|P4|Overall Study|Incomplete data|0
370099|NCT00953017|1247124|P3|Overall Study|Incomplete data|0
370100|NCT00953017|1247125|P2|Overall Study|Incomplete data|1
370101|NCT00953017|1247126|P1|Overall Study|Incomplete data|1
370102|NCT00953017|1247123|P4|Overall Study|DId not show up for colonoscopy|4
370103|NCT00953017|1247124|P3|Overall Study|DId not show up for colonoscopy|5
370104|NCT00953017|1247125|P2|Overall Study|DId not show up for colonoscopy|4
370105|NCT00953017|1247126|P1|Overall Study|DId not show up for colonoscopy|4
370106|NCT00952848|1247148|P1|Overall Study|Withdrawal by Subject|4
370107|NCT00952822|1247155|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
370108|NCT00952822|1247156|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
370109|NCT00952822|1247157|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
370110|NCT00952822|1247158|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
370111|NCT00952822|1247155|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
370112|NCT00952822|1247156|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
370113|NCT00952822|1247157|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
370114|NCT00952822|1247158|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
370115|NCT00952731|1247190|P2|Overall Study|Drug supply expired|0
370116|NCT00952731|1247191|P1|Overall Study|Drug supply expired|1
370117|NCT00952705|1247210|P3|Overall Study|Exclusion criteria not met pre dose|0
370118|NCT00952705|1247211|P2|Overall Study|Exclusion criteria not met pre dose|1
370119|NCT00952705|1247212|P1|Overall Study|Exclusion criteria not met pre dose|0
370120|NCT00952705|1247210|P3|Overall Study|Incarcerated post dose|0
370121|NCT00952705|1247211|P2|Overall Study|Incarcerated post dose|0
370122|NCT00952705|1247212|P1|Overall Study|Incarcerated post dose|5
370123|NCT00952705|1247210|P3|Overall Study|Death|0
370124|NCT00952705|1247211|P2|Overall Study|Death|0
370125|NCT00952705|1247212|P1|Overall Study|Death|2
370126|NCT00952705|1247210|P3|Overall Study|Withdrawal by Subject|1
370127|NCT00952705|1247211|P2|Overall Study|Withdrawal by Subject|1
370128|NCT00952705|1247212|P1|Overall Study|Withdrawal by Subject|2
370129|NCT00952705|1247210|P3|Overall Study|Lost to Follow-up|9
370130|NCT00952705|1247211|P2|Overall Study|Lost to Follow-up|8
370131|NCT00952705|1247212|P1|Overall Study|Lost to Follow-up|24
370132|NCT00952614|1247299|P1|Overall Study|other reason|1
370133|NCT00952614|1247299|P1|Overall Study|Lost to Follow-up|3
370134|NCT00952614|1247299|P1|Overall Study|Death|3
370135|NCT00952588|1247306|P2|Overall Study|Lack of Efficacy|2
370136|NCT00952588|1247307|P1|Overall Study|Lack of Efficacy|2
370137|NCT00952588|1247306|P2|Overall Study|Physician Decision|1
370138|NCT00952588|1247307|P1|Overall Study|Physician Decision|0
370139|NCT00952588|1247306|P2|Overall Study|Lost to Follow-up|0
370140|NCT00952588|1247307|P1|Overall Study|Lost to Follow-up|2
370141|NCT00952588|1247306|P2|Overall Study|Adverse Event|3
370142|NCT00952588|1247307|P1|Overall Study|Adverse Event|2
370143|NCT00952588|1247306|P2|Overall Study|Withdrawal by Subject|5
370144|NCT00952588|1247307|P1|Overall Study|Withdrawal by Subject|2
370145|NCT00952588|1247306|P2|Overall Study|Death|13
370146|NCT00952588|1247307|P1|Overall Study|Death|28
370147|NCT00952523|1247325|P1|Overall Study|Withdrawal by Subject|7
370148|NCT00952484|1247334|P3|Overall Study|Withdrawal by Subject|0
370149|NCT00952484|1247335|P2|Overall Study|Withdrawal by Subject|1
370150|NCT00952484|1247336|P1|Overall Study|Withdrawal by Subject|0
370151|NCT00952419|1247363|P3|Overall Study|Withdrawal by Subject|0
370152|NCT00952419|1247364|P2|Overall Study|Withdrawal by Subject|3
370153|NCT00952419|1247365|P1|Overall Study|Withdrawal by Subject|1
370154|NCT00952419|1247363|P3|Overall Study|Protocol Violation|0
370155|NCT00952419|1247364|P2|Overall Study|Protocol Violation|7
370156|NCT00952419|1247365|P1|Overall Study|Protocol Violation|3
370157|NCT00952419|1247363|P3|Overall Study|Adverse Event|0
370158|NCT00952419|1247364|P2|Overall Study|Adverse Event|0
370159|NCT00952419|1247365|P1|Overall Study|Adverse Event|2
370160|NCT00952367|1247401|P1|Overall Study|Protocol Violation|3
370161|NCT00952367|1247401|P1|Overall Study|Noncoordination|1
370162|NCT00952367|1247401|P1|Overall Study|Withdrawal by Subject|2
370163|NCT00952341|1247416|P2|Cycle 2|Progressive Disease|1
370164|NCT00952341|1247417|P1|Cycle 2|Progressive Disease|0
370165|NCT00952341|1247416|P2|Cycle 2|Physician Decision|1
370166|NCT00952341|1247417|P1|Cycle 2|Physician Decision|1
370167|NCT00952341|1247416|P2|Cycle 2|Lost to Follow-up|9
370168|NCT00952341|1247417|P1|Cycle 2|Lost to Follow-up|6
370169|NCT00952341|1247416|P2|Cycle 2|Protocol Violation|0
370170|NCT00952341|1247417|P1|Cycle 2|Protocol Violation|1
370171|NCT00952341|1247416|P2|Cycle 2|Withdrawal by Subject|1
370172|NCT00952341|1247417|P1|Cycle 2|Withdrawal by Subject|1
370173|NCT00952341|1247416|P2|Cycle 1|Physician Decision|1
370174|NCT00952341|1247417|P1|Cycle 1|Physician Decision|0
370175|NCT00952341|1247416|P2|Cycle 1|Lost to Follow-up|2
370176|NCT00952341|1247417|P1|Cycle 1|Lost to Follow-up|11
370177|NCT00952341|1247416|P2|Cycle 1|Protocol Violation|1
370178|NCT00952341|1247417|P1|Cycle 1|Protocol Violation|2
370179|NCT00952341|1247416|P2|Cycle 1|Withdrawal by Subject|8
370180|NCT00952341|1247417|P1|Cycle 1|Withdrawal by Subject|3
370181|NCT00952341|1247416|P2|Cycle 1|Adverse Event|1
370182|NCT00952341|1247417|P1|Cycle 1|Adverse Event|4
370183|NCT00952289|1247439|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
370184|NCT00952289|1247440|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
370185|NCT00952289|1247439|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
370186|NCT00952289|1247440|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
370187|NCT00952289|1247439|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
370188|NCT00952289|1247440|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
370189|NCT00952289|1247439|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
370190|NCT00952289|1247440|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
370191|NCT00952289|1247439|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
370192|NCT00952289|1247440|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
370193|NCT00952289|1247439|P2|All Participants|Data lost during site relocation|1
370194|NCT00952289|1247440|P1|All Participants|Data lost during site relocation|0
370195|NCT00952289|1247439|P2|All Participants|Withdrawal by Subject|10
370196|NCT00952289|1247440|P1|All Participants|Withdrawal by Subject|1
370197|NCT00952289|1247439|P2|All Participants|Disease progression|12
370198|NCT00952289|1247440|P1|All Participants|Disease progression|3
370199|NCT00952289|1247439|P2|All Participants|Adverse Event|8
370200|NCT00952289|1247440|P1|All Participants|Adverse Event|8
370201|NCT00952289|1247439|P2|All Participants|Death|9
370202|NCT00952289|1247440|P1|All Participants|Death|9
370203|NCT00952276|1247469|P5|Overall Study|Withdrawal by Subject|0
370204|NCT00952276|1247470|P4|Overall Study|Withdrawal by Subject|1
370205|NCT00952276|1247471|P3|Overall Study|Withdrawal by Subject|0
370206|NCT00952276|1247472|P2|Overall Study|Withdrawal by Subject|0
370207|NCT00952276|1247473|P1|Overall Study|Withdrawal by Subject|1
370208|NCT00952068|1247559|P1|Overall Study|Withdrawal by Subject|4
370209|NCT00952068|1247559|P1|Overall Study|Adverse Event|3
370210|NCT00951912|1247570|P3|Overall Study|Other: Stroke|0
370211|NCT00951912|1247571|P2|Overall Study|Other: Stroke|1
370212|NCT00951912|1247572|P1|Overall Study|Other: Stroke|0
370213|NCT00951912|1247570|P3|Overall Study|Other: Colon cancer|0
370214|NCT00951912|1247571|P2|Overall Study|Other: Colon cancer|0
370215|NCT00951912|1247572|P1|Overall Study|Other: Colon cancer|1
370216|NCT00951912|1247570|P3|Overall Study|Other:Depression|0
370217|NCT00951912|1247571|P2|Overall Study|Other:Depression|0
370218|NCT00951912|1247572|P1|Overall Study|Other:Depression|1
370219|NCT00951912|1247570|P3|Overall Study|Withdrawal by Subject|0
370220|NCT00951912|1247571|P2|Overall Study|Withdrawal by Subject|1
370221|NCT00951912|1247572|P1|Overall Study|Withdrawal by Subject|1
370222|NCT00951912|1247570|P3|Overall Study|Physician Decision|1
370223|NCT00951912|1247571|P2|Overall Study|Physician Decision|0
370224|NCT00951912|1247572|P1|Overall Study|Physician Decision|1
370225|NCT00951912|1247570|P3|Overall Study|Lost to Follow-up|0
370226|NCT00951912|1247571|P2|Overall Study|Lost to Follow-up|2
370227|NCT00951912|1247572|P1|Overall Study|Lost to Follow-up|2
370228|NCT00951912|1247570|P3|Overall Study|Adverse Event|1
370229|NCT00951912|1247571|P2|Overall Study|Adverse Event|1
370230|NCT00951912|1247572|P1|Overall Study|Adverse Event|0
370231|NCT00951912|1247570|P3|Overall Study|Lack of Efficacy|0
370232|NCT00951912|1247571|P2|Overall Study|Lack of Efficacy|0
370233|NCT00951912|1247572|P1|Overall Study|Lack of Efficacy|1
370234|NCT00951665|1247672|P6|Phase 2a|Disease Progression|5
370235|NCT00951665|1247673|P5|Phase 2a|Disease Progression|6
370236|NCT00951665|1247674|P4|Phase 2a|Disease Progression|0
370237|NCT00951665|1247675|P3|Phase 2a|Disease Progression|0
370238|NCT00951665|1247676|P2|Phase 2a|Disease Progression|0
370239|NCT00951665|1247677|P1|Phase 2a|Disease Progression|0
370240|NCT00951665|1247672|P6|Phase 2a|Withdrawal by Subject|0
370241|NCT00951665|1247673|P5|Phase 2a|Withdrawal by Subject|2
370242|NCT00951665|1247674|P4|Phase 2a|Withdrawal by Subject|0
370243|NCT00951665|1247675|P3|Phase 2a|Withdrawal by Subject|0
370244|NCT00951665|1247676|P2|Phase 2a|Withdrawal by Subject|0
370245|NCT00951665|1247677|P1|Phase 2a|Withdrawal by Subject|0
370246|NCT00951665|1247672|P6|Phase 2a|Physician Decision|1
370247|NCT00951665|1247673|P5|Phase 2a|Physician Decision|0
370248|NCT00951665|1247674|P4|Phase 2a|Physician Decision|0
370249|NCT00951665|1247675|P3|Phase 2a|Physician Decision|0
370250|NCT00951665|1247676|P2|Phase 2a|Physician Decision|0
370251|NCT00951665|1247677|P1|Phase 2a|Physician Decision|0
370252|NCT00951665|1247672|P6|Phase 2a|Lost to Follow-up|0
370253|NCT00951665|1247673|P5|Phase 2a|Lost to Follow-up|1
370254|NCT00951665|1247674|P4|Phase 2a|Lost to Follow-up|0
370255|NCT00951665|1247675|P3|Phase 2a|Lost to Follow-up|0
370256|NCT00951665|1247676|P2|Phase 2a|Lost to Follow-up|0
370257|NCT00951665|1247677|P1|Phase 2a|Lost to Follow-up|0
370258|NCT00951665|1247672|P6|Phase 2a|Death|1
370259|NCT00951665|1247673|P5|Phase 2a|Death|1
370260|NCT00951665|1247674|P4|Phase 2a|Death|0
370261|NCT00951665|1247675|P3|Phase 2a|Death|0
370262|NCT00951665|1247676|P2|Phase 2a|Death|0
370263|NCT00951665|1247677|P1|Phase 2a|Death|0
370264|NCT00951665|1247672|P6|Phase 2a|Adverse Event|0
370265|NCT00951665|1247673|P5|Phase 2a|Adverse Event|2
370266|NCT00951665|1247674|P4|Phase 2a|Adverse Event|0
370267|NCT00951665|1247675|P3|Phase 2a|Adverse Event|0
370268|NCT00951665|1247676|P2|Phase 2a|Adverse Event|0
370269|NCT00951665|1247677|P1|Phase 2a|Adverse Event|0
370270|NCT00951665|1247672|P6|Phase 1b|Protocol Violation|0
370271|NCT00951665|1247673|P5|Phase 1b|Protocol Violation|0
370272|NCT00951665|1247674|P4|Phase 1b|Protocol Violation|0
370273|NCT00951665|1247675|P3|Phase 1b|Protocol Violation|0
370274|NCT00951665|1247676|P2|Phase 1b|Protocol Violation|0
370275|NCT00951665|1247677|P1|Phase 1b|Protocol Violation|2
370276|NCT00951665|1247672|P6|Phase 1b|Disease Progression|0
370277|NCT00951665|1247673|P5|Phase 1b|Disease Progression|0
370278|NCT00951665|1247674|P4|Phase 1b|Disease Progression|0
370279|NCT00951665|1247675|P3|Phase 1b|Disease Progression|14
370280|NCT00951665|1247676|P2|Phase 1b|Disease Progression|2
370281|NCT00951665|1247677|P1|Phase 1b|Disease Progression|13
370282|NCT00951665|1247672|P6|Phase 1b|Withdrawal by Subject|0
370283|NCT00951665|1247673|P5|Phase 1b|Withdrawal by Subject|0
370284|NCT00951665|1247674|P4|Phase 1b|Withdrawal by Subject|0
370285|NCT00951665|1247675|P3|Phase 1b|Withdrawal by Subject|0
370286|NCT00951665|1247676|P2|Phase 1b|Withdrawal by Subject|1
370287|NCT00951665|1247677|P1|Phase 1b|Withdrawal by Subject|0
370288|NCT00951665|1247672|P6|Phase 1b|Physician Decision|0
370289|NCT00951665|1247673|P5|Phase 1b|Physician Decision|0
370290|NCT00951665|1247674|P4|Phase 1b|Physician Decision|0
370291|NCT00951665|1247675|P3|Phase 1b|Physician Decision|1
370292|NCT00951665|1247676|P2|Phase 1b|Physician Decision|0
370293|NCT00951665|1247677|P1|Phase 1b|Physician Decision|4
370294|NCT00951665|1247672|P6|Phase 1b|Death|0
370295|NCT00951665|1247673|P5|Phase 1b|Death|0
370296|NCT00951665|1247674|P4|Phase 1b|Death|0
370297|NCT00951665|1247675|P3|Phase 1b|Death|2
370298|NCT00951665|1247676|P2|Phase 1b|Death|0
370299|NCT00951665|1247677|P1|Phase 1b|Death|1
370300|NCT00951665|1247672|P6|Phase 1b|Adverse Event|0
370301|NCT00951665|1247673|P5|Phase 1b|Adverse Event|0
370302|NCT00951665|1247674|P4|Phase 1b|Adverse Event|1
370303|NCT00951665|1247675|P3|Phase 1b|Adverse Event|0
370304|NCT00951665|1247676|P2|Phase 1b|Adverse Event|1
370305|NCT00951665|1247677|P1|Phase 1b|Adverse Event|2
370306|NCT00951509|1247786|P1|Overall Study|Withdrawal by Subject|2
370307|NCT00951496|1247797|P3|Overall Study|Did not initiate study treatment|13
370308|NCT00951496|1247798|P2|Overall Study|Did not initiate study treatment|8
370309|NCT00951496|1247799|P1|Overall Study|Did not initiate study treatment|10
370310|NCT00951483|1247827|P2|Overall Study|Withdrawal by Subject|0
370311|NCT00951483|1247828|P1|Overall Study|Withdrawal by Subject|15
370312|NCT00951483|1247827|P2|Overall Study|Physician Decision|0
370313|NCT00951483|1247828|P1|Overall Study|Physician Decision|4
370314|NCT00951379|1247848|P2|Overall Study|Disease Progression|1
370315|NCT00951379|1247849|P1|Overall Study|Disease Progression|0
370316|NCT00951379|1247848|P2|Overall Study|Noncompliance|0
370317|NCT00951379|1247849|P1|Overall Study|Noncompliance|1
370318|NCT00951379|1247848|P2|Overall Study|Withdrawal by Subject|0
370319|NCT00951379|1247849|P1|Overall Study|Withdrawal by Subject|1
370320|NCT00951379|1247848|P2|Overall Study|Adverse Event|1
370321|NCT00951379|1247849|P1|Overall Study|Adverse Event|4
370322|NCT00951275|1247891|P1|Overall Study|Protocol Violation|1
370323|NCT00951275|1247891|P1|Overall Study|Withdrawal by Subject|4
370324|NCT00951275|1247891|P1|Overall Study|Adverse Event|7
370325|NCT00951275|1247891|P1|Overall Study|Administrative Reason|1
370326|NCT00951171|1247923|P2|Overall Study|Adverse Event|0
370327|NCT00951171|1247924|P1|Overall Study|Adverse Event|2
370328|NCT00951015|1247958|P5|Open-label Phase|Physician Decision|8
370329|NCT00951015|1247959|P4|Open-label Phase|Physician Decision|0
370330|NCT00951015|1247960|P3|Open-label Phase|Physician Decision|0
370331|NCT00951015|1247961|P2|Open-label Phase|Physician Decision|0
370332|NCT00951015|1247962|P1|Open-label Phase|Physician Decision|0
370333|NCT00951015|1247958|P5|Open-label Phase|Withdrawal by Subject|14
370334|NCT00951015|1247959|P4|Open-label Phase|Withdrawal by Subject|0
370335|NCT00951015|1247960|P3|Open-label Phase|Withdrawal by Subject|0
370336|NCT00951015|1247961|P2|Open-label Phase|Withdrawal by Subject|0
370337|NCT00951015|1247962|P1|Open-label Phase|Withdrawal by Subject|0
370338|NCT00951015|1247958|P5|Open-label Phase|Lost to Follow-up|12
370339|NCT00951015|1247959|P4|Open-label Phase|Lost to Follow-up|0
370340|NCT00951015|1247960|P3|Open-label Phase|Lost to Follow-up|0
370341|NCT00951015|1247961|P2|Open-label Phase|Lost to Follow-up|0
370342|NCT00951015|1247962|P1|Open-label Phase|Lost to Follow-up|0
370343|NCT00951015|1247958|P5|Open-label Phase|Protocol Violation|12
370344|NCT00951015|1247959|P4|Open-label Phase|Protocol Violation|0
370345|NCT00951015|1247960|P3|Open-label Phase|Protocol Violation|0
370346|NCT00951015|1247961|P2|Open-label Phase|Protocol Violation|0
370347|NCT00951015|1247962|P1|Open-label Phase|Protocol Violation|0
370348|NCT00951015|1247958|P5|Open-label Phase|Lack of Efficacy|1
370349|NCT00951015|1247959|P4|Open-label Phase|Lack of Efficacy|0
370350|NCT00951015|1247960|P3|Open-label Phase|Lack of Efficacy|0
370351|NCT00951015|1247961|P2|Open-label Phase|Lack of Efficacy|0
370352|NCT00951015|1247962|P1|Open-label Phase|Lack of Efficacy|0
370353|NCT00951015|1247958|P5|Open-label Phase|Adverse Event|3
370354|NCT00951015|1247959|P4|Open-label Phase|Adverse Event|0
370355|NCT00951015|1247960|P3|Open-label Phase|Adverse Event|0
370356|NCT00951015|1247961|P2|Open-label Phase|Adverse Event|0
370357|NCT00951015|1247962|P1|Open-label Phase|Adverse Event|0
370358|NCT00951015|1247958|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
370359|NCT00951015|1247959|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
370360|NCT00951015|1247960|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
370361|NCT00951015|1247961|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
370362|NCT00951015|1247962|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
370363|NCT00951015|1247958|P5|Randomization Phase 96 Week|Lost to Follow-up|0
370364|NCT00951015|1247959|P4|Randomization Phase 96 Week|Lost to Follow-up|2
370365|NCT00951015|1247960|P3|Randomization Phase 96 Week|Lost to Follow-up|1
370366|NCT00951015|1247961|P2|Randomization Phase 96 Week|Lost to Follow-up|3
370367|NCT00951015|1247962|P1|Randomization Phase 96 Week|Lost to Follow-up|0
370368|NCT00951015|1247958|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
370369|NCT00951015|1247959|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
370370|NCT00951015|1247960|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
370371|NCT00951015|1247961|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
370372|NCT00951015|1247962|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
370373|NCT00951015|1247958|P5|Randomization Phase 96 Week|Protocol Violation|0
370374|NCT00951015|1247959|P4|Randomization Phase 96 Week|Protocol Violation|0
370375|NCT00951015|1247960|P3|Randomization Phase 96 Week|Protocol Violation|1
370376|NCT00951015|1247961|P2|Randomization Phase 96 Week|Protocol Violation|1
370377|NCT00951015|1247962|P1|Randomization Phase 96 Week|Protocol Violation|1
370378|NCT00951015|1247958|P5|Randomization Phase 96 Week|Lack of Efficacy|0
370379|NCT00951015|1247959|P4|Randomization Phase 96 Week|Lack of Efficacy|0
370380|NCT00951015|1247960|P3|Randomization Phase 96 Week|Lack of Efficacy|0
370381|NCT00951015|1247961|P2|Randomization Phase 96 Week|Lack of Efficacy|1
370382|NCT00951015|1247962|P1|Randomization Phase 96 Week|Lack of Efficacy|1
370383|NCT00951015|1247958|P5|Randomization Phase 96 Week|Adverse Event|0
370384|NCT00951015|1247959|P4|Randomization Phase 96 Week|Adverse Event|5
370385|NCT00951015|1247960|P3|Randomization Phase 96 Week|Adverse Event|2
370386|NCT00951015|1247961|P2|Randomization Phase 96 Week|Adverse Event|1
370387|NCT00951015|1247962|P1|Randomization Phase 96 Week|Adverse Event|1
370388|NCT00950963|1248059|P2|Overall Study|Lost to Follow-up|24
370389|NCT00950963|1248060|P1|Overall Study|Lost to Follow-up|29
370390|NCT00950911|1248095|P2|Overall Study|Poor performance status|1
370391|NCT00950911|1248096|P1|Overall Study|Poor performance status|0
370392|NCT00950911|1248095|P2|Overall Study|Noncompliance|0
370393|NCT00950911|1248096|P1|Overall Study|Noncompliance|1
370394|NCT00950911|1248095|P2|Overall Study|Ineligibility determined|0
370395|NCT00950911|1248096|P1|Overall Study|Ineligibility determined|1
370396|NCT00950911|1248095|P2|Overall Study|Administrative decision|1
370397|NCT00950911|1248096|P1|Overall Study|Administrative decision|3
370398|NCT00950911|1248095|P2|Overall Study|Consent withdrawn|3
370399|NCT00950911|1248096|P1|Overall Study|Consent withdrawn|1
370400|NCT00950911|1248095|P2|Overall Study|Disease progression|2
370401|NCT00950911|1248096|P1|Overall Study|Disease progression|2
370402|NCT00950911|1248095|P2|Overall Study|Death|6
370403|NCT00950911|1248096|P1|Overall Study|Death|4
370404|NCT00950911|1248095|P2|Overall Study|Adverse Event|2
370405|NCT00950911|1248096|P1|Overall Study|Adverse Event|0
370406|NCT00950872|1248102|P1|Overall Study|Did not have surgery|2
370407|NCT00950872|1248102|P1|Overall Study|Withdrawal by Subject|1
370408|NCT00950859|1248111|P2|Overall Study|Lost to Follow-up|3
370409|NCT00950859|1248112|P1|Overall Study|Lost to Follow-up|0
370410|NCT00950859|1248111|P2|Overall Study|Protocol Violation|1
370411|NCT00950859|1248112|P1|Overall Study|Protocol Violation|1
370412|NCT00950859|1248111|P2|Overall Study|Insufficient Viral Load Response|3
370413|NCT00950859|1248112|P1|Overall Study|Insufficient Viral Load Response|12
370414|NCT00950859|1248111|P2|Overall Study|Adverse Event|3
370415|NCT00950859|1248112|P1|Overall Study|Adverse Event|3
370416|NCT00950807|1248211|P10|Treatment Period 3|Adverse Event|0
370417|NCT00950807|1248212|P9|Treatment Period 3|Adverse Event|0
370418|NCT00950807|1248213|P8|Treatment Period 3|Adverse Event|0
370419|NCT00950807|1248214|P7|Treatment Period 3|Adverse Event|1
370420|NCT00950807|1248215|P6|Treatment Period 3|Adverse Event|0
370421|NCT00950807|1248216|P5|Treatment Period 3|Adverse Event|0
370422|NCT00950807|1248217|P4|Treatment Period 3|Adverse Event|0
370423|NCT00950807|1248218|P3|Treatment Period 3|Adverse Event|0
370424|NCT00950807|1248219|P2|Treatment Period 3|Adverse Event|0
370425|NCT00950807|1248220|P1|Treatment Period 3|Adverse Event|0
370426|NCT00950807|1248211|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
370427|NCT00950807|1248212|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
370428|NCT00950807|1248213|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
370429|NCT00950807|1248214|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
370430|NCT00950807|1248215|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
370431|NCT00950807|1248216|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
370432|NCT00950807|1248217|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
370433|NCT00950807|1248218|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
370434|NCT00950807|1248219|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
370435|NCT00950807|1248220|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
370436|NCT00950807|1248211|P10|Treatment Period 3|Withdrawal by Subject|1
370437|NCT00950807|1248212|P9|Treatment Period 3|Withdrawal by Subject|0
370438|NCT00950807|1248213|P8|Treatment Period 3|Withdrawal by Subject|0
370439|NCT00950807|1248214|P7|Treatment Period 3|Withdrawal by Subject|0
370440|NCT00950807|1248215|P6|Treatment Period 3|Withdrawal by Subject|0
370441|NCT00950807|1248216|P5|Treatment Period 3|Withdrawal by Subject|0
370442|NCT00950807|1248217|P4|Treatment Period 3|Withdrawal by Subject|0
370443|NCT00950807|1248218|P3|Treatment Period 3|Withdrawal by Subject|0
370444|NCT00950807|1248219|P2|Treatment Period 3|Withdrawal by Subject|0
370445|NCT00950807|1248220|P1|Treatment Period 3|Withdrawal by Subject|0
370446|NCT00950807|1248211|P10|Washout Period 2|Adverse Event|0
370447|NCT00950807|1248212|P9|Washout Period 2|Adverse Event|0
370448|NCT00950807|1248213|P8|Washout Period 2|Adverse Event|0
370449|NCT00950807|1248214|P7|Washout Period 2|Adverse Event|0
370450|NCT00950807|1248215|P6|Washout Period 2|Adverse Event|0
370451|NCT00950807|1248216|P5|Washout Period 2|Adverse Event|0
370452|NCT00950807|1248217|P4|Washout Period 2|Adverse Event|1
370453|NCT00950807|1248218|P3|Washout Period 2|Adverse Event|0
370454|NCT00950807|1248219|P2|Washout Period 2|Adverse Event|0
370455|NCT00950807|1248220|P1|Washout Period 2|Adverse Event|3
370456|NCT00950807|1248211|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
370457|NCT00950807|1248212|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
370458|NCT00950807|1248213|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
370459|NCT00950807|1248214|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
370460|NCT00950807|1248215|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
370461|NCT00950807|1248216|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
370462|NCT00950807|1248217|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
370463|NCT00950807|1248218|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
370464|NCT00950807|1248219|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
370465|NCT00950807|1248220|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
370466|NCT00950807|1248211|P10|Washout Period 2|Lack of Efficacy|0
370467|NCT00950807|1248212|P9|Washout Period 2|Lack of Efficacy|0
370468|NCT00950807|1248213|P8|Washout Period 2|Lack of Efficacy|0
370469|NCT00950807|1248214|P7|Washout Period 2|Lack of Efficacy|0
370470|NCT00950807|1248215|P6|Washout Period 2|Lack of Efficacy|0
370471|NCT00950807|1248216|P5|Washout Period 2|Lack of Efficacy|0
370472|NCT00950807|1248217|P4|Washout Period 2|Lack of Efficacy|0
370473|NCT00950807|1248218|P3|Washout Period 2|Lack of Efficacy|0
370474|NCT00950807|1248219|P2|Washout Period 2|Lack of Efficacy|0
370475|NCT00950807|1248220|P1|Washout Period 2|Lack of Efficacy|1
370476|NCT00950807|1248211|P10|Treatment Period 2|Adverse Event|0
370477|NCT00950807|1248212|P9|Treatment Period 2|Adverse Event|0
370478|NCT00950807|1248213|P8|Treatment Period 2|Adverse Event|1
370479|NCT00950807|1248214|P7|Treatment Period 2|Adverse Event|0
370480|NCT00950807|1248215|P6|Treatment Period 2|Adverse Event|1
370481|NCT00950807|1248216|P5|Treatment Period 2|Adverse Event|0
370482|NCT00950807|1248217|P4|Treatment Period 2|Adverse Event|1
370483|NCT00950807|1248218|P3|Treatment Period 2|Adverse Event|0
370484|NCT00950807|1248219|P2|Treatment Period 2|Adverse Event|1
370485|NCT00950807|1248220|P1|Treatment Period 2|Adverse Event|0
370486|NCT00950807|1248211|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
370487|NCT00950807|1248212|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
370488|NCT00950807|1248213|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
370489|NCT00950807|1248214|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
370490|NCT00950807|1248215|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
370491|NCT00950807|1248216|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
370492|NCT00950807|1248217|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
370493|NCT00950807|1248218|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
370494|NCT00950807|1248219|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
370495|NCT00950807|1248220|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
370496|NCT00950807|1248211|P10|Treatment Period 2|Withdrawal by Subject|0
370497|NCT00950807|1248212|P9|Treatment Period 2|Withdrawal by Subject|0
370498|NCT00950807|1248213|P8|Treatment Period 2|Withdrawal by Subject|2
370499|NCT00950807|1248214|P7|Treatment Period 2|Withdrawal by Subject|1
370500|NCT00950807|1248215|P6|Treatment Period 2|Withdrawal by Subject|0
370501|NCT00950807|1248216|P5|Treatment Period 2|Withdrawal by Subject|0
370502|NCT00950807|1248217|P4|Treatment Period 2|Withdrawal by Subject|0
370503|NCT00950807|1248218|P3|Treatment Period 2|Withdrawal by Subject|0
370504|NCT00950807|1248219|P2|Treatment Period 2|Withdrawal by Subject|0
370505|NCT00950807|1248220|P1|Treatment Period 2|Withdrawal by Subject|0
370506|NCT00950807|1248211|P10|Treatment Period 2|Lack of Efficacy|0
370507|NCT00950807|1248212|P9|Treatment Period 2|Lack of Efficacy|0
370508|NCT00950807|1248213|P8|Treatment Period 2|Lack of Efficacy|0
370509|NCT00950807|1248214|P7|Treatment Period 2|Lack of Efficacy|0
370510|NCT00950807|1248215|P6|Treatment Period 2|Lack of Efficacy|0
370511|NCT00950807|1248216|P5|Treatment Period 2|Lack of Efficacy|0
370512|NCT00950807|1248217|P4|Treatment Period 2|Lack of Efficacy|0
370513|NCT00950807|1248218|P3|Treatment Period 2|Lack of Efficacy|0
370514|NCT00950807|1248219|P2|Treatment Period 2|Lack of Efficacy|0
370515|NCT00950807|1248220|P1|Treatment Period 2|Lack of Efficacy|1
370516|NCT00950807|1248211|P10|Washout Period 1|Adverse Event|0
370517|NCT00950807|1248212|P9|Washout Period 1|Adverse Event|0
370518|NCT00950807|1248213|P8|Washout Period 1|Adverse Event|0
370519|NCT00950807|1248214|P7|Washout Period 1|Adverse Event|0
370520|NCT00950807|1248215|P6|Washout Period 1|Adverse Event|0
370521|NCT00950807|1248216|P5|Washout Period 1|Adverse Event|1
370522|NCT00950807|1248217|P4|Washout Period 1|Adverse Event|1
370523|NCT00950807|1248218|P3|Washout Period 1|Adverse Event|0
370524|NCT00950807|1248219|P2|Washout Period 1|Adverse Event|0
370525|NCT00950807|1248220|P1|Washout Period 1|Adverse Event|2
370526|NCT00950807|1248211|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
370527|NCT00950807|1248212|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
370528|NCT00950807|1248213|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
370529|NCT00950807|1248214|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
370530|NCT00950807|1248215|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
370531|NCT00950807|1248216|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
370532|NCT00950807|1248217|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
370533|NCT00950807|1248218|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
370534|NCT00950807|1248219|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
370535|NCT00950807|1248220|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
370536|NCT00950807|1248211|P10|Washout Period 1|Withdrawal by Subject|0
370537|NCT00950807|1248212|P9|Washout Period 1|Withdrawal by Subject|1
370538|NCT00950807|1248213|P8|Washout Period 1|Withdrawal by Subject|0
370539|NCT00950807|1248214|P7|Washout Period 1|Withdrawal by Subject|0
370540|NCT00950807|1248215|P6|Washout Period 1|Withdrawal by Subject|0
370541|NCT00950807|1248216|P5|Washout Period 1|Withdrawal by Subject|0
370542|NCT00950807|1248217|P4|Washout Period 1|Withdrawal by Subject|0
370543|NCT00950807|1248218|P3|Washout Period 1|Withdrawal by Subject|0
370544|NCT00950807|1248219|P2|Washout Period 1|Withdrawal by Subject|0
370545|NCT00950807|1248220|P1|Washout Period 1|Withdrawal by Subject|0
370546|NCT00950807|1248211|P10|Washout Period 1|Lack of Efficacy|0
370547|NCT00950807|1248212|P9|Washout Period 1|Lack of Efficacy|0
370548|NCT00950807|1248213|P8|Washout Period 1|Lack of Efficacy|0
370549|NCT00950807|1248214|P7|Washout Period 1|Lack of Efficacy|1
370550|NCT00950807|1248215|P6|Washout Period 1|Lack of Efficacy|0
370551|NCT00950807|1248216|P5|Washout Period 1|Lack of Efficacy|0
370552|NCT00950807|1248217|P4|Washout Period 1|Lack of Efficacy|0
370553|NCT00950807|1248218|P3|Washout Period 1|Lack of Efficacy|0
370554|NCT00950807|1248219|P2|Washout Period 1|Lack of Efficacy|0
370555|NCT00950807|1248220|P1|Washout Period 1|Lack of Efficacy|0
370556|NCT00950807|1248211|P10|Treatment Period 1|Adverse Event|0
370557|NCT00950807|1248212|P9|Treatment Period 1|Adverse Event|0
370558|NCT00950807|1248213|P8|Treatment Period 1|Adverse Event|0
370559|NCT00950807|1248214|P7|Treatment Period 1|Adverse Event|0
370560|NCT00950807|1248215|P6|Treatment Period 1|Adverse Event|1
370561|NCT00950807|1248216|P5|Treatment Period 1|Adverse Event|0
370562|NCT00950807|1248217|P4|Treatment Period 1|Adverse Event|0
370563|NCT00950807|1248218|P3|Treatment Period 1|Adverse Event|0
370564|NCT00950807|1248219|P2|Treatment Period 1|Adverse Event|0
370565|NCT00950807|1248220|P1|Treatment Period 1|Adverse Event|0
370566|NCT00950807|1248211|P10|Treatment Period 1|Withdrawal by Subject|0
370567|NCT00950807|1248212|P9|Treatment Period 1|Withdrawal by Subject|1
370568|NCT00950807|1248213|P8|Treatment Period 1|Withdrawal by Subject|0
370569|NCT00950807|1248214|P7|Treatment Period 1|Withdrawal by Subject|0
370570|NCT00950807|1248215|P6|Treatment Period 1|Withdrawal by Subject|0
370571|NCT00950807|1248216|P5|Treatment Period 1|Withdrawal by Subject|1
370572|NCT00950807|1248217|P4|Treatment Period 1|Withdrawal by Subject|0
370573|NCT00950807|1248218|P3|Treatment Period 1|Withdrawal by Subject|0
370574|NCT00950807|1248219|P2|Treatment Period 1|Withdrawal by Subject|0
370575|NCT00950807|1248220|P1|Treatment Period 1|Withdrawal by Subject|1
370576|NCT00950807|1248211|P10|Treatment Period 1|Lost to Follow-up|0
370577|NCT00950807|1248212|P9|Treatment Period 1|Lost to Follow-up|0
370578|NCT00950807|1248213|P8|Treatment Period 1|Lost to Follow-up|0
370579|NCT00950807|1248214|P7|Treatment Period 1|Lost to Follow-up|0
370580|NCT00950807|1248215|P6|Treatment Period 1|Lost to Follow-up|0
370581|NCT00950807|1248216|P5|Treatment Period 1|Lost to Follow-up|0
370582|NCT00950807|1248217|P4|Treatment Period 1|Lost to Follow-up|0
370583|NCT00950807|1248218|P3|Treatment Period 1|Lost to Follow-up|1
370584|NCT00950807|1248219|P2|Treatment Period 1|Lost to Follow-up|0
370585|NCT00950807|1248220|P1|Treatment Period 1|Lost to Follow-up|0
370586|NCT00950807|1248211|P10|Treatment Period 1|Protocol Violation|0
370587|NCT00950807|1248212|P9|Treatment Period 1|Protocol Violation|0
370588|NCT00950807|1248213|P8|Treatment Period 1|Protocol Violation|0
370589|NCT00950807|1248214|P7|Treatment Period 1|Protocol Violation|0
370590|NCT00950807|1248215|P6|Treatment Period 1|Protocol Violation|0
370591|NCT00950807|1248216|P5|Treatment Period 1|Protocol Violation|0
370592|NCT00950807|1248217|P4|Treatment Period 1|Protocol Violation|0
370593|NCT00950807|1248218|P3|Treatment Period 1|Protocol Violation|0
370594|NCT00950807|1248219|P2|Treatment Period 1|Protocol Violation|0
370595|NCT00950807|1248220|P1|Treatment Period 1|Protocol Violation|1
370596|NCT00950807|1248211|P10|Treatment Period 1|Lack of Efficacy|0
370597|NCT00950807|1248212|P9|Treatment Period 1|Lack of Efficacy|0
370598|NCT00950807|1248213|P8|Treatment Period 1|Lack of Efficacy|0
370599|NCT00950807|1248214|P7|Treatment Period 1|Lack of Efficacy|0
370600|NCT00950807|1248215|P6|Treatment Period 1|Lack of Efficacy|1
370601|NCT00950807|1248216|P5|Treatment Period 1|Lack of Efficacy|0
370602|NCT00950807|1248217|P4|Treatment Period 1|Lack of Efficacy|0
370603|NCT00950807|1248218|P3|Treatment Period 1|Lack of Efficacy|0
370604|NCT00950807|1248219|P2|Treatment Period 1|Lack of Efficacy|0
370605|NCT00950807|1248220|P1|Treatment Period 1|Lack of Efficacy|1
370606|NCT00950755|1248262|P1|Long-Term Follow-Up|Death|8
370607|NCT00950755|1248262|P1|Long-Term Follow-Up|Lost to Follow-up|1
370608|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
370609|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
370610|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
370611|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
370612|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Death|1
370613|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
370614|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
370615|NCT00950755|1248262|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
370616|NCT00950742|1248288|P2|Overall Study|Dose limiting toxicity|0
370617|NCT00950742|1248289|P1|Overall Study|Dose limiting toxicity|6
370618|NCT00950742|1248288|P2|Overall Study|Progressive Disease|2
370619|NCT00950742|1248289|P1|Overall Study|Progressive Disease|6
370620|NCT00950742|1248288|P2|Overall Study|Withdrawal by Subject|0
370621|NCT00950742|1248289|P1|Overall Study|Withdrawal by Subject|3
370622|NCT00950742|1248288|P2|Overall Study|Other Adverse Event|0
370623|NCT00950742|1248289|P1|Overall Study|Other Adverse Event|1
370624|NCT00950690|1248310|P1|Overall Study|Other|163
370625|NCT00950690|1248310|P1|Overall Study|Lost to Follow-up|40
370626|NCT00950690|1248310|P1|Overall Study|Lack of Efficacy|22
370627|NCT00950690|1248310|P1|Overall Study|Adverse Event|15
370628|NCT00950690|1248310|P1|Overall Study|Death|4
370629|NCT00950664|1248317|P2|First Intervention|Withdrawal by Subject|2
370630|NCT00950664|1248318|P1|First Intervention|Withdrawal by Subject|2
370631|NCT00950664|1248317|P2|First Intervention|Lost to Follow-up|3
370632|NCT00950664|1248318|P1|First Intervention|Lost to Follow-up|1
370633|NCT00950651|1248338|P2|Overall Study|Withdrawal by Subject|9
370634|NCT00950651|1248339|P1|Overall Study|Withdrawal by Subject|8
370635|NCT00950651|1248338|P2|Overall Study|Protocol Violation|4
370636|NCT00950651|1248339|P1|Overall Study|Protocol Violation|3
370637|NCT00950651|1248338|P2|Overall Study|Lack of Efficacy|2
370638|NCT00950651|1248339|P1|Overall Study|Lack of Efficacy|2
370639|NCT00950651|1248338|P2|Overall Study|Death|0
370640|NCT00950651|1248339|P1|Overall Study|Death|1
370641|NCT00950651|1248338|P2|Overall Study|Adverse Event|20
370642|NCT00950651|1248339|P1|Overall Study|Adverse Event|17
370643|NCT00950599|1248432|P10|Follow-Up Period|Subject withdrew Consent|1
370644|NCT00950599|1248433|P9|Follow-Up Period|Subject withdrew Consent|2
370645|NCT00950599|1248434|P8|Follow-Up Period|Subject withdrew Consent|0
370646|NCT00950599|1248435|P7|Follow-Up Period|Subject withdrew Consent|0
370647|NCT00950599|1248436|P6|Follow-Up Period|Subject withdrew Consent|0
370648|NCT00950599|1248437|P5|Follow-Up Period|Subject withdrew Consent|0
370649|NCT00950599|1248438|P4|Follow-Up Period|Subject withdrew Consent|0
370650|NCT00950599|1248439|P3|Follow-Up Period|Subject withdrew Consent|0
370651|NCT00950599|1248440|P2|Follow-Up Period|Subject withdrew Consent|0
370652|NCT00950599|1248441|P1|Follow-Up Period|Subject withdrew Consent|0
370653|NCT00950599|1248432|P10|Follow-Up Period|Poor/Noncompliance|0
370654|NCT00950599|1248433|P9|Follow-Up Period|Poor/Noncompliance|1
370655|NCT00950599|1248434|P8|Follow-Up Period|Poor/Noncompliance|0
370656|NCT00950599|1248435|P7|Follow-Up Period|Poor/Noncompliance|0
370657|NCT00950599|1248436|P6|Follow-Up Period|Poor/Noncompliance|0
370658|NCT00950599|1248437|P5|Follow-Up Period|Poor/Noncompliance|0
370659|NCT00950599|1248438|P4|Follow-Up Period|Poor/Noncompliance|0
370660|NCT00950599|1248439|P3|Follow-Up Period|Poor/Noncompliance|0
370661|NCT00950599|1248440|P2|Follow-Up Period|Poor/Noncompliance|0
370662|NCT00950599|1248441|P1|Follow-Up Period|Poor/Noncompliance|0
370663|NCT00950599|1248432|P10|Follow-Up Period|Physician Decision|0
370664|NCT00950599|1248433|P9|Follow-Up Period|Physician Decision|1
370665|NCT00950599|1248434|P8|Follow-Up Period|Physician Decision|0
370666|NCT00950599|1248435|P7|Follow-Up Period|Physician Decision|0
370667|NCT00950599|1248436|P6|Follow-Up Period|Physician Decision|0
370668|NCT00950599|1248437|P5|Follow-Up Period|Physician Decision|0
370669|NCT00950599|1248438|P4|Follow-Up Period|Physician Decision|0
370670|NCT00950599|1248439|P3|Follow-Up Period|Physician Decision|0
370671|NCT00950599|1248440|P2|Follow-Up Period|Physician Decision|0
370672|NCT00950599|1248441|P1|Follow-Up Period|Physician Decision|0
370673|NCT00950599|1248432|P10|Follow-Up Period|Lost to Follow-up|1
370674|NCT00950599|1248433|P9|Follow-Up Period|Lost to Follow-up|5
370675|NCT00950599|1248434|P8|Follow-Up Period|Lost to Follow-up|0
370676|NCT00950599|1248435|P7|Follow-Up Period|Lost to Follow-up|0
370677|NCT00950599|1248436|P6|Follow-Up Period|Lost to Follow-up|0
370678|NCT00950599|1248437|P5|Follow-Up Period|Lost to Follow-up|0
370679|NCT00950599|1248438|P4|Follow-Up Period|Lost to Follow-up|0
370680|NCT00950599|1248439|P3|Follow-Up Period|Lost to Follow-up|0
370681|NCT00950599|1248440|P2|Follow-Up Period|Lost to Follow-up|0
370682|NCT00950599|1248441|P1|Follow-Up Period|Lost to Follow-up|0
370683|NCT00950599|1248432|P10|Follow-Up Period|Lack of Efficacy|0
370684|NCT00950599|1248433|P9|Follow-Up Period|Lack of Efficacy|3
370685|NCT00950599|1248434|P8|Follow-Up Period|Lack of Efficacy|0
370686|NCT00950599|1248435|P7|Follow-Up Period|Lack of Efficacy|0
370687|NCT00950599|1248436|P6|Follow-Up Period|Lack of Efficacy|0
370688|NCT00950599|1248437|P5|Follow-Up Period|Lack of Efficacy|0
370689|NCT00950599|1248438|P4|Follow-Up Period|Lack of Efficacy|0
370690|NCT00950599|1248439|P3|Follow-Up Period|Lack of Efficacy|0
370691|NCT00950599|1248440|P2|Follow-Up Period|Lack of Efficacy|0
370692|NCT00950599|1248441|P1|Follow-Up Period|Lack of Efficacy|0
370693|NCT00950599|1248432|P10|Follow-Up Period|Adverse Event|0
370694|NCT00950599|1248433|P9|Follow-Up Period|Adverse Event|1
370695|NCT00950599|1248434|P8|Follow-Up Period|Adverse Event|0
370696|NCT00950599|1248435|P7|Follow-Up Period|Adverse Event|0
370697|NCT00950599|1248436|P6|Follow-Up Period|Adverse Event|0
370698|NCT00950599|1248437|P5|Follow-Up Period|Adverse Event|0
370699|NCT00950599|1248438|P4|Follow-Up Period|Adverse Event|0
370700|NCT00950599|1248439|P3|Follow-Up Period|Adverse Event|0
370701|NCT00950599|1248440|P2|Follow-Up Period|Adverse Event|0
370702|NCT00950599|1248441|P1|Follow-Up Period|Adverse Event|0
370703|NCT00950599|1248432|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
370704|NCT00950599|1248433|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
370705|NCT00950599|1248434|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
370706|NCT00950599|1248435|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
370707|NCT00950599|1248436|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
370708|NCT00950599|1248437|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
370709|NCT00950599|1248438|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
370710|NCT00950599|1248439|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
370711|NCT00950599|1248440|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
370712|NCT00950599|1248441|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
370713|NCT00950599|1248432|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370714|NCT00950599|1248433|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370715|NCT00950599|1248434|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370716|NCT00950599|1248435|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370717|NCT00950599|1248436|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
370718|NCT00950599|1248437|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
370719|NCT00950599|1248438|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370720|NCT00950599|1248439|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370721|NCT00950599|1248440|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370722|NCT00950599|1248441|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
370723|NCT00950599|1248432|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
370724|NCT00950599|1248433|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
370725|NCT00950599|1248434|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
370726|NCT00950599|1248435|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
370727|NCT00950599|1248436|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
370728|NCT00950599|1248437|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
370729|NCT00950599|1248438|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
370730|NCT00950599|1248439|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
370731|NCT00950599|1248440|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
370732|NCT00950599|1248441|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
370733|NCT00950599|1248432|P10|Double-Blind Treatment Period|Lost to Follow-up|0
370734|NCT00950599|1248433|P9|Double-Blind Treatment Period|Lost to Follow-up|0
370735|NCT00950599|1248434|P8|Double-Blind Treatment Period|Lost to Follow-up|1
370736|NCT00950599|1248435|P7|Double-Blind Treatment Period|Lost to Follow-up|0
370737|NCT00950599|1248436|P6|Double-Blind Treatment Period|Lost to Follow-up|2
370738|NCT00950599|1248437|P5|Double-Blind Treatment Period|Lost to Follow-up|1
370739|NCT00950599|1248438|P4|Double-Blind Treatment Period|Lost to Follow-up|1
370740|NCT00950599|1248439|P3|Double-Blind Treatment Period|Lost to Follow-up|0
370741|NCT00950599|1248440|P2|Double-Blind Treatment Period|Lost to Follow-up|0
370742|NCT00950599|1248441|P1|Double-Blind Treatment Period|Lost to Follow-up|0
370743|NCT00950599|1248432|P10|Double-Blind Treatment Period|Lack of Efficacy|0
370744|NCT00950599|1248433|P9|Double-Blind Treatment Period|Lack of Efficacy|0
370745|NCT00950599|1248434|P8|Double-Blind Treatment Period|Lack of Efficacy|1
370746|NCT00950599|1248435|P7|Double-Blind Treatment Period|Lack of Efficacy|0
370747|NCT00950599|1248436|P6|Double-Blind Treatment Period|Lack of Efficacy|6
370748|NCT00950599|1248437|P5|Double-Blind Treatment Period|Lack of Efficacy|3
370749|NCT00950599|1248438|P4|Double-Blind Treatment Period|Lack of Efficacy|7
370750|NCT00950599|1248439|P3|Double-Blind Treatment Period|Lack of Efficacy|5
370751|NCT00950599|1248440|P2|Double-Blind Treatment Period|Lack of Efficacy|5
370752|NCT00950599|1248441|P1|Double-Blind Treatment Period|Lack of Efficacy|2
370753|NCT00950599|1248432|P10|Double-Blind Treatment Period|Adverse Event|0
370754|NCT00950599|1248433|P9|Double-Blind Treatment Period|Adverse Event|0
370755|NCT00950599|1248434|P8|Double-Blind Treatment Period|Adverse Event|0
370756|NCT00950599|1248435|P7|Double-Blind Treatment Period|Adverse Event|0
370757|NCT00950599|1248436|P6|Double-Blind Treatment Period|Adverse Event|1
370758|NCT00950599|1248437|P5|Double-Blind Treatment Period|Adverse Event|1
370759|NCT00950599|1248438|P4|Double-Blind Treatment Period|Adverse Event|1
370760|NCT00950599|1248439|P3|Double-Blind Treatment Period|Adverse Event|1
370761|NCT00950599|1248440|P2|Double-Blind Treatment Period|Adverse Event|1
370762|NCT00950599|1248441|P1|Double-Blind Treatment Period|Adverse Event|0
370763|NCT00950599|1248432|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
370764|NCT00950599|1248433|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
370765|NCT00950599|1248434|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
370766|NCT00950599|1248435|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
370767|NCT00950599|1248436|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
370768|NCT00950599|1248437|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
370769|NCT00950599|1248438|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
370770|NCT00950599|1248439|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
370771|NCT00950599|1248440|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
370772|NCT00950599|1248441|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
370773|NCT00950300|1249014|P2|SFU Period|Withdrawal by Subject|8
370774|NCT00950300|1249015|P1|SFU Period|Withdrawal by Subject|4
370775|NCT00950300|1249014|P2|SFU Period|Lost to Follow-up|28
370776|NCT00950300|1249015|P1|SFU Period|Lost to Follow-up|30
370777|NCT00950300|1249014|P2|SFU Period|Death|42
370778|NCT00950300|1249015|P1|SFU Period|Death|44
370779|NCT00950300|1249014|P2|TFFU Period|Not Specified|3
370780|NCT00950300|1249015|P1|TFFU Period|Not Specified|4
370781|NCT00950300|1249014|P2|TFFU Period|Recurrence of Disease|72
370782|NCT00950300|1249015|P1|TFFU Period|Recurrence of Disease|63
370783|NCT00950300|1249014|P2|TFFU Period|Failure to Return|16
370784|NCT00950300|1249015|P1|TFFU Period|Failure to Return|16
370785|NCT00950300|1249014|P2|TFFU Period|Refused Treatment|11
370786|NCT00950300|1249015|P1|TFFU Period|Refused Treatment|10
370787|NCT00950300|1249014|P2|TFFU Period|Death|1
370788|NCT00950300|1249015|P1|TFFU Period|Death|4
370789|NCT00950300|1249014|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
370790|NCT00950300|1249015|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
370791|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
370792|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
370793|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
370794|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
370795|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
370796|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
370797|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
370798|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
370799|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
370800|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
370801|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
370802|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
370803|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
370804|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
370805|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
370806|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
370807|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
370808|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
370809|NCT00950300|1249014|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
370810|NCT00950300|1249015|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
370811|NCT00949975|1249087|P4|Overall Study|Other|0
370812|NCT00949975|1249088|P3|Overall Study|Other|0
370813|NCT00949975|1249089|P2|Overall Study|Other|0
370814|NCT00949975|1249090|P1|Overall Study|Other|1
370815|NCT00949975|1249087|P4|Overall Study|Lost to Follow-up|3
370816|NCT00949975|1249088|P3|Overall Study|Lost to Follow-up|1
370817|NCT00949975|1249089|P2|Overall Study|Lost to Follow-up|0
370818|NCT00949975|1249090|P1|Overall Study|Lost to Follow-up|1
370819|NCT00949975|1249087|P4|Overall Study|Severe non-compliance|2
370820|NCT00949975|1249088|P3|Overall Study|Severe non-compliance|0
370821|NCT00949975|1249089|P2|Overall Study|Severe non-compliance|1
370822|NCT00949975|1249090|P1|Overall Study|Severe non-compliance|3
370823|NCT00949975|1249087|P4|Overall Study|Incorrect enrolment|7
370824|NCT00949975|1249088|P3|Overall Study|Incorrect enrolment|4
370825|NCT00949975|1249089|P2|Overall Study|Incorrect enrolment|10
370826|NCT00949975|1249090|P1|Overall Study|Incorrect enrolment|5
370827|NCT00949975|1249087|P4|Overall Study|Study-specific criteria|0
370828|NCT00949975|1249088|P3|Overall Study|Study-specific criteria|1
370829|NCT00949975|1249089|P2|Overall Study|Study-specific criteria|1
370830|NCT00949975|1249090|P1|Overall Study|Study-specific criteria|0
370831|NCT00949975|1249087|P4|Overall Study|Safety reason|0
370832|NCT00949975|1249088|P3|Overall Study|Safety reason|0
370833|NCT00949975|1249089|P2|Overall Study|Safety reason|1
370834|NCT00949975|1249090|P1|Overall Study|Safety reason|0
370835|NCT00949975|1249087|P4|Overall Study|Adverse Event|10
370836|NCT00949975|1249088|P3|Overall Study|Adverse Event|10
370837|NCT00949975|1249089|P2|Overall Study|Adverse Event|11
370838|NCT00949975|1249090|P1|Overall Study|Adverse Event|11
370839|NCT00949975|1249087|P4|Overall Study|Voluntary discontinuation|6
370840|NCT00949975|1249088|P3|Overall Study|Voluntary discontinuation|3
370841|NCT00949975|1249089|P2|Overall Study|Voluntary discontinuation|5
370842|NCT00949975|1249090|P1|Overall Study|Voluntary discontinuation|6
370843|NCT00949910|1249208|P1|Overall Study|No Data|9
370844|NCT00949910|1249208|P1|Overall Study|Other|4
370845|NCT00949910|1249208|P1|Overall Study|Physician/Participant Decision|7
370846|NCT00949910|1249208|P1|Overall Study|Serious Adverse Event|6
370847|NCT00949910|1249208|P1|Overall Study|Adverse Event|83
370848|NCT00949910|1249208|P1|Overall Study|Prolonged Dosing Interruption|4
370849|NCT00949910|1249208|P1|Overall Study|Non-Compliance|10
370850|NCT00949910|1249208|P1|Overall Study|Logistical Reasons|13
370851|NCT00949910|1249208|P1|Overall Study|Violation of Eligibility|23
370852|NCT00949910|1249208|P1|Overall Study|Switched to Commercial Treatment|4
370853|NCT00949910|1249208|P1|Overall Study|Switched to Compassionate/Other Use|174
370854|NCT00949910|1249208|P1|Overall Study|Unspecified Progression/Deterioration|13
370855|NCT00949910|1249208|P1|Overall Study|Death from Unknown Cause|5
370856|NCT00949910|1249208|P1|Overall Study|Death Due to Toxicity|3
370857|NCT00949910|1249208|P1|Overall Study|Death Due to Adverse Event|115
370858|NCT00949910|1249208|P1|Overall Study|Death Due to Progression/Deterioration|4
370859|NCT00949910|1249208|P1|Overall Study|Death Due to Malignant Disease|456
370860|NCT00949910|1249208|P1|Overall Study|Participant Refusal|390
370861|NCT00949910|1249208|P1|Overall Study|Study Drug-Related Adverse Event|315
370862|NCT00949910|1249208|P1|Overall Study|Lost to Follow-up|100
370863|NCT00949910|1249208|P1|Overall Study|Symptomatic Deterioration|1088
370864|NCT00949910|1249208|P1|Overall Study|Progressive Disease|3750
370865|NCT00949884|1249221|P3|Overall Study|Study terminated by sponsor|1
370866|NCT00949884|1249222|P2|Overall Study|Study terminated by sponsor|0
370867|NCT00949884|1249223|P1|Overall Study|Study terminated by sponsor|0
370868|NCT00949884|1249221|P3|Overall Study|Lack of Efficacy|7
370869|NCT00949884|1249222|P2|Overall Study|Lack of Efficacy|2
370870|NCT00949884|1249223|P1|Overall Study|Lack of Efficacy|4
370871|NCT00949884|1249221|P3|Overall Study|Withdrawal by Subject|16
370872|NCT00949884|1249222|P2|Overall Study|Withdrawal by Subject|4
370873|NCT00949884|1249223|P1|Overall Study|Withdrawal by Subject|13
370874|NCT00949884|1249221|P3|Overall Study|Treatment non-compliance|8
370875|NCT00949884|1249222|P2|Overall Study|Treatment non-compliance|0
370876|NCT00949884|1249223|P1|Overall Study|Treatment non-compliance|5
370877|NCT00949884|1249221|P3|Overall Study|Physician Decision|6
370878|NCT00949884|1249222|P2|Overall Study|Physician Decision|0
370879|NCT00949884|1249223|P1|Overall Study|Physician Decision|5
370880|NCT00949884|1249221|P3|Overall Study|Lost to Follow-up|5
370881|NCT00949884|1249222|P2|Overall Study|Lost to Follow-up|5
370882|NCT00949884|1249223|P1|Overall Study|Lost to Follow-up|7
370883|NCT00949884|1249221|P3|Overall Study|Did not meet inclusion/exclusion|3
370884|NCT00949884|1249222|P2|Overall Study|Did not meet inclusion/exclusion|1
370885|NCT00949884|1249223|P1|Overall Study|Did not meet inclusion/exclusion|2
370886|NCT00949884|1249221|P3|Overall Study|Adverse Event|12
370887|NCT00949884|1249222|P2|Overall Study|Adverse Event|3
370888|NCT00949884|1249223|P1|Overall Study|Adverse Event|14
370889|NCT00949715|1249278|P2|Overall Study|Missing 24 month LVEF measurement|0
370890|NCT00949715|1249279|P1|Overall Study|Missing 24 month LVEF measurement|2
370891|NCT00949715|1249278|P2|Overall Study|Lost to Follow-up|0
370892|NCT00949715|1249279|P1|Overall Study|Lost to Follow-up|1
370893|NCT00949715|1249278|P2|Overall Study|Physician Decision|0
370894|NCT00949715|1249279|P1|Overall Study|Physician Decision|1
370895|NCT00949702|1249290|P1|Overall Study|Withdrawal of consent|1
370896|NCT00949702|1249290|P1|Overall Study|Disease progression|7
370897|NCT00949702|1249290|P1|Overall Study|Death|40
370898|NCT00949650|1249307|P2|Overall Study|Other not specified above|0
370899|NCT00949650|1249308|P1|Overall Study|Other not specified above|5
370900|NCT00949650|1249307|P2|Overall Study|Not treated|4
370901|NCT00949650|1249308|P1|Overall Study|Not treated|1
370902|NCT00949650|1249307|P2|Overall Study|Refusal to continue medication|11
370903|NCT00949650|1249308|P1|Overall Study|Refusal to continue medication|7
370904|NCT00949650|1249307|P2|Overall Study|Protocol Violation|4
370905|NCT00949650|1249308|P1|Overall Study|Protocol Violation|1
370906|NCT00949650|1249307|P2|Overall Study|Other Adverse Event (AE)|17
370907|NCT00949650|1249308|P1|Overall Study|Other Adverse Event (AE)|28
370908|NCT00949650|1249307|P2|Overall Study|Completed 6 courses of chemotherapy|60
370909|NCT00949650|1249308|P1|Overall Study|Completed 6 courses of chemotherapy|0
370910|NCT00949650|1249307|P2|Overall Study|Progressive disease|19
370911|NCT00949650|1249308|P1|Overall Study|Progressive disease|188
370912|NCT00949533|1249346|P2|Overall Study|Lost to Follow-up|1
370913|NCT00949533|1249347|P1|Overall Study|Lost to Follow-up|0
370914|NCT00949117|1249365|P2|Overall Study|Adverse Event|1
370915|NCT00949117|1249366|P1|Overall Study|Adverse Event|0
370916|NCT00949117|1249365|P2|Overall Study|Protocol Violation|1
370917|NCT00949117|1249366|P1|Overall Study|Protocol Violation|1
370918|NCT00949117|1249365|P2|Overall Study|Lack of Efficacy|3
370919|NCT00949117|1249366|P1|Overall Study|Lack of Efficacy|2
370920|NCT00948896|1249413|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
370921|NCT00948896|1249414|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
370922|NCT00948896|1249415|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
370923|NCT00948896|1249416|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
370924|NCT00948896|1249417|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
370925|NCT00948896|1249418|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
370926|NCT00948896|1249419|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
370927|NCT00948896|1249420|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
370928|NCT00948896|1249413|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
370929|NCT00948896|1249414|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
370930|NCT00948896|1249415|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
370931|NCT00948896|1249416|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
370932|NCT00948896|1249417|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
370933|NCT00948896|1249418|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
370934|NCT00948896|1249419|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
370935|NCT00948896|1249420|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
370936|NCT00948896|1249413|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
370937|NCT00948896|1249414|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
370938|NCT00948896|1249415|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
370939|NCT00948896|1249416|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
370940|NCT00948896|1249417|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
370941|NCT00948896|1249418|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
370942|NCT00948896|1249419|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
370943|NCT00948896|1249420|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
370944|NCT00948896|1249413|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
370945|NCT00948896|1249414|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
370946|NCT00948896|1249415|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
370947|NCT00948896|1249416|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
370948|NCT00948896|1249417|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
370949|NCT00948896|1249418|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
370950|NCT00948896|1249419|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
370951|NCT00948896|1249420|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
370952|NCT00948896|1249413|P8|24 Months of Age to 36 Months of Age|Death|0
370953|NCT00948896|1249414|P7|24 Months of Age to 36 Months of Age|Death|0
370954|NCT00948896|1249415|P6|24 Months of Age to 36 Months of Age|Death|1
370955|NCT00948896|1249416|P5|24 Months of Age to 36 Months of Age|Death|0
370956|NCT00948896|1249417|P4|24 Months of Age to 36 Months of Age|Death|0
370957|NCT00948896|1249418|P3|24 Months of Age to 36 Months of Age|Death|2
370958|NCT00948896|1249419|P2|24 Months of Age to 36 Months of Age|Death|2
370959|NCT00948896|1249420|P1|24 Months of Age to 36 Months of Age|Death|0
370960|NCT00948896|1249413|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
370961|NCT00948896|1249414|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
370962|NCT00948896|1249415|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
370963|NCT00948896|1249416|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
370964|NCT00948896|1249417|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
370965|NCT00948896|1249418|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
370966|NCT00948896|1249419|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
370967|NCT00948896|1249420|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
370968|NCT00948896|1249413|P8|Randomization to 24 Months of Age|Protocol Violation|1
370969|NCT00948896|1249414|P7|Randomization to 24 Months of Age|Protocol Violation|1
370970|NCT00948896|1249415|P6|Randomization to 24 Months of Age|Protocol Violation|0
370971|NCT00948896|1249416|P5|Randomization to 24 Months of Age|Protocol Violation|0
370972|NCT00948896|1249417|P4|Randomization to 24 Months of Age|Protocol Violation|1
370973|NCT00948896|1249418|P3|Randomization to 24 Months of Age|Protocol Violation|0
370974|NCT00948896|1249419|P2|Randomization to 24 Months of Age|Protocol Violation|1
370975|NCT00948896|1249420|P1|Randomization to 24 Months of Age|Protocol Violation|0
370976|NCT00948896|1249413|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
370977|NCT00948896|1249414|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
370978|NCT00948896|1249415|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
370979|NCT00948896|1249416|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
370980|NCT00948896|1249417|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
370981|NCT00948896|1249418|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
370982|NCT00948896|1249419|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
370983|NCT00948896|1249420|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
370984|NCT00948896|1249413|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
370985|NCT00948896|1249414|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
370986|NCT00948896|1249415|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
370987|NCT00948896|1249416|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
370988|NCT00948896|1249417|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
370989|NCT00948896|1249418|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
370990|NCT00948896|1249419|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
370991|NCT00948896|1249420|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
370992|NCT00948896|1249413|P8|Randomization to 24 Months of Age|Death|1
370993|NCT00948896|1249414|P7|Randomization to 24 Months of Age|Death|2
370994|NCT00948896|1249415|P6|Randomization to 24 Months of Age|Death|1
370995|NCT00948896|1249416|P5|Randomization to 24 Months of Age|Death|2
370996|NCT00948896|1249417|P4|Randomization to 24 Months of Age|Death|0
370997|NCT00948896|1249418|P3|Randomization to 24 Months of Age|Death|0
370998|NCT00948896|1249419|P2|Randomization to 24 Months of Age|Death|0
370999|NCT00948896|1249420|P1|Randomization to 24 Months of Age|Death|1
371000|NCT00948857|1249456|P2|Overall Study|Lost to Follow-up|0
371001|NCT00948857|1249457|P1|Overall Study|Lost to Follow-up|1
371002|NCT00948818|1249465|P2|Overall Study|Other Reason|5
371003|NCT00948818|1249466|P1|Overall Study|Other Reason|4
371004|NCT00948818|1249465|P2|Overall Study|Lack of Efficacy|5
371005|NCT00948818|1249466|P1|Overall Study|Lack of Efficacy|4
371006|NCT00948818|1249465|P2|Overall Study|Lost to Follow-up|17
371007|NCT00948818|1249466|P1|Overall Study|Lost to Follow-up|10
371008|NCT00948818|1249465|P2|Overall Study|Withdrawal by Subject|25
371009|NCT00948818|1249466|P1|Overall Study|Withdrawal by Subject|25
371010|NCT00948818|1249465|P2|Overall Study|Protocol Violation|10
371011|NCT00948818|1249466|P1|Overall Study|Protocol Violation|9
371012|NCT00948818|1249465|P2|Overall Study|Adverse Event|32
371013|NCT00948818|1249466|P1|Overall Study|Adverse Event|10
371014|NCT00948766|1249513|P2|Extension Study|Death|0
371015|NCT00948766|1249514|P1|Extension Study|Death|4
371016|NCT00948766|1249513|P2|Extension Study|Administrative Problems|0
371017|NCT00948766|1249514|P1|Extension Study|Administrative Problems|1
371018|NCT00948766|1249513|P2|Extension Study|Lost to Follow-up|0
371019|NCT00948766|1249514|P1|Extension Study|Lost to Follow-up|8
371020|NCT00948766|1249513|P2|Extension Study|Patient Withdrew Consent|0
371021|NCT00948766|1249514|P1|Extension Study|Patient Withdrew Consent|32
371022|NCT00948766|1249513|P2|Extension Study|Study Drug No Longer Required|0
371023|NCT00948766|1249514|P1|Extension Study|Study Drug No Longer Required|1
371024|NCT00948766|1249513|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
371025|NCT00948766|1249514|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
371026|NCT00948766|1249513|P2|Extension Study|Adverse Event|0
371027|NCT00948766|1249514|P1|Extension Study|Adverse Event|43
371028|NCT00948766|1249513|P2|Core Study|Protocol Deviation|10
371029|NCT00948766|1249514|P1|Core Study|Protocol Deviation|8
371030|NCT00948766|1249513|P2|Core Study|Death|1
371031|NCT00948766|1249514|P1|Core Study|Death|1
371032|NCT00948766|1249513|P2|Core Study|Administrative Problems|2
371033|NCT00948766|1249514|P1|Core Study|Administrative Problems|2
371034|NCT00948766|1249513|P2|Core Study|Lost to Follow-up|2
371035|NCT00948766|1249514|P1|Core Study|Lost to Follow-up|3
371036|NCT00948766|1249513|P2|Core Study|Patient Withdrew Consent|46
371037|NCT00948766|1249514|P1|Core Study|Patient Withdrew Consent|27
371038|NCT00948766|1249513|P2|Core Study|Unsatisfactory Therapeutic Effect|14
371039|NCT00948766|1249514|P1|Core Study|Unsatisfactory Therapeutic Effect|13
371040|NCT00948766|1249513|P2|Core Study|Adverse Event|51
371041|NCT00948766|1249514|P1|Core Study|Adverse Event|73
371042|NCT00948688|1249530|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
371043|NCT00948688|1249531|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
371044|NCT00948688|1249530|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
371045|NCT00948688|1249531|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
371046|NCT00948688|1249530|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
371047|NCT00948688|1249531|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
371052|NCT00948506|1249573|P2|Overall Study|Withdrawal by Subject|1
371053|NCT00948506|1249574|P1|Overall Study|Withdrawal by Subject|3
371054|NCT00948441|1249585|P2|Overall Study|no longer meet inclusion criteria|4
371055|NCT00948441|1249586|P1|Overall Study|no longer meet inclusion criteria|1
371056|NCT00948389|1249599|P5|Overall Study|Both Progression and Toxicity|0
371057|NCT00948389|1249600|P4|Overall Study|Both Progression and Toxicity|0
371058|NCT00948389|1249601|P3|Overall Study|Both Progression and Toxicity|0
371059|NCT00948389|1249602|P2|Overall Study|Both Progression and Toxicity|0
371060|NCT00948389|1249603|P1|Overall Study|Both Progression and Toxicity|1
371061|NCT00948389|1249599|P5|Overall Study|Thrombocytopenia, Grade 4|0
371062|NCT00948389|1249600|P4|Overall Study|Thrombocytopenia, Grade 4|1
371063|NCT00948389|1249601|P3|Overall Study|Thrombocytopenia, Grade 4|0
371064|NCT00948389|1249602|P2|Overall Study|Thrombocytopenia, Grade 4|0
371065|NCT00948389|1249603|P1|Overall Study|Thrombocytopenia, Grade 4|2
371066|NCT00948389|1249599|P5|Overall Study|Disease Progression/Relapse/Death|1
371067|NCT00948389|1249600|P4|Overall Study|Disease Progression/Relapse/Death|8
371068|NCT00948389|1249601|P3|Overall Study|Disease Progression/Relapse/Death|7
371069|NCT00948389|1249602|P2|Overall Study|Disease Progression/Relapse/Death|3
371070|NCT00948389|1249603|P1|Overall Study|Disease Progression/Relapse/Death|3
371071|NCT00948246|1249640|P1|Overall Study|Withdrawal by Subject|1
371072|NCT00948246|1249640|P1|Overall Study|Death|1
371073|NCT00948246|1249640|P1|Overall Study|Adverse Event|11
371074|NCT00948246|1249640|P1|Overall Study|Lost to Follow-up|11
371075|NCT00948155|1249649|P2|Washout 14 Days|Lost to Follow-up|2
371076|NCT00948155|1249650|P1|Washout 14 Days|Lost to Follow-up|1
371077|NCT00948155|1249649|P2|First Intervention 21 Days|Lost to Follow-up|2
371078|NCT00948155|1249650|P1|First Intervention 21 Days|Lost to Follow-up|2
371079|NCT00948064|1249697|P3|Phase II|Withdrawal by Subject|0
371080|NCT00948064|1249698|P2|Phase II|Withdrawal by Subject|1
371081|NCT00948064|1249699|P1|Phase II|Withdrawal by Subject|0
371082|NCT00948064|1249697|P3|Phase II|Physician Decision|1
371083|NCT00948064|1249698|P2|Phase II|Physician Decision|0
371084|NCT00948064|1249699|P1|Phase II|Physician Decision|0
371085|NCT00948064|1249697|P3|Phase I|No treatment received|0
371086|NCT00948064|1249698|P2|Phase I|No treatment received|0
371087|NCT00948064|1249699|P1|Phase I|No treatment received|1
371088|NCT00947882|1249714|P4|Overall Study|Trial Terminated by Sponsor|70
371089|NCT00947882|1249715|P3|Overall Study|Trial Terminated by Sponsor|62
371090|NCT00947882|1249716|P2|Overall Study|Trial Terminated by Sponsor|61
371091|NCT00947882|1249717|P1|Overall Study|Trial Terminated by Sponsor|62
371092|NCT00947882|1249714|P4|Overall Study|Other/Unknown|6
371093|NCT00947882|1249715|P3|Overall Study|Other/Unknown|3
371094|NCT00947882|1249716|P2|Overall Study|Other/Unknown|13
371095|NCT00947882|1249717|P1|Overall Study|Other/Unknown|10
371096|NCT00947882|1249714|P4|Overall Study|Lost to Follow-up|0
371097|NCT00947882|1249715|P3|Overall Study|Lost to Follow-up|1
371098|NCT00947882|1249716|P2|Overall Study|Lost to Follow-up|2
371099|NCT00947882|1249717|P1|Overall Study|Lost to Follow-up|0
371100|NCT00947882|1249714|P4|Overall Study|Protocol Violation|0
371101|NCT00947882|1249715|P3|Overall Study|Protocol Violation|1
371102|NCT00947882|1249716|P2|Overall Study|Protocol Violation|0
371103|NCT00947882|1249717|P1|Overall Study|Protocol Violation|0
371104|NCT00947882|1249714|P4|Overall Study|Withdrawal by Subject|2
371105|NCT00947882|1249715|P3|Overall Study|Withdrawal by Subject|8
371106|NCT00947882|1249716|P2|Overall Study|Withdrawal by Subject|0
371107|NCT00947882|1249717|P1|Overall Study|Withdrawal by Subject|2
371108|NCT00947882|1249714|P4|Overall Study|Adverse Event|4
371109|NCT00947882|1249715|P3|Overall Study|Adverse Event|4
371110|NCT00947882|1249716|P2|Overall Study|Adverse Event|1
371111|NCT00947882|1249717|P1|Overall Study|Adverse Event|0
371112|NCT00947856|1249745|P2|Follow-up Period|Withdrawal by Subject|0
371113|NCT00947856|1249746|P1|Follow-up Period|Withdrawal by Subject|1
371114|NCT00947856|1249745|P2|Follow-up Period|Patient unavailable for site visits|0
371115|NCT00947856|1249746|P1|Follow-up Period|Patient unavailable for site visits|1
371116|NCT00947856|1249745|P2|Follow-up Period|Lost to Follow-up|0
371117|NCT00947856|1249746|P1|Follow-up Period|Lost to Follow-up|7
371118|NCT00947856|1249745|P2|Follow-up Period|Re-enrolled for Retreatment|3
371119|NCT00947856|1249746|P1|Follow-up Period|Re-enrolled for Retreatment|2
371120|NCT00947856|1249745|P2|Follow-up Period|Study Stopped by Sponsor|20
371121|NCT00947856|1249746|P1|Follow-up Period|Study Stopped by Sponsor|40
371122|NCT00947856|1249745|P2|Treatment Period|Withdrawal by Subject|1
371123|NCT00947856|1249746|P1|Treatment Period|Withdrawal by Subject|12
371124|NCT00947856|1249745|P2|Treatment Period|Study Stopped by Sponsor|4
371125|NCT00947856|1249746|P1|Treatment Period|Study Stopped by Sponsor|4
371126|NCT00947856|1249745|P2|Treatment Period|Physician Decision|6
371127|NCT00947856|1249746|P1|Treatment Period|Physician Decision|14
371128|NCT00947856|1249745|P2|Treatment Period|Adverse Event|9
371129|NCT00947856|1249746|P1|Treatment Period|Adverse Event|15
371130|NCT00947856|1249745|P2|Treatment Period|Progressive Disease|12
371131|NCT00947856|1249746|P1|Treatment Period|Progressive Disease|33
371132|NCT00947544|1249835|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
371133|NCT00947544|1249836|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
371134|NCT00947531|1249862|P2|Overall Study|Other|1
371135|NCT00947531|1249863|P1|Overall Study|Other|1
371136|NCT00947531|1249862|P2|Overall Study|Lack of Efficacy|0
371137|NCT00947531|1249863|P1|Overall Study|Lack of Efficacy|1
371138|NCT00947531|1249862|P2|Overall Study|Adverse Event|2
371139|NCT00947531|1249863|P1|Overall Study|Adverse Event|2
371140|NCT00947531|1249862|P2|Overall Study|Administrative Reason|1
371141|NCT00947531|1249863|P1|Overall Study|Administrative Reason|0
371142|NCT00947531|1249862|P2|Overall Study|Withdrawal by Subject|7
371143|NCT00947531|1249863|P1|Overall Study|Withdrawal by Subject|10
371144|NCT00947427|1249899|P2|Overall Study|Protocol Violation|1
371145|NCT00947427|1249900|P1|Overall Study|Protocol Violation|0
371146|NCT00947427|1249899|P2|Overall Study|Withdrawal by Subject|3
371147|NCT00947427|1249900|P1|Overall Study|Withdrawal by Subject|1
371148|NCT00947349|1249910|P4|Overall Study Standard of Care|not specified|1
371149|NCT00947349|1249911|P3|Overall Study Standard of Care|not specified|0
371150|NCT00947349|1249912|P2|Overall Study Standard of Care|not specified|0
371151|NCT00947349|1249913|P1|Overall Study Standard of Care|not specified|0
371152|NCT00947349|1249910|P4|Overall Study Standard of Care|Withdrawal by Subject|0
371153|NCT00947349|1249911|P3|Overall Study Standard of Care|Withdrawal by Subject|1
371154|NCT00947349|1249912|P2|Overall Study Standard of Care|Withdrawal by Subject|0
371155|NCT00947349|1249913|P1|Overall Study Standard of Care|Withdrawal by Subject|0
371156|NCT00947349|1249910|P4|Overall Study Standard of Care|Lack of Efficacy|1
371157|NCT00947349|1249911|P3|Overall Study Standard of Care|Lack of Efficacy|1
371158|NCT00947349|1249912|P2|Overall Study Standard of Care|Lack of Efficacy|0
371159|NCT00947349|1249913|P1|Overall Study Standard of Care|Lack of Efficacy|0
371160|NCT00947349|1249910|P4|Triple Treatment Combination Period|Adverse Event|0
371161|NCT00947349|1249911|P3|Triple Treatment Combination Period|Adverse Event|0
371162|NCT00947349|1249912|P2|Triple Treatment Combination Period|Adverse Event|1
371163|NCT00947349|1249913|P1|Triple Treatment Combination Period|Adverse Event|0
371164|NCT00947154|1250127|P1|Overall Study|Lost to Follow-up|1
371165|NCT00947115|1250137|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
371166|NCT00947115|1250138|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
371167|NCT00947115|1250139|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
371168|NCT00947115|1250137|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
371169|NCT00947115|1250138|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
371170|NCT00947115|1250139|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
371171|NCT00947115|1250137|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
371172|NCT00947115|1250138|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
371173|NCT00947115|1250139|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
371174|NCT00947115|1250137|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
371175|NCT00947115|1250138|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
371176|NCT00947115|1250139|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
371177|NCT00947115|1250137|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
371178|NCT00947115|1250138|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
371179|NCT00947115|1250139|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
371180|NCT00947115|1250137|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
371181|NCT00947115|1250138|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
371182|NCT00947115|1250139|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
371183|NCT00947011|1250201|P1|Overall Study|Study was terminated,PI left institution|12
371184|NCT00946998|1250211|P2|Overall Study|Exited prior to first outcome assessment|3
371185|NCT00946998|1250212|P1|Overall Study|Exited prior to first outcome assessment|5
371186|NCT00946985|1250226|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
371187|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
371188|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
371189|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
371190|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
371191|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
371192|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
371193|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
371194|NCT00946985|1250226|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
371195|NCT00946920|1250232|P2|Overall Study|Miscellaneous reasons|3
371196|NCT00946920|1250233|P1|Overall Study|Miscellaneous reasons|18
371197|NCT00946920|1250232|P2|Overall Study|Protocol Violation|8
371198|NCT00946920|1250233|P1|Overall Study|Protocol Violation|16
371199|NCT00946920|1250232|P2|Overall Study|Adverse Event|14
371200|NCT00946920|1250233|P1|Overall Study|Adverse Event|41
371201|NCT00946920|1250232|P2|Overall Study|Physician Decision|2
371202|NCT00946920|1250233|P1|Overall Study|Physician Decision|5
371203|NCT00946920|1250232|P2|Overall Study|Lost to Follow-up|2
371204|NCT00946920|1250233|P1|Overall Study|Lost to Follow-up|2
371205|NCT00946920|1250232|P2|Overall Study|Withdrawal by Subject|15
371206|NCT00946920|1250233|P1|Overall Study|Withdrawal by Subject|28
371207|NCT00946881|1250248|P1|Retreatment|Withdrawal by Subject|1
371208|NCT00946881|1250248|P1|First Treatment|Patient relocated to another state|1
371209|NCT00946881|1250248|P1|First Treatment|Withdrawal by Subject|1
371210|NCT00946530|1250281|P4|Overall Study|Physician Decision|1
371211|NCT00946530|1250282|P3|Overall Study|Physician Decision|1
371212|NCT00946530|1250283|P2|Overall Study|Physician Decision|1
371213|NCT00946530|1250284|P1|Overall Study|Physician Decision|1
371214|NCT00946530|1250281|P4|Overall Study|Withdrawal by Subject|3
371215|NCT00946530|1250282|P3|Overall Study|Withdrawal by Subject|0
371216|NCT00946530|1250283|P2|Overall Study|Withdrawal by Subject|3
371217|NCT00946530|1250284|P1|Overall Study|Withdrawal by Subject|0
371218|NCT00946322|1250316|P1|Post-treatment|participant failure to follow up|2
371219|NCT00946322|1250316|P1|Pre-treatment|participant failure to follow up|1
371220|NCT00946309|1250329|P2|Overall Study|Procedure cancelled/discontinued|3
371221|NCT00946309|1250330|P1|Overall Study|Procedure cancelled/discontinued|0
371222|NCT00946309|1250329|P2|Overall Study|Lost to Follow-up|1
371223|NCT00946309|1250330|P1|Overall Study|Lost to Follow-up|0
371224|NCT00946309|1250329|P2|Overall Study|Protocol Violation|0
371225|NCT00946309|1250330|P1|Overall Study|Protocol Violation|1
371226|NCT00946296|1250348|P2|Overall Study|Physician Decision|0
371227|NCT00946296|1250349|P1|Overall Study|Physician Decision|3
371228|NCT00946114|1250357|P2|Overall Study|Withdrawal by Subject|0
371229|NCT00946114|1250358|P1|Overall Study|Withdrawal by Subject|2
371230|NCT00946114|1250357|P2|Overall Study|Other|0
371231|NCT00946114|1250358|P1|Overall Study|Other|1
371232|NCT00946114|1250357|P2|Overall Study|Death|2
371233|NCT00946114|1250358|P1|Overall Study|Death|5
371234|NCT00946101|1250366|P2|Overall Study|Physician Decision|1
371235|NCT00946101|1250367|P1|Overall Study|Physician Decision|0
371236|NCT00946101|1250366|P2|Overall Study|Withdrawal of consent|0
371237|NCT00946101|1250367|P1|Overall Study|Withdrawal of consent|2
371238|NCT00946101|1250366|P2|Overall Study|Lost to Follow-up|1
371239|NCT00946101|1250367|P1|Overall Study|Lost to Follow-up|2
371240|NCT00946088|1250433|P2|Overall Study|Withdrawal by Subject|1
371241|NCT00946088|1250434|P1|Overall Study|Withdrawal by Subject|0
371242|NCT00945945|1250463|P2|Overall Study|Entry Criteria Not Met|1
371243|NCT00945945|1250464|P1|Overall Study|Entry Criteria Not Met|0
371244|NCT00945945|1250463|P2|Overall Study|Protocol Violation|2
371245|NCT00945945|1250464|P1|Overall Study|Protocol Violation|4
371246|NCT00945945|1250463|P2|Overall Study|Lack of Efficacy|2
371247|NCT00945945|1250464|P1|Overall Study|Lack of Efficacy|6
371248|NCT00945945|1250463|P2|Overall Study|Lost to Follow-up|5
371249|NCT00945945|1250464|P1|Overall Study|Lost to Follow-up|4
371250|NCT00945945|1250463|P2|Overall Study|Withdrawal by Subject|10
371251|NCT00945945|1250464|P1|Overall Study|Withdrawal by Subject|7
371252|NCT00945945|1250463|P2|Overall Study|Adverse Event|35
371253|NCT00945945|1250464|P1|Overall Study|Adverse Event|15
371254|NCT00945906|1250490|P1|Overall Study|Moved to another country|2
371255|NCT00945906|1250490|P1|Overall Study|Unable to return for last visit|2
371256|NCT00945906|1250490|P1|Overall Study|Did not want to return for last visit|2
371257|NCT00945906|1250490|P1|Overall Study|Withdrawal by Subject|1
371258|NCT00945893|1250501|P2|Overall Study|Withdrawal of consent|2
371259|NCT00945893|1250502|P1|Overall Study|Withdrawal of consent|1
371260|NCT00945893|1250501|P2|Overall Study|Lost to Follow-up|8
371261|NCT00945893|1250502|P1|Overall Study|Lost to Follow-up|2
371262|NCT00945815|1250579|P1|Overall Study|Did not begin protocol therapy|1
371263|NCT00945815|1250579|P1|Overall Study|Ineligible|3
371264|NCT00945815|1250579|P1|Overall Study|Not protocol specified|1
371265|NCT00945815|1250579|P1|Overall Study|Death|3
371266|NCT00945555|1250608|P1|Overall Study|Other|1
371267|NCT00945555|1250608|P1|Overall Study|Death|18
371268|NCT00945555|1250608|P1|Overall Study|Participant continued treatment at home|1
371269|NCT00945555|1250608|P1|Overall Study|Withdrawal by Subject|2
371270|NCT00945555|1250608|P1|Overall Study|Worsening condition, intensive care unit|1
371271|NCT00945555|1250608|P1|Overall Study|Referred to another hospital|5
371272|NCT00945477|1250619|P1|Overall Study|Withdrawal by Subject|1
371273|NCT00945477|1250619|P1|Overall Study|Lack of Efficacy|2
371274|NCT00945477|1250619|P1|Overall Study|Adverse Event|3
371275|NCT00945321|1250635|P6|Period 4|Lost to Follow-up|1
371276|NCT00945321|1250636|P5|Period 4|Lost to Follow-up|0
371277|NCT00945321|1250637|P4|Period 4|Lost to Follow-up|0
371278|NCT00945321|1250638|P3|Period 4|Lost to Follow-up|0
371279|NCT00945321|1250639|P2|Period 4|Lost to Follow-up|0
371280|NCT00945321|1250640|P1|Period 4|Lost to Follow-up|0
371281|NCT00945321|1250635|P6|Period 1|Adverse Event|0
371282|NCT00945321|1250636|P5|Period 1|Adverse Event|1
371283|NCT00945321|1250637|P4|Period 1|Adverse Event|0
371284|NCT00945321|1250638|P3|Period 1|Adverse Event|0
371285|NCT00945321|1250639|P2|Period 1|Adverse Event|0
371286|NCT00945321|1250640|P1|Period 1|Adverse Event|0
371287|NCT00945243|1250692|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
371288|NCT00944697|1250849|P2|Overall Study|Administrative|1
371289|NCT00944697|1250850|P1|Overall Study|Administrative|1
371290|NCT00944697|1250849|P2|Overall Study|Adverse Event|3
371291|NCT00944697|1250850|P1|Overall Study|Adverse Event|0
371292|NCT00944697|1250849|P2|Overall Study|Withdrawal by Subject|1
371293|NCT00944697|1250850|P1|Overall Study|Withdrawal by Subject|1
371294|NCT00944645|1250880|P2|Period 2|Withdrawal by Subject|6
371295|NCT00944645|1250881|P1|Period 2|Withdrawal by Subject|7
371296|NCT00944645|1250880|P2|Period 2|Lost to Follow-up|3
371297|NCT00944645|1250881|P1|Period 2|Lost to Follow-up|0
371298|NCT00944645|1250880|P2|Period 2|Adverse Event|0
371299|NCT00944645|1250881|P1|Period 2|Adverse Event|1
371300|NCT00944229|1250911|P1|Overall Study|Physician Decision|14
371301|NCT00944229|1250911|P1|Overall Study|Withdrawal by Subject|11
371302|NCT00944125|1250917|P2|6 Months to Study Completion|Withdrawal by Subject|2
371303|NCT00944125|1250918|P1|6 Months to Study Completion|Withdrawal by Subject|0
371304|NCT00944125|1250917|P2|3 to 6 Months|Withdrawal by Subject|2
371305|NCT00944125|1250918|P1|3 to 6 Months|Withdrawal by Subject|0
371306|NCT00944034|1251021|P12|Overall Study|Administrative reason|0
371307|NCT00944034|1251022|P11|Overall Study|Administrative reason|0
371308|NCT00944034|1251023|P10|Overall Study|Administrative reason|0
371309|NCT00944034|1251024|P9|Overall Study|Administrative reason|0
371310|NCT00944034|1251025|P8|Overall Study|Administrative reason|0
371311|NCT00944034|1251026|P7|Overall Study|Administrative reason|1
371312|NCT00944034|1251027|P6|Overall Study|Administrative reason|0
371313|NCT00944034|1251028|P5|Overall Study|Administrative reason|0
371314|NCT00944034|1251029|P4|Overall Study|Administrative reason|0
371315|NCT00944034|1251030|P3|Overall Study|Administrative reason|0
371316|NCT00944034|1251031|P2|Overall Study|Administrative reason|0
371317|NCT00944034|1251032|P1|Overall Study|Administrative reason|0
371318|NCT00944034|1251021|P12|Overall Study|Unable to classify|0
371319|NCT00944034|1251022|P11|Overall Study|Unable to classify|0
371320|NCT00944034|1251023|P10|Overall Study|Unable to classify|0
371321|NCT00944034|1251024|P9|Overall Study|Unable to classify|0
371322|NCT00944034|1251025|P8|Overall Study|Unable to classify|1
371323|NCT00944034|1251026|P7|Overall Study|Unable to classify|1
371324|NCT00944034|1251027|P6|Overall Study|Unable to classify|1
371325|NCT00944034|1251028|P5|Overall Study|Unable to classify|0
371326|NCT00944034|1251029|P4|Overall Study|Unable to classify|0
371327|NCT00944034|1251030|P3|Overall Study|Unable to classify|0
371328|NCT00944034|1251031|P2|Overall Study|Unable to classify|0
371329|NCT00944034|1251032|P1|Overall Study|Unable to classify|0
371330|NCT00944034|1251021|P12|Overall Study|Protocol Violation|0
371331|NCT00944034|1251022|P11|Overall Study|Protocol Violation|0
371332|NCT00944034|1251023|P10|Overall Study|Protocol Violation|4
371333|NCT00944034|1251024|P9|Overall Study|Protocol Violation|1
371334|NCT00944034|1251025|P8|Overall Study|Protocol Violation|1
371335|NCT00944034|1251026|P7|Overall Study|Protocol Violation|0
371336|NCT00944034|1251027|P6|Overall Study|Protocol Violation|3
371337|NCT00944034|1251028|P5|Overall Study|Protocol Violation|2
371338|NCT00944034|1251029|P4|Overall Study|Protocol Violation|1
371339|NCT00944034|1251030|P3|Overall Study|Protocol Violation|0
371340|NCT00944034|1251031|P2|Overall Study|Protocol Violation|0
371341|NCT00944034|1251032|P1|Overall Study|Protocol Violation|2
371342|NCT00944034|1251021|P12|Overall Study|Death|0
371343|NCT00944034|1251022|P11|Overall Study|Death|0
371344|NCT00944034|1251023|P10|Overall Study|Death|0
371345|NCT00944034|1251024|P9|Overall Study|Death|0
371346|NCT00944034|1251025|P8|Overall Study|Death|0
371347|NCT00944034|1251026|P7|Overall Study|Death|0
371348|NCT00944034|1251027|P6|Overall Study|Death|0
371349|NCT00944034|1251028|P5|Overall Study|Death|0
371350|NCT00944034|1251029|P4|Overall Study|Death|0
371351|NCT00944034|1251030|P3|Overall Study|Death|1
371352|NCT00944034|1251031|P2|Overall Study|Death|0
371353|NCT00944034|1251032|P1|Overall Study|Death|0
371354|NCT00944034|1251021|P12|Overall Study|Lost to Follow-up|0
371355|NCT00944034|1251022|P11|Overall Study|Lost to Follow-up|1
371356|NCT00944034|1251023|P10|Overall Study|Lost to Follow-up|1
371357|NCT00944034|1251024|P9|Overall Study|Lost to Follow-up|5
371358|NCT00944034|1251025|P8|Overall Study|Lost to Follow-up|1
371359|NCT00944034|1251026|P7|Overall Study|Lost to Follow-up|0
371360|NCT00944034|1251027|P6|Overall Study|Lost to Follow-up|7
371361|NCT00944034|1251028|P5|Overall Study|Lost to Follow-up|5
371362|NCT00944034|1251029|P4|Overall Study|Lost to Follow-up|0
371363|NCT00944034|1251030|P3|Overall Study|Lost to Follow-up|2
371364|NCT00944034|1251031|P2|Overall Study|Lost to Follow-up|4
371365|NCT00944034|1251032|P1|Overall Study|Lost to Follow-up|0
371366|NCT00944034|1251021|P12|Overall Study|Withdrawal by Subject|4
371367|NCT00944034|1251022|P11|Overall Study|Withdrawal by Subject|0
371368|NCT00944034|1251023|P10|Overall Study|Withdrawal by Subject|4
371369|NCT00944034|1251024|P9|Overall Study|Withdrawal by Subject|3
371370|NCT00944034|1251025|P8|Overall Study|Withdrawal by Subject|2
371371|NCT00944034|1251026|P7|Overall Study|Withdrawal by Subject|2
371372|NCT00944034|1251027|P6|Overall Study|Withdrawal by Subject|8
371373|NCT00944034|1251028|P5|Overall Study|Withdrawal by Subject|5
371374|NCT00944034|1251029|P4|Overall Study|Withdrawal by Subject|2
371375|NCT00944034|1251030|P3|Overall Study|Withdrawal by Subject|6
371376|NCT00944034|1251031|P2|Overall Study|Withdrawal by Subject|2
371377|NCT00944034|1251032|P1|Overall Study|Withdrawal by Subject|3
371378|NCT00944034|1251021|P12|Overall Study|Inappropriate enrollment|0
371379|NCT00944034|1251022|P11|Overall Study|Inappropriate enrollment|0
371380|NCT00944034|1251023|P10|Overall Study|Inappropriate enrollment|1
371381|NCT00944034|1251024|P9|Overall Study|Inappropriate enrollment|1
371382|NCT00944034|1251025|P8|Overall Study|Inappropriate enrollment|0
371383|NCT00944034|1251026|P7|Overall Study|Inappropriate enrollment|0
371384|NCT00944034|1251027|P6|Overall Study|Inappropriate enrollment|1
371385|NCT00944034|1251028|P5|Overall Study|Inappropriate enrollment|2
371386|NCT00944034|1251029|P4|Overall Study|Inappropriate enrollment|1
371387|NCT00944034|1251030|P3|Overall Study|Inappropriate enrollment|0
371388|NCT00944034|1251031|P2|Overall Study|Inappropriate enrollment|1
371389|NCT00944034|1251032|P1|Overall Study|Inappropriate enrollment|0
371390|NCT00943917|1251178|P15|Stage II Continuation|A1C elevation|0
371391|NCT00943917|1251179|P14|Stage II Continuation|A1C elevation|1
371392|NCT00943917|1251180|P13|Stage II Continuation|A1C elevation|0
371393|NCT00943917|1251181|P12|Stage II Continuation|A1C elevation|0
371394|NCT00943917|1251182|P11|Stage II Continuation|A1C elevation|0
371395|NCT00943917|1251183|P10|Stage II Continuation|A1C elevation|0
371396|NCT00943917|1251184|P9|Stage II Continuation|A1C elevation|0
371397|NCT00943917|1251185|P8|Stage II Continuation|A1C elevation|0
371398|NCT00943917|1251186|P7|Stage II Continuation|A1C elevation|0
371399|NCT00943917|1251187|P6|Stage II Continuation|A1C elevation|0
371400|NCT00943917|1251188|P5|Stage II Continuation|A1C elevation|0
371401|NCT00943917|1251189|P4|Stage II Continuation|A1C elevation|0
371402|NCT00943917|1251190|P3|Stage II Continuation|A1C elevation|0
371403|NCT00943917|1251191|P2|Stage II Continuation|A1C elevation|0
371404|NCT00943917|1251192|P1|Stage II Continuation|A1C elevation|0
371405|NCT00943917|1251178|P15|Stage II Continuation|hypoglycemia|0
371406|NCT00943917|1251179|P14|Stage II Continuation|hypoglycemia|0
371407|NCT00943917|1251180|P13|Stage II Continuation|hypoglycemia|1
371408|NCT00943917|1251181|P12|Stage II Continuation|hypoglycemia|0
371409|NCT00943917|1251182|P11|Stage II Continuation|hypoglycemia|0
371410|NCT00943917|1251183|P10|Stage II Continuation|hypoglycemia|0
371411|NCT00943917|1251184|P9|Stage II Continuation|hypoglycemia|0
371412|NCT00943917|1251185|P8|Stage II Continuation|hypoglycemia|0
371413|NCT00943917|1251186|P7|Stage II Continuation|hypoglycemia|0
371414|NCT00943917|1251187|P6|Stage II Continuation|hypoglycemia|0
371415|NCT00943917|1251188|P5|Stage II Continuation|hypoglycemia|0
371416|NCT00943917|1251189|P4|Stage II Continuation|hypoglycemia|0
371417|NCT00943917|1251190|P3|Stage II Continuation|hypoglycemia|0
371418|NCT00943917|1251191|P2|Stage II Continuation|hypoglycemia|0
371419|NCT00943917|1251192|P1|Stage II Continuation|hypoglycemia|0
371420|NCT00943917|1251178|P15|Stage II Continuation|Protocol Violation|0
371421|NCT00943917|1251179|P14|Stage II Continuation|Protocol Violation|0
371422|NCT00943917|1251180|P13|Stage II Continuation|Protocol Violation|0
371423|NCT00943917|1251181|P12|Stage II Continuation|Protocol Violation|1
371424|NCT00943917|1251182|P11|Stage II Continuation|Protocol Violation|0
371425|NCT00943917|1251183|P10|Stage II Continuation|Protocol Violation|1
371426|NCT00943917|1251184|P9|Stage II Continuation|Protocol Violation|0
371427|NCT00943917|1251185|P8|Stage II Continuation|Protocol Violation|0
371428|NCT00943917|1251186|P7|Stage II Continuation|Protocol Violation|0
371429|NCT00943917|1251187|P6|Stage II Continuation|Protocol Violation|0
371430|NCT00943917|1251188|P5|Stage II Continuation|Protocol Violation|0
371431|NCT00943917|1251189|P4|Stage II Continuation|Protocol Violation|0
371432|NCT00943917|1251190|P3|Stage II Continuation|Protocol Violation|0
371433|NCT00943917|1251191|P2|Stage II Continuation|Protocol Violation|0
371434|NCT00943917|1251192|P1|Stage II Continuation|Protocol Violation|0
371435|NCT00943917|1251178|P15|Stage II Continuation|Withdrawal by Subject|3
371436|NCT00943917|1251179|P14|Stage II Continuation|Withdrawal by Subject|1
371437|NCT00943917|1251180|P13|Stage II Continuation|Withdrawal by Subject|0
371438|NCT00943917|1251181|P12|Stage II Continuation|Withdrawal by Subject|0
371439|NCT00943917|1251182|P11|Stage II Continuation|Withdrawal by Subject|0
371440|NCT00943917|1251183|P10|Stage II Continuation|Withdrawal by Subject|0
371441|NCT00943917|1251184|P9|Stage II Continuation|Withdrawal by Subject|0
371442|NCT00943917|1251185|P8|Stage II Continuation|Withdrawal by Subject|0
371443|NCT00943917|1251186|P7|Stage II Continuation|Withdrawal by Subject|0
371444|NCT00943917|1251187|P6|Stage II Continuation|Withdrawal by Subject|0
371445|NCT00943917|1251188|P5|Stage II Continuation|Withdrawal by Subject|0
371446|NCT00943917|1251189|P4|Stage II Continuation|Withdrawal by Subject|0
371447|NCT00943917|1251190|P3|Stage II Continuation|Withdrawal by Subject|0
371448|NCT00943917|1251191|P2|Stage II Continuation|Withdrawal by Subject|0
371449|NCT00943917|1251192|P1|Stage II Continuation|Withdrawal by Subject|0
371450|NCT00943917|1251178|P15|Stage II Continuation|Adverse Event|1
371451|NCT00943917|1251179|P14|Stage II Continuation|Adverse Event|1
371452|NCT00943917|1251180|P13|Stage II Continuation|Adverse Event|2
371453|NCT00943917|1251181|P12|Stage II Continuation|Adverse Event|1
371454|NCT00943917|1251182|P11|Stage II Continuation|Adverse Event|0
371455|NCT00943917|1251183|P10|Stage II Continuation|Adverse Event|0
371456|NCT00943917|1251184|P9|Stage II Continuation|Adverse Event|0
371457|NCT00943917|1251185|P8|Stage II Continuation|Adverse Event|0
371458|NCT00943917|1251186|P7|Stage II Continuation|Adverse Event|0
371459|NCT00943917|1251187|P6|Stage II Continuation|Adverse Event|0
371460|NCT00943917|1251188|P5|Stage II Continuation|Adverse Event|0
371461|NCT00943917|1251189|P4|Stage II Continuation|Adverse Event|0
371462|NCT00943917|1251190|P3|Stage II Continuation|Adverse Event|0
371463|NCT00943917|1251191|P2|Stage II Continuation|Adverse Event|0
371464|NCT00943917|1251192|P1|Stage II Continuation|Adverse Event|0
371465|NCT00943917|1251178|P15|Stage II|Pregnancy|0
371466|NCT00943917|1251179|P14|Stage II|Pregnancy|0
371467|NCT00943917|1251180|P13|Stage II|Pregnancy|0
371468|NCT00943917|1251181|P12|Stage II|Pregnancy|0
371469|NCT00943917|1251182|P11|Stage II|Pregnancy|0
371470|NCT00943917|1251183|P10|Stage II|Pregnancy|0
371471|NCT00943917|1251184|P9|Stage II|Pregnancy|0
371472|NCT00943917|1251185|P8|Stage II|Pregnancy|0
371473|NCT00943917|1251186|P7|Stage II|Pregnancy|0
371474|NCT00943917|1251187|P6|Stage II|Pregnancy|1
371475|NCT00943917|1251188|P5|Stage II|Pregnancy|0
371476|NCT00943917|1251189|P4|Stage II|Pregnancy|0
371477|NCT00943917|1251190|P3|Stage II|Pregnancy|0
371478|NCT00943917|1251191|P2|Stage II|Pregnancy|0
371479|NCT00943917|1251192|P1|Stage II|Pregnancy|0
371480|NCT00943917|1251178|P15|Stage II|Withdrawal by Subject|0
371481|NCT00943917|1251179|P14|Stage II|Withdrawal by Subject|0
371482|NCT00943917|1251180|P13|Stage II|Withdrawal by Subject|0
371483|NCT00943917|1251181|P12|Stage II|Withdrawal by Subject|0
371484|NCT00943917|1251182|P11|Stage II|Withdrawal by Subject|0
371485|NCT00943917|1251183|P10|Stage II|Withdrawal by Subject|0
371486|NCT00943917|1251184|P9|Stage II|Withdrawal by Subject|0
371487|NCT00943917|1251185|P8|Stage II|Withdrawal by Subject|0
371488|NCT00943917|1251186|P7|Stage II|Withdrawal by Subject|0
371489|NCT00943917|1251187|P6|Stage II|Withdrawal by Subject|1
371490|NCT00943917|1251188|P5|Stage II|Withdrawal by Subject|0
371491|NCT00943917|1251189|P4|Stage II|Withdrawal by Subject|0
371492|NCT00943917|1251190|P3|Stage II|Withdrawal by Subject|0
371493|NCT00943917|1251191|P2|Stage II|Withdrawal by Subject|0
371494|NCT00943917|1251192|P1|Stage II|Withdrawal by Subject|0
371495|NCT00943917|1251178|P15|Stage II|Adverse Event|0
371496|NCT00943917|1251179|P14|Stage II|Adverse Event|0
371497|NCT00943917|1251180|P13|Stage II|Adverse Event|0
371498|NCT00943917|1251181|P12|Stage II|Adverse Event|0
371499|NCT00943917|1251182|P11|Stage II|Adverse Event|0
371500|NCT00943917|1251183|P10|Stage II|Adverse Event|0
371501|NCT00943917|1251184|P9|Stage II|Adverse Event|1
371502|NCT00943917|1251185|P8|Stage II|Adverse Event|0
371503|NCT00943917|1251186|P7|Stage II|Adverse Event|3
371504|NCT00943917|1251187|P6|Stage II|Adverse Event|1
371505|NCT00943917|1251188|P5|Stage II|Adverse Event|0
371506|NCT00943917|1251189|P4|Stage II|Adverse Event|0
371507|NCT00943917|1251190|P3|Stage II|Adverse Event|0
371508|NCT00943917|1251191|P2|Stage II|Adverse Event|0
371509|NCT00943917|1251192|P1|Stage II|Adverse Event|0
371510|NCT00943917|1251178|P15|Stage I|Withdrawal by Subject|0
371511|NCT00943917|1251179|P14|Stage I|Withdrawal by Subject|0
371512|NCT00943917|1251180|P13|Stage I|Withdrawal by Subject|0
371513|NCT00943917|1251181|P12|Stage I|Withdrawal by Subject|0
371514|NCT00943917|1251182|P11|Stage I|Withdrawal by Subject|0
371515|NCT00943917|1251183|P10|Stage I|Withdrawal by Subject|0
371516|NCT00943917|1251184|P9|Stage I|Withdrawal by Subject|0
371517|NCT00943917|1251185|P8|Stage I|Withdrawal by Subject|0
371518|NCT00943917|1251186|P7|Stage I|Withdrawal by Subject|0
371519|NCT00943917|1251187|P6|Stage I|Withdrawal by Subject|0
371520|NCT00943917|1251188|P5|Stage I|Withdrawal by Subject|0
371521|NCT00943917|1251189|P4|Stage I|Withdrawal by Subject|0
371522|NCT00943917|1251190|P3|Stage I|Withdrawal by Subject|2
371523|NCT00943917|1251191|P2|Stage I|Withdrawal by Subject|1
371524|NCT00943917|1251192|P1|Stage I|Withdrawal by Subject|2
371525|NCT00943917|1251178|P15|Stage I|A1C elevation|0
371526|NCT00943917|1251179|P14|Stage I|A1C elevation|0
371527|NCT00943917|1251180|P13|Stage I|A1C elevation|0
371528|NCT00943917|1251181|P12|Stage I|A1C elevation|0
371529|NCT00943917|1251182|P11|Stage I|A1C elevation|0
371530|NCT00943917|1251183|P10|Stage I|A1C elevation|0
371531|NCT00943917|1251184|P9|Stage I|A1C elevation|0
371532|NCT00943917|1251185|P8|Stage I|A1C elevation|0
371533|NCT00943917|1251186|P7|Stage I|A1C elevation|0
371534|NCT00943917|1251187|P6|Stage I|A1C elevation|0
371535|NCT00943917|1251188|P5|Stage I|A1C elevation|0
371536|NCT00943917|1251189|P4|Stage I|A1C elevation|0
371537|NCT00943917|1251190|P3|Stage I|A1C elevation|0
371538|NCT00943917|1251191|P2|Stage I|A1C elevation|0
371539|NCT00943917|1251192|P1|Stage I|A1C elevation|1
371540|NCT00943917|1251178|P15|Stage I|hyperglycemia|0
371541|NCT00943917|1251179|P14|Stage I|hyperglycemia|0
371542|NCT00943917|1251180|P13|Stage I|hyperglycemia|0
371543|NCT00943917|1251181|P12|Stage I|hyperglycemia|0
371544|NCT00943917|1251182|P11|Stage I|hyperglycemia|0
371545|NCT00943917|1251183|P10|Stage I|hyperglycemia|0
371546|NCT00943917|1251184|P9|Stage I|hyperglycemia|0
371547|NCT00943917|1251185|P8|Stage I|hyperglycemia|0
371548|NCT00943917|1251186|P7|Stage I|hyperglycemia|0
371549|NCT00943917|1251187|P6|Stage I|hyperglycemia|0
371550|NCT00943917|1251188|P5|Stage I|hyperglycemia|0
371551|NCT00943917|1251189|P4|Stage I|hyperglycemia|0
371552|NCT00943917|1251190|P3|Stage I|hyperglycemia|1
371553|NCT00943917|1251191|P2|Stage I|hyperglycemia|0
371554|NCT00943917|1251192|P1|Stage I|hyperglycemia|0
371555|NCT00943917|1251178|P15|Stage I|Lost to Follow-up|0
371556|NCT00943917|1251179|P14|Stage I|Lost to Follow-up|0
371557|NCT00943917|1251180|P13|Stage I|Lost to Follow-up|0
371558|NCT00943917|1251181|P12|Stage I|Lost to Follow-up|0
371559|NCT00943917|1251182|P11|Stage I|Lost to Follow-up|0
371560|NCT00943917|1251183|P10|Stage I|Lost to Follow-up|0
371561|NCT00943917|1251184|P9|Stage I|Lost to Follow-up|0
371562|NCT00943917|1251185|P8|Stage I|Lost to Follow-up|0
371563|NCT00943917|1251186|P7|Stage I|Lost to Follow-up|0
371564|NCT00943917|1251187|P6|Stage I|Lost to Follow-up|0
371565|NCT00943917|1251188|P5|Stage I|Lost to Follow-up|0
371566|NCT00943917|1251189|P4|Stage I|Lost to Follow-up|0
371567|NCT00943917|1251190|P3|Stage I|Lost to Follow-up|1
371568|NCT00943917|1251191|P2|Stage I|Lost to Follow-up|0
371569|NCT00943917|1251192|P1|Stage I|Lost to Follow-up|0
371570|NCT00943917|1251178|P15|Stage I|Adverse Event|0
371571|NCT00943917|1251179|P14|Stage I|Adverse Event|0
371572|NCT00943917|1251180|P13|Stage I|Adverse Event|0
371573|NCT00943917|1251181|P12|Stage I|Adverse Event|0
371574|NCT00943917|1251182|P11|Stage I|Adverse Event|0
371575|NCT00943917|1251183|P10|Stage I|Adverse Event|0
371576|NCT00943917|1251184|P9|Stage I|Adverse Event|0
371577|NCT00943917|1251185|P8|Stage I|Adverse Event|0
371578|NCT00943917|1251186|P7|Stage I|Adverse Event|0
371579|NCT00943917|1251187|P6|Stage I|Adverse Event|0
371580|NCT00943917|1251188|P5|Stage I|Adverse Event|0
371581|NCT00943917|1251189|P4|Stage I|Adverse Event|0
371582|NCT00943917|1251190|P3|Stage I|Adverse Event|2
371583|NCT00943917|1251191|P2|Stage I|Adverse Event|2
371584|NCT00943917|1251192|P1|Stage I|Adverse Event|1
371585|NCT00943852|1251368|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
371586|NCT00943852|1251369|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
371587|NCT00943852|1251370|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
371588|NCT00943852|1251371|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
371589|NCT00943852|1251372|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
371590|NCT00943852|1251373|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
371591|NCT00943852|1251374|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
371592|NCT00943852|1251375|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
371593|NCT00943852|1251376|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
371594|NCT00943852|1251377|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
371595|NCT00943852|1251368|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371596|NCT00943852|1251369|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371597|NCT00943852|1251370|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
371598|NCT00943852|1251371|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371599|NCT00943852|1251372|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371600|NCT00943852|1251373|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371601|NCT00943852|1251374|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371602|NCT00943852|1251375|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371603|NCT00943852|1251376|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371604|NCT00943852|1251377|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
371605|NCT00943852|1251368|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371606|NCT00943852|1251369|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371607|NCT00943852|1251370|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371608|NCT00943852|1251371|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
371609|NCT00943852|1251372|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371610|NCT00943852|1251373|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371611|NCT00943852|1251374|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371612|NCT00943852|1251375|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371613|NCT00943852|1251376|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371614|NCT00943852|1251377|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
371615|NCT00943852|1251368|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
371616|NCT00943852|1251369|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
371617|NCT00943852|1251370|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
371618|NCT00943852|1251371|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
371619|NCT00943852|1251372|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
371620|NCT00943852|1251373|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
371621|NCT00943852|1251374|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
371622|NCT00943852|1251375|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
371623|NCT00943852|1251376|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
371624|NCT00943852|1251377|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
371625|NCT00943852|1251368|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371626|NCT00943852|1251369|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371627|NCT00943852|1251370|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371628|NCT00943852|1251371|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371629|NCT00943852|1251372|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371630|NCT00943852|1251373|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371631|NCT00943852|1251374|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
371632|NCT00943852|1251375|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371633|NCT00943852|1251376|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371634|NCT00943852|1251377|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
371635|NCT00943826|1251390|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
371636|NCT00943826|1251391|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
371637|NCT00943826|1251390|P2|After Primary Overall Survival Analysis|Progression of Disease|4
371638|NCT00943826|1251391|P1|After Primary Overall Survival Analysis|Progression of Disease|2
371639|NCT00943826|1251390|P2|After Primary Overall Survival Analysis|Administrative reasons|16
371640|NCT00943826|1251391|P1|After Primary Overall Survival Analysis|Administrative reasons|10
371641|NCT00943826|1251390|P2|After Primary Overall Survival Analysis|Adverse Event|0
371642|NCT00943826|1251391|P1|After Primary Overall Survival Analysis|Adverse Event|11
371643|NCT00943826|1251390|P2|Monotherapy Phase|Failure to return|1
371644|NCT00943826|1251391|P1|Monotherapy Phase|Failure to return|2
371645|NCT00943826|1251390|P2|Monotherapy Phase|Withdrew Consent|3
371646|NCT00943826|1251391|P1|Monotherapy Phase|Withdrew Consent|2
371647|NCT00943826|1251390|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
371648|NCT00943826|1251391|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
371649|NCT00943826|1251390|P2|Monotherapy Phase|Administrative reasons|5
371650|NCT00943826|1251391|P1|Monotherapy Phase|Administrative reasons|11
371651|NCT00943826|1251390|P2|Monotherapy Phase|Adverse Event|5
371652|NCT00943826|1251391|P1|Monotherapy Phase|Adverse Event|42
371653|NCT00943826|1251390|P2|Maintenance Phase|Failure to return|1
371654|NCT00943826|1251391|P1|Maintenance Phase|Failure to return|0
371655|NCT00943826|1251390|P2|Maintenance Phase|Administrative reasons|1
371656|NCT00943826|1251391|P1|Maintenance Phase|Administrative reasons|4
371657|NCT00943826|1251390|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
371658|NCT00943826|1251391|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
371659|NCT00943826|1251390|P2|Maintenance Phase|Withdrew consent|4
371660|NCT00943826|1251391|P1|Maintenance Phase|Withdrew consent|2
371661|NCT00943826|1251390|P2|Maintenance Phase|Adverse Event|30
371662|NCT00943826|1251391|P1|Maintenance Phase|Adverse Event|31
371663|NCT00943826|1251390|P2|Concurrent Phase|Protocol Violation|0
371664|NCT00943826|1251391|P1|Concurrent Phase|Protocol Violation|1
371665|NCT00943826|1251390|P2|Concurrent Phase|Administrative reasons|1
371666|NCT00943826|1251391|P1|Concurrent Phase|Administrative reasons|2
371667|NCT00943826|1251390|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
371668|NCT00943826|1251391|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
371669|NCT00943826|1251390|P2|Concurrent Phase|Withdrew consent|7
371670|NCT00943826|1251391|P1|Concurrent Phase|Withdrew consent|3
371671|NCT00943826|1251390|P2|Concurrent Phase|Adverse Event|27
371672|NCT00943826|1251391|P1|Concurrent Phase|Adverse Event|50
371673|NCT00943787|1251409|P1|Overall Study|Withdrawal by Subject|3
371674|NCT00943787|1251409|P1|Overall Study|Physician Decision|4
371675|NCT00943761|1251416|P2|Overall Study|Withdrawal by Subject|1
371676|NCT00943761|1251417|P1|Overall Study|Withdrawal by Subject|2
371677|NCT00943761|1251416|P2|Overall Study|Lost to Follow-up|0
371678|NCT00943761|1251417|P1|Overall Study|Lost to Follow-up|2
371679|NCT00943735|1251429|P1|Overall Study|Other|3
371680|NCT00943735|1251429|P1|Overall Study|Other|8
371681|NCT00943735|1251429|P1|Overall Study|Death|1
371682|NCT00943735|1251429|P1|Overall Study|Withdrawal by Subject|8
371683|NCT00943735|1251429|P1|Overall Study|Adverse Event|12
371684|NCT00943722|1251467|P5|Overall Study|Withdrawal by Subject|8
371685|NCT00943722|1251468|P4|Overall Study|Withdrawal by Subject|13
371686|NCT00943722|1251469|P3|Overall Study|Withdrawal by Subject|2
371687|NCT00943722|1251470|P2|Overall Study|Withdrawal by Subject|13
371688|NCT00943722|1251471|P1|Overall Study|Withdrawal by Subject|12
371689|NCT00943722|1251467|P5|Overall Study|Protocol Violation|2
371690|NCT00943722|1251468|P4|Overall Study|Protocol Violation|0
371691|NCT00943722|1251469|P3|Overall Study|Protocol Violation|0
371692|NCT00943722|1251470|P2|Overall Study|Protocol Violation|1
371693|NCT00943722|1251471|P1|Overall Study|Protocol Violation|0
371694|NCT00943722|1251467|P5|Overall Study|Pregnancy|0
371695|NCT00943722|1251468|P4|Overall Study|Pregnancy|0
371696|NCT00943722|1251469|P3|Overall Study|Pregnancy|1
371697|NCT00943722|1251470|P2|Overall Study|Pregnancy|0
371698|NCT00943722|1251471|P1|Overall Study|Pregnancy|0
371699|NCT00943722|1251467|P5|Overall Study|Physician Decision|1
371700|NCT00943722|1251468|P4|Overall Study|Physician Decision|0
371701|NCT00943722|1251469|P3|Overall Study|Physician Decision|0
371702|NCT00943722|1251470|P2|Overall Study|Physician Decision|0
371703|NCT00943722|1251471|P1|Overall Study|Physician Decision|1
371704|NCT00943722|1251467|P5|Overall Study|Lost to Follow-up|11
371705|NCT00943722|1251468|P4|Overall Study|Lost to Follow-up|8
371706|NCT00943722|1251469|P3|Overall Study|Lost to Follow-up|10
371707|NCT00943722|1251470|P2|Overall Study|Lost to Follow-up|8
371708|NCT00943722|1251471|P1|Overall Study|Lost to Follow-up|12
371709|NCT00943722|1251467|P5|Overall Study|Adverse Event|0
371710|NCT00943722|1251468|P4|Overall Study|Adverse Event|1
371711|NCT00943722|1251469|P3|Overall Study|Adverse Event|0
371712|NCT00943722|1251470|P2|Overall Study|Adverse Event|0
371713|NCT00943722|1251471|P1|Overall Study|Adverse Event|0
371714|NCT00943683|1251501|P2|Overall Study|Patient Moved|0
371715|NCT00943683|1251502|P1|Overall Study|Patient Moved|1
371716|NCT00943683|1251501|P2|Overall Study|Withdrawal by Subject|0
371717|NCT00943683|1251502|P1|Overall Study|Withdrawal by Subject|1
371718|NCT00943683|1251501|P2|Overall Study|Protocol Violation|2
371719|NCT00943683|1251502|P1|Overall Study|Protocol Violation|1
371720|NCT00943683|1251501|P2|Overall Study|Lost to Follow-up|1
371721|NCT00943683|1251502|P1|Overall Study|Lost to Follow-up|1
371722|NCT00943683|1251501|P2|Overall Study|Adverse Event|3
371723|NCT00943683|1251502|P1|Overall Study|Adverse Event|3
371724|NCT00943670|1251508|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
371725|NCT00943670|1251508|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
371726|NCT00943670|1251508|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
371727|NCT00943670|1251508|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
371728|NCT00943670|1251508|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
371729|NCT00943670|1251508|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
371811|NCT00942994|1252159|P1|Overall Study|Abnormal laboratory value(s)|1
371730|NCT00943670|1251508|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
371731|NCT00943670|1251508|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
371732|NCT00943670|1251508|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
371733|NCT00943670|1251508|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
371734|NCT00943605|1251597|P2|Overall Study|Study termination|30
371735|NCT00943605|1251598|P1|Overall Study|Study termination|30
371736|NCT00943592|1251608|P1|Overall Study|Death|3
371737|NCT00943579|1251621|P2|Overall Study|Lack of Efficacy|2
371738|NCT00943579|1251622|P1|Overall Study|Lack of Efficacy|2
371739|NCT00943579|1251621|P2|Overall Study|Adverse Event|3
371740|NCT00943579|1251622|P1|Overall Study|Adverse Event|4
371741|NCT00943397|1251723|P2|Overall Study|Site terminated and other|56
371742|NCT00943397|1251724|P1|Overall Study|Site terminated and other|12
371743|NCT00943397|1251723|P2|Overall Study|Withdrawal by Subject|1
371744|NCT00943397|1251724|P1|Overall Study|Withdrawal by Subject|1
371745|NCT00943397|1251723|P2|Overall Study|Protocol Violation|5
371746|NCT00943397|1251724|P1|Overall Study|Protocol Violation|2
371747|NCT00943397|1251723|P2|Overall Study|Lost to Follow-up|4
371748|NCT00943397|1251724|P1|Overall Study|Lost to Follow-up|0
371749|NCT00943397|1251723|P2|Overall Study|Adverse Event|6
371750|NCT00943397|1251724|P1|Overall Study|Adverse Event|0
371751|NCT00943384|1251730|P1|Overall Study|Withdrawal by Subject|5
371752|NCT00943384|1251730|P1|Overall Study|Lost to Follow-up|16
371753|NCT00943384|1251730|P1|Overall Study|Treated off protocol-protocol violation|5
371754|NCT00943384|1251730|P1|Overall Study|Dispositioned prior to treatment|23
371755|NCT00943306|1251744|P1|Overall Study|Sponsor decision due to non-compliance|1
371756|NCT00943306|1251744|P1|Overall Study|Death|1
371757|NCT00943306|1251744|P1|Overall Study|Physician Decision|1
371758|NCT00943124|1252046|P2|Period 1|Personal Reasons|1
371759|NCT00943124|1252047|P1|Period 1|Personal Reasons|0
371760|NCT00943124|1252046|P2|Period 1|Did Not Follow Study Procedures|0
371761|NCT00943124|1252047|P1|Period 1|Did Not Follow Study Procedures|1
371762|NCT00943124|1252046|P2|Period 1|Withdrawal by Subject|1
371763|NCT00943124|1252047|P1|Period 1|Withdrawal by Subject|1
371764|NCT00943111|1252069|P3|5 Years Long-term Treatment Period|Other than specified above|2
371765|NCT00943111|1252070|P2|5 Years Long-term Treatment Period|Other than specified above|0
371766|NCT00943111|1252071|P1|5 Years Long-term Treatment Period|Other than specified above|0
371767|NCT00943111|1252069|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
371768|NCT00943111|1252070|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
371769|NCT00943111|1252071|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
371770|NCT00943111|1252069|P3|5 Years Long-term Treatment Period|Pregnancy|4
371771|NCT00943111|1252070|P2|5 Years Long-term Treatment Period|Pregnancy|0
371772|NCT00943111|1252071|P1|5 Years Long-term Treatment Period|Pregnancy|0
371773|NCT00943111|1252069|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
371774|NCT00943111|1252070|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
371775|NCT00943111|1252071|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
371776|NCT00943111|1252069|P3|5 Years Long-term Treatment Period|Adverse Event|9
371777|NCT00943111|1252070|P2|5 Years Long-term Treatment Period|Adverse Event|0
371778|NCT00943111|1252071|P1|5 Years Long-term Treatment Period|Adverse Event|0
371779|NCT00943111|1252069|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
371780|NCT00943111|1252070|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
371781|NCT00943111|1252071|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
371782|NCT00943111|1252069|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
371783|NCT00943111|1252070|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
371784|NCT00943111|1252071|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
371785|NCT00943111|1252069|P3|52-Weeks Primary Analysis Period|Adverse Event|0
371786|NCT00943111|1252070|P2|52-Weeks Primary Analysis Period|Adverse Event|1
371787|NCT00943111|1252071|P1|52-Weeks Primary Analysis Period|Adverse Event|2
371788|NCT00943072|1252139|P2|Overall Study|Other|1
371789|NCT00943072|1252140|P1|Overall Study|Other|1
371790|NCT00943072|1252139|P2|Overall Study|Lack of Efficacy|4
371791|NCT00943072|1252140|P1|Overall Study|Lack of Efficacy|0
371792|NCT00943072|1252139|P2|Overall Study|Lost to Follow-up|2
371793|NCT00943072|1252140|P1|Overall Study|Lost to Follow-up|1
371794|NCT00943072|1252139|P2|Overall Study|Protocol Violation|1
371795|NCT00943072|1252140|P1|Overall Study|Protocol Violation|0
371796|NCT00943072|1252139|P2|Overall Study|Withdrawal by Subject|1
371797|NCT00943072|1252140|P1|Overall Study|Withdrawal by Subject|3
371798|NCT00943072|1252139|P2|Overall Study|Death|2
371799|NCT00943072|1252140|P1|Overall Study|Death|0
371800|NCT00943072|1252139|P2|Overall Study|Adverse Event|3
371801|NCT00943072|1252140|P1|Overall Study|Adverse Event|0
371802|NCT00942994|1252158|P2|Overall Study|Protocol deviation|2
371803|NCT00942994|1252159|P1|Overall Study|Protocol deviation|1
371804|NCT00942994|1252158|P2|Overall Study|Lost to Follow-up|4
371805|NCT00942994|1252159|P1|Overall Study|Lost to Follow-up|1
371806|NCT00942994|1252158|P2|Overall Study|Patient withdrew consent|8
371807|NCT00942994|1252159|P1|Overall Study|Patient withdrew consent|5
371808|NCT00942994|1252158|P2|Overall Study|Unsatisfactory therapeutic effect|1
371809|NCT00942994|1252159|P1|Overall Study|Unsatisfactory therapeutic effect|1
371810|NCT00942994|1252158|P2|Overall Study|Abnormal laboratory value(s)|0
376319|NCT00906399|1266622|P6|Year 2|Death|0
371812|NCT00942994|1252158|P2|Overall Study|Adverse Event|4
371813|NCT00942994|1252159|P1|Overall Study|Adverse Event|7
371814|NCT00942968|1252175|P1|Overall Study|Deep vein thrombosis (DVT)|2
371815|NCT00942968|1252175|P1|Overall Study|Participant required pancreatic biopsy|1
371816|NCT00942968|1252175|P1|Overall Study|Pulmonary embolism (PE)|1
371817|NCT00942968|1252175|P1|Overall Study|Inferior vena cava filter placement|4
371818|NCT00942968|1252175|P1|Overall Study|Progression of disease|12
371819|NCT00942968|1252175|P1|Overall Study|Physician Decision|11
371820|NCT00942968|1252175|P1|Overall Study|Sponsor request|5
371821|NCT00942968|1252175|P1|Overall Study|Withdrawal by Subject|44
371822|NCT00942968|1252175|P1|Overall Study|Lost to Follow-up|4
371823|NCT00942968|1252175|P1|Overall Study|Protocol Violation|9
371824|NCT00942968|1252175|P1|Overall Study|Death|76
371825|NCT00942968|1252175|P1|Overall Study|Adverse Event|60
371826|NCT00942734|1252253|P1|Overall Study|Physician Decision|1
371827|NCT00942734|1252253|P1|Overall Study|Disease Progression|2
371828|NCT00942734|1252253|P1|Overall Study|Protocol Violation|3
371829|NCT00942734|1252253|P1|Overall Study|Adverse Event|2
371830|NCT00942604|1252259|P2|Overall Study|Patient relocation|1
371831|NCT00942604|1252260|P1|Overall Study|Patient relocation|1
371832|NCT00942604|1252259|P2|Overall Study|Withdrawal by Subject|1
371833|NCT00942604|1252260|P1|Overall Study|Withdrawal by Subject|0
371834|NCT00942604|1252259|P2|Overall Study|Adverse Event|1
371835|NCT00942604|1252260|P1|Overall Study|Adverse Event|0
371836|NCT00942604|1252259|P2|Overall Study|Protocol Violation|1
371837|NCT00942604|1252260|P1|Overall Study|Protocol Violation|1
371838|NCT00942422|1252337|P1|Overall Study|Progressive diease|1
371839|NCT00942422|1252337|P1|Overall Study|Death|1
371840|NCT00942422|1252337|P1|Overall Study|Withdrawal by Subject|1
371841|NCT00942409|1252341|P1|Overall Study|study drug unavailable|2
371842|NCT00942409|1252341|P1|Overall Study|Lack of Efficacy|1
371843|NCT00942266|1252347|P2|Overall Study|medical deterioration (pneumonia)|1
371844|NCT00942266|1252348|P1|Overall Study|medical deterioration (pneumonia)|0
371845|NCT00942266|1252347|P2|Overall Study|Physician Decision|0
371846|NCT00942266|1252348|P1|Overall Study|Physician Decision|2
371847|NCT00942266|1252347|P2|Overall Study|Intercurrent illness|1
371848|NCT00942266|1252348|P1|Overall Study|Intercurrent illness|0
371849|NCT00942266|1252347|P2|Overall Study|Failure to thrive and pt withdrawal|1
371850|NCT00942266|1252348|P1|Overall Study|Failure to thrive and pt withdrawal|0
371851|NCT00942266|1252347|P2|Overall Study|Disease Progression|11
371852|NCT00942266|1252348|P1|Overall Study|Disease Progression|38
371853|NCT00942266|1252347|P2|Overall Study|Adverse Event|1
371854|NCT00942266|1252348|P1|Overall Study|Adverse Event|2
371855|NCT00942266|1252347|P2|Overall Study|Withdrawal by Subject|0
371856|NCT00942266|1252348|P1|Overall Study|Withdrawal by Subject|1
371857|NCT00942188|1252370|P4|Overall Study|Sponsor Decision|1
371858|NCT00942188|1252371|P3|Overall Study|Sponsor Decision|0
371859|NCT00942188|1252372|P2|Overall Study|Sponsor Decision|2
371860|NCT00942188|1252373|P1|Overall Study|Sponsor Decision|0
371861|NCT00942188|1252370|P4|Overall Study|Physician Decision|0
371862|NCT00942188|1252371|P3|Overall Study|Physician Decision|1
371863|NCT00942188|1252372|P2|Overall Study|Physician Decision|0
371864|NCT00942188|1252373|P1|Overall Study|Physician Decision|0
371865|NCT00942188|1252370|P4|Overall Study|Withdrawal by Subject|2
371866|NCT00942188|1252371|P3|Overall Study|Withdrawal by Subject|4
371867|NCT00942188|1252372|P2|Overall Study|Withdrawal by Subject|3
371868|NCT00942188|1252373|P1|Overall Study|Withdrawal by Subject|1
371869|NCT00942188|1252370|P4|Overall Study|Lost to Follow-up|0
371870|NCT00942188|1252371|P3|Overall Study|Lost to Follow-up|2
371871|NCT00942188|1252372|P2|Overall Study|Lost to Follow-up|1
371872|NCT00942188|1252373|P1|Overall Study|Lost to Follow-up|2
371873|NCT00942188|1252370|P4|Overall Study|Protocol Violation|0
371874|NCT00942188|1252371|P3|Overall Study|Protocol Violation|0
371875|NCT00942188|1252372|P2|Overall Study|Protocol Violation|1
371876|NCT00942188|1252373|P1|Overall Study|Protocol Violation|1
371877|NCT00942188|1252370|P4|Overall Study|Lack of Efficacy|1
371878|NCT00942188|1252371|P3|Overall Study|Lack of Efficacy|0
371879|NCT00942188|1252372|P2|Overall Study|Lack of Efficacy|0
371880|NCT00942188|1252373|P1|Overall Study|Lack of Efficacy|0
371881|NCT00942188|1252370|P4|Overall Study|Adverse Event|0
371882|NCT00942188|1252371|P3|Overall Study|Adverse Event|2
371883|NCT00942188|1252372|P2|Overall Study|Adverse Event|3
371884|NCT00942188|1252373|P1|Overall Study|Adverse Event|0
371885|NCT00942175|1252412|P4|Overall Study|Low Platelet Count|0
371886|NCT00942175|1252413|P3|Overall Study|Low Platelet Count|0
371887|NCT00942175|1252414|P2|Overall Study|Low Platelet Count|2
371888|NCT00942175|1252415|P1|Overall Study|Low Platelet Count|0
371889|NCT00942175|1252412|P4|Overall Study|Elevated Alanine Amino Transferase|1
371890|NCT00942175|1252413|P3|Overall Study|Elevated Alanine Amino Transferase|0
371891|NCT00942175|1252414|P2|Overall Study|Elevated Alanine Amino Transferase|0
371892|NCT00942175|1252415|P1|Overall Study|Elevated Alanine Amino Transferase|0
371893|NCT00942175|1252412|P4|Overall Study|Pregnancy|1
371894|NCT00942175|1252413|P3|Overall Study|Pregnancy|0
371895|NCT00942175|1252414|P2|Overall Study|Pregnancy|0
371896|NCT00942175|1252415|P1|Overall Study|Pregnancy|0
371897|NCT00942175|1252412|P4|Overall Study|Protocol Violation|0
371898|NCT00942175|1252413|P3|Overall Study|Protocol Violation|2
371899|NCT00942175|1252414|P2|Overall Study|Protocol Violation|1
371900|NCT00942175|1252415|P1|Overall Study|Protocol Violation|0
371901|NCT00942175|1252412|P4|Overall Study|Adverse Event|0
371902|NCT00942175|1252413|P3|Overall Study|Adverse Event|0
371903|NCT00942175|1252414|P2|Overall Study|Adverse Event|1
371904|NCT00942175|1252415|P1|Overall Study|Adverse Event|2
371905|NCT00942084|1252469|P1|Overall Study|Death|2
371906|NCT00941928|1252486|P1|Overall Study|Disease Progression|1
371907|NCT00941928|1252486|P1|Overall Study|Withdrawal by Subject|1
371908|NCT00941863|1252504|P5|Continued After PCD|Disease progression, recurrence, relapse|18
371909|NCT00941863|1252505|P4|Continued After PCD|Disease progression, recurrence, relapse|0
371910|NCT00941863|1252506|P3|Continued After PCD|Disease progression, recurrence, relapse|0
371911|NCT00941863|1252507|P2|Continued After PCD|Disease progression, recurrence, relapse|0
371912|NCT00941863|1252508|P1|Continued After PCD|Disease progression, recurrence, relapse|0
371913|NCT00941863|1252504|P5|Continued After PCD|Withdrawal by Subject|1
371914|NCT00941863|1252505|P4|Continued After PCD|Withdrawal by Subject|0
371915|NCT00941863|1252506|P3|Continued After PCD|Withdrawal by Subject|0
371916|NCT00941863|1252507|P2|Continued After PCD|Withdrawal by Subject|0
371917|NCT00941863|1252508|P1|Continued After PCD|Withdrawal by Subject|0
371918|NCT00941863|1252504|P5|Until Primary Completion Date (PCD)|Disease progression|73
371919|NCT00941863|1252505|P4|Until Primary Completion Date (PCD)|Disease progression|14
371920|NCT00941863|1252506|P3|Until Primary Completion Date (PCD)|Disease progression|8
371921|NCT00941863|1252507|P2|Until Primary Completion Date (PCD)|Disease progression|1
371922|NCT00941863|1252508|P1|Until Primary Completion Date (PCD)|Disease progression|6
371923|NCT00941863|1252504|P5|Until Primary Completion Date (PCD)|Death|7
371924|NCT00941863|1252505|P4|Until Primary Completion Date (PCD)|Death|2
371925|NCT00941863|1252506|P3|Until Primary Completion Date (PCD)|Death|1
371926|NCT00941863|1252507|P2|Until Primary Completion Date (PCD)|Death|0
371927|NCT00941863|1252508|P1|Until Primary Completion Date (PCD)|Death|0
371928|NCT00941863|1252504|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
371929|NCT00941863|1252505|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
371930|NCT00941863|1252506|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
371931|NCT00941863|1252507|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
371932|NCT00941863|1252508|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
371933|NCT00941863|1252504|P5|Until Primary Completion Date (PCD)|Physician Decision|1
371934|NCT00941863|1252505|P4|Until Primary Completion Date (PCD)|Physician Decision|0
371935|NCT00941863|1252506|P3|Until Primary Completion Date (PCD)|Physician Decision|0
371936|NCT00941863|1252507|P2|Until Primary Completion Date (PCD)|Physician Decision|0
371937|NCT00941863|1252508|P1|Until Primary Completion Date (PCD)|Physician Decision|0
371938|NCT00941863|1252504|P5|Until Primary Completion Date (PCD)|Adverse Event|5
371939|NCT00941863|1252505|P4|Until Primary Completion Date (PCD)|Adverse Event|1
371940|NCT00941863|1252506|P3|Until Primary Completion Date (PCD)|Adverse Event|2
371941|NCT00941863|1252507|P2|Until Primary Completion Date (PCD)|Adverse Event|2
371942|NCT00941863|1252508|P1|Until Primary Completion Date (PCD)|Adverse Event|1
371943|NCT00941798|1252535|P2|Overall Study|Death|1
371944|NCT00941798|1252536|P1|Overall Study|Death|0
371945|NCT00941798|1252535|P2|Overall Study|Abnormal laboratory values|2
371946|NCT00941798|1252536|P1|Overall Study|Abnormal laboratory values|1
371947|NCT00941798|1252535|P2|Overall Study|Abnormal test procedure results|1
371948|NCT00941798|1252536|P1|Overall Study|Abnormal test procedure results|3
371949|NCT00941798|1252535|P2|Overall Study|Patient's inability to use device|1
371950|NCT00941798|1252536|P1|Overall Study|Patient's inability to use device|6
371951|NCT00941798|1252535|P2|Overall Study|Lack of Efficacy|17
371952|NCT00941798|1252536|P1|Overall Study|Lack of Efficacy|10
371953|NCT00941798|1252535|P2|Overall Study|Administrative problems|23
371954|NCT00941798|1252536|P1|Overall Study|Administrative problems|13
371955|NCT00941798|1252535|P2|Overall Study|Protocol Violation|20
371956|NCT00941798|1252536|P1|Overall Study|Protocol Violation|17
371957|NCT00941798|1252535|P2|Overall Study|Lost to Follow-up|23
371958|NCT00941798|1252536|P1|Overall Study|Lost to Follow-up|29
371959|NCT00941798|1252535|P2|Overall Study|Adverse Event|23
371960|NCT00941798|1252536|P1|Overall Study|Adverse Event|43
371961|NCT00941798|1252535|P2|Overall Study|Withdrawal by Subject|74
371962|NCT00941798|1252536|P1|Overall Study|Withdrawal by Subject|72
371963|NCT00941733|1252566|P2|Overall Study|Protocol Violation|6
371964|NCT00941733|1252567|P1|Overall Study|Protocol Violation|15
371965|NCT00941733|1252566|P2|Overall Study|Lost to Follow-up|2
371966|NCT00941733|1252567|P1|Overall Study|Lost to Follow-up|1
371967|NCT00941733|1252566|P2|Overall Study|Adverse Event|4
371968|NCT00941733|1252567|P1|Overall Study|Adverse Event|20
371969|NCT00941733|1252566|P2|Overall Study|Withdrawal by Subject|6
371970|NCT00941733|1252567|P1|Overall Study|Withdrawal by Subject|14
371971|NCT00941733|1252566|P2|Overall Study|Death|10
371972|NCT00941733|1252567|P1|Overall Study|Death|24
371973|NCT00941720|1252607|P1|Overall Study|ineligible|2
371974|NCT00941720|1252607|P1|Overall Study|Insurance denied participation|11
371975|NCT00941720|1252607|P1|Overall Study|Withdrawal by Subject|1
371976|NCT00941655|1252654|P2|Overall Study|non-compliant|1
371977|NCT00941655|1252655|P1|Overall Study|non-compliant|0
371978|NCT00941655|1252654|P2|Overall Study|withdrew consent|1
371979|NCT00941655|1252655|P1|Overall Study|withdrew consent|0
371980|NCT00941655|1252654|P2|Overall Study|refused further treatment|1
371981|NCT00941655|1252655|P1|Overall Study|refused further treatment|0
371982|NCT00941655|1252654|P2|Overall Study|progressed while on chemo|2
371983|NCT00941655|1252655|P1|Overall Study|progressed while on chemo|0
371984|NCT00941655|1252654|P2|Overall Study|not meet criteria for chemo foll surgery|0
371985|NCT00941655|1252655|P1|Overall Study|not meet criteria for chemo foll surgery|4
371986|NCT00941655|1252654|P2|Overall Study|received some chemo, 4 and 9 cycles|0
371987|NCT00941655|1252655|P1|Overall Study|received some chemo, 4 and 9 cycles|1
371988|NCT00941603|1252680|P6|Overall Study|Did not meet protocol eligibility|0
371989|NCT00941603|1252681|P5|Overall Study|Did not meet protocol eligibility|0
371990|NCT00941603|1252682|P4|Overall Study|Did not meet protocol eligibility|0
371991|NCT00941603|1252683|P3|Overall Study|Did not meet protocol eligibility|0
371992|NCT00941603|1252684|P2|Overall Study|Did not meet protocol eligibility|0
371993|NCT00941603|1252685|P1|Overall Study|Did not meet protocol eligibility|1
371994|NCT00941603|1252680|P6|Overall Study|Protocol Violation|0
371995|NCT00941603|1252681|P5|Overall Study|Protocol Violation|0
371996|NCT00941603|1252682|P4|Overall Study|Protocol Violation|0
371997|NCT00941603|1252683|P3|Overall Study|Protocol Violation|0
371998|NCT00941603|1252684|P2|Overall Study|Protocol Violation|1
371999|NCT00941603|1252685|P1|Overall Study|Protocol Violation|0
372000|NCT00941603|1252680|P6|Overall Study|Withdrawal by Subject|1
372001|NCT00941603|1252681|P5|Overall Study|Withdrawal by Subject|0
372002|NCT00941603|1252682|P4|Overall Study|Withdrawal by Subject|2
372003|NCT00941603|1252683|P3|Overall Study|Withdrawal by Subject|0
372004|NCT00941603|1252684|P2|Overall Study|Withdrawal by Subject|0
372005|NCT00941603|1252685|P1|Overall Study|Withdrawal by Subject|0
372006|NCT00941603|1252680|P6|Overall Study|Lost to Follow-up|2
372007|NCT00941603|1252681|P5|Overall Study|Lost to Follow-up|0
372008|NCT00941603|1252682|P4|Overall Study|Lost to Follow-up|1
372009|NCT00941603|1252683|P3|Overall Study|Lost to Follow-up|0
372010|NCT00941603|1252684|P2|Overall Study|Lost to Follow-up|0
372011|NCT00941603|1252685|P1|Overall Study|Lost to Follow-up|0
372012|NCT00941603|1252680|P6|Overall Study|Adverse Event|0
372013|NCT00941603|1252681|P5|Overall Study|Adverse Event|4
372014|NCT00941603|1252682|P4|Overall Study|Adverse Event|1
372015|NCT00941603|1252683|P3|Overall Study|Adverse Event|5
372016|NCT00941603|1252684|P2|Overall Study|Adverse Event|15
372017|NCT00941603|1252685|P1|Overall Study|Adverse Event|10
372018|NCT00941330|1252707|P2|Overall Study|Physician Decision|2
372019|NCT00941330|1252708|P1|Overall Study|Physician Decision|0
372020|NCT00941330|1252707|P2|Overall Study|Other|0
372021|NCT00941330|1252708|P1|Overall Study|Other|1
372022|NCT00941304|1252721|P5|Overall Study|Lost to Follow-up|0
372023|NCT00941304|1252722|P4|Overall Study|Lost to Follow-up|0
372024|NCT00941304|1252723|P3|Overall Study|Lost to Follow-up|0
372025|NCT00941304|1252724|P2|Overall Study|Lost to Follow-up|0
372026|NCT00941304|1252725|P1|Overall Study|Lost to Follow-up|1
372027|NCT00941070|1252787|P1|Overall Study|Patient non-compliant|1
372028|NCT00941031|1252807|P7|Maintenance Period|Lack of Efficacy|13
372029|NCT00941031|1252808|P6|Maintenance Period|Lack of Efficacy|0
372030|NCT00941031|1252809|P5|Maintenance Period|Lack of Efficacy|0
372031|NCT00941031|1252810|P4|Maintenance Period|Lack of Efficacy|0
372032|NCT00941031|1252811|P3|Maintenance Period|Lack of Efficacy|0
372033|NCT00941031|1252812|P2|Maintenance Period|Lack of Efficacy|0
372034|NCT00941031|1252813|P1|Maintenance Period|Lack of Efficacy|0
372035|NCT00941031|1252807|P7|Maintenance Period|Lost to Follow-up|7
372036|NCT00941031|1252808|P6|Maintenance Period|Lost to Follow-up|2
372037|NCT00941031|1252809|P5|Maintenance Period|Lost to Follow-up|2
372038|NCT00941031|1252810|P4|Maintenance Period|Lost to Follow-up|0
372039|NCT00941031|1252811|P3|Maintenance Period|Lost to Follow-up|0
372040|NCT00941031|1252812|P2|Maintenance Period|Lost to Follow-up|0
372041|NCT00941031|1252813|P1|Maintenance Period|Lost to Follow-up|0
372042|NCT00941031|1252807|P7|Maintenance Period|Adverse Event|8
372043|NCT00941031|1252808|P6|Maintenance Period|Adverse Event|2
372044|NCT00941031|1252809|P5|Maintenance Period|Adverse Event|0
372045|NCT00941031|1252810|P4|Maintenance Period|Adverse Event|0
372046|NCT00941031|1252811|P3|Maintenance Period|Adverse Event|0
372047|NCT00941031|1252812|P2|Maintenance Period|Adverse Event|0
372048|NCT00941031|1252813|P1|Maintenance Period|Adverse Event|0
372049|NCT00941031|1252807|P7|Maintenance Period|Protocol Violation|1
372050|NCT00941031|1252808|P6|Maintenance Period|Protocol Violation|0
372051|NCT00941031|1252809|P5|Maintenance Period|Protocol Violation|0
372052|NCT00941031|1252810|P4|Maintenance Period|Protocol Violation|0
372053|NCT00941031|1252811|P3|Maintenance Period|Protocol Violation|0
372054|NCT00941031|1252812|P2|Maintenance Period|Protocol Violation|0
372055|NCT00941031|1252813|P1|Maintenance Period|Protocol Violation|0
372056|NCT00941031|1252807|P7|Maintenance Period|Administrative Problems|1
372057|NCT00941031|1252808|P6|Maintenance Period|Administrative Problems|0
372058|NCT00941031|1252809|P5|Maintenance Period|Administrative Problems|1
372059|NCT00941031|1252810|P4|Maintenance Period|Administrative Problems|0
372060|NCT00941031|1252811|P3|Maintenance Period|Administrative Problems|0
372061|NCT00941031|1252812|P2|Maintenance Period|Administrative Problems|0
372062|NCT00941031|1252813|P1|Maintenance Period|Administrative Problems|0
372063|NCT00941031|1252807|P7|Maintenance Period|Withdrawal by Subject|13
372064|NCT00941031|1252808|P6|Maintenance Period|Withdrawal by Subject|2
372065|NCT00941031|1252809|P5|Maintenance Period|Withdrawal by Subject|6
372066|NCT00941031|1252810|P4|Maintenance Period|Withdrawal by Subject|0
376320|NCT00906399|1266623|P5|Year 2|Death|0
372067|NCT00941031|1252811|P3|Maintenance Period|Withdrawal by Subject|0
372068|NCT00941031|1252812|P2|Maintenance Period|Withdrawal by Subject|0
372069|NCT00941031|1252813|P1|Maintenance Period|Withdrawal by Subject|0
372070|NCT00941031|1252807|P7|Induction Period|Adverse Event|0
372071|NCT00941031|1252808|P6|Induction Period|Adverse Event|0
372072|NCT00941031|1252809|P5|Induction Period|Adverse Event|0
372073|NCT00941031|1252810|P4|Induction Period|Adverse Event|2
372074|NCT00941031|1252811|P3|Induction Period|Adverse Event|3
372075|NCT00941031|1252812|P2|Induction Period|Adverse Event|0
372076|NCT00941031|1252813|P1|Induction Period|Adverse Event|1
372077|NCT00941031|1252807|P7|Induction Period|Adminstative Problems|0
372078|NCT00941031|1252808|P6|Induction Period|Adminstative Problems|0
372079|NCT00941031|1252809|P5|Induction Period|Adminstative Problems|0
372080|NCT00941031|1252810|P4|Induction Period|Adminstative Problems|0
372081|NCT00941031|1252811|P3|Induction Period|Adminstative Problems|1
372082|NCT00941031|1252812|P2|Induction Period|Adminstative Problems|1
372083|NCT00941031|1252813|P1|Induction Period|Adminstative Problems|1
372084|NCT00941031|1252807|P7|Induction Period|Withdrawal by Subject|0
372085|NCT00941031|1252808|P6|Induction Period|Withdrawal by Subject|0
372086|NCT00941031|1252809|P5|Induction Period|Withdrawal by Subject|0
372087|NCT00941031|1252810|P4|Induction Period|Withdrawal by Subject|2
372088|NCT00941031|1252811|P3|Induction Period|Withdrawal by Subject|2
372089|NCT00941031|1252812|P2|Induction Period|Withdrawal by Subject|2
372090|NCT00941031|1252813|P1|Induction Period|Withdrawal by Subject|1
372091|NCT00941031|1252807|P7|Induction Period|Lack of Efficacy|0
372092|NCT00941031|1252808|P6|Induction Period|Lack of Efficacy|0
372093|NCT00941031|1252809|P5|Induction Period|Lack of Efficacy|0
372094|NCT00941031|1252810|P4|Induction Period|Lack of Efficacy|5
372095|NCT00941031|1252811|P3|Induction Period|Lack of Efficacy|0
372096|NCT00941031|1252812|P2|Induction Period|Lack of Efficacy|1
372097|NCT00941031|1252813|P1|Induction Period|Lack of Efficacy|2
372098|NCT00940992|1252839|P3|Overall Study|Lost to Follow-up|1
372099|NCT00940992|1252840|P2|Overall Study|Lost to Follow-up|1
372100|NCT00940992|1252841|P1|Overall Study|Lost to Follow-up|0
372101|NCT00940992|1252839|P3|Overall Study|subject request|0
372102|NCT00940992|1252840|P2|Overall Study|subject request|1
372103|NCT00940992|1252841|P1|Overall Study|subject request|2
372104|NCT00940992|1252839|P3|Overall Study|Adverse Event|1
372105|NCT00940992|1252840|P2|Overall Study|Adverse Event|0
372106|NCT00940992|1252841|P1|Overall Study|Adverse Event|2
372107|NCT00940888|1252870|P1|Overall Study|Lost to Follow-up|6
372108|NCT00940888|1252870|P1|Overall Study|Withdrawn - Non-Death|364
372109|NCT00940888|1252870|P1|Overall Study|Death|461
372110|NCT00940888|1252870|P1|Overall Study|Unsuccessful Implant|4
372111|NCT00940875|1252877|P2|Post-Study Treatment|Disease Progression|2
372112|NCT00940875|1252878|P1|Post-Study Treatment|Disease Progression|0
372113|NCT00940875|1252877|P2|Post-Study Treatment|Death|1
372114|NCT00940875|1252878|P1|Post-Study Treatment|Death|0
372115|NCT00940875|1252877|P2|Treatment Phase|Physician Decision|0
372116|NCT00940875|1252878|P1|Treatment Phase|Physician Decision|1
372117|NCT00940875|1252877|P2|Treatment Phase|Disease progression|11
372118|NCT00940875|1252878|P1|Treatment Phase|Disease progression|9
372119|NCT00940875|1252877|P2|Treatment Phase|Withdrawal by Subject|0
372120|NCT00940875|1252878|P1|Treatment Phase|Withdrawal by Subject|3
372121|NCT00940875|1252877|P2|Treatment Phase|Lack of Efficacy|0
372122|NCT00940875|1252878|P1|Treatment Phase|Lack of Efficacy|1
372123|NCT00940875|1252877|P2|Treatment Phase|Death|5
372124|NCT00940875|1252878|P1|Treatment Phase|Death|3
372125|NCT00940875|1252877|P2|Treatment Phase|Adverse Event|3
372126|NCT00940875|1252878|P1|Treatment Phase|Adverse Event|9
372127|NCT00940823|1252898|P2|Overall Study|Lost to Follow-up|20
372128|NCT00940823|1252899|P1|Overall Study|Lost to Follow-up|27
372129|NCT00940823|1252898|P2|Overall Study|Death|12
372130|NCT00940823|1252899|P1|Overall Study|Death|8
372131|NCT00940485|1252950|P2|Overall Study|Others|1
372132|NCT00940485|1252951|P1|Overall Study|Others|1
372133|NCT00940485|1252950|P2|Overall Study|Withdrawal by Subject|1
372134|NCT00940485|1252951|P1|Overall Study|Withdrawal by Subject|1
372135|NCT00940485|1252950|P2|Overall Study|Adverse Event|0
372136|NCT00940485|1252951|P1|Overall Study|Adverse Event|8
372137|NCT00940485|1252950|P2|Overall Study|Lost to Follow-up|3
372138|NCT00940485|1252951|P1|Overall Study|Lost to Follow-up|2
372139|NCT00940485|1252950|P2|Overall Study|HBeAb positive at Baseline|2
372140|NCT00940485|1252951|P1|Overall Study|HBeAb positive at Baseline|3
372141|NCT00940108|1253007|P4|Overall Study|Diagnosed with H1N1|1
372142|NCT00940108|1253008|P3|Overall Study|Diagnosed with H1N1|0
372143|NCT00940108|1253009|P2|Overall Study|Diagnosed with H1N1|0
372144|NCT00940108|1253010|P1|Overall Study|Diagnosed with H1N1|0
372145|NCT00940108|1253007|P4|Overall Study|Viral illness after Dose 1|0
372146|NCT00940108|1253008|P3|Overall Study|Viral illness after Dose 1|0
372147|NCT00940108|1253009|P2|Overall Study|Viral illness after Dose 1|1
372148|NCT00940108|1253010|P1|Overall Study|Viral illness after Dose 1|0
372149|NCT00940108|1253007|P4|Overall Study|Refused - pyrexia after Dose 1|0
372150|NCT00940108|1253008|P3|Overall Study|Refused - pyrexia after Dose 1|0
372151|NCT00940108|1253009|P2|Overall Study|Refused - pyrexia after Dose 1|1
372152|NCT00940108|1253010|P1|Overall Study|Refused - pyrexia after Dose 1|0
372153|NCT00940108|1253007|P4|Overall Study|Declined further vaccination|0
372154|NCT00940108|1253008|P3|Overall Study|Declined further vaccination|3
372155|NCT00940108|1253009|P2|Overall Study|Declined further vaccination|1
372156|NCT00940108|1253010|P1|Overall Study|Declined further vaccination|0
372157|NCT00940108|1253007|P4|Overall Study|Dose 2 contraindicated|1
372158|NCT00940108|1253008|P3|Overall Study|Dose 2 contraindicated|0
372159|NCT00940108|1253009|P2|Overall Study|Dose 2 contraindicated|1
372160|NCT00940108|1253010|P1|Overall Study|Dose 2 contraindicated|1
372161|NCT00940108|1253007|P4|Overall Study|Withdrew Consent|1
372162|NCT00940108|1253008|P3|Overall Study|Withdrew Consent|0
372163|NCT00940108|1253009|P2|Overall Study|Withdrew Consent|1
372164|NCT00940108|1253010|P1|Overall Study|Withdrew Consent|2
372165|NCT00940108|1253007|P4|Overall Study|Adverse Event|2
372166|NCT00940108|1253008|P3|Overall Study|Adverse Event|0
372167|NCT00940108|1253009|P2|Overall Study|Adverse Event|4
372168|NCT00940108|1253010|P1|Overall Study|Adverse Event|2
372169|NCT00940017|1253060|P1|Overall Study|Adverse Event|1
372170|NCT00940017|1253060|P1|Overall Study|did not meet entrance criteria|3
372171|NCT00939809|1253116|P1|Overall Study|Death|1
372172|NCT00939809|1253116|P1|Overall Study|Adverse Event|2
372173|NCT00939783|1253131|P1|Overall Study|Enrolled but not treated|1
372174|NCT00939783|1253131|P1|Overall Study|Protocol Violation|3
372175|NCT00939783|1253131|P1|Overall Study|Lost to Follow-up|8
372176|NCT00939783|1253131|P1|Overall Study|Other|16
372177|NCT00939783|1253131|P1|Overall Study|Withdrawal by Subject|78
372178|NCT00939783|1253131|P1|Overall Study|Study Terminated by Sponsor|498
372179|NCT00939783|1253131|P1|Overall Study|Adverse Event|39
372180|NCT00939783|1253131|P1|Overall Study|Death|6
372181|NCT00939692|1253172|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
372182|NCT00939692|1253173|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
372183|NCT00939692|1253172|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
372184|NCT00939692|1253173|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
372185|NCT00939627|1253185|P3|Overall Study|No off-tx reason given|0
372186|NCT00939627|1253186|P2|Overall Study|No off-tx reason given|2
372187|NCT00939627|1253187|P1|Overall Study|No off-tx reason given|0
372188|NCT00939627|1253185|P3|Overall Study|Not compliant|0
372189|NCT00939627|1253186|P2|Overall Study|Not compliant|0
372190|NCT00939627|1253187|P1|Overall Study|Not compliant|2
372191|NCT00939627|1253185|P3|Overall Study|Other complicating disease|0
372192|NCT00939627|1253186|P2|Overall Study|Other complicating disease|1
372193|NCT00939627|1253187|P1|Overall Study|Other complicating disease|1
372194|NCT00939627|1253185|P3|Overall Study|Withdrawal by Subject|0
372195|NCT00939627|1253186|P2|Overall Study|Withdrawal by Subject|4
372196|NCT00939627|1253187|P1|Overall Study|Withdrawal by Subject|2
372197|NCT00939627|1253185|P3|Overall Study|Death|0
372198|NCT00939627|1253186|P2|Overall Study|Death|2
372199|NCT00939627|1253187|P1|Overall Study|Death|0
372200|NCT00939627|1253185|P3|Overall Study|Adverse Event|0
372201|NCT00939627|1253186|P2|Overall Study|Adverse Event|7
372202|NCT00939627|1253187|P1|Overall Study|Adverse Event|6
372203|NCT00939627|1253185|P3|Overall Study|Disease Progression|0
372204|NCT00939627|1253186|P2|Overall Study|Disease Progression|12
372205|NCT00939627|1253187|P1|Overall Study|Disease Progression|16
372206|NCT00939510|1253227|P1|Overall Study|Withdrawal by Subject|1
372207|NCT00939484|1253236|P3|Overall Study|Progression/Relapse|3
372208|NCT00939484|1253237|P2|Overall Study|Progression/Relapse|20
372209|NCT00939484|1253238|P1|Overall Study|Progression/Relapse|8
372210|NCT00939393|1253264|P2|Overall Study|Lost to Follow-up|0
372211|NCT00939393|1253265|P1|Overall Study|Lost to Follow-up|3
372212|NCT00939393|1253264|P2|Overall Study|Withdrawal by Subject|0
372213|NCT00939393|1253265|P1|Overall Study|Withdrawal by Subject|1
372214|NCT00939341|1253296|P1|Overall Study|Incorrect enrolment|8
372215|NCT00939341|1253296|P1|Overall Study|Protocol Violation|6
372216|NCT00939341|1253296|P1|Overall Study|Withdrawal by Subject|13
372217|NCT00939341|1253296|P1|Overall Study|Lost to Follow-up|23
372218|NCT00939341|1253296|P1|Overall Study|Pregnancy|1
372219|NCT00939341|1253296|P1|Overall Study|Adverse Event|15
372220|NCT00939185|1253378|P1|Overall Study|Randomized But Did Not Receive Treatment|10
372221|NCT00939185|1253378|P1|Overall Study|Withdrawal by Subject|2
372222|NCT00939185|1253378|P1|Overall Study|Other|3
372223|NCT00939185|1253378|P1|Overall Study|Lost to Follow-up|6
372224|NCT00939185|1253378|P1|Overall Study|Lack of Efficacy|1
372225|NCT00939185|1253378|P1|Overall Study|Adverse Event|3
372226|NCT00939107|1253416|P2|Overall Study|Lost to Follow-up|12
372227|NCT00939107|1253417|P1|Overall Study|Lost to Follow-up|14
372228|NCT00939094|1253431|P2|Overall Study|Abnormal ECG findings|0
372229|NCT00939094|1253432|P1|Overall Study|Abnormal ECG findings|1
372230|NCT00939094|1253431|P2|Overall Study|Study stopped by sponsor|2
372231|NCT00939094|1253432|P1|Overall Study|Study stopped by sponsor|0
372232|NCT00939094|1253431|P2|Overall Study|Severe non-compliance to protocol|1
372233|NCT00939094|1253432|P1|Overall Study|Severe non-compliance to protocol|0
372234|NCT00939094|1253431|P2|Overall Study|Eligibility criteria not fulfilled|0
372235|NCT00939094|1253432|P1|Overall Study|Eligibility criteria not fulfilled|2
372236|NCT00939094|1253431|P2|Overall Study|Lost to Follow-up|1
372237|NCT00939094|1253432|P1|Overall Study|Lost to Follow-up|1
372238|NCT00939094|1253431|P2|Overall Study|Withdrawal by Subject|6
372239|NCT00939094|1253432|P1|Overall Study|Withdrawal by Subject|1
372240|NCT00939094|1253431|P2|Overall Study|Adverse Event|0
372241|NCT00939094|1253432|P1|Overall Study|Adverse Event|9
372242|NCT00939055|1253454|P2|Overall Study|Discontinuation prior to procedure|0
372243|NCT00939055|1253455|P1|Overall Study|Discontinuation prior to procedure|4
372244|NCT00939029|1253465|P2|Overall Study|Adverse Event|1
372245|NCT00939029|1253466|P1|Overall Study|Adverse Event|0
372246|NCT00939029|1253465|P2|Overall Study|Lost to Follow-up|4
372247|NCT00939029|1253466|P1|Overall Study|Lost to Follow-up|3
372248|NCT00939029|1253465|P2|Overall Study|Withdrawal by Subject|7
372249|NCT00939029|1253466|P1|Overall Study|Withdrawal by Subject|3
372250|NCT00939003|1253478|P2|Open-label Treatment Period|Site Closure|4
372251|NCT00939003|1253479|P1|Open-label Treatment Period|Site Closure|3
372252|NCT00939003|1253478|P2|Open-label Treatment Period|Exclusion Criteria|0
372253|NCT00939003|1253479|P1|Open-label Treatment Period|Exclusion Criteria|1
372254|NCT00939003|1253478|P2|Open-label Treatment Period|Pregnancy|1
372255|NCT00939003|1253479|P1|Open-label Treatment Period|Pregnancy|1
372256|NCT00939003|1253478|P2|Open-label Treatment Period|Lack of Efficacy|9
372257|NCT00939003|1253479|P1|Open-label Treatment Period|Lack of Efficacy|6
372258|NCT00939003|1253478|P2|Open-label Treatment Period|Withdrawal by Subject|7
372259|NCT00939003|1253479|P1|Open-label Treatment Period|Withdrawal by Subject|14
372260|NCT00939003|1253478|P2|Open-label Treatment Period|Adverse Event|8
372261|NCT00939003|1253479|P1|Open-label Treatment Period|Adverse Event|4
372262|NCT00939003|1253478|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
372263|NCT00939003|1253479|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
372264|NCT00939003|1253478|P2|Double-blind Treatment Period|Pregnancy|1
372265|NCT00939003|1253479|P1|Double-blind Treatment Period|Pregnancy|0
372266|NCT00939003|1253478|P2|Double-blind Treatment Period|Lack of Efficacy|1
372267|NCT00939003|1253479|P1|Double-blind Treatment Period|Lack of Efficacy|0
372268|NCT00939003|1253478|P2|Double-blind Treatment Period|Adverse Event|1
372269|NCT00939003|1253479|P1|Double-blind Treatment Period|Adverse Event|1
372270|NCT00938964|1253516|P2|Overall Study|Found to Meet Exclusion Criteria|4
372271|NCT00938964|1253517|P1|Overall Study|Found to Meet Exclusion Criteria|3
372272|NCT00938964|1253516|P2|Overall Study|Withdrawal by Subject|18
372273|NCT00938964|1253517|P1|Overall Study|Withdrawal by Subject|22
372274|NCT00938964|1253516|P2|Overall Study|Lost to Follow-up|3
372275|NCT00938964|1253517|P1|Overall Study|Lost to Follow-up|2
372276|NCT00938964|1253516|P2|Overall Study|Death|3
372277|NCT00938964|1253517|P1|Overall Study|Death|3
372278|NCT00938886|1253581|P2|Overall Study|Lost to Follow-up|2
372279|NCT00938886|1253582|P1|Overall Study|Lost to Follow-up|3
372280|NCT00938886|1253581|P2|Overall Study|Withdrawal by Subject|7
372281|NCT00938886|1253582|P1|Overall Study|Withdrawal by Subject|4
372282|NCT00938886|1253581|P2|Overall Study|Death|1
372283|NCT00938886|1253582|P1|Overall Study|Death|0
372284|NCT00938860|1253592|P2|Overall Study|Protocol Violation|1
372285|NCT00938860|1253593|P1|Overall Study|Protocol Violation|3
372286|NCT00938860|1253592|P2|Overall Study|Death|1
372287|NCT00938860|1253593|P1|Overall Study|Death|1
372288|NCT00938860|1253592|P2|Overall Study|Administration problems|0
372289|NCT00938860|1253593|P1|Overall Study|Administration problems|2
372290|NCT00938860|1253592|P2|Overall Study|Lost to Follow-up|4
372291|NCT00938860|1253593|P1|Overall Study|Lost to Follow-up|4
372292|NCT00938860|1253592|P2|Overall Study|Withdrawal by Subject|8
372293|NCT00938860|1253593|P1|Overall Study|Withdrawal by Subject|11
372294|NCT00938860|1253592|P2|Overall Study|Abnormal laboratory values|2
372295|NCT00938860|1253593|P1|Overall Study|Abnormal laboratory values|2
372296|NCT00938860|1253592|P2|Overall Study|Adverse Event|1
372297|NCT00938860|1253593|P1|Overall Study|Adverse Event|2
372298|NCT00938717|1253626|P2|Overall Study|Other reason|2
372299|NCT00938717|1253627|P1|Overall Study|Other reason|5
372300|NCT00938717|1253626|P2|Overall Study|Lack of Efficacy|15
372301|NCT00938717|1253627|P1|Overall Study|Lack of Efficacy|33
372302|NCT00938717|1253626|P2|Overall Study|Lost to Follow-up|18
372303|NCT00938717|1253627|P1|Overall Study|Lost to Follow-up|13
372304|NCT00938717|1253626|P2|Overall Study|Withdrawal by Subject|24
372305|NCT00938717|1253627|P1|Overall Study|Withdrawal by Subject|26
372306|NCT00938717|1253626|P2|Overall Study|Protocol Violation|8
372307|NCT00938717|1253627|P1|Overall Study|Protocol Violation|11
372308|NCT00938717|1253626|P2|Overall Study|Adverse Event|41
372309|NCT00938717|1253627|P1|Overall Study|Adverse Event|10
372310|NCT00938639|1253678|P2|Overall Study|Participant noncompliance|0
372311|NCT00938639|1253679|P1|Overall Study|Participant noncompliance|1
372312|NCT00938639|1253678|P2|Overall Study|Family issues|1
372313|NCT00938639|1253679|P1|Overall Study|Family issues|1
372314|NCT00938639|1253678|P2|Overall Study|Lost to Follow-up|2
372315|NCT00938639|1253679|P1|Overall Study|Lost to Follow-up|1
372316|NCT00938639|1253678|P2|Overall Study|Moved away from study area|1
372317|NCT00938639|1253679|P1|Overall Study|Moved away from study area|0
372318|NCT00938470|1253762|P2|Overall Study|Other Reason|1
372319|NCT00938470|1253763|P1|Overall Study|Other Reason|0
372320|NCT00938470|1253762|P2|Overall Study|Death|2
372321|NCT00938470|1253763|P1|Overall Study|Death|3
372322|NCT00938470|1253762|P2|Overall Study|Alternate Treatment|0
372323|NCT00938470|1253763|P1|Overall Study|Alternate Treatment|1
372324|NCT00938470|1253762|P2|Overall Study|Disease Progression|0
372325|NCT00938470|1253763|P1|Overall Study|Disease Progression|3
372326|NCT00938431|1253793|P3|Overall Study|Reached maximum dose early|1
372327|NCT00938431|1253794|P2|Overall Study|Reached maximum dose early|0
372328|NCT00938431|1253795|P1|Overall Study|Reached maximum dose early|0
372329|NCT00938431|1253793|P3|Overall Study|Dosing compliance issue|1
372330|NCT00938431|1253794|P2|Overall Study|Dosing compliance issue|0
372331|NCT00938431|1253795|P1|Overall Study|Dosing compliance issue|0
372332|NCT00938431|1253793|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
372333|NCT00938431|1253794|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
372334|NCT00938431|1253795|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
372335|NCT00938431|1253793|P3|Overall Study|Lack of Efficacy|0
372336|NCT00938431|1253794|P2|Overall Study|Lack of Efficacy|1
372337|NCT00938431|1253795|P1|Overall Study|Lack of Efficacy|0
372338|NCT00938431|1253793|P3|Overall Study|Adverse Event|6
372339|NCT00938431|1253794|P2|Overall Study|Adverse Event|8
372340|NCT00938431|1253795|P1|Overall Study|Adverse Event|5
372341|NCT00938392|1253822|P2|Overall Study|Lost to Follow-up|2
372342|NCT00938392|1253823|P1|Overall Study|Lost to Follow-up|2
372343|NCT00938392|1253822|P2|Overall Study|Withdrawal by Subject|1
372344|NCT00938392|1253823|P1|Overall Study|Withdrawal by Subject|0
372345|NCT00938392|1253822|P2|Overall Study|Adverse Event|1
372346|NCT00938392|1253823|P1|Overall Study|Adverse Event|0
372347|NCT00938366|1253849|P2|Overall Study|Withdrawal by Subject|0
372348|NCT00938366|1253850|P1|Overall Study|Withdrawal by Subject|1
372349|NCT00938327|1253870|P1|Overall Study|Vaccine not received as out of stock|9
372350|NCT00938327|1253870|P1|Overall Study|2nd dose received outside of the study|7
372351|NCT00938327|1253870|P1|Overall Study|Lost to Follow-up|37
372352|NCT00938327|1253870|P1|Overall Study|Withdrawal by Subject|4
372353|NCT00938327|1253870|P1|Overall Study|Protocol Violation|1
372354|NCT00938327|1253870|P1|Overall Study|Adverse Event|2
372355|NCT00938041|1253938|P1|Overall Study|Adrenal Insufficiency|3
372356|NCT00938041|1253938|P1|Overall Study|Death|12
372357|NCT00938041|1253938|P1|Overall Study|Progressive Disease|5
372358|NCT00938041|1253938|P1|Overall Study|Received Alternative Therapy|1
372359|NCT00938041|1253938|P1|Overall Study|Lost to Follow-up|6
372360|NCT00938015|1253947|P1|Overall Study|Reason not related to Etanercept|29
372361|NCT00938015|1253947|P1|Overall Study|Non-responder|52
372362|NCT00938015|1253947|P1|Overall Study|Adverse Event|32
372363|NCT00938015|1253947|P1|Overall Study|Lost to Follow-up|32
372364|NCT00938015|1253947|P1|Overall Study|Death|2
372365|NCT00937950|1253963|P1|Overall Study|Others|18
372366|NCT00937950|1253963|P1|Overall Study|Missing confirmed|4
372367|NCT00937950|1253963|P1|Overall Study|Lost to Follow-up|144
372368|NCT00937950|1253963|P1|Overall Study|Migrated/moved from study area|27
372369|NCT00937950|1253963|P1|Overall Study|Withdrawal by Subject|23
372370|NCT00937937|1253979|P1|Overall Study|Not specified|2
372371|NCT00937937|1253979|P1|Overall Study|Death|1
372372|NCT00937937|1253979|P1|Overall Study|Progression/relapse|61
372373|NCT00937937|1253979|P1|Overall Study|Withdrawal by Subject|2
372374|NCT00937937|1253979|P1|Overall Study|Adverse Event|6
372375|NCT00937833|1253988|P2|Overall Study|Withdrawal by Subject|6
372376|NCT00937833|1253989|P1|Overall Study|Withdrawal by Subject|4
372377|NCT00937833|1253988|P2|Overall Study|Lost to Follow-up|8
372378|NCT00937833|1253989|P1|Overall Study|Lost to Follow-up|10
372379|NCT00937833|1253988|P2|Overall Study|Procedure delayed; enrollment closed|1
372380|NCT00937833|1253989|P1|Overall Study|Procedure delayed; enrollment closed|0
372381|NCT00937833|1253988|P2|Overall Study|Protocol Violation|2
372382|NCT00937833|1253989|P1|Overall Study|Protocol Violation|1
372383|NCT00937768|1254002|P2|Overall Study|No Further Funding|4
372384|NCT00937768|1254003|P1|Overall Study|No Further Funding|4
372385|NCT00937768|1254002|P2|Overall Study|Alternate Treatment|1
372386|NCT00937768|1254003|P1|Overall Study|Alternate Treatment|0
372387|NCT00937768|1254002|P2|Overall Study|Disease Progression|1
372388|NCT00937768|1254003|P1|Overall Study|Disease Progression|1
372389|NCT00937768|1254002|P2|Overall Study|Refused Further Treatment|2
372390|NCT00937768|1254003|P1|Overall Study|Refused Further Treatment|3
372391|NCT00937560|1254009|P1|Maintenance Treatment|According to protocol|1
372392|NCT00937560|1254009|P1|Maintenance Treatment|Withdraw consent|5
372393|NCT00937560|1254009|P1|Maintenance Treatment|Death|12
372394|NCT00937560|1254009|P1|Initial Treatment|No end of study page|10
372395|NCT00937560|1254009|P1|Initial Treatment|Lost to Follow-up|1
372396|NCT00937560|1254009|P1|Initial Treatment|Adverse Event|1
372397|NCT00937560|1254009|P1|Initial Treatment|Withdraw consent|3
372398|NCT00937560|1254009|P1|Initial Treatment|Death|6
372399|NCT00937547|1254020|P3|Overall Study|misdiagnosis|7
372400|NCT00937547|1254021|P2|Overall Study|misdiagnosis|6
372401|NCT00937547|1254022|P1|Overall Study|misdiagnosis|1
372402|NCT00937521|1254059|P8|Booster Phase|Protocol Deviation|0
372403|NCT00937521|1254060|P7|Booster Phase|Protocol Deviation|1
372404|NCT00937521|1254061|P6|Booster Phase|Protocol Deviation|0
372405|NCT00937521|1254062|P5|Booster Phase|Protocol Deviation|0
372406|NCT00937521|1254063|P4|Booster Phase|Protocol Deviation|0
372407|NCT00937521|1254064|P3|Booster Phase|Protocol Deviation|0
372408|NCT00937521|1254065|P2|Booster Phase|Protocol Deviation|0
372409|NCT00937521|1254066|P1|Booster Phase|Protocol Deviation|0
372410|NCT00937521|1254059|P8|Booster Phase|Administrative Reason|0
372411|NCT00937521|1254060|P7|Booster Phase|Administrative Reason|0
372412|NCT00937521|1254061|P6|Booster Phase|Administrative Reason|1
372413|NCT00937521|1254062|P5|Booster Phase|Administrative Reason|1
372414|NCT00937521|1254063|P4|Booster Phase|Administrative Reason|0
372415|NCT00937521|1254064|P3|Booster Phase|Administrative Reason|1
372416|NCT00937521|1254065|P2|Booster Phase|Administrative Reason|0
372417|NCT00937521|1254066|P1|Booster Phase|Administrative Reason|0
372418|NCT00937521|1254059|P8|Booster Phase|Lost to Follow-up|0
372419|NCT00937521|1254060|P7|Booster Phase|Lost to Follow-up|3
372420|NCT00937521|1254061|P6|Booster Phase|Lost to Follow-up|4
372421|NCT00937521|1254062|P5|Booster Phase|Lost to Follow-up|4
372422|NCT00937521|1254063|P4|Booster Phase|Lost to Follow-up|2
372423|NCT00937521|1254064|P3|Booster Phase|Lost to Follow-up|4
372424|NCT00937521|1254065|P2|Booster Phase|Lost to Follow-up|2
372425|NCT00937521|1254066|P1|Booster Phase|Lost to Follow-up|2
372426|NCT00937521|1254059|P8|Booster Phase|Withdrawal by Subject|2
372427|NCT00937521|1254060|P7|Booster Phase|Withdrawal by Subject|0
372428|NCT00937521|1254061|P6|Booster Phase|Withdrawal by Subject|0
372429|NCT00937521|1254062|P5|Booster Phase|Withdrawal by Subject|0
372430|NCT00937521|1254063|P4|Booster Phase|Withdrawal by Subject|1
372431|NCT00937521|1254064|P3|Booster Phase|Withdrawal by Subject|0
372432|NCT00937521|1254065|P2|Booster Phase|Withdrawal by Subject|0
372433|NCT00937521|1254066|P1|Booster Phase|Withdrawal by Subject|1
372434|NCT00937521|1254059|P8|Booster Phase|Adverse Event|0
372435|NCT00937521|1254060|P7|Booster Phase|Adverse Event|1
372436|NCT00937521|1254061|P6|Booster Phase|Adverse Event|0
372437|NCT00937521|1254062|P5|Booster Phase|Adverse Event|0
372438|NCT00937521|1254063|P4|Booster Phase|Adverse Event|0
372439|NCT00937521|1254064|P3|Booster Phase|Adverse Event|0
372440|NCT00937521|1254065|P2|Booster Phase|Adverse Event|0
372441|NCT00937521|1254066|P1|Booster Phase|Adverse Event|0
372442|NCT00937521|1254059|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
372443|NCT00937521|1254060|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
372444|NCT00937521|1254061|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
372445|NCT00937521|1254062|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
372446|NCT00937521|1254063|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
372447|NCT00937521|1254064|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
372448|NCT00937521|1254065|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
372449|NCT00937521|1254066|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
372450|NCT00937521|1254059|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
372451|NCT00937521|1254060|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
372452|NCT00937521|1254061|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
372453|NCT00937521|1254062|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
372454|NCT00937521|1254063|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
372455|NCT00937521|1254064|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
372456|NCT00937521|1254065|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
372457|NCT00937521|1254066|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
372458|NCT00937521|1254059|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
372459|NCT00937521|1254060|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
372460|NCT00937521|1254061|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
372461|NCT00937521|1254062|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
372462|NCT00937521|1254063|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
372463|NCT00937521|1254064|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
372464|NCT00937521|1254065|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
372465|NCT00937521|1254066|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
372466|NCT00937521|1254059|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
372467|NCT00937521|1254060|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
372468|NCT00937521|1254061|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
372469|NCT00937521|1254062|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
372470|NCT00937521|1254063|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
372471|NCT00937521|1254064|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
372472|NCT00937521|1254065|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
372473|NCT00937521|1254066|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
372474|NCT00937521|1254059|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
372475|NCT00937521|1254060|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
372476|NCT00937521|1254061|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
372477|NCT00937521|1254062|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
372478|NCT00937521|1254063|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
372479|NCT00937521|1254064|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
372480|NCT00937521|1254065|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
372481|NCT00937521|1254066|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
372482|NCT00937495|1254172|P1|Overall Study|Protocol Violation|2
372483|NCT00937391|1254180|P1|Stage 2|Withdrawal by Subject|1
372484|NCT00937326|1254236|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
372485|NCT00937326|1254237|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
372486|NCT00937326|1254238|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
372487|NCT00937326|1254239|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
372488|NCT00937326|1254240|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
372489|NCT00937326|1254236|P5|Overall Study|Withdrawal by Subject|3
372490|NCT00937326|1254237|P4|Overall Study|Withdrawal by Subject|4
372491|NCT00937326|1254238|P3|Overall Study|Withdrawal by Subject|1
372492|NCT00937326|1254239|P2|Overall Study|Withdrawal by Subject|4
372493|NCT00937326|1254240|P1|Overall Study|Withdrawal by Subject|3
372494|NCT00937326|1254236|P5|Overall Study|Death|0
372495|NCT00937326|1254237|P4|Overall Study|Death|0
372496|NCT00937326|1254238|P3|Overall Study|Death|1
372497|NCT00937326|1254239|P2|Overall Study|Death|0
372498|NCT00937326|1254240|P1|Overall Study|Death|0
372499|NCT00937326|1254236|P5|Overall Study|Adverse Event|2
372500|NCT00937326|1254237|P4|Overall Study|Adverse Event|1
372501|NCT00937326|1254238|P3|Overall Study|Adverse Event|1
372502|NCT00937326|1254239|P2|Overall Study|Adverse Event|3
372503|NCT00937326|1254240|P1|Overall Study|Adverse Event|0
372504|NCT00937157|1254489|P1|Overall Study|Lost to Follow-up|3
372505|NCT00937157|1254489|P1|Overall Study|Pregnancy|1
372506|NCT00937040|1254520|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
372507|NCT00937040|1254521|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
372508|NCT00937040|1254520|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
372509|NCT00937040|1254521|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
372510|NCT00937040|1254520|P2|Overall Study|Withdrawal by Subject|7
372511|NCT00937040|1254521|P1|Overall Study|Withdrawal by Subject|13
372512|NCT00937040|1254520|P2|Overall Study|Protocol Violation|0
372513|NCT00937040|1254521|P1|Overall Study|Protocol Violation|3
372514|NCT00937040|1254520|P2|Overall Study|Lost to Follow-up|12
372515|NCT00937040|1254521|P1|Overall Study|Lost to Follow-up|12
372516|NCT00937040|1254520|P2|Overall Study|Adverse Event|8
372517|NCT00937040|1254521|P1|Overall Study|Adverse Event|5
372518|NCT00936975|1254563|P1|Overall Study|Post-Tx scan uninterpretable|2
372519|NCT00936975|1254563|P1|Overall Study|Disease progression|3
372520|NCT00936975|1254563|P1|Overall Study|Withdrawal by Subject|1
372521|NCT00936910|1254572|P1|Overall Study|Lack of Efficacy|3
372522|NCT00936897|1254581|P2|Overall Study|Death|1
372523|NCT00936897|1254582|P1|Overall Study|Death|0
372524|NCT00936897|1254581|P2|Overall Study|Noncompliance|2
372525|NCT00936897|1254582|P1|Overall Study|Noncompliance|0
372526|NCT00936897|1254581|P2|Overall Study|Ineligibility Determined|3
372527|NCT00936897|1254582|P1|Overall Study|Ineligibility Determined|0
372528|NCT00936897|1254581|P2|Overall Study|Protocol Violation|1
372529|NCT00936897|1254582|P1|Overall Study|Protocol Violation|1
372530|NCT00936897|1254581|P2|Overall Study|Administrative Decision|2
372531|NCT00936897|1254582|P1|Overall Study|Administrative Decision|1
372532|NCT00936897|1254581|P2|Overall Study|Lost to Follow-up|10
372533|NCT00936897|1254582|P1|Overall Study|Lost to Follow-up|1
372534|NCT00936897|1254581|P2|Overall Study|Other|9
372535|NCT00936897|1254582|P1|Overall Study|Other|3
372536|NCT00936897|1254581|P2|Overall Study|Adverse Event|13
372537|NCT00936897|1254582|P1|Overall Study|Adverse Event|4
372538|NCT00936897|1254581|P2|Overall Study|Withdrawal by Subject|19
372539|NCT00936897|1254582|P1|Overall Study|Withdrawal by Subject|9
372540|NCT00936715|1254599|P1|Overall Study|Safety or Tolerability Reasons|4
372541|NCT00936715|1254599|P1|Overall Study|Protocol Violation|1
372542|NCT00936715|1254599|P1|Overall Study|Investigators Discretion|1
372543|NCT00936702|1254603|P1|Overall Study|Other|1
372544|NCT00936702|1254603|P1|Overall Study|Alternative Treatment|1
372545|NCT00936702|1254603|P1|Overall Study|Withdrawal by Subject|2
372546|NCT00936702|1254603|P1|Overall Study|Adverse Event|8
372547|NCT00936702|1254603|P1|Overall Study|Disease progression|34
372548|NCT00936598|1254636|P2|Overall Study|Ineligible after consent|0
372549|NCT00936598|1254637|P1|Overall Study|Ineligible after consent|1
372550|NCT00936598|1254636|P2|Overall Study|Withdrawal by Subject|0
372551|NCT00936598|1254637|P1|Overall Study|Withdrawal by Subject|1
372552|NCT00936221|1254726|P2|Overall Study|Withdrawal by Subject|1
372553|NCT00936221|1254727|P1|Overall Study|Withdrawal by Subject|1
372554|NCT00936208|1254741|P2|Overall Study|Protocol Violation|22
372555|NCT00936208|1254742|P1|Overall Study|Protocol Violation|37
372556|NCT00936117|1254760|P1|Overall Study|Unable to continue oral medication|3
372557|NCT00936117|1254760|P1|Overall Study|Adverse Event|7
372558|NCT00936065|1254768|P3|Overall Study|Withdrawal by Subject|4
372559|NCT00936065|1254769|P2|Overall Study|Withdrawal by Subject|2
372560|NCT00936065|1254770|P1|Overall Study|Withdrawal by Subject|0
372561|NCT00936065|1254768|P3|Overall Study|Protocol Violation|1
372562|NCT00936065|1254769|P2|Overall Study|Protocol Violation|2
372563|NCT00936065|1254770|P1|Overall Study|Protocol Violation|1
372564|NCT00936065|1254768|P3|Overall Study|Lost to Follow-up|0
372565|NCT00936065|1254769|P2|Overall Study|Lost to Follow-up|0
372566|NCT00936065|1254770|P1|Overall Study|Lost to Follow-up|1
372567|NCT00936065|1254768|P3|Overall Study|Lack of Efficacy|1
372568|NCT00936065|1254769|P2|Overall Study|Lack of Efficacy|0
372569|NCT00936065|1254770|P1|Overall Study|Lack of Efficacy|1
372570|NCT00936065|1254768|P3|Overall Study|Adverse Event|1
372571|NCT00936065|1254769|P2|Overall Study|Adverse Event|0
372572|NCT00936065|1254770|P1|Overall Study|Adverse Event|1
372573|NCT00935883|1254876|P2|Treatment Period|Withdrawal by Subject|2
372574|NCT00935883|1254877|P1|Treatment Period|Withdrawal by Subject|0
372575|NCT00935883|1254876|P2|Treatment Period|Physician Decision|0
372576|NCT00935883|1254877|P1|Treatment Period|Physician Decision|1
372577|NCT00935818|1254904|P2|Overall Study|Physician Decision|1
372578|NCT00935818|1254905|P1|Overall Study|Physician Decision|0
372579|NCT00935818|1254904|P2|Overall Study|Adverse Event|7
372580|NCT00935818|1254905|P1|Overall Study|Adverse Event|6
372581|NCT00935818|1254904|P2|Overall Study|Lost to Follow-up|42
372582|NCT00935818|1254905|P1|Overall Study|Lost to Follow-up|40
372583|NCT00935818|1254904|P2|Overall Study|Withdrawal by Subject|50
372584|NCT00935818|1254905|P1|Overall Study|Withdrawal by Subject|45
372585|NCT00935701|1254956|P1|Overall Study|Failure to Transition to Acupuncture|1
372586|NCT00935584|1254973|P2|Overall Study|Provider dropped out of study|4
372587|NCT00935584|1254974|P1|Overall Study|Provider dropped out of study|14
372588|NCT00935584|1254973|P2|Overall Study|Patient changed provider|0
372589|NCT00935584|1254974|P1|Overall Study|Patient changed provider|3
372590|NCT00935584|1254973|P2|Overall Study|Relocated|0
372591|NCT00935584|1254974|P1|Overall Study|Relocated|3
372592|NCT00935584|1254973|P2|Overall Study|No show|0
372593|NCT00935584|1254974|P1|Overall Study|No show|9
372594|NCT00935584|1254973|P2|Overall Study|Lost to Follow-up|0
372595|NCT00935584|1254974|P1|Overall Study|Lost to Follow-up|8
372596|NCT00935584|1254973|P2|Overall Study|Death|0
372597|NCT00935584|1254974|P1|Overall Study|Death|3
372598|NCT00935584|1254973|P2|Overall Study|Withdrawal by Subject|0
372599|NCT00935584|1254974|P1|Overall Study|Withdrawal by Subject|9
372600|NCT00935532|1254986|P2|Overall Study|Loss Glucose Control|0
372601|NCT00935532|1254987|P1|Overall Study|Loss Glucose Control|4
372602|NCT00935532|1254986|P2|Overall Study|Sponsor Decision|1
372603|NCT00935532|1254987|P1|Overall Study|Sponsor Decision|0
372604|NCT00935532|1254986|P2|Overall Study|Subject Decision|1
372605|NCT00935532|1254987|P1|Overall Study|Subject Decision|2
372606|NCT00935532|1254986|P2|Overall Study|Protocol Violation|1
372607|NCT00935532|1254987|P1|Overall Study|Protocol Violation|2
372608|NCT00935532|1254986|P2|Overall Study|Physician Decision|2
372609|NCT00935532|1254987|P1|Overall Study|Physician Decision|1
372610|NCT00935532|1254986|P2|Overall Study|Lost to Follow-up|0
372611|NCT00935532|1254987|P1|Overall Study|Lost to Follow-up|1
372612|NCT00935532|1254986|P2|Overall Study|Death|0
372613|NCT00935532|1254987|P1|Overall Study|Death|1
372614|NCT00935532|1254986|P2|Overall Study|Adverse Event|6
372615|NCT00935532|1254987|P1|Overall Study|Adverse Event|11
372616|NCT00935493|1255016|P3|Overall Study|Treatment Discontinued|0
372617|NCT00935493|1255017|P2|Overall Study|Treatment Discontinued|1
372618|NCT00935493|1255018|P1|Overall Study|Treatment Discontinued|0
372619|NCT00935493|1255016|P3|Overall Study|Lost to Follow-up|1
372620|NCT00935493|1255017|P2|Overall Study|Lost to Follow-up|1
372621|NCT00935493|1255018|P1|Overall Study|Lost to Follow-up|1
372622|NCT00935272|1255056|P2|Overall Study|Protocol Violation|1
372623|NCT00935272|1255057|P1|Overall Study|Protocol Violation|0
372624|NCT00935272|1255056|P2|Overall Study|Physician Decision|0
372625|NCT00935272|1255057|P1|Overall Study|Physician Decision|1
372626|NCT00935272|1255056|P2|Overall Study|Withdrawal by Subject|2
372627|NCT00935272|1255057|P1|Overall Study|Withdrawal by Subject|8
372628|NCT00935272|1255056|P2|Overall Study|Lost to Follow-up|3
372629|NCT00935272|1255057|P1|Overall Study|Lost to Follow-up|10
372630|NCT00935259|1255066|P2|Period 1|Administrative (scheduling conflict)|1
372631|NCT00935259|1255067|P1|Period 1|Administrative (scheduling conflict)|1
372632|NCT00935220|1255081|P1|Overall Study|Other reason (not specified)|1
372633|NCT00935220|1255081|P1|Overall Study|Adverse Event|1
372634|NCT00934947|1255112|P2|Overall Study|Adverse Event|2
372635|NCT00934947|1255113|P1|Overall Study|Adverse Event|0
372636|NCT00934856|1255142|P6|Extension Part|Non-compliance with drug|1
372637|NCT00934856|1255143|P5|Extension Part|Non-compliance with drug|0
372638|NCT00934856|1255144|P4|Extension Part|Non-compliance with drug|0
372639|NCT00934856|1255145|P3|Extension Part|Non-compliance with drug|0
372640|NCT00934856|1255146|P2|Extension Part|Non-compliance with drug|0
372641|NCT00934856|1255147|P1|Extension Part|Non-compliance with drug|0
372642|NCT00934856|1255142|P6|Extension Part|Progressive disease|0
372643|NCT00934856|1255143|P5|Extension Part|Progressive disease|0
372644|NCT00934856|1255144|P4|Extension Part|Progressive disease|1
372645|NCT00934856|1255145|P3|Extension Part|Progressive disease|0
372646|NCT00934856|1255146|P2|Extension Part|Progressive disease|0
372647|NCT00934856|1255147|P1|Extension Part|Progressive disease|0
372648|NCT00934856|1255142|P6|Extension Part|Adverse Event|4
372649|NCT00934856|1255143|P5|Extension Part|Adverse Event|4
372650|NCT00934856|1255144|P4|Extension Part|Adverse Event|1
372651|NCT00934856|1255145|P3|Extension Part|Adverse Event|0
372652|NCT00934856|1255146|P2|Extension Part|Adverse Event|0
372653|NCT00934856|1255147|P1|Extension Part|Adverse Event|0
372654|NCT00934856|1255142|P6|Feasibility Part|Withdrawal by Subject|1
372655|NCT00934856|1255143|P5|Feasibility Part|Withdrawal by Subject|0
372656|NCT00934856|1255144|P4|Feasibility Part|Withdrawal by Subject|1
372657|NCT00934856|1255145|P3|Feasibility Part|Withdrawal by Subject|0
372658|NCT00934856|1255146|P2|Feasibility Part|Withdrawal by Subject|0
372659|NCT00934856|1255147|P1|Feasibility Part|Withdrawal by Subject|0
372660|NCT00934856|1255142|P6|Feasibility Part|Adverse Event|2
372661|NCT00934856|1255143|P5|Feasibility Part|Adverse Event|0
372662|NCT00934856|1255144|P4|Feasibility Part|Adverse Event|1
372663|NCT00934856|1255145|P3|Feasibility Part|Adverse Event|0
372664|NCT00934856|1255146|P2|Feasibility Part|Adverse Event|1
372665|NCT00934856|1255147|P1|Feasibility Part|Adverse Event|1
372666|NCT00934856|1255142|P6|Feasibility Part|Physician Decision|0
372667|NCT00934856|1255143|P5|Feasibility Part|Physician Decision|0
372668|NCT00934856|1255144|P4|Feasibility Part|Physician Decision|0
372669|NCT00934856|1255145|P3|Feasibility Part|Physician Decision|1
372670|NCT00934856|1255146|P2|Feasibility Part|Physician Decision|0
372671|NCT00934856|1255147|P1|Feasibility Part|Physician Decision|0
372672|NCT00934856|1255142|P6|Feasibility Part|Progressive disease|0
376321|NCT00906399|1266624|P4|Year 2|Death|1
372673|NCT00934856|1255143|P5|Feasibility Part|Progressive disease|0
372674|NCT00934856|1255144|P4|Feasibility Part|Progressive disease|3
372675|NCT00934856|1255145|P3|Feasibility Part|Progressive disease|2
372676|NCT00934856|1255146|P2|Feasibility Part|Progressive disease|4
372677|NCT00934856|1255147|P1|Feasibility Part|Progressive disease|4
372678|NCT00934843|1255245|P2|Overall Study|Protocol Violation|1
372679|NCT00934843|1255246|P1|Overall Study|Protocol Violation|0
372680|NCT00934791|1255262|P2|Overall Study|Withdrawal by Subject|0
372681|NCT00934791|1255263|P1|Overall Study|Withdrawal by Subject|1
372682|NCT00934661|1255271|P2|Overall Study|Failure of Combined/Spinal Epidural|0
372683|NCT00934661|1255272|P1|Overall Study|Failure of Combined/Spinal Epidural|1
372684|NCT00934648|1255292|P1|Overall Study|Withdrawal by Subject|1
372685|NCT00934648|1255292|P1|Overall Study|Failure to return|8
372686|NCT00934622|1255336|P1|Overall Study|2nd Intraoperative exclusion criteria|1
372687|NCT00934622|1255336|P1|Overall Study|Lost to Follow-up|7
372688|NCT00934544|1255374|P2|Overall Study|Entered Extension phase INC424|18
372689|NCT00934544|1255375|P1|Overall Study|Entered Extension phase INC424|29
372690|NCT00934544|1255374|P2|Overall Study|Other Reasons|7
372691|NCT00934544|1255375|P1|Overall Study|Other Reasons|7
372692|NCT00934544|1255374|P2|Overall Study|Non-compliance with study procedures|1
372693|NCT00934544|1255375|P1|Overall Study|Non-compliance with study procedures|0
372694|NCT00934544|1255374|P2|Overall Study|Non-compliance with study Medication|0
372695|NCT00934544|1255375|P1|Overall Study|Non-compliance with study Medication|2
372696|NCT00934544|1255374|P2|Overall Study|Disease Progression|3
372697|NCT00934544|1255375|P1|Overall Study|Disease Progression|1
372698|NCT00934544|1255374|P2|Overall Study|Protocol Violation|0
372699|NCT00934544|1255375|P1|Overall Study|Protocol Violation|2
372700|NCT00934544|1255374|P2|Overall Study|Withdrawal by Subject|9
372701|NCT00934544|1255375|P1|Overall Study|Withdrawal by Subject|2
372702|NCT00934544|1255374|P2|Overall Study|Adverse Event|4
372703|NCT00934544|1255375|P1|Overall Study|Adverse Event|12
372704|NCT00934440|1255389|P1|Overall Study|Lost to Follow-up|1
372705|NCT00934362|1255405|P2|Overall Study|Adverse Event|0
372706|NCT00934362|1255406|P1|Overall Study|Adverse Event|1
372707|NCT00934128|1255456|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
372708|NCT00934128|1255457|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
372709|NCT00934128|1255456|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
372710|NCT00934128|1255457|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
372711|NCT00934128|1255456|P2|Washout Period (1 Hour)|Too tired|0
372712|NCT00934128|1255457|P1|Washout Period (1 Hour)|Too tired|1
372713|NCT00934128|1255456|P2|Washout Period (1 Hour)|Pain|0
372714|NCT00934128|1255457|P1|Washout Period (1 Hour)|Pain|1
372715|NCT00934128|1255456|P2|Washout Period (1 Hour)|Patient preference|3
372716|NCT00934128|1255457|P1|Washout Period (1 Hour)|Patient preference|1
372717|NCT00934128|1255456|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
372718|NCT00934128|1255457|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
372719|NCT00934128|1255456|P2|First Intervention (2 Hours)|Adverse Event|1
372720|NCT00934128|1255457|P1|First Intervention (2 Hours)|Adverse Event|4
372721|NCT00934128|1255456|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
372722|NCT00934128|1255457|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
372723|NCT00934102|1255465|P3|Period 1, One Night of Wear|Personal Reasons|0
372724|NCT00934102|1255466|P2|Period 1, One Night of Wear|Personal Reasons|0
372725|NCT00934102|1255467|P1|Period 1, One Night of Wear|Personal Reasons|1
372726|NCT00934050|1255481|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
372727|NCT00934050|1255482|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
372728|NCT00934050|1255483|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
372729|NCT00934050|1255484|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
372730|NCT00934050|1255485|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
372731|NCT00934050|1255486|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
372732|NCT00934050|1255481|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
372733|NCT00934050|1255482|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
372734|NCT00934050|1255483|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
372735|NCT00934050|1255484|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
372736|NCT00934050|1255485|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
372737|NCT00934050|1255486|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
372738|NCT00934050|1255481|P6|Enrolled After 15 Dec 2009|Death|1
372739|NCT00934050|1255482|P5|Enrolled After 15 Dec 2009|Death|0
372740|NCT00934050|1255483|P4|Enrolled After 15 Dec 2009|Death|0
372741|NCT00934050|1255484|P3|Enrolled After 15 Dec 2009|Death|0
372742|NCT00934050|1255485|P2|Enrolled After 15 Dec 2009|Death|0
372743|NCT00934050|1255486|P1|Enrolled After 15 Dec 2009|Death|0
372744|NCT00934050|1255481|P6|Enrolled After 15 Dec 2009|Adverse Event|0
372745|NCT00934050|1255482|P5|Enrolled After 15 Dec 2009|Adverse Event|3
372746|NCT00934050|1255483|P4|Enrolled After 15 Dec 2009|Adverse Event|0
372747|NCT00934050|1255484|P3|Enrolled After 15 Dec 2009|Adverse Event|0
372748|NCT00934050|1255485|P2|Enrolled After 15 Dec 2009|Adverse Event|0
372749|NCT00934050|1255486|P1|Enrolled After 15 Dec 2009|Adverse Event|0
372750|NCT00934050|1255481|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
372751|NCT00934050|1255482|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
372752|NCT00934050|1255483|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
372753|NCT00934050|1255484|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
372754|NCT00934050|1255485|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
376322|NCT00906399|1266625|P3|Year 2|Death|0
372755|NCT00934050|1255486|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
372756|NCT00934050|1255481|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
372757|NCT00934050|1255482|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
372758|NCT00934050|1255483|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
372759|NCT00934050|1255484|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
372760|NCT00934050|1255485|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
372761|NCT00934050|1255486|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
372762|NCT00934050|1255481|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
372763|NCT00934050|1255482|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
372764|NCT00934050|1255483|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
372765|NCT00934050|1255484|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
372766|NCT00934050|1255485|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
372767|NCT00934050|1255486|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
372768|NCT00933933|1255501|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
372769|NCT00933933|1255502|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
372770|NCT00933933|1255503|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
372771|NCT00933933|1255501|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
372772|NCT00933933|1255502|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
372773|NCT00933933|1255503|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
372774|NCT00933686|1255521|P2|Overall Study|Failure to show up at endpoint visits|2
372775|NCT00933686|1255522|P1|Overall Study|Failure to show up at endpoint visits|0
372776|NCT00933686|1255521|P2|Overall Study|Physician Decision|0
372777|NCT00933686|1255522|P1|Overall Study|Physician Decision|1
372778|NCT00933686|1255521|P2|Overall Study|Adverse Event|1
372779|NCT00933686|1255522|P1|Overall Study|Adverse Event|1
372780|NCT00933686|1255521|P2|Overall Study|Withdrawal by Subject|5
372781|NCT00933686|1255522|P1|Overall Study|Withdrawal by Subject|6
372782|NCT00933686|1255521|P2|Overall Study|Lost to Follow-up|2
372783|NCT00933686|1255522|P1|Overall Study|Lost to Follow-up|2
372784|NCT00933686|1255521|P2|Overall Study|Protocol Violation|1
372785|NCT00933686|1255522|P1|Overall Study|Protocol Violation|0
372786|NCT00933608|1255542|P2|Overall Study|Physician Decision|0
372787|NCT00933608|1255543|P1|Overall Study|Physician Decision|1
372788|NCT00933608|1255542|P2|Overall Study|Adverse Event|2
372789|NCT00933608|1255543|P1|Overall Study|Adverse Event|4
372790|NCT00933543|1255551|P2|Overall Study|Other|1
372791|NCT00933543|1255552|P1|Overall Study|Other|1
372792|NCT00933543|1255551|P2|Overall Study|Lack of Efficacy|3
372793|NCT00933543|1255552|P1|Overall Study|Lack of Efficacy|0
372794|NCT00933543|1255551|P2|Overall Study|Withdrawal by Subject|1
372795|NCT00933543|1255552|P1|Overall Study|Withdrawal by Subject|0
372796|NCT00933543|1255551|P2|Overall Study|Lost to Follow-up|1
372797|NCT00933543|1255552|P1|Overall Study|Lost to Follow-up|0
372798|NCT00933543|1255551|P2|Overall Study|Adverse Event|1
372799|NCT00933543|1255552|P1|Overall Study|Adverse Event|2
372800|NCT00933335|1255621|P2|Overall Study|Co-morbid Illness|0
372801|NCT00933335|1255622|P1|Overall Study|Co-morbid Illness|1
372802|NCT00933335|1255621|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
372803|NCT00933335|1255622|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
372804|NCT00933335|1255621|P2|Overall Study|Progressive Disease|11
372805|NCT00933335|1255622|P1|Overall Study|Progressive Disease|0
372806|NCT00933335|1255621|P2|Overall Study|Withdrawal by Subject|1
372807|NCT00933335|1255622|P1|Overall Study|Withdrawal by Subject|0
372808|NCT00933335|1255621|P2|Overall Study|Lost to Follow-up|3
372809|NCT00933335|1255622|P1|Overall Study|Lost to Follow-up|1
372810|NCT00933270|1255692|P1|Overall Study|Moved or would not return|10
372811|NCT00933270|1255692|P1|Overall Study|Death|24
372812|NCT00933270|1255692|P1|Overall Study|Missed Visit|2
372813|NCT00933270|1255692|P1|Overall Study|Adverse Event|1
372814|NCT00933270|1255692|P1|Overall Study|Lost to Follow-up|14
372815|NCT00933270|1255692|P1|Overall Study|Insufficient Follow-up|10
372816|NCT00933270|1255692|P1|Overall Study|Withdrawal by Subject|26
372817|NCT00933244|1255786|P3|Overall Study|Withdrawal by Subject|3
372818|NCT00933244|1255787|P2|Overall Study|Withdrawal by Subject|1
372819|NCT00933244|1255788|P1|Overall Study|Withdrawal by Subject|5
372820|NCT00933166|1255805|P1|Overall Study|Withdrawal by Subject|1
372821|NCT00933166|1255805|P1|Overall Study|Unavailable|4
372822|NCT00933166|1255805|P1|Overall Study|Lack of Efficacy|9
372823|NCT00933166|1255805|P1|Overall Study|Lost to Follow-up|4
372824|NCT00932893|1255811|P2|Overall Study|Other|144
372825|NCT00932893|1255812|P1|Overall Study|Other|5
372826|NCT00932893|1255811|P2|Overall Study|Withdrawal by Subject|2
372827|NCT00932893|1255812|P1|Overall Study|Withdrawal by Subject|5
372828|NCT00932893|1255811|P2|Overall Study|Lost to Follow-up|0
372829|NCT00932893|1255812|P1|Overall Study|Lost to Follow-up|8
372830|NCT00932893|1255811|P2|Overall Study|Death|24
372831|NCT00932893|1255812|P1|Overall Study|Death|115
372832|NCT00932646|1255854|P4|Overall Study|Withdrawal by Subject|0
372833|NCT00932646|1255855|P3|Overall Study|Withdrawal by Subject|3
372834|NCT00932646|1255856|P2|Overall Study|Withdrawal by Subject|1
372835|NCT00932646|1255857|P1|Overall Study|Withdrawal by Subject|1
372836|NCT00932646|1255854|P4|Overall Study|Lost to Follow-up|0
372837|NCT00932646|1255855|P3|Overall Study|Lost to Follow-up|0
372838|NCT00932646|1255856|P2|Overall Study|Lost to Follow-up|1
372839|NCT00932646|1255857|P1|Overall Study|Lost to Follow-up|2
372840|NCT00932646|1255854|P4|Overall Study|Adverse Event|1
372841|NCT00932646|1255855|P3|Overall Study|Adverse Event|1
372842|NCT00932646|1255856|P2|Overall Study|Adverse Event|1
372843|NCT00932646|1255857|P1|Overall Study|Adverse Event|2
372844|NCT00932451|1255944|P1|Overall Study|Other reasons|5
372845|NCT00932451|1255944|P1|Overall Study|Death|726
372846|NCT00932451|1255944|P1|Overall Study|Lost to Follow-up|22
372847|NCT00932451|1255944|P1|Overall Study|Withdrawal by Subject|69
372848|NCT00932425|1255968|P2|Overall Study|Withdrawal by Subject|1
372849|NCT00932425|1255969|P1|Overall Study|Withdrawal by Subject|0
372850|NCT00932425|1255968|P2|Overall Study|Lost to Follow-up|1
372851|NCT00932425|1255969|P1|Overall Study|Lost to Follow-up|0
372852|NCT00932373|1256002|P11|Overall Study|Lack of Efficacy|0
372853|NCT00932373|1256003|P10|Overall Study|Lack of Efficacy|1
372854|NCT00932373|1256004|P9|Overall Study|Lack of Efficacy|0
372855|NCT00932373|1256005|P8|Overall Study|Lack of Efficacy|0
372856|NCT00932373|1256006|P7|Overall Study|Lack of Efficacy|0
372857|NCT00932373|1256007|P6|Overall Study|Lack of Efficacy|0
372858|NCT00932373|1256008|P5|Overall Study|Lack of Efficacy|0
372859|NCT00932373|1256009|P4|Overall Study|Lack of Efficacy|0
372860|NCT00932373|1256010|P3|Overall Study|Lack of Efficacy|0
372861|NCT00932373|1256011|P2|Overall Study|Lack of Efficacy|0
372862|NCT00932373|1256012|P1|Overall Study|Lack of Efficacy|0
372863|NCT00932373|1256002|P11|Overall Study|Clinical progression|0
372864|NCT00932373|1256003|P10|Overall Study|Clinical progression|0
372865|NCT00932373|1256004|P9|Overall Study|Clinical progression|0
372866|NCT00932373|1256005|P8|Overall Study|Clinical progression|0
372867|NCT00932373|1256006|P7|Overall Study|Clinical progression|1
372868|NCT00932373|1256007|P6|Overall Study|Clinical progression|0
372869|NCT00932373|1256008|P5|Overall Study|Clinical progression|0
372870|NCT00932373|1256009|P4|Overall Study|Clinical progression|0
372871|NCT00932373|1256010|P3|Overall Study|Clinical progression|0
372872|NCT00932373|1256011|P2|Overall Study|Clinical progression|0
372873|NCT00932373|1256012|P1|Overall Study|Clinical progression|0
372874|NCT00932373|1256002|P11|Overall Study|Withdrawal by Subject|0
372875|NCT00932373|1256003|P10|Overall Study|Withdrawal by Subject|0
372876|NCT00932373|1256004|P9|Overall Study|Withdrawal by Subject|1
372877|NCT00932373|1256005|P8|Overall Study|Withdrawal by Subject|0
372878|NCT00932373|1256006|P7|Overall Study|Withdrawal by Subject|0
372879|NCT00932373|1256007|P6|Overall Study|Withdrawal by Subject|0
372880|NCT00932373|1256008|P5|Overall Study|Withdrawal by Subject|0
372881|NCT00932373|1256009|P4|Overall Study|Withdrawal by Subject|0
372882|NCT00932373|1256010|P3|Overall Study|Withdrawal by Subject|0
372883|NCT00932373|1256011|P2|Overall Study|Withdrawal by Subject|0
372884|NCT00932373|1256012|P1|Overall Study|Withdrawal by Subject|0
372885|NCT00932373|1256002|P11|Overall Study|Dose limiting toxicity|0
372886|NCT00932373|1256003|P10|Overall Study|Dose limiting toxicity|0
372887|NCT00932373|1256004|P9|Overall Study|Dose limiting toxicity|0
372888|NCT00932373|1256005|P8|Overall Study|Dose limiting toxicity|0
372889|NCT00932373|1256006|P7|Overall Study|Dose limiting toxicity|0
372890|NCT00932373|1256007|P6|Overall Study|Dose limiting toxicity|1
372891|NCT00932373|1256008|P5|Overall Study|Dose limiting toxicity|0
372892|NCT00932373|1256009|P4|Overall Study|Dose limiting toxicity|0
372893|NCT00932373|1256010|P3|Overall Study|Dose limiting toxicity|0
372894|NCT00932373|1256011|P2|Overall Study|Dose limiting toxicity|0
372895|NCT00932373|1256012|P1|Overall Study|Dose limiting toxicity|0
372896|NCT00932373|1256002|P11|Overall Study|Physician Decision|0
372897|NCT00932373|1256003|P10|Overall Study|Physician Decision|1
372898|NCT00932373|1256004|P9|Overall Study|Physician Decision|0
372899|NCT00932373|1256005|P8|Overall Study|Physician Decision|0
372900|NCT00932373|1256006|P7|Overall Study|Physician Decision|0
372901|NCT00932373|1256007|P6|Overall Study|Physician Decision|0
372902|NCT00932373|1256008|P5|Overall Study|Physician Decision|2
372903|NCT00932373|1256009|P4|Overall Study|Physician Decision|0
372904|NCT00932373|1256010|P3|Overall Study|Physician Decision|1
372905|NCT00932373|1256011|P2|Overall Study|Physician Decision|0
372906|NCT00932373|1256012|P1|Overall Study|Physician Decision|0
372907|NCT00932373|1256002|P11|Overall Study|Adverse Event|1
372908|NCT00932373|1256003|P10|Overall Study|Adverse Event|2
372909|NCT00932373|1256004|P9|Overall Study|Adverse Event|0
372910|NCT00932373|1256005|P8|Overall Study|Adverse Event|1
372911|NCT00932373|1256006|P7|Overall Study|Adverse Event|0
372912|NCT00932373|1256007|P6|Overall Study|Adverse Event|1
372913|NCT00932373|1256008|P5|Overall Study|Adverse Event|2
372914|NCT00932373|1256009|P4|Overall Study|Adverse Event|0
372915|NCT00932373|1256010|P3|Overall Study|Adverse Event|0
372916|NCT00932373|1256011|P2|Overall Study|Adverse Event|0
372917|NCT00932373|1256012|P1|Overall Study|Adverse Event|0
372918|NCT00932373|1256002|P11|Overall Study|Progressive disease|2
372919|NCT00932373|1256003|P10|Overall Study|Progressive disease|9
372920|NCT00932373|1256004|P9|Overall Study|Progressive disease|1
372921|NCT00932373|1256005|P8|Overall Study|Progressive disease|2
372922|NCT00932373|1256006|P7|Overall Study|Progressive disease|0
372923|NCT00932373|1256007|P6|Overall Study|Progressive disease|1
372924|NCT00932373|1256008|P5|Overall Study|Progressive disease|10
372925|NCT00932373|1256009|P4|Overall Study|Progressive disease|0
372926|NCT00932373|1256010|P3|Overall Study|Progressive disease|0
372927|NCT00932373|1256011|P2|Overall Study|Progressive disease|1
372928|NCT00932373|1256012|P1|Overall Study|Progressive disease|3
372929|NCT00932165|1256140|P1|Overall Study|Lost to Follow-up|1
372930|NCT00932126|1256164|P8|Overall Study|Other|2
372931|NCT00932126|1256165|P7|Overall Study|Other|1
372932|NCT00932126|1256166|P6|Overall Study|Other|0
372933|NCT00932126|1256167|P5|Overall Study|Other|1
372934|NCT00932126|1256168|P4|Overall Study|Other|0
372935|NCT00932126|1256169|P3|Overall Study|Other|0
372936|NCT00932126|1256170|P2|Overall Study|Other|0
372937|NCT00932126|1256171|P1|Overall Study|Other|0
372938|NCT00932126|1256164|P8|Overall Study|Objective progression or relapse|5
372939|NCT00932126|1256165|P7|Overall Study|Objective progression or relapse|3
372940|NCT00932126|1256166|P6|Overall Study|Objective progression or relapse|3
372941|NCT00932126|1256167|P5|Overall Study|Objective progression or relapse|3
372942|NCT00932126|1256168|P4|Overall Study|Objective progression or relapse|3
372943|NCT00932126|1256169|P3|Overall Study|Objective progression or relapse|2
372944|NCT00932126|1256170|P2|Overall Study|Objective progression or relapse|3
372945|NCT00932126|1256171|P1|Overall Study|Objective progression or relapse|3
372946|NCT00932126|1256164|P8|Overall Study|Withdrawal by Subject|1
372947|NCT00932126|1256165|P7|Overall Study|Withdrawal by Subject|0
372948|NCT00932126|1256166|P6|Overall Study|Withdrawal by Subject|0
372949|NCT00932126|1256167|P5|Overall Study|Withdrawal by Subject|0
372950|NCT00932126|1256168|P4|Overall Study|Withdrawal by Subject|0
372951|NCT00932126|1256169|P3|Overall Study|Withdrawal by Subject|1
372952|NCT00932126|1256170|P2|Overall Study|Withdrawal by Subject|0
372953|NCT00932126|1256171|P1|Overall Study|Withdrawal by Subject|0
372954|NCT00932126|1256164|P8|Overall Study|Protocol Violation|0
372955|NCT00932126|1256165|P7|Overall Study|Protocol Violation|0
372956|NCT00932126|1256166|P6|Overall Study|Protocol Violation|0
372957|NCT00932126|1256167|P5|Overall Study|Protocol Violation|1
372958|NCT00932126|1256168|P4|Overall Study|Protocol Violation|0
372959|NCT00932126|1256169|P3|Overall Study|Protocol Violation|0
372960|NCT00932126|1256170|P2|Overall Study|Protocol Violation|0
372961|NCT00932126|1256171|P1|Overall Study|Protocol Violation|0
372962|NCT00932126|1256164|P8|Overall Study|Adverse Event|2
372963|NCT00932126|1256165|P7|Overall Study|Adverse Event|1
372964|NCT00932126|1256166|P6|Overall Study|Adverse Event|0
372965|NCT00932126|1256167|P5|Overall Study|Adverse Event|0
372966|NCT00932126|1256168|P4|Overall Study|Adverse Event|0
372967|NCT00932126|1256169|P3|Overall Study|Adverse Event|0
372968|NCT00932126|1256170|P2|Overall Study|Adverse Event|0
372969|NCT00932126|1256171|P1|Overall Study|Adverse Event|0
372970|NCT00932113|1256209|P2|Overall Study|Lost to Follow-up|0
372971|NCT00932113|1256210|P1|Overall Study|Lost to Follow-up|1
372972|NCT00931918|1256262|P2|Overall Study|Did not receive study drug|2
372973|NCT00931918|1256263|P1|Overall Study|Did not receive study drug|3
372974|NCT00931918|1256262|P2|Overall Study|Other Reason not Specified|4
372975|NCT00931918|1256263|P1|Overall Study|Other Reason not Specified|4
372976|NCT00931918|1256262|P2|Overall Study|Withdrawal by Patient|4
372977|NCT00931918|1256263|P1|Overall Study|Withdrawal by Patient|3
372978|NCT00931918|1256262|P2|Overall Study|Symptomatic Deterioration|0
372979|NCT00931918|1256263|P1|Overall Study|Symptomatic Deterioration|1
372980|NCT00931918|1256262|P2|Overall Study|Progressive Disease|1
372981|NCT00931918|1256263|P1|Overall Study|Progressive Disease|2
372982|NCT00931918|1256262|P2|Overall Study|Adverse Event|6
372983|NCT00931918|1256263|P1|Overall Study|Adverse Event|4
372984|NCT00931801|1256315|P3|Overall Study|Confirmed Virologic Failure|3
372985|NCT00931801|1256316|P2|Overall Study|Confirmed Virologic Failure|0
372986|NCT00931801|1256317|P1|Overall Study|Confirmed Virologic Failure|0
372987|NCT00931801|1256315|P3|Overall Study|Withdrawal by Subject|0
372988|NCT00931801|1256316|P2|Overall Study|Withdrawal by Subject|0
372989|NCT00931801|1256317|P1|Overall Study|Withdrawal by Subject|1
372990|NCT00931801|1256315|P3|Overall Study|Lost to Follow-up|0
372991|NCT00931801|1256316|P2|Overall Study|Lost to Follow-up|1
372992|NCT00931801|1256317|P1|Overall Study|Lost to Follow-up|0
372993|NCT00931801|1256315|P3|Overall Study|Adverse Event|1
372994|NCT00931801|1256316|P2|Overall Study|Adverse Event|0
372995|NCT00931801|1256317|P1|Overall Study|Adverse Event|0
372996|NCT00931723|1256340|P2|Overall Study|Late hospital discharge|0
372997|NCT00931723|1256341|P1|Overall Study|Late hospital discharge|1
372998|NCT00931723|1256340|P2|Overall Study|Sponsor decision|0
372999|NCT00931723|1256341|P1|Overall Study|Sponsor decision|1
373000|NCT00931723|1256340|P2|Overall Study|Lack or insufficient theraputic response|5
373001|NCT00931723|1256341|P1|Overall Study|Lack or insufficient theraputic response|2
373002|NCT00931723|1256340|P2|Overall Study|Took prohibited concomitant medication|1
373003|NCT00931723|1256341|P1|Overall Study|Took prohibited concomitant medication|0
373004|NCT00931723|1256340|P2|Overall Study|Safety reasons|1
373005|NCT00931723|1256341|P1|Overall Study|Safety reasons|0
373006|NCT00931723|1256340|P2|Overall Study|Severe non-compliance to protocol|0
373007|NCT00931723|1256341|P1|Overall Study|Severe non-compliance to protocol|2
373008|NCT00931723|1256340|P2|Overall Study|Study-specific discontinuation criteria|1
373009|NCT00931723|1256341|P1|Overall Study|Study-specific discontinuation criteria|1
373010|NCT00931723|1256340|P2|Overall Study|Lost to Follow-up|2
373011|NCT00931723|1256341|P1|Overall Study|Lost to Follow-up|1
373012|NCT00931723|1256340|P2|Overall Study|Condition under investigation worsened|2
373013|NCT00931723|1256341|P1|Overall Study|Condition under investigation worsened|1
373014|NCT00931723|1256340|P2|Overall Study|Lithium found in blood|1
373015|NCT00931723|1256341|P1|Overall Study|Lithium found in blood|0
373016|NCT00931723|1256340|P2|Overall Study|Adverse Event|13
373017|NCT00931723|1256341|P1|Overall Study|Adverse Event|6
373018|NCT00931723|1256340|P2|Overall Study|Withdrawal by Subject|13
373019|NCT00931723|1256341|P1|Overall Study|Withdrawal by Subject|11
373020|NCT00931710|1256389|P2|Overall Study|Protocol deviation|2
373021|NCT00931710|1256390|P1|Overall Study|Protocol deviation|1
373022|NCT00931710|1256389|P2|Overall Study|Lost to Follow-up|5
373023|NCT00931710|1256390|P1|Overall Study|Lost to Follow-up|6
373024|NCT00931710|1256389|P2|Overall Study|Patient withdrew consent|9
373025|NCT00931710|1256390|P1|Overall Study|Patient withdrew consent|4
373026|NCT00931710|1256389|P2|Overall Study|Unsatisfactory therapeutic effects|12
373027|NCT00931710|1256390|P1|Overall Study|Unsatisfactory therapeutic effects|5
373028|NCT00931710|1256389|P2|Overall Study|Abnormal test procedure results|0
373029|NCT00931710|1256390|P1|Overall Study|Abnormal test procedure results|2
373030|NCT00931710|1256389|P2|Overall Study|Adverse Event|10
373031|NCT00931710|1256390|P1|Overall Study|Adverse Event|16
373032|NCT00931632|1256408|P2|Overall Study|Adverse Event|15
373033|NCT00931632|1256409|P1|Overall Study|Adverse Event|19
373034|NCT00931632|1256408|P2|Overall Study|Withdrawal by Subject|3
373035|NCT00931632|1256409|P1|Overall Study|Withdrawal by Subject|2
373036|NCT00931528|1256431|P2|Overall Study|Assessment outside of Time Frame|23
373037|NCT00931528|1256432|P1|Overall Study|Assessment outside of Time Frame|22
373038|NCT00931528|1256431|P2|Overall Study|Lost to Follow-up|13
373039|NCT00931528|1256432|P1|Overall Study|Lost to Follow-up|6
373040|NCT00931528|1256431|P2|Overall Study|Withdrawal by Subject|12
373041|NCT00931528|1256432|P1|Overall Study|Withdrawal by Subject|4
373042|NCT00931528|1256431|P2|Overall Study|Protocol Violation|12
373043|NCT00931528|1256432|P1|Overall Study|Protocol Violation|9
373044|NCT00931515|1256452|P2|Overall Study|Lost to Follow-up|5
373045|NCT00931515|1256453|P1|Overall Study|Lost to Follow-up|2
373046|NCT00931463|1256483|P2|Overall Study|Lost to Follow-up|1
373047|NCT00931463|1256484|P1|Overall Study|Lost to Follow-up|4
373048|NCT00931463|1256483|P2|Overall Study|Withdrawal by Subject|0
373049|NCT00931463|1256484|P1|Overall Study|Withdrawal by Subject|5
373050|NCT00931463|1256483|P2|Overall Study|Death|4
373051|NCT00931463|1256484|P1|Overall Study|Death|8
373052|NCT00931411|1256500|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
373053|NCT00931411|1256501|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
373054|NCT00931411|1256500|P2|First Intervention - 42 Days|Lost to Follow-up|0
373055|NCT00931411|1256501|P1|First Intervention - 42 Days|Lost to Follow-up|2
373056|NCT00931411|1256500|P2|First Intervention - 42 Days|Adverse Event|3
373057|NCT00931411|1256501|P1|First Intervention - 42 Days|Adverse Event|2
373058|NCT00931385|1256522|P4|Overall Study|Lost to Follow-up|1
373059|NCT00931385|1256523|P3|Overall Study|Lost to Follow-up|0
373060|NCT00931385|1256524|P2|Overall Study|Lost to Follow-up|0
373061|NCT00931385|1256525|P1|Overall Study|Lost to Follow-up|0
373062|NCT00931385|1256522|P4|Overall Study|Withdrawal by Subject|1
373063|NCT00931385|1256523|P3|Overall Study|Withdrawal by Subject|0
373064|NCT00931385|1256524|P2|Overall Study|Withdrawal by Subject|1
373065|NCT00931385|1256525|P1|Overall Study|Withdrawal by Subject|0
373066|NCT00931385|1256522|P4|Overall Study|Protocol Violation|0
373067|NCT00931385|1256523|P3|Overall Study|Protocol Violation|1
373068|NCT00931385|1256524|P2|Overall Study|Protocol Violation|0
373069|NCT00931385|1256525|P1|Overall Study|Protocol Violation|0
373070|NCT00931385|1256522|P4|Overall Study|Adverse Event|3
373071|NCT00931385|1256523|P3|Overall Study|Adverse Event|0
373072|NCT00931385|1256524|P2|Overall Study|Adverse Event|1
373073|NCT00931385|1256525|P1|Overall Study|Adverse Event|2
373074|NCT00931307|1256594|P1|Overall Study|Biomicroscopy|1
373075|NCT00931307|1256594|P1|Overall Study|Lack of Efficacy|12
373076|NCT00931268|1256598|P1|Overall Study|Lost to Follow-up|6
373077|NCT00931255|1256610|P2|Overall Study|Follow up biopsy not done|3
373078|NCT00931255|1256611|P1|Overall Study|Follow up biopsy not done|2
373079|NCT00930982|1256648|P2|Overall Study|Withdrawal by Subject|1
373080|NCT00930982|1256649|P1|Overall Study|Withdrawal by Subject|1
373081|NCT00930982|1256648|P2|Overall Study|Protocol Violation|5
373082|NCT00930982|1256649|P1|Overall Study|Protocol Violation|1
373083|NCT00930982|1256648|P2|Overall Study|Adverse Event|23
373084|NCT00930982|1256649|P1|Overall Study|Adverse Event|19
373085|NCT00930969|1256683|P1|Overall Study|Withdrawal by Subject|19
373086|NCT00930969|1256683|P1|Overall Study|Physician Decision|13
373087|NCT00930969|1256683|P1|Overall Study|Lost to Follow-up|1
373088|NCT00930969|1256683|P1|Overall Study|Death|5
373089|NCT00930930|1256693|P2|Overall Study|patients not compliant|1
373090|NCT00930930|1256694|P1|Overall Study|patients not compliant|1
373091|NCT00930930|1256693|P2|Overall Study|excessive lapse btw txs, not eligible|1
373092|NCT00930930|1256694|P1|Overall Study|excessive lapse btw txs, not eligible|0
373093|NCT00930930|1256693|P2|Overall Study|Disease progression|3
373094|NCT00930930|1256694|P1|Overall Study|Disease progression|2
373095|NCT00930930|1256693|P2|Overall Study|Withdrawal by Subject|1
373096|NCT00930930|1256694|P1|Overall Study|Withdrawal by Subject|3
373097|NCT00930930|1256693|P2|Overall Study|Adverse Event|3
373098|NCT00930930|1256694|P1|Overall Study|Adverse Event|13
373099|NCT00930930|1256693|P2|Overall Study|Physician Decision|0
373100|NCT00930930|1256694|P1|Overall Study|Physician Decision|1
373101|NCT00930930|1256693|P2|Overall Study|Death|0
373102|NCT00930930|1256694|P1|Overall Study|Death|1
373103|NCT00930813|1256708|P2|Overall Study|Lost to Follow-up|4
373104|NCT00930813|1256709|P1|Overall Study|Lost to Follow-up|2
373105|NCT00930813|1256708|P2|Overall Study|Withdrawal by Subject|5
373106|NCT00930813|1256709|P1|Overall Study|Withdrawal by Subject|2
373107|NCT00930813|1256708|P2|Overall Study|Death|5
373108|NCT00930813|1256709|P1|Overall Study|Death|4
373109|NCT00930774|1256730|P4|Overall Study|Withdrawal by Subject|0
373110|NCT00930774|1256731|P3|Overall Study|Withdrawal by Subject|2
373111|NCT00930774|1256732|P2|Overall Study|Withdrawal by Subject|9
373112|NCT00930774|1256733|P1|Overall Study|Withdrawal by Subject|1
373113|NCT00930761|1256773|P2|Overall Study|less than 3 music therapy sessions|3
373114|NCT00930761|1256774|P1|Overall Study|less than 3 music therapy sessions|0
373115|NCT00930761|1256773|P2|Overall Study|3 newborns died; 1 mother quit the study|0
373116|NCT00930761|1256774|P1|Overall Study|3 newborns died; 1 mother quit the study|4
373117|NCT00930722|1256786|P1|Overall Study|Study terminated by sponsor|2
373118|NCT00930722|1256786|P1|Overall Study|No longer willing to participate|9
373119|NCT00930722|1256786|P1|Overall Study|Lost to Follow-up|16
373120|NCT00930644|1256801|P1|Overall Study|Adverse Event|16
373121|NCT00930644|1256801|P1|Overall Study|Death|1
373122|NCT00930644|1256801|P1|Overall Study|Physician Decision|2
373123|NCT00930644|1256801|P1|Overall Study|Withdrawal by Subject|4
373124|NCT00930553|1256814|P1|Overall Study|Other than specified above|28
373125|NCT00930553|1256814|P1|Overall Study|Study terminated by sponsor|24
373126|NCT00930553|1256814|P1|Overall Study|Death|9
373127|NCT00930553|1256814|P1|Overall Study|Lost to Follow-up|25
373128|NCT00930553|1256814|P1|Overall Study|Withdrawal by Subject|88
373129|NCT00930553|1256814|P1|Overall Study|Pregnancy|1
373130|NCT00930553|1256814|P1|Overall Study|Protocol Violation|1
373131|NCT00930553|1256814|P1|Overall Study|Physician Decision|39
373132|NCT00930553|1256814|P1|Overall Study|Lack of Efficacy|7
373133|NCT00930553|1256814|P1|Overall Study|Adverse Event|1
373134|NCT00930176|1256891|P1|Overall Study|Death|1
373135|NCT00929864|1256908|P2|Overall Study|Non-specified|7
373136|NCT00929864|1256909|P1|Overall Study|Non-specified|2
373137|NCT00929864|1256908|P2|Overall Study|Administrative reason by Sponsor|1
373138|NCT00929864|1256909|P1|Overall Study|Administrative reason by Sponsor|1
373139|NCT00929864|1256908|P2|Overall Study|Pregnancy|3
373140|NCT00929864|1256909|P1|Overall Study|Pregnancy|0
373141|NCT00929864|1256908|P2|Overall Study|Poor or non-compliance|3
373142|NCT00929864|1256909|P1|Overall Study|Poor or non-compliance|3
373143|NCT00929864|1256908|P2|Overall Study|No longer met criteria|1
373144|NCT00929864|1256909|P1|Overall Study|No longer met criteria|2
373145|NCT00929864|1256908|P2|Overall Study|Withdrawal by Subject|9
373146|NCT00929864|1256909|P1|Overall Study|Withdrawal by Subject|20
373147|NCT00929864|1256908|P2|Overall Study|Lost to Follow-up|12
373148|NCT00929864|1256909|P1|Overall Study|Lost to Follow-up|7
373149|NCT00929864|1256908|P2|Overall Study|Lack of Efficacy|16
373150|NCT00929864|1256909|P1|Overall Study|Lack of Efficacy|19
373151|NCT00929864|1256908|P2|Overall Study|Adverse Event|30
373152|NCT00929864|1256909|P1|Overall Study|Adverse Event|11
373153|NCT00929864|1256908|P2|Overall Study|Death|1
373154|NCT00929864|1256909|P1|Overall Study|Death|1
373155|NCT00929734|1256948|P2|Overall Study|Withdrawal by Subject|2
373156|NCT00929734|1256949|P1|Overall Study|Withdrawal by Subject|0
373157|NCT00929734|1256948|P2|Overall Study|Lost to Follow-up|1
373158|NCT00929734|1256949|P1|Overall Study|Lost to Follow-up|2
373159|NCT00929708|1256966|P5|Overall Study|Lost to Follow-up|0
373160|NCT00929708|1256967|P4|Overall Study|Lost to Follow-up|1
373161|NCT00929708|1256968|P3|Overall Study|Lost to Follow-up|0
373162|NCT00929708|1256969|P2|Overall Study|Lost to Follow-up|0
373163|NCT00929708|1256970|P1|Overall Study|Lost to Follow-up|0
373164|NCT00929708|1256966|P5|Overall Study|Physician Decision|1
373165|NCT00929708|1256967|P4|Overall Study|Physician Decision|2
373166|NCT00929708|1256968|P3|Overall Study|Physician Decision|2
373167|NCT00929708|1256969|P2|Overall Study|Physician Decision|2
373168|NCT00929708|1256970|P1|Overall Study|Physician Decision|0
373169|NCT00929708|1256966|P5|Overall Study|Adverse Event|3
373170|NCT00929708|1256967|P4|Overall Study|Adverse Event|0
373171|NCT00929708|1256968|P3|Overall Study|Adverse Event|0
373172|NCT00929708|1256969|P2|Overall Study|Adverse Event|0
373173|NCT00929708|1256970|P1|Overall Study|Adverse Event|0
373174|NCT00929708|1256966|P5|Overall Study|Withdrawal by Subject|1
373175|NCT00929708|1256967|P4|Overall Study|Withdrawal by Subject|2
373176|NCT00929708|1256968|P3|Overall Study|Withdrawal by Subject|0
373177|NCT00929708|1256969|P2|Overall Study|Withdrawal by Subject|0
373178|NCT00929708|1256970|P1|Overall Study|Withdrawal by Subject|2
373179|NCT00929708|1256966|P5|Overall Study|Protocol Violation|1
373180|NCT00929708|1256967|P4|Overall Study|Protocol Violation|1
373181|NCT00929708|1256968|P3|Overall Study|Protocol Violation|1
373182|NCT00929708|1256969|P2|Overall Study|Protocol Violation|1
373183|NCT00929708|1256970|P1|Overall Study|Protocol Violation|2
373184|NCT00929695|1257024|P2|Overall Study|incorrect stratification|0
373185|NCT00929695|1257025|P1|Overall Study|incorrect stratification|2
373186|NCT00929695|1257024|P2|Overall Study|discharge home|3
373187|NCT00929695|1257025|P1|Overall Study|discharge home|4
373188|NCT00929695|1257024|P2|Overall Study|Withdrawal by Subject|2
373189|NCT00929695|1257025|P1|Overall Study|Withdrawal by Subject|0
373190|NCT00929695|1257024|P2|Overall Study|Death|1
373191|NCT00929695|1257025|P1|Overall Study|Death|2
373192|NCT00929669|1257055|P1|Overall Study|elevated glucose levels|1
373193|NCT00929656|1257062|P2|Overall Study|Lost to Follow-up|1
376323|NCT00906399|1266626|P2|Year 2|Death|0
373194|NCT00929656|1257063|P1|Overall Study|Lost to Follow-up|0
373195|NCT00929643|1257077|P1|Overall Study|Protocol Violation|2
373196|NCT00929526|1257099|P2|Overall Study|Other|6
373197|NCT00929526|1257100|P1|Overall Study|Other|8
373198|NCT00929526|1257099|P2|Overall Study|Lost to Follow-up|12
373199|NCT00929526|1257100|P1|Overall Study|Lost to Follow-up|8
373200|NCT00929526|1257099|P2|Overall Study|Withdrawal by Subject|11
373201|NCT00929526|1257100|P1|Overall Study|Withdrawal by Subject|1
373202|NCT00929240|1257254|P3|Maintenance Phase|Participant not treated|0
373203|NCT00929240|1257255|P2|Maintenance Phase|Participant not treated|2
373204|NCT00929240|1257256|P1|Maintenance Phase|Participant not treated|0
373205|NCT00929240|1257254|P3|Maintenance Phase|Treatment ongoing at study closure|10
373206|NCT00929240|1257255|P2|Maintenance Phase|Treatment ongoing at study closure|0
373207|NCT00929240|1257256|P1|Maintenance Phase|Treatment ongoing at study closure|0
373208|NCT00929240|1257254|P3|Maintenance Phase|Change of treatment|0
373209|NCT00929240|1257255|P2|Maintenance Phase|Change of treatment|4
373210|NCT00929240|1257256|P1|Maintenance Phase|Change of treatment|0
373211|NCT00929240|1257254|P3|Maintenance Phase|Physician Decision|1
373212|NCT00929240|1257255|P2|Maintenance Phase|Physician Decision|2
373213|NCT00929240|1257256|P1|Maintenance Phase|Physician Decision|0
373214|NCT00929240|1257254|P3|Maintenance Phase|Health authority/Study termination|2
373215|NCT00929240|1257255|P2|Maintenance Phase|Health authority/Study termination|1
373216|NCT00929240|1257256|P1|Maintenance Phase|Health authority/Study termination|0
373217|NCT00929240|1257254|P3|Maintenance Phase|Protocol Violation|0
373218|NCT00929240|1257255|P2|Maintenance Phase|Protocol Violation|1
373219|NCT00929240|1257256|P1|Maintenance Phase|Protocol Violation|0
373220|NCT00929240|1257254|P3|Maintenance Phase|Withdrawal by Subject|6
373221|NCT00929240|1257255|P2|Maintenance Phase|Withdrawal by Subject|2
373222|NCT00929240|1257256|P1|Maintenance Phase|Withdrawal by Subject|0
373223|NCT00929240|1257254|P3|Maintenance Phase|Adverse Event|12
373224|NCT00929240|1257255|P2|Maintenance Phase|Adverse Event|9
373225|NCT00929240|1257256|P1|Maintenance Phase|Adverse Event|0
373226|NCT00929240|1257254|P3|Maintenance Phase|Disease progression|60
373227|NCT00929240|1257255|P2|Maintenance Phase|Disease progression|73
373228|NCT00929240|1257256|P1|Maintenance Phase|Disease progression|0
373229|NCT00929240|1257254|P3|Initial Treatment Phase|Physician Decision|0
373230|NCT00929240|1257255|P2|Initial Treatment Phase|Physician Decision|0
373231|NCT00929240|1257256|P1|Initial Treatment Phase|Physician Decision|4
373232|NCT00929240|1257254|P3|Initial Treatment Phase|Health authority/Study termination|0
373233|NCT00929240|1257255|P2|Initial Treatment Phase|Health authority/Study termination|0
373234|NCT00929240|1257256|P1|Initial Treatment Phase|Health authority/Study termination|3
373235|NCT00929240|1257254|P3|Initial Treatment Phase|Death|0
373236|NCT00929240|1257255|P2|Initial Treatment Phase|Death|0
373237|NCT00929240|1257256|P1|Initial Treatment Phase|Death|2
373238|NCT00929240|1257254|P3|Initial Treatment Phase|Protocol Violation|0
373239|NCT00929240|1257255|P2|Initial Treatment Phase|Protocol Violation|0
373240|NCT00929240|1257256|P1|Initial Treatment Phase|Protocol Violation|5
373241|NCT00929240|1257254|P3|Initial Treatment Phase|Withdrawal by Subject|0
373242|NCT00929240|1257255|P2|Initial Treatment Phase|Withdrawal by Subject|0
373243|NCT00929240|1257256|P1|Initial Treatment Phase|Withdrawal by Subject|13
373244|NCT00929240|1257254|P3|Initial Treatment Phase|Disease progression|0
373245|NCT00929240|1257255|P2|Initial Treatment Phase|Disease progression|0
373246|NCT00929240|1257256|P1|Initial Treatment Phase|Disease progression|41
373247|NCT00929240|1257254|P3|Initial Treatment Phase|Adverse Event|0
373248|NCT00929240|1257255|P2|Initial Treatment Phase|Adverse Event|0
373249|NCT00929240|1257256|P1|Initial Treatment Phase|Adverse Event|31
373250|NCT00929201|1257283|P2|Period 1|Withdrawal by Subject|1
373251|NCT00929201|1257284|P1|Period 1|Withdrawal by Subject|0
373252|NCT00929162|1257294|P2|Overall Study|Other termination reason|6
373253|NCT00929162|1257295|P1|Overall Study|Other termination reason|5
373254|NCT00929162|1257294|P2|Overall Study|Protocol Violation|30
373255|NCT00929162|1257295|P1|Overall Study|Protocol Violation|32
373256|NCT00929162|1257294|P2|Overall Study|Withdrawal by Subject|1
373257|NCT00929162|1257295|P1|Overall Study|Withdrawal by Subject|3
373258|NCT00929162|1257294|P2|Overall Study|Adverse Event|5
373259|NCT00929162|1257295|P1|Overall Study|Adverse Event|8
373260|NCT00929110|1257308|P3|Overall Study|Patient inability to use the device|0
373261|NCT00929110|1257309|P2|Overall Study|Patient inability to use the device|1
373262|NCT00929110|1257310|P1|Overall Study|Patient inability to use the device|0
373263|NCT00929110|1257308|P3|Overall Study|Abnormal test procedure result(s)|1
373264|NCT00929110|1257309|P2|Overall Study|Abnormal test procedure result(s)|1
373265|NCT00929110|1257310|P1|Overall Study|Abnormal test procedure result(s)|0
373266|NCT00929110|1257308|P3|Overall Study|Abnormal laboratory value(s)|0
373267|NCT00929110|1257309|P2|Overall Study|Abnormal laboratory value(s)|1
373268|NCT00929110|1257310|P1|Overall Study|Abnormal laboratory value(s)|0
373269|NCT00929110|1257308|P3|Overall Study|Death|2
373270|NCT00929110|1257309|P2|Overall Study|Death|2
373271|NCT00929110|1257310|P1|Overall Study|Death|2
373272|NCT00929110|1257308|P3|Overall Study|Administrative problems|2
373273|NCT00929110|1257309|P2|Overall Study|Administrative problems|1
373274|NCT00929110|1257310|P1|Overall Study|Administrative problems|4
373275|NCT00929110|1257308|P3|Overall Study|Protocol deviation|4
373276|NCT00929110|1257309|P2|Overall Study|Protocol deviation|2
373277|NCT00929110|1257310|P1|Overall Study|Protocol deviation|5
373278|NCT00929110|1257308|P3|Overall Study|Lost to Follow-up|3
373279|NCT00929110|1257309|P2|Overall Study|Lost to Follow-up|7
373280|NCT00929110|1257310|P1|Overall Study|Lost to Follow-up|7
373281|NCT00929110|1257308|P3|Overall Study|Unsatisfactory therapeutic effect|6
373282|NCT00929110|1257309|P2|Overall Study|Unsatisfactory therapeutic effect|9
373283|NCT00929110|1257310|P1|Overall Study|Unsatisfactory therapeutic effect|20
373284|NCT00929110|1257308|P3|Overall Study|Subject withdrew consent|26
373285|NCT00929110|1257309|P2|Overall Study|Subject withdrew consent|23
373286|NCT00929110|1257310|P1|Overall Study|Subject withdrew consent|40
373287|NCT00929110|1257308|P3|Overall Study|Adverse Event|18
373288|NCT00929110|1257309|P2|Overall Study|Adverse Event|29
373289|NCT00929110|1257310|P1|Overall Study|Adverse Event|40
373290|NCT00928889|1257393|P2|Overall Study|Other|0
373291|NCT00928889|1257394|P1|Overall Study|Other|1
373292|NCT00928889|1257393|P2|Overall Study|Adverse Event|0
373293|NCT00928889|1257394|P1|Overall Study|Adverse Event|1
373294|NCT00928889|1257393|P2|Overall Study|Protocol Violation|1
373295|NCT00928889|1257394|P1|Overall Study|Protocol Violation|0
373296|NCT00928889|1257393|P2|Overall Study|Lost to Follow-up|1
373297|NCT00928889|1257394|P1|Overall Study|Lost to Follow-up|3
373298|NCT00928746|1257440|P1|Overall Study|Other|2
373299|NCT00928746|1257440|P1|Overall Study|Withdrawal by Subject|1
373300|NCT00928746|1257440|P1|Overall Study|Protocol Violation|1
373301|NCT00928746|1257440|P1|Overall Study|Adverse Event|2
373302|NCT00928668|1257497|P5|Overall Study|Other reasons not listed above|0
373303|NCT00928668|1257498|P4|Overall Study|Other reasons not listed above|1
373304|NCT00928668|1257499|P3|Overall Study|Other reasons not listed above|0
373305|NCT00928668|1257500|P2|Overall Study|Other reasons not listed above|0
373306|NCT00928668|1257501|P1|Overall Study|Other reasons not listed above|0
373307|NCT00928668|1257497|P5|Overall Study|Withdrawal by Subject|0
373308|NCT00928668|1257498|P4|Overall Study|Withdrawal by Subject|0
373309|NCT00928668|1257499|P3|Overall Study|Withdrawal by Subject|1
373310|NCT00928668|1257500|P2|Overall Study|Withdrawal by Subject|1
373311|NCT00928668|1257501|P1|Overall Study|Withdrawal by Subject|0
373312|NCT00928668|1257497|P5|Overall Study|Protocol Violation|1
373313|NCT00928668|1257498|P4|Overall Study|Protocol Violation|0
373314|NCT00928668|1257499|P3|Overall Study|Protocol Violation|0
373315|NCT00928668|1257500|P2|Overall Study|Protocol Violation|0
373316|NCT00928668|1257501|P1|Overall Study|Protocol Violation|0
373317|NCT00928668|1257497|P5|Overall Study|Adverse Event|0
373318|NCT00928668|1257498|P4|Overall Study|Adverse Event|0
373319|NCT00928668|1257499|P3|Overall Study|Adverse Event|0
373320|NCT00928668|1257500|P2|Overall Study|Adverse Event|0
373321|NCT00928668|1257501|P1|Overall Study|Adverse Event|1
373322|NCT00928512|1257557|P5|Overall Study|Administrative Problems|0
373323|NCT00928512|1257558|P4|Overall Study|Administrative Problems|0
373324|NCT00928512|1257559|P3|Overall Study|Administrative Problems|0
373325|NCT00928512|1257560|P2|Overall Study|Administrative Problems|1
373326|NCT00928512|1257561|P1|Overall Study|Administrative Problems|0
373327|NCT00928512|1257557|P5|Overall Study|Lost to Follow-up|3
373328|NCT00928512|1257558|P4|Overall Study|Lost to Follow-up|1
373329|NCT00928512|1257559|P3|Overall Study|Lost to Follow-up|2
373330|NCT00928512|1257560|P2|Overall Study|Lost to Follow-up|1
373331|NCT00928512|1257561|P1|Overall Study|Lost to Follow-up|1
373332|NCT00928512|1257557|P5|Overall Study|Withdrawal by Subject|0
373333|NCT00928512|1257558|P4|Overall Study|Withdrawal by Subject|4
373334|NCT00928512|1257559|P3|Overall Study|Withdrawal by Subject|3
373335|NCT00928512|1257560|P2|Overall Study|Withdrawal by Subject|0
373336|NCT00928512|1257561|P1|Overall Study|Withdrawal by Subject|3
373337|NCT00928512|1257557|P5|Overall Study|Protocol Violation|3
373338|NCT00928512|1257558|P4|Overall Study|Protocol Violation|1
373339|NCT00928512|1257559|P3|Overall Study|Protocol Violation|0
373340|NCT00928512|1257560|P2|Overall Study|Protocol Violation|1
373341|NCT00928512|1257561|P1|Overall Study|Protocol Violation|0
373342|NCT00928512|1257557|P5|Overall Study|Lack of Efficacy|3
373343|NCT00928512|1257558|P4|Overall Study|Lack of Efficacy|7
373344|NCT00928512|1257559|P3|Overall Study|Lack of Efficacy|4
373345|NCT00928512|1257560|P2|Overall Study|Lack of Efficacy|0
373346|NCT00928512|1257561|P1|Overall Study|Lack of Efficacy|2
373347|NCT00928512|1257557|P5|Overall Study|Adverse Event|6
373348|NCT00928512|1257558|P4|Overall Study|Adverse Event|8
373349|NCT00928512|1257559|P3|Overall Study|Adverse Event|2
373350|NCT00928512|1257560|P2|Overall Study|Adverse Event|3
373351|NCT00928512|1257561|P1|Overall Study|Adverse Event|4
373352|NCT00928486|1257662|P1|Overall Study|Withdrawal by Subject|1
373353|NCT00928486|1257662|P1|Overall Study|Disease Progression|7
373354|NCT00928486|1257662|P1|Overall Study|Adverse Event|2
373355|NCT00928434|1257671|P3|Overall Study|Other (not meeting above criteria)|2
373356|NCT00928434|1257672|P2|Overall Study|Other (not meeting above criteria)|1
373357|NCT00928434|1257673|P1|Overall Study|Other (not meeting above criteria)|5
373358|NCT00928434|1257671|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
373359|NCT00928434|1257672|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
373360|NCT00928434|1257673|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
373361|NCT00928434|1257671|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
373362|NCT00928434|1257672|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
373363|NCT00928434|1257673|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
373364|NCT00928434|1257671|P3|Overall Study|Withdrawal by Subject|2
373365|NCT00928434|1257672|P2|Overall Study|Withdrawal by Subject|3
373366|NCT00928434|1257673|P1|Overall Study|Withdrawal by Subject|5
373367|NCT00928434|1257671|P3|Overall Study|Lost to Follow-up|3
373368|NCT00928434|1257672|P2|Overall Study|Lost to Follow-up|0
373369|NCT00928434|1257673|P1|Overall Study|Lost to Follow-up|1
373370|NCT00928434|1257671|P3|Overall Study|Physician Decision|3
373371|NCT00928434|1257672|P2|Overall Study|Physician Decision|0
373372|NCT00928434|1257673|P1|Overall Study|Physician Decision|2
373373|NCT00928434|1257671|P3|Overall Study|Protocol Violation|8
373374|NCT00928434|1257672|P2|Overall Study|Protocol Violation|0
373375|NCT00928434|1257673|P1|Overall Study|Protocol Violation|5
373376|NCT00928434|1257671|P3|Overall Study|Adverse Event|18
373377|NCT00928434|1257672|P2|Overall Study|Adverse Event|5
373378|NCT00928434|1257673|P1|Overall Study|Adverse Event|14
373379|NCT00928408|1257749|P1|Overall Study|Lost to Follow-up|12
373380|NCT00928408|1257749|P1|Overall Study|Death|5
373381|NCT00928408|1257749|P1|Overall Study|Withdrawal by Subject|4
373382|NCT00928408|1257749|P1|Overall Study|Other|2
373383|NCT00928252|1257795|P1|Overall Study|Physician Decision|3
373384|NCT00928187|1257804|P3|Overall Study|Protocol Violation|0
373385|NCT00928187|1257805|P2|Overall Study|Protocol Violation|1
373386|NCT00928187|1257806|P1|Overall Study|Protocol Violation|0
373387|NCT00928187|1257804|P3|Overall Study|Withdrawal by Subject|1
373388|NCT00928187|1257805|P2|Overall Study|Withdrawal by Subject|1
373389|NCT00928187|1257806|P1|Overall Study|Withdrawal by Subject|0
373390|NCT00928187|1257804|P3|Overall Study|Lost to Follow-up|1
373391|NCT00928187|1257805|P2|Overall Study|Lost to Follow-up|2
373392|NCT00928187|1257806|P1|Overall Study|Lost to Follow-up|1
373393|NCT00928187|1257804|P3|Overall Study|Death|3
373394|NCT00928187|1257805|P2|Overall Study|Death|2
373395|NCT00928187|1257806|P1|Overall Study|Death|1
373396|NCT00928070|1257976|P2|Overall Study|Other|5
373397|NCT00928070|1257977|P1|Overall Study|Other|5
373398|NCT00928070|1257976|P2|Overall Study|Randomized but not treated|2
373399|NCT00928070|1257977|P1|Overall Study|Randomized but not treated|2
373400|NCT00928070|1257976|P2|Overall Study|Protocol Violation|5
373401|NCT00928070|1257977|P1|Overall Study|Protocol Violation|6
373402|NCT00928070|1257976|P2|Overall Study|Did not meet entrance criteria|9
373403|NCT00928070|1257977|P1|Overall Study|Did not meet entrance criteria|16
373404|NCT00928070|1257976|P2|Overall Study|Lack of Efficacy|5
373405|NCT00928070|1257977|P1|Overall Study|Lack of Efficacy|9
373406|NCT00928070|1257976|P2|Overall Study|Adverse Event|26
373407|NCT00928070|1257977|P1|Overall Study|Adverse Event|14
373408|NCT00928070|1257976|P2|Overall Study|Withdrawal by Subject|3
373409|NCT00928070|1257977|P1|Overall Study|Withdrawal by Subject|10
373410|NCT00928070|1257976|P2|Overall Study|Lost to Follow-up|2
373411|NCT00928070|1257977|P1|Overall Study|Lost to Follow-up|1
373412|NCT00928057|1258035|P2|Overall Study|Protocol Violation|1
373413|NCT00928057|1258036|P1|Overall Study|Protocol Violation|0
373414|NCT00928057|1258035|P2|Overall Study|Lost to Follow-up|1
373415|NCT00928057|1258036|P1|Overall Study|Lost to Follow-up|0
373416|NCT00928057|1258035|P2|Overall Study|Withdrawal by Subject|0
373417|NCT00928057|1258036|P1|Overall Study|Withdrawal by Subject|1
373418|NCT00928057|1258035|P2|Overall Study|Adverse Event|2
373419|NCT00928057|1258036|P1|Overall Study|Adverse Event|1
373420|NCT00928018|1258061|P2|Overall Study|Withdrawal by Subject|0
373421|NCT00928018|1258062|P1|Overall Study|Withdrawal by Subject|1
373422|NCT00927953|1258092|P2|Overall Study|Death|1
373423|NCT00927953|1258093|P1|Overall Study|Death|2
373424|NCT00927940|1258107|P1|Overall Study|Death|1
373425|NCT00927927|1258127|P15|Overall Study|Withdrawal by Subject|0
373426|NCT00927927|1258128|P14|Overall Study|Withdrawal by Subject|0
373427|NCT00927927|1258129|P13|Overall Study|Withdrawal by Subject|0
373428|NCT00927927|1258130|P12|Overall Study|Withdrawal by Subject|2
373429|NCT00927927|1258131|P11|Overall Study|Withdrawal by Subject|0
373430|NCT00927927|1258132|P10|Overall Study|Withdrawal by Subject|0
373431|NCT00927927|1258133|P9|Overall Study|Withdrawal by Subject|0
373432|NCT00927927|1258134|P8|Overall Study|Withdrawal by Subject|2
373433|NCT00927927|1258135|P7|Overall Study|Withdrawal by Subject|0
373434|NCT00927927|1258136|P6|Overall Study|Withdrawal by Subject|0
373435|NCT00927927|1258137|P5|Overall Study|Withdrawal by Subject|0
373436|NCT00927927|1258138|P4|Overall Study|Withdrawal by Subject|0
373437|NCT00927927|1258139|P3|Overall Study|Withdrawal by Subject|0
373438|NCT00927927|1258140|P2|Overall Study|Withdrawal by Subject|0
373439|NCT00927927|1258141|P1|Overall Study|Withdrawal by Subject|0
373440|NCT00927901|1258188|P4|Treatment Period 4|Subject withdrew consent|0
373441|NCT00927901|1258189|P3|Treatment Period 4|Subject withdrew consent|1
373442|NCT00927901|1258190|P2|Treatment Period 4|Subject withdrew consent|0
373443|NCT00927901|1258191|P1|Treatment Period 4|Subject withdrew consent|0
373444|NCT00927901|1258188|P4|Treatment Period 4|Adverse Event|1
373445|NCT00927901|1258189|P3|Treatment Period 4|Adverse Event|0
373446|NCT00927901|1258190|P2|Treatment Period 4|Adverse Event|0
373447|NCT00927901|1258191|P1|Treatment Period 4|Adverse Event|0
373448|NCT00927901|1258188|P4|Treatment Period 1|Subject withdrew consent|0
373449|NCT00927901|1258189|P3|Treatment Period 1|Subject withdrew consent|1
373450|NCT00927901|1258190|P2|Treatment Period 1|Subject withdrew consent|0
373451|NCT00927901|1258191|P1|Treatment Period 1|Subject withdrew consent|0
373452|NCT00927862|1258232|P2|Overall Study|Missing data needed for endpt analyses|45
376324|NCT00906399|1266627|P1|Year 2|Death|0
373453|NCT00927862|1258233|P1|Overall Study|Missing data needed for endpt analyses|27
373454|NCT00927823|1258268|P4|Continuous Dosing Period|Other|3
373455|NCT00927823|1258269|P3|Continuous Dosing Period|Other|9
373456|NCT00927823|1258270|P2|Continuous Dosing Period|Other|2
373457|NCT00927823|1258271|P1|Continuous Dosing Period|Other|1
373458|NCT00927823|1258268|P4|Continuous Dosing Period|Withdrawal by Subject|2
373459|NCT00927823|1258269|P3|Continuous Dosing Period|Withdrawal by Subject|2
373460|NCT00927823|1258270|P2|Continuous Dosing Period|Withdrawal by Subject|0
373461|NCT00927823|1258271|P1|Continuous Dosing Period|Withdrawal by Subject|1
373462|NCT00927823|1258268|P4|Continuous Dosing Period|Lost to Follow-up|0
373463|NCT00927823|1258269|P3|Continuous Dosing Period|Lost to Follow-up|9
373464|NCT00927823|1258270|P2|Continuous Dosing Period|Lost to Follow-up|1
373465|NCT00927823|1258271|P1|Continuous Dosing Period|Lost to Follow-up|1
373466|NCT00927823|1258268|P4|Continuous Dosing Period|Death|0
373467|NCT00927823|1258269|P3|Continuous Dosing Period|Death|6
373468|NCT00927823|1258270|P2|Continuous Dosing Period|Death|0
373469|NCT00927823|1258271|P1|Continuous Dosing Period|Death|0
373470|NCT00927758|1258335|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
373471|NCT00927758|1258336|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
373472|NCT00927758|1258337|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
373473|NCT00927758|1258338|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
373474|NCT00927758|1258339|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
373475|NCT00927758|1258340|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
373476|NCT00927758|1258335|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
373477|NCT00927758|1258336|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
373478|NCT00927758|1258337|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
373479|NCT00927758|1258338|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
373480|NCT00927758|1258339|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
373481|NCT00927758|1258340|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
373482|NCT00927589|1258348|P1|Overall Study|Non-compliance|1
373483|NCT00927589|1258348|P1|Overall Study|Disease Progression|8
373484|NCT00927589|1258348|P1|Overall Study|Adverse Event|2
373485|NCT00927589|1258348|P1|Overall Study|Withdrawal by Subject|3
373486|NCT00927589|1258348|P1|Overall Study|Physician Decision|1
373487|NCT00927589|1258348|P1|Overall Study|Death|1
373488|NCT00927563|1258378|P1|Overall Study|Withdrawal by Subject|1
373489|NCT00927563|1258378|P1|Overall Study|Lost to Follow-up|1
373490|NCT00927472|1258386|P2|Overall Study|Post treatment Assessment out of window|4
373491|NCT00927472|1258387|P1|Overall Study|Post treatment Assessment out of window|0
373492|NCT00927472|1258386|P2|Overall Study|Protocol Violation|1
373493|NCT00927472|1258387|P1|Overall Study|Protocol Violation|0
373494|NCT00927472|1258386|P2|Overall Study|Lost to Follow-up|6
373495|NCT00927472|1258387|P1|Overall Study|Lost to Follow-up|1
373496|NCT00927472|1258386|P2|Overall Study|Withdrawal by Subject|11
373497|NCT00927472|1258387|P1|Overall Study|Withdrawal by Subject|10
373498|NCT00927394|1258413|P2|Overall Study|Randomized in error|1
373499|NCT00927394|1258414|P1|Overall Study|Randomized in error|0
373500|NCT00927394|1258413|P2|Overall Study|Protocol deviation|13
373501|NCT00927394|1258414|P1|Overall Study|Protocol deviation|16
373502|NCT00927394|1258413|P2|Overall Study|Death|1
373503|NCT00927394|1258414|P1|Overall Study|Death|1
373504|NCT00927394|1258413|P2|Overall Study|Administrative Problem|0
373505|NCT00927394|1258414|P1|Overall Study|Administrative Problem|1
373506|NCT00927394|1258413|P2|Overall Study|Lost to Follow-up|14
373507|NCT00927394|1258414|P1|Overall Study|Lost to Follow-up|8
373508|NCT00927394|1258413|P2|Overall Study|Withdrawal by Subject|24
373509|NCT00927394|1258414|P1|Overall Study|Withdrawal by Subject|20
373510|NCT00927394|1258413|P2|Overall Study|Unsatisfactory therapeutic effect|23
373511|NCT00927394|1258414|P1|Overall Study|Unsatisfactory therapeutic effect|17
373512|NCT00927394|1258413|P2|Overall Study|Adverse Event|9
373513|NCT00927394|1258414|P1|Overall Study|Adverse Event|14
373514|NCT00927368|1258445|P3|Overall Study|cancellation of surgery|2
373515|NCT00927368|1258446|P2|Overall Study|cancellation of surgery|1
373516|NCT00927368|1258447|P1|Overall Study|cancellation of surgery|0
373517|NCT00927368|1258445|P3|Overall Study|ineligible post randomization|1
373518|NCT00927368|1258446|P2|Overall Study|ineligible post randomization|3
373519|NCT00927368|1258447|P1|Overall Study|ineligible post randomization|0
373520|NCT00927368|1258445|P3|Overall Study|equipment failure|0
373521|NCT00927368|1258446|P2|Overall Study|equipment failure|0
373522|NCT00927368|1258447|P1|Overall Study|equipment failure|1
373523|NCT00927368|1258445|P3|Overall Study|Lost to Follow-up|0
373524|NCT00927368|1258446|P2|Overall Study|Lost to Follow-up|0
373525|NCT00927368|1258447|P1|Overall Study|Lost to Follow-up|4
373526|NCT00927368|1258445|P3|Overall Study|enrollment in another study|2
373527|NCT00927368|1258446|P2|Overall Study|enrollment in another study|1
373528|NCT00927368|1258447|P1|Overall Study|enrollment in another study|1
373529|NCT00927355|1258466|P2|Overall Study|Adverse Event|1
373530|NCT00927355|1258467|P1|Overall Study|Adverse Event|1
373531|NCT00927251|1258502|P1|Overall Study|Patients not implanted with 4296 lead|8
373532|NCT00927186|1258508|P2|12 Months Primary Study|Withdrawal by Subject|1
373533|NCT00927186|1258509|P1|12 Months Primary Study|Withdrawal by Subject|1
373534|NCT00927186|1258508|P2|12 Months Primary Study|Protocol Violation|1
373535|NCT00927186|1258509|P1|12 Months Primary Study|Protocol Violation|0
373536|NCT00927186|1258508|P2|12 Months Primary Study|Lost to Follow-up|0
373537|NCT00927186|1258509|P1|12 Months Primary Study|Lost to Follow-up|1
373538|NCT00927186|1258508|P2|12 Months Primary Study|Adverse Event|2
373539|NCT00927186|1258509|P1|12 Months Primary Study|Adverse Event|5
373540|NCT00927095|1258639|P3|Overall Study|Physician Decision|1
373541|NCT00927095|1258640|P2|Overall Study|Physician Decision|2
373542|NCT00927095|1258641|P1|Overall Study|Physician Decision|1
373543|NCT00927095|1258639|P3|Overall Study|Withdrawal by Subject|1
373544|NCT00927095|1258640|P2|Overall Study|Withdrawal by Subject|1
373545|NCT00927095|1258641|P1|Overall Study|Withdrawal by Subject|2
373546|NCT00927095|1258639|P3|Overall Study|Adverse Event|0
373547|NCT00927095|1258640|P2|Overall Study|Adverse Event|1
373548|NCT00927095|1258641|P1|Overall Study|Adverse Event|3
373549|NCT00927082|1258653|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
373550|NCT00927082|1258654|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
373551|NCT00927082|1258655|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
373552|NCT00927082|1258656|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
373553|NCT00927082|1258653|P4|Overall Study|Death|0
373554|NCT00927082|1258654|P3|Overall Study|Death|1
373555|NCT00927082|1258655|P2|Overall Study|Death|0
373556|NCT00927082|1258656|P1|Overall Study|Death|0
373557|NCT00927082|1258653|P4|Overall Study|Withdrawal by Subject|2
373558|NCT00927082|1258654|P3|Overall Study|Withdrawal by Subject|7
373559|NCT00927082|1258655|P2|Overall Study|Withdrawal by Subject|2
373560|NCT00927082|1258656|P1|Overall Study|Withdrawal by Subject|3
373561|NCT00927082|1258653|P4|Overall Study|Lost to Follow-up|16
373562|NCT00927082|1258654|P3|Overall Study|Lost to Follow-up|12
373563|NCT00927082|1258655|P2|Overall Study|Lost to Follow-up|8
373564|NCT00927082|1258656|P1|Overall Study|Lost to Follow-up|9
373565|NCT00927069|1258720|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
373566|NCT00927069|1258721|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
373567|NCT00927069|1258722|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
373568|NCT00927069|1258723|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
373569|NCT00927069|1258720|P4|Week 12 to Week 24|Withdrawal by Subject|0
373570|NCT00927069|1258721|P3|Week 12 to Week 24|Withdrawal by Subject|0
373571|NCT00927069|1258722|P2|Week 12 to Week 24|Withdrawal by Subject|0
373572|NCT00927069|1258723|P1|Week 12 to Week 24|Withdrawal by Subject|1
373573|NCT00927069|1258720|P4|Week 12 to Week 24|Lost to Follow-up|0
373574|NCT00927069|1258721|P3|Week 12 to Week 24|Lost to Follow-up|1
373575|NCT00927069|1258722|P2|Week 12 to Week 24|Lost to Follow-up|0
373576|NCT00927069|1258723|P1|Week 12 to Week 24|Lost to Follow-up|0
373577|NCT00927069|1258720|P4|Week 12 to Week 24|Lack of Efficacy|3
373578|NCT00927069|1258721|P3|Week 12 to Week 24|Lack of Efficacy|2
373579|NCT00927069|1258722|P2|Week 12 to Week 24|Lack of Efficacy|0
373580|NCT00927069|1258723|P1|Week 12 to Week 24|Lack of Efficacy|0
373581|NCT00927069|1258720|P4|Week 0 to Week 12|Worsening of psoriasis|0
373582|NCT00927069|1258721|P3|Week 0 to Week 12|Worsening of psoriasis|0
373583|NCT00927069|1258722|P2|Week 0 to Week 12|Worsening of psoriasis|1
373584|NCT00927069|1258723|P1|Week 0 to Week 12|Worsening of psoriasis|1
373585|NCT00926796|1258779|P2|Overall Study|Withdrawal by Subject|0
373586|NCT00926796|1258780|P1|Overall Study|Withdrawal by Subject|1
373587|NCT00926796|1258779|P2|Overall Study|Protocol Violation|11
373588|NCT00926796|1258780|P1|Overall Study|Protocol Violation|15
373589|NCT00926796|1258779|P2|Overall Study|Lost to Follow-up|13
373590|NCT00926796|1258780|P1|Overall Study|Lost to Follow-up|22
373591|NCT00926796|1258779|P2|Overall Study|Adverse Event|14
373592|NCT00926796|1258780|P1|Overall Study|Adverse Event|7
373593|NCT00926796|1258779|P2|Overall Study|Ineligible, but positive for gonorrhea|1
373594|NCT00926796|1258780|P1|Overall Study|Ineligible, but positive for gonorrhea|1
373595|NCT00926796|1258779|P2|Overall Study|Ineligible, negative for gonorrhea|60
373596|NCT00926796|1258780|P1|Overall Study|Ineligible, negative for gonorrhea|57
373597|NCT00926796|1258779|P2|Overall Study|Did not receive randomized treatment|7
373598|NCT00926796|1258780|P1|Overall Study|Did not receive randomized treatment|4
373599|NCT00926783|1258801|P2|Overall Study|Incomplete CFAE Procedures|3
373600|NCT00926783|1258802|P1|Overall Study|Incomplete CFAE Procedures|3
373601|NCT00926575|1258829|P2|Overall Study|Withdrawal by Subject|9
373602|NCT00926575|1258830|P1|Overall Study|Withdrawal by Subject|8
373603|NCT00926575|1258829|P2|Overall Study|Protocol Violation|0
373604|NCT00926575|1258830|P1|Overall Study|Protocol Violation|1
373605|NCT00926575|1258829|P2|Overall Study|Physician Decision|2
373606|NCT00926575|1258830|P1|Overall Study|Physician Decision|1
373607|NCT00926575|1258829|P2|Overall Study|Lost to Follow-up|1
373608|NCT00926575|1258830|P1|Overall Study|Lost to Follow-up|1
373609|NCT00926575|1258829|P2|Overall Study|Death|4
373610|NCT00926575|1258830|P1|Overall Study|Death|4
373611|NCT00926575|1258829|P2|Overall Study|Adverse Event|1
373612|NCT00926575|1258830|P1|Overall Study|Adverse Event|1
373613|NCT00926536|1258842|P2|Overall Study|Physician Decision|2
373614|NCT00926536|1258843|P1|Overall Study|Physician Decision|1
373615|NCT00926393|1258864|P2|Overall Study|Adverse Event|1
373616|NCT00926393|1258865|P1|Overall Study|Adverse Event|1
373617|NCT00926393|1258864|P2|Overall Study|Withdrawal by Subject|2
373618|NCT00926393|1258865|P1|Overall Study|Withdrawal by Subject|1
373619|NCT00926367|1258910|P2|Overall Study|Skin Irritation|2
373620|NCT00926367|1258911|P1|Overall Study|Skin Irritation|1
373621|NCT00926367|1258910|P2|Overall Study|Lost to Follow-up|0
373622|NCT00926367|1258911|P1|Overall Study|Lost to Follow-up|1
373623|NCT00926367|1258910|P2|Overall Study|Withdrawal by Subject|1
373624|NCT00926367|1258911|P1|Overall Study|Withdrawal by Subject|0
373625|NCT00926328|1258953|P2|Overall Study|Lost to Follow-up|14
373626|NCT00926328|1258954|P1|Overall Study|Lost to Follow-up|12
373627|NCT00926289|1258964|P2|Overall Study|not specified|3
373628|NCT00926289|1258965|P1|Overall Study|not specified|1
373629|NCT00926289|1258964|P2|Overall Study|Withdrawal by Subject|4
373630|NCT00926289|1258965|P1|Overall Study|Withdrawal by Subject|4
373631|NCT00926289|1258964|P2|Overall Study|Lost to Follow-up|6
373632|NCT00926289|1258965|P1|Overall Study|Lost to Follow-up|3
373633|NCT00926289|1258964|P2|Overall Study|Protocol Violation|12
373634|NCT00926289|1258965|P1|Overall Study|Protocol Violation|8
373635|NCT00926289|1258964|P2|Overall Study|Adverse Event|11
373636|NCT00926289|1258965|P1|Overall Study|Adverse Event|9
373637|NCT00926211|1259033|P1|Overall Study|Lost to Follow-up|1
373638|NCT00926029|1259064|P3|Overall Study|Lost to Follow-up|1
373639|NCT00926029|1259065|P2|Overall Study|Lost to Follow-up|1
373640|NCT00926029|1259066|P1|Overall Study|Lost to Follow-up|2
373641|NCT00925990|1259079|P2|Overall Study|moved out of state, missed medication|2
373642|NCT00925990|1259080|P1|Overall Study|moved out of state, missed medication|0
373643|NCT00925990|1259079|P2|Overall Study|Physician Decision|1
373644|NCT00925990|1259080|P1|Overall Study|Physician Decision|1
373645|NCT00925990|1259079|P2|Overall Study|Lost to Follow-up|3
373646|NCT00925990|1259080|P1|Overall Study|Lost to Follow-up|1
373647|NCT00925990|1259079|P2|Overall Study|Withdrawal by Subject|2
373648|NCT00925990|1259080|P1|Overall Study|Withdrawal by Subject|2
373649|NCT00925990|1259079|P2|Overall Study|Adverse Event|3
373650|NCT00925990|1259080|P1|Overall Study|Adverse Event|1
373651|NCT00925899|1259115|P2|Part 1|Withdrawal by Subject|9
373652|NCT00925899|1259116|P1|Part 1|Withdrawal by Subject|10
373653|NCT00925899|1259115|P2|Part 1|Death|2
373654|NCT00925899|1259116|P1|Part 1|Death|1
373655|NCT00925769|1259144|P6|Overall Study|Adverse Event|0
373656|NCT00925769|1259145|P5|Overall Study|Adverse Event|1
373657|NCT00925769|1259146|P4|Overall Study|Adverse Event|0
373658|NCT00925769|1259147|P3|Overall Study|Adverse Event|0
373659|NCT00925769|1259148|P2|Overall Study|Adverse Event|0
373660|NCT00925769|1259149|P1|Overall Study|Adverse Event|0
373661|NCT00925769|1259144|P6|Overall Study|Participant is unable to swallow drug|0
373662|NCT00925769|1259145|P5|Overall Study|Participant is unable to swallow drug|0
373663|NCT00925769|1259146|P4|Overall Study|Participant is unable to swallow drug|1
373664|NCT00925769|1259147|P3|Overall Study|Participant is unable to swallow drug|0
373665|NCT00925769|1259148|P2|Overall Study|Participant is unable to swallow drug|0
373666|NCT00925769|1259149|P1|Overall Study|Participant is unable to swallow drug|0
373667|NCT00925769|1259144|P6|Overall Study|End of study visit not done|0
373668|NCT00925769|1259145|P5|Overall Study|End of study visit not done|0
373669|NCT00925769|1259146|P4|Overall Study|End of study visit not done|0
373670|NCT00925769|1259147|P3|Overall Study|End of study visit not done|1
373671|NCT00925769|1259148|P2|Overall Study|End of study visit not done|0
373672|NCT00925769|1259149|P1|Overall Study|End of study visit not done|0
373673|NCT00925769|1259144|P6|Overall Study|Missing documentation|0
373674|NCT00925769|1259145|P5|Overall Study|Missing documentation|0
373675|NCT00925769|1259146|P4|Overall Study|Missing documentation|0
373676|NCT00925769|1259147|P3|Overall Study|Missing documentation|0
373677|NCT00925769|1259148|P2|Overall Study|Missing documentation|1
373678|NCT00925769|1259149|P1|Overall Study|Missing documentation|0
373679|NCT00925769|1259144|P6|Overall Study|Physician Decision|0
373680|NCT00925769|1259145|P5|Overall Study|Physician Decision|0
373681|NCT00925769|1259146|P4|Overall Study|Physician Decision|0
373682|NCT00925769|1259147|P3|Overall Study|Physician Decision|0
373683|NCT00925769|1259148|P2|Overall Study|Physician Decision|0
373684|NCT00925769|1259149|P1|Overall Study|Physician Decision|1
373685|NCT00925769|1259144|P6|Overall Study|Death|0
373686|NCT00925769|1259145|P5|Overall Study|Death|0
373687|NCT00925769|1259146|P4|Overall Study|Death|0
373688|NCT00925769|1259147|P3|Overall Study|Death|1
373689|NCT00925769|1259148|P2|Overall Study|Death|0
373690|NCT00925769|1259149|P1|Overall Study|Death|0
373691|NCT00925769|1259144|P6|Overall Study|Disease progression|3
373692|NCT00925769|1259145|P5|Overall Study|Disease progression|2
373693|NCT00925769|1259146|P4|Overall Study|Disease progression|4
373694|NCT00925769|1259147|P3|Overall Study|Disease progression|3
373695|NCT00925769|1259148|P2|Overall Study|Disease progression|5
373696|NCT00925769|1259149|P1|Overall Study|Disease progression|4
373697|NCT00925769|1259144|P6|Overall Study|Major toxicity|0
373698|NCT00925769|1259145|P5|Overall Study|Major toxicity|0
373699|NCT00925769|1259146|P4|Overall Study|Major toxicity|1
373700|NCT00925769|1259147|P3|Overall Study|Major toxicity|1
373701|NCT00925769|1259148|P2|Overall Study|Major toxicity|0
373702|NCT00925769|1259149|P1|Overall Study|Major toxicity|1
373703|NCT00925704|1259217|P6|Third Intervention|Withdrew consent|1
373704|NCT00925704|1259218|P5|Third Intervention|Withdrew consent|0
373705|NCT00925704|1259219|P4|Third Intervention|Withdrew consent|0
373706|NCT00925704|1259220|P3|Third Intervention|Withdrew consent|0
373707|NCT00925704|1259221|P2|Third Intervention|Withdrew consent|0
373708|NCT00925704|1259222|P1|Third Intervention|Withdrew consent|0
373709|NCT00925704|1259217|P6|Second Intervention|Withdrawal by Subject|0
373710|NCT00925704|1259218|P5|Second Intervention|Withdrawal by Subject|1
373711|NCT00925704|1259219|P4|Second Intervention|Withdrawal by Subject|0
373712|NCT00925704|1259220|P3|Second Intervention|Withdrawal by Subject|0
373713|NCT00925704|1259221|P2|Second Intervention|Withdrawal by Subject|0
373714|NCT00925704|1259222|P1|Second Intervention|Withdrawal by Subject|1
373715|NCT00925704|1259217|P6|First Intervention|Withdrew consent|0
373716|NCT00925704|1259218|P5|First Intervention|Withdrew consent|1
373717|NCT00925704|1259219|P4|First Intervention|Withdrew consent|1
373718|NCT00925704|1259220|P3|First Intervention|Withdrew consent|0
373719|NCT00925704|1259221|P2|First Intervention|Withdrew consent|0
373720|NCT00925704|1259222|P1|First Intervention|Withdrew consent|0
373721|NCT00925600|1259235|P2|Overall Study|Adverse Event|2
373722|NCT00925600|1259236|P1|Overall Study|Adverse Event|1
373723|NCT00925600|1259235|P2|Overall Study|Other|1
373724|NCT00925600|1259236|P1|Overall Study|Other|3
373725|NCT00925600|1259235|P2|Overall Study|Requirement for Alternative Therapy|1
373726|NCT00925600|1259236|P1|Overall Study|Requirement for Alternative Therapy|0
373727|NCT00925600|1259235|P2|Overall Study|Protocol Deviation|1
373728|NCT00925600|1259236|P1|Overall Study|Protocol Deviation|0
373729|NCT00925600|1259235|P2|Overall Study|Ineligibility Determined|0
373730|NCT00925600|1259236|P1|Overall Study|Ineligibility Determined|2
373731|NCT00925600|1259235|P2|Overall Study|Noncompliance|0
373732|NCT00925600|1259236|P1|Overall Study|Noncompliance|2
373733|NCT00925600|1259235|P2|Overall Study|Administrative Decision|1
373734|NCT00925600|1259236|P1|Overall Study|Administrative Decision|1
373735|NCT00925600|1259235|P2|Overall Study|Disease Progression|3
373736|NCT00925600|1259236|P1|Overall Study|Disease Progression|1
373737|NCT00925600|1259235|P2|Overall Study|Lost to Follow-up|2
373738|NCT00925600|1259236|P1|Overall Study|Lost to Follow-up|2
373739|NCT00925600|1259235|P2|Overall Study|Death|3
373740|NCT00925600|1259236|P1|Overall Study|Death|4
373741|NCT00925600|1259235|P2|Overall Study|Withdrawal by Subject|14
373742|NCT00925600|1259236|P1|Overall Study|Withdrawal by Subject|16
373743|NCT00925587|1259258|P2|Overall Study|Lost to Follow-up|1
373744|NCT00925587|1259259|P1|Overall Study|Lost to Follow-up|0
373745|NCT00925587|1259258|P2|Overall Study|Adverse Event|2
373746|NCT00925587|1259259|P1|Overall Study|Adverse Event|6
373747|NCT00925587|1259258|P2|Overall Study|Death|5
373748|NCT00925587|1259259|P1|Overall Study|Death|5
373749|NCT00925587|1259258|P2|Overall Study|Withdrawal by Subject|6
373750|NCT00925587|1259259|P1|Overall Study|Withdrawal by Subject|9
373751|NCT00925587|1259258|P2|Overall Study|Protocol Violation|4
373752|NCT00925587|1259259|P1|Overall Study|Protocol Violation|6
373753|NCT00925587|1259258|P2|Overall Study|Physician Decision|1
373754|NCT00925587|1259259|P1|Overall Study|Physician Decision|4
373755|NCT00925587|1259258|P2|Overall Study|Protocol Specified Criteria|6
373756|NCT00925587|1259259|P1|Overall Study|Protocol Specified Criteria|6
373757|NCT00925548|1259373|P2|Overall Study|Discontinuation of trial by sponsor|5
373758|NCT00925548|1259374|P1|Overall Study|Discontinuation of trial by sponsor|10
373759|NCT00925353|1259404|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
373760|NCT00925288|1259410|P2|Overall Study|Lost to Follow-up|7
373761|NCT00925288|1259411|P1|Overall Study|Lost to Follow-up|9
373762|NCT00925132|1259423|P5|Overall Study|Removed due to disease progression|4
373763|NCT00925132|1259424|P4|Overall Study|Removed due to disease progression|0
373764|NCT00925132|1259425|P3|Overall Study|Removed due to disease progression|0
373765|NCT00925132|1259426|P2|Overall Study|Removed due to disease progression|0
373766|NCT00925132|1259427|P1|Overall Study|Removed due to disease progression|0
373767|NCT00925132|1259423|P5|Overall Study|Withdrawal by Subject|1
373768|NCT00925132|1259424|P4|Overall Study|Withdrawal by Subject|0
373769|NCT00925132|1259425|P3|Overall Study|Withdrawal by Subject|0
373770|NCT00925132|1259426|P2|Overall Study|Withdrawal by Subject|0
373771|NCT00925132|1259427|P1|Overall Study|Withdrawal by Subject|2
373772|NCT00925015|1259446|P3|Overall Study|Withdrawal by Subject|1
373773|NCT00925015|1259447|P2|Overall Study|Withdrawal by Subject|0
373774|NCT00925015|1259448|P1|Overall Study|Withdrawal by Subject|0
373775|NCT00925015|1259446|P3|Overall Study|Progressive Disease|4
373776|NCT00925015|1259447|P2|Overall Study|Progressive Disease|3
373777|NCT00925015|1259448|P1|Overall Study|Progressive Disease|7
373778|NCT00925015|1259446|P3|Overall Study|Physician Decision|0
373779|NCT00925015|1259447|P2|Overall Study|Physician Decision|1
373780|NCT00925015|1259448|P1|Overall Study|Physician Decision|0
373781|NCT00925015|1259446|P3|Overall Study|Adverse Event|1
373782|NCT00925015|1259447|P2|Overall Study|Adverse Event|2
373783|NCT00925015|1259448|P1|Overall Study|Adverse Event|1
373784|NCT00924950|1259504|P1|Overall Study|Lost to Follow-up|2
373785|NCT00924898|1259509|P1|Overall Study|Withdrawal by Subject|2
373786|NCT00924781|1259545|P2|Overall Study|Study terminated by sponsor|10
373787|NCT00924781|1259546|P1|Overall Study|Study terminated by sponsor|12
373788|NCT00924729|1259580|P2|Overall Study|Protocol Violation|0
373789|NCT00924729|1259581|P1|Overall Study|Protocol Violation|1
373790|NCT00924729|1259580|P2|Overall Study|insufficient volume for analysis|0
373791|NCT00924729|1259581|P1|Overall Study|insufficient volume for analysis|1
373792|NCT00924651|1259591|P2|Overall Study|Incomplete Form|1
373793|NCT00924651|1259592|P1|Overall Study|Incomplete Form|2
373794|NCT00924651|1259591|P2|Overall Study|Changed Mind|1
373795|NCT00924651|1259592|P1|Overall Study|Changed Mind|10
373796|NCT00924651|1259591|P2|Overall Study|Medical|3
373797|NCT00924651|1259592|P1|Overall Study|Medical|1
373798|NCT00924651|1259591|P2|Overall Study|Noncompliant|4
373799|NCT00924651|1259592|P1|Overall Study|Noncompliant|1
373800|NCT00924651|1259591|P2|Overall Study|Overwhelmed|6
373801|NCT00924651|1259592|P1|Overall Study|Overwhelmed|6
373802|NCT00924651|1259591|P2|Overall Study|No Reason|7
373803|NCT00924651|1259592|P1|Overall Study|No Reason|3
373804|NCT00924651|1259591|P2|Overall Study|Chemo started too soon|3
373805|NCT00924651|1259592|P1|Overall Study|Chemo started too soon|2
373806|NCT00924638|1259600|P2|Overall Study|Physician Decision|3
373807|NCT00924638|1259601|P1|Overall Study|Physician Decision|3
373808|NCT00924638|1259600|P2|Overall Study|Withdrawal by Subject|7
373809|NCT00924638|1259601|P1|Overall Study|Withdrawal by Subject|5
373810|NCT00924638|1259600|P2|Overall Study|Lost to Follow-up|1
373811|NCT00924638|1259601|P1|Overall Study|Lost to Follow-up|1
373812|NCT00924638|1259600|P2|Overall Study|Death|2
373813|NCT00924638|1259601|P1|Overall Study|Death|3
373814|NCT00924560|1259623|P3|Overall Study|Miscellaneous Reasons|10
373815|NCT00924560|1259624|P2|Overall Study|Miscellaneous Reasons|10
373816|NCT00924560|1259625|P1|Overall Study|Miscellaneous Reasons|13
373817|NCT00924560|1259623|P3|Overall Study|Lost to Follow-up|45
373818|NCT00924560|1259624|P2|Overall Study|Lost to Follow-up|94
373819|NCT00924560|1259625|P1|Overall Study|Lost to Follow-up|78
373820|NCT00924560|1259623|P3|Overall Study|Pregnancy|1
373821|NCT00924560|1259624|P2|Overall Study|Pregnancy|7
373822|NCT00924560|1259625|P1|Overall Study|Pregnancy|5
373823|NCT00924560|1259623|P3|Overall Study|Adverse Event|0
373824|NCT00924560|1259624|P2|Overall Study|Adverse Event|33
373825|NCT00924560|1259625|P1|Overall Study|Adverse Event|39
373826|NCT00924560|1259623|P3|Overall Study|Withdrawal by Subject|18
373827|NCT00924560|1259624|P2|Overall Study|Withdrawal by Subject|44
373828|NCT00924560|1259625|P1|Overall Study|Withdrawal by Subject|50
373829|NCT00924560|1259623|P3|Overall Study|Physician Decision|4
373830|NCT00924560|1259624|P2|Overall Study|Physician Decision|3
373831|NCT00924560|1259625|P1|Overall Study|Physician Decision|2
373832|NCT00924560|1259623|P3|Overall Study|Non Compliance with the Protocol|4
373833|NCT00924560|1259624|P2|Overall Study|Non Compliance with the Protocol|15
373834|NCT00924560|1259625|P1|Overall Study|Non Compliance with the Protocol|20
373835|NCT00924560|1259623|P3|Overall Study|Did Not Meet Protocol Requirements|1
373836|NCT00924560|1259624|P2|Overall Study|Did Not Meet Protocol Requirements|2
373837|NCT00924560|1259625|P1|Overall Study|Did Not Meet Protocol Requirements|4
373838|NCT00924508|1259669|P1|Overall Study|Withdrawal by Subject|3
373839|NCT00924469|1259683|P2|Overall Study|Lost to Follow-up|1
373840|NCT00924469|1259684|P1|Overall Study|Lost to Follow-up|0
373841|NCT00924469|1259683|P2|Overall Study|Withdrawal by Subject|1
373842|NCT00924469|1259684|P1|Overall Study|Withdrawal by Subject|0
373843|NCT00924469|1259683|P2|Overall Study|Adverse Event|0
373844|NCT00924469|1259684|P1|Overall Study|Adverse Event|2
373845|NCT00924443|1259706|P1|Overall Study|Protocol Violation|1
373846|NCT00924443|1259706|P1|Overall Study|Physician Decision|2
373847|NCT00924404|1259716|P2|Overall Study|Lost to Follow-up|4
373848|NCT00924404|1259717|P1|Overall Study|Lost to Follow-up|6
373849|NCT00924313|1259739|P1|Overall Study|not imaged due to failed tracer imaging|1
373850|NCT00924287|1259751|P1|Overall Study|Death|1
373851|NCT00924170|1259764|P2|Overall Study|Death|0
373852|NCT00924170|1259765|P1|Overall Study|Death|1
373853|NCT00924170|1259764|P2|Overall Study|Stopped due to neutralizing antibodies|0
373854|NCT00924170|1259765|P1|Overall Study|Stopped due to neutralizing antibodies|3
373855|NCT00924170|1259764|P2|Overall Study|Progressive disease|6
373856|NCT00924170|1259765|P1|Overall Study|Progressive disease|3
373857|NCT00924170|1259764|P2|Overall Study|Physician Decision|1
373858|NCT00924170|1259765|P1|Overall Study|Physician Decision|0
373859|NCT00924170|1259764|P2|Overall Study|Refused further treatment|1
373860|NCT00924170|1259765|P1|Overall Study|Refused further treatment|0
373861|NCT00923975|1259890|P1|Overall Study|Did not meet inclusion criteria|1
373862|NCT00923936|1259909|P2|Overall Study|Continuing in follow up period|1
373863|NCT00923936|1259910|P1|Overall Study|Continuing in follow up period|2
373864|NCT00923936|1259909|P2|Overall Study|Lost to follow up|0
373865|NCT00923936|1259910|P1|Overall Study|Lost to follow up|2
373866|NCT00923936|1259909|P2|Overall Study|Adverse Event|1
373867|NCT00923936|1259910|P1|Overall Study|Adverse Event|2
373868|NCT00923936|1259909|P2|Overall Study|progressive disease on study|1
373869|NCT00923936|1259910|P1|Overall Study|progressive disease on study|2
373870|NCT00923845|1259939|P2|Induction Therapy|Poor performance status|2
373871|NCT00923845|1259940|P1|Induction Therapy|Poor performance status|0
373872|NCT00923364|1259966|P2|Overall Study|Did not go to transplant|0
373873|NCT00923364|1259967|P1|Overall Study|Did not go to transplant|1
373874|NCT00923364|1259966|P2|Overall Study|Death|0
373875|NCT00923364|1259967|P1|Overall Study|Death|3
373876|NCT00923351|1259979|P3|Overall Study|no apheresis/adequate tumor sample|12
373877|NCT00923351|1259980|P2|Overall Study|no apheresis/adequate tumor sample|0
373878|NCT00923351|1259981|P1|Overall Study|no apheresis/adequate tumor sample|0
373879|NCT00923273|1259996|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
373880|NCT00923273|1259997|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
373881|NCT00923273|1259998|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
373882|NCT00923273|1259999|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
373883|NCT00923273|1260000|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
373884|NCT00923273|1259996|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
373885|NCT00923273|1259997|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
373886|NCT00923273|1259998|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
373887|NCT00923273|1259999|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
373888|NCT00923273|1260000|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
373889|NCT00923260|1260025|P2|Overall Study|Lost to Follow-up|1
373890|NCT00923260|1260026|P1|Overall Study|Lost to Follow-up|1
373891|NCT00923195|1260189|P2|Overall Study|Death|1
373892|NCT00923195|1260190|P1|Overall Study|Death|0
373893|NCT00923156|1260201|P3|Overall Study|Lack of Efficacy|1
373894|NCT00923156|1260202|P2|Overall Study|Lack of Efficacy|0
373895|NCT00923156|1260203|P1|Overall Study|Lack of Efficacy|0
373896|NCT00923156|1260201|P3|Overall Study|Death|0
373897|NCT00923156|1260202|P2|Overall Study|Death|1
373898|NCT00923156|1260203|P1|Overall Study|Death|0
373899|NCT00923156|1260201|P3|Overall Study|Withdrawal by Subject|0
373900|NCT00923156|1260202|P2|Overall Study|Withdrawal by Subject|1
373901|NCT00923156|1260203|P1|Overall Study|Withdrawal by Subject|0
373902|NCT00923156|1260201|P3|Overall Study|Abnormal laboratory values|1
373903|NCT00923156|1260202|P2|Overall Study|Abnormal laboratory values|0
373904|NCT00923156|1260203|P1|Overall Study|Abnormal laboratory values|0
373905|NCT00923156|1260201|P3|Overall Study|Adverse Event|1
373906|NCT00923156|1260202|P2|Overall Study|Adverse Event|2
373907|NCT00923156|1260203|P1|Overall Study|Adverse Event|0
373908|NCT00923130|1260229|P1|Overall Study|Refused further treatment|2
373909|NCT00923130|1260229|P1|Overall Study|Switched to alternative treatment|2
373910|NCT00923130|1260229|P1|Overall Study|Discontinued treatment due to toxicities|3
373911|NCT00923130|1260229|P1|Overall Study|Death|1
373912|NCT00923130|1260229|P1|Overall Study|Stopped treatment due to progression|17
373913|NCT00923091|1260264|P13|Period VI (Open-Label)|Other Reason|0
373914|NCT00923091|1260265|P12|Period VI (Open-Label)|Other Reason|0
373915|NCT00923091|1260266|P11|Period VI (Open-Label)|Other Reason|0
373916|NCT00923091|1260267|P10|Period VI (Open-Label)|Other Reason|0
373917|NCT00923091|1260268|P9|Period VI (Open-Label)|Other Reason|0
373918|NCT00923091|1260269|P8|Period VI (Open-Label)|Other Reason|0
373919|NCT00923091|1260270|P7|Period VI (Open-Label)|Other Reason|0
373920|NCT00923091|1260271|P6|Period VI (Open-Label)|Other Reason|0
373921|NCT00923091|1260272|P5|Period VI (Open-Label)|Other Reason|1
373922|NCT00923091|1260273|P4|Period VI (Open-Label)|Other Reason|1
373923|NCT00923091|1260274|P3|Period VI (Open-Label)|Other Reason|0
373924|NCT00923091|1260275|P2|Period VI (Open-Label)|Other Reason|0
373925|NCT00923091|1260276|P1|Period VI (Open-Label)|Other Reason|0
373926|NCT00923091|1260264|P13|Period VI (Open-Label)|Lost to Follow-up|0
373927|NCT00923091|1260265|P12|Period VI (Open-Label)|Lost to Follow-up|0
373928|NCT00923091|1260266|P11|Period VI (Open-Label)|Lost to Follow-up|0
373929|NCT00923091|1260267|P10|Period VI (Open-Label)|Lost to Follow-up|0
373930|NCT00923091|1260268|P9|Period VI (Open-Label)|Lost to Follow-up|0
373931|NCT00923091|1260269|P8|Period VI (Open-Label)|Lost to Follow-up|0
373932|NCT00923091|1260270|P7|Period VI (Open-Label)|Lost to Follow-up|0
373933|NCT00923091|1260271|P6|Period VI (Open-Label)|Lost to Follow-up|0
373934|NCT00923091|1260272|P5|Period VI (Open-Label)|Lost to Follow-up|0
373935|NCT00923091|1260273|P4|Period VI (Open-Label)|Lost to Follow-up|0
373936|NCT00923091|1260274|P3|Period VI (Open-Label)|Lost to Follow-up|1
373937|NCT00923091|1260275|P2|Period VI (Open-Label)|Lost to Follow-up|0
373938|NCT00923091|1260276|P1|Period VI (Open-Label)|Lost to Follow-up|1
373939|NCT00923091|1260264|P13|Period VI (Open-Label)|Protocol Violation|0
373940|NCT00923091|1260265|P12|Period VI (Open-Label)|Protocol Violation|0
373941|NCT00923091|1260266|P11|Period VI (Open-Label)|Protocol Violation|0
373942|NCT00923091|1260267|P10|Period VI (Open-Label)|Protocol Violation|0
373943|NCT00923091|1260268|P9|Period VI (Open-Label)|Protocol Violation|0
373944|NCT00923091|1260269|P8|Period VI (Open-Label)|Protocol Violation|0
373945|NCT00923091|1260270|P7|Period VI (Open-Label)|Protocol Violation|0
373946|NCT00923091|1260271|P6|Period VI (Open-Label)|Protocol Violation|0
373947|NCT00923091|1260272|P5|Period VI (Open-Label)|Protocol Violation|4
373948|NCT00923091|1260273|P4|Period VI (Open-Label)|Protocol Violation|1
373949|NCT00923091|1260274|P3|Period VI (Open-Label)|Protocol Violation|3
373950|NCT00923091|1260275|P2|Period VI (Open-Label)|Protocol Violation|1
373951|NCT00923091|1260276|P1|Period VI (Open-Label)|Protocol Violation|6
373952|NCT00923091|1260264|P13|Period VI (Open-Label)|Withdrawal by Subject|0
373953|NCT00923091|1260265|P12|Period VI (Open-Label)|Withdrawal by Subject|0
373954|NCT00923091|1260266|P11|Period VI (Open-Label)|Withdrawal by Subject|0
373955|NCT00923091|1260267|P10|Period VI (Open-Label)|Withdrawal by Subject|0
373956|NCT00923091|1260268|P9|Period VI (Open-Label)|Withdrawal by Subject|0
373957|NCT00923091|1260269|P8|Period VI (Open-Label)|Withdrawal by Subject|0
373958|NCT00923091|1260270|P7|Period VI (Open-Label)|Withdrawal by Subject|0
373959|NCT00923091|1260271|P6|Period VI (Open-Label)|Withdrawal by Subject|0
373960|NCT00923091|1260272|P5|Period VI (Open-Label)|Withdrawal by Subject|1
373961|NCT00923091|1260273|P4|Period VI (Open-Label)|Withdrawal by Subject|0
373962|NCT00923091|1260274|P3|Period VI (Open-Label)|Withdrawal by Subject|5
373963|NCT00923091|1260275|P2|Period VI (Open-Label)|Withdrawal by Subject|7
373964|NCT00923091|1260276|P1|Period VI (Open-Label)|Withdrawal by Subject|15
373965|NCT00923091|1260264|P13|Period VI (Open-Label)|Adverse Event|0
373966|NCT00923091|1260265|P12|Period VI (Open-Label)|Adverse Event|0
373967|NCT00923091|1260266|P11|Period VI (Open-Label)|Adverse Event|0
373968|NCT00923091|1260267|P10|Period VI (Open-Label)|Adverse Event|0
373969|NCT00923091|1260268|P9|Period VI (Open-Label)|Adverse Event|0
373970|NCT00923091|1260269|P8|Period VI (Open-Label)|Adverse Event|0
373971|NCT00923091|1260270|P7|Period VI (Open-Label)|Adverse Event|0
373972|NCT00923091|1260271|P6|Period VI (Open-Label)|Adverse Event|0
373973|NCT00923091|1260272|P5|Period VI (Open-Label)|Adverse Event|1
373974|NCT00923091|1260273|P4|Period VI (Open-Label)|Adverse Event|1
373975|NCT00923091|1260274|P3|Period VI (Open-Label)|Adverse Event|4
373976|NCT00923091|1260275|P2|Period VI (Open-Label)|Adverse Event|0
373977|NCT00923091|1260276|P1|Period VI (Open-Label)|Adverse Event|17
373978|NCT00923091|1260264|P13|Period V (Double -Blind)|Lost to Follow-up|0
373979|NCT00923091|1260265|P12|Period V (Double -Blind)|Lost to Follow-up|0
373980|NCT00923091|1260266|P11|Period V (Double -Blind)|Lost to Follow-up|1
373981|NCT00923091|1260267|P10|Period V (Double -Blind)|Lost to Follow-up|0
373982|NCT00923091|1260268|P9|Period V (Double -Blind)|Lost to Follow-up|0
373983|NCT00923091|1260269|P8|Period V (Double -Blind)|Lost to Follow-up|0
373984|NCT00923091|1260270|P7|Period V (Double -Blind)|Lost to Follow-up|0
373985|NCT00923091|1260271|P6|Period V (Double -Blind)|Lost to Follow-up|0
373986|NCT00923091|1260272|P5|Period V (Double -Blind)|Lost to Follow-up|0
373987|NCT00923091|1260273|P4|Period V (Double -Blind)|Lost to Follow-up|0
373988|NCT00923091|1260274|P3|Period V (Double -Blind)|Lost to Follow-up|0
373989|NCT00923091|1260275|P2|Period V (Double -Blind)|Lost to Follow-up|0
373990|NCT00923091|1260276|P1|Period V (Double -Blind)|Lost to Follow-up|0
373991|NCT00923091|1260264|P13|Period V (Double -Blind)|Protocol Violation|1
373992|NCT00923091|1260265|P12|Period V (Double -Blind)|Protocol Violation|0
373993|NCT00923091|1260266|P11|Period V (Double -Blind)|Protocol Violation|0
373994|NCT00923091|1260267|P10|Period V (Double -Blind)|Protocol Violation|0
373995|NCT00923091|1260268|P9|Period V (Double -Blind)|Protocol Violation|0
373996|NCT00923091|1260269|P8|Period V (Double -Blind)|Protocol Violation|0
373997|NCT00923091|1260270|P7|Period V (Double -Blind)|Protocol Violation|0
373998|NCT00923091|1260271|P6|Period V (Double -Blind)|Protocol Violation|0
373999|NCT00923091|1260272|P5|Period V (Double -Blind)|Protocol Violation|0
374000|NCT00923091|1260273|P4|Period V (Double -Blind)|Protocol Violation|0
374001|NCT00923091|1260274|P3|Period V (Double -Blind)|Protocol Violation|0
374002|NCT00923091|1260275|P2|Period V (Double -Blind)|Protocol Violation|0
374003|NCT00923091|1260276|P1|Period V (Double -Blind)|Protocol Violation|0
374004|NCT00923091|1260264|P13|Period V (Double -Blind)|Withdrawal by Subject|1
374005|NCT00923091|1260265|P12|Period V (Double -Blind)|Withdrawal by Subject|0
374006|NCT00923091|1260266|P11|Period V (Double -Blind)|Withdrawal by Subject|0
374007|NCT00923091|1260267|P10|Period V (Double -Blind)|Withdrawal by Subject|0
374008|NCT00923091|1260268|P9|Period V (Double -Blind)|Withdrawal by Subject|1
374009|NCT00923091|1260269|P8|Period V (Double -Blind)|Withdrawal by Subject|0
374010|NCT00923091|1260270|P7|Period V (Double -Blind)|Withdrawal by Subject|0
374011|NCT00923091|1260271|P6|Period V (Double -Blind)|Withdrawal by Subject|0
374012|NCT00923091|1260272|P5|Period V (Double -Blind)|Withdrawal by Subject|0
374013|NCT00923091|1260273|P4|Period V (Double -Blind)|Withdrawal by Subject|0
374014|NCT00923091|1260274|P3|Period V (Double -Blind)|Withdrawal by Subject|0
374015|NCT00923091|1260275|P2|Period V (Double -Blind)|Withdrawal by Subject|0
374016|NCT00923091|1260276|P1|Period V (Double -Blind)|Withdrawal by Subject|0
374017|NCT00923091|1260264|P13|Period IV (Double-Blind)|Protocol Violation|0
374018|NCT00923091|1260265|P12|Period IV (Double-Blind)|Protocol Violation|0
374019|NCT00923091|1260266|P11|Period IV (Double-Blind)|Protocol Violation|0
374020|NCT00923091|1260267|P10|Period IV (Double-Blind)|Protocol Violation|0
374021|NCT00923091|1260268|P9|Period IV (Double-Blind)|Protocol Violation|0
374022|NCT00923091|1260269|P8|Period IV (Double-Blind)|Protocol Violation|0
374023|NCT00923091|1260270|P7|Period IV (Double-Blind)|Protocol Violation|0
374024|NCT00923091|1260271|P6|Period IV (Double-Blind)|Protocol Violation|0
374025|NCT00923091|1260272|P5|Period IV (Double-Blind)|Protocol Violation|0
374026|NCT00923091|1260273|P4|Period IV (Double-Blind)|Protocol Violation|0
374027|NCT00923091|1260274|P3|Period IV (Double-Blind)|Protocol Violation|0
374028|NCT00923091|1260275|P2|Period IV (Double-Blind)|Protocol Violation|1
374029|NCT00923091|1260276|P1|Period IV (Double-Blind)|Protocol Violation|0
374030|NCT00923091|1260264|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
374031|NCT00923091|1260265|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
374032|NCT00923091|1260266|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
374033|NCT00923091|1260267|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
374034|NCT00923091|1260268|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
374035|NCT00923091|1260269|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
374036|NCT00923091|1260270|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
374037|NCT00923091|1260271|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
374038|NCT00923091|1260272|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
374039|NCT00923091|1260273|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
374040|NCT00923091|1260274|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
374041|NCT00923091|1260275|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
374042|NCT00923091|1260276|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
374043|NCT00923091|1260264|P13|Period IV (Double-Blind)|Adverse Event|0
374044|NCT00923091|1260265|P12|Period IV (Double-Blind)|Adverse Event|0
374045|NCT00923091|1260266|P11|Period IV (Double-Blind)|Adverse Event|0
374046|NCT00923091|1260267|P10|Period IV (Double-Blind)|Adverse Event|0
374047|NCT00923091|1260268|P9|Period IV (Double-Blind)|Adverse Event|0
374048|NCT00923091|1260269|P8|Period IV (Double-Blind)|Adverse Event|0
374049|NCT00923091|1260270|P7|Period IV (Double-Blind)|Adverse Event|0
374050|NCT00923091|1260271|P6|Period IV (Double-Blind)|Adverse Event|0
374051|NCT00923091|1260272|P5|Period IV (Double-Blind)|Adverse Event|0
374052|NCT00923091|1260273|P4|Period IV (Double-Blind)|Adverse Event|0
374053|NCT00923091|1260274|P3|Period IV (Double-Blind)|Adverse Event|0
374054|NCT00923091|1260275|P2|Period IV (Double-Blind)|Adverse Event|0
374055|NCT00923091|1260276|P1|Period IV (Double-Blind)|Adverse Event|2
374056|NCT00923091|1260264|P13|Period III (Single-Blind)|Lost to Follow-up|0
374057|NCT00923091|1260265|P12|Period III (Single-Blind)|Lost to Follow-up|0
374058|NCT00923091|1260266|P11|Period III (Single-Blind)|Lost to Follow-up|0
374059|NCT00923091|1260267|P10|Period III (Single-Blind)|Lost to Follow-up|0
374060|NCT00923091|1260268|P9|Period III (Single-Blind)|Lost to Follow-up|0
374061|NCT00923091|1260269|P8|Period III (Single-Blind)|Lost to Follow-up|0
374062|NCT00923091|1260270|P7|Period III (Single-Blind)|Lost to Follow-up|0
374063|NCT00923091|1260271|P6|Period III (Single-Blind)|Lost to Follow-up|0
374064|NCT00923091|1260272|P5|Period III (Single-Blind)|Lost to Follow-up|0
374065|NCT00923091|1260273|P4|Period III (Single-Blind)|Lost to Follow-up|0
374066|NCT00923091|1260274|P3|Period III (Single-Blind)|Lost to Follow-up|0
374067|NCT00923091|1260275|P2|Period III (Single-Blind)|Lost to Follow-up|0
374068|NCT00923091|1260276|P1|Period III (Single-Blind)|Lost to Follow-up|2
374069|NCT00923091|1260264|P13|Period III (Single-Blind)|Protocol Violation|0
374070|NCT00923091|1260265|P12|Period III (Single-Blind)|Protocol Violation|0
374071|NCT00923091|1260266|P11|Period III (Single-Blind)|Protocol Violation|0
374072|NCT00923091|1260267|P10|Period III (Single-Blind)|Protocol Violation|0
374073|NCT00923091|1260268|P9|Period III (Single-Blind)|Protocol Violation|0
374074|NCT00923091|1260269|P8|Period III (Single-Blind)|Protocol Violation|0
374075|NCT00923091|1260270|P7|Period III (Single-Blind)|Protocol Violation|0
374076|NCT00923091|1260271|P6|Period III (Single-Blind)|Protocol Violation|0
374077|NCT00923091|1260272|P5|Period III (Single-Blind)|Protocol Violation|0
374078|NCT00923091|1260273|P4|Period III (Single-Blind)|Protocol Violation|0
374079|NCT00923091|1260274|P3|Period III (Single-Blind)|Protocol Violation|0
374080|NCT00923091|1260275|P2|Period III (Single-Blind)|Protocol Violation|0
374081|NCT00923091|1260276|P1|Period III (Single-Blind)|Protocol Violation|3
374082|NCT00923091|1260264|P13|Period III (Single-Blind)|Withdrawal by Subject|0
374083|NCT00923091|1260265|P12|Period III (Single-Blind)|Withdrawal by Subject|0
374084|NCT00923091|1260266|P11|Period III (Single-Blind)|Withdrawal by Subject|0
374085|NCT00923091|1260267|P10|Period III (Single-Blind)|Withdrawal by Subject|0
374086|NCT00923091|1260268|P9|Period III (Single-Blind)|Withdrawal by Subject|0
374087|NCT00923091|1260269|P8|Period III (Single-Blind)|Withdrawal by Subject|0
374088|NCT00923091|1260270|P7|Period III (Single-Blind)|Withdrawal by Subject|0
374089|NCT00923091|1260271|P6|Period III (Single-Blind)|Withdrawal by Subject|0
374090|NCT00923091|1260272|P5|Period III (Single-Blind)|Withdrawal by Subject|0
374091|NCT00923091|1260273|P4|Period III (Single-Blind)|Withdrawal by Subject|0
374092|NCT00923091|1260274|P3|Period III (Single-Blind)|Withdrawal by Subject|0
374093|NCT00923091|1260275|P2|Period III (Single-Blind)|Withdrawal by Subject|0
374094|NCT00923091|1260276|P1|Period III (Single-Blind)|Withdrawal by Subject|10
374095|NCT00923091|1260264|P13|Period III (Single-Blind)|Adverse Event|0
374096|NCT00923091|1260265|P12|Period III (Single-Blind)|Adverse Event|0
374097|NCT00923091|1260266|P11|Period III (Single-Blind)|Adverse Event|0
374098|NCT00923091|1260267|P10|Period III (Single-Blind)|Adverse Event|0
374099|NCT00923091|1260268|P9|Period III (Single-Blind)|Adverse Event|0
374100|NCT00923091|1260269|P8|Period III (Single-Blind)|Adverse Event|0
374101|NCT00923091|1260270|P7|Period III (Single-Blind)|Adverse Event|0
374102|NCT00923091|1260271|P6|Period III (Single-Blind)|Adverse Event|0
374103|NCT00923091|1260272|P5|Period III (Single-Blind)|Adverse Event|0
374104|NCT00923091|1260273|P4|Period III (Single-Blind)|Adverse Event|0
374105|NCT00923091|1260274|P3|Period III (Single-Blind)|Adverse Event|0
374106|NCT00923091|1260275|P2|Period III (Single-Blind)|Adverse Event|0
374107|NCT00923091|1260276|P1|Period III (Single-Blind)|Adverse Event|5
374108|NCT00923091|1260264|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374109|NCT00923091|1260265|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374110|NCT00923091|1260266|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374111|NCT00923091|1260267|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374112|NCT00923091|1260268|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374113|NCT00923091|1260269|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374114|NCT00923091|1260270|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374115|NCT00923091|1260271|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
374116|NCT00923091|1260272|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374117|NCT00923091|1260273|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
374118|NCT00923091|1260274|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374119|NCT00923091|1260275|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
374120|NCT00923091|1260276|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
374121|NCT00923091|1260264|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374122|NCT00923091|1260265|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374123|NCT00923091|1260266|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374124|NCT00923091|1260267|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374125|NCT00923091|1260268|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374126|NCT00923091|1260269|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374127|NCT00923091|1260270|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374128|NCT00923091|1260271|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
374129|NCT00923091|1260272|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374130|NCT00923091|1260273|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374131|NCT00923091|1260274|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374132|NCT00923091|1260275|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374133|NCT00923091|1260276|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
374134|NCT00923091|1260264|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
374135|NCT00923091|1260265|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
374136|NCT00923091|1260266|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
374137|NCT00923091|1260267|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
374138|NCT00923091|1260268|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
374139|NCT00923091|1260269|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
374140|NCT00923091|1260270|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
374141|NCT00923091|1260271|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
374142|NCT00923091|1260272|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
374143|NCT00923091|1260273|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
374144|NCT00923091|1260274|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
374145|NCT00923091|1260275|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
374146|NCT00923091|1260276|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
374147|NCT00923091|1260264|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
374148|NCT00923091|1260265|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
374149|NCT00923091|1260266|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
374150|NCT00923091|1260267|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
374151|NCT00923091|1260268|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
374152|NCT00923091|1260269|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
374153|NCT00923091|1260270|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
374154|NCT00923091|1260271|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
374155|NCT00923091|1260272|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
374156|NCT00923091|1260273|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
374157|NCT00923091|1260274|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
374158|NCT00923091|1260275|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
374159|NCT00923091|1260276|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
374160|NCT00923091|1260264|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
374161|NCT00923091|1260265|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
374162|NCT00923091|1260266|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
374163|NCT00923091|1260267|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
374164|NCT00923091|1260268|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
374165|NCT00923091|1260269|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
374166|NCT00923091|1260270|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
374167|NCT00923091|1260271|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
374168|NCT00923091|1260272|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
374169|NCT00923091|1260273|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
374170|NCT00923091|1260274|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
374171|NCT00923091|1260275|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
374172|NCT00923091|1260276|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
374173|NCT00923078|1260326|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
374174|NCT00923078|1260327|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
374175|NCT00923078|1260328|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
374176|NCT00923078|1260326|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
374177|NCT00923078|1260327|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
374178|NCT00923078|1260328|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
374179|NCT00922987|1260347|P1|Overall Study|Adverse Event|1
374180|NCT00922987|1260347|P1|Overall Study|Protocol Violation|2
374181|NCT00922987|1260347|P1|Overall Study|Insufficient clinical response|1
374182|NCT00922935|1260362|P3|Overall Study|Lost to Follow-up|0
374183|NCT00922935|1260363|P2|Overall Study|Lost to Follow-up|1
374184|NCT00922935|1260364|P1|Overall Study|Lost to Follow-up|0
374185|NCT00922935|1260362|P3|Overall Study|Physician Decision|0
374186|NCT00922935|1260363|P2|Overall Study|Physician Decision|1
374187|NCT00922935|1260364|P1|Overall Study|Physician Decision|1
374188|NCT00922935|1260362|P3|Overall Study|Protocol Violation|0
374189|NCT00922935|1260363|P2|Overall Study|Protocol Violation|3
374190|NCT00922935|1260364|P1|Overall Study|Protocol Violation|0
374191|NCT00922779|1260372|P1|Overall Study|Missing|1874
374192|NCT00922779|1260372|P1|Overall Study|Other|27
374193|NCT00922779|1260372|P1|Overall Study|Lost to Follow-up|44
374194|NCT00922779|1260372|P1|Overall Study|Withdrawal by Subject|308
374195|NCT00922779|1260372|P1|Overall Study|Pregnancy|7
374196|NCT00922779|1260372|P1|Overall Study|Adverse Event|67
374197|NCT00922766|1260379|P1|Overall Study|Adverse Event|1
374198|NCT00922766|1260379|P1|Overall Study|Other|1
374199|NCT00922766|1260379|P1|Overall Study|Withdrawal by Subject|2
374200|NCT00922766|1260379|P1|Overall Study|Death|3
374201|NCT00922636|1260397|P5|Overall Study|Lost to Follow-up|4
374202|NCT00922636|1260398|P4|Overall Study|Lost to Follow-up|2
374203|NCT00922636|1260399|P3|Overall Study|Lost to Follow-up|2
374204|NCT00922636|1260400|P2|Overall Study|Lost to Follow-up|2
374205|NCT00922636|1260401|P1|Overall Study|Lost to Follow-up|1
374206|NCT00922636|1260397|P5|Overall Study|Parent/Caregiver Decision|2
374207|NCT00922636|1260398|P4|Overall Study|Parent/Caregiver Decision|5
374208|NCT00922636|1260399|P3|Overall Study|Parent/Caregiver Decision|3
374209|NCT00922636|1260400|P2|Overall Study|Parent/Caregiver Decision|4
374210|NCT00922636|1260401|P1|Overall Study|Parent/Caregiver Decision|2
374211|NCT00922636|1260397|P5|Overall Study|Entry Criteria Not Met|0
374212|NCT00922636|1260398|P4|Overall Study|Entry Criteria Not Met|1
374213|NCT00922636|1260399|P3|Overall Study|Entry Criteria Not Met|1
374214|NCT00922636|1260400|P2|Overall Study|Entry Criteria Not Met|0
374215|NCT00922636|1260401|P1|Overall Study|Entry Criteria Not Met|0
374216|NCT00922636|1260397|P5|Overall Study|Protocol Violation|0
374217|NCT00922636|1260398|P4|Overall Study|Protocol Violation|2
374218|NCT00922636|1260399|P3|Overall Study|Protocol Violation|2
374219|NCT00922636|1260400|P2|Overall Study|Protocol Violation|0
374220|NCT00922636|1260401|P1|Overall Study|Protocol Violation|0
374221|NCT00922636|1260397|P5|Overall Study|Withdrawal by Subject|4
374222|NCT00922636|1260398|P4|Overall Study|Withdrawal by Subject|2
374223|NCT00922636|1260399|P3|Overall Study|Withdrawal by Subject|5
374224|NCT00922636|1260400|P2|Overall Study|Withdrawal by Subject|0
374225|NCT00922636|1260401|P1|Overall Study|Withdrawal by Subject|0
374226|NCT00922636|1260397|P5|Overall Study|Sponsor Decision|0
374227|NCT00922636|1260398|P4|Overall Study|Sponsor Decision|0
374228|NCT00922636|1260399|P3|Overall Study|Sponsor Decision|2
374229|NCT00922636|1260400|P2|Overall Study|Sponsor Decision|0
374230|NCT00922636|1260401|P1|Overall Study|Sponsor Decision|0
374231|NCT00922636|1260397|P5|Overall Study|Lack of Efficacy|4
374232|NCT00922636|1260398|P4|Overall Study|Lack of Efficacy|2
374233|NCT00922636|1260399|P3|Overall Study|Lack of Efficacy|3
374234|NCT00922636|1260400|P2|Overall Study|Lack of Efficacy|7
374235|NCT00922636|1260401|P1|Overall Study|Lack of Efficacy|1
374236|NCT00922636|1260397|P5|Overall Study|Adverse Event|2
374237|NCT00922636|1260398|P4|Overall Study|Adverse Event|3
374238|NCT00922636|1260399|P3|Overall Study|Adverse Event|2
374239|NCT00922636|1260400|P2|Overall Study|Adverse Event|3
374240|NCT00922636|1260401|P1|Overall Study|Adverse Event|3
374241|NCT00922623|1260548|P1|Overall Study|Lost to Follow-up|1
374242|NCT00922623|1260548|P1|Overall Study|Other|4
374243|NCT00922480|1260556|P2|Extension Study|Others|1
374244|NCT00922480|1260557|P1|Extension Study|Others|0
374245|NCT00922480|1260556|P2|Extension Study|Withdrawal by Subject|1
374246|NCT00922480|1260557|P1|Extension Study|Withdrawal by Subject|1
374247|NCT00922480|1260556|P2|Extension Study|Adverse Event|1
374248|NCT00922480|1260557|P1|Extension Study|Adverse Event|1
374249|NCT00922480|1260556|P2|Extension Study|Protocol Violation|0
374250|NCT00922480|1260557|P1|Extension Study|Protocol Violation|3
374251|NCT00922480|1260556|P2|Main Study|Physician Decision|1
374252|NCT00922480|1260557|P1|Main Study|Physician Decision|0
374253|NCT00922480|1260556|P2|Main Study|Lost to Follow-up|0
374254|NCT00922480|1260557|P1|Main Study|Lost to Follow-up|5
374255|NCT00922480|1260556|P2|Main Study|Withdrawal by Subject|15
374256|NCT00922480|1260557|P1|Main Study|Withdrawal by Subject|20
374257|NCT00922480|1260556|P2|Main Study|Lack of Efficacy|0
374258|NCT00922480|1260557|P1|Main Study|Lack of Efficacy|3
374259|NCT00922480|1260556|P2|Main Study|Adverse Event|7
374260|NCT00922480|1260557|P1|Main Study|Adverse Event|6
374261|NCT00922480|1260556|P2|Main Study|Protocol Violation|6
374262|NCT00922480|1260557|P1|Main Study|Protocol Violation|3
374263|NCT00922441|1260568|P3|Overall Study|Withdrawal by Subject|1
374264|NCT00922441|1260569|P2|Overall Study|Withdrawal by Subject|0
374265|NCT00922441|1260570|P1|Overall Study|Withdrawal by Subject|0
374266|NCT00922441|1260568|P3|Overall Study|Protocol Violation|2
374267|NCT00922441|1260569|P2|Overall Study|Protocol Violation|0
374268|NCT00922441|1260570|P1|Overall Study|Protocol Violation|0
374269|NCT00922428|1260578|P1|Overall Study|no medication use or questionable use|13
374270|NCT00922428|1260578|P1|Overall Study|retrospective/extremely implausible data|2
374271|NCT00922272|1260607|P2|Double-blind Phase|Positive urine drug screen|1
374272|NCT00922272|1260608|P1|Double-blind Phase|Positive urine drug screen|1
374273|NCT00922272|1260607|P2|Double-blind Phase|Noncompliance|1
374274|NCT00922272|1260608|P1|Double-blind Phase|Noncompliance|1
374275|NCT00922272|1260607|P2|Double-blind Phase|Withdrawal criteria met|1
374276|NCT00922272|1260608|P1|Double-blind Phase|Withdrawal criteria met|1
374277|NCT00922272|1260607|P2|Double-blind Phase|Lost to Follow-up|1
374278|NCT00922272|1260608|P1|Double-blind Phase|Lost to Follow-up|2
374279|NCT00922272|1260607|P2|Double-blind Phase|Withdrawal by Subject|1
374280|NCT00922272|1260608|P1|Double-blind Phase|Withdrawal by Subject|1
374281|NCT00922272|1260607|P2|Double-blind Phase|Adverse Event|1
374282|NCT00922272|1260608|P1|Double-blind Phase|Adverse Event|1
374283|NCT00922272|1260607|P2|Open-label Phase|Withdrawal criteria met|0
374284|NCT00922272|1260608|P1|Open-label Phase|Withdrawal criteria met|5
374285|NCT00922272|1260607|P2|Open-label Phase|Failure to meet randomization criteria|0
374286|NCT00922272|1260608|P1|Open-label Phase|Failure to meet randomization criteria|1
374287|NCT00922272|1260607|P2|Open-label Phase|Withdrawal by Subject|0
374288|NCT00922272|1260608|P1|Open-label Phase|Withdrawal by Subject|11
374289|NCT00922272|1260607|P2|Open-label Phase|Protocol Violation|0
374290|NCT00922272|1260608|P1|Open-label Phase|Protocol Violation|1
374291|NCT00922272|1260607|P2|Open-label Phase|Adverse Event|0
374292|NCT00922272|1260608|P1|Open-label Phase|Adverse Event|5
374293|NCT00922207|1260673|P3|Overall Study|Abnormality of Laboratory Test|1
374294|NCT00922207|1260674|P2|Overall Study|Abnormality of Laboratory Test|1
374295|NCT00922207|1260675|P1|Overall Study|Abnormality of Laboratory Test|0
374296|NCT00922207|1260673|P3|Overall Study|Withdrew Consent|2
374297|NCT00922207|1260674|P2|Overall Study|Withdrew Consent|5
374298|NCT00922207|1260675|P1|Overall Study|Withdrew Consent|2
374299|NCT00922207|1260673|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
374300|NCT00922207|1260674|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
374301|NCT00922207|1260675|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
374302|NCT00922207|1260673|P3|Overall Study|Violation of Selection Criteria at Entry|0
374303|NCT00922207|1260674|P2|Overall Study|Violation of Selection Criteria at Entry|1
374304|NCT00922207|1260675|P1|Overall Study|Violation of Selection Criteria at Entry|0
374305|NCT00922207|1260673|P3|Overall Study|Insufficient Therapeutic Response|1
374306|NCT00922207|1260674|P2|Overall Study|Insufficient Therapeutic Response|0
374307|NCT00922207|1260675|P1|Overall Study|Insufficient Therapeutic Response|0
374308|NCT00922207|1260673|P3|Overall Study|Adverse Event/Intercurrent Illness|0
374309|NCT00922207|1260674|P2|Overall Study|Adverse Event/Intercurrent Illness|0
374310|NCT00922207|1260675|P1|Overall Study|Adverse Event/Intercurrent Illness|3
374311|NCT00922116|1260711|P1|Overall Study|Other|5
374312|NCT00922116|1260711|P1|Overall Study|Withdrawal by Subject|4
374313|NCT00922116|1260711|P1|Overall Study|Lost to Follow-up|1
374314|NCT00922116|1260711|P1|Overall Study|Death|1
374315|NCT00922116|1260711|P1|Overall Study|Adverse Event|4
374316|NCT00921557|1260756|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
374317|NCT00921557|1260757|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
374318|NCT00921557|1260758|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
374319|NCT00921557|1260756|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
374320|NCT00921557|1260757|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
374321|NCT00921557|1260758|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
374322|NCT00921557|1260756|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
374323|NCT00921557|1260757|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
374324|NCT00921557|1260758|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
374325|NCT00921557|1260756|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
374326|NCT00921557|1260757|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
374327|NCT00921557|1260758|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
374328|NCT00921557|1260756|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
374329|NCT00921557|1260757|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
374330|NCT00921557|1260758|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
374331|NCT00921024|1260860|P2|Overall Study|Withdrawal by Subject|3
374332|NCT00921024|1260861|P1|Overall Study|Withdrawal by Subject|0
374333|NCT00921024|1260860|P2|Overall Study|Received concomittant therapy|0
374334|NCT00921024|1260861|P1|Overall Study|Received concomittant therapy|2
374335|NCT00921024|1260860|P2|Overall Study|Lost to Follow-up|0
374336|NCT00921024|1260861|P1|Overall Study|Lost to Follow-up|2
374337|NCT00920907|1260871|P2|Maintenance Period|Adverse Event|1
374338|NCT00920907|1260872|P1|Maintenance Period|Adverse Event|0
374339|NCT00920907|1260871|P2|Maintenance Period|Withdrawal by Subject|0
374340|NCT00920907|1260872|P1|Maintenance Period|Withdrawal by Subject|1
374341|NCT00920907|1260871|P2|Maintenance Period|Death|1
374342|NCT00920907|1260872|P1|Maintenance Period|Death|1
374343|NCT00920907|1260871|P2|Maintenance Period|Study Drug Toxicity|2
374344|NCT00920907|1260872|P1|Maintenance Period|Study Drug Toxicity|0
374345|NCT00920907|1260871|P2|Maintenance Period|Administrative (study closure)|2
374346|NCT00920907|1260872|P1|Maintenance Period|Administrative (study closure)|7
374347|NCT00920907|1260871|P2|Maintenance Period|Disease Progression|7
374348|NCT00920907|1260872|P1|Maintenance Period|Disease Progression|3
374349|NCT00920907|1260871|P2|Induction Period|Withdrawal by Subject|1
374350|NCT00920907|1260872|P1|Induction Period|Withdrawal by Subject|1
374351|NCT00920907|1260871|P2|Induction Period|No longer meets study criteria|1
374352|NCT00920907|1260872|P1|Induction Period|No longer meets study criteria|0
374353|NCT00920907|1260871|P2|Induction Period|Study Drug Toxicity|6
374354|NCT00920907|1260872|P1|Induction Period|Study Drug Toxicity|8
374355|NCT00920907|1260871|P2|Induction Period|Disease Progression|11
374356|NCT00920907|1260872|P1|Induction Period|Disease Progression|12
374357|NCT00920907|1260871|P2|Induction Period|Death|1
374358|NCT00920907|1260872|P1|Induction Period|Death|1
374359|NCT00920907|1260871|P2|Induction Period|Adverse Event|2
374360|NCT00920907|1260872|P1|Induction Period|Adverse Event|0
374361|NCT00920855|1260913|P3|Overall Study|Response plateau; started maintenance|1
374362|NCT00920855|1260914|P2|Overall Study|Response plateau; started maintenance|0
374363|NCT00920855|1260915|P1|Overall Study|Response plateau; started maintenance|0
374364|NCT00920855|1260913|P3|Overall Study|Noncompliance to study medication|1
374365|NCT00920855|1260914|P2|Overall Study|Noncompliance to study medication|0
374366|NCT00920855|1260915|P1|Overall Study|Noncompliance to study medication|0
374367|NCT00920855|1260913|P3|Overall Study|Disease progression|10
374368|NCT00920855|1260914|P2|Overall Study|Disease progression|1
374369|NCT00920855|1260915|P1|Overall Study|Disease progression|2
374370|NCT00920855|1260913|P3|Overall Study|Withdrawal by Subject|6
374371|NCT00920855|1260914|P2|Overall Study|Withdrawal by Subject|1
374372|NCT00920855|1260915|P1|Overall Study|Withdrawal by Subject|2
374373|NCT00920855|1260913|P3|Overall Study|Adverse Event|4
374374|NCT00920855|1260914|P2|Overall Study|Adverse Event|1
374375|NCT00920855|1260915|P1|Overall Study|Adverse Event|1
374376|NCT00920829|1260941|P4|Available for Analysis|Required more treatment|1
374377|NCT00920829|1260942|P3|Available for Analysis|Required more treatment|0
374378|NCT00920829|1260943|P2|Available for Analysis|Required more treatment|2
374379|NCT00920829|1260944|P1|Available for Analysis|Required more treatment|0
374380|NCT00920829|1260941|P4|Available for Analysis|Protocol Violation|0
374381|NCT00920829|1260942|P3|Available for Analysis|Protocol Violation|1
374382|NCT00920829|1260943|P2|Available for Analysis|Protocol Violation|0
374383|NCT00920829|1260944|P1|Available for Analysis|Protocol Violation|0
374384|NCT00920829|1260941|P4|Available for Analysis|Death|0
374385|NCT00920829|1260942|P3|Available for Analysis|Death|0
374386|NCT00920829|1260943|P2|Available for Analysis|Death|0
374387|NCT00920829|1260944|P1|Available for Analysis|Death|1
374388|NCT00920829|1260941|P4|Available for Analysis|Adverse Event|0
374389|NCT00920829|1260942|P3|Available for Analysis|Adverse Event|1
374390|NCT00920829|1260943|P2|Available for Analysis|Adverse Event|2
374391|NCT00920829|1260944|P1|Available for Analysis|Adverse Event|1
374392|NCT00920829|1260941|P4|Available for Analysis|Required Medical Treatment|0
374393|NCT00920829|1260942|P3|Available for Analysis|Required Medical Treatment|2
374394|NCT00920829|1260943|P2|Available for Analysis|Required Medical Treatment|1
374395|NCT00920829|1260944|P1|Available for Analysis|Required Medical Treatment|0
374396|NCT00920829|1260941|P4|Available for Analysis|Withdrawal by Subject|10
374397|NCT00920829|1260942|P3|Available for Analysis|Withdrawal by Subject|6
374398|NCT00920829|1260943|P2|Available for Analysis|Withdrawal by Subject|6
374399|NCT00920829|1260944|P1|Available for Analysis|Withdrawal by Subject|6
374400|NCT00920829|1260941|P4|Allocation|No post randomization data|2
374401|NCT00920829|1260942|P3|Allocation|No post randomization data|0
374402|NCT00920829|1260943|P2|Allocation|No post randomization data|1
374403|NCT00920829|1260944|P1|Allocation|No post randomization data|3
374404|NCT00920816|1260958|P4|Overall Study|Ongoing|36
374405|NCT00920816|1260959|P3|Overall Study|Ongoing|70
374406|NCT00920816|1260960|P2|Overall Study|Ongoing|56
374407|NCT00920816|1260961|P1|Overall Study|Ongoing|106
374408|NCT00920816|1260958|P4|Overall Study|Withdrawal by Subject|1
374409|NCT00920816|1260959|P3|Overall Study|Withdrawal by Subject|1
374410|NCT00920816|1260960|P2|Overall Study|Withdrawal by Subject|2
374411|NCT00920816|1260961|P1|Overall Study|Withdrawal by Subject|7
374412|NCT00920816|1260958|P4|Overall Study|Objective progression or relapse|0
374413|NCT00920816|1260959|P3|Overall Study|Objective progression or relapse|2
374414|NCT00920816|1260960|P2|Overall Study|Objective progression or relapse|0
374415|NCT00920816|1260961|P1|Overall Study|Objective progression or relapse|0
374416|NCT00920816|1260958|P4|Overall Study|Lost to Follow-up|4
374417|NCT00920816|1260959|P3|Overall Study|Lost to Follow-up|3
374418|NCT00920816|1260960|P2|Overall Study|Lost to Follow-up|2
374419|NCT00920816|1260961|P1|Overall Study|Lost to Follow-up|1
374420|NCT00920816|1260958|P4|Overall Study|Adverse Event|0
374421|NCT00920816|1260959|P3|Overall Study|Adverse Event|1
374422|NCT00920816|1260960|P2|Overall Study|Adverse Event|0
374423|NCT00920816|1260961|P1|Overall Study|Adverse Event|1
374424|NCT00920816|1260958|P4|Overall Study|Death|28
374425|NCT00920816|1260959|P3|Overall Study|Death|58
374426|NCT00920816|1260960|P2|Overall Study|Death|36
374427|NCT00920816|1260961|P1|Overall Study|Death|77
374428|NCT00920790|1260999|P1|Overall Study|aggravation of general condition|14
374429|NCT00920699|1261011|P3|Overall Study|Lost to Follow-up|2
374430|NCT00920699|1261012|P2|Overall Study|Lost to Follow-up|0
374431|NCT00920699|1261013|P1|Overall Study|Lost to Follow-up|0
374432|NCT00920699|1261011|P3|Overall Study|no longer met eligibility|0
374433|NCT00920699|1261012|P2|Overall Study|no longer met eligibility|1
374434|NCT00920699|1261013|P1|Overall Study|no longer met eligibility|0
374435|NCT00920699|1261011|P3|Overall Study|Withdrawal by Subject|2
374436|NCT00920699|1261012|P2|Overall Study|Withdrawal by Subject|0
374437|NCT00920699|1261013|P1|Overall Study|Withdrawal by Subject|2
374438|NCT00920686|1261030|P3|Overall Study|Study drug dosing criteria not met|12
374439|NCT00920686|1261031|P2|Overall Study|Study drug dosing criteria not met|19
374440|NCT00920686|1261032|P1|Overall Study|Study drug dosing criteria not met|17
374441|NCT00920686|1261030|P3|Overall Study|Lost to Follow-up|1
374442|NCT00920686|1261031|P2|Overall Study|Lost to Follow-up|3
374443|NCT00920686|1261032|P1|Overall Study|Lost to Follow-up|2
374444|NCT00920621|1261111|P4|Overall Study|Blood sample not collected|0
374445|NCT00920621|1261112|P3|Overall Study|Blood sample not collected|0
374446|NCT00920621|1261113|P2|Overall Study|Blood sample not collected|14
374447|NCT00920621|1261114|P1|Overall Study|Blood sample not collected|22
374448|NCT00920621|1261111|P4|Overall Study|Fetal/neonatal deaths|14
374449|NCT00920621|1261112|P3|Overall Study|Fetal/neonatal deaths|16
374450|NCT00920621|1261113|P2|Overall Study|Fetal/neonatal deaths|14
374451|NCT00920621|1261114|P1|Overall Study|Fetal/neonatal deaths|16
374452|NCT00920621|1261111|P4|Overall Study|Lost to Follow-up|21
374453|NCT00920621|1261112|P3|Overall Study|Lost to Follow-up|19
374454|NCT00920621|1261113|P2|Overall Study|Lost to Follow-up|17
374455|NCT00920621|1261114|P1|Overall Study|Lost to Follow-up|16
374456|NCT00920426|1261148|P4|ITZ111451|Adverse Event|0
374457|NCT00920426|1261149|P3|ITZ111451|Adverse Event|0
374458|NCT00920426|1261150|P2|ITZ111451|Adverse Event|0
374459|NCT00920426|1261151|P1|ITZ111451|Adverse Event|1
374460|NCT00920218|1261271|P4|Overall Study|Not specified|0
374461|NCT00920218|1261272|P3|Overall Study|Not specified|1
374462|NCT00920218|1261273|P2|Overall Study|Not specified|0
374463|NCT00920218|1261274|P1|Overall Study|Not specified|0
374464|NCT00920218|1261271|P4|Overall Study|Transplant failed/malignancy recurrence|3
374465|NCT00920218|1261272|P3|Overall Study|Transplant failed/malignancy recurrence|2
374466|NCT00920218|1261273|P2|Overall Study|Transplant failed/malignancy recurrence|1
374467|NCT00920218|1261274|P1|Overall Study|Transplant failed/malignancy recurrence|0
374468|NCT00920218|1261271|P4|Overall Study|Lost to Follow-up|3
374469|NCT00920218|1261272|P3|Overall Study|Lost to Follow-up|0
374470|NCT00920218|1261273|P2|Overall Study|Lost to Follow-up|1
374471|NCT00920218|1261274|P1|Overall Study|Lost to Follow-up|0
374472|NCT00920218|1261271|P4|Overall Study|Migrated/moved from study area|0
374473|NCT00920218|1261272|P3|Overall Study|Migrated/moved from study area|1
374474|NCT00920218|1261273|P2|Overall Study|Migrated/moved from study area|0
374475|NCT00920218|1261274|P1|Overall Study|Migrated/moved from study area|0
374476|NCT00920218|1261271|P4|Overall Study|Withdrawal by Subject|0
374477|NCT00920218|1261272|P3|Overall Study|Withdrawal by Subject|2
374478|NCT00920218|1261273|P2|Overall Study|Withdrawal by Subject|3
374479|NCT00920218|1261274|P1|Overall Study|Withdrawal by Subject|0
374480|NCT00920218|1261271|P4|Overall Study|Serious Adverse Event|1
374481|NCT00920218|1261272|P3|Overall Study|Serious Adverse Event|2
374482|NCT00920218|1261273|P2|Overall Study|Serious Adverse Event|0
374483|NCT00920218|1261274|P1|Overall Study|Serious Adverse Event|2
374484|NCT00920140|1261377|P5|Phase 2|Withdrawal by Subject|1
374485|NCT00920140|1261378|P4|Phase 2|Withdrawal by Subject|2
374486|NCT00920140|1261379|P3|Phase 2|Withdrawal by Subject|4
374487|NCT00920140|1261380|P2|Phase 2|Withdrawal by Subject|0
374488|NCT00920140|1261381|P1|Phase 2|Withdrawal by Subject|0
374489|NCT00920140|1261377|P5|Phase 2|Physician Decision|2
374490|NCT00920140|1261378|P4|Phase 2|Physician Decision|3
374491|NCT00920140|1261379|P3|Phase 2|Physician Decision|3
374492|NCT00920140|1261380|P2|Phase 2|Physician Decision|0
374493|NCT00920140|1261381|P1|Phase 2|Physician Decision|0
374494|NCT00920140|1261377|P5|Phase 2|Lost to Follow-up|0
374495|NCT00920140|1261378|P4|Phase 2|Lost to Follow-up|1
374496|NCT00920140|1261379|P3|Phase 2|Lost to Follow-up|0
374497|NCT00920140|1261380|P2|Phase 2|Lost to Follow-up|0
374498|NCT00920140|1261381|P1|Phase 2|Lost to Follow-up|0
374499|NCT00920140|1261377|P5|Phase 2|Lack of Efficacy|5
374500|NCT00920140|1261378|P4|Phase 2|Lack of Efficacy|14
374501|NCT00920140|1261379|P3|Phase 2|Lack of Efficacy|29
374502|NCT00920140|1261380|P2|Phase 2|Lack of Efficacy|0
374503|NCT00920140|1261381|P1|Phase 2|Lack of Efficacy|0
374504|NCT00920140|1261377|P5|Phase 2|Adverse Event|3
374505|NCT00920140|1261378|P4|Phase 2|Adverse Event|2
374506|NCT00920140|1261379|P3|Phase 2|Adverse Event|14
374507|NCT00920140|1261380|P2|Phase 2|Adverse Event|0
374508|NCT00920140|1261381|P1|Phase 2|Adverse Event|0
374509|NCT00920140|1261377|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
374510|NCT00920140|1261378|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
374511|NCT00920140|1261379|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
374512|NCT00920140|1261380|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
374513|NCT00920140|1261381|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
374514|NCT00920140|1261377|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
374515|NCT00920140|1261378|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
374516|NCT00920140|1261379|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
374517|NCT00920140|1261380|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
374518|NCT00920140|1261381|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
374519|NCT00920140|1261377|P5|Phase 1 (Dose Escalation)|Adverse Event|0
374520|NCT00920140|1261378|P4|Phase 1 (Dose Escalation)|Adverse Event|0
374521|NCT00920140|1261379|P3|Phase 1 (Dose Escalation)|Adverse Event|0
374522|NCT00920140|1261380|P2|Phase 1 (Dose Escalation)|Adverse Event|3
374523|NCT00920140|1261381|P1|Phase 1 (Dose Escalation)|Adverse Event|3
374524|NCT00919893|1261443|P2|Overall Study|Protocol Violation|9
374525|NCT00919893|1261444|P1|Overall Study|Protocol Violation|19
374526|NCT00919867|1261456|P6|First Intervention|Physician Decision|1
374527|NCT00919867|1261457|P5|First Intervention|Physician Decision|0
374528|NCT00919867|1261458|P4|First Intervention|Physician Decision|0
374529|NCT00919867|1261459|P3|First Intervention|Physician Decision|0
374530|NCT00919867|1261460|P2|First Intervention|Physician Decision|0
374531|NCT00919867|1261461|P1|First Intervention|Physician Decision|0
374532|NCT00919867|1261456|P6|First Intervention|Withdrawal by Subject|0
374533|NCT00919867|1261457|P5|First Intervention|Withdrawal by Subject|0
374534|NCT00919867|1261458|P4|First Intervention|Withdrawal by Subject|0
374535|NCT00919867|1261459|P3|First Intervention|Withdrawal by Subject|1
374536|NCT00919867|1261460|P2|First Intervention|Withdrawal by Subject|0
374537|NCT00919867|1261461|P1|First Intervention|Withdrawal by Subject|0
374538|NCT00919854|1261482|P1|Overall Study|Adverse Event|1
374539|NCT00919711|1261520|P2|Overall Study|Noncompliance|0
374540|NCT00919711|1261521|P1|Overall Study|Noncompliance|1
374541|NCT00919711|1261520|P2|Overall Study|Death|0
374542|NCT00919711|1261521|P1|Overall Study|Death|1
374543|NCT00919711|1261520|P2|Overall Study|Lost to Follow-up|0
374544|NCT00919711|1261521|P1|Overall Study|Lost to Follow-up|2
374545|NCT00919711|1261520|P2|Overall Study|Administrative Decision|1
374546|NCT00919711|1261521|P1|Overall Study|Administrative Decision|0
374547|NCT00919711|1261520|P2|Overall Study|Other|2
374548|NCT00919711|1261521|P1|Overall Study|Other|1
374549|NCT00919711|1261520|P2|Overall Study|Adverse Event|3
374550|NCT00919711|1261521|P1|Overall Study|Adverse Event|13
374551|NCT00919711|1261520|P2|Overall Study|Withdrawal by Subject|7
374552|NCT00919711|1261521|P1|Overall Study|Withdrawal by Subject|15
374553|NCT00919633|1261537|P4|Overall Study|Viral rebound outside protocol timepoint|0
374554|NCT00919633|1261538|P3|Overall Study|Viral rebound outside protocol timepoint|1
374555|NCT00919633|1261539|P2|Overall Study|Viral rebound outside protocol timepoint|0
374556|NCT00919633|1261540|P1|Overall Study|Viral rebound outside protocol timepoint|0
374557|NCT00919633|1261537|P4|Overall Study|Request of withdrawal w/o future contact|0
374558|NCT00919633|1261538|P3|Overall Study|Request of withdrawal w/o future contact|1
374559|NCT00919633|1261539|P2|Overall Study|Request of withdrawal w/o future contact|0
374560|NCT00919633|1261540|P1|Overall Study|Request of withdrawal w/o future contact|0
374561|NCT00919633|1261537|P4|Overall Study|Physician Decision|1
374562|NCT00919633|1261538|P3|Overall Study|Physician Decision|0
374563|NCT00919633|1261539|P2|Overall Study|Physician Decision|0
374564|NCT00919633|1261540|P1|Overall Study|Physician Decision|0
374565|NCT00919633|1261537|P4|Overall Study|Protocol Violation|1
374566|NCT00919633|1261538|P3|Overall Study|Protocol Violation|0
374567|NCT00919633|1261539|P2|Overall Study|Protocol Violation|0
374568|NCT00919633|1261540|P1|Overall Study|Protocol Violation|0
374569|NCT00919633|1261537|P4|Overall Study|Withdraw consent post transition to SOC|1
374570|NCT00919633|1261538|P3|Overall Study|Withdraw consent post transition to SOC|1
374571|NCT00919633|1261539|P2|Overall Study|Withdraw consent post transition to SOC|0
374572|NCT00919633|1261540|P1|Overall Study|Withdraw consent post transition to SOC|0
374573|NCT00919633|1261537|P4|Overall Study|Lost to Follow-up|2
374574|NCT00919633|1261538|P3|Overall Study|Lost to Follow-up|0
374575|NCT00919633|1261539|P2|Overall Study|Lost to Follow-up|1
374576|NCT00919633|1261540|P1|Overall Study|Lost to Follow-up|3
374577|NCT00919633|1261537|P4|Overall Study|Withdrawal by Subject|3
374578|NCT00919633|1261538|P3|Overall Study|Withdrawal by Subject|4
374579|NCT00919633|1261539|P2|Overall Study|Withdrawal by Subject|2
374580|NCT00919633|1261540|P1|Overall Study|Withdrawal by Subject|1
374581|NCT00919633|1261537|P4|Overall Study|Lack of Efficacy|3
374582|NCT00919633|1261538|P3|Overall Study|Lack of Efficacy|2
374583|NCT00919633|1261539|P2|Overall Study|Lack of Efficacy|3
374584|NCT00919633|1261540|P1|Overall Study|Lack of Efficacy|17
374585|NCT00919633|1261537|P4|Overall Study|Death|0
374586|NCT00919633|1261538|P3|Overall Study|Death|2
374587|NCT00919633|1261539|P2|Overall Study|Death|0
374588|NCT00919633|1261540|P1|Overall Study|Death|0
374589|NCT00919633|1261537|P4|Overall Study|Adverse Event|10
374590|NCT00919633|1261538|P3|Overall Study|Adverse Event|12
374591|NCT00919633|1261539|P2|Overall Study|Adverse Event|9
374592|NCT00919633|1261540|P1|Overall Study|Adverse Event|1
374593|NCT00919061|1261625|P1|Overall Study|Withdrawal by Subject|1
374594|NCT00919061|1261625|P1|Overall Study|Adverse Event|1
374595|NCT00918957|1261638|P2|Overall Study|Withdrawal by Subject|0
374596|NCT00918957|1261639|P1|Overall Study|Withdrawal by Subject|1
374597|NCT00918957|1261638|P2|Overall Study|Adverse Event|0
374598|NCT00918957|1261639|P1|Overall Study|Adverse Event|2
374599|NCT00918879|1261672|P2|Overall Study|Severe non-compliance to protocol|1
374600|NCT00918879|1261673|P1|Overall Study|Severe non-compliance to protocol|1
374601|NCT00918879|1261672|P2|Overall Study|Lost to Follow-up|1
374602|NCT00918879|1261673|P1|Overall Study|Lost to Follow-up|1
374603|NCT00918879|1261672|P2|Overall Study|Withdrawal by Subject|4
374604|NCT00918879|1261673|P1|Overall Study|Withdrawal by Subject|4
374605|NCT00918749|1261705|P3|Overall Study|No Study Medication Taken|0
374606|NCT00918749|1261706|P2|Overall Study|No Study Medication Taken|0
374607|NCT00918749|1261707|P1|Overall Study|No Study Medication Taken|1
374608|NCT00918749|1261705|P3|Overall Study|Withdrawal by Subject|5
374609|NCT00918749|1261706|P2|Overall Study|Withdrawal by Subject|3
374610|NCT00918749|1261707|P1|Overall Study|Withdrawal by Subject|5
374611|NCT00918749|1261705|P3|Overall Study|Lost to Follow-up|1
374612|NCT00918749|1261706|P2|Overall Study|Lost to Follow-up|0
374613|NCT00918749|1261707|P1|Overall Study|Lost to Follow-up|0
374614|NCT00918749|1261705|P3|Overall Study|Adverse Event|1
374615|NCT00918749|1261706|P2|Overall Study|Adverse Event|0
374616|NCT00918749|1261707|P1|Overall Study|Adverse Event|1
374617|NCT00918736|1261739|P1|Overall Study|Withdrawal by Subject|4
374618|NCT00918684|1261752|P1|Treatment Phase|Withdrawal by Subject|8
374619|NCT00918684|1261752|P1|Treatment Phase|Protocol Violation|1
374620|NCT00918684|1261752|P1|Treatment Phase|Physician Decision|8
374621|NCT00918684|1261752|P1|Treatment Phase|Lost to Follow-up|2
374622|NCT00918684|1261752|P1|Treatment Phase|Lack of Efficacy|6
374623|NCT00918684|1261752|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
374624|NCT00918645|1261763|P1|Overall Study|Withdrawal by Subject|1
374625|NCT00918580|1261769|P1|After 6-month FU to 1-year FU|Failed to Return|2
374626|NCT00918580|1261769|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
374627|NCT00918580|1261769|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
374628|NCT00918580|1261769|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
374629|NCT00918580|1261769|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
374630|NCT00918580|1261769|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
374631|NCT00918580|1261769|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
374632|NCT00918385|1261789|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
374633|NCT00918385|1261790|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
374634|NCT00918385|1261789|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
374635|NCT00918385|1261790|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
374636|NCT00918385|1261789|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
374637|NCT00918385|1261790|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
374638|NCT00918385|1261789|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
374639|NCT00918385|1261790|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
374640|NCT00918385|1261789|P2|Monotherapy|Complicating illness|0
374641|NCT00918385|1261790|P1|Monotherapy|Complicating illness|1
374642|NCT00918385|1261789|P2|Monotherapy|Adverse Event|6
374643|NCT00918385|1261790|P1|Monotherapy|Adverse Event|1
374644|NCT00918346|1261799|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
374645|NCT00918346|1261800|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
374646|NCT00918333|1261816|P2|Overall Study|Withdrawal by Subject|1
374647|NCT00918333|1261817|P1|Overall Study|Withdrawal by Subject|0
374648|NCT00918333|1261816|P2|Overall Study|Ineligible|0
374649|NCT00918333|1261817|P1|Overall Study|Ineligible|1
374650|NCT00918333|1261816|P2|Overall Study|Inadequate amount of drugs provided|4
374651|NCT00918333|1261817|P1|Overall Study|Inadequate amount of drugs provided|1
374652|NCT00918333|1261816|P2|Overall Study|Drug not taken per protocol|0
374653|NCT00918333|1261817|P1|Overall Study|Drug not taken per protocol|1
374654|NCT00918281|1261837|P1|Overall Study|Physician Decision|29
374655|NCT00918255|1261847|P3|Overall Study|Investigator discretion|0
374656|NCT00918255|1261848|P2|Overall Study|Investigator discretion|0
374657|NCT00918255|1261849|P1|Overall Study|Investigator discretion|1
374658|NCT00918255|1261847|P3|Overall Study|Non-compliance|0
374659|NCT00918255|1261848|P2|Overall Study|Non-compliance|0
374660|NCT00918255|1261849|P1|Overall Study|Non-compliance|1
374661|NCT00918255|1261847|P3|Overall Study|Exceeded allowed number of interventions|1
374662|NCT00918255|1261848|P2|Overall Study|Exceeded allowed number of interventions|0
374663|NCT00918255|1261849|P1|Overall Study|Exceeded allowed number of interventions|0
374664|NCT00918255|1261847|P3|Overall Study|Lost to Follow-up|2
374665|NCT00918255|1261848|P2|Overall Study|Lost to Follow-up|0
374666|NCT00918255|1261849|P1|Overall Study|Lost to Follow-up|1
374667|NCT00918255|1261847|P3|Overall Study|Lack of Efficacy|0
374668|NCT00918255|1261848|P2|Overall Study|Lack of Efficacy|0
374669|NCT00918255|1261849|P1|Overall Study|Lack of Efficacy|1
374670|NCT00918255|1261847|P3|Overall Study|Withdrawal by Subject|2
374671|NCT00918255|1261848|P2|Overall Study|Withdrawal by Subject|0
374672|NCT00918255|1261849|P1|Overall Study|Withdrawal by Subject|1
374673|NCT00918255|1261847|P3|Overall Study|Adverse Event|0
374674|NCT00918255|1261848|P2|Overall Study|Adverse Event|0
374675|NCT00918255|1261849|P1|Overall Study|Adverse Event|1
374676|NCT00918203|1261877|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
374677|NCT00918203|1261878|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
374678|NCT00918203|1261879|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
374679|NCT00918203|1261877|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
374680|NCT00918203|1261878|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
374681|NCT00918203|1261879|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
374682|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|On Treatment|0
374683|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|On Treatment|0
374684|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|On Treatment|1
374685|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|Physician Decision|0
374686|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|Physician Decision|1
374687|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|Physician Decision|0
374688|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
374689|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
374690|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
374691|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|Never Treated|0
374692|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|Never Treated|1
374693|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|Never Treated|2
374694|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|Adverse Event|0
374695|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|Adverse Event|1
374696|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|Adverse Event|1
374697|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
374698|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
374699|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
374700|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
374701|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
374702|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
374703|NCT00918203|1261877|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
374704|NCT00918203|1261878|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
374705|NCT00918203|1261879|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
374706|NCT00918138|1261910|P2|Overall Study|Death|0
374707|NCT00918138|1261911|P1|Overall Study|Death|1
374708|NCT00918138|1261910|P2|Overall Study|Subject withdrew consent|1
374709|NCT00918138|1261911|P1|Overall Study|Subject withdrew consent|1
374710|NCT00917852|1261950|P1|Overall Study|Death|6
374711|NCT00917644|1261968|P2|Period 2: Second Intervention|family emergency|0
374712|NCT00917644|1261969|P1|Period 2: Second Intervention|family emergency|1
374713|NCT00917644|1261968|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
374714|NCT00917644|1261969|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
374715|NCT00917644|1261968|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
374716|NCT00917644|1261969|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
374717|NCT00917579|1261983|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
374718|NCT00917579|1261984|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
374719|NCT00917579|1261983|P2|Washout >= 2 Weeks|Adverse Event|0
374720|NCT00917579|1261984|P1|Washout >= 2 Weeks|Adverse Event|1
374721|NCT00917501|1262000|P2|Overall Study|trouble swollowing capsules|1
374722|NCT00917501|1262001|P1|Overall Study|trouble swollowing capsules|0
374723|NCT00917501|1262000|P2|Overall Study|Lack of Efficacy|2
374724|NCT00917501|1262001|P1|Overall Study|Lack of Efficacy|1
374725|NCT00917501|1262000|P2|Overall Study|Withdrawal by Subject|1
374726|NCT00917501|1262001|P1|Overall Study|Withdrawal by Subject|3
374727|NCT00917501|1262000|P2|Overall Study|Lost to Follow-up|1
374728|NCT00917501|1262001|P1|Overall Study|Lost to Follow-up|4
374729|NCT00917384|1262009|P2|Overall Study|Withdrawal by Subject|2
374730|NCT00917384|1262010|P1|Overall Study|Withdrawal by Subject|10
374731|NCT00917384|1262009|P2|Overall Study|Lost to Follow-up|2
374732|NCT00917384|1262010|P1|Overall Study|Lost to Follow-up|4
374733|NCT00917267|1262034|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
374734|NCT00917267|1262035|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
374735|NCT00917267|1262034|P2|Overall Study|Sponsor Decision|5
374736|NCT00917267|1262035|P1|Overall Study|Sponsor Decision|5
374737|NCT00917267|1262034|P2|Overall Study|Entry Criteria Not Met|0
374738|NCT00917267|1262035|P1|Overall Study|Entry Criteria Not Met|1
374739|NCT00917267|1262034|P2|Overall Study|Lost to follow up|2
374740|NCT00917267|1262035|P1|Overall Study|Lost to follow up|0
374741|NCT00917267|1262034|P2|Overall Study|Withdrawal by Subject|12
374742|NCT00917267|1262035|P1|Overall Study|Withdrawal by Subject|5
374743|NCT00917267|1262034|P2|Overall Study|Protocol Violation|18
374744|NCT00917267|1262035|P1|Overall Study|Protocol Violation|9
374745|NCT00917267|1262034|P2|Overall Study|Physician Decision|4
374746|NCT00917267|1262035|P1|Overall Study|Physician Decision|2
374747|NCT00917267|1262034|P2|Overall Study|Adverse Event|36
374748|NCT00917267|1262035|P1|Overall Study|Adverse Event|15
374749|NCT00917124|1262063|P2|Overall Study|Protocol Violation|6
374750|NCT00917124|1262064|P1|Overall Study|Protocol Violation|4
374751|NCT00916929|1262074|P2|Overall Study|Device unable to process impedance data|7
374752|NCT00916929|1262075|P1|Overall Study|Device unable to process impedance data|0
374753|NCT00916929|1262074|P2|Overall Study|Moved to another state|1
374754|NCT00916929|1262075|P1|Overall Study|Moved to another state|0
374755|NCT00916929|1262074|P2|Overall Study|System explant|0
374756|NCT00916929|1262075|P1|Overall Study|System explant|1
374757|NCT00916929|1262074|P2|Overall Study|Transferred to hospice care|1
374758|NCT00916929|1262075|P1|Overall Study|Transferred to hospice care|1
374759|NCT00916929|1262074|P2|Overall Study|Left ventricular epicardial lead|2
374760|NCT00916929|1262075|P1|Overall Study|Left ventricular epicardial lead|1
374761|NCT00916929|1262074|P2|Overall Study|Withdrawal by Subject|5
374762|NCT00916929|1262075|P1|Overall Study|Withdrawal by Subject|1
374763|NCT00916929|1262074|P2|Overall Study|Death|10
374764|NCT00916929|1262075|P1|Overall Study|Death|5
374765|NCT00916929|1262074|P2|Overall Study|Lost to Follow-up|3
374766|NCT00916929|1262075|P1|Overall Study|Lost to Follow-up|1
374767|NCT00916721|1262085|P2|Overall Study|Protocol Violation|4
374768|NCT00916721|1262086|P1|Overall Study|Protocol Violation|2
374769|NCT00916721|1262085|P2|Overall Study|Withdrawal by Subject|2
374770|NCT00916721|1262086|P1|Overall Study|Withdrawal by Subject|2
374771|NCT00916721|1262085|P2|Overall Study|Adverse Event|3
374772|NCT00916721|1262086|P1|Overall Study|Adverse Event|6
374773|NCT00916721|1262085|P2|Overall Study|Lost to Follow-up|1
374774|NCT00916721|1262086|P1|Overall Study|Lost to Follow-up|0
374775|NCT00916617|1262109|P4|Overall Study|Not specified|2
374776|NCT00916617|1262110|P3|Overall Study|Not specified|0
374777|NCT00916617|1262111|P2|Overall Study|Not specified|0
374778|NCT00916617|1262112|P1|Overall Study|Not specified|2
374779|NCT00916617|1262109|P4|Overall Study|Lack of Efficacy|0
374780|NCT00916617|1262110|P3|Overall Study|Lack of Efficacy|0
374781|NCT00916617|1262111|P2|Overall Study|Lack of Efficacy|0
374782|NCT00916617|1262112|P1|Overall Study|Lack of Efficacy|1
374783|NCT00916617|1262109|P4|Overall Study|Lost to Follow-up|0
374784|NCT00916617|1262110|P3|Overall Study|Lost to Follow-up|0
374785|NCT00916617|1262111|P2|Overall Study|Lost to Follow-up|1
374786|NCT00916617|1262112|P1|Overall Study|Lost to Follow-up|2
374787|NCT00916617|1262109|P4|Overall Study|Discontinuation of Study by Sponsor|1
374788|NCT00916617|1262110|P3|Overall Study|Discontinuation of Study by Sponsor|3
374789|NCT00916617|1262111|P2|Overall Study|Discontinuation of Study by Sponsor|13
374790|NCT00916617|1262112|P1|Overall Study|Discontinuation of Study by Sponsor|8
374791|NCT00916617|1262109|P4|Overall Study|Physician Decision|0
374792|NCT00916617|1262110|P3|Overall Study|Physician Decision|0
374793|NCT00916617|1262111|P2|Overall Study|Physician Decision|1
374794|NCT00916617|1262112|P1|Overall Study|Physician Decision|1
374795|NCT00916617|1262109|P4|Overall Study|Caregiver Request|0
374796|NCT00916617|1262110|P3|Overall Study|Caregiver Request|1
374797|NCT00916617|1262111|P2|Overall Study|Caregiver Request|2
374798|NCT00916617|1262112|P1|Overall Study|Caregiver Request|3
374799|NCT00916617|1262109|P4|Overall Study|Withdrawal by Subject|1
374800|NCT00916617|1262110|P3|Overall Study|Withdrawal by Subject|0
374801|NCT00916617|1262111|P2|Overall Study|Withdrawal by Subject|2
374802|NCT00916617|1262112|P1|Overall Study|Withdrawal by Subject|3
374803|NCT00916617|1262109|P4|Overall Study|Adverse Event|3
374804|NCT00916617|1262110|P3|Overall Study|Adverse Event|6
374805|NCT00916617|1262111|P2|Overall Study|Adverse Event|2
374806|NCT00916617|1262112|P1|Overall Study|Adverse Event|3
374807|NCT00916578|1262126|P1|Overall Study|Insurance Denial|2
374808|NCT00916578|1262126|P1|Overall Study|Withdrawal by Subject|3
374809|NCT00916578|1262126|P1|Overall Study|Physician Decision|2
374810|NCT00916383|1262155|P1|Overall Study|Protocol Violation|1
374811|NCT00916383|1262155|P1|Overall Study|Death|1
374812|NCT00916383|1262155|P1|Overall Study|Adverse Event|1
374813|NCT00916370|1262183|P2|Overall Study|Physician Decision|1
374814|NCT00916370|1262184|P1|Overall Study|Physician Decision|0
374815|NCT00916370|1262183|P2|Overall Study|Withdrawal by Subject|0
374816|NCT00916370|1262184|P1|Overall Study|Withdrawal by Subject|2
374817|NCT00916370|1262183|P2|Overall Study|Death|1
374818|NCT00916370|1262184|P1|Overall Study|Death|3
374819|NCT00916357|1262358|P6|Period 2|Weight loss > 3 kilograms (kg)|0
374820|NCT00916357|1262359|P5|Period 2|Weight loss > 3 kilograms (kg)|0
374821|NCT00916357|1262360|P4|Period 2|Weight loss > 3 kilograms (kg)|1
374822|NCT00916357|1262361|P3|Period 2|Weight loss > 3 kilograms (kg)|0
374823|NCT00916357|1262362|P2|Period 2|Weight loss > 3 kilograms (kg)|0
374824|NCT00916357|1262363|P1|Period 2|Weight loss > 3 kilograms (kg)|0
374825|NCT00916357|1262358|P6|Period 1|Withdrawal by Subject|0
374826|NCT00916357|1262359|P5|Period 1|Withdrawal by Subject|0
374827|NCT00916357|1262360|P4|Period 1|Withdrawal by Subject|0
374828|NCT00916357|1262361|P3|Period 1|Withdrawal by Subject|0
374829|NCT00916357|1262362|P2|Period 1|Withdrawal by Subject|0
374830|NCT00916357|1262363|P1|Period 1|Withdrawal by Subject|1
374831|NCT00916344|1262401|P1|Overall Study|Drop-out|5
374832|NCT00916344|1262401|P1|Overall Study|ICD upgrade|1
374833|NCT00916344|1262401|P1|Overall Study|Death|2
374834|NCT00916305|1262408|P2|Overall Study|Withdrawal by Subject|1
374835|NCT00916305|1262409|P1|Overall Study|Withdrawal by Subject|0
374836|NCT00916305|1262408|P2|Overall Study|Lost to Follow-up|27
374837|NCT00916305|1262409|P1|Overall Study|Lost to Follow-up|21
374838|NCT00916279|1262417|P1|Overall Study|Lost to Follow-up|2
374839|NCT00916279|1262417|P1|Overall Study|Death|2
374840|NCT00916006|1262479|P2|Overall Study|Protocol Violation|1
374841|NCT00916006|1262480|P1|Overall Study|Protocol Violation|0
374842|NCT00916006|1262479|P2|Overall Study|Withdrawal by Subject|5
374843|NCT00916006|1262480|P1|Overall Study|Withdrawal by Subject|2
374844|NCT00916006|1262479|P2|Overall Study|Adverse Event|1
374845|NCT00916006|1262480|P1|Overall Study|Adverse Event|1
374846|NCT00915876|1262501|P2|Overall Study|Adverse Event|1
374847|NCT00915876|1262502|P1|Overall Study|Adverse Event|0
374848|NCT00915772|1262538|P3|Overall Study|Any other reason|7
374849|NCT00915772|1262539|P2|Overall Study|Any other reason|7
374850|NCT00915772|1262540|P1|Overall Study|Any other reason|4
374851|NCT00915772|1262538|P3|Overall Study|Refused to continue trial medication|4
374852|NCT00915772|1262539|P2|Overall Study|Refused to continue trial medication|8
374853|NCT00915772|1262540|P1|Overall Study|Refused to continue trial medication|6
374854|NCT00915772|1262538|P3|Overall Study|Lack of Efficacy|3
374855|NCT00915772|1262539|P2|Overall Study|Lack of Efficacy|15
374856|NCT00915772|1262540|P1|Overall Study|Lack of Efficacy|9
374857|NCT00915772|1262538|P3|Overall Study|Lost to Follow-up|2
374858|NCT00915772|1262539|P2|Overall Study|Lost to Follow-up|2
374859|NCT00915772|1262540|P1|Overall Study|Lost to Follow-up|1
374860|NCT00915772|1262538|P3|Overall Study|Protocol Violation|2
374861|NCT00915772|1262539|P2|Overall Study|Protocol Violation|1
374862|NCT00915772|1262540|P1|Overall Study|Protocol Violation|4
374863|NCT00915772|1262538|P3|Overall Study|Adverse Event|11
374864|NCT00915772|1262539|P2|Overall Study|Adverse Event|13
374865|NCT00915772|1262540|P1|Overall Study|Adverse Event|12
374866|NCT00915551|1262639|P2|Overall Study|Withdrawal by Subject|1
374867|NCT00915551|1262640|P1|Overall Study|Withdrawal by Subject|0
374868|NCT00915525|1262650|P2|Overall Study|Patient Moved|9
374869|NCT00915525|1262651|P1|Overall Study|Patient Moved|15
374870|NCT00915525|1262650|P2|Overall Study|Non-Compliance|1
374871|NCT00915525|1262651|P1|Overall Study|Non-Compliance|3
374872|NCT00915525|1262650|P2|Overall Study|Study Burden|12
374873|NCT00915525|1262651|P1|Overall Study|Study Burden|28
374874|NCT00915525|1262650|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
374875|NCT00915525|1262651|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
374876|NCT00915525|1262650|P2|Overall Study|Site Closed|9
374877|NCT00915525|1262651|P1|Overall Study|Site Closed|27
374878|NCT00915525|1262650|P2|Overall Study|Other Reason|12
374879|NCT00915525|1262651|P1|Overall Study|Other Reason|35
374880|NCT00915525|1262650|P2|Overall Study|Missing|1
374881|NCT00915525|1262651|P1|Overall Study|Missing|12
374882|NCT00915525|1262650|P2|Overall Study|Adverse Event|13
374883|NCT00915525|1262651|P1|Overall Study|Adverse Event|29
374884|NCT00915525|1262650|P2|Overall Study|Lack of Efficacy|32
374885|NCT00915525|1262651|P1|Overall Study|Lack of Efficacy|15
374886|NCT00915525|1262650|P2|Overall Study|Pregnancy|0
374887|NCT00915525|1262651|P1|Overall Study|Pregnancy|2
374888|NCT00915525|1262650|P2|Overall Study|Lost to Follow-up|16
374889|NCT00915525|1262651|P1|Overall Study|Lost to Follow-up|27
374890|NCT00915525|1262650|P2|Overall Study|Withdrawal by Subject|21
374891|NCT00915525|1262651|P1|Overall Study|Withdrawal by Subject|59
374892|NCT00915525|1262650|P2|Overall Study|Protocol Violation|4
374893|NCT00915525|1262651|P1|Overall Study|Protocol Violation|9
374894|NCT00915473|1262765|P2|4-week Follow Up|Lost to Follow-up|5
374895|NCT00915473|1262766|P1|4-week Follow Up|Lost to Follow-up|1
374896|NCT00915473|1262765|P2|Screening|Withdrawal by Subject|0
374897|NCT00915473|1262766|P1|Screening|Withdrawal by Subject|1
374898|NCT00915356|1262783|P5|Overall Study|Withdrawal by Subject|0
374899|NCT00915356|1262784|P4|Overall Study|Withdrawal by Subject|0
374900|NCT00915356|1262785|P3|Overall Study|Withdrawal by Subject|0
374901|NCT00915356|1262786|P2|Overall Study|Withdrawal by Subject|0
374902|NCT00915356|1262787|P1|Overall Study|Withdrawal by Subject|1
374903|NCT00915343|1262849|P3|Part B - Open Label Period|Did not attend the last visit|1
374904|NCT00915343|1262850|P2|Part B - Open Label Period|Did not attend the last visit|0
374905|NCT00915343|1262851|P1|Part B - Open Label Period|Did not attend the last visit|0
374906|NCT00915343|1262849|P3|Part B - Open Label Period|Treatment switch|1
374907|NCT00915343|1262850|P2|Part B - Open Label Period|Treatment switch|0
374908|NCT00915343|1262851|P1|Part B - Open Label Period|Treatment switch|0
374909|NCT00915278|1262936|P6|Overall Study|Admission to hospice|0
374910|NCT00915278|1262937|P5|Overall Study|Admission to hospice|0
374911|NCT00915278|1262938|P4|Overall Study|Admission to hospice|0
374912|NCT00915278|1262939|P3|Overall Study|Admission to hospice|1
374913|NCT00915278|1262940|P2|Overall Study|Admission to hospice|0
374914|NCT00915278|1262941|P1|Overall Study|Admission to hospice|0
374915|NCT00915278|1262936|P6|Overall Study|Infusion related AEs|2
374916|NCT00915278|1262937|P5|Overall Study|Infusion related AEs|0
374917|NCT00915278|1262938|P4|Overall Study|Infusion related AEs|0
374918|NCT00915278|1262939|P3|Overall Study|Infusion related AEs|0
374919|NCT00915278|1262940|P2|Overall Study|Infusion related AEs|0
374920|NCT00915278|1262941|P1|Overall Study|Infusion related AEs|0
374921|NCT00915278|1262936|P6|Overall Study|Progressive disease/clinical progression|2
374922|NCT00915278|1262937|P5|Overall Study|Progressive disease/clinical progression|1
374923|NCT00915278|1262938|P4|Overall Study|Progressive disease/clinical progression|3
374924|NCT00915278|1262939|P3|Overall Study|Progressive disease/clinical progression|0
374925|NCT00915278|1262940|P2|Overall Study|Progressive disease/clinical progression|0
374926|NCT00915278|1262941|P1|Overall Study|Progressive disease/clinical progression|0
374927|NCT00915278|1262936|P6|Overall Study|Adverse Event|0
374928|NCT00915278|1262937|P5|Overall Study|Adverse Event|0
374929|NCT00915278|1262938|P4|Overall Study|Adverse Event|0
374930|NCT00915278|1262939|P3|Overall Study|Adverse Event|0
374931|NCT00915278|1262940|P2|Overall Study|Adverse Event|1
374932|NCT00915278|1262941|P1|Overall Study|Adverse Event|4
374933|NCT00915278|1262936|P6|Overall Study|Withdrawal by Subject|4
374934|NCT00915278|1262937|P5|Overall Study|Withdrawal by Subject|1
374935|NCT00915278|1262938|P4|Overall Study|Withdrawal by Subject|0
374936|NCT00915278|1262939|P3|Overall Study|Withdrawal by Subject|0
374937|NCT00915278|1262940|P2|Overall Study|Withdrawal by Subject|1
374938|NCT00915278|1262941|P1|Overall Study|Withdrawal by Subject|0
374939|NCT00915278|1262936|P6|Overall Study|Lost to Follow-up|0
374940|NCT00915278|1262937|P5|Overall Study|Lost to Follow-up|0
374941|NCT00915278|1262938|P4|Overall Study|Lost to Follow-up|0
374942|NCT00915278|1262939|P3|Overall Study|Lost to Follow-up|0
374943|NCT00915278|1262940|P2|Overall Study|Lost to Follow-up|1
374944|NCT00915278|1262941|P1|Overall Study|Lost to Follow-up|0
374945|NCT00915278|1262936|P6|Overall Study|Death|0
374946|NCT00915278|1262937|P5|Overall Study|Death|0
374947|NCT00915278|1262938|P4|Overall Study|Death|0
374948|NCT00915278|1262939|P3|Overall Study|Death|0
374949|NCT00915278|1262940|P2|Overall Study|Death|0
374950|NCT00915278|1262941|P1|Overall Study|Death|1
374951|NCT00915018|1263094|P2|Overall Study|By Sponsor due to Protocol Amendment|105
374952|NCT00915018|1263095|P1|Overall Study|By Sponsor due to Protocol Amendment|92
374953|NCT00915018|1263094|P2|Overall Study|Withdrawal by Subject|27
374954|NCT00915018|1263095|P1|Overall Study|Withdrawal by Subject|38
374955|NCT00915018|1263094|P2|Overall Study|Lost to Follow-up|5
374956|NCT00915018|1263095|P1|Overall Study|Lost to Follow-up|10
374957|NCT00915018|1263094|P2|Overall Study|Death|70
374958|NCT00915018|1263095|P1|Overall Study|Death|75
374959|NCT00914966|1263109|P1|Step 2: 2000 Units|Withdrawal by Subject|1
374960|NCT00914966|1263109|P1|Step 1: 1500 Units|Physician Decision|1
374961|NCT00914966|1263109|P1|Step 1: 1500 Units|Withdrawal by Subject|1
374962|NCT00914927|1263128|P7|Overall Study|Administrative/Other|0
374963|NCT00914927|1263129|P6|Overall Study|Administrative/Other|0
374964|NCT00914927|1263130|P5|Overall Study|Administrative/Other|1
374965|NCT00914927|1263131|P4|Overall Study|Administrative/Other|0
374966|NCT00914927|1263132|P3|Overall Study|Administrative/Other|0
374967|NCT00914927|1263133|P2|Overall Study|Administrative/Other|1
374968|NCT00914927|1263134|P1|Overall Study|Administrative/Other|2
374969|NCT00914927|1263128|P7|Overall Study|Lost to Follow-up|0
374970|NCT00914927|1263129|P6|Overall Study|Lost to Follow-up|0
374971|NCT00914927|1263130|P5|Overall Study|Lost to Follow-up|0
374972|NCT00914927|1263131|P4|Overall Study|Lost to Follow-up|1
374973|NCT00914927|1263132|P3|Overall Study|Lost to Follow-up|0
374974|NCT00914927|1263133|P2|Overall Study|Lost to Follow-up|0
374975|NCT00914927|1263134|P1|Overall Study|Lost to Follow-up|0
374976|NCT00914927|1263128|P7|Overall Study|Withdrawal by Subject|0
374977|NCT00914927|1263129|P6|Overall Study|Withdrawal by Subject|0
374978|NCT00914927|1263130|P5|Overall Study|Withdrawal by Subject|0
374979|NCT00914927|1263131|P4|Overall Study|Withdrawal by Subject|1
374980|NCT00914927|1263132|P3|Overall Study|Withdrawal by Subject|0
374981|NCT00914927|1263133|P2|Overall Study|Withdrawal by Subject|1
374982|NCT00914927|1263134|P1|Overall Study|Withdrawal by Subject|0
374983|NCT00914927|1263128|P7|Overall Study|Adverse Event|0
374984|NCT00914927|1263129|P6|Overall Study|Adverse Event|0
374985|NCT00914927|1263130|P5|Overall Study|Adverse Event|1
374986|NCT00914927|1263131|P4|Overall Study|Adverse Event|0
374987|NCT00914927|1263132|P3|Overall Study|Adverse Event|0
374988|NCT00914927|1263133|P2|Overall Study|Adverse Event|0
374989|NCT00914927|1263134|P1|Overall Study|Adverse Event|0
374990|NCT00914849|1263261|P2|Overall Study|Not eligible|1
374991|NCT00914849|1263262|P1|Overall Study|Not eligible|0
374992|NCT00914849|1263261|P2|Overall Study|Withdrawal by Subject|0
374993|NCT00914849|1263262|P1|Overall Study|Withdrawal by Subject|1
374994|NCT00914810|1263296|P2|Overall Study|Hospitalized and unable to follow up.|1
374995|NCT00914810|1263297|P1|Overall Study|Hospitalized and unable to follow up.|0
374996|NCT00914810|1263296|P2|Overall Study|Relocated out of state|0
374997|NCT00914810|1263297|P1|Overall Study|Relocated out of state|1
374998|NCT00914810|1263296|P2|Overall Study|Withdrawal by Subject|0
374999|NCT00914810|1263297|P1|Overall Study|Withdrawal by Subject|1
375000|NCT00914589|1263308|P3|Overall Study|Death|1
375001|NCT00914589|1263309|P2|Overall Study|Death|1
375002|NCT00914589|1263310|P1|Overall Study|Death|0
375003|NCT00914589|1263308|P3|Overall Study|unclassified|7
375004|NCT00914589|1263309|P2|Overall Study|unclassified|9
375005|NCT00914589|1263310|P1|Overall Study|unclassified|16
375006|NCT00914589|1263308|P3|Overall Study|Protocol Violation|3
375007|NCT00914589|1263309|P2|Overall Study|Protocol Violation|6
375008|NCT00914589|1263310|P1|Overall Study|Protocol Violation|8
375009|NCT00914589|1263308|P3|Overall Study|Adverse Event|1
375010|NCT00914589|1263309|P2|Overall Study|Adverse Event|0
375011|NCT00914589|1263310|P1|Overall Study|Adverse Event|1
375012|NCT00914459|1263336|P2|Overall Study|Parent/Legal guardian request|0
375013|NCT00914459|1263337|P1|Overall Study|Parent/Legal guardian request|1
375014|NCT00914459|1263336|P2|Overall Study|Protocol Violation|1
375015|NCT00914459|1263337|P1|Overall Study|Protocol Violation|0
375016|NCT00914316|1263367|P4|Phase 2|Withdrawal by Subject|0
375017|NCT00914316|1263368|P3|Phase 2|Withdrawal by Subject|1
375018|NCT00914316|1263369|P2|Phase 2|Withdrawal by Subject|0
375019|NCT00914316|1263370|P1|Phase 2|Withdrawal by Subject|1
375020|NCT00914316|1263367|P4|Phase 1|Adverse Event|0
375021|NCT00914316|1263368|P3|Phase 1|Adverse Event|0
375022|NCT00914316|1263369|P2|Phase 1|Adverse Event|0
375023|NCT00914316|1263370|P1|Phase 1|Adverse Event|1
375024|NCT00914316|1263367|P4|Phase 1|Withdrawal by Subject|0
375025|NCT00914316|1263368|P3|Phase 1|Withdrawal by Subject|4
375026|NCT00914316|1263369|P2|Phase 1|Withdrawal by Subject|2
375027|NCT00914316|1263370|P1|Phase 1|Withdrawal by Subject|0
375028|NCT00914316|1263367|P4|Phase 1|Physician Decision|2
375029|NCT00914316|1263368|P3|Phase 1|Physician Decision|1
375030|NCT00914316|1263369|P2|Phase 1|Physician Decision|0
375031|NCT00914316|1263370|P1|Phase 1|Physician Decision|4
375032|NCT00913835|1263449|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
375033|NCT00913835|1263450|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
375034|NCT00913835|1263449|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
375035|NCT00913835|1263450|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
375036|NCT00913835|1263449|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
375037|NCT00913835|1263450|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
375038|NCT00913835|1263449|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
375039|NCT00913835|1263450|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
375040|NCT00913835|1263449|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
375041|NCT00913835|1263450|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
375042|NCT00913770|1263489|P3|Overall Study|Refused|8
375043|NCT00913770|1263490|P2|Overall Study|Refused|10
375044|NCT00913770|1263491|P1|Overall Study|Refused|11
375045|NCT00913770|1263489|P3|Overall Study|Unable to contact|13
375046|NCT00913770|1263490|P2|Overall Study|Unable to contact|19
375047|NCT00913770|1263491|P1|Overall Study|Unable to contact|24
375048|NCT00913744|1263504|P2|Overall Study|Death|0
375049|NCT00913744|1263505|P1|Overall Study|Death|1
375050|NCT00913744|1263504|P2|Overall Study|Withdrawal by Subject|1
375051|NCT00913744|1263505|P1|Overall Study|Withdrawal by Subject|2
375052|NCT00913744|1263504|P2|Overall Study|Adverse Event|0
375053|NCT00913744|1263505|P1|Overall Study|Adverse Event|2
375054|NCT00913692|1263511|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
375055|NCT00913692|1263511|P1|Screening (4 Months)|Not eligible after screening phase.|6
375056|NCT00913692|1263511|P1|Screening (4 Months)|Physician Decision|3
375057|NCT00913523|1263605|P3|Overall Study|Inadequate Number of Tampons Used|3
375058|NCT00913523|1263606|P2|Overall Study|Inadequate Number of Tampons Used|2
375059|NCT00913523|1263607|P1|Overall Study|Inadequate Number of Tampons Used|7
375060|NCT00913523|1263605|P3|Overall Study|Pregnancy|0
375061|NCT00913523|1263606|P2|Overall Study|Pregnancy|3
375062|NCT00913523|1263607|P1|Overall Study|Pregnancy|1
375063|NCT00913523|1263605|P3|Overall Study|Protocol Violation|8
375064|NCT00913523|1263606|P2|Overall Study|Protocol Violation|8
375065|NCT00913523|1263607|P1|Overall Study|Protocol Violation|5
375066|NCT00913523|1263605|P3|Overall Study|Adverse Event|0
375067|NCT00913523|1263606|P2|Overall Study|Adverse Event|0
375068|NCT00913523|1263607|P1|Overall Study|Adverse Event|1
375069|NCT00913523|1263605|P3|Overall Study|Lost to Follow-up|1
375070|NCT00913523|1263606|P2|Overall Study|Lost to Follow-up|1
375071|NCT00913523|1263607|P1|Overall Study|Lost to Follow-up|1
375072|NCT00913523|1263605|P3|Overall Study|Withdrawal by Subject|2
375073|NCT00913523|1263606|P2|Overall Study|Withdrawal by Subject|2
375074|NCT00913523|1263607|P1|Overall Study|Withdrawal by Subject|3
375075|NCT00913458|1263639|P7|Phase 3|Unsatisfactory Response per Investigator|4
375076|NCT00913458|1263640|P6|Phase 3|Unsatisfactory Response per Investigator|11
375077|NCT00913458|1263641|P5|Phase 3|Unsatisfactory Response per Investigator|14
375078|NCT00913458|1263642|P4|Phase 3|Unsatisfactory Response per Investigator|0
375079|NCT00913458|1263643|P3|Phase 3|Unsatisfactory Response per Investigator|0
375080|NCT00913458|1263644|P2|Phase 3|Unsatisfactory Response per Investigator|0
375081|NCT00913458|1263645|P1|Phase 3|Unsatisfactory Response per Investigator|0
375082|NCT00913458|1263639|P7|Phase 3|Withdrawal by Subject|0
375083|NCT00913458|1263640|P6|Phase 3|Withdrawal by Subject|2
375084|NCT00913458|1263641|P5|Phase 3|Withdrawal by Subject|1
375085|NCT00913458|1263642|P4|Phase 3|Withdrawal by Subject|0
375086|NCT00913458|1263643|P3|Phase 3|Withdrawal by Subject|0
375087|NCT00913458|1263644|P2|Phase 3|Withdrawal by Subject|0
375088|NCT00913458|1263645|P1|Phase 3|Withdrawal by Subject|0
375089|NCT00913458|1263639|P7|Phase 3|Non-Responder|3
375090|NCT00913458|1263640|P6|Phase 3|Non-Responder|1
375091|NCT00913458|1263641|P5|Phase 3|Non-Responder|0
375092|NCT00913458|1263642|P4|Phase 3|Non-Responder|0
375093|NCT00913458|1263643|P3|Phase 3|Non-Responder|0
375094|NCT00913458|1263644|P2|Phase 3|Non-Responder|0
375095|NCT00913458|1263645|P1|Phase 3|Non-Responder|0
375096|NCT00913458|1263639|P7|Phase 3|Lost to Follow-up|0
375097|NCT00913458|1263640|P6|Phase 3|Lost to Follow-up|0
375098|NCT00913458|1263641|P5|Phase 3|Lost to Follow-up|2
375099|NCT00913458|1263642|P4|Phase 3|Lost to Follow-up|0
375100|NCT00913458|1263643|P3|Phase 3|Lost to Follow-up|0
375101|NCT00913458|1263644|P2|Phase 3|Lost to Follow-up|0
375102|NCT00913458|1263645|P1|Phase 3|Lost to Follow-up|0
375103|NCT00913458|1263639|P7|Phase 3|Adverse Event|1
375104|NCT00913458|1263640|P6|Phase 3|Adverse Event|4
375105|NCT00913458|1263641|P5|Phase 3|Adverse Event|5
375106|NCT00913458|1263642|P4|Phase 3|Adverse Event|0
375107|NCT00913458|1263643|P3|Phase 3|Adverse Event|0
375108|NCT00913458|1263644|P2|Phase 3|Adverse Event|0
375109|NCT00913458|1263645|P1|Phase 3|Adverse Event|0
375110|NCT00913458|1263639|P7|Phase 2|Unsatisfactory Response per Investigator|0
375111|NCT00913458|1263640|P6|Phase 2|Unsatisfactory Response per Investigator|0
375112|NCT00913458|1263641|P5|Phase 2|Unsatisfactory Response per Investigator|0
375113|NCT00913458|1263642|P4|Phase 2|Unsatisfactory Response per Investigator|17
375114|NCT00913458|1263643|P3|Phase 2|Unsatisfactory Response per Investigator|11
375115|NCT00913458|1263644|P2|Phase 2|Unsatisfactory Response per Investigator|0
375116|NCT00913458|1263645|P1|Phase 2|Unsatisfactory Response per Investigator|0
375117|NCT00913458|1263639|P7|Phase 2|Protocol Violation|0
375118|NCT00913458|1263640|P6|Phase 2|Protocol Violation|0
375119|NCT00913458|1263641|P5|Phase 2|Protocol Violation|0
375120|NCT00913458|1263642|P4|Phase 2|Protocol Violation|0
375121|NCT00913458|1263643|P3|Phase 2|Protocol Violation|0
375122|NCT00913458|1263644|P2|Phase 2|Protocol Violation|2
375123|NCT00913458|1263645|P1|Phase 2|Protocol Violation|0
375124|NCT00913458|1263639|P7|Phase 2|Lost to Follow-up|0
375125|NCT00913458|1263640|P6|Phase 2|Lost to Follow-up|0
375126|NCT00913458|1263641|P5|Phase 2|Lost to Follow-up|0
375127|NCT00913458|1263642|P4|Phase 2|Lost to Follow-up|1
375128|NCT00913458|1263643|P3|Phase 2|Lost to Follow-up|0
375129|NCT00913458|1263644|P2|Phase 2|Lost to Follow-up|0
375130|NCT00913458|1263645|P1|Phase 2|Lost to Follow-up|0
375131|NCT00913458|1263639|P7|Phase 2|Adverse Event|0
375132|NCT00913458|1263640|P6|Phase 2|Adverse Event|0
375133|NCT00913458|1263641|P5|Phase 2|Adverse Event|0
375134|NCT00913458|1263642|P4|Phase 2|Adverse Event|1
375135|NCT00913458|1263643|P3|Phase 2|Adverse Event|0
375136|NCT00913458|1263644|P2|Phase 2|Adverse Event|3
375137|NCT00913458|1263645|P1|Phase 2|Adverse Event|0
375138|NCT00913458|1263639|P7|Phase 2|Subject Request|0
375139|NCT00913458|1263640|P6|Phase 2|Subject Request|0
375140|NCT00913458|1263641|P5|Phase 2|Subject Request|0
375141|NCT00913458|1263642|P4|Phase 2|Subject Request|2
375142|NCT00913458|1263643|P3|Phase 2|Subject Request|1
375143|NCT00913458|1263644|P2|Phase 2|Subject Request|0
375144|NCT00913458|1263645|P1|Phase 2|Subject Request|0
375145|NCT00913458|1263639|P7|Phase 2|Non-Responder|0
375146|NCT00913458|1263640|P6|Phase 2|Non-Responder|0
375147|NCT00913458|1263641|P5|Phase 2|Non-Responder|0
375148|NCT00913458|1263642|P4|Phase 2|Non-Responder|12
375149|NCT00913458|1263643|P3|Phase 2|Non-Responder|7
375150|NCT00913458|1263644|P2|Phase 2|Non-Responder|5
375151|NCT00913458|1263645|P1|Phase 2|Non-Responder|0
375152|NCT00913458|1263639|P7|Phase 1|Unsatisfactory Response per Investigator|0
375153|NCT00913458|1263640|P6|Phase 1|Unsatisfactory Response per Investigator|0
375154|NCT00913458|1263641|P5|Phase 1|Unsatisfactory Response per Investigator|0
375155|NCT00913458|1263642|P4|Phase 1|Unsatisfactory Response per Investigator|0
375156|NCT00913458|1263643|P3|Phase 1|Unsatisfactory Response per Investigator|0
375157|NCT00913458|1263644|P2|Phase 1|Unsatisfactory Response per Investigator|0
375158|NCT00913458|1263645|P1|Phase 1|Unsatisfactory Response per Investigator|7
375159|NCT00913458|1263639|P7|Phase 1|Sponsor|0
375160|NCT00913458|1263640|P6|Phase 1|Sponsor|0
375161|NCT00913458|1263641|P5|Phase 1|Sponsor|0
375162|NCT00913458|1263642|P4|Phase 1|Sponsor|0
375163|NCT00913458|1263643|P3|Phase 1|Sponsor|0
375164|NCT00913458|1263644|P2|Phase 1|Sponsor|0
375165|NCT00913458|1263645|P1|Phase 1|Sponsor|2
375166|NCT00913458|1263639|P7|Phase 1|Protocol Violation|0
375167|NCT00913458|1263640|P6|Phase 1|Protocol Violation|0
375168|NCT00913458|1263641|P5|Phase 1|Protocol Violation|0
375169|NCT00913458|1263642|P4|Phase 1|Protocol Violation|0
375170|NCT00913458|1263643|P3|Phase 1|Protocol Violation|0
375171|NCT00913458|1263644|P2|Phase 1|Protocol Violation|0
375172|NCT00913458|1263645|P1|Phase 1|Protocol Violation|10
375173|NCT00913458|1263639|P7|Phase 1|Lost to Follow-up|0
375174|NCT00913458|1263640|P6|Phase 1|Lost to Follow-up|0
375175|NCT00913458|1263641|P5|Phase 1|Lost to Follow-up|0
375176|NCT00913458|1263642|P4|Phase 1|Lost to Follow-up|0
375177|NCT00913458|1263643|P3|Phase 1|Lost to Follow-up|0
375178|NCT00913458|1263644|P2|Phase 1|Lost to Follow-up|0
375179|NCT00913458|1263645|P1|Phase 1|Lost to Follow-up|2
375180|NCT00913458|1263639|P7|Phase 1|Adverse Event|0
375181|NCT00913458|1263640|P6|Phase 1|Adverse Event|0
375182|NCT00913458|1263641|P5|Phase 1|Adverse Event|0
375183|NCT00913458|1263642|P4|Phase 1|Adverse Event|0
375184|NCT00913458|1263643|P3|Phase 1|Adverse Event|0
375185|NCT00913458|1263644|P2|Phase 1|Adverse Event|0
375186|NCT00913458|1263645|P1|Phase 1|Adverse Event|20
375187|NCT00913458|1263639|P7|Phase 1|Subject Request|0
375188|NCT00913458|1263640|P6|Phase 1|Subject Request|0
375189|NCT00913458|1263641|P5|Phase 1|Subject Request|0
375190|NCT00913458|1263642|P4|Phase 1|Subject Request|0
375191|NCT00913458|1263643|P3|Phase 1|Subject Request|0
375192|NCT00913458|1263644|P2|Phase 1|Subject Request|0
375193|NCT00913458|1263645|P1|Phase 1|Subject Request|17
375194|NCT00913458|1263639|P7|Phase 1|Non-Responder|0
375195|NCT00913458|1263640|P6|Phase 1|Non-Responder|0
375196|NCT00913458|1263641|P5|Phase 1|Non-Responder|0
375197|NCT00913458|1263642|P4|Phase 1|Non-Responder|0
375198|NCT00913458|1263643|P3|Phase 1|Non-Responder|0
375199|NCT00913458|1263644|P2|Phase 1|Non-Responder|0
375200|NCT00913458|1263645|P1|Phase 1|Non-Responder|54
375201|NCT00913380|1263738|P2|Clinical Outcomes|Lost to Follow-up|6
375202|NCT00913380|1263739|P1|Clinical Outcomes|Lost to Follow-up|6
375203|NCT00912964|1263805|P3|Overall Study|Randomized but never received study drug|0
375204|NCT00912964|1263806|P2|Overall Study|Randomized but never received study drug|1
375205|NCT00912964|1263807|P1|Overall Study|Randomized but never received study drug|0
375206|NCT00912964|1263805|P3|Overall Study|Violation of exclusion criterion|2
375207|NCT00912964|1263806|P2|Overall Study|Violation of exclusion criterion|0
375208|NCT00912964|1263807|P1|Overall Study|Violation of exclusion criterion|0
375209|NCT00912964|1263805|P3|Overall Study|Non-compliance with study procedures|0
375210|NCT00912964|1263806|P2|Overall Study|Non-compliance with study procedures|0
375211|NCT00912964|1263807|P1|Overall Study|Non-compliance with study procedures|2
375212|NCT00912964|1263805|P3|Overall Study|Medical History|0
375213|NCT00912964|1263806|P2|Overall Study|Medical History|0
375214|NCT00912964|1263807|P1|Overall Study|Medical History|1
375215|NCT00912964|1263805|P3|Overall Study|Taking exclusionary medications|8
375216|NCT00912964|1263806|P2|Overall Study|Taking exclusionary medications|4
375217|NCT00912964|1263807|P1|Overall Study|Taking exclusionary medications|7
375218|NCT00912964|1263805|P3|Overall Study|Protocol Violation|8
375219|NCT00912964|1263806|P2|Overall Study|Protocol Violation|3
375220|NCT00912964|1263807|P1|Overall Study|Protocol Violation|5
375221|NCT00912964|1263805|P3|Overall Study|Lost to Follow-up|3
375222|NCT00912964|1263806|P2|Overall Study|Lost to Follow-up|3
375223|NCT00912964|1263807|P1|Overall Study|Lost to Follow-up|4
375224|NCT00912964|1263805|P3|Overall Study|Withdrawal by Subject|18
375225|NCT00912964|1263806|P2|Overall Study|Withdrawal by Subject|12
375226|NCT00912964|1263807|P1|Overall Study|Withdrawal by Subject|20
375227|NCT00912964|1263805|P3|Overall Study|Lack of Efficacy|3
375228|NCT00912964|1263806|P2|Overall Study|Lack of Efficacy|4
375229|NCT00912964|1263807|P1|Overall Study|Lack of Efficacy|11
375230|NCT00912964|1263805|P3|Overall Study|Adverse Event|12
375231|NCT00912964|1263806|P2|Overall Study|Adverse Event|18
375232|NCT00912964|1263807|P1|Overall Study|Adverse Event|15
375233|NCT00912964|1263805|P3|Overall Study|Eligibility criterion not met|0
375234|NCT00912964|1263806|P2|Overall Study|Eligibility criterion not met|1
375235|NCT00912964|1263807|P1|Overall Study|Eligibility criterion not met|1
375236|NCT00912912|1263950|P1|Overall Study|Disease Progression|3
375237|NCT00912912|1263950|P1|Overall Study|Withdrawal by Subject|1
375238|NCT00912808|1263956|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
375239|NCT00912808|1263957|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
375240|NCT00912808|1263956|P2|Second Intervention (6 Weeks)|Adverse Event|1
375241|NCT00912808|1263957|P1|Second Intervention (6 Weeks)|Adverse Event|0
375242|NCT00912808|1263956|P2|Washout|Withdrawal by Subject|1
375243|NCT00912808|1263957|P1|Washout|Withdrawal by Subject|0
375244|NCT00912808|1263956|P2|First Intervention (6 Weeks)|Adverse Event|1
375245|NCT00912808|1263957|P1|First Intervention (6 Weeks)|Adverse Event|2
375246|NCT00912782|1263982|P2|Overall Study|Relocated before study completion|1
375247|NCT00912782|1263983|P1|Overall Study|Relocated before study completion|0
375248|NCT00912782|1263982|P2|Overall Study|Did not receive vascular access type|2
375249|NCT00912782|1263983|P1|Overall Study|Did not receive vascular access type|1
375250|NCT00912782|1263982|P2|Overall Study|Lost to Follow-up|1
375251|NCT00912782|1263983|P1|Overall Study|Lost to Follow-up|0
375252|NCT00912782|1263982|P2|Overall Study|Death|1
375253|NCT00912782|1263983|P1|Overall Study|Death|2
375254|NCT00912743|1263993|P2|Overall Study|End of treatment form was not collected|0
375255|NCT00912743|1263994|P1|Overall Study|End of treatment form was not collected|1
375256|NCT00912743|1263993|P2|Overall Study|Toxicity|1
375257|NCT00912743|1263994|P1|Overall Study|Toxicity|0
375258|NCT00912743|1263993|P2|Overall Study|Lack of Efficacy|18
375259|NCT00912743|1263994|P1|Overall Study|Lack of Efficacy|9
375260|NCT00912743|1263993|P2|Overall Study|Adverse Event|1
375261|NCT00912743|1263994|P1|Overall Study|Adverse Event|3
375262|NCT00912509|1264006|P2|Overall Study|Lack of Efficacy|3
375263|NCT00912509|1264007|P1|Overall Study|Lack of Efficacy|4
375264|NCT00912509|1264006|P2|Overall Study|Lost to Follow-up|0
375265|NCT00912509|1264007|P1|Overall Study|Lost to Follow-up|1
375266|NCT00912405|1264015|P1|Overall Study|Lost to Follow-up|5
375267|NCT00912288|1264049|P2|Overall Study|Other|0
375268|NCT00912288|1264050|P1|Overall Study|Other|1
375269|NCT00912288|1264049|P2|Overall Study|Study terminated by sponsor|35
375270|NCT00912288|1264050|P1|Overall Study|Study terminated by sponsor|34
375271|NCT00912288|1264049|P2|Overall Study|Withdrawal by Subject|3
375272|NCT00912288|1264050|P1|Overall Study|Withdrawal by Subject|3
375273|NCT00912288|1264049|P2|Overall Study|Protocol Violation|0
375274|NCT00912288|1264050|P1|Overall Study|Protocol Violation|1
375275|NCT00912288|1264049|P2|Overall Study|Lost to Follow-up|0
375276|NCT00912288|1264050|P1|Overall Study|Lost to Follow-up|1
375277|NCT00912288|1264049|P2|Overall Study|Adverse Event|1
375278|NCT00912288|1264050|P1|Overall Study|Adverse Event|1
375279|NCT00912288|1264049|P2|Overall Study|Death|1
375280|NCT00912288|1264050|P1|Overall Study|Death|0
375281|NCT00912223|1264072|P1|Overall Study|Transformed disease|1
375282|NCT00912223|1264072|P1|Overall Study|Not transplanted|1
375283|NCT00912223|1264072|P1|Overall Study|Withdrawal by Subject|1
375284|NCT00912093|1264103|P5|The Controlled Phase|Lost to Follow-up|1
375285|NCT00912093|1264104|P4|The Controlled Phase|Lost to Follow-up|0
375286|NCT00912093|1264105|P3|The Controlled Phase|Lost to Follow-up|0
375287|NCT00912093|1264106|P2|The Controlled Phase|Lost to Follow-up|0
375288|NCT00912093|1264107|P1|The Controlled Phase|Lost to Follow-up|0
375289|NCT00912093|1264103|P5|The Controlled Phase|Medical Condition|0
375290|NCT00912093|1264104|P4|The Controlled Phase|Medical Condition|0
375291|NCT00912093|1264105|P3|The Controlled Phase|Medical Condition|0
375292|NCT00912093|1264106|P2|The Controlled Phase|Medical Condition|1
375293|NCT00912093|1264107|P1|The Controlled Phase|Medical Condition|0
375294|NCT00912093|1264103|P5|The Controlled Phase|Death|0
375295|NCT00912093|1264104|P4|The Controlled Phase|Death|0
375296|NCT00912093|1264105|P3|The Controlled Phase|Death|0
375297|NCT00912093|1264106|P2|The Controlled Phase|Death|1
375298|NCT00912093|1264107|P1|The Controlled Phase|Death|0
375299|NCT00912028|1264126|P5|Overall Study|Withdrawal by Subject|0
375300|NCT00912028|1264127|P4|Overall Study|Withdrawal by Subject|0
375301|NCT00912028|1264128|P3|Overall Study|Withdrawal by Subject|0
375302|NCT00912028|1264129|P2|Overall Study|Withdrawal by Subject|0
375303|NCT00912028|1264130|P1|Overall Study|Withdrawal by Subject|3
375304|NCT00912028|1264126|P5|Overall Study|Lost to Follow-up|3
375305|NCT00912028|1264127|P4|Overall Study|Lost to Follow-up|1
375306|NCT00912028|1264128|P3|Overall Study|Lost to Follow-up|0
375307|NCT00912028|1264129|P2|Overall Study|Lost to Follow-up|3
375308|NCT00912028|1264130|P1|Overall Study|Lost to Follow-up|2
375309|NCT00912015|1264159|P4|Overall Study|Adverse Event|1
375310|NCT00912015|1264160|P3|Overall Study|Adverse Event|0
375311|NCT00912015|1264161|P2|Overall Study|Adverse Event|0
375312|NCT00912015|1264162|P1|Overall Study|Adverse Event|6
375313|NCT00912015|1264159|P4|Overall Study|Protocol Violation|1
375314|NCT00912015|1264160|P3|Overall Study|Protocol Violation|0
375315|NCT00912015|1264161|P2|Overall Study|Protocol Violation|0
375316|NCT00912015|1264162|P1|Overall Study|Protocol Violation|1
375317|NCT00912015|1264159|P4|Overall Study|Withdrawal by Subject|0
375318|NCT00912015|1264160|P3|Overall Study|Withdrawal by Subject|3
375319|NCT00912015|1264161|P2|Overall Study|Withdrawal by Subject|8
375320|NCT00912015|1264162|P1|Overall Study|Withdrawal by Subject|8
375321|NCT00912015|1264159|P4|Overall Study|Lack of Efficacy|0
375322|NCT00912015|1264160|P3|Overall Study|Lack of Efficacy|0
375323|NCT00912015|1264161|P2|Overall Study|Lack of Efficacy|0
375324|NCT00912015|1264162|P1|Overall Study|Lack of Efficacy|1
375325|NCT00911989|1264178|P1|Overall Study|Adverse Event|1
375326|NCT00911937|1264184|P2|Overall Study|Other|5
375327|NCT00911937|1264185|P1|Overall Study|Other|9
375328|NCT00911937|1264184|P2|Overall Study|Randomized but not treated|13
375329|NCT00911937|1264185|P1|Overall Study|Randomized but not treated|13
375330|NCT00911937|1264184|P2|Overall Study|Protocol Violation|23
375331|NCT00911937|1264185|P1|Overall Study|Protocol Violation|14
375332|NCT00911937|1264184|P2|Overall Study|Did not meet inclusion criteria|11
375333|NCT00911937|1264185|P1|Overall Study|Did not meet inclusion criteria|9
375334|NCT00911937|1264184|P2|Overall Study|Lack of Efficacy|6
375335|NCT00911937|1264185|P1|Overall Study|Lack of Efficacy|11
375336|NCT00911937|1264184|P2|Overall Study|Adverse Event|25
375337|NCT00911937|1264185|P1|Overall Study|Adverse Event|11
375338|NCT00911937|1264184|P2|Overall Study|Withdrawn due to pregnancy|0
375339|NCT00911937|1264185|P1|Overall Study|Withdrawn due to pregnancy|1
375340|NCT00911937|1264184|P2|Overall Study|Withdrawal by Subject|7
375341|NCT00911937|1264185|P1|Overall Study|Withdrawal by Subject|10
375342|NCT00911937|1264184|P2|Overall Study|Lost to Follow-up|5
375343|NCT00911937|1264185|P1|Overall Study|Lost to Follow-up|8
375344|NCT00911937|1264184|P2|Overall Study|Death|0
375345|NCT00911937|1264185|P1|Overall Study|Death|1
375346|NCT00911859|1264252|P3|Follow-up Period|Study terminated by sponsor|27
375347|NCT00911859|1264253|P2|Follow-up Period|Study terminated by sponsor|33
375348|NCT00911859|1264254|P1|Follow-up Period|Study terminated by sponsor|5
375349|NCT00911859|1264252|P3|Follow-up Period|Withdrawal by Subject|4
375350|NCT00911859|1264253|P2|Follow-up Period|Withdrawal by Subject|4
375351|NCT00911859|1264254|P1|Follow-up Period|Withdrawal by Subject|0
375352|NCT00911859|1264252|P3|Follow-up Period|Lost to Follow-up|0
375353|NCT00911859|1264253|P2|Follow-up Period|Lost to Follow-up|1
375354|NCT00911859|1264254|P1|Follow-up Period|Lost to Follow-up|1
375355|NCT00911859|1264252|P3|Follow-up Period|Death|10
375356|NCT00911859|1264253|P2|Follow-up Period|Death|8
375357|NCT00911859|1264254|P1|Follow-up Period|Death|5
375358|NCT00911859|1264252|P3|Maintainance Period|Withdrawal by Subject|3
375359|NCT00911859|1264253|P2|Maintainance Period|Withdrawal by Subject|0
375360|NCT00911859|1264254|P1|Maintainance Period|Withdrawal by Subject|0
375361|NCT00911859|1264252|P3|Maintainance Period|Physician Decision|9
375362|NCT00911859|1264253|P2|Maintainance Period|Physician Decision|0
375363|NCT00911859|1264254|P1|Maintainance Period|Physician Decision|0
375364|NCT00911859|1264252|P3|Maintainance Period|Lack of Efficacy|9
375365|NCT00911859|1264253|P2|Maintainance Period|Lack of Efficacy|0
375366|NCT00911859|1264254|P1|Maintainance Period|Lack of Efficacy|0
375367|NCT00911859|1264252|P3|Treatment Period|Did not receive study treatment|0
375368|NCT00911859|1264253|P2|Treatment Period|Did not receive study treatment|1
375369|NCT00911859|1264254|P1|Treatment Period|Did not receive study treatment|0
375370|NCT00911859|1264252|P3|Treatment Period|Withdrawal by Subject|5
375371|NCT00911859|1264253|P2|Treatment Period|Withdrawal by Subject|4
375372|NCT00911859|1264254|P1|Treatment Period|Withdrawal by Subject|0
375373|NCT00911859|1264252|P3|Treatment Period|Physician Decision|3
375374|NCT00911859|1264253|P2|Treatment Period|Physician Decision|3
375375|NCT00911859|1264254|P1|Treatment Period|Physician Decision|3
375376|NCT00911859|1264252|P3|Treatment Period|Lack of Efficacy|5
375377|NCT00911859|1264253|P2|Treatment Period|Lack of Efficacy|7
375378|NCT00911859|1264254|P1|Treatment Period|Lack of Efficacy|1
375379|NCT00911859|1264252|P3|Treatment Period|Death|5
375380|NCT00911859|1264253|P2|Treatment Period|Death|3
375381|NCT00911859|1264254|P1|Treatment Period|Death|1
375382|NCT00911859|1264252|P3|Treatment Period|Adverse Event|7
375383|NCT00911859|1264253|P2|Treatment Period|Adverse Event|3
375384|NCT00911859|1264254|P1|Treatment Period|Adverse Event|3
375385|NCT00911820|1264280|P2|Overall Study|Withdraw before Receive Treatment|2
375386|NCT00911820|1264281|P1|Overall Study|Withdraw before Receive Treatment|0
375387|NCT00911820|1264280|P2|Overall Study|Pathology Not Confirmed|0
375388|NCT00911820|1264281|P1|Overall Study|Pathology Not Confirmed|1
375389|NCT00911820|1264280|P2|Overall Study|Still on Therapy|2
375390|NCT00911820|1264281|P1|Overall Study|Still on Therapy|2
375391|NCT00911820|1264280|P2|Overall Study|Pursue Radiation|0
375392|NCT00911820|1264281|P1|Overall Study|Pursue Radiation|1
375393|NCT00911820|1264280|P2|Overall Study|Pursue surgery|1
375394|NCT00911820|1264281|P1|Overall Study|Pursue surgery|1
375395|NCT00911820|1264280|P2|Overall Study|Death|2
375396|NCT00911820|1264281|P1|Overall Study|Death|1
375397|NCT00911820|1264280|P2|Overall Study|Withdrawal by Subject|4
375398|NCT00911820|1264281|P1|Overall Study|Withdrawal by Subject|3
375399|NCT00911820|1264280|P2|Overall Study|Decline in Performance Status|2
375400|NCT00911820|1264281|P1|Overall Study|Decline in Performance Status|4
375401|NCT00911820|1264280|P2|Overall Study|Physician Decision|9
375402|NCT00911820|1264281|P1|Overall Study|Physician Decision|5
375403|NCT00911820|1264280|P2|Overall Study|Clinical Progression|5
375404|NCT00911820|1264281|P1|Overall Study|Clinical Progression|7
375405|NCT00911820|1264280|P2|Overall Study|Adverse Event|8
375406|NCT00911820|1264281|P1|Overall Study|Adverse Event|8
375407|NCT00911820|1264280|P2|Overall Study|RECIST progression|8
375408|NCT00911820|1264281|P1|Overall Study|RECIST progression|12
375409|NCT00911807|1264298|P3|Overall Study|Organizational reasons|1
375410|NCT00911807|1264299|P2|Overall Study|Organizational reasons|3
375411|NCT00911807|1264300|P1|Overall Study|Organizational reasons|1
375412|NCT00911807|1264298|P3|Overall Study|Withdrawal by Subject|7
375413|NCT00911807|1264299|P2|Overall Study|Withdrawal by Subject|10
375414|NCT00911807|1264300|P1|Overall Study|Withdrawal by Subject|8
375415|NCT00911807|1264298|P3|Overall Study|Protocol Violation|9
375416|NCT00911807|1264299|P2|Overall Study|Protocol Violation|4
375417|NCT00911807|1264300|P1|Overall Study|Protocol Violation|6
375418|NCT00911807|1264298|P3|Overall Study|Death|1
375419|NCT00911807|1264299|P2|Overall Study|Death|0
375420|NCT00911807|1264300|P1|Overall Study|Death|0
375421|NCT00911807|1264298|P3|Overall Study|Adverse Event|5
375422|NCT00911807|1264299|P2|Overall Study|Adverse Event|1
375423|NCT00911807|1264300|P1|Overall Study|Adverse Event|2
375424|NCT00911768|1264310|P2|Overall Study|Withdrawal by Subject|0
375425|NCT00911768|1264311|P1|Overall Study|Withdrawal by Subject|1
375426|NCT00911768|1264310|P2|Overall Study|Protocol Violation|4
375427|NCT00911768|1264311|P1|Overall Study|Protocol Violation|5
375428|NCT00911625|1264340|P2|Overall Study|Lost to Follow-up|0
375429|NCT00911625|1264341|P1|Overall Study|Lost to Follow-up|7
375430|NCT00911547|1264370|P4|Overall Study|Withdrawal by Subject|8
375431|NCT00911547|1264371|P3|Overall Study|Withdrawal by Subject|4
375432|NCT00911547|1264372|P2|Overall Study|Withdrawal by Subject|10
375433|NCT00911547|1264373|P1|Overall Study|Withdrawal by Subject|3
375434|NCT00911547|1264370|P4|Overall Study|Protocol Violation|1
375435|NCT00911547|1264371|P3|Overall Study|Protocol Violation|5
375436|NCT00911547|1264372|P2|Overall Study|Protocol Violation|5
375437|NCT00911547|1264373|P1|Overall Study|Protocol Violation|0
375438|NCT00911547|1264370|P4|Overall Study|Lost to Follow-up|1
375439|NCT00911547|1264371|P3|Overall Study|Lost to Follow-up|2
375440|NCT00911547|1264372|P2|Overall Study|Lost to Follow-up|0
375441|NCT00911547|1264373|P1|Overall Study|Lost to Follow-up|0
375442|NCT00911547|1264370|P4|Overall Study|Adverse Event|6
375443|NCT00911547|1264371|P3|Overall Study|Adverse Event|11
375444|NCT00911547|1264372|P2|Overall Study|Adverse Event|27
375445|NCT00911547|1264373|P1|Overall Study|Adverse Event|8
375446|NCT00911534|1264401|P2|Overall Study|Not specified|2
375447|NCT00911534|1264402|P1|Overall Study|Not specified|2
375448|NCT00911534|1264401|P2|Overall Study|Withdrawal of consent|4
375449|NCT00911534|1264402|P1|Overall Study|Withdrawal of consent|1
375450|NCT00911534|1264401|P2|Overall Study|Lack of Efficacy|1
375451|NCT00911534|1264402|P1|Overall Study|Lack of Efficacy|4
375452|NCT00911534|1264401|P2|Overall Study|Withdrawal by Subject|1
375453|NCT00911534|1264402|P1|Overall Study|Withdrawal by Subject|2
375454|NCT00911534|1264401|P2|Overall Study|Lost to Follow-up|4
375455|NCT00911534|1264402|P1|Overall Study|Lost to Follow-up|2
375456|NCT00911534|1264401|P2|Overall Study|Adverse Event|4
375457|NCT00911534|1264402|P1|Overall Study|Adverse Event|4
375458|NCT00911300|1264457|P2|Overall Study|Randomized; No Study Medication Received|2
375459|NCT00911300|1264458|P1|Overall Study|Randomized; No Study Medication Received|0
375460|NCT00911300|1264457|P2|Overall Study|Treatment Stopped by Mistake|1
375461|NCT00911300|1264458|P1|Overall Study|Treatment Stopped by Mistake|0
375462|NCT00911300|1264457|P2|Overall Study|Physician Decision|1
375463|NCT00911300|1264458|P1|Overall Study|Physician Decision|0
375464|NCT00911300|1264457|P2|Overall Study|Underlying Disease (Myocarditis)|1
375465|NCT00911300|1264458|P1|Overall Study|Underlying Disease (Myocarditis)|0
375466|NCT00911300|1264457|P2|Overall Study|Participant Refused Hospital Consulation|1
375467|NCT00911300|1264458|P1|Overall Study|Participant Refused Hospital Consulation|0
375468|NCT00911300|1264457|P2|Overall Study|International Normalized Ratio Too High|1
375469|NCT00911300|1264458|P1|Overall Study|International Normalized Ratio Too High|0
375470|NCT00911300|1264457|P2|Overall Study|Investigator's Decision; New AF Episode|1
375471|NCT00911300|1264458|P1|Overall Study|Investigator's Decision; New AF Episode|0
375472|NCT00911300|1264457|P2|Overall Study|Participant Could Not Stay in Hospital|1
375473|NCT00911300|1264458|P1|Overall Study|Participant Could Not Stay in Hospital|0
375474|NCT00911300|1264457|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
375475|NCT00911300|1264458|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
375476|NCT00911300|1264457|P2|Overall Study|Nurse Unavailable in Participant's City|0
375477|NCT00911300|1264458|P1|Overall Study|Nurse Unavailable in Participant's City|1
375478|NCT00911300|1264457|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
375479|NCT00911300|1264458|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
375480|NCT00911300|1264457|P2|Overall Study|Recurrent Tachyarrhythmia|1
375481|NCT00911300|1264458|P1|Overall Study|Recurrent Tachyarrhythmia|1
375482|NCT00911300|1264457|P2|Overall Study|Received Commercial Treatment|0
375483|NCT00911300|1264458|P1|Overall Study|Received Commercial Treatment|1
375484|NCT00911300|1264457|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
375485|NCT00911300|1264458|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
375486|NCT00911300|1264457|P2|Overall Study|Coronary Angiography Performed|0
375487|NCT00911300|1264458|P1|Overall Study|Coronary Angiography Performed|1
375488|NCT00911300|1264457|P2|Overall Study|Consent Withdrawn|12
375489|NCT00911300|1264458|P1|Overall Study|Consent Withdrawn|4
375490|NCT00911300|1264457|P2|Overall Study|Protocol Violation|2
375491|NCT00911300|1264458|P1|Overall Study|Protocol Violation|3
375492|NCT00911300|1264457|P2|Overall Study|Adverse Event|6
375493|NCT00911300|1264458|P1|Overall Study|Adverse Event|14
375494|NCT00911300|1264457|P2|Overall Study|Thrombus Persistant in Second TEE|7
375495|NCT00911300|1264458|P1|Overall Study|Thrombus Persistant in Second TEE|3
375496|NCT00911300|1264457|P2|Overall Study|Death|0
375497|NCT00911300|1264458|P1|Overall Study|Death|1
375498|NCT00911300|1264457|P2|Overall Study|Primary Endpoint Component Occurred|2
375499|NCT00911300|1264458|P1|Overall Study|Primary Endpoint Component Occurred|1
375500|NCT00911170|1264495|P2|Long Term Follow-Up|Death|121
375501|NCT00911170|1264496|P1|Long Term Follow-Up|Death|116
375502|NCT00911170|1264495|P2|Long Term Follow-Up|Lost to Follow-up|7
375503|NCT00911170|1264496|P1|Long Term Follow-Up|Lost to Follow-up|8
375504|NCT00911170|1264495|P2|Long Term Follow-Up|Physician Decision|4
375505|NCT00911170|1264496|P1|Long Term Follow-Up|Physician Decision|5
375506|NCT00911170|1264495|P2|Long Term Follow-Up|Withdrawal by Subject|21
375507|NCT00911170|1264496|P1|Long Term Follow-Up|Withdrawal by Subject|20
375508|NCT00911170|1264495|P2|Long Term Follow-Up|Continuing in study|269
375509|NCT00911170|1264496|P1|Long Term Follow-Up|Continuing in study|274
375510|NCT00911170|1264495|P2|Treatment Period|Death|9
375511|NCT00911170|1264496|P1|Treatment Period|Death|6
375512|NCT00911170|1264495|P2|Treatment Period|Lost to Follow-up|1
375513|NCT00911170|1264496|P1|Treatment Period|Lost to Follow-up|0
375514|NCT00911170|1264495|P2|Treatment Period|Physician Decision|5
375515|NCT00911170|1264496|P1|Treatment Period|Physician Decision|5
375516|NCT00911170|1264495|P2|Treatment Period|Disease progression|2
375517|NCT00911170|1264496|P1|Treatment Period|Disease progression|0
375518|NCT00911170|1264495|P2|Treatment Period|Withdrawal by Subject|4
375519|NCT00911170|1264496|P1|Treatment Period|Withdrawal by Subject|4
375520|NCT00911170|1264495|P2|Treatment Period|Adverse Event|10
375521|NCT00911170|1264496|P1|Treatment Period|Adverse Event|9
375522|NCT00911170|1264495|P2|Treatment Period|Protocol deviation|2
375523|NCT00911170|1264496|P1|Treatment Period|Protocol deviation|1
375524|NCT00911170|1264495|P2|Treatment Period|Ineligibility determined|3
375525|NCT00911170|1264496|P1|Treatment Period|Ineligibility determined|1
375526|NCT00911170|1264495|P2|Treatment Period|Randomized in error|1
375527|NCT00911170|1264496|P1|Treatment Period|Randomized in error|1
375528|NCT00911157|1264520|P2|Overall Study|Need to treat for lung cancer|0
375529|NCT00911157|1264521|P1|Overall Study|Need to treat for lung cancer|1
375530|NCT00911157|1264520|P2|Overall Study|Need for prohibited drug (heparin)|0
375531|NCT00911157|1264521|P1|Overall Study|Need for prohibited drug (heparin)|1
375532|NCT00911157|1264520|P2|Overall Study|Withdrawal by Subject|1
375533|NCT00911157|1264521|P1|Overall Study|Withdrawal by Subject|1
375534|NCT00911157|1264520|P2|Overall Study|Adverse Event|1
375535|NCT00911157|1264521|P1|Overall Study|Adverse Event|4
375536|NCT00911144|1264537|P2|Overall Study|Withdrawal by Subject|5
375537|NCT00911144|1264538|P1|Overall Study|Withdrawal by Subject|16
375538|NCT00910988|1264566|P4|Overall Study|Lost to Follow-up|0
375539|NCT00910988|1264567|P3|Overall Study|Lost to Follow-up|3
375540|NCT00910988|1264568|P2|Overall Study|Lost to Follow-up|4
375541|NCT00910988|1264569|P1|Overall Study|Lost to Follow-up|2
375542|NCT00910962|1264614|P3|Overall Study|Reached defined stopping criteria|17
375543|NCT00910962|1264615|P2|Overall Study|Reached defined stopping criteria|14
375544|NCT00910962|1264616|P1|Overall Study|Reached defined stopping criteria|12
375545|NCT00910962|1264614|P3|Overall Study|Withdrawal by Subject|32
375546|NCT00910962|1264615|P2|Overall Study|Withdrawal by Subject|32
375547|NCT00910962|1264616|P1|Overall Study|Withdrawal by Subject|25
375548|NCT00910962|1264614|P3|Overall Study|Physician Decision|6
375549|NCT00910962|1264615|P2|Overall Study|Physician Decision|6
375550|NCT00910962|1264616|P1|Overall Study|Physician Decision|0
375551|NCT00910962|1264614|P3|Overall Study|Lost to Follow-up|1
375552|NCT00910962|1264615|P2|Overall Study|Lost to Follow-up|3
375553|NCT00910962|1264616|P1|Overall Study|Lost to Follow-up|0
375554|NCT00910962|1264614|P3|Overall Study|Protocol Violation|3
375555|NCT00910962|1264615|P2|Overall Study|Protocol Violation|3
375556|NCT00910962|1264616|P1|Overall Study|Protocol Violation|1
375557|NCT00910962|1264614|P3|Overall Study|Adverse Event|17
375558|NCT00910962|1264615|P2|Overall Study|Adverse Event|20
375559|NCT00910962|1264616|P1|Overall Study|Adverse Event|5
375560|NCT00910910|1264708|P2|Overall Study|Untreated before cycle 1|2
375561|NCT00910910|1264709|P1|Overall Study|Untreated before cycle 1|1
375562|NCT00910910|1264708|P2|Overall Study|Other|32
375563|NCT00910910|1264709|P1|Overall Study|Other|114
375564|NCT00910910|1264708|P2|Overall Study|Completed 13 cycles of treatment|118
375565|NCT00910910|1264709|P1|Overall Study|Completed 13 cycles of treatment|0
375566|NCT00910910|1264708|P2|Overall Study|Protocol Violation|2
375567|NCT00910910|1264709|P1|Overall Study|Protocol Violation|2
375568|NCT00910910|1264708|P2|Overall Study|Death|3
375569|NCT00910910|1264709|P1|Overall Study|Death|9
375570|NCT00910910|1264708|P2|Overall Study|Lost to Follow-up|2
375571|NCT00910910|1264709|P1|Overall Study|Lost to Follow-up|2
375572|NCT00910910|1264708|P2|Overall Study|Withdrawal by Subject|5
375573|NCT00910910|1264709|P1|Overall Study|Withdrawal by Subject|7
375574|NCT00910910|1264708|P2|Overall Study|PD with histologic change|2
375575|NCT00910910|1264709|P1|Overall Study|PD with histologic change|0
375576|NCT00910910|1264708|P2|Overall Study|PD without histologic change|23
375577|NCT00910910|1264709|P1|Overall Study|PD without histologic change|27
375578|NCT00910910|1264708|P2|Overall Study|Adverse Event|35
375579|NCT00910910|1264709|P1|Overall Study|Adverse Event|63
375580|NCT00910871|1264743|P1|Overall Study|Undefined|1
375581|NCT00910871|1264743|P1|Overall Study|Subject didn’t meet eligibility criteria|5
375582|NCT00910871|1264743|P1|Overall Study|Withdrawal by Subject|12
375583|NCT00910871|1264743|P1|Overall Study|Protocol Violation|11
375584|NCT00910871|1264743|P1|Overall Study|Lost to Follow-up|8
375585|NCT00910871|1264743|P1|Overall Study|Death|12
375586|NCT00910871|1264743|P1|Overall Study|Adverse Event|5
375587|NCT00910858|1264751|P3|Combined Treatment Phase|Other|1
375588|NCT00910858|1264752|P2|Combined Treatment Phase|Other|2
375589|NCT00910858|1264753|P1|Combined Treatment Phase|Other|0
375590|NCT00910858|1264751|P3|Combined Treatment Phase|Protocol Violation|0
375591|NCT00910858|1264752|P2|Combined Treatment Phase|Protocol Violation|0
375592|NCT00910858|1264753|P1|Combined Treatment Phase|Protocol Violation|1
375593|NCT00910858|1264751|P3|Combined Treatment Phase|Withdrawal by Subject|0
375594|NCT00910858|1264752|P2|Combined Treatment Phase|Withdrawal by Subject|2
375595|NCT00910858|1264753|P1|Combined Treatment Phase|Withdrawal by Subject|0
375596|NCT00910858|1264751|P3|Combined Treatment Phase|Lack of therapeutic effect|3
375597|NCT00910858|1264752|P2|Combined Treatment Phase|Lack of therapeutic effect|6
375598|NCT00910858|1264753|P1|Combined Treatment Phase|Lack of therapeutic effect|8
375599|NCT00910858|1264751|P3|Monotherapy Phase|Other|2
375600|NCT00910858|1264752|P2|Monotherapy Phase|Other|4
375601|NCT00910858|1264753|P1|Monotherapy Phase|Other|3
375602|NCT00910858|1264751|P3|Monotherapy Phase|Protocol Violation|0
375603|NCT00910858|1264752|P2|Monotherapy Phase|Protocol Violation|0
375604|NCT00910858|1264753|P1|Monotherapy Phase|Protocol Violation|1
375605|NCT00910858|1264751|P3|Monotherapy Phase|Withdrawal by Subject|1
375606|NCT00910858|1264752|P2|Monotherapy Phase|Withdrawal by Subject|3
375607|NCT00910858|1264753|P1|Monotherapy Phase|Withdrawal by Subject|1
375608|NCT00910858|1264751|P3|Monotherapy Phase|Lack of therapeutic effect|4
375609|NCT00910858|1264752|P2|Monotherapy Phase|Lack of therapeutic effect|6
375610|NCT00910858|1264753|P1|Monotherapy Phase|Lack of therapeutic effect|9
375611|NCT00910858|1264751|P3|Monotherapy Phase|Adverse Event|0
375612|NCT00910858|1264752|P2|Monotherapy Phase|Adverse Event|2
375613|NCT00910858|1264753|P1|Monotherapy Phase|Adverse Event|3
375614|NCT00910858|1264751|P3|Pharmacokinetic Phase|Adverse Event|0
375615|NCT00910858|1264752|P2|Pharmacokinetic Phase|Adverse Event|0
375616|NCT00910858|1264753|P1|Pharmacokinetic Phase|Adverse Event|1
375617|NCT00910728|1264798|P9|Overall Study|Adverse Event|1
375618|NCT00910728|1264799|P8|Overall Study|Adverse Event|1
375619|NCT00910728|1264800|P7|Overall Study|Adverse Event|2
375620|NCT00910728|1264801|P6|Overall Study|Adverse Event|0
375621|NCT00910728|1264802|P5|Overall Study|Adverse Event|0
375622|NCT00910728|1264803|P4|Overall Study|Adverse Event|1
375623|NCT00910728|1264804|P3|Overall Study|Adverse Event|1
375624|NCT00910728|1264805|P2|Overall Study|Adverse Event|0
375625|NCT00910728|1264806|P1|Overall Study|Adverse Event|2
375626|NCT00910728|1264798|P9|Overall Study|(not specified)|0
375627|NCT00910728|1264799|P8|Overall Study|(not specified)|0
375628|NCT00910728|1264800|P7|Overall Study|(not specified)|0
375629|NCT00910728|1264801|P6|Overall Study|(not specified)|0
375630|NCT00910728|1264802|P5|Overall Study|(not specified)|1
375631|NCT00910728|1264803|P4|Overall Study|(not specified)|0
375632|NCT00910728|1264804|P3|Overall Study|(not specified)|1
375633|NCT00910728|1264805|P2|Overall Study|(not specified)|0
375634|NCT00910728|1264806|P1|Overall Study|(not specified)|2
375635|NCT00910728|1264798|P9|Overall Study|Withdrawal by Subject|0
375636|NCT00910728|1264799|P8|Overall Study|Withdrawal by Subject|0
375637|NCT00910728|1264800|P7|Overall Study|Withdrawal by Subject|2
375638|NCT00910728|1264801|P6|Overall Study|Withdrawal by Subject|1
375639|NCT00910728|1264802|P5|Overall Study|Withdrawal by Subject|3
375640|NCT00910728|1264803|P4|Overall Study|Withdrawal by Subject|0
375641|NCT00910728|1264804|P3|Overall Study|Withdrawal by Subject|0
375642|NCT00910728|1264805|P2|Overall Study|Withdrawal by Subject|0
375643|NCT00910728|1264806|P1|Overall Study|Withdrawal by Subject|0
375644|NCT00910728|1264798|P9|Overall Study|Lack of Efficacy|2
375645|NCT00910728|1264799|P8|Overall Study|Lack of Efficacy|2
375646|NCT00910728|1264800|P7|Overall Study|Lack of Efficacy|2
375647|NCT00910728|1264801|P6|Overall Study|Lack of Efficacy|0
375648|NCT00910728|1264802|P5|Overall Study|Lack of Efficacy|1
375649|NCT00910728|1264803|P4|Overall Study|Lack of Efficacy|2
375650|NCT00910728|1264804|P3|Overall Study|Lack of Efficacy|1
375651|NCT00910728|1264805|P2|Overall Study|Lack of Efficacy|3
375652|NCT00910728|1264806|P1|Overall Study|Lack of Efficacy|2
375653|NCT00910715|1264928|P3|Overall Study|Lost to Follow-up|0
375654|NCT00910715|1264929|P2|Overall Study|Lost to Follow-up|26
375655|NCT00910715|1264930|P1|Overall Study|Lost to Follow-up|22
375656|NCT00910689|1264944|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
375657|NCT00910689|1264945|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
375658|NCT00910689|1264946|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
375659|NCT00910689|1264947|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
375660|NCT00910689|1264944|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
375661|NCT00910689|1264945|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
375662|NCT00910689|1264946|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
375663|NCT00910689|1264947|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
375664|NCT00910689|1264944|P4|Months 11- 16: Evaluation Period II|Time Demands|0
375665|NCT00910689|1264945|P3|Months 11- 16: Evaluation Period II|Time Demands|0
375666|NCT00910689|1264946|P2|Months 11- 16: Evaluation Period II|Time Demands|1
375667|NCT00910689|1264947|P1|Months 11- 16: Evaluation Period II|Time Demands|2
375668|NCT00910689|1264944|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
375669|NCT00910689|1264945|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
375670|NCT00910689|1264946|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
375671|NCT00910689|1264947|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
375672|NCT00910689|1264944|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
375673|NCT00910689|1264945|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
375674|NCT00910689|1264946|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
375675|NCT00910689|1264947|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
375676|NCT00910689|1264944|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
375677|NCT00910689|1264945|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
375678|NCT00910689|1264946|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
375679|NCT00910689|1264947|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
375680|NCT00910689|1264944|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
375681|NCT00910689|1264945|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
375682|NCT00910689|1264946|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
375683|NCT00910689|1264947|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
375684|NCT00910689|1264944|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
375685|NCT00910689|1264945|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
375686|NCT00910689|1264946|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
375687|NCT00910689|1264947|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
375688|NCT00910689|1264944|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
375689|NCT00910689|1264945|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
375690|NCT00910689|1264946|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
375691|NCT00910689|1264947|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
375692|NCT00910689|1264944|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
375693|NCT00910689|1264945|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
375694|NCT00910689|1264946|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
375695|NCT00910689|1264947|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
375696|NCT00910689|1264944|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
375697|NCT00910689|1264945|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
375698|NCT00910689|1264946|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
375699|NCT00910689|1264947|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
375700|NCT00910689|1264944|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
375701|NCT00910689|1264945|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
375702|NCT00910689|1264946|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
375703|NCT00910689|1264947|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
375704|NCT00910689|1264944|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
375705|NCT00910689|1264945|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
375706|NCT00910689|1264946|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
375707|NCT00910689|1264947|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
375708|NCT00910689|1264944|P4|Month 2- 4: Treatment Period|Protocol Violation|0
375709|NCT00910689|1264945|P3|Month 2- 4: Treatment Period|Protocol Violation|0
375710|NCT00910689|1264946|P2|Month 2- 4: Treatment Period|Protocol Violation|0
375711|NCT00910689|1264947|P1|Month 2- 4: Treatment Period|Protocol Violation|1
375712|NCT00910689|1264944|P4|Month 2- 4: Treatment Period|Pregnancy|0
375713|NCT00910689|1264945|P3|Month 2- 4: Treatment Period|Pregnancy|0
375714|NCT00910689|1264946|P2|Month 2- 4: Treatment Period|Pregnancy|2
375715|NCT00910689|1264947|P1|Month 2- 4: Treatment Period|Pregnancy|0
375716|NCT00910689|1264944|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
375717|NCT00910689|1264945|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
375718|NCT00910689|1264946|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
375719|NCT00910689|1264947|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
375720|NCT00910689|1264944|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
375721|NCT00910689|1264945|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
375722|NCT00910689|1264946|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
375723|NCT00910689|1264947|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
375724|NCT00910689|1264944|P4|Month 2- 4: Treatment Period|Time Demands|8
375725|NCT00910689|1264945|P3|Month 2- 4: Treatment Period|Time Demands|4
375726|NCT00910689|1264946|P2|Month 2- 4: Treatment Period|Time Demands|0
375727|NCT00910689|1264947|P1|Month 2- 4: Treatment Period|Time Demands|1
375728|NCT00910689|1264944|P4|Month 2- 4: Treatment Period|Adverse Event|0
375729|NCT00910689|1264945|P3|Month 2- 4: Treatment Period|Adverse Event|2
375730|NCT00910689|1264946|P2|Month 2- 4: Treatment Period|Adverse Event|3
375731|NCT00910689|1264947|P1|Month 2- 4: Treatment Period|Adverse Event|2
375732|NCT00910689|1264944|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
375733|NCT00910689|1264945|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
375734|NCT00910689|1264946|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
375735|NCT00910689|1264947|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
375736|NCT00910689|1264944|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
375737|NCT00910689|1264945|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
375738|NCT00910689|1264946|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
375739|NCT00910689|1264947|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
375740|NCT00910663|1264979|P2|Period 1|Withdrawal by Subject|1
375741|NCT00910663|1264980|P1|Period 1|Withdrawal by Subject|0
375742|NCT00910624|1264994|P4|Follow-Up Phase|Administrative|0
375743|NCT00910624|1264995|P3|Follow-Up Phase|Administrative|1
375744|NCT00910624|1264996|P2|Follow-Up Phase|Administrative|1
375745|NCT00910624|1264997|P1|Follow-Up Phase|Administrative|0
375746|NCT00910624|1264994|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
375747|NCT00910624|1264995|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
375748|NCT00910624|1264996|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
375749|NCT00910624|1264997|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
375750|NCT00910624|1264994|P4|Follow-Up Phase|Withdrawal by Subject|0
375751|NCT00910624|1264995|P3|Follow-Up Phase|Withdrawal by Subject|0
375752|NCT00910624|1264996|P2|Follow-Up Phase|Withdrawal by Subject|0
375753|NCT00910624|1264997|P1|Follow-Up Phase|Withdrawal by Subject|1
375754|NCT00910624|1264994|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
375755|NCT00910624|1264995|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
375756|NCT00910624|1264996|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
375757|NCT00910624|1264997|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
375758|NCT00910624|1264994|P4|Follow-Up Phase|Lost to Follow-up|0
375759|NCT00910624|1264995|P3|Follow-Up Phase|Lost to Follow-up|2
375760|NCT00910624|1264996|P2|Follow-Up Phase|Lost to Follow-up|1
375761|NCT00910624|1264997|P1|Follow-Up Phase|Lost to Follow-up|3
375762|NCT00910624|1264994|P4|Follow-Up Phase|Adverse Event|0
375763|NCT00910624|1264995|P3|Follow-Up Phase|Adverse Event|1
375764|NCT00910624|1264996|P2|Follow-Up Phase|Adverse Event|0
375765|NCT00910624|1264997|P1|Follow-Up Phase|Adverse Event|0
375766|NCT00910624|1264994|P4|Treatment Phase|Non-Compliance With Protocol|0
375767|NCT00910624|1264995|P3|Treatment Phase|Non-Compliance With Protocol|1
375768|NCT00910624|1264996|P2|Treatment Phase|Non-Compliance With Protocol|1
375769|NCT00910624|1264997|P1|Treatment Phase|Non-Compliance With Protocol|0
375770|NCT00910624|1264994|P4|Treatment Phase|Withdrawal by Subject|0
375771|NCT00910624|1264995|P3|Treatment Phase|Withdrawal by Subject|0
375772|NCT00910624|1264996|P2|Treatment Phase|Withdrawal by Subject|1
375773|NCT00910624|1264997|P1|Treatment Phase|Withdrawal by Subject|2
375774|NCT00910624|1264994|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
375775|NCT00910624|1264995|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
375776|NCT00910624|1264996|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
375777|NCT00910624|1264997|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
375778|NCT00910624|1264994|P4|Treatment Phase|Lost to Follow-up|0
375779|NCT00910624|1264995|P3|Treatment Phase|Lost to Follow-up|1
375780|NCT00910624|1264996|P2|Treatment Phase|Lost to Follow-up|0
375781|NCT00910624|1264997|P1|Treatment Phase|Lost to Follow-up|0
375782|NCT00910624|1264994|P4|Treatment Phase|Treatment Failure|0
375783|NCT00910624|1264995|P3|Treatment Phase|Treatment Failure|0
375784|NCT00910624|1264996|P2|Treatment Phase|Treatment Failure|10
375785|NCT00910624|1264997|P1|Treatment Phase|Treatment Failure|23
375786|NCT00910624|1264994|P4|Treatment Phase|Adverse Event|0
375787|NCT00910624|1264995|P3|Treatment Phase|Adverse Event|6
375788|NCT00910624|1264996|P2|Treatment Phase|Adverse Event|6
375789|NCT00910624|1264997|P1|Treatment Phase|Adverse Event|2
375790|NCT00910299|1265024|P2|Overall Study|Didn't receive any study drug|1
375791|NCT00910299|1265025|P1|Overall Study|Didn't receive any study drug|2
375792|NCT00910299|1265024|P2|Overall Study|Sponsor Decision|60
375793|NCT00910299|1265025|P1|Overall Study|Sponsor Decision|58
375794|NCT00910299|1265024|P2|Overall Study|Withdrawal by Subject|13
375795|NCT00910299|1265025|P1|Overall Study|Withdrawal by Subject|16
375796|NCT00910273|1265037|P2|Overall Study|Lost to Follow-up|1
375797|NCT00910273|1265038|P1|Overall Study|Lost to Follow-up|1
375798|NCT00910273|1265037|P2|Overall Study|Protocol Violation|0
375799|NCT00910273|1265038|P1|Overall Study|Protocol Violation|1
375800|NCT00910273|1265037|P2|Overall Study|Discontinuation of study by sponsor|2
375801|NCT00910273|1265038|P1|Overall Study|Discontinuation of study by sponsor|8
375802|NCT00910273|1265037|P2|Overall Study|Withdrawal by Subject|0
375803|NCT00910273|1265038|P1|Overall Study|Withdrawal by Subject|1
375804|NCT00910273|1265037|P2|Overall Study|Adverse Event|1
375805|NCT00910273|1265038|P1|Overall Study|Adverse Event|1
375806|NCT00910273|1265037|P2|Overall Study|Lack of Efficacy|9
375807|NCT00910273|1265038|P1|Overall Study|Lack of Efficacy|6
375808|NCT00910091|1265090|P2|Treatment and Survival|Adverse Event|0
375809|NCT00910091|1265091|P1|Treatment and Survival|Adverse Event|1
375810|NCT00910091|1265090|P2|Treatment and Survival|Withdrawal by Subject|4
375811|NCT00910091|1265091|P1|Treatment and Survival|Withdrawal by Subject|3
375812|NCT00910091|1265090|P2|Pre-assignment|Withdrawal by Subject|2
375813|NCT00910091|1265091|P1|Pre-assignment|Withdrawal by Subject|0
375814|NCT00910039|1265119|P1|Overall Study|Physician Decision|1
375815|NCT00910000|1265136|P6|Overall Study|Withdrawal by Subject|0
375816|NCT00910000|1265137|P5|Overall Study|Withdrawal by Subject|1
375817|NCT00910000|1265138|P4|Overall Study|Withdrawal by Subject|0
375818|NCT00910000|1265139|P3|Overall Study|Withdrawal by Subject|1
375819|NCT00910000|1265140|P2|Overall Study|Withdrawal by Subject|0
375820|NCT00910000|1265141|P1|Overall Study|Withdrawal by Subject|0
375821|NCT00910000|1265136|P6|Overall Study|Adverse Event|1
375822|NCT00910000|1265137|P5|Overall Study|Adverse Event|0
375823|NCT00910000|1265138|P4|Overall Study|Adverse Event|2
375824|NCT00910000|1265139|P3|Overall Study|Adverse Event|2
375825|NCT00910000|1265140|P2|Overall Study|Adverse Event|3
375826|NCT00910000|1265141|P1|Overall Study|Adverse Event|0
375827|NCT00909870|1265159|P2|Overall Study|Other|5
375828|NCT00909870|1265160|P1|Overall Study|Other|1
375829|NCT00909870|1265159|P2|Overall Study|Physician Decision|2
375830|NCT00909870|1265160|P1|Overall Study|Physician Decision|0
375831|NCT00909870|1265159|P2|Overall Study|Lost to Follow-up|3
375832|NCT00909870|1265160|P1|Overall Study|Lost to Follow-up|3
375833|NCT00909870|1265159|P2|Overall Study|Withdrawal by Subject|8
375834|NCT00909870|1265160|P1|Overall Study|Withdrawal by Subject|5
375835|NCT00909870|1265159|P2|Overall Study|Protocol Violation|2
375836|NCT00909870|1265160|P1|Overall Study|Protocol Violation|1
375837|NCT00909870|1265159|P2|Overall Study|Adverse Event|7
375838|NCT00909870|1265160|P1|Overall Study|Adverse Event|13
375839|NCT00909857|1265172|P2|Overall Study|Did not receive study medication|24
375840|NCT00909857|1265173|P1|Overall Study|Did not receive study medication|19
375841|NCT00909857|1265172|P2|Overall Study|Other|0
375842|NCT00909857|1265173|P1|Overall Study|Other|1
375843|NCT00909857|1265172|P2|Overall Study|Pregnancy|0
375844|NCT00909857|1265173|P1|Overall Study|Pregnancy|1
375845|NCT00909857|1265172|P2|Overall Study|Protocol Violation|1
375846|NCT00909857|1265173|P1|Overall Study|Protocol Violation|2
375847|NCT00909857|1265172|P2|Overall Study|Lost to Follow-up|5
375848|NCT00909857|1265173|P1|Overall Study|Lost to Follow-up|2
375849|NCT00909857|1265172|P2|Overall Study|Adverse Event|5
375850|NCT00909857|1265173|P1|Overall Study|Adverse Event|5
375851|NCT00909857|1265172|P2|Overall Study|Withdrawal by Subject|10
375852|NCT00909857|1265173|P1|Overall Study|Withdrawal by Subject|6
375853|NCT00909844|1265313|P1|Overall Study|Lost to Follow-up|2
375854|NCT00909844|1265313|P1|Overall Study|Withdrawal by Subject|1
375855|NCT00909844|1265313|P1|Overall Study|Adverse Event|1
375856|NCT00909792|1265331|P2|Period 2|Lost to Follow-up|1
375857|NCT00909792|1265332|P1|Period 2|Lost to Follow-up|0
375858|NCT00909792|1265331|P2|Period 2|Biomicroscopy|0
375859|NCT00909792|1265332|P1|Period 2|Biomicroscopy|1
375860|NCT00909792|1265331|P2|Period 1|Did not meet inclusion criteria|1
375861|NCT00909792|1265332|P1|Period 1|Did not meet inclusion criteria|0
375862|NCT00909779|1265340|P2|Overall Study|Randomized in error|1
375863|NCT00909779|1265341|P1|Overall Study|Randomized in error|1
375864|NCT00909779|1265340|P2|Overall Study|Noncompliance|1
375865|NCT00909779|1265341|P1|Overall Study|Noncompliance|1
375866|NCT00909779|1265340|P2|Overall Study|Medical Monitor Decision|0
375867|NCT00909779|1265341|P1|Overall Study|Medical Monitor Decision|1
375868|NCT00909779|1265340|P2|Overall Study|Site Ceasing Operation|2
375869|NCT00909779|1265341|P1|Overall Study|Site Ceasing Operation|2
375870|NCT00909779|1265340|P2|Overall Study|Withdrawal by Subject|80
375871|NCT00909779|1265341|P1|Overall Study|Withdrawal by Subject|116
375872|NCT00909779|1265340|P2|Overall Study|Protocol Violation|5
375873|NCT00909779|1265341|P1|Overall Study|Protocol Violation|2
375874|NCT00909779|1265340|P2|Overall Study|Physician Decision|2
375875|NCT00909779|1265341|P1|Overall Study|Physician Decision|8
375876|NCT00909779|1265340|P2|Overall Study|Lost to Follow-up|15
375877|NCT00909779|1265341|P1|Overall Study|Lost to Follow-up|19
375878|NCT00909779|1265340|P2|Overall Study|Lack of Efficacy|4
375879|NCT00909779|1265341|P1|Overall Study|Lack of Efficacy|7
375880|NCT00909779|1265340|P2|Overall Study|Adverse Event|55
375881|NCT00909779|1265341|P1|Overall Study|Adverse Event|53
375882|NCT00909753|1265365|P2|Period: Second Intervention|Protocol Violation|0
375883|NCT00909753|1265366|P1|Period: Second Intervention|Protocol Violation|1
375884|NCT00909753|1265365|P2|Period: Washout of 28 Days|Protocol Violation|3
375885|NCT00909753|1265366|P1|Period: Washout of 28 Days|Protocol Violation|2
375886|NCT00909727|1265386|P2|Overall Study|Prohibited Medication|0
375887|NCT00909727|1265387|P1|Overall Study|Prohibited Medication|1
375888|NCT00909727|1265386|P2|Overall Study|Withdrawal of Consent|0
375889|NCT00909727|1265387|P1|Overall Study|Withdrawal of Consent|1
375890|NCT00909727|1265386|P2|Overall Study|Wrong Genotype|0
375891|NCT00909727|1265387|P1|Overall Study|Wrong Genotype|1
375892|NCT00909727|1265386|P2|Overall Study|Adverse Event|0
375893|NCT00909727|1265387|P1|Overall Study|Adverse Event|1
375894|NCT00909610|1265410|P2|Period: Second Intervention|Adverse Event|0
375895|NCT00909610|1265411|P1|Period: Second Intervention|Adverse Event|1
375896|NCT00909610|1265410|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
375897|NCT00909610|1265411|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
375898|NCT00909610|1265410|P2|Period: First Intervention|Adverse Event|1
375899|NCT00909610|1265411|P1|Period: First Intervention|Adverse Event|0
375900|NCT00909532|1265572|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
375901|NCT00909532|1265573|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
375902|NCT00909532|1265572|P2|Overall Study|Wrong Genotype|0
375903|NCT00909532|1265573|P1|Overall Study|Wrong Genotype|1
375904|NCT00909532|1265572|P2|Overall Study|Physician Decision|0
375905|NCT00909532|1265573|P1|Overall Study|Physician Decision|1
375906|NCT00909532|1265572|P2|Overall Study|Noncompliance with Study Requirements|2
375907|NCT00909532|1265573|P1|Overall Study|Noncompliance with Study Requirements|0
375908|NCT00909532|1265572|P2|Overall Study|Withdrawal of Consent|1
375909|NCT00909532|1265573|P1|Overall Study|Withdrawal of Consent|1
375910|NCT00909532|1265572|P2|Overall Study|Prohibited Medication|1
375911|NCT00909532|1265573|P1|Overall Study|Prohibited Medication|2
375912|NCT00909532|1265572|P2|Overall Study|Pregnancy|1
375913|NCT00909532|1265573|P1|Overall Study|Pregnancy|0
375914|NCT00909532|1265572|P2|Overall Study|Adverse Event|1
375915|NCT00909532|1265573|P1|Overall Study|Adverse Event|4
375916|NCT00909480|1265591|P2|Overall Study|Unclassified|19
375917|NCT00909480|1265592|P1|Overall Study|Unclassified|18
375918|NCT00909480|1265591|P2|Overall Study|Withdrawal criteria|11
375919|NCT00909480|1265592|P1|Overall Study|Withdrawal criteria|9
375920|NCT00909480|1265591|P2|Overall Study|Protocol Violation|8
375921|NCT00909480|1265592|P1|Overall Study|Protocol Violation|6
375922|NCT00909480|1265591|P2|Overall Study|Adverse Event|3
375923|NCT00909480|1265592|P1|Overall Study|Adverse Event|5
375924|NCT00909428|1265627|P3|Overall Study|Lost to Follow-up|9
375925|NCT00909428|1265628|P2|Overall Study|Lost to Follow-up|10
375926|NCT00909428|1265629|P1|Overall Study|Lost to Follow-up|13
375927|NCT00909389|1265636|P1|Overall Study|No Information|103
375928|NCT00909389|1265636|P1|Overall Study|Lost to Follow-up|4
375929|NCT00909389|1265636|P1|Overall Study|Poor Compliance|16
375930|NCT00909389|1265636|P1|Overall Study|Death|4
375931|NCT00909389|1265636|P1|Overall Study|Adverse Event|6
375932|NCT00909181|1265670|P3|Overall Study|Lost to Follow-up|33
375933|NCT00909181|1265671|P2|Overall Study|Lost to Follow-up|18
375934|NCT00909181|1265672|P1|Overall Study|Lost to Follow-up|39
375935|NCT00909038|1265699|P1|Overall Study|Non-evaluable Subjects|230
375936|NCT00909038|1265699|P1|Overall Study|Protocol Violation|187
375937|NCT00908960|1265711|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
375938|NCT00908960|1265712|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
375939|NCT00908960|1265713|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
375940|NCT00908895|1265735|P2|Overall Study|Adverse Event|1
375941|NCT00908895|1265736|P1|Overall Study|Adverse Event|1
375942|NCT00908895|1265735|P2|Overall Study|algodystrophy|2
375943|NCT00908895|1265736|P1|Overall Study|algodystrophy|2
375944|NCT00908895|1265735|P2|Overall Study|Lost to Follow-up|3
375945|NCT00908895|1265736|P1|Overall Study|Lost to Follow-up|1
375946|NCT00908596|1265809|P4|Overall Study|Withdrawal by Subject|1
375947|NCT00908596|1265810|P3|Overall Study|Withdrawal by Subject|3
375948|NCT00908596|1265811|P2|Overall Study|Withdrawal by Subject|1
375949|NCT00908596|1265812|P1|Overall Study|Withdrawal by Subject|0
375950|NCT00908596|1265809|P4|Overall Study|Protocol Violation|0
375951|NCT00908596|1265810|P3|Overall Study|Protocol Violation|0
375952|NCT00908596|1265811|P2|Overall Study|Protocol Violation|0
375953|NCT00908596|1265812|P1|Overall Study|Protocol Violation|1
375954|NCT00908596|1265809|P4|Overall Study|Death|32
375955|NCT00908596|1265810|P3|Overall Study|Death|57
375956|NCT00908596|1265811|P2|Overall Study|Death|5
375957|NCT00908596|1265812|P1|Overall Study|Death|0
375958|NCT00908596|1265809|P4|Overall Study|Lost to Follow-up|4
375959|NCT00908596|1265810|P3|Overall Study|Lost to Follow-up|12
375960|NCT00908596|1265811|P2|Overall Study|Lost to Follow-up|1
375961|NCT00908596|1265812|P1|Overall Study|Lost to Follow-up|0
375962|NCT00908596|1265809|P4|Overall Study|Other reasons|0
375963|NCT00908596|1265810|P3|Overall Study|Other reasons|2
375964|NCT00908596|1265811|P2|Overall Study|Other reasons|6
375965|NCT00908596|1265812|P1|Overall Study|Other reasons|46
375966|NCT00908583|1265842|P1|Phase 5|Adverse Event|3
375967|NCT00908583|1265842|P1|Phase 4|Physician Decision|1
375968|NCT00908583|1265842|P1|Phase 4|Adverse Event|1
375969|NCT00908583|1265842|P1|Phase 3|Adverse Event|2
375970|NCT00908583|1265842|P1|Phase 2|Adverse Event|1
375971|NCT00908583|1265842|P1|Phase 2|Physician Decision|1
375972|NCT00908583|1265842|P1|Phase 1|Adverse Event|4
375973|NCT00908583|1265842|P1|Phase 1|Withdrawal by Subject|1
375974|NCT00908375|1265870|P2|Overall Study|Lost to Follow-up|6
375975|NCT00908375|1265871|P1|Overall Study|Lost to Follow-up|8
375976|NCT00908375|1265870|P2|Overall Study|Withdrawal by Subject|4
375977|NCT00908375|1265871|P1|Overall Study|Withdrawal by Subject|2
375978|NCT00908349|1265881|P1|Overall Study|Various|6
375979|NCT00908349|1265881|P1|Overall Study|Lost to Follow-up|5
375980|NCT00908349|1265881|P1|Overall Study|Physician Decision|5
375981|NCT00908349|1265881|P1|Overall Study|Withdrawal by Subject|9
375982|NCT00908349|1265881|P1|Overall Study|Adverse Event|10
375983|NCT00908310|1265885|P1|Overall Study|Other reasons|4
375984|NCT00908310|1265885|P1|Overall Study|Screening failure|5
375985|NCT00908310|1265885|P1|Overall Study|Lost to Follow-up|7
375986|NCT00908310|1265885|P1|Overall Study|Withdrawal by Subject|7
375987|NCT00908310|1265885|P1|Overall Study|Death|37
375988|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
375989|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
375990|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
375991|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
375992|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Other|0
375993|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Other|0
375994|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Other|1
375995|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Other|3
375996|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
375997|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
375998|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
375999|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
376000|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
376001|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
376002|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
376003|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
376004|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
376005|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
376006|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
376007|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
376008|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Death|0
376009|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Death|0
376010|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Death|0
376011|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Death|2
376012|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
376013|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
376014|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
376015|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
376016|NCT00908232|1265889|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
376017|NCT00908232|1265890|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
376018|NCT00908232|1265891|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
376019|NCT00908232|1265892|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
376020|NCT00908232|1265889|P4|Cycle 1 to 4|not specified|0
376021|NCT00908232|1265890|P3|Cycle 1 to 4|not specified|0
376022|NCT00908232|1265891|P2|Cycle 1 to 4|not specified|0
376023|NCT00908232|1265892|P1|Cycle 1 to 4|not specified|1
376024|NCT00908232|1265889|P4|Cycle 1 to 4|Adverse Event|0
376025|NCT00908232|1265890|P3|Cycle 1 to 4|Adverse Event|0
376026|NCT00908232|1265891|P2|Cycle 1 to 4|Adverse Event|0
376027|NCT00908232|1265892|P1|Cycle 1 to 4|Adverse Event|12
376028|NCT00908232|1265889|P4|Cycle 1 to 4|Progressive Disease|0
376029|NCT00908232|1265890|P3|Cycle 1 to 4|Progressive Disease|0
376030|NCT00908232|1265891|P2|Cycle 1 to 4|Progressive Disease|0
376031|NCT00908232|1265892|P1|Cycle 1 to 4|Progressive Disease|6
376032|NCT00908232|1265889|P4|Cycle 1 to 4|Withdrawal by Subject|0
376033|NCT00908232|1265890|P3|Cycle 1 to 4|Withdrawal by Subject|0
376034|NCT00908232|1265891|P2|Cycle 1 to 4|Withdrawal by Subject|0
376035|NCT00908232|1265892|P1|Cycle 1 to 4|Withdrawal by Subject|4
376036|NCT00908232|1265889|P4|Cycle 1 to 4|Death|0
376037|NCT00908232|1265890|P3|Cycle 1 to 4|Death|0
376038|NCT00908232|1265891|P2|Cycle 1 to 4|Death|0
376039|NCT00908232|1265892|P1|Cycle 1 to 4|Death|5
376040|NCT00908141|1265910|P2|Overall Study|Withdrawal by Subject|1
376041|NCT00908141|1265911|P1|Overall Study|Withdrawal by Subject|0
376042|NCT00908115|1265928|P1|Overall Study|Other|14
376043|NCT00908076|1265936|P2|Overall Study|Lack of Efficacy|1
376044|NCT00908076|1265937|P1|Overall Study|Lack of Efficacy|1
376045|NCT00908037|1265950|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376046|NCT00908037|1265951|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
376047|NCT00908037|1265952|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376048|NCT00908037|1265953|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376049|NCT00908037|1265954|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376050|NCT00908037|1265955|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376051|NCT00908037|1265956|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376052|NCT00908037|1265957|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376053|NCT00908037|1265958|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376054|NCT00908037|1265959|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376055|NCT00908037|1265960|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376056|NCT00908037|1265961|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
376057|NCT00908037|1265950|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376058|NCT00908037|1265951|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376059|NCT00908037|1265952|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
376060|NCT00908037|1265953|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376061|NCT00908037|1265954|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376062|NCT00908037|1265955|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376063|NCT00908037|1265956|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376064|NCT00908037|1265957|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376065|NCT00908037|1265958|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376066|NCT00908037|1265959|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376067|NCT00908037|1265960|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376068|NCT00908037|1265961|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
376069|NCT00908037|1265950|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376070|NCT00908037|1265951|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
376071|NCT00908037|1265952|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376072|NCT00908037|1265953|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376073|NCT00908037|1265954|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376074|NCT00908037|1265955|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376075|NCT00908037|1265956|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376076|NCT00908037|1265957|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376077|NCT00908037|1265958|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376078|NCT00908037|1265959|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376079|NCT00908037|1265960|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376080|NCT00908037|1265961|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
376081|NCT00908037|1265950|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376082|NCT00908037|1265951|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376083|NCT00908037|1265952|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
376084|NCT00908037|1265953|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376085|NCT00908037|1265954|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376086|NCT00908037|1265955|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376087|NCT00908037|1265956|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376088|NCT00908037|1265957|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376089|NCT00908037|1265958|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376090|NCT00908037|1265959|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376091|NCT00908037|1265960|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376092|NCT00908037|1265961|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
376093|NCT00908037|1265950|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
376094|NCT00908037|1265951|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376095|NCT00908037|1265952|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
376096|NCT00908037|1265953|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376097|NCT00908037|1265954|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376098|NCT00908037|1265955|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376099|NCT00908037|1265956|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376100|NCT00908037|1265957|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376101|NCT00908037|1265958|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376102|NCT00908037|1265959|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376103|NCT00908037|1265960|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376104|NCT00908037|1265961|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
376105|NCT00908037|1265950|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
376106|NCT00908037|1265951|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376107|NCT00908037|1265952|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376108|NCT00908037|1265953|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376109|NCT00908037|1265954|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376110|NCT00908037|1265955|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376111|NCT00908037|1265956|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376112|NCT00908037|1265957|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376113|NCT00908037|1265958|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376114|NCT00908037|1265959|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376115|NCT00908037|1265960|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376116|NCT00908037|1265961|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
376117|NCT00908037|1265950|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376118|NCT00908037|1265951|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376119|NCT00908037|1265952|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376120|NCT00908037|1265953|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376121|NCT00908037|1265954|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376122|NCT00908037|1265955|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
376123|NCT00908037|1265956|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376124|NCT00908037|1265957|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376125|NCT00908037|1265958|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
376126|NCT00908037|1265959|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376127|NCT00908037|1265960|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376128|NCT00908037|1265961|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
376129|NCT00908037|1265950|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376130|NCT00908037|1265951|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376131|NCT00908037|1265952|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376132|NCT00908037|1265953|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
376133|NCT00908037|1265954|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376134|NCT00908037|1265955|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376135|NCT00908037|1265956|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376136|NCT00908037|1265957|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
376137|NCT00908037|1265958|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376138|NCT00908037|1265959|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376139|NCT00908037|1265960|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376140|NCT00908037|1265961|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
376141|NCT00908037|1265950|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376142|NCT00908037|1265951|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376143|NCT00908037|1265952|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376144|NCT00908037|1265953|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
376145|NCT00908037|1265954|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376146|NCT00908037|1265955|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
376147|NCT00908037|1265956|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376148|NCT00908037|1265957|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
376149|NCT00908037|1265958|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376150|NCT00908037|1265959|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376151|NCT00908037|1265960|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376152|NCT00908037|1265961|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
376153|NCT00908011|1266110|P2|Overall Study|Withdrawal by Subject|2
376154|NCT00908011|1266111|P1|Overall Study|Withdrawal by Subject|2
376155|NCT00907881|1266128|P1|Overall Study|Missing discontinuation information|15
376156|NCT00907881|1266128|P1|Overall Study|Protocol Violation|1
376157|NCT00907881|1266128|P1|Overall Study|Withdrawal by Subject|5
376158|NCT00907881|1266128|P1|Overall Study|Noncompliance|5
376159|NCT00907881|1266128|P1|Overall Study|Lost to Follow-up|59
376160|NCT00907803|1266138|P3|Overall Study|Protocol Violation|0
376161|NCT00907803|1266139|P2|Overall Study|Protocol Violation|1
376162|NCT00907803|1266140|P1|Overall Study|Protocol Violation|0
376163|NCT00907803|1266138|P3|Overall Study|Lost to Follow-up|0
376164|NCT00907803|1266139|P2|Overall Study|Lost to Follow-up|1
376165|NCT00907803|1266140|P1|Overall Study|Lost to Follow-up|0
376166|NCT00907803|1266138|P3|Overall Study|Withdrawal by Subject|0
376167|NCT00907803|1266139|P2|Overall Study|Withdrawal by Subject|1
376168|NCT00907803|1266140|P1|Overall Study|Withdrawal by Subject|0
376169|NCT00907803|1266138|P3|Overall Study|Adverse Event|0
376170|NCT00907803|1266139|P2|Overall Study|Adverse Event|0
376171|NCT00907803|1266140|P1|Overall Study|Adverse Event|2
376172|NCT00907803|1266138|P3|Overall Study|Withdrawal of consent - long commute|0
376173|NCT00907803|1266139|P2|Overall Study|Withdrawal of consent - long commute|0
376174|NCT00907803|1266140|P1|Overall Study|Withdrawal of consent - long commute|1
376175|NCT00907777|1266171|P2|Overall Study|Withdrawal by Subject|1
376176|NCT00907777|1266172|P1|Overall Study|Withdrawal by Subject|0
376177|NCT00907738|1266199|P5|Overall Study|Disease progression|2
376178|NCT00907738|1266200|P4|Overall Study|Disease progression|4
376179|NCT00907738|1266201|P3|Overall Study|Disease progression|6
376180|NCT00907738|1266202|P2|Overall Study|Disease progression|1
376181|NCT00907738|1266203|P1|Overall Study|Disease progression|8
376182|NCT00907738|1266199|P5|Overall Study|not specified or withdrew consent|0
376183|NCT00907738|1266200|P4|Overall Study|not specified or withdrew consent|0
376184|NCT00907738|1266201|P3|Overall Study|not specified or withdrew consent|0
376185|NCT00907738|1266202|P2|Overall Study|not specified or withdrew consent|0
376186|NCT00907738|1266203|P1|Overall Study|not specified or withdrew consent|3
376187|NCT00907738|1266199|P5|Overall Study|Adverse Event|0
376188|NCT00907738|1266200|P4|Overall Study|Adverse Event|0
376189|NCT00907738|1266201|P3|Overall Study|Adverse Event|1
376190|NCT00907738|1266202|P2|Overall Study|Adverse Event|0
376191|NCT00907738|1266203|P1|Overall Study|Adverse Event|2
376192|NCT00907621|1266221|P2|Overall Study|intercurrent febrile illness|1
376193|NCT00907621|1266222|P1|Overall Study|intercurrent febrile illness|1
376194|NCT00907621|1266221|P2|Overall Study|Lost to Follow-up|3
376195|NCT00907621|1266222|P1|Overall Study|Lost to Follow-up|6
376196|NCT00907517|1266235|P5|Overall Study|Symptomatic Deterioration|1
376197|NCT00907517|1266236|P4|Overall Study|Symptomatic Deterioration|0
376198|NCT00907517|1266237|P3|Overall Study|Symptomatic Deterioration|0
376199|NCT00907517|1266238|P2|Overall Study|Symptomatic Deterioration|0
376200|NCT00907517|1266239|P1|Overall Study|Symptomatic Deterioration|0
376201|NCT00907517|1266235|P5|Overall Study|Progressive Disease|4
376202|NCT00907517|1266236|P4|Overall Study|Progressive Disease|4
376203|NCT00907517|1266237|P3|Overall Study|Progressive Disease|4
376204|NCT00907517|1266238|P2|Overall Study|Progressive Disease|3
376205|NCT00907517|1266239|P1|Overall Study|Progressive Disease|3
376206|NCT00907478|1266264|P3|Overall Study|Other|1
376207|NCT00907478|1266265|P2|Overall Study|Other|0
376208|NCT00907478|1266266|P1|Overall Study|Other|3
376209|NCT00907478|1266264|P3|Overall Study|Lost to Follow-up|0
376210|NCT00907478|1266265|P2|Overall Study|Lost to Follow-up|0
376211|NCT00907478|1266266|P1|Overall Study|Lost to Follow-up|1
376212|NCT00907478|1266264|P3|Overall Study|Pregnancy|1
376213|NCT00907478|1266265|P2|Overall Study|Pregnancy|1
376214|NCT00907478|1266266|P1|Overall Study|Pregnancy|0
376215|NCT00907478|1266264|P3|Overall Study|Protocol-specified criteria|3
376216|NCT00907478|1266265|P2|Overall Study|Protocol-specified criteria|2
376217|NCT00907478|1266266|P1|Overall Study|Protocol-specified criteria|5
376218|NCT00907478|1266264|P3|Overall Study|Death|1
376219|NCT00907478|1266265|P2|Overall Study|Death|2
376220|NCT00907478|1266266|P1|Overall Study|Death|4
376221|NCT00907478|1266264|P3|Overall Study|Physician Decision|3
376222|NCT00907478|1266265|P2|Overall Study|Physician Decision|0
376223|NCT00907478|1266266|P1|Overall Study|Physician Decision|2
376224|NCT00907478|1266264|P3|Overall Study|Requirement for alternative therapy|3
376225|NCT00907478|1266265|P2|Overall Study|Requirement for alternative therapy|2
376226|NCT00907478|1266266|P1|Overall Study|Requirement for alternative therapy|1
376227|NCT00907478|1266264|P3|Overall Study|Withdrawal by Subject|6
376228|NCT00907478|1266265|P2|Overall Study|Withdrawal by Subject|9
376229|NCT00907478|1266266|P1|Overall Study|Withdrawal by Subject|8
376230|NCT00907478|1266264|P3|Overall Study|Adverse Event|2
376231|NCT00907478|1266265|P2|Overall Study|Adverse Event|1
376232|NCT00907478|1266266|P1|Overall Study|Adverse Event|3
376233|NCT00907478|1266264|P3|Overall Study|Noncompliance|1
376234|NCT00907478|1266265|P2|Overall Study|Noncompliance|0
376235|NCT00907478|1266266|P1|Overall Study|Noncompliance|0
376236|NCT00907478|1266264|P3|Overall Study|Ineligibility determined|1
376237|NCT00907478|1266265|P2|Overall Study|Ineligibility determined|0
376238|NCT00907478|1266266|P1|Overall Study|Ineligibility determined|0
376239|NCT00907374|1266316|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
376240|NCT00907374|1266317|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
376241|NCT00907335|1266331|P2|Overall Study|Lost to Follow-up|0
376242|NCT00907335|1266332|P1|Overall Study|Lost to Follow-up|2
376243|NCT00907335|1266331|P2|Overall Study|Adverse Event|1
376244|NCT00907335|1266332|P1|Overall Study|Adverse Event|4
376245|NCT00907335|1266331|P2|Overall Study|Withdrawal by Subject|0
376246|NCT00907335|1266332|P1|Overall Study|Withdrawal by Subject|2
376247|NCT00907257|1266350|P2|Overall Study|Personal Reasons|1
376248|NCT00907257|1266351|P1|Overall Study|Personal Reasons|6
376249|NCT00907257|1266350|P2|Overall Study|Moved|0
376250|NCT00907257|1266351|P1|Overall Study|Moved|1
376251|NCT00907257|1266350|P2|Overall Study|Per IRB-Subject became vulnerable|0
376252|NCT00907257|1266351|P1|Overall Study|Per IRB-Subject became vulnerable|1
376253|NCT00907257|1266350|P2|Overall Study|Withdrawal by Subject|2
376254|NCT00907257|1266351|P1|Overall Study|Withdrawal by Subject|1
376255|NCT00907257|1266350|P2|Overall Study|Lost to Follow-up|3
376256|NCT00907257|1266351|P1|Overall Study|Lost to Follow-up|3
376257|NCT00907257|1266350|P2|Overall Study|Protocol Violation|2
376258|NCT00907257|1266351|P1|Overall Study|Protocol Violation|1
376259|NCT00907257|1266350|P2|Overall Study|Adverse Event|4
376260|NCT00907257|1266351|P1|Overall Study|Adverse Event|0
376261|NCT00907153|1266373|P2|Overall Study|Withdrawal by Subject|3
376262|NCT00907153|1266374|P1|Overall Study|Withdrawal by Subject|1
376263|NCT00907153|1266373|P2|Overall Study|Lost to Follow-up|1
376264|NCT00907153|1266374|P1|Overall Study|Lost to Follow-up|1
376265|NCT00906971|1266435|P2|Overall Study|Lost to Follow-up|1
376266|NCT00906971|1266436|P1|Overall Study|Lost to Follow-up|0
376267|NCT00906971|1266435|P2|Overall Study|Withdrawal by Subject|2
376268|NCT00906971|1266436|P1|Overall Study|Withdrawal by Subject|8
376269|NCT00906945|1266449|P6|Overall Study|Physician Decision|1
376270|NCT00906945|1266450|P5|Overall Study|Physician Decision|0
376271|NCT00906945|1266451|P4|Overall Study|Physician Decision|0
376272|NCT00906945|1266452|P3|Overall Study|Physician Decision|0
376273|NCT00906945|1266453|P2|Overall Study|Physician Decision|0
376274|NCT00906945|1266454|P1|Overall Study|Physician Decision|0
376275|NCT00906945|1266449|P6|Overall Study|Found to be not eligible|1
376276|NCT00906945|1266450|P5|Overall Study|Found to be not eligible|1
376277|NCT00906945|1266451|P4|Overall Study|Found to be not eligible|1
376278|NCT00906945|1266452|P3|Overall Study|Found to be not eligible|0
376279|NCT00906945|1266453|P2|Overall Study|Found to be not eligible|0
376280|NCT00906945|1266454|P1|Overall Study|Found to be not eligible|0
376281|NCT00906698|1266514|P6|Overall Study|incl. non compliance, lost to follow-up|0
376282|NCT00906698|1266515|P5|Overall Study|incl. non compliance, lost to follow-up|0
376283|NCT00906698|1266516|P4|Overall Study|incl. non compliance, lost to follow-up|0
376284|NCT00906698|1266517|P3|Overall Study|incl. non compliance, lost to follow-up|0
376285|NCT00906698|1266518|P2|Overall Study|incl. non compliance, lost to follow-up|1
376286|NCT00906698|1266519|P1|Overall Study|incl. non compliance, lost to follow-up|0
376287|NCT00906698|1266514|P6|Overall Study|Withdrawal by Subject|0
376288|NCT00906698|1266515|P5|Overall Study|Withdrawal by Subject|1
376289|NCT00906698|1266516|P4|Overall Study|Withdrawal by Subject|0
376290|NCT00906698|1266517|P3|Overall Study|Withdrawal by Subject|0
376291|NCT00906698|1266518|P2|Overall Study|Withdrawal by Subject|0
376292|NCT00906698|1266519|P1|Overall Study|Withdrawal by Subject|0
376293|NCT00906698|1266514|P6|Overall Study|Disease progression|4
376294|NCT00906698|1266515|P5|Overall Study|Disease progression|12
376295|NCT00906698|1266516|P4|Overall Study|Disease progression|4
376296|NCT00906698|1266517|P3|Overall Study|Disease progression|4
376297|NCT00906698|1266518|P2|Overall Study|Disease progression|12
376298|NCT00906698|1266519|P1|Overall Study|Disease progression|3
376299|NCT00906698|1266514|P6|Overall Study|Adverse Event|1
376300|NCT00906698|1266515|P5|Overall Study|Adverse Event|4
376301|NCT00906698|1266516|P4|Overall Study|Adverse Event|0
376302|NCT00906698|1266517|P3|Overall Study|Adverse Event|2
376303|NCT00906698|1266518|P2|Overall Study|Adverse Event|0
376304|NCT00906698|1266519|P1|Overall Study|Adverse Event|0
376305|NCT00906698|1266514|P6|Overall Study|Dose-limiting toxicity (DLT)|0
376306|NCT00906698|1266515|P5|Overall Study|Dose-limiting toxicity (DLT)|1
376307|NCT00906698|1266516|P4|Overall Study|Dose-limiting toxicity (DLT)|0
376308|NCT00906698|1266517|P3|Overall Study|Dose-limiting toxicity (DLT)|0
376309|NCT00906698|1266518|P2|Overall Study|Dose-limiting toxicity (DLT)|6
376310|NCT00906698|1266519|P1|Overall Study|Dose-limiting toxicity (DLT)|0
376311|NCT00906399|1266621|P7|Year 2|Not specified|0
376312|NCT00906399|1266622|P6|Year 2|Not specified|1
376313|NCT00906399|1266623|P5|Year 2|Not specified|3
376314|NCT00906399|1266624|P4|Year 2|Not specified|2
376315|NCT00906399|1266625|P3|Year 2|Not specified|0
376316|NCT00906399|1266626|P2|Year 2|Not specified|0
376317|NCT00906399|1266627|P1|Year 2|Not specified|0
376318|NCT00906399|1266621|P7|Year 2|Death|3
376325|NCT00906399|1266621|P7|Year 2|Physician Decision|3
376326|NCT00906399|1266622|P6|Year 2|Physician Decision|6
376327|NCT00906399|1266623|P5|Year 2|Physician Decision|2
376328|NCT00906399|1266624|P4|Year 2|Physician Decision|0
376329|NCT00906399|1266625|P3|Year 2|Physician Decision|0
376330|NCT00906399|1266626|P2|Year 2|Physician Decision|0
376331|NCT00906399|1266627|P1|Year 2|Physician Decision|0
376332|NCT00906399|1266621|P7|Year 2|Withdrawal by Subject|13
376333|NCT00906399|1266622|P6|Year 2|Withdrawal by Subject|27
376334|NCT00906399|1266623|P5|Year 2|Withdrawal by Subject|18
376335|NCT00906399|1266624|P4|Year 2|Withdrawal by Subject|17
376336|NCT00906399|1266625|P3|Year 2|Withdrawal by Subject|0
376337|NCT00906399|1266626|P2|Year 2|Withdrawal by Subject|0
376338|NCT00906399|1266627|P1|Year 2|Withdrawal by Subject|0
376339|NCT00906399|1266621|P7|Year 2|Lost to Follow-up|4
376340|NCT00906399|1266622|P6|Year 2|Lost to Follow-up|2
376341|NCT00906399|1266623|P5|Year 2|Lost to Follow-up|4
376342|NCT00906399|1266624|P4|Year 2|Lost to Follow-up|1
376343|NCT00906399|1266625|P3|Year 2|Lost to Follow-up|0
376344|NCT00906399|1266626|P2|Year 2|Lost to Follow-up|0
376345|NCT00906399|1266627|P1|Year 2|Lost to Follow-up|0
376346|NCT00906399|1266621|P7|Year 2|Adverse Event|6
376347|NCT00906399|1266622|P6|Year 2|Adverse Event|11
376348|NCT00906399|1266623|P5|Year 2|Adverse Event|8
376349|NCT00906399|1266624|P4|Year 2|Adverse Event|9
376350|NCT00906399|1266625|P3|Year 2|Adverse Event|0
376351|NCT00906399|1266626|P2|Year 2|Adverse Event|0
376352|NCT00906399|1266627|P1|Year 2|Adverse Event|0
376353|NCT00906399|1266621|P7|Year 1|Not specified|0
376354|NCT00906399|1266622|P6|Year 1|Not specified|0
376355|NCT00906399|1266623|P5|Year 1|Not specified|0
376356|NCT00906399|1266624|P4|Year 1|Not specified|0
376357|NCT00906399|1266625|P3|Year 1|Not specified|7
376358|NCT00906399|1266626|P2|Year 1|Not specified|2
376359|NCT00906399|1266627|P1|Year 1|Not specified|4
376360|NCT00906399|1266621|P7|Year 1|Death|0
376361|NCT00906399|1266622|P6|Year 1|Death|0
376362|NCT00906399|1266623|P5|Year 1|Death|0
376363|NCT00906399|1266624|P4|Year 1|Death|0
376364|NCT00906399|1266625|P3|Year 1|Death|1
376365|NCT00906399|1266626|P2|Year 1|Death|1
376366|NCT00906399|1266627|P1|Year 1|Death|2
376367|NCT00906399|1266621|P7|Year 1|Physician Decision|0
376368|NCT00906399|1266622|P6|Year 1|Physician Decision|0
376369|NCT00906399|1266623|P5|Year 1|Physician Decision|0
376370|NCT00906399|1266624|P4|Year 1|Physician Decision|0
376371|NCT00906399|1266625|P3|Year 1|Physician Decision|3
376372|NCT00906399|1266626|P2|Year 1|Physician Decision|1
376373|NCT00906399|1266627|P1|Year 1|Physician Decision|0
376374|NCT00906399|1266621|P7|Year 1|Withdrawal by Subject|0
376375|NCT00906399|1266622|P6|Year 1|Withdrawal by Subject|0
376376|NCT00906399|1266623|P5|Year 1|Withdrawal by Subject|0
376377|NCT00906399|1266624|P4|Year 1|Withdrawal by Subject|0
376378|NCT00906399|1266625|P3|Year 1|Withdrawal by Subject|36
376379|NCT00906399|1266626|P2|Year 1|Withdrawal by Subject|32
376380|NCT00906399|1266627|P1|Year 1|Withdrawal by Subject|30
376381|NCT00906399|1266621|P7|Year 1|Lost to Follow-up|0
376382|NCT00906399|1266622|P6|Year 1|Lost to Follow-up|0
376383|NCT00906399|1266623|P5|Year 1|Lost to Follow-up|0
376384|NCT00906399|1266624|P4|Year 1|Lost to Follow-up|0
376385|NCT00906399|1266625|P3|Year 1|Lost to Follow-up|2
376386|NCT00906399|1266626|P2|Year 1|Lost to Follow-up|4
376387|NCT00906399|1266627|P1|Year 1|Lost to Follow-up|4
376388|NCT00906399|1266621|P7|Year 1|Adverse Event|0
376389|NCT00906399|1266622|P6|Year 1|Adverse Event|0
376390|NCT00906399|1266623|P5|Year 1|Adverse Event|0
376391|NCT00906399|1266624|P4|Year 1|Adverse Event|0
376392|NCT00906399|1266625|P3|Year 1|Adverse Event|24
376393|NCT00906399|1266626|P2|Year 1|Adverse Event|22
376394|NCT00906399|1266627|P1|Year 1|Adverse Event|4
376395|NCT00906399|1266621|P7|Year 1|Randomized But Not Treated|0
376396|NCT00906399|1266622|P6|Year 1|Randomized But Not Treated|0
376397|NCT00906399|1266623|P5|Year 1|Randomized But Not Treated|0
376398|NCT00906399|1266624|P4|Year 1|Randomized But Not Treated|0
376399|NCT00906399|1266625|P3|Year 1|Randomized But Not Treated|3
376400|NCT00906399|1266626|P2|Year 1|Randomized But Not Treated|1
376401|NCT00906399|1266627|P1|Year 1|Randomized But Not Treated|0
376402|NCT00906373|1266650|P2|Overall Study|Still on treatment at cutoff date|2
376403|NCT00906373|1266651|P1|Overall Study|Still on treatment at cutoff date|0
376404|NCT00906373|1266650|P2|Overall Study|Other|1
376405|NCT00906373|1266651|P1|Overall Study|Other|0
376406|NCT00906373|1266650|P2|Overall Study|Withdrawal by Subject|5
376407|NCT00906373|1266651|P1|Overall Study|Withdrawal by Subject|0
376408|NCT00906347|1266690|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
376409|NCT00906347|1266691|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
376410|NCT00906347|1266690|P2|Received Study Drug|Refused study drug|0
376411|NCT00906347|1266691|P1|Received Study Drug|Refused study drug|1
376412|NCT00906347|1266690|P2|Received Study Drug|Nonreassuring fetal heart rate|1
376413|NCT00906347|1266691|P1|Received Study Drug|Nonreassuring fetal heart rate|13
376414|NCT00906347|1266690|P2|Received Study Drug|8 cm prior to initiation of study drug|30
376415|NCT00906347|1266691|P1|Received Study Drug|8 cm prior to initiation of study drug|18
376416|NCT00906282|1266711|P1|Preoperative Chemotherapy|Toxicity|1
376417|NCT00906282|1266711|P1|Preoperative Chemotherapy|Progressive disease|6
376418|NCT00906282|1266711|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
376419|NCT00906282|1266711|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
376420|NCT00906204|1266725|P2|Secondary Endpoints (Long-term Safety)|Death|1
376421|NCT00906204|1266726|P1|Secondary Endpoints (Long-term Safety)|Death|0
376422|NCT00906204|1266725|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
376423|NCT00906204|1266726|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
376424|NCT00906204|1266725|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
376425|NCT00906204|1266726|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
376426|NCT00906204|1266725|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
376427|NCT00906204|1266726|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
376428|NCT00906204|1266725|P2|Primary Endpoint (Early Safety)|Physician Decision|0
376429|NCT00906204|1266726|P1|Primary Endpoint (Early Safety)|Physician Decision|1
376430|NCT00906087|1266757|P1|Initial Washout|Physician Decision|1
376431|NCT00906087|1266757|P1|Initial Washout|Withdrawal by Subject|1
376432|NCT00906035|1266794|P3|Overall Study|Withdrawal by Subject|0
376433|NCT00906035|1266795|P2|Overall Study|Withdrawal by Subject|3
376434|NCT00906035|1266796|P1|Overall Study|Withdrawal by Subject|2
376435|NCT00905840|1266810|P1|Overall Study|Adverse Event|1
376436|NCT00905840|1266810|P1|Overall Study|Withdrawal by Subject|1
376437|NCT00905840|1266810|P1|Overall Study|Death|3
376438|NCT00905840|1266810|P1|Overall Study|Lost to Follow-up|11
376439|NCT00905632|1266841|P7|Overall Study|Adverse Event|4
376440|NCT00905632|1266842|P6|Overall Study|Adverse Event|1
376441|NCT00905632|1266843|P5|Overall Study|Adverse Event|0
376442|NCT00905632|1266844|P4|Overall Study|Adverse Event|0
376443|NCT00905632|1266845|P3|Overall Study|Adverse Event|0
376444|NCT00905632|1266846|P2|Overall Study|Adverse Event|0
376445|NCT00905632|1266847|P1|Overall Study|Adverse Event|0
376446|NCT00905606|1266985|P2|Washout|Withdrawal by Subject|0
376447|NCT00905606|1266986|P1|Washout|Withdrawal by Subject|1
376448|NCT00905606|1266985|P2|Period 1|Adverse Event|1
376449|NCT00905606|1266986|P1|Period 1|Adverse Event|0
376450|NCT00905567|1267011|P2|Washout|Withdrawal by Subject|1
376451|NCT00905567|1267012|P1|Washout|Withdrawal by Subject|0
376452|NCT00905489|1267044|P1|Optional Extension Phase (OEP)|Adverse Event|1
376453|NCT00905489|1267044|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
376454|NCT00905489|1267044|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
376455|NCT00905437|1267093|P2|Overall Study|Other|6
376456|NCT00905437|1267094|P1|Overall Study|Other|5
376457|NCT00905437|1267093|P2|Overall Study|Withdrawal by Subject|1
376458|NCT00905437|1267094|P1|Overall Study|Withdrawal by Subject|0
376459|NCT00905437|1267093|P2|Overall Study|Lost to Follow-up|1
376460|NCT00905437|1267094|P1|Overall Study|Lost to Follow-up|0
376461|NCT00905437|1267093|P2|Overall Study|Adverse Event|2
376462|NCT00905437|1267094|P1|Overall Study|Adverse Event|3
376463|NCT00905424|1267114|P2|Overall Study|Non-adherence to visit schedule|1
376464|NCT00905424|1267115|P1|Overall Study|Non-adherence to visit schedule|0
376465|NCT00905424|1267114|P2|Overall Study|Positive urine drug screen|1
376466|NCT00905424|1267115|P1|Overall Study|Positive urine drug screen|0
376467|NCT00905424|1267114|P2|Overall Study|Sponsor decision|0
376468|NCT00905424|1267115|P1|Overall Study|Sponsor decision|1
376469|NCT00905424|1267114|P2|Overall Study|Non-compliance with study medication|0
376470|NCT00905424|1267115|P1|Overall Study|Non-compliance with study medication|2
376471|NCT00905424|1267114|P2|Overall Study|Adverse Event|2
376472|NCT00905424|1267115|P1|Overall Study|Adverse Event|4
376473|NCT00905424|1267114|P2|Overall Study|Withdrawal by Subject|2
376474|NCT00905424|1267115|P1|Overall Study|Withdrawal by Subject|1
376475|NCT00905424|1267114|P2|Overall Study|Lost to Follow-up|3
376476|NCT00905424|1267115|P1|Overall Study|Lost to Follow-up|3
376477|NCT00905359|1267157|P2|Overall Study|Withdrawal consent|6
376478|NCT00905359|1267158|P1|Overall Study|Withdrawal consent|5
376479|NCT00905359|1267157|P2|Overall Study|Death|0
376480|NCT00905359|1267158|P1|Overall Study|Death|2
376481|NCT00905359|1267157|P2|Overall Study|Lost to Follow-up|10
376482|NCT00905359|1267158|P1|Overall Study|Lost to Follow-up|17
376483|NCT00905346|1267194|P2|Period 1|Withdrawal by Subject|0
376484|NCT00905346|1267195|P1|Period 1|Withdrawal by Subject|1
376485|NCT00905307|1267209|P6|Overall Study|Lack of Efficacy|8
376486|NCT00905307|1267210|P5|Overall Study|Lack of Efficacy|4
376487|NCT00905307|1267211|P4|Overall Study|Lack of Efficacy|4
376488|NCT00905307|1267212|P3|Overall Study|Lack of Efficacy|5
376489|NCT00905307|1267213|P2|Overall Study|Lack of Efficacy|3
376490|NCT00905307|1267214|P1|Overall Study|Lack of Efficacy|6
376491|NCT00905307|1267209|P6|Overall Study|Protocol Violation|0
376492|NCT00905307|1267210|P5|Overall Study|Protocol Violation|0
376493|NCT00905307|1267211|P4|Overall Study|Protocol Violation|0
376494|NCT00905307|1267212|P3|Overall Study|Protocol Violation|1
376495|NCT00905307|1267213|P2|Overall Study|Protocol Violation|0
376496|NCT00905307|1267214|P1|Overall Study|Protocol Violation|1
376497|NCT00905307|1267209|P6|Overall Study|Withdrawal by Subject|13
376498|NCT00905307|1267210|P5|Overall Study|Withdrawal by Subject|4
376499|NCT00905307|1267211|P4|Overall Study|Withdrawal by Subject|11
376500|NCT00905307|1267212|P3|Overall Study|Withdrawal by Subject|15
376501|NCT00905307|1267213|P2|Overall Study|Withdrawal by Subject|13
376502|NCT00905307|1267214|P1|Overall Study|Withdrawal by Subject|5
376503|NCT00905307|1267209|P6|Overall Study|Adverse Event|5
376504|NCT00905307|1267210|P5|Overall Study|Adverse Event|3
376505|NCT00905307|1267211|P4|Overall Study|Adverse Event|11
376506|NCT00905307|1267212|P3|Overall Study|Adverse Event|5
376507|NCT00905307|1267213|P2|Overall Study|Adverse Event|4
376508|NCT00905307|1267214|P1|Overall Study|Adverse Event|3
376509|NCT00905307|1267209|P6|Overall Study|Lost to Follow-up|1
376510|NCT00905307|1267210|P5|Overall Study|Lost to Follow-up|1
376511|NCT00905307|1267211|P4|Overall Study|Lost to Follow-up|0
376512|NCT00905307|1267212|P3|Overall Study|Lost to Follow-up|0
376513|NCT00905307|1267213|P2|Overall Study|Lost to Follow-up|0
376514|NCT00905307|1267214|P1|Overall Study|Lost to Follow-up|0
376515|NCT00905307|1267209|P6|Overall Study|Switched to Open Label Rescue|15
376516|NCT00905307|1267210|P5|Overall Study|Switched to Open Label Rescue|4
376517|NCT00905307|1267211|P4|Overall Study|Switched to Open Label Rescue|11
376518|NCT00905307|1267212|P3|Overall Study|Switched to Open Label Rescue|11
376519|NCT00905307|1267213|P2|Overall Study|Switched to Open Label Rescue|17
376520|NCT00905307|1267214|P1|Overall Study|Switched to Open Label Rescue|7
376521|NCT00905255|1267309|P2|Overall Study|Familial and Personal Reasons|0
376522|NCT00905255|1267310|P1|Overall Study|Familial and Personal Reasons|1
376523|NCT00905255|1267309|P2|Overall Study|Withdrawal by Subject|4
376524|NCT00905255|1267310|P1|Overall Study|Withdrawal by Subject|5
376525|NCT00905255|1267309|P2|Overall Study|Adverse Event|5
376526|NCT00905255|1267310|P1|Overall Study|Adverse Event|7
376527|NCT00905164|1267328|P2|Period 1|Protocol Violation|1
376528|NCT00905164|1267329|P1|Period 1|Protocol Violation|0
376529|NCT00905034|1267376|P1|Overall Study|Withdrawal by Subject|1
376530|NCT00905021|1267380|P1|Overall Study|Adverse Event|2
376531|NCT00904982|1267398|P4|Overall Study|Withdrawal by Subject|0
376532|NCT00904982|1267399|P3|Overall Study|Withdrawal by Subject|0
376533|NCT00904982|1267400|P2|Overall Study|Withdrawal by Subject|0
376534|NCT00904982|1267401|P1|Overall Study|Withdrawal by Subject|2
376535|NCT00904969|1267411|P1|Overall Study|Case Aborted; Subject Exited|1
376536|NCT00904969|1267411|P1|Overall Study|Additional Treatments|11
376537|NCT00904969|1267411|P1|Overall Study|Withdrawal by Subject|3
376538|NCT00904969|1267411|P1|Overall Study|Lost to Follow-up|4
376539|NCT00904917|1267476|P4|Overall Study|Lost to Follow-up|2
376540|NCT00904917|1267477|P3|Overall Study|Lost to Follow-up|2
376541|NCT00904917|1267478|P2|Overall Study|Lost to Follow-up|2
376542|NCT00904917|1267479|P1|Overall Study|Lost to Follow-up|2
376543|NCT00904839|1267497|P3|Overall Study|Other than above|7
376544|NCT00904839|1267498|P2|Overall Study|Other than above|9
376545|NCT00904839|1267499|P1|Overall Study|Other than above|0
376546|NCT00904839|1267497|P3|Overall Study|Not treated|1
376547|NCT00904839|1267498|P2|Overall Study|Not treated|0
376548|NCT00904839|1267499|P1|Overall Study|Not treated|1
376549|NCT00904839|1267497|P3|Overall Study|Withdrawal by Subject|0
376550|NCT00904839|1267498|P2|Overall Study|Withdrawal by Subject|2
376551|NCT00904839|1267499|P1|Overall Study|Withdrawal by Subject|0
376552|NCT00904839|1267497|P3|Overall Study|Lost to Follow-up|2
376553|NCT00904839|1267498|P2|Overall Study|Lost to Follow-up|1
376554|NCT00904839|1267499|P1|Overall Study|Lost to Follow-up|0
376555|NCT00904839|1267497|P3|Overall Study|Protocol Violation|1
376556|NCT00904839|1267498|P2|Overall Study|Protocol Violation|1
376557|NCT00904839|1267499|P1|Overall Study|Protocol Violation|0
376558|NCT00904839|1267497|P3|Overall Study|Adverse Event|4
376559|NCT00904839|1267498|P2|Overall Study|Adverse Event|5
376560|NCT00904839|1267499|P1|Overall Study|Adverse Event|0
376561|NCT00904748|1267545|P6|Overall Study|Adverse Event|0
376562|NCT00904748|1267546|P5|Overall Study|Adverse Event|1
376563|NCT00904748|1267547|P4|Overall Study|Adverse Event|0
376564|NCT00904748|1267548|P3|Overall Study|Adverse Event|0
376565|NCT00904748|1267549|P2|Overall Study|Adverse Event|0
376566|NCT00904748|1267550|P1|Overall Study|Adverse Event|0
376567|NCT00904748|1267545|P6|Overall Study|Withdrawal by Subject|0
376568|NCT00904748|1267546|P5|Overall Study|Withdrawal by Subject|0
376569|NCT00904748|1267547|P4|Overall Study|Withdrawal by Subject|2
376570|NCT00904748|1267548|P3|Overall Study|Withdrawal by Subject|1
376571|NCT00904748|1267549|P2|Overall Study|Withdrawal by Subject|1
376572|NCT00904748|1267550|P1|Overall Study|Withdrawal by Subject|1
376573|NCT00904722|1267574|P1|Overall Study|Physician Decision|1
376574|NCT00904670|1267579|P2|Open Label Phase|Lost to Follow-up|0
376575|NCT00904670|1267580|P1|Open Label Phase|Lost to Follow-up|1
376576|NCT00904670|1267579|P2|Open Label Phase|Lack of Efficacy|0
376577|NCT00904670|1267580|P1|Open Label Phase|Lack of Efficacy|1
376578|NCT00904670|1267579|P2|Open Label Phase|Adverse Event|0
376579|NCT00904670|1267580|P1|Open Label Phase|Adverse Event|2
376580|NCT00904670|1267579|P2|Open Label Phase|Withdrawal by Subject|0
376581|NCT00904670|1267580|P1|Open Label Phase|Withdrawal by Subject|2
376582|NCT00904371|1267650|P1|Overall Study|Continued with Tritace|1
376583|NCT00904371|1267650|P1|Overall Study|Discontinued at target blood pressure|2
376584|NCT00904371|1267650|P1|Overall Study|Lost to Follow-up|4
376585|NCT00904371|1267650|P1|Overall Study|Adverse Event|2
376586|NCT00904215|1267664|P1|Overall Study|Other|28
376587|NCT00904215|1267664|P1|Overall Study|Withdrawal by Subject|9
376588|NCT00904215|1267664|P1|Overall Study|Lost to Follow-up|63
376589|NCT00904215|1267664|P1|Overall Study|Protocol Violation|10
376590|NCT00904215|1267664|P1|Overall Study|Adverse Event|25
376591|NCT00904150|1267678|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
376592|NCT00904150|1267679|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
376593|NCT00904150|1267678|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
376594|NCT00904150|1267679|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
376595|NCT00903968|1267708|P8|Overall Study|Lack of Efficacy|3
376596|NCT00903968|1267709|P7|Overall Study|Lack of Efficacy|0
376597|NCT00903968|1267710|P6|Overall Study|Lack of Efficacy|0
376598|NCT00903968|1267711|P5|Overall Study|Lack of Efficacy|0
376599|NCT00903968|1267712|P4|Overall Study|Lack of Efficacy|0
376600|NCT00903968|1267713|P3|Overall Study|Lack of Efficacy|0
376601|NCT00903968|1267714|P2|Overall Study|Lack of Efficacy|0
376602|NCT00903968|1267715|P1|Overall Study|Lack of Efficacy|0
376603|NCT00903968|1267708|P8|Overall Study|Progressive Disease|18
376604|NCT00903968|1267709|P7|Overall Study|Progressive Disease|0
376605|NCT00903968|1267710|P6|Overall Study|Progressive Disease|3
376606|NCT00903968|1267711|P5|Overall Study|Progressive Disease|3
376607|NCT00903968|1267712|P4|Overall Study|Progressive Disease|3
376608|NCT00903968|1267713|P3|Overall Study|Progressive Disease|2
376609|NCT00903968|1267714|P2|Overall Study|Progressive Disease|3
376610|NCT00903968|1267715|P1|Overall Study|Progressive Disease|2
376611|NCT00903968|1267708|P8|Overall Study|Physician Decision|0
376612|NCT00903968|1267709|P7|Overall Study|Physician Decision|0
376613|NCT00903968|1267710|P6|Overall Study|Physician Decision|1
376614|NCT00903968|1267711|P5|Overall Study|Physician Decision|0
376615|NCT00903968|1267712|P4|Overall Study|Physician Decision|0
376616|NCT00903968|1267713|P3|Overall Study|Physician Decision|0
376617|NCT00903968|1267714|P2|Overall Study|Physician Decision|0
376618|NCT00903968|1267715|P1|Overall Study|Physician Decision|0
376619|NCT00903968|1267708|P8|Overall Study|Non-Compliance|0
376620|NCT00903968|1267709|P7|Overall Study|Non-Compliance|0
376621|NCT00903968|1267710|P6|Overall Study|Non-Compliance|1
376622|NCT00903968|1267711|P5|Overall Study|Non-Compliance|0
376623|NCT00903968|1267712|P4|Overall Study|Non-Compliance|0
376624|NCT00903968|1267713|P3|Overall Study|Non-Compliance|0
376625|NCT00903968|1267714|P2|Overall Study|Non-Compliance|0
376626|NCT00903968|1267715|P1|Overall Study|Non-Compliance|0
376627|NCT00903968|1267708|P8|Overall Study|Withdrawal by Subject|4
376628|NCT00903968|1267709|P7|Overall Study|Withdrawal by Subject|0
376629|NCT00903968|1267710|P6|Overall Study|Withdrawal by Subject|1
376630|NCT00903968|1267711|P5|Overall Study|Withdrawal by Subject|1
376631|NCT00903968|1267712|P4|Overall Study|Withdrawal by Subject|0
376632|NCT00903968|1267713|P3|Overall Study|Withdrawal by Subject|1
376633|NCT00903968|1267714|P2|Overall Study|Withdrawal by Subject|0
376634|NCT00903968|1267715|P1|Overall Study|Withdrawal by Subject|1
376635|NCT00903968|1267708|P8|Overall Study|DLT|0
376636|NCT00903968|1267709|P7|Overall Study|DLT|2
376637|NCT00903968|1267710|P6|Overall Study|DLT|0
376638|NCT00903968|1267711|P5|Overall Study|DLT|0
376639|NCT00903968|1267712|P4|Overall Study|DLT|0
376640|NCT00903968|1267713|P3|Overall Study|DLT|0
376641|NCT00903968|1267714|P2|Overall Study|DLT|0
376642|NCT00903968|1267715|P1|Overall Study|DLT|0
376643|NCT00903968|1267708|P8|Overall Study|Adverse Event|8
376644|NCT00903968|1267709|P7|Overall Study|Adverse Event|1
376645|NCT00903968|1267710|P6|Overall Study|Adverse Event|0
376646|NCT00903968|1267711|P5|Overall Study|Adverse Event|0
376647|NCT00903968|1267712|P4|Overall Study|Adverse Event|0
376648|NCT00903968|1267713|P3|Overall Study|Adverse Event|0
376649|NCT00903968|1267714|P2|Overall Study|Adverse Event|0
376650|NCT00903968|1267715|P1|Overall Study|Adverse Event|0
376651|NCT00903929|1267745|P4|Overall Study|Adverse Event|1
376652|NCT00903929|1267746|P3|Overall Study|Adverse Event|0
376653|NCT00903929|1267747|P2|Overall Study|Adverse Event|0
376654|NCT00903929|1267748|P1|Overall Study|Adverse Event|0
376655|NCT00903929|1267745|P4|Overall Study|Withdrawal by Subject|2
376656|NCT00903929|1267746|P3|Overall Study|Withdrawal by Subject|1
376657|NCT00903929|1267747|P2|Overall Study|Withdrawal by Subject|0
376658|NCT00903929|1267748|P1|Overall Study|Withdrawal by Subject|0
376659|NCT00903877|1267754|P1|Overall Study|Participation put on hold|4
376660|NCT00903877|1267754|P1|Overall Study|Lost to Follow-up|1
376661|NCT00903877|1267754|P1|Overall Study|Adverse Event|2
376662|NCT00903877|1267754|P1|Overall Study|Withdrawal by Subject|3
376663|NCT00903877|1267754|P1|Overall Study|Did not meet study criteria|33
376664|NCT00903695|1267760|P2|Overall Study|lung cancer|0
376665|NCT00903695|1267761|P1|Overall Study|lung cancer|1
376666|NCT00903695|1267760|P2|Overall Study|medical exclusion after 1st testing|0
376667|NCT00903695|1267761|P1|Overall Study|medical exclusion after 1st testing|1
376668|NCT00903682|1267783|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
376669|NCT00903682|1267784|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
376670|NCT00903682|1267783|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
376671|NCT00903682|1267784|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
376672|NCT00903682|1267783|P2|Overall Study|Subject Non-Compliant|0
376673|NCT00903682|1267784|P1|Overall Study|Subject Non-Compliant|1
376674|NCT00903682|1267783|P2|Overall Study|Subject Reached A Virologic Endpoint|1
376675|NCT00903682|1267784|P1|Overall Study|Subject Reached A Virologic Endpoint|1
376676|NCT00903682|1267783|P2|Overall Study|Pregnancy|1
376677|NCT00903682|1267784|P1|Overall Study|Pregnancy|0
376678|NCT00903682|1267783|P2|Overall Study|Withdrawal by Subject|0
376679|NCT00903682|1267784|P1|Overall Study|Withdrawal by Subject|5
376680|NCT00903682|1267783|P2|Overall Study|Lost to Follow-up|0
376681|NCT00903682|1267784|P1|Overall Study|Lost to Follow-up|1
376682|NCT00903682|1267783|P2|Overall Study|Adverse Event|13
376683|NCT00903682|1267784|P1|Overall Study|Adverse Event|6
376684|NCT00903630|1267805|P3|Phase 2|Adverse Event|1
376685|NCT00903630|1267806|P2|Phase 2|Adverse Event|0
376686|NCT00903630|1267807|P1|Phase 2|Adverse Event|0
376687|NCT00903617|1267825|P4|Overall Study|Withdrawal by Subject|0
376688|NCT00903617|1267826|P3|Overall Study|Withdrawal by Subject|3
376689|NCT00903617|1267827|P2|Overall Study|Withdrawal by Subject|2
376690|NCT00903617|1267828|P1|Overall Study|Withdrawal by Subject|1
376691|NCT00903617|1267825|P4|Overall Study|Lost to Follow-up|1
376692|NCT00903617|1267826|P3|Overall Study|Lost to Follow-up|1
376693|NCT00903617|1267827|P2|Overall Study|Lost to Follow-up|0
376694|NCT00903617|1267828|P1|Overall Study|Lost to Follow-up|2
376695|NCT00903617|1267825|P4|Overall Study|Protocol-defined stopping criteria|0
376696|NCT00903617|1267826|P3|Overall Study|Protocol-defined stopping criteria|0
376697|NCT00903617|1267827|P2|Overall Study|Protocol-defined stopping criteria|2
376698|NCT00903617|1267828|P1|Overall Study|Protocol-defined stopping criteria|0
376699|NCT00903617|1267825|P4|Overall Study|Adverse Event|0
376700|NCT00903617|1267826|P3|Overall Study|Adverse Event|1
376701|NCT00903617|1267827|P2|Overall Study|Adverse Event|1
376702|NCT00903617|1267828|P1|Overall Study|Adverse Event|0
376703|NCT00903409|1267931|P2|Overall Study|Lost to Follow-up|6
376704|NCT00903409|1267932|P1|Overall Study|Lost to Follow-up|2
376705|NCT00903409|1267931|P2|Overall Study|Not specified|3
376706|NCT00903409|1267932|P1|Overall Study|Not specified|2
376707|NCT00903409|1267931|P2|Overall Study|Withdrawal by Subject|8
376708|NCT00903409|1267932|P1|Overall Study|Withdrawal by Subject|8
376709|NCT00903409|1267931|P2|Overall Study|Laboratory Abnormality|0
376710|NCT00903409|1267932|P1|Overall Study|Laboratory Abnormality|2
376711|NCT00903409|1267931|P2|Overall Study|Non-compliance with Protocol|1
376712|NCT00903409|1267932|P1|Overall Study|Non-compliance with Protocol|1
376713|NCT00903409|1267931|P2|Overall Study|Adverse Event|9
376714|NCT00903409|1267932|P1|Overall Study|Adverse Event|11
376715|NCT00903383|1267983|P4|Overall Study|Patient Decision|1
376716|NCT00903383|1267984|P3|Overall Study|Patient Decision|0
376717|NCT00903383|1267985|P2|Overall Study|Patient Decision|0
376718|NCT00903383|1267986|P1|Overall Study|Patient Decision|0
376719|NCT00903383|1267983|P4|Overall Study|Patient Decision - Lack of Efficacy|0
376720|NCT00903383|1267984|P3|Overall Study|Patient Decision - Lack of Efficacy|0
376721|NCT00903383|1267985|P2|Overall Study|Patient Decision - Lack of Efficacy|1
376722|NCT00903383|1267986|P1|Overall Study|Patient Decision - Lack of Efficacy|0
376723|NCT00903383|1267983|P4|Overall Study|Withdrawal by Subject|2
376724|NCT00903383|1267984|P3|Overall Study|Withdrawal by Subject|0
376725|NCT00903383|1267985|P2|Overall Study|Withdrawal by Subject|1
376726|NCT00903383|1267986|P1|Overall Study|Withdrawal by Subject|4
376727|NCT00903383|1267983|P4|Overall Study|Decision of Sponsor|0
376728|NCT00903383|1267984|P3|Overall Study|Decision of Sponsor|0
376729|NCT00903383|1267985|P2|Overall Study|Decision of Sponsor|0
376730|NCT00903383|1267986|P1|Overall Study|Decision of Sponsor|1
376731|NCT00903383|1267983|P4|Overall Study|Lost to Follow-up|1
376732|NCT00903383|1267984|P3|Overall Study|Lost to Follow-up|0
376733|NCT00903383|1267985|P2|Overall Study|Lost to Follow-up|0
376734|NCT00903383|1267986|P1|Overall Study|Lost to Follow-up|0
376735|NCT00903383|1267983|P4|Overall Study|Physician Decision|0
376736|NCT00903383|1267984|P3|Overall Study|Physician Decision|0
376737|NCT00903383|1267985|P2|Overall Study|Physician Decision|2
376738|NCT00903383|1267986|P1|Overall Study|Physician Decision|1
376739|NCT00903383|1267983|P4|Overall Study|Adverse Event|1
376740|NCT00903383|1267984|P3|Overall Study|Adverse Event|3
376741|NCT00903383|1267985|P2|Overall Study|Adverse Event|2
376742|NCT00903383|1267986|P1|Overall Study|Adverse Event|1
376743|NCT00903370|1268018|P2|Overall Study|Lost to Follow-up|8
376744|NCT00903370|1268019|P1|Overall Study|Lost to Follow-up|6
376745|NCT00903370|1268018|P2|Overall Study|Withdrawal by Subject|6
376746|NCT00903370|1268019|P1|Overall Study|Withdrawal by Subject|9
376747|NCT00903370|1268018|P2|Overall Study|Death|10
376748|NCT00903370|1268019|P1|Overall Study|Death|13
376749|NCT00903357|1268027|P2|Second Intervention|Lost to Follow-up|0
376750|NCT00903357|1268028|P1|Second Intervention|Lost to Follow-up|1
376751|NCT00903357|1268027|P2|Wash Out Period of 2 Weeks|Flu|1
376752|NCT00903357|1268028|P1|Wash Out Period of 2 Weeks|Flu|0
376753|NCT00903357|1268027|P2|First Intervention|Flu|1
376754|NCT00903357|1268028|P1|First Intervention|Flu|0
376755|NCT00903357|1268027|P2|First Intervention|Withdrawal by Subject|3
376756|NCT00903357|1268028|P1|First Intervention|Withdrawal by Subject|5
376757|NCT00903344|1268040|P2|Overall Study|Lost to Follow-up|0
376758|NCT00903344|1268041|P1|Overall Study|Lost to Follow-up|3
376759|NCT00903344|1268040|P2|Overall Study|Pregnancy|3
376760|NCT00903344|1268041|P1|Overall Study|Pregnancy|2
376761|NCT00903331|1268059|P2|Overall Study|Lung transplant|2
376762|NCT00903331|1268060|P1|Overall Study|Lung transplant|0
376763|NCT00903331|1268059|P2|Overall Study|Withdrawal of consent|8
376764|NCT00903331|1268060|P1|Overall Study|Withdrawal of consent|1
376765|NCT00903331|1268059|P2|Overall Study|Death|8
376766|NCT00903331|1268060|P1|Overall Study|Death|4
376767|NCT00903201|1268071|P3|Overall Study|Withdrawal by Subject|1
376768|NCT00903201|1268072|P2|Overall Study|Withdrawal by Subject|0
376769|NCT00903201|1268073|P1|Overall Study|Withdrawal by Subject|1
376770|NCT00903201|1268071|P3|Overall Study|Physician Decision|1
376771|NCT00903201|1268072|P2|Overall Study|Physician Decision|0
376772|NCT00903201|1268073|P1|Overall Study|Physician Decision|1
376773|NCT00903201|1268071|P3|Overall Study|Lost to Follow-up|0
376774|NCT00903201|1268072|P2|Overall Study|Lost to Follow-up|1
376775|NCT00903201|1268073|P1|Overall Study|Lost to Follow-up|0
376776|NCT00903201|1268071|P3|Overall Study|Protocol Violation|0
376777|NCT00903201|1268072|P2|Overall Study|Protocol Violation|1
376778|NCT00903201|1268073|P1|Overall Study|Protocol Violation|2
376779|NCT00903201|1268071|P3|Overall Study|Adverse Event|0
376780|NCT00903201|1268072|P2|Overall Study|Adverse Event|4
376781|NCT00903201|1268073|P1|Overall Study|Adverse Event|1
376782|NCT00903175|1268131|P2|Period 2 - Second Line|Death|2
376783|NCT00903175|1268132|P1|Period 2 - Second Line|Death|5
376784|NCT00903175|1268131|P2|Period 2 - Second Line|Administrative problems|9
376785|NCT00903175|1268132|P1|Period 2 - Second Line|Administrative problems|19
376786|NCT00903175|1268131|P2|Period 2 - Second Line|Lost to Follow-up|0
376787|NCT00903175|1268132|P1|Period 2 - Second Line|Lost to Follow-up|1
376788|NCT00903175|1268131|P2|Period 2 - Second Line|Withdrawal by Subject|5
376789|NCT00903175|1268132|P1|Period 2 - Second Line|Withdrawal by Subject|7
376790|NCT00903175|1268131|P2|Period 2 - Second Line|Adverse Event|20
376791|NCT00903175|1268132|P1|Period 2 - Second Line|Adverse Event|16
376792|NCT00903175|1268131|P2|Period 2 - Second Line|Missing|0
376793|NCT00903175|1268132|P1|Period 2 - Second Line|Missing|1
376794|NCT00903175|1268131|P2|Period 1 - First Line|Death|10
376795|NCT00903175|1268132|P1|Period 1 - First Line|Death|17
376796|NCT00903175|1268131|P2|Period 1 - First Line|Administrative problems|13
376797|NCT00903175|1268132|P1|Period 1 - First Line|Administrative problems|12
376798|NCT00903175|1268131|P2|Period 1 - First Line|Withdrawal by Subject|12
376799|NCT00903175|1268132|P1|Period 1 - First Line|Withdrawal by Subject|8
376800|NCT00903175|1268131|P2|Period 1 - First Line|Protocol Violation|3
376801|NCT00903175|1268132|P1|Period 1 - First Line|Protocol Violation|3
376802|NCT00903175|1268131|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
376803|NCT00903175|1268132|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
376804|NCT00903175|1268131|P2|Period 1 - First Line|Abnormal lab value(s)|1
376805|NCT00903175|1268132|P1|Period 1 - First Line|Abnormal lab value(s)|0
376806|NCT00903175|1268131|P2|Period 1 - First Line|Adverse Event|50
376807|NCT00903175|1268132|P1|Period 1 - First Line|Adverse Event|36
376808|NCT00903032|1268170|P2|Overall Study|Lost to Follow-up|2
376809|NCT00903032|1268171|P1|Overall Study|Lost to Follow-up|2
376810|NCT00903032|1268170|P2|Overall Study|Withdrawal by Subject|3
376811|NCT00903032|1268171|P1|Overall Study|Withdrawal by Subject|5
376812|NCT00903006|1268181|P4|Overall Study|Progressive Disease|0
376813|NCT00903006|1268182|P3|Overall Study|Progressive Disease|1
376814|NCT00903006|1268183|P2|Overall Study|Progressive Disease|3
376815|NCT00903006|1268184|P1|Overall Study|Progressive Disease|0
376816|NCT00903006|1268181|P4|Overall Study|Withdrawal by Subject|0
376817|NCT00903006|1268182|P3|Overall Study|Withdrawal by Subject|0
376818|NCT00903006|1268183|P2|Overall Study|Withdrawal by Subject|0
376819|NCT00903006|1268184|P1|Overall Study|Withdrawal by Subject|2
376820|NCT00902850|1268196|P2|Overall Study|Physician Decision|2
376821|NCT00902850|1268197|P1|Overall Study|Physician Decision|2
376822|NCT00902746|1268203|P1|Overall Study|Physician Decision|2
376823|NCT00902746|1268203|P1|Overall Study|Lost to Follow-up|3
376824|NCT00902746|1268203|P1|Overall Study|Adverse Event|8
376825|NCT00902746|1268203|P1|Overall Study|Withdrawal by Subject|16
376826|NCT00902746|1268203|P1|Overall Study|Protocol Violation|7
376827|NCT00902668|1268208|P1|Overall Study|Protocol stopped due to slow accrual.|3
376828|NCT00902564|1268212|P1|Overall Study|Withdrawal by Subject|2
376829|NCT00902538|1268227|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
376830|NCT00902538|1268228|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
376831|NCT00902538|1268229|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
376832|NCT00902538|1268230|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
376833|NCT00902538|1268231|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
376834|NCT00902538|1268232|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
376835|NCT00902538|1268227|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
376836|NCT00902538|1268228|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
376837|NCT00902538|1268229|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
376838|NCT00902538|1268230|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
376839|NCT00902538|1268231|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
376840|NCT00902538|1268232|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
376841|NCT00902538|1268227|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
376842|NCT00902538|1268228|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
376843|NCT00902538|1268229|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
376844|NCT00902538|1268230|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
376845|NCT00902538|1268231|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
376846|NCT00902538|1268232|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
376847|NCT00902538|1268227|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
376848|NCT00902538|1268228|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
376849|NCT00902538|1268229|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
376850|NCT00902538|1268230|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
376851|NCT00902538|1268231|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
376852|NCT00902538|1268232|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
376853|NCT00902538|1268227|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
376854|NCT00902538|1268228|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
376855|NCT00902538|1268229|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
376856|NCT00902538|1268230|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
376857|NCT00902538|1268231|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
376858|NCT00902538|1268232|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
376859|NCT00902538|1268227|P6|3-Single-blind, Single Treatment|Protocol Violation|0
376860|NCT00902538|1268228|P5|3-Single-blind, Single Treatment|Protocol Violation|0
376861|NCT00902538|1268229|P4|3-Single-blind, Single Treatment|Protocol Violation|0
376862|NCT00902538|1268230|P3|3-Single-blind, Single Treatment|Protocol Violation|0
376863|NCT00902538|1268231|P2|3-Single-blind, Single Treatment|Protocol Violation|5
376864|NCT00902538|1268232|P1|3-Single-blind, Single Treatment|Protocol Violation|0
376865|NCT00902538|1268227|P6|3-Single-blind, Single Treatment|Adverse Event|0
376866|NCT00902538|1268228|P5|3-Single-blind, Single Treatment|Adverse Event|0
376867|NCT00902538|1268229|P4|3-Single-blind, Single Treatment|Adverse Event|0
376868|NCT00902538|1268230|P3|3-Single-blind, Single Treatment|Adverse Event|0
376869|NCT00902538|1268231|P2|3-Single-blind, Single Treatment|Adverse Event|5
376870|NCT00902538|1268232|P1|3-Single-blind, Single Treatment|Adverse Event|0
376871|NCT00902538|1268227|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
376872|NCT00902538|1268228|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
376873|NCT00902538|1268229|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
376874|NCT00902538|1268230|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
376875|NCT00902538|1268231|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
376876|NCT00902538|1268232|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
376877|NCT00902538|1268227|P6|2-Randomized Double-blind 3 Treatments|Other|0
376878|NCT00902538|1268228|P5|2-Randomized Double-blind 3 Treatments|Other|0
376879|NCT00902538|1268229|P4|2-Randomized Double-blind 3 Treatments|Other|0
376880|NCT00902538|1268230|P3|2-Randomized Double-blind 3 Treatments|Other|0
376881|NCT00902538|1268231|P2|2-Randomized Double-blind 3 Treatments|Other|1
376882|NCT00902538|1268232|P1|2-Randomized Double-blind 3 Treatments|Other|2
376883|NCT00902538|1268227|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
376884|NCT00902538|1268228|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
376885|NCT00902538|1268229|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
376886|NCT00902538|1268230|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
376887|NCT00902538|1268231|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
376888|NCT00902538|1268232|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
376889|NCT00902538|1268227|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
376890|NCT00902538|1268228|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
376891|NCT00902538|1268229|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
376892|NCT00902538|1268230|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
376893|NCT00902538|1268231|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
376894|NCT00902538|1268232|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
376895|NCT00902538|1268227|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
376896|NCT00902538|1268228|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
376897|NCT00902538|1268229|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
376898|NCT00902538|1268230|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
376899|NCT00902538|1268231|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
376900|NCT00902538|1268232|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
376901|NCT00902538|1268227|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
376902|NCT00902538|1268228|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
376903|NCT00902538|1268229|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
376904|NCT00902538|1268230|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
376905|NCT00902538|1268231|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
376906|NCT00902538|1268232|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
376907|NCT00902538|1268227|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
376908|NCT00902538|1268228|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
376909|NCT00902538|1268229|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
376910|NCT00902538|1268230|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
376911|NCT00902538|1268231|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
376912|NCT00902538|1268232|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
376913|NCT00902538|1268227|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
376914|NCT00902538|1268228|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
376915|NCT00902538|1268229|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
376916|NCT00902538|1268230|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
376917|NCT00902538|1268231|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
376918|NCT00902538|1268232|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
376919|NCT00902538|1268227|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
376920|NCT00902538|1268228|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
376921|NCT00902538|1268229|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
376922|NCT00902538|1268230|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
376923|NCT00902538|1268231|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
376924|NCT00902538|1268232|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
376925|NCT00902538|1268227|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
376926|NCT00902538|1268228|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
376927|NCT00902538|1268229|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
376928|NCT00902538|1268230|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
376929|NCT00902538|1268231|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
376930|NCT00902538|1268232|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
376931|NCT00902330|1268264|P2|Overall Study|No post baseline data|0
376932|NCT00902330|1268265|P1|Overall Study|No post baseline data|1
376933|NCT00902330|1268264|P2|Overall Study|Adverse Event|0
376934|NCT00902330|1268265|P1|Overall Study|Adverse Event|1
376935|NCT00902330|1268264|P2|Overall Study|Too overwhelmed by treatment|5
376936|NCT00902330|1268265|P1|Overall Study|Too overwhelmed by treatment|2
376937|NCT00902304|1268302|P3|Overall Study|includes pregnancy|2
376938|NCT00902304|1268303|P2|Overall Study|includes pregnancy|9
376939|NCT00902304|1268304|P1|Overall Study|includes pregnancy|3
376940|NCT00902304|1268302|P3|Overall Study|Withdrawal by Subject|43
376941|NCT00902304|1268303|P2|Overall Study|Withdrawal by Subject|22
376942|NCT00902304|1268304|P1|Overall Study|Withdrawal by Subject|32
376943|NCT00902304|1268302|P3|Overall Study|Protocol Violation|20
376944|NCT00902304|1268303|P2|Overall Study|Protocol Violation|18
376945|NCT00902304|1268304|P1|Overall Study|Protocol Violation|9
376946|NCT00902304|1268302|P3|Overall Study|Lost to Follow-up|7
376947|NCT00902304|1268303|P2|Overall Study|Lost to Follow-up|7
376948|NCT00902304|1268304|P1|Overall Study|Lost to Follow-up|7
376949|NCT00902304|1268302|P3|Overall Study|Investigator discretion|13
376950|NCT00902304|1268303|P2|Overall Study|Investigator discretion|5
376951|NCT00902304|1268304|P1|Overall Study|Investigator discretion|3
376952|NCT00902304|1268302|P3|Overall Study|Adverse Event|25
376953|NCT00902304|1268303|P2|Overall Study|Adverse Event|10
376954|NCT00902304|1268304|P1|Overall Study|Adverse Event|4
376955|NCT00902278|1268354|P5|Overall Study|Lost to Follow-up|1
376956|NCT00902278|1268355|P4|Overall Study|Lost to Follow-up|0
376957|NCT00902278|1268356|P3|Overall Study|Lost to Follow-up|3
376958|NCT00902278|1268357|P2|Overall Study|Lost to Follow-up|2
376959|NCT00902278|1268358|P1|Overall Study|Lost to Follow-up|3
376960|NCT00902278|1268354|P5|Overall Study|Physician Decision|1
376961|NCT00902278|1268355|P4|Overall Study|Physician Decision|0
376962|NCT00902278|1268356|P3|Overall Study|Physician Decision|2
376963|NCT00902278|1268357|P2|Overall Study|Physician Decision|0
376964|NCT00902278|1268358|P1|Overall Study|Physician Decision|1
376965|NCT00902265|1268375|P1|Overall Study|Protocol Violation|1
376966|NCT00902265|1268375|P1|Overall Study|Lack of Efficacy|2
376967|NCT00902265|1268375|P1|Overall Study|Adverse Event|2
376968|NCT00902265|1268375|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
376969|NCT00902174|1268399|P2|Overall Study|Administration problem|1
376970|NCT00902174|1268400|P1|Overall Study|Administration problem|0
376971|NCT00902174|1268399|P2|Overall Study|Protocol Violation|1
376972|NCT00902174|1268400|P1|Overall Study|Protocol Violation|1
376973|NCT00902174|1268399|P2|Overall Study|Abnormal labs|1
376974|NCT00902174|1268400|P1|Overall Study|Abnormal labs|1
376975|NCT00902174|1268399|P2|Overall Study|Withdrawal by Subject|1
376976|NCT00902174|1268400|P1|Overall Study|Withdrawal by Subject|2
376977|NCT00902174|1268399|P2|Overall Study|Death|2
376978|NCT00902174|1268400|P1|Overall Study|Death|2
376979|NCT00902174|1268399|P2|Overall Study|Lack of Efficacy|5
376980|NCT00902174|1268400|P1|Overall Study|Lack of Efficacy|1
376981|NCT00902174|1268399|P2|Overall Study|Adverse Event|7
376982|NCT00902174|1268400|P1|Overall Study|Adverse Event|27
376983|NCT00901901|1268457|P2|Follow-up Period|Lost to Follow-up|8
376984|NCT00901901|1268458|P1|Follow-up Period|Lost to Follow-up|12
376985|NCT00901901|1268457|P2|Follow-up Period|Withdrawal by Subject|9
376986|NCT00901901|1268458|P1|Follow-up Period|Withdrawal by Subject|6
376987|NCT00901901|1268457|P2|Follow-up Period|Protocol driven decision point|35
376988|NCT00901901|1268458|P1|Follow-up Period|Protocol driven decision point|47
376989|NCT00901901|1268457|P2|Follow-up Period|Death|207
376990|NCT00901901|1268458|P1|Follow-up Period|Death|181
376991|NCT00901901|1268457|P2|Treatment Period|Never treated|3
376992|NCT00901901|1268458|P1|Treatment Period|Never treated|0
376993|NCT00901901|1268457|P2|Treatment Period|Missing|1
376994|NCT00901901|1268458|P1|Treatment Period|Missing|1
376995|NCT00901901|1268457|P2|Treatment Period|Protocol Violation|9
376996|NCT00901901|1268458|P1|Treatment Period|Protocol Violation|4
376997|NCT00901901|1268457|P2|Treatment Period|Noncompliance with study medication|1
376998|NCT00901901|1268458|P1|Treatment Period|Noncompliance with study medication|4
376999|NCT00901901|1268457|P2|Treatment Period|Lost to Follow-up|5
377000|NCT00901901|1268458|P1|Treatment Period|Lost to Follow-up|3
377001|NCT00901901|1268457|P2|Treatment Period|Physician Decision|2
377002|NCT00901901|1268458|P1|Treatment Period|Physician Decision|2
377003|NCT00901901|1268457|P2|Treatment Period|Withdrawal by Subject|24
377004|NCT00901901|1268458|P1|Treatment Period|Withdrawal by Subject|26
377005|NCT00901901|1268457|P2|Treatment Period|Adverse Event|123
377006|NCT00901901|1268458|P1|Treatment Period|Adverse Event|117
377007|NCT00901628|1268480|P2|Overall Study|peroneal nerve palsy|1
377008|NCT00901628|1268481|P1|Overall Study|peroneal nerve palsy|0
377009|NCT00901628|1268480|P2|Overall Study|disconnection of drain|1
377010|NCT00901628|1268481|P1|Overall Study|disconnection of drain|0
377011|NCT00901628|1268480|P2|Overall Study|disconnection of catheter|8
377012|NCT00901628|1268481|P1|Overall Study|disconnection of catheter|4
377013|NCT00901576|1268503|P6|Second Intervention|Physician Decision|0
377014|NCT00901576|1268504|P5|Second Intervention|Physician Decision|0
377015|NCT00901576|1268505|P4|Second Intervention|Physician Decision|0
377016|NCT00901576|1268506|P3|Second Intervention|Physician Decision|0
377017|NCT00901576|1268507|P2|Second Intervention|Physician Decision|0
377018|NCT00901576|1268508|P1|Second Intervention|Physician Decision|1
377019|NCT00901576|1268503|P6|Second Intervention|Withdrawal by Subject|1
377020|NCT00901576|1268504|P5|Second Intervention|Withdrawal by Subject|0
377021|NCT00901576|1268505|P4|Second Intervention|Withdrawal by Subject|1
377022|NCT00901576|1268506|P3|Second Intervention|Withdrawal by Subject|0
377023|NCT00901576|1268507|P2|Second Intervention|Withdrawal by Subject|0
377024|NCT00901576|1268508|P1|Second Intervention|Withdrawal by Subject|0
377025|NCT00901459|1268529|P1|Overall Study|Withdrawal by Subject|6
377026|NCT00901342|1268540|P1|Overall Study|Withdrawal by Subject|9
377027|NCT00901342|1268540|P1|Overall Study|Disease progression|1
377028|NCT00901342|1268540|P1|Overall Study|Death|4
377029|NCT00901342|1268540|P1|Overall Study|Adverse Event|1
377030|NCT00901186|1268564|P2|Overall Study|Protocol deviations|4
377031|NCT00901186|1268565|P1|Overall Study|Protocol deviations|5
377032|NCT00901186|1268564|P2|Overall Study|Administration problems|1
377033|NCT00901186|1268565|P1|Overall Study|Administration problems|0
377034|NCT00901186|1268564|P2|Overall Study|Adverse Event|4
377035|NCT00901186|1268565|P1|Overall Study|Adverse Event|2
377036|NCT00901186|1268564|P2|Overall Study|Lost to Follow-up|0
377037|NCT00901186|1268565|P1|Overall Study|Lost to Follow-up|2
377038|NCT00901186|1268564|P2|Overall Study|Abnormal laboratory values|1
377039|NCT00901186|1268565|P1|Overall Study|Abnormal laboratory values|0
377040|NCT00901186|1268564|P2|Overall Study|Lack of Efficacy|1
377041|NCT00901186|1268565|P1|Overall Study|Lack of Efficacy|0
377042|NCT00900796|1268605|P1|Phase 2|Lost to Follow-up|5
377043|NCT00900796|1268605|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
377044|NCT00900796|1268605|P1|Phase 1|Missing information at Week 16|7
377045|NCT00900796|1268605|P1|Phase 1|Lacked sufficient information|4
377046|NCT00900757|1268615|P1|Overall Study|screen failure|19
377047|NCT00900731|1268625|P2|Overall Study|Death|2
377048|NCT00900731|1268626|P1|Overall Study|Death|0
377049|NCT00900731|1268625|P2|Overall Study|Lack of Efficacy|3
377050|NCT00900731|1268626|P1|Overall Study|Lack of Efficacy|1
377051|NCT00900731|1268625|P2|Overall Study|Lost to Follow-up|3
377052|NCT00900731|1268626|P1|Overall Study|Lost to Follow-up|2
377053|NCT00900731|1268625|P2|Overall Study|Abnormal Laboratory Value(s)|4
377054|NCT00900731|1268626|P1|Overall Study|Abnormal Laboratory Value(s)|2
377055|NCT00900731|1268625|P2|Overall Study|Abnormal Test Procedure Result(s)|0
377056|NCT00900731|1268626|P1|Overall Study|Abnormal Test Procedure Result(s)|3
377057|NCT00900731|1268625|P2|Overall Study|Administrative Problems|4
377058|NCT00900731|1268626|P1|Overall Study|Administrative Problems|5
377059|NCT00900731|1268625|P2|Overall Study|Protocol Deviation|11
377060|NCT00900731|1268626|P1|Overall Study|Protocol Deviation|8
377061|NCT00900731|1268625|P2|Overall Study|Withdrawal by Subject|7
377062|NCT00900731|1268626|P1|Overall Study|Withdrawal by Subject|8
377063|NCT00900731|1268625|P2|Overall Study|Adverse Event|27
377064|NCT00900731|1268626|P1|Overall Study|Adverse Event|31
377065|NCT00900627|1268663|P6|Overall Study|Death|24
377066|NCT00900627|1268664|P5|Overall Study|Death|28
377067|NCT00900627|1268665|P4|Overall Study|Death|0
377068|NCT00900627|1268666|P3|Overall Study|Death|0
377069|NCT00900627|1268667|P2|Overall Study|Death|0
377070|NCT00900627|1268668|P1|Overall Study|Death|0
377071|NCT00900627|1268663|P6|Overall Study|Adverse Event|0
377072|NCT00900627|1268664|P5|Overall Study|Adverse Event|0
377073|NCT00900627|1268665|P4|Overall Study|Adverse Event|3
377074|NCT00900627|1268666|P3|Overall Study|Adverse Event|0
377075|NCT00900627|1268667|P2|Overall Study|Adverse Event|2
377076|NCT00900627|1268668|P1|Overall Study|Adverse Event|1
377077|NCT00900627|1268663|P6|Overall Study|Withdrawal by Subject|2
377078|NCT00900627|1268664|P5|Overall Study|Withdrawal by Subject|1
377079|NCT00900627|1268665|P4|Overall Study|Withdrawal by Subject|0
377080|NCT00900627|1268666|P3|Overall Study|Withdrawal by Subject|1
377081|NCT00900627|1268667|P2|Overall Study|Withdrawal by Subject|0
377082|NCT00900627|1268668|P1|Overall Study|Withdrawal by Subject|1
377083|NCT00900627|1268663|P6|Overall Study|Condition under investigation worsened|0
377084|NCT00900627|1268664|P5|Overall Study|Condition under investigation worsened|0
377085|NCT00900627|1268665|P4|Overall Study|Condition under investigation worsened|3
377086|NCT00900627|1268666|P3|Overall Study|Condition under investigation worsened|5
377087|NCT00900627|1268667|P2|Overall Study|Condition under investigation worsened|0
377088|NCT00900627|1268668|P1|Overall Study|Condition under investigation worsened|4
377089|NCT00900601|1268686|P1|Overall Study|Physician Decision|1
377090|NCT00900159|1268705|P2|Second Intervention|disempanelled for inappropriate behavior|0
377091|NCT00900159|1268706|P1|Second Intervention|disempanelled for inappropriate behavior|1
377092|NCT00900146|1268725|P5|Intermediate: Period III|Administrative problems|163
377093|NCT00900146|1268726|P4|Intermediate: Period III|Administrative problems|90
377094|NCT00900146|1268727|P3|Intermediate: Period III|Administrative problems|84
377095|NCT00900146|1268728|P2|Intermediate: Period III|Administrative problems|92
377096|NCT00900146|1268729|P1|Intermediate: Period III|Administrative problems|85
377097|NCT00900146|1268725|P5|Intermediate: Period III|Lost to Follow-up|1
377098|NCT00900146|1268726|P4|Intermediate: Period III|Lost to Follow-up|0
377099|NCT00900146|1268727|P3|Intermediate: Period III|Lost to Follow-up|0
377100|NCT00900146|1268728|P2|Intermediate: Period III|Lost to Follow-up|0
377101|NCT00900146|1268729|P1|Intermediate: Period III|Lost to Follow-up|2
377102|NCT00900146|1268725|P5|Intermediate: Period III|Withdrawal by Subject|3
377103|NCT00900146|1268726|P4|Intermediate: Period III|Withdrawal by Subject|0
377104|NCT00900146|1268727|P3|Intermediate: Period III|Withdrawal by Subject|0
377105|NCT00900146|1268728|P2|Intermediate: Period III|Withdrawal by Subject|1
377106|NCT00900146|1268729|P1|Intermediate: Period III|Withdrawal by Subject|0
377107|NCT00900146|1268725|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
377108|NCT00900146|1268726|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
377109|NCT00900146|1268727|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
377110|NCT00900146|1268728|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
377111|NCT00900146|1268729|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
377112|NCT00900146|1268725|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
377113|NCT00900146|1268726|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
377114|NCT00900146|1268727|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
377115|NCT00900146|1268728|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
377116|NCT00900146|1268729|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
377117|NCT00900146|1268725|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
377118|NCT00900146|1268726|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
377119|NCT00900146|1268727|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
377120|NCT00900146|1268728|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
377121|NCT00900146|1268729|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
377122|NCT00900029|1268846|P5|Overall Study|Death|0
377123|NCT00900029|1268847|P4|Overall Study|Death|1
377124|NCT00900029|1268848|P3|Overall Study|Death|0
377125|NCT00900029|1268849|P2|Overall Study|Death|0
377126|NCT00900029|1268850|P1|Overall Study|Death|1
377127|NCT00900029|1268846|P5|Overall Study|Adverse Event|1
377128|NCT00900029|1268847|P4|Overall Study|Adverse Event|1
377129|NCT00900029|1268848|P3|Overall Study|Adverse Event|1
377130|NCT00900029|1268849|P2|Overall Study|Adverse Event|0
377131|NCT00900029|1268850|P1|Overall Study|Adverse Event|0
377132|NCT00900029|1268846|P5|Overall Study|Withdrawal by Subject|1
377133|NCT00900029|1268847|P4|Overall Study|Withdrawal by Subject|1
377134|NCT00900029|1268848|P3|Overall Study|Withdrawal by Subject|1
377135|NCT00900029|1268849|P2|Overall Study|Withdrawal by Subject|2
377136|NCT00900029|1268850|P1|Overall Study|Withdrawal by Subject|2
377137|NCT00900029|1268846|P5|Overall Study|Lost to Follow-up|4
377138|NCT00900029|1268847|P4|Overall Study|Lost to Follow-up|4
377139|NCT00900029|1268848|P3|Overall Study|Lost to Follow-up|1
377140|NCT00900029|1268849|P2|Overall Study|Lost to Follow-up|2
377141|NCT00900029|1268850|P1|Overall Study|Lost to Follow-up|0
377142|NCT00899847|1268867|P1|Overall Study|Lack of suitable allogeneic donor|2
377143|NCT00899678|1268898|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
377144|NCT00899678|1268899|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
377145|NCT00899678|1268900|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
377146|NCT00899678|1268898|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
377147|NCT00899678|1268899|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
377148|NCT00899678|1268900|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
377149|NCT00899678|1268898|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
377150|NCT00899678|1268899|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
377151|NCT00899678|1268900|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
377152|NCT00899678|1268898|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
377153|NCT00899678|1268899|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
377154|NCT00899678|1268900|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
377155|NCT00899678|1268898|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
377156|NCT00899678|1268899|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
377157|NCT00899678|1268900|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
377158|NCT00899678|1268898|P3|Induction Period (Weeks 0 to 6)|Other reason|0
377159|NCT00899678|1268899|P2|Induction Period (Weeks 0 to 6)|Other reason|0
377160|NCT00899678|1268900|P1|Induction Period (Weeks 0 to 6)|Other reason|1
377161|NCT00899678|1268898|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
377162|NCT00899678|1268899|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
377163|NCT00899678|1268900|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
377164|NCT00899678|1268898|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
377165|NCT00899678|1268899|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
377166|NCT00899678|1268900|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
377167|NCT00899678|1268898|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
377168|NCT00899678|1268899|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
377169|NCT00899678|1268900|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
377170|NCT00899392|1269023|P2|Overall Study|Subject didn't finish/partial pilot data|24
377171|NCT00899392|1269024|P1|Overall Study|Subject didn't finish/partial pilot data|21
377172|NCT00899379|1269041|P5|Overall Study|Inc/Exc Criteria Not Met|0
377173|NCT00899379|1269042|P4|Overall Study|Inc/Exc Criteria Not Met|0
377174|NCT00899379|1269043|P3|Overall Study|Inc/Exc Criteria Not Met|1
377175|NCT00899379|1269044|P2|Overall Study|Inc/Exc Criteria Not Met|0
377176|NCT00899379|1269045|P1|Overall Study|Inc/Exc Criteria Not Met|0
377177|NCT00899379|1269041|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
377178|NCT00899379|1269042|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
377179|NCT00899379|1269043|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
377180|NCT00899379|1269044|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
377181|NCT00899379|1269045|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
377182|NCT00899379|1269041|P5|Overall Study|No Attack Pretreatment|4
377183|NCT00899379|1269042|P4|Overall Study|No Attack Pretreatment|6
377184|NCT00899379|1269043|P3|Overall Study|No Attack Pretreatment|5
377185|NCT00899379|1269044|P2|Overall Study|No Attack Pretreatment|5
377186|NCT00899379|1269045|P1|Overall Study|No Attack Pretreatment|3
377187|NCT00899379|1269041|P5|Overall Study|Abnormal Baseline ECG|0
377188|NCT00899379|1269042|P4|Overall Study|Abnormal Baseline ECG|1
377189|NCT00899379|1269043|P3|Overall Study|Abnormal Baseline ECG|1
377190|NCT00899379|1269044|P2|Overall Study|Abnormal Baseline ECG|0
377191|NCT00899379|1269045|P1|Overall Study|Abnormal Baseline ECG|0
377192|NCT00899379|1269041|P5|Overall Study|Abnormal Prestudy Labs|2
377193|NCT00899379|1269042|P4|Overall Study|Abnormal Prestudy Labs|0
377194|NCT00899379|1269043|P3|Overall Study|Abnormal Prestudy Labs|0
377195|NCT00899379|1269044|P2|Overall Study|Abnormal Prestudy Labs|0
377196|NCT00899379|1269045|P1|Overall Study|Abnormal Prestudy Labs|0
377197|NCT00899379|1269041|P5|Overall Study|Patient Uncooperative|0
377198|NCT00899379|1269042|P4|Overall Study|Patient Uncooperative|1
377199|NCT00899379|1269043|P3|Overall Study|Patient Uncooperative|0
377200|NCT00899379|1269044|P2|Overall Study|Patient Uncooperative|0
377201|NCT00899379|1269045|P1|Overall Study|Patient Uncooperative|0
377202|NCT00899379|1269041|P5|Overall Study|Pregnancy|0
377203|NCT00899379|1269042|P4|Overall Study|Pregnancy|0
377204|NCT00899379|1269043|P3|Overall Study|Pregnancy|0
377205|NCT00899379|1269044|P2|Overall Study|Pregnancy|0
377206|NCT00899379|1269045|P1|Overall Study|Pregnancy|1
377207|NCT00899379|1269041|P5|Overall Study|Withdrawal by Subject|2
377208|NCT00899379|1269042|P4|Overall Study|Withdrawal by Subject|7
377209|NCT00899379|1269043|P3|Overall Study|Withdrawal by Subject|4
377210|NCT00899379|1269044|P2|Overall Study|Withdrawal by Subject|7
377211|NCT00899379|1269045|P1|Overall Study|Withdrawal by Subject|4
377212|NCT00899379|1269041|P5|Overall Study|Lost to Follow-up|5
377213|NCT00899379|1269042|P4|Overall Study|Lost to Follow-up|2
377214|NCT00899379|1269043|P3|Overall Study|Lost to Follow-up|0
377215|NCT00899379|1269044|P2|Overall Study|Lost to Follow-up|1
377216|NCT00899379|1269045|P1|Overall Study|Lost to Follow-up|3
377217|NCT00899379|1269041|P5|Overall Study|Study Terminated|1
377218|NCT00899379|1269042|P4|Overall Study|Study Terminated|3
377219|NCT00899379|1269043|P3|Overall Study|Study Terminated|3
377220|NCT00899379|1269044|P2|Overall Study|Study Terminated|0
377221|NCT00899379|1269045|P1|Overall Study|Study Terminated|3
377222|NCT00899379|1269041|P5|Overall Study|Not Completed/Entered Extn|3
377223|NCT00899379|1269042|P4|Overall Study|Not Completed/Entered Extn|4
377224|NCT00899379|1269043|P3|Overall Study|Not Completed/Entered Extn|6
377225|NCT00899379|1269044|P2|Overall Study|Not Completed/Entered Extn|1
377226|NCT00899379|1269045|P1|Overall Study|Not Completed/Entered Extn|5
377227|NCT00899379|1269041|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
377228|NCT00899379|1269042|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
377229|NCT00899379|1269043|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
377230|NCT00899379|1269044|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
377231|NCT00899379|1269045|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
377232|NCT00899379|1269041|P5|Overall Study|Abnormal Baseline ECG|0
377233|NCT00899379|1269042|P4|Overall Study|Abnormal Baseline ECG|1
377234|NCT00899379|1269043|P3|Overall Study|Abnormal Baseline ECG|0
377235|NCT00899379|1269044|P2|Overall Study|Abnormal Baseline ECG|0
377236|NCT00899379|1269045|P1|Overall Study|Abnormal Baseline ECG|0
377237|NCT00899379|1269041|P5|Overall Study|Patient Uncooperative|2
377238|NCT00899379|1269042|P4|Overall Study|Patient Uncooperative|1
377239|NCT00899379|1269043|P3|Overall Study|Patient Uncooperative|0
377240|NCT00899379|1269044|P2|Overall Study|Patient Uncooperative|1
377241|NCT00899379|1269045|P1|Overall Study|Patient Uncooperative|0
377242|NCT00899379|1269041|P5|Overall Study|Pregnancy|1
377243|NCT00899379|1269042|P4|Overall Study|Pregnancy|0
377244|NCT00899379|1269043|P3|Overall Study|Pregnancy|1
377245|NCT00899379|1269044|P2|Overall Study|Pregnancy|0
377246|NCT00899379|1269045|P1|Overall Study|Pregnancy|0
377247|NCT00899379|1269041|P5|Overall Study|Withdrawal by Subject|6
377248|NCT00899379|1269042|P4|Overall Study|Withdrawal by Subject|3
377249|NCT00899379|1269043|P3|Overall Study|Withdrawal by Subject|2
377250|NCT00899379|1269044|P2|Overall Study|Withdrawal by Subject|4
377251|NCT00899379|1269045|P1|Overall Study|Withdrawal by Subject|2
377252|NCT00899379|1269041|P5|Overall Study|Protocol Violation|0
377253|NCT00899379|1269042|P4|Overall Study|Protocol Violation|1
377254|NCT00899379|1269043|P3|Overall Study|Protocol Violation|1
377255|NCT00899379|1269044|P2|Overall Study|Protocol Violation|0
377256|NCT00899379|1269045|P1|Overall Study|Protocol Violation|0
377257|NCT00899379|1269041|P5|Overall Study|Lost to Follow-up|2
377258|NCT00899379|1269042|P4|Overall Study|Lost to Follow-up|6
377259|NCT00899379|1269043|P3|Overall Study|Lost to Follow-up|0
377260|NCT00899379|1269044|P2|Overall Study|Lost to Follow-up|3
377261|NCT00899379|1269045|P1|Overall Study|Lost to Follow-up|9
377262|NCT00899379|1269041|P5|Overall Study|Lack of Efficacy|1
377263|NCT00899379|1269042|P4|Overall Study|Lack of Efficacy|0
377264|NCT00899379|1269043|P3|Overall Study|Lack of Efficacy|3
377265|NCT00899379|1269044|P2|Overall Study|Lack of Efficacy|4
377266|NCT00899379|1269045|P1|Overall Study|Lack of Efficacy|0
377267|NCT00899379|1269041|P5|Overall Study|Adverse Event|2
377268|NCT00899379|1269042|P4|Overall Study|Adverse Event|1
377269|NCT00899379|1269043|P3|Overall Study|Adverse Event|1
377270|NCT00899379|1269044|P2|Overall Study|Adverse Event|2
377271|NCT00899379|1269045|P1|Overall Study|Adverse Event|2
377272|NCT00899353|1269057|P1|Overall Study|Withdrawal by Subject|2
377273|NCT00899353|1269057|P1|Overall Study|Lost to Follow-up|1
377274|NCT00899353|1269057|P1|Overall Study|Adverse Event|2
377275|NCT00898807|1269093|P2|Overall Study|Death|1
377276|NCT00898807|1269094|P1|Overall Study|Death|0
377277|NCT00898807|1269093|P2|Overall Study|Lost to Follow-up|3
377278|NCT00898807|1269094|P1|Overall Study|Lost to Follow-up|1
377279|NCT00898807|1269093|P2|Overall Study|Family pressure to discontinue|2
377280|NCT00898807|1269094|P1|Overall Study|Family pressure to discontinue|2
377281|NCT00898807|1269093|P2|Overall Study|Withdrawal by Subject|3
377282|NCT00898807|1269094|P1|Overall Study|Withdrawal by Subject|5
377283|NCT00898677|1269110|P4|Overall Study|Not Treated: Other (Not Specified)|0
377284|NCT00898677|1269111|P3|Overall Study|Not Treated: Other (Not Specified)|2
377285|NCT00898677|1269112|P2|Overall Study|Not Treated: Other (Not Specified)|0
377286|NCT00898677|1269113|P1|Overall Study|Not Treated: Other (Not Specified)|0
377287|NCT00898677|1269110|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
377288|NCT00898677|1269111|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
377289|NCT00898677|1269112|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
377290|NCT00898677|1269113|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
377291|NCT00898677|1269110|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
377292|NCT00898677|1269111|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
377293|NCT00898677|1269112|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
377294|NCT00898677|1269113|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
377295|NCT00898677|1269110|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
377296|NCT00898677|1269111|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
377297|NCT00898677|1269112|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
377298|NCT00898677|1269113|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
377299|NCT00898677|1269110|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
377300|NCT00898677|1269111|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
377301|NCT00898677|1269112|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
377302|NCT00898677|1269113|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
377303|NCT00898677|1269110|P4|Overall Study|Not Treated: Patient uncooperative|0
377304|NCT00898677|1269111|P3|Overall Study|Not Treated: Patient uncooperative|1
377305|NCT00898677|1269112|P2|Overall Study|Not Treated: Patient uncooperative|3
377306|NCT00898677|1269113|P1|Overall Study|Not Treated: Patient uncooperative|2
377307|NCT00898677|1269110|P4|Overall Study|Not Treated: Withdraw by Subject|3
377308|NCT00898677|1269111|P3|Overall Study|Not Treated: Withdraw by Subject|11
377309|NCT00898677|1269112|P2|Overall Study|Not Treated: Withdraw by Subject|16
377310|NCT00898677|1269113|P1|Overall Study|Not Treated: Withdraw by Subject|2
377311|NCT00898677|1269110|P4|Overall Study|Not Treated: Protocol Violation|0
377312|NCT00898677|1269111|P3|Overall Study|Not Treated: Protocol Violation|2
377313|NCT00898677|1269112|P2|Overall Study|Not Treated: Protocol Violation|0
377314|NCT00898677|1269113|P1|Overall Study|Not Treated: Protocol Violation|2
377315|NCT00898677|1269110|P4|Overall Study|Not Treated: Pregnancy|0
377316|NCT00898677|1269111|P3|Overall Study|Not Treated: Pregnancy|1
377317|NCT00898677|1269112|P2|Overall Study|Not Treated: Pregnancy|0
377318|NCT00898677|1269113|P1|Overall Study|Not Treated: Pregnancy|0
377319|NCT00898677|1269110|P4|Overall Study|Not Treated: Lost to Follow-Up|2
377320|NCT00898677|1269111|P3|Overall Study|Not Treated: Lost to Follow-Up|5
377321|NCT00898677|1269112|P2|Overall Study|Not Treated: Lost to Follow-Up|5
377322|NCT00898677|1269113|P1|Overall Study|Not Treated: Lost to Follow-Up|0
377323|NCT00898677|1269110|P4|Overall Study|Not Treated: Adverse Event|0
377324|NCT00898677|1269111|P3|Overall Study|Not Treated: Adverse Event|1
377325|NCT00898677|1269112|P2|Overall Study|Not Treated: Adverse Event|2
377326|NCT00898677|1269113|P1|Overall Study|Not Treated: Adverse Event|0
377327|NCT00898677|1269110|P4|Overall Study|Withdrawal by Subject|1
377328|NCT00898677|1269111|P3|Overall Study|Withdrawal by Subject|0
377329|NCT00898677|1269112|P2|Overall Study|Withdrawal by Subject|0
377330|NCT00898677|1269113|P1|Overall Study|Withdrawal by Subject|0
377331|NCT00898677|1269110|P4|Overall Study|Protocol Violation|0
377332|NCT00898677|1269111|P3|Overall Study|Protocol Violation|2
377333|NCT00898677|1269112|P2|Overall Study|Protocol Violation|1
377334|NCT00898677|1269113|P1|Overall Study|Protocol Violation|1
377335|NCT00898677|1269110|P4|Overall Study|Lost to Follow-up|0
377336|NCT00898677|1269111|P3|Overall Study|Lost to Follow-up|2
377337|NCT00898677|1269112|P2|Overall Study|Lost to Follow-up|0
377338|NCT00898677|1269113|P1|Overall Study|Lost to Follow-up|0
377339|NCT00898677|1269110|P4|Overall Study|Adverse Event|0
377340|NCT00898677|1269111|P3|Overall Study|Adverse Event|1
377341|NCT00898677|1269112|P2|Overall Study|Adverse Event|0
377342|NCT00898677|1269113|P1|Overall Study|Adverse Event|0
377343|NCT00898443|1269151|P2|Overall Study|Withdrawal by Subject|0
377344|NCT00898443|1269152|P1|Overall Study|Withdrawal by Subject|1
377345|NCT00897949|1269167|P3|Overall Study|Did not take study drug|4
377346|NCT00897949|1269168|P2|Overall Study|Did not take study drug|3
377347|NCT00897949|1269169|P1|Overall Study|Did not take study drug|9
377348|NCT00897949|1269167|P3|Overall Study|Lack of Migraine Attack|19
377349|NCT00897949|1269168|P2|Overall Study|Lack of Migraine Attack|30
377350|NCT00897949|1269169|P1|Overall Study|Lack of Migraine Attack|29
377351|NCT00897949|1269167|P3|Overall Study|Need for Concom. Med.|1
377352|NCT00897949|1269168|P2|Overall Study|Need for Concom. Med.|1
377353|NCT00897949|1269169|P1|Overall Study|Need for Concom. Med.|0
377354|NCT00897949|1269167|P3|Overall Study|Abnormal Baseline ECG|4
377355|NCT00897949|1269168|P2|Overall Study|Abnormal Baseline ECG|2
377356|NCT00897949|1269169|P1|Overall Study|Abnormal Baseline ECG|2
377357|NCT00897949|1269167|P3|Overall Study|Abnormal Prestudy Labs|4
377358|NCT00897949|1269168|P2|Overall Study|Abnormal Prestudy Labs|3
377359|NCT00897949|1269169|P1|Overall Study|Abnormal Prestudy Labs|2
377360|NCT00897949|1269167|P3|Overall Study|Withdrawal by Subject|17
377361|NCT00897949|1269168|P2|Overall Study|Withdrawal by Subject|31
377362|NCT00897949|1269169|P1|Overall Study|Withdrawal by Subject|24
377363|NCT00897949|1269167|P3|Overall Study|Lost to Follow-up|17
377364|NCT00897949|1269168|P2|Overall Study|Lost to Follow-up|23
377365|NCT00897949|1269169|P1|Overall Study|Lost to Follow-up|30
377366|NCT00897949|1269167|P3|Overall Study|Patient Uncoorperative|1
377367|NCT00897949|1269168|P2|Overall Study|Patient Uncoorperative|2
377368|NCT00897949|1269169|P1|Overall Study|Patient Uncoorperative|0
377369|NCT00897949|1269167|P3|Overall Study|Withdrawal by Subject|0
377370|NCT00897949|1269168|P2|Overall Study|Withdrawal by Subject|2
377371|NCT00897949|1269169|P1|Overall Study|Withdrawal by Subject|1
377372|NCT00897949|1269167|P3|Overall Study|Protocol Violation|1
377373|NCT00897949|1269168|P2|Overall Study|Protocol Violation|3
377374|NCT00897949|1269169|P1|Overall Study|Protocol Violation|6
377375|NCT00897949|1269167|P3|Overall Study|Lost to Follow-up|1
377376|NCT00897949|1269168|P2|Overall Study|Lost to Follow-up|2
377377|NCT00897949|1269169|P1|Overall Study|Lost to Follow-up|0
377378|NCT00897949|1269167|P3|Overall Study|Adverse Event|0
377379|NCT00897949|1269168|P2|Overall Study|Adverse Event|1
377380|NCT00897949|1269169|P1|Overall Study|Adverse Event|1
377381|NCT00897715|1269203|P2|Overall Study|increased risk of infection|0
377382|NCT00897715|1269204|P1|Overall Study|increased risk of infection|1
377383|NCT00897715|1269203|P2|Overall Study|Physician Decision|0
377384|NCT00897715|1269204|P1|Overall Study|Physician Decision|1
377385|NCT00897715|1269203|P2|Overall Study|Lost to Follow-up|1
377386|NCT00897715|1269204|P1|Overall Study|Lost to Follow-up|0
377387|NCT00897390|1269229|P1|Overall Study|Did not Return for the Clinic Visit|2
377388|NCT00897390|1269229|P1|Overall Study|Personal Reasons|1
377389|NCT00897390|1269229|P1|Overall Study|No Longer Met Study Criteria|1
377390|NCT00897390|1269229|P1|Overall Study|Adverse Event|2
377391|NCT00897104|1269319|P3|Overall Study|Withdrawal by Subject|1
377392|NCT00897104|1269320|P2|Overall Study|Withdrawal by Subject|0
377393|NCT00897104|1269321|P1|Overall Study|Withdrawal by Subject|0
377394|NCT00897104|1269319|P3|Overall Study|Protocol Violation|0
377395|NCT00897104|1269320|P2|Overall Study|Protocol Violation|0
377396|NCT00897104|1269321|P1|Overall Study|Protocol Violation|1
377397|NCT00897104|1269319|P3|Overall Study|Not Specified|0
377398|NCT00897104|1269320|P2|Overall Study|Not Specified|0
377399|NCT00897104|1269321|P1|Overall Study|Not Specified|3
377400|NCT00897104|1269319|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
377401|NCT00897104|1269320|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
377402|NCT00897104|1269321|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
377403|NCT00897104|1269319|P3|Overall Study|Lack of Migraine Attack|1
377404|NCT00897104|1269320|P2|Overall Study|Lack of Migraine Attack|22
377405|NCT00897104|1269321|P1|Overall Study|Lack of Migraine Attack|20
377406|NCT00897104|1269319|P3|Overall Study|Need for Concom. Med.|1
377407|NCT00897104|1269320|P2|Overall Study|Need for Concom. Med.|1
377408|NCT00897104|1269321|P1|Overall Study|Need for Concom. Med.|0
377409|NCT00897104|1269319|P3|Overall Study|Abnormal Baseline ECG|0
377410|NCT00897104|1269320|P2|Overall Study|Abnormal Baseline ECG|2
377411|NCT00897104|1269321|P1|Overall Study|Abnormal Baseline ECG|2
377412|NCT00897104|1269319|P3|Overall Study|Abnormal Prestudy Labs|0
377413|NCT00897104|1269320|P2|Overall Study|Abnormal Prestudy Labs|0
377414|NCT00897104|1269321|P1|Overall Study|Abnormal Prestudy Labs|2
377415|NCT00897104|1269319|P3|Overall Study|Withdrawal by Subject|3
377416|NCT00897104|1269320|P2|Overall Study|Withdrawal by Subject|27
377417|NCT00897104|1269321|P1|Overall Study|Withdrawal by Subject|23
377418|NCT00897104|1269319|P3|Overall Study|Protocol Violation|0
377419|NCT00897104|1269320|P2|Overall Study|Protocol Violation|1
377420|NCT00897104|1269321|P1|Overall Study|Protocol Violation|0
377421|NCT00897104|1269319|P3|Overall Study|Pregnancy|0
377422|NCT00897104|1269320|P2|Overall Study|Pregnancy|1
377423|NCT00897104|1269321|P1|Overall Study|Pregnancy|0
377424|NCT00897104|1269319|P3|Overall Study|Lost to Follow-up|2
377425|NCT00897104|1269320|P2|Overall Study|Lost to Follow-up|17
377426|NCT00897104|1269321|P1|Overall Study|Lost to Follow-up|12
377427|NCT00896649|1269356|P1|Overall Study|technical difficulties|2
377428|NCT00896649|1269356|P1|Overall Study|missing documentation|1
377429|NCT00896649|1269356|P1|Overall Study|Pregnancy|1
377430|NCT00896649|1269356|P1|Overall Study|Physician Decision|1
377431|NCT00896454|1269361|P1|Overall Study|Withdrawal by Subject|1
377432|NCT00896454|1269361|P1|Overall Study|Ongoing in study|2
377433|NCT00896454|1269361|P1|Overall Study|Requirement for alternative therapy|3
377434|NCT00896454|1269361|P1|Overall Study|Other|4
377435|NCT00896454|1269361|P1|Overall Study|Disease Progression|5
377436|NCT00896454|1269361|P1|Overall Study|Adverse Event|8
377437|NCT00896454|1269361|P1|Overall Study|Death|10
377438|NCT00896363|1269400|P3|Overall Study|Withdrawal by Subject|5
377439|NCT00896363|1269401|P2|Overall Study|Withdrawal by Subject|5
377440|NCT00896363|1269402|P1|Overall Study|Withdrawal by Subject|3
377441|NCT00896363|1269400|P3|Overall Study|Lack of Efficacy|1
377442|NCT00896363|1269401|P2|Overall Study|Lack of Efficacy|2
377443|NCT00896363|1269402|P1|Overall Study|Lack of Efficacy|0
377444|NCT00896363|1269400|P3|Overall Study|Adverse Event|2
377445|NCT00896363|1269401|P2|Overall Study|Adverse Event|4
377446|NCT00896363|1269402|P1|Overall Study|Adverse Event|3
377447|NCT00896337|1269454|P1|Overall Study|Lost to Follow-up|11
377448|NCT00896337|1269454|P1|Overall Study|Withdrawal by Subject|7
377449|NCT00896337|1269454|P1|Overall Study|Death|7
377450|NCT00896233|1269521|P1|Overall Study|Claustrophobia during MRI|1
377451|NCT00896168|1269534|P2|Overall Study|Other|1
377452|NCT00896168|1269535|P1|Overall Study|Other|1
377453|NCT00896168|1269534|P2|Overall Study|Lost to Follow-up|1
377454|NCT00896168|1269535|P1|Overall Study|Lost to Follow-up|1
377455|NCT00896168|1269534|P2|Overall Study|Treatment failure|10
377456|NCT00896168|1269535|P1|Overall Study|Treatment failure|8
377457|NCT00896168|1269534|P2|Overall Study|Adverse Event|7
377458|NCT00896168|1269535|P1|Overall Study|Adverse Event|4
377459|NCT00896051|1269596|P2|Overall Study|Not specified|1
377460|NCT00896051|1269597|P1|Overall Study|Not specified|1
377461|NCT00896051|1269596|P2|Overall Study|Subject noncompliant|3
377462|NCT00896051|1269597|P1|Overall Study|Subject noncompliant|1
377463|NCT00896051|1269596|P2|Overall Study|Withdrawal by Subject|2
377464|NCT00896051|1269597|P1|Overall Study|Withdrawal by Subject|3
377465|NCT00896051|1269596|P2|Overall Study|Lost to Follow-up|2
377466|NCT00896051|1269597|P1|Overall Study|Lost to Follow-up|3
377467|NCT00896051|1269596|P2|Overall Study|Adverse Event|1
377468|NCT00896051|1269597|P1|Overall Study|Adverse Event|2
377469|NCT00895947|1269684|P2|Overall Study|Withdrawal by Subject|0
377470|NCT00895947|1269685|P1|Overall Study|Withdrawal by Subject|2
377471|NCT00895947|1269684|P2|Overall Study|Protocol Violation|2
377472|NCT00895947|1269685|P1|Overall Study|Protocol Violation|4
377473|NCT00895947|1269684|P2|Overall Study|Lost to Follow-up|4
377474|NCT00895947|1269685|P1|Overall Study|Lost to Follow-up|3
377475|NCT00895947|1269684|P2|Overall Study|Adverse Event|4
377476|NCT00895947|1269685|P1|Overall Study|Adverse Event|3
377477|NCT00895934|1269703|P2|Overall Study|ineligible|0
377478|NCT00895934|1269704|P1|Overall Study|ineligible|1
377479|NCT00895934|1269703|P2|Overall Study|Death|1
377480|NCT00895934|1269704|P1|Overall Study|Death|0
377481|NCT00895934|1269703|P2|Overall Study|Lack of Efficacy|24
377482|NCT00895934|1269704|P1|Overall Study|Lack of Efficacy|5
377483|NCT00895895|1269715|P5|Period 2|unsatisfactory response-efficacy|0
377484|NCT00895895|1269716|P4|Period 2|unsatisfactory response-efficacy|0
377485|NCT00895895|1269717|P3|Period 2|unsatisfactory response-efficacy|0
377486|NCT00895895|1269718|P2|Period 2|unsatisfactory response-efficacy|1
377487|NCT00895895|1269719|P1|Period 2|unsatisfactory response-efficacy|2
377488|NCT00895895|1269715|P5|Period 2|Withdrawal by Subject|5
377489|NCT00895895|1269716|P4|Period 2|Withdrawal by Subject|3
377490|NCT00895895|1269717|P3|Period 2|Withdrawal by Subject|0
377491|NCT00895895|1269718|P2|Period 2|Withdrawal by Subject|2
377492|NCT00895895|1269719|P1|Period 2|Withdrawal by Subject|0
377493|NCT00895895|1269715|P5|Period 2|Protocol Violation|1
377494|NCT00895895|1269716|P4|Period 2|Protocol Violation|1
377495|NCT00895895|1269717|P3|Period 2|Protocol Violation|1
377496|NCT00895895|1269718|P2|Period 2|Protocol Violation|0
377497|NCT00895895|1269719|P1|Period 2|Protocol Violation|1
377498|NCT00895895|1269715|P5|Period 2|Other|1
377499|NCT00895895|1269716|P4|Period 2|Other|1
377500|NCT00895895|1269717|P3|Period 2|Other|3
377501|NCT00895895|1269718|P2|Period 2|Other|1
377502|NCT00895895|1269719|P1|Period 2|Other|1
377503|NCT00895895|1269715|P5|Period 2|Lost to Follow-up|0
377504|NCT00895895|1269716|P4|Period 2|Lost to Follow-up|1
377505|NCT00895895|1269717|P3|Period 2|Lost to Follow-up|1
377506|NCT00895895|1269718|P2|Period 2|Lost to Follow-up|2
377507|NCT00895895|1269719|P1|Period 2|Lost to Follow-up|1
377508|NCT00895895|1269715|P5|Period 2|investigator request|0
377509|NCT00895895|1269716|P4|Period 2|investigator request|0
377510|NCT00895895|1269717|P3|Period 2|investigator request|0
377511|NCT00895895|1269718|P2|Period 2|investigator request|0
377512|NCT00895895|1269719|P1|Period 2|investigator request|2
377513|NCT00895895|1269715|P5|Period 2|failed to return|0
377514|NCT00895895|1269716|P4|Period 2|failed to return|0
377515|NCT00895895|1269717|P3|Period 2|failed to return|0
377516|NCT00895895|1269718|P2|Period 2|failed to return|0
377517|NCT00895895|1269719|P1|Period 2|failed to return|2
377518|NCT00895895|1269715|P5|Period 2|discontinued by sponsor|37
377519|NCT00895895|1269716|P4|Period 2|discontinued by sponsor|46
377520|NCT00895895|1269717|P3|Period 2|discontinued by sponsor|38
377521|NCT00895895|1269718|P2|Period 2|discontinued by sponsor|44
377522|NCT00895895|1269719|P1|Period 2|discontinued by sponsor|44
377523|NCT00895895|1269715|P5|Period 2|Death|0
377524|NCT00895895|1269716|P4|Period 2|Death|0
377525|NCT00895895|1269717|P3|Period 2|Death|1
377526|NCT00895895|1269718|P2|Period 2|Death|0
377527|NCT00895895|1269719|P1|Period 2|Death|0
377528|NCT00895895|1269715|P5|Period 2|Adverse Event|5
377529|NCT00895895|1269716|P4|Period 2|Adverse Event|2
377530|NCT00895895|1269717|P3|Period 2|Adverse Event|5
377531|NCT00895895|1269718|P2|Period 2|Adverse Event|3
377532|NCT00895895|1269719|P1|Period 2|Adverse Event|3
377533|NCT00895895|1269715|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
377534|NCT00895895|1269716|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
377535|NCT00895895|1269717|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
377536|NCT00895895|1269718|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
377537|NCT00895895|1269719|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
377538|NCT00895895|1269715|P5|After Period 1, Prior to Period 2|Protocol Violation|1
377539|NCT00895895|1269716|P4|After Period 1, Prior to Period 2|Protocol Violation|0
377540|NCT00895895|1269717|P3|After Period 1, Prior to Period 2|Protocol Violation|0
377541|NCT00895895|1269718|P2|After Period 1, Prior to Period 2|Protocol Violation|0
377542|NCT00895895|1269719|P1|After Period 1, Prior to Period 2|Protocol Violation|0
377543|NCT00895895|1269715|P5|After Period 1, Prior to Period 2|Other|0
377544|NCT00895895|1269716|P4|After Period 1, Prior to Period 2|Other|0
377545|NCT00895895|1269717|P3|After Period 1, Prior to Period 2|Other|1
377546|NCT00895895|1269718|P2|After Period 1, Prior to Period 2|Other|0
377547|NCT00895895|1269719|P1|After Period 1, Prior to Period 2|Other|0
377548|NCT00895895|1269715|P5|After Period 1, Prior to Period 2|Adverse Event|0
377549|NCT00895895|1269716|P4|After Period 1, Prior to Period 2|Adverse Event|0
377550|NCT00895895|1269717|P3|After Period 1, Prior to Period 2|Adverse Event|1
377551|NCT00895895|1269718|P2|After Period 1, Prior to Period 2|Adverse Event|0
377552|NCT00895895|1269719|P1|After Period 1, Prior to Period 2|Adverse Event|0
377553|NCT00895895|1269715|P5|Period 1|randomized and not treated|2
377554|NCT00895895|1269716|P4|Period 1|randomized and not treated|1
377555|NCT00895895|1269717|P3|Period 1|randomized and not treated|1
377556|NCT00895895|1269718|P2|Period 1|randomized and not treated|3
377557|NCT00895895|1269719|P1|Period 1|randomized and not treated|1
377558|NCT00895895|1269715|P5|Period 1|unsatisfactory response-efficacy|0
377559|NCT00895895|1269716|P4|Period 1|unsatisfactory response-efficacy|0
377560|NCT00895895|1269717|P3|Period 1|unsatisfactory response-efficacy|0
377561|NCT00895895|1269718|P2|Period 1|unsatisfactory response-efficacy|0
377562|NCT00895895|1269719|P1|Period 1|unsatisfactory response-efficacy|2
377563|NCT00895895|1269715|P5|Period 1|Withdrawal by Subject|4
377564|NCT00895895|1269716|P4|Period 1|Withdrawal by Subject|2
377565|NCT00895895|1269717|P3|Period 1|Withdrawal by Subject|8
377566|NCT00895895|1269718|P2|Period 1|Withdrawal by Subject|6
377567|NCT00895895|1269719|P1|Period 1|Withdrawal by Subject|6
377568|NCT00895895|1269715|P5|Period 1|Protocol Violation|0
377569|NCT00895895|1269716|P4|Period 1|Protocol Violation|0
377570|NCT00895895|1269717|P3|Period 1|Protocol Violation|0
377571|NCT00895895|1269718|P2|Period 1|Protocol Violation|1
377572|NCT00895895|1269719|P1|Period 1|Protocol Violation|0
377573|NCT00895895|1269715|P5|Period 1|Other|1
377574|NCT00895895|1269716|P4|Period 1|Other|1
377575|NCT00895895|1269717|P3|Period 1|Other|1
377576|NCT00895895|1269718|P2|Period 1|Other|2
377577|NCT00895895|1269719|P1|Period 1|Other|1
377578|NCT00895895|1269715|P5|Period 1|Lost to Follow-up|3
377579|NCT00895895|1269716|P4|Period 1|Lost to Follow-up|2
377580|NCT00895895|1269717|P3|Period 1|Lost to Follow-up|3
377581|NCT00895895|1269718|P2|Period 1|Lost to Follow-up|1
377582|NCT00895895|1269719|P1|Period 1|Lost to Follow-up|2
377583|NCT00895895|1269715|P5|Period 1|investigator request|0
377584|NCT00895895|1269716|P4|Period 1|investigator request|0
377585|NCT00895895|1269717|P3|Period 1|investigator request|0
377586|NCT00895895|1269718|P2|Period 1|investigator request|1
377587|NCT00895895|1269719|P1|Period 1|investigator request|0
377588|NCT00895895|1269715|P5|Period 1|failed to return|1
377589|NCT00895895|1269716|P4|Period 1|failed to return|0
377590|NCT00895895|1269717|P3|Period 1|failed to return|1
377591|NCT00895895|1269718|P2|Period 1|failed to return|0
377592|NCT00895895|1269719|P1|Period 1|failed to return|0
377593|NCT00895895|1269715|P5|Period 1|discontinued by sponsor|1
377594|NCT00895895|1269716|P4|Period 1|discontinued by sponsor|1
377595|NCT00895895|1269717|P3|Period 1|discontinued by sponsor|2
377596|NCT00895895|1269718|P2|Period 1|discontinued by sponsor|1
377597|NCT00895895|1269719|P1|Period 1|discontinued by sponsor|2
377598|NCT00895895|1269715|P5|Period 1|Death|1
377599|NCT00895895|1269716|P4|Period 1|Death|0
377600|NCT00895895|1269717|P3|Period 1|Death|0
377601|NCT00895895|1269718|P2|Period 1|Death|0
377602|NCT00895895|1269719|P1|Period 1|Death|0
377603|NCT00895895|1269715|P5|Period 1|Adverse Event|7
377604|NCT00895895|1269716|P4|Period 1|Adverse Event|6
377605|NCT00895895|1269717|P3|Period 1|Adverse Event|4
377606|NCT00895895|1269718|P2|Period 1|Adverse Event|6
377607|NCT00895895|1269719|P1|Period 1|Adverse Event|7
377608|NCT00895843|1269833|P2|Overall Study|Protocol Violation|12
377609|NCT00895843|1269834|P1|Overall Study|Protocol Violation|12
377610|NCT00895661|1269881|P1|Overall Study|reason unknown|2
377611|NCT00895661|1269881|P1|Overall Study|Death|1
377612|NCT00895622|1269891|P3|Overall Study|Protocol Violation|4
377613|NCT00895622|1269892|P2|Overall Study|Protocol Violation|4
377614|NCT00895622|1269893|P1|Overall Study|Protocol Violation|5
377615|NCT00895583|1269916|P2|Overall Study|Not specified|1
377616|NCT00895583|1269917|P1|Overall Study|Not specified|0
377617|NCT00895583|1269916|P2|Overall Study|Lack of Efficacy|0
377618|NCT00895583|1269917|P1|Overall Study|Lack of Efficacy|5
377619|NCT00895583|1269916|P2|Overall Study|Withdrawal by Subject|2
377620|NCT00895583|1269917|P1|Overall Study|Withdrawal by Subject|4
377621|NCT00895583|1269916|P2|Overall Study|Protocol Violation|0
377622|NCT00895583|1269917|P1|Overall Study|Protocol Violation|1
377623|NCT00895583|1269916|P2|Overall Study|Lost to Follow-up|3
377624|NCT00895583|1269917|P1|Overall Study|Lost to Follow-up|1
377625|NCT00895583|1269916|P2|Overall Study|Physician Decision|1
377626|NCT00895583|1269917|P1|Overall Study|Physician Decision|3
377627|NCT00895583|1269916|P2|Overall Study|Death|1
377628|NCT00895583|1269917|P1|Overall Study|Death|2
377629|NCT00895583|1269916|P2|Overall Study|Adverse Event|4
377630|NCT00895583|1269917|P1|Overall Study|Adverse Event|28
377631|NCT00895453|1270007|P3|Overall Study|Lost to Follow-up|23
377632|NCT00895453|1270008|P2|Overall Study|Lost to Follow-up|25
377633|NCT00895453|1270009|P1|Overall Study|Lost to Follow-up|25
377634|NCT00895310|1270017|P1|Overall Study|Withdrawal by Subject|1
377635|NCT00895245|1270033|P1|Overall Study|Lack of Efficacy|6
377636|NCT00895011|1270112|P3|Overall Study|schedule conflict|0
377637|NCT00895011|1270113|P2|Overall Study|schedule conflict|0
377638|NCT00895011|1270114|P1|Overall Study|schedule conflict|1
377639|NCT00895011|1270112|P3|Overall Study|Adverse Event|2
377640|NCT00895011|1270113|P2|Overall Study|Adverse Event|2
377641|NCT00895011|1270114|P1|Overall Study|Adverse Event|1
377642|NCT00895011|1270112|P3|Overall Study|Protocol Violation|3
377643|NCT00895011|1270113|P2|Overall Study|Protocol Violation|1
377644|NCT00895011|1270114|P1|Overall Study|Protocol Violation|3
377645|NCT00895011|1270112|P3|Overall Study|Lost to Follow-up|1
377646|NCT00895011|1270113|P2|Overall Study|Lost to Follow-up|4
377647|NCT00895011|1270114|P1|Overall Study|Lost to Follow-up|5
377648|NCT00895011|1270112|P3|Overall Study|Withdrawal by Subject|2
377649|NCT00895011|1270113|P2|Overall Study|Withdrawal by Subject|7
377650|NCT00895011|1270114|P1|Overall Study|Withdrawal by Subject|14
377651|NCT00894933|1270128|P1|Overall Study|Did not meeting incl/excl criteria|1
377652|NCT00894933|1270128|P1|Overall Study|Cancelled Procedure|1
377653|NCT00894933|1270128|P1|Overall Study|Lost to Follow-up|2
377654|NCT00894803|1270146|P2|Overall Study|Lost to Follow-up|1
377655|NCT00894803|1270147|P1|Overall Study|Lost to Follow-up|0
377656|NCT00894803|1270146|P2|Overall Study|Death|4
377657|NCT00894803|1270147|P1|Overall Study|Death|20
377658|NCT00894790|1270183|P2|Overall Study|Did not meet entrance criteria|0
377659|NCT00894790|1270184|P1|Overall Study|Did not meet entrance criteria|1
377660|NCT00894790|1270183|P2|Overall Study|Lost to Follow-up|1
377661|NCT00894790|1270184|P1|Overall Study|Lost to Follow-up|0
377662|NCT00894790|1270183|P2|Overall Study|Protocol Violation|1
377663|NCT00894790|1270184|P1|Overall Study|Protocol Violation|0
377664|NCT00894647|1270217|P2|Overall Study|Other, not due to AE|2
377665|NCT00894647|1270218|P1|Overall Study|Other, not due to AE|1
377666|NCT00894647|1270217|P2|Overall Study|Non-compliance with study procedures|2
377667|NCT00894647|1270218|P1|Overall Study|Non-compliance with study procedures|0
377668|NCT00894647|1270217|P2|Overall Study|Lost to Follow-up|2
377669|NCT00894647|1270218|P1|Overall Study|Lost to Follow-up|0
377670|NCT00894647|1270217|P2|Overall Study|Withdrawal by Subject|4
377671|NCT00894647|1270218|P1|Overall Study|Withdrawal by Subject|4
377672|NCT00894647|1270217|P2|Overall Study|Adverse Event|4
377673|NCT00894647|1270218|P1|Overall Study|Adverse Event|5
377674|NCT00894556|1270231|P4|Treatment Phase|Lack of Qualifying Event|0
377675|NCT00894556|1270232|P3|Treatment Phase|Lack of Qualifying Event|0
377676|NCT00894556|1270233|P2|Treatment Phase|Lack of Qualifying Event|1
377677|NCT00894556|1270234|P1|Treatment Phase|Lack of Qualifying Event|2
377678|NCT00894556|1270231|P4|Treatment Phase|Lost to Follow-up|0
377679|NCT00894556|1270232|P3|Treatment Phase|Lost to Follow-up|1
377680|NCT00894556|1270233|P2|Treatment Phase|Lost to Follow-up|3
377681|NCT00894556|1270234|P1|Treatment Phase|Lost to Follow-up|2
377682|NCT00894556|1270231|P4|Baseline Phase|Did not meet Randomization Criteria|85
377683|NCT00894556|1270232|P3|Baseline Phase|Did not meet Randomization Criteria|0
377684|NCT00894556|1270233|P2|Baseline Phase|Did not meet Randomization Criteria|0
377685|NCT00894556|1270234|P1|Baseline Phase|Did not meet Randomization Criteria|0
377686|NCT00894543|1270245|P2|Week 4 to Week 8|No diary or lost or withdrew|2
377687|NCT00894543|1270246|P1|Week 4 to Week 8|No diary or lost or withdrew|4
377688|NCT00894543|1270245|P2|Baseline to Week 4|No diary or lost or withdrew|2
377689|NCT00894543|1270246|P1|Baseline to Week 4|No diary or lost or withdrew|3
377690|NCT00894387|1270312|P2|Overall Study|GCP non-compliance|2
377691|NCT00894387|1270313|P1|Overall Study|GCP non-compliance|0
377692|NCT00894387|1270312|P2|Overall Study|Mis-randomized|9
377693|NCT00894387|1270313|P1|Overall Study|Mis-randomized|13
377694|NCT00894387|1270312|P2|Overall Study|Other (Missing)|3
377695|NCT00894387|1270313|P1|Overall Study|Other (Missing)|5
377696|NCT00894387|1270312|P2|Overall Study|Patient's request|30
377697|NCT00894387|1270313|P1|Overall Study|Patient's request|25
377698|NCT00894387|1270312|P2|Overall Study|Protocol Deviation|0
377699|NCT00894387|1270313|P1|Overall Study|Protocol Deviation|4
377700|NCT00894387|1270312|P2|Overall Study|Death|76
377701|NCT00894387|1270313|P1|Overall Study|Death|77
377702|NCT00894387|1270312|P2|Overall Study|Administrative problems|2
377703|NCT00894387|1270313|P1|Overall Study|Administrative problems|2
377704|NCT00894387|1270312|P2|Overall Study|Lost to Follow-up|5
377705|NCT00894387|1270313|P1|Overall Study|Lost to Follow-up|3
377706|NCT00894387|1270312|P2|Overall Study|Unsatisfactory therapeutic effect|1
377707|NCT00894387|1270313|P1|Overall Study|Unsatisfactory therapeutic effect|0
377708|NCT00894387|1270312|P2|Overall Study|Abnormal Laboratory values|2
377709|NCT00894387|1270313|P1|Overall Study|Abnormal Laboratory values|2
377710|NCT00894387|1270312|P2|Overall Study|Adverse Event|45
377711|NCT00894387|1270313|P1|Overall Study|Adverse Event|44
377712|NCT00894361|1270333|P2|Overall Study|deaths and less than 2 yr followup|64
377713|NCT00894361|1270334|P1|Overall Study|deaths and less than 2 yr followup|24
377714|NCT00894322|1270343|P3|Overall Study|Withdrawal by Subject|0
377715|NCT00894322|1270344|P2|Overall Study|Withdrawal by Subject|0
377716|NCT00894322|1270345|P1|Overall Study|Withdrawal by Subject|1
377717|NCT00894166|1270396|P8|Overall Study|Death|0
377718|NCT00894166|1270397|P7|Overall Study|Death|0
377719|NCT00894166|1270398|P6|Overall Study|Death|0
377720|NCT00894166|1270399|P5|Overall Study|Death|0
377721|NCT00894166|1270400|P4|Overall Study|Death|1
377722|NCT00894166|1270401|P3|Overall Study|Death|0
377723|NCT00894166|1270402|P2|Overall Study|Death|0
377724|NCT00894166|1270403|P1|Overall Study|Death|0
377725|NCT00894166|1270396|P8|Overall Study|Withdrew or Lost to Follow-Up|34
377726|NCT00894166|1270397|P7|Overall Study|Withdrew or Lost to Follow-Up|16
377727|NCT00894166|1270398|P6|Overall Study|Withdrew or Lost to Follow-Up|16
377728|NCT00894166|1270399|P5|Overall Study|Withdrew or Lost to Follow-Up|24
377729|NCT00894166|1270400|P4|Overall Study|Withdrew or Lost to Follow-Up|68
377730|NCT00894166|1270401|P3|Overall Study|Withdrew or Lost to Follow-Up|62
377731|NCT00894166|1270402|P2|Overall Study|Withdrew or Lost to Follow-Up|63
377732|NCT00894166|1270403|P1|Overall Study|Withdrew or Lost to Follow-Up|61
377733|NCT00893971|1270442|P1|Overall Study|Physician Decision|3
377734|NCT00893789|1270560|P4|Overall Study|Lost to Follow-up|1
377735|NCT00893789|1270561|P3|Overall Study|Lost to Follow-up|0
377736|NCT00893789|1270562|P2|Overall Study|Lost to Follow-up|0
377737|NCT00893789|1270563|P1|Overall Study|Lost to Follow-up|0
377738|NCT00893789|1270560|P4|Overall Study|Protocol Violation|4
377739|NCT00893789|1270561|P3|Overall Study|Protocol Violation|1
377740|NCT00893789|1270562|P2|Overall Study|Protocol Violation|1
377741|NCT00893789|1270563|P1|Overall Study|Protocol Violation|0
377742|NCT00893789|1270560|P4|Overall Study|Adverse Event|5
377743|NCT00893789|1270561|P3|Overall Study|Adverse Event|1
377744|NCT00893789|1270562|P2|Overall Study|Adverse Event|2
377745|NCT00893789|1270563|P1|Overall Study|Adverse Event|0
377746|NCT00893789|1270560|P4|Overall Study|Taking Excluded Concomitant Medication|0
377747|NCT00893789|1270561|P3|Overall Study|Taking Excluded Concomitant Medication|1
377748|NCT00893789|1270562|P2|Overall Study|Taking Excluded Concomitant Medication|0
377749|NCT00893789|1270563|P1|Overall Study|Taking Excluded Concomitant Medication|1
377750|NCT00893789|1270560|P4|Overall Study|Noncompliance With Study Procedures|0
377751|NCT00893789|1270561|P3|Overall Study|Noncompliance With Study Procedures|0
377752|NCT00893789|1270562|P2|Overall Study|Noncompliance With Study Procedures|0
377753|NCT00893789|1270563|P1|Overall Study|Noncompliance With Study Procedures|1
377754|NCT00893789|1270560|P4|Overall Study|Noncompliance With Study Drug|2
377755|NCT00893789|1270561|P3|Overall Study|Noncompliance With Study Drug|1
377756|NCT00893789|1270562|P2|Overall Study|Noncompliance With Study Drug|0
377757|NCT00893789|1270563|P1|Overall Study|Noncompliance With Study Drug|1
377758|NCT00893789|1270560|P4|Overall Study|Withdrawal by Subject|1
377759|NCT00893789|1270561|P3|Overall Study|Withdrawal by Subject|3
377760|NCT00893789|1270562|P2|Overall Study|Withdrawal by Subject|1
377761|NCT00893789|1270563|P1|Overall Study|Withdrawal by Subject|3
377762|NCT00893763|1270647|P2|Overall Study|extubated|110
377763|NCT00893763|1270648|P1|Overall Study|extubated|110
377764|NCT00893737|1270656|P1|Overall Study|Lost to Follow-up|6
377765|NCT00893737|1270656|P1|Overall Study|Withdrawal by Subject|2
377766|NCT00893737|1270656|P1|Overall Study|Adverse Event|4
377767|NCT00893464|1270670|P8|Overall Study|Did not complete therapy/experience PD|2
377768|NCT00893464|1270671|P7|Overall Study|Did not complete therapy/experience PD|2
377769|NCT00893464|1270672|P6|Overall Study|Did not complete therapy/experience PD|0
377770|NCT00893464|1270673|P5|Overall Study|Did not complete therapy/experience PD|0
377771|NCT00893464|1270674|P4|Overall Study|Did not complete therapy/experience PD|0
377772|NCT00893464|1270675|P3|Overall Study|Did not complete therapy/experience PD|0
377773|NCT00893464|1270676|P2|Overall Study|Did not complete therapy/experience PD|0
377774|NCT00893464|1270677|P1|Overall Study|Did not complete therapy/experience PD|0
377775|NCT00893113|1270804|P2|Overall Study|Withdrew Consent|7
377776|NCT00893113|1270805|P1|Overall Study|Withdrew Consent|8
377777|NCT00893113|1270804|P2|Overall Study|Early Termination|1
377778|NCT00893113|1270805|P1|Overall Study|Early Termination|1
377779|NCT00893113|1270804|P2|Overall Study|Lost to Follow-up|8
377780|NCT00893113|1270805|P1|Overall Study|Lost to Follow-up|4
377781|NCT00892957|1270835|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
377782|NCT00892957|1270836|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
377783|NCT00892957|1270835|P2|Between Postoperative Day 1 and Day 14|Death|2
377784|NCT00892957|1270836|P1|Between Postoperative Day 1 and Day 14|Death|0
377785|NCT00892775|1270924|P2|Overall Study|Lost to Follow-up|0
377786|NCT00892775|1270925|P1|Overall Study|Lost to Follow-up|1
377787|NCT00892775|1270924|P2|Overall Study|Withdrawal by Subject|1
377788|NCT00892775|1270925|P1|Overall Study|Withdrawal by Subject|0
377789|NCT00892775|1270924|P2|Overall Study|Migrated/ moved from study area|0
377790|NCT00892775|1270925|P1|Overall Study|Migrated/ moved from study area|1
377791|NCT00892775|1270924|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
377792|NCT00892775|1270925|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
377793|NCT00892775|1270924|P2|Overall Study|Subject difficulties with blood drawing|0
377794|NCT00892775|1270925|P1|Overall Study|Subject difficulties with blood drawing|1
377795|NCT00892775|1270924|P2|Overall Study|Protocol Violation|0
377796|NCT00892775|1270925|P1|Overall Study|Protocol Violation|1
377797|NCT00892723|1270952|P3|Overall Study|Withdrawal by Subject|1
377798|NCT00892723|1270953|P2|Overall Study|Withdrawal by Subject|1
377799|NCT00892723|1270954|P1|Overall Study|Withdrawal by Subject|1
377800|NCT00892723|1270952|P3|Overall Study|Lost to Follow-up|1
377801|NCT00892723|1270953|P2|Overall Study|Lost to Follow-up|3
377802|NCT00892723|1270954|P1|Overall Study|Lost to Follow-up|1
377803|NCT00892437|1271043|P2|Open-Label Extension Phase|Withdrew Consent|1
377804|NCT00892437|1271044|P1|Open-Label Extension Phase|Withdrew Consent|3
377805|NCT00892437|1271043|P2|Open-Label Extension Phase|Investigator's Discretion|0
377806|NCT00892437|1271044|P1|Open-Label Extension Phase|Investigator's Discretion|1
377807|NCT00892437|1271043|P2|Open-Label Extension Phase|Lost to Follow-up|1
377808|NCT00892437|1271044|P1|Open-Label Extension Phase|Lost to Follow-up|3
377809|NCT00892437|1271043|P2|Open-Label Extension Phase|Lack of Efficacy|0
377810|NCT00892437|1271044|P1|Open-Label Extension Phase|Lack of Efficacy|1
377811|NCT00892437|1271043|P2|Open-Label Extension Phase|Adverse Event|2
377812|NCT00892437|1271044|P1|Open-Label Extension Phase|Adverse Event|4
377813|NCT00892437|1271043|P2|Randomized Phase|Withdrew Consent|0
377814|NCT00892437|1271044|P1|Randomized Phase|Withdrew Consent|1
377815|NCT00892437|1271043|P2|Randomized Phase|Investigator’s Discretion|0
377816|NCT00892437|1271044|P1|Randomized Phase|Investigator’s Discretion|1
377817|NCT00892437|1271043|P2|Randomized Phase|Lost to Follow-up|3
377818|NCT00892437|1271044|P1|Randomized Phase|Lost to Follow-up|1
377819|NCT00892437|1271043|P2|Randomized Phase|Adverse Event|2
377820|NCT00892437|1271044|P1|Randomized Phase|Adverse Event|2
377821|NCT00892437|1271043|P2|Randomized Phase|Randomized but not treated|0
377822|NCT00892437|1271044|P1|Randomized Phase|Randomized but not treated|6
377823|NCT00892281|1271063|P2|Overall Study|Visit 4 date out of window|0
377824|NCT00892281|1271064|P1|Overall Study|Visit 4 date out of window|1
377825|NCT00892281|1271063|P2|Overall Study|Rash on hand|0
377826|NCT00892281|1271064|P1|Overall Study|Rash on hand|1
377827|NCT00892281|1271063|P2|Overall Study|Subject had history of drug abuse|0
377828|NCT00892281|1271064|P1|Overall Study|Subject had history of drug abuse|1
377829|NCT00892281|1271063|P2|Overall Study|Non-compliant with visits as scheduled|0
377830|NCT00892281|1271064|P1|Overall Study|Non-compliant with visits as scheduled|1
377831|NCT00892281|1271063|P2|Overall Study|Missed visits rescheduled out of window|0
377832|NCT00892281|1271064|P1|Overall Study|Missed visits rescheduled out of window|1
377833|NCT00892281|1271063|P2|Overall Study|Missed multiple visits|0
377834|NCT00892281|1271064|P1|Overall Study|Missed multiple visits|1
377835|NCT00892281|1271063|P2|Overall Study|No show Visit 2; prescription not filled|0
377836|NCT00892281|1271064|P1|Overall Study|No show Visit 2; prescription not filled|1
377837|NCT00892281|1271063|P2|Overall Study|Subject not seen by PI at final visit|0
377838|NCT00892281|1271064|P1|Overall Study|Subject not seen by PI at final visit|1
377839|NCT00892281|1271063|P2|Overall Study|Lack of efficacy of study product|0
377840|NCT00892281|1271064|P1|Overall Study|Lack of efficacy of study product|2
377841|NCT00892281|1271063|P2|Overall Study|Death in family|0
377842|NCT00892281|1271064|P1|Overall Study|Death in family|1
377843|NCT00892281|1271063|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
377844|NCT00892281|1271064|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
377845|NCT00892281|1271063|P2|Overall Study|Subject lost interest in program|1
377846|NCT00892281|1271064|P1|Overall Study|Subject lost interest in program|0
377847|NCT00892281|1271063|P2|Overall Study|PI complained of inadequate compensation|0
377848|NCT00892281|1271064|P1|Overall Study|PI complained of inadequate compensation|3
377849|NCT00892281|1271063|P2|Overall Study|Scheduled for knee replacement|1
377850|NCT00892281|1271064|P1|Overall Study|Scheduled for knee replacement|0
377851|NCT00892281|1271063|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
377852|NCT00892281|1271064|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
377853|NCT00892281|1271063|P2|Overall Study|Subject missed several visits/lost meds|0
377854|NCT00892281|1271064|P1|Overall Study|Subject missed several visits/lost meds|1
377855|NCT00892281|1271063|P2|Overall Study|Subject did not return for any visits|0
377856|NCT00892281|1271064|P1|Overall Study|Subject did not return for any visits|1
377857|NCT00892281|1271063|P2|Overall Study|Subject not good candidate for study|0
377858|NCT00892281|1271064|P1|Overall Study|Subject not good candidate for study|1
377859|NCT00892281|1271063|P2|Overall Study|Unable to redeem the drug voucher|0
377860|NCT00892281|1271064|P1|Overall Study|Unable to redeem the drug voucher|1
377861|NCT00892281|1271063|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
377862|NCT00892281|1271064|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
377863|NCT00892281|1271063|P2|Overall Study|Did not meet incl/excl criteria|0
377864|NCT00892281|1271064|P1|Overall Study|Did not meet incl/excl criteria|1
377865|NCT00892281|1271063|P2|Overall Study|Last visit not done - death in family|0
377866|NCT00892281|1271064|P1|Overall Study|Last visit not done - death in family|1
377867|NCT00892281|1271063|P2|Overall Study|Family emergency|0
377868|NCT00892281|1271064|P1|Overall Study|Family emergency|1
377869|NCT00892281|1271063|P2|Overall Study|Subject completed day after study closed|0
377870|NCT00892281|1271064|P1|Overall Study|Subject completed day after study closed|1
377871|NCT00892281|1271063|P2|Overall Study|Final visit completed 4 weeks late|1
377872|NCT00892281|1271064|P1|Overall Study|Final visit completed 4 weeks late|0
377873|NCT00892281|1271063|P2|Overall Study|Subject unable to keep follow-up visits|0
377874|NCT00892281|1271064|P1|Overall Study|Subject unable to keep follow-up visits|1
377875|NCT00892281|1271063|P2|Overall Study|Subject failed to return for final visit|0
377876|NCT00892281|1271064|P1|Overall Study|Subject failed to return for final visit|2
377877|NCT00892281|1271063|P2|Overall Study|Withdrawal by Subject|14
377878|NCT00892281|1271064|P1|Overall Study|Withdrawal by Subject|86
377879|NCT00892281|1271063|P2|Overall Study|Protocol Violation|2
377880|NCT00892281|1271064|P1|Overall Study|Protocol Violation|7
377881|NCT00892281|1271063|P2|Overall Study|Pregnancy|0
377882|NCT00892281|1271064|P1|Overall Study|Pregnancy|1
377883|NCT00892281|1271063|P2|Overall Study|Lost to Follow-up|8
377884|NCT00892281|1271064|P1|Overall Study|Lost to Follow-up|81
377885|NCT00892281|1271063|P2|Overall Study|Adverse Event|8
377886|NCT00892281|1271064|P1|Overall Study|Adverse Event|65
377887|NCT00892177|1271077|P6|Phase II|Withdrawal by Subject|1
377888|NCT00892177|1271078|P5|Phase II|Withdrawal by Subject|4
377889|NCT00892177|1271079|P4|Phase II|Withdrawal by Subject|0
377890|NCT00892177|1271080|P3|Phase II|Withdrawal by Subject|0
377891|NCT00892177|1271081|P2|Phase II|Withdrawal by Subject|0
377892|NCT00892177|1271082|P1|Phase II|Withdrawal by Subject|0
377893|NCT00892177|1271077|P6|Phase II|Ineligible|1
377894|NCT00892177|1271078|P5|Phase II|Ineligible|1
377895|NCT00892177|1271079|P4|Phase II|Ineligible|0
377896|NCT00892177|1271080|P3|Phase II|Ineligible|0
377897|NCT00892177|1271081|P2|Phase II|Ineligible|0
377898|NCT00892177|1271082|P1|Phase II|Ineligible|0
377899|NCT00892151|1271107|P1|Overall Study|Protocol Violation|1
377900|NCT00892099|1271116|P3|Overall Study|Lost to Follow-up|1
377901|NCT00892099|1271117|P2|Overall Study|Lost to Follow-up|0
377902|NCT00892099|1271118|P1|Overall Study|Lost to Follow-up|0
377903|NCT00892099|1271116|P3|Overall Study|investigator decision|1
377904|NCT00892099|1271117|P2|Overall Study|investigator decision|0
377905|NCT00892099|1271118|P1|Overall Study|investigator decision|0
377906|NCT00892099|1271116|P3|Overall Study|kidney function recovered|0
377907|NCT00892099|1271117|P2|Overall Study|kidney function recovered|1
377908|NCT00892099|1271118|P1|Overall Study|kidney function recovered|0
377909|NCT00892099|1271116|P3|Overall Study|no further details|1
377910|NCT00892099|1271117|P2|Overall Study|no further details|0
377911|NCT00892099|1271118|P1|Overall Study|no further details|1
377912|NCT00892099|1271116|P3|Overall Study|Prolonged hospitalization|1
377913|NCT00892099|1271117|P2|Overall Study|Prolonged hospitalization|0
377914|NCT00892099|1271118|P1|Overall Study|Prolonged hospitalization|1
377915|NCT00892099|1271116|P3|Overall Study|replocated|2
377916|NCT00892099|1271117|P2|Overall Study|replocated|0
377917|NCT00892099|1271118|P1|Overall Study|replocated|1
377918|NCT00892099|1271116|P3|Overall Study|Adverse Event|0
377919|NCT00892099|1271117|P2|Overall Study|Adverse Event|0
377920|NCT00892099|1271118|P1|Overall Study|Adverse Event|1
377921|NCT00892099|1271116|P3|Overall Study|Death|1
377922|NCT00892099|1271117|P2|Overall Study|Death|0
377923|NCT00892099|1271118|P1|Overall Study|Death|1
377924|NCT00892047|1271143|P2|Overall Study|Lack of Efficacy|2
377925|NCT00892047|1271144|P1|Overall Study|Lack of Efficacy|0
377926|NCT00892047|1271143|P2|Overall Study|subject burden|3
377927|NCT00892047|1271144|P1|Overall Study|subject burden|2
377928|NCT00892047|1271143|P2|Overall Study|Adverse Event|2
377929|NCT00892047|1271144|P1|Overall Study|Adverse Event|2
377930|NCT00892008|1271160|P1|Overall Study|Adverse Event|37
377931|NCT00892008|1271160|P1|Overall Study|Other|378
377932|NCT00892008|1271160|P1|Overall Study|Lost to Follow-up|142
377933|NCT00892008|1271160|P1|Overall Study|Lack of Efficacy|3
377934|NCT00892008|1271160|P1|Overall Study|Death|5
377935|NCT00891930|1271246|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
377936|NCT00891930|1271246|P1|Part 2: Panitumumab + Ganitumab|Death|30
377937|NCT00891930|1271246|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
377938|NCT00891930|1271246|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
377939|NCT00891930|1271246|P1|Part 1: Panitumumab +Irinotecan|Death|38
377940|NCT00891904|1271267|P1|Overall Study|Adverse Event|1
377941|NCT00891904|1271267|P1|Overall Study|Death|1
377942|NCT00891839|1271274|P1|Overall Study|Disease progression|3
377943|NCT00891839|1271274|P1|Overall Study|Withdrawal by Subject|2
377944|NCT00891839|1271274|P1|Overall Study|Adverse Event|2
377945|NCT00891813|1271283|P1|Overall Study|Protocol Violation|2
377946|NCT00891813|1271283|P1|Overall Study|Patient Noncompliance|6
377947|NCT00891813|1271283|P1|Overall Study|Withdrawal by Subject|1
377948|NCT00891813|1271283|P1|Overall Study|Adverse Event|3
377949|NCT00891774|1271289|P1|Overall Study|Protocol Violation|4
377950|NCT00891774|1271289|P1|Overall Study|Withdrawal by Subject|2
377951|NCT00891774|1271289|P1|Overall Study|Illness (Self/Mother)|3
377952|NCT00891774|1271289|P1|Overall Study|Lost to Follow-up|5
377953|NCT00891735|1271297|P4|Overall Study|Patient's decision to withdraw|8
377954|NCT00891735|1271298|P3|Overall Study|Patient's decision to withdraw|4
377955|NCT00891735|1271299|P2|Overall Study|Patient's decision to withdraw|9
377956|NCT00891735|1271300|P1|Overall Study|Patient's decision to withdraw|4
377957|NCT00891735|1271297|P4|Overall Study|Physician's decision to withdraw patient|0
377958|NCT00891735|1271298|P3|Overall Study|Physician's decision to withdraw patient|0
377959|NCT00891735|1271299|P2|Overall Study|Physician's decision to withdraw patient|0
377960|NCT00891735|1271300|P1|Overall Study|Physician's decision to withdraw patient|1
377961|NCT00891735|1271297|P4|Overall Study|Lost to Follow-up|2
377962|NCT00891735|1271298|P3|Overall Study|Lost to Follow-up|2
377963|NCT00891735|1271299|P2|Overall Study|Lost to Follow-up|2
377964|NCT00891735|1271300|P1|Overall Study|Lost to Follow-up|2
377965|NCT00891735|1271297|P4|Overall Study|Death|5
377966|NCT00891735|1271298|P3|Overall Study|Death|4
377967|NCT00891735|1271299|P2|Overall Study|Death|5
377968|NCT00891735|1271300|P1|Overall Study|Death|8
377969|NCT00891735|1271297|P4|Overall Study|Adverse Event|0
377970|NCT00891735|1271298|P3|Overall Study|Adverse Event|2
377971|NCT00891735|1271299|P2|Overall Study|Adverse Event|0
377972|NCT00891735|1271300|P1|Overall Study|Adverse Event|2
377973|NCT00891657|1271340|P2|Overall Study|Withdrawal by Subject|1
377974|NCT00891657|1271341|P1|Overall Study|Withdrawal by Subject|1
377975|NCT00891618|1271353|P1|Overall Study|Withdrawal by Subject|1
377976|NCT00891527|1271357|P1|Overall Study|Withdrawal by Subject|2
377977|NCT00891462|1271366|P3|Overall Study|Lost to Follow-up|0
377978|NCT00891462|1271367|P2|Overall Study|Lost to Follow-up|2
377979|NCT00891462|1271368|P1|Overall Study|Lost to Follow-up|0
377980|NCT00891462|1271366|P3|Overall Study|Inclusion/exclusion criteria|2
377981|NCT00891462|1271367|P2|Overall Study|Inclusion/exclusion criteria|2
377982|NCT00891462|1271368|P1|Overall Study|Inclusion/exclusion criteria|0
377983|NCT00891462|1271366|P3|Overall Study|Protocol Violation|3
377984|NCT00891462|1271367|P2|Overall Study|Protocol Violation|1
377985|NCT00891462|1271368|P1|Overall Study|Protocol Violation|2
377986|NCT00891462|1271366|P3|Overall Study|Other Reason|3
377987|NCT00891462|1271367|P2|Overall Study|Other Reason|5
377988|NCT00891462|1271368|P1|Overall Study|Other Reason|2
377989|NCT00891462|1271366|P3|Overall Study|COPD exacerbation|1
377990|NCT00891462|1271367|P2|Overall Study|COPD exacerbation|4
377991|NCT00891462|1271368|P1|Overall Study|COPD exacerbation|7
377992|NCT00891462|1271366|P3|Overall Study|Lack of Efficacy|1
377993|NCT00891462|1271367|P2|Overall Study|Lack of Efficacy|5
377994|NCT00891462|1271368|P1|Overall Study|Lack of Efficacy|10
377995|NCT00891462|1271366|P3|Overall Study|Adverse Event|7
377996|NCT00891462|1271367|P2|Overall Study|Adverse Event|8
377997|NCT00891462|1271368|P1|Overall Study|Adverse Event|7
377998|NCT00891462|1271366|P3|Overall Study|Withdrawal by Subject|7
377999|NCT00891462|1271367|P2|Overall Study|Withdrawal by Subject|6
378000|NCT00891462|1271368|P1|Overall Study|Withdrawal by Subject|9
378001|NCT00891371|1271390|P1|Treatment|Lost to Follow-up|1
378002|NCT00891371|1271390|P1|Treatment|Death|1
378003|NCT00891371|1271390|P1|Treatment|Adverse Event|2
378004|NCT00891371|1271390|P1|Treatment|Lack of Efficacy|5
378005|NCT00891371|1271390|P1|Pre-assignment|Consent withdrawal|1
378006|NCT00891371|1271390|P1|Pre-assignment|Inclusion/exclusion|5
378007|NCT00891293|1271412|P1|Overall Study|Sponsor termination|62
378008|NCT00891293|1271412|P1|Overall Study|Subject withdrew consent|7
378009|NCT00891293|1271412|P1|Overall Study|Lost to Follow-up|7
378010|NCT00891293|1271412|P1|Overall Study|Laboratory abnormality|4
378011|NCT00891293|1271412|P1|Overall Study|Protocol Violation|2
378012|NCT00891293|1271412|P1|Overall Study|Adverse Event|2
378013|NCT00891228|1271427|P3|Overall Study|Pregnancy|0
378014|NCT00891228|1271428|P2|Overall Study|Pregnancy|1
378015|NCT00891228|1271429|P1|Overall Study|Pregnancy|0
378016|NCT00891228|1271427|P3|Overall Study|Lost to Follow-up|5
378017|NCT00891228|1271428|P2|Overall Study|Lost to Follow-up|4
378018|NCT00891228|1271429|P1|Overall Study|Lost to Follow-up|4
378019|NCT00891228|1271427|P3|Overall Study|Physician Decision|0
378020|NCT00891228|1271428|P2|Overall Study|Physician Decision|1
378021|NCT00891228|1271429|P1|Overall Study|Physician Decision|2
378022|NCT00891228|1271427|P3|Overall Study|Protocol Violation|2
378023|NCT00891228|1271428|P2|Overall Study|Protocol Violation|1
378024|NCT00891228|1271429|P1|Overall Study|Protocol Violation|3
378025|NCT00891228|1271427|P3|Overall Study|Withdrawal by Subject|5
378026|NCT00891228|1271428|P2|Overall Study|Withdrawal by Subject|4
378027|NCT00891228|1271429|P1|Overall Study|Withdrawal by Subject|2
378028|NCT00891228|1271427|P3|Overall Study|Adverse Event|3
378029|NCT00891228|1271428|P2|Overall Study|Adverse Event|2
378030|NCT00891228|1271429|P1|Overall Study|Adverse Event|0
378031|NCT00891202|1271451|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
378032|NCT00891202|1271452|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
378033|NCT00891202|1271453|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
378034|NCT00891202|1271454|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
378035|NCT00891202|1271451|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
378036|NCT00891202|1271452|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
378037|NCT00891202|1271453|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
378038|NCT00891202|1271454|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
378039|NCT00891202|1271451|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
378040|NCT00891202|1271452|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
378041|NCT00891202|1271453|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
378042|NCT00891202|1271454|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
378043|NCT00891202|1271451|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
378044|NCT00891202|1271452|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
378045|NCT00891202|1271453|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
378046|NCT00891202|1271454|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
378047|NCT00891046|1271630|P5|Overall Study|Lost to Follow-up|1
378048|NCT00891046|1271631|P4|Overall Study|Lost to Follow-up|0
378049|NCT00891046|1271632|P3|Overall Study|Lost to Follow-up|0
378050|NCT00891046|1271633|P2|Overall Study|Lost to Follow-up|0
378051|NCT00891046|1271634|P1|Overall Study|Lost to Follow-up|0
378052|NCT00891046|1271630|P5|Overall Study|Withdrawal by Subject|1
378053|NCT00891046|1271631|P4|Overall Study|Withdrawal by Subject|1
378054|NCT00891046|1271632|P3|Overall Study|Withdrawal by Subject|2
378055|NCT00891046|1271633|P2|Overall Study|Withdrawal by Subject|1
378056|NCT00891046|1271634|P1|Overall Study|Withdrawal by Subject|2
378057|NCT00891046|1271630|P5|Overall Study|Adverse Event|14
378058|NCT00891046|1271631|P4|Overall Study|Adverse Event|0
378059|NCT00891046|1271632|P3|Overall Study|Adverse Event|2
378060|NCT00891046|1271633|P2|Overall Study|Adverse Event|3
378061|NCT00891046|1271634|P1|Overall Study|Adverse Event|4
378062|NCT00891046|1271630|P5|Overall Study|Participant no longer required drug|1
378063|NCT00891046|1271631|P4|Overall Study|Participant no longer required drug|0
378064|NCT00891046|1271632|P3|Overall Study|Participant no longer required drug|0
378065|NCT00891046|1271633|P2|Overall Study|Participant no longer required drug|2
378066|NCT00891046|1271634|P1|Overall Study|Participant no longer required drug|0
378067|NCT00891046|1271630|P5|Overall Study|Administrative problems|1
378068|NCT00891046|1271631|P4|Overall Study|Administrative problems|0
378069|NCT00891046|1271632|P3|Overall Study|Administrative problems|0
378070|NCT00891046|1271633|P2|Overall Study|Administrative problems|0
378071|NCT00891046|1271634|P1|Overall Study|Administrative problems|0
378072|NCT00891046|1271630|P5|Overall Study|Unsatisfactory therapeutic effect|20
378073|NCT00891046|1271631|P4|Overall Study|Unsatisfactory therapeutic effect|2
378074|NCT00891046|1271632|P3|Overall Study|Unsatisfactory therapeutic effect|19
378075|NCT00891046|1271633|P2|Overall Study|Unsatisfactory therapeutic effect|2
378076|NCT00891046|1271634|P1|Overall Study|Unsatisfactory therapeutic effect|5
378077|NCT00891046|1271630|P5|Overall Study|Protocol Violation|1
378078|NCT00891046|1271631|P4|Overall Study|Protocol Violation|0
378079|NCT00891046|1271632|P3|Overall Study|Protocol Violation|0
378080|NCT00891046|1271633|P2|Overall Study|Protocol Violation|1
378081|NCT00891046|1271634|P1|Overall Study|Protocol Violation|1
378082|NCT00891020|1271710|P3|Long-term Extension Period|Administrative|2
378083|NCT00891020|1271711|P2|Long-term Extension Period|Administrative|2
378084|NCT00891020|1271712|P1|Long-term Extension Period|Administrative|1
378085|NCT00891020|1271710|P3|Long-term Extension Period|Failure to return|3
378086|NCT00891020|1271711|P2|Long-term Extension Period|Failure to return|2
378087|NCT00891020|1271712|P1|Long-term Extension Period|Failure to return|0
378088|NCT00891020|1271710|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
378089|NCT00891020|1271711|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
378090|NCT00891020|1271712|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
378091|NCT00891020|1271710|P3|Long-term Extension Period|Protocol Violation|1
378092|NCT00891020|1271711|P2|Long-term Extension Period|Protocol Violation|1
378093|NCT00891020|1271712|P1|Long-term Extension Period|Protocol Violation|0
378094|NCT00891020|1271710|P3|Long-term Extension Period|Insufficient therapeutic response|2
378095|NCT00891020|1271711|P2|Long-term Extension Period|Insufficient therapeutic response|2
378096|NCT00891020|1271712|P1|Long-term Extension Period|Insufficient therapeutic response|3
378097|NCT00891020|1271710|P3|Long-term Extension Period|Death|1
378098|NCT00891020|1271711|P2|Long-term Extension Period|Death|0
378099|NCT00891020|1271712|P1|Long-term Extension Period|Death|0
378100|NCT00891020|1271710|P3|Long-term Extension Period|Adverse Event|10
378101|NCT00891020|1271711|P2|Long-term Extension Period|Adverse Event|11
378102|NCT00891020|1271712|P1|Long-term Extension Period|Adverse Event|1
378103|NCT00891020|1271710|P3|24 Week Treatment Period|Administrative/Other|1
378104|NCT00891020|1271711|P2|24 Week Treatment Period|Administrative/Other|6
378105|NCT00891020|1271712|P1|24 Week Treatment Period|Administrative/Other|5
378106|NCT00891020|1271710|P3|24 Week Treatment Period|Withdrew consent|15
378107|NCT00891020|1271711|P2|24 Week Treatment Period|Withdrew consent|3
378108|NCT00891020|1271712|P1|24 Week Treatment Period|Withdrew consent|6
378109|NCT00891020|1271710|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
378110|NCT00891020|1271711|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
378111|NCT00891020|1271712|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
378112|NCT00891020|1271710|P3|24 Week Treatment Period|Other protocol violation|2
378113|NCT00891020|1271711|P2|24 Week Treatment Period|Other protocol violation|1
378114|NCT00891020|1271712|P1|24 Week Treatment Period|Other protocol violation|1
378115|NCT00891020|1271710|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
378116|NCT00891020|1271711|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
378117|NCT00891020|1271712|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
378118|NCT00891020|1271710|P3|24 Week Treatment Period|Failure to return|5
378119|NCT00891020|1271711|P2|24 Week Treatment Period|Failure to return|5
378120|NCT00891020|1271712|P1|24 Week Treatment Period|Failure to return|4
378121|NCT00891020|1271710|P3|24 Week Treatment Period|Insufficient therapeutic response|15
378122|NCT00891020|1271711|P2|24 Week Treatment Period|Insufficient therapeutic response|9
378123|NCT00891020|1271712|P1|24 Week Treatment Period|Insufficient therapeutic response|6
378124|NCT00891020|1271710|P3|24 Week Treatment Period|Death|0
378125|NCT00891020|1271711|P2|24 Week Treatment Period|Death|2
378126|NCT00891020|1271712|P1|24 Week Treatment Period|Death|0
378127|NCT00891020|1271710|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
378128|NCT00891020|1271711|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
378129|NCT00891020|1271712|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
378130|NCT00890929|1271776|P1|Overall Study|Physician Decision|1
378131|NCT00890929|1271776|P1|Overall Study|Withdrawal by Subject|3
378132|NCT00890929|1271776|P1|Overall Study|Death before treatment|2
378133|NCT00890825|1271794|P2|Overall Study|Alive at data cut off (DCO)|14
378134|NCT00890825|1271795|P1|Overall Study|Alive at data cut off (DCO)|13
378135|NCT00890825|1271794|P2|Overall Study|Withdrawal by Subject|0
378136|NCT00890825|1271795|P1|Overall Study|Withdrawal by Subject|1
378137|NCT00890695|1271824|P2|Overall Study|Protocol Violation|0
378138|NCT00890695|1271825|P1|Overall Study|Protocol Violation|1
378139|NCT00890591|1271854|P1|Overall Study|Lack of Efficacy|20
378140|NCT00890552|1271860|P1|On-treatment|Early prog disease/ death|10
378141|NCT00890552|1271860|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
378142|NCT00890409|1271869|P2|Overall Study|Lost to Follow-up|21
378143|NCT00890409|1271870|P1|Overall Study|Lost to Follow-up|20
378144|NCT00890201|1271880|P2|Overall Study|Protocol Violation|56
378145|NCT00890201|1271881|P1|Overall Study|Protocol Violation|5
378146|NCT00890097|1271890|P3|Overall Study|Protocol Deviation|1
378147|NCT00890097|1271891|P2|Overall Study|Protocol Deviation|1
378148|NCT00890097|1271892|P1|Overall Study|Protocol Deviation|1
378149|NCT00890097|1271890|P3|Overall Study|Subject Moved|0
378150|NCT00890097|1271891|P2|Overall Study|Subject Moved|4
378151|NCT00890097|1271892|P1|Overall Study|Subject Moved|0
378152|NCT00890097|1271890|P3|Overall Study|Transportation|0
378153|NCT00890097|1271891|P2|Overall Study|Transportation|2
378154|NCT00890097|1271892|P1|Overall Study|Transportation|0
378155|NCT00890097|1271890|P3|Overall Study|Failed inclusion criteria|0
378156|NCT00890097|1271891|P2|Overall Study|Failed inclusion criteria|4
378157|NCT00890097|1271892|P1|Overall Study|Failed inclusion criteria|3
378158|NCT00890097|1271890|P3|Overall Study|Randomization Error|0
378159|NCT00890097|1271891|P2|Overall Study|Randomization Error|0
378160|NCT00890097|1271892|P1|Overall Study|Randomization Error|2
378161|NCT00890097|1271890|P3|Overall Study|Subject Decision|6
378162|NCT00890097|1271891|P2|Overall Study|Subject Decision|2
378163|NCT00890097|1271892|P1|Overall Study|Subject Decision|3
378164|NCT00890097|1271890|P3|Overall Study|Did not attend final visit|0
378165|NCT00890097|1271891|P2|Overall Study|Did not attend final visit|3
378166|NCT00890097|1271892|P1|Overall Study|Did not attend final visit|2
378167|NCT00890097|1271890|P3|Overall Study|Sponsor Decision|7
378168|NCT00890097|1271891|P2|Overall Study|Sponsor Decision|11
378169|NCT00890097|1271892|P1|Overall Study|Sponsor Decision|7
378170|NCT00890097|1271890|P3|Overall Study|Noncompliance|4
378171|NCT00890097|1271891|P2|Overall Study|Noncompliance|4
378172|NCT00890097|1271892|P1|Overall Study|Noncompliance|0
378173|NCT00890097|1271890|P3|Overall Study|Lost to Follow-up|5
378174|NCT00890097|1271891|P2|Overall Study|Lost to Follow-up|5
378175|NCT00890097|1271892|P1|Overall Study|Lost to Follow-up|5
378176|NCT00890097|1271890|P3|Overall Study|Withdrew Consent|9
378177|NCT00890097|1271891|P2|Overall Study|Withdrew Consent|6
378178|NCT00890097|1271892|P1|Overall Study|Withdrew Consent|9
378179|NCT00890097|1271890|P3|Overall Study|Decision Unrelated to an Adverse Event|17
378180|NCT00890097|1271891|P2|Overall Study|Decision Unrelated to an Adverse Event|12
378181|NCT00890097|1271892|P1|Overall Study|Decision Unrelated to an Adverse Event|15
378182|NCT00890097|1271890|P3|Overall Study|Adverse Event|28
378183|NCT00890097|1271891|P2|Overall Study|Adverse Event|32
378184|NCT00890097|1271892|P1|Overall Study|Adverse Event|21
378185|NCT00890084|1271900|P1|Overall Study|Lost to Follow-up|126
378186|NCT00890084|1271900|P1|Overall Study|Adverse Event|16
378187|NCT00889863|1271940|P2|Part II: Randomized Double Blind|Protocol deviation|1
378188|NCT00889863|1271941|P1|Part II: Randomized Double Blind|Protocol deviation|0
378189|NCT00889863|1271940|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
378190|NCT00889863|1271941|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
378191|NCT00889863|1271940|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
378192|NCT00889863|1271941|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
378193|NCT00889863|1271940|P2|Part II: Randomized Double Blind|Adverse Event|4
378194|NCT00889863|1271941|P1|Part II: Randomized Double Blind|Adverse Event|0
378195|NCT00889863|1271940|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
378196|NCT00889863|1271941|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
378197|NCT00889863|1271940|P2|Part I: Open Label|Adverse Event|0
378198|NCT00889863|1271941|P1|Part I: Open Label|Adverse Event|4
378199|NCT00889863|1271940|P2|Part I: Open Label|Death|0
378200|NCT00889863|1271941|P1|Part I: Open Label|Death|1
378201|NCT00889720|1271967|P1|Overall Study|Other|4
378202|NCT00889720|1271967|P1|Overall Study|Withdrawal by Subject|4
378203|NCT00889707|1271994|P2|Overall Study|Lack of Efficacy|5
378204|NCT00889707|1271995|P1|Overall Study|Lack of Efficacy|2
378205|NCT00889707|1271994|P2|Overall Study|Lost to Follow-up|2
378206|NCT00889707|1271995|P1|Overall Study|Lost to Follow-up|0
378207|NCT00889707|1271994|P2|Overall Study|Withdrawal by Subject|3
378208|NCT00889707|1271995|P1|Overall Study|Withdrawal by Subject|4
378209|NCT00889707|1271994|P2|Overall Study|Adverse Event|0
378210|NCT00889707|1271995|P1|Overall Study|Adverse Event|1
378211|NCT00889681|1272003|P1|Overall Study|Insurance disapproval|1
378212|NCT00889681|1272003|P1|Overall Study|Not meeting qualification Criteria|2
378213|NCT00889603|1272010|P1|Overall Study|Not Specified|4
378214|NCT00889603|1272010|P1|Overall Study|No longer willing to participant in stud|4
378215|NCT00889603|1272010|P1|Overall Study|Lost to Follow-up|19
378216|NCT00889603|1272010|P1|Overall Study|Death|3
378217|NCT00889603|1272010|P1|Overall Study|Adverse Event|7
378218|NCT00889421|1272032|P1|Overall Study|Lack of Efficacy|3
378219|NCT00889265|1272073|P1|Overall Study|Protocol Violation|1
378220|NCT00889265|1272073|P1|Overall Study|Lost to Follow-up|5
378221|NCT00889265|1272073|P1|Overall Study|Adverse Event|1
378222|NCT00889252|1272080|P2|Overall Study|Protocol Violation|0
378223|NCT00889252|1272081|P1|Overall Study|Protocol Violation|2
378224|NCT00889252|1272080|P2|Overall Study|Withdrawal by Subject|0
378225|NCT00889252|1272081|P1|Overall Study|Withdrawal by Subject|3
378226|NCT00889252|1272080|P2|Overall Study|Adverse Event|4
378227|NCT00889252|1272081|P1|Overall Study|Adverse Event|2
378228|NCT00888940|1272153|P2|Overall Study|Randomized Not Treated|13
378229|NCT00888940|1272154|P1|Overall Study|Randomized Not Treated|11
378230|NCT00888940|1272153|P2|Overall Study|Lost to Follow-up|5
378231|NCT00888940|1272154|P1|Overall Study|Lost to Follow-up|5
378232|NCT00888940|1272153|P2|Overall Study|Adverse Event|3
378233|NCT00888940|1272154|P1|Overall Study|Adverse Event|12
378234|NCT00888849|1272164|P2|Overall Study|Lost to Follow-up|2
378235|NCT00888849|1272165|P1|Overall Study|Lost to Follow-up|1
378236|NCT00888849|1272164|P2|Overall Study|Death|7
378237|NCT00888849|1272165|P1|Overall Study|Death|4
378238|NCT00888654|1272175|P1|Overall Study|Stopped meds due to headaches|1
378239|NCT00888654|1272175|P1|Overall Study|Change in surg date|1
378240|NCT00888654|1272175|P1|Overall Study|Inelig. due to contraindication of med|1
378241|NCT00888654|1272175|P1|Overall Study|Withdrawal by Subject|1
378242|NCT00888654|1272175|P1|Overall Study|Surgery aborted|2
378243|NCT00888654|1272175|P1|Overall Study|Not enough oral meds before surgery|3
378244|NCT00888654|1272175|P1|Overall Study|Problems swallowing oral meds.|1
378245|NCT00888433|1272204|P2|Overall Study|Missed Visit|1
378246|NCT00888433|1272205|P1|Overall Study|Missed Visit|2
378247|NCT00888433|1272204|P2|Overall Study|Withdrawal by Subject|2
378248|NCT00888433|1272205|P1|Overall Study|Withdrawal by Subject|1
378249|NCT00888381|1272213|P2|Overall Study|Lost to Follow-up|1
378250|NCT00888381|1272214|P1|Overall Study|Lost to Follow-up|0
378251|NCT00888355|1272234|P4|Overall Study|Withdrawal by Subject|3
378252|NCT00888355|1272235|P3|Overall Study|Withdrawal by Subject|1
378253|NCT00888355|1272236|P2|Overall Study|Withdrawal by Subject|3
378254|NCT00888355|1272237|P1|Overall Study|Withdrawal by Subject|0
378255|NCT00888355|1272234|P4|Overall Study|Protocol Violation|2
378256|NCT00888355|1272235|P3|Overall Study|Protocol Violation|1
378257|NCT00888355|1272236|P2|Overall Study|Protocol Violation|2
378258|NCT00888355|1272237|P1|Overall Study|Protocol Violation|3
378259|NCT00888355|1272234|P4|Overall Study|Lost to Follow-up|0
378260|NCT00888355|1272235|P3|Overall Study|Lost to Follow-up|2
378261|NCT00888355|1272236|P2|Overall Study|Lost to Follow-up|2
378262|NCT00888355|1272237|P1|Overall Study|Lost to Follow-up|0
378263|NCT00888355|1272234|P4|Overall Study|Lack of Efficacy|2
378264|NCT00888355|1272235|P3|Overall Study|Lack of Efficacy|5
378265|NCT00888355|1272236|P2|Overall Study|Lack of Efficacy|2
378266|NCT00888355|1272237|P1|Overall Study|Lack of Efficacy|9
378267|NCT00888355|1272234|P4|Overall Study|Adverse Event|3
378268|NCT00888355|1272235|P3|Overall Study|Adverse Event|3
378269|NCT00888355|1272236|P2|Overall Study|Adverse Event|0
378270|NCT00888355|1272237|P1|Overall Study|Adverse Event|10
378271|NCT00888329|1272293|P2|Overall Study|Physician Decision|9
378272|NCT00888329|1272294|P1|Overall Study|Physician Decision|6
378273|NCT00888238|1272300|P3|Washout Period After Period 2|Adverse Event|1
378274|NCT00888238|1272301|P2|Washout Period After Period 2|Adverse Event|0
378275|NCT00888238|1272302|P1|Washout Period After Period 2|Adverse Event|0
378276|NCT00888173|1272310|P1|Overall Study|Ineligible: required test not done|1
378277|NCT00888173|1272310|P1|Overall Study|Wrong Primary|1
378278|NCT00888134|1272318|P1|Follow-up|being followed for long-term survival|1
378279|NCT00888134|1272318|P1|Treatment With Study Drug|Withdrawal by Subject|1
378280|NCT00887978|1272328|P2|Overall Study|Lost to Follow-up|1
378281|NCT00887978|1272329|P1|Overall Study|Lost to Follow-up|0
378282|NCT00887978|1272328|P2|Overall Study|Withdrawal by Subject|2
378283|NCT00887978|1272329|P1|Overall Study|Withdrawal by Subject|1
378284|NCT00887978|1272328|P2|Overall Study|Death|3
378285|NCT00887978|1272329|P1|Overall Study|Death|2
378286|NCT00887978|1272328|P2|Overall Study|Clinical Worsening|4
378287|NCT00887978|1272329|P1|Overall Study|Clinical Worsening|4
378288|NCT00887978|1272328|P2|Overall Study|Adverse Event|5
378289|NCT00887978|1272329|P1|Overall Study|Adverse Event|18
378290|NCT00887913|1272395|P1|Overall Study|Withdrawal by Subject|6
378291|NCT00887822|1272403|P2|Overall Study|Randomized but not treated|1
378292|NCT00887822|1272404|P1|Overall Study|Randomized but not treated|0
378293|NCT00887822|1272403|P2|Overall Study|Protocol Violation|1
378294|NCT00887822|1272404|P1|Overall Study|Protocol Violation|0
378295|NCT00887822|1272403|P2|Overall Study|Death|3
378296|NCT00887822|1272404|P1|Overall Study|Death|2
378297|NCT00887822|1272403|P2|Overall Study|Administrative/Other than specified|4
378298|NCT00887822|1272404|P1|Overall Study|Administrative/Other than specified|5
378299|NCT00887822|1272403|P2|Overall Study|Refused treatment/Did not cooperate|10
378300|NCT00887822|1272404|P1|Overall Study|Refused treatment/Did not cooperate|12
378301|NCT00887822|1272403|P2|Overall Study|Failure to return|11
378302|NCT00887822|1272404|P1|Overall Study|Failure to return|11
378303|NCT00887822|1272403|P2|Overall Study|Adverse Event|17
378304|NCT00887822|1272404|P1|Overall Study|Adverse Event|14
378305|NCT00887822|1272403|P2|Overall Study|Insufficient therapeutic response|55
378306|NCT00887822|1272404|P1|Overall Study|Insufficient therapeutic response|53
378307|NCT00887809|1272436|P2|Overall Study|Death|0
378308|NCT00887809|1272437|P1|Overall Study|Death|1
378309|NCT00887809|1272436|P2|Overall Study|Patient Not Treated|0
378310|NCT00887809|1272437|P1|Overall Study|Patient Not Treated|3
378311|NCT00887744|1272443|P1|Overall Study|Various reasons|9
378312|NCT00887744|1272443|P1|Overall Study|Withdrawal by Subject|18
378313|NCT00887744|1272443|P1|Overall Study|Lost to Follow-up|3
378314|NCT00887744|1272443|P1|Overall Study|Death|1
378315|NCT00887744|1272443|P1|Overall Study|Adverse Event|3
378316|NCT00887679|1272452|P1|Overall Study|Physician Decision|5
378317|NCT00887679|1272452|P1|Overall Study|Lost to Follow-up|4
378318|NCT00887679|1272452|P1|Overall Study|Withdrawal by Subject|1
378319|NCT00887588|1272482|P2|Extension Period|Lost to Follow-up|0
378320|NCT00887588|1272483|P1|Extension Period|Lost to Follow-up|1
378321|NCT00887588|1272482|P2|Extension Period|Protocol deviation|0
378322|NCT00887588|1272483|P1|Extension Period|Protocol deviation|1
378323|NCT00887588|1272482|P2|Extension Period|Death|1
378324|NCT00887588|1272483|P1|Extension Period|Death|0
378325|NCT00887588|1272482|P2|Extension Period|Adverse Event|4
378326|NCT00887588|1272483|P1|Extension Period|Adverse Event|4
378327|NCT00887588|1272482|P2|Core Period|Adverse Event|11
378328|NCT00887588|1272483|P1|Core Period|Adverse Event|9
378329|NCT00887588|1272482|P2|Core Period|Withdrawal by Subject|8
378330|NCT00887588|1272483|P1|Core Period|Withdrawal by Subject|6
378331|NCT00887588|1272482|P2|Core Period|Lost to Follow-up|1
378332|NCT00887588|1272483|P1|Core Period|Lost to Follow-up|3
378333|NCT00887588|1272482|P2|Core Period|Death|1
378334|NCT00887588|1272483|P1|Core Period|Death|1
378335|NCT00887549|1272564|P1|Maintenance Therapy|Death due to adverse event|1
378336|NCT00887549|1272564|P1|Maintenance Therapy|Progressive Disease|25
378337|NCT00887549|1272564|P1|Maintenance Therapy|Physician Decision|1
378338|NCT00887549|1272564|P1|Maintenance Therapy|Adverse Event|16
378339|NCT00887549|1272564|P1|Induction Therapy|Death due to Study Drug Toxicity|1
378340|NCT00887549|1272564|P1|Induction Therapy|Death due to Study Disease|4
378341|NCT00887549|1272564|P1|Induction Therapy|Progressive Disease|13
378342|NCT00887549|1272564|P1|Induction Therapy|Physician Decision|1
378343|NCT00887549|1272564|P1|Induction Therapy|Adverse Event|8
378344|NCT00887484|1272582|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
378345|NCT00887484|1272582|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
378346|NCT00887484|1272582|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
378347|NCT00887354|1272670|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
378348|NCT00887354|1272671|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
378349|NCT00887354|1272670|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
378350|NCT00887354|1272671|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
378351|NCT00887354|1272670|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
378352|NCT00887354|1272671|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
378353|NCT00887354|1272670|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
378354|NCT00887354|1272671|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
378355|NCT00887354|1272670|P2|Open Label Phase (Week 26 to Week 78)|Death|2
378356|NCT00887354|1272671|P1|Open Label Phase (Week 26 to Week 78)|Death|0
378357|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
378358|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
378359|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
378360|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
378361|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
378362|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
378363|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
378364|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
378365|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
378366|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
378367|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
378368|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
378369|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
378370|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
378371|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
378372|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
378373|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
378374|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
378375|NCT00887354|1272670|P2|Treatment Phase (Week 0 to Week 26)|Death|1
378376|NCT00887354|1272671|P1|Treatment Phase (Week 0 to Week 26)|Death|0
378377|NCT00887341|1272691|P2|Overall Study|Lost to Follow-up|1
378378|NCT00887341|1272692|P1|Overall Study|Lost to Follow-up|0
378379|NCT00887341|1272691|P2|Overall Study|Adverse Event|1
378380|NCT00887341|1272692|P1|Overall Study|Adverse Event|0
378381|NCT00887341|1272691|P2|Overall Study|Withdrawal by Subject|1
378382|NCT00887341|1272692|P1|Overall Study|Withdrawal by Subject|1
378383|NCT00887341|1272691|P2|Overall Study|Refused treatment|0
378384|NCT00887341|1272692|P1|Overall Study|Refused treatment|1
378385|NCT00887315|1272728|P2|Overall Study|Study termination|4
378386|NCT00887315|1272729|P1|Overall Study|Study termination|7
378387|NCT00887289|1272737|P1|Overall Study|not specified|20
378388|NCT00887289|1272737|P1|Overall Study|Lost to Follow-up|8
378389|NCT00887289|1272737|P1|Overall Study|Withdrawal by Subject|26
378390|NCT00887289|1272737|P1|Overall Study|Adverse Event|27
378391|NCT00887289|1272737|P1|Overall Study|Lack of Efficacy|14
378392|NCT00887250|1272749|P3|Overall Study|Patient uncooperative|1
378393|NCT00887250|1272750|P2|Overall Study|Patient uncooperative|0
378394|NCT00887250|1272751|P1|Overall Study|Patient uncooperative|0
378395|NCT00887250|1272749|P3|Overall Study|Withdrawal by Subject|2
378396|NCT00887250|1272750|P2|Overall Study|Withdrawal by Subject|1
378397|NCT00887250|1272751|P1|Overall Study|Withdrawal by Subject|2
378398|NCT00887250|1272749|P3|Overall Study|Protocol Violation|1
378399|NCT00887250|1272750|P2|Overall Study|Protocol Violation|2
378400|NCT00887250|1272751|P1|Overall Study|Protocol Violation|2
378401|NCT00887250|1272749|P3|Overall Study|Lost to Follow-up|1
378402|NCT00887250|1272750|P2|Overall Study|Lost to Follow-up|3
378403|NCT00887250|1272751|P1|Overall Study|Lost to Follow-up|2
378404|NCT00887250|1272749|P3|Overall Study|Lack of Efficacy|1
378405|NCT00887250|1272750|P2|Overall Study|Lack of Efficacy|6
378406|NCT00887250|1272751|P1|Overall Study|Lack of Efficacy|9
378407|NCT00887250|1272749|P3|Overall Study|Adverse Event|7
378408|NCT00887250|1272750|P2|Overall Study|Adverse Event|0
378409|NCT00887250|1272751|P1|Overall Study|Adverse Event|3
378410|NCT00887224|1272774|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
378411|NCT00887224|1272775|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
378412|NCT00887224|1272776|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
378413|NCT00887224|1272774|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
378414|NCT00887224|1272775|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
378415|NCT00887224|1272776|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
378416|NCT00887224|1272774|P3|DB Taper Phase / Post Study Follow Up|Other|12
378417|NCT00887224|1272775|P2|DB Taper Phase / Post Study Follow Up|Other|11
378418|NCT00887224|1272776|P1|DB Taper Phase / Post Study Follow Up|Other|0
378419|NCT00887224|1272774|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
378420|NCT00887224|1272775|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
378421|NCT00887224|1272776|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
378422|NCT00887224|1272774|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
378423|NCT00887224|1272775|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
378424|NCT00887224|1272776|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
378425|NCT00887224|1272774|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
378426|NCT00887224|1272775|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
378427|NCT00887224|1272776|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
378428|NCT00887224|1272774|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
378429|NCT00887224|1272775|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
378430|NCT00887224|1272776|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
378431|NCT00887224|1272774|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
378432|NCT00887224|1272775|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
378433|NCT00887224|1272776|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
378434|NCT00887224|1272774|P3|Double-blind (DB) Phase|Protocol Violation|5
378435|NCT00887224|1272775|P2|Double-blind (DB) Phase|Protocol Violation|8
378436|NCT00887224|1272776|P1|Double-blind (DB) Phase|Protocol Violation|0
378437|NCT00887224|1272774|P3|Double-blind (DB) Phase|Other|0
378438|NCT00887224|1272775|P2|Double-blind (DB) Phase|Other|2
378439|NCT00887224|1272776|P1|Double-blind (DB) Phase|Other|0
378440|NCT00887224|1272774|P3|Double-blind (DB) Phase|Lost to Follow-up|8
378441|NCT00887224|1272775|P2|Double-blind (DB) Phase|Lost to Follow-up|8
378442|NCT00887224|1272776|P1|Double-blind (DB) Phase|Lost to Follow-up|0
378443|NCT00887224|1272774|P3|Double-blind (DB) Phase|Lack of Efficacy|33
378444|NCT00887224|1272775|P2|Double-blind (DB) Phase|Lack of Efficacy|67
378445|NCT00887224|1272776|P1|Double-blind (DB) Phase|Lack of Efficacy|0
378446|NCT00887224|1272774|P3|Double-blind (DB) Phase|Failed to return|2
378447|NCT00887224|1272775|P2|Double-blind (DB) Phase|Failed to return|2
378448|NCT00887224|1272776|P1|Double-blind (DB) Phase|Failed to return|0
378449|NCT00887224|1272774|P3|Double-blind (DB) Phase|Adverse Event|2
378450|NCT00887224|1272775|P2|Double-blind (DB) Phase|Adverse Event|7
378451|NCT00887224|1272776|P1|Double-blind (DB) Phase|Adverse Event|0
378452|NCT00887224|1272774|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
378453|NCT00887224|1272775|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
378454|NCT00887224|1272776|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
378455|NCT00887224|1272774|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
378456|NCT00887224|1272775|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
378457|NCT00887224|1272776|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
378458|NCT00887224|1272774|P3|OL Taper Phase / OL Follow Up|Other|0
378459|NCT00887224|1272775|P2|OL Taper Phase / OL Follow Up|Other|0
378460|NCT00887224|1272776|P1|OL Taper Phase / OL Follow Up|Other|30
378461|NCT00887224|1272774|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
378462|NCT00887224|1272775|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
378463|NCT00887224|1272776|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
378464|NCT00887224|1272774|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
378465|NCT00887224|1272775|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
378466|NCT00887224|1272776|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
378467|NCT00887224|1272774|P3|OL Taper Phase / OL Follow Up|Failed to return|0
378468|NCT00887224|1272775|P2|OL Taper Phase / OL Follow Up|Failed to return|0
378469|NCT00887224|1272776|P1|OL Taper Phase / OL Follow Up|Failed to return|17
378470|NCT00887224|1272774|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
378471|NCT00887224|1272775|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
378472|NCT00887224|1272776|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
378473|NCT00887224|1272774|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
378474|NCT00887224|1272775|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
378475|NCT00887224|1272776|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
378476|NCT00887224|1272774|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
378477|NCT00887224|1272775|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
378478|NCT00887224|1272776|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
378479|NCT00887224|1272774|P3|Open-label Stability (OLS) Phase|Other|0
378480|NCT00887224|1272775|P2|Open-label Stability (OLS) Phase|Other|0
378481|NCT00887224|1272776|P1|Open-label Stability (OLS) Phase|Other|1
378482|NCT00887224|1272774|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
378483|NCT00887224|1272775|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
378484|NCT00887224|1272776|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
378485|NCT00887224|1272774|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
378486|NCT00887224|1272775|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
378487|NCT00887224|1272776|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
378488|NCT00887224|1272774|P3|Open-label Stability (OLS) Phase|Failed to return|0
378489|NCT00887224|1272775|P2|Open-label Stability (OLS) Phase|Failed to return|0
378490|NCT00887224|1272776|P1|Open-label Stability (OLS) Phase|Failed to return|3
378491|NCT00887224|1272774|P3|Open-label Stability (OLS) Phase|Adverse Event|0
378492|NCT00887224|1272775|P2|Open-label Stability (OLS) Phase|Adverse Event|0
378493|NCT00887224|1272776|P1|Open-label Stability (OLS) Phase|Adverse Event|22
378494|NCT00887224|1272774|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
378495|NCT00887224|1272775|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
378496|NCT00887224|1272776|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
378497|NCT00887224|1272774|P3|Open-label Response (OLR) Phase|Protocol Violation|0
378498|NCT00887224|1272775|P2|Open-label Response (OLR) Phase|Protocol Violation|0
378499|NCT00887224|1272776|P1|Open-label Response (OLR) Phase|Protocol Violation|12
378500|NCT00887224|1272774|P3|Open-label Response (OLR) Phase|Other|0
378501|NCT00887224|1272775|P2|Open-label Response (OLR) Phase|Other|0
378502|NCT00887224|1272776|P1|Open-label Response (OLR) Phase|Other|1
378503|NCT00887224|1272774|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
378504|NCT00887224|1272775|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
378505|NCT00887224|1272776|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
378506|NCT00887224|1272774|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
378507|NCT00887224|1272775|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
378508|NCT00887224|1272776|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
378509|NCT00887224|1272774|P3|Open-label Response (OLR) Phase|Failed to return|0
378510|NCT00887224|1272775|P2|Open-label Response (OLR) Phase|Failed to return|0
378511|NCT00887224|1272776|P1|Open-label Response (OLR) Phase|Failed to return|6
378512|NCT00887224|1272774|P3|Open-label Response (OLR) Phase|Adverse Event|0
378513|NCT00887224|1272775|P2|Open-label Response (OLR) Phase|Adverse Event|0
378514|NCT00887224|1272776|P1|Open-label Response (OLR) Phase|Adverse Event|46
378515|NCT00887198|1272803|P3|Cross Over (Placebo to AA)|Other|19
378516|NCT00887198|1272804|P2|Cross Over (Placebo to AA)|Other|0
378517|NCT00887198|1272805|P1|Cross Over (Placebo to AA)|Other|0
378518|NCT00887198|1272803|P3|Cross Over (Placebo to AA)|Progressive disease|20
378519|NCT00887198|1272804|P2|Cross Over (Placebo to AA)|Progressive disease|0
378520|NCT00887198|1272805|P1|Cross Over (Placebo to AA)|Progressive disease|0
378521|NCT00887198|1272803|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
378522|NCT00887198|1272804|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
378523|NCT00887198|1272805|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
378524|NCT00887198|1272803|P3|Cross Over (Placebo to AA)|Adverse Event|9
378525|NCT00887198|1272804|P2|Cross Over (Placebo to AA)|Adverse Event|0
378526|NCT00887198|1272805|P1|Cross Over (Placebo to AA)|Adverse Event|0
378527|NCT00887198|1272803|P3|Cross Over (Placebo to AA)|Ongoing|35
378528|NCT00887198|1272804|P2|Cross Over (Placebo to AA)|Ongoing|0
378529|NCT00887198|1272805|P1|Cross Over (Placebo to AA)|Ongoing|0
378530|NCT00887198|1272803|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
378531|NCT00887198|1272804|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
378532|NCT00887198|1272805|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
378533|NCT00887198|1272803|P3|Randomized Period|Randomized, Not treated|0
378534|NCT00887198|1272804|P2|Randomized Period|Randomized, Not treated|2
378535|NCT00887198|1272805|P1|Randomized Period|Randomized, Not treated|4
378536|NCT00887198|1272803|P3|Randomized Period|Other|0
378537|NCT00887198|1272804|P2|Randomized Period|Other|30
378538|NCT00887198|1272805|P1|Randomized Period|Other|42
378539|NCT00887198|1272803|P3|Randomized Period|Progressive disease|0
378540|NCT00887198|1272804|P2|Randomized Period|Progressive disease|370
378541|NCT00887198|1272805|P1|Randomized Period|Progressive disease|366
378542|NCT00887198|1272803|P3|Randomized Period|Withdrawal by Subject|0
378543|NCT00887198|1272804|P2|Randomized Period|Withdrawal by Subject|56
378544|NCT00887198|1272805|P1|Randomized Period|Withdrawal by Subject|41
378545|NCT00887198|1272803|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
378546|NCT00887198|1272804|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
378547|NCT00887198|1272805|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
378548|NCT00887198|1272803|P3|Randomized Period|Lost to Follow-up|0
378549|NCT00887198|1272804|P2|Randomized Period|Lost to Follow-up|0
378550|NCT00887198|1272805|P1|Randomized Period|Lost to Follow-up|1
378551|NCT00887198|1272803|P3|Randomized Period|Adverse Event|0
378552|NCT00887198|1272804|P2|Randomized Period|Adverse Event|33
378553|NCT00887198|1272805|P1|Randomized Period|Adverse Event|50
378554|NCT00887198|1272803|P3|Randomized Period|Ongoing|0
378555|NCT00887198|1272804|P2|Randomized Period|Ongoing|0
378556|NCT00887198|1272805|P1|Randomized Period|Ongoing|42
378557|NCT00887159|1272836|P3|Overall Study|Never started assigned therapy|4
378558|NCT00887159|1272837|P2|Overall Study|Never started assigned therapy|3
378559|NCT00887159|1272838|P1|Overall Study|Never started assigned therapy|3
378560|NCT00887159|1272836|P3|Overall Study|Ineligible|0
378561|NCT00887159|1272837|P2|Overall Study|Ineligible|1
378562|NCT00887159|1272838|P1|Overall Study|Ineligible|5
378563|NCT00887159|1272836|P3|Overall Study|Received more tx instead of observation|0
378564|NCT00887159|1272837|P2|Overall Study|Received more tx instead of observation|0
378565|NCT00887159|1272838|P1|Overall Study|Received more tx instead of observation|1
378566|NCT00887159|1272836|P3|Overall Study|Pt had PD but was SD when re-measured|0
378567|NCT00887159|1272837|P2|Overall Study|Pt had PD but was SD when re-measured|1
378568|NCT00887159|1272838|P1|Overall Study|Pt had PD but was SD when re-measured|0
378569|NCT00887159|1272836|P3|Overall Study|Treatment delayed|0
378570|NCT00887159|1272837|P2|Overall Study|Treatment delayed|1
378571|NCT00887159|1272838|P1|Overall Study|Treatment delayed|1
378572|NCT00887159|1272836|P3|Overall Study|Sympomatic deterioration|0
378573|NCT00887159|1272837|P2|Overall Study|Sympomatic deterioration|0
378574|NCT00887159|1272838|P1|Overall Study|Sympomatic deterioration|1
378575|NCT00887159|1272836|P3|Overall Study|Physician Decision|0
378576|NCT00887159|1272837|P2|Overall Study|Physician Decision|1
378577|NCT00887159|1272838|P1|Overall Study|Physician Decision|1
378578|NCT00887159|1272836|P3|Overall Study|Alternative therapy|0
378579|NCT00887159|1272837|P2|Overall Study|Alternative therapy|0
378580|NCT00887159|1272838|P1|Overall Study|Alternative therapy|2
378581|NCT00887159|1272836|P3|Overall Study|Withdrawal by Subject|2
378582|NCT00887159|1272837|P2|Overall Study|Withdrawal by Subject|4
378583|NCT00887159|1272838|P1|Overall Study|Withdrawal by Subject|4
378584|NCT00887159|1272836|P3|Overall Study|Death|0
378585|NCT00887159|1272837|P2|Overall Study|Death|2
378586|NCT00887159|1272838|P1|Overall Study|Death|2
378587|NCT00887159|1272836|P3|Overall Study|Adverse Event|17
378588|NCT00887159|1272837|P2|Overall Study|Adverse Event|4
378589|NCT00887159|1272838|P1|Overall Study|Adverse Event|3
378590|NCT00887159|1272836|P3|Overall Study|Disease progression|33
378591|NCT00887159|1272837|P2|Overall Study|Disease progression|39
378592|NCT00887159|1272838|P1|Overall Study|Disease progression|6
378593|NCT00886938|1272854|P1|Overall Study|Withdrawal by Subject|1
378594|NCT00886938|1272854|P1|Overall Study|Adverse Event|1
378595|NCT00886834|1272867|P2|Overall Study|Protocol Violation|3
378596|NCT00886834|1272868|P1|Overall Study|Protocol Violation|0
378597|NCT00886821|1272890|P14|Stage 2|Lost to Follow-up|1
378598|NCT00886821|1272891|P13|Stage 2|Lost to Follow-up|2
378599|NCT00886821|1272892|P12|Stage 2|Lost to Follow-up|0
378600|NCT00886821|1272893|P11|Stage 2|Lost to Follow-up|0
378601|NCT00886821|1272894|P10|Stage 2|Lost to Follow-up|0
378602|NCT00886821|1272895|P9|Stage 2|Lost to Follow-up|0
378603|NCT00886821|1272896|P8|Stage 2|Lost to Follow-up|0
378604|NCT00886821|1272897|P7|Stage 2|Lost to Follow-up|0
378605|NCT00886821|1272898|P6|Stage 2|Lost to Follow-up|0
378606|NCT00886821|1272899|P5|Stage 2|Lost to Follow-up|0
378607|NCT00886821|1272900|P4|Stage 2|Lost to Follow-up|0
378608|NCT00886821|1272901|P3|Stage 2|Lost to Follow-up|0
378609|NCT00886821|1272902|P2|Stage 2|Lost to Follow-up|0
378610|NCT00886821|1272903|P1|Stage 2|Lost to Follow-up|0
378611|NCT00886821|1272890|P14|Stage 2|Adverse Event|0
378612|NCT00886821|1272891|P13|Stage 2|Adverse Event|3
378613|NCT00886821|1272892|P12|Stage 2|Adverse Event|1
378614|NCT00886821|1272893|P11|Stage 2|Adverse Event|0
378615|NCT00886821|1272894|P10|Stage 2|Adverse Event|0
378616|NCT00886821|1272895|P9|Stage 2|Adverse Event|0
378617|NCT00886821|1272896|P8|Stage 2|Adverse Event|0
378618|NCT00886821|1272897|P7|Stage 2|Adverse Event|0
378619|NCT00886821|1272898|P6|Stage 2|Adverse Event|0
378620|NCT00886821|1272899|P5|Stage 2|Adverse Event|0
378621|NCT00886821|1272900|P4|Stage 2|Adverse Event|0
378622|NCT00886821|1272901|P3|Stage 2|Adverse Event|0
378623|NCT00886821|1272902|P2|Stage 2|Adverse Event|0
378624|NCT00886821|1272903|P1|Stage 2|Adverse Event|0
378625|NCT00886795|1273128|P1|Overall Study|Lack of Efficacy|1
378626|NCT00886769|1273135|P2|Overall Study|Unsatisfactory therapeutic effect|37
378627|NCT00886769|1273136|P1|Overall Study|Unsatisfactory therapeutic effect|6
378628|NCT00886743|1273160|P1|Overall Study|Other|1
378629|NCT00886743|1273160|P1|Overall Study|Adverse Event|3
378630|NCT00886639|1273179|P1|Overall Study|non-compliance|2
378631|NCT00886639|1273179|P1|Overall Study|acute exacerbation|14
378632|NCT00886613|1273193|P3|Overall Study|Subject withdrew consent (Part A)|2
378633|NCT00886613|1273194|P2|Overall Study|Subject withdrew consent (Part A)|0
378634|NCT00886613|1273195|P1|Overall Study|Subject withdrew consent (Part A)|0
378635|NCT00886613|1273193|P3|Overall Study|Lost to follow-up (Part B)|1
378636|NCT00886613|1273194|P2|Overall Study|Lost to follow-up (Part B)|0
378637|NCT00886613|1273195|P1|Overall Study|Lost to follow-up (Part B)|1
378638|NCT00886613|1273193|P3|Overall Study|Protocol deviation (Part B)|0
378639|NCT00886613|1273194|P2|Overall Study|Protocol deviation (Part B)|0
378640|NCT00886613|1273195|P1|Overall Study|Protocol deviation (Part B)|1
378641|NCT00886600|1273217|P4|Combination Therapy Period|Protocol Violation|0
378642|NCT00886600|1273218|P3|Combination Therapy Period|Protocol Violation|1
378643|NCT00886600|1273219|P2|Combination Therapy Period|Protocol Violation|0
378644|NCT00886600|1273220|P1|Combination Therapy Period|Protocol Violation|0
378645|NCT00886600|1273217|P4|Combination Therapy Period|Adverse Event|0
378646|NCT00886600|1273218|P3|Combination Therapy Period|Adverse Event|1
378647|NCT00886600|1273219|P2|Combination Therapy Period|Adverse Event|0
378648|NCT00886600|1273220|P1|Combination Therapy Period|Adverse Event|0
378649|NCT00886600|1273217|P4|Double-blind Monotherapy|Withdrawal by Subject|0
378650|NCT00886600|1273218|P3|Double-blind Monotherapy|Withdrawal by Subject|0
378651|NCT00886600|1273219|P2|Double-blind Monotherapy|Withdrawal by Subject|0
378652|NCT00886600|1273220|P1|Double-blind Monotherapy|Withdrawal by Subject|1
378653|NCT00886600|1273217|P4|Double-blind Monotherapy|Protocol Violation|1
378654|NCT00886600|1273218|P3|Double-blind Monotherapy|Protocol Violation|0
378655|NCT00886600|1273219|P2|Double-blind Monotherapy|Protocol Violation|0
378656|NCT00886600|1273220|P1|Double-blind Monotherapy|Protocol Violation|0
378657|NCT00886600|1273217|P4|Double-blind Monotherapy|Adverse Event|1
378658|NCT00886600|1273218|P3|Double-blind Monotherapy|Adverse Event|1
378659|NCT00886600|1273219|P2|Double-blind Monotherapy|Adverse Event|1
378660|NCT00886600|1273220|P1|Double-blind Monotherapy|Adverse Event|1
378661|NCT00886587|1273244|P2|Overall Study|Withdrawal by Subject|1
378662|NCT00886587|1273245|P1|Overall Study|Withdrawal by Subject|0
378663|NCT00886587|1273244|P2|Overall Study|Protocol Violation|0
378664|NCT00886587|1273245|P1|Overall Study|Protocol Violation|2
378665|NCT00886587|1273244|P2|Overall Study|Adverse Event|1
378666|NCT00886587|1273245|P1|Overall Study|Adverse Event|2
378667|NCT00886483|1273259|P2|Overall Study|Distance to center, poor grades|0
378668|NCT00886483|1273260|P1|Overall Study|Distance to center, poor grades|1
378669|NCT00886483|1273259|P2|Overall Study|Pursue medications|2
378670|NCT00886483|1273260|P1|Overall Study|Pursue medications|1
378671|NCT00886483|1273259|P2|Overall Study|Lost to Follow-up|1
378672|NCT00886483|1273260|P1|Overall Study|Lost to Follow-up|0
378673|NCT00886340|1273278|P2|Overall Study|Withdrawal by Subject|7
378674|NCT00886340|1273279|P1|Overall Study|Withdrawal by Subject|0
378675|NCT00886288|1273287|P2|Overall Study|Lost to Follow-up|0
378676|NCT00886288|1273288|P1|Overall Study|Lost to Follow-up|86
378677|NCT00886288|1273287|P2|Overall Study|no respect of the 12 weeks period|227
378678|NCT00886288|1273288|P1|Overall Study|no respect of the 12 weeks period|657
378679|NCT00886119|1273310|P2|Period 1|Did not meet inclusion criteria|0
378680|NCT00886119|1273311|P1|Period 1|Did not meet inclusion criteria|1
378681|NCT00886015|1273319|P2|Overall Study|Death|2
378682|NCT00886015|1273320|P1|Overall Study|Death|0
378683|NCT00885846|1273339|P3|Overall Study|Withdrawal by Subject|2
378684|NCT00885846|1273340|P2|Overall Study|Withdrawal by Subject|5
378685|NCT00885846|1273341|P1|Overall Study|Withdrawal by Subject|2
378686|NCT00885755|1273356|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
378687|NCT00885755|1273357|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
378688|NCT00885755|1273358|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
378689|NCT00885755|1273356|P3|Part I: Trastuzumab+Taxane|Death|1
378690|NCT00885755|1273357|P2|Part I: Trastuzumab+Taxane|Death|0
378691|NCT00885755|1273358|P1|Part I: Trastuzumab+Taxane|Death|0
378692|NCT00885755|1273356|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
378693|NCT00885755|1273357|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
378694|NCT00885755|1273358|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
378695|NCT00885755|1273356|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
378696|NCT00885755|1273357|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
378697|NCT00885755|1273358|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
378698|NCT00885755|1273356|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
378699|NCT00885755|1273357|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
378700|NCT00885755|1273358|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
378701|NCT00885703|1273401|P7|Overall Study|Ineligible (no CM)|1
378702|NCT00885703|1273402|P6|Overall Study|Ineligible (no CM)|3
378703|NCT00885703|1273403|P5|Overall Study|Ineligible (no CM)|2
378704|NCT00885703|1273404|P4|Overall Study|Ineligible (no CM)|1
378705|NCT00885703|1273405|P3|Overall Study|Ineligible (no CM)|2
378706|NCT00885703|1273406|P2|Overall Study|Ineligible (no CM)|3
378707|NCT00885703|1273407|P1|Overall Study|Ineligible (no CM)|1
378708|NCT00885703|1273401|P7|Overall Study|Withdrawal by Subject|1
378709|NCT00885703|1273402|P6|Overall Study|Withdrawal by Subject|1
378710|NCT00885703|1273403|P5|Overall Study|Withdrawal by Subject|3
378711|NCT00885703|1273404|P4|Overall Study|Withdrawal by Subject|1
378712|NCT00885703|1273405|P3|Overall Study|Withdrawal by Subject|0
378713|NCT00885703|1273406|P2|Overall Study|Withdrawal by Subject|0
378714|NCT00885703|1273407|P1|Overall Study|Withdrawal by Subject|0
378715|NCT00885703|1273401|P7|Overall Study|Lost to Follow-up|0
378716|NCT00885703|1273402|P6|Overall Study|Lost to Follow-up|1
378717|NCT00885703|1273403|P5|Overall Study|Lost to Follow-up|0
378718|NCT00885703|1273404|P4|Overall Study|Lost to Follow-up|0
378719|NCT00885703|1273405|P3|Overall Study|Lost to Follow-up|1
378720|NCT00885703|1273406|P2|Overall Study|Lost to Follow-up|0
378721|NCT00885703|1273407|P1|Overall Study|Lost to Follow-up|0
378722|NCT00885703|1273401|P7|Overall Study|Death|4
378723|NCT00885703|1273402|P6|Overall Study|Death|8
378724|NCT00885703|1273403|P5|Overall Study|Death|7
378725|NCT00885703|1273404|P4|Overall Study|Death|7
378726|NCT00885703|1273405|P3|Overall Study|Death|8
378727|NCT00885703|1273406|P2|Overall Study|Death|7
378728|NCT00885703|1273407|P1|Overall Study|Death|9
378729|NCT00885677|1273465|P2|Overall Study|Inclusion/exclusion not met|27
378730|NCT00885677|1273466|P1|Overall Study|Inclusion/exclusion not met|25
378731|NCT00885677|1273465|P2|Overall Study|Heart transplantation|0
378732|NCT00885677|1273466|P1|Overall Study|Heart transplantation|1
378733|NCT00885677|1273465|P2|Overall Study|device/lead revision or replacement|6
378734|NCT00885677|1273466|P1|Overall Study|device/lead revision or replacement|7
378735|NCT00885677|1273465|P2|Overall Study|premature study closure|44
378736|NCT00885677|1273466|P1|Overall Study|premature study closure|41
378737|NCT00885677|1273465|P2|Overall Study|Protocol Violation|54
378738|NCT00885677|1273466|P1|Overall Study|Protocol Violation|54
378739|NCT00885677|1273465|P2|Overall Study|Lost to Follow-up|13
378740|NCT00885677|1273466|P1|Overall Study|Lost to Follow-up|15
378741|NCT00885677|1273465|P2|Overall Study|Death|34
378742|NCT00885677|1273466|P1|Overall Study|Death|40
378743|NCT00885534|1273482|P1|Overall Study|Patient deemed ineligible|1
378744|NCT00885482|1273486|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
378745|NCT00885482|1273486|P1|Overall Study|Death|1
378746|NCT00885482|1273486|P1|Overall Study|Lack of Efficacy|1
378747|NCT00885482|1273486|P1|Overall Study|Pregnancy|1
378748|NCT00885378|1273492|P2|Overall Study|Protocol Violation|0
378749|NCT00885378|1273493|P1|Overall Study|Protocol Violation|2
378750|NCT00885378|1273492|P2|Overall Study|Poor/Noncompliance|2
378751|NCT00885378|1273493|P1|Overall Study|Poor/Noncompliance|2
378752|NCT00885378|1273492|P2|Overall Study|Lost to Follow-up|2
378753|NCT00885378|1273493|P1|Overall Study|Lost to Follow-up|1
378754|NCT00885378|1273492|P2|Overall Study|Withdrawal by Subject|2
378755|NCT00885378|1273493|P1|Overall Study|Withdrawal by Subject|1
378756|NCT00885378|1273492|P2|Overall Study|Lack of Efficacy|2
378757|NCT00885378|1273493|P1|Overall Study|Lack of Efficacy|2
378758|NCT00885365|1273523|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
378759|NCT00885365|1273524|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
378760|NCT00885365|1273523|P2|4 Weeks ON Treatment|Protocol Violation|2
378761|NCT00885365|1273524|P1|4 Weeks ON Treatment|Protocol Violation|1
378762|NCT00885365|1273523|P2|4 Weeks ON Treatment|Adverse Event|4
378763|NCT00885365|1273524|P1|4 Weeks ON Treatment|Adverse Event|2
378764|NCT00885352|1273560|P2|Overall Study|Lab abnormalities|1
378765|NCT00885352|1273561|P1|Overall Study|Lab abnormalities|1
378766|NCT00885352|1273560|P2|Overall Study|Excluded medication|2
378767|NCT00885352|1273561|P1|Overall Study|Excluded medication|2
378768|NCT00885352|1273560|P2|Overall Study|Contradiction to study medication|2
378769|NCT00885352|1273561|P1|Overall Study|Contradiction to study medication|0
378770|NCT00885352|1273560|P2|Overall Study|Withdrawal by Subject|5
378771|NCT00885352|1273561|P1|Overall Study|Withdrawal by Subject|1
378772|NCT00885352|1273560|P2|Overall Study|Protocol Violation|2
378773|NCT00885352|1273561|P1|Overall Study|Protocol Violation|0
378774|NCT00885352|1273560|P2|Overall Study|Physician Decision|3
378775|NCT00885352|1273561|P1|Overall Study|Physician Decision|0
378776|NCT00885352|1273560|P2|Overall Study|Lost to Follow-up|2
378777|NCT00885352|1273561|P1|Overall Study|Lost to Follow-up|2
378778|NCT00885352|1273560|P2|Overall Study|Adverse Event|3
378779|NCT00885352|1273561|P1|Overall Study|Adverse Event|2
378780|NCT00885170|1273573|P2|Overall Study|Withdrawal by Subject|13
378781|NCT00885170|1273574|P1|Overall Study|Withdrawal by Subject|13
378782|NCT00885170|1273573|P2|Overall Study|Protocol Violation|1
378783|NCT00885170|1273574|P1|Overall Study|Protocol Violation|3
378784|NCT00885170|1273573|P2|Overall Study|Physician Decision|1
378785|NCT00885170|1273574|P1|Overall Study|Physician Decision|2
378786|NCT00885170|1273573|P2|Overall Study|Lost to Follow-up|1
378787|NCT00885170|1273574|P1|Overall Study|Lost to Follow-up|2
378788|NCT00885170|1273573|P2|Overall Study|Excessive bone loss|3
378789|NCT00885170|1273574|P1|Overall Study|Excessive bone loss|6
378790|NCT00885170|1273573|P2|Overall Study|Adverse Event|4
378791|NCT00885170|1273574|P1|Overall Study|Adverse Event|12
378792|NCT00885118|1273633|P5|Overall Study|Other reason not defined above|0
378793|NCT00885118|1273634|P4|Overall Study|Other reason not defined above|0
378794|NCT00885118|1273635|P3|Overall Study|Other reason not defined above|1
378795|NCT00885118|1273636|P2|Overall Study|Other reason not defined above|0
378796|NCT00885118|1273637|P1|Overall Study|Other reason not defined above|0
378797|NCT00885118|1273633|P5|Overall Study|Withdrawal by Subject|1
378798|NCT00885118|1273634|P4|Overall Study|Withdrawal by Subject|0
378799|NCT00885118|1273635|P3|Overall Study|Withdrawal by Subject|0
378800|NCT00885118|1273636|P2|Overall Study|Withdrawal by Subject|0
378801|NCT00885118|1273637|P1|Overall Study|Withdrawal by Subject|0
378802|NCT00885118|1273633|P5|Overall Study|Adverse Event|0
378803|NCT00885118|1273634|P4|Overall Study|Adverse Event|0
378804|NCT00885118|1273635|P3|Overall Study|Adverse Event|0
378805|NCT00885118|1273636|P2|Overall Study|Adverse Event|0
378806|NCT00885118|1273637|P1|Overall Study|Adverse Event|1
378807|NCT00885105|1273776|P2|Overall Study|Protocol Violation|2
378808|NCT00885105|1273777|P1|Overall Study|Protocol Violation|0
378809|NCT00885105|1273776|P2|Overall Study|Adverse Event|0
378810|NCT00885105|1273777|P1|Overall Study|Adverse Event|1
378811|NCT00885105|1273776|P2|Overall Study|Withdrawal by Subject|8
378812|NCT00885105|1273777|P1|Overall Study|Withdrawal by Subject|0
378813|NCT00884949|1273817|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
378814|NCT00884949|1273817|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
378815|NCT00884832|1273852|P2|Overall Study|Withdrawal by Subject|1
378816|NCT00884832|1273853|P1|Overall Study|Withdrawal by Subject|0
378817|NCT00884793|1273888|P1|Overall Study|Withdrawal by Subject|1
378818|NCT00884741|1273907|P4|Randomization|Protocol Violation|8
378819|NCT00884741|1273908|P3|Randomization|Protocol Violation|8
378820|NCT00884741|1273909|P2|Randomization|Protocol Violation|0
378821|NCT00884741|1273910|P1|Randomization|Protocol Violation|0
378822|NCT00884741|1273907|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
378823|NCT00884741|1273908|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
378824|NCT00884741|1273909|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
378825|NCT00884741|1273910|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
378826|NCT00884741|1273907|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
378827|NCT00884741|1273908|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
378828|NCT00884741|1273909|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
378829|NCT00884741|1273910|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
378830|NCT00884741|1273907|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
378831|NCT00884741|1273908|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
378832|NCT00884741|1273909|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
378833|NCT00884741|1273910|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
378834|NCT00884741|1273907|P4|Step 2 Registration: Tissue Analysis|Death|0
378835|NCT00884741|1273908|P3|Step 2 Registration: Tissue Analysis|Death|0
378836|NCT00884741|1273909|P2|Step 2 Registration: Tissue Analysis|Death|1
378837|NCT00884741|1273910|P1|Step 2 Registration: Tissue Analysis|Death|0
378838|NCT00884741|1273907|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
378839|NCT00884741|1273908|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
378840|NCT00884741|1273909|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
378841|NCT00884741|1273910|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
378842|NCT00884741|1273907|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
378843|NCT00884741|1273908|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
378844|NCT00884741|1273909|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
378845|NCT00884741|1273910|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
378846|NCT00884741|1273907|P4|Step 1 Registration: Tissue Screening|Disease progression|0
378847|NCT00884741|1273908|P3|Step 1 Registration: Tissue Screening|Disease progression|0
378848|NCT00884741|1273909|P2|Step 1 Registration: Tissue Screening|Disease progression|0
378849|NCT00884741|1273910|P1|Step 1 Registration: Tissue Screening|Disease progression|12
378850|NCT00884741|1273907|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
378851|NCT00884741|1273908|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
378852|NCT00884741|1273909|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
378853|NCT00884741|1273910|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
378854|NCT00884741|1273907|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
378855|NCT00884741|1273908|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
378856|NCT00884741|1273909|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
378857|NCT00884741|1273910|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
378858|NCT00884741|1273907|P4|Step 1 Registration: Tissue Screening|Death|0
378859|NCT00884741|1273908|P3|Step 1 Registration: Tissue Screening|Death|0
378860|NCT00884741|1273909|P2|Step 1 Registration: Tissue Screening|Death|0
378861|NCT00884741|1273910|P1|Step 1 Registration: Tissue Screening|Death|3
378862|NCT00884741|1273907|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
378863|NCT00884741|1273908|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
378864|NCT00884741|1273909|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
378865|NCT00884741|1273910|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
378866|NCT00884390|1273960|P2|Overall Study|Not specified|1
378867|NCT00884390|1273961|P1|Overall Study|Not specified|11
378868|NCT00884390|1273960|P2|Overall Study|Discontinuation of Study by Sponsor|2
378869|NCT00884390|1273961|P1|Overall Study|Discontinuation of Study by Sponsor|2
378870|NCT00884390|1273960|P2|Overall Study|Withdrawal by Subject|1
378871|NCT00884390|1273961|P1|Overall Study|Withdrawal by Subject|4
378872|NCT00884390|1273960|P2|Overall Study|Protocol Violation|1
378873|NCT00884390|1273961|P1|Overall Study|Protocol Violation|4
378874|NCT00884390|1273960|P2|Overall Study|Physician Decision|1
378875|NCT00884390|1273961|P1|Overall Study|Physician Decision|2
378876|NCT00884390|1273960|P2|Overall Study|Lost to Follow-up|1
378877|NCT00884390|1273961|P1|Overall Study|Lost to Follow-up|0
378878|NCT00884390|1273960|P2|Overall Study|Adverse Event|1
378879|NCT00884390|1273961|P1|Overall Study|Adverse Event|0
378880|NCT00884377|1273979|P2|Overall Study|Physician Decision|1
378881|NCT00884377|1273980|P1|Overall Study|Physician Decision|0
378882|NCT00884377|1273979|P2|Overall Study|Could not confirm diagnosis|0
378883|NCT00884377|1273980|P1|Overall Study|Could not confirm diagnosis|1
378884|NCT00884377|1273979|P2|Overall Study|Withdrawal by Subject|0
378885|NCT00884377|1273980|P1|Overall Study|Withdrawal by Subject|1
378886|NCT00884325|1274002|P2|Overall Study|Not provided|0
378887|NCT00884325|1274003|P1|Overall Study|Not provided|1
378888|NCT00884325|1274002|P2|Overall Study|Withdrawal by Subject|1
378889|NCT00884325|1274003|P1|Overall Study|Withdrawal by Subject|1
378890|NCT00884325|1274002|P2|Overall Study|Lack of Efficacy|1
378891|NCT00884325|1274003|P1|Overall Study|Lack of Efficacy|0
378892|NCT00884325|1274002|P2|Overall Study|Lost to Follow-up|2
378893|NCT00884325|1274003|P1|Overall Study|Lost to Follow-up|1
378894|NCT00884312|1274013|P2|Overall Study|Did Not Receive Study Drug|1
378895|NCT00884312|1274014|P1|Overall Study|Did Not Receive Study Drug|0
378896|NCT00884312|1274013|P2|Overall Study|Other|4
378897|NCT00884312|1274014|P1|Overall Study|Other|0
378898|NCT00884312|1274013|P2|Overall Study|Physician Decision|1
378899|NCT00884312|1274014|P1|Overall Study|Physician Decision|0
378900|NCT00884312|1274013|P2|Overall Study|Withdrawal by Subject|6
378901|NCT00884312|1274014|P1|Overall Study|Withdrawal by Subject|0
378902|NCT00884312|1274013|P2|Overall Study|Fatal Adverse Event|4
378903|NCT00884312|1274014|P1|Overall Study|Fatal Adverse Event|1
378904|NCT00884312|1274013|P2|Overall Study|Non-fatal Adverse Event|0
378905|NCT00884312|1274014|P1|Overall Study|Non-fatal Adverse Event|1
378906|NCT00884312|1274013|P2|Overall Study|Fatal Progressive Disease|1
378907|NCT00884312|1274014|P1|Overall Study|Fatal Progressive Disease|0
378908|NCT00884312|1274013|P2|Overall Study|Non-fatal Progressive Disease|8
378909|NCT00884312|1274014|P1|Overall Study|Non-fatal Progressive Disease|0
378910|NCT00884286|1274030|P2|Overall Study|Comprised lung carcinoma|1
378911|NCT00884286|1274031|P1|Overall Study|Comprised lung carcinoma|0
378912|NCT00884286|1274030|P2|Overall Study|Not treated|1
378913|NCT00884286|1274031|P1|Overall Study|Not treated|2
378914|NCT00884286|1274030|P2|Overall Study|Thrombus in right auricle|0
378915|NCT00884286|1274031|P1|Overall Study|Thrombus in right auricle|1
378916|NCT00884286|1274030|P2|Overall Study|Septic shock|0
378917|NCT00884286|1274031|P1|Overall Study|Septic shock|1
378918|NCT00884286|1274030|P2|Overall Study|Physician Decision|0
378919|NCT00884286|1274031|P1|Overall Study|Physician Decision|1
378920|NCT00884286|1274030|P2|Overall Study|Death|2
378921|NCT00884286|1274031|P1|Overall Study|Death|2
378922|NCT00884286|1274030|P2|Overall Study|Toxicity|1
378923|NCT00884286|1274031|P1|Overall Study|Toxicity|4
378924|NCT00884286|1274030|P2|Overall Study|Progressive disease|28
378925|NCT00884286|1274031|P1|Overall Study|Progressive disease|21
378926|NCT00884273|1274045|P2|Overall Study|Practical reasons|0
378927|NCT00884273|1274046|P1|Overall Study|Practical reasons|1
378928|NCT00884273|1274045|P2|Overall Study|Protocol Violation|3
378929|NCT00884273|1274046|P1|Overall Study|Protocol Violation|1
378930|NCT00884273|1274045|P2|Overall Study|Adverse Event|2
378931|NCT00884273|1274046|P1|Overall Study|Adverse Event|0
378932|NCT00884221|1274072|P2|Overall Study|Cancellation of Cycle and Other Reason|13
378933|NCT00884221|1274073|P1|Overall Study|Cancellation of Cycle and Other Reason|12
378934|NCT00884221|1274072|P2|Overall Study|Protocol Violation|13
378935|NCT00884221|1274073|P1|Overall Study|Protocol Violation|16
378936|NCT00884221|1274072|P2|Overall Study|Adverse Event|3
378937|NCT00884221|1274073|P1|Overall Study|Adverse Event|6
378938|NCT00884221|1274072|P2|Overall Study|Withdrawal by Subject|3
378939|NCT00884221|1274073|P1|Overall Study|Withdrawal by Subject|0
378940|NCT00884117|1274109|P1|Overall Study|Not Specified|12
378941|NCT00884117|1274109|P1|Overall Study|Lost to Follow-up|143
378942|NCT00884117|1274109|P1|Overall Study|Death|3
378943|NCT00884117|1274109|P1|Overall Study|Withdrawal by Subject|89
378944|NCT00884117|1274109|P1|Overall Study|Adverse Event|2
378945|NCT00884039|1274172|P2|Overall Study|Lack of Efficacy|0
378946|NCT00884039|1274173|P1|Overall Study|Lack of Efficacy|2
378947|NCT00884039|1274172|P2|Overall Study|Withdrawal by Subject|1
378948|NCT00884039|1274173|P1|Overall Study|Withdrawal by Subject|0
378949|NCT00883779|1274181|P2|Off-study Phase|Other|21
378950|NCT00883779|1274182|P1|Off-study Phase|Other|18
378951|NCT00883779|1274181|P2|Off-study Phase|Failure to return|6
378952|NCT00883779|1274182|P1|Off-study Phase|Failure to return|5
378953|NCT00883779|1274181|P2|Off-study Phase|Refused treatment|1
378954|NCT00883779|1274182|P1|Off-study Phase|Refused treatment|1
378955|NCT00883779|1274181|P2|Off-study Phase|Death|174
378956|NCT00883779|1274182|P1|Off-study Phase|Death|185
378957|NCT00883779|1274181|P2|Post-Study Treatment Phase|Ongoing in the study|6
378958|NCT00883779|1274182|P1|Post-Study Treatment Phase|Ongoing in the study|0
378959|NCT00883779|1274181|P2|Post-Study Treatment Phase|Other|0
378960|NCT00883779|1274182|P1|Post-Study Treatment Phase|Other|3
378961|NCT00883779|1274181|P2|Post-Study Treatment Phase|Disease progression|122
378962|NCT00883779|1274182|P1|Post-Study Treatment Phase|Disease progression|103
378963|NCT00883779|1274181|P2|Post-Study Treatment Phase|Refused Treatment|0
378964|NCT00883779|1274182|P1|Post-Study Treatment Phase|Refused Treatment|3
378965|NCT00883779|1274181|P2|Post-Study Treatment Phase|Protocol Violation|1
378966|NCT00883779|1274182|P1|Post-Study Treatment Phase|Protocol Violation|0
378967|NCT00883779|1274181|P2|Post-Study Treatment Phase|Death|3
378968|NCT00883779|1274182|P1|Post-Study Treatment Phase|Death|1
378969|NCT00883779|1274181|P2|Post-Study Treatment Phase|Adverse Event|3
378970|NCT00883779|1274182|P1|Post-Study Treatment Phase|Adverse Event|2
378971|NCT00883779|1274181|P2|Primary Study Treatment Phase|Other|0
378972|NCT00883779|1274182|P1|Primary Study Treatment Phase|Other|3
378973|NCT00883779|1274181|P2|Primary Study Treatment Phase|Refused Treatment|4
378974|NCT00883779|1274182|P1|Primary Study Treatment Phase|Refused Treatment|5
378975|NCT00883779|1274181|P2|Primary Study Treatment Phase|Death|3
378976|NCT00883779|1274182|P1|Primary Study Treatment Phase|Death|2
378977|NCT00883779|1274181|P2|Primary Study Treatment Phase|Adverse Event|16
378978|NCT00883779|1274182|P1|Primary Study Treatment Phase|Adverse Event|16
378979|NCT00883779|1274181|P2|Primary Study Treatment Phase|Disease progression|59
378980|NCT00883779|1274182|P1|Primary Study Treatment Phase|Disease progression|75
378981|NCT00883779|1274181|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
378982|NCT00883779|1274182|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
378983|NCT00883753|1274218|P1|Overall Study|Administrative/Other|8
378984|NCT00883753|1274218|P1|Overall Study|Investigator's decision|17
378985|NCT00883753|1274218|P1|Overall Study|Withdrew consent|10
378986|NCT00883753|1274218|P1|Overall Study|Refused treatment|4
378987|NCT00883753|1274218|P1|Overall Study|Protocol Violation|2
378988|NCT00883753|1274218|P1|Overall Study|Violation of selection criteria at entry|7
378989|NCT00883753|1274218|P1|Overall Study|Lost to Follow-up|4
378990|NCT00883753|1274218|P1|Overall Study|Insufficient therapeutic response|16
378991|NCT00883753|1274218|P1|Overall Study|Death|2
378992|NCT00883753|1274218|P1|Overall Study|Adverse Event|37
378993|NCT00883740|1274258|P2|Second Intervention|No longer willing to participate|1
378994|NCT00883740|1274259|P1|Second Intervention|No longer willing to participate|0
378995|NCT00883740|1274258|P2|Second Intervention|Protocol Violation|0
378996|NCT00883740|1274259|P1|Second Intervention|Protocol Violation|1
378997|NCT00883740|1274258|P2|First Intervention|Adverse Event|2
378998|NCT00883740|1274259|P1|First Intervention|Adverse Event|1
378999|NCT00883740|1274258|P2|First Intervention|Protocol Violation|6
379000|NCT00883740|1274259|P1|First Intervention|Protocol Violation|3
379001|NCT00883740|1274258|P2|First Intervention|No longer willing to participate|0
379002|NCT00883740|1274259|P1|First Intervention|No longer willing to participate|2
379003|NCT00883740|1274258|P2|First Intervention|Lost to Follow-up|0
379004|NCT00883740|1274259|P1|First Intervention|Lost to Follow-up|1
379005|NCT00883558|1274303|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
379006|NCT00883558|1274304|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
379007|NCT00883558|1274305|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
379008|NCT00883558|1274303|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
379009|NCT00883558|1274304|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
379010|NCT00883558|1274305|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
379011|NCT00883558|1274303|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
379012|NCT00883558|1274304|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
379013|NCT00883558|1274305|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
379014|NCT00883558|1274303|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
379015|NCT00883558|1274304|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
379016|NCT00883558|1274305|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
379017|NCT00883558|1274303|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
379018|NCT00883558|1274304|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
379019|NCT00883558|1274305|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
379020|NCT00883493|1274317|P2|Overall Study|Not specified|3
379021|NCT00883493|1274318|P1|Overall Study|Not specified|5
379022|NCT00883493|1274317|P2|Overall Study|Study specific disc. criteria|0
379023|NCT00883493|1274318|P1|Overall Study|Study specific disc. criteria|2
379024|NCT00883493|1274317|P2|Overall Study|Eligibility Criteria not fullfilled|6
379025|NCT00883493|1274318|P1|Overall Study|Eligibility Criteria not fullfilled|6
379026|NCT00883493|1274317|P2|Overall Study|Withdrawal by Subject|20
379027|NCT00883493|1274318|P1|Overall Study|Withdrawal by Subject|11
379028|NCT00883493|1274317|P2|Overall Study|Lost to Follow-up|6
379029|NCT00883493|1274318|P1|Overall Study|Lost to Follow-up|7
379030|NCT00883493|1274317|P2|Overall Study|Lack of Efficacy|3
379031|NCT00883493|1274318|P1|Overall Study|Lack of Efficacy|4
379032|NCT00883493|1274317|P2|Overall Study|Adverse Event|12
379033|NCT00883493|1274318|P1|Overall Study|Adverse Event|11
379034|NCT00883337|1274349|P3|Extension Treatment Period|Other than above|5
379035|NCT00883337|1274350|P2|Extension Treatment Period|Other than above|9
379036|NCT00883337|1274351|P1|Extension Treatment Period|Other than above|10
379037|NCT00883337|1274349|P3|Extension Treatment Period|Lost to Follow-up|0
379038|NCT00883337|1274350|P2|Extension Treatment Period|Lost to Follow-up|0
379039|NCT00883337|1274351|P1|Extension Treatment Period|Lost to Follow-up|1
379040|NCT00883337|1274349|P3|Extension Treatment Period|Poor compliance to protocol|1
379041|NCT00883337|1274350|P2|Extension Treatment Period|Poor compliance to protocol|1
379042|NCT00883337|1274351|P1|Extension Treatment Period|Poor compliance to protocol|1
379043|NCT00883337|1274349|P3|Extension Treatment Period|Lack of Efficacy|8
379044|NCT00883337|1274350|P2|Extension Treatment Period|Lack of Efficacy|8
379045|NCT00883337|1274351|P1|Extension Treatment Period|Lack of Efficacy|8
379046|NCT00883337|1274349|P3|Extension Treatment Period|Adverse Event|5
379047|NCT00883337|1274350|P2|Extension Treatment Period|Adverse Event|5
379048|NCT00883337|1274351|P1|Extension Treatment Period|Adverse Event|8
379049|NCT00883337|1274349|P3|Core Treatment Period|Other than above|1
379050|NCT00883337|1274350|P2|Core Treatment Period|Other than above|1
379051|NCT00883337|1274351|P1|Core Treatment Period|Other than above|0
379052|NCT00883337|1274349|P3|Core Treatment Period|Poor compliance to protocol|1
379053|NCT00883337|1274350|P2|Core Treatment Period|Poor compliance to protocol|0
379054|NCT00883337|1274351|P1|Core Treatment Period|Poor compliance to protocol|0
379055|NCT00883337|1274349|P3|Core Treatment Period|Wish to be pregnant|1
379056|NCT00883337|1274350|P2|Core Treatment Period|Wish to be pregnant|2
379057|NCT00883337|1274351|P1|Core Treatment Period|Wish to be pregnant|1
379058|NCT00883337|1274349|P3|Core Treatment Period|Withdrawal by Subject|6
379059|NCT00883337|1274350|P2|Core Treatment Period|Withdrawal by Subject|2
379060|NCT00883337|1274351|P1|Core Treatment Period|Withdrawal by Subject|2
379061|NCT00883337|1274349|P3|Core Treatment Period|Lost to Follow-up|0
379062|NCT00883337|1274350|P2|Core Treatment Period|Lost to Follow-up|1
379063|NCT00883337|1274351|P1|Core Treatment Period|Lost to Follow-up|1
379064|NCT00883337|1274349|P3|Core Treatment Period|Lack of Efficacy|2
379065|NCT00883337|1274350|P2|Core Treatment Period|Lack of Efficacy|4
379066|NCT00883337|1274351|P1|Core Treatment Period|Lack of Efficacy|7
379067|NCT00883337|1274349|P3|Core Treatment Period|Adverse Event|22
379068|NCT00883337|1274350|P2|Core Treatment Period|Adverse Event|12
379069|NCT00883337|1274351|P1|Core Treatment Period|Adverse Event|9
379070|NCT00883181|1274418|P1|Overall Study|Noncompliance|3
379071|NCT00883181|1274418|P1|Overall Study|Protocol Deviation|3
379072|NCT00883181|1274418|P1|Overall Study|Other|38
379073|NCT00883181|1274418|P1|Overall Study|Death|31
379074|NCT00883181|1274418|P1|Overall Study|Withdrawal by Subject|4
379075|NCT00883181|1274418|P1|Overall Study|Administrative Reason|24
379076|NCT00883181|1274418|P1|Overall Study|Disease Progression|94
379077|NCT00883181|1274418|P1|Overall Study|Non-hematological Adverse Event|55
379078|NCT00883181|1274418|P1|Overall Study|Hematological Adverse Event|26
379079|NCT00883129|1274654|P2|Overall Study|Defined Treatment Failure|2
379080|NCT00883129|1274655|P1|Overall Study|Defined Treatment Failure|0
379081|NCT00883129|1274654|P2|Overall Study|Death|2
379082|NCT00883129|1274655|P1|Overall Study|Death|1
379083|NCT00883129|1274654|P2|Overall Study|Lost to Follow-up|2
379084|NCT00883129|1274655|P1|Overall Study|Lost to Follow-up|1
379085|NCT00883129|1274654|P2|Overall Study|Non-compliance|6
379086|NCT00883129|1274655|P1|Overall Study|Non-compliance|3
379087|NCT00883129|1274654|P2|Overall Study|Withdrawal by Subject|9
379088|NCT00883129|1274655|P1|Overall Study|Withdrawal by Subject|8
379089|NCT00883129|1274654|P2|Overall Study|Adverse Event|15
379090|NCT00883129|1274655|P1|Overall Study|Adverse Event|7
379091|NCT00883116|1274679|P2|Overall Study|No longer meets study criteria|2
379092|NCT00883116|1274680|P1|Overall Study|No longer meets study criteria|2
379093|NCT00883116|1274679|P2|Overall Study|Withdrawal by Subject|8
379094|NCT00883116|1274680|P1|Overall Study|Withdrawal by Subject|14
379095|NCT00883116|1274679|P2|Overall Study|Study drug toxicity|16
379096|NCT00883116|1274680|P1|Overall Study|Study drug toxicity|36
379097|NCT00883116|1274679|P2|Overall Study|Not identified|6
379098|NCT00883116|1274680|P1|Overall Study|Not identified|3
379099|NCT00883116|1274679|P2|Overall Study|Maximum clinical benefit|46
379100|NCT00883116|1274680|P1|Overall Study|Maximum clinical benefit|13
379101|NCT00883116|1274679|P2|Overall Study|Lost to Follow-up|1
379102|NCT00883116|1274680|P1|Overall Study|Lost to Follow-up|0
379103|NCT00883116|1274679|P2|Overall Study|Disease progression|128
379104|NCT00883116|1274680|P1|Overall Study|Disease progression|130
379105|NCT00883116|1274679|P2|Overall Study|Death|2
379106|NCT00883116|1274680|P1|Overall Study|Death|6
379107|NCT00883116|1274679|P2|Overall Study|Adverse event unrelated to study drug|10
379108|NCT00883116|1274680|P1|Overall Study|Adverse event unrelated to study drug|5
379109|NCT00883090|1274702|P1|Overall Study|Withdrawal by Subject|1
379110|NCT00883090|1274702|P1|Overall Study|Sponsor's decision|1
379111|NCT00882921|1274717|P1|Overall Study|Withdrawal Of Consent|1
379112|NCT00882921|1274717|P1|Overall Study|Termination By Investigator|3
379113|NCT00882921|1274717|P1|Overall Study|Lost to Follow-up|2
379114|NCT00882921|1274717|P1|Overall Study|Not specified|3
379115|NCT00882921|1274717|P1|Overall Study|Death|2
379116|NCT00882908|1274727|P5|Overall Study|Study terminated in error|0
379117|NCT00882908|1274728|P4|Overall Study|Study terminated in error|1
379118|NCT00882908|1274729|P3|Overall Study|Study terminated in error|0
379119|NCT00882908|1274730|P2|Overall Study|Study terminated in error|0
379120|NCT00882908|1274731|P1|Overall Study|Study terminated in error|0
379121|NCT00882908|1274727|P5|Overall Study|Subject reached a virologic endpoint|1
379122|NCT00882908|1274728|P4|Overall Study|Subject reached a virologic endpoint|0
379123|NCT00882908|1274729|P3|Overall Study|Subject reached a virologic endpoint|0
379124|NCT00882908|1274730|P2|Overall Study|Subject reached a virologic endpoint|0
379125|NCT00882908|1274731|P1|Overall Study|Subject reached a virologic endpoint|0
379126|NCT00882908|1274727|P5|Overall Study|Withdrawal by Subject|2
379127|NCT00882908|1274728|P4|Overall Study|Withdrawal by Subject|5
379128|NCT00882908|1274729|P3|Overall Study|Withdrawal by Subject|3
379129|NCT00882908|1274730|P2|Overall Study|Withdrawal by Subject|0
379130|NCT00882908|1274731|P1|Overall Study|Withdrawal by Subject|0
379131|NCT00882908|1274727|P5|Overall Study|Protocol Violation|0
379132|NCT00882908|1274728|P4|Overall Study|Protocol Violation|0
379133|NCT00882908|1274729|P3|Overall Study|Protocol Violation|0
379134|NCT00882908|1274730|P2|Overall Study|Protocol Violation|1
379135|NCT00882908|1274731|P1|Overall Study|Protocol Violation|0
379136|NCT00882908|1274727|P5|Overall Study|Lost to Follow-up|2
379137|NCT00882908|1274728|P4|Overall Study|Lost to Follow-up|1
379138|NCT00882908|1274729|P3|Overall Study|Lost to Follow-up|3
379139|NCT00882908|1274730|P2|Overall Study|Lost to Follow-up|5
379140|NCT00882908|1274731|P1|Overall Study|Lost to Follow-up|3
379141|NCT00882908|1274727|P5|Overall Study|Adverse Event|1
379142|NCT00882908|1274728|P4|Overall Study|Adverse Event|0
379143|NCT00882908|1274729|P3|Overall Study|Adverse Event|1
379144|NCT00882908|1274730|P2|Overall Study|Adverse Event|0
379145|NCT00882908|1274731|P1|Overall Study|Adverse Event|0
379146|NCT00882713|1274837|P1|Overall Study|Other - Reasons|2
379147|NCT00882713|1274837|P1|Overall Study|Failure to return|2
379148|NCT00882713|1274837|P1|Overall Study|Insufficient therapeutic response|3
379149|NCT00882713|1274837|P1|Overall Study|Blood transfusion|2
379150|NCT00882713|1274837|P1|Overall Study|refused treatment/withdrew consent|4
379151|NCT00882713|1274837|P1|Overall Study|Administrative reasons|4
379152|NCT00882713|1274837|P1|Overall Study|Death|3
379153|NCT00882713|1274837|P1|Overall Study|Adverse Event|2
379154|NCT00882583|1274930|P2|Overall Study|Adverse Event|1
379155|NCT00882583|1274931|P1|Overall Study|Adverse Event|0
379156|NCT00882583|1274930|P2|Overall Study|Physician Decision|0
379157|NCT00882583|1274931|P1|Overall Study|Physician Decision|1
379158|NCT00882557|1274939|P2|Overall Study|Randomized Not Treated|1
379159|NCT00882557|1274940|P1|Overall Study|Randomized Not Treated|0
379160|NCT00882557|1274939|P2|Overall Study|Trouble with Vein Access|0
379161|NCT00882557|1274940|P1|Overall Study|Trouble with Vein Access|1
379162|NCT00882557|1274939|P2|Overall Study|Withdrawal by Subject|0
379163|NCT00882557|1274940|P1|Overall Study|Withdrawal by Subject|1
379164|NCT00882518|1274960|P2|Overall Study|Allocating random number by mistake|1
379165|NCT00882518|1274961|P1|Overall Study|Allocating random number by mistake|0
379166|NCT00882518|1274960|P2|Overall Study|Central lab closure for National day|0
379167|NCT00882518|1274961|P1|Overall Study|Central lab closure for National day|1
379168|NCT00882518|1274960|P2|Overall Study|Incorrect enrolment|2
379169|NCT00882518|1274961|P1|Overall Study|Incorrect enrolment|4
379170|NCT00882518|1274960|P2|Overall Study|Severe non-compliance to protocol|1
379171|NCT00882518|1274961|P1|Overall Study|Severe non-compliance to protocol|3
379172|NCT00882518|1274960|P2|Overall Study|Lack of Efficacy|9
379173|NCT00882518|1274961|P1|Overall Study|Lack of Efficacy|12
379174|NCT00882518|1274960|P2|Overall Study|Withdrawal by Subject|13
379175|NCT00882518|1274961|P1|Overall Study|Withdrawal by Subject|9
379176|NCT00882518|1274960|P2|Overall Study|Adverse Event|18
379177|NCT00882518|1274961|P1|Overall Study|Adverse Event|9
379178|NCT00882440|1274990|P7|Overall Study|Patient Uncooperative|0
379179|NCT00882440|1274991|P6|Overall Study|Patient Uncooperative|0
379180|NCT00882440|1274992|P5|Overall Study|Patient Uncooperative|1
379181|NCT00882440|1274993|P4|Overall Study|Patient Uncooperative|0
379182|NCT00882440|1274994|P3|Overall Study|Patient Uncooperative|0
379183|NCT00882440|1274995|P2|Overall Study|Patient Uncooperative|0
379184|NCT00882440|1274996|P1|Overall Study|Patient Uncooperative|2
379185|NCT00882440|1274990|P7|Overall Study|Withdrawal by Subject|1
379186|NCT00882440|1274991|P6|Overall Study|Withdrawal by Subject|0
379187|NCT00882440|1274992|P5|Overall Study|Withdrawal by Subject|6
379188|NCT00882440|1274993|P4|Overall Study|Withdrawal by Subject|0
379189|NCT00882440|1274994|P3|Overall Study|Withdrawal by Subject|1
379190|NCT00882440|1274995|P2|Overall Study|Withdrawal by Subject|1
379191|NCT00882440|1274996|P1|Overall Study|Withdrawal by Subject|2
379192|NCT00882440|1274990|P7|Overall Study|Protocol Violation|0
379193|NCT00882440|1274991|P6|Overall Study|Protocol Violation|0
379194|NCT00882440|1274992|P5|Overall Study|Protocol Violation|1
379195|NCT00882440|1274993|P4|Overall Study|Protocol Violation|1
379196|NCT00882440|1274994|P3|Overall Study|Protocol Violation|1
379197|NCT00882440|1274995|P2|Overall Study|Protocol Violation|0
379198|NCT00882440|1274996|P1|Overall Study|Protocol Violation|0
379199|NCT00882440|1274990|P7|Overall Study|Lost to Follow-up|1
379200|NCT00882440|1274991|P6|Overall Study|Lost to Follow-up|0
379201|NCT00882440|1274992|P5|Overall Study|Lost to Follow-up|1
379202|NCT00882440|1274993|P4|Overall Study|Lost to Follow-up|1
379203|NCT00882440|1274994|P3|Overall Study|Lost to Follow-up|1
379204|NCT00882440|1274995|P2|Overall Study|Lost to Follow-up|0
379205|NCT00882440|1274996|P1|Overall Study|Lost to Follow-up|2
379206|NCT00882440|1274990|P7|Overall Study|Lack of Efficacy|0
379207|NCT00882440|1274991|P6|Overall Study|Lack of Efficacy|3
379208|NCT00882440|1274992|P5|Overall Study|Lack of Efficacy|0
379209|NCT00882440|1274993|P4|Overall Study|Lack of Efficacy|0
379210|NCT00882440|1274994|P3|Overall Study|Lack of Efficacy|2
379211|NCT00882440|1274995|P2|Overall Study|Lack of Efficacy|5
379212|NCT00882440|1274996|P1|Overall Study|Lack of Efficacy|3
379213|NCT00882440|1274990|P7|Overall Study|Adverse Event|2
379214|NCT00882440|1274991|P6|Overall Study|Adverse Event|4
379215|NCT00882440|1274992|P5|Overall Study|Adverse Event|1
379216|NCT00882440|1274993|P4|Overall Study|Adverse Event|1
379217|NCT00882440|1274994|P3|Overall Study|Adverse Event|2
379218|NCT00882440|1274995|P2|Overall Study|Adverse Event|2
379219|NCT00882440|1274996|P1|Overall Study|Adverse Event|2
379220|NCT00882362|1275021|P2|Overall Study|change of residence or other commitments|0
379221|NCT00882362|1275022|P1|Overall Study|change of residence or other commitments|5
379222|NCT00882362|1275021|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
379223|NCT00882362|1275022|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
379224|NCT00882362|1275021|P2|Overall Study|Physician Decision|1
379225|NCT00882362|1275022|P1|Overall Study|Physician Decision|5
379226|NCT00882362|1275021|P2|Overall Study|Pregnancy|0
379227|NCT00882362|1275022|P1|Overall Study|Pregnancy|1
379228|NCT00882362|1275021|P2|Overall Study|Protocol Violation|2
379229|NCT00882362|1275022|P1|Overall Study|Protocol Violation|7
379230|NCT00882362|1275021|P2|Overall Study|Lack of Efficacy|0
379231|NCT00882362|1275022|P1|Overall Study|Lack of Efficacy|3
379232|NCT00882362|1275021|P2|Overall Study|Withdrawal by Subject|10
379233|NCT00882362|1275022|P1|Overall Study|Withdrawal by Subject|13
379234|NCT00882362|1275021|P2|Overall Study|Adverse Event|10
379235|NCT00882362|1275022|P1|Overall Study|Adverse Event|13
379236|NCT00882310|1275028|P1|Overall Study|Adverse Event|1
379237|NCT00882310|1275028|P1|Overall Study|Progression of disease|4
379238|NCT00882310|1275028|P1|Overall Study|Death|6
379239|NCT00882310|1275028|P1|Overall Study|Never received treatment|1
379240|NCT00882310|1275028|P1|Overall Study|Screen Failure|10
379241|NCT00881959|1275047|P2|Overall Study|Lost to Follow-up|4
379242|NCT00881959|1275048|P1|Overall Study|Lost to Follow-up|2
379243|NCT00881894|1275056|P2|Overall Study|Other reasons for premature termination|2
379244|NCT00881894|1275057|P1|Overall Study|Other reasons for premature termination|1
379245|NCT00881894|1275056|P2|Overall Study|Consent withdrawn|1
379246|NCT00881894|1275057|P1|Overall Study|Consent withdrawn|0
379247|NCT00881868|1275089|P2|Overall Study|Protocol Violation|0
379248|NCT00881868|1275090|P1|Overall Study|Protocol Violation|2
379249|NCT00881868|1275089|P2|Overall Study|Physician Decision|0
379250|NCT00881868|1275090|P1|Overall Study|Physician Decision|4
379251|NCT00881868|1275089|P2|Overall Study|Lost to Follow-up|1
379252|NCT00881868|1275090|P1|Overall Study|Lost to Follow-up|2
379253|NCT00881868|1275089|P2|Overall Study|Adverse Event|1
379254|NCT00881868|1275090|P1|Overall Study|Adverse Event|0
379255|NCT00881751|1275104|P2|Overall Study|Withdrawal by Subject|2
379256|NCT00881751|1275105|P1|Overall Study|Withdrawal by Subject|0
379257|NCT00881751|1275104|P2|Overall Study|Adverse Event|2
379258|NCT00881751|1275105|P1|Overall Study|Adverse Event|0
379259|NCT00881751|1275104|P2|Overall Study|Physician Decision|1
379260|NCT00881751|1275105|P1|Overall Study|Physician Decision|0
379261|NCT00881712|1275120|P3|Overall Study|Withdrawal by Subject|0
379262|NCT00881712|1275121|P2|Overall Study|Withdrawal by Subject|0
379263|NCT00881712|1275122|P1|Overall Study|Withdrawal by Subject|1
379264|NCT00881712|1275120|P3|Overall Study|Death|0
379265|NCT00881712|1275121|P2|Overall Study|Death|0
379266|NCT00881712|1275122|P1|Overall Study|Death|1
379267|NCT00881621|1275155|P1|Overall Study|Physician Decision|34
379268|NCT00881608|1275167|P1|Overall Study|Study prematurely terminated|11
379269|NCT00881530|1275190|P6|Overall Study|Other reason not defined above|2
379270|NCT00881530|1275191|P5|Overall Study|Other reason not defined above|0
379271|NCT00881530|1275192|P4|Overall Study|Other reason not defined above|0
379272|NCT00881530|1275193|P3|Overall Study|Other reason not defined above|2
379273|NCT00881530|1275194|P2|Overall Study|Other reason not defined above|1
379274|NCT00881530|1275195|P1|Overall Study|Other reason not defined above|1
379275|NCT00881530|1275190|P6|Overall Study|Refused to continue medication|0
379276|NCT00881530|1275191|P5|Overall Study|Refused to continue medication|0
379277|NCT00881530|1275192|P4|Overall Study|Refused to continue medication|2
379278|NCT00881530|1275193|P3|Overall Study|Refused to continue medication|1
379279|NCT00881530|1275194|P2|Overall Study|Refused to continue medication|2
379280|NCT00881530|1275195|P1|Overall Study|Refused to continue medication|7
379281|NCT00881530|1275190|P6|Overall Study|Lost to Follow-up|0
379282|NCT00881530|1275191|P5|Overall Study|Lost to Follow-up|1
379283|NCT00881530|1275192|P4|Overall Study|Lost to Follow-up|3
379284|NCT00881530|1275193|P3|Overall Study|Lost to Follow-up|1
379285|NCT00881530|1275194|P2|Overall Study|Lost to Follow-up|1
379286|NCT00881530|1275195|P1|Overall Study|Lost to Follow-up|0
379287|NCT00881530|1275190|P6|Overall Study|Not compliant with the protocol|0
379288|NCT00881530|1275191|P5|Overall Study|Not compliant with the protocol|2
379289|NCT00881530|1275192|P4|Overall Study|Not compliant with the protocol|0
379290|NCT00881530|1275193|P3|Overall Study|Not compliant with the protocol|0
379291|NCT00881530|1275194|P2|Overall Study|Not compliant with the protocol|0
379292|NCT00881530|1275195|P1|Overall Study|Not compliant with the protocol|0
379293|NCT00881530|1275190|P6|Overall Study|Lack of Efficacy|1
379294|NCT00881530|1275191|P5|Overall Study|Lack of Efficacy|1
379295|NCT00881530|1275192|P4|Overall Study|Lack of Efficacy|0
379296|NCT00881530|1275193|P3|Overall Study|Lack of Efficacy|0
379297|NCT00881530|1275194|P2|Overall Study|Lack of Efficacy|0
379298|NCT00881530|1275195|P1|Overall Study|Lack of Efficacy|1
379299|NCT00881530|1275190|P6|Overall Study|Adverse Event|2
379300|NCT00881530|1275191|P5|Overall Study|Adverse Event|10
379301|NCT00881530|1275192|P4|Overall Study|Adverse Event|4
379302|NCT00881530|1275193|P3|Overall Study|Adverse Event|1
379303|NCT00881530|1275194|P2|Overall Study|Adverse Event|1
379304|NCT00881530|1275195|P1|Overall Study|Adverse Event|5
379305|NCT00881504|1275251|P1|Overall Study|Withdrawal by Subject|1
379306|NCT00881335|1275271|P2|Overall Study|Lost to Follow-up|2
379307|NCT00881335|1275272|P1|Overall Study|Lost to Follow-up|3
379308|NCT00881205|1275292|P2|Overall Study|Condition no longer requires drug|0
379309|NCT00881205|1275293|P1|Overall Study|Condition no longer requires drug|1
379310|NCT00881205|1275292|P2|Overall Study|Administrative problems|1
379311|NCT00881205|1275293|P1|Overall Study|Administrative problems|1
379312|NCT00881205|1275292|P2|Overall Study|Lost to Follow-up|1
379313|NCT00881205|1275293|P1|Overall Study|Lost to Follow-up|0
379314|NCT00881205|1275292|P2|Overall Study|Withdrawal by Subject|2
379315|NCT00881205|1275293|P1|Overall Study|Withdrawal by Subject|1
379316|NCT00881205|1275292|P2|Overall Study|Adverse Event|3
379317|NCT00881205|1275293|P1|Overall Study|Adverse Event|8
379318|NCT00880906|1275339|P2|Overall Study|Did not meet criteria following patholog|6
379319|NCT00880906|1275340|P1|Overall Study|Did not meet criteria following patholog|12
379320|NCT00880906|1275339|P2|Overall Study|Lost to Follow-up|1
379321|NCT00880906|1275340|P1|Overall Study|Lost to Follow-up|0
379322|NCT00880763|1275352|P4|Extension Period (Part 2)|Lack of Efficacy|1
379323|NCT00880763|1275353|P3|Extension Period (Part 2)|Lack of Efficacy|0
379324|NCT00880763|1275354|P2|Extension Period (Part 2)|Lack of Efficacy|0
379325|NCT00880763|1275355|P1|Extension Period (Part 2)|Lack of Efficacy|0
379326|NCT00880763|1275352|P4|Extension Period (Part 2)|Physician Decision|0
379327|NCT00880763|1275353|P3|Extension Period (Part 2)|Physician Decision|1
379328|NCT00880763|1275354|P2|Extension Period (Part 2)|Physician Decision|1
379329|NCT00880763|1275355|P1|Extension Period (Part 2)|Physician Decision|0
379330|NCT00880763|1275352|P4|Extension Period (Part 2)|Withdrawal by Subject|1
379331|NCT00880763|1275353|P3|Extension Period (Part 2)|Withdrawal by Subject|1
379332|NCT00880763|1275354|P2|Extension Period (Part 2)|Withdrawal by Subject|2
379333|NCT00880763|1275355|P1|Extension Period (Part 2)|Withdrawal by Subject|0
379334|NCT00880763|1275352|P4|Extension Period (Part 2)|Adverse Event|1
379335|NCT00880763|1275353|P3|Extension Period (Part 2)|Adverse Event|1
379336|NCT00880763|1275354|P2|Extension Period (Part 2)|Adverse Event|0
379337|NCT00880763|1275355|P1|Extension Period (Part 2)|Adverse Event|0
379338|NCT00880750|1275387|P2|Second Intervention|Unable to collect urine|0
379339|NCT00880750|1275388|P1|Second Intervention|Unable to collect urine|1
379340|NCT00880750|1275387|P2|Second Intervention|Protocol Violation|0
379341|NCT00880750|1275388|P1|Second Intervention|Protocol Violation|1
379342|NCT00880750|1275387|P2|Second Intervention|Withdrawal by Subject|2
379343|NCT00880750|1275388|P1|Second Intervention|Withdrawal by Subject|2
379344|NCT00880750|1275387|P2|First Intervention|Lost to Follow-up|0
379345|NCT00880750|1275388|P1|First Intervention|Lost to Follow-up|2
379346|NCT00880750|1275387|P2|First Intervention|Withdrawal by Subject|0
379347|NCT00880750|1275388|P1|First Intervention|Withdrawal by Subject|2
379348|NCT00880750|1275387|P2|First Intervention|Non-compliance with meals|1
379349|NCT00880750|1275388|P1|First Intervention|Non-compliance with meals|0
379350|NCT00880750|1275387|P2|First Intervention|Unable to collect urine|0
379351|NCT00880750|1275388|P1|First Intervention|Unable to collect urine|4
379352|NCT00880750|1275387|P2|First Intervention|Adverse Event|0
379353|NCT00880750|1275388|P1|First Intervention|Adverse Event|1
379354|NCT00880698|1275406|P4|Overall Study|Lost to Follow-up|1
379355|NCT00880698|1275407|P3|Overall Study|Lost to Follow-up|0
379356|NCT00880698|1275408|P2|Overall Study|Lost to Follow-up|3
379357|NCT00880698|1275409|P1|Overall Study|Lost to Follow-up|1
379358|NCT00880698|1275406|P4|Overall Study|Death|2
379359|NCT00880698|1275407|P3|Overall Study|Death|1
379360|NCT00880698|1275408|P2|Overall Study|Death|0
379361|NCT00880698|1275409|P1|Overall Study|Death|0
379362|NCT00880685|1275435|P1|Memantine 20mg|Withdrawal by Subject|1
379363|NCT00880685|1275435|P1|Memantine 10mg|Lost to Follow-up|2
379364|NCT00880620|1275447|P4|Overall Study|Not specified|2
379365|NCT00880620|1275448|P3|Overall Study|Not specified|2
379366|NCT00880620|1275449|P2|Overall Study|Not specified|1
379367|NCT00880620|1275450|P1|Overall Study|Not specified|1
379368|NCT00880620|1275447|P4|Overall Study|Noncompliance|1
379369|NCT00880620|1275448|P3|Overall Study|Noncompliance|1
379370|NCT00880620|1275449|P2|Overall Study|Noncompliance|0
379371|NCT00880620|1275450|P1|Overall Study|Noncompliance|0
379372|NCT00880620|1275447|P4|Overall Study|Withdrawal by Subject|3
379373|NCT00880620|1275448|P3|Overall Study|Withdrawal by Subject|1
379374|NCT00880620|1275449|P2|Overall Study|Withdrawal by Subject|3
379375|NCT00880620|1275450|P1|Overall Study|Withdrawal by Subject|4
379376|NCT00880620|1275447|P4|Overall Study|Protocol Violation|2
379377|NCT00880620|1275448|P3|Overall Study|Protocol Violation|0
379378|NCT00880620|1275449|P2|Overall Study|Protocol Violation|1
379379|NCT00880620|1275450|P1|Overall Study|Protocol Violation|0
379380|NCT00880620|1275447|P4|Overall Study|Lost to Follow-up|0
379381|NCT00880620|1275448|P3|Overall Study|Lost to Follow-up|1
379382|NCT00880620|1275449|P2|Overall Study|Lost to Follow-up|1
379383|NCT00880620|1275450|P1|Overall Study|Lost to Follow-up|0
379384|NCT00880620|1275447|P4|Overall Study|Lack of Efficacy|1
379385|NCT00880620|1275448|P3|Overall Study|Lack of Efficacy|0
379386|NCT00880620|1275449|P2|Overall Study|Lack of Efficacy|4
379387|NCT00880620|1275450|P1|Overall Study|Lack of Efficacy|12
379388|NCT00880620|1275447|P4|Overall Study|Death|0
379389|NCT00880620|1275448|P3|Overall Study|Death|1
379390|NCT00880620|1275449|P2|Overall Study|Death|0
379391|NCT00880620|1275450|P1|Overall Study|Death|0
379392|NCT00880620|1275447|P4|Overall Study|Adverse Event|15
379393|NCT00880620|1275448|P3|Overall Study|Adverse Event|15
379394|NCT00880620|1275449|P2|Overall Study|Adverse Event|5
379395|NCT00880620|1275450|P1|Overall Study|Adverse Event|4
379396|NCT00880568|1275478|P9|Overall Study|Withdrawal by Subject|0
379397|NCT00880568|1275479|P8|Overall Study|Withdrawal by Subject|1
379398|NCT00880568|1275480|P7|Overall Study|Withdrawal by Subject|0
379399|NCT00880568|1275481|P6|Overall Study|Withdrawal by Subject|0
379400|NCT00880568|1275482|P5|Overall Study|Withdrawal by Subject|0
379401|NCT00880568|1275483|P4|Overall Study|Withdrawal by Subject|0
379402|NCT00880568|1275484|P3|Overall Study|Withdrawal by Subject|0
379403|NCT00880568|1275485|P2|Overall Study|Withdrawal by Subject|0
379404|NCT00880568|1275486|P1|Overall Study|Withdrawal by Subject|0
379405|NCT00880568|1275478|P9|Overall Study|Adverse Event|0
379406|NCT00880568|1275479|P8|Overall Study|Adverse Event|1
379407|NCT00880568|1275480|P7|Overall Study|Adverse Event|1
379408|NCT00880568|1275481|P6|Overall Study|Adverse Event|0
379409|NCT00880568|1275482|P5|Overall Study|Adverse Event|0
379410|NCT00880568|1275483|P4|Overall Study|Adverse Event|0
379411|NCT00880568|1275484|P3|Overall Study|Adverse Event|0
379412|NCT00880568|1275485|P2|Overall Study|Adverse Event|0
379413|NCT00880568|1275486|P1|Overall Study|Adverse Event|0
379414|NCT00880568|1275478|P9|Overall Study|Disease progression|3
379415|NCT00880568|1275479|P8|Overall Study|Disease progression|0
379416|NCT00880568|1275480|P7|Overall Study|Disease progression|5
379417|NCT00880568|1275481|P6|Overall Study|Disease progression|3
379418|NCT00880568|1275482|P5|Overall Study|Disease progression|3
379419|NCT00880568|1275483|P4|Overall Study|Disease progression|1
379420|NCT00880568|1275484|P3|Overall Study|Disease progression|3
379421|NCT00880568|1275485|P2|Overall Study|Disease progression|3
379422|NCT00880568|1275486|P1|Overall Study|Disease progression|3
379423|NCT00880555|1275532|P6|Overall Study|Lost to Follow-up|0
379424|NCT00880555|1275533|P5|Overall Study|Lost to Follow-up|0
379425|NCT00880555|1275534|P4|Overall Study|Lost to Follow-up|0
379426|NCT00880555|1275535|P3|Overall Study|Lost to Follow-up|0
379427|NCT00880555|1275536|P2|Overall Study|Lost to Follow-up|1
379428|NCT00880555|1275537|P1|Overall Study|Lost to Follow-up|0
379429|NCT00880555|1275532|P6|Overall Study|Death|1
379430|NCT00880555|1275533|P5|Overall Study|Death|0
379431|NCT00880555|1275534|P4|Overall Study|Death|0
379432|NCT00880555|1275535|P3|Overall Study|Death|0
379433|NCT00880555|1275536|P2|Overall Study|Death|0
379434|NCT00880555|1275537|P1|Overall Study|Death|0
379435|NCT00880555|1275532|P6|Overall Study|Lack of resources (hired rater)|0
379436|NCT00880555|1275533|P5|Overall Study|Lack of resources (hired rater)|0
379437|NCT00880555|1275534|P4|Overall Study|Lack of resources (hired rater)|0
379438|NCT00880555|1275535|P3|Overall Study|Lack of resources (hired rater)|5
379439|NCT00880555|1275536|P2|Overall Study|Lack of resources (hired rater)|7
379440|NCT00880555|1275537|P1|Overall Study|Lack of resources (hired rater)|9
379441|NCT00880555|1275532|P6|Overall Study|Withdrawal by Subject|0
379442|NCT00880555|1275533|P5|Overall Study|Withdrawal by Subject|0
379443|NCT00880555|1275534|P4|Overall Study|Withdrawal by Subject|0
379444|NCT00880555|1275535|P3|Overall Study|Withdrawal by Subject|0
379445|NCT00880555|1275536|P2|Overall Study|Withdrawal by Subject|1
379446|NCT00880555|1275537|P1|Overall Study|Withdrawal by Subject|1
379447|NCT00880555|1275532|P6|Overall Study|Physician Decision|0
379448|NCT00880555|1275533|P5|Overall Study|Physician Decision|1
379449|NCT00880555|1275534|P4|Overall Study|Physician Decision|2
379450|NCT00880555|1275535|P3|Overall Study|Physician Decision|0
379451|NCT00880555|1275536|P2|Overall Study|Physician Decision|8
379452|NCT00880555|1275537|P1|Overall Study|Physician Decision|0
379453|NCT00880542|1275548|P1|REP: Surgical Resection|progressive disease|1
379454|NCT00880542|1275548|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
379455|NCT00880542|1275548|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
379456|NCT00880399|1275565|P3|Overall Study|Withdrawal by Subject|3
379457|NCT00880399|1275566|P2|Overall Study|Withdrawal by Subject|3
379458|NCT00880399|1275567|P1|Overall Study|Withdrawal by Subject|6
379459|NCT00880399|1275565|P3|Overall Study|Physician Decision|3
379460|NCT00880399|1275566|P2|Overall Study|Physician Decision|0
379461|NCT00880399|1275567|P1|Overall Study|Physician Decision|5
379462|NCT00880399|1275565|P3|Overall Study|Lost to Follow-up|3
379463|NCT00880399|1275566|P2|Overall Study|Lost to Follow-up|5
379464|NCT00880399|1275567|P1|Overall Study|Lost to Follow-up|8
379465|NCT00880399|1275565|P3|Overall Study|Study closed/terminated|4
379466|NCT00880399|1275566|P2|Overall Study|Study closed/terminated|7
379467|NCT00880399|1275567|P1|Overall Study|Study closed/terminated|3
379468|NCT00880399|1275565|P3|Overall Study|Protocol Violation|6
379469|NCT00880399|1275566|P2|Overall Study|Protocol Violation|4
379470|NCT00880399|1275567|P1|Overall Study|Protocol Violation|4
379471|NCT00880399|1275565|P3|Overall Study|Lack of Efficacy|2
379472|NCT00880399|1275566|P2|Overall Study|Lack of Efficacy|4
379473|NCT00880399|1275567|P1|Overall Study|Lack of Efficacy|1
379474|NCT00880399|1275565|P3|Overall Study|Adverse Event|5
379475|NCT00880399|1275566|P2|Overall Study|Adverse Event|6
379476|NCT00880399|1275567|P1|Overall Study|Adverse Event|4
379477|NCT00880334|1275630|P2|Overall Study|Brain Metastasis|1
379478|NCT00880334|1275631|P1|Overall Study|Brain Metastasis|0
379479|NCT00880334|1275630|P2|Overall Study|Inadequate Labs|1
379480|NCT00880334|1275631|P1|Overall Study|Inadequate Labs|1
379481|NCT00880334|1275630|P2|Overall Study|Withdrawal by Subject|1
379482|NCT00880334|1275631|P1|Overall Study|Withdrawal by Subject|2
379483|NCT00880334|1275630|P2|Overall Study|Physician Decision|0
379484|NCT00880334|1275631|P1|Overall Study|Physician Decision|1
379485|NCT00880269|1275647|P2|Overall Study|Adverse Event|9
379486|NCT00880269|1275648|P1|Overall Study|Adverse Event|10
379487|NCT00880269|1275647|P2|Overall Study|Withdrawal by Subject|4
379488|NCT00880269|1275648|P1|Overall Study|Withdrawal by Subject|3
379489|NCT00880269|1275647|P2|Overall Study|Lost to Follow-up|1
379490|NCT00880269|1275648|P1|Overall Study|Lost to Follow-up|0
379491|NCT00880269|1275647|P2|Overall Study|Death|2
379492|NCT00880269|1275648|P1|Overall Study|Death|4
379493|NCT00880269|1275647|P2|Overall Study|New Cancer Therapy|0
379494|NCT00880269|1275648|P1|Overall Study|New Cancer Therapy|1
379495|NCT00880269|1275647|P2|Overall Study|Disease Progression|11
379496|NCT00880269|1275648|P1|Overall Study|Disease Progression|13
379497|NCT00880269|1275647|P2|Overall Study|Protocol Violation|0
379498|NCT00880269|1275648|P1|Overall Study|Protocol Violation|1
379499|NCT00880256|1275664|P1|Overall Study|Lost to Follow-up|28
379500|NCT00880191|1275691|P2|Overall Study|Hospitalization/efficacy|1
379501|NCT00880191|1275692|P1|Overall Study|Hospitalization/efficacy|1
379502|NCT00880191|1275691|P2|Overall Study|Adverse Event|6
379503|NCT00880191|1275692|P1|Overall Study|Adverse Event|8
379504|NCT00880191|1275691|P2|Overall Study|Refused further treatment|1
379505|NCT00880191|1275692|P1|Overall Study|Refused further treatment|4
379506|NCT00880165|1275712|P2|Overall Study|Lost to follow|15
379507|NCT00880165|1275713|P1|Overall Study|Lost to follow|9
379508|NCT00880165|1275712|P2|Overall Study|Required BIPAP or oxygen treatment|4
379509|NCT00880165|1275713|P1|Overall Study|Required BIPAP or oxygen treatment|12
379510|NCT00880165|1275712|P2|Overall Study|Not diagnosed with OSA|8
379511|NCT00880165|1275713|P1|Overall Study|Not diagnosed with OSA|14
379512|NCT00880165|1275712|P2|Overall Study|Withdrawal by Subject|23
379513|NCT00880165|1275713|P1|Overall Study|Withdrawal by Subject|27
379514|NCT00880100|1275723|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
379515|NCT00880100|1275723|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
379516|NCT00880100|1275723|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
379517|NCT00880087|1275736|P2|Overall Study|Lost to Follow-up|2
379518|NCT00880087|1275737|P1|Overall Study|Lost to Follow-up|0
379519|NCT00880048|1275752|P3|Overall Study|Study closed/terminated|6
379520|NCT00880048|1275753|P2|Overall Study|Study closed/terminated|7
379521|NCT00880048|1275754|P1|Overall Study|Study closed/terminated|9
379522|NCT00880048|1275752|P3|Overall Study|Withdrawal by Subject|5
379523|NCT00880048|1275753|P2|Overall Study|Withdrawal by Subject|8
379524|NCT00880048|1275754|P1|Overall Study|Withdrawal by Subject|5
379525|NCT00880048|1275752|P3|Overall Study|Physician Decision|7
379526|NCT00880048|1275753|P2|Overall Study|Physician Decision|1
379527|NCT00880048|1275754|P1|Overall Study|Physician Decision|1
379528|NCT00880048|1275752|P3|Overall Study|Lost to Follow-up|5
379529|NCT00880048|1275753|P2|Overall Study|Lost to Follow-up|6
379530|NCT00880048|1275754|P1|Overall Study|Lost to Follow-up|6
379531|NCT00880048|1275752|P3|Overall Study|Protocol Violation|5
379532|NCT00880048|1275753|P2|Overall Study|Protocol Violation|6
379533|NCT00880048|1275754|P1|Overall Study|Protocol Violation|4
379534|NCT00880048|1275752|P3|Overall Study|Lack of Efficacy|2
379535|NCT00880048|1275753|P2|Overall Study|Lack of Efficacy|2
379536|NCT00880048|1275754|P1|Overall Study|Lack of Efficacy|1
379537|NCT00880048|1275752|P3|Overall Study|Adverse Event|5
379538|NCT00880048|1275753|P2|Overall Study|Adverse Event|3
379539|NCT00880048|1275754|P1|Overall Study|Adverse Event|2
379540|NCT00880009|1275821|P1|Overall Study|Protocol Violation|1
379541|NCT00880009|1275821|P1|Overall Study|Withdrawal by Subject|1
379542|NCT00880009|1275821|P1|Overall Study|Study terminated by sponsor|14
379543|NCT00879996|1275845|P2|Overall Study|put on parole|0
379544|NCT00879996|1275846|P1|Overall Study|put on parole|1
379545|NCT00879996|1275845|P2|Overall Study|psychiatric problem|1
379546|NCT00879996|1275846|P1|Overall Study|psychiatric problem|0
379547|NCT00879996|1275845|P2|Overall Study|Physician Decision|2
379548|NCT00879996|1275846|P1|Overall Study|Physician Decision|1
379549|NCT00879996|1275845|P2|Overall Study|non-compliance|4
379550|NCT00879996|1275846|P1|Overall Study|non-compliance|6
379551|NCT00879996|1275845|P2|Overall Study|Lost to Follow-up|6
379552|NCT00879996|1275846|P1|Overall Study|Lost to Follow-up|7
379553|NCT00879970|1275861|P5|Period 2 Vitamin D Randomization|Death|0
379554|NCT00879970|1275862|P4|Period 2 Vitamin D Randomization|Death|2
379555|NCT00879970|1275863|P3|Period 2 Vitamin D Randomization|Death|0
379556|NCT00879970|1275864|P2|Period 2 Vitamin D Randomization|Death|0
379557|NCT00879970|1275865|P1|Period 2 Vitamin D Randomization|Death|0
379558|NCT00879970|1275861|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
379559|NCT00879970|1275862|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
379560|NCT00879970|1275863|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
379561|NCT00879970|1275864|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
379562|NCT00879970|1275865|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
379563|NCT00879970|1275861|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
379564|NCT00879970|1275862|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
379565|NCT00879970|1275863|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
379566|NCT00879970|1275864|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
379567|NCT00879970|1275865|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
379568|NCT00879970|1275861|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
379569|NCT00879970|1275862|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
379570|NCT00879970|1275863|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
379571|NCT00879970|1275864|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
379572|NCT00879970|1275865|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
379573|NCT00879970|1275861|P5|Period 1 TZD Randomization|Death|0
379574|NCT00879970|1275862|P4|Period 1 TZD Randomization|Death|0
379575|NCT00879970|1275863|P3|Period 1 TZD Randomization|Death|0
379576|NCT00879970|1275864|P2|Period 1 TZD Randomization|Death|1
379577|NCT00879970|1275865|P1|Period 1 TZD Randomization|Death|2
379578|NCT00879970|1275861|P5|Period 1 TZD Randomization|Lost to Follow-up|0
379579|NCT00879970|1275862|P4|Period 1 TZD Randomization|Lost to Follow-up|0
379580|NCT00879970|1275863|P3|Period 1 TZD Randomization|Lost to Follow-up|1
379581|NCT00879970|1275864|P2|Period 1 TZD Randomization|Lost to Follow-up|0
379582|NCT00879970|1275865|P1|Period 1 TZD Randomization|Lost to Follow-up|1
379583|NCT00879970|1275861|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
379584|NCT00879970|1275862|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
379585|NCT00879970|1275863|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
379586|NCT00879970|1275864|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
379587|NCT00879970|1275865|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
379588|NCT00879879|1275947|P1|Overall Study|Physician Decision|1
379589|NCT00879879|1275947|P1|Overall Study|Withdrawal by Subject|1
379590|NCT00879879|1275947|P1|Overall Study|Death|1
379591|NCT00879814|1275955|P4|Overall Study|Other|0
379592|NCT00879814|1275956|P3|Overall Study|Other|1
379593|NCT00879814|1275957|P2|Overall Study|Other|0
379594|NCT00879814|1275958|P1|Overall Study|Other|0
379595|NCT00879814|1275955|P4|Overall Study|Physician Decision|0
379596|NCT00879814|1275956|P3|Overall Study|Physician Decision|1
379597|NCT00879814|1275957|P2|Overall Study|Physician Decision|0
379598|NCT00879814|1275958|P1|Overall Study|Physician Decision|0
379599|NCT00879814|1275955|P4|Overall Study|Withdrawal by Subject|2
379600|NCT00879814|1275956|P3|Overall Study|Withdrawal by Subject|1
379601|NCT00879814|1275957|P2|Overall Study|Withdrawal by Subject|1
379602|NCT00879814|1275958|P1|Overall Study|Withdrawal by Subject|3
379603|NCT00879814|1275955|P4|Overall Study|Participant Failed to Return|1
379604|NCT00879814|1275956|P3|Overall Study|Participant Failed to Return|0
379605|NCT00879814|1275957|P2|Overall Study|Participant Failed to Return|0
379606|NCT00879814|1275958|P1|Overall Study|Participant Failed to Return|0
379607|NCT00879814|1275955|P4|Overall Study|Lost to Follow-up|2
379608|NCT00879814|1275956|P3|Overall Study|Lost to Follow-up|0
379609|NCT00879814|1275957|P2|Overall Study|Lost to Follow-up|0
379610|NCT00879814|1275958|P1|Overall Study|Lost to Follow-up|1
379611|NCT00879814|1275955|P4|Overall Study|Adverse Event|0
379612|NCT00879814|1275956|P3|Overall Study|Adverse Event|0
379613|NCT00879814|1275957|P2|Overall Study|Adverse Event|1
379614|NCT00879814|1275958|P1|Overall Study|Adverse Event|0
379615|NCT00879775|1276066|P2|Overall Study|Lost to Follow-up|1
379616|NCT00879775|1276067|P1|Overall Study|Lost to Follow-up|2
379617|NCT00879710|1276083|P4|Phase 1 - 6 Weeks|Adverse Event|0
379618|NCT00879710|1276084|P3|Phase 1 - 6 Weeks|Adverse Event|1
379619|NCT00879710|1276085|P2|Phase 1 - 6 Weeks|Adverse Event|0
379620|NCT00879710|1276086|P1|Phase 1 - 6 Weeks|Adverse Event|0
379621|NCT00879710|1276083|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
379622|NCT00879710|1276084|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
379623|NCT00879710|1276085|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
379624|NCT00879710|1276086|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
379625|NCT00879697|1276096|P2|Overall Study|Physician Decision|2
379626|NCT00879697|1276097|P1|Overall Study|Physician Decision|2
379627|NCT00879684|1276103|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
379628|NCT00879684|1276104|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
379629|NCT00879684|1276105|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
379630|NCT00879684|1276106|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
379631|NCT00879684|1276107|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
379632|NCT00879684|1276108|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
379633|NCT00879684|1276109|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
379634|NCT00879684|1276103|P7|Stage 2: Expanded Cohort|Progressive Disease|11
379635|NCT00879684|1276104|P6|Stage 2: Expanded Cohort|Progressive Disease|0
379636|NCT00879684|1276105|P5|Stage 2: Expanded Cohort|Progressive Disease|0
379637|NCT00879684|1276106|P4|Stage 2: Expanded Cohort|Progressive Disease|0
379638|NCT00879684|1276107|P3|Stage 2: Expanded Cohort|Progressive Disease|0
379639|NCT00879684|1276108|P2|Stage 2: Expanded Cohort|Progressive Disease|0
379640|NCT00879684|1276109|P1|Stage 2: Expanded Cohort|Progressive Disease|0
379641|NCT00879684|1276103|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
379642|NCT00879684|1276104|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
379643|NCT00879684|1276105|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
379644|NCT00879684|1276106|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
379645|NCT00879684|1276107|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
379646|NCT00879684|1276108|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
379647|NCT00879684|1276109|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
379648|NCT00879684|1276103|P7|Stage 1: Dose Escalation|Death|0
379649|NCT00879684|1276104|P6|Stage 1: Dose Escalation|Death|0
379650|NCT00879684|1276105|P5|Stage 1: Dose Escalation|Death|0
379651|NCT00879684|1276106|P4|Stage 1: Dose Escalation|Death|0
379652|NCT00879684|1276107|P3|Stage 1: Dose Escalation|Death|1
379653|NCT00879684|1276108|P2|Stage 1: Dose Escalation|Death|0
379654|NCT00879684|1276109|P1|Stage 1: Dose Escalation|Death|0
379655|NCT00879684|1276103|P7|Stage 1: Dose Escalation|Investigator declined participation|0
379656|NCT00879684|1276104|P6|Stage 1: Dose Escalation|Investigator declined participation|0
379657|NCT00879684|1276105|P5|Stage 1: Dose Escalation|Investigator declined participation|0
379658|NCT00879684|1276106|P4|Stage 1: Dose Escalation|Investigator declined participation|2
379659|NCT00879684|1276107|P3|Stage 1: Dose Escalation|Investigator declined participation|2
379660|NCT00879684|1276108|P2|Stage 1: Dose Escalation|Investigator declined participation|0
379661|NCT00879684|1276109|P1|Stage 1: Dose Escalation|Investigator declined participation|0
379662|NCT00879684|1276103|P7|Stage 1: Dose Escalation|Progressive Disease|0
379663|NCT00879684|1276104|P6|Stage 1: Dose Escalation|Progressive Disease|3
379664|NCT00879684|1276105|P5|Stage 1: Dose Escalation|Progressive Disease|3
379665|NCT00879684|1276106|P4|Stage 1: Dose Escalation|Progressive Disease|4
379666|NCT00879684|1276107|P3|Stage 1: Dose Escalation|Progressive Disease|0
379667|NCT00879684|1276108|P2|Stage 1: Dose Escalation|Progressive Disease|3
379668|NCT00879684|1276109|P1|Stage 1: Dose Escalation|Progressive Disease|2
379669|NCT00879684|1276103|P7|Stage 1: Dose Escalation|Adverse Event|0
379670|NCT00879684|1276104|P6|Stage 1: Dose Escalation|Adverse Event|0
379671|NCT00879684|1276105|P5|Stage 1: Dose Escalation|Adverse Event|0
379672|NCT00879684|1276106|P4|Stage 1: Dose Escalation|Adverse Event|0
379673|NCT00879684|1276107|P3|Stage 1: Dose Escalation|Adverse Event|0
379674|NCT00879684|1276108|P2|Stage 1: Dose Escalation|Adverse Event|0
379675|NCT00879684|1276109|P1|Stage 1: Dose Escalation|Adverse Event|1
379676|NCT00879645|1276175|P4|Overall Study|Adverse Event|0
379677|NCT00879645|1276176|P3|Overall Study|Adverse Event|0
379678|NCT00879645|1276177|P2|Overall Study|Adverse Event|0
379679|NCT00879645|1276178|P1|Overall Study|Adverse Event|1
379680|NCT00879411|1276205|P1|Overall Study|lost to follow-up (non-AE)|162
379681|NCT00879398|1276211|P1|Overall Study|Other Reasons|171
379682|NCT00879398|1276211|P1|Overall Study|Adverse Event|41
379683|NCT00879398|1276211|P1|Overall Study|Lack of Efficacy|64
379684|NCT00879398|1276211|P1|Overall Study|Visit Stop|399
379685|NCT00879333|1276229|P2|Overall Study|Protocol Violation|1
379686|NCT00879333|1276230|P1|Overall Study|Protocol Violation|1
379687|NCT00879333|1276229|P2|Overall Study|Disease Progression|169
379688|NCT00879333|1276230|P1|Overall Study|Disease Progression|292
379689|NCT00879333|1276229|P2|Overall Study|Death|5
379690|NCT00879333|1276230|P1|Overall Study|Death|16
379691|NCT00879333|1276229|P2|Overall Study|Administrative Problems|0
379692|NCT00879333|1276230|P1|Overall Study|Administrative Problems|2
379693|NCT00879333|1276229|P2|Overall Study|Lost to Follow-up|1
379694|NCT00879333|1276230|P1|Overall Study|Lost to Follow-up|2
379695|NCT00879333|1276229|P2|Overall Study|Withdrawal by Subject|7
379696|NCT00879333|1276230|P1|Overall Study|Withdrawal by Subject|20
379697|NCT00879333|1276229|P2|Overall Study|Abnormal Laboratory Value|0
379698|NCT00879333|1276230|P1|Overall Study|Abnormal Laboratory Value|1
379699|NCT00879333|1276229|P2|Overall Study|Adverse Event|34
379700|NCT00879333|1276230|P1|Overall Study|Adverse Event|94
379701|NCT00879229|1276263|P2|Overall Study|Other|0
379702|NCT00879229|1276264|P1|Overall Study|Other|1
379703|NCT00879229|1276263|P2|Overall Study|Clinical status did not improve|0
379704|NCT00879229|1276264|P1|Overall Study|Clinical status did not improve|1
379705|NCT00879229|1276263|P2|Overall Study|Withdrawal by Subject|0
379706|NCT00879229|1276264|P1|Overall Study|Withdrawal by Subject|1
379707|NCT00879229|1276263|P2|Overall Study|Adverse Event|0
379708|NCT00879229|1276264|P1|Overall Study|Adverse Event|2
379709|NCT00879229|1276263|P2|Overall Study|Death|2
379710|NCT00879229|1276264|P1|Overall Study|Death|4
379711|NCT00879229|1276263|P2|Overall Study|Study terminated by Sponsor|12
379712|NCT00879229|1276264|P1|Overall Study|Study terminated by Sponsor|13
379713|NCT00878995|1276312|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
379714|NCT00878995|1276313|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
379715|NCT00878969|1276414|P3|Overall Study|Pregnancy|0
379716|NCT00878969|1276415|P2|Overall Study|Pregnancy|1
379717|NCT00878969|1276416|P1|Overall Study|Pregnancy|0
379718|NCT00878969|1276414|P3|Overall Study|Death|2
379719|NCT00878969|1276415|P2|Overall Study|Death|0
379720|NCT00878969|1276416|P1|Overall Study|Death|0
379721|NCT00878969|1276414|P3|Overall Study|Protocol Violation|0
379722|NCT00878969|1276415|P2|Overall Study|Protocol Violation|0
379723|NCT00878969|1276416|P1|Overall Study|Protocol Violation|2
379724|NCT00878969|1276414|P3|Overall Study|Lost to Follow-up|0
379725|NCT00878969|1276415|P2|Overall Study|Lost to Follow-up|1
379726|NCT00878969|1276416|P1|Overall Study|Lost to Follow-up|2
379727|NCT00878969|1276414|P3|Overall Study|Adverse Event|2
379728|NCT00878969|1276415|P2|Overall Study|Adverse Event|1
379729|NCT00878969|1276416|P1|Overall Study|Adverse Event|3
379730|NCT00878969|1276414|P3|Overall Study|kidney transplant|2
379731|NCT00878969|1276415|P2|Overall Study|kidney transplant|3
379732|NCT00878969|1276416|P1|Overall Study|kidney transplant|2
379733|NCT00878969|1276414|P3|Overall Study|Withdrawal by Subject|3
379734|NCT00878969|1276415|P2|Overall Study|Withdrawal by Subject|6
379735|NCT00878969|1276416|P1|Overall Study|Withdrawal by Subject|1
379736|NCT00878969|1276414|P3|Overall Study|Physician Decision|2
379737|NCT00878969|1276415|P2|Overall Study|Physician Decision|3
379738|NCT00878969|1276416|P1|Overall Study|Physician Decision|5
379739|NCT00878800|1276464|P5|Overall Study|Other|1
379740|NCT00878800|1276465|P4|Overall Study|Other|0
379741|NCT00878800|1276466|P3|Overall Study|Other|0
379742|NCT00878800|1276467|P2|Overall Study|Other|1
379743|NCT00878800|1276468|P1|Overall Study|Other|1
379744|NCT00878800|1276464|P5|Overall Study|Death|0
379745|NCT00878800|1276465|P4|Overall Study|Death|0
379746|NCT00878800|1276466|P3|Overall Study|Death|1
379747|NCT00878800|1276467|P2|Overall Study|Death|0
379748|NCT00878800|1276468|P1|Overall Study|Death|0
379749|NCT00878800|1276464|P5|Overall Study|Withdrew consent|1
379750|NCT00878800|1276465|P4|Overall Study|Withdrew consent|1
379751|NCT00878800|1276466|P3|Overall Study|Withdrew consent|0
379752|NCT00878800|1276467|P2|Overall Study|Withdrew consent|1
379753|NCT00878800|1276468|P1|Overall Study|Withdrew consent|1
379754|NCT00878800|1276464|P5|Overall Study|Progressive disease|13
379755|NCT00878800|1276465|P4|Overall Study|Progressive disease|5
379756|NCT00878800|1276466|P3|Overall Study|Progressive disease|6
379757|NCT00878800|1276467|P2|Overall Study|Progressive disease|5
379758|NCT00878800|1276468|P1|Overall Study|Progressive disease|1
379759|NCT00878800|1276464|P5|Overall Study|Adverse Event|1
379760|NCT00878800|1276465|P4|Overall Study|Adverse Event|0
379761|NCT00878800|1276466|P3|Overall Study|Adverse Event|2
379762|NCT00878800|1276467|P2|Overall Study|Adverse Event|0
379763|NCT00878800|1276468|P1|Overall Study|Adverse Event|0
379764|NCT00878722|1276503|P8|Overall Study|Relapse|0
379765|NCT00878722|1276504|P7|Overall Study|Relapse|0
379766|NCT00878722|1276505|P6|Overall Study|Relapse|0
379767|NCT00878722|1276506|P5|Overall Study|Relapse|0
379768|NCT00878722|1276507|P4|Overall Study|Relapse|1
379769|NCT00878722|1276508|P3|Overall Study|Relapse|0
379770|NCT00878722|1276509|P2|Overall Study|Relapse|0
379771|NCT00878722|1276510|P1|Overall Study|Relapse|0
379772|NCT00878722|1276503|P8|Overall Study|Withdrawal by Subject|2
379773|NCT00878722|1276504|P7|Overall Study|Withdrawal by Subject|0
379774|NCT00878722|1276505|P6|Overall Study|Withdrawal by Subject|0
379775|NCT00878722|1276506|P5|Overall Study|Withdrawal by Subject|0
379776|NCT00878722|1276507|P4|Overall Study|Withdrawal by Subject|0
379777|NCT00878722|1276508|P3|Overall Study|Withdrawal by Subject|0
379778|NCT00878722|1276509|P2|Overall Study|Withdrawal by Subject|0
379779|NCT00878722|1276510|P1|Overall Study|Withdrawal by Subject|0
379780|NCT00878722|1276503|P8|Overall Study|Adverse Event|0
379781|NCT00878722|1276504|P7|Overall Study|Adverse Event|2
379782|NCT00878722|1276505|P6|Overall Study|Adverse Event|0
379783|NCT00878722|1276506|P5|Overall Study|Adverse Event|0
379784|NCT00878722|1276507|P4|Overall Study|Adverse Event|0
379785|NCT00878722|1276508|P3|Overall Study|Adverse Event|0
379786|NCT00878722|1276509|P2|Overall Study|Adverse Event|0
379787|NCT00878722|1276510|P1|Overall Study|Adverse Event|0
379788|NCT00878722|1276503|P8|Overall Study|Death|2
379789|NCT00878722|1276504|P7|Overall Study|Death|0
379790|NCT00878722|1276505|P6|Overall Study|Death|1
379791|NCT00878722|1276506|P5|Overall Study|Death|0
379792|NCT00878722|1276507|P4|Overall Study|Death|1
379793|NCT00878722|1276508|P3|Overall Study|Death|0
379794|NCT00878722|1276509|P2|Overall Study|Death|0
379795|NCT00878722|1276510|P1|Overall Study|Death|0
379796|NCT00878722|1276503|P8|Overall Study|Progressive disease|3
379797|NCT00878722|1276504|P7|Overall Study|Progressive disease|4
379798|NCT00878722|1276505|P6|Overall Study|Progressive disease|1
379799|NCT00878722|1276506|P5|Overall Study|Progressive disease|7
379800|NCT00878722|1276507|P4|Overall Study|Progressive disease|7
379801|NCT00878722|1276508|P3|Overall Study|Progressive disease|3
379802|NCT00878722|1276509|P2|Overall Study|Progressive disease|3
379803|NCT00878722|1276510|P1|Overall Study|Progressive disease|3
379804|NCT00878709|1276595|P2|Overall Study|Other Reasons|84
379805|NCT00878709|1276596|P1|Overall Study|Other Reasons|93
379806|NCT00878709|1276595|P2|Overall Study|Lost to Follow-up|33
379807|NCT00878709|1276596|P1|Overall Study|Lost to Follow-up|35
379808|NCT00878709|1276595|P2|Overall Study|Withdrawal by Subject|120
379809|NCT00878709|1276596|P1|Overall Study|Withdrawal by Subject|197
379810|NCT00878553|1276656|P5|PK Study|Withdrawal by Subject|0
379811|NCT00878553|1276657|P4|PK Study|Withdrawal by Subject|1
379812|NCT00878553|1276658|P3|PK Study|Withdrawal by Subject|0
379813|NCT00878553|1276659|P2|PK Study|Withdrawal by Subject|0
379814|NCT00878553|1276660|P1|PK Study|Withdrawal by Subject|0
379815|NCT00878553|1276656|P5|Sleep Study|family emergency|0
379816|NCT00878553|1276657|P4|Sleep Study|family emergency|0
379817|NCT00878553|1276658|P3|Sleep Study|family emergency|0
379818|NCT00878553|1276659|P2|Sleep Study|family emergency|0
379819|NCT00878553|1276660|P1|Sleep Study|family emergency|1
379820|NCT00878553|1276656|P5|Sleep Study|car accident|0
379821|NCT00878553|1276657|P4|Sleep Study|car accident|0
379822|NCT00878553|1276658|P3|Sleep Study|car accident|0
379823|NCT00878553|1276659|P2|Sleep Study|car accident|0
379824|NCT00878553|1276660|P1|Sleep Study|car accident|1
379825|NCT00878553|1276656|P5|Sleep Study|Lost to Follow-up|0
379826|NCT00878553|1276657|P4|Sleep Study|Lost to Follow-up|0
379827|NCT00878553|1276658|P3|Sleep Study|Lost to Follow-up|0
379828|NCT00878553|1276659|P2|Sleep Study|Lost to Follow-up|0
379829|NCT00878553|1276660|P1|Sleep Study|Lost to Follow-up|1
379830|NCT00878553|1276656|P5|Sleep Study|Withdrawal by Subject|0
379831|NCT00878553|1276657|P4|Sleep Study|Withdrawal by Subject|0
379832|NCT00878553|1276658|P3|Sleep Study|Withdrawal by Subject|0
379833|NCT00878553|1276659|P2|Sleep Study|Withdrawal by Subject|0
379834|NCT00878553|1276660|P1|Sleep Study|Withdrawal by Subject|2
379835|NCT00878501|1276719|P3|Overall Study|Administrative|1
379836|NCT00878501|1276720|P2|Overall Study|Administrative|0
379837|NCT00878501|1276721|P1|Overall Study|Administrative|0
379838|NCT00878501|1276719|P3|Overall Study|Mis-randomisation of patient|0
379839|NCT00878501|1276720|P2|Overall Study|Mis-randomisation of patient|0
379840|NCT00878501|1276721|P1|Overall Study|Mis-randomisation of patient|1
379841|NCT00878501|1276719|P3|Overall Study|Intake of prohibited concom. medication|1
379842|NCT00878501|1276720|P2|Overall Study|Intake of prohibited concom. medication|0
379843|NCT00878501|1276721|P1|Overall Study|Intake of prohibited concom. medication|0
379844|NCT00878501|1276719|P3|Overall Study|Incorrect enrolment|0
379845|NCT00878501|1276720|P2|Overall Study|Incorrect enrolment|2
379846|NCT00878501|1276721|P1|Overall Study|Incorrect enrolment|1
379847|NCT00878501|1276719|P3|Overall Study|Protocol Violation|1
379848|NCT00878501|1276720|P2|Overall Study|Protocol Violation|0
379849|NCT00878501|1276721|P1|Overall Study|Protocol Violation|0
379850|NCT00878501|1276719|P3|Overall Study|Withdrawal by Subject|2
379851|NCT00878501|1276720|P2|Overall Study|Withdrawal by Subject|1
379852|NCT00878501|1276721|P1|Overall Study|Withdrawal by Subject|2
379853|NCT00878501|1276719|P3|Overall Study|Lack of Efficacy|0
379854|NCT00878501|1276720|P2|Overall Study|Lack of Efficacy|1
379855|NCT00878501|1276721|P1|Overall Study|Lack of Efficacy|2
379856|NCT00878501|1276719|P3|Overall Study|Adverse Event|3
379857|NCT00878501|1276720|P2|Overall Study|Adverse Event|3
379858|NCT00878501|1276721|P1|Overall Study|Adverse Event|11
379859|NCT00878215|1276770|P4|Overall Study|Determined to be ineligible|0
379860|NCT00878215|1276771|P3|Overall Study|Determined to be ineligible|0
379861|NCT00878215|1276772|P2|Overall Study|Determined to be ineligible|10
379862|NCT00878215|1276773|P1|Overall Study|Determined to be ineligible|0
379863|NCT00877929|1276785|P2|Overall Study|Other reason (not specified)|6
379864|NCT00877929|1276786|P1|Overall Study|Other reason (not specified)|2
379865|NCT00877929|1276785|P2|Overall Study|Lack of Efficacy|1
379866|NCT00877929|1276786|P1|Overall Study|Lack of Efficacy|0
379867|NCT00877929|1276785|P2|Overall Study|Withdrawal by Subject|4
379868|NCT00877929|1276786|P1|Overall Study|Withdrawal by Subject|4
379869|NCT00877929|1276785|P2|Overall Study|Lost to Follow-up|1
379870|NCT00877929|1276786|P1|Overall Study|Lost to Follow-up|0
379871|NCT00877929|1276785|P2|Overall Study|Protocol Violation|3
379872|NCT00877929|1276786|P1|Overall Study|Protocol Violation|3
379873|NCT00877929|1276785|P2|Overall Study|Adverse Event|20
379874|NCT00877929|1276786|P1|Overall Study|Adverse Event|11
379875|NCT00877890|1276874|P2|Overall Study|Loss of Glucose Control|4
379876|NCT00877890|1276875|P1|Overall Study|Loss of Glucose Control|3
379877|NCT00877890|1276874|P2|Overall Study|Investigator Decision|2
379878|NCT00877890|1276875|P1|Overall Study|Investigator Decision|0
379879|NCT00877890|1276874|P2|Overall Study|Withdrawal of Consent|12
379880|NCT00877890|1276875|P1|Overall Study|Withdrawal of Consent|6
379881|NCT00877890|1276874|P2|Overall Study|Protocol Violation|1
379882|NCT00877890|1276875|P1|Overall Study|Protocol Violation|0
379883|NCT00877890|1276874|P2|Overall Study|Lost to Follow-up|5
379884|NCT00877890|1276875|P1|Overall Study|Lost to Follow-up|5
379885|NCT00877890|1276874|P2|Overall Study|Adverse Event|6
379886|NCT00877890|1276875|P1|Overall Study|Adverse Event|6
379887|NCT00877799|1276940|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
379888|NCT00877799|1276941|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
379889|NCT00877799|1276942|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
379890|NCT00877799|1276943|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
379891|NCT00877799|1276944|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
379892|NCT00877799|1276940|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
379893|NCT00877799|1276941|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
379894|NCT00877799|1276942|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
379895|NCT00877799|1276943|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
379896|NCT00877799|1276944|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
379897|NCT00877799|1276940|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
379898|NCT00877799|1276941|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
379899|NCT00877799|1276942|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
379900|NCT00877799|1276943|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
379901|NCT00877799|1276944|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
379902|NCT00877799|1276940|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
379903|NCT00877799|1276941|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
379904|NCT00877799|1276942|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
379905|NCT00877799|1276943|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
379906|NCT00877799|1276944|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
379907|NCT00877799|1276940|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
379908|NCT00877799|1276941|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
379909|NCT00877799|1276942|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
379910|NCT00877799|1276943|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
379911|NCT00877799|1276944|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
379912|NCT00877773|1276959|P1|Overall Study|Disease Progression|44
379913|NCT00877487|1276972|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
379914|NCT00877487|1276973|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
379915|NCT00877487|1276972|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
379916|NCT00877487|1276973|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
379917|NCT00877487|1276972|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
379918|NCT00877487|1276973|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
379919|NCT00877487|1276972|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
379920|NCT00877487|1276973|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
379921|NCT00877487|1276972|P2|Open-label Treatment Phase|Out of country for business|0
379922|NCT00877487|1276973|P1|Open-label Treatment Phase|Out of country for business|1
379923|NCT00877487|1276972|P2|Open-label Treatment Phase|Lost to Follow-up|0
379924|NCT00877487|1276973|P1|Open-label Treatment Phase|Lost to Follow-up|1
379925|NCT00877487|1276972|P2|Open-label Treatment Phase|Withdrawal by Subject|0
379926|NCT00877487|1276973|P1|Open-label Treatment Phase|Withdrawal by Subject|1
379927|NCT00877487|1276972|P2|Open-label Treatment Phase|Protocol Violation|0
379928|NCT00877487|1276973|P1|Open-label Treatment Phase|Protocol Violation|3
379929|NCT00877487|1276972|P2|Open-label Treatment Phase|Adverse Event|0
379930|NCT00877487|1276973|P1|Open-label Treatment Phase|Adverse Event|1
379931|NCT00877383|1277021|P2|Overall Study|Death|2
379932|NCT00877383|1277022|P1|Overall Study|Death|1
379933|NCT00877383|1277021|P2|Overall Study|Unsatisfactory therapeutic effect|0
379934|NCT00877383|1277022|P1|Overall Study|Unsatisfactory therapeutic effect|1
379935|NCT00877383|1277021|P2|Overall Study|Protocol deviation|6
379936|NCT00877383|1277022|P1|Overall Study|Protocol deviation|2
379937|NCT00877383|1277021|P2|Overall Study|Administrative problems|0
379938|NCT00877383|1277022|P1|Overall Study|Administrative problems|2
379939|NCT00877383|1277021|P2|Overall Study|Subject no longer requires study drug|0
379940|NCT00877383|1277022|P1|Overall Study|Subject no longer requires study drug|2
379941|NCT00877383|1277021|P2|Overall Study|Subject withdrew consent|12
379942|NCT00877383|1277022|P1|Overall Study|Subject withdrew consent|3
379943|NCT00877383|1277021|P2|Overall Study|Lost to Follow-up|3
379944|NCT00877383|1277022|P1|Overall Study|Lost to Follow-up|5
379945|NCT00877383|1277021|P2|Overall Study|Adverse Event|14
379946|NCT00877383|1277022|P1|Overall Study|Adverse Event|13
379947|NCT00877071|1277042|P1|Overall Study|disease progression|2
379948|NCT00877032|1277075|P7|Overall Study|Did not meet entrance criteria|2
379949|NCT00877032|1277076|P6|Overall Study|Did not meet entrance criteria|0
379950|NCT00877032|1277077|P5|Overall Study|Did not meet entrance criteria|0
379951|NCT00877032|1277078|P4|Overall Study|Did not meet entrance criteria|1
379952|NCT00877032|1277079|P3|Overall Study|Did not meet entrance criteria|0
379953|NCT00877032|1277080|P2|Overall Study|Did not meet entrance criteria|0
379954|NCT00877032|1277081|P1|Overall Study|Did not meet entrance criteria|0
379955|NCT00877006|1277182|P2|Long-Term Follow-up Period|Not specified|9
379956|NCT00877006|1277183|P1|Long-Term Follow-up Period|Not specified|7
379957|NCT00877006|1277182|P2|Long-Term Follow-up Period|Death|18
379958|NCT00877006|1277183|P1|Long-Term Follow-up Period|Death|26
379959|NCT00877006|1277182|P2|Long-Term Follow-up Period|Lost to Follow-up|9
379960|NCT00877006|1277183|P1|Long-Term Follow-up Period|Lost to Follow-up|8
379961|NCT00877006|1277182|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
379962|NCT00877006|1277183|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
379963|NCT00877006|1277182|P2|Treatment Period|Randomized but Not Treated|8
379964|NCT00877006|1277183|P1|Treatment Period|Randomized but Not Treated|3
379965|NCT00877006|1277182|P2|Treatment Period|Not Specified|4
379966|NCT00877006|1277183|P1|Treatment Period|Not Specified|4
379967|NCT00877006|1277182|P2|Treatment Period|Started New Treatment Regimen|5
379968|NCT00877006|1277183|P1|Treatment Period|Started New Treatment Regimen|2
379969|NCT00877006|1277182|P2|Treatment Period|Disease Progression|2
379970|NCT00877006|1277183|P1|Treatment Period|Disease Progression|1
379971|NCT00877006|1277182|P2|Treatment Period|Lost to Follow-up|1
379972|NCT00877006|1277183|P1|Treatment Period|Lost to Follow-up|0
379973|NCT00877006|1277182|P2|Treatment Period|Protocol Violation|0
379974|NCT00877006|1277183|P1|Treatment Period|Protocol Violation|1
379975|NCT00877006|1277182|P2|Treatment Period|Withdrawal by Subject|3
379976|NCT00877006|1277183|P1|Treatment Period|Withdrawal by Subject|2
379977|NCT00877006|1277182|P2|Treatment Period|Adverse Event|3
379978|NCT00877006|1277183|P1|Treatment Period|Adverse Event|10
379979|NCT00877006|1277182|P2|Treatment Period|Death|1
379980|NCT00877006|1277183|P1|Treatment Period|Death|2
379981|NCT00876928|1277223|P2|Overall Study|Hypokalemia-affects insulin secretion|0
379982|NCT00876928|1277224|P1|Overall Study|Hypokalemia-affects insulin secretion|1
379983|NCT00876928|1277223|P2|Overall Study|Lost to Follow-up|5
379984|NCT00876928|1277224|P1|Overall Study|Lost to Follow-up|2
379985|NCT00876733|1277261|P4|Overall Study|Data not available|1
379986|NCT00876733|1277262|P3|Overall Study|Data not available|7
379987|NCT00876733|1277263|P2|Overall Study|Data not available|3
379988|NCT00876733|1277264|P1|Overall Study|Data not available|14
379989|NCT00876733|1277261|P4|Overall Study|Lost to Follow-up|2
379990|NCT00876733|1277262|P3|Overall Study|Lost to Follow-up|3
379991|NCT00876733|1277263|P2|Overall Study|Lost to Follow-up|10
379992|NCT00876733|1277264|P1|Overall Study|Lost to Follow-up|26
379993|NCT00876733|1277261|P4|Overall Study|Lack of Efficacy|1
379994|NCT00876733|1277262|P3|Overall Study|Lack of Efficacy|10
379995|NCT00876733|1277263|P2|Overall Study|Lack of Efficacy|9
379996|NCT00876733|1277264|P1|Overall Study|Lack of Efficacy|17
379997|NCT00876733|1277261|P4|Overall Study|Adverse Event|3
379998|NCT00876733|1277262|P3|Overall Study|Adverse Event|10
379999|NCT00876733|1277263|P2|Overall Study|Adverse Event|20
380000|NCT00876733|1277264|P1|Overall Study|Adverse Event|34
380001|NCT00876694|1277372|P2|Overall Study|Death|0
380002|NCT00876694|1277373|P1|Overall Study|Death|1
380003|NCT00876694|1277372|P2|Overall Study|Administrative problems|1
380004|NCT00876694|1277373|P1|Overall Study|Administrative problems|1
380005|NCT00876694|1277372|P2|Overall Study|Abnormal test procedure result(s)|0
380006|NCT00876694|1277373|P1|Overall Study|Abnormal test procedure result(s)|1
380007|NCT00876694|1277372|P2|Overall Study|Unsatisfactory therapeutic effect|0
380008|NCT00876694|1277373|P1|Overall Study|Unsatisfactory therapeutic effect|2
380009|NCT00876694|1277372|P2|Overall Study|Subject withdrew consent|4
380010|NCT00876694|1277373|P1|Overall Study|Subject withdrew consent|6
380011|NCT00876694|1277372|P2|Overall Study|Adverse Event|7
380012|NCT00876694|1277373|P1|Overall Study|Adverse Event|10
380013|NCT00876460|1277399|P8|Mono Therapy Phase|Adverse Event|0
380014|NCT00876460|1277400|P7|Mono Therapy Phase|Adverse Event|0
380015|NCT00876460|1277401|P6|Mono Therapy Phase|Adverse Event|0
380016|NCT00876460|1277402|P5|Mono Therapy Phase|Adverse Event|0
380017|NCT00876460|1277403|P4|Mono Therapy Phase|Adverse Event|1
380018|NCT00876460|1277404|P3|Mono Therapy Phase|Adverse Event|0
380019|NCT00876460|1277405|P2|Mono Therapy Phase|Adverse Event|0
380020|NCT00876460|1277406|P1|Mono Therapy Phase|Adverse Event|0
380021|NCT00876460|1277399|P8|Mono Therapy Phase|Withdrawal by Subject|0
380022|NCT00876460|1277400|P7|Mono Therapy Phase|Withdrawal by Subject|0
380023|NCT00876460|1277401|P6|Mono Therapy Phase|Withdrawal by Subject|0
380024|NCT00876460|1277402|P5|Mono Therapy Phase|Withdrawal by Subject|0
380025|NCT00876460|1277403|P4|Mono Therapy Phase|Withdrawal by Subject|0
380026|NCT00876460|1277404|P3|Mono Therapy Phase|Withdrawal by Subject|0
380027|NCT00876460|1277405|P2|Mono Therapy Phase|Withdrawal by Subject|1
380028|NCT00876460|1277406|P1|Mono Therapy Phase|Withdrawal by Subject|0
380029|NCT00876460|1277399|P8|Mono Therapy Phase|Progressive disease|3
380030|NCT00876460|1277400|P7|Mono Therapy Phase|Progressive disease|1
380031|NCT00876460|1277401|P6|Mono Therapy Phase|Progressive disease|0
380032|NCT00876460|1277402|P5|Mono Therapy Phase|Progressive disease|2
380033|NCT00876460|1277403|P4|Mono Therapy Phase|Progressive disease|0
380034|NCT00876460|1277404|P3|Mono Therapy Phase|Progressive disease|0
380035|NCT00876460|1277405|P2|Mono Therapy Phase|Progressive disease|0
380036|NCT00876460|1277406|P1|Mono Therapy Phase|Progressive disease|0
380037|NCT00876460|1277399|P8|Combination Therapy Phase|Not treated|0
380038|NCT00876460|1277400|P7|Combination Therapy Phase|Not treated|1
380039|NCT00876460|1277401|P6|Combination Therapy Phase|Not treated|0
380040|NCT00876460|1277402|P5|Combination Therapy Phase|Not treated|0
380041|NCT00876460|1277403|P4|Combination Therapy Phase|Not treated|0
380042|NCT00876460|1277404|P3|Combination Therapy Phase|Not treated|0
380043|NCT00876460|1277405|P2|Combination Therapy Phase|Not treated|0
380044|NCT00876460|1277406|P1|Combination Therapy Phase|Not treated|0
380045|NCT00876460|1277399|P8|Combination Therapy Phase|Other reason not defined above|2
380046|NCT00876460|1277400|P7|Combination Therapy Phase|Other reason not defined above|1
380047|NCT00876460|1277401|P6|Combination Therapy Phase|Other reason not defined above|0
380048|NCT00876460|1277402|P5|Combination Therapy Phase|Other reason not defined above|0
380049|NCT00876460|1277403|P4|Combination Therapy Phase|Other reason not defined above|0
380050|NCT00876460|1277404|P3|Combination Therapy Phase|Other reason not defined above|0
380051|NCT00876460|1277405|P2|Combination Therapy Phase|Other reason not defined above|0
380052|NCT00876460|1277406|P1|Combination Therapy Phase|Other reason not defined above|0
380053|NCT00876460|1277399|P8|Combination Therapy Phase|Withdrawal by Subject|0
380054|NCT00876460|1277400|P7|Combination Therapy Phase|Withdrawal by Subject|0
380055|NCT00876460|1277401|P6|Combination Therapy Phase|Withdrawal by Subject|0
380056|NCT00876460|1277402|P5|Combination Therapy Phase|Withdrawal by Subject|1
380057|NCT00876460|1277403|P4|Combination Therapy Phase|Withdrawal by Subject|0
380058|NCT00876460|1277404|P3|Combination Therapy Phase|Withdrawal by Subject|0
380059|NCT00876460|1277405|P2|Combination Therapy Phase|Withdrawal by Subject|1
380060|NCT00876460|1277406|P1|Combination Therapy Phase|Withdrawal by Subject|1
380061|NCT00876460|1277399|P8|Combination Therapy Phase|Adverse Event|2
380062|NCT00876460|1277400|P7|Combination Therapy Phase|Adverse Event|3
380063|NCT00876460|1277401|P6|Combination Therapy Phase|Adverse Event|0
380064|NCT00876460|1277402|P5|Combination Therapy Phase|Adverse Event|2
380065|NCT00876460|1277403|P4|Combination Therapy Phase|Adverse Event|2
380066|NCT00876460|1277404|P3|Combination Therapy Phase|Adverse Event|0
380067|NCT00876460|1277405|P2|Combination Therapy Phase|Adverse Event|2
380068|NCT00876460|1277406|P1|Combination Therapy Phase|Adverse Event|0
380069|NCT00876460|1277399|P8|Combination Therapy Phase|Dose limiting toxicity|1
380070|NCT00876460|1277400|P7|Combination Therapy Phase|Dose limiting toxicity|2
380071|NCT00876460|1277401|P6|Combination Therapy Phase|Dose limiting toxicity|2
380072|NCT00876460|1277402|P5|Combination Therapy Phase|Dose limiting toxicity|1
380073|NCT00876460|1277403|P4|Combination Therapy Phase|Dose limiting toxicity|1
380074|NCT00876460|1277404|P3|Combination Therapy Phase|Dose limiting toxicity|0
380075|NCT00876460|1277405|P2|Combination Therapy Phase|Dose limiting toxicity|1
380076|NCT00876460|1277406|P1|Combination Therapy Phase|Dose limiting toxicity|0
380077|NCT00876460|1277399|P8|Combination Therapy Phase|Progressive disease|1
380078|NCT00876460|1277400|P7|Combination Therapy Phase|Progressive disease|1
380079|NCT00876460|1277401|P6|Combination Therapy Phase|Progressive disease|1
380080|NCT00876460|1277402|P5|Combination Therapy Phase|Progressive disease|3
380081|NCT00876460|1277403|P4|Combination Therapy Phase|Progressive disease|3
380082|NCT00876460|1277404|P3|Combination Therapy Phase|Progressive disease|3
380083|NCT00876460|1277405|P2|Combination Therapy Phase|Progressive disease|3
380084|NCT00876460|1277406|P1|Combination Therapy Phase|Progressive disease|2
380085|NCT00876447|1277478|P2|Overall Study|Adverse Event|8
380086|NCT00876447|1277479|P1|Overall Study|Adverse Event|4
380087|NCT00876447|1277478|P2|Overall Study|Lack of Efficacy|3
380088|NCT00876447|1277479|P1|Overall Study|Lack of Efficacy|5
380089|NCT00876447|1277478|P2|Overall Study|Pregnancy|2
380090|NCT00876447|1277479|P1|Overall Study|Pregnancy|4
380091|NCT00876447|1277478|P2|Overall Study|Lost to Follow-up|15
380092|NCT00876447|1277479|P1|Overall Study|Lost to Follow-up|6
380093|NCT00876447|1277478|P2|Overall Study|Personal reasons|28
380094|NCT00876447|1277479|P1|Overall Study|Personal reasons|30
380095|NCT00876447|1277478|P2|Overall Study|Protocol Violation|3
380096|NCT00876447|1277479|P1|Overall Study|Protocol Violation|9
380097|NCT00876447|1277478|P2|Overall Study|Site closure|14
380098|NCT00876447|1277479|P1|Overall Study|Site closure|19
380099|NCT00876447|1277478|P2|Overall Study|Other miscellaneous reasons|8
380100|NCT00876447|1277479|P1|Overall Study|Other miscellaneous reasons|3
380101|NCT00876343|1277540|P3|Overall Study|Change of residence or other commitments|3
380102|NCT00876343|1277541|P2|Overall Study|Change of residence or other commitments|2
380103|NCT00876343|1277542|P1|Overall Study|Change of residence or other commitments|2
380104|NCT00876343|1277540|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
380105|NCT00876343|1277541|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
380106|NCT00876343|1277542|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
380107|NCT00876343|1277540|P3|Overall Study|Physician Decision|1
380108|NCT00876343|1277541|P2|Overall Study|Physician Decision|1
380109|NCT00876343|1277542|P1|Overall Study|Physician Decision|0
380110|NCT00876343|1277540|P3|Overall Study|Protocol Violation|1
380111|NCT00876343|1277541|P2|Overall Study|Protocol Violation|1
380112|NCT00876343|1277542|P1|Overall Study|Protocol Violation|4
380113|NCT00876343|1277540|P3|Overall Study|Lack of Efficacy|1
380114|NCT00876343|1277541|P2|Overall Study|Lack of Efficacy|0
380115|NCT00876343|1277542|P1|Overall Study|Lack of Efficacy|0
380116|NCT00876343|1277540|P3|Overall Study|Withdrawal by Subject|3
380117|NCT00876343|1277541|P2|Overall Study|Withdrawal by Subject|4
380118|NCT00876343|1277542|P1|Overall Study|Withdrawal by Subject|4
380119|NCT00876343|1277540|P3|Overall Study|Adverse Event|2
380120|NCT00876343|1277541|P2|Overall Study|Adverse Event|8
380121|NCT00876343|1277542|P1|Overall Study|Adverse Event|7
380122|NCT00876265|1277556|P1|Overall Study|Withdrawal by Subject|2
380123|NCT00876265|1277556|P1|Overall Study|Lost to Follow-up|6
380124|NCT00876265|1277556|P1|Overall Study|Miscellaneous reasons|4
380125|NCT00876018|1277565|P3|Overall Study|Withdrew Consent due to Adverse Event|2
380126|NCT00876018|1277566|P2|Overall Study|Withdrew Consent due to Adverse Event|4
380127|NCT00876018|1277567|P1|Overall Study|Withdrew Consent due to Adverse Event|5
380128|NCT00876018|1277565|P3|Overall Study|Lost to Follow-up|1
380129|NCT00876018|1277566|P2|Overall Study|Lost to Follow-up|1
380130|NCT00876018|1277567|P1|Overall Study|Lost to Follow-up|0
380131|NCT00875979|1277622|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
380132|NCT00875979|1277623|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
380133|NCT00875979|1277622|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
380134|NCT00875979|1277623|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
380135|NCT00875979|1277622|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
380136|NCT00875979|1277623|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
380137|NCT00875979|1277622|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
380138|NCT00875979|1277623|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
380139|NCT00875979|1277622|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
380140|NCT00875979|1277623|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
380141|NCT00875979|1277622|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
380142|NCT00875979|1277623|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
380143|NCT00875979|1277622|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
380144|NCT00875979|1277623|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
380145|NCT00875979|1277622|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
380146|NCT00875979|1277623|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
380147|NCT00875979|1277622|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
380148|NCT00875979|1277623|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
380149|NCT00875810|1277646|P1|Overall Study|Device explanted|1
380150|NCT00875810|1277646|P1|Overall Study|Patient enroled but not implanted|2
380151|NCT00875810|1277646|P1|Overall Study|Lost to Follow-up|39
380152|NCT00875810|1277646|P1|Overall Study|Physician Decision|3
380153|NCT00875810|1277646|P1|Overall Study|Withdrawal by Subject|1
380154|NCT00875797|1277655|P2|Overall Study|Protocol Violation|3
380155|NCT00875797|1277656|P1|Overall Study|Protocol Violation|6
380156|NCT00875706|1277669|P3|Overall Study|Withdrawal by Subject|0
380157|NCT00875706|1277670|P2|Overall Study|Withdrawal by Subject|0
380158|NCT00875706|1277671|P1|Overall Study|Withdrawal by Subject|1
380159|NCT00875615|1277688|P1|Overall Study|Withdrawal by Subject|1
380160|NCT00875563|1277702|P1|Overall Study|Still be eligible for follow-up|7
380161|NCT00875563|1277702|P1|Overall Study|No long-term (3-5 year) consent|6
380162|NCT00875563|1277702|P1|Overall Study|Withdrawal by Subject|7
380163|NCT00875563|1277702|P1|Overall Study|Death|4
380164|NCT00875485|1277727|P2|Challenge Dose Epoch|Pregnancy|0
380165|NCT00875485|1277728|P1|Challenge Dose Epoch|Pregnancy|1
380166|NCT00875433|1277768|P1|Overall Study|Not specified|3
380167|NCT00875433|1277768|P1|Overall Study|Withdrawal by Subject|2
380168|NCT00875433|1277768|P1|Overall Study|Other Adverse Event|14
380169|NCT00875433|1277768|P1|Overall Study|Progressive disease|41
380170|NCT00875420|1277798|P5|Overall Study|Withdrawal by Subject|0
380171|NCT00875420|1277799|P4|Overall Study|Withdrawal by Subject|0
380172|NCT00875420|1277800|P3|Overall Study|Withdrawal by Subject|1
380173|NCT00875420|1277801|P2|Overall Study|Withdrawal by Subject|0
380174|NCT00875420|1277802|P1|Overall Study|Withdrawal by Subject|0
380175|NCT00875420|1277798|P5|Overall Study|Sponsor decision|0
380176|NCT00875420|1277799|P4|Overall Study|Sponsor decision|0
380177|NCT00875420|1277800|P3|Overall Study|Sponsor decision|0
380178|NCT00875420|1277801|P2|Overall Study|Sponsor decision|1
380179|NCT00875420|1277802|P1|Overall Study|Sponsor decision|0
380180|NCT00875420|1277798|P5|Overall Study|Prohibited medication|0
380181|NCT00875420|1277799|P4|Overall Study|Prohibited medication|1
380182|NCT00875420|1277800|P3|Overall Study|Prohibited medication|0
380183|NCT00875420|1277801|P2|Overall Study|Prohibited medication|0
380184|NCT00875420|1277802|P1|Overall Study|Prohibited medication|0
380185|NCT00875420|1277798|P5|Overall Study|Personal reason|1
380186|NCT00875420|1277799|P4|Overall Study|Personal reason|0
380187|NCT00875420|1277800|P3|Overall Study|Personal reason|0
380188|NCT00875420|1277801|P2|Overall Study|Personal reason|0
380189|NCT00875420|1277802|P1|Overall Study|Personal reason|0
380190|NCT00875420|1277798|P5|Overall Study|Lost to Follow-up|0
380191|NCT00875420|1277799|P4|Overall Study|Lost to Follow-up|0
380192|NCT00875420|1277800|P3|Overall Study|Lost to Follow-up|0
380193|NCT00875420|1277801|P2|Overall Study|Lost to Follow-up|0
380194|NCT00875420|1277802|P1|Overall Study|Lost to Follow-up|1
380195|NCT00875420|1277798|P5|Overall Study|Inability to complete study procedures|1
380196|NCT00875420|1277799|P4|Overall Study|Inability to complete study procedures|1
380197|NCT00875420|1277800|P3|Overall Study|Inability to complete study procedures|1
380198|NCT00875420|1277801|P2|Overall Study|Inability to complete study procedures|0
380199|NCT00875420|1277802|P1|Overall Study|Inability to complete study procedures|1
380200|NCT00875420|1277798|P5|Overall Study|Adverse Event|0
380201|NCT00875420|1277799|P4|Overall Study|Adverse Event|0
380202|NCT00875420|1277800|P3|Overall Study|Adverse Event|1
380203|NCT00875420|1277801|P2|Overall Study|Adverse Event|1
380204|NCT00875420|1277802|P1|Overall Study|Adverse Event|0
380205|NCT00875017|1277863|P6|Fourth Intervention|Inability to comply with fasting|1
380206|NCT00875017|1277864|P5|Fourth Intervention|Inability to comply with fasting|0
380207|NCT00875017|1277865|P4|Fourth Intervention|Inability to comply with fasting|0
380208|NCT00875017|1277866|P3|Fourth Intervention|Inability to comply with fasting|0
380209|NCT00875017|1277867|P2|Fourth Intervention|Inability to comply with fasting|0
380210|NCT00875017|1277868|P1|Fourth Intervention|Inability to comply with fasting|0
380211|NCT00875017|1277863|P6|Washout|Withdrawal by Subject|0
380212|NCT00875017|1277864|P5|Washout|Withdrawal by Subject|1
380213|NCT00875017|1277865|P4|Washout|Withdrawal by Subject|0
380214|NCT00875017|1277866|P3|Washout|Withdrawal by Subject|0
380215|NCT00875017|1277867|P2|Washout|Withdrawal by Subject|0
380216|NCT00875017|1277868|P1|Washout|Withdrawal by Subject|0
380217|NCT00875017|1277863|P6|Third Intervention|Adverse Event|0
380218|NCT00875017|1277864|P5|Third Intervention|Adverse Event|0
380219|NCT00875017|1277865|P4|Third Intervention|Adverse Event|0
380220|NCT00875017|1277866|P3|Third Intervention|Adverse Event|1
380221|NCT00875017|1277867|P2|Third Intervention|Adverse Event|1
380222|NCT00875017|1277868|P1|Third Intervention|Adverse Event|0
380223|NCT00875017|1277863|P6|Washout|Problems collecting rectal effluent|0
380224|NCT00875017|1277864|P5|Washout|Problems collecting rectal effluent|0
380225|NCT00875017|1277865|P4|Washout|Problems collecting rectal effluent|0
380226|NCT00875017|1277866|P3|Washout|Problems collecting rectal effluent|0
380227|NCT00875017|1277867|P2|Washout|Problems collecting rectal effluent|1
380228|NCT00875017|1277868|P1|Washout|Problems collecting rectal effluent|0
380229|NCT00875017|1277863|P6|Second Intervention|Adverse Event|0
380230|NCT00875017|1277864|P5|Second Intervention|Adverse Event|0
380231|NCT00875017|1277865|P4|Second Intervention|Adverse Event|1
380232|NCT00875017|1277866|P3|Second Intervention|Adverse Event|0
380233|NCT00875017|1277867|P2|Second Intervention|Adverse Event|0
380234|NCT00875017|1277868|P1|Second Intervention|Adverse Event|0
380235|NCT00875017|1277863|P6|Washout|Problem collecting rectal effluent|0
380236|NCT00875017|1277864|P5|Washout|Problem collecting rectal effluent|0
380237|NCT00875017|1277865|P4|Washout|Problem collecting rectal effluent|0
380238|NCT00875017|1277866|P3|Washout|Problem collecting rectal effluent|1
380239|NCT00875017|1277867|P2|Washout|Problem collecting rectal effluent|0
380240|NCT00875017|1277868|P1|Washout|Problem collecting rectal effluent|0
380241|NCT00875017|1277863|P6|First Intervention|Intolerance to nasogastric tube|0
380242|NCT00875017|1277864|P5|First Intervention|Intolerance to nasogastric tube|1
380243|NCT00875017|1277865|P4|First Intervention|Intolerance to nasogastric tube|0
380244|NCT00875017|1277866|P3|First Intervention|Intolerance to nasogastric tube|0
380245|NCT00875017|1277867|P2|First Intervention|Intolerance to nasogastric tube|0
380246|NCT00875017|1277868|P1|First Intervention|Intolerance to nasogastric tube|0
380247|NCT00875017|1277863|P6|First Intervention|Problems collecting rectal effluent|0
380248|NCT00875017|1277864|P5|First Intervention|Problems collecting rectal effluent|0
380249|NCT00875017|1277865|P4|First Intervention|Problems collecting rectal effluent|0
380250|NCT00875017|1277866|P3|First Intervention|Problems collecting rectal effluent|0
380251|NCT00875017|1277867|P2|First Intervention|Problems collecting rectal effluent|0
380252|NCT00875017|1277868|P1|First Intervention|Problems collecting rectal effluent|1
380253|NCT00875017|1277863|P6|First Intervention|Adverse Event|0
380254|NCT00875017|1277864|P5|First Intervention|Adverse Event|0
380255|NCT00875017|1277865|P4|First Intervention|Adverse Event|1
380256|NCT00875017|1277866|P3|First Intervention|Adverse Event|0
380257|NCT00875017|1277867|P2|First Intervention|Adverse Event|0
380258|NCT00875017|1277868|P1|First Intervention|Adverse Event|0
380259|NCT00875017|1277863|P6|First Intervention|Withdrawal by Subject|0
380260|NCT00875017|1277864|P5|First Intervention|Withdrawal by Subject|0
380261|NCT00875017|1277865|P4|First Intervention|Withdrawal by Subject|0
380262|NCT00875017|1277866|P3|First Intervention|Withdrawal by Subject|1
380263|NCT00875017|1277867|P2|First Intervention|Withdrawal by Subject|0
380264|NCT00875017|1277868|P1|First Intervention|Withdrawal by Subject|1
380265|NCT00874939|1277882|P1|Overall Study|Study terminated|4
380266|NCT00874848|1277915|P2|Overall Study|Physician Decision|2
380267|NCT00874848|1277916|P1|Overall Study|Physician Decision|0
380268|NCT00874848|1277915|P2|Overall Study|Failure to comply with protocol|1
380269|NCT00874848|1277916|P1|Overall Study|Failure to comply with protocol|0
380270|NCT00874848|1277915|P2|Overall Study|Noncompliance|1
380271|NCT00874848|1277916|P1|Overall Study|Noncompliance|1
380272|NCT00874848|1277915|P2|Overall Study|Withdrawal by Subject|4
380273|NCT00874848|1277916|P1|Overall Study|Withdrawal by Subject|7
380274|NCT00874848|1277915|P2|Overall Study|Progressive neoplastic disease|18
380275|NCT00874848|1277916|P1|Overall Study|Progressive neoplastic disease|38
380276|NCT00874848|1277915|P2|Overall Study|Adverse Event|2
380277|NCT00874848|1277916|P1|Overall Study|Adverse Event|13
380278|NCT00874822|1277932|P1|Overall Study|excluded by criteria|8
380279|NCT00874770|1277940|P4|Overall Study|Subject no Longer Meets Study Criteria|0
380280|NCT00874770|1277941|P3|Overall Study|Subject no Longer Meets Study Criteria|0
380281|NCT00874770|1277942|P2|Overall Study|Subject no Longer Meets Study Criteria|0
380282|NCT00874770|1277943|P1|Overall Study|Subject no Longer Meets Study Criteria|1
380283|NCT00874770|1277940|P4|Overall Study|Lost to Follow-up|1
380284|NCT00874770|1277941|P3|Overall Study|Lost to Follow-up|0
380285|NCT00874770|1277942|P2|Overall Study|Lost to Follow-up|0
380286|NCT00874770|1277943|P1|Overall Study|Lost to Follow-up|1
380287|NCT00874770|1277940|P4|Overall Study|Adverse Event|2
380288|NCT00874770|1277941|P3|Overall Study|Adverse Event|4
380289|NCT00874770|1277942|P2|Overall Study|Adverse Event|1
380290|NCT00874770|1277943|P1|Overall Study|Adverse Event|1
380291|NCT00874770|1277940|P4|Overall Study|Lack of Efficacy|2
380292|NCT00874770|1277941|P3|Overall Study|Lack of Efficacy|0
380293|NCT00874770|1277942|P2|Overall Study|Lack of Efficacy|0
380294|NCT00874770|1277943|P1|Overall Study|Lack of Efficacy|2
380295|NCT00874549|1277981|P4|Overall Study|Withdrawal by Subject|1
380296|NCT00874549|1277982|P3|Overall Study|Withdrawal by Subject|0
380297|NCT00874549|1277983|P2|Overall Study|Withdrawal by Subject|1
380298|NCT00874549|1277984|P1|Overall Study|Withdrawal by Subject|0
380299|NCT00874549|1277981|P4|Overall Study|Lost to Follow-up|0
380300|NCT00874549|1277982|P3|Overall Study|Lost to Follow-up|1
380301|NCT00874549|1277983|P2|Overall Study|Lost to Follow-up|0
380302|NCT00874549|1277984|P1|Overall Study|Lost to Follow-up|0
380303|NCT00874549|1277981|P4|Overall Study|Protocol Violation|1
380304|NCT00874549|1277982|P3|Overall Study|Protocol Violation|2
380305|NCT00874549|1277983|P2|Overall Study|Protocol Violation|0
380306|NCT00874549|1277984|P1|Overall Study|Protocol Violation|1
380307|NCT00874549|1277981|P4|Overall Study|Adverse Event|0
380308|NCT00874549|1277982|P3|Overall Study|Adverse Event|1
380309|NCT00874549|1277983|P2|Overall Study|Adverse Event|0
380310|NCT00874549|1277984|P1|Overall Study|Adverse Event|0
380311|NCT00874497|1278061|P2|Overall Study|Withdrawal by Subject|4
380312|NCT00874497|1278062|P1|Overall Study|Withdrawal by Subject|5
380313|NCT00874497|1278061|P2|Overall Study|Physician Decision|1
380314|NCT00874497|1278062|P1|Overall Study|Physician Decision|1
380315|NCT00874497|1278061|P2|Overall Study|Met Withdrawal Criteria|2
380316|NCT00874497|1278062|P1|Overall Study|Met Withdrawal Criteria|4
380317|NCT00874497|1278061|P2|Overall Study|Sponsor Discontinued Trial|3
380318|NCT00874497|1278062|P1|Overall Study|Sponsor Discontinued Trial|7
380319|NCT00874497|1278061|P2|Overall Study|Adverse Event|4
380320|NCT00874497|1278062|P1|Overall Study|Adverse Event|9
380321|NCT00874497|1278061|P2|Overall Study|Lost to Follow-up|4
380322|NCT00874497|1278062|P1|Overall Study|Lost to Follow-up|2
380323|NCT00874276|1278102|P2|Overall Study|Withdrawal by Subject|1
380324|NCT00874276|1278103|P1|Overall Study|Withdrawal by Subject|1
380325|NCT00874120|1278125|P2|Second Intervention|Protocol Violation|0
380326|NCT00874120|1278126|P1|Second Intervention|Protocol Violation|1
380327|NCT00874120|1278125|P2|Second Intervention|Withdrawal by Subject|0
380328|NCT00874120|1278126|P1|Second Intervention|Withdrawal by Subject|1
380329|NCT00874120|1278125|P2|First Intervention|positive drug test|0
380330|NCT00874120|1278126|P1|First Intervention|positive drug test|1
380331|NCT00874120|1278125|P2|First Intervention|Protocol Violation|0
380332|NCT00874120|1278126|P1|First Intervention|Protocol Violation|3
380333|NCT00874120|1278125|P2|First Intervention|Lost to Follow-up|1
380334|NCT00874120|1278126|P1|First Intervention|Lost to Follow-up|0
380335|NCT00874120|1278125|P2|First Intervention|Withdrawal by Subject|0
380336|NCT00874120|1278126|P1|First Intervention|Withdrawal by Subject|2
380337|NCT00874120|1278125|P2|First Intervention|Adverse Event|1
380338|NCT00874120|1278126|P1|First Intervention|Adverse Event|0
380339|NCT00874029|1278139|P1|Overall Study|Lost to Follow-up|5
380340|NCT00874029|1278139|P1|Overall Study|Adverse Event|1
380341|NCT00874029|1278139|P1|Overall Study|Physician Decision|1
380342|NCT00874029|1278139|P1|Overall Study|Pregnancy|4
380343|NCT00874029|1278139|P1|Overall Study|Withdrawal by Subject|10
380344|NCT00873912|1278155|P2|Overall Study|Lost to Follow-up|0
380345|NCT00873912|1278156|P1|Overall Study|Lost to Follow-up|2
380346|NCT00873912|1278155|P2|Overall Study|Withdrawal by Subject|0
380347|NCT00873912|1278156|P1|Overall Study|Withdrawal by Subject|1
380348|NCT00873860|1278195|P4|Overall Study|Other|0
380349|NCT00873860|1278196|P3|Overall Study|Other|1
380350|NCT00873860|1278197|P2|Overall Study|Other|0
380351|NCT00873860|1278198|P1|Overall Study|Other|1
380352|NCT00873860|1278195|P4|Overall Study|Death|0
380353|NCT00873860|1278196|P3|Overall Study|Death|0
380354|NCT00873860|1278197|P2|Overall Study|Death|0
380355|NCT00873860|1278198|P1|Overall Study|Death|1
380356|NCT00873860|1278195|P4|Overall Study|Withdrawal by Subject|0
380357|NCT00873860|1278196|P3|Overall Study|Withdrawal by Subject|2
380358|NCT00873860|1278197|P2|Overall Study|Withdrawal by Subject|0
380359|NCT00873860|1278198|P1|Overall Study|Withdrawal by Subject|1
380360|NCT00873860|1278195|P4|Overall Study|Lost to Follow-up|1
380361|NCT00873860|1278196|P3|Overall Study|Lost to Follow-up|0
380362|NCT00873860|1278197|P2|Overall Study|Lost to Follow-up|0
380363|NCT00873860|1278198|P1|Overall Study|Lost to Follow-up|1
380364|NCT00873730|1278286|P2|Overall Study|Sponsor decision|0
380365|NCT00873730|1278287|P1|Overall Study|Sponsor decision|1
380366|NCT00873730|1278286|P2|Overall Study|Withdrawal by Subject|1
380367|NCT00873730|1278287|P1|Overall Study|Withdrawal by Subject|0
380368|NCT00873730|1278286|P2|Overall Study|Adverse Event|2
380369|NCT00873730|1278287|P1|Overall Study|Adverse Event|0
380370|NCT00873730|1278286|P2|Overall Study|Protocol Deviation|2
380371|NCT00873730|1278287|P1|Overall Study|Protocol Deviation|5
380372|NCT00873366|1278330|P1|Overall Study|Refused to continue DM-BT testing|3
380373|NCT00873366|1278330|P1|Overall Study|Off tamoxifen due to side effects|2
380374|NCT00873366|1278330|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
380375|NCT00873119|1278355|P2|Overall Study|Not treated|0
380376|NCT00873119|1278356|P1|Overall Study|Not treated|2
380377|NCT00873119|1278355|P2|Overall Study|Other|5
380378|NCT00873119|1278356|P1|Overall Study|Other|2
380379|NCT00873119|1278355|P2|Overall Study|Death|1
380380|NCT00873119|1278356|P1|Overall Study|Death|2
380381|NCT00873119|1278355|P2|Overall Study|Progressive disease|18
380382|NCT00873119|1278356|P1|Overall Study|Progressive disease|26
380383|NCT00873119|1278355|P2|Overall Study|Adverse Event|0
380384|NCT00873119|1278356|P1|Overall Study|Adverse Event|8
380385|NCT00873119|1278355|P2|Overall Study|Patient request|2
380386|NCT00873119|1278356|P1|Overall Study|Patient request|4
380387|NCT00873093|1278377|P5|Overall Study|Ineligible|0
380388|NCT00873093|1278378|P4|Overall Study|Ineligible|1
380389|NCT00873093|1278379|P3|Overall Study|Ineligible|0
380390|NCT00873093|1278380|P2|Overall Study|Ineligible|1
380391|NCT00873093|1278381|P1|Overall Study|Ineligible|0
380392|NCT00873093|1278377|P5|Overall Study|Withdrawal by Subject|0
380393|NCT00873093|1278378|P4|Overall Study|Withdrawal by Subject|0
380394|NCT00873093|1278379|P3|Overall Study|Withdrawal by Subject|4
380395|NCT00873093|1278380|P2|Overall Study|Withdrawal by Subject|4
380396|NCT00873093|1278381|P1|Overall Study|Withdrawal by Subject|1
380397|NCT00873093|1278377|P5|Overall Study|Physician Decision|2
380398|NCT00873093|1278378|P4|Overall Study|Physician Decision|10
380399|NCT00873093|1278379|P3|Overall Study|Physician Decision|10
380400|NCT00873093|1278380|P2|Overall Study|Physician Decision|17
380401|NCT00873093|1278381|P1|Overall Study|Physician Decision|0
380402|NCT00873093|1278377|P5|Overall Study|Death|0
380403|NCT00873093|1278378|P4|Overall Study|Death|0
380404|NCT00873093|1278379|P3|Overall Study|Death|2
380405|NCT00873093|1278380|P2|Overall Study|Death|3
380406|NCT00873093|1278381|P1|Overall Study|Death|0
380407|NCT00873093|1278377|P5|Overall Study|Adverse Event|0
380408|NCT00873093|1278378|P4|Overall Study|Adverse Event|0
380409|NCT00873093|1278379|P3|Overall Study|Adverse Event|0
380410|NCT00873093|1278380|P2|Overall Study|Adverse Event|2
380411|NCT00873093|1278381|P1|Overall Study|Adverse Event|0
380412|NCT00873041|1278438|P3|Extension Study|Administrative reasons|1
380413|NCT00873041|1278439|P2|Extension Study|Administrative reasons|0
380414|NCT00873041|1278440|P1|Extension Study|Administrative reasons|0
380415|NCT00873041|1278438|P3|Extension Study|Adverse Event|1
380416|NCT00873041|1278439|P2|Extension Study|Adverse Event|0
380417|NCT00873041|1278440|P1|Extension Study|Adverse Event|1
380418|NCT00873041|1278438|P3|Core Study|Protocol deviation|1
380419|NCT00873041|1278439|P2|Core Study|Protocol deviation|0
380420|NCT00873041|1278440|P1|Core Study|Protocol deviation|1
380421|NCT00873041|1278438|P3|Core Study|Abnormal laboratory value|1
380422|NCT00873041|1278439|P2|Core Study|Abnormal laboratory value|0
380423|NCT00873041|1278440|P1|Core Study|Abnormal laboratory value|0
380424|NCT00873041|1278438|P3|Core Study|Lost to Follow-up|0
380425|NCT00873041|1278439|P2|Core Study|Lost to Follow-up|1
380426|NCT00873041|1278440|P1|Core Study|Lost to Follow-up|3
380427|NCT00873041|1278438|P3|Core Study|Withdrawal by Subject|2
380428|NCT00873041|1278439|P2|Core Study|Withdrawal by Subject|2
380429|NCT00873041|1278440|P1|Core Study|Withdrawal by Subject|1
380430|NCT00873041|1278438|P3|Core Study|Adverse Event|1
380431|NCT00873041|1278439|P2|Core Study|Adverse Event|3
380432|NCT00873041|1278440|P1|Core Study|Adverse Event|2
380433|NCT00873015|1278498|P4|Overall Study|Withdrawal by Subject|0
380434|NCT00873015|1278499|P3|Overall Study|Withdrawal by Subject|0
380435|NCT00873015|1278500|P2|Overall Study|Withdrawal by Subject|1
380436|NCT00873015|1278501|P1|Overall Study|Withdrawal by Subject|0
380437|NCT00872989|1278510|P2|Overall Study|Not protocol specified|8
380438|NCT00872989|1278511|P1|Overall Study|Not protocol specified|3
380439|NCT00872989|1278510|P2|Overall Study|Progression/relapse|35
380440|NCT00872989|1278511|P1|Overall Study|Progression/relapse|47
380441|NCT00872989|1278510|P2|Overall Study|Withdrawal by Subject|5
380442|NCT00872989|1278511|P1|Overall Study|Withdrawal by Subject|8
380443|NCT00872989|1278510|P2|Overall Study|Adverse Event|15
380444|NCT00872989|1278511|P1|Overall Study|Adverse Event|7
380445|NCT00872898|1278530|P2|Part Two - Double Blind|Other reasons|0
380446|NCT00872898|1278531|P1|Part Two - Double Blind|Other reasons|2
380447|NCT00872898|1278530|P2|Part Two - Double Blind|Lost to Follow-up|2
380448|NCT00872898|1278531|P1|Part Two - Double Blind|Lost to Follow-up|0
380449|NCT00872898|1278530|P2|Part Two - Double Blind|Withdrawal by Subject|1
380450|NCT00872898|1278531|P1|Part Two - Double Blind|Withdrawal by Subject|3
380451|NCT00872898|1278530|P2|Part Two - Double Blind|Protocol Violation|0
380452|NCT00872898|1278531|P1|Part Two - Double Blind|Protocol Violation|1
380453|NCT00872898|1278530|P2|Part Two - Double Blind|Lack of Efficacy|0
380454|NCT00872898|1278531|P1|Part Two - Double Blind|Lack of Efficacy|1
380455|NCT00872898|1278530|P2|Part Two - Double Blind|Adverse Event|3
380456|NCT00872898|1278531|P1|Part Two - Double Blind|Adverse Event|4
380457|NCT00872599|1278605|P2|Second Washout Period|Adverse Event|1
380458|NCT00872599|1278606|P1|Second Washout Period|Adverse Event|1
380459|NCT00872521|1278626|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
380460|NCT00872521|1278627|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
380461|NCT00872521|1278628|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
380462|NCT00872521|1278626|P3|Completed 3-month Follow up|Physician Decision|0
380463|NCT00872521|1278627|P2|Completed 3-month Follow up|Physician Decision|1
380464|NCT00872521|1278628|P1|Completed 3-month Follow up|Physician Decision|0
380465|NCT00872521|1278626|P3|Completed 3-month Follow up|Not specified|0
380466|NCT00872521|1278627|P2|Completed 3-month Follow up|Not specified|2
380467|NCT00872521|1278628|P1|Completed 3-month Follow up|Not specified|0
380468|NCT00872521|1278626|P3|Primary Endpoint Analysis|Patient response missing|1
380469|NCT00872521|1278627|P2|Primary Endpoint Analysis|Patient response missing|0
380470|NCT00872521|1278628|P1|Primary Endpoint Analysis|Patient response missing|0
380471|NCT00872521|1278626|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
380472|NCT00872521|1278627|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
380473|NCT00872521|1278628|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
380474|NCT00872521|1278626|P3|Primary Endpoint Analysis|Patient choice|0
380475|NCT00872521|1278627|P2|Primary Endpoint Analysis|Patient choice|1
380476|NCT00872521|1278628|P1|Primary Endpoint Analysis|Patient choice|0
380477|NCT00872521|1278626|P3|Primary Endpoint Analysis|Not specified|0
380478|NCT00872521|1278627|P2|Primary Endpoint Analysis|Not specified|2
380479|NCT00872521|1278628|P1|Primary Endpoint Analysis|Not specified|1
380480|NCT00872521|1278626|P3|Completed PAD Induction|Death|0
380481|NCT00872521|1278627|P2|Completed PAD Induction|Death|1
380482|NCT00872521|1278628|P1|Completed PAD Induction|Death|1
380483|NCT00872521|1278626|P3|Completed PAD Induction|Adverse Event|0
380484|NCT00872521|1278627|P2|Completed PAD Induction|Adverse Event|0
380485|NCT00872521|1278628|P1|Completed PAD Induction|Adverse Event|4
380486|NCT00872521|1278626|P3|Completed PAD Induction|Disease progression|0
380487|NCT00872521|1278627|P2|Completed PAD Induction|Disease progression|2
380488|NCT00872521|1278628|P1|Completed PAD Induction|Disease progression|0
380489|NCT00872521|1278626|P3|Completed PAD Induction|Patient choice|0
380490|NCT00872521|1278627|P2|Completed PAD Induction|Patient choice|1
380491|NCT00872521|1278628|P1|Completed PAD Induction|Patient choice|0
380492|NCT00872170|1278699|P2|Overall Study|Adverse Event|0
380493|NCT00872170|1278700|P1|Overall Study|Adverse Event|1
380494|NCT00872001|1278730|P2|Overall Study|Administrative|15
380495|NCT00872001|1278731|P1|Overall Study|Administrative|23
380496|NCT00872001|1278730|P2|Overall Study|Did Not Meet Protocol Eligibility|36
380497|NCT00872001|1278731|P1|Overall Study|Did Not Meet Protocol Eligibility|38
380498|NCT00872001|1278730|P2|Overall Study|Protocol Violation|8
380499|NCT00872001|1278731|P1|Overall Study|Protocol Violation|5
380500|NCT00872001|1278730|P2|Overall Study|Withdrawal by Subject|30
380501|NCT00872001|1278731|P1|Overall Study|Withdrawal by Subject|18
380502|NCT00872001|1278730|P2|Overall Study|Lost to Follow-up|12
380503|NCT00872001|1278731|P1|Overall Study|Lost to Follow-up|13
380504|NCT00872001|1278730|P2|Overall Study|Protocol Defined Clinical Event|7
380505|NCT00872001|1278731|P1|Overall Study|Protocol Defined Clinical Event|5
380506|NCT00872001|1278730|P2|Overall Study|Adverse Event|23
380507|NCT00872001|1278731|P1|Overall Study|Adverse Event|34
380508|NCT00871975|1278739|P1|Overall Study|Motion artifact, tracing uninterpretable|5
380509|NCT00871975|1278739|P1|Overall Study|Patient unable to void/insufficient vol|13
380510|NCT00871975|1278739|P1|Overall Study|Catheters could not be inserted|1
380511|NCT00871975|1278739|P1|Overall Study|Technical difficulty w155-1ith equipment|3
380512|NCT00871871|1278745|P4|Part II|Protocol Violation|1
380513|NCT00871871|1278746|P3|Part II|Protocol Violation|0
380514|NCT00871871|1278747|P2|Part II|Protocol Violation|0
380515|NCT00871871|1278748|P1|Part II|Protocol Violation|0
380516|NCT00871871|1278745|P4|Part II|Adverse Event|2
380517|NCT00871871|1278746|P3|Part II|Adverse Event|1
380518|NCT00871871|1278747|P2|Part II|Adverse Event|0
380519|NCT00871871|1278748|P1|Part II|Adverse Event|0
380520|NCT00871871|1278745|P4|Part II|Withdrawal by Subject|1
380521|NCT00871871|1278746|P3|Part II|Withdrawal by Subject|2
380522|NCT00871871|1278747|P2|Part II|Withdrawal by Subject|0
380523|NCT00871871|1278748|P1|Part II|Withdrawal by Subject|0
380524|NCT00871871|1278745|P4|Part II|Lack of Efficacy|0
380525|NCT00871871|1278746|P3|Part II|Lack of Efficacy|1
380526|NCT00871871|1278747|P2|Part II|Lack of Efficacy|0
380527|NCT00871871|1278748|P1|Part II|Lack of Efficacy|0
380528|NCT00871871|1278745|P4|Part I|Laboratory abnormality|0
380529|NCT00871871|1278746|P3|Part I|Laboratory abnormality|0
380530|NCT00871871|1278747|P2|Part I|Laboratory abnormality|1
380531|NCT00871871|1278748|P1|Part I|Laboratory abnormality|0
380532|NCT00871871|1278745|P4|Part I|Withdrawal by Subject|0
380533|NCT00871871|1278746|P3|Part I|Withdrawal by Subject|0
380534|NCT00871871|1278747|P2|Part I|Withdrawal by Subject|0
380535|NCT00871871|1278748|P1|Part I|Withdrawal by Subject|3
380536|NCT00871871|1278745|P4|Part I|Adverse Event|0
380537|NCT00871871|1278746|P3|Part I|Adverse Event|0
380538|NCT00871871|1278747|P2|Part I|Adverse Event|2
380539|NCT00871871|1278748|P1|Part I|Adverse Event|0
380540|NCT00871780|1278772|P1|Overall Study|Physician Decision|1
380541|NCT00871780|1278772|P1|Overall Study|Death|1
380542|NCT00871780|1278772|P1|Overall Study|Voluntary Discontinuation|4
380543|NCT00871780|1278772|P1|Overall Study|Adverse Event|6
380544|NCT00871780|1278772|P1|Overall Study|Withdrawal by Subject|9
380545|NCT00871780|1278772|P1|Overall Study|Enrolled But Not Treated|6
380546|NCT00871741|1278792|P2|Overall Study|Premature study termination|7
380547|NCT00871741|1278793|P1|Overall Study|Premature study termination|9
380548|NCT00871728|1278807|P1|Overall Study|Withdrawal of Informed Consent|5
380549|NCT00871728|1278807|P1|Overall Study|Participant Non-compliance|1
380550|NCT00871728|1278807|P1|Overall Study|Failed to Visit Hospital|4
380551|NCT00871728|1278807|P1|Overall Study|Lost to Follow-up|2
380552|NCT00871728|1278807|P1|Overall Study|Protocol Violation|7
380553|NCT00871728|1278807|P1|Overall Study|Adverse Event|1
380554|NCT00871715|1278820|P3|Overall Study|Lost to Follow-up|9
380555|NCT00871715|1278821|P2|Overall Study|Lost to Follow-up|6
380556|NCT00871715|1278822|P1|Overall Study|Lost to Follow-up|3
380557|NCT00871715|1278820|P3|Overall Study|Physician Decision|2
380558|NCT00871715|1278821|P2|Overall Study|Physician Decision|0
380559|NCT00871715|1278822|P1|Overall Study|Physician Decision|6
380560|NCT00871715|1278820|P3|Overall Study|Withdrawal by Subject|15
380561|NCT00871715|1278821|P2|Overall Study|Withdrawal by Subject|10
380562|NCT00871715|1278822|P1|Overall Study|Withdrawal by Subject|6
380563|NCT00871572|1278866|P4|Overall Study|Withdrawal by Subject|1
380564|NCT00871572|1278867|P3|Overall Study|Withdrawal by Subject|3
380565|NCT00871572|1278868|P2|Overall Study|Withdrawal by Subject|2
380566|NCT00871572|1278869|P1|Overall Study|Withdrawal by Subject|1
380567|NCT00871572|1278866|P4|Overall Study|Sponsor Decision|0
380568|NCT00871572|1278867|P3|Overall Study|Sponsor Decision|0
380569|NCT00871572|1278868|P2|Overall Study|Sponsor Decision|0
380570|NCT00871572|1278869|P1|Overall Study|Sponsor Decision|1
380571|NCT00871572|1278866|P4|Overall Study|Protocol Violation|1
380572|NCT00871572|1278867|P3|Overall Study|Protocol Violation|1
380573|NCT00871572|1278868|P2|Overall Study|Protocol Violation|0
380574|NCT00871572|1278869|P1|Overall Study|Protocol Violation|0
380575|NCT00871572|1278866|P4|Overall Study|Lost to Follow-up|1
380576|NCT00871572|1278867|P3|Overall Study|Lost to Follow-up|0
380577|NCT00871572|1278868|P2|Overall Study|Lost to Follow-up|1
380578|NCT00871572|1278869|P1|Overall Study|Lost to Follow-up|0
380579|NCT00871572|1278866|P4|Overall Study|Investigator Decision|1
380580|NCT00871572|1278867|P3|Overall Study|Investigator Decision|0
380581|NCT00871572|1278868|P2|Overall Study|Investigator Decision|1
380582|NCT00871572|1278869|P1|Overall Study|Investigator Decision|0
380583|NCT00871572|1278866|P4|Overall Study|Adverse Event|3
380584|NCT00871572|1278867|P3|Overall Study|Adverse Event|0
380585|NCT00871572|1278868|P2|Overall Study|Adverse Event|2
380586|NCT00871572|1278869|P1|Overall Study|Adverse Event|0
380587|NCT00871494|1278939|P1|Overall Study|Lost to Follow-up|1
380588|NCT00871494|1278939|P1|Overall Study|Adverse Event|4
380589|NCT00871494|1278939|P1|Overall Study|Lack of Efficacy|4
380590|NCT00871494|1278939|P1|Overall Study|Protocol Violation|5
380591|NCT00871429|1278946|P1|Overall Study|Questionnaire not completed|1
380592|NCT00871429|1278946|P1|Overall Study|Withdrawal by Subject|17
380593|NCT00871429|1278946|P1|Overall Study|Lost to Follow-up|6
380594|NCT00871403|1278957|P3|Monotherapy Treatment Phase|Adverse Event|0
380595|NCT00871403|1278958|P2|Monotherapy Treatment Phase|Adverse Event|4
380596|NCT00871403|1278959|P1|Monotherapy Treatment Phase|Adverse Event|0
380597|NCT00871403|1278957|P3|Monotherapy Treatment Phase|Disease Progression|1
380598|NCT00871403|1278958|P2|Monotherapy Treatment Phase|Disease Progression|9
380599|NCT00871403|1278959|P1|Monotherapy Treatment Phase|Disease Progression|0
380600|NCT00871403|1278957|P3|Combination Treatment Phase|Physician Decision|3
380601|NCT00871403|1278958|P2|Combination Treatment Phase|Physician Decision|1
380602|NCT00871403|1278959|P1|Combination Treatment Phase|Physician Decision|0
380603|NCT00871403|1278957|P3|Combination Treatment Phase|Withdrawal by Subject|1
380604|NCT00871403|1278958|P2|Combination Treatment Phase|Withdrawal by Subject|3
380605|NCT00871403|1278959|P1|Combination Treatment Phase|Withdrawal by Subject|0
380606|NCT00871403|1278957|P3|Combination Treatment Phase|Disease Progression|5
380607|NCT00871403|1278958|P2|Combination Treatment Phase|Disease Progression|8
380608|NCT00871403|1278959|P1|Combination Treatment Phase|Disease Progression|0
380609|NCT00871403|1278957|P3|Combination Treatment Phase|Adverse Event|2
380610|NCT00871403|1278958|P2|Combination Treatment Phase|Adverse Event|17
380611|NCT00871403|1278959|P1|Combination Treatment Phase|Adverse Event|0
380612|NCT00871403|1278957|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
380613|NCT00871403|1278958|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
380614|NCT00871403|1278959|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
380615|NCT00871403|1278957|P3|Combination Treatment Phase|Randomized but Not Treated|1
380616|NCT00871403|1278958|P2|Combination Treatment Phase|Randomized but Not Treated|1
380617|NCT00871403|1278959|P1|Combination Treatment Phase|Randomized but Not Treated|1
380618|NCT00871377|1278972|P6|Third Intervention (10 Weeks)|Death|0
380619|NCT00871377|1278973|P5|Third Intervention (10 Weeks)|Death|0
380620|NCT00871377|1278974|P4|Third Intervention (10 Weeks)|Death|1
380621|NCT00871377|1278975|P3|Third Intervention (10 Weeks)|Death|0
380622|NCT00871377|1278976|P2|Third Intervention (10 Weeks)|Death|0
380623|NCT00871377|1278977|P1|Third Intervention (10 Weeks)|Death|0
380624|NCT00871377|1278972|P6|Washout (6 Weeks)|Withdrawal by Subject|1
380625|NCT00871377|1278973|P5|Washout (6 Weeks)|Withdrawal by Subject|0
380626|NCT00871377|1278974|P4|Washout (6 Weeks)|Withdrawal by Subject|0
380627|NCT00871377|1278975|P3|Washout (6 Weeks)|Withdrawal by Subject|0
380628|NCT00871377|1278976|P2|Washout (6 Weeks)|Withdrawal by Subject|0
380629|NCT00871377|1278977|P1|Washout (6 Weeks)|Withdrawal by Subject|0
380630|NCT00871377|1278972|P6|Washout (6 Weeks)|Withdrawal by Subject|0
380631|NCT00871377|1278973|P5|Washout (6 Weeks)|Withdrawal by Subject|0
380632|NCT00871377|1278974|P4|Washout (6 Weeks)|Withdrawal by Subject|0
380633|NCT00871377|1278975|P3|Washout (6 Weeks)|Withdrawal by Subject|0
380634|NCT00871377|1278976|P2|Washout (6 Weeks)|Withdrawal by Subject|0
380635|NCT00871377|1278977|P1|Washout (6 Weeks)|Withdrawal by Subject|1
380636|NCT00871377|1278972|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
380637|NCT00871377|1278973|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
380638|NCT00871377|1278974|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
380639|NCT00871377|1278975|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
380640|NCT00871377|1278976|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
380641|NCT00871377|1278977|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
380642|NCT00871377|1278972|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
380643|NCT00871377|1278973|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
380644|NCT00871377|1278974|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
380645|NCT00871377|1278975|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
380646|NCT00871377|1278976|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
380647|NCT00871377|1278977|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
380648|NCT00871351|1278988|P3|Overall Study|Adverse Event|0
380649|NCT00871351|1278989|P2|Overall Study|Adverse Event|1
380650|NCT00871351|1278990|P1|Overall Study|Adverse Event|3
380651|NCT00871351|1278988|P3|Overall Study|Withdrawal by Subject|0
380652|NCT00871351|1278989|P2|Overall Study|Withdrawal by Subject|0
380653|NCT00871351|1278990|P1|Overall Study|Withdrawal by Subject|1
380654|NCT00871338|1279012|P2|Prior to Booster|Lost to Follow-up|0
380655|NCT00871338|1279013|P1|Prior to Booster|Lost to Follow-up|1
380656|NCT00871338|1279012|P2|Prior to Booster|Withdrawal by Subject|3
380657|NCT00871338|1279013|P1|Prior to Booster|Withdrawal by Subject|1
380658|NCT00871234|1279102|P1|Overall Study|Lost to Follow-up|3
380659|NCT00871234|1279102|P1|Overall Study|Adverse Event|2
380660|NCT00871169|1279106|P1|Overall Study|Patient did not receive study treatment|2
380661|NCT00871169|1279106|P1|Overall Study|Protocol Violation|1
380662|NCT00871117|1279134|P2|Overall Study|Lost to Follow-up|10
380663|NCT00871117|1279135|P1|Overall Study|Lost to Follow-up|5
380664|NCT00871000|1279167|P2|Overall Study|Withdrawal by Subject|0
380665|NCT00871000|1279168|P1|Overall Study|Withdrawal by Subject|1
380666|NCT00870870|1279220|P4|Overall Study|Adverse Event|2
380667|NCT00870870|1279221|P3|Overall Study|Adverse Event|2
380668|NCT00870870|1279222|P2|Overall Study|Adverse Event|0
380669|NCT00870870|1279223|P1|Overall Study|Adverse Event|0
380670|NCT00870870|1279220|P4|Overall Study|Withdrawal by Subject|3
380671|NCT00870870|1279221|P3|Overall Study|Withdrawal by Subject|1
380672|NCT00870870|1279222|P2|Overall Study|Withdrawal by Subject|1
380673|NCT00870870|1279223|P1|Overall Study|Withdrawal by Subject|0
380674|NCT00870740|1279267|P6|Overall Study|Not Specified|5
380675|NCT00870740|1279268|P5|Overall Study|Not Specified|3
380676|NCT00870740|1279269|P4|Overall Study|Not Specified|4
380677|NCT00870740|1279270|P3|Overall Study|Not Specified|2
380678|NCT00870740|1279271|P2|Overall Study|Not Specified|5
380679|NCT00870740|1279272|P1|Overall Study|Not Specified|2
380680|NCT00870740|1279267|P6|Overall Study|Death|0
380681|NCT00870740|1279268|P5|Overall Study|Death|1
380682|NCT00870740|1279269|P4|Overall Study|Death|0
380683|NCT00870740|1279270|P3|Overall Study|Death|0
380684|NCT00870740|1279271|P2|Overall Study|Death|0
380685|NCT00870740|1279272|P1|Overall Study|Death|0
380686|NCT00870740|1279267|P6|Overall Study|Subject Non-compliance|1
380687|NCT00870740|1279268|P5|Overall Study|Subject Non-compliance|0
380688|NCT00870740|1279269|P4|Overall Study|Subject Non-compliance|0
380689|NCT00870740|1279270|P3|Overall Study|Subject Non-compliance|0
380690|NCT00870740|1279271|P2|Overall Study|Subject Non-compliance|0
380691|NCT00870740|1279272|P1|Overall Study|Subject Non-compliance|0
380692|NCT00870740|1279267|P6|Overall Study|Investigator Decision|0
380693|NCT00870740|1279268|P5|Overall Study|Investigator Decision|0
380694|NCT00870740|1279269|P4|Overall Study|Investigator Decision|0
380695|NCT00870740|1279270|P3|Overall Study|Investigator Decision|1
380696|NCT00870740|1279271|P2|Overall Study|Investigator Decision|0
380697|NCT00870740|1279272|P1|Overall Study|Investigator Decision|2
380698|NCT00870740|1279267|P6|Overall Study|Consent Withdrawn|5
380699|NCT00870740|1279268|P5|Overall Study|Consent Withdrawn|6
380700|NCT00870740|1279269|P4|Overall Study|Consent Withdrawn|6
380701|NCT00870740|1279270|P3|Overall Study|Consent Withdrawn|4
380702|NCT00870740|1279271|P2|Overall Study|Consent Withdrawn|3
380703|NCT00870740|1279272|P1|Overall Study|Consent Withdrawn|6
380704|NCT00870740|1279267|P6|Overall Study|Adverse Event|6
380705|NCT00870740|1279268|P5|Overall Study|Adverse Event|1
380706|NCT00870740|1279269|P4|Overall Study|Adverse Event|2
380707|NCT00870740|1279270|P3|Overall Study|Adverse Event|3
380708|NCT00870740|1279271|P2|Overall Study|Adverse Event|1
380709|NCT00870740|1279272|P1|Overall Study|Adverse Event|2
380710|NCT00870688|1279346|P1|Overall Study|Granules in the Stools|1
380711|NCT00870688|1279346|P1|Overall Study|Death, Unrelated|1
380712|NCT00870688|1279346|P1|Overall Study|Lost to Follow-up|2
380713|NCT00870584|1279351|P2|Overall Study|Protocol Deviation|2
380714|NCT00870584|1279352|P1|Overall Study|Protocol Deviation|2
380715|NCT00870584|1279351|P2|Overall Study|Lost to Follow-up|1
380716|NCT00870584|1279352|P1|Overall Study|Lost to Follow-up|5
380717|NCT00870584|1279351|P2|Overall Study|Withdrawal by Subject|7
380718|NCT00870584|1279352|P1|Overall Study|Withdrawal by Subject|6
380719|NCT00870584|1279351|P2|Overall Study|Adverse Event|3
380720|NCT00870584|1279352|P1|Overall Study|Adverse Event|3
380721|NCT00870194|1279463|P2|Overall Study|Subject Decision|2
380722|NCT00870194|1279464|P1|Overall Study|Subject Decision|7
380723|NCT00870194|1279463|P2|Overall Study|Entry Criteria Not Met|2
380724|NCT00870194|1279464|P1|Overall Study|Entry Criteria Not Met|1
380725|NCT00870194|1279463|P2|Overall Study|Protocol Violation|3
380726|NCT00870194|1279464|P1|Overall Study|Protocol Violation|3
380727|NCT00870194|1279463|P2|Overall Study|Physician Decision|1
380728|NCT00870194|1279464|P1|Overall Study|Physician Decision|3
380729|NCT00870194|1279463|P2|Overall Study|Lost to Follow-up|0
380730|NCT00870194|1279464|P1|Overall Study|Lost to Follow-up|2
380731|NCT00870194|1279463|P2|Overall Study|Lack of Efficacy|1
380732|NCT00870194|1279464|P1|Overall Study|Lack of Efficacy|0
380733|NCT00870194|1279463|P2|Overall Study|Adverse Event|5
380734|NCT00870194|1279464|P1|Overall Study|Adverse Event|10
380735|NCT00870103|1279502|P1|Overall Study|Lost to Follow-up|2
380736|NCT00870103|1279502|P1|Overall Study|Physician Decision|2
380737|NCT00869999|1279507|P1|Overall Study|removed prior to starting therapy|1
380738|NCT00869999|1279507|P1|Overall Study|Withdrawal by Subject|1
380739|NCT00869960|1279513|P1|Overall Study|Lost to Follow-up|2
380740|NCT00869778|1279562|P3|Overall Study|Unblinding|0
380741|NCT00869778|1279563|P2|Overall Study|Unblinding|0
380742|NCT00869778|1279564|P1|Overall Study|Unblinding|1
380743|NCT00869778|1279562|P3|Overall Study|Protocol Violation|5
380744|NCT00869778|1279563|P2|Overall Study|Protocol Violation|3
380745|NCT00869778|1279564|P1|Overall Study|Protocol Violation|5
380746|NCT00869778|1279562|P3|Overall Study|Pregnancy|0
380747|NCT00869778|1279563|P2|Overall Study|Pregnancy|0
380748|NCT00869778|1279564|P1|Overall Study|Pregnancy|1
380749|NCT00869778|1279562|P3|Overall Study|Withdrawal by Subject|5
380750|NCT00869778|1279563|P2|Overall Study|Withdrawal by Subject|4
380751|NCT00869778|1279564|P1|Overall Study|Withdrawal by Subject|3
380752|NCT00869778|1279562|P3|Overall Study|Adverse Event|0
380753|NCT00869778|1279563|P2|Overall Study|Adverse Event|0
380754|NCT00869778|1279564|P1|Overall Study|Adverse Event|2
380755|NCT00869557|1279639|P2|Extension Phase|Withdrew Consent|0
380756|NCT00869557|1279640|P1|Extension Phase|Withdrew Consent|2
380757|NCT00869557|1279639|P2|Extension Phase|Investigator's Discretion|0
380758|NCT00869557|1279640|P1|Extension Phase|Investigator's Discretion|2
380759|NCT00869557|1279639|P2|Extension Phase|Lost to Follow-up|1
380760|NCT00869557|1279640|P1|Extension Phase|Lost to Follow-up|3
380761|NCT00869557|1279639|P2|Extension Phase|Lack of Efficacy|0
380762|NCT00869557|1279640|P1|Extension Phase|Lack of Efficacy|1
380763|NCT00869557|1279639|P2|Extension Phase|Adverse Event|2
380764|NCT00869557|1279640|P1|Extension Phase|Adverse Event|2
380765|NCT00869557|1279639|P2|Randomized Phase|Withdrew Consent|1
380766|NCT00869557|1279640|P1|Randomized Phase|Withdrew Consent|0
380767|NCT00869557|1279639|P2|Randomized Phase|Investigator's Discretion|0
380768|NCT00869557|1279640|P1|Randomized Phase|Investigator's Discretion|1
380769|NCT00869557|1279639|P2|Randomized Phase|Lost to Follow-up|1
380770|NCT00869557|1279640|P1|Randomized Phase|Lost to Follow-up|2
380771|NCT00869518|1279659|P2|Overall Study|Lost to Follow-up|1
380772|NCT00869518|1279660|P1|Overall Study|Lost to Follow-up|1
380773|NCT00869401|1279688|P5|Overall Study|Withdrawal by Subject|3
380774|NCT00869401|1279689|P4|Overall Study|Withdrawal by Subject|5
380775|NCT00869401|1279690|P3|Overall Study|Withdrawal by Subject|0
380776|NCT00869401|1279691|P2|Overall Study|Withdrawal by Subject|0
380777|NCT00869401|1279692|P1|Overall Study|Withdrawal by Subject|0
380778|NCT00869362|1279721|P2|Overall Study|Lost to Follow-up|3
380779|NCT00869362|1279722|P1|Overall Study|Lost to Follow-up|1
380780|NCT00869362|1279721|P2|Overall Study|Death|2
380781|NCT00869362|1279722|P1|Overall Study|Death|0
380782|NCT00869323|1279743|P1|Maintenance Therapy|concurrent illness|1
380783|NCT00869258|1279751|P1|Overall Study|Physician Decision|1
380784|NCT00869128|1279785|P2|Overall Study|lack of Compliance|6
380785|NCT00869128|1279786|P1|Overall Study|lack of Compliance|6
380786|NCT00869089|1279790|P1|Overall Study|Screen Fail|1
380787|NCT00869089|1279790|P1|Overall Study|Withdrawal by Subject|1
380788|NCT00869089|1279790|P1|Overall Study|Lost to Follow-up|1
380789|NCT00869050|1279794|P1|Overall Study|Screen Failure|3
380790|NCT00868998|1279799|P1|Overall Study|Death|1
380791|NCT00868998|1279799|P1|Overall Study|Progression of disease|2
380792|NCT00868998|1279799|P1|Overall Study|Withdrawal by Subject|1
380793|NCT00868998|1279799|P1|Overall Study|Screen Failure|1
380794|NCT00868790|1279810|P14|Post-study|Excluded Medication|0
380795|NCT00868790|1279811|P13|Post-study|Excluded Medication|0
380796|NCT00868790|1279812|P12|Post-study|Excluded Medication|0
380797|NCT00868790|1279813|P11|Post-study|Excluded Medication|0
380798|NCT00868790|1279814|P10|Post-study|Excluded Medication|1
380799|NCT00868790|1279815|P9|Post-study|Excluded Medication|0
380800|NCT00868790|1279816|P8|Post-study|Excluded Medication|2
380801|NCT00868790|1279817|P7|Post-study|Excluded Medication|0
380802|NCT00868790|1279818|P6|Post-study|Excluded Medication|0
380803|NCT00868790|1279819|P5|Post-study|Excluded Medication|0
380804|NCT00868790|1279820|P4|Post-study|Excluded Medication|0
380805|NCT00868790|1279821|P3|Post-study|Excluded Medication|0
380806|NCT00868790|1279822|P2|Post-study|Excluded Medication|0
380807|NCT00868790|1279823|P1|Post-study|Excluded Medication|0
380808|NCT00868790|1279810|P14|Post-study|Withdrawal by Subject|0
380809|NCT00868790|1279811|P13|Post-study|Withdrawal by Subject|0
380810|NCT00868790|1279812|P12|Post-study|Withdrawal by Subject|0
380811|NCT00868790|1279813|P11|Post-study|Withdrawal by Subject|0
380812|NCT00868790|1279814|P10|Post-study|Withdrawal by Subject|0
380813|NCT00868790|1279815|P9|Post-study|Withdrawal by Subject|0
380814|NCT00868790|1279816|P8|Post-study|Withdrawal by Subject|0
380815|NCT00868790|1279817|P7|Post-study|Withdrawal by Subject|0
380816|NCT00868790|1279818|P6|Post-study|Withdrawal by Subject|0
380817|NCT00868790|1279819|P5|Post-study|Withdrawal by Subject|1
380818|NCT00868790|1279820|P4|Post-study|Withdrawal by Subject|0
380819|NCT00868790|1279821|P3|Post-study|Withdrawal by Subject|0
380820|NCT00868790|1279822|P2|Post-study|Withdrawal by Subject|0
380821|NCT00868790|1279823|P1|Post-study|Withdrawal by Subject|0
380822|NCT00868790|1279810|P14|Period 4|Abnormal ALT/AST|0
380823|NCT00868790|1279811|P13|Period 4|Abnormal ALT/AST|0
380824|NCT00868790|1279812|P12|Period 4|Abnormal ALT/AST|0
380825|NCT00868790|1279813|P11|Period 4|Abnormal ALT/AST|0
380826|NCT00868790|1279814|P10|Period 4|Abnormal ALT/AST|0
380827|NCT00868790|1279815|P9|Period 4|Abnormal ALT/AST|0
380828|NCT00868790|1279816|P8|Period 4|Abnormal ALT/AST|0
380829|NCT00868790|1279817|P7|Period 4|Abnormal ALT/AST|0
380830|NCT00868790|1279818|P6|Period 4|Abnormal ALT/AST|0
380831|NCT00868790|1279819|P5|Period 4|Abnormal ALT/AST|0
380832|NCT00868790|1279820|P4|Period 4|Abnormal ALT/AST|0
380833|NCT00868790|1279821|P3|Period 4|Abnormal ALT/AST|1
380834|NCT00868790|1279822|P2|Period 4|Abnormal ALT/AST|0
380835|NCT00868790|1279823|P1|Period 4|Abnormal ALT/AST|0
380836|NCT00868790|1279810|P14|Period 4|Study Terminated by Sponsor|1
380837|NCT00868790|1279811|P13|Period 4|Study Terminated by Sponsor|0
380838|NCT00868790|1279812|P12|Period 4|Study Terminated by Sponsor|1
380839|NCT00868790|1279813|P11|Period 4|Study Terminated by Sponsor|2
380840|NCT00868790|1279814|P10|Period 4|Study Terminated by Sponsor|0
380841|NCT00868790|1279815|P9|Period 4|Study Terminated by Sponsor|2
380842|NCT00868790|1279816|P8|Period 4|Study Terminated by Sponsor|1
380843|NCT00868790|1279817|P7|Period 4|Study Terminated by Sponsor|0
380844|NCT00868790|1279818|P6|Period 4|Study Terminated by Sponsor|0
380845|NCT00868790|1279819|P5|Period 4|Study Terminated by Sponsor|0
380846|NCT00868790|1279820|P4|Period 4|Study Terminated by Sponsor|0
380847|NCT00868790|1279821|P3|Period 4|Study Terminated by Sponsor|0
380848|NCT00868790|1279822|P2|Period 4|Study Terminated by Sponsor|0
380849|NCT00868790|1279823|P1|Period 4|Study Terminated by Sponsor|2
380850|NCT00868790|1279810|P14|Period 4|Lost to Follow-up|0
380851|NCT00868790|1279811|P13|Period 4|Lost to Follow-up|0
380852|NCT00868790|1279812|P12|Period 4|Lost to Follow-up|0
380853|NCT00868790|1279813|P11|Period 4|Lost to Follow-up|0
380854|NCT00868790|1279814|P10|Period 4|Lost to Follow-up|0
380855|NCT00868790|1279815|P9|Period 4|Lost to Follow-up|0
380856|NCT00868790|1279816|P8|Period 4|Lost to Follow-up|1
380857|NCT00868790|1279817|P7|Period 4|Lost to Follow-up|0
380858|NCT00868790|1279818|P6|Period 4|Lost to Follow-up|0
380859|NCT00868790|1279819|P5|Period 4|Lost to Follow-up|0
380860|NCT00868790|1279820|P4|Period 4|Lost to Follow-up|0
380861|NCT00868790|1279821|P3|Period 4|Lost to Follow-up|0
380862|NCT00868790|1279822|P2|Period 4|Lost to Follow-up|0
380863|NCT00868790|1279823|P1|Period 4|Lost to Follow-up|0
380864|NCT00868790|1279810|P14|Period 4|Adverse Event|0
380865|NCT00868790|1279811|P13|Period 4|Adverse Event|1
380866|NCT00868790|1279812|P12|Period 4|Adverse Event|0
380867|NCT00868790|1279813|P11|Period 4|Adverse Event|1
380868|NCT00868790|1279814|P10|Period 4|Adverse Event|0
380869|NCT00868790|1279815|P9|Period 4|Adverse Event|0
380870|NCT00868790|1279816|P8|Period 4|Adverse Event|1
380871|NCT00868790|1279817|P7|Period 4|Adverse Event|0
380872|NCT00868790|1279818|P6|Period 4|Adverse Event|0
380873|NCT00868790|1279819|P5|Period 4|Adverse Event|0
380874|NCT00868790|1279820|P4|Period 4|Adverse Event|0
380875|NCT00868790|1279821|P3|Period 4|Adverse Event|0
380876|NCT00868790|1279822|P2|Period 4|Adverse Event|0
380877|NCT00868790|1279823|P1|Period 4|Adverse Event|0
380878|NCT00868790|1279810|P14|Period 3|Study Terminated by Sponsor|0
380879|NCT00868790|1279811|P13|Period 3|Study Terminated by Sponsor|0
380880|NCT00868790|1279812|P12|Period 3|Study Terminated by Sponsor|0
380881|NCT00868790|1279813|P11|Period 3|Study Terminated by Sponsor|0
380882|NCT00868790|1279814|P10|Period 3|Study Terminated by Sponsor|0
380883|NCT00868790|1279815|P9|Period 3|Study Terminated by Sponsor|0
380884|NCT00868790|1279816|P8|Period 3|Study Terminated by Sponsor|0
380885|NCT00868790|1279817|P7|Period 3|Study Terminated by Sponsor|0
380886|NCT00868790|1279818|P6|Period 3|Study Terminated by Sponsor|0
380887|NCT00868790|1279819|P5|Period 3|Study Terminated by Sponsor|0
380888|NCT00868790|1279820|P4|Period 3|Study Terminated by Sponsor|1
380889|NCT00868790|1279821|P3|Period 3|Study Terminated by Sponsor|0
380890|NCT00868790|1279822|P2|Period 3|Study Terminated by Sponsor|0
380891|NCT00868790|1279823|P1|Period 3|Study Terminated by Sponsor|0
380892|NCT00868790|1279810|P14|Period 3|Protocol Violation|0
380893|NCT00868790|1279811|P13|Period 3|Protocol Violation|0
380894|NCT00868790|1279812|P12|Period 3|Protocol Violation|0
380895|NCT00868790|1279813|P11|Period 3|Protocol Violation|1
380896|NCT00868790|1279814|P10|Period 3|Protocol Violation|0
380897|NCT00868790|1279815|P9|Period 3|Protocol Violation|0
380898|NCT00868790|1279816|P8|Period 3|Protocol Violation|0
380899|NCT00868790|1279817|P7|Period 3|Protocol Violation|0
380900|NCT00868790|1279818|P6|Period 3|Protocol Violation|0
380901|NCT00868790|1279819|P5|Period 3|Protocol Violation|0
380902|NCT00868790|1279820|P4|Period 3|Protocol Violation|0
380903|NCT00868790|1279821|P3|Period 3|Protocol Violation|0
380904|NCT00868790|1279822|P2|Period 3|Protocol Violation|0
380905|NCT00868790|1279823|P1|Period 3|Protocol Violation|0
380906|NCT00868790|1279810|P14|Period 3|Adverse Event|0
380907|NCT00868790|1279811|P13|Period 3|Adverse Event|0
380908|NCT00868790|1279812|P12|Period 3|Adverse Event|0
380909|NCT00868790|1279813|P11|Period 3|Adverse Event|0
380910|NCT00868790|1279814|P10|Period 3|Adverse Event|1
380911|NCT00868790|1279815|P9|Period 3|Adverse Event|0
380912|NCT00868790|1279816|P8|Period 3|Adverse Event|0
380913|NCT00868790|1279817|P7|Period 3|Adverse Event|0
380914|NCT00868790|1279818|P6|Period 3|Adverse Event|0
380915|NCT00868790|1279819|P5|Period 3|Adverse Event|0
380916|NCT00868790|1279820|P4|Period 3|Adverse Event|0
380917|NCT00868790|1279821|P3|Period 3|Adverse Event|0
380918|NCT00868790|1279822|P2|Period 3|Adverse Event|0
380919|NCT00868790|1279823|P1|Period 3|Adverse Event|0
380920|NCT00868790|1279810|P14|Period 2|Withdrawal by Subject|1
380921|NCT00868790|1279811|P13|Period 2|Withdrawal by Subject|0
380922|NCT00868790|1279812|P12|Period 2|Withdrawal by Subject|0
380923|NCT00868790|1279813|P11|Period 2|Withdrawal by Subject|0
380924|NCT00868790|1279814|P10|Period 2|Withdrawal by Subject|0
380925|NCT00868790|1279815|P9|Period 2|Withdrawal by Subject|1
380926|NCT00868790|1279816|P8|Period 2|Withdrawal by Subject|0
380927|NCT00868790|1279817|P7|Period 2|Withdrawal by Subject|0
380928|NCT00868790|1279818|P6|Period 2|Withdrawal by Subject|0
380929|NCT00868790|1279819|P5|Period 2|Withdrawal by Subject|0
380930|NCT00868790|1279820|P4|Period 2|Withdrawal by Subject|0
380931|NCT00868790|1279821|P3|Period 2|Withdrawal by Subject|0
380932|NCT00868790|1279822|P2|Period 2|Withdrawal by Subject|0
380933|NCT00868790|1279823|P1|Period 2|Withdrawal by Subject|0
380934|NCT00868790|1279810|P14|Period 2|Lost to Follow-up|0
380935|NCT00868790|1279811|P13|Period 2|Lost to Follow-up|0
380936|NCT00868790|1279812|P12|Period 2|Lost to Follow-up|0
380937|NCT00868790|1279813|P11|Period 2|Lost to Follow-up|0
380938|NCT00868790|1279814|P10|Period 2|Lost to Follow-up|0
380939|NCT00868790|1279815|P9|Period 2|Lost to Follow-up|0
380940|NCT00868790|1279816|P8|Period 2|Lost to Follow-up|0
380941|NCT00868790|1279817|P7|Period 2|Lost to Follow-up|0
380942|NCT00868790|1279818|P6|Period 2|Lost to Follow-up|1
380943|NCT00868790|1279819|P5|Period 2|Lost to Follow-up|0
380944|NCT00868790|1279820|P4|Period 2|Lost to Follow-up|0
380945|NCT00868790|1279821|P3|Period 2|Lost to Follow-up|0
380946|NCT00868790|1279822|P2|Period 2|Lost to Follow-up|1
380947|NCT00868790|1279823|P1|Period 2|Lost to Follow-up|0
380948|NCT00868790|1279810|P14|Period 2|Adverse Event|0
380949|NCT00868790|1279811|P13|Period 2|Adverse Event|0
380950|NCT00868790|1279812|P12|Period 2|Adverse Event|0
380951|NCT00868790|1279813|P11|Period 2|Adverse Event|0
380952|NCT00868790|1279814|P10|Period 2|Adverse Event|0
380953|NCT00868790|1279815|P9|Period 2|Adverse Event|1
380954|NCT00868790|1279816|P8|Period 2|Adverse Event|0
380955|NCT00868790|1279817|P7|Period 2|Adverse Event|0
380956|NCT00868790|1279818|P6|Period 2|Adverse Event|0
380957|NCT00868790|1279819|P5|Period 2|Adverse Event|0
380958|NCT00868790|1279820|P4|Period 2|Adverse Event|0
380959|NCT00868790|1279821|P3|Period 2|Adverse Event|0
380960|NCT00868790|1279822|P2|Period 2|Adverse Event|0
380961|NCT00868790|1279823|P1|Period 2|Adverse Event|0
380962|NCT00868790|1279810|P14|Period 1|Lost to Follow-up|0
380963|NCT00868790|1279811|P13|Period 1|Lost to Follow-up|0
380964|NCT00868790|1279812|P12|Period 1|Lost to Follow-up|0
380965|NCT00868790|1279813|P11|Period 1|Lost to Follow-up|0
380966|NCT00868790|1279814|P10|Period 1|Lost to Follow-up|0
380967|NCT00868790|1279815|P9|Period 1|Lost to Follow-up|0
380968|NCT00868790|1279816|P8|Period 1|Lost to Follow-up|0
380969|NCT00868790|1279817|P7|Period 1|Lost to Follow-up|0
380970|NCT00868790|1279818|P6|Period 1|Lost to Follow-up|1
380971|NCT00868790|1279819|P5|Period 1|Lost to Follow-up|0
380972|NCT00868790|1279820|P4|Period 1|Lost to Follow-up|0
380973|NCT00868790|1279821|P3|Period 1|Lost to Follow-up|0
380974|NCT00868790|1279822|P2|Period 1|Lost to Follow-up|0
380975|NCT00868790|1279823|P1|Period 1|Lost to Follow-up|0
380976|NCT00868790|1279810|P14|Period 1|Abnormal Triglycerides|0
380977|NCT00868790|1279811|P13|Period 1|Abnormal Triglycerides|0
380978|NCT00868790|1279812|P12|Period 1|Abnormal Triglycerides|0
380979|NCT00868790|1279813|P11|Period 1|Abnormal Triglycerides|0
380980|NCT00868790|1279814|P10|Period 1|Abnormal Triglycerides|0
380981|NCT00868790|1279815|P9|Period 1|Abnormal Triglycerides|0
380982|NCT00868790|1279816|P8|Period 1|Abnormal Triglycerides|0
380983|NCT00868790|1279817|P7|Period 1|Abnormal Triglycerides|0
380984|NCT00868790|1279818|P6|Period 1|Abnormal Triglycerides|0
380985|NCT00868790|1279819|P5|Period 1|Abnormal Triglycerides|1
380986|NCT00868790|1279820|P4|Period 1|Abnormal Triglycerides|0
380987|NCT00868790|1279821|P3|Period 1|Abnormal Triglycerides|0
380988|NCT00868790|1279822|P2|Period 1|Abnormal Triglycerides|0
380989|NCT00868790|1279823|P1|Period 1|Abnormal Triglycerides|0
380990|NCT00868790|1279810|P14|Period 1|Withdrawal by Subject|1
380991|NCT00868790|1279811|P13|Period 1|Withdrawal by Subject|0
380992|NCT00868790|1279812|P12|Period 1|Withdrawal by Subject|0
380993|NCT00868790|1279813|P11|Period 1|Withdrawal by Subject|0
380994|NCT00868790|1279814|P10|Period 1|Withdrawal by Subject|0
380995|NCT00868790|1279815|P9|Period 1|Withdrawal by Subject|0
380996|NCT00868790|1279816|P8|Period 1|Withdrawal by Subject|0
380997|NCT00868790|1279817|P7|Period 1|Withdrawal by Subject|0
380998|NCT00868790|1279818|P6|Period 1|Withdrawal by Subject|0
380999|NCT00868790|1279819|P5|Period 1|Withdrawal by Subject|0
381000|NCT00868790|1279820|P4|Period 1|Withdrawal by Subject|0
381001|NCT00868790|1279821|P3|Period 1|Withdrawal by Subject|0
381002|NCT00868790|1279822|P2|Period 1|Withdrawal by Subject|1
381003|NCT00868790|1279823|P1|Period 1|Withdrawal by Subject|0
381004|NCT00868790|1279810|P14|Period 1|Protocol Violation|0
381005|NCT00868790|1279811|P13|Period 1|Protocol Violation|0
381006|NCT00868790|1279812|P12|Period 1|Protocol Violation|0
381007|NCT00868790|1279813|P11|Period 1|Protocol Violation|0
381008|NCT00868790|1279814|P10|Period 1|Protocol Violation|0
381009|NCT00868790|1279815|P9|Period 1|Protocol Violation|0
381010|NCT00868790|1279816|P8|Period 1|Protocol Violation|0
381011|NCT00868790|1279817|P7|Period 1|Protocol Violation|0
381012|NCT00868790|1279818|P6|Period 1|Protocol Violation|0
381013|NCT00868790|1279819|P5|Period 1|Protocol Violation|0
381014|NCT00868790|1279820|P4|Period 1|Protocol Violation|0
381015|NCT00868790|1279821|P3|Period 1|Protocol Violation|0
381016|NCT00868790|1279822|P2|Period 1|Protocol Violation|0
381017|NCT00868790|1279823|P1|Period 1|Protocol Violation|1
381018|NCT00868790|1279810|P14|Period 1|Adverse Event|1
381019|NCT00868790|1279811|P13|Period 1|Adverse Event|0
381020|NCT00868790|1279812|P12|Period 1|Adverse Event|0
381021|NCT00868790|1279813|P11|Period 1|Adverse Event|0
381022|NCT00868790|1279814|P10|Period 1|Adverse Event|0
381023|NCT00868790|1279815|P9|Period 1|Adverse Event|1
381024|NCT00868790|1279816|P8|Period 1|Adverse Event|3
381025|NCT00868790|1279817|P7|Period 1|Adverse Event|0
381026|NCT00868790|1279818|P6|Period 1|Adverse Event|0
381027|NCT00868790|1279819|P5|Period 1|Adverse Event|0
381028|NCT00868790|1279820|P4|Period 1|Adverse Event|0
381029|NCT00868790|1279821|P3|Period 1|Adverse Event|0
381030|NCT00868790|1279822|P2|Period 1|Adverse Event|0
381031|NCT00868790|1279823|P1|Period 1|Adverse Event|1
381032|NCT00868608|1279906|P3|Overall Study|Other - Unspecified|0
381033|NCT00868608|1279907|P2|Overall Study|Other - Unspecified|0
381034|NCT00868608|1279908|P1|Overall Study|Other - Unspecified|1
381035|NCT00868608|1279906|P3|Overall Study|Death|4
381036|NCT00868608|1279907|P2|Overall Study|Death|2
381037|NCT00868608|1279908|P1|Overall Study|Death|16
381038|NCT00868608|1279906|P3|Overall Study|Lost to Follow-up|1
381039|NCT00868608|1279907|P2|Overall Study|Lost to Follow-up|0
381040|NCT00868608|1279908|P1|Overall Study|Lost to Follow-up|3
381041|NCT00868608|1279906|P3|Overall Study|Withdrawal by Subject|0
381042|NCT00868608|1279907|P2|Overall Study|Withdrawal by Subject|1
381043|NCT00868608|1279908|P1|Overall Study|Withdrawal by Subject|3
381044|NCT00868530|1279932|P1|Overall Study|Lost to Follow-up|1
381045|NCT00868530|1279932|P1|Overall Study|Adverse Event|3
381046|NCT00868517|1279947|P3|Overall Study|Protocol Violation|0
381047|NCT00868517|1279948|P2|Overall Study|Protocol Violation|1
381048|NCT00868517|1279949|P1|Overall Study|Protocol Violation|1
381049|NCT00868517|1279947|P3|Overall Study|Withdrawal by Subject|2
381050|NCT00868517|1279948|P2|Overall Study|Withdrawal by Subject|3
381051|NCT00868517|1279949|P1|Overall Study|Withdrawal by Subject|3
381052|NCT00868439|1279987|P2|Overall Study|Withdrawal by Subject|1
381053|NCT00868439|1279988|P1|Overall Study|Withdrawal by Subject|0
381054|NCT00868439|1279987|P2|Overall Study|Physician Decision|0
381055|NCT00868439|1279988|P1|Overall Study|Physician Decision|1
381056|NCT00868439|1279987|P2|Overall Study|Protocol Violation|1
381057|NCT00868439|1279988|P1|Overall Study|Protocol Violation|1
381058|NCT00868439|1279987|P2|Overall Study|Death|1
381059|NCT00868439|1279988|P1|Overall Study|Death|0
381060|NCT00868439|1279987|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
381061|NCT00868439|1279988|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
381062|NCT00868439|1279987|P2|Overall Study|Adverse Event|3
381063|NCT00868439|1279988|P1|Overall Study|Adverse Event|4
381064|NCT00868296|1280045|P2|Overall Study|Withdrawal by Subject|1
381065|NCT00868296|1280046|P1|Overall Study|Withdrawal by Subject|0
381066|NCT00868296|1280045|P2|Overall Study|Adverse Event|2
381067|NCT00868296|1280046|P1|Overall Study|Adverse Event|0
381068|NCT00868231|1280054|P6|Treatment Period 3|Adverse Event|0
381069|NCT00868231|1280055|P5|Treatment Period 3|Adverse Event|0
381070|NCT00868231|1280056|P4|Treatment Period 3|Adverse Event|0
381071|NCT00868231|1280057|P3|Treatment Period 3|Adverse Event|1
381072|NCT00868231|1280058|P2|Treatment Period 3|Adverse Event|0
381073|NCT00868231|1280059|P1|Treatment Period 3|Adverse Event|0
381074|NCT00868231|1280054|P6|Treatment Period 2|Adverse Event|0
381075|NCT00868231|1280055|P5|Treatment Period 2|Adverse Event|0
381076|NCT00868231|1280056|P4|Treatment Period 2|Adverse Event|0
381077|NCT00868231|1280057|P3|Treatment Period 2|Adverse Event|0
381078|NCT00868231|1280058|P2|Treatment Period 2|Adverse Event|0
381079|NCT00868231|1280059|P1|Treatment Period 2|Adverse Event|1
381080|NCT00868231|1280054|P6|Treatment Period 1|Adverse Event|0
381081|NCT00868231|1280055|P5|Treatment Period 1|Adverse Event|1
381082|NCT00868231|1280056|P4|Treatment Period 1|Adverse Event|0
381083|NCT00868231|1280057|P3|Treatment Period 1|Adverse Event|0
381084|NCT00868231|1280058|P2|Treatment Period 1|Adverse Event|0
381085|NCT00868231|1280059|P1|Treatment Period 1|Adverse Event|0
381086|NCT00868192|1280125|P1|Overall Study|Ineligible|4
381087|NCT00867568|1280179|P1|Overall Study|Withdrawal by Subject|1
381088|NCT00867568|1280179|P1|Overall Study|Adverse Event|4
381089|NCT00867568|1280179|P1|Overall Study|Lack of Efficacy|10
381090|NCT00867503|1280196|P1|Overall Study|Withdrawal by Subject|1
381091|NCT00867490|1280202|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
381092|NCT00867490|1280202|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
381093|NCT00867490|1280202|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
381094|NCT00867490|1280202|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
381095|NCT00867490|1280202|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
381096|NCT00867360|1280244|P2|Overall Study|Physician Decision|1
381097|NCT00867360|1280245|P1|Overall Study|Physician Decision|0
381098|NCT00867360|1280244|P2|Overall Study|Withdrawal by Subject|0
381099|NCT00867360|1280245|P1|Overall Study|Withdrawal by Subject|1
381100|NCT00867165|1280292|P2|Overall Study|Withdrawal by Subject|0
381101|NCT00867165|1280293|P1|Overall Study|Withdrawal by Subject|1
381102|NCT00867165|1280292|P2|Overall Study|Adverse Event|0
381103|NCT00867165|1280293|P1|Overall Study|Adverse Event|3
381104|NCT00867113|1280441|P1|Post Treatment After Survival Follow-up|Administrative problems|4
381105|NCT00867113|1280441|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
381106|NCT00867113|1280441|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
381107|NCT00867113|1280441|P1|Post Treatment After Survival Follow-up|Death|1
381108|NCT00867113|1280441|P1|Treatment Period|Protocol Violation|4
381109|NCT00867113|1280441|P1|Treatment Period|Disease progression/relapse|1
381110|NCT00867113|1280441|P1|Treatment Period|Administrative problems|1
381111|NCT00867113|1280441|P1|Treatment Period|Lost to Follow-up|3
381112|NCT00867113|1280441|P1|Treatment Period|Withdrawal by Subject|19
381113|NCT00867113|1280441|P1|Treatment Period|Death|2
381114|NCT00867113|1280441|P1|Treatment Period|Adverse Event|15
381115|NCT00867087|1280448|P1|Overall Study|Death|37
381116|NCT00867087|1280448|P1|Overall Study|Withdrawal by Subject|4
381117|NCT00867087|1280448|P1|Overall Study|Other|1
381118|NCT00867035|1280464|P2|Baseline to 1 Week|Withdrawal by Subject|0
381119|NCT00867035|1280465|P1|Baseline to 1 Week|Withdrawal by Subject|1
381120|NCT00867035|1280464|P2|Baseline to 1 Hour|Withdrawal by Subject|1
381121|NCT00867035|1280465|P1|Baseline to 1 Hour|Withdrawal by Subject|1
381210|NCT00866606|1280700|P1|Overall Study|Adverse Event|1
381122|NCT00867009|1280491|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
381123|NCT00867009|1280491|P1|Induction Period|Progressive Disease (PD)|25
381124|NCT00867009|1280491|P1|Induction Period|Physician Decision|3
381125|NCT00867009|1280491|P1|Induction Period|Withdrawal by Subject|8
381126|NCT00867009|1280491|P1|Induction Period|Protocol Violation|1
381127|NCT00867009|1280491|P1|Induction Period|Death due to Study Disease|4
381128|NCT00867009|1280491|P1|Induction Period|Death due to serious adverse event|6
381129|NCT00867009|1280491|P1|Induction Period|Serious Adverse Event|10
381130|NCT00867009|1280491|P1|Induction Period|Nonserious Adverse Event|5
381131|NCT00866918|1280500|P2|Overall Study|Secondary malignancy|0
381132|NCT00866918|1280501|P1|Overall Study|Secondary malignancy|1
381133|NCT00866918|1280500|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
381134|NCT00866918|1280501|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
381135|NCT00866918|1280500|P2|Overall Study|Ineligible|4
381136|NCT00866918|1280501|P1|Overall Study|Ineligible|2
381137|NCT00866918|1280500|P2|Overall Study|Physician Decision|2
381138|NCT00866918|1280501|P1|Overall Study|Physician Decision|10
381139|NCT00866918|1280500|P2|Overall Study|Lack of Efficacy|1
381140|NCT00866918|1280501|P1|Overall Study|Lack of Efficacy|1
381141|NCT00866918|1280500|P2|Overall Study|Death|5
381142|NCT00866918|1280501|P1|Overall Study|Death|1
381143|NCT00866814|1280518|P1|Overall Study|Moved to area without study site|1
381144|NCT00866814|1280518|P1|Overall Study|Unable to meet follow-up requirements|2
381145|NCT00866814|1280518|P1|Overall Study|No longer wished to participate|1
381146|NCT00866814|1280518|P1|Overall Study|Death|1
381147|NCT00866814|1280518|P1|Overall Study|Physician Decision|1
381148|NCT00866814|1280518|P1|Overall Study|Adverse Event|2
381149|NCT00866814|1280518|P1|Overall Study|Lost to Follow-up|12
381150|NCT00866788|1280531|P4|Overall Study|Physician Decision|1
381151|NCT00866788|1280532|P3|Overall Study|Physician Decision|1
381152|NCT00866788|1280533|P2|Overall Study|Physician Decision|0
381153|NCT00866788|1280534|P1|Overall Study|Physician Decision|0
381154|NCT00866788|1280531|P4|Overall Study|Disease progression|0
381155|NCT00866788|1280532|P3|Overall Study|Disease progression|1
381156|NCT00866788|1280533|P2|Overall Study|Disease progression|1
381157|NCT00866788|1280534|P1|Overall Study|Disease progression|3
381158|NCT00866788|1280531|P4|Overall Study|Pregnancy|0
381159|NCT00866788|1280532|P3|Overall Study|Pregnancy|0
381160|NCT00866788|1280533|P2|Overall Study|Pregnancy|1
381161|NCT00866788|1280534|P1|Overall Study|Pregnancy|0
381162|NCT00866788|1280531|P4|Overall Study|Withdrawal by Subject|1
381163|NCT00866788|1280532|P3|Overall Study|Withdrawal by Subject|0
381164|NCT00866788|1280533|P2|Overall Study|Withdrawal by Subject|1
381165|NCT00866788|1280534|P1|Overall Study|Withdrawal by Subject|2
381166|NCT00866788|1280531|P4|Overall Study|Lost to Follow-up|2
381167|NCT00866788|1280532|P3|Overall Study|Lost to Follow-up|0
381168|NCT00866788|1280533|P2|Overall Study|Lost to Follow-up|1
381169|NCT00866788|1280534|P1|Overall Study|Lost to Follow-up|1
381170|NCT00866788|1280531|P4|Overall Study|Adverse Event|1
381171|NCT00866788|1280532|P3|Overall Study|Adverse Event|0
381172|NCT00866788|1280533|P2|Overall Study|Adverse Event|2
381173|NCT00866788|1280534|P1|Overall Study|Adverse Event|0
381174|NCT00866775|1280582|P2|Overall Study|discontinued due to communication error|1
381175|NCT00866775|1280583|P1|Overall Study|discontinued due to communication error|0
381176|NCT00866775|1280582|P2|Overall Study|met exit criteria|17
381177|NCT00866775|1280583|P1|Overall Study|met exit criteria|23
381178|NCT00866775|1280582|P2|Overall Study|Withdrawal by Subject|4
381179|NCT00866775|1280583|P1|Overall Study|Withdrawal by Subject|4
381180|NCT00866775|1280582|P2|Overall Study|Protocol Violation|4
381181|NCT00866775|1280583|P1|Overall Study|Protocol Violation|3
381182|NCT00866775|1280582|P2|Overall Study|Physician Decision|3
381183|NCT00866775|1280583|P1|Overall Study|Physician Decision|0
381184|NCT00866775|1280582|P2|Overall Study|Lost to Follow-up|4
381185|NCT00866775|1280583|P1|Overall Study|Lost to Follow-up|0
381186|NCT00866775|1280582|P2|Overall Study|Death|0
381187|NCT00866775|1280583|P1|Overall Study|Death|1
381188|NCT00866775|1280582|P2|Overall Study|Adverse Event|19
381189|NCT00866775|1280583|P1|Overall Study|Adverse Event|5
381190|NCT00866723|1280619|P1|Overall Study|Disease Progression|4
381191|NCT00866723|1280619|P1|Overall Study|Withdrawal by Subject|1
381192|NCT00866697|1280626|P2|Overall Study|Ongoing|312
381193|NCT00866697|1280627|P1|Overall Study|Ongoing|335
381194|NCT00866697|1280626|P2|Overall Study|Withdrawal by Subject|53
381195|NCT00866697|1280627|P1|Overall Study|Withdrawal by Subject|28
381196|NCT00866697|1280626|P2|Overall Study|Physician Decision|4
381197|NCT00866697|1280627|P1|Overall Study|Physician Decision|3
381198|NCT00866697|1280626|P2|Overall Study|Lost to Follow-up|8
381199|NCT00866697|1280627|P1|Overall Study|Lost to Follow-up|7
381200|NCT00866658|1280671|P2|Overall Study|Familial and Personal Reasons|5
381201|NCT00866658|1280672|P1|Overall Study|Familial and Personal Reasons|4
381202|NCT00866658|1280671|P2|Overall Study|Protocol Violation|1
381203|NCT00866658|1280672|P1|Overall Study|Protocol Violation|1
381204|NCT00866658|1280671|P2|Overall Study|Withdrawal by Subject|0
381205|NCT00866658|1280672|P1|Overall Study|Withdrawal by Subject|1
381206|NCT00866658|1280671|P2|Overall Study|Lack of Efficacy|1
381207|NCT00866658|1280672|P1|Overall Study|Lack of Efficacy|2
381208|NCT00866658|1280671|P2|Overall Study|Adverse Event|14
381209|NCT00866658|1280672|P1|Overall Study|Adverse Event|5
381211|NCT00866606|1280700|P1|Overall Study|Lost to Follow-up|3
381212|NCT00866359|1280714|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
381213|NCT00866359|1280715|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
381214|NCT00866359|1280716|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
381215|NCT00866359|1280717|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
381216|NCT00866359|1280714|P4|Treatment Phase (Days 1 to 85)|Other|0
381217|NCT00866359|1280715|P3|Treatment Phase (Days 1 to 85)|Other|0
381218|NCT00866359|1280716|P2|Treatment Phase (Days 1 to 85)|Other|0
381219|NCT00866359|1280717|P1|Treatment Phase (Days 1 to 85)|Other|1
381220|NCT00866359|1280714|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
381221|NCT00866359|1280715|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
381222|NCT00866359|1280716|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
381223|NCT00866359|1280717|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
381224|NCT00866359|1280714|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
381225|NCT00866359|1280715|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
381226|NCT00866359|1280716|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
381227|NCT00866359|1280717|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
381228|NCT00866359|1280714|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
381229|NCT00866359|1280715|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
381230|NCT00866359|1280716|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
381231|NCT00866359|1280717|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
381232|NCT00866359|1280714|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
381233|NCT00866359|1280715|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
381234|NCT00866359|1280716|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
381235|NCT00866359|1280717|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
381236|NCT00866320|1280770|P1|Overall Study|Death|2
381237|NCT00866320|1280770|P1|Overall Study|Withdrawal by Subject|4
381238|NCT00866307|1280777|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
381239|NCT00866307|1280778|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
381240|NCT00866307|1280779|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
381241|NCT00866307|1280777|P3|Consolidation/Maintenance|Non-compliance|1
381242|NCT00866307|1280778|P2|Consolidation/Maintenance|Non-compliance|0
381243|NCT00866307|1280779|P1|Consolidation/Maintenance|Non-compliance|0
381244|NCT00866307|1280777|P3|Consolidation/Maintenance|Therapy error|0
381245|NCT00866307|1280778|P2|Consolidation/Maintenance|Therapy error|1
381246|NCT00866307|1280779|P1|Consolidation/Maintenance|Therapy error|0
381247|NCT00866307|1280777|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
381248|NCT00866307|1280778|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
381249|NCT00866307|1280779|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
381250|NCT00866307|1280777|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
381251|NCT00866307|1280778|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
381252|NCT00866307|1280779|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
381253|NCT00866307|1280777|P3|Consolidation/Maintenance|Withdrawal by Subject|1
381254|NCT00866307|1280778|P2|Consolidation/Maintenance|Withdrawal by Subject|1
381255|NCT00866307|1280779|P1|Consolidation/Maintenance|Withdrawal by Subject|0
381256|NCT00866307|1280777|P3|Consolidation/Maintenance|Physician Decision|2
381257|NCT00866307|1280778|P2|Consolidation/Maintenance|Physician Decision|3
381258|NCT00866307|1280779|P1|Consolidation/Maintenance|Physician Decision|0
381259|NCT00866307|1280777|P3|Consolidation/Maintenance|Death|1
381260|NCT00866307|1280778|P2|Consolidation/Maintenance|Death|0
381261|NCT00866307|1280779|P1|Consolidation/Maintenance|Death|0
381262|NCT00866307|1280777|P3|Consolidation/Maintenance|Adverse Event|8
381263|NCT00866307|1280778|P2|Consolidation/Maintenance|Adverse Event|0
381264|NCT00866307|1280779|P1|Consolidation/Maintenance|Adverse Event|0
381265|NCT00866307|1280777|P3|Induction|Study was closed at the time|0
381266|NCT00866307|1280778|P2|Induction|Study was closed at the time|0
381267|NCT00866307|1280779|P1|Induction|Study was closed at the time|1
381268|NCT00866307|1280777|P3|Induction|Improper post-induction consent|0
381269|NCT00866307|1280778|P2|Induction|Improper post-induction consent|0
381270|NCT00866307|1280779|P1|Induction|Improper post-induction consent|2
381271|NCT00866307|1280777|P3|Induction|Inadequate cytognetic samples th|0
381272|NCT00866307|1280778|P2|Induction|Inadequate cytognetic samples th|0
381273|NCT00866307|1280779|P1|Induction|Inadequate cytognetic samples th|1
381274|NCT00866307|1280777|P3|Induction|Identification of Patients with Day 29 M|0
381275|NCT00866307|1280778|P2|Induction|Identification of Patients with Day 29 M|0
381276|NCT00866307|1280779|P1|Induction|Identification of Patients with Day 29 M|3
381277|NCT00866307|1280777|P3|Induction|Progressive Disease|0
381278|NCT00866307|1280778|P2|Induction|Progressive Disease|0
381279|NCT00866307|1280779|P1|Induction|Progressive Disease|1
381280|NCT00866307|1280777|P3|Induction|Physician Decision|0
381281|NCT00866307|1280778|P2|Induction|Physician Decision|0
381282|NCT00866307|1280779|P1|Induction|Physician Decision|5
381283|NCT00866307|1280777|P3|Induction|Death|0
381284|NCT00866307|1280778|P2|Induction|Death|0
381285|NCT00866307|1280779|P1|Induction|Death|2
381286|NCT00866307|1280777|P3|Induction|Adverse Event|0
381287|NCT00866307|1280778|P2|Induction|Adverse Event|0
381288|NCT00866307|1280779|P1|Induction|Adverse Event|5
381289|NCT00866294|1280789|P3|Overall Study|Physician Decision|1
381290|NCT00866294|1280790|P2|Overall Study|Physician Decision|2
381291|NCT00866294|1280791|P1|Overall Study|Physician Decision|6
381292|NCT00866294|1280789|P3|Overall Study|Lost to Follow-up|0
381293|NCT00866294|1280790|P2|Overall Study|Lost to Follow-up|3
381294|NCT00866294|1280791|P1|Overall Study|Lost to Follow-up|1
381295|NCT00866294|1280789|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
381296|NCT00866294|1280790|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
381297|NCT00866294|1280791|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
381298|NCT00866294|1280789|P3|Overall Study|Protocol Violation|0
381299|NCT00866294|1280790|P2|Overall Study|Protocol Violation|0
381300|NCT00866294|1280791|P1|Overall Study|Protocol Violation|2
381301|NCT00866294|1280789|P3|Overall Study|Lack of Efficacy|0
381302|NCT00866294|1280790|P2|Overall Study|Lack of Efficacy|1
381303|NCT00866294|1280791|P1|Overall Study|Lack of Efficacy|7
381304|NCT00866294|1280789|P3|Overall Study|Adverse Event|9
381305|NCT00866294|1280790|P2|Overall Study|Adverse Event|13
381306|NCT00866294|1280791|P1|Overall Study|Adverse Event|12
381307|NCT00866281|1280820|P2|Overall Study|New cancer therapy|4
381308|NCT00866281|1280821|P1|Overall Study|New cancer therapy|0
381309|NCT00866281|1280820|P2|Overall Study|Disease progression|11
381310|NCT00866281|1280821|P1|Overall Study|Disease progression|3
381311|NCT00866281|1280820|P2|Overall Study|Withdrawal by participants|0
381312|NCT00866281|1280821|P1|Overall Study|Withdrawal by participants|3
381313|NCT00866281|1280820|P2|Overall Study|Adverse Event|0
381314|NCT00866281|1280821|P1|Overall Study|Adverse Event|1
381315|NCT00866177|1280837|P1|Overall Study|Not Treated|151
381316|NCT00866177|1280837|P1|Overall Study|Withdrawal by Subject|1
381317|NCT00866047|1280841|P1|Follow-up Period|Lost to Follow-up|5
381318|NCT00866047|1280841|P1|Treatment Period|Withdrawal by Subject|5
381319|NCT00866047|1280841|P1|Treatment Period|Physician Decision|14
381320|NCT00866047|1280841|P1|Treatment Period|Adverse Event|16
381321|NCT00866047|1280841|P1|Treatment Period|Progressive disease|13
381322|NCT00865904|1280873|P5|Overall Study|Randomized but not Treated|1
381323|NCT00865904|1280874|P4|Overall Study|Randomized but not Treated|1
381324|NCT00865904|1280875|P3|Overall Study|Randomized but not Treated|0
381325|NCT00865904|1280876|P2|Overall Study|Randomized but not Treated|0
381326|NCT00865904|1280877|P1|Overall Study|Randomized but not Treated|2
381327|NCT00865709|1280934|P2|Treatment|Surgery|3
381328|NCT00865709|1280935|P1|Treatment|Surgery|8
381329|NCT00865709|1280934|P2|Treatment|Physician Decision|2
381330|NCT00865709|1280935|P1|Treatment|Physician Decision|3
381331|NCT00865709|1280934|P2|Treatment|Withdrawal by Subject|7
381332|NCT00865709|1280935|P1|Treatment|Withdrawal by Subject|10
381333|NCT00865709|1280934|P2|Treatment|Adverse Event|6
381334|NCT00865709|1280935|P1|Treatment|Adverse Event|9
381335|NCT00865514|1280951|P1|Overall Study|Infusion cost exceeded funding|2
381336|NCT00865345|1280956|P1|Overall Study|Withdrawal by Subject|2
381337|NCT00865306|1280963|P2|Controlled Trial|Withdrawal by Subject|1
381338|NCT00865306|1280964|P1|Controlled Trial|Withdrawal by Subject|0
381339|NCT00865306|1280963|P2|Controlled Trial|Sought treatment for conduct disorder|0
381340|NCT00865306|1280964|P1|Controlled Trial|Sought treatment for conduct disorder|1
381341|NCT00865306|1280963|P2|Controlled Trial|Improved btw baseline and first session|0
381342|NCT00865306|1280964|P1|Controlled Trial|Improved btw baseline and first session|1
381343|NCT00865306|1280963|P2|Controlled Trial|Difficulty commuting|0
381344|NCT00865306|1280964|P1|Controlled Trial|Difficulty commuting|2
381345|NCT00865306|1280963|P2|Controlled Trial|Lost to Follow-up|1
381346|NCT00865306|1280964|P1|Controlled Trial|Lost to Follow-up|1
381347|NCT00865189|1280993|P2|Overall Study|Withdrawal by Subject|0
381348|NCT00865189|1280994|P1|Overall Study|Withdrawal by Subject|1
381349|NCT00865189|1280993|P2|Overall Study|Lost to Follow-up|6
381350|NCT00865189|1280994|P1|Overall Study|Lost to Follow-up|6
381351|NCT00865189|1280993|P2|Overall Study|Death|11
381352|NCT00865189|1280994|P1|Overall Study|Death|4
381353|NCT00865189|1280993|P2|Overall Study|Other|2
381354|NCT00865189|1280994|P1|Overall Study|Other|1
381355|NCT00865124|1281022|P3|Overall Study|Withdrawn consent|0
381356|NCT00865124|1281023|P2|Overall Study|Withdrawn consent|0
381357|NCT00865124|1281024|P1|Overall Study|Withdrawn consent|2
381358|NCT00865124|1281022|P3|Overall Study|Physician Decision|0
381359|NCT00865124|1281023|P2|Overall Study|Physician Decision|1
381360|NCT00865124|1281024|P1|Overall Study|Physician Decision|2
381361|NCT00865098|1281041|P1|Overall Study|Progressive disease|1
381362|NCT00865046|1281053|P3|Overall Study|Withdrawal by Subject|0
381363|NCT00865046|1281054|P2|Overall Study|Withdrawal by Subject|0
381364|NCT00865046|1281055|P1|Overall Study|Withdrawal by Subject|5
381365|NCT00865046|1281053|P3|Overall Study|Death|1
381366|NCT00865046|1281054|P2|Overall Study|Death|1
381367|NCT00865046|1281055|P1|Overall Study|Death|0
381368|NCT00865046|1281053|P3|Overall Study|Lost to Follow-up|0
381369|NCT00865046|1281054|P2|Overall Study|Lost to Follow-up|4
381370|NCT00865046|1281055|P1|Overall Study|Lost to Follow-up|1
381371|NCT00865020|1281065|P2|Overall Study|Randomized but discontinued|4
381372|NCT00865020|1281066|P1|Overall Study|Randomized but discontinued|2
381373|NCT00865020|1281065|P2|Overall Study|Death|1
381374|NCT00865020|1281066|P1|Overall Study|Death|0
381375|NCT00865020|1281065|P2|Overall Study|Abnormal laboratory value(s)|1
381376|NCT00865020|1281066|P1|Overall Study|Abnormal laboratory value(s)|0
381377|NCT00865020|1281065|P2|Overall Study|Administrative problems|2
381378|NCT00865020|1281066|P1|Overall Study|Administrative problems|0
381379|NCT00865020|1281065|P2|Overall Study|Protocol deviation|1
381380|NCT00865020|1281066|P1|Overall Study|Protocol deviation|4
381381|NCT00865020|1281065|P2|Overall Study|Lost to Follow-up|4
381382|NCT00865020|1281066|P1|Overall Study|Lost to Follow-up|6
381383|NCT00865020|1281065|P2|Overall Study|Abnormal test procedure result(s)|8
381384|NCT00865020|1281066|P1|Overall Study|Abnormal test procedure result(s)|6
381385|NCT00865020|1281065|P2|Overall Study|Adverse Event|14
381386|NCT00865020|1281066|P1|Overall Study|Adverse Event|9
381387|NCT00865020|1281065|P2|Overall Study|Withdrawal by Subject|16
381388|NCT00865020|1281066|P1|Overall Study|Withdrawal by Subject|22
381389|NCT00864916|1281082|P2|Overall Study|Withdrawal by Subject|0
381390|NCT00864916|1281083|P1|Overall Study|Withdrawal by Subject|1
381391|NCT00864916|1281082|P2|Overall Study|Protocol Violation|0
381392|NCT00864916|1281083|P1|Overall Study|Protocol Violation|1
381393|NCT00864916|1281082|P2|Overall Study|Lost to Follow-up|4
381394|NCT00864916|1281083|P1|Overall Study|Lost to Follow-up|4
381395|NCT00864851|1281092|P3|Overall Study|Patient uncooperative|0
381396|NCT00864851|1281093|P2|Overall Study|Patient uncooperative|0
381397|NCT00864851|1281094|P1|Overall Study|Patient uncooperative|1
381398|NCT00864851|1281092|P3|Overall Study|Death|0
381399|NCT00864851|1281093|P2|Overall Study|Death|0
381400|NCT00864851|1281094|P1|Overall Study|Death|1
381401|NCT00864851|1281092|P3|Overall Study|Physician Decision|0
381402|NCT00864851|1281093|P2|Overall Study|Physician Decision|0
381403|NCT00864851|1281094|P1|Overall Study|Physician Decision|1
381404|NCT00864851|1281092|P3|Overall Study|Withdrawal by Subject|0
381405|NCT00864851|1281093|P2|Overall Study|Withdrawal by Subject|1
381406|NCT00864851|1281094|P1|Overall Study|Withdrawal by Subject|0
381407|NCT00864682|1281140|P3|Overall Study|Protocol Violation|2
381408|NCT00864682|1281141|P2|Overall Study|Protocol Violation|1
381409|NCT00864682|1281142|P1|Overall Study|Protocol Violation|2
381410|NCT00864513|1281181|P1|Overall Study|Withdrawal by Subject|3
381411|NCT00864253|1281227|P2|Overall Study|Untreated|7
381412|NCT00864253|1281228|P1|Overall Study|Untreated|7
381413|NCT00864253|1281227|P2|Overall Study|Ongoing|3
381414|NCT00864253|1281228|P1|Overall Study|Ongoing|2
381415|NCT00864253|1281227|P2|Overall Study|Death|0
381416|NCT00864253|1281228|P1|Overall Study|Death|1
381417|NCT00864253|1281227|P2|Overall Study|Withdrawal by Subject|18
381418|NCT00864253|1281228|P1|Overall Study|Withdrawal by Subject|18
381419|NCT00864253|1281227|P2|Overall Study|Lost to Follow-up|1
381420|NCT00864253|1281228|P1|Overall Study|Lost to Follow-up|1
381421|NCT00864253|1281227|P2|Overall Study|Protocol Violation|2
381422|NCT00864253|1281228|P1|Overall Study|Protocol Violation|0
381423|NCT00864253|1281227|P2|Overall Study|Physician Decision|15
381424|NCT00864253|1281228|P1|Overall Study|Physician Decision|11
381425|NCT00864253|1281227|P2|Overall Study|Unrelated Adverse Event|1
381426|NCT00864253|1281228|P1|Overall Study|Unrelated Adverse Event|3
381427|NCT00864253|1281227|P2|Overall Study|Adverse Event|11
381428|NCT00864253|1281228|P1|Overall Study|Adverse Event|56
381429|NCT00864227|1281258|P1|Overall Study|Disease Relapse/Progression|3
381430|NCT00864227|1281258|P1|Overall Study|Withdrawal by Subject|1
381431|NCT00863798|1281320|P3|Overall Study|Randomized not treated|3
381432|NCT00863798|1281321|P2|Overall Study|Randomized not treated|2
381433|NCT00863798|1281322|P1|Overall Study|Randomized not treated|4
381434|NCT00863798|1281320|P3|Overall Study|Withdrawal by Subject|4
381435|NCT00863798|1281321|P2|Overall Study|Withdrawal by Subject|7
381436|NCT00863798|1281322|P1|Overall Study|Withdrawal by Subject|8
381437|NCT00863798|1281320|P3|Overall Study|Protocol Violation|1
381438|NCT00863798|1281321|P2|Overall Study|Protocol Violation|1
381439|NCT00863798|1281322|P1|Overall Study|Protocol Violation|0
381440|NCT00863798|1281320|P3|Overall Study|Other|1
381441|NCT00863798|1281321|P2|Overall Study|Other|3
381442|NCT00863798|1281322|P1|Overall Study|Other|2
381443|NCT00863798|1281320|P3|Overall Study|Lost to Follow-up|5
381444|NCT00863798|1281321|P2|Overall Study|Lost to Follow-up|9
381445|NCT00863798|1281322|P1|Overall Study|Lost to Follow-up|6
381446|NCT00863798|1281320|P3|Overall Study|Lack of Efficacy|6
381447|NCT00863798|1281321|P2|Overall Study|Lack of Efficacy|3
381448|NCT00863798|1281322|P1|Overall Study|Lack of Efficacy|4
381449|NCT00863798|1281320|P3|Overall Study|Investigator request|1
381450|NCT00863798|1281321|P2|Overall Study|Investigator request|2
381451|NCT00863798|1281322|P1|Overall Study|Investigator request|1
381452|NCT00863798|1281320|P3|Overall Study|Participant failed to return|0
381453|NCT00863798|1281321|P2|Overall Study|Participant failed to return|1
381454|NCT00863798|1281322|P1|Overall Study|Participant failed to return|2
381455|NCT00863798|1281320|P3|Overall Study|Adverse Event|4
381456|NCT00863798|1281321|P2|Overall Study|Adverse Event|2
381457|NCT00863798|1281322|P1|Overall Study|Adverse Event|5
381458|NCT00863746|1281374|P2|Survival Follow up|Consent Withdrawn|8
381459|NCT00863746|1281375|P1|Survival Follow up|Consent Withdrawn|7
381460|NCT00863746|1281374|P2|Survival Follow up|Lost to Follow-up|1
381461|NCT00863746|1281375|P1|Survival Follow up|Lost to Follow-up|2
381462|NCT00863746|1281374|P2|Survival Follow up|Death|271
381463|NCT00863746|1281375|P1|Survival Follow up|Death|244
381464|NCT00863746|1281374|P2|Treatment|not available|0
381465|NCT00863746|1281375|P1|Treatment|not available|1
381466|NCT00863746|1281374|P2|Treatment|Protocol Violation|3
381467|NCT00863746|1281375|P1|Treatment|Protocol Violation|5
381468|NCT00863746|1281374|P2|Treatment|Lost to Follow-up|0
381469|NCT00863746|1281375|P1|Treatment|Lost to Follow-up|1
381470|NCT00863746|1281374|P2|Treatment|Consent withdrawn|14
381471|NCT00863746|1281375|P1|Treatment|Consent withdrawn|15
381472|NCT00863746|1281374|P2|Treatment|non-compliant with study medication|0
381473|NCT00863746|1281375|P1|Treatment|non-compliant with study medication|4
381474|NCT00863746|1281374|P2|Treatment|Adverse Event|16
381475|NCT00863746|1281375|P1|Treatment|Adverse Event|41
381476|NCT00863746|1281374|P2|Treatment|Not treated|2
381477|NCT00863746|1281375|P1|Treatment|Not treated|4
381478|NCT00863707|1281401|P2|Overall Study|Randomized, but drug not received|3
381479|NCT00863707|1281402|P1|Overall Study|Randomized, but drug not received|4
381480|NCT00863655|1281410|P2|Overall Study|Treatment completed as per protocol|1
381481|NCT00863655|1281411|P1|Overall Study|Treatment completed as per protocol|5
381482|NCT00863655|1281410|P2|Overall Study|Disease progression|221
381483|NCT00863655|1281411|P1|Overall Study|Disease progression|364
381484|NCT00863655|1281410|P2|Overall Study|New cancer therapy|1
381485|NCT00863655|1281411|P1|Overall Study|New cancer therapy|5
381486|NCT00863655|1281410|P2|Overall Study|Death|1
381487|NCT00863655|1281411|P1|Overall Study|Death|7
381488|NCT00863655|1281410|P2|Overall Study|Administrative problems|0
381489|NCT00863655|1281411|P1|Overall Study|Administrative problems|1
381490|NCT00863655|1281410|P2|Overall Study|Withdrawal by Subject|7
381491|NCT00863655|1281411|P1|Overall Study|Withdrawal by Subject|47
381492|NCT00863655|1281410|P2|Overall Study|Adverse Event|8
381493|NCT00863655|1281411|P1|Overall Study|Adverse Event|52
381494|NCT00863655|1281410|P2|Overall Study|Protocol Violation|0
381495|NCT00863655|1281411|P1|Overall Study|Protocol Violation|4
381496|NCT00863512|1281448|P2|Overall Study|Physician Decision|0
381497|NCT00863512|1281449|P1|Overall Study|Physician Decision|1
381498|NCT00863512|1281448|P2|Overall Study|Withdrawal by Subject|0
381499|NCT00863512|1281449|P1|Overall Study|Withdrawal by Subject|11
381500|NCT00863512|1281448|P2|Overall Study|Adverse Event|0
381501|NCT00863512|1281449|P1|Overall Study|Adverse Event|2
381502|NCT00863330|1281480|P1|Overall Study|study terminated early due to administra|6
381503|NCT00863317|1281486|P2|Overall Study|Lost to Follow-up|9
381504|NCT00863317|1281487|P1|Overall Study|Lost to Follow-up|8
381505|NCT00863057|1281529|P4|Period 2 (Weeks 6-10)|Physician Decision|1
381506|NCT00863057|1281530|P3|Period 2 (Weeks 6-10)|Physician Decision|0
381507|NCT00863057|1281531|P2|Period 2 (Weeks 6-10)|Physician Decision|0
381508|NCT00863057|1281532|P1|Period 2 (Weeks 6-10)|Physician Decision|0
381509|NCT00863057|1281529|P4|Period 2 (Weeks 6-10)|Adverse Event|0
381510|NCT00863057|1281530|P3|Period 2 (Weeks 6-10)|Adverse Event|1
381511|NCT00863057|1281531|P2|Period 2 (Weeks 6-10)|Adverse Event|1
381512|NCT00863057|1281532|P1|Period 2 (Weeks 6-10)|Adverse Event|0
381513|NCT00863057|1281529|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
381514|NCT00863057|1281530|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
381515|NCT00863057|1281531|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
381516|NCT00863057|1281532|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
381517|NCT00863057|1281529|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
381518|NCT00863057|1281530|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
381519|NCT00863057|1281531|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
381520|NCT00863057|1281532|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
381521|NCT00862979|1281582|P2|Overall Study|Death|1
381522|NCT00862979|1281583|P1|Overall Study|Death|0
381523|NCT00862979|1281582|P2|Overall Study|Administrative problems|1
381524|NCT00862979|1281583|P1|Overall Study|Administrative problems|0
381525|NCT00862979|1281582|P2|Overall Study|Patient withdrew consent|1
381526|NCT00862979|1281583|P1|Overall Study|Patient withdrew consent|2
381527|NCT00862979|1281582|P2|Overall Study|Protocol Violation|1
381528|NCT00862979|1281583|P1|Overall Study|Protocol Violation|0
381529|NCT00862979|1281582|P2|Overall Study|Adverse Event|3
381530|NCT00862979|1281583|P1|Overall Study|Adverse Event|6
381531|NCT00862940|1281601|P2|Overall Study|Administrative or other reason(s)|3
381532|NCT00862940|1281602|P1|Overall Study|Administrative or other reason(s)|4
381533|NCT00862940|1281601|P2|Overall Study|Lost to Follow-up|1
381534|NCT00862940|1281602|P1|Overall Study|Lost to Follow-up|0
381535|NCT00862940|1281601|P2|Overall Study|Non-compliance|0
381536|NCT00862940|1281602|P1|Overall Study|Non-compliance|4
381537|NCT00862940|1281601|P2|Overall Study|Withdrawal by Subject|6
381538|NCT00862940|1281602|P1|Overall Study|Withdrawal by Subject|4
381539|NCT00862940|1281601|P2|Overall Study|Protocol Violation|5
381540|NCT00862940|1281602|P1|Overall Study|Protocol Violation|2
381541|NCT00862940|1281601|P2|Overall Study|Lack of Efficacy|3
381542|NCT00862940|1281602|P1|Overall Study|Lack of Efficacy|1
381543|NCT00862940|1281601|P2|Overall Study|Adverse Event|12
381544|NCT00862940|1281602|P1|Overall Study|Adverse Event|15
381545|NCT00862849|1281614|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
381546|NCT00862849|1281615|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
381547|NCT00862849|1281616|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
381548|NCT00862849|1281617|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
381549|NCT00862849|1281618|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
381550|NCT00862849|1281619|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
381551|NCT00862849|1281614|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
381552|NCT00862849|1281615|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
381553|NCT00862849|1281616|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
381554|NCT00862849|1281617|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
381555|NCT00862849|1281618|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
381556|NCT00862849|1281619|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
381557|NCT00862836|1281642|P1|Overall Study|Withdrawal by Subject|1
381558|NCT00862823|1281653|P2|First Intervention|Withdrawal by Subject|1
381559|NCT00862823|1281654|P1|First Intervention|Withdrawal by Subject|1
381560|NCT00862719|1281703|P4|Overall Study|Veno-Occlusive Disease|0
381561|NCT00862719|1281704|P3|Overall Study|Veno-Occlusive Disease|1
381562|NCT00862719|1281705|P2|Overall Study|Veno-Occlusive Disease|0
381563|NCT00862719|1281706|P1|Overall Study|Veno-Occlusive Disease|0
381564|NCT00862719|1281703|P4|Overall Study|Engraftment failure|0
381565|NCT00862719|1281704|P3|Overall Study|Engraftment failure|1
381566|NCT00862719|1281705|P2|Overall Study|Engraftment failure|0
381567|NCT00862719|1281706|P1|Overall Study|Engraftment failure|0
381568|NCT00862719|1281703|P4|Overall Study|Death|1
381569|NCT00862719|1281704|P3|Overall Study|Death|1
381570|NCT00862719|1281705|P2|Overall Study|Death|6
381571|NCT00862719|1281706|P1|Overall Study|Death|5
381572|NCT00862719|1281703|P4|Overall Study|Disease Progression|0
381573|NCT00862719|1281704|P3|Overall Study|Disease Progression|1
381574|NCT00862719|1281705|P2|Overall Study|Disease Progression|0
381575|NCT00862719|1281706|P1|Overall Study|Disease Progression|5
381576|NCT00862654|1281729|P4|Overall Study|Included after end of inclusions|0
381577|NCT00862654|1281730|P3|Overall Study|Included after end of inclusions|1
381578|NCT00862654|1281731|P2|Overall Study|Included after end of inclusions|0
381579|NCT00862654|1281732|P1|Overall Study|Included after end of inclusions|0
381580|NCT00862654|1281729|P4|Overall Study|Never used study drugs|0
381581|NCT00862654|1281730|P3|Overall Study|Never used study drugs|0
381582|NCT00862654|1281731|P2|Overall Study|Never used study drugs|0
381583|NCT00862654|1281732|P1|Overall Study|Never used study drugs|1
381584|NCT00862654|1281729|P4|Overall Study|Familly constraint|0
381585|NCT00862654|1281730|P3|Overall Study|Familly constraint|0
381586|NCT00862654|1281731|P2|Overall Study|Familly constraint|1
381587|NCT00862654|1281732|P1|Overall Study|Familly constraint|0
381588|NCT00862654|1281729|P4|Overall Study|Subject mistake|0
381589|NCT00862654|1281730|P3|Overall Study|Subject mistake|0
381590|NCT00862654|1281731|P2|Overall Study|Subject mistake|1
381591|NCT00862654|1281732|P1|Overall Study|Subject mistake|0
381592|NCT00862654|1281729|P4|Overall Study|Withdrawal by Subject|3
381593|NCT00862654|1281730|P3|Overall Study|Withdrawal by Subject|2
381594|NCT00862654|1281731|P2|Overall Study|Withdrawal by Subject|2
381595|NCT00862654|1281732|P1|Overall Study|Withdrawal by Subject|2
381596|NCT00862654|1281729|P4|Overall Study|Pregnancy|0
381597|NCT00862654|1281730|P3|Overall Study|Pregnancy|0
381598|NCT00862654|1281731|P2|Overall Study|Pregnancy|1
381599|NCT00862654|1281732|P1|Overall Study|Pregnancy|1
381600|NCT00862654|1281729|P4|Overall Study|Adverse Event|0
381601|NCT00862654|1281730|P3|Overall Study|Adverse Event|1
381602|NCT00862654|1281731|P2|Overall Study|Adverse Event|1
381603|NCT00862654|1281732|P1|Overall Study|Adverse Event|0
381604|NCT00862654|1281729|P4|Overall Study|Lost to Follow-up|3
381605|NCT00862654|1281730|P3|Overall Study|Lost to Follow-up|1
381606|NCT00862654|1281731|P2|Overall Study|Lost to Follow-up|2
381607|NCT00862654|1281732|P1|Overall Study|Lost to Follow-up|1
381608|NCT00862654|1281729|P4|Overall Study|Lack of Efficacy|0
381609|NCT00862654|1281730|P3|Overall Study|Lack of Efficacy|1
381610|NCT00862654|1281731|P2|Overall Study|Lack of Efficacy|0
381611|NCT00862654|1281732|P1|Overall Study|Lack of Efficacy|1
381612|NCT00862641|1281746|P4|Overall Study|Randomized, but drug not received|4
381613|NCT00862641|1281747|P3|Overall Study|Randomized, but drug not received|1
381614|NCT00862641|1281748|P2|Overall Study|Randomized, but drug not received|4
381615|NCT00862641|1281749|P1|Overall Study|Randomized, but drug not received|1
381616|NCT00862459|1281843|P3|Overall Study|Administrative problems|0
381617|NCT00862459|1281844|P2|Overall Study|Administrative problems|1
381618|NCT00862459|1281845|P1|Overall Study|Administrative problems|0
381619|NCT00862459|1281843|P3|Overall Study|Inclusion/exclusion criteria not met|0
381620|NCT00862459|1281844|P2|Overall Study|Inclusion/exclusion criteria not met|1
381621|NCT00862459|1281845|P1|Overall Study|Inclusion/exclusion criteria not met|0
381622|NCT00862459|1281843|P3|Overall Study|Unable to hold still for imaging|0
381623|NCT00862459|1281844|P2|Overall Study|Unable to hold still for imaging|1
381624|NCT00862459|1281845|P1|Overall Study|Unable to hold still for imaging|0
381625|NCT00862459|1281843|P3|Overall Study|Intravenous (IV) site problems|1
381626|NCT00862459|1281844|P2|Overall Study|Intravenous (IV) site problems|0
381627|NCT00862459|1281845|P1|Overall Study|Intravenous (IV) site problems|1
381628|NCT00862459|1281843|P3|Overall Study|Operation|0
381629|NCT00862459|1281844|P2|Overall Study|Operation|1
381630|NCT00862459|1281845|P1|Overall Study|Operation|1
381631|NCT00862459|1281843|P3|Overall Study|Personal reasons|0
381632|NCT00862459|1281844|P2|Overall Study|Personal reasons|0
381633|NCT00862459|1281845|P1|Overall Study|Personal reasons|1
381634|NCT00862459|1281843|P3|Overall Study|Adverse Event|0
381635|NCT00862459|1281844|P2|Overall Study|Adverse Event|1
381636|NCT00862459|1281845|P1|Overall Study|Adverse Event|0
381637|NCT00862459|1281843|P3|Overall Study|Withdrawal by Subject|3
381638|NCT00862459|1281844|P2|Overall Study|Withdrawal by Subject|1
381639|NCT00862459|1281845|P1|Overall Study|Withdrawal by Subject|1
381640|NCT00862459|1281843|P3|Overall Study|Protocol Violation|0
381641|NCT00862459|1281844|P2|Overall Study|Protocol Violation|0
381642|NCT00862459|1281845|P1|Overall Study|Protocol Violation|1
381643|NCT00862459|1281843|P3|Overall Study|Lost to Follow-up|2
381644|NCT00862459|1281844|P2|Overall Study|Lost to Follow-up|2
381645|NCT00862459|1281845|P1|Overall Study|Lost to Follow-up|1
381646|NCT00862277|1281992|P3|Overall Study|Protocol Violation|5
381647|NCT00862277|1281993|P2|Overall Study|Protocol Violation|2
381648|NCT00862277|1281994|P1|Overall Study|Protocol Violation|1
381649|NCT00862251|1282008|P3|Overall Study|Withdrawal by Subject|6
381650|NCT00862251|1282009|P2|Overall Study|Withdrawal by Subject|2
381651|NCT00862251|1282010|P1|Overall Study|Withdrawal by Subject|9
381652|NCT00862251|1282008|P3|Overall Study|Protocol Violation|1
381653|NCT00862251|1282009|P2|Overall Study|Protocol Violation|0
381654|NCT00862251|1282010|P1|Overall Study|Protocol Violation|2
381655|NCT00862251|1282008|P3|Overall Study|Lost to Follow-up|1
381656|NCT00862251|1282009|P2|Overall Study|Lost to Follow-up|0
381657|NCT00862251|1282010|P1|Overall Study|Lost to Follow-up|0
381658|NCT00862251|1282008|P3|Overall Study|Adverse Event|1
381659|NCT00862251|1282009|P2|Overall Study|Adverse Event|3
381660|NCT00862251|1282010|P1|Overall Study|Adverse Event|8
381661|NCT00862134|1282070|P2|Overall Study|Withdrew prior to dosing|0
381662|NCT00862134|1282071|P1|Overall Study|Withdrew prior to dosing|2
381663|NCT00862134|1282070|P2|Overall Study|Adverse Event|2
381664|NCT00862134|1282071|P1|Overall Study|Adverse Event|2
381665|NCT00862134|1282070|P2|Overall Study|Sponsor terminated study|7
381666|NCT00862134|1282071|P1|Overall Study|Sponsor terminated study|5
381667|NCT00862134|1282070|P2|Overall Study|Withdrawal by Subject|2
381668|NCT00862134|1282071|P1|Overall Study|Withdrawal by Subject|1
381669|NCT00862134|1282070|P2|Overall Study|Physician Decision|1
381670|NCT00862134|1282071|P1|Overall Study|Physician Decision|0
381671|NCT00862134|1282070|P2|Overall Study|Death|0
381672|NCT00862134|1282071|P1|Overall Study|Death|1
381673|NCT00862121|1282083|P2|Overall Study|Incorrect randomisation|1
381674|NCT00862121|1282084|P1|Overall Study|Incorrect randomisation|0
381675|NCT00862121|1282083|P2|Overall Study|Exclusion criterion violation|1
381676|NCT00862121|1282084|P1|Overall Study|Exclusion criterion violation|0
381677|NCT00862121|1282083|P2|Overall Study|Protocol Violation|1
381678|NCT00862121|1282084|P1|Overall Study|Protocol Violation|0
381679|NCT00862121|1282083|P2|Overall Study|Lack of Efficacy|3
381680|NCT00862121|1282084|P1|Overall Study|Lack of Efficacy|0
381681|NCT00862121|1282083|P2|Overall Study|Adverse Event|2
381682|NCT00862121|1282084|P1|Overall Study|Adverse Event|1
381683|NCT00862082|1282102|P2|Overall Study|Withdrawal by Subject|1
381684|NCT00862082|1282103|P1|Overall Study|Withdrawal by Subject|0
381685|NCT00862082|1282102|P2|Overall Study|Sponsor decision to terminate the study|0
381686|NCT00862082|1282103|P1|Overall Study|Sponsor decision to terminate the study|5
381687|NCT00861757|1282158|P4|Overall Study|Withdrawal by Subject|2
381688|NCT00861757|1282159|P3|Overall Study|Withdrawal by Subject|5
381689|NCT00861757|1282160|P2|Overall Study|Withdrawal by Subject|5
381690|NCT00861757|1282161|P1|Overall Study|Withdrawal by Subject|1
381691|NCT00861757|1282158|P4|Overall Study|Protocol Violation|1
381692|NCT00861757|1282159|P3|Overall Study|Protocol Violation|4
381693|NCT00861757|1282160|P2|Overall Study|Protocol Violation|2
381694|NCT00861757|1282161|P1|Overall Study|Protocol Violation|2
381695|NCT00861757|1282158|P4|Overall Study|Physician Decision|1
381696|NCT00861757|1282159|P3|Overall Study|Physician Decision|0
381697|NCT00861757|1282160|P2|Overall Study|Physician Decision|0
381698|NCT00861757|1282161|P1|Overall Study|Physician Decision|0
381699|NCT00861757|1282158|P4|Overall Study|Lost to Follow-up|1
381700|NCT00861757|1282159|P3|Overall Study|Lost to Follow-up|1
381701|NCT00861757|1282160|P2|Overall Study|Lost to Follow-up|0
381702|NCT00861757|1282161|P1|Overall Study|Lost to Follow-up|1
381703|NCT00861757|1282158|P4|Overall Study|Lack of Efficacy|1
381704|NCT00861757|1282159|P3|Overall Study|Lack of Efficacy|0
381705|NCT00861757|1282160|P2|Overall Study|Lack of Efficacy|1
381706|NCT00861757|1282161|P1|Overall Study|Lack of Efficacy|3
381707|NCT00861757|1282158|P4|Overall Study|Entry Criteria Not Met|1
381708|NCT00861757|1282159|P3|Overall Study|Entry Criteria Not Met|1
381709|NCT00861757|1282160|P2|Overall Study|Entry Criteria Not Met|2
381710|NCT00861757|1282161|P1|Overall Study|Entry Criteria Not Met|1
381711|NCT00861757|1282158|P4|Overall Study|Adverse Event|2
381712|NCT00861757|1282159|P3|Overall Study|Adverse Event|7
381713|NCT00861757|1282160|P2|Overall Study|Adverse Event|5
381714|NCT00861757|1282161|P1|Overall Study|Adverse Event|1
381715|NCT00861744|1282219|P4|Overall Study|Blood draws|1
381716|NCT00861744|1282220|P3|Overall Study|Blood draws|0
381717|NCT00861744|1282221|P2|Overall Study|Blood draws|0
381718|NCT00861744|1282222|P1|Overall Study|Blood draws|0
381719|NCT00861744|1282219|P4|Overall Study|Migration from study area|0
381720|NCT00861744|1282220|P3|Overall Study|Migration from study area|1
381721|NCT00861744|1282221|P2|Overall Study|Migration from study area|3
381722|NCT00861744|1282222|P1|Overall Study|Migration from study area|0
381723|NCT00861744|1282219|P4|Overall Study|Protocol Violation|0
381724|NCT00861744|1282220|P3|Overall Study|Protocol Violation|0
381725|NCT00861744|1282221|P2|Overall Study|Protocol Violation|1
381726|NCT00861744|1282222|P1|Overall Study|Protocol Violation|0
381727|NCT00861744|1282219|P4|Overall Study|Withdrawal by Subject|19
381728|NCT00861744|1282220|P3|Overall Study|Withdrawal by Subject|6
381729|NCT00861744|1282221|P2|Overall Study|Withdrawal by Subject|6
381730|NCT00861744|1282222|P1|Overall Study|Withdrawal by Subject|10
381731|NCT00861744|1282219|P4|Overall Study|Lost to Follow-up|12
381732|NCT00861744|1282220|P3|Overall Study|Lost to Follow-up|17
381733|NCT00861744|1282221|P2|Overall Study|Lost to Follow-up|19
381734|NCT00861744|1282222|P1|Overall Study|Lost to Follow-up|7
381735|NCT00861744|1282219|P4|Overall Study|Adverse Event|1
381736|NCT00861744|1282220|P3|Overall Study|Adverse Event|0
381737|NCT00861744|1282221|P2|Overall Study|Adverse Event|0
381738|NCT00861744|1282222|P1|Overall Study|Adverse Event|0
381739|NCT00861705|1282404|P4|Overall Study|Never Began Treatment|1
381740|NCT00861705|1282405|P3|Overall Study|Never Began Treatment|0
381741|NCT00861705|1282406|P2|Overall Study|Never Began Treatment|3
381742|NCT00861705|1282407|P1|Overall Study|Never Began Treatment|7
381743|NCT00861692|1282423|P1|Overall Study|Death|6
381744|NCT00861614|1282435|P2|Overall Study|Other|22
381745|NCT00861614|1282436|P1|Overall Study|Other|17
381746|NCT00861614|1282435|P2|Overall Study|Withdrawal by Subject|35
381747|NCT00861614|1282436|P1|Overall Study|Withdrawal by Subject|34
381748|NCT00861614|1282435|P2|Overall Study|Adverse Event|23
381749|NCT00861614|1282436|P1|Overall Study|Adverse Event|27
381750|NCT00861614|1282435|P2|Overall Study|Death|19
381751|NCT00861614|1282436|P1|Overall Study|Death|32
381752|NCT00861614|1282435|P2|Overall Study|Study Drug Toxicity|6
381753|NCT00861614|1282436|P1|Overall Study|Study Drug Toxicity|79
381754|NCT00861614|1282435|P2|Overall Study|Disease Progression|263
381755|NCT00861614|1282436|P1|Overall Study|Disease Progression|182
381756|NCT00861471|1282521|P1|Overall Study|Physician Decision|2
381757|NCT00861471|1282521|P1|Overall Study|treatment for lumbar laminectomy|1
381758|NCT00861471|1282521|P1|Overall Study|Lack of Efficacy|3
381759|NCT00861471|1282521|P1|Overall Study|Adverse Event|2
381760|NCT00861471|1282521|P1|Overall Study|Withdrawal by Subject|1
381761|NCT00861341|1282529|P1|Overall Study|Withdrawal by Subject|2
381762|NCT00861198|1282538|P1|Overall Study|SpyGlass Failed|5
381763|NCT00860951|1282555|P1|Overall Study|Lost to Follow-up|5
381764|NCT00860951|1282555|P1|Overall Study|Withdrawal by Subject|2
381765|NCT00860743|1282597|P2|Overall Study|Withdrawal by Subject|0
381766|NCT00860743|1282598|P1|Overall Study|Withdrawal by Subject|3
381767|NCT00860470|1282611|P2|Overall Study|Lost to Follow-up|39
381768|NCT00860470|1282612|P1|Overall Study|Lost to Follow-up|34
381769|NCT00860470|1282611|P2|Overall Study|Moved away|10
381770|NCT00860470|1282612|P1|Overall Study|Moved away|8
381771|NCT00860470|1282611|P2|Overall Study|Death|10
381772|NCT00860470|1282612|P1|Overall Study|Death|6
381773|NCT00860405|1282642|P2|Overall Study|Main reason: Follow-up data not complete|4
381774|NCT00860405|1282643|P1|Overall Study|Main reason: Follow-up data not complete|5
381775|NCT00860262|1282683|P3|Overall Study|Not Specified|1
381776|NCT00860262|1282684|P2|Overall Study|Not Specified|3
381777|NCT00860262|1282685|P1|Overall Study|Not Specified|5
381778|NCT00860262|1282683|P3|Overall Study|Lack of Efficacy|3
381779|NCT00860262|1282684|P2|Overall Study|Lack of Efficacy|4
381780|NCT00860262|1282685|P1|Overall Study|Lack of Efficacy|0
381781|NCT00860262|1282683|P3|Overall Study|Withdrawal by Subject|6
381782|NCT00860262|1282684|P2|Overall Study|Withdrawal by Subject|8
381783|NCT00860262|1282685|P1|Overall Study|Withdrawal by Subject|4
381784|NCT00860262|1282683|P3|Overall Study|Lost to Follow-up|1
381785|NCT00860262|1282684|P2|Overall Study|Lost to Follow-up|0
381786|NCT00860262|1282685|P1|Overall Study|Lost to Follow-up|2
381787|NCT00860262|1282683|P3|Overall Study|Protocol Violation|0
381788|NCT00860262|1282684|P2|Overall Study|Protocol Violation|1
381789|NCT00860262|1282685|P1|Overall Study|Protocol Violation|0
381790|NCT00860262|1282683|P3|Overall Study|Adverse Event|7
381791|NCT00860262|1282684|P2|Overall Study|Adverse Event|6
381792|NCT00860262|1282685|P1|Overall Study|Adverse Event|9
381793|NCT00860249|1282798|P3|Overall Study|trial was terminated prior to completion|21
381794|NCT00860249|1282799|P2|Overall Study|trial was terminated prior to completion|18
381795|NCT00860249|1282800|P1|Overall Study|trial was terminated prior to completion|21
381796|NCT00860158|1282818|P1|Overall Study|Study Terminated|1
381797|NCT00860067|1282830|P3|Overall Study|Pregnancy|0
381798|NCT00860067|1282831|P2|Overall Study|Pregnancy|0
381799|NCT00860067|1282832|P1|Overall Study|Pregnancy|1
381800|NCT00860067|1282830|P3|Overall Study|Withdrawal by Subject|0
381801|NCT00860067|1282831|P2|Overall Study|Withdrawal by Subject|0
381802|NCT00860067|1282832|P1|Overall Study|Withdrawal by Subject|4
381803|NCT00860067|1282830|P3|Overall Study|Lost to Follow-up|9
381804|NCT00860067|1282831|P2|Overall Study|Lost to Follow-up|9
381805|NCT00860067|1282832|P1|Overall Study|Lost to Follow-up|46
381806|NCT00860028|1282892|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
381807|NCT00860028|1282893|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
381808|NCT00859937|1282914|P2|Overall Study|Protocol Violation|0
381809|NCT00859937|1282915|P1|Overall Study|Protocol Violation|1
381810|NCT00859898|1282930|P3|Overall Study|non-specified|1
381811|NCT00859898|1282931|P2|Overall Study|non-specified|1
381812|NCT00859898|1282932|P1|Overall Study|non-specified|1
381813|NCT00859898|1282930|P3|Overall Study|No longer meets criteria|0
381814|NCT00859898|1282931|P2|Overall Study|No longer meets criteria|1
381815|NCT00859898|1282932|P1|Overall Study|No longer meets criteria|0
381816|NCT00859898|1282930|P3|Overall Study|poor/non-compliance|0
381817|NCT00859898|1282931|P2|Overall Study|poor/non-compliance|0
381818|NCT00859898|1282932|P1|Overall Study|poor/non-compliance|2
381819|NCT00859898|1282930|P3|Overall Study|Lost to Follow-up|5
381820|NCT00859898|1282931|P2|Overall Study|Lost to Follow-up|11
381821|NCT00859898|1282932|P1|Overall Study|Lost to Follow-up|10
381822|NCT00859898|1282930|P3|Overall Study|Death|1
381823|NCT00859898|1282931|P2|Overall Study|Death|0
381824|NCT00859898|1282932|P1|Overall Study|Death|0
381825|NCT00859898|1282930|P3|Overall Study|Withdrawal by Subject|11
381826|NCT00859898|1282931|P2|Overall Study|Withdrawal by Subject|8
381827|NCT00859898|1282932|P1|Overall Study|Withdrawal by Subject|11
381828|NCT00859898|1282930|P3|Overall Study|Adverse Event|8
381829|NCT00859898|1282931|P2|Overall Study|Adverse Event|9
381830|NCT00859898|1282932|P1|Overall Study|Adverse Event|4
381831|NCT00859898|1282930|P3|Overall Study|Lack of Efficacy|1
381832|NCT00859898|1282931|P2|Overall Study|Lack of Efficacy|1
381833|NCT00859898|1282932|P1|Overall Study|Lack of Efficacy|0
381834|NCT00859638|1282991|P2|Overall Study|Ill health|1
381835|NCT00859638|1282992|P1|Overall Study|Ill health|1
381836|NCT00859638|1282991|P2|Overall Study|Withdrawal by Subject|2
381837|NCT00859638|1282992|P1|Overall Study|Withdrawal by Subject|3
381838|NCT00859638|1282991|P2|Overall Study|Lost to Follow-up|1
381839|NCT00859638|1282992|P1|Overall Study|Lost to Follow-up|6
381840|NCT00859586|1282998|P1|Overall Study|Donors|4
381841|NCT00859573|1283004|P2|Overall Study|Physician Decision|1
381842|NCT00859573|1283005|P1|Overall Study|Physician Decision|1
381843|NCT00859573|1283004|P2|Overall Study|Withdrawal by Subject|1
381844|NCT00859573|1283005|P1|Overall Study|Withdrawal by Subject|4
381845|NCT00859547|1283011|P1|Overall Study|Parent withdrew consent|1
381846|NCT00859547|1283011|P1|Overall Study|Lost to Follow-up|1
381847|NCT00859521|1283024|P2|Washout|Withdrawal by Subject|1
381848|NCT00859521|1283025|P1|Washout|Withdrawal by Subject|0
381849|NCT00859469|1283042|P1|Overall Study|Death|16
381850|NCT00859469|1283042|P1|Overall Study|Withdrawal by Subject|1
381851|NCT00859469|1283042|P1|Overall Study|Lack of Efficacy|9
381852|NCT00859469|1283042|P1|Overall Study|Adverse Event|2
381853|NCT00859430|1283050|P2|First Intervention|Withdrawal by Subject|1
381854|NCT00859430|1283051|P1|First Intervention|Withdrawal by Subject|0
381855|NCT00859313|1283067|P1|Overall Study|staff error|1
381856|NCT00859313|1283067|P1|Overall Study|Adverse Event|1
381857|NCT00859313|1283067|P1|Overall Study|Lack of Efficacy|2
381858|NCT00859222|1283074|P5|Overall Study|DLT|0
381859|NCT00859222|1283075|P4|Overall Study|DLT|0
381860|NCT00859222|1283076|P3|Overall Study|DLT|0
381861|NCT00859222|1283077|P2|Overall Study|DLT|0
381862|NCT00859222|1283078|P1|Overall Study|DLT|1
381863|NCT00859222|1283074|P5|Overall Study|Adverse Event|15
381864|NCT00859222|1283075|P4|Overall Study|Adverse Event|24
381865|NCT00859222|1283076|P3|Overall Study|Adverse Event|6
381866|NCT00859222|1283077|P2|Overall Study|Adverse Event|3
381867|NCT00859222|1283078|P1|Overall Study|Adverse Event|2
381868|NCT00859014|1283200|P1|Overall Study|Lost to Follow-up|1
381869|NCT00859014|1283200|P1|Overall Study|Death|4
381870|NCT00858845|1283215|P2|Overall Study|Patient underwent heart transplant.|1
381871|NCT00858845|1283216|P1|Overall Study|Patient underwent heart transplant.|0
381872|NCT00858832|1283228|P2|Overall Study|Adverse Event|1
381873|NCT00858832|1283229|P1|Overall Study|Adverse Event|0
381874|NCT00858832|1283228|P2|Overall Study|became ineligible: delivered vaginally|0
381875|NCT00858832|1283229|P1|Overall Study|became ineligible: delivered vaginally|1
381876|NCT00858780|1283235|P5|OL Re-Treatment (Failure to Week 48)|Other|1
381877|NCT00858780|1283236|P4|OL Re-Treatment (Failure to Week 48)|Other|0
381878|NCT00858780|1283237|P3|OL Re-Treatment (Failure to Week 48)|Other|0
381879|NCT00858780|1283238|P2|OL Re-Treatment (Failure to Week 48)|Other|0
381880|NCT00858780|1283239|P1|OL Re-Treatment (Failure to Week 48)|Other|0
381881|NCT00858780|1283235|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
381882|NCT00858780|1283236|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
381883|NCT00858780|1283237|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
381884|NCT00858780|1283238|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
381885|NCT00858780|1283239|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
381886|NCT00858780|1283235|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
381887|NCT00858780|1283236|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
381888|NCT00858780|1283237|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
381889|NCT00858780|1283238|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
381890|NCT00858780|1283239|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
381891|NCT00858780|1283235|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
381892|NCT00858780|1283236|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
381893|NCT00858780|1283237|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
381894|NCT00858780|1283238|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
381895|NCT00858780|1283239|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
381896|NCT00858780|1283235|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
381897|NCT00858780|1283236|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
381898|NCT00858780|1283237|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
381899|NCT00858780|1283238|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
381900|NCT00858780|1283239|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
381901|NCT00858780|1283235|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
381902|NCT00858780|1283236|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
381903|NCT00858780|1283237|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
381904|NCT00858780|1283238|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
381905|NCT00858780|1283239|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
381906|NCT00858702|1283314|P2|Overall Study|Withdrawal by Subject|0
381907|NCT00858702|1283315|P1|Overall Study|Withdrawal by Subject|1
381908|NCT00858702|1283314|P2|Overall Study|Other|1
381909|NCT00858702|1283315|P1|Overall Study|Other|2
381910|NCT00858702|1283314|P2|Overall Study|Protocol Violation|1
381911|NCT00858702|1283315|P1|Overall Study|Protocol Violation|1
381912|NCT00858702|1283314|P2|Overall Study|Lack of Efficacy|0
381913|NCT00858702|1283315|P1|Overall Study|Lack of Efficacy|1
381914|NCT00858637|1283330|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
381915|NCT00858637|1283331|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
381916|NCT00858637|1283332|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
381917|NCT00858637|1283333|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
381918|NCT00858637|1283334|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
381919|NCT00858637|1283335|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
381920|NCT00858637|1283330|P6|Placebo-controlled Withdrawal Phase|Death|0
381921|NCT00858637|1283331|P5|Placebo-controlled Withdrawal Phase|Death|1
381922|NCT00858637|1283332|P4|Placebo-controlled Withdrawal Phase|Death|0
381923|NCT00858637|1283333|P3|Placebo-controlled Withdrawal Phase|Death|1
381924|NCT00858637|1283334|P2|Placebo-controlled Withdrawal Phase|Death|0
381925|NCT00858637|1283335|P1|Placebo-controlled Withdrawal Phase|Death|0
381926|NCT00858637|1283330|P6|Active Comparison Phase|Other Reasons|0
381927|NCT00858637|1283331|P5|Active Comparison Phase|Other Reasons|0
381928|NCT00858637|1283332|P4|Active Comparison Phase|Other Reasons|1
381929|NCT00858637|1283333|P3|Active Comparison Phase|Other Reasons|0
381930|NCT00858637|1283334|P2|Active Comparison Phase|Other Reasons|0
381931|NCT00858637|1283335|P1|Active Comparison Phase|Other Reasons|1
381932|NCT00858637|1283330|P6|Active Comparison Phase|Withdrawal by Subject|0
381933|NCT00858637|1283331|P5|Active Comparison Phase|Withdrawal by Subject|0
381934|NCT00858637|1283332|P4|Active Comparison Phase|Withdrawal by Subject|6
381935|NCT00858637|1283333|P3|Active Comparison Phase|Withdrawal by Subject|0
381936|NCT00858637|1283334|P2|Active Comparison Phase|Withdrawal by Subject|0
381937|NCT00858637|1283335|P1|Active Comparison Phase|Withdrawal by Subject|7
381938|NCT00858637|1283330|P6|Active Comparison Phase|Physician Decision|0
381939|NCT00858637|1283331|P5|Active Comparison Phase|Physician Decision|0
381940|NCT00858637|1283332|P4|Active Comparison Phase|Physician Decision|1
381941|NCT00858637|1283333|P3|Active Comparison Phase|Physician Decision|0
381942|NCT00858637|1283334|P2|Active Comparison Phase|Physician Decision|0
381943|NCT00858637|1283335|P1|Active Comparison Phase|Physician Decision|1
381944|NCT00858637|1283330|P6|Active Comparison Phase|Death|0
381945|NCT00858637|1283331|P5|Active Comparison Phase|Death|0
381946|NCT00858637|1283332|P4|Active Comparison Phase|Death|1
381947|NCT00858637|1283333|P3|Active Comparison Phase|Death|0
381948|NCT00858637|1283334|P2|Active Comparison Phase|Death|0
381949|NCT00858637|1283335|P1|Active Comparison Phase|Death|1
381950|NCT00858637|1283330|P6|Active Comparison Phase|Adverse Event|0
381951|NCT00858637|1283331|P5|Active Comparison Phase|Adverse Event|0
381952|NCT00858637|1283332|P4|Active Comparison Phase|Adverse Event|9
381953|NCT00858637|1283333|P3|Active Comparison Phase|Adverse Event|0
381954|NCT00858637|1283334|P2|Active Comparison Phase|Adverse Event|0
381955|NCT00858637|1283335|P1|Active Comparison Phase|Adverse Event|14
381956|NCT00858442|1283376|P2|Compression:Start to Finish|Lost to Follow-up|3
381957|NCT00858442|1283377|P1|Compression:Start to Finish|Lost to Follow-up|1
381958|NCT00858403|1283387|P1|Overall Study|Disease Progression|1
381959|NCT00858403|1283387|P1|Overall Study|Death|3
381960|NCT00858403|1283387|P1|Overall Study|Withdrawal by Subject|1
381961|NCT00858247|1283408|P2|Week 12 Follow-up|Withdrawal by Subject|1
381962|NCT00858247|1283409|P1|Week 12 Follow-up|Withdrawal by Subject|0
381963|NCT00858247|1283408|P2|Baseline Assessment|Protocol Violation|1
381964|NCT00858247|1283409|P1|Baseline Assessment|Protocol Violation|0
381965|NCT00858247|1283408|P2|Baseline Assessment|Poor IV access|0
381966|NCT00858247|1283409|P1|Baseline Assessment|Poor IV access|1
381967|NCT00858247|1283408|P2|Baseline Assessment|Withdrawal by Subject|1
381968|NCT00858247|1283409|P1|Baseline Assessment|Withdrawal by Subject|1
381969|NCT00858208|1283425|P1|Overall Study|Other|10
381970|NCT00858208|1283425|P1|Overall Study|Participant refused|40
381971|NCT00858208|1283425|P1|Overall Study|Lost to Follow-up|26
381972|NCT00858208|1283425|P1|Overall Study|Adverse Event|3
381973|NCT00858143|1283442|P1|Overall Study|Other|23
381974|NCT00858143|1283442|P1|Overall Study|Death|7
381975|NCT00858143|1283442|P1|Overall Study|Lack of Efficacy|4
381976|NCT00858143|1283442|P1|Overall Study|Adverse Event|16
381977|NCT00857948|1283554|P4|Overall Study|Protocol Violation|0
381978|NCT00857948|1283555|P3|Overall Study|Protocol Violation|1
381979|NCT00857948|1283556|P2|Overall Study|Protocol Violation|0
381980|NCT00857948|1283557|P1|Overall Study|Protocol Violation|1
381981|NCT00857948|1283554|P4|Overall Study|Withdrawal by Subject|0
381982|NCT00857948|1283555|P3|Overall Study|Withdrawal by Subject|0
381983|NCT00857948|1283556|P2|Overall Study|Withdrawal by Subject|0
381984|NCT00857948|1283557|P1|Overall Study|Withdrawal by Subject|2
381985|NCT00857896|1283579|P1|Baseline to Week 4|Withdrawal by Subject|1
381986|NCT00857818|1283735|P2|Overall Study|Investigator decision|0
381987|NCT00857818|1283736|P1|Overall Study|Investigator decision|1
381988|NCT00857818|1283735|P2|Overall Study|Sponsor terminated study|4
381989|NCT00857818|1283736|P1|Overall Study|Sponsor terminated study|6
381990|NCT00857818|1283735|P2|Overall Study|Withdrawal by Subject|4
381991|NCT00857818|1283736|P1|Overall Study|Withdrawal by Subject|0
381992|NCT00857818|1283735|P2|Overall Study|Adverse Event|0
381993|NCT00857818|1283736|P1|Overall Study|Adverse Event|3
381994|NCT00857818|1283735|P2|Overall Study|Lack of Efficacy|0
381995|NCT00857818|1283736|P1|Overall Study|Lack of Efficacy|1
381996|NCT00857792|1283764|P1|Overall Study|inadequate image quality for analysis|12
381997|NCT00857766|1283770|P2|Overall Study|Participant Withdrew Consent|4
381998|NCT00857766|1283771|P1|Overall Study|Participant Withdrew Consent|4
381999|NCT00857766|1283770|P2|Overall Study|Investigator Discretion|3
382000|NCT00857766|1283771|P1|Overall Study|Investigator Discretion|2
382001|NCT00857766|1283770|P2|Overall Study|Lost to Follow-up|0
382002|NCT00857766|1283771|P1|Overall Study|Lost to Follow-up|1
382003|NCT00857766|1283770|P2|Overall Study|Protocol Violation|11
382004|NCT00857766|1283771|P1|Overall Study|Protocol Violation|11
382005|NCT00857766|1283770|P2|Overall Study|Adverse Event|12
382006|NCT00857766|1283771|P1|Overall Study|Adverse Event|13
382007|NCT00857649|1283788|P2|Overall Study|Other Reasons|3
382008|NCT00857649|1283789|P1|Overall Study|Other Reasons|1
382009|NCT00857649|1283788|P2|Overall Study|Nursing Home Placement|9
382010|NCT00857649|1283789|P1|Overall Study|Nursing Home Placement|2
382011|NCT00857649|1283788|P2|Overall Study|Withdrawal of Consent|7
382012|NCT00857649|1283789|P1|Overall Study|Withdrawal of Consent|10
382013|NCT00857649|1283788|P2|Overall Study|Protocol Violation|2
382014|NCT00857649|1283789|P1|Overall Study|Protocol Violation|2
382015|NCT00857649|1283788|P2|Overall Study|Non-compliance|1
382016|NCT00857649|1283789|P1|Overall Study|Non-compliance|1
382017|NCT00857649|1283788|P2|Overall Study|Adverse Event|10
382018|NCT00857649|1283789|P1|Overall Study|Adverse Event|15
382019|NCT00857623|1283805|P2|Overall Study|Positive for HEP C|1
382020|NCT00857623|1283806|P1|Overall Study|Positive for HEP C|0
382021|NCT00857623|1283805|P2|Overall Study|Intake of prohibited medication|1
382022|NCT00857623|1283806|P1|Overall Study|Intake of prohibited medication|0
382023|NCT00857623|1283805|P2|Overall Study|Severe non-compliance to protocol|1
382024|NCT00857623|1283806|P1|Overall Study|Severe non-compliance to protocol|1
382025|NCT00857623|1283805|P2|Overall Study|Lack of Efficacy|1
382026|NCT00857623|1283806|P1|Overall Study|Lack of Efficacy|1
382027|NCT00857623|1283805|P2|Overall Study|Withdrawal by Subject|1
382028|NCT00857623|1283806|P1|Overall Study|Withdrawal by Subject|2
382029|NCT00857623|1283805|P2|Overall Study|Study-specific discontinuation criteria|3
382030|NCT00857623|1283806|P1|Overall Study|Study-specific discontinuation criteria|5
382031|NCT00857623|1283805|P2|Overall Study|Adverse Event|2
382032|NCT00857623|1283806|P1|Overall Study|Adverse Event|5
382033|NCT00857584|1283830|P2|Overall Study|Physician Decision|1
382034|NCT00857584|1283831|P1|Overall Study|Physician Decision|1
382035|NCT00857584|1283830|P2|Overall Study|Adverse Event|2
382036|NCT00857584|1283831|P1|Overall Study|Adverse Event|2
382037|NCT00857584|1283830|P2|Overall Study|Lack of Efficacy|2
382038|NCT00857584|1283831|P1|Overall Study|Lack of Efficacy|1
382039|NCT00857454|1283923|P1|Overall Study|MTE09 enrollment criteria not met|6
382040|NCT00857454|1283923|P1|Overall Study|Total Testosterone <300 ng/dL|8
382041|NCT00857454|1283923|P1|Overall Study|Total Testosterone >1050 ng/dL|1
382042|NCT00857454|1283923|P1|Overall Study|Adverse Event|2
382043|NCT00857454|1283923|P1|Overall Study|Lost to Follow-up|1
382044|NCT00857454|1283923|P1|Overall Study|Withdrawal by Subject|2
382045|NCT00857415|1283936|P2|Overall Study|Deceased with no autopsy|0
382046|NCT00857415|1283937|P1|Overall Study|Deceased with no autopsy|2
382047|NCT00857415|1283936|P2|Overall Study|Subject still living at end of study|0
382048|NCT00857415|1283937|P1|Overall Study|Subject still living at end of study|110
382049|NCT00857415|1283936|P2|Overall Study|Invalid image or not imaged|0
382050|NCT00857415|1283937|P1|Overall Study|Invalid image or not imaged|3
382051|NCT00857415|1283936|P2|Overall Study|Image acquisition failure|0
382052|NCT00857415|1283937|P1|Overall Study|Image acquisition failure|2
382053|NCT00857311|1283948|P4|Overall Study|Lost to Follow-up|0
382054|NCT00857311|1283949|P3|Overall Study|Lost to Follow-up|0
382055|NCT00857311|1283950|P2|Overall Study|Lost to Follow-up|0
382056|NCT00857311|1283951|P1|Overall Study|Lost to Follow-up|1
382057|NCT00857285|1283963|P2|Overall Study|Randomization criteria not met|1
382058|NCT00857285|1283964|P1|Overall Study|Randomization criteria not met|1
382059|NCT00857285|1283963|P2|Overall Study|Withdrawal by Subject|0
382060|NCT00857285|1283964|P1|Overall Study|Withdrawal by Subject|4
382061|NCT00857285|1283963|P2|Overall Study|Protocol Violation|1
382062|NCT00857285|1283964|P1|Overall Study|Protocol Violation|3
382063|NCT00857285|1283963|P2|Overall Study|Lack of Efficacy|2
382064|NCT00857285|1283964|P1|Overall Study|Lack of Efficacy|0
382065|NCT00857285|1283963|P2|Overall Study|Adverse Event|2
382066|NCT00857285|1283964|P1|Overall Study|Adverse Event|4
382067|NCT00857259|1283980|P3|Overall Study|Protocol Violation|1
382068|NCT00857259|1283981|P2|Overall Study|Protocol Violation|0
382069|NCT00857259|1283982|P1|Overall Study|Protocol Violation|1
382070|NCT00857246|1283992|P1|ChemoRT|Adverse Event|2
382071|NCT00857246|1283992|P1|ChemoRT|Withdrawal by Subject|1
382072|NCT00857246|1283992|P1|Surgery (Curative)|disease progression|6
382073|NCT00857246|1283992|P1|Induction Regimen|Withdrawal by Subject|1
382074|NCT00857246|1283992|P1|Induction Regimen|disease-related complications|1
382075|NCT00857246|1283992|P1|Induction Regimen|Adverse Event|1
382076|NCT00857233|1284002|P1|Overall Study|Other Reasons|2
382077|NCT00857233|1284002|P1|Overall Study|Nursing Home Placement|14
382078|NCT00857233|1284002|P1|Overall Study|Lost to Follow-up|4
382079|NCT00857233|1284002|P1|Overall Study|Withdrawal of Consent|9
382080|NCT00857233|1284002|P1|Overall Study|Non-compliance|1
382081|NCT00857233|1284002|P1|Overall Study|Lack of Efficacy|1
382082|NCT00857233|1284002|P1|Overall Study|Adverse Event|24
382083|NCT00857220|1284011|P1|Overall Study|Miscellaneous|8
382084|NCT00857220|1284011|P1|Overall Study|Site Closed|5
382085|NCT00857220|1284011|P1|Overall Study|Clinical Hold|6
382086|NCT00857220|1284011|P1|Overall Study|Withdrawal by Subject|67
382087|NCT00857220|1284011|P1|Overall Study|Protocol Violation|16
382088|NCT00857220|1284011|P1|Overall Study|Physician Decision|4
382089|NCT00857220|1284011|P1|Overall Study|Lost to Follow-up|30
382090|NCT00857220|1284011|P1|Overall Study|Lack of Efficacy|11
382091|NCT00857220|1284011|P1|Overall Study|Death|1
382092|NCT00857220|1284011|P1|Overall Study|Adverse Event|35
382093|NCT00856986|1284033|P5|Extension Period, Weeks 26-52|Unclassified|0
382094|NCT00856986|1284034|P4|Extension Period, Weeks 26-52|Unclassified|0
382095|NCT00856986|1284035|P3|Extension Period, Weeks 26-52|Unclassified|11
382096|NCT00856986|1284036|P2|Extension Period, Weeks 26-52|Unclassified|2
382097|NCT00856986|1284037|P1|Extension Period, Weeks 26-52|Unclassified|4
382098|NCT00856986|1284033|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
382099|NCT00856986|1284034|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
382100|NCT00856986|1284035|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
382101|NCT00856986|1284036|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
382102|NCT00856986|1284037|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
382103|NCT00856986|1284033|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
382104|NCT00856986|1284034|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
382105|NCT00856986|1284035|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
382106|NCT00856986|1284036|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
382107|NCT00856986|1284037|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
382108|NCT00856986|1284033|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
382109|NCT00856986|1284034|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
382110|NCT00856986|1284035|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
382111|NCT00856986|1284036|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
382112|NCT00856986|1284037|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
382113|NCT00856986|1284033|P5|Extension Period, Weeks 26-52|Protocol Violation|0
382114|NCT00856986|1284034|P4|Extension Period, Weeks 26-52|Protocol Violation|0
382115|NCT00856986|1284035|P3|Extension Period, Weeks 26-52|Protocol Violation|5
382116|NCT00856986|1284036|P2|Extension Period, Weeks 26-52|Protocol Violation|2
382117|NCT00856986|1284037|P1|Extension Period, Weeks 26-52|Protocol Violation|6
382118|NCT00856986|1284033|P5|Extension Period, Weeks 26-52|Adverse Event|0
382119|NCT00856986|1284034|P4|Extension Period, Weeks 26-52|Adverse Event|0
382120|NCT00856986|1284035|P3|Extension Period, Weeks 26-52|Adverse Event|10
382121|NCT00856986|1284036|P2|Extension Period, Weeks 26-52|Adverse Event|3
382122|NCT00856986|1284037|P1|Extension Period, Weeks 26-52|Adverse Event|3
382123|NCT00856986|1284033|P5|Main Period, Weeks 0-26|Unclassified|0
382124|NCT00856986|1284034|P4|Main Period, Weeks 0-26|Unclassified|0
382125|NCT00856986|1284035|P3|Main Period, Weeks 0-26|Unclassified|7
382126|NCT00856986|1284036|P2|Main Period, Weeks 0-26|Unclassified|6
382127|NCT00856986|1284037|P1|Main Period, Weeks 0-26|Unclassified|7
382128|NCT00856986|1284033|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
382129|NCT00856986|1284034|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
382130|NCT00856986|1284035|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
382131|NCT00856986|1284036|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
382132|NCT00856986|1284037|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
382133|NCT00856986|1284033|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
382134|NCT00856986|1284034|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
382135|NCT00856986|1284035|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
382136|NCT00856986|1284036|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
382137|NCT00856986|1284037|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
382138|NCT00856986|1284033|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
382139|NCT00856986|1284034|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
382140|NCT00856986|1284035|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
382141|NCT00856986|1284036|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
382142|NCT00856986|1284037|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
382143|NCT00856986|1284033|P5|Main Period, Weeks 0-26|Protocol Violation|0
382144|NCT00856986|1284034|P4|Main Period, Weeks 0-26|Protocol Violation|0
382145|NCT00856986|1284035|P3|Main Period, Weeks 0-26|Protocol Violation|7
382146|NCT00856986|1284036|P2|Main Period, Weeks 0-26|Protocol Violation|5
382147|NCT00856986|1284037|P1|Main Period, Weeks 0-26|Protocol Violation|4
382148|NCT00856986|1284033|P5|Main Period, Weeks 0-26|Adverse Event|0
382149|NCT00856986|1284034|P4|Main Period, Weeks 0-26|Adverse Event|0
382150|NCT00856986|1284035|P3|Main Period, Weeks 0-26|Adverse Event|9
382151|NCT00856986|1284036|P2|Main Period, Weeks 0-26|Adverse Event|4
382152|NCT00856986|1284037|P1|Main Period, Weeks 0-26|Adverse Event|6
382153|NCT00856986|1284033|P5|Run-in Period, Weeks -12-0|Unclassified|0
382154|NCT00856986|1284034|P4|Run-in Period, Weeks -12-0|Unclassified|24
382155|NCT00856986|1284035|P3|Run-in Period, Weeks -12-0|Unclassified|0
382156|NCT00856986|1284036|P2|Run-in Period, Weeks -12-0|Unclassified|0
382157|NCT00856986|1284037|P1|Run-in Period, Weeks -12-0|Unclassified|0
382158|NCT00856986|1284033|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
382159|NCT00856986|1284034|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
382160|NCT00856986|1284035|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
382161|NCT00856986|1284036|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
382162|NCT00856986|1284037|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
382163|NCT00856986|1284033|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
382164|NCT00856986|1284034|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
382165|NCT00856986|1284035|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
382166|NCT00856986|1284036|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
382167|NCT00856986|1284037|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
382168|NCT00856986|1284033|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
382169|NCT00856986|1284034|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
382170|NCT00856986|1284035|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
382171|NCT00856986|1284036|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
382172|NCT00856986|1284037|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
382173|NCT00856986|1284033|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
382174|NCT00856986|1284034|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
382175|NCT00856986|1284035|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
382176|NCT00856986|1284036|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
382177|NCT00856986|1284037|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
382178|NCT00856986|1284033|P5|Run-in Period, Weeks -12-0|Adverse Event|0
382179|NCT00856986|1284034|P4|Run-in Period, Weeks -12-0|Adverse Event|92
382180|NCT00856986|1284035|P3|Run-in Period, Weeks -12-0|Adverse Event|0
382181|NCT00856986|1284036|P2|Run-in Period, Weeks -12-0|Adverse Event|0
382182|NCT00856986|1284037|P1|Run-in Period, Weeks -12-0|Adverse Event|0
382183|NCT00856973|1284207|P3|Overall Study|Other|13
382184|NCT00856973|1284208|P2|Overall Study|Other|12
382185|NCT00856973|1284209|P1|Overall Study|Other|11
382186|NCT00856973|1284207|P3|Overall Study|Withdrawal by Subject|15
382187|NCT00856973|1284208|P2|Overall Study|Withdrawal by Subject|16
382188|NCT00856973|1284209|P1|Overall Study|Withdrawal by Subject|13
382189|NCT00856973|1284207|P3|Overall Study|Protocol Violation|1
382190|NCT00856973|1284208|P2|Overall Study|Protocol Violation|2
382191|NCT00856973|1284209|P1|Overall Study|Protocol Violation|1
382192|NCT00856973|1284207|P3|Overall Study|Physician Decision|1
382193|NCT00856973|1284208|P2|Overall Study|Physician Decision|3
382194|NCT00856973|1284209|P1|Overall Study|Physician Decision|0
382195|NCT00856973|1284207|P3|Overall Study|Lost to Follow-up|5
382196|NCT00856973|1284208|P2|Overall Study|Lost to Follow-up|3
382197|NCT00856973|1284209|P1|Overall Study|Lost to Follow-up|6
382198|NCT00856973|1284207|P3|Overall Study|Adverse Event|3
382199|NCT00856973|1284208|P2|Overall Study|Adverse Event|5
382200|NCT00856973|1284209|P1|Overall Study|Adverse Event|5
382201|NCT00856908|1284289|P2|Overall Study|Lost to Follow-up|0
382202|NCT00856908|1284290|P1|Overall Study|Lost to Follow-up|1
382203|NCT00856843|1284317|P2|Overall Study|Lack of Efficacy|0
382204|NCT00856843|1284318|P1|Overall Study|Lack of Efficacy|1
382205|NCT00856843|1284317|P2|Overall Study|Withdrawal by Subject|5
382206|NCT00856843|1284318|P1|Overall Study|Withdrawal by Subject|1
382207|NCT00856830|1284354|P4|Irinotecan & Bendamustine|Physician Decision|1
382208|NCT00856830|1284355|P3|Irinotecan & Bendamustine|Physician Decision|0
382209|NCT00856830|1284356|P2|Irinotecan & Bendamustine|Physician Decision|0
382210|NCT00856830|1284357|P1|Irinotecan & Bendamustine|Physician Decision|0
382211|NCT00856830|1284354|P4|Irinotecan & Bendamustine|Death|2
382212|NCT00856830|1284355|P3|Irinotecan & Bendamustine|Death|0
382213|NCT00856830|1284356|P2|Irinotecan & Bendamustine|Death|0
382214|NCT00856830|1284357|P1|Irinotecan & Bendamustine|Death|0
382215|NCT00856778|1284368|P1|Overall Study|Lost to Follow-up|5
382216|NCT00856778|1284368|P1|Overall Study|Study deviation|2
382217|NCT00856778|1284368|P1|Overall Study|Withdrawal by Subject|10
382218|NCT00856778|1284368|P1|Overall Study|Adverse Event|7
382219|NCT00856661|1284411|P2|Overall Study|Physician Judgement|5
382220|NCT00856661|1284412|P1|Overall Study|Physician Judgement|8
382221|NCT00856661|1284411|P2|Overall Study|Lost to Follow-up|3
382222|NCT00856661|1284412|P1|Overall Study|Lost to Follow-up|1
382223|NCT00856661|1284411|P2|Overall Study|Withdrawal by Subject|2
382224|NCT00856661|1284412|P1|Overall Study|Withdrawal by Subject|1
382225|NCT00856661|1284411|P2|Overall Study|Protocol Violation|1
382226|NCT00856661|1284412|P1|Overall Study|Protocol Violation|2
382227|NCT00856661|1284411|P2|Overall Study|Death|18
382228|NCT00856661|1284412|P1|Overall Study|Death|15
382229|NCT00856635|1284426|P2|Overall Study|Discontinued at Randomization|2
382230|NCT00856635|1284427|P1|Overall Study|Discontinued at Randomization|2
382231|NCT00856635|1284426|P2|Overall Study|Other|0
382232|NCT00856635|1284427|P1|Overall Study|Other|1
382233|NCT00856635|1284426|P2|Overall Study|Serious Adverse Event|0
382234|NCT00856635|1284427|P1|Overall Study|Serious Adverse Event|1
382235|NCT00856635|1284426|P2|Overall Study|Withdrawal by Subject|1
382236|NCT00856635|1284427|P1|Overall Study|Withdrawal by Subject|3
382237|NCT00856635|1284426|P2|Overall Study|Pregnancy|0
382238|NCT00856635|1284427|P1|Overall Study|Pregnancy|1
382239|NCT00856635|1284426|P2|Overall Study|Lost to Follow-up|5
382240|NCT00856635|1284427|P1|Overall Study|Lost to Follow-up|2
382241|NCT00856609|1284437|P2|Overall Study|Adverse Event|0
382242|NCT00856609|1284438|P1|Overall Study|Adverse Event|1
382243|NCT00856583|1284450|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
382244|NCT00856583|1284451|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
382245|NCT00856583|1284450|P2|Overall Study|Other|104
382246|NCT00856583|1284451|P1|Overall Study|Other|92
382247|NCT00856583|1284450|P2|Overall Study|Pregnancy|5
382248|NCT00856583|1284451|P1|Overall Study|Pregnancy|14
382249|NCT00856583|1284450|P2|Overall Study|Physician Decision|82
382250|NCT00856583|1284451|P1|Overall Study|Physician Decision|59
382251|NCT00856583|1284450|P2|Overall Study|Withdrawal by Subject|919
382252|NCT00856583|1284451|P1|Overall Study|Withdrawal by Subject|1092
382253|NCT00856583|1284450|P2|Overall Study|Non-compliance|262
382254|NCT00856583|1284451|P1|Overall Study|Non-compliance|305
382255|NCT00856583|1284450|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
382256|NCT00856583|1284451|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
382257|NCT00856583|1284450|P2|Overall Study|Serious Adverse Event (SAE)|65
382258|NCT00856583|1284451|P1|Overall Study|Serious Adverse Event (SAE)|99
382259|NCT00856583|1284450|P2|Overall Study|Lack of Efficacy|377
382260|NCT00856583|1284451|P1|Overall Study|Lack of Efficacy|389
382261|NCT00856557|1284481|P2|Overall Study|No patients with contextual flags|16
382262|NCT00856557|1284482|P1|Overall Study|No patients with contextual flags|12
382263|NCT00856544|1284496|P4|Overall Study|Withdrawal by Subject|1
382264|NCT00856544|1284497|P3|Overall Study|Withdrawal by Subject|0
382265|NCT00856544|1284498|P2|Overall Study|Withdrawal by Subject|5
382266|NCT00856544|1284499|P1|Overall Study|Withdrawal by Subject|8
382267|NCT00856544|1284496|P4|Overall Study|Lost to Follow-up|0
382268|NCT00856544|1284497|P3|Overall Study|Lost to Follow-up|2
382269|NCT00856544|1284498|P2|Overall Study|Lost to Follow-up|2
382270|NCT00856544|1284499|P1|Overall Study|Lost to Follow-up|1
382271|NCT00856544|1284496|P4|Overall Study|Other|6
382272|NCT00856544|1284497|P3|Overall Study|Other|1
382273|NCT00856544|1284498|P2|Overall Study|Other|16
382274|NCT00856544|1284499|P1|Overall Study|Other|9
382275|NCT00856544|1284496|P4|Overall Study|Lack of Efficacy|3
382276|NCT00856544|1284497|P3|Overall Study|Lack of Efficacy|3
382277|NCT00856544|1284498|P2|Overall Study|Lack of Efficacy|12
382278|NCT00856544|1284499|P1|Overall Study|Lack of Efficacy|16
382279|NCT00856544|1284496|P4|Overall Study|Adverse Event|3
382280|NCT00856544|1284497|P3|Overall Study|Adverse Event|2
382281|NCT00856544|1284498|P2|Overall Study|Adverse Event|29
382282|NCT00856544|1284499|P1|Overall Study|Adverse Event|20
382283|NCT00856544|1284496|P4|Overall Study|Death|0
382284|NCT00856544|1284497|P3|Overall Study|Death|0
382285|NCT00856544|1284498|P2|Overall Study|Death|2
382286|NCT00856544|1284499|P1|Overall Study|Death|0
382287|NCT00856544|1284496|P4|Overall Study|Randomized but not treated|0
382288|NCT00856544|1284497|P3|Overall Study|Randomized but not treated|0
382289|NCT00856544|1284498|P2|Overall Study|Randomized but not treated|0
382290|NCT00856544|1284499|P1|Overall Study|Randomized but not treated|3
382291|NCT00856518|1284678|P2|Overall Study|Lost to Follow-up|2
382292|NCT00856518|1284679|P1|Overall Study|Lost to Follow-up|4
382293|NCT00856492|1284692|P3|Overall Study|Ineligible or withdrew consent|2
382294|NCT00856492|1284693|P2|Overall Study|Ineligible or withdrew consent|1
382295|NCT00856492|1284694|P1|Overall Study|Ineligible or withdrew consent|1
382296|NCT00856388|1284716|P1|Overall Study|Not Specified|1
382297|NCT00856349|1284727|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
382298|NCT00856349|1284727|P1|Overall Study|Site closure|78
382299|NCT00856349|1284727|P1|Overall Study|Device explant|33
382300|NCT00856349|1284727|P1|Overall Study|Subject relocation|104
382301|NCT00856349|1284727|P1|Overall Study|Physician Decision|13
382302|NCT00856349|1284727|P1|Overall Study|Protocol Violation|38
382303|NCT00856349|1284727|P1|Overall Study|Lost to Follow-up|91
382304|NCT00856349|1284727|P1|Overall Study|Withdrawal by Subject|116
382305|NCT00856349|1284727|P1|Overall Study|Death|418
382306|NCT00856323|1284736|P1|Overall Study|Withdrawal by Subject|2
382307|NCT00856297|1284748|P5|Overall Study|Unable to classify|0
382308|NCT00856297|1284749|P4|Overall Study|Unable to classify|0
382309|NCT00856297|1284750|P3|Overall Study|Unable to classify|0
382310|NCT00856297|1284751|P2|Overall Study|Unable to classify|0
382311|NCT00856297|1284752|P1|Overall Study|Unable to classify|2
382312|NCT00856284|1284785|P3|Overall Study|Randomized in error|1
382313|NCT00856284|1284786|P2|Overall Study|Randomized in error|0
382314|NCT00856284|1284787|P1|Overall Study|Randomized in error|0
382315|NCT00856284|1284785|P3|Overall Study|Other|14
382316|NCT00856284|1284786|P2|Overall Study|Other|17
382317|NCT00856284|1284787|P1|Overall Study|Other|15
382318|NCT00856284|1284785|P3|Overall Study|Investigator discretion|10
382319|NCT00856284|1284786|P2|Overall Study|Investigator discretion|8
382320|NCT00856284|1284787|P1|Overall Study|Investigator discretion|9
382321|NCT00856284|1284785|P3|Overall Study|Pregnancy|0
382322|NCT00856284|1284786|P2|Overall Study|Pregnancy|2
382323|NCT00856284|1284787|P1|Overall Study|Pregnancy|1
382324|NCT00856284|1284785|P3|Overall Study|Voluntary withdrawal|62
382325|NCT00856284|1284786|P2|Overall Study|Voluntary withdrawal|52
382326|NCT00856284|1284787|P1|Overall Study|Voluntary withdrawal|48
382327|NCT00856284|1284785|P3|Overall Study|Lost to Follow-up|28
382328|NCT00856284|1284786|P2|Overall Study|Lost to Follow-up|22
382329|NCT00856284|1284787|P1|Overall Study|Lost to Follow-up|20
382330|NCT00856284|1284785|P3|Overall Study|Major protocol deviation|15
382331|NCT00856284|1284786|P2|Overall Study|Major protocol deviation|16
382332|NCT00856284|1284787|P1|Overall Study|Major protocol deviation|24
382333|NCT00856284|1284785|P3|Overall Study|Adverse Event|82
382334|NCT00856284|1284786|P2|Overall Study|Adverse Event|74
382335|NCT00856284|1284787|P1|Overall Study|Adverse Event|60
382336|NCT00856284|1284785|P3|Overall Study|Hyperglycemic rescue|235
382337|NCT00856284|1284786|P2|Overall Study|Hyperglycemic rescue|201
382338|NCT00856284|1284787|P1|Overall Study|Hyperglycemic rescue|231
382339|NCT00856245|1284813|P1|Overall Study|Was not transplanted|5
382340|NCT00856206|1284836|P2|Overall Study|Other than specified above|10
382341|NCT00856206|1284837|P1|Overall Study|Other than specified above|3
382342|NCT00856206|1284836|P2|Overall Study|Decision by the Sponsor|8
382343|NCT00856206|1284837|P1|Overall Study|Decision by the Sponsor|4
382344|NCT00856206|1284836|P2|Overall Study|Death|2
382345|NCT00856206|1284837|P1|Overall Study|Death|2
382346|NCT00856206|1284836|P2|Overall Study|Lost to Follow-up|39
382347|NCT00856206|1284837|P1|Overall Study|Lost to Follow-up|13
382348|NCT00856206|1284836|P2|Overall Study|Withdrawal by Subject|36
382349|NCT00856206|1284837|P1|Overall Study|Withdrawal by Subject|15
382350|NCT00856206|1284836|P2|Overall Study|Lack of Efficacy|2
382351|NCT00856206|1284837|P1|Overall Study|Lack of Efficacy|1
382352|NCT00856206|1284836|P2|Overall Study|Adverse Event|46
382353|NCT00856206|1284837|P1|Overall Study|Adverse Event|10
382354|NCT00856206|1284836|P2|Overall Study|Protocol Violation|18
382355|NCT00856206|1284837|P1|Overall Study|Protocol Violation|6
382356|NCT00856193|1284851|P2|Period 2|Lost to Follow-up|1
382357|NCT00856193|1284852|P1|Period 2|Lost to Follow-up|0
382358|NCT00856193|1284851|P2|Period 2|Abnormal test procedure results|1
382359|NCT00856193|1284852|P1|Period 2|Abnormal test procedure results|0
382360|NCT00856180|1284864|P1|Overall Study|Progressive Disease|16
382361|NCT00856180|1284864|P1|Overall Study|Adverse Event|4
382362|NCT00855959|1284889|P1|Overall Study|Incorrect enrolment|1
382363|NCT00855959|1284889|P1|Overall Study|Pregnancy|1
382364|NCT00855959|1284889|P1|Overall Study|Withdrawal by Subject|3
382365|NCT00855959|1284889|P1|Overall Study|Lost to Follow-up|2
382366|NCT00855959|1284889|P1|Overall Study|Adverse Event|2
382367|NCT00855933|1284906|P2|Overall Study|Withdrawal by Subject|1
382368|NCT00855933|1284907|P1|Overall Study|Withdrawal by Subject|0
382369|NCT00855920|1284916|P3|Overall Study|Other than specified above|1
382370|NCT00855920|1284917|P2|Overall Study|Other than specified above|1
382371|NCT00855920|1284918|P1|Overall Study|Other than specified above|1
382372|NCT00855920|1284916|P3|Overall Study|Decision by the sponsor|1
382373|NCT00855920|1284917|P2|Overall Study|Decision by the sponsor|1
382374|NCT00855920|1284918|P1|Overall Study|Decision by the sponsor|0
382375|NCT00855920|1284916|P3|Overall Study|Death|0
382376|NCT00855920|1284917|P2|Overall Study|Death|1
382377|NCT00855920|1284918|P1|Overall Study|Death|0
382378|NCT00855920|1284916|P3|Overall Study|Lost to Follow-up|2
382379|NCT00855920|1284917|P2|Overall Study|Lost to Follow-up|0
382380|NCT00855920|1284918|P1|Overall Study|Lost to Follow-up|1
382381|NCT00855920|1284916|P3|Overall Study|Withdrawal by Subject|2
382382|NCT00855920|1284917|P2|Overall Study|Withdrawal by Subject|3
382383|NCT00855920|1284918|P1|Overall Study|Withdrawal by Subject|2
382384|NCT00855920|1284916|P3|Overall Study|Lack of Efficacy|2
382385|NCT00855920|1284917|P2|Overall Study|Lack of Efficacy|2
382386|NCT00855920|1284918|P1|Overall Study|Lack of Efficacy|2
382387|NCT00855920|1284916|P3|Overall Study|Adverse Event|1
382388|NCT00855920|1284917|P2|Overall Study|Adverse Event|1
382389|NCT00855920|1284918|P1|Overall Study|Adverse Event|2
382390|NCT00855920|1284916|P3|Overall Study|Protocol Violation|2
382391|NCT00855920|1284917|P2|Overall Study|Protocol Violation|0
382392|NCT00855920|1284918|P1|Overall Study|Protocol Violation|0
382393|NCT00855894|1284935|P1|Overall Study|Disease progression|1
382394|NCT00855894|1284935|P1|Overall Study|Patient's decision|1
382395|NCT00855894|1284935|P1|Overall Study|Death|31
382396|NCT00855816|1284958|P2|Overall Study|Became ineligible|1
382397|NCT00855816|1284959|P1|Overall Study|Became ineligible|0
382398|NCT00855816|1284958|P2|Overall Study|Death|0
382399|NCT00855816|1284959|P1|Overall Study|Death|1
382400|NCT00855816|1284958|P2|Overall Study|Lost to Follow-up|5
382401|NCT00855816|1284959|P1|Overall Study|Lost to Follow-up|3
382402|NCT00855816|1284958|P2|Overall Study|Withdrawal by Subject|15
382403|NCT00855816|1284959|P1|Overall Study|Withdrawal by Subject|22
382404|NCT00855738|1284965|P1|Overall Study|Death|1
382405|NCT00855738|1284965|P1|Overall Study|Subject Defaulted|1
382406|NCT00855738|1284965|P1|Overall Study|Adverse Event|1
382407|NCT00855738|1284965|P1|Overall Study|Lost to Follow-up|2
382408|NCT00855595|1284993|P2|Overall Study|patient left country|1
382409|NCT00855595|1284994|P1|Overall Study|patient left country|0
382410|NCT00855595|1284993|P2|Overall Study|patient moved out of state|0
382411|NCT00855595|1284994|P1|Overall Study|patient moved out of state|1
382412|NCT00855595|1284993|P2|Overall Study|Adverse Event|1
382413|NCT00855595|1284994|P1|Overall Study|Adverse Event|1
382414|NCT00855595|1284993|P2|Overall Study|Lost to Follow-up|3
382415|NCT00855595|1284994|P1|Overall Study|Lost to Follow-up|3
382416|NCT00855595|1284993|P2|Overall Study|Withdrawal by Subject|2
382417|NCT00855595|1284994|P1|Overall Study|Withdrawal by Subject|1
382418|NCT00855582|1285033|P3|Overall Study|Withdrawal by Subject|8
382419|NCT00855582|1285034|P2|Overall Study|Withdrawal by Subject|4
382420|NCT00855582|1285035|P1|Overall Study|Withdrawal by Subject|7
382421|NCT00855582|1285033|P3|Overall Study|Entry Criteria Not Met|3
382422|NCT00855582|1285034|P2|Overall Study|Entry Criteria Not Met|6
382423|NCT00855582|1285035|P1|Overall Study|Entry Criteria Not Met|8
382424|NCT00855582|1285033|P3|Overall Study|Protocol Violation|6
382425|NCT00855582|1285034|P2|Overall Study|Protocol Violation|2
382426|NCT00855582|1285035|P1|Overall Study|Protocol Violation|6
382427|NCT00855582|1285033|P3|Overall Study|Physician Decision|1
382428|NCT00855582|1285034|P2|Overall Study|Physician Decision|0
382429|NCT00855582|1285035|P1|Overall Study|Physician Decision|0
382430|NCT00855582|1285033|P3|Overall Study|Lost to Follow-up|1
382431|NCT00855582|1285034|P2|Overall Study|Lost to Follow-up|3
382432|NCT00855582|1285035|P1|Overall Study|Lost to Follow-up|1
382433|NCT00855582|1285033|P3|Overall Study|Lack of Efficacy|8
382434|NCT00855582|1285034|P2|Overall Study|Lack of Efficacy|3
382435|NCT00855582|1285035|P1|Overall Study|Lack of Efficacy|1
382436|NCT00855582|1285033|P3|Overall Study|Death|0
382437|NCT00855582|1285034|P2|Overall Study|Death|0
382438|NCT00855582|1285035|P1|Overall Study|Death|1
382439|NCT00855582|1285033|P3|Overall Study|Adverse Event|3
382440|NCT00855582|1285034|P2|Overall Study|Adverse Event|6
382441|NCT00855582|1285035|P1|Overall Study|Adverse Event|2
382442|NCT00855465|1285124|P2|Follow-up Period (FUP)|Missing|0
382443|NCT00855465|1285125|P1|Follow-up Period (FUP)|Missing|1
382444|NCT00855465|1285124|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
382445|NCT00855465|1285125|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
382446|NCT00855465|1285124|P2|Follow-up Period (FUP)|Lost to Follow-up|0
382447|NCT00855465|1285125|P1|Follow-up Period (FUP)|Lost to Follow-up|3
382448|NCT00855465|1285124|P2|Follow-up Period (FUP)|Death|1
382449|NCT00855465|1285125|P1|Follow-up Period (FUP)|Death|0
382450|NCT00855465|1285124|P2|Follow-up Period (FUP)|Adverse Event|1
382451|NCT00855465|1285125|P1|Follow-up Period (FUP)|Adverse Event|0
382452|NCT00855465|1285124|P2|Treatment Period|Not treated|0
382453|NCT00855465|1285125|P1|Treatment Period|Not treated|1
382454|NCT00855465|1285124|P2|Treatment Period|Withdrawal by Subject|0
382455|NCT00855465|1285125|P1|Treatment Period|Withdrawal by Subject|2
382456|NCT00855465|1285124|P2|Treatment Period|Protocol Violation|0
382457|NCT00855465|1285125|P1|Treatment Period|Protocol Violation|2
382458|NCT00855465|1285124|P2|Treatment Period|Non-compliance|0
382459|NCT00855465|1285125|P1|Treatment Period|Non-compliance|1
382460|NCT00855465|1285124|P2|Treatment Period|Lack of Efficacy|1
382461|NCT00855465|1285125|P1|Treatment Period|Lack of Efficacy|2
382462|NCT00855465|1285124|P2|Treatment Period|Death|2
382463|NCT00855465|1285125|P1|Treatment Period|Death|2
382464|NCT00855465|1285124|P2|Treatment Period|Adverse Event|2
382465|NCT00855465|1285125|P1|Treatment Period|Adverse Event|4
382466|NCT00855439|1285215|P2|Overall Study|Pregnancy|0
382467|NCT00855439|1285216|P1|Overall Study|Pregnancy|1
382468|NCT00855439|1285215|P2|Overall Study|Withdrawal by Subject|0
382469|NCT00855439|1285216|P1|Overall Study|Withdrawal by Subject|2
382470|NCT00855335|1285274|P5|Overall Study|Other|1
382471|NCT00855335|1285275|P4|Overall Study|Other|5
382472|NCT00855335|1285276|P3|Overall Study|Other|2
382473|NCT00855335|1285277|P2|Overall Study|Other|1
382474|NCT00855335|1285278|P1|Overall Study|Other|2
382475|NCT00855335|1285274|P5|Overall Study|Physician Decision|0
382476|NCT00855335|1285275|P4|Overall Study|Physician Decision|0
382477|NCT00855335|1285276|P3|Overall Study|Physician Decision|0
382478|NCT00855335|1285277|P2|Overall Study|Physician Decision|1
382479|NCT00855335|1285278|P1|Overall Study|Physician Decision|1
382480|NCT00855335|1285274|P5|Overall Study|Adverse Event|0
382481|NCT00855335|1285275|P4|Overall Study|Adverse Event|0
382482|NCT00855335|1285276|P3|Overall Study|Adverse Event|0
382483|NCT00855335|1285277|P2|Overall Study|Adverse Event|0
382484|NCT00855335|1285278|P1|Overall Study|Adverse Event|2
382485|NCT00855335|1285274|P5|Overall Study|Withdrawal by Subject|0
382486|NCT00855335|1285275|P4|Overall Study|Withdrawal by Subject|1
382487|NCT00855335|1285276|P3|Overall Study|Withdrawal by Subject|0
382488|NCT00855335|1285277|P2|Overall Study|Withdrawal by Subject|0
382489|NCT00855335|1285278|P1|Overall Study|Withdrawal by Subject|0
382490|NCT00855335|1285274|P5|Overall Study|Lost to Follow-up|0
382491|NCT00855335|1285275|P4|Overall Study|Lost to Follow-up|1
382492|NCT00855335|1285276|P3|Overall Study|Lost to Follow-up|3
382493|NCT00855335|1285277|P2|Overall Study|Lost to Follow-up|0
382494|NCT00855335|1285278|P1|Overall Study|Lost to Follow-up|0
382495|NCT00855309|1285365|P2|Overall Study|patient never recieved drug|0
382496|NCT00855309|1285366|P1|Overall Study|patient never recieved drug|1
382497|NCT00855218|1285374|P2|Overall Study|Clinical endpoint reached|13
382498|NCT00855218|1285375|P1|Overall Study|Clinical endpoint reached|10
382499|NCT00855218|1285374|P2|Overall Study|Progression measurement proven|15
382500|NCT00855218|1285375|P1|Overall Study|Progression measurement proven|7
382501|NCT00855218|1285374|P2|Overall Study|Second malignancy|1
382502|NCT00855218|1285375|P1|Overall Study|Second malignancy|0
382503|NCT00855218|1285374|P2|Overall Study|Untreatable disease progression|67
382504|NCT00855218|1285375|P1|Overall Study|Untreatable disease progression|54
382505|NCT00855218|1285374|P2|Overall Study|Still treated with study medication|1
382506|NCT00855218|1285375|P1|Overall Study|Still treated with study medication|0
382507|NCT00855218|1285374|P2|Overall Study|technical problems|1
382508|NCT00855218|1285375|P1|Overall Study|technical problems|2
382509|NCT00855218|1285374|P2|Overall Study|patient convenience|0
382510|NCT00855218|1285375|P1|Overall Study|patient convenience|2
382511|NCT00855218|1285374|P2|Overall Study|non-compliant with study drug|1
382512|NCT00855218|1285375|P1|Overall Study|non-compliant with study drug|3
382513|NCT00855218|1285374|P2|Overall Study|Protocol Violation|9
382514|NCT00855218|1285375|P1|Overall Study|Protocol Violation|5
382515|NCT00855218|1285374|P2|Overall Study|Lost to Follow-up|1
382516|NCT00855218|1285375|P1|Overall Study|Lost to Follow-up|0
382517|NCT00855218|1285374|P2|Overall Study|Physician Decision|11
382518|NCT00855218|1285375|P1|Overall Study|Physician Decision|18
382519|NCT00855218|1285374|P2|Overall Study|Withdrawal by Subject|6
382520|NCT00855218|1285375|P1|Overall Study|Withdrawal by Subject|10
382521|NCT00855218|1285374|P2|Overall Study|Adverse Event|27
382522|NCT00855218|1285375|P1|Overall Study|Adverse Event|43
382523|NCT00855166|1285393|P2|Overall Study|Subject no longer meets study criteria|1
382524|NCT00855166|1285394|P1|Overall Study|Subject no longer meets study criteria|1
382525|NCT00855166|1285393|P2|Overall Study|Administrative reasons by sponsor|0
382526|NCT00855166|1285394|P1|Overall Study|Administrative reasons by sponsor|1
382527|NCT00855166|1285393|P2|Overall Study|Poor/non-compliance|0
382528|NCT00855166|1285394|P1|Overall Study|Poor/non-compliance|2
382529|NCT00855166|1285393|P2|Overall Study|Withdrawal by Subject|4
382530|NCT00855166|1285394|P1|Overall Study|Withdrawal by Subject|1
382531|NCT00855166|1285393|P2|Overall Study|Death|1
382532|NCT00855166|1285394|P1|Overall Study|Death|0
382533|NCT00855166|1285393|P2|Overall Study|Adverse Event|2
382534|NCT00855166|1285394|P1|Overall Study|Adverse Event|0
382535|NCT00855062|1285414|P2|Step2|Initiation of antiretroviral therapy/ART|1
382536|NCT00855062|1285415|P1|Step2|Initiation of antiretroviral therapy/ART|0
382537|NCT00855062|1285414|P2|Step2|Adverse Event|3
382538|NCT00855062|1285415|P1|Step2|Adverse Event|0
382539|NCT00855062|1285414|P2|Step2|Early Study Closure|2
382540|NCT00855062|1285415|P1|Step2|Early Study Closure|6
382541|NCT00855062|1285414|P2|Step1|Withdrawal by Subject|3
382542|NCT00855062|1285415|P1|Step1|Withdrawal by Subject|2
382543|NCT00855062|1285414|P2|Step1|Pregnancy|0
382544|NCT00855062|1285415|P1|Step1|Pregnancy|1
382545|NCT00855062|1285414|P2|Step1|Protocol Violation|0
382546|NCT00855062|1285415|P1|Step1|Protocol Violation|1
382547|NCT00855062|1285414|P2|Step1|Adverse Event|1
382548|NCT00855062|1285415|P1|Step1|Adverse Event|1
382549|NCT00855062|1285414|P2|Step1|Early Study Closure|7
382550|NCT00855062|1285415|P1|Step1|Early Study Closure|5
382551|NCT00854906|1285464|P1|Overall Study|One person had no ocular history|1
382552|NCT00854724|1285473|P2|Second Intervention|Physician Decision|1
382553|NCT00854724|1285474|P1|Second Intervention|Physician Decision|0
382554|NCT00854724|1285473|P2|Second Intervention|Protocol Violation|0
382555|NCT00854724|1285474|P1|Second Intervention|Protocol Violation|1
382556|NCT00854724|1285473|P2|Washout|Withdrawal by Subject|1
382557|NCT00854724|1285474|P1|Washout|Withdrawal by Subject|0
382558|NCT00854724|1285473|P2|Washout|Protocol Violation|0
382559|NCT00854724|1285474|P1|Washout|Protocol Violation|1
382560|NCT00854724|1285473|P2|First Intervention|Withdrawal by Subject|1
382561|NCT00854724|1285474|P1|First Intervention|Withdrawal by Subject|1
382562|NCT00854620|1285480|P1|Overall Study|Adverse Event|1
382563|NCT00854607|1285484|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
382564|NCT00854581|1285532|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
382565|NCT00854581|1285532|P1|Induction (Up to Day 21)|Physician Decision|1
382566|NCT00854581|1285532|P1|Induction (Up to Day 21)|Death|1
382567|NCT00854581|1285532|P1|Induction (Up to Day 21)|Lack of Efficacy|4
382568|NCT00854373|1285547|P2|Overall Study|Forgot to take study drug|1
382569|NCT00854373|1285548|P1|Overall Study|Forgot to take study drug|1
382570|NCT00854373|1285547|P2|Overall Study|Withdrawal by Subject|3
382571|NCT00854373|1285548|P1|Overall Study|Withdrawal by Subject|1
382572|NCT00854360|1285562|P4|Overall Study|Other|3
382573|NCT00854360|1285563|P3|Overall Study|Other|0
382574|NCT00854360|1285564|P2|Overall Study|Other|0
382575|NCT00854360|1285565|P1|Overall Study|Other|0
382576|NCT00854360|1285562|P4|Overall Study|Lack of Efficacy|0
382577|NCT00854360|1285563|P3|Overall Study|Lack of Efficacy|0
382578|NCT00854360|1285564|P2|Overall Study|Lack of Efficacy|1
382579|NCT00854360|1285565|P1|Overall Study|Lack of Efficacy|2
382580|NCT00854360|1285562|P4|Overall Study|Pregnancy|0
382581|NCT00854360|1285563|P3|Overall Study|Pregnancy|0
382582|NCT00854360|1285564|P2|Overall Study|Pregnancy|1
382583|NCT00854360|1285565|P1|Overall Study|Pregnancy|0
382584|NCT00854360|1285562|P4|Overall Study|Withdrawal by Subject|1
382585|NCT00854360|1285563|P3|Overall Study|Withdrawal by Subject|0
382586|NCT00854360|1285564|P2|Overall Study|Withdrawal by Subject|0
382587|NCT00854360|1285565|P1|Overall Study|Withdrawal by Subject|0
382588|NCT00854360|1285562|P4|Overall Study|Adverse Event|6
382589|NCT00854360|1285563|P3|Overall Study|Adverse Event|2
382590|NCT00854360|1285564|P2|Overall Study|Adverse Event|1
382591|NCT00854360|1285565|P1|Overall Study|Adverse Event|0
382592|NCT00854308|1285597|P2|Overall Study|Sponsor's decision to terminate study|1
382593|NCT00854308|1285598|P1|Overall Study|Sponsor's decision to terminate study|0
382594|NCT00854308|1285597|P2|Overall Study|Withdrawal by Subject|2
382595|NCT00854308|1285598|P1|Overall Study|Withdrawal by Subject|4
382596|NCT00854308|1285597|P2|Overall Study|Physician Decision|6
382597|NCT00854308|1285598|P1|Overall Study|Physician Decision|6
382598|NCT00854308|1285597|P2|Overall Study|Death|5
382599|NCT00854308|1285598|P1|Overall Study|Death|2
382600|NCT00854308|1285597|P2|Overall Study|Adverse Event|3
382601|NCT00854308|1285598|P1|Overall Study|Adverse Event|8
382602|NCT00854308|1285597|P2|Overall Study|Disease progression|50
382603|NCT00854308|1285598|P1|Overall Study|Disease progression|42
382604|NCT00854113|1285623|P11|Overall Study|Withdrawal by Subject|0
382605|NCT00854113|1285624|P10|Overall Study|Withdrawal by Subject|0
382606|NCT00854113|1285625|P9|Overall Study|Withdrawal by Subject|1
382607|NCT00854113|1285626|P8|Overall Study|Withdrawal by Subject|1
382608|NCT00854113|1285627|P7|Overall Study|Withdrawal by Subject|0
382609|NCT00854113|1285628|P6|Overall Study|Withdrawal by Subject|0
382610|NCT00854113|1285629|P5|Overall Study|Withdrawal by Subject|0
382611|NCT00854113|1285630|P4|Overall Study|Withdrawal by Subject|0
382612|NCT00854113|1285631|P3|Overall Study|Withdrawal by Subject|0
382613|NCT00854113|1285632|P2|Overall Study|Withdrawal by Subject|0
382614|NCT00854113|1285633|P1|Overall Study|Withdrawal by Subject|0
382615|NCT00854113|1285623|P11|Overall Study|Adverse Event|0
382616|NCT00854113|1285624|P10|Overall Study|Adverse Event|0
382617|NCT00854113|1285625|P9|Overall Study|Adverse Event|0
382618|NCT00854113|1285626|P8|Overall Study|Adverse Event|2
382619|NCT00854113|1285627|P7|Overall Study|Adverse Event|0
382620|NCT00854113|1285628|P6|Overall Study|Adverse Event|0
382621|NCT00854113|1285629|P5|Overall Study|Adverse Event|0
382622|NCT00854113|1285630|P4|Overall Study|Adverse Event|0
382623|NCT00854113|1285631|P3|Overall Study|Adverse Event|0
382624|NCT00854113|1285632|P2|Overall Study|Adverse Event|0
382625|NCT00854113|1285633|P1|Overall Study|Adverse Event|0
382626|NCT00853970|1285755|P2|Overall Study|Cancelled surgery|2
382627|NCT00853970|1285756|P1|Overall Study|Cancelled surgery|4
382628|NCT00853970|1285755|P2|Overall Study|Withdrawal by Subject|1
382629|NCT00853970|1285756|P1|Overall Study|Withdrawal by Subject|2
382630|NCT00853957|1285766|P2|Overall Study|Protocol deviation|3
382631|NCT00853957|1285767|P1|Overall Study|Protocol deviation|0
382632|NCT00853957|1285766|P2|Overall Study|Lost to Follow-up|6
382633|NCT00853957|1285767|P1|Overall Study|Lost to Follow-up|1
382634|NCT00853957|1285766|P2|Overall Study|Subject withdrew consent|5
382635|NCT00853957|1285767|P1|Overall Study|Subject withdrew consent|4
382636|NCT00853957|1285766|P2|Overall Study|Unsatisfactory therapeutic effect|2
382637|NCT00853957|1285767|P1|Overall Study|Unsatisfactory therapeutic effect|0
382638|NCT00853957|1285766|P2|Overall Study|Adverse Event|3
382639|NCT00853957|1285767|P1|Overall Study|Adverse Event|9
382640|NCT00853905|1285785|P2|Overall Study|never had surgery|0
382641|NCT00853905|1285786|P1|Overall Study|never had surgery|1
382642|NCT00853905|1285785|P2|Overall Study|Withdrawal by Subject|1
382643|NCT00853905|1285786|P1|Overall Study|Withdrawal by Subject|0
382644|NCT00853905|1285785|P2|Overall Study|Lost to Follow-up|3
382645|NCT00853905|1285786|P1|Overall Study|Lost to Follow-up|1
382646|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Death|6
382647|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Death|1
382648|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Administrative problems|56
382649|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Administrative problems|45
382650|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
382651|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
382652|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
382653|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
382654|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
382655|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
382656|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
382657|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
382658|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
382659|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
382660|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
382661|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
382662|NCT00853827|1285810|P2|Double Blind Period (103 Weeks)|Adverse Event|14
382663|NCT00853827|1285811|P1|Double Blind Period (103 Weeks)|Adverse Event|25
382664|NCT00853827|1285810|P2|Single Blind Period (1 Week)|Protocol Violation|0
382665|NCT00853827|1285811|P1|Single Blind Period (1 Week)|Protocol Violation|12
382666|NCT00853827|1285810|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
382667|NCT00853827|1285811|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
382668|NCT00853827|1285810|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
382669|NCT00853827|1285811|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
382670|NCT00853827|1285810|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
382671|NCT00853827|1285811|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
382672|NCT00853827|1285810|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
382673|NCT00853827|1285811|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
382674|NCT00853827|1285810|P2|Single Blind Period (1 Week)|Adverse Event|0
382675|NCT00853827|1285811|P1|Single Blind Period (1 Week)|Adverse Event|9
382676|NCT00853827|1285810|P2|Single Blind Period (1 Week)|Other|0
382677|NCT00853827|1285811|P1|Single Blind Period (1 Week)|Other|4
382678|NCT00853762|1285827|P4|Overall Study|Randomised but not Treated|0
382679|NCT00853762|1285828|P3|Overall Study|Randomised but not Treated|2
382680|NCT00853762|1285829|P2|Overall Study|Randomised but not Treated|2
382681|NCT00853762|1285830|P1|Overall Study|Randomised but not Treated|0
382682|NCT00853762|1285827|P4|Overall Study|Other|0
382683|NCT00853762|1285828|P3|Overall Study|Other|0
382684|NCT00853762|1285829|P2|Overall Study|Other|2
382685|NCT00853762|1285830|P1|Overall Study|Other|0
382686|NCT00853762|1285827|P4|Overall Study|Withdrawal by Subject|0
382687|NCT00853762|1285828|P3|Overall Study|Withdrawal by Subject|1
382688|NCT00853762|1285829|P2|Overall Study|Withdrawal by Subject|0
382689|NCT00853762|1285830|P1|Overall Study|Withdrawal by Subject|0
382690|NCT00853762|1285827|P4|Overall Study|Protocol Violation|1
382691|NCT00853762|1285828|P3|Overall Study|Protocol Violation|0
382692|NCT00853762|1285829|P2|Overall Study|Protocol Violation|0
382693|NCT00853762|1285830|P1|Overall Study|Protocol Violation|0
382694|NCT00853762|1285827|P4|Overall Study|Premature Termination|21
382695|NCT00853762|1285828|P3|Overall Study|Premature Termination|14
382696|NCT00853762|1285829|P2|Overall Study|Premature Termination|15
382697|NCT00853762|1285830|P1|Overall Study|Premature Termination|16
382698|NCT00853749|1285898|P2|Overall Study|Lost to Follow-up|1
382699|NCT00853749|1285899|P1|Overall Study|Lost to Follow-up|0
382700|NCT00853723|1285920|P3|Overall Study|Protocol Violation|1
382701|NCT00853723|1285921|P2|Overall Study|Protocol Violation|2
382702|NCT00853723|1285922|P1|Overall Study|Protocol Violation|1
382703|NCT00853723|1285920|P3|Overall Study|Withdrawal by Subject|0
382704|NCT00853723|1285921|P2|Overall Study|Withdrawal by Subject|1
382705|NCT00853723|1285922|P1|Overall Study|Withdrawal by Subject|2
382706|NCT00853723|1285920|P3|Overall Study|Adverse Event|1
382707|NCT00853723|1285921|P2|Overall Study|Adverse Event|4
382708|NCT00853723|1285922|P1|Overall Study|Adverse Event|3
382709|NCT00853658|1285969|P3|Overall Study|Missing study completion information|6
382710|NCT00853658|1285970|P2|Overall Study|Missing study completion information|4
382711|NCT00853658|1285971|P1|Overall Study|Missing study completion information|5
382712|NCT00853658|1285969|P3|Overall Study|Patient's request|11
382713|NCT00853658|1285970|P2|Overall Study|Patient's request|17
382714|NCT00853658|1285971|P1|Overall Study|Patient's request|21
382715|NCT00853658|1285969|P3|Overall Study|Vital Status at study end N/A|10
382716|NCT00853658|1285970|P2|Overall Study|Vital Status at study end N/A|10
382717|NCT00853658|1285971|P1|Overall Study|Vital Status at study end N/A|8
382718|NCT00853658|1285969|P3|Overall Study|Vital Status unknown at study end|0
382719|NCT00853658|1285970|P2|Overall Study|Vital Status unknown at study end|1
382720|NCT00853658|1285971|P1|Overall Study|Vital Status unknown at study end|1
382721|NCT00853658|1285969|P3|Overall Study|Vital Status known (alive) at study end|3
382722|NCT00853658|1285970|P2|Overall Study|Vital Status known (alive) at study end|3
382723|NCT00853658|1285971|P1|Overall Study|Vital Status known (alive) at study end|2
382724|NCT00853658|1285969|P3|Overall Study|IRB request|2
382725|NCT00853658|1285970|P2|Overall Study|IRB request|0
382726|NCT00853658|1285971|P1|Overall Study|IRB request|0
382727|NCT00853658|1285969|P3|Overall Study|H.A. Request|19
382728|NCT00853658|1285970|P2|Overall Study|H.A. Request|23
382729|NCT00853658|1285971|P1|Overall Study|H.A. Request|26
382730|NCT00853658|1285969|P3|Overall Study|Lost to Follow-up|11
382731|NCT00853658|1285970|P2|Overall Study|Lost to Follow-up|6
382732|NCT00853658|1285971|P1|Overall Study|Lost to Follow-up|11
382733|NCT00853658|1285969|P3|Overall Study|Death|753
382734|NCT00853658|1285970|P2|Overall Study|Death|768
382735|NCT00853658|1285971|P1|Overall Study|Death|713
382736|NCT00853593|1285991|P1|Overall Study|Implant not attempted|4
382737|NCT00853593|1285991|P1|Overall Study|Model 4396 lead not attempted|29
382738|NCT00853593|1285991|P1|Overall Study|Subjects did not receive a 4396 lead|12
382739|NCT00853580|1286018|P2|Overall Study|Commenced contraindicated therapy|2
382740|NCT00853580|1286019|P1|Overall Study|Commenced contraindicated therapy|0
382741|NCT00853580|1286018|P2|Overall Study|Withdrawal by Subject|8
382742|NCT00853580|1286019|P1|Overall Study|Withdrawal by Subject|2
382743|NCT00853580|1286018|P2|Overall Study|Protocol Violation|1
382744|NCT00853580|1286019|P1|Overall Study|Protocol Violation|2
382745|NCT00853580|1286018|P2|Overall Study|Lost to Follow-up|5
382746|NCT00853580|1286019|P1|Overall Study|Lost to Follow-up|3
382747|NCT00853567|1286066|P1|Overall Study|Study prematurely terminated|71
382748|NCT00853489|1286076|P2|Overall Study|Lost to Follow-up|2
382749|NCT00853489|1286077|P1|Overall Study|Lost to Follow-up|5
382750|NCT00853385|1286092|P5|Overall Study|Other|12
382751|NCT00853385|1286093|P4|Overall Study|Other|4
382752|NCT00853385|1286094|P3|Overall Study|Other|4
382753|NCT00853385|1286095|P2|Overall Study|Other|9
382754|NCT00853385|1286096|P1|Overall Study|Other|18
382755|NCT00853385|1286092|P5|Overall Study|Withdrawal by Subject|1
382756|NCT00853385|1286093|P4|Overall Study|Withdrawal by Subject|1
382757|NCT00853385|1286094|P3|Overall Study|Withdrawal by Subject|0
382758|NCT00853385|1286095|P2|Overall Study|Withdrawal by Subject|2
382759|NCT00853385|1286096|P1|Overall Study|Withdrawal by Subject|4
382760|NCT00853385|1286092|P5|Overall Study|Lost to Follow-up|0
382761|NCT00853385|1286093|P4|Overall Study|Lost to Follow-up|0
382762|NCT00853385|1286094|P3|Overall Study|Lost to Follow-up|0
382763|NCT00853385|1286095|P2|Overall Study|Lost to Follow-up|1
382764|NCT00853385|1286096|P1|Overall Study|Lost to Follow-up|2
382765|NCT00853385|1286092|P5|Overall Study|Lack of Efficacy|6
382766|NCT00853385|1286093|P4|Overall Study|Lack of Efficacy|3
382767|NCT00853385|1286094|P3|Overall Study|Lack of Efficacy|3
382768|NCT00853385|1286095|P2|Overall Study|Lack of Efficacy|7
382769|NCT00853385|1286096|P1|Overall Study|Lack of Efficacy|6
382770|NCT00853385|1286092|P5|Overall Study|Adverse Event|22
382771|NCT00853385|1286093|P4|Overall Study|Adverse Event|5
382772|NCT00853385|1286094|P3|Overall Study|Adverse Event|2
382773|NCT00853385|1286095|P2|Overall Study|Adverse Event|24
382774|NCT00853385|1286096|P1|Overall Study|Adverse Event|24
382775|NCT00853385|1286092|P5|Overall Study|Death|1
382776|NCT00853385|1286093|P4|Overall Study|Death|0
382777|NCT00853385|1286094|P3|Overall Study|Death|0
382778|NCT00853385|1286095|P2|Overall Study|Death|0
382779|NCT00853385|1286096|P1|Overall Study|Death|0
382780|NCT00853307|1286324|P2|Overall Study|Reason Not Specified|1
382781|NCT00853307|1286325|P1|Overall Study|Reason Not Specified|0
382782|NCT00853307|1286324|P2|Overall Study|Withdrawal by Subject|2
382783|NCT00853307|1286325|P1|Overall Study|Withdrawal by Subject|1
382784|NCT00853307|1286324|P2|Overall Study|Adverse Event|2
382785|NCT00853307|1286325|P1|Overall Study|Adverse Event|1
382786|NCT00853242|1286352|P7|Overall Study|Other|2
382787|NCT00853242|1286353|P6|Overall Study|Other|1
382788|NCT00853242|1286354|P5|Overall Study|Other|0
382789|NCT00853242|1286355|P4|Overall Study|Other|0
382790|NCT00853242|1286356|P3|Overall Study|Other|2
382791|NCT00853242|1286357|P2|Overall Study|Other|0
382792|NCT00853242|1286358|P1|Overall Study|Other|2
382793|NCT00853242|1286352|P7|Overall Study|Withdrawal by Subject|2
382794|NCT00853242|1286353|P6|Overall Study|Withdrawal by Subject|0
382795|NCT00853242|1286354|P5|Overall Study|Withdrawal by Subject|0
382796|NCT00853242|1286355|P4|Overall Study|Withdrawal by Subject|4
382797|NCT00853242|1286356|P3|Overall Study|Withdrawal by Subject|0
382798|NCT00853242|1286357|P2|Overall Study|Withdrawal by Subject|2
382799|NCT00853242|1286358|P1|Overall Study|Withdrawal by Subject|1
382800|NCT00853242|1286352|P7|Overall Study|Noncompliant|0
382801|NCT00853242|1286353|P6|Overall Study|Noncompliant|0
382802|NCT00853242|1286354|P5|Overall Study|Noncompliant|1
382803|NCT00853242|1286355|P4|Overall Study|Noncompliant|0
382804|NCT00853242|1286356|P3|Overall Study|Noncompliant|0
382805|NCT00853242|1286357|P2|Overall Study|Noncompliant|0
382806|NCT00853242|1286358|P1|Overall Study|Noncompliant|0
382807|NCT00853242|1286352|P7|Overall Study|Adverse Event|1
382808|NCT00853242|1286353|P6|Overall Study|Adverse Event|1
382809|NCT00853242|1286354|P5|Overall Study|Adverse Event|3
382810|NCT00853242|1286355|P4|Overall Study|Adverse Event|0
382811|NCT00853242|1286356|P3|Overall Study|Adverse Event|1
382812|NCT00853242|1286357|P2|Overall Study|Adverse Event|1
382813|NCT00853242|1286358|P1|Overall Study|Adverse Event|0
382814|NCT00853229|1286400|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
382815|NCT00853229|1286401|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
382816|NCT00853151|1286411|P4|Overall Study|Sponsor Decision|0
382817|NCT00853151|1286412|P3|Overall Study|Sponsor Decision|0
382818|NCT00853151|1286413|P2|Overall Study|Sponsor Decision|3
382819|NCT00853151|1286414|P1|Overall Study|Sponsor Decision|0
382820|NCT00853151|1286411|P4|Overall Study|Physician Decision|0
382821|NCT00853151|1286412|P3|Overall Study|Physician Decision|1
382822|NCT00853151|1286413|P2|Overall Study|Physician Decision|2
382823|NCT00853151|1286414|P1|Overall Study|Physician Decision|0
382824|NCT00853151|1286411|P4|Overall Study|Withdrawal by Subject|1
382825|NCT00853151|1286412|P3|Overall Study|Withdrawal by Subject|2
382826|NCT00853151|1286413|P2|Overall Study|Withdrawal by Subject|4
382827|NCT00853151|1286414|P1|Overall Study|Withdrawal by Subject|5
382828|NCT00853151|1286411|P4|Overall Study|Protocol Violation|1
382829|NCT00853151|1286412|P3|Overall Study|Protocol Violation|0
382830|NCT00853151|1286413|P2|Overall Study|Protocol Violation|0
382831|NCT00853151|1286414|P1|Overall Study|Protocol Violation|0
382832|NCT00853151|1286411|P4|Overall Study|Death|1
382833|NCT00853151|1286412|P3|Overall Study|Death|0
382834|NCT00853151|1286413|P2|Overall Study|Death|0
382835|NCT00853151|1286414|P1|Overall Study|Death|1
382836|NCT00853151|1286411|P4|Overall Study|Lost to Follow-up|0
382837|NCT00853151|1286412|P3|Overall Study|Lost to Follow-up|3
382838|NCT00853151|1286413|P2|Overall Study|Lost to Follow-up|0
382839|NCT00853151|1286414|P1|Overall Study|Lost to Follow-up|2
382840|NCT00853151|1286411|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
382841|NCT00853151|1286412|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
382842|NCT00853151|1286413|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
382843|NCT00853151|1286414|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
382844|NCT00853151|1286411|P4|Overall Study|Adverse Event|0
382845|NCT00853151|1286412|P3|Overall Study|Adverse Event|2
382846|NCT00853151|1286413|P2|Overall Study|Adverse Event|4
382847|NCT00853151|1286414|P1|Overall Study|Adverse Event|1
382848|NCT00853112|1286563|P7|Overall Study|Randomized but not treated|1
382849|NCT00853112|1286564|P6|Overall Study|Randomized but not treated|0
382850|NCT00853112|1286565|P5|Overall Study|Randomized but not treated|0
382851|NCT00853112|1286566|P4|Overall Study|Randomized but not treated|2
382852|NCT00853112|1286567|P3|Overall Study|Randomized but not treated|0
382853|NCT00853112|1286568|P2|Overall Study|Randomized but not treated|1
382854|NCT00853112|1286569|P1|Overall Study|Randomized but not treated|0
382855|NCT00853099|1286679|P4|Double-blind + Open-label Periods|Not Specified|6
382856|NCT00853099|1286680|P3|Double-blind + Open-label Periods|Not Specified|0
382857|NCT00853099|1286681|P2|Double-blind + Open-label Periods|Not Specified|0
382858|NCT00853099|1286682|P1|Double-blind + Open-label Periods|Not Specified|0
382859|NCT00853099|1286679|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
382860|NCT00853099|1286680|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
382861|NCT00853099|1286681|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
382862|NCT00853099|1286682|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
382863|NCT00853099|1286679|P4|Double-blind + Open-label Periods|Adverse Event|47
382864|NCT00853099|1286680|P3|Double-blind + Open-label Periods|Adverse Event|0
382865|NCT00853099|1286681|P2|Double-blind + Open-label Periods|Adverse Event|0
382866|NCT00853099|1286682|P1|Double-blind + Open-label Periods|Adverse Event|0
382867|NCT00853099|1286679|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
382868|NCT00853099|1286680|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
382869|NCT00853099|1286681|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
382870|NCT00853099|1286682|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
382871|NCT00853099|1286679|P4|Double-blind Period|Mistreated with rescue study drug|0
382872|NCT00853099|1286680|P3|Double-blind Period|Mistreated with rescue study drug|1
382873|NCT00853099|1286681|P2|Double-blind Period|Mistreated with rescue study drug|0
382874|NCT00853099|1286682|P1|Double-blind Period|Mistreated with rescue study drug|0
382875|NCT00853099|1286679|P4|Double-blind Period|Not Specified|0
382876|NCT00853099|1286680|P3|Double-blind Period|Not Specified|1
382877|NCT00853099|1286681|P2|Double-blind Period|Not Specified|0
382878|NCT00853099|1286682|P1|Double-blind Period|Not Specified|0
382879|NCT00853099|1286679|P4|Double-blind Period|Lack of Efficacy|0
382880|NCT00853099|1286680|P3|Double-blind Period|Lack of Efficacy|16
382881|NCT00853099|1286681|P2|Double-blind Period|Lack of Efficacy|17
382882|NCT00853099|1286682|P1|Double-blind Period|Lack of Efficacy|14
382883|NCT00853099|1286679|P4|Double-blind Period|Withdrawal by Subject|0
382884|NCT00853099|1286680|P3|Double-blind Period|Withdrawal by Subject|0
382885|NCT00853099|1286681|P2|Double-blind Period|Withdrawal by Subject|3
382886|NCT00853099|1286682|P1|Double-blind Period|Withdrawal by Subject|2
382887|NCT00853099|1286679|P4|Double-blind Period|Adverse Event|0
382888|NCT00853099|1286680|P3|Double-blind Period|Adverse Event|13
382889|NCT00853099|1286681|P2|Double-blind Period|Adverse Event|9
382890|NCT00853099|1286682|P1|Double-blind Period|Adverse Event|7
382891|NCT00853073|1286724|P2|Overall Study|Withdrawal by Subject|2
382892|NCT00853073|1286725|P1|Overall Study|Withdrawal by Subject|3
382893|NCT00853021|1286733|P1|Overall Study|Death|1
382894|NCT00853021|1286733|P1|Overall Study|Withdrawal by Subject|2
382895|NCT00853021|1286733|P1|Overall Study|Adverse Event|2
382896|NCT00852995|1286745|P5|Overall Study|Moved Out of Area|0
382897|NCT00852995|1286746|P4|Overall Study|Moved Out of Area|0
382898|NCT00852995|1286747|P3|Overall Study|Moved Out of Area|0
382899|NCT00852995|1286748|P2|Overall Study|Moved Out of Area|0
382900|NCT00852995|1286749|P1|Overall Study|Moved Out of Area|1
382901|NCT00852995|1286745|P5|Overall Study|Protocol Violation|1
382902|NCT00852995|1286746|P4|Overall Study|Protocol Violation|0
382903|NCT00852995|1286747|P3|Overall Study|Protocol Violation|0
382904|NCT00852995|1286748|P2|Overall Study|Protocol Violation|0
382905|NCT00852995|1286749|P1|Overall Study|Protocol Violation|0
382906|NCT00852995|1286745|P5|Overall Study|Physician Decision|0
382907|NCT00852995|1286746|P4|Overall Study|Physician Decision|0
382908|NCT00852995|1286747|P3|Overall Study|Physician Decision|0
382909|NCT00852995|1286748|P2|Overall Study|Physician Decision|0
382910|NCT00852995|1286749|P1|Overall Study|Physician Decision|1
382911|NCT00852995|1286745|P5|Overall Study|Progressive Disease|1
382912|NCT00852995|1286746|P4|Overall Study|Progressive Disease|2
382913|NCT00852995|1286747|P3|Overall Study|Progressive Disease|0
382914|NCT00852995|1286748|P2|Overall Study|Progressive Disease|0
382915|NCT00852995|1286749|P1|Overall Study|Progressive Disease|1
382916|NCT00852995|1286745|P5|Overall Study|Non-Compliance|0
382917|NCT00852995|1286746|P4|Overall Study|Non-Compliance|2
382918|NCT00852995|1286747|P3|Overall Study|Non-Compliance|0
382919|NCT00852995|1286748|P2|Overall Study|Non-Compliance|0
382920|NCT00852995|1286749|P1|Overall Study|Non-Compliance|0
382921|NCT00852995|1286745|P5|Overall Study|Withdrawal by Subject|2
382922|NCT00852995|1286746|P4|Overall Study|Withdrawal by Subject|1
382923|NCT00852995|1286747|P3|Overall Study|Withdrawal by Subject|0
382924|NCT00852995|1286748|P2|Overall Study|Withdrawal by Subject|0
382925|NCT00852995|1286749|P1|Overall Study|Withdrawal by Subject|4
382926|NCT00852995|1286745|P5|Overall Study|Lost to Follow-up|0
382927|NCT00852995|1286746|P4|Overall Study|Lost to Follow-up|0
382928|NCT00852995|1286747|P3|Overall Study|Lost to Follow-up|1
382929|NCT00852995|1286748|P2|Overall Study|Lost to Follow-up|1
382930|NCT00852995|1286749|P1|Overall Study|Lost to Follow-up|0
382931|NCT00852995|1286745|P5|Overall Study|Adverse Event|0
382932|NCT00852995|1286746|P4|Overall Study|Adverse Event|0
382933|NCT00852995|1286747|P3|Overall Study|Adverse Event|4
382934|NCT00852995|1286748|P2|Overall Study|Adverse Event|0
382935|NCT00852995|1286749|P1|Overall Study|Adverse Event|1
382936|NCT00852969|1286793|P2|Overall Study|Lost to Follow-up|1
382937|NCT00852969|1286794|P1|Overall Study|Lost to Follow-up|0
382938|NCT00852969|1286793|P2|Overall Study|Adverse Event|1
382939|NCT00852969|1286794|P1|Overall Study|Adverse Event|0
382940|NCT00852930|1286805|P3|Overall Study|Physician Decision|1
382941|NCT00852930|1286806|P2|Overall Study|Physician Decision|0
382942|NCT00852930|1286807|P1|Overall Study|Physician Decision|0
382943|NCT00852930|1286805|P3|Overall Study|Withdrawal by Subject|1
382944|NCT00852930|1286806|P2|Overall Study|Withdrawal by Subject|1
382945|NCT00852930|1286807|P1|Overall Study|Withdrawal by Subject|1
382946|NCT00852917|1286828|P4|Overall Study|Death|1
382947|NCT00852917|1286829|P3|Overall Study|Death|0
382948|NCT00852917|1286830|P2|Overall Study|Death|0
382949|NCT00852917|1286831|P1|Overall Study|Death|0
382950|NCT00852917|1286828|P4|Overall Study|Physician Decision|19
382951|NCT00852917|1286829|P3|Overall Study|Physician Decision|2
382952|NCT00852917|1286830|P2|Overall Study|Physician Decision|7
382953|NCT00852917|1286831|P1|Overall Study|Physician Decision|6
382954|NCT00852917|1286828|P4|Overall Study|Withdrawal by Subject|9
382955|NCT00852917|1286829|P3|Overall Study|Withdrawal by Subject|10
382956|NCT00852917|1286830|P2|Overall Study|Withdrawal by Subject|8
382957|NCT00852917|1286831|P1|Overall Study|Withdrawal by Subject|4
382958|NCT00852917|1286828|P4|Overall Study|Lack of Efficacy|47
382959|NCT00852917|1286829|P3|Overall Study|Lack of Efficacy|11
382960|NCT00852917|1286830|P2|Overall Study|Lack of Efficacy|11
382961|NCT00852917|1286831|P1|Overall Study|Lack of Efficacy|21
382962|NCT00852917|1286828|P4|Overall Study|Adverse Event|17
382963|NCT00852917|1286829|P3|Overall Study|Adverse Event|35
382964|NCT00852917|1286830|P2|Overall Study|Adverse Event|20
382965|NCT00852917|1286831|P1|Overall Study|Adverse Event|13
382966|NCT00852540|1286959|P2|Overall Study|Did Not Receive Study Drug|3
382967|NCT00852540|1286960|P1|Overall Study|Did Not Receive Study Drug|3
382968|NCT00852540|1286959|P2|Overall Study|Withdrawal by Subject|1
382969|NCT00852540|1286960|P1|Overall Study|Withdrawal by Subject|3
382970|NCT00852540|1286959|P2|Overall Study|Investigator Discretion|3
382971|NCT00852540|1286960|P1|Overall Study|Investigator Discretion|2
382972|NCT00852540|1286959|P2|Overall Study|Lost to Follow-up|3
382973|NCT00852540|1286960|P1|Overall Study|Lost to Follow-up|2
382974|NCT00852540|1286959|P2|Overall Study|Protocol Violation|2
382975|NCT00852540|1286960|P1|Overall Study|Protocol Violation|1
382976|NCT00852540|1286959|P2|Overall Study|Lack of Efficacy|3
382977|NCT00852540|1286960|P1|Overall Study|Lack of Efficacy|15
382978|NCT00852540|1286959|P2|Overall Study|Adverse Event|3
382979|NCT00852540|1286960|P1|Overall Study|Adverse Event|10
382980|NCT00852475|1286994|P2|Overall Study|Lost to Follow-up|4
382981|NCT00852475|1286995|P1|Overall Study|Lost to Follow-up|3
382982|NCT00852397|1287006|P3|Overall Study|Protocol Violation|1
382983|NCT00852397|1287007|P2|Overall Study|Protocol Violation|0
382984|NCT00852397|1287008|P1|Overall Study|Protocol Violation|0
382985|NCT00852397|1287006|P3|Overall Study|Difficulty in study site visit|0
382986|NCT00852397|1287007|P2|Overall Study|Difficulty in study site visit|0
382987|NCT00852397|1287008|P1|Overall Study|Difficulty in study site visit|1
382988|NCT00852397|1287006|P3|Overall Study|Study terminated by sponsor|6
382989|NCT00852397|1287007|P2|Overall Study|Study terminated by sponsor|1
382990|NCT00852397|1287008|P1|Overall Study|Study terminated by sponsor|2
382991|NCT00852397|1287006|P3|Overall Study|Withdrawal by Subject|2
382992|NCT00852397|1287007|P2|Overall Study|Withdrawal by Subject|1
382993|NCT00852397|1287008|P1|Overall Study|Withdrawal by Subject|4
382994|NCT00852397|1287006|P3|Overall Study|Death|1
382995|NCT00852397|1287007|P2|Overall Study|Death|0
382996|NCT00852397|1287008|P1|Overall Study|Death|0
382997|NCT00852397|1287006|P3|Overall Study|Adverse Event|4
382998|NCT00852397|1287007|P2|Overall Study|Adverse Event|6
382999|NCT00852397|1287008|P1|Overall Study|Adverse Event|4
383000|NCT00852241|1287037|P1|Overall Study|Physician Decision|18
383001|NCT00851903|1287072|P1|Overall Study|Withdrawal by Subject|2
383002|NCT00851890|1287086|P4|Overall Study|Lost to Follow-up|1
383003|NCT00851890|1287087|P3|Overall Study|Lost to Follow-up|0
383004|NCT00851890|1287088|P2|Overall Study|Lost to Follow-up|1
383005|NCT00851890|1287089|P1|Overall Study|Lost to Follow-up|0
383006|NCT00851799|1287149|P3|Overall Study|Completed protocol due to pregnancy|1
383007|NCT00851799|1287150|P2|Overall Study|Completed protocol due to pregnancy|0
383008|NCT00851799|1287151|P1|Overall Study|Completed protocol due to pregnancy|0
383009|NCT00851799|1287149|P3|Overall Study|Severe Debilitation|0
383010|NCT00851799|1287150|P2|Overall Study|Severe Debilitation|1
383011|NCT00851799|1287151|P1|Overall Study|Severe Debilitation|0
383012|NCT00851799|1287149|P3|Overall Study|Withdrew consent prior study completion|1
383013|NCT00851799|1287150|P2|Overall Study|Withdrew consent prior study completion|2
383014|NCT00851799|1287151|P1|Overall Study|Withdrew consent prior study completion|1
383015|NCT00851799|1287149|P3|Overall Study|Not willing to adhere to requirements|2
383016|NCT00851799|1287150|P2|Overall Study|Not willing to adhere to requirements|2
383017|NCT00851799|1287151|P1|Overall Study|Not willing to adhere to requirements|1
383018|NCT00851799|1287149|P3|Overall Study|Not able to get to clinic|9
383019|NCT00851799|1287150|P2|Overall Study|Not able to get to clinic|5
383020|NCT00851799|1287151|P1|Overall Study|Not able to get to clinic|8
383021|NCT00851799|1287149|P3|Overall Study|Lost to Follow-up|10
383022|NCT00851799|1287150|P2|Overall Study|Lost to Follow-up|3
383023|NCT00851799|1287151|P1|Overall Study|Lost to Follow-up|5
383024|NCT00851799|1287149|P3|Overall Study|Death|1
383025|NCT00851799|1287150|P2|Overall Study|Death|0
383026|NCT00851799|1287151|P1|Overall Study|Death|1
383027|NCT00851786|1287239|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
383028|NCT00851786|1287240|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
383029|NCT00851786|1287239|P2|Overall Study|Site Closure|0
383030|NCT00851786|1287240|P1|Overall Study|Site Closure|1
383031|NCT00851786|1287239|P2|Overall Study|Incarceration|0
383032|NCT00851786|1287240|P1|Overall Study|Incarceration|1
383033|NCT00851786|1287239|P2|Overall Study|Lost to Follow-up|0
383034|NCT00851786|1287240|P1|Overall Study|Lost to Follow-up|1
383035|NCT00851786|1287239|P2|Overall Study|Protocol Violation|1
383036|NCT00851786|1287240|P1|Overall Study|Protocol Violation|0
383037|NCT00851786|1287239|P2|Overall Study|Withdrawal by Subject|1
383038|NCT00851786|1287240|P1|Overall Study|Withdrawal by Subject|0
383039|NCT00851747|1287253|P3|Overall Study|Physician Decision|6
383040|NCT00851747|1287254|P2|Overall Study|Physician Decision|6
383041|NCT00851747|1287255|P1|Overall Study|Physician Decision|6
383042|NCT00851721|1287264|P2|Overall Study|Adverse Event|1
383043|NCT00851721|1287265|P1|Overall Study|Adverse Event|0
383044|NCT00851721|1287264|P2|Overall Study|Death|0
383045|NCT00851721|1287265|P1|Overall Study|Death|1
383046|NCT00851721|1287264|P2|Overall Study|planned surgery|0
383047|NCT00851721|1287265|P1|Overall Study|planned surgery|1
383048|NCT00851682|1287355|P2|Overall Study|screen failure|0
383049|NCT00851682|1287356|P1|Overall Study|screen failure|5
383050|NCT00851643|1287370|P6|Extension Study (Up to 36 Months)|Moved|1
383051|NCT00851643|1287371|P5|Extension Study (Up to 36 Months)|Moved|0
383052|NCT00851643|1287372|P4|Extension Study (Up to 36 Months)|Moved|1
383053|NCT00851643|1287373|P3|Extension Study (Up to 36 Months)|Moved|1
383054|NCT00851643|1287374|P2|Extension Study (Up to 36 Months)|Moved|2
383055|NCT00851643|1287375|P1|Extension Study (Up to 36 Months)|Moved|0
383056|NCT00851643|1287370|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
383057|NCT00851643|1287371|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
383058|NCT00851643|1287372|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
383059|NCT00851643|1287373|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
383060|NCT00851643|1287374|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
383061|NCT00851643|1287375|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
383062|NCT00851643|1287370|P6|Base Study (Up to 12 Months)|Other|1
383063|NCT00851643|1287371|P5|Base Study (Up to 12 Months)|Other|0
383064|NCT00851643|1287372|P4|Base Study (Up to 12 Months)|Other|0
383065|NCT00851643|1287373|P3|Base Study (Up to 12 Months)|Other|0
383066|NCT00851643|1287374|P2|Base Study (Up to 12 Months)|Other|0
383067|NCT00851643|1287375|P1|Base Study (Up to 12 Months)|Other|0
383068|NCT00851643|1287370|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
383069|NCT00851643|1287371|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
383070|NCT00851643|1287372|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
383071|NCT00851643|1287373|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
383072|NCT00851643|1287374|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
383073|NCT00851643|1287375|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
383074|NCT00851630|1287396|P2|Overall Study|Clinical failure|1
383075|NCT00851630|1287397|P1|Overall Study|Clinical failure|0
383076|NCT00851630|1287396|P2|Overall Study|Death|1
383077|NCT00851630|1287397|P1|Overall Study|Death|2
383078|NCT00851591|1287411|P2|Overall Study|Withdrawal by Subject|0
383079|NCT00851591|1287412|P1|Overall Study|Withdrawal by Subject|2
383080|NCT00851552|1287418|P1|Overall Study|Disease Progression|4
383081|NCT00851552|1287418|P1|Overall Study|Adverse Event|1
383082|NCT00851552|1287418|P1|Overall Study|Death|2
383083|NCT00851318|1287432|P4|Overall Study|Physician Decision|1
383084|NCT00851318|1287433|P3|Overall Study|Physician Decision|1
383085|NCT00851318|1287434|P2|Overall Study|Physician Decision|0
383086|NCT00851318|1287435|P1|Overall Study|Physician Decision|0
383087|NCT00851318|1287432|P4|Overall Study|Non-compliance with Study Procedures|0
383088|NCT00851318|1287433|P3|Overall Study|Non-compliance with Study Procedures|1
383089|NCT00851318|1287434|P2|Overall Study|Non-compliance with Study Procedures|0
383090|NCT00851318|1287435|P1|Overall Study|Non-compliance with Study Procedures|2
383091|NCT00851318|1287432|P4|Overall Study|Lack of Efficacy|2
383092|NCT00851318|1287433|P3|Overall Study|Lack of Efficacy|4
383093|NCT00851318|1287434|P2|Overall Study|Lack of Efficacy|2
383094|NCT00851318|1287435|P1|Overall Study|Lack of Efficacy|8
383095|NCT00851318|1287432|P4|Overall Study|Pregnancy|1
383096|NCT00851318|1287433|P3|Overall Study|Pregnancy|1
383097|NCT00851318|1287434|P2|Overall Study|Pregnancy|0
383098|NCT00851318|1287435|P1|Overall Study|Pregnancy|0
383099|NCT00851318|1287432|P4|Overall Study|Adverse Event|12
383100|NCT00851318|1287433|P3|Overall Study|Adverse Event|9
383101|NCT00851318|1287434|P2|Overall Study|Adverse Event|2
383102|NCT00851318|1287435|P1|Overall Study|Adverse Event|13
383103|NCT00851318|1287432|P4|Overall Study|Withdrawal by Subject|3
383104|NCT00851318|1287433|P3|Overall Study|Withdrawal by Subject|5
383105|NCT00851318|1287434|P2|Overall Study|Withdrawal by Subject|1
383106|NCT00851318|1287435|P1|Overall Study|Withdrawal by Subject|7
383107|NCT00851253|1287471|P2|Overall Study|Disease Progression|0
383108|NCT00851253|1287472|P1|Overall Study|Disease Progression|1
383109|NCT00851084|1287482|P2|Overall Study|Not specified|1
383110|NCT00851084|1287483|P1|Overall Study|Not specified|7
383111|NCT00851084|1287482|P2|Overall Study|Metastatic surgery|6
383112|NCT00851084|1287483|P1|Overall Study|Metastatic surgery|6
383113|NCT00851084|1287482|P2|Overall Study|Withdrawal by Subject|12
383114|NCT00851084|1287483|P1|Overall Study|Withdrawal by Subject|11
383115|NCT00851084|1287482|P2|Overall Study|Consent withdrawn|2
383116|NCT00851084|1287483|P1|Overall Study|Consent withdrawn|0
383117|NCT00851084|1287482|P2|Overall Study|Physician Decision|14
383118|NCT00851084|1287483|P1|Overall Study|Physician Decision|13
383119|NCT00851084|1287482|P2|Overall Study|Poor compliance to protocol|1
383120|NCT00851084|1287483|P1|Overall Study|Poor compliance to protocol|1
383121|NCT00851084|1287482|P2|Overall Study|Disease progression|47
383122|NCT00851084|1287483|P1|Overall Study|Disease progression|52
383123|NCT00851084|1287482|P2|Overall Study|Adverse Event|36
383124|NCT00851084|1287483|P1|Overall Study|Adverse Event|26
383125|NCT00851084|1287482|P2|Overall Study|Randomized but not treated|0
383126|NCT00851084|1287483|P1|Overall Study|Randomized but not treated|1
383127|NCT00850759|1287543|P4|Overall Study|Lost to Follow-up|3
383128|NCT00850759|1287544|P3|Overall Study|Lost to Follow-up|5
383129|NCT00850759|1287545|P2|Overall Study|Lost to Follow-up|5
383130|NCT00850759|1287546|P1|Overall Study|Lost to Follow-up|7
383131|NCT00850564|1287627|P1|Overall Study|Withdrawal by Subject|2
383132|NCT00850538|1287632|P1|Overall Study|Protocol Violation|2
383133|NCT00850538|1287632|P1|Overall Study|radiology error|2
383134|NCT00850538|1287632|P1|Overall Study|Withdrawal by Subject|3
383135|NCT00850538|1287632|P1|Overall Study|specimen unusable|7
383136|NCT00850538|1287632|P1|Overall Study|specimen missed due to scheduling error|14
383137|NCT00850538|1287632|P1|Overall Study|unable/unwilling to complete MRI|13
383138|NCT00850499|1287638|P2|Overall Study|Lack of Efficacy|1
383139|NCT00850499|1287639|P1|Overall Study|Lack of Efficacy|0
383140|NCT00850499|1287638|P2|Overall Study|Adverse Event|1
383141|NCT00850499|1287639|P1|Overall Study|Adverse Event|3
383142|NCT00850460|1287649|P2|Overall Study|Lost to Follow-up|4
383143|NCT00850460|1287650|P1|Overall Study|Lost to Follow-up|4
383144|NCT00850395|1287662|P1|Overall Study|Other|5
383145|NCT00850395|1287662|P1|Overall Study|Insufficient clinical response|3
383146|NCT00850395|1287662|P1|Overall Study|Adverse Event|1
383147|NCT00850395|1287662|P1|Overall Study|Death|1
383148|NCT00850343|1287682|P4|Overall Study|Physician Decision|1
383149|NCT00850343|1287683|P3|Overall Study|Physician Decision|1
383150|NCT00850343|1287684|P2|Overall Study|Physician Decision|1
383151|NCT00850343|1287685|P1|Overall Study|Physician Decision|2
383152|NCT00850343|1287682|P4|Overall Study|Non-compliance with Study Procedures|1
383153|NCT00850343|1287683|P3|Overall Study|Non-compliance with Study Procedures|1
383154|NCT00850343|1287684|P2|Overall Study|Non-compliance with Study Procedures|0
383155|NCT00850343|1287685|P1|Overall Study|Non-compliance with Study Procedures|1
383156|NCT00850343|1287682|P4|Overall Study|Lack of Efficacy|2
383157|NCT00850343|1287683|P3|Overall Study|Lack of Efficacy|3
383158|NCT00850343|1287684|P2|Overall Study|Lack of Efficacy|0
383159|NCT00850343|1287685|P1|Overall Study|Lack of Efficacy|17
383160|NCT00850343|1287682|P4|Overall Study|Pregnancy|1
383161|NCT00850343|1287683|P3|Overall Study|Pregnancy|0
383162|NCT00850343|1287684|P2|Overall Study|Pregnancy|0
383163|NCT00850343|1287685|P1|Overall Study|Pregnancy|0
383164|NCT00850343|1287682|P4|Overall Study|Adverse Event|6
383165|NCT00850343|1287683|P3|Overall Study|Adverse Event|6
383166|NCT00850343|1287684|P2|Overall Study|Adverse Event|2
383167|NCT00850343|1287685|P1|Overall Study|Adverse Event|15
383168|NCT00850343|1287682|P4|Overall Study|Withdrawal by Subject|2
383169|NCT00850343|1287683|P3|Overall Study|Withdrawal by Subject|3
383170|NCT00850343|1287684|P2|Overall Study|Withdrawal by Subject|0
383171|NCT00850343|1287685|P1|Overall Study|Withdrawal by Subject|11
383172|NCT00850200|1287715|P1|Overall Study|Withdrawal by Subject|1
383173|NCT00850174|1287723|P2|Second Intervention|Withdrawal by Subject|0
383174|NCT00850174|1287724|P1|Second Intervention|Withdrawal by Subject|1
383175|NCT00850174|1287723|P2|Washout: One Week|Withdrawal by Subject|2
383176|NCT00850174|1287724|P1|Washout: One Week|Withdrawal by Subject|0
383177|NCT00850135|1287738|P1|Overall Study|Physician Decision|1
383178|NCT00850070|1287757|P2|Overall Study|Adverse Event|0
383179|NCT00850070|1287758|P1|Overall Study|Adverse Event|2
383180|NCT00850070|1287757|P2|Overall Study|Lack of Efficacy|1
383181|NCT00850070|1287758|P1|Overall Study|Lack of Efficacy|1
383182|NCT00849940|1287787|P1|Overall Study|Physician Decision|4
383183|NCT00849901|1287798|P3|Extension Phase|Lack of Efficacy|1
383184|NCT00849901|1287799|P2|Extension Phase|Lack of Efficacy|4
383185|NCT00849901|1287800|P1|Extension Phase|Lack of Efficacy|2
383186|NCT00849901|1287798|P3|Extension Phase|Physician Decision|0
383187|NCT00849901|1287799|P2|Extension Phase|Physician Decision|2
383188|NCT00849901|1287800|P1|Extension Phase|Physician Decision|1
383189|NCT00849901|1287798|P3|Extension Phase|Parent or Caregiver Decision|4
383190|NCT00849901|1287799|P2|Extension Phase|Parent or Caregiver Decision|4
383191|NCT00849901|1287800|P1|Extension Phase|Parent or Caregiver Decision|10
383192|NCT00849901|1287798|P3|Extension Phase|Withdrawal by Subject|3
383193|NCT00849901|1287799|P2|Extension Phase|Withdrawal by Subject|6
383194|NCT00849901|1287800|P1|Extension Phase|Withdrawal by Subject|7
383195|NCT00849901|1287798|P3|Extension Phase|Protocol Violation|4
383196|NCT00849901|1287799|P2|Extension Phase|Protocol Violation|2
383197|NCT00849901|1287800|P1|Extension Phase|Protocol Violation|2
383198|NCT00849901|1287798|P3|Extension Phase|Lost to Follow-up|1
383199|NCT00849901|1287799|P2|Extension Phase|Lost to Follow-up|0
383200|NCT00849901|1287800|P1|Extension Phase|Lost to Follow-up|3
383201|NCT00849901|1287798|P3|Extension Phase|Adverse Event|4
383202|NCT00849901|1287799|P2|Extension Phase|Adverse Event|8
383203|NCT00849901|1287800|P1|Extension Phase|Adverse Event|2
383204|NCT00849901|1287798|P3|Acute Treatment Phase|Lack of Efficacy|2
383205|NCT00849901|1287799|P2|Acute Treatment Phase|Lack of Efficacy|3
383206|NCT00849901|1287800|P1|Acute Treatment Phase|Lack of Efficacy|2
383207|NCT00849901|1287798|P3|Acute Treatment Phase|Sponsor Decision|0
383208|NCT00849901|1287799|P2|Acute Treatment Phase|Sponsor Decision|0
383209|NCT00849901|1287800|P1|Acute Treatment Phase|Sponsor Decision|1
383210|NCT00849901|1287798|P3|Acute Treatment Phase|Physician Decision|1
383211|NCT00849901|1287799|P2|Acute Treatment Phase|Physician Decision|1
383212|NCT00849901|1287800|P1|Acute Treatment Phase|Physician Decision|1
383213|NCT00849901|1287798|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
383214|NCT00849901|1287799|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
383215|NCT00849901|1287800|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
383216|NCT00849901|1287798|P3|Acute Treatment Phase|Withdrawal by Subject|4
383217|NCT00849901|1287799|P2|Acute Treatment Phase|Withdrawal by Subject|10
383218|NCT00849901|1287800|P1|Acute Treatment Phase|Withdrawal by Subject|4
383219|NCT00849901|1287798|P3|Acute Treatment Phase|Protocol Violation|1
383220|NCT00849901|1287799|P2|Acute Treatment Phase|Protocol Violation|2
383221|NCT00849901|1287800|P1|Acute Treatment Phase|Protocol Violation|0
383222|NCT00849901|1287798|P3|Acute Treatment Phase|Lost to Follow-up|1
383223|NCT00849901|1287799|P2|Acute Treatment Phase|Lost to Follow-up|4
383224|NCT00849901|1287800|P1|Acute Treatment Phase|Lost to Follow-up|2
383225|NCT00849901|1287798|P3|Acute Treatment Phase|Adverse Event|3
383226|NCT00849901|1287799|P2|Acute Treatment Phase|Adverse Event|1
383227|NCT00849901|1287800|P1|Acute Treatment Phase|Adverse Event|9
383228|NCT00849875|1287847|P1|Overall Study|Lost to Follow-up|2
383229|NCT00849875|1287847|P1|Overall Study|Others|6
383230|NCT00849875|1287847|P1|Overall Study|Ongoing (unknown completion status)|11
383231|NCT00849875|1287847|P1|Overall Study|Death|28
383232|NCT00849797|1287944|P2|Washout: One Week|Withdrawal by Subject|2
383233|NCT00849797|1287945|P1|Washout: One Week|Withdrawal by Subject|0
383234|NCT00849797|1287944|P2|First Intervention|Adverse Event|1
383235|NCT00849797|1287945|P1|First Intervention|Adverse Event|0
383236|NCT00849797|1287944|P2|First Intervention|bad veins|0
383237|NCT00849797|1287945|P1|First Intervention|bad veins|1
383238|NCT00849693|1287963|P4|Extension Phase|Lack of Efficacy|1
383239|NCT00849693|1287964|P3|Extension Phase|Lack of Efficacy|2
383240|NCT00849693|1287965|P2|Extension Phase|Lack of Efficacy|2
383241|NCT00849693|1287966|P1|Extension Phase|Lack of Efficacy|2
383242|NCT00849693|1287963|P4|Extension Phase|Sponsor decision|1
383243|NCT00849693|1287964|P3|Extension Phase|Sponsor decision|0
383244|NCT00849693|1287965|P2|Extension Phase|Sponsor decision|0
383245|NCT00849693|1287966|P1|Extension Phase|Sponsor decision|1
383246|NCT00849693|1287963|P4|Extension Phase|Physician Decision|0
383247|NCT00849693|1287964|P3|Extension Phase|Physician Decision|2
383248|NCT00849693|1287965|P2|Extension Phase|Physician Decision|1
383249|NCT00849693|1287966|P1|Extension Phase|Physician Decision|1
383250|NCT00849693|1287963|P4|Extension Phase|Parent or caregiver decision|5
383251|NCT00849693|1287964|P3|Extension Phase|Parent or caregiver decision|10
383252|NCT00849693|1287965|P2|Extension Phase|Parent or caregiver decision|4
383253|NCT00849693|1287966|P1|Extension Phase|Parent or caregiver decision|9
383254|NCT00849693|1287963|P4|Extension Phase|Withdrawal by Subject|15
383255|NCT00849693|1287964|P3|Extension Phase|Withdrawal by Subject|10
383256|NCT00849693|1287965|P2|Extension Phase|Withdrawal by Subject|9
383257|NCT00849693|1287966|P1|Extension Phase|Withdrawal by Subject|6
383258|NCT00849693|1287963|P4|Extension Phase|Protocol Violation|3
383259|NCT00849693|1287964|P3|Extension Phase|Protocol Violation|2
383260|NCT00849693|1287965|P2|Extension Phase|Protocol Violation|3
383261|NCT00849693|1287966|P1|Extension Phase|Protocol Violation|0
383262|NCT00849693|1287963|P4|Extension Phase|Lost to Follow-up|6
383263|NCT00849693|1287964|P3|Extension Phase|Lost to Follow-up|6
383264|NCT00849693|1287965|P2|Extension Phase|Lost to Follow-up|5
383265|NCT00849693|1287966|P1|Extension Phase|Lost to Follow-up|7
383266|NCT00849693|1287963|P4|Extension Phase|Adverse Event|7
383267|NCT00849693|1287964|P3|Extension Phase|Adverse Event|3
383268|NCT00849693|1287965|P2|Extension Phase|Adverse Event|6
383269|NCT00849693|1287966|P1|Extension Phase|Adverse Event|4
383270|NCT00849693|1287963|P4|Acute Treatment Phase|Lack of Efficacy|2
383271|NCT00849693|1287964|P3|Acute Treatment Phase|Lack of Efficacy|1
383272|NCT00849693|1287965|P2|Acute Treatment Phase|Lack of Efficacy|3
383273|NCT00849693|1287966|P1|Acute Treatment Phase|Lack of Efficacy|1
383274|NCT00849693|1287963|P4|Acute Treatment Phase|Sponsor decision|0
383275|NCT00849693|1287964|P3|Acute Treatment Phase|Sponsor decision|1
383276|NCT00849693|1287965|P2|Acute Treatment Phase|Sponsor decision|0
383277|NCT00849693|1287966|P1|Acute Treatment Phase|Sponsor decision|0
383278|NCT00849693|1287963|P4|Acute Treatment Phase|Physician Decision|1
383279|NCT00849693|1287964|P3|Acute Treatment Phase|Physician Decision|2
383280|NCT00849693|1287965|P2|Acute Treatment Phase|Physician Decision|1
383281|NCT00849693|1287966|P1|Acute Treatment Phase|Physician Decision|2
383282|NCT00849693|1287963|P4|Acute Treatment Phase|Parent or caregiver decision|7
383283|NCT00849693|1287964|P3|Acute Treatment Phase|Parent or caregiver decision|7
383284|NCT00849693|1287965|P2|Acute Treatment Phase|Parent or caregiver decision|6
383285|NCT00849693|1287966|P1|Acute Treatment Phase|Parent or caregiver decision|7
383286|NCT00849693|1287963|P4|Acute Treatment Phase|Withdrawal by Subject|8
383287|NCT00849693|1287964|P3|Acute Treatment Phase|Withdrawal by Subject|3
383288|NCT00849693|1287965|P2|Acute Treatment Phase|Withdrawal by Subject|5
383289|NCT00849693|1287966|P1|Acute Treatment Phase|Withdrawal by Subject|5
383290|NCT00849693|1287963|P4|Acute Treatment Phase|Protocol Violation|6
383291|NCT00849693|1287964|P3|Acute Treatment Phase|Protocol Violation|2
383292|NCT00849693|1287965|P2|Acute Treatment Phase|Protocol Violation|5
383293|NCT00849693|1287966|P1|Acute Treatment Phase|Protocol Violation|1
383294|NCT00849693|1287963|P4|Acute Treatment Phase|Lost to Follow-up|9
383295|NCT00849693|1287964|P3|Acute Treatment Phase|Lost to Follow-up|11
383296|NCT00849693|1287965|P2|Acute Treatment Phase|Lost to Follow-up|8
383297|NCT00849693|1287966|P1|Acute Treatment Phase|Lost to Follow-up|5
383298|NCT00849693|1287963|P4|Acute Treatment Phase|Adverse Event|4
383299|NCT00849693|1287964|P3|Acute Treatment Phase|Adverse Event|6
383300|NCT00849693|1287965|P2|Acute Treatment Phase|Adverse Event|7
383301|NCT00849693|1287966|P1|Acute Treatment Phase|Adverse Event|12
383302|NCT00849680|1288033|P8|Overall Study|Subject unable to comply with protocol|0
383303|NCT00849680|1288034|P7|Overall Study|Subject unable to comply with protocol|0
383304|NCT00849680|1288035|P6|Overall Study|Subject unable to comply with protocol|0
383305|NCT00849680|1288036|P5|Overall Study|Subject unable to comply with protocol|0
383306|NCT00849680|1288037|P4|Overall Study|Subject unable to comply with protocol|0
383307|NCT00849680|1288038|P3|Overall Study|Subject unable to comply with protocol|0
383308|NCT00849680|1288039|P2|Overall Study|Subject unable to comply with protocol|0
383309|NCT00849680|1288040|P1|Overall Study|Subject unable to comply with protocol|1
383310|NCT00849680|1288033|P8|Overall Study|Withdrawal by Subject|1
383311|NCT00849680|1288034|P7|Overall Study|Withdrawal by Subject|1
383312|NCT00849680|1288035|P6|Overall Study|Withdrawal by Subject|2
383313|NCT00849680|1288036|P5|Overall Study|Withdrawal by Subject|2
383314|NCT00849680|1288037|P4|Overall Study|Withdrawal by Subject|2
383315|NCT00849680|1288038|P3|Overall Study|Withdrawal by Subject|0
383316|NCT00849680|1288039|P2|Overall Study|Withdrawal by Subject|0
383317|NCT00849680|1288040|P1|Overall Study|Withdrawal by Subject|2
383318|NCT00849680|1288033|P8|Overall Study|Subject moved|2
383319|NCT00849680|1288034|P7|Overall Study|Subject moved|2
383320|NCT00849680|1288035|P6|Overall Study|Subject moved|2
383321|NCT00849680|1288036|P5|Overall Study|Subject moved|0
383322|NCT00849680|1288037|P4|Overall Study|Subject moved|1
383323|NCT00849680|1288038|P3|Overall Study|Subject moved|3
383324|NCT00849680|1288039|P2|Overall Study|Subject moved|0
383325|NCT00849680|1288040|P1|Overall Study|Subject moved|1
383326|NCT00849680|1288033|P8|Overall Study|Lost to Follow-up|5
383327|NCT00849680|1288034|P7|Overall Study|Lost to Follow-up|12
383328|NCT00849680|1288035|P6|Overall Study|Lost to Follow-up|11
383329|NCT00849680|1288036|P5|Overall Study|Lost to Follow-up|8
383330|NCT00849680|1288037|P4|Overall Study|Lost to Follow-up|11
383331|NCT00849680|1288038|P3|Overall Study|Lost to Follow-up|12
383332|NCT00849680|1288039|P2|Overall Study|Lost to Follow-up|3
383333|NCT00849680|1288040|P1|Overall Study|Lost to Follow-up|7
383334|NCT00849680|1288033|P8|Overall Study|Adverse Event|0
383335|NCT00849680|1288034|P7|Overall Study|Adverse Event|2
383336|NCT00849680|1288035|P6|Overall Study|Adverse Event|0
383337|NCT00849680|1288036|P5|Overall Study|Adverse Event|0
383338|NCT00849680|1288037|P4|Overall Study|Adverse Event|0
383339|NCT00849680|1288038|P3|Overall Study|Adverse Event|0
383340|NCT00849680|1288039|P2|Overall Study|Adverse Event|0
383341|NCT00849680|1288040|P1|Overall Study|Adverse Event|0
383342|NCT00849524|1288082|P1|Overall Study|Lack of Efficacy|3
383343|NCT00849472|1288099|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
383344|NCT00849472|1288099|P1|Pazopanib Postsurgery Treatment|Moved|1
383345|NCT00849472|1288099|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
383346|NCT00849472|1288099|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
383347|NCT00849472|1288099|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
383348|NCT00849472|1288099|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
383349|NCT00849472|1288099|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
383350|NCT00849472|1288099|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
383351|NCT00849472|1288099|P1|Weekly Paclitaxel|Physician Decision|3
383352|NCT00849472|1288099|P1|Weekly Paclitaxel|Withdrawal by Subject|1
383353|NCT00849472|1288099|P1|Weekly Paclitaxel|Adverse Event|11
383354|NCT00849472|1288099|P1|Weekly Paclitaxel|Disease Progression|1
383355|NCT00849472|1288099|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
383356|NCT00849472|1288099|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
383357|NCT00849472|1288099|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
383358|NCT00849472|1288099|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
383359|NCT00849472|1288099|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
383360|NCT00849381|1288113|P1|Overall Study|Other|4
383361|NCT00849381|1288113|P1|Overall Study|Withdrawal by Subject|6
383362|NCT00849381|1288113|P1|Overall Study|Protocol Violation|5
383363|NCT00849381|1288113|P1|Overall Study|Lost to Follow-up|129
383364|NCT00849381|1288113|P1|Overall Study|Adverse Event|1
383365|NCT00849290|1288119|P1|Overall Study|Disease Progression|20
383366|NCT00849290|1288119|P1|Overall Study|Protocol Violation|5
383367|NCT00849290|1288119|P1|Overall Study|Lost to Follow-up|2
383368|NCT00849290|1288119|P1|Overall Study|Withdrawal by Subject|11
383369|NCT00849290|1288119|P1|Overall Study|Death|14
383370|NCT00849290|1288119|P1|Overall Study|Adverse Event|3
383371|NCT00849212|1288130|P1|Overall Study|Miscellaneous|1
383372|NCT00849212|1288130|P1|Overall Study|Adverse Event|2
383373|NCT00849212|1288130|P1|Overall Study|Withdrawal by Subject|3
383374|NCT00849212|1288130|P1|Overall Study|Lack of Efficacy|1
383375|NCT00849186|1288135|P1|Overall Study|Other|1
383376|NCT00849186|1288135|P1|Overall Study|not treated|6
383377|NCT00849186|1288135|P1|Overall Study|Withdrawal by Subject|1
383378|NCT00849186|1288135|P1|Overall Study|Adverse Event|2
383379|NCT00849147|1288141|P1|Overall Study|Disease Relapse/Progression|2
383380|NCT00849147|1288141|P1|Overall Study|Protocol Violation|2
383381|NCT00849147|1288141|P1|Overall Study|Withdrawal by Subject|1
383382|NCT00849108|1288174|P2|Cohort 2 Efficacy|Not specified|9
383383|NCT00849108|1288175|P1|Cohort 2 Efficacy|Not specified|0
383384|NCT00849108|1288174|P2|Cohort 2 Efficacy|Adverse Event|1
383385|NCT00849108|1288175|P1|Cohort 2 Efficacy|Adverse Event|0
383386|NCT00849108|1288174|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
383387|NCT00849108|1288175|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
383388|NCT00849056|1288185|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
383389|NCT00849056|1288186|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
383390|NCT00849056|1288185|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
383391|NCT00849056|1288186|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
383392|NCT00849056|1288185|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
383393|NCT00849056|1288186|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
383394|NCT00849056|1288185|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
383395|NCT00849056|1288186|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
383396|NCT00849056|1288185|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
383397|NCT00849056|1288186|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
383398|NCT00849056|1288185|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
383399|NCT00849056|1288186|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
383400|NCT00849056|1288185|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
383401|NCT00849056|1288186|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
383402|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
383403|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
383404|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
383405|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
383406|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
383407|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
383408|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
383409|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
383410|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
383411|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
383412|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
383413|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
383414|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
383415|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
383416|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
383417|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
383418|NCT00849056|1288185|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
383419|NCT00849056|1288186|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
383420|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
383421|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
383422|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
383423|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
383424|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
383425|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
383426|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Physician Decision|1
383427|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Physician Decision|1
383428|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Physician Decision|0
383429|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
383430|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
383431|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
383432|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
383433|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
383434|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
383435|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
383436|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
383437|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
383438|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Noncompliance|0
383439|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Noncompliance|1
383440|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Noncompliance|2
383441|NCT00849017|1288211|P3|Follow-up Period (8 Weeks)|Adverse Event|0
383442|NCT00849017|1288212|P2|Follow-up Period (8 Weeks)|Adverse Event|0
383443|NCT00849017|1288213|P1|Follow-up Period (8 Weeks)|Adverse Event|1
383444|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
383445|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
383446|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
383447|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Pregnancy|1
383448|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Pregnancy|0
383449|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Pregnancy|1
383450|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
383451|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
383452|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
383453|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
383454|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
383455|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
383456|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
383457|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
383458|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
383459|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
383460|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
383461|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
383462|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Physician Decision|1
383463|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Physician Decision|2
383464|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Physician Decision|0
383465|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
383466|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
383467|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
383468|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
383469|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
383470|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
383471|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Noncompliance|4
383472|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Noncompliance|3
383473|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Noncompliance|3
383474|NCT00849017|1288211|P3|Treatment Period (156 Weeks)|Adverse Event|15
383475|NCT00849017|1288212|P2|Treatment Period (156 Weeks)|Adverse Event|6
383476|NCT00849017|1288213|P1|Treatment Period (156 Weeks)|Adverse Event|5
383477|NCT00848965|1288256|P1|Overall Study|Withdrawal by Subject|1
383478|NCT00848965|1288256|P1|Overall Study|Adverse Event|1
383479|NCT00848926|1288298|P1|Follow-up Period|Not specified|2
383480|NCT00848926|1288298|P1|Follow-up Period|Withdrawal by Subject|3
383481|NCT00848926|1288298|P1|Follow-up Period|Lost to Follow-up|7
383482|NCT00848926|1288298|P1|Treatment Period|Withdrawal by Subject|7
383483|NCT00848926|1288298|P1|Treatment Period|Physician Decision|12
383484|NCT00848926|1288298|P1|Treatment Period|Adverse Event|20
383485|NCT00848926|1288298|P1|Treatment Period|Progressive disease|45
383486|NCT00848549|1288337|P2|E2090-E044-314 (Extension Study)|Not Specified|6
383487|NCT00848549|1288338|P1|E2090-E044-314 (Extension Study)|Not Specified|5
383488|NCT00848549|1288337|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
383489|NCT00848549|1288338|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
383490|NCT00848549|1288337|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
383491|NCT00848549|1288338|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
383492|NCT00848549|1288337|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
383493|NCT00848549|1288338|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
383494|NCT00848549|1288337|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
383495|NCT00848549|1288338|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
383496|NCT00848549|1288337|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
383497|NCT00848549|1288338|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
383498|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
383499|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
383500|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
383501|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
383502|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
383503|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
383504|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
383505|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
383506|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
383507|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
383508|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
383509|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
383510|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
383511|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
383512|NCT00848549|1288337|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
383513|NCT00848549|1288338|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
383514|NCT00848536|1288356|P2|Overall Study|Patient Moved|2
383515|NCT00848536|1288357|P1|Overall Study|Patient Moved|0
383516|NCT00848536|1288356|P2|Overall Study|Inadequate Control of IOP|1
383517|NCT00848536|1288357|P1|Overall Study|Inadequate Control of IOP|1
383518|NCT00848536|1288356|P2|Overall Study|Noncompliance|0
383519|NCT00848536|1288357|P1|Overall Study|Noncompliance|1
383520|NCT00848536|1288356|P2|Overall Study|Protocol Violation|1
383521|NCT00848536|1288357|P1|Overall Study|Protocol Violation|0
383522|NCT00848536|1288356|P2|Overall Study|Withdrawal by Subject|1
383523|NCT00848536|1288357|P1|Overall Study|Withdrawal by Subject|0
383524|NCT00848536|1288356|P2|Overall Study|Adverse Event|2
383525|NCT00848536|1288357|P1|Overall Study|Adverse Event|2
383526|NCT00848497|1288422|P2|Overall Study|Withdrawal by Subject|1
383527|NCT00848497|1288423|P1|Overall Study|Withdrawal by Subject|0
383528|NCT00848497|1288422|P2|Overall Study|Screen failure|0
383529|NCT00848497|1288423|P1|Overall Study|Screen failure|2
383530|NCT00848484|1288437|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
383531|NCT00848484|1288438|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
383532|NCT00848484|1288437|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
383533|NCT00848484|1288438|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
383534|NCT00848484|1288437|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
383535|NCT00848484|1288438|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
383536|NCT00848484|1288437|P2|First Intervention (Treatment Period 1)|Physician Decision|1
383537|NCT00848484|1288438|P1|First Intervention (Treatment Period 1)|Physician Decision|0
383538|NCT00848484|1288437|P2|First Intervention (Treatment Period 1)|Adverse Event|1
383539|NCT00848484|1288438|P1|First Intervention (Treatment Period 1)|Adverse Event|2
383540|NCT00848354|1288467|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
383541|NCT00848354|1288468|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
383542|NCT00848354|1288467|P2|Phase 2 Year 2|Subject Request|1
383543|NCT00848354|1288468|P1|Phase 2 Year 2|Subject Request|1
383544|NCT00848354|1288467|P2|Phase 2 Year 2|Protocol Violation|1
383545|NCT00848354|1288468|P1|Phase 2 Year 2|Protocol Violation|1
383546|NCT00848354|1288467|P2|Phase 2 Year 2|Unspecified Reason|0
383547|NCT00848354|1288468|P1|Phase 2 Year 2|Unspecified Reason|1
383548|NCT00848354|1288467|P2|Phase 2 Year 2|Lost to Follow-up|3
383549|NCT00848354|1288468|P1|Phase 2 Year 2|Lost to Follow-up|1
383550|NCT00848354|1288467|P2|Phase 2 Year 2|Failed to return|0
383551|NCT00848354|1288468|P1|Phase 2 Year 2|Failed to return|3
383552|NCT00848354|1288467|P2|Phase 2 Year 2|Death|0
383553|NCT00848354|1288468|P1|Phase 2 Year 2|Death|2
383554|NCT00848354|1288467|P2|Phase 2 Year 2|Adverse Event|2
383555|NCT00848354|1288468|P1|Phase 2 Year 2|Adverse Event|12
383556|NCT00848354|1288467|P2|Phase 2 Year 1|Subject Request|2
383557|NCT00848354|1288468|P1|Phase 2 Year 1|Subject Request|1
383558|NCT00848354|1288467|P2|Phase 2 Year 1|Protocol Violation|1
383559|NCT00848354|1288468|P1|Phase 2 Year 1|Protocol Violation|4
383560|NCT00848354|1288467|P2|Phase 2 Year 1|Unspecified Reason|0
383561|NCT00848354|1288468|P1|Phase 2 Year 1|Unspecified Reason|3
383562|NCT00848354|1288467|P2|Phase 2 Year 1|Lost to Follow-up|0
383563|NCT00848354|1288468|P1|Phase 2 Year 1|Lost to Follow-up|1
383564|NCT00848354|1288467|P2|Phase 2 Year 1|Failed to Return|1
383565|NCT00848354|1288468|P1|Phase 2 Year 1|Failed to Return|1
383566|NCT00848354|1288467|P2|Phase 2 Year 1|Death|0
383567|NCT00848354|1288468|P1|Phase 2 Year 1|Death|1
383568|NCT00848354|1288467|P2|Phase 2 Year 1|Adverse Event|2
383569|NCT00848354|1288468|P1|Phase 2 Year 1|Adverse Event|7
383570|NCT00848354|1288467|P2|Phase 1|Lack of Efficacy|1
383571|NCT00848354|1288468|P1|Phase 1|Lack of Efficacy|0
383572|NCT00848354|1288467|P2|Phase 1|Withdrawal by Subject|4
383573|NCT00848354|1288468|P1|Phase 1|Withdrawal by Subject|2
383574|NCT00848354|1288467|P2|Phase 1|Protocol Violation|1
383575|NCT00848354|1288468|P1|Phase 1|Protocol Violation|1
383576|NCT00848354|1288467|P2|Phase 1|Unspecified Reason|1
383577|NCT00848354|1288468|P1|Phase 1|Unspecified Reason|1
383578|NCT00848354|1288467|P2|Phase 1|Lost to Follow-up|1
383579|NCT00848354|1288468|P1|Phase 1|Lost to Follow-up|1
383580|NCT00848354|1288467|P2|Phase 1|Failed to return|1
383581|NCT00848354|1288468|P1|Phase 1|Failed to return|0
383582|NCT00848354|1288467|P2|Phase 1|Discontinuation of study by sponsor|1
383583|NCT00848354|1288468|P1|Phase 1|Discontinuation of study by sponsor|2
383584|NCT00848354|1288467|P2|Phase 1|Adverse Event|4
383585|NCT00848354|1288468|P1|Phase 1|Adverse Event|5
383586|NCT00848250|1288620|P2|Overall Study|surgery was completed without cardiopulm|1
383587|NCT00848250|1288621|P1|Overall Study|surgery was completed without cardiopulm|0
383588|NCT00848211|1288652|P4|Overall Study|Adverse Event|0
383589|NCT00848211|1288653|P3|Overall Study|Adverse Event|0
383590|NCT00848211|1288654|P2|Overall Study|Adverse Event|0
383591|NCT00848211|1288655|P1|Overall Study|Adverse Event|0
383592|NCT00848211|1288652|P4|Overall Study|Protocol Violation|0
383593|NCT00848211|1288653|P3|Overall Study|Protocol Violation|1
383594|NCT00848211|1288654|P2|Overall Study|Protocol Violation|1
383595|NCT00848211|1288655|P1|Overall Study|Protocol Violation|0
383596|NCT00848198|1288673|P1|Overall Study|Incomplete Case Report Forms|15
383597|NCT00848120|1288738|P1|Overall Study|Adverse Event|1
383598|NCT00848107|1288750|P1|Overall Study|Pregnancy|1
383599|NCT00848107|1288750|P1|Overall Study|Death|1
383600|NCT00848107|1288750|P1|Overall Study|Adverse Event|9
383601|NCT00848107|1288750|P1|Overall Study|Withdrawal by Subject|8
383602|NCT00848107|1288750|P1|Overall Study|Lost to Follow-up|2
383603|NCT00848081|1288760|P2|Overall Study|Withdrawal by Subject|3
383604|NCT00848081|1288761|P1|Overall Study|Withdrawal by Subject|5
383605|NCT00848081|1288760|P2|Overall Study|Physician Decision|3
383606|NCT00848081|1288761|P1|Overall Study|Physician Decision|0
383607|NCT00848081|1288760|P2|Overall Study|Lost to Follow-up|0
383608|NCT00848081|1288761|P1|Overall Study|Lost to Follow-up|1
383609|NCT00848081|1288760|P2|Overall Study|Protocol Violation|5
383610|NCT00848081|1288761|P1|Overall Study|Protocol Violation|8
383611|NCT00848081|1288760|P2|Overall Study|Adverse Event|7
383612|NCT00848081|1288761|P1|Overall Study|Adverse Event|6
383613|NCT00848042|1288778|P3|Overall Study|Other Therapy|0
383614|NCT00848042|1288779|P2|Overall Study|Other Therapy|0
383615|NCT00848042|1288780|P1|Overall Study|Other Therapy|3
383616|NCT00848042|1288778|P3|Overall Study|Death|0
383617|NCT00848042|1288779|P2|Overall Study|Death|2
383618|NCT00848042|1288780|P1|Overall Study|Death|1
383619|NCT00847912|1288799|P2|Overall Study|Withdrawal by Subject|6
383620|NCT00847912|1288800|P1|Overall Study|Withdrawal by Subject|3
383621|NCT00847912|1288799|P2|Overall Study|Protocol Violation|7
383622|NCT00847912|1288800|P1|Overall Study|Protocol Violation|6
383623|NCT00847886|1288810|P2|Overall Study|Adverse Event|1
383624|NCT00847886|1288811|P1|Overall Study|Adverse Event|0
383625|NCT00847808|1288837|P1|Overall Study|Participant Took Excluded Medication|1
383626|NCT00847808|1288837|P1|Overall Study|Participant Reported Lack of Efficacy|1
383627|NCT00847808|1288837|P1|Overall Study|Withdrawal by Subject|4
383628|NCT00847808|1288837|P1|Overall Study|Lost to Follow-up|1
383629|NCT00847808|1288837|P1|Overall Study|Protocol Violation|1
383630|NCT00847808|1288837|P1|Overall Study|Adverse Event|7
383631|NCT00847704|1288854|P1|Overall Study|Withdrawal by Subject|1
383632|NCT00847665|1288865|P2|Overall Study|Withdrawal by Subject|0
383633|NCT00847665|1288866|P1|Overall Study|Withdrawal by Subject|1
383634|NCT00847626|1288889|P11|Overall Study|Other|3
383635|NCT00847626|1288890|P10|Overall Study|Other|1
383636|NCT00847626|1288891|P9|Overall Study|Other|1
383637|NCT00847626|1288892|P8|Overall Study|Other|3
383638|NCT00847626|1288893|P7|Overall Study|Other|2
383639|NCT00847626|1288894|P6|Overall Study|Other|2
383640|NCT00847626|1288895|P5|Overall Study|Other|2
383641|NCT00847626|1288896|P4|Overall Study|Other|1
383642|NCT00847626|1288897|P3|Overall Study|Other|4
383643|NCT00847626|1288898|P2|Overall Study|Other|5
383644|NCT00847626|1288899|P1|Overall Study|Other|1
383645|NCT00847626|1288889|P11|Overall Study|Lack of Efficacy|7
383646|NCT00847626|1288890|P10|Overall Study|Lack of Efficacy|1
383647|NCT00847626|1288891|P9|Overall Study|Lack of Efficacy|5
383648|NCT00847626|1288892|P8|Overall Study|Lack of Efficacy|2
383649|NCT00847626|1288893|P7|Overall Study|Lack of Efficacy|6
383650|NCT00847626|1288894|P6|Overall Study|Lack of Efficacy|0
383651|NCT00847626|1288895|P5|Overall Study|Lack of Efficacy|2
383652|NCT00847626|1288896|P4|Overall Study|Lack of Efficacy|1
383653|NCT00847626|1288897|P3|Overall Study|Lack of Efficacy|0
383654|NCT00847626|1288898|P2|Overall Study|Lack of Efficacy|1
383655|NCT00847626|1288899|P1|Overall Study|Lack of Efficacy|3
383656|NCT00847626|1288889|P11|Overall Study|Withdrawal by Subject|2
383657|NCT00847626|1288890|P10|Overall Study|Withdrawal by Subject|5
383658|NCT00847626|1288891|P9|Overall Study|Withdrawal by Subject|4
383659|NCT00847626|1288892|P8|Overall Study|Withdrawal by Subject|4
383660|NCT00847626|1288893|P7|Overall Study|Withdrawal by Subject|8
383661|NCT00847626|1288894|P6|Overall Study|Withdrawal by Subject|9
383662|NCT00847626|1288895|P5|Overall Study|Withdrawal by Subject|12
383663|NCT00847626|1288896|P4|Overall Study|Withdrawal by Subject|8
383664|NCT00847626|1288897|P3|Overall Study|Withdrawal by Subject|3
383665|NCT00847626|1288898|P2|Overall Study|Withdrawal by Subject|5
383666|NCT00847626|1288899|P1|Overall Study|Withdrawal by Subject|5
383667|NCT00847626|1288889|P11|Overall Study|Lost to Follow-up|1
383668|NCT00847626|1288890|P10|Overall Study|Lost to Follow-up|0
383669|NCT00847626|1288891|P9|Overall Study|Lost to Follow-up|1
383670|NCT00847626|1288892|P8|Overall Study|Lost to Follow-up|3
383671|NCT00847626|1288893|P7|Overall Study|Lost to Follow-up|1
383672|NCT00847626|1288894|P6|Overall Study|Lost to Follow-up|3
383673|NCT00847626|1288895|P5|Overall Study|Lost to Follow-up|0
383674|NCT00847626|1288896|P4|Overall Study|Lost to Follow-up|1
383675|NCT00847626|1288897|P3|Overall Study|Lost to Follow-up|1
383676|NCT00847626|1288898|P2|Overall Study|Lost to Follow-up|1
383677|NCT00847626|1288899|P1|Overall Study|Lost to Follow-up|0
383678|NCT00847626|1288889|P11|Overall Study|Protocol Violation|1
383679|NCT00847626|1288890|P10|Overall Study|Protocol Violation|1
383680|NCT00847626|1288891|P9|Overall Study|Protocol Violation|0
383681|NCT00847626|1288892|P8|Overall Study|Protocol Violation|1
383682|NCT00847626|1288893|P7|Overall Study|Protocol Violation|1
383683|NCT00847626|1288894|P6|Overall Study|Protocol Violation|1
383684|NCT00847626|1288895|P5|Overall Study|Protocol Violation|1
383685|NCT00847626|1288896|P4|Overall Study|Protocol Violation|1
383686|NCT00847626|1288897|P3|Overall Study|Protocol Violation|2
383687|NCT00847626|1288898|P2|Overall Study|Protocol Violation|1
383688|NCT00847626|1288899|P1|Overall Study|Protocol Violation|2
383689|NCT00847626|1288889|P11|Overall Study|Adverse Event|6
383690|NCT00847626|1288890|P10|Overall Study|Adverse Event|6
383691|NCT00847626|1288891|P9|Overall Study|Adverse Event|3
383692|NCT00847626|1288892|P8|Overall Study|Adverse Event|6
383693|NCT00847626|1288893|P7|Overall Study|Adverse Event|4
383694|NCT00847626|1288894|P6|Overall Study|Adverse Event|22
383695|NCT00847626|1288895|P5|Overall Study|Adverse Event|11
383696|NCT00847626|1288896|P4|Overall Study|Adverse Event|19
383697|NCT00847626|1288897|P3|Overall Study|Adverse Event|6
383698|NCT00847626|1288898|P2|Overall Study|Adverse Event|10
383699|NCT00847626|1288899|P1|Overall Study|Adverse Event|10
383700|NCT00847613|1289098|P4|Overall Study|Other|0
383701|NCT00847613|1289099|P3|Overall Study|Other|2
383702|NCT00847613|1289100|P2|Overall Study|Other|1
383703|NCT00847613|1289101|P1|Overall Study|Other|1
383704|NCT00847613|1289098|P4|Overall Study|Randomized, but not treated|0
383705|NCT00847613|1289099|P3|Overall Study|Randomized, but not treated|0
383706|NCT00847613|1289100|P2|Overall Study|Randomized, but not treated|3
383707|NCT00847613|1289101|P1|Overall Study|Randomized, but not treated|0
383708|NCT00847613|1289098|P4|Overall Study|Sponsor request|0
383709|NCT00847613|1289099|P3|Overall Study|Sponsor request|0
383710|NCT00847613|1289100|P2|Overall Study|Sponsor request|1
383711|NCT00847613|1289101|P1|Overall Study|Sponsor request|0
383712|NCT00847613|1289098|P4|Overall Study|Participant moved|0
383713|NCT00847613|1289099|P3|Overall Study|Participant moved|0
383714|NCT00847613|1289100|P2|Overall Study|Participant moved|1
383715|NCT00847613|1289101|P1|Overall Study|Participant moved|4
383716|NCT00847613|1289098|P4|Overall Study|Withdrawal by Subject|2
383717|NCT00847613|1289099|P3|Overall Study|Withdrawal by Subject|2
383718|NCT00847613|1289100|P2|Overall Study|Withdrawal by Subject|11
383719|NCT00847613|1289101|P1|Overall Study|Withdrawal by Subject|8
383720|NCT00847613|1289098|P4|Overall Study|Site closure|1
383721|NCT00847613|1289099|P3|Overall Study|Site closure|0
383722|NCT00847613|1289100|P2|Overall Study|Site closure|0
383723|NCT00847613|1289101|P1|Overall Study|Site closure|1
383724|NCT00847613|1289098|P4|Overall Study|Pregnancy|0
383725|NCT00847613|1289099|P3|Overall Study|Pregnancy|0
383726|NCT00847613|1289100|P2|Overall Study|Pregnancy|1
383727|NCT00847613|1289101|P1|Overall Study|Pregnancy|1
383728|NCT00847613|1289098|P4|Overall Study|Protocol Violation|1
383729|NCT00847613|1289099|P3|Overall Study|Protocol Violation|3
383730|NCT00847613|1289100|P2|Overall Study|Protocol Violation|6
383731|NCT00847613|1289101|P1|Overall Study|Protocol Violation|6
383732|NCT00847613|1289098|P4|Overall Study|Lost to Follow-up|3
383733|NCT00847613|1289099|P3|Overall Study|Lost to Follow-up|0
383734|NCT00847613|1289100|P2|Overall Study|Lost to Follow-up|0
383735|NCT00847613|1289101|P1|Overall Study|Lost to Follow-up|5
383736|NCT00847613|1289098|P4|Overall Study|Study terminated by Sponsor|1
383737|NCT00847613|1289099|P3|Overall Study|Study terminated by Sponsor|2
383738|NCT00847613|1289100|P2|Overall Study|Study terminated by Sponsor|0
383739|NCT00847613|1289101|P1|Overall Study|Study terminated by Sponsor|1
383740|NCT00847613|1289098|P4|Overall Study|Lack of Efficacy|1
383741|NCT00847613|1289099|P3|Overall Study|Lack of Efficacy|3
383742|NCT00847613|1289100|P2|Overall Study|Lack of Efficacy|3
383743|NCT00847613|1289101|P1|Overall Study|Lack of Efficacy|7
383744|NCT00847613|1289098|P4|Overall Study|Adverse Event|6
383745|NCT00847613|1289099|P3|Overall Study|Adverse Event|5
383746|NCT00847613|1289100|P2|Overall Study|Adverse Event|26
383747|NCT00847613|1289101|P1|Overall Study|Adverse Event|36
383748|NCT00847613|1289098|P4|Overall Study|Death|0
383749|NCT00847613|1289099|P3|Overall Study|Death|0
383750|NCT00847613|1289100|P2|Overall Study|Death|1
383751|NCT00847613|1289101|P1|Overall Study|Death|1
383752|NCT00847613|1289098|P4|Overall Study|Ongoing at cut-off date|64
383753|NCT00847613|1289099|P3|Overall Study|Ongoing at cut-off date|64
383754|NCT00847613|1289100|P2|Overall Study|Ongoing at cut-off date|265
383755|NCT00847613|1289101|P1|Overall Study|Ongoing at cut-off date|250
383756|NCT00847561|1289352|P2|Overall Study|Unable to schedule|1
383757|NCT00847561|1289353|P1|Overall Study|Unable to schedule|9
383758|NCT00847561|1289352|P2|Overall Study|Withdrawal by Subject|3
383759|NCT00847561|1289353|P1|Overall Study|Withdrawal by Subject|4
383760|NCT00847535|1289359|P3|Overall Study|Lost to Follow-up|0
383761|NCT00847535|1289360|P2|Overall Study|Lost to Follow-up|1
383762|NCT00847535|1289361|P1|Overall Study|Lost to Follow-up|0
383763|NCT00847535|1289359|P3|Overall Study|Withdrawal by Subject|1
383764|NCT00847535|1289360|P2|Overall Study|Withdrawal by Subject|1
383765|NCT00847535|1289361|P1|Overall Study|Withdrawal by Subject|2
383766|NCT00847405|1289380|P2|Washout of 7 Days|Withdrawal by Subject|0
383767|NCT00847405|1289381|P1|Washout of 7 Days|Withdrawal by Subject|1
383768|NCT00847405|1289380|P2|First Intervention|Adverse Event|1
383769|NCT00847405|1289381|P1|First Intervention|Adverse Event|0
383770|NCT00847301|1289389|P1|Overall Study|Other reason not defined above|1
383771|NCT00847301|1289389|P1|Overall Study|No prescription after hospital discharge|1
383772|NCT00847301|1289389|P1|Overall Study|Lost to Follow-up|1
383773|NCT00847301|1289389|P1|Overall Study|Switch to other anticoagulants|16
383774|NCT00847301|1289389|P1|Overall Study|Adverse Event|35
383775|NCT00847197|1289437|P2|Overall Study|Withdrawal by Subject|1
383776|NCT00847197|1289438|P1|Overall Study|Withdrawal by Subject|3
383777|NCT00847197|1289437|P2|Overall Study|Protocol Violation|1
383778|NCT00847197|1289438|P1|Overall Study|Protocol Violation|0
383779|NCT00847197|1289437|P2|Overall Study|Adverse Event|3
383780|NCT00847197|1289438|P1|Overall Study|Adverse Event|21
383781|NCT00847145|1289456|P8|Overall Study|Protocol Violation|1
383782|NCT00847145|1289457|P7|Overall Study|Protocol Violation|0
383783|NCT00847145|1289458|P6|Overall Study|Protocol Violation|0
383784|NCT00847145|1289459|P5|Overall Study|Protocol Violation|1
383785|NCT00847145|1289460|P4|Overall Study|Protocol Violation|0
383786|NCT00847145|1289461|P3|Overall Study|Protocol Violation|3
383787|NCT00847145|1289462|P2|Overall Study|Protocol Violation|0
383788|NCT00847145|1289463|P1|Overall Study|Protocol Violation|0
383789|NCT00847145|1289456|P8|Overall Study|Inappropriate enrollment|0
383790|NCT00847145|1289457|P7|Overall Study|Inappropriate enrollment|0
383791|NCT00847145|1289458|P6|Overall Study|Inappropriate enrollment|0
383792|NCT00847145|1289459|P5|Overall Study|Inappropriate enrollment|1
383793|NCT00847145|1289460|P4|Overall Study|Inappropriate enrollment|0
383794|NCT00847145|1289461|P3|Overall Study|Inappropriate enrollment|0
383795|NCT00847145|1289462|P2|Overall Study|Inappropriate enrollment|0
383796|NCT00847145|1289463|P1|Overall Study|Inappropriate enrollment|0
383797|NCT00847145|1289456|P8|Overall Study|Lost to Follow-up|2
383798|NCT00847145|1289457|P7|Overall Study|Lost to Follow-up|8
383799|NCT00847145|1289458|P6|Overall Study|Lost to Follow-up|4
383800|NCT00847145|1289459|P5|Overall Study|Lost to Follow-up|4
383801|NCT00847145|1289460|P4|Overall Study|Lost to Follow-up|0
383802|NCT00847145|1289461|P3|Overall Study|Lost to Follow-up|1
383803|NCT00847145|1289462|P2|Overall Study|Lost to Follow-up|1
383804|NCT00847145|1289463|P1|Overall Study|Lost to Follow-up|3
383805|NCT00847145|1289456|P8|Overall Study|Withdrawal by Subject|1
383806|NCT00847145|1289457|P7|Overall Study|Withdrawal by Subject|1
383807|NCT00847145|1289458|P6|Overall Study|Withdrawal by Subject|0
383808|NCT00847145|1289459|P5|Overall Study|Withdrawal by Subject|0
383809|NCT00847145|1289460|P4|Overall Study|Withdrawal by Subject|1
383810|NCT00847145|1289461|P3|Overall Study|Withdrawal by Subject|6
383811|NCT00847145|1289462|P2|Overall Study|Withdrawal by Subject|4
383812|NCT00847145|1289463|P1|Overall Study|Withdrawal by Subject|3
383813|NCT00847145|1289456|P8|Overall Study|AE or Death|0
383814|NCT00847145|1289457|P7|Overall Study|AE or Death|0
383815|NCT00847145|1289458|P6|Overall Study|AE or Death|0
383816|NCT00847145|1289459|P5|Overall Study|AE or Death|0
383817|NCT00847145|1289460|P4|Overall Study|AE or Death|0
383818|NCT00847145|1289461|P3|Overall Study|AE or Death|1
383819|NCT00847145|1289462|P2|Overall Study|AE or Death|1
383820|NCT00847145|1289463|P1|Overall Study|AE or Death|0
383821|NCT00847132|1289513|P2|Overall Study|Death|1
383822|NCT00847132|1289514|P1|Overall Study|Death|1
383823|NCT00847015|1289522|P1|Overall Study|partial cystectomy vs radical cystectomy|1
383824|NCT00847015|1289522|P1|Overall Study|declined any surgery|1
383825|NCT00847015|1289522|P1|Overall Study|Withdrawal by Subject|1
383826|NCT00846846|1289550|P1|Overall Study|Withdrawal by Subject|19
383827|NCT00846846|1289550|P1|Overall Study|Death|56
383828|NCT00846807|1289555|P1|Overall Study|Other|60
383829|NCT00846807|1289555|P1|Overall Study|No prescription after hospital discharge|56
383830|NCT00846807|1289555|P1|Overall Study|Switch to other anticoagulants|89
383831|NCT00846807|1289555|P1|Overall Study|Non compliant with European label|7
383832|NCT00846807|1289555|P1|Overall Study|Withdrawal by Subject|56
383833|NCT00846807|1289555|P1|Overall Study|Lost to Follow-up|94
383834|NCT00846807|1289555|P1|Overall Study|Adverse Event|270
383835|NCT00846768|1289563|P4|Overall Study|Adverse Event|0
383836|NCT00846768|1289564|P3|Overall Study|Adverse Event|0
383837|NCT00846768|1289565|P2|Overall Study|Adverse Event|1
383838|NCT00846768|1289566|P1|Overall Study|Adverse Event|0
383839|NCT00846586|1289657|P2|Overall Study|Unsatisfactory therapeutic effect|1
383840|NCT00846586|1289658|P1|Overall Study|Unsatisfactory therapeutic effect|0
383841|NCT00846586|1289657|P2|Overall Study|Lost to Follow-up|4
383842|NCT00846586|1289658|P1|Overall Study|Lost to Follow-up|1
383843|NCT00846586|1289657|P2|Overall Study|Abnormal test procedure result(s)|0
383844|NCT00846586|1289658|P1|Overall Study|Abnormal test procedure result(s)|1
383845|NCT00846586|1289657|P2|Overall Study|Protocol deviation|6
383846|NCT00846586|1289658|P1|Overall Study|Protocol deviation|2
383847|NCT00846586|1289657|P2|Overall Study|Death|0
383848|NCT00846586|1289658|P1|Overall Study|Death|2
383849|NCT00846586|1289657|P2|Overall Study|Administrative problems|4
383850|NCT00846586|1289658|P1|Overall Study|Administrative problems|5
383851|NCT00846586|1289657|P2|Overall Study|Subject withdrew consent|10
383852|NCT00846586|1289658|P1|Overall Study|Subject withdrew consent|8
383853|NCT00846586|1289657|P2|Overall Study|Adverse Event|10
383854|NCT00846586|1289658|P1|Overall Study|Adverse Event|20
383855|NCT00846521|1289692|P1|Overall Study|Protocol Violation|1
383856|NCT00846521|1289692|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
383857|NCT00846521|1289692|P1|Overall Study|Withdrawal by Subject|5
383858|NCT00846495|1289699|P2|Overall Study|Physician Decision|0
383859|NCT00846495|1289700|P1|Overall Study|Physician Decision|1
383860|NCT00846495|1289699|P2|Overall Study|Lack of Efficacy|2
383861|NCT00846495|1289700|P1|Overall Study|Lack of Efficacy|1
383862|NCT00846495|1289699|P2|Overall Study|Adverse Event|1
383863|NCT00846495|1289700|P1|Overall Study|Adverse Event|5
383864|NCT00846495|1289699|P2|Overall Study|Lost to Follow-up|0
383865|NCT00846495|1289700|P1|Overall Study|Lost to Follow-up|1
383866|NCT00846391|1289723|P3|Overall Study|Study Terminated by Sponsor|2
383867|NCT00846391|1289724|P2|Overall Study|Study Terminated by Sponsor|2
383868|NCT00846391|1289725|P1|Overall Study|Study Terminated by Sponsor|1
383869|NCT00846391|1289723|P3|Overall Study|Physician Decision|1
383870|NCT00846391|1289724|P2|Overall Study|Physician Decision|0
383871|NCT00846391|1289725|P1|Overall Study|Physician Decision|0
383872|NCT00846365|1289736|P3|Overall Study|Other|6
383873|NCT00846365|1289737|P2|Overall Study|Other|1
383874|NCT00846365|1289738|P1|Overall Study|Other|9
383875|NCT00846365|1289736|P3|Overall Study|Lack of Efficacy|2
383876|NCT00846365|1289737|P2|Overall Study|Lack of Efficacy|1
383877|NCT00846365|1289738|P1|Overall Study|Lack of Efficacy|1
383878|NCT00846365|1289736|P3|Overall Study|Pregnancy|0
383879|NCT00846365|1289737|P2|Overall Study|Pregnancy|0
383880|NCT00846365|1289738|P1|Overall Study|Pregnancy|1
383881|NCT00846365|1289736|P3|Overall Study|Withdrawal by Subject|9
383882|NCT00846365|1289737|P2|Overall Study|Withdrawal by Subject|11
383883|NCT00846365|1289738|P1|Overall Study|Withdrawal by Subject|11
383884|NCT00846365|1289736|P3|Overall Study|Lost to Follow-up|5
383885|NCT00846365|1289737|P2|Overall Study|Lost to Follow-up|2
383886|NCT00846365|1289738|P1|Overall Study|Lost to Follow-up|8
383887|NCT00846365|1289736|P3|Overall Study|Protocol Violation|0
383888|NCT00846365|1289737|P2|Overall Study|Protocol Violation|4
383889|NCT00846365|1289738|P1|Overall Study|Protocol Violation|5
383890|NCT00846365|1289736|P3|Overall Study|Adverse Event|11
383891|NCT00846365|1289737|P2|Overall Study|Adverse Event|30
383892|NCT00846365|1289738|P1|Overall Study|Adverse Event|20
383893|NCT00846027|1289817|P1|Overall Study|Subject Not Treated|7
383894|NCT00846027|1289817|P1|Overall Study|Protocol Violation|2
383895|NCT00846027|1289817|P1|Overall Study|Investigator Discretion|29
383896|NCT00846027|1289817|P1|Overall Study|Patient Decision|7
383897|NCT00846027|1289817|P1|Overall Study|Toxicity|12
383898|NCT00846027|1289817|P1|Overall Study|Disease Progression|30
383899|NCT00846027|1289817|P1|Overall Study|Death|3
383900|NCT00845897|1289840|P3|Overall Study|Too ill to participate|0
383901|NCT00845897|1289841|P2|Overall Study|Too ill to participate|1
383902|NCT00845897|1289842|P1|Overall Study|Too ill to participate|0
383903|NCT00845897|1289840|P3|Overall Study|Ulcer did not heal|1
383904|NCT00845897|1289841|P2|Overall Study|Ulcer did not heal|0
383905|NCT00845897|1289842|P1|Overall Study|Ulcer did not heal|1
383906|NCT00845897|1289840|P3|Overall Study|Withdrawal by Subject|2
383907|NCT00845897|1289841|P2|Overall Study|Withdrawal by Subject|3
383908|NCT00845897|1289842|P1|Overall Study|Withdrawal by Subject|0
383909|NCT00845897|1289840|P3|Overall Study|Lost to Follow-up|0
383910|NCT00845897|1289841|P2|Overall Study|Lost to Follow-up|1
383911|NCT00845897|1289842|P1|Overall Study|Lost to Follow-up|1
383912|NCT00845858|1289856|P3|Overall Study|not eligible|2
383913|NCT00845858|1289857|P2|Overall Study|not eligible|3
383914|NCT00845858|1289858|P1|Overall Study|not eligible|0
383915|NCT00845858|1289856|P3|Overall Study|Protocol Violation|1
383916|NCT00845858|1289857|P2|Overall Study|Protocol Violation|0
383917|NCT00845858|1289858|P1|Overall Study|Protocol Violation|0
383918|NCT00845858|1289856|P3|Overall Study|Adverse Event|4
383919|NCT00845858|1289857|P2|Overall Study|Adverse Event|8
383920|NCT00845858|1289858|P1|Overall Study|Adverse Event|3
383921|NCT00845858|1289856|P3|Overall Study|Withdrawal by Subject|1
383922|NCT00845858|1289857|P2|Overall Study|Withdrawal by Subject|1
383923|NCT00845858|1289858|P1|Overall Study|Withdrawal by Subject|5
383924|NCT00845845|1289871|P2|Overall Study|Lost to Follow-up|4
383925|NCT00845845|1289872|P1|Overall Study|Lost to Follow-up|0
383926|NCT00845832|1289883|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
383927|NCT00845832|1289884|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
383928|NCT00845832|1289885|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
383929|NCT00845832|1289883|P3|Safety Follow-Up|Withdrawal by Subject|0
383930|NCT00845832|1289884|P2|Safety Follow-Up|Withdrawal by Subject|0
383931|NCT00845832|1289885|P1|Safety Follow-Up|Withdrawal by Subject|1
383932|NCT00845832|1289883|P3|Treatment Period|Protocol Violation|0
383933|NCT00845832|1289884|P2|Treatment Period|Protocol Violation|1
383934|NCT00845832|1289885|P1|Treatment Period|Protocol Violation|1
383935|NCT00845832|1289883|P3|Treatment Period|Adverse Event|0
383936|NCT00845832|1289884|P2|Treatment Period|Adverse Event|2
383937|NCT00845832|1289885|P1|Treatment Period|Adverse Event|0
383938|NCT00845728|1289931|P2|Overall Study|Withdrawal by Subject|108
383939|NCT00845728|1289932|P1|Overall Study|Withdrawal by Subject|105
383940|NCT00845728|1289931|P2|Overall Study|Adverse Event|96
383941|NCT00845728|1289932|P1|Overall Study|Adverse Event|101
383942|NCT00845728|1289931|P2|Overall Study|Lack of Efficacy|39
383943|NCT00845728|1289932|P1|Overall Study|Lack of Efficacy|51
383944|NCT00845728|1289931|P2|Overall Study|Protocol Violation|24
383945|NCT00845728|1289932|P1|Overall Study|Protocol Violation|36
383946|NCT00845728|1289931|P2|Overall Study|Administrative Problems|26
383947|NCT00845728|1289932|P1|Overall Study|Administrative Problems|34
383948|NCT00845728|1289931|P2|Overall Study|Death|26
383949|NCT00845728|1289932|P1|Overall Study|Death|24
383950|NCT00845728|1289931|P2|Overall Study|Lost to Follow-up|13
383951|NCT00845728|1289932|P1|Overall Study|Lost to Follow-up|22
383952|NCT00845728|1289931|P2|Overall Study|Abnormal test procedure result (s)|2
383953|NCT00845728|1289932|P1|Overall Study|Abnormal test procedure result (s)|7
383954|NCT00845728|1289931|P2|Overall Study|Patient's inability to use the device|6
383955|NCT00845728|1289932|P1|Overall Study|Patient's inability to use the device|4
383956|NCT00845728|1289931|P2|Overall Study|Abnormal laboratory value (s)|2
383957|NCT00845728|1289932|P1|Overall Study|Abnormal laboratory value (s)|2
383958|NCT00845676|1289946|P1|Overall Study|Adverse Event|1
383959|NCT00845676|1289946|P1|Overall Study|Virologic breakthrough at week 20|1
383960|NCT00845650|1290007|P6|Overall Study|Unable to access IV line|0
383961|NCT00845650|1290008|P5|Overall Study|Unable to access IV line|0
383962|NCT00845650|1290009|P4|Overall Study|Unable to access IV line|0
383963|NCT00845650|1290010|P3|Overall Study|Unable to access IV line|0
383964|NCT00845650|1290011|P2|Overall Study|Unable to access IV line|0
383965|NCT00845650|1290012|P1|Overall Study|Unable to access IV line|1
383966|NCT00845650|1290007|P6|Overall Study|Sponsor hold on dosing|1
383967|NCT00845650|1290008|P5|Overall Study|Sponsor hold on dosing|1
383968|NCT00845650|1290009|P4|Overall Study|Sponsor hold on dosing|0
383969|NCT00845650|1290010|P3|Overall Study|Sponsor hold on dosing|0
383970|NCT00845650|1290011|P2|Overall Study|Sponsor hold on dosing|0
383971|NCT00845650|1290012|P1|Overall Study|Sponsor hold on dosing|0
383972|NCT00845650|1290007|P6|Overall Study|Lost to Follow-up|1
383973|NCT00845650|1290008|P5|Overall Study|Lost to Follow-up|0
383974|NCT00845650|1290009|P4|Overall Study|Lost to Follow-up|1
383975|NCT00845650|1290010|P3|Overall Study|Lost to Follow-up|3
383976|NCT00845650|1290011|P2|Overall Study|Lost to Follow-up|0
383977|NCT00845650|1290012|P1|Overall Study|Lost to Follow-up|0
383978|NCT00845650|1290007|P6|Overall Study|Withdrawal by Subject|0
383979|NCT00845650|1290008|P5|Overall Study|Withdrawal by Subject|2
383980|NCT00845650|1290009|P4|Overall Study|Withdrawal by Subject|0
383981|NCT00845650|1290010|P3|Overall Study|Withdrawal by Subject|0
383982|NCT00845650|1290011|P2|Overall Study|Withdrawal by Subject|0
383983|NCT00845650|1290012|P1|Overall Study|Withdrawal by Subject|0
383984|NCT00845429|1290070|P3|Overall Study|Serious adverse event|1
383985|NCT00845429|1290071|P2|Overall Study|Serious adverse event|0
383986|NCT00845429|1290072|P1|Overall Study|Serious adverse event|0
383987|NCT00845429|1290070|P3|Overall Study|Withdrawal by Subject|2
383988|NCT00845429|1290071|P2|Overall Study|Withdrawal by Subject|2
383989|NCT00845429|1290072|P1|Overall Study|Withdrawal by Subject|2
383990|NCT00845429|1290070|P3|Overall Study|Lost to Follow-up|10
383991|NCT00845429|1290071|P2|Overall Study|Lost to Follow-up|9
383992|NCT00845429|1290072|P1|Overall Study|Lost to Follow-up|7
383993|NCT00845429|1290070|P3|Overall Study|Protocol Violation|7
383994|NCT00845429|1290071|P2|Overall Study|Protocol Violation|4
383995|NCT00845429|1290072|P1|Overall Study|Protocol Violation|5
383996|NCT00845182|1290107|P3|Overall Study|Physician Decision|1
383997|NCT00845182|1290108|P2|Overall Study|Physician Decision|0
383998|NCT00845182|1290109|P1|Overall Study|Physician Decision|0
383999|NCT00845182|1290107|P3|Overall Study|Adverse Event|1
384000|NCT00845182|1290108|P2|Overall Study|Adverse Event|1
384001|NCT00845182|1290109|P1|Overall Study|Adverse Event|0
384002|NCT00845182|1290107|P3|Overall Study|Lost to Follow-up|4
384003|NCT00845182|1290108|P2|Overall Study|Lost to Follow-up|3
384004|NCT00845182|1290109|P1|Overall Study|Lost to Follow-up|3
384005|NCT00845065|1290134|P2|Overall Study|Non-Medical Reasons|11
384006|NCT00845065|1290135|P1|Overall Study|Non-Medical Reasons|1
384007|NCT00845065|1290134|P2|Overall Study|Lack of Efficacy|21
384008|NCT00845065|1290135|P1|Overall Study|Lack of Efficacy|43
384009|NCT00845065|1290134|P2|Overall Study|Adverse Event|23
384010|NCT00845065|1290135|P1|Overall Study|Adverse Event|3
384011|NCT00844896|1290203|P2|Overall Study|Parents did not have time to complete|1
384012|NCT00844896|1290204|P1|Overall Study|Parents did not have time to complete|0
384013|NCT00844896|1290203|P2|Overall Study|Lost to Follow-up|16
384014|NCT00844896|1290204|P1|Overall Study|Lost to Follow-up|12
384015|NCT00844883|1290226|P1|Overall Study|Bridged to resection|1
384016|NCT00844883|1290226|P1|Overall Study|Bridged to liver transplant|3
384017|NCT00844857|1290238|P2|Overall Study|Good Clinical Practice Violations|11
384018|NCT00844857|1290239|P1|Overall Study|Good Clinical Practice Violations|21
384019|NCT00844857|1290238|P2|Overall Study|Did Not Take Study Drug|1
384020|NCT00844857|1290239|P1|Overall Study|Did Not Take Study Drug|3
384021|NCT00844857|1290238|P2|Overall Study|Lost to Follow-up|3
384022|NCT00844857|1290239|P1|Overall Study|Lost to Follow-up|2
384023|NCT00844857|1290238|P2|Overall Study|Entry Criteria Not Met|1
384024|NCT00844857|1290239|P1|Overall Study|Entry Criteria Not Met|0
384025|NCT00844857|1290238|P2|Overall Study|Clinical Relapse|1
384026|NCT00844857|1290239|P1|Overall Study|Clinical Relapse|0
384027|NCT00844857|1290238|P2|Overall Study|Lack of Efficacy|5
384028|NCT00844857|1290239|P1|Overall Study|Lack of Efficacy|5
384029|NCT00844857|1290238|P2|Overall Study|Protocol Violation|0
384030|NCT00844857|1290239|P1|Overall Study|Protocol Violation|6
384031|NCT00844857|1290238|P2|Overall Study|Withdrawal by Subject|7
384032|NCT00844857|1290239|P1|Overall Study|Withdrawal by Subject|8
384033|NCT00844857|1290238|P2|Overall Study|Parent/Caregiver Decision|2
384034|NCT00844857|1290239|P1|Overall Study|Parent/Caregiver Decision|6
384035|NCT00844857|1290238|P2|Overall Study|Physician Decision|0
384036|NCT00844857|1290239|P1|Overall Study|Physician Decision|2
384037|NCT00844857|1290238|P2|Overall Study|Sponsor Decision|1
384038|NCT00844857|1290239|P1|Overall Study|Sponsor Decision|1
384039|NCT00844857|1290238|P2|Overall Study|Adverse Event|5
384040|NCT00844857|1290239|P1|Overall Study|Adverse Event|24
384041|NCT00844844|1290283|P1|Post Treatment Period|Withdrawal by Subject|1
384042|NCT00844844|1290283|P1|Extension Treatment Period|Adverse Event|2
384043|NCT00844844|1290283|P1|Treatment Period (26 Weeks)|Protocol Violation|1
384044|NCT00844844|1290283|P1|Treatment Period (26 Weeks)|Adverse Event|1
384045|NCT00844831|1290297|P1|Overall Study|Physician Decision|1
384046|NCT00844831|1290297|P1|Overall Study|Adverse Event|1
384047|NCT00844831|1290297|P1|Overall Study|Withdrawal by Subject|4
384048|NCT00844805|1290307|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
384049|NCT00844805|1290308|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
384050|NCT00844805|1290309|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
384051|NCT00844805|1290310|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
384052|NCT00844805|1290307|P4|Follow-Up Phase|Relapse/Recurrence|4
384053|NCT00844805|1290308|P3|Follow-Up Phase|Relapse/Recurrence|2
384054|NCT00844805|1290309|P2|Follow-Up Phase|Relapse/Recurrence|0
384055|NCT00844805|1290310|P1|Follow-Up Phase|Relapse/Recurrence|0
384056|NCT00844805|1290307|P4|Follow-Up Phase|Noncompliance With Protocol|1
384057|NCT00844805|1290308|P3|Follow-Up Phase|Noncompliance With Protocol|0
384058|NCT00844805|1290309|P2|Follow-Up Phase|Noncompliance With Protocol|0
384059|NCT00844805|1290310|P1|Follow-Up Phase|Noncompliance With Protocol|0
384060|NCT00844805|1290307|P4|Follow-Up Phase|Withdrawal by Subject|3
384061|NCT00844805|1290308|P3|Follow-Up Phase|Withdrawal by Subject|6
384062|NCT00844805|1290309|P2|Follow-Up Phase|Withdrawal by Subject|0
384063|NCT00844805|1290310|P1|Follow-Up Phase|Withdrawal by Subject|0
384064|NCT00844805|1290307|P4|Follow-Up Phase|Adverse Event|0
384065|NCT00844805|1290308|P3|Follow-Up Phase|Adverse Event|1
384066|NCT00844805|1290309|P2|Follow-Up Phase|Adverse Event|0
384067|NCT00844805|1290310|P1|Follow-Up Phase|Adverse Event|0
384068|NCT00844805|1290307|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
384069|NCT00844805|1290308|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
384070|NCT00844805|1290309|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
384071|NCT00844805|1290310|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
384072|NCT00844805|1290307|P4|Treatment Phase|Noncompliance With Protocol|0
384073|NCT00844805|1290308|P3|Treatment Phase|Noncompliance With Protocol|0
384074|NCT00844805|1290309|P2|Treatment Phase|Noncompliance With Protocol|0
384075|NCT00844805|1290310|P1|Treatment Phase|Noncompliance With Protocol|1
384076|NCT00844805|1290307|P4|Treatment Phase|Withdrawal by Subject|0
384077|NCT00844805|1290308|P3|Treatment Phase|Withdrawal by Subject|0
384078|NCT00844805|1290309|P2|Treatment Phase|Withdrawal by Subject|4
384079|NCT00844805|1290310|P1|Treatment Phase|Withdrawal by Subject|3
384080|NCT00844805|1290307|P4|Treatment Phase|Adverse Event|0
384081|NCT00844805|1290308|P3|Treatment Phase|Adverse Event|0
384082|NCT00844805|1290309|P2|Treatment Phase|Adverse Event|1
384083|NCT00844805|1290310|P1|Treatment Phase|Adverse Event|5
384084|NCT00844753|1290354|P4|Overall Study|Withdrawal by Subject|3
384085|NCT00844753|1290355|P3|Overall Study|Withdrawal by Subject|0
384086|NCT00844753|1290356|P2|Overall Study|Withdrawal by Subject|0
384087|NCT00844753|1290357|P1|Overall Study|Withdrawal by Subject|1
384088|NCT00844753|1290354|P4|Overall Study|could not swallow medication|0
384089|NCT00844753|1290355|P3|Overall Study|could not swallow medication|0
384090|NCT00844753|1290356|P2|Overall Study|could not swallow medication|0
384091|NCT00844753|1290357|P1|Overall Study|could not swallow medication|2
384092|NCT00844753|1290354|P4|Overall Study|Lost to Follow-up|1
384093|NCT00844753|1290355|P3|Overall Study|Lost to Follow-up|0
384094|NCT00844753|1290356|P2|Overall Study|Lost to Follow-up|1
384095|NCT00844753|1290357|P1|Overall Study|Lost to Follow-up|1
384096|NCT00844753|1290354|P4|Overall Study|Adverse Event|5
384097|NCT00844753|1290355|P3|Overall Study|Adverse Event|5
384098|NCT00844753|1290356|P2|Overall Study|Adverse Event|2
384099|NCT00844753|1290357|P1|Overall Study|Adverse Event|3
384100|NCT00844753|1290354|P4|Overall Study|Lack of Efficacy|2
384101|NCT00844753|1290355|P3|Overall Study|Lack of Efficacy|2
384102|NCT00844753|1290356|P2|Overall Study|Lack of Efficacy|0
384103|NCT00844753|1290357|P1|Overall Study|Lack of Efficacy|1
384104|NCT00844649|1290375|P2|Overall Study|Withdrew prior to starting treatment|27
384105|NCT00844649|1290376|P1|Overall Study|Withdrew prior to starting treatment|11
384106|NCT00844649|1290375|P2|Overall Study|Other|10
384107|NCT00844649|1290376|P1|Overall Study|Other|7
384108|NCT00844649|1290375|P2|Overall Study|Withdrawal by Subject|39
384109|NCT00844649|1290376|P1|Overall Study|Withdrawal by Subject|28
384110|NCT00844649|1290375|P2|Overall Study|Protocol Violation|6
384111|NCT00844649|1290376|P1|Overall Study|Protocol Violation|10
384112|NCT00844649|1290375|P2|Overall Study|Physician Decision|18
384113|NCT00844649|1290376|P1|Overall Study|Physician Decision|25
384114|NCT00844649|1290375|P2|Overall Study|Adverse Event|73
384115|NCT00844649|1290376|P1|Overall Study|Adverse Event|128
384116|NCT00844649|1290375|P2|Overall Study|Progressive Disease|245
384117|NCT00844649|1290376|P1|Overall Study|Progressive Disease|196
384118|NCT00844597|1290400|P6|Overall Study|Adverse Event|0
384119|NCT00844597|1290401|P5|Overall Study|Adverse Event|0
384120|NCT00844597|1290402|P4|Overall Study|Adverse Event|1
384121|NCT00844597|1290403|P3|Overall Study|Adverse Event|0
384122|NCT00844597|1290404|P2|Overall Study|Adverse Event|0
384123|NCT00844597|1290405|P1|Overall Study|Adverse Event|0
384124|NCT00844558|1290425|P2|Overall Study|Physician Decision|0
384125|NCT00844558|1290426|P1|Overall Study|Physician Decision|1
384126|NCT00844558|1290425|P2|Overall Study|Lost to Follow-up|1
384127|NCT00844558|1290426|P1|Overall Study|Lost to Follow-up|0
384128|NCT00844558|1290425|P2|Overall Study|Protocol Violation|1
384129|NCT00844558|1290426|P1|Overall Study|Protocol Violation|1
384130|NCT00844558|1290425|P2|Overall Study|Death|0
384131|NCT00844558|1290426|P1|Overall Study|Death|1
384132|NCT00844558|1290425|P2|Overall Study|Withdrawal by Subject|2
384133|NCT00844558|1290426|P1|Overall Study|Withdrawal by Subject|9
384134|NCT00844545|1290442|P1|Post Treatment Period|Withdrawal by Subject|1
384135|NCT00844545|1290442|P1|Extension Treatment Period|Adverse Event|2
384136|NCT00844545|1290442|P1|Treatment Period (26 Weeks)|Protocol Violation|1
384137|NCT00844545|1290442|P1|Treatment Period (26 Weeks)|Adverse Event|1
384138|NCT00844532|1290456|P1|Overall Study|Lost to Follow-up|7
384139|NCT00844532|1290456|P1|Overall Study|Withdrawal by Subject|16
384140|NCT00844532|1290456|P1|Overall Study|Death|16
384141|NCT00844519|1290542|P2|Overall Study|Adverse Event|0
384142|NCT00844519|1290543|P1|Overall Study|Adverse Event|1
384143|NCT00844519|1290542|P2|Overall Study|Withdrawal by Subject|1
384144|NCT00844519|1290543|P1|Overall Study|Withdrawal by Subject|1
384145|NCT00844480|1290551|P2|Overall Study|Withdrawal by Subject|3
384146|NCT00844480|1290552|P1|Overall Study|Withdrawal by Subject|2
384147|NCT00844428|1290560|P1|Post Treatment Period (Patients Who Disc|Death|1
384148|NCT00844428|1290560|P1|Extension Treatment Period|Death|1
384149|NCT00844428|1290560|P1|Screening Period|Screen Failure|3
384150|NCT00844415|1290576|P1|Overall Study|Withdrawal by Subject|1
384151|NCT00844376|1290590|P2|Period 1: First Intervention|Withdrawal by Subject|0
384152|NCT00844376|1290591|P1|Period 1: First Intervention|Withdrawal by Subject|1
384153|NCT00844194|1290615|P2|Overall Study|Other reason (not specified)|0
384154|NCT00844194|1290616|P1|Overall Study|Other reason (not specified)|1
384155|NCT00844194|1290615|P2|Overall Study|Lack of Efficacy|0
384156|NCT00844194|1290616|P1|Overall Study|Lack of Efficacy|3
384157|NCT00844194|1290615|P2|Overall Study|Withdrawal by Subject|1
384158|NCT00844194|1290616|P1|Overall Study|Withdrawal by Subject|2
384159|NCT00844194|1290615|P2|Overall Study|Lost to Follow-up|1
384160|NCT00844194|1290616|P1|Overall Study|Lost to Follow-up|1
384161|NCT00844194|1290615|P2|Overall Study|Protocol Violation|1
384162|NCT00844194|1290616|P1|Overall Study|Protocol Violation|1
384163|NCT00844194|1290615|P2|Overall Study|Adverse Event|5
384164|NCT00844194|1290616|P1|Overall Study|Adverse Event|17
384165|NCT00843843|1290871|P2|Overall Study|Protocol Violation|1
384166|NCT00843843|1290872|P1|Overall Study|Protocol Violation|1
384167|NCT00843843|1290871|P2|Overall Study|Physician Decision|1
384168|NCT00843843|1290872|P1|Overall Study|Physician Decision|1
384169|NCT00843778|1290885|P1|Overall Study|Withdrawal by Subject|4
384170|NCT00843778|1290885|P1|Overall Study|Loss of efficacy|2
384171|NCT00843778|1290885|P1|Overall Study|Lack of Efficacy|14
384172|NCT00843778|1290885|P1|Overall Study|Adverse Event|15
384173|NCT00843635|1290930|P3|Overall Study|Adverse Event|0
384174|NCT00843635|1290931|P2|Overall Study|Adverse Event|2
384175|NCT00843635|1290932|P1|Overall Study|Adverse Event|2
384176|NCT00843518|1290961|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
384177|NCT00843518|1290962|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
384178|NCT00843518|1290961|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
384179|NCT00843518|1290962|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
384180|NCT00843518|1290961|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
384181|NCT00843518|1290962|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
384182|NCT00843518|1290961|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
384183|NCT00843518|1290962|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
384184|NCT00843518|1290961|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
384185|NCT00843518|1290962|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
384186|NCT00843518|1290961|P2|Period 2 (Double-blind Treatment)|Death|1
384187|NCT00843518|1290962|P1|Period 2 (Double-blind Treatment)|Death|0
384188|NCT00843518|1290961|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
384189|NCT00843518|1290962|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
384190|NCT00843492|1290992|P2|Overall Study|Deep-vein Thrombosis|0
384191|NCT00843492|1290993|P1|Overall Study|Deep-vein Thrombosis|1
384192|NCT00843492|1290992|P2|Overall Study|Visit Not Performed|0
384193|NCT00843492|1290993|P1|Overall Study|Visit Not Performed|1
384194|NCT00843492|1290992|P2|Overall Study|Orthopedic Surgery|2
384195|NCT00843492|1290993|P1|Overall Study|Orthopedic Surgery|0
384196|NCT00843492|1290992|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
384197|NCT00843492|1290993|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
384198|NCT00843492|1290992|P2|Overall Study|Immobilization Stopped|0
384199|NCT00843492|1290993|P1|Overall Study|Immobilization Stopped|1
384200|NCT00843492|1290992|P2|Overall Study|Withdrawal by Subject|4
384201|NCT00843492|1290993|P1|Overall Study|Withdrawal by Subject|0
384202|NCT00843492|1290992|P2|Overall Study|Lost to Follow-up|4
384203|NCT00843492|1290993|P1|Overall Study|Lost to Follow-up|4
384204|NCT00843492|1290992|P2|Overall Study|Adverse Event|3
384205|NCT00843492|1290993|P1|Overall Study|Adverse Event|0
384206|NCT00843284|1291064|P1|Overall Study|Death|3
384207|NCT00843284|1291064|P1|Overall Study|Withdrawal by Subject|4
384208|NCT00843284|1291064|P1|Overall Study|Other|10
384209|NCT00843284|1291064|P1|Overall Study|Lost to Follow-up|11
384210|NCT00843284|1291064|P1|Overall Study|Lack of Efficacy|5
384211|NCT00843284|1291064|P1|Overall Study|Adverse Event|39
384212|NCT00843193|1291074|P2|Overall Study|Withdrawal by Subject|3
384213|NCT00843193|1291075|P1|Overall Study|Withdrawal by Subject|3
384214|NCT00843193|1291074|P2|Overall Study|Physician Decision|1
384215|NCT00843193|1291075|P1|Overall Study|Physician Decision|0
384216|NCT00843193|1291074|P2|Overall Study|Lost to Follow-up|0
384217|NCT00843193|1291075|P1|Overall Study|Lost to Follow-up|1
384218|NCT00843193|1291074|P2|Overall Study|Protocol Violation|2
384219|NCT00843193|1291075|P1|Overall Study|Protocol Violation|1
384220|NCT00843193|1291074|P2|Overall Study|Lack of Efficacy|1
384221|NCT00843193|1291075|P1|Overall Study|Lack of Efficacy|1
384222|NCT00843193|1291074|P2|Overall Study|Adverse Event|4
384223|NCT00843193|1291075|P1|Overall Study|Adverse Event|2
384224|NCT00843167|1291126|P2|Treatment Period|Withdrawal by Subject|3
384225|NCT00843167|1291127|P1|Treatment Period|Withdrawal by Subject|2
384226|NCT00843167|1291126|P2|Treatment Period|Adverse Event|5
384227|NCT00843167|1291127|P1|Treatment Period|Adverse Event|1
384228|NCT00843115|1291140|P1|Overall Study|Syndrome De Glissement|1
384229|NCT00843115|1291140|P1|Overall Study|week 12 not done|1
384230|NCT00843115|1291140|P1|Overall Study|hospitalized due to deterioration|1
384231|NCT00843115|1291140|P1|Overall Study|patient never took the medication|1
384232|NCT00843115|1291140|P1|Overall Study|patient took for 2 days then stopped|1
384233|NCT00843115|1291140|P1|Overall Study|Family discontinued meds|1
384234|NCT00843115|1291140|P1|Overall Study|Physician Decision|1
384235|NCT00843115|1291140|P1|Overall Study|Does not meet entrance criteria|1
384236|NCT00843115|1291140|P1|Overall Study|Patient forgot to take meds|1
384237|NCT00843115|1291140|P1|Overall Study|Family does not want continuation|1
384238|NCT00843115|1291140|P1|Overall Study|Family wanted meds stopped|1
384239|NCT00843115|1291140|P1|Overall Study|Withdrawal by Subject|17
384240|NCT00843115|1291140|P1|Overall Study|Lost to Follow-up|4
384241|NCT00843115|1291140|P1|Overall Study|Adverse Event|30
384242|NCT00843115|1291140|P1|Overall Study|Death|4
384243|NCT00843024|1291196|P6|Double-blind Treatment Phase|Lack of Efficacy|0
384244|NCT00843024|1291197|P5|Double-blind Treatment Phase|Lack of Efficacy|1
384245|NCT00843024|1291198|P4|Double-blind Treatment Phase|Lack of Efficacy|0
384246|NCT00843024|1291199|P3|Double-blind Treatment Phase|Lack of Efficacy|0
384247|NCT00843024|1291200|P2|Double-blind Treatment Phase|Lack of Efficacy|0
384248|NCT00843024|1291201|P1|Double-blind Treatment Phase|Lack of Efficacy|0
384249|NCT00843024|1291196|P6|Double-blind Treatment Phase|Adverse Event|1
384250|NCT00843024|1291197|P5|Double-blind Treatment Phase|Adverse Event|1
384251|NCT00843024|1291198|P4|Double-blind Treatment Phase|Adverse Event|0
384252|NCT00843024|1291199|P3|Double-blind Treatment Phase|Adverse Event|0
384253|NCT00843024|1291200|P2|Double-blind Treatment Phase|Adverse Event|0
384254|NCT00843024|1291201|P1|Double-blind Treatment Phase|Adverse Event|0
384255|NCT00843024|1291196|P6|Double-blind Treatment Phase|Physician Decision|1
384256|NCT00843024|1291197|P5|Double-blind Treatment Phase|Physician Decision|1
384257|NCT00843024|1291198|P4|Double-blind Treatment Phase|Physician Decision|3
384258|NCT00843024|1291199|P3|Double-blind Treatment Phase|Physician Decision|0
384259|NCT00843024|1291200|P2|Double-blind Treatment Phase|Physician Decision|0
384260|NCT00843024|1291201|P1|Double-blind Treatment Phase|Physician Decision|0
384261|NCT00843024|1291196|P6|Double-blind Treatment Phase|Protocol Violation|3
384262|NCT00843024|1291197|P5|Double-blind Treatment Phase|Protocol Violation|0
384263|NCT00843024|1291198|P4|Double-blind Treatment Phase|Protocol Violation|0
384264|NCT00843024|1291199|P3|Double-blind Treatment Phase|Protocol Violation|3
384265|NCT00843024|1291200|P2|Double-blind Treatment Phase|Protocol Violation|0
384266|NCT00843024|1291201|P1|Double-blind Treatment Phase|Protocol Violation|0
384267|NCT00843024|1291196|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
384268|NCT00843024|1291197|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
384269|NCT00843024|1291198|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
384270|NCT00843024|1291199|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
384271|NCT00843024|1291200|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
384272|NCT00843024|1291201|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
384273|NCT00843024|1291196|P6|Double-blind Treatment Phase|Lost to Follow-up|4
384274|NCT00843024|1291197|P5|Double-blind Treatment Phase|Lost to Follow-up|4
384275|NCT00843024|1291198|P4|Double-blind Treatment Phase|Lost to Follow-up|4
384276|NCT00843024|1291199|P3|Double-blind Treatment Phase|Lost to Follow-up|8
384277|NCT00843024|1291200|P2|Double-blind Treatment Phase|Lost to Follow-up|0
384278|NCT00843024|1291201|P1|Double-blind Treatment Phase|Lost to Follow-up|0
384279|NCT00843024|1291196|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
384280|NCT00843024|1291197|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
384281|NCT00843024|1291198|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
384282|NCT00843024|1291199|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
384283|NCT00843024|1291200|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
384284|NCT00843024|1291201|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
384285|NCT00843024|1291196|P6|Single-blind Placebo Run-In Phase|Other|0
384286|NCT00843024|1291197|P5|Single-blind Placebo Run-In Phase|Other|0
384287|NCT00843024|1291198|P4|Single-blind Placebo Run-In Phase|Other|0
384288|NCT00843024|1291199|P3|Single-blind Placebo Run-In Phase|Other|0
384289|NCT00843024|1291200|P2|Single-blind Placebo Run-In Phase|Other|1
384290|NCT00843024|1291201|P1|Single-blind Placebo Run-In Phase|Other|0
384291|NCT00843024|1291196|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
384292|NCT00843024|1291197|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
384293|NCT00843024|1291198|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
384294|NCT00843024|1291199|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
384295|NCT00843024|1291200|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
384296|NCT00843024|1291201|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
384297|NCT00843024|1291196|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
384298|NCT00843024|1291197|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
384299|NCT00843024|1291198|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
384300|NCT00843024|1291199|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
384301|NCT00843024|1291200|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
384302|NCT00843024|1291201|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
384303|NCT00843024|1291196|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
384304|NCT00843024|1291197|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
384305|NCT00843024|1291198|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
384306|NCT00843024|1291199|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
384307|NCT00843024|1291200|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
384308|NCT00843024|1291201|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
384309|NCT00843024|1291196|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
384310|NCT00843024|1291197|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
384311|NCT00843024|1291198|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
384312|NCT00843024|1291199|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
384313|NCT00843024|1291200|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
384314|NCT00843024|1291201|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
384315|NCT00843024|1291196|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
384316|NCT00843024|1291197|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
384317|NCT00843024|1291198|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
384318|NCT00843024|1291199|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
384319|NCT00843024|1291200|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
384320|NCT00843024|1291201|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
384321|NCT00843024|1291196|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
384322|NCT00843024|1291197|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
384323|NCT00843024|1291198|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
384324|NCT00843024|1291199|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
384325|NCT00843024|1291200|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
384326|NCT00843024|1291201|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
384327|NCT00842985|1291266|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
384328|NCT00842985|1291266|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
384329|NCT00842985|1291266|P1|First Intervention|Protocol Violation|3
384330|NCT00842985|1291266|P1|First Intervention|Withdrawal by Subject|3
384331|NCT00842985|1291266|P1|Screening|Did not meet entrance requirements|27
384332|NCT00842829|1291284|P3|Continuation Period|Non-compliance to study drug|1
384333|NCT00842829|1291285|P2|Continuation Period|Non-compliance to study drug|0
384334|NCT00842829|1291286|P1|Continuation Period|Non-compliance to study drug|0
384335|NCT00842829|1291284|P3|Continuation Period|Non-compliance to study procedures|2
384336|NCT00842829|1291285|P2|Continuation Period|Non-compliance to study procedures|0
384337|NCT00842829|1291286|P1|Continuation Period|Non-compliance to study procedures|0
384338|NCT00842829|1291284|P3|Continuation Period|Not specified|7
384339|NCT00842829|1291285|P2|Continuation Period|Not specified|0
384340|NCT00842829|1291286|P1|Continuation Period|Not specified|0
384341|NCT00842829|1291284|P3|Continuation Period|Withdrawal by Subject|10
384342|NCT00842829|1291285|P2|Continuation Period|Withdrawal by Subject|0
384343|NCT00842829|1291286|P1|Continuation Period|Withdrawal by Subject|0
384344|NCT00842829|1291284|P3|Continuation Period|Unstable persistent cancer pain|3
384345|NCT00842829|1291285|P2|Continuation Period|Unstable persistent cancer pain|0
384346|NCT00842829|1291286|P1|Continuation Period|Unstable persistent cancer pain|0
384347|NCT00842829|1291284|P3|Continuation Period|Lack of Efficacy|6
384348|NCT00842829|1291285|P2|Continuation Period|Lack of Efficacy|0
384349|NCT00842829|1291286|P1|Continuation Period|Lack of Efficacy|0
384350|NCT00842829|1291284|P3|Continuation Period|Adverse Event|32
384351|NCT00842829|1291285|P2|Continuation Period|Adverse Event|0
384352|NCT00842829|1291286|P1|Continuation Period|Adverse Event|0
384353|NCT00842829|1291284|P3|Treatment Period|Unclear completion status|1
384354|NCT00842829|1291285|P2|Treatment Period|Unclear completion status|0
384355|NCT00842829|1291286|P1|Treatment Period|Unclear completion status|0
384356|NCT00842829|1291284|P3|Treatment Period|Non-compliance to study procedures|4
384357|NCT00842829|1291285|P2|Treatment Period|Non-compliance to study procedures|0
384358|NCT00842829|1291286|P1|Treatment Period|Non-compliance to study procedures|0
384359|NCT00842829|1291284|P3|Treatment Period|Not specified|18
384360|NCT00842829|1291285|P2|Treatment Period|Not specified|0
384361|NCT00842829|1291286|P1|Treatment Period|Not specified|0
384362|NCT00842829|1291284|P3|Treatment Period|Protocol Violation|2
384363|NCT00842829|1291285|P2|Treatment Period|Protocol Violation|0
384364|NCT00842829|1291286|P1|Treatment Period|Protocol Violation|0
384365|NCT00842829|1291284|P3|Treatment Period|Consistently >4 BTP episodes daily|1
384366|NCT00842829|1291285|P2|Treatment Period|Consistently >4 BTP episodes daily|0
384367|NCT00842829|1291286|P1|Treatment Period|Consistently >4 BTP episodes daily|0
384368|NCT00842829|1291284|P3|Treatment Period|Withdrawal by Subject|11
384369|NCT00842829|1291285|P2|Treatment Period|Withdrawal by Subject|0
384370|NCT00842829|1291286|P1|Treatment Period|Withdrawal by Subject|0
384371|NCT00842829|1291284|P3|Treatment Period|Unstable persistent cancer pain|5
384372|NCT00842829|1291285|P2|Treatment Period|Unstable persistent cancer pain|0
384373|NCT00842829|1291286|P1|Treatment Period|Unstable persistent cancer pain|0
384374|NCT00842829|1291284|P3|Treatment Period|Lack of Efficacy|6
384375|NCT00842829|1291285|P2|Treatment Period|Lack of Efficacy|0
384376|NCT00842829|1291286|P1|Treatment Period|Lack of Efficacy|0
384377|NCT00842829|1291284|P3|Treatment Period|Adverse Event|15
384378|NCT00842829|1291285|P2|Treatment Period|Adverse Event|0
384379|NCT00842829|1291286|P1|Treatment Period|Adverse Event|0
384380|NCT00842829|1291284|P3|Dose Titration Period|Non-compliance to study drug|0
384381|NCT00842829|1291285|P2|Dose Titration Period|Non-compliance to study drug|1
384382|NCT00842829|1291286|P1|Dose Titration Period|Non-compliance to study drug|2
384383|NCT00842829|1291284|P3|Dose Titration Period|Non-compliance to study procedures|0
384384|NCT00842829|1291285|P2|Dose Titration Period|Non-compliance to study procedures|1
384385|NCT00842829|1291286|P1|Dose Titration Period|Non-compliance to study procedures|1
384386|NCT00842829|1291284|P3|Dose Titration Period|Not specified|0
384387|NCT00842829|1291285|P2|Dose Titration Period|Not specified|4
384388|NCT00842829|1291286|P1|Dose Titration Period|Not specified|5
384389|NCT00842829|1291284|P3|Dose Titration Period|Withdrawal by Subject|0
384390|NCT00842829|1291285|P2|Dose Titration Period|Withdrawal by Subject|6
384391|NCT00842829|1291286|P1|Dose Titration Period|Withdrawal by Subject|2
384392|NCT00842829|1291284|P3|Dose Titration Period|Unstable persistent cancer pain|0
384393|NCT00842829|1291285|P2|Dose Titration Period|Unstable persistent cancer pain|0
384394|NCT00842829|1291286|P1|Dose Titration Period|Unstable persistent cancer pain|1
384395|NCT00842829|1291284|P3|Dose Titration Period|Lack of Efficacy|0
384396|NCT00842829|1291285|P2|Dose Titration Period|Lack of Efficacy|1
384397|NCT00842829|1291286|P1|Dose Titration Period|Lack of Efficacy|4
384398|NCT00842829|1291284|P3|Dose Titration Period|Adverse Event|0
384399|NCT00842829|1291285|P2|Dose Titration Period|Adverse Event|10
384400|NCT00842829|1291286|P1|Dose Titration Period|Adverse Event|11
384401|NCT00842712|1291341|P7|Randomized Part|Ongoing at cut-off date|2
384402|NCT00842712|1291342|P6|Randomized Part|Ongoing at cut-off date|0
384403|NCT00842712|1291343|P5|Randomized Part|Ongoing at cut-off date|0
384404|NCT00842712|1291344|P4|Randomized Part|Ongoing at cut-off date|0
384405|NCT00842712|1291345|P3|Randomized Part|Ongoing at cut-off date|0
384406|NCT00842712|1291346|P2|Randomized Part|Ongoing at cut-off date|0
384407|NCT00842712|1291347|P1|Randomized Part|Ongoing at cut-off date|0
384408|NCT00842712|1291341|P7|Randomized Part|Randomized but not treated|4
384409|NCT00842712|1291342|P6|Randomized Part|Randomized but not treated|1
384410|NCT00842712|1291343|P5|Randomized Part|Randomized but not treated|0
384411|NCT00842712|1291344|P4|Randomized Part|Randomized but not treated|0
384412|NCT00842712|1291345|P3|Randomized Part|Randomized but not treated|0
384413|NCT00842712|1291346|P2|Randomized Part|Randomized but not treated|0
384414|NCT00842712|1291347|P1|Randomized Part|Randomized but not treated|0
384415|NCT00842712|1291341|P7|Safety Run-in Part|Progressive disease|0
384416|NCT00842712|1291342|P6|Safety Run-in Part|Progressive disease|0
384417|NCT00842712|1291343|P5|Safety Run-in Part|Progressive disease|0
384418|NCT00842712|1291344|P4|Safety Run-in Part|Progressive disease|1
384419|NCT00842712|1291345|P3|Safety Run-in Part|Progressive disease|0
384420|NCT00842712|1291346|P2|Safety Run-in Part|Progressive disease|1
384421|NCT00842712|1291347|P1|Safety Run-in Part|Progressive disease|3
384422|NCT00842712|1291341|P7|Safety Run-in Part|Adverse Event|0
384423|NCT00842712|1291342|P6|Safety Run-in Part|Adverse Event|0
384424|NCT00842712|1291343|P5|Safety Run-in Part|Adverse Event|0
384425|NCT00842712|1291344|P4|Safety Run-in Part|Adverse Event|0
384426|NCT00842712|1291345|P3|Safety Run-in Part|Adverse Event|0
384427|NCT00842712|1291346|P2|Safety Run-in Part|Adverse Event|1
384428|NCT00842712|1291347|P1|Safety Run-in Part|Adverse Event|0
384429|NCT00842543|1291404|P4|Overall Study|Withdrawal by Subject|4
384430|NCT00842543|1291405|P3|Overall Study|Withdrawal by Subject|3
384431|NCT00842543|1291406|P2|Overall Study|Withdrawal by Subject|0
384432|NCT00842543|1291407|P1|Overall Study|Withdrawal by Subject|2
384433|NCT00842361|1291421|P2|Overall Study|Unclassified|2
384434|NCT00842361|1291422|P1|Overall Study|Unclassified|0
384435|NCT00842361|1291421|P2|Overall Study|Protocol Violation|0
384436|NCT00842361|1291422|P1|Overall Study|Protocol Violation|1
384437|NCT00842348|1291442|P2|Study 729|Surgical resection|0
384438|NCT00842348|1291443|P1|Study 729|Surgical resection|1
384439|NCT00842348|1291442|P2|Study 729|Sponsor's decision|0
384440|NCT00842348|1291443|P1|Study 729|Sponsor's decision|1
384441|NCT00842348|1291442|P2|Study 729|Due to non-availability of IP|1
384442|NCT00842348|1291443|P1|Study 729|Due to non-availability of IP|0
384443|NCT00842348|1291442|P2|Study 729|Due to Sponsor stopping the study|1
384444|NCT00842348|1291443|P1|Study 729|Due to Sponsor stopping the study|1
384445|NCT00842348|1291442|P2|Study 729|Withdrawal by Subject|4
384446|NCT00842348|1291443|P1|Study 729|Withdrawal by Subject|2
384447|NCT00842348|1291442|P2|Study 729|Protocol Violation|1
384448|NCT00842348|1291443|P1|Study 729|Protocol Violation|1
384449|NCT00842348|1291442|P2|Study 729|Adverse Event|1
384450|NCT00842348|1291443|P1|Study 729|Adverse Event|1
384451|NCT00842348|1291442|P2|Study 729|Disease progression/death|30
384452|NCT00842348|1291443|P1|Study 729|Disease progression/death|19
384453|NCT00842348|1291442|P2|Patients Randomised in Study 726|Did not enter Study 729|56
384454|NCT00842348|1291443|P1|Patients Randomised in Study 726|Did not enter Study 729|59
384455|NCT00842257|1291486|P1|Overall Study|Adverse Event|1
384456|NCT00842244|1291493|P1|Overall Study|Other|17
384457|NCT00842244|1291493|P1|Overall Study|Withdrawal by Subject|1
384458|NCT00842244|1291493|P1|Overall Study|Death|3
384459|NCT00842153|1291520|P2|Overall Study|Lost to Follow-up|2
384460|NCT00842153|1291521|P1|Overall Study|Lost to Follow-up|1
384461|NCT00842153|1291520|P2|Overall Study|Adverse Event|1
384462|NCT00842153|1291521|P1|Overall Study|Adverse Event|0
384463|NCT00841906|1291596|P2|Overall Study|Withdrawal by Subject|0
384464|NCT00841906|1291597|P1|Overall Study|Withdrawal by Subject|2
384465|NCT00841815|1291611|P2|Washout|Withdrawal by Subject|1
384466|NCT00841815|1291612|P1|Washout|Withdrawal by Subject|0
384467|NCT00841776|1291622|P2|Overall Study|Withdrawal by Subject|1
384468|NCT00841776|1291623|P1|Overall Study|Withdrawal by Subject|0
384469|NCT00841776|1291622|P2|Overall Study|Lost to Follow-up|1
384470|NCT00841776|1291623|P1|Overall Study|Lost to Follow-up|2
384471|NCT00841776|1291622|P2|Overall Study|Lack of Efficacy|1
384472|NCT00841776|1291623|P1|Overall Study|Lack of Efficacy|0
384473|NCT00841763|1291641|P4|Overall Study|Unable to Classify|0
384474|NCT00841763|1291642|P3|Overall Study|Unable to Classify|0
384475|NCT00841763|1291643|P2|Overall Study|Unable to Classify|1
384476|NCT00841763|1291644|P1|Overall Study|Unable to Classify|7
384477|NCT00841763|1291641|P4|Overall Study|Administrative Reasons|0
384478|NCT00841763|1291642|P3|Overall Study|Administrative Reasons|0
384479|NCT00841763|1291643|P2|Overall Study|Administrative Reasons|1
384480|NCT00841763|1291644|P1|Overall Study|Administrative Reasons|3
384481|NCT00841763|1291641|P4|Overall Study|Protocol Violation|0
384482|NCT00841763|1291642|P3|Overall Study|Protocol Violation|1
384483|NCT00841763|1291643|P2|Overall Study|Protocol Violation|3
384484|NCT00841763|1291644|P1|Overall Study|Protocol Violation|20
384485|NCT00841763|1291641|P4|Overall Study|Lost to Follow-up|0
384486|NCT00841763|1291642|P3|Overall Study|Lost to Follow-up|0
384487|NCT00841763|1291643|P2|Overall Study|Lost to Follow-up|25
384488|NCT00841763|1291644|P1|Overall Study|Lost to Follow-up|63
384489|NCT00841763|1291641|P4|Overall Study|Adverse Event|2
384490|NCT00841763|1291642|P3|Overall Study|Adverse Event|3
384491|NCT00841763|1291643|P2|Overall Study|Adverse Event|10
384492|NCT00841763|1291644|P1|Overall Study|Adverse Event|9
384493|NCT00841763|1291641|P4|Overall Study|Withdrawal by Subject|1
384494|NCT00841763|1291642|P3|Overall Study|Withdrawal by Subject|4
384495|NCT00841763|1291643|P2|Overall Study|Withdrawal by Subject|17
384496|NCT00841763|1291644|P1|Overall Study|Withdrawal by Subject|60
384497|NCT00841698|1291706|P2|First Intervention|Withdrawal by Subject|0
384498|NCT00841698|1291707|P1|First Intervention|Withdrawal by Subject|1
384499|NCT00841672|1291717|P2|Overall Study|Protocol Deviation|1
384500|NCT00841672|1291718|P1|Overall Study|Protocol Deviation|0
384501|NCT00841672|1291717|P2|Overall Study|Misrandomized|0
384502|NCT00841672|1291718|P1|Overall Study|Misrandomized|1
384503|NCT00841672|1291717|P2|Overall Study|Administrative problems|9
384504|NCT00841672|1291718|P1|Overall Study|Administrative problems|9
384505|NCT00841672|1291717|P2|Overall Study|Lost to Follow-up|1
384506|NCT00841672|1291718|P1|Overall Study|Lost to Follow-up|1
384507|NCT00841672|1291717|P2|Overall Study|Subject withdrew consent|4
384508|NCT00841672|1291718|P1|Overall Study|Subject withdrew consent|2
384509|NCT00841672|1291717|P2|Overall Study|Abnormal test procedure result(s)|1
384510|NCT00841672|1291718|P1|Overall Study|Abnormal test procedure result(s)|0
384511|NCT00841672|1291717|P2|Overall Study|Adverse Event|16
384512|NCT00841672|1291718|P1|Overall Study|Adverse Event|7
384513|NCT00841659|1291734|P2|Washout: 2 Weeks|Protocol Violation|0
384514|NCT00841659|1291735|P1|Washout: 2 Weeks|Protocol Violation|1
384515|NCT00841542|1291758|P2|Period 1|Adverse Event|0
384516|NCT00841542|1291759|P1|Period 1|Adverse Event|1
384517|NCT00841321|1291774|P2|Overall Study|Adverse Event|2
384518|NCT00841321|1291775|P1|Overall Study|Adverse Event|0
384519|NCT00841321|1291774|P2|Overall Study|Lost to Follow-up|1
384520|NCT00841321|1291775|P1|Overall Study|Lost to Follow-up|1
384521|NCT00841035|1291843|P1|Phase 1 Overall Study|Physician Decision|13
384522|NCT00840996|1291850|P2|Overall Study|Withdrawal by Subject|0
384523|NCT00840996|1291851|P1|Overall Study|Withdrawal by Subject|1
384524|NCT00840879|1291871|P2|Second Intervention|Withdrawal by Subject|0
384525|NCT00840879|1291872|P1|Second Intervention|Withdrawal by Subject|1
384526|NCT00840658|1291912|P4|Overall Study|Lost to Follow-up|1
384527|NCT00840658|1291913|P3|Overall Study|Lost to Follow-up|2
384528|NCT00840658|1291914|P2|Overall Study|Lost to Follow-up|1
384529|NCT00840658|1291915|P1|Overall Study|Lost to Follow-up|3
384530|NCT00840658|1291912|P4|Overall Study|Death|3
384531|NCT00840658|1291913|P3|Overall Study|Death|3
384532|NCT00840658|1291914|P2|Overall Study|Death|2
384533|NCT00840658|1291915|P1|Overall Study|Death|2
384534|NCT00840632|1291927|P2|Washout|Withdrawal by Subject|1
384535|NCT00840632|1291928|P1|Washout|Withdrawal by Subject|1
384536|NCT00840632|1291927|P2|First Intervention|Withdrawal by Subject|1
384537|NCT00840632|1291928|P1|First Intervention|Withdrawal by Subject|0
384538|NCT00840450|1291953|P1|Overall Study|Lack of Efficacy|2
384539|NCT00840450|1291953|P1|Overall Study|Adverse Event|1
384540|NCT00840411|1291961|P2|Washout|Withdrawal by Subject|0
384541|NCT00840411|1291962|P1|Washout|Withdrawal by Subject|1
384542|NCT00840411|1291961|P2|First Intervention|Adverse Event|0
384543|NCT00840411|1291962|P1|First Intervention|Adverse Event|1
384544|NCT00840294|1291976|P2|Overall Study|Illness|1
384545|NCT00840294|1291977|P1|Overall Study|Illness|0
384546|NCT00840294|1291976|P2|Overall Study|Protocol Violation|3
384547|NCT00840294|1291977|P1|Overall Study|Protocol Violation|1
384548|NCT00840294|1291976|P2|Overall Study|Withdrawal by Subject|1
384549|NCT00840294|1291977|P1|Overall Study|Withdrawal by Subject|2
384550|NCT00840216|1291998|P2|Washout: 7 Days|Withdrawal by Subject|0
384551|NCT00840216|1291999|P1|Washout: 7 Days|Withdrawal by Subject|1
384552|NCT00840203|1292009|P2|Washout|Protocol Violation|0
384553|NCT00840203|1292010|P1|Washout|Protocol Violation|1
384554|NCT00840203|1292009|P2|First Intervention|Protocol Violation|1
384555|NCT00840203|1292010|P1|First Intervention|Protocol Violation|1
384556|NCT00840086|1292041|P1|Overall Study|Lost to Follow-up|1
384557|NCT00840086|1292041|P1|Overall Study|Protocol Violation|2
384558|NCT00840086|1292041|P1|Overall Study|Adverse Event|1
384559|NCT00840073|1292050|P2|Second Intervention|Missed 72 hour blood draw|1
384560|NCT00840073|1292051|P1|Second Intervention|Missed 72 hour blood draw|1
384561|NCT00840060|1292065|P2|Overall Study|Change in emotional/behavioral status|1
384562|NCT00840060|1292066|P1|Overall Study|Change in emotional/behavioral status|0
384563|NCT00840060|1292065|P2|Overall Study|Withdrawal by Subject|0
384564|NCT00840060|1292066|P1|Overall Study|Withdrawal by Subject|1
384565|NCT00840034|1292076|P2|Taper Phase|Withdrawal by Subject|1
384566|NCT00840034|1292077|P1|Taper Phase|Withdrawal by Subject|1
384567|NCT00840034|1292076|P2|Taper Phase|Lost to Follow-up|1
384568|NCT00840034|1292077|P1|Taper Phase|Lost to Follow-up|1
384569|NCT00840034|1292076|P2|Taper Phase|Adverse Event|0
384570|NCT00840034|1292077|P1|Taper Phase|Adverse Event|1
384571|NCT00840034|1292076|P2|Acute Treatment Phase|Withdrawal by Subject|11
384572|NCT00840034|1292077|P1|Acute Treatment Phase|Withdrawal by Subject|6
384573|NCT00840034|1292076|P2|Acute Treatment Phase|Protocol Violation|4
384574|NCT00840034|1292077|P1|Acute Treatment Phase|Protocol Violation|2
384575|NCT00840034|1292076|P2|Acute Treatment Phase|Physician Decision|1
384576|NCT00840034|1292077|P1|Acute Treatment Phase|Physician Decision|0
384577|NCT00840034|1292076|P2|Acute Treatment Phase|Lost to Follow-up|12
384578|NCT00840034|1292077|P1|Acute Treatment Phase|Lost to Follow-up|5
384579|NCT00840034|1292076|P2|Acute Treatment Phase|Lack of Efficacy|0
384580|NCT00840034|1292077|P1|Acute Treatment Phase|Lack of Efficacy|2
384581|NCT00840034|1292076|P2|Acute Treatment Phase|Adverse Event|8
384582|NCT00840034|1292077|P1|Acute Treatment Phase|Adverse Event|6
384583|NCT00839956|1292130|P1|Overall Study|Withdrawal by Subject|3
384584|NCT00839956|1292130|P1|Overall Study|Physician Decision|1
384585|NCT00839956|1292130|P1|Overall Study|Lack of Efficacy|6
384586|NCT00839956|1292130|P1|Overall Study|Adverse Event|2
384587|NCT00839917|1292150|P2|Overall Study|Did not receive vaccine|1
384588|NCT00839917|1292151|P1|Overall Study|Did not receive vaccine|0
384589|NCT00839917|1292150|P2|Overall Study|Lost to Follow-up|0
384590|NCT00839917|1292151|P1|Overall Study|Lost to Follow-up|1
384591|NCT00839800|1292189|P2|Overall Study|Severe Non-Compliance to Protocol|7
384592|NCT00839800|1292190|P1|Overall Study|Severe Non-Compliance to Protocol|7
384593|NCT00839800|1292189|P2|Overall Study|Not Specified|14
384594|NCT00839800|1292190|P1|Overall Study|Not Specified|8
384595|NCT00839800|1292189|P2|Overall Study|Safety Reasons|1
384596|NCT00839800|1292190|P1|Overall Study|Safety Reasons|2
384597|NCT00839800|1292189|P2|Overall Study|Study-Specific Discontinuation Criteria|13
384598|NCT00839800|1292190|P1|Overall Study|Study-Specific Discontinuation Criteria|6
384599|NCT00839800|1292189|P2|Overall Study|Incorrect Enrolment|3
384600|NCT00839800|1292190|P1|Overall Study|Incorrect Enrolment|3
384601|NCT00839800|1292189|P2|Overall Study|Withdrawal by Subject|34
384602|NCT00839800|1292190|P1|Overall Study|Withdrawal by Subject|28
384603|NCT00839800|1292189|P2|Overall Study|Lost to Follow-up|26
384604|NCT00839800|1292190|P1|Overall Study|Lost to Follow-up|31
384605|NCT00839800|1292189|P2|Overall Study|Adverse Event|12
384606|NCT00839800|1292190|P1|Overall Study|Adverse Event|8
384607|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
384608|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
384609|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
384610|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
384611|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
384612|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
384613|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
384614|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
384615|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
384616|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
384617|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
384618|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
384619|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
384620|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
384621|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
384622|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
384623|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
384624|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
384625|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
384626|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
384627|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
384628|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
384629|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
384630|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
384631|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
384632|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
384633|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
384634|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
384635|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
384636|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
384637|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
384638|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
384639|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
384640|NCT00839527|1292236|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
384641|NCT00839527|1292237|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
384642|NCT00839527|1292238|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
384643|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
384644|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
384645|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
384646|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
384647|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
384648|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
384649|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
384650|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
384651|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
384652|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
384653|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
384654|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
384655|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Missing|0
384656|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Missing|1
384657|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Missing|0
384658|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
384659|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
384660|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
384661|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
384662|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
384663|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
384664|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
384665|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
384666|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
384667|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
384668|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
384669|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
384670|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
384671|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
384672|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
384673|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
384674|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
384675|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
384676|NCT00839527|1292236|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
384677|NCT00839527|1292237|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
384678|NCT00839527|1292238|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
384679|NCT00839436|1292273|P3|Overall Study|Study drug no longer available|1
384680|NCT00839436|1292274|P2|Overall Study|Study drug no longer available|0
384681|NCT00839436|1292275|P1|Overall Study|Study drug no longer available|0
384682|NCT00839436|1292273|P3|Overall Study|Withdrawal by Subject|0
384683|NCT00839436|1292274|P2|Overall Study|Withdrawal by Subject|1
384684|NCT00839436|1292275|P1|Overall Study|Withdrawal by Subject|0
384685|NCT00839436|1292273|P3|Overall Study|Developed exclusionary condition|0
384686|NCT00839436|1292274|P2|Overall Study|Developed exclusionary condition|0
384687|NCT00839436|1292275|P1|Overall Study|Developed exclusionary condition|1
384688|NCT00839423|1292287|P4|Overall Study|Administrative or other reasons|0
384689|NCT00839423|1292288|P3|Overall Study|Administrative or other reasons|1
384690|NCT00839423|1292289|P2|Overall Study|Administrative or other reasons|0
384691|NCT00839423|1292290|P1|Overall Study|Administrative or other reasons|3
384692|NCT00839423|1292287|P4|Overall Study|Lost to Follow-up|0
384693|NCT00839423|1292288|P3|Overall Study|Lost to Follow-up|1
384694|NCT00839423|1292289|P2|Overall Study|Lost to Follow-up|0
384695|NCT00839423|1292290|P1|Overall Study|Lost to Follow-up|1
384696|NCT00839423|1292287|P4|Overall Study|Withdrawal of consent|1
384697|NCT00839423|1292288|P3|Overall Study|Withdrawal of consent|4
384698|NCT00839423|1292289|P2|Overall Study|Withdrawal of consent|0
384699|NCT00839423|1292290|P1|Overall Study|Withdrawal of consent|4
384700|NCT00839423|1292287|P4|Overall Study|Protocol Violation|0
384701|NCT00839423|1292288|P3|Overall Study|Protocol Violation|2
384702|NCT00839423|1292289|P2|Overall Study|Protocol Violation|1
384703|NCT00839423|1292290|P1|Overall Study|Protocol Violation|0
384704|NCT00839423|1292287|P4|Overall Study|Non-compliance|1
384705|NCT00839423|1292288|P3|Overall Study|Non-compliance|0
384706|NCT00839423|1292289|P2|Overall Study|Non-compliance|0
384707|NCT00839423|1292290|P1|Overall Study|Non-compliance|0
384708|NCT00839423|1292287|P4|Overall Study|Lack of Efficacy|2
384709|NCT00839423|1292288|P3|Overall Study|Lack of Efficacy|3
384710|NCT00839423|1292289|P2|Overall Study|Lack of Efficacy|6
384711|NCT00839423|1292290|P1|Overall Study|Lack of Efficacy|6
384712|NCT00839423|1292287|P4|Overall Study|Adverse Event|16
384713|NCT00839423|1292288|P3|Overall Study|Adverse Event|7
384714|NCT00839423|1292289|P2|Overall Study|Adverse Event|3
384715|NCT00839423|1292290|P1|Overall Study|Adverse Event|4
384716|NCT00839332|1292331|P3|Phase 2|Lost to Follow-up|1
384717|NCT00839332|1292332|P2|Phase 2|Lost to Follow-up|0
384718|NCT00839332|1292333|P1|Phase 2|Lost to Follow-up|0
384719|NCT00839332|1292331|P3|Phase 2|Physician Decision|1
384720|NCT00839332|1292332|P2|Phase 2|Physician Decision|4
384721|NCT00839332|1292333|P1|Phase 2|Physician Decision|0
384722|NCT00839332|1292331|P3|Phase 2|Withdrawal by Subject|8
384723|NCT00839332|1292332|P2|Phase 2|Withdrawal by Subject|5
384724|NCT00839332|1292333|P1|Phase 2|Withdrawal by Subject|0
384725|NCT00839332|1292331|P3|Phase 2|Death|2
384726|NCT00839332|1292332|P2|Phase 2|Death|4
384727|NCT00839332|1292333|P1|Phase 2|Death|0
384728|NCT00839332|1292331|P3|Phase 2|Adverse Event|6
384729|NCT00839332|1292332|P2|Phase 2|Adverse Event|8
384730|NCT00839332|1292333|P1|Phase 2|Adverse Event|0
384731|NCT00839332|1292331|P3|Phase 2|Disease Progression|21
384732|NCT00839332|1292332|P2|Phase 2|Disease Progression|46
384733|NCT00839332|1292333|P1|Phase 2|Disease Progression|0
384734|NCT00839332|1292331|P3|Phase 2|Protocol Violation|0
384735|NCT00839332|1292332|P2|Phase 2|Protocol Violation|1
384736|NCT00839332|1292333|P1|Phase 2|Protocol Violation|0
384737|NCT00839332|1292331|P3|Phase 1|Physician Decision|0
384738|NCT00839332|1292332|P2|Phase 1|Physician Decision|0
384739|NCT00839332|1292333|P1|Phase 1|Physician Decision|2
384740|NCT00839332|1292331|P3|Phase 1|Withdrawal by Subject|0
384741|NCT00839332|1292332|P2|Phase 1|Withdrawal by Subject|0
384742|NCT00839332|1292333|P1|Phase 1|Withdrawal by Subject|4
384743|NCT00839332|1292331|P3|Phase 1|Adverse Event|0
384744|NCT00839332|1292332|P2|Phase 1|Adverse Event|0
384745|NCT00839332|1292333|P1|Phase 1|Adverse Event|6
384746|NCT00839332|1292331|P3|Phase 1|Disease Progression|0
384747|NCT00839332|1292332|P2|Phase 1|Disease Progression|0
384748|NCT00839332|1292333|P1|Phase 1|Disease Progression|38
384749|NCT00839306|1292394|P2|Overall Study|Not specified|18
384750|NCT00839306|1292395|P1|Overall Study|Not specified|6
384751|NCT00839306|1292394|P2|Overall Study|Lack of Efficacy|4
384752|NCT00839306|1292395|P1|Overall Study|Lack of Efficacy|5
384753|NCT00839306|1292394|P2|Overall Study|Withdrawal by Subject|7
384754|NCT00839306|1292395|P1|Overall Study|Withdrawal by Subject|5
384755|NCT00839306|1292394|P2|Overall Study|Lost to Follow-up|9
384756|NCT00839306|1292395|P1|Overall Study|Lost to Follow-up|6
384757|NCT00839306|1292394|P2|Overall Study|Adverse Event|5
384758|NCT00839306|1292395|P1|Overall Study|Adverse Event|3
384759|NCT00839098|1292493|P3|Overall Study|Withdrawal by Subject|7
384760|NCT00839098|1292494|P2|Overall Study|Withdrawal by Subject|1
384761|NCT00839098|1292495|P1|Overall Study|Withdrawal by Subject|2
384762|NCT00839072|1292521|P2|Second Intervention Period|Withdrawal by Subject|0
384763|NCT00839072|1292522|P1|Second Intervention Period|Withdrawal by Subject|1
384764|NCT00839072|1292521|P2|First Intervention Period|Adverse Event|1
384765|NCT00839072|1292522|P1|First Intervention Period|Adverse Event|1
384766|NCT00839072|1292521|P2|First Intervention Period|Withdrawal by Subject|0
384767|NCT00839072|1292522|P1|First Intervention Period|Withdrawal by Subject|1
384768|NCT00838929|1292566|P3|Overall Study|Disease progression|1
384769|NCT00838929|1292567|P2|Overall Study|Disease progression|2
384770|NCT00838929|1292568|P1|Overall Study|Disease progression|0
384771|NCT00838929|1292566|P3|Overall Study|Protocol Violation|0
384772|NCT00838929|1292567|P2|Overall Study|Protocol Violation|1
384773|NCT00838929|1292568|P1|Overall Study|Protocol Violation|0
384774|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Missing|0
384775|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Missing|3
384776|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
384777|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
384778|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
384779|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
384780|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Physician Decision|0
384781|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Physician Decision|2
384782|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
384783|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
384784|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
384785|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
384786|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
384787|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
384788|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Noncompliance|5
384789|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Noncompliance|6
384790|NCT00838916|1292576|P2|Follow-up Period (8 Weeks)|Adverse Event|5
384791|NCT00838916|1292577|P1|Follow-up Period (8 Weeks)|Adverse Event|10
384792|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Pregnancy|0
384793|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Pregnancy|2
384794|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Missing|1
384795|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Missing|3
384796|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
384797|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
384798|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Physician Decision|1
384799|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Physician Decision|6
384800|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
384801|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
384802|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
384803|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
384804|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
384805|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
384806|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Noncompliance|14
384807|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Noncompliance|21
384808|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Protocol Violation|3
384809|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Protocol Violation|12
384810|NCT00838916|1292576|P2|Treatment Period (156 Weeks)|Adverse Event|11
384811|NCT00838916|1292577|P1|Treatment Period (156 Weeks)|Adverse Event|50
384812|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Missing|1
384813|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Missing|1
384814|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Missing|2
384815|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Missing|1
384816|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
384817|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
384818|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
384819|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
384820|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
384821|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
384822|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
384823|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
384824|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
384825|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
384826|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
384827|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
384828|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
384829|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
384830|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
384831|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
384832|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Physician Decision|1
384833|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Physician Decision|1
384834|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Physician Decision|1
384835|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Physician Decision|1
384836|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
384837|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
384838|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
384839|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
384840|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
384841|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
384842|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
384843|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
384844|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
384845|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
384846|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
384847|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
384848|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Noncompliance|5
384849|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Noncompliance|5
384850|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Noncompliance|8
384851|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Noncompliance|2
384852|NCT00838903|1292606|P4|Follow-up Period (8 Weeks)|Adverse Event|1
384853|NCT00838903|1292607|P3|Follow-up Period (8 Weeks)|Adverse Event|3
384854|NCT00838903|1292608|P2|Follow-up Period (8 Weeks)|Adverse Event|0
384855|NCT00838903|1292609|P1|Follow-up Period (8 Weeks)|Adverse Event|0
384856|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
384857|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
384858|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
384859|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
384860|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
384861|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
384862|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
384863|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
384864|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
384865|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
384866|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
384867|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
384868|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Site closed|0
384869|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Site closed|1
384870|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Site closed|0
384871|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Site closed|0
384872|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
384873|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
384874|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
384875|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
384876|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Pregnancy|0
384877|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Pregnancy|1
384878|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Pregnancy|0
384879|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Pregnancy|0
384880|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
384881|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
384882|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
384883|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
384884|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
384885|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
384886|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
384887|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
384888|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
384889|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
384890|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
384891|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
384892|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
384893|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
384894|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
384895|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
384896|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Physician Decision|2
384897|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Physician Decision|1
384898|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Physician Decision|2
384899|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Physician Decision|1
384900|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
384901|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
384902|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
384903|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
384904|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
384905|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
384906|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
384907|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
384908|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
384909|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
384910|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
384911|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
384912|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Noncompliance|6
384913|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Noncompliance|12
384914|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Noncompliance|13
384915|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Noncompliance|9
384916|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Protocol Violation|5
384917|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Protocol Violation|6
384918|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Protocol Violation|6
384919|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Protocol Violation|1
384920|NCT00838903|1292606|P4|Treatment Period (156 Weeks)|Adverse Event|25
384921|NCT00838903|1292607|P3|Treatment Period (156 Weeks)|Adverse Event|17
384922|NCT00838903|1292608|P2|Treatment Period (156 Weeks)|Adverse Event|13
384923|NCT00838903|1292609|P1|Treatment Period (156 Weeks)|Adverse Event|5
384924|NCT00838682|1292653|P2|Overall Study|Withdrawal by Subject|1
384925|NCT00838682|1292654|P1|Overall Study|Withdrawal by Subject|0
384926|NCT00838682|1292653|P2|Overall Study|Protocol Violation|1
384927|NCT00838682|1292654|P1|Overall Study|Protocol Violation|0
384928|NCT00838682|1292653|P2|Overall Study|detection of exclusion criteria|3
384929|NCT00838682|1292654|P1|Overall Study|detection of exclusion criteria|4
384930|NCT00838682|1292653|P2|Overall Study|Lost to Follow-up|14
384931|NCT00838682|1292654|P1|Overall Study|Lost to Follow-up|21
384932|NCT00838630|1292672|P2|Washout: 7 Days|Protocol Violation|0
384933|NCT00838630|1292673|P1|Washout: 7 Days|Protocol Violation|1
384934|NCT00838630|1292672|P2|First Intervention|Adverse Event|0
384935|NCT00838630|1292673|P1|First Intervention|Adverse Event|1
384936|NCT00838578|1292681|P1|Overall Study|Protocol Violation|2
384937|NCT00838539|1292701|P12|Overall Study|Symptomatic Deterioration|0
384938|NCT00838539|1292702|P11|Overall Study|Symptomatic Deterioration|0
384939|NCT00838539|1292703|P10|Overall Study|Symptomatic Deterioration|1
384940|NCT00838539|1292704|P9|Overall Study|Symptomatic Deterioration|0
384941|NCT00838539|1292705|P8|Overall Study|Symptomatic Deterioration|0
384942|NCT00838539|1292706|P7|Overall Study|Symptomatic Deterioration|0
384943|NCT00838539|1292707|P6|Overall Study|Symptomatic Deterioration|1
384944|NCT00838539|1292708|P5|Overall Study|Symptomatic Deterioration|0
384945|NCT00838539|1292709|P4|Overall Study|Symptomatic Deterioration|1
384946|NCT00838539|1292710|P3|Overall Study|Symptomatic Deterioration|1
384947|NCT00838539|1292711|P2|Overall Study|Symptomatic Deterioration|0
384948|NCT00838539|1292712|P1|Overall Study|Symptomatic Deterioration|0
384949|NCT00838539|1292701|P12|Overall Study|Clinical Progression|0
384950|NCT00838539|1292702|P11|Overall Study|Clinical Progression|0
384951|NCT00838539|1292703|P10|Overall Study|Clinical Progression|0
384952|NCT00838539|1292704|P9|Overall Study|Clinical Progression|0
384953|NCT00838539|1292705|P8|Overall Study|Clinical Progression|0
384954|NCT00838539|1292706|P7|Overall Study|Clinical Progression|1
384955|NCT00838539|1292707|P6|Overall Study|Clinical Progression|0
384956|NCT00838539|1292708|P5|Overall Study|Clinical Progression|0
384957|NCT00838539|1292709|P4|Overall Study|Clinical Progression|0
384958|NCT00838539|1292710|P3|Overall Study|Clinical Progression|0
384959|NCT00838539|1292711|P2|Overall Study|Clinical Progression|0
384960|NCT00838539|1292712|P1|Overall Study|Clinical Progression|0
384961|NCT00838539|1292701|P12|Overall Study|Physician Decision|0
384962|NCT00838539|1292702|P11|Overall Study|Physician Decision|0
384963|NCT00838539|1292703|P10|Overall Study|Physician Decision|0
384964|NCT00838539|1292704|P9|Overall Study|Physician Decision|1
384965|NCT00838539|1292705|P8|Overall Study|Physician Decision|0
384966|NCT00838539|1292706|P7|Overall Study|Physician Decision|0
384967|NCT00838539|1292707|P6|Overall Study|Physician Decision|0
384968|NCT00838539|1292708|P5|Overall Study|Physician Decision|0
384969|NCT00838539|1292709|P4|Overall Study|Physician Decision|0
384970|NCT00838539|1292710|P3|Overall Study|Physician Decision|0
384971|NCT00838539|1292711|P2|Overall Study|Physician Decision|0
384972|NCT00838539|1292712|P1|Overall Study|Physician Decision|0
384973|NCT00838539|1292701|P12|Overall Study|Death|0
384974|NCT00838539|1292702|P11|Overall Study|Death|0
384975|NCT00838539|1292703|P10|Overall Study|Death|0
384976|NCT00838539|1292704|P9|Overall Study|Death|0
384977|NCT00838539|1292705|P8|Overall Study|Death|0
384978|NCT00838539|1292706|P7|Overall Study|Death|1
384979|NCT00838539|1292707|P6|Overall Study|Death|0
384980|NCT00838539|1292708|P5|Overall Study|Death|0
384981|NCT00838539|1292709|P4|Overall Study|Death|0
384982|NCT00838539|1292710|P3|Overall Study|Death|0
384983|NCT00838539|1292711|P2|Overall Study|Death|0
384984|NCT00838539|1292712|P1|Overall Study|Death|0
384985|NCT00838539|1292701|P12|Overall Study|Withdrawal by Subject|0
384986|NCT00838539|1292702|P11|Overall Study|Withdrawal by Subject|2
384987|NCT00838539|1292703|P10|Overall Study|Withdrawal by Subject|1
384988|NCT00838539|1292704|P9|Overall Study|Withdrawal by Subject|0
384989|NCT00838539|1292705|P8|Overall Study|Withdrawal by Subject|0
384990|NCT00838539|1292706|P7|Overall Study|Withdrawal by Subject|0
384991|NCT00838539|1292707|P6|Overall Study|Withdrawal by Subject|0
384992|NCT00838539|1292708|P5|Overall Study|Withdrawal by Subject|0
384993|NCT00838539|1292709|P4|Overall Study|Withdrawal by Subject|0
384994|NCT00838539|1292710|P3|Overall Study|Withdrawal by Subject|0
384995|NCT00838539|1292711|P2|Overall Study|Withdrawal by Subject|1
384996|NCT00838539|1292712|P1|Overall Study|Withdrawal by Subject|0
384997|NCT00838539|1292701|P12|Overall Study|Adverse Event|0
384998|NCT00838539|1292702|P11|Overall Study|Adverse Event|2
384999|NCT00838539|1292703|P10|Overall Study|Adverse Event|1
385000|NCT00838539|1292704|P9|Overall Study|Adverse Event|0
385001|NCT00838539|1292705|P8|Overall Study|Adverse Event|2
385002|NCT00838539|1292706|P7|Overall Study|Adverse Event|0
385003|NCT00838539|1292707|P6|Overall Study|Adverse Event|1
385004|NCT00838539|1292708|P5|Overall Study|Adverse Event|2
385005|NCT00838539|1292709|P4|Overall Study|Adverse Event|1
385006|NCT00838539|1292710|P3|Overall Study|Adverse Event|1
385007|NCT00838539|1292711|P2|Overall Study|Adverse Event|1
385008|NCT00838539|1292712|P1|Overall Study|Adverse Event|1
385009|NCT00838539|1292701|P12|Overall Study|Disease Progression|4
385010|NCT00838539|1292702|P11|Overall Study|Disease Progression|1
385011|NCT00838539|1292703|P10|Overall Study|Disease Progression|5
385012|NCT00838539|1292704|P9|Overall Study|Disease Progression|4
385013|NCT00838539|1292705|P8|Overall Study|Disease Progression|4
385014|NCT00838539|1292706|P7|Overall Study|Disease Progression|3
385015|NCT00838539|1292707|P6|Overall Study|Disease Progression|2
385016|NCT00838539|1292708|P5|Overall Study|Disease Progression|4
385017|NCT00838539|1292709|P4|Overall Study|Disease Progression|2
385018|NCT00838539|1292710|P3|Overall Study|Disease Progression|3
385019|NCT00838539|1292711|P2|Overall Study|Disease Progression|4
385020|NCT00838539|1292712|P1|Overall Study|Disease Progression|2
385021|NCT00838526|1292750|P2|Overall Study|Not specified|7
385022|NCT00838526|1292751|P1|Overall Study|Not specified|11
385023|NCT00838526|1292750|P2|Overall Study|Lack of Efficacy|3
385024|NCT00838526|1292751|P1|Overall Study|Lack of Efficacy|2
385025|NCT00838526|1292750|P2|Overall Study|Withdrawal by Subject|5
385026|NCT00838526|1292751|P1|Overall Study|Withdrawal by Subject|4
385027|NCT00838526|1292750|P2|Overall Study|Lost to Follow-up|12
385028|NCT00838526|1292751|P1|Overall Study|Lost to Follow-up|4
385029|NCT00838526|1292750|P2|Overall Study|Adverse Event|12
385030|NCT00838526|1292751|P1|Overall Study|Adverse Event|3
385031|NCT00838513|1292759|P1|Post Treatment Period (Patients Who Disc|Death|1
385032|NCT00838513|1292759|P1|Extension Treatment Period|Death|1
385033|NCT00838513|1292759|P1|Screening Period|Screen Failure|3
385034|NCT00838331|1292775|P1|Aged Blood Transfusion|Withdrawal by Subject|9
385035|NCT00838279|1292781|P2|Washout|Withdrawal by Subject|1
385036|NCT00838279|1292782|P1|Washout|Withdrawal by Subject|0
385037|NCT00838279|1292781|P2|Washout|Protocol Violation|0
385038|NCT00838279|1292782|P1|Washout|Protocol Violation|1
385039|NCT00838201|1292792|P2|Overall Study|Death|13
385040|NCT00838201|1292793|P1|Overall Study|Death|11
385041|NCT00838201|1292792|P2|Overall Study|Adverse Event|9
385042|NCT00838201|1292793|P1|Overall Study|Adverse Event|5
385043|NCT00838201|1292792|P2|Overall Study|Lost to Follow-up|3
385044|NCT00838201|1292793|P1|Overall Study|Lost to Follow-up|4
385045|NCT00838201|1292792|P2|Overall Study|Consetn withdrawn|19
385046|NCT00838201|1292793|P1|Overall Study|Consetn withdrawn|16
385047|NCT00838201|1292792|P2|Overall Study|Disease progression|3
385048|NCT00838201|1292793|P1|Overall Study|Disease progression|3
385049|NCT00838201|1292792|P2|Overall Study|Administrative decision|2
385050|NCT00838201|1292793|P1|Overall Study|Administrative decision|1
385051|NCT00838201|1292792|P2|Overall Study|Noncompliance|1
385052|NCT00838201|1292793|P1|Overall Study|Noncompliance|0
385053|NCT00838201|1292792|P2|Overall Study|Investigator decision, or other reasons|3
385054|NCT00838201|1292793|P1|Overall Study|Investigator decision, or other reasons|2
385055|NCT00838110|1292861|P4|Overall Study|Randomized but not treated|0
385056|NCT00838110|1292862|P3|Overall Study|Randomized but not treated|0
385057|NCT00838110|1292863|P2|Overall Study|Randomized but not treated|1
385058|NCT00838110|1292864|P1|Overall Study|Randomized but not treated|0
385059|NCT00838110|1292861|P4|Overall Study|Did not meet eligibility criteria|2
385060|NCT00838110|1292862|P3|Overall Study|Did not meet eligibility criteria|1
385061|NCT00838110|1292863|P2|Overall Study|Did not meet eligibility criteria|0
385062|NCT00838110|1292864|P1|Overall Study|Did not meet eligibility criteria|0
385063|NCT00838110|1292861|P4|Overall Study|Lost to Follow-up|0
385064|NCT00838110|1292862|P3|Overall Study|Lost to Follow-up|0
385065|NCT00838110|1292863|P2|Overall Study|Lost to Follow-up|0
385066|NCT00838110|1292864|P1|Overall Study|Lost to Follow-up|3
385067|NCT00838110|1292861|P4|Overall Study|Protocol Violation|1
385068|NCT00838110|1292862|P3|Overall Study|Protocol Violation|1
385069|NCT00838110|1292863|P2|Overall Study|Protocol Violation|2
385070|NCT00838110|1292864|P1|Overall Study|Protocol Violation|0
385071|NCT00838110|1292861|P4|Overall Study|Other|2
385072|NCT00838110|1292862|P3|Overall Study|Other|3
385073|NCT00838110|1292863|P2|Overall Study|Other|3
385074|NCT00838110|1292864|P1|Overall Study|Other|3
385075|NCT00838110|1292861|P4|Overall Study|Withdrawal by Subject|4
385076|NCT00838110|1292862|P3|Overall Study|Withdrawal by Subject|3
385077|NCT00838110|1292863|P2|Overall Study|Withdrawal by Subject|6
385078|NCT00838110|1292864|P1|Overall Study|Withdrawal by Subject|5
385079|NCT00838110|1292861|P4|Overall Study|Adverse Event|7
385080|NCT00838110|1292862|P3|Overall Study|Adverse Event|8
385081|NCT00838110|1292863|P2|Overall Study|Adverse Event|10
385082|NCT00838110|1292864|P1|Overall Study|Adverse Event|11
385083|NCT00838110|1292861|P4|Overall Study|Death|2
385084|NCT00838110|1292862|P3|Overall Study|Death|1
385085|NCT00838110|1292863|P2|Overall Study|Death|0
385086|NCT00838110|1292864|P1|Overall Study|Death|0
385087|NCT00838097|1292884|P1|Overall Study|Protocol-specified criteria|142
385088|NCT00838097|1292884|P1|Overall Study|Death|6
385089|NCT00838097|1292884|P1|Overall Study|Lost to Follow-up|11
385090|NCT00838097|1292884|P1|Overall Study|Physician Decision|4
385091|NCT00838097|1292884|P1|Overall Study|Requirement for alternative therapy|2
385092|NCT00838097|1292884|P1|Overall Study|Withdrawal by Subject|3
385093|NCT00838097|1292884|P1|Overall Study|Adverse Event|2
385094|NCT00838097|1292884|P1|Overall Study|Ineligibility determined|6
385095|NCT00837967|1292892|P2|Washout Period of 7 - 14 Days|Adverse Event|0
385096|NCT00837967|1292893|P1|Washout Period of 7 - 14 Days|Adverse Event|2
385097|NCT00837876|1292909|P1|Overall Study|disease progression|24
385098|NCT00837876|1292909|P1|Overall Study|Withdrawal by Subject|3
385099|NCT00837876|1292909|P1|Overall Study|Physician Decision|1
385100|NCT00837876|1292909|P1|Overall Study|Adverse Event|7
385101|NCT00837876|1292909|P1|Overall Study|Death|2
385102|NCT00837811|1292931|P3|Overall Study|Sponsor Decision|0
385103|NCT00837811|1292932|P2|Overall Study|Sponsor Decision|2
385104|NCT00837811|1292933|P1|Overall Study|Sponsor Decision|0
385105|NCT00837811|1292931|P3|Overall Study|Withdrawal by Subject|0
385106|NCT00837811|1292932|P2|Overall Study|Withdrawal by Subject|9
385107|NCT00837811|1292933|P1|Overall Study|Withdrawal by Subject|1
385108|NCT00837811|1292931|P3|Overall Study|Physician Decision|1
385109|NCT00837811|1292932|P2|Overall Study|Physician Decision|2
385110|NCT00837811|1292933|P1|Overall Study|Physician Decision|0
385111|NCT00837811|1292931|P3|Overall Study|Lost to Follow-up|0
385112|NCT00837811|1292932|P2|Overall Study|Lost to Follow-up|3
385113|NCT00837811|1292933|P1|Overall Study|Lost to Follow-up|1
385114|NCT00837811|1292931|P3|Overall Study|Lack of Efficacy|0
385115|NCT00837811|1292932|P2|Overall Study|Lack of Efficacy|11
385116|NCT00837811|1292933|P1|Overall Study|Lack of Efficacy|0
385117|NCT00837811|1292931|P3|Overall Study|Death|0
385118|NCT00837811|1292932|P2|Overall Study|Death|1
385119|NCT00837811|1292933|P1|Overall Study|Death|1
385120|NCT00837811|1292931|P3|Overall Study|Adverse Event|0
385121|NCT00837811|1292932|P2|Overall Study|Adverse Event|6
385122|NCT00837811|1292933|P1|Overall Study|Adverse Event|4
385123|NCT00837759|1293018|P1|Overall Study|Lost to Follow-up|1
385124|NCT00837759|1293018|P1|Overall Study|Protocol Violation|3
385125|NCT00837616|1293029|P2|Overall Study|Withdrawal by Subject|1
385126|NCT00837616|1293030|P1|Overall Study|Withdrawal by Subject|0
385127|NCT00837577|1293056|P2|Open-label Period|Other Reason|1
385128|NCT00837577|1293057|P1|Open-label Period|Other Reason|1
385129|NCT00837577|1293056|P2|Open-label Period|Withdrawal by Subject|2
385130|NCT00837577|1293057|P1|Open-label Period|Withdrawal by Subject|1
385131|NCT00837577|1293056|P2|Open-label Period|Lack of Efficacy|3
385132|NCT00837577|1293057|P1|Open-label Period|Lack of Efficacy|4
385133|NCT00837577|1293056|P2|Open-label Period|Laboratory Adverse Event|1
385134|NCT00837577|1293057|P1|Open-label Period|Laboratory Adverse Event|0
385135|NCT00837577|1293056|P2|Open-label Period|Clinical Adverse Event|2
385136|NCT00837577|1293057|P1|Open-label Period|Clinical Adverse Event|2
385137|NCT00837577|1293056|P2|Double-blind Period|Withdrawal by Subject|0
385138|NCT00837577|1293057|P1|Double-blind Period|Withdrawal by Subject|1
385139|NCT00837577|1293056|P2|Double-blind Period|Clinical Adverse Event|0
385140|NCT00837577|1293057|P1|Double-blind Period|Clinical Adverse Event|1
385141|NCT00837486|1293077|P2|Long-term Follow-up Phase - Open Label|Death|0
385142|NCT00837486|1293078|P1|Long-term Follow-up Phase - Open Label|Death|1
385143|NCT00837486|1293077|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
385144|NCT00837486|1293078|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
385145|NCT00837486|1293077|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
385146|NCT00837486|1293078|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
385147|NCT00837486|1293077|P2|Blinded-treatment Phase|Physician Decision|0
385148|NCT00837486|1293078|P1|Blinded-treatment Phase|Physician Decision|1
385149|NCT00837473|1293090|P1|Overall Study|Withdrawal by Subject|2
385150|NCT00837473|1293090|P1|Overall Study|Lost to Follow-up|1
385151|NCT00837434|1293110|P2|Overall Study|Unable to obtain study drug|0
385152|NCT00837434|1293111|P1|Overall Study|Unable to obtain study drug|1
385153|NCT00837434|1293110|P2|Overall Study|Baseline assessments not done in time|0
385154|NCT00837434|1293111|P1|Overall Study|Baseline assessments not done in time|1
385155|NCT00837434|1293110|P2|Overall Study|Noncompliant|0
385156|NCT00837434|1293111|P1|Overall Study|Noncompliant|2
385157|NCT00837434|1293110|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
385158|NCT00837434|1293111|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
385159|NCT00837434|1293110|P2|Overall Study|Lost to Follow-up|1
385160|NCT00837434|1293111|P1|Overall Study|Lost to Follow-up|1
385161|NCT00837434|1293110|P2|Overall Study|Physician Decision|0
385162|NCT00837434|1293111|P1|Overall Study|Physician Decision|3
385163|NCT00837330|1293131|P2|Overall Study|Lost to Follow-up|3
385164|NCT00837330|1293132|P1|Overall Study|Lost to Follow-up|1
385165|NCT00837213|1293155|P2|Overall Study|not stated|1
385166|NCT00837213|1293156|P1|Overall Study|not stated|1
385167|NCT00837213|1293155|P2|Overall Study|Withdrawal by Subject|2
385168|NCT00837213|1293156|P1|Overall Study|Withdrawal by Subject|2
385169|NCT00837213|1293155|P2|Overall Study|Lost to Follow-up|2
385170|NCT00837213|1293156|P1|Overall Study|Lost to Follow-up|3
385171|NCT00837161|1293182|P1|Overall Study|refused hysterectomy|2
385172|NCT00837148|1293190|P1|Overall Study|Death|1
385173|NCT00837148|1293190|P1|Overall Study|Adverse Event|1
385174|NCT00836953|1293200|P1|Overall Study|Lost to Follow-up|1
385175|NCT00836953|1293200|P1|Overall Study|Withdrawal by Subject|1
385176|NCT00836927|1293211|P5|Overall Study|Withdrawal by Subject|0
385177|NCT00836927|1293212|P4|Overall Study|Withdrawal by Subject|0
385178|NCT00836927|1293213|P3|Overall Study|Withdrawal by Subject|0
385179|NCT00836927|1293214|P2|Overall Study|Withdrawal by Subject|0
385180|NCT00836927|1293215|P1|Overall Study|Withdrawal by Subject|1
385181|NCT00836927|1293211|P5|Overall Study|Study drug terminated by sponsor|0
385182|NCT00836927|1293212|P4|Overall Study|Study drug terminated by sponsor|0
385183|NCT00836927|1293213|P3|Overall Study|Study drug terminated by sponsor|1
385184|NCT00836927|1293214|P2|Overall Study|Study drug terminated by sponsor|1
385185|NCT00836927|1293215|P1|Overall Study|Study drug terminated by sponsor|0
385186|NCT00836927|1293211|P5|Overall Study|Progressive disease|1
385187|NCT00836927|1293212|P4|Overall Study|Progressive disease|1
385188|NCT00836927|1293213|P3|Overall Study|Progressive disease|0
385189|NCT00836927|1293214|P2|Overall Study|Progressive disease|0
385190|NCT00836927|1293215|P1|Overall Study|Progressive disease|2
385191|NCT00836901|1293249|P2|First Intervention|Withdrawal by Subject|0
385192|NCT00836901|1293250|P1|First Intervention|Withdrawal by Subject|1
385193|NCT00836875|1293266|P2|Overall Study|Withdrawal by Subject|1
385194|NCT00836875|1293267|P1|Overall Study|Withdrawal by Subject|0
385195|NCT00836875|1293266|P2|Overall Study|Death|2
385196|NCT00836875|1293267|P1|Overall Study|Death|3
385197|NCT00836810|1293283|P2|Overall Study|New diagnosis|0
385198|NCT00836810|1293284|P1|Overall Study|New diagnosis|1
385199|NCT00836745|1293300|P1|Overall Study|Other|2
385200|NCT00836745|1293300|P1|Overall Study|Objective progression or relapse|4
385201|NCT00836745|1293300|P1|Overall Study|Adverse Event|3
385202|NCT00836745|1293300|P1|Overall Study|Lost to Follow-up|10
385203|NCT00836745|1293300|P1|Overall Study|Death|2
385204|NCT00836706|1293314|P2|Washout: 7 Days|Withdrawal by Subject|1
385205|NCT00836706|1293315|P1|Washout: 7 Days|Withdrawal by Subject|0
385206|NCT00836693|1293325|P2|Overall Study|Lost to Follow-up|0
385207|NCT00836693|1293326|P1|Overall Study|Lost to Follow-up|1
385208|NCT00836693|1293325|P2|Overall Study|Protocol Violation|0
385209|NCT00836693|1293326|P1|Overall Study|Protocol Violation|1
385210|NCT00836693|1293325|P2|Overall Study|Withdrawal by Subject|4
385211|NCT00836693|1293326|P1|Overall Study|Withdrawal by Subject|9
385212|NCT00836693|1293325|P2|Overall Study|Physician Decision|0
385213|NCT00836693|1293326|P1|Overall Study|Physician Decision|2
385214|NCT00836693|1293325|P2|Overall Study|Sponsor Decision|1
385215|NCT00836693|1293326|P1|Overall Study|Sponsor Decision|0
385216|NCT00836693|1293325|P2|Overall Study|Adverse Event|1
385217|NCT00836693|1293326|P1|Overall Study|Adverse Event|4
385218|NCT00836498|1293378|P2|Overall Study|Withdrawal by Subject|1
385219|NCT00836498|1293379|P1|Overall Study|Withdrawal by Subject|2
385220|NCT00836498|1293378|P2|Overall Study|Lost to Follow-up|0
385221|NCT00836498|1293379|P1|Overall Study|Lost to Follow-up|1
385222|NCT00836498|1293378|P2|Overall Study|Adverse Event|0
385223|NCT00836498|1293379|P1|Overall Study|Adverse Event|1
385224|NCT00836472|1293411|P2|Washout|Withdrawal by Subject|1
385225|NCT00836472|1293412|P1|Washout|Withdrawal by Subject|1
385226|NCT00836472|1293411|P2|Washout|Adverse Event|2
385227|NCT00836472|1293412|P1|Washout|Adverse Event|1
385228|NCT00836277|1293489|P1|Overall Study|Not evaluable for response|6
385229|NCT00836095|1293499|P2|Overall Study|Physician Decision|3
385230|NCT00836095|1293500|P1|Overall Study|Physician Decision|0
385231|NCT00836056|1293510|P2|First Intervention|Adverse Event|0
385232|NCT00836056|1293511|P1|First Intervention|Adverse Event|1
385233|NCT00835991|1293540|P2|Washout|Withdrawal by Subject|1
385234|NCT00835991|1293541|P1|Washout|Withdrawal by Subject|3
385235|NCT00835991|1293540|P2|Washout|Protocol Violation|2
385236|NCT00835991|1293541|P1|Washout|Protocol Violation|0
385237|NCT00835991|1293540|P2|First Intervention|Adverse Event|1
385238|NCT00835991|1293541|P1|First Intervention|Adverse Event|0
385239|NCT00835978|1293559|P4|Overall Study|Study terminated by sponsor|0
385240|NCT00835978|1293560|P3|Overall Study|Study terminated by sponsor|30
385241|NCT00835978|1293561|P2|Overall Study|Study terminated by sponsor|8
385242|NCT00835978|1293562|P1|Overall Study|Study terminated by sponsor|12
385243|NCT00835978|1293559|P4|Overall Study|Withdrawal by Subject|5
385244|NCT00835978|1293560|P3|Overall Study|Withdrawal by Subject|0
385245|NCT00835978|1293561|P2|Overall Study|Withdrawal by Subject|3
385246|NCT00835978|1293562|P1|Overall Study|Withdrawal by Subject|0
385247|NCT00835978|1293559|P4|Overall Study|Adverse Event|0
385248|NCT00835978|1293560|P3|Overall Study|Adverse Event|1
385249|NCT00835978|1293561|P2|Overall Study|Adverse Event|0
385250|NCT00835978|1293562|P1|Overall Study|Adverse Event|1
385251|NCT00835978|1293559|P4|Overall Study|Objective progression or relapse|0
385252|NCT00835978|1293560|P3|Overall Study|Objective progression or relapse|1
385253|NCT00835978|1293561|P2|Overall Study|Objective progression or relapse|0
385254|NCT00835978|1293562|P1|Overall Study|Objective progression or relapse|2
385255|NCT00835978|1293559|P4|Overall Study|Not Specified|0
385256|NCT00835978|1293560|P3|Overall Study|Not Specified|8
385257|NCT00835978|1293561|P2|Overall Study|Not Specified|1
385258|NCT00835978|1293562|P1|Overall Study|Not Specified|5
385259|NCT00835978|1293559|P4|Overall Study|Lost to Follow-up|1
385260|NCT00835978|1293560|P3|Overall Study|Lost to Follow-up|2
385261|NCT00835978|1293561|P2|Overall Study|Lost to Follow-up|4
385262|NCT00835978|1293562|P1|Overall Study|Lost to Follow-up|3
385263|NCT00835978|1293559|P4|Overall Study|Death|4
385264|NCT00835978|1293560|P3|Overall Study|Death|49
385265|NCT00835978|1293561|P2|Overall Study|Death|40
385266|NCT00835978|1293562|P1|Overall Study|Death|33
385267|NCT00835796|1293673|P2|First Intervention|Withdrawal by Subject|1
385268|NCT00835796|1293674|P1|First Intervention|Withdrawal by Subject|0
385269|NCT00835731|1293684|P2|Overall Study|Physician Decision|1
385270|NCT00835731|1293685|P1|Overall Study|Physician Decision|1
385271|NCT00835731|1293684|P2|Overall Study|Withdrawal by Subject|0
385272|NCT00835731|1293685|P1|Overall Study|Withdrawal by Subject|1
385273|NCT00835705|1293705|P2|Second Intervention|Difficulty with vein|0
385274|NCT00835705|1293706|P1|Second Intervention|Difficulty with vein|1
385275|NCT00835705|1293705|P2|First Intervention|Difficulty with vein|0
385276|NCT00835705|1293706|P1|First Intervention|Difficulty with vein|1
385277|NCT00835692|1293722|P2|First Intervention|Withdrawal by Subject|0
385278|NCT00835692|1293723|P1|First Intervention|Withdrawal by Subject|1
385279|NCT00835679|1293735|P4|Overall Study|Withdrawal by Subject|0
385280|NCT00835679|1293736|P3|Overall Study|Withdrawal by Subject|0
385281|NCT00835679|1293737|P2|Overall Study|Withdrawal by Subject|0
385282|NCT00835679|1293738|P1|Overall Study|Withdrawal by Subject|1
385283|NCT00835666|1293762|P2|Washout|Withdrawal by Subject|0
385284|NCT00835666|1293763|P1|Washout|Withdrawal by Subject|1
385285|NCT00835666|1293762|P2|Washout|Protocol Violation|0
385286|NCT00835666|1293763|P1|Washout|Protocol Violation|1
385287|NCT00835640|1293773|P2|Second Intervention|Protocol Violation|0
385288|NCT00835640|1293774|P1|Second Intervention|Protocol Violation|1
385289|NCT00835575|1293806|P2|Washout of 14 Days|Withdrawal by Subject|0
385290|NCT00835575|1293807|P1|Washout of 14 Days|Withdrawal by Subject|1
385291|NCT00835549|1293817|P2|Washout of 7 Days|Withdrawal by Subject|0
385292|NCT00835549|1293818|P1|Washout of 7 Days|Withdrawal by Subject|2
385293|NCT00835536|1293828|P2|Washout of 5 Weeks|Withdrawal by Subject|0
385294|NCT00835536|1293829|P1|Washout of 5 Weeks|Withdrawal by Subject|1
385295|NCT00835406|1293890|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
385296|NCT00835406|1293891|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
385297|NCT00835406|1293890|P2|Period: First Intervention|Withdrawal by Subject|0
385298|NCT00835406|1293891|P1|Period: First Intervention|Withdrawal by Subject|2
385299|NCT00835406|1293890|P2|Period: First Intervention|Adverse Event|1
385300|NCT00835406|1293891|P1|Period: First Intervention|Adverse Event|0
385301|NCT00835380|1293897|P1|Overall Study|Withdrawal by Subject|2
385302|NCT00835367|1293904|P2|Second Intervention|Adverse Event|1
385303|NCT00835367|1293905|P1|Second Intervention|Adverse Event|1
385304|NCT00835367|1293904|P2|Washout|Withdrawal by Subject|0
385305|NCT00835367|1293905|P1|Washout|Withdrawal by Subject|1
385306|NCT00835367|1293904|P2|Washout|Adverse Event|0
385307|NCT00835367|1293905|P1|Washout|Adverse Event|2
385308|NCT00835354|1293927|P2|First Intervention|Adverse Event|1
385309|NCT00835354|1293928|P1|First Intervention|Adverse Event|0
385310|NCT00835341|1293938|P2|Overall Study|Lost to Follow-up|12
385311|NCT00835341|1293939|P1|Overall Study|Lost to Follow-up|3
385312|NCT00835263|1293958|P2|Second Intervention|Adverse Event|0
385313|NCT00835263|1293959|P1|Second Intervention|Adverse Event|1
385314|NCT00835237|1293969|P2|Overall Study|Withdrawal by Subject|0
385315|NCT00835237|1293970|P1|Overall Study|Withdrawal by Subject|2
385316|NCT00835237|1293969|P2|Overall Study|Lost to Follow-up|0
385317|NCT00835237|1293970|P1|Overall Study|Lost to Follow-up|4
385318|NCT00835211|1294010|P2|Washout: 7 Days|Withdrawal by Subject|0
385319|NCT00835211|1294011|P1|Washout: 7 Days|Withdrawal by Subject|1
385320|NCT00835211|1294010|P2|Washout: 7 Days|Adverse Event|1
385321|NCT00835211|1294011|P1|Washout: 7 Days|Adverse Event|2
385322|NCT00835211|1294010|P2|First Intervention|Withdrawal by Subject|1
385323|NCT00835211|1294011|P1|First Intervention|Withdrawal by Subject|0
385324|NCT00835172|1294057|P2|Washout|Protocol Violation|1
385325|NCT00835172|1294058|P1|Washout|Protocol Violation|0
385326|NCT00835120|1294084|P1|Overall Study|Withdrawal by Subject|2
385327|NCT00835120|1294084|P1|Overall Study|Adverse Event|2
385328|NCT00835120|1294084|P1|Overall Study|Lost to Follow-up|3
385329|NCT00835120|1294084|P1|Overall Study|Lack of Efficacy|1
385330|NCT00835081|1294094|P2|Washout of 7 Days|Withdrawal by Subject|0
385331|NCT00835081|1294095|P1|Washout of 7 Days|Withdrawal by Subject|1
385332|NCT00835068|1294105|P2|Overall Study|Withdrawal by Subject|0
385333|NCT00835068|1294106|P1|Overall Study|Withdrawal by Subject|1
385334|NCT00835068|1294105|P2|Overall Study|Other|0
385335|NCT00835068|1294106|P1|Overall Study|Other|8
385336|NCT00835068|1294105|P2|Overall Study|Adverse Event|1
385337|NCT00835068|1294106|P1|Overall Study|Adverse Event|0
385338|NCT00835068|1294105|P2|Overall Study|Death|0
385339|NCT00835068|1294106|P1|Overall Study|Death|1
385340|NCT00835042|1294126|P2|Washout of 21 Days|Withdrawal by Subject|2
385341|NCT00835042|1294127|P1|Washout of 21 Days|Withdrawal by Subject|0
385342|NCT00835042|1294126|P2|First Intervention|Adverse Event|2
385343|NCT00835042|1294127|P1|First Intervention|Adverse Event|1
385344|NCT00835042|1294126|P2|First Intervention|Withdrawal by Subject|0
385345|NCT00835042|1294127|P1|First Intervention|Withdrawal by Subject|3
385346|NCT00834912|1294213|P6|Treatment Period 2|Withdrawal by Subject|0
385347|NCT00834912|1294214|P5|Treatment Period 2|Withdrawal by Subject|1
385348|NCT00834912|1294215|P4|Treatment Period 2|Withdrawal by Subject|0
385349|NCT00834912|1294216|P3|Treatment Period 2|Withdrawal by Subject|1
385350|NCT00834912|1294217|P2|Treatment Period 2|Withdrawal by Subject|0
385351|NCT00834912|1294218|P1|Treatment Period 2|Withdrawal by Subject|0
385352|NCT00834912|1294213|P6|Treatment Period 1|Adverse Event|0
385353|NCT00834912|1294214|P5|Treatment Period 1|Adverse Event|0
385354|NCT00834912|1294215|P4|Treatment Period 1|Adverse Event|1
385355|NCT00834912|1294216|P3|Treatment Period 1|Adverse Event|0
385356|NCT00834912|1294217|P2|Treatment Period 1|Adverse Event|1
385357|NCT00834912|1294218|P1|Treatment Period 1|Adverse Event|0
385358|NCT00834899|1294240|P2|Overall Study|Withdrawal by Subject|1
385359|NCT00834899|1294241|P1|Overall Study|Withdrawal by Subject|1
385360|NCT00834873|1294280|P2|First Intervention|Adverse Event|1
385361|NCT00834873|1294281|P1|First Intervention|Adverse Event|0
385362|NCT00834834|1294291|P2|Overall Study|Withdrawal by Subject|3
385363|NCT00834834|1294292|P1|Overall Study|Withdrawal by Subject|4
385364|NCT00834795|1294327|P2|Second Intervention|Adverse Event|0
385365|NCT00834795|1294328|P1|Second Intervention|Adverse Event|1
385366|NCT00834795|1294327|P2|Washout: 7 Days|Withdrawal by Subject|1
385367|NCT00834795|1294328|P1|Washout: 7 Days|Withdrawal by Subject|0
385368|NCT00834756|1294338|P2|Washout: 21 Days|Withdrawal by Subject|0
385369|NCT00834756|1294339|P1|Washout: 21 Days|Withdrawal by Subject|1
385370|NCT00834756|1294338|P2|First Intervention|Adverse Event|0
385371|NCT00834756|1294339|P1|First Intervention|Adverse Event|1
385372|NCT00834743|1294349|P2|Second Intervention|Withdrawal by Subject|0
385373|NCT00834743|1294350|P1|Second Intervention|Withdrawal by Subject|1
385374|NCT00834717|1294360|P2|First Intervention|Withdrawal by Subject|1
385375|NCT00834717|1294361|P1|First Intervention|Withdrawal by Subject|0
385376|NCT00834717|1294360|P2|First Intervention|Adverse Event|0
385377|NCT00834717|1294361|P1|First Intervention|Adverse Event|1
385378|NCT00834639|1294392|P2|Second Intervention|Physician Decision|2
385379|NCT00834639|1294393|P1|Second Intervention|Physician Decision|0
385380|NCT00834613|1294410|P2|First Intervention|Protocol Violation|0
385381|NCT00834613|1294411|P1|First Intervention|Protocol Violation|1
385382|NCT00834587|1294421|P2|Washout: 7 Days|Withdrawal by Subject|0
385383|NCT00834587|1294422|P1|Washout: 7 Days|Withdrawal by Subject|1
385384|NCT00834522|1294471|P2|Washout|Withdrawal by Subject|1
385385|NCT00834522|1294472|P1|Washout|Withdrawal by Subject|2
385386|NCT00834522|1294471|P2|Washout|Adverse Event|0
385387|NCT00834522|1294472|P1|Washout|Adverse Event|1
385388|NCT00834444|1294495|P2|Second Intervention|Adverse Event|0
385389|NCT00834444|1294496|P1|Second Intervention|Adverse Event|1
385390|NCT00834444|1294495|P2|Washout of 7 Days|Withdrawal by Subject|1
385391|NCT00834444|1294496|P1|Washout of 7 Days|Withdrawal by Subject|0
385392|NCT00834444|1294495|P2|First Intervention|Intolerance to Venopuncture|1
385393|NCT00834444|1294496|P1|First Intervention|Intolerance to Venopuncture|0
385394|NCT00834444|1294495|P2|First Intervention|Adverse Event|0
385395|NCT00834444|1294496|P1|First Intervention|Adverse Event|1
385396|NCT00834431|1294506|P2|Washout of 7 Days|Withdrawal by Subject|1
385397|NCT00834431|1294507|P1|Washout of 7 Days|Withdrawal by Subject|0
385398|NCT00834431|1294506|P2|First Intervention|Adverse Event|1
385399|NCT00834431|1294507|P1|First Intervention|Adverse Event|0
385400|NCT00834418|1294517|P2|Overall Study|Adverse Event|2
385401|NCT00834418|1294518|P1|Overall Study|Adverse Event|0
385402|NCT00834366|1294535|P2|Treatment Period 1|Adverse Event|1
385403|NCT00834366|1294536|P1|Treatment Period 1|Adverse Event|1
385404|NCT00834340|1294552|P2|Washout|Withdrawal by Subject|0
385405|NCT00834340|1294553|P1|Washout|Withdrawal by Subject|1
385406|NCT00834340|1294552|P2|Washout|Adverse Event|0
385407|NCT00834340|1294553|P1|Washout|Adverse Event|1
385408|NCT00834249|1294597|P2|Second Intervention|Adverse Event|0
385409|NCT00834249|1294598|P1|Second Intervention|Adverse Event|1
385410|NCT00834249|1294597|P2|Washout: 7 Days|Withdrawal by Subject|1
385411|NCT00834249|1294598|P1|Washout: 7 Days|Withdrawal by Subject|1
385412|NCT00834080|1294694|P1|Overall Study|Subject Relocated|1
385413|NCT00834080|1294694|P1|Overall Study|Physician Decision|1
385414|NCT00834080|1294694|P1|Overall Study|Other - False positive tests of the UDS|1
385415|NCT00834080|1294694|P1|Overall Study|Other - Pregnancy|1
385416|NCT00834080|1294694|P1|Overall Study|Withdrawal by Subject|5
385417|NCT00834080|1294694|P1|Overall Study|Lost to Follow-up|7
385418|NCT00834080|1294694|P1|Overall Study|Adverse Event|7
385419|NCT00834067|1294700|P2|Washout of 21 Days|Protocol Violation|1
385420|NCT00834067|1294701|P1|Washout of 21 Days|Protocol Violation|0
385421|NCT00834041|1294723|P2|Overall Study|Lost to Follow-up|1
385422|NCT00834041|1294724|P1|Overall Study|Lost to Follow-up|0
385423|NCT00834041|1294723|P2|Overall Study|Withdrawal by Subject|0
385424|NCT00834041|1294724|P1|Overall Study|Withdrawal by Subject|1
385425|NCT00833989|1294742|P4|Overall Study|Withdrawal by Subject|1
385426|NCT00833989|1294743|P3|Overall Study|Withdrawal by Subject|1
385427|NCT00833989|1294744|P2|Overall Study|Withdrawal by Subject|0
385428|NCT00833989|1294745|P1|Overall Study|Withdrawal by Subject|3
385429|NCT00833989|1294742|P4|Overall Study|Physician Decision|1
385430|NCT00833989|1294743|P3|Overall Study|Physician Decision|0
385431|NCT00833989|1294744|P2|Overall Study|Physician Decision|0
385432|NCT00833989|1294745|P1|Overall Study|Physician Decision|0
385433|NCT00833976|1294849|P1|Overall Study|Physician Decision|1
385434|NCT00833976|1294849|P1|Overall Study|Did not meet eligibility criteria|41
385435|NCT00833976|1294849|P1|Overall Study|Lost to Follow-up|4
385436|NCT00833976|1294849|P1|Overall Study|Withdrawal by Subject|5
385437|NCT00833937|1294857|P2|Washout|Withdrawal by Subject|0
385438|NCT00833937|1294858|P1|Washout|Withdrawal by Subject|1
385439|NCT00833924|1294866|P1|Overall Study|In study follow-up|71
385440|NCT00833924|1294866|P1|Overall Study|Withdrawal by Subject|13
385441|NCT00833924|1294866|P1|Overall Study|Lost to Follow-up|2
385442|NCT00833924|1294866|P1|Overall Study|Conversion|2
385443|NCT00833924|1294866|P1|Overall Study|Death|21
385444|NCT00833911|1294871|P1|Maintenance Phase II|Lack of Efficacy|1
385445|NCT00833911|1294871|P1|Maintenance Phase II|Withdrawal by Subject|1
385446|NCT00833911|1294871|P1|Maintenance Phase II|Physician Decision|2
385447|NCT00833911|1294871|P1|Maintenance Phase II|Adverse Event|6
385448|NCT00833911|1294871|P1|Maintenance Phase I|Lack of Efficacy|4
385449|NCT00833911|1294871|P1|Maintenance Phase I|Physician Decision|10
385450|NCT00833911|1294871|P1|Maintenance Phase I|Withdrawal by Subject|11
385451|NCT00833911|1294871|P1|Maintenance Phase I|Adverse Event|73
385452|NCT00833911|1294871|P1|Titration|Withdrawal by Subject|3
385453|NCT00833911|1294871|P1|Titration|Adverse Event|18
385454|NCT00833898|1294881|P2|Overall Study|Patient did not receive transplant|2
385455|NCT00833898|1294882|P1|Overall Study|Patient did not receive transplant|0
385456|NCT00833898|1294881|P2|Overall Study|Lost to Follow-up|7
385457|NCT00833898|1294882|P1|Overall Study|Lost to Follow-up|7
385458|NCT00833898|1294881|P2|Overall Study|Withdrawal by Subject|27
385459|NCT00833898|1294882|P1|Overall Study|Withdrawal by Subject|33
385460|NCT00833833|1294941|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
385461|NCT00833833|1294942|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
385462|NCT00833833|1294943|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
385463|NCT00833833|1294944|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
385464|NCT00833833|1294945|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
385465|NCT00833833|1294946|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
385466|NCT00833833|1294941|P6|Phase 2 (as of 01 April 2011)|Other|3
385467|NCT00833833|1294942|P5|Phase 2 (as of 01 April 2011)|Other|4
385468|NCT00833833|1294943|P4|Phase 2 (as of 01 April 2011)|Other|0
385469|NCT00833833|1294944|P3|Phase 2 (as of 01 April 2011)|Other|0
385470|NCT00833833|1294945|P2|Phase 2 (as of 01 April 2011)|Other|0
385471|NCT00833833|1294946|P1|Phase 2 (as of 01 April 2011)|Other|0
385472|NCT00833833|1294941|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
385473|NCT00833833|1294942|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
385474|NCT00833833|1294943|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
385475|NCT00833833|1294944|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
385476|NCT00833833|1294945|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
385477|NCT00833833|1294946|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
385478|NCT00833833|1294941|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
385479|NCT00833833|1294942|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
385480|NCT00833833|1294943|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
385481|NCT00833833|1294944|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
385482|NCT00833833|1294945|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
385483|NCT00833833|1294946|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
385484|NCT00833833|1294941|P6|Phase 2 (as of 01 April 2011)|Death|9
385485|NCT00833833|1294942|P5|Phase 2 (as of 01 April 2011)|Death|8
385486|NCT00833833|1294943|P4|Phase 2 (as of 01 April 2011)|Death|0
385487|NCT00833833|1294944|P3|Phase 2 (as of 01 April 2011)|Death|0
385488|NCT00833833|1294945|P2|Phase 2 (as of 01 April 2011)|Death|0
385489|NCT00833833|1294946|P1|Phase 2 (as of 01 April 2011)|Death|0
385490|NCT00833833|1294941|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
385491|NCT00833833|1294942|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
385492|NCT00833833|1294943|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
385493|NCT00833833|1294944|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
385494|NCT00833833|1294945|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
385495|NCT00833833|1294946|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
385496|NCT00833833|1294941|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
385497|NCT00833833|1294942|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
385498|NCT00833833|1294943|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
385499|NCT00833833|1294944|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
385500|NCT00833833|1294945|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
385501|NCT00833833|1294946|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
385502|NCT00833833|1294941|P6|Phase 1 (as of 01 April 2011)|Other|0
385503|NCT00833833|1294942|P5|Phase 1 (as of 01 April 2011)|Other|0
385504|NCT00833833|1294943|P4|Phase 1 (as of 01 April 2011)|Other|1
385505|NCT00833833|1294944|P3|Phase 1 (as of 01 April 2011)|Other|0
385506|NCT00833833|1294945|P2|Phase 1 (as of 01 April 2011)|Other|3
385507|NCT00833833|1294946|P1|Phase 1 (as of 01 April 2011)|Other|1
385508|NCT00833833|1294941|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
385509|NCT00833833|1294942|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
385510|NCT00833833|1294943|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
385511|NCT00833833|1294944|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
385512|NCT00833833|1294945|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
385513|NCT00833833|1294946|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
385514|NCT00833833|1294941|P6|Phase 1 (as of 01 April 2011)|Death|0
385515|NCT00833833|1294942|P5|Phase 1 (as of 01 April 2011)|Death|0
385516|NCT00833833|1294943|P4|Phase 1 (as of 01 April 2011)|Death|0
385517|NCT00833833|1294944|P3|Phase 1 (as of 01 April 2011)|Death|2
385518|NCT00833833|1294945|P2|Phase 1 (as of 01 April 2011)|Death|1
385519|NCT00833833|1294946|P1|Phase 1 (as of 01 April 2011)|Death|0
385520|NCT00833833|1294941|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
385521|NCT00833833|1294942|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
385522|NCT00833833|1294943|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
385523|NCT00833833|1294944|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
385524|NCT00833833|1294945|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
385525|NCT00833833|1294946|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
385526|NCT00833833|1294941|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
385527|NCT00833833|1294942|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
385528|NCT00833833|1294943|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
385529|NCT00833833|1294944|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
385530|NCT00833833|1294945|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
385531|NCT00833833|1294946|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
385532|NCT00833833|1294941|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
385533|NCT00833833|1294942|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
385534|NCT00833833|1294943|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
385535|NCT00833833|1294944|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
385536|NCT00833833|1294945|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
385537|NCT00833833|1294946|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
385538|NCT00833794|1294986|P2|Double-blind Phase|Administrative reason|3
385539|NCT00833794|1294987|P1|Double-blind Phase|Administrative reason|1
385540|NCT00833794|1294986|P2|Double-blind Phase|Physician Decision|7
385541|NCT00833794|1294987|P1|Double-blind Phase|Physician Decision|4
385542|NCT00833794|1294986|P2|Double-blind Phase|Withdrawal by Subject|6
385543|NCT00833794|1294987|P1|Double-blind Phase|Withdrawal by Subject|23
385544|NCT00833794|1294986|P2|Double-blind Phase|Lack of Efficacy|22
385545|NCT00833794|1294987|P1|Double-blind Phase|Lack of Efficacy|34
385546|NCT00833794|1294986|P2|Double-blind Phase|Adverse Event|11
385547|NCT00833794|1294987|P1|Double-blind Phase|Adverse Event|44
385548|NCT00833794|1294986|P2|Open-label Phase|enrolled in error (immediately D/C)|0
385549|NCT00833794|1294987|P1|Open-label Phase|enrolled in error (immediately D/C)|1
385550|NCT00833794|1294986|P2|Open-label Phase|Did not complete wash-out period|0
385551|NCT00833794|1294987|P1|Open-label Phase|Did not complete wash-out period|12
385552|NCT00833794|1294986|P2|Open-label Phase|Protocol Violation|0
385553|NCT00833794|1294987|P1|Open-label Phase|Protocol Violation|47
385554|NCT00833794|1294986|P2|Open-label Phase|Administrative reason|0
385555|NCT00833794|1294987|P1|Open-label Phase|Administrative reason|1
385556|NCT00833794|1294986|P2|Open-label Phase|Physician Decision|0
385557|NCT00833794|1294987|P1|Open-label Phase|Physician Decision|20
385558|NCT00833794|1294986|P2|Open-label Phase|Withdrawal by Subject|0
385559|NCT00833794|1294987|P1|Open-label Phase|Withdrawal by Subject|48
385560|NCT00833794|1294986|P2|Open-label Phase|Lack of Efficacy|0
385561|NCT00833794|1294987|P1|Open-label Phase|Lack of Efficacy|28
385562|NCT00833794|1294986|P2|Open-label Phase|Adverse Event|0
385563|NCT00833794|1294987|P1|Open-label Phase|Adverse Event|225
385564|NCT00833755|1295031|P4|Overall Study|Subject had scheduling issues|0
385565|NCT00833755|1295032|P3|Overall Study|Subject had scheduling issues|0
385566|NCT00833755|1295033|P2|Overall Study|Subject had scheduling issues|1
385567|NCT00833755|1295034|P1|Overall Study|Subject had scheduling issues|0
385568|NCT00833755|1295031|P4|Overall Study|Physician Decision|6
385569|NCT00833755|1295032|P3|Overall Study|Physician Decision|2
385570|NCT00833755|1295033|P2|Overall Study|Physician Decision|4
385571|NCT00833755|1295034|P1|Overall Study|Physician Decision|4
385572|NCT00833703|1295054|P2|Overall Study|Parent(s)/guardian(s)'s request|1
385573|NCT00833703|1295055|P1|Overall Study|Parent(s)/guardian(s)'s request|0
385574|NCT00833690|1295068|P3|Overall Study|Discontinued study drug|0
385575|NCT00833690|1295069|P2|Overall Study|Discontinued study drug|2
385576|NCT00833690|1295070|P1|Overall Study|Discontinued study drug|3
385577|NCT00833690|1295068|P3|Overall Study|Withdrawal by Subject|0
385578|NCT00833690|1295069|P2|Overall Study|Withdrawal by Subject|0
385579|NCT00833690|1295070|P1|Overall Study|Withdrawal by Subject|1
385580|NCT00833638|1295206|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
385581|NCT00833638|1295207|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
385582|NCT00833638|1295208|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
385583|NCT00833638|1295206|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
385584|NCT00833638|1295207|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
385585|NCT00833638|1295208|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
385586|NCT00833638|1295206|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
385587|NCT00833638|1295207|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
385588|NCT00833638|1295208|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
385589|NCT00833638|1295206|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
385590|NCT00833638|1295207|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
385591|NCT00833638|1295208|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
385592|NCT00833638|1295206|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
385593|NCT00833638|1295207|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
385594|NCT00833638|1295208|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
385595|NCT00833638|1295206|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
385596|NCT00833638|1295207|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
385597|NCT00833638|1295208|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
385598|NCT00833638|1295206|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
385599|NCT00833638|1295207|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
385600|NCT00833638|1295208|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
385601|NCT00833638|1295206|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
385602|NCT00833638|1295207|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
385603|NCT00833638|1295208|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
385604|NCT00833638|1295206|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
385605|NCT00833638|1295207|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
385606|NCT00833638|1295208|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
385607|NCT00833560|1295259|P1|Overall Study|Not specified|5
385608|NCT00833560|1295259|P1|Overall Study|Pregression of other disease|1
385609|NCT00833560|1295259|P1|Overall Study|Death|2
385610|NCT00833560|1295259|P1|Overall Study|Lack of Efficacy|4
385611|NCT00833560|1295259|P1|Overall Study|Protocol Violation|6
385612|NCT00833560|1295259|P1|Overall Study|Adverse Event|11
385613|NCT00833560|1295259|P1|Overall Study|Toxicity|13
385614|NCT00833547|1295268|P2|Overall Study|Withdrawal by Subject|2
385615|NCT00833547|1295269|P1|Overall Study|Withdrawal by Subject|2
385616|NCT00833482|1295290|P6|Days 21-30|Withdrawal by Subject|0
385617|NCT00833482|1295291|P5|Days 21-30|Withdrawal by Subject|1
385618|NCT00833482|1295292|P4|Days 21-30|Withdrawal by Subject|0
385619|NCT00833482|1295293|P3|Days 21-30|Withdrawal by Subject|0
385620|NCT00833482|1295294|P2|Days 21-30|Withdrawal by Subject|0
385621|NCT00833482|1295295|P1|Days 21-30|Withdrawal by Subject|0
385622|NCT00833482|1295290|P6|Days 21-30|Adverse Event|0
385623|NCT00833482|1295291|P5|Days 21-30|Adverse Event|0
385624|NCT00833482|1295292|P4|Days 21-30|Adverse Event|0
385625|NCT00833482|1295293|P3|Days 21-30|Adverse Event|1
385626|NCT00833482|1295294|P2|Days 21-30|Adverse Event|0
385627|NCT00833482|1295295|P1|Days 21-30|Adverse Event|0
385628|NCT00833482|1295290|P6|Days 11-20|Withdrawal by Subject|0
385629|NCT00833482|1295291|P5|Days 11-20|Withdrawal by Subject|0
385630|NCT00833482|1295292|P4|Days 11-20|Withdrawal by Subject|0
385631|NCT00833482|1295293|P3|Days 11-20|Withdrawal by Subject|0
385632|NCT00833482|1295294|P2|Days 11-20|Withdrawal by Subject|1
385633|NCT00833482|1295295|P1|Days 11-20|Withdrawal by Subject|0
385634|NCT00833482|1295290|P6|Days 11-20|Adverse Event|0
385635|NCT00833482|1295291|P5|Days 11-20|Adverse Event|0
385636|NCT00833482|1295292|P4|Days 11-20|Adverse Event|0
385637|NCT00833482|1295293|P3|Days 11-20|Adverse Event|0
385638|NCT00833482|1295294|P2|Days 11-20|Adverse Event|2
385639|NCT00833482|1295295|P1|Days 11-20|Adverse Event|0
385640|NCT00833469|1295351|P1|Overall Study|Lost to Follow-up|1
385641|NCT00833469|1295351|P1|Overall Study|Withdrawal by Subject|1
385642|NCT00833417|1295374|P2|Overall Study|Reason Not Specified|1
385643|NCT00833417|1295375|P1|Overall Study|Reason Not Specified|0
385644|NCT00833417|1295374|P2|Overall Study|Disease Progression|17
385645|NCT00833417|1295375|P1|Overall Study|Disease Progression|18
385646|NCT00833417|1295374|P2|Overall Study|Sponsor Decision to Terminate Study|2
385647|NCT00833417|1295375|P1|Overall Study|Sponsor Decision to Terminate Study|1
385648|NCT00833417|1295374|P2|Overall Study|Patient Decision to Withdraw|23
385649|NCT00833417|1295375|P1|Overall Study|Patient Decision to Withdraw|4
385650|NCT00833417|1295374|P2|Overall Study|Physician Decision to Withdraw Patient|7
385651|NCT00833417|1295375|P1|Overall Study|Physician Decision to Withdraw Patient|3
385652|NCT00833417|1295374|P2|Overall Study|Lost to Follow-up|2
385653|NCT00833417|1295375|P1|Overall Study|Lost to Follow-up|1
385654|NCT00833417|1295374|P2|Overall Study|Death|3
385655|NCT00833417|1295375|P1|Overall Study|Death|1
385656|NCT00833417|1295374|P2|Overall Study|Adverse Event|16
385657|NCT00833417|1295375|P1|Overall Study|Adverse Event|5
385658|NCT00833248|1295401|P2|Overall Study|Withdrawal by Subject|1
385659|NCT00833248|1295402|P1|Overall Study|Withdrawal by Subject|0
385660|NCT00833248|1295401|P2|Overall Study|Protocol Violation|2
385661|NCT00833248|1295402|P1|Overall Study|Protocol Violation|1
385662|NCT00833248|1295401|P2|Overall Study|Adverse Event|0
385663|NCT00833248|1295402|P1|Overall Study|Adverse Event|3
385664|NCT00833092|1295426|P2|Overall Study|constipation|1
385665|NCT00833092|1295427|P1|Overall Study|constipation|0
385666|NCT00833092|1295426|P2|Overall Study|Diarrhea|2
385667|NCT00833092|1295427|P1|Overall Study|Diarrhea|0
385668|NCT00833092|1295426|P2|Overall Study|Protocol Violation|1
385669|NCT00833092|1295427|P1|Overall Study|Protocol Violation|2
385670|NCT00833092|1295426|P2|Overall Study|Withdrawal by Subject|3
385671|NCT00833092|1295427|P1|Overall Study|Withdrawal by Subject|2
385672|NCT00833053|1295435|P2|Overall Study|Protocol Violation|1
385673|NCT00833053|1295436|P1|Overall Study|Protocol Violation|2
385674|NCT00833053|1295435|P2|Overall Study|Withdrawal by Subject|1
385675|NCT00833053|1295436|P1|Overall Study|Withdrawal by Subject|0
385676|NCT00833053|1295435|P2|Overall Study|Treatment Failure|1
385677|NCT00833053|1295436|P1|Overall Study|Treatment Failure|3
385678|NCT00833053|1295435|P2|Overall Study|Adverse Event|0
385679|NCT00833053|1295436|P1|Overall Study|Adverse Event|4
385680|NCT00833040|1295454|P6|Overall Study|Adverse Event|1
385681|NCT00833040|1295455|P5|Overall Study|Adverse Event|0
385682|NCT00833040|1295456|P4|Overall Study|Adverse Event|0
385683|NCT00833040|1295457|P3|Overall Study|Adverse Event|0
385684|NCT00833040|1295458|P2|Overall Study|Adverse Event|0
385685|NCT00833040|1295459|P1|Overall Study|Adverse Event|0
385686|NCT00833027|1295464|P1|Overall Study|Missing|10
385687|NCT00833027|1295464|P1|Overall Study|Withdrawal by Subject|16
385688|NCT00833027|1295464|P1|Overall Study|Protocol Violation|115
385689|NCT00833027|1295464|P1|Overall Study|Lost to Follow-up|24
385690|NCT00833027|1295464|P1|Overall Study|Lack of Efficacy|12
385691|NCT00833027|1295464|P1|Overall Study|Death|1
385692|NCT00833027|1295464|P1|Overall Study|Adverse Event|33
385693|NCT00832975|1295469|P1|Overall Study|Other reasons|14
385694|NCT00832975|1295469|P1|Overall Study|Withdrawal by Subject|3
385695|NCT00832975|1295469|P1|Overall Study|Physician Decision|4
385696|NCT00832975|1295469|P1|Overall Study|Death|5
385697|NCT00832975|1295469|P1|Overall Study|Protocol Violation|6
385698|NCT00832975|1295469|P1|Overall Study|Lost to Follow-up|7
385699|NCT00832819|1295483|P3|Overall Study|Protocol Violation|1
385700|NCT00832819|1295484|P2|Overall Study|Protocol Violation|0
385701|NCT00832819|1295485|P1|Overall Study|Protocol Violation|0
385702|NCT00832819|1295483|P3|Overall Study|Adverse Event|0
385703|NCT00832819|1295484|P2|Overall Study|Adverse Event|1
385704|NCT00832819|1295485|P1|Overall Study|Adverse Event|0
385705|NCT00832780|1295491|P1|Overall Study|Physician Decision|1
385706|NCT00832780|1295491|P1|Overall Study|other complicating condition|2
385707|NCT00832780|1295491|P1|Overall Study|no reason given|2
385708|NCT00832780|1295491|P1|Overall Study|Lost to Follow-up|4
385709|NCT00832780|1295491|P1|Overall Study|Death|16
385710|NCT00832650|1295533|P3|Overall Study|Randomized but not treated|1
385711|NCT00832650|1295534|P2|Overall Study|Randomized but not treated|0
385712|NCT00832650|1295535|P1|Overall Study|Randomized but not treated|0
385713|NCT00832624|1295575|P1|Overall Study|Study Terminated|10
385714|NCT00832585|1295585|P1|Overall Study|Lost to Follow-up|1
385715|NCT00832585|1295585|P1|Overall Study|Withdrawal by Subject|1
385716|NCT00832455|1295610|P1|Overall Study|Patient moved|1
385717|NCT00832455|1295610|P1|Overall Study|No improvement|3
385718|NCT00832455|1295610|P1|Overall Study|Parent dissatisfied|1
385719|NCT00832455|1295610|P1|Overall Study|Parent misunderstood study|1
385720|NCT00832455|1295610|P1|Overall Study|Stopped Medication|4
385721|NCT00832455|1295610|P1|Overall Study|Screening Failure|2
385722|NCT00832455|1295610|P1|Overall Study|Withdrawal by Subject|17
385723|NCT00832455|1295610|P1|Overall Study|Protocol Violation|4
385724|NCT00832455|1295610|P1|Overall Study|Lost to Follow-up|26
385725|NCT00832455|1295610|P1|Overall Study|Adverse Event|13
385726|NCT00832416|1295634|P4|Overall Study|Death|0
385727|NCT00832416|1295635|P3|Overall Study|Death|0
385728|NCT00832416|1295636|P2|Overall Study|Death|0
385729|NCT00832416|1295637|P1|Overall Study|Death|1
385730|NCT00832416|1295634|P4|Overall Study|Adverse Event|10
385731|NCT00832416|1295635|P3|Overall Study|Adverse Event|41
385732|NCT00832416|1295636|P2|Overall Study|Adverse Event|19
385733|NCT00832416|1295637|P1|Overall Study|Adverse Event|21
385734|NCT00832416|1295634|P4|Overall Study|Administrative|1
385735|NCT00832416|1295635|P3|Overall Study|Administrative|0
385736|NCT00832416|1295636|P2|Overall Study|Administrative|0
385737|NCT00832416|1295637|P1|Overall Study|Administrative|0
385738|NCT00832416|1295634|P4|Overall Study|Physician Decision|10
385739|NCT00832416|1295635|P3|Overall Study|Physician Decision|5
385740|NCT00832416|1295636|P2|Overall Study|Physician Decision|12
385741|NCT00832416|1295637|P1|Overall Study|Physician Decision|2
385742|NCT00832416|1295634|P4|Overall Study|Withdrawal by Subject|10
385743|NCT00832416|1295635|P3|Overall Study|Withdrawal by Subject|2
385744|NCT00832416|1295636|P2|Overall Study|Withdrawal by Subject|7
385745|NCT00832416|1295637|P1|Overall Study|Withdrawal by Subject|5
385746|NCT00832416|1295634|P4|Overall Study|Lack of Efficacy|52
385747|NCT00832416|1295635|P3|Overall Study|Lack of Efficacy|13
385748|NCT00832416|1295636|P2|Overall Study|Lack of Efficacy|15
385749|NCT00832416|1295637|P1|Overall Study|Lack of Efficacy|17
385750|NCT00832377|1295688|P1|Overall Study|Protocol Violation|1
385751|NCT00832117|1295734|P1|Overall Study|Disease Progression|11
385752|NCT00832117|1295734|P1|Overall Study|Death|1
385753|NCT00832091|1295753|P2|Overall Study|Prohibited Medication|0
385754|NCT00832091|1295754|P1|Overall Study|Prohibited Medication|1
385755|NCT00832091|1295753|P2|Overall Study|Withdrawal by Subject|1
385756|NCT00832091|1295754|P1|Overall Study|Withdrawal by Subject|2
385757|NCT00832091|1295753|P2|Overall Study|Protocol Violation|0
385758|NCT00832091|1295754|P1|Overall Study|Protocol Violation|1
385759|NCT00832091|1295753|P2|Overall Study|Adverse Event|1
385760|NCT00832091|1295754|P1|Overall Study|Adverse Event|1
385761|NCT00832078|1295762|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
385762|NCT00832078|1295763|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
385763|NCT00832078|1295762|P2|Test Day 1-2 Period|Lack of Efficacy|2
385764|NCT00832078|1295763|P1|Test Day 1-2 Period|Lack of Efficacy|0
385765|NCT00832000|1295769|P2|Overall Study|No calls to IVR in period 2|0
385766|NCT00832000|1295770|P1|Overall Study|No calls to IVR in period 2|2
385767|NCT00832000|1295769|P2|Overall Study|No calls to IVR in either period|1
385768|NCT00832000|1295770|P1|Overall Study|No calls to IVR in either period|1
385769|NCT00832000|1295769|P2|Overall Study|Withdrawal by Subject|0
385770|NCT00832000|1295770|P1|Overall Study|Withdrawal by Subject|1
385771|NCT00832000|1295769|P2|Overall Study|Adverse Event|0
385772|NCT00832000|1295770|P1|Overall Study|Adverse Event|2
385773|NCT00831844|1295831|P10|Overall Study|Ineligible|0
385774|NCT00831844|1295832|P9|Overall Study|Ineligible|0
385775|NCT00831844|1295833|P8|Overall Study|Ineligible|0
385776|NCT00831844|1295834|P7|Overall Study|Ineligible|0
385777|NCT00831844|1295835|P6|Overall Study|Ineligible|0
385778|NCT00831844|1295836|P5|Overall Study|Ineligible|1
385779|NCT00831844|1295837|P4|Overall Study|Ineligible|0
385780|NCT00831844|1295838|P3|Overall Study|Ineligible|1
385781|NCT00831844|1295839|P2|Overall Study|Ineligible|1
385782|NCT00831844|1295840|P1|Overall Study|Ineligible|0
385783|NCT00831844|1295831|P10|Overall Study|Withdrawal by Subject|0
385784|NCT00831844|1295832|P9|Overall Study|Withdrawal by Subject|1
385785|NCT00831844|1295833|P8|Overall Study|Withdrawal by Subject|1
385786|NCT00831844|1295834|P7|Overall Study|Withdrawal by Subject|0
385787|NCT00831844|1295835|P6|Overall Study|Withdrawal by Subject|0
385788|NCT00831844|1295836|P5|Overall Study|Withdrawal by Subject|0
385789|NCT00831844|1295837|P4|Overall Study|Withdrawal by Subject|0
385790|NCT00831844|1295838|P3|Overall Study|Withdrawal by Subject|1
385791|NCT00831844|1295839|P2|Overall Study|Withdrawal by Subject|0
385792|NCT00831844|1295840|P1|Overall Study|Withdrawal by Subject|0
385793|NCT00831844|1295831|P10|Overall Study|Physician Decision|0
385794|NCT00831844|1295832|P9|Overall Study|Physician Decision|1
385795|NCT00831844|1295833|P8|Overall Study|Physician Decision|0
385796|NCT00831844|1295834|P7|Overall Study|Physician Decision|0
385797|NCT00831844|1295835|P6|Overall Study|Physician Decision|1
385798|NCT00831844|1295836|P5|Overall Study|Physician Decision|1
385799|NCT00831844|1295837|P4|Overall Study|Physician Decision|1
385800|NCT00831844|1295838|P3|Overall Study|Physician Decision|3
385801|NCT00831844|1295839|P2|Overall Study|Physician Decision|1
385802|NCT00831844|1295840|P1|Overall Study|Physician Decision|0
385803|NCT00831844|1295831|P10|Overall Study|Lack of Efficacy|0
385804|NCT00831844|1295832|P9|Overall Study|Lack of Efficacy|7
385805|NCT00831844|1295833|P8|Overall Study|Lack of Efficacy|9
385806|NCT00831844|1295834|P7|Overall Study|Lack of Efficacy|8
385807|NCT00831844|1295835|P6|Overall Study|Lack of Efficacy|17
385808|NCT00831844|1295836|P5|Overall Study|Lack of Efficacy|11
385809|NCT00831844|1295837|P4|Overall Study|Lack of Efficacy|8
385810|NCT00831844|1295838|P3|Overall Study|Lack of Efficacy|15
385811|NCT00831844|1295839|P2|Overall Study|Lack of Efficacy|10
385812|NCT00831844|1295840|P1|Overall Study|Lack of Efficacy|8
385813|NCT00831844|1295831|P10|Overall Study|Death|0
385814|NCT00831844|1295832|P9|Overall Study|Death|0
385815|NCT00831844|1295833|P8|Overall Study|Death|0
385816|NCT00831844|1295834|P7|Overall Study|Death|0
385817|NCT00831844|1295835|P6|Overall Study|Death|0
385818|NCT00831844|1295836|P5|Overall Study|Death|0
385819|NCT00831844|1295837|P4|Overall Study|Death|1
385820|NCT00831844|1295838|P3|Overall Study|Death|0
385821|NCT00831844|1295839|P2|Overall Study|Death|0
385822|NCT00831844|1295840|P1|Overall Study|Death|0
385823|NCT00831844|1295831|P10|Overall Study|Adverse Event|0
385824|NCT00831844|1295832|P9|Overall Study|Adverse Event|0
385825|NCT00831844|1295833|P8|Overall Study|Adverse Event|0
385826|NCT00831844|1295834|P7|Overall Study|Adverse Event|2
385827|NCT00831844|1295835|P6|Overall Study|Adverse Event|1
385828|NCT00831844|1295836|P5|Overall Study|Adverse Event|1
385829|NCT00831844|1295837|P4|Overall Study|Adverse Event|0
385830|NCT00831844|1295838|P3|Overall Study|Adverse Event|0
385831|NCT00831844|1295839|P2|Overall Study|Adverse Event|0
385832|NCT00831844|1295840|P1|Overall Study|Adverse Event|2
385833|NCT00831779|1295864|P2|Overall Study|No longer met criteria|1
385834|NCT00831779|1295865|P1|Overall Study|No longer met criteria|0
385835|NCT00831779|1295864|P2|Overall Study|Lost to Follow-up|0
385836|NCT00831779|1295865|P1|Overall Study|Lost to Follow-up|1
385837|NCT00831701|1295902|P2|Overall Study|Lost to Follow-up|3
385838|NCT00831701|1295903|P1|Overall Study|Lost to Follow-up|1
385839|NCT00831701|1295902|P2|Overall Study|Stone expulsion before first medication|2
385840|NCT00831701|1295903|P1|Overall Study|Stone expulsion before first medication|2
385841|NCT00831701|1295902|P2|Overall Study|Withdrawal by Subject|0
385842|NCT00831701|1295903|P1|Overall Study|Withdrawal by Subject|2
385843|NCT00831493|1295932|P1|Overall Study|Intractable nausea and vomiting|1
385844|NCT00831441|1295942|P2|Follow Up (30 Days)|missing end of study status|1
385845|NCT00831441|1295943|P1|Follow Up (30 Days)|missing end of study status|0
385846|NCT00831441|1295942|P2|Follow Up (30 Days)|non-specified|26
385847|NCT00831441|1295943|P1|Follow Up (30 Days)|non-specified|16
385848|NCT00831441|1295942|P2|Follow Up (30 Days)|Death|86
385849|NCT00831441|1295943|P1|Follow Up (30 Days)|Death|63
385850|NCT00831441|1295942|P2|Follow Up (30 Days)|Lost to Follow-up|27
385851|NCT00831441|1295943|P1|Follow Up (30 Days)|Lost to Follow-up|13
385852|NCT00831441|1295942|P2|Follow Up (30 Days)|Withdrawal by Subject|34
385853|NCT00831441|1295943|P1|Follow Up (30 Days)|Withdrawal by Subject|41
385854|NCT00831441|1295942|P2|Randomized|non-specified|266
385855|NCT00831441|1295943|P1|Randomized|non-specified|276
385856|NCT00831441|1295942|P2|Randomized|poor/non-compliance|38
385857|NCT00831441|1295943|P1|Randomized|poor/non-compliance|30
385858|NCT00831441|1295942|P2|Randomized|Administrative reason by sponsor|2671
385859|NCT00831441|1295943|P1|Randomized|Administrative reason by sponsor|2780
385860|NCT00831441|1295942|P2|Randomized|Lost to Follow-up|35
385861|NCT00831441|1295943|P1|Randomized|Lost to Follow-up|26
385862|NCT00831441|1295942|P2|Randomized|Withdrawal by Subject|212
385863|NCT00831441|1295943|P1|Randomized|Withdrawal by Subject|178
385864|NCT00831441|1295942|P2|Randomized|No longer met criteria|19
385865|NCT00831441|1295943|P1|Randomized|No longer met criteria|13
385866|NCT00831441|1295942|P2|Randomized|Physician Decision|35
385867|NCT00831441|1295943|P1|Randomized|Physician Decision|26
385868|NCT00831441|1295942|P2|Randomized|Elective procedure|25
385869|NCT00831441|1295943|P1|Randomized|Elective procedure|26
385870|NCT00831441|1295942|P2|Randomized|Emergency procedure|2
385871|NCT00831441|1295943|P1|Randomized|Emergency procedure|2
385872|NCT00831441|1295942|P2|Randomized|Adverse Event|321
385873|NCT00831441|1295943|P1|Randomized|Adverse Event|248
385874|NCT00831441|1295942|P2|Randomized|Death|81
385875|NCT00831441|1295943|P1|Randomized|Death|82
385876|NCT00831415|1295975|P1|Overall Study|Death|1
385877|NCT00831415|1295975|P1|Overall Study|Unsatisfactory response - Efficacy|4
385878|NCT00831415|1295975|P1|Overall Study|Withdrawal by Subject|35
385879|NCT00831415|1295975|P1|Overall Study|Protocol Violation|3
385880|NCT00831415|1295975|P1|Overall Study|Lost to Follow-up|9
385881|NCT00831415|1295975|P1|Overall Study|Physician Decision|6
385882|NCT00831415|1295975|P1|Overall Study|Failed to return|3
385883|NCT00831415|1295975|P1|Overall Study|Adverse Event|14
385884|NCT00831389|1295984|P2|Overall Study|Withdrawal by Subject|1
385885|NCT00831389|1295985|P1|Overall Study|Withdrawal by Subject|0
385886|NCT00831311|1296011|P2|Overall Study|Withdrawal by Subject|4
385887|NCT00831311|1296012|P1|Overall Study|Withdrawal by Subject|6
385888|NCT00831311|1296011|P2|Overall Study|Physician Decision|1
385889|NCT00831311|1296012|P1|Overall Study|Physician Decision|0
385890|NCT00831311|1296011|P2|Overall Study|Lost to Follow-up|0
385891|NCT00831311|1296012|P1|Overall Study|Lost to Follow-up|3
385892|NCT00831311|1296011|P2|Overall Study|Definitive Contraindication|3
385893|NCT00831311|1296012|P1|Overall Study|Definitive Contraindication|3
385894|NCT00831233|1296049|P2|Overall Study|Selection Criteria Not Met|0
385895|NCT00831233|1296050|P1|Overall Study|Selection Criteria Not Met|2
385896|NCT00831233|1296049|P2|Overall Study|Protocol Violation|0
385897|NCT00831233|1296050|P1|Overall Study|Protocol Violation|1
385898|NCT00831233|1296049|P2|Overall Study|Adverse Event|1
385899|NCT00831233|1296050|P1|Overall Study|Adverse Event|0
385900|NCT00831181|1296074|P1|Overall Study|Adverse Event|12
385901|NCT00831129|1296087|P2|Overall Study|9 lost to follow-up reasons uknown|9
385902|NCT00831129|1296088|P1|Overall Study|9 lost to follow-up reasons uknown|0
385903|NCT00831129|1296087|P2|Overall Study|Adverse Event|1
385904|NCT00831129|1296088|P1|Overall Study|Adverse Event|0
385905|NCT00830960|1296130|P6|Overall Study|No study drug received|7
385906|NCT00830960|1296131|P5|Overall Study|No study drug received|5
385907|NCT00830960|1296132|P4|Overall Study|No study drug received|3
385908|NCT00830960|1296133|P3|Overall Study|No study drug received|4
385909|NCT00830960|1296134|P2|Overall Study|No study drug received|2
385910|NCT00830960|1296135|P1|Overall Study|No study drug received|7
385911|NCT00830960|1296130|P6|Overall Study|Sponsor Decision|7
385912|NCT00830960|1296131|P5|Overall Study|Sponsor Decision|5
385913|NCT00830960|1296132|P4|Overall Study|Sponsor Decision|4
385914|NCT00830960|1296133|P3|Overall Study|Sponsor Decision|3
385915|NCT00830960|1296134|P2|Overall Study|Sponsor Decision|2
385916|NCT00830960|1296135|P1|Overall Study|Sponsor Decision|1
385917|NCT00830960|1296130|P6|Overall Study|Withdrawal by Subject|21
385918|NCT00830960|1296131|P5|Overall Study|Withdrawal by Subject|16
385919|NCT00830960|1296132|P4|Overall Study|Withdrawal by Subject|23
385920|NCT00830960|1296133|P3|Overall Study|Withdrawal by Subject|18
385921|NCT00830960|1296134|P2|Overall Study|Withdrawal by Subject|19
385922|NCT00830960|1296135|P1|Overall Study|Withdrawal by Subject|19
385923|NCT00830960|1296130|P6|Overall Study|Lost to Follow-up|1
385924|NCT00830960|1296131|P5|Overall Study|Lost to Follow-up|0
385925|NCT00830960|1296132|P4|Overall Study|Lost to Follow-up|0
385926|NCT00830960|1296133|P3|Overall Study|Lost to Follow-up|1
385927|NCT00830960|1296134|P2|Overall Study|Lost to Follow-up|1
385928|NCT00830960|1296135|P1|Overall Study|Lost to Follow-up|1
385929|NCT00830960|1296130|P6|Overall Study|Death|1
385930|NCT00830960|1296131|P5|Overall Study|Death|6
385931|NCT00830960|1296132|P4|Overall Study|Death|2
385932|NCT00830960|1296133|P3|Overall Study|Death|3
385933|NCT00830960|1296134|P2|Overall Study|Death|4
385934|NCT00830960|1296135|P1|Overall Study|Death|5
385935|NCT00830947|1296251|P2|Overall Study|Lost to Follow-up|4
385936|NCT00830947|1296252|P1|Overall Study|Lost to Follow-up|4
385937|NCT00830804|1296258|P1|Overall Study|Unwilling to adhere to study requirement|1
385938|NCT00830804|1296258|P1|Overall Study|Consent withdrawn|2
385939|NCT00830804|1296258|P1|Overall Study|Unable to get to clinic|7
385940|NCT00830804|1296258|P1|Overall Study|Death|1
385941|NCT00830804|1296258|P1|Overall Study|Lost to Follow-up|4
385942|NCT00830765|1296338|P2|Overall Study|Protocol Violation|2
385943|NCT00830765|1296339|P1|Overall Study|Protocol Violation|3
385944|NCT00830518|1296372|P2|Overall Study|Reason not Specified|1
385945|NCT00830518|1296373|P1|Overall Study|Reason not Specified|8
385946|NCT00830518|1296372|P2|Overall Study|Withdrawal by Patient|0
385947|NCT00830518|1296373|P1|Overall Study|Withdrawal by Patient|2
385948|NCT00830518|1296372|P2|Overall Study|Adverse Event|1
385949|NCT00830518|1296373|P1|Overall Study|Adverse Event|14
385950|NCT00830518|1296372|P2|Overall Study|Symptomatic Deterioration|1
385951|NCT00830518|1296373|P1|Overall Study|Symptomatic Deterioration|4
385952|NCT00830518|1296372|P2|Overall Study|Progressive Disease|8
385953|NCT00830518|1296373|P1|Overall Study|Progressive Disease|18
385954|NCT00830440|1296392|P2|Overall Study|Adverse Event|0
385955|NCT00830440|1296393|P1|Overall Study|Adverse Event|2
385956|NCT00830440|1296392|P2|Overall Study|unsuccessful procedure|0
385957|NCT00830440|1296393|P1|Overall Study|unsuccessful procedure|4
385958|NCT00830440|1296392|P2|Overall Study|Withdrawal by Subject|0
385959|NCT00830440|1296393|P1|Overall Study|Withdrawal by Subject|1
385960|NCT00830440|1296392|P2|Overall Study|Protocol Violation|0
385961|NCT00830440|1296393|P1|Overall Study|Protocol Violation|1
385962|NCT00830375|1296408|P1|Overall Study|Lost to Follow-up|1
385963|NCT00830336|1296423|P2|Washout: 21 Days|Withdrawal by Subject|0
385964|NCT00830336|1296424|P1|Washout: 21 Days|Withdrawal by Subject|1
385965|NCT00830258|1296451|P2|Washout: 7 Days|Protocol Violation|0
385966|NCT00830258|1296452|P1|Washout: 7 Days|Protocol Violation|1
385967|NCT00830258|1296451|P2|First Intervention|Adverse Event|0
385968|NCT00830258|1296452|P1|First Intervention|Adverse Event|1
385969|NCT00830219|1296471|P2|Washout of 7 Days|Withdrawal by Subject|1
385970|NCT00830219|1296472|P1|Washout of 7 Days|Withdrawal by Subject|1
385971|NCT00830206|1296482|P2|Washout: 21 Days|Withdrawal by Subject|1
385972|NCT00830206|1296483|P1|Washout: 21 Days|Withdrawal by Subject|1
385973|NCT00830167|1296493|P2|Overall Study|Other|2
385974|NCT00830167|1296494|P1|Overall Study|Other|2
385975|NCT00830167|1296493|P2|Overall Study|Protocol Violation|1
385976|NCT00830167|1296494|P1|Overall Study|Protocol Violation|0
385977|NCT00830167|1296493|P2|Overall Study|Lost to Follow-up|1
385978|NCT00830167|1296494|P1|Overall Study|Lost to Follow-up|0
385979|NCT00830167|1296493|P2|Overall Study|Withdrawal by Subject|0
385980|NCT00830167|1296494|P1|Overall Study|Withdrawal by Subject|2
385981|NCT00830167|1296493|P2|Overall Study|Not meeting entrance criteria|5
385982|NCT00830167|1296494|P1|Overall Study|Not meeting entrance criteria|2
385983|NCT00830167|1296493|P2|Overall Study|Adverse Event|24
385984|NCT00830167|1296494|P1|Overall Study|Adverse Event|8
385985|NCT00830167|1296493|P2|Overall Study|Lack of Efficacy|10
385986|NCT00830167|1296494|P1|Overall Study|Lack of Efficacy|26
385987|NCT00830128|1296564|P1|Overall Study|Operating a vehicle|1
385988|NCT00830128|1296564|P1|Overall Study|Work obligation|1
385989|NCT00830128|1296564|P1|Overall Study|Relocation|1
385990|NCT00830128|1296564|P1|Overall Study|Family obligation|1
385991|NCT00830128|1296564|P1|Overall Study|Withdrawal by Subject|2
385992|NCT00830128|1296564|P1|Overall Study|Protocol Violation|1
385993|NCT00830128|1296564|P1|Overall Study|Lack of Efficacy|7
385994|NCT00830128|1296564|P1|Overall Study|Adverse Event|5
385995|NCT00830115|1296579|P1|Overall Study|Improvement/recovery|1
385996|NCT00830115|1296579|P1|Overall Study|Adverse Event|2
385997|NCT00830037|1296606|P2|Overall Study|Active when terminated by DSMB|14
385998|NCT00830037|1296607|P1|Overall Study|Active when terminated by DSMB|15
385999|NCT00830037|1296606|P2|Overall Study|Lost to Follow-up|2
386000|NCT00830037|1296607|P1|Overall Study|Lost to Follow-up|1
386001|NCT00830037|1296606|P2|Overall Study|Withdrawal by Subject|3
386002|NCT00830037|1296607|P1|Overall Study|Withdrawal by Subject|2
386003|NCT00830024|1296617|P2|Washout: 7 Days|Withdrawal by Subject|0
386004|NCT00830024|1296618|P1|Washout: 7 Days|Withdrawal by Subject|1
386005|NCT00829998|1296628|P2|Washout|Adverse Event|1
386006|NCT00829998|1296629|P1|Washout|Adverse Event|0
386007|NCT00829933|1296658|P4|Overall Study|withdrew before treatment started|9
386008|NCT00829933|1296659|P3|Overall Study|withdrew before treatment started|2
386009|NCT00829933|1296660|P2|Overall Study|withdrew before treatment started|1
386010|NCT00829933|1296661|P1|Overall Study|withdrew before treatment started|5
386011|NCT00829933|1296658|P4|Overall Study|Protocol Violation|0
386012|NCT00829933|1296659|P3|Overall Study|Protocol Violation|0
386013|NCT00829933|1296660|P2|Overall Study|Protocol Violation|1
386014|NCT00829933|1296661|P1|Overall Study|Protocol Violation|2
386015|NCT00829933|1296658|P4|Overall Study|Pregnancy|2
386016|NCT00829933|1296659|P3|Overall Study|Pregnancy|0
386017|NCT00829933|1296660|P2|Overall Study|Pregnancy|0
386018|NCT00829933|1296661|P1|Overall Study|Pregnancy|0
386019|NCT00829933|1296658|P4|Overall Study|Physician Decision|1
386020|NCT00829933|1296659|P3|Overall Study|Physician Decision|8
386021|NCT00829933|1296660|P2|Overall Study|Physician Decision|7
386022|NCT00829933|1296661|P1|Overall Study|Physician Decision|5
386023|NCT00829933|1296658|P4|Overall Study|Lack of Efficacy|0
386024|NCT00829933|1296659|P3|Overall Study|Lack of Efficacy|0
386025|NCT00829933|1296660|P2|Overall Study|Lack of Efficacy|1
386026|NCT00829933|1296661|P1|Overall Study|Lack of Efficacy|0
386027|NCT00829933|1296658|P4|Overall Study|Death|1
386028|NCT00829933|1296659|P3|Overall Study|Death|1
386029|NCT00829933|1296660|P2|Overall Study|Death|0
386030|NCT00829933|1296661|P1|Overall Study|Death|0
386031|NCT00829933|1296658|P4|Overall Study|Adverse Event|1
386032|NCT00829933|1296659|P3|Overall Study|Adverse Event|2
386033|NCT00829933|1296660|P2|Overall Study|Adverse Event|3
386034|NCT00829933|1296661|P1|Overall Study|Adverse Event|2
386035|NCT00829868|1296673|P2|Washout|Physician Decision|0
386036|NCT00829868|1296674|P1|Washout|Physician Decision|1
386037|NCT00829829|1296685|P3|Overall Study|Other than specified above|1
386038|NCT00829829|1296686|P2|Overall Study|Other than specified above|2
386039|NCT00829829|1296687|P1|Overall Study|Other than specified above|2
386040|NCT00829829|1296685|P3|Overall Study|Lost to Follow-up|3
386041|NCT00829829|1296686|P2|Overall Study|Lost to Follow-up|3
386042|NCT00829829|1296687|P1|Overall Study|Lost to Follow-up|7
386043|NCT00829829|1296685|P3|Overall Study|Decision by the Sponsor|2
386044|NCT00829829|1296686|P2|Overall Study|Decision by the Sponsor|0
386045|NCT00829829|1296687|P1|Overall Study|Decision by the Sponsor|1
386046|NCT00829829|1296685|P3|Overall Study|Withdrawal by Subject|2
386047|NCT00829829|1296686|P2|Overall Study|Withdrawal by Subject|4
386048|NCT00829829|1296687|P1|Overall Study|Withdrawal by Subject|8
386049|NCT00829829|1296685|P3|Overall Study|Adverse Event|3
386050|NCT00829829|1296686|P2|Overall Study|Adverse Event|4
386051|NCT00829829|1296687|P1|Overall Study|Adverse Event|4
386052|NCT00829829|1296685|P3|Overall Study|Protocol Violation|0
386053|NCT00829829|1296686|P2|Overall Study|Protocol Violation|3
386054|NCT00829829|1296687|P1|Overall Study|Protocol Violation|0
386055|NCT00829790|1296712|P2|Washout of 14 Days|Withdrawal by Subject|1
386056|NCT00829790|1296713|P1|Washout of 14 Days|Withdrawal by Subject|0
386057|NCT00829764|1296723|P2|First Intervention|Withdrawal by Subject|1
386058|NCT00829764|1296724|P1|First Intervention|Withdrawal by Subject|1
386059|NCT00829764|1296723|P2|First Intervention|Adverse Event|0
386060|NCT00829764|1296724|P1|First Intervention|Adverse Event|1
386061|NCT00829712|1296750|P2|Washout of 7 Days|Withdrawal by Subject|1
386062|NCT00829712|1296751|P1|Washout of 7 Days|Withdrawal by Subject|0
386063|NCT00829673|1296770|P2|Washout of 7 Days|Withdrawal by Subject|0
386064|NCT00829673|1296771|P1|Washout of 7 Days|Withdrawal by Subject|1
386065|NCT00829621|1296781|P2|Overall Study|Lost to Follow-up|4
386066|NCT00829621|1296782|P1|Overall Study|Lost to Follow-up|3
386067|NCT00829621|1296781|P2|Overall Study|Death|0
386068|NCT00829621|1296782|P1|Overall Study|Death|1
386069|NCT00829530|1296790|P2|Second Intervention|Intolerance to Venopuncture|0
386070|NCT00829530|1296791|P1|Second Intervention|Intolerance to Venopuncture|1
386071|NCT00829530|1296790|P2|First Intervention|Intolerance to Venopuncture|1
386072|NCT00829530|1296791|P1|First Intervention|Intolerance to Venopuncture|0
386073|NCT00829530|1296790|P2|First Intervention|Adverse Event|1
386074|NCT00829530|1296791|P1|First Intervention|Adverse Event|0
386075|NCT00829504|1296805|P2|Second Intervention|Physician Decision|0
386076|NCT00829504|1296806|P1|Second Intervention|Physician Decision|1
386077|NCT00829504|1296805|P2|Washout of 7 Days|Withdrawal by Subject|0
386078|NCT00829504|1296806|P1|Washout of 7 Days|Withdrawal by Subject|1
386079|NCT00829504|1296805|P2|First Intervention|Adverse Event|0
386080|NCT00829504|1296806|P1|First Intervention|Adverse Event|1
386081|NCT00829452|1296816|P2|Second Intervention|Physician Decision|1
386082|NCT00829452|1296817|P1|Second Intervention|Physician Decision|0
386083|NCT00829452|1296816|P2|Washout of 42 Days|Withdrawal by Subject|1
386084|NCT00829452|1296817|P1|Washout of 42 Days|Withdrawal by Subject|0
386085|NCT00829452|1296816|P2|First Intervention|Withdrawal by Subject|1
386086|NCT00829452|1296817|P1|First Intervention|Withdrawal by Subject|0
386087|NCT00829439|1296829|P4|Overall Study|Adverse Event|0
386088|NCT00829439|1296830|P3|Overall Study|Adverse Event|1
386089|NCT00829439|1296831|P2|Overall Study|Adverse Event|0
386090|NCT00829439|1296832|P1|Overall Study|Adverse Event|0
386091|NCT00829426|1296838|P2|Washout: 7 Days|Withdrawal by Subject|0
386092|NCT00829426|1296839|P1|Washout: 7 Days|Withdrawal by Subject|1
386093|NCT00829387|1296849|P2|Overall Study|Disqualified by PI|0
386094|NCT00829387|1296850|P1|Overall Study|Disqualified by PI|1
386095|NCT00829387|1296849|P2|Overall Study|Withdrawal by Subject|3
386096|NCT00829387|1296850|P1|Overall Study|Withdrawal by Subject|2
386097|NCT00829309|1296868|P2|Washout: 7 Days|Protocol Violation|0
386098|NCT00829309|1296869|P1|Washout: 7 Days|Protocol Violation|1
386099|NCT00829296|1296879|P2|Overall Study|Adverse Event|4
386100|NCT00829296|1296880|P1|Overall Study|Adverse Event|5
386101|NCT00829283|1296894|P2|Overall Study|Lost to Follow-up|25
386102|NCT00829283|1296895|P1|Overall Study|Lost to Follow-up|7
386103|NCT00829244|1296905|P2|Overall Study|No embryo cleavage|2
386104|NCT00829244|1296906|P1|Overall Study|No embryo cleavage|0
386105|NCT00829244|1296905|P2|Overall Study|All embryos discarded|3
386106|NCT00829244|1296906|P1|Overall Study|All embryos discarded|0
386107|NCT00829244|1296905|P2|Overall Study|No fertilization|2
386108|NCT00829244|1296906|P1|Overall Study|No fertilization|2
386109|NCT00829244|1296905|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
386110|NCT00829244|1296906|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
386111|NCT00829244|1296905|P2|Overall Study|Lack of ovarian response to stimulation|5
386112|NCT00829244|1296906|P1|Overall Study|Lack of ovarian response to stimulation|9
386113|NCT00829244|1296905|P2|Overall Study|Protocol Violation|0
386114|NCT00829244|1296906|P1|Overall Study|Protocol Violation|1
386115|NCT00829244|1296905|P2|Overall Study|Adverse Event|3
386116|NCT00829244|1296906|P1|Overall Study|Adverse Event|1
386117|NCT00829179|1296936|P1|Overall Study|Withdrawal by Subject|1
386118|NCT00829166|1296942|P2|Overall Study|Reason Not Specified|3
386119|NCT00829166|1296943|P1|Overall Study|Reason Not Specified|3
386120|NCT00829166|1296942|P2|Overall Study|Sponsor’s Decision|98
386121|NCT00829166|1296943|P1|Overall Study|Sponsor’s Decision|137
386122|NCT00829166|1296942|P2|Overall Study|Subject's Decision|55
386123|NCT00829166|1296943|P1|Overall Study|Subject's Decision|41
386124|NCT00829166|1296942|P2|Overall Study|Physician's Decision|3
386125|NCT00829166|1296943|P1|Overall Study|Physician's Decision|4
386126|NCT00829166|1296942|P2|Overall Study|Lost to Follow-up|4
386127|NCT00829166|1296943|P1|Overall Study|Lost to Follow-up|5
386128|NCT00829166|1296942|P2|Overall Study|Death|333
386129|NCT00829166|1296943|P1|Overall Study|Death|305
386130|NCT00829010|1297006|P5|Overall Study|Migrated/Moved from study area|0
386131|NCT00829010|1297007|P4|Overall Study|Migrated/Moved from study area|5
386132|NCT00829010|1297008|P3|Overall Study|Migrated/Moved from study area|0
386133|NCT00829010|1297009|P2|Overall Study|Migrated/Moved from study area|4
386134|NCT00829010|1297010|P1|Overall Study|Migrated/Moved from study area|3
386135|NCT00829010|1297006|P5|Overall Study|Fatality|0
386136|NCT00829010|1297007|P4|Overall Study|Fatality|3
386137|NCT00829010|1297008|P3|Overall Study|Fatality|0
386138|NCT00829010|1297009|P2|Overall Study|Fatality|4
386139|NCT00829010|1297010|P1|Overall Study|Fatality|5
386140|NCT00829010|1297006|P5|Overall Study|Lost to Follow-up|0
386141|NCT00829010|1297007|P4|Overall Study|Lost to Follow-up|0
386142|NCT00829010|1297008|P3|Overall Study|Lost to Follow-up|2
386143|NCT00829010|1297009|P2|Overall Study|Lost to Follow-up|0
386144|NCT00829010|1297010|P1|Overall Study|Lost to Follow-up|1
386145|NCT00829010|1297006|P5|Overall Study|Withdrawal by Subject|2
386146|NCT00829010|1297007|P4|Overall Study|Withdrawal by Subject|0
386147|NCT00829010|1297008|P3|Overall Study|Withdrawal by Subject|1
386148|NCT00829010|1297009|P2|Overall Study|Withdrawal by Subject|1
386149|NCT00829010|1297010|P1|Overall Study|Withdrawal by Subject|0
386150|NCT00829010|1297006|P5|Overall Study|Adverse Event|0
386151|NCT00829010|1297007|P4|Overall Study|Adverse Event|0
386152|NCT00829010|1297008|P3|Overall Study|Adverse Event|0
386153|NCT00829010|1297009|P2|Overall Study|Adverse Event|0
386154|NCT00829010|1297010|P1|Overall Study|Adverse Event|1
386155|NCT00828984|1297175|P3|Overall Study|ConMed|1
386156|NCT00828984|1297176|P2|Overall Study|ConMed|1
386157|NCT00828984|1297177|P1|Overall Study|ConMed|1
386158|NCT00828984|1297175|P3|Overall Study|Noncompliant|3
386159|NCT00828984|1297176|P2|Overall Study|Noncompliant|2
386160|NCT00828984|1297177|P1|Overall Study|Noncompliant|1
386161|NCT00828984|1297175|P3|Overall Study|Medical Contraindication|0
386162|NCT00828984|1297176|P2|Overall Study|Medical Contraindication|1
386163|NCT00828984|1297177|P1|Overall Study|Medical Contraindication|0
386164|NCT00828984|1297175|P3|Overall Study|Ineligable|0
386165|NCT00828984|1297176|P2|Overall Study|Ineligable|2
386166|NCT00828984|1297177|P1|Overall Study|Ineligable|1
386167|NCT00828984|1297175|P3|Overall Study|Withdrawal by Subject|4
386168|NCT00828984|1297176|P2|Overall Study|Withdrawal by Subject|4
386169|NCT00828984|1297177|P1|Overall Study|Withdrawal by Subject|4
386170|NCT00828984|1297175|P3|Overall Study|Lost to Follow-up|1
386171|NCT00828984|1297176|P2|Overall Study|Lost to Follow-up|3
386172|NCT00828984|1297177|P1|Overall Study|Lost to Follow-up|5
386173|NCT00828984|1297175|P3|Overall Study|Adverse Event|0
386174|NCT00828984|1297176|P2|Overall Study|Adverse Event|3
386175|NCT00828984|1297177|P1|Overall Study|Adverse Event|2
386176|NCT00828945|1297200|P1|Overall Study|Other|36
386177|NCT00828945|1297200|P1|Overall Study|Participant was missing|1
386178|NCT00828945|1297200|P1|Overall Study|Death|4
386179|NCT00828750|1297232|P1|Overall Study|Normal PC Remained While No Treatment|1
386180|NCT00828750|1297232|P1|Overall Study|Lack of Efficacy|3
386181|NCT00828711|1297246|P3|Overall Study|Lost to Follow-up|0
386182|NCT00828711|1297247|P2|Overall Study|Lost to Follow-up|0
386183|NCT00828711|1297248|P1|Overall Study|Lost to Follow-up|1
386184|NCT00828568|1297280|P3|Treated - Received at Least One Dose|Protocol Violation|3
386185|NCT00828568|1297281|P2|Treated - Received at Least One Dose|Protocol Violation|5
386186|NCT00828568|1297282|P1|Treated - Received at Least One Dose|Protocol Violation|9
386187|NCT00828568|1297280|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
386188|NCT00828568|1297281|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
386189|NCT00828568|1297282|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
386190|NCT00828568|1297280|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
386191|NCT00828568|1297281|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
386192|NCT00828568|1297282|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
386193|NCT00828568|1297280|P3|Treated - Received at Least One Dose|Adverse Event|1
386194|NCT00828568|1297281|P2|Treated - Received at Least One Dose|Adverse Event|8
386195|NCT00828568|1297282|P1|Treated - Received at Least One Dose|Adverse Event|11
386196|NCT00828568|1297280|P3|Randomized|Withdrawal by Subject|2
386197|NCT00828568|1297281|P2|Randomized|Withdrawal by Subject|0
386198|NCT00828568|1297282|P1|Randomized|Withdrawal by Subject|1
386199|NCT00828516|1297304|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
386200|NCT00828464|1297309|P1|Overall Study|Withdrawal by Subject|1
386201|NCT00828451|1297326|P1|Overall Study|Deterioration in clinical status|1
386202|NCT00828451|1297326|P1|Overall Study|Withdrawal by Subject|1
386203|NCT00828451|1297326|P1|Overall Study|Lack of intravenous line|7
386204|NCT00828451|1297326|P1|Overall Study|Death|2
386205|NCT00828321|1297352|P2|Second Intervention|Protocol Violation|1
386206|NCT00828321|1297353|P1|Second Intervention|Protocol Violation|0
386207|NCT00828321|1297352|P2|Washout of 42 Days|Withdrawal by Subject|0
386208|NCT00828321|1297353|P1|Washout of 42 Days|Withdrawal by Subject|2
386209|NCT00828204|1297382|P2|Extension Study|Physician Decision|2
386210|NCT00828204|1297383|P1|Extension Study|Physician Decision|0
386211|NCT00828204|1297382|P2|Extension Study|Lost to Follow-up|1
386212|NCT00828204|1297383|P1|Extension Study|Lost to Follow-up|0
386213|NCT00828204|1297382|P2|Main Study: After Study Restart|Noncompliance|1
386214|NCT00828204|1297383|P1|Main Study: After Study Restart|Noncompliance|0
386215|NCT00828204|1297382|P2|Main Study: After Study Restart|Adverse Event|2
386216|NCT00828204|1297383|P1|Main Study: After Study Restart|Adverse Event|0
386217|NCT00828204|1297382|P2|Main Study: Prior to Study Suspension|Study Suspension|0
386218|NCT00828204|1297383|P1|Main Study: Prior to Study Suspension|Study Suspension|11
386219|NCT00828204|1297382|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
386220|NCT00828204|1297383|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
386221|NCT00828204|1297382|P2|Main Study: Prior to Study Suspension|Adverse Event|0
386222|NCT00828204|1297383|P1|Main Study: Prior to Study Suspension|Adverse Event|1
386223|NCT00828139|1297430|P4|Overall Study|Not specified|2
386224|NCT00828139|1297431|P3|Overall Study|Not specified|5
386225|NCT00828139|1297432|P2|Overall Study|Not specified|2
386226|NCT00828139|1297433|P1|Overall Study|Not specified|4
386227|NCT00828139|1297430|P4|Overall Study|Disease Progression|39
386228|NCT00828139|1297431|P3|Overall Study|Disease Progression|35
386229|NCT00828139|1297432|P2|Overall Study|Disease Progression|33
386230|NCT00828139|1297433|P1|Overall Study|Disease Progression|24
386231|NCT00828139|1297430|P4|Overall Study|Refusal unrelated to toxicity|3
386232|NCT00828139|1297431|P3|Overall Study|Refusal unrelated to toxicity|5
386233|NCT00828139|1297432|P2|Overall Study|Refusal unrelated to toxicity|4
386234|NCT00828139|1297433|P1|Overall Study|Refusal unrelated to toxicity|3
386235|NCT00828139|1297430|P4|Overall Study|Death|2
386236|NCT00828139|1297431|P3|Overall Study|Death|0
386237|NCT00828139|1297432|P2|Overall Study|Death|1
386238|NCT00828139|1297433|P1|Overall Study|Death|2
386239|NCT00828139|1297430|P4|Overall Study|Adverse Event|5
386240|NCT00828139|1297431|P3|Overall Study|Adverse Event|10
386241|NCT00828139|1297432|P2|Overall Study|Adverse Event|1
386242|NCT00828139|1297433|P1|Overall Study|Adverse Event|8
386243|NCT00828113|1297453|P2|Overall Study|Lost to Follow-up|5
386244|NCT00828113|1297454|P1|Overall Study|Lost to Follow-up|3
386245|NCT00828113|1297453|P2|Overall Study|Withdrawal by Subject|26
386246|NCT00828113|1297454|P1|Overall Study|Withdrawal by Subject|27
386247|NCT00827931|1297528|P2|Overall Study|Other|0
386248|NCT00827931|1297529|P1|Overall Study|Other|1
386249|NCT00827931|1297528|P2|Overall Study|Withdrawal by Subject|1
386250|NCT00827931|1297529|P1|Overall Study|Withdrawal by Subject|0
386251|NCT00827931|1297528|P2|Overall Study|Lost to Follow-up|0
386252|NCT00827931|1297529|P1|Overall Study|Lost to Follow-up|1
386253|NCT00827931|1297528|P2|Overall Study|Adverse Event|0
386254|NCT00827931|1297529|P1|Overall Study|Adverse Event|1
386255|NCT00827931|1297528|P2|Overall Study|Death|5
386256|NCT00827931|1297529|P1|Overall Study|Death|3
386257|NCT00827918|1297550|P3|Overall Study|Withdrawal by Subject|6
386258|NCT00827918|1297551|P2|Overall Study|Withdrawal by Subject|2
386259|NCT00827918|1297552|P1|Overall Study|Withdrawal by Subject|6
386260|NCT00827918|1297550|P3|Overall Study|Protocol Violation|0
386261|NCT00827918|1297551|P2|Overall Study|Protocol Violation|1
386262|NCT00827918|1297552|P1|Overall Study|Protocol Violation|0
386263|NCT00827918|1297550|P3|Overall Study|Progressive Disease|0
386264|NCT00827918|1297551|P2|Overall Study|Progressive Disease|1
386265|NCT00827918|1297552|P1|Overall Study|Progressive Disease|1
386266|NCT00827918|1297550|P3|Overall Study|Pregnancy|0
386267|NCT00827918|1297551|P2|Overall Study|Pregnancy|1
386268|NCT00827918|1297552|P1|Overall Study|Pregnancy|0
386269|NCT00827918|1297550|P3|Overall Study|Physician Decision|0
386270|NCT00827918|1297551|P2|Overall Study|Physician Decision|0
386271|NCT00827918|1297552|P1|Overall Study|Physician Decision|1
386272|NCT00827918|1297550|P3|Overall Study|Lack of Efficacy|15
386273|NCT00827918|1297551|P2|Overall Study|Lack of Efficacy|4
386274|NCT00827918|1297552|P1|Overall Study|Lack of Efficacy|16
386275|NCT00827918|1297550|P3|Overall Study|Adverse Event|0
386276|NCT00827918|1297551|P2|Overall Study|Adverse Event|0
386277|NCT00827918|1297552|P1|Overall Study|Adverse Event|4
386278|NCT00827827|1297580|P2|Overall Study|Burned with water at home|0
386279|NCT00827827|1297581|P1|Overall Study|Burned with water at home|1
386280|NCT00827827|1297580|P2|Overall Study|Transportation issues|0
386281|NCT00827827|1297581|P1|Overall Study|Transportation issues|1
386282|NCT00827827|1297580|P2|Overall Study|Gout|0
386283|NCT00827827|1297581|P1|Overall Study|Gout|1
386284|NCT00827827|1297580|P2|Overall Study|Another cerebrovascular accident (CVA)|0
386285|NCT00827827|1297581|P1|Overall Study|Another cerebrovascular accident (CVA)|1
386286|NCT00827827|1297580|P2|Overall Study|Fall at home- hospitalization|0
386287|NCT00827827|1297581|P1|Overall Study|Fall at home- hospitalization|1
386288|NCT00827827|1297580|P2|Overall Study|Lost to Follow-up|0
386289|NCT00827827|1297581|P1|Overall Study|Lost to Follow-up|3
386290|NCT00827632|1297625|P2|Overall Study|Early withdrawal|11
386291|NCT00827632|1297626|P1|Overall Study|Early withdrawal|14
386292|NCT00827632|1297625|P2|Overall Study|Lost to Follow-up|12
386293|NCT00827632|1297626|P1|Overall Study|Lost to Follow-up|8
386294|NCT00827606|1297634|P2|Overall Study|Adverse Event|2
386295|NCT00827606|1297635|P1|Overall Study|Adverse Event|4
386296|NCT00827606|1297634|P2|Overall Study|LDL below 2.59 mmol/L|12
386297|NCT00827606|1297635|P1|Overall Study|LDL below 2.59 mmol/L|4
386298|NCT00827606|1297634|P2|Overall Study|Not specified|13
386299|NCT00827606|1297635|P1|Overall Study|Not specified|5
386300|NCT00827606|1297634|P2|Overall Study|Pregnancy|1
386301|NCT00827606|1297635|P1|Overall Study|Pregnancy|0
386302|NCT00827606|1297634|P2|Overall Study|Withdrawal by Subject|6
386303|NCT00827606|1297635|P1|Overall Study|Withdrawal by Subject|7
386304|NCT00827606|1297634|P2|Overall Study|Lost to Follow-up|1
386305|NCT00827606|1297635|P1|Overall Study|Lost to Follow-up|3
386306|NCT00827606|1297634|P2|Overall Study|Protocol Violation|3
386307|NCT00827606|1297635|P1|Overall Study|Protocol Violation|4
386308|NCT00827567|1297696|P1|Overall Study|Progression of Disease/Screen Failure|4
386309|NCT00827541|1297702|P2|Overall Study|Lack of effectiveness|0
386310|NCT00827541|1297703|P1|Overall Study|Lack of effectiveness|1
386311|NCT00827541|1297702|P2|Overall Study|Pathogen not susceptible|0
386312|NCT00827541|1297703|P1|Overall Study|Pathogen not susceptible|1
386313|NCT00827541|1297702|P2|Overall Study|Other|3
386314|NCT00827541|1297703|P1|Overall Study|Other|1
386315|NCT00827541|1297702|P2|Overall Study|Exitus|8
386316|NCT00827541|1297703|P1|Overall Study|Exitus|1
386317|NCT00827502|1297715|P1|Overall Study|Withdrawal by Subject|5
386318|NCT00827502|1297715|P1|Overall Study|Lost to Follow-up|4
386319|NCT00827502|1297715|P1|Overall Study|Adverse Event|1
386320|NCT00827502|1297715|P1|Overall Study|randomized but not treated|11
386321|NCT00827372|1297721|P1|Overall Study|Lack of Efficacy|3
386322|NCT00827372|1297721|P1|Overall Study|Adverse Event|5
386323|NCT00827242|1297736|P2|Overall Study|Lack of Efficacy|0
386324|NCT00827242|1297737|P1|Overall Study|Lack of Efficacy|1
386325|NCT00827242|1297736|P2|Overall Study|Death|0
386326|NCT00827242|1297737|P1|Overall Study|Death|1
386327|NCT00827242|1297736|P2|Overall Study|Physician Decision|0
386328|NCT00827242|1297737|P1|Overall Study|Physician Decision|2
386329|NCT00827242|1297736|P2|Overall Study|Entry Criteria Not Met|1
386330|NCT00827242|1297737|P1|Overall Study|Entry Criteria Not Met|4
386331|NCT00827242|1297736|P2|Overall Study|Adverse Event Excluding Death|1
386332|NCT00827242|1297737|P1|Overall Study|Adverse Event Excluding Death|2
386333|NCT00827242|1297736|P2|Overall Study|Lost to Follow-up|3
386334|NCT00827242|1297737|P1|Overall Study|Lost to Follow-up|0
386335|NCT00827242|1297736|P2|Overall Study|Protocol Violation|3
386336|NCT00827242|1297737|P1|Overall Study|Protocol Violation|1
386337|NCT00827242|1297736|P2|Overall Study|Withdrawal by Subject|4
386338|NCT00827242|1297737|P1|Overall Study|Withdrawal by Subject|2
386339|NCT00827112|1297775|P2|Overall Study|Other|3
386340|NCT00827112|1297776|P1|Overall Study|Other|1
386341|NCT00827112|1297775|P2|Overall Study|Randomized but not treated|3
386342|NCT00827112|1297776|P1|Overall Study|Randomized but not treated|5
386343|NCT00827112|1297775|P2|Overall Study|Withdrawal by Subject|1
386344|NCT00827112|1297776|P1|Overall Study|Withdrawal by Subject|2
386345|NCT00827112|1297775|P2|Overall Study|Protocol Violation|2
386346|NCT00827112|1297776|P1|Overall Study|Protocol Violation|0
386347|NCT00827112|1297775|P2|Overall Study|Pregnancy|1
386348|NCT00827112|1297776|P1|Overall Study|Pregnancy|0
386349|NCT00827112|1297775|P2|Overall Study|Lost to Follow-up|2
386350|NCT00827112|1297776|P1|Overall Study|Lost to Follow-up|3
386351|NCT00827112|1297775|P2|Overall Study|Lack of Efficacy|0
386352|NCT00827112|1297776|P1|Overall Study|Lack of Efficacy|2
386353|NCT00827112|1297775|P2|Overall Study|Adverse Event|0
386354|NCT00827112|1297776|P1|Overall Study|Adverse Event|2
386355|NCT00826943|1297829|P6|Overall Study|Withdrawal by Subject|0
386356|NCT00826943|1297830|P5|Overall Study|Withdrawal by Subject|1
386357|NCT00826943|1297831|P4|Overall Study|Withdrawal by Subject|0
386358|NCT00826943|1297832|P3|Overall Study|Withdrawal by Subject|0
386359|NCT00826943|1297833|P2|Overall Study|Withdrawal by Subject|0
386360|NCT00826943|1297834|P1|Overall Study|Withdrawal by Subject|0
386361|NCT00826748|1297855|P3|Overall Study|Samples Did Not pass QC|1
386362|NCT00826748|1297856|P2|Overall Study|Samples Did Not pass QC|0
386363|NCT00826748|1297857|P1|Overall Study|Samples Did Not pass QC|0
386364|NCT00826748|1297855|P3|Overall Study|Physician Decision|1
386365|NCT00826748|1297856|P2|Overall Study|Physician Decision|0
386366|NCT00826748|1297857|P1|Overall Study|Physician Decision|0
386367|NCT00826748|1297855|P3|Overall Study|Withdrawal by Subject|2
386368|NCT00826748|1297856|P2|Overall Study|Withdrawal by Subject|0
386369|NCT00826748|1297857|P1|Overall Study|Withdrawal by Subject|0
386370|NCT00826618|1297865|P1|Overall Study|Withdrawal by Subject|1
386371|NCT00826540|1297869|P1|Overall Study|Withdrawal by Subject|1
386372|NCT00826540|1297869|P1|Overall Study|ineligible|3
386373|NCT00826449|1297875|P1|Overall Study|Withdrawal by Subject|1
386374|NCT00826449|1297875|P1|Overall Study|Disease Progression|4
386375|NCT00826280|1297884|P3|Overall Study|One or more non-interpretable scan|1
386376|NCT00826280|1297885|P2|Overall Study|One or more non-interpretable scan|1
386377|NCT00826280|1297886|P1|Overall Study|One or more non-interpretable scan|0
386378|NCT00826280|1297884|P3|Overall Study|Machine Failure|0
386379|NCT00826280|1297885|P2|Overall Study|Machine Failure|1
386380|NCT00826280|1297886|P1|Overall Study|Machine Failure|1
386381|NCT00826280|1297884|P3|Overall Study|Interpretation Failure|0
386382|NCT00826280|1297885|P2|Overall Study|Interpretation Failure|0
386383|NCT00826280|1297886|P1|Overall Study|Interpretation Failure|1
386384|NCT00826280|1297884|P3|Overall Study|Reversible ischemic defect not present|44
386385|NCT00826280|1297885|P2|Overall Study|Reversible ischemic defect not present|40
386386|NCT00826280|1297886|P1|Overall Study|Reversible ischemic defect not present|43
386387|NCT00826280|1297884|P3|Overall Study|Sponsor discontinued subject or study|0
386388|NCT00826280|1297885|P2|Overall Study|Sponsor discontinued subject or study|0
386389|NCT00826280|1297886|P1|Overall Study|Sponsor discontinued subject or study|1
386390|NCT00826280|1297884|P3|Overall Study|Lost to Follow-up|0
386391|NCT00826280|1297885|P2|Overall Study|Lost to Follow-up|1
386392|NCT00826280|1297886|P1|Overall Study|Lost to Follow-up|0
386393|NCT00826280|1297884|P3|Overall Study|Adverse Event|0
386394|NCT00826280|1297885|P2|Overall Study|Adverse Event|3
386395|NCT00826280|1297886|P1|Overall Study|Adverse Event|1
386396|NCT00826280|1297884|P3|Overall Study|Randomized but drug not received|1
386397|NCT00826280|1297885|P2|Overall Study|Randomized but drug not received|0
386398|NCT00826280|1297886|P1|Overall Study|Randomized but drug not received|1
386399|NCT00826267|1297915|P3|Overall Study|Other Adverse Event|0
386400|NCT00826267|1297916|P2|Overall Study|Other Adverse Event|0
386401|NCT00826267|1297917|P1|Overall Study|Other Adverse Event|1
386402|NCT00826228|1297935|P1|Overall Study|Withdrawal by Subject|1
386403|NCT00826176|1297957|P2|Overall Study|Administrative|0
386404|NCT00826176|1297958|P1|Overall Study|Administrative|9
386405|NCT00826176|1297957|P2|Overall Study|Subject Withdrew Consent|0
386406|NCT00826176|1297958|P1|Overall Study|Subject Withdrew Consent|3
386407|NCT00826176|1297957|P2|Overall Study|Lost to Follow-up|0
386408|NCT00826176|1297958|P1|Overall Study|Lost to Follow-up|1
386409|NCT00826111|1297970|P2|Overall Study|Physician Decision|1
386410|NCT00826111|1297971|P1|Overall Study|Physician Decision|1
386411|NCT00826111|1297970|P2|Overall Study|Withdrawal by Subject|0
386412|NCT00826111|1297971|P1|Overall Study|Withdrawal by Subject|5
386413|NCT00826111|1297970|P2|Overall Study|Protocol Violation|0
386414|NCT00826111|1297971|P1|Overall Study|Protocol Violation|1
386415|NCT00826111|1297970|P2|Overall Study|Lost to Follow-up|1
386416|NCT00826111|1297971|P1|Overall Study|Lost to Follow-up|0
386417|NCT00825994|1298001|P1|Overall Study|Placebo Responder at V2|1
386418|NCT00825994|1298001|P1|Overall Study|Protocol Violation|1
386419|NCT00825994|1298001|P1|Overall Study|Lost to Follow-up|1
386420|NCT00825994|1298001|P1|Overall Study|Withdrawal by Subject|2
386421|NCT00825916|1298009|P3|Overall Study|Lost to Follow-up|1
386422|NCT00825916|1298010|P2|Overall Study|Lost to Follow-up|2
386423|NCT00825916|1298011|P1|Overall Study|Lost to Follow-up|4
386424|NCT00825825|1298052|P6|Third Medication Period (14 Days)|poor data quality|0
386425|NCT00825825|1298053|P5|Third Medication Period (14 Days)|poor data quality|0
386426|NCT00825825|1298054|P4|Third Medication Period (14 Days)|poor data quality|0
386427|NCT00825825|1298055|P3|Third Medication Period (14 Days)|poor data quality|0
386428|NCT00825825|1298056|P2|Third Medication Period (14 Days)|poor data quality|1
386429|NCT00825825|1298057|P1|Third Medication Period (14 Days)|poor data quality|0
386430|NCT00825825|1298052|P6|Third Medication Period (14 Days)|Protocol Violation|2
386431|NCT00825825|1298053|P5|Third Medication Period (14 Days)|Protocol Violation|0
386432|NCT00825825|1298054|P4|Third Medication Period (14 Days)|Protocol Violation|0
386433|NCT00825825|1298055|P3|Third Medication Period (14 Days)|Protocol Violation|0
386434|NCT00825825|1298056|P2|Third Medication Period (14 Days)|Protocol Violation|0
386435|NCT00825825|1298057|P1|Third Medication Period (14 Days)|Protocol Violation|0
386436|NCT00825825|1298052|P6|Third Medication Period (14 Days)|Adverse Event|0
386437|NCT00825825|1298053|P5|Third Medication Period (14 Days)|Adverse Event|0
386438|NCT00825825|1298054|P4|Third Medication Period (14 Days)|Adverse Event|0
386439|NCT00825825|1298055|P3|Third Medication Period (14 Days)|Adverse Event|0
386440|NCT00825825|1298056|P2|Third Medication Period (14 Days)|Adverse Event|1
386441|NCT00825825|1298057|P1|Third Medication Period (14 Days)|Adverse Event|0
386442|NCT00825825|1298052|P6|Second Medication Period (14 Days)|Protocol Violation|0
386443|NCT00825825|1298053|P5|Second Medication Period (14 Days)|Protocol Violation|1
386444|NCT00825825|1298054|P4|Second Medication Period (14 Days)|Protocol Violation|0
386445|NCT00825825|1298055|P3|Second Medication Period (14 Days)|Protocol Violation|0
386446|NCT00825825|1298056|P2|Second Medication Period (14 Days)|Protocol Violation|0
386447|NCT00825825|1298057|P1|Second Medication Period (14 Days)|Protocol Violation|1
386448|NCT00825825|1298052|P6|Second Medication Period (14 Days)|Physician Decision|0
386449|NCT00825825|1298053|P5|Second Medication Period (14 Days)|Physician Decision|0
386450|NCT00825825|1298054|P4|Second Medication Period (14 Days)|Physician Decision|2
386451|NCT00825825|1298055|P3|Second Medication Period (14 Days)|Physician Decision|0
386452|NCT00825825|1298056|P2|Second Medication Period (14 Days)|Physician Decision|0
386453|NCT00825825|1298057|P1|Second Medication Period (14 Days)|Physician Decision|1
386454|NCT00825825|1298052|P6|First Medication Period (14 Days)|Physician Decision|1
386455|NCT00825825|1298053|P5|First Medication Period (14 Days)|Physician Decision|0
386456|NCT00825825|1298054|P4|First Medication Period (14 Days)|Physician Decision|0
386457|NCT00825825|1298055|P3|First Medication Period (14 Days)|Physician Decision|1
386458|NCT00825825|1298056|P2|First Medication Period (14 Days)|Physician Decision|0
386459|NCT00825825|1298057|P1|First Medication Period (14 Days)|Physician Decision|2
386460|NCT00825825|1298052|P6|First Medication Period (14 Days)|Adverse Event|1
386461|NCT00825825|1298053|P5|First Medication Period (14 Days)|Adverse Event|0
386462|NCT00825825|1298054|P4|First Medication Period (14 Days)|Adverse Event|0
386463|NCT00825825|1298055|P3|First Medication Period (14 Days)|Adverse Event|0
386464|NCT00825825|1298056|P2|First Medication Period (14 Days)|Adverse Event|0
386465|NCT00825825|1298057|P1|First Medication Period (14 Days)|Adverse Event|1
386466|NCT00825812|1298073|P4|Overall Study|Administrative|5
386467|NCT00825812|1298074|P3|Overall Study|Administrative|3
386468|NCT00825812|1298075|P2|Overall Study|Administrative|1
386469|NCT00825812|1298076|P1|Overall Study|Administrative|0
386470|NCT00825812|1298073|P4|Overall Study|Non-compliance with protocol|1
386471|NCT00825812|1298074|P3|Overall Study|Non-compliance with protocol|0
386472|NCT00825812|1298075|P2|Overall Study|Non-compliance with protocol|0
386473|NCT00825812|1298076|P1|Overall Study|Non-compliance with protocol|0
386474|NCT00825812|1298073|P4|Overall Study|Subject withdrew consent|2
386475|NCT00825812|1298074|P3|Overall Study|Subject withdrew consent|3
386476|NCT00825812|1298075|P2|Overall Study|Subject withdrew consent|0
386477|NCT00825812|1298076|P1|Overall Study|Subject withdrew consent|0
386478|NCT00825812|1298073|P4|Overall Study|Adverse Event|1
386479|NCT00825812|1298074|P3|Overall Study|Adverse Event|0
386480|NCT00825812|1298075|P2|Overall Study|Adverse Event|0
386481|NCT00825812|1298076|P1|Overall Study|Adverse Event|0
386482|NCT00825812|1298073|P4|Overall Study|Never entered follow up|1
386483|NCT00825812|1298074|P3|Overall Study|Never entered follow up|0
386484|NCT00825812|1298075|P2|Overall Study|Never entered follow up|0
386485|NCT00825812|1298076|P1|Overall Study|Never entered follow up|0
386486|NCT00825682|1298123|P2|Overall Study|personal reasons/ inconvenience|5
386487|NCT00825682|1298124|P1|Overall Study|personal reasons/ inconvenience|13
386488|NCT00825305|1298215|P2|Overall Study|Can not be classified|1
386489|NCT00825305|1298216|P1|Overall Study|Can not be classified|0
386490|NCT00825305|1298215|P2|Overall Study|Protocol Violation|9
386491|NCT00825305|1298216|P1|Overall Study|Protocol Violation|9
386492|NCT00825305|1298215|P2|Overall Study|Inappropriate inclusion|0
386493|NCT00825305|1298216|P1|Overall Study|Inappropriate inclusion|1
386494|NCT00825305|1298215|P2|Overall Study|Withdrawal by Subject|12
386495|NCT00825305|1298216|P1|Overall Study|Withdrawal by Subject|6
386496|NCT00825305|1298215|P2|Overall Study|Adverse Event|1
386497|NCT00825305|1298216|P1|Overall Study|Adverse Event|1
386498|NCT00825175|1298256|P2|Overall Study|Withdrawal by Subject|5
386499|NCT00825175|1298257|P1|Overall Study|Withdrawal by Subject|0
386500|NCT00825162|1298266|P3|Overall Study|Unable to attend the study visit|0
386501|NCT00825162|1298267|P2|Overall Study|Unable to attend the study visit|2
386502|NCT00825162|1298268|P1|Overall Study|Unable to attend the study visit|5
386503|NCT00825162|1298266|P3|Overall Study|Move away from the study area|0
386504|NCT00825162|1298267|P2|Overall Study|Move away from the study area|0
386505|NCT00825162|1298268|P1|Overall Study|Move away from the study area|1
386506|NCT00825162|1298266|P3|Overall Study|Physician Decision|0
386507|NCT00825162|1298267|P2|Overall Study|Physician Decision|0
386508|NCT00825162|1298268|P1|Overall Study|Physician Decision|2
386509|NCT00825162|1298266|P3|Overall Study|Lost to Follow-up|3
386510|NCT00825162|1298267|P2|Overall Study|Lost to Follow-up|6
386511|NCT00825162|1298268|P1|Overall Study|Lost to Follow-up|9
386512|NCT00825162|1298266|P3|Overall Study|Withdrawal by Subject|3
386513|NCT00825162|1298267|P2|Overall Study|Withdrawal by Subject|13
386514|NCT00825162|1298268|P1|Overall Study|Withdrawal by Subject|11
386515|NCT00824993|1298294|P2|Overall Study|Death|3
386516|NCT00824993|1298295|P1|Overall Study|Death|0
386517|NCT00824993|1298294|P2|Overall Study|Insurance Issue|1
386518|NCT00824993|1298295|P1|Overall Study|Insurance Issue|2
386519|NCT00824993|1298294|P2|Overall Study|Non-Compliant|1
386520|NCT00824993|1298295|P1|Overall Study|Non-Compliant|2
386521|NCT00824993|1298294|P2|Overall Study|Rapid Bone Loss|1
386522|NCT00824993|1298295|P1|Overall Study|Rapid Bone Loss|0
386523|NCT00824993|1298294|P2|Overall Study|Malignancy Relapse|10
386524|NCT00824993|1298295|P1|Overall Study|Malignancy Relapse|9
386525|NCT00824993|1298294|P2|Overall Study|Withdrawal by Subject|1
386526|NCT00824993|1298295|P1|Overall Study|Withdrawal by Subject|1
386527|NCT00824850|1298303|P2|Overall Study|Withdrawal by Subject|1
386528|NCT00824850|1298304|P1|Overall Study|Withdrawal by Subject|0
386529|NCT00824772|1298357|P1|Overall Study|Withdrawal by Subject|8
386530|NCT00824720|1298377|P3|Overall Study|Protocol Violation|1
386531|NCT00824720|1298378|P2|Overall Study|Protocol Violation|0
386532|NCT00824720|1298379|P1|Overall Study|Protocol Violation|0
386533|NCT00824720|1298377|P3|Overall Study|failed plug insertion|0
386534|NCT00824720|1298378|P2|Overall Study|failed plug insertion|1
386535|NCT00824720|1298379|P1|Overall Study|failed plug insertion|3
386536|NCT00824655|1298395|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
386537|NCT00824655|1298396|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
386538|NCT00824655|1298395|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
386539|NCT00824655|1298396|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
386540|NCT00824616|1298416|P2|Overall Study|Withdrawal by Subject|1
386541|NCT00824616|1298417|P1|Overall Study|Withdrawal by Subject|1
386542|NCT00824616|1298416|P2|Overall Study|Lost to Follow-up|1
386543|NCT00824616|1298417|P1|Overall Study|Lost to Follow-up|0
386544|NCT00824616|1298416|P2|Overall Study|Lack of Efficacy|1
386545|NCT00824616|1298417|P1|Overall Study|Lack of Efficacy|2
386546|NCT00824616|1298416|P2|Overall Study|Hyperglycemia|1
386547|NCT00824616|1298417|P1|Overall Study|Hyperglycemia|1
386548|NCT00824616|1298416|P2|Overall Study|Creatinine/Creatinine Clearance|2
386549|NCT00824616|1298417|P1|Overall Study|Creatinine/Creatinine Clearance|0
386550|NCT00824616|1298416|P2|Overall Study|Adverse Event|1
386551|NCT00824616|1298417|P1|Overall Study|Adverse Event|2
386552|NCT00824564|1298427|P2|Overall Study|Randomized, but not treated|0
386553|NCT00824564|1298428|P1|Overall Study|Randomized, but not treated|1
386554|NCT00824564|1298427|P2|Overall Study|Other|2
386555|NCT00824564|1298428|P1|Overall Study|Other|1
386556|NCT00824564|1298427|P2|Overall Study|Withdrawal by Subject|1
386557|NCT00824564|1298428|P1|Overall Study|Withdrawal by Subject|1
386558|NCT00824564|1298427|P2|Overall Study|Lost to Follow-up|7
386559|NCT00824564|1298428|P1|Overall Study|Lost to Follow-up|5
386560|NCT00824473|1298507|P2|Overall Study|Other|1
386561|NCT00824473|1298508|P1|Overall Study|Other|1
386562|NCT00824473|1298507|P2|Overall Study|Withdrawal by Subject|3
386563|NCT00824473|1298508|P1|Overall Study|Withdrawal by Subject|2
386564|NCT00824473|1298507|P2|Overall Study|Non-Compliance|2
386565|NCT00824473|1298508|P1|Overall Study|Non-Compliance|4
386566|NCT00824473|1298507|P2|Overall Study|Protocol Violation|0
386567|NCT00824473|1298508|P1|Overall Study|Protocol Violation|2
386568|NCT00824473|1298507|P2|Overall Study|Lack of Efficacy|2
386569|NCT00824473|1298508|P1|Overall Study|Lack of Efficacy|2
386570|NCT00824473|1298507|P2|Overall Study|Adverse Event|5
386571|NCT00824473|1298508|P1|Overall Study|Adverse Event|4
386572|NCT00824421|1298589|P3|Overall Study|Other|0
386573|NCT00824421|1298590|P2|Overall Study|Other|1
386574|NCT00824421|1298591|P1|Overall Study|Other|0
386575|NCT00824421|1298589|P3|Overall Study|Randomized but not Treated|0
386576|NCT00824421|1298590|P2|Overall Study|Randomized but not Treated|1
386577|NCT00824421|1298591|P1|Overall Study|Randomized but not Treated|1
386578|NCT00824421|1298589|P3|Overall Study|Withdrawal by Subject|3
386579|NCT00824421|1298590|P2|Overall Study|Withdrawal by Subject|3
386580|NCT00824421|1298591|P1|Overall Study|Withdrawal by Subject|2
386581|NCT00824421|1298589|P3|Overall Study|Pregnancy|1
386582|NCT00824421|1298590|P2|Overall Study|Pregnancy|0
386583|NCT00824421|1298591|P1|Overall Study|Pregnancy|1
386584|NCT00824421|1298589|P3|Overall Study|Lost to Follow-up|0
386585|NCT00824421|1298590|P2|Overall Study|Lost to Follow-up|3
386586|NCT00824421|1298591|P1|Overall Study|Lost to Follow-up|2
386587|NCT00824421|1298589|P3|Overall Study|Lack of Efficacy|4
386588|NCT00824421|1298590|P2|Overall Study|Lack of Efficacy|7
386589|NCT00824421|1298591|P1|Overall Study|Lack of Efficacy|5
386590|NCT00824421|1298589|P3|Overall Study|Death|0
386591|NCT00824421|1298590|P2|Overall Study|Death|1
386592|NCT00824421|1298591|P1|Overall Study|Death|0
386593|NCT00824421|1298589|P3|Overall Study|Adverse Event|6
386594|NCT00824421|1298590|P2|Overall Study|Adverse Event|6
386595|NCT00824421|1298591|P1|Overall Study|Adverse Event|6
386596|NCT00824408|1298642|P5|Randomized Phase|Other reason not defined above|4
386597|NCT00824408|1298643|P4|Randomized Phase|Other reason not defined above|2
386598|NCT00824408|1298644|P3|Randomized Phase|Other reason not defined above|4
386599|NCT00824408|1298645|P2|Randomized Phase|Other reason not defined above|0
386600|NCT00824408|1298646|P1|Randomized Phase|Other reason not defined above|0
386601|NCT00824408|1298642|P5|Randomized Phase|Refused to continue medication|2
386602|NCT00824408|1298643|P4|Randomized Phase|Refused to continue medication|2
386603|NCT00824408|1298644|P3|Randomized Phase|Refused to continue medication|2
386604|NCT00824408|1298645|P2|Randomized Phase|Refused to continue medication|0
386605|NCT00824408|1298646|P1|Randomized Phase|Refused to continue medication|0
386606|NCT00824408|1298642|P5|Randomized Phase|Adverse Event|5
386607|NCT00824408|1298643|P4|Randomized Phase|Adverse Event|5
386608|NCT00824408|1298644|P3|Randomized Phase|Adverse Event|4
386609|NCT00824408|1298645|P2|Randomized Phase|Adverse Event|0
386610|NCT00824408|1298646|P1|Randomized Phase|Adverse Event|0
386611|NCT00824408|1298642|P5|Randomized Phase|Progressive disease|34
386612|NCT00824408|1298643|P4|Randomized Phase|Progressive disease|36
386613|NCT00824408|1298644|P3|Randomized Phase|Progressive disease|25
386614|NCT00824408|1298645|P2|Randomized Phase|Progressive disease|0
386615|NCT00824408|1298646|P1|Randomized Phase|Progressive disease|0
386616|NCT00824408|1298642|P5|Randomized Phase|Not treated|1
386617|NCT00824408|1298643|P4|Randomized Phase|Not treated|1
386618|NCT00824408|1298644|P3|Randomized Phase|Not treated|1
386619|NCT00824408|1298645|P2|Randomized Phase|Not treated|0
386620|NCT00824408|1298646|P1|Randomized Phase|Not treated|0
386621|NCT00824408|1298642|P5|Run-in Phase|Other reason not defined above|0
386622|NCT00824408|1298643|P4|Run-in Phase|Other reason not defined above|0
386623|NCT00824408|1298644|P3|Run-in Phase|Other reason not defined above|0
386624|NCT00824408|1298645|P2|Run-in Phase|Other reason not defined above|1
386625|NCT00824408|1298646|P1|Run-in Phase|Other reason not defined above|0
386626|NCT00824408|1298642|P5|Run-in Phase|Refused to continue medication|0
386627|NCT00824408|1298643|P4|Run-in Phase|Refused to continue medication|0
386628|NCT00824408|1298644|P3|Run-in Phase|Refused to continue medication|0
386629|NCT00824408|1298645|P2|Run-in Phase|Refused to continue medication|0
386630|NCT00824408|1298646|P1|Run-in Phase|Refused to continue medication|1
386631|NCT00824408|1298642|P5|Run-in Phase|Adverse Event|0
386632|NCT00824408|1298643|P4|Run-in Phase|Adverse Event|0
386633|NCT00824408|1298644|P3|Run-in Phase|Adverse Event|0
386634|NCT00824408|1298645|P2|Run-in Phase|Adverse Event|1
386635|NCT00824408|1298646|P1|Run-in Phase|Adverse Event|1
386636|NCT00824408|1298642|P5|Run-in Phase|Progressive disease|0
386637|NCT00824408|1298643|P4|Run-in Phase|Progressive disease|0
386638|NCT00824408|1298644|P3|Run-in Phase|Progressive disease|0
386639|NCT00824408|1298645|P2|Run-in Phase|Progressive disease|4
386640|NCT00824408|1298646|P1|Run-in Phase|Progressive disease|4
386641|NCT00824382|1298698|P4|Overall Study|Investigator's decision|0
386642|NCT00824382|1298699|P3|Overall Study|Investigator's decision|2
386643|NCT00824382|1298700|P2|Overall Study|Investigator's decision|1
386644|NCT00824382|1298701|P1|Overall Study|Investigator's decision|0
386645|NCT00824382|1298698|P4|Overall Study|Protocol Violation|1
386646|NCT00824382|1298699|P3|Overall Study|Protocol Violation|0
386647|NCT00824382|1298700|P2|Overall Study|Protocol Violation|0
386648|NCT00824382|1298701|P1|Overall Study|Protocol Violation|1
386649|NCT00824382|1298698|P4|Overall Study|Adverse Event|4
386650|NCT00824382|1298699|P3|Overall Study|Adverse Event|1
386651|NCT00824382|1298700|P2|Overall Study|Adverse Event|1
386652|NCT00824382|1298701|P1|Overall Study|Adverse Event|4
386653|NCT00824369|1298777|P6|Overall Study|Lost to Follow-up|0
386654|NCT00824369|1298778|P5|Overall Study|Lost to Follow-up|1
386655|NCT00824369|1298779|P4|Overall Study|Lost to Follow-up|0
386656|NCT00824369|1298780|P3|Overall Study|Lost to Follow-up|0
386657|NCT00824369|1298781|P2|Overall Study|Lost to Follow-up|0
386658|NCT00824369|1298782|P1|Overall Study|Lost to Follow-up|0
386659|NCT00824369|1298777|P6|Overall Study|Nolonger willing to participate in study|1
386660|NCT00824369|1298778|P5|Overall Study|Nolonger willing to participate in study|0
386661|NCT00824369|1298779|P4|Overall Study|Nolonger willing to participate in study|2
386662|NCT00824369|1298780|P3|Overall Study|Nolonger willing to participate in study|1
386663|NCT00824369|1298781|P2|Overall Study|Nolonger willing to participate in study|0
386664|NCT00824369|1298782|P1|Overall Study|Nolonger willing to participate in study|1
386665|NCT00824291|1298822|P2|Overall Study|Participant on prohibited medication|0
386666|NCT00824291|1298823|P1|Overall Study|Participant on prohibited medication|1
386667|NCT00824291|1298822|P2|Overall Study|Lack of Efficacy|8
386668|NCT00824291|1298823|P1|Overall Study|Lack of Efficacy|7
386669|NCT00824291|1298822|P2|Overall Study|Withdrawal by Subject|8
386670|NCT00824291|1298823|P1|Overall Study|Withdrawal by Subject|14
386671|NCT00824291|1298822|P2|Overall Study|Protocol Violation|1
386672|NCT00824291|1298823|P1|Overall Study|Protocol Violation|4
386673|NCT00824291|1298822|P2|Overall Study|Non-compliance|1
386674|NCT00824291|1298823|P1|Overall Study|Non-compliance|1
386675|NCT00824291|1298822|P2|Overall Study|Lost to Follow-up|9
386676|NCT00824291|1298823|P1|Overall Study|Lost to Follow-up|11
386677|NCT00824291|1298822|P2|Overall Study|Discontinuation of Study by Sponsor|2
386678|NCT00824291|1298823|P1|Overall Study|Discontinuation of Study by Sponsor|1
386679|NCT00824291|1298822|P2|Overall Study|Adverse Event|6
386680|NCT00824291|1298823|P1|Overall Study|Adverse Event|15
386681|NCT00824265|1298845|P2|Overall Study|Withdrawal by Subject|15
386682|NCT00824265|1298846|P1|Overall Study|Withdrawal by Subject|6
386683|NCT00824265|1298845|P2|Overall Study|Physician Decision|12
386684|NCT00824265|1298846|P1|Overall Study|Physician Decision|6
386685|NCT00824265|1298845|P2|Overall Study|Lost to Follow-up|1
386686|NCT00824265|1298846|P1|Overall Study|Lost to Follow-up|1
386687|NCT00824265|1298845|P2|Overall Study|Protocol Violation|0
386688|NCT00824265|1298846|P1|Overall Study|Protocol Violation|1
386689|NCT00824265|1298845|P2|Overall Study|Adverse Event,non-fatal|52
386690|NCT00824265|1298846|P1|Overall Study|Adverse Event,non-fatal|50
386691|NCT00824161|1298905|P1|Overall Study|Screen Failure|1
386692|NCT00824161|1298905|P1|Overall Study|Withdrawal by Subject|1
386693|NCT00824005|1298971|P2|Overall Study|Lost to Follow-up|1
386694|NCT00824005|1298972|P1|Overall Study|Lost to Follow-up|0
386695|NCT00824005|1298971|P2|Overall Study|Death|1
386696|NCT00824005|1298972|P1|Overall Study|Death|0
386697|NCT00823979|1299007|P3|Overall Study|Study Terminated by Sponsor|7
386698|NCT00823979|1299008|P2|Overall Study|Study Terminated by Sponsor|5
386699|NCT00823979|1299009|P1|Overall Study|Study Terminated by Sponsor|5
386700|NCT00823979|1299007|P3|Overall Study|Randomized but not Treated|1
386701|NCT00823979|1299008|P2|Overall Study|Randomized but not Treated|3
386702|NCT00823979|1299009|P1|Overall Study|Randomized but not Treated|4
386703|NCT00823979|1299007|P3|Overall Study|Other|1
386704|NCT00823979|1299008|P2|Overall Study|Other|0
386705|NCT00823979|1299009|P1|Overall Study|Other|2
386706|NCT00823979|1299007|P3|Overall Study|Adverse Event|4
386707|NCT00823979|1299008|P2|Overall Study|Adverse Event|2
386708|NCT00823979|1299009|P1|Overall Study|Adverse Event|0
386709|NCT00823979|1299007|P3|Overall Study|Pregnancy|0
386710|NCT00823979|1299008|P2|Overall Study|Pregnancy|1
386711|NCT00823979|1299009|P1|Overall Study|Pregnancy|0
386712|NCT00823979|1299007|P3|Overall Study|Protocol Violation|0
386713|NCT00823979|1299008|P2|Overall Study|Protocol Violation|1
386714|NCT00823979|1299009|P1|Overall Study|Protocol Violation|1
386715|NCT00823979|1299007|P3|Overall Study|Withdrawal by Subject|2
386716|NCT00823979|1299008|P2|Overall Study|Withdrawal by Subject|3
386717|NCT00823979|1299009|P1|Overall Study|Withdrawal by Subject|2
386718|NCT00823979|1299007|P3|Overall Study|Lost to Follow-up|0
386719|NCT00823979|1299008|P2|Overall Study|Lost to Follow-up|1
386720|NCT00823979|1299009|P1|Overall Study|Lost to Follow-up|2
386721|NCT00823979|1299007|P3|Overall Study|Lack of Efficacy|9
386722|NCT00823979|1299008|P2|Overall Study|Lack of Efficacy|16
386723|NCT00823979|1299009|P1|Overall Study|Lack of Efficacy|13
386724|NCT00823901|1299054|P2|Overall Study|Lost to Follow-up|1
386725|NCT00823901|1299055|P1|Overall Study|Lost to Follow-up|2
386726|NCT00823901|1299054|P2|Overall Study|Lack of Efficacy|0
386727|NCT00823901|1299055|P1|Overall Study|Lack of Efficacy|1
386728|NCT00823901|1299054|P2|Overall Study|Adverse Event|1
386729|NCT00823901|1299055|P1|Overall Study|Adverse Event|1
386730|NCT00823836|1299063|P2|Long-term Phase|Withdrawal by Subject|1
386731|NCT00823836|1299064|P1|Long-term Phase|Withdrawal by Subject|1
386732|NCT00823836|1299063|P2|Long-term Phase|Physician Decision|2
386733|NCT00823836|1299064|P1|Long-term Phase|Physician Decision|1
386734|NCT00823836|1299063|P2|Long-term Phase|Adverse Event|2
386735|NCT00823836|1299064|P1|Long-term Phase|Adverse Event|3
386736|NCT00823836|1299063|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
386737|NCT00823836|1299064|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
386738|NCT00823836|1299063|P2|NV and PR/XR Switching Phases|Physician Decision|2
386739|NCT00823836|1299064|P1|NV and PR/XR Switching Phases|Physician Decision|5
386740|NCT00823836|1299063|P2|NV and PR/XR Switching Phases|Protocol Violation|1
386741|NCT00823836|1299064|P1|NV and PR/XR Switching Phases|Protocol Violation|1
386742|NCT00823836|1299063|P2|NV and PR/XR Switching Phases|Adverse Event|21
386743|NCT00823836|1299064|P1|NV and PR/XR Switching Phases|Adverse Event|22
386744|NCT00823823|1299170|P2|Overall Study|Protocol Violation|5
386745|NCT00823823|1299171|P1|Overall Study|Protocol Violation|5
386746|NCT00823823|1299170|P2|Overall Study|Lost to Follow-up|1
386747|NCT00823823|1299171|P1|Overall Study|Lost to Follow-up|3
386748|NCT00823719|1299195|P2|Overall Study|Disease Progression|4
386749|NCT00823719|1299196|P1|Overall Study|Disease Progression|4
386750|NCT00823719|1299195|P2|Overall Study|Withdrawal by Subject|1
386751|NCT00823719|1299196|P1|Overall Study|Withdrawal by Subject|0
386752|NCT00823719|1299195|P2|Overall Study|Physician Decision|4
386753|NCT00823719|1299196|P1|Overall Study|Physician Decision|1
386754|NCT00823719|1299195|P2|Overall Study|Adverse Event|2
386755|NCT00823719|1299196|P1|Overall Study|Adverse Event|1
386756|NCT00823615|1299249|P2|Period 2|Time/Job Conflict|2
386757|NCT00823615|1299250|P1|Period 2|Time/Job Conflict|1
386758|NCT00823615|1299249|P2|Period 2|Lost to Follow-up|0
386759|NCT00823615|1299250|P1|Period 2|Lost to Follow-up|2
386760|NCT00823472|1299260|P2|Overall Study|Physician Decision|28
386761|NCT00823472|1299261|P1|Overall Study|Physician Decision|24
386762|NCT00823264|1299280|P2|Overall Study|Protocol Violation|0
386763|NCT00823264|1299281|P1|Overall Study|Protocol Violation|2
386764|NCT00823212|1299289|P2|Overall Study|Missed 12-month visit|21
386765|NCT00823212|1299290|P1|Overall Study|Missed 12-month visit|21
386766|NCT00823212|1299289|P2|Overall Study|Incarcerated|1
386767|NCT00823212|1299290|P1|Overall Study|Incarcerated|0
386768|NCT00823212|1299289|P2|Overall Study|Withdrawal by Subject|1
386769|NCT00823212|1299290|P1|Overall Study|Withdrawal by Subject|6
386770|NCT00823212|1299289|P2|Overall Study|Death|10
386771|NCT00823212|1299290|P1|Overall Study|Death|8
386772|NCT00823199|1299372|P1|Overall Study|Withdrawal by Subject|2
386773|NCT00822926|1299441|P2|Second Injection Visit|Withdrawal by Subject|1
386774|NCT00822926|1299442|P1|Second Injection Visit|Withdrawal by Subject|0
386775|NCT00822926|1299441|P2|Second Injection Visit|Lost to Follow-up|0
386776|NCT00822926|1299442|P1|Second Injection Visit|Lost to Follow-up|1
386777|NCT00822900|1299456|P2|Overall Study|Became a ward of the state|1
386778|NCT00822900|1299457|P1|Overall Study|Became a ward of the state|2
386779|NCT00822900|1299456|P2|Overall Study|Death|69
386780|NCT00822900|1299457|P1|Overall Study|Death|83
386781|NCT00822900|1299456|P2|Overall Study|Lost to Follow-up|9
386782|NCT00822900|1299457|P1|Overall Study|Lost to Follow-up|9
386783|NCT00822900|1299456|P2|Overall Study|Withdrawal by Subject|14
386784|NCT00822900|1299457|P1|Overall Study|Withdrawal by Subject|14
386785|NCT00822692|1299504|P2|Overall Study|Lost to Follow-up|25
386786|NCT00822692|1299505|P1|Overall Study|Lost to Follow-up|17
386787|NCT00822237|1299643|P2|Dose 2 Vaccination|Lost to Follow-up|9
386788|NCT00822237|1299644|P1|Dose 2 Vaccination|Lost to Follow-up|2
386789|NCT00822237|1299643|P2|Dose 2 Vaccination|Withdrawal by Subject|2
386790|NCT00822237|1299644|P1|Dose 2 Vaccination|Withdrawal by Subject|2
386791|NCT00822237|1299643|P2|Dose 1 Vaccination|Lost to Follow-up|12
386792|NCT00822237|1299644|P1|Dose 1 Vaccination|Lost to Follow-up|9
386793|NCT00822237|1299643|P2|Dose 1 Vaccination|Withdrawal by Subject|14
386794|NCT00822237|1299644|P1|Dose 1 Vaccination|Withdrawal by Subject|13
386795|NCT00822237|1299643|P2|Dose 1 Vaccination|Not vaccinated|0
386796|NCT00822237|1299644|P1|Dose 1 Vaccination|Not vaccinated|3
386797|NCT00822172|1299725|P2|Overall Study|Other|1
386798|NCT00822172|1299726|P1|Overall Study|Other|0
386799|NCT00822172|1299725|P2|Overall Study|site closed|1
386800|NCT00822172|1299726|P1|Overall Study|site closed|0
386801|NCT00822172|1299725|P2|Overall Study|Withdrawal by Subject|4
386802|NCT00822172|1299726|P1|Overall Study|Withdrawal by Subject|1
386803|NCT00822172|1299725|P2|Overall Study|Lost to Follow-up|1
386804|NCT00822172|1299726|P1|Overall Study|Lost to Follow-up|3
386805|NCT00822172|1299725|P2|Overall Study|Death|0
386806|NCT00822172|1299726|P1|Overall Study|Death|1
386807|NCT00822172|1299725|P2|Overall Study|Adverse Event|12
386808|NCT00822172|1299726|P1|Overall Study|Adverse Event|10
386809|NCT00822120|1299734|P6|PET-directed Therapy|Protocol Violation|0
386810|NCT00822120|1299735|P5|PET-directed Therapy|Protocol Violation|0
386811|NCT00822120|1299736|P4|PET-directed Therapy|Protocol Violation|6
386812|NCT00822120|1299737|P3|PET-directed Therapy|Protocol Violation|0
386813|NCT00822120|1299738|P2|PET-directed Therapy|Protocol Violation|0
386814|NCT00822120|1299739|P1|PET-directed Therapy|Protocol Violation|0
386815|NCT00822120|1299734|P6|PET-directed Therapy|Death|0
386816|NCT00822120|1299735|P5|PET-directed Therapy|Death|0
386817|NCT00822120|1299736|P4|PET-directed Therapy|Death|2
386818|NCT00822120|1299737|P3|PET-directed Therapy|Death|0
386819|NCT00822120|1299738|P2|PET-directed Therapy|Death|0
386820|NCT00822120|1299739|P1|PET-directed Therapy|Death|0
386821|NCT00822120|1299734|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
386822|NCT00822120|1299735|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
386823|NCT00822120|1299736|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
386824|NCT00822120|1299737|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
386825|NCT00822120|1299738|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
386826|NCT00822120|1299739|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
386827|NCT00822120|1299734|P6|PET-directed Therapy|Adverse Event|0
386828|NCT00822120|1299735|P5|PET-directed Therapy|Adverse Event|0
386829|NCT00822120|1299736|P4|PET-directed Therapy|Adverse Event|1
386830|NCT00822120|1299737|P3|PET-directed Therapy|Adverse Event|0
386831|NCT00822120|1299738|P2|PET-directed Therapy|Adverse Event|0
386832|NCT00822120|1299739|P1|PET-directed Therapy|Adverse Event|0
386833|NCT00822120|1299734|P6|Initial Registration|Ineligible|0
386834|NCT00822120|1299735|P5|Initial Registration|Ineligible|0
386835|NCT00822120|1299736|P4|Initial Registration|Ineligible|0
386836|NCT00822120|1299737|P3|Initial Registration|Ineligible|0
386837|NCT00822120|1299738|P2|Initial Registration|Ineligible|1
386838|NCT00822120|1299739|P1|Initial Registration|Ineligible|22
386839|NCT00822120|1299734|P6|Initial Registration|Reasons not Protocol Specified|0
386840|NCT00822120|1299735|P5|Initial Registration|Reasons not Protocol Specified|0
386841|NCT00822120|1299736|P4|Initial Registration|Reasons not Protocol Specified|0
386842|NCT00822120|1299737|P3|Initial Registration|Reasons not Protocol Specified|0
386843|NCT00822120|1299738|P2|Initial Registration|Reasons not Protocol Specified|0
386844|NCT00822120|1299739|P1|Initial Registration|Reasons not Protocol Specified|2
386845|NCT00822120|1299734|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
386846|NCT00822120|1299735|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
386847|NCT00822120|1299736|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
386848|NCT00822120|1299737|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
386849|NCT00822120|1299738|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
386850|NCT00822120|1299739|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
386851|NCT00822120|1299734|P6|Initial Registration|Adverse Event|0
386852|NCT00822120|1299735|P5|Initial Registration|Adverse Event|0
386853|NCT00822120|1299736|P4|Initial Registration|Adverse Event|0
386854|NCT00822120|1299737|P3|Initial Registration|Adverse Event|0
386855|NCT00822120|1299738|P2|Initial Registration|Adverse Event|0
386856|NCT00822120|1299739|P1|Initial Registration|Adverse Event|1
386857|NCT00821873|1299801|P1|Overall Study|Lost to Follow-up|4
386858|NCT00821678|1299822|P2|Overall Study|Death|2
386859|NCT00821678|1299823|P1|Overall Study|Death|0
386860|NCT00821678|1299822|P2|Overall Study|Lost to Follow-up|12
386861|NCT00821678|1299823|P1|Overall Study|Lost to Follow-up|13
386862|NCT00821678|1299822|P2|Overall Study|Withdrawal by Subject|0
386863|NCT00821678|1299823|P1|Overall Study|Withdrawal by Subject|8
386864|NCT00821587|1299841|P2|Overall Study|Physician Decision|1
386865|NCT00821587|1299842|P1|Overall Study|Physician Decision|0
386866|NCT00821509|1299851|P3|Overall Study|Withdrawal by Subject|34
386867|NCT00821509|1299852|P2|Overall Study|Withdrawal by Subject|11
386868|NCT00821509|1299853|P1|Overall Study|Withdrawal by Subject|12
386869|NCT00821431|1299866|P2|Overall Study|Physician Decision|1
386870|NCT00821431|1299867|P1|Overall Study|Physician Decision|0
386871|NCT00821431|1299866|P2|Overall Study|Protocol Violation|1
386872|NCT00821431|1299867|P1|Overall Study|Protocol Violation|3
386873|NCT00821431|1299866|P2|Overall Study|Lost to Follow-up|0
386874|NCT00821431|1299867|P1|Overall Study|Lost to Follow-up|1
386875|NCT00821431|1299866|P2|Overall Study|Withdrawal by Subject|0
386876|NCT00821431|1299867|P1|Overall Study|Withdrawal by Subject|5
386877|NCT00821431|1299866|P2|Overall Study|Adverse Event|3
386878|NCT00821431|1299867|P1|Overall Study|Adverse Event|6
386879|NCT00821327|1299875|P1|Overall Study|Other/Unknown|5
386880|NCT00821327|1299875|P1|Overall Study|Disease Progression|13
386881|NCT00821327|1299875|P1|Overall Study|Sponsor Request|1
386882|NCT00821327|1299875|P1|Overall Study|Investigator Request|2
386883|NCT00821327|1299875|P1|Overall Study|Patient Request|1
386884|NCT00821327|1299875|P1|Overall Study|Adverse Event|13
386885|NCT00821236|1299884|P1|Overall Study|Lost to Follow-up|3
386886|NCT00821093|1299924|P2|Overall Study|Administrative problems|2
386887|NCT00821093|1299925|P1|Overall Study|Administrative problems|1
386888|NCT00821093|1299924|P2|Overall Study|Abnormal test procedure result(s)|1
386889|NCT00821093|1299925|P1|Overall Study|Abnormal test procedure result(s)|1
386890|NCT00821093|1299924|P2|Overall Study|Death|1
386891|NCT00821093|1299925|P1|Overall Study|Death|2
386892|NCT00821093|1299924|P2|Overall Study|Lack of Efficacy|2
386893|NCT00821093|1299925|P1|Overall Study|Lack of Efficacy|2
386894|NCT00821093|1299924|P2|Overall Study|Abnormal laboratory value(s)|0
386895|NCT00821093|1299925|P1|Overall Study|Abnormal laboratory value(s)|2
386896|NCT00821093|1299924|P2|Overall Study|Protocol deviation|6
386897|NCT00821093|1299925|P1|Overall Study|Protocol deviation|3
386898|NCT00821093|1299924|P2|Overall Study|Lost to Follow-up|3
386899|NCT00821093|1299925|P1|Overall Study|Lost to Follow-up|9
386900|NCT00821093|1299924|P2|Overall Study|Withdrawal by Subject|13
386901|NCT00821093|1299925|P1|Overall Study|Withdrawal by Subject|9
386902|NCT00821093|1299924|P2|Overall Study|Adverse Event|12
386903|NCT00821093|1299925|P1|Overall Study|Adverse Event|20
386904|NCT00820898|1299944|P1|Overall Study|Inelgible - wrong primary site|1
386905|NCT00820755|1299958|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
386906|NCT00820755|1299959|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
386907|NCT00820755|1299960|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
386908|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Other|0
386909|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Other|0
386910|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Other|11
386911|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
386912|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
386913|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
386914|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Progressive disease|0
386915|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Progressive disease|0
386916|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Progressive disease|114
386917|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
386918|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
386919|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
386920|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
386921|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
386922|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
386923|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
386924|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
386925|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
386926|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Death|0
386927|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Death|0
386928|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Death|28
386929|NCT00820755|1299958|P3|Period 1: Combination Therapy Phase|Adverse Event|0
386930|NCT00820755|1299959|P2|Period 1: Combination Therapy Phase|Adverse Event|0
386931|NCT00820755|1299960|P1|Period 1: Combination Therapy Phase|Adverse Event|77
386932|NCT00820248|1300053|P2|Overall Study|No treated|1
386933|NCT00820248|1300054|P1|Overall Study|No treated|4
386934|NCT00820222|1300064|P2|Overall Study|Ongoing|191
386935|NCT00820222|1300065|P1|Overall Study|Ongoing|185
386936|NCT00820222|1300064|P2|Overall Study|Sponsor Terminated Study|1
386937|NCT00820222|1300065|P1|Overall Study|Sponsor Terminated Study|0
386938|NCT00820222|1300064|P2|Overall Study|Physician Decision|6
386939|NCT00820222|1300065|P1|Overall Study|Physician Decision|4
386940|NCT00820222|1300064|P2|Overall Study|Withdrawal by Subject|9
386941|NCT00820222|1300065|P1|Overall Study|Withdrawal by Subject|8
386942|NCT00820222|1300064|P2|Overall Study|Lost to Follow-up|4
386943|NCT00820222|1300065|P1|Overall Study|Lost to Follow-up|4
386944|NCT00819910|1300095|P4|Overall Study|Lost to Follow-up|0
386945|NCT00819910|1300096|P3|Overall Study|Lost to Follow-up|0
386946|NCT00819910|1300097|P2|Overall Study|Lost to Follow-up|0
386947|NCT00819910|1300098|P1|Overall Study|Lost to Follow-up|1
386948|NCT00819910|1300095|P4|Overall Study|Withdrawal by Subject|0
386949|NCT00819910|1300096|P3|Overall Study|Withdrawal by Subject|1
386950|NCT00819910|1300097|P2|Overall Study|Withdrawal by Subject|1
386951|NCT00819910|1300098|P1|Overall Study|Withdrawal by Subject|1
386952|NCT00819910|1300095|P4|Overall Study|Adverse Event|1
386953|NCT00819910|1300096|P3|Overall Study|Adverse Event|2
386954|NCT00819910|1300097|P2|Overall Study|Adverse Event|0
386955|NCT00819910|1300098|P1|Overall Study|Adverse Event|0
386956|NCT00819832|1300130|P6|Overall Study|Sponsor Termination of Study|0
386957|NCT00819832|1300131|P5|Overall Study|Sponsor Termination of Study|0
386958|NCT00819832|1300132|P4|Overall Study|Sponsor Termination of Study|0
386959|NCT00819832|1300133|P3|Overall Study|Sponsor Termination of Study|0
386960|NCT00819832|1300134|P2|Overall Study|Sponsor Termination of Study|0
386961|NCT00819832|1300135|P1|Overall Study|Sponsor Termination of Study|3
386962|NCT00819780|1300151|P2|Overall Study|Still in treatment|17
386963|NCT00819780|1300152|P1|Overall Study|Still in treatment|25
386964|NCT00819780|1300151|P2|Overall Study|Did not receive study drug|4
386965|NCT00819780|1300152|P1|Overall Study|Did not receive study drug|3
386966|NCT00819767|1300186|P2|Overall Study|Unsatisfactory therapeutic effect|2
386967|NCT00819767|1300187|P1|Overall Study|Unsatisfactory therapeutic effect|1
386968|NCT00819741|1300199|P2|Overall Study|Reasons unknown|3
386969|NCT00819741|1300200|P1|Overall Study|Reasons unknown|3
386970|NCT00819741|1300199|P2|Overall Study|Unclassified|0
386971|NCT00819741|1300200|P1|Overall Study|Unclassified|6
386972|NCT00819741|1300199|P2|Overall Study|Withdrawal by Subject|2
386973|NCT00819741|1300200|P1|Overall Study|Withdrawal by Subject|2
386974|NCT00819741|1300199|P2|Overall Study|Protocol Violation|4
386975|NCT00819741|1300200|P1|Overall Study|Protocol Violation|3
386976|NCT00819741|1300199|P2|Overall Study|Lost to Follow-up|1
386977|NCT00819741|1300200|P1|Overall Study|Lost to Follow-up|3
386978|NCT00819741|1300199|P2|Overall Study|Lack of Efficacy|2
386979|NCT00819741|1300200|P1|Overall Study|Lack of Efficacy|0
386980|NCT00819741|1300199|P2|Overall Study|Adverse Event|2
386981|NCT00819741|1300200|P1|Overall Study|Adverse Event|5
386982|NCT00819585|1300254|P7|Overall Study|Protocol Violation|3
386983|NCT00819585|1300255|P6|Overall Study|Protocol Violation|1
386984|NCT00819585|1300256|P5|Overall Study|Protocol Violation|0
386985|NCT00819585|1300257|P4|Overall Study|Protocol Violation|0
386986|NCT00819585|1300258|P3|Overall Study|Protocol Violation|1
386987|NCT00819585|1300259|P2|Overall Study|Protocol Violation|0
386988|NCT00819585|1300260|P1|Overall Study|Protocol Violation|0
386989|NCT00819585|1300254|P7|Overall Study|Death|1
386990|NCT00819585|1300255|P6|Overall Study|Death|0
386991|NCT00819585|1300256|P5|Overall Study|Death|0
386992|NCT00819585|1300257|P4|Overall Study|Death|0
386993|NCT00819585|1300258|P3|Overall Study|Death|0
386994|NCT00819585|1300259|P2|Overall Study|Death|0
386995|NCT00819585|1300260|P1|Overall Study|Death|0
386996|NCT00819585|1300254|P7|Overall Study|Administrative problems|2
386997|NCT00819585|1300255|P6|Overall Study|Administrative problems|0
386998|NCT00819585|1300256|P5|Overall Study|Administrative problems|0
386999|NCT00819585|1300257|P4|Overall Study|Administrative problems|0
387000|NCT00819585|1300258|P3|Overall Study|Administrative problems|0
387001|NCT00819585|1300259|P2|Overall Study|Administrative problems|0
387002|NCT00819585|1300260|P1|Overall Study|Administrative problems|0
387003|NCT00819585|1300254|P7|Overall Study|Lost to Follow-up|1
387004|NCT00819585|1300255|P6|Overall Study|Lost to Follow-up|1
387005|NCT00819585|1300256|P5|Overall Study|Lost to Follow-up|1
387006|NCT00819585|1300257|P4|Overall Study|Lost to Follow-up|0
387007|NCT00819585|1300258|P3|Overall Study|Lost to Follow-up|2
387008|NCT00819585|1300259|P2|Overall Study|Lost to Follow-up|1
387009|NCT00819585|1300260|P1|Overall Study|Lost to Follow-up|2
387010|NCT00819585|1300254|P7|Overall Study|Subject withdrew consent|3
387011|NCT00819585|1300255|P6|Overall Study|Subject withdrew consent|0
387012|NCT00819585|1300256|P5|Overall Study|Subject withdrew consent|0
387013|NCT00819585|1300257|P4|Overall Study|Subject withdrew consent|1
387014|NCT00819585|1300258|P3|Overall Study|Subject withdrew consent|2
387015|NCT00819585|1300259|P2|Overall Study|Subject withdrew consent|3
387016|NCT00819585|1300260|P1|Overall Study|Subject withdrew consent|0
387017|NCT00819585|1300254|P7|Overall Study|Subject no longer requires study drug|0
387018|NCT00819585|1300255|P6|Overall Study|Subject no longer requires study drug|0
387019|NCT00819585|1300256|P5|Overall Study|Subject no longer requires study drug|1
387020|NCT00819585|1300257|P4|Overall Study|Subject no longer requires study drug|0
387021|NCT00819585|1300258|P3|Overall Study|Subject no longer requires study drug|0
387022|NCT00819585|1300259|P2|Overall Study|Subject no longer requires study drug|0
387023|NCT00819585|1300260|P1|Overall Study|Subject no longer requires study drug|0
387024|NCT00819585|1300254|P7|Overall Study|Unsatisfactory therapeutic effect|1
387025|NCT00819585|1300255|P6|Overall Study|Unsatisfactory therapeutic effect|0
387026|NCT00819585|1300256|P5|Overall Study|Unsatisfactory therapeutic effect|0
387027|NCT00819585|1300257|P4|Overall Study|Unsatisfactory therapeutic effect|0
387028|NCT00819585|1300258|P3|Overall Study|Unsatisfactory therapeutic effect|0
387029|NCT00819585|1300259|P2|Overall Study|Unsatisfactory therapeutic effect|1
387030|NCT00819585|1300260|P1|Overall Study|Unsatisfactory therapeutic effect|0
387031|NCT00819585|1300254|P7|Overall Study|Abnormal laboratory value(s)|0
387032|NCT00819585|1300255|P6|Overall Study|Abnormal laboratory value(s)|0
387033|NCT00819585|1300256|P5|Overall Study|Abnormal laboratory value(s)|0
387034|NCT00819585|1300257|P4|Overall Study|Abnormal laboratory value(s)|0
387035|NCT00819585|1300258|P3|Overall Study|Abnormal laboratory value(s)|0
387036|NCT00819585|1300259|P2|Overall Study|Abnormal laboratory value(s)|0
387037|NCT00819585|1300260|P1|Overall Study|Abnormal laboratory value(s)|2
387038|NCT00819585|1300254|P7|Overall Study|Adverse Event|2
387039|NCT00819585|1300255|P6|Overall Study|Adverse Event|0
387040|NCT00819585|1300256|P5|Overall Study|Adverse Event|1
387041|NCT00819585|1300257|P4|Overall Study|Adverse Event|4
387042|NCT00819585|1300258|P3|Overall Study|Adverse Event|1
387043|NCT00819585|1300259|P2|Overall Study|Adverse Event|1
387044|NCT00819585|1300260|P1|Overall Study|Adverse Event|2
387045|NCT00819390|1300337|P4|Overall Study|Adverse Event|0
387046|NCT00819390|1300338|P3|Overall Study|Adverse Event|1
387047|NCT00819390|1300339|P2|Overall Study|Adverse Event|0
387048|NCT00819390|1300340|P1|Overall Study|Adverse Event|0
387049|NCT00819390|1300337|P4|Overall Study|Withdrawal by Subject|0
387050|NCT00819390|1300338|P3|Overall Study|Withdrawal by Subject|0
387051|NCT00819390|1300339|P2|Overall Study|Withdrawal by Subject|0
387052|NCT00819390|1300340|P1|Overall Study|Withdrawal by Subject|2
387053|NCT00819390|1300337|P4|Overall Study|Lost to Follow-up|0
387054|NCT00819390|1300338|P3|Overall Study|Lost to Follow-up|0
387055|NCT00819390|1300339|P2|Overall Study|Lost to Follow-up|1
387056|NCT00819390|1300340|P1|Overall Study|Lost to Follow-up|1
387057|NCT00819247|1300476|P3|Overall Study|not specified|0
387058|NCT00819247|1300477|P2|Overall Study|not specified|0
387059|NCT00819247|1300478|P1|Overall Study|not specified|1
387060|NCT00819247|1300476|P3|Overall Study|Bad prostate-specific antigen response|0
387061|NCT00819247|1300477|P2|Overall Study|Bad prostate-specific antigen response|2
387062|NCT00819247|1300478|P1|Overall Study|Bad prostate-specific antigen response|3
387063|NCT00819247|1300476|P3|Overall Study|Mistakenly withdrawn|0
387064|NCT00819247|1300477|P2|Overall Study|Mistakenly withdrawn|1
387065|NCT00819247|1300478|P1|Overall Study|Mistakenly withdrawn|0
387066|NCT00819247|1300476|P3|Overall Study|Protocol Violation|1
387067|NCT00819247|1300477|P2|Overall Study|Protocol Violation|0
387068|NCT00819247|1300478|P1|Overall Study|Protocol Violation|1
387069|NCT00819247|1300476|P3|Overall Study|Withdrawal by Subject|0
387070|NCT00819247|1300477|P2|Overall Study|Withdrawal by Subject|0
387071|NCT00819247|1300478|P1|Overall Study|Withdrawal by Subject|1
387072|NCT00819247|1300476|P3|Overall Study|Insufficient testosterone response|10
387073|NCT00819247|1300477|P2|Overall Study|Insufficient testosterone response|8
387074|NCT00819247|1300478|P1|Overall Study|Insufficient testosterone response|5
387075|NCT00819247|1300476|P3|Overall Study|Adverse Event|3
387076|NCT00819247|1300477|P2|Overall Study|Adverse Event|5
387077|NCT00819247|1300478|P1|Overall Study|Adverse Event|0
387078|NCT00819234|1300504|P10|Overall Study|Lost to Follow-up|2
387079|NCT00819234|1300505|P9|Overall Study|Lost to Follow-up|1
387080|NCT00819234|1300506|P8|Overall Study|Lost to Follow-up|1
387081|NCT00819234|1300507|P7|Overall Study|Lost to Follow-up|1
387082|NCT00819234|1300508|P6|Overall Study|Lost to Follow-up|1
387083|NCT00819234|1300509|P5|Overall Study|Lost to Follow-up|1
387084|NCT00819234|1300510|P4|Overall Study|Lost to Follow-up|2
387085|NCT00819234|1300511|P3|Overall Study|Lost to Follow-up|0
387086|NCT00819234|1300512|P2|Overall Study|Lost to Follow-up|2
387087|NCT00819234|1300513|P1|Overall Study|Lost to Follow-up|2
387088|NCT00819234|1300504|P10|Overall Study|Protocol Violation|0
387089|NCT00819234|1300505|P9|Overall Study|Protocol Violation|0
387090|NCT00819234|1300506|P8|Overall Study|Protocol Violation|0
387091|NCT00819234|1300507|P7|Overall Study|Protocol Violation|0
387092|NCT00819234|1300508|P6|Overall Study|Protocol Violation|0
387093|NCT00819234|1300509|P5|Overall Study|Protocol Violation|0
387094|NCT00819234|1300510|P4|Overall Study|Protocol Violation|0
387095|NCT00819234|1300511|P3|Overall Study|Protocol Violation|1
387096|NCT00819234|1300512|P2|Overall Study|Protocol Violation|0
387097|NCT00819234|1300513|P1|Overall Study|Protocol Violation|0
387098|NCT00819234|1300504|P10|Overall Study|Physician Decision|2
387099|NCT00819234|1300505|P9|Overall Study|Physician Decision|0
387100|NCT00819234|1300506|P8|Overall Study|Physician Decision|0
387101|NCT00819234|1300507|P7|Overall Study|Physician Decision|0
387102|NCT00819234|1300508|P6|Overall Study|Physician Decision|0
387103|NCT00819234|1300509|P5|Overall Study|Physician Decision|0
387104|NCT00819234|1300510|P4|Overall Study|Physician Decision|1
387105|NCT00819234|1300511|P3|Overall Study|Physician Decision|0
387106|NCT00819234|1300512|P2|Overall Study|Physician Decision|0
387107|NCT00819234|1300513|P1|Overall Study|Physician Decision|0
387108|NCT00819234|1300504|P10|Overall Study|Adverse Event|0
387109|NCT00819234|1300505|P9|Overall Study|Adverse Event|0
387110|NCT00819234|1300506|P8|Overall Study|Adverse Event|0
387111|NCT00819234|1300507|P7|Overall Study|Adverse Event|0
387112|NCT00819234|1300508|P6|Overall Study|Adverse Event|2
387113|NCT00819234|1300509|P5|Overall Study|Adverse Event|0
387114|NCT00819234|1300510|P4|Overall Study|Adverse Event|0
387115|NCT00819234|1300511|P3|Overall Study|Adverse Event|1
387116|NCT00819234|1300512|P2|Overall Study|Adverse Event|0
387117|NCT00819234|1300513|P1|Overall Study|Adverse Event|0
387118|NCT00819234|1300504|P10|Overall Study|Withdrawal by Subject|3
387119|NCT00819234|1300505|P9|Overall Study|Withdrawal by Subject|5
387120|NCT00819234|1300506|P8|Overall Study|Withdrawal by Subject|8
387121|NCT00819234|1300507|P7|Overall Study|Withdrawal by Subject|4
387122|NCT00819234|1300508|P6|Overall Study|Withdrawal by Subject|4
387123|NCT00819234|1300509|P5|Overall Study|Withdrawal by Subject|0
387124|NCT00819234|1300510|P4|Overall Study|Withdrawal by Subject|3
387125|NCT00819234|1300511|P3|Overall Study|Withdrawal by Subject|6
387126|NCT00819234|1300512|P2|Overall Study|Withdrawal by Subject|13
387127|NCT00819234|1300513|P1|Overall Study|Withdrawal by Subject|8
387128|NCT00819156|1300712|P6|Overall Study|Prostate-specific antigen progression|0
387129|NCT00819156|1300713|P5|Overall Study|Prostate-specific antigen progression|1
387130|NCT00819156|1300714|P4|Overall Study|Prostate-specific antigen progression|0
387131|NCT00819156|1300715|P3|Overall Study|Prostate-specific antigen progression|0
387132|NCT00819156|1300716|P2|Overall Study|Prostate-specific antigen progression|0
387133|NCT00819156|1300717|P1|Overall Study|Prostate-specific antigen progression|0
387134|NCT00819156|1300712|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
387135|NCT00819156|1300713|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
387136|NCT00819156|1300714|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
387137|NCT00819156|1300715|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
387138|NCT00819156|1300716|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
387139|NCT00819156|1300717|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
387140|NCT00819156|1300712|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
387141|NCT00819156|1300713|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
387142|NCT00819156|1300714|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
387143|NCT00819156|1300715|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
387144|NCT00819156|1300716|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
387145|NCT00819156|1300717|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
387146|NCT00819156|1300712|P6|Overall Study|Lost to Follow-up|2
387147|NCT00819156|1300713|P5|Overall Study|Lost to Follow-up|0
387148|NCT00819156|1300714|P4|Overall Study|Lost to Follow-up|0
387149|NCT00819156|1300715|P3|Overall Study|Lost to Follow-up|0
387150|NCT00819156|1300716|P2|Overall Study|Lost to Follow-up|1
387151|NCT00819156|1300717|P1|Overall Study|Lost to Follow-up|0
387152|NCT00819156|1300712|P6|Overall Study|Protocol Violation|1
387153|NCT00819156|1300713|P5|Overall Study|Protocol Violation|0
387154|NCT00819156|1300714|P4|Overall Study|Protocol Violation|0
387155|NCT00819156|1300715|P3|Overall Study|Protocol Violation|1
387156|NCT00819156|1300716|P2|Overall Study|Protocol Violation|0
387157|NCT00819156|1300717|P1|Overall Study|Protocol Violation|1
387158|NCT00819156|1300712|P6|Overall Study|Withdrawal by Subject|0
387159|NCT00819156|1300713|P5|Overall Study|Withdrawal by Subject|1
387160|NCT00819156|1300714|P4|Overall Study|Withdrawal by Subject|0
387161|NCT00819156|1300715|P3|Overall Study|Withdrawal by Subject|2
387162|NCT00819156|1300716|P2|Overall Study|Withdrawal by Subject|3
387163|NCT00819156|1300717|P1|Overall Study|Withdrawal by Subject|0
387164|NCT00819156|1300712|P6|Overall Study|Adverse Event|3
387165|NCT00819156|1300713|P5|Overall Study|Adverse Event|2
387166|NCT00819156|1300714|P4|Overall Study|Adverse Event|1
387167|NCT00819156|1300715|P3|Overall Study|Adverse Event|2
387168|NCT00819156|1300716|P2|Overall Study|Adverse Event|4
387169|NCT00819156|1300717|P1|Overall Study|Adverse Event|1
387170|NCT00819091|1300807|P2|Overall Study|Not Specified|2
387171|NCT00819091|1300808|P1|Overall Study|Not Specified|1
387172|NCT00819091|1300807|P2|Overall Study|Withdrawal by Subject|2
387173|NCT00819091|1300808|P1|Overall Study|Withdrawal by Subject|1
387174|NCT00819091|1300807|P2|Overall Study|Lost to Follow-up|0
387175|NCT00819091|1300808|P1|Overall Study|Lost to Follow-up|2
387176|NCT00819091|1300807|P2|Overall Study|Protocol Violation|1
387177|NCT00819091|1300808|P1|Overall Study|Protocol Violation|0
387178|NCT00819091|1300807|P2|Overall Study|Adverse Event|5
387179|NCT00819091|1300808|P1|Overall Study|Adverse Event|3
387180|NCT00819052|1300834|P2|Overall Study|Death or events leading to death|0
387181|NCT00819052|1300835|P1|Overall Study|Death or events leading to death|1
387182|NCT00819052|1300834|P2|Overall Study|Pregnancy|2
387183|NCT00819052|1300835|P1|Overall Study|Pregnancy|1
387184|NCT00819052|1300834|P2|Overall Study|Lack of Efficacy|1
387185|NCT00819052|1300835|P1|Overall Study|Lack of Efficacy|1
387186|NCT00819052|1300834|P2|Overall Study|Withdrawal by Subject|2
387187|NCT00819052|1300835|P1|Overall Study|Withdrawal by Subject|1
387188|NCT00819052|1300834|P2|Overall Study|Lost to Follow-up|2
387189|NCT00819052|1300835|P1|Overall Study|Lost to Follow-up|1
387190|NCT00819052|1300834|P2|Overall Study|Protocol Violation|2
387191|NCT00819052|1300835|P1|Overall Study|Protocol Violation|1
387192|NCT00819052|1300834|P2|Overall Study|Adverse Event|5
387193|NCT00819052|1300835|P1|Overall Study|Adverse Event|0
387194|NCT00819039|1300950|P3|Overall Study|Protocol Violation|0
387195|NCT00819039|1300951|P2|Overall Study|Protocol Violation|0
387196|NCT00819039|1300952|P1|Overall Study|Protocol Violation|1
387197|NCT00819039|1300950|P3|Overall Study|Physician Decision|1
387198|NCT00819039|1300951|P2|Overall Study|Physician Decision|0
387199|NCT00819039|1300952|P1|Overall Study|Physician Decision|1
387200|NCT00819013|1300982|P4|Overall Study|Death|1
387201|NCT00819013|1300983|P3|Overall Study|Death|0
387202|NCT00819013|1300984|P2|Overall Study|Death|0
387203|NCT00819013|1300985|P1|Overall Study|Death|0
387204|NCT00819013|1300982|P4|Overall Study|Lost to Follow-up|2
387205|NCT00819013|1300983|P3|Overall Study|Lost to Follow-up|1
387206|NCT00819013|1300984|P2|Overall Study|Lost to Follow-up|0
387207|NCT00819013|1300985|P1|Overall Study|Lost to Follow-up|0
387208|NCT00819013|1300982|P4|Overall Study|Withdrawal by Subject|0
387209|NCT00819013|1300983|P3|Overall Study|Withdrawal by Subject|1
387210|NCT00819013|1300984|P2|Overall Study|Withdrawal by Subject|0
387211|NCT00819013|1300985|P1|Overall Study|Withdrawal by Subject|1
387212|NCT00819013|1300982|P4|Overall Study|Adverse Event|0
387213|NCT00819013|1300983|P3|Overall Study|Adverse Event|1
387214|NCT00819013|1300984|P2|Overall Study|Adverse Event|0
387215|NCT00819013|1300985|P1|Overall Study|Adverse Event|0
387216|NCT00819013|1300982|P4|Overall Study|Not meeting continuing study eligibility|1
387217|NCT00819013|1300983|P3|Overall Study|Not meeting continuing study eligibility|2
387218|NCT00819013|1300984|P2|Overall Study|Not meeting continuing study eligibility|1
387219|NCT00819013|1300985|P1|Overall Study|Not meeting continuing study eligibility|2
387220|NCT00818883|1301051|P2|Overall Study|Other|7
387221|NCT00818883|1301052|P1|Overall Study|Other|2
387222|NCT00818883|1301051|P2|Overall Study|Lack of Efficacy|2
387223|NCT00818883|1301052|P1|Overall Study|Lack of Efficacy|0
387224|NCT00818883|1301051|P2|Overall Study|Withdrawal by Subject|14
387225|NCT00818883|1301052|P1|Overall Study|Withdrawal by Subject|16
387226|NCT00818883|1301051|P2|Overall Study|Lost to Follow-up|2
387227|NCT00818883|1301052|P1|Overall Study|Lost to Follow-up|3
387228|NCT00818883|1301051|P2|Overall Study|Protocol Violation|2
387229|NCT00818883|1301052|P1|Overall Study|Protocol Violation|2
387230|NCT00818883|1301051|P2|Overall Study|Adverse Event|19
387231|NCT00818883|1301052|P1|Overall Study|Adverse Event|28
387232|NCT00818779|1301099|P2|Overall Study|Adverse Event|1
387233|NCT00818779|1301100|P1|Overall Study|Adverse Event|4
387234|NCT00818779|1301099|P2|Overall Study|Lost to Follow-up|0
387235|NCT00818779|1301100|P1|Overall Study|Lost to Follow-up|1
387236|NCT00818779|1301099|P2|Overall Study|Protocol Violation|0
387237|NCT00818779|1301100|P1|Overall Study|Protocol Violation|1
387238|NCT00818766|1301116|P2|Overall Study|Did not Receive Allocated Intervention|0
387239|NCT00818766|1301117|P1|Overall Study|Did not Receive Allocated Intervention|3
387240|NCT00818766|1301116|P2|Overall Study|Death|0
387241|NCT00818766|1301117|P1|Overall Study|Death|1
387242|NCT00818766|1301116|P2|Overall Study|Could not be Contacted on Day 28|10
387243|NCT00818766|1301117|P1|Overall Study|Could not be Contacted on Day 28|11
387244|NCT00818753|1301146|P3|Overall Study|Randomised and not treated|0
387245|NCT00818753|1301147|P2|Overall Study|Randomised and not treated|0
387246|NCT00818753|1301148|P1|Overall Study|Randomised and not treated|2
387247|NCT00818753|1301146|P3|Overall Study|Other reason (not specified)|1
387248|NCT00818753|1301147|P2|Overall Study|Other reason (not specified)|0
387249|NCT00818753|1301148|P1|Overall Study|Other reason (not specified)|0
387250|NCT00818753|1301146|P3|Overall Study|Protocol Violation|0
387251|NCT00818753|1301147|P2|Overall Study|Protocol Violation|0
387252|NCT00818753|1301148|P1|Overall Study|Protocol Violation|1
387253|NCT00818662|1301172|P4|Overall Study|Admitted to long term nursing care|0
387254|NCT00818662|1301173|P3|Overall Study|Admitted to long term nursing care|0
387255|NCT00818662|1301174|P2|Overall Study|Admitted to long term nursing care|1
387256|NCT00818662|1301175|P1|Overall Study|Admitted to long term nursing care|0
387257|NCT00818662|1301172|P4|Overall Study|Study partner decision|1
387258|NCT00818662|1301173|P3|Overall Study|Study partner decision|0
387259|NCT00818662|1301174|P2|Overall Study|Study partner decision|0
387260|NCT00818662|1301175|P1|Overall Study|Study partner decision|0
387261|NCT00818662|1301172|P4|Overall Study|Change in living situation|1
387262|NCT00818662|1301173|P3|Overall Study|Change in living situation|0
387263|NCT00818662|1301174|P2|Overall Study|Change in living situation|0
387264|NCT00818662|1301175|P1|Overall Study|Change in living situation|0
387265|NCT00818662|1301172|P4|Overall Study|Declined move to another study site|0
387266|NCT00818662|1301173|P3|Overall Study|Declined move to another study site|0
387267|NCT00818662|1301174|P2|Overall Study|Declined move to another study site|0
387268|NCT00818662|1301175|P1|Overall Study|Declined move to another study site|1
387269|NCT00818662|1301172|P4|Overall Study|Moving out of state|1
387270|NCT00818662|1301173|P3|Overall Study|Moving out of state|0
387271|NCT00818662|1301174|P2|Overall Study|Moving out of state|0
387272|NCT00818662|1301175|P1|Overall Study|Moving out of state|0
387273|NCT00818662|1301172|P4|Overall Study|Caregiver to pursue other treatment|0
387274|NCT00818662|1301173|P3|Overall Study|Caregiver to pursue other treatment|0
387275|NCT00818662|1301174|P2|Overall Study|Caregiver to pursue other treatment|1
387276|NCT00818662|1301175|P1|Overall Study|Caregiver to pursue other treatment|0
387277|NCT00818662|1301172|P4|Overall Study|Participant's health declined|1
387278|NCT00818662|1301173|P3|Overall Study|Participant's health declined|0
387279|NCT00818662|1301174|P2|Overall Study|Participant's health declined|0
387280|NCT00818662|1301175|P1|Overall Study|Participant's health declined|0
387281|NCT00818662|1301172|P4|Overall Study|Study Partner Unwilling or Unable|1
387282|NCT00818662|1301173|P3|Overall Study|Study Partner Unwilling or Unable|1
387283|NCT00818662|1301174|P2|Overall Study|Study Partner Unwilling or Unable|2
387284|NCT00818662|1301175|P1|Overall Study|Study Partner Unwilling or Unable|3
387285|NCT00818662|1301172|P4|Overall Study|Safety Risk|1
387286|NCT00818662|1301173|P3|Overall Study|Safety Risk|0
387287|NCT00818662|1301174|P2|Overall Study|Safety Risk|1
387288|NCT00818662|1301175|P1|Overall Study|Safety Risk|1
387289|NCT00818662|1301172|P4|Overall Study|Requires a Prohibited Medication|0
387290|NCT00818662|1301173|P3|Overall Study|Requires a Prohibited Medication|0
387291|NCT00818662|1301174|P2|Overall Study|Requires a Prohibited Medication|0
387292|NCT00818662|1301175|P1|Overall Study|Requires a Prohibited Medication|1
387293|NCT00818662|1301172|P4|Overall Study|Protocol Violation|0
387294|NCT00818662|1301173|P3|Overall Study|Protocol Violation|0
387295|NCT00818662|1301174|P2|Overall Study|Protocol Violation|1
387296|NCT00818662|1301175|P1|Overall Study|Protocol Violation|1
387297|NCT00818662|1301172|P4|Overall Study|Unwilling or Unable to Participate|4
387298|NCT00818662|1301173|P3|Overall Study|Unwilling or Unable to Participate|2
387299|NCT00818662|1301174|P2|Overall Study|Unwilling or Unable to Participate|6
387300|NCT00818662|1301175|P1|Overall Study|Unwilling or Unable to Participate|4
387301|NCT00818662|1301172|P4|Overall Study|Lost to Follow-up|1
387302|NCT00818662|1301173|P3|Overall Study|Lost to Follow-up|0
387303|NCT00818662|1301174|P2|Overall Study|Lost to Follow-up|0
387304|NCT00818662|1301175|P1|Overall Study|Lost to Follow-up|0
387305|NCT00818662|1301172|P4|Overall Study|Physician Decision|0
387306|NCT00818662|1301173|P3|Overall Study|Physician Decision|0
387307|NCT00818662|1301174|P2|Overall Study|Physician Decision|0
387308|NCT00818662|1301175|P1|Overall Study|Physician Decision|1
387309|NCT00818662|1301172|P4|Overall Study|Death|0
387310|NCT00818662|1301173|P3|Overall Study|Death|0
387311|NCT00818662|1301174|P2|Overall Study|Death|3
387312|NCT00818662|1301175|P1|Overall Study|Death|1
387313|NCT00818662|1301172|P4|Overall Study|Withdrawal by Subject|2
387314|NCT00818662|1301173|P3|Overall Study|Withdrawal by Subject|2
387315|NCT00818662|1301174|P2|Overall Study|Withdrawal by Subject|4
387316|NCT00818662|1301175|P1|Overall Study|Withdrawal by Subject|5
387317|NCT00818662|1301172|P4|Overall Study|Adverse Event|3
387318|NCT00818662|1301173|P3|Overall Study|Adverse Event|4
387319|NCT00818662|1301174|P2|Overall Study|Adverse Event|14
387320|NCT00818662|1301175|P1|Overall Study|Adverse Event|5
387321|NCT00818649|1301261|P1|Overall Study|Adverse Event|1
387322|NCT00818649|1301261|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
387323|NCT00818649|1301261|P1|Overall Study|Declining performance status|2
387324|NCT00818623|1301275|P8|Overall Study|Disease progression|0
387325|NCT00818623|1301276|P7|Overall Study|Disease progression|1
387326|NCT00818623|1301277|P6|Overall Study|Disease progression|0
387327|NCT00818623|1301278|P5|Overall Study|Disease progression|0
387328|NCT00818623|1301279|P4|Overall Study|Disease progression|0
387329|NCT00818623|1301280|P3|Overall Study|Disease progression|0
387330|NCT00818623|1301281|P2|Overall Study|Disease progression|0
387331|NCT00818623|1301282|P1|Overall Study|Disease progression|0
387332|NCT00818623|1301275|P8|Overall Study|Lack of trial drug at site|0
387333|NCT00818623|1301276|P7|Overall Study|Lack of trial drug at site|1
387334|NCT00818623|1301277|P6|Overall Study|Lack of trial drug at site|0
387335|NCT00818623|1301278|P5|Overall Study|Lack of trial drug at site|2
387336|NCT00818623|1301279|P4|Overall Study|Lack of trial drug at site|0
387337|NCT00818623|1301280|P3|Overall Study|Lack of trial drug at site|0
387338|NCT00818623|1301281|P2|Overall Study|Lack of trial drug at site|0
387339|NCT00818623|1301282|P1|Overall Study|Lack of trial drug at site|0
387340|NCT00818623|1301275|P8|Overall Study|Need of additional treatment|0
387341|NCT00818623|1301276|P7|Overall Study|Need of additional treatment|0
387342|NCT00818623|1301277|P6|Overall Study|Need of additional treatment|0
387343|NCT00818623|1301278|P5|Overall Study|Need of additional treatment|1
387344|NCT00818623|1301279|P4|Overall Study|Need of additional treatment|0
387345|NCT00818623|1301280|P3|Overall Study|Need of additional treatment|0
387346|NCT00818623|1301281|P2|Overall Study|Need of additional treatment|0
387347|NCT00818623|1301282|P1|Overall Study|Need of additional treatment|0
387348|NCT00818623|1301275|P8|Overall Study|Protocol Violation|0
387349|NCT00818623|1301276|P7|Overall Study|Protocol Violation|1
387350|NCT00818623|1301277|P6|Overall Study|Protocol Violation|0
387351|NCT00818623|1301278|P5|Overall Study|Protocol Violation|1
387352|NCT00818623|1301279|P4|Overall Study|Protocol Violation|0
387353|NCT00818623|1301280|P3|Overall Study|Protocol Violation|0
387354|NCT00818623|1301281|P2|Overall Study|Protocol Violation|0
387355|NCT00818623|1301282|P1|Overall Study|Protocol Violation|1
387356|NCT00818623|1301275|P8|Overall Study|Withdrawal by Subject|1
387357|NCT00818623|1301276|P7|Overall Study|Withdrawal by Subject|1
387358|NCT00818623|1301277|P6|Overall Study|Withdrawal by Subject|1
387359|NCT00818623|1301278|P5|Overall Study|Withdrawal by Subject|0
387360|NCT00818623|1301279|P4|Overall Study|Withdrawal by Subject|0
387361|NCT00818623|1301280|P3|Overall Study|Withdrawal by Subject|1
387362|NCT00818623|1301281|P2|Overall Study|Withdrawal by Subject|1
387363|NCT00818623|1301282|P1|Overall Study|Withdrawal by Subject|0
387364|NCT00818623|1301275|P8|Overall Study|Bad prostate specific antigen response|0
387365|NCT00818623|1301276|P7|Overall Study|Bad prostate specific antigen response|0
387366|NCT00818623|1301277|P6|Overall Study|Bad prostate specific antigen response|1
387367|NCT00818623|1301278|P5|Overall Study|Bad prostate specific antigen response|0
387368|NCT00818623|1301279|P4|Overall Study|Bad prostate specific antigen response|5
387369|NCT00818623|1301280|P3|Overall Study|Bad prostate specific antigen response|2
387370|NCT00818623|1301281|P2|Overall Study|Bad prostate specific antigen response|3
387371|NCT00818623|1301282|P1|Overall Study|Bad prostate specific antigen response|0
387372|NCT00818623|1301275|P8|Overall Study|Adverse Event|0
387373|NCT00818623|1301276|P7|Overall Study|Adverse Event|0
387374|NCT00818623|1301277|P6|Overall Study|Adverse Event|1
387375|NCT00818623|1301278|P5|Overall Study|Adverse Event|0
387376|NCT00818623|1301279|P4|Overall Study|Adverse Event|0
387377|NCT00818623|1301280|P3|Overall Study|Adverse Event|1
387378|NCT00818623|1301281|P2|Overall Study|Adverse Event|0
387379|NCT00818623|1301282|P1|Overall Study|Adverse Event|1
387380|NCT00818519|1301358|P2|Overall Study|participant will leave for long tme|0
387381|NCT00818519|1301359|P1|Overall Study|participant will leave for long tme|1
387382|NCT00818519|1301358|P2|Overall Study|participant recovered completely|0
387383|NCT00818519|1301359|P1|Overall Study|participant recovered completely|1
387384|NCT00818519|1301358|P2|Overall Study|Withdrawal by Subject|9
387385|NCT00818519|1301359|P1|Overall Study|Withdrawal by Subject|4
387386|NCT00818519|1301358|P2|Overall Study|Pregnancy|1
387387|NCT00818519|1301359|P1|Overall Study|Pregnancy|0
387388|NCT00818519|1301358|P2|Overall Study|Protocol Violation|1
387389|NCT00818519|1301359|P1|Overall Study|Protocol Violation|2
387390|NCT00818519|1301358|P2|Overall Study|Lost to Follow-up|6
387391|NCT00818519|1301359|P1|Overall Study|Lost to Follow-up|4
387392|NCT00818519|1301358|P2|Overall Study|Adverse Event|2
387393|NCT00818519|1301359|P1|Overall Study|Adverse Event|2
387394|NCT00818454|1301389|P4|Treatment Period 3|Adverse Event|1
387395|NCT00818454|1301390|P3|Treatment Period 3|Adverse Event|0
387396|NCT00818454|1301391|P2|Treatment Period 3|Adverse Event|0
387397|NCT00818454|1301392|P1|Treatment Period 3|Adverse Event|0
387398|NCT00818454|1301389|P4|Treatment Period 2|not specified|0
387399|NCT00818454|1301390|P3|Treatment Period 2|not specified|0
387400|NCT00818454|1301391|P2|Treatment Period 2|not specified|1
387401|NCT00818454|1301392|P1|Treatment Period 2|not specified|2
387402|NCT00818454|1301389|P4|Washout Period of 1 Week|not specified|0
387403|NCT00818454|1301390|P3|Washout Period of 1 Week|not specified|0
387404|NCT00818454|1301391|P2|Washout Period of 1 Week|not specified|2
387405|NCT00818454|1301392|P1|Washout Period of 1 Week|not specified|1
387406|NCT00818454|1301389|P4|Washout Period of 1 Week|Protocol Violation|0
387407|NCT00818454|1301390|P3|Washout Period of 1 Week|Protocol Violation|0
387408|NCT00818454|1301391|P2|Washout Period of 1 Week|Protocol Violation|0
387409|NCT00818454|1301392|P1|Washout Period of 1 Week|Protocol Violation|2
387410|NCT00818454|1301389|P4|Washout Period of 1 Week|Adverse Event|0
387411|NCT00818454|1301390|P3|Washout Period of 1 Week|Adverse Event|0
387412|NCT00818454|1301391|P2|Washout Period of 1 Week|Adverse Event|1
387413|NCT00818454|1301392|P1|Washout Period of 1 Week|Adverse Event|1
387414|NCT00818454|1301389|P4|Treatment Period 1|not specified|0
387415|NCT00818454|1301390|P3|Treatment Period 1|not specified|0
387416|NCT00818454|1301391|P2|Treatment Period 1|not specified|0
387417|NCT00818454|1301392|P1|Treatment Period 1|not specified|3
387418|NCT00818454|1301389|P4|Treatment Period 1|Adverse Event|0
387419|NCT00818454|1301390|P3|Treatment Period 1|Adverse Event|0
387420|NCT00818454|1301391|P2|Treatment Period 1|Adverse Event|1
387421|NCT00818454|1301392|P1|Treatment Period 1|Adverse Event|0
387422|NCT00818441|1301420|P2|Overall Study|Study terminated by sponsor|2
387423|NCT00818441|1301421|P1|Overall Study|Study terminated by sponsor|11
387424|NCT00818441|1301420|P2|Overall Study|Adverse Event|1
387425|NCT00818441|1301421|P1|Overall Study|Adverse Event|0
387426|NCT00818441|1301420|P2|Overall Study|Withdrawal by Subject|0
387427|NCT00818441|1301421|P1|Overall Study|Withdrawal by Subject|2
387428|NCT00818441|1301420|P2|Overall Study|Lost to Follow-up|1
387429|NCT00818441|1301421|P1|Overall Study|Lost to Follow-up|2
387430|NCT00818441|1301420|P2|Overall Study|Other|0
387431|NCT00818441|1301421|P1|Overall Study|Other|5
387432|NCT00818441|1301420|P2|Overall Study|Death|26
387433|NCT00818441|1301421|P1|Overall Study|Death|69
387434|NCT00818389|1301443|P2|Overall Study|Adverse Event|1
387435|NCT00818389|1301444|P1|Overall Study|Adverse Event|0
387436|NCT00818389|1301443|P2|Overall Study|Withdrawal by Subject|2
387437|NCT00818389|1301444|P1|Overall Study|Withdrawal by Subject|2
387438|NCT00818389|1301443|P2|Overall Study|ALS Disease Progression|0
387439|NCT00818389|1301444|P1|Overall Study|ALS Disease Progression|1
387440|NCT00818389|1301443|P2|Overall Study|Death|3
387441|NCT00818389|1301444|P1|Overall Study|Death|1
387442|NCT00818259|1301479|P9|Part V|Adverse Event|0
387443|NCT00818259|1301480|P8|Part V|Adverse Event|1
387444|NCT00818259|1301481|P7|Part V|Adverse Event|0
387445|NCT00818259|1301482|P6|Part V|Adverse Event|0
387446|NCT00818259|1301483|P5|Part V|Adverse Event|0
387447|NCT00818259|1301484|P4|Part V|Adverse Event|0
387448|NCT00818259|1301485|P3|Part V|Adverse Event|0
387449|NCT00818259|1301486|P2|Part V|Adverse Event|0
387450|NCT00818259|1301487|P1|Part V|Adverse Event|0
387451|NCT00818259|1301479|P9|Part IV|Physician Decision|0
387452|NCT00818259|1301480|P8|Part IV|Physician Decision|0
387453|NCT00818259|1301481|P7|Part IV|Physician Decision|0
387454|NCT00818259|1301482|P6|Part IV|Physician Decision|1
387455|NCT00818259|1301483|P5|Part IV|Physician Decision|0
387456|NCT00818259|1301484|P4|Part IV|Physician Decision|0
387457|NCT00818259|1301485|P3|Part IV|Physician Decision|0
387458|NCT00818259|1301486|P2|Part IV|Physician Decision|0
387459|NCT00818259|1301487|P1|Part IV|Physician Decision|0
387460|NCT00818259|1301479|P9|Part II|Not Treated|0
387461|NCT00818259|1301480|P8|Part II|Not Treated|0
387462|NCT00818259|1301481|P7|Part II|Not Treated|0
387463|NCT00818259|1301482|P6|Part II|Not Treated|0
387464|NCT00818259|1301483|P5|Part II|Not Treated|0
387465|NCT00818259|1301484|P4|Part II|Not Treated|1
387466|NCT00818259|1301485|P3|Part II|Not Treated|0
387467|NCT00818259|1301486|P2|Part II|Not Treated|0
387468|NCT00818259|1301487|P1|Part II|Not Treated|0
387469|NCT00818259|1301479|P9|Part II|Lack of Efficacy|0
387470|NCT00818259|1301480|P8|Part II|Lack of Efficacy|0
387471|NCT00818259|1301481|P7|Part II|Lack of Efficacy|0
387472|NCT00818259|1301482|P6|Part II|Lack of Efficacy|0
387473|NCT00818259|1301483|P5|Part II|Lack of Efficacy|0
387474|NCT00818259|1301484|P4|Part II|Lack of Efficacy|1
387475|NCT00818259|1301485|P3|Part II|Lack of Efficacy|0
387476|NCT00818259|1301486|P2|Part II|Lack of Efficacy|0
387477|NCT00818259|1301487|P1|Part II|Lack of Efficacy|0
387478|NCT00818259|1301479|P9|Part II|Physician Decision|0
387479|NCT00818259|1301480|P8|Part II|Physician Decision|0
387480|NCT00818259|1301481|P7|Part II|Physician Decision|0
387481|NCT00818259|1301482|P6|Part II|Physician Decision|0
387482|NCT00818259|1301483|P5|Part II|Physician Decision|0
387483|NCT00818259|1301484|P4|Part II|Physician Decision|0
387484|NCT00818259|1301485|P3|Part II|Physician Decision|1
387485|NCT00818259|1301486|P2|Part II|Physician Decision|0
387486|NCT00818259|1301487|P1|Part II|Physician Decision|0
387487|NCT00818259|1301479|P9|Part I|Withdrawal by Subject|0
387488|NCT00818259|1301480|P8|Part I|Withdrawal by Subject|0
387489|NCT00818259|1301481|P7|Part I|Withdrawal by Subject|0
387490|NCT00818259|1301482|P6|Part I|Withdrawal by Subject|0
387491|NCT00818259|1301483|P5|Part I|Withdrawal by Subject|0
387492|NCT00818259|1301484|P4|Part I|Withdrawal by Subject|0
387493|NCT00818259|1301485|P3|Part I|Withdrawal by Subject|0
387494|NCT00818259|1301486|P2|Part I|Withdrawal by Subject|0
387495|NCT00818259|1301487|P1|Part I|Withdrawal by Subject|1
387496|NCT00818246|1301559|P1|Overall Study|Impossible to match pictures|5
387497|NCT00818207|1301568|P2|Overall Study|Death|5
387498|NCT00818207|1301569|P1|Overall Study|Death|3
387499|NCT00818207|1301568|P2|Overall Study|Withdrawal by Subject|104
387500|NCT00818207|1301569|P1|Overall Study|Withdrawal by Subject|42
387501|NCT00818207|1301568|P2|Overall Study|Multiple reasons|12
387502|NCT00818207|1301569|P1|Overall Study|Multiple reasons|11
387503|NCT00818207|1301568|P2|Overall Study|Lost to Follow-up|146
387504|NCT00818207|1301569|P1|Overall Study|Lost to Follow-up|160
387505|NCT00818207|1301568|P2|Overall Study|Adverse Event|0
387506|NCT00818207|1301569|P1|Overall Study|Adverse Event|6
387507|NCT00818168|1301583|P1|Overall Study|Participant Moved|2
387508|NCT00818168|1301583|P1|Overall Study|Reason for Non-completion Not reported|6
387509|NCT00818168|1301583|P1|Overall Study|Adverse Event|19
387510|NCT00818168|1301583|P1|Overall Study|Lost to Follow-up|7
387511|NCT00818168|1301583|P1|Overall Study|Withdrawal by Subject|16
387512|NCT00818168|1301583|P1|Overall Study|Pregnancy|2
387513|NCT00818168|1301583|P1|Overall Study|Lack of Efficacy|18
387514|NCT00817778|1301623|P2|Overall Study|Poor venous access|0
387515|NCT00817778|1301624|P1|Overall Study|Poor venous access|1
387516|NCT00817778|1301623|P2|Overall Study|Study-specific discontinuation criteria|1
387517|NCT00817778|1301624|P1|Overall Study|Study-specific discontinuation criteria|0
387518|NCT00817778|1301623|P2|Overall Study|Protocol Violation|1
387519|NCT00817778|1301624|P1|Overall Study|Protocol Violation|0
387520|NCT00817778|1301623|P2|Overall Study|Withdrawal by Subject|1
387521|NCT00817778|1301624|P1|Overall Study|Withdrawal by Subject|1
387522|NCT00817778|1301623|P2|Overall Study|Adverse Event|0
387523|NCT00817778|1301624|P1|Overall Study|Adverse Event|1
387524|NCT00817531|1301653|P1|Overall Study|Lack of Efficacy|1
387525|NCT00817531|1301653|P1|Overall Study|Adverse Event|1
387526|NCT00817479|1301659|P2|Overall Study|Physician Decision|1
387527|NCT00817479|1301660|P1|Overall Study|Physician Decision|1
387528|NCT00817336|1301670|P2|Overall Study|Withdrawal by Subject|1
387529|NCT00817336|1301671|P1|Overall Study|Withdrawal by Subject|1
387530|NCT00817206|1301697|P2|Overall Study|Physician Decision|0
387531|NCT00817206|1301698|P1|Overall Study|Physician Decision|2
387532|NCT00817206|1301697|P2|Overall Study|Withdrawal by Subject|3
387533|NCT00817206|1301698|P1|Overall Study|Withdrawal by Subject|7
387534|NCT00817206|1301697|P2|Overall Study|Death|0
387535|NCT00817206|1301698|P1|Overall Study|Death|2
387536|NCT00817206|1301697|P2|Overall Study|Lost to Follow-up|1
387537|NCT00817206|1301698|P1|Overall Study|Lost to Follow-up|0
387538|NCT00817206|1301697|P2|Overall Study|Protocol Violation|2
387539|NCT00817206|1301698|P1|Overall Study|Protocol Violation|0
387540|NCT00817206|1301697|P2|Overall Study|Adverse Event|3
387541|NCT00817206|1301698|P1|Overall Study|Adverse Event|10
387542|NCT00817063|1301706|P2|Overall Study|Abnormality of Laboratory Test|1
387543|NCT00817063|1301707|P1|Overall Study|Abnormality of Laboratory Test|2
387544|NCT00817063|1301706|P2|Overall Study|Administrative|4
387545|NCT00817063|1301707|P1|Overall Study|Administrative|10
387546|NCT00817063|1301706|P2|Overall Study|Early Improvement|4
387547|NCT00817063|1301707|P1|Overall Study|Early Improvement|19
387548|NCT00817063|1301706|P2|Overall Study|Withdrawal by Subject|37
387549|NCT00817063|1301707|P1|Overall Study|Withdrawal by Subject|17
387550|NCT00817063|1301706|P2|Overall Study|Protocol Violation|8
387551|NCT00817063|1301707|P1|Overall Study|Protocol Violation|3
387552|NCT00817063|1301706|P2|Overall Study|Violation of Selection at Entry|4
387553|NCT00817063|1301707|P1|Overall Study|Violation of Selection at Entry|7
387554|NCT00817063|1301706|P2|Overall Study|Failure to Return|12
387555|NCT00817063|1301707|P1|Overall Study|Failure to Return|13
387556|NCT00817063|1301706|P2|Overall Study|Lack of Efficacy|86
387557|NCT00817063|1301707|P1|Overall Study|Lack of Efficacy|33
387558|NCT00817063|1301706|P2|Overall Study|Death|1
387559|NCT00817063|1301707|P1|Overall Study|Death|1
387560|NCT00817063|1301706|P2|Overall Study|Adverse Event|13
387561|NCT00817063|1301707|P1|Overall Study|Adverse Event|32
387562|NCT00816595|1301810|P2|Overall Study|Withdrawal by Subject|0
387563|NCT00816595|1301811|P1|Overall Study|Withdrawal by Subject|2
387564|NCT00816556|1301824|P3|Overall Study|Lost to Follow-up|1
387565|NCT00816556|1301825|P2|Overall Study|Lost to Follow-up|0
387566|NCT00816556|1301826|P1|Overall Study|Lost to Follow-up|0
387567|NCT00816556|1301824|P3|Overall Study|Withdrawal by Subject|1
387568|NCT00816556|1301825|P2|Overall Study|Withdrawal by Subject|1
387569|NCT00816556|1301826|P1|Overall Study|Withdrawal by Subject|1
387570|NCT00816556|1301824|P3|Overall Study|Adverse Event|1
387571|NCT00816556|1301825|P2|Overall Study|Adverse Event|1
387572|NCT00816556|1301826|P1|Overall Study|Adverse Event|1
387573|NCT00816400|1301849|P9|Overall Study|In hospice care at the end of the study|0
387574|NCT00816400|1301850|P8|Overall Study|In hospice care at the end of the study|0
387575|NCT00816400|1301851|P7|Overall Study|In hospice care at the end of the study|0
387576|NCT00816400|1301852|P6|Overall Study|In hospice care at the end of the study|0
387577|NCT00816400|1301853|P5|Overall Study|In hospice care at the end of the study|0
387578|NCT00816400|1301854|P4|Overall Study|In hospice care at the end of the study|0
387579|NCT00816400|1301855|P3|Overall Study|In hospice care at the end of the study|2
387580|NCT00816400|1301856|P2|Overall Study|In hospice care at the end of the study|0
387581|NCT00816400|1301857|P1|Overall Study|In hospice care at the end of the study|0
387582|NCT00816400|1301849|P9|Overall Study|Death|6
387583|NCT00816400|1301850|P8|Overall Study|Death|5
387584|NCT00816400|1301851|P7|Overall Study|Death|2
387585|NCT00816400|1301852|P6|Overall Study|Death|3
387586|NCT00816400|1301853|P5|Overall Study|Death|2
387587|NCT00816400|1301854|P4|Overall Study|Death|3
387588|NCT00816400|1301855|P3|Overall Study|Death|3
387589|NCT00816400|1301856|P2|Overall Study|Death|3
387590|NCT00816400|1301857|P1|Overall Study|Death|2
387591|NCT00816166|1302047|P2|Overall Study|Death|2
387592|NCT00816166|1302048|P1|Overall Study|Death|4
387593|NCT00816166|1302047|P2|Overall Study|Lost to Follow-up|10
387594|NCT00816166|1302048|P1|Overall Study|Lost to Follow-up|6
387595|NCT00816036|1302080|P2|Overall Study|Withdrawal by Subject|23
387596|NCT00816036|1302081|P1|Overall Study|Withdrawal by Subject|54
387597|NCT00816036|1302080|P2|Overall Study|Lost to Follow-up|57
387598|NCT00816036|1302081|P1|Overall Study|Lost to Follow-up|75
387599|NCT00816036|1302080|P2|Overall Study|Death|28
387600|NCT00816036|1302081|P1|Overall Study|Death|47
387601|NCT00816023|1302095|P4|Overall Study|Randomized Not Treated|11
387602|NCT00816023|1302096|P3|Overall Study|Randomized Not Treated|6
387603|NCT00816023|1302097|P2|Overall Study|Randomized Not Treated|4
387604|NCT00816023|1302098|P1|Overall Study|Randomized Not Treated|6
387605|NCT00816023|1302095|P4|Overall Study|assessments complete prior to window|1
387606|NCT00816023|1302096|P3|Overall Study|assessments complete prior to window|2
387607|NCT00816023|1302097|P2|Overall Study|assessments complete prior to window|1
387608|NCT00816023|1302098|P1|Overall Study|assessments complete prior to window|1
387609|NCT00816023|1302095|P4|Overall Study|Physician Decision|0
387610|NCT00816023|1302096|P3|Overall Study|Physician Decision|1
387611|NCT00816023|1302097|P2|Overall Study|Physician Decision|0
387612|NCT00816023|1302098|P1|Overall Study|Physician Decision|0
387613|NCT00816023|1302095|P4|Overall Study|Withdrawal by Subject|0
387614|NCT00816023|1302096|P3|Overall Study|Withdrawal by Subject|0
387615|NCT00816023|1302097|P2|Overall Study|Withdrawal by Subject|0
387616|NCT00816023|1302098|P1|Overall Study|Withdrawal by Subject|1
387617|NCT00816023|1302095|P4|Overall Study|Lost to Follow-up|0
387618|NCT00816023|1302096|P3|Overall Study|Lost to Follow-up|0
387619|NCT00816023|1302097|P2|Overall Study|Lost to Follow-up|1
387620|NCT00816023|1302098|P1|Overall Study|Lost to Follow-up|1
387621|NCT00815919|1302112|P1|Overall Study|Lack of Efficacy|2
387622|NCT00815919|1302112|P1|Overall Study|AML Relapse|1
387623|NCT00815919|1302112|P1|Overall Study|Unrelated Fungal Infection|1
387624|NCT00815659|1302155|P1|Overall Study|Protocol Violation|1
387625|NCT00815659|1302155|P1|Overall Study|Lost to Follow-up|4
387626|NCT00815659|1302155|P1|Overall Study|Withdrawal by Subject|9
387627|NCT00815659|1302155|P1|Overall Study|Adverse Event|9
387628|NCT00815633|1302198|P1|Overall Study|study terminated|1
387629|NCT00815516|1302205|P2|Overall Study|Physician Decision|0
387630|NCT00815516|1302206|P1|Overall Study|Physician Decision|1
387631|NCT00815516|1302205|P2|Overall Study|Death|1
387632|NCT00815516|1302206|P1|Overall Study|Death|3
387633|NCT00815308|1302271|P1|Overall Study|Protocol Violation|6
387634|NCT00815308|1302271|P1|Overall Study|Withdrawal by Subject|0
387635|NCT00815308|1302271|P1|Overall Study|Adverse Event|4
387636|NCT00815295|1302280|P3|Overall Study|Cetuximab hypersensitivity reaction|3
387637|NCT00815295|1302281|P2|Overall Study|Cetuximab hypersensitivity reaction|1
387638|NCT00815295|1302282|P1|Overall Study|Cetuximab hypersensitivity reaction|0
387639|NCT00815191|1302294|P2|Overall Study|Protocol Violation|1
387640|NCT00815191|1302295|P1|Overall Study|Protocol Violation|1
387641|NCT00814983|1302332|P2|Overall Study|Graft failure|0
387642|NCT00814983|1302333|P1|Overall Study|Graft failure|1
387643|NCT00814983|1302332|P2|Overall Study|Withdrawal by Subject|0
387644|NCT00814983|1302333|P1|Overall Study|Withdrawal by Subject|1
387645|NCT00814983|1302332|P2|Overall Study|Screen failure|0
387646|NCT00814983|1302333|P1|Overall Study|Screen failure|1
387647|NCT00814892|1302364|P1|Overall Study|Study Termination|1
387648|NCT00814892|1302364|P1|Overall Study|Disease Progression|1
387649|NCT00814879|1302376|P2|By Week 48|Death|1
387650|NCT00814879|1302377|P1|By Week 48|Death|0
387651|NCT00814879|1302376|P2|By Week 48|Lost to Follow-up|2
387652|NCT00814879|1302377|P1|By Week 48|Lost to Follow-up|2
387653|NCT00814879|1302376|P2|By Week 24|Incarceration|1
387654|NCT00814879|1302377|P1|By Week 24|Incarceration|0
387655|NCT00814879|1302376|P2|By Week 24|Cancer Diagnosis|0
387656|NCT00814879|1302377|P1|By Week 24|Cancer Diagnosis|1
387657|NCT00814801|1302396|P3|Overall Study|Not specified|4
387658|NCT00814801|1302397|P2|Overall Study|Not specified|6
387659|NCT00814801|1302398|P1|Overall Study|Not specified|2
387660|NCT00814801|1302396|P3|Overall Study|Non-compliance|1
387661|NCT00814801|1302397|P2|Overall Study|Non-compliance|1
387662|NCT00814801|1302398|P1|Overall Study|Non-compliance|0
387663|NCT00814801|1302396|P3|Overall Study|Missing or change of caregiver|4
387664|NCT00814801|1302397|P2|Overall Study|Missing or change of caregiver|2
387665|NCT00814801|1302398|P1|Overall Study|Missing or change of caregiver|6
387666|NCT00814801|1302396|P3|Overall Study|Change of patients for CIBIC plus-J|0
387667|NCT00814801|1302397|P2|Overall Study|Change of patients for CIBIC plus-J|1
387668|NCT00814801|1302398|P1|Overall Study|Change of patients for CIBIC plus-J|1
387669|NCT00814801|1302396|P3|Overall Study|Inappropriate as a subject|1
387670|NCT00814801|1302397|P2|Overall Study|Inappropriate as a subject|1
387671|NCT00814801|1302398|P1|Overall Study|Inappropriate as a subject|1
387672|NCT00814801|1302396|P3|Overall Study|Withdrawal by Subject|14
387673|NCT00814801|1302397|P2|Overall Study|Withdrawal by Subject|11
387674|NCT00814801|1302398|P1|Overall Study|Withdrawal by Subject|9
387675|NCT00814801|1302396|P3|Overall Study|Adverse Event|19
387676|NCT00814801|1302397|P2|Overall Study|Adverse Event|16
387677|NCT00814801|1302398|P1|Overall Study|Adverse Event|15
387678|NCT00814710|1302437|P2|Overall Study|Lost to Follow-up|3
387679|NCT00814710|1302438|P1|Overall Study|Lost to Follow-up|7
387680|NCT00814710|1302437|P2|Overall Study|Adverse Event|0
387681|NCT00814710|1302438|P1|Overall Study|Adverse Event|1
387682|NCT00814658|1302506|P2|Overall Study|Adverse Event|3
387683|NCT00814658|1302507|P1|Overall Study|Adverse Event|3
387684|NCT00814658|1302506|P2|Overall Study|Physician Decision|0
387685|NCT00814658|1302507|P1|Overall Study|Physician Decision|1
387686|NCT00814658|1302506|P2|Overall Study|Lost to Follow-up|1
387687|NCT00814658|1302507|P1|Overall Study|Lost to Follow-up|0
387688|NCT00814632|1302573|P1|Overall Study|Lack of Efficacy|2
387689|NCT00814580|1302579|P2|Overall Study|Did Not Take Drug|2
387690|NCT00814580|1302580|P1|Overall Study|Did Not Take Drug|2
387691|NCT00814580|1302579|P2|Overall Study|Other|3
387692|NCT00814580|1302580|P1|Overall Study|Other|1
387693|NCT00814580|1302579|P2|Overall Study|Withdrawal by Subject|2
387694|NCT00814580|1302580|P1|Overall Study|Withdrawal by Subject|2
387695|NCT00814580|1302579|P2|Overall Study|Protocol Violation|0
387696|NCT00814580|1302580|P1|Overall Study|Protocol Violation|2
387697|NCT00814580|1302579|P2|Overall Study|Lack of Efficacy|25
387698|NCT00814580|1302580|P1|Overall Study|Lack of Efficacy|18
387699|NCT00814580|1302579|P2|Overall Study|Adverse Event|15
387700|NCT00814580|1302580|P1|Overall Study|Adverse Event|6
387701|NCT00814502|1302710|P2|Overall Study|Withdrawal by Subject|2
387702|NCT00814502|1302711|P1|Overall Study|Withdrawal by Subject|0
387703|NCT00814502|1302710|P2|Overall Study|Adverse Event|0
387704|NCT00814502|1302711|P1|Overall Study|Adverse Event|1
387705|NCT00814489|1302724|P3|Overall Study|Other|1
387706|NCT00814489|1302725|P2|Overall Study|Other|0
387707|NCT00814489|1302726|P1|Overall Study|Other|2
387708|NCT00814463|1302758|P1|Overall Study|Lost to Follow-up|1
387709|NCT00814346|1302764|P2|Open Phase (17 Months)|Not otherwise specified|0
387710|NCT00814346|1302765|P1|Open Phase (17 Months)|Not otherwise specified|1
387711|NCT00814346|1302764|P2|Open Phase (17 Months)|Lost to Follow-up|0
387712|NCT00814346|1302765|P1|Open Phase (17 Months)|Lost to Follow-up|2
387713|NCT00814346|1302764|P2|Open Phase (17 Months)|Consent|0
387714|NCT00814346|1302765|P1|Open Phase (17 Months)|Consent|2
387715|NCT00814346|1302764|P2|Open Phase (17 Months)|Adverse Event|0
387716|NCT00814346|1302765|P1|Open Phase (17 Months)|Adverse Event|5
387717|NCT00814346|1302764|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
387718|NCT00814346|1302765|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
387719|NCT00814346|1302764|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
387720|NCT00814346|1302765|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
387721|NCT00814333|1302831|P2|Enrollment|Lost to Follow-up|0
387722|NCT00814333|1302832|P1|Enrollment|Lost to Follow-up|1
387723|NCT00814320|1302840|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
387724|NCT00814320|1302841|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
387725|NCT00814320|1302840|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
387726|NCT00814320|1302841|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
387727|NCT00814320|1302840|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
387728|NCT00814320|1302841|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
387729|NCT00814320|1302840|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
387730|NCT00814320|1302841|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
387731|NCT00814320|1302840|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
387732|NCT00814320|1302841|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
387733|NCT00814320|1302840|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
387821|NCT00813761|1303305|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
387734|NCT00814320|1302841|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
387735|NCT00814320|1302840|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
387736|NCT00814320|1302841|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
387737|NCT00814320|1302840|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
387738|NCT00814320|1302841|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
387739|NCT00814320|1302840|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
387740|NCT00814320|1302841|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
387741|NCT00814320|1302840|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
387742|NCT00814320|1302841|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
387743|NCT00814307|1302973|P4|Overall Study|Death|0
387744|NCT00814307|1302974|P3|Overall Study|Death|0
387745|NCT00814307|1302975|P2|Overall Study|Death|1
387746|NCT00814307|1302976|P1|Overall Study|Death|0
387747|NCT00814307|1302973|P4|Overall Study|Withdrawal by Subject|2
387748|NCT00814307|1302974|P3|Overall Study|Withdrawal by Subject|0
387749|NCT00814307|1302975|P2|Overall Study|Withdrawal by Subject|6
387750|NCT00814307|1302976|P1|Overall Study|Withdrawal by Subject|4
387751|NCT00814307|1302973|P4|Overall Study|Protocol Violation|1
387752|NCT00814307|1302974|P3|Overall Study|Protocol Violation|1
387753|NCT00814307|1302975|P2|Overall Study|Protocol Violation|8
387754|NCT00814307|1302976|P1|Overall Study|Protocol Violation|2
387755|NCT00814307|1302973|P4|Overall Study|Other|1
387756|NCT00814307|1302974|P3|Overall Study|Other|0
387757|NCT00814307|1302975|P2|Overall Study|Other|2
387758|NCT00814307|1302976|P1|Overall Study|Other|1
387759|NCT00814307|1302973|P4|Overall Study|Lack of Efficacy|4
387760|NCT00814307|1302974|P3|Overall Study|Lack of Efficacy|3
387761|NCT00814307|1302975|P2|Overall Study|Lack of Efficacy|1
387762|NCT00814307|1302976|P1|Overall Study|Lack of Efficacy|1
387763|NCT00814307|1302973|P4|Overall Study|Adverse Event|2
387764|NCT00814307|1302974|P3|Overall Study|Adverse Event|3
387765|NCT00814307|1302975|P2|Overall Study|Adverse Event|9
387766|NCT00814307|1302976|P1|Overall Study|Adverse Event|3
387767|NCT00814307|1302973|P4|Overall Study|Randomized but not treated|0
387768|NCT00814307|1302974|P3|Overall Study|Randomized but not treated|0
387769|NCT00814307|1302975|P2|Overall Study|Randomized but not treated|0
387770|NCT00814307|1302976|P1|Overall Study|Randomized but not treated|1
387771|NCT00814164|1303172|P1|Overall Study|Death|5
387772|NCT00814164|1303172|P1|Overall Study|not stated|7
387773|NCT00814164|1303172|P1|Overall Study|Progression|7
387774|NCT00813995|1303206|P2|Overall Study|Withdrawal by Subject|5
387775|NCT00813995|1303207|P1|Overall Study|Withdrawal by Subject|0
387776|NCT00813995|1303206|P2|Overall Study|Subject moved|0
387777|NCT00813995|1303207|P1|Overall Study|Subject moved|4
387778|NCT00813995|1303206|P2|Overall Study|Protocol Violation|2
387779|NCT00813995|1303207|P1|Overall Study|Protocol Violation|3
387780|NCT00813995|1303206|P2|Overall Study|Other reason|2
387781|NCT00813995|1303207|P1|Overall Study|Other reason|2
387782|NCT00813995|1303206|P2|Overall Study|Lost to Follow-up|2
387783|NCT00813995|1303207|P1|Overall Study|Lost to Follow-up|4
387784|NCT00813995|1303206|P2|Overall Study|Lack of Efficacy|0
387785|NCT00813995|1303207|P1|Overall Study|Lack of Efficacy|1
387786|NCT00813995|1303206|P2|Overall Study|Laboratory adverse event|2
387787|NCT00813995|1303207|P1|Overall Study|Laboratory adverse event|0
387788|NCT00813995|1303206|P2|Overall Study|Clinical adverse event|3
387789|NCT00813995|1303207|P1|Overall Study|Clinical adverse event|9
387790|NCT00813943|1303230|P3|Overall Study|Ongoing at cut-off date|3
387791|NCT00813943|1303231|P2|Overall Study|Ongoing at cut-off date|5
387792|NCT00813943|1303232|P1|Overall Study|Ongoing at cut-off date|5
387793|NCT00813917|1303262|P2|Overall Study|Lost to Follow-up|1
387794|NCT00813917|1303263|P1|Overall Study|Lost to Follow-up|3
387795|NCT00813917|1303262|P2|Overall Study|Withdrawal by Subject|4
387796|NCT00813917|1303263|P1|Overall Study|Withdrawal by Subject|3
387797|NCT00813917|1303262|P2|Overall Study|Adverse Event|1
387798|NCT00813917|1303263|P1|Overall Study|Adverse Event|0
387799|NCT00813904|1303269|P1|Overall Study|Death|1
387800|NCT00813813|1303277|P2|Overall Study|Other|1
387801|NCT00813813|1303278|P1|Overall Study|Other|0
387802|NCT00813813|1303277|P2|Overall Study|Lost to Follow-up|7
387803|NCT00813813|1303278|P1|Overall Study|Lost to Follow-up|2
387804|NCT00813813|1303277|P2|Overall Study|Withdrawal by Subject|1
387805|NCT00813813|1303278|P1|Overall Study|Withdrawal by Subject|1
387806|NCT00813800|1303294|P1|Overall Study|Physician Decision|1
387807|NCT00813800|1303294|P1|Overall Study|Worsening of depression|2
387808|NCT00813800|1303294|P1|Overall Study|Adverse Event|1
387809|NCT00813800|1303294|P1|Overall Study|Screen Failure after Consent|2
387810|NCT00813761|1303302|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
387811|NCT00813761|1303303|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
387812|NCT00813761|1303304|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
387813|NCT00813761|1303305|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
387814|NCT00813761|1303302|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
387815|NCT00813761|1303303|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
387816|NCT00813761|1303304|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
387817|NCT00813761|1303305|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
387818|NCT00813761|1303302|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
387819|NCT00813761|1303303|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
387820|NCT00813761|1303304|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
387822|NCT00813761|1303302|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
387823|NCT00813761|1303303|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
387824|NCT00813761|1303304|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
387825|NCT00813761|1303305|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
387826|NCT00813761|1303302|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
387827|NCT00813761|1303303|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
387828|NCT00813761|1303304|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
387829|NCT00813761|1303305|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
387830|NCT00813761|1303302|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
387831|NCT00813761|1303303|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
387832|NCT00813761|1303304|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
387833|NCT00813761|1303305|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
387834|NCT00813761|1303302|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
387835|NCT00813761|1303303|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
387836|NCT00813761|1303304|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
387837|NCT00813761|1303305|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
387838|NCT00813761|1303302|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
387839|NCT00813761|1303303|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
387840|NCT00813761|1303304|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
387841|NCT00813761|1303305|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
387842|NCT00813761|1303302|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
387843|NCT00813761|1303303|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
387844|NCT00813761|1303304|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
387845|NCT00813761|1303305|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
387846|NCT00813761|1303302|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
387847|NCT00813761|1303303|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
387848|NCT00813761|1303304|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
387849|NCT00813761|1303305|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
387850|NCT00813761|1303302|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
387851|NCT00813761|1303303|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
387852|NCT00813761|1303304|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
387853|NCT00813761|1303305|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
387854|NCT00813761|1303302|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
387855|NCT00813761|1303303|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
387856|NCT00813761|1303304|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
387857|NCT00813761|1303305|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
387858|NCT00813748|1303355|P2|Skin Test Substudy|Physician Decision|1
387859|NCT00813748|1303356|P1|Skin Test Substudy|Physician Decision|0
387860|NCT00813709|1303385|P6|Open Label Period|Other|6
387861|NCT00813709|1303386|P5|Open Label Period|Other|5
387862|NCT00813709|1303387|P4|Open Label Period|Other|11
387863|NCT00813709|1303388|P3|Open Label Period|Other|0
387864|NCT00813709|1303389|P2|Open Label Period|Other|0
387865|NCT00813709|1303390|P1|Open Label Period|Other|0
387866|NCT00813709|1303385|P6|Open Label Period|Randomized but not treated|1
387867|NCT00813709|1303386|P5|Open Label Period|Randomized but not treated|0
387868|NCT00813709|1303387|P4|Open Label Period|Randomized but not treated|1
387869|NCT00813709|1303388|P3|Open Label Period|Randomized but not treated|0
387870|NCT00813709|1303389|P2|Open Label Period|Randomized but not treated|0
387871|NCT00813709|1303390|P1|Open Label Period|Randomized but not treated|0
387872|NCT00813709|1303385|P6|Open Label Period|Lack of Efficacy|1
387873|NCT00813709|1303386|P5|Open Label Period|Lack of Efficacy|1
387874|NCT00813709|1303387|P4|Open Label Period|Lack of Efficacy|3
387875|NCT00813709|1303388|P3|Open Label Period|Lack of Efficacy|0
387876|NCT00813709|1303389|P2|Open Label Period|Lack of Efficacy|0
387877|NCT00813709|1303390|P1|Open Label Period|Lack of Efficacy|0
387878|NCT00813709|1303385|P6|Open Label Period|Adverse Event|3
387879|NCT00813709|1303386|P5|Open Label Period|Adverse Event|4
387880|NCT00813709|1303387|P4|Open Label Period|Adverse Event|5
387881|NCT00813709|1303388|P3|Open Label Period|Adverse Event|0
387882|NCT00813709|1303389|P2|Open Label Period|Adverse Event|0
387883|NCT00813709|1303390|P1|Open Label Period|Adverse Event|0
387884|NCT00813709|1303385|P6|Double Blind Period|Other|0
387885|NCT00813709|1303386|P5|Double Blind Period|Other|0
387886|NCT00813709|1303387|P4|Double Blind Period|Other|0
387887|NCT00813709|1303388|P3|Double Blind Period|Other|6
387888|NCT00813709|1303389|P2|Double Blind Period|Other|9
387889|NCT00813709|1303390|P1|Double Blind Period|Other|14
387890|NCT00813709|1303385|P6|Double Blind Period|Randomized but not treated|0
387891|NCT00813709|1303386|P5|Double Blind Period|Randomized but not treated|0
387892|NCT00813709|1303387|P4|Double Blind Period|Randomized but not treated|0
387893|NCT00813709|1303388|P3|Double Blind Period|Randomized but not treated|1
387894|NCT00813709|1303389|P2|Double Blind Period|Randomized but not treated|3
387895|NCT00813709|1303390|P1|Double Blind Period|Randomized but not treated|1
387896|NCT00813709|1303385|P6|Double Blind Period|Switched to open label phase|0
387897|NCT00813709|1303386|P5|Double Blind Period|Switched to open label phase|0
387898|NCT00813709|1303387|P4|Double Blind Period|Switched to open label phase|0
387899|NCT00813709|1303388|P3|Double Blind Period|Switched to open label phase|18
387900|NCT00813709|1303389|P2|Double Blind Period|Switched to open label phase|26
387901|NCT00813709|1303390|P1|Double Blind Period|Switched to open label phase|9
387902|NCT00813709|1303385|P6|Double Blind Period|Lost to Follow-up|0
387903|NCT00813709|1303386|P5|Double Blind Period|Lost to Follow-up|0
387904|NCT00813709|1303387|P4|Double Blind Period|Lost to Follow-up|0
387905|NCT00813709|1303388|P3|Double Blind Period|Lost to Follow-up|2
387906|NCT00813709|1303389|P2|Double Blind Period|Lost to Follow-up|2
387907|NCT00813709|1303390|P1|Double Blind Period|Lost to Follow-up|3
387908|NCT00813709|1303385|P6|Double Blind Period|Adverse Event|0
387909|NCT00813709|1303386|P5|Double Blind Period|Adverse Event|0
387910|NCT00813709|1303387|P4|Double Blind Period|Adverse Event|0
387911|NCT00813709|1303388|P3|Double Blind Period|Adverse Event|4
387912|NCT00813709|1303389|P2|Double Blind Period|Adverse Event|1
387913|NCT00813709|1303390|P1|Double Blind Period|Adverse Event|4
387914|NCT00813592|1303470|P1|Overall Study|Disease assessment was not completed per|2
387915|NCT00813488|1303479|P2|Open-label Extension|Not specified|0
387916|NCT00813488|1303480|P1|Open-label Extension|Not specified|1
387917|NCT00813488|1303479|P2|Open-label Extension|Non-compliance study procedures|1
387918|NCT00813488|1303480|P1|Open-label Extension|Non-compliance study procedures|2
387919|NCT00813488|1303479|P2|Open-label Extension|Non-compliance study medication|0
387920|NCT00813488|1303480|P1|Open-label Extension|Non-compliance study medication|4
387921|NCT00813488|1303479|P2|Open-label Extension|Protocol Violation|2
387922|NCT00813488|1303480|P1|Open-label Extension|Protocol Violation|1
387923|NCT00813488|1303479|P2|Open-label Extension|Withdrawal by Subject|2
387924|NCT00813488|1303480|P1|Open-label Extension|Withdrawal by Subject|0
387925|NCT00813488|1303479|P2|Open-label Extension|Lack of Efficacy|0
387926|NCT00813488|1303480|P1|Open-label Extension|Lack of Efficacy|3
387927|NCT00813488|1303479|P2|Open-label Extension|Adverse Event|2
387928|NCT00813488|1303480|P1|Open-label Extension|Adverse Event|1
387929|NCT00813488|1303479|P2|Double-blind Treatment Period 2|Not Specified|0
387930|NCT00813488|1303480|P1|Double-blind Treatment Period 2|Not Specified|1
387931|NCT00813488|1303479|P2|Double-blind Treatment Period 2|Protocol Violation|0
387932|NCT00813488|1303480|P1|Double-blind Treatment Period 2|Protocol Violation|2
387933|NCT00813488|1303479|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
387934|NCT00813488|1303480|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
387935|NCT00813488|1303479|P2|Double-blind Treatment Period 2|Adverse Event|0
387936|NCT00813488|1303480|P1|Double-blind Treatment Period 2|Adverse Event|1
387937|NCT00813488|1303479|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
387938|NCT00813488|1303480|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
387939|NCT00813488|1303479|P2|Double-blind Treatment Period 1|Protocol Violation|2
387940|NCT00813488|1303480|P1|Double-blind Treatment Period 1|Protocol Violation|0
387941|NCT00813488|1303479|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
387942|NCT00813488|1303480|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
387943|NCT00813488|1303479|P2|Double-blind Treatment Period 1|Adverse Event|1
387944|NCT00813488|1303480|P1|Double-blind Treatment Period 1|Adverse Event|1
387945|NCT00813488|1303479|P2|Titration Period 2|Non-compliance with study procedures|1
387946|NCT00813488|1303480|P1|Titration Period 2|Non-compliance with study procedures|2
387947|NCT00813488|1303479|P2|Titration Period 2|Lost to Follow-up|0
387948|NCT00813488|1303480|P1|Titration Period 2|Lost to Follow-up|1
387949|NCT00813488|1303479|P2|Titration Period 2|Protocol Violation|2
387950|NCT00813488|1303480|P1|Titration Period 2|Protocol Violation|3
387951|NCT00813488|1303479|P2|Titration Period 2|Lack of Efficacy|4
387952|NCT00813488|1303480|P1|Titration Period 2|Lack of Efficacy|8
387953|NCT00813488|1303479|P2|Titration Period 2|Adverse Event|3
387954|NCT00813488|1303480|P1|Titration Period 2|Adverse Event|2
387955|NCT00813488|1303479|P2|Titration Period 1|Technical Difficulties|1
387956|NCT00813488|1303480|P1|Titration Period 1|Technical Difficulties|0
387957|NCT00813488|1303479|P2|Titration Period 1|Non-compliance to study procedures|2
387958|NCT00813488|1303480|P1|Titration Period 1|Non-compliance to study procedures|2
387959|NCT00813488|1303479|P2|Titration Period 1|Non-compliance to study medication|1
387960|NCT00813488|1303480|P1|Titration Period 1|Non-compliance to study medication|4
387961|NCT00813488|1303479|P2|Titration Period 1|Protocol Violation|3
387962|NCT00813488|1303480|P1|Titration Period 1|Protocol Violation|4
387963|NCT00813488|1303479|P2|Titration Period 1|Withdrawal by Subject|2
387964|NCT00813488|1303480|P1|Titration Period 1|Withdrawal by Subject|2
387965|NCT00813488|1303479|P2|Titration Period 1|Lack of Efficacy|7
387966|NCT00813488|1303480|P1|Titration Period 1|Lack of Efficacy|9
387967|NCT00813488|1303479|P2|Titration Period 1|Adverse Event|1
387968|NCT00813488|1303480|P1|Titration Period 1|Adverse Event|6
387969|NCT00813150|1303610|P2|Long Term Follow-up|Progression/Relapse|24
387970|NCT00813150|1303611|P1|Long Term Follow-up|Progression/Relapse|22
387971|NCT00813150|1303610|P2|Long Term Follow-up|Lost to Follow-up|0
387972|NCT00813150|1303611|P1|Long Term Follow-up|Lost to Follow-up|2
387973|NCT00813150|1303610|P2|Long Term Follow-up|Not specified|3
387974|NCT00813150|1303611|P1|Long Term Follow-up|Not specified|0
387975|NCT00813150|1303610|P2|Long Term Follow-up|Death|4
387976|NCT00813150|1303611|P1|Long Term Follow-up|Death|0
387977|NCT00813150|1303610|P2|Treatment Period|Data not available|2
387978|NCT00813150|1303611|P1|Treatment Period|Data not available|1
387979|NCT00813150|1303610|P2|Treatment Period|Reason not specified|4
387980|NCT00813150|1303611|P1|Treatment Period|Reason not specified|3
387981|NCT00813150|1303610|P2|Treatment Period|Non compliance|1
387982|NCT00813150|1303611|P1|Treatment Period|Non compliance|0
387983|NCT00813150|1303610|P2|Treatment Period|Withdrawal by Subject|3
387984|NCT00813150|1303611|P1|Treatment Period|Withdrawal by Subject|5
387985|NCT00813150|1303610|P2|Treatment Period|Protocol Violation|4
387986|NCT00813150|1303611|P1|Treatment Period|Protocol Violation|3
387987|NCT00813150|1303610|P2|Treatment Period|Stable disease|2
387988|NCT00813150|1303611|P1|Treatment Period|Stable disease|1
387989|NCT00813150|1303610|P2|Treatment Period|Complete response|1
387990|NCT00813150|1303611|P1|Treatment Period|Complete response|0
387991|NCT00813150|1303610|P2|Treatment Period|Progressive disease|0
387992|NCT00813150|1303611|P1|Treatment Period|Progressive disease|1
387993|NCT00813150|1303610|P2|Treatment Period|Death|0
387994|NCT00813150|1303611|P1|Treatment Period|Death|2
387995|NCT00813150|1303610|P2|Treatment Period|Adverse Event|15
387996|NCT00813150|1303611|P1|Treatment Period|Adverse Event|16
387997|NCT00813098|1303635|P3|Overall Study|Withdrew Consent|0
387998|NCT00813098|1303636|P2|Overall Study|Withdrew Consent|1
387999|NCT00813098|1303637|P1|Overall Study|Withdrew Consent|0
388000|NCT00813098|1303635|P3|Overall Study|Principal Investigator decision|0
388001|NCT00813098|1303636|P2|Overall Study|Principal Investigator decision|1
388002|NCT00813098|1303637|P1|Overall Study|Principal Investigator decision|0
388003|NCT00813098|1303635|P3|Overall Study|Protocol Violation|1
388004|NCT00813098|1303636|P2|Overall Study|Protocol Violation|0
388005|NCT00813098|1303637|P1|Overall Study|Protocol Violation|0
388006|NCT00813098|1303635|P3|Overall Study|Lost to Follow-up|0
388007|NCT00813098|1303636|P2|Overall Study|Lost to Follow-up|1
388008|NCT00813098|1303637|P1|Overall Study|Lost to Follow-up|0
388009|NCT00813098|1303635|P3|Overall Study|Inability to complete study procedures|0
388010|NCT00813098|1303636|P2|Overall Study|Inability to complete study procedures|0
388011|NCT00813098|1303637|P1|Overall Study|Inability to complete study procedures|1
388012|NCT00813098|1303635|P3|Overall Study|Withdrawal by Subject|0
388013|NCT00813098|1303636|P2|Overall Study|Withdrawal by Subject|1
388014|NCT00813098|1303637|P1|Overall Study|Withdrawal by Subject|0
388015|NCT00813098|1303635|P3|Overall Study|Adverse Event|1
388016|NCT00813098|1303636|P2|Overall Study|Adverse Event|4
388017|NCT00813098|1303637|P1|Overall Study|Adverse Event|2
388018|NCT00812981|1303662|P2|Overall Study|Other|1
388019|NCT00812981|1303663|P1|Overall Study|Other|0
388020|NCT00812968|1303701|P1|Overall Study|Study closed due to marketing approval|3
388021|NCT00812968|1303701|P1|Overall Study|No further treatment required|1
388022|NCT00812968|1303701|P1|Overall Study|Disease progression|1
388023|NCT00812968|1303701|P1|Overall Study|Relapse after erythroid response|6
388024|NCT00812955|1303736|P4|Overall Study|randomized in error|0
388025|NCT00812955|1303737|P3|Overall Study|randomized in error|1
388026|NCT00812955|1303738|P2|Overall Study|randomized in error|0
388027|NCT00812955|1303739|P1|Overall Study|randomized in error|0
388028|NCT00812955|1303736|P4|Overall Study|Withdrawal by Subject|2
388029|NCT00812955|1303737|P3|Overall Study|Withdrawal by Subject|1
388030|NCT00812955|1303738|P2|Overall Study|Withdrawal by Subject|0
388031|NCT00812955|1303739|P1|Overall Study|Withdrawal by Subject|1
388032|NCT00812955|1303736|P4|Overall Study|Lost to Follow-up|2
388033|NCT00812955|1303737|P3|Overall Study|Lost to Follow-up|1
388034|NCT00812955|1303738|P2|Overall Study|Lost to Follow-up|1
388035|NCT00812955|1303739|P1|Overall Study|Lost to Follow-up|2
388036|NCT00812955|1303736|P4|Overall Study|Adverse Event|4
388037|NCT00812955|1303737|P3|Overall Study|Adverse Event|3
388038|NCT00812955|1303738|P2|Overall Study|Adverse Event|6
388039|NCT00812955|1303739|P1|Overall Study|Adverse Event|7
388040|NCT00812929|1303759|P10|Washout Period 3 (7 Days)|Adverse Event|0
388041|NCT00812929|1303760|P9|Washout Period 3 (7 Days)|Adverse Event|0
388042|NCT00812929|1303761|P8|Washout Period 3 (7 Days)|Adverse Event|0
388043|NCT00812929|1303762|P7|Washout Period 3 (7 Days)|Adverse Event|0
388044|NCT00812929|1303763|P6|Washout Period 3 (7 Days)|Adverse Event|1
388045|NCT00812929|1303764|P5|Washout Period 3 (7 Days)|Adverse Event|0
388046|NCT00812929|1303765|P4|Washout Period 3 (7 Days)|Adverse Event|0
388047|NCT00812929|1303766|P3|Washout Period 3 (7 Days)|Adverse Event|0
388048|NCT00812929|1303767|P2|Washout Period 3 (7 Days)|Adverse Event|0
388049|NCT00812929|1303768|P1|Washout Period 3 (7 Days)|Adverse Event|0
388050|NCT00812929|1303759|P10|Washout Period 2 (7 Days)|Physician Decision|1
388051|NCT00812929|1303760|P9|Washout Period 2 (7 Days)|Physician Decision|0
388052|NCT00812929|1303761|P8|Washout Period 2 (7 Days)|Physician Decision|0
388053|NCT00812929|1303762|P7|Washout Period 2 (7 Days)|Physician Decision|0
388054|NCT00812929|1303763|P6|Washout Period 2 (7 Days)|Physician Decision|0
388055|NCT00812929|1303764|P5|Washout Period 2 (7 Days)|Physician Decision|0
388056|NCT00812929|1303765|P4|Washout Period 2 (7 Days)|Physician Decision|0
388057|NCT00812929|1303766|P3|Washout Period 2 (7 Days)|Physician Decision|0
388058|NCT00812929|1303767|P2|Washout Period 2 (7 Days)|Physician Decision|0
388059|NCT00812929|1303768|P1|Washout Period 2 (7 Days)|Physician Decision|0
388060|NCT00812929|1303759|P10|Washout Period 1 (7 Days)|Physician Decision|0
388061|NCT00812929|1303760|P9|Washout Period 1 (7 Days)|Physician Decision|0
388062|NCT00812929|1303761|P8|Washout Period 1 (7 Days)|Physician Decision|0
388063|NCT00812929|1303762|P7|Washout Period 1 (7 Days)|Physician Decision|0
388064|NCT00812929|1303763|P6|Washout Period 1 (7 Days)|Physician Decision|0
388065|NCT00812929|1303764|P5|Washout Period 1 (7 Days)|Physician Decision|0
388066|NCT00812929|1303765|P4|Washout Period 1 (7 Days)|Physician Decision|0
388067|NCT00812929|1303766|P3|Washout Period 1 (7 Days)|Physician Decision|1
388068|NCT00812929|1303767|P2|Washout Period 1 (7 Days)|Physician Decision|0
388069|NCT00812929|1303768|P1|Washout Period 1 (7 Days)|Physician Decision|0
388070|NCT00812812|1303906|P2|Overall Study|Withdrawal by Subject|2
388071|NCT00812812|1303907|P1|Overall Study|Withdrawal by Subject|0
388072|NCT00812812|1303906|P2|Overall Study|Lost to Follow-up|1
388073|NCT00812812|1303907|P1|Overall Study|Lost to Follow-up|0
388074|NCT00812812|1303906|P2|Overall Study|Lack of Efficacy|0
388075|NCT00812812|1303907|P1|Overall Study|Lack of Efficacy|1
388076|NCT00812812|1303906|P2|Overall Study|Adverse Event|1
388077|NCT00812812|1303907|P1|Overall Study|Adverse Event|2
388078|NCT00812708|1303920|P1|Overall Study|Signed consent but later withdrew|3
388079|NCT00812708|1303920|P1|Overall Study|Surgery cancelled due to uveitis|1
388080|NCT00812708|1303920|P1|Overall Study|Switched to another study|1
388081|NCT00812708|1303920|P1|Overall Study|Lack of medical insurance|1
388082|NCT00812708|1303920|P1|Overall Study|Device could not be implanted|2
388083|NCT00812565|1303948|P8|Overall Study|Reason Not Specified|0
388084|NCT00812565|1303949|P7|Overall Study|Reason Not Specified|0
388085|NCT00812565|1303950|P6|Overall Study|Reason Not Specified|1
388086|NCT00812565|1303951|P5|Overall Study|Reason Not Specified|0
388087|NCT00812565|1303952|P4|Overall Study|Reason Not Specified|0
388088|NCT00812565|1303953|P3|Overall Study|Reason Not Specified|0
388089|NCT00812565|1303954|P2|Overall Study|Reason Not Specified|0
388090|NCT00812565|1303955|P1|Overall Study|Reason Not Specified|0
388091|NCT00812565|1303948|P8|Overall Study|Withdrawal of Consent|0
388092|NCT00812565|1303949|P7|Overall Study|Withdrawal of Consent|0
388093|NCT00812565|1303950|P6|Overall Study|Withdrawal of Consent|0
388094|NCT00812565|1303951|P5|Overall Study|Withdrawal of Consent|1
388095|NCT00812565|1303952|P4|Overall Study|Withdrawal of Consent|0
388096|NCT00812565|1303953|P3|Overall Study|Withdrawal of Consent|0
388097|NCT00812565|1303954|P2|Overall Study|Withdrawal of Consent|0
388098|NCT00812565|1303955|P1|Overall Study|Withdrawal of Consent|1
388099|NCT00812565|1303948|P8|Overall Study|Did Not Come to Study Visit|0
388100|NCT00812565|1303949|P7|Overall Study|Did Not Come to Study Visit|0
388101|NCT00812565|1303950|P6|Overall Study|Did Not Come to Study Visit|0
388102|NCT00812565|1303951|P5|Overall Study|Did Not Come to Study Visit|0
388103|NCT00812565|1303952|P4|Overall Study|Did Not Come to Study Visit|0
388104|NCT00812565|1303953|P3|Overall Study|Did Not Come to Study Visit|0
388105|NCT00812565|1303954|P2|Overall Study|Did Not Come to Study Visit|0
388106|NCT00812565|1303955|P1|Overall Study|Did Not Come to Study Visit|1
388107|NCT00812565|1303948|P8|Overall Study|Adverse Event|1
388108|NCT00812565|1303949|P7|Overall Study|Adverse Event|0
388109|NCT00812565|1303950|P6|Overall Study|Adverse Event|0
388110|NCT00812565|1303951|P5|Overall Study|Adverse Event|0
388111|NCT00812565|1303952|P4|Overall Study|Adverse Event|2
388112|NCT00812565|1303953|P3|Overall Study|Adverse Event|0
388113|NCT00812565|1303954|P2|Overall Study|Adverse Event|0
388114|NCT00812565|1303955|P1|Overall Study|Adverse Event|0
388115|NCT00812565|1303948|P8|Overall Study|Did Not Receive Study Medication|0
388116|NCT00812565|1303949|P7|Overall Study|Did Not Receive Study Medication|0
388117|NCT00812565|1303950|P6|Overall Study|Did Not Receive Study Medication|0
388118|NCT00812565|1303951|P5|Overall Study|Did Not Receive Study Medication|0
388119|NCT00812565|1303952|P4|Overall Study|Did Not Receive Study Medication|0
388120|NCT00812565|1303953|P3|Overall Study|Did Not Receive Study Medication|0
388121|NCT00812565|1303954|P2|Overall Study|Did Not Receive Study Medication|1
388122|NCT00812565|1303955|P1|Overall Study|Did Not Receive Study Medication|1
388123|NCT00812487|1304079|P2|Overall Study|Protocol Violation|1
388124|NCT00812487|1304080|P1|Overall Study|Protocol Violation|0
388125|NCT00812487|1304079|P2|Overall Study|Transfer to ICU prior to intervention|0
388126|NCT00812487|1304080|P1|Overall Study|Transfer to ICU prior to intervention|1
388127|NCT00812487|1304079|P2|Overall Study|Withdrawal by Subject|2
388128|NCT00812487|1304080|P1|Overall Study|Withdrawal by Subject|3
388129|NCT00812487|1304079|P2|Overall Study|Lost to Follow-up|0
388130|NCT00812487|1304080|P1|Overall Study|Lost to Follow-up|2
388131|NCT00812461|1304106|P2|All Treated Patients|Other Reason|21
388132|NCT00812461|1304107|P1|All Treated Patients|Other Reason|13
388133|NCT00812461|1304106|P2|All Treated Patients|Lost to Follow-up|14
388134|NCT00812461|1304107|P1|All Treated Patients|Lost to Follow-up|11
388135|NCT00812461|1304106|P2|All Treated Patients|Withdrawal by Subject|54
388136|NCT00812461|1304107|P1|All Treated Patients|Withdrawal by Subject|45
388137|NCT00812461|1304106|P2|All Treated Patients|Protocol Violation|27
388138|NCT00812461|1304107|P1|All Treated Patients|Protocol Violation|36
388139|NCT00812461|1304106|P2|All Treated Patients|Non-compliance|9
388140|NCT00812461|1304107|P1|All Treated Patients|Non-compliance|6
388141|NCT00812461|1304106|P2|All Treated Patients|Lack of Efficacy|7
388142|NCT00812461|1304107|P1|All Treated Patients|Lack of Efficacy|13
388143|NCT00812461|1304106|P2|All Treated Patients|Adverse Event|15
388144|NCT00812461|1304107|P1|All Treated Patients|Adverse Event|8
388145|NCT00812461|1304106|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
388146|NCT00812461|1304107|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
388147|NCT00812331|1304130|P5|Overall Study|Adverse Event|0
388148|NCT00812331|1304131|P4|Overall Study|Adverse Event|0
388149|NCT00812331|1304132|P3|Overall Study|Adverse Event|0
388150|NCT00812331|1304133|P2|Overall Study|Adverse Event|0
388151|NCT00812331|1304134|P1|Overall Study|Adverse Event|1
388152|NCT00812253|1304209|P2|Overall Study|Lost to Follow-up|0
388153|NCT00812253|1304210|P1|Overall Study|Lost to Follow-up|2
388154|NCT00812253|1304209|P2|Overall Study|Protocol Violation|1
388155|NCT00812253|1304210|P1|Overall Study|Protocol Violation|1
388156|NCT00812253|1304209|P2|Overall Study|Withdrawal by Subject|2
388157|NCT00812253|1304210|P1|Overall Study|Withdrawal by Subject|3
388158|NCT00812097|1304235|P4|Overall Study|Unknown reasons and patient/doctor moves|5
388159|NCT00812097|1304236|P3|Overall Study|Unknown reasons and patient/doctor moves|15
388160|NCT00812097|1304237|P2|Overall Study|Unknown reasons and patient/doctor moves|24
388161|NCT00812097|1304238|P1|Overall Study|Unknown reasons and patient/doctor moves|111
388162|NCT00812097|1304235|P4|Overall Study|Explantation of study device(s)|20
388163|NCT00812097|1304236|P3|Overall Study|Explantation of study device(s)|14
388164|NCT00812097|1304237|P2|Overall Study|Explantation of study device(s)|29
388165|NCT00812097|1304238|P1|Overall Study|Explantation of study device(s)|27
388166|NCT00812097|1304235|P4|Overall Study|Lost to Follow-up|5
388167|NCT00812097|1304236|P3|Overall Study|Lost to Follow-up|17
388168|NCT00812097|1304237|P2|Overall Study|Lost to Follow-up|14
388169|NCT00812097|1304238|P1|Overall Study|Lost to Follow-up|90
388170|NCT00812097|1304235|P4|Overall Study|Withdrawal by Subject|2
388171|NCT00812097|1304236|P3|Overall Study|Withdrawal by Subject|8
388172|NCT00812097|1304237|P2|Overall Study|Withdrawal by Subject|12
388173|NCT00812097|1304238|P1|Overall Study|Withdrawal by Subject|14
388174|NCT00812097|1304235|P4|Overall Study|Death|3
388175|NCT00812097|1304236|P3|Overall Study|Death|3
388176|NCT00812097|1304237|P2|Overall Study|Death|10
388177|NCT00812097|1304238|P1|Overall Study|Death|3
388178|NCT00812006|1304267|P3|Overall Study|Lack of Qualifying Event|2
388179|NCT00812006|1304268|P2|Overall Study|Lack of Qualifying Event|2
388180|NCT00812006|1304269|P1|Overall Study|Lack of Qualifying Event|4
388181|NCT00812006|1304267|P3|Overall Study|Withdrawal by Subject|1
388182|NCT00812006|1304268|P2|Overall Study|Withdrawal by Subject|1
388183|NCT00812006|1304269|P1|Overall Study|Withdrawal by Subject|2
388184|NCT00812006|1304267|P3|Overall Study|Physician Decision|1
388185|NCT00812006|1304268|P2|Overall Study|Physician Decision|0
388186|NCT00812006|1304269|P1|Overall Study|Physician Decision|0
388187|NCT00812006|1304267|P3|Overall Study|Lost to Follow-up|2
388188|NCT00812006|1304268|P2|Overall Study|Lost to Follow-up|0
388189|NCT00812006|1304269|P1|Overall Study|Lost to Follow-up|0
388190|NCT00811954|1304286|P3|Overall Study|Complete Protocol: No follow-up|1
388191|NCT00811954|1304287|P2|Overall Study|Complete Protocol: No follow-up|0
388192|NCT00811954|1304288|P1|Overall Study|Complete Protocol: No follow-up|0
388193|NCT00811954|1304286|P3|Overall Study|Severe Debilitation|1
388194|NCT00811954|1304287|P2|Overall Study|Severe Debilitation|0
388195|NCT00811954|1304288|P1|Overall Study|Severe Debilitation|2
388196|NCT00811954|1304286|P3|Overall Study|Site Closure|1
388197|NCT00811954|1304287|P2|Overall Study|Site Closure|0
388198|NCT00811954|1304288|P1|Overall Study|Site Closure|4
388199|NCT00811954|1304286|P3|Overall Study|Withdraw consent prior study completion|5
388200|NCT00811954|1304287|P2|Overall Study|Withdraw consent prior study completion|6
388201|NCT00811954|1304288|P1|Overall Study|Withdraw consent prior study completion|4
388202|NCT00811954|1304286|P3|Overall Study|Not willing to adhere to requirements|16
388203|NCT00811954|1304287|P2|Overall Study|Not willing to adhere to requirements|2
388204|NCT00811954|1304288|P1|Overall Study|Not willing to adhere to requirements|12
388205|NCT00811954|1304286|P3|Overall Study|Not able to get to clinic|30
388206|NCT00811954|1304287|P2|Overall Study|Not able to get to clinic|35
388207|NCT00811954|1304288|P1|Overall Study|Not able to get to clinic|28
388208|NCT00811954|1304286|P3|Overall Study|Lost to Follow-up|34
388209|NCT00811954|1304287|P2|Overall Study|Lost to Follow-up|23
388210|NCT00811954|1304288|P1|Overall Study|Lost to Follow-up|29
388211|NCT00811954|1304286|P3|Overall Study|Death|13
388212|NCT00811954|1304287|P2|Overall Study|Death|6
388213|NCT00811954|1304288|P1|Overall Study|Death|10
388214|NCT00811941|1304352|P2|All Treated Patients|Other Reason|14
388215|NCT00811941|1304353|P1|All Treated Patients|Other Reason|4
388216|NCT00811941|1304352|P2|All Treated Patients|Lost to Follow-up|12
388217|NCT00811941|1304353|P1|All Treated Patients|Lost to Follow-up|3
388218|NCT00811941|1304352|P2|All Treated Patients|Withdrawal by Subject|94
388219|NCT00811941|1304353|P1|All Treated Patients|Withdrawal by Subject|35
388220|NCT00811941|1304352|P2|All Treated Patients|Protocol Violation|17
388221|NCT00811941|1304353|P1|All Treated Patients|Protocol Violation|5
388222|NCT00811941|1304352|P2|All Treated Patients|Non-compliance|8
388223|NCT00811941|1304353|P1|All Treated Patients|Non-compliance|1
388224|NCT00811941|1304352|P2|All Treated Patients|Lack of Efficacy|3
388225|NCT00811941|1304353|P1|All Treated Patients|Lack of Efficacy|2
388226|NCT00811941|1304352|P2|All Treated Patients|Adverse Event|43
388227|NCT00811941|1304353|P1|All Treated Patients|Adverse Event|2
388228|NCT00811941|1304352|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
388229|NCT00811941|1304353|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
388230|NCT00811928|1304391|P2|Overall Study|Poor Compliance|5
388231|NCT00811928|1304392|P1|Overall Study|Poor Compliance|2
388232|NCT00811928|1304391|P2|Overall Study|Investigator Decision|1
388233|NCT00811928|1304392|P1|Overall Study|Investigator Decision|2
388234|NCT00811928|1304391|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
388235|NCT00811928|1304392|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
388236|NCT00811928|1304391|P2|Overall Study|Did Not Take Study Drug|0
388237|NCT00811928|1304392|P1|Overall Study|Did Not Take Study Drug|3
388238|NCT00811928|1304391|P2|Overall Study|Withdrawal by Subject|12
388239|NCT00811928|1304392|P1|Overall Study|Withdrawal by Subject|18
388240|NCT00811928|1304391|P2|Overall Study|AEs and SAEs Including Death|11
388241|NCT00811928|1304392|P1|Overall Study|AEs and SAEs Including Death|7
388242|NCT00811733|1304436|P2|Overall Study|Withdrawal by Subject|2
388243|NCT00811733|1304437|P1|Overall Study|Withdrawal by Subject|1
388244|NCT00811733|1304436|P2|Overall Study|Investigator Discretion|8
388245|NCT00811733|1304437|P1|Overall Study|Investigator Discretion|10
388246|NCT00811720|1304485|P2|All Treated Patients|Other Reason|4
388247|NCT00811720|1304486|P1|All Treated Patients|Other Reason|7
388248|NCT00811720|1304485|P2|All Treated Patients|Lost to Follow-up|16
388249|NCT00811720|1304486|P1|All Treated Patients|Lost to Follow-up|10
388250|NCT00811720|1304485|P2|All Treated Patients|Withdrawal by Subject|34
388251|NCT00811720|1304486|P1|All Treated Patients|Withdrawal by Subject|28
388252|NCT00811720|1304485|P2|All Treated Patients|Protocol Violation|16
388253|NCT00811720|1304486|P1|All Treated Patients|Protocol Violation|9
388254|NCT00811720|1304485|P2|All Treated Patients|Non-compliance|14
388255|NCT00811720|1304486|P1|All Treated Patients|Non-compliance|0
388256|NCT00811720|1304485|P2|All Treated Patients|Lack of Efficacy|18
388257|NCT00811720|1304486|P1|All Treated Patients|Lack of Efficacy|22
388258|NCT00811720|1304485|P2|All Treated Patients|Adverse Event|62
388259|NCT00811720|1304486|P1|All Treated Patients|Adverse Event|20
388260|NCT00811720|1304485|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
388261|NCT00811720|1304486|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
388262|NCT00811655|1304504|P1|Overall Study|Physician Decision|1
388263|NCT00811642|1304516|P1|Overall Study|Cumulative use of antifungal agent|2
388264|NCT00811642|1304516|P1|Overall Study|Withdrawal by Subject|7
388265|NCT00811642|1304516|P1|Overall Study|Death|2
388266|NCT00811642|1304516|P1|Overall Study|Protocol Violation|1
388267|NCT00811642|1304516|P1|Overall Study|Adverse Event|3
388268|NCT00811577|1304532|P2|Overall Study|Withdrawal by Subject|0
388269|NCT00811577|1304533|P1|Overall Study|Withdrawal by Subject|3
388270|NCT00811577|1304532|P2|Overall Study|Lost to Follow-up|1
388271|NCT00811577|1304533|P1|Overall Study|Lost to Follow-up|7
388272|NCT00811473|1304593|P2|Overall Study|Safety Reasons|0
388273|NCT00811473|1304594|P1|Overall Study|Safety Reasons|1
388274|NCT00811473|1304593|P2|Overall Study|Incorrect Enrollment|0
388275|NCT00811473|1304594|P1|Overall Study|Incorrect Enrollment|1
388276|NCT00811473|1304593|P2|Overall Study|Other 2|1
388277|NCT00811473|1304594|P1|Overall Study|Other 2|4
388278|NCT00811473|1304593|P2|Overall Study|Condition under investigation worsened|3
388279|NCT00811473|1304594|P1|Overall Study|Condition under investigation worsened|1
388280|NCT00811473|1304593|P2|Overall Study|Lack of therapeutic response|1
388281|NCT00811473|1304594|P1|Overall Study|Lack of therapeutic response|4
388282|NCT00811473|1304593|P2|Overall Study|Severe non-compliance to protocol|4
388283|NCT00811473|1304594|P1|Overall Study|Severe non-compliance to protocol|2
388284|NCT00811473|1304593|P2|Overall Study|Withdrawal by Subject|4
388285|NCT00811473|1304594|P1|Overall Study|Withdrawal by Subject|2
388286|NCT00811473|1304593|P2|Overall Study|Lost to Follow-up|1
388287|NCT00811473|1304594|P1|Overall Study|Lost to Follow-up|5
388288|NCT00811473|1304593|P2|Overall Study|Adverse Event|12
388289|NCT00811473|1304594|P1|Overall Study|Adverse Event|3
388290|NCT00811395|1304625|P6|Extension Treatment|Other than above|0
388291|NCT00811395|1304626|P5|Extension Treatment|Other than above|0
388292|NCT00811395|1304627|P4|Extension Treatment|Other than above|0
388293|NCT00811395|1304628|P3|Extension Treatment|Other than above|1
388294|NCT00811395|1304629|P2|Extension Treatment|Other than above|0
388295|NCT00811395|1304630|P1|Extension Treatment|Other than above|0
388296|NCT00811395|1304625|P6|Extension Treatment|Participant did not wish to continue|1
388297|NCT00811395|1304626|P5|Extension Treatment|Participant did not wish to continue|0
388298|NCT00811395|1304627|P4|Extension Treatment|Participant did not wish to continue|1
388299|NCT00811395|1304628|P3|Extension Treatment|Participant did not wish to continue|0
388300|NCT00811395|1304629|P2|Extension Treatment|Participant did not wish to continue|3
388301|NCT00811395|1304630|P1|Extension Treatment|Participant did not wish to continue|0
388302|NCT00811395|1304625|P6|Extension Treatment|Progressive disease|0
388303|NCT00811395|1304626|P5|Extension Treatment|Progressive disease|0
388304|NCT00811395|1304627|P4|Extension Treatment|Progressive disease|0
388305|NCT00811395|1304628|P3|Extension Treatment|Progressive disease|0
388306|NCT00811395|1304629|P2|Extension Treatment|Progressive disease|1
388307|NCT00811395|1304630|P1|Extension Treatment|Progressive disease|1
388308|NCT00811395|1304625|P6|Extension Treatment|Adverse Event|1
388309|NCT00811395|1304626|P5|Extension Treatment|Adverse Event|0
388310|NCT00811395|1304627|P4|Extension Treatment|Adverse Event|2
388311|NCT00811395|1304628|P3|Extension Treatment|Adverse Event|2
388312|NCT00811395|1304629|P2|Extension Treatment|Adverse Event|2
388313|NCT00811395|1304630|P1|Extension Treatment|Adverse Event|1
388314|NCT00811252|1304736|P3|Overall Study|Administrative or Other Reasons|2
388315|NCT00811252|1304737|P2|Overall Study|Administrative or Other Reasons|3
388316|NCT00811252|1304738|P1|Overall Study|Administrative or Other Reasons|0
388317|NCT00811252|1304736|P3|Overall Study|Lost to Follow-up|2
388318|NCT00811252|1304737|P2|Overall Study|Lost to Follow-up|0
388319|NCT00811252|1304738|P1|Overall Study|Lost to Follow-up|0
388320|NCT00811252|1304736|P3|Overall Study|Withdrawal of Consent|2
388321|NCT00811252|1304737|P2|Overall Study|Withdrawal of Consent|2
388322|NCT00811252|1304738|P1|Overall Study|Withdrawal of Consent|1
388323|NCT00811252|1304736|P3|Overall Study|Protocol Violation|2
388324|NCT00811252|1304737|P2|Overall Study|Protocol Violation|3
388325|NCT00811252|1304738|P1|Overall Study|Protocol Violation|3
388326|NCT00811252|1304736|P3|Overall Study|Lack of Efficacy|0
388327|NCT00811252|1304737|P2|Overall Study|Lack of Efficacy|2
388328|NCT00811252|1304738|P1|Overall Study|Lack of Efficacy|7
388329|NCT00811252|1304736|P3|Overall Study|Adverse Event|15
388330|NCT00811252|1304737|P2|Overall Study|Adverse Event|10
388331|NCT00811252|1304738|P1|Overall Study|Adverse Event|6
388332|NCT00811174|1304782|P1|Overall Study|Sponsors Decision|1
388333|NCT00811174|1304782|P1|Overall Study|Protocol Violation|2
388334|NCT00811135|1304793|P1|Overall Study|Ongoing|59
388335|NCT00811135|1304793|P1|Overall Study|Administrative/Other Unspecified|11
388336|NCT00811135|1304793|P1|Overall Study|Withdrawal by Subject|3
388337|NCT00811135|1304793|P1|Overall Study|Refused Treatment|1
388338|NCT00811135|1304793|P1|Overall Study|Violation of Selection Criteria|1
388339|NCT00811135|1304793|P1|Overall Study|Protocol Violation|2
388340|NCT00811135|1304793|P1|Overall Study|Death|3
388341|NCT00811135|1304793|P1|Overall Study|Adverse Event/Intercurrent Illness|8
388342|NCT00811070|1304811|P6|Overall Study|Physician Decision|1
388343|NCT00811070|1304812|P5|Overall Study|Physician Decision|0
388344|NCT00811070|1304813|P4|Overall Study|Physician Decision|0
388345|NCT00811070|1304814|P3|Overall Study|Physician Decision|0
388346|NCT00811070|1304815|P2|Overall Study|Physician Decision|0
388347|NCT00811070|1304816|P1|Overall Study|Physician Decision|0
388348|NCT00811070|1304811|P6|Overall Study|Withdrawal by Subject|0
388349|NCT00811070|1304812|P5|Overall Study|Withdrawal by Subject|0
388350|NCT00811070|1304813|P4|Overall Study|Withdrawal by Subject|0
388351|NCT00811070|1304814|P3|Overall Study|Withdrawal by Subject|0
388352|NCT00811070|1304815|P2|Overall Study|Withdrawal by Subject|1
388353|NCT00811070|1304816|P1|Overall Study|Withdrawal by Subject|0
388354|NCT00811070|1304811|P6|Overall Study|Other|0
388355|NCT00811070|1304812|P5|Overall Study|Other|0
388356|NCT00811070|1304813|P4|Overall Study|Other|0
388357|NCT00811070|1304814|P3|Overall Study|Other|0
388358|NCT00811070|1304815|P2|Overall Study|Other|0
388359|NCT00811070|1304816|P1|Overall Study|Other|1
388360|NCT00811070|1304811|P6|Overall Study|Death|0
388361|NCT00811070|1304812|P5|Overall Study|Death|5
388362|NCT00811070|1304813|P4|Overall Study|Death|2
388363|NCT00811070|1304814|P3|Overall Study|Death|0
388364|NCT00811070|1304815|P2|Overall Study|Death|0
388365|NCT00811070|1304816|P1|Overall Study|Death|0
388366|NCT00811057|1304876|P3|Overall Study|Protocol Violation|10
388367|NCT00811057|1304877|P2|Overall Study|Protocol Violation|10
388368|NCT00811057|1304878|P1|Overall Study|Protocol Violation|5
388369|NCT00811018|1304889|P1|Overall Study|Other|26
388370|NCT00811018|1304889|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
388371|NCT00811018|1304889|P1|Overall Study|Withdrawal by Subject|70
388372|NCT00811018|1304889|P1|Overall Study|Sponsor Decision|450
388373|NCT00811018|1304889|P1|Overall Study|Pregnancy|6
388374|NCT00811018|1304889|P1|Overall Study|Lost to Follow-up|19
388375|NCT00811018|1304889|P1|Overall Study|Investigator Decision|57
388376|NCT00811018|1304889|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
388377|NCT00811018|1304889|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
388378|NCT00811018|1304889|P1|Overall Study|Death|147
388379|NCT00811018|1304889|P1|Overall Study|Adverse Event|79
388380|NCT00811018|1304889|P1|Overall Study|Additional Chronic Treatment|31
388381|NCT00810901|1304907|P2|Overall Study|Lost to Follow-up|58
388382|NCT00810901|1304908|P1|Overall Study|Lost to Follow-up|88
388383|NCT00810810|1304954|P4|Overall Study|Physician Decision|5
388384|NCT00810810|1304955|P3|Overall Study|Physician Decision|1
388385|NCT00810810|1304956|P2|Overall Study|Physician Decision|3
388386|NCT00810810|1304957|P1|Overall Study|Physician Decision|0
388387|NCT00810810|1304954|P4|Overall Study|Withdrawal by Subject|8
388388|NCT00810810|1304955|P3|Overall Study|Withdrawal by Subject|10
388389|NCT00810810|1304956|P2|Overall Study|Withdrawal by Subject|8
388390|NCT00810810|1304957|P1|Overall Study|Withdrawal by Subject|0
388391|NCT00810693|1305005|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
388392|NCT00810693|1305006|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
388393|NCT00810693|1305007|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
388394|NCT00810693|1305005|P3|Follow-up Period (FUP)|Protocol Violation|0
388395|NCT00810693|1305006|P2|Follow-up Period (FUP)|Protocol Violation|1
388396|NCT00810693|1305007|P1|Follow-up Period (FUP)|Protocol Violation|0
388397|NCT00810693|1305005|P3|Follow-up Period (FUP)|Lost to Follow-up|2
388398|NCT00810693|1305006|P2|Follow-up Period (FUP)|Lost to Follow-up|0
388399|NCT00810693|1305007|P1|Follow-up Period (FUP)|Lost to Follow-up|1
388400|NCT00810693|1305005|P3|Follow-up Period (FUP)|Death|1
388401|NCT00810693|1305006|P2|Follow-up Period (FUP)|Death|0
388402|NCT00810693|1305007|P1|Follow-up Period (FUP)|Death|2
388403|NCT00810693|1305005|P3|Follow-up Period (FUP)|Adverse Event|1
388404|NCT00810693|1305006|P2|Follow-up Period (FUP)|Adverse Event|1
388405|NCT00810693|1305007|P1|Follow-up Period (FUP)|Adverse Event|3
388406|NCT00810693|1305005|P3|Treatment Period|Not treated|1
388407|NCT00810693|1305006|P2|Treatment Period|Not treated|1
388408|NCT00810693|1305007|P1|Treatment Period|Not treated|0
388409|NCT00810693|1305005|P3|Treatment Period|Withdrawal by Subject|3
388410|NCT00810693|1305006|P2|Treatment Period|Withdrawal by Subject|2
388411|NCT00810693|1305007|P1|Treatment Period|Withdrawal by Subject|6
388412|NCT00810693|1305005|P3|Treatment Period|Protocol Violation|2
388413|NCT00810693|1305006|P2|Treatment Period|Protocol Violation|2
388414|NCT00810693|1305007|P1|Treatment Period|Protocol Violation|1
388415|NCT00810693|1305005|P3|Treatment Period|Non-compliance|0
388416|NCT00810693|1305006|P2|Treatment Period|Non-compliance|0
388417|NCT00810693|1305007|P1|Treatment Period|Non-compliance|1
388418|NCT00810693|1305005|P3|Treatment Period|Lost to Follow-up|0
388419|NCT00810693|1305006|P2|Treatment Period|Lost to Follow-up|0
388420|NCT00810693|1305007|P1|Treatment Period|Lost to Follow-up|1
388421|NCT00810693|1305005|P3|Treatment Period|Lack of Efficacy|1
388422|NCT00810693|1305006|P2|Treatment Period|Lack of Efficacy|0
388423|NCT00810693|1305007|P1|Treatment Period|Lack of Efficacy|0
388424|NCT00810693|1305005|P3|Treatment Period|Death|2
388425|NCT00810693|1305006|P2|Treatment Period|Death|1
388426|NCT00810693|1305007|P1|Treatment Period|Death|0
388427|NCT00810693|1305005|P3|Treatment Period|Adverse Event|7
388428|NCT00810693|1305006|P2|Treatment Period|Adverse Event|1
388429|NCT00810693|1305007|P1|Treatment Period|Adverse Event|8
388430|NCT00810641|1305039|P3|Overall Study|Withdrawal by Subject|2
388431|NCT00810641|1305040|P2|Overall Study|Withdrawal by Subject|1
388432|NCT00810641|1305041|P1|Overall Study|Withdrawal by Subject|0
388433|NCT00810602|1305049|P2|Overall Study|Withdrawal by Subject|3
388434|NCT00810602|1305050|P1|Overall Study|Withdrawal by Subject|8
388435|NCT00810511|1305063|P2|Overall Study|deposits on contact lens|1
388436|NCT00810511|1305064|P1|Overall Study|deposits on contact lens|0
388437|NCT00810511|1305063|P2|Overall Study|Lost to Follow-up|0
388438|NCT00810511|1305064|P1|Overall Study|Lost to Follow-up|1
388439|NCT00810511|1305063|P2|Overall Study|death in the family|1
388440|NCT00810511|1305064|P1|Overall Study|death in the family|0
388441|NCT00810511|1305063|P2|Overall Study|Lack of Efficacy|1
388442|NCT00810511|1305064|P1|Overall Study|Lack of Efficacy|9
388443|NCT00810511|1305063|P2|Overall Study|Protocol Violation|1
388444|NCT00810511|1305064|P1|Overall Study|Protocol Violation|0
388445|NCT00810394|1305070|P1|Overall Study|Withdrawal by Subject|3
388446|NCT00810368|1305078|P2|Overall Study|Lack of Efficacy|0
388447|NCT00810368|1305079|P1|Overall Study|Lack of Efficacy|2
388448|NCT00810368|1305078|P2|Overall Study|Lost to Follow-up|2
388449|NCT00810368|1305079|P1|Overall Study|Lost to Follow-up|4
388450|NCT00810355|1305100|P3|Overall Study|Withdrawal by Subject|0
388451|NCT00810355|1305101|P2|Overall Study|Withdrawal by Subject|0
388452|NCT00810355|1305102|P1|Overall Study|Withdrawal by Subject|1
388453|NCT00810355|1305100|P3|Overall Study|Lost to Follow-up|11
388454|NCT00810355|1305101|P2|Overall Study|Lost to Follow-up|17
388455|NCT00810355|1305102|P1|Overall Study|Lost to Follow-up|13
388456|NCT00810342|1305118|P2|12-month Followup|Lost to Follow-up|1
388457|NCT00810342|1305119|P1|12-month Followup|Lost to Follow-up|3
388458|NCT00810342|1305118|P2|12-month Followup|Pregnancy|10
388459|NCT00810342|1305119|P1|12-month Followup|Pregnancy|9
388460|NCT00810342|1305118|P2|6-month Follow-up|Pregnancy|2
388461|NCT00810342|1305119|P1|6-month Follow-up|Pregnancy|6
388462|NCT00810342|1305118|P2|6-month Follow-up|Lost to Follow-up|6
388463|NCT00810342|1305119|P1|6-month Follow-up|Lost to Follow-up|18
388464|NCT00810342|1305118|P2|Month 1 Follow-up|Pregnancy|0
388465|NCT00810342|1305119|P1|Month 1 Follow-up|Pregnancy|1
388466|NCT00810342|1305118|P2|Month 1 Follow-up|Lost to Follow-up|2
388467|NCT00810342|1305119|P1|Month 1 Follow-up|Lost to Follow-up|4
388468|NCT00810277|1305152|P1|Overall Study|Adverse Event|1
388469|NCT00810199|1305167|P2|Overall Study|Did not receive study drug|1
388470|NCT00810199|1305168|P1|Overall Study|Did not receive study drug|2
388471|NCT00810199|1305167|P2|Overall Study|Failure to return|4
388472|NCT00810199|1305168|P1|Overall Study|Failure to return|1
388473|NCT00810199|1305167|P2|Overall Study|Protocol Violation|6
388474|NCT00810199|1305168|P1|Overall Study|Protocol Violation|2
388475|NCT00810199|1305167|P2|Overall Study|Administrative/Other|6
388476|NCT00810199|1305168|P1|Overall Study|Administrative/Other|5
388477|NCT00810199|1305167|P2|Overall Study|Refused treatment/Did not cooperate|7
388478|NCT00810199|1305168|P1|Overall Study|Refused treatment/Did not cooperate|7
388479|NCT00810199|1305167|P2|Overall Study|Insufficient therapeutic response|14
388480|NCT00810199|1305168|P1|Overall Study|Insufficient therapeutic response|5
388481|NCT00810199|1305167|P2|Overall Study|Withdrew consent|12
388482|NCT00810199|1305168|P1|Overall Study|Withdrew consent|9
388483|NCT00810199|1305167|P2|Overall Study|Death|6
388484|NCT00810199|1305168|P1|Overall Study|Death|4
388485|NCT00810199|1305167|P2|Overall Study|Adverse Event|26
388486|NCT00810199|1305168|P1|Overall Study|Adverse Event|24
388487|NCT00810108|1305246|P2|Overall Study|Withdrawal by Subject|0
388488|NCT00810108|1305247|P1|Overall Study|Withdrawal by Subject|1
388489|NCT00810082|1305261|P2|Overall Study|Lost to Follow-up|4
388490|NCT00810082|1305262|P1|Overall Study|Lost to Follow-up|0
388491|NCT00810069|1305270|P3|Double-Blind Period II|Protocol Violation|6
388492|NCT00810069|1305271|P2|Double-Blind Period II|Protocol Violation|7
388493|NCT00810069|1305272|P1|Double-Blind Period II|Protocol Violation|0
388494|NCT00810069|1305270|P3|Double-Blind Period II|Clinical relapse|0
388495|NCT00810069|1305271|P2|Double-Blind Period II|Clinical relapse|3
388496|NCT00810069|1305272|P1|Double-Blind Period II|Clinical relapse|0
388497|NCT00810069|1305270|P3|Double-Blind Period II|Protocol entry criterion not met|1
388498|NCT00810069|1305271|P2|Double-Blind Period II|Protocol entry criterion not met|0
388499|NCT00810069|1305272|P1|Double-Blind Period II|Protocol entry criterion not met|0
388500|NCT00810069|1305270|P3|Double-Blind Period II|Withdrawal by Subject|35
388501|NCT00810069|1305271|P2|Double-Blind Period II|Withdrawal by Subject|21
388502|NCT00810069|1305272|P1|Double-Blind Period II|Withdrawal by Subject|0
388503|NCT00810069|1305270|P3|Double-Blind Period II|Physician Decision|1
388504|NCT00810069|1305271|P2|Double-Blind Period II|Physician Decision|0
388505|NCT00810069|1305272|P1|Double-Blind Period II|Physician Decision|0
388506|NCT00810069|1305270|P3|Double-Blind Period II|Lost to Follow-up|9
388507|NCT00810069|1305271|P2|Double-Blind Period II|Lost to Follow-up|9
388508|NCT00810069|1305272|P1|Double-Blind Period II|Lost to Follow-up|0
388509|NCT00810069|1305270|P3|Double-Blind Period II|Lack of Efficacy|12
388510|NCT00810069|1305271|P2|Double-Blind Period II|Lack of Efficacy|7
388511|NCT00810069|1305272|P1|Double-Blind Period II|Lack of Efficacy|0
388512|NCT00810069|1305270|P3|Double-Blind Period II|Adverse Event|8
388513|NCT00810069|1305271|P2|Double-Blind Period II|Adverse Event|9
388514|NCT00810069|1305272|P1|Double-Blind Period II|Adverse Event|0
388515|NCT00810069|1305270|P3|Lead-in Period I|Randomization criteria not met|0
388516|NCT00810069|1305271|P2|Lead-in Period I|Randomization criteria not met|0
388517|NCT00810069|1305272|P1|Lead-in Period I|Randomization criteria not met|158
388518|NCT00810069|1305270|P3|Lead-in Period I|Protocol entry criterion not met|0
388519|NCT00810069|1305271|P2|Lead-in Period I|Protocol entry criterion not met|0
388520|NCT00810069|1305272|P1|Lead-in Period I|Protocol entry criterion not met|5
388521|NCT00810069|1305270|P3|Lead-in Period I|Withdrawal by Subject|0
388522|NCT00810069|1305271|P2|Lead-in Period I|Withdrawal by Subject|0
388523|NCT00810069|1305272|P1|Lead-in Period I|Withdrawal by Subject|46
388524|NCT00810069|1305270|P3|Lead-in Period I|Protocol Violation|0
388525|NCT00810069|1305271|P2|Lead-in Period I|Protocol Violation|0
388526|NCT00810069|1305272|P1|Lead-in Period I|Protocol Violation|1
388527|NCT00810069|1305270|P3|Lead-in Period I|Physician Decision|0
388528|NCT00810069|1305271|P2|Lead-in Period I|Physician Decision|0
388529|NCT00810069|1305272|P1|Lead-in Period I|Physician Decision|1
388530|NCT00810069|1305270|P3|Lead-in Period I|Lost to Follow-up|0
388531|NCT00810069|1305271|P2|Lead-in Period I|Lost to Follow-up|0
388532|NCT00810069|1305272|P1|Lead-in Period I|Lost to Follow-up|19
388533|NCT00810069|1305270|P3|Lead-in Period I|Lack of Efficacy|0
388534|NCT00810069|1305271|P2|Lead-in Period I|Lack of Efficacy|0
388535|NCT00810069|1305272|P1|Lead-in Period I|Lack of Efficacy|1
388536|NCT00810069|1305270|P3|Lead-in Period I|Adverse Event|0
388537|NCT00810069|1305271|P2|Lead-in Period I|Adverse Event|0
388538|NCT00810069|1305272|P1|Lead-in Period I|Adverse Event|43
388539|NCT00810043|1305317|P3|Overall Study|No longer met enrollment criteria|3
388540|NCT00810043|1305318|P2|Overall Study|No longer met enrollment criteria|0
388541|NCT00810043|1305319|P1|Overall Study|No longer met enrollment criteria|0
388542|NCT00810043|1305317|P3|Overall Study|Non-medical problem|1
388543|NCT00810043|1305318|P2|Overall Study|Non-medical problem|0
388544|NCT00810043|1305319|P1|Overall Study|Non-medical problem|0
388545|NCT00810043|1305317|P3|Overall Study|Unrelated medical problem|0
388546|NCT00810043|1305318|P2|Overall Study|Unrelated medical problem|1
388547|NCT00810043|1305319|P1|Overall Study|Unrelated medical problem|0
388548|NCT00810043|1305317|P3|Overall Study|Death|0
388549|NCT00810043|1305318|P2|Overall Study|Death|0
388550|NCT00810043|1305319|P1|Overall Study|Death|2
388551|NCT00810043|1305317|P3|Overall Study|Physician Decision|2
388552|NCT00810043|1305318|P2|Overall Study|Physician Decision|0
388553|NCT00810043|1305319|P1|Overall Study|Physician Decision|0
388554|NCT00810043|1305317|P3|Overall Study|Lost to Follow-up|0
388555|NCT00810043|1305318|P2|Overall Study|Lost to Follow-up|0
388556|NCT00810043|1305319|P1|Overall Study|Lost to Follow-up|1
388557|NCT00810043|1305317|P3|Overall Study|Withdrawal by Subject|2
388558|NCT00810043|1305318|P2|Overall Study|Withdrawal by Subject|0
388559|NCT00810043|1305319|P1|Overall Study|Withdrawal by Subject|1
388560|NCT00809965|1305341|P3|Overall Study|Other Reason|189
388561|NCT00809965|1305342|P2|Overall Study|Other Reason|170
388562|NCT00809965|1305343|P1|Overall Study|Other Reason|167
388563|NCT00809965|1305341|P3|Overall Study|Withdrawal by Subject|441
388564|NCT00809965|1305342|P2|Overall Study|Withdrawal by Subject|448
388565|NCT00809965|1305343|P1|Overall Study|Withdrawal by Subject|405
388566|NCT00809965|1305341|P3|Overall Study|Lost to Follow-up|18
388567|NCT00809965|1305342|P2|Overall Study|Lost to Follow-up|10
388568|NCT00809965|1305343|P1|Overall Study|Lost to Follow-up|17
388569|NCT00809965|1305341|P3|Overall Study|Death|196
388570|NCT00809965|1305342|P2|Overall Study|Death|147
388571|NCT00809965|1305343|P1|Overall Study|Death|194
388572|NCT00809926|1305365|P2|Overall Study|Protocol deviation|2
388573|NCT00809926|1305366|P1|Overall Study|Protocol deviation|0
388574|NCT00809926|1305365|P2|Overall Study|Administrative Problems|1
388575|NCT00809926|1305366|P1|Overall Study|Administrative Problems|0
388576|NCT00809926|1305365|P2|Overall Study|Lost to Follow-up|1
388577|NCT00809926|1305366|P1|Overall Study|Lost to Follow-up|2
388578|NCT00809926|1305365|P2|Overall Study|Patient withdrew consent|6
388579|NCT00809926|1305366|P1|Overall Study|Patient withdrew consent|8
388580|NCT00809926|1305365|P2|Overall Study|Unsatisfactory therapeutic effect|3
388581|NCT00809926|1305366|P1|Overall Study|Unsatisfactory therapeutic effect|3
388582|NCT00809926|1305365|P2|Overall Study|Adverse Event|10
388583|NCT00809926|1305366|P1|Overall Study|Adverse Event|18
388584|NCT00809835|1305420|P4|Overall Study|Withdrawal by Subject|0
388585|NCT00809835|1305421|P3|Overall Study|Withdrawal by Subject|1
388586|NCT00809835|1305422|P2|Overall Study|Withdrawal by Subject|1
388587|NCT00809835|1305423|P1|Overall Study|Withdrawal by Subject|1
388588|NCT00809835|1305420|P4|Overall Study|Lost to Follow-up|2
388589|NCT00809835|1305421|P3|Overall Study|Lost to Follow-up|10
388590|NCT00809835|1305422|P2|Overall Study|Lost to Follow-up|6
388591|NCT00809835|1305423|P1|Overall Study|Lost to Follow-up|7
388592|NCT00809757|1305453|P3|Overall Study|Noncompliance with Medication|1
388593|NCT00809757|1305454|P2|Overall Study|Noncompliance with Medication|0
388594|NCT00809757|1305455|P1|Overall Study|Noncompliance with Medication|0
388595|NCT00809757|1305453|P3|Overall Study|Subject Uncooperative|2
388596|NCT00809757|1305454|P2|Overall Study|Subject Uncooperative|0
388597|NCT00809757|1305455|P1|Overall Study|Subject Uncooperative|1
388598|NCT00809757|1305453|P3|Overall Study|Withdrawal by Subject|3
388599|NCT00809757|1305454|P2|Overall Study|Withdrawal by Subject|1
388600|NCT00809757|1305455|P1|Overall Study|Withdrawal by Subject|2
388601|NCT00809757|1305453|P3|Overall Study|Protocol Violation|1
388602|NCT00809757|1305454|P2|Overall Study|Protocol Violation|1
388603|NCT00809757|1305455|P1|Overall Study|Protocol Violation|1
388604|NCT00809757|1305453|P3|Overall Study|Lost to Follow-up|1
388605|NCT00809757|1305454|P2|Overall Study|Lost to Follow-up|0
388606|NCT00809757|1305455|P1|Overall Study|Lost to Follow-up|0
388607|NCT00809757|1305453|P3|Overall Study|Adverse Event|3
388608|NCT00809757|1305454|P2|Overall Study|Adverse Event|3
388609|NCT00809757|1305455|P1|Overall Study|Adverse Event|2
388610|NCT00809614|1305540|P2|Overall Study|Withdrawal by Subject|1
388611|NCT00809614|1305541|P1|Overall Study|Withdrawal by Subject|1
388612|NCT00809614|1305540|P2|Overall Study|Lack of Efficacy|3
388613|NCT00809614|1305541|P1|Overall Study|Lack of Efficacy|2
388614|NCT00809471|1305585|P3|Overall Study|Requirement for restricted medication|0
388615|NCT00809471|1305586|P2|Overall Study|Requirement for restricted medication|1
388616|NCT00809471|1305587|P1|Overall Study|Requirement for restricted medication|1
388617|NCT00809471|1305585|P3|Overall Study|Adverse Event|2
388618|NCT00809471|1305586|P2|Overall Study|Adverse Event|2
388619|NCT00809471|1305587|P1|Overall Study|Adverse Event|0
388620|NCT00809471|1305585|P3|Overall Study|Lost to Follow-up|9
388621|NCT00809471|1305586|P2|Overall Study|Lost to Follow-up|2
388622|NCT00809471|1305587|P1|Overall Study|Lost to Follow-up|4
388623|NCT00809471|1305585|P3|Overall Study|Protocol non-compliance|6
388624|NCT00809471|1305586|P2|Overall Study|Protocol non-compliance|15
388625|NCT00809471|1305587|P1|Overall Study|Protocol non-compliance|15
388626|NCT00809445|1305617|P3|6 Month Follow-up|Withdrew consent|1
388627|NCT00809445|1305618|P2|6 Month Follow-up|Withdrew consent|0
388628|NCT00809445|1305619|P1|6 Month Follow-up|Withdrew consent|0
388629|NCT00809445|1305617|P3|6 Month Follow-up|Incarcerated|8
388630|NCT00809445|1305618|P2|6 Month Follow-up|Incarcerated|8
388631|NCT00809445|1305619|P1|6 Month Follow-up|Incarcerated|6
388632|NCT00809445|1305617|P3|6 Month Follow-up|Death|1
388633|NCT00809445|1305618|P2|6 Month Follow-up|Death|1
388634|NCT00809445|1305619|P1|6 Month Follow-up|Death|2
388635|NCT00809445|1305617|P3|6 Month Follow-up|Lost contact|14
388636|NCT00809445|1305618|P2|6 Month Follow-up|Lost contact|14
388637|NCT00809445|1305619|P1|6 Month Follow-up|Lost contact|16
388638|NCT00809445|1305617|P3|1 Month Follow-up|Incarcerated|1
388639|NCT00809445|1305618|P2|1 Month Follow-up|Incarcerated|0
388640|NCT00809445|1305619|P1|1 Month Follow-up|Incarcerated|0
388641|NCT00809445|1305617|P3|1 Month Follow-up|Death|1
388642|NCT00809445|1305618|P2|1 Month Follow-up|Death|1
388643|NCT00809445|1305619|P1|1 Month Follow-up|Death|0
388644|NCT00809445|1305617|P3|1 Month Follow-up|Withdrew consent|1
388645|NCT00809445|1305618|P2|1 Month Follow-up|Withdrew consent|1
388646|NCT00809445|1305619|P1|1 Month Follow-up|Withdrew consent|1
388647|NCT00809445|1305617|P3|1 Month Follow-up|Lost contact|1
388648|NCT00809445|1305618|P2|1 Month Follow-up|Lost contact|2
388649|NCT00809445|1305619|P1|1 Month Follow-up|Lost contact|1
388650|NCT00809328|1305636|P1|Overall Study|Withdrawal by Subject|2
388651|NCT00809328|1305636|P1|Overall Study|Protocol Violation|3
388652|NCT00809328|1305636|P1|Overall Study|Adverse Event|6
388653|NCT00809328|1305636|P1|Overall Study|Lack of Efficacy|18
388654|NCT00809159|1305656|P6|Part 1 and 2|Withdrawal by Subject|1
388655|NCT00809159|1305657|P5|Part 1 and 2|Withdrawal by Subject|0
388656|NCT00809159|1305658|P4|Part 1 and 2|Withdrawal by Subject|0
388657|NCT00809159|1305659|P3|Part 1 and 2|Withdrawal by Subject|4
388658|NCT00809159|1305660|P2|Part 1 and 2|Withdrawal by Subject|0
388659|NCT00809159|1305661|P1|Part 1 and 2|Withdrawal by Subject|0
388660|NCT00809159|1305656|P6|Part 1 and 2|Lost to Follow-up|0
388661|NCT00809159|1305657|P5|Part 1 and 2|Lost to Follow-up|0
388662|NCT00809159|1305658|P4|Part 1 and 2|Lost to Follow-up|1
388663|NCT00809159|1305659|P3|Part 1 and 2|Lost to Follow-up|1
388664|NCT00809159|1305660|P2|Part 1 and 2|Lost to Follow-up|0
388665|NCT00809159|1305661|P1|Part 1 and 2|Lost to Follow-up|0
388666|NCT00809159|1305656|P6|Part 1 and 2|Adverse Event|1
388667|NCT00809159|1305657|P5|Part 1 and 2|Adverse Event|1
388668|NCT00809159|1305658|P4|Part 1 and 2|Adverse Event|0
388669|NCT00809159|1305659|P3|Part 1 and 2|Adverse Event|1
388670|NCT00809159|1305660|P2|Part 1 and 2|Adverse Event|0
388671|NCT00809159|1305661|P1|Part 1 and 2|Adverse Event|0
388672|NCT00809159|1305656|P6|Part 1 and 2|Administrative problems|0
388673|NCT00809159|1305657|P5|Part 1 and 2|Administrative problems|0
388674|NCT00809159|1305658|P4|Part 1 and 2|Administrative problems|1
388675|NCT00809159|1305659|P3|Part 1 and 2|Administrative problems|0
388676|NCT00809159|1305660|P2|Part 1 and 2|Administrative problems|0
388677|NCT00809159|1305661|P1|Part 1 and 2|Administrative problems|0
388678|NCT00809159|1305656|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
388679|NCT00809159|1305657|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
388680|NCT00809159|1305658|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
388681|NCT00809159|1305659|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
388682|NCT00809159|1305660|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
388683|NCT00809159|1305661|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
388684|NCT00809159|1305656|P6|Part 1|Unsatisfactory therapeutic effect|0
388685|NCT00809159|1305657|P5|Part 1|Unsatisfactory therapeutic effect|0
388686|NCT00809159|1305658|P4|Part 1|Unsatisfactory therapeutic effect|0
388687|NCT00809159|1305659|P3|Part 1|Unsatisfactory therapeutic effect|0
388688|NCT00809159|1305660|P2|Part 1|Unsatisfactory therapeutic effect|1
388689|NCT00809159|1305661|P1|Part 1|Unsatisfactory therapeutic effect|3
388690|NCT00809159|1305656|P6|Part 1|Withdrawal by Subject|0
388691|NCT00809159|1305657|P5|Part 1|Withdrawal by Subject|0
388692|NCT00809159|1305658|P4|Part 1|Withdrawal by Subject|0
388693|NCT00809159|1305659|P3|Part 1|Withdrawal by Subject|0
388694|NCT00809159|1305660|P2|Part 1|Withdrawal by Subject|1
388695|NCT00809159|1305661|P1|Part 1|Withdrawal by Subject|3
388696|NCT00809159|1305656|P6|Part 1|Lost to Follow-up|0
388697|NCT00809159|1305657|P5|Part 1|Lost to Follow-up|0
388698|NCT00809159|1305658|P4|Part 1|Lost to Follow-up|0
388699|NCT00809159|1305659|P3|Part 1|Lost to Follow-up|0
388700|NCT00809159|1305660|P2|Part 1|Lost to Follow-up|0
388701|NCT00809159|1305661|P1|Part 1|Lost to Follow-up|1
388702|NCT00809159|1305656|P6|Part 1|Adverse Event|0
388703|NCT00809159|1305657|P5|Part 1|Adverse Event|0
388704|NCT00809159|1305658|P4|Part 1|Adverse Event|0
388705|NCT00809159|1305659|P3|Part 1|Adverse Event|0
388706|NCT00809159|1305660|P2|Part 1|Adverse Event|1
388707|NCT00809159|1305661|P1|Part 1|Adverse Event|1
388708|NCT00809133|1305766|P14|Overall Study|Other not mentioned above|0
388709|NCT00809133|1305767|P13|Overall Study|Other not mentioned above|0
388710|NCT00809133|1305768|P12|Overall Study|Other not mentioned above|0
388711|NCT00809133|1305769|P11|Overall Study|Other not mentioned above|0
388712|NCT00809133|1305770|P10|Overall Study|Other not mentioned above|0
388713|NCT00809133|1305771|P9|Overall Study|Other not mentioned above|0
388714|NCT00809133|1305772|P8|Overall Study|Other not mentioned above|0
388715|NCT00809133|1305773|P7|Overall Study|Other not mentioned above|0
388716|NCT00809133|1305774|P6|Overall Study|Other not mentioned above|1
388717|NCT00809133|1305775|P5|Overall Study|Other not mentioned above|0
388718|NCT00809133|1305776|P4|Overall Study|Other not mentioned above|0
388719|NCT00809133|1305777|P3|Overall Study|Other not mentioned above|0
388720|NCT00809133|1305778|P2|Overall Study|Other not mentioned above|1
388721|NCT00809133|1305779|P1|Overall Study|Other not mentioned above|0
388722|NCT00809133|1305766|P14|Overall Study|Consent withdrawn|0
388723|NCT00809133|1305767|P13|Overall Study|Consent withdrawn|0
388724|NCT00809133|1305768|P12|Overall Study|Consent withdrawn|0
388725|NCT00809133|1305769|P11|Overall Study|Consent withdrawn|0
388726|NCT00809133|1305770|P10|Overall Study|Consent withdrawn|0
388727|NCT00809133|1305771|P9|Overall Study|Consent withdrawn|0
388728|NCT00809133|1305772|P8|Overall Study|Consent withdrawn|0
388729|NCT00809133|1305773|P7|Overall Study|Consent withdrawn|0
388730|NCT00809133|1305774|P6|Overall Study|Consent withdrawn|0
388731|NCT00809133|1305775|P5|Overall Study|Consent withdrawn|1
388732|NCT00809133|1305776|P4|Overall Study|Consent withdrawn|0
388733|NCT00809133|1305777|P3|Overall Study|Consent withdrawn|0
388734|NCT00809133|1305778|P2|Overall Study|Consent withdrawn|0
388735|NCT00809133|1305779|P1|Overall Study|Consent withdrawn|0
388736|NCT00809133|1305766|P14|Overall Study|Lost to Follow-up|0
388737|NCT00809133|1305767|P13|Overall Study|Lost to Follow-up|0
388738|NCT00809133|1305768|P12|Overall Study|Lost to Follow-up|0
388739|NCT00809133|1305769|P11|Overall Study|Lost to Follow-up|0
388740|NCT00809133|1305770|P10|Overall Study|Lost to Follow-up|0
388741|NCT00809133|1305771|P9|Overall Study|Lost to Follow-up|0
388742|NCT00809133|1305772|P8|Overall Study|Lost to Follow-up|0
388743|NCT00809133|1305773|P7|Overall Study|Lost to Follow-up|0
388744|NCT00809133|1305774|P6|Overall Study|Lost to Follow-up|1
388745|NCT00809133|1305775|P5|Overall Study|Lost to Follow-up|0
388746|NCT00809133|1305776|P4|Overall Study|Lost to Follow-up|0
388747|NCT00809133|1305777|P3|Overall Study|Lost to Follow-up|0
388748|NCT00809133|1305778|P2|Overall Study|Lost to Follow-up|0
388749|NCT00809133|1305779|P1|Overall Study|Lost to Follow-up|0
388750|NCT00809133|1305766|P14|Overall Study|Other adverse event|1
388751|NCT00809133|1305767|P13|Overall Study|Other adverse event|0
388752|NCT00809133|1305768|P12|Overall Study|Other adverse event|1
388753|NCT00809133|1305769|P11|Overall Study|Other adverse event|1
388754|NCT00809133|1305770|P10|Overall Study|Other adverse event|0
388755|NCT00809133|1305771|P9|Overall Study|Other adverse event|0
388756|NCT00809133|1305772|P8|Overall Study|Other adverse event|4
388757|NCT00809133|1305773|P7|Overall Study|Other adverse event|2
388758|NCT00809133|1305774|P6|Overall Study|Other adverse event|3
388759|NCT00809133|1305775|P5|Overall Study|Other adverse event|0
388760|NCT00809133|1305776|P4|Overall Study|Other adverse event|0
388761|NCT00809133|1305777|P3|Overall Study|Other adverse event|1
388762|NCT00809133|1305778|P2|Overall Study|Other adverse event|1
388763|NCT00809133|1305779|P1|Overall Study|Other adverse event|1
388764|NCT00809133|1305766|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
388765|NCT00809133|1305767|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
388766|NCT00809133|1305768|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
388767|NCT00809133|1305769|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
388768|NCT00809133|1305770|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
388769|NCT00809133|1305771|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
388770|NCT00809133|1305772|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
388771|NCT00809133|1305773|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
388772|NCT00809133|1305774|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
388773|NCT00809133|1305775|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
388774|NCT00809133|1305776|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
388775|NCT00809133|1305777|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
388776|NCT00809133|1305778|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
388777|NCT00809133|1305779|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
388778|NCT00809133|1305766|P14|Overall Study|Progressive disease|4
388779|NCT00809133|1305767|P13|Overall Study|Progressive disease|5
388780|NCT00809133|1305768|P12|Overall Study|Progressive disease|7
388781|NCT00809133|1305769|P11|Overall Study|Progressive disease|5
388782|NCT00809133|1305770|P10|Overall Study|Progressive disease|9
388783|NCT00809133|1305771|P9|Overall Study|Progressive disease|3
388784|NCT00809133|1305772|P8|Overall Study|Progressive disease|3
388785|NCT00809133|1305773|P7|Overall Study|Progressive disease|3
388786|NCT00809133|1305774|P6|Overall Study|Progressive disease|1
388787|NCT00809133|1305775|P5|Overall Study|Progressive disease|4
388788|NCT00809133|1305776|P4|Overall Study|Progressive disease|3
388789|NCT00809133|1305777|P3|Overall Study|Progressive disease|5
388790|NCT00809133|1305778|P2|Overall Study|Progressive disease|5
388791|NCT00809133|1305779|P1|Overall Study|Progressive disease|2
388792|NCT00809094|1305933|P2|Overall Study|Lost to Follow-up|1
388793|NCT00809094|1305934|P1|Overall Study|Lost to Follow-up|0
388794|NCT00808899|1305979|P1|Overall Study|Physician Decision|3
388795|NCT00808899|1305979|P1|Overall Study|Death|1
388796|NCT00808808|1305993|P3|Overall Study|Employee was not vaccinated.|2255
388797|NCT00808808|1305994|P2|Overall Study|Employee was not vaccinated.|2268
388798|NCT00808808|1305995|P1|Overall Study|Employee was not vaccinated.|2686
388799|NCT00808808|1305993|P3|Overall Study|Vaccinated; survey not completed|302
388800|NCT00808808|1305994|P2|Overall Study|Vaccinated; survey not completed|169
388801|NCT00808808|1305995|P1|Overall Study|Vaccinated; survey not completed|131
388802|NCT00808665|1306030|P2|Overall Study|Medication stopped by resident|1
388803|NCT00808665|1306031|P1|Overall Study|Medication stopped by resident|0
388804|NCT00808665|1306030|P2|Overall Study|Physician Decision|1
388805|NCT00808665|1306031|P1|Overall Study|Physician Decision|3
388806|NCT00808665|1306030|P2|Overall Study|required an additional procedure|1
388807|NCT00808665|1306031|P1|Overall Study|required an additional procedure|0
388808|NCT00808665|1306030|P2|Overall Study|surgery cancelled|0
388809|NCT00808665|1306031|P1|Overall Study|surgery cancelled|1
388810|NCT00808665|1306030|P2|Overall Study|only required minimally invasive surgery|0
388811|NCT00808665|1306031|P1|Overall Study|only required minimally invasive surgery|1
388812|NCT00808665|1306030|P2|Overall Study|Withdrawal by Subject|0
388813|NCT00808665|1306031|P1|Overall Study|Withdrawal by Subject|1
388814|NCT00808639|1306037|P1|Overall Study|Disease progression before surgery.|1
388815|NCT00808509|1306045|P2|Randomized Phase|Patient refused rescue therapy|3
388816|NCT00808509|1306046|P1|Randomized Phase|Patient refused rescue therapy|0
388817|NCT00808509|1306045|P2|Randomized Phase|Reduced methotrexate dose|2
388818|NCT00808509|1306046|P1|Randomized Phase|Reduced methotrexate dose|1
388819|NCT00808509|1306045|P2|Randomized Phase|Did not meet eligibility criteria|0
388820|NCT00808509|1306046|P1|Randomized Phase|Did not meet eligibility criteria|1
388821|NCT00808483|1306144|P2|From 5 Months to 12 Months|Lack of Efficacy|0
388822|NCT00808483|1306145|P1|From 5 Months to 12 Months|Lack of Efficacy|1
388823|NCT00808483|1306144|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
388824|NCT00808483|1306145|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
388825|NCT00808483|1306144|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
388826|NCT00808483|1306145|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
388827|NCT00808444|1306182|P2|Overall Study|Lost to Follow-up|1
388828|NCT00808444|1306183|P1|Overall Study|Lost to Follow-up|0
388829|NCT00808444|1306182|P2|Overall Study|Withdrawal by Subject|0
388830|NCT00808444|1306183|P1|Overall Study|Withdrawal by Subject|1
388831|NCT00808249|1306258|P4|Overall Study|All other reasons|1
388832|NCT00808249|1306259|P3|Overall Study|All other reasons|3
388833|NCT00808249|1306260|P2|Overall Study|All other reasons|1
388834|NCT00808249|1306261|P1|Overall Study|All other reasons|2
388835|NCT00808249|1306258|P4|Overall Study|study specific discontinuation criteria|0
388836|NCT00808249|1306259|P3|Overall Study|study specific discontinuation criteria|1
388837|NCT00808249|1306260|P2|Overall Study|study specific discontinuation criteria|0
388838|NCT00808249|1306261|P1|Overall Study|study specific discontinuation criteria|1
388839|NCT00808249|1306258|P4|Overall Study|Lack of Efficacy|0
388840|NCT00808249|1306259|P3|Overall Study|Lack of Efficacy|0
388841|NCT00808249|1306260|P2|Overall Study|Lack of Efficacy|1
388842|NCT00808249|1306261|P1|Overall Study|Lack of Efficacy|1
388843|NCT00808249|1306258|P4|Overall Study|Protocol Violation|0
388844|NCT00808249|1306259|P3|Overall Study|Protocol Violation|3
388845|NCT00808249|1306260|P2|Overall Study|Protocol Violation|3
388846|NCT00808249|1306261|P1|Overall Study|Protocol Violation|3
388847|NCT00808249|1306258|P4|Overall Study|Withdrawal by Subject|4
388848|NCT00808249|1306259|P3|Overall Study|Withdrawal by Subject|2
388849|NCT00808249|1306260|P2|Overall Study|Withdrawal by Subject|0
388850|NCT00808249|1306261|P1|Overall Study|Withdrawal by Subject|4
388851|NCT00808249|1306258|P4|Overall Study|Lost to Follow-up|5
388852|NCT00808249|1306259|P3|Overall Study|Lost to Follow-up|3
388853|NCT00808249|1306260|P2|Overall Study|Lost to Follow-up|3
388854|NCT00808249|1306261|P1|Overall Study|Lost to Follow-up|2
388855|NCT00808249|1306258|P4|Overall Study|Adverse Event|6
388856|NCT00808249|1306259|P3|Overall Study|Adverse Event|10
388857|NCT00808249|1306260|P2|Overall Study|Adverse Event|7
388858|NCT00808249|1306261|P1|Overall Study|Adverse Event|4
388859|NCT00808236|1306289|P2|Overall Study|Death|30
388860|NCT00808236|1306290|P1|Overall Study|Death|18
388861|NCT00808236|1306289|P2|Overall Study|Physician Decision|1
388862|NCT00808236|1306290|P1|Overall Study|Physician Decision|0
388863|NCT00808236|1306289|P2|Overall Study|Lost to Follow-up|1
388864|NCT00808236|1306290|P1|Overall Study|Lost to Follow-up|1
388865|NCT00808236|1306289|P2|Overall Study|Pre-defined exclusion|3
388866|NCT00808236|1306290|P1|Overall Study|Pre-defined exclusion|13
388867|NCT00808236|1306289|P2|Overall Study|Was not resuscitated|56
388868|NCT00808236|1306290|P1|Overall Study|Was not resuscitated|50
388869|NCT00808132|1306323|P5|Overall Study|Unsatisfactory response|12
388870|NCT00808132|1306324|P4|Overall Study|Unsatisfactory response|4
388871|NCT00808132|1306325|P3|Overall Study|Unsatisfactory response|6
388872|NCT00808132|1306326|P2|Overall Study|Unsatisfactory response|6
388873|NCT00808132|1306327|P1|Overall Study|Unsatisfactory response|5
388874|NCT00808132|1306323|P5|Overall Study|Randomized, but not treated|9
388875|NCT00808132|1306324|P4|Overall Study|Randomized, but not treated|8
388876|NCT00808132|1306325|P3|Overall Study|Randomized, but not treated|9
388877|NCT00808132|1306326|P2|Overall Study|Randomized, but not treated|7
388878|NCT00808132|1306327|P1|Overall Study|Randomized, but not treated|10
388879|NCT00808132|1306323|P5|Overall Study|Other|15
388880|NCT00808132|1306324|P4|Overall Study|Other|2
388881|NCT00808132|1306325|P3|Overall Study|Other|6
388882|NCT00808132|1306326|P2|Overall Study|Other|4
388883|NCT00808132|1306327|P1|Overall Study|Other|6
388884|NCT00808132|1306323|P5|Overall Study|Withdrawal by Subject|16
388885|NCT00808132|1306324|P4|Overall Study|Withdrawal by Subject|7
388886|NCT00808132|1306325|P3|Overall Study|Withdrawal by Subject|2
388887|NCT00808132|1306326|P2|Overall Study|Withdrawal by Subject|18
388888|NCT00808132|1306327|P1|Overall Study|Withdrawal by Subject|27
388889|NCT00808132|1306323|P5|Overall Study|Protocol Violation|5
388890|NCT00808132|1306324|P4|Overall Study|Protocol Violation|9
388891|NCT00808132|1306325|P3|Overall Study|Protocol Violation|4
388892|NCT00808132|1306326|P2|Overall Study|Protocol Violation|9
388893|NCT00808132|1306327|P1|Overall Study|Protocol Violation|8
388894|NCT00808132|1306323|P5|Overall Study|Lost to Follow-up|9
388895|NCT00808132|1306324|P4|Overall Study|Lost to Follow-up|8
388896|NCT00808132|1306325|P3|Overall Study|Lost to Follow-up|11
388897|NCT00808132|1306326|P2|Overall Study|Lost to Follow-up|10
388898|NCT00808132|1306327|P1|Overall Study|Lost to Follow-up|8
388899|NCT00808132|1306323|P5|Overall Study|Physician Decision|0
388900|NCT00808132|1306324|P4|Overall Study|Physician Decision|0
388901|NCT00808132|1306325|P3|Overall Study|Physician Decision|0
388902|NCT00808132|1306326|P2|Overall Study|Physician Decision|1
388903|NCT00808132|1306327|P1|Overall Study|Physician Decision|0
388904|NCT00808132|1306323|P5|Overall Study|Death|1
388905|NCT00808132|1306324|P4|Overall Study|Death|0
388906|NCT00808132|1306325|P3|Overall Study|Death|0
388907|NCT00808132|1306326|P2|Overall Study|Death|0
388908|NCT00808132|1306327|P1|Overall Study|Death|0
388909|NCT00808132|1306323|P5|Overall Study|Adverse Event|33
388910|NCT00808132|1306324|P4|Overall Study|Adverse Event|31
388911|NCT00808132|1306325|P3|Overall Study|Adverse Event|16
388912|NCT00808132|1306326|P2|Overall Study|Adverse Event|33
388913|NCT00808132|1306327|P1|Overall Study|Adverse Event|34
388914|NCT00808080|1306399|P1|Overall Study|Patients Became Ineligible for infusion|6
388915|NCT00808067|1306405|P2|Overall Study|Excluded from analysis|19
388916|NCT00808067|1306406|P1|Overall Study|Excluded from analysis|13
388917|NCT00808067|1306405|P2|Overall Study|Other reason not defined above|5
388918|NCT00808067|1306406|P1|Overall Study|Other reason not defined above|5
388919|NCT00808067|1306405|P2|Overall Study|Site closed for cause|19
388920|NCT00808067|1306406|P1|Overall Study|Site closed for cause|19
388921|NCT00808067|1306405|P2|Overall Study|Patient elected|9
388922|NCT00808067|1306406|P1|Overall Study|Patient elected|7
388923|NCT00808067|1306405|P2|Overall Study|Protocol Violation|11
388924|NCT00808067|1306406|P1|Overall Study|Protocol Violation|3
388925|NCT00808067|1306405|P2|Overall Study|Physician Decision|38
388926|NCT00808067|1306406|P1|Overall Study|Physician Decision|47
388927|NCT00808067|1306405|P2|Overall Study|Site closed|3
388928|NCT00808067|1306406|P1|Overall Study|Site closed|4
388929|NCT00808067|1306405|P2|Overall Study|Withdrawal by Subject|25
388930|NCT00808067|1306406|P1|Overall Study|Withdrawal by Subject|21
388931|NCT00808067|1306405|P2|Overall Study|Procedure|7
388932|NCT00808067|1306406|P1|Overall Study|Procedure|6
388933|NCT00808067|1306405|P2|Overall Study|Death|1
388934|NCT00808067|1306406|P1|Overall Study|Death|1
388935|NCT00808067|1306405|P2|Overall Study|Missing|0
388936|NCT00808067|1306406|P1|Overall Study|Missing|1
388937|NCT00808067|1306405|P2|Overall Study|Patient refused to take study medication|76
388938|NCT00808067|1306406|P1|Overall Study|Patient refused to take study medication|65
388939|NCT00808067|1306405|P2|Overall Study|Elevated LFT results|3
388940|NCT00808067|1306406|P1|Overall Study|Elevated LFT results|7
388941|NCT00808067|1306405|P2|Overall Study|Reduced creatinine clearance|55
388942|NCT00808067|1306406|P1|Overall Study|Reduced creatinine clearance|53
388943|NCT00808067|1306405|P2|Overall Study|Hospitalization due to surgery|40
388944|NCT00808067|1306406|P1|Overall Study|Hospitalization due to surgery|37
388945|NCT00808067|1306405|P2|Overall Study|Hospitalization (not including surgery)|17
388946|NCT00808067|1306406|P1|Overall Study|Hospitalization (not including surgery)|18
388947|NCT00808067|1306405|P2|Overall Study|Adverse Event|121
388948|NCT00808067|1306406|P1|Overall Study|Adverse Event|111
388949|NCT00808067|1306405|P2|Overall Study|Outcome event - other|25
388950|NCT00808067|1306406|P1|Overall Study|Outcome event - other|33
388951|NCT00808067|1306405|P2|Overall Study|Major/minor bleed|44
388952|NCT00808067|1306406|P1|Overall Study|Major/minor bleed|30
388953|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
388954|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
388955|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
388956|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
388957|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Death|0
388958|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Death|1
388959|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Death|0
388960|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Death|0
388961|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
388962|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
388963|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
388964|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
388965|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Other|1
388966|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Other|1
388967|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Other|0
388968|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Other|0
388969|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
388970|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
388971|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
388972|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
388973|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
388974|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
388975|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
388976|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
388977|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
388978|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
388979|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
388980|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
388981|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
388982|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
388983|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
388984|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
388985|NCT00808028|1306442|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
388986|NCT00808028|1306443|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
388987|NCT00808028|1306444|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
388988|NCT00808028|1306445|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
388989|NCT00808028|1306442|P4|Stage 1 (6 Months)|Protocol Violation|1
388990|NCT00808028|1306443|P3|Stage 1 (6 Months)|Protocol Violation|0
388991|NCT00808028|1306444|P2|Stage 1 (6 Months)|Protocol Violation|0
388992|NCT00808028|1306445|P1|Stage 1 (6 Months)|Protocol Violation|0
388993|NCT00808028|1306442|P4|Stage 1 (6 Months)|Lost to Follow-up|0
388994|NCT00808028|1306443|P3|Stage 1 (6 Months)|Lost to Follow-up|1
388995|NCT00808028|1306444|P2|Stage 1 (6 Months)|Lost to Follow-up|0
388996|NCT00808028|1306445|P1|Stage 1 (6 Months)|Lost to Follow-up|1
388997|NCT00808028|1306442|P4|Stage 1 (6 Months)|Adverse Event|2
388998|NCT00808028|1306443|P3|Stage 1 (6 Months)|Adverse Event|1
388999|NCT00808028|1306444|P2|Stage 1 (6 Months)|Adverse Event|0
389000|NCT00808028|1306445|P1|Stage 1 (6 Months)|Adverse Event|0
389001|NCT00808028|1306442|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
389002|NCT00808028|1306443|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
389003|NCT00808028|1306444|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
389004|NCT00808028|1306445|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
389005|NCT00808028|1306442|P4|Stage 1 (6 Months)|Other|4
389006|NCT00808028|1306443|P3|Stage 1 (6 Months)|Other|2
389007|NCT00808028|1306444|P2|Stage 1 (6 Months)|Other|0
389008|NCT00808028|1306445|P1|Stage 1 (6 Months)|Other|1
389009|NCT00808028|1306442|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
389010|NCT00808028|1306443|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
389011|NCT00808028|1306444|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
389012|NCT00808028|1306445|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
389013|NCT00808015|1306481|P1|Overall Study|Enrolled but not treated|4
389014|NCT00808015|1306481|P1|Overall Study|Other|25
389015|NCT00808015|1306481|P1|Overall Study|Adverse Event|22
389016|NCT00808015|1306481|P1|Overall Study|Participants not willing to participate|158
389017|NCT00808015|1306481|P1|Overall Study|Lost to Follow-up|76
389018|NCT00808015|1306481|P1|Overall Study|Lack of Efficacy|58
389019|NCT00808015|1306481|P1|Overall Study|Death|1
389020|NCT00807937|1306510|P4|Overall Study|All other reasons (not provided)|1
389021|NCT00807937|1306511|P3|Overall Study|All other reasons (not provided)|0
389022|NCT00807937|1306512|P2|Overall Study|All other reasons (not provided)|4
389023|NCT00807937|1306513|P1|Overall Study|All other reasons (not provided)|2
389024|NCT00807937|1306510|P4|Overall Study|Intake of prohibited medicine|0
389025|NCT00807937|1306511|P3|Overall Study|Intake of prohibited medicine|2
389026|NCT00807937|1306512|P2|Overall Study|Intake of prohibited medicine|0
389027|NCT00807937|1306513|P1|Overall Study|Intake of prohibited medicine|0
389028|NCT00807937|1306510|P4|Overall Study|Lack of Efficacy|2
389029|NCT00807937|1306511|P3|Overall Study|Lack of Efficacy|1
389030|NCT00807937|1306512|P2|Overall Study|Lack of Efficacy|0
389031|NCT00807937|1306513|P1|Overall Study|Lack of Efficacy|0
389032|NCT00807937|1306510|P4|Overall Study|Lost to Follow-up|1
389033|NCT00807937|1306511|P3|Overall Study|Lost to Follow-up|2
389034|NCT00807937|1306512|P2|Overall Study|Lost to Follow-up|0
389035|NCT00807937|1306513|P1|Overall Study|Lost to Follow-up|4
389036|NCT00807937|1306510|P4|Overall Study|Withdrawal by Subject|4
389037|NCT00807937|1306511|P3|Overall Study|Withdrawal by Subject|1
389038|NCT00807937|1306512|P2|Overall Study|Withdrawal by Subject|4
389039|NCT00807937|1306513|P1|Overall Study|Withdrawal by Subject|5
389040|NCT00807937|1306510|P4|Overall Study|Protocol Violation|3
389041|NCT00807937|1306511|P3|Overall Study|Protocol Violation|3
389042|NCT00807937|1306512|P2|Overall Study|Protocol Violation|5
389043|NCT00807937|1306513|P1|Overall Study|Protocol Violation|4
389044|NCT00807937|1306510|P4|Overall Study|Adverse Event|4
389045|NCT00807937|1306511|P3|Overall Study|Adverse Event|5
389046|NCT00807937|1306512|P2|Overall Study|Adverse Event|12
389047|NCT00807937|1306513|P1|Overall Study|Adverse Event|12
389048|NCT00807885|1306548|P9|Overall Study|Lost to Follow-up|0
389049|NCT00807885|1306549|P8|Overall Study|Lost to Follow-up|0
389050|NCT00807885|1306550|P7|Overall Study|Lost to Follow-up|0
389051|NCT00807885|1306551|P6|Overall Study|Lost to Follow-up|1
389052|NCT00807885|1306552|P5|Overall Study|Lost to Follow-up|0
389053|NCT00807885|1306553|P4|Overall Study|Lost to Follow-up|0
389054|NCT00807885|1306554|P3|Overall Study|Lost to Follow-up|0
389055|NCT00807885|1306555|P2|Overall Study|Lost to Follow-up|0
389056|NCT00807885|1306556|P1|Overall Study|Lost to Follow-up|0
389057|NCT00807846|1306605|P2|Overall Study|Not Specified|2
389058|NCT00807846|1306606|P1|Overall Study|Not Specified|1
389059|NCT00807846|1306605|P2|Overall Study|Withdrawal by Subject|1
389060|NCT00807846|1306606|P1|Overall Study|Withdrawal by Subject|2
389061|NCT00807846|1306605|P2|Overall Study|Protocol Violation|1
389062|NCT00807846|1306606|P1|Overall Study|Protocol Violation|2
389063|NCT00807846|1306605|P2|Overall Study|Lack of Efficacy|0
389064|NCT00807846|1306606|P1|Overall Study|Lack of Efficacy|2
389065|NCT00807846|1306605|P2|Overall Study|Adverse Event|0
389066|NCT00807846|1306606|P1|Overall Study|Adverse Event|5
389067|NCT00807573|1306670|P1|Overall Study|Adverse Event|1
389068|NCT00807573|1306670|P1|Overall Study|Withdrawal by Subject|1
389069|NCT00807495|1306716|P5|Overall Study|Reason Not Specified|3
389070|NCT00807495|1306717|P4|Overall Study|Reason Not Specified|0
389071|NCT00807495|1306718|P3|Overall Study|Reason Not Specified|2
389072|NCT00807495|1306719|P2|Overall Study|Reason Not Specified|3
389073|NCT00807495|1306720|P1|Overall Study|Reason Not Specified|0
389074|NCT00807495|1306716|P5|Overall Study|Withdrawal by Patient|0
389075|NCT00807495|1306717|P4|Overall Study|Withdrawal by Patient|0
389076|NCT00807495|1306718|P3|Overall Study|Withdrawal by Patient|1
389077|NCT00807495|1306719|P2|Overall Study|Withdrawal by Patient|0
389078|NCT00807495|1306720|P1|Overall Study|Withdrawal by Patient|2
389079|NCT00807495|1306716|P5|Overall Study|Adverse Event|2
389080|NCT00807495|1306717|P4|Overall Study|Adverse Event|1
389081|NCT00807495|1306718|P3|Overall Study|Adverse Event|1
389082|NCT00807495|1306719|P2|Overall Study|Adverse Event|3
389083|NCT00807495|1306720|P1|Overall Study|Adverse Event|6
389084|NCT00807365|1306766|P1|Overall Study|Study Terminated|5
389085|NCT00807248|1306774|P4|Overall Study|Other Reason|0
389086|NCT00807248|1306775|P3|Overall Study|Other Reason|2
389087|NCT00807248|1306776|P2|Overall Study|Other Reason|0
389088|NCT00807248|1306777|P1|Overall Study|Other Reason|0
389089|NCT00807248|1306774|P4|Overall Study|Lost to Follow-up|0
389090|NCT00807248|1306775|P3|Overall Study|Lost to Follow-up|0
389091|NCT00807248|1306776|P2|Overall Study|Lost to Follow-up|0
389092|NCT00807248|1306777|P1|Overall Study|Lost to Follow-up|1
389093|NCT00807248|1306774|P4|Overall Study|Withdrawal of Consent|5
389094|NCT00807248|1306775|P3|Overall Study|Withdrawal of Consent|5
389095|NCT00807248|1306776|P2|Overall Study|Withdrawal of Consent|5
389096|NCT00807248|1306777|P1|Overall Study|Withdrawal of Consent|5
389097|NCT00807248|1306774|P4|Overall Study|Protocol Violation|0
389098|NCT00807248|1306775|P3|Overall Study|Protocol Violation|1
389099|NCT00807248|1306776|P2|Overall Study|Protocol Violation|1
389100|NCT00807248|1306777|P1|Overall Study|Protocol Violation|0
389101|NCT00807248|1306774|P4|Overall Study|Lack of Efficacy|3
389102|NCT00807248|1306775|P3|Overall Study|Lack of Efficacy|8
389103|NCT00807248|1306776|P2|Overall Study|Lack of Efficacy|4
389104|NCT00807248|1306777|P1|Overall Study|Lack of Efficacy|14
389105|NCT00807248|1306774|P4|Overall Study|Adverse Event|6
389106|NCT00807248|1306775|P3|Overall Study|Adverse Event|2
389107|NCT00807248|1306776|P2|Overall Study|Adverse Event|2
389108|NCT00807248|1306777|P1|Overall Study|Adverse Event|1
389109|NCT00807235|1306821|P2|Overall Study|Adverse Event|0
389110|NCT00807235|1306822|P1|Overall Study|Adverse Event|1
389111|NCT00807092|1306867|P2|Overall Study|CGMS data collection failed|1
389112|NCT00807092|1306868|P1|Overall Study|CGMS data collection failed|0
389113|NCT00807092|1306867|P2|Overall Study|Withdrawal by Subject|0
389114|NCT00807092|1306868|P1|Overall Study|Withdrawal by Subject|1
389115|NCT00807092|1306867|P2|Overall Study|Protocol Violation|2
389116|NCT00807092|1306868|P1|Overall Study|Protocol Violation|0
389117|NCT00807092|1306867|P2|Overall Study|Adverse Event|1
389118|NCT00807092|1306868|P1|Overall Study|Adverse Event|0
389119|NCT00807040|1306898|P2|Overall Study|Lost to Follow-up|6
389120|NCT00807040|1306899|P1|Overall Study|Lost to Follow-up|4
389121|NCT00807040|1306898|P2|Overall Study|Withdrawal by Subject|6
389122|NCT00807040|1306899|P1|Overall Study|Withdrawal by Subject|8
389123|NCT00807040|1306898|P2|Overall Study|Death|29
389124|NCT00807040|1306899|P1|Overall Study|Death|24
389125|NCT00807014|1306909|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
389126|NCT00807014|1306910|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
389127|NCT00807014|1306909|P2|Overall Study|Recovery|0
389128|NCT00807014|1306910|P1|Overall Study|Recovery|1
389129|NCT00807014|1306909|P2|Overall Study|Lost to Follow-up|7
389130|NCT00807014|1306910|P1|Overall Study|Lost to Follow-up|9
389131|NCT00807014|1306909|P2|Overall Study|Adverse Event|2
389132|NCT00807014|1306910|P1|Overall Study|Adverse Event|0
389133|NCT00807014|1306909|P2|Overall Study|Protocol Violation|8
389134|NCT00807014|1306910|P1|Overall Study|Protocol Violation|2
389135|NCT00807014|1306909|P2|Overall Study|Participant Considered Disease Not Cured|7
389136|NCT00807014|1306910|P1|Overall Study|Participant Considered Disease Not Cured|2
389137|NCT00807014|1306909|P2|Overall Study|Participant Considered Disease Cured|2
389138|NCT00807014|1306910|P1|Overall Study|Participant Considered Disease Cured|13
389139|NCT00807001|1306941|P5|Overall Study|Non-compliance|0
389140|NCT00807001|1306942|P4|Overall Study|Non-compliance|0
389141|NCT00807001|1306943|P3|Overall Study|Non-compliance|0
389142|NCT00807001|1306944|P2|Overall Study|Non-compliance|1
389143|NCT00807001|1306945|P1|Overall Study|Non-compliance|0
389144|NCT00806988|1306964|P2|Overall Study|Lost to Follow-up|19
389145|NCT00806988|1306965|P1|Overall Study|Lost to Follow-up|4
389146|NCT00806988|1306964|P2|Overall Study|Withdrawal by Subject|8
389147|NCT00806988|1306965|P1|Overall Study|Withdrawal by Subject|8
389148|NCT00806988|1306964|P2|Overall Study|Death|16
389149|NCT00806988|1306965|P1|Overall Study|Death|15
389150|NCT00806819|1306975|P2|Overall Study|Reasons other than stated above|41
389151|NCT00806819|1306976|P1|Overall Study|Reasons other than stated above|25
389152|NCT00806819|1306975|P2|Overall Study|Not treated|3
389153|NCT00806819|1306976|P1|Overall Study|Not treated|6
389154|NCT00806819|1306975|P2|Overall Study|Withdrawal by Subject|29
389155|NCT00806819|1306976|P1|Overall Study|Withdrawal by Subject|32
389156|NCT00806819|1306975|P2|Overall Study|Lost to Follow-up|0
389157|NCT00806819|1306976|P1|Overall Study|Lost to Follow-up|1
389158|NCT00806819|1306975|P2|Overall Study|Protocol Violation|4
389159|NCT00806819|1306976|P1|Overall Study|Protocol Violation|9
389160|NCT00806819|1306975|P2|Overall Study|Other AE|40
389161|NCT00806819|1306976|P1|Overall Study|Other AE|38
389162|NCT00806819|1306975|P2|Overall Study|Worsening or AE of underlying disease|25
389163|NCT00806819|1306976|P1|Overall Study|Worsening or AE of underlying disease|18
389164|NCT00806819|1306975|P2|Overall Study|progressive disease (modified RECIST )|216
389165|NCT00806819|1306976|P1|Overall Study|progressive disease (modified RECIST )|217
389166|NCT00806624|1307045|P3|Overall Study|discontinued before start of treatment|1
389167|NCT00806624|1307046|P2|Overall Study|discontinued before start of treatment|0
389168|NCT00806624|1307047|P1|Overall Study|discontinued before start of treatment|0
389169|NCT00806624|1307045|P3|Overall Study|Withdrawal by Subject|3
389170|NCT00806624|1307046|P2|Overall Study|Withdrawal by Subject|3
389171|NCT00806624|1307047|P1|Overall Study|Withdrawal by Subject|6
389172|NCT00806624|1307045|P3|Overall Study|Lost to Follow-up|1
389173|NCT00806624|1307046|P2|Overall Study|Lost to Follow-up|0
389174|NCT00806624|1307047|P1|Overall Study|Lost to Follow-up|1
389175|NCT00806624|1307045|P3|Overall Study|Death|1
389176|NCT00806624|1307046|P2|Overall Study|Death|1
389177|NCT00806624|1307047|P1|Overall Study|Death|0
389178|NCT00806624|1307045|P3|Overall Study|Adverse Event|0
389179|NCT00806624|1307046|P2|Overall Study|Adverse Event|8
389180|NCT00806624|1307047|P1|Overall Study|Adverse Event|2
389181|NCT00806585|1307064|P5|Overall Study|Completion status unknown|12
389182|NCT00806585|1307065|P4|Overall Study|Completion status unknown|4
389183|NCT00806585|1307066|P3|Overall Study|Completion status unknown|12
389184|NCT00806585|1307067|P2|Overall Study|Completion status unknown|14
389185|NCT00806585|1307068|P1|Overall Study|Completion status unknown|15
389186|NCT00806585|1307064|P5|Overall Study|Withdrawal by Subject|11
389187|NCT00806585|1307065|P4|Overall Study|Withdrawal by Subject|3
389188|NCT00806585|1307066|P3|Overall Study|Withdrawal by Subject|9
389189|NCT00806585|1307067|P2|Overall Study|Withdrawal by Subject|8
389190|NCT00806585|1307068|P1|Overall Study|Withdrawal by Subject|10
389191|NCT00806585|1307064|P5|Overall Study|Adverse Event|2
389192|NCT00806585|1307065|P4|Overall Study|Adverse Event|4
389193|NCT00806585|1307066|P3|Overall Study|Adverse Event|3
389194|NCT00806585|1307067|P2|Overall Study|Adverse Event|5
389195|NCT00806585|1307068|P1|Overall Study|Adverse Event|1
389196|NCT00806585|1307064|P5|Overall Study|Lack of Efficacy|0
389197|NCT00806585|1307065|P4|Overall Study|Lack of Efficacy|0
389198|NCT00806585|1307066|P3|Overall Study|Lack of Efficacy|0
389199|NCT00806585|1307067|P2|Overall Study|Lack of Efficacy|0
389200|NCT00806585|1307068|P1|Overall Study|Lack of Efficacy|1
389201|NCT00806585|1307064|P5|Overall Study|Lost to Follow-up|5
389202|NCT00806585|1307065|P4|Overall Study|Lost to Follow-up|2
389203|NCT00806585|1307066|P3|Overall Study|Lost to Follow-up|2
389204|NCT00806585|1307067|P2|Overall Study|Lost to Follow-up|1
389205|NCT00806585|1307068|P1|Overall Study|Lost to Follow-up|2
389206|NCT00806585|1307064|P5|Overall Study|Physician Decision|1
389207|NCT00806585|1307065|P4|Overall Study|Physician Decision|0
389208|NCT00806585|1307066|P3|Overall Study|Physician Decision|3
389209|NCT00806585|1307067|P2|Overall Study|Physician Decision|2
389210|NCT00806585|1307068|P1|Overall Study|Physician Decision|0
389211|NCT00806585|1307064|P5|Overall Study|Protocol Violation|0
389212|NCT00806585|1307065|P4|Overall Study|Protocol Violation|0
389213|NCT00806585|1307066|P3|Overall Study|Protocol Violation|2
389214|NCT00806585|1307067|P2|Overall Study|Protocol Violation|1
389215|NCT00806585|1307068|P1|Overall Study|Protocol Violation|3
389216|NCT00806585|1307064|P5|Overall Study|Study terminated by Sponsor|0
389217|NCT00806585|1307065|P4|Overall Study|Study terminated by Sponsor|2
389218|NCT00806585|1307066|P3|Overall Study|Study terminated by Sponsor|1
389219|NCT00806585|1307067|P2|Overall Study|Study terminated by Sponsor|0
389220|NCT00806585|1307068|P1|Overall Study|Study terminated by Sponsor|0
389221|NCT00806546|1307100|P1|Overall Study|Various|42
389222|NCT00806546|1307100|P1|Overall Study|Protocol Violation|49
389223|NCT00806546|1307100|P1|Overall Study|Withdrawal by Subject|75
389224|NCT00806546|1307100|P1|Overall Study|Adverse Event|74
389225|NCT00806546|1307100|P1|Overall Study|Lost to Follow-up|32
389226|NCT00806546|1307100|P1|Overall Study|Enrolled, not treated|35
389227|NCT00806494|1307104|P1|Overall Study|Withdrawal by Subject|5
389228|NCT00806494|1307104|P1|Overall Study|Other|30
389229|NCT00806494|1307104|P1|Overall Study|Lost to Follow-up|10
389230|NCT00806494|1307104|P1|Overall Study|Lack of Efficacy|6
389231|NCT00806494|1307104|P1|Overall Study|Adverse Event|29
389232|NCT00806442|1307128|P2|Overall Study|Withdrawal by Subject|5
389233|NCT00806442|1307129|P1|Overall Study|Withdrawal by Subject|1
389234|NCT00806442|1307128|P2|Overall Study|Lost to Follow-up|2
389235|NCT00806442|1307129|P1|Overall Study|Lost to Follow-up|3
389236|NCT00806416|1307151|P4|Period 1 - Part II|Withdrawal by Subject|2
389237|NCT00806416|1307152|P3|Period 1 - Part II|Withdrawal by Subject|0
389238|NCT00806416|1307153|P2|Period 1 - Part II|Withdrawal by Subject|0
389239|NCT00806416|1307154|P1|Period 1 - Part II|Withdrawal by Subject|0
389240|NCT00806416|1307151|P4|Period 1 - Part I|Withdrawal by Subject|0
389241|NCT00806416|1307152|P3|Period 1 - Part I|Withdrawal by Subject|0
389242|NCT00806416|1307153|P2|Period 1 - Part I|Withdrawal by Subject|1
389243|NCT00806416|1307154|P1|Period 1 - Part I|Withdrawal by Subject|3
389244|NCT00806416|1307151|P4|Period 1 - Part I|Lost to Follow-up|0
389245|NCT00806416|1307152|P3|Period 1 - Part I|Lost to Follow-up|0
389246|NCT00806416|1307153|P2|Period 1 - Part I|Lost to Follow-up|2
389247|NCT00806416|1307154|P1|Period 1 - Part I|Lost to Follow-up|0
389248|NCT00806416|1307151|P4|Period 1 - Part I|Adverse Event|0
389249|NCT00806416|1307152|P3|Period 1 - Part I|Adverse Event|0
389250|NCT00806416|1307153|P2|Period 1 - Part I|Adverse Event|1
389251|NCT00806416|1307154|P1|Period 1 - Part I|Adverse Event|0
389252|NCT00806403|1307167|P2|Overall Study|Death|3
389253|NCT00806403|1307168|P1|Overall Study|Death|4
389254|NCT00806351|1307191|P2|Overall Study|Death|4
389255|NCT00806351|1307192|P1|Overall Study|Death|5
389256|NCT00806260|1307229|P6|Period 3|Pregnancy|0
389257|NCT00806260|1307230|P5|Period 3|Pregnancy|0
389258|NCT00806260|1307231|P4|Period 3|Pregnancy|0
389259|NCT00806260|1307232|P3|Period 3|Pregnancy|0
389260|NCT00806260|1307233|P2|Period 3|Pregnancy|0
389261|NCT00806260|1307234|P1|Period 3|Pregnancy|1
389262|NCT00806260|1307229|P6|Period 3|Protocol Violation|0
389263|NCT00806260|1307230|P5|Period 3|Protocol Violation|0
389264|NCT00806260|1307231|P4|Period 3|Protocol Violation|0
389265|NCT00806260|1307232|P3|Period 3|Protocol Violation|1
389266|NCT00806260|1307233|P2|Period 3|Protocol Violation|1
389267|NCT00806260|1307234|P1|Period 3|Protocol Violation|0
389268|NCT00806260|1307229|P6|Period 2|sponsor request|0
389269|NCT00806260|1307230|P5|Period 2|sponsor request|0
389270|NCT00806260|1307231|P4|Period 2|sponsor request|1
389271|NCT00806260|1307232|P3|Period 2|sponsor request|1
389272|NCT00806260|1307233|P2|Period 2|sponsor request|0
389273|NCT00806260|1307234|P1|Period 2|sponsor request|0
389274|NCT00806260|1307229|P6|Period 2|Need to take concomitant medication|0
389275|NCT00806260|1307230|P5|Period 2|Need to take concomitant medication|0
389276|NCT00806260|1307231|P4|Period 2|Need to take concomitant medication|0
389277|NCT00806260|1307232|P3|Period 2|Need to take concomitant medication|0
389278|NCT00806260|1307233|P2|Period 2|Need to take concomitant medication|0
389279|NCT00806260|1307234|P1|Period 2|Need to take concomitant medication|1
389280|NCT00806260|1307229|P6|Period 2|Protocol Violation|0
389281|NCT00806260|1307230|P5|Period 2|Protocol Violation|0
389282|NCT00806260|1307231|P4|Period 2|Protocol Violation|0
389283|NCT00806260|1307232|P3|Period 2|Protocol Violation|1
389284|NCT00806260|1307233|P2|Period 2|Protocol Violation|0
389285|NCT00806260|1307234|P1|Period 2|Protocol Violation|1
389286|NCT00806260|1307229|P6|Period 2|Adverse Event|0
389287|NCT00806260|1307230|P5|Period 2|Adverse Event|0
389288|NCT00806260|1307231|P4|Period 2|Adverse Event|1
389289|NCT00806260|1307232|P3|Period 2|Adverse Event|0
389290|NCT00806260|1307233|P2|Period 2|Adverse Event|0
389291|NCT00806260|1307234|P1|Period 2|Adverse Event|0
389292|NCT00806260|1307229|P6|Period 1 (1 Day)|Adverse Event|0
389293|NCT00806260|1307230|P5|Period 1 (1 Day)|Adverse Event|3
389294|NCT00806260|1307231|P4|Period 1 (1 Day)|Adverse Event|0
389295|NCT00806260|1307232|P3|Period 1 (1 Day)|Adverse Event|0
389296|NCT00806260|1307233|P2|Period 1 (1 Day)|Adverse Event|0
389297|NCT00806260|1307234|P1|Period 1 (1 Day)|Adverse Event|0
389298|NCT00806195|1307279|P4|Overall Study|Protocol Violation|9
389299|NCT00806195|1307280|P3|Overall Study|Protocol Violation|26
389300|NCT00806195|1307281|P2|Overall Study|Protocol Violation|24
389301|NCT00806195|1307282|P1|Overall Study|Protocol Violation|34
389302|NCT00806195|1307279|P4|Overall Study|Administrative Reason|26
389303|NCT00806195|1307280|P3|Overall Study|Administrative Reason|66
389304|NCT00806195|1307281|P2|Overall Study|Administrative Reason|35
389305|NCT00806195|1307282|P1|Overall Study|Administrative Reason|113
389306|NCT00806195|1307279|P4|Overall Study|Inappropriate Enrollment|0
389307|NCT00806195|1307280|P3|Overall Study|Inappropriate Enrollment|0
389308|NCT00806195|1307281|P2|Overall Study|Inappropriate Enrollment|1
389309|NCT00806195|1307282|P1|Overall Study|Inappropriate Enrollment|0
389310|NCT00806195|1307279|P4|Overall Study|Lost to Follow-up|34
389311|NCT00806195|1307280|P3|Overall Study|Lost to Follow-up|90
389312|NCT00806195|1307281|P2|Overall Study|Lost to Follow-up|66
389313|NCT00806195|1307282|P1|Overall Study|Lost to Follow-up|217
389314|NCT00806195|1307279|P4|Overall Study|Withdrawal by Subject|35
389315|NCT00806195|1307280|P3|Overall Study|Withdrawal by Subject|76
389316|NCT00806195|1307281|P2|Overall Study|Withdrawal by Subject|31
389317|NCT00806195|1307282|P1|Overall Study|Withdrawal by Subject|119
389318|NCT00806195|1307279|P4|Overall Study|Adverse Event|2
389319|NCT00806195|1307280|P3|Overall Study|Adverse Event|11
389320|NCT00806195|1307281|P2|Overall Study|Adverse Event|5
389321|NCT00806195|1307282|P1|Overall Study|Adverse Event|25
389322|NCT00806195|1307279|P4|Overall Study|Death|0
389323|NCT00806195|1307280|P3|Overall Study|Death|1
389324|NCT00806195|1307281|P2|Overall Study|Death|0
389325|NCT00806195|1307282|P1|Overall Study|Death|6
389326|NCT00806026|1307313|P6|Overall Study|Adverse Event|9
389327|NCT00806026|1307314|P5|Overall Study|Adverse Event|9
389328|NCT00806026|1307315|P4|Overall Study|Adverse Event|17
389329|NCT00806026|1307316|P3|Overall Study|Adverse Event|44
389330|NCT00806026|1307317|P2|Overall Study|Adverse Event|35
389331|NCT00806026|1307318|P1|Overall Study|Adverse Event|52
389332|NCT00806026|1307313|P6|Overall Study|Protocol Violation|3
389333|NCT00806026|1307314|P5|Overall Study|Protocol Violation|2
389334|NCT00806026|1307315|P4|Overall Study|Protocol Violation|0
389335|NCT00806026|1307316|P3|Overall Study|Protocol Violation|9
389336|NCT00806026|1307317|P2|Overall Study|Protocol Violation|9
389337|NCT00806026|1307318|P1|Overall Study|Protocol Violation|6
389338|NCT00806026|1307313|P6|Overall Study|Other|4
389339|NCT00806026|1307314|P5|Overall Study|Other|0
389340|NCT00806026|1307315|P4|Overall Study|Other|2
389341|NCT00806026|1307316|P3|Overall Study|Other|8
389342|NCT00806026|1307317|P2|Overall Study|Other|6
389343|NCT00806026|1307318|P1|Overall Study|Other|3
389344|NCT00806026|1307313|P6|Overall Study|Withdrawal by Subject|3
389345|NCT00806026|1307314|P5|Overall Study|Withdrawal by Subject|5
389346|NCT00806026|1307315|P4|Overall Study|Withdrawal by Subject|2
389347|NCT00806026|1307316|P3|Overall Study|Withdrawal by Subject|9
389348|NCT00806026|1307317|P2|Overall Study|Withdrawal by Subject|17
389349|NCT00806026|1307318|P1|Overall Study|Withdrawal by Subject|14
389350|NCT00806026|1307313|P6|Overall Study|Lost to Follow-up|6
389351|NCT00806026|1307314|P5|Overall Study|Lost to Follow-up|6
389352|NCT00806026|1307315|P4|Overall Study|Lost to Follow-up|2
389353|NCT00806026|1307316|P3|Overall Study|Lost to Follow-up|8
389354|NCT00806026|1307317|P2|Overall Study|Lost to Follow-up|15
389355|NCT00806026|1307318|P1|Overall Study|Lost to Follow-up|8
389356|NCT00806026|1307313|P6|Overall Study|Lack of Efficacy|7
389357|NCT00806026|1307314|P5|Overall Study|Lack of Efficacy|8
389358|NCT00806026|1307315|P4|Overall Study|Lack of Efficacy|4
389359|NCT00806026|1307316|P3|Overall Study|Lack of Efficacy|13
389360|NCT00806026|1307317|P2|Overall Study|Lack of Efficacy|18
389361|NCT00806026|1307318|P1|Overall Study|Lack of Efficacy|5
389362|NCT00806026|1307313|P6|Overall Study|Did not meet entrance criteria|0
389363|NCT00806026|1307314|P5|Overall Study|Did not meet entrance criteria|0
389364|NCT00806026|1307315|P4|Overall Study|Did not meet entrance criteria|1
389365|NCT00806026|1307316|P3|Overall Study|Did not meet entrance criteria|2
389366|NCT00806026|1307317|P2|Overall Study|Did not meet entrance criteria|1
389367|NCT00806026|1307318|P1|Overall Study|Did not meet entrance criteria|4
389368|NCT00806026|1307313|P6|Overall Study|Death|0
389369|NCT00806026|1307314|P5|Overall Study|Death|0
389370|NCT00806026|1307315|P4|Overall Study|Death|1
389371|NCT00806026|1307316|P3|Overall Study|Death|0
389372|NCT00806026|1307317|P2|Overall Study|Death|0
389373|NCT00806026|1307318|P1|Overall Study|Death|0
389374|NCT00805961|1307413|P1|Maintenance Treatment|Withdrawn Consent|1
389375|NCT00805961|1307413|P1|Maintenance Treatment|Symptomatic Deterioration|2
389376|NCT00805961|1307413|P1|Maintenance Treatment|Withdrawal by Subject|5
389377|NCT00805961|1307413|P1|Maintenance Treatment|Adverse Event|6
389378|NCT00805961|1307413|P1|Maintenance Treatment|Intercurrent Illness|7
389379|NCT00805961|1307413|P1|Maintenance Treatment|Lack of Efficacy|13
389380|NCT00805961|1307413|P1|Treatment-Free Interval|Lack of Efficacy|1
389381|NCT00805961|1307413|P1|Treatment-Free Interval|Physician Decision|1
389382|NCT00805961|1307413|P1|Treatment-Free Interval|Intercurrent Illness|2
389383|NCT00805961|1307413|P1|Treatment-Free Interval|Adverse Event|3
389384|NCT00805961|1307413|P1|Modality Therapy|Disease Progression|2
389385|NCT00805961|1307413|P1|Modality Therapy|Adverse Event|1
389386|NCT00805961|1307413|P1|Modality Therapy|Withdrawal by Subject|1
389387|NCT00805935|1307423|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
389388|NCT00805935|1307424|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
389389|NCT00805935|1307425|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
389390|NCT00805935|1307426|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
389391|NCT00805935|1307423|P4|Overall Study|Ectopic pregnancy|0
389392|NCT00805935|1307424|P3|Overall Study|Ectopic pregnancy|1
389393|NCT00805935|1307425|P2|Overall Study|Ectopic pregnancy|0
389394|NCT00805935|1307426|P1|Overall Study|Ectopic pregnancy|0
389395|NCT00805935|1307423|P4|Overall Study|Chemical pregnancy|2
389396|NCT00805935|1307424|P3|Overall Study|Chemical pregnancy|3
389397|NCT00805935|1307425|P2|Overall Study|Chemical pregnancy|5
389398|NCT00805935|1307426|P1|Overall Study|Chemical pregnancy|0
389399|NCT00805935|1307423|P4|Overall Study|Biochemical pregnancy|0
389400|NCT00805935|1307424|P3|Overall Study|Biochemical pregnancy|0
389401|NCT00805935|1307425|P2|Overall Study|Biochemical pregnancy|1
389402|NCT00805935|1307426|P1|Overall Study|Biochemical pregnancy|0
389403|NCT00805935|1307423|P4|Overall Study|Pregnancy loss/miscarriage|0
389404|NCT00805935|1307424|P3|Overall Study|Pregnancy loss/miscarriage|0
389405|NCT00805935|1307425|P2|Overall Study|Pregnancy loss/miscarriage|0
389406|NCT00805935|1307426|P1|Overall Study|Pregnancy loss/miscarriage|2
389407|NCT00805935|1307423|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
389408|NCT00805935|1307424|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
389409|NCT00805935|1307425|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
389410|NCT00805935|1307426|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
389411|NCT00805935|1307423|P4|Overall Study|No positive serum pregnancy|5
389412|NCT00805935|1307424|P3|Overall Study|No positive serum pregnancy|6
389413|NCT00805935|1307425|P2|Overall Study|No positive serum pregnancy|7
389414|NCT00805935|1307426|P1|Overall Study|No positive serum pregnancy|8
389415|NCT00805935|1307423|P4|Overall Study|Lost to Follow-up|0
389416|NCT00805935|1307424|P3|Overall Study|Lost to Follow-up|0
389417|NCT00805935|1307425|P2|Overall Study|Lost to Follow-up|0
389418|NCT00805935|1307426|P1|Overall Study|Lost to Follow-up|1
389419|NCT00805935|1307423|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
389420|NCT00805935|1307424|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
389421|NCT00805935|1307425|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
389422|NCT00805935|1307426|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
389423|NCT00805935|1307423|P4|Overall Study|Cycle cancellation for risk of OHSS|0
389424|NCT00805935|1307424|P3|Overall Study|Cycle cancellation for risk of OHSS|1
389425|NCT00805935|1307425|P2|Overall Study|Cycle cancellation for risk of OHSS|0
389426|NCT00805935|1307426|P1|Overall Study|Cycle cancellation for risk of OHSS|1
389427|NCT00805935|1307423|P4|Overall Study|Cycle cancelled|0
389428|NCT00805935|1307424|P3|Overall Study|Cycle cancelled|2
389429|NCT00805935|1307425|P2|Overall Study|Cycle cancelled|0
389430|NCT00805935|1307426|P1|Overall Study|Cycle cancelled|0
389431|NCT00805935|1307423|P4|Overall Study|Stimulation Failure|2
389432|NCT00805935|1307424|P3|Overall Study|Stimulation Failure|2
389433|NCT00805935|1307425|P2|Overall Study|Stimulation Failure|5
389434|NCT00805935|1307426|P1|Overall Study|Stimulation Failure|1
389435|NCT00805792|1307493|P1|Overall Study|Lost to Follow-up|2
389436|NCT00805792|1307493|P1|Overall Study|Death|3
389437|NCT00805766|1307501|P1|Increased Dose Period|Withdrawal by Subject|1
389438|NCT00805766|1307501|P1|Increased Dose Period|Pregnancy|1
389439|NCT00805766|1307501|P1|Increased Dose Period|Lack of Efficacy|7
389440|NCT00805766|1307501|P1|Increased Dose Period|Adverse Event|4
389441|NCT00805766|1307501|P1|Screening Period|Responder|2
389442|NCT00805766|1307501|P1|Screening Period|Pregnancy|1
389443|NCT00805766|1307501|P1|Screening Period|Lack of Efficacy|2
389444|NCT00805766|1307501|P1|Screening Period|Adverse Event|1
389445|NCT00805740|1307515|P2|Overall Study|Randomized, but not treated|0
389446|NCT00805740|1307516|P1|Overall Study|Randomized, but not treated|2
389447|NCT00805740|1307515|P2|Overall Study|Lost to Follow-up|0
389448|NCT00805740|1307516|P1|Overall Study|Lost to Follow-up|1
389449|NCT00805740|1307515|P2|Overall Study|Withdrawal by Subject|0
389450|NCT00805740|1307516|P1|Overall Study|Withdrawal by Subject|1
389451|NCT00805740|1307515|P2|Overall Study|Death|4
389452|NCT00805740|1307516|P1|Overall Study|Death|7
389453|NCT00805675|1307541|P3|Overall Study|Adverse Event|1
389454|NCT00805675|1307542|P2|Overall Study|Adverse Event|0
389455|NCT00805675|1307543|P1|Overall Study|Adverse Event|0
389456|NCT00805545|1307577|P2|Overall Study|Protocol Violation|1
389457|NCT00805545|1307578|P1|Overall Study|Protocol Violation|3
389458|NCT00805545|1307577|P2|Overall Study|Protocol Violation|2
389459|NCT00805545|1307578|P1|Overall Study|Protocol Violation|3
389460|NCT00805480|1307604|P4|Overall Study|Adverse Event|0
389461|NCT00805480|1307605|P3|Overall Study|Adverse Event|1
389462|NCT00805480|1307606|P2|Overall Study|Adverse Event|0
389463|NCT00805480|1307607|P1|Overall Study|Adverse Event|0
389464|NCT00805480|1307604|P4|Overall Study|Lost to Follow-up|0
389465|NCT00805480|1307605|P3|Overall Study|Lost to Follow-up|0
389466|NCT00805480|1307606|P2|Overall Study|Lost to Follow-up|2
389467|NCT00805480|1307607|P1|Overall Study|Lost to Follow-up|1
389468|NCT00805480|1307604|P4|Overall Study|Withdrawal by Subject|5
389469|NCT00805480|1307605|P3|Overall Study|Withdrawal by Subject|11
389470|NCT00805480|1307606|P2|Overall Study|Withdrawal by Subject|5
389471|NCT00805480|1307607|P1|Overall Study|Withdrawal by Subject|13
389472|NCT00805467|1307636|P4|Overall Study|Not reported|7
389473|NCT00805467|1307637|P3|Overall Study|Not reported|3
389474|NCT00805467|1307638|P2|Overall Study|Not reported|0
389475|NCT00805467|1307639|P1|Overall Study|Not reported|0
389476|NCT00805467|1307636|P4|Overall Study|Physician Decision|6
389477|NCT00805467|1307637|P3|Overall Study|Physician Decision|2
389478|NCT00805467|1307638|P2|Overall Study|Physician Decision|1
389479|NCT00805467|1307639|P1|Overall Study|Physician Decision|0
389480|NCT00805467|1307636|P4|Overall Study|Death|5
389481|NCT00805467|1307637|P3|Overall Study|Death|7
389482|NCT00805467|1307638|P2|Overall Study|Death|2
389483|NCT00805467|1307639|P1|Overall Study|Death|0
389484|NCT00805467|1307636|P4|Overall Study|Adverse Event|57
389485|NCT00805467|1307637|P3|Overall Study|Adverse Event|26
389486|NCT00805467|1307638|P2|Overall Study|Adverse Event|13
389487|NCT00805467|1307639|P1|Overall Study|Adverse Event|0
389488|NCT00805467|1307636|P4|Overall Study|Protocol Violation|5
389489|NCT00805467|1307637|P3|Overall Study|Protocol Violation|0
389490|NCT00805467|1307638|P2|Overall Study|Protocol Violation|3
389491|NCT00805467|1307639|P1|Overall Study|Protocol Violation|0
389492|NCT00805467|1307636|P4|Overall Study|Withdrawal by Subject|50
389493|NCT00805467|1307637|P3|Overall Study|Withdrawal by Subject|45
389494|NCT00805467|1307638|P2|Overall Study|Withdrawal by Subject|6
389495|NCT00805467|1307639|P1|Overall Study|Withdrawal by Subject|0
389496|NCT00805467|1307636|P4|Overall Study|Lost to Follow-up|21
389497|NCT00805467|1307637|P3|Overall Study|Lost to Follow-up|7
389498|NCT00805467|1307638|P2|Overall Study|Lost to Follow-up|1
389499|NCT00805467|1307639|P1|Overall Study|Lost to Follow-up|0
389500|NCT00805467|1307636|P4|Overall Study|Lack of Efficacy|86
389501|NCT00805467|1307637|P3|Overall Study|Lack of Efficacy|13
389502|NCT00805467|1307638|P2|Overall Study|Lack of Efficacy|8
389503|NCT00805467|1307639|P1|Overall Study|Lack of Efficacy|0
389504|NCT00805441|1307659|P2|Overall Study|Acute Alcohol Withdrawal|1
389505|NCT00805441|1307660|P1|Overall Study|Acute Alcohol Withdrawal|0
389506|NCT00805441|1307659|P2|Overall Study|Physician Decision|1
389507|NCT00805441|1307660|P1|Overall Study|Physician Decision|0
389508|NCT00805441|1307659|P2|Overall Study|Withdrawal by Subject|9
389509|NCT00805441|1307660|P1|Overall Study|Withdrawal by Subject|15
389510|NCT00805441|1307659|P2|Overall Study|Lost to Follow-up|13
389511|NCT00805441|1307660|P1|Overall Study|Lost to Follow-up|10
389512|NCT00805441|1307659|P2|Overall Study|Protocol Violation|8
389513|NCT00805441|1307660|P1|Overall Study|Protocol Violation|4
389514|NCT00805441|1307659|P2|Overall Study|Lack of Efficacy|2
389515|NCT00805441|1307660|P1|Overall Study|Lack of Efficacy|0
389516|NCT00805441|1307659|P2|Overall Study|Adverse Event|2
389517|NCT00805441|1307660|P1|Overall Study|Adverse Event|5
389518|NCT00805389|1307695|P5|Overall Study|Withdrawal by Subject|4
389519|NCT00805389|1307696|P4|Overall Study|Withdrawal by Subject|5
389520|NCT00805389|1307697|P3|Overall Study|Withdrawal by Subject|4
389521|NCT00805389|1307698|P2|Overall Study|Withdrawal by Subject|2
389522|NCT00805389|1307699|P1|Overall Study|Withdrawal by Subject|3
389523|NCT00805389|1307695|P5|Overall Study|Protocol Violation|0
389524|NCT00805389|1307696|P4|Overall Study|Protocol Violation|0
389525|NCT00805389|1307697|P3|Overall Study|Protocol Violation|1
389526|NCT00805389|1307698|P2|Overall Study|Protocol Violation|0
389527|NCT00805389|1307699|P1|Overall Study|Protocol Violation|0
389528|NCT00805389|1307695|P5|Overall Study|Lost to Follow-up|9
389529|NCT00805389|1307696|P4|Overall Study|Lost to Follow-up|10
389530|NCT00805389|1307697|P3|Overall Study|Lost to Follow-up|6
389531|NCT00805389|1307698|P2|Overall Study|Lost to Follow-up|3
389532|NCT00805389|1307699|P1|Overall Study|Lost to Follow-up|4
389533|NCT00805389|1307695|P5|Overall Study|Adverse Event|0
389534|NCT00805389|1307696|P4|Overall Study|Adverse Event|2
389535|NCT00805389|1307697|P3|Overall Study|Adverse Event|1
389536|NCT00805389|1307698|P2|Overall Study|Adverse Event|0
389537|NCT00805389|1307699|P1|Overall Study|Adverse Event|0
389538|NCT00805285|1307941|P1|Overall Study|Lack of Efficacy|1
389539|NCT00805194|1307951|P2|Overall Study|Reasons other than stated above|16
389540|NCT00805194|1307952|P1|Overall Study|Reasons other than stated above|20
389541|NCT00805194|1307951|P2|Overall Study|Not treated|4
389542|NCT00805194|1307952|P1|Overall Study|Not treated|3
389543|NCT00805194|1307951|P2|Overall Study|Withdrawal by Subject|42
389544|NCT00805194|1307952|P1|Overall Study|Withdrawal by Subject|60
389545|NCT00805194|1307951|P2|Overall Study|Lost to Follow-up|5
389546|NCT00805194|1307952|P1|Overall Study|Lost to Follow-up|5
389547|NCT00805194|1307951|P2|Overall Study|Protocol Violation|9
389548|NCT00805194|1307952|P1|Overall Study|Protocol Violation|9
389549|NCT00805194|1307951|P2|Overall Study|Other AE|73
389550|NCT00805194|1307952|P1|Overall Study|Other AE|84
389551|NCT00805194|1307951|P2|Overall Study|Worsening or AE of underlying disease|70
389552|NCT00805194|1307952|P1|Overall Study|Worsening or AE of underlying disease|64
389553|NCT00805194|1307951|P2|Overall Study|Progressive disease (modified RECIST)|435
389554|NCT00805194|1307952|P1|Overall Study|Progressive disease (modified RECIST)|404
389555|NCT00805142|1307986|P2|Maintenance Period|Other|1
389556|NCT00805142|1307987|P1|Maintenance Period|Other|0
389557|NCT00805142|1307986|P2|Maintenance Period|Adverse Event|1
389558|NCT00805142|1307987|P1|Maintenance Period|Adverse Event|0
389559|NCT00805142|1307986|P2|Titration Period|Other|3
389560|NCT00805142|1307987|P1|Titration Period|Other|0
389561|NCT00805142|1307986|P2|Titration Period|Withdrawal of consent|1
389562|NCT00805142|1307987|P1|Titration Period|Withdrawal of consent|0
389563|NCT00805142|1307986|P2|Titration Period|Disease Progression|1
389564|NCT00805142|1307987|P1|Titration Period|Disease Progression|2
389565|NCT00805142|1307986|P2|Titration Period|Lost to Follow-up|1
389566|NCT00805142|1307987|P1|Titration Period|Lost to Follow-up|0
389567|NCT00805142|1307986|P2|Titration Period|Lack of Efficacy|1
389568|NCT00805142|1307987|P1|Titration Period|Lack of Efficacy|1
389569|NCT00805142|1307986|P2|Titration Period|Adverse Event|3
389570|NCT00805142|1307987|P1|Titration Period|Adverse Event|3
389571|NCT00805025|1308020|P1|Overall Study|Physician Decision|1
389572|NCT00805025|1308020|P1|Overall Study|Withdrawal by Subject|2
389573|NCT00805025|1308020|P1|Overall Study|Adverse Event|4
389574|NCT00805025|1308020|P1|Overall Study|Screened but not enrolled/treated|42
389575|NCT00804986|1308049|P6|Overall Study|Physician Decision|0
389576|NCT00804986|1308050|P5|Overall Study|Physician Decision|0
389577|NCT00804986|1308051|P4|Overall Study|Physician Decision|0
389578|NCT00804986|1308052|P3|Overall Study|Physician Decision|0
389579|NCT00804986|1308053|P2|Overall Study|Physician Decision|0
389580|NCT00804986|1308054|P1|Overall Study|Physician Decision|1
389581|NCT00804986|1308049|P6|Overall Study|Sponsor Decision|0
389582|NCT00804986|1308050|P5|Overall Study|Sponsor Decision|0
389583|NCT00804986|1308051|P4|Overall Study|Sponsor Decision|0
389584|NCT00804986|1308052|P3|Overall Study|Sponsor Decision|0
389585|NCT00804986|1308053|P2|Overall Study|Sponsor Decision|1
389586|NCT00804986|1308054|P1|Overall Study|Sponsor Decision|0
389587|NCT00804986|1308049|P6|Overall Study|Inclusion/Exclusion criteria not met|1
389588|NCT00804986|1308050|P5|Overall Study|Inclusion/Exclusion criteria not met|0
389589|NCT00804986|1308051|P4|Overall Study|Inclusion/Exclusion criteria not met|1
389590|NCT00804986|1308052|P3|Overall Study|Inclusion/Exclusion criteria not met|0
389591|NCT00804986|1308053|P2|Overall Study|Inclusion/Exclusion criteria not met|2
389592|NCT00804986|1308054|P1|Overall Study|Inclusion/Exclusion criteria not met|0
389593|NCT00804986|1308049|P6|Overall Study|Withdrawal by Subject|3
389594|NCT00804986|1308050|P5|Overall Study|Withdrawal by Subject|5
389595|NCT00804986|1308051|P4|Overall Study|Withdrawal by Subject|3
389596|NCT00804986|1308052|P3|Overall Study|Withdrawal by Subject|0
389597|NCT00804986|1308053|P2|Overall Study|Withdrawal by Subject|3
389598|NCT00804986|1308054|P1|Overall Study|Withdrawal by Subject|0
389599|NCT00804986|1308049|P6|Overall Study|Protocol Violation|0
389600|NCT00804986|1308050|P5|Overall Study|Protocol Violation|0
389601|NCT00804986|1308051|P4|Overall Study|Protocol Violation|1
389602|NCT00804986|1308052|P3|Overall Study|Protocol Violation|0
389603|NCT00804986|1308053|P2|Overall Study|Protocol Violation|1
389604|NCT00804986|1308054|P1|Overall Study|Protocol Violation|0
389605|NCT00804986|1308049|P6|Overall Study|Lost to Follow-up|3
389606|NCT00804986|1308050|P5|Overall Study|Lost to Follow-up|1
389607|NCT00804986|1308051|P4|Overall Study|Lost to Follow-up|1
389608|NCT00804986|1308052|P3|Overall Study|Lost to Follow-up|0
389609|NCT00804986|1308053|P2|Overall Study|Lost to Follow-up|0
389610|NCT00804986|1308054|P1|Overall Study|Lost to Follow-up|0
389611|NCT00804986|1308049|P6|Overall Study|Lack of Efficacy|3
389612|NCT00804986|1308050|P5|Overall Study|Lack of Efficacy|0
389613|NCT00804986|1308051|P4|Overall Study|Lack of Efficacy|1
389614|NCT00804986|1308052|P3|Overall Study|Lack of Efficacy|0
389615|NCT00804986|1308053|P2|Overall Study|Lack of Efficacy|0
389616|NCT00804986|1308054|P1|Overall Study|Lack of Efficacy|0
389617|NCT00804986|1308049|P6|Overall Study|Adverse Event|0
389618|NCT00804986|1308050|P5|Overall Study|Adverse Event|3
389619|NCT00804986|1308051|P4|Overall Study|Adverse Event|1
389620|NCT00804986|1308052|P3|Overall Study|Adverse Event|2
389621|NCT00804986|1308053|P2|Overall Study|Adverse Event|1
389622|NCT00804986|1308054|P1|Overall Study|Adverse Event|0
389623|NCT00804908|1308149|P3|Overall Study|Not specified|114
389624|NCT00804908|1308150|P2|Overall Study|Not specified|116
389625|NCT00804908|1308151|P1|Overall Study|Not specified|115
389626|NCT00804843|1308182|P2|Overall Study|Withdrawal by Subject|2
389627|NCT00804843|1308183|P1|Overall Study|Withdrawal by Subject|1
389628|NCT00804843|1308182|P2|Overall Study|Adverse Event|5
389629|NCT00804843|1308183|P1|Overall Study|Adverse Event|8
389630|NCT00804843|1308182|P2|Overall Study|Protocol Violation|0
389631|NCT00804843|1308183|P1|Overall Study|Protocol Violation|1
389632|NCT00804687|1308201|P6|Period 5: Treatment Period|Positive drug test|0
389633|NCT00804687|1308202|P5|Period 5: Treatment Period|Positive drug test|0
389634|NCT00804687|1308203|P4|Period 5: Treatment Period|Positive drug test|0
389635|NCT00804687|1308204|P3|Period 5: Treatment Period|Positive drug test|0
389636|NCT00804687|1308205|P2|Period 5: Treatment Period|Positive drug test|0
389637|NCT00804687|1308206|P1|Period 5: Treatment Period|Positive drug test|1
389638|NCT00804687|1308201|P6|Period 5: Treatment Period|Positive drugs of abuse|0
389639|NCT00804687|1308202|P5|Period 5: Treatment Period|Positive drugs of abuse|0
389640|NCT00804687|1308203|P4|Period 5: Treatment Period|Positive drugs of abuse|0
389641|NCT00804687|1308204|P3|Period 5: Treatment Period|Positive drugs of abuse|1
389642|NCT00804687|1308205|P2|Period 5: Treatment Period|Positive drugs of abuse|0
389643|NCT00804687|1308206|P1|Period 5: Treatment Period|Positive drugs of abuse|0
389644|NCT00804687|1308201|P6|Period 5: Treatment Period|Withdrawal by Subject|0
389645|NCT00804687|1308202|P5|Period 5: Treatment Period|Withdrawal by Subject|1
389646|NCT00804687|1308203|P4|Period 5: Treatment Period|Withdrawal by Subject|0
389647|NCT00804687|1308204|P3|Period 5: Treatment Period|Withdrawal by Subject|0
389648|NCT00804687|1308205|P2|Period 5: Treatment Period|Withdrawal by Subject|0
389649|NCT00804687|1308206|P1|Period 5: Treatment Period|Withdrawal by Subject|0
389650|NCT00804687|1308201|P6|Period 3: Treatment Period|Positive Drug screen|0
389651|NCT00804687|1308202|P5|Period 3: Treatment Period|Positive Drug screen|0
389652|NCT00804687|1308203|P4|Period 3: Treatment Period|Positive Drug screen|1
389653|NCT00804687|1308204|P3|Period 3: Treatment Period|Positive Drug screen|0
389654|NCT00804687|1308205|P2|Period 3: Treatment Period|Positive Drug screen|0
389655|NCT00804687|1308206|P1|Period 3: Treatment Period|Positive Drug screen|0
389656|NCT00804570|1308285|P2|Overall Study|Withdrawal by Subject|38
389657|NCT00804570|1308286|P1|Overall Study|Withdrawal by Subject|21
389658|NCT00804570|1308285|P2|Overall Study|Sponsor decision|4
389659|NCT00804570|1308286|P1|Overall Study|Sponsor decision|1
389660|NCT00804570|1308285|P2|Overall Study|Physician Decision|2
389661|NCT00804570|1308286|P1|Overall Study|Physician Decision|1
389662|NCT00804570|1308285|P2|Overall Study|Protocol Violation|16
389663|NCT00804570|1308286|P1|Overall Study|Protocol Violation|12
389664|NCT00804570|1308285|P2|Overall Study|Entry criteria not met|5
389665|NCT00804570|1308286|P1|Overall Study|Entry criteria not met|5
389666|NCT00804570|1308285|P2|Overall Study|Lost to Follow-up|21
389667|NCT00804570|1308286|P1|Overall Study|Lost to Follow-up|18
389668|NCT00804570|1308285|P2|Overall Study|Lack of Efficacy|1
389669|NCT00804570|1308286|P1|Overall Study|Lack of Efficacy|0
389670|NCT00804570|1308285|P2|Overall Study|Adverse Event|7
389671|NCT00804570|1308286|P1|Overall Study|Adverse Event|14
389672|NCT00804193|1308345|P3|Overall Study|Withdrawal by Subject|2
389673|NCT00804193|1308346|P2|Overall Study|Withdrawal by Subject|1
389674|NCT00804193|1308347|P1|Overall Study|Withdrawal by Subject|3
389675|NCT00804193|1308345|P3|Overall Study|Lost to Follow-up|4
389676|NCT00804193|1308346|P2|Overall Study|Lost to Follow-up|3
389677|NCT00804193|1308347|P1|Overall Study|Lost to Follow-up|3
389678|NCT00804193|1308345|P3|Overall Study|Protocol Violation|2
389679|NCT00804193|1308346|P2|Overall Study|Protocol Violation|8
389680|NCT00804193|1308347|P1|Overall Study|Protocol Violation|0
389681|NCT00804193|1308345|P3|Overall Study|Lack of Efficacy|3
389682|NCT00804193|1308346|P2|Overall Study|Lack of Efficacy|1
389683|NCT00804193|1308347|P1|Overall Study|Lack of Efficacy|1
389684|NCT00804193|1308345|P3|Overall Study|Adverse Event|2
389685|NCT00804193|1308346|P2|Overall Study|Adverse Event|0
389686|NCT00804193|1308347|P1|Overall Study|Adverse Event|0
389687|NCT00804193|1308345|P3|Overall Study|Lack of baseline fungus|19
389688|NCT00804193|1308346|P2|Overall Study|Lack of baseline fungus|31
389689|NCT00804193|1308347|P1|Overall Study|Lack of baseline fungus|32
389690|NCT00803790|1308396|P4|Period 2|Positive Drug Screen or Personal Reasons|0
389691|NCT00803790|1308397|P3|Period 2|Positive Drug Screen or Personal Reasons|0
389692|NCT00803790|1308398|P2|Period 2|Positive Drug Screen or Personal Reasons|0
389693|NCT00803790|1308399|P1|Period 2|Positive Drug Screen or Personal Reasons|1
389694|NCT00803790|1308396|P4|Period 2|Withdrawal by Subject|0
389695|NCT00803790|1308397|P3|Period 2|Withdrawal by Subject|0
389696|NCT00803790|1308398|P2|Period 2|Withdrawal by Subject|0
389697|NCT00803790|1308399|P1|Period 2|Withdrawal by Subject|1
389698|NCT00803790|1308396|P4|Period 2|Adverse Event|1
389699|NCT00803790|1308397|P3|Period 2|Adverse Event|1
389700|NCT00803790|1308398|P2|Period 2|Adverse Event|0
389701|NCT00803790|1308399|P1|Period 2|Adverse Event|0
389702|NCT00803790|1308396|P4|Period 1|Protocol Violation|0
389703|NCT00803790|1308397|P3|Period 1|Protocol Violation|1
389704|NCT00803790|1308398|P2|Period 1|Protocol Violation|0
389705|NCT00803790|1308399|P1|Period 1|Protocol Violation|0
389706|NCT00803790|1308396|P4|Period 1|positive drug screen or personal reasons|4
389707|NCT00803790|1308397|P3|Period 1|positive drug screen or personal reasons|0
389708|NCT00803790|1308398|P2|Period 1|positive drug screen or personal reasons|3
389709|NCT00803790|1308399|P1|Period 1|positive drug screen or personal reasons|0
389710|NCT00803790|1308396|P4|Period 1|Withdrawal by Subject|0
389711|NCT00803790|1308397|P3|Period 1|Withdrawal by Subject|0
389712|NCT00803790|1308398|P2|Period 1|Withdrawal by Subject|6
389713|NCT00803790|1308399|P1|Period 1|Withdrawal by Subject|8
389714|NCT00803790|1308396|P4|Period 1|Lost to Follow-up|0
389715|NCT00803790|1308397|P3|Period 1|Lost to Follow-up|0
389716|NCT00803790|1308398|P2|Period 1|Lost to Follow-up|2
389717|NCT00803790|1308399|P1|Period 1|Lost to Follow-up|1
389718|NCT00803790|1308396|P4|Period 1|Adverse Event|0
389719|NCT00803790|1308397|P3|Period 1|Adverse Event|0
389720|NCT00803790|1308398|P2|Period 1|Adverse Event|1
389721|NCT00803790|1308399|P1|Period 1|Adverse Event|0
389722|NCT00803738|1308439|P2|Overall Study|Positive Results for STD or abnormal PAP|8
389723|NCT00803738|1308440|P1|Overall Study|Positive Results for STD or abnormal PAP|2
389724|NCT00803738|1308439|P2|Overall Study|Negative Baseline Culture of Candida|63
389725|NCT00803738|1308440|P1|Overall Study|Negative Baseline Culture of Candida|56
389726|NCT00803738|1308439|P2|Overall Study|Lack of Efficacy|16
389727|NCT00803738|1308440|P1|Overall Study|Lack of Efficacy|10
389728|NCT00803738|1308439|P2|Overall Study|Withdrawal by Subject|4
389729|NCT00803738|1308440|P1|Overall Study|Withdrawal by Subject|1
389730|NCT00803738|1308439|P2|Overall Study|Protocol Violation|10
389731|NCT00803738|1308440|P1|Overall Study|Protocol Violation|18
389732|NCT00803738|1308439|P2|Overall Study|Lost to Follow-up|4
389733|NCT00803738|1308440|P1|Overall Study|Lost to Follow-up|4
389734|NCT00803738|1308439|P2|Overall Study|Adverse Event|5
389735|NCT00803738|1308440|P1|Overall Study|Adverse Event|3
389736|NCT00803712|1308452|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
389737|NCT00803712|1308453|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
389738|NCT00803712|1308452|P2|Overall Study|Administrative decision|3
389739|NCT00803712|1308453|P1|Overall Study|Administrative decision|2
389740|NCT00803712|1308452|P2|Overall Study|Protocol criteria (renal transplant)|8
389741|NCT00803712|1308453|P1|Overall Study|Protocol criteria (renal transplant)|12
389742|NCT00803712|1308452|P2|Overall Study|Protocol criteria (other)|2
389743|NCT00803712|1308453|P1|Overall Study|Protocol criteria (other)|0
389744|NCT00803712|1308452|P2|Overall Study|"Other in electronic Case Report Form"|1
389745|NCT00803712|1308453|P1|Overall Study|"Other in electronic Case Report Form"|0
389746|NCT00803712|1308452|P2|Overall Study|Withdrawal by Subject|4
389747|NCT00803712|1308453|P1|Overall Study|Withdrawal by Subject|2
389748|NCT00803712|1308452|P2|Overall Study|Lost to Follow-up|1
389749|NCT00803712|1308453|P1|Overall Study|Lost to Follow-up|3
389750|NCT00803712|1308452|P2|Overall Study|Death|7
389751|NCT00803712|1308453|P1|Overall Study|Death|8
389752|NCT00803712|1308452|P2|Overall Study|Adverse Event|0
389753|NCT00803712|1308453|P1|Overall Study|Adverse Event|5
389754|NCT00803712|1308452|P2|Overall Study|Noncompliance|0
389755|NCT00803712|1308453|P1|Overall Study|Noncompliance|3
389756|NCT00803634|1308552|P2|Overall Study|Death|2
389757|NCT00803634|1308553|P1|Overall Study|Death|3
389758|NCT00803634|1308552|P2|Overall Study|Lost to Follow-up|3
389759|NCT00803634|1308553|P1|Overall Study|Lost to Follow-up|2
389760|NCT00803634|1308552|P2|Overall Study|Withdrew Consent|0
389761|NCT00803634|1308553|P1|Overall Study|Withdrew Consent|1
389762|NCT00803595|1308582|P3|Overall Study|Withdrawal by Subject|3
389763|NCT00803595|1308583|P2|Overall Study|Withdrawal by Subject|2
389764|NCT00803595|1308584|P1|Overall Study|Withdrawal by Subject|5
389765|NCT00803595|1308582|P3|Overall Study|Protocol Violation|12
389766|NCT00803595|1308583|P2|Overall Study|Protocol Violation|2
389767|NCT00803595|1308584|P1|Overall Study|Protocol Violation|7
389768|NCT00803595|1308582|P3|Overall Study|Adverse Event|1
389769|NCT00803595|1308583|P2|Overall Study|Adverse Event|4
389770|NCT00803595|1308584|P1|Overall Study|Adverse Event|3
389771|NCT00803452|1308621|P2|Overall Study|Lost to Follow-up|3
389772|NCT00803452|1308622|P1|Overall Study|Lost to Follow-up|0
389773|NCT00803452|1308621|P2|Overall Study|Adverse Event|2
389774|NCT00803452|1308622|P1|Overall Study|Adverse Event|0
389775|NCT00803361|1308660|P2|Overall Study|Withdrawal by Subject|6
389776|NCT00803361|1308661|P1|Overall Study|Withdrawal by Subject|5
389777|NCT00803361|1308660|P2|Overall Study|Protocol Violation|4
389778|NCT00803361|1308661|P1|Overall Study|Protocol Violation|2
389779|NCT00803361|1308660|P2|Overall Study|Physician Decision|0
389780|NCT00803361|1308661|P1|Overall Study|Physician Decision|1
389781|NCT00803361|1308660|P2|Overall Study|Lost to Follow-up|2
389782|NCT00803361|1308661|P1|Overall Study|Lost to Follow-up|1
389783|NCT00803361|1308660|P2|Overall Study|Lack of Efficacy|13
389784|NCT00803361|1308661|P1|Overall Study|Lack of Efficacy|4
389785|NCT00803361|1308660|P2|Overall Study|Adverse Event|3
389786|NCT00803361|1308661|P1|Overall Study|Adverse Event|13
389787|NCT00803270|1308708|P2|Overall Study|Lost to Follow-up|2
389788|NCT00803270|1308709|P1|Overall Study|Lost to Follow-up|1
389789|NCT00803244|1308719|P2|Overall Study|Any other reason not above-mentioned|10
389790|NCT00803244|1308720|P1|Overall Study|Any other reason not above-mentioned|4
389791|NCT00803244|1308719|P2|Overall Study|Withdrawal by Subject|3
389792|NCT00803244|1308720|P1|Overall Study|Withdrawal by Subject|2
389793|NCT00803244|1308719|P2|Overall Study|Adverse Event|2
389794|NCT00803244|1308720|P1|Overall Study|Adverse Event|1
389795|NCT00803179|1308728|P1|Overall Study|Lost to Follow-up|3
389796|NCT00803101|1308747|P2|Overall Study|Patient did not have surgery|1
389797|NCT00803101|1308748|P1|Overall Study|Patient did not have surgery|1
389798|NCT00803101|1308747|P2|Overall Study|Patient did not attend scheduled visit|1
389799|NCT00803101|1308748|P1|Overall Study|Patient did not attend scheduled visit|2
389800|NCT00803101|1308747|P2|Overall Study|Patient died outside SAE report period|0
389801|NCT00803101|1308748|P1|Overall Study|Patient died outside SAE report period|1
389802|NCT00803101|1308747|P2|Overall Study|Surgery finished outside protocol window|1
389803|NCT00803101|1308748|P1|Overall Study|Surgery finished outside protocol window|1
389804|NCT00803101|1308747|P2|Overall Study|Protocol Violation|7
389805|NCT00803101|1308748|P1|Overall Study|Protocol Violation|1
389806|NCT00803101|1308747|P2|Overall Study|Lost to Follow-up|2
389807|NCT00803101|1308748|P1|Overall Study|Lost to Follow-up|2
389808|NCT00803101|1308747|P2|Overall Study|Withdrawal by Subject|4
389809|NCT00803101|1308748|P1|Overall Study|Withdrawal by Subject|6
389810|NCT00803101|1308747|P2|Overall Study|Death / Serious Adverse Event|6
389811|NCT00803101|1308748|P1|Overall Study|Death / Serious Adverse Event|4
389812|NCT00803049|1308799|P4|Overall Study|Other than Specified Above|5
389813|NCT00803049|1308800|P3|Overall Study|Other than Specified Above|2
389814|NCT00803049|1308801|P2|Overall Study|Other than Specified Above|9
389815|NCT00803049|1308802|P1|Overall Study|Other than Specified Above|3
389816|NCT00803049|1308799|P4|Overall Study|Randomized and Not Treated|2
389817|NCT00803049|1308800|P3|Overall Study|Randomized and Not Treated|0
389818|NCT00803049|1308801|P2|Overall Study|Randomized and Not Treated|0
389819|NCT00803049|1308802|P1|Overall Study|Randomized and Not Treated|0
389820|NCT00803049|1308799|P4|Overall Study|Protocol Violation|0
389821|NCT00803049|1308800|P3|Overall Study|Protocol Violation|1
389822|NCT00803049|1308801|P2|Overall Study|Protocol Violation|1
389823|NCT00803049|1308802|P1|Overall Study|Protocol Violation|0
389824|NCT00803049|1308799|P4|Overall Study|Withdrawal by Subject|44
389825|NCT00803049|1308800|P3|Overall Study|Withdrawal by Subject|16
389826|NCT00803049|1308801|P2|Overall Study|Withdrawal by Subject|43
389827|NCT00803049|1308802|P1|Overall Study|Withdrawal by Subject|19
389828|NCT00803049|1308799|P4|Overall Study|Progressive Disease|6
389829|NCT00803049|1308800|P3|Overall Study|Progressive Disease|6
389830|NCT00803049|1308801|P2|Overall Study|Progressive Disease|10
389831|NCT00803049|1308802|P1|Overall Study|Progressive Disease|6
389832|NCT00803049|1308799|P4|Overall Study|Death|2
389833|NCT00803049|1308800|P3|Overall Study|Death|0
389834|NCT00803049|1308801|P2|Overall Study|Death|1
389835|NCT00803049|1308802|P1|Overall Study|Death|2
389836|NCT00803049|1308799|P4|Overall Study|Lost to Follow-up|3
389837|NCT00803049|1308800|P3|Overall Study|Lost to Follow-up|0
389838|NCT00803049|1308801|P2|Overall Study|Lost to Follow-up|2
389839|NCT00803049|1308802|P1|Overall Study|Lost to Follow-up|0
389840|NCT00803049|1308799|P4|Overall Study|Lack of Efficacy|13
389841|NCT00803049|1308800|P3|Overall Study|Lack of Efficacy|6
389842|NCT00803049|1308801|P2|Overall Study|Lack of Efficacy|19
389843|NCT00803049|1308802|P1|Overall Study|Lack of Efficacy|10
389844|NCT00803049|1308799|P4|Overall Study|Adverse Event|27
389845|NCT00803049|1308800|P3|Overall Study|Adverse Event|13
389846|NCT00803049|1308801|P2|Overall Study|Adverse Event|33
389847|NCT00803049|1308802|P1|Overall Study|Adverse Event|21
389848|NCT00803023|1308836|P4|Overall Study|Lack of Efficacy|1
389849|NCT00803023|1308837|P3|Overall Study|Lack of Efficacy|1
389850|NCT00803023|1308838|P2|Overall Study|Lack of Efficacy|1
389851|NCT00803023|1308839|P1|Overall Study|Lack of Efficacy|0
389852|NCT00803023|1308836|P4|Overall Study|Lost to Follow-up|1
389853|NCT00803023|1308837|P3|Overall Study|Lost to Follow-up|2
389854|NCT00803023|1308838|P2|Overall Study|Lost to Follow-up|1
389855|NCT00803023|1308839|P1|Overall Study|Lost to Follow-up|0
389856|NCT00803023|1308836|P4|Overall Study|Withdrawal by Subject|0
389857|NCT00803023|1308837|P3|Overall Study|Withdrawal by Subject|0
389858|NCT00803023|1308838|P2|Overall Study|Withdrawal by Subject|2
389859|NCT00803023|1308839|P1|Overall Study|Withdrawal by Subject|0
389860|NCT00803023|1308836|P4|Overall Study|Adverse Event|6
389861|NCT00803023|1308837|P3|Overall Study|Adverse Event|8
389862|NCT00803023|1308838|P2|Overall Study|Adverse Event|4
389863|NCT00803023|1308839|P1|Overall Study|Adverse Event|5
389864|NCT00802893|1308890|P1|Overall Study|study terminated|3
389865|NCT00802867|1308914|P1|Overall Study|Withdrawal by Subject|1
389866|NCT00802867|1308914|P1|Overall Study|Protocol Violation|6
389867|NCT00802867|1308914|P1|Overall Study|Lost to Follow-up|6
389868|NCT00802841|1308937|P2|Overall Study|Treatment duration completed|76
389869|NCT00802841|1308938|P1|Overall Study|Treatment duration completed|66
389870|NCT00802841|1308937|P2|Overall Study|Protocol deviation|6
389871|NCT00802841|1308938|P1|Overall Study|Protocol deviation|2
389872|NCT00802841|1308937|P2|Overall Study|Withdrawal by Subject|5
389873|NCT00802841|1308938|P1|Overall Study|Withdrawal by Subject|9
389874|NCT00802841|1308937|P2|Overall Study|Disease progression|3
389875|NCT00802841|1308938|P1|Overall Study|Disease progression|7
389876|NCT00802841|1308937|P2|Overall Study|Adverse Event|2
389877|NCT00802841|1308938|P1|Overall Study|Adverse Event|8
389878|NCT00802841|1308937|P2|Overall Study|Death|2
389879|NCT00802841|1308938|P1|Overall Study|Death|1
389880|NCT00802841|1308937|P2|Overall Study|Lost to Follow-up|1
389881|NCT00802841|1308938|P1|Overall Study|Lost to Follow-up|2
389882|NCT00802841|1308937|P2|Overall Study|Administrative problems|0
389883|NCT00802841|1308938|P1|Overall Study|Administrative problems|1
389884|NCT00802737|1308963|P3|Overall Study|Participant too Unwell|0
389885|NCT00802737|1308964|P2|Overall Study|Participant too Unwell|2
389886|NCT00802737|1308965|P1|Overall Study|Participant too Unwell|0
389887|NCT00802737|1308963|P3|Overall Study|Ongoing CLL-Treatment|0
389888|NCT00802737|1308964|P2|Overall Study|Ongoing CLL-Treatment|1
389889|NCT00802737|1308965|P1|Overall Study|Ongoing CLL-Treatment|0
389890|NCT00802737|1308963|P3|Overall Study|Received Prohibited Therapy|0
389891|NCT00802737|1308964|P2|Overall Study|Received Prohibited Therapy|0
389892|NCT00802737|1308965|P1|Overall Study|Received Prohibited Therapy|1
389893|NCT00802737|1308963|P3|Overall Study|Adverse Event|0
389894|NCT00802737|1308964|P2|Overall Study|Adverse Event|0
389895|NCT00802737|1308965|P1|Overall Study|Adverse Event|1
389896|NCT00802737|1308963|P3|Overall Study|Death|1
389897|NCT00802737|1308964|P2|Overall Study|Death|5
389898|NCT00802737|1308965|P1|Overall Study|Death|6
389899|NCT00802737|1308963|P3|Overall Study|Withdrawn due to Disease Progression|0
389900|NCT00802737|1308964|P2|Overall Study|Withdrawn due to Disease Progression|3
389901|NCT00802737|1308965|P1|Overall Study|Withdrawn due to Disease Progression|9
389902|NCT00802672|1309025|P3|Overall Study|other|2
389903|NCT00802672|1309026|P2|Overall Study|other|1
389904|NCT00802672|1309027|P1|Overall Study|other|3
389905|NCT00802672|1309025|P3|Overall Study|Withdrawal by Subject|2
389906|NCT00802672|1309026|P2|Overall Study|Withdrawal by Subject|1
389907|NCT00802672|1309027|P1|Overall Study|Withdrawal by Subject|1
389908|NCT00802672|1309025|P3|Overall Study|Lost to Follow-up|3
389909|NCT00802672|1309026|P2|Overall Study|Lost to Follow-up|5
389910|NCT00802672|1309027|P1|Overall Study|Lost to Follow-up|5
389911|NCT00802672|1309025|P3|Overall Study|Protocol Violation|1
389912|NCT00802672|1309026|P2|Overall Study|Protocol Violation|1
389913|NCT00802672|1309027|P1|Overall Study|Protocol Violation|2
389914|NCT00802672|1309025|P3|Overall Study|Adverse Event|1
389915|NCT00802672|1309026|P2|Overall Study|Adverse Event|1
389916|NCT00802672|1309027|P1|Overall Study|Adverse Event|1
389917|NCT00802672|1309025|P3|Overall Study|Lack of fungal pathogen at baseline|25
389918|NCT00802672|1309026|P2|Overall Study|Lack of fungal pathogen at baseline|43
389919|NCT00802672|1309027|P1|Overall Study|Lack of fungal pathogen at baseline|56
389920|NCT00802659|1309045|P4|Overall Study|Physician Decision|0
389921|NCT00802659|1309046|P3|Overall Study|Physician Decision|0
389922|NCT00802659|1309047|P2|Overall Study|Physician Decision|1
389923|NCT00802659|1309048|P1|Overall Study|Physician Decision|0
389924|NCT00802529|1309087|P2|Overall Study|Lost to Follow-up|1
389925|NCT00802529|1309088|P1|Overall Study|Lost to Follow-up|0
389926|NCT00802464|1309127|P4|Month 8 - Month 14|Lost to Follow-up|0
389927|NCT00802464|1309128|P3|Month 8 - Month 14|Lost to Follow-up|1
389928|NCT00802464|1309129|P2|Month 8 - Month 14|Lost to Follow-up|0
389929|NCT00802464|1309130|P1|Month 8 - Month 14|Lost to Follow-up|0
389930|NCT00802464|1309127|P4|Month 8 - Month 14|Withdrawal by Subject|0
389931|NCT00802464|1309128|P3|Month 8 - Month 14|Withdrawal by Subject|0
389932|NCT00802464|1309129|P2|Month 8 - Month 14|Withdrawal by Subject|1
389933|NCT00802464|1309130|P1|Month 8 - Month 14|Withdrawal by Subject|1
389934|NCT00802464|1309127|P4|Month 8 - Month 14|Adverse Event|0
389935|NCT00802464|1309128|P3|Month 8 - Month 14|Adverse Event|0
389936|NCT00802464|1309129|P2|Month 8 - Month 14|Adverse Event|1
389937|NCT00802464|1309130|P1|Month 8 - Month 14|Adverse Event|0
389938|NCT00802464|1309127|P4|Month 0 - Month 8|Not specified|0
389939|NCT00802464|1309128|P3|Month 0 - Month 8|Not specified|1
389940|NCT00802464|1309129|P2|Month 0 - Month 8|Not specified|0
389941|NCT00802464|1309130|P1|Month 0 - Month 8|Not specified|0
389942|NCT00802464|1309127|P4|Month 0 - Month 8|Lost to Follow-up|2
389943|NCT00802464|1309128|P3|Month 0 - Month 8|Lost to Follow-up|2
389944|NCT00802464|1309129|P2|Month 0 - Month 8|Lost to Follow-up|1
389945|NCT00802464|1309130|P1|Month 0 - Month 8|Lost to Follow-up|0
389946|NCT00802464|1309127|P4|Month 0 - Month 8|Withdrawal by Subject|5
389947|NCT00802464|1309128|P3|Month 0 - Month 8|Withdrawal by Subject|2
389948|NCT00802464|1309129|P2|Month 0 - Month 8|Withdrawal by Subject|1
389949|NCT00802464|1309130|P1|Month 0 - Month 8|Withdrawal by Subject|0
389950|NCT00802464|1309127|P4|Month 0 - Month 8|Protocol Violation|0
389951|NCT00802464|1309128|P3|Month 0 - Month 8|Protocol Violation|1
389952|NCT00802464|1309129|P2|Month 0 - Month 8|Protocol Violation|0
389953|NCT00802464|1309130|P1|Month 0 - Month 8|Protocol Violation|0
389954|NCT00802464|1309127|P4|Month 0 - Month 8|Adverse Event|2
389955|NCT00802464|1309128|P3|Month 0 - Month 8|Adverse Event|1
389956|NCT00802464|1309129|P2|Month 0 - Month 8|Adverse Event|1
389957|NCT00802464|1309130|P1|Month 0 - Month 8|Adverse Event|0
389958|NCT00802438|1309216|P1|Overall Study|Physician Decision|1
389959|NCT00802438|1309216|P1|Overall Study|Withdrawal by Subject|7
389960|NCT00802438|1309216|P1|Overall Study|Screen Failure|20
389961|NCT00802360|1309236|P4|Overall Study|Other|3
389962|NCT00802360|1309237|P3|Overall Study|Other|6
389963|NCT00802360|1309238|P2|Overall Study|Other|3
389964|NCT00802360|1309239|P1|Overall Study|Other|2
389965|NCT00802360|1309236|P4|Overall Study|Pregnancy loss/miscarriage|3
389966|NCT00802360|1309237|P3|Overall Study|Pregnancy loss/miscarriage|0
389967|NCT00802360|1309238|P2|Overall Study|Pregnancy loss/miscarriage|2
389968|NCT00802360|1309239|P1|Overall Study|Pregnancy loss/miscarriage|0
389969|NCT00802360|1309236|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
389970|NCT00802360|1309237|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
389971|NCT00802360|1309238|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
389972|NCT00802360|1309239|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
389973|NCT00802360|1309236|P4|Overall Study|No positive serum pregnancy|10
389974|NCT00802360|1309237|P3|Overall Study|No positive serum pregnancy|14
389975|NCT00802360|1309238|P2|Overall Study|No positive serum pregnancy|20
389976|NCT00802360|1309239|P1|Overall Study|No positive serum pregnancy|17
389977|NCT00802360|1309236|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
389978|NCT00802360|1309237|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
389979|NCT00802360|1309238|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
389980|NCT00802360|1309239|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
389981|NCT00802360|1309236|P4|Overall Study|Cycle cancelled|1
389982|NCT00802360|1309237|P3|Overall Study|Cycle cancelled|1
389983|NCT00802360|1309238|P2|Overall Study|Cycle cancelled|1
389984|NCT00802360|1309239|P1|Overall Study|Cycle cancelled|0
389985|NCT00802360|1309236|P4|Overall Study|Inadequate number of oocytes retrieved|1
389986|NCT00802360|1309237|P3|Overall Study|Inadequate number of oocytes retrieved|0
389987|NCT00802360|1309238|P2|Overall Study|Inadequate number of oocytes retrieved|0
389988|NCT00802360|1309239|P1|Overall Study|Inadequate number of oocytes retrieved|0
389989|NCT00802360|1309236|P4|Overall Study|Stimulation failure|3
389990|NCT00802360|1309237|P3|Overall Study|Stimulation failure|3
389991|NCT00802360|1309238|P2|Overall Study|Stimulation failure|0
389992|NCT00802360|1309239|P1|Overall Study|Stimulation failure|4
389993|NCT00802178|1309306|P1|Overall Study|Patients wish and other reason|1
389994|NCT00802178|1309306|P1|Overall Study|IT and patient wish|8
389995|NCT00802178|1309306|P1|Overall Study|Lack of efficacy and patient wish|1
389996|NCT00802178|1309306|P1|Overall Study|Other|32
389997|NCT00802178|1309306|P1|Overall Study|Withdrawal by Subject|18
389998|NCT00802178|1309306|P1|Overall Study|Insufficient tolerability (IT)|17
389999|NCT00802178|1309306|P1|Overall Study|Lack of Efficacy|36
390000|NCT00802074|1309333|P6|Overall Study|Withdrawal by Subject|0
390001|NCT00802074|1309334|P5|Overall Study|Withdrawal by Subject|0
390002|NCT00802074|1309335|P4|Overall Study|Withdrawal by Subject|0
390003|NCT00802074|1309336|P3|Overall Study|Withdrawal by Subject|0
390004|NCT00802074|1309337|P2|Overall Study|Withdrawal by Subject|0
390005|NCT00802074|1309338|P1|Overall Study|Withdrawal by Subject|1
390006|NCT00802074|1309333|P6|Overall Study|Adverse Event|0
390007|NCT00802074|1309334|P5|Overall Study|Adverse Event|0
390008|NCT00802074|1309335|P4|Overall Study|Adverse Event|0
390009|NCT00802074|1309336|P3|Overall Study|Adverse Event|1
390010|NCT00802074|1309337|P2|Overall Study|Adverse Event|1
390011|NCT00802074|1309338|P1|Overall Study|Adverse Event|1
390012|NCT00801983|1309372|P2|Period 2|Withdrawal by Subject|1
390013|NCT00801983|1309373|P1|Period 2|Withdrawal by Subject|2
390014|NCT00801983|1309372|P2|Period 1|Withdrawal by Subject|8
390015|NCT00801983|1309373|P1|Period 1|Withdrawal by Subject|2
390016|NCT00801983|1309372|P2|Period 1|Lost to Follow-up|0
390017|NCT00801983|1309373|P1|Period 1|Lost to Follow-up|2
390018|NCT00801892|1309381|P2|Sham Crossover Period|Lost to Follow-up|2
390019|NCT00801892|1309382|P1|Sham Crossover Period|Lost to Follow-up|0
390020|NCT00801892|1309381|P2|Main Study Period|Withdrawal by Subject|1
390021|NCT00801892|1309382|P1|Main Study Period|Withdrawal by Subject|0
390022|NCT00801632|1309429|P1|Overall Study|Re-transplant|1
390023|NCT00801242|1309440|P1|Overall Study|Miscellaneous reasons|20
390024|NCT00801242|1309440|P1|Overall Study|Lost to Follow-up|1
390025|NCT00801242|1309440|P1|Overall Study|Physician Decision|3
390026|NCT00801242|1309440|P1|Overall Study|Protocol Violation|5
390027|NCT00801242|1309440|P1|Overall Study|Withdrawal by Subject|13
390028|NCT00801242|1309440|P1|Overall Study|Adverse Event|10
390029|NCT00801229|1309453|P2|Received Study Drug/Placebo|Adverse Event|1
390030|NCT00801229|1309454|P1|Received Study Drug/Placebo|Adverse Event|1
390031|NCT00801229|1309453|P2|Received Study Drug/Placebo|Lost to Follow-up|1
390032|NCT00801229|1309454|P1|Received Study Drug/Placebo|Lost to Follow-up|0
390033|NCT00801229|1309453|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
390034|NCT00801229|1309454|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
390035|NCT00801229|1309453|P2|Received Study Drug/Placebo|Simulator sickness|1
390036|NCT00801229|1309454|P1|Received Study Drug/Placebo|Simulator sickness|1
390037|NCT00801229|1309453|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
390038|NCT00801229|1309454|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
390039|NCT00801229|1309453|P2|Received Study Drug/Placebo|Elevated SGOT level|0
390040|NCT00801229|1309454|P1|Received Study Drug/Placebo|Elevated SGOT level|1
390041|NCT00801229|1309453|P2|Signed Consent|Found Ineligible|1
390042|NCT00801229|1309454|P1|Signed Consent|Found Ineligible|1
390043|NCT00801229|1309453|P2|Signed Consent|Withdrawal by Subject|2
390044|NCT00801229|1309454|P1|Signed Consent|Withdrawal by Subject|2
390045|NCT00801099|1309489|P1|Overall Study|Lost to Follow-up|101
390046|NCT00800982|1309495|P2|Overall Study|Patient moved out of state|0
390047|NCT00800982|1309496|P1|Overall Study|Patient moved out of state|1
390048|NCT00800982|1309495|P2|Overall Study|Withdrawal by Subject|1
390049|NCT00800982|1309496|P1|Overall Study|Withdrawal by Subject|0
390050|NCT00800982|1309495|P2|Overall Study|Lost to Follow-up|2
390051|NCT00800982|1309496|P1|Overall Study|Lost to Follow-up|1
390052|NCT00800735|1309522|P1|Overall Study|Withdrew Consent|3
390053|NCT00800735|1309522|P1|Overall Study|Violation of Selection Criteria at Entry|7
390054|NCT00800735|1309522|P1|Overall Study|Insufficient Therapeutic Response|2
390055|NCT00800735|1309522|P1|Overall Study|Administrative/Other|2
390056|NCT00800683|1309528|P2|Overall Study|Not specified|2
390057|NCT00800683|1309529|P1|Overall Study|Not specified|1
390058|NCT00800683|1309528|P2|Overall Study|Lack of Efficacy|1
390059|NCT00800683|1309529|P1|Overall Study|Lack of Efficacy|1
390060|NCT00800683|1309528|P2|Overall Study|Withdrawal by Subject|7
390061|NCT00800683|1309529|P1|Overall Study|Withdrawal by Subject|1
390062|NCT00800683|1309528|P2|Overall Study|Lost to Follow-up|1
390063|NCT00800683|1309529|P1|Overall Study|Lost to Follow-up|3
390064|NCT00800683|1309528|P2|Overall Study|Adverse Event|8
390065|NCT00800683|1309529|P1|Overall Study|Adverse Event|11
390066|NCT00800540|1309575|P2|Period 2: 6 Weeks|Adverse Event|1
390067|NCT00800540|1309576|P1|Period 2: 6 Weeks|Adverse Event|0
390068|NCT00800540|1309575|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
390069|NCT00800540|1309576|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
390070|NCT00800540|1309575|P2|Period One: 6 Weeks|Noncompliance|0
390071|NCT00800540|1309576|P1|Period One: 6 Weeks|Noncompliance|1
390072|NCT00800436|1309611|P7|Overall Study|Withdrawal by Subject|0
390073|NCT00800436|1309612|P6|Overall Study|Withdrawal by Subject|0
390074|NCT00800436|1309613|P5|Overall Study|Withdrawal by Subject|0
390075|NCT00800436|1309614|P4|Overall Study|Withdrawal by Subject|1
390076|NCT00800436|1309615|P3|Overall Study|Withdrawal by Subject|1
390077|NCT00800436|1309616|P2|Overall Study|Withdrawal by Subject|0
390078|NCT00800436|1309617|P1|Overall Study|Withdrawal by Subject|0
390079|NCT00800384|1309663|P2|Overall Study|Lost to Follow-up|26
390080|NCT00800384|1309664|P1|Overall Study|Lost to Follow-up|17
390081|NCT00800384|1309663|P2|Overall Study|Withdrawal by Subject|17
390082|NCT00800384|1309664|P1|Overall Study|Withdrawal by Subject|24
390083|NCT00800202|1309702|P2|Overall Study|Disease Progression|18
390084|NCT00800202|1309703|P1|Overall Study|Disease Progression|54
390085|NCT00800202|1309702|P2|Overall Study|Other|0
390086|NCT00800202|1309703|P1|Overall Study|Other|5
390087|NCT00800202|1309702|P2|Overall Study|Death|0
390088|NCT00800202|1309703|P1|Overall Study|Death|1
390089|NCT00800202|1309702|P2|Overall Study|Adverse Event|6
390090|NCT00800202|1309703|P1|Overall Study|Adverse Event|7
390091|NCT00799903|1309723|P2|Overall Study|Lost to Follow-up|80
390092|NCT00799903|1309724|P1|Overall Study|Lost to Follow-up|69
390093|NCT00799903|1309723|P2|Overall Study|Withdrawal by Subject|175
390094|NCT00799903|1309724|P1|Overall Study|Withdrawal by Subject|179
390095|NCT00799903|1309723|P2|Overall Study|Investigator Site Closed|23
390096|NCT00799903|1309724|P1|Overall Study|Investigator Site Closed|25
390097|NCT00799825|1309744|P1|Overall Study|Pregnancy|3
390098|NCT00799825|1309744|P1|Overall Study|Lost to Follow-up|38
390099|NCT00799825|1309744|P1|Overall Study|Withdrawal by Subject|6
390100|NCT00799825|1309744|P1|Overall Study|Adverse Event|1
390101|NCT00799708|1309784|P3|Overall Study|non-compliance|0
390102|NCT00799708|1309785|P2|Overall Study|non-compliance|0
390103|NCT00799708|1309786|P1|Overall Study|non-compliance|1
390104|NCT00799617|1309809|P2|Anemia Trial|Withdrawal by Subject|3
390105|NCT00799617|1309810|P1|Anemia Trial|Withdrawal by Subject|3
390106|NCT00799617|1309809|P2|Cognitive Function Trial|Lost to Follow-up|1
390107|NCT00799617|1309810|P1|Cognitive Function Trial|Lost to Follow-up|0
390108|NCT00799617|1309809|P2|Bone Trial|Month 12 scan not available|16
390109|NCT00799617|1309810|P1|Bone Trial|Month 12 scan not available|6
390110|NCT00799617|1309809|P2|Cardiovascular Trial|Baseline scan not analyzable|2
390111|NCT00799617|1309810|P1|Cardiovascular Trial|Baseline scan not analyzable|0
390112|NCT00799617|1309809|P2|Cardiovascular Trial|Month 12 scan not available|15
390113|NCT00799617|1309810|P1|Cardiovascular Trial|Month 12 scan not available|15
390114|NCT00799617|1309809|P2|Vitality Trial|Lost to Follow-up|22
390115|NCT00799617|1309810|P1|Vitality Trial|Lost to Follow-up|7
390116|NCT00799617|1309809|P2|Physical Function Trial|Lost to Follow-up|11
390117|NCT00799617|1309810|P1|Physical Function Trial|Lost to Follow-up|6
390118|NCT00799617|1309809|P2|Sexual Funtion Trial|No Baseline Data|7
390119|NCT00799617|1309810|P1|Sexual Funtion Trial|No Baseline Data|4
390120|NCT00799617|1309809|P2|Sexual Funtion Trial|Lost to Follow-up|14
390121|NCT00799617|1309810|P1|Sexual Funtion Trial|Lost to Follow-up|12
390122|NCT00799617|1309809|P2|Main Testosterone Trial|Lost to Follow-up|20
390123|NCT00799617|1309810|P1|Main Testosterone Trial|Lost to Follow-up|18
390124|NCT00799617|1309809|P2|Main Testosterone Trial|Randomized in error|1
390125|NCT00799617|1309810|P1|Main Testosterone Trial|Randomized in error|1
390126|NCT00799591|1309917|P1|Overall Study|Infectious origin not probable|1
390127|NCT00799591|1309917|P1|Overall Study|Antibiotic changed, no apparent reason|1
390128|NCT00799591|1309917|P1|Overall Study|Persistance of fever undetermined origin|1
390129|NCT00799591|1309917|P1|Overall Study|Resistance germ and technical failure|2
390130|NCT00799591|1309917|P1|Overall Study|New infection|4
390131|NCT00799591|1309917|P1|Overall Study|Resistant germ|11
390132|NCT00799591|1309917|P1|Overall Study|Technical failure|12
390133|NCT00799591|1309917|P1|Overall Study|Death|14
390134|NCT00799591|1309917|P1|Overall Study|De-escalation of doses|20
390135|NCT00799487|1309935|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
390136|NCT00799487|1309936|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
390137|NCT00799487|1309937|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
390138|NCT00799487|1309935|P3|Double-Blind Assessment Period|Subject was out of the state|1
390139|NCT00799487|1309936|P2|Double-Blind Assessment Period|Subject was out of the state|0
390140|NCT00799487|1309937|P1|Double-Blind Assessment Period|Subject was out of the state|0
390141|NCT00799487|1309935|P3|Double-Blind Assessment Period|Lost to Follow-up|1
390142|NCT00799487|1309936|P2|Double-Blind Assessment Period|Lost to Follow-up|0
390143|NCT00799487|1309937|P1|Double-Blind Assessment Period|Lost to Follow-up|0
390144|NCT00799487|1309935|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
390145|NCT00799487|1309936|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
390146|NCT00799487|1309937|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
390147|NCT00799487|1309935|P3|Dose Adjustment Period|Missed laboratory day 1|0
390148|NCT00799487|1309936|P2|Dose Adjustment Period|Missed laboratory day 1|0
390149|NCT00799487|1309937|P1|Dose Adjustment Period|Missed laboratory day 1|1
390150|NCT00799487|1309935|P3|Dose Adjustment Period|Child too young (exclusion)|0
390151|NCT00799487|1309936|P2|Dose Adjustment Period|Child too young (exclusion)|0
390152|NCT00799487|1309937|P1|Dose Adjustment Period|Child too young (exclusion)|1
390153|NCT00799487|1309935|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
390154|NCT00799487|1309936|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
390155|NCT00799487|1309937|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
390156|NCT00799487|1309935|P3|Dose Adjustment Period|Withdrawal by Subject|0
390157|NCT00799487|1309936|P2|Dose Adjustment Period|Withdrawal by Subject|0
390158|NCT00799487|1309937|P1|Dose Adjustment Period|Withdrawal by Subject|3
390159|NCT00799487|1309935|P3|Dose Adjustment Period|Investigator Discretion|0
390160|NCT00799487|1309936|P2|Dose Adjustment Period|Investigator Discretion|0
390161|NCT00799487|1309937|P1|Dose Adjustment Period|Investigator Discretion|2
390162|NCT00799487|1309935|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
390163|NCT00799487|1309936|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
390164|NCT00799487|1309937|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
390165|NCT00799487|1309935|P3|Dose Adjustment Period|Adverse Event|0
390166|NCT00799487|1309936|P2|Dose Adjustment Period|Adverse Event|0
390167|NCT00799487|1309937|P1|Dose Adjustment Period|Adverse Event|2
390168|NCT00799487|1309935|P3|Dose Adjustment Period|Lost to Follow-up|0
390169|NCT00799487|1309936|P2|Dose Adjustment Period|Lost to Follow-up|0
390170|NCT00799487|1309937|P1|Dose Adjustment Period|Lost to Follow-up|1
390171|NCT00799422|1310032|P6|First Week of Wear|Adverse Event|0
390172|NCT00799422|1310033|P5|First Week of Wear|Adverse Event|0
390173|NCT00799422|1310034|P4|First Week of Wear|Adverse Event|1
390174|NCT00799422|1310035|P3|First Week of Wear|Adverse Event|0
390175|NCT00799422|1310036|P2|First Week of Wear|Adverse Event|0
390176|NCT00799422|1310037|P1|First Week of Wear|Adverse Event|0
390177|NCT00799422|1310032|P6|First Week of Wear|Lost to Follow-up|0
390178|NCT00799422|1310033|P5|First Week of Wear|Lost to Follow-up|0
390179|NCT00799422|1310034|P4|First Week of Wear|Lost to Follow-up|0
390180|NCT00799422|1310035|P3|First Week of Wear|Lost to Follow-up|1
390181|NCT00799422|1310036|P2|First Week of Wear|Lost to Follow-up|0
390182|NCT00799422|1310037|P1|First Week of Wear|Lost to Follow-up|0
390183|NCT00799409|1310054|P3|Overall Study|medication compliance|0
390184|NCT00799409|1310055|P2|Overall Study|medication compliance|0
390185|NCT00799409|1310056|P1|Overall Study|medication compliance|1
390186|NCT00799409|1310054|P3|Overall Study|Did not attend lab school day 1|0
390187|NCT00799409|1310055|P2|Overall Study|Did not attend lab school day 1|0
390188|NCT00799409|1310056|P1|Overall Study|Did not attend lab school day 1|1
390189|NCT00799409|1310054|P3|Overall Study|Failure to follow study protocol)|0
390190|NCT00799409|1310055|P2|Overall Study|Failure to follow study protocol)|0
390191|NCT00799409|1310056|P1|Overall Study|Failure to follow study protocol)|1
390192|NCT00799409|1310054|P3|Overall Study|Optimal Dose Not Achieved|0
390193|NCT00799409|1310055|P2|Overall Study|Optimal Dose Not Achieved|0
390194|NCT00799409|1310056|P1|Overall Study|Optimal Dose Not Achieved|2
390195|NCT00799409|1310054|P3|Overall Study|Lost to Follow-up|0
390196|NCT00799409|1310055|P2|Overall Study|Lost to Follow-up|0
390197|NCT00799409|1310056|P1|Overall Study|Lost to Follow-up|1
390198|NCT00799409|1310054|P3|Overall Study|Withdrawal by Subject|0
390199|NCT00799409|1310055|P2|Overall Study|Withdrawal by Subject|0
390200|NCT00799409|1310056|P1|Overall Study|Withdrawal by Subject|1
390201|NCT00799396|1310136|P1|Clopidogrel Plus Aspirin|Physician Decision|4
390202|NCT00799396|1310136|P1|Clopidogrel Plus Aspirin|Adverse Event|2
390203|NCT00799396|1310136|P1|Clopidogrel Treatment|Withdrawal by Subject|2
390204|NCT00799396|1310136|P1|Clopidogrel Treatment|Physician Decision|5
390205|NCT00799396|1310136|P1|Clopidogrel Treatment|Adverse Event|6
390206|NCT00799383|1310143|P2|Overall Study|Withdrawal by Subject|1
390207|NCT00799383|1310144|P1|Overall Study|Withdrawal by Subject|0
390208|NCT00799383|1310143|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
390209|NCT00799383|1310144|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
390210|NCT00799383|1310143|P2|Overall Study|Lost to Follow-up|2
390211|NCT00799383|1310144|P1|Overall Study|Lost to Follow-up|1
390212|NCT00799383|1310143|P2|Overall Study|Adverse Event|1
390213|NCT00799383|1310144|P1|Overall Study|Adverse Event|0
390214|NCT00799383|1310143|P2|Overall Study|Protocol Violation|1
390215|NCT00799383|1310144|P1|Overall Study|Protocol Violation|1
390216|NCT00798967|1310180|P2|Overall Study|Randomized in error by site|0
390217|NCT00798967|1310181|P1|Overall Study|Randomized in error by site|1
390218|NCT00798967|1310180|P2|Overall Study|Physician Decision|0
390219|NCT00798967|1310181|P1|Overall Study|Physician Decision|1
390220|NCT00798967|1310180|P2|Overall Study|Withdrawal by Subject|1
390221|NCT00798967|1310181|P1|Overall Study|Withdrawal by Subject|0
390222|NCT00798967|1310180|P2|Overall Study|Adverse Event|3
390223|NCT00798967|1310181|P1|Overall Study|Adverse Event|2
390224|NCT00798889|1310189|P1|Overall Study|Enrolled, Not treated|3
390225|NCT00798889|1310189|P1|Overall Study|Decision of Sponsor|11
390226|NCT00798889|1310189|P1|Overall Study|Lack of Efficacy|213
390227|NCT00798889|1310189|P1|Overall Study|Lost to Follow-up|1
390228|NCT00798889|1310189|P1|Overall Study|Withdrawal by Subject|31
390229|NCT00798889|1310189|P1|Overall Study|Protocol Violation|2
390230|NCT00798889|1310189|P1|Overall Study|Adverse Event|53
390231|NCT00798759|1310195|P2|Overall Study|Not specified|1
390232|NCT00798759|1310196|P1|Overall Study|Not specified|0
390233|NCT00798759|1310195|P2|Overall Study|Protocol Violation|8
390234|NCT00798759|1310196|P1|Overall Study|Protocol Violation|4
390235|NCT00798759|1310195|P2|Overall Study|Lost to Follow-up|1
390236|NCT00798759|1310196|P1|Overall Study|Lost to Follow-up|1
390237|NCT00798759|1310195|P2|Overall Study|Adverse Event|3
390238|NCT00798759|1310196|P1|Overall Study|Adverse Event|3
390239|NCT00798707|1310214|P3|Overall Study|Randomized not treated|1
390240|NCT00798707|1310215|P2|Overall Study|Randomized not treated|5
390241|NCT00798707|1310216|P1|Overall Study|Randomized not treated|4
390242|NCT00798707|1310214|P3|Overall Study|Withdrawal by Subject|2
390243|NCT00798707|1310215|P2|Overall Study|Withdrawal by Subject|8
390244|NCT00798707|1310216|P1|Overall Study|Withdrawal by Subject|3
390245|NCT00798707|1310214|P3|Overall Study|Protocol Violation|2
390246|NCT00798707|1310215|P2|Overall Study|Protocol Violation|0
390247|NCT00798707|1310216|P1|Overall Study|Protocol Violation|4
390248|NCT00798707|1310214|P3|Overall Study|Other|0
390249|NCT00798707|1310215|P2|Overall Study|Other|1
390250|NCT00798707|1310216|P1|Overall Study|Other|0
390251|NCT00798707|1310214|P3|Overall Study|Lost to Follow-up|6
390252|NCT00798707|1310215|P2|Overall Study|Lost to Follow-up|6
390253|NCT00798707|1310216|P1|Overall Study|Lost to Follow-up|5
390254|NCT00798707|1310214|P3|Overall Study|Lack of Efficacy|1
390255|NCT00798707|1310215|P2|Overall Study|Lack of Efficacy|2
390256|NCT00798707|1310216|P1|Overall Study|Lack of Efficacy|2
390257|NCT00798707|1310214|P3|Overall Study|Investigator|2
390258|NCT00798707|1310215|P2|Overall Study|Investigator|1
390259|NCT00798707|1310216|P1|Overall Study|Investigator|0
390260|NCT00798707|1310214|P3|Overall Study|Failed to return|0
390261|NCT00798707|1310215|P2|Overall Study|Failed to return|2
390262|NCT00798707|1310216|P1|Overall Study|Failed to return|2
390263|NCT00798707|1310214|P3|Overall Study|Adverse Event|8
390264|NCT00798707|1310215|P2|Overall Study|Adverse Event|8
390265|NCT00798707|1310216|P1|Overall Study|Adverse Event|6
390266|NCT00798655|1310266|P1|Overall Study|Did not receive at least one dose of pan|2
390267|NCT00798603|1310271|P1|Overall Study|Lack of insurance coverage|1
390268|NCT00798603|1310271|P1|Overall Study|Physician Decision|1
390269|NCT00798603|1310271|P1|Overall Study|Adverse Event|22
390270|NCT00798603|1310271|P1|Overall Study|Withdrawal by Subject|10
390271|NCT00798603|1310271|P1|Overall Study|Still on treatment as of 11/6/2012|1
390272|NCT00798590|1310293|P2|Overall Study|P.I, Left institution. Study terminated|8
390273|NCT00798590|1310294|P1|Overall Study|P.I, Left institution. Study terminated|11
390274|NCT00798434|1310328|P2|Open-Label|Not Treated|1
390275|NCT00798434|1310329|P1|Open-Label|Not Treated|0
390276|NCT00798434|1310328|P2|Open-Label|Not Specified|2
390277|NCT00798434|1310329|P1|Open-Label|Not Specified|1
390278|NCT00798434|1310328|P2|Open-Label|Protocol Violation|0
390279|NCT00798434|1310329|P1|Open-Label|Protocol Violation|1
390280|NCT00798434|1310328|P2|Open-Label|Withdrawal by Subject|7
390281|NCT00798434|1310329|P1|Open-Label|Withdrawal by Subject|2
390282|NCT00798434|1310328|P2|Open-Label|Lack of Efficacy|11
390283|NCT00798434|1310329|P1|Open-Label|Lack of Efficacy|5
390284|NCT00798434|1310328|P2|Open-Label|Adverse Event|11
390285|NCT00798434|1310329|P1|Open-Label|Adverse Event|33
390286|NCT00798434|1310328|P2|Double-Blind|Not Treated|6
390287|NCT00798434|1310329|P1|Double-Blind|Not Treated|3
390288|NCT00798434|1310328|P2|Double-Blind|Not Specified|0
390289|NCT00798434|1310329|P1|Double-Blind|Not Specified|1
390290|NCT00798434|1310328|P2|Double-Blind|Did Not Meet Entrance Criteria|1
390291|NCT00798434|1310329|P1|Double-Blind|Did Not Meet Entrance Criteria|2
390292|NCT00798434|1310328|P2|Double-Blind|Protocol Violation|4
390293|NCT00798434|1310329|P1|Double-Blind|Protocol Violation|1
390294|NCT00798434|1310328|P2|Double-Blind|Withdrawal by Subject|14
390295|NCT00798434|1310329|P1|Double-Blind|Withdrawal by Subject|17
390296|NCT00798434|1310328|P2|Double-Blind|Lack of Efficacy|12
390297|NCT00798434|1310329|P1|Double-Blind|Lack of Efficacy|8
390298|NCT00798434|1310328|P2|Double-Blind|Lost to Follow-up|0
390299|NCT00798434|1310329|P1|Double-Blind|Lost to Follow-up|1
390300|NCT00798434|1310328|P2|Double-Blind|Death|1
390301|NCT00798434|1310329|P1|Double-Blind|Death|0
390302|NCT00798434|1310328|P2|Double-Blind|Adverse Event|46
390303|NCT00798434|1310329|P1|Double-Blind|Adverse Event|22
390304|NCT00798369|1310415|P6|Overall Study|Adminstrative problems|1
390305|NCT00798369|1310416|P5|Overall Study|Adminstrative problems|0
390306|NCT00798369|1310417|P4|Overall Study|Adminstrative problems|0
390307|NCT00798369|1310418|P3|Overall Study|Adminstrative problems|0
390308|NCT00798369|1310419|P2|Overall Study|Adminstrative problems|0
390309|NCT00798369|1310420|P1|Overall Study|Adminstrative problems|0
390310|NCT00798369|1310415|P6|Overall Study|Lost to Follow-up|0
390311|NCT00798369|1310416|P5|Overall Study|Lost to Follow-up|1
390312|NCT00798369|1310417|P4|Overall Study|Lost to Follow-up|0
390313|NCT00798369|1310418|P3|Overall Study|Lost to Follow-up|1
390314|NCT00798369|1310419|P2|Overall Study|Lost to Follow-up|1
390315|NCT00798369|1310420|P1|Overall Study|Lost to Follow-up|1
390316|NCT00798369|1310415|P6|Overall Study|Subject withdrew consent|2
390317|NCT00798369|1310416|P5|Overall Study|Subject withdrew consent|0
390318|NCT00798369|1310417|P4|Overall Study|Subject withdrew consent|1
390319|NCT00798369|1310418|P3|Overall Study|Subject withdrew consent|1
390320|NCT00798369|1310419|P2|Overall Study|Subject withdrew consent|0
390321|NCT00798369|1310420|P1|Overall Study|Subject withdrew consent|0
390322|NCT00798317|1310467|P2|Overall Study|Death|0
390323|NCT00798317|1310468|P1|Overall Study|Death|1
390324|NCT00798317|1310467|P2|Overall Study|Adverse Event|0
390325|NCT00798317|1310468|P1|Overall Study|Adverse Event|2
390326|NCT00798317|1310467|P2|Overall Study|Lost to Follow-up|2
390327|NCT00798317|1310468|P1|Overall Study|Lost to Follow-up|2
390328|NCT00798317|1310467|P2|Overall Study|Withdrawal by Subject|4
390329|NCT00798317|1310468|P1|Overall Study|Withdrawal by Subject|5
390330|NCT00798317|1310467|P2|Overall Study|Physician Decision|1
390331|NCT00798317|1310468|P1|Overall Study|Physician Decision|0
390332|NCT00798304|1310479|P3|Overall Study|Discontinuation by Sponsor|9
390333|NCT00798304|1310480|P2|Overall Study|Discontinuation by Sponsor|21
390334|NCT00798304|1310481|P1|Overall Study|Discontinuation by Sponsor|14
390335|NCT00798304|1310479|P3|Overall Study|Adverse Event|1
390336|NCT00798304|1310480|P2|Overall Study|Adverse Event|1
390337|NCT00798304|1310481|P1|Overall Study|Adverse Event|0
390338|NCT00798161|1310514|P7|Overall Study|Other reason (incl. lack of efficacy)|5
390339|NCT00798161|1310515|P6|Overall Study|Other reason (incl. lack of efficacy)|4
390340|NCT00798161|1310516|P5|Overall Study|Other reason (incl. lack of efficacy)|2
390341|NCT00798161|1310517|P4|Overall Study|Other reason (incl. lack of efficacy)|5
390342|NCT00798161|1310518|P3|Overall Study|Other reason (incl. lack of efficacy)|3
390343|NCT00798161|1310519|P2|Overall Study|Other reason (incl. lack of efficacy)|5
390344|NCT00798161|1310520|P1|Overall Study|Other reason (incl. lack of efficacy)|7
390345|NCT00798161|1310514|P7|Overall Study|Withdrawal by Subject|1
390346|NCT00798161|1310515|P6|Overall Study|Withdrawal by Subject|3
390347|NCT00798161|1310516|P5|Overall Study|Withdrawal by Subject|2
390348|NCT00798161|1310517|P4|Overall Study|Withdrawal by Subject|4
390349|NCT00798161|1310518|P3|Overall Study|Withdrawal by Subject|5
390350|NCT00798161|1310519|P2|Overall Study|Withdrawal by Subject|4
390351|NCT00798161|1310520|P1|Overall Study|Withdrawal by Subject|5
390352|NCT00798161|1310514|P7|Overall Study|Lost to Follow-up|0
390353|NCT00798161|1310515|P6|Overall Study|Lost to Follow-up|0
390354|NCT00798161|1310516|P5|Overall Study|Lost to Follow-up|4
390355|NCT00798161|1310517|P4|Overall Study|Lost to Follow-up|3
390356|NCT00798161|1310518|P3|Overall Study|Lost to Follow-up|4
390357|NCT00798161|1310519|P2|Overall Study|Lost to Follow-up|3
390358|NCT00798161|1310520|P1|Overall Study|Lost to Follow-up|1
390359|NCT00798161|1310514|P7|Overall Study|Protocol Violation|0
390360|NCT00798161|1310515|P6|Overall Study|Protocol Violation|2
390361|NCT00798161|1310516|P5|Overall Study|Protocol Violation|3
390362|NCT00798161|1310517|P4|Overall Study|Protocol Violation|3
390363|NCT00798161|1310518|P3|Overall Study|Protocol Violation|3
390364|NCT00798161|1310519|P2|Overall Study|Protocol Violation|1
390365|NCT00798161|1310520|P1|Overall Study|Protocol Violation|2
390366|NCT00798161|1310514|P7|Overall Study|Adverse Event|4
390367|NCT00798161|1310515|P6|Overall Study|Adverse Event|2
390368|NCT00798161|1310516|P5|Overall Study|Adverse Event|5
390369|NCT00798161|1310517|P4|Overall Study|Adverse Event|6
390370|NCT00798161|1310518|P3|Overall Study|Adverse Event|6
390371|NCT00798161|1310519|P2|Overall Study|Adverse Event|4
390372|NCT00798161|1310520|P1|Overall Study|Adverse Event|3
390373|NCT00798135|1310627|P1|Overall Study|Physician Decision|1
390374|NCT00798135|1310627|P1|Overall Study|Disease progression, refractory|1
390375|NCT00798135|1310627|P1|Overall Study|Disease progression, relapse|11
390376|NCT00798096|1310633|P1|Overall Study|Ongoing|2
390377|NCT00797966|1310661|P6|Phase A+|Protocol deviation|4
390378|NCT00797966|1310662|P5|Phase A+|Protocol deviation|0
390379|NCT00797966|1310663|P4|Phase A+|Protocol deviation|0
390380|NCT00797966|1310664|P3|Phase A+|Protocol deviation|0
390381|NCT00797966|1310665|P2|Phase A+|Protocol deviation|0
390382|NCT00797966|1310666|P1|Phase A+|Protocol deviation|0
390383|NCT00797966|1310661|P6|Phase A+|Adverse Event|4
390384|NCT00797966|1310662|P5|Phase A+|Adverse Event|0
390385|NCT00797966|1310663|P4|Phase A+|Adverse Event|0
390386|NCT00797966|1310664|P3|Phase A+|Adverse Event|0
390387|NCT00797966|1310665|P2|Phase A+|Adverse Event|0
390388|NCT00797966|1310666|P1|Phase A+|Adverse Event|0
390389|NCT00797966|1310661|P6|Phase A+|Withdrawal by Subject|6
390390|NCT00797966|1310662|P5|Phase A+|Withdrawal by Subject|0
390391|NCT00797966|1310663|P4|Phase A+|Withdrawal by Subject|0
390392|NCT00797966|1310664|P3|Phase A+|Withdrawal by Subject|0
390393|NCT00797966|1310665|P2|Phase A+|Withdrawal by Subject|0
390394|NCT00797966|1310666|P1|Phase A+|Withdrawal by Subject|0
390395|NCT00797966|1310661|P6|Phase A+|Met withdrawal criteria|5
390396|NCT00797966|1310662|P5|Phase A+|Met withdrawal criteria|0
390397|NCT00797966|1310663|P4|Phase A+|Met withdrawal criteria|0
390398|NCT00797966|1310664|P3|Phase A+|Met withdrawal criteria|0
390399|NCT00797966|1310665|P2|Phase A+|Met withdrawal criteria|0
390400|NCT00797966|1310666|P1|Phase A+|Met withdrawal criteria|0
390401|NCT00797966|1310661|P6|Phase A+|Lost to Follow-up|9
390402|NCT00797966|1310662|P5|Phase A+|Lost to Follow-up|0
390403|NCT00797966|1310663|P4|Phase A+|Lost to Follow-up|0
390404|NCT00797966|1310664|P3|Phase A+|Lost to Follow-up|0
390405|NCT00797966|1310665|P2|Phase A+|Lost to Follow-up|0
390406|NCT00797966|1310666|P1|Phase A+|Lost to Follow-up|0
390407|NCT00797966|1310661|P6|Phase B|Lack of Efficacy|0
390408|NCT00797966|1310662|P5|Phase B|Lack of Efficacy|0
390409|NCT00797966|1310663|P4|Phase B|Lack of Efficacy|4
390410|NCT00797966|1310664|P3|Phase B|Lack of Efficacy|1
390411|NCT00797966|1310665|P2|Phase B|Lack of Efficacy|1
390412|NCT00797966|1310666|P1|Phase B|Lack of Efficacy|0
390413|NCT00797966|1310661|P6|Phase B|Protocol Deviation|0
390414|NCT00797966|1310662|P5|Phase B|Protocol Deviation|0
390415|NCT00797966|1310663|P4|Phase B|Protocol Deviation|6
390416|NCT00797966|1310664|P3|Phase B|Protocol Deviation|2
390417|NCT00797966|1310665|P2|Phase B|Protocol Deviation|8
390418|NCT00797966|1310666|P1|Phase B|Protocol Deviation|4
390419|NCT00797966|1310661|P6|Phase B|Withdrawal by Subject|0
390420|NCT00797966|1310662|P5|Phase B|Withdrawal by Subject|0
390421|NCT00797966|1310663|P4|Phase B|Withdrawal by Subject|3
390422|NCT00797966|1310664|P3|Phase B|Withdrawal by Subject|3
390423|NCT00797966|1310665|P2|Phase B|Withdrawal by Subject|4
390424|NCT00797966|1310666|P1|Phase B|Withdrawal by Subject|1
390425|NCT00797966|1310661|P6|Phase B|Physician Decision|0
390426|NCT00797966|1310662|P5|Phase B|Physician Decision|0
390427|NCT00797966|1310663|P4|Phase B|Physician Decision|1
390428|NCT00797966|1310664|P3|Phase B|Physician Decision|3
390429|NCT00797966|1310665|P2|Phase B|Physician Decision|0
390430|NCT00797966|1310666|P1|Phase B|Physician Decision|1
390431|NCT00797966|1310661|P6|Phase B|Met Withdrawal Criteria|0
390432|NCT00797966|1310662|P5|Phase B|Met Withdrawal Criteria|0
390433|NCT00797966|1310663|P4|Phase B|Met Withdrawal Criteria|1
390434|NCT00797966|1310664|P3|Phase B|Met Withdrawal Criteria|6
390435|NCT00797966|1310665|P2|Phase B|Met Withdrawal Criteria|3
390436|NCT00797966|1310666|P1|Phase B|Met Withdrawal Criteria|3
390437|NCT00797966|1310661|P6|Phase B|Adverse Event|0
390438|NCT00797966|1310662|P5|Phase B|Adverse Event|0
390439|NCT00797966|1310663|P4|Phase B|Adverse Event|1
390440|NCT00797966|1310664|P3|Phase B|Adverse Event|3
390441|NCT00797966|1310665|P2|Phase B|Adverse Event|1
390442|NCT00797966|1310666|P1|Phase B|Adverse Event|2
390443|NCT00797966|1310661|P6|Phase B|Lost to Follow-up|0
390444|NCT00797966|1310662|P5|Phase B|Lost to Follow-up|0
390445|NCT00797966|1310663|P4|Phase B|Lost to Follow-up|0
390446|NCT00797966|1310664|P3|Phase B|Lost to Follow-up|3
390447|NCT00797966|1310665|P2|Phase B|Lost to Follow-up|1
390448|NCT00797966|1310666|P1|Phase B|Lost to Follow-up|0
390449|NCT00797966|1310661|P6|Phase A|Protocol deviation|0
390450|NCT00797966|1310662|P5|Phase A|Protocol deviation|56
390451|NCT00797966|1310663|P4|Phase A|Protocol deviation|0
390452|NCT00797966|1310664|P3|Phase A|Protocol deviation|0
390453|NCT00797966|1310665|P2|Phase A|Protocol deviation|0
390454|NCT00797966|1310666|P1|Phase A|Protocol deviation|0
390455|NCT00797966|1310661|P6|Phase A|Withdrawal by Subject|0
390456|NCT00797966|1310662|P5|Phase A|Withdrawal by Subject|33
390457|NCT00797966|1310663|P4|Phase A|Withdrawal by Subject|0
390458|NCT00797966|1310664|P3|Phase A|Withdrawal by Subject|0
390459|NCT00797966|1310665|P2|Phase A|Withdrawal by Subject|0
390460|NCT00797966|1310666|P1|Phase A|Withdrawal by Subject|0
390461|NCT00797966|1310661|P6|Phase A|Physician Decision|0
390462|NCT00797966|1310662|P5|Phase A|Physician Decision|13
390463|NCT00797966|1310663|P4|Phase A|Physician Decision|0
390464|NCT00797966|1310664|P3|Phase A|Physician Decision|0
390465|NCT00797966|1310665|P2|Phase A|Physician Decision|0
390466|NCT00797966|1310666|P1|Phase A|Physician Decision|0
390467|NCT00797966|1310661|P6|Phase A|Met withdrawal criteria|0
390468|NCT00797966|1310662|P5|Phase A|Met withdrawal criteria|4
390469|NCT00797966|1310663|P4|Phase A|Met withdrawal criteria|0
390470|NCT00797966|1310664|P3|Phase A|Met withdrawal criteria|0
390471|NCT00797966|1310665|P2|Phase A|Met withdrawal criteria|0
390472|NCT00797966|1310666|P1|Phase A|Met withdrawal criteria|0
390473|NCT00797966|1310661|P6|Phase A|Adverse Event|0
390474|NCT00797966|1310662|P5|Phase A|Adverse Event|46
390475|NCT00797966|1310663|P4|Phase A|Adverse Event|0
390476|NCT00797966|1310664|P3|Phase A|Adverse Event|0
390477|NCT00797966|1310665|P2|Phase A|Adverse Event|0
390478|NCT00797966|1310666|P1|Phase A|Adverse Event|0
390479|NCT00797966|1310661|P6|Phase A|Lost to Follow-up|0
390480|NCT00797966|1310662|P5|Phase A|Lost to Follow-up|33
390481|NCT00797966|1310663|P4|Phase A|Lost to Follow-up|0
390482|NCT00797966|1310664|P3|Phase A|Lost to Follow-up|0
390483|NCT00797966|1310665|P2|Phase A|Lost to Follow-up|0
390484|NCT00797966|1310666|P1|Phase A|Lost to Follow-up|0
390485|NCT00797862|1310731|P3|Overall Study|Mis-randomized|1
390486|NCT00797862|1310732|P2|Overall Study|Mis-randomized|3
390487|NCT00797862|1310733|P1|Overall Study|Mis-randomized|3
390488|NCT00797862|1310731|P3|Overall Study|Protocol Violation|8
390489|NCT00797862|1310732|P2|Overall Study|Protocol Violation|6
390490|NCT00797862|1310733|P1|Overall Study|Protocol Violation|4
390491|NCT00797862|1310731|P3|Overall Study|Administrative Problem|0
390492|NCT00797862|1310732|P2|Overall Study|Administrative Problem|0
390493|NCT00797862|1310733|P1|Overall Study|Administrative Problem|4
390494|NCT00797862|1310731|P3|Overall Study|Lost to Follow-up|5
390495|NCT00797862|1310732|P2|Overall Study|Lost to Follow-up|0
390496|NCT00797862|1310733|P1|Overall Study|Lost to Follow-up|11
390497|NCT00797862|1310731|P3|Overall Study|Withdrawal by Subject|7
390498|NCT00797862|1310732|P2|Overall Study|Withdrawal by Subject|7
390499|NCT00797862|1310733|P1|Overall Study|Withdrawal by Subject|14
390500|NCT00797862|1310731|P3|Overall Study|No longer required study medication|0
390501|NCT00797862|1310732|P2|Overall Study|No longer required study medication|0
390502|NCT00797862|1310733|P1|Overall Study|No longer required study medication|1
390503|NCT00797862|1310731|P3|Overall Study|Lack of Efficacy|6
390504|NCT00797862|1310732|P2|Overall Study|Lack of Efficacy|7
390505|NCT00797862|1310733|P1|Overall Study|Lack of Efficacy|1
390506|NCT00797862|1310731|P3|Overall Study|Abnormal Test Procedure Result|1
390507|NCT00797862|1310732|P2|Overall Study|Abnormal Test Procedure Result|1
390508|NCT00797862|1310733|P1|Overall Study|Abnormal Test Procedure Result|0
390509|NCT00797862|1310731|P3|Overall Study|Adverse Event|58
390510|NCT00797862|1310732|P2|Overall Study|Adverse Event|44
390511|NCT00797862|1310733|P1|Overall Study|Adverse Event|86
390512|NCT00797823|1310762|P3|First Period (Initial Randomization)|Physician Decision|0
390513|NCT00797823|1310763|P2|First Period (Initial Randomization)|Physician Decision|0
390514|NCT00797823|1310764|P1|First Period (Initial Randomization)|Physician Decision|1
390515|NCT00797732|1310786|P3|Overall Study|Refused to Participate|123
390516|NCT00797732|1310787|P2|Overall Study|Refused to Participate|0
390517|NCT00797732|1310788|P1|Overall Study|Refused to Participate|0
390518|NCT00797732|1310786|P3|Overall Study|Excluded due to time constraints|24
390519|NCT00797732|1310787|P2|Overall Study|Excluded due to time constraints|0
390520|NCT00797732|1310788|P1|Overall Study|Excluded due to time constraints|0
390521|NCT00797732|1310786|P3|Overall Study|Not meet inclusion criteria|7
390522|NCT00797732|1310787|P2|Overall Study|Not meet inclusion criteria|0
390523|NCT00797732|1310788|P1|Overall Study|Not meet inclusion criteria|0
390524|NCT00797732|1310786|P3|Overall Study|Death|0
390525|NCT00797732|1310787|P2|Overall Study|Death|0
390526|NCT00797732|1310788|P1|Overall Study|Death|1
390527|NCT00797732|1310786|P3|Overall Study|Lost to Follow-up|0
390528|NCT00797732|1310787|P2|Overall Study|Lost to Follow-up|0
390529|NCT00797732|1310788|P1|Overall Study|Lost to Follow-up|1
390530|NCT00797732|1310786|P3|Overall Study|Withdrawal by Subject|0
390531|NCT00797732|1310787|P2|Overall Study|Withdrawal by Subject|3
390532|NCT00797732|1310788|P1|Overall Study|Withdrawal by Subject|3
390533|NCT00797667|1310803|P3|Overall Study|Adverse Event|8
390534|NCT00797667|1310804|P2|Overall Study|Adverse Event|8
390535|NCT00797667|1310805|P1|Overall Study|Adverse Event|19
390536|NCT00797667|1310803|P3|Overall Study|Withdrawal by Subject|2
390537|NCT00797667|1310804|P2|Overall Study|Withdrawal by Subject|14
390538|NCT00797667|1310805|P1|Overall Study|Withdrawal by Subject|9
390539|NCT00797667|1310803|P3|Overall Study|Study Terminated by Sponsor|115
390540|NCT00797667|1310804|P2|Overall Study|Study Terminated by Sponsor|216
390541|NCT00797667|1310805|P1|Overall Study|Study Terminated by Sponsor|217
390542|NCT00797667|1310803|P3|Overall Study|Protocol Violation|0
390543|NCT00797667|1310804|P2|Overall Study|Protocol Violation|7
390544|NCT00797667|1310805|P1|Overall Study|Protocol Violation|2
390545|NCT00797667|1310803|P3|Overall Study|Pregnancy|0
390546|NCT00797667|1310804|P2|Overall Study|Pregnancy|0
390547|NCT00797667|1310805|P1|Overall Study|Pregnancy|2
390548|NCT00797667|1310803|P3|Overall Study|Physician Decision|0
390549|NCT00797667|1310804|P2|Overall Study|Physician Decision|1
390550|NCT00797667|1310805|P1|Overall Study|Physician Decision|3
390551|NCT00797667|1310803|P3|Overall Study|Lost to Follow-up|2
390552|NCT00797667|1310804|P2|Overall Study|Lost to Follow-up|12
390553|NCT00797667|1310805|P1|Overall Study|Lost to Follow-up|8
390554|NCT00797667|1310803|P3|Overall Study|Lack of Efficacy|0
390555|NCT00797667|1310804|P2|Overall Study|Lack of Efficacy|1
390556|NCT00797667|1310805|P1|Overall Study|Lack of Efficacy|0
390557|NCT00797563|1310831|P1|Overall Study|Adverse Event|1
390558|NCT00797511|1310837|P1|Overall Study|Withdrawal by Subject|1
390559|NCT00797316|1310855|P2|Overall Study|Unsatisfactory therapeutic effect|13
390560|NCT00797316|1310856|P1|Overall Study|Unsatisfactory therapeutic effect|0
390561|NCT00797316|1310855|P2|Overall Study|Patient withdrew consent|6
390562|NCT00797316|1310856|P1|Overall Study|Patient withdrew consent|12
390563|NCT00797316|1310855|P2|Overall Study|Protocol Deviation|2
390564|NCT00797316|1310856|P1|Overall Study|Protocol Deviation|1
390565|NCT00797316|1310855|P2|Overall Study|Lost to Follow-up|8
390566|NCT00797316|1310856|P1|Overall Study|Lost to Follow-up|4
390567|NCT00797316|1310855|P2|Overall Study|Adverse Event|3
390568|NCT00797316|1310856|P1|Overall Study|Adverse Event|5
390569|NCT00797316|1310855|P2|Overall Study|Administrative problems|0
390570|NCT00797316|1310856|P1|Overall Study|Administrative problems|1
390571|NCT00797108|1310890|P3|Overall Study|Randomized but not Treated|0
390572|NCT00797108|1310891|P2|Overall Study|Randomized but not Treated|0
390573|NCT00797108|1310892|P1|Overall Study|Randomized but not Treated|2
390574|NCT00797108|1310890|P3|Overall Study|Other|2
390575|NCT00797108|1310891|P2|Overall Study|Other|0
390576|NCT00797108|1310892|P1|Overall Study|Other|0
390577|NCT00797108|1310890|P3|Overall Study|Lack of Efficacy|1
390578|NCT00797108|1310891|P2|Overall Study|Lack of Efficacy|0
390579|NCT00797108|1310892|P1|Overall Study|Lack of Efficacy|1
390580|NCT00797108|1310890|P3|Overall Study|Global Deterioration of Health Status|0
390581|NCT00797108|1310891|P2|Overall Study|Global Deterioration of Health Status|1
390582|NCT00797108|1310892|P1|Overall Study|Global Deterioration of Health Status|0
390583|NCT00797108|1310890|P3|Overall Study|Did Not Meet Entrance Criteria|0
390584|NCT00797108|1310891|P2|Overall Study|Did Not Meet Entrance Criteria|1
390585|NCT00797108|1310892|P1|Overall Study|Did Not Meet Entrance Criteria|0
390586|NCT00797108|1310890|P3|Overall Study|Adverse Event|3
390587|NCT00797108|1310891|P2|Overall Study|Adverse Event|0
390588|NCT00797108|1310892|P1|Overall Study|Adverse Event|1
390589|NCT00796991|1310927|P3|Overall Study|Withdrawal by Subject|1
390590|NCT00796991|1310928|P2|Overall Study|Withdrawal by Subject|0
390591|NCT00796991|1310929|P1|Overall Study|Withdrawal by Subject|0
390592|NCT00796991|1310927|P3|Overall Study|Study Drug Toxicity|5
390593|NCT00796991|1310928|P2|Overall Study|Study Drug Toxicity|3
390594|NCT00796991|1310929|P1|Overall Study|Study Drug Toxicity|3
390595|NCT00796991|1310927|P3|Overall Study|Disease Progression|7
390596|NCT00796991|1310928|P2|Overall Study|Disease Progression|9
390597|NCT00796991|1310929|P1|Overall Study|Disease Progression|10
390598|NCT00796991|1310927|P3|Overall Study|Death|0
390599|NCT00796991|1310928|P2|Overall Study|Death|0
390600|NCT00796991|1310929|P1|Overall Study|Death|2
390601|NCT00796991|1310927|P3|Overall Study|Adverse Event|1
390602|NCT00796991|1310928|P2|Overall Study|Adverse Event|0
390603|NCT00796991|1310929|P1|Overall Study|Adverse Event|0
390604|NCT00796861|1311036|P1|Overall Study|Death|2
390605|NCT00796861|1311036|P1|Overall Study|Withdrawal by Subject|2
390606|NCT00796822|1311042|P2|Overall Study|Adverse Event|0
390607|NCT00796822|1311043|P1|Overall Study|Adverse Event|1
390608|NCT00796822|1311042|P2|Overall Study|Lost to Follow-up|0
390609|NCT00796822|1311043|P1|Overall Study|Lost to Follow-up|2
390610|NCT00796757|1311051|P1|Overall Study|Not specified|7
390611|NCT00796757|1311051|P1|Overall Study|Investigator's decision|2
390612|NCT00796757|1311051|P1|Overall Study|Participant noncompliance|1
390613|NCT00796757|1311051|P1|Overall Study|Protocol Violation|1
390614|NCT00796757|1311051|P1|Overall Study|Death|61
390615|NCT00796757|1311051|P1|Overall Study|Withdrawal by Subject|14
390616|NCT00796718|1311085|P1|Overall Study|Withdrawal by Informed Consent|1
390617|NCT00796718|1311085|P1|Overall Study|Lost to Follow-up|5
390618|NCT00796718|1311085|P1|Overall Study|Exclusion Criteria|1
390619|NCT00796718|1311085|P1|Overall Study|Adverse Event|2
390620|NCT00796666|1311137|P2|Overall Study|Randomized and not treated|0
390621|NCT00796666|1311138|P1|Overall Study|Randomized and not treated|1
390622|NCT00796666|1311137|P2|Overall Study|Terminated by sponsor|55
390623|NCT00796666|1311138|P1|Overall Study|Terminated by sponsor|53
390624|NCT00796666|1311137|P2|Overall Study|Other|0
390625|NCT00796666|1311138|P1|Overall Study|Other|1
390626|NCT00796666|1311137|P2|Overall Study|Protocol Violation|0
390627|NCT00796666|1311138|P1|Overall Study|Protocol Violation|1
390628|NCT00796666|1311137|P2|Overall Study|Adverse Event|5
390629|NCT00796666|1311138|P1|Overall Study|Adverse Event|7
390630|NCT00796666|1311137|P2|Overall Study|Withdrawal by Subject|0
390631|NCT00796666|1311138|P1|Overall Study|Withdrawal by Subject|2
390632|NCT00796666|1311137|P2|Overall Study|Death|4
390633|NCT00796666|1311138|P1|Overall Study|Death|2
390634|NCT00796653|1311172|P4|Overall Study|Other reason not described above|4
390635|NCT00796653|1311173|P3|Overall Study|Other reason not described above|7
390636|NCT00796653|1311174|P2|Overall Study|Other reason not described above|9
390637|NCT00796653|1311175|P1|Overall Study|Other reason not described above|4
390638|NCT00796653|1311172|P4|Overall Study|Non compliance with protocol|2
390639|NCT00796653|1311173|P3|Overall Study|Non compliance with protocol|0
390640|NCT00796653|1311174|P2|Overall Study|Non compliance with protocol|2
390641|NCT00796653|1311175|P1|Overall Study|Non compliance with protocol|2
390642|NCT00796653|1311172|P4|Overall Study|Lack of Efficacy|2
390643|NCT00796653|1311173|P3|Overall Study|Lack of Efficacy|3
390644|NCT00796653|1311174|P2|Overall Study|Lack of Efficacy|1
390645|NCT00796653|1311175|P1|Overall Study|Lack of Efficacy|8
390646|NCT00796653|1311172|P4|Overall Study|Withdrawal by Subject|13
390647|NCT00796653|1311173|P3|Overall Study|Withdrawal by Subject|8
390648|NCT00796653|1311174|P2|Overall Study|Withdrawal by Subject|8
390649|NCT00796653|1311175|P1|Overall Study|Withdrawal by Subject|16
390650|NCT00796653|1311172|P4|Overall Study|Lost to Follow-up|3
390651|NCT00796653|1311173|P3|Overall Study|Lost to Follow-up|2
390652|NCT00796653|1311174|P2|Overall Study|Lost to Follow-up|1
390653|NCT00796653|1311175|P1|Overall Study|Lost to Follow-up|2
390654|NCT00796653|1311172|P4|Overall Study|Adverse Event|16
390655|NCT00796653|1311173|P3|Overall Study|Adverse Event|16
390656|NCT00796653|1311174|P2|Overall Study|Adverse Event|16
390657|NCT00796653|1311175|P1|Overall Study|Adverse Event|19
390658|NCT00796614|1311460|P4|Overall Study|Other than stated|0
390659|NCT00796614|1311461|P3|Overall Study|Other than stated|0
390660|NCT00796614|1311462|P2|Overall Study|Other than stated|0
390661|NCT00796614|1311463|P1|Overall Study|Other than stated|1
390662|NCT00796614|1311460|P4|Overall Study|Withdrawal by Subject|1
390663|NCT00796614|1311461|P3|Overall Study|Withdrawal by Subject|0
390664|NCT00796614|1311462|P2|Overall Study|Withdrawal by Subject|0
390665|NCT00796614|1311463|P1|Overall Study|Withdrawal by Subject|1
390666|NCT00796614|1311460|P4|Overall Study|Lost to Follow-up|0
390667|NCT00796614|1311461|P3|Overall Study|Lost to Follow-up|1
390668|NCT00796614|1311462|P2|Overall Study|Lost to Follow-up|2
390669|NCT00796614|1311463|P1|Overall Study|Lost to Follow-up|2
390670|NCT00796614|1311460|P4|Overall Study|Protocol Violation|0
390671|NCT00796614|1311461|P3|Overall Study|Protocol Violation|2
390672|NCT00796614|1311462|P2|Overall Study|Protocol Violation|0
390673|NCT00796614|1311463|P1|Overall Study|Protocol Violation|0
390674|NCT00796614|1311460|P4|Overall Study|Adverse Event|0
390675|NCT00796614|1311461|P3|Overall Study|Adverse Event|0
390676|NCT00796614|1311462|P2|Overall Study|Adverse Event|2
390677|NCT00796614|1311463|P1|Overall Study|Adverse Event|1
390678|NCT00796549|1311505|P1|Overall Study|Progressive disease|56
390679|NCT00796549|1311505|P1|Overall Study|Other|2
390680|NCT00796549|1311505|P1|Overall Study|not entered|149
390681|NCT00796549|1311505|P1|Overall Study|Adverse Event|11
390682|NCT00796523|1311522|P2|Overall Study|Lost to Follow-up|7
390683|NCT00796523|1311523|P1|Overall Study|Lost to Follow-up|9
390684|NCT00796510|1311533|P2|Overall Study|Study Terminated|0
390685|NCT00796510|1311534|P1|Overall Study|Study Terminated|2
390686|NCT00796510|1311533|P2|Overall Study|Death|0
390687|NCT00796510|1311534|P1|Overall Study|Death|1
390688|NCT00796419|1311546|P2|Overall Study|Death|1
390689|NCT00796419|1311547|P1|Overall Study|Death|0
390690|NCT00796367|1311560|P3|Overall Study|other|3
390691|NCT00796367|1311561|P2|Overall Study|other|4
390692|NCT00796367|1311562|P1|Overall Study|other|2
390693|NCT00796367|1311560|P3|Overall Study|Requirement for restricted medication|2
390694|NCT00796367|1311561|P2|Overall Study|Requirement for restricted medication|0
390695|NCT00796367|1311562|P1|Overall Study|Requirement for restricted medication|2
390696|NCT00796367|1311560|P3|Overall Study|Pregnancy|1
390697|NCT00796367|1311561|P2|Overall Study|Pregnancy|0
390698|NCT00796367|1311562|P1|Overall Study|Pregnancy|1
390699|NCT00796367|1311560|P3|Overall Study|non compliance|1
390700|NCT00796367|1311561|P2|Overall Study|non compliance|1
390701|NCT00796367|1311562|P1|Overall Study|non compliance|3
390702|NCT00796367|1311560|P3|Overall Study|Lack of Efficacy|0
390703|NCT00796367|1311561|P2|Overall Study|Lack of Efficacy|1
390704|NCT00796367|1311562|P1|Overall Study|Lack of Efficacy|2
390705|NCT00796367|1311560|P3|Overall Study|Withdrawal by Subject|12
390706|NCT00796367|1311561|P2|Overall Study|Withdrawal by Subject|11
390707|NCT00796367|1311562|P1|Overall Study|Withdrawal by Subject|9
390708|NCT00796367|1311560|P3|Overall Study|Lost to Follow-up|21
390709|NCT00796367|1311561|P2|Overall Study|Lost to Follow-up|4
390710|NCT00796367|1311562|P1|Overall Study|Lost to Follow-up|5
390711|NCT00796367|1311560|P3|Overall Study|Adverse Event|7
390712|NCT00796367|1311561|P2|Overall Study|Adverse Event|4
390713|NCT00796367|1311562|P1|Overall Study|Adverse Event|6
390714|NCT00796328|1311573|P1|Overall Study|experienced hypotension requiring tx|6
390715|NCT00796315|1311577|P3|Overall Study|Protocol Violation|0
390716|NCT00796315|1311578|P2|Overall Study|Protocol Violation|1
390717|NCT00796315|1311579|P1|Overall Study|Protocol Violation|0
390718|NCT00796224|1311607|P2|Overall Study|Protocol Violation|1
390719|NCT00796224|1311608|P1|Overall Study|Protocol Violation|0
390720|NCT00796224|1311607|P2|Overall Study|Adverse Event|0
390721|NCT00796224|1311608|P1|Overall Study|Adverse Event|1
390722|NCT00796120|1311628|P2|Overall Study|Randomized but not treated|3
390723|NCT00796120|1311629|P1|Overall Study|Randomized but not treated|0
390724|NCT00796120|1311628|P2|Overall Study|Physician Decision|17
390725|NCT00796120|1311629|P1|Overall Study|Physician Decision|16
390726|NCT00796120|1311628|P2|Overall Study|Other|17
390727|NCT00796120|1311629|P1|Overall Study|Other|6
390728|NCT00796120|1311628|P2|Overall Study|Participant refusal|4
390729|NCT00796120|1311629|P1|Overall Study|Participant refusal|3
390730|NCT00796120|1311628|P2|Overall Study|Progressive disease|13
390731|NCT00796120|1311629|P1|Overall Study|Progressive disease|22
390732|NCT00796120|1311628|P2|Overall Study|Adverse Event|6
390733|NCT00796120|1311629|P1|Overall Study|Adverse Event|11
390734|NCT00796120|1311628|P2|Overall Study|Death|0
390735|NCT00796120|1311629|P1|Overall Study|Death|3
390736|NCT00796003|1311645|P2|Overall Study|Participants Not treated|2
390737|NCT00796003|1311646|P1|Overall Study|Participants Not treated|0
390738|NCT00796003|1311645|P2|Overall Study|Other|1
390739|NCT00796003|1311646|P1|Overall Study|Other|0
390740|NCT00796003|1311645|P2|Overall Study|Withdrawal by Subject|1
390741|NCT00796003|1311646|P1|Overall Study|Withdrawal by Subject|0
390742|NCT00796003|1311645|P2|Overall Study|Physician Decision|4
390743|NCT00796003|1311646|P1|Overall Study|Physician Decision|0
390744|NCT00796003|1311645|P2|Overall Study|Specified organ function not met|1
390745|NCT00796003|1311646|P1|Overall Study|Specified organ function not met|0
390746|NCT00796003|1311645|P2|Overall Study|Adverse Event|7
390747|NCT00796003|1311646|P1|Overall Study|Adverse Event|1
390748|NCT00796003|1311645|P2|Overall Study|Disease Progression|13
390749|NCT00796003|1311646|P1|Overall Study|Disease Progression|2
390750|NCT00795951|1311667|P1|Overall Study|Withdrawal by Subject|1
390751|NCT00795951|1311667|P1|Overall Study|Lost to Follow-up|1
390752|NCT00795886|1311704|P1|Overall Study|Death|10
390753|NCT00795821|1311712|P2|Taper Phase|Withdrawal by Subject|0
390754|NCT00795821|1311713|P1|Taper Phase|Withdrawal by Subject|4
390755|NCT00795821|1311712|P2|Taper Phase|Physician Decision|0
390756|NCT00795821|1311713|P1|Taper Phase|Physician Decision|2
390757|NCT00795821|1311712|P2|Taper Phase|Lost to Follow-up|0
390758|NCT00795821|1311713|P1|Taper Phase|Lost to Follow-up|1
390759|NCT00795821|1311712|P2|Taper Phase|Adverse Event|0
390760|NCT00795821|1311713|P1|Taper Phase|Adverse Event|2
390761|NCT00795821|1311712|P2|Long-term Extension Phase|Withdrawal by Subject|25
390762|NCT00795821|1311713|P1|Long-term Extension Phase|Withdrawal by Subject|25
390763|NCT00795821|1311712|P2|Long-term Extension Phase|Protocol Violation|5
390764|NCT00795821|1311713|P1|Long-term Extension Phase|Protocol Violation|3
390765|NCT00795821|1311712|P2|Long-term Extension Phase|Physician Decision|2
390766|NCT00795821|1311713|P1|Long-term Extension Phase|Physician Decision|1
390767|NCT00795821|1311712|P2|Long-term Extension Phase|Lost to Follow-up|16
390768|NCT00795821|1311713|P1|Long-term Extension Phase|Lost to Follow-up|20
390769|NCT00795821|1311712|P2|Long-term Extension Phase|Lack of Efficacy|12
390770|NCT00795821|1311713|P1|Long-term Extension Phase|Lack of Efficacy|16
390771|NCT00795821|1311712|P2|Long-term Extension Phase|Adverse Event|32
390772|NCT00795821|1311713|P1|Long-term Extension Phase|Adverse Event|25
390773|NCT00795821|1311712|P2|Acute Treatment Phase|Withdrawal by Subject|10
390774|NCT00795821|1311713|P1|Acute Treatment Phase|Withdrawal by Subject|16
390775|NCT00795821|1311712|P2|Acute Treatment Phase|Protocol Violation|2
390776|NCT00795821|1311713|P1|Acute Treatment Phase|Protocol Violation|1
390777|NCT00795821|1311712|P2|Acute Treatment Phase|Physician Decision|1
390778|NCT00795821|1311713|P1|Acute Treatment Phase|Physician Decision|1
390779|NCT00795821|1311712|P2|Acute Treatment Phase|Lost to Follow-up|12
390780|NCT00795821|1311713|P1|Acute Treatment Phase|Lost to Follow-up|9
390781|NCT00795821|1311712|P2|Acute Treatment Phase|Lack of Efficacy|2
390782|NCT00795821|1311713|P1|Acute Treatment Phase|Lack of Efficacy|5
390783|NCT00795821|1311712|P2|Acute Treatment Phase|Death|0
390784|NCT00795821|1311713|P1|Acute Treatment Phase|Death|1
390785|NCT00795821|1311712|P2|Acute Treatment Phase|Adverse Event|4
390786|NCT00795821|1311713|P1|Acute Treatment Phase|Adverse Event|23
390787|NCT00795717|1311788|P2|Phase II|too busy|1
390788|NCT00795717|1311789|P1|Phase II|too busy|0
390789|NCT00795717|1311788|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
390790|NCT00795717|1311789|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
390791|NCT00795717|1311788|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
390792|NCT00795717|1311789|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
390793|NCT00795717|1311788|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
390794|NCT00795717|1311789|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
390795|NCT00795704|1311801|P2|Overall Study|Adverse Event|1
390796|NCT00795704|1311802|P1|Overall Study|Adverse Event|1
390797|NCT00795704|1311801|P2|Overall Study|Withdrawal by Subject|2
390798|NCT00795704|1311802|P1|Overall Study|Withdrawal by Subject|3
390799|NCT00795639|1311814|P2|Overall Study|Randomized and not treated|1
390800|NCT00795639|1311815|P1|Overall Study|Randomized and not treated|0
390801|NCT00795639|1311814|P2|Overall Study|Terminated by sponsor|12
390802|NCT00795639|1311815|P1|Overall Study|Terminated by sponsor|13
390803|NCT00795639|1311814|P2|Overall Study|Other|2
390804|NCT00795639|1311815|P1|Overall Study|Other|0
390805|NCT00795639|1311814|P2|Overall Study|Adverse Event|2
390806|NCT00795639|1311815|P1|Overall Study|Adverse Event|5
390807|NCT00795639|1311814|P2|Overall Study|Pregnancy|0
390808|NCT00795639|1311815|P1|Overall Study|Pregnancy|1
390809|NCT00795639|1311814|P2|Overall Study|Withdrawal by Subject|3
390810|NCT00795639|1311815|P1|Overall Study|Withdrawal by Subject|1
390811|NCT00795639|1311814|P2|Overall Study|Death|6
390812|NCT00795639|1311815|P1|Overall Study|Death|1
390813|NCT00795600|1311827|P2|Overall Study|Unclassified|1
390814|NCT00795600|1311828|P1|Overall Study|Unclassified|1
390815|NCT00795600|1311827|P2|Overall Study|Withdrawal by Subject|0
390816|NCT00795600|1311828|P1|Overall Study|Withdrawal by Subject|1
390817|NCT00795600|1311827|P2|Overall Study|Protocol Violation|2
390818|NCT00795600|1311828|P1|Overall Study|Protocol Violation|1
390819|NCT00795600|1311827|P2|Overall Study|Adverse Event|1
390820|NCT00795600|1311828|P1|Overall Study|Adverse Event|1
390821|NCT00795535|1311948|P1|Overall Study|incomplete data and technical problems|20
390822|NCT00795509|1311955|P1|Overall Study|Protocol Violation|31
390823|NCT00795184|1312011|P2|Overall Study|Tissue sampling incomplete/conclusive|13
390824|NCT00795184|1312012|P1|Overall Study|Tissue sampling incomplete/conclusive|8
390825|NCT00795132|1312073|P1|Overall Study|Relapse|2
390826|NCT00795132|1312073|P1|Overall Study|Death|1
390827|NCT00794963|1312096|P2|Overall Study|Withdrawal by Subject|4
390828|NCT00794963|1312097|P1|Overall Study|Withdrawal by Subject|1
390829|NCT00794924|1312105|P2|Overall Study|Adverse Event|2
390830|NCT00794924|1312106|P1|Overall Study|Adverse Event|6
390831|NCT00794924|1312105|P2|Overall Study|Withdrawal by Subject|60
390832|NCT00794924|1312106|P1|Overall Study|Withdrawal by Subject|48
390833|NCT00794924|1312105|P2|Overall Study|Lost to Follow-up|8
390834|NCT00794924|1312106|P1|Overall Study|Lost to Follow-up|6
390835|NCT00794820|1312110|P1|Overall Study|Ineligible/Screen Failure|1
390836|NCT00794820|1312110|P1|Overall Study|Resistant Disease|2
390837|NCT00794820|1312110|P1|Overall Study|Secondary Malignancies|2
390838|NCT00794820|1312110|P1|Overall Study|Adverse Event|11
390839|NCT00794677|1312118|P2|First Intervention|Withdrawal by Subject|0
390840|NCT00794677|1312119|P1|First Intervention|Withdrawal by Subject|2
390841|NCT00794664|1312141|P2|Follow-up Period|Protocol non-compliance|1
390842|NCT00794664|1312142|P1|Follow-up Period|Protocol non-compliance|0
390843|NCT00794664|1312141|P2|Follow-up Period|Withdrawal by Subject|2
390844|NCT00794664|1312142|P1|Follow-up Period|Withdrawal by Subject|0
390845|NCT00794664|1312141|P2|Follow-up Period|Not specified|2
390846|NCT00794664|1312142|P1|Follow-up Period|Not specified|1
390847|NCT00794664|1312141|P2|Treatment Period|Adverse Event|8
390848|NCT00794664|1312142|P1|Treatment Period|Adverse Event|1
390849|NCT00794664|1312141|P2|Treatment Period|Not specified|1
390850|NCT00794664|1312142|P1|Treatment Period|Not specified|0
390851|NCT00794664|1312141|P2|Treatment Period|Protocol non-compliance|1
390852|NCT00794664|1312142|P1|Treatment Period|Protocol non-compliance|0
390853|NCT00794664|1312141|P2|Treatment Period|Withdrawal by Subject|2
390854|NCT00794664|1312142|P1|Treatment Period|Withdrawal by Subject|0
390855|NCT00794365|1312227|P1|Overall Study|Lack of Efficacy|3
390856|NCT00794365|1312227|P1|Overall Study|Adverse Event|10
390857|NCT00794365|1312227|P1|Overall Study|Poor Compliance|11
390858|NCT00794365|1312227|P1|Overall Study|Other|17
390859|NCT00794365|1312227|P1|Overall Study|Lost to Follow-up|38
390860|NCT00794196|1312248|P2|Overall Study|Lost to Follow-up|23
390861|NCT00794196|1312249|P1|Overall Study|Lost to Follow-up|5
390862|NCT00794157|1312269|P3|Overall Study|Protocol deviation|1
390863|NCT00794157|1312270|P2|Overall Study|Protocol deviation|1
390864|NCT00794157|1312271|P1|Overall Study|Protocol deviation|0
390865|NCT00794157|1312269|P3|Overall Study|Abnormal test procedure result(s)|0
390866|NCT00794157|1312270|P2|Overall Study|Abnormal test procedure result(s)|1
390867|NCT00794157|1312271|P1|Overall Study|Abnormal test procedure result(s)|0
390868|NCT00794157|1312269|P3|Overall Study|Administrative problems|4
390869|NCT00794157|1312270|P2|Overall Study|Administrative problems|7
390870|NCT00794157|1312271|P1|Overall Study|Administrative problems|1
390871|NCT00794157|1312269|P3|Overall Study|Unsatisfactory therapeutic effect|2
390872|NCT00794157|1312270|P2|Overall Study|Unsatisfactory therapeutic effect|0
390873|NCT00794157|1312271|P1|Overall Study|Unsatisfactory therapeutic effect|1
390874|NCT00794157|1312269|P3|Overall Study|Lost to Follow-up|1
390875|NCT00794157|1312270|P2|Overall Study|Lost to Follow-up|0
390876|NCT00794157|1312271|P1|Overall Study|Lost to Follow-up|2
390877|NCT00794157|1312269|P3|Overall Study|Subject withdrew consent|3
390878|NCT00794157|1312270|P2|Overall Study|Subject withdrew consent|0
390879|NCT00794157|1312271|P1|Overall Study|Subject withdrew consent|2
390880|NCT00794157|1312269|P3|Overall Study|Adverse Event|8
390881|NCT00794157|1312270|P2|Overall Study|Adverse Event|1
390882|NCT00794157|1312271|P1|Overall Study|Adverse Event|4
390883|NCT00794118|1312300|P1|Overall Study|Changed hospital center|2
390884|NCT00794118|1312300|P1|Overall Study|Withdrawal by Subject|9
390885|NCT00794118|1312300|P1|Overall Study|Lost to Follow-up|16
390886|NCT00793910|1312358|P2|Overall Study|Withdrawal by Subject|1
390887|NCT00793910|1312359|P1|Overall Study|Withdrawal by Subject|0
390888|NCT00793910|1312358|P2|Overall Study|decided to undergo LASIK instead of PRK|1
390889|NCT00793910|1312359|P1|Overall Study|decided to undergo LASIK instead of PRK|2
390890|NCT00793910|1312358|P2|Overall Study|ineligible based on entry criteria|3
390891|NCT00793910|1312359|P1|Overall Study|ineligible based on entry criteria|2
390892|NCT00793910|1312358|P2|Overall Study|did not pick up medications|1
390893|NCT00793910|1312359|P1|Overall Study|did not pick up medications|1
390894|NCT00793910|1312358|P2|Overall Study|discarded study pills|1
390895|NCT00793910|1312359|P1|Overall Study|discarded study pills|0
390896|NCT00793871|1312373|P1|Overall Study|Study terminated by the Sponsor|7
390897|NCT00793871|1312373|P1|Overall Study|Lost to Follow-up|3
390898|NCT00793871|1312373|P1|Overall Study|Death|50
390899|NCT00793819|1312387|P2|Overall Study|Lost to Follow-up|1
390900|NCT00793819|1312388|P1|Overall Study|Lost to Follow-up|1
390901|NCT00793819|1312387|P2|Overall Study|Withdrawal by Subject|3
390902|NCT00793819|1312388|P1|Overall Study|Withdrawal by Subject|4
390903|NCT00793819|1312387|P2|Overall Study|Lack of Efficacy|1
390904|NCT00793819|1312388|P1|Overall Study|Lack of Efficacy|1
390905|NCT00793819|1312387|P2|Overall Study|Adverse Event|4
390906|NCT00793819|1312388|P1|Overall Study|Adverse Event|8
390907|NCT00793793|1312406|P12|Overall Study|reason not specified|4
390908|NCT00793793|1312407|P11|Overall Study|reason not specified|2
390909|NCT00793793|1312408|P10|Overall Study|reason not specified|6
390910|NCT00793793|1312409|P9|Overall Study|reason not specified|7
390911|NCT00793793|1312410|P8|Overall Study|reason not specified|0
390912|NCT00793793|1312411|P7|Overall Study|reason not specified|2
390913|NCT00793793|1312412|P6|Overall Study|reason not specified|1
390914|NCT00793793|1312413|P5|Overall Study|reason not specified|1
390915|NCT00793793|1312414|P4|Overall Study|reason not specified|1
390916|NCT00793793|1312415|P3|Overall Study|reason not specified|0
390917|NCT00793793|1312416|P2|Overall Study|reason not specified|1
390918|NCT00793793|1312417|P1|Overall Study|reason not specified|0
390919|NCT00793793|1312406|P12|Overall Study|Withdrawal by Subject|0
390920|NCT00793793|1312407|P11|Overall Study|Withdrawal by Subject|0
390921|NCT00793793|1312408|P10|Overall Study|Withdrawal by Subject|0
390922|NCT00793793|1312409|P9|Overall Study|Withdrawal by Subject|1
390923|NCT00793793|1312410|P8|Overall Study|Withdrawal by Subject|0
390924|NCT00793793|1312411|P7|Overall Study|Withdrawal by Subject|0
390925|NCT00793793|1312412|P6|Overall Study|Withdrawal by Subject|0
390926|NCT00793793|1312413|P5|Overall Study|Withdrawal by Subject|1
390927|NCT00793793|1312414|P4|Overall Study|Withdrawal by Subject|0
390928|NCT00793793|1312415|P3|Overall Study|Withdrawal by Subject|0
390929|NCT00793793|1312416|P2|Overall Study|Withdrawal by Subject|0
390930|NCT00793793|1312417|P1|Overall Study|Withdrawal by Subject|0
390931|NCT00793793|1312406|P12|Overall Study|Lost to Follow-up|0
390932|NCT00793793|1312407|P11|Overall Study|Lost to Follow-up|1
390933|NCT00793793|1312408|P10|Overall Study|Lost to Follow-up|3
390934|NCT00793793|1312409|P9|Overall Study|Lost to Follow-up|1
390935|NCT00793793|1312410|P8|Overall Study|Lost to Follow-up|0
390936|NCT00793793|1312411|P7|Overall Study|Lost to Follow-up|0
390937|NCT00793793|1312412|P6|Overall Study|Lost to Follow-up|0
390938|NCT00793793|1312413|P5|Overall Study|Lost to Follow-up|0
390939|NCT00793793|1312414|P4|Overall Study|Lost to Follow-up|0
390940|NCT00793793|1312415|P3|Overall Study|Lost to Follow-up|1
390941|NCT00793793|1312416|P2|Overall Study|Lost to Follow-up|0
390942|NCT00793793|1312417|P1|Overall Study|Lost to Follow-up|0
390943|NCT00793793|1312406|P12|Overall Study|Protocol Violation|0
390944|NCT00793793|1312407|P11|Overall Study|Protocol Violation|0
390945|NCT00793793|1312408|P10|Overall Study|Protocol Violation|0
390946|NCT00793793|1312409|P9|Overall Study|Protocol Violation|0
390947|NCT00793793|1312410|P8|Overall Study|Protocol Violation|0
390948|NCT00793793|1312411|P7|Overall Study|Protocol Violation|0
390949|NCT00793793|1312412|P6|Overall Study|Protocol Violation|0
390950|NCT00793793|1312413|P5|Overall Study|Protocol Violation|0
390951|NCT00793793|1312414|P4|Overall Study|Protocol Violation|1
390952|NCT00793793|1312415|P3|Overall Study|Protocol Violation|0
390953|NCT00793793|1312416|P2|Overall Study|Protocol Violation|0
390954|NCT00793793|1312417|P1|Overall Study|Protocol Violation|0
390955|NCT00793793|1312406|P12|Overall Study|Adverse Event|2
390956|NCT00793793|1312407|P11|Overall Study|Adverse Event|0
390957|NCT00793793|1312408|P10|Overall Study|Adverse Event|0
390958|NCT00793793|1312409|P9|Overall Study|Adverse Event|0
390959|NCT00793793|1312410|P8|Overall Study|Adverse Event|0
390960|NCT00793793|1312411|P7|Overall Study|Adverse Event|2
390961|NCT00793793|1312412|P6|Overall Study|Adverse Event|1
390962|NCT00793793|1312413|P5|Overall Study|Adverse Event|0
390963|NCT00793793|1312414|P4|Overall Study|Adverse Event|1
390964|NCT00793793|1312415|P3|Overall Study|Adverse Event|1
390965|NCT00793793|1312416|P2|Overall Study|Adverse Event|0
390966|NCT00793793|1312417|P1|Overall Study|Adverse Event|0
390967|NCT00793780|1312792|P2|Overall Study|Withdrawal by Subject|1
390968|NCT00793780|1312793|P1|Overall Study|Withdrawal by Subject|2
390969|NCT00793624|1312824|P4|Overall Study|Other reason not described above|3
390970|NCT00793624|1312825|P3|Overall Study|Other reason not described above|6
390971|NCT00793624|1312826|P2|Overall Study|Other reason not described above|4
390972|NCT00793624|1312827|P1|Overall Study|Other reason not described above|6
390973|NCT00793624|1312824|P4|Overall Study|Non compliance with protocol|3
390974|NCT00793624|1312825|P3|Overall Study|Non compliance with protocol|2
390975|NCT00793624|1312826|P2|Overall Study|Non compliance with protocol|3
390976|NCT00793624|1312827|P1|Overall Study|Non compliance with protocol|2
390977|NCT00793624|1312824|P4|Overall Study|Lack of Efficacy|3
390978|NCT00793624|1312825|P3|Overall Study|Lack of Efficacy|1
390979|NCT00793624|1312826|P2|Overall Study|Lack of Efficacy|2
390980|NCT00793624|1312827|P1|Overall Study|Lack of Efficacy|9
390981|NCT00793624|1312824|P4|Overall Study|Withdrawal by Subject|14
390982|NCT00793624|1312825|P3|Overall Study|Withdrawal by Subject|11
390983|NCT00793624|1312826|P2|Overall Study|Withdrawal by Subject|9
390984|NCT00793624|1312827|P1|Overall Study|Withdrawal by Subject|20
390985|NCT00793624|1312824|P4|Overall Study|Lost to Follow-up|0
390986|NCT00793624|1312825|P3|Overall Study|Lost to Follow-up|4
390987|NCT00793624|1312826|P2|Overall Study|Lost to Follow-up|2
390988|NCT00793624|1312827|P1|Overall Study|Lost to Follow-up|2
390989|NCT00793624|1312824|P4|Overall Study|Adverse Event|20
390990|NCT00793624|1312825|P3|Overall Study|Adverse Event|15
390991|NCT00793624|1312826|P2|Overall Study|Adverse Event|16
390992|NCT00793624|1312827|P1|Overall Study|Adverse Event|18
390993|NCT00793585|1313108|P2|Overall Study|Protocol Violation|2
390994|NCT00793585|1313109|P1|Overall Study|Protocol Violation|1
390995|NCT00793585|1313108|P2|Overall Study|Adverse Event|1
390996|NCT00793585|1313109|P1|Overall Study|Adverse Event|1
390997|NCT00793546|1313128|P2|Overall Study|Other|0
390998|NCT00793546|1313129|P1|Overall Study|Other|1
390999|NCT00793546|1313128|P2|Overall Study|Study Terminated by Sponsor|27
391000|NCT00793546|1313129|P1|Overall Study|Study Terminated by Sponsor|8
391001|NCT00793546|1313128|P2|Overall Study|Withdrawal by Subject|1
391002|NCT00793546|1313129|P1|Overall Study|Withdrawal by Subject|1
391003|NCT00793546|1313128|P2|Overall Study|Lost to Follow-up|0
391004|NCT00793546|1313129|P1|Overall Study|Lost to Follow-up|1
391005|NCT00793546|1313128|P2|Overall Study|Death|0
391006|NCT00793546|1313129|P1|Overall Study|Death|3
391007|NCT00793403|1313179|P1|Overall Study|Other|73
391008|NCT00793325|1313226|P1|Overall Study|Lost to Follow-up|1
391009|NCT00793325|1313226|P1|Overall Study|Protocol Violation|18
391010|NCT00793104|1313258|P1|Overall Study|Lost to Follow-up|1
391011|NCT00792948|1313266|P1|Overall Study|Protocol Violation|1
391012|NCT00792948|1313266|P1|Overall Study|Physician Decision|11
391013|NCT00792948|1313266|P1|Overall Study|Insurance denial - not treated|1
391014|NCT00792948|1313266|P1|Overall Study|Ineligible|2
391015|NCT00792948|1313266|P1|Overall Study|Withdrawal by Subject|3
391016|NCT00792948|1313266|P1|Overall Study|Death|4
391017|NCT00792948|1313266|P1|Overall Study|Adverse Event|6
391018|NCT00792935|1313277|P2|Overall Study|Withdrawal by Subject|1
391019|NCT00792935|1313278|P1|Overall Study|Withdrawal by Subject|0
391020|NCT00792935|1313277|P2|Overall Study|Protocol Violation|0
391021|NCT00792935|1313278|P1|Overall Study|Protocol Violation|2
391022|NCT00792935|1313277|P2|Overall Study|Lost to Follow-up|1
391023|NCT00792935|1313278|P1|Overall Study|Lost to Follow-up|0
391024|NCT00792935|1313277|P2|Overall Study|Adverse Event|1
391025|NCT00792935|1313278|P1|Overall Study|Adverse Event|2
391026|NCT00792909|1313310|P3|Overall Study|Withdrawal by Subject|0
391027|NCT00792909|1313311|P2|Overall Study|Withdrawal by Subject|1
391028|NCT00792909|1313312|P1|Overall Study|Withdrawal by Subject|0
391029|NCT00792805|1313368|P3|Overall Study|Protocol deviation|1
391030|NCT00792805|1313369|P2|Overall Study|Protocol deviation|1
391031|NCT00792805|1313370|P1|Overall Study|Protocol deviation|0
391032|NCT00792805|1313368|P3|Overall Study|Abnormal laboratory value(s)|1
391033|NCT00792805|1313369|P2|Overall Study|Abnormal laboratory value(s)|0
391034|NCT00792805|1313370|P1|Overall Study|Abnormal laboratory value(s)|0
391035|NCT00792805|1313368|P3|Overall Study|Lost to Follow-up|6
391036|NCT00792805|1313369|P2|Overall Study|Lost to Follow-up|1
391037|NCT00792805|1313370|P1|Overall Study|Lost to Follow-up|1
391038|NCT00792805|1313368|P3|Overall Study|Unsatisfactory therapeutic effect|6
391039|NCT00792805|1313369|P2|Overall Study|Unsatisfactory therapeutic effect|6
391040|NCT00792805|1313370|P1|Overall Study|Unsatisfactory therapeutic effect|1
391041|NCT00792805|1313368|P3|Overall Study|Abnormal test procedure result(s)|0
391042|NCT00792805|1313369|P2|Overall Study|Abnormal test procedure result(s)|2
391043|NCT00792805|1313370|P1|Overall Study|Abnormal test procedure result(s)|1
391044|NCT00792805|1313368|P3|Overall Study|Administrative problems|4
391045|NCT00792805|1313369|P2|Overall Study|Administrative problems|0
391046|NCT00792805|1313370|P1|Overall Study|Administrative problems|2
391047|NCT00792805|1313368|P3|Overall Study|Subject withdrew consent|5
391048|NCT00792805|1313369|P2|Overall Study|Subject withdrew consent|6
391049|NCT00792805|1313370|P1|Overall Study|Subject withdrew consent|5
391050|NCT00792805|1313368|P3|Overall Study|Adverse Event|10
391051|NCT00792805|1313369|P2|Overall Study|Adverse Event|10
391052|NCT00792805|1313370|P1|Overall Study|Adverse Event|12
391053|NCT00792701|1313380|P2|Overall Study|Not protocol specified|0
391054|NCT00792701|1313381|P1|Overall Study|Not protocol specified|17
391055|NCT00792701|1313380|P2|Overall Study|Withdrawal by Subject|19
391056|NCT00792701|1313381|P1|Overall Study|Withdrawal by Subject|1
391057|NCT00792701|1313380|P2|Overall Study|Ineligible|3
391058|NCT00792701|1313381|P1|Overall Study|Ineligible|1
391059|NCT00792701|1313380|P2|Overall Study|Adverse Event|22
391060|NCT00792701|1313381|P1|Overall Study|Adverse Event|0
391061|NCT00792636|1313411|P3|Overall Study|Investigator Discretion|2
391062|NCT00792636|1313412|P2|Overall Study|Investigator Discretion|0
391063|NCT00792636|1313413|P1|Overall Study|Investigator Discretion|2
391064|NCT00792636|1313411|P3|Overall Study|Adverse Event|3
391065|NCT00792636|1313412|P2|Overall Study|Adverse Event|2
391066|NCT00792636|1313413|P1|Overall Study|Adverse Event|4
391067|NCT00792636|1313411|P3|Overall Study|Lack of Efficacy|13
391068|NCT00792636|1313412|P2|Overall Study|Lack of Efficacy|4
391069|NCT00792636|1313413|P1|Overall Study|Lack of Efficacy|3
391070|NCT00792636|1313411|P3|Overall Study|Withdrew Consent|9
391071|NCT00792636|1313412|P2|Overall Study|Withdrew Consent|13
391072|NCT00792636|1313413|P1|Overall Study|Withdrew Consent|10
391073|NCT00792636|1313411|P3|Overall Study|Lost to Follow-up|14
391074|NCT00792636|1313412|P2|Overall Study|Lost to Follow-up|19
391075|NCT00792636|1313413|P1|Overall Study|Lost to Follow-up|13
391076|NCT00792636|1313411|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
391077|NCT00792636|1313412|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
391078|NCT00792636|1313413|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
391079|NCT00792636|1313411|P3|Overall Study|Protocol Violation|20
391080|NCT00792636|1313412|P2|Overall Study|Protocol Violation|23
391081|NCT00792636|1313413|P1|Overall Study|Protocol Violation|17
391082|NCT00792623|1313450|P1|Overall Study|Withdrawal by Subject|5
391083|NCT00792623|1313450|P1|Overall Study|Adverse Event|2
391084|NCT00792298|1313478|P8|Treatment Period 2|Withdrawal by Subject|2
391085|NCT00792298|1313479|P7|Treatment Period 2|Withdrawal by Subject|0
391086|NCT00792298|1313480|P6|Treatment Period 2|Withdrawal by Subject|0
391087|NCT00792298|1313481|P5|Treatment Period 2|Withdrawal by Subject|1
391088|NCT00792298|1313482|P4|Treatment Period 2|Withdrawal by Subject|2
391089|NCT00792298|1313483|P3|Treatment Period 2|Withdrawal by Subject|0
391090|NCT00792298|1313484|P2|Treatment Period 2|Withdrawal by Subject|1
391091|NCT00792298|1313485|P1|Treatment Period 2|Withdrawal by Subject|1
391092|NCT00792298|1313478|P8|Treatment Period 2|Pregnancy|0
391093|NCT00792298|1313479|P7|Treatment Period 2|Pregnancy|0
391094|NCT00792298|1313480|P6|Treatment Period 2|Pregnancy|0
391095|NCT00792298|1313481|P5|Treatment Period 2|Pregnancy|0
391096|NCT00792298|1313482|P4|Treatment Period 2|Pregnancy|0
391097|NCT00792298|1313483|P3|Treatment Period 2|Pregnancy|1
391098|NCT00792298|1313484|P2|Treatment Period 2|Pregnancy|0
391099|NCT00792298|1313485|P1|Treatment Period 2|Pregnancy|0
391100|NCT00792298|1313478|P8|Treatment Period 2|Physician Decision|0
391101|NCT00792298|1313479|P7|Treatment Period 2|Physician Decision|1
391102|NCT00792298|1313480|P6|Treatment Period 2|Physician Decision|0
391103|NCT00792298|1313481|P5|Treatment Period 2|Physician Decision|0
391104|NCT00792298|1313482|P4|Treatment Period 2|Physician Decision|0
391105|NCT00792298|1313483|P3|Treatment Period 2|Physician Decision|0
391106|NCT00792298|1313484|P2|Treatment Period 2|Physician Decision|0
391107|NCT00792298|1313485|P1|Treatment Period 2|Physician Decision|0
391108|NCT00792298|1313478|P8|Treatment Period 2|Lack of Efficacy|0
391109|NCT00792298|1313479|P7|Treatment Period 2|Lack of Efficacy|0
391110|NCT00792298|1313480|P6|Treatment Period 2|Lack of Efficacy|0
391111|NCT00792298|1313481|P5|Treatment Period 2|Lack of Efficacy|1
391112|NCT00792298|1313482|P4|Treatment Period 2|Lack of Efficacy|0
391113|NCT00792298|1313483|P3|Treatment Period 2|Lack of Efficacy|0
391114|NCT00792298|1313484|P2|Treatment Period 2|Lack of Efficacy|0
391115|NCT00792298|1313485|P1|Treatment Period 2|Lack of Efficacy|0
391116|NCT00792298|1313478|P8|Washout|Withdrawal by Subject|0
391117|NCT00792298|1313479|P7|Washout|Withdrawal by Subject|0
391118|NCT00792298|1313480|P6|Washout|Withdrawal by Subject|1
391119|NCT00792298|1313481|P5|Washout|Withdrawal by Subject|0
391120|NCT00792298|1313482|P4|Washout|Withdrawal by Subject|0
391121|NCT00792298|1313483|P3|Washout|Withdrawal by Subject|1
391122|NCT00792298|1313484|P2|Washout|Withdrawal by Subject|0
391123|NCT00792298|1313485|P1|Washout|Withdrawal by Subject|0
391124|NCT00792298|1313478|P8|Washout|Adverse Event|0
391125|NCT00792298|1313479|P7|Washout|Adverse Event|0
391126|NCT00792298|1313480|P6|Washout|Adverse Event|1
391127|NCT00792298|1313481|P5|Washout|Adverse Event|0
391128|NCT00792298|1313482|P4|Washout|Adverse Event|0
391129|NCT00792298|1313483|P3|Washout|Adverse Event|0
391130|NCT00792298|1313484|P2|Washout|Adverse Event|0
391131|NCT00792298|1313485|P1|Washout|Adverse Event|0
391132|NCT00792298|1313478|P8|Treatment Period 1|Protocol Violation|1
391133|NCT00792298|1313479|P7|Treatment Period 1|Protocol Violation|0
391134|NCT00792298|1313480|P6|Treatment Period 1|Protocol Violation|0
391135|NCT00792298|1313481|P5|Treatment Period 1|Protocol Violation|0
391136|NCT00792298|1313482|P4|Treatment Period 1|Protocol Violation|0
391137|NCT00792298|1313483|P3|Treatment Period 1|Protocol Violation|0
391138|NCT00792298|1313484|P2|Treatment Period 1|Protocol Violation|0
391139|NCT00792298|1313485|P1|Treatment Period 1|Protocol Violation|0
391140|NCT00792298|1313478|P8|Treatment Period 1|Physician Decision|0
391141|NCT00792298|1313479|P7|Treatment Period 1|Physician Decision|1
391142|NCT00792298|1313480|P6|Treatment Period 1|Physician Decision|0
391143|NCT00792298|1313481|P5|Treatment Period 1|Physician Decision|0
391144|NCT00792298|1313482|P4|Treatment Period 1|Physician Decision|1
391145|NCT00792298|1313483|P3|Treatment Period 1|Physician Decision|0
391146|NCT00792298|1313484|P2|Treatment Period 1|Physician Decision|0
391147|NCT00792298|1313485|P1|Treatment Period 1|Physician Decision|0
391148|NCT00792298|1313478|P8|Treatment Period 1|Lost to Follow-up|0
391149|NCT00792298|1313479|P7|Treatment Period 1|Lost to Follow-up|1
391150|NCT00792298|1313480|P6|Treatment Period 1|Lost to Follow-up|0
391151|NCT00792298|1313481|P5|Treatment Period 1|Lost to Follow-up|0
391152|NCT00792298|1313482|P4|Treatment Period 1|Lost to Follow-up|0
391153|NCT00792298|1313483|P3|Treatment Period 1|Lost to Follow-up|0
391154|NCT00792298|1313484|P2|Treatment Period 1|Lost to Follow-up|0
391155|NCT00792298|1313485|P1|Treatment Period 1|Lost to Follow-up|0
391156|NCT00792298|1313478|P8|Treatment Period 1|Withdrawal by Subject|0
391157|NCT00792298|1313479|P7|Treatment Period 1|Withdrawal by Subject|1
391158|NCT00792298|1313480|P6|Treatment Period 1|Withdrawal by Subject|2
391159|NCT00792298|1313481|P5|Treatment Period 1|Withdrawal by Subject|0
391160|NCT00792298|1313482|P4|Treatment Period 1|Withdrawal by Subject|2
391161|NCT00792298|1313483|P3|Treatment Period 1|Withdrawal by Subject|1
391162|NCT00792298|1313484|P2|Treatment Period 1|Withdrawal by Subject|0
391163|NCT00792298|1313485|P1|Treatment Period 1|Withdrawal by Subject|1
391164|NCT00792298|1313478|P8|Treatment Period 1|Lack of Efficacy|0
391165|NCT00792298|1313479|P7|Treatment Period 1|Lack of Efficacy|0
391166|NCT00792298|1313480|P6|Treatment Period 1|Lack of Efficacy|0
391167|NCT00792298|1313481|P5|Treatment Period 1|Lack of Efficacy|0
391168|NCT00792298|1313482|P4|Treatment Period 1|Lack of Efficacy|0
391169|NCT00792298|1313483|P3|Treatment Period 1|Lack of Efficacy|1
391170|NCT00792298|1313484|P2|Treatment Period 1|Lack of Efficacy|0
391171|NCT00792298|1313485|P1|Treatment Period 1|Lack of Efficacy|0
391172|NCT00792298|1313478|P8|Treatment Period 1|Adverse Event|0
391173|NCT00792298|1313479|P7|Treatment Period 1|Adverse Event|1
391174|NCT00792298|1313480|P6|Treatment Period 1|Adverse Event|1
391175|NCT00792298|1313481|P5|Treatment Period 1|Adverse Event|0
391176|NCT00792298|1313482|P4|Treatment Period 1|Adverse Event|1
391177|NCT00792298|1313483|P3|Treatment Period 1|Adverse Event|0
391178|NCT00792298|1313484|P2|Treatment Period 1|Adverse Event|1
391179|NCT00792298|1313485|P1|Treatment Period 1|Adverse Event|0
391180|NCT00792259|1313515|P3|Overall Study|Poor Quality Scans|0
391181|NCT00792259|1313516|P2|Overall Study|Poor Quality Scans|0
391182|NCT00792259|1313517|P1|Overall Study|Poor Quality Scans|1
391183|NCT00792116|1313527|P2|Overall Study|Discontnued intervention|0
391184|NCT00792116|1313528|P1|Overall Study|Discontnued intervention|1
391185|NCT00792116|1313527|P2|Overall Study|Lost to Follow-up|1
391186|NCT00792116|1313528|P1|Overall Study|Lost to Follow-up|0
391187|NCT00792103|1313538|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
391188|NCT00792103|1313538|P1|Overall Study|Protocol Violation|10
391189|NCT00792103|1313538|P1|Overall Study|Withdrawal by Subject|52
391190|NCT00792103|1313538|P1|Overall Study|Adverse Event|25
391191|NCT00792103|1313538|P1|Overall Study|Lost to Follow-up|17
391192|NCT00792103|1313538|P1|Overall Study|Enrolled, not treated|15
391193|NCT00791999|1313550|P4|Overall Study|Reason other than those above|0
391194|NCT00791999|1313551|P3|Overall Study|Reason other than those above|1
391195|NCT00791999|1313552|P2|Overall Study|Reason other than those above|0
391196|NCT00791999|1313553|P1|Overall Study|Reason other than those above|1
391197|NCT00791999|1313550|P4|Overall Study|Lack of Efficacy|2
391198|NCT00791999|1313551|P3|Overall Study|Lack of Efficacy|0
391199|NCT00791999|1313552|P2|Overall Study|Lack of Efficacy|1
391200|NCT00791999|1313553|P1|Overall Study|Lack of Efficacy|0
391201|NCT00791999|1313550|P4|Overall Study|Adverse Event|3
391202|NCT00791999|1313551|P3|Overall Study|Adverse Event|7
391203|NCT00791999|1313552|P2|Overall Study|Adverse Event|3
391204|NCT00791999|1313553|P1|Overall Study|Adverse Event|3
391205|NCT00791999|1313550|P4|Overall Study|Protocol Violation|0
391206|NCT00791999|1313551|P3|Overall Study|Protocol Violation|1
391207|NCT00791999|1313552|P2|Overall Study|Protocol Violation|0
391208|NCT00791999|1313553|P1|Overall Study|Protocol Violation|3
391209|NCT00791999|1313550|P4|Overall Study|Withdrawal by Subject|2
391210|NCT00791999|1313551|P3|Overall Study|Withdrawal by Subject|0
391211|NCT00791999|1313552|P2|Overall Study|Withdrawal by Subject|1
391212|NCT00791999|1313553|P1|Overall Study|Withdrawal by Subject|0
391213|NCT00791999|1313550|P4|Overall Study|Protocol planed withdrawal|45
391214|NCT00791999|1313551|P3|Overall Study|Protocol planed withdrawal|11
391215|NCT00791999|1313552|P2|Overall Study|Protocol planed withdrawal|11
391216|NCT00791999|1313553|P1|Overall Study|Protocol planed withdrawal|14
391217|NCT00791934|1313578|P1|Overall Study|Did not consent for extended follow-up|13
391218|NCT00791934|1313578|P1|Overall Study|Withdrawal by Subject|2
391219|NCT00791921|1313588|P2|Overall Study|Reason other than those above|1
391220|NCT00791921|1313589|P1|Overall Study|Reason other than those above|0
391221|NCT00791921|1313588|P2|Overall Study|Lack of study drug administration|1
391222|NCT00791921|1313589|P1|Overall Study|Lack of study drug administration|1
391223|NCT00791921|1313588|P2|Overall Study|Lack of Efficacy|2
391224|NCT00791921|1313589|P1|Overall Study|Lack of Efficacy|0
391225|NCT00791921|1313588|P2|Overall Study|Adverse Event|2
391226|NCT00791921|1313589|P1|Overall Study|Adverse Event|8
391227|NCT00791921|1313588|P2|Overall Study|Withdrawal by Subject|2
391228|NCT00791921|1313589|P1|Overall Study|Withdrawal by Subject|1
391229|NCT00791921|1313588|P2|Overall Study|Protocol planed|88
391230|NCT00791921|1313589|P1|Overall Study|Protocol planed|24
391231|NCT00791778|1313616|P2|Follow-up|Lost to Follow-up|1
391232|NCT00791778|1313617|P1|Follow-up|Lost to Follow-up|2
391233|NCT00791778|1313616|P2|Follow-up|Withdrawal by Subject|0
391234|NCT00791778|1313617|P1|Follow-up|Withdrawal by Subject|3
391235|NCT00791778|1313616|P2|Double-blind Treatment|Non-compliant with study medication|0
391236|NCT00791778|1313617|P1|Double-blind Treatment|Non-compliant with study medication|2
391237|NCT00791778|1313616|P2|Double-blind Treatment|Withdrawal by Subject|9
391238|NCT00791778|1313617|P1|Double-blind Treatment|Withdrawal by Subject|20
391239|NCT00791778|1313616|P2|Double-blind Treatment|Protocol Violation|4
391240|NCT00791778|1313617|P1|Double-blind Treatment|Protocol Violation|0
391241|NCT00791778|1313616|P2|Double-blind Treatment|Physician Decision|26
391242|NCT00791778|1313617|P1|Double-blind Treatment|Physician Decision|6
391243|NCT00791778|1313616|P2|Double-blind Treatment|Adverse Event|9
391244|NCT00791778|1313617|P1|Double-blind Treatment|Adverse Event|49
391245|NCT00791765|1313671|P2|Weeks 13 to 24|Other|1
391246|NCT00791765|1313672|P1|Weeks 13 to 24|Other|0
391247|NCT00791765|1313671|P2|Weeks 13 to 24|Lost to Follow-up|2
391248|NCT00791765|1313672|P1|Weeks 13 to 24|Lost to Follow-up|1
391249|NCT00791765|1313671|P2|Weeks 13 to 24|Disease progression|1
391250|NCT00791765|1313672|P1|Weeks 13 to 24|Disease progression|0
391251|NCT00791765|1313671|P2|Weeks 13 to 24|Withdrawal by Subject|1
391252|NCT00791765|1313672|P1|Weeks 13 to 24|Withdrawal by Subject|2
391253|NCT00791765|1313671|P2|Weeks 13 to 24|Adverse Event|3
391254|NCT00791765|1313672|P1|Weeks 13 to 24|Adverse Event|0
391255|NCT00791765|1313671|P2|Weeks 13 to 24|Protocol deviation|0
391256|NCT00791765|1313672|P1|Weeks 13 to 24|Protocol deviation|2
391257|NCT00791765|1313671|P2|Weeks 1 to 12|Ineligibility determined|3
391258|NCT00791765|1313672|P1|Weeks 1 to 12|Ineligibility determined|0
391259|NCT00791765|1313671|P2|Weeks 1 to 12|Disease progression|0
391260|NCT00791765|1313672|P1|Weeks 1 to 12|Disease progression|3
391261|NCT00791765|1313671|P2|Weeks 1 to 12|Physician Decision|0
391262|NCT00791765|1313672|P1|Weeks 1 to 12|Physician Decision|1
391263|NCT00791765|1313671|P2|Weeks 1 to 12|Withdrawal by Subject|0
391264|NCT00791765|1313672|P1|Weeks 1 to 12|Withdrawal by Subject|3
391265|NCT00791765|1313671|P2|Weeks 1 to 12|Lost to Follow-up|0
391266|NCT00791765|1313672|P1|Weeks 1 to 12|Lost to Follow-up|1
391267|NCT00791765|1313671|P2|Weeks 1 to 12|Adverse Event|1
391268|NCT00791765|1313672|P1|Weeks 1 to 12|Adverse Event|0
391269|NCT00791700|1313687|P4|Overall Study|Blood sampling not done before Stage 1|1
391270|NCT00791700|1313688|P3|Overall Study|Blood sampling not done before Stage 1|0
391271|NCT00791700|1313689|P2|Overall Study|Blood sampling not done before Stage 1|0
391272|NCT00791700|1313690|P1|Overall Study|Blood sampling not done before Stage 1|0
391273|NCT00791700|1313687|P4|Overall Study|Non-compliance with study treatment|2
391274|NCT00791700|1313688|P3|Overall Study|Non-compliance with study treatment|0
391275|NCT00791700|1313689|P2|Overall Study|Non-compliance with study treatment|0
391276|NCT00791700|1313690|P1|Overall Study|Non-compliance with study treatment|1
391277|NCT00791700|1313687|P4|Overall Study|No longer willing to participate|1
391278|NCT00791700|1313688|P3|Overall Study|No longer willing to participate|0
391279|NCT00791700|1313689|P2|Overall Study|No longer willing to participate|1
391280|NCT00791700|1313690|P1|Overall Study|No longer willing to participate|0
391281|NCT00791700|1313687|P4|Overall Study|Adverse Event|1
391282|NCT00791700|1313688|P3|Overall Study|Adverse Event|1
391283|NCT00791700|1313689|P2|Overall Study|Adverse Event|0
391284|NCT00791700|1313690|P1|Overall Study|Adverse Event|0
391285|NCT00791700|1313687|P4|Overall Study|Insufficient clinical response|13
391286|NCT00791700|1313688|P3|Overall Study|Insufficient clinical response|3
391287|NCT00791700|1313689|P2|Overall Study|Insufficient clinical response|4
391288|NCT00791700|1313690|P1|Overall Study|Insufficient clinical response|3
391289|NCT00791661|1313778|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
391290|NCT00791661|1313779|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
391291|NCT00791661|1313780|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
391292|NCT00791661|1313778|P3|7 Day Wash-out|Adverse Event|1
391293|NCT00791661|1313779|P2|7 Day Wash-out|Adverse Event|0
391294|NCT00791661|1313780|P1|7 Day Wash-out|Adverse Event|0
391295|NCT00791648|1313873|P2|Overall Study|Withdrawal by Subject|1
391296|NCT00791648|1313874|P1|Overall Study|Withdrawal by Subject|0
391297|NCT00791648|1313873|P2|Overall Study|Physician Decision|1
391298|NCT00791648|1313874|P1|Overall Study|Physician Decision|0
391299|NCT00791557|1313890|P1|Overall Study|Adverse Event|1
391300|NCT00791518|1313894|P1|Overall Study|Protocol Violation|93
391301|NCT00791492|1313922|P2|Overall Study|Liver transplantation|1
391302|NCT00791492|1313923|P1|Overall Study|Liver transplantation|5
391303|NCT00791492|1313922|P2|Overall Study|Withdrawal by Subject|2
391304|NCT00791492|1313923|P1|Overall Study|Withdrawal by Subject|1
391305|NCT00791479|1313971|P6|Overall Study|Withdrawal by Subject|1
391306|NCT00791479|1313972|P5|Overall Study|Withdrawal by Subject|0
391307|NCT00791479|1313973|P4|Overall Study|Withdrawal by Subject|1
391308|NCT00791479|1313974|P3|Overall Study|Withdrawal by Subject|0
391309|NCT00791479|1313975|P2|Overall Study|Withdrawal by Subject|0
391310|NCT00791479|1313976|P1|Overall Study|Withdrawal by Subject|0
391311|NCT00791479|1313971|P6|Overall Study|Protocol Violation|0
391312|NCT00791479|1313972|P5|Overall Study|Protocol Violation|0
391313|NCT00791479|1313973|P4|Overall Study|Protocol Violation|1
391314|NCT00791479|1313974|P3|Overall Study|Protocol Violation|0
391315|NCT00791479|1313975|P2|Overall Study|Protocol Violation|1
391316|NCT00791479|1313976|P1|Overall Study|Protocol Violation|2
391317|NCT00791479|1313971|P6|Overall Study|Lost to Follow-up|1
391318|NCT00791479|1313972|P5|Overall Study|Lost to Follow-up|0
391319|NCT00791479|1313973|P4|Overall Study|Lost to Follow-up|0
391320|NCT00791479|1313974|P3|Overall Study|Lost to Follow-up|0
391321|NCT00791479|1313975|P2|Overall Study|Lost to Follow-up|1
391322|NCT00791479|1313976|P1|Overall Study|Lost to Follow-up|0
391323|NCT00791479|1313971|P6|Overall Study|Adverse Event|1
391324|NCT00791479|1313972|P5|Overall Study|Adverse Event|0
391325|NCT00791479|1313973|P4|Overall Study|Adverse Event|2
391326|NCT00791479|1313974|P3|Overall Study|Adverse Event|0
391327|NCT00791479|1313975|P2|Overall Study|Adverse Event|1
391328|NCT00791479|1313976|P1|Overall Study|Adverse Event|0
391329|NCT00791479|1313971|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
391330|NCT00791479|1313972|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
391331|NCT00791479|1313973|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
391332|NCT00791479|1313974|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
391333|NCT00791479|1313975|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
391334|NCT00791479|1313976|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
391335|NCT00791388|1314075|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
391336|NCT00791388|1314076|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
391337|NCT00791388|1314077|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
391338|NCT00791388|1314078|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
391339|NCT00791388|1314079|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
391340|NCT00791388|1314075|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
391341|NCT00791388|1314076|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
391342|NCT00791388|1314077|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
391343|NCT00791388|1314078|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
391344|NCT00791388|1314079|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
391345|NCT00791388|1314075|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
391346|NCT00791388|1314076|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
391347|NCT00791388|1314077|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
391348|NCT00791388|1314078|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
391349|NCT00791388|1314079|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
391350|NCT00791258|1314121|P1|Overall Study|Lack of Efficacy|1
391351|NCT00791258|1314121|P1|Overall Study|Subject required restricted medication|1
391352|NCT00791258|1314121|P1|Overall Study|Subject incarcerated|1
391353|NCT00791258|1314121|P1|Overall Study|non-compliance|3
391354|NCT00791258|1314121|P1|Overall Study|subject left area|2
391355|NCT00791258|1314121|P1|Overall Study|Did not take medication for >3 days|1
391356|NCT00791258|1314121|P1|Overall Study|Withdrawal by Subject|40
391357|NCT00791258|1314121|P1|Overall Study|Protocol Violation|109
391358|NCT00791258|1314121|P1|Overall Study|Lost to Follow-up|18
391359|NCT00791258|1314121|P1|Overall Study|Adverse Event|87
391360|NCT00791128|1314183|P1|Overall Study|abdominal tumor, unrelated to device|1
391361|NCT00791128|1314183|P1|Overall Study|non-compliance by subject|2
391362|NCT00791128|1314183|P1|Overall Study|Device migration|2
391363|NCT00791128|1314183|P1|Overall Study|Adverse Event|4
391364|NCT00791076|1314214|P1|Overall Study|Study was terminated,PI left institution|8
391365|NCT00790907|1314232|P3|Overall Study|Did Not Receive Study Drug|0
391366|NCT00790907|1314233|P2|Overall Study|Did Not Receive Study Drug|0
391367|NCT00790907|1314234|P1|Overall Study|Did Not Receive Study Drug|10
391368|NCT00790907|1314232|P3|Overall Study|Verbatim Reason on the Case Report Form|29
391369|NCT00790907|1314233|P2|Overall Study|Verbatim Reason on the Case Report Form|20
391370|NCT00790907|1314234|P1|Overall Study|Verbatim Reason on the Case Report Form|74
391371|NCT00790907|1314232|P3|Overall Study|Qualifying Condition Not Present|16
391372|NCT00790907|1314233|P2|Overall Study|Qualifying Condition Not Present|14
391373|NCT00790907|1314234|P1|Overall Study|Qualifying Condition Not Present|29
391374|NCT00790907|1314232|P3|Overall Study|Required Protocol-prohibited Therapy|7
391375|NCT00790907|1314233|P2|Overall Study|Required Protocol-prohibited Therapy|5
391376|NCT00790907|1314234|P1|Overall Study|Required Protocol-prohibited Therapy|17
391377|NCT00790907|1314232|P3|Overall Study|Bleeding Event|21
391378|NCT00790907|1314233|P2|Overall Study|Bleeding Event|16
391379|NCT00790907|1314234|P1|Overall Study|Bleeding Event|11
391380|NCT00790907|1314232|P3|Overall Study|Withdrawal by Subject|5
391381|NCT00790907|1314233|P2|Overall Study|Withdrawal by Subject|7
391382|NCT00790907|1314234|P1|Overall Study|Withdrawal by Subject|1
391383|NCT00790907|1314232|P3|Overall Study|Physician Decision|255
391384|NCT00790907|1314233|P2|Overall Study|Physician Decision|271
391385|NCT00790907|1314234|P1|Overall Study|Physician Decision|304
391386|NCT00790907|1314232|P3|Overall Study|Adverse Event|6
391387|NCT00790907|1314233|P2|Overall Study|Adverse Event|7
391388|NCT00790907|1314234|P1|Overall Study|Adverse Event|9
391389|NCT00790868|1314257|P2|Overall Study|Lost to Follow-up|12
391390|NCT00790868|1314258|P1|Overall Study|Lost to Follow-up|2
391391|NCT00790868|1314257|P2|Overall Study|Withdrawal by Subject|5
391392|NCT00790868|1314258|P1|Overall Study|Withdrawal by Subject|4
391393|NCT00790790|1314288|P3|Study Period 2: Therapy Phase|Physician Decision|0
391394|NCT00790790|1314289|P2|Study Period 2: Therapy Phase|Physician Decision|1
391395|NCT00790790|1314290|P1|Study Period 2: Therapy Phase|Physician Decision|0
391396|NCT00790790|1314288|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
391397|NCT00790790|1314289|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
391398|NCT00790790|1314290|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
391399|NCT00790790|1314288|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
391400|NCT00790790|1314289|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
391401|NCT00790790|1314290|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
391402|NCT00790790|1314288|P3|Study Period 2: Therapy Phase|Protocol Violation|0
391403|NCT00790790|1314289|P2|Study Period 2: Therapy Phase|Protocol Violation|1
391404|NCT00790790|1314290|P1|Study Period 2: Therapy Phase|Protocol Violation|1
391405|NCT00790790|1314288|P3|Study Period 2: Therapy Phase|Adverse Event|16
391406|NCT00790790|1314289|P2|Study Period 2: Therapy Phase|Adverse Event|16
391407|NCT00790790|1314290|P1|Study Period 2: Therapy Phase|Adverse Event|3
391408|NCT00790751|1314367|P4|Overall Study|Physician Decision|1
391409|NCT00790751|1314368|P3|Overall Study|Physician Decision|0
391410|NCT00790751|1314369|P2|Overall Study|Physician Decision|0
391411|NCT00790751|1314370|P1|Overall Study|Physician Decision|0
391412|NCT00790751|1314367|P4|Overall Study|Death|0
391413|NCT00790751|1314368|P3|Overall Study|Death|1
391414|NCT00790751|1314369|P2|Overall Study|Death|0
391415|NCT00790751|1314370|P1|Overall Study|Death|0
391416|NCT00790751|1314367|P4|Overall Study|Requirement for restricted medication|0
391417|NCT00790751|1314368|P3|Overall Study|Requirement for restricted medication|0
391418|NCT00790751|1314369|P2|Overall Study|Requirement for restricted medication|2
391419|NCT00790751|1314370|P1|Overall Study|Requirement for restricted medication|0
391420|NCT00790751|1314367|P4|Overall Study|Adverse Event|4
391421|NCT00790751|1314368|P3|Overall Study|Adverse Event|5
391422|NCT00790751|1314369|P2|Overall Study|Adverse Event|3
391423|NCT00790751|1314370|P1|Overall Study|Adverse Event|5
391424|NCT00790751|1314367|P4|Overall Study|Lost to Follow-up|5
391425|NCT00790751|1314368|P3|Overall Study|Lost to Follow-up|4
391426|NCT00790751|1314369|P2|Overall Study|Lost to Follow-up|9
391427|NCT00790751|1314370|P1|Overall Study|Lost to Follow-up|4
391428|NCT00790751|1314367|P4|Overall Study|Protocol non-compliance|11
391429|NCT00790751|1314368|P3|Overall Study|Protocol non-compliance|10
391430|NCT00790751|1314369|P2|Overall Study|Protocol non-compliance|16
391431|NCT00790751|1314370|P1|Overall Study|Protocol non-compliance|16
391432|NCT00790647|1314418|P1|Overall Study|Adverse Event|1
391433|NCT00790569|1314428|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
391434|NCT00790569|1314429|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
391435|NCT00790569|1314430|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
391436|NCT00790569|1314428|P3|End of Treatment (6 Month Interview)|Incarcerated|3
391437|NCT00790569|1314429|P2|End of Treatment (6 Month Interview)|Incarcerated|0
391438|NCT00790569|1314430|P1|End of Treatment (6 Month Interview)|Incarcerated|0
391439|NCT00790569|1314428|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
391440|NCT00790569|1314429|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
391441|NCT00790569|1314430|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
391442|NCT00790569|1314428|P3|End of Treatment (6 Month Interview)|Hospitalized|0
391443|NCT00790569|1314429|P2|End of Treatment (6 Month Interview)|Hospitalized|0
391444|NCT00790569|1314430|P1|End of Treatment (6 Month Interview)|Hospitalized|2
391445|NCT00790569|1314428|P3|End of Treatment (6 Month Interview)|Death|1
391446|NCT00790569|1314429|P2|End of Treatment (6 Month Interview)|Death|2
391447|NCT00790569|1314430|P1|End of Treatment (6 Month Interview)|Death|0
391448|NCT00790569|1314428|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
391449|NCT00790569|1314429|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
391450|NCT00790569|1314430|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
391451|NCT00790556|1314471|P2|Treatment Period 1|Withdrawal by Subject|0
391452|NCT00790556|1314472|P1|Treatment Period 1|Withdrawal by Subject|1
391453|NCT00790556|1314471|P2|Treatment Period 1|Physician Decision|0
391454|NCT00790556|1314472|P1|Treatment Period 1|Physician Decision|1
391455|NCT00790452|1314484|P2|Overall Study|Drug supply issue|0
391456|NCT00790452|1314485|P1|Overall Study|Drug supply issue|1
391457|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|New treatment|0
391458|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|New treatment|2
391459|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
391460|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
391461|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Disease progression|0
391462|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Disease progression|5
391463|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Death|0
391464|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Death|1
391465|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Administrative problems|0
391466|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Administrative problems|2
391467|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
391468|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
391469|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
391470|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
391471|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
391472|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
391473|NCT00790400|1314493|P2|Everolimus Period (Core or Extension)|Adverse Event|0
391474|NCT00790400|1314494|P1|Everolimus Period (Core or Extension)|Adverse Event|9
391475|NCT00790400|1314493|P2|Double-blind Period (Core Phase)|Death|0
391476|NCT00790400|1314494|P1|Double-blind Period (Core Phase)|Death|1
391477|NCT00790400|1314493|P2|Double-blind Period (Core Phase)|Administrative problems|0
391478|NCT00790400|1314494|P1|Double-blind Period (Core Phase)|Administrative problems|1
391479|NCT00790400|1314493|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
391480|NCT00790400|1314494|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
391481|NCT00790400|1314493|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
391482|NCT00790400|1314494|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
391483|NCT00790400|1314493|P2|Double-blind Period (Core Phase)|Adverse Event|4
391484|NCT00790400|1314494|P1|Double-blind Period (Core Phase)|Adverse Event|2
391485|NCT00790400|1314493|P2|Double-blind Period (Core Phase)|Progressive disease|9
391486|NCT00790400|1314494|P1|Double-blind Period (Core Phase)|Progressive disease|0
391487|NCT00790400|1314493|P2|Double-blind Period (Core Phase)|Protocol Violation|0
391488|NCT00790400|1314494|P1|Double-blind Period (Core Phase)|Protocol Violation|1
391489|NCT00790296|1314584|P2|Overall Study|Adverse Event|1
391490|NCT00790296|1314585|P1|Overall Study|Adverse Event|0
391491|NCT00790296|1314584|P2|Overall Study|Did not meet study eligibility criteria|1
391492|NCT00790296|1314585|P1|Overall Study|Did not meet study eligibility criteria|1
391493|NCT00790218|1314607|P3|Overall Study|Death|0
391494|NCT00790218|1314608|P2|Overall Study|Death|0
391495|NCT00790218|1314609|P1|Overall Study|Death|1
391496|NCT00790205|1314619|P2|Overall Study|Withdrawal by Subject|363
391497|NCT00790205|1314620|P1|Overall Study|Withdrawal by Subject|299
391498|NCT00790205|1314619|P2|Overall Study|Lost to Follow-up|71
391499|NCT00790205|1314620|P1|Overall Study|Lost to Follow-up|61
391500|NCT00790036|1314717|P2|Overall Study|Subject/guardian decision|7
391501|NCT00790036|1314718|P1|Overall Study|Subject/guardian decision|20
391502|NCT00790036|1314717|P2|Overall Study|Withdrawal by Subject|7
391503|NCT00790036|1314718|P1|Overall Study|Withdrawal by Subject|18
391504|NCT00790036|1314717|P2|Overall Study|Protocol Violation|2
391505|NCT00790036|1314718|P1|Overall Study|Protocol Violation|10
391506|NCT00790036|1314717|P2|Overall Study|Lost to Follow-up|2
391507|NCT00790036|1314718|P1|Overall Study|Lost to Follow-up|1
391508|NCT00790036|1314717|P2|Overall Study|Disease progression|48
391509|NCT00790036|1314718|P1|Overall Study|Disease progression|24
391510|NCT00790036|1314717|P2|Overall Study|Death|0
391511|NCT00790036|1314718|P1|Overall Study|Death|1
391512|NCT00790036|1314717|P2|Overall Study|Adverse Event|44
391513|NCT00790036|1314718|P1|Overall Study|Adverse Event|113
391514|NCT00790036|1314717|P2|Overall Study|Administrative problems|9
391515|NCT00790036|1314718|P1|Overall Study|Administrative problems|5
391516|NCT00790036|1314717|P2|Overall Study|Abnormal lab values|2
391517|NCT00790036|1314718|P1|Overall Study|Abnormal lab values|3
391518|NCT00790023|1314732|P3|Overall Study|Not specified|8
391519|NCT00790023|1314733|P2|Overall Study|Not specified|5
391520|NCT00790023|1314734|P1|Overall Study|Not specified|5
391521|NCT00790023|1314732|P3|Overall Study|Lost to Follow-up|1
391522|NCT00790023|1314733|P2|Overall Study|Lost to Follow-up|0
391523|NCT00790023|1314734|P1|Overall Study|Lost to Follow-up|0
391524|NCT00790023|1314732|P3|Overall Study|Withdrawal by Subject|6
391525|NCT00790023|1314733|P2|Overall Study|Withdrawal by Subject|0
391526|NCT00790023|1314734|P1|Overall Study|Withdrawal by Subject|2
391527|NCT00790023|1314732|P3|Overall Study|Protocol Violation|2
391528|NCT00790023|1314733|P2|Overall Study|Protocol Violation|4
391529|NCT00790023|1314734|P1|Overall Study|Protocol Violation|2
391530|NCT00790023|1314732|P3|Overall Study|Adverse Event|4
391531|NCT00790023|1314733|P2|Overall Study|Adverse Event|1
391532|NCT00790023|1314734|P1|Overall Study|Adverse Event|2
391533|NCT00789958|1314833|P1|Overall Study|Not eligible/not analyzable|26
391534|NCT00789958|1314833|P1|Overall Study|not protocol specified|1
391535|NCT00789958|1314833|P1|Overall Study|Progression|3
391536|NCT00789958|1314833|P1|Overall Study|Withdrawal by Subject|4
391537|NCT00789958|1314833|P1|Overall Study|Adverse Event|3
391538|NCT00789880|1314852|P6|Overall Study|Withdrawal by Subject|0
391539|NCT00789880|1314853|P5|Overall Study|Withdrawal by Subject|2
391540|NCT00789880|1314854|P4|Overall Study|Withdrawal by Subject|0
391541|NCT00789880|1314855|P3|Overall Study|Withdrawal by Subject|0
391542|NCT00789880|1314856|P2|Overall Study|Withdrawal by Subject|0
391543|NCT00789880|1314857|P1|Overall Study|Withdrawal by Subject|1
391544|NCT00789880|1314852|P6|Overall Study|Protocol Violation|0
391545|NCT00789880|1314853|P5|Overall Study|Protocol Violation|0
391546|NCT00789880|1314854|P4|Overall Study|Protocol Violation|1
391547|NCT00789880|1314855|P3|Overall Study|Protocol Violation|0
391548|NCT00789880|1314856|P2|Overall Study|Protocol Violation|1
391549|NCT00789880|1314857|P1|Overall Study|Protocol Violation|0
391550|NCT00789880|1314852|P6|Overall Study|Adverse Event|0
391551|NCT00789880|1314853|P5|Overall Study|Adverse Event|1
391552|NCT00789880|1314854|P4|Overall Study|Adverse Event|0
391553|NCT00789880|1314855|P3|Overall Study|Adverse Event|0
391554|NCT00789880|1314856|P2|Overall Study|Adverse Event|0
391555|NCT00789880|1314857|P1|Overall Study|Adverse Event|0
391556|NCT00789854|1314886|P3|Overall Study|Other|5
391557|NCT00789854|1314887|P2|Overall Study|Other|0
391558|NCT00789854|1314888|P1|Overall Study|Other|6
391559|NCT00789854|1314886|P3|Overall Study|Safety reasons|2
391560|NCT00789854|1314887|P2|Overall Study|Safety reasons|0
391561|NCT00789854|1314888|P1|Overall Study|Safety reasons|0
391562|NCT00789854|1314886|P3|Overall Study|Severe non-compliance to the protocol|0
391563|NCT00789854|1314887|P2|Overall Study|Severe non-compliance to the protocol|0
391564|NCT00789854|1314888|P1|Overall Study|Severe non-compliance to the protocol|3
391565|NCT00789854|1314886|P3|Overall Study|Eligibility criteria not fulfilled|1
391566|NCT00789854|1314887|P2|Overall Study|Eligibility criteria not fulfilled|5
391567|NCT00789854|1314888|P1|Overall Study|Eligibility criteria not fulfilled|2
391568|NCT00789854|1314886|P3|Overall Study|Withdrawal by Subject|17
391569|NCT00789854|1314887|P2|Overall Study|Withdrawal by Subject|6
391570|NCT00789854|1314888|P1|Overall Study|Withdrawal by Subject|9
391571|NCT00789854|1314886|P3|Overall Study|Lost to Follow-up|4
391572|NCT00789854|1314887|P2|Overall Study|Lost to Follow-up|1
391573|NCT00789854|1314888|P1|Overall Study|Lost to Follow-up|1
391574|NCT00789854|1314886|P3|Overall Study|Adverse Event|18
391575|NCT00789854|1314887|P2|Overall Study|Adverse Event|23
391576|NCT00789854|1314888|P1|Overall Study|Adverse Event|28
391577|NCT00789828|1314985|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
391578|NCT00789828|1314986|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
391579|NCT00789828|1314985|P2|Open-label Extension Period (4 Years)|Disease progression|0
391580|NCT00789828|1314986|P1|Open-label Extension Period (4 Years)|Disease progression|1
391581|NCT00789828|1314985|P2|Open-label Extension Period (4 Years)|Death|0
391582|NCT00789828|1314986|P1|Open-label Extension Period (4 Years)|Death|1
391583|NCT00789828|1314985|P2|Open-label Extension Period (4 Years)|Administrative problems|0
391584|NCT00789828|1314986|P1|Open-label Extension Period (4 Years)|Administrative problems|7
391585|NCT00789828|1314985|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
391586|NCT00789828|1314986|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
391587|NCT00789828|1314985|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
391588|NCT00789828|1314986|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
391589|NCT00789828|1314985|P2|Open-label Extension Period (4 Years)|Adverse Event|0
391590|NCT00789828|1314986|P1|Open-label Extension Period (4 Years)|Adverse Event|10
391591|NCT00789828|1314985|P2|Core Period (48 Weeks)|Lost to Follow-up|1
391592|NCT00789828|1314986|P1|Core Period (48 Weeks)|Lost to Follow-up|0
391593|NCT00789828|1314985|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
391594|NCT00789828|1314986|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
391595|NCT00789828|1314985|P2|Core Period (48 Weeks)|Administrative problems|1
391596|NCT00789828|1314986|P1|Core Period (48 Weeks)|Administrative problems|0
391597|NCT00789815|1315020|P2|Overall Study|Intubation due to massive bleeding|0
391598|NCT00789815|1315021|P1|Overall Study|Intubation due to massive bleeding|1
391599|NCT00789815|1315020|P2|Overall Study|Protocol Violation|1
391600|NCT00789815|1315021|P1|Overall Study|Protocol Violation|6
391601|NCT00789737|1315110|P2|Overall Study|not specified|7
391602|NCT00789737|1315111|P1|Overall Study|not specified|11
391603|NCT00789737|1315110|P2|Overall Study|hyperglycemia that met protocol-specifie|4
391604|NCT00789737|1315111|P1|Overall Study|hyperglycemia that met protocol-specifie|0
391605|NCT00789737|1315110|P2|Overall Study|Lack of Efficacy|0
391606|NCT00789737|1315111|P1|Overall Study|Lack of Efficacy|3
391607|NCT00789737|1315110|P2|Overall Study|Protocol Violation|0
391608|NCT00789737|1315111|P1|Overall Study|Protocol Violation|3
391609|NCT00789737|1315110|P2|Overall Study|Adverse Event|8
391610|NCT00789737|1315111|P1|Overall Study|Adverse Event|8
391611|NCT00789737|1315110|P2|Overall Study|Lost to Follow-up|14
391612|NCT00789737|1315111|P1|Overall Study|Lost to Follow-up|10
391613|NCT00789737|1315110|P2|Overall Study|Withdrawal by Subject|22
391614|NCT00789737|1315111|P1|Overall Study|Withdrawal by Subject|13
391615|NCT00789698|1315154|P4|Overall Study|Administrative|1
391616|NCT00789698|1315155|P3|Overall Study|Administrative|3
391617|NCT00789698|1315156|P2|Overall Study|Administrative|3
391618|NCT00789698|1315157|P1|Overall Study|Administrative|0
391619|NCT00789698|1315154|P4|Overall Study|Withdrawal by Subject|19
391620|NCT00789698|1315155|P3|Overall Study|Withdrawal by Subject|12
391621|NCT00789698|1315156|P2|Overall Study|Withdrawal by Subject|15
391622|NCT00789698|1315157|P1|Overall Study|Withdrawal by Subject|14
391623|NCT00789698|1315154|P4|Overall Study|Protocol Violation|1
391624|NCT00789698|1315155|P3|Overall Study|Protocol Violation|2
391625|NCT00789698|1315156|P2|Overall Study|Protocol Violation|1
391626|NCT00789698|1315157|P1|Overall Study|Protocol Violation|6
391627|NCT00789698|1315154|P4|Overall Study|Lost to Follow-up|9
391628|NCT00789698|1315155|P3|Overall Study|Lost to Follow-up|2
391629|NCT00789698|1315156|P2|Overall Study|Lost to Follow-up|5
391630|NCT00789698|1315157|P1|Overall Study|Lost to Follow-up|5
391631|NCT00789698|1315154|P4|Overall Study|Adverse Event|4
391632|NCT00789698|1315155|P3|Overall Study|Adverse Event|3
391633|NCT00789698|1315156|P2|Overall Study|Adverse Event|5
391634|NCT00789698|1315157|P1|Overall Study|Adverse Event|5
391635|NCT00789698|1315154|P4|Overall Study|Lack of Efficacy|18
391636|NCT00789698|1315155|P3|Overall Study|Lack of Efficacy|5
391637|NCT00789698|1315156|P2|Overall Study|Lack of Efficacy|4
391638|NCT00789698|1315157|P1|Overall Study|Lack of Efficacy|10
391639|NCT00789581|1315212|P2|Adjuvant Therapy|Not Specified|1
391640|NCT00789581|1315213|P1|Adjuvant Therapy|Not Specified|0
391641|NCT00789581|1315212|P2|Adjuvant Therapy|Protocol Violation|1
391642|NCT00789581|1315213|P1|Adjuvant Therapy|Protocol Violation|1
391643|NCT00789581|1315212|P2|Adjuvant Therapy|Intercurrent Illness|3
391644|NCT00789581|1315213|P1|Adjuvant Therapy|Intercurrent Illness|1
391645|NCT00789581|1315212|P2|Adjuvant Therapy|Disease recurrence|1
391646|NCT00789581|1315213|P1|Adjuvant Therapy|Disease recurrence|2
391647|NCT00789581|1315212|P2|Adjuvant Therapy|Withdrawal by Subject|5
391648|NCT00789581|1315213|P1|Adjuvant Therapy|Withdrawal by Subject|14
391649|NCT00789581|1315212|P2|Adjuvant Therapy|Adverse Event|44
391650|NCT00789581|1315213|P1|Adjuvant Therapy|Adverse Event|20
391651|NCT00789581|1315212|P2|Adjuvant Therapy|Never treated|2
391652|NCT00789581|1315213|P1|Adjuvant Therapy|Never treated|2
391653|NCT00789581|1315212|P2|AC Therapy|Not specified|2
391654|NCT00789581|1315213|P1|AC Therapy|Not specified|0
391655|NCT00789581|1315212|P2|AC Therapy|Never Treated|4
391656|NCT00789581|1315213|P1|AC Therapy|Never Treated|1
391657|NCT00789581|1315212|P2|AC Therapy|Intercurrent Illness|0
391658|NCT00789581|1315213|P1|AC Therapy|Intercurrent Illness|1
391659|NCT00789581|1315212|P2|AC Therapy|Disease recurrence|1
391660|NCT00789581|1315213|P1|AC Therapy|Disease recurrence|3
391661|NCT00789581|1315212|P2|AC Therapy|Withdrawal by Subject|7
391662|NCT00789581|1315213|P1|AC Therapy|Withdrawal by Subject|4
391663|NCT00789581|1315212|P2|AC Therapy|Adverse Event|3
391664|NCT00789581|1315213|P1|AC Therapy|Adverse Event|2
391665|NCT00789555|1315224|P3|Overall Study|Protocol Violation|13
391666|NCT00789555|1315225|P2|Overall Study|Protocol Violation|9
391667|NCT00789555|1315226|P1|Overall Study|Protocol Violation|6
391668|NCT00789555|1315224|P3|Overall Study|Treatment failure|12
391669|NCT00789555|1315225|P2|Overall Study|Treatment failure|8
391670|NCT00789555|1315226|P1|Overall Study|Treatment failure|11
391671|NCT00789555|1315224|P3|Overall Study|Patient decision unnrelated to adv event|26
391672|NCT00789555|1315225|P2|Overall Study|Patient decision unnrelated to adv event|29
391673|NCT00789555|1315226|P1|Overall Study|Patient decision unnrelated to adv event|38
391674|NCT00789555|1315224|P3|Overall Study|Lost to Follow-up|18
391675|NCT00789555|1315225|P2|Overall Study|Lost to Follow-up|10
391676|NCT00789555|1315226|P1|Overall Study|Lost to Follow-up|9
391677|NCT00789555|1315224|P3|Overall Study|Adverse Event|10
391678|NCT00789555|1315225|P2|Overall Study|Adverse Event|7
391679|NCT00789555|1315226|P1|Overall Study|Adverse Event|17
391680|NCT00789555|1315224|P3|Overall Study|Protocol Amendment|80
391681|NCT00789555|1315225|P2|Overall Study|Protocol Amendment|76
391682|NCT00789555|1315226|P1|Overall Study|Protocol Amendment|78
391683|NCT00789529|1315251|P2|Overall Study|Other Reason|0
391684|NCT00789529|1315252|P1|Overall Study|Other Reason|1
391685|NCT00789529|1315251|P2|Overall Study|Withdrawal by Subject|1
391686|NCT00789529|1315252|P1|Overall Study|Withdrawal by Subject|0
391687|NCT00789477|1315265|P5|Overall Study|Other|0
391688|NCT00789477|1315266|P4|Overall Study|Other|3
391689|NCT00789477|1315267|P3|Overall Study|Other|1
391690|NCT00789477|1315268|P2|Overall Study|Other|0
391691|NCT00789477|1315269|P1|Overall Study|Other|2
391692|NCT00789477|1315265|P5|Overall Study|Lack of Efficacy|0
391693|NCT00789477|1315266|P4|Overall Study|Lack of Efficacy|0
391694|NCT00789477|1315267|P3|Overall Study|Lack of Efficacy|0
391695|NCT00789477|1315268|P2|Overall Study|Lack of Efficacy|0
391696|NCT00789477|1315269|P1|Overall Study|Lack of Efficacy|2
391697|NCT00789477|1315265|P5|Overall Study|Lost to Follow-up|4
391698|NCT00789477|1315266|P4|Overall Study|Lost to Follow-up|2
391699|NCT00789477|1315267|P3|Overall Study|Lost to Follow-up|4
391700|NCT00789477|1315268|P2|Overall Study|Lost to Follow-up|1
391701|NCT00789477|1315269|P1|Overall Study|Lost to Follow-up|0
391702|NCT00789477|1315265|P5|Overall Study|Death|0
391703|NCT00789477|1315266|P4|Overall Study|Death|2
391704|NCT00789477|1315267|P3|Overall Study|Death|2
391705|NCT00789477|1315268|P2|Overall Study|Death|1
391706|NCT00789477|1315269|P1|Overall Study|Death|1
391707|NCT00789477|1315265|P5|Overall Study|Adverse Event|0
391708|NCT00789477|1315266|P4|Overall Study|Adverse Event|0
391709|NCT00789477|1315267|P3|Overall Study|Adverse Event|1
391710|NCT00789477|1315268|P2|Overall Study|Adverse Event|3
391711|NCT00789477|1315269|P1|Overall Study|Adverse Event|3
391712|NCT00789477|1315265|P5|Overall Study|Protocol Violation|0
391713|NCT00789477|1315266|P4|Overall Study|Protocol Violation|1
391714|NCT00789477|1315267|P3|Overall Study|Protocol Violation|0
391715|NCT00789477|1315268|P2|Overall Study|Protocol Violation|0
391716|NCT00789477|1315269|P1|Overall Study|Protocol Violation|1
391717|NCT00789477|1315265|P5|Overall Study|Withdrawal by Subject|3
391718|NCT00789477|1315266|P4|Overall Study|Withdrawal by Subject|2
391719|NCT00789477|1315267|P3|Overall Study|Withdrawal by Subject|3
391720|NCT00789477|1315268|P2|Overall Study|Withdrawal by Subject|1
391721|NCT00789477|1315269|P1|Overall Study|Withdrawal by Subject|2
391722|NCT00789373|1315314|P3|Maintenance|Participants On-Going at Data Cut-Off|0
391723|NCT00789373|1315315|P2|Maintenance|Participants On-Going at Data Cut-Off|4
391724|NCT00789373|1315316|P1|Maintenance|Participants On-Going at Data Cut-Off|0
391725|NCT00789373|1315314|P3|Maintenance|Sponsor Decision|2
391726|NCT00789373|1315315|P2|Maintenance|Sponsor Decision|0
391727|NCT00789373|1315316|P1|Maintenance|Sponsor Decision|0
391728|NCT00789373|1315314|P3|Maintenance|Withdrawal by Subject|8
391729|NCT00789373|1315315|P2|Maintenance|Withdrawal by Subject|21
391730|NCT00789373|1315316|P1|Maintenance|Withdrawal by Subject|0
391731|NCT00789373|1315314|P3|Maintenance|Progressive Disease|152
391732|NCT00789373|1315315|P2|Maintenance|Progressive Disease|253
391733|NCT00789373|1315316|P1|Maintenance|Progressive Disease|0
391734|NCT00789373|1315314|P3|Maintenance|Lost to Follow-up|0
391735|NCT00789373|1315315|P2|Maintenance|Lost to Follow-up|2
391736|NCT00789373|1315316|P1|Maintenance|Lost to Follow-up|0
391737|NCT00789373|1315314|P3|Maintenance|Protocol entry criteria not met|0
391738|NCT00789373|1315315|P2|Maintenance|Protocol entry criteria not met|2
391739|NCT00789373|1315316|P1|Maintenance|Protocol entry criteria not met|0
391740|NCT00789373|1315314|P3|Maintenance|Investigator Decision|2
391741|NCT00789373|1315315|P2|Maintenance|Investigator Decision|4
391742|NCT00789373|1315316|P1|Maintenance|Investigator Decision|0
391743|NCT00789373|1315314|P3|Maintenance|Death due to toxicity|2
391744|NCT00789373|1315315|P2|Maintenance|Death due to toxicity|1
391745|NCT00789373|1315316|P1|Maintenance|Death due to toxicity|0
391746|NCT00789373|1315314|P3|Maintenance|Death due to adverse event|1
391747|NCT00789373|1315315|P2|Maintenance|Death due to adverse event|4
391748|NCT00789373|1315316|P1|Maintenance|Death due to adverse event|0
391749|NCT00789373|1315314|P3|Maintenance|Death due to study disease|1
391750|NCT00789373|1315315|P2|Maintenance|Death due to study disease|3
391751|NCT00789373|1315316|P1|Maintenance|Death due to study disease|0
391752|NCT00789373|1315314|P3|Maintenance|Adverse Event|12
391753|NCT00789373|1315315|P2|Maintenance|Adverse Event|65
391754|NCT00789373|1315316|P1|Maintenance|Adverse Event|0
391755|NCT00789373|1315314|P3|Induction|Withdrawal by Subject|0
391756|NCT00789373|1315315|P2|Induction|Withdrawal by Subject|0
391757|NCT00789373|1315316|P1|Induction|Withdrawal by Subject|37
391758|NCT00789373|1315314|P3|Induction|Progressive Disease|0
391759|NCT00789373|1315315|P2|Induction|Progressive Disease|0
391760|NCT00789373|1315316|P1|Induction|Progressive Disease|220
391761|NCT00789373|1315314|P3|Induction|Protocol Violation|0
391762|NCT00789373|1315315|P2|Induction|Protocol Violation|0
391763|NCT00789373|1315316|P1|Induction|Protocol Violation|1
391764|NCT00789373|1315314|P3|Induction|Lost to Follow-up|0
391765|NCT00789373|1315315|P2|Induction|Lost to Follow-up|0
391766|NCT00789373|1315316|P1|Induction|Lost to Follow-up|6
391767|NCT00789373|1315314|P3|Induction|Protocol entry criteria not met|0
391768|NCT00789373|1315315|P2|Induction|Protocol entry criteria not met|0
391769|NCT00789373|1315316|P1|Induction|Protocol entry criteria not met|9
391770|NCT00789373|1315314|P3|Induction|Investigator decision|0
391771|NCT00789373|1315315|P2|Induction|Investigator decision|0
391772|NCT00789373|1315316|P1|Induction|Investigator decision|7
391773|NCT00789373|1315314|P3|Induction|Death due to procedure|0
391774|NCT00789373|1315315|P2|Induction|Death due to procedure|0
391775|NCT00789373|1315316|P1|Induction|Death due to procedure|1
391776|NCT00789373|1315314|P3|Induction|Death due to toxicity|0
391777|NCT00789373|1315315|P2|Induction|Death due to toxicity|0
391778|NCT00789373|1315316|P1|Induction|Death due to toxicity|11
391779|NCT00789373|1315314|P3|Induction|Death due to adverse event|0
391780|NCT00789373|1315315|P2|Induction|Death due to adverse event|0
391781|NCT00789373|1315316|P1|Induction|Death due to adverse event|19
391782|NCT00789373|1315314|P3|Induction|Death Due to study disease|0
391783|NCT00789373|1315315|P2|Induction|Death Due to study disease|0
391784|NCT00789373|1315316|P1|Induction|Death Due to study disease|24
391785|NCT00789373|1315314|P3|Induction|Adverse Event|0
391786|NCT00789373|1315315|P2|Induction|Adverse Event|0
391787|NCT00789373|1315316|P1|Induction|Adverse Event|64
391788|NCT00789321|1315343|P2|Overall Study|Adverse Event|1
391789|NCT00789321|1315344|P1|Overall Study|Adverse Event|0
391790|NCT00789191|1315363|P2|Overall Study|Unclassified|3
391791|NCT00789191|1315364|P1|Overall Study|Unclassified|5
391792|NCT00789191|1315363|P2|Overall Study|Withdrawal Criteria|4
391793|NCT00789191|1315364|P1|Overall Study|Withdrawal Criteria|2
391794|NCT00789191|1315363|P2|Overall Study|Protocol Violation|3
391795|NCT00789191|1315364|P1|Overall Study|Protocol Violation|5
391796|NCT00789191|1315363|P2|Overall Study|Lack of Efficacy|5
391797|NCT00789191|1315364|P1|Overall Study|Lack of Efficacy|0
391798|NCT00789191|1315363|P2|Overall Study|Adverse Event|4
391799|NCT00789191|1315364|P1|Overall Study|Adverse Event|2
391800|NCT00789035|1315421|P5|Overall Study|Other reason not defined above|1
391801|NCT00789035|1315422|P4|Overall Study|Other reason not defined above|0
391802|NCT00789035|1315423|P3|Overall Study|Other reason not defined above|1
391803|NCT00789035|1315424|P2|Overall Study|Other reason not defined above|3
391804|NCT00789035|1315425|P1|Overall Study|Other reason not defined above|2
391805|NCT00789035|1315421|P5|Overall Study|Withdrawal by Subject|0
391806|NCT00789035|1315422|P4|Overall Study|Withdrawal by Subject|0
391807|NCT00789035|1315423|P3|Overall Study|Withdrawal by Subject|0
391808|NCT00789035|1315424|P2|Overall Study|Withdrawal by Subject|2
391809|NCT00789035|1315425|P1|Overall Study|Withdrawal by Subject|0
391810|NCT00789035|1315421|P5|Overall Study|Protocol Violation|0
391811|NCT00789035|1315422|P4|Overall Study|Protocol Violation|0
391812|NCT00789035|1315423|P3|Overall Study|Protocol Violation|0
391813|NCT00789035|1315424|P2|Overall Study|Protocol Violation|0
391814|NCT00789035|1315425|P1|Overall Study|Protocol Violation|1
391815|NCT00789035|1315421|P5|Overall Study|Lack of Efficacy|2
391816|NCT00789035|1315422|P4|Overall Study|Lack of Efficacy|0
391817|NCT00789035|1315423|P3|Overall Study|Lack of Efficacy|0
391818|NCT00789035|1315424|P2|Overall Study|Lack of Efficacy|0
391819|NCT00789035|1315425|P1|Overall Study|Lack of Efficacy|3
391820|NCT00789035|1315421|P5|Overall Study|Adverse Event|3
391821|NCT00789035|1315422|P4|Overall Study|Adverse Event|1
391822|NCT00789035|1315423|P3|Overall Study|Adverse Event|0
391823|NCT00789035|1315424|P2|Overall Study|Adverse Event|2
391824|NCT00789035|1315425|P1|Overall Study|Adverse Event|0
391825|NCT00788957|1315484|P6|Part 3|On-study at time of data cut-off|0
391826|NCT00788957|1315485|P5|Part 3|On-study at time of data cut-off|1
391827|NCT00788957|1315486|P4|Part 3|On-study at time of data cut-off|0
391828|NCT00788957|1315487|P3|Part 3|On-study at time of data cut-off|0
391829|NCT00788957|1315488|P2|Part 3|On-study at time of data cut-off|0
391830|NCT00788957|1315489|P1|Part 3|On-study at time of data cut-off|0
391831|NCT00788957|1315484|P6|Part 3|Death|9
391832|NCT00788957|1315485|P5|Part 3|Death|8
391833|NCT00788957|1315486|P4|Part 3|Death|0
391834|NCT00788957|1315487|P3|Part 3|Death|0
391835|NCT00788957|1315488|P2|Part 3|Death|0
391836|NCT00788957|1315489|P1|Part 3|Death|0
391837|NCT00788957|1315484|P6|Part 3|Withdrawal by Subject|2
391838|NCT00788957|1315485|P5|Part 3|Withdrawal by Subject|0
391839|NCT00788957|1315486|P4|Part 3|Withdrawal by Subject|0
391840|NCT00788957|1315487|P3|Part 3|Withdrawal by Subject|0
391841|NCT00788957|1315488|P2|Part 3|Withdrawal by Subject|0
391842|NCT00788957|1315489|P1|Part 3|Withdrawal by Subject|0
391843|NCT00788957|1315484|P6|Part 2|On-study at time of data cut-off|0
391844|NCT00788957|1315485|P5|Part 2|On-study at time of data cut-off|0
391845|NCT00788957|1315486|P4|Part 2|On-study at time of data cut-off|1
391846|NCT00788957|1315487|P3|Part 2|On-study at time of data cut-off|1
391847|NCT00788957|1315488|P2|Part 2|On-study at time of data cut-off|1
391848|NCT00788957|1315489|P1|Part 2|On-study at time of data cut-off|0
391849|NCT00788957|1315484|P6|Part 2|Lost to Follow-up|0
391850|NCT00788957|1315485|P5|Part 2|Lost to Follow-up|0
391851|NCT00788957|1315486|P4|Part 2|Lost to Follow-up|0
391852|NCT00788957|1315487|P3|Part 2|Lost to Follow-up|3
391853|NCT00788957|1315488|P2|Part 2|Lost to Follow-up|0
391854|NCT00788957|1315489|P1|Part 2|Lost to Follow-up|0
391855|NCT00788957|1315484|P6|Part 2|Death|0
391856|NCT00788957|1315485|P5|Part 2|Death|0
391857|NCT00788957|1315486|P4|Part 2|Death|37
391858|NCT00788957|1315487|P3|Part 2|Death|35
391859|NCT00788957|1315488|P2|Part 2|Death|32
391860|NCT00788957|1315489|P1|Part 2|Death|0
391861|NCT00788957|1315484|P6|Part 2|Withdrawal by Subject|0
391862|NCT00788957|1315485|P5|Part 2|Withdrawal by Subject|0
391863|NCT00788957|1315486|P4|Part 2|Withdrawal by Subject|3
391864|NCT00788957|1315487|P3|Part 2|Withdrawal by Subject|5
391865|NCT00788957|1315488|P2|Part 2|Withdrawal by Subject|9
391866|NCT00788957|1315489|P1|Part 2|Withdrawal by Subject|0
391867|NCT00788957|1315484|P6|Part 1|Lost to Follow-up|0
391868|NCT00788957|1315485|P5|Part 1|Lost to Follow-up|0
391869|NCT00788957|1315486|P4|Part 1|Lost to Follow-up|0
391870|NCT00788957|1315487|P3|Part 1|Lost to Follow-up|0
391871|NCT00788957|1315488|P2|Part 1|Lost to Follow-up|0
391872|NCT00788957|1315489|P1|Part 1|Lost to Follow-up|1
391873|NCT00788957|1315484|P6|Part 1|Death|0
391874|NCT00788957|1315485|P5|Part 1|Death|0
391875|NCT00788957|1315486|P4|Part 1|Death|0
391876|NCT00788957|1315487|P3|Part 1|Death|0
391877|NCT00788957|1315488|P2|Part 1|Death|0
391878|NCT00788957|1315489|P1|Part 1|Death|8
391879|NCT00788775|1315564|P2|Overall Study|Patient's measurable disease resected.|0
391880|NCT00788775|1315565|P1|Overall Study|Patient's measurable disease resected.|1
391881|NCT00788775|1315564|P2|Overall Study|Patient Non-Compliance|0
391882|NCT00788775|1315565|P1|Overall Study|Patient Non-Compliance|1
391883|NCT00788775|1315564|P2|Overall Study|Withdrawal by Subject|2
391884|NCT00788775|1315565|P1|Overall Study|Withdrawal by Subject|0
391885|NCT00788775|1315564|P2|Overall Study|Progressive Disease|6
391886|NCT00788775|1315565|P1|Overall Study|Progressive Disease|8
391887|NCT00788710|1315580|P3|Overall Study|Withdrawal by Subject|0
391888|NCT00788710|1315581|P2|Overall Study|Withdrawal by Subject|2
391889|NCT00788710|1315582|P1|Overall Study|Withdrawal by Subject|2
391890|NCT00788710|1315580|P3|Overall Study|Protocol Violation|1
391891|NCT00788710|1315581|P2|Overall Study|Protocol Violation|1
391892|NCT00788710|1315582|P1|Overall Study|Protocol Violation|0
391893|NCT00788710|1315580|P3|Overall Study|Physician Decision|0
391894|NCT00788710|1315581|P2|Overall Study|Physician Decision|1
391895|NCT00788710|1315582|P1|Overall Study|Physician Decision|2
391896|NCT00788710|1315580|P3|Overall Study|Lost to Follow-up|0
391897|NCT00788710|1315581|P2|Overall Study|Lost to Follow-up|1
391898|NCT00788710|1315582|P1|Overall Study|Lost to Follow-up|0
391899|NCT00788710|1315580|P3|Overall Study|Lack of Efficacy|1
391900|NCT00788710|1315581|P2|Overall Study|Lack of Efficacy|0
391901|NCT00788710|1315582|P1|Overall Study|Lack of Efficacy|0
391902|NCT00788710|1315580|P3|Overall Study|Adverse Event|4
391903|NCT00788710|1315581|P2|Overall Study|Adverse Event|3
391904|NCT00788710|1315582|P1|Overall Study|Adverse Event|1
391905|NCT00788697|1315596|P1|Overall Study|Indeterminate diagnosis from truth stand|17
391906|NCT00788697|1315596|P1|Overall Study|Technically inadequate truth standard|1
391907|NCT00788697|1315596|P1|Overall Study|no truth standard procedure available|5
391908|NCT00788697|1315596|P1|Overall Study|Training Patients|74
391909|NCT00788697|1315596|P1|Overall Study|No study drug administered|12
391910|NCT00788593|1315643|P3|Second Intervention Period|Other|1
391911|NCT00788593|1315644|P2|Second Intervention Period|Other|0
391912|NCT00788593|1315645|P1|Second Intervention Period|Other|0
391913|NCT00788593|1315643|P3|Second Intervention Period|Lost to Follow-up|0
391914|NCT00788593|1315644|P2|Second Intervention Period|Lost to Follow-up|1
391915|NCT00788593|1315645|P1|Second Intervention Period|Lost to Follow-up|0
391916|NCT00788593|1315643|P3|First Intervention Period|Adverse Event|0
391917|NCT00788593|1315644|P2|First Intervention Period|Adverse Event|1
391918|NCT00788593|1315645|P1|First Intervention Period|Adverse Event|0
391919|NCT00788593|1315643|P3|Placebo Run-in Phase|Protocol Violation|0
391920|NCT00788593|1315644|P2|Placebo Run-in Phase|Protocol Violation|0
391921|NCT00788593|1315645|P1|Placebo Run-in Phase|Protocol Violation|2
391922|NCT00788593|1315643|P3|Placebo Run-in Phase|Withdrawal by Subject|0
391923|NCT00788593|1315644|P2|Placebo Run-in Phase|Withdrawal by Subject|0
391924|NCT00788593|1315645|P1|Placebo Run-in Phase|Withdrawal by Subject|2
391925|NCT00788593|1315643|P3|Placebo Run-in Phase|Adverse Event|0
391926|NCT00788593|1315644|P2|Placebo Run-in Phase|Adverse Event|0
391927|NCT00788593|1315645|P1|Placebo Run-in Phase|Adverse Event|2
391928|NCT00788372|1315662|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
391929|NCT00788372|1315662|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
391930|NCT00788372|1315662|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
391931|NCT00788372|1315662|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
391932|NCT00788372|1315662|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
391933|NCT00788372|1315662|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
391934|NCT00788372|1315662|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
391935|NCT00788073|1315691|P2|Placebo Then STX209|Protocol Violation|1
391936|NCT00788073|1315692|P1|Placebo Then STX209|Protocol Violation|0
391937|NCT00788073|1315691|P2|Placebo Then STX209|Adverse Event|0
391938|NCT00788073|1315692|P1|Placebo Then STX209|Adverse Event|2
391939|NCT00788073|1315691|P2|STX209 Then Placebo|unable to return due to travel|1
391940|NCT00788073|1315692|P1|STX209 Then Placebo|unable to return due to travel|0
391941|NCT00788073|1315691|P2|STX209 Then Placebo|Withdrawal by Subject|1
391942|NCT00788073|1315692|P1|STX209 Then Placebo|Withdrawal by Subject|0
391943|NCT00788073|1315691|P2|STX209 Then Placebo|Lost to Follow-up|1
391944|NCT00788073|1315692|P1|STX209 Then Placebo|Lost to Follow-up|0
391945|NCT00788073|1315691|P2|STX209 Then Placebo|Adverse Event|0
391946|NCT00788073|1315692|P1|STX209 Then Placebo|Adverse Event|1
391947|NCT00787930|1315717|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
391948|NCT00787917|1315732|P2|Open Label|Administrative problems|0
391949|NCT00787917|1315733|P1|Open Label|Administrative problems|3
391950|NCT00787917|1315732|P2|Open Label|Unsatisfactory therapeutic effect|0
391951|NCT00787917|1315733|P1|Open Label|Unsatisfactory therapeutic effect|1
391952|NCT00787917|1315732|P2|Blinded Treatment|Administrative problems|2
391953|NCT00787917|1315733|P1|Blinded Treatment|Administrative problems|3
391954|NCT00787917|1315732|P2|Blinded Treatment|Lack of Efficacy|0
391955|NCT00787917|1315733|P1|Blinded Treatment|Lack of Efficacy|1
391956|NCT00787917|1315732|P2|Blinded Treatment|Adverse Event|0
391957|NCT00787917|1315733|P1|Blinded Treatment|Adverse Event|1
391958|NCT00787891|1315763|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
391959|NCT00787891|1315764|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
391960|NCT00787891|1315763|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
391961|NCT00787891|1315764|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
391962|NCT00787891|1315763|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
391963|NCT00787891|1315764|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
391964|NCT00787891|1315763|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
391965|NCT00787891|1315764|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
391966|NCT00787891|1315763|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
391967|NCT00787891|1315764|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
391968|NCT00787891|1315763|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
391969|NCT00787891|1315764|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
391970|NCT00787891|1315763|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
391971|NCT00787891|1315764|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
391972|NCT00787891|1315763|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
391973|NCT00787891|1315764|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
391974|NCT00787891|1315763|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
391975|NCT00787891|1315764|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
391976|NCT00787891|1315763|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
391977|NCT00787891|1315764|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
391978|NCT00787839|1315791|P1|Overall Study|Failure to have the OGTT was most common|404
391979|NCT00787800|1315814|P2|Overall Study|Death|2
391980|NCT00787800|1315815|P1|Overall Study|Death|0
391981|NCT00787800|1315814|P2|Overall Study|Withdrawal by Subject|5
391982|NCT00787800|1315815|P1|Overall Study|Withdrawal by Subject|3
391983|NCT00787787|1315831|P1|Overall Study|Adverse Event|3
391984|NCT00787787|1315831|P1|Overall Study|Lack of Efficacy|4
391985|NCT00787644|1315850|P2|Overall Study|Withdrawal by Subject|1
391986|NCT00787644|1315851|P1|Overall Study|Withdrawal by Subject|1
391987|NCT00787644|1315850|P2|Overall Study|Lost to Follow-up|1
391988|NCT00787644|1315851|P1|Overall Study|Lost to Follow-up|1
391989|NCT00787605|1315872|P2|Overall Study|Lack of Efficacy|9
391990|NCT00787605|1315873|P1|Overall Study|Lack of Efficacy|13
391991|NCT00787605|1315872|P2|Overall Study|Withdrawal by Subject|13
391992|NCT00787605|1315873|P1|Overall Study|Withdrawal by Subject|6
391993|NCT00787605|1315872|P2|Overall Study|Protocol Violation|3
391994|NCT00787605|1315873|P1|Overall Study|Protocol Violation|7
391995|NCT00787605|1315872|P2|Overall Study|Lost to Follow-up|6
391996|NCT00787605|1315873|P1|Overall Study|Lost to Follow-up|3
391997|NCT00787605|1315872|P2|Overall Study|Adverse Event|25
391998|NCT00787605|1315873|P1|Overall Study|Adverse Event|14
391999|NCT00787605|1315872|P2|Overall Study|Administrative Problems|0
392000|NCT00787605|1315873|P1|Overall Study|Administrative Problems|3
392001|NCT00787566|1315892|P3|Overall Study|AE related to chemotherapy|0
392002|NCT00787566|1315893|P2|Overall Study|AE related to chemotherapy|1
392003|NCT00787566|1315894|P1|Overall Study|AE related to chemotherapy|0
392004|NCT00787527|1315902|P1|Overall Study|Toxicity|3
392005|NCT00787319|1315919|P1|Overall Study|Inactive disease|5
392006|NCT00787319|1315919|P1|Overall Study|Stabilized disease findings|3
392007|NCT00787319|1315919|P1|Overall Study|No health insurance reimbursement|2
392008|NCT00787319|1315919|P1|Overall Study|Unresponsiveness to visit invitation|1
392009|NCT00787319|1315919|P1|Overall Study|Budget exhausted/exceeded|1
392010|NCT00787319|1315919|P1|Overall Study|Lack of Efficacy|1
392011|NCT00787319|1315919|P1|Overall Study|Objective progression or relapse|30
392012|NCT00787319|1315919|P1|Overall Study|Adverse Event|3
392013|NCT00787319|1315919|P1|Overall Study|Withdrawal by Subject|15
392014|NCT00787319|1315919|P1|Overall Study|Lost to Follow-up|2
392015|NCT00787267|1315931|P1|Overall Study|Withdrawal by Subject|1
392016|NCT00787267|1315931|P1|Overall Study|No Reason Provided|1
392017|NCT00787267|1315931|P1|Overall Study|Screen failure/Ineligible|10
392018|NCT00787254|1315941|P2|Overall Study|Physician Decision|8
392019|NCT00787254|1315942|P1|Overall Study|Physician Decision|4
392020|NCT00787254|1315941|P2|Overall Study|Institution closed|0
392021|NCT00787254|1315942|P1|Overall Study|Institution closed|1
392022|NCT00787254|1315941|P2|Overall Study|NSAIDs discontinuation|2
392023|NCT00787254|1315942|P1|Overall Study|NSAIDs discontinuation|1
392024|NCT00787254|1315941|P2|Overall Study|Lack of Efficacy|15
392025|NCT00787254|1315942|P1|Overall Study|Lack of Efficacy|4
392026|NCT00787254|1315941|P2|Overall Study|Withdrawal by Subject|11
392027|NCT00787254|1315942|P1|Overall Study|Withdrawal by Subject|16
392028|NCT00787254|1315941|P2|Overall Study|Protocol Violation|23
392029|NCT00787254|1315942|P1|Overall Study|Protocol Violation|26
392030|NCT00787254|1315941|P2|Overall Study|Adverse Event|23
392031|NCT00787254|1315942|P1|Overall Study|Adverse Event|24
392032|NCT00787202|1316066|P5|Overall Study|Randomized, not treated|0
392033|NCT00787202|1316067|P4|Overall Study|Randomized, not treated|0
392034|NCT00787202|1316068|P3|Overall Study|Randomized, not treated|0
392035|NCT00787202|1316069|P2|Overall Study|Randomized, not treated|0
392036|NCT00787202|1316070|P1|Overall Study|Randomized, not treated|1
392037|NCT00787202|1316066|P5|Overall Study|Protocol Violation|1
392038|NCT00787202|1316067|P4|Overall Study|Protocol Violation|0
392039|NCT00787202|1316068|P3|Overall Study|Protocol Violation|0
392040|NCT00787202|1316069|P2|Overall Study|Protocol Violation|1
392041|NCT00787202|1316070|P1|Overall Study|Protocol Violation|2
392042|NCT00787202|1316066|P5|Overall Study|Withdrawal by Subject|0
392043|NCT00787202|1316067|P4|Overall Study|Withdrawal by Subject|0
392044|NCT00787202|1316068|P3|Overall Study|Withdrawal by Subject|2
392045|NCT00787202|1316069|P2|Overall Study|Withdrawal by Subject|2
392046|NCT00787202|1316070|P1|Overall Study|Withdrawal by Subject|2
392047|NCT00787202|1316066|P5|Overall Study|Lost to Follow-up|0
392048|NCT00787202|1316067|P4|Overall Study|Lost to Follow-up|0
392049|NCT00787202|1316068|P3|Overall Study|Lost to Follow-up|0
392050|NCT00787202|1316069|P2|Overall Study|Lost to Follow-up|0
392051|NCT00787202|1316070|P1|Overall Study|Lost to Follow-up|1
392052|NCT00787202|1316066|P5|Overall Study|Lack of Efficacy|1
392053|NCT00787202|1316067|P4|Overall Study|Lack of Efficacy|2
392054|NCT00787202|1316068|P3|Overall Study|Lack of Efficacy|5
392055|NCT00787202|1316069|P2|Overall Study|Lack of Efficacy|6
392056|NCT00787202|1316070|P1|Overall Study|Lack of Efficacy|5
392057|NCT00787202|1316066|P5|Overall Study|Adverse Event|2
392058|NCT00787202|1316067|P4|Overall Study|Adverse Event|0
392059|NCT00787202|1316068|P3|Overall Study|Adverse Event|0
392060|NCT00787202|1316069|P2|Overall Study|Adverse Event|2
392061|NCT00787202|1316070|P1|Overall Study|Adverse Event|3
392062|NCT00787189|1316123|P2|Overall Study|Lost to Follow-up|2
392063|NCT00787189|1316124|P1|Overall Study|Lost to Follow-up|2
392064|NCT00787150|1316133|P3|Overall Study|Dosing incorrect study durg|0
392065|NCT00787150|1316134|P2|Overall Study|Dosing incorrect study durg|0
392066|NCT00787150|1316135|P1|Overall Study|Dosing incorrect study durg|2
392067|NCT00787150|1316133|P3|Overall Study|Withdrawal by Subject|0
392068|NCT00787150|1316134|P2|Overall Study|Withdrawal by Subject|1
392069|NCT00787150|1316135|P1|Overall Study|Withdrawal by Subject|2
392070|NCT00787150|1316133|P3|Overall Study|Physician Decision|1
392071|NCT00787150|1316134|P2|Overall Study|Physician Decision|2
392072|NCT00787150|1316135|P1|Overall Study|Physician Decision|1
392073|NCT00787150|1316133|P3|Overall Study|Adverse Event|4
392074|NCT00787150|1316134|P2|Overall Study|Adverse Event|4
392075|NCT00787150|1316135|P1|Overall Study|Adverse Event|4
392076|NCT00787137|1316180|P3|Overall Study|Study Termination|1
392077|NCT00787137|1316181|P2|Overall Study|Study Termination|0
392078|NCT00787137|1316182|P1|Overall Study|Study Termination|0
392079|NCT00786864|1316257|P2|Overall Study|Sustained serious back injury|0
392080|NCT00786864|1316258|P1|Overall Study|Sustained serious back injury|1
392081|NCT00786864|1316257|P2|Overall Study|Lost to Follow-up|1
392082|NCT00786864|1316258|P1|Overall Study|Lost to Follow-up|0
392083|NCT00786838|1316270|P1|Overall Study|Withdrawal by Subject|4
392084|NCT00786838|1316270|P1|Overall Study|Progressive disease|31
392085|NCT00786838|1316270|P1|Overall Study|Adverse Event|6
392086|NCT00786838|1316270|P1|Overall Study|Death|4
392087|NCT00786838|1316270|P1|Overall Study|Physician Decision|4
392088|NCT00786799|1316297|P2|Overall Study|Lost to Follow-up|1
392089|NCT00786799|1316298|P1|Overall Study|Lost to Follow-up|1
392090|NCT00786565|1316328|P1|Post Surgery|Adapt AO implanted posterior side up|1
392091|NCT00786565|1316328|P1|Post Surgery|Abnormal macular pucker|1
392092|NCT00786565|1316328|P1|Enrollment Prior to Surgery|Protocol Violation|3
392093|NCT00786565|1316328|P1|Enrollment Prior to Surgery|Site Closed|3
392094|NCT00786474|1316385|P2|Overall Study|Not Specified|4
392095|NCT00786474|1316386|P1|Overall Study|Not Specified|4
392096|NCT00786474|1316385|P2|Overall Study|Physician Decision|1
392097|NCT00786474|1316386|P1|Overall Study|Physician Decision|2
392098|NCT00786474|1316385|P2|Overall Study|Lost to Follow-up|3
392099|NCT00786474|1316386|P1|Overall Study|Lost to Follow-up|3
392100|NCT00786474|1316385|P2|Overall Study|Withdrawal by Subject|31
392101|NCT00786474|1316386|P1|Overall Study|Withdrawal by Subject|23
392102|NCT00786474|1316385|P2|Overall Study|Death|4
392103|NCT00786474|1316386|P1|Overall Study|Death|5
392104|NCT00786422|1316398|P1|Follow-up Period|End-of-study done up to 4 days early|2
392105|NCT00786422|1316398|P1|Follow-up Period|Death|1
392106|NCT00786422|1316398|P1|Rivaroxaban Treatment|Adverse Event|2
392107|NCT00786422|1316398|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
392108|NCT00786422|1316398|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
392109|NCT00786422|1316398|P1|Rivaroxaban Treatment|Physician Decision|1
392110|NCT00786422|1316398|P1|Rivaroxaban Treatment|Lack of Efficacy|1
392111|NCT00786422|1316398|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
392112|NCT00786422|1316398|P1|Rivaroxaban Treatment|Death|2
392113|NCT00786409|1316414|P1|Overall Study|Lost to Follow-up|1
392114|NCT00786409|1316414|P1|Overall Study|Pregnancy|2
392115|NCT00786409|1316414|P1|Overall Study|Adverse Event|2
392116|NCT00786409|1316414|P1|Overall Study|Withdrawal by Subject|2
392117|NCT00786188|1316431|P2|Overall Study|Withdrawal by Subject|0
392118|NCT00786188|1316432|P1|Overall Study|Withdrawal by Subject|2
392119|NCT00786188|1316431|P2|Overall Study|Adverse Event|1
392120|NCT00786188|1316432|P1|Overall Study|Adverse Event|3
392121|NCT00786032|1316458|P1|Overall Study|Did not complete in the timeframe|6
392122|NCT00786032|1316458|P1|Overall Study|Withdrawal by Subject|14
392123|NCT00786032|1316458|P1|Overall Study|Death|4
392124|NCT00785980|1316468|P1|7 Day Washout Period|Protocol Violation|3
392125|NCT00785785|1316486|P2|Optional Extension Phase|Study terminated by sponsor|37
392126|NCT00785785|1316487|P1|Optional Extension Phase|Study terminated by sponsor|3
392127|NCT00785785|1316486|P2|Optional Extension Phase|Protocol deviation|2
392128|NCT00785785|1316487|P1|Optional Extension Phase|Protocol deviation|0
392129|NCT00785785|1316486|P2|Optional Extension Phase|Disease progression|70
392130|NCT00785785|1316487|P1|Optional Extension Phase|Disease progression|22
392131|NCT00785785|1316486|P2|Optional Extension Phase|Death|5
392132|NCT00785785|1316487|P1|Optional Extension Phase|Death|1
392133|NCT00785785|1316486|P2|Optional Extension Phase|Administrative problems|0
392134|NCT00785785|1316487|P1|Optional Extension Phase|Administrative problems|2
392135|NCT00785785|1316486|P2|Optional Extension Phase|Lost to Follow-up|0
392136|NCT00785785|1316487|P1|Optional Extension Phase|Lost to Follow-up|1
392137|NCT00785785|1316486|P2|Optional Extension Phase|Withdrawal by Subject|6
392138|NCT00785785|1316487|P1|Optional Extension Phase|Withdrawal by Subject|6
392139|NCT00785785|1316486|P2|Optional Extension Phase|Adverse Event|5
392140|NCT00785785|1316487|P1|Optional Extension Phase|Adverse Event|4
392141|NCT00785785|1316486|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
392142|NCT00785785|1316487|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
392143|NCT00785785|1316486|P2|Core Phase up to 36 Months|Protocol deviation|6
392144|NCT00785785|1316487|P1|Core Phase up to 36 Months|Protocol deviation|5
392145|NCT00785785|1316486|P2|Core Phase up to 36 Months|Disease progression|119
392146|NCT00785785|1316487|P1|Core Phase up to 36 Months|Disease progression|139
392147|NCT00785785|1316486|P2|Core Phase up to 36 Months|Death|8
392148|NCT00785785|1316487|P1|Core Phase up to 36 Months|Death|5
392149|NCT00785785|1316486|P2|Core Phase up to 36 Months|Administrative problems|3
392150|NCT00785785|1316487|P1|Core Phase up to 36 Months|Administrative problems|3
392151|NCT00785785|1316486|P2|Core Phase up to 36 Months|Lost to Follow-up|7
392152|NCT00785785|1316487|P1|Core Phase up to 36 Months|Lost to Follow-up|3
392153|NCT00785785|1316486|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
392154|NCT00785785|1316487|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
392155|NCT00785785|1316486|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
392156|NCT00785785|1316487|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
392157|NCT00785785|1316486|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
392158|NCT00785785|1316487|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
392159|NCT00785785|1316486|P2|Core Phase up to 36 Months|Adverse Event|21
392160|NCT00785785|1316487|P1|Core Phase up to 36 Months|Adverse Event|31
392161|NCT00785785|1316486|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
392162|NCT00785785|1316487|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
392163|NCT00785707|1316501|P1|Overall Study|Lost to Follow-up|7
392164|NCT00785629|1316510|P4|Overall Study|Withdrawal by Subject|2
392165|NCT00785629|1316511|P3|Overall Study|Withdrawal by Subject|2
392166|NCT00785629|1316512|P2|Overall Study|Withdrawal by Subject|1
392167|NCT00785629|1316513|P1|Overall Study|Withdrawal by Subject|0
392168|NCT00785629|1316510|P4|Overall Study|administrative decision|4
392169|NCT00785629|1316511|P3|Overall Study|administrative decision|3
392170|NCT00785629|1316512|P2|Overall Study|administrative decision|1
392171|NCT00785629|1316513|P1|Overall Study|administrative decision|5
392172|NCT00785629|1316510|P4|Overall Study|Protocol Violation|5
392173|NCT00785629|1316511|P3|Overall Study|Protocol Violation|4
392174|NCT00785629|1316512|P2|Overall Study|Protocol Violation|2
392175|NCT00785629|1316513|P1|Overall Study|Protocol Violation|1
392176|NCT00785629|1316510|P4|Overall Study|Adverse Event|5
392177|NCT00785629|1316511|P3|Overall Study|Adverse Event|1
392178|NCT00785629|1316512|P2|Overall Study|Adverse Event|1
392179|NCT00785629|1316513|P1|Overall Study|Adverse Event|2
392180|NCT00785577|1316526|P5|Study Period 3: 1-Week Washout Phase|Death|1
392181|NCT00785577|1316527|P4|Study Period 3: 1-Week Washout Phase|Death|0
392182|NCT00785577|1316528|P3|Study Period 3: 1-Week Washout Phase|Death|0
392183|NCT00785577|1316529|P2|Study Period 3: 1-Week Washout Phase|Death|0
392184|NCT00785577|1316530|P1|Study Period 3: 1-Week Washout Phase|Death|0
392185|NCT00785577|1316526|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
392186|NCT00785577|1316527|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
392187|NCT00785577|1316528|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
392188|NCT00785577|1316529|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
392189|NCT00785577|1316530|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
392190|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
392191|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
392192|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
392193|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
392194|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
392195|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
392196|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
392197|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
392198|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
392199|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
392200|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
392201|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
392202|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
392203|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
392204|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
392205|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Protocol Violation|1
392206|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Protocol Violation|0
392207|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Protocol Violation|1
392208|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Protocol Violation|1
392209|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Protocol Violation|1
392210|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Physician Decision|0
392211|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Physician Decision|0
392212|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Physician Decision|0
392213|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Physician Decision|0
392214|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Physician Decision|1
392215|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
392216|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
392217|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
392218|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
392219|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
392220|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
392221|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
392222|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
392223|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
392224|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
392225|NCT00785577|1316526|P5|Study Period 2: Therapy Phase|Adverse Event|17
392226|NCT00785577|1316527|P4|Study Period 2: Therapy Phase|Adverse Event|10
392227|NCT00785577|1316528|P3|Study Period 2: Therapy Phase|Adverse Event|14
392228|NCT00785577|1316529|P2|Study Period 2: Therapy Phase|Adverse Event|7
392229|NCT00785577|1316530|P1|Study Period 2: Therapy Phase|Adverse Event|5
392230|NCT00785512|1316668|P2|Overall Study|Lack of compliance|1
392231|NCT00785512|1316669|P1|Overall Study|Lack of compliance|0
392232|NCT00785512|1316668|P2|Overall Study|Physician Decision|0
392233|NCT00785512|1316669|P1|Overall Study|Physician Decision|0
392234|NCT00785512|1316668|P2|Overall Study|IVRS Programing Error|0
392235|NCT00785512|1316669|P1|Overall Study|IVRS Programing Error|0
392236|NCT00785512|1316668|P2|Overall Study|Precedure Refused|0
392237|NCT00785512|1316669|P1|Overall Study|Precedure Refused|0
392238|NCT00785512|1316668|P2|Overall Study|Lost to Follow-up|0
392239|NCT00785512|1316669|P1|Overall Study|Lost to Follow-up|3
392240|NCT00785512|1316668|P2|Overall Study|Withdrawal by Subject|1
392241|NCT00785512|1316669|P1|Overall Study|Withdrawal by Subject|0
392242|NCT00785512|1316668|P2|Overall Study|Lack of Efficacy|2
392243|NCT00785512|1316669|P1|Overall Study|Lack of Efficacy|0
392244|NCT00785512|1316668|P2|Overall Study|Adverse Event|0
392245|NCT00785512|1316669|P1|Overall Study|Adverse Event|0
392246|NCT00785512|1316668|P2|Overall Study|Inclusion/Exclusion not meet|0
392247|NCT00785512|1316669|P1|Overall Study|Inclusion/Exclusion not meet|0
392248|NCT00785486|1316678|P1|Midazolam Alone|Withdrawal by Subject|1
392249|NCT00785356|1316702|P1|Overall Study|Study prematurely terminated|8
392250|NCT00785291|1316713|P3|Overall Study|Other Medical Reasons|15
392251|NCT00785291|1316714|P2|Overall Study|Other Medical Reasons|25
392252|NCT00785291|1316715|P1|Overall Study|Other Medical Reasons|29
392253|NCT00785291|1316713|P3|Overall Study|Complicating illness|4
392254|NCT00785291|1316714|P2|Overall Study|Complicating illness|4
392255|NCT00785291|1316715|P1|Overall Study|Complicating illness|6
392256|NCT00785291|1316713|P3|Overall Study|Alternative Therapy|7
392257|NCT00785291|1316714|P2|Overall Study|Alternative Therapy|6
392258|NCT00785291|1316715|P1|Overall Study|Alternative Therapy|12
392259|NCT00785291|1316713|P3|Overall Study|Withdrawal by Subject|17
392260|NCT00785291|1316714|P2|Overall Study|Withdrawal by Subject|36
392261|NCT00785291|1316715|P1|Overall Study|Withdrawal by Subject|35
392262|NCT00785291|1316713|P3|Overall Study|Death|3
392263|NCT00785291|1316714|P2|Overall Study|Death|4
392264|NCT00785291|1316715|P1|Overall Study|Death|7
392265|NCT00785291|1316713|P3|Overall Study|Adverse Event|56
392266|NCT00785291|1316714|P2|Overall Study|Adverse Event|70
392267|NCT00785291|1316715|P1|Overall Study|Adverse Event|39
392268|NCT00785291|1316713|P3|Overall Study|Never began treatment|4
392269|NCT00785291|1316714|P2|Overall Study|Never began treatment|4
392270|NCT00785291|1316715|P1|Overall Study|Never began treatment|8
392271|NCT00785213|1316735|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
392272|NCT00785213|1316735|P1|Quinine Sulfate Alone|Adverse Event|4
392273|NCT00785044|1316746|P1|Overall Study|Withdrawal by Subject|1
392274|NCT00785044|1316746|P1|Overall Study|Lost to Follow-up|266
392275|NCT00785044|1316746|P1|Overall Study|Death|77
392276|NCT00785044|1316746|P1|Overall Study|Dosed at non-participating sites|152
392277|NCT00784979|1316751|P1|Overall Study|incomplete data|6
392278|NCT00784927|1316755|P1|Overall Study|Ineligible|1
392279|NCT00784927|1316755|P1|Overall Study|Protocol Violation|1
392280|NCT00784927|1316755|P1|Overall Study|Cancel Prior to Initiating Treatment|1
392281|NCT00784875|1316767|P4|Period D|Lost to Follow-up|1
392282|NCT00784875|1316768|P3|Period D|Lost to Follow-up|1
392283|NCT00784875|1316769|P2|Period D|Lost to Follow-up|0
392284|NCT00784875|1316770|P1|Period D|Lost to Follow-up|1
392285|NCT00784875|1316767|P4|Period D|Sponsor Decision|0
392286|NCT00784875|1316768|P3|Period D|Sponsor Decision|1
392287|NCT00784875|1316769|P2|Period D|Sponsor Decision|1
392288|NCT00784875|1316770|P1|Period D|Sponsor Decision|1
392289|NCT00784875|1316767|P4|Period D|Physician Decision|0
392290|NCT00784875|1316768|P3|Period D|Physician Decision|0
392291|NCT00784875|1316769|P2|Period D|Physician Decision|1
392292|NCT00784875|1316770|P1|Period D|Physician Decision|0
392293|NCT00784875|1316767|P4|Period D|Withdrawal by Subject|0
392294|NCT00784875|1316768|P3|Period D|Withdrawal by Subject|2
392295|NCT00784875|1316769|P2|Period D|Withdrawal by Subject|0
392296|NCT00784875|1316770|P1|Period D|Withdrawal by Subject|2
392297|NCT00784875|1316767|P4|Period D|Protocol Violation|0
392298|NCT00784875|1316768|P3|Period D|Protocol Violation|0
392299|NCT00784875|1316769|P2|Period D|Protocol Violation|0
392300|NCT00784875|1316770|P1|Period D|Protocol Violation|1
392301|NCT00784875|1316767|P4|Period D|Adverse Event|0
392302|NCT00784875|1316768|P3|Period D|Adverse Event|2
392303|NCT00784875|1316769|P2|Period D|Adverse Event|2
392304|NCT00784875|1316770|P1|Period D|Adverse Event|0
392305|NCT00784875|1316767|P4|Period C|Sponsor Decision|2
392306|NCT00784875|1316768|P3|Period C|Sponsor Decision|4
392307|NCT00784875|1316769|P2|Period C|Sponsor Decision|5
392308|NCT00784875|1316770|P1|Period C|Sponsor Decision|5
392309|NCT00784875|1316767|P4|Period C|Physician Decision|1
392310|NCT00784875|1316768|P3|Period C|Physician Decision|1
392311|NCT00784875|1316769|P2|Period C|Physician Decision|0
392312|NCT00784875|1316770|P1|Period C|Physician Decision|0
392313|NCT00784875|1316767|P4|Period C|Withdrawal by Subject|0
392314|NCT00784875|1316768|P3|Period C|Withdrawal by Subject|2
392315|NCT00784875|1316769|P2|Period C|Withdrawal by Subject|1
392316|NCT00784875|1316770|P1|Period C|Withdrawal by Subject|1
392317|NCT00784875|1316767|P4|Period C|Lack of Efficacy|0
392318|NCT00784875|1316768|P3|Period C|Lack of Efficacy|1
392319|NCT00784875|1316769|P2|Period C|Lack of Efficacy|0
392320|NCT00784875|1316770|P1|Period C|Lack of Efficacy|0
392321|NCT00784875|1316767|P4|Period C|Protocol Violation|2
392322|NCT00784875|1316768|P3|Period C|Protocol Violation|1
392323|NCT00784875|1316769|P2|Period C|Protocol Violation|0
392324|NCT00784875|1316770|P1|Period C|Protocol Violation|0
392325|NCT00784875|1316767|P4|Period C|Adverse Event|2
392326|NCT00784875|1316768|P3|Period C|Adverse Event|4
392327|NCT00784875|1316769|P2|Period C|Adverse Event|0
392328|NCT00784875|1316770|P1|Period C|Adverse Event|1
392329|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
392330|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
392331|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
392332|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
392333|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
392334|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
392335|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
392336|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
392337|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Physician Decision|0
392338|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Physician Decision|1
392339|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Physician Decision|0
392340|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Physician Decision|0
392341|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
392342|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
392343|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
392344|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
392345|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
392346|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
392347|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
392348|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
392349|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Protocol Violation|3
392350|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Protocol Violation|2
392351|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Protocol Violation|1
392352|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Protocol Violation|1
392353|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Adverse Event|1
392354|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Adverse Event|2
392355|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Adverse Event|3
392356|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Adverse Event|0
392357|NCT00784875|1316767|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
392358|NCT00784875|1316768|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
392359|NCT00784875|1316769|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
392360|NCT00784875|1316770|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
392361|NCT00784875|1316767|P4|Period A - Baseline|Lost to Follow-up|2
392362|NCT00784875|1316768|P3|Period A - Baseline|Lost to Follow-up|0
392363|NCT00784875|1316769|P2|Period A - Baseline|Lost to Follow-up|0
392364|NCT00784875|1316770|P1|Period A - Baseline|Lost to Follow-up|0
392365|NCT00784875|1316767|P4|Period A - Baseline|Sponsor Decision|113
392366|NCT00784875|1316768|P3|Period A - Baseline|Sponsor Decision|0
392367|NCT00784875|1316769|P2|Period A - Baseline|Sponsor Decision|0
392368|NCT00784875|1316770|P1|Period A - Baseline|Sponsor Decision|0
392369|NCT00784875|1316767|P4|Period A - Baseline|Physician Decision|2
392370|NCT00784875|1316768|P3|Period A - Baseline|Physician Decision|0
392371|NCT00784875|1316769|P2|Period A - Baseline|Physician Decision|0
392372|NCT00784875|1316770|P1|Period A - Baseline|Physician Decision|0
392373|NCT00784875|1316767|P4|Period A - Baseline|Withdrawal by Subject|27
392374|NCT00784875|1316768|P3|Period A - Baseline|Withdrawal by Subject|0
392375|NCT00784875|1316769|P2|Period A - Baseline|Withdrawal by Subject|0
392376|NCT00784875|1316770|P1|Period A - Baseline|Withdrawal by Subject|0
392377|NCT00784875|1316767|P4|Period A - Baseline|Protocol Violation|25
392378|NCT00784875|1316768|P3|Period A - Baseline|Protocol Violation|0
392379|NCT00784875|1316769|P2|Period A - Baseline|Protocol Violation|0
392380|NCT00784875|1316770|P1|Period A - Baseline|Protocol Violation|0
392381|NCT00784875|1316767|P4|Period A - Baseline|Adverse Event|8
392382|NCT00784875|1316768|P3|Period A - Baseline|Adverse Event|0
392383|NCT00784875|1316769|P2|Period A - Baseline|Adverse Event|0
392384|NCT00784875|1316770|P1|Period A - Baseline|Adverse Event|0
392385|NCT00784875|1316767|P4|Period A - Baseline|Entry Criteria Not Met|5
392386|NCT00784875|1316768|P3|Period A - Baseline|Entry Criteria Not Met|0
392387|NCT00784875|1316769|P2|Period A - Baseline|Entry Criteria Not Met|0
392388|NCT00784875|1316770|P1|Period A - Baseline|Entry Criteria Not Met|0
392389|NCT00784836|1316890|P1|Overall Study|Early Study Termination|3
392390|NCT00784810|1316897|P2|Overall Study|Lost to Follow-up|1
392391|NCT00784810|1316898|P1|Overall Study|Lost to Follow-up|1
392392|NCT00784810|1316897|P2|Overall Study|Administrative|8
392393|NCT00784810|1316898|P1|Overall Study|Administrative|5
392394|NCT00784810|1316897|P2|Overall Study|Withdrawal by Subject|9
392395|NCT00784810|1316898|P1|Overall Study|Withdrawal by Subject|11
392396|NCT00784810|1316897|P2|Overall Study|Lack of Efficacy|11
392397|NCT00784810|1316898|P1|Overall Study|Lack of Efficacy|14
392398|NCT00784810|1316897|P2|Overall Study|Adverse Event|20
392399|NCT00784810|1316898|P1|Overall Study|Adverse Event|32
392400|NCT00784784|1316908|P2|Overall Study|Withdrawal by Subject|2
392401|NCT00784784|1316909|P1|Overall Study|Withdrawal by Subject|2
392402|NCT00784719|1316924|P7|Overall Study|Withdrawal by Subject|1
392403|NCT00784719|1316925|P6|Overall Study|Withdrawal by Subject|0
392404|NCT00784719|1316926|P5|Overall Study|Withdrawal by Subject|2
392405|NCT00784719|1316927|P4|Overall Study|Withdrawal by Subject|0
392406|NCT00784719|1316928|P3|Overall Study|Withdrawal by Subject|0
392407|NCT00784719|1316929|P2|Overall Study|Withdrawal by Subject|0
392408|NCT00784719|1316930|P1|Overall Study|Withdrawal by Subject|1
392409|NCT00784719|1316924|P7|Overall Study|Other|3
392410|NCT00784719|1316925|P6|Overall Study|Other|1
392411|NCT00784719|1316926|P5|Overall Study|Other|2
392412|NCT00784719|1316927|P4|Overall Study|Other|0
392413|NCT00784719|1316928|P3|Overall Study|Other|1
392414|NCT00784719|1316929|P2|Overall Study|Other|1
392415|NCT00784719|1316930|P1|Overall Study|Other|2
392416|NCT00784719|1316924|P7|Overall Study|Lost to Follow-up|0
392417|NCT00784719|1316925|P6|Overall Study|Lost to Follow-up|1
392418|NCT00784719|1316926|P5|Overall Study|Lost to Follow-up|1
392419|NCT00784719|1316927|P4|Overall Study|Lost to Follow-up|0
392420|NCT00784719|1316928|P3|Overall Study|Lost to Follow-up|0
392421|NCT00784719|1316929|P2|Overall Study|Lost to Follow-up|0
392422|NCT00784719|1316930|P1|Overall Study|Lost to Follow-up|0
392423|NCT00784719|1316924|P7|Overall Study|Adverse Event|1
392424|NCT00784719|1316925|P6|Overall Study|Adverse Event|1
392425|NCT00784719|1316926|P5|Overall Study|Adverse Event|1
392426|NCT00784719|1316927|P4|Overall Study|Adverse Event|0
392427|NCT00784719|1316928|P3|Overall Study|Adverse Event|0
392428|NCT00784719|1316929|P2|Overall Study|Adverse Event|2
392429|NCT00784719|1316930|P1|Overall Study|Adverse Event|0
392430|NCT00784654|1317100|P3|Randomized Withdrawal Period|Family reasons|1
392431|NCT00784654|1317101|P2|Randomized Withdrawal Period|Family reasons|0
392432|NCT00784654|1317102|P1|Randomized Withdrawal Period|Family reasons|0
392433|NCT00784654|1317100|P3|Randomized Withdrawal Period|Did not complete a visit|0
392434|NCT00784654|1317101|P2|Randomized Withdrawal Period|Did not complete a visit|1
392435|NCT00784654|1317102|P1|Randomized Withdrawal Period|Did not complete a visit|0
392436|NCT00784654|1317100|P3|Randomized Withdrawal Period|Adverse Event|1
392437|NCT00784654|1317101|P2|Randomized Withdrawal Period|Adverse Event|1
392438|NCT00784654|1317102|P1|Randomized Withdrawal Period|Adverse Event|0
392439|NCT00784654|1317100|P3|Randomized Withdrawal Period|Protocol Violation|1
392440|NCT00784654|1317101|P2|Randomized Withdrawal Period|Protocol Violation|2
392441|NCT00784654|1317102|P1|Randomized Withdrawal Period|Protocol Violation|0
392442|NCT00784654|1317100|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
392443|NCT00784654|1317101|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
392444|NCT00784654|1317102|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
392445|NCT00784654|1317100|P3|Randomized Withdrawal Period|Lack of Efficacy|18
392446|NCT00784654|1317101|P2|Randomized Withdrawal Period|Lack of Efficacy|5
392447|NCT00784654|1317102|P1|Randomized Withdrawal Period|Lack of Efficacy|0
392448|NCT00784654|1317100|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
392449|NCT00784654|1317101|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
392450|NCT00784654|1317102|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
392451|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
392452|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
392453|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
392454|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
392455|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
392456|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
392457|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
392458|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
392459|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
392460|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
392461|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
392462|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
392463|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
392464|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
392465|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
392466|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
392467|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
392468|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
392469|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
392470|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
392471|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
392472|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
392473|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
392474|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
392475|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
392476|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
392477|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
392478|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
392568|NCT00784277|1317230|P5|ER Treatment|Adverse Event|1
392479|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
392480|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
392481|NCT00784654|1317100|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
392482|NCT00784654|1317101|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
392483|NCT00784654|1317102|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
392484|NCT00784563|1317137|P3|Year 3|Adverse Event|1
392485|NCT00784563|1317138|P2|Year 3|Adverse Event|0
392486|NCT00784563|1317139|P1|Year 3|Adverse Event|0
392487|NCT00784563|1317137|P3|Year 3|Withdrawal by Subject|2
392488|NCT00784563|1317138|P2|Year 3|Withdrawal by Subject|0
392489|NCT00784563|1317139|P1|Year 3|Withdrawal by Subject|0
392490|NCT00784563|1317137|P3|Years 1 & 2|Adverse Event|0
392491|NCT00784563|1317138|P2|Years 1 & 2|Adverse Event|3
392492|NCT00784563|1317139|P1|Years 1 & 2|Adverse Event|0
392493|NCT00784563|1317137|P3|Years 1 & 2|Withdrawal by Subject|0
392494|NCT00784563|1317138|P2|Years 1 & 2|Withdrawal by Subject|2
392495|NCT00784563|1317139|P1|Years 1 & 2|Withdrawal by Subject|3
392496|NCT00784550|1317157|P2|Overall Study|Withdrawal by Subject|13
392497|NCT00784550|1317158|P1|Overall Study|Withdrawal by Subject|4
392498|NCT00784550|1317157|P2|Overall Study|Physician Decision|3
392499|NCT00784550|1317158|P1|Overall Study|Physician Decision|2
392500|NCT00784550|1317157|P2|Overall Study|Lost to Follow-up|5
392501|NCT00784550|1317158|P1|Overall Study|Lost to Follow-up|8
392502|NCT00784550|1317157|P2|Overall Study|Protocol Violation|10
392503|NCT00784550|1317158|P1|Overall Study|Protocol Violation|10
392504|NCT00784550|1317157|P2|Overall Study|Lack of Efficacy|1
392505|NCT00784550|1317158|P1|Overall Study|Lack of Efficacy|0
392506|NCT00784550|1317157|P2|Overall Study|Adverse Event|10
392507|NCT00784550|1317158|P1|Overall Study|Adverse Event|12
392508|NCT00784459|1317176|P2|Overall Study|Adverse Event|2
392509|NCT00784459|1317177|P1|Overall Study|Adverse Event|0
392510|NCT00784368|1317188|P3|Overall Study|Withdrawal of informed consent|0
392511|NCT00784368|1317189|P2|Overall Study|Withdrawal of informed consent|1
392512|NCT00784368|1317190|P1|Overall Study|Withdrawal of informed consent|0
392513|NCT00784368|1317188|P3|Overall Study|Worsening of symptoms|0
392514|NCT00784368|1317189|P2|Overall Study|Worsening of symptoms|1
392515|NCT00784368|1317190|P1|Overall Study|Worsening of symptoms|0
392516|NCT00784368|1317188|P3|Overall Study|Worsening of complications|1
392517|NCT00784368|1317189|P2|Overall Study|Worsening of complications|0
392518|NCT00784368|1317190|P1|Overall Study|Worsening of complications|0
392519|NCT00784368|1317188|P3|Overall Study|Diagnosis of fever|1
392520|NCT00784368|1317189|P2|Overall Study|Diagnosis of fever|0
392521|NCT00784368|1317190|P1|Overall Study|Diagnosis of fever|0
392522|NCT00784368|1317188|P3|Overall Study|Adverse Event|2
392523|NCT00784368|1317189|P2|Overall Study|Adverse Event|9
392524|NCT00784368|1317190|P1|Overall Study|Adverse Event|6
392525|NCT00784368|1317188|P3|Overall Study|Lack of Efficacy|1
392526|NCT00784368|1317189|P2|Overall Study|Lack of Efficacy|0
392527|NCT00784368|1317190|P1|Overall Study|Lack of Efficacy|2
392528|NCT00784368|1317188|P3|Overall Study|Physician Decision|6
392529|NCT00784368|1317189|P2|Overall Study|Physician Decision|0
392530|NCT00784368|1317190|P1|Overall Study|Physician Decision|0
392531|NCT00784277|1317228|P7|ER Treatment|Other|2
392532|NCT00784277|1317229|P6|ER Treatment|Other|3
392533|NCT00784277|1317230|P5|ER Treatment|Other|1
392534|NCT00784277|1317231|P4|ER Treatment|Other|0
392535|NCT00784277|1317232|P3|ER Treatment|Other|0
392536|NCT00784277|1317233|P2|ER Treatment|Other|0
392537|NCT00784277|1317234|P1|ER Treatment|Other|0
392538|NCT00784277|1317228|P7|ER Treatment|Study Medication Non-Compliant|3
392539|NCT00784277|1317229|P6|ER Treatment|Study Medication Non-Compliant|3
392540|NCT00784277|1317230|P5|ER Treatment|Study Medication Non-Compliant|2
392541|NCT00784277|1317231|P4|ER Treatment|Study Medication Non-Compliant|0
392542|NCT00784277|1317232|P3|ER Treatment|Study Medication Non-Compliant|0
392543|NCT00784277|1317233|P2|ER Treatment|Study Medication Non-Compliant|0
392544|NCT00784277|1317234|P1|ER Treatment|Study Medication Non-Compliant|0
392545|NCT00784277|1317228|P7|ER Treatment|Withdrawal by Subject|3
392546|NCT00784277|1317229|P6|ER Treatment|Withdrawal by Subject|5
392547|NCT00784277|1317230|P5|ER Treatment|Withdrawal by Subject|2
392548|NCT00784277|1317231|P4|ER Treatment|Withdrawal by Subject|0
392549|NCT00784277|1317232|P3|ER Treatment|Withdrawal by Subject|0
392550|NCT00784277|1317233|P2|ER Treatment|Withdrawal by Subject|0
392551|NCT00784277|1317234|P1|ER Treatment|Withdrawal by Subject|0
392552|NCT00784277|1317228|P7|ER Treatment|Lost to Follow-up|0
392553|NCT00784277|1317229|P6|ER Treatment|Lost to Follow-up|2
392554|NCT00784277|1317230|P5|ER Treatment|Lost to Follow-up|0
392555|NCT00784277|1317231|P4|ER Treatment|Lost to Follow-up|0
392556|NCT00784277|1317232|P3|ER Treatment|Lost to Follow-up|0
392557|NCT00784277|1317233|P2|ER Treatment|Lost to Follow-up|0
392558|NCT00784277|1317234|P1|ER Treatment|Lost to Follow-up|0
392559|NCT00784277|1317228|P7|ER Treatment|Lack of Efficacy|0
392560|NCT00784277|1317229|P6|ER Treatment|Lack of Efficacy|4
392561|NCT00784277|1317230|P5|ER Treatment|Lack of Efficacy|3
392562|NCT00784277|1317231|P4|ER Treatment|Lack of Efficacy|0
392563|NCT00784277|1317232|P3|ER Treatment|Lack of Efficacy|0
392564|NCT00784277|1317233|P2|ER Treatment|Lack of Efficacy|0
392565|NCT00784277|1317234|P1|ER Treatment|Lack of Efficacy|0
392566|NCT00784277|1317228|P7|ER Treatment|Adverse Event|7
392567|NCT00784277|1317229|P6|ER Treatment|Adverse Event|7
392569|NCT00784277|1317231|P4|ER Treatment|Adverse Event|0
392570|NCT00784277|1317232|P3|ER Treatment|Adverse Event|0
392571|NCT00784277|1317233|P2|ER Treatment|Adverse Event|0
392572|NCT00784277|1317234|P1|ER Treatment|Adverse Event|0
392573|NCT00784277|1317228|P7|IR Treatment|Other|0
392574|NCT00784277|1317229|P6|IR Treatment|Other|0
392575|NCT00784277|1317230|P5|IR Treatment|Other|0
392576|NCT00784277|1317231|P4|IR Treatment|Other|2
392577|NCT00784277|1317232|P3|IR Treatment|Other|3
392578|NCT00784277|1317233|P2|IR Treatment|Other|3
392579|NCT00784277|1317234|P1|IR Treatment|Other|2
392580|NCT00784277|1317228|P7|IR Treatment|Resolution Of Pain|0
392581|NCT00784277|1317229|P6|IR Treatment|Resolution Of Pain|0
392582|NCT00784277|1317230|P5|IR Treatment|Resolution Of Pain|0
392583|NCT00784277|1317231|P4|IR Treatment|Resolution Of Pain|0
392584|NCT00784277|1317232|P3|IR Treatment|Resolution Of Pain|0
392585|NCT00784277|1317233|P2|IR Treatment|Resolution Of Pain|1
392586|NCT00784277|1317234|P1|IR Treatment|Resolution Of Pain|0
392587|NCT00784277|1317228|P7|IR Treatment|Withdrawal by Subject|0
392588|NCT00784277|1317229|P6|IR Treatment|Withdrawal by Subject|0
392589|NCT00784277|1317230|P5|IR Treatment|Withdrawal by Subject|0
392590|NCT00784277|1317231|P4|IR Treatment|Withdrawal by Subject|6
392591|NCT00784277|1317232|P3|IR Treatment|Withdrawal by Subject|4
392592|NCT00784277|1317233|P2|IR Treatment|Withdrawal by Subject|1
392593|NCT00784277|1317234|P1|IR Treatment|Withdrawal by Subject|5
392594|NCT00784277|1317228|P7|IR Treatment|Lost to Follow-up|0
392595|NCT00784277|1317229|P6|IR Treatment|Lost to Follow-up|0
392596|NCT00784277|1317230|P5|IR Treatment|Lost to Follow-up|0
392597|NCT00784277|1317231|P4|IR Treatment|Lost to Follow-up|0
392598|NCT00784277|1317232|P3|IR Treatment|Lost to Follow-up|1
392599|NCT00784277|1317233|P2|IR Treatment|Lost to Follow-up|0
392600|NCT00784277|1317234|P1|IR Treatment|Lost to Follow-up|1
392601|NCT00784277|1317228|P7|IR Treatment|Lack of Efficacy|0
392602|NCT00784277|1317229|P6|IR Treatment|Lack of Efficacy|0
392603|NCT00784277|1317230|P5|IR Treatment|Lack of Efficacy|0
392604|NCT00784277|1317231|P4|IR Treatment|Lack of Efficacy|0
392605|NCT00784277|1317232|P3|IR Treatment|Lack of Efficacy|1
392606|NCT00784277|1317233|P2|IR Treatment|Lack of Efficacy|4
392607|NCT00784277|1317234|P1|IR Treatment|Lack of Efficacy|4
392608|NCT00784277|1317228|P7|IR Treatment|Adverse Event|0
392609|NCT00784277|1317229|P6|IR Treatment|Adverse Event|0
392610|NCT00784277|1317230|P5|IR Treatment|Adverse Event|0
392611|NCT00784277|1317231|P4|IR Treatment|Adverse Event|35
392612|NCT00784277|1317232|P3|IR Treatment|Adverse Event|19
392613|NCT00784277|1317233|P2|IR Treatment|Adverse Event|8
392614|NCT00784277|1317234|P1|IR Treatment|Adverse Event|4
392615|NCT00784238|1317251|P1|Overall Study|Other|14
392616|NCT00784238|1317251|P1|Overall Study|Withdrawal by Subject|26
392617|NCT00784238|1317251|P1|Overall Study|Pregnancy|1
392618|NCT00784238|1317251|P1|Overall Study|Lost to Follow-up|29
392619|NCT00784238|1317251|P1|Overall Study|Lack of Efficacy|33
392620|NCT00784238|1317251|P1|Overall Study|Death|2
392621|NCT00784238|1317251|P1|Overall Study|Adverse Event|14
392622|NCT00784147|1317294|P2|Overall Study|Death|0
392623|NCT00784147|1317295|P1|Overall Study|Death|2
392624|NCT00784147|1317294|P2|Overall Study|Protocol Violation|1
392625|NCT00784147|1317295|P1|Overall Study|Protocol Violation|1
392626|NCT00784147|1317294|P2|Overall Study|Physician Decision|1
392627|NCT00784147|1317295|P1|Overall Study|Physician Decision|2
392628|NCT00784147|1317294|P2|Overall Study|Withdrawal by Subject|3
392629|NCT00784147|1317295|P1|Overall Study|Withdrawal by Subject|1
392630|NCT00784147|1317294|P2|Overall Study|Lost to Follow-up|4
392631|NCT00784147|1317295|P1|Overall Study|Lost to Follow-up|2
392632|NCT00784134|1317315|P2|Overall Study|Lost to Follow-up|6
392633|NCT00784134|1317316|P1|Overall Study|Lost to Follow-up|3
392634|NCT00784043|1317439|P2|Overall Study|Protocol Terminated|1
392635|NCT00784043|1317440|P1|Overall Study|Protocol Terminated|23
392636|NCT00784043|1317439|P2|Overall Study|Withdrawal by Subject|5
392637|NCT00784043|1317440|P1|Overall Study|Withdrawal by Subject|8
392638|NCT00783835|1317475|P1|Overall Study|Participant not Adherent|3
392639|NCT00783835|1317475|P1|Overall Study|Lost to Follow-up|1
392640|NCT00783835|1317475|P1|Overall Study|Withdrawal by Subject|2
392641|NCT00783835|1317475|P1|Overall Study|Medical Criteria|1
392642|NCT00783835|1317475|P1|Overall Study|Adverse Event|3
392643|NCT00783796|1317487|P1|Overall Study|Received commercial XIENCE V stent|1
392644|NCT00783796|1317487|P1|Overall Study|Received non-XIENCE V stent|1
392645|NCT00783796|1317487|P1|Overall Study|Did not receive any stent|4
392646|NCT00783718|1317592|P7|Maintenance Phase|Lost to Follow-up|2
392647|NCT00783718|1317593|P6|Maintenance Phase|Lost to Follow-up|0
392648|NCT00783718|1317594|P5|Maintenance Phase|Lost to Follow-up|2
392649|NCT00783718|1317595|P4|Maintenance Phase|Lost to Follow-up|0
392650|NCT00783718|1317596|P3|Maintenance Phase|Lost to Follow-up|0
392651|NCT00783718|1317597|P2|Maintenance Phase|Lost to Follow-up|0
392652|NCT00783718|1317598|P1|Maintenance Phase|Lost to Follow-up|3
392653|NCT00783718|1317592|P7|Maintenance Phase|Withdrawal by Subject|20
392654|NCT00783718|1317593|P6|Maintenance Phase|Withdrawal by Subject|2
392655|NCT00783718|1317594|P5|Maintenance Phase|Withdrawal by Subject|5
392656|NCT00783718|1317595|P4|Maintenance Phase|Withdrawal by Subject|2
392657|NCT00783718|1317596|P3|Maintenance Phase|Withdrawal by Subject|0
392658|NCT00783718|1317597|P2|Maintenance Phase|Withdrawal by Subject|0
392659|NCT00783718|1317598|P1|Maintenance Phase|Withdrawal by Subject|6
392660|NCT00783718|1317592|P7|Maintenance Phase|Lack of Efficacy|155
392661|NCT00783718|1317593|P6|Maintenance Phase|Lack of Efficacy|33
392662|NCT00783718|1317594|P5|Maintenance Phase|Lack of Efficacy|31
392663|NCT00783718|1317595|P4|Maintenance Phase|Lack of Efficacy|61
392664|NCT00783718|1317596|P3|Maintenance Phase|Lack of Efficacy|0
392665|NCT00783718|1317597|P2|Maintenance Phase|Lack of Efficacy|0
392666|NCT00783718|1317598|P1|Maintenance Phase|Lack of Efficacy|83
392667|NCT00783718|1317592|P7|Maintenance Phase|Protocol Violation|2
392668|NCT00783718|1317593|P6|Maintenance Phase|Protocol Violation|0
392669|NCT00783718|1317594|P5|Maintenance Phase|Protocol Violation|0
392670|NCT00783718|1317595|P4|Maintenance Phase|Protocol Violation|0
392671|NCT00783718|1317596|P3|Maintenance Phase|Protocol Violation|0
392672|NCT00783718|1317597|P2|Maintenance Phase|Protocol Violation|0
392673|NCT00783718|1317598|P1|Maintenance Phase|Protocol Violation|1
392674|NCT00783718|1317592|P7|Maintenance Phase|Adverse Event|16
392675|NCT00783718|1317593|P6|Maintenance Phase|Adverse Event|6
392676|NCT00783718|1317594|P5|Maintenance Phase|Adverse Event|7
392677|NCT00783718|1317595|P4|Maintenance Phase|Adverse Event|15
392678|NCT00783718|1317596|P3|Maintenance Phase|Adverse Event|0
392679|NCT00783718|1317597|P2|Maintenance Phase|Adverse Event|0
392680|NCT00783718|1317598|P1|Maintenance Phase|Adverse Event|12
392681|NCT00783718|1317592|P7|Induction Phase|Lost to Follow-up|0
392682|NCT00783718|1317593|P6|Induction Phase|Lost to Follow-up|0
392683|NCT00783718|1317594|P5|Induction Phase|Lost to Follow-up|0
392684|NCT00783718|1317595|P4|Induction Phase|Lost to Follow-up|0
392685|NCT00783718|1317596|P3|Induction Phase|Lost to Follow-up|1
392686|NCT00783718|1317597|P2|Induction Phase|Lost to Follow-up|0
392687|NCT00783718|1317598|P1|Induction Phase|Lost to Follow-up|1
392688|NCT00783718|1317592|P7|Induction Phase|Withdrawal by Subject|0
392689|NCT00783718|1317593|P6|Induction Phase|Withdrawal by Subject|0
392690|NCT00783718|1317594|P5|Induction Phase|Withdrawal by Subject|0
392691|NCT00783718|1317595|P4|Induction Phase|Withdrawal by Subject|0
392692|NCT00783718|1317596|P3|Induction Phase|Withdrawal by Subject|8
392693|NCT00783718|1317597|P2|Induction Phase|Withdrawal by Subject|4
392694|NCT00783718|1317598|P1|Induction Phase|Withdrawal by Subject|3
392695|NCT00783718|1317592|P7|Induction Phase|Lack of Efficacy|0
392696|NCT00783718|1317593|P6|Induction Phase|Lack of Efficacy|0
392697|NCT00783718|1317594|P5|Induction Phase|Lack of Efficacy|0
392698|NCT00783718|1317595|P4|Induction Phase|Lack of Efficacy|0
392699|NCT00783718|1317596|P3|Induction Phase|Lack of Efficacy|14
392700|NCT00783718|1317597|P2|Induction Phase|Lack of Efficacy|2
392701|NCT00783718|1317598|P1|Induction Phase|Lack of Efficacy|5
392702|NCT00783718|1317592|P7|Induction Phase|Protocol Violation|0
392703|NCT00783718|1317593|P6|Induction Phase|Protocol Violation|0
392704|NCT00783718|1317594|P5|Induction Phase|Protocol Violation|0
392705|NCT00783718|1317595|P4|Induction Phase|Protocol Violation|0
392706|NCT00783718|1317596|P3|Induction Phase|Protocol Violation|6
392707|NCT00783718|1317597|P2|Induction Phase|Protocol Violation|1
392708|NCT00783718|1317598|P1|Induction Phase|Protocol Violation|1
392709|NCT00783718|1317592|P7|Induction Phase|Adverse Event|0
392710|NCT00783718|1317593|P6|Induction Phase|Adverse Event|0
392711|NCT00783718|1317594|P5|Induction Phase|Adverse Event|0
392712|NCT00783718|1317595|P4|Induction Phase|Adverse Event|0
392713|NCT00783718|1317596|P3|Induction Phase|Adverse Event|7
392714|NCT00783718|1317597|P2|Induction Phase|Adverse Event|0
392715|NCT00783718|1317598|P1|Induction Phase|Adverse Event|4
392716|NCT00783705|1317626|P2|Overall Study|Lost to Follow-up|3
392717|NCT00783705|1317627|P1|Overall Study|Lost to Follow-up|1
392718|NCT00783705|1317626|P2|Overall Study|Withdrawal by Subject|2
392719|NCT00783705|1317627|P1|Overall Study|Withdrawal by Subject|3
392720|NCT00783705|1317626|P2|Overall Study|Adverse Event|0
392721|NCT00783705|1317627|P1|Overall Study|Adverse Event|2
392722|NCT00783692|1317674|P7|Maintenance Phase|Other|1
392723|NCT00783692|1317675|P6|Maintenance Phase|Other|1
392724|NCT00783692|1317676|P5|Maintenance Phase|Other|0
392725|NCT00783692|1317677|P4|Maintenance Phase|Other|1
392726|NCT00783692|1317678|P3|Maintenance Phase|Other|0
392727|NCT00783692|1317679|P2|Maintenance Phase|Other|0
392728|NCT00783692|1317680|P1|Maintenance Phase|Other|0
392729|NCT00783692|1317674|P7|Maintenance Phase|Lost to Follow-up|5
392730|NCT00783692|1317675|P6|Maintenance Phase|Lost to Follow-up|2
392731|NCT00783692|1317676|P5|Maintenance Phase|Lost to Follow-up|3
392732|NCT00783692|1317677|P4|Maintenance Phase|Lost to Follow-up|1
392733|NCT00783692|1317678|P3|Maintenance Phase|Lost to Follow-up|0
392734|NCT00783692|1317679|P2|Maintenance Phase|Lost to Follow-up|0
392735|NCT00783692|1317680|P1|Maintenance Phase|Lost to Follow-up|2
392736|NCT00783692|1317674|P7|Maintenance Phase|Withdrawal by Subject|24
392737|NCT00783692|1317675|P6|Maintenance Phase|Withdrawal by Subject|9
392738|NCT00783692|1317676|P5|Maintenance Phase|Withdrawal by Subject|6
392739|NCT00783692|1317677|P4|Maintenance Phase|Withdrawal by Subject|7
392740|NCT00783692|1317678|P3|Maintenance Phase|Withdrawal by Subject|0
392741|NCT00783692|1317679|P2|Maintenance Phase|Withdrawal by Subject|0
392742|NCT00783692|1317680|P1|Maintenance Phase|Withdrawal by Subject|7
392743|NCT00783692|1317674|P7|Maintenance Phase|Lack of Efficacy|177
392744|NCT00783692|1317675|P6|Maintenance Phase|Lack of Efficacy|48
392745|NCT00783692|1317676|P5|Maintenance Phase|Lack of Efficacy|58
392746|NCT00783692|1317677|P4|Maintenance Phase|Lack of Efficacy|64
392747|NCT00783692|1317678|P3|Maintenance Phase|Lack of Efficacy|0
392748|NCT00783692|1317679|P2|Maintenance Phase|Lack of Efficacy|0
392749|NCT00783692|1317680|P1|Maintenance Phase|Lack of Efficacy|79
392750|NCT00783692|1317674|P7|Maintenance Phase|Protocol Violation|4
392751|NCT00783692|1317675|P6|Maintenance Phase|Protocol Violation|3
392752|NCT00783692|1317676|P5|Maintenance Phase|Protocol Violation|2
392753|NCT00783692|1317677|P4|Maintenance Phase|Protocol Violation|1
392754|NCT00783692|1317678|P3|Maintenance Phase|Protocol Violation|0
392755|NCT00783692|1317679|P2|Maintenance Phase|Protocol Violation|0
392756|NCT00783692|1317680|P1|Maintenance Phase|Protocol Violation|0
392757|NCT00783692|1317674|P7|Maintenance Phase|Adverse Event|38
392758|NCT00783692|1317675|P6|Maintenance Phase|Adverse Event|9
392759|NCT00783692|1317676|P5|Maintenance Phase|Adverse Event|12
392760|NCT00783692|1317677|P4|Maintenance Phase|Adverse Event|15
392761|NCT00783692|1317678|P3|Maintenance Phase|Adverse Event|0
392762|NCT00783692|1317679|P2|Maintenance Phase|Adverse Event|0
392763|NCT00783692|1317680|P1|Maintenance Phase|Adverse Event|7
392764|NCT00783692|1317674|P7|Induction Phase|Other|0
392765|NCT00783692|1317675|P6|Induction Phase|Other|0
392766|NCT00783692|1317676|P5|Induction Phase|Other|0
392767|NCT00783692|1317677|P4|Induction Phase|Other|0
392768|NCT00783692|1317678|P3|Induction Phase|Other|2
392769|NCT00783692|1317679|P2|Induction Phase|Other|0
392770|NCT00783692|1317680|P1|Induction Phase|Other|0
392771|NCT00783692|1317674|P7|Induction Phase|Lost to Follow-up|0
392772|NCT00783692|1317675|P6|Induction Phase|Lost to Follow-up|0
392773|NCT00783692|1317676|P5|Induction Phase|Lost to Follow-up|0
392774|NCT00783692|1317677|P4|Induction Phase|Lost to Follow-up|0
392775|NCT00783692|1317678|P3|Induction Phase|Lost to Follow-up|3
392776|NCT00783692|1317679|P2|Induction Phase|Lost to Follow-up|0
392777|NCT00783692|1317680|P1|Induction Phase|Lost to Follow-up|0
392778|NCT00783692|1317674|P7|Induction Phase|Withdrawal by Subject|0
392779|NCT00783692|1317675|P6|Induction Phase|Withdrawal by Subject|0
392780|NCT00783692|1317676|P5|Induction Phase|Withdrawal by Subject|0
392781|NCT00783692|1317677|P4|Induction Phase|Withdrawal by Subject|0
392782|NCT00783692|1317678|P3|Induction Phase|Withdrawal by Subject|16
392783|NCT00783692|1317679|P2|Induction Phase|Withdrawal by Subject|9
392784|NCT00783692|1317680|P1|Induction Phase|Withdrawal by Subject|3
392785|NCT00783692|1317674|P7|Induction Phase|Lack of Efficacy|0
392786|NCT00783692|1317675|P6|Induction Phase|Lack of Efficacy|0
392787|NCT00783692|1317676|P5|Induction Phase|Lack of Efficacy|0
392788|NCT00783692|1317677|P4|Induction Phase|Lack of Efficacy|0
392789|NCT00783692|1317678|P3|Induction Phase|Lack of Efficacy|28
392790|NCT00783692|1317679|P2|Induction Phase|Lack of Efficacy|3
392791|NCT00783692|1317680|P1|Induction Phase|Lack of Efficacy|1
392792|NCT00783692|1317674|P7|Induction Phase|Protocol Violation|0
392793|NCT00783692|1317675|P6|Induction Phase|Protocol Violation|0
392794|NCT00783692|1317676|P5|Induction Phase|Protocol Violation|0
392795|NCT00783692|1317677|P4|Induction Phase|Protocol Violation|0
392796|NCT00783692|1317678|P3|Induction Phase|Protocol Violation|1
392797|NCT00783692|1317679|P2|Induction Phase|Protocol Violation|0
392798|NCT00783692|1317680|P1|Induction Phase|Protocol Violation|0
392799|NCT00783692|1317674|P7|Induction Phase|Adverse Event|0
392800|NCT00783692|1317675|P6|Induction Phase|Adverse Event|0
392801|NCT00783692|1317676|P5|Induction Phase|Adverse Event|0
392802|NCT00783692|1317677|P4|Induction Phase|Adverse Event|0
392803|NCT00783692|1317678|P3|Induction Phase|Adverse Event|24
392804|NCT00783692|1317679|P2|Induction Phase|Adverse Event|9
392805|NCT00783692|1317680|P1|Induction Phase|Adverse Event|7
392806|NCT00783432|1317726|P2|Overall Study|Protocol Violation|9
392807|NCT00783432|1317727|P1|Overall Study|Protocol Violation|6
392808|NCT00783432|1317726|P2|Overall Study|subject moved|5
392809|NCT00783432|1317727|P1|Overall Study|subject moved|3
392810|NCT00783432|1317726|P2|Overall Study|Withdrawal by Subject|20
392811|NCT00783432|1317727|P1|Overall Study|Withdrawal by Subject|23
392812|NCT00783432|1317726|P2|Overall Study|Lost to Follow-up|6
392813|NCT00783432|1317727|P1|Overall Study|Lost to Follow-up|11
392814|NCT00783432|1317726|P2|Overall Study|Lack of Efficacy|21
392815|NCT00783432|1317727|P1|Overall Study|Lack of Efficacy|20
392816|NCT00783432|1317726|P2|Overall Study|Adverse Event|17
392817|NCT00783432|1317727|P1|Overall Study|Adverse Event|22
392818|NCT00783302|1317737|P1|Overall Study|Withdrawal by Subject|3
392819|NCT00783302|1317737|P1|Overall Study|Physician Decision|1
392820|NCT00783302|1317737|P1|Overall Study|Protocol Violation|3
392821|NCT00783302|1317737|P1|Overall Study|Technical Problems|11
392822|NCT00783302|1317737|P1|Overall Study|Lost to Follow-up|17
392823|NCT00783263|1317759|P4|Overall Study|Withdrawal by Subject|2
392824|NCT00783263|1317760|P3|Overall Study|Withdrawal by Subject|1
392825|NCT00783263|1317761|P2|Overall Study|Withdrawal by Subject|1
392826|NCT00783263|1317762|P1|Overall Study|Withdrawal by Subject|0
392827|NCT00783263|1317759|P4|Overall Study|Lost to Follow-up|0
392828|NCT00783263|1317760|P3|Overall Study|Lost to Follow-up|0
392829|NCT00783263|1317761|P2|Overall Study|Lost to Follow-up|1
392830|NCT00783263|1317762|P1|Overall Study|Lost to Follow-up|1
392831|NCT00783263|1317759|P4|Overall Study|Adverse Event|1
392832|NCT00783263|1317760|P3|Overall Study|Adverse Event|2
392833|NCT00783263|1317761|P2|Overall Study|Adverse Event|0
392834|NCT00783263|1317762|P1|Overall Study|Adverse Event|3
392835|NCT00783224|1317792|P4|Overall Study|Inappropriate as a study subject|1
392836|NCT00783224|1317793|P3|Overall Study|Inappropriate as a study subject|0
392837|NCT00783224|1317794|P2|Overall Study|Inappropriate as a study subject|0
392838|NCT00783224|1317795|P1|Overall Study|Inappropriate as a study subject|0
392839|NCT00783224|1317792|P4|Overall Study|Discarded the Investigational Drug Used|1
392840|NCT00783224|1317793|P3|Overall Study|Discarded the Investigational Drug Used|0
392841|NCT00783224|1317794|P2|Overall Study|Discarded the Investigational Drug Used|0
392842|NCT00783224|1317795|P1|Overall Study|Discarded the Investigational Drug Used|0
392843|NCT00783224|1317792|P4|Overall Study|Adverse Event|0
392844|NCT00783224|1317793|P3|Overall Study|Adverse Event|1
392845|NCT00783224|1317794|P2|Overall Study|Adverse Event|0
392846|NCT00783224|1317795|P1|Overall Study|Adverse Event|0
392847|NCT00783198|1317807|P3|Overall Study|Administrative|2
392848|NCT00783198|1317808|P2|Overall Study|Administrative|1
392849|NCT00783198|1317809|P1|Overall Study|Administrative|2
392850|NCT00783198|1317807|P3|Overall Study|Did not meet protocol eligibility|0
392851|NCT00783198|1317808|P2|Overall Study|Did not meet protocol eligibility|1
392852|NCT00783198|1317809|P1|Overall Study|Did not meet protocol eligibility|0
392853|NCT00783198|1317807|P3|Overall Study|Noncompliance with protocol|10
392854|NCT00783198|1317808|P2|Overall Study|Noncompliance with protocol|7
392855|NCT00783198|1317809|P1|Overall Study|Noncompliance with protocol|7
392856|NCT00783198|1317807|P3|Overall Study|Withdrawal by Subject|20
392857|NCT00783198|1317808|P2|Overall Study|Withdrawal by Subject|14
392858|NCT00783198|1317809|P1|Overall Study|Withdrawal by Subject|22
392859|NCT00783198|1317807|P3|Overall Study|Lost to Follow-up|7
392860|NCT00783198|1317808|P2|Overall Study|Lost to Follow-up|1
392861|NCT00783198|1317809|P1|Overall Study|Lost to Follow-up|11
392862|NCT00783198|1317807|P3|Overall Study|Adverse Event|3
392863|NCT00783198|1317808|P2|Overall Study|Adverse Event|19
392864|NCT00783198|1317809|P1|Overall Study|Adverse Event|15
392865|NCT00783094|1317832|P3|Open-Label Extension Period|Lack of Efficacy|0
392866|NCT00783094|1317833|P2|Open-Label Extension Period|Lack of Efficacy|4
392867|NCT00783094|1317834|P1|Open-Label Extension Period|Lack of Efficacy|1
392868|NCT00783094|1317832|P3|Open-Label Extension Period|Physician Decision|3
392869|NCT00783094|1317833|P2|Open-Label Extension Period|Physician Decision|2
392870|NCT00783094|1317834|P1|Open-Label Extension Period|Physician Decision|4
392871|NCT00783094|1317832|P3|Open-Label Extension Period|Withdrawal by Subject|3
392872|NCT00783094|1317833|P2|Open-Label Extension Period|Withdrawal by Subject|1
392873|NCT00783094|1317834|P1|Open-Label Extension Period|Withdrawal by Subject|1
392874|NCT00783094|1317832|P3|Open-Label Extension Period|Protocol Violation|7
392875|NCT00783094|1317833|P2|Open-Label Extension Period|Protocol Violation|5
392876|NCT00783094|1317834|P1|Open-Label Extension Period|Protocol Violation|4
392877|NCT00783094|1317832|P3|Open-Label Extension Period|Death|1
392878|NCT00783094|1317833|P2|Open-Label Extension Period|Death|0
392879|NCT00783094|1317834|P1|Open-Label Extension Period|Death|0
392880|NCT00783094|1317832|P3|Open-Label Extension Period|Adverse Event|16
392881|NCT00783094|1317833|P2|Open-Label Extension Period|Adverse Event|7
392882|NCT00783094|1317834|P1|Open-Label Extension Period|Adverse Event|12
392883|NCT00783094|1317832|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
392884|NCT00783094|1317833|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
392885|NCT00783094|1317834|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
392886|NCT00783094|1317832|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
392887|NCT00783094|1317833|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
392888|NCT00783094|1317834|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
392889|NCT00783094|1317832|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
392890|NCT00783094|1317833|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
392891|NCT00783094|1317834|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
392892|NCT00783094|1317832|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
392893|NCT00783094|1317833|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
392894|NCT00783094|1317834|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
392895|NCT00783094|1317832|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
392896|NCT00783094|1317833|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
392897|NCT00783094|1317834|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
392898|NCT00782834|1317910|P1|Treatment Phase|fibrous tumor not GIST|1
392899|NCT00782795|1317950|P2|Overall Study|Withdrawal by Subject|2
392900|NCT00782795|1317951|P1|Overall Study|Withdrawal by Subject|1
392901|NCT00782717|1317991|P2|Overall Study|Exited in error|2
392902|NCT00782717|1317992|P1|Overall Study|Exited in error|0
392903|NCT00782717|1317991|P2|Overall Study|Did not meet entrance criteria|3
392904|NCT00782717|1317992|P1|Overall Study|Did not meet entrance criteria|1
392905|NCT00782717|1317991|P2|Overall Study|Enrollment close prior to surgery|0
392906|NCT00782717|1317992|P1|Overall Study|Enrollment close prior to surgery|1
392907|NCT00782717|1317991|P2|Overall Study|Treatment failure|14
392908|NCT00782717|1317992|P1|Overall Study|Treatment failure|3
392909|NCT00782717|1317991|P2|Overall Study|Noncompliance|1
392910|NCT00782717|1317992|P1|Overall Study|Noncompliance|2
392911|NCT00782717|1317991|P2|Overall Study|Patient decision unrelated to AE|3
392912|NCT00782717|1317992|P1|Overall Study|Patient decision unrelated to AE|6
392913|NCT00782717|1317991|P2|Overall Study|Adverse Event|5
392914|NCT00782717|1317992|P1|Overall Study|Adverse Event|2
392915|NCT00782626|1318019|P1|Overall Study|Other Complicating Disease|1
392916|NCT00782626|1318019|P1|Overall Study|Progressive Disease|5
392917|NCT00782626|1318019|P1|Overall Study|Adverse Event|1
392918|NCT00782509|1318026|P3|Overall Study|Lack of Efficacy|2
392919|NCT00782509|1318027|P2|Overall Study|Lack of Efficacy|5
392920|NCT00782509|1318028|P1|Overall Study|Lack of Efficacy|10
392921|NCT00782509|1318026|P3|Overall Study|Other reasons not stated above|3
392922|NCT00782509|1318027|P2|Overall Study|Other reasons not stated above|2
392923|NCT00782509|1318028|P1|Overall Study|Other reasons not stated above|5
392924|NCT00782509|1318026|P3|Overall Study|Non compliance with protocol|0
392925|NCT00782509|1318027|P2|Overall Study|Non compliance with protocol|0
392926|NCT00782509|1318028|P1|Overall Study|Non compliance with protocol|2
392927|NCT00782509|1318026|P3|Overall Study|Withdrawal by Subject|8
392928|NCT00782509|1318027|P2|Overall Study|Withdrawal by Subject|5
392929|NCT00782509|1318028|P1|Overall Study|Withdrawal by Subject|3
392930|NCT00782509|1318026|P3|Overall Study|Lost to Follow-up|3
392931|NCT00782509|1318027|P2|Overall Study|Lost to Follow-up|2
392932|NCT00782509|1318028|P1|Overall Study|Lost to Follow-up|1
392933|NCT00782509|1318026|P3|Overall Study|Adverse Event|20
392934|NCT00782509|1318027|P2|Overall Study|Adverse Event|10
392935|NCT00782509|1318028|P1|Overall Study|Adverse Event|20
392936|NCT00782496|1318221|P2|Overall Study|Lost to Follow-up|15
392937|NCT00782496|1318222|P1|Overall Study|Lost to Follow-up|14
392938|NCT00782483|1318229|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
392939|NCT00782418|1318233|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
392940|NCT00782418|1318234|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
392941|NCT00782418|1318235|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
392942|NCT00782418|1318236|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
392943|NCT00782418|1318237|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
392944|NCT00782418|1318238|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
392945|NCT00782418|1318239|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
392946|NCT00782418|1318233|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
392947|NCT00782418|1318234|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
392948|NCT00782418|1318235|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
392949|NCT00782418|1318236|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
392950|NCT00782418|1318237|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
392951|NCT00782418|1318238|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
392952|NCT00782418|1318239|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
392953|NCT00782340|1318276|P3|Open Label Titration|Randomized in error|0
392954|NCT00782340|1318277|P2|Open Label Titration|Randomized in error|0
392955|NCT00782340|1318278|P1|Open Label Titration|Randomized in error|6
392956|NCT00782340|1318276|P3|Open Label Titration|Lost to Follow-up|0
392957|NCT00782340|1318277|P2|Open Label Titration|Lost to Follow-up|0
392958|NCT00782340|1318278|P1|Open Label Titration|Lost to Follow-up|5
392959|NCT00782340|1318276|P3|Open Label Titration|Did not meet responder criteria|0
392960|NCT00782340|1318277|P2|Open Label Titration|Did not meet responder criteria|0
392961|NCT00782340|1318278|P1|Open Label Titration|Did not meet responder criteria|2
392962|NCT00782340|1318276|P3|Open Label Titration|Enrollment capped|0
392963|NCT00782340|1318277|P2|Open Label Titration|Enrollment capped|0
392964|NCT00782340|1318278|P1|Open Label Titration|Enrollment capped|16
392965|NCT00782340|1318276|P3|Open Label Titration|Withdrawal by Subject|0
392966|NCT00782340|1318277|P2|Open Label Titration|Withdrawal by Subject|0
392967|NCT00782340|1318278|P1|Open Label Titration|Withdrawal by Subject|5
392968|NCT00782340|1318276|P3|Open Label Titration|Protocol Violation|0
392969|NCT00782340|1318277|P2|Open Label Titration|Protocol Violation|0
392970|NCT00782340|1318278|P1|Open Label Titration|Protocol Violation|5
392971|NCT00782340|1318276|P3|Open Label Titration|Treatment failure|0
392972|NCT00782340|1318277|P2|Open Label Titration|Treatment failure|0
392973|NCT00782340|1318278|P1|Open Label Titration|Treatment failure|50
392974|NCT00782340|1318276|P3|Open Label Titration|Adverse Event|0
392975|NCT00782340|1318277|P2|Open Label Titration|Adverse Event|0
392976|NCT00782340|1318278|P1|Open Label Titration|Adverse Event|12
392977|NCT00782275|1318348|P1|Overall Study|Other|3
392978|NCT00782275|1318348|P1|Overall Study|Not started treatment|1
392979|NCT00782275|1318348|P1|Overall Study|Physician Decision|4
392980|NCT00782275|1318348|P1|Overall Study|Progressive Disease|21
392981|NCT00782275|1318348|P1|Overall Study|Withdrawal by Subject|1
392982|NCT00782275|1318348|P1|Overall Study|Adverse Event|11
392983|NCT00782210|1318357|P3|Overall Study|Other reason not described above|3
392984|NCT00782210|1318358|P2|Overall Study|Other reason not described above|2
392985|NCT00782210|1318359|P1|Overall Study|Other reason not described above|3
392986|NCT00782210|1318357|P3|Overall Study|Lack of Efficacy|1
392987|NCT00782210|1318358|P2|Overall Study|Lack of Efficacy|4
392988|NCT00782210|1318359|P1|Overall Study|Lack of Efficacy|13
392989|NCT00782210|1318357|P3|Overall Study|Non compliance with protocol|2
392990|NCT00782210|1318358|P2|Overall Study|Non compliance with protocol|3
392991|NCT00782210|1318359|P1|Overall Study|Non compliance with protocol|0
392992|NCT00782210|1318357|P3|Overall Study|Withdrawal by Subject|11
392993|NCT00782210|1318358|P2|Overall Study|Withdrawal by Subject|8
392994|NCT00782210|1318359|P1|Overall Study|Withdrawal by Subject|11
392995|NCT00782210|1318357|P3|Overall Study|Lost to Follow-up|2
392996|NCT00782210|1318358|P2|Overall Study|Lost to Follow-up|1
392997|NCT00782210|1318359|P1|Overall Study|Lost to Follow-up|2
392998|NCT00782210|1318357|P3|Overall Study|Adverse Event|16
392999|NCT00782210|1318358|P2|Overall Study|Adverse Event|17
393000|NCT00782210|1318359|P1|Overall Study|Adverse Event|21
393001|NCT00782184|1318552|P2|Overall Study|Withdrawal by Subject|2
393002|NCT00782184|1318553|P1|Overall Study|Withdrawal by Subject|3
393003|NCT00782184|1318552|P2|Overall Study|Protocol Violation|1
393004|NCT00782184|1318553|P1|Overall Study|Protocol Violation|0
393005|NCT00782184|1318552|P2|Overall Study|Adverse Event|2
393006|NCT00782184|1318553|P1|Overall Study|Adverse Event|1
393007|NCT00782171|1318590|P2|Overall Study|not eligible|6
393008|NCT00782171|1318591|P1|Overall Study|not eligible|8
393009|NCT00782171|1318590|P2|Overall Study|others|9
393010|NCT00782171|1318591|P1|Overall Study|others|7
393011|NCT00782171|1318590|P2|Overall Study|complications|1
393012|NCT00782171|1318591|P1|Overall Study|complications|3
393013|NCT00782171|1318590|P2|Overall Study|Withdrawal by Subject|1
393014|NCT00782171|1318591|P1|Overall Study|Withdrawal by Subject|2
393015|NCT00782171|1318590|P2|Overall Study|Lost to Follow-up|2
393016|NCT00782171|1318591|P1|Overall Study|Lost to Follow-up|2
393017|NCT00782067|1318623|P1|Overall Study|Disease progression|44
393018|NCT00782067|1318623|P1|Overall Study|Withdrawal by Subject|10
393019|NCT00782067|1318623|P1|Overall Study|Adverse Event|28
393020|NCT00782067|1318623|P1|Overall Study|Death|8
393021|NCT00782067|1318623|P1|Overall Study|Protocol deviation|2
393022|NCT00782067|1318623|P1|Overall Study|Lost to Follow-up|1
393023|NCT00782067|1318623|P1|Overall Study|Administrative problems|1
393024|NCT00782067|1318623|P1|Overall Study|Abnormal procedure results|1
393025|NCT00781963|1318633|P3|Overall Study|Refused follow-up|0
393026|NCT00781963|1318634|P2|Overall Study|Refused follow-up|5
393027|NCT00781963|1318635|P1|Overall Study|Refused follow-up|4
393028|NCT00781963|1318633|P3|Overall Study|Withdrawal by Subject|1
393029|NCT00781963|1318634|P2|Overall Study|Withdrawal by Subject|3
393030|NCT00781963|1318635|P1|Overall Study|Withdrawal by Subject|0
393031|NCT00781963|1318633|P3|Overall Study|Lost to Follow-up|1
393032|NCT00781963|1318634|P2|Overall Study|Lost to Follow-up|1
393033|NCT00781963|1318635|P1|Overall Study|Lost to Follow-up|1
393034|NCT00781963|1318633|P3|Overall Study|Death|0
393035|NCT00781963|1318634|P2|Overall Study|Death|0
393036|NCT00781963|1318635|P1|Overall Study|Death|3
393037|NCT00781937|1318656|P2|Follow up Period (Week 56-68)|Unclassified|4
393038|NCT00781937|1318657|P1|Follow up Period (Week 56-68)|Unclassified|5
393039|NCT00781937|1318656|P2|Follow up Period (Week 56-68)|Protocol Violation|1
393040|NCT00781937|1318657|P1|Follow up Period (Week 56-68)|Protocol Violation|1
393041|NCT00781937|1318656|P2|Main Trial Period Through Week 56|Unclassified|15
393042|NCT00781937|1318657|P1|Main Trial Period Through Week 56|Unclassified|10
393043|NCT00781937|1318656|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
393044|NCT00781937|1318657|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
393045|NCT00781937|1318656|P2|Main Trial Period Through Week 56|Protocol Violation|5
393046|NCT00781937|1318657|P1|Main Trial Period Through Week 56|Protocol Violation|8
393047|NCT00781937|1318656|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
393048|NCT00781937|1318657|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
393049|NCT00781937|1318656|P2|Main Trial Period Through Week 56|Adverse Event|18
393050|NCT00781937|1318657|P1|Main Trial Period Through Week 56|Adverse Event|18
393051|NCT00781911|1318715|P2|Overall Study|Sponsor Decision|0
393052|NCT00781911|1318716|P1|Overall Study|Sponsor Decision|1
393053|NCT00781911|1318715|P2|Overall Study|Physician Decision|2
393054|NCT00781911|1318716|P1|Overall Study|Physician Decision|0
393055|NCT00781911|1318715|P2|Overall Study|Withdrawal by Subject|2
393056|NCT00781911|1318716|P1|Overall Study|Withdrawal by Subject|1
393057|NCT00781911|1318715|P2|Overall Study|Adverse Event|4
393058|NCT00781911|1318716|P1|Overall Study|Adverse Event|4
393059|NCT00781859|1318753|P2|Overall Study|Death|0
393060|NCT00781859|1318754|P1|Overall Study|Death|3
393061|NCT00781859|1318753|P2|Overall Study|Lost to Follow-up|3
393062|NCT00781859|1318754|P1|Overall Study|Lost to Follow-up|6
393063|NCT00781859|1318753|P2|Overall Study|Withdrawal by Subject|4
393064|NCT00781859|1318754|P1|Overall Study|Withdrawal by Subject|8
393065|NCT00781859|1318753|P2|Overall Study|Adverse Event|2
393066|NCT00781859|1318754|P1|Overall Study|Adverse Event|2
393067|NCT00781599|1318764|P2|Overall Study|Lost to Follow-up|4
393068|NCT00781599|1318765|P1|Overall Study|Lost to Follow-up|7
393069|NCT00781456|1318790|P2|Overall Study|Other Reason, Unknown|1
393070|NCT00781456|1318791|P1|Overall Study|Other Reason, Unknown|0
393071|NCT00781456|1318790|P2|Overall Study|Lost to Follow-up|5
393072|NCT00781456|1318791|P1|Overall Study|Lost to Follow-up|10
393073|NCT00781456|1318790|P2|Overall Study|Noncompliance With Protocol|1
393074|NCT00781456|1318791|P1|Overall Study|Noncompliance With Protocol|1
393075|NCT00781456|1318790|P2|Overall Study|Protocol Violation|1
393076|NCT00781456|1318791|P1|Overall Study|Protocol Violation|4
393077|NCT00781456|1318790|P2|Overall Study|Withdrawal by Subject|5
393078|NCT00781456|1318791|P1|Overall Study|Withdrawal by Subject|3
393079|NCT00781456|1318790|P2|Overall Study|Adverse Event|3
393080|NCT00781456|1318791|P1|Overall Study|Adverse Event|3
393081|NCT00781391|1318814|P3|Overall Study|Lost to Follow-up|1
393082|NCT00781391|1318815|P2|Overall Study|Lost to Follow-up|0
393083|NCT00781391|1318816|P1|Overall Study|Lost to Follow-up|0
393084|NCT00781391|1318814|P3|Overall Study|Withdrawal by Subject|25
393085|NCT00781391|1318815|P2|Overall Study|Withdrawal by Subject|37
393086|NCT00781391|1318816|P1|Overall Study|Withdrawal by Subject|47
393087|NCT00781391|1318814|P3|Overall Study|Death|706
393088|NCT00781391|1318815|P2|Overall Study|Death|730
393089|NCT00781391|1318816|P1|Overall Study|Death|789
393090|NCT00781391|1318814|P3|Overall Study|Protocol Violation|20
393091|NCT00781391|1318815|P2|Overall Study|Protocol Violation|17
393092|NCT00781391|1318816|P1|Overall Study|Protocol Violation|19
393093|NCT00781391|1318814|P3|Overall Study|never received study drug|32
393094|NCT00781391|1318815|P2|Overall Study|never received study drug|23
393095|NCT00781391|1318816|P1|Overall Study|never received study drug|24
393096|NCT00781365|1318850|P2|Overall Study|Language barrier|0
393097|NCT00781365|1318851|P1|Overall Study|Language barrier|1
393098|NCT00781365|1318850|P2|Overall Study|Did Not Attend Visit|28
393099|NCT00781365|1318851|P1|Overall Study|Did Not Attend Visit|20
393100|NCT00781365|1318850|P2|Overall Study|Withdrawal by Subject|8
393101|NCT00781365|1318851|P1|Overall Study|Withdrawal by Subject|13
393102|NCT00781326|1318861|P1|Phase I|Physician Decision|2
393103|NCT00781326|1318861|P1|Phase I|Withdrawal by Subject|1
393104|NCT00781326|1318861|P1|Phase I|Adverse Event|1
393105|NCT00781274|1318865|P1|Overall Study|Withdrawal by Subject|2
393106|NCT00780910|1318889|P1|Overall Study|Adverse Event|2
393107|NCT00780416|1318985|P2|Overall Study|Withdrawal by Subject|6
393108|NCT00780416|1318986|P1|Overall Study|Withdrawal by Subject|8
393109|NCT00780416|1318985|P2|Overall Study|Protocol Violation|0
393110|NCT00780416|1318986|P1|Overall Study|Protocol Violation|1
393111|NCT00780416|1318985|P2|Overall Study|Physician Decision|3
393112|NCT00780416|1318986|P1|Overall Study|Physician Decision|3
393113|NCT00780273|1319031|P1|Overall Study|Lost to Follow-up|1
393114|NCT00780273|1319031|P1|Overall Study|Death|1
393115|NCT00779909|1319070|P4|Overall Study|Withdrawal by Subject|0
393116|NCT00779909|1319071|P3|Overall Study|Withdrawal by Subject|0
393117|NCT00779909|1319072|P2|Overall Study|Withdrawal by Subject|1
393118|NCT00779909|1319073|P1|Overall Study|Withdrawal by Subject|0
393119|NCT00779909|1319070|P4|Overall Study|Lost to Follow-up|1
393120|NCT00779909|1319071|P3|Overall Study|Lost to Follow-up|0
393121|NCT00779909|1319072|P2|Overall Study|Lost to Follow-up|0
393122|NCT00779909|1319073|P1|Overall Study|Lost to Follow-up|1
393123|NCT00779857|1319115|P1|Overall Study|Missed Visit|2
393124|NCT00779857|1319115|P1|Overall Study|Withdrawal by Subject|3
393125|NCT00779857|1319115|P1|Overall Study|Death|1
393126|NCT00779779|1319120|P1|Overall Study|Lost to Follow-up|5
393127|NCT00779779|1319120|P1|Overall Study|Withdrawal by Subject|4
393128|NCT00779779|1319120|P1|Overall Study|Protocol Violation|14
393129|NCT00779779|1319120|P1|Overall Study|Adverse Event|1
393130|NCT00779766|1319129|P2|Overall Study|Withdrawal by Subject|67
393131|NCT00779766|1319130|P1|Overall Study|Withdrawal by Subject|84
393132|NCT00779766|1319129|P2|Overall Study|Protocol Violation|1
393133|NCT00779766|1319130|P1|Overall Study|Protocol Violation|1
393134|NCT00779675|1319212|P1|Extended Treatment Period|Lost to Follow-up|6
393135|NCT00779675|1319212|P1|Extended Treatment Period|Protocol defined clinical event|1
393136|NCT00779675|1319212|P1|Extended Treatment Period|Treatment Failure|11
393137|NCT00779675|1319212|P1|Extended Treatment Period|Adverse Event|6
393138|NCT00779675|1319212|P1|Extended Treatment Period|Protocol Violation|13
393139|NCT00779675|1319212|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
393140|NCT00779675|1319212|P1|Treatment Period|Administrative|3
393141|NCT00779675|1319212|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
393142|NCT00779675|1319212|P1|Treatment Period|Protocol Violation|54
393143|NCT00779675|1319212|P1|Treatment Period|Withdrawal by Subject|46
393144|NCT00779675|1319212|P1|Treatment Period|Lost to Follow-up|23
393145|NCT00779675|1319212|P1|Treatment Period|Transferred to Another Study|38
393146|NCT00779675|1319212|P1|Treatment Period|Treatment Failure|80
393147|NCT00779675|1319212|P1|Treatment Period|Adverse Event|87
393148|NCT00779584|1319240|P9|Overall Study|Ongoing in Study|0
393149|NCT00779584|1319241|P8|Overall Study|Ongoing in Study|0
393150|NCT00779584|1319242|P7|Overall Study|Ongoing in Study|0
393151|NCT00779584|1319243|P6|Overall Study|Ongoing in Study|1
393152|NCT00779584|1319244|P5|Overall Study|Ongoing in Study|1
393153|NCT00779584|1319245|P4|Overall Study|Ongoing in Study|0
393154|NCT00779584|1319246|P3|Overall Study|Ongoing in Study|0
393155|NCT00779584|1319247|P2|Overall Study|Ongoing in Study|0
393156|NCT00779584|1319248|P1|Overall Study|Ongoing in Study|0
393157|NCT00779584|1319240|P9|Overall Study|Symptomatic Deterioration|0
393158|NCT00779584|1319241|P8|Overall Study|Symptomatic Deterioration|0
393159|NCT00779584|1319242|P7|Overall Study|Symptomatic Deterioration|1
393160|NCT00779584|1319243|P6|Overall Study|Symptomatic Deterioration|1
393161|NCT00779584|1319244|P5|Overall Study|Symptomatic Deterioration|0
393162|NCT00779584|1319245|P4|Overall Study|Symptomatic Deterioration|0
393163|NCT00779584|1319246|P3|Overall Study|Symptomatic Deterioration|1
393164|NCT00779584|1319247|P2|Overall Study|Symptomatic Deterioration|1
393165|NCT00779584|1319248|P1|Overall Study|Symptomatic Deterioration|1
393166|NCT00779584|1319240|P9|Overall Study|Adverse Event|1
393167|NCT00779584|1319241|P8|Overall Study|Adverse Event|1
393168|NCT00779584|1319242|P7|Overall Study|Adverse Event|2
393169|NCT00779584|1319243|P6|Overall Study|Adverse Event|0
393170|NCT00779584|1319244|P5|Overall Study|Adverse Event|0
393171|NCT00779584|1319245|P4|Overall Study|Adverse Event|0
393172|NCT00779584|1319246|P3|Overall Study|Adverse Event|2
393173|NCT00779584|1319247|P2|Overall Study|Adverse Event|0
393174|NCT00779584|1319248|P1|Overall Study|Adverse Event|1
393175|NCT00779584|1319240|P9|Overall Study|Progression of Disease|1
393176|NCT00779584|1319241|P8|Overall Study|Progression of Disease|2
393177|NCT00779584|1319242|P7|Overall Study|Progression of Disease|4
393178|NCT00779584|1319243|P6|Overall Study|Progression of Disease|1
393179|NCT00779584|1319244|P5|Overall Study|Progression of Disease|5
393180|NCT00779584|1319245|P4|Overall Study|Progression of Disease|6
393181|NCT00779584|1319246|P3|Overall Study|Progression of Disease|2
393182|NCT00779584|1319247|P2|Overall Study|Progression of Disease|1
393183|NCT00779584|1319248|P1|Overall Study|Progression of Disease|0
393184|NCT00779584|1319240|P9|Overall Study|Lost to Follow-up|0
393185|NCT00779584|1319241|P8|Overall Study|Lost to Follow-up|0
393186|NCT00779584|1319242|P7|Overall Study|Lost to Follow-up|0
393187|NCT00779584|1319243|P6|Overall Study|Lost to Follow-up|0
393188|NCT00779584|1319244|P5|Overall Study|Lost to Follow-up|1
393189|NCT00779584|1319245|P4|Overall Study|Lost to Follow-up|0
393190|NCT00779584|1319246|P3|Overall Study|Lost to Follow-up|0
393191|NCT00779584|1319247|P2|Overall Study|Lost to Follow-up|0
393192|NCT00779584|1319248|P1|Overall Study|Lost to Follow-up|0
393193|NCT00779584|1319240|P9|Overall Study|Withdrawal by Subject|0
393194|NCT00779584|1319241|P8|Overall Study|Withdrawal by Subject|0
393195|NCT00779584|1319242|P7|Overall Study|Withdrawal by Subject|1
393196|NCT00779584|1319243|P6|Overall Study|Withdrawal by Subject|2
393197|NCT00779584|1319244|P5|Overall Study|Withdrawal by Subject|0
393198|NCT00779584|1319245|P4|Overall Study|Withdrawal by Subject|0
393199|NCT00779584|1319246|P3|Overall Study|Withdrawal by Subject|2
393200|NCT00779584|1319247|P2|Overall Study|Withdrawal by Subject|1
393201|NCT00779584|1319248|P1|Overall Study|Withdrawal by Subject|1
393202|NCT00779584|1319240|P9|Overall Study|Protocol Violation|0
393203|NCT00779584|1319241|P8|Overall Study|Protocol Violation|0
393204|NCT00779584|1319242|P7|Overall Study|Protocol Violation|0
393205|NCT00779584|1319243|P6|Overall Study|Protocol Violation|1
393206|NCT00779584|1319244|P5|Overall Study|Protocol Violation|0
393207|NCT00779584|1319245|P4|Overall Study|Protocol Violation|0
393208|NCT00779584|1319246|P3|Overall Study|Protocol Violation|0
393209|NCT00779584|1319247|P2|Overall Study|Protocol Violation|0
393210|NCT00779584|1319248|P1|Overall Study|Protocol Violation|0
393211|NCT00779506|1319339|P1|Overall Study|Lost to Follow-up|1
393212|NCT00779506|1319339|P1|Overall Study|Withdrawal by Subject|6
393213|NCT00779506|1319339|P1|Overall Study|Protocol Violation|5
393214|NCT00779506|1319339|P1|Overall Study|Lack of Efficacy|11
393215|NCT00779506|1319339|P1|Overall Study|Adverse Event|4
393216|NCT00779506|1319339|P1|Overall Study|Screening Failed|2
393217|NCT00779467|1319353|P4|Overall Study|unavailable research staff|1
393218|NCT00779467|1319354|P3|Overall Study|unavailable research staff|0
393219|NCT00779467|1319355|P2|Overall Study|unavailable research staff|0
393220|NCT00779467|1319356|P1|Overall Study|unavailable research staff|0
393221|NCT00779467|1319353|P4|Overall Study|technical issue|1
393222|NCT00779467|1319354|P3|Overall Study|technical issue|2
393223|NCT00779467|1319355|P2|Overall Study|technical issue|0
393224|NCT00779467|1319356|P1|Overall Study|technical issue|0
393225|NCT00779467|1319353|P4|Overall Study|missing data|4
393226|NCT00779467|1319354|P3|Overall Study|missing data|1
393227|NCT00779467|1319355|P2|Overall Study|missing data|0
393228|NCT00779467|1319356|P1|Overall Study|missing data|1
393229|NCT00779467|1319353|P4|Overall Study|failed inclusion criteria|2
393230|NCT00779467|1319354|P3|Overall Study|failed inclusion criteria|1
393231|NCT00779467|1319355|P2|Overall Study|failed inclusion criteria|3
393232|NCT00779467|1319356|P1|Overall Study|failed inclusion criteria|3
393233|NCT00779467|1319353|P4|Overall Study|Lack of Efficacy|11
393234|NCT00779467|1319354|P3|Overall Study|Lack of Efficacy|6
393235|NCT00779467|1319355|P2|Overall Study|Lack of Efficacy|2
393236|NCT00779467|1319356|P1|Overall Study|Lack of Efficacy|11
393237|NCT00779402|1319396|P2|Long-term Follow-up|Completed Protocol Visits|2
393238|NCT00779402|1319397|P1|Long-term Follow-up|Completed Protocol Visits|6
393239|NCT00779402|1319396|P2|Long-term Follow-up|Closure of Study|4
393240|NCT00779402|1319397|P1|Long-term Follow-up|Closure of Study|8
393241|NCT00779402|1319396|P2|Long-term Follow-up|Not specified|0
393242|NCT00779402|1319397|P1|Long-term Follow-up|Not specified|5
393243|NCT00779402|1319396|P2|Long-term Follow-up|Patient refused to continue|0
393244|NCT00779402|1319397|P1|Long-term Follow-up|Patient refused to continue|2
393245|NCT00779402|1319396|P2|Surveillance Phase|Completed Protocol Visits|2
393246|NCT00779402|1319397|P1|Surveillance Phase|Completed Protocol Visits|3
393247|NCT00779402|1319396|P2|Surveillance Phase|Closure of study|6
393248|NCT00779402|1319397|P1|Surveillance Phase|Closure of study|5
393249|NCT00779402|1319396|P2|Surveillance Phase|Withdrawal by Subject|1
393250|NCT00779402|1319397|P1|Surveillance Phase|Withdrawal by Subject|4
393251|NCT00779402|1319396|P2|Surveillance Phase|Not specified|5
393252|NCT00779402|1319397|P1|Surveillance Phase|Not specified|5
393253|NCT00779402|1319396|P2|Surveillance Phase|Intercurrent Illness|0
393254|NCT00779402|1319397|P1|Surveillance Phase|Intercurrent Illness|2
393255|NCT00779402|1319396|P2|Surveillance Phase|Death|1
393256|NCT00779402|1319397|P1|Surveillance Phase|Death|0
393257|NCT00779402|1319396|P2|Surveillance Phase|Lost to Follow-up|1
393258|NCT00779402|1319397|P1|Surveillance Phase|Lost to Follow-up|2
393259|NCT00779402|1319396|P2|Surveillance Phase|Patient refused to continue|14
393260|NCT00779402|1319397|P1|Surveillance Phase|Patient refused to continue|22
393261|NCT00779402|1319396|P2|Surveillance Phase|Protocol Violation|1
393262|NCT00779402|1319397|P1|Surveillance Phase|Protocol Violation|0
393263|NCT00779402|1319396|P2|Treatment Phase 1|Completed Protocol Visits|6
393264|NCT00779402|1319397|P1|Treatment Phase 1|Completed Protocol Visits|3
393265|NCT00779402|1319396|P2|Treatment Phase 1|Closure of Study|2
393266|NCT00779402|1319397|P1|Treatment Phase 1|Closure of Study|3
393267|NCT00779402|1319396|P2|Treatment Phase 1|Not Specified|2
393268|NCT00779402|1319397|P1|Treatment Phase 1|Not Specified|4
393269|NCT00779402|1319396|P2|Treatment Phase 1|Withdrawal by Subject|0
393270|NCT00779402|1319397|P1|Treatment Phase 1|Withdrawal by Subject|1
393271|NCT00779402|1319396|P2|Treatment Phase 1|Intercurrent Illness|1
393272|NCT00779402|1319397|P1|Treatment Phase 1|Intercurrent Illness|1
393273|NCT00779402|1319396|P2|Treatment Phase 1|Death|1
393274|NCT00779402|1319397|P1|Treatment Phase 1|Death|0
393275|NCT00779402|1319396|P2|Treatment Phase 1|Lost to Follow-up|1
393276|NCT00779402|1319397|P1|Treatment Phase 1|Lost to Follow-up|0
393277|NCT00779402|1319396|P2|Treatment Phase 1|Patient Refused to Continue|2
393278|NCT00779402|1319397|P1|Treatment Phase 1|Patient Refused to Continue|17
393279|NCT00779402|1319396|P2|Treatment Phase 1|Protocol Violation|0
393280|NCT00779402|1319397|P1|Treatment Phase 1|Protocol Violation|1
393281|NCT00779402|1319396|P2|Treatment Phase 1|Adverse Event|0
393282|NCT00779402|1319397|P1|Treatment Phase 1|Adverse Event|2
393283|NCT00779402|1319396|P2|Treatment Phase 1|Disease Progression|0
393284|NCT00779402|1319397|P1|Treatment Phase 1|Disease Progression|1
393285|NCT00779259|1319440|P1|Quinine Alone|Adverse Event|2
393286|NCT00779246|1319461|P2|Overall Study|Missing sufficient data for analysis|53
393287|NCT00779246|1319462|P1|Overall Study|Missing sufficient data for analysis|33
393288|NCT00779142|1319481|P1|Overall Study|Screen Failures|3
393289|NCT00779038|1319495|P1|Overall Study|Study Prematurely Terminated|13
393290|NCT00779025|1319504|P1|Overall Study|Withdrawal by Subject|1
393291|NCT00778999|1319515|P2|Overall Study|Did not receive recFSH|20
393292|NCT00778999|1319516|P1|Overall Study|Did not receive recFSH|14
393293|NCT00778999|1319515|P2|Overall Study|Discontinuation: no embryo transfer|14
393294|NCT00778999|1319516|P1|Overall Study|Discontinuation: no embryo transfer|14
393295|NCT00778921|1319525|P3|Overall Study|Not treated|2
393296|NCT00778921|1319526|P2|Overall Study|Not treated|2
393297|NCT00778921|1319527|P1|Overall Study|Not treated|0
393298|NCT00778921|1319525|P3|Overall Study|Protocol Violation|2
393299|NCT00778921|1319526|P2|Overall Study|Protocol Violation|0
393300|NCT00778921|1319527|P1|Overall Study|Protocol Violation|3
393301|NCT00778921|1319525|P3|Overall Study|Administrative Problems|0
393302|NCT00778921|1319526|P2|Overall Study|Administrative Problems|2
393303|NCT00778921|1319527|P1|Overall Study|Administrative Problems|1
393304|NCT00778921|1319525|P3|Overall Study|Lost to Follow-up|1
393305|NCT00778921|1319526|P2|Overall Study|Lost to Follow-up|2
393306|NCT00778921|1319527|P1|Overall Study|Lost to Follow-up|0
393307|NCT00778921|1319525|P3|Overall Study|Patient withdrew request|6
393308|NCT00778921|1319526|P2|Overall Study|Patient withdrew request|1
393309|NCT00778921|1319527|P1|Overall Study|Patient withdrew request|3
393310|NCT00778921|1319525|P3|Overall Study|Patient No Longer Requires Study Drug|0
393311|NCT00778921|1319526|P2|Overall Study|Patient No Longer Requires Study Drug|1
393312|NCT00778921|1319527|P1|Overall Study|Patient No Longer Requires Study Drug|0
393313|NCT00778921|1319525|P3|Overall Study|Unsatisfactory therapeutic response|1
393314|NCT00778921|1319526|P2|Overall Study|Unsatisfactory therapeutic response|1
393315|NCT00778921|1319527|P1|Overall Study|Unsatisfactory therapeutic response|1
393316|NCT00778921|1319525|P3|Overall Study|Abnormal Test Procedure Result(s)|2
393317|NCT00778921|1319526|P2|Overall Study|Abnormal Test Procedure Result(s)|0
393318|NCT00778921|1319527|P1|Overall Study|Abnormal Test Procedure Result(s)|0
393319|NCT00778921|1319525|P3|Overall Study|Abnormal Laboratory Value(s)|0
393320|NCT00778921|1319526|P2|Overall Study|Abnormal Laboratory Value(s)|0
393321|NCT00778921|1319527|P1|Overall Study|Abnormal Laboratory Value(s)|1
393322|NCT00778921|1319525|P3|Overall Study|Adverse Event|14
393323|NCT00778921|1319526|P2|Overall Study|Adverse Event|10
393324|NCT00778921|1319527|P1|Overall Study|Adverse Event|9
393325|NCT00778895|1319544|P3|ESFU Phase|Other|0
393326|NCT00778895|1319545|P2|ESFU Phase|Other|0
393327|NCT00778895|1319546|P1|ESFU Phase|Other|2
393328|NCT00778895|1319544|P3|ESFU Phase|Lost to Follow-up|2
393329|NCT00778895|1319545|P2|ESFU Phase|Lost to Follow-up|7
393330|NCT00778895|1319546|P1|ESFU Phase|Lost to Follow-up|6
393331|NCT00778895|1319544|P3|ESFU Phase|Withdrawal by Subject|0
393332|NCT00778895|1319545|P2|ESFU Phase|Withdrawal by Subject|4
393333|NCT00778895|1319546|P1|ESFU Phase|Withdrawal by Subject|1
393334|NCT00778895|1319544|P3|ESFU Phase|Adverse Event|0
393335|NCT00778895|1319545|P2|ESFU Phase|Adverse Event|1
393336|NCT00778895|1319546|P1|ESFU Phase|Adverse Event|2
393337|NCT00778895|1319544|P3|Active Phase|Other|0
393338|NCT00778895|1319545|P2|Active Phase|Other|0
393339|NCT00778895|1319546|P1|Active Phase|Other|2
393340|NCT00778895|1319544|P3|Active Phase|Lost to Follow-up|0
393341|NCT00778895|1319545|P2|Active Phase|Lost to Follow-up|1
393342|NCT00778895|1319546|P1|Active Phase|Lost to Follow-up|1
393343|NCT00778895|1319544|P3|Active Phase|Withdrawal by Subject|0
393344|NCT00778895|1319545|P2|Active Phase|Withdrawal by Subject|4
393345|NCT00778895|1319546|P1|Active Phase|Withdrawal by Subject|1
393346|NCT00778895|1319544|P3|Active Phase|Adverse Event|0
393347|NCT00778895|1319545|P2|Active Phase|Adverse Event|1
393348|NCT00778895|1319546|P1|Active Phase|Adverse Event|3
393349|NCT00778830|1319590|P2|Overall Study|Ongoing at data cut-off|1
393350|NCT00778830|1319591|P1|Overall Study|Ongoing at data cut-off|0
393351|NCT00778817|1319603|P1|Overall Study|Withdrawal by Subject|2
393352|NCT00778817|1319603|P1|Overall Study|Adverse Event|2
393353|NCT00778622|1319630|P3|Overall Study|Other|1
393354|NCT00778622|1319631|P2|Overall Study|Other|0
393355|NCT00778622|1319632|P1|Overall Study|Other|1
393356|NCT00778622|1319630|P3|Overall Study|immigration|0
393357|NCT00778622|1319631|P2|Overall Study|immigration|0
393358|NCT00778622|1319632|P1|Overall Study|immigration|1
393359|NCT00778622|1319630|P3|Overall Study|Lack of Efficacy|0
393360|NCT00778622|1319631|P2|Overall Study|Lack of Efficacy|0
393361|NCT00778622|1319632|P1|Overall Study|Lack of Efficacy|2
393362|NCT00778622|1319630|P3|Overall Study|Protocol Violation|0
393363|NCT00778622|1319631|P2|Overall Study|Protocol Violation|3
393364|NCT00778622|1319632|P1|Overall Study|Protocol Violation|0
393365|NCT00778622|1319630|P3|Overall Study|Lost to Follow-up|2
393366|NCT00778622|1319631|P2|Overall Study|Lost to Follow-up|3
393367|NCT00778622|1319632|P1|Overall Study|Lost to Follow-up|3
393368|NCT00778622|1319630|P3|Overall Study|Withdrawal by Subject|5
393369|NCT00778622|1319631|P2|Overall Study|Withdrawal by Subject|5
393370|NCT00778622|1319632|P1|Overall Study|Withdrawal by Subject|4
393371|NCT00778622|1319630|P3|Overall Study|Adverse Event|7
393372|NCT00778622|1319631|P2|Overall Study|Adverse Event|4
393373|NCT00778622|1319632|P1|Overall Study|Adverse Event|5
393374|NCT00778375|1319685|P1|Overall Study|Ineligible|3
393375|NCT00778336|1319699|P4|3 Month Follow Up|Death|0
393376|NCT00778336|1319700|P3|3 Month Follow Up|Death|2
393377|NCT00778336|1319701|P2|3 Month Follow Up|Death|3
393378|NCT00778336|1319702|P1|3 Month Follow Up|Death|8
393379|NCT00778336|1319699|P4|3 Month Follow Up|Lost to Follow-up|0
393380|NCT00778336|1319700|P3|3 Month Follow Up|Lost to Follow-up|3
393381|NCT00778336|1319701|P2|3 Month Follow Up|Lost to Follow-up|20
393382|NCT00778336|1319702|P1|3 Month Follow Up|Lost to Follow-up|15
393383|NCT00778336|1319699|P4|Index Procedure-Discharge|Death|0
393384|NCT00778336|1319700|P3|Index Procedure-Discharge|Death|2
393385|NCT00778336|1319701|P2|Index Procedure-Discharge|Death|3
393386|NCT00778336|1319702|P1|Index Procedure-Discharge|Death|6
393387|NCT00778258|1319740|P9|Overall Study|Other|0
393388|NCT00778258|1319741|P8|Overall Study|Other|0
393389|NCT00778258|1319742|P7|Overall Study|Other|1
393390|NCT00778258|1319743|P6|Overall Study|Other|0
393391|NCT00778258|1319744|P5|Overall Study|Other|0
393392|NCT00778258|1319745|P4|Overall Study|Other|0
393393|NCT00778258|1319746|P3|Overall Study|Other|0
393394|NCT00778258|1319747|P2|Overall Study|Other|0
393395|NCT00778258|1319748|P1|Overall Study|Other|0
393396|NCT00778258|1319740|P9|Overall Study|Non-compliance|0
393397|NCT00778258|1319741|P8|Overall Study|Non-compliance|0
393398|NCT00778258|1319742|P7|Overall Study|Non-compliance|0
393399|NCT00778258|1319743|P6|Overall Study|Non-compliance|0
393400|NCT00778258|1319744|P5|Overall Study|Non-compliance|0
393401|NCT00778258|1319745|P4|Overall Study|Non-compliance|1
393402|NCT00778258|1319746|P3|Overall Study|Non-compliance|0
393403|NCT00778258|1319747|P2|Overall Study|Non-compliance|0
393404|NCT00778258|1319748|P1|Overall Study|Non-compliance|0
393405|NCT00778258|1319740|P9|Overall Study|New Contraindication|0
393406|NCT00778258|1319741|P8|Overall Study|New Contraindication|1
393407|NCT00778258|1319742|P7|Overall Study|New Contraindication|0
393408|NCT00778258|1319743|P6|Overall Study|New Contraindication|0
393409|NCT00778258|1319744|P5|Overall Study|New Contraindication|0
393410|NCT00778258|1319745|P4|Overall Study|New Contraindication|0
393411|NCT00778258|1319746|P3|Overall Study|New Contraindication|0
393412|NCT00778258|1319747|P2|Overall Study|New Contraindication|0
393413|NCT00778258|1319748|P1|Overall Study|New Contraindication|0
393414|NCT00778258|1319740|P9|Overall Study|Withdrawal by Subject|4
393415|NCT00778258|1319741|P8|Overall Study|Withdrawal by Subject|12
393416|NCT00778258|1319742|P7|Overall Study|Withdrawal by Subject|12
393417|NCT00778258|1319743|P6|Overall Study|Withdrawal by Subject|6
393418|NCT00778258|1319744|P5|Overall Study|Withdrawal by Subject|0
393419|NCT00778258|1319745|P4|Overall Study|Withdrawal by Subject|2
393420|NCT00778258|1319746|P3|Overall Study|Withdrawal by Subject|8
393421|NCT00778258|1319747|P2|Overall Study|Withdrawal by Subject|2
393422|NCT00778258|1319748|P1|Overall Study|Withdrawal by Subject|6
393423|NCT00778258|1319740|P9|Overall Study|Lost to Follow-up|0
393424|NCT00778258|1319741|P8|Overall Study|Lost to Follow-up|2
393425|NCT00778258|1319742|P7|Overall Study|Lost to Follow-up|2
393426|NCT00778258|1319743|P6|Overall Study|Lost to Follow-up|3
393427|NCT00778258|1319744|P5|Overall Study|Lost to Follow-up|0
393428|NCT00778258|1319745|P4|Overall Study|Lost to Follow-up|0
393429|NCT00778258|1319746|P3|Overall Study|Lost to Follow-up|2
393430|NCT00778258|1319747|P2|Overall Study|Lost to Follow-up|0
393431|NCT00778258|1319748|P1|Overall Study|Lost to Follow-up|0
393432|NCT00778258|1319740|P9|Overall Study|Adverse Event|0
393433|NCT00778258|1319741|P8|Overall Study|Adverse Event|0
393434|NCT00778258|1319742|P7|Overall Study|Adverse Event|0
393435|NCT00778258|1319743|P6|Overall Study|Adverse Event|1
393436|NCT00778258|1319744|P5|Overall Study|Adverse Event|0
393437|NCT00778258|1319745|P4|Overall Study|Adverse Event|0
393438|NCT00778258|1319746|P3|Overall Study|Adverse Event|0
393439|NCT00778258|1319747|P2|Overall Study|Adverse Event|0
393440|NCT00778258|1319748|P1|Overall Study|Adverse Event|1
393441|NCT00778102|1319815|P2|Overall Study|Administrative Reason|10
393442|NCT00778102|1319816|P1|Overall Study|Administrative Reason|7
393443|NCT00778102|1319815|P2|Overall Study|Withdrawal by Subject|1
393444|NCT00778102|1319816|P1|Overall Study|Withdrawal by Subject|1
393445|NCT00778102|1319815|P2|Overall Study|Refused Treatment|3
393446|NCT00778102|1319816|P1|Overall Study|Refused Treatment|2
393447|NCT00778102|1319815|P2|Overall Study|Protocol Violation|1
393448|NCT00778102|1319816|P1|Overall Study|Protocol Violation|0
393449|NCT00778102|1319815|P2|Overall Study|Violation of Selection Criteria|1
393450|NCT00778102|1319816|P1|Overall Study|Violation of Selection Criteria|1
393451|NCT00778102|1319815|P2|Overall Study|Lost to Follow-up|0
393452|NCT00778102|1319816|P1|Overall Study|Lost to Follow-up|1
393453|NCT00778102|1319815|P2|Overall Study|Death|1
393454|NCT00778102|1319816|P1|Overall Study|Death|1
393455|NCT00778102|1319815|P2|Overall Study|Adverse Event|5
393456|NCT00778102|1319816|P1|Overall Study|Adverse Event|8
393457|NCT00777946|1319851|P3|Overall Study|Randomized in error|0
393458|NCT00777946|1319852|P2|Overall Study|Randomized in error|1
393459|NCT00777946|1319853|P1|Overall Study|Randomized in error|1
393460|NCT00777946|1319851|P3|Overall Study|Protocol deviation|1
393461|NCT00777946|1319852|P2|Overall Study|Protocol deviation|1
393462|NCT00777946|1319853|P1|Overall Study|Protocol deviation|2
393463|NCT00777946|1319851|P3|Overall Study|Lost to Follow-up|0
393464|NCT00777946|1319852|P2|Overall Study|Lost to Follow-up|1
393465|NCT00777946|1319853|P1|Overall Study|Lost to Follow-up|3
393466|NCT00777946|1319851|P3|Overall Study|Patient withdrew consent|3
393467|NCT00777946|1319852|P2|Overall Study|Patient withdrew consent|2
393468|NCT00777946|1319853|P1|Overall Study|Patient withdrew consent|3
393469|NCT00777946|1319851|P3|Overall Study|Condition no longer required study drug|0
393470|NCT00777946|1319852|P2|Overall Study|Condition no longer required study drug|0
393471|NCT00777946|1319853|P1|Overall Study|Condition no longer required study drug|1
393472|NCT00777946|1319851|P3|Overall Study|Lack of Efficacy|9
393473|NCT00777946|1319852|P2|Overall Study|Lack of Efficacy|0
393474|NCT00777946|1319853|P1|Overall Study|Lack of Efficacy|0
393475|NCT00777946|1319851|P3|Overall Study|Adverse Event|3
393476|NCT00777946|1319852|P2|Overall Study|Adverse Event|1
393477|NCT00777946|1319853|P1|Overall Study|Adverse Event|11
393478|NCT00777803|1319888|P2|Overall Study|Non-compliance|2
393479|NCT00777803|1319889|P1|Overall Study|Non-compliance|2
393480|NCT00777803|1319888|P2|Overall Study|Adverse Event|0
393481|NCT00777803|1319889|P1|Overall Study|Adverse Event|1
393482|NCT00777803|1319888|P2|Overall Study|Lost to Follow-up|5
393483|NCT00777803|1319889|P1|Overall Study|Lost to Follow-up|12
393484|NCT00777608|1319968|P2|Overall Study|Investigator Decision|2
393485|NCT00777608|1319969|P1|Overall Study|Investigator Decision|1
393486|NCT00777608|1319968|P2|Overall Study|Protocol Violation|0
393487|NCT00777608|1319969|P1|Overall Study|Protocol Violation|1
393488|NCT00777608|1319968|P2|Overall Study|Withdrawal by Subject|3
393489|NCT00777608|1319969|P1|Overall Study|Withdrawal by Subject|1
393490|NCT00777608|1319968|P2|Overall Study|Lost to Follow-up|1
393491|NCT00777608|1319969|P1|Overall Study|Lost to Follow-up|1
393492|NCT00777556|1319979|P1|Overall Study|Did not complete all 3 follow-up visits|20
393493|NCT00777556|1319979|P1|Overall Study|Dispensed but did not use product|12
393494|NCT00777556|1319979|P1|Overall Study|Inappropriate self-selection|34
393495|NCT00777257|1320000|P3|Overall Study|Withdrawal by Subject|5
393496|NCT00777257|1320001|P2|Overall Study|Withdrawal by Subject|6
393497|NCT00777257|1320002|P1|Overall Study|Withdrawal by Subject|3
393498|NCT00777257|1320000|P3|Overall Study|Protocol Violation|2
393499|NCT00777257|1320001|P2|Overall Study|Protocol Violation|2
393500|NCT00777257|1320002|P1|Overall Study|Protocol Violation|2
393501|NCT00777257|1320000|P3|Overall Study|Lost to Follow-up|2
393502|NCT00777257|1320001|P2|Overall Study|Lost to Follow-up|3
393503|NCT00777257|1320002|P1|Overall Study|Lost to Follow-up|3
393504|NCT00777257|1320000|P3|Overall Study|Adverse Event|0
393505|NCT00777257|1320001|P2|Overall Study|Adverse Event|1
393506|NCT00777257|1320002|P1|Overall Study|Adverse Event|3
393507|NCT00777205|1320021|P2|Overall Study|Protocol Violation|56
393508|NCT00777205|1320022|P1|Overall Study|Protocol Violation|0
393509|NCT00777205|1320021|P2|Overall Study|Death|2
393510|NCT00777205|1320022|P1|Overall Study|Death|0
393511|NCT00777205|1320021|P2|Overall Study|Withdrawal by Subject|4
393512|NCT00777205|1320022|P1|Overall Study|Withdrawal by Subject|6
393513|NCT00777205|1320021|P2|Overall Study|Lost to Follow-up|9
393514|NCT00777205|1320022|P1|Overall Study|Lost to Follow-up|25
393515|NCT00777153|1320056|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
393516|NCT00777153|1320057|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
393517|NCT00777153|1320058|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
393518|NCT00777153|1320056|P3|Overall Study|Withdrawal by Subject|3
393519|NCT00777153|1320057|P2|Overall Study|Withdrawal by Subject|4
393520|NCT00777153|1320058|P1|Overall Study|Withdrawal by Subject|3
393521|NCT00777153|1320056|P3|Overall Study|Death|33
393522|NCT00777153|1320057|P2|Overall Study|Death|73
393523|NCT00777153|1320058|P1|Overall Study|Death|85
393524|NCT00777153|1320056|P3|Overall Study|Lost to Follow-up|0
393525|NCT00777153|1320057|P2|Overall Study|Lost to Follow-up|1
393526|NCT00777153|1320058|P1|Overall Study|Lost to Follow-up|1
393527|NCT00777101|1320083|P2|Overall Study|Failed to Return|1
393528|NCT00777101|1320084|P1|Overall Study|Failed to Return|0
393529|NCT00777101|1320083|P2|Overall Study|Discontinuation of Study by Sponsor|0
393530|NCT00777101|1320084|P1|Overall Study|Discontinuation of Study by Sponsor|1
393531|NCT00777101|1320083|P2|Overall Study|Lost to Follow-up|1
393532|NCT00777101|1320084|P1|Overall Study|Lost to Follow-up|2
393533|NCT00777101|1320083|P2|Overall Study|Withdrawal by Subject|6
393534|NCT00777101|1320084|P1|Overall Study|Withdrawal by Subject|11
393535|NCT00777101|1320083|P2|Overall Study|Death|43
393536|NCT00777101|1320084|P1|Overall Study|Death|48
393537|NCT00777049|1320115|P2|Overall Study|No treatment (elevated liver enzymes)|1
393538|NCT00777049|1320116|P1|Overall Study|No treatment (elevated liver enzymes)|0
393539|NCT00777049|1320115|P2|Overall Study|Withdrawal by Subject|0
393540|NCT00777049|1320116|P1|Overall Study|Withdrawal by Subject|1
393541|NCT00777036|1320125|P3|Follow-Up|Death|0
393542|NCT00777036|1320126|P2|Follow-Up|Death|8
393543|NCT00777036|1320127|P1|Follow-Up|Death|1
393544|NCT00777036|1320125|P3|Follow-Up|Withdrawal by Subject|4
393545|NCT00777036|1320126|P2|Follow-Up|Withdrawal by Subject|0
393546|NCT00777036|1320127|P1|Follow-Up|Withdrawal by Subject|1
393547|NCT00777036|1320125|P3|Follow-Up|Reason Not Specified|0
393548|NCT00777036|1320126|P2|Follow-Up|Reason Not Specified|0
393549|NCT00777036|1320127|P1|Follow-Up|Reason Not Specified|2
393550|NCT00777036|1320125|P3|Follow-Up|Lost to Follow-up|0
393551|NCT00777036|1320126|P2|Follow-Up|Lost to Follow-up|0
393552|NCT00777036|1320127|P1|Follow-Up|Lost to Follow-up|1
393553|NCT00777036|1320125|P3|On Treatment|Progressive Disease|6
393554|NCT00777036|1320126|P2|On Treatment|Progressive Disease|4
393555|NCT00777036|1320127|P1|On Treatment|Progressive Disease|5
393556|NCT00777036|1320125|P3|On Treatment|Study Drug Toxicity|1
393557|NCT00777036|1320126|P2|On Treatment|Study Drug Toxicity|0
393558|NCT00777036|1320127|P1|On Treatment|Study Drug Toxicity|0
393559|NCT00777036|1320125|P3|On Treatment|Death|0
393560|NCT00777036|1320126|P2|On Treatment|Death|2
393561|NCT00777036|1320127|P1|On Treatment|Death|0
393562|NCT00777036|1320125|P3|On Treatment|Withdrawal by Subject|3
393563|NCT00777036|1320126|P2|On Treatment|Withdrawal by Subject|2
393564|NCT00777036|1320127|P1|On Treatment|Withdrawal by Subject|3
393565|NCT00777036|1320125|P3|On Treatment|Maximum Clinical Benefit|1
393566|NCT00777036|1320126|P2|On Treatment|Maximum Clinical Benefit|0
393567|NCT00777036|1320127|P1|On Treatment|Maximum Clinical Benefit|2
393568|NCT00777036|1320125|P3|On Treatment|Non-compliance with Study Drug|0
393569|NCT00777036|1320126|P2|On Treatment|Non-compliance with Study Drug|0
393570|NCT00777036|1320127|P1|On Treatment|Non-compliance with Study Drug|1
393571|NCT00777036|1320125|P3|On Treatment|Failure to Meet Study Criteria|0
393572|NCT00777036|1320126|P2|On Treatment|Failure to Meet Study Criteria|1
393573|NCT00777036|1320127|P1|On Treatment|Failure to Meet Study Criteria|0
393574|NCT00777036|1320125|P3|On Treatment|Reason Not Specified|12
393575|NCT00777036|1320126|P2|On Treatment|Reason Not Specified|7
393576|NCT00777036|1320127|P1|On Treatment|Reason Not Specified|4
393577|NCT00777023|1320223|P3|Overall Study|Last dose date unknown|1
393578|NCT00777023|1320224|P2|Overall Study|Last dose date unknown|3
393579|NCT00777023|1320225|P1|Overall Study|Last dose date unknown|3
393580|NCT00777023|1320223|P3|Overall Study|Reasons not specified|2
393581|NCT00777023|1320224|P2|Overall Study|Reasons not specified|4
393582|NCT00777023|1320225|P1|Overall Study|Reasons not specified|4
393583|NCT00777023|1320223|P3|Overall Study|Missing data|0
393584|NCT00777023|1320224|P2|Overall Study|Missing data|1
393585|NCT00777023|1320225|P1|Overall Study|Missing data|1
393586|NCT00777023|1320223|P3|Overall Study|Withdrawal by Subject|8
393587|NCT00777023|1320224|P2|Overall Study|Withdrawal by Subject|7
393588|NCT00777023|1320225|P1|Overall Study|Withdrawal by Subject|7
393589|NCT00777023|1320223|P3|Overall Study|Death|0
393590|NCT00777023|1320224|P2|Overall Study|Death|1
393591|NCT00777023|1320225|P1|Overall Study|Death|0
393592|NCT00777023|1320223|P3|Overall Study|Lost to Follow-up|3
393593|NCT00777023|1320224|P2|Overall Study|Lost to Follow-up|3
393594|NCT00777023|1320225|P1|Overall Study|Lost to Follow-up|2
393595|NCT00777023|1320223|P3|Overall Study|Protocol Violation|1
393596|NCT00777023|1320224|P2|Overall Study|Protocol Violation|1
393597|NCT00777023|1320225|P1|Overall Study|Protocol Violation|2
393598|NCT00777023|1320223|P3|Overall Study|Lack of Efficacy|14
393599|NCT00777023|1320224|P2|Overall Study|Lack of Efficacy|0
393600|NCT00777023|1320225|P1|Overall Study|Lack of Efficacy|1
393601|NCT00777023|1320223|P3|Overall Study|Adverse Event|8
393602|NCT00777023|1320224|P2|Overall Study|Adverse Event|21
393603|NCT00777023|1320225|P1|Overall Study|Adverse Event|15
393604|NCT00776997|1320242|P1|Overall Study|Adverse Event|2
393605|NCT00776984|1320251|P2|Overall Study|Other|9
393606|NCT00776984|1320252|P1|Overall Study|Other|5
393607|NCT00776984|1320251|P2|Overall Study|Lack of Efficacy|1
393608|NCT00776984|1320252|P1|Overall Study|Lack of Efficacy|0
393609|NCT00776984|1320251|P2|Overall Study|Withdrawal by Subject|7
393610|NCT00776984|1320252|P1|Overall Study|Withdrawal by Subject|12
393611|NCT00776984|1320251|P2|Overall Study|Lost to Follow-up|0
393612|NCT00776984|1320252|P1|Overall Study|Lost to Follow-up|2
393613|NCT00776984|1320251|P2|Overall Study|Protocol Violation|2
393614|NCT00776984|1320252|P1|Overall Study|Protocol Violation|4
393615|NCT00776984|1320251|P2|Overall Study|Adverse Event|2
393616|NCT00776984|1320252|P1|Overall Study|Adverse Event|8
393617|NCT00776919|1320326|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
393618|NCT00776919|1320327|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
393619|NCT00776919|1320328|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
393620|NCT00776919|1320329|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
393621|NCT00776919|1320326|P4|Overall Study|Protocol Violation|1
393622|NCT00776919|1320327|P3|Overall Study|Protocol Violation|0
393623|NCT00776919|1320328|P2|Overall Study|Protocol Violation|2
393624|NCT00776919|1320329|P1|Overall Study|Protocol Violation|1
393625|NCT00776919|1320326|P4|Overall Study|Adverse Event|2
393626|NCT00776919|1320327|P3|Overall Study|Adverse Event|2
393627|NCT00776919|1320328|P2|Overall Study|Adverse Event|0
393628|NCT00776919|1320329|P1|Overall Study|Adverse Event|1
393629|NCT00776919|1320326|P4|Overall Study|Lost to Follow-up|8
393630|NCT00776919|1320327|P3|Overall Study|Lost to Follow-up|11
393631|NCT00776919|1320328|P2|Overall Study|Lost to Follow-up|12
393632|NCT00776919|1320329|P1|Overall Study|Lost to Follow-up|8
393633|NCT00776919|1320326|P4|Overall Study|Withdrawal by Subject|26
393634|NCT00776919|1320327|P3|Overall Study|Withdrawal by Subject|15
393635|NCT00776919|1320328|P2|Overall Study|Withdrawal by Subject|14
393636|NCT00776919|1320329|P1|Overall Study|Withdrawal by Subject|16
393637|NCT00776789|1320393|P2|Overall Study|Poor quality video|1
393638|NCT00776789|1320394|P1|Overall Study|Poor quality video|1
393639|NCT00776789|1320393|P2|Overall Study|Consent refusal|2
393640|NCT00776789|1320394|P1|Overall Study|Consent refusal|2
393641|NCT00776659|1320406|P1|Overall Study|Study Terminated by Sponsor|1
393642|NCT00776659|1320406|P1|Overall Study|Withdrawal by Subject|10
393643|NCT00776659|1320406|P1|Overall Study|Lost to Follow-up|15
393644|NCT00776555|1320433|P2|Overall Study|Study terminated|0
393645|NCT00776555|1320434|P1|Overall Study|Study terminated|3
393646|NCT00776230|1320452|P3|Overall Study|Subject missed Visit 4|0
393647|NCT00776230|1320453|P2|Overall Study|Subject missed Visit 4|1
393648|NCT00776230|1320454|P1|Overall Study|Subject missed Visit 4|0
393649|NCT00776230|1320452|P3|Overall Study|Withdrawal by Subject|0
393650|NCT00776230|1320453|P2|Overall Study|Withdrawal by Subject|1
393651|NCT00776230|1320454|P1|Overall Study|Withdrawal by Subject|0
393652|NCT00776230|1320452|P3|Overall Study|Not vaccinated at Day 0|0
393653|NCT00776230|1320453|P2|Overall Study|Not vaccinated at Day 0|0
393654|NCT00776230|1320454|P1|Overall Study|Not vaccinated at Day 0|1
393655|NCT00776230|1320452|P3|Overall Study|Lost to Follow-up|5
393656|NCT00776230|1320453|P2|Overall Study|Lost to Follow-up|1
393657|NCT00776230|1320454|P1|Overall Study|Lost to Follow-up|2
393658|NCT00776100|1320464|P2|Overall Study|Disease Progression|0
393659|NCT00776100|1320465|P1|Overall Study|Disease Progression|1
393660|NCT00776009|1320487|P6|Period 3: Third Intervention|Withdrawal by Subject|0
393661|NCT00776009|1320488|P5|Period 3: Third Intervention|Withdrawal by Subject|0
393662|NCT00776009|1320489|P4|Period 3: Third Intervention|Withdrawal by Subject|0
393663|NCT00776009|1320490|P3|Period 3: Third Intervention|Withdrawal by Subject|0
393664|NCT00776009|1320491|P2|Period 3: Third Intervention|Withdrawal by Subject|0
393665|NCT00776009|1320492|P1|Period 3: Third Intervention|Withdrawal by Subject|1
393666|NCT00776009|1320487|P6|Period 2: Second Intervention|Protocol Violation|0
393667|NCT00776009|1320488|P5|Period 2: Second Intervention|Protocol Violation|0
393668|NCT00776009|1320489|P4|Period 2: Second Intervention|Protocol Violation|0
393669|NCT00776009|1320490|P3|Period 2: Second Intervention|Protocol Violation|1
393670|NCT00776009|1320491|P2|Period 2: Second Intervention|Protocol Violation|0
393671|NCT00776009|1320492|P1|Period 2: Second Intervention|Protocol Violation|1
393672|NCT00776009|1320487|P6|Period 2: Second Intervention|Withdrawal by Subject|1
393673|NCT00776009|1320488|P5|Period 2: Second Intervention|Withdrawal by Subject|0
393674|NCT00776009|1320489|P4|Period 2: Second Intervention|Withdrawal by Subject|0
393675|NCT00776009|1320490|P3|Period 2: Second Intervention|Withdrawal by Subject|0
393676|NCT00776009|1320491|P2|Period 2: Second Intervention|Withdrawal by Subject|0
393677|NCT00776009|1320492|P1|Period 2: Second Intervention|Withdrawal by Subject|0
393678|NCT00776009|1320487|P6|Period 1: First Intervention|Protocol Violation|0
393679|NCT00776009|1320488|P5|Period 1: First Intervention|Protocol Violation|1
393680|NCT00776009|1320489|P4|Period 1: First Intervention|Protocol Violation|0
393681|NCT00776009|1320490|P3|Period 1: First Intervention|Protocol Violation|0
393682|NCT00776009|1320491|P2|Period 1: First Intervention|Protocol Violation|1
393683|NCT00776009|1320492|P1|Period 1: First Intervention|Protocol Violation|0
393684|NCT00776009|1320487|P6|Period 1: First Intervention|Withdrawal by Subject|0
393685|NCT00776009|1320488|P5|Period 1: First Intervention|Withdrawal by Subject|1
393686|NCT00776009|1320489|P4|Period 1: First Intervention|Withdrawal by Subject|0
393687|NCT00776009|1320490|P3|Period 1: First Intervention|Withdrawal by Subject|1
393688|NCT00776009|1320491|P2|Period 1: First Intervention|Withdrawal by Subject|0
393689|NCT00776009|1320492|P1|Period 1: First Intervention|Withdrawal by Subject|0
393690|NCT00775983|1320514|P2|Overall Study|Protocol Violation|2
393691|NCT00775983|1320515|P1|Overall Study|Protocol Violation|1
393692|NCT00775606|1320626|P2|Overall Study|Study sponsor terminated funding|0
393693|NCT00775606|1320627|P1|Overall Study|Study sponsor terminated funding|3
393694|NCT00775593|1320637|P1|Overall Study|Death|1
393695|NCT00775593|1320637|P1|Overall Study|Unmet eligibility criteria|6
393696|NCT00775528|1320644|P1|Overall Study|Protocol Violation|1
393697|NCT00775463|1320653|P2|Overall Study|Lack of Efficacy|1
393698|NCT00775463|1320654|P1|Overall Study|Lack of Efficacy|1
393699|NCT00775463|1320653|P2|Overall Study|Lost to Follow-up|0
393700|NCT00775463|1320654|P1|Overall Study|Lost to Follow-up|1
393701|NCT00775463|1320653|P2|Overall Study|Protocol Violation|2
393702|NCT00775463|1320654|P1|Overall Study|Protocol Violation|2
393703|NCT00775463|1320653|P2|Overall Study|Adverse Event|9
393704|NCT00775463|1320654|P1|Overall Study|Adverse Event|7
393705|NCT00775463|1320653|P2|Overall Study|Withdrawal by Subject|1
393706|NCT00775463|1320654|P1|Overall Study|Withdrawal by Subject|0
393707|NCT00775450|1320691|P5|Overall Study|Withdrawal by Subject|1
393708|NCT00775450|1320692|P4|Overall Study|Withdrawal by Subject|0
393709|NCT00775450|1320693|P3|Overall Study|Withdrawal by Subject|0
393710|NCT00775450|1320694|P2|Overall Study|Withdrawal by Subject|0
393711|NCT00775450|1320695|P1|Overall Study|Withdrawal by Subject|1
393712|NCT00775450|1320691|P5|Overall Study|Protocol Violation|1
393713|NCT00775450|1320692|P4|Overall Study|Protocol Violation|0
393714|NCT00775450|1320693|P3|Overall Study|Protocol Violation|0
393715|NCT00775450|1320694|P2|Overall Study|Protocol Violation|0
393716|NCT00775450|1320695|P1|Overall Study|Protocol Violation|0
393717|NCT00775450|1320691|P5|Overall Study|Serious Adverse Event|0
393718|NCT00775450|1320692|P4|Overall Study|Serious Adverse Event|0
393719|NCT00775450|1320693|P3|Overall Study|Serious Adverse Event|0
393720|NCT00775450|1320694|P2|Overall Study|Serious Adverse Event|0
393721|NCT00775450|1320695|P1|Overall Study|Serious Adverse Event|2
393722|NCT00775437|1320722|P1|Overall Study|Lost to Follow-up|1
393723|NCT00775437|1320722|P1|Overall Study|Withdrawal by Subject|3
393724|NCT00775437|1320722|P1|Overall Study|Loss of efficacy|2
393725|NCT00775203|1320797|P2|Overall Study|Physician Decision|1
393726|NCT00775203|1320798|P1|Overall Study|Physician Decision|0
393727|NCT00775203|1320797|P2|Overall Study|Entered other study|0
393728|NCT00775203|1320798|P1|Overall Study|Entered other study|1
393729|NCT00775203|1320797|P2|Overall Study|Protocol Violation|1
393730|NCT00775203|1320798|P1|Overall Study|Protocol Violation|0
393731|NCT00775203|1320797|P2|Overall Study|Noncompliance|2
393732|NCT00775203|1320798|P1|Overall Study|Noncompliance|4
393733|NCT00775203|1320797|P2|Overall Study|Administrative reason|0
393734|NCT00775203|1320798|P1|Overall Study|Administrative reason|2
393735|NCT00775203|1320797|P2|Overall Study|Lost to Follow-up|15
393736|NCT00775203|1320798|P1|Overall Study|Lost to Follow-up|11
393737|NCT00775203|1320797|P2|Overall Study|Withdrawal by Subject|9
393738|NCT00775203|1320798|P1|Overall Study|Withdrawal by Subject|11
393739|NCT00775203|1320797|P2|Overall Study|Lack of Efficacy|9
393740|NCT00775203|1320798|P1|Overall Study|Lack of Efficacy|8
393741|NCT00775203|1320797|P2|Overall Study|Adverse Event|6
393742|NCT00775203|1320798|P1|Overall Study|Adverse Event|25
393743|NCT00775190|1320832|P2|Overall Study|Protocol Violation|0
393744|NCT00775190|1320833|P1|Overall Study|Protocol Violation|1
393745|NCT00775190|1320832|P2|Overall Study|Withdrawal by Subject|2
393746|NCT00775190|1320833|P1|Overall Study|Withdrawal by Subject|1
393747|NCT00775190|1320832|P2|Overall Study|Lost to Follow-up|3
393748|NCT00775190|1320833|P1|Overall Study|Lost to Follow-up|2
393749|NCT00775021|1320855|P2|Second Intervention|Adverse Event|1
393750|NCT00775021|1320856|P1|Second Intervention|Adverse Event|0
393751|NCT00775021|1320855|P2|First Intervention|Lost to Follow-up|0
393752|NCT00775021|1320856|P1|First Intervention|Lost to Follow-up|1
393753|NCT00774995|1320874|P4|Overall Study|Protocol Violation|0
393754|NCT00774995|1320875|P3|Overall Study|Protocol Violation|1
393755|NCT00774995|1320876|P2|Overall Study|Protocol Violation|0
393756|NCT00774995|1320877|P1|Overall Study|Protocol Violation|0
393757|NCT00774930|1320917|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
393758|NCT00774930|1320918|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
393759|NCT00774930|1320917|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
393760|NCT00774930|1320918|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
393761|NCT00774930|1320917|P2|LTOLE Phase|Disease Progression|5
393762|NCT00774930|1320918|P1|LTOLE Phase|Disease Progression|2
393763|NCT00774930|1320917|P2|LTOLE Phase|Sponsor decision|1
393764|NCT00774930|1320918|P1|LTOLE Phase|Sponsor decision|2
393765|NCT00774930|1320917|P2|LTOLE Phase|Physician Decision|1
393766|NCT00774930|1320918|P1|LTOLE Phase|Physician Decision|4
393767|NCT00774930|1320917|P2|LTOLE Phase|Subject decision|5
393768|NCT00774930|1320918|P1|LTOLE Phase|Subject decision|0
393769|NCT00774930|1320917|P2|LTOLE Phase|Adverse Event|3
393770|NCT00774930|1320918|P1|LTOLE Phase|Adverse Event|7
393771|NCT00774930|1320917|P2|IOL Phase|Brain radiation|1
393772|NCT00774930|1320918|P1|IOL Phase|Brain radiation|0
393773|NCT00774930|1320917|P2|IOL Phase|Other|0
393774|NCT00774930|1320918|P1|IOL Phase|Other|1
393775|NCT00774930|1320917|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
393776|NCT00774930|1320918|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
393777|NCT00774930|1320917|P2|IOL Phase|Subject Consumed Prohibited Medication|0
393778|NCT00774930|1320918|P1|IOL Phase|Subject Consumed Prohibited Medication|1
393779|NCT00774930|1320917|P2|IOL Phase|Disease Progression|1
393780|NCT00774930|1320918|P1|IOL Phase|Disease Progression|2
393781|NCT00774930|1320917|P2|IOL Phase|Sponsor Decision|0
393782|NCT00774930|1320918|P1|IOL Phase|Sponsor Decision|1
393783|NCT00774930|1320917|P2|IOL Phase|Physician Decision|2
393784|NCT00774930|1320918|P1|IOL Phase|Physician Decision|3
393785|NCT00774930|1320917|P2|IOL Phase|Subject Decision|3
393786|NCT00774930|1320918|P1|IOL Phase|Subject Decision|4
393787|NCT00774930|1320917|P2|IOL Phase|Adverse Event|1
393788|NCT00774930|1320918|P1|IOL Phase|Adverse Event|1
393789|NCT00774930|1320917|P2|DB Phase|Started Nonprotocol Radiation therapy|1
393790|NCT00774930|1320918|P1|DB Phase|Started Nonprotocol Radiation therapy|0
393791|NCT00774930|1320917|P2|DB Phase|Disease Progression|1
393792|NCT00774930|1320918|P1|DB Phase|Disease Progression|1
393793|NCT00774930|1320917|P2|DB Phase|Sponsor Decision|1
393794|NCT00774930|1320918|P1|DB Phase|Sponsor Decision|0
393795|NCT00774930|1320917|P2|DB Phase|Subject Decision|5
393796|NCT00774930|1320918|P1|DB Phase|Subject Decision|1
393797|NCT00774930|1320917|P2|DB Phase|Adverse Event|2
393798|NCT00774930|1320918|P1|DB Phase|Adverse Event|1
393799|NCT00774930|1320917|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
393800|NCT00774930|1320918|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
393801|NCT00774852|1320946|P2|Overall Study|Subject received prohibited medication|0
393802|NCT00774852|1320947|P1|Overall Study|Subject received prohibited medication|1
393803|NCT00774852|1320946|P2|Overall Study|Protocol Violation|0
393804|NCT00774852|1320947|P1|Overall Study|Protocol Violation|1
393805|NCT00774852|1320946|P2|Overall Study|Subject non-compliance|1
393806|NCT00774852|1320947|P1|Overall Study|Subject non-compliance|0
393807|NCT00774852|1320946|P2|Overall Study|Non-responder|11
393808|NCT00774852|1320947|P1|Overall Study|Non-responder|15
393809|NCT00774852|1320946|P2|Overall Study|Withdrawal by Subject|2
393810|NCT00774852|1320947|P1|Overall Study|Withdrawal by Subject|2
393811|NCT00774852|1320946|P2|Overall Study|Pregnancy|2
393812|NCT00774852|1320947|P1|Overall Study|Pregnancy|1
393813|NCT00774852|1320946|P2|Overall Study|Physician Decision|6
393814|NCT00774852|1320947|P1|Overall Study|Physician Decision|2
393815|NCT00774852|1320946|P2|Overall Study|Lost to Follow-up|5
393816|NCT00774852|1320947|P1|Overall Study|Lost to Follow-up|9
393817|NCT00774852|1320946|P2|Overall Study|Lack of Efficacy|7
393818|NCT00774852|1320947|P1|Overall Study|Lack of Efficacy|3
393819|NCT00774852|1320946|P2|Overall Study|Death|1
393820|NCT00774852|1320947|P1|Overall Study|Death|2
393821|NCT00774852|1320946|P2|Overall Study|Adverse Event|6
393822|NCT00774852|1320947|P1|Overall Study|Adverse Event|9
393823|NCT00774800|1320995|P1|Intervention 4|Withdrawal by Subject|1
393824|NCT00774787|1321017|P1|Overall Study|Lost to Follow-up|1
393825|NCT00774748|1321024|P1|Overall Study|Lost to Follow-up|3
393826|NCT00774397|1321039|P7|Overall Study|Other than those stated above|1
393827|NCT00774397|1321040|P6|Overall Study|Other than those stated above|0
393828|NCT00774397|1321041|P5|Overall Study|Other than those stated above|2
393829|NCT00774397|1321042|P4|Overall Study|Other than those stated above|2
393830|NCT00774397|1321043|P3|Overall Study|Other than those stated above|3
393831|NCT00774397|1321044|P2|Overall Study|Other than those stated above|1
393832|NCT00774397|1321045|P1|Overall Study|Other than those stated above|1
393833|NCT00774397|1321039|P7|Overall Study|Not treated|1
393834|NCT00774397|1321040|P6|Overall Study|Not treated|0
393835|NCT00774397|1321041|P5|Overall Study|Not treated|1
393836|NCT00774397|1321042|P4|Overall Study|Not treated|0
393837|NCT00774397|1321043|P3|Overall Study|Not treated|0
393838|NCT00774397|1321044|P2|Overall Study|Not treated|0
393839|NCT00774397|1321045|P1|Overall Study|Not treated|0
393840|NCT00774397|1321039|P7|Overall Study|Refused to continue trial medication|3
393841|NCT00774397|1321040|P6|Overall Study|Refused to continue trial medication|2
393842|NCT00774397|1321041|P5|Overall Study|Refused to continue trial medication|6
393843|NCT00774397|1321042|P4|Overall Study|Refused to continue trial medication|2
393844|NCT00774397|1321043|P3|Overall Study|Refused to continue trial medication|2
393845|NCT00774397|1321044|P2|Overall Study|Refused to continue trial medication|3
393846|NCT00774397|1321045|P1|Overall Study|Refused to continue trial medication|1
393847|NCT00774397|1321039|P7|Overall Study|Lost to Follow-up|0
393848|NCT00774397|1321040|P6|Overall Study|Lost to Follow-up|1
393849|NCT00774397|1321041|P5|Overall Study|Lost to Follow-up|0
393850|NCT00774397|1321042|P4|Overall Study|Lost to Follow-up|1
393851|NCT00774397|1321043|P3|Overall Study|Lost to Follow-up|1
393852|NCT00774397|1321044|P2|Overall Study|Lost to Follow-up|1
393853|NCT00774397|1321045|P1|Overall Study|Lost to Follow-up|0
393854|NCT00774397|1321039|P7|Overall Study|Protocol Violation|0
393855|NCT00774397|1321040|P6|Overall Study|Protocol Violation|1
393856|NCT00774397|1321041|P5|Overall Study|Protocol Violation|2
393857|NCT00774397|1321042|P4|Overall Study|Protocol Violation|1
393858|NCT00774397|1321043|P3|Overall Study|Protocol Violation|3
393859|NCT00774397|1321044|P2|Overall Study|Protocol Violation|1
393860|NCT00774397|1321045|P1|Overall Study|Protocol Violation|0
393861|NCT00774397|1321039|P7|Overall Study|Lack of Efficacy|9
393862|NCT00774397|1321040|P6|Overall Study|Lack of Efficacy|15
393863|NCT00774397|1321041|P5|Overall Study|Lack of Efficacy|27
393864|NCT00774397|1321042|P4|Overall Study|Lack of Efficacy|3
393865|NCT00774397|1321043|P3|Overall Study|Lack of Efficacy|5
393866|NCT00774397|1321044|P2|Overall Study|Lack of Efficacy|4
393867|NCT00774397|1321045|P1|Overall Study|Lack of Efficacy|11
393868|NCT00774397|1321039|P7|Overall Study|Adverse Event|16
393869|NCT00774397|1321040|P6|Overall Study|Adverse Event|3
393870|NCT00774397|1321041|P5|Overall Study|Adverse Event|8
393871|NCT00774397|1321042|P4|Overall Study|Adverse Event|8
393872|NCT00774397|1321043|P3|Overall Study|Adverse Event|16
393873|NCT00774397|1321044|P2|Overall Study|Adverse Event|3
393874|NCT00774397|1321045|P1|Overall Study|Adverse Event|1
393875|NCT00774306|1321281|P4|Overall Study|Death|0
393876|NCT00774306|1321282|P3|Overall Study|Death|0
393877|NCT00774306|1321283|P2|Overall Study|Death|1
393878|NCT00774306|1321284|P1|Overall Study|Death|1
393879|NCT00774306|1321281|P4|Overall Study|Lost to Follow-up|5
393880|NCT00774306|1321282|P3|Overall Study|Lost to Follow-up|4
393881|NCT00774306|1321283|P2|Overall Study|Lost to Follow-up|0
393882|NCT00774306|1321284|P1|Overall Study|Lost to Follow-up|6
393883|NCT00774306|1321281|P4|Overall Study|Withdrawal by Subject|0
393884|NCT00774306|1321282|P3|Overall Study|Withdrawal by Subject|1
393885|NCT00774306|1321283|P2|Overall Study|Withdrawal by Subject|1
393886|NCT00774306|1321284|P1|Overall Study|Withdrawal by Subject|6
393887|NCT00774306|1321281|P4|Overall Study|Protocol Violation|0
393888|NCT00774306|1321282|P3|Overall Study|Protocol Violation|3
393889|NCT00774306|1321283|P2|Overall Study|Protocol Violation|0
393890|NCT00774306|1321284|P1|Overall Study|Protocol Violation|2
393891|NCT00774306|1321281|P4|Overall Study|Adverse Event|0
393892|NCT00774306|1321282|P3|Overall Study|Adverse Event|0
393893|NCT00774306|1321283|P2|Overall Study|Adverse Event|0
393894|NCT00774306|1321284|P1|Overall Study|Adverse Event|3
393895|NCT00774046|1321352|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
393896|NCT00774046|1321352|P1|Enrollment|Desired other therapy/refused|28
393897|NCT00774046|1321352|P1|Screening|Not eligible|56
393898|NCT00773968|1321362|P1|Overall Study|Other|8
393899|NCT00773968|1321362|P1|Overall Study|Screen Failure|17
393900|NCT00773968|1321362|P1|Overall Study|Withdrawal by Subject|11
393901|NCT00773968|1321362|P1|Overall Study|Protocol Violation|1
393902|NCT00773968|1321362|P1|Overall Study|Lack of Efficacy|3
393903|NCT00773968|1321362|P1|Overall Study|Failure to Return|2
393904|NCT00773968|1321362|P1|Overall Study|Death|1
393905|NCT00773968|1321362|P1|Overall Study|Adverse Event|2
393906|NCT00773734|1321393|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
393907|NCT00773734|1321394|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
393908|NCT00773734|1321395|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
393909|NCT00773734|1321396|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
393910|NCT00773734|1321397|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
393911|NCT00773734|1321398|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
393912|NCT00773734|1321393|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
393913|NCT00773734|1321394|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
393914|NCT00773734|1321395|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
393915|NCT00773734|1321396|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
393916|NCT00773734|1321397|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
393917|NCT00773734|1321398|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
393918|NCT00773734|1321393|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
393919|NCT00773734|1321394|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
393920|NCT00773734|1321395|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
393921|NCT00773734|1321396|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
393922|NCT00773734|1321397|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
393923|NCT00773734|1321398|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
393924|NCT00773734|1321393|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
393925|NCT00773734|1321394|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
393926|NCT00773734|1321395|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
393927|NCT00773734|1321396|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
393928|NCT00773734|1321397|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
393929|NCT00773734|1321398|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
393930|NCT00773734|1321393|P6|Extension: Active Treatment Week 24-52|Other|1
393931|NCT00773734|1321394|P5|Extension: Active Treatment Week 24-52|Other|0
393932|NCT00773734|1321395|P4|Extension: Active Treatment Week 24-52|Other|2
393933|NCT00773734|1321396|P3|Extension: Active Treatment Week 24-52|Other|1
393934|NCT00773734|1321397|P2|Extension: Active Treatment Week 24-52|Other|0
393935|NCT00773734|1321398|P1|Extension: Active Treatment Week 24-52|Other|0
393936|NCT00773734|1321393|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
393937|NCT00773734|1321394|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
393938|NCT00773734|1321395|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
393939|NCT00773734|1321396|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
393940|NCT00773734|1321397|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
393941|NCT00773734|1321398|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
393942|NCT00773734|1321393|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
393943|NCT00773734|1321394|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
393944|NCT00773734|1321395|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
393945|NCT00773734|1321396|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
393946|NCT00773734|1321397|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
393947|NCT00773734|1321398|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
393948|NCT00773734|1321393|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
393949|NCT00773734|1321394|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
393950|NCT00773734|1321395|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
393951|NCT00773734|1321396|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
393952|NCT00773734|1321397|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
393953|NCT00773734|1321398|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
393954|NCT00773734|1321393|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
393955|NCT00773734|1321394|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
393956|NCT00773734|1321395|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
393957|NCT00773734|1321396|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
393958|NCT00773734|1321397|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
393959|NCT00773734|1321398|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
393960|NCT00773734|1321393|P6|Core: Active Treatment Phase Week 16-24|Other|0
393961|NCT00773734|1321394|P5|Core: Active Treatment Phase Week 16-24|Other|0
393962|NCT00773734|1321395|P4|Core: Active Treatment Phase Week 16-24|Other|0
393963|NCT00773734|1321396|P3|Core: Active Treatment Phase Week 16-24|Other|0
393964|NCT00773734|1321397|P2|Core: Active Treatment Phase Week 16-24|Other|1
393965|NCT00773734|1321398|P1|Core: Active Treatment Phase Week 16-24|Other|0
393966|NCT00773734|1321393|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
393967|NCT00773734|1321394|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
393968|NCT00773734|1321395|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
393969|NCT00773734|1321396|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
393970|NCT00773734|1321397|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
393971|NCT00773734|1321398|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
393972|NCT00773734|1321393|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
393973|NCT00773734|1321394|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
393974|NCT00773734|1321395|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
393975|NCT00773734|1321396|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
393976|NCT00773734|1321397|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
393977|NCT00773734|1321398|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
393978|NCT00773734|1321393|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
393979|NCT00773734|1321394|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
393980|NCT00773734|1321395|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
393981|NCT00773734|1321396|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
393982|NCT00773734|1321397|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
393983|NCT00773734|1321398|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
393984|NCT00773734|1321393|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
393985|NCT00773734|1321394|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
393986|NCT00773734|1321395|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
393987|NCT00773734|1321396|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
393988|NCT00773734|1321397|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
393989|NCT00773734|1321398|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
393990|NCT00773734|1321393|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
393991|NCT00773734|1321394|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
393992|NCT00773734|1321395|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
393993|NCT00773734|1321396|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
393994|NCT00773734|1321397|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
393995|NCT00773734|1321398|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
393996|NCT00773734|1321393|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
393997|NCT00773734|1321394|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
393998|NCT00773734|1321395|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
393999|NCT00773734|1321396|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
394000|NCT00773734|1321397|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
394001|NCT00773734|1321398|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
394002|NCT00773734|1321393|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
394003|NCT00773734|1321394|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
394004|NCT00773734|1321395|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
394005|NCT00773734|1321396|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
394006|NCT00773734|1321397|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
394007|NCT00773734|1321398|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
394008|NCT00773734|1321393|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
394009|NCT00773734|1321394|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
394010|NCT00773734|1321395|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
394011|NCT00773734|1321396|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
394012|NCT00773734|1321397|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
394013|NCT00773734|1321398|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
394014|NCT00773734|1321393|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
394015|NCT00773734|1321394|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
394016|NCT00773734|1321395|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
394017|NCT00773734|1321396|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
394018|NCT00773734|1321397|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
394019|NCT00773734|1321398|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
394020|NCT00773734|1321393|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
394021|NCT00773734|1321394|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
394022|NCT00773734|1321395|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
394023|NCT00773734|1321396|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
394024|NCT00773734|1321397|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
394025|NCT00773734|1321398|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
394026|NCT00773734|1321393|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
394027|NCT00773734|1321394|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
394115|NCT00772603|1322269|P1|Overall Study|Other|2
394028|NCT00773734|1321395|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
394029|NCT00773734|1321396|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
394030|NCT00773734|1321397|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
394031|NCT00773734|1321398|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
394032|NCT00773734|1321393|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
394033|NCT00773734|1321394|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
394034|NCT00773734|1321395|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
394035|NCT00773734|1321396|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
394036|NCT00773734|1321397|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
394037|NCT00773734|1321398|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
394038|NCT00773461|1321969|P2|Overall Study|Withdrawal by Subject|1
394039|NCT00773461|1321970|P1|Overall Study|Withdrawal by Subject|4
394040|NCT00773461|1321969|P2|Overall Study|Adverse Event|3
394041|NCT00773461|1321970|P1|Overall Study|Adverse Event|1
394042|NCT00773383|1322024|P1|Overall Study|No study dose received|1
394043|NCT00773383|1322024|P1|Overall Study|not specified|2
394044|NCT00773383|1322024|P1|Overall Study|Progression of Disease|23
394045|NCT00773383|1322024|P1|Overall Study|Death|1
394046|NCT00773383|1322024|P1|Overall Study|Adverse Event|4
394047|NCT00773279|1322059|P2|Period 2|Unclassified|2
394048|NCT00773279|1322060|P1|Period 2|Unclassified|2
394049|NCT00773279|1322059|P2|Period 2|Protocol Violation|3
394050|NCT00773279|1322060|P1|Period 2|Protocol Violation|0
394051|NCT00773279|1322059|P2|Period 2|Lack of Efficacy|0
394052|NCT00773279|1322060|P1|Period 2|Lack of Efficacy|1
394053|NCT00773279|1322059|P2|Period 2|Adverse Event|1
394054|NCT00773279|1322060|P1|Period 2|Adverse Event|0
394055|NCT00773279|1322059|P2|Period 1|Unclassified|1
394056|NCT00773279|1322060|P1|Period 1|Unclassified|5
394057|NCT00773279|1322059|P2|Period 1|Lack of Efficacy|2
394058|NCT00773279|1322060|P1|Period 1|Lack of Efficacy|0
394059|NCT00773279|1322059|P2|Period 1|Adverse Event|1
394060|NCT00773279|1322060|P1|Period 1|Adverse Event|2
394061|NCT00773253|1322081|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
394062|NCT00773253|1322082|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
394063|NCT00773136|1322088|P1|Overall Study|Physician Decision|2
394064|NCT00773097|1322093|P1|Overall Study|Physician Decision|6
394065|NCT00773097|1322093|P1|Overall Study|Withdrawal by Subject|1
394066|NCT00772967|1322099|P6|Crossover Treatment 3|Adverse Event|0
394067|NCT00772967|1322100|P5|Crossover Treatment 3|Adverse Event|1
394068|NCT00772967|1322101|P4|Crossover Treatment 3|Adverse Event|0
394069|NCT00772967|1322102|P3|Crossover Treatment 3|Adverse Event|0
394070|NCT00772967|1322103|P2|Crossover Treatment 3|Adverse Event|0
394071|NCT00772967|1322104|P1|Crossover Treatment 3|Adverse Event|0
394072|NCT00772967|1322099|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
394073|NCT00772967|1322100|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
394074|NCT00772967|1322101|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
394075|NCT00772967|1322102|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
394076|NCT00772967|1322103|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
394077|NCT00772967|1322104|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
394078|NCT00772967|1322099|P6|Crossover Treatment 1|Adverse Event (Pain)|0
394079|NCT00772967|1322100|P5|Crossover Treatment 1|Adverse Event (Pain)|0
394080|NCT00772967|1322101|P4|Crossover Treatment 1|Adverse Event (Pain)|1
394081|NCT00772967|1322102|P3|Crossover Treatment 1|Adverse Event (Pain)|0
394082|NCT00772967|1322103|P2|Crossover Treatment 1|Adverse Event (Pain)|0
394083|NCT00772967|1322104|P1|Crossover Treatment 1|Adverse Event (Pain)|0
394084|NCT00772954|1322124|P3|Overall Study|Adverse Event|1
394085|NCT00772954|1322125|P2|Overall Study|Adverse Event|0
394086|NCT00772954|1322126|P1|Overall Study|Adverse Event|0
394087|NCT00772941|1322134|P1|Overall Study|GPSP Violation|90
394088|NCT00772941|1322134|P1|Overall Study|Poor Compliance|7
394089|NCT00772941|1322134|P1|Overall Study|Missed Visits|374
394090|NCT00772941|1322134|P1|Overall Study|Study not completed|16
394091|NCT00772941|1322134|P1|Overall Study|CRFs not available|195
394092|NCT00772928|1322165|P2|Overall Study|Did not receive vaccine|1
394093|NCT00772928|1322166|P1|Overall Study|Did not receive vaccine|0
394094|NCT00772928|1322165|P2|Overall Study|Withdrawal by Subject|22
394095|NCT00772928|1322166|P1|Overall Study|Withdrawal by Subject|25
394096|NCT00772928|1322165|P2|Overall Study|Protocol Violation|12
394097|NCT00772928|1322166|P1|Overall Study|Protocol Violation|10
394098|NCT00772928|1322165|P2|Overall Study|Lost to Follow-up|6
394099|NCT00772928|1322166|P1|Overall Study|Lost to Follow-up|9
394100|NCT00772889|1322183|P3|Overall Study|Lost to Follow-up|7
394101|NCT00772889|1322184|P2|Overall Study|Lost to Follow-up|6
394102|NCT00772889|1322185|P1|Overall Study|Lost to Follow-up|6
394103|NCT00772889|1322183|P3|Overall Study|Withdrawal by Subject|9
394104|NCT00772889|1322184|P2|Overall Study|Withdrawal by Subject|8
394105|NCT00772889|1322185|P1|Overall Study|Withdrawal by Subject|9
394106|NCT00772889|1322183|P3|Overall Study|Adverse Event|0
394107|NCT00772889|1322184|P2|Overall Study|Adverse Event|4
394108|NCT00772889|1322185|P1|Overall Study|Adverse Event|7
394109|NCT00772707|1322243|P1|Overall Study|Withdrawn|3
394110|NCT00772668|1322248|P1|Overall Study|Physician Decision|3
394111|NCT00772629|1322257|P2|Overall Study|Subject was not vaccinated|0
394112|NCT00772629|1322258|P1|Overall Study|Subject was not vaccinated|1
394113|NCT00772603|1322267|P3|Overall Study|Other|2
394114|NCT00772603|1322268|P2|Overall Study|Other|0
394116|NCT00772603|1322267|P3|Overall Study|Physician Decision|1
394117|NCT00772603|1322268|P2|Overall Study|Physician Decision|0
394118|NCT00772603|1322269|P1|Overall Study|Physician Decision|0
394119|NCT00772603|1322267|P3|Overall Study|Lost to Follow-up|2
394120|NCT00772603|1322268|P2|Overall Study|Lost to Follow-up|5
394121|NCT00772603|1322269|P1|Overall Study|Lost to Follow-up|1
394122|NCT00772603|1322267|P3|Overall Study|Protocol Violation|1
394123|NCT00772603|1322268|P2|Overall Study|Protocol Violation|1
394124|NCT00772603|1322269|P1|Overall Study|Protocol Violation|0
394125|NCT00772603|1322267|P3|Overall Study|Subject Non-compliance|4
394126|NCT00772603|1322268|P2|Overall Study|Subject Non-compliance|6
394127|NCT00772603|1322269|P1|Overall Study|Subject Non-compliance|1
394128|NCT00772603|1322267|P3|Overall Study|Adverse Event|10
394129|NCT00772603|1322268|P2|Overall Study|Adverse Event|18
394130|NCT00772603|1322269|P1|Overall Study|Adverse Event|37
394131|NCT00772603|1322267|P3|Overall Study|Withdrawal by Subject|6
394132|NCT00772603|1322268|P2|Overall Study|Withdrawal by Subject|10
394133|NCT00772603|1322269|P1|Overall Study|Withdrawal by Subject|11
394134|NCT00772577|1322308|P2|Overall Study|Protocol Deviation|2
394135|NCT00772577|1322309|P1|Overall Study|Protocol Deviation|3
394136|NCT00772577|1322308|P2|Overall Study|Administrative problems|1
394137|NCT00772577|1322309|P1|Overall Study|Administrative problems|2
394138|NCT00772577|1322308|P2|Overall Study|Lost to Follow-up|3
394139|NCT00772577|1322309|P1|Overall Study|Lost to Follow-up|4
394140|NCT00772577|1322308|P2|Overall Study|Patient withdrew consent|5
394141|NCT00772577|1322309|P1|Overall Study|Patient withdrew consent|8
394142|NCT00772577|1322308|P2|Overall Study|Unsatisfactory therapeutic effect|8
394143|NCT00772577|1322309|P1|Overall Study|Unsatisfactory therapeutic effect|0
394144|NCT00772577|1322308|P2|Overall Study|Abnormal laboratory values|1
394145|NCT00772577|1322309|P1|Overall Study|Abnormal laboratory values|0
394146|NCT00772577|1322308|P2|Overall Study|Adverse Event|3
394147|NCT00772577|1322309|P1|Overall Study|Adverse Event|6
394148|NCT00772538|1322325|P2|Overall Study|Other|7
394149|NCT00772538|1322326|P1|Overall Study|Other|7
394150|NCT00772538|1322325|P2|Overall Study|Lack of Efficacy|1
394151|NCT00772538|1322326|P1|Overall Study|Lack of Efficacy|0
394152|NCT00772538|1322325|P2|Overall Study|Withdrawal by Subject|8
394153|NCT00772538|1322326|P1|Overall Study|Withdrawal by Subject|3
394154|NCT00772538|1322325|P2|Overall Study|Lost to Follow-up|1
394155|NCT00772538|1322326|P1|Overall Study|Lost to Follow-up|1
394156|NCT00772538|1322325|P2|Overall Study|Protocol Violation|3
394157|NCT00772538|1322326|P1|Overall Study|Protocol Violation|3
394158|NCT00772538|1322325|P2|Overall Study|Adverse Event|6
394159|NCT00772538|1322326|P1|Overall Study|Adverse Event|6
394160|NCT00772447|1322398|P2|Overall Study|all others|2
394161|NCT00772447|1322399|P1|Overall Study|all others|2
394162|NCT00772447|1322398|P2|Overall Study|Protocol Violation|1
394163|NCT00772447|1322399|P1|Overall Study|Protocol Violation|0
394164|NCT00772447|1322398|P2|Overall Study|incorrect enrolment|4
394165|NCT00772447|1322399|P1|Overall Study|incorrect enrolment|3
394166|NCT00772447|1322398|P2|Overall Study|Lost to Follow-up|4
394167|NCT00772447|1322399|P1|Overall Study|Lost to Follow-up|2
394168|NCT00772447|1322398|P2|Overall Study|Physician Decision|8
394169|NCT00772447|1322399|P1|Overall Study|Physician Decision|4
394170|NCT00772447|1322398|P2|Overall Study|Withdrawal by Subject|5
394171|NCT00772447|1322399|P1|Overall Study|Withdrawal by Subject|9
394172|NCT00772382|1322427|P1|Overall Study|Other Reasons|10
394173|NCT00772382|1322427|P1|Overall Study|Withdrawal by Subject|10
394174|NCT00772382|1322427|P1|Overall Study|Protocol Violation|1
394175|NCT00772382|1322427|P1|Overall Study|Physician Decision|5
394176|NCT00772382|1322427|P1|Overall Study|Lack of Efficacy|4
394177|NCT00772382|1322427|P1|Overall Study|Death|6
394178|NCT00772382|1322427|P1|Overall Study|Adverse Event|19
394179|NCT00772369|1322432|P1|Overall Study|Did not return record release form|1
394180|NCT00772148|1322443|P2|Maintenance Phase (Week 52)|Administrative/other|2
394181|NCT00772148|1322444|P1|Maintenance Phase (Week 52)|Administrative/other|1
394182|NCT00772148|1322443|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
394183|NCT00772148|1322444|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
394184|NCT00772148|1322443|P2|Maintenance Phase (Week 52)|Adverse Event|0
394185|NCT00772148|1322444|P1|Maintenance Phase (Week 52)|Adverse Event|1
394186|NCT00772148|1322443|P2|Maintenance Phase (Week 52)|Death|2
394187|NCT00772148|1322444|P1|Maintenance Phase (Week 52)|Death|2
394188|NCT00772148|1322443|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
394189|NCT00772148|1322444|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
394190|NCT00772148|1322443|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
394191|NCT00772148|1322444|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
394192|NCT00772148|1322443|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
394193|NCT00772148|1322444|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
394194|NCT00772109|1322464|P4|Overall Study|Withdrawal by Subject|16
394195|NCT00772109|1322465|P3|Overall Study|Withdrawal by Subject|6
394196|NCT00772109|1322466|P2|Overall Study|Withdrawal by Subject|8
394197|NCT00772109|1322467|P1|Overall Study|Withdrawal by Subject|8
394198|NCT00772109|1322464|P4|Overall Study|Lost to Follow-up|9
394199|NCT00772109|1322465|P3|Overall Study|Lost to Follow-up|5
394200|NCT00772109|1322466|P2|Overall Study|Lost to Follow-up|3
394201|NCT00772109|1322467|P1|Overall Study|Lost to Follow-up|7
394202|NCT00772109|1322464|P4|Overall Study|Protocol Violation|6
394203|NCT00772109|1322465|P3|Overall Study|Protocol Violation|7
394204|NCT00772109|1322466|P2|Overall Study|Protocol Violation|8
394205|NCT00772109|1322467|P1|Overall Study|Protocol Violation|5
394206|NCT00772109|1322464|P4|Overall Study|Serious adverse event|0
394207|NCT00772109|1322465|P3|Overall Study|Serious adverse event|1
394208|NCT00772109|1322466|P2|Overall Study|Serious adverse event|0
394209|NCT00772109|1322467|P1|Overall Study|Serious adverse event|1
394210|NCT00772070|1322491|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
394211|NCT00772070|1322492|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
394212|NCT00772070|1322491|P2|Overall Study|Withdrawal by Subject|2
394213|NCT00772070|1322492|P1|Overall Study|Withdrawal by Subject|0
394214|NCT00772070|1322491|P2|Overall Study|Lost to Follow-up|8
394215|NCT00772070|1322492|P1|Overall Study|Lost to Follow-up|0
394216|NCT00772031|1322504|P2|Overall Study|Lost to Follow-up|33
394217|NCT00772031|1322505|P1|Overall Study|Lost to Follow-up|20
394218|NCT00772031|1322504|P2|Overall Study|Early termination of trial|10
394219|NCT00772031|1322505|P1|Overall Study|Early termination of trial|12
394220|NCT00772005|1322531|P4|Overall Study|Non-compliance with drug administration|1
394221|NCT00772005|1322532|P3|Overall Study|Non-compliance with drug administration|1
394222|NCT00772005|1322533|P2|Overall Study|Non-compliance with drug administration|0
394223|NCT00772005|1322534|P1|Overall Study|Non-compliance with drug administration|3
394224|NCT00772005|1322531|P4|Overall Study|Non-compliance with study procedures|1
394225|NCT00772005|1322532|P3|Overall Study|Non-compliance with study procedures|0
394226|NCT00772005|1322533|P2|Overall Study|Non-compliance with study procedures|1
394227|NCT00772005|1322534|P1|Overall Study|Non-compliance with study procedures|1
394228|NCT00772005|1322531|P4|Overall Study|Lost to Follow-up|3
394229|NCT00772005|1322532|P3|Overall Study|Lost to Follow-up|6
394230|NCT00772005|1322533|P2|Overall Study|Lost to Follow-up|3
394231|NCT00772005|1322534|P1|Overall Study|Lost to Follow-up|7
394232|NCT00772005|1322531|P4|Overall Study|Protocol Violation|6
394233|NCT00772005|1322532|P3|Overall Study|Protocol Violation|1
394234|NCT00772005|1322533|P2|Overall Study|Protocol Violation|4
394235|NCT00772005|1322534|P1|Overall Study|Protocol Violation|2
394236|NCT00772005|1322531|P4|Overall Study|Withdrawal by Subject|2
394237|NCT00772005|1322532|P3|Overall Study|Withdrawal by Subject|10
394238|NCT00772005|1322533|P2|Overall Study|Withdrawal by Subject|7
394239|NCT00772005|1322534|P1|Overall Study|Withdrawal by Subject|3
394240|NCT00772005|1322531|P4|Overall Study|Lack of Efficacy|0
394241|NCT00772005|1322532|P3|Overall Study|Lack of Efficacy|0
394242|NCT00772005|1322533|P2|Overall Study|Lack of Efficacy|1
394243|NCT00772005|1322534|P1|Overall Study|Lack of Efficacy|0
394244|NCT00772005|1322531|P4|Overall Study|Adverse Event|13
394245|NCT00772005|1322532|P3|Overall Study|Adverse Event|10
394246|NCT00772005|1322533|P2|Overall Study|Adverse Event|14
394247|NCT00772005|1322534|P1|Overall Study|Adverse Event|9
394248|NCT00771953|1323222|P2|Overall Study|Withdrawal by Subject|3
394249|NCT00771953|1323223|P1|Overall Study|Withdrawal by Subject|0
394250|NCT00771953|1323222|P2|Overall Study|Other complicating disease|0
394251|NCT00771953|1323223|P1|Overall Study|Other complicating disease|1
394252|NCT00771953|1323222|P2|Overall Study|Sponsor decision|0
394253|NCT00771953|1323223|P1|Overall Study|Sponsor decision|1
394254|NCT00771953|1323222|P2|Overall Study|Progression before active Tx|2
394255|NCT00771953|1323223|P1|Overall Study|Progression before active Tx|1
394256|NCT00771953|1323222|P2|Overall Study|Death|2
394257|NCT00771953|1323223|P1|Overall Study|Death|2
394258|NCT00771953|1323222|P2|Overall Study|Adverse Event|3
394259|NCT00771953|1323223|P1|Overall Study|Adverse Event|5
394260|NCT00771927|1323233|P2|Overall Study|Other reason|27
394261|NCT00771927|1323234|P1|Overall Study|Other reason|23
394262|NCT00771927|1323233|P2|Overall Study|Withdrawal by Subject|17
394263|NCT00771927|1323234|P1|Overall Study|Withdrawal by Subject|16
394264|NCT00771927|1323233|P2|Overall Study|Lost to Follow-up|46
394265|NCT00771927|1323234|P1|Overall Study|Lost to Follow-up|46
394266|NCT00771927|1323233|P2|Overall Study|Lack of Efficacy|42
394267|NCT00771927|1323234|P1|Overall Study|Lack of Efficacy|70
394268|NCT00771927|1323233|P2|Overall Study|Adverse Event|105
394269|NCT00771927|1323234|P1|Overall Study|Adverse Event|100
394270|NCT00771914|1323246|P4|Overall Study|Lost to Follow-up|1
394271|NCT00771914|1323247|P3|Overall Study|Lost to Follow-up|0
394272|NCT00771914|1323248|P2|Overall Study|Lost to Follow-up|0
394273|NCT00771914|1323249|P1|Overall Study|Lost to Follow-up|0
394274|NCT00771914|1323246|P4|Overall Study|Physician Decision|1
394275|NCT00771914|1323247|P3|Overall Study|Physician Decision|0
394276|NCT00771914|1323248|P2|Overall Study|Physician Decision|0
394277|NCT00771914|1323249|P1|Overall Study|Physician Decision|0
394278|NCT00771901|1323262|P3|Overall Study|Dissat w/# of study medication (40/day)|4
394279|NCT00771901|1323263|P2|Overall Study|Dissat w/# of study medication (40/day)|0
394280|NCT00771901|1323264|P1|Overall Study|Dissat w/# of study medication (40/day)|0
394281|NCT00771849|1323311|P2|Overall Study|Not vaccinated|1
394282|NCT00771849|1323312|P1|Overall Study|Not vaccinated|0
394283|NCT00771849|1323311|P2|Overall Study|Withdrawal by Subject|1
394284|NCT00771849|1323312|P1|Overall Study|Withdrawal by Subject|1
394285|NCT00771849|1323311|P2|Overall Study|Lost to Follow-up|2
394286|NCT00771849|1323312|P1|Overall Study|Lost to Follow-up|1
394287|NCT00771810|1323323|P3|Overall Study|Other|1
394288|NCT00771810|1323324|P2|Overall Study|Other|0
394289|NCT00771810|1323325|P1|Overall Study|Other|0
394290|NCT00771810|1323323|P3|Overall Study|Withdrawal by Subject|0
394291|NCT00771810|1323324|P2|Overall Study|Withdrawal by Subject|2
394292|NCT00771810|1323325|P1|Overall Study|Withdrawal by Subject|1
394293|NCT00771810|1323323|P3|Overall Study|Protocol Violation|1
394294|NCT00771810|1323324|P2|Overall Study|Protocol Violation|1
394295|NCT00771810|1323325|P1|Overall Study|Protocol Violation|0
394296|NCT00771810|1323323|P3|Overall Study|Physician Decision|2
394297|NCT00771810|1323324|P2|Overall Study|Physician Decision|2
394298|NCT00771810|1323325|P1|Overall Study|Physician Decision|1
394299|NCT00771810|1323323|P3|Overall Study|Lost to Follow-up|1
394300|NCT00771810|1323324|P2|Overall Study|Lost to Follow-up|0
394301|NCT00771810|1323325|P1|Overall Study|Lost to Follow-up|0
394302|NCT00771810|1323323|P3|Overall Study|Adverse Event|2
394303|NCT00771810|1323324|P2|Overall Study|Adverse Event|0
394304|NCT00771810|1323325|P1|Overall Study|Adverse Event|3
394305|NCT00771758|1323363|P3|Overall Study|Other|0
394306|NCT00771758|1323364|P2|Overall Study|Other|2
394307|NCT00771758|1323365|P1|Overall Study|Other|3
394308|NCT00771758|1323363|P3|Overall Study|Withdrawal by Subject|0
394309|NCT00771758|1323364|P2|Overall Study|Withdrawal by Subject|0
394310|NCT00771758|1323365|P1|Overall Study|Withdrawal by Subject|1
394311|NCT00771758|1323363|P3|Overall Study|Protocol Violation|0
394312|NCT00771758|1323364|P2|Overall Study|Protocol Violation|0
394313|NCT00771758|1323365|P1|Overall Study|Protocol Violation|1
394314|NCT00771758|1323363|P3|Overall Study|Lost to Follow-up|0
394315|NCT00771758|1323364|P2|Overall Study|Lost to Follow-up|0
394316|NCT00771758|1323365|P1|Overall Study|Lost to Follow-up|1
394317|NCT00771758|1323363|P3|Overall Study|Lack of Efficacy|1
394318|NCT00771758|1323364|P2|Overall Study|Lack of Efficacy|2
394319|NCT00771758|1323365|P1|Overall Study|Lack of Efficacy|0
394320|NCT00771758|1323363|P3|Overall Study|Adverse Event|1
394321|NCT00771758|1323364|P2|Overall Study|Adverse Event|8
394322|NCT00771758|1323365|P1|Overall Study|Adverse Event|2
394323|NCT00771667|1323526|P10|Maintenance Phase|Other|3
394324|NCT00771667|1323527|P9|Maintenance Phase|Other|3
394325|NCT00771667|1323528|P8|Maintenance Phase|Other|2
394326|NCT00771667|1323529|P7|Maintenance Phase|Other|2
394327|NCT00771667|1323530|P6|Maintenance Phase|Other|1
394328|NCT00771667|1323531|P5|Maintenance Phase|Other|0
394329|NCT00771667|1323532|P4|Maintenance Phase|Other|0
394330|NCT00771667|1323533|P3|Maintenance Phase|Other|0
394331|NCT00771667|1323534|P2|Maintenance Phase|Other|0
394332|NCT00771667|1323535|P1|Maintenance Phase|Other|0
394333|NCT00771667|1323526|P10|Maintenance Phase|Lack of Efficacy|7
394334|NCT00771667|1323527|P9|Maintenance Phase|Lack of Efficacy|11
394335|NCT00771667|1323528|P8|Maintenance Phase|Lack of Efficacy|2
394336|NCT00771667|1323529|P7|Maintenance Phase|Lack of Efficacy|3
394337|NCT00771667|1323530|P6|Maintenance Phase|Lack of Efficacy|3
394338|NCT00771667|1323531|P5|Maintenance Phase|Lack of Efficacy|1
394339|NCT00771667|1323532|P4|Maintenance Phase|Lack of Efficacy|0
394340|NCT00771667|1323533|P3|Maintenance Phase|Lack of Efficacy|0
394341|NCT00771667|1323534|P2|Maintenance Phase|Lack of Efficacy|0
394342|NCT00771667|1323535|P1|Maintenance Phase|Lack of Efficacy|0
394343|NCT00771667|1323526|P10|Maintenance Phase|Adverse Event|7
394344|NCT00771667|1323527|P9|Maintenance Phase|Adverse Event|8
394345|NCT00771667|1323528|P8|Maintenance Phase|Adverse Event|1
394346|NCT00771667|1323529|P7|Maintenance Phase|Adverse Event|5
394347|NCT00771667|1323530|P6|Maintenance Phase|Adverse Event|3
394348|NCT00771667|1323531|P5|Maintenance Phase|Adverse Event|1
394349|NCT00771667|1323532|P4|Maintenance Phase|Adverse Event|0
394350|NCT00771667|1323533|P3|Maintenance Phase|Adverse Event|0
394351|NCT00771667|1323534|P2|Maintenance Phase|Adverse Event|0
394352|NCT00771667|1323535|P1|Maintenance Phase|Adverse Event|0
394353|NCT00771667|1323526|P10|Induction Phase|Other|0
394354|NCT00771667|1323527|P9|Induction Phase|Other|0
394355|NCT00771667|1323528|P8|Induction Phase|Other|0
394356|NCT00771667|1323529|P7|Induction Phase|Other|0
394357|NCT00771667|1323530|P6|Induction Phase|Other|0
394358|NCT00771667|1323531|P5|Induction Phase|Other|0
394359|NCT00771667|1323532|P4|Induction Phase|Other|4
394360|NCT00771667|1323533|P3|Induction Phase|Other|3
394361|NCT00771667|1323534|P2|Induction Phase|Other|6
394362|NCT00771667|1323535|P1|Induction Phase|Other|4
394363|NCT00771667|1323526|P10|Induction Phase|Lost to Follow-up|0
394364|NCT00771667|1323527|P9|Induction Phase|Lost to Follow-up|0
394365|NCT00771667|1323528|P8|Induction Phase|Lost to Follow-up|0
394366|NCT00771667|1323529|P7|Induction Phase|Lost to Follow-up|0
394367|NCT00771667|1323530|P6|Induction Phase|Lost to Follow-up|0
394368|NCT00771667|1323531|P5|Induction Phase|Lost to Follow-up|0
394369|NCT00771667|1323532|P4|Induction Phase|Lost to Follow-up|0
394370|NCT00771667|1323533|P3|Induction Phase|Lost to Follow-up|1
394371|NCT00771667|1323534|P2|Induction Phase|Lost to Follow-up|0
394372|NCT00771667|1323535|P1|Induction Phase|Lost to Follow-up|1
394373|NCT00771667|1323526|P10|Induction Phase|Lack of Efficacy|0
394374|NCT00771667|1323527|P9|Induction Phase|Lack of Efficacy|0
394375|NCT00771667|1323528|P8|Induction Phase|Lack of Efficacy|0
394376|NCT00771667|1323529|P7|Induction Phase|Lack of Efficacy|0
394377|NCT00771667|1323530|P6|Induction Phase|Lack of Efficacy|0
394378|NCT00771667|1323531|P5|Induction Phase|Lack of Efficacy|0
394379|NCT00771667|1323532|P4|Induction Phase|Lack of Efficacy|3
394380|NCT00771667|1323533|P3|Induction Phase|Lack of Efficacy|4
394381|NCT00771667|1323534|P2|Induction Phase|Lack of Efficacy|2
394382|NCT00771667|1323535|P1|Induction Phase|Lack of Efficacy|9
394383|NCT00771667|1323526|P10|Induction Phase|Adverse Event|0
394384|NCT00771667|1323527|P9|Induction Phase|Adverse Event|0
394385|NCT00771667|1323528|P8|Induction Phase|Adverse Event|0
394386|NCT00771667|1323529|P7|Induction Phase|Adverse Event|0
394387|NCT00771667|1323530|P6|Induction Phase|Adverse Event|0
394388|NCT00771667|1323531|P5|Induction Phase|Adverse Event|0
394389|NCT00771667|1323532|P4|Induction Phase|Adverse Event|1
394390|NCT00771667|1323533|P3|Induction Phase|Adverse Event|4
394391|NCT00771667|1323534|P2|Induction Phase|Adverse Event|2
394392|NCT00771667|1323535|P1|Induction Phase|Adverse Event|5
394393|NCT00771615|1323580|P9|Overall Study|Lost to Follow-up|0
394394|NCT00771615|1323581|P8|Overall Study|Lost to Follow-up|0
394395|NCT00771615|1323582|P7|Overall Study|Lost to Follow-up|1
394396|NCT00771615|1323583|P6|Overall Study|Lost to Follow-up|1
394397|NCT00771615|1323584|P5|Overall Study|Lost to Follow-up|0
394398|NCT00771615|1323585|P4|Overall Study|Lost to Follow-up|1
394399|NCT00771615|1323586|P3|Overall Study|Lost to Follow-up|1
394400|NCT00771615|1323587|P2|Overall Study|Lost to Follow-up|1
394401|NCT00771615|1323588|P1|Overall Study|Lost to Follow-up|1
394402|NCT00771615|1323580|P9|Overall Study|Withdrawal by Subject|0
394403|NCT00771615|1323581|P8|Overall Study|Withdrawal by Subject|1
394404|NCT00771615|1323582|P7|Overall Study|Withdrawal by Subject|0
394405|NCT00771615|1323583|P6|Overall Study|Withdrawal by Subject|0
394406|NCT00771615|1323584|P5|Overall Study|Withdrawal by Subject|0
394407|NCT00771615|1323585|P4|Overall Study|Withdrawal by Subject|0
394408|NCT00771615|1323586|P3|Overall Study|Withdrawal by Subject|0
394409|NCT00771615|1323587|P2|Overall Study|Withdrawal by Subject|1
394410|NCT00771615|1323588|P1|Overall Study|Withdrawal by Subject|0
394411|NCT00771472|1323849|P2|Overall Study|Protocol Violation|0
394412|NCT00771472|1323850|P1|Overall Study|Protocol Violation|1
394413|NCT00771472|1323849|P2|Overall Study|Progressive Disease|1
394414|NCT00771472|1323850|P1|Overall Study|Progressive Disease|3
394415|NCT00771472|1323849|P2|Overall Study|Physician Decision|3
394416|NCT00771472|1323850|P1|Overall Study|Physician Decision|2
394417|NCT00771316|1323870|P2|Overall Study|Discontinued due to early termination|0
394418|NCT00771316|1323871|P1|Overall Study|Discontinued due to early termination|1
394419|NCT00771316|1323870|P2|Overall Study|Patient withdrew consent|0
394420|NCT00771316|1323871|P1|Overall Study|Patient withdrew consent|1
394421|NCT00771316|1323870|P2|Overall Study|Adverse Event|1
394422|NCT00771316|1323871|P1|Overall Study|Adverse Event|0
394423|NCT00770991|1323923|P2|Overall Study|Pregnancy|0
394424|NCT00770991|1323924|P1|Overall Study|Pregnancy|1
394425|NCT00770991|1323923|P2|Overall Study|Adverse Event|5
394426|NCT00770991|1323924|P1|Overall Study|Adverse Event|1
394427|NCT00770991|1323923|P2|Overall Study|Withdrawal by Subject|0
394428|NCT00770991|1323924|P1|Overall Study|Withdrawal by Subject|1
394429|NCT00770991|1323923|P2|Overall Study|Physician Decision|0
394430|NCT00770991|1323924|P1|Overall Study|Physician Decision|2
394431|NCT00770965|1323940|P4|Excluded Set|Withdrawal by Subject|3
394432|NCT00770965|1323941|P3|Excluded Set|Withdrawal by Subject|2
394433|NCT00770965|1323942|P2|Excluded Set|Withdrawal by Subject|1
394434|NCT00770965|1323943|P1|Excluded Set|Withdrawal by Subject|1
394435|NCT00770965|1323940|P4|Excluded Set|Administrative problems|10
394436|NCT00770965|1323941|P3|Excluded Set|Administrative problems|12
394437|NCT00770965|1323942|P2|Excluded Set|Administrative problems|12
394438|NCT00770965|1323943|P1|Excluded Set|Administrative problems|14
394439|NCT00770965|1323940|P4|Safety Set|Protocol deviation|0
394440|NCT00770965|1323941|P3|Safety Set|Protocol deviation|1
394441|NCT00770965|1323942|P2|Safety Set|Protocol deviation|0
394442|NCT00770965|1323943|P1|Safety Set|Protocol deviation|0
394443|NCT00770965|1323940|P4|Safety Set|Withdrawal by Subject|1
394444|NCT00770965|1323941|P3|Safety Set|Withdrawal by Subject|0
394445|NCT00770965|1323942|P2|Safety Set|Withdrawal by Subject|0
394446|NCT00770965|1323943|P1|Safety Set|Withdrawal by Subject|0
394447|NCT00770913|1323964|P3|Overall Study|Incorrect drug was allocated|0
394448|NCT00770913|1323965|P2|Overall Study|Incorrect drug was allocated|0
394449|NCT00770913|1323966|P1|Overall Study|Incorrect drug was allocated|1
394450|NCT00770913|1323964|P3|Overall Study|Protocol Violation|1
394451|NCT00770913|1323965|P2|Overall Study|Protocol Violation|0
394452|NCT00770913|1323966|P1|Overall Study|Protocol Violation|3
394453|NCT00770913|1323964|P3|Overall Study|Physician Decision|1
394454|NCT00770913|1323965|P2|Overall Study|Physician Decision|1
394455|NCT00770913|1323966|P1|Overall Study|Physician Decision|0
394456|NCT00770913|1323964|P3|Overall Study|Refusal to continue participation|5
394457|NCT00770913|1323965|P2|Overall Study|Refusal to continue participation|4
394458|NCT00770913|1323966|P1|Overall Study|Refusal to continue participation|6
394459|NCT00770913|1323964|P3|Overall Study|Adverse Event|6
394460|NCT00770913|1323965|P2|Overall Study|Adverse Event|3
394461|NCT00770913|1323966|P1|Overall Study|Adverse Event|1
394462|NCT00770809|1323988|P3|Overall Study|Other Medical Reasons|3
394463|NCT00770809|1323989|P2|Overall Study|Other Medical Reasons|4
394464|NCT00770809|1323990|P1|Overall Study|Other Medical Reasons|2
394465|NCT00770809|1323988|P3|Overall Study|Complicating illness|1
394466|NCT00770809|1323989|P2|Overall Study|Complicating illness|0
394467|NCT00770809|1323990|P1|Overall Study|Complicating illness|0
394468|NCT00770809|1323988|P3|Overall Study|Progression|0
394469|NCT00770809|1323989|P2|Overall Study|Progression|2
394470|NCT00770809|1323990|P1|Overall Study|Progression|2
394471|NCT00770809|1323988|P3|Overall Study|Withdrawal by Subject|7
394472|NCT00770809|1323989|P2|Overall Study|Withdrawal by Subject|3
394473|NCT00770809|1323990|P1|Overall Study|Withdrawal by Subject|3
394474|NCT00770809|1323988|P3|Overall Study|Death|0
394475|NCT00770809|1323989|P2|Overall Study|Death|0
394476|NCT00770809|1323990|P1|Overall Study|Death|1
394477|NCT00770809|1323988|P3|Overall Study|Adverse Event|12
394478|NCT00770809|1323989|P2|Overall Study|Adverse Event|1
394479|NCT00770809|1323990|P1|Overall Study|Adverse Event|9
394480|NCT00770770|1324000|P2|Overall Study|Study Terminated|0
394481|NCT00770770|1324001|P1|Overall Study|Study Terminated|8
394482|NCT00770770|1324000|P2|Overall Study|Death|1
394483|NCT00770770|1324001|P1|Overall Study|Death|0
394484|NCT00770770|1324000|P2|Overall Study|Withdrawal by Subject|0
394485|NCT00770770|1324001|P1|Overall Study|Withdrawal by Subject|1
394486|NCT00770770|1324000|P2|Overall Study|Lost to Follow-up|0
394487|NCT00770770|1324001|P1|Overall Study|Lost to Follow-up|1
394488|NCT00770692|1324019|P4|Overall Study|Investigator judgment|1
394489|NCT00770692|1324020|P3|Overall Study|Investigator judgment|1
394490|NCT00770692|1324021|P2|Overall Study|Investigator judgment|0
394491|NCT00770692|1324022|P1|Overall Study|Investigator judgment|2
394492|NCT00770692|1324019|P4|Overall Study|Adverse Event|4
394493|NCT00770692|1324020|P3|Overall Study|Adverse Event|4
394494|NCT00770692|1324021|P2|Overall Study|Adverse Event|0
394495|NCT00770692|1324022|P1|Overall Study|Adverse Event|3
394496|NCT00770692|1324019|P4|Overall Study|Withdrawal by Subject|6
394497|NCT00770692|1324020|P3|Overall Study|Withdrawal by Subject|9
394498|NCT00770692|1324021|P2|Overall Study|Withdrawal by Subject|9
394499|NCT00770692|1324022|P1|Overall Study|Withdrawal by Subject|7
394500|NCT00770679|1324048|P1|Overall Study|Follow-up LDL measurement not collected|3
394501|NCT00770679|1324048|P1|Overall Study|Lost to Follow-up|3
394502|NCT00770653|1324056|P2|Overall Study|Physician Decision|0
394503|NCT00770653|1324057|P1|Overall Study|Physician Decision|1
394504|NCT00770653|1324056|P2|Overall Study|Lost to Follow-up|2
394505|NCT00770653|1324057|P1|Overall Study|Lost to Follow-up|1
394506|NCT00770653|1324056|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
394507|NCT00770653|1324057|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
394508|NCT00770653|1324056|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
394509|NCT00770653|1324057|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
394510|NCT00770653|1324056|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
394511|NCT00770653|1324057|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
394512|NCT00770653|1324056|P2|Overall Study|Lack of Compliance|4
394513|NCT00770653|1324057|P1|Overall Study|Lack of Compliance|1
394514|NCT00770653|1324056|P2|Overall Study|Withdrawal by Subject|7
394515|NCT00770653|1324057|P1|Overall Study|Withdrawal by Subject|4
394516|NCT00770653|1324056|P2|Overall Study|Protocol Violation|6
394517|NCT00770653|1324057|P1|Overall Study|Protocol Violation|8
394518|NCT00770653|1324056|P2|Overall Study|Adverse Event|5
394519|NCT00770653|1324057|P1|Overall Study|Adverse Event|13
394520|NCT00770588|1324127|P2|Overall Study|Withdrawal by Subject|1
394521|NCT00770588|1324128|P1|Overall Study|Withdrawal by Subject|1
394522|NCT00770588|1324127|P2|Overall Study|Lost to Follow-up|1
394523|NCT00770588|1324128|P1|Overall Study|Lost to Follow-up|1
394524|NCT00770588|1324127|P2|Overall Study|Death caused by progression of disease|91
394525|NCT00770588|1324128|P1|Overall Study|Death caused by progression of disease|70
394526|NCT00770588|1324127|P2|Overall Study|Adverse Event|2
394527|NCT00770588|1324128|P1|Overall Study|Adverse Event|9
394528|NCT00770562|1324144|P2|Overall Study|Did not take treatment|1
394529|NCT00770562|1324145|P1|Overall Study|Did not take treatment|1
394530|NCT00770510|1324156|P1|Overall Study|Withdrawal by Subject|2
394531|NCT00770510|1324156|P1|Overall Study|Pregnancy|1
394532|NCT00770510|1324156|P1|Overall Study|Lost to Follow-up|2
394533|NCT00770484|1324195|P2|Overall Study|Withdrawal by Subject|0
394534|NCT00770484|1324196|P1|Overall Study|Withdrawal by Subject|1
394535|NCT00770432|1324204|P2|Overall Study|Non-compliance|1
394536|NCT00770432|1324205|P1|Overall Study|Non-compliance|0
394537|NCT00770432|1324204|P2|Overall Study|Not specified|6
394538|NCT00770432|1324205|P1|Overall Study|Not specified|4
394539|NCT00770367|1324213|P2|Second Intervention|Lost to Follow-up|0
394540|NCT00770367|1324214|P1|Second Intervention|Lost to Follow-up|2
394541|NCT00770367|1324213|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
394542|NCT00770367|1324214|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
394543|NCT00770367|1324213|P2|First Intervention|Withdrawal by Subject|2
394544|NCT00770367|1324214|P1|First Intervention|Withdrawal by Subject|0
394545|NCT00770341|1324223|P3|Overall Study|Not treated|0
394546|NCT00770341|1324224|P2|Overall Study|Not treated|0
394547|NCT00770341|1324225|P1|Overall Study|Not treated|1
394548|NCT00770341|1324223|P3|Overall Study|Not specified|0
394549|NCT00770341|1324224|P2|Overall Study|Not specified|0
394550|NCT00770341|1324225|P1|Overall Study|Not specified|1
394551|NCT00770341|1324223|P3|Overall Study|Lack of Efficacy|1
394552|NCT00770341|1324224|P2|Overall Study|Lack of Efficacy|0
394553|NCT00770341|1324225|P1|Overall Study|Lack of Efficacy|3
394554|NCT00770341|1324223|P3|Overall Study|Laboratory adverse event|0
394555|NCT00770341|1324224|P2|Overall Study|Laboratory adverse event|3
394556|NCT00770341|1324225|P1|Overall Study|Laboratory adverse event|3
394557|NCT00770341|1324223|P3|Overall Study|Clinical Adverse Event|2
394558|NCT00770341|1324224|P2|Overall Study|Clinical Adverse Event|1
394559|NCT00770341|1324225|P1|Overall Study|Clinical Adverse Event|3
394560|NCT00770341|1324223|P3|Overall Study|Withdrawal by Subject|0
394561|NCT00770341|1324224|P2|Overall Study|Withdrawal by Subject|1
394562|NCT00770341|1324225|P1|Overall Study|Withdrawal by Subject|0
394563|NCT00770341|1324223|P3|Overall Study|Did not meet eligibility criteria|0
394564|NCT00770341|1324224|P2|Overall Study|Did not meet eligibility criteria|0
394565|NCT00770341|1324225|P1|Overall Study|Did not meet eligibility criteria|1
394566|NCT00770328|1324251|P2|Overall Study|Lost to Follow-up|2
394567|NCT00770328|1324252|P1|Overall Study|Lost to Follow-up|2
394568|NCT00770328|1324251|P2|Overall Study|Adverse Event|2
394569|NCT00770328|1324252|P1|Overall Study|Adverse Event|11
394570|NCT00770315|1324268|P4|Overall Study|Noncompliance with Protocol|9
394571|NCT00770315|1324269|P3|Overall Study|Noncompliance with Protocol|7
394572|NCT00770315|1324270|P2|Overall Study|Noncompliance with Protocol|4
394573|NCT00770315|1324271|P1|Overall Study|Noncompliance with Protocol|7
394574|NCT00770315|1324268|P4|Overall Study|Withdrawal by Subject|20
394575|NCT00770315|1324269|P3|Overall Study|Withdrawal by Subject|24
394576|NCT00770315|1324270|P2|Overall Study|Withdrawal by Subject|17
394577|NCT00770315|1324271|P1|Overall Study|Withdrawal by Subject|13
394578|NCT00770315|1324268|P4|Overall Study|Lost to Follow-up|3
394579|NCT00770315|1324269|P3|Overall Study|Lost to Follow-up|10
394580|NCT00770315|1324270|P2|Overall Study|Lost to Follow-up|5
394581|NCT00770315|1324271|P1|Overall Study|Lost to Follow-up|9
394582|NCT00770315|1324268|P4|Overall Study|Adverse Event|6
394583|NCT00770315|1324269|P3|Overall Study|Adverse Event|16
394584|NCT00770315|1324270|P2|Overall Study|Adverse Event|17
394585|NCT00770315|1324271|P1|Overall Study|Adverse Event|11
394586|NCT00770289|1324297|P1|Overall Study|Other|6
394587|NCT00770211|1324308|P2|Overall Study|Withdrawal by Subject|2
394588|NCT00770211|1324309|P1|Overall Study|Withdrawal by Subject|0
394589|NCT00770211|1324308|P2|Overall Study|Lost to Follow-up|0
394590|NCT00770211|1324309|P1|Overall Study|Lost to Follow-up|1
394591|NCT00770146|1324325|P2|Follow-up Period|Other|5
394592|NCT00770146|1324326|P1|Follow-up Period|Other|4
394593|NCT00770146|1324325|P2|Follow-up Period|Adverse Event|2
394594|NCT00770146|1324326|P1|Follow-up Period|Adverse Event|0
394595|NCT00770146|1324325|P2|Follow-up Period|Withdrawal by Subject|13
394596|NCT00770146|1324326|P1|Follow-up Period|Withdrawal by Subject|7
394597|NCT00770146|1324325|P2|Treatment Period|Protocol non-compliance|1
394598|NCT00770146|1324326|P1|Treatment Period|Protocol non-compliance|0
394599|NCT00770146|1324325|P2|Treatment Period|Other|5
394600|NCT00770146|1324326|P1|Treatment Period|Other|1
394601|NCT00770146|1324325|P2|Treatment Period|Adverse Event|26
394602|NCT00770146|1324326|P1|Treatment Period|Adverse Event|2
394603|NCT00770146|1324325|P2|Treatment Period|Withdrawal by Subject|13
394604|NCT00770146|1324326|P1|Treatment Period|Withdrawal by Subject|6
394605|NCT00770120|1324370|P1|Overall Study|Reason under Review|1
394606|NCT00770120|1324370|P1|Overall Study|Never Received Treatment/Not Analyzable|1
394607|NCT00770120|1324370|P1|Overall Study|Ineligible|1
394608|NCT00770120|1324370|P1|Overall Study|Withdrawal by Subject|2
394609|NCT00770120|1324370|P1|Overall Study|Death|3
394610|NCT00770120|1324370|P1|Overall Study|Not Protocol Specified|11
394611|NCT00770120|1324370|P1|Overall Study|Adverse Event|11
394612|NCT00770120|1324370|P1|Overall Study|Progression|31
394613|NCT00770029|1324379|P2|Overall Study|Adverse Event|0
394614|NCT00770029|1324380|P1|Overall Study|Adverse Event|1
394615|NCT00770029|1324379|P2|Overall Study|Withdrawal by Subject|3
394616|NCT00770029|1324380|P1|Overall Study|Withdrawal by Subject|3
394617|NCT00770029|1324379|P2|Overall Study|Lost to Follow-up|0
394618|NCT00770029|1324380|P1|Overall Study|Lost to Follow-up|2
394619|NCT00769860|1324396|P2|Overall Study|Withdrawal by Subject|0
394620|NCT00769860|1324397|P1|Overall Study|Withdrawal by Subject|2
394621|NCT00769704|1324425|P2|Overall Study|Other|2
394622|NCT00769704|1324426|P1|Overall Study|Other|1
394623|NCT00769704|1324425|P2|Overall Study|Withdrawal by Subject|5
394624|NCT00769704|1324426|P1|Overall Study|Withdrawal by Subject|12
394625|NCT00769704|1324425|P2|Overall Study|Death|190
394626|NCT00769704|1324426|P1|Overall Study|Death|95
394627|NCT00769704|1324425|P2|Overall Study|Lost to Follow-up|2
394628|NCT00769704|1324426|P1|Overall Study|Lost to Follow-up|3
394629|NCT00769561|1324459|P2|Overall Study|Lost to Follow-up|3
394630|NCT00769561|1324460|P1|Overall Study|Lost to Follow-up|1
394631|NCT00769561|1324459|P2|Overall Study|Withdrawal by Subject|2
394632|NCT00769561|1324460|P1|Overall Study|Withdrawal by Subject|2
394633|NCT00769184|1324509|P2|No Treatment (6 Weeks)|Adverse Event|1
394634|NCT00769184|1324510|P1|No Treatment (6 Weeks)|Adverse Event|1
394635|NCT00769184|1324509|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
394636|NCT00769184|1324510|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
394637|NCT00769184|1324509|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
394638|NCT00769184|1324510|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
394639|NCT00769132|1324518|P4|Period 4|Withdrawal by Subject|0
394640|NCT00769132|1324519|P3|Period 4|Withdrawal by Subject|0
394641|NCT00769132|1324520|P2|Period 4|Withdrawal by Subject|1
394642|NCT00769132|1324521|P1|Period 4|Withdrawal by Subject|0
394643|NCT00769132|1324518|P4|Period 3|Withdrawal by Subject|0
394644|NCT00769132|1324519|P3|Period 3|Withdrawal by Subject|0
394645|NCT00769132|1324520|P2|Period 3|Withdrawal by Subject|0
394646|NCT00769132|1324521|P1|Period 3|Withdrawal by Subject|1
394647|NCT00769132|1324518|P4|Period 2|Withdrawal by Subject|1
394648|NCT00769132|1324519|P3|Period 2|Withdrawal by Subject|0
394649|NCT00769132|1324520|P2|Period 2|Withdrawal by Subject|0
394650|NCT00769132|1324521|P1|Period 2|Withdrawal by Subject|0
394651|NCT00769132|1324518|P4|Period 1|Adverse Event|1
394652|NCT00769132|1324519|P3|Period 1|Adverse Event|0
394653|NCT00769132|1324520|P2|Period 1|Adverse Event|0
394654|NCT00769132|1324521|P1|Period 1|Adverse Event|1
394655|NCT00769119|1324537|P2|Overall Study|Disallowed medication|0
394656|NCT00769119|1324538|P1|Overall Study|Disallowed medication|1
394657|NCT00769119|1324537|P2|Overall Study|Adverse Event|1
394658|NCT00769119|1324538|P1|Overall Study|Adverse Event|1
394659|NCT00769119|1324537|P2|Overall Study|Voluntary discontinuation|2
394660|NCT00769119|1324538|P1|Overall Study|Voluntary discontinuation|0
394661|NCT00769067|1324584|P2|Overall Study|Withdrawal by Subject|1
394662|NCT00769067|1324585|P1|Overall Study|Withdrawal by Subject|0
394663|NCT00769067|1324584|P2|Overall Study|Other|3
394664|NCT00769067|1324585|P1|Overall Study|Other|1
394665|NCT00769067|1324584|P2|Overall Study|Study terminated by sponsor|3
394666|NCT00769067|1324585|P1|Overall Study|Study terminated by sponsor|1
394667|NCT00769067|1324584|P2|Overall Study|Lost to Follow-up|1
394668|NCT00769067|1324585|P1|Overall Study|Lost to Follow-up|3
394669|NCT00769067|1324584|P2|Overall Study|Death|86
394670|NCT00769067|1324585|P1|Overall Study|Death|89
394671|NCT00768989|1324633|P2|On or After Week 36|Sponsor Termination|26
394672|NCT00768989|1324634|P1|On or After Week 36|Sponsor Termination|45
394673|NCT00768989|1324633|P2|On or After Week 36|Did not attend termination visit|0
394674|NCT00768989|1324634|P1|On or After Week 36|Did not attend termination visit|2
394675|NCT00768989|1324633|P2|On or After Week 36|Protocol Violation|0
394676|NCT00768989|1324634|P1|On or After Week 36|Protocol Violation|1
394677|NCT00768989|1324633|P2|On or After Week 36|Poor Compliance|0
394678|NCT00768989|1324634|P1|On or After Week 36|Poor Compliance|1
394679|NCT00768989|1324633|P2|On or After Week 36|Lost to Follow-up|0
394680|NCT00768989|1324634|P1|On or After Week 36|Lost to Follow-up|1
394681|NCT00768989|1324633|P2|On or After Week 36|Adverse Event|1
394682|NCT00768989|1324634|P1|On or After Week 36|Adverse Event|0
394683|NCT00768989|1324633|P2|On or After Week 36|Lack of Efficacy|0
394684|NCT00768989|1324634|P1|On or After Week 36|Lack of Efficacy|1
394685|NCT00768989|1324633|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
394686|NCT00768989|1324634|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
394687|NCT00768989|1324633|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
394688|NCT00768989|1324634|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
394689|NCT00768989|1324633|P2|Week 24 to Prior to Week 36|Adverse Event|0
394690|NCT00768989|1324634|P1|Week 24 to Prior to Week 36|Adverse Event|1
394691|NCT00768989|1324633|P2|Prior to Week 24|Protocol Violation|2
394692|NCT00768989|1324634|P1|Prior to Week 24|Protocol Violation|0
394693|NCT00768989|1324633|P2|Prior to Week 24|Lost to Follow-up|1
394694|NCT00768989|1324634|P1|Prior to Week 24|Lost to Follow-up|0
394695|NCT00768989|1324633|P2|Prior to Week 24|Adverse Event|0
394696|NCT00768989|1324634|P1|Prior to Week 24|Adverse Event|3
394697|NCT00768989|1324633|P2|Prior to Week 24|Withdrawal by Subject|0
394698|NCT00768989|1324634|P1|Prior to Week 24|Withdrawal by Subject|1
394699|NCT00768898|1324682|P1|Overall Study|Headache|1
394700|NCT00768898|1324682|P1|Overall Study|Unrelated injury|1
394701|NCT00768755|1324706|P4|Phase 2|Randomized but not treated|2
394702|NCT00768755|1324707|P3|Phase 2|Randomized but not treated|0
394703|NCT00768755|1324708|P2|Phase 2|Randomized but not treated|0
394704|NCT00768755|1324709|P1|Phase 2|Randomized but not treated|0
394705|NCT00768755|1324706|P4|Phase 2|Study Terminated by Sponsor|14
394706|NCT00768755|1324707|P3|Phase 2|Study Terminated by Sponsor|7
394707|NCT00768755|1324708|P2|Phase 2|Study Terminated by Sponsor|13
394708|NCT00768755|1324709|P1|Phase 2|Study Terminated by Sponsor|0
394709|NCT00768755|1324706|P4|Phase 2|Other|4
394710|NCT00768755|1324707|P3|Phase 2|Other|2
394711|NCT00768755|1324708|P2|Phase 2|Other|1
394712|NCT00768755|1324709|P1|Phase 2|Other|0
394713|NCT00768755|1324706|P4|Phase 2|Withdrawal by Subject|1
394714|NCT00768755|1324707|P3|Phase 2|Withdrawal by Subject|0
394715|NCT00768755|1324708|P2|Phase 2|Withdrawal by Subject|1
394716|NCT00768755|1324709|P1|Phase 2|Withdrawal by Subject|0
394717|NCT00768755|1324706|P4|Phase 2|Lost to Follow-up|4
394718|NCT00768755|1324707|P3|Phase 2|Lost to Follow-up|1
394719|NCT00768755|1324708|P2|Phase 2|Lost to Follow-up|1
394720|NCT00768755|1324709|P1|Phase 2|Lost to Follow-up|0
394721|NCT00768755|1324706|P4|Phase 2|Protocol Violation|1
394722|NCT00768755|1324707|P3|Phase 2|Protocol Violation|0
394723|NCT00768755|1324708|P2|Phase 2|Protocol Violation|2
394724|NCT00768755|1324709|P1|Phase 2|Protocol Violation|0
394725|NCT00768755|1324706|P4|Phase 2|Death|31
394726|NCT00768755|1324707|P3|Phase 2|Death|48
394727|NCT00768755|1324708|P2|Phase 2|Death|37
394728|NCT00768755|1324709|P1|Phase 2|Death|0
394729|NCT00768755|1324706|P4|Phase 1|Other|0
394730|NCT00768755|1324707|P3|Phase 1|Other|0
394731|NCT00768755|1324708|P2|Phase 1|Other|0
394732|NCT00768755|1324709|P1|Phase 1|Other|4
394733|NCT00768755|1324706|P4|Phase 1|Death|0
394734|NCT00768755|1324707|P3|Phase 1|Death|0
394735|NCT00768755|1324708|P2|Phase 1|Death|0
394736|NCT00768755|1324709|P1|Phase 1|Death|6
394737|NCT00768651|1324733|P1|Overall Study|Withdrawal by Subject|1
394738|NCT00768560|1324772|P6|Intervention Set 1|Adverse Event|0
394739|NCT00768560|1324773|P5|Intervention Set 1|Adverse Event|0
394740|NCT00768560|1324774|P4|Intervention Set 1|Adverse Event|0
394741|NCT00768560|1324775|P3|Intervention Set 1|Adverse Event|0
394742|NCT00768560|1324776|P2|Intervention Set 1|Adverse Event|1
394743|NCT00768560|1324777|P1|Intervention Set 1|Adverse Event|0
394744|NCT00768430|1324814|P2|7 Day Endpoint|Withdrawal by Subject|3
394745|NCT00768430|1324815|P1|7 Day Endpoint|Withdrawal by Subject|2
394746|NCT00768300|1324823|P2|Overall Study|Missing data|0
394747|NCT00768300|1324824|P1|Overall Study|Missing data|1
394748|NCT00768300|1324823|P2|Overall Study|Treated but never dosed with Study drug|0
394749|NCT00768300|1324824|P1|Overall Study|Treated but never dosed with Study drug|1
394750|NCT00768300|1324823|P2|Overall Study|Began prohibited concomitant medication|1
394751|NCT00768300|1324824|P1|Overall Study|Began prohibited concomitant medication|0
394752|NCT00768300|1324823|P2|Overall Study|Lost to Follow-up|1
394753|NCT00768300|1324824|P1|Overall Study|Lost to Follow-up|0
394754|NCT00768300|1324823|P2|Overall Study|Received lung transplant|1
394755|NCT00768300|1324824|P1|Overall Study|Received lung transplant|1
394756|NCT00768300|1324823|P2|Overall Study|Screen failure following randomization|0
394757|NCT00768300|1324824|P1|Overall Study|Screen failure following randomization|1
394758|NCT00768300|1324823|P2|Overall Study|Subject moved to pursue lung transplant|1
394759|NCT00768300|1324824|P1|Overall Study|Subject moved to pursue lung transplant|1
394760|NCT00768300|1324823|P2|Overall Study|Death|5
394761|NCT00768300|1324824|P1|Overall Study|Death|21
394762|NCT00768300|1324823|P2|Overall Study|Study discontinued by Sponsor|140
394763|NCT00768300|1324824|P1|Overall Study|Study discontinued by Sponsor|271
394764|NCT00768300|1324823|P2|Overall Study|Physician Decision|3
394765|NCT00768300|1324824|P1|Overall Study|Physician Decision|2
394766|NCT00768300|1324823|P2|Overall Study|Withdrawal by Subject|7
394767|NCT00768300|1324824|P1|Overall Study|Withdrawal by Subject|13
394768|NCT00768300|1324823|P2|Overall Study|Protocol Violation|1
394769|NCT00768300|1324824|P1|Overall Study|Protocol Violation|6
394770|NCT00768300|1324823|P2|Overall Study|Adverse Event|2
394771|NCT00768300|1324824|P1|Overall Study|Adverse Event|10
394772|NCT00768300|1324823|P2|Overall Study|Randomized but not treated|1
394773|NCT00768300|1324824|P1|Overall Study|Randomized but not treated|1
394774|NCT00768222|1324848|P2|Overall Study|Protocol Violation|2
394775|NCT00768222|1324849|P1|Overall Study|Protocol Violation|0
394776|NCT00768222|1324848|P2|Overall Study|Withdrawal by Subject|1
394777|NCT00768222|1324849|P1|Overall Study|Withdrawal by Subject|3
394778|NCT00768222|1324848|P2|Overall Study|Lost to Follow-up|1
394779|NCT00768222|1324849|P1|Overall Study|Lost to Follow-up|1
394780|NCT00768144|1324871|P1|Overall Study|Pt Withdrew Consent|1
394781|NCT00768144|1324871|P1|Overall Study|Patient or MD Decision to End Treatment|1
394782|NCT00768144|1324871|P1|Overall Study|Progressive Disease|21
394783|NCT00768144|1324871|P1|Overall Study|Adverse Event|13
394784|NCT00768066|1324884|P3|Overall Study|Did not receive study product injection.|0
394785|NCT00768066|1324885|P2|Overall Study|Did not receive study product injection.|3
394786|NCT00768066|1324886|P1|Overall Study|Did not receive study product injection.|3
394787|NCT00768053|1324918|P1|Overall Study|Lost to Follow-up|1
394788|NCT00768053|1324918|P1|Overall Study|Adverse Event|10
394789|NCT00768040|1324949|P2|Overall Study|Abnormal laboratory value|1
394790|NCT00768040|1324950|P1|Overall Study|Abnormal laboratory value|1
394791|NCT00768040|1324949|P2|Overall Study|Adverse Event|2
394792|NCT00768040|1324950|P1|Overall Study|Adverse Event|3
394793|NCT00767806|1324958|P2|Overall Study|Sponsor Decision|1
394794|NCT00767806|1324959|P1|Overall Study|Sponsor Decision|0
394795|NCT00767806|1324958|P2|Overall Study|Entry Criteria Not Met|1
394796|NCT00767806|1324959|P1|Overall Study|Entry Criteria Not Met|1
394797|NCT00767806|1324958|P2|Overall Study|Lost to Follow-up|4
394798|NCT00767806|1324959|P1|Overall Study|Lost to Follow-up|1
394799|NCT00767806|1324958|P2|Overall Study|Physician Decision|3
394800|NCT00767806|1324959|P1|Overall Study|Physician Decision|4
394801|NCT00767806|1324958|P2|Overall Study|Lack of Efficacy|9
394802|NCT00767806|1324959|P1|Overall Study|Lack of Efficacy|1
394803|NCT00767806|1324958|P2|Overall Study|Protocol Violation|5
394804|NCT00767806|1324959|P1|Overall Study|Protocol Violation|6
394805|NCT00767806|1324958|P2|Overall Study|Withdrawal by Subject|13
394806|NCT00767806|1324959|P1|Overall Study|Withdrawal by Subject|8
394807|NCT00767806|1324958|P2|Overall Study|Adverse Event|11
394808|NCT00767806|1324959|P1|Overall Study|Adverse Event|30
394809|NCT00767676|1325036|P1|Overall Study|Investigator error|54
394810|NCT00767520|1325059|P2|Overall Study|Randomized in error and Never treated|2
394811|NCT00767520|1325060|P1|Overall Study|Randomized in error and Never treated|0
394812|NCT00767520|1325059|P2|Overall Study|Participants still on treatment|15
394813|NCT00767520|1325060|P1|Overall Study|Participants still on treatment|11
394814|NCT00767455|1325113|P1|Overall Study|Investigator error|19
394815|NCT00767325|1325147|P1|Overall Study|Missed visit due to family reasons|1
394816|NCT00767325|1325147|P1|Overall Study|No longer met study criteria|2
394817|NCT00767325|1325147|P1|Overall Study|Lost to Follow-up|3
394818|NCT00767325|1325147|P1|Overall Study|Adverse Event|7
394819|NCT00767325|1325147|P1|Overall Study|Lack of Efficacy|2
394820|NCT00767104|1325158|P2|Overall Study|Lost to Follow-up|2
394821|NCT00767104|1325159|P1|Overall Study|Lost to Follow-up|1
394822|NCT00767039|1325169|P2|Overall Study|Death|2
394823|NCT00767039|1325170|P1|Overall Study|Death|5
394824|NCT00767000|1325201|P5|Optional 104-week Extension|Study terminated by sponsor|4
394825|NCT00767000|1325202|P4|Optional 104-week Extension|Study terminated by sponsor|2
394826|NCT00767000|1325203|P3|Optional 104-week Extension|Study terminated by sponsor|7
394827|NCT00767000|1325204|P2|Optional 104-week Extension|Study terminated by sponsor|3
394828|NCT00767000|1325205|P1|Optional 104-week Extension|Study terminated by sponsor|7
394829|NCT00767000|1325201|P5|54-week Study|Reason not reported|0
394830|NCT00767000|1325202|P4|54-week Study|Reason not reported|1
394831|NCT00767000|1325203|P3|54-week Study|Reason not reported|0
394832|NCT00767000|1325204|P2|54-week Study|Reason not reported|0
394833|NCT00767000|1325205|P1|54-week Study|Reason not reported|0
394834|NCT00767000|1325201|P5|54-week Study|Study terminated by sponsor|194
394835|NCT00767000|1325202|P4|54-week Study|Study terminated by sponsor|196
394836|NCT00767000|1325203|P3|54-week Study|Study terminated by sponsor|89
394837|NCT00767000|1325204|P2|54-week Study|Study terminated by sponsor|102
394838|NCT00767000|1325205|P1|54-week Study|Study terminated by sponsor|90
394839|NCT00767000|1325201|P5|54-week Study|Withdrawal by Subject|13
394840|NCT00767000|1325202|P4|54-week Study|Withdrawal by Subject|11
394841|NCT00767000|1325203|P3|54-week Study|Withdrawal by Subject|5
394842|NCT00767000|1325204|P2|54-week Study|Withdrawal by Subject|3
394843|NCT00767000|1325205|P1|54-week Study|Withdrawal by Subject|2
394844|NCT00767000|1325201|P5|54-week Study|Protocol Violation|0
394845|NCT00767000|1325202|P4|54-week Study|Protocol Violation|2
394846|NCT00767000|1325203|P3|54-week Study|Protocol Violation|1
394847|NCT00767000|1325204|P2|54-week Study|Protocol Violation|0
394848|NCT00767000|1325205|P1|54-week Study|Protocol Violation|0
394849|NCT00767000|1325201|P5|54-week Study|Progressive disease|0
394850|NCT00767000|1325202|P4|54-week Study|Progressive disease|0
394851|NCT00767000|1325203|P3|54-week Study|Progressive disease|1
394852|NCT00767000|1325204|P2|54-week Study|Progressive disease|0
394853|NCT00767000|1325205|P1|54-week Study|Progressive disease|0
394854|NCT00767000|1325201|P5|54-week Study|Physician Decision|1
394855|NCT00767000|1325202|P4|54-week Study|Physician Decision|1
394856|NCT00767000|1325203|P3|54-week Study|Physician Decision|1
394857|NCT00767000|1325204|P2|54-week Study|Physician Decision|0
394858|NCT00767000|1325205|P1|54-week Study|Physician Decision|4
394859|NCT00767000|1325201|P5|54-week Study|Lost to Follow-up|2
394860|NCT00767000|1325202|P4|54-week Study|Lost to Follow-up|4
394861|NCT00767000|1325203|P3|54-week Study|Lost to Follow-up|1
394862|NCT00767000|1325204|P2|54-week Study|Lost to Follow-up|0
394863|NCT00767000|1325205|P1|54-week Study|Lost to Follow-up|4
394864|NCT00767000|1325201|P5|54-week Study|Lack of Efficacy|5
394865|NCT00767000|1325202|P4|54-week Study|Lack of Efficacy|0
394866|NCT00767000|1325203|P3|54-week Study|Lack of Efficacy|1
394867|NCT00767000|1325204|P2|54-week Study|Lack of Efficacy|0
394868|NCT00767000|1325205|P1|54-week Study|Lack of Efficacy|2
394869|NCT00767000|1325201|P5|54-week Study|Interruption of study medication|0
394870|NCT00767000|1325202|P4|54-week Study|Interruption of study medication|0
394871|NCT00767000|1325203|P3|54-week Study|Interruption of study medication|1
394872|NCT00767000|1325204|P2|54-week Study|Interruption of study medication|0
394873|NCT00767000|1325205|P1|54-week Study|Interruption of study medication|0
394874|NCT00767000|1325201|P5|54-week Study|Hypoglycemia|0
394875|NCT00767000|1325202|P4|54-week Study|Hypoglycemia|0
394876|NCT00767000|1325203|P3|54-week Study|Hypoglycemia|0
394877|NCT00767000|1325204|P2|54-week Study|Hypoglycemia|1
394878|NCT00767000|1325205|P1|54-week Study|Hypoglycemia|0
394879|NCT00767000|1325201|P5|54-week Study|Hyperglycemia|1
394880|NCT00767000|1325202|P4|54-week Study|Hyperglycemia|0
394881|NCT00767000|1325203|P3|54-week Study|Hyperglycemia|1
394882|NCT00767000|1325204|P2|54-week Study|Hyperglycemia|0
394883|NCT00767000|1325205|P1|54-week Study|Hyperglycemia|0
394884|NCT00767000|1325201|P5|54-week Study|Creaninine/creatinine clearance|4
394885|NCT00767000|1325202|P4|54-week Study|Creaninine/creatinine clearance|2
394886|NCT00767000|1325203|P3|54-week Study|Creaninine/creatinine clearance|2
394887|NCT00767000|1325204|P2|54-week Study|Creaninine/creatinine clearance|1
394888|NCT00767000|1325205|P1|54-week Study|Creaninine/creatinine clearance|2
394889|NCT00767000|1325201|P5|54-week Study|Adverse Event|4
394890|NCT00767000|1325202|P4|54-week Study|Adverse Event|8
394891|NCT00767000|1325203|P3|54-week Study|Adverse Event|6
394892|NCT00767000|1325204|P2|54-week Study|Adverse Event|6
394893|NCT00767000|1325205|P1|54-week Study|Adverse Event|4
394894|NCT00766831|1325247|P1|Overall Study|Not specified|28
394895|NCT00766831|1325247|P1|Overall Study|Non cooperation by participants|14
394896|NCT00766831|1325247|P1|Overall Study|Withdrawal of consent|26
394897|NCT00766831|1325247|P1|Overall Study|Physician Decision|5
394898|NCT00766831|1325247|P1|Overall Study|Protocol Violation|15
394899|NCT00766831|1325247|P1|Overall Study|Adverse Event|20
394900|NCT00766831|1325247|P1|Overall Study|Lost to Follow-up|3
394901|NCT00766831|1325247|P1|Overall Study|Withdrawal by Subject|4
394902|NCT00766675|1325277|P1|Overall Study|Insufficient therapy|1
394903|NCT00766675|1325277|P1|Overall Study|Receive other anti-neoplastic treatment|1
394904|NCT00766675|1325277|P1|Overall Study|Participant took prohibited medication|1
394905|NCT00766675|1325277|P1|Overall Study|Protocol Violation|8
394906|NCT00766675|1325277|P1|Overall Study|Withdrawal by Subject|11
394907|NCT00766675|1325277|P1|Overall Study|Lost to Follow-up|2
394908|NCT00766675|1325277|P1|Overall Study|Adverse Event|16
394909|NCT00766636|1325304|P2|Overall Study|Disease Progression|0
394910|NCT00766636|1325305|P1|Overall Study|Disease Progression|1
394911|NCT00766636|1325304|P2|Overall Study|Adverse Event|0
394912|NCT00766636|1325305|P1|Overall Study|Adverse Event|1
394913|NCT00766636|1325304|P2|Overall Study|Incomplete Treatment|1
394914|NCT00766636|1325305|P1|Overall Study|Incomplete Treatment|0
394915|NCT00766636|1325304|P2|Overall Study|Withdrawal by Subject|1
394916|NCT00766636|1325305|P1|Overall Study|Withdrawal by Subject|1
394917|NCT00766597|1325311|P1|Overall Study|Without CCR5-tropic virus|5
394918|NCT00766597|1325311|P1|Overall Study|Unexpected closure of study|4
394919|NCT00766532|1325323|P1|Overall Study|Protocol Violation|2
394920|NCT00766506|1325329|P2|Overall Study|Other|2
394921|NCT00766506|1325330|P1|Overall Study|Other|2
394922|NCT00766506|1325329|P2|Overall Study|Use rescue medication after 3 hours|0
394923|NCT00766506|1325330|P1|Overall Study|Use rescue medication after 3 hours|3
394924|NCT00766493|1325354|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
394925|NCT00766493|1325354|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
394926|NCT00766493|1325354|P1|30 Days Post-Procedure|Discontinued|7
394927|NCT00766467|1325364|P2|Overall Study|Physician Decision|0
394928|NCT00766467|1325365|P1|Overall Study|Physician Decision|1
394929|NCT00766467|1325364|P2|Overall Study|Tumor Progression on Study|1
394930|NCT00766467|1325365|P1|Overall Study|Tumor Progression on Study|0
394931|NCT00766467|1325364|P2|Overall Study|Protocol Violation|4
394932|NCT00766467|1325365|P1|Overall Study|Protocol Violation|2
394933|NCT00766467|1325364|P2|Overall Study|Adverse Event|1
394934|NCT00766467|1325365|P1|Overall Study|Adverse Event|1
394935|NCT00766467|1325364|P2|Overall Study|Withdrawal by Subject|2
394936|NCT00766467|1325365|P1|Overall Study|Withdrawal by Subject|7
394937|NCT00766415|1325377|P2|Overall Study|Withdrawal by Subject|1
394938|NCT00766415|1325378|P1|Overall Study|Withdrawal by Subject|0
394939|NCT00766376|1325426|P1|Overall Study|Withdrawal by Subject|27
394940|NCT00766363|1325435|P4|Overall Study|Adverse Event Prior to Randomization|0
394941|NCT00766363|1325436|P3|Overall Study|Adverse Event Prior to Randomization|0
394942|NCT00766363|1325437|P2|Overall Study|Adverse Event Prior to Randomization|1
394943|NCT00766363|1325438|P1|Overall Study|Adverse Event Prior to Randomization|0
394944|NCT00766363|1325435|P4|Overall Study|Withdrawal by Subject|0
394945|NCT00766363|1325436|P3|Overall Study|Withdrawal by Subject|0
394946|NCT00766363|1325437|P2|Overall Study|Withdrawal by Subject|0
394947|NCT00766363|1325438|P1|Overall Study|Withdrawal by Subject|1
394948|NCT00766090|1325477|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394949|NCT00766090|1325478|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394950|NCT00766090|1325479|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394951|NCT00766090|1325480|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394952|NCT00766090|1325481|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394953|NCT00766090|1325482|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394954|NCT00766090|1325483|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394955|NCT00766090|1325484|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
394956|NCT00766090|1325485|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394957|NCT00766090|1325486|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394958|NCT00766090|1325487|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394959|NCT00766090|1325488|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
394960|NCT00766090|1325477|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
394961|NCT00766090|1325478|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394962|NCT00766090|1325479|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394963|NCT00766090|1325480|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394964|NCT00766090|1325481|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394965|NCT00766090|1325482|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394966|NCT00766090|1325483|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394967|NCT00766090|1325484|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394968|NCT00766090|1325485|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
394969|NCT00766090|1325486|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394970|NCT00766090|1325487|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
394971|NCT00766090|1325488|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
394972|NCT00766090|1325477|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
394973|NCT00766090|1325478|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
394974|NCT00766090|1325479|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
394975|NCT00766090|1325480|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
394976|NCT00766090|1325481|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
394977|NCT00766090|1325482|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
394978|NCT00766090|1325483|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
394979|NCT00766090|1325484|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
394980|NCT00766090|1325485|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
394981|NCT00766090|1325486|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
394982|NCT00766090|1325487|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
394983|NCT00766090|1325488|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
394984|NCT00766090|1325477|P12|Washout Period 2 (14 Days)|Physician Decision|0
394985|NCT00766090|1325478|P11|Washout Period 2 (14 Days)|Physician Decision|0
394986|NCT00766090|1325479|P10|Washout Period 2 (14 Days)|Physician Decision|0
394987|NCT00766090|1325480|P9|Washout Period 2 (14 Days)|Physician Decision|0
394988|NCT00766090|1325481|P8|Washout Period 2 (14 Days)|Physician Decision|0
394989|NCT00766090|1325482|P7|Washout Period 2 (14 Days)|Physician Decision|0
394990|NCT00766090|1325483|P6|Washout Period 2 (14 Days)|Physician Decision|0
394991|NCT00766090|1325484|P5|Washout Period 2 (14 Days)|Physician Decision|0
394992|NCT00766090|1325485|P4|Washout Period 2 (14 Days)|Physician Decision|0
394993|NCT00766090|1325486|P3|Washout Period 2 (14 Days)|Physician Decision|1
394994|NCT00766090|1325487|P2|Washout Period 2 (14 Days)|Physician Decision|0
394995|NCT00766090|1325488|P1|Washout Period 2 (14 Days)|Physician Decision|0
394996|NCT00766090|1325477|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
394997|NCT00766090|1325478|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
394998|NCT00766090|1325479|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
394999|NCT00766090|1325480|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395000|NCT00766090|1325481|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395001|NCT00766090|1325482|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395002|NCT00766090|1325483|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395003|NCT00766090|1325484|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395004|NCT00766090|1325485|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395005|NCT00766090|1325486|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
395006|NCT00766090|1325487|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395007|NCT00766090|1325488|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
395008|NCT00766090|1325477|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395009|NCT00766090|1325478|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395010|NCT00766090|1325479|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395011|NCT00766090|1325480|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395012|NCT00766090|1325481|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395013|NCT00766090|1325482|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395014|NCT00766090|1325483|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395015|NCT00766090|1325484|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
395016|NCT00766090|1325485|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395017|NCT00766090|1325486|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395018|NCT00766090|1325487|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395019|NCT00766090|1325488|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
395020|NCT00766090|1325477|P12|Washout Period 1 (14 Days)|Protocol Violation|0
395021|NCT00766090|1325478|P11|Washout Period 1 (14 Days)|Protocol Violation|0
395022|NCT00766090|1325479|P10|Washout Period 1 (14 Days)|Protocol Violation|0
395023|NCT00766090|1325480|P9|Washout Period 1 (14 Days)|Protocol Violation|0
395024|NCT00766090|1325481|P8|Washout Period 1 (14 Days)|Protocol Violation|0
395025|NCT00766090|1325482|P7|Washout Period 1 (14 Days)|Protocol Violation|0
395026|NCT00766090|1325483|P6|Washout Period 1 (14 Days)|Protocol Violation|0
395027|NCT00766090|1325484|P5|Washout Period 1 (14 Days)|Protocol Violation|0
395028|NCT00766090|1325485|P4|Washout Period 1 (14 Days)|Protocol Violation|0
395029|NCT00766090|1325486|P3|Washout Period 1 (14 Days)|Protocol Violation|1
395030|NCT00766090|1325487|P2|Washout Period 1 (14 Days)|Protocol Violation|0
395031|NCT00766090|1325488|P1|Washout Period 1 (14 Days)|Protocol Violation|0
395032|NCT00766090|1325477|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395033|NCT00766090|1325478|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395034|NCT00766090|1325479|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395035|NCT00766090|1325480|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395036|NCT00766090|1325481|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395037|NCT00766090|1325482|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395038|NCT00766090|1325483|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395039|NCT00766090|1325484|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395040|NCT00766090|1325485|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
395041|NCT00766090|1325486|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395042|NCT00766090|1325487|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
395043|NCT00766090|1325488|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
395044|NCT00766090|1325477|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395045|NCT00766090|1325478|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395046|NCT00766090|1325479|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395047|NCT00766090|1325480|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395048|NCT00766090|1325481|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395049|NCT00766090|1325482|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395050|NCT00766090|1325483|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395051|NCT00766090|1325484|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395052|NCT00766090|1325485|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395053|NCT00766090|1325486|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395054|NCT00766090|1325487|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
395055|NCT00766090|1325488|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
395056|NCT00766090|1325477|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395057|NCT00766090|1325478|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395058|NCT00766090|1325479|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395059|NCT00766090|1325480|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
395060|NCT00766090|1325481|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395061|NCT00766090|1325482|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395062|NCT00766090|1325483|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395063|NCT00766090|1325484|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395064|NCT00766090|1325485|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395065|NCT00766090|1325486|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395066|NCT00766090|1325487|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395067|NCT00766090|1325488|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
395068|NCT00766051|1325529|P2|Overall Study|Withdrawal by Subject|0
395069|NCT00766051|1325530|P1|Overall Study|Withdrawal by Subject|2
395070|NCT00765882|1325561|P3|Overall Study|Other Reason|2
395071|NCT00765882|1325562|P2|Overall Study|Other Reason|1
395072|NCT00765882|1325563|P1|Overall Study|Other Reason|3
395073|NCT00765882|1325561|P3|Overall Study|Lost to Follow-up|6
395074|NCT00765882|1325562|P2|Overall Study|Lost to Follow-up|9
395075|NCT00765882|1325563|P1|Overall Study|Lost to Follow-up|1
395076|NCT00765882|1325561|P3|Overall Study|Withdrawal by Subject|6
395077|NCT00765882|1325562|P2|Overall Study|Withdrawal by Subject|6
395078|NCT00765882|1325563|P1|Overall Study|Withdrawal by Subject|2
395079|NCT00765882|1325561|P3|Overall Study|Protocol Violation|1
395080|NCT00765882|1325562|P2|Overall Study|Protocol Violation|3
395081|NCT00765882|1325563|P1|Overall Study|Protocol Violation|4
395082|NCT00765882|1325561|P3|Overall Study|Lack of Efficacy|1
395083|NCT00765882|1325562|P2|Overall Study|Lack of Efficacy|0
395084|NCT00765882|1325563|P1|Overall Study|Lack of Efficacy|4
395085|NCT00765882|1325561|P3|Overall Study|Adverse Event|20
395086|NCT00765882|1325562|P2|Overall Study|Adverse Event|21
395087|NCT00765882|1325563|P1|Overall Study|Adverse Event|10
395088|NCT00765843|1325595|P3|Overall Study|Adverse Event|1
395089|NCT00765843|1325596|P2|Overall Study|Adverse Event|0
395090|NCT00765843|1325597|P1|Overall Study|Adverse Event|0
395091|NCT00765843|1325595|P3|Overall Study|did not return to receive intervention|0
395092|NCT00765843|1325596|P2|Overall Study|did not return to receive intervention|1
395093|NCT00765843|1325597|P1|Overall Study|did not return to receive intervention|0
395094|NCT00765843|1325595|P3|Overall Study|Lost to Follow-up|2
395095|NCT00765843|1325596|P2|Overall Study|Lost to Follow-up|3
395096|NCT00765843|1325597|P1|Overall Study|Lost to Follow-up|1
395097|NCT00765817|1325607|P2|Overall Study|Subject decision|11
395098|NCT00765817|1325608|P1|Overall Study|Subject decision|7
395099|NCT00765817|1325607|P2|Overall Study|Protocol Violation|1
395100|NCT00765817|1325608|P1|Overall Study|Protocol Violation|1
395101|NCT00765817|1325607|P2|Overall Study|Physician Decision|1
395102|NCT00765817|1325608|P1|Overall Study|Physician Decision|2
395103|NCT00765817|1325607|P2|Overall Study|Lost to Follow-up|3
395104|NCT00765817|1325608|P1|Overall Study|Lost to Follow-up|1
395105|NCT00765817|1325607|P2|Overall Study|Loss of glucose control|2
395106|NCT00765817|1325608|P1|Overall Study|Loss of glucose control|0
395107|NCT00765817|1325607|P2|Overall Study|Entry criteria not met|2
395108|NCT00765817|1325608|P1|Overall Study|Entry criteria not met|2
395109|NCT00765817|1325607|P2|Overall Study|Death|1
395110|NCT00765817|1325608|P1|Overall Study|Death|0
395111|NCT00765817|1325607|P2|Overall Study|Adverse Event|1
395112|NCT00765817|1325608|P1|Overall Study|Adverse Event|13
395113|NCT00765726|1325656|P1|Overall Study|Discontinuation of study by sponsor|8
395114|NCT00765726|1325656|P1|Overall Study|Withdrawal by Subject|1
395115|NCT00765674|1325664|P4|Overall Study|Randomized in Error - No Study Drug|1
395116|NCT00765674|1325665|P3|Overall Study|Randomized in Error - No Study Drug|0
395117|NCT00765674|1325666|P2|Overall Study|Randomized in Error - No Study Drug|1
395118|NCT00765674|1325667|P1|Overall Study|Randomized in Error - No Study Drug|0
395119|NCT00765674|1325664|P4|Overall Study|Lost to Follow-up|1
395120|NCT00765674|1325665|P3|Overall Study|Lost to Follow-up|2
395121|NCT00765674|1325666|P2|Overall Study|Lost to Follow-up|6
395122|NCT00765674|1325667|P1|Overall Study|Lost to Follow-up|4
395123|NCT00765674|1325664|P4|Overall Study|Withdrawal by Subject|8
395124|NCT00765674|1325665|P3|Overall Study|Withdrawal by Subject|3
395125|NCT00765674|1325666|P2|Overall Study|Withdrawal by Subject|7
395126|NCT00765674|1325667|P1|Overall Study|Withdrawal by Subject|5
395127|NCT00765674|1325664|P4|Overall Study|Protocol Violation|0
395128|NCT00765674|1325665|P3|Overall Study|Protocol Violation|1
395129|NCT00765674|1325666|P2|Overall Study|Protocol Violation|0
395130|NCT00765674|1325667|P1|Overall Study|Protocol Violation|2
395131|NCT00765674|1325664|P4|Overall Study|Lack of Efficacy|2
395132|NCT00765674|1325665|P3|Overall Study|Lack of Efficacy|1
395133|NCT00765674|1325666|P2|Overall Study|Lack of Efficacy|3
395134|NCT00765674|1325667|P1|Overall Study|Lack of Efficacy|2
395135|NCT00765674|1325664|P4|Overall Study|Abnormal Test Procedure Result(s)|2
395136|NCT00765674|1325665|P3|Overall Study|Abnormal Test Procedure Result(s)|1
395137|NCT00765674|1325666|P2|Overall Study|Abnormal Test Procedure Result(s)|3
395138|NCT00765674|1325667|P1|Overall Study|Abnormal Test Procedure Result(s)|1
395139|NCT00765674|1325664|P4|Overall Study|Abnormal Laboratory Value(s)|0
395140|NCT00765674|1325665|P3|Overall Study|Abnormal Laboratory Value(s)|1
395141|NCT00765674|1325666|P2|Overall Study|Abnormal Laboratory Value(s)|0
395142|NCT00765674|1325667|P1|Overall Study|Abnormal Laboratory Value(s)|0
395143|NCT00765674|1325664|P4|Overall Study|Adverse Event|11
395144|NCT00765674|1325665|P3|Overall Study|Adverse Event|8
395145|NCT00765674|1325666|P2|Overall Study|Adverse Event|2
395146|NCT00765674|1325667|P1|Overall Study|Adverse Event|7
395147|NCT00765388|1325734|P2|Period 1|Hip operation|1
395148|NCT00765388|1325735|P1|Period 1|Hip operation|0
395149|NCT00765388|1325734|P2|Period 1|Herpes Zoster|1
395150|NCT00765388|1325735|P1|Period 1|Herpes Zoster|0
395151|NCT00765388|1325734|P2|Period 1|Lost to Follow-up|1
395152|NCT00765388|1325735|P1|Period 1|Lost to Follow-up|0
395153|NCT00765388|1325734|P2|Period 1|Lack of Efficacy|2
395154|NCT00765388|1325735|P1|Period 1|Lack of Efficacy|1
395155|NCT00765362|1325769|P1|Overall Study|Lost to Follow-up|95
395156|NCT00765362|1325769|P1|Overall Study|Withdrawal by Subject|13
395157|NCT00765362|1325769|P1|Overall Study|Protocol Violation|18
395158|NCT00765362|1325769|P1|Overall Study|Adverse Event|2
395159|NCT00765362|1325769|P1|Overall Study|Death|9
395160|NCT00765336|1325777|P2|Overall Study|Adverse Event|1
395161|NCT00765336|1325778|P1|Overall Study|Adverse Event|2
395162|NCT00765336|1325777|P2|Overall Study|Lost to Follow-up|9
395163|NCT00765336|1325778|P1|Overall Study|Lost to Follow-up|7
395164|NCT00765336|1325777|P2|Overall Study|Withdrawal by Subject|4
395165|NCT00765336|1325778|P1|Overall Study|Withdrawal by Subject|6
395166|NCT00765336|1325777|P2|Overall Study|Protocol Violation|2
395167|NCT00765336|1325778|P1|Overall Study|Protocol Violation|4
395168|NCT00765245|1325786|P2|Overall Study|Death|0
395169|NCT00765245|1325787|P1|Overall Study|Death|1
395170|NCT00765245|1325786|P2|Overall Study|Physician Decision|0
395171|NCT00765245|1325787|P1|Overall Study|Physician Decision|1
395172|NCT00765245|1325786|P2|Overall Study|Adverse Event|0
395173|NCT00765245|1325787|P1|Overall Study|Adverse Event|5
395174|NCT00765245|1325786|P2|Overall Study|Withdrawal by Subject|0
395175|NCT00765245|1325787|P1|Overall Study|Withdrawal by Subject|3
395176|NCT00765245|1325786|P2|Overall Study|disease progression|2
395177|NCT00765245|1325787|P1|Overall Study|disease progression|3
395178|NCT00765102|1325833|P1|Overall Study|Protocol Violation|1
395179|NCT00765102|1325833|P1|Overall Study|Withdrawal by Subject|2
395180|NCT00765102|1325833|P1|Overall Study|Physician Decision|4
395181|NCT00765102|1325833|P1|Overall Study|Adverse Event|6
395182|NCT00765102|1325833|P1|Overall Study|Progressive disease|18
395183|NCT00765076|1325858|P3|Overall Study|Withdrawal by Subject|1
395184|NCT00765076|1325859|P2|Overall Study|Withdrawal by Subject|0
395185|NCT00765076|1325860|P1|Overall Study|Withdrawal by Subject|0
395186|NCT00765076|1325858|P3|Overall Study|Adverse Event|0
395187|NCT00765076|1325859|P2|Overall Study|Adverse Event|0
395188|NCT00765076|1325860|P1|Overall Study|Adverse Event|1
395189|NCT00765063|1325913|P1|Overall Study|Adverse Event|4
395190|NCT00765063|1325913|P1|Overall Study|Protocol Violation|6
395191|NCT00765063|1325913|P1|Overall Study|Other|16
395192|NCT00765063|1325913|P1|Overall Study|Withdrawal by Subject|1
395193|NCT00765063|1325913|P1|Overall Study|Lack of Efficacy|5
395194|NCT00765037|1325929|P1|Overall Study|Adverse Event|1
395195|NCT00765037|1325929|P1|Overall Study|Lost to Follow-up|5
395196|NCT00764946|1325936|P3|Overall Study|Never Treated|1
395197|NCT00764946|1325937|P2|Overall Study|Never Treated|1
395198|NCT00764946|1325938|P1|Overall Study|Never Treated|1
395199|NCT00764946|1325936|P3|Overall Study|Withdrawal by Subject|2
395200|NCT00764946|1325937|P2|Overall Study|Withdrawal by Subject|6
395201|NCT00764946|1325938|P1|Overall Study|Withdrawal by Subject|3
395202|NCT00764946|1325936|P3|Overall Study|Adverse Event|1
395203|NCT00764946|1325937|P2|Overall Study|Adverse Event|2
395204|NCT00764946|1325938|P1|Overall Study|Adverse Event|3
395205|NCT00764946|1325936|P3|Overall Study|Physician Decision|0
395206|NCT00764946|1325937|P2|Overall Study|Physician Decision|4
395207|NCT00764946|1325938|P1|Overall Study|Physician Decision|2
395208|NCT00764946|1325936|P3|Overall Study|Lost to Follow-up|0
395209|NCT00764946|1325937|P2|Overall Study|Lost to Follow-up|4
395210|NCT00764946|1325938|P1|Overall Study|Lost to Follow-up|3
395211|NCT00764946|1325936|P3|Overall Study|Lack of Efficacy|0
395212|NCT00764946|1325937|P2|Overall Study|Lack of Efficacy|0
395213|NCT00764946|1325938|P1|Overall Study|Lack of Efficacy|1
395214|NCT00764881|1325966|P2|Overall Study|no treatment or no observation|2
395215|NCT00764881|1325967|P1|Overall Study|no treatment or no observation|2
395216|NCT00764881|1325966|P2|Overall Study|Possibly noncompliant (study drug)|2
395217|NCT00764881|1325967|P1|Overall Study|Possibly noncompliant (study drug)|0
395218|NCT00764881|1325966|P2|Overall Study|Carcinoma detected|0
395219|NCT00764881|1325967|P1|Overall Study|Carcinoma detected|1
395220|NCT00764881|1325966|P2|Overall Study|Wished to become pregnant|0
395221|NCT00764881|1325967|P1|Overall Study|Wished to become pregnant|1
395222|NCT00764881|1325966|P2|Overall Study|Accidentally discontinued study drug|0
395223|NCT00764881|1325967|P1|Overall Study|Accidentally discontinued study drug|1
395224|NCT00764881|1325966|P2|Overall Study|Noncompliant|0
395225|NCT00764881|1325967|P1|Overall Study|Noncompliant|1
395226|NCT00764881|1325966|P2|Overall Study|Lost to Follow-up|0
395227|NCT00764881|1325967|P1|Overall Study|Lost to Follow-up|2
395228|NCT00764881|1325966|P2|Overall Study|Protocol Violation|2
395229|NCT00764881|1325967|P1|Overall Study|Protocol Violation|2
395230|NCT00764881|1325966|P2|Overall Study|Withdrawal by Subject|3
395231|NCT00764881|1325967|P1|Overall Study|Withdrawal by Subject|1
395232|NCT00764881|1325966|P2|Overall Study|Adverse Event|1
395233|NCT00764881|1325967|P1|Overall Study|Adverse Event|5
395234|NCT00764868|1326191|P1|Overall Study|Sponsor requested withdrawal|1
395235|NCT00764868|1326191|P1|Overall Study|Positive drug screen|2
395236|NCT00764868|1326191|P1|Overall Study|Met an exclusion criteria|1
395237|NCT00764868|1326191|P1|Overall Study|Subject sent to boarding school|1
395238|NCT00764868|1326191|P1|Overall Study|Misuse and compliance of study drug|1
395239|NCT00764868|1326191|P1|Overall Study|Out of town|1
395240|NCT00764868|1326191|P1|Overall Study|Prohibited medication|1
395241|NCT00764868|1326191|P1|Overall Study|Pregnancy|3
395242|NCT00764868|1326191|P1|Overall Study|Subject moved|7
395243|NCT00764868|1326191|P1|Overall Study|Lack of Efficacy|5
395244|NCT00764868|1326191|P1|Overall Study|Lost to Follow-up|25
395245|NCT00764868|1326191|P1|Overall Study|Non-compliance|16
395246|NCT00764868|1326191|P1|Overall Study|Withdrawal by Subject|31
395247|NCT00764868|1326191|P1|Overall Study|Adverse Event|18
395248|NCT00764790|1326200|P3|Overall Study|Lost to Follow-up|23
395249|NCT00764790|1326201|P2|Overall Study|Lost to Follow-up|29
395250|NCT00764790|1326202|P1|Overall Study|Lost to Follow-up|28
395251|NCT00764790|1326200|P3|Overall Study|Withdrawal by Subject|6
395252|NCT00764790|1326201|P2|Overall Study|Withdrawal by Subject|12
395253|NCT00764790|1326202|P1|Overall Study|Withdrawal by Subject|10
395254|NCT00764790|1326200|P3|Overall Study|Protocol Violation|1
395255|NCT00764790|1326201|P2|Overall Study|Protocol Violation|0
395256|NCT00764790|1326202|P1|Overall Study|Protocol Violation|0
395257|NCT00764699|1326234|P1|Overall Study|PI left and study terminated|3
395258|NCT00764673|1326238|P1|Overall Study|Revision of Device|2
395259|NCT00764673|1326238|P1|Overall Study|Withdrawal by Subject|6
395260|NCT00764673|1326238|P1|Overall Study|Lost to Follow-up|3
395261|NCT00764673|1326238|P1|Overall Study|Death|1
395262|NCT00764660|1326248|P2|Overall Study|Did Not Meet Protocol Eligibility|0
395263|NCT00764660|1326249|P1|Overall Study|Did Not Meet Protocol Eligibility|1
395264|NCT00764660|1326248|P2|Overall Study|Noncompliance With Protocol|1
395265|NCT00764660|1326249|P1|Overall Study|Noncompliance With Protocol|5
395266|NCT00764660|1326248|P2|Overall Study|Withdrawal by Subject|3
395267|NCT00764660|1326249|P1|Overall Study|Withdrawal by Subject|7
395268|NCT00764660|1326248|P2|Overall Study|Lost to Follow-up|4
395269|NCT00764660|1326249|P1|Overall Study|Lost to Follow-up|3
395270|NCT00764660|1326248|P2|Overall Study|Adverse Event|3
395271|NCT00764660|1326249|P1|Overall Study|Adverse Event|6
395272|NCT00764517|1326283|P2|Overall Study|Physician Decision|0
395273|NCT00764517|1326284|P1|Overall Study|Physician Decision|3
395274|NCT00764517|1326283|P2|Overall Study|Death|11
395275|NCT00764517|1326284|P1|Overall Study|Death|3
395276|NCT00764517|1326283|P2|Overall Study|Adverse Event|3
395277|NCT00764517|1326284|P1|Overall Study|Adverse Event|9
395278|NCT00764504|1326305|P3|Overall Study|Lost to Follow-up|72
395279|NCT00764504|1326306|P2|Overall Study|Lost to Follow-up|34
395280|NCT00764504|1326307|P1|Overall Study|Lost to Follow-up|40
395281|NCT00764504|1326305|P3|Overall Study|Withdrawal by Subject|4
395282|NCT00764504|1326306|P2|Overall Study|Withdrawal by Subject|7
395283|NCT00764504|1326307|P1|Overall Study|Withdrawal by Subject|1
395284|NCT00764504|1326305|P3|Overall Study|Physician Decision|0
395285|NCT00764504|1326306|P2|Overall Study|Physician Decision|0
395286|NCT00764504|1326307|P1|Overall Study|Physician Decision|1
395287|NCT00764504|1326305|P3|Overall Study|Revision of Device|14
395288|NCT00764504|1326306|P2|Overall Study|Revision of Device|23
395289|NCT00764504|1326307|P1|Overall Study|Revision of Device|12
395290|NCT00764504|1326305|P3|Overall Study|Death|13
395291|NCT00764504|1326306|P2|Overall Study|Death|6
395292|NCT00764504|1326307|P1|Overall Study|Death|12
395293|NCT00764478|1326336|P3|Overall Study|Protocol Violation|1
395294|NCT00764478|1326337|P2|Overall Study|Protocol Violation|1
395295|NCT00764478|1326338|P1|Overall Study|Protocol Violation|0
395296|NCT00764478|1326336|P3|Overall Study|Lost to Follow-up|5
395297|NCT00764478|1326337|P2|Overall Study|Lost to Follow-up|8
395298|NCT00764478|1326338|P1|Overall Study|Lost to Follow-up|7
395299|NCT00764478|1326336|P3|Overall Study|Withdrawal by Subject|1
395300|NCT00764478|1326337|P2|Overall Study|Withdrawal by Subject|12
395301|NCT00764478|1326338|P1|Overall Study|Withdrawal by Subject|7
395302|NCT00764478|1326336|P3|Overall Study|Adverse Event|1
395303|NCT00764478|1326337|P2|Overall Study|Adverse Event|1
395304|NCT00764478|1326338|P1|Overall Study|Adverse Event|1
395305|NCT00764465|1326418|P6|Overall Study|Withdrawal by Subject|0
395306|NCT00764465|1326419|P5|Overall Study|Withdrawal by Subject|0
395307|NCT00764465|1326420|P4|Overall Study|Withdrawal by Subject|0
395308|NCT00764465|1326421|P3|Overall Study|Withdrawal by Subject|1
395309|NCT00764465|1326422|P2|Overall Study|Withdrawal by Subject|1
395310|NCT00764465|1326423|P1|Overall Study|Withdrawal by Subject|0
395311|NCT00764465|1326418|P6|Overall Study|Adverse Event|1
395312|NCT00764465|1326419|P5|Overall Study|Adverse Event|1
395313|NCT00764465|1326420|P4|Overall Study|Adverse Event|1
395314|NCT00764465|1326421|P3|Overall Study|Adverse Event|0
395315|NCT00764465|1326422|P2|Overall Study|Adverse Event|0
395316|NCT00764465|1326423|P1|Overall Study|Adverse Event|2
395317|NCT00764361|1326451|P2|Overall Study|Adverse Event|1
395318|NCT00764361|1326452|P1|Overall Study|Adverse Event|0
395319|NCT00764361|1326451|P2|Overall Study|Withdrawal by Subject|3
395320|NCT00764361|1326452|P1|Overall Study|Withdrawal by Subject|2
395321|NCT00764322|1326460|P1|Overall Study|No CYP2D6 genotyping|9
395322|NCT00764322|1326460|P1|Overall Study|Withdrawal by Subject|11
395323|NCT00763971|1326487|P3|Overall Study|Participation in 489-326 required|0
395324|NCT00763971|1326488|P2|Overall Study|Participation in 489-326 required|0
395325|NCT00763971|1326489|P1|Overall Study|Participation in 489-326 required|1
395326|NCT00763971|1326487|P3|Overall Study|Performed final visit on phone|0
395327|NCT00763971|1326488|P2|Overall Study|Performed final visit on phone|1
395328|NCT00763971|1326489|P1|Overall Study|Performed final visit on phone|0
395329|NCT00763971|1326487|P3|Overall Study|Lack of availability|0
395330|NCT00763971|1326488|P2|Overall Study|Lack of availability|1
395331|NCT00763971|1326489|P1|Overall Study|Lack of availability|0
395332|NCT00763971|1326487|P3|Overall Study|Subject wanted dose reduction|0
395333|NCT00763971|1326488|P2|Overall Study|Subject wanted dose reduction|1
395334|NCT00763971|1326489|P1|Overall Study|Subject wanted dose reduction|0
395335|NCT00763971|1326487|P3|Overall Study|Moved to another country|0
395336|NCT00763971|1326488|P2|Overall Study|Moved to another country|1
395337|NCT00763971|1326489|P1|Overall Study|Moved to another country|0
395338|NCT00763971|1326487|P3|Overall Study|Medical monitor decision|1
395339|NCT00763971|1326488|P2|Overall Study|Medical monitor decision|0
395340|NCT00763971|1326489|P1|Overall Study|Medical monitor decision|0
395341|NCT00763971|1326487|P3|Overall Study|Randomization error|1
395342|NCT00763971|1326488|P2|Overall Study|Randomization error|0
395343|NCT00763971|1326489|P1|Overall Study|Randomization error|0
395344|NCT00763971|1326487|P3|Overall Study|Due to holiday season|1
395345|NCT00763971|1326488|P2|Overall Study|Due to holiday season|0
395346|NCT00763971|1326489|P1|Overall Study|Due to holiday season|2
395347|NCT00763971|1326487|P3|Overall Study|Sponsor decision|0
395348|NCT00763971|1326488|P2|Overall Study|Sponsor decision|0
395349|NCT00763971|1326489|P1|Overall Study|Sponsor decision|1
395350|NCT00763971|1326487|P3|Overall Study|Exclusion criteria met|0
395351|NCT00763971|1326488|P2|Overall Study|Exclusion criteria met|0
395352|NCT00763971|1326489|P1|Overall Study|Exclusion criteria met|1
395353|NCT00763971|1326487|P3|Overall Study|Personal reason|0
395354|NCT00763971|1326488|P2|Overall Study|Personal reason|0
395355|NCT00763971|1326489|P1|Overall Study|Personal reason|3
395356|NCT00763971|1326487|P3|Overall Study|Unable to swallow capsule|1
395357|NCT00763971|1326488|P2|Overall Study|Unable to swallow capsule|1
395358|NCT00763971|1326489|P1|Overall Study|Unable to swallow capsule|2
395359|NCT00763971|1326487|P3|Overall Study|Lack of Efficacy|54
395360|NCT00763971|1326488|P2|Overall Study|Lack of Efficacy|22
395361|NCT00763971|1326489|P1|Overall Study|Lack of Efficacy|11
395362|NCT00763971|1326487|P3|Overall Study|Lost to Follow-up|0
395363|NCT00763971|1326488|P2|Overall Study|Lost to Follow-up|1
395364|NCT00763971|1326489|P1|Overall Study|Lost to Follow-up|0
395365|NCT00763971|1326487|P3|Overall Study|Withdrawal by Subject|5
395366|NCT00763971|1326488|P2|Overall Study|Withdrawal by Subject|5
395367|NCT00763971|1326489|P1|Overall Study|Withdrawal by Subject|4
395368|NCT00763971|1326487|P3|Overall Study|Protocol Violation|2
395369|NCT00763971|1326488|P2|Overall Study|Protocol Violation|3
395370|NCT00763971|1326489|P1|Overall Study|Protocol Violation|3
395371|NCT00763971|1326487|P3|Overall Study|Adverse Event|4
395372|NCT00763971|1326488|P2|Overall Study|Adverse Event|2
395373|NCT00763971|1326489|P1|Overall Study|Adverse Event|5
395374|NCT00763958|1326520|P2|Overall Study|Believed they were receiving placebo|5
395375|NCT00763958|1326521|P1|Overall Study|Believed they were receiving placebo|0
395376|NCT00763958|1326520|P2|Overall Study|Lost to Follow-up|2
395377|NCT00763958|1326521|P1|Overall Study|Lost to Follow-up|10
395378|NCT00763958|1326520|P2|Overall Study|did not meet final criteria|4
395379|NCT00763958|1326521|P1|Overall Study|did not meet final criteria|4
395380|NCT00763815|1326656|P2|Overall Study|Sponsor's Decision|1
395381|NCT00763815|1326657|P1|Overall Study|Sponsor's Decision|0
395382|NCT00763815|1326656|P2|Overall Study|Protocol Violation|5
395383|NCT00763815|1326657|P1|Overall Study|Protocol Violation|2
395384|NCT00763815|1326656|P2|Overall Study|Withdrawal by Subject|12
395385|NCT00763815|1326657|P1|Overall Study|Withdrawal by Subject|7
395386|NCT00763815|1326656|P2|Overall Study|Physician Decision|0
395387|NCT00763815|1326657|P1|Overall Study|Physician Decision|1
395388|NCT00763815|1326656|P2|Overall Study|Familial and Personal Reasons|16
395389|NCT00763815|1326657|P1|Overall Study|Familial and Personal Reasons|9
395390|NCT00763815|1326656|P2|Overall Study|Early Termination|0
395391|NCT00763815|1326657|P1|Overall Study|Early Termination|1
395392|NCT00763815|1326656|P2|Overall Study|Lost to Follow-up|4
395393|NCT00763815|1326657|P1|Overall Study|Lost to Follow-up|2
395394|NCT00763815|1326656|P2|Overall Study|Poor Compliance to Protocol|6
395395|NCT00763815|1326657|P1|Overall Study|Poor Compliance to Protocol|6
395396|NCT00763815|1326656|P2|Overall Study|Lack of Efficacy|11
395397|NCT00763815|1326657|P1|Overall Study|Lack of Efficacy|10
395398|NCT00763815|1326656|P2|Overall Study|Adverse Event|29
395399|NCT00763815|1326657|P1|Overall Study|Adverse Event|14
395400|NCT00763698|1326685|P1|Overall Study|Withdrawal by Subject|1
395401|NCT00763698|1326685|P1|Overall Study|Death|4
395402|NCT00763698|1326685|P1|Overall Study|Unsuccessful Implant|5
395403|NCT00763451|1326702|P4|Overall Study|Study Site Reason|1
395404|NCT00763451|1326703|P3|Overall Study|Study Site Reason|1
395405|NCT00763451|1326704|P2|Overall Study|Study Site Reason|1
395406|NCT00763451|1326705|P1|Overall Study|Study Site Reason|0
395407|NCT00763451|1326702|P4|Overall Study|Randomized but not Treated|0
395408|NCT00763451|1326703|P3|Overall Study|Randomized but not Treated|0
395409|NCT00763451|1326704|P2|Overall Study|Randomized but not Treated|1
395410|NCT00763451|1326705|P1|Overall Study|Randomized but not Treated|1
395411|NCT00763451|1326702|P4|Overall Study|Familial and Personal Reasons|4
395412|NCT00763451|1326703|P3|Overall Study|Familial and Personal Reasons|5
395413|NCT00763451|1326704|P2|Overall Study|Familial and Personal Reasons|3
395414|NCT00763451|1326705|P1|Overall Study|Familial and Personal Reasons|5
395415|NCT00763451|1326702|P4|Overall Study|Poor Compliance to Protocol|2
395416|NCT00763451|1326703|P3|Overall Study|Poor Compliance to Protocol|2
395417|NCT00763451|1326704|P2|Overall Study|Poor Compliance to Protocol|1
395418|NCT00763451|1326705|P1|Overall Study|Poor Compliance to Protocol|1
395419|NCT00763451|1326702|P4|Overall Study|Protocol Violation|0
395420|NCT00763451|1326703|P3|Overall Study|Protocol Violation|1
395421|NCT00763451|1326704|P2|Overall Study|Protocol Violation|0
395422|NCT00763451|1326705|P1|Overall Study|Protocol Violation|0
395423|NCT00763451|1326702|P4|Overall Study|Withdrawal by Subject|7
395424|NCT00763451|1326703|P3|Overall Study|Withdrawal by Subject|9
395425|NCT00763451|1326704|P2|Overall Study|Withdrawal by Subject|6
395426|NCT00763451|1326705|P1|Overall Study|Withdrawal by Subject|1
395427|NCT00763451|1326702|P4|Overall Study|Lack of Efficacy|2
395428|NCT00763451|1326703|P3|Overall Study|Lack of Efficacy|3
395429|NCT00763451|1326704|P2|Overall Study|Lack of Efficacy|4
395430|NCT00763451|1326705|P1|Overall Study|Lack of Efficacy|1
395431|NCT00763451|1326702|P4|Overall Study|Adverse Event|14
395432|NCT00763451|1326703|P3|Overall Study|Adverse Event|19
395433|NCT00763451|1326704|P2|Overall Study|Adverse Event|6
395434|NCT00763451|1326705|P1|Overall Study|Adverse Event|4
395435|NCT00763386|1326764|P2|Overall Study|Study Prosthesis Removed|0
395436|NCT00763386|1326765|P1|Overall Study|Study Prosthesis Removed|1
395437|NCT00763386|1326764|P2|Overall Study|CRF missing|1
395438|NCT00763386|1326765|P1|Overall Study|CRF missing|0
395439|NCT00763386|1326764|P2|Overall Study|Withdrawal by Subject|1
395440|NCT00763386|1326765|P1|Overall Study|Withdrawal by Subject|0
395441|NCT00763386|1326764|P2|Overall Study|Lost to Follow-up|3
395442|NCT00763386|1326765|P1|Overall Study|Lost to Follow-up|3
395443|NCT00763386|1326764|P2|Overall Study|Death|2
395444|NCT00763386|1326765|P1|Overall Study|Death|1
395445|NCT00763386|1326764|P2|Overall Study|Adverse Event|33
395446|NCT00763386|1326765|P1|Overall Study|Adverse Event|43
395447|NCT00763321|1326798|P3|Double-blind Period|Not specified|3
395448|NCT00763321|1326799|P2|Double-blind Period|Not specified|2
395449|NCT00763321|1326800|P1|Double-blind Period|Not specified|0
395450|NCT00763321|1326798|P3|Double-blind Period|Withdrawal by Subject|3
395451|NCT00763321|1326799|P2|Double-blind Period|Withdrawal by Subject|2
395452|NCT00763321|1326800|P1|Double-blind Period|Withdrawal by Subject|0
395453|NCT00763321|1326798|P3|Double-blind Period|Lost to Follow-up|2
395454|NCT00763321|1326799|P2|Double-blind Period|Lost to Follow-up|4
395455|NCT00763321|1326800|P1|Double-blind Period|Lost to Follow-up|0
395456|NCT00763321|1326798|P3|Double-blind Period|Adverse Event|4
395457|NCT00763321|1326799|P2|Double-blind Period|Adverse Event|4
395458|NCT00763321|1326800|P1|Double-blind Period|Adverse Event|0
395459|NCT00763321|1326798|P3|Double-blind Period|Lack of Efficacy|17
395460|NCT00763321|1326799|P2|Double-blind Period|Lack of Efficacy|9
395461|NCT00763321|1326800|P1|Double-blind Period|Lack of Efficacy|0
395462|NCT00763321|1326798|P3|Open-label Period|Not specified|0
395463|NCT00763321|1326799|P2|Open-label Period|Not specified|0
395464|NCT00763321|1326800|P1|Open-label Period|Not specified|4
395465|NCT00763321|1326798|P3|Open-label Period|Lack of Efficacy|0
395466|NCT00763321|1326799|P2|Open-label Period|Lack of Efficacy|0
395467|NCT00763321|1326800|P1|Open-label Period|Lack of Efficacy|2
395468|NCT00763321|1326798|P3|Open-label Period|Did not meet DB randomization criteria|0
395469|NCT00763321|1326799|P2|Open-label Period|Did not meet DB randomization criteria|0
395470|NCT00763321|1326800|P1|Open-label Period|Did not meet DB randomization criteria|5
395471|NCT00763321|1326798|P3|Open-label Period|Subject noncompliant|0
395472|NCT00763321|1326799|P2|Open-label Period|Subject noncompliant|0
395473|NCT00763321|1326800|P1|Open-label Period|Subject noncompliant|7
395474|NCT00763321|1326798|P3|Open-label Period|Withdrawal by Subject|0
395475|NCT00763321|1326799|P2|Open-label Period|Withdrawal by Subject|0
395476|NCT00763321|1326800|P1|Open-label Period|Withdrawal by Subject|7
395477|NCT00763321|1326798|P3|Open-label Period|Lost to Follow-up|0
395478|NCT00763321|1326799|P2|Open-label Period|Lost to Follow-up|0
395479|NCT00763321|1326800|P1|Open-label Period|Lost to Follow-up|14
395480|NCT00763321|1326798|P3|Open-label Period|Adverse Event|0
395481|NCT00763321|1326799|P2|Open-label Period|Adverse Event|0
395482|NCT00763321|1326800|P1|Open-label Period|Adverse Event|24
395483|NCT00763282|1326811|P2|Overall Study|Lost to Follow-up|26
395484|NCT00763282|1326812|P1|Overall Study|Lost to Follow-up|22
395485|NCT00763282|1326811|P2|Overall Study|Death|3
395486|NCT00763282|1326812|P1|Overall Study|Death|4
395487|NCT00763282|1326811|P2|Overall Study|Withdrawal by Subject|5
395488|NCT00763282|1326812|P1|Overall Study|Withdrawal by Subject|6
395489|NCT00763269|1326828|P2|Overall Study|Lost to Follow-up|13
395490|NCT00763269|1326829|P1|Overall Study|Lost to Follow-up|12
395491|NCT00763256|1326843|P2|Overall Study|Didn't return for appointments|10
395492|NCT00763256|1326844|P1|Overall Study|Didn't return for appointments|7
395493|NCT00763139|1326880|P2|Overall Study|med change not allowed by protocol|0
395494|NCT00763139|1326881|P1|Overall Study|med change not allowed by protocol|1
395495|NCT00763139|1326880|P2|Overall Study|Withdrawal by Subject|1
395496|NCT00763139|1326881|P1|Overall Study|Withdrawal by Subject|0
395497|NCT00763139|1326880|P2|Overall Study|Adverse Event|2
395498|NCT00763139|1326881|P1|Overall Study|Adverse Event|4
395499|NCT00763009|1326943|P1|Overall Study|Coronary Anatomy unsuitable|1
395500|NCT00762996|1326948|P4|Period One|Withdrawal by Subject|0
395501|NCT00762996|1326949|P3|Period One|Withdrawal by Subject|1
395502|NCT00762996|1326950|P2|Period One|Withdrawal by Subject|0
395503|NCT00762996|1326951|P1|Period One|Withdrawal by Subject|0
395504|NCT00762996|1326948|P4|Period One|Adverse Event|0
395505|NCT00762996|1326949|P3|Period One|Adverse Event|1
395506|NCT00762996|1326950|P2|Period One|Adverse Event|0
395507|NCT00762996|1326951|P1|Period One|Adverse Event|0
395508|NCT00762996|1326948|P4|Period One|ineligible|1
395509|NCT00762996|1326949|P3|Period One|ineligible|1
395510|NCT00762996|1326950|P2|Period One|ineligible|0
395511|NCT00762996|1326951|P1|Period One|ineligible|0
395512|NCT00762996|1326948|P4|Period One|Protocol Violation|0
395513|NCT00762996|1326949|P3|Period One|Protocol Violation|1
395514|NCT00762996|1326950|P2|Period One|Protocol Violation|0
395515|NCT00762996|1326951|P1|Period One|Protocol Violation|0
395516|NCT00762970|1326964|P3|Overall Study|Difficulty of handling lens|0
395517|NCT00762970|1326965|P2|Overall Study|Difficulty of handling lens|2
395518|NCT00762970|1326966|P1|Overall Study|Difficulty of handling lens|1
395519|NCT00762970|1326964|P3|Overall Study|Lost to Follow-up|0
395520|NCT00762970|1326965|P2|Overall Study|Lost to Follow-up|2
395521|NCT00762970|1326966|P1|Overall Study|Lost to Follow-up|1
395522|NCT00762970|1326964|P3|Overall Study|Protocol Violation|1
395523|NCT00762970|1326965|P2|Overall Study|Protocol Violation|1
395524|NCT00762970|1326966|P1|Overall Study|Protocol Violation|3
395525|NCT00762970|1326964|P3|Overall Study|Withdrawal by Subject|0
395526|NCT00762970|1326965|P2|Overall Study|Withdrawal by Subject|4
395527|NCT00762970|1326966|P1|Overall Study|Withdrawal by Subject|7
395528|NCT00762892|1326984|P2|Overall Study|Incarceration|0
395529|NCT00762892|1326985|P1|Overall Study|Incarceration|1
395530|NCT00762892|1326984|P2|Overall Study|Pregnancy|0
395531|NCT00762892|1326985|P1|Overall Study|Pregnancy|1
395532|NCT00762892|1326984|P2|Overall Study|Death|0
395533|NCT00762892|1326985|P1|Overall Study|Death|1
395534|NCT00762892|1326984|P2|Overall Study|Withdrawal by Subject|1
395535|NCT00762892|1326985|P1|Overall Study|Withdrawal by Subject|0
395536|NCT00762892|1326984|P2|Overall Study|Lost to Follow-up|5
395537|NCT00762892|1326985|P1|Overall Study|Lost to Follow-up|2
395538|NCT00762788|1327014|P6|Overall Study|Lost to Follow-up|21
395539|NCT00762788|1327015|P5|Overall Study|Lost to Follow-up|13
395540|NCT00762788|1327016|P4|Overall Study|Lost to Follow-up|26
395541|NCT00762788|1327017|P3|Overall Study|Lost to Follow-up|21
395542|NCT00762788|1327018|P2|Overall Study|Lost to Follow-up|37
395543|NCT00762788|1327019|P1|Overall Study|Lost to Follow-up|26
395544|NCT00762762|1327041|P2|Overall Study|Did not report for appointments|10
395545|NCT00762762|1327042|P1|Overall Study|Did not report for appointments|8
395546|NCT00762723|1327059|P3|Overall Study|Study Terminated slow enrollement|3
395547|NCT00762723|1327060|P2|Overall Study|Study Terminated slow enrollement|5
395548|NCT00762723|1327061|P1|Overall Study|Study Terminated slow enrollement|5
395549|NCT00762606|1327225|P2|Overall Study|Lost to Follow-up|13
395550|NCT00762606|1327226|P1|Overall Study|Lost to Follow-up|18
395551|NCT00762502|1327271|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
395552|NCT00762502|1327272|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
395553|NCT00762502|1327273|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
395554|NCT00762502|1327271|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
395555|NCT00762502|1327272|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
395556|NCT00762502|1327273|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
395557|NCT00762502|1327271|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
395558|NCT00762502|1327272|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
395559|NCT00762502|1327273|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
395560|NCT00762476|1327287|P2|Overall Study|Seasonal allergies|0
395561|NCT00762476|1327288|P1|Overall Study|Seasonal allergies|1
395562|NCT00762476|1327287|P2|Overall Study|non-compliance with study visits|2
395563|NCT00762476|1327288|P1|Overall Study|non-compliance with study visits|0
395564|NCT00762476|1327287|P2|Overall Study|antibiotic use|1
395565|NCT00762476|1327288|P1|Overall Study|antibiotic use|0
395566|NCT00762476|1327287|P2|Overall Study|Withdrawal by Subject|12
395567|NCT00762476|1327288|P1|Overall Study|Withdrawal by Subject|6
395568|NCT00762476|1327287|P2|Overall Study|Physician Decision|14
395569|NCT00762476|1327288|P1|Overall Study|Physician Decision|2
395570|NCT00762476|1327287|P2|Overall Study|Protocol Violation|6
395571|NCT00762476|1327288|P1|Overall Study|Protocol Violation|5
395572|NCT00762476|1327287|P2|Overall Study|Lost to Follow-up|0
395573|NCT00762476|1327288|P1|Overall Study|Lost to Follow-up|2
395574|NCT00762476|1327287|P2|Overall Study|Adverse Event|1
395575|NCT00762476|1327288|P1|Overall Study|Adverse Event|7
395576|NCT00762463|1327300|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
395577|NCT00762463|1327301|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
395578|NCT00762463|1327302|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
395579|NCT00762463|1327303|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
395580|NCT00762463|1327300|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
395581|NCT00762463|1327301|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
395582|NCT00762463|1327302|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
395583|NCT00762463|1327303|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
395584|NCT00762463|1327300|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
395585|NCT00762463|1327301|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
395586|NCT00762463|1327302|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
395587|NCT00762463|1327303|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
395588|NCT00762463|1327300|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
395589|NCT00762463|1327301|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
395590|NCT00762463|1327302|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
395591|NCT00762463|1327303|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
395592|NCT00762463|1327300|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
395593|NCT00762463|1327301|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
395594|NCT00762463|1327302|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
395595|NCT00762463|1327303|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
395596|NCT00762463|1327300|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
395597|NCT00762463|1327301|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
395598|NCT00762463|1327302|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
395599|NCT00762463|1327303|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
395600|NCT00762463|1327300|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
395601|NCT00762463|1327301|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
395602|NCT00762463|1327302|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
395603|NCT00762463|1327303|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
395604|NCT00762463|1327300|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
395605|NCT00762463|1327301|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
395606|NCT00762463|1327302|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
395607|NCT00762463|1327303|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
395608|NCT00762411|1327409|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
395609|NCT00762411|1327410|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
395610|NCT00762411|1327409|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
395611|NCT00762411|1327410|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
395612|NCT00762411|1327409|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
395613|NCT00762411|1327410|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
395614|NCT00762411|1327409|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
395615|NCT00762411|1327410|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
395616|NCT00762411|1327409|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
395617|NCT00762411|1327410|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
395618|NCT00762411|1327409|P2|Safety Follow Up (SFU)-Optional|Death|8
395619|NCT00762411|1327410|P1|Safety Follow Up (SFU)-Optional|Death|1
395620|NCT00762411|1327409|P2|Delayed Start|Caregiver Decision|1
395621|NCT00762411|1327410|P1|Delayed Start|Caregiver Decision|1
395622|NCT00762411|1327409|P2|Delayed Start|Sponsor Decision|20
395623|NCT00762411|1327410|P1|Delayed Start|Sponsor Decision|16
395624|NCT00762411|1327409|P2|Delayed Start|Protocol Violation|1
395625|NCT00762411|1327410|P1|Delayed Start|Protocol Violation|0
395626|NCT00762411|1327409|P2|Delayed Start|Adverse Event|4
395627|NCT00762411|1327410|P1|Delayed Start|Adverse Event|0
395628|NCT00762411|1327409|P2|Initial Treatment|Entry Criteria Exclusion|1
395629|NCT00762411|1327410|P1|Initial Treatment|Entry Criteria Exclusion|0
395630|NCT00762411|1327409|P2|Initial Treatment|Abnormal Lab/ECG Result|4
395631|NCT00762411|1327410|P1|Initial Treatment|Abnormal Lab/ECG Result|6
395632|NCT00762411|1327409|P2|Initial Treatment|Caregiver Decision|16
395633|NCT00762411|1327410|P1|Initial Treatment|Caregiver Decision|21
395634|NCT00762411|1327409|P2|Initial Treatment|Lost to Follow-up|0
395635|NCT00762411|1327410|P1|Initial Treatment|Lost to Follow-up|5
395636|NCT00762411|1327409|P2|Initial Treatment|Sponsor Decision|401
395637|NCT00762411|1327410|P1|Initial Treatment|Sponsor Decision|293
395638|NCT00762411|1327409|P2|Initial Treatment|Physician Decision|0
395639|NCT00762411|1327410|P1|Initial Treatment|Physician Decision|1
395640|NCT00762411|1327409|P2|Initial Treatment|Withdrawal by Subject|52
395641|NCT00762411|1327410|P1|Initial Treatment|Withdrawal by Subject|65
395642|NCT00762411|1327409|P2|Initial Treatment|Protocol Violation|1
395643|NCT00762411|1327410|P1|Initial Treatment|Protocol Violation|4
395644|NCT00762411|1327409|P2|Initial Treatment|Adverse Event|40
395645|NCT00762411|1327410|P1|Initial Treatment|Adverse Event|132
395646|NCT00762411|1327409|P2|Initial Treatment|Death|6
395647|NCT00762411|1327410|P1|Initial Treatment|Death|7
395648|NCT00762385|1327474|P2|Second Intervention|Protocol Violation|3
395649|NCT00762385|1327475|P1|Second Intervention|Protocol Violation|3
395650|NCT00762385|1327474|P2|First Intervention|Protocol Violation|1
395651|NCT00762385|1327475|P1|First Intervention|Protocol Violation|0
395652|NCT00762385|1327474|P2|First Intervention|Ineligible|0
395653|NCT00762385|1327475|P1|First Intervention|Ineligible|1
395654|NCT00762385|1327474|P2|First Intervention|Lost to Follow-up|2
395655|NCT00762385|1327475|P1|First Intervention|Lost to Follow-up|0
395656|NCT00762385|1327474|P2|First Intervention|Lens Issue|1
395657|NCT00762385|1327475|P1|First Intervention|Lens Issue|1
395658|NCT00762359|1327487|P2|Overall Study|Withdrew consent|0
395659|NCT00762359|1327488|P1|Overall Study|Withdrew consent|1
395660|NCT00762359|1327487|P2|Overall Study|Removal|1
395661|NCT00762359|1327488|P1|Overall Study|Removal|0
395662|NCT00762359|1327487|P2|Overall Study|Physician Decision|3
395663|NCT00762359|1327488|P1|Overall Study|Physician Decision|2
395664|NCT00762359|1327487|P2|Overall Study|Institution closed|3
395665|NCT00762359|1327488|P1|Overall Study|Institution closed|2
395666|NCT00762359|1327487|P2|Overall Study|Lack of Efficacy|4
395667|NCT00762359|1327488|P1|Overall Study|Lack of Efficacy|0
395668|NCT00762359|1327487|P2|Overall Study|Withdrawal by Subject|10
395669|NCT00762359|1327488|P1|Overall Study|Withdrawal by Subject|13
395670|NCT00762359|1327487|P2|Overall Study|Protocol Violation|13
395671|NCT00762359|1327488|P1|Overall Study|Protocol Violation|21
395672|NCT00762359|1327487|P2|Overall Study|Adverse Event|23
395673|NCT00762359|1327488|P1|Overall Study|Adverse Event|20
395674|NCT00762268|1327605|P2|Overall Study|Protocol Violation|2
395675|NCT00762268|1327606|P1|Overall Study|Protocol Violation|1
395676|NCT00762229|1327614|P2|Overall Study|did not recveive intervention|1
395677|NCT00762229|1327615|P1|Overall Study|did not recveive intervention|0
395678|NCT00762229|1327614|P2|Overall Study|Lost to Follow-up|1
395679|NCT00762229|1327615|P1|Overall Study|Lost to Follow-up|1
395680|NCT00762164|1327712|P2|Overall Study|Withdrawal by Subject|1
395681|NCT00762164|1327713|P1|Overall Study|Withdrawal by Subject|0
395682|NCT00762164|1327712|P2|Overall Study|Discontinued medication|0
395683|NCT00762164|1327713|P1|Overall Study|Discontinued medication|2
395684|NCT00762164|1327712|P2|Overall Study|Lost to Follow-up|1
395685|NCT00762164|1327713|P1|Overall Study|Lost to Follow-up|1
395686|NCT00762086|1327723|P2|Overall Study|Ineligible to participate in the study|0
395687|NCT00762086|1327724|P1|Overall Study|Ineligible to participate in the study|1
395688|NCT00762086|1327723|P2|Overall Study|Withdrawal by Subject|2
395689|NCT00762086|1327724|P1|Overall Study|Withdrawal by Subject|2
395690|NCT00762086|1327723|P2|Overall Study|Non compliance|0
395691|NCT00762086|1327724|P1|Overall Study|Non compliance|1
395692|NCT00762086|1327723|P2|Overall Study|Lost to Follow-up|2
395693|NCT00762086|1327724|P1|Overall Study|Lost to Follow-up|0
395694|NCT00762086|1327723|P2|Overall Study|Adverse Event|0
395695|NCT00762086|1327724|P1|Overall Study|Adverse Event|2
395696|NCT00762073|1327734|P4|Overall Study|Not on treatment for >/= 77 days|0
395697|NCT00762073|1327735|P3|Overall Study|Not on treatment for >/= 77 days|0
395698|NCT00762073|1327736|P2|Overall Study|Not on treatment for >/= 77 days|0
395699|NCT00762073|1327737|P1|Overall Study|Not on treatment for >/= 77 days|1
395700|NCT00762073|1327734|P4|Overall Study|Withdrawal by Subject|1
395701|NCT00762073|1327735|P3|Overall Study|Withdrawal by Subject|1
395702|NCT00762073|1327736|P2|Overall Study|Withdrawal by Subject|2
395703|NCT00762073|1327737|P1|Overall Study|Withdrawal by Subject|1
395704|NCT00762073|1327734|P4|Overall Study|Significant Subject Noncompliance|1
395705|NCT00762073|1327735|P3|Overall Study|Significant Subject Noncompliance|0
395706|NCT00762073|1327736|P2|Overall Study|Significant Subject Noncompliance|1
395707|NCT00762073|1327737|P1|Overall Study|Significant Subject Noncompliance|0
395708|NCT00762073|1327734|P4|Overall Study|Adverse Event|1
395709|NCT00762073|1327735|P3|Overall Study|Adverse Event|1
395710|NCT00762073|1327736|P2|Overall Study|Adverse Event|0
395711|NCT00762073|1327737|P1|Overall Study|Adverse Event|1
395712|NCT00762073|1327734|P4|Overall Study|Lack of Efficacy|0
395713|NCT00762073|1327735|P3|Overall Study|Lack of Efficacy|0
395714|NCT00762073|1327736|P2|Overall Study|Lack of Efficacy|1
395715|NCT00762073|1327737|P1|Overall Study|Lack of Efficacy|1
395716|NCT00762034|1327801|P2|Maintenance Period|Other|1
395717|NCT00762034|1327802|P1|Maintenance Period|Other|1
395718|NCT00762034|1327801|P2|Maintenance Period|Death due to study disease|3
395719|NCT00762034|1327802|P1|Maintenance Period|Death due to study disease|3
395720|NCT00762034|1327801|P2|Maintenance Period|Death not due to study disease|5
395721|NCT00762034|1327802|P1|Maintenance Period|Death not due to study disease|2
395722|NCT00762034|1327801|P2|Maintenance Period|Withdrawal by Subject|14
395723|NCT00762034|1327802|P1|Maintenance Period|Withdrawal by Subject|34
395724|NCT00762034|1327801|P2|Maintenance Period|Physician Decision|20
395725|NCT00762034|1327802|P1|Maintenance Period|Physician Decision|25
395726|NCT00762034|1327801|P2|Maintenance Period|Progressive Disease|224
395727|NCT00762034|1327802|P1|Maintenance Period|Progressive Disease|186
395728|NCT00762034|1327801|P2|Maintenance Period|Adverse Event|26
395729|NCT00762034|1327802|P1|Maintenance Period|Adverse Event|42
395730|NCT00762034|1327801|P2|Maintenance Period|Entry Criterion Not Met|2
395731|NCT00762034|1327802|P1|Maintenance Period|Entry Criterion Not Met|0
395732|NCT00762034|1327801|P2|Maintenance Period|Protocol Violation|3
395733|NCT00762034|1327802|P1|Maintenance Period|Protocol Violation|1
395734|NCT00762034|1327801|P2|Induction Period|Deaths Due to Study Disease|9
395735|NCT00762034|1327802|P1|Induction Period|Deaths Due to Study Disease|9
395736|NCT00762034|1327801|P2|Induction Period|Deaths Not Due to Study Disease|14
395737|NCT00762034|1327802|P1|Induction Period|Deaths Not Due to Study Disease|19
395738|NCT00762034|1327801|P2|Induction Period|Withdrawal by Subject|19
395739|NCT00762034|1327802|P1|Induction Period|Withdrawal by Subject|15
395740|NCT00762034|1327801|P2|Induction Period|Physician Decision|20
395741|NCT00762034|1327802|P1|Induction Period|Physician Decision|21
395742|NCT00762034|1327801|P2|Induction Period|Progressive Disease|55
395743|NCT00762034|1327802|P1|Induction Period|Progressive Disease|73
395744|NCT00762034|1327801|P2|Induction Period|Lost to Follow-up|1
395745|NCT00762034|1327802|P1|Induction Period|Lost to Follow-up|1
395746|NCT00762034|1327801|P2|Induction Period|Adverse Event|38
395747|NCT00762034|1327802|P1|Induction Period|Adverse Event|27
395748|NCT00762034|1327801|P2|Induction Period|Entry Criterion Not Met|11
395749|NCT00762034|1327802|P1|Induction Period|Entry Criterion Not Met|12
395750|NCT00762034|1327801|P2|Induction Period|Protocol Violation|2
395751|NCT00762034|1327802|P1|Induction Period|Protocol Violation|1
395752|NCT00761969|1327874|P2|Overall Study|Lost to Follow-up|93
395753|NCT00761969|1327875|P1|Overall Study|Lost to Follow-up|88
395754|NCT00761969|1327874|P2|Overall Study|Death|47
395755|NCT00761969|1327875|P1|Overall Study|Death|112
395756|NCT00761956|1327885|P2|Overall Study|Adverse Event|34
395757|NCT00761956|1327886|P1|Overall Study|Adverse Event|26
395758|NCT00761956|1327885|P2|Overall Study|Death|1
395759|NCT00761956|1327886|P1|Overall Study|Death|0
395760|NCT00761956|1327885|P2|Overall Study|Withdrawal by Subject|8
395761|NCT00761956|1327886|P1|Overall Study|Withdrawal by Subject|3
395762|NCT00761956|1327885|P2|Overall Study|Lost to Follow-up|11
395763|NCT00761956|1327886|P1|Overall Study|Lost to Follow-up|6
395764|NCT00761865|1327915|P2|Overall Study|Lost to Follow-up|7
395765|NCT00761865|1327916|P1|Overall Study|Lost to Follow-up|8
395766|NCT00761774|1327937|P1|Overall Study|IP stopped by hospital physician|1
395767|NCT00761774|1327937|P1|Overall Study|Subject IP non-compliance|1
395768|NCT00761774|1327937|P1|Overall Study|Coordinator leaving site|1
395769|NCT00761774|1327937|P1|Overall Study|Patient moved out of study area|1
395770|NCT00761774|1327937|P1|Overall Study|Investigator clinical judgement|1
395771|NCT00761774|1327937|P1|Overall Study|Sponsor decision|1
395772|NCT00761774|1327937|P1|Overall Study|Medical decision to read SUSAR reports|1
395773|NCT00761774|1327937|P1|Overall Study|Reclassification of seizures|1
395774|NCT00761774|1327937|P1|Overall Study|End of study|2
395775|NCT00761774|1327937|P1|Overall Study|Non-compliance|4
395776|NCT00761774|1327937|P1|Overall Study|Withdrawal by Subject|9
395777|NCT00761774|1327937|P1|Overall Study|Lost to Follow-up|2
395778|NCT00761774|1327937|P1|Overall Study|Lack of Efficacy|37
395779|NCT00761774|1327937|P1|Overall Study|Adverse Event|17
395780|NCT00761761|1327948|P2|Overall Study|Withdrawal by Subject|0
395781|NCT00761761|1327949|P1|Overall Study|Withdrawal by Subject|3
395782|NCT00761761|1327948|P2|Overall Study|Lost to Follow-up|1
395783|NCT00761761|1327949|P1|Overall Study|Lost to Follow-up|3
395784|NCT00761748|1327961|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
395785|NCT00761748|1327962|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
395786|NCT00761748|1327961|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
395787|NCT00761748|1327962|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
395788|NCT00761735|1327968|P1|Overall Study|Administrative|1
395789|NCT00761735|1327968|P1|Overall Study|Non-compliance with protocol|1
395790|NCT00761735|1327968|P1|Overall Study|Withdrawal by Subject|6
395791|NCT00761735|1327968|P1|Overall Study|Lost to Follow-up|6
395792|NCT00761631|1327984|P6|Overall Study|Other|1
395793|NCT00761631|1327985|P5|Overall Study|Other|1
395794|NCT00761631|1327986|P4|Overall Study|Other|0
395795|NCT00761631|1327987|P3|Overall Study|Other|0
395796|NCT00761631|1327988|P2|Overall Study|Other|0
395797|NCT00761631|1327989|P1|Overall Study|Other|0
395798|NCT00761631|1327984|P6|Overall Study|Physician Decision|0
395799|NCT00761631|1327985|P5|Overall Study|Physician Decision|0
395800|NCT00761631|1327986|P4|Overall Study|Physician Decision|0
395801|NCT00761631|1327987|P3|Overall Study|Physician Decision|0
395802|NCT00761631|1327988|P2|Overall Study|Physician Decision|0
395803|NCT00761631|1327989|P1|Overall Study|Physician Decision|1
395804|NCT00761631|1327984|P6|Overall Study|Failed to return|2
395805|NCT00761631|1327985|P5|Overall Study|Failed to return|5
395806|NCT00761631|1327986|P4|Overall Study|Failed to return|1
395807|NCT00761631|1327987|P3|Overall Study|Failed to return|1
395808|NCT00761631|1327988|P2|Overall Study|Failed to return|0
395809|NCT00761631|1327989|P1|Overall Study|Failed to return|1
395810|NCT00761631|1327984|P6|Overall Study|Randomized, not treated|0
395811|NCT00761631|1327985|P5|Overall Study|Randomized, not treated|0
395812|NCT00761631|1327986|P4|Overall Study|Randomized, not treated|0
395813|NCT00761631|1327987|P3|Overall Study|Randomized, not treated|0
395814|NCT00761631|1327988|P2|Overall Study|Randomized, not treated|0
395815|NCT00761631|1327989|P1|Overall Study|Randomized, not treated|1
395816|NCT00761631|1327984|P6|Overall Study|Protocol Violation|1
395817|NCT00761631|1327985|P5|Overall Study|Protocol Violation|5
395818|NCT00761631|1327986|P4|Overall Study|Protocol Violation|1
395819|NCT00761631|1327987|P3|Overall Study|Protocol Violation|0
395820|NCT00761631|1327988|P2|Overall Study|Protocol Violation|0
395821|NCT00761631|1327989|P1|Overall Study|Protocol Violation|2
395822|NCT00761631|1327984|P6|Overall Study|Lost to Follow-up|1
395823|NCT00761631|1327985|P5|Overall Study|Lost to Follow-up|6
395824|NCT00761631|1327986|P4|Overall Study|Lost to Follow-up|1
395825|NCT00761631|1327987|P3|Overall Study|Lost to Follow-up|7
395826|NCT00761631|1327988|P2|Overall Study|Lost to Follow-up|4
395827|NCT00761631|1327989|P1|Overall Study|Lost to Follow-up|2
395828|NCT00761631|1327984|P6|Overall Study|Parent/legal guardian request|0
395829|NCT00761631|1327985|P5|Overall Study|Parent/legal guardian request|5
395830|NCT00761631|1327986|P4|Overall Study|Parent/legal guardian request|0
395831|NCT00761631|1327987|P3|Overall Study|Parent/legal guardian request|8
395832|NCT00761631|1327988|P2|Overall Study|Parent/legal guardian request|3
395833|NCT00761631|1327989|P1|Overall Study|Parent/legal guardian request|8
395834|NCT00761605|1328024|P1|Overall Study|Other|21
395835|NCT00761605|1328024|P1|Overall Study|Withdrawal by Subject|37
395836|NCT00761605|1328024|P1|Overall Study|Lost to Follow-up|29
395837|NCT00761605|1328024|P1|Overall Study|Lack of Efficacy|26
395838|NCT00761605|1328024|P1|Overall Study|Death|2
395839|NCT00761605|1328024|P1|Overall Study|Adverse Event|26
395840|NCT00761579|1328068|P1|Overall Study|Intake of prohibited concomitant drug|1
395841|NCT00761579|1328068|P1|Overall Study|Lost survey form|1
395842|NCT00761579|1328068|P1|Overall Study|Aggravation of symptoms by changing drug|1
395843|NCT00761579|1328068|P1|Overall Study|Aggravation of depression|1
395844|NCT00761579|1328068|P1|Overall Study|Drug overdose|1
395845|NCT00761579|1328068|P1|Overall Study|Protocol deviation|1
395846|NCT00761579|1328068|P1|Overall Study|Lack of compliance|2
395847|NCT00761579|1328068|P1|Overall Study|Withdrawal by Subject|34
395848|NCT00761579|1328068|P1|Overall Study|Pregnancy|1
395849|NCT00761579|1328068|P1|Overall Study|Lost to Follow-up|16
395850|NCT00761579|1328068|P1|Overall Study|Lack of Efficacy|21
395851|NCT00761579|1328068|P1|Overall Study|Death|2
395852|NCT00761579|1328068|P1|Overall Study|Adverse Event|10
395853|NCT00761527|1328101|P1|Overall Study|Unknown reason|2
395854|NCT00761527|1328101|P1|Overall Study|Lost to Follow-up|9
395855|NCT00761527|1328101|P1|Overall Study|Poor Compliance|8
395856|NCT00761527|1328101|P1|Overall Study|Adverse Event|3
395857|NCT00761514|1328108|P1|Overall Study|Unable to pay for medications|1
395858|NCT00761514|1328108|P1|Overall Study|Problem complying with study visit|1
395859|NCT00761514|1328108|P1|Overall Study|Health insurance didn't cover study drug|1
395860|NCT00761514|1328108|P1|Overall Study|Lost to Follow-up|1
395861|NCT00761514|1328108|P1|Overall Study|Withdrawal by Subject|2
395862|NCT00761514|1328108|P1|Overall Study|Adverse Event|1
395863|NCT00761462|1328115|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
395864|NCT00761462|1328116|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
395865|NCT00761462|1328115|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
395866|NCT00761462|1328116|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
395867|NCT00761462|1328115|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
395868|NCT00761462|1328116|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
395869|NCT00761462|1328115|P2|Treatment|Subjects never received study medication|12
395870|NCT00761462|1328116|P1|Treatment|Subjects never received study medication|23
395871|NCT00761319|1328130|P2|Overall Study|Missing|0
395872|NCT00761319|1328131|P1|Overall Study|Missing|1
395873|NCT00761319|1328130|P2|Overall Study|Nonspecified|2
395874|NCT00761319|1328131|P1|Overall Study|Nonspecified|2
395875|NCT00761319|1328130|P2|Overall Study|Lost to Follow-up|1
395876|NCT00761319|1328131|P1|Overall Study|Lost to Follow-up|1
395877|NCT00761319|1328130|P2|Overall Study|Noncompliance|3
395878|NCT00761319|1328131|P1|Overall Study|Noncompliance|4
395879|NCT00761319|1328130|P2|Overall Study|Withdrawal by Subject|7
395880|NCT00761319|1328131|P1|Overall Study|Withdrawal by Subject|8
395881|NCT00761319|1328130|P2|Overall Study|Adverse Event|7
395882|NCT00761319|1328131|P1|Overall Study|Adverse Event|11
395883|NCT00761319|1328130|P2|Overall Study|Protocol Violation|14
395884|NCT00761319|1328131|P1|Overall Study|Protocol Violation|21
395885|NCT00761306|1328139|P1|Overall Study|Administrative or Other Reasons|5
395886|NCT00761306|1328139|P1|Overall Study|Lost to Follow-up|1
395887|NCT00761306|1328139|P1|Overall Study|Withdrawal of Consent|3
395888|NCT00761306|1328139|P1|Overall Study|Protocol Violation|2
395889|NCT00761306|1328139|P1|Overall Study|Lack of Efficacy|4
395890|NCT00761306|1328139|P1|Overall Study|Adverse Event|5
395891|NCT00761280|1328150|P2|First Dose to End of Study|Lost to Follow-up|1
395892|NCT00761280|1328151|P1|First Dose to End of Study|Lost to Follow-up|0
395893|NCT00761280|1328150|P2|First Dose to End of Study|Death|0
395894|NCT00761280|1328151|P1|First Dose to End of Study|Death|1
395895|NCT00761280|1328150|P2|First Dose to End of Study|Sponsor decision|2
395896|NCT00761280|1328151|P1|First Dose to End of Study|Sponsor decision|1
395897|NCT00761280|1328150|P2|First Dose to End of Study|Progressive disease|3
395898|NCT00761280|1328151|P1|First Dose to End of Study|Progressive disease|5
395899|NCT00761280|1328150|P2|First Dose to End of Study|End of trial|5
395900|NCT00761280|1328151|P1|First Dose to End of Study|End of trial|5
395901|NCT00761280|1328150|P2|Randomization to First Dose|Other|0
395902|NCT00761280|1328151|P1|Randomization to First Dose|Other|1
395903|NCT00761280|1328150|P2|Randomization to First Dose|Sponsor decision|0
395904|NCT00761280|1328151|P1|Randomization to First Dose|Sponsor decision|1
395905|NCT00761280|1328150|P2|Randomization to First Dose|Withdrawal by Subject|2
395906|NCT00761280|1328151|P1|Randomization to First Dose|Withdrawal by Subject|0
395907|NCT00761215|1328182|P3|Overall Study|Bacteremia|0
395908|NCT00761215|1328183|P2|Overall Study|Bacteremia|0
395909|NCT00761215|1328184|P1|Overall Study|Bacteremia|1
395910|NCT00761215|1328182|P3|Overall Study|Withdrawal by Subject|0
395911|NCT00761215|1328183|P2|Overall Study|Withdrawal by Subject|0
395912|NCT00761215|1328184|P1|Overall Study|Withdrawal by Subject|1
395913|NCT00761215|1328182|P3|Overall Study|Lost to Follow-up|6
395914|NCT00761215|1328183|P2|Overall Study|Lost to Follow-up|3
395915|NCT00761215|1328184|P1|Overall Study|Lost to Follow-up|6
395916|NCT00761215|1328182|P3|Overall Study|Randomized but didn't receive drug|2
395917|NCT00761215|1328183|P2|Overall Study|Randomized but didn't receive drug|1
395918|NCT00761215|1328184|P1|Overall Study|Randomized but didn't receive drug|1
395919|NCT00761189|1328226|P1|Overall Study|Other|13
395920|NCT00761189|1328226|P1|Overall Study|Withdrawal by Subject|49
395921|NCT00761189|1328226|P1|Overall Study|Lost to Follow-up|36
395922|NCT00761189|1328226|P1|Overall Study|Lack of Efficacy|45
395923|NCT00761189|1328226|P1|Overall Study|Adverse Event|42
395924|NCT00761176|1328243|P2|Overall Study|Withdrawal by Subject|1
395925|NCT00761176|1328244|P1|Overall Study|Withdrawal by Subject|1
395926|NCT00761176|1328243|P2|Overall Study|Death|0
395927|NCT00761176|1328244|P1|Overall Study|Death|1
395928|NCT00761150|1328253|P3|Double-blind Period|Not specified|3
395929|NCT00761150|1328254|P2|Double-blind Period|Not specified|3
395930|NCT00761150|1328255|P1|Double-blind Period|Not specified|0
395931|NCT00761150|1328253|P3|Double-blind Period|Noncompliance|0
395932|NCT00761150|1328254|P2|Double-blind Period|Noncompliance|1
395933|NCT00761150|1328255|P1|Double-blind Period|Noncompliance|0
395934|NCT00761150|1328253|P3|Double-blind Period|Did not meet DB randomization criteria|1
395935|NCT00761150|1328254|P2|Double-blind Period|Did not meet DB randomization criteria|0
395936|NCT00761150|1328255|P1|Double-blind Period|Did not meet DB randomization criteria|0
395937|NCT00761150|1328253|P3|Double-blind Period|Lost to Follow-up|1
395938|NCT00761150|1328254|P2|Double-blind Period|Lost to Follow-up|2
395939|NCT00761150|1328255|P1|Double-blind Period|Lost to Follow-up|0
395940|NCT00761150|1328253|P3|Double-blind Period|Withdrawal by Subject|2
395941|NCT00761150|1328254|P2|Double-blind Period|Withdrawal by Subject|3
395942|NCT00761150|1328255|P1|Double-blind Period|Withdrawal by Subject|0
395943|NCT00761150|1328253|P3|Double-blind Period|Adverse Event|3
395944|NCT00761150|1328254|P2|Double-blind Period|Adverse Event|3
395945|NCT00761150|1328255|P1|Double-blind Period|Adverse Event|0
395946|NCT00761150|1328253|P3|Double-blind Period|Lack of Efficacy|19
395947|NCT00761150|1328254|P2|Double-blind Period|Lack of Efficacy|2
395948|NCT00761150|1328255|P1|Double-blind Period|Lack of Efficacy|0
395949|NCT00761150|1328253|P3|Open-label Period|Not specified|0
395950|NCT00761150|1328254|P2|Open-label Period|Not specified|0
395951|NCT00761150|1328255|P1|Open-label Period|Not specified|5
395952|NCT00761150|1328253|P3|Open-label Period|Noncompliance|0
395953|NCT00761150|1328254|P2|Open-label Period|Noncompliance|0
395954|NCT00761150|1328255|P1|Open-label Period|Noncompliance|2
395955|NCT00761150|1328253|P3|Open-label Period|Withdrawal by Subject|0
395956|NCT00761150|1328254|P2|Open-label Period|Withdrawal by Subject|0
395957|NCT00761150|1328255|P1|Open-label Period|Withdrawal by Subject|5
395958|NCT00761150|1328253|P3|Open-label Period|Lack of Efficacy|0
395959|NCT00761150|1328254|P2|Open-label Period|Lack of Efficacy|0
395960|NCT00761150|1328255|P1|Open-label Period|Lack of Efficacy|4
395961|NCT00761150|1328253|P3|Open-label Period|Lost to Follow-up|0
395962|NCT00761150|1328254|P2|Open-label Period|Lost to Follow-up|0
395963|NCT00761150|1328255|P1|Open-label Period|Lost to Follow-up|7
395964|NCT00761150|1328253|P3|Open-label Period|Did not meet DB randomization criteria|0
395965|NCT00761150|1328254|P2|Open-label Period|Did not meet DB randomization criteria|0
395966|NCT00761150|1328255|P1|Open-label Period|Did not meet DB randomization criteria|11
395967|NCT00761150|1328253|P3|Open-label Period|Adverse Event|0
395968|NCT00761150|1328254|P2|Open-label Period|Adverse Event|0
395969|NCT00761150|1328255|P1|Open-label Period|Adverse Event|36
395970|NCT00760877|1328306|P2|Overall Study|Treatment failure|0
395971|NCT00760877|1328307|P1|Overall Study|Treatment failure|1
395972|NCT00760877|1328306|P2|Overall Study|Participants transferred to AMN107A2408|1
395973|NCT00760877|1328307|P1|Overall Study|Participants transferred to AMN107A2408|11
395974|NCT00760877|1328306|P2|Overall Study|Physician Decision|2
395975|NCT00760877|1328307|P1|Overall Study|Physician Decision|1
395976|NCT00760877|1328306|P2|Overall Study|Participant not eligible to cross-over|1
395977|NCT00760877|1328307|P1|Overall Study|Participant not eligible to cross-over|0
395978|NCT00760877|1328306|P2|Overall Study|Participant diagnosed with AML|1
395979|NCT00760877|1328307|P1|Overall Study|Participant diagnosed with AML|0
395980|NCT00760877|1328306|P2|Overall Study|Adverse Event|12
395981|NCT00760877|1328307|P1|Overall Study|Adverse Event|19
395982|NCT00760877|1328306|P2|Overall Study|Withdrawal by Subject|3
395983|NCT00760877|1328307|P1|Overall Study|Withdrawal by Subject|7
395984|NCT00760877|1328306|P2|Overall Study|Death|1
395985|NCT00760877|1328307|P1|Overall Study|Death|2
395986|NCT00760877|1328306|P2|Overall Study|Pregnancy|4
395987|NCT00760877|1328307|P1|Overall Study|Pregnancy|1
395988|NCT00760877|1328306|P2|Overall Study|Non-compliance with protocol treatment|1
395989|NCT00760877|1328307|P1|Overall Study|Non-compliance with protocol treatment|2
395990|NCT00760877|1328306|P2|Overall Study|Protocol Violation|0
395991|NCT00760877|1328307|P1|Overall Study|Protocol Violation|1
395992|NCT00760838|1328325|P2|Overall Study|Withdrawal by Subject|1
395993|NCT00760838|1328326|P1|Overall Study|Withdrawal by Subject|1
395994|NCT00760838|1328325|P2|Overall Study|Lost to Follow-up|0
395995|NCT00760838|1328326|P1|Overall Study|Lost to Follow-up|2
395996|NCT00760838|1328325|P2|Overall Study|Lack of Efficacy|0
395997|NCT00760838|1328326|P1|Overall Study|Lack of Efficacy|1
395998|NCT00760838|1328325|P2|Overall Study|Adverse Event|1
395999|NCT00760838|1328326|P1|Overall Study|Adverse Event|1
396000|NCT00760747|1328344|P2|Study Period III|Physician Decision|1
396001|NCT00760747|1328345|P1|Study Period III|Physician Decision|0
396002|NCT00760747|1328344|P2|Study Period III|Protocol Violation|1
396003|NCT00760747|1328345|P1|Study Period III|Protocol Violation|1
396004|NCT00760747|1328344|P2|Study Period III|Parent/Caregiver Decision|1
396005|NCT00760747|1328345|P1|Study Period III|Parent/Caregiver Decision|0
396006|NCT00760747|1328344|P2|Study Period III|Lack of Efficacy|0
396007|NCT00760747|1328345|P1|Study Period III|Lack of Efficacy|1
396008|NCT00760747|1328344|P2|Study Period III|Adverse Event|0
396009|NCT00760747|1328345|P1|Study Period III|Adverse Event|1
396010|NCT00760747|1328344|P2|Study Period II|No drug administered|1
396011|NCT00760747|1328345|P1|Study Period II|No drug administered|0
396012|NCT00760747|1328344|P2|Study Period II|Withdrawal by Subject|0
396013|NCT00760747|1328345|P1|Study Period II|Withdrawal by Subject|1
396014|NCT00760747|1328344|P2|Study Period II|Protocol Violation|3
396015|NCT00760747|1328345|P1|Study Period II|Protocol Violation|6
396016|NCT00760747|1328344|P2|Study Period II|Parent/Caregiver Decision|0
396017|NCT00760747|1328345|P1|Study Period II|Parent/Caregiver Decision|3
396018|NCT00760747|1328344|P2|Study Period II|Lack of Efficacy|6
396019|NCT00760747|1328345|P1|Study Period II|Lack of Efficacy|0
396020|NCT00760747|1328344|P2|Study Period II|Adverse Event|4
396021|NCT00760747|1328345|P1|Study Period II|Adverse Event|3
396022|NCT00760669|1328373|P1|Overall Study|Took drug before entering in contract|5
396023|NCT00760669|1328373|P1|Overall Study|Participants with overlapping cases|1
396024|NCT00760669|1328373|P1|Overall Study|Participants missing efficacy assessment|6
396025|NCT00760669|1328373|P1|Overall Study|Not assessed for overall improvement|18
396026|NCT00760617|1328390|P3|Overall Study|Lost to Follow-up|5
396027|NCT00760617|1328391|P2|Overall Study|Lost to Follow-up|0
396028|NCT00760617|1328392|P1|Overall Study|Lost to Follow-up|0
396029|NCT00760617|1328390|P3|Overall Study|Adverse Event|0
396030|NCT00760617|1328391|P2|Overall Study|Adverse Event|2
396031|NCT00760617|1328392|P1|Overall Study|Adverse Event|5
396032|NCT00760552|1328506|P2|Overall Study|Lost to Follow-up|10
396033|NCT00760552|1328507|P1|Overall Study|Lost to Follow-up|11
396034|NCT00760552|1328506|P2|Overall Study|Death|0
396035|NCT00760552|1328507|P1|Overall Study|Death|2
396036|NCT00760487|1328541|P1|Overall Study|Unilateral implantation|3
396037|NCT00760474|1328547|P2|Period 2 (P2)|Adverse Event|1
396038|NCT00760474|1328548|P1|Period 2 (P2)|Adverse Event|0
396039|NCT00760474|1328547|P2|Period 2 (P2)|Lost to Follow-up|0
396040|NCT00760474|1328548|P1|Period 2 (P2)|Lost to Follow-up|1
396041|NCT00760474|1328547|P2|Placebo Washout Period|Other|1
396042|NCT00760474|1328548|P1|Placebo Washout Period|Other|0
396043|NCT00760474|1328547|P2|Period 1 (P1)|Discontinued then re-entered|1
396044|NCT00760474|1328548|P1|Period 1 (P1)|Discontinued then re-entered|1
396045|NCT00760383|1328605|P2|Overall Study|moved away; withdrew; medical reasons|7
396046|NCT00760383|1328606|P1|Overall Study|moved away; withdrew; medical reasons|5
396047|NCT00760266|1328618|P2|Overall Study|Administrative Problems|1
396048|NCT00760266|1328619|P1|Overall Study|Administrative Problems|0
396049|NCT00760266|1328618|P2|Overall Study|Lost to Follow-up|1
396050|NCT00760266|1328619|P1|Overall Study|Lost to Follow-up|2
396051|NCT00760266|1328618|P2|Overall Study|Patient withdrew consent|3
396052|NCT00760266|1328619|P1|Overall Study|Patient withdrew consent|3
396053|NCT00760266|1328618|P2|Overall Study|Protocol deviation|4
396054|NCT00760266|1328619|P1|Overall Study|Protocol deviation|2
396055|NCT00760266|1328618|P2|Overall Study|Lack of Efficacy|2
396056|NCT00760266|1328619|P1|Overall Study|Lack of Efficacy|2
396057|NCT00760266|1328618|P2|Overall Study|Abnormal test procedure result(s)|0
396058|NCT00760266|1328619|P1|Overall Study|Abnormal test procedure result(s)|1
396059|NCT00760266|1328618|P2|Overall Study|Abnormal laboratory value(s)|0
396060|NCT00760266|1328619|P1|Overall Study|Abnormal laboratory value(s)|1
396061|NCT00760266|1328618|P2|Overall Study|Adverse Event|7
396062|NCT00760266|1328619|P1|Overall Study|Adverse Event|13
396063|NCT00760214|1328636|P3|Overall Study|Other|6
396064|NCT00760214|1328637|P2|Overall Study|Other|4
396065|NCT00760214|1328638|P1|Overall Study|Other|3
396066|NCT00760214|1328636|P3|Overall Study|Physician Decision|1
396067|NCT00760214|1328637|P2|Overall Study|Physician Decision|1
396068|NCT00760214|1328638|P1|Overall Study|Physician Decision|1
396069|NCT00760214|1328636|P3|Overall Study|Pregnancy|1
396070|NCT00760214|1328637|P2|Overall Study|Pregnancy|0
396071|NCT00760214|1328638|P1|Overall Study|Pregnancy|0
396072|NCT00760214|1328636|P3|Overall Study|Lack of Efficacy|4
396073|NCT00760214|1328637|P2|Overall Study|Lack of Efficacy|2
396074|NCT00760214|1328638|P1|Overall Study|Lack of Efficacy|3
396075|NCT00760214|1328636|P3|Overall Study|Withdrawal by Subject|13
396076|NCT00760214|1328637|P2|Overall Study|Withdrawal by Subject|14
396077|NCT00760214|1328638|P1|Overall Study|Withdrawal by Subject|12
396078|NCT00760214|1328636|P3|Overall Study|Lost to Follow-up|1
396079|NCT00760214|1328637|P2|Overall Study|Lost to Follow-up|0
396080|NCT00760214|1328638|P1|Overall Study|Lost to Follow-up|0
396081|NCT00760214|1328636|P3|Overall Study|Protocol Violation|3
396082|NCT00760214|1328637|P2|Overall Study|Protocol Violation|0
396083|NCT00760214|1328638|P1|Overall Study|Protocol Violation|3
396084|NCT00760214|1328636|P3|Overall Study|Adverse Event|12
396085|NCT00760214|1328637|P2|Overall Study|Adverse Event|9
396086|NCT00760214|1328638|P1|Overall Study|Adverse Event|8
396087|NCT00760084|1328679|P1|Overall Study|Progressive Disease|3
396088|NCT00760084|1328679|P1|Overall Study|Withdrawal by Subject|2
396089|NCT00760084|1328679|P1|Overall Study|Physician Decision|5
396090|NCT00759954|1328722|P2|Overall Study|Adverse Event|2
396091|NCT00759954|1328723|P1|Overall Study|Adverse Event|1
396092|NCT00759954|1328722|P2|Overall Study|Personal reason|0
396093|NCT00759954|1328723|P1|Overall Study|Personal reason|1
396094|NCT00759941|1328737|P2|Overall Study|Exited in error by site|1
396095|NCT00759941|1328738|P1|Overall Study|Exited in error by site|1
396096|NCT00759941|1328737|P2|Overall Study|Adverse Event|0
396097|NCT00759941|1328738|P1|Overall Study|Adverse Event|1
396098|NCT00759941|1328737|P2|Overall Study|Use of medication|0
396099|NCT00759941|1328738|P1|Overall Study|Use of medication|1
396100|NCT00759915|1328752|P2|Overall Study|Adverse Event|1
396101|NCT00759915|1328753|P1|Overall Study|Adverse Event|0
396102|NCT00759915|1328752|P2|Overall Study|Withdrawal by Subject|0
396103|NCT00759915|1328753|P1|Overall Study|Withdrawal by Subject|1
396104|NCT00759902|1328767|P2|Overall Study|Adverse Event|1
396105|NCT00759902|1328768|P1|Overall Study|Adverse Event|0
396106|NCT00759863|1328782|P2|Overall Study|Death, moved, or lost contact|18
396107|NCT00759863|1328783|P1|Overall Study|Death, moved, or lost contact|20
396108|NCT00759785|1328804|P2|Overall Study|Withdrawal by Subject|1
396109|NCT00759785|1328805|P1|Overall Study|Withdrawal by Subject|0
396110|NCT00759785|1328804|P2|Overall Study|Physician Decision|1
396111|NCT00759785|1328805|P1|Overall Study|Physician Decision|0
396112|NCT00759785|1328804|P2|Overall Study|Protocol Violation|0
396113|NCT00759785|1328805|P1|Overall Study|Protocol Violation|1
396114|NCT00759785|1328804|P2|Overall Study|Participant sample lost|1
396115|NCT00759785|1328805|P1|Overall Study|Participant sample lost|0
396116|NCT00759785|1328804|P2|Overall Study|Participant sample not evaluable|2
396117|NCT00759785|1328805|P1|Overall Study|Participant sample not evaluable|11
396118|NCT00759759|1328828|P2|Overall Study|Withdrawal by Subject|1
396119|NCT00759759|1328829|P1|Overall Study|Withdrawal by Subject|2
396120|NCT00759759|1328828|P2|Overall Study|Didn't receive drug in period 2|0
396121|NCT00759759|1328829|P1|Overall Study|Didn't receive drug in period 2|1
396122|NCT00759759|1328828|P2|Overall Study|didn't return for period 2|0
396123|NCT00759759|1328829|P1|Overall Study|didn't return for period 2|1
396124|NCT00759681|1328847|P2|Overall Study|Lost to Follow-up|5
396125|NCT00759681|1328848|P1|Overall Study|Lost to Follow-up|8
396126|NCT00759681|1328847|P2|Overall Study|Death|5
396127|NCT00759681|1328848|P1|Overall Study|Death|2
396128|NCT00759655|1328875|P1|Overall Study|Termination of the study by sponsor|1
396129|NCT00759564|1328903|P5|Washout Period (at Least 14 Days)|Adverse Event|1
396130|NCT00759564|1328904|P4|Washout Period (at Least 14 Days)|Adverse Event|0
396131|NCT00759564|1328905|P3|Washout Period (at Least 14 Days)|Adverse Event|0
396132|NCT00759564|1328906|P2|Washout Period (at Least 14 Days)|Adverse Event|0
396133|NCT00759564|1328907|P1|Washout Period (at Least 14 Days)|Adverse Event|0
396134|NCT00759395|1329077|P2|Overall Study|Lack of Efficacy|2
396135|NCT00759395|1329078|P1|Overall Study|Lack of Efficacy|0
396136|NCT00759395|1329077|P2|Overall Study|Withdrawal by Subject|0
396137|NCT00759395|1329078|P1|Overall Study|Withdrawal by Subject|1
396138|NCT00759395|1329077|P2|Overall Study|Adverse Event|0
396139|NCT00759395|1329078|P1|Overall Study|Adverse Event|1
396140|NCT00759356|1329094|P2|Overall Study|Subject was unable to return|0
396141|NCT00759356|1329095|P1|Overall Study|Subject was unable to return|1
396142|NCT00759356|1329094|P2|Overall Study|Withdrawal by Subject|2
396143|NCT00759356|1329095|P1|Overall Study|Withdrawal by Subject|0
396144|NCT00759356|1329094|P2|Overall Study|Adverse Event|1
396145|NCT00759356|1329095|P1|Overall Study|Adverse Event|0
396146|NCT00759174|1329175|P2|Overall Study|Other|2
396147|NCT00759174|1329176|P1|Overall Study|Other|0
396148|NCT00759148|1329200|P2|Overall Study|Reason not given|0
396149|NCT00759148|1329201|P1|Overall Study|Reason not given|1
396150|NCT00759148|1329200|P2|Overall Study|Treatment Failure|10
396151|NCT00759148|1329201|P1|Overall Study|Treatment Failure|6
396152|NCT00759148|1329200|P2|Overall Study|Lost to Follow-up|9
396153|NCT00759148|1329201|P1|Overall Study|Lost to Follow-up|3
396154|NCT00759148|1329200|P2|Overall Study|Withdrawal by Subject|7
396155|NCT00759148|1329201|P1|Overall Study|Withdrawal by Subject|3
396156|NCT00759148|1329200|P2|Overall Study|Adverse Event|6
396157|NCT00759148|1329201|P1|Overall Study|Adverse Event|1
396158|NCT00759109|1329211|P2|Overall Study|Lost during study|0
396159|NCT00759109|1329212|P1|Overall Study|Lost during study|1
396160|NCT00759109|1329211|P2|Overall Study|Participant had a liver transplant|1
396161|NCT00759109|1329212|P1|Overall Study|Participant had a liver transplant|0
396162|NCT00759109|1329211|P2|Overall Study|Participant moved to a different city|1
396163|NCT00759109|1329212|P1|Overall Study|Participant moved to a different city|0
396164|NCT00759109|1329211|P2|Overall Study|HCV RNA negative|0
396165|NCT00759109|1329212|P1|Overall Study|HCV RNA negative|1
396166|NCT00759109|1329211|P2|Overall Study|Started new therapy|6
396167|NCT00759109|1329212|P1|Overall Study|Started new therapy|2
396168|NCT00759109|1329211|P2|Overall Study|Lost to Follow-up|6
396169|NCT00759109|1329212|P1|Overall Study|Lost to Follow-up|4
396170|NCT00759109|1329211|P2|Overall Study|Death|3
396171|NCT00759109|1329212|P1|Overall Study|Death|4
396172|NCT00759109|1329211|P2|Overall Study|Withdrawal by Subject|5
396173|NCT00759109|1329212|P1|Overall Study|Withdrawal by Subject|9
396174|NCT00759109|1329211|P2|Overall Study|Inability to comply|1
396175|NCT00759109|1329212|P1|Overall Study|Inability to comply|1
396176|NCT00759109|1329211|P2|Overall Study|Adverse Event|12
396177|NCT00759109|1329212|P1|Overall Study|Adverse Event|17
396178|NCT00759031|1329234|P2|First Intervention (1 Day)|Screening failure|0
396179|NCT00759031|1329235|P1|First Intervention (1 Day)|Screening failure|1
396180|NCT00759031|1329234|P2|First Intervention (1 Day)|Withdrawal by Subject|1
396181|NCT00759031|1329235|P1|First Intervention (1 Day)|Withdrawal by Subject|0
396182|NCT00759031|1329234|P2|First Intervention (1 Day)|Physician Decision|0
396183|NCT00759031|1329235|P1|First Intervention (1 Day)|Physician Decision|1
396184|NCT00758771|1329272|P2|Overall Study|Did not meet eligibility criteria|4
396185|NCT00758771|1329273|P1|Overall Study|Did not meet eligibility criteria|2
396186|NCT00758771|1329272|P2|Overall Study|Withdrawal by Subject|1
396187|NCT00758771|1329273|P1|Overall Study|Withdrawal by Subject|1
396188|NCT00758706|1329331|P2|Overall Study|Adverse Event|4
396189|NCT00758706|1329332|P1|Overall Study|Adverse Event|4
396190|NCT00758680|1329368|P10|Overall Study|Withdrawal by Subject|0
396191|NCT00758680|1329369|P9|Overall Study|Withdrawal by Subject|1
396192|NCT00758680|1329370|P8|Overall Study|Withdrawal by Subject|0
396193|NCT00758680|1329371|P7|Overall Study|Withdrawal by Subject|1
396194|NCT00758680|1329372|P6|Overall Study|Withdrawal by Subject|0
396195|NCT00758680|1329373|P5|Overall Study|Withdrawal by Subject|0
396196|NCT00758680|1329374|P4|Overall Study|Withdrawal by Subject|0
396197|NCT00758680|1329375|P3|Overall Study|Withdrawal by Subject|0
396198|NCT00758680|1329376|P2|Overall Study|Withdrawal by Subject|0
396199|NCT00758680|1329377|P1|Overall Study|Withdrawal by Subject|0
396200|NCT00758680|1329368|P10|Overall Study|Laboratory Adverse Event|0
396201|NCT00758680|1329369|P9|Overall Study|Laboratory Adverse Event|1
396202|NCT00758680|1329370|P8|Overall Study|Laboratory Adverse Event|0
396203|NCT00758680|1329371|P7|Overall Study|Laboratory Adverse Event|0
396204|NCT00758680|1329372|P6|Overall Study|Laboratory Adverse Event|0
396205|NCT00758680|1329373|P5|Overall Study|Laboratory Adverse Event|0
396206|NCT00758680|1329374|P4|Overall Study|Laboratory Adverse Event|0
396207|NCT00758680|1329375|P3|Overall Study|Laboratory Adverse Event|0
396208|NCT00758680|1329376|P2|Overall Study|Laboratory Adverse Event|0
396209|NCT00758680|1329377|P1|Overall Study|Laboratory Adverse Event|0
396210|NCT00758680|1329368|P10|Overall Study|Adverse Event|1
396211|NCT00758680|1329369|P9|Overall Study|Adverse Event|0
396212|NCT00758680|1329370|P8|Overall Study|Adverse Event|1
396213|NCT00758680|1329371|P7|Overall Study|Adverse Event|0
396214|NCT00758680|1329372|P6|Overall Study|Adverse Event|0
396215|NCT00758680|1329373|P5|Overall Study|Adverse Event|0
396216|NCT00758680|1329374|P4|Overall Study|Adverse Event|0
396217|NCT00758680|1329375|P3|Overall Study|Adverse Event|0
396218|NCT00758680|1329376|P2|Overall Study|Adverse Event|0
396219|NCT00758680|1329377|P1|Overall Study|Adverse Event|0
396220|NCT00758602|1329430|P2|Overall Study|Reason not specified|3
396221|NCT00758602|1329431|P1|Overall Study|Reason not specified|3
396222|NCT00758602|1329430|P2|Overall Study|Death|1
396223|NCT00758602|1329431|P1|Overall Study|Death|0
396224|NCT00758602|1329430|P2|Overall Study|Protocol Violation|2
396225|NCT00758602|1329431|P1|Overall Study|Protocol Violation|0
396226|NCT00758602|1329430|P2|Overall Study|Withdrawal by Subject|3
396227|NCT00758602|1329431|P1|Overall Study|Withdrawal by Subject|1
396228|NCT00758602|1329430|P2|Overall Study|Lost to Follow-up|3
396229|NCT00758602|1329431|P1|Overall Study|Lost to Follow-up|4
396230|NCT00758602|1329430|P2|Overall Study|Adverse Event|10
396231|NCT00758602|1329431|P1|Overall Study|Adverse Event|11
396232|NCT00758589|1329457|P4|Overall Study|Palm stopped to work|1
396233|NCT00758589|1329458|P3|Overall Study|Palm stopped to work|0
396234|NCT00758589|1329459|P2|Overall Study|Palm stopped to work|0
396235|NCT00758589|1329460|P1|Overall Study|Palm stopped to work|0
396236|NCT00758589|1329457|P4|Overall Study|Withdrawal by Subject|1
396237|NCT00758589|1329458|P3|Overall Study|Withdrawal by Subject|1
396238|NCT00758589|1329459|P2|Overall Study|Withdrawal by Subject|1
396239|NCT00758589|1329460|P1|Overall Study|Withdrawal by Subject|0
396240|NCT00758589|1329457|P4|Overall Study|Adverse Event|4
396241|NCT00758589|1329458|P3|Overall Study|Adverse Event|5
396242|NCT00758589|1329459|P2|Overall Study|Adverse Event|2
396243|NCT00758589|1329460|P1|Overall Study|Adverse Event|3
396244|NCT00758498|1329553|P3|Overall Study|Noncompliance to study procedures|1
396245|NCT00758498|1329554|P2|Overall Study|Noncompliance to study procedures|0
396246|NCT00758498|1329555|P1|Overall Study|Noncompliance to study procedures|0
396247|NCT00758498|1329553|P3|Overall Study|Withdrawal by Subject|1
396248|NCT00758498|1329554|P2|Overall Study|Withdrawal by Subject|0
396249|NCT00758498|1329555|P1|Overall Study|Withdrawal by Subject|0
396250|NCT00758498|1329553|P3|Overall Study|Subject legally detained out of state|0
396251|NCT00758498|1329554|P2|Overall Study|Subject legally detained out of state|0
396252|NCT00758498|1329555|P1|Overall Study|Subject legally detained out of state|1
396253|NCT00758498|1329553|P3|Overall Study|Adverse Event|3
396254|NCT00758498|1329554|P2|Overall Study|Adverse Event|2
396255|NCT00758498|1329555|P1|Overall Study|Adverse Event|2
396256|NCT00758485|1329640|P2|Overall Study|Not Treated|2
396257|NCT00758485|1329641|P1|Overall Study|Not Treated|1
396258|NCT00758485|1329640|P2|Overall Study|Lost to Follow-up|1
396259|NCT00758485|1329641|P1|Overall Study|Lost to Follow-up|0
396260|NCT00758459|1329653|P2|Overall Study|Withdrawal by Subject|1
396261|NCT00758459|1329654|P1|Overall Study|Withdrawal by Subject|0
396262|NCT00758459|1329653|P2|Overall Study|Protocol Violation|1
396263|NCT00758459|1329654|P1|Overall Study|Protocol Violation|0
396264|NCT00758459|1329653|P2|Overall Study|Adverse Event|2
396265|NCT00758459|1329654|P1|Overall Study|Adverse Event|3
396266|NCT00758394|1329699|P4|3rd Intervention|Lost to Follow-up|1
396267|NCT00758394|1329700|P3|3rd Intervention|Lost to Follow-up|0
396268|NCT00758394|1329701|P2|3rd Intervention|Lost to Follow-up|0
396269|NCT00758394|1329702|P1|3rd Intervention|Lost to Follow-up|1
396270|NCT00758394|1329699|P4|2nd Intervention Order|Lost to Follow-up|0
396271|NCT00758394|1329700|P3|2nd Intervention Order|Lost to Follow-up|0
396272|NCT00758394|1329701|P2|2nd Intervention Order|Lost to Follow-up|1
396273|NCT00758394|1329702|P1|2nd Intervention Order|Lost to Follow-up|0
396274|NCT00758264|1329731|P3|Active Phase|Not specified|4
396275|NCT00758264|1329732|P2|Active Phase|Not specified|0
396276|NCT00758264|1329733|P1|Active Phase|Not specified|0
396277|NCT00758264|1329731|P3|Active Phase|Lost to Follow-up|0
396278|NCT00758264|1329732|P2|Active Phase|Lost to Follow-up|0
396279|NCT00758264|1329733|P1|Active Phase|Lost to Follow-up|1
396280|NCT00758264|1329731|P3|Active Phase|Withdrawal by Subject|1
396281|NCT00758264|1329732|P2|Active Phase|Withdrawal by Subject|0
396282|NCT00758264|1329733|P1|Active Phase|Withdrawal by Subject|0
396283|NCT00758160|1329792|P1|Overall Study|Withdrawal by Subject|8
396284|NCT00758160|1329792|P1|Overall Study|Protocol Violation|12
396285|NCT00758160|1329792|P1|Overall Study|Lost to Follow-up|14
396286|NCT00758160|1329792|P1|Overall Study|Lack of Efficacy|10
396287|NCT00758160|1329792|P1|Overall Study|Adverse Event|15
396288|NCT00758160|1329792|P1|Overall Study|Administration Problems|3
396289|NCT00758160|1329792|P1|Overall Study|No Longer Requires Study Medication|4
396290|NCT00758069|1329813|P3|Overall Study|Incorrect Study Drug|0
396291|NCT00758069|1329814|P2|Overall Study|Incorrect Study Drug|0
396292|NCT00758069|1329815|P1|Overall Study|Incorrect Study Drug|1
396293|NCT00758069|1329813|P3|Overall Study|Lack of Efficacy|1
396294|NCT00758069|1329814|P2|Overall Study|Lack of Efficacy|0
396295|NCT00758069|1329815|P1|Overall Study|Lack of Efficacy|0
396296|NCT00758043|1329830|P4|Overall Study|Other Reasons|5
396297|NCT00758043|1329831|P3|Overall Study|Other Reasons|0
396298|NCT00758043|1329832|P2|Overall Study|Other Reasons|1
396299|NCT00758043|1329833|P1|Overall Study|Other Reasons|0
396300|NCT00758043|1329830|P4|Overall Study|Non-Compliant With study Drug|1
396301|NCT00758043|1329831|P3|Overall Study|Non-Compliant With study Drug|0
396302|NCT00758043|1329832|P2|Overall Study|Non-Compliant With study Drug|0
396303|NCT00758043|1329833|P1|Overall Study|Non-Compliant With study Drug|0
396304|NCT00758043|1329830|P4|Overall Study|Required Prohibited Medication|3
396305|NCT00758043|1329831|P3|Overall Study|Required Prohibited Medication|1
396306|NCT00758043|1329832|P2|Overall Study|Required Prohibited Medication|0
396307|NCT00758043|1329833|P1|Overall Study|Required Prohibited Medication|0
396308|NCT00758043|1329830|P4|Overall Study|Withdrawal by Subject|4
396309|NCT00758043|1329831|P3|Overall Study|Withdrawal by Subject|1
396310|NCT00758043|1329832|P2|Overall Study|Withdrawal by Subject|1
396311|NCT00758043|1329833|P1|Overall Study|Withdrawal by Subject|0
396312|NCT00758043|1329830|P4|Overall Study|Lost to Follow-up|5
396313|NCT00758043|1329831|P3|Overall Study|Lost to Follow-up|2
396314|NCT00758043|1329832|P2|Overall Study|Lost to Follow-up|2
396315|NCT00758043|1329833|P1|Overall Study|Lost to Follow-up|0
396316|NCT00758043|1329830|P4|Overall Study|Refused Further Treatment|8
396317|NCT00758043|1329831|P3|Overall Study|Refused Further Treatment|5
396318|NCT00758043|1329832|P2|Overall Study|Refused Further Treatment|11
396319|NCT00758043|1329833|P1|Overall Study|Refused Further Treatment|0
396320|NCT00758043|1329830|P4|Overall Study|Lack of Efficacy|12
396321|NCT00758043|1329831|P3|Overall Study|Lack of Efficacy|18
396322|NCT00758043|1329832|P2|Overall Study|Lack of Efficacy|6
396323|NCT00758043|1329833|P1|Overall Study|Lack of Efficacy|0
396324|NCT00758043|1329830|P4|Overall Study|Adverse Event|62
396325|NCT00758043|1329831|P3|Overall Study|Adverse Event|12
396326|NCT00758043|1329832|P2|Overall Study|Adverse Event|20
396327|NCT00758043|1329833|P1|Overall Study|Adverse Event|1
396328|NCT00757848|1329861|P2|Overall Study|Incorrect enrolment|0
396329|NCT00757848|1329862|P1|Overall Study|Incorrect enrolment|1
396330|NCT00757848|1329861|P2|Overall Study|Adverse Event|2
396331|NCT00757848|1329862|P1|Overall Study|Adverse Event|1
396332|NCT00757848|1329861|P2|Overall Study|Voluntary discontinuation|0
396333|NCT00757848|1329862|P1|Overall Study|Voluntary discontinuation|1
396334|NCT00757783|1329931|P2|Overall Study|Other|2
396335|NCT00757783|1329932|P1|Overall Study|Other|1
396336|NCT00757783|1329931|P2|Overall Study|Withdrawal by Subject|1
396337|NCT00757783|1329932|P1|Overall Study|Withdrawal by Subject|2
396338|NCT00757783|1329931|P2|Overall Study|Protocol Violation|0
396339|NCT00757783|1329932|P1|Overall Study|Protocol Violation|1
396340|NCT00757783|1329931|P2|Overall Study|Lost to Follow-up|1
396341|NCT00757783|1329932|P1|Overall Study|Lost to Follow-up|1
396342|NCT00757783|1329931|P2|Overall Study|Adverse Event|2
396343|NCT00757783|1329932|P1|Overall Study|Adverse Event|0
396344|NCT00757705|1329968|P1|Overall Study|Other|18
396345|NCT00757705|1329968|P1|Overall Study|Non-compliant|9
396346|NCT00757705|1329968|P1|Overall Study|Ineligible to continue|8
396347|NCT00757705|1329968|P1|Overall Study|Insufficient Response|26
396348|NCT00757705|1329968|P1|Overall Study|Withdrawal by Subject|25
396349|NCT00757705|1329968|P1|Overall Study|Lost to Follow-up|16
396350|NCT00757705|1329968|P1|Overall Study|Adverse Event|19
396351|NCT00757627|1329997|P1|Overall Study|Other|1
396352|NCT00757627|1329997|P1|Overall Study|Withdrawal by Subject|27
396353|NCT00757627|1329997|P1|Overall Study|Lost to Follow-up|28
396354|NCT00757627|1329997|P1|Overall Study|Lack of Efficacy|10
396355|NCT00757627|1329997|P1|Overall Study|Adverse Event|15
396356|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|Not specified|0
396357|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|Not specified|1
396358|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
396359|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
396360|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
396361|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
396362|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
396363|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
396364|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
396365|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
396366|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
396367|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
396368|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
396369|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
396370|NCT00757588|1330132|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
396371|NCT00757588|1330133|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
396372|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|Not specified|1
396373|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|Not specified|0
396374|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
396375|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
396376|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
396377|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
396378|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
396379|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
396380|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|Death|0
396381|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|Death|1
396382|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
396383|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
396384|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
396385|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
396386|NCT00757588|1330132|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
396387|NCT00757588|1330133|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
396388|NCT00757237|1330174|P2|Overall Study|Other|2
396389|NCT00757237|1330175|P1|Overall Study|Other|0
396390|NCT00757237|1330174|P2|Overall Study|Safety or Tolerability|5
396391|NCT00757237|1330175|P1|Overall Study|Safety or Tolerability|3
396392|NCT00757237|1330174|P2|Overall Study|Withdrawal by Subject|12
396393|NCT00757237|1330175|P1|Overall Study|Withdrawal by Subject|8
396394|NCT00757237|1330174|P2|Overall Study|Physician Decision|3
396395|NCT00757237|1330175|P1|Overall Study|Physician Decision|2
396396|NCT00757237|1330174|P2|Overall Study|Protocol Violation|2
396397|NCT00757237|1330175|P1|Overall Study|Protocol Violation|0
396398|NCT00757237|1330174|P2|Overall Study|Lost to Follow-up|1
396399|NCT00757237|1330175|P1|Overall Study|Lost to Follow-up|0
396400|NCT00757172|1330203|P1|Overall Study|Progression|4
396401|NCT00757172|1330203|P1|Overall Study|Physician Decision|3
396402|NCT00757172|1330203|P1|Overall Study|Withdrawal by Subject|4
396403|NCT00757003|1330211|P1|Overall Study|Not implanted|1
396404|NCT00757003|1330211|P1|Overall Study|Surgically explanted|2
396405|NCT00757003|1330211|P1|Overall Study|Withdrawal by Subject|4
396406|NCT00757003|1330211|P1|Overall Study|Lost to Follow-up|9
396407|NCT00757003|1330211|P1|Overall Study|Death|33
396408|NCT00756938|1330258|P4|Optional Extension|Adverse Event|1
396409|NCT00756938|1330259|P3|Optional Extension|Adverse Event|0
396410|NCT00756938|1330260|P2|Optional Extension|Adverse Event|0
396411|NCT00756938|1330261|P1|Optional Extension|Adverse Event|0
396412|NCT00756938|1330258|P4|Optional Extension|Withdrawal by Subject|10
396413|NCT00756938|1330259|P3|Optional Extension|Withdrawal by Subject|0
396414|NCT00756938|1330260|P2|Optional Extension|Withdrawal by Subject|0
396415|NCT00756938|1330261|P1|Optional Extension|Withdrawal by Subject|0
396416|NCT00756938|1330258|P4|Optional Extension|Protocol Violation|1
396417|NCT00756938|1330259|P3|Optional Extension|Protocol Violation|0
396418|NCT00756938|1330260|P2|Optional Extension|Protocol Violation|0
396419|NCT00756938|1330261|P1|Optional Extension|Protocol Violation|0
396420|NCT00756938|1330258|P4|Optional Extension|Lost to Follow-up|1
396421|NCT00756938|1330259|P3|Optional Extension|Lost to Follow-up|0
396422|NCT00756938|1330260|P2|Optional Extension|Lost to Follow-up|0
396423|NCT00756938|1330261|P1|Optional Extension|Lost to Follow-up|0
396424|NCT00756938|1330258|P4|Optional Extension|Physician Decision|3
396425|NCT00756938|1330259|P3|Optional Extension|Physician Decision|0
396426|NCT00756938|1330260|P2|Optional Extension|Physician Decision|0
396427|NCT00756938|1330261|P1|Optional Extension|Physician Decision|0
396428|NCT00756938|1330258|P4|Optional Extension|Protocol-specific criteria met|9
396429|NCT00756938|1330259|P3|Optional Extension|Protocol-specific criteria met|0
396430|NCT00756938|1330260|P2|Optional Extension|Protocol-specific criteria met|0
396431|NCT00756938|1330261|P1|Optional Extension|Protocol-specific criteria met|0
396432|NCT00756938|1330258|P4|Optional Extension|End of Study|11
396433|NCT00756938|1330259|P3|Optional Extension|End of Study|0
396434|NCT00756938|1330260|P2|Optional Extension|End of Study|0
396435|NCT00756938|1330261|P1|Optional Extension|End of Study|0
396436|NCT00756938|1330258|P4|Optional Extension|Lack of Efficacy|1
396437|NCT00756938|1330259|P3|Optional Extension|Lack of Efficacy|0
396438|NCT00756938|1330260|P2|Optional Extension|Lack of Efficacy|0
396439|NCT00756938|1330261|P1|Optional Extension|Lack of Efficacy|0
396440|NCT00756938|1330258|P4|12-week Base Study|Lost to Follow-up|0
396441|NCT00756938|1330259|P3|12-week Base Study|Lost to Follow-up|0
396442|NCT00756938|1330260|P2|12-week Base Study|Lost to Follow-up|0
396443|NCT00756938|1330261|P1|12-week Base Study|Lost to Follow-up|1
396444|NCT00756938|1330258|P4|12-week Base Study|Protocol Violation|0
396445|NCT00756938|1330259|P3|12-week Base Study|Protocol Violation|1
396446|NCT00756938|1330260|P2|12-week Base Study|Protocol Violation|0
396447|NCT00756938|1330261|P1|12-week Base Study|Protocol Violation|0
396448|NCT00756938|1330258|P4|12-week Base Study|Protocol-specific Criteria Met|0
396449|NCT00756938|1330259|P3|12-week Base Study|Protocol-specific Criteria Met|1
396450|NCT00756938|1330260|P2|12-week Base Study|Protocol-specific Criteria Met|0
396451|NCT00756938|1330261|P1|12-week Base Study|Protocol-specific Criteria Met|1
396452|NCT00756886|1330289|P2|Overall Study|Ineligible|4
396453|NCT00756886|1330290|P1|Overall Study|Ineligible|9
396454|NCT00756886|1330289|P2|Overall Study|Lack of Efficacy|0
396455|NCT00756886|1330290|P1|Overall Study|Lack of Efficacy|1
396456|NCT00756886|1330289|P2|Overall Study|Adverse Event|3
396457|NCT00756886|1330290|P1|Overall Study|Adverse Event|0
396458|NCT00756886|1330289|P2|Overall Study|Lost to Follow-up|0
396459|NCT00756886|1330290|P1|Overall Study|Lost to Follow-up|1
396460|NCT00756730|1330298|P2|Overall Study|persistent low-level viremmia|1
396461|NCT00756730|1330299|P1|Overall Study|persistent low-level viremmia|0
396462|NCT00756730|1330298|P2|Overall Study|discontinued due to rash prior to week 4|1
396463|NCT00756730|1330299|P1|Overall Study|discontinued due to rash prior to week 4|0
396464|NCT00756574|1330332|P2|Overall Study|Lost to Follow-up|4
396465|NCT00756574|1330333|P1|Overall Study|Lost to Follow-up|4
396466|NCT00756574|1330332|P2|Overall Study|Withdrawal by Subject|7
396467|NCT00756574|1330333|P1|Overall Study|Withdrawal by Subject|9
396468|NCT00756470|1330377|P1|Overall Study|Adverse Event|4
396469|NCT00756470|1330377|P1|Overall Study|Withdrawal by Subject|1
396470|NCT00756457|1330384|P2|Overall Study|Lost to Follow-up|2
396471|NCT00756457|1330385|P1|Overall Study|Lost to Follow-up|1
396472|NCT00756444|1330415|P2|Overall Study|Ineligibility Determined|0
396473|NCT00756444|1330416|P1|Overall Study|Ineligibility Determined|1
396474|NCT00756444|1330415|P2|Overall Study|Disease Progression|7
396475|NCT00756444|1330416|P1|Overall Study|Disease Progression|2
396476|NCT00756444|1330415|P2|Overall Study|Death|4
396477|NCT00756444|1330416|P1|Overall Study|Death|5
396478|NCT00756444|1330415|P2|Overall Study|Lost to Follow-up|1
396479|NCT00756444|1330416|P1|Overall Study|Lost to Follow-up|0
396480|NCT00756444|1330415|P2|Overall Study|Withdrawal by Subject|8
396481|NCT00756444|1330416|P1|Overall Study|Withdrawal by Subject|6
396482|NCT00756444|1330415|P2|Overall Study|Adverse Event|1
396483|NCT00756444|1330416|P1|Overall Study|Adverse Event|1
396484|NCT00756314|1330427|P2|Overall Study|Lost to Follow-up|59
396485|NCT00756314|1330428|P1|Overall Study|Lost to Follow-up|2
396486|NCT00756275|1330444|P2|Overall Study|Withdrawal by Subject|7
396487|NCT00756275|1330445|P1|Overall Study|Withdrawal by Subject|4
396488|NCT00756275|1330444|P2|Overall Study|Lost to Follow-up|21
396489|NCT00756275|1330445|P1|Overall Study|Lost to Follow-up|25
396490|NCT00756002|1330497|P2|Double-Blind Treatment Period|Not Specified|2
396491|NCT00756002|1330498|P1|Double-Blind Treatment Period|Not Specified|2
396492|NCT00756002|1330497|P2|Double-Blind Treatment Period|Protocol Violation|5
396493|NCT00756002|1330498|P1|Double-Blind Treatment Period|Protocol Violation|6
396494|NCT00756002|1330497|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
396495|NCT00756002|1330498|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
396496|NCT00756002|1330497|P2|Double-Blind Treatment Period|Lost to Follow-up|1
396497|NCT00756002|1330498|P1|Double-Blind Treatment Period|Lost to Follow-up|0
396498|NCT00756002|1330497|P2|Double-Blind Treatment Period|Lack of Efficacy|1
396499|NCT00756002|1330498|P1|Double-Blind Treatment Period|Lack of Efficacy|1
396500|NCT00755937|1330592|P1|Observational Follow-up|Lost to Follow-up|148
396501|NCT00755937|1330592|P1|Recruitment|Unknown if infliximab received|164
396502|NCT00755846|1330619|P6|Overall Study|Participant Non-compliance|0
396503|NCT00755846|1330620|P5|Overall Study|Participant Non-compliance|1
396504|NCT00755846|1330621|P4|Overall Study|Participant Non-compliance|0
396505|NCT00755846|1330622|P3|Overall Study|Participant Non-compliance|0
396506|NCT00755846|1330623|P2|Overall Study|Participant Non-compliance|0
396507|NCT00755846|1330624|P1|Overall Study|Participant Non-compliance|0
396508|NCT00755846|1330619|P6|Overall Study|Administrative Error|0
396509|NCT00755846|1330620|P5|Overall Study|Administrative Error|0
396510|NCT00755846|1330621|P4|Overall Study|Administrative Error|0
396511|NCT00755846|1330622|P3|Overall Study|Administrative Error|0
396512|NCT00755846|1330623|P2|Overall Study|Administrative Error|1
396513|NCT00755846|1330624|P1|Overall Study|Administrative Error|0
396514|NCT00755846|1330619|P6|Overall Study|Physician Decision|1
396515|NCT00755846|1330620|P5|Overall Study|Physician Decision|0
396516|NCT00755846|1330621|P4|Overall Study|Physician Decision|1
396517|NCT00755846|1330622|P3|Overall Study|Physician Decision|0
396518|NCT00755846|1330623|P2|Overall Study|Physician Decision|3
396519|NCT00755846|1330624|P1|Overall Study|Physician Decision|1
396520|NCT00755846|1330619|P6|Overall Study|Hyperglycemic Rescue|7
396521|NCT00755846|1330620|P5|Overall Study|Hyperglycemic Rescue|8
396522|NCT00755846|1330621|P4|Overall Study|Hyperglycemic Rescue|8
396523|NCT00755846|1330622|P3|Overall Study|Hyperglycemic Rescue|5
396524|NCT00755846|1330623|P2|Overall Study|Hyperglycemic Rescue|7
396525|NCT00755846|1330624|P1|Overall Study|Hyperglycemic Rescue|21
396526|NCT00755846|1330619|P6|Overall Study|Withdrawal by Subject|1
396527|NCT00755846|1330620|P5|Overall Study|Withdrawal by Subject|0
396528|NCT00755846|1330621|P4|Overall Study|Withdrawal by Subject|2
396529|NCT00755846|1330622|P3|Overall Study|Withdrawal by Subject|5
396530|NCT00755846|1330623|P2|Overall Study|Withdrawal by Subject|3
396531|NCT00755846|1330624|P1|Overall Study|Withdrawal by Subject|2
396532|NCT00755846|1330619|P6|Overall Study|Lost to Follow-up|2
396533|NCT00755846|1330620|P5|Overall Study|Lost to Follow-up|4
396534|NCT00755846|1330621|P4|Overall Study|Lost to Follow-up|0
396535|NCT00755846|1330622|P3|Overall Study|Lost to Follow-up|1
396536|NCT00755846|1330623|P2|Overall Study|Lost to Follow-up|2
396537|NCT00755846|1330624|P1|Overall Study|Lost to Follow-up|0
396538|NCT00755846|1330619|P6|Overall Study|Protocol Violation|1
396539|NCT00755846|1330620|P5|Overall Study|Protocol Violation|1
396540|NCT00755846|1330621|P4|Overall Study|Protocol Violation|1
396541|NCT00755846|1330622|P3|Overall Study|Protocol Violation|1
396542|NCT00755846|1330623|P2|Overall Study|Protocol Violation|1
396543|NCT00755846|1330624|P1|Overall Study|Protocol Violation|1
396544|NCT00755846|1330619|P6|Overall Study|Adverse Event|2
396545|NCT00755846|1330620|P5|Overall Study|Adverse Event|3
396546|NCT00755846|1330621|P4|Overall Study|Adverse Event|1
396547|NCT00755846|1330622|P3|Overall Study|Adverse Event|0
396548|NCT00755846|1330623|P2|Overall Study|Adverse Event|0
396549|NCT00755846|1330624|P1|Overall Study|Adverse Event|0
396550|NCT00755807|1330724|P2|Open-label Extension Phase|Sponsor Decision|1
396551|NCT00755807|1330725|P1|Open-label Extension Phase|Sponsor Decision|0
396552|NCT00755807|1330724|P2|Open-label Extension Phase|Lost to Follow-up|0
396553|NCT00755807|1330725|P1|Open-label Extension Phase|Lost to Follow-up|2
396554|NCT00755807|1330724|P2|Open-label Extension Phase|Withdrawal by Subject|3
396555|NCT00755807|1330725|P1|Open-label Extension Phase|Withdrawal by Subject|1
396556|NCT00755807|1330724|P2|Open-label Extension Phase|Lack of Efficacy|3
396557|NCT00755807|1330725|P1|Open-label Extension Phase|Lack of Efficacy|3
396558|NCT00755807|1330724|P2|Open-label Extension Phase|Protocol Violation|2
396559|NCT00755807|1330725|P1|Open-label Extension Phase|Protocol Violation|5
396560|NCT00755807|1330724|P2|Open-label Extension Phase|Adverse Event|7
396561|NCT00755807|1330725|P1|Open-label Extension Phase|Adverse Event|7
396562|NCT00755807|1330724|P2|Acute Phase|Physician Decision|1
396563|NCT00755807|1330725|P1|Acute Phase|Physician Decision|0
396564|NCT00755807|1330724|P2|Acute Phase|Lack of Efficacy|1
396565|NCT00755807|1330725|P1|Acute Phase|Lack of Efficacy|0
396566|NCT00755807|1330724|P2|Acute Phase|Withdrawal by Subject|2
396567|NCT00755807|1330725|P1|Acute Phase|Withdrawal by Subject|1
396568|NCT00755807|1330724|P2|Acute Phase|Protocol Violation|3
396569|NCT00755807|1330725|P1|Acute Phase|Protocol Violation|1
396570|NCT00755807|1330724|P2|Acute Phase|Adverse Event|5
396571|NCT00755807|1330725|P1|Acute Phase|Adverse Event|16
396572|NCT00755716|1330805|P3|Overall Study|work schedule issues|1
396573|NCT00755716|1330806|P2|Overall Study|work schedule issues|1
396574|NCT00755716|1330807|P1|Overall Study|work schedule issues|0
396575|NCT00755716|1330805|P3|Overall Study|Lost to Follow-up|1
396576|NCT00755716|1330806|P2|Overall Study|Lost to Follow-up|3
396577|NCT00755716|1330807|P1|Overall Study|Lost to Follow-up|5
396578|NCT00755716|1330805|P3|Overall Study|Lack of Efficacy|0
396579|NCT00755716|1330806|P2|Overall Study|Lack of Efficacy|0
396580|NCT00755716|1330807|P1|Overall Study|Lack of Efficacy|2
396581|NCT00755716|1330805|P3|Overall Study|Adverse Event|1
396582|NCT00755716|1330806|P2|Overall Study|Adverse Event|4
396583|NCT00755716|1330807|P1|Overall Study|Adverse Event|1
396584|NCT00755417|1330821|P3|Overall Study|Not specified or missing data|12
396585|NCT00755417|1330822|P2|Overall Study|Not specified or missing data|18
396586|NCT00755417|1330823|P1|Overall Study|Not specified or missing data|9
396587|NCT00755417|1330821|P3|Overall Study|Withdrawal by Subject|12
396588|NCT00755417|1330822|P2|Overall Study|Withdrawal by Subject|12
396589|NCT00755417|1330823|P1|Overall Study|Withdrawal by Subject|12
396590|NCT00755417|1330821|P3|Overall Study|Lost to Follow-up|1
396591|NCT00755417|1330822|P2|Overall Study|Lost to Follow-up|0
396592|NCT00755417|1330823|P1|Overall Study|Lost to Follow-up|3
396593|NCT00755417|1330821|P3|Overall Study|Protocol Violation|1
396594|NCT00755417|1330822|P2|Overall Study|Protocol Violation|1
396595|NCT00755417|1330823|P1|Overall Study|Protocol Violation|2
396596|NCT00755417|1330821|P3|Overall Study|Lack of Efficacy|9
396597|NCT00755417|1330822|P2|Overall Study|Lack of Efficacy|4
396598|NCT00755417|1330823|P1|Overall Study|Lack of Efficacy|8
396599|NCT00755417|1330821|P3|Overall Study|Adverse Event|7
396600|NCT00755417|1330822|P2|Overall Study|Adverse Event|20
396601|NCT00755417|1330823|P1|Overall Study|Adverse Event|28
396602|NCT00755222|1330880|P2|Overall Study|Protocol Violation|0
396603|NCT00755222|1330881|P1|Overall Study|Protocol Violation|2
396604|NCT00755222|1330880|P2|Overall Study|Adverse Event|0
396605|NCT00755222|1330881|P1|Overall Study|Adverse Event|2
396606|NCT00755222|1330880|P2|Overall Study|Withdrawal by Subject|2
396607|NCT00755222|1330881|P1|Overall Study|Withdrawal by Subject|4
396608|NCT00755196|1330895|P1|Overall Study|Lack of Efficiency|1
396609|NCT00755196|1330895|P1|Overall Study|Lost to Follow-up|1
396610|NCT00755105|1330916|P3|Overall Study|Withdrawal by Subject|4
396611|NCT00755105|1330917|P2|Overall Study|Withdrawal by Subject|11
396612|NCT00755105|1330918|P1|Overall Study|Withdrawal by Subject|9
396613|NCT00755079|1330928|P2|Overall Study|Withdrawal by Subject|2
396614|NCT00755079|1330929|P1|Overall Study|Withdrawal by Subject|0
396615|NCT00755079|1330928|P2|Overall Study|Adverse Event|1
396616|NCT00755079|1330929|P1|Overall Study|Adverse Event|0
396617|NCT00755079|1330928|P2|Overall Study|Lost to Follow-up|3
396618|NCT00755079|1330929|P1|Overall Study|Lost to Follow-up|1
396619|NCT00754793|1330966|P2|Overall Study|voluntary withdrawn from study|1
396620|NCT00754793|1330967|P1|Overall Study|voluntary withdrawn from study|0
396621|NCT00754741|1330985|P3|Overall Study|Died or disenrolled|54
396622|NCT00754741|1330986|P2|Overall Study|Died or disenrolled|69
396623|NCT00754741|1330987|P1|Overall Study|Died or disenrolled|57
396624|NCT00754650|1331034|P1|Overall Study|Disease Progression|2
396625|NCT00754624|1331039|P1|Overall Study|Lost to Follow-up|3
396626|NCT00754624|1331039|P1|Overall Study|Various|12
396627|NCT00754624|1331039|P1|Overall Study|Withdrawal by Subject|28
396628|NCT00754624|1331039|P1|Overall Study|Protocol Violation|1
396629|NCT00754624|1331039|P1|Overall Study|Physician Decision|8
396630|NCT00754624|1331039|P1|Overall Study|Death|1
396631|NCT00754624|1331039|P1|Overall Study|Adverse Event|16
396632|NCT00754572|1331049|P1|Overall Study|Lost to Follow-up|1
396633|NCT00754572|1331049|P1|Overall Study|Administrative Reason|3
396634|NCT00754572|1331049|P1|Overall Study|Death|1
396635|NCT00754572|1331049|P1|Overall Study|Lack of Efficacy|2
396636|NCT00754572|1331049|P1|Overall Study|Withdrawal by Subject|3
396637|NCT00754572|1331049|P1|Overall Study|Protocol Violation|3
396638|NCT00754572|1331049|P1|Overall Study|Other|39
396639|NCT00754572|1331049|P1|Overall Study|Adverse Event|19
396640|NCT00754559|1331076|P1|Overall Study|Withdrawal by Subject|3
396641|NCT00754559|1331076|P1|Overall Study|Other|5
396642|NCT00754559|1331076|P1|Overall Study|Administrative reason|1
396643|NCT00754559|1331076|P1|Overall Study|Lost to Follow-up|2
396644|NCT00754559|1331076|P1|Overall Study|Lack of Efficacy|10
396645|NCT00754559|1331076|P1|Overall Study|Protocol Violation|11
396646|NCT00754559|1331076|P1|Overall Study|Adverse Event|15
396647|NCT00754442|1331176|P2|Overall Study|Withdrawal by Subject|3
396648|NCT00754442|1331177|P1|Overall Study|Withdrawal by Subject|5
396649|NCT00754390|1331184|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
396650|NCT00754390|1331184|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
396651|NCT00754390|1331184|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
396652|NCT00754390|1331184|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
396653|NCT00754338|1331206|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
396654|NCT00754338|1331207|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
396655|NCT00754338|1331208|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
396656|NCT00754338|1331209|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
396657|NCT00754338|1331206|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
396658|NCT00754338|1331207|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
396659|NCT00754338|1331208|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
396660|NCT00754338|1331209|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
396661|NCT00754325|1331241|P2|Initial Treatment|Disease Progression|35
396662|NCT00754325|1331242|P1|Initial Treatment|Disease Progression|35
396663|NCT00754325|1331241|P2|Initial Treatment|Sponsor Request|1
396664|NCT00754325|1331242|P1|Initial Treatment|Sponsor Request|0
396665|NCT00754325|1331241|P2|Initial Treatment|Physician Decision|0
396666|NCT00754325|1331242|P1|Initial Treatment|Physician Decision|2
396667|NCT00754325|1331241|P2|Initial Treatment|Withdrawal by Subject|2
396668|NCT00754325|1331242|P1|Initial Treatment|Withdrawal by Subject|2
396669|NCT00754325|1331241|P2|Initial Treatment|Adverse Event|6
396670|NCT00754325|1331242|P1|Initial Treatment|Adverse Event|7
396671|NCT00754325|1331241|P2|Initial Treatment|Continuing Active Treatment|5
396672|NCT00754325|1331242|P1|Initial Treatment|Continuing Active Treatment|4
396673|NCT00754234|1331261|P1|Overall Study|Withdrawal by Subject|3
396674|NCT00754065|1331347|P2|Overall Study|Reason not specified or unknown, etc.|27
396675|NCT00754065|1331348|P1|Overall Study|Reason not specified or unknown, etc.|21
396676|NCT00754065|1331347|P2|Overall Study|Pregnancy|0
396677|NCT00754065|1331348|P1|Overall Study|Pregnancy|6
396678|NCT00754065|1331347|P2|Overall Study|Withdrawal by Subject|5
396679|NCT00754065|1331348|P1|Overall Study|Withdrawal by Subject|4
396680|NCT00754065|1331347|P2|Overall Study|Protocol Violation|10
396681|NCT00754065|1331348|P1|Overall Study|Protocol Violation|12
396682|NCT00754065|1331347|P2|Overall Study|Lost to Follow-up|11
396683|NCT00754065|1331348|P1|Overall Study|Lost to Follow-up|7
396684|NCT00754065|1331347|P2|Overall Study|Adverse Event|25
396685|NCT00754065|1331348|P1|Overall Study|Adverse Event|19
396686|NCT00754065|1331347|P2|Overall Study|Never received treatment|2
396687|NCT00754065|1331348|P1|Overall Study|Never received treatment|12
396688|NCT00754052|1331588|P2|Overall Study|Study terminated by Sponsor|3
396689|NCT00754052|1331589|P1|Overall Study|Study terminated by Sponsor|5
396690|NCT00754013|1331603|P2|Overall Study|didn't return after study termed|4
396691|NCT00754013|1331604|P1|Overall Study|didn't return after study termed|3
396692|NCT00754013|1331603|P2|Overall Study|Lost to Follow-up|1
396693|NCT00754013|1331604|P1|Overall Study|Lost to Follow-up|1
396694|NCT00753922|1331638|P4|Overall Study|Discontinuation Due to Explantation|4
396695|NCT00753922|1331639|P3|Overall Study|Discontinuation Due to Explantation|14
396696|NCT00753922|1331640|P2|Overall Study|Discontinuation Due to Explantation|14
396697|NCT00753922|1331641|P1|Overall Study|Discontinuation Due to Explantation|14
396698|NCT00753922|1331638|P4|Overall Study|Death|1
396699|NCT00753922|1331639|P3|Overall Study|Death|2
396700|NCT00753922|1331640|P2|Overall Study|Death|23
396701|NCT00753922|1331641|P1|Overall Study|Death|2
396702|NCT00753922|1331638|P4|Overall Study|Patients Not Completing Visit|0
396703|NCT00753922|1331639|P3|Overall Study|Patients Not Completing Visit|1
396704|NCT00753922|1331640|P2|Overall Study|Patients Not Completing Visit|0
396705|NCT00753922|1331641|P1|Overall Study|Patients Not Completing Visit|11
396706|NCT00753922|1331638|P4|Overall Study|Patient Non-compliance|11
396707|NCT00753922|1331639|P3|Overall Study|Patient Non-compliance|14
396708|NCT00753922|1331640|P2|Overall Study|Patient Non-compliance|22
396709|NCT00753922|1331641|P1|Overall Study|Patient Non-compliance|55
396710|NCT00753922|1331638|P4|Overall Study|Withdrawal by Subject|2
396711|NCT00753922|1331639|P3|Overall Study|Withdrawal by Subject|4
396712|NCT00753922|1331640|P2|Overall Study|Withdrawal by Subject|11
396713|NCT00753922|1331641|P1|Overall Study|Withdrawal by Subject|9
396714|NCT00753922|1331638|P4|Overall Study|Lost to Follow-up|5
396715|NCT00753922|1331639|P3|Overall Study|Lost to Follow-up|28
396716|NCT00753922|1331640|P2|Overall Study|Lost to Follow-up|24
396717|NCT00753922|1331641|P1|Overall Study|Lost to Follow-up|155
396718|NCT00753896|1331671|P1|Overall Study|Entry Criteria Not Met|4
396719|NCT00753896|1331671|P1|Overall Study|Withdrawal by Subject|4
396720|NCT00753896|1331671|P1|Overall Study|Protocol Violation|1
396721|NCT00753896|1331671|P1|Overall Study|Lost to Follow-up|2
396722|NCT00753896|1331671|P1|Overall Study|Death|1
396723|NCT00753896|1331671|P1|Overall Study|Adverse Event|4
396724|NCT00753766|1331687|P2|Overall Study|Physician Decision|0
396725|NCT00753766|1331688|P1|Overall Study|Physician Decision|1
396726|NCT00753714|1331698|P2|Overall Study|not specified|5
396727|NCT00753714|1331699|P1|Overall Study|not specified|7
396728|NCT00753714|1331698|P2|Overall Study|Death|3
396729|NCT00753714|1331699|P1|Overall Study|Death|3
396730|NCT00753714|1331698|P2|Overall Study|Withdrawal by Subject|1
396731|NCT00753714|1331699|P1|Overall Study|Withdrawal by Subject|2
396732|NCT00753714|1331698|P2|Overall Study|Lost to Follow-up|1
396733|NCT00753714|1331699|P1|Overall Study|Lost to Follow-up|0
396734|NCT00753714|1331698|P2|Overall Study|Protocol Violation|0
396735|NCT00753714|1331699|P1|Overall Study|Protocol Violation|1
396736|NCT00753714|1331698|P2|Overall Study|Adverse Event|18
396737|NCT00753714|1331699|P1|Overall Study|Adverse Event|26
396738|NCT00753714|1331698|P2|Overall Study|Lack of Efficacy|34
396739|NCT00753714|1331699|P1|Overall Study|Lack of Efficacy|21
396740|NCT00753688|1331715|P2|Overall Study|Adverse Event|1
396741|NCT00753688|1331716|P1|Overall Study|Adverse Event|0
396742|NCT00753688|1331715|P2|Overall Study|Ongoing - in Follow-up|31
396743|NCT00753688|1331716|P1|Overall Study|Ongoing - in Follow-up|15
396744|NCT00753688|1331715|P2|Overall Study|Participant Withdrew Consent|2
396745|NCT00753688|1331716|P1|Overall Study|Participant Withdrew Consent|2
396746|NCT00753688|1331715|P2|Overall Study|Missing|9
396747|NCT00753688|1331716|P1|Overall Study|Missing|4
396748|NCT00753688|1331715|P2|Overall Study|Death|203
396749|NCT00753688|1331716|P1|Overall Study|Death|102
396750|NCT00753675|1331745|P3|Overall Study|Lost to Follow-up|0
396751|NCT00753675|1331746|P2|Overall Study|Lost to Follow-up|0
396752|NCT00753675|1331747|P1|Overall Study|Lost to Follow-up|1
396753|NCT00753675|1331745|P3|Overall Study|Withdrawal by Subject|0
396754|NCT00753675|1331746|P2|Overall Study|Withdrawal by Subject|1
396755|NCT00753675|1331747|P1|Overall Study|Withdrawal by Subject|0
396756|NCT00753675|1331745|P3|Overall Study|Objective progression of disease|35
396757|NCT00753675|1331746|P2|Overall Study|Objective progression of disease|35
396758|NCT00753675|1331747|P1|Overall Study|Objective progression of disease|35
396759|NCT00753675|1331745|P3|Overall Study|Adverse Event|4
396760|NCT00753675|1331746|P2|Overall Study|Adverse Event|9
396761|NCT00753675|1331747|P1|Overall Study|Adverse Event|11
396762|NCT00753675|1331745|P3|Overall Study|Death|4
396763|NCT00753675|1331746|P2|Overall Study|Death|2
396764|NCT00753675|1331747|P1|Overall Study|Death|1
396765|NCT00753675|1331745|P3|Overall Study|other reason|13
396766|NCT00753675|1331746|P2|Overall Study|other reason|12
396767|NCT00753675|1331747|P1|Overall Study|other reason|11
396768|NCT00753649|1331769|P2|Overall Study|Protocol Violation|0
396769|NCT00753649|1331770|P1|Overall Study|Protocol Violation|2
396770|NCT00753649|1331769|P2|Overall Study|Lost to follow-up-complete vaccination|0
396771|NCT00753649|1331770|P1|Overall Study|Lost to follow-up-complete vaccination|1
396772|NCT00753649|1331769|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
396773|NCT00753649|1331770|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
396774|NCT00753649|1331769|P2|Overall Study|Migrated/moved from study area|0
396775|NCT00753649|1331770|P1|Overall Study|Migrated/moved from study area|1
396776|NCT00753623|1331802|P2|Phase II (14 Days)|Physician Decision|1
396777|NCT00753623|1331803|P1|Phase II (14 Days)|Physician Decision|0
396778|NCT00753623|1331802|P2|Washout (7 Days)|Physician Decision|0
396779|NCT00753623|1331803|P1|Washout (7 Days)|Physician Decision|1
396780|NCT00753623|1331802|P2|Phase I (14 Days)|Adverse Event|1
396781|NCT00753623|1331803|P1|Phase I (14 Days)|Adverse Event|0
396782|NCT00753623|1331802|P2|Phase I (14 Days)|Physician Decision|2
396783|NCT00753623|1331803|P1|Phase I (14 Days)|Physician Decision|1
396784|NCT00753623|1331802|P2|Phase I (14 Days)|Withdrawal by Subject|1
396785|NCT00753623|1331803|P1|Phase I (14 Days)|Withdrawal by Subject|1
396786|NCT00753545|1331811|P2|Overall Study|Voluntary Discontinuation of Patient|3
396787|NCT00753545|1331812|P1|Overall Study|Voluntary Discontinuation of Patient|7
396788|NCT00753545|1331811|P2|Overall Study|Protocol Violation|0
396789|NCT00753545|1331812|P1|Overall Study|Protocol Violation|1
396790|NCT00753545|1331811|P2|Overall Study|Lost to Follow-up|3
396791|NCT00753545|1331812|P1|Overall Study|Lost to Follow-up|2
396792|NCT00753545|1331811|P2|Overall Study|Death|112
396793|NCT00753545|1331812|P1|Overall Study|Death|98
396794|NCT00753519|1331850|P2|Overall Study|Withdrawal by Subject|2
396795|NCT00753519|1331851|P1|Overall Study|Withdrawal by Subject|0
396796|NCT00753506|1331873|P2|Overall Study|Other reason|1
396797|NCT00753506|1331874|P1|Overall Study|Other reason|1
396798|NCT00753506|1331873|P2|Overall Study|Lost to Follow-up|0
396799|NCT00753506|1331874|P1|Overall Study|Lost to Follow-up|2
396800|NCT00753506|1331873|P2|Overall Study|Withdrawal by Subject|1
396801|NCT00753506|1331874|P1|Overall Study|Withdrawal by Subject|4
396802|NCT00753454|1331880|P1|Overall Study|Investigator Decision|1
396803|NCT00753454|1331880|P1|Overall Study|Withdrawal by Subject|5
396804|NCT00753454|1331880|P1|Overall Study|Lost to Follow-up|3
396805|NCT00753454|1331880|P1|Overall Study|Lack of Efficacy|1
396806|NCT00753454|1331880|P1|Overall Study|Adverse Event|4
396807|NCT00753415|1331914|P10|Part B|Disease progression|1
396808|NCT00753415|1331915|P9|Part B|Disease progression|2
396809|NCT00753415|1331916|P8|Part B|Disease progression|0
396810|NCT00753415|1331917|P7|Part B|Disease progression|0
396811|NCT00753415|1331918|P6|Part B|Disease progression|0
396812|NCT00753415|1331919|P5|Part B|Disease progression|0
396813|NCT00753415|1331920|P4|Part B|Disease progression|0
396814|NCT00753415|1331921|P3|Part B|Disease progression|0
396815|NCT00753415|1331922|P2|Part B|Disease progression|0
396816|NCT00753415|1331923|P1|Part B|Disease progression|0
396817|NCT00753415|1331914|P10|Part B|Lost to Follow-up|0
396818|NCT00753415|1331915|P9|Part B|Lost to Follow-up|1
396819|NCT00753415|1331916|P8|Part B|Lost to Follow-up|1
396820|NCT00753415|1331917|P7|Part B|Lost to Follow-up|0
396821|NCT00753415|1331918|P6|Part B|Lost to Follow-up|0
396822|NCT00753415|1331919|P5|Part B|Lost to Follow-up|0
396823|NCT00753415|1331920|P4|Part B|Lost to Follow-up|0
396824|NCT00753415|1331921|P3|Part B|Lost to Follow-up|0
396825|NCT00753415|1331922|P2|Part B|Lost to Follow-up|0
396826|NCT00753415|1331923|P1|Part B|Lost to Follow-up|0
396827|NCT00753415|1331914|P10|Part A|Withdrawal by Subject|0
396828|NCT00753415|1331915|P9|Part A|Withdrawal by Subject|0
396829|NCT00753415|1331916|P8|Part A|Withdrawal by Subject|0
396830|NCT00753415|1331917|P7|Part A|Withdrawal by Subject|0
396831|NCT00753415|1331918|P6|Part A|Withdrawal by Subject|0
396832|NCT00753415|1331919|P5|Part A|Withdrawal by Subject|0
396833|NCT00753415|1331920|P4|Part A|Withdrawal by Subject|0
396834|NCT00753415|1331921|P3|Part A|Withdrawal by Subject|1
396835|NCT00753415|1331922|P2|Part A|Withdrawal by Subject|0
396836|NCT00753415|1331923|P1|Part A|Withdrawal by Subject|0
396837|NCT00753415|1331914|P10|Part A|Disease progression|0
396838|NCT00753415|1331915|P9|Part A|Disease progression|0
396839|NCT00753415|1331916|P8|Part A|Disease progression|0
396840|NCT00753415|1331917|P7|Part A|Disease progression|0
396841|NCT00753415|1331918|P6|Part A|Disease progression|0
396842|NCT00753415|1331919|P5|Part A|Disease progression|0
396843|NCT00753415|1331920|P4|Part A|Disease progression|2
396844|NCT00753415|1331921|P3|Part A|Disease progression|1
396845|NCT00753415|1331922|P2|Part A|Disease progression|0
396846|NCT00753415|1331923|P1|Part A|Disease progression|1
396847|NCT00753272|1332013|P2|Overall Study|Other|1088
396848|NCT00753272|1332014|P1|Overall Study|Other|1104
396849|NCT00753272|1332013|P2|Overall Study|Lost to Follow-up|497
396850|NCT00753272|1332014|P1|Overall Study|Lost to Follow-up|491
396851|NCT00753272|1332013|P2|Overall Study|Withdrawal by Subject|2407
396852|NCT00753272|1332014|P1|Overall Study|Withdrawal by Subject|2481
396853|NCT00753272|1332013|P2|Overall Study|Protocol Violation|46
396854|NCT00753272|1332014|P1|Overall Study|Protocol Violation|28
396855|NCT00753272|1332013|P2|Overall Study|Adverse Event|869
396856|NCT00753272|1332014|P1|Overall Study|Adverse Event|878
396857|NCT00753012|1332095|P2|Overall Study|Confounded endpoint data|0
396858|NCT00753012|1332096|P1|Overall Study|Confounded endpoint data|1
396859|NCT00753012|1332095|P2|Overall Study|Lost to Follow-up|0
396860|NCT00753012|1332096|P1|Overall Study|Lost to Follow-up|4
396861|NCT00753012|1332095|P2|Overall Study|Withdrawal by Subject|1
396862|NCT00753012|1332096|P1|Overall Study|Withdrawal by Subject|0
396863|NCT00753012|1332095|P2|Overall Study|Adverse Event|0
396864|NCT00753012|1332096|P1|Overall Study|Adverse Event|2
396865|NCT00753012|1332095|P2|Overall Study|Ineligible, abnormal cardiac histo|0
396866|NCT00753012|1332096|P1|Overall Study|Ineligible, abnormal cardiac histo|1
396867|NCT00752986|1332109|P3|Overall Study|Protocol Violation|0
396868|NCT00752986|1332110|P2|Overall Study|Protocol Violation|0
396869|NCT00752986|1332111|P1|Overall Study|Protocol Violation|3
396870|NCT00752986|1332109|P3|Overall Study|Withdrawal by Subject|2
396871|NCT00752986|1332110|P2|Overall Study|Withdrawal by Subject|1
396872|NCT00752986|1332111|P1|Overall Study|Withdrawal by Subject|2
396873|NCT00752895|1332140|P2|Overall Study|Withdrawal by Subject|3
396874|NCT00752895|1332141|P1|Overall Study|Withdrawal by Subject|8
396875|NCT00752791|1332149|P1|Overall Study|Protocol deviation|1
396876|NCT00752791|1332149|P1|Overall Study|Switched to hemodialysis|2
396877|NCT00752791|1332149|P1|Overall Study|Renal transplant|3
396878|NCT00752791|1332149|P1|Overall Study|Death|1
396879|NCT00752791|1332149|P1|Overall Study|Physician Decision|1
396880|NCT00752791|1332149|P1|Overall Study|Withdrawal by Subject|1
396881|NCT00752791|1332149|P1|Overall Study|Adverse Event|7
396882|NCT00752726|1332161|P2|Overall Study|Other Reason|2
396883|NCT00752726|1332162|P1|Overall Study|Other Reason|1
396884|NCT00752726|1332161|P2|Overall Study|Withdrawal by Subject|10
396885|NCT00752726|1332162|P1|Overall Study|Withdrawal by Subject|5
396886|NCT00752726|1332161|P2|Overall Study|Adverse Event|0
396887|NCT00752726|1332162|P1|Overall Study|Adverse Event|3
396888|NCT00752726|1332161|P2|Overall Study|Lost to Follow-up|1
396889|NCT00752726|1332162|P1|Overall Study|Lost to Follow-up|2
396890|NCT00752622|1332187|P1|Interventional Phase|Premature Study Termination|5
396891|NCT00752622|1332187|P1|Interventional Phase|Physician Decision|1
396892|NCT00752622|1332187|P1|Interventional Phase|Non-responder|2
396893|NCT00752622|1332187|P1|Observational Phase|Other|2
396894|NCT00752622|1332187|P1|Observational Phase|Adverse Event|1
396895|NCT00752622|1332187|P1|Observational Phase|Withdrawal by Subject|2
396896|NCT00752622|1332187|P1|Observational Phase|Non-responder|2
396897|NCT00752622|1332187|P1|Observational Phase|Premature Study Termination|36
396898|NCT00752622|1332187|P1|Induction Phase|Premature study termination|14
396899|NCT00752622|1332187|P1|Induction Phase|Withdrawal by Subject|1
396900|NCT00752622|1332187|P1|Induction Phase|Non-responder|14
396901|NCT00752622|1332187|P1|Induction Phase|Other|3
396902|NCT00752622|1332187|P1|Induction Phase|Adverse Event|3
396903|NCT00752609|1332200|P2|Overall Study|Received Aranesp in error|0
396904|NCT00752609|1332201|P1|Overall Study|Received Aranesp in error|1
396905|NCT00752609|1332200|P2|Overall Study|Met exclusion criteria|0
396906|NCT00752609|1332201|P1|Overall Study|Met exclusion criteria|1
396907|NCT00752609|1332200|P2|Overall Study|Death|0
396908|NCT00752609|1332201|P1|Overall Study|Death|1
396909|NCT00752609|1332200|P2|Overall Study|Physician Decision|0
396910|NCT00752609|1332201|P1|Overall Study|Physician Decision|1
396911|NCT00752609|1332200|P2|Overall Study|Withdrawal by Subject|0
396912|NCT00752609|1332201|P1|Overall Study|Withdrawal by Subject|3
396913|NCT00752609|1332200|P2|Overall Study|Adverse Event|2
396914|NCT00752609|1332201|P1|Overall Study|Adverse Event|2
396915|NCT00752232|1332227|P7|Overall Study|Caregiver could not attend the subject|0
396916|NCT00752232|1332228|P6|Overall Study|Caregiver could not attend the subject|0
396917|NCT00752232|1332229|P5|Overall Study|Caregiver could not attend the subject|1
396918|NCT00752232|1332230|P4|Overall Study|Caregiver could not attend the subject|0
396919|NCT00752232|1332231|P3|Overall Study|Caregiver could not attend the subject|0
396920|NCT00752232|1332232|P2|Overall Study|Caregiver could not attend the subject|0
396921|NCT00752232|1332233|P1|Overall Study|Caregiver could not attend the subject|0
396922|NCT00752232|1332227|P7|Overall Study|Group home admission|0
396923|NCT00752232|1332228|P6|Overall Study|Group home admission|0
396924|NCT00752232|1332229|P5|Overall Study|Group home admission|0
396925|NCT00752232|1332230|P4|Overall Study|Group home admission|1
396926|NCT00752232|1332231|P3|Overall Study|Group home admission|0
396927|NCT00752232|1332232|P2|Overall Study|Group home admission|0
396928|NCT00752232|1332233|P1|Overall Study|Group home admission|0
396929|NCT00752232|1332227|P7|Overall Study|Subject request|0
396930|NCT00752232|1332228|P6|Overall Study|Subject request|0
396931|NCT00752232|1332229|P5|Overall Study|Subject request|0
396932|NCT00752232|1332230|P4|Overall Study|Subject request|0
396933|NCT00752232|1332231|P3|Overall Study|Subject request|1
396934|NCT00752232|1332232|P2|Overall Study|Subject request|0
396935|NCT00752232|1332233|P1|Overall Study|Subject request|0
396936|NCT00752232|1332227|P7|Overall Study|Investigator request|0
396937|NCT00752232|1332228|P6|Overall Study|Investigator request|0
396938|NCT00752232|1332229|P5|Overall Study|Investigator request|1
396939|NCT00752232|1332230|P4|Overall Study|Investigator request|0
396940|NCT00752232|1332231|P3|Overall Study|Investigator request|0
396941|NCT00752232|1332232|P2|Overall Study|Investigator request|0
396942|NCT00752232|1332233|P1|Overall Study|Investigator request|0
396943|NCT00752232|1332227|P7|Overall Study|Caregiver request|0
396944|NCT00752232|1332228|P6|Overall Study|Caregiver request|0
396945|NCT00752232|1332229|P5|Overall Study|Caregiver request|1
396946|NCT00752232|1332230|P4|Overall Study|Caregiver request|0
396947|NCT00752232|1332231|P3|Overall Study|Caregiver request|0
396948|NCT00752232|1332232|P2|Overall Study|Caregiver request|0
396949|NCT00752232|1332233|P1|Overall Study|Caregiver request|2
396950|NCT00752232|1332227|P7|Overall Study|Protocol Violation|0
396951|NCT00752232|1332228|P6|Overall Study|Protocol Violation|1
396952|NCT00752232|1332229|P5|Overall Study|Protocol Violation|0
396953|NCT00752232|1332230|P4|Overall Study|Protocol Violation|0
396954|NCT00752232|1332231|P3|Overall Study|Protocol Violation|0
396955|NCT00752232|1332232|P2|Overall Study|Protocol Violation|0
396956|NCT00752232|1332233|P1|Overall Study|Protocol Violation|0
396957|NCT00752128|1332305|P1|Overall Study|Withdrawal by Subject|4
396958|NCT00752089|1332319|P1|Overall Study|Cannot continue the study|1
396959|NCT00752089|1332319|P1|Overall Study|Not capable of wearing partial denture|1
396960|NCT00752089|1332319|P1|Overall Study|Could not attend visit 9|1
396961|NCT00752089|1332319|P1|Overall Study|Protocol Deviation|2
396962|NCT00752089|1332319|P1|Overall Study|Adverse Event|1
396963|NCT00751998|1332333|P1|Overall Study|Withdrawal by Subject|2
396964|NCT00751998|1332333|P1|Overall Study|Death|11
396965|NCT00751998|1332333|P1|Overall Study|Lost to Follow-up|7
396966|NCT00751933|1332352|P4|Overall Study|Physician Decision|1
396967|NCT00751933|1332353|P3|Overall Study|Physician Decision|1
396968|NCT00751933|1332354|P2|Overall Study|Physician Decision|0
396969|NCT00751933|1332355|P1|Overall Study|Physician Decision|0
396970|NCT00751933|1332352|P4|Overall Study|Withdrawal by Subject|0
396971|NCT00751933|1332353|P3|Overall Study|Withdrawal by Subject|0
396972|NCT00751933|1332354|P2|Overall Study|Withdrawal by Subject|1
396973|NCT00751933|1332355|P1|Overall Study|Withdrawal by Subject|0
396974|NCT00751881|1332363|P3|Extension Study Period|Other than specified above|18
396975|NCT00751881|1332364|P2|Extension Study Period|Other than specified above|30
396976|NCT00751881|1332365|P1|Extension Study Period|Other than specified above|26
396977|NCT00751881|1332363|P3|Extension Study Period|Poor Compliance to Protocol|1
396978|NCT00751881|1332364|P2|Extension Study Period|Poor Compliance to Protocol|2
396979|NCT00751881|1332365|P1|Extension Study Period|Poor Compliance to Protocol|3
396980|NCT00751881|1332363|P3|Extension Study Period|Lost to Follow-up|6
396981|NCT00751881|1332364|P2|Extension Study Period|Lost to Follow-up|9
396982|NCT00751881|1332365|P1|Extension Study Period|Lost to Follow-up|4
396983|NCT00751881|1332363|P3|Extension Study Period|Lack of Efficacy|20
396984|NCT00751881|1332364|P2|Extension Study Period|Lack of Efficacy|10
396985|NCT00751881|1332365|P1|Extension Study Period|Lack of Efficacy|14
396986|NCT00751881|1332363|P3|Extension Study Period|Adverse Event|21
396987|NCT00751881|1332364|P2|Extension Study Period|Adverse Event|20
396988|NCT00751881|1332365|P1|Extension Study Period|Adverse Event|18
396989|NCT00751881|1332363|P3|Core Treatment Period|Other:participant's decision/unspecified|16
396990|NCT00751881|1332364|P2|Core Treatment Period|Other:participant's decision/unspecified|22
396991|NCT00751881|1332365|P1|Core Treatment Period|Other:participant's decision/unspecified|19
396992|NCT00751881|1332363|P3|Core Treatment Period|Other: tolerability complaints|0
396993|NCT00751881|1332364|P2|Core Treatment Period|Other: tolerability complaints|0
396994|NCT00751881|1332365|P1|Core Treatment Period|Other: tolerability complaints|2
396995|NCT00751881|1332363|P3|Core Treatment Period|Other: MS treatment change|4
396996|NCT00751881|1332364|P2|Core Treatment Period|Other: MS treatment change|4
396997|NCT00751881|1332365|P1|Core Treatment Period|Other: MS treatment change|6
396998|NCT00751881|1332363|P3|Core Treatment Period|Other: personal/family constraints|10
396999|NCT00751881|1332364|P2|Core Treatment Period|Other: personal/family constraints|7
397000|NCT00751881|1332365|P1|Core Treatment Period|Other: personal/family constraints|6
397001|NCT00751881|1332363|P3|Core Treatment Period|Other: wish to parent|4
397002|NCT00751881|1332364|P2|Core Treatment Period|Other: wish to parent|7
397003|NCT00751881|1332365|P1|Core Treatment Period|Other: wish to parent|5
397004|NCT00751881|1332363|P3|Core Treatment Period|Other: protocol deviation|7
397005|NCT00751881|1332364|P2|Core Treatment Period|Other: protocol deviation|3
397006|NCT00751881|1332365|P1|Core Treatment Period|Other: protocol deviation|3
397007|NCT00751881|1332363|P3|Core Treatment Period|Lost to Follow-up|3
397008|NCT00751881|1332364|P2|Core Treatment Period|Lost to Follow-up|4
397009|NCT00751881|1332365|P1|Core Treatment Period|Lost to Follow-up|6
397010|NCT00751881|1332363|P3|Core Treatment Period|Poor compliance to protocol|4
397011|NCT00751881|1332364|P2|Core Treatment Period|Poor compliance to protocol|3
397012|NCT00751881|1332365|P1|Core Treatment Period|Poor compliance to protocol|15
397013|NCT00751881|1332363|P3|Core Treatment Period|Lack of Efficacy|20
397014|NCT00751881|1332364|P2|Core Treatment Period|Lack of Efficacy|30
397015|NCT00751881|1332365|P1|Core Treatment Period|Lack of Efficacy|37
397016|NCT00751881|1332363|P3|Core Treatment Period|Adverse Event|58
397017|NCT00751881|1332364|P2|Core Treatment Period|Adverse Event|54
397018|NCT00751881|1332365|P1|Core Treatment Period|Adverse Event|26
397019|NCT00751881|1332363|P3|Core Treatment Period|Not treated|2
397020|NCT00751881|1332364|P2|Core Treatment Period|Not treated|1
397021|NCT00751881|1332365|P1|Core Treatment Period|Not treated|1
397022|NCT00751790|1332412|P1|Overall Study|Withdrawal by Subject|1
397023|NCT00751790|1332412|P1|Overall Study|Death|3
397024|NCT00751790|1332412|P1|Overall Study|Lost to Follow-up|1
397025|NCT00751621|1332437|P1|Overall Study|Poor adherence to asthma treatment|1
397026|NCT00751621|1332437|P1|Overall Study|Subject moved to another country|1
397027|NCT00751621|1332437|P1|Overall Study|Withdrawal by Subject|1
397028|NCT00751621|1332437|P1|Overall Study|Adverse Event|1
397029|NCT00751400|1332471|P1|Overall Study|Lost to Follow-up|10
397030|NCT00751348|1332486|P2|Overall Study|Migration from study area|0
397031|NCT00751348|1332487|P1|Overall Study|Migration from study area|1
397032|NCT00751348|1332486|P2|Overall Study|Withdrawal by Subject|2
397033|NCT00751348|1332487|P1|Overall Study|Withdrawal by Subject|5
397034|NCT00751296|1332509|P1|Overall Study|Adverse Event|2
397035|NCT00751140|1332537|P1|Overall Study|benign angioma excluded from analysis|1
397036|NCT00751114|1332547|P2|Overall Study|Move to another city|0
397037|NCT00751114|1332548|P1|Overall Study|Move to another city|1
397038|NCT00751114|1332547|P2|Overall Study|Out of country for 2 months|0
397039|NCT00751114|1332548|P1|Overall Study|Out of country for 2 months|1
397040|NCT00751114|1332547|P2|Overall Study|Not Treated|1
397041|NCT00751114|1332548|P1|Overall Study|Not Treated|13
397042|NCT00751114|1332547|P2|Overall Study|Lack of Efficacy|7
397043|NCT00751114|1332548|P1|Overall Study|Lack of Efficacy|0
397044|NCT00751114|1332547|P2|Overall Study|Lost to Follow-up|7
397045|NCT00751114|1332548|P1|Overall Study|Lost to Follow-up|4
397046|NCT00751114|1332547|P2|Overall Study|Withdrawal by Subject|4
397047|NCT00751114|1332548|P1|Overall Study|Withdrawal by Subject|9
397048|NCT00751114|1332547|P2|Overall Study|Protocol Violation|9
397049|NCT00751114|1332548|P1|Overall Study|Protocol Violation|8
397050|NCT00751114|1332547|P2|Overall Study|Adverse Event|4
397051|NCT00751114|1332548|P1|Overall Study|Adverse Event|2
397052|NCT00751036|1332573|P2|Overall Study|Missing end of Treatment Page|3
397053|NCT00751036|1332574|P1|Overall Study|Missing end of Treatment Page|2
397054|NCT00751036|1332573|P2|Overall Study|Protocol Violation|0
397055|NCT00751036|1332574|P1|Overall Study|Protocol Violation|1
397056|NCT00751036|1332573|P2|Overall Study|Lost to Follow-up|1
397057|NCT00751036|1332574|P1|Overall Study|Lost to Follow-up|0
397058|NCT00751036|1332573|P2|Overall Study|Death|3
397059|NCT00751036|1332574|P1|Overall Study|Death|3
397060|NCT00751036|1332573|P2|Overall Study|Withdrawal by Subject|2
397061|NCT00751036|1332574|P1|Overall Study|Withdrawal by Subject|5
397062|NCT00751036|1332573|P2|Overall Study|Administrative Problems|4
397063|NCT00751036|1332574|P1|Overall Study|Administrative Problems|3
397064|NCT00751036|1332573|P2|Overall Study|Adverse Event|4
397065|NCT00751036|1332574|P1|Overall Study|Adverse Event|6
397066|NCT00751036|1332573|P2|Overall Study|Disease Progression|29
397067|NCT00751036|1332574|P1|Overall Study|Disease Progression|28
397068|NCT00750919|1332586|P1|Overall Study|Other|36
397069|NCT00750919|1332586|P1|Overall Study|Could not cooperate, unrelated to trial|4
397070|NCT00750919|1332586|P1|Overall Study|Lack of Efficacy|8
397071|NCT00750919|1332586|P1|Overall Study|Withdrawal by Subject|1
397072|NCT00750919|1332586|P1|Overall Study|Adverse Event|9
397073|NCT00750893|1332594|P1|Overall Study|Other|17
397074|NCT00750893|1332594|P1|Overall Study|Lost to Follow-up|510
397075|NCT00750893|1332594|P1|Overall Study|Withdrawal by Subject|10
397076|NCT00750893|1332594|P1|Overall Study|Adverse Event|5
397077|NCT00750880|1332609|P1|Overall Study|Administrative|11
397078|NCT00750880|1332609|P1|Overall Study|Physician Decision|20
397079|NCT00750880|1332609|P1|Overall Study|Withdrawal by Subject|33
397080|NCT00750880|1332609|P1|Overall Study|Protocol Violation|15
397081|NCT00750880|1332609|P1|Overall Study|Lost to Follow-up|10
397082|NCT00750880|1332609|P1|Overall Study|Lack of Efficacy|46
397083|NCT00750880|1332609|P1|Overall Study|Death|4
397084|NCT00750880|1332609|P1|Overall Study|Adverse Event|76
397085|NCT00750867|1332632|P1|Overall Study|Adverse Event|2
397086|NCT00750737|1332653|P2|Overall Study|Withdrawal by Subject|3
397087|NCT00750737|1332654|P1|Overall Study|Withdrawal by Subject|3
397088|NCT00750308|1332714|P12|Third Treatment|Withdrawal by Subject|0
397089|NCT00750308|1332715|P11|Third Treatment|Withdrawal by Subject|0
397090|NCT00750308|1332716|P10|Third Treatment|Withdrawal by Subject|0
397091|NCT00750308|1332717|P9|Third Treatment|Withdrawal by Subject|0
397092|NCT00750308|1332718|P8|Third Treatment|Withdrawal by Subject|0
397093|NCT00750308|1332719|P7|Third Treatment|Withdrawal by Subject|0
397094|NCT00750308|1332720|P6|Third Treatment|Withdrawal by Subject|0
397095|NCT00750308|1332721|P5|Third Treatment|Withdrawal by Subject|0
397096|NCT00750308|1332722|P4|Third Treatment|Withdrawal by Subject|0
397097|NCT00750308|1332723|P3|Third Treatment|Withdrawal by Subject|0
397098|NCT00750308|1332724|P2|Third Treatment|Withdrawal by Subject|1
397099|NCT00750308|1332725|P1|Third Treatment|Withdrawal by Subject|0
397100|NCT00750308|1332714|P12|Second Treatment|Withdrawal by Subject|0
397101|NCT00750308|1332715|P11|Second Treatment|Withdrawal by Subject|0
397102|NCT00750308|1332716|P10|Second Treatment|Withdrawal by Subject|0
397103|NCT00750308|1332717|P9|Second Treatment|Withdrawal by Subject|0
397104|NCT00750308|1332718|P8|Second Treatment|Withdrawal by Subject|0
397105|NCT00750308|1332719|P7|Second Treatment|Withdrawal by Subject|0
397106|NCT00750308|1332720|P6|Second Treatment|Withdrawal by Subject|0
397107|NCT00750308|1332721|P5|Second Treatment|Withdrawal by Subject|1
397108|NCT00750308|1332722|P4|Second Treatment|Withdrawal by Subject|0
397109|NCT00750308|1332723|P3|Second Treatment|Withdrawal by Subject|0
397110|NCT00750308|1332724|P2|Second Treatment|Withdrawal by Subject|0
397111|NCT00750308|1332725|P1|Second Treatment|Withdrawal by Subject|0
397112|NCT00750308|1332714|P12|Second Treatment|Adverse Event|0
397113|NCT00750308|1332715|P11|Second Treatment|Adverse Event|0
397114|NCT00750308|1332716|P10|Second Treatment|Adverse Event|0
397115|NCT00750308|1332717|P9|Second Treatment|Adverse Event|1
397116|NCT00750308|1332718|P8|Second Treatment|Adverse Event|0
397117|NCT00750308|1332719|P7|Second Treatment|Adverse Event|0
397118|NCT00750308|1332720|P6|Second Treatment|Adverse Event|1
397119|NCT00750308|1332721|P5|Second Treatment|Adverse Event|0
397120|NCT00750308|1332722|P4|Second Treatment|Adverse Event|0
397121|NCT00750308|1332723|P3|Second Treatment|Adverse Event|0
397122|NCT00750308|1332724|P2|Second Treatment|Adverse Event|0
397123|NCT00750308|1332725|P1|Second Treatment|Adverse Event|0
397124|NCT00750308|1332714|P12|First Treatment|Withdrawal by Subject|0
397125|NCT00750308|1332715|P11|First Treatment|Withdrawal by Subject|0
397126|NCT00750308|1332716|P10|First Treatment|Withdrawal by Subject|0
397127|NCT00750308|1332717|P9|First Treatment|Withdrawal by Subject|0
397128|NCT00750308|1332718|P8|First Treatment|Withdrawal by Subject|1
397129|NCT00750308|1332719|P7|First Treatment|Withdrawal by Subject|0
397130|NCT00750308|1332720|P6|First Treatment|Withdrawal by Subject|0
397131|NCT00750308|1332721|P5|First Treatment|Withdrawal by Subject|0
397132|NCT00750308|1332722|P4|First Treatment|Withdrawal by Subject|1
397133|NCT00750308|1332723|P3|First Treatment|Withdrawal by Subject|0
397134|NCT00750308|1332724|P2|First Treatment|Withdrawal by Subject|0
397135|NCT00750308|1332725|P1|First Treatment|Withdrawal by Subject|0
397136|NCT00750308|1332714|P12|First Treatment|Adverse Event|1
397137|NCT00750308|1332715|P11|First Treatment|Adverse Event|1
397138|NCT00750308|1332716|P10|First Treatment|Adverse Event|0
397139|NCT00750308|1332717|P9|First Treatment|Adverse Event|0
397140|NCT00750308|1332718|P8|First Treatment|Adverse Event|0
397141|NCT00750308|1332719|P7|First Treatment|Adverse Event|0
397142|NCT00750308|1332720|P6|First Treatment|Adverse Event|0
397143|NCT00750308|1332721|P5|First Treatment|Adverse Event|0
397144|NCT00750308|1332722|P4|First Treatment|Adverse Event|0
397145|NCT00750308|1332723|P3|First Treatment|Adverse Event|0
397146|NCT00750308|1332724|P2|First Treatment|Adverse Event|1
397147|NCT00750308|1332725|P1|First Treatment|Adverse Event|0
397148|NCT00750269|1332775|P5|Overall Study|Fiducials could not be placed|1
397149|NCT00750269|1332776|P4|Overall Study|Fiducials could not be placed|0
397150|NCT00750269|1332777|P3|Overall Study|Fiducials could not be placed|0
397151|NCT00750269|1332778|P2|Overall Study|Fiducials could not be placed|0
397152|NCT00750269|1332779|P1|Overall Study|Fiducials could not be placed|0
397153|NCT00750269|1332775|P5|Overall Study|SBRT plan could not be drawn|1
397154|NCT00750269|1332776|P4|Overall Study|SBRT plan could not be drawn|0
397155|NCT00750269|1332777|P3|Overall Study|SBRT plan could not be drawn|0
397156|NCT00750269|1332778|P2|Overall Study|SBRT plan could not be drawn|0
397157|NCT00750269|1332779|P1|Overall Study|SBRT plan could not be drawn|0
397158|NCT00750269|1332775|P5|Overall Study|Site error|0
397159|NCT00750269|1332776|P4|Overall Study|Site error|1
397160|NCT00750269|1332777|P3|Overall Study|Site error|0
397161|NCT00750269|1332778|P2|Overall Study|Site error|0
397162|NCT00750269|1332779|P1|Overall Study|Site error|0
397163|NCT00750269|1332775|P5|Overall Study|Patient too large for positioning|0
397164|NCT00750269|1332776|P4|Overall Study|Patient too large for positioning|0
397165|NCT00750269|1332777|P3|Overall Study|Patient too large for positioning|1
397166|NCT00750269|1332778|P2|Overall Study|Patient too large for positioning|0
397167|NCT00750269|1332779|P1|Overall Study|Patient too large for positioning|0
397168|NCT00750269|1332775|P5|Overall Study|Physician Decision|2
397169|NCT00750269|1332776|P4|Overall Study|Physician Decision|0
397170|NCT00750269|1332777|P3|Overall Study|Physician Decision|0
397171|NCT00750269|1332778|P2|Overall Study|Physician Decision|0
397172|NCT00750269|1332779|P1|Overall Study|Physician Decision|0
397173|NCT00750269|1332775|P5|Overall Study|Withdrawal by Subject|2
397174|NCT00750269|1332776|P4|Overall Study|Withdrawal by Subject|2
397175|NCT00750269|1332777|P3|Overall Study|Withdrawal by Subject|2
397176|NCT00750269|1332778|P2|Overall Study|Withdrawal by Subject|0
397177|NCT00750269|1332779|P1|Overall Study|Withdrawal by Subject|0
397178|NCT00750269|1332775|P5|Overall Study|Protocol Violation|4
397179|NCT00750269|1332776|P4|Overall Study|Protocol Violation|2
397180|NCT00750269|1332777|P3|Overall Study|Protocol Violation|1
397181|NCT00750269|1332778|P2|Overall Study|Protocol Violation|1
397182|NCT00750269|1332779|P1|Overall Study|Protocol Violation|0
397183|NCT00750204|1332826|P2|Overall Study|study halted prematurely|1
397184|NCT00750204|1332827|P1|Overall Study|study halted prematurely|1
397185|NCT00750152|1332850|P2|Overall Study|Not specified|8
397186|NCT00750152|1332851|P1|Overall Study|Not specified|7
397187|NCT00750152|1332850|P2|Overall Study|Termination by sponsor|0
397188|NCT00750152|1332851|P1|Overall Study|Termination by sponsor|1
397189|NCT00750152|1332850|P2|Overall Study|Non-compliance|1
397190|NCT00750152|1332851|P1|Overall Study|Non-compliance|0
397191|NCT00750152|1332850|P2|Overall Study|Physician Decision|1
397192|NCT00750152|1332851|P1|Overall Study|Physician Decision|1
397193|NCT00750152|1332850|P2|Overall Study|Withdrawal by Subject|3
397194|NCT00750152|1332851|P1|Overall Study|Withdrawal by Subject|3
397195|NCT00750152|1332850|P2|Overall Study|Lost to Follow-up|13
397196|NCT00750152|1332851|P1|Overall Study|Lost to Follow-up|8
397197|NCT00750152|1332850|P2|Overall Study|Adverse Event|1
397198|NCT00750152|1332851|P1|Overall Study|Adverse Event|2
397199|NCT00750139|1332863|P4|Overall Study|Non-specific|33
397200|NCT00750139|1332864|P3|Overall Study|Non-specific|79
397201|NCT00750139|1332865|P2|Overall Study|Non-specific|42
397202|NCT00750139|1332866|P1|Overall Study|Non-specific|62
397203|NCT00750139|1332863|P4|Overall Study|Termination by sponsor|1
397204|NCT00750139|1332864|P3|Overall Study|Termination by sponsor|0
397205|NCT00750139|1332865|P2|Overall Study|Termination by sponsor|0
397206|NCT00750139|1332866|P1|Overall Study|Termination by sponsor|4
397207|NCT00750139|1332863|P4|Overall Study|Non-compliance|3
397208|NCT00750139|1332864|P3|Overall Study|Non-compliance|1
397209|NCT00750139|1332865|P2|Overall Study|Non-compliance|0
397210|NCT00750139|1332866|P1|Overall Study|Non-compliance|1
397211|NCT00750139|1332863|P4|Overall Study|Physician Decision|0
397212|NCT00750139|1332864|P3|Overall Study|Physician Decision|0
397213|NCT00750139|1332865|P2|Overall Study|Physician Decision|1
397214|NCT00750139|1332866|P1|Overall Study|Physician Decision|1
397215|NCT00750139|1332863|P4|Overall Study|Withdrawal by Subject|2
397216|NCT00750139|1332864|P3|Overall Study|Withdrawal by Subject|6
397217|NCT00750139|1332865|P2|Overall Study|Withdrawal by Subject|2
397218|NCT00750139|1332866|P1|Overall Study|Withdrawal by Subject|3
397219|NCT00750139|1332863|P4|Overall Study|Lost to Follow-up|6
397220|NCT00750139|1332864|P3|Overall Study|Lost to Follow-up|15
397221|NCT00750139|1332865|P2|Overall Study|Lost to Follow-up|12
397222|NCT00750139|1332866|P1|Overall Study|Lost to Follow-up|17
397223|NCT00750139|1332863|P4|Overall Study|Adverse Event|1
397224|NCT00750139|1332864|P3|Overall Study|Adverse Event|0
397225|NCT00750139|1332865|P2|Overall Study|Adverse Event|2
397226|NCT00750139|1332866|P1|Overall Study|Adverse Event|1
397227|NCT00750061|1332882|P2|Overall Study|Physician Decision|1
397228|NCT00750061|1332883|P1|Overall Study|Physician Decision|0
397229|NCT00750061|1332882|P2|Overall Study|Withdrawal by Subject|1
397230|NCT00750061|1332883|P1|Overall Study|Withdrawal by Subject|0
397231|NCT00750061|1332882|P2|Overall Study|Adverse Event|0
397232|NCT00750061|1332883|P1|Overall Study|Adverse Event|2
397233|NCT00749996|1332893|P2|Overall Study|Death|0
397234|NCT00749996|1332894|P1|Overall Study|Death|1
397235|NCT00749996|1332893|P2|Overall Study|Adverse Event|0
397236|NCT00749996|1332894|P1|Overall Study|Adverse Event|1
397237|NCT00749996|1332893|P2|Overall Study|Pregnancy|2
397238|NCT00749996|1332894|P1|Overall Study|Pregnancy|0
397239|NCT00749996|1332893|P2|Overall Study|Physician Decision|0
397240|NCT00749996|1332894|P1|Overall Study|Physician Decision|2
397241|NCT00749996|1332893|P2|Overall Study|Protocol Violation|3
397242|NCT00749996|1332894|P1|Overall Study|Protocol Violation|2
397243|NCT00749996|1332893|P2|Overall Study|Withdrawal by Subject|4
397244|NCT00749996|1332894|P1|Overall Study|Withdrawal by Subject|5
397245|NCT00749996|1332893|P2|Overall Study|Lost to Follow-up|4
397246|NCT00749996|1332894|P1|Overall Study|Lost to Follow-up|7
397247|NCT00749944|1332917|P2|Overall Study|Withdrawal by Subject|0
397248|NCT00749944|1332918|P1|Overall Study|Withdrawal by Subject|2
397249|NCT00749944|1332917|P2|Overall Study|Not specified|0
397250|NCT00749944|1332918|P1|Overall Study|Not specified|1
397251|NCT00749944|1332917|P2|Overall Study|Lost to Follow-up|1
397252|NCT00749944|1332918|P1|Overall Study|Lost to Follow-up|2
397253|NCT00749775|1332997|P1|Overall Study|No drug administration|3
397254|NCT00749775|1332997|P1|Overall Study|No visit after first day of treatment|44
397255|NCT00749775|1332997|P1|Overall Study|Lost to Follow-up|36
397256|NCT00749775|1332997|P1|Overall Study|Protocol Violation|24
397257|NCT00749684|1333013|P1|Overall Study|Missing|9
397258|NCT00749684|1333013|P1|Overall Study|AE+discontinuation on participants wish|1
397259|NCT00749684|1333013|P1|Overall Study|Therapy according to protocol + AE|2
397260|NCT00749684|1333013|P1|Overall Study|Progressive Desease|31
397261|NCT00749684|1333013|P1|Overall Study|Not Documented|1
397262|NCT00749684|1333013|P1|Overall Study|Participant's Wish|10
397263|NCT00749684|1333013|P1|Overall Study|Adverse Event|27
397264|NCT00749684|1333013|P1|Overall Study|Death|1
397265|NCT00749580|1333052|P2|Overall Study|Adverse Event|1
397266|NCT00749580|1333053|P1|Overall Study|Adverse Event|0
397267|NCT00749580|1333052|P2|Overall Study|Lost to Follow-up|8
397268|NCT00749580|1333053|P1|Overall Study|Lost to Follow-up|4
397269|NCT00749463|1333068|P3|Overall Study|Withdrawal by Subject|0
397270|NCT00749463|1333069|P2|Overall Study|Withdrawal by Subject|0
397271|NCT00749463|1333070|P1|Overall Study|Withdrawal by Subject|1
397272|NCT00749463|1333068|P3|Overall Study|Adverse Event|1
397273|NCT00749463|1333069|P2|Overall Study|Adverse Event|4
397274|NCT00749463|1333070|P1|Overall Study|Adverse Event|0
397275|NCT00749398|1333096|P1|Overall Study|Unknown reason|1
397276|NCT00749398|1333096|P1|Overall Study|Reason not specified|2
397277|NCT00749398|1333096|P1|Overall Study|Lost to Follow-up|11
397278|NCT00749398|1333096|P1|Overall Study|Withdrawal by Subject|17
397279|NCT00749398|1333096|P1|Overall Study|Serious adverse event|11
397280|NCT00749398|1333096|P1|Overall Study|Adverse Event|4
397281|NCT00749398|1333096|P1|Overall Study|Lack of Efficacy|7
397282|NCT00749203|1333139|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
397283|NCT00749203|1333140|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
397284|NCT00749203|1333139|P2|Second Infusion at 2 Weeks|Protocol Violation|1
397285|NCT00749203|1333140|P1|Second Infusion at 2 Weeks|Protocol Violation|0
397286|NCT00749203|1333139|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
397287|NCT00749203|1333140|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
397288|NCT00749203|1333139|P2|no Infusion at Week 1|delayed-onset sedation|1
397289|NCT00749203|1333140|P1|no Infusion at Week 1|delayed-onset sedation|0
397290|NCT00749203|1333139|P2|no Infusion at Week 1|Withdrawal by Subject|1
397291|NCT00749203|1333140|P1|no Infusion at Week 1|Withdrawal by Subject|0
397292|NCT00749203|1333139|P2|no Infusion at Week 1|Lost to Follow-up|1
397293|NCT00749203|1333140|P1|no Infusion at Week 1|Lost to Follow-up|0
397294|NCT00749190|1333161|P7|Overall Study|Other reason not defined above|0
397295|NCT00749190|1333162|P6|Overall Study|Other reason not defined above|0
397296|NCT00749190|1333163|P5|Overall Study|Other reason not defined above|0
397297|NCT00749190|1333164|P4|Overall Study|Other reason not defined above|1
397298|NCT00749190|1333165|P3|Overall Study|Other reason not defined above|0
397299|NCT00749190|1333166|P2|Overall Study|Other reason not defined above|0
397300|NCT00749190|1333167|P1|Overall Study|Other reason not defined above|0
397301|NCT00749190|1333161|P7|Overall Study|Protocol Violation|1
397302|NCT00749190|1333162|P6|Overall Study|Protocol Violation|0
397303|NCT00749190|1333163|P5|Overall Study|Protocol Violation|0
397304|NCT00749190|1333164|P4|Overall Study|Protocol Violation|0
397305|NCT00749190|1333165|P3|Overall Study|Protocol Violation|0
397306|NCT00749190|1333166|P2|Overall Study|Protocol Violation|1
397307|NCT00749190|1333167|P1|Overall Study|Protocol Violation|0
397308|NCT00749190|1333161|P7|Overall Study|Withdrawal by Subject|0
397309|NCT00749190|1333162|P6|Overall Study|Withdrawal by Subject|1
397310|NCT00749190|1333163|P5|Overall Study|Withdrawal by Subject|0
397311|NCT00749190|1333164|P4|Overall Study|Withdrawal by Subject|0
397312|NCT00749190|1333165|P3|Overall Study|Withdrawal by Subject|0
397313|NCT00749190|1333166|P2|Overall Study|Withdrawal by Subject|1
397314|NCT00749190|1333167|P1|Overall Study|Withdrawal by Subject|2
397315|NCT00749190|1333161|P7|Overall Study|Lack of Efficacy|0
397316|NCT00749190|1333162|P6|Overall Study|Lack of Efficacy|1
397317|NCT00749190|1333163|P5|Overall Study|Lack of Efficacy|0
397318|NCT00749190|1333164|P4|Overall Study|Lack of Efficacy|0
397319|NCT00749190|1333165|P3|Overall Study|Lack of Efficacy|1
397320|NCT00749190|1333166|P2|Overall Study|Lack of Efficacy|1
397321|NCT00749190|1333167|P1|Overall Study|Lack of Efficacy|3
397322|NCT00749190|1333161|P7|Overall Study|Adverse Event|0
397323|NCT00749190|1333162|P6|Overall Study|Adverse Event|3
397324|NCT00749190|1333163|P5|Overall Study|Adverse Event|0
397325|NCT00749190|1333164|P4|Overall Study|Adverse Event|4
397326|NCT00749190|1333165|P3|Overall Study|Adverse Event|0
397327|NCT00749190|1333166|P2|Overall Study|Adverse Event|2
397328|NCT00749190|1333167|P1|Overall Study|Adverse Event|0
397329|NCT00748969|1333267|P2|Overall Study|Withdrawal by Subject|1
397330|NCT00748969|1333268|P1|Overall Study|Withdrawal by Subject|0
397331|NCT00748969|1333267|P2|Overall Study|Withdrawal by Subject|0
397332|NCT00748969|1333268|P1|Overall Study|Withdrawal by Subject|1
397333|NCT00748709|1333316|P1|Overall Study|Other Reasons|1
397334|NCT00748709|1333316|P1|Overall Study|Withdrawal by Subject|1
397335|NCT00748709|1333316|P1|Overall Study|Other Adverse Event|1
397336|NCT00748709|1333316|P1|Overall Study|Drug reducing Toxity|2
397337|NCT00748709|1333316|P1|Overall Study|Progressive disease|15
397338|NCT00748566|1333343|P1|Overall Study|Other|9
397339|NCT00748566|1333343|P1|Overall Study|Study terminated by sponsor|5
397340|NCT00748566|1333343|P1|Overall Study|Withdrawal by Subject|22
397341|NCT00748566|1333343|P1|Overall Study|Protocol Violation|13
397342|NCT00748566|1333343|P1|Overall Study|Lost to Follow-up|1
397343|NCT00748566|1333343|P1|Overall Study|Lack of Efficacy|12
397344|NCT00748566|1333343|P1|Overall Study|Death|1
397345|NCT00748566|1333343|P1|Overall Study|Adverse Event|49
397346|NCT00748553|1333373|P2|Overall Study|noncompliance|0
397347|NCT00748553|1333374|P1|Overall Study|noncompliance|1
397348|NCT00748553|1333373|P2|Overall Study|disease progression|0
397349|NCT00748553|1333374|P1|Overall Study|disease progression|2
397350|NCT00748553|1333373|P2|Overall Study|Adverse Event|1
397351|NCT00748553|1333374|P1|Overall Study|Adverse Event|0
397352|NCT00748241|1333400|P1|Overall Study|Death|2
397353|NCT00748241|1333400|P1|Overall Study|Lost to Follow-up|5
397354|NCT00748241|1333400|P1|Overall Study|Implant failure|1
397355|NCT00748189|1333410|P2|Overall Study|Ongoing|162
397356|NCT00748189|1333411|P1|Overall Study|Ongoing|155
397357|NCT00748189|1333410|P2|Overall Study|Study terminated by Sponsor|1
397358|NCT00748189|1333411|P1|Overall Study|Study terminated by Sponsor|0
397359|NCT00748189|1333410|P2|Overall Study|Lost to Follow-up|4
397360|NCT00748189|1333411|P1|Overall Study|Lost to Follow-up|2
397361|NCT00748189|1333410|P2|Overall Study|Physician Decision|4
397362|NCT00748189|1333411|P1|Overall Study|Physician Decision|13
397363|NCT00748189|1333410|P2|Overall Study|Withdrawal by Subject|16
397364|NCT00748189|1333411|P1|Overall Study|Withdrawal by Subject|15
397365|NCT00748189|1333410|P2|Overall Study|Death|34
397366|NCT00748189|1333411|P1|Overall Study|Death|40
397367|NCT00748098|1333465|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
397368|NCT00748098|1333466|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
397369|NCT00748098|1333465|P2|Second Treatment Intervention Period|Lost to Follow-up|1
397370|NCT00748098|1333466|P1|Second Treatment Intervention Period|Lost to Follow-up|1
397371|NCT00748098|1333465|P2|Second Treatment Intervention Period|Adverse Event|1
397372|NCT00748098|1333466|P1|Second Treatment Intervention Period|Adverse Event|4
397373|NCT00748098|1333465|P2|1-Week Washout Period|Withdrawal by Subject|0
397374|NCT00748098|1333466|P1|1-Week Washout Period|Withdrawal by Subject|2
397375|NCT00748098|1333465|P2|1-Week Washout Period|Adverse Event|1
397376|NCT00748098|1333466|P1|1-Week Washout Period|Adverse Event|0
397377|NCT00748098|1333465|P2|First Taper Period|Protocol Stopping Criteria Met|1
397378|NCT00748098|1333466|P1|First Taper Period|Protocol Stopping Criteria Met|0
397379|NCT00748098|1333465|P2|First Taper Period|Withdrawal by Subject|0
397380|NCT00748098|1333466|P1|First Taper Period|Withdrawal by Subject|2
397381|NCT00748098|1333465|P2|First Taper Period|Protocol Violation|0
397382|NCT00748098|1333466|P1|First Taper Period|Protocol Violation|1
397383|NCT00748098|1333465|P2|First Treatment Intervention Period|Withdrawal by Subject|0
397384|NCT00748098|1333466|P1|First Treatment Intervention Period|Withdrawal by Subject|2
397385|NCT00748098|1333465|P2|First Treatment Intervention Period|Lost to Follow-up|0
397386|NCT00748098|1333466|P1|First Treatment Intervention Period|Lost to Follow-up|1
397387|NCT00748098|1333465|P2|First Treatment Intervention Period|Protocol Violation|0
397388|NCT00748098|1333466|P1|First Treatment Intervention Period|Protocol Violation|1
397389|NCT00748098|1333465|P2|First Treatment Intervention Period|Adverse Event|1
397390|NCT00748098|1333466|P1|First Treatment Intervention Period|Adverse Event|1
397391|NCT00747812|1333547|P2|Overall Study|Research Site Staff Relocation|3
397392|NCT00747812|1333548|P1|Overall Study|Research Site Staff Relocation|5
397393|NCT00747643|1333586|P2|Overall Study|Withdrawal by Subject|27
397394|NCT00747643|1333587|P1|Overall Study|Withdrawal by Subject|36
397395|NCT00747617|1333601|P2|Overall Study|Lost to Follow-up|1
397396|NCT00747617|1333602|P1|Overall Study|Lost to Follow-up|3
397397|NCT00747565|1333610|P2|Overall Study|Lost to Follow-up|1
397398|NCT00747565|1333611|P1|Overall Study|Lost to Follow-up|4
397399|NCT00747565|1333610|P2|Overall Study|Withdrawal by Subject|6
397400|NCT00747565|1333611|P1|Overall Study|Withdrawal by Subject|10
397401|NCT00747474|1333624|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397402|NCT00747474|1333625|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397403|NCT00747474|1333626|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397404|NCT00747474|1333627|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397405|NCT00747474|1333628|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
397406|NCT00747474|1333629|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397407|NCT00747474|1333630|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397408|NCT00747474|1333631|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397409|NCT00747474|1333632|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397410|NCT00747474|1333633|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397411|NCT00747474|1333634|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397412|NCT00747474|1333635|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
397413|NCT00747461|1333661|P1|Overall Study|study terminated by sponsor|5
397414|NCT00747435|1333666|P1|Overall Study|Still undergoing follow up|1
397415|NCT00747435|1333666|P1|Overall Study|Withdrawal by Subject|3
397416|NCT00747435|1333666|P1|Overall Study|Lost to Follow-up|2
397417|NCT00747344|1333676|P4|After Controlled Period|Adverse Event|1
397418|NCT00747344|1333677|P3|After Controlled Period|Adverse Event|0
397419|NCT00747344|1333678|P2|After Controlled Period|Adverse Event|0
397420|NCT00747344|1333679|P1|After Controlled Period|Adverse Event|0
397421|NCT00747344|1333676|P4|Controlled Period|Other|0
397422|NCT00747344|1333677|P3|Controlled Period|Other|0
397423|NCT00747344|1333678|P2|Controlled Period|Other|3
397424|NCT00747344|1333679|P1|Controlled Period|Other|0
397425|NCT00747344|1333676|P4|Controlled Period|Lack of Efficacy|0
397426|NCT00747344|1333677|P3|Controlled Period|Lack of Efficacy|0
397427|NCT00747344|1333678|P2|Controlled Period|Lack of Efficacy|1
397428|NCT00747344|1333679|P1|Controlled Period|Lack of Efficacy|2
397429|NCT00747344|1333676|P4|Controlled Period|Adverse Event|0
397430|NCT00747344|1333677|P3|Controlled Period|Adverse Event|0
397431|NCT00747344|1333678|P2|Controlled Period|Adverse Event|0
397432|NCT00747344|1333679|P1|Controlled Period|Adverse Event|3
397433|NCT00747227|1333693|P2|Overall Study|Illness|1
397434|NCT00747227|1333694|P1|Overall Study|Illness|1
397435|NCT00747227|1333693|P2|Overall Study|Lost to Follow-up|2
397436|NCT00747227|1333694|P1|Overall Study|Lost to Follow-up|1
397437|NCT00747227|1333693|P2|Overall Study|Withdrawal by Subject|0
397438|NCT00747227|1333694|P1|Overall Study|Withdrawal by Subject|1
397439|NCT00747227|1333693|P2|Overall Study|Death|1
397440|NCT00747227|1333694|P1|Overall Study|Death|3
397441|NCT00747149|1333723|P2|Overall Study|Not reported|4
397442|NCT00747149|1333724|P1|Overall Study|Not reported|1
397443|NCT00747149|1333723|P2|Overall Study|Severe non-compliance to protocol|1
397444|NCT00747149|1333724|P1|Overall Study|Severe non-compliance to protocol|0
397445|NCT00747149|1333723|P2|Overall Study|Incorrect enrollment|6
397446|NCT00747149|1333724|P1|Overall Study|Incorrect enrollment|0
397447|NCT00747149|1333723|P2|Overall Study|Did not receive treatment|1
397448|NCT00747149|1333724|P1|Overall Study|Did not receive treatment|0
397449|NCT00747149|1333723|P2|Overall Study|Withdrawal by Subject|6
397450|NCT00747149|1333724|P1|Overall Study|Withdrawal by Subject|0
397451|NCT00747149|1333723|P2|Overall Study|Lost to Follow-up|10
397452|NCT00747149|1333724|P1|Overall Study|Lost to Follow-up|0
397453|NCT00747149|1333723|P2|Overall Study|Adverse Event|15
397454|NCT00747149|1333724|P1|Overall Study|Adverse Event|0
397455|NCT00747006|1333739|P3|Overall Study|Physician Decision|1
397456|NCT00747006|1333740|P2|Overall Study|Physician Decision|0
397457|NCT00747006|1333741|P1|Overall Study|Physician Decision|2
397458|NCT00747006|1333739|P3|Overall Study|Lost to Follow-up|0
397459|NCT00747006|1333740|P2|Overall Study|Lost to Follow-up|1
397460|NCT00747006|1333741|P1|Overall Study|Lost to Follow-up|0
397461|NCT00747006|1333739|P3|Overall Study|Adverse Event|0
397462|NCT00747006|1333740|P2|Overall Study|Adverse Event|0
397463|NCT00747006|1333741|P1|Overall Study|Adverse Event|1
397464|NCT00746941|1333819|P4|Overall Study|Adverse Event|1
397465|NCT00746941|1333820|P3|Overall Study|Adverse Event|0
397466|NCT00746941|1333821|P2|Overall Study|Adverse Event|0
397467|NCT00746941|1333822|P1|Overall Study|Adverse Event|0
397468|NCT00746941|1333819|P4|Overall Study|Other, reason not provided|4
397469|NCT00746941|1333820|P3|Overall Study|Other, reason not provided|0
397470|NCT00746941|1333821|P2|Overall Study|Other, reason not provided|4
397471|NCT00746941|1333822|P1|Overall Study|Other, reason not provided|2
397472|NCT00746941|1333819|P4|Overall Study|Withdrawal by Subject|2
397473|NCT00746941|1333820|P3|Overall Study|Withdrawal by Subject|0
397474|NCT00746941|1333821|P2|Overall Study|Withdrawal by Subject|0
397475|NCT00746941|1333822|P1|Overall Study|Withdrawal by Subject|3
397476|NCT00746941|1333819|P4|Overall Study|Physician Decision|0
397477|NCT00746941|1333820|P3|Overall Study|Physician Decision|2
397478|NCT00746941|1333821|P2|Overall Study|Physician Decision|0
397479|NCT00746941|1333822|P1|Overall Study|Physician Decision|0
397480|NCT00746941|1333819|P4|Overall Study|Death|6
397481|NCT00746941|1333820|P3|Overall Study|Death|0
397482|NCT00746941|1333821|P2|Overall Study|Death|0
397483|NCT00746941|1333822|P1|Overall Study|Death|2
397484|NCT00746798|1333880|P4|Overall Study|Participant unable to return for visit|0
397485|NCT00746798|1333881|P3|Overall Study|Participant unable to return for visit|0
397486|NCT00746798|1333882|P2|Overall Study|Participant unable to return for visit|0
397487|NCT00746798|1333883|P1|Overall Study|Participant unable to return for visit|1
397488|NCT00746798|1333880|P4|Overall Study|Death|0
397489|NCT00746798|1333881|P3|Overall Study|Death|2
397490|NCT00746798|1333882|P2|Overall Study|Death|0
397491|NCT00746798|1333883|P1|Overall Study|Death|0
397492|NCT00746798|1333880|P4|Overall Study|Withdrawal by Subject|0
397493|NCT00746798|1333881|P3|Overall Study|Withdrawal by Subject|1
397494|NCT00746798|1333882|P2|Overall Study|Withdrawal by Subject|1
397495|NCT00746798|1333883|P1|Overall Study|Withdrawal by Subject|0
397496|NCT00746798|1333880|P4|Overall Study|Protocol Violation|0
397497|NCT00746798|1333881|P3|Overall Study|Protocol Violation|0
397498|NCT00746798|1333882|P2|Overall Study|Protocol Violation|1
397499|NCT00746798|1333883|P1|Overall Study|Protocol Violation|0
397500|NCT00746785|1333908|P3|Overall Study|Lost to Follow-up|27
397501|NCT00746785|1333909|P2|Overall Study|Lost to Follow-up|25
397502|NCT00746785|1333910|P1|Overall Study|Lost to Follow-up|29
397503|NCT00746733|1333918|P2|Third Intervention|Withdrawal by Subject|1
397504|NCT00746733|1333919|P1|Third Intervention|Withdrawal by Subject|1
397505|NCT00746733|1333918|P2|Second Intervention|Adverse Event|0
397506|NCT00746733|1333919|P1|Second Intervention|Adverse Event|1
397507|NCT00746590|1334003|P1|Overall Study|Death|1
397508|NCT00746564|1334007|P1|Overall Study|Required Pacemaker/ICD Implant|2
397509|NCT00746551|1334022|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
397510|NCT00746551|1334023|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
397511|NCT00746551|1334022|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
397512|NCT00746551|1334023|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
397513|NCT00746551|1334022|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
397514|NCT00746551|1334023|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
397515|NCT00746356|1334074|P2|Overall Study|Patient relocated|0
397516|NCT00746356|1334075|P1|Overall Study|Patient relocated|1
397517|NCT00746356|1334074|P2|Overall Study|Removal of Device|1
397518|NCT00746356|1334075|P1|Overall Study|Removal of Device|0
397519|NCT00746356|1334074|P2|Overall Study|Lost to Follow-up|0
397520|NCT00746356|1334075|P1|Overall Study|Lost to Follow-up|1
397521|NCT00746356|1334074|P2|Overall Study|Death|3
397522|NCT00746356|1334075|P1|Overall Study|Death|7
397523|NCT00746356|1334074|P2|Overall Study|Withdrawal by Subject|3
397524|NCT00746356|1334075|P1|Overall Study|Withdrawal by Subject|2
397525|NCT00746330|1334087|P4|Period 1|Abnormal test procedure result|0
397526|NCT00746330|1334088|P3|Period 1|Abnormal test procedure result|1
397527|NCT00746330|1334089|P2|Period 1|Abnormal test procedure result|0
397528|NCT00746330|1334090|P1|Period 1|Abnormal test procedure result|0
397529|NCT00746252|1334120|P2|Overall Study|weight gain >7.5 %|2
397530|NCT00746252|1334121|P1|Overall Study|weight gain >7.5 %|1
397531|NCT00746096|1334143|P2|Overall Study|No study drug treatment|1
397532|NCT00746096|1334144|P1|Overall Study|No study drug treatment|1
397533|NCT00746096|1334143|P2|Overall Study|Protocol Violation|0
397534|NCT00746096|1334144|P1|Overall Study|Protocol Violation|1
397535|NCT00746096|1334143|P2|Overall Study|Lost to Follow-up|1
397536|NCT00746096|1334144|P1|Overall Study|Lost to Follow-up|2
397537|NCT00746096|1334143|P2|Overall Study|Withdrawal by Subject|1
397538|NCT00746096|1334144|P1|Overall Study|Withdrawal by Subject|5
397539|NCT00746096|1334143|P2|Overall Study|Adverse Event|0
397540|NCT00746096|1334144|P1|Overall Study|Adverse Event|1
397541|NCT00745901|1334175|P2|Overall Study|Patient didn't take any study medication|3
397542|NCT00745901|1334176|P1|Overall Study|Patient didn't take any study medication|7
397543|NCT00745901|1334175|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
397544|NCT00745901|1334176|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
397545|NCT00745901|1334175|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
397546|NCT00745901|1334176|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
397547|NCT00745901|1334175|P2|Overall Study|Patient's next menses did not start with|0
397548|NCT00745901|1334176|P1|Overall Study|Patient's next menses did not start with|1
397549|NCT00745901|1334175|P2|Overall Study|Lack of compliance|2
397550|NCT00745901|1334176|P1|Overall Study|Lack of compliance|2
397551|NCT00745901|1334175|P2|Overall Study|Pregnancy|4
397552|NCT00745901|1334176|P1|Overall Study|Pregnancy|2
397553|NCT00745901|1334175|P2|Overall Study|Lost to Follow-up|4
397554|NCT00745901|1334176|P1|Overall Study|Lost to Follow-up|7
397555|NCT00745901|1334175|P2|Overall Study|Withdrawal by Subject|0
397556|NCT00745901|1334176|P1|Overall Study|Withdrawal by Subject|1
397557|NCT00745901|1334175|P2|Overall Study|Protocol Violation|1
397558|NCT00745901|1334176|P1|Overall Study|Protocol Violation|0
397559|NCT00745901|1334175|P2|Overall Study|Adverse Event|4
397560|NCT00745901|1334176|P1|Overall Study|Adverse Event|3
397561|NCT00745875|1334222|P2|Overall Study|Continuing study treatment|4
397562|NCT00745875|1334223|P1|Overall Study|Continuing study treatment|4
397563|NCT00745823|1334233|P2|Overall Study|Study Terminated by Sponsor|349
397564|NCT00745823|1334234|P1|Overall Study|Study Terminated by Sponsor|326
397565|NCT00745823|1334233|P2|Overall Study|Withdrawal by Subject|8
397566|NCT00745823|1334234|P1|Overall Study|Withdrawal by Subject|14
397567|NCT00745823|1334233|P2|Overall Study|Pregnancy|4
397568|NCT00745823|1334234|P1|Overall Study|Pregnancy|0
397569|NCT00745823|1334233|P2|Overall Study|Physician Decision|5
397570|NCT00745823|1334234|P1|Overall Study|Physician Decision|10
397571|NCT00745823|1334233|P2|Overall Study|Lost to Follow-up|11
397572|NCT00745823|1334234|P1|Overall Study|Lost to Follow-up|10
397573|NCT00745823|1334233|P2|Overall Study|Lack of Efficacy|6
397574|NCT00745823|1334234|P1|Overall Study|Lack of Efficacy|20
397575|NCT00745823|1334233|P2|Overall Study|Adverse Event|3
397576|NCT00745823|1334234|P1|Overall Study|Adverse Event|5
397577|NCT00745498|1334261|P3|Overall Study|Edophthalmitis after preoperative IVB|0
397578|NCT00745498|1334262|P2|Overall Study|Edophthalmitis after preoperative IVB|0
397579|NCT00745498|1334263|P1|Overall Study|Edophthalmitis after preoperative IVB|1
397580|NCT00745498|1334261|P3|Overall Study|Non-PDR related VH|1
397581|NCT00745498|1334262|P2|Overall Study|Non-PDR related VH|1
397582|NCT00745498|1334263|P1|Overall Study|Non-PDR related VH|0
397583|NCT00745498|1334261|P3|Overall Study|Injection of intravitreal silicone oil o|4
397584|NCT00745498|1334262|P2|Overall Study|Injection of intravitreal silicone oil o|4
397585|NCT00745498|1334263|P1|Overall Study|Injection of intravitreal silicone oil o|3
397586|NCT00745498|1334261|P3|Overall Study|Lost to Follow-up|3
397587|NCT00745498|1334262|P2|Overall Study|Lost to Follow-up|1
397588|NCT00745498|1334263|P1|Overall Study|Lost to Follow-up|1
397589|NCT00745420|1334277|P1|Overall Study|Ineligible|1
397590|NCT00745368|1334294|P1|Overall Study|Unable to provide sample|3
397591|NCT00745251|1334316|P2|Overall Study|Withdrawal by Subject|1
397592|NCT00745251|1334317|P1|Overall Study|Withdrawal by Subject|1
397593|NCT00745251|1334316|P2|Overall Study|Adverse Event|2
397594|NCT00745251|1334317|P1|Overall Study|Adverse Event|1
397595|NCT00745095|1334331|P6|Overall Study|Ineligible due to GFR criteria|28
397596|NCT00745095|1334332|P5|Overall Study|Ineligible due to GFR criteria|30
397597|NCT00745095|1334333|P4|Overall Study|Ineligible due to GFR criteria|3
397598|NCT00745095|1334334|P3|Overall Study|Ineligible due to GFR criteria|3
397599|NCT00745095|1334335|P2|Overall Study|Ineligible due to GFR criteria|2
397600|NCT00745095|1334336|P1|Overall Study|Ineligible due to GFR criteria|0
397601|NCT00745095|1334331|P6|Overall Study|Declined to participate|95
397602|NCT00745095|1334332|P5|Overall Study|Declined to participate|92
397603|NCT00745095|1334333|P4|Overall Study|Declined to participate|0
397604|NCT00745095|1334334|P3|Overall Study|Declined to participate|0
397605|NCT00745095|1334335|P2|Overall Study|Declined to participate|0
397606|NCT00745095|1334336|P1|Overall Study|Declined to participate|1
397607|NCT00744978|1334367|P2|Period 2|Adverse Event|1
397608|NCT00744978|1334368|P1|Period 2|Adverse Event|0
397609|NCT00744978|1334367|P2|Period 1|Randomized but not Treated|1
397610|NCT00744978|1334368|P1|Period 1|Randomized but not Treated|1
397611|NCT00744978|1334367|P2|Period 1|Adverse Event|0
397612|NCT00744978|1334368|P1|Period 1|Adverse Event|4
397613|NCT00744978|1334367|P2|Period 1|Other|2
397614|NCT00744978|1334368|P1|Period 1|Other|0
397615|NCT00744978|1334367|P2|Period 1|Withdrawal by Subject|2
397616|NCT00744978|1334368|P1|Period 1|Withdrawal by Subject|0
397617|NCT00744978|1334367|P2|Period 1|Lost to Follow-up|0
397618|NCT00744978|1334368|P1|Period 1|Lost to Follow-up|1
397619|NCT00744939|1334420|P1|Overall Study|incorrect race|1
397620|NCT00744939|1334420|P1|Overall Study|coma|1
397621|NCT00744939|1334420|P1|Overall Study|Failed inclusion/exclusion criteria|19
397622|NCT00744939|1334420|P1|Overall Study|Did not receive Magnevist|7
397623|NCT00744939|1334420|P1|Overall Study|Medical history exclusionary|1
397624|NCT00744939|1334420|P1|Overall Study|Lost to Follow-up|12
397625|NCT00744939|1334420|P1|Overall Study|distance|4
397626|NCT00744939|1334420|P1|Overall Study|Death|24
397627|NCT00744939|1334420|P1|Overall Study|Protocol Violation|13
397628|NCT00744939|1334420|P1|Overall Study|Withdrawal by Subject|9
397629|NCT00744874|1334456|P1|Overall Study|Unable to accomodate schedule|1
397630|NCT00744874|1334456|P1|Overall Study|Study Device not available at procedure|1
397631|NCT00744874|1334456|P1|Overall Study|Withdrawal by Subject|1
397632|NCT00744874|1334456|P1|Overall Study|Lost to Follow-up|1
397633|NCT00744757|1334481|P1|Overall Study|Adverse Event|2
397634|NCT00744757|1334481|P1|Overall Study|Death|6
397635|NCT00744757|1334481|P1|Overall Study|Withdrawal by Subject|1
397636|NCT00744757|1334481|P1|Overall Study|Physician Decision|5
397637|NCT00744757|1334481|P1|Overall Study|Objective disease progression|7
397638|NCT00744653|1334506|P1|Overall Study|Physician Decision|3
397639|NCT00744653|1334506|P1|Overall Study|Lost to Follow-up|1
397640|NCT00744653|1334506|P1|Overall Study|Death|1
397641|NCT00744653|1334506|P1|Overall Study|antineoplastic treatment|11
397642|NCT00744627|1334514|P2|Overall Study|Other|0
397643|NCT00744627|1334515|P1|Overall Study|Other|1
397644|NCT00744627|1334514|P2|Overall Study|Lost to Follow-up|1
397645|NCT00744627|1334515|P1|Overall Study|Lost to Follow-up|2
397646|NCT00744627|1334514|P2|Overall Study|Voluntary Withdrawal|6
397647|NCT00744627|1334515|P1|Overall Study|Voluntary Withdrawal|9
397648|NCT00744627|1334514|P2|Overall Study|Protocol Deviations|2
397649|NCT00744627|1334515|P1|Overall Study|Protocol Deviations|0
397650|NCT00744627|1334514|P2|Overall Study|Noncompliance|1
397651|NCT00744627|1334515|P1|Overall Study|Noncompliance|0
397652|NCT00744627|1334514|P2|Overall Study|Lack of Efficacy|3
397653|NCT00744627|1334515|P1|Overall Study|Lack of Efficacy|7
397654|NCT00744627|1334514|P2|Overall Study|Adverse Event|9
397655|NCT00744627|1334515|P1|Overall Study|Adverse Event|6
397656|NCT00744523|1334571|P2|30 Days After the Procedure|Insufficient follow-up|5
397657|NCT00744523|1334572|P1|30 Days After the Procedure|Insufficient follow-up|0
397658|NCT00744497|1334592|P2|Overall Study|Not defined|13
397659|NCT00744497|1334593|P1|Overall Study|Not defined|19
397660|NCT00744497|1334592|P2|Overall Study|Maximum clinical benefit|142
397661|NCT00744497|1334593|P1|Overall Study|Maximum clinical benefit|141
397662|NCT00744497|1334592|P2|Overall Study|Patient requested to stop study drug|80
397663|NCT00744497|1334593|P1|Overall Study|Patient requested to stop study drug|65
397664|NCT00744497|1334592|P2|Overall Study|Adverse event unrelated to study drug|122
397665|NCT00744497|1334593|P1|Overall Study|Adverse event unrelated to study drug|78
397666|NCT00744497|1334592|P2|Overall Study|Study drug toxicity|141
397667|NCT00744497|1334593|P1|Overall Study|Study drug toxicity|68
397668|NCT00744497|1334592|P2|Overall Study|Disease progression|219
397669|NCT00744497|1334593|P1|Overall Study|Disease progression|312
397670|NCT00744497|1334592|P2|Overall Study|Administrative Reason By Sponsor|8
397671|NCT00744497|1334593|P1|Overall Study|Administrative Reason By Sponsor|25
397672|NCT00744497|1334592|P2|Overall Study|No longer meets study criteria|3
397673|NCT00744497|1334593|P1|Overall Study|No longer meets study criteria|7
397674|NCT00744497|1334592|P2|Overall Study|Poor compliance/noncompliance|5
397675|NCT00744497|1334593|P1|Overall Study|Poor compliance/noncompliance|9
397676|NCT00744497|1334592|P2|Overall Study|Lost to Follow-up|2
397677|NCT00744497|1334593|P1|Overall Study|Lost to Follow-up|4
397678|NCT00744497|1334592|P2|Overall Study|Death|9
397679|NCT00744497|1334593|P1|Overall Study|Death|11
397680|NCT00744497|1334592|P2|Overall Study|Withdrawal by Subject|18
397681|NCT00744497|1334593|P1|Overall Study|Withdrawal by Subject|21
397682|NCT00744328|1334653|P3|Overall Study|Found ineligible after randomization|1
397683|NCT00744328|1334654|P2|Overall Study|Found ineligible after randomization|0
397684|NCT00744328|1334655|P1|Overall Study|Found ineligible after randomization|0
397685|NCT00744328|1334653|P3|Overall Study|Withdrawal by Subject|4
397686|NCT00744328|1334654|P2|Overall Study|Withdrawal by Subject|3
397687|NCT00744328|1334655|P1|Overall Study|Withdrawal by Subject|5
397688|NCT00744328|1334653|P3|Overall Study|Lost to Follow-up|3
397689|NCT00744328|1334654|P2|Overall Study|Lost to Follow-up|5
397690|NCT00744328|1334655|P1|Overall Study|Lost to Follow-up|2
397691|NCT00744263|1334665|P2|Overall Study|Other|2
397692|NCT00744263|1334666|P1|Overall Study|Other|2
397693|NCT00744263|1334665|P2|Overall Study|Adverse Event|0
397694|NCT00744263|1334666|P1|Overall Study|Adverse Event|1
397695|NCT00744263|1334665|P2|Overall Study|Protocol Violation|5
397696|NCT00744263|1334666|P1|Overall Study|Protocol Violation|3
397697|NCT00744263|1334665|P2|Overall Study|Physician Decision|23
397698|NCT00744263|1334666|P1|Overall Study|Physician Decision|20
397699|NCT00744263|1334665|P2|Overall Study|Withdrawal by Subject|150
397700|NCT00744263|1334666|P1|Overall Study|Withdrawal by Subject|166
397701|NCT00744263|1334665|P2|Overall Study|Lost to Follow-up|2135
397702|NCT00744263|1334666|P1|Overall Study|Lost to Follow-up|2038
397703|NCT00744263|1334665|P2|Overall Study|Death|3005
397704|NCT00744263|1334666|P1|Overall Study|Death|3006
397705|NCT00744237|1334689|P3|Overall Study|Adverse Event|5
397706|NCT00744237|1334690|P2|Overall Study|Adverse Event|13
397707|NCT00744237|1334691|P1|Overall Study|Adverse Event|9
397708|NCT00744237|1334689|P3|Overall Study|Administrative. Site Closed|1
397709|NCT00744237|1334690|P2|Overall Study|Administrative. Site Closed|1
397710|NCT00744237|1334691|P1|Overall Study|Administrative. Site Closed|1
397711|NCT00744237|1334689|P3|Overall Study|Poor Compliance|0
397712|NCT00744237|1334690|P2|Overall Study|Poor Compliance|2
397713|NCT00744237|1334691|P1|Overall Study|Poor Compliance|0
397714|NCT00744237|1334689|P3|Overall Study|Prohibited Concomitant Medication|1
397715|NCT00744237|1334690|P2|Overall Study|Prohibited Concomitant Medication|0
397716|NCT00744237|1334691|P1|Overall Study|Prohibited Concomitant Medication|0
397717|NCT00744237|1334689|P3|Overall Study|Study Drug Error|0
397718|NCT00744237|1334690|P2|Overall Study|Study Drug Error|0
397719|NCT00744237|1334691|P1|Overall Study|Study Drug Error|1
397720|NCT00744237|1334689|P3|Overall Study|Dosing Error|1
397721|NCT00744237|1334690|P2|Overall Study|Dosing Error|0
397722|NCT00744237|1334691|P1|Overall Study|Dosing Error|1
397723|NCT00744237|1334689|P3|Overall Study|Inclusion/Exclusion criteria not met|0
397724|NCT00744237|1334690|P2|Overall Study|Inclusion/Exclusion criteria not met|0
397725|NCT00744237|1334691|P1|Overall Study|Inclusion/Exclusion criteria not met|1
397726|NCT00744237|1334689|P3|Overall Study|Protocol Violation|3
397727|NCT00744237|1334690|P2|Overall Study|Protocol Violation|4
397728|NCT00744237|1334691|P1|Overall Study|Protocol Violation|3
397729|NCT00744237|1334689|P3|Overall Study|Lost to Follow-up|1
397730|NCT00744237|1334690|P2|Overall Study|Lost to Follow-up|1
397731|NCT00744237|1334691|P1|Overall Study|Lost to Follow-up|1
397732|NCT00744237|1334689|P3|Overall Study|Withdrawal by Subject|3
397733|NCT00744237|1334690|P2|Overall Study|Withdrawal by Subject|5
397734|NCT00744237|1334691|P1|Overall Study|Withdrawal by Subject|9
397735|NCT00744237|1334689|P3|Overall Study|Lack of Efficacy|0
397736|NCT00744237|1334690|P2|Overall Study|Lack of Efficacy|1
397737|NCT00744237|1334691|P1|Overall Study|Lack of Efficacy|1
397738|NCT00744055|1334725|P2|Overall Study|Lost to Follow-up|1
397739|NCT00744055|1334726|P1|Overall Study|Lost to Follow-up|0
397740|NCT00744055|1334725|P2|Overall Study|Protocol Violation|1
397741|NCT00744055|1334726|P1|Overall Study|Protocol Violation|1
397742|NCT00744055|1334725|P2|Overall Study|Physician Decision|2
397743|NCT00744055|1334726|P1|Overall Study|Physician Decision|0
397744|NCT00744055|1334725|P2|Overall Study|Lack of Efficacy|1
397745|NCT00744055|1334726|P1|Overall Study|Lack of Efficacy|0
397746|NCT00744055|1334725|P2|Overall Study|Withdrawal by Subject|9
397747|NCT00744055|1334726|P1|Overall Study|Withdrawal by Subject|6
397748|NCT00744042|1334734|P1|Overall Study|Withdrawal by Subject|1
397749|NCT00743652|1334777|P5|Overall Study|Lost to Follow-up|0
397750|NCT00743652|1334778|P4|Overall Study|Lost to Follow-up|0
397751|NCT00743652|1334779|P3|Overall Study|Lost to Follow-up|0
397752|NCT00743652|1334780|P2|Overall Study|Lost to Follow-up|0
397753|NCT00743652|1334781|P1|Overall Study|Lost to Follow-up|1
397754|NCT00743652|1334777|P5|Overall Study|Other|0
397755|NCT00743652|1334778|P4|Overall Study|Other|0
397756|NCT00743652|1334779|P3|Overall Study|Other|0
397757|NCT00743652|1334780|P2|Overall Study|Other|1
397758|NCT00743652|1334781|P1|Overall Study|Other|1
397759|NCT00743652|1334777|P5|Overall Study|Investigator Request|0
397760|NCT00743652|1334778|P4|Overall Study|Investigator Request|2
397761|NCT00743652|1334779|P3|Overall Study|Investigator Request|0
397762|NCT00743652|1334780|P2|Overall Study|Investigator Request|0
397763|NCT00743652|1334781|P1|Overall Study|Investigator Request|0
397764|NCT00743652|1334777|P5|Overall Study|Death|0
397765|NCT00743652|1334778|P4|Overall Study|Death|0
397766|NCT00743652|1334779|P3|Overall Study|Death|0
397767|NCT00743652|1334780|P2|Overall Study|Death|0
397768|NCT00743652|1334781|P1|Overall Study|Death|2
397769|NCT00743652|1334777|P5|Overall Study|Adverse Event|0
397770|NCT00743652|1334778|P4|Overall Study|Adverse Event|0
397771|NCT00743652|1334779|P3|Overall Study|Adverse Event|0
397772|NCT00743652|1334780|P2|Overall Study|Adverse Event|0
397773|NCT00743652|1334781|P1|Overall Study|Adverse Event|3
397774|NCT00743652|1334777|P5|Overall Study|Parent/Legal Guardian Request|0
397775|NCT00743652|1334778|P4|Overall Study|Parent/Legal Guardian Request|2
397776|NCT00743652|1334779|P3|Overall Study|Parent/Legal Guardian Request|2
397777|NCT00743652|1334780|P2|Overall Study|Parent/Legal Guardian Request|2
397778|NCT00743652|1334781|P1|Overall Study|Parent/Legal Guardian Request|3
397779|NCT00743509|1334865|P1|Overall Study|Withdrawal by Subject|2
397780|NCT00743483|1334870|P1|Treatment Period|Adverse Event|1
397781|NCT00743483|1334870|P1|Baseline Period|Physician Decision|1
397782|NCT00743444|1334874|P2|Washout Period|Adverse Event|1
397783|NCT00743444|1334875|P1|Washout Period|Adverse Event|0
397784|NCT00743444|1334874|P2|First Intervention|Catheter placement problems|1
397785|NCT00743444|1334875|P1|First Intervention|Catheter placement problems|0
397786|NCT00743431|1334884|P1|Overall Study|No documentation available|13
397787|NCT00743431|1334884|P1|Overall Study|Reason for discontinuation not specified|29
397788|NCT00743431|1334884|P1|Overall Study|Death|9
397789|NCT00743431|1334884|P1|Overall Study|Withdrawal by Subject|13
397790|NCT00743431|1334884|P1|Overall Study|Tumor progression|56
397791|NCT00743431|1334884|P1|Overall Study|Toxicity|6
397792|NCT00743366|1334888|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
397793|NCT00743366|1334889|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
397794|NCT00743340|1334895|P1|Overall Study|Participant Relocated|1
397795|NCT00743340|1334895|P1|Overall Study|Rolled over to other Gilead Study|23
397796|NCT00743340|1334895|P1|Overall Study|Pregnancy|1
397797|NCT00743340|1334895|P1|Overall Study|Virologic failure|8
397798|NCT00743340|1334895|P1|Overall Study|Protocol Violation|1
397799|NCT00743340|1334895|P1|Overall Study|Withdrawal from the Study|5
397800|NCT00743340|1334895|P1|Overall Study|Lost to Follow-up|1
397801|NCT00743340|1334895|P1|Overall Study|Study medication non-compliance|1
397802|NCT00743288|1334899|P7|Overall Study|Worsening of condition (Not PD)|0
397803|NCT00743288|1334900|P6|Overall Study|Worsening of condition (Not PD)|0
397804|NCT00743288|1334901|P5|Overall Study|Worsening of condition (Not PD)|0
397805|NCT00743288|1334902|P4|Overall Study|Worsening of condition (Not PD)|1
397806|NCT00743288|1334903|P3|Overall Study|Worsening of condition (Not PD)|1
397807|NCT00743288|1334904|P2|Overall Study|Worsening of condition (Not PD)|2
397808|NCT00743288|1334905|P1|Overall Study|Worsening of condition (Not PD)|0
397809|NCT00743288|1334899|P7|Overall Study|Progressive disease (PD)|6
397810|NCT00743288|1334900|P6|Overall Study|Progressive disease (PD)|3
397811|NCT00743288|1334901|P5|Overall Study|Progressive disease (PD)|5
397812|NCT00743288|1334902|P4|Overall Study|Progressive disease (PD)|4
397813|NCT00743288|1334903|P3|Overall Study|Progressive disease (PD)|1
397814|NCT00743288|1334904|P2|Overall Study|Progressive disease (PD)|0
397815|NCT00743288|1334905|P1|Overall Study|Progressive disease (PD)|2
397816|NCT00743288|1334899|P7|Overall Study|Withdrawal by Subject|1
397817|NCT00743288|1334900|P6|Overall Study|Withdrawal by Subject|1
397818|NCT00743288|1334901|P5|Overall Study|Withdrawal by Subject|0
397819|NCT00743288|1334902|P4|Overall Study|Withdrawal by Subject|0
397820|NCT00743288|1334903|P3|Overall Study|Withdrawal by Subject|1
397821|NCT00743288|1334904|P2|Overall Study|Withdrawal by Subject|0
397822|NCT00743288|1334905|P1|Overall Study|Withdrawal by Subject|0
397823|NCT00743288|1334899|P7|Overall Study|Adverse Event|2
397824|NCT00743288|1334900|P6|Overall Study|Adverse Event|1
397825|NCT00743288|1334901|P5|Overall Study|Adverse Event|1
397826|NCT00743288|1334902|P4|Overall Study|Adverse Event|2
397827|NCT00743288|1334903|P3|Overall Study|Adverse Event|2
397828|NCT00743288|1334904|P2|Overall Study|Adverse Event|1
397829|NCT00743288|1334905|P1|Overall Study|Adverse Event|1
397830|NCT00743275|1334919|P2|Overall Study|Protocol Violation|1
397831|NCT00743275|1334920|P1|Overall Study|Protocol Violation|0
397832|NCT00743249|1334940|P2|Overall Study|Unsuccessful insertion of stent|1
397833|NCT00743249|1334941|P1|Overall Study|Unsuccessful insertion of stent|2
397834|NCT00743249|1334940|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
397835|NCT00743249|1334941|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
397836|NCT00743249|1334940|P2|Overall Study|Adverse Event|4
397837|NCT00743249|1334941|P1|Overall Study|Adverse Event|0
397838|NCT00743197|1334951|P2|Overall Study|Study terminated due to departure of PI.|2
397839|NCT00743197|1334952|P1|Overall Study|Study terminated due to departure of PI.|1
397840|NCT00743119|1334958|P1|Overall Study|Withdrawal by Subject|1
397841|NCT00743119|1334958|P1|Overall Study|unreliable|3
397842|NCT00743106|1334972|P2|Overall Study|Met intraoperative exclusion criterion|5
397843|NCT00743106|1334973|P1|Overall Study|Met intraoperative exclusion criterion|8
397844|NCT00742924|1335000|P4|Overall Study|Withdrawal by Subject|0
397845|NCT00742924|1335001|P3|Overall Study|Withdrawal by Subject|1
397846|NCT00742924|1335002|P2|Overall Study|Withdrawal by Subject|1
397847|NCT00742924|1335003|P1|Overall Study|Withdrawal by Subject|0
397848|NCT00742924|1335000|P4|Overall Study|Physician Decision|1
397849|NCT00742924|1335001|P3|Overall Study|Physician Decision|0
397850|NCT00742924|1335002|P2|Overall Study|Physician Decision|0
397851|NCT00742924|1335003|P1|Overall Study|Physician Decision|0
397852|NCT00742924|1335000|P4|Overall Study|Lack of Efficacy|4
397853|NCT00742924|1335001|P3|Overall Study|Lack of Efficacy|2
397854|NCT00742924|1335002|P2|Overall Study|Lack of Efficacy|1
397855|NCT00742924|1335003|P1|Overall Study|Lack of Efficacy|5
397856|NCT00742924|1335000|P4|Overall Study|Adverse Event|1
397857|NCT00742924|1335001|P3|Overall Study|Adverse Event|1
397858|NCT00742924|1335002|P2|Overall Study|Adverse Event|0
397859|NCT00742924|1335003|P1|Overall Study|Adverse Event|0
397860|NCT00742885|1335015|P2|Overall Study|Lost to Follow-up|0
397861|NCT00742885|1335016|P1|Overall Study|Lost to Follow-up|1
397862|NCT00742859|1335075|P4|Overall Study|Site error|1
397863|NCT00742859|1335076|P3|Overall Study|Site error|1
397864|NCT00742859|1335077|P2|Overall Study|Site error|0
397865|NCT00742859|1335078|P1|Overall Study|Site error|0
397866|NCT00742859|1335075|P4|Overall Study|Sponsor request patient out of town|1
397867|NCT00742859|1335076|P3|Overall Study|Sponsor request patient out of town|1
397868|NCT00742859|1335077|P2|Overall Study|Sponsor request patient out of town|0
397869|NCT00742859|1335078|P1|Overall Study|Sponsor request patient out of town|0
397870|NCT00742859|1335075|P4|Overall Study|Sponsor req visit schedule noncompliance|1
397871|NCT00742859|1335076|P3|Overall Study|Sponsor req visit schedule noncompliance|0
397872|NCT00742859|1335077|P2|Overall Study|Sponsor req visit schedule noncompliance|0
397873|NCT00742859|1335078|P1|Overall Study|Sponsor req visit schedule noncompliance|0
397874|NCT00742859|1335075|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
397875|NCT00742859|1335076|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
397876|NCT00742859|1335077|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
397877|NCT00742859|1335078|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
397878|NCT00742859|1335075|P4|Overall Study|Endpoint|2
397879|NCT00742859|1335076|P3|Overall Study|Endpoint|1
397880|NCT00742859|1335077|P2|Overall Study|Endpoint|1
397881|NCT00742859|1335078|P1|Overall Study|Endpoint|0
397882|NCT00742859|1335075|P4|Overall Study|Withdrawal by Subject|1
397883|NCT00742859|1335076|P3|Overall Study|Withdrawal by Subject|4
397884|NCT00742859|1335077|P2|Overall Study|Withdrawal by Subject|2
397885|NCT00742859|1335078|P1|Overall Study|Withdrawal by Subject|4
397886|NCT00742859|1335075|P4|Overall Study|Physician Decision|0
397887|NCT00742859|1335076|P3|Overall Study|Physician Decision|0
397888|NCT00742859|1335077|P2|Overall Study|Physician Decision|2
397889|NCT00742859|1335078|P1|Overall Study|Physician Decision|1
397890|NCT00742859|1335075|P4|Overall Study|Death|1
397891|NCT00742859|1335076|P3|Overall Study|Death|0
397892|NCT00742859|1335077|P2|Overall Study|Death|0
397893|NCT00742859|1335078|P1|Overall Study|Death|1
397894|NCT00742859|1335075|P4|Overall Study|Adverse Event|1
397895|NCT00742859|1335076|P3|Overall Study|Adverse Event|3
397896|NCT00742859|1335077|P2|Overall Study|Adverse Event|6
397897|NCT00742859|1335078|P1|Overall Study|Adverse Event|5
397898|NCT00742781|1335092|P1|Overall Study|Withdrawal by Subject|3
397899|NCT00742625|1335101|P1|Consolidation|Non protocol therapy|13
397900|NCT00742625|1335101|P1|Consolidation|Refused|1
397901|NCT00742625|1335101|P1|Consolidation|Death|1
397902|NCT00742625|1335101|P1|Consolidation|Adverse Event|1
397903|NCT00742625|1335101|P1|Consolidation|Progression|5
397904|NCT00742625|1335101|P1|Remission Induction|Other, not specified|5
397905|NCT00742625|1335101|P1|Remission Induction|Non protocol treatment|17
397906|NCT00742625|1335101|P1|Remission Induction|Refusal|5
397907|NCT00742625|1335101|P1|Remission Induction|Death|10
397908|NCT00742625|1335101|P1|Remission Induction|Adverse Event|3
397909|NCT00742625|1335101|P1|Remission Induction|Failed induction|8
397910|NCT00742625|1335101|P1|Remission Induction|Progression|6
397911|NCT00742560|1335115|P5|Overall Study|MIssing|1
397912|NCT00742560|1335116|P4|Overall Study|MIssing|0
397913|NCT00742560|1335117|P3|Overall Study|MIssing|0
397914|NCT00742560|1335118|P2|Overall Study|MIssing|0
397915|NCT00742560|1335119|P1|Overall Study|MIssing|0
397916|NCT00742560|1335115|P5|Overall Study|Not Specified|9
397917|NCT00742560|1335116|P4|Overall Study|Not Specified|9
397918|NCT00742560|1335117|P3|Overall Study|Not Specified|8
397919|NCT00742560|1335118|P2|Overall Study|Not Specified|1
397920|NCT00742560|1335119|P1|Overall Study|Not Specified|0
397921|NCT00742560|1335115|P5|Overall Study|New Multiple Myeloma Therapy|4
397922|NCT00742560|1335116|P4|Overall Study|New Multiple Myeloma Therapy|3
397923|NCT00742560|1335117|P3|Overall Study|New Multiple Myeloma Therapy|2
397924|NCT00742560|1335118|P2|Overall Study|New Multiple Myeloma Therapy|0
397925|NCT00742560|1335119|P1|Overall Study|New Multiple Myeloma Therapy|1
397926|NCT00742560|1335115|P5|Overall Study|Disease Progression|16
397927|NCT00742560|1335116|P4|Overall Study|Disease Progression|17
397928|NCT00742560|1335117|P3|Overall Study|Disease Progression|5
397929|NCT00742560|1335118|P2|Overall Study|Disease Progression|0
397930|NCT00742560|1335119|P1|Overall Study|Disease Progression|1
397931|NCT00742560|1335115|P5|Overall Study|Investigator's Decision|0
397932|NCT00742560|1335116|P4|Overall Study|Investigator's Decision|1
397933|NCT00742560|1335117|P3|Overall Study|Investigator's Decision|4
397934|NCT00742560|1335118|P2|Overall Study|Investigator's Decision|0
397935|NCT00742560|1335119|P1|Overall Study|Investigator's Decision|0
397936|NCT00742560|1335115|P5|Overall Study|Subject's Decision|3
397937|NCT00742560|1335116|P4|Overall Study|Subject's Decision|3
397938|NCT00742560|1335117|P3|Overall Study|Subject's Decision|2
397939|NCT00742560|1335118|P2|Overall Study|Subject's Decision|0
397940|NCT00742560|1335119|P1|Overall Study|Subject's Decision|1
397941|NCT00742560|1335115|P5|Overall Study|Death|3
397942|NCT00742560|1335116|P4|Overall Study|Death|2
397943|NCT00742560|1335117|P3|Overall Study|Death|0
397944|NCT00742560|1335118|P2|Overall Study|Death|2
397945|NCT00742560|1335119|P1|Overall Study|Death|0
397946|NCT00742560|1335115|P5|Overall Study|Adverse Event|1
397947|NCT00742560|1335116|P4|Overall Study|Adverse Event|1
397948|NCT00742560|1335117|P3|Overall Study|Adverse Event|1
397949|NCT00742560|1335118|P2|Overall Study|Adverse Event|0
397950|NCT00742560|1335119|P1|Overall Study|Adverse Event|0
397951|NCT00742508|1335193|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
397952|NCT00742508|1335194|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
397953|NCT00742508|1335193|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
397954|NCT00742508|1335194|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
397955|NCT00742508|1335193|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
397956|NCT00742508|1335194|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
397957|NCT00742508|1335193|P2|8-Week Primary Evaluation Period|Protocol Violation|0
397958|NCT00742508|1335194|P1|8-Week Primary Evaluation Period|Protocol Violation|1
397959|NCT00742508|1335193|P2|8-Week Primary Evaluation Period|Adverse Event|4
397960|NCT00742508|1335194|P1|8-Week Primary Evaluation Period|Adverse Event|2
397961|NCT00742417|1335258|P2|Intensive Period|Adverse Event|0
397962|NCT00742417|1335259|P1|Intensive Period|Adverse Event|2
397963|NCT00742417|1335258|P2|Intensive Period|Withdrawal by Subject|1
397964|NCT00742417|1335259|P1|Intensive Period|Withdrawal by Subject|1
397965|NCT00742417|1335258|P2|Randomized|Physician Decision|0
397966|NCT00742417|1335259|P1|Randomized|Physician Decision|1
397967|NCT00742417|1335258|P2|Randomized|Withdrawal by Subject|0
397968|NCT00742417|1335259|P1|Randomized|Withdrawal by Subject|1
397969|NCT00742417|1335258|P2|Randomized|Withdrawal by legal representative|1
397970|NCT00742417|1335259|P1|Randomized|Withdrawal by legal representative|0
397971|NCT00742391|1335283|P2|Overall Study|Protocol Violation|0
397972|NCT00742391|1335284|P1|Overall Study|Protocol Violation|1
397973|NCT00742391|1335283|P2|Overall Study|Lost to Follow-up|0
397974|NCT00742391|1335284|P1|Overall Study|Lost to Follow-up|1
397975|NCT00742391|1335283|P2|Overall Study|Adverse Event|1
397976|NCT00742391|1335284|P1|Overall Study|Adverse Event|2
397977|NCT00742326|1335294|P2|Overall Study|Physician Decision|1
397978|NCT00742326|1335295|P1|Overall Study|Physician Decision|0
397979|NCT00742274|1335314|P2|Overall Study|Removed for medical reasons|1
397980|NCT00742274|1335315|P1|Overall Study|Removed for medical reasons|1
397981|NCT00742274|1335314|P2|Overall Study|Withdrawal by Subject|2
397982|NCT00742274|1335315|P1|Overall Study|Withdrawal by Subject|1
397983|NCT00742274|1335314|P2|Overall Study|Death|0
397984|NCT00742274|1335315|P1|Overall Study|Death|1
397985|NCT00742235|1335323|P2|Overall Study|Lost to Follow-up|31
397986|NCT00742235|1335324|P1|Overall Study|Lost to Follow-up|0
397987|NCT00742209|1335337|P5|Overall Study|Investigator Discretion|1
397988|NCT00742209|1335338|P4|Overall Study|Investigator Discretion|1
397989|NCT00742209|1335339|P3|Overall Study|Investigator Discretion|5
397990|NCT00742209|1335340|P2|Overall Study|Investigator Discretion|0
397991|NCT00742209|1335341|P1|Overall Study|Investigator Discretion|0
397992|NCT00742209|1335337|P5|Overall Study|Lack of Efficacy|1
397993|NCT00742209|1335338|P4|Overall Study|Lack of Efficacy|3
397994|NCT00742209|1335339|P3|Overall Study|Lack of Efficacy|1
397995|NCT00742209|1335340|P2|Overall Study|Lack of Efficacy|1
397996|NCT00742209|1335341|P1|Overall Study|Lack of Efficacy|6
397997|NCT00742209|1335337|P5|Overall Study|Lost to Follow-up|3
397998|NCT00742209|1335338|P4|Overall Study|Lost to Follow-up|5
397999|NCT00742209|1335339|P3|Overall Study|Lost to Follow-up|5
398000|NCT00742209|1335340|P2|Overall Study|Lost to Follow-up|4
398001|NCT00742209|1335341|P1|Overall Study|Lost to Follow-up|3
398002|NCT00742209|1335337|P5|Overall Study|Protocol Violation|3
398003|NCT00742209|1335338|P4|Overall Study|Protocol Violation|5
398004|NCT00742209|1335339|P3|Overall Study|Protocol Violation|4
398005|NCT00742209|1335340|P2|Overall Study|Protocol Violation|5
398006|NCT00742209|1335341|P1|Overall Study|Protocol Violation|6
398007|NCT00742209|1335337|P5|Overall Study|Participant Withdrew Consent|4
398008|NCT00742209|1335338|P4|Overall Study|Participant Withdrew Consent|7
398009|NCT00742209|1335339|P3|Overall Study|Participant Withdrew Consent|14
398010|NCT00742209|1335340|P2|Overall Study|Participant Withdrew Consent|4
398011|NCT00742209|1335341|P1|Overall Study|Participant Withdrew Consent|8
398012|NCT00742209|1335337|P5|Overall Study|Adverse Event|13
398013|NCT00742209|1335338|P4|Overall Study|Adverse Event|16
398014|NCT00742209|1335339|P3|Overall Study|Adverse Event|17
398015|NCT00742209|1335340|P2|Overall Study|Adverse Event|4
398016|NCT00742209|1335341|P1|Overall Study|Adverse Event|11
398017|NCT00742183|1335444|P2|Overall Study|Lack of Efficacy|3
398018|NCT00742183|1335445|P1|Overall Study|Lack of Efficacy|0
398019|NCT00742183|1335444|P2|Overall Study|Withdrawal by Subject|0
398020|NCT00742183|1335445|P1|Overall Study|Withdrawal by Subject|1
398021|NCT00742183|1335444|P2|Overall Study|Required skin-graft|1
398022|NCT00742183|1335445|P1|Overall Study|Required skin-graft|1
398023|NCT00742183|1335444|P2|Overall Study|Lost to Follow-up|4
398024|NCT00742183|1335445|P1|Overall Study|Lost to Follow-up|4
398025|NCT00742183|1335444|P2|Overall Study|Physician Decision|2
398026|NCT00742183|1335445|P1|Overall Study|Physician Decision|0
398027|NCT00742183|1335444|P2|Overall Study|Death|0
398028|NCT00742183|1335445|P1|Overall Study|Death|1
398029|NCT00742183|1335444|P2|Overall Study|Adverse Event|2
398030|NCT00742183|1335445|P1|Overall Study|Adverse Event|2
398031|NCT00742079|1335464|P2|Overall Study|Lost to Follow-up|1
398032|NCT00742079|1335465|P1|Overall Study|Lost to Follow-up|0
398033|NCT00741988|1335485|P2|Overall Study|Lack of Efficacy|0
398034|NCT00741988|1335486|P1|Overall Study|Lack of Efficacy|2
398035|NCT00741988|1335485|P2|Overall Study|Adverse Event|4
398036|NCT00741988|1335486|P1|Overall Study|Adverse Event|2
398037|NCT00741936|1335498|P2|Overall Study|Low compliance|0
398038|NCT00741936|1335499|P1|Overall Study|Low compliance|3
398039|NCT00741936|1335498|P2|Overall Study|Lack of Efficacy|2
398040|NCT00741936|1335499|P1|Overall Study|Lack of Efficacy|0
398041|NCT00741936|1335498|P2|Overall Study|Protocol Violation|0
398042|NCT00741936|1335499|P1|Overall Study|Protocol Violation|2
398043|NCT00741936|1335498|P2|Overall Study|Pregnancy|1
398044|NCT00741936|1335499|P1|Overall Study|Pregnancy|0
398045|NCT00741936|1335498|P2|Overall Study|Adverse Event|4
398046|NCT00741936|1335499|P1|Overall Study|Adverse Event|3
398047|NCT00741936|1335498|P2|Overall Study|Lost to Follow-up|1
398048|NCT00741936|1335499|P1|Overall Study|Lost to Follow-up|1
398049|NCT00741819|1335534|P1|Overall Study|Disease progression|1
398050|NCT00741819|1335534|P1|Overall Study|Death|1
398051|NCT00741819|1335534|P1|Overall Study|Withdrawal by Subject|3
398052|NCT00741819|1335534|P1|Overall Study|Adverse Event|3
398053|NCT00741611|1335548|P3|Overall Study|Withdrawal by Subject|2
398054|NCT00741611|1335549|P2|Overall Study|Withdrawal by Subject|2
398055|NCT00741611|1335550|P1|Overall Study|Withdrawal by Subject|0
398056|NCT00741611|1335548|P3|Overall Study|Death|1
398057|NCT00741611|1335549|P2|Overall Study|Death|0
398058|NCT00741611|1335550|P1|Overall Study|Death|0
398059|NCT00741598|1335569|P2|Overall Study|Withdrawal by Subject|2
398060|NCT00741598|1335570|P1|Overall Study|Withdrawal by Subject|3
398061|NCT00741598|1335569|P2|Overall Study|Pregnancy|0
398062|NCT00741598|1335570|P1|Overall Study|Pregnancy|1
398063|NCT00741598|1335569|P2|Overall Study|Physician Decision|1
398064|NCT00741598|1335570|P1|Overall Study|Physician Decision|1
398065|NCT00741598|1335569|P2|Overall Study|Lack of Efficacy|2
398066|NCT00741598|1335570|P1|Overall Study|Lack of Efficacy|1
398067|NCT00741598|1335569|P2|Overall Study|Lost to Follow-up|4
398068|NCT00741598|1335570|P1|Overall Study|Lost to Follow-up|3
398069|NCT00741338|1335616|P2|Overall Study|Adverse Event|1
398070|NCT00741338|1335617|P1|Overall Study|Adverse Event|0
398071|NCT00741286|1335627|P2|Overall Study|Primary Outcome|1
398072|NCT00741286|1335628|P1|Overall Study|Primary Outcome|1
398073|NCT00741286|1335627|P2|Overall Study|Protocol Violation|2
398074|NCT00741286|1335628|P1|Overall Study|Protocol Violation|3
398075|NCT00741286|1335627|P2|Overall Study|Adverse Event|6
398076|NCT00741286|1335628|P1|Overall Study|Adverse Event|1
398077|NCT00741286|1335627|P2|Overall Study|Lost to Follow-up|10
398078|NCT00741286|1335628|P1|Overall Study|Lost to Follow-up|15
398079|NCT00741260|1335662|P7|Overall Study|Not Specified|1
398080|NCT00741260|1335663|P6|Overall Study|Not Specified|3
398081|NCT00741260|1335664|P5|Overall Study|Not Specified|1
398082|NCT00741260|1335665|P4|Overall Study|Not Specified|2
398083|NCT00741260|1335666|P3|Overall Study|Not Specified|1
398084|NCT00741260|1335667|P2|Overall Study|Not Specified|1
398085|NCT00741260|1335668|P1|Overall Study|Not Specified|2
398086|NCT00741260|1335662|P7|Overall Study|Physician Decision|0
398087|NCT00741260|1335663|P6|Overall Study|Physician Decision|0
398088|NCT00741260|1335664|P5|Overall Study|Physician Decision|0
398089|NCT00741260|1335665|P4|Overall Study|Physician Decision|0
398090|NCT00741260|1335666|P3|Overall Study|Physician Decision|0
398091|NCT00741260|1335667|P2|Overall Study|Physician Decision|1
398092|NCT00741260|1335668|P1|Overall Study|Physician Decision|1
398093|NCT00741260|1335662|P7|Overall Study|Withdrawal by Subject|1
398094|NCT00741260|1335663|P6|Overall Study|Withdrawal by Subject|3
398095|NCT00741260|1335664|P5|Overall Study|Withdrawal by Subject|1
398096|NCT00741260|1335665|P4|Overall Study|Withdrawal by Subject|0
398097|NCT00741260|1335666|P3|Overall Study|Withdrawal by Subject|0
398098|NCT00741260|1335667|P2|Overall Study|Withdrawal by Subject|0
398099|NCT00741260|1335668|P1|Overall Study|Withdrawal by Subject|0
398100|NCT00741260|1335662|P7|Overall Study|Death|1
398101|NCT00741260|1335663|P6|Overall Study|Death|2
398102|NCT00741260|1335664|P5|Overall Study|Death|2
398103|NCT00741260|1335665|P4|Overall Study|Death|1
398104|NCT00741260|1335666|P3|Overall Study|Death|0
398105|NCT00741260|1335667|P2|Overall Study|Death|1
398106|NCT00741260|1335668|P1|Overall Study|Death|0
398107|NCT00741260|1335662|P7|Overall Study|Disease Progression|4
398108|NCT00741260|1335663|P6|Overall Study|Disease Progression|37
398109|NCT00741260|1335664|P5|Overall Study|Disease Progression|5
398110|NCT00741260|1335665|P4|Overall Study|Disease Progression|3
398111|NCT00741260|1335666|P3|Overall Study|Disease Progression|3
398112|NCT00741260|1335667|P2|Overall Study|Disease Progression|5
398113|NCT00741260|1335668|P1|Overall Study|Disease Progression|3
398114|NCT00741091|1335715|P1|Overall Study|Missed Visit|22
398115|NCT00741091|1335715|P1|Overall Study|Withdrawal by Subject|6
398116|NCT00741091|1335715|P1|Overall Study|Lost to Follow-up|16
398117|NCT00741091|1335715|P1|Overall Study|Death|13
398118|NCT00741039|1335725|P2|Overall Study|Patient non-compliance|0
398119|NCT00741039|1335726|P1|Overall Study|Patient non-compliance|2
398120|NCT00741013|1335763|P3|Overall Study|Discovered failed screen after enrolled|0
398121|NCT00741013|1335764|P2|Overall Study|Discovered failed screen after enrolled|2
398122|NCT00741013|1335765|P1|Overall Study|Discovered failed screen after enrolled|0
398123|NCT00741013|1335763|P3|Overall Study|Withdrawal by Subject|1
398124|NCT00741013|1335764|P2|Overall Study|Withdrawal by Subject|0
398125|NCT00741013|1335765|P1|Overall Study|Withdrawal by Subject|0
398126|NCT00741013|1335763|P3|Overall Study|Adverse Event|0
398127|NCT00741013|1335764|P2|Overall Study|Adverse Event|0
398128|NCT00741013|1335765|P1|Overall Study|Adverse Event|1
398129|NCT00740870|1335776|P1|Overall Study|Further testing contraindicated implant|17
398130|NCT00740870|1335776|P1|Overall Study|Not Catheterized|4
398131|NCT00740857|1335791|P3|Overall Study|Withdrawal by Subject|0
398132|NCT00740857|1335792|P2|Overall Study|Withdrawal by Subject|0
398133|NCT00740857|1335793|P1|Overall Study|Withdrawal by Subject|1
398134|NCT00740792|1335848|P4|Overall Study|administrative|2
398135|NCT00740792|1335849|P3|Overall Study|administrative|8
398136|NCT00740792|1335850|P2|Overall Study|administrative|3
398137|NCT00740792|1335851|P1|Overall Study|administrative|3
398138|NCT00740792|1335848|P4|Overall Study|Withdrawal by Subject|0
398139|NCT00740792|1335849|P3|Overall Study|Withdrawal by Subject|0
398140|NCT00740792|1335850|P2|Overall Study|Withdrawal by Subject|1
398141|NCT00740792|1335851|P1|Overall Study|Withdrawal by Subject|1
398142|NCT00740792|1335848|P4|Overall Study|Protocol Violation|2
398143|NCT00740792|1335849|P3|Overall Study|Protocol Violation|0
398144|NCT00740792|1335850|P2|Overall Study|Protocol Violation|1
398145|NCT00740792|1335851|P1|Overall Study|Protocol Violation|0
398146|NCT00740792|1335848|P4|Overall Study|Lost to Follow-up|0
398147|NCT00740792|1335849|P3|Overall Study|Lost to Follow-up|0
398148|NCT00740792|1335850|P2|Overall Study|Lost to Follow-up|1
398149|NCT00740792|1335851|P1|Overall Study|Lost to Follow-up|2
398150|NCT00740792|1335848|P4|Overall Study|Lack of Efficacy|3
398151|NCT00740792|1335849|P3|Overall Study|Lack of Efficacy|0
398152|NCT00740792|1335850|P2|Overall Study|Lack of Efficacy|1
398153|NCT00740792|1335851|P1|Overall Study|Lack of Efficacy|1
398154|NCT00740792|1335848|P4|Overall Study|Adverse Event|3
398155|NCT00740792|1335849|P3|Overall Study|Adverse Event|1
398156|NCT00740792|1335850|P2|Overall Study|Adverse Event|1
398157|NCT00740792|1335851|P1|Overall Study|Adverse Event|3
398158|NCT00740779|1335872|P3|Overall Study|Lost to Follow-up|5
398159|NCT00740779|1335873|P2|Overall Study|Lost to Follow-up|3
398160|NCT00740779|1335874|P1|Overall Study|Lost to Follow-up|2
398161|NCT00740779|1335872|P3|Overall Study|Withdrawal by Subject|2
398162|NCT00740779|1335873|P2|Overall Study|Withdrawal by Subject|4
398163|NCT00740779|1335874|P1|Overall Study|Withdrawal by Subject|2
398164|NCT00740779|1335872|P3|Overall Study|Lack of Efficacy|2
398165|NCT00740779|1335873|P2|Overall Study|Lack of Efficacy|0
398166|NCT00740779|1335874|P1|Overall Study|Lack of Efficacy|0
398167|NCT00740779|1335872|P3|Overall Study|Protocol Violation|1
398168|NCT00740779|1335873|P2|Overall Study|Protocol Violation|1
398169|NCT00740779|1335874|P1|Overall Study|Protocol Violation|1
398170|NCT00740779|1335872|P3|Overall Study|Adverse Event|3
398171|NCT00740779|1335873|P2|Overall Study|Adverse Event|6
398172|NCT00740779|1335874|P1|Overall Study|Adverse Event|4
398173|NCT00740714|1335891|P3|Overall Study|Withdrawal by Subject|29
398174|NCT00740714|1335892|P2|Overall Study|Withdrawal by Subject|19
398175|NCT00740714|1335893|P1|Overall Study|Withdrawal by Subject|17
398176|NCT00740636|1335969|P2|Overall Study|Death|0
398177|NCT00740636|1335970|P1|Overall Study|Death|1
398178|NCT00740636|1335969|P2|Overall Study|Progressive Disease|0
398179|NCT00740636|1335970|P1|Overall Study|Progressive Disease|1
398180|NCT00740636|1335969|P2|Overall Study|Patient Not Treated|1
398181|NCT00740636|1335970|P1|Overall Study|Patient Not Treated|0
398182|NCT00740636|1335969|P2|Overall Study|Patient Ineligible|1
398183|NCT00740636|1335970|P1|Overall Study|Patient Ineligible|0
398184|NCT00740636|1335969|P2|Overall Study|Adverse Event|2
398185|NCT00740636|1335970|P1|Overall Study|Adverse Event|0
398186|NCT00740597|1335976|P1|Overall Study|insurance would not cover treatment|1
398187|NCT00740584|1335980|P1|Overall Study|Withdrawal by Subject|1
398188|NCT00740480|1335984|P1|Overall Study|Physician Decision|1
398189|NCT00740480|1335984|P1|Overall Study|Adverse Event|1
398190|NCT00740220|1335988|P1|Overall Study|screen failures (non-COPD patients)|9
398191|NCT00740051|1336013|P2|Overall Study|Other reason (not specified)|1
398192|NCT00740051|1336014|P1|Overall Study|Other reason (not specified)|4
398193|NCT00740051|1336013|P2|Overall Study|Withdrawal by Subject|8
398194|NCT00740051|1336014|P1|Overall Study|Withdrawal by Subject|6
398195|NCT00740051|1336013|P2|Overall Study|Lost to Follow-up|8
398196|NCT00740051|1336014|P1|Overall Study|Lost to Follow-up|3
398197|NCT00740051|1336013|P2|Overall Study|Protocol Violation|6
398198|NCT00740051|1336014|P1|Overall Study|Protocol Violation|2
398199|NCT00740051|1336013|P2|Overall Study|Adverse Event|4
398200|NCT00740051|1336014|P1|Overall Study|Adverse Event|1
398201|NCT00740051|1336013|P2|Overall Study|Lack of Efficacy|5
398202|NCT00740051|1336014|P1|Overall Study|Lack of Efficacy|2
398203|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
398204|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
398205|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
398206|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
398207|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
398208|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
398209|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
398210|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
398211|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
398212|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
398213|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
398214|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
398215|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
398216|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
398217|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
398218|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
398219|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
398220|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
398221|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398222|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398223|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
398224|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398225|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398226|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398227|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398228|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398229|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
398230|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
398231|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
398232|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
398233|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
398234|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
398235|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
398236|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
398237|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
398238|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
398239|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
398240|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
398241|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
398242|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
398243|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
398244|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
398245|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
398246|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
398247|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
398248|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398249|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398250|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398251|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398252|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398253|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398254|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
398255|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398256|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
398257|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
398258|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
398259|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
398260|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
398261|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
398262|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
398263|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
398264|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
398265|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
398266|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
398267|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
398268|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
398269|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
398270|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
398271|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
398272|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
398273|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
398274|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
398275|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
398276|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
398277|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
398278|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
398279|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
398280|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
398281|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
398282|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
398283|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
398284|NCT00739973|1336117|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
398285|NCT00739973|1336118|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
398286|NCT00739973|1336119|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
398287|NCT00739973|1336120|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
398288|NCT00739973|1336121|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
398289|NCT00739973|1336122|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
398290|NCT00739973|1336123|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
398291|NCT00739973|1336124|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
398292|NCT00739973|1336125|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
398293|NCT00739973|1336117|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398294|NCT00739973|1336118|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398295|NCT00739973|1336119|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398296|NCT00739973|1336120|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398297|NCT00739973|1336121|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398298|NCT00739973|1336122|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398299|NCT00739973|1336123|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398300|NCT00739973|1336124|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
398301|NCT00739973|1336125|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
398302|NCT00739973|1336117|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398303|NCT00739973|1336118|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398304|NCT00739973|1336119|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398305|NCT00739973|1336120|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398306|NCT00739973|1336121|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398307|NCT00739973|1336122|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398308|NCT00739973|1336123|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398309|NCT00739973|1336124|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
398310|NCT00739973|1336125|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
398311|NCT00739973|1336117|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398312|NCT00739973|1336118|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398313|NCT00739973|1336119|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398314|NCT00739973|1336120|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398315|NCT00739973|1336121|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398316|NCT00739973|1336122|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398317|NCT00739973|1336123|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398318|NCT00739973|1336124|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
398319|NCT00739973|1336125|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
398320|NCT00739973|1336117|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398321|NCT00739973|1336118|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398322|NCT00739973|1336119|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398323|NCT00739973|1336120|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398324|NCT00739973|1336121|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398325|NCT00739973|1336122|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398326|NCT00739973|1336123|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398327|NCT00739973|1336124|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
398328|NCT00739973|1336125|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
398329|NCT00739973|1336117|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398330|NCT00739973|1336118|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398331|NCT00739973|1336119|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398332|NCT00739973|1336120|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398333|NCT00739973|1336121|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398334|NCT00739973|1336122|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398335|NCT00739973|1336123|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398336|NCT00739973|1336124|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
398337|NCT00739973|1336125|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
398338|NCT00739973|1336117|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398339|NCT00739973|1336118|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398340|NCT00739973|1336119|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398341|NCT00739973|1336120|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398342|NCT00739973|1336121|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398343|NCT00739973|1336122|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398344|NCT00739973|1336123|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398345|NCT00739973|1336124|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
398346|NCT00739973|1336125|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
398347|NCT00739973|1336117|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398348|NCT00739973|1336118|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398349|NCT00739973|1336119|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398350|NCT00739973|1336120|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398351|NCT00739973|1336121|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398352|NCT00739973|1336122|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398353|NCT00739973|1336123|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398354|NCT00739973|1336124|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
398355|NCT00739973|1336125|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
398356|NCT00739934|1336211|P1|Voriconazole Oral|Other|3
398357|NCT00739934|1336211|P1|Voriconazole IV|Adverse Event|6
398358|NCT00739908|1336233|P2|Overall Study|Relocation|1
398359|NCT00739908|1336234|P1|Overall Study|Relocation|0
398360|NCT00739908|1336233|P2|Overall Study|Lack of Efficacy|1
398361|NCT00739908|1336234|P1|Overall Study|Lack of Efficacy|0
398362|NCT00739908|1336233|P2|Overall Study|Non-Compliance With Study Medication|3
398363|NCT00739908|1336234|P1|Overall Study|Non-Compliance With Study Medication|0
398364|NCT00739908|1336233|P2|Overall Study|Non-Compliance With Study Procedures|3
398365|NCT00739908|1336234|P1|Overall Study|Non-Compliance With Study Procedures|2
398366|NCT00739908|1336233|P2|Overall Study|Lost to Follow-up|9
398367|NCT00739908|1336234|P1|Overall Study|Lost to Follow-up|14
398368|NCT00739908|1336233|P2|Overall Study|Withdrawal by Subject|2
398369|NCT00739908|1336234|P1|Overall Study|Withdrawal by Subject|4
398370|NCT00739908|1336233|P2|Overall Study|Adverse Event|6
398371|NCT00739908|1336234|P1|Overall Study|Adverse Event|5
398372|NCT00739882|1336254|P2|Open-label Period|Other|5
398373|NCT00739882|1336255|P1|Open-label Period|Other|9
398374|NCT00739882|1336254|P2|Open-label Period|Adverse Event|0
398375|NCT00739882|1336255|P1|Open-label Period|Adverse Event|1
398376|NCT00739882|1336254|P2|Double-blind Period|Not specified|8
398377|NCT00739882|1336255|P1|Double-blind Period|Not specified|16
398378|NCT00739882|1336254|P2|Double-blind Period|Lack of Efficacy|1
398379|NCT00739882|1336255|P1|Double-blind Period|Lack of Efficacy|1
398380|NCT00739882|1336254|P2|Double-blind Period|Protocol Violation|0
398381|NCT00739882|1336255|P1|Double-blind Period|Protocol Violation|1
398382|NCT00739882|1336254|P2|Double-blind Period|Adverse Event|2
398383|NCT00739882|1336255|P1|Double-blind Period|Adverse Event|1
398384|NCT00739674|1336316|P2|Overall Study|Erectile dysfunction|1
398385|NCT00739674|1336317|P1|Overall Study|Erectile dysfunction|0
398386|NCT00739674|1336316|P2|Overall Study|Home monitoring off meds|0
398387|NCT00739674|1336317|P1|Overall Study|Home monitoring off meds|1
398388|NCT00739674|1336316|P2|Overall Study|Unable to attend visit|1
398389|NCT00739674|1336317|P1|Overall Study|Unable to attend visit|3
398390|NCT00739674|1336316|P2|Overall Study|Non compliant|0
398391|NCT00739674|1336317|P1|Overall Study|Non compliant|4
398392|NCT00739674|1336316|P2|Overall Study|Patient moved|2
398393|NCT00739674|1336317|P1|Overall Study|Patient moved|3
398394|NCT00739674|1336316|P2|Overall Study|Clinic closed|4
398395|NCT00739674|1336317|P1|Overall Study|Clinic closed|6
398396|NCT00739674|1336316|P2|Overall Study|Reason missing|0
398397|NCT00739674|1336317|P1|Overall Study|Reason missing|2
398398|NCT00739674|1336316|P2|Overall Study|Withdrawal by Subject|9
398399|NCT00739674|1336317|P1|Overall Study|Withdrawal by Subject|9
398400|NCT00739674|1336316|P2|Overall Study|Protocol Violation|5
398401|NCT00739674|1336317|P1|Overall Study|Protocol Violation|5
398402|NCT00739674|1336316|P2|Overall Study|Lost to Follow-up|30
398403|NCT00739674|1336317|P1|Overall Study|Lost to Follow-up|52
398404|NCT00739674|1336316|P2|Overall Study|Lack of Efficacy|0
398405|NCT00739674|1336317|P1|Overall Study|Lack of Efficacy|1
398406|NCT00739674|1336316|P2|Overall Study|Death|0
398407|NCT00739674|1336317|P1|Overall Study|Death|1
398408|NCT00739674|1336316|P2|Overall Study|Adverse Event|13
398409|NCT00739674|1336317|P1|Overall Study|Adverse Event|22
398410|NCT00739674|1336316|P2|Overall Study|Dietician consultation >30 days|9
398411|NCT00739674|1336317|P1|Overall Study|Dietician consultation >30 days|1
398412|NCT00739674|1336316|P2|Overall Study|No follow-up data|18
398413|NCT00739674|1336317|P1|Overall Study|No follow-up data|33
398414|NCT00739674|1336316|P2|Overall Study|Site 212 removal|13
398415|NCT00739674|1336317|P1|Overall Study|Site 212 removal|19
398416|NCT00739674|1336316|P2|Overall Study|Screening failures|17
398417|NCT00739674|1336317|P1|Overall Study|Screening failures|19
398418|NCT00739661|1336345|P2|Overall Study|Reason for discontinuation not available|1
398419|NCT00739661|1336346|P1|Overall Study|Reason for discontinuation not available|1
398420|NCT00739661|1336345|P2|Overall Study|Disease progression, radiographic|37
398421|NCT00739661|1336346|P1|Overall Study|Disease progression, radiographic|33
398422|NCT00739661|1336345|P2|Overall Study|Patient decision to withdraw|4
398423|NCT00739661|1336346|P1|Overall Study|Patient decision to withdraw|9
398424|NCT00739661|1336345|P2|Overall Study|Physician decision to withdraw patient|0
398425|NCT00739661|1336346|P1|Overall Study|Physician decision to withdraw patient|1
398426|NCT00739661|1336345|P2|Overall Study|Adverse Event|0
398427|NCT00739661|1336346|P1|Overall Study|Adverse Event|2
398428|NCT00739648|1336358|P2|Overall Study|Do not know|6
398429|NCT00739648|1336359|P1|Overall Study|Do not know|4
398430|NCT00739648|1336358|P2|Overall Study|Death|0
398431|NCT00739648|1336359|P1|Overall Study|Death|2
398432|NCT00739648|1336358|P2|Overall Study|Lost to Follow-up|7
398433|NCT00739648|1336359|P1|Overall Study|Lost to Follow-up|4
398434|NCT00739648|1336358|P2|Overall Study|Withdrawal by Subject|25
398435|NCT00739648|1336359|P1|Overall Study|Withdrawal by Subject|13
398436|NCT00739648|1336358|P2|Overall Study|Adverse Event|15
398437|NCT00739648|1336359|P1|Overall Study|Adverse Event|3
398438|NCT00739596|1336373|P2|Overall Study|Protocol Deviation|1
398439|NCT00739596|1336374|P1|Overall Study|Protocol Deviation|1
398440|NCT00739596|1336373|P2|Overall Study|Lost to Follow-up|2
398441|NCT00739596|1336374|P1|Overall Study|Lost to Follow-up|0
398442|NCT00739596|1336373|P2|Overall Study|Patient Withdrew Consent|8
398443|NCT00739596|1336374|P1|Overall Study|Patient Withdrew Consent|8
398444|NCT00739596|1336373|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
398445|NCT00739596|1336374|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
398446|NCT00739596|1336373|P2|Overall Study|Adverse Event|6
398447|NCT00739596|1336374|P1|Overall Study|Adverse Event|12
398448|NCT00739310|1336416|P1|Overall Study|Lost to Follow-up|2
398449|NCT00739310|1336416|P1|Overall Study|Withdrawal by Subject|1
398450|NCT00739310|1336416|P1|Overall Study|Poor adherance to prescribed therapy|4
398451|NCT00739297|1336421|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
398452|NCT00739297|1336422|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
398453|NCT00739297|1336423|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
398454|NCT00739297|1336424|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
398455|NCT00739297|1336425|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
398456|NCT00739297|1336426|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
398457|NCT00739297|1336427|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
398458|NCT00739297|1336421|P7|First Washout Period of 4-7 Days|Adverse Event|2
398459|NCT00739297|1336422|P6|First Washout Period of 4-7 Days|Adverse Event|0
398460|NCT00739297|1336423|P5|First Washout Period of 4-7 Days|Adverse Event|0
398461|NCT00739297|1336424|P4|First Washout Period of 4-7 Days|Adverse Event|2
398462|NCT00739297|1336425|P3|First Washout Period of 4-7 Days|Adverse Event|0
398463|NCT00739297|1336426|P2|First Washout Period of 4-7 Days|Adverse Event|0
398464|NCT00739297|1336427|P1|First Washout Period of 4-7 Days|Adverse Event|0
398465|NCT00739102|1336455|P1|Overall Study|Withdrawal by Subject|10
398466|NCT00739102|1336455|P1|Overall Study|Death|5
398467|NCT00739063|1336471|P1|Overall Study|Screen failures|8
398468|NCT00738881|1336516|P2|Overall Study|Withdrawal by Subject|2
398469|NCT00738881|1336517|P1|Overall Study|Withdrawal by Subject|0
398470|NCT00738699|1336531|P2|Overall Study|Not specified|0
398471|NCT00738699|1336532|P1|Overall Study|Not specified|2
398472|NCT00738699|1336531|P2|Overall Study|Discontinuation of study by Sponsor|72
398473|NCT00738699|1336532|P1|Overall Study|Discontinuation of study by Sponsor|123
398474|NCT00738699|1336531|P2|Overall Study|Death|68
398475|NCT00738699|1336532|P1|Overall Study|Death|144
398476|NCT00738699|1336531|P2|Overall Study|Lost to Follow-up|0
398477|NCT00738699|1336532|P1|Overall Study|Lost to Follow-up|1
398478|NCT00738699|1336531|P2|Overall Study|Withdrawal by Subject|0
398479|NCT00738699|1336532|P1|Overall Study|Withdrawal by Subject|5
398480|NCT00738673|1336550|P2|Overall Study|Withdrawal by Subject|1
398481|NCT00738673|1336551|P1|Overall Study|Withdrawal by Subject|3
398482|NCT00738673|1336550|P2|Overall Study|Protocol Violation|2
398483|NCT00738673|1336551|P1|Overall Study|Protocol Violation|1
398484|NCT00738673|1336550|P2|Overall Study|Lack of Efficacy|8
398485|NCT00738673|1336551|P1|Overall Study|Lack of Efficacy|19
398486|NCT00738673|1336550|P2|Overall Study|Adverse Event|0
398487|NCT00738673|1336551|P1|Overall Study|Adverse Event|1
398488|NCT00738530|1336589|P2|Overall Study|Withdrawal by Subject|8
398489|NCT00738530|1336590|P1|Overall Study|Withdrawal by Subject|6
398490|NCT00738530|1336589|P2|Overall Study|Lost to Follow-up|6
398491|NCT00738530|1336590|P1|Overall Study|Lost to Follow-up|8
398492|NCT00738530|1336589|P2|Overall Study|Death|224
398493|NCT00738530|1336590|P1|Overall Study|Death|220
398494|NCT00738400|1336625|P2|Overall Study|Non-compliant with study medication|1
398495|NCT00738400|1336626|P1|Overall Study|Non-compliant with study medication|0
398496|NCT00738400|1336625|P2|Overall Study|Protocol Violation|0
398497|NCT00738400|1336626|P1|Overall Study|Protocol Violation|1
398498|NCT00738400|1336625|P2|Overall Study|Lost to Follow-up|3
398499|NCT00738400|1336626|P1|Overall Study|Lost to Follow-up|0
398500|NCT00738400|1336625|P2|Overall Study|Lack of Efficacy|1
398501|NCT00738400|1336626|P1|Overall Study|Lack of Efficacy|0
398502|NCT00738400|1336625|P2|Overall Study|Withdrawal by Subject|1
398503|NCT00738400|1336626|P1|Overall Study|Withdrawal by Subject|0
398504|NCT00738400|1336625|P2|Overall Study|Adverse Event|1
398505|NCT00738400|1336626|P1|Overall Study|Adverse Event|3
398506|NCT00738374|1336647|P4|Maintenance Treatment/Observation Phase|Not Specified|0
398507|NCT00738374|1336648|P3|Maintenance Treatment/Observation Phase|Not Specified|0
398508|NCT00738374|1336649|P2|Maintenance Treatment/Observation Phase|Not Specified|1
398509|NCT00738374|1336650|P1|Maintenance Treatment/Observation Phase|Not Specified|0
398510|NCT00738374|1336647|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
398511|NCT00738374|1336648|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
398512|NCT00738374|1336649|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
398513|NCT00738374|1336650|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
398514|NCT00738374|1336647|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
398515|NCT00738374|1336648|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
398516|NCT00738374|1336649|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
398517|NCT00738374|1336650|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
398518|NCT00738374|1336647|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
398519|NCT00738374|1336648|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
398520|NCT00738374|1336649|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
398521|NCT00738374|1336650|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
398522|NCT00738374|1336647|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
398523|NCT00738374|1336648|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
398524|NCT00738374|1336649|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
398525|NCT00738374|1336650|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
398526|NCT00738374|1336647|P4|Induction Treatment Phase|Withdrawal by Subject|0
398527|NCT00738374|1336648|P3|Induction Treatment Phase|Withdrawal by Subject|0
398528|NCT00738374|1336649|P2|Induction Treatment Phase|Withdrawal by Subject|0
398529|NCT00738374|1336650|P1|Induction Treatment Phase|Withdrawal by Subject|1
398530|NCT00738374|1336647|P4|Induction Treatment Phase|Non-compliance|0
398531|NCT00738374|1336648|P3|Induction Treatment Phase|Non-compliance|0
398532|NCT00738374|1336649|P2|Induction Treatment Phase|Non-compliance|0
398533|NCT00738374|1336650|P1|Induction Treatment Phase|Non-compliance|1
398534|NCT00738374|1336647|P4|Induction Treatment Phase|Protocol Violation|0
398535|NCT00738374|1336648|P3|Induction Treatment Phase|Protocol Violation|0
398536|NCT00738374|1336649|P2|Induction Treatment Phase|Protocol Violation|0
398537|NCT00738374|1336650|P1|Induction Treatment Phase|Protocol Violation|2
398538|NCT00738374|1336647|P4|Induction Treatment Phase|Physician Decision|0
398539|NCT00738374|1336648|P3|Induction Treatment Phase|Physician Decision|0
398540|NCT00738374|1336649|P2|Induction Treatment Phase|Physician Decision|0
398541|NCT00738374|1336650|P1|Induction Treatment Phase|Physician Decision|2
398542|NCT00738374|1336647|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
398543|NCT00738374|1336648|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
398544|NCT00738374|1336649|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
398545|NCT00738374|1336650|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
398546|NCT00738374|1336647|P4|Induction Treatment Phase|Adverse Event|0
398547|NCT00738374|1336648|P3|Induction Treatment Phase|Adverse Event|0
398548|NCT00738374|1336649|P2|Induction Treatment Phase|Adverse Event|0
398549|NCT00738374|1336650|P1|Induction Treatment Phase|Adverse Event|14
398550|NCT00738283|1336688|P1|Overall Study|Discharge home prior to end of study|1
398551|NCT00738283|1336688|P1|Overall Study|Transfer to another facility|2
398552|NCT00738283|1336688|P1|Overall Study|Death|1
398553|NCT00738062|1336695|P3|Open-Label Extension|Study Terminated|0
398554|NCT00738062|1336696|P2|Open-Label Extension|Study Terminated|0
398555|NCT00738062|1336697|P1|Open-Label Extension|Study Terminated|2
398556|NCT00738062|1336695|P3|Open-Label Extension|Protocol Violation|0
398557|NCT00738062|1336696|P2|Open-Label Extension|Protocol Violation|0
398558|NCT00738062|1336697|P1|Open-Label Extension|Protocol Violation|1
398559|NCT00738062|1336695|P3|Open-Label Extension|Withdrawal by Subject|0
398560|NCT00738062|1336696|P2|Open-Label Extension|Withdrawal by Subject|0
398561|NCT00738062|1336697|P1|Open-Label Extension|Withdrawal by Subject|6
398562|NCT00738062|1336695|P3|Open-Label Extension|Lack of Efficacy|0
398563|NCT00738062|1336696|P2|Open-Label Extension|Lack of Efficacy|0
398564|NCT00738062|1336697|P1|Open-Label Extension|Lack of Efficacy|2
398565|NCT00738062|1336695|P3|Open-Label Extension|Physician Decision|0
398566|NCT00738062|1336696|P2|Open-Label Extension|Physician Decision|0
398567|NCT00738062|1336697|P1|Open-Label Extension|Physician Decision|1
398568|NCT00738062|1336695|P3|Open-Label Extension|Adverse Event|0
398569|NCT00738062|1336696|P2|Open-Label Extension|Adverse Event|0
398570|NCT00738062|1336697|P1|Open-Label Extension|Adverse Event|5
398571|NCT00738062|1336695|P3|Open Label Treatment|Investigator Decision|0
398572|NCT00738062|1336696|P2|Open Label Treatment|Investigator Decision|0
398573|NCT00738062|1336697|P1|Open Label Treatment|Investigator Decision|1
398574|NCT00738062|1336695|P3|Open Label Treatment|Withdrawal by Subject|0
398575|NCT00738062|1336696|P2|Open Label Treatment|Withdrawal by Subject|0
398576|NCT00738062|1336697|P1|Open Label Treatment|Withdrawal by Subject|9
398577|NCT00738062|1336695|P3|Open Label Treatment|Protocol Violation|0
398578|NCT00738062|1336696|P2|Open Label Treatment|Protocol Violation|0
398579|NCT00738062|1336697|P1|Open Label Treatment|Protocol Violation|2
398580|NCT00738062|1336695|P3|Open Label Treatment|Adverse Event|0
398581|NCT00738062|1336696|P2|Open Label Treatment|Adverse Event|0
398582|NCT00738062|1336697|P1|Open Label Treatment|Adverse Event|11
398583|NCT00738062|1336695|P3|Open Label Treatment|Lack of Efficacy|0
398584|NCT00738062|1336696|P2|Open Label Treatment|Lack of Efficacy|0
398585|NCT00738062|1336697|P1|Open Label Treatment|Lack of Efficacy|5
398586|NCT00737711|1336759|P1|Overall Study|Other|5
398587|NCT00737711|1336759|P1|Overall Study|Blood transfusion|6
398588|NCT00737711|1336759|P1|Overall Study|Withdrawal by Subject|5
398589|NCT00737711|1336759|P1|Overall Study|Protocol Violation|1
398590|NCT00737711|1336759|P1|Overall Study|Failure to return|4
398591|NCT00737711|1336759|P1|Overall Study|Death|8
398592|NCT00737711|1336759|P1|Overall Study|Adverse Event|2
398593|NCT00737672|1336792|P2|Overall Study|Physician Decision|2
398594|NCT00737672|1336793|P1|Overall Study|Physician Decision|0
398595|NCT00737672|1336792|P2|Overall Study|Miscellaneous|1
398596|NCT00737672|1336793|P1|Overall Study|Miscellaneous|7
398597|NCT00737672|1336792|P2|Overall Study|Lost to Follow-up|0
398598|NCT00737672|1336793|P1|Overall Study|Lost to Follow-up|1
398599|NCT00737672|1336792|P2|Overall Study|Withdrawal by Subject|2
398600|NCT00737672|1336793|P1|Overall Study|Withdrawal by Subject|1
398601|NCT00737672|1336792|P2|Overall Study|Death|22
398602|NCT00737672|1336793|P1|Overall Study|Death|23
398603|NCT00737672|1336792|P2|Overall Study|Graft Abandonment|56
398604|NCT00737672|1336793|P1|Overall Study|Graft Abandonment|48
398605|NCT00737633|1336831|P2|Overall Study|protocol non-compliance|1
398606|NCT00737633|1336832|P1|Overall Study|protocol non-compliance|0
398607|NCT00737633|1336831|P2|Overall Study|Lost to Follow-up|1
398608|NCT00737633|1336832|P1|Overall Study|Lost to Follow-up|0
398609|NCT00737633|1336831|P2|Overall Study|Study terminated by sponsor|55
398610|NCT00737633|1336832|P1|Overall Study|Study terminated by sponsor|44
398611|NCT00737568|1336855|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
398612|NCT00737568|1336856|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
398613|NCT00737568|1336855|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
398614|NCT00737568|1336856|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
398615|NCT00737568|1336855|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
398616|NCT00737568|1336856|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
398617|NCT00737568|1336855|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
398618|NCT00737568|1336856|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
398619|NCT00737568|1336855|P2|Treatment Period Through Week 240|Protocol Violation|3
398620|NCT00737568|1336856|P1|Treatment Period Through Week 240|Protocol Violation|2
398621|NCT00737568|1336855|P2|Treatment Period Through Week 240|Lost to Follow-up|3
398622|NCT00737568|1336856|P1|Treatment Period Through Week 240|Lost to Follow-up|3
398623|NCT00737568|1336855|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
398624|NCT00737568|1336856|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
398625|NCT00737568|1336855|P2|Treatment Period Through Week 240|Withdrew Consent|6
398626|NCT00737568|1336856|P1|Treatment Period Through Week 240|Withdrew Consent|5
398627|NCT00737568|1336855|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
398628|NCT00737568|1336856|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
398629|NCT00737529|1336886|P1|Overall Study|Other|2
398630|NCT00737529|1336886|P1|Overall Study|Protocol Violation|1
398631|NCT00737529|1336886|P1|Overall Study|Death|3
398632|NCT00737529|1336886|P1|Overall Study|Withdrawal by Subject|3
398633|NCT00737529|1336886|P1|Overall Study|Adverse Event|23
398634|NCT00737529|1336886|P1|Overall Study|Disease Progression|80
398635|NCT00737477|1336900|P1|Overall Study|Not Specified|4
398636|NCT00737477|1336900|P1|Overall Study|Renal Transplantation|10
398637|NCT00737477|1336900|P1|Overall Study|Withdrawal by Subject|1
398638|NCT00737477|1336900|P1|Overall Study|Treatment Refusal|1
398639|NCT00737477|1336900|P1|Overall Study|Death|9
398640|NCT00737477|1336900|P1|Overall Study|Adverse Event|9
398641|NCT00737464|1336916|P1|Overall Study|Other reasons|4
398642|NCT00737464|1336916|P1|Overall Study|Refused Treatment / Withdrew Consent|6
398643|NCT00737464|1336916|P1|Overall Study|Other - Failure to Return|1
398644|NCT00737464|1336916|P1|Overall Study|Death|6
398645|NCT00737464|1336916|P1|Overall Study|Adverse Event|1
398646|NCT00737438|1336937|P1|Overall Study|Patient ineligible|1
398647|NCT00737438|1336937|P1|Overall Study|Withdrawal by Subject|2
398648|NCT00737282|1336950|P1|Overall Study|Study prematurely terminated|175
398649|NCT00737100|1336993|P3|Overall Study|Reason discontinued not explained above|1
398650|NCT00737100|1336994|P2|Overall Study|Reason discontinued not explained above|1
398651|NCT00737100|1336995|P1|Overall Study|Reason discontinued not explained above|1
398652|NCT00737100|1336993|P3|Overall Study|Withdrawal by Subject|3
398653|NCT00737100|1336994|P2|Overall Study|Withdrawal by Subject|0
398654|NCT00737100|1336995|P1|Overall Study|Withdrawal by Subject|0
398655|NCT00737100|1336993|P3|Overall Study|Lost to Follow-up|0
398656|NCT00737100|1336994|P2|Overall Study|Lost to Follow-up|1
398657|NCT00737100|1336995|P1|Overall Study|Lost to Follow-up|0
398658|NCT00737100|1336993|P3|Overall Study|Adverse Event|3
398659|NCT00737100|1336994|P2|Overall Study|Adverse Event|5
398660|NCT00737100|1336995|P1|Overall Study|Adverse Event|6
398661|NCT00737061|1337039|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
398662|NCT00737061|1337039|P1|1 Year Wearing Period|Discontinued reilance|3
398663|NCT00737061|1337039|P1|1 Year Wearing Period|Withdrawal by Subject|2
398664|NCT00737061|1337039|P1|1 Year Wearing Period|Lost to Follow-up|11
398665|NCT00737061|1337039|P1|Waiting Period|Elected surgical tubal ligation|5
398666|NCT00737061|1337039|P1|Waiting Period|Alternative contraception failure|3
398667|NCT00737061|1337039|P1|Waiting Period|Deemed patent following HSG|26
398668|NCT00737061|1337039|P1|Waiting Period|Bilateral placement failure|34
398669|NCT00737061|1337039|P1|Waiting Period|Withdrawal by Subject|1
398670|NCT00737061|1337039|P1|Waiting Period|Lost to Follow-up|6
398671|NCT00737048|1337056|P3|Overall Study|Worsening of the symptoms|3
398672|NCT00737048|1337057|P2|Overall Study|Worsening of the symptoms|5
398673|NCT00737048|1337058|P1|Overall Study|Worsening of the symptoms|3
398674|NCT00737048|1337056|P3|Overall Study|Adverse Event|0
398675|NCT00737048|1337057|P2|Overall Study|Adverse Event|1
398676|NCT00737048|1337058|P1|Overall Study|Adverse Event|0
398677|NCT00737048|1337056|P3|Overall Study|Physician Decision|1
398678|NCT00737048|1337057|P2|Overall Study|Physician Decision|0
398679|NCT00737048|1337058|P1|Overall Study|Physician Decision|0
398680|NCT00736996|1337102|P3|Overall Study|Lost to Follow-up|2
398681|NCT00736996|1337103|P2|Overall Study|Lost to Follow-up|9
398682|NCT00736996|1337104|P1|Overall Study|Lost to Follow-up|1
398683|NCT00736957|1337118|P1|Overall Study|Physician Decision|5
398684|NCT00736957|1337118|P1|Overall Study|not eligible for Treatment Period I|22
398685|NCT00736957|1337118|P1|Overall Study|did not attend hospital appointments|1
398686|NCT00736957|1337118|P1|Overall Study|violation of eligibility criteria|2
398687|NCT00736957|1337118|P1|Overall Study|Withdrawal by Subject|49
398688|NCT00736957|1337118|P1|Overall Study|Adverse Event|43
398689|NCT00736944|1337128|P1|Definitive Treatment|Physician Decision|1
398690|NCT00736944|1337128|P1|Induction|Death|1
398691|NCT00736879|1337159|P4|Follow up Period - No Drug Treatment|non-specified|0
398692|NCT00736879|1337160|P3|Follow up Period - No Drug Treatment|non-specified|0
398693|NCT00736879|1337161|P2|Follow up Period - No Drug Treatment|non-specified|2
398694|NCT00736879|1337162|P1|Follow up Period - No Drug Treatment|non-specified|1
398695|NCT00736879|1337159|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
398696|NCT00736879|1337160|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
398697|NCT00736879|1337161|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
398698|NCT00736879|1337162|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
398699|NCT00736879|1337159|P4|Double Blind Treatment Period|non-specified|0
398700|NCT00736879|1337160|P3|Double Blind Treatment Period|non-specified|0
398701|NCT00736879|1337161|P2|Double Blind Treatment Period|non-specified|1
398702|NCT00736879|1337162|P1|Double Blind Treatment Period|non-specified|0
398703|NCT00736879|1337159|P4|Double Blind Treatment Period|No longer met criteria|0
398704|NCT00736879|1337160|P3|Double Blind Treatment Period|No longer met criteria|0
398705|NCT00736879|1337161|P2|Double Blind Treatment Period|No longer met criteria|1
398706|NCT00736879|1337162|P1|Double Blind Treatment Period|No longer met criteria|0
398707|NCT00736879|1337159|P4|Double Blind Treatment Period|Poor non-compliance|1
398708|NCT00736879|1337160|P3|Double Blind Treatment Period|Poor non-compliance|1
398709|NCT00736879|1337161|P2|Double Blind Treatment Period|Poor non-compliance|0
398710|NCT00736879|1337162|P1|Double Blind Treatment Period|Poor non-compliance|0
398711|NCT00736879|1337159|P4|Double Blind Treatment Period|Lost to Follow-up|1
398712|NCT00736879|1337160|P3|Double Blind Treatment Period|Lost to Follow-up|2
398713|NCT00736879|1337161|P2|Double Blind Treatment Period|Lost to Follow-up|0
398714|NCT00736879|1337162|P1|Double Blind Treatment Period|Lost to Follow-up|0
398715|NCT00736879|1337159|P4|Double Blind Treatment Period|Withdrawal by Subject|3
398716|NCT00736879|1337160|P3|Double Blind Treatment Period|Withdrawal by Subject|3
398717|NCT00736879|1337161|P2|Double Blind Treatment Period|Withdrawal by Subject|1
398718|NCT00736879|1337162|P1|Double Blind Treatment Period|Withdrawal by Subject|2
398719|NCT00736879|1337159|P4|Double Blind Treatment Period|Adverse Event|0
398720|NCT00736879|1337160|P3|Double Blind Treatment Period|Adverse Event|1
398721|NCT00736879|1337161|P2|Double Blind Treatment Period|Adverse Event|1
398722|NCT00736879|1337162|P1|Double Blind Treatment Period|Adverse Event|0
398723|NCT00736879|1337159|P4|Double Blind Treatment Period|Lack of Efficacy|0
398724|NCT00736879|1337160|P3|Double Blind Treatment Period|Lack of Efficacy|0
398725|NCT00736879|1337161|P2|Double Blind Treatment Period|Lack of Efficacy|0
398726|NCT00736879|1337162|P1|Double Blind Treatment Period|Lack of Efficacy|1
398727|NCT00736853|1337216|P3|Double-Blind Period|Ineligible to participate the study|0
398728|NCT00736853|1337217|P2|Double-Blind Period|Ineligible to participate the study|1
398729|NCT00736853|1337218|P1|Double-Blind Period|Ineligible to participate the study|0
398730|NCT00736853|1337216|P3|Double-Blind Period|Withdrawal by Subject|4
398731|NCT00736853|1337217|P2|Double-Blind Period|Withdrawal by Subject|1
398732|NCT00736853|1337218|P1|Double-Blind Period|Withdrawal by Subject|0
398733|NCT00736853|1337216|P3|Double-Blind Period|Adverse Event|2
398734|NCT00736853|1337217|P2|Double-Blind Period|Adverse Event|3
398735|NCT00736853|1337218|P1|Double-Blind Period|Adverse Event|0
398736|NCT00736853|1337216|P3|Double-Blind Period|Lack of Efficacy|42
398737|NCT00736853|1337217|P2|Double-Blind Period|Lack of Efficacy|19
398738|NCT00736853|1337218|P1|Double-Blind Period|Lack of Efficacy|0
398739|NCT00736853|1337216|P3|Open-Label Period|Unable to attend hospital appointments|0
398740|NCT00736853|1337217|P2|Open-Label Period|Unable to attend hospital appointments|0
398741|NCT00736853|1337218|P1|Open-Label Period|Unable to attend hospital appointments|1
398742|NCT00736853|1337216|P3|Open-Label Period|Failed to meet the transfer criteria|0
398743|NCT00736853|1337217|P2|Open-Label Period|Failed to meet the transfer criteria|0
398744|NCT00736853|1337218|P1|Open-Label Period|Failed to meet the transfer criteria|40
398745|NCT00736853|1337216|P3|Open-Label Period|Started but not treated|0
398746|NCT00736853|1337217|P2|Open-Label Period|Started but not treated|0
398747|NCT00736853|1337218|P1|Open-Label Period|Started but not treated|42
398748|NCT00736853|1337216|P3|Open-Label Period|Withdrawal by Subject|0
398749|NCT00736853|1337217|P2|Open-Label Period|Withdrawal by Subject|0
398750|NCT00736853|1337218|P1|Open-Label Period|Withdrawal by Subject|16
398751|NCT00736853|1337216|P3|Open-Label Period|Adverse Event|0
398752|NCT00736853|1337217|P2|Open-Label Period|Adverse Event|0
398753|NCT00736853|1337218|P1|Open-Label Period|Adverse Event|31
398754|NCT00736853|1337216|P3|Open-Label Period|Physician Decision|0
398755|NCT00736853|1337217|P2|Open-Label Period|Physician Decision|0
398756|NCT00736853|1337218|P1|Open-Label Period|Physician Decision|2
398757|NCT00736840|1337258|P1|Overall Study|Lost to Follow-up|13
398758|NCT00736723|1337265|P2|Overall Study|Withdrawal by Subject|3
398759|NCT00736723|1337266|P1|Overall Study|Withdrawal by Subject|4
398760|NCT00736645|1337276|P4|Overall Study|Adverse Event|0
398761|NCT00736645|1337277|P3|Overall Study|Adverse Event|0
398762|NCT00736645|1337278|P2|Overall Study|Adverse Event|2
398763|NCT00736645|1337279|P1|Overall Study|Adverse Event|0
398764|NCT00736502|1337302|P1|Overall Study|Lost to Follow-up|27
398765|NCT00736502|1337302|P1|Overall Study|Lack of Efficacy|16
398766|NCT00736502|1337302|P1|Overall Study|Adverse Event|22
398767|NCT00736489|1337308|P6|Period 1|Withdrawal by Subject|1
398768|NCT00736489|1337309|P5|Period 1|Withdrawal by Subject|0
398769|NCT00736489|1337310|P4|Period 1|Withdrawal by Subject|0
398770|NCT00736489|1337311|P3|Period 1|Withdrawal by Subject|0
398771|NCT00736489|1337312|P2|Period 1|Withdrawal by Subject|0
398772|NCT00736489|1337313|P1|Period 1|Withdrawal by Subject|0
398773|NCT00736489|1337308|P6|Period 1|Lost to Follow-up|0
398774|NCT00736489|1337309|P5|Period 1|Lost to Follow-up|0
398775|NCT00736489|1337310|P4|Period 1|Lost to Follow-up|0
398776|NCT00736489|1337311|P3|Period 1|Lost to Follow-up|0
398777|NCT00736489|1337312|P2|Period 1|Lost to Follow-up|0
398778|NCT00736489|1337313|P1|Period 1|Lost to Follow-up|1
398779|NCT00736476|1337467|P2|Overall Study|Adverse Event|0
398780|NCT00736476|1337468|P1|Overall Study|Adverse Event|1
398781|NCT00736385|1337490|P2|Overall Study|Adverse Event|1
398782|NCT00736385|1337491|P1|Overall Study|Adverse Event|0
398783|NCT00736385|1337490|P2|Overall Study|Withdrawal by Subject|2
398784|NCT00736385|1337491|P1|Overall Study|Withdrawal by Subject|2
398785|NCT00736333|1337503|P1|Overall Study|Not Specified|4
398786|NCT00736333|1337503|P1|Overall Study|Death|7
398787|NCT00736333|1337503|P1|Overall Study|Withdrawal by Subject|10
398788|NCT00736333|1337503|P1|Overall Study|Toxicity|6
398789|NCT00736333|1337503|P1|Overall Study|Tumor Progression|75
398790|NCT00736333|1337503|P1|Overall Study|Data Missing|2
398791|NCT00736333|1337503|P1|Overall Study|Did Not Receive Drug or Not Documented|7
398792|NCT00736255|1337514|P2|Overall Study|Non-compliance|1
398793|NCT00736255|1337515|P1|Overall Study|Non-compliance|1
398794|NCT00736255|1337514|P2|Overall Study|Physician Decision|0
398795|NCT00736255|1337515|P1|Overall Study|Physician Decision|1
398796|NCT00736255|1337514|P2|Overall Study|Adverse Event|0
398797|NCT00736255|1337515|P1|Overall Study|Adverse Event|1
398798|NCT00736190|1337554|P1|Overall Study|Adverse Event|1
398799|NCT00736190|1337554|P1|Overall Study|Withdrawal by Subject|1
398800|NCT00736190|1337554|P1|Overall Study|Pregnancy|1
398801|NCT00736099|1337580|P2|Overall Study|Other reason|10
398802|NCT00736099|1337581|P1|Overall Study|Other reason|43
398803|NCT00736099|1337580|P2|Overall Study|Lack of Efficacy|8
398804|NCT00736099|1337581|P1|Overall Study|Lack of Efficacy|15
398805|NCT00736099|1337580|P2|Overall Study|Withdrawal by Subject|13
398806|NCT00736099|1337581|P1|Overall Study|Withdrawal by Subject|42
398807|NCT00736099|1337580|P2|Overall Study|Lost to Follow-up|5
398808|NCT00736099|1337581|P1|Overall Study|Lost to Follow-up|12
398809|NCT00736099|1337580|P2|Overall Study|Protocol Violation|4
398810|NCT00736099|1337581|P1|Overall Study|Protocol Violation|10
398811|NCT00736099|1337580|P2|Overall Study|Adverse Event|18
398812|NCT00736099|1337581|P1|Overall Study|Adverse Event|61
398813|NCT00736034|1337690|P1|Overall Study|Adverse Event|2
398814|NCT00735943|1337698|P1|Overall Study|Adverse Event|1
398815|NCT00735943|1337698|P1|Overall Study|Lost to Follow-up|1
398816|NCT00735904|1337723|P1|Overall Study|Other|8
398817|NCT00735904|1337723|P1|Overall Study|Study Terminated by Sponsor|5
398818|NCT00735904|1337723|P1|Overall Study|Withdrawal by Subject|1
398819|NCT00735904|1337723|P1|Overall Study|Protocol Violation|1
398820|NCT00735904|1337723|P1|Overall Study|Death|20
398821|NCT00735904|1337723|P1|Overall Study|Adverse Event|3
398822|NCT00735709|1337792|P4|Overall Study|Excluded medication|1
398823|NCT00735709|1337793|P3|Overall Study|Excluded medication|0
398824|NCT00735709|1337794|P2|Overall Study|Excluded medication|0
398825|NCT00735709|1337795|P1|Overall Study|Excluded medication|1
398826|NCT00735709|1337792|P4|Overall Study|Lost to Follow-up|1
398827|NCT00735709|1337793|P3|Overall Study|Lost to Follow-up|1
398828|NCT00735709|1337794|P2|Overall Study|Lost to Follow-up|1
398829|NCT00735709|1337795|P1|Overall Study|Lost to Follow-up|0
398830|NCT00735709|1337792|P4|Overall Study|Voluntary Withdrawal|7
398831|NCT00735709|1337793|P3|Overall Study|Voluntary Withdrawal|5
398832|NCT00735709|1337794|P2|Overall Study|Voluntary Withdrawal|3
398833|NCT00735709|1337795|P1|Overall Study|Voluntary Withdrawal|1
398834|NCT00735709|1337792|P4|Overall Study|Protocol deviations|1
398835|NCT00735709|1337793|P3|Overall Study|Protocol deviations|1
398836|NCT00735709|1337794|P2|Overall Study|Protocol deviations|2
398837|NCT00735709|1337795|P1|Overall Study|Protocol deviations|1
398838|NCT00735709|1337792|P4|Overall Study|Noncompliance|0
398839|NCT00735709|1337793|P3|Overall Study|Noncompliance|1
398840|NCT00735709|1337794|P2|Overall Study|Noncompliance|0
398841|NCT00735709|1337795|P1|Overall Study|Noncompliance|0
398842|NCT00735709|1337792|P4|Overall Study|Lack of Efficacy|3
398843|NCT00735709|1337793|P3|Overall Study|Lack of Efficacy|2
398844|NCT00735709|1337794|P2|Overall Study|Lack of Efficacy|4
398845|NCT00735709|1337795|P1|Overall Study|Lack of Efficacy|8
398846|NCT00735709|1337792|P4|Overall Study|Adverse Event|5
398847|NCT00735709|1337793|P3|Overall Study|Adverse Event|1
398848|NCT00735709|1337794|P2|Overall Study|Adverse Event|3
398849|NCT00735709|1337795|P1|Overall Study|Adverse Event|2
398850|NCT00735696|1337905|P1|Overall Study|Enrolled but never Treated|1
398851|NCT00735696|1337905|P1|Overall Study|Withdrawal by Subject|1
398852|NCT00735644|1337933|P5|Overall Study|Withdrawal by Subject|0
398853|NCT00735644|1337934|P4|Overall Study|Withdrawal by Subject|1
398854|NCT00735644|1337935|P3|Overall Study|Withdrawal by Subject|1
398855|NCT00735644|1337936|P2|Overall Study|Withdrawal by Subject|1
398856|NCT00735644|1337937|P1|Overall Study|Withdrawal by Subject|0
398857|NCT00735644|1337933|P5|Overall Study|Did not receive study vaccine|0
398858|NCT00735644|1337934|P4|Overall Study|Did not receive study vaccine|0
398859|NCT00735644|1337935|P3|Overall Study|Did not receive study vaccine|0
398860|NCT00735644|1337936|P2|Overall Study|Did not receive study vaccine|1
398861|NCT00735644|1337937|P1|Overall Study|Did not receive study vaccine|0
398862|NCT00735553|1337981|P1|Overall Study|Study prematurely terminated|77
398863|NCT00735475|1337991|P2|Overall Study|Withdrawal by Subject|5
398864|NCT00735475|1337992|P1|Overall Study|Withdrawal by Subject|4
398865|NCT00735475|1337991|P2|Overall Study|Physician Decision|1
398866|NCT00735475|1337992|P1|Overall Study|Physician Decision|0
398867|NCT00735475|1337991|P2|Overall Study|Lost to Follow-up|3
398868|NCT00735475|1337992|P1|Overall Study|Lost to Follow-up|3
398869|NCT00735475|1337991|P2|Overall Study|Death|1
398870|NCT00735475|1337992|P1|Overall Study|Death|1
398871|NCT00735475|1337991|P2|Overall Study|Adverse Event|1
398872|NCT00735475|1337992|P1|Overall Study|Adverse Event|0
398873|NCT00735397|1338052|P1|Overall Study|Administrative/Other|502
398874|NCT00735397|1338052|P1|Overall Study|Inadequate therapeutic effect|202
398875|NCT00735397|1338052|P1|Overall Study|Participant choice|252
398876|NCT00735397|1338052|P1|Overall Study|Lost to Follow-up|33
398877|NCT00735397|1338052|P1|Overall Study|Adverse Event|194
398878|NCT00735371|1338066|P4|Overall Study|Exclusion criteria|0
398879|NCT00735371|1338067|P3|Overall Study|Exclusion criteria|0
398880|NCT00735371|1338068|P2|Overall Study|Exclusion criteria|0
398881|NCT00735371|1338069|P1|Overall Study|Exclusion criteria|1
398882|NCT00735371|1338066|P4|Overall Study|Prior Vyvanse Exposure|0
398883|NCT00735371|1338067|P3|Overall Study|Prior Vyvanse Exposure|0
398884|NCT00735371|1338068|P2|Overall Study|Prior Vyvanse Exposure|1
398885|NCT00735371|1338069|P1|Overall Study|Prior Vyvanse Exposure|1
398886|NCT00735371|1338066|P4|Overall Study|Protocol Violation|0
398887|NCT00735371|1338067|P3|Overall Study|Protocol Violation|2
398888|NCT00735371|1338068|P2|Overall Study|Protocol Violation|1
398889|NCT00735371|1338069|P1|Overall Study|Protocol Violation|0
398890|NCT00735371|1338066|P4|Overall Study|Sponsor Decision|1
398891|NCT00735371|1338067|P3|Overall Study|Sponsor Decision|0
398892|NCT00735371|1338068|P2|Overall Study|Sponsor Decision|1
398893|NCT00735371|1338069|P1|Overall Study|Sponsor Decision|3
398894|NCT00735371|1338066|P4|Overall Study|Lack of Efficacy|4
398895|NCT00735371|1338067|P3|Overall Study|Lack of Efficacy|0
398896|NCT00735371|1338068|P2|Overall Study|Lack of Efficacy|2
398897|NCT00735371|1338069|P1|Overall Study|Lack of Efficacy|4
398898|NCT00735371|1338066|P4|Overall Study|Lost to Follow-up|1
398899|NCT00735371|1338067|P3|Overall Study|Lost to Follow-up|3
398900|NCT00735371|1338068|P2|Overall Study|Lost to Follow-up|1
398901|NCT00735371|1338069|P1|Overall Study|Lost to Follow-up|1
398902|NCT00735371|1338066|P4|Overall Study|Withdrawal by Subject|0
398903|NCT00735371|1338067|P3|Overall Study|Withdrawal by Subject|2
398904|NCT00735371|1338068|P2|Overall Study|Withdrawal by Subject|2
398905|NCT00735371|1338069|P1|Overall Study|Withdrawal by Subject|0
398906|NCT00735371|1338066|P4|Overall Study|Protocol Violation|3
398907|NCT00735371|1338067|P3|Overall Study|Protocol Violation|0
398908|NCT00735371|1338068|P2|Overall Study|Protocol Violation|2
398909|NCT00735371|1338069|P1|Overall Study|Protocol Violation|2
398910|NCT00735371|1338066|P4|Overall Study|Adverse Event|1
398911|NCT00735371|1338067|P3|Overall Study|Adverse Event|4
398912|NCT00735371|1338068|P2|Overall Study|Adverse Event|3
398913|NCT00735371|1338069|P1|Overall Study|Adverse Event|3
398914|NCT00735254|1338097|P4|Overall Study|Protocol Violation|0
398915|NCT00735254|1338098|P3|Overall Study|Protocol Violation|1
398916|NCT00735254|1338099|P2|Overall Study|Protocol Violation|1
398917|NCT00735254|1338100|P1|Overall Study|Protocol Violation|1
398918|NCT00735072|1338112|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
398919|NCT00735072|1338113|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
398920|NCT00735072|1338112|P2|Overall Study|interrupted study med during ARV change|0
398921|NCT00735072|1338113|P1|Overall Study|interrupted study med during ARV change|1
398922|NCT00735007|1338119|P1|Overall Study|Protocol Violation|1
398923|NCT00735007|1338119|P1|Overall Study|Adverse Event|4
398924|NCT00734994|1338144|P1|Overall Study|Withdrawal by Subject|1
398925|NCT00734929|1338164|P2|Overall Study|No intervention/ screen fail|3
398926|NCT00734929|1338165|P1|Overall Study|No intervention/ screen fail|5
398927|NCT00734929|1338164|P2|Overall Study|Lost to Follow-up|2
398928|NCT00734929|1338165|P1|Overall Study|Lost to Follow-up|1
398929|NCT00734851|1338193|P1|Overall Study|Physician Decision|18
398930|NCT00734851|1338193|P1|Overall Study|Lost to Follow-up|1
398931|NCT00734851|1338193|P1|Overall Study|Withdrawal by Subject|2
398932|NCT00734747|1338214|P1|6 Month Follow-up|Did not meet inclusion criteria|3
398933|NCT00734747|1338214|P1|SRS Procedure|No staples placed|3
398934|NCT00734656|1338228|P4|Lab Session 4|Withdrawal by Subject|1
398935|NCT00734656|1338229|P3|Lab Session 4|Withdrawal by Subject|0
398936|NCT00734656|1338230|P2|Lab Session 4|Withdrawal by Subject|0
398937|NCT00734656|1338231|P1|Lab Session 4|Withdrawal by Subject|0
398938|NCT00734656|1338228|P4|Washout 3|Withdrawal by Subject|1
398939|NCT00734656|1338229|P3|Washout 3|Withdrawal by Subject|0
398940|NCT00734656|1338230|P2|Washout 3|Withdrawal by Subject|0
398941|NCT00734656|1338231|P1|Washout 3|Withdrawal by Subject|1
398942|NCT00734656|1338228|P4|Washout 2|Withdrawal by Subject|0
398943|NCT00734656|1338229|P3|Washout 2|Withdrawal by Subject|1
398944|NCT00734656|1338230|P2|Washout 2|Withdrawal by Subject|1
398945|NCT00734656|1338231|P1|Washout 2|Withdrawal by Subject|1
398946|NCT00734656|1338228|P4|Lab Session 2|Withdrawal by Subject|1
398947|NCT00734656|1338229|P3|Lab Session 2|Withdrawal by Subject|0
398948|NCT00734656|1338230|P2|Lab Session 2|Withdrawal by Subject|0
398949|NCT00734656|1338231|P1|Lab Session 2|Withdrawal by Subject|1
398950|NCT00734656|1338228|P4|Washout 1|Withdrawal by Subject|3
398951|NCT00734656|1338229|P3|Washout 1|Withdrawal by Subject|2
398952|NCT00734656|1338230|P2|Washout 1|Withdrawal by Subject|5
398953|NCT00734656|1338231|P1|Washout 1|Withdrawal by Subject|1
398954|NCT00734656|1338228|P4|Lab Session 1|Withdrawal by Subject|0
398955|NCT00734656|1338229|P3|Lab Session 1|Withdrawal by Subject|0
398956|NCT00734656|1338230|P2|Lab Session 1|Withdrawal by Subject|0
398957|NCT00734656|1338231|P1|Lab Session 1|Withdrawal by Subject|2
398958|NCT00734630|1338255|P2|Overall Study|Poor Compliance|1
398959|NCT00734630|1338256|P1|Overall Study|Poor Compliance|1
398960|NCT00734630|1338255|P2|Overall Study|Tested Positive for Illegal Drug Use|1
398961|NCT00734630|1338256|P1|Overall Study|Tested Positive for Illegal Drug Use|1
398962|NCT00734630|1338255|P2|Overall Study|Randomized in Error|1
398963|NCT00734630|1338256|P1|Overall Study|Randomized in Error|0
398964|NCT00734630|1338255|P2|Overall Study|Adverse Event|6
398965|NCT00734630|1338256|P1|Overall Study|Adverse Event|3
398966|NCT00734630|1338255|P2|Overall Study|Inclusion/Exclusion criteria not met|1
398967|NCT00734630|1338256|P1|Overall Study|Inclusion/Exclusion criteria not met|0
398968|NCT00734630|1338255|P2|Overall Study|Protocol Violation|3
398969|NCT00734630|1338256|P1|Overall Study|Protocol Violation|0
398970|NCT00734630|1338255|P2|Overall Study|Lost to Follow-up|7
398971|NCT00734630|1338256|P1|Overall Study|Lost to Follow-up|13
398972|NCT00734630|1338255|P2|Overall Study|Withdrawal by Subject|9
398973|NCT00734630|1338256|P1|Overall Study|Withdrawal by Subject|7
398974|NCT00734630|1338255|P2|Overall Study|Lack of Efficacy|4
398975|NCT00734630|1338256|P1|Overall Study|Lack of Efficacy|4
398976|NCT00734617|1338266|P2|Overall Study|Withdrawal by Subject|95
398977|NCT00734617|1338267|P1|Overall Study|Withdrawal by Subject|103
398978|NCT00734617|1338266|P2|Overall Study|Adverse Event|7
398979|NCT00734617|1338267|P1|Overall Study|Adverse Event|4
398980|NCT00734604|1338279|P6|Overall Study|Lack of Efficacy|0
398981|NCT00734604|1338280|P5|Overall Study|Lack of Efficacy|0
398982|NCT00734604|1338281|P4|Overall Study|Lack of Efficacy|0
398983|NCT00734604|1338282|P3|Overall Study|Lack of Efficacy|1
398984|NCT00734604|1338283|P2|Overall Study|Lack of Efficacy|1
398985|NCT00734604|1338284|P1|Overall Study|Lack of Efficacy|0
398986|NCT00734604|1338279|P6|Overall Study|Withdrawal by Subject|1
398987|NCT00734604|1338280|P5|Overall Study|Withdrawal by Subject|2
398988|NCT00734604|1338281|P4|Overall Study|Withdrawal by Subject|1
398989|NCT00734604|1338282|P3|Overall Study|Withdrawal by Subject|0
398990|NCT00734604|1338283|P2|Overall Study|Withdrawal by Subject|2
398991|NCT00734604|1338284|P1|Overall Study|Withdrawal by Subject|0
398992|NCT00734604|1338279|P6|Overall Study|Sponsor Decision|0
398993|NCT00734604|1338280|P5|Overall Study|Sponsor Decision|2
398994|NCT00734604|1338281|P4|Overall Study|Sponsor Decision|0
398995|NCT00734604|1338282|P3|Overall Study|Sponsor Decision|1
398996|NCT00734604|1338283|P2|Overall Study|Sponsor Decision|2
398997|NCT00734604|1338284|P1|Overall Study|Sponsor Decision|1
398998|NCT00734604|1338279|P6|Overall Study|Protocol Violation|0
398999|NCT00734604|1338280|P5|Overall Study|Protocol Violation|1
399000|NCT00734604|1338281|P4|Overall Study|Protocol Violation|0
399001|NCT00734604|1338282|P3|Overall Study|Protocol Violation|0
399002|NCT00734604|1338283|P2|Overall Study|Protocol Violation|2
399003|NCT00734604|1338284|P1|Overall Study|Protocol Violation|0
399004|NCT00734604|1338279|P6|Overall Study|Physician Decision|0
399005|NCT00734604|1338280|P5|Overall Study|Physician Decision|0
399006|NCT00734604|1338281|P4|Overall Study|Physician Decision|0
399007|NCT00734604|1338282|P3|Overall Study|Physician Decision|1
399008|NCT00734604|1338283|P2|Overall Study|Physician Decision|1
399009|NCT00734604|1338284|P1|Overall Study|Physician Decision|0
399010|NCT00734604|1338279|P6|Overall Study|Lost to Follow-up|3
399011|NCT00734604|1338280|P5|Overall Study|Lost to Follow-up|2
399012|NCT00734604|1338281|P4|Overall Study|Lost to Follow-up|4
399013|NCT00734604|1338282|P3|Overall Study|Lost to Follow-up|2
399014|NCT00734604|1338283|P2|Overall Study|Lost to Follow-up|2
399015|NCT00734604|1338284|P1|Overall Study|Lost to Follow-up|1
399016|NCT00734604|1338279|P6|Overall Study|Serious Adverse Event|1
399017|NCT00734604|1338280|P5|Overall Study|Serious Adverse Event|0
399018|NCT00734604|1338281|P4|Overall Study|Serious Adverse Event|2
399019|NCT00734604|1338282|P3|Overall Study|Serious Adverse Event|1
399020|NCT00734604|1338283|P2|Overall Study|Serious Adverse Event|0
399021|NCT00734604|1338284|P1|Overall Study|Serious Adverse Event|1
399022|NCT00734604|1338279|P6|Overall Study|Adverse Event|1
399023|NCT00734604|1338280|P5|Overall Study|Adverse Event|1
399024|NCT00734604|1338281|P4|Overall Study|Adverse Event|2
399025|NCT00734604|1338282|P3|Overall Study|Adverse Event|0
399026|NCT00734604|1338283|P2|Overall Study|Adverse Event|2
399027|NCT00734604|1338284|P1|Overall Study|Adverse Event|0
399028|NCT00734591|1338334|P2|Prospective Period|Other|2
399029|NCT00734591|1338335|P1|Prospective Period|Other|2
399030|NCT00734591|1338334|P2|Prospective Period|Study Terminated|0
399031|NCT00734591|1338335|P1|Prospective Period|Study Terminated|1
399032|NCT00734591|1338334|P2|Prospective Period|Lost to Follow-up|33
399033|NCT00734591|1338335|P1|Prospective Period|Lost to Follow-up|37
399034|NCT00734591|1338334|P2|Prospective Period|Withdrawal by Subject|9
399035|NCT00734591|1338335|P1|Prospective Period|Withdrawal by Subject|11
399036|NCT00734591|1338334|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
399037|NCT00734591|1338335|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
399038|NCT00734591|1338334|P2|Screening for Prospective Period|Site did not participate|1488
399039|NCT00734591|1338335|P1|Screening for Prospective Period|Site did not participate|1604
399040|NCT00734578|1338350|P3|Overall Study|Exclusion criteria|0
399041|NCT00734578|1338351|P2|Overall Study|Exclusion criteria|0
399042|NCT00734578|1338352|P1|Overall Study|Exclusion criteria|1
399043|NCT00734578|1338350|P3|Overall Study|Randomized in error|0
399044|NCT00734578|1338351|P2|Overall Study|Randomized in error|0
399045|NCT00734578|1338352|P1|Overall Study|Randomized in error|1
399046|NCT00734578|1338350|P3|Overall Study|Lack of Efficacy|5
399047|NCT00734578|1338351|P2|Overall Study|Lack of Efficacy|2
399048|NCT00734578|1338352|P1|Overall Study|Lack of Efficacy|3
399049|NCT00734578|1338350|P3|Overall Study|Lost to Follow-up|5
399050|NCT00734578|1338351|P2|Overall Study|Lost to Follow-up|3
399051|NCT00734578|1338352|P1|Overall Study|Lost to Follow-up|9
399052|NCT00734578|1338350|P3|Overall Study|Withdrawal by Subject|11
399053|NCT00734578|1338351|P2|Overall Study|Withdrawal by Subject|8
399054|NCT00734578|1338352|P1|Overall Study|Withdrawal by Subject|7
399055|NCT00734578|1338350|P3|Overall Study|Protocol Violation|3
399056|NCT00734578|1338351|P2|Overall Study|Protocol Violation|6
399057|NCT00734578|1338352|P1|Overall Study|Protocol Violation|8
399058|NCT00734578|1338350|P3|Overall Study|Adverse Event|1
399059|NCT00734578|1338351|P2|Overall Study|Adverse Event|6
399060|NCT00734578|1338352|P1|Overall Study|Adverse Event|4
399061|NCT00734539|1338386|P2|Main Study|Enrolled in error; ineligible|0
399062|NCT00734539|1338387|P1|Main Study|Enrolled in error; ineligible|1
399063|NCT00734539|1338386|P2|Main Study|Withdrawal by Subject|3
399064|NCT00734539|1338387|P1|Main Study|Withdrawal by Subject|1
399065|NCT00734539|1338386|P2|Main Study|Physician Decision|0
399066|NCT00734539|1338387|P1|Main Study|Physician Decision|2
399067|NCT00734539|1338386|P2|Main Study|Death|32
399068|NCT00734539|1338387|P1|Main Study|Death|33
399069|NCT00734474|1338429|P9|Overall Study|Lack of Efficacy|6
399070|NCT00734474|1338430|P8|Overall Study|Lack of Efficacy|4
399071|NCT00734474|1338431|P7|Overall Study|Lack of Efficacy|0
399072|NCT00734474|1338432|P6|Overall Study|Lack of Efficacy|0
399073|NCT00734474|1338433|P5|Overall Study|Lack of Efficacy|0
399074|NCT00734474|1338434|P4|Overall Study|Lack of Efficacy|0
399075|NCT00734474|1338435|P3|Overall Study|Lack of Efficacy|4
399076|NCT00734474|1338436|P2|Overall Study|Lack of Efficacy|0
399077|NCT00734474|1338437|P1|Overall Study|Lack of Efficacy|0
399078|NCT00734474|1338429|P9|Overall Study|Death|1
399079|NCT00734474|1338430|P8|Overall Study|Death|2
399080|NCT00734474|1338431|P7|Overall Study|Death|0
399081|NCT00734474|1338432|P6|Overall Study|Death|0
399082|NCT00734474|1338433|P5|Overall Study|Death|0
399083|NCT00734474|1338434|P4|Overall Study|Death|0
399084|NCT00734474|1338435|P3|Overall Study|Death|1
399085|NCT00734474|1338436|P2|Overall Study|Death|0
399086|NCT00734474|1338437|P1|Overall Study|Death|0
399087|NCT00734474|1338429|P9|Overall Study|Sponsor Decision|0
399088|NCT00734474|1338430|P8|Overall Study|Sponsor Decision|0
399089|NCT00734474|1338431|P7|Overall Study|Sponsor Decision|0
399090|NCT00734474|1338432|P6|Overall Study|Sponsor Decision|0
399091|NCT00734474|1338433|P5|Overall Study|Sponsor Decision|2
399092|NCT00734474|1338434|P4|Overall Study|Sponsor Decision|0
399093|NCT00734474|1338435|P3|Overall Study|Sponsor Decision|0
399094|NCT00734474|1338436|P2|Overall Study|Sponsor Decision|0
399095|NCT00734474|1338437|P1|Overall Study|Sponsor Decision|0
399096|NCT00734474|1338429|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
399097|NCT00734474|1338430|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
399098|NCT00734474|1338431|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
399099|NCT00734474|1338432|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
399100|NCT00734474|1338433|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
399101|NCT00734474|1338434|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
399102|NCT00734474|1338435|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
399103|NCT00734474|1338436|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
399104|NCT00734474|1338437|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
399105|NCT00734474|1338429|P9|Overall Study|Protocol Violation|1
399106|NCT00734474|1338430|P8|Overall Study|Protocol Violation|3
399107|NCT00734474|1338431|P7|Overall Study|Protocol Violation|0
399108|NCT00734474|1338432|P6|Overall Study|Protocol Violation|0
399109|NCT00734474|1338433|P5|Overall Study|Protocol Violation|3
399110|NCT00734474|1338434|P4|Overall Study|Protocol Violation|0
399111|NCT00734474|1338435|P3|Overall Study|Protocol Violation|4
399112|NCT00734474|1338436|P2|Overall Study|Protocol Violation|0
399113|NCT00734474|1338437|P1|Overall Study|Protocol Violation|0
399114|NCT00734474|1338429|P9|Overall Study|Adverse Event|39
399115|NCT00734474|1338430|P8|Overall Study|Adverse Event|65
399116|NCT00734474|1338431|P7|Overall Study|Adverse Event|1
399117|NCT00734474|1338432|P6|Overall Study|Adverse Event|0
399118|NCT00734474|1338433|P5|Overall Study|Adverse Event|64
399119|NCT00734474|1338434|P4|Overall Study|Adverse Event|1
399120|NCT00734474|1338435|P3|Overall Study|Adverse Event|63
399121|NCT00734474|1338436|P2|Overall Study|Adverse Event|4
399122|NCT00734474|1338437|P1|Overall Study|Adverse Event|4
399123|NCT00734474|1338429|P9|Overall Study|Physician Decision|9
399124|NCT00734474|1338430|P8|Overall Study|Physician Decision|9
399125|NCT00734474|1338431|P7|Overall Study|Physician Decision|0
399126|NCT00734474|1338432|P6|Overall Study|Physician Decision|0
399127|NCT00734474|1338433|P5|Overall Study|Physician Decision|11
399128|NCT00734474|1338434|P4|Overall Study|Physician Decision|1
399129|NCT00734474|1338435|P3|Overall Study|Physician Decision|4
399130|NCT00734474|1338436|P2|Overall Study|Physician Decision|0
399131|NCT00734474|1338437|P1|Overall Study|Physician Decision|0
399132|NCT00734474|1338429|P9|Overall Study|Withdrawal by Subject|21
399133|NCT00734474|1338430|P8|Overall Study|Withdrawal by Subject|36
399134|NCT00734474|1338431|P7|Overall Study|Withdrawal by Subject|0
399135|NCT00734474|1338432|P6|Overall Study|Withdrawal by Subject|2
399136|NCT00734474|1338433|P5|Overall Study|Withdrawal by Subject|24
399137|NCT00734474|1338434|P4|Overall Study|Withdrawal by Subject|0
399138|NCT00734474|1338435|P3|Overall Study|Withdrawal by Subject|18
399139|NCT00734474|1338436|P2|Overall Study|Withdrawal by Subject|1
399140|NCT00734474|1338437|P1|Overall Study|Withdrawal by Subject|2
399141|NCT00734474|1338429|P9|Overall Study|Lost to Follow-up|4
399142|NCT00734474|1338430|P8|Overall Study|Lost to Follow-up|9
399143|NCT00734474|1338431|P7|Overall Study|Lost to Follow-up|0
399144|NCT00734474|1338432|P6|Overall Study|Lost to Follow-up|1
399145|NCT00734474|1338433|P5|Overall Study|Lost to Follow-up|11
399146|NCT00734474|1338434|P4|Overall Study|Lost to Follow-up|0
399147|NCT00734474|1338435|P3|Overall Study|Lost to Follow-up|13
399148|NCT00734474|1338436|P2|Overall Study|Lost to Follow-up|0
399149|NCT00734474|1338437|P1|Overall Study|Lost to Follow-up|1
399150|NCT00734474|1338429|P9|Overall Study|Entry Criteria Not Met|1
399151|NCT00734474|1338430|P8|Overall Study|Entry Criteria Not Met|1
399152|NCT00734474|1338431|P7|Overall Study|Entry Criteria Not Met|0
399153|NCT00734474|1338432|P6|Overall Study|Entry Criteria Not Met|1
399154|NCT00734474|1338433|P5|Overall Study|Entry Criteria Not Met|3
399155|NCT00734474|1338434|P4|Overall Study|Entry Criteria Not Met|0
399156|NCT00734474|1338435|P3|Overall Study|Entry Criteria Not Met|5
399157|NCT00734474|1338436|P2|Overall Study|Entry Criteria Not Met|0
399158|NCT00734474|1338437|P1|Overall Study|Entry Criteria Not Met|0
399159|NCT00734214|1338727|P2|Overall Study|MD withdrawal|0
399160|NCT00734214|1338728|P1|Overall Study|MD withdrawal|1
399161|NCT00734214|1338727|P2|Overall Study|Withdrawal by Subject|4
399162|NCT00734214|1338728|P1|Overall Study|Withdrawal by Subject|3
399163|NCT00734162|1338738|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
399164|NCT00734162|1338739|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
399165|NCT00734162|1338740|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
399166|NCT00734162|1338741|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
399167|NCT00734162|1338738|P4|Open-Label Phase|Lost to Follow-up|1
399168|NCT00734162|1338739|P3|Open-Label Phase|Lost to Follow-up|0
399169|NCT00734162|1338740|P2|Open-Label Phase|Lost to Follow-up|2
399170|NCT00734162|1338741|P1|Open-Label Phase|Lost to Follow-up|1
399171|NCT00734162|1338738|P4|Open-Label Phase|Withdrew Consent|1
399172|NCT00734162|1338739|P3|Open-Label Phase|Withdrew Consent|1
399173|NCT00734162|1338740|P2|Open-Label Phase|Withdrew Consent|0
399174|NCT00734162|1338741|P1|Open-Label Phase|Withdrew Consent|1
399175|NCT00734162|1338738|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
399176|NCT00734162|1338739|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
399177|NCT00734162|1338740|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
399178|NCT00734162|1338741|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
399179|NCT00734162|1338738|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
399180|NCT00734162|1338739|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
399181|NCT00734162|1338740|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
399182|NCT00734162|1338741|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
399183|NCT00734162|1338738|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
399184|NCT00734162|1338739|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
399185|NCT00734162|1338740|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
399186|NCT00734162|1338741|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
399187|NCT00734149|1338965|P1|Overall Study|Withdrawal by Subject|1
399188|NCT00734097|1338972|P1|Open Label|Protocol Violation|4
399189|NCT00734097|1338972|P1|Open Label|Withdrawal by Subject|5
399190|NCT00734097|1338972|P1|Open Label|Lost to Follow-up|7
399191|NCT00734097|1338972|P1|Screening|Unconfirmed pregnancy|1
399192|NCT00734097|1338972|P1|Screening|Lost to Follow-up|2
399193|NCT00734097|1338972|P1|Screening|Withdrawal by Subject|5
399194|NCT00734097|1338972|P1|Screening|Protocol Violation|12
399195|NCT00734071|1338989|P2|Overall Study|Other|2
399196|NCT00734071|1338990|P1|Overall Study|Other|1
399197|NCT00734071|1338989|P2|Overall Study|Lost to Follow-up|8
399198|NCT00734071|1338990|P1|Overall Study|Lost to Follow-up|16
399199|NCT00734071|1338989|P2|Overall Study|Voluntary Withdrawal|7
399200|NCT00734071|1338990|P1|Overall Study|Voluntary Withdrawal|9
399201|NCT00734071|1338989|P2|Overall Study|Protocol Deviations|4
399202|NCT00734071|1338990|P1|Overall Study|Protocol Deviations|3
399203|NCT00734071|1338989|P2|Overall Study|Noncompliance|2
399204|NCT00734071|1338990|P1|Overall Study|Noncompliance|2
399205|NCT00734071|1338989|P2|Overall Study|Lack of Efficacy|1
399206|NCT00734071|1338990|P1|Overall Study|Lack of Efficacy|3
399207|NCT00734071|1338989|P2|Overall Study|Adverse Event|3
399208|NCT00734071|1338990|P1|Overall Study|Adverse Event|4
399209|NCT00734032|1339048|P4|Overall Study|Adverse Event|0
399210|NCT00734032|1339049|P3|Overall Study|Adverse Event|0
399211|NCT00734032|1339050|P2|Overall Study|Adverse Event|1
399212|NCT00734032|1339051|P1|Overall Study|Adverse Event|0
399213|NCT00733980|1339107|P2|Overall Study|Withdrawal by Subject|2
399214|NCT00733980|1339108|P1|Overall Study|Withdrawal by Subject|6
399215|NCT00733980|1339107|P2|Overall Study|Physician Decision|3
399216|NCT00733980|1339108|P1|Overall Study|Physician Decision|2
399217|NCT00733980|1339107|P2|Overall Study|Lost to Follow-up|11
399218|NCT00733980|1339108|P1|Overall Study|Lost to Follow-up|6
399219|NCT00733980|1339107|P2|Overall Study|Protocol defined stopping criteria reach|1
399220|NCT00733980|1339108|P1|Overall Study|Protocol defined stopping criteria reach|1
399221|NCT00733980|1339107|P2|Overall Study|Protocol Violation|1
399222|NCT00733980|1339108|P1|Overall Study|Protocol Violation|2
399223|NCT00733980|1339107|P2|Overall Study|Lack of Efficacy|1
399224|NCT00733980|1339108|P1|Overall Study|Lack of Efficacy|0
399225|NCT00733980|1339107|P2|Overall Study|Adverse Event|2
399226|NCT00733980|1339108|P1|Overall Study|Adverse Event|5
399227|NCT00733954|1339152|P2|Overall Study|Withdrawal by Subject|0
399228|NCT00733954|1339153|P1|Overall Study|Withdrawal by Subject|2
399229|NCT00733954|1339152|P2|Overall Study|Protocol Violation|0
399230|NCT00733954|1339153|P1|Overall Study|Protocol Violation|1
399231|NCT00733954|1339152|P2|Overall Study|Lost to Follow-up|2
399232|NCT00733954|1339153|P1|Overall Study|Lost to Follow-up|5
399233|NCT00733824|1339200|P5|Phase I|Withdrawal by Subject|0
399234|NCT00733824|1339201|P4|Phase I|Withdrawal by Subject|0
399235|NCT00733824|1339202|P3|Phase I|Withdrawal by Subject|0
399236|NCT00733824|1339203|P2|Phase I|Withdrawal by Subject|0
399237|NCT00733824|1339204|P1|Phase I|Withdrawal by Subject|1
399238|NCT00733746|1339223|P1|Overall Study|Ineligible|5
399239|NCT00733499|1339238|P2|24 Months Follow-up|Death|1
399240|NCT00733499|1339239|P1|24 Months Follow-up|Death|0
399241|NCT00733499|1339238|P2|12 Months Follow-up|Death|1
399242|NCT00733499|1339239|P1|12 Months Follow-up|Death|2
399243|NCT00733499|1339238|P2|6 Months Follow-up|Adverse Event|1
399244|NCT00733499|1339239|P1|6 Months Follow-up|Adverse Event|0
399245|NCT00733499|1339238|P2|6 Months Follow-up|Death|2
399246|NCT00733499|1339239|P1|6 Months Follow-up|Death|0
399247|NCT00733499|1339238|P2|3 Months Follow-up|Death|2
399248|NCT00733499|1339239|P1|3 Months Follow-up|Death|1
399249|NCT00733499|1339238|P2|Pre-operative|Protocol Violation|1
399250|NCT00733499|1339239|P1|Pre-operative|Protocol Violation|0
399251|NCT00733421|1339247|P2|Overall Study|Withdrawal by Subject|1
399252|NCT00733421|1339248|P1|Overall Study|Withdrawal by Subject|1
399253|NCT00733369|1339272|P2|Overall Study|Protocol Violation|4
399254|NCT00733369|1339273|P1|Overall Study|Protocol Violation|4
399255|NCT00733369|1339272|P2|Overall Study|Adverse Event|4
399256|NCT00733369|1339273|P1|Overall Study|Adverse Event|4
399257|NCT00733369|1339272|P2|Overall Study|Lost to Follow-up|1
399258|NCT00733369|1339273|P1|Overall Study|Lost to Follow-up|2
399259|NCT00733304|1339481|P3|Overall Study|Withdrawal by Subject|0
399260|NCT00733304|1339482|P2|Overall Study|Withdrawal by Subject|1
399261|NCT00733304|1339483|P1|Overall Study|Withdrawal by Subject|1
399262|NCT00733304|1339481|P3|Overall Study|Physician Decision|3
399263|NCT00733304|1339482|P2|Overall Study|Physician Decision|1
399264|NCT00733304|1339483|P1|Overall Study|Physician Decision|3
399265|NCT00733304|1339481|P3|Overall Study|Lost to Follow-up|0
399266|NCT00733304|1339482|P2|Overall Study|Lost to Follow-up|1
399267|NCT00733304|1339483|P1|Overall Study|Lost to Follow-up|0
399268|NCT00733304|1339481|P3|Overall Study|Lack of Efficacy|2
399269|NCT00733304|1339482|P2|Overall Study|Lack of Efficacy|0
399270|NCT00733304|1339483|P1|Overall Study|Lack of Efficacy|0
399271|NCT00733304|1339481|P3|Overall Study|Adverse Event|0
399272|NCT00733304|1339482|P2|Overall Study|Adverse Event|0
399273|NCT00733304|1339483|P1|Overall Study|Adverse Event|3
399274|NCT00733291|1339565|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
399275|NCT00733291|1339566|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
399276|NCT00733291|1339567|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
399277|NCT00733291|1339568|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
399278|NCT00733226|1339597|P2|Overall Study|moved to another place|0
399279|NCT00733226|1339598|P1|Overall Study|moved to another place|2
399280|NCT00733226|1339597|P2|Overall Study|Lost to Follow-up|0
399281|NCT00733226|1339598|P1|Overall Study|Lost to Follow-up|2
399282|NCT00733226|1339597|P2|Overall Study|Withdrawal by Subject|0
399283|NCT00733226|1339598|P1|Overall Study|Withdrawal by Subject|1
399284|NCT00733005|1339647|P2|Overall Study|Protocol Violation|0
399285|NCT00733005|1339648|P1|Overall Study|Protocol Violation|2
399286|NCT00733005|1339647|P2|Overall Study|Withdrawal by Subject|1
399287|NCT00733005|1339648|P1|Overall Study|Withdrawal by Subject|0
399288|NCT00733005|1339647|P2|Overall Study|Treatment Failure|1
399289|NCT00733005|1339648|P1|Overall Study|Treatment Failure|0
399290|NCT00733005|1339647|P2|Overall Study|Adverse Event|1
399291|NCT00733005|1339648|P1|Overall Study|Adverse Event|0
399292|NCT00732992|1339658|P2|Overall Study|Withdrawal by Subject|0
399293|NCT00732992|1339659|P1|Overall Study|Withdrawal by Subject|1
399294|NCT00732992|1339658|P2|Overall Study|Global Deterioration of Health Status|0
399295|NCT00732992|1339659|P1|Overall Study|Global Deterioration of Health Status|1
399296|NCT00732992|1339658|P2|Overall Study|Objective Progression or Relapse|5
399297|NCT00732992|1339659|P1|Overall Study|Objective Progression or Relapse|3
399298|NCT00732992|1339658|P2|Overall Study|Adverse Event|1
399299|NCT00732992|1339659|P1|Overall Study|Adverse Event|1
399300|NCT00732940|1339678|P2|Overall Study|Lost to Follow-up|0
399301|NCT00732940|1339679|P1|Overall Study|Lost to Follow-up|1
399302|NCT00732940|1339678|P2|Overall Study|Adverse Event|1
399303|NCT00732940|1339679|P1|Overall Study|Adverse Event|0
399304|NCT00732940|1339678|P2|Overall Study|Withdrawal by Subject|2
399305|NCT00732940|1339679|P1|Overall Study|Withdrawal by Subject|1
399306|NCT00732875|1339760|P1|Overall Study|Lack of Efficacy|13
399307|NCT00732875|1339760|P1|Overall Study|Withdrawal by Subject|6
399308|NCT00732875|1339760|P1|Overall Study|Adverse Event|16
399309|NCT00732758|1339768|P2|Overall Study|Lost to Follow-up|16
399310|NCT00732758|1339769|P1|Overall Study|Lost to Follow-up|8
399311|NCT00732641|1339809|P2|Overall Study|Not Specified|5
399312|NCT00732641|1339810|P1|Overall Study|Not Specified|18
399313|NCT00732641|1339809|P2|Overall Study|Unable to Complete|1
399314|NCT00732641|1339810|P1|Overall Study|Unable to Complete|1
399315|NCT00732641|1339809|P2|Overall Study|Withdrawal by Subject|2
399316|NCT00732641|1339810|P1|Overall Study|Withdrawal by Subject|4
399317|NCT00732641|1339809|P2|Overall Study|Physician Decision|0
399318|NCT00732641|1339810|P1|Overall Study|Physician Decision|6
399319|NCT00732641|1339809|P2|Overall Study|Serious Adverse Events|3
399320|NCT00732641|1339810|P1|Overall Study|Serious Adverse Events|12
399321|NCT00732641|1339809|P2|Overall Study|Relapse or Progressive Disease|101
399322|NCT00732641|1339810|P1|Overall Study|Relapse or Progressive Disease|65
399323|NCT00732615|1339830|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
399324|NCT00732615|1339831|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
399325|NCT00732615|1339830|P2|Overall Study|Physician Decision|0
399326|NCT00732615|1339831|P1|Overall Study|Physician Decision|3
399327|NCT00732615|1339830|P2|Overall Study|Adverse Event|2
399328|NCT00732615|1339831|P1|Overall Study|Adverse Event|0
399329|NCT00732615|1339830|P2|Overall Study|Lost to Follow-up|1
399330|NCT00732615|1339831|P1|Overall Study|Lost to Follow-up|0
399331|NCT00732615|1339830|P2|Overall Study|Withdrawal by Subject|1
399332|NCT00732615|1339831|P1|Overall Study|Withdrawal by Subject|3
399333|NCT00732472|1339847|P4|Overall Study|Withdrawal by Subject|1
399334|NCT00732472|1339848|P3|Overall Study|Withdrawal by Subject|0
399335|NCT00732472|1339849|P2|Overall Study|Withdrawal by Subject|2
399336|NCT00732472|1339850|P1|Overall Study|Withdrawal by Subject|0
399337|NCT00732472|1339847|P4|Overall Study|Protocol Violation|1
399338|NCT00732472|1339848|P3|Overall Study|Protocol Violation|0
399339|NCT00732472|1339849|P2|Overall Study|Protocol Violation|0
399340|NCT00732472|1339850|P1|Overall Study|Protocol Violation|0
399341|NCT00732472|1339847|P4|Overall Study|Adverse Event|1
399342|NCT00732472|1339848|P3|Overall Study|Adverse Event|1
399343|NCT00732472|1339849|P2|Overall Study|Adverse Event|1
399344|NCT00732472|1339850|P1|Overall Study|Adverse Event|0
399345|NCT00732381|1339950|P2|Overall Study|Treatment Failure|1
399346|NCT00732381|1339951|P1|Overall Study|Treatment Failure|1
399347|NCT00732381|1339950|P2|Overall Study|Adverse Event|0
399348|NCT00732381|1339951|P1|Overall Study|Adverse Event|1
399349|NCT00732303|1339959|P1|Overall Study|Study Terminated|2
399350|NCT00732251|1339965|P1|Overall Study|Early Term due to Site Closure|1
399351|NCT00732251|1339965|P1|Overall Study|Withdrawal by Subject|3
399352|NCT00732251|1339965|P1|Overall Study|Lost to Follow-up|3
399353|NCT00732238|1339971|P2|Overall Study|Asymptomatic bacteriuria|0
399354|NCT00732238|1339972|P1|Overall Study|Asymptomatic bacteriuria|1
399355|NCT00732238|1339971|P2|Overall Study|Bacteremia|1
399356|NCT00732238|1339972|P1|Overall Study|Bacteremia|4
399357|NCT00732199|1340073|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
399358|NCT00732199|1340074|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
399359|NCT00732199|1340073|P2|Overall Study|Withdrawal by Subject|18
399360|NCT00732199|1340074|P1|Overall Study|Withdrawal by Subject|25
399361|NCT00732160|1340089|P4|Overall Study|scheduling|1
399362|NCT00732160|1340090|P3|Overall Study|scheduling|2
399363|NCT00732160|1340091|P2|Overall Study|scheduling|4
399364|NCT00732160|1340092|P1|Overall Study|scheduling|4
399365|NCT00732160|1340089|P4|Overall Study|Adverse Event|1
399366|NCT00732160|1340090|P3|Overall Study|Adverse Event|1
399367|NCT00732160|1340091|P2|Overall Study|Adverse Event|0
399368|NCT00732160|1340092|P1|Overall Study|Adverse Event|1
399369|NCT00732069|1340106|P6|Washout After First Study Drug|Adverse Event|0
399370|NCT00732069|1340107|P5|Washout After First Study Drug|Adverse Event|0
399371|NCT00732069|1340108|P4|Washout After First Study Drug|Adverse Event|0
399372|NCT00732069|1340109|P3|Washout After First Study Drug|Adverse Event|0
399373|NCT00732069|1340110|P2|Washout After First Study Drug|Adverse Event|0
399374|NCT00732069|1340111|P1|Washout After First Study Drug|Adverse Event|1
399375|NCT00731939|1340129|P1|Overall Study|Did not meet enrollment criteria|2
399376|NCT00731939|1340129|P1|Overall Study|Withdrawal by Subject|2
399377|NCT00731939|1340129|P1|Overall Study|Not implanted with study device|9
399378|NCT00731939|1340129|P1|Overall Study|Lost to Follow-up|15
399379|NCT00731939|1340129|P1|Overall Study|Adverse Event|6
399380|NCT00731822|1340190|P2|Overall Study|Lost to Follow-up|0
399381|NCT00731822|1340191|P1|Overall Study|Lost to Follow-up|1
399382|NCT00731822|1340190|P2|Overall Study|Protocol Violation|0
399383|NCT00731822|1340191|P1|Overall Study|Protocol Violation|1
399384|NCT00731822|1340190|P2|Overall Study|Adverse Event|1
399385|NCT00731822|1340191|P1|Overall Study|Adverse Event|2
399386|NCT00731783|1340205|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
399387|NCT00731783|1340206|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
399388|NCT00731783|1340205|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
399389|NCT00731783|1340206|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
399390|NCT00731783|1340205|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
399391|NCT00731783|1340206|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
399392|NCT00731783|1340205|P2|One Month Follow-Up Visit|Lost to Follow-up|22
399393|NCT00731783|1340206|P1|One Month Follow-Up Visit|Lost to Follow-up|14
399394|NCT00731731|1340229|P3|Overall Study|Cancel prior to treatment|2
399395|NCT00731731|1340230|P2|Overall Study|Cancel prior to treatment|0
399396|NCT00731731|1340231|P1|Overall Study|Cancel prior to treatment|0
399397|NCT00731731|1340229|P3|Overall Study|Protocol Violation|1
399398|NCT00731731|1340230|P2|Overall Study|Protocol Violation|0
399399|NCT00731731|1340231|P1|Overall Study|Protocol Violation|0
399400|NCT00731692|1340249|P3|Extension Phase|Adverse Event|15
399401|NCT00731692|1340250|P2|Extension Phase|Adverse Event|1
399402|NCT00731692|1340251|P1|Extension Phase|Adverse Event|1
399403|NCT00731692|1340249|P3|Extension Phase|Withdrawal by Subject|3
399404|NCT00731692|1340250|P2|Extension Phase|Withdrawal by Subject|5
399405|NCT00731692|1340251|P1|Extension Phase|Withdrawal by Subject|4
399406|NCT00731692|1340249|P3|Extension Phase|Lost to Follow-up|4
399407|NCT00731692|1340250|P2|Extension Phase|Lost to Follow-up|1
399408|NCT00731692|1340251|P1|Extension Phase|Lost to Follow-up|0
399409|NCT00731692|1340249|P3|Extension Phase|Abnormal lab values|1
399410|NCT00731692|1340250|P2|Extension Phase|Abnormal lab values|0
399411|NCT00731692|1340251|P1|Extension Phase|Abnormal lab values|0
399412|NCT00731692|1340249|P3|Extension Phase|Abnormal test procedure|1
399413|NCT00731692|1340250|P2|Extension Phase|Abnormal test procedure|0
399414|NCT00731692|1340251|P1|Extension Phase|Abnormal test procedure|0
399415|NCT00731692|1340249|P3|Extension Phase|Admin Problems: Terminated # patients|277
399416|NCT00731692|1340250|P2|Extension Phase|Admin Problems: Terminated # patients|189
399417|NCT00731692|1340251|P1|Extension Phase|Admin Problems: Terminated # patients|69
399418|NCT00731692|1340249|P3|Core Study (36 Months)|Withdrawal by Subject|46
399419|NCT00731692|1340250|P2|Core Study (36 Months)|Withdrawal by Subject|32
399420|NCT00731692|1340251|P1|Core Study (36 Months)|Withdrawal by Subject|12
399421|NCT00731692|1340249|P3|Core Study (36 Months)|Adverse Event|29
399422|NCT00731692|1340250|P2|Core Study (36 Months)|Adverse Event|28
399423|NCT00731692|1340251|P1|Core Study (36 Months)|Adverse Event|25
399424|NCT00731692|1340249|P3|Core Study (36 Months)|Abnormal Lab values|5
399425|NCT00731692|1340250|P2|Core Study (36 Months)|Abnormal Lab values|19
399426|NCT00731692|1340251|P1|Core Study (36 Months)|Abnormal Lab values|6
399427|NCT00731692|1340249|P3|Core Study (36 Months)|Protocol Violation|8
399428|NCT00731692|1340250|P2|Core Study (36 Months)|Protocol Violation|5
399429|NCT00731692|1340251|P1|Core Study (36 Months)|Protocol Violation|4
399430|NCT00731692|1340249|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
399431|NCT00731692|1340250|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
399432|NCT00731692|1340251|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
399433|NCT00731692|1340249|P3|Core Study (36 Months)|Administrative|6
399434|NCT00731692|1340250|P2|Core Study (36 Months)|Administrative|2
399435|NCT00731692|1340251|P1|Core Study (36 Months)|Administrative|2
399436|NCT00731692|1340249|P3|Core Study (36 Months)|Lost to Follow-up|3
399437|NCT00731692|1340250|P2|Core Study (36 Months)|Lost to Follow-up|3
399438|NCT00731692|1340251|P1|Core Study (36 Months)|Lost to Follow-up|1
399439|NCT00731692|1340249|P3|Core Study (36 Months)|Death|2
399440|NCT00731692|1340250|P2|Core Study (36 Months)|Death|1
399441|NCT00731692|1340251|P1|Core Study (36 Months)|Death|2
399442|NCT00731692|1340249|P3|Core Study (36 Months)|Physician Decision|2
399443|NCT00731692|1340250|P2|Core Study (36 Months)|Physician Decision|0
399444|NCT00731692|1340251|P1|Core Study (36 Months)|Physician Decision|1
399445|NCT00731692|1340249|P3|Core Study (36 Months)|Lack of Efficacy|64
399446|NCT00731692|1340250|P2|Core Study (36 Months)|Lack of Efficacy|23
399447|NCT00731692|1340251|P1|Core Study (36 Months)|Lack of Efficacy|11
399448|NCT00731679|1340297|P2|Overall Study|Pregnancy|1
399449|NCT00731679|1340298|P1|Overall Study|Pregnancy|0
399450|NCT00731679|1340297|P2|Overall Study|Noncompliance|1
399451|NCT00731679|1340298|P1|Overall Study|Noncompliance|0
399452|NCT00731679|1340297|P2|Overall Study|Lost to Follow-up|8
399453|NCT00731679|1340298|P1|Overall Study|Lost to Follow-up|7
399454|NCT00731679|1340297|P2|Overall Study|Withdrawal by Subject|8
399455|NCT00731679|1340298|P1|Overall Study|Withdrawal by Subject|8
399456|NCT00731679|1340297|P2|Overall Study|Adverse Event|8
399457|NCT00731679|1340298|P1|Overall Study|Adverse Event|7
399458|NCT00731666|1340306|P1|Overall Study|Withdrawal by Subject|2
399459|NCT00731666|1340306|P1|Overall Study|Lost to Follow-up|8
399460|NCT00731666|1340306|P1|Overall Study|Adverse Event|2
399461|NCT00731549|1340340|P1|Overall Study|Lack of efficacy without AE|6
399462|NCT00731549|1340340|P1|Overall Study|Lack of efficacy with AE|37
399463|NCT00731549|1340340|P1|Overall Study|Adverse Event|31
399464|NCT00731549|1340340|P1|Overall Study|Protocol deviation|1
399465|NCT00731549|1340340|P1|Overall Study|Withdrawal by Subject|89
399466|NCT00731549|1340340|P1|Overall Study|Physician Decision|16
399467|NCT00731549|1340340|P1|Overall Study|Met withdrawal criteria|24
399468|NCT00731549|1340340|P1|Overall Study|Lost to Follow-up|19
399469|NCT00731133|1340380|P1|Overall Study|Withdrawal by Subject|10
399470|NCT00731120|1340388|P3|Overall Study|Other|1
399471|NCT00731120|1340389|P2|Overall Study|Other|0
399472|NCT00731120|1340390|P1|Overall Study|Other|4
399473|NCT00731120|1340388|P3|Overall Study|Lost to Follow-up|17
399474|NCT00731120|1340389|P2|Overall Study|Lost to Follow-up|15
399475|NCT00731120|1340390|P1|Overall Study|Lost to Follow-up|10
399476|NCT00731120|1340388|P3|Overall Study|Withdrawal of Consent|4
399477|NCT00731120|1340389|P2|Overall Study|Withdrawal of Consent|8
399478|NCT00731120|1340390|P1|Overall Study|Withdrawal of Consent|13
399479|NCT00731120|1340388|P3|Overall Study|Protocol Deviations|1
399480|NCT00731120|1340389|P2|Overall Study|Protocol Deviations|6
399481|NCT00731120|1340390|P1|Overall Study|Protocol Deviations|1
399482|NCT00731120|1340388|P3|Overall Study|Noncompliance with Study Drug|1
399483|NCT00731120|1340389|P2|Overall Study|Noncompliance with Study Drug|3
399484|NCT00731120|1340390|P1|Overall Study|Noncompliance with Study Drug|3
399485|NCT00731120|1340388|P3|Overall Study|Lack of Efficacy|4
399486|NCT00731120|1340389|P2|Overall Study|Lack of Efficacy|5
399487|NCT00731120|1340390|P1|Overall Study|Lack of Efficacy|4
399488|NCT00731120|1340388|P3|Overall Study|Adverse Event|8
399489|NCT00731120|1340389|P2|Overall Study|Adverse Event|6
399490|NCT00731120|1340390|P1|Overall Study|Adverse Event|7
399491|NCT00731042|1340507|P2|Second Intervention|Did not meet inclusion criteria|2
399492|NCT00731042|1340508|P1|Second Intervention|Did not meet inclusion criteria|0
399493|NCT00730925|1340519|P1|Overall Study|Other|1
399494|NCT00730925|1340519|P1|Overall Study|Switch to combination therapy|8
399495|NCT00730925|1340519|P1|Overall Study|Withdrawal by Subject|1
399496|NCT00730925|1340519|P1|Overall Study|Protocol Violation|1
399497|NCT00730925|1340519|P1|Overall Study|Other Averse Event|7
399498|NCT00730925|1340519|P1|Overall Study|Dose reducing Event|2
399499|NCT00730925|1340519|P1|Overall Study|Progressive Disease|21
399500|NCT00730912|1340529|P3|Overall Study|Discontinued|1
399501|NCT00730912|1340530|P2|Overall Study|Discontinued|0
399502|NCT00730912|1340531|P1|Overall Study|Discontinued|0
399503|NCT00730847|1340542|P1|Overall Study|Other|24
399504|NCT00730847|1340542|P1|Overall Study|Unknown completion status|21
399505|NCT00730847|1340542|P1|Overall Study|Lost to Follow-up|67
399506|NCT00730847|1340542|P1|Overall Study|Withdrawal by Subject|16
399507|NCT00730847|1340542|P1|Overall Study|Protocol Violation|2
399508|NCT00730847|1340542|P1|Overall Study|Adverse Event|1
399509|NCT00730756|1340551|P2|Overall Study|Withdrew Consent|1
399510|NCT00730756|1340552|P1|Overall Study|Withdrew Consent|0
399511|NCT00730756|1340551|P2|Overall Study|Lost to Follow-up|1
399512|NCT00730756|1340552|P1|Overall Study|Lost to Follow-up|0
399513|NCT00730756|1340551|P2|Overall Study|Protocol Deviation|2
399514|NCT00730756|1340552|P1|Overall Study|Protocol Deviation|1
399515|NCT00730756|1340551|P2|Overall Study|Lack of Efficacy|1
399516|NCT00730756|1340552|P1|Overall Study|Lack of Efficacy|1
399517|NCT00730756|1340551|P2|Overall Study|Adverse Event|0
399518|NCT00730756|1340552|P1|Overall Study|Adverse Event|2
399519|NCT00730691|1340586|P5|Overall Study|Other|2
399520|NCT00730691|1340587|P4|Overall Study|Other|2
399521|NCT00730691|1340588|P3|Overall Study|Other|1
399522|NCT00730691|1340589|P2|Overall Study|Other|1
399523|NCT00730691|1340590|P1|Overall Study|Other|1
399524|NCT00730691|1340586|P5|Overall Study|Lost to Follow-up|13
399525|NCT00730691|1340587|P4|Overall Study|Lost to Follow-up|15
399526|NCT00730691|1340588|P3|Overall Study|Lost to Follow-up|13
399527|NCT00730691|1340589|P2|Overall Study|Lost to Follow-up|8
399528|NCT00730691|1340590|P1|Overall Study|Lost to Follow-up|11
399529|NCT00730691|1340586|P5|Overall Study|Withdrawal of Consent|3
399530|NCT00730691|1340587|P4|Overall Study|Withdrawal of Consent|6
399531|NCT00730691|1340588|P3|Overall Study|Withdrawal of Consent|3
399532|NCT00730691|1340589|P2|Overall Study|Withdrawal of Consent|9
399533|NCT00730691|1340590|P1|Overall Study|Withdrawal of Consent|7
399534|NCT00730691|1340586|P5|Overall Study|Protocol Deviations|5
399535|NCT00730691|1340587|P4|Overall Study|Protocol Deviations|7
399536|NCT00730691|1340588|P3|Overall Study|Protocol Deviations|3
399537|NCT00730691|1340589|P2|Overall Study|Protocol Deviations|5
399538|NCT00730691|1340590|P1|Overall Study|Protocol Deviations|3
399539|NCT00730691|1340586|P5|Overall Study|Non-compliance with Study Drug|3
399540|NCT00730691|1340587|P4|Overall Study|Non-compliance with Study Drug|3
399541|NCT00730691|1340588|P3|Overall Study|Non-compliance with Study Drug|6
399542|NCT00730691|1340589|P2|Overall Study|Non-compliance with Study Drug|1
399543|NCT00730691|1340590|P1|Overall Study|Non-compliance with Study Drug|6
399544|NCT00730691|1340586|P5|Overall Study|Lack of Efficacy|1
399545|NCT00730691|1340587|P4|Overall Study|Lack of Efficacy|1
399546|NCT00730691|1340588|P3|Overall Study|Lack of Efficacy|2
399547|NCT00730691|1340589|P2|Overall Study|Lack of Efficacy|4
399548|NCT00730691|1340590|P1|Overall Study|Lack of Efficacy|4
399549|NCT00730691|1340586|P5|Overall Study|Adverse Event|23
399550|NCT00730691|1340587|P4|Overall Study|Adverse Event|11
399551|NCT00730691|1340588|P3|Overall Study|Adverse Event|11
399552|NCT00730691|1340589|P2|Overall Study|Adverse Event|8
399553|NCT00730691|1340590|P1|Overall Study|Adverse Event|4
399554|NCT00730639|1340682|P5|Overall Study|Treatment on-going|4
399555|NCT00730639|1340683|P4|Overall Study|Treatment on-going|4
399556|NCT00730639|1340684|P3|Overall Study|Treatment on-going|5
399557|NCT00730639|1340685|P2|Overall Study|Treatment on-going|5
399558|NCT00730639|1340686|P1|Overall Study|Treatment on-going|2
399559|NCT00730639|1340682|P5|Overall Study|Withdrawal by Subject|4
399560|NCT00730639|1340683|P4|Overall Study|Withdrawal by Subject|3
399561|NCT00730639|1340684|P3|Overall Study|Withdrawal by Subject|6
399562|NCT00730639|1340685|P2|Overall Study|Withdrawal by Subject|0
399563|NCT00730639|1340686|P1|Overall Study|Withdrawal by Subject|0
399564|NCT00730639|1340682|P5|Overall Study|Protocol Violation|0
399565|NCT00730639|1340683|P4|Overall Study|Protocol Violation|0
399566|NCT00730639|1340684|P3|Overall Study|Protocol Violation|1
399567|NCT00730639|1340685|P2|Overall Study|Protocol Violation|0
399568|NCT00730639|1340686|P1|Overall Study|Protocol Violation|0
399569|NCT00730639|1340682|P5|Overall Study|non-specified|3
399570|NCT00730639|1340683|P4|Overall Study|non-specified|2
399571|NCT00730639|1340684|P3|Overall Study|non-specified|4
399572|NCT00730639|1340685|P2|Overall Study|non-specified|0
399573|NCT00730639|1340686|P1|Overall Study|non-specified|0
399574|NCT00730639|1340682|P5|Overall Study|Disease Progression|88
399575|NCT00730639|1340683|P4|Overall Study|Disease Progression|32
399576|NCT00730639|1340684|P3|Overall Study|Disease Progression|48
399577|NCT00730639|1340685|P2|Overall Study|Disease Progression|13
399578|NCT00730639|1340686|P1|Overall Study|Disease Progression|12
399579|NCT00730639|1340682|P5|Overall Study|Death|2
399580|NCT00730639|1340683|P4|Overall Study|Death|0
399581|NCT00730639|1340684|P3|Overall Study|Death|0
399582|NCT00730639|1340685|P2|Overall Study|Death|0
399583|NCT00730639|1340686|P1|Overall Study|Death|0
399584|NCT00730639|1340682|P5|Overall Study|Completed Maximum Cycles|6
399585|NCT00730639|1340683|P4|Overall Study|Completed Maximum Cycles|3
399586|NCT00730639|1340684|P3|Overall Study|Completed Maximum Cycles|11
399587|NCT00730639|1340685|P2|Overall Study|Completed Maximum Cycles|0
399588|NCT00730639|1340686|P1|Overall Study|Completed Maximum Cycles|0
399589|NCT00730639|1340682|P5|Overall Study|Complete Response|1
399590|NCT00730639|1340683|P4|Overall Study|Complete Response|2
399591|NCT00730639|1340684|P3|Overall Study|Complete Response|2
399592|NCT00730639|1340685|P2|Overall Study|Complete Response|0
399593|NCT00730639|1340686|P1|Overall Study|Complete Response|0
399594|NCT00730639|1340682|P5|Overall Study|Adverse Event|23
399595|NCT00730639|1340683|P4|Overall Study|Adverse Event|8
399596|NCT00730639|1340684|P3|Overall Study|Adverse Event|9
399597|NCT00730639|1340685|P2|Overall Study|Adverse Event|0
399598|NCT00730639|1340686|P1|Overall Study|Adverse Event|3
399599|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
399600|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
399601|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
399602|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
399603|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
399604|NCT00730405|1340763|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
399605|NCT00730405|1340764|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
399606|NCT00730405|1340765|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
399607|NCT00730405|1340766|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
399608|NCT00730405|1340767|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
399609|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Other Protocol violation|0
399610|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Other Protocol violation|0
399611|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Other Protocol violation|1
399612|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Other Protocol violation|0
399613|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Other Protocol violation|0
399614|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Mis-randomized|0
399615|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Mis-randomized|0
399616|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Mis-randomized|0
399617|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Mis-randomized|1
399618|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Mis-randomized|0
399619|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
399620|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
399621|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
399622|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
399623|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
399624|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
399625|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
399626|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
399627|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
399628|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
399629|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Missing|0
399630|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Missing|0
399631|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Missing|2
399632|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Missing|0
399633|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Missing|0
399634|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Non-compliance|0
399635|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Non-compliance|0
399636|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Non-compliance|2
399637|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Non-compliance|0
399638|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Non-compliance|1
399639|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Use of restricted medication|0
399640|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Use of restricted medication|0
399641|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Use of restricted medication|0
399642|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Use of restricted medication|1
399643|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Use of restricted medication|0
399644|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
399645|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
399646|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
399647|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
399648|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
399649|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
399650|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
399651|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
399652|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
399653|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
399654|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
399655|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
399656|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
399657|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
399658|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
399659|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
399660|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
399661|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
399662|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
399663|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
399664|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
399665|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
399666|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
399667|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
399668|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
399669|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
399817|NCT00730171|1340884|P1|Overall Study|Withdrawal by Subject|202
399670|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
399671|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
399672|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
399673|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
399674|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
399675|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
399676|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
399677|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
399678|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
399679|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Did not met eligibility|0
399680|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Did not met eligibility|0
399681|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Did not met eligibility|1
399682|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Did not met eligibility|0
399683|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Did not met eligibility|0
399684|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Change of location|0
399685|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Change of location|1
399686|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Change of location|0
399687|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Change of location|1
399688|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Change of location|1
399689|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Death|0
399690|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Death|1
399691|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Death|0
399692|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Death|1
399693|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Death|0
399694|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
399695|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
399696|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
399697|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
399698|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
399699|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
399700|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
399701|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
399702|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
399703|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
399704|NCT00730405|1340763|P5|Overall Study-follow-up Phase|Adverse Event|4
399705|NCT00730405|1340764|P4|Overall Study-follow-up Phase|Adverse Event|3
399706|NCT00730405|1340765|P3|Overall Study-follow-up Phase|Adverse Event|2
399707|NCT00730405|1340766|P2|Overall Study-follow-up Phase|Adverse Event|6
399708|NCT00730405|1340767|P1|Overall Study-follow-up Phase|Adverse Event|2
399709|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
399710|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
399711|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
399712|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
399713|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
399714|NCT00730405|1340763|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
399715|NCT00730405|1340764|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
399716|NCT00730405|1340765|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
399717|NCT00730405|1340766|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
399718|NCT00730405|1340767|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
399719|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Pregnancy|0
399720|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Pregnancy|0
399721|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Pregnancy|0
399722|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Pregnancy|1
399723|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Pregnancy|0
399724|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Change of location|0
399725|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Change of location|1
399726|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Change of location|0
399727|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Change of location|0
399728|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Change of location|0
399729|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
399730|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
399731|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
399732|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
399733|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
399734|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
399735|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
399736|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
399737|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
399738|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
399739|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Study drug interrupted|0
399740|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Study drug interrupted|0
399741|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Study drug interrupted|0
399742|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Study drug interrupted|1
399743|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Study drug interrupted|0
399744|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Misrandomized|0
399745|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Misrandomized|0
399746|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Misrandomized|0
399747|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Misrandomized|1
399748|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Misrandomized|0
399749|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
399750|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
399751|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
399752|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
399753|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
399754|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
399755|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
399756|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
399757|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
399758|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
399759|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
399760|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
399761|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
399762|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
399763|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
399764|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
399765|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
399766|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
399767|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
399768|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
399769|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
399770|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
399771|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
399772|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
399773|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
399774|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Did not met eligibility|0
399775|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Did not met eligibility|0
399776|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Did not met eligibility|1
399777|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Did not met eligibility|0
399778|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Did not met eligibility|0
399779|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
399780|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
399781|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
399782|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
399783|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
399784|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
399785|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
399786|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
399787|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
399788|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
399789|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
399790|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
399791|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
399792|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
399793|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
399794|NCT00730405|1340763|P5|Overall Study-Treatment Phase|Adverse Event|4
399795|NCT00730405|1340764|P4|Overall Study-Treatment Phase|Adverse Event|8
399796|NCT00730405|1340765|P3|Overall Study-Treatment Phase|Adverse Event|4
399797|NCT00730405|1340766|P2|Overall Study-Treatment Phase|Adverse Event|10
399798|NCT00730405|1340767|P1|Overall Study-Treatment Phase|Adverse Event|5
399799|NCT00730327|1340814|P2|Overall Study|Subject withdrew (reason not specified)|7
399800|NCT00730327|1340815|P1|Overall Study|Subject withdrew (reason not specified)|2
399801|NCT00730327|1340814|P2|Overall Study|Withdrawal by Subject|13
399802|NCT00730327|1340815|P1|Overall Study|Withdrawal by Subject|3
399803|NCT00730327|1340814|P2|Overall Study|Adverse Event|1
399804|NCT00730327|1340815|P1|Overall Study|Adverse Event|8
399805|NCT00730327|1340814|P2|Overall Study|Lost to Follow-up|16
399806|NCT00730327|1340815|P1|Overall Study|Lost to Follow-up|14
399807|NCT00730275|1340840|P4|Overall Study|Withdrawal by Subject|1
399808|NCT00730275|1340841|P3|Overall Study|Withdrawal by Subject|0
399809|NCT00730275|1340842|P2|Overall Study|Withdrawal by Subject|0
399810|NCT00730275|1340843|P1|Overall Study|Withdrawal by Subject|0
399811|NCT00730236|1340869|P1|Overall Study|Non-compliance|1
399812|NCT00730236|1340869|P1|Overall Study|Withdrawal by Subject|1
399813|NCT00730236|1340869|P1|Overall Study|Adverse Event|4
399814|NCT00730171|1340884|P1|Overall Study|Not Specified|61
399815|NCT00730171|1340884|P1|Overall Study|Insufficient Therapeutic Response|141
399816|NCT00730171|1340884|P1|Overall Study|Lost to Follow-up|121
399818|NCT00730171|1340884|P1|Overall Study|Protocol Violation|48
399819|NCT00730171|1340884|P1|Overall Study|Adverse Event|193
399820|NCT00730171|1340884|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
399821|NCT00730132|1340892|P1|Overall Study|Death|1
399822|NCT00730132|1340892|P1|Overall Study|Protocol Violation|154
399823|NCT00730041|1340910|P2|Overall Study|Lost to Follow-up|2
399824|NCT00730041|1340911|P1|Overall Study|Lost to Follow-up|0
399825|NCT00730028|1340934|P5|Overall Study|Randomization Error|2
399826|NCT00730028|1340935|P4|Overall Study|Randomization Error|0
399827|NCT00730028|1340936|P3|Overall Study|Randomization Error|0
399828|NCT00730028|1340937|P2|Overall Study|Randomization Error|0
399829|NCT00730028|1340938|P1|Overall Study|Randomization Error|1
399830|NCT00730028|1340934|P5|Overall Study|Treatment Failure|1
399831|NCT00730028|1340935|P4|Overall Study|Treatment Failure|0
399832|NCT00730028|1340936|P3|Overall Study|Treatment Failure|0
399833|NCT00730028|1340937|P2|Overall Study|Treatment Failure|5
399834|NCT00730028|1340938|P1|Overall Study|Treatment Failure|5
399835|NCT00730028|1340934|P5|Overall Study|Physician Decision|2
399836|NCT00730028|1340935|P4|Overall Study|Physician Decision|3
399837|NCT00730028|1340936|P3|Overall Study|Physician Decision|2
399838|NCT00730028|1340937|P2|Overall Study|Physician Decision|3
399839|NCT00730028|1340938|P1|Overall Study|Physician Decision|3
399840|NCT00730028|1340934|P5|Overall Study|Withdrawal by Subject|9
399841|NCT00730028|1340935|P4|Overall Study|Withdrawal by Subject|5
399842|NCT00730028|1340936|P3|Overall Study|Withdrawal by Subject|4
399843|NCT00730028|1340937|P2|Overall Study|Withdrawal by Subject|5
399844|NCT00730028|1340938|P1|Overall Study|Withdrawal by Subject|9
399845|NCT00730028|1340934|P5|Overall Study|Protocol Violation|0
399846|NCT00730028|1340935|P4|Overall Study|Protocol Violation|2
399847|NCT00730028|1340936|P3|Overall Study|Protocol Violation|1
399848|NCT00730028|1340937|P2|Overall Study|Protocol Violation|1
399849|NCT00730028|1340938|P1|Overall Study|Protocol Violation|6
399850|NCT00730028|1340934|P5|Overall Study|Lost to Follow-up|25
399851|NCT00730028|1340935|P4|Overall Study|Lost to Follow-up|26
399852|NCT00730028|1340936|P3|Overall Study|Lost to Follow-up|22
399853|NCT00730028|1340937|P2|Overall Study|Lost to Follow-up|26
399854|NCT00730028|1340938|P1|Overall Study|Lost to Follow-up|13
399855|NCT00730028|1340934|P5|Overall Study|Adverse Event|43
399856|NCT00730028|1340935|P4|Overall Study|Adverse Event|20
399857|NCT00730028|1340936|P3|Overall Study|Adverse Event|16
399858|NCT00730028|1340937|P2|Overall Study|Adverse Event|26
399859|NCT00730028|1340938|P1|Overall Study|Adverse Event|23
399860|NCT00730015|1340988|P3|Overall Study|Other Reason|1
399861|NCT00730015|1340989|P2|Overall Study|Other Reason|0
399862|NCT00730015|1340990|P1|Overall Study|Other Reason|1
399863|NCT00730015|1340988|P3|Overall Study|Lack of Efficacy|8
399864|NCT00730015|1340989|P2|Overall Study|Lack of Efficacy|2
399865|NCT00730015|1340990|P1|Overall Study|Lack of Efficacy|1
399866|NCT00730015|1340988|P3|Overall Study|Lost to Follow-up|3
399867|NCT00730015|1340989|P2|Overall Study|Lost to Follow-up|10
399868|NCT00730015|1340990|P1|Overall Study|Lost to Follow-up|4
399869|NCT00730015|1340988|P3|Overall Study|Withdrawal by Subject|8
399870|NCT00730015|1340989|P2|Overall Study|Withdrawal by Subject|12
399871|NCT00730015|1340990|P1|Overall Study|Withdrawal by Subject|12
399872|NCT00730015|1340988|P3|Overall Study|Protocol Violation|4
399873|NCT00730015|1340989|P2|Overall Study|Protocol Violation|6
399874|NCT00730015|1340990|P1|Overall Study|Protocol Violation|2
399875|NCT00730015|1340988|P3|Overall Study|Adverse Event|8
399876|NCT00730015|1340989|P2|Overall Study|Adverse Event|10
399877|NCT00730015|1340990|P1|Overall Study|Adverse Event|11
399878|NCT00729937|1341030|P6|Overall Study|Incarcerated|0
399879|NCT00729937|1341031|P5|Overall Study|Incarcerated|0
399880|NCT00729937|1341032|P4|Overall Study|Incarcerated|1
399881|NCT00729937|1341033|P3|Overall Study|Incarcerated|1
399882|NCT00729937|1341034|P2|Overall Study|Incarcerated|2
399883|NCT00729937|1341035|P1|Overall Study|Incarcerated|0
399884|NCT00729937|1341030|P6|Overall Study|Did not meet eligibility criteria|0
399885|NCT00729937|1341031|P5|Overall Study|Did not meet eligibility criteria|0
399886|NCT00729937|1341032|P4|Overall Study|Did not meet eligibility criteria|0
399887|NCT00729937|1341033|P3|Overall Study|Did not meet eligibility criteria|0
399888|NCT00729937|1341034|P2|Overall Study|Did not meet eligibility criteria|1
399889|NCT00729937|1341035|P1|Overall Study|Did not meet eligibility criteria|2
399890|NCT00729937|1341030|P6|Overall Study|Randomized but not treated|3
399891|NCT00729937|1341031|P5|Overall Study|Randomized but not treated|1
399892|NCT00729937|1341032|P4|Overall Study|Randomized but not treated|0
399893|NCT00729937|1341033|P3|Overall Study|Randomized but not treated|1
399894|NCT00729937|1341034|P2|Overall Study|Randomized but not treated|6
399895|NCT00729937|1341035|P1|Overall Study|Randomized but not treated|12
399896|NCT00729937|1341030|P6|Overall Study|Withdrawal by Subject|2
399897|NCT00729937|1341031|P5|Overall Study|Withdrawal by Subject|4
399898|NCT00729937|1341032|P4|Overall Study|Withdrawal by Subject|0
399899|NCT00729937|1341033|P3|Overall Study|Withdrawal by Subject|6
399900|NCT00729937|1341034|P2|Overall Study|Withdrawal by Subject|5
399901|NCT00729937|1341035|P1|Overall Study|Withdrawal by Subject|3
399902|NCT00729937|1341030|P6|Overall Study|Death|1
399903|NCT00729937|1341031|P5|Overall Study|Death|0
399904|NCT00729937|1341032|P4|Overall Study|Death|0
399905|NCT00729937|1341033|P3|Overall Study|Death|1
399906|NCT00729937|1341034|P2|Overall Study|Death|0
399907|NCT00729937|1341035|P1|Overall Study|Death|1
399908|NCT00729937|1341030|P6|Overall Study|Physician Decision|8
399909|NCT00729937|1341031|P5|Overall Study|Physician Decision|5
399910|NCT00729937|1341032|P4|Overall Study|Physician Decision|0
399911|NCT00729937|1341033|P3|Overall Study|Physician Decision|2
399912|NCT00729937|1341034|P2|Overall Study|Physician Decision|16
399913|NCT00729937|1341035|P1|Overall Study|Physician Decision|7
399914|NCT00729937|1341030|P6|Overall Study|Lost to Follow-up|23
399915|NCT00729937|1341031|P5|Overall Study|Lost to Follow-up|18
399916|NCT00729937|1341032|P4|Overall Study|Lost to Follow-up|33
399917|NCT00729937|1341033|P3|Overall Study|Lost to Follow-up|18
399918|NCT00729937|1341034|P2|Overall Study|Lost to Follow-up|58
399919|NCT00729937|1341035|P1|Overall Study|Lost to Follow-up|49
399920|NCT00729859|1341239|P3|Overall Study|Withdrawal by Subject|0
399921|NCT00729859|1341240|P2|Overall Study|Withdrawal by Subject|1
399922|NCT00729859|1341241|P1|Overall Study|Withdrawal by Subject|0
399923|NCT00729859|1341239|P3|Overall Study|Adverse Event|0
399924|NCT00729859|1341240|P2|Overall Study|Adverse Event|1
399925|NCT00729859|1341241|P1|Overall Study|Adverse Event|0
399926|NCT00729833|1341285|P4|Overall Study|Unspecified Reasons|1
399927|NCT00729833|1341286|P3|Overall Study|Unspecified Reasons|5
399928|NCT00729833|1341287|P2|Overall Study|Unspecified Reasons|5
399929|NCT00729833|1341288|P1|Overall Study|Unspecified Reasons|11
399930|NCT00729833|1341285|P4|Overall Study|Withdrawal by Subject|0
399931|NCT00729833|1341286|P3|Overall Study|Withdrawal by Subject|3
399932|NCT00729833|1341287|P2|Overall Study|Withdrawal by Subject|1
399933|NCT00729833|1341288|P1|Overall Study|Withdrawal by Subject|3
399934|NCT00729833|1341285|P4|Overall Study|Lost to Follow-up|0
399935|NCT00729833|1341286|P3|Overall Study|Lost to Follow-up|0
399936|NCT00729833|1341287|P2|Overall Study|Lost to Follow-up|0
399937|NCT00729833|1341288|P1|Overall Study|Lost to Follow-up|1
399938|NCT00729833|1341285|P4|Overall Study|Study Terminated by Sponsor|0
399939|NCT00729833|1341286|P3|Overall Study|Study Terminated by Sponsor|1
399940|NCT00729833|1341287|P2|Overall Study|Study Terminated by Sponsor|0
399941|NCT00729833|1341288|P1|Overall Study|Study Terminated by Sponsor|0
399942|NCT00729833|1341285|P4|Overall Study|Death|5
399943|NCT00729833|1341286|P3|Overall Study|Death|3
399944|NCT00729833|1341287|P2|Overall Study|Death|1
399945|NCT00729833|1341288|P1|Overall Study|Death|5
399946|NCT00729690|1341340|P3|Overall Study|IT Catheter Malfunction|2
399947|NCT00729690|1341341|P2|Overall Study|IT Catheter Malfunction|2
399948|NCT00729690|1341342|P1|Overall Study|IT Catheter Malfunction|0
399949|NCT00729651|1341372|P2|Overall Study|Subject’s private reason|0
399950|NCT00729651|1341373|P1|Overall Study|Subject’s private reason|2
399951|NCT00729651|1341372|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
399952|NCT00729651|1341373|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
399953|NCT00729651|1341372|P2|Overall Study|Adverse Event|3
399954|NCT00729651|1341373|P1|Overall Study|Adverse Event|7
399955|NCT00729651|1341372|P2|Overall Study|Protocol Violation|1
399956|NCT00729651|1341373|P1|Overall Study|Protocol Violation|0
399957|NCT00729651|1341372|P2|Overall Study|Lost to Follow-up|4
399958|NCT00729651|1341373|P1|Overall Study|Lost to Follow-up|5
399959|NCT00729651|1341372|P2|Overall Study|Withdrawal by Subject|6
399960|NCT00729651|1341373|P1|Overall Study|Withdrawal by Subject|5
399961|NCT00729612|1341385|P1|Overall Study|Non evaluable for response|10
399962|NCT00729560|1341392|P1|Overall Study|Withdrawal by Subject|3
399963|NCT00729469|1341418|P2|Overall Study|Other-Not mentioned|4
399964|NCT00729469|1341419|P1|Overall Study|Other-Not mentioned|9
399965|NCT00729469|1341418|P2|Overall Study|Withdrawal by Subject|8
399966|NCT00729469|1341419|P1|Overall Study|Withdrawal by Subject|19
399967|NCT00729469|1341418|P2|Overall Study|Protocol Violation|1
399968|NCT00729469|1341419|P1|Overall Study|Protocol Violation|2
399969|NCT00729469|1341418|P2|Overall Study|Lost to Follow-up|9
399970|NCT00729469|1341419|P1|Overall Study|Lost to Follow-up|9
399971|NCT00729469|1341418|P2|Overall Study|Adverse Event|25
399972|NCT00729469|1341419|P1|Overall Study|Adverse Event|14
399973|NCT00729378|1341472|P2|36-months|Lost to Follow-up|6
399974|NCT00729378|1341473|P1|36-months|Lost to Follow-up|15
399975|NCT00729378|1341472|P2|24-months|Lost to Follow-up|51
399976|NCT00729378|1341473|P1|24-months|Lost to Follow-up|72
399977|NCT00729378|1341472|P2|12-months|Lost to Follow-up|65
399978|NCT00729378|1341473|P1|12-months|Lost to Follow-up|100
399979|NCT00729378|1341472|P2|Baseline|Withdrawal by Subject|59
399980|NCT00729378|1341473|P1|Baseline|Withdrawal by Subject|66
399981|NCT00729378|1341472|P2|Baseline|Did not complete study measurements|33
399982|NCT00729378|1341473|P1|Baseline|Did not complete study measurements|72
399983|NCT00729365|1341672|P3|Overall Study|Physician Decision|7
399984|NCT00729365|1341673|P2|Overall Study|Physician Decision|6
399985|NCT00729365|1341674|P1|Overall Study|Physician Decision|33
399986|NCT00729326|1341687|P2|Overall Study|Sponsor Decision|2
399987|NCT00729326|1341688|P1|Overall Study|Sponsor Decision|1
399988|NCT00729326|1341687|P2|Overall Study|Subject Decision|4
399989|NCT00729326|1341688|P1|Overall Study|Subject Decision|4
399990|NCT00729326|1341687|P2|Overall Study|Protocol Violation|2
399991|NCT00729326|1341688|P1|Overall Study|Protocol Violation|3
399992|NCT00729326|1341687|P2|Overall Study|Physician Decision|1
399993|NCT00729326|1341688|P1|Overall Study|Physician Decision|0
399994|NCT00729326|1341687|P2|Overall Study|Lost to Follow-up|0
399995|NCT00729326|1341688|P1|Overall Study|Lost to Follow-up|2
399996|NCT00729248|1341730|P1|Overall Study|Physician Decision|2
399997|NCT00729183|1341737|P2|Overall Study|Withdrawal by Subject|7
399998|NCT00729183|1341738|P1|Overall Study|Withdrawal by Subject|9
399999|NCT00729183|1341737|P2|Overall Study|Protocol Violation|0
400000|NCT00729183|1341738|P1|Overall Study|Protocol Violation|1
400001|NCT00729183|1341737|P2|Overall Study|Physician Decision|1
400002|NCT00729183|1341738|P1|Overall Study|Physician Decision|1
400003|NCT00729183|1341737|P2|Overall Study|Lost to Follow-up|1
400004|NCT00729183|1341738|P1|Overall Study|Lost to Follow-up|3
400005|NCT00729183|1341737|P2|Overall Study|Lack of Efficacy|1
400006|NCT00729183|1341738|P1|Overall Study|Lack of Efficacy|0
400007|NCT00729183|1341737|P2|Overall Study|Adverse Event|5
400008|NCT00729183|1341738|P1|Overall Study|Adverse Event|11
400009|NCT00729157|1341770|P1|Overall Study|Withdrawal by Subject|1
400010|NCT00728988|1341813|P2|Overall Study|Withdrawal by Subject|6
400011|NCT00728988|1341814|P1|Overall Study|Withdrawal by Subject|2
400012|NCT00728988|1341813|P2|Overall Study|Other|77
400013|NCT00728988|1341814|P1|Overall Study|Other|85
400014|NCT00728988|1341813|P2|Overall Study|Adverse Event|2
400015|NCT00728988|1341814|P1|Overall Study|Adverse Event|3
400016|NCT00728988|1341813|P2|Overall Study|Death|1
400017|NCT00728988|1341814|P1|Overall Study|Death|1
400018|NCT00728988|1341813|P2|Overall Study|Not Treated|2
400019|NCT00728988|1341814|P1|Overall Study|Not Treated|2
400020|NCT00728962|1341832|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
400021|NCT00728962|1341832|P1|Permanent Prosthesis Placement|Adverse Event|3
400022|NCT00728962|1341832|P1|Implant Placement Surgery|Protocol Violation|1
400023|NCT00728962|1341832|P1|Implant Placement Surgery|Lost to Follow-up|1
400024|NCT00728962|1341832|P1|Implant Placement Surgery|Adverse Event|8
400025|NCT00728949|1341838|P2|Overall Study|On treatment at cutoff date|0
400026|NCT00728949|1341839|P1|Overall Study|On treatment at cutoff date|1
400027|NCT00728949|1341838|P2|Overall Study|Abnormal Lab Results|2
400028|NCT00728949|1341839|P1|Overall Study|Abnormal Lab Results|0
400029|NCT00728949|1341838|P2|Overall Study|Withdrawal by Subject|2
400030|NCT00728949|1341839|P1|Overall Study|Withdrawal by Subject|2
400031|NCT00728949|1341838|P2|Overall Study|Adverse Event|0
400032|NCT00728949|1341839|P1|Overall Study|Adverse Event|8
400033|NCT00728884|1341874|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
400034|NCT00728884|1341874|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
400035|NCT00728754|1341910|P2|One Year Post Placement Follow-up|Adverse Event|0
400036|NCT00728754|1341911|P1|One Year Post Placement Follow-up|Adverse Event|1
400037|NCT00728754|1341910|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
400038|NCT00728754|1341911|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
400039|NCT00728754|1341910|P2|Permanent Prosthesis Placement|Adverse Event|1
400040|NCT00728754|1341911|P1|Permanent Prosthesis Placement|Adverse Event|1
400041|NCT00728689|1341940|P2|Washout Period (Days 4 - 10)|Death in family|0
400042|NCT00728689|1341941|P1|Washout Period (Days 4 - 10)|Death in family|1
400043|NCT00728494|1341970|P2|Overall Study|No data available|1
400044|NCT00728494|1341971|P1|Overall Study|No data available|0
400045|NCT00728494|1341970|P2|Overall Study|Lack of Efficacy|4
400046|NCT00728494|1341971|P1|Overall Study|Lack of Efficacy|2
400047|NCT00728494|1341970|P2|Overall Study|Withdrawal by Subject|2
400048|NCT00728494|1341971|P1|Overall Study|Withdrawal by Subject|0
400049|NCT00728494|1341970|P2|Overall Study|Adverse Event|0
400050|NCT00728494|1341971|P1|Overall Study|Adverse Event|7
400051|NCT00728481|1341989|P2|Overall Study|Incorrectly assigned to opposite arm|0
400052|NCT00728481|1341990|P1|Overall Study|Incorrectly assigned to opposite arm|1
400053|NCT00728481|1341989|P2|Overall Study|Study medication non-compliance|2
400054|NCT00728481|1341990|P1|Overall Study|Study medication non-compliance|0
400055|NCT00728481|1341989|P2|Overall Study|Adverse Event|1
400056|NCT00728481|1341990|P1|Overall Study|Adverse Event|0
400057|NCT00728481|1341989|P2|Overall Study|Withdrawal by Subject|1
400058|NCT00728481|1341990|P1|Overall Study|Withdrawal by Subject|0
400059|NCT00728468|1342006|P1|Overall Study|Study terminated by sponsor|1
400060|NCT00728468|1342006|P1|Overall Study|Objective progression or relapse|9
400061|NCT00728468|1342006|P1|Overall Study|Protocol Violation|4
400062|NCT00728468|1342006|P1|Overall Study|Death|1
400063|NCT00728468|1342006|P1|Overall Study|Enrolled but not treated|1
400064|NCT00728416|1342030|P2|Overall Study|Withdrawal by Subject|0
400065|NCT00728416|1342031|P1|Overall Study|Withdrawal by Subject|1
400066|NCT00728416|1342030|P2|Overall Study|Treatment Failure|1
400067|NCT00728416|1342031|P1|Overall Study|Treatment Failure|0
400068|NCT00728416|1342030|P2|Overall Study|Adverse Event|1
400069|NCT00728416|1342031|P1|Overall Study|Adverse Event|1
400070|NCT00728182|1342047|P2|Overall Study|Protocol Noncompliance|1
400071|NCT00728182|1342048|P1|Overall Study|Protocol Noncompliance|0
400072|NCT00728182|1342047|P2|Overall Study|Death|2
400073|NCT00728182|1342048|P1|Overall Study|Death|0
400074|NCT00728182|1342047|P2|Overall Study|Lost to Follow-up|0
400075|NCT00728182|1342048|P1|Overall Study|Lost to Follow-up|2
400076|NCT00728182|1342047|P2|Overall Study|Adverse Event|0
400077|NCT00728182|1342048|P1|Overall Study|Adverse Event|1
400078|NCT00728130|1342076|P1|Overall Study|Physician Decision|1
400079|NCT00728130|1342076|P1|Overall Study|Paperwork not completed in time|1
400080|NCT00728130|1342076|P1|Overall Study|Withdrawal by Subject|1
400081|NCT00727961|1342081|P1|Overall Study|Progression|30
400082|NCT00727961|1342081|P1|Overall Study|Patient's refusal|2
400083|NCT00727961|1342081|P1|Overall Study|Adverse Event|4
400084|NCT00727961|1342081|P1|Overall Study|Lost to Follow-up|1
400085|NCT00727909|1342091|P4|Overall Study|Death|0
400086|NCT00727909|1342092|P3|Overall Study|Death|1
400087|NCT00727909|1342093|P2|Overall Study|Death|0
400088|NCT00727909|1342094|P1|Overall Study|Death|0
400089|NCT00727909|1342091|P4|Overall Study|Withdrawal by Subject|5
400090|NCT00727909|1342092|P3|Overall Study|Withdrawal by Subject|8
400091|NCT00727909|1342093|P2|Overall Study|Withdrawal by Subject|11
400092|NCT00727909|1342094|P1|Overall Study|Withdrawal by Subject|5
400093|NCT00727844|1342191|P4|Initial Randomization|Physician Decision|0
400094|NCT00727844|1342192|P3|Initial Randomization|Physician Decision|0
400095|NCT00727844|1342193|P2|Initial Randomization|Physician Decision|0
400096|NCT00727844|1342194|P1|Initial Randomization|Physician Decision|2
400097|NCT00727714|1342208|P1|Overall Study|Lost to Follow-up|2
400098|NCT00727649|1342218|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
400099|NCT00727649|1342219|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
400100|NCT00727649|1342218|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
400101|NCT00727649|1342219|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
400102|NCT00727649|1342218|P2|Second Intervention (4-weeks)|Death|0
400103|NCT00727649|1342219|P1|Second Intervention (4-weeks)|Death|1
400104|NCT00727649|1342218|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
400105|NCT00727649|1342219|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
400106|NCT00727649|1342218|P2|Wash-out (2-weeks)|Lost to Follow-up|1
400107|NCT00727649|1342219|P1|Wash-out (2-weeks)|Lost to Follow-up|3
400108|NCT00727649|1342218|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
400109|NCT00727649|1342219|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
400110|NCT00727649|1342218|P2|First Intervention (4-weeks)|Lost to Follow-up|2
400111|NCT00727649|1342219|P1|First Intervention (4-weeks)|Lost to Follow-up|1
400112|NCT00727571|1342261|P4|Overall Study|Other|0
400113|NCT00727571|1342262|P3|Overall Study|Other|6
400114|NCT00727571|1342263|P2|Overall Study|Other|4
400115|NCT00727571|1342264|P1|Overall Study|Other|0
400116|NCT00727571|1342261|P4|Overall Study|AE not leading to hospitalization|0
400117|NCT00727571|1342262|P3|Overall Study|AE not leading to hospitalization|2
400118|NCT00727571|1342263|P2|Overall Study|AE not leading to hospitalization|0
400119|NCT00727571|1342264|P1|Overall Study|AE not leading to hospitalization|0
400120|NCT00727571|1342261|P4|Overall Study|Hospitalization|1
400121|NCT00727571|1342262|P3|Overall Study|Hospitalization|0
400122|NCT00727571|1342263|P2|Overall Study|Hospitalization|1
400123|NCT00727571|1342264|P1|Overall Study|Hospitalization|0
400124|NCT00727571|1342261|P4|Overall Study|Dismissed from nursing home|0
400125|NCT00727571|1342262|P3|Overall Study|Dismissed from nursing home|5
400126|NCT00727571|1342263|P2|Overall Study|Dismissed from nursing home|9
400127|NCT00727571|1342264|P1|Overall Study|Dismissed from nursing home|0
400128|NCT00727571|1342261|P4|Overall Study|Subject Non Compliance|4
400129|NCT00727571|1342262|P3|Overall Study|Subject Non Compliance|0
400130|NCT00727571|1342263|P2|Overall Study|Subject Non Compliance|6
400131|NCT00727571|1342264|P1|Overall Study|Subject Non Compliance|0
400132|NCT00727571|1342261|P4|Overall Study|Withdrawal by Subject|0
400133|NCT00727571|1342262|P3|Overall Study|Withdrawal by Subject|11
400134|NCT00727571|1342263|P2|Overall Study|Withdrawal by Subject|10
400135|NCT00727571|1342264|P1|Overall Study|Withdrawal by Subject|0
400136|NCT00727571|1342261|P4|Overall Study|Physician Decision|0
400137|NCT00727571|1342262|P3|Overall Study|Physician Decision|0
400138|NCT00727571|1342263|P2|Overall Study|Physician Decision|5
400139|NCT00727571|1342264|P1|Overall Study|Physician Decision|0
400140|NCT00727571|1342261|P4|Overall Study|Death|1
400141|NCT00727571|1342262|P3|Overall Study|Death|5
400142|NCT00727571|1342263|P2|Overall Study|Death|19
400143|NCT00727571|1342264|P1|Overall Study|Death|0
400144|NCT00727571|1342261|P4|Overall Study|Ineligibility determined|0
400145|NCT00727571|1342262|P3|Overall Study|Ineligibility determined|1
400146|NCT00727571|1342263|P2|Overall Study|Ineligibility determined|1
400147|NCT00727571|1342264|P1|Overall Study|Ineligibility determined|1
400148|NCT00727558|1342291|P2|Overall Study|Lost to Follow-up|0
400149|NCT00727558|1342292|P1|Overall Study|Lost to Follow-up|1
400150|NCT00727558|1342291|P2|Overall Study|Subject unable to return for follow-up|1
400151|NCT00727558|1342292|P1|Overall Study|Subject unable to return for follow-up|1
400152|NCT00727558|1342291|P2|Overall Study|Adverse Event|1
400153|NCT00727558|1342292|P1|Overall Study|Adverse Event|0
400154|NCT00727558|1342291|P2|Overall Study|Lens issue|1
400155|NCT00727558|1342292|P1|Overall Study|Lens issue|0
400156|NCT00727506|1342316|P6|Overall Study|Other reason not described above|1
400157|NCT00727506|1342317|P5|Overall Study|Other reason not described above|1
400158|NCT00727506|1342318|P4|Overall Study|Other reason not described above|4
400159|NCT00727506|1342319|P3|Overall Study|Other reason not described above|1
400160|NCT00727506|1342320|P2|Overall Study|Other reason not described above|0
400161|NCT00727506|1342321|P1|Overall Study|Other reason not described above|0
400162|NCT00727506|1342316|P6|Overall Study|Refused to continue medication|2
400163|NCT00727506|1342317|P5|Overall Study|Refused to continue medication|1
400164|NCT00727506|1342318|P4|Overall Study|Refused to continue medication|3
400165|NCT00727506|1342319|P3|Overall Study|Refused to continue medication|2
400166|NCT00727506|1342320|P2|Overall Study|Refused to continue medication|1
400167|NCT00727506|1342321|P1|Overall Study|Refused to continue medication|0
400168|NCT00727506|1342316|P6|Overall Study|Progressive disease|28
400169|NCT00727506|1342317|P5|Overall Study|Progressive disease|38
400170|NCT00727506|1342318|P4|Overall Study|Progressive disease|28
400171|NCT00727506|1342319|P3|Overall Study|Progressive disease|9
400172|NCT00727506|1342320|P2|Overall Study|Progressive disease|7
400173|NCT00727506|1342321|P1|Overall Study|Progressive disease|4
400174|NCT00727506|1342316|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
400175|NCT00727506|1342317|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
400176|NCT00727506|1342318|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
400177|NCT00727506|1342319|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
400178|NCT00727506|1342320|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
400179|NCT00727506|1342321|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
400180|NCT00727506|1342316|P6|Overall Study|Adverse Event|8
400181|NCT00727506|1342317|P5|Overall Study|Adverse Event|1
400182|NCT00727506|1342318|P4|Overall Study|Adverse Event|4
400183|NCT00727506|1342319|P3|Overall Study|Adverse Event|4
400184|NCT00727506|1342320|P2|Overall Study|Adverse Event|0
400185|NCT00727506|1342321|P1|Overall Study|Adverse Event|0
400186|NCT00727402|1342414|P1|Overall Study|Physician Decision|116
400187|NCT00727311|1342435|P1|Overall Study|Multiple reasons|39
400188|NCT00727311|1342435|P1|Overall Study|not specified|97
400189|NCT00727311|1342435|P1|Overall Study|Withdrawal by Subject|77
400190|NCT00727311|1342435|P1|Overall Study|Lost to Follow-up|73
400191|NCT00727311|1342435|P1|Overall Study|Lack of Efficacy|242
400192|NCT00727311|1342435|P1|Overall Study|Adverse Event|58
400193|NCT00727311|1342435|P1|Overall Study|Missing end of therapy data|205
400194|NCT00727311|1342435|P1|Overall Study|Did not receive drug|316
400195|NCT00727272|1342448|P3|Washout Period B|Withdrawal by Subject|1
400196|NCT00727272|1342449|P2|Washout Period B|Withdrawal by Subject|0
400197|NCT00727272|1342450|P1|Washout Period B|Withdrawal by Subject|0
400198|NCT00727272|1342448|P3|Washout Period A|Adverse Event|1
400199|NCT00727272|1342449|P2|Washout Period A|Adverse Event|0
400200|NCT00727272|1342450|P1|Washout Period A|Adverse Event|0
400201|NCT00727259|1342467|P1|Overall Study|Not all questionnaires completed|1055
400202|NCT00727246|1342476|P4|Overall Study|withdrawn|0
400203|NCT00727246|1342477|P3|Overall Study|withdrawn|1
400204|NCT00727246|1342478|P2|Overall Study|withdrawn|0
400205|NCT00727246|1342479|P1|Overall Study|withdrawn|0
400206|NCT00727246|1342476|P4|Overall Study|incidental finding|1
400207|NCT00727246|1342477|P3|Overall Study|incidental finding|0
400208|NCT00727246|1342478|P2|Overall Study|incidental finding|0
400209|NCT00727246|1342479|P1|Overall Study|incidental finding|0
400210|NCT00727246|1342476|P4|Overall Study|could not complete MRI|1
400211|NCT00727246|1342477|P3|Overall Study|could not complete MRI|0
400212|NCT00727246|1342478|P2|Overall Study|could not complete MRI|1
400213|NCT00727246|1342479|P1|Overall Study|could not complete MRI|0
400214|NCT00727194|1342502|P3|Treatment Period 2|Lack of Efficacy|0
400215|NCT00727194|1342503|P2|Treatment Period 2|Lack of Efficacy|1
400216|NCT00727194|1342504|P1|Treatment Period 2|Lack of Efficacy|0
400217|NCT00727194|1342502|P3|Screening Period|History of thymoma|1
400218|NCT00727194|1342503|P2|Screening Period|History of thymoma|0
400219|NCT00727194|1342504|P1|Screening Period|History of thymoma|0
400220|NCT00727194|1342502|P3|Screening Period|Severe infections|2
400221|NCT00727194|1342503|P2|Screening Period|Severe infections|0
400222|NCT00727194|1342504|P1|Screening Period|Severe infections|0
400223|NCT00727194|1342502|P3|Screening Period|Not stable on concomitant MG therapy|2
400224|NCT00727194|1342503|P2|Screening Period|Not stable on concomitant MG therapy|0
400225|NCT00727194|1342504|P1|Screening Period|Not stable on concomitant MG therapy|0
400226|NCT00727194|1342502|P3|Screening Period|Lacked AChR antibodies|5
400227|NCT00727194|1342503|P2|Screening Period|Lacked AChR antibodies|0
400228|NCT00727194|1342504|P1|Screening Period|Lacked AChR antibodies|0
400229|NCT00727194|1342502|P3|Screening Period|Low QMG scores|6
400230|NCT00727194|1342503|P2|Screening Period|Low QMG scores|0
400231|NCT00727194|1342504|P1|Screening Period|Low QMG scores|0
400232|NCT00727025|1342576|P1|Overall Study|Physician Decision|23
400233|NCT00726999|1342588|P2|Overall Study|Protocol Violation|0
400234|NCT00726999|1342589|P1|Overall Study|Protocol Violation|1
400235|NCT00726999|1342588|P2|Overall Study|Withdrawal by Subject|0
400236|NCT00726999|1342589|P1|Overall Study|Withdrawal by Subject|2
400237|NCT00726999|1342588|P2|Overall Study|Physician Decision|1
400238|NCT00726999|1342589|P1|Overall Study|Physician Decision|0
400239|NCT00726986|1342599|P1|Maintenance Phase|Lack of Efficacy|2
400240|NCT00726986|1342599|P1|Maintenance Phase|Adverse Event|1
400241|NCT00726986|1342599|P1|Induction Phase|Secondary Disease|2
400242|NCT00726986|1342599|P1|Induction Phase|Lack of Efficacy|5
400243|NCT00726986|1342599|P1|Induction Phase|Death|2
400244|NCT00726986|1342599|P1|Induction Phase|Withdrawal by Subject|2
400245|NCT00726986|1342599|P1|Induction Phase|Adverse Event|4
400246|NCT00726895|1342606|P2|Washout Period of 7 Days|Withdrawal by Subject|1
400247|NCT00726895|1342607|P1|Washout Period of 7 Days|Withdrawal by Subject|0
400248|NCT00726882|1342620|P1|Overall Study|Not Specified|10
400249|NCT00726882|1342620|P1|Overall Study|Lost to Follow-up|7
400250|NCT00726882|1342620|P1|Overall Study|Withdrawal by Subject|5
400251|NCT00726752|1342635|P1|Overall Study|Lack of Efficacy|6
400252|NCT00726661|1342697|P2|Overall Study|Not specified|35
400253|NCT00726661|1342698|P1|Overall Study|Not specified|47
400254|NCT00726661|1342697|P2|Overall Study|Physician Decision|13
400255|NCT00726661|1342698|P1|Overall Study|Physician Decision|25
400256|NCT00726661|1342697|P2|Overall Study|Death|159
400257|NCT00726661|1342698|P1|Overall Study|Death|475
400258|NCT00726661|1342697|P2|Overall Study|Trial terminated by sponsor|187
400259|NCT00726661|1342698|P1|Overall Study|Trial terminated by sponsor|214
400260|NCT00726661|1342697|P2|Overall Study|Withdrawal by Subject|13
400261|NCT00726661|1342698|P1|Overall Study|Withdrawal by Subject|17
400262|NCT00726661|1342697|P2|Overall Study|Lost to Follow-up|11
400263|NCT00726661|1342698|P1|Overall Study|Lost to Follow-up|36
400264|NCT00726622|1342715|P2|Overall Study|Metastasis|0
400265|NCT00726622|1342716|P1|Overall Study|Metastasis|2
400266|NCT00726622|1342715|P2|Overall Study|Physician Decision|1
400267|NCT00726622|1342716|P1|Overall Study|Physician Decision|0
400268|NCT00726622|1342715|P2|Overall Study|Withdrawal by Subject|2
400269|NCT00726622|1342716|P1|Overall Study|Withdrawal by Subject|16
400270|NCT00726609|1342734|P1|Overall Study|Other|3
400271|NCT00726609|1342734|P1|Overall Study|Missing|42
400272|NCT00726609|1342734|P1|Overall Study|Not specified|16
400273|NCT00726609|1342734|P1|Overall Study|Lack of Efficacy|25
400274|NCT00726609|1342734|P1|Overall Study|Withdrawal by Subject|2
400275|NCT00726609|1342734|P1|Overall Study|Adverse Event|10
400276|NCT00726557|1342738|P1|Overall Study|Inclusion criteria not met|15
400277|NCT00726557|1342738|P1|Overall Study|Treatment less than 3 months|17
400278|NCT00726557|1342738|P1|Overall Study|No follow-up documentation available|55
400279|NCT00726557|1342738|P1|Overall Study|No end of treatment documentation|37
400280|NCT00726557|1342738|P1|Overall Study|Screening failure|4
400281|NCT00726453|1342745|P2|38 mm Length Group|Death|3
400282|NCT00726453|1342746|P1|38 mm Length Group|Death|0
400283|NCT00726453|1342745|P2|Primary Enrollment Group|Withdrawal by Subject|0
400284|NCT00726453|1342746|P1|Primary Enrollment Group|Withdrawal by Subject|13
400285|NCT00726453|1342745|P2|Primary Enrollment Group|Death|0
400286|NCT00726453|1342746|P1|Primary Enrollment Group|Death|18
400287|NCT00726323|1342774|P2|Overall Study|Metastatic lesions inferred cyst|1
400288|NCT00726323|1342775|P1|Overall Study|Metastatic lesions inferred cyst|0
400289|NCT00726323|1342774|P2|Overall Study|Participant wished to discontinue|1
400290|NCT00726323|1342775|P1|Overall Study|Participant wished to discontinue|0
400291|NCT00726323|1342774|P2|Overall Study|Death|0
400292|NCT00726323|1342775|P1|Overall Study|Death|1
400293|NCT00726323|1342774|P2|Overall Study|Adverse Event|9
400294|NCT00726323|1342775|P1|Overall Study|Adverse Event|9
400295|NCT00726323|1342774|P2|Overall Study|Clinical progression|3
400296|NCT00726323|1342775|P1|Overall Study|Clinical progression|0
400297|NCT00726323|1342774|P2|Overall Study|Progressive disease|16
400298|NCT00726323|1342775|P1|Overall Study|Progressive disease|23
400299|NCT00726323|1342774|P2|Overall Study|Physician Decision|0
400300|NCT00726323|1342775|P1|Overall Study|Physician Decision|1
400301|NCT00726323|1342774|P2|Overall Study|Withdrawal by Subject|1
400302|NCT00726323|1342775|P1|Overall Study|Withdrawal by Subject|3
400303|NCT00726232|1342805|P6|Overall Study|No response|1
400304|NCT00726232|1342806|P5|Overall Study|No response|3
400305|NCT00726232|1342807|P4|Overall Study|No response|0
400306|NCT00726232|1342808|P3|Overall Study|No response|0
400307|NCT00726232|1342809|P2|Overall Study|No response|0
400308|NCT00726232|1342810|P1|Overall Study|No response|1
400309|NCT00726232|1342805|P6|Overall Study|Disease progression|0
400310|NCT00726232|1342806|P5|Overall Study|Disease progression|0
400311|NCT00726232|1342807|P4|Overall Study|Disease progression|0
400312|NCT00726232|1342808|P3|Overall Study|Disease progression|0
400313|NCT00726232|1342809|P2|Overall Study|Disease progression|0
400314|NCT00726232|1342810|P1|Overall Study|Disease progression|1
400315|NCT00726232|1342805|P6|Overall Study|Adverse Event|1
400316|NCT00726232|1342806|P5|Overall Study|Adverse Event|2
400317|NCT00726232|1342807|P4|Overall Study|Adverse Event|1
400318|NCT00726232|1342808|P3|Overall Study|Adverse Event|0
400319|NCT00726232|1342809|P2|Overall Study|Adverse Event|1
400320|NCT00726232|1342810|P1|Overall Study|Adverse Event|1
400321|NCT00726232|1342805|P6|Overall Study|Withdrawal by Subject|2
400322|NCT00726232|1342806|P5|Overall Study|Withdrawal by Subject|0
400323|NCT00726232|1342807|P4|Overall Study|Withdrawal by Subject|0
400324|NCT00726232|1342808|P3|Overall Study|Withdrawal by Subject|0
400325|NCT00726232|1342809|P2|Overall Study|Withdrawal by Subject|0
400326|NCT00726232|1342810|P1|Overall Study|Withdrawal by Subject|2
400327|NCT00726063|1342860|P2|Overall Study|Adverse Event|7
400328|NCT00726063|1342861|P1|Overall Study|Adverse Event|9
400329|NCT00725985|1342875|P12|LTFU (No Cladribine Treatment)|Other|14
400330|NCT00725985|1342876|P11|LTFU (No Cladribine Treatment)|Other|36
400331|NCT00725985|1342877|P10|LTFU (No Cladribine Treatment)|Other|34
400332|NCT00725985|1342878|P9|LTFU (No Cladribine Treatment)|Other|0
400333|NCT00725985|1342879|P8|LTFU (No Cladribine Treatment)|Other|0
400334|NCT00725985|1342880|P7|LTFU (No Cladribine Treatment)|Other|0
400335|NCT00725985|1342881|P6|LTFU (No Cladribine Treatment)|Other|0
400336|NCT00725985|1342882|P5|LTFU (No Cladribine Treatment)|Other|0
400337|NCT00725985|1342883|P4|LTFU (No Cladribine Treatment)|Other|0
400338|NCT00725985|1342884|P3|LTFU (No Cladribine Treatment)|Other|0
400339|NCT00725985|1342885|P2|LTFU (No Cladribine Treatment)|Other|0
400340|NCT00725985|1342886|P1|LTFU (No Cladribine Treatment)|Other|0
400341|NCT00725985|1342875|P12|LTFU (With Cladribine Treatment)|Other|0
400342|NCT00725985|1342876|P11|LTFU (With Cladribine Treatment)|Other|0
400343|NCT00725985|1342877|P10|LTFU (With Cladribine Treatment)|Other|0
400344|NCT00725985|1342878|P9|LTFU (With Cladribine Treatment)|Other|16
400345|NCT00725985|1342879|P8|LTFU (With Cladribine Treatment)|Other|8
400346|NCT00725985|1342880|P7|LTFU (With Cladribine Treatment)|Other|9
400347|NCT00725985|1342881|P6|LTFU (With Cladribine Treatment)|Other|0
400348|NCT00725985|1342882|P5|LTFU (With Cladribine Treatment)|Other|0
400349|NCT00725985|1342883|P4|LTFU (With Cladribine Treatment)|Other|0
400350|NCT00725985|1342884|P3|LTFU (With Cladribine Treatment)|Other|0
400351|NCT00725985|1342885|P2|LTFU (With Cladribine Treatment)|Other|0
400352|NCT00725985|1342886|P1|LTFU (With Cladribine Treatment)|Other|0
400353|NCT00725985|1342875|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400354|NCT00725985|1342876|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400355|NCT00725985|1342877|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400356|NCT00725985|1342878|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
400357|NCT00725985|1342879|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400358|NCT00725985|1342880|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400359|NCT00725985|1342881|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400360|NCT00725985|1342882|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400361|NCT00725985|1342883|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400362|NCT00725985|1342884|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400363|NCT00725985|1342885|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400364|NCT00725985|1342886|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
400365|NCT00725985|1342875|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
400366|NCT00725985|1342876|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
400367|NCT00725985|1342877|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
400368|NCT00725985|1342878|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
400369|NCT00725985|1342879|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
400370|NCT00725985|1342880|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
400371|NCT00725985|1342881|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
400372|NCT00725985|1342882|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
400373|NCT00725985|1342883|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
400374|NCT00725985|1342884|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
400375|NCT00725985|1342885|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
400376|NCT00725985|1342886|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
400377|NCT00725985|1342875|P12|OLMP|Other|0
400378|NCT00725985|1342876|P11|OLMP|Other|0
400379|NCT00725985|1342877|P10|OLMP|Other|0
400380|NCT00725985|1342878|P9|OLMP|Other|0
400381|NCT00725985|1342879|P8|OLMP|Other|0
400382|NCT00725985|1342880|P7|OLMP|Other|0
400383|NCT00725985|1342881|P6|OLMP|Other|44
400384|NCT00725985|1342882|P5|OLMP|Other|20
400385|NCT00725985|1342883|P4|OLMP|Other|15
400386|NCT00725985|1342884|P3|OLMP|Other|0
400387|NCT00725985|1342885|P2|OLMP|Other|0
400388|NCT00725985|1342886|P1|OLMP|Other|0
400389|NCT00725985|1342875|P12|OLMP|Disease progression|0
400390|NCT00725985|1342876|P11|OLMP|Disease progression|0
400391|NCT00725985|1342877|P10|OLMP|Disease progression|0
400392|NCT00725985|1342878|P9|OLMP|Disease progression|0
400393|NCT00725985|1342879|P8|OLMP|Disease progression|0
400394|NCT00725985|1342880|P7|OLMP|Disease progression|0
400395|NCT00725985|1342881|P6|OLMP|Disease progression|4
400396|NCT00725985|1342882|P5|OLMP|Disease progression|0
400397|NCT00725985|1342883|P4|OLMP|Disease progression|0
400398|NCT00725985|1342884|P3|OLMP|Disease progression|0
400399|NCT00725985|1342885|P2|OLMP|Disease progression|0
400400|NCT00725985|1342886|P1|OLMP|Disease progression|0
400401|NCT00725985|1342875|P12|OLMP|Lost to Follow-up|0
400402|NCT00725985|1342876|P11|OLMP|Lost to Follow-up|0
400403|NCT00725985|1342877|P10|OLMP|Lost to Follow-up|0
400404|NCT00725985|1342878|P9|OLMP|Lost to Follow-up|0
400405|NCT00725985|1342879|P8|OLMP|Lost to Follow-up|0
400406|NCT00725985|1342880|P7|OLMP|Lost to Follow-up|0
400407|NCT00725985|1342881|P6|OLMP|Lost to Follow-up|0
400408|NCT00725985|1342882|P5|OLMP|Lost to Follow-up|0
400409|NCT00725985|1342883|P4|OLMP|Lost to Follow-up|1
400410|NCT00725985|1342884|P3|OLMP|Lost to Follow-up|0
400411|NCT00725985|1342885|P2|OLMP|Lost to Follow-up|0
400412|NCT00725985|1342886|P1|OLMP|Lost to Follow-up|0
400413|NCT00725985|1342875|P12|OLMP|Death|0
400414|NCT00725985|1342876|P11|OLMP|Death|0
400415|NCT00725985|1342877|P10|OLMP|Death|0
400416|NCT00725985|1342878|P9|OLMP|Death|0
400417|NCT00725985|1342879|P8|OLMP|Death|0
400418|NCT00725985|1342880|P7|OLMP|Death|0
400419|NCT00725985|1342881|P6|OLMP|Death|0
400420|NCT00725985|1342882|P5|OLMP|Death|1
400421|NCT00725985|1342883|P4|OLMP|Death|0
400422|NCT00725985|1342884|P3|OLMP|Death|0
400423|NCT00725985|1342885|P2|OLMP|Death|0
400424|NCT00725985|1342886|P1|OLMP|Death|0
400425|NCT00725985|1342875|P12|OLMP|Adverse Event|0
400426|NCT00725985|1342876|P11|OLMP|Adverse Event|0
400427|NCT00725985|1342877|P10|OLMP|Adverse Event|0
400428|NCT00725985|1342878|P9|OLMP|Adverse Event|0
400429|NCT00725985|1342879|P8|OLMP|Adverse Event|0
400430|NCT00725985|1342880|P7|OLMP|Adverse Event|0
400431|NCT00725985|1342881|P6|OLMP|Adverse Event|5
400432|NCT00725985|1342882|P5|OLMP|Adverse Event|2
400433|NCT00725985|1342883|P4|OLMP|Adverse Event|2
400434|NCT00725985|1342884|P3|OLMP|Adverse Event|0
400435|NCT00725985|1342885|P2|OLMP|Adverse Event|0
400436|NCT00725985|1342886|P1|OLMP|Adverse Event|0
400437|NCT00725985|1342875|P12|ITP (Up to 96 Weeks)|Other|0
400438|NCT00725985|1342876|P11|ITP (Up to 96 Weeks)|Other|0
400439|NCT00725985|1342877|P10|ITP (Up to 96 Weeks)|Other|0
400440|NCT00725985|1342878|P9|ITP (Up to 96 Weeks)|Other|0
400441|NCT00725985|1342879|P8|ITP (Up to 96 Weeks)|Other|0
400442|NCT00725985|1342880|P7|ITP (Up to 96 Weeks)|Other|0
400443|NCT00725985|1342881|P6|ITP (Up to 96 Weeks)|Other|0
400444|NCT00725985|1342882|P5|ITP (Up to 96 Weeks)|Other|0
400445|NCT00725985|1342883|P4|ITP (Up to 96 Weeks)|Other|0
400446|NCT00725985|1342884|P3|ITP (Up to 96 Weeks)|Other|24
400447|NCT00725985|1342885|P2|ITP (Up to 96 Weeks)|Other|38
400448|NCT00725985|1342886|P1|ITP (Up to 96 Weeks)|Other|50
400449|NCT00725985|1342875|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
400450|NCT00725985|1342876|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
400451|NCT00725985|1342877|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
400452|NCT00725985|1342878|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
400453|NCT00725985|1342879|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
400454|NCT00725985|1342880|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
400455|NCT00725985|1342881|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
400456|NCT00725985|1342882|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
400457|NCT00725985|1342883|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
400458|NCT00725985|1342884|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
400459|NCT00725985|1342885|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
400460|NCT00725985|1342886|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
400461|NCT00725985|1342875|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
400462|NCT00725985|1342876|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
400463|NCT00725985|1342877|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
400464|NCT00725985|1342878|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
400465|NCT00725985|1342879|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
400466|NCT00725985|1342880|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
400467|NCT00725985|1342881|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
400468|NCT00725985|1342882|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
400469|NCT00725985|1342883|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
400470|NCT00725985|1342884|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
400471|NCT00725985|1342885|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
400472|NCT00725985|1342886|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
400473|NCT00725985|1342875|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400474|NCT00725985|1342876|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400475|NCT00725985|1342877|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400476|NCT00725985|1342878|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400477|NCT00725985|1342879|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400478|NCT00725985|1342880|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400479|NCT00725985|1342881|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400480|NCT00725985|1342882|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400481|NCT00725985|1342883|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400482|NCT00725985|1342884|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
400483|NCT00725985|1342885|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400484|NCT00725985|1342886|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
400485|NCT00725985|1342875|P12|ITP (Up to 96 Weeks)|Adverse Event|0
400486|NCT00725985|1342876|P11|ITP (Up to 96 Weeks)|Adverse Event|0
400487|NCT00725985|1342877|P10|ITP (Up to 96 Weeks)|Adverse Event|0
400488|NCT00725985|1342878|P9|ITP (Up to 96 Weeks)|Adverse Event|0
400489|NCT00725985|1342879|P8|ITP (Up to 96 Weeks)|Adverse Event|0
400490|NCT00725985|1342880|P7|ITP (Up to 96 Weeks)|Adverse Event|0
400491|NCT00725985|1342881|P6|ITP (Up to 96 Weeks)|Adverse Event|0
400492|NCT00725985|1342882|P5|ITP (Up to 96 Weeks)|Adverse Event|0
400493|NCT00725985|1342883|P4|ITP (Up to 96 Weeks)|Adverse Event|0
400494|NCT00725985|1342884|P3|ITP (Up to 96 Weeks)|Adverse Event|5
400495|NCT00725985|1342885|P2|ITP (Up to 96 Weeks)|Adverse Event|10
400496|NCT00725985|1342886|P1|ITP (Up to 96 Weeks)|Adverse Event|20
400497|NCT00725920|1342923|P2|Overall Study|Lack of Efficacy|6
400498|NCT00725920|1342924|P1|Overall Study|Lack of Efficacy|3
400499|NCT00725842|1342930|P1|Overall Study|No Visit 1 data|1
400500|NCT00725842|1342930|P1|Overall Study|Inclusion criterion not met|1
400501|NCT00725842|1342930|P1|Overall Study|Consent date prior to study start date|5
400502|NCT00725842|1342930|P1|Overall Study|Positive HCV-RNA at Visit 2|13
400503|NCT00725842|1342930|P1|Overall Study|Death|1
400504|NCT00725842|1342930|P1|Overall Study|Lost to Follow-up|19
400505|NCT00725764|1342937|P1|Overall Study|Decline in performance status|1
400506|NCT00725764|1342937|P1|Overall Study|Participant non compliant with protocol|1
400507|NCT00725764|1342937|P1|Overall Study|Death|1
400508|NCT00725764|1342937|P1|Overall Study|Lost to Follow-up|1
400509|NCT00725764|1342937|P1|Overall Study|Progressive Disease|7
400510|NCT00725764|1342937|P1|Overall Study|Physician Decision|1
400511|NCT00725764|1342937|P1|Overall Study|Withdrawal by Subject|2
400512|NCT00725725|1342970|P3|Overall Study|Protocol Violation|0
400513|NCT00725725|1342971|P2|Overall Study|Protocol Violation|1
400514|NCT00725725|1342972|P1|Overall Study|Protocol Violation|0
400515|NCT00725725|1342970|P3|Overall Study|Withdrawal by Subject|1
400516|NCT00725725|1342971|P2|Overall Study|Withdrawal by Subject|0
400517|NCT00725725|1342972|P1|Overall Study|Withdrawal by Subject|1
400518|NCT00725725|1342970|P3|Overall Study|Lost to Follow-up|2
400519|NCT00725725|1342971|P2|Overall Study|Lost to Follow-up|0
400520|NCT00725725|1342972|P1|Overall Study|Lost to Follow-up|2
400521|NCT00725725|1342970|P3|Overall Study|Adverse Event|2
400522|NCT00725725|1342971|P2|Overall Study|Adverse Event|3
400523|NCT00725725|1342972|P1|Overall Study|Adverse Event|1
400524|NCT00725712|1343015|P2|Overall Study|Hospitalized, unable to continue|1
400525|NCT00725712|1343016|P1|Overall Study|Hospitalized, unable to continue|0
400526|NCT00725712|1343015|P2|Overall Study|Other: Death|0
400527|NCT00725712|1343016|P1|Overall Study|Other: Death|1
400528|NCT00725712|1343015|P2|Overall Study|Death|0
400529|NCT00725712|1343016|P1|Overall Study|Death|2
400530|NCT00725712|1343015|P2|Overall Study|Adverse Event|5
400531|NCT00725712|1343016|P1|Overall Study|Adverse Event|5
400532|NCT00725712|1343015|P2|Overall Study|Clinical progression not based on RECIST|3
400533|NCT00725712|1343016|P1|Overall Study|Clinical progression not based on RECIST|0
400534|NCT00725712|1343015|P2|Overall Study|Progressive disease|16
400535|NCT00725712|1343016|P1|Overall Study|Progressive disease|37
400536|NCT00725712|1343015|P2|Overall Study|Protocol Violation|0
400537|NCT00725712|1343016|P1|Overall Study|Protocol Violation|1
400538|NCT00725712|1343015|P2|Overall Study|Withdrawal by Subject|1
400539|NCT00725712|1343016|P1|Overall Study|Withdrawal by Subject|2
400540|NCT00725621|1343052|P1|Overall Study|Reason not specified|55
400541|NCT00725621|1343052|P1|Overall Study|Prepared for elective surgery|1
400542|NCT00725621|1343052|P1|Overall Study|Switched to other drug|1
400543|NCT00725621|1343052|P1|Overall Study|Switched to other study|1
400544|NCT00725621|1343052|P1|Overall Study|Continued treatment by other physician|6
400545|NCT00725621|1343052|P1|Overall Study|Non-compliance|8
400546|NCT00725621|1343052|P1|Overall Study|Lost to Follow-up|52
400547|NCT00725621|1343052|P1|Overall Study|Physician Decision|19
400548|NCT00725621|1343052|P1|Overall Study|Withdrawal by Subject|57
400549|NCT00725621|1343052|P1|Overall Study|Lack of Efficacy|46
400550|NCT00725621|1343052|P1|Overall Study|Adverse Event|25
400551|NCT00725608|1343075|P1|Overall Study|Other|7
400552|NCT00725608|1343075|P1|Overall Study|Individual reasons|86
400553|NCT00725608|1343075|P1|Overall Study|Adverse Event|14
400554|NCT00725608|1343075|P1|Overall Study|Lost to Follow-up|60
400555|NCT00725543|1343081|P1|Overall Study|Not specified|119
400556|NCT00725543|1343081|P1|Overall Study|Non-compliance|2
400557|NCT00725543|1343081|P1|Overall Study|Lost to Follow-up|4
400558|NCT00725543|1343081|P1|Overall Study|Physician Decision|5
400559|NCT00725543|1343081|P1|Overall Study|Withdrawal by Subject|10
400560|NCT00725543|1343081|P1|Overall Study|Lack of Efficacy|3
400561|NCT00725543|1343081|P1|Overall Study|Adverse Event|10
400562|NCT00725491|1343106|P2|Overall Study|No/too few embryos/ bad quality embryos|2
400563|NCT00725491|1343107|P1|Overall Study|No/too few embryos/ bad quality embryos|3
400564|NCT00725491|1343106|P2|Overall Study|Fertilization failure|1
400565|NCT00725491|1343107|P1|Overall Study|Fertilization failure|0
400566|NCT00725491|1343106|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
400567|NCT00725491|1343107|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
400568|NCT00725491|1343106|P2|Overall Study|Risk for hyperstimulation|9
400569|NCT00725491|1343107|P1|Overall Study|Risk for hyperstimulation|2
400570|NCT00725491|1343106|P2|Overall Study|Pregnancy|3
400571|NCT00725491|1343107|P1|Overall Study|Pregnancy|0
400572|NCT00725491|1343106|P2|Overall Study|Adverse Event|2
400573|NCT00725491|1343107|P1|Overall Study|Adverse Event|3
400574|NCT00725452|1343113|P1|Overall Study|Lost to Follow-up|1
400575|NCT00725452|1343113|P1|Overall Study|Withdrawal by Subject|3
400576|NCT00725452|1343113|P1|Overall Study|Physician Decision|1
400577|NCT00725452|1343113|P1|Overall Study|Reason not specified|1
400578|NCT00725452|1343113|P1|Overall Study|Lack of Efficacy|2
400579|NCT00725452|1343113|P1|Overall Study|Adverse Event|3
400580|NCT00725322|1343132|P2|Washout (28 Days)|Protocol Violation|1
400581|NCT00725322|1343133|P1|Washout (28 Days)|Protocol Violation|0
400582|NCT00725322|1343132|P2|Washout (28 Days)|Withdrawal by Subject|0
400583|NCT00725322|1343133|P1|Washout (28 Days)|Withdrawal by Subject|2
400584|NCT00725296|1343141|P1|Overall Study|Not Specified|38
400585|NCT00725296|1343141|P1|Overall Study|Lost to Follow-up|1
400586|NCT00725296|1343141|P1|Overall Study|Non-Compliance|2
400587|NCT00725296|1343141|P1|Overall Study|Withdrawal by Subject|3
400588|NCT00725296|1343141|P1|Overall Study|Lack of Efficacy|7
400589|NCT00725296|1343141|P1|Overall Study|Adverse Event|11
400590|NCT00725205|1343161|P1|Overall Study|Treatment Failure|41
400591|NCT00725205|1343161|P1|Overall Study|Protocol Defined Clinical Event|1
400592|NCT00725205|1343161|P1|Overall Study|Other|8
400593|NCT00725205|1343161|P1|Overall Study|Non-compliance With Protocol|14
400594|NCT00725205|1343161|P1|Overall Study|Investigator Discontinued|1
400595|NCT00725205|1343161|P1|Overall Study|Adverse Event|22
400596|NCT00725101|1343174|P1|Overall Study|not specified/no reason given|11
400597|NCT00725101|1343174|P1|Overall Study|Withdrawal by Subject|127
400598|NCT00725101|1343174|P1|Overall Study|Protocol Violation|1
400599|NCT00725101|1343174|P1|Overall Study|Lost to Follow-up|353
400600|NCT00725101|1343174|P1|Overall Study|Death|3
400601|NCT00725075|1343197|P3|Overall Study|Other|0
400602|NCT00725075|1343198|P2|Overall Study|Other|0
400603|NCT00725075|1343199|P1|Overall Study|Other|1
400604|NCT00725075|1343197|P3|Overall Study|Inclusion/Exclusion Criteria|1
400605|NCT00725075|1343198|P2|Overall Study|Inclusion/Exclusion Criteria|0
400606|NCT00725075|1343199|P1|Overall Study|Inclusion/Exclusion Criteria|1
400607|NCT00725075|1343197|P3|Overall Study|Worsening of Disease|2
400608|NCT00725075|1343198|P2|Overall Study|Worsening of Disease|1
400609|NCT00725075|1343199|P1|Overall Study|Worsening of Disease|2
400610|NCT00725075|1343197|P3|Overall Study|Adverse Event|1
400611|NCT00725075|1343198|P2|Overall Study|Adverse Event|1
400612|NCT00725075|1343199|P1|Overall Study|Adverse Event|2
400613|NCT00725075|1343197|P3|Overall Study|Withdrawal by Subject|4
400614|NCT00725075|1343198|P2|Overall Study|Withdrawal by Subject|5
400615|NCT00725075|1343199|P1|Overall Study|Withdrawal by Subject|4
400616|NCT00725075|1343197|P3|Overall Study|Lost to Follow-up|0
400617|NCT00725075|1343198|P2|Overall Study|Lost to Follow-up|0
400618|NCT00725075|1343199|P1|Overall Study|Lost to Follow-up|1
400619|NCT00725075|1343197|P3|Overall Study|Protocol Violation|1
400620|NCT00725075|1343198|P2|Overall Study|Protocol Violation|0
400621|NCT00725075|1343199|P1|Overall Study|Protocol Violation|0
400622|NCT00725075|1343197|P3|Overall Study|Use of Excluded Medication|0
400623|NCT00725075|1343198|P2|Overall Study|Use of Excluded Medication|1
400624|NCT00725075|1343199|P1|Overall Study|Use of Excluded Medication|0
400625|NCT00725010|1343252|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
400626|NCT00725010|1343252|P1|Overall Study|No further documentation|1
400627|NCT00725010|1343252|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
400628|NCT00725010|1343252|P1|Overall Study|Hepatopathy probably not Temodal-related|1
400629|NCT00725010|1343252|P1|Overall Study|Lost to Follow-up|1
400630|NCT00725010|1343252|P1|Overall Study|Death|1
400631|NCT00725010|1343252|P1|Overall Study|Withdrawal by Subject|2
400632|NCT00725010|1343252|P1|Overall Study|Tumor Progression|7
400633|NCT00725010|1343252|P1|Overall Study|Toxicity|9
400634|NCT00724958|1343285|P1|Overall Study|No documentation for end of therapy|13
400635|NCT00724958|1343285|P1|Overall Study|Other Reason|76
400636|NCT00724958|1343285|P1|Overall Study|Remission|7
400637|NCT00724958|1343285|P1|Overall Study|No Response|18
400638|NCT00724958|1343285|P1|Overall Study|Loss of Response|40
400639|NCT00724958|1343285|P1|Overall Study|Adverse Event|28
400640|NCT00724945|1343294|P2|Period 2|lens physiology issue|0
400641|NCT00724945|1343295|P1|Period 2|lens physiology issue|1
400642|NCT00724945|1343294|P2|Period 2|lens comfort issue|0
400643|NCT00724945|1343295|P1|Period 2|lens comfort issue|3
400644|NCT00724945|1343294|P2|Period 1|Lost to Follow-up|0
400645|NCT00724945|1343295|P1|Period 1|Lost to Follow-up|1
400646|NCT00724945|1343294|P2|Period 1|Adverse Event|1
400647|NCT00724945|1343295|P1|Period 1|Adverse Event|1
400648|NCT00724945|1343294|P2|Period 1|non-compliance|0
400649|NCT00724945|1343295|P1|Period 1|non-compliance|1
400650|NCT00724932|1343307|P2|Overall Study|Not treated|3
400651|NCT00724932|1343308|P1|Overall Study|Not treated|4
400652|NCT00724932|1343307|P2|Overall Study|Lost to Follow-up|0
400653|NCT00724932|1343308|P1|Overall Study|Lost to Follow-up|1
400654|NCT00724893|1343379|P2|Overall Study|Unknown, missing data|1
400655|NCT00724893|1343380|P1|Overall Study|Unknown, missing data|1
400656|NCT00724893|1343379|P2|Overall Study|Lost to Follow-up|52
400657|NCT00724893|1343380|P1|Overall Study|Lost to Follow-up|0
400658|NCT00724893|1343379|P2|Overall Study|Assigned shorter treatment|2
400659|NCT00724893|1343380|P1|Overall Study|Assigned shorter treatment|0
400660|NCT00724893|1343379|P2|Overall Study|Financial reasons|2
400661|NCT00724893|1343380|P1|Overall Study|Financial reasons|0
400662|NCT00724893|1343379|P2|Overall Study|Substance abuse|3
400663|NCT00724893|1343380|P1|Overall Study|Substance abuse|0
400664|NCT00724893|1343379|P2|Overall Study|Incarceration|9
400665|NCT00724893|1343380|P1|Overall Study|Incarceration|0
400666|NCT00724893|1343379|P2|Overall Study|Geographic reasons|11
400667|NCT00724893|1343380|P1|Overall Study|Geographic reasons|0
400668|NCT00724893|1343379|P2|Overall Study|Patient choice|26
400669|NCT00724893|1343380|P1|Overall Study|Patient choice|0
400670|NCT00724893|1343379|P2|Overall Study|Reason not specified|7
400671|NCT00724893|1343380|P1|Overall Study|Reason not specified|193
400672|NCT00724893|1343379|P2|Overall Study|Lack of virologic response|202
400673|NCT00724893|1343380|P1|Overall Study|Lack of virologic response|94
400674|NCT00724893|1343379|P2|Overall Study|Withdrawal by Subject|1
400675|NCT00724893|1343380|P1|Overall Study|Withdrawal by Subject|0
400676|NCT00724893|1343379|P2|Overall Study|Adverse Event|142
400677|NCT00724893|1343380|P1|Overall Study|Adverse Event|76
400678|NCT00724867|1343448|P1|Overall Study|Elected to exit due to site closure|2
400679|NCT00724867|1343448|P1|Overall Study|Subject moved out of state|1
400680|NCT00724867|1343448|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
400681|NCT00724867|1343448|P1|Overall Study|Subject incarcerated|1
400682|NCT00724867|1343448|P1|Overall Study|Sponsor decision to end study|14
400683|NCT00724867|1343448|P1|Overall Study|Withdrawal by Subject|31
400684|NCT00724867|1343448|P1|Overall Study|Protocol Violation|1
400685|NCT00724867|1343448|P1|Overall Study|Physician Decision|17
400686|NCT00724867|1343448|P1|Overall Study|Non-compliance with study drug|6
400687|NCT00724867|1343448|P1|Overall Study|Lost to Follow-up|12
400688|NCT00724867|1343448|P1|Overall Study|Lack of Efficacy|14
400689|NCT00724867|1343448|P1|Overall Study|Adverse Event|25
400690|NCT00724854|1343488|P2|Overall Study|Adverse event + lack of efficacy|1
400691|NCT00724854|1343489|P1|Overall Study|Adverse event + lack of efficacy|2
400692|NCT00724854|1343488|P2|Overall Study|Withdrawal by Subject|0
400693|NCT00724854|1343489|P1|Overall Study|Withdrawal by Subject|5
400694|NCT00724854|1343488|P2|Overall Study|Change of treatment|0
400695|NCT00724854|1343489|P1|Overall Study|Change of treatment|7
400696|NCT00724854|1343488|P2|Overall Study|Death|0
400697|NCT00724854|1343489|P1|Overall Study|Death|11
400698|NCT00724854|1343488|P2|Overall Study|Not specified|3
400699|NCT00724854|1343489|P1|Overall Study|Not specified|42
400700|NCT00724854|1343488|P2|Overall Study|Adverse Event|4
400701|NCT00724854|1343489|P1|Overall Study|Adverse Event|62
400702|NCT00724854|1343488|P2|Overall Study|Lost to Follow-up|10
400703|NCT00724854|1343489|P1|Overall Study|Lost to Follow-up|87
400704|NCT00724854|1343488|P2|Overall Study|Lack of Efficacy|13
400705|NCT00724854|1343489|P1|Overall Study|Lack of Efficacy|187
400706|NCT00724815|1343506|P2|Overall Study|Other Various|5
400707|NCT00724815|1343507|P1|Overall Study|Other Various|3
400708|NCT00724815|1343506|P2|Overall Study|Lost to Follow-up|1
400709|NCT00724815|1343507|P1|Overall Study|Lost to Follow-up|4
400710|NCT00724815|1343506|P2|Overall Study|Adverse Event|3
400711|NCT00724815|1343507|P1|Overall Study|Adverse Event|5
400712|NCT00724815|1343506|P2|Overall Study|Randomized, not treated|30
400713|NCT00724815|1343507|P1|Overall Study|Randomized, not treated|31
400714|NCT00724711|1343540|P2|Overall Study|Protocol Violation|0
400715|NCT00724711|1343541|P1|Overall Study|Protocol Violation|1
400716|NCT00724711|1343540|P2|Overall Study|Lost to Follow-up|5
400717|NCT00724711|1343541|P1|Overall Study|Lost to Follow-up|4
400718|NCT00724711|1343540|P2|Overall Study|Withdrawal by Subject|4
400719|NCT00724711|1343541|P1|Overall Study|Withdrawal by Subject|5
400720|NCT00724711|1343540|P2|Overall Study|Physician Decision|3
400721|NCT00724711|1343541|P1|Overall Study|Physician Decision|0
400722|NCT00724711|1343540|P2|Overall Study|Lack of Efficacy|1
400723|NCT00724711|1343541|P1|Overall Study|Lack of Efficacy|0
400724|NCT00724711|1343540|P2|Overall Study|Pregnancy|1
400725|NCT00724711|1343541|P1|Overall Study|Pregnancy|0
400726|NCT00724711|1343540|P2|Overall Study|Adverse Event|3
400727|NCT00724711|1343541|P1|Overall Study|Adverse Event|7
400728|NCT00724698|1343573|P1|Overall Study|No Info|25
400729|NCT00724698|1343573|P1|Overall Study|Lost to Follow-up|36
400730|NCT00724698|1343573|P1|Overall Study|Poor Compliance|16
400731|NCT00724698|1343573|P1|Overall Study|Failure of Therapy|4
400732|NCT00724698|1343573|P1|Overall Study|Adverse Event|9
400733|NCT00724451|1343628|P1|Overall Study|Investigator + Participant Decision|13
400734|NCT00724451|1343628|P1|Overall Study|Withdrawal by Subject|45
400735|NCT00724451|1343628|P1|Overall Study|Physician Decision|116
400736|NCT00724451|1343628|P1|Overall Study|Unknown; No Data Sources Available|9
400737|NCT00724451|1343628|P1|Overall Study|Never Started Treatment|89
400738|NCT00724451|1343628|P1|Overall Study|Participant Refused Treatment|89
400739|NCT00724451|1343628|P1|Overall Study|Not Eligible for Treatment|431
400740|NCT00724451|1343628|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
400741|NCT00724451|1343628|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
400742|NCT00724373|1343634|P1|Overall Study|Tolerability|23
400743|NCT00724373|1343634|P1|Overall Study|Drug Relapse|1
400744|NCT00724373|1343634|P1|Overall Study|Acute HCV infection|1
400745|NCT00724373|1343634|P1|Overall Study|Viral Relapse|1
400746|NCT00724373|1343634|P1|Overall Study|Only to have 24 week regimen|1
400747|NCT00724373|1343634|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
400748|NCT00724373|1343634|P1|Overall Study|Participant moved away|1
400749|NCT00724373|1343634|P1|Overall Study|HCV RNA negative after 4 weeks|9
400750|NCT00724373|1343634|P1|Overall Study|Non-compliance|2
400751|NCT00724373|1343634|P1|Overall Study|Lost to Follow-up|7
400752|NCT00724373|1343634|P1|Overall Study|Lack of Efficacy|82
400753|NCT00724373|1343634|P1|Overall Study|Adverse Event|41
400754|NCT00724282|1343651|P1|Overall Study|Physician Decision|1
400755|NCT00724282|1343651|P1|Overall Study|Withdrawal by Subject|3
400756|NCT00724243|1343655|P1|Overall Study|Adverse Event|5
400757|NCT00724243|1343655|P1|Overall Study|Lack of Efficacy|10
400758|NCT00724152|1343665|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
400759|NCT00724152|1343666|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
400760|NCT00724152|1343667|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
400761|NCT00724152|1343665|P3|Two-arm Study Period|Withdrawal by Subject|0
400762|NCT00724152|1343666|P2|Two-arm Study Period|Withdrawal by Subject|2
400763|NCT00724152|1343667|P1|Two-arm Study Period|Withdrawal by Subject|3
400764|NCT00724126|1343684|P2|Overall Study|Subject had to leave vicinity of site|1
400765|NCT00724126|1343685|P1|Overall Study|Subject had to leave vicinity of site|0
400766|NCT00724126|1343684|P2|Overall Study|Subject randomized although ineligible|1
400767|NCT00724126|1343685|P1|Overall Study|Subject randomized although ineligible|1
400768|NCT00724126|1343684|P2|Overall Study|Noncompliance|1
400769|NCT00724126|1343685|P1|Overall Study|Noncompliance|2
400770|NCT00724126|1343684|P2|Overall Study|Lost to Follow-up|6
400771|NCT00724126|1343685|P1|Overall Study|Lost to Follow-up|6
400772|NCT00724126|1343684|P2|Overall Study|Withdrawal by Subject|6
400773|NCT00724126|1343685|P1|Overall Study|Withdrawal by Subject|8
400774|NCT00724126|1343684|P2|Overall Study|Adverse Event|0
400775|NCT00724126|1343685|P1|Overall Study|Adverse Event|2
400776|NCT00724061|1343693|P1|Dose Escalation Phase|Disease Progression|3
400777|NCT00724061|1343693|P1|Dose Escalation Phase|Adverse Event|2
400778|NCT00723957|1343710|P2|Overall Study|Never received treatment|3
400779|NCT00723957|1343711|P1|Overall Study|Never received treatment|3
400780|NCT00723957|1343710|P2|Overall Study|Reason not analyzed|0
400781|NCT00723957|1343711|P1|Overall Study|Reason not analyzed|1
400782|NCT00723957|1343710|P2|Overall Study|Withdrawal by Subject|5
400783|NCT00723957|1343711|P1|Overall Study|Withdrawal by Subject|7
400784|NCT00723957|1343710|P2|Overall Study|Study drug toxicity|6
400785|NCT00723957|1343711|P1|Overall Study|Study drug toxicity|4
400786|NCT00723957|1343710|P2|Overall Study|Investigator decision|1
400787|NCT00723957|1343711|P1|Overall Study|Investigator decision|1
400788|NCT00723957|1343710|P2|Overall Study|Maximum clinical benefit|5
400789|NCT00723957|1343711|P1|Overall Study|Maximum clinical benefit|4
400790|NCT00723957|1343710|P2|Overall Study|Disease progression|25
400791|NCT00723957|1343711|P1|Overall Study|Disease progression|27
400792|NCT00723957|1343710|P2|Overall Study|Death|4
400793|NCT00723957|1343711|P1|Overall Study|Death|3
400794|NCT00723957|1343710|P2|Overall Study|Adverse event unrelated to study drug|4
400795|NCT00723957|1343711|P1|Overall Study|Adverse event unrelated to study drug|1
400796|NCT00723944|1343735|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
400797|NCT00723944|1343736|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
400798|NCT00723944|1343735|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
400799|NCT00723944|1343736|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
400800|NCT00723944|1343735|P2|Permanent Prosthesis Placement|Adverse Event|7
400801|NCT00723944|1343736|P1|Permanent Prosthesis Placement|Adverse Event|1
400802|NCT00723892|1343749|P2|Overall Study|Drug addiction|0
400803|NCT00723892|1343750|P1|Overall Study|Drug addiction|1
400804|NCT00723892|1343749|P2|Overall Study|Intercurrent infection|0
400805|NCT00723892|1343750|P1|Overall Study|Intercurrent infection|2
400806|NCT00723892|1343749|P2|Overall Study|Alcohol abuse|1
400807|NCT00723892|1343750|P1|Overall Study|Alcohol abuse|0
400808|NCT00723892|1343749|P2|Overall Study|Weight loss|3
400809|NCT00723892|1343750|P1|Overall Study|Weight loss|1
400810|NCT00723892|1343749|P2|Overall Study|Study end|3
400811|NCT00723892|1343750|P1|Overall Study|Study end|1
400812|NCT00723892|1343749|P2|Overall Study|Not specified|3
400813|NCT00723892|1343750|P1|Overall Study|Not specified|6
400814|NCT00723892|1343749|P2|Overall Study|Multiple reasons|12
400815|NCT00723892|1343750|P1|Overall Study|Multiple reasons|17
400816|NCT00723892|1343749|P2|Overall Study|Bad tolerance|5
400817|NCT00723892|1343750|P1|Overall Study|Bad tolerance|5
400818|NCT00723892|1343749|P2|Overall Study|End planned|7
400819|NCT00723892|1343750|P1|Overall Study|End planned|11
400820|NCT00723892|1343749|P2|Overall Study|Withdrawal by Subject|9
400821|NCT00723892|1343750|P1|Overall Study|Withdrawal by Subject|6
400822|NCT00723892|1343749|P2|Overall Study|Virological criterion|9
400823|NCT00723892|1343750|P1|Overall Study|Virological criterion|24
400824|NCT00723892|1343749|P2|Overall Study|Participant not tracked|35
400825|NCT00723892|1343750|P1|Overall Study|Participant not tracked|33
400826|NCT00723840|1343757|P1|Overall Study|Unspecified reason|2
400827|NCT00723840|1343757|P1|Overall Study|Other Medical Event|2
400828|NCT00723840|1343757|P1|Overall Study|Serious Adverse Events|3
400829|NCT00723840|1343757|P1|Overall Study|Withdrawal by Subject|55
400830|NCT00723840|1343757|P1|Overall Study|Failure to return|18
400831|NCT00723840|1343757|P1|Overall Study|Lost to Follow-up|2
400832|NCT00723801|1343778|P2|Overall Study|Protocol Violation|1
400833|NCT00723801|1343779|P1|Overall Study|Protocol Violation|2
400834|NCT00723801|1343778|P2|Overall Study|Lost to Follow-up|2
400835|NCT00723801|1343779|P1|Overall Study|Lost to Follow-up|1
400836|NCT00723710|1343804|P1|Overall Study|Physician Decision|2
400837|NCT00723710|1343804|P1|Overall Study|Withdrawal by Subject|36
400838|NCT00723710|1343804|P1|Overall Study|Adverse Event|88
400839|NCT00723710|1343804|P1|Overall Study|Disease progression|48
400840|NCT00723697|1343808|P1|Overall Study|Other exclusion criteria applied|6
400841|NCT00723697|1343808|P1|Overall Study|Missing Informed Consent Form|10
400842|NCT00723697|1343808|P1|Overall Study|Physician questionnaires not received|2
400843|NCT00723606|1343829|P2|Overall Study|Withdrawal by Subject|2
400844|NCT00723606|1343830|P1|Overall Study|Withdrawal by Subject|0
400845|NCT00723606|1343829|P2|Overall Study|Other|0
400846|NCT00723606|1343830|P1|Overall Study|Other|2
400847|NCT00723606|1343829|P2|Overall Study|Adverse Event|5
400848|NCT00723606|1343830|P1|Overall Study|Adverse Event|2
400849|NCT00723554|1343850|P1|Overall Study|Non-compliance|1
400850|NCT00723554|1343850|P1|Overall Study|Lost to Follow-up|1
400851|NCT00723554|1343850|P1|Overall Study|Not specified|3
400852|NCT00723554|1343850|P1|Overall Study|Withdrawal of consent|3
400853|NCT00723554|1343850|P1|Overall Study|Inhaled medication other than iloprost|4
400854|NCT00723554|1343850|P1|Overall Study|Investigator's judgement|5
400855|NCT00723554|1343850|P1|Overall Study|Adverse Event|12
400856|NCT00723528|1343900|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
400857|NCT00723528|1343901|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
400858|NCT00723528|1343902|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
400859|NCT00723528|1343903|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
400860|NCT00723528|1343904|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
400861|NCT00723528|1343905|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
400862|NCT00723528|1343906|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
400863|NCT00723528|1343900|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
400864|NCT00723528|1343901|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
400865|NCT00723528|1343902|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
400866|NCT00723528|1343903|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
400867|NCT00723528|1343904|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
400868|NCT00723528|1343905|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
400869|NCT00723528|1343906|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
400870|NCT00723528|1343900|P7|Period 2: After Controlled Period|Adverse Event|1
400871|NCT00723528|1343901|P6|Period 2: After Controlled Period|Adverse Event|0
400872|NCT00723528|1343902|P5|Period 2: After Controlled Period|Adverse Event|1
400873|NCT00723528|1343903|P4|Period 2: After Controlled Period|Adverse Event|0
400874|NCT00723528|1343904|P3|Period 2: After Controlled Period|Adverse Event|0
400875|NCT00723528|1343905|P2|Period 2: After Controlled Period|Adverse Event|0
400876|NCT00723528|1343906|P1|Period 2: After Controlled Period|Adverse Event|0
400877|NCT00723528|1343900|P7|Period 2: After Controlled Period|Other|0
400878|NCT00723528|1343901|P6|Period 2: After Controlled Period|Other|4
400879|NCT00723528|1343902|P5|Period 2: After Controlled Period|Other|1
400880|NCT00723528|1343903|P4|Period 2: After Controlled Period|Other|0
400881|NCT00723528|1343904|P3|Period 2: After Controlled Period|Other|0
400882|NCT00723528|1343905|P2|Period 2: After Controlled Period|Other|0
400883|NCT00723528|1343906|P1|Period 2: After Controlled Period|Other|0
400884|NCT00723528|1343900|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
400885|NCT00723528|1343901|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
400886|NCT00723528|1343902|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
400887|NCT00723528|1343903|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
400888|NCT00723528|1343904|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
400889|NCT00723528|1343905|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
400890|NCT00723528|1343906|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
400891|NCT00723528|1343900|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
400892|NCT00723528|1343901|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
400893|NCT00723528|1343902|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
400894|NCT00723528|1343903|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
400895|NCT00723528|1343904|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
400896|NCT00723528|1343905|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
400897|NCT00723528|1343906|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
400898|NCT00723528|1343900|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
400899|NCT00723528|1343901|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
400900|NCT00723528|1343902|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
400901|NCT00723528|1343903|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
400902|NCT00723528|1343904|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
400903|NCT00723528|1343905|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
400904|NCT00723528|1343906|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
400905|NCT00723528|1343900|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
400906|NCT00723528|1343901|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
400907|NCT00723528|1343902|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
400908|NCT00723528|1343903|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
400909|NCT00723528|1343904|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
400910|NCT00723528|1343905|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
400911|NCT00723528|1343906|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
400912|NCT00723528|1343900|P7|Period 1: Controlled Period (CP)|Physician Decision|0
400913|NCT00723528|1343901|P6|Period 1: Controlled Period (CP)|Physician Decision|0
400914|NCT00723528|1343902|P5|Period 1: Controlled Period (CP)|Physician Decision|0
400915|NCT00723528|1343903|P4|Period 1: Controlled Period (CP)|Physician Decision|0
400916|NCT00723528|1343904|P3|Period 1: Controlled Period (CP)|Physician Decision|1
400917|NCT00723528|1343905|P2|Period 1: Controlled Period (CP)|Physician Decision|0
400918|NCT00723528|1343906|P1|Period 1: Controlled Period (CP)|Physician Decision|0
400919|NCT00723528|1343900|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
400920|NCT00723528|1343901|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
400921|NCT00723528|1343902|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
400922|NCT00723528|1343903|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
400923|NCT00723528|1343904|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
400924|NCT00723528|1343905|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
400925|NCT00723528|1343906|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
400926|NCT00723528|1343900|P7|Period 1: Controlled Period (CP)|Adverse Event|0
400927|NCT00723528|1343901|P6|Period 1: Controlled Period (CP)|Adverse Event|0
400928|NCT00723528|1343902|P5|Period 1: Controlled Period (CP)|Adverse Event|0
400929|NCT00723528|1343903|P4|Period 1: Controlled Period (CP)|Adverse Event|0
400930|NCT00723528|1343904|P3|Period 1: Controlled Period (CP)|Adverse Event|1
400931|NCT00723528|1343905|P2|Period 1: Controlled Period (CP)|Adverse Event|0
400932|NCT00723528|1343906|P1|Period 1: Controlled Period (CP)|Adverse Event|0
400933|NCT00723489|1343968|P4|Overall Study|Samples Collected Out of Window|0
400934|NCT00723489|1343969|P3|Overall Study|Samples Collected Out of Window|0
400935|NCT00723489|1343970|P2|Overall Study|Samples Collected Out of Window|3
400936|NCT00723489|1343971|P1|Overall Study|Samples Collected Out of Window|0
400937|NCT00723489|1343968|P4|Overall Study|Prohibited Medication|1
400938|NCT00723489|1343969|P3|Overall Study|Prohibited Medication|0
400939|NCT00723489|1343970|P2|Overall Study|Prohibited Medication|0
400940|NCT00723489|1343971|P1|Overall Study|Prohibited Medication|0
400941|NCT00723489|1343968|P4|Overall Study|Seropositive at baseline|0
400942|NCT00723489|1343969|P3|Overall Study|Seropositive at baseline|0
400943|NCT00723489|1343970|P2|Overall Study|Seropositive at baseline|0
400944|NCT00723489|1343971|P1|Overall Study|Seropositive at baseline|1
400945|NCT00723489|1343968|P4|Overall Study|Withdrawal by Subject|1
400946|NCT00723489|1343969|P3|Overall Study|Withdrawal by Subject|0
400947|NCT00723489|1343970|P2|Overall Study|Withdrawal by Subject|0
400948|NCT00723489|1343971|P1|Overall Study|Withdrawal by Subject|0
400949|NCT00723489|1343968|P4|Overall Study|Pregnancy|1
400950|NCT00723489|1343969|P3|Overall Study|Pregnancy|0
400951|NCT00723489|1343970|P2|Overall Study|Pregnancy|0
400952|NCT00723489|1343971|P1|Overall Study|Pregnancy|0
400953|NCT00723489|1343968|P4|Overall Study|Physician Decision|0
400954|NCT00723489|1343969|P3|Overall Study|Physician Decision|0
400955|NCT00723489|1343970|P2|Overall Study|Physician Decision|1
400956|NCT00723489|1343971|P1|Overall Study|Physician Decision|0
400957|NCT00723450|1343999|P3|Randomized Phase|Withdrawal by Subject|22
400958|NCT00723450|1344000|P2|Randomized Phase|Withdrawal by Subject|14
400959|NCT00723450|1344001|P1|Randomized Phase|Withdrawal by Subject|0
400960|NCT00723450|1343999|P3|Randomized Phase|Physician Decision|1
400961|NCT00723450|1344000|P2|Randomized Phase|Physician Decision|3
400962|NCT00723450|1344001|P1|Randomized Phase|Physician Decision|0
400963|NCT00723450|1343999|P3|Randomized Phase|Lost to Follow-up|3
400964|NCT00723450|1344000|P2|Randomized Phase|Lost to Follow-up|2
400965|NCT00723450|1344001|P1|Randomized Phase|Lost to Follow-up|0
400966|NCT00723450|1343999|P3|Randomized Phase|Protocol Violation|13
400967|NCT00723450|1344000|P2|Randomized Phase|Protocol Violation|9
400968|NCT00723450|1344001|P1|Randomized Phase|Protocol Violation|0
400969|NCT00723450|1343999|P3|Randomized Phase|Lack of Efficacy|11
400970|NCT00723450|1344000|P2|Randomized Phase|Lack of Efficacy|11
400971|NCT00723450|1344001|P1|Randomized Phase|Lack of Efficacy|0
400972|NCT00723450|1343999|P3|Randomized Phase|Adverse Event|17
400973|NCT00723450|1344000|P2|Randomized Phase|Adverse Event|26
400974|NCT00723450|1344001|P1|Randomized Phase|Adverse Event|0
400975|NCT00723450|1343999|P3|Open-Label Phase|Withdrawal by Subject|0
400976|NCT00723450|1344000|P2|Open-Label Phase|Withdrawal by Subject|0
400977|NCT00723450|1344001|P1|Open-Label Phase|Withdrawal by Subject|37
400978|NCT00723450|1343999|P3|Open-Label Phase|Physician Decision|0
400979|NCT00723450|1344000|P2|Open-Label Phase|Physician Decision|0
400980|NCT00723450|1344001|P1|Open-Label Phase|Physician Decision|2
400981|NCT00723450|1343999|P3|Open-Label Phase|Lost to Follow-up|0
400982|NCT00723450|1344000|P2|Open-Label Phase|Lost to Follow-up|0
400983|NCT00723450|1344001|P1|Open-Label Phase|Lost to Follow-up|7
400984|NCT00723450|1343999|P3|Open-Label Phase|Protocol Violation|0
400985|NCT00723450|1344000|P2|Open-Label Phase|Protocol Violation|0
400986|NCT00723450|1344001|P1|Open-Label Phase|Protocol Violation|35
400987|NCT00723450|1343999|P3|Open-Label Phase|Lack of Efficacy|0
400988|NCT00723450|1344000|P2|Open-Label Phase|Lack of Efficacy|0
400989|NCT00723450|1344001|P1|Open-Label Phase|Lack of Efficacy|18
400990|NCT00723450|1343999|P3|Open-Label Phase|Adverse Event|0
400991|NCT00723450|1344000|P2|Open-Label Phase|Adverse Event|0
400992|NCT00723450|1344001|P1|Open-Label Phase|Adverse Event|26
400993|NCT00723294|1344042|P1|Overall Study|No treatment due to probe failure|1
400994|NCT00723294|1344042|P1|Overall Study|Withdrawal by Subject|1
400995|NCT00723294|1344042|P1|Overall Study|Benign lesion|1
400996|NCT00723294|1344042|P1|Overall Study|Treated by non-credentialed surgeon|1
400997|NCT00723294|1344042|P1|Overall Study|Treated prior to registration|1
400998|NCT00723294|1344042|P1|Overall Study|Did not undergo surgery|1
400999|NCT00723294|1344042|P1|Overall Study|No cryoabalation|2
401000|NCT00723294|1344042|P1|Overall Study|1.0-Tesla MRI|1
401001|NCT00723294|1344042|P1|Overall Study|No MRI tumor enhancement|1
401002|NCT00723294|1344042|P1|Overall Study|>25% intraductal component|1
401003|NCT00723294|1344042|P1|Overall Study|Lobular histology|2
401004|NCT00723255|1344047|P1|Overall Study|Ineligible: Wrong Primary|2
401005|NCT00723255|1344047|P1|Overall Study|Ineligible: Second primary|1
401006|NCT00723255|1344047|P1|Overall Study|Ineligible: Inadequate pathology|1
401007|NCT00723229|1344074|P2|First Intervention|Lost to Follow-up|3
401008|NCT00723229|1344075|P1|First Intervention|Lost to Follow-up|7
401009|NCT00723203|1344087|P1|Overall Study|Withdrawal by Subject|3
401010|NCT00723190|1344091|P1|Overall Study|Other-Not included in safety population|2
401011|NCT00723190|1344091|P1|Overall Study|Other-Premature Discontinuation|9
401012|NCT00723190|1344091|P1|Overall Study|Protocol Violation|15
401013|NCT00723190|1344091|P1|Overall Study|Lack of Efficacy|16
401014|NCT00723190|1344091|P1|Overall Study|Adverse Event|18
401015|NCT00723190|1344091|P1|Overall Study|Lost to Follow-up|37
401016|NCT00723190|1344091|P1|Overall Study|Withdrawal by Subject|45
401017|NCT00723125|1344124|P2|Overall Study|Adverse Event|0
401018|NCT00723125|1344125|P1|Overall Study|Adverse Event|2
401019|NCT00723125|1344124|P2|Overall Study|Withdrawal by Subject|6
401020|NCT00723125|1344125|P1|Overall Study|Withdrawal by Subject|15
401021|NCT00723125|1344124|P2|Overall Study|Met Dx|0
401022|NCT00723125|1344125|P1|Overall Study|Met Dx|1
401023|NCT00723021|1344162|P5|Intervention Period 4|Adverse Event|1
401024|NCT00723021|1344163|P4|Intervention Period 4|Adverse Event|0
401025|NCT00723021|1344164|P3|Intervention Period 4|Adverse Event|0
401026|NCT00723021|1344165|P2|Intervention Period 4|Adverse Event|0
401027|NCT00723021|1344166|P1|Intervention Period 4|Adverse Event|0
401028|NCT00723008|1344220|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
401029|NCT00723008|1344221|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
401030|NCT00723008|1344220|P2|4-Week Unblinded Treatment|Adverse Event|0
401031|NCT00723008|1344221|P1|4-Week Unblinded Treatment|Adverse Event|1
401032|NCT00723008|1344220|P2|4-Week Double Blinded|Lost to Follow-up|3
401033|NCT00723008|1344221|P1|4-Week Double Blinded|Lost to Follow-up|4
401034|NCT00723008|1344220|P2|4-Week Double Blinded|Withdrawal by Subject|1
401035|NCT00723008|1344221|P1|4-Week Double Blinded|Withdrawal by Subject|1
401036|NCT00723008|1344220|P2|4-Week Double Blinded|Lack of Efficacy|1
401037|NCT00723008|1344221|P1|4-Week Double Blinded|Lack of Efficacy|0
401038|NCT00723008|1344220|P2|Enrollment|Lost to Follow-up|0
401039|NCT00723008|1344221|P1|Enrollment|Lost to Follow-up|1
401040|NCT00722800|1344253|P2|Overall Study|Physician Decision|0
401041|NCT00722800|1344254|P1|Overall Study|Physician Decision|1
401042|NCT00722800|1344253|P2|Overall Study|Withdrawal by Subject|0
401043|NCT00722800|1344254|P1|Overall Study|Withdrawal by Subject|1
401044|NCT00722761|1344266|P2|Overall Study|Withdrawal by Subject|2
401045|NCT00722761|1344267|P1|Overall Study|Withdrawal by Subject|5
401046|NCT00722761|1344266|P2|Overall Study|Lost to Follow-up|4
401047|NCT00722761|1344267|P1|Overall Study|Lost to Follow-up|1
401048|NCT00722423|1344324|P2|Overall Study|Protocol Violation|1
401049|NCT00722423|1344325|P1|Overall Study|Protocol Violation|0
401050|NCT00722371|1344340|P7|Overall Study|Withdrawal by Subject|26
401051|NCT00722371|1344341|P6|Overall Study|Withdrawal by Subject|18
401052|NCT00722371|1344342|P5|Overall Study|Withdrawal by Subject|19
401053|NCT00722371|1344343|P4|Overall Study|Withdrawal by Subject|23
401054|NCT00722371|1344344|P3|Overall Study|Withdrawal by Subject|19
401055|NCT00722371|1344345|P2|Overall Study|Withdrawal by Subject|27
401056|NCT00722371|1344346|P1|Overall Study|Withdrawal by Subject|18
401057|NCT00722371|1344340|P7|Overall Study|Protocol Violation|1
401058|NCT00722371|1344341|P6|Overall Study|Protocol Violation|2
401059|NCT00722371|1344342|P5|Overall Study|Protocol Violation|4
401060|NCT00722371|1344343|P4|Overall Study|Protocol Violation|1
401061|NCT00722371|1344344|P3|Overall Study|Protocol Violation|0
401062|NCT00722371|1344345|P2|Overall Study|Protocol Violation|1
401063|NCT00722371|1344346|P1|Overall Study|Protocol Violation|6
401064|NCT00722371|1344340|P7|Overall Study|Pregnancy|0
401065|NCT00722371|1344341|P6|Overall Study|Pregnancy|1
401066|NCT00722371|1344342|P5|Overall Study|Pregnancy|0
401067|NCT00722371|1344343|P4|Overall Study|Pregnancy|0
401068|NCT00722371|1344344|P3|Overall Study|Pregnancy|0
401069|NCT00722371|1344345|P2|Overall Study|Pregnancy|1
401070|NCT00722371|1344346|P1|Overall Study|Pregnancy|1
401071|NCT00722371|1344340|P7|Overall Study|Physician Decision|4
401072|NCT00722371|1344341|P6|Overall Study|Physician Decision|3
401073|NCT00722371|1344342|P5|Overall Study|Physician Decision|2
401074|NCT00722371|1344343|P4|Overall Study|Physician Decision|5
401075|NCT00722371|1344344|P3|Overall Study|Physician Decision|2
401076|NCT00722371|1344345|P2|Overall Study|Physician Decision|2
401077|NCT00722371|1344346|P1|Overall Study|Physician Decision|5
401078|NCT00722371|1344340|P7|Overall Study|Lost to Follow-up|13
401079|NCT00722371|1344341|P6|Overall Study|Lost to Follow-up|16
401080|NCT00722371|1344342|P5|Overall Study|Lost to Follow-up|8
401081|NCT00722371|1344343|P4|Overall Study|Lost to Follow-up|13
401082|NCT00722371|1344344|P3|Overall Study|Lost to Follow-up|21
401083|NCT00722371|1344345|P2|Overall Study|Lost to Follow-up|14
401084|NCT00722371|1344346|P1|Overall Study|Lost to Follow-up|11
401085|NCT00722371|1344340|P7|Overall Study|Lack of Efficacy|0
401086|NCT00722371|1344341|P6|Overall Study|Lack of Efficacy|3
401087|NCT00722371|1344342|P5|Overall Study|Lack of Efficacy|2
401088|NCT00722371|1344343|P4|Overall Study|Lack of Efficacy|6
401089|NCT00722371|1344344|P3|Overall Study|Lack of Efficacy|6
401090|NCT00722371|1344345|P2|Overall Study|Lack of Efficacy|6
401091|NCT00722371|1344346|P1|Overall Study|Lack of Efficacy|4
401092|NCT00722371|1344340|P7|Overall Study|Hypoglycemia|0
401093|NCT00722371|1344341|P6|Overall Study|Hypoglycemia|0
401094|NCT00722371|1344342|P5|Overall Study|Hypoglycemia|0
401095|NCT00722371|1344343|P4|Overall Study|Hypoglycemia|0
401096|NCT00722371|1344344|P3|Overall Study|Hypoglycemia|0
401097|NCT00722371|1344345|P2|Overall Study|Hypoglycemia|0
401098|NCT00722371|1344346|P1|Overall Study|Hypoglycemia|1
401099|NCT00722371|1344340|P7|Overall Study|Hyperglycemia|1
401100|NCT00722371|1344341|P6|Overall Study|Hyperglycemia|1
401101|NCT00722371|1344342|P5|Overall Study|Hyperglycemia|5
401102|NCT00722371|1344343|P4|Overall Study|Hyperglycemia|2
401103|NCT00722371|1344344|P3|Overall Study|Hyperglycemia|4
401104|NCT00722371|1344345|P2|Overall Study|Hyperglycemia|6
401105|NCT00722371|1344346|P1|Overall Study|Hyperglycemia|2
401106|NCT00722371|1344340|P7|Overall Study|Excluded medication|1
401107|NCT00722371|1344341|P6|Overall Study|Excluded medication|0
401108|NCT00722371|1344342|P5|Overall Study|Excluded medication|0
401109|NCT00722371|1344343|P4|Overall Study|Excluded medication|0
401110|NCT00722371|1344344|P3|Overall Study|Excluded medication|1
401111|NCT00722371|1344345|P2|Overall Study|Excluded medication|1
401112|NCT00722371|1344346|P1|Overall Study|Excluded medication|0
401113|NCT00722371|1344340|P7|Overall Study|Creatinine / Creatinine clearance|1
401114|NCT00722371|1344341|P6|Overall Study|Creatinine / Creatinine clearance|1
401115|NCT00722371|1344342|P5|Overall Study|Creatinine / Creatinine clearance|2
401116|NCT00722371|1344343|P4|Overall Study|Creatinine / Creatinine clearance|3
401117|NCT00722371|1344344|P3|Overall Study|Creatinine / Creatinine clearance|2
401118|NCT00722371|1344345|P2|Overall Study|Creatinine / Creatinine clearance|1
401119|NCT00722371|1344346|P1|Overall Study|Creatinine / Creatinine clearance|2
401120|NCT00722371|1344340|P7|Overall Study|Contraindication|0
401121|NCT00722371|1344341|P6|Overall Study|Contraindication|0
401122|NCT00722371|1344342|P5|Overall Study|Contraindication|0
401123|NCT00722371|1344343|P4|Overall Study|Contraindication|0
401124|NCT00722371|1344344|P3|Overall Study|Contraindication|1
401125|NCT00722371|1344345|P2|Overall Study|Contraindication|0
401126|NCT00722371|1344346|P1|Overall Study|Contraindication|0
401127|NCT00722371|1344340|P7|Overall Study|Adverse Event|4
401128|NCT00722371|1344341|P6|Overall Study|Adverse Event|8
401129|NCT00722371|1344342|P5|Overall Study|Adverse Event|6
401130|NCT00722371|1344343|P4|Overall Study|Adverse Event|10
401131|NCT00722371|1344344|P3|Overall Study|Adverse Event|9
401132|NCT00722371|1344345|P2|Overall Study|Adverse Event|13
401133|NCT00722371|1344346|P1|Overall Study|Adverse Event|6
401134|NCT00722137|1344399|P2|Overall Study|Randomized But Not Treated|2
401135|NCT00722137|1344400|P1|Overall Study|Randomized But Not Treated|3
401136|NCT00722137|1344399|P2|Overall Study|Other Reason Uknown|3
401137|NCT00722137|1344400|P1|Overall Study|Other Reason Uknown|4
401138|NCT00722137|1344399|P2|Overall Study|Withdrawal by Subject|6
401139|NCT00722137|1344400|P1|Overall Study|Withdrawal by Subject|9
401140|NCT00722137|1344399|P2|Overall Study|Death|12
401141|NCT00722137|1344400|P1|Overall Study|Death|7
401142|NCT00722137|1344399|P2|Overall Study|Adverse Event|17
401143|NCT00722137|1344400|P1|Overall Study|Adverse Event|21
401144|NCT00722137|1344399|P2|Overall Study|Overt Disease Progression|5
401145|NCT00722137|1344400|P1|Overall Study|Overt Disease Progression|4
401146|NCT00721968|1344468|P2|Overall Study|Lost to Follow-up|0
401147|NCT00721968|1344469|P1|Overall Study|Lost to Follow-up|2
401148|NCT00721955|1344480|P3|Overall Study|Adverse Event|2
401149|NCT00721955|1344481|P2|Overall Study|Adverse Event|0
401150|NCT00721955|1344482|P1|Overall Study|Adverse Event|0
401151|NCT00721799|1344496|P1|Overall Study|withdraw by subject after scan 1|1
401152|NCT00721799|1344496|P1|Overall Study|Withdrawal by Subject|7
401153|NCT00721734|1344536|P5|Overall Study|Other|0
401154|NCT00721734|1344537|P4|Overall Study|Other|1
401155|NCT00721734|1344538|P3|Overall Study|Other|0
401156|NCT00721734|1344539|P2|Overall Study|Other|0
401157|NCT00721734|1344540|P1|Overall Study|Other|0
401158|NCT00721734|1344536|P5|Overall Study|Withdrawal by Subject|1
401159|NCT00721734|1344537|P4|Overall Study|Withdrawal by Subject|0
401160|NCT00721734|1344538|P3|Overall Study|Withdrawal by Subject|0
401161|NCT00721734|1344539|P2|Overall Study|Withdrawal by Subject|1
401162|NCT00721734|1344540|P1|Overall Study|Withdrawal by Subject|2
401163|NCT00721734|1344536|P5|Overall Study|Adverse Event|3
401164|NCT00721734|1344537|P4|Overall Study|Adverse Event|0
401165|NCT00721734|1344538|P3|Overall Study|Adverse Event|4
401166|NCT00721734|1344539|P2|Overall Study|Adverse Event|1
401167|NCT00721734|1344540|P1|Overall Study|Adverse Event|3
401168|NCT00721734|1344536|P5|Overall Study|Progressive Disease|2
401169|NCT00721734|1344537|P4|Overall Study|Progressive Disease|5
401170|NCT00721734|1344538|P3|Overall Study|Progressive Disease|4
401171|NCT00721734|1344539|P2|Overall Study|Progressive Disease|10
401172|NCT00721734|1344540|P1|Overall Study|Progressive Disease|3
401173|NCT00721630|1344652|P1|Overall Study|Participant found to be ineligible|1
401174|NCT00721578|1344681|P2|Overall Study|Withdrawal by Subject|1
401175|NCT00721578|1344682|P1|Overall Study|Withdrawal by Subject|1
401176|NCT00721578|1344681|P2|Overall Study|Death|1
401177|NCT00721578|1344682|P1|Overall Study|Death|1
401178|NCT00721409|1344725|P3|Overall Study|Death|0
401179|NCT00721409|1344726|P2|Overall Study|Death|1
401180|NCT00721409|1344727|P1|Overall Study|Death|0
401181|NCT00721409|1344725|P3|Overall Study|Adverse Event|2
401182|NCT00721409|1344726|P2|Overall Study|Adverse Event|11
401183|NCT00721409|1344727|P1|Overall Study|Adverse Event|0
401184|NCT00721409|1344725|P3|Overall Study|Reason not specified|5
401185|NCT00721409|1344726|P2|Overall Study|Reason not specified|1
401186|NCT00721409|1344727|P1|Overall Study|Reason not specified|0
401187|NCT00721409|1344725|P3|Overall Study|Withdrawal by Subject|6
401188|NCT00721409|1344726|P2|Overall Study|Withdrawal by Subject|5
401189|NCT00721409|1344727|P1|Overall Study|Withdrawal by Subject|1
401190|NCT00721409|1344725|P3|Overall Study|Objective progression or relapse|57
401191|NCT00721409|1344726|P2|Overall Study|Objective progression or relapse|42
401192|NCT00721409|1344727|P1|Overall Study|Objective progression or relapse|7
401193|NCT00721409|1344725|P3|Overall Study|Global deterioration of health status|3
401194|NCT00721409|1344726|P2|Overall Study|Global deterioration of health status|5
401195|NCT00721409|1344727|P1|Overall Study|Global deterioration of health status|2
401196|NCT00721409|1344725|P3|Overall Study|Ongoing at date of cutoff|8
401197|NCT00721409|1344726|P2|Overall Study|Ongoing at date of cutoff|19
401198|NCT00721409|1344727|P1|Overall Study|Ongoing at date of cutoff|2
401199|NCT00721396|1344854|P4|Overall Study|Administrative reason|0
401200|NCT00721396|1344855|P3|Overall Study|Administrative reason|1
401201|NCT00721396|1344856|P2|Overall Study|Administrative reason|0
401202|NCT00721396|1344857|P1|Overall Study|Administrative reason|3
401203|NCT00721396|1344854|P4|Overall Study|Inappropriate enrollment|0
401204|NCT00721396|1344855|P3|Overall Study|Inappropriate enrollment|0
401205|NCT00721396|1344856|P2|Overall Study|Inappropriate enrollment|2
401206|NCT00721396|1344857|P1|Overall Study|Inappropriate enrollment|0
401207|NCT00721396|1344854|P4|Overall Study|Protocol Violation|0
401208|NCT00721396|1344855|P3|Overall Study|Protocol Violation|1
401209|NCT00721396|1344856|P2|Overall Study|Protocol Violation|3
401210|NCT00721396|1344857|P1|Overall Study|Protocol Violation|4
401211|NCT00721396|1344854|P4|Overall Study|Lost to Follow-up|3
401212|NCT00721396|1344855|P3|Overall Study|Lost to Follow-up|3
401213|NCT00721396|1344856|P2|Overall Study|Lost to Follow-up|9
401214|NCT00721396|1344857|P1|Overall Study|Lost to Follow-up|7
401215|NCT00721396|1344854|P4|Overall Study|Withdrawal by Subject|7
401216|NCT00721396|1344855|P3|Overall Study|Withdrawal by Subject|3
401217|NCT00721396|1344856|P2|Overall Study|Withdrawal by Subject|15
401218|NCT00721396|1344857|P1|Overall Study|Withdrawal by Subject|12
401219|NCT00721396|1344854|P4|Overall Study|Adverse Event|0
401220|NCT00721396|1344855|P3|Overall Study|Adverse Event|2
401221|NCT00721396|1344856|P2|Overall Study|Adverse Event|7
401222|NCT00721396|1344857|P1|Overall Study|Adverse Event|4
401223|NCT00721279|1344904|P2|Overall Study|Other|16
401224|NCT00721279|1344905|P1|Overall Study|Other|12
401225|NCT00721279|1344904|P2|Overall Study|Withdrawal by Subject|3
401226|NCT00721279|1344905|P1|Overall Study|Withdrawal by Subject|13
401227|NCT00721279|1344904|P2|Overall Study|Tolerability insufficient|2
401228|NCT00721279|1344905|P1|Overall Study|Tolerability insufficient|5
401229|NCT00721279|1344904|P2|Overall Study|Lack of Efficacy|3
401230|NCT00721279|1344905|P1|Overall Study|Lack of Efficacy|6
401231|NCT00721227|1344933|P2|Overall Study|Noncompliance with scheduled visits.|0
401232|NCT00721227|1344934|P1|Overall Study|Noncompliance with scheduled visits.|1
401233|NCT00721227|1344933|P2|Overall Study|Lost to Follow-up|0
401234|NCT00721227|1344934|P1|Overall Study|Lost to Follow-up|3
401235|NCT00721214|1344944|P1|Overall Study|Death|3
401236|NCT00721214|1344944|P1|Overall Study|Chose another center for transplant|1
401237|NCT00721149|1344994|P1|Overall Study|Physician Decision|1
401238|NCT00721123|1345028|P1|Overall Study|Withdrawal by Subject|5
401239|NCT00721123|1345028|P1|Overall Study|Failure to Return|9
401240|NCT00721123|1345028|P1|Overall Study|Refused Treatment|41
401241|NCT00721123|1345028|P1|Overall Study|Protocol Violation|1
401242|NCT00721123|1345028|P1|Overall Study|Insufficient Therapeutic Response|21
401243|NCT00721123|1345028|P1|Overall Study|Death|10
401244|NCT00721123|1345028|P1|Overall Study|Adverse Event|96
401245|NCT00721110|1345106|P4|Overall Study|vertical incision|0
401246|NCT00721110|1345107|P3|Overall Study|vertical incision|1
401247|NCT00721110|1345108|P2|Overall Study|vertical incision|0
401248|NCT00721110|1345109|P1|Overall Study|vertical incision|0
401249|NCT00721110|1345106|P4|Overall Study|Ultram use|0
401250|NCT00721110|1345107|P3|Overall Study|Ultram use|0
401251|NCT00721110|1345108|P2|Overall Study|Ultram use|0
401252|NCT00721110|1345109|P1|Overall Study|Ultram use|1
401253|NCT00720941|1345137|P2|Overall Study|Ongoing|23
401254|NCT00720941|1345138|P1|Overall Study|Ongoing|34
401255|NCT00720941|1345137|P2|Overall Study|Withdrawal by Subject|35
401256|NCT00720941|1345138|P1|Overall Study|Withdrawal by Subject|27
401257|NCT00720941|1345137|P2|Overall Study|Physician Decision|5
401258|NCT00720941|1345138|P1|Overall Study|Physician Decision|1
401259|NCT00720941|1345137|P2|Overall Study|Lost to Follow-up|15
401260|NCT00720941|1345138|P1|Overall Study|Lost to Follow-up|17
401261|NCT00720941|1345137|P2|Overall Study|Protocol Violation|2
401262|NCT00720941|1345138|P1|Overall Study|Protocol Violation|0
401263|NCT00720941|1345137|P2|Overall Study|Death|335
401264|NCT00720941|1345138|P1|Overall Study|Death|334
401265|NCT00720798|1345178|P1|Overall Study|Reason not Specified|83
401266|NCT00720798|1345178|P1|Overall Study|Failure to Return|46
401267|NCT00720798|1345178|P1|Overall Study|Refused Treatment|151
401268|NCT00720798|1345178|P1|Overall Study|Protocol Violation|4
401269|NCT00720798|1345178|P1|Overall Study|Insufficient Therapeutic Response|129
401270|NCT00720798|1345178|P1|Overall Study|Death|39
401271|NCT00720798|1345178|P1|Overall Study|Adverse Event|304
401272|NCT00720759|1345201|P4|Overall Study|Lost to Follow-up|0
401273|NCT00720759|1345202|P3|Overall Study|Lost to Follow-up|1
401274|NCT00720759|1345203|P2|Overall Study|Lost to Follow-up|1
401275|NCT00720759|1345204|P1|Overall Study|Lost to Follow-up|0
401276|NCT00720499|1345224|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
401277|NCT00720499|1345225|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
401278|NCT00720499|1345224|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
401279|NCT00720499|1345225|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
401280|NCT00720499|1345224|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
401281|NCT00720499|1345225|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
401282|NCT00720434|1345318|P4|Open-Label Period (Week 5-72)|Other|2
401283|NCT00720434|1345319|P3|Open-Label Period (Week 5-72)|Other|3
401284|NCT00720434|1345320|P2|Open-Label Period (Week 5-72)|Other|3
401285|NCT00720434|1345321|P1|Open-Label Period (Week 5-72)|Other|4
401286|NCT00720434|1345318|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
401287|NCT00720434|1345319|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
401288|NCT00720434|1345320|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
401289|NCT00720434|1345321|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
401290|NCT00720434|1345318|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
401291|NCT00720434|1345319|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
401292|NCT00720434|1345320|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
401293|NCT00720434|1345321|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
401294|NCT00720434|1345318|P4|Open-Label Period (Week 5-72)|Adverse Event|2
401295|NCT00720434|1345319|P3|Open-Label Period (Week 5-72)|Adverse Event|0
401296|NCT00720434|1345320|P2|Open-Label Period (Week 5-72)|Adverse Event|0
401297|NCT00720434|1345321|P1|Open-Label Period (Week 5-72)|Adverse Event|0
401298|NCT00720434|1345318|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
401299|NCT00720434|1345319|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
401300|NCT00720434|1345320|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
401301|NCT00720434|1345321|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
401302|NCT00720382|1345345|P2|Overall Study|administrative|5
401303|NCT00720382|1345346|P1|Overall Study|administrative|14
401304|NCT00720382|1345345|P2|Overall Study|Lost to Follow-up|14
401305|NCT00720382|1345346|P1|Overall Study|Lost to Follow-up|28
401306|NCT00720382|1345345|P2|Overall Study|Withdrawal by Subject|11
401307|NCT00720382|1345346|P1|Overall Study|Withdrawal by Subject|47
401308|NCT00720382|1345345|P2|Overall Study|Non-Compliance|5
401309|NCT00720382|1345346|P1|Overall Study|Non-Compliance|15
401310|NCT00720382|1345345|P2|Overall Study|Lack of Efficacy|7
401311|NCT00720382|1345346|P1|Overall Study|Lack of Efficacy|18
401312|NCT00720382|1345345|P2|Overall Study|Adverse Event|17
401313|NCT00720382|1345346|P1|Overall Study|Adverse Event|54
401314|NCT00720343|1345365|P1|Overall Study|No data|3
401315|NCT00720343|1345365|P1|Overall Study|Physician Decision|3
401316|NCT00720278|1345399|P3|Overall Study|eligibility criteria violation|1
401317|NCT00720278|1345400|P2|Overall Study|eligibility criteria violation|0
401318|NCT00720278|1345401|P1|Overall Study|eligibility criteria violation|1
401319|NCT00720278|1345399|P3|Overall Study|Non-compliance|0
401320|NCT00720278|1345400|P2|Overall Study|Non-compliance|0
401321|NCT00720278|1345401|P1|Overall Study|Non-compliance|1
401322|NCT00720278|1345399|P3|Overall Study|Lost to Follow-up|1
401323|NCT00720278|1345400|P2|Overall Study|Lost to Follow-up|0
401324|NCT00720278|1345401|P1|Overall Study|Lost to Follow-up|0
401325|NCT00720278|1345399|P3|Overall Study|Withdrawal by Subject|0
401326|NCT00720278|1345400|P2|Overall Study|Withdrawal by Subject|1
401327|NCT00720278|1345401|P1|Overall Study|Withdrawal by Subject|0
401328|NCT00720278|1345399|P3|Overall Study|Adverse Event|4
401329|NCT00720278|1345400|P2|Overall Study|Adverse Event|3
401330|NCT00720278|1345401|P1|Overall Study|Adverse Event|5
401331|NCT00720226|1345423|P2|Overall Study|Withdrawal by Subject|4
401332|NCT00720226|1345424|P1|Overall Study|Withdrawal by Subject|7
401333|NCT00720122|1345432|P1|Overall Study|Withdrawal by Subject|7
401334|NCT00720122|1345432|P1|Overall Study|Physician Decision|1
401335|NCT00720122|1345432|P1|Overall Study|Lost to Follow-up|1
401336|NCT00720109|1345436|P3|Risk Stratification Period|Development of second malignant neoplasm|0
401337|NCT00720109|1345437|P2|Risk Stratification Period|Development of second malignant neoplasm|1
401338|NCT00720109|1345438|P1|Risk Stratification Period|Development of second malignant neoplasm|0
401339|NCT00720109|1345436|P3|Risk Stratification Period|Disease progression or relapse|0
401340|NCT00720109|1345437|P2|Risk Stratification Period|Disease progression or relapse|2
401341|NCT00720109|1345438|P1|Risk Stratification Period|Disease progression or relapse|0
401342|NCT00720109|1345436|P3|Risk Stratification Period|Bone marrow transplant|7
401343|NCT00720109|1345437|P2|Risk Stratification Period|Bone marrow transplant|9
401344|NCT00720109|1345438|P1|Risk Stratification Period|Bone marrow transplant|0
401345|NCT00720109|1345436|P3|Risk Stratification Period|Physician Decision|1
401346|NCT00720109|1345437|P2|Risk Stratification Period|Physician Decision|2
401347|NCT00720109|1345438|P1|Risk Stratification Period|Physician Decision|0
401348|NCT00720109|1345436|P3|Risk Stratification Period|Adverse Event|0
401349|NCT00720109|1345437|P2|Risk Stratification Period|Adverse Event|1
401350|NCT00720109|1345438|P1|Risk Stratification Period|Adverse Event|0
401351|NCT00720109|1345436|P3|Induction Period|Physician Decision|0
401352|NCT00720109|1345437|P2|Induction Period|Physician Decision|0
401353|NCT00720109|1345438|P1|Induction Period|Physician Decision|1
401354|NCT00720109|1345436|P3|Induction Period|Bone Marrow Transplant|0
401355|NCT00720109|1345437|P2|Induction Period|Bone Marrow Transplant|0
401356|NCT00720109|1345438|P1|Induction Period|Bone Marrow Transplant|2
401357|NCT00720109|1345436|P3|Induction Period|Did not meet eligibility criteria|0
401358|NCT00720109|1345437|P2|Induction Period|Did not meet eligibility criteria|0
401359|NCT00720109|1345438|P1|Induction Period|Did not meet eligibility criteria|3
401360|NCT00720096|1345458|P2|Overall Study|Withdrawal by Subject|2
401361|NCT00720096|1345459|P1|Overall Study|Withdrawal by Subject|0
401362|NCT00720083|1345471|P2|Overall Study|Ineligible|2
401363|NCT00720083|1345472|P1|Overall Study|Ineligible|1
401364|NCT00720057|1345480|P2|Overall Study|Withdrawal by Subject|1
401365|NCT00720057|1345481|P1|Overall Study|Withdrawal by Subject|0
401366|NCT00720057|1345480|P2|Overall Study|Protocol Violation|0
401367|NCT00720057|1345481|P1|Overall Study|Protocol Violation|1
401368|NCT00720057|1345480|P2|Overall Study|Lost to Follow-up|2
401369|NCT00720057|1345481|P1|Overall Study|Lost to Follow-up|0
401370|NCT00719953|1345497|P1|Overall Study|Adverse Event|4
401371|NCT00719901|1345510|P1|Overall Study|Availability of Study Drug|1
401372|NCT00719901|1345510|P1|Overall Study|Disease Progression|3
401373|NCT00719901|1345510|P1|Overall Study|Alternate Treatment|1
401374|NCT00719901|1345510|P1|Overall Study|Withdrawal by Subject|1
401375|NCT00719901|1345510|P1|Overall Study|Adverse Event|5
401376|NCT00719862|1345522|P2|Overall Study|Other|3
401377|NCT00719862|1345523|P1|Overall Study|Other|2
401378|NCT00719862|1345522|P2|Overall Study|Lost to Follow-up|1
401379|NCT00719862|1345523|P1|Overall Study|Lost to Follow-up|0
401380|NCT00719862|1345522|P2|Overall Study|Withdrawal by Subject|0
401381|NCT00719862|1345523|P1|Overall Study|Withdrawal by Subject|1
401382|NCT00719862|1345522|P2|Overall Study|Non-Compliance|0
401383|NCT00719862|1345523|P1|Overall Study|Non-Compliance|1
401384|NCT00719862|1345522|P2|Overall Study|Lack of Efficacy|0
401385|NCT00719862|1345523|P1|Overall Study|Lack of Efficacy|3
401386|NCT00719862|1345522|P2|Overall Study|Adverse Event|2
401387|NCT00719862|1345523|P1|Overall Study|Adverse Event|1
401388|NCT00719849|1345541|P2|Overall Study|Death|1
401389|NCT00719849|1345542|P1|Overall Study|Death|0
401390|NCT00719810|1345581|P3|Overall Study|Withdrawal by Subject|2
401391|NCT00719810|1345582|P2|Overall Study|Withdrawal by Subject|1
401392|NCT00719810|1345583|P1|Overall Study|Withdrawal by Subject|1
401393|NCT00719810|1345581|P3|Overall Study|Physician Decision|0
401394|NCT00719810|1345582|P2|Overall Study|Physician Decision|1
401395|NCT00719810|1345583|P1|Overall Study|Physician Decision|0
401396|NCT00719810|1345581|P3|Overall Study|Lost to Follow-up|3
401397|NCT00719810|1345582|P2|Overall Study|Lost to Follow-up|0
401398|NCT00719810|1345583|P1|Overall Study|Lost to Follow-up|2
401399|NCT00719810|1345581|P3|Overall Study|Adverse Event|3
401400|NCT00719810|1345582|P2|Overall Study|Adverse Event|2
401401|NCT00719810|1345583|P1|Overall Study|Adverse Event|0
401402|NCT00719732|1345594|P1|Overall Study|Illness not associated with device|1
401403|NCT00719732|1345594|P1|Overall Study|Unilateral (not bilateral) implantation|1
401404|NCT00719732|1345594|P1|Overall Study|Lost to Follow-up|20
401405|NCT00719706|1345600|P2|Overall Study|Protocol Violation|0
401406|NCT00719706|1345601|P1|Overall Study|Protocol Violation|3
401407|NCT00719706|1345600|P2|Overall Study|Withdrawal by Subject|2
401408|NCT00719706|1345601|P1|Overall Study|Withdrawal by Subject|1
401409|NCT00719706|1345600|P2|Overall Study|Adverse Event|4
401410|NCT00719706|1345601|P1|Overall Study|Adverse Event|5
401411|NCT00719680|1345615|P1|Overall Study|Withdrawal by Subject|3
401412|NCT00719680|1345615|P1|Overall Study|Lost to Follow-up|1
401413|NCT00719680|1345615|P1|Overall Study|Adverse Event|1
401414|NCT00719563|1345671|P2|Overall Study|Lost to Follow-up|3
401415|NCT00719563|1345672|P1|Overall Study|Lost to Follow-up|5
401416|NCT00719563|1345671|P2|Overall Study|Noncompliant|1
401417|NCT00719563|1345672|P1|Overall Study|Noncompliant|1
401418|NCT00719563|1345671|P2|Overall Study|Unknown reasons|6
401419|NCT00719563|1345672|P1|Overall Study|Unknown reasons|4
401420|NCT00719563|1345671|P2|Overall Study|Personal reasons|7
401421|NCT00719563|1345672|P1|Overall Study|Personal reasons|6
401422|NCT00719563|1345671|P2|Overall Study|Lack of Efficacy|7
401423|NCT00719563|1345672|P1|Overall Study|Lack of Efficacy|3
401424|NCT00719563|1345671|P2|Overall Study|Medical condition changed|5
401425|NCT00719563|1345672|P1|Overall Study|Medical condition changed|3
401426|NCT00719563|1345671|P2|Overall Study|Adverse Event|13
401427|NCT00719563|1345672|P1|Overall Study|Adverse Event|16
401428|NCT00719537|1345704|P2|Overall Study|Lost to Follow-up|1
401429|NCT00719537|1345705|P1|Overall Study|Lost to Follow-up|0
401430|NCT00719537|1345704|P2|Overall Study|Withdrawal by Subject|0
401431|NCT00719537|1345705|P1|Overall Study|Withdrawal by Subject|1
401432|NCT00719472|1345711|P1|Received Cycle 2 Treatment|Various Reasons|25
401433|NCT00719472|1345711|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
401434|NCT00719472|1345711|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
401435|NCT00719472|1345711|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
401436|NCT00719472|1345711|P1|Received Cycle 2 Treatment|Disease progression|3
401437|NCT00719472|1345711|P1|Received Cycle 2 Treatment|Death|6
401438|NCT00719472|1345711|P1|Received Cycle 2 Treatment|Adverse Event|12
401439|NCT00719472|1345711|P1|Received Cycle 1 Treatment|Various Reasons|13
401440|NCT00719472|1345711|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
401441|NCT00719472|1345711|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
401442|NCT00719472|1345711|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
401443|NCT00719472|1345711|P1|Received Cycle 1 Treatment|Death|5
401444|NCT00719472|1345711|P1|Received Cycle 1 Treatment|Adverse Event|8
401445|NCT00719472|1345711|P1|Enrolled in Study|Various Reasons|17
401446|NCT00719472|1345711|P1|Enrolled in Study|Subject decision to withdraw|8
401447|NCT00719472|1345711|P1|Enrolled in Study|Physician decision to withdraw patient|1
401448|NCT00719355|1345722|P2|Overall Study|Moved|1
401449|NCT00719355|1345723|P1|Overall Study|Moved|0
401450|NCT00719355|1345722|P2|Overall Study|Compliance|6
401451|NCT00719355|1345723|P1|Overall Study|Compliance|4
401452|NCT00719355|1345722|P2|Overall Study|Medical|5
401453|NCT00719355|1345723|P1|Overall Study|Medical|14
401454|NCT00719355|1345722|P2|Overall Study|Death|1
401455|NCT00719355|1345723|P1|Overall Study|Death|0
401456|NCT00719264|1345752|P2|Overall Study|Disease Progression|107
401457|NCT00719264|1345753|P1|Overall Study|Disease Progression|104
401458|NCT00719264|1345752|P2|Overall Study|New Cancer Therapy|2
401459|NCT00719264|1345753|P1|Overall Study|New Cancer Therapy|4
401460|NCT00719264|1345752|P2|Overall Study|Protocol Deviation|3
401461|NCT00719264|1345753|P1|Overall Study|Protocol Deviation|1
401462|NCT00719264|1345752|P2|Overall Study|Withdrawal by Subject|7
401463|NCT00719264|1345753|P1|Overall Study|Withdrawal by Subject|12
401464|NCT00719264|1345752|P2|Overall Study|Lost to Follow-up|1
401465|NCT00719264|1345753|P1|Overall Study|Lost to Follow-up|1
401466|NCT00719264|1345752|P2|Overall Study|Administrative Problems|4
401467|NCT00719264|1345753|P1|Overall Study|Administrative Problems|6
401468|NCT00719264|1345752|P2|Overall Study|Death|10
401469|NCT00719264|1345753|P1|Overall Study|Death|13
401470|NCT00719264|1345752|P2|Overall Study|Adverse Event|49
401471|NCT00719264|1345753|P1|Overall Study|Adverse Event|41
401472|NCT00719212|1345772|P1|Overall Study|Withdrawal by Subject|1
401473|NCT00719212|1345772|P1|Overall Study|Lost to Follow-up|2
401474|NCT00719212|1345772|P1|Overall Study|Death|41
401475|NCT00719043|1345820|P7|Overall Study|Withdrawal by Subject|14
401476|NCT00719043|1345821|P6|Overall Study|Withdrawal by Subject|18
401477|NCT00719043|1345822|P5|Overall Study|Withdrawal by Subject|16
401478|NCT00719043|1345823|P4|Overall Study|Withdrawal by Subject|10
401479|NCT00719043|1345824|P3|Overall Study|Withdrawal by Subject|9
401480|NCT00719043|1345825|P2|Overall Study|Withdrawal by Subject|14
401481|NCT00719043|1345826|P1|Overall Study|Withdrawal by Subject|12
401482|NCT00719043|1345820|P7|Overall Study|Other|1
401483|NCT00719043|1345821|P6|Overall Study|Other|2
401484|NCT00719043|1345822|P5|Overall Study|Other|0
401485|NCT00719043|1345823|P4|Overall Study|Other|2
401486|NCT00719043|1345824|P3|Overall Study|Other|1
401487|NCT00719043|1345825|P2|Overall Study|Other|0
401488|NCT00719043|1345826|P1|Overall Study|Other|1
401489|NCT00719043|1345820|P7|Overall Study|Protocol Violation|0
401490|NCT00719043|1345821|P6|Overall Study|Protocol Violation|1
401491|NCT00719043|1345822|P5|Overall Study|Protocol Violation|0
401492|NCT00719043|1345823|P4|Overall Study|Protocol Violation|0
401493|NCT00719043|1345824|P3|Overall Study|Protocol Violation|0
401494|NCT00719043|1345825|P2|Overall Study|Protocol Violation|0
401495|NCT00719043|1345826|P1|Overall Study|Protocol Violation|0
401496|NCT00719043|1345820|P7|Overall Study|Lost to Follow-up|9
401497|NCT00719043|1345821|P6|Overall Study|Lost to Follow-up|9
401498|NCT00719043|1345822|P5|Overall Study|Lost to Follow-up|10
401499|NCT00719043|1345823|P4|Overall Study|Lost to Follow-up|9
401500|NCT00719043|1345824|P3|Overall Study|Lost to Follow-up|8
401501|NCT00719043|1345825|P2|Overall Study|Lost to Follow-up|10
401502|NCT00719043|1345826|P1|Overall Study|Lost to Follow-up|14
401503|NCT00719043|1345820|P7|Overall Study|Adverse Event|4
401504|NCT00719043|1345821|P6|Overall Study|Adverse Event|4
401505|NCT00719043|1345822|P5|Overall Study|Adverse Event|1
401506|NCT00719043|1345823|P4|Overall Study|Adverse Event|2
401507|NCT00719043|1345824|P3|Overall Study|Adverse Event|2
401508|NCT00719043|1345825|P2|Overall Study|Adverse Event|1
401509|NCT00719043|1345826|P1|Overall Study|Adverse Event|5
401510|NCT00718887|1345950|P2|Overall Study|Not identified|7
401511|NCT00718887|1345951|P1|Overall Study|Not identified|2
401512|NCT00718887|1345950|P2|Overall Study|Withdrawal by Subject|2
401513|NCT00718887|1345951|P1|Overall Study|Withdrawal by Subject|3
401514|NCT00718861|1345975|P2|Overall Study|Death|5
401515|NCT00718861|1345976|P1|Overall Study|Death|1
401516|NCT00718861|1345975|P2|Overall Study|Administrative Problems|1
401517|NCT00718861|1345976|P1|Overall Study|Administrative Problems|1
401518|NCT00718861|1345975|P2|Overall Study|Lost to Follow-up|1
401519|NCT00718861|1345976|P1|Overall Study|Lost to Follow-up|2
401520|NCT00718861|1345975|P2|Overall Study|Adverse Event|1
401521|NCT00718861|1345976|P1|Overall Study|Adverse Event|2
401522|NCT00718861|1345975|P2|Overall Study|Withdrawal by Subject|10
401523|NCT00718861|1345976|P1|Overall Study|Withdrawal by Subject|15
401524|NCT00718809|1346004|P2|Overall Study|Noncompliance|0
401525|NCT00718809|1346005|P1|Overall Study|Noncompliance|1
401526|NCT00718809|1346004|P2|Overall Study|Lost to Follow-up|0
401527|NCT00718809|1346005|P1|Overall Study|Lost to Follow-up|1
401528|NCT00718809|1346004|P2|Overall Study|Withdrawal by Subject|1
401529|NCT00718809|1346005|P1|Overall Study|Withdrawal by Subject|0
401530|NCT00718809|1346004|P2|Overall Study|Adverse Event|1
401531|NCT00718809|1346005|P1|Overall Study|Adverse Event|1
401532|NCT00718809|1346004|P2|Overall Study|Disease progression|7
401533|NCT00718809|1346005|P1|Overall Study|Disease progression|9
401534|NCT00718770|1346019|P1|Overall Study|Adverse Event|1
401535|NCT00718770|1346019|P1|Overall Study|Lack of Efficacy|1
401536|NCT00718770|1346019|P1|Overall Study|Adverse Event|1
401537|NCT00718770|1346019|P1|Overall Study|Lack of Efficacy|1
401538|NCT00718770|1346019|P1|Overall Study|Adverse Event|1
401539|NCT00718770|1346019|P1|Overall Study|Lack of Efficacy|1
401540|NCT00718770|1346019|P1|Overall Study|Lack of Efficacy|1
401541|NCT00718770|1346019|P1|Overall Study|Adverse Event|1
401542|NCT00718718|1346030|P10|Week 12 to End of Study|Other|0
401543|NCT00718718|1346031|P9|Week 12 to End of Study|Other|0
401544|NCT00718718|1346032|P8|Week 12 to End of Study|Other|0
401545|NCT00718718|1346033|P7|Week 12 to End of Study|Other|1
401546|NCT00718718|1346034|P6|Week 12 to End of Study|Other|0
401547|NCT00718718|1346035|P5|Week 12 to End of Study|Other|0
401548|NCT00718718|1346036|P4|Week 12 to End of Study|Other|1
401549|NCT00718718|1346037|P3|Week 12 to End of Study|Other|0
401550|NCT00718718|1346038|P2|Week 12 to End of Study|Other|1
401551|NCT00718718|1346039|P1|Week 12 to End of Study|Other|0
401552|NCT00718718|1346030|P10|Week 12 to End of Study|Lost to Follow-up|0
401553|NCT00718718|1346031|P9|Week 12 to End of Study|Lost to Follow-up|1
401554|NCT00718718|1346032|P8|Week 12 to End of Study|Lost to Follow-up|0
401555|NCT00718718|1346033|P7|Week 12 to End of Study|Lost to Follow-up|0
401556|NCT00718718|1346034|P6|Week 12 to End of Study|Lost to Follow-up|0
401557|NCT00718718|1346035|P5|Week 12 to End of Study|Lost to Follow-up|0
401558|NCT00718718|1346036|P4|Week 12 to End of Study|Lost to Follow-up|0
401559|NCT00718718|1346037|P3|Week 12 to End of Study|Lost to Follow-up|0
401560|NCT00718718|1346038|P2|Week 12 to End of Study|Lost to Follow-up|0
401561|NCT00718718|1346039|P1|Week 12 to End of Study|Lost to Follow-up|0
401562|NCT00718718|1346030|P10|Week 12 to End of Study|Withdrawal by Subject|0
401563|NCT00718718|1346031|P9|Week 12 to End of Study|Withdrawal by Subject|0
401564|NCT00718718|1346032|P8|Week 12 to End of Study|Withdrawal by Subject|0
401565|NCT00718718|1346033|P7|Week 12 to End of Study|Withdrawal by Subject|1
401566|NCT00718718|1346034|P6|Week 12 to End of Study|Withdrawal by Subject|2
401567|NCT00718718|1346035|P5|Week 12 to End of Study|Withdrawal by Subject|0
401568|NCT00718718|1346036|P4|Week 12 to End of Study|Withdrawal by Subject|0
401569|NCT00718718|1346037|P3|Week 12 to End of Study|Withdrawal by Subject|0
401570|NCT00718718|1346038|P2|Week 12 to End of Study|Withdrawal by Subject|0
401571|NCT00718718|1346039|P1|Week 12 to End of Study|Withdrawal by Subject|0
401572|NCT00718718|1346030|P10|Week 12 to End of Study|Death|0
401573|NCT00718718|1346031|P9|Week 12 to End of Study|Death|0
401574|NCT00718718|1346032|P8|Week 12 to End of Study|Death|0
401575|NCT00718718|1346033|P7|Week 12 to End of Study|Death|0
401576|NCT00718718|1346034|P6|Week 12 to End of Study|Death|1
401577|NCT00718718|1346035|P5|Week 12 to End of Study|Death|0
401578|NCT00718718|1346036|P4|Week 12 to End of Study|Death|0
401579|NCT00718718|1346037|P3|Week 12 to End of Study|Death|0
401580|NCT00718718|1346038|P2|Week 12 to End of Study|Death|0
401581|NCT00718718|1346039|P1|Week 12 to End of Study|Death|0
401582|NCT00718718|1346030|P10|Week 12 to End of Study|Adverse Event|0
401583|NCT00718718|1346031|P9|Week 12 to End of Study|Adverse Event|0
401584|NCT00718718|1346032|P8|Week 12 to End of Study|Adverse Event|1
401585|NCT00718718|1346033|P7|Week 12 to End of Study|Adverse Event|0
401586|NCT00718718|1346034|P6|Week 12 to End of Study|Adverse Event|0
401587|NCT00718718|1346035|P5|Week 12 to End of Study|Adverse Event|0
401588|NCT00718718|1346036|P4|Week 12 to End of Study|Adverse Event|0
401589|NCT00718718|1346037|P3|Week 12 to End of Study|Adverse Event|0
401590|NCT00718718|1346038|P2|Week 12 to End of Study|Adverse Event|0
401591|NCT00718718|1346039|P1|Week 12 to End of Study|Adverse Event|0
401592|NCT00718718|1346030|P10|Prior to Week 12|Other|0
401593|NCT00718718|1346031|P9|Prior to Week 12|Other|0
401594|NCT00718718|1346032|P8|Prior to Week 12|Other|0
401595|NCT00718718|1346033|P7|Prior to Week 12|Other|0
401596|NCT00718718|1346034|P6|Prior to Week 12|Other|0
401597|NCT00718718|1346035|P5|Prior to Week 12|Other|0
401598|NCT00718718|1346036|P4|Prior to Week 12|Other|0
401599|NCT00718718|1346037|P3|Prior to Week 12|Other|1
401600|NCT00718718|1346038|P2|Prior to Week 12|Other|0
401601|NCT00718718|1346039|P1|Prior to Week 12|Other|1
401602|NCT00718718|1346030|P10|Prior to Week 12|Withdrawal by Subject|0
401603|NCT00718718|1346031|P9|Prior to Week 12|Withdrawal by Subject|1
401604|NCT00718718|1346032|P8|Prior to Week 12|Withdrawal by Subject|1
401605|NCT00718718|1346033|P7|Prior to Week 12|Withdrawal by Subject|1
401606|NCT00718718|1346034|P6|Prior to Week 12|Withdrawal by Subject|0
401607|NCT00718718|1346035|P5|Prior to Week 12|Withdrawal by Subject|3
401608|NCT00718718|1346036|P4|Prior to Week 12|Withdrawal by Subject|0
401609|NCT00718718|1346037|P3|Prior to Week 12|Withdrawal by Subject|0
401610|NCT00718718|1346038|P2|Prior to Week 12|Withdrawal by Subject|0
401611|NCT00718718|1346039|P1|Prior to Week 12|Withdrawal by Subject|0
401612|NCT00718718|1346030|P10|Prior to Week 12|Adverse Event|0
401613|NCT00718718|1346031|P9|Prior to Week 12|Adverse Event|1
401614|NCT00718718|1346032|P8|Prior to Week 12|Adverse Event|1
401615|NCT00718718|1346033|P7|Prior to Week 12|Adverse Event|0
401616|NCT00718718|1346034|P6|Prior to Week 12|Adverse Event|0
401617|NCT00718718|1346035|P5|Prior to Week 12|Adverse Event|0
401618|NCT00718718|1346036|P4|Prior to Week 12|Adverse Event|0
401619|NCT00718718|1346037|P3|Prior to Week 12|Adverse Event|0
401620|NCT00718718|1346038|P2|Prior to Week 12|Adverse Event|0
401621|NCT00718718|1346039|P1|Prior to Week 12|Adverse Event|0
401622|NCT00718640|1346079|P1|Overall Study|Unresolved toxicity after 2 weeks|2
401623|NCT00718640|1346079|P1|Overall Study|Death|1
401624|NCT00718640|1346079|P1|Overall Study|Adverse Event|4
401625|NCT00718523|1346093|P2|Overall Study|Death|17
401626|NCT00718523|1346094|P1|Overall Study|Death|13
401627|NCT00718523|1346093|P2|Overall Study|Withdrawal by Subject|7
401628|NCT00718523|1346094|P1|Overall Study|Withdrawal by Subject|5
401629|NCT00718510|1346106|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
401630|NCT00718510|1346107|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
401631|NCT00718510|1346106|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
401632|NCT00718510|1346107|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
401633|NCT00718328|1346119|P2|Overall Study|Lost to Follow-up|0
401634|NCT00718328|1346120|P1|Overall Study|Lost to Follow-up|1
401635|NCT00718315|1346129|P3|Overall Study|Use of ATB and Corticoids|2
401636|NCT00718315|1346130|P2|Overall Study|Use of ATB and Corticoids|1
401637|NCT00718315|1346131|P1|Overall Study|Use of ATB and Corticoids|0
401638|NCT00718315|1346129|P3|Overall Study|Other|1
401639|NCT00718315|1346130|P2|Overall Study|Other|0
401640|NCT00718315|1346131|P1|Overall Study|Other|0
401641|NCT00718315|1346129|P3|Overall Study|Disease progression|1
401642|NCT00718315|1346130|P2|Overall Study|Disease progression|1
401643|NCT00718315|1346131|P1|Overall Study|Disease progression|0
401644|NCT00718315|1346129|P3|Overall Study|Use of Minocyclin|1
401645|NCT00718315|1346130|P2|Overall Study|Use of Minocyclin|1
401646|NCT00718315|1346131|P1|Overall Study|Use of Minocyclin|1
401647|NCT00718315|1346129|P3|Overall Study|Erlotinib dose decreased|1
401648|NCT00718315|1346130|P2|Overall Study|Erlotinib dose decreased|3
401649|NCT00718315|1346131|P1|Overall Study|Erlotinib dose decreased|4
401650|NCT00718315|1346129|P3|Overall Study|Protocol Violation|3
401651|NCT00718315|1346130|P2|Overall Study|Protocol Violation|5
401652|NCT00718315|1346131|P1|Overall Study|Protocol Violation|5
401653|NCT00718315|1346129|P3|Overall Study|Lost to Follow-up|4
401654|NCT00718315|1346130|P2|Overall Study|Lost to Follow-up|3
401655|NCT00718315|1346131|P1|Overall Study|Lost to Follow-up|2
401656|NCT00718315|1346129|P3|Overall Study|Death|5
401657|NCT00718315|1346130|P2|Overall Study|Death|6
401658|NCT00718315|1346131|P1|Overall Study|Death|6
401659|NCT00718315|1346129|P3|Overall Study|Adverse Event|3
401660|NCT00718315|1346130|P2|Overall Study|Adverse Event|2
401661|NCT00718315|1346131|P1|Overall Study|Adverse Event|1
401662|NCT00718237|1346182|P2|Overall Study|Withdrawal by Subject|10
401663|NCT00718237|1346183|P1|Overall Study|Withdrawal by Subject|9
401664|NCT00718237|1346182|P2|Overall Study|Physician Decision|0
401665|NCT00718237|1346183|P1|Overall Study|Physician Decision|1
401666|NCT00718237|1346182|P2|Overall Study|Lost to Follow-up|2
401667|NCT00718237|1346183|P1|Overall Study|Lost to Follow-up|2
401668|NCT00718237|1346182|P2|Overall Study|Adverse Event|3
401669|NCT00718237|1346183|P1|Overall Study|Adverse Event|1
401670|NCT00718081|1346226|P3|Overall Study|Lack of Efficacy|21
401671|NCT00718081|1346227|P2|Overall Study|Lack of Efficacy|3
401672|NCT00718081|1346228|P1|Overall Study|Lack of Efficacy|7
401673|NCT00718081|1346226|P3|Overall Study|Adverse Event|0
401674|NCT00718081|1346227|P2|Overall Study|Adverse Event|1
401675|NCT00718081|1346228|P1|Overall Study|Adverse Event|0
401676|NCT00718042|1346245|P6|Donor Follow-up|Lost to Follow-up|0
401677|NCT00718042|1346246|P5|Donor Follow-up|Lost to Follow-up|19
401678|NCT00718042|1346247|P4|Donor Follow-up|Lost to Follow-up|0
401679|NCT00718042|1346248|P3|Donor Follow-up|Lost to Follow-up|0
401680|NCT00718042|1346249|P2|Donor Follow-up|Lost to Follow-up|0
401681|NCT00718042|1346250|P1|Donor Follow-up|Lost to Follow-up|13
401682|NCT00718042|1346245|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
401683|NCT00718042|1346246|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
401684|NCT00718042|1346247|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
401685|NCT00718042|1346248|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
401686|NCT00718042|1346249|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
401687|NCT00718042|1346250|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
401688|NCT00718042|1346245|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
401689|NCT00718042|1346246|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
401690|NCT00718042|1346247|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
401691|NCT00718042|1346248|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
401692|NCT00718042|1346249|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
401693|NCT00718042|1346250|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
401694|NCT00718042|1346245|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
401695|NCT00718042|1346246|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
401696|NCT00718042|1346247|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
401697|NCT00718042|1346248|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
401698|NCT00718042|1346249|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
401699|NCT00718042|1346250|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
401700|NCT00718042|1346245|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
401701|NCT00718042|1346246|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
401702|NCT00718042|1346247|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
401703|NCT00718042|1346248|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
401704|NCT00718042|1346249|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
401705|NCT00718042|1346250|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
401706|NCT00717886|1346306|P1|Overall Study|Treatment Failure|1
401707|NCT00717886|1346306|P1|Overall Study|Withdrawal by Subject|3
401708|NCT00717860|1346321|P2|Overall Study|Withdrew consent|3
401709|NCT00717860|1346322|P1|Overall Study|Withdrew consent|7
401710|NCT00717860|1346321|P2|Overall Study|Discontinued for other reason|1
401711|NCT00717860|1346322|P1|Overall Study|Discontinued for other reason|6
401712|NCT00717860|1346321|P2|Overall Study|Lack of Efficacy|13
401713|NCT00717860|1346322|P1|Overall Study|Lack of Efficacy|7
401714|NCT00717860|1346321|P2|Overall Study|Laboratory adverse experience|2
401715|NCT00717860|1346322|P1|Overall Study|Laboratory adverse experience|2
401716|NCT00717860|1346321|P2|Overall Study|Clinical adverse experience|9
401717|NCT00717860|1346322|P1|Overall Study|Clinical adverse experience|5
401718|NCT00717756|1346332|P1|Overall Study|Withdrawal by Subject|1
401719|NCT00717522|1346345|P1|Overall Study|Death|1
401720|NCT00717522|1346345|P1|Overall Study|Adverse Event|1
401721|NCT00717522|1346345|P1|Overall Study|Disease Progression|5
401722|NCT00717366|1346381|P2|Extension Period (52 Weeks)|Withdrew consent|1
401723|NCT00717366|1346382|P1|Extension Period (52 Weeks)|Withdrew consent|1
401724|NCT00717366|1346381|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
401725|NCT00717366|1346382|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
401726|NCT00717366|1346381|P2|Extension Period (52 Weeks)|Renal transplant|13
401727|NCT00717366|1346382|P1|Extension Period (52 Weeks)|Renal transplant|3
401728|NCT00717366|1346381|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
401729|NCT00717366|1346382|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
401730|NCT00717366|1346381|P2|Core Study Period (20 Weeks)|Death|1
401731|NCT00717366|1346382|P1|Core Study Period (20 Weeks)|Death|0
401732|NCT00717366|1346381|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
401733|NCT00717366|1346382|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
401734|NCT00717366|1346381|P2|Core Study Period (20 Weeks)|Renal transplant|9
401735|NCT00717366|1346382|P1|Core Study Period (20 Weeks)|Renal transplant|4
401736|NCT00717314|1346406|P2|Overall Study|Withdrawal by Subject|3
401737|NCT00717314|1346407|P1|Overall Study|Withdrawal by Subject|1
401738|NCT00717314|1346406|P2|Overall Study|Lost to Follow-up|5
401739|NCT00717314|1346407|P1|Overall Study|Lost to Follow-up|1
401740|NCT00717314|1346406|P2|Overall Study|Protocol Violation|0
401741|NCT00717314|1346407|P1|Overall Study|Protocol Violation|1
401742|NCT00717314|1346406|P2|Overall Study|Adverse Event|2
401743|NCT00717314|1346407|P1|Overall Study|Adverse Event|3
401744|NCT00717275|1346444|P1|Overall Study|Premature study termination.|3
401745|NCT00717249|1346450|P2|Overall Study|Headaches|0
401746|NCT00717249|1346451|P1|Overall Study|Headaches|1
401747|NCT00717249|1346450|P2|Overall Study|Subject relocated|0
401748|NCT00717249|1346451|P1|Overall Study|Subject relocated|1
401749|NCT00717249|1346450|P2|Overall Study|Diagnosed with Multiple Scletosis|0
401750|NCT00717249|1346451|P1|Overall Study|Diagnosed with Multiple Scletosis|1
401751|NCT00717249|1346450|P2|Overall Study|Diagnosed with Diabetes|0
401752|NCT00717249|1346451|P1|Overall Study|Diagnosed with Diabetes|1
401753|NCT00717249|1346450|P2|Overall Study|Gastric Surgery|1
401754|NCT00717249|1346451|P1|Overall Study|Gastric Surgery|0
401755|NCT00717249|1346450|P2|Overall Study|Unsatisfactory Physiological Response|1
401756|NCT00717249|1346451|P1|Overall Study|Unsatisfactory Physiological Response|0
401757|NCT00717249|1346450|P2|Overall Study|Subject became Ineligible|1
401758|NCT00717249|1346451|P1|Overall Study|Subject became Ineligible|1
401759|NCT00717249|1346450|P2|Overall Study|Protocol Violation|2
401760|NCT00717249|1346451|P1|Overall Study|Protocol Violation|0
401761|NCT00717249|1346450|P2|Overall Study|Pregnancy|3
401762|NCT00717249|1346451|P1|Overall Study|Pregnancy|6
401763|NCT00717249|1346450|P2|Overall Study|Withdrawal by Subject|2
401764|NCT00717249|1346451|P1|Overall Study|Withdrawal by Subject|1
401765|NCT00717249|1346450|P2|Overall Study|Lost to Follow-up|0
401766|NCT00717249|1346451|P1|Overall Study|Lost to Follow-up|2
401767|NCT00717249|1346450|P2|Overall Study|Adverse Event|2
401768|NCT00717249|1346451|P1|Overall Study|Adverse Event|4
401769|NCT00717249|1346450|P2|Overall Study|Unsatisfactory visual Response|2
401770|NCT00717249|1346451|P1|Overall Study|Unsatisfactory visual Response|0
401771|NCT00717249|1346450|P2|Overall Study|Lens Discomfort|1
401772|NCT00717249|1346451|P1|Overall Study|Lens Discomfort|4
401773|NCT00717236|1346465|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
401774|NCT00717236|1346466|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
401775|NCT00717236|1346465|P2|Open-Label Period|Other: Completion Accidently Performed|0
401776|NCT00717236|1346466|P1|Open-Label Period|Other: Completion Accidently Performed|1
401777|NCT00717236|1346465|P2|Open-Label Period|Other: Administration of Golimumab|0
401778|NCT00717236|1346466|P1|Open-Label Period|Other: Administration of Golimumab|1
401779|NCT00717236|1346465|P2|Open-Label Period|Other: Cataract Surgery|0
401780|NCT00717236|1346466|P1|Open-Label Period|Other: Cataract Surgery|1
401781|NCT00717236|1346465|P2|Open-Label Period|Other: Sponsor Request|0
401782|NCT00717236|1346466|P1|Open-Label Period|Other: Sponsor Request|3
401783|NCT00717236|1346465|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
401784|NCT00717236|1346466|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
401785|NCT00717236|1346465|P2|Open-Label Period|Other: Investigator Decision|0
401786|NCT00717236|1346466|P1|Open-Label Period|Other: Investigator Decision|1
401787|NCT00717236|1346465|P2|Open-Label Period|Other: Moved|0
401788|NCT00717236|1346466|P1|Open-Label Period|Other: Moved|1
401789|NCT00717236|1346465|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
401790|NCT00717236|1346466|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
401791|NCT00717236|1346465|P2|Open-Label Period|Other: Lack of Compliance|1
401792|NCT00717236|1346466|P1|Open-Label Period|Other: Lack of Compliance|1
401793|NCT00717236|1346465|P2|Open-Label Period|Other: Peripheral Neuropathy|1
401794|NCT00717236|1346466|P1|Open-Label Period|Other: Peripheral Neuropathy|0
401795|NCT00717236|1346465|P2|Open-Label Period|Loss of Efficacy|1
401796|NCT00717236|1346466|P1|Open-Label Period|Loss of Efficacy|6
401797|NCT00717236|1346465|P2|Open-Label Period|Withdrawal by Subject|2
401798|NCT00717236|1346466|P1|Open-Label Period|Withdrawal by Subject|20
401799|NCT00717236|1346465|P2|Open-Label Period|Lost to Follow-up|4
401800|NCT00717236|1346466|P1|Open-Label Period|Lost to Follow-up|28
401801|NCT00717236|1346465|P2|Open-Label Period|Lack of Efficacy|8
401802|NCT00717236|1346466|P1|Open-Label Period|Lack of Efficacy|30
401803|NCT00717236|1346465|P2|Open-Label Period|Adverse Event|4
401804|NCT00717236|1346466|P1|Open-Label Period|Adverse Event|29
401805|NCT00717236|1346465|P2|Double-Blind Period|Other: Investigator Decision|1
401806|NCT00717236|1346466|P1|Double-Blind Period|Other: Investigator Decision|0
401807|NCT00717236|1346465|P2|Double-Blind Period|Other: Transportation problems|1
401808|NCT00717236|1346466|P1|Double-Blind Period|Other: Transportation problems|0
401809|NCT00717236|1346465|P2|Double-Blind Period|Other: Prohibited medication taken|2
401810|NCT00717236|1346466|P1|Double-Blind Period|Other: Prohibited medication taken|2
401811|NCT00717236|1346465|P2|Double-Blind Period|Other: Stopped taking DMARD|0
401812|NCT00717236|1346466|P1|Double-Blind Period|Other: Stopped taking DMARD|1
401813|NCT00717236|1346465|P2|Double-Blind Period|Other: Subject moved|1
401814|NCT00717236|1346466|P1|Double-Blind Period|Other: Subject moved|1
401815|NCT00717236|1346465|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
401816|NCT00717236|1346466|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
401817|NCT00717236|1346465|P2|Double-Blind Period|Other: Inappropriate randomization|0
401818|NCT00717236|1346466|P1|Double-Blind Period|Other: Inappropriate randomization|1
401819|NCT00717236|1346465|P2|Double-Blind Period|Other: Sponsor request|0
401820|NCT00717236|1346466|P1|Double-Blind Period|Other: Sponsor request|1
401821|NCT00717236|1346465|P2|Double-Blind Period|Other: History of cancer|0
401822|NCT00717236|1346466|P1|Double-Blind Period|Other: History of cancer|1
401823|NCT00717236|1346465|P2|Double-Blind Period|Other: History of adenoid grown|0
401824|NCT00717236|1346466|P1|Double-Blind Period|Other: History of adenoid grown|1
401825|NCT00717236|1346465|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
401826|NCT00717236|1346466|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
401827|NCT00717236|1346465|P2|Double-Blind Period|Other: subject withdrew consent|1
401828|NCT00717236|1346466|P1|Double-Blind Period|Other: subject withdrew consent|1
401829|NCT00717236|1346465|P2|Double-Blind Period|Other: Screening failure|0
401830|NCT00717236|1346466|P1|Double-Blind Period|Other: Screening failure|1
401831|NCT00717236|1346465|P2|Double-Blind Period|Other: Site withdrew|0
401832|NCT00717236|1346466|P1|Double-Blind Period|Other: Site withdrew|2
401833|NCT00717236|1346465|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
401834|NCT00717236|1346466|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
401835|NCT00717236|1346465|P2|Double-Blind Period|Other: Protocol Violation|0
401836|NCT00717236|1346466|P1|Double-Blind Period|Other: Protocol Violation|2
401837|NCT00717236|1346465|P2|Double-Blind Period|Other: Pregnancy|0
401838|NCT00717236|1346466|P1|Double-Blind Period|Other: Pregnancy|1
401839|NCT00717236|1346465|P2|Double-Blind Period|Other: Death|0
401840|NCT00717236|1346466|P1|Double-Blind Period|Other: Death|1
401841|NCT00717236|1346465|P2|Double-Blind Period|Loss of efficacy|0
401842|NCT00717236|1346466|P1|Double-Blind Period|Loss of efficacy|3
401843|NCT00717236|1346465|P2|Double-Blind Period|Withdrawal by Subject|2
401844|NCT00717236|1346466|P1|Double-Blind Period|Withdrawal by Subject|10
401845|NCT00717236|1346465|P2|Double-Blind Period|Lost to Follow-up|5
401846|NCT00717236|1346466|P1|Double-Blind Period|Lost to Follow-up|3
401847|NCT00717236|1346465|P2|Double-Blind Period|Lack of Efficacy|6
401848|NCT00717236|1346466|P1|Double-Blind Period|Lack of Efficacy|6
401849|NCT00717236|1346465|P2|Double-Blind Period|Adverse Event|6
401850|NCT00717236|1346466|P1|Double-Blind Period|Adverse Event|33
401851|NCT00717197|1346535|P1|Overall Study|Physician Decision|1
401852|NCT00717197|1346535|P1|Overall Study|Tumor Progression|1
401853|NCT00717197|1346535|P1|Overall Study|Unable to purchase study drug|5
401854|NCT00717093|1346541|P2|Overall Study|Randomized but not treated|0
401855|NCT00717093|1346542|P1|Overall Study|Randomized but not treated|1
401856|NCT00717093|1346541|P2|Overall Study|Other|1
401857|NCT00717093|1346542|P1|Overall Study|Other|0
401858|NCT00717093|1346541|P2|Overall Study|Withdrawal by Subject|19
401859|NCT00717093|1346542|P1|Overall Study|Withdrawal by Subject|12
401860|NCT00717093|1346541|P2|Overall Study|Lost to Follow-up|6
401861|NCT00717093|1346542|P1|Overall Study|Lost to Follow-up|9
401862|NCT00717093|1346541|P2|Overall Study|Lack of Efficacy|13
401863|NCT00717093|1346542|P1|Overall Study|Lack of Efficacy|3
401864|NCT00717093|1346541|P2|Overall Study|Adverse Event|9
401865|NCT00717093|1346542|P1|Overall Study|Adverse Event|19
401866|NCT00717067|1346559|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
401867|NCT00717067|1346560|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
401868|NCT00717067|1346561|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
401869|NCT00717067|1346562|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
401870|NCT00717067|1346563|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
401871|NCT00716976|1346670|P2|Overall Study|Ineligibles|2
401872|NCT00716976|1346671|P1|Overall Study|Ineligibles|4
401873|NCT00716976|1346670|P2|Overall Study|Radiation during protocol|0
401874|NCT00716976|1346671|P1|Overall Study|Radiation during protocol|1
401875|NCT00716976|1346670|P2|Overall Study|Premature discontinuation cisplatin|4
401876|NCT00716976|1346671|P1|Overall Study|Premature discontinuation cisplatin|5
401877|NCT00716976|1346670|P2|Overall Study|Withdrawal by Subject|1
401878|NCT00716976|1346671|P1|Overall Study|Withdrawal by Subject|5
401879|NCT00716976|1346670|P2|Overall Study|Physician Decision|2
401880|NCT00716976|1346671|P1|Overall Study|Physician Decision|2
401881|NCT00716976|1346670|P2|Overall Study|Death|0
401882|NCT00716976|1346671|P1|Overall Study|Death|1
401883|NCT00716976|1346670|P2|Overall Study|Adverse Event|0
401884|NCT00716976|1346671|P1|Overall Study|Adverse Event|2
401885|NCT00716859|1346709|P2|Overall Study|Not treated|1
401886|NCT00716859|1346710|P1|Overall Study|Not treated|1
401887|NCT00716859|1346709|P2|Overall Study|Withdrawal by Subject|3
401888|NCT00716859|1346710|P1|Overall Study|Withdrawal by Subject|1
401889|NCT00716859|1346709|P2|Overall Study|Lack of Efficacy|0
401890|NCT00716859|1346710|P1|Overall Study|Lack of Efficacy|3
401891|NCT00716859|1346709|P2|Overall Study|Adverse Event|1
401892|NCT00716859|1346710|P1|Overall Study|Adverse Event|4
401893|NCT00716625|1346795|P1|Overall Study|Safety was not Assessable|1
401894|NCT00716482|1346820|P1|Overall Study|inclusion/exclusion criteria not met|25
401895|NCT00716482|1346820|P1|Overall Study|technical/machine error|28
401896|NCT00716482|1346820|P1|Overall Study|no pathology obtained|10
401897|NCT00716482|1346820|P1|Overall Study|Inadequate acquisition or analysis|50
401898|NCT00716482|1346820|P1|Overall Study|Lost to Follow-up|6
401899|NCT00716456|1346833|P3|Overall Study|Adverse Event|0
401900|NCT00716456|1346834|P2|Overall Study|Adverse Event|2
401901|NCT00716456|1346835|P1|Overall Study|Adverse Event|0
401902|NCT00716417|1346886|P10|Overall Study|On patient request due to toxicities|0
401903|NCT00716417|1346887|P9|Overall Study|On patient request due to toxicities|0
401904|NCT00716417|1346888|P8|Overall Study|On patient request due to toxicities|1
401905|NCT00716417|1346889|P7|Overall Study|On patient request due to toxicities|0
401906|NCT00716417|1346890|P6|Overall Study|On patient request due to toxicities|0
401907|NCT00716417|1346891|P5|Overall Study|On patient request due to toxicities|0
401908|NCT00716417|1346892|P4|Overall Study|On patient request due to toxicities|0
401909|NCT00716417|1346893|P3|Overall Study|On patient request due to toxicities|0
401910|NCT00716417|1346894|P2|Overall Study|On patient request due to toxicities|0
401911|NCT00716417|1346895|P1|Overall Study|On patient request due to toxicities|0
401912|NCT00716417|1346886|P10|Overall Study|Dose limiting toxicity (DLT)|0
401913|NCT00716417|1346887|P9|Overall Study|Dose limiting toxicity (DLT)|0
401914|NCT00716417|1346888|P8|Overall Study|Dose limiting toxicity (DLT)|0
401915|NCT00716417|1346889|P7|Overall Study|Dose limiting toxicity (DLT)|0
401916|NCT00716417|1346890|P6|Overall Study|Dose limiting toxicity (DLT)|0
401917|NCT00716417|1346891|P5|Overall Study|Dose limiting toxicity (DLT)|1
401918|NCT00716417|1346892|P4|Overall Study|Dose limiting toxicity (DLT)|0
401919|NCT00716417|1346893|P3|Overall Study|Dose limiting toxicity (DLT)|0
401920|NCT00716417|1346894|P2|Overall Study|Dose limiting toxicity (DLT)|0
401921|NCT00716417|1346895|P1|Overall Study|Dose limiting toxicity (DLT)|0
401922|NCT00716417|1346886|P10|Overall Study|Progressive disease|0
401923|NCT00716417|1346887|P9|Overall Study|Progressive disease|5
401924|NCT00716417|1346888|P8|Overall Study|Progressive disease|1
401925|NCT00716417|1346889|P7|Overall Study|Progressive disease|3
401926|NCT00716417|1346890|P6|Overall Study|Progressive disease|3
401927|NCT00716417|1346891|P5|Overall Study|Progressive disease|0
401928|NCT00716417|1346892|P4|Overall Study|Progressive disease|8
401929|NCT00716417|1346893|P3|Overall Study|Progressive disease|3
401930|NCT00716417|1346894|P2|Overall Study|Progressive disease|5
401931|NCT00716417|1346895|P1|Overall Study|Progressive disease|3
401932|NCT00716417|1346886|P10|Overall Study|Withdrawal by Subject|0
401933|NCT00716417|1346887|P9|Overall Study|Withdrawal by Subject|0
401934|NCT00716417|1346888|P8|Overall Study|Withdrawal by Subject|0
401935|NCT00716417|1346889|P7|Overall Study|Withdrawal by Subject|1
401936|NCT00716417|1346890|P6|Overall Study|Withdrawal by Subject|0
401937|NCT00716417|1346891|P5|Overall Study|Withdrawal by Subject|0
401938|NCT00716417|1346892|P4|Overall Study|Withdrawal by Subject|2
401939|NCT00716417|1346893|P3|Overall Study|Withdrawal by Subject|0
401940|NCT00716417|1346894|P2|Overall Study|Withdrawal by Subject|1
401941|NCT00716417|1346895|P1|Overall Study|Withdrawal by Subject|0
401942|NCT00716417|1346886|P10|Overall Study|Adverse Event|3
401943|NCT00716417|1346887|P9|Overall Study|Adverse Event|0
401944|NCT00716417|1346888|P8|Overall Study|Adverse Event|1
401945|NCT00716417|1346889|P7|Overall Study|Adverse Event|3
401946|NCT00716417|1346890|P6|Overall Study|Adverse Event|0
401947|NCT00716417|1346891|P5|Overall Study|Adverse Event|0
401948|NCT00716417|1346892|P4|Overall Study|Adverse Event|1
401949|NCT00716417|1346893|P3|Overall Study|Adverse Event|2
401950|NCT00716417|1346894|P2|Overall Study|Adverse Event|0
401951|NCT00716417|1346895|P1|Overall Study|Adverse Event|0
401952|NCT00716274|1346942|P6|Study Period III (16-Weeks)|Adverse Event|0
401953|NCT00716274|1346943|P5|Study Period III (16-Weeks)|Adverse Event|1
401954|NCT00716274|1346944|P4|Study Period III (16-Weeks)|Adverse Event|0
401955|NCT00716274|1346945|P3|Study Period III (16-Weeks)|Adverse Event|0
401956|NCT00716274|1346946|P2|Study Period III (16-Weeks)|Adverse Event|0
401957|NCT00716274|1346947|P1|Study Period III (16-Weeks)|Adverse Event|0
401958|NCT00716274|1346942|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
401959|NCT00716274|1346943|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
401960|NCT00716274|1346944|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
401961|NCT00716274|1346945|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
401962|NCT00716274|1346946|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
401963|NCT00716274|1346947|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
401964|NCT00716274|1346942|P6|Study Period III (16-Weeks)|Physician Decision|0
401965|NCT00716274|1346943|P5|Study Period III (16-Weeks)|Physician Decision|1
401966|NCT00716274|1346944|P4|Study Period III (16-Weeks)|Physician Decision|0
401967|NCT00716274|1346945|P3|Study Period III (16-Weeks)|Physician Decision|0
401968|NCT00716274|1346946|P2|Study Period III (16-Weeks)|Physician Decision|0
401969|NCT00716274|1346947|P1|Study Period III (16-Weeks)|Physician Decision|0
401970|NCT00716274|1346942|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
401971|NCT00716274|1346943|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
401972|NCT00716274|1346944|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
401973|NCT00716274|1346945|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
401974|NCT00716274|1346946|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
401975|NCT00716274|1346947|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
401976|NCT00716274|1346942|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
401977|NCT00716274|1346943|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
401978|NCT00716274|1346944|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
401979|NCT00716274|1346945|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
401980|NCT00716274|1346946|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
401981|NCT00716274|1346947|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
401982|NCT00716274|1346942|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
401983|NCT00716274|1346943|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
401984|NCT00716274|1346944|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
401985|NCT00716274|1346945|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
401986|NCT00716274|1346946|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
401987|NCT00716274|1346947|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
401988|NCT00716274|1346942|P6|Study Period II (16-Weeks)|Physician Decision|1
401989|NCT00716274|1346943|P5|Study Period II (16-Weeks)|Physician Decision|0
401990|NCT00716274|1346944|P4|Study Period II (16-Weeks)|Physician Decision|0
401991|NCT00716274|1346945|P3|Study Period II (16-Weeks)|Physician Decision|0
401992|NCT00716274|1346946|P2|Study Period II (16-Weeks)|Physician Decision|1
401993|NCT00716274|1346947|P1|Study Period II (16-Weeks)|Physician Decision|3
401994|NCT00716274|1346942|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
401995|NCT00716274|1346943|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
401996|NCT00716274|1346944|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
401997|NCT00716274|1346945|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
401998|NCT00716274|1346946|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
401999|NCT00716274|1346947|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
402000|NCT00716274|1346942|P6|Study Period II (16-Weeks)|Protocol Violation|1
402001|NCT00716274|1346943|P5|Study Period II (16-Weeks)|Protocol Violation|0
402002|NCT00716274|1346944|P4|Study Period II (16-Weeks)|Protocol Violation|0
402003|NCT00716274|1346945|P3|Study Period II (16-Weeks)|Protocol Violation|0
402004|NCT00716274|1346946|P2|Study Period II (16-Weeks)|Protocol Violation|3
402005|NCT00716274|1346947|P1|Study Period II (16-Weeks)|Protocol Violation|0
402006|NCT00716274|1346942|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
402007|NCT00716274|1346943|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
402008|NCT00716274|1346944|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
402009|NCT00716274|1346945|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
402010|NCT00716274|1346946|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
402011|NCT00716274|1346947|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
402012|NCT00716144|1347081|P4|Overall Study|Clinical Depression|0
402013|NCT00716144|1347082|P3|Overall Study|Clinical Depression|0
402014|NCT00716144|1347083|P2|Overall Study|Clinical Depression|1
402015|NCT00716144|1347084|P1|Overall Study|Clinical Depression|0
402016|NCT00716144|1347081|P4|Overall Study|Adverse event: left foot pain|0
402017|NCT00716144|1347082|P3|Overall Study|Adverse event: left foot pain|0
402018|NCT00716144|1347083|P2|Overall Study|Adverse event: left foot pain|1
402019|NCT00716144|1347084|P1|Overall Study|Adverse event: left foot pain|0
402020|NCT00716144|1347081|P4|Overall Study|Withdrew consent, allowed use of data|0
402021|NCT00716144|1347082|P3|Overall Study|Withdrew consent, allowed use of data|1
402022|NCT00716144|1347083|P2|Overall Study|Withdrew consent, allowed use of data|0
402023|NCT00716144|1347084|P1|Overall Study|Withdrew consent, allowed use of data|0
402024|NCT00716144|1347081|P4|Overall Study|Intercurrent illness|0
402025|NCT00716144|1347082|P3|Overall Study|Intercurrent illness|1
402026|NCT00716144|1347083|P2|Overall Study|Intercurrent illness|0
402027|NCT00716144|1347084|P1|Overall Study|Intercurrent illness|0
402028|NCT00716144|1347081|P4|Overall Study|Physician Decision|2
402029|NCT00716144|1347082|P3|Overall Study|Physician Decision|2
402030|NCT00716144|1347083|P2|Overall Study|Physician Decision|1
402031|NCT00716144|1347084|P1|Overall Study|Physician Decision|0
402032|NCT00716144|1347081|P4|Overall Study|Protocol Violation|0
402033|NCT00716144|1347082|P3|Overall Study|Protocol Violation|1
402034|NCT00716144|1347083|P2|Overall Study|Protocol Violation|0
402035|NCT00716144|1347084|P1|Overall Study|Protocol Violation|2
402036|NCT00716144|1347081|P4|Overall Study|Non-compliance|0
402037|NCT00716144|1347082|P3|Overall Study|Non-compliance|0
402038|NCT00716144|1347083|P2|Overall Study|Non-compliance|0
402039|NCT00716144|1347084|P1|Overall Study|Non-compliance|1
402040|NCT00716144|1347081|P4|Overall Study|Adverse Event|2
402041|NCT00716144|1347082|P3|Overall Study|Adverse Event|0
402042|NCT00716144|1347083|P2|Overall Study|Adverse Event|0
402043|NCT00716144|1347084|P1|Overall Study|Adverse Event|0
402044|NCT00716144|1347081|P4|Overall Study|Lost to Follow-up|2
402045|NCT00716144|1347082|P3|Overall Study|Lost to Follow-up|1
402046|NCT00716144|1347083|P2|Overall Study|Lost to Follow-up|2
402047|NCT00716144|1347084|P1|Overall Study|Lost to Follow-up|2
402048|NCT00716144|1347081|P4|Overall Study|Withdrawal by Subject|6
402049|NCT00716144|1347082|P3|Overall Study|Withdrawal by Subject|6
402050|NCT00716144|1347083|P2|Overall Study|Withdrawal by Subject|2
402051|NCT00716144|1347084|P1|Overall Study|Withdrawal by Subject|4
402052|NCT00716092|1347109|P3|Overall Study|Other incl. Lack of Efficacy|0
402053|NCT00716092|1347110|P2|Overall Study|Other incl. Lack of Efficacy|1
402054|NCT00716092|1347111|P1|Overall Study|Other incl. Lack of Efficacy|2
402055|NCT00715949|1347164|P1|Overall Study|could not finish first test|4
402056|NCT00715910|1347172|P6|Booster and ESFU Phase|Other|0
402057|NCT00715910|1347173|P5|Booster and ESFU Phase|Other|1
402058|NCT00715910|1347174|P4|Booster and ESFU Phase|Other|5
402059|NCT00715910|1347175|P3|Booster and ESFU Phase|Other|0
402060|NCT00715910|1347176|P2|Booster and ESFU Phase|Other|0
402061|NCT00715910|1347177|P1|Booster and ESFU Phase|Other|0
402062|NCT00715910|1347172|P6|Booster and ESFU Phase|Lost to Follow-up|13
402063|NCT00715910|1347173|P5|Booster and ESFU Phase|Lost to Follow-up|1
402064|NCT00715910|1347174|P4|Booster and ESFU Phase|Lost to Follow-up|6
402065|NCT00715910|1347175|P3|Booster and ESFU Phase|Lost to Follow-up|0
402066|NCT00715910|1347176|P2|Booster and ESFU Phase|Lost to Follow-up|0
402067|NCT00715910|1347177|P1|Booster and ESFU Phase|Lost to Follow-up|0
402068|NCT00715793|1347296|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
402069|NCT00715793|1347297|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
402070|NCT00715793|1347296|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
402071|NCT00715793|1347297|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
402072|NCT00715676|1347347|P3|Overall Study|Elevated Blood Glucose|0
402073|NCT00715676|1347348|P2|Overall Study|Elevated Blood Glucose|1
402074|NCT00715676|1347349|P1|Overall Study|Elevated Blood Glucose|0
402075|NCT00715676|1347347|P3|Overall Study|Use of Exclusionary Medication|1
402076|NCT00715676|1347348|P2|Overall Study|Use of Exclusionary Medication|0
402077|NCT00715676|1347349|P1|Overall Study|Use of Exclusionary Medication|0
402078|NCT00715676|1347347|P3|Overall Study|Did Not Meet Entry Criteria|1
402079|NCT00715676|1347348|P2|Overall Study|Did Not Meet Entry Criteria|0
402080|NCT00715676|1347349|P1|Overall Study|Did Not Meet Entry Criteria|0
402081|NCT00715676|1347347|P3|Overall Study|Terminated by Sponsor|0
402082|NCT00715676|1347348|P2|Overall Study|Terminated by Sponsor|0
402083|NCT00715676|1347349|P1|Overall Study|Terminated by Sponsor|1
402084|NCT00715676|1347347|P3|Overall Study|Lost to Follow-up|1
402085|NCT00715676|1347348|P2|Overall Study|Lost to Follow-up|2
402086|NCT00715676|1347349|P1|Overall Study|Lost to Follow-up|1
402087|NCT00715676|1347347|P3|Overall Study|Withdrawal by Subject|8
402088|NCT00715676|1347348|P2|Overall Study|Withdrawal by Subject|3
402089|NCT00715676|1347349|P1|Overall Study|Withdrawal by Subject|1
402090|NCT00715676|1347347|P3|Overall Study|Adverse Event|21
402091|NCT00715676|1347348|P2|Overall Study|Adverse Event|5
402092|NCT00715676|1347349|P1|Overall Study|Adverse Event|3
402093|NCT00715624|1347392|P2|Overall Study|Other|1
402094|NCT00715624|1347393|P1|Overall Study|Other|0
402095|NCT00715624|1347392|P2|Overall Study|Incorrect randomization (not treated)|1
402096|NCT00715624|1347393|P1|Overall Study|Incorrect randomization (not treated)|0
402097|NCT00715624|1347392|P2|Overall Study|Sponsor decision|4
402098|NCT00715624|1347393|P1|Overall Study|Sponsor decision|0
402099|NCT00715624|1347392|P2|Overall Study|Poor compliance|13
402100|NCT00715624|1347393|P1|Overall Study|Poor compliance|6
402101|NCT00715624|1347392|P2|Overall Study|Familial and personal reasons|22
402102|NCT00715624|1347393|P1|Overall Study|Familial and personal reasons|10
402103|NCT00715624|1347392|P2|Overall Study|Withdrawal by Subject|25
402104|NCT00715624|1347393|P1|Overall Study|Withdrawal by Subject|11
402105|NCT00715624|1347392|P2|Overall Study|Protocol Violation|0
402106|NCT00715624|1347393|P1|Overall Study|Protocol Violation|1
402107|NCT00715624|1347392|P2|Overall Study|Lost to Follow-up|2
402108|NCT00715624|1347393|P1|Overall Study|Lost to Follow-up|1
402109|NCT00715624|1347392|P2|Overall Study|Lack of Efficacy|11
402110|NCT00715624|1347393|P1|Overall Study|Lack of Efficacy|11
402111|NCT00715624|1347392|P2|Overall Study|Adverse Event|37
402112|NCT00715624|1347393|P1|Overall Study|Adverse Event|12
402113|NCT00715559|1347421|P1|Overall Study|medication not tolerated - nausea|1
402114|NCT00715520|1347431|P3|Overall Study|Withdrawal by Subject|1
402115|NCT00715520|1347432|P2|Overall Study|Withdrawal by Subject|0
402116|NCT00715520|1347433|P1|Overall Study|Withdrawal by Subject|2
402117|NCT00715520|1347431|P3|Overall Study|Screen failure|1
402118|NCT00715520|1347432|P2|Overall Study|Screen failure|1
402119|NCT00715520|1347433|P1|Overall Study|Screen failure|8
402120|NCT00715403|1347453|P7|Overall Study|Other reason not defined above|0
402121|NCT00715403|1347454|P6|Overall Study|Other reason not defined above|1
402122|NCT00715403|1347455|P5|Overall Study|Other reason not defined above|1
402123|NCT00715403|1347456|P4|Overall Study|Other reason not defined above|0
402124|NCT00715403|1347457|P3|Overall Study|Other reason not defined above|1
402125|NCT00715403|1347458|P2|Overall Study|Other reason not defined above|0
402126|NCT00715403|1347459|P1|Overall Study|Other reason not defined above|0
402127|NCT00715403|1347453|P7|Overall Study|Protocol Violation|0
402128|NCT00715403|1347454|P6|Overall Study|Protocol Violation|1
402129|NCT00715403|1347455|P5|Overall Study|Protocol Violation|0
402130|NCT00715403|1347456|P4|Overall Study|Protocol Violation|0
402131|NCT00715403|1347457|P3|Overall Study|Protocol Violation|0
402132|NCT00715403|1347458|P2|Overall Study|Protocol Violation|0
402133|NCT00715403|1347459|P1|Overall Study|Protocol Violation|0
402134|NCT00715403|1347453|P7|Overall Study|Other Adverse Event than DLT|0
402135|NCT00715403|1347454|P6|Overall Study|Other Adverse Event than DLT|2
402136|NCT00715403|1347455|P5|Overall Study|Other Adverse Event than DLT|0
402137|NCT00715403|1347456|P4|Overall Study|Other Adverse Event than DLT|0
402138|NCT00715403|1347457|P3|Overall Study|Other Adverse Event than DLT|0
402139|NCT00715403|1347458|P2|Overall Study|Other Adverse Event than DLT|0
402140|NCT00715403|1347459|P1|Overall Study|Other Adverse Event than DLT|1
402141|NCT00715403|1347453|P7|Overall Study|Dose limiting Toxicity (DLT)|0
402142|NCT00715403|1347454|P6|Overall Study|Dose limiting Toxicity (DLT)|1
402143|NCT00715403|1347455|P5|Overall Study|Dose limiting Toxicity (DLT)|0
402144|NCT00715403|1347456|P4|Overall Study|Dose limiting Toxicity (DLT)|0
402145|NCT00715403|1347457|P3|Overall Study|Dose limiting Toxicity (DLT)|0
402146|NCT00715403|1347458|P2|Overall Study|Dose limiting Toxicity (DLT)|0
402147|NCT00715403|1347459|P1|Overall Study|Dose limiting Toxicity (DLT)|0
402148|NCT00715403|1347453|P7|Overall Study|Progressive disease|1
402149|NCT00715403|1347454|P6|Overall Study|Progressive disease|14
402150|NCT00715403|1347455|P5|Overall Study|Progressive disease|5
402151|NCT00715403|1347456|P4|Overall Study|Progressive disease|9
402152|NCT00715403|1347457|P3|Overall Study|Progressive disease|3
402153|NCT00715403|1347458|P2|Overall Study|Progressive disease|1
402154|NCT00715403|1347459|P1|Overall Study|Progressive disease|0
402155|NCT00715299|1347598|P1|Overall Study|failed the pre-screen exercise test|2
402156|NCT00715299|1347598|P1|Overall Study|Adverse Event|3
402157|NCT00715299|1347598|P1|Overall Study|Withdrawal by Subject|1
402158|NCT00715208|1347604|P2|Overall Study|Lack of Efficacy|2
402159|NCT00715208|1347605|P1|Overall Study|Lack of Efficacy|0
402160|NCT00715208|1347604|P2|Overall Study|Adverse Event|6
402161|NCT00715208|1347605|P1|Overall Study|Adverse Event|0
402162|NCT00715208|1347604|P2|Overall Study|Withdrawal by Subject|1
402163|NCT00715208|1347605|P1|Overall Study|Withdrawal by Subject|1
402164|NCT00715117|1347621|P2|Overall Study|Crohn's flare and rescue with steroids|1
402165|NCT00715117|1347622|P1|Overall Study|Crohn's flare and rescue with steroids|0
402166|NCT00715078|1347690|P3|Overall Study|Unable to start due to disease prog.|1
402167|NCT00715078|1347691|P2|Overall Study|Unable to start due to disease prog.|0
402168|NCT00715078|1347692|P1|Overall Study|Unable to start due to disease prog.|0
402169|NCT00715078|1347690|P3|Overall Study|Withdrawal by Subject|1
402170|NCT00715078|1347691|P2|Overall Study|Withdrawal by Subject|0
402171|NCT00715078|1347692|P1|Overall Study|Withdrawal by Subject|1
402172|NCT00715078|1347690|P3|Overall Study|Death|36
402173|NCT00715078|1347691|P2|Overall Study|Death|36
402174|NCT00715078|1347692|P1|Overall Study|Death|29
402175|NCT00715026|1347700|P1|Overall Study|Surgery done on non-study consented hip|1
402176|NCT00715026|1347700|P1|Overall Study|Protocol Violation|1
402177|NCT00715026|1347700|P1|Overall Study|Lost to Follow-up|3
402178|NCT00715026|1347700|P1|Overall Study|Withdrawal by Subject|5
402179|NCT00714948|1347705|P1|Overall Study|Adverse Event|2
402180|NCT00714870|1347711|P2|Overall Study|did not attend minimum of 4 sessions|0
402181|NCT00714870|1347712|P1|Overall Study|did not attend minimum of 4 sessions|4
402182|NCT00714870|1347711|P2|Overall Study|patient unable to come b/c back pain|0
402183|NCT00714870|1347712|P1|Overall Study|patient unable to come b/c back pain|1
402184|NCT00714870|1347711|P2|Overall Study|Lost to Follow-up|5
402185|NCT00714870|1347712|P1|Overall Study|Lost to Follow-up|22
402186|NCT00714714|1347727|P1|Overall Study|Adverse Event|1
402187|NCT00714688|1347736|P3|Overall Study|Other|5
402188|NCT00714688|1347737|P2|Overall Study|Other|6
402189|NCT00714688|1347738|P1|Overall Study|Other|1
402190|NCT00714688|1347736|P3|Overall Study|Sponsor's Decision|0
402191|NCT00714688|1347737|P2|Overall Study|Sponsor's Decision|2
402192|NCT00714688|1347738|P1|Overall Study|Sponsor's Decision|0
402193|NCT00714688|1347736|P3|Overall Study|Ineligible to Continue the Study|1
402194|NCT00714688|1347737|P2|Overall Study|Ineligible to Continue the Study|1
402195|NCT00714688|1347738|P1|Overall Study|Ineligible to Continue the Study|0
402196|NCT00714688|1347736|P3|Overall Study|Subject Non-compliant|5
402197|NCT00714688|1347737|P2|Overall Study|Subject Non-compliant|5
402198|NCT00714688|1347738|P1|Overall Study|Subject Non-compliant|3
402199|NCT00714688|1347736|P3|Overall Study|Adverse Event|19
402200|NCT00714688|1347737|P2|Overall Study|Adverse Event|15
402201|NCT00714688|1347738|P1|Overall Study|Adverse Event|2
402202|NCT00714688|1347736|P3|Overall Study|Lost to Follow-up|0
402203|NCT00714688|1347737|P2|Overall Study|Lost to Follow-up|2
402204|NCT00714688|1347738|P1|Overall Study|Lost to Follow-up|5
402205|NCT00714688|1347736|P3|Overall Study|Withdrawal by Subject|3
402206|NCT00714688|1347737|P2|Overall Study|Withdrawal by Subject|3
402207|NCT00714688|1347738|P1|Overall Study|Withdrawal by Subject|4
402208|NCT00714688|1347736|P3|Overall Study|Lack of Efficacy|4
402209|NCT00714688|1347737|P2|Overall Study|Lack of Efficacy|1
402210|NCT00714688|1347738|P1|Overall Study|Lack of Efficacy|14
402211|NCT00714493|1347780|P1|Overall Study|OTHER|2
402212|NCT00714493|1347780|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
402213|NCT00714493|1347780|P1|Overall Study|Protocol Violation|12
402214|NCT00714493|1347780|P1|Overall Study|Lost to Follow-up|3
402215|NCT00714493|1347780|P1|Overall Study|Lack of Efficacy|10
402216|NCT00714493|1347780|P1|Overall Study|Death|3
402217|NCT00714493|1347780|P1|Overall Study|Adverse Event|11
402218|NCT00714285|1347808|P4|Overall Study|Migrated/moved from study area|0
402219|NCT00714285|1347809|P3|Overall Study|Migrated/moved from study area|0
402220|NCT00714285|1347810|P2|Overall Study|Migrated/moved from study area|1
402221|NCT00714285|1347811|P1|Overall Study|Migrated/moved from study area|0
402222|NCT00714285|1347808|P4|Overall Study|Lost to Follow-up|1
402223|NCT00714285|1347809|P3|Overall Study|Lost to Follow-up|0
402224|NCT00714285|1347810|P2|Overall Study|Lost to Follow-up|2
402225|NCT00714285|1347811|P1|Overall Study|Lost to Follow-up|0
402226|NCT00714259|1347861|P1|Overall Study|Death|2
402227|NCT00714168|1347907|P2|Overall Study|Non-study medical condition|2
402228|NCT00714168|1347908|P1|Overall Study|Non-study medical condition|3
402229|NCT00714168|1347907|P2|Overall Study|Relocation|3
402230|NCT00714168|1347908|P1|Overall Study|Relocation|4
402231|NCT00714168|1347907|P2|Overall Study|Lost to Follow-up|50
402232|NCT00714168|1347908|P1|Overall Study|Lost to Follow-up|32
402233|NCT00714168|1347907|P2|Overall Study|Pregnancy|4
402234|NCT00714168|1347908|P1|Overall Study|Pregnancy|5
402235|NCT00714051|1347924|P2|Overall Study|Death|1
402236|NCT00714051|1347925|P1|Overall Study|Death|0
402237|NCT00714051|1347924|P2|Overall Study|Withdrawal by Subject|0
402238|NCT00714051|1347925|P1|Overall Study|Withdrawal by Subject|1
402239|NCT00713830|1347933|P2|Overall Study|Sponsor Decision|10
402240|NCT00713830|1347934|P1|Overall Study|Sponsor Decision|4
402241|NCT00713830|1347933|P2|Overall Study|Familial and Personal Reasons|34
402242|NCT00713830|1347934|P1|Overall Study|Familial and Personal Reasons|9
402243|NCT00713830|1347933|P2|Overall Study|Poor Compliance to Protocol|14
402244|NCT00713830|1347934|P1|Overall Study|Poor Compliance to Protocol|7
402245|NCT00713830|1347933|P2|Overall Study|Withdrawal by Subject|23
402246|NCT00713830|1347934|P1|Overall Study|Withdrawal by Subject|13
402247|NCT00713830|1347933|P2|Overall Study|Lost to Follow-up|9
402248|NCT00713830|1347934|P1|Overall Study|Lost to Follow-up|2
402249|NCT00713830|1347933|P2|Overall Study|Lack of Efficacy|16
402250|NCT00713830|1347934|P1|Overall Study|Lack of Efficacy|24
402251|NCT00713830|1347933|P2|Overall Study|Adverse Event|71
402252|NCT00713830|1347934|P1|Overall Study|Adverse Event|23
402253|NCT00713700|1347991|P1|Overall Study|Withdrawal by Subject|1
402254|NCT00713700|1347991|P1|Overall Study|Lost to Follow-up|3
402255|NCT00713648|1348017|P1|Overall Study|Development of antibodies|3
402256|NCT00713648|1348017|P1|Overall Study|According to Protocol|2
402257|NCT00713648|1348017|P1|Overall Study|Unclassified|2
402258|NCT00713648|1348017|P1|Overall Study|Adverse Event|1
402259|NCT00713609|1348030|P6|Overall Study|Protocol Violation|0
402260|NCT00713609|1348031|P5|Overall Study|Protocol Violation|2
402261|NCT00713609|1348032|P4|Overall Study|Protocol Violation|1
402262|NCT00713609|1348033|P3|Overall Study|Protocol Violation|1
402263|NCT00713609|1348034|P2|Overall Study|Protocol Violation|3
402264|NCT00713609|1348035|P1|Overall Study|Protocol Violation|6
402265|NCT00713609|1348030|P6|Overall Study|Withdrawal by Subject|7
402266|NCT00713609|1348031|P5|Overall Study|Withdrawal by Subject|5
402267|NCT00713609|1348032|P4|Overall Study|Withdrawal by Subject|1
402268|NCT00713609|1348033|P3|Overall Study|Withdrawal by Subject|5
402269|NCT00713609|1348034|P2|Overall Study|Withdrawal by Subject|1
402270|NCT00713609|1348035|P1|Overall Study|Withdrawal by Subject|6
402271|NCT00713609|1348030|P6|Overall Study|Non-Compliance with Study Treatment|0
402272|NCT00713609|1348031|P5|Overall Study|Non-Compliance with Study Treatment|1
402273|NCT00713609|1348032|P4|Overall Study|Non-Compliance with Study Treatment|0
402274|NCT00713609|1348033|P3|Overall Study|Non-Compliance with Study Treatment|2
402275|NCT00713609|1348034|P2|Overall Study|Non-Compliance with Study Treatment|1
402276|NCT00713609|1348035|P1|Overall Study|Non-Compliance with Study Treatment|1
402277|NCT00713609|1348030|P6|Overall Study|Lack of Efficacy|0
402278|NCT00713609|1348031|P5|Overall Study|Lack of Efficacy|1
402279|NCT00713609|1348032|P4|Overall Study|Lack of Efficacy|0
402280|NCT00713609|1348033|P3|Overall Study|Lack of Efficacy|0
402281|NCT00713609|1348034|P2|Overall Study|Lack of Efficacy|3
402282|NCT00713609|1348035|P1|Overall Study|Lack of Efficacy|1
402283|NCT00713609|1348030|P6|Overall Study|Lost to Follow-up|0
402284|NCT00713609|1348031|P5|Overall Study|Lost to Follow-up|7
402285|NCT00713609|1348032|P4|Overall Study|Lost to Follow-up|5
402286|NCT00713609|1348033|P3|Overall Study|Lost to Follow-up|5
402287|NCT00713609|1348034|P2|Overall Study|Lost to Follow-up|7
402288|NCT00713609|1348035|P1|Overall Study|Lost to Follow-up|5
402289|NCT00713609|1348030|P6|Overall Study|Adverse Event|1
402290|NCT00713609|1348031|P5|Overall Study|Adverse Event|3
402291|NCT00713609|1348032|P4|Overall Study|Adverse Event|2
402292|NCT00713609|1348033|P3|Overall Study|Adverse Event|2
402293|NCT00713609|1348034|P2|Overall Study|Adverse Event|0
402294|NCT00713609|1348035|P1|Overall Study|Adverse Event|2
402295|NCT00713596|1348070|P3|Overall Study|Study was terminated|2
402296|NCT00713596|1348071|P2|Overall Study|Study was terminated|3
402297|NCT00713596|1348072|P1|Overall Study|Study was terminated|2
402298|NCT00713544|1348098|P6|Overall Study|Hepatotoxicity - not an AE|0
402299|NCT00713544|1348099|P5|Overall Study|Hepatotoxicity - not an AE|1
402300|NCT00713544|1348100|P4|Overall Study|Hepatotoxicity - not an AE|0
402301|NCT00713544|1348101|P3|Overall Study|Hepatotoxicity - not an AE|0
402302|NCT00713544|1348102|P2|Overall Study|Hepatotoxicity - not an AE|0
402303|NCT00713544|1348103|P1|Overall Study|Hepatotoxicity - not an AE|0
402304|NCT00713544|1348098|P6|Overall Study|Incorrect enrollment|0
402305|NCT00713544|1348099|P5|Overall Study|Incorrect enrollment|0
402306|NCT00713544|1348100|P4|Overall Study|Incorrect enrollment|0
402307|NCT00713544|1348101|P3|Overall Study|Incorrect enrollment|0
402308|NCT00713544|1348102|P2|Overall Study|Incorrect enrollment|1
402309|NCT00713544|1348103|P1|Overall Study|Incorrect enrollment|0
402310|NCT00713544|1348098|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
402311|NCT00713544|1348099|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
402312|NCT00713544|1348100|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
402313|NCT00713544|1348101|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
402314|NCT00713544|1348102|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
402315|NCT00713544|1348103|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
402316|NCT00713544|1348098|P6|Overall Study|Lost to Follow-up|0
402317|NCT00713544|1348099|P5|Overall Study|Lost to Follow-up|0
402318|NCT00713544|1348100|P4|Overall Study|Lost to Follow-up|0
402319|NCT00713544|1348101|P3|Overall Study|Lost to Follow-up|1
402320|NCT00713544|1348102|P2|Overall Study|Lost to Follow-up|0
402321|NCT00713544|1348103|P1|Overall Study|Lost to Follow-up|0
402322|NCT00713544|1348098|P6|Overall Study|Lack of Efficacy|0
402323|NCT00713544|1348099|P5|Overall Study|Lack of Efficacy|1
402324|NCT00713544|1348100|P4|Overall Study|Lack of Efficacy|1
402325|NCT00713544|1348101|P3|Overall Study|Lack of Efficacy|0
402326|NCT00713544|1348102|P2|Overall Study|Lack of Efficacy|1
402327|NCT00713544|1348103|P1|Overall Study|Lack of Efficacy|0
402328|NCT00713544|1348098|P6|Overall Study|Physician Decision|2
402329|NCT00713544|1348099|P5|Overall Study|Physician Decision|0
402330|NCT00713544|1348100|P4|Overall Study|Physician Decision|0
402331|NCT00713544|1348101|P3|Overall Study|Physician Decision|0
402332|NCT00713544|1348102|P2|Overall Study|Physician Decision|0
402333|NCT00713544|1348103|P1|Overall Study|Physician Decision|0
402334|NCT00713544|1348098|P6|Overall Study|Protocol Violation|1
402335|NCT00713544|1348099|P5|Overall Study|Protocol Violation|0
402336|NCT00713544|1348100|P4|Overall Study|Protocol Violation|0
402337|NCT00713544|1348101|P3|Overall Study|Protocol Violation|0
402338|NCT00713544|1348102|P2|Overall Study|Protocol Violation|0
402339|NCT00713544|1348103|P1|Overall Study|Protocol Violation|0
402340|NCT00713544|1348098|P6|Overall Study|Withdrawal by Subject|1
402341|NCT00713544|1348099|P5|Overall Study|Withdrawal by Subject|3
402342|NCT00713544|1348100|P4|Overall Study|Withdrawal by Subject|2
402343|NCT00713544|1348101|P3|Overall Study|Withdrawal by Subject|3
402344|NCT00713544|1348102|P2|Overall Study|Withdrawal by Subject|0
402345|NCT00713544|1348103|P1|Overall Study|Withdrawal by Subject|2
402346|NCT00713544|1348098|P6|Overall Study|Adverse Event|5
402347|NCT00713544|1348099|P5|Overall Study|Adverse Event|3
402348|NCT00713544|1348100|P4|Overall Study|Adverse Event|7
402349|NCT00713544|1348101|P3|Overall Study|Adverse Event|7
402350|NCT00713544|1348102|P2|Overall Study|Adverse Event|3
402351|NCT00713544|1348103|P1|Overall Study|Adverse Event|5
402352|NCT00713349|1348154|P1|Overall Study|Protocol Violation|1
402353|NCT00713323|1348160|P1|Overall Study|Treatment that may interact with Sativex|1
402354|NCT00713323|1348160|P1|Overall Study|Subject travelling to Dominica Republic|1
402355|NCT00713323|1348160|P1|Overall Study|Subject travelling to USA|1
402356|NCT00713323|1348160|P1|Overall Study|Pain resolved|1
402357|NCT00713323|1348160|P1|Overall Study|Non-compliance|1
402358|NCT00713323|1348160|P1|Overall Study|Pain free|1
402359|NCT00713323|1348160|P1|Overall Study|Surgery cured allodynic pain|1
402360|NCT00713323|1348160|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
402361|NCT00713323|1348160|P1|Overall Study|Low creatine clearance at screening|1
402362|NCT00713323|1348160|P1|Overall Study|Lack of Efficacy|36
402363|NCT00713323|1348160|P1|Overall Study|Lost to Follow-up|11
402364|NCT00713323|1348160|P1|Overall Study|Withdrawal by Subject|15
402365|NCT00713323|1348160|P1|Overall Study|Adverse Event|75
402366|NCT00713310|1348173|P2|Overall Study|Withdrawal by Subject|2
402367|NCT00713310|1348174|P1|Overall Study|Withdrawal by Subject|0
402368|NCT00713310|1348173|P2|Overall Study|Lack of Efficacy|2
402369|NCT00713310|1348174|P1|Overall Study|Lack of Efficacy|0
402370|NCT00713310|1348173|P2|Overall Study|Adverse Event|2
402371|NCT00713310|1348174|P1|Overall Study|Adverse Event|5
402372|NCT00713258|1348184|P2|Overall Study|Other|1
402373|NCT00713258|1348185|P1|Overall Study|Other|1
402374|NCT00713258|1348184|P2|Overall Study|Non-Compliance|1
402375|NCT00713258|1348185|P1|Overall Study|Non-Compliance|2
402376|NCT00713258|1348184|P2|Overall Study|Adverse Event|4
402377|NCT00713258|1348185|P1|Overall Study|Adverse Event|2
402378|NCT00713219|1348193|P1|Overall Study|Protocol Violation|1
402379|NCT00713219|1348193|P1|Overall Study|Death|1
402380|NCT00713206|1348199|P2|Overall Study|Adverse Event|1
402381|NCT00713206|1348200|P1|Overall Study|Adverse Event|2
402382|NCT00713206|1348199|P2|Overall Study|Lost to Follow-up|2
402383|NCT00713206|1348200|P1|Overall Study|Lost to Follow-up|5
402384|NCT00712985|1348206|P1|Overall Study|Lack of Efficacy|3
402385|NCT00712985|1348206|P1|Overall Study|1 patient moved out of state|1
402386|NCT00712985|1348206|P1|Overall Study|1 withdrew prior to start of drug|1
402387|NCT00712959|1348212|P2|Overall Study|Withdrawal by Subject|0
402388|NCT00712959|1348213|P1|Overall Study|Withdrawal by Subject|3
402389|NCT00712959|1348212|P2|Overall Study|Lost to Follow-up|2
402390|NCT00712959|1348213|P1|Overall Study|Lost to Follow-up|13
402391|NCT00712959|1348212|P2|Overall Study|Protocol Violation|1
402392|NCT00712959|1348213|P1|Overall Study|Protocol Violation|3
402393|NCT00712933|1348231|P1|Overall Study|Withdrawal by Subject|151
402394|NCT00712933|1348231|P1|Overall Study|Protocol Violation|4
402395|NCT00712933|1348231|P1|Overall Study|Physician Decision|36
402396|NCT00712933|1348231|P1|Overall Study|Participant received medication|1
402397|NCT00712933|1348231|P1|Overall Study|Not committed to contraception|1
402398|NCT00712933|1348231|P1|Overall Study|Other Physician decision|1
402399|NCT00712933|1348231|P1|Overall Study|Death of patient|1
402400|NCT00712933|1348231|P1|Overall Study|Participant travelled overseas|2
402401|NCT00712933|1348231|P1|Overall Study|Participant hospitalized|1
402402|NCT00712933|1348231|P1|Overall Study|Involved in Clinical research|3
402403|NCT00712933|1348231|P1|Overall Study|Hip replacement surgery|1
402404|NCT00712933|1348231|P1|Overall Study|Withdrew consent|4
402405|NCT00712933|1348231|P1|Overall Study|Sponsor decision|14
402406|NCT00712933|1348231|P1|Overall Study|Other Pregnancy|37
402407|NCT00712933|1348231|P1|Overall Study|Non-compliance with study drug|13
402408|NCT00712933|1348231|P1|Overall Study|Lost to Follow-up|22
402409|NCT00712933|1348231|P1|Overall Study|Lack of Efficacy|6
402410|NCT00712933|1348231|P1|Overall Study|Adverse Event|69
402411|NCT00712920|1348261|P3|Overall Study|Non-compliance|0
402412|NCT00712920|1348262|P2|Overall Study|Non-compliance|0
402413|NCT00712920|1348263|P1|Overall Study|Non-compliance|3
402414|NCT00712920|1348261|P3|Overall Study|Other|3
402415|NCT00712920|1348262|P2|Overall Study|Other|7
402416|NCT00712920|1348263|P1|Overall Study|Other|5
402417|NCT00712920|1348261|P3|Overall Study|Lack of Efficacy|1
402418|NCT00712920|1348262|P2|Overall Study|Lack of Efficacy|0
402419|NCT00712920|1348263|P1|Overall Study|Lack of Efficacy|1
402420|NCT00712920|1348261|P3|Overall Study|Lost to Follow-up|0
402421|NCT00712920|1348262|P2|Overall Study|Lost to Follow-up|4
402422|NCT00712920|1348263|P1|Overall Study|Lost to Follow-up|1
402423|NCT00712920|1348261|P3|Overall Study|Withdrawal by Subject|1
402424|NCT00712920|1348262|P2|Overall Study|Withdrawal by Subject|2
402425|NCT00712920|1348263|P1|Overall Study|Withdrawal by Subject|4
402426|NCT00712920|1348261|P3|Overall Study|Adverse Event|7
402427|NCT00712920|1348262|P2|Overall Study|Adverse Event|4
402428|NCT00712920|1348263|P1|Overall Study|Adverse Event|3
402429|NCT00712725|1348291|P8|Overall Study|Protocol Specified Criteria|1
402430|NCT00712725|1348292|P7|Overall Study|Protocol Specified Criteria|2
402431|NCT00712725|1348293|P6|Overall Study|Protocol Specified Criteria|0
402432|NCT00712725|1348294|P5|Overall Study|Protocol Specified Criteria|1
402433|NCT00712725|1348295|P4|Overall Study|Protocol Specified Criteria|2
402434|NCT00712725|1348296|P3|Overall Study|Protocol Specified Criteria|1
402435|NCT00712725|1348297|P2|Overall Study|Protocol Specified Criteria|0
402436|NCT00712725|1348298|P1|Overall Study|Protocol Specified Criteria|3
402437|NCT00712725|1348291|P8|Overall Study|Lack of Qualifying Event|6
402438|NCT00712725|1348292|P7|Overall Study|Lack of Qualifying Event|11
402439|NCT00712725|1348293|P6|Overall Study|Lack of Qualifying Event|13
402440|NCT00712725|1348294|P5|Overall Study|Lack of Qualifying Event|11
402441|NCT00712725|1348295|P4|Overall Study|Lack of Qualifying Event|8
402442|NCT00712725|1348296|P3|Overall Study|Lack of Qualifying Event|6
402443|NCT00712725|1348297|P2|Overall Study|Lack of Qualifying Event|2
402444|NCT00712725|1348298|P1|Overall Study|Lack of Qualifying Event|16
402445|NCT00712725|1348291|P8|Overall Study|Withdrawal by Subject|2
402446|NCT00712725|1348292|P7|Overall Study|Withdrawal by Subject|1
402447|NCT00712725|1348293|P6|Overall Study|Withdrawal by Subject|1
402448|NCT00712725|1348294|P5|Overall Study|Withdrawal by Subject|1
402449|NCT00712725|1348295|P4|Overall Study|Withdrawal by Subject|2
402450|NCT00712725|1348296|P3|Overall Study|Withdrawal by Subject|1
402451|NCT00712725|1348297|P2|Overall Study|Withdrawal by Subject|1
402452|NCT00712725|1348298|P1|Overall Study|Withdrawal by Subject|2
402453|NCT00712725|1348291|P8|Overall Study|Protocol Violation|1
402454|NCT00712725|1348292|P7|Overall Study|Protocol Violation|1
402455|NCT00712725|1348293|P6|Overall Study|Protocol Violation|0
402456|NCT00712725|1348294|P5|Overall Study|Protocol Violation|2
402457|NCT00712725|1348295|P4|Overall Study|Protocol Violation|3
402458|NCT00712725|1348296|P3|Overall Study|Protocol Violation|1
402459|NCT00712725|1348297|P2|Overall Study|Protocol Violation|0
402460|NCT00712725|1348298|P1|Overall Study|Protocol Violation|2
402461|NCT00712725|1348291|P8|Overall Study|Pregnancy|0
402462|NCT00712725|1348292|P7|Overall Study|Pregnancy|2
402463|NCT00712725|1348293|P6|Overall Study|Pregnancy|0
402464|NCT00712725|1348294|P5|Overall Study|Pregnancy|1
402465|NCT00712725|1348295|P4|Overall Study|Pregnancy|0
402466|NCT00712725|1348296|P3|Overall Study|Pregnancy|0
402467|NCT00712725|1348297|P2|Overall Study|Pregnancy|1
402468|NCT00712725|1348298|P1|Overall Study|Pregnancy|0
402469|NCT00712725|1348291|P8|Overall Study|Physician Decision|0
402470|NCT00712725|1348292|P7|Overall Study|Physician Decision|2
402471|NCT00712725|1348293|P6|Overall Study|Physician Decision|0
402472|NCT00712725|1348294|P5|Overall Study|Physician Decision|1
402473|NCT00712725|1348295|P4|Overall Study|Physician Decision|0
402474|NCT00712725|1348296|P3|Overall Study|Physician Decision|0
402475|NCT00712725|1348297|P2|Overall Study|Physician Decision|0
402476|NCT00712725|1348298|P1|Overall Study|Physician Decision|2
402477|NCT00712725|1348291|P8|Overall Study|Lost to Follow-up|1
402478|NCT00712725|1348292|P7|Overall Study|Lost to Follow-up|3
402479|NCT00712725|1348293|P6|Overall Study|Lost to Follow-up|2
402480|NCT00712725|1348294|P5|Overall Study|Lost to Follow-up|2
402481|NCT00712725|1348295|P4|Overall Study|Lost to Follow-up|1
402482|NCT00712725|1348296|P3|Overall Study|Lost to Follow-up|1
402483|NCT00712725|1348297|P2|Overall Study|Lost to Follow-up|2
402484|NCT00712725|1348298|P1|Overall Study|Lost to Follow-up|3
402485|NCT00712725|1348291|P8|Overall Study|Adverse Event|0
402486|NCT00712725|1348292|P7|Overall Study|Adverse Event|0
402487|NCT00712725|1348293|P6|Overall Study|Adverse Event|0
402488|NCT00712725|1348294|P5|Overall Study|Adverse Event|0
402489|NCT00712725|1348295|P4|Overall Study|Adverse Event|1
402490|NCT00712725|1348296|P3|Overall Study|Adverse Event|0
402491|NCT00712725|1348297|P2|Overall Study|Adverse Event|0
402492|NCT00712725|1348298|P1|Overall Study|Adverse Event|1
402493|NCT00712673|1348359|P4|Overall Study|Protocol Violation|0
402494|NCT00712673|1348360|P3|Overall Study|Protocol Violation|2
402495|NCT00712673|1348361|P2|Overall Study|Protocol Violation|0
402496|NCT00712673|1348362|P1|Overall Study|Protocol Violation|0
402497|NCT00712673|1348359|P4|Overall Study|Investigator's Decision|0
402498|NCT00712673|1348360|P3|Overall Study|Investigator's Decision|0
402499|NCT00712673|1348361|P2|Overall Study|Investigator's Decision|0
402500|NCT00712673|1348362|P1|Overall Study|Investigator's Decision|1
402501|NCT00712673|1348359|P4|Overall Study|Familial and Personal Reasons|2
402502|NCT00712673|1348360|P3|Overall Study|Familial and Personal Reasons|5
402503|NCT00712673|1348361|P2|Overall Study|Familial and Personal Reasons|0
402504|NCT00712673|1348362|P1|Overall Study|Familial and Personal Reasons|5
402505|NCT00712673|1348359|P4|Overall Study|Withdrawal by Subject|20
402506|NCT00712673|1348360|P3|Overall Study|Withdrawal by Subject|15
402507|NCT00712673|1348361|P2|Overall Study|Withdrawal by Subject|7
402508|NCT00712673|1348362|P1|Overall Study|Withdrawal by Subject|6
402509|NCT00712673|1348359|P4|Overall Study|Lost to Follow-up|0
402510|NCT00712673|1348360|P3|Overall Study|Lost to Follow-up|2
402511|NCT00712673|1348361|P2|Overall Study|Lost to Follow-up|0
402512|NCT00712673|1348362|P1|Overall Study|Lost to Follow-up|1
402513|NCT00712673|1348359|P4|Overall Study|Poor Compliance to Protocol|16
402514|NCT00712673|1348360|P3|Overall Study|Poor Compliance to Protocol|4
402515|NCT00712673|1348361|P2|Overall Study|Poor Compliance to Protocol|3
402516|NCT00712673|1348362|P1|Overall Study|Poor Compliance to Protocol|3
402517|NCT00712673|1348359|P4|Overall Study|Lack of Efficacy|6
402518|NCT00712673|1348360|P3|Overall Study|Lack of Efficacy|8
402519|NCT00712673|1348361|P2|Overall Study|Lack of Efficacy|8
402520|NCT00712673|1348362|P1|Overall Study|Lack of Efficacy|2
402521|NCT00712673|1348359|P4|Overall Study|Adverse Event|26
402522|NCT00712673|1348360|P3|Overall Study|Adverse Event|21
402523|NCT00712673|1348361|P2|Overall Study|Adverse Event|3
402524|NCT00712673|1348362|P1|Overall Study|Adverse Event|3
402525|NCT00712543|1348426|P2|Day 8-14|Lost to Follow-up|2
402526|NCT00712543|1348427|P1|Day 8-14|Lost to Follow-up|0
402527|NCT00712348|1348461|P1|Overall Study|Withdrawal by Subject|1
402528|NCT00712335|1348473|P5|Overall Study|Other Reason|0
402529|NCT00712335|1348474|P4|Overall Study|Other Reason|0
402530|NCT00712335|1348475|P3|Overall Study|Other Reason|1
402531|NCT00712335|1348476|P2|Overall Study|Other Reason|3
402532|NCT00712335|1348477|P1|Overall Study|Other Reason|0
402533|NCT00712335|1348473|P5|Overall Study|Lack of Efficacy|0
402534|NCT00712335|1348474|P4|Overall Study|Lack of Efficacy|1
402535|NCT00712335|1348475|P3|Overall Study|Lack of Efficacy|1
402536|NCT00712335|1348476|P2|Overall Study|Lack of Efficacy|0
402537|NCT00712335|1348477|P1|Overall Study|Lack of Efficacy|0
402538|NCT00712335|1348473|P5|Overall Study|Protocol Violation|0
402539|NCT00712335|1348474|P4|Overall Study|Protocol Violation|0
402540|NCT00712335|1348475|P3|Overall Study|Protocol Violation|1
402541|NCT00712335|1348476|P2|Overall Study|Protocol Violation|2
402542|NCT00712335|1348477|P1|Overall Study|Protocol Violation|1
402543|NCT00712335|1348473|P5|Overall Study|Lost to Follow-up|0
402544|NCT00712335|1348474|P4|Overall Study|Lost to Follow-up|1
402545|NCT00712335|1348475|P3|Overall Study|Lost to Follow-up|0
402546|NCT00712335|1348476|P2|Overall Study|Lost to Follow-up|5
402547|NCT00712335|1348477|P1|Overall Study|Lost to Follow-up|2
402548|NCT00712335|1348473|P5|Overall Study|Withdrawal by Subject|0
402549|NCT00712335|1348474|P4|Overall Study|Withdrawal by Subject|3
402550|NCT00712335|1348475|P3|Overall Study|Withdrawal by Subject|2
402551|NCT00712335|1348476|P2|Overall Study|Withdrawal by Subject|7
402552|NCT00712335|1348477|P1|Overall Study|Withdrawal by Subject|0
402553|NCT00712166|1348574|P2|Overall Study|Noncompliance|1
402554|NCT00712166|1348575|P1|Overall Study|Noncompliance|0
402555|NCT00712010|1348618|P1|Washout (7 Days)|Withdrawal by Subject|1
402556|NCT00711971|1348657|P3|Overall Study|Lost to Follow-up|1
402557|NCT00711971|1348658|P2|Overall Study|Lost to Follow-up|4
402558|NCT00711971|1348659|P1|Overall Study|Lost to Follow-up|3
402559|NCT00711958|1348693|P2|Overall Study|Progression of disease|0
402560|NCT00711958|1348694|P1|Overall Study|Progression of disease|1
402561|NCT00711958|1348693|P2|Overall Study|Death|5
402562|NCT00711958|1348694|P1|Overall Study|Death|10
402563|NCT00711958|1348693|P2|Overall Study|Lost to Follow-up|2
402564|NCT00711958|1348694|P1|Overall Study|Lost to Follow-up|2
402565|NCT00711958|1348693|P2|Overall Study|Protocol Violation|0
402566|NCT00711958|1348694|P1|Overall Study|Protocol Violation|1
402567|NCT00711958|1348693|P2|Overall Study|Adverse Event|7
402568|NCT00711958|1348694|P1|Overall Study|Adverse Event|9
402569|NCT00711958|1348693|P2|Overall Study|Clinical deterioration|0
402570|NCT00711958|1348694|P1|Overall Study|Clinical deterioration|1
402571|NCT00711958|1348693|P2|Overall Study|Lack of Efficacy|1
402572|NCT00711958|1348694|P1|Overall Study|Lack of Efficacy|3
402573|NCT00711958|1348693|P2|Overall Study|Withdrawal by Subject|8
402574|NCT00711958|1348694|P1|Overall Study|Withdrawal by Subject|6
402575|NCT00711880|1348702|P2|Overall Study|Lack of Efficacy|5
402576|NCT00711880|1348703|P1|Overall Study|Lack of Efficacy|1
402577|NCT00711880|1348702|P2|Overall Study|Patient non-compliance|0
402578|NCT00711880|1348703|P1|Overall Study|Patient non-compliance|1
402579|NCT00711880|1348702|P2|Overall Study|Adverse Event|2
402580|NCT00711880|1348703|P1|Overall Study|Adverse Event|11
402581|NCT00711802|1348765|P8|Overall Study|Reason not reported|0
402582|NCT00711802|1348766|P7|Overall Study|Reason not reported|1
402583|NCT00711802|1348767|P6|Overall Study|Reason not reported|0
402584|NCT00711802|1348768|P5|Overall Study|Reason not reported|1
402585|NCT00711802|1348769|P4|Overall Study|Reason not reported|0
402586|NCT00711802|1348770|P3|Overall Study|Reason not reported|1
402587|NCT00711802|1348771|P2|Overall Study|Reason not reported|1
402588|NCT00711802|1348772|P1|Overall Study|Reason not reported|0
402589|NCT00711802|1348765|P8|Overall Study|Lost to Follow-up|2
402590|NCT00711802|1348766|P7|Overall Study|Lost to Follow-up|4
402591|NCT00711802|1348767|P6|Overall Study|Lost to Follow-up|6
402592|NCT00711802|1348768|P5|Overall Study|Lost to Follow-up|10
402593|NCT00711802|1348769|P4|Overall Study|Lost to Follow-up|1
402594|NCT00711802|1348770|P3|Overall Study|Lost to Follow-up|3
402595|NCT00711802|1348771|P2|Overall Study|Lost to Follow-up|0
402596|NCT00711802|1348772|P1|Overall Study|Lost to Follow-up|0
402597|NCT00711802|1348765|P8|Overall Study|Withdrawal by Subject|0
402598|NCT00711802|1348766|P7|Overall Study|Withdrawal by Subject|0
402599|NCT00711802|1348767|P6|Overall Study|Withdrawal by Subject|0
402600|NCT00711802|1348768|P5|Overall Study|Withdrawal by Subject|0
402601|NCT00711802|1348769|P4|Overall Study|Withdrawal by Subject|1
402602|NCT00711802|1348770|P3|Overall Study|Withdrawal by Subject|0
402603|NCT00711802|1348771|P2|Overall Study|Withdrawal by Subject|1
402604|NCT00711802|1348772|P1|Overall Study|Withdrawal by Subject|0
402605|NCT00711802|1348765|P8|Overall Study|Physician Decision|0
402606|NCT00711802|1348766|P7|Overall Study|Physician Decision|0
402607|NCT00711802|1348767|P6|Overall Study|Physician Decision|0
402608|NCT00711802|1348768|P5|Overall Study|Physician Decision|0
402609|NCT00711802|1348769|P4|Overall Study|Physician Decision|0
402610|NCT00711802|1348770|P3|Overall Study|Physician Decision|0
402611|NCT00711802|1348771|P2|Overall Study|Physician Decision|2
402612|NCT00711802|1348772|P1|Overall Study|Physician Decision|0
402613|NCT00711802|1348765|P8|Overall Study|Protocol Violation|0
402614|NCT00711802|1348766|P7|Overall Study|Protocol Violation|0
402615|NCT00711802|1348767|P6|Overall Study|Protocol Violation|0
402616|NCT00711802|1348768|P5|Overall Study|Protocol Violation|0
402617|NCT00711802|1348769|P4|Overall Study|Protocol Violation|1
402618|NCT00711802|1348770|P3|Overall Study|Protocol Violation|0
402619|NCT00711802|1348771|P2|Overall Study|Protocol Violation|0
402620|NCT00711802|1348772|P1|Overall Study|Protocol Violation|0
402621|NCT00711802|1348765|P8|Overall Study|Microbiological failure|0
402622|NCT00711802|1348766|P7|Overall Study|Microbiological failure|0
402623|NCT00711802|1348767|P6|Overall Study|Microbiological failure|1
402624|NCT00711802|1348768|P5|Overall Study|Microbiological failure|0
402625|NCT00711802|1348769|P4|Overall Study|Microbiological failure|0
402626|NCT00711802|1348770|P3|Overall Study|Microbiological failure|0
402627|NCT00711802|1348771|P2|Overall Study|Microbiological failure|1
402628|NCT00711802|1348772|P1|Overall Study|Microbiological failure|0
402629|NCT00711802|1348765|P8|Overall Study|Adverse Event|0
402630|NCT00711802|1348766|P7|Overall Study|Adverse Event|0
402631|NCT00711802|1348767|P6|Overall Study|Adverse Event|1
402632|NCT00711802|1348768|P5|Overall Study|Adverse Event|1
402633|NCT00711802|1348769|P4|Overall Study|Adverse Event|0
402634|NCT00711802|1348770|P3|Overall Study|Adverse Event|0
402635|NCT00711802|1348771|P2|Overall Study|Adverse Event|0
402636|NCT00711802|1348772|P1|Overall Study|Adverse Event|0
402637|NCT00711802|1348765|P8|Overall Study|Not treated (no further detail)|0
402638|NCT00711802|1348766|P7|Overall Study|Not treated (no further detail)|0
402639|NCT00711802|1348767|P6|Overall Study|Not treated (no further detail)|0
402640|NCT00711802|1348768|P5|Overall Study|Not treated (no further detail)|2
402641|NCT00711802|1348769|P4|Overall Study|Not treated (no further detail)|0
402642|NCT00711802|1348770|P3|Overall Study|Not treated (no further detail)|2
402643|NCT00711802|1348771|P2|Overall Study|Not treated (no further detail)|1
402644|NCT00711802|1348772|P1|Overall Study|Not treated (no further detail)|2
402645|NCT00711646|1348804|P2|Overall Study|patient non-compliance|0
402646|NCT00711646|1348805|P1|Overall Study|patient non-compliance|1
402647|NCT00711646|1348804|P2|Overall Study|administrative decision|1
402648|NCT00711646|1348805|P1|Overall Study|administrative decision|0
402649|NCT00711646|1348804|P2|Overall Study|Lost to Follow-up|0
402650|NCT00711646|1348805|P1|Overall Study|Lost to Follow-up|1
402651|NCT00711646|1348804|P2|Overall Study|Protocol Violation|1
402652|NCT00711646|1348805|P1|Overall Study|Protocol Violation|0
402653|NCT00711646|1348804|P2|Overall Study|Withdrawal by Subject|0
402654|NCT00711646|1348805|P1|Overall Study|Withdrawal by Subject|4
402655|NCT00711646|1348804|P2|Overall Study|Adverse Event|1
402656|NCT00711646|1348805|P1|Overall Study|Adverse Event|6
402657|NCT00711594|1348827|P4|Overall Study|Withdrawal by Subject|2
402658|NCT00711594|1348828|P3|Overall Study|Withdrawal by Subject|0
402659|NCT00711594|1348829|P2|Overall Study|Withdrawal by Subject|1
402660|NCT00711594|1348830|P1|Overall Study|Withdrawal by Subject|0
402661|NCT00711594|1348827|P4|Overall Study|Other Adverse Event|16
402662|NCT00711594|1348828|P3|Overall Study|Other Adverse Event|0
402663|NCT00711594|1348829|P2|Overall Study|Other Adverse Event|0
402664|NCT00711594|1348830|P1|Overall Study|Other Adverse Event|1
402665|NCT00711594|1348827|P4|Overall Study|Progressive disease|44
402666|NCT00711594|1348828|P3|Overall Study|Progressive disease|6
402667|NCT00711594|1348829|P2|Overall Study|Progressive disease|2
402668|NCT00711594|1348830|P1|Overall Study|Progressive disease|2
402669|NCT00711555|1348867|P1|Overall Study|Adverse Event|3
402670|NCT00711529|1348876|P2|Overall Study|Withdrawal by Subject|6
402671|NCT00711529|1348877|P1|Overall Study|Withdrawal by Subject|2
402672|NCT00711529|1348876|P2|Overall Study|Protocol Violation|0
402673|NCT00711529|1348877|P1|Overall Study|Protocol Violation|2
402674|NCT00711516|1348901|P2|Overall Study|Protocol Violation|1
402675|NCT00711516|1348902|P1|Overall Study|Protocol Violation|0
402676|NCT00711516|1348901|P2|Overall Study|Withdrawal by Subject|1
402677|NCT00711516|1348902|P1|Overall Study|Withdrawal by Subject|0
402678|NCT00711516|1348901|P2|Overall Study|Adverse Event|1
402679|NCT00711516|1348902|P1|Overall Study|Adverse Event|1
402680|NCT00711477|1349009|P2|Overall Study|Noncompliance|1
402681|NCT00711477|1349010|P1|Overall Study|Noncompliance|0
402682|NCT00711477|1349009|P2|Overall Study|Lost to Follow-up|1
402683|NCT00711477|1349010|P1|Overall Study|Lost to Follow-up|0
402684|NCT00711477|1349009|P2|Overall Study|Adverse Event|1
402685|NCT00711477|1349010|P1|Overall Study|Adverse Event|3
402686|NCT00711425|1349056|P1|Overall Study|Lost to Follow-up|1
402687|NCT00711425|1349056|P1|Overall Study|Death|2
402688|NCT00711425|1349056|P1|Overall Study|Protocol Violation|1
402689|NCT00711191|1349084|P3|Overall Study|Withdrawal by Subject|3
402690|NCT00711191|1349085|P2|Overall Study|Withdrawal by Subject|1
402691|NCT00711191|1349086|P1|Overall Study|Withdrawal by Subject|0
402692|NCT00711191|1349084|P3|Overall Study|Objective progression or relapse|7
402693|NCT00711191|1349085|P2|Overall Study|Objective progression or relapse|3
402694|NCT00711191|1349086|P1|Overall Study|Objective progression or relapse|2
402695|NCT00711191|1349084|P3|Overall Study|Adverse Event|2
402696|NCT00711191|1349085|P2|Overall Study|Adverse Event|1
402697|NCT00711191|1349086|P1|Overall Study|Adverse Event|1
402698|NCT00711113|1349123|P1|Overall Study|Implant lost|2
402699|NCT00711113|1349123|P1|Overall Study|Lost to Follow-up|9
402700|NCT00711100|1349129|P1|Overall Study|Withdrawal by Subject|8
402701|NCT00711100|1349129|P1|Overall Study|Lack of Efficacy|5
402702|NCT00711087|1349147|P2|Overall Study|Lost to Follow-up|0
402703|NCT00711087|1349148|P1|Overall Study|Lost to Follow-up|1
402704|NCT00711009|1349160|P2|Overall Study|Dose adjustment|0
402705|NCT00711009|1349161|P1|Overall Study|Dose adjustment|1
402706|NCT00711009|1349160|P2|Overall Study|Site closing|1
402707|NCT00711009|1349161|P1|Overall Study|Site closing|0
402708|NCT00711009|1349160|P2|Overall Study|Pregnancy|0
402709|NCT00711009|1349161|P1|Overall Study|Pregnancy|1
402710|NCT00711009|1349160|P2|Overall Study|Virologic Failure|1
402711|NCT00711009|1349161|P1|Overall Study|Virologic Failure|2
402712|NCT00711009|1349160|P2|Overall Study|Participant Noncompliant|1
402713|NCT00711009|1349161|P1|Overall Study|Participant Noncompliant|0
402714|NCT00711009|1349160|P2|Overall Study|Lost to Follow-up|9
402715|NCT00711009|1349161|P1|Overall Study|Lost to Follow-up|3
402716|NCT00711009|1349160|P2|Overall Study|Withdrawal by Subject|2
402717|NCT00711009|1349161|P1|Overall Study|Withdrawal by Subject|4
402718|NCT00711009|1349160|P2|Overall Study|Adverse Event/HIV-Related Event|5
402719|NCT00711009|1349161|P1|Overall Study|Adverse Event/HIV-Related Event|4
402720|NCT00710970|1349342|P1|Overall Study|Never took drug|2
402721|NCT00710970|1349342|P1|Overall Study|Lost to Follow-up|8
402722|NCT00710879|1349369|P2|Overall Study|Protocol Violation|3
402723|NCT00710879|1349370|P1|Overall Study|Protocol Violation|0
402724|NCT00710879|1349369|P2|Overall Study|Lost to Follow-up|1
402725|NCT00710879|1349370|P1|Overall Study|Lost to Follow-up|2
402726|NCT00710866|1349382|P2|Overall Study|Failed to meet eligibility|1
402727|NCT00710866|1349383|P1|Overall Study|Failed to meet eligibility|1
402728|NCT00710866|1349382|P2|Overall Study|Lost to Follow-up|0
402729|NCT00710866|1349383|P1|Overall Study|Lost to Follow-up|1
402730|NCT00710866|1349382|P2|Overall Study|Withdrawal by Subject|1
402731|NCT00710866|1349383|P1|Overall Study|Withdrawal by Subject|2
402732|NCT00710866|1349382|P2|Overall Study|Protocol Violation|4
402733|NCT00710866|1349383|P1|Overall Study|Protocol Violation|5
402734|NCT00710762|1349429|P2|Overall Study|Reason other than listed above|2
402735|NCT00710762|1349430|P1|Overall Study|Reason other than listed above|2
402736|NCT00710762|1349429|P2|Overall Study|Lost to Follow-up|0
402737|NCT00710762|1349430|P1|Overall Study|Lost to Follow-up|1
402738|NCT00710762|1349429|P2|Overall Study|Other Adverse Event|7
402739|NCT00710762|1349430|P1|Overall Study|Other Adverse Event|7
402740|NCT00710762|1349429|P2|Overall Study|Adverse Event other disease worsening|1
402741|NCT00710762|1349430|P1|Overall Study|Adverse Event other disease worsening|2
402742|NCT00710762|1349429|P2|Overall Study|Progressive disease|30
402743|NCT00710762|1349430|P1|Overall Study|Progressive disease|27
402744|NCT00710749|1349446|P2|First Intervention|Withdrawal by Subject|0
402745|NCT00710749|1349447|P1|First Intervention|Withdrawal by Subject|1
402746|NCT00710684|1349458|P3|Overall Study|Did not continue after week 24|16
402747|NCT00710684|1349459|P2|Overall Study|Did not continue after week 24|21
402748|NCT00710684|1349460|P1|Overall Study|Did not continue after week 24|25
402749|NCT00710684|1349458|P3|Overall Study|Missing|0
402750|NCT00710684|1349459|P2|Overall Study|Missing|0
402751|NCT00710684|1349460|P1|Overall Study|Missing|1
402752|NCT00710684|1349458|P3|Overall Study|Withdrawal by Subject|11
402753|NCT00710684|1349459|P2|Overall Study|Withdrawal by Subject|18
402754|NCT00710684|1349460|P1|Overall Study|Withdrawal by Subject|24
402755|NCT00710684|1349458|P3|Overall Study|Physician Decision|4
402756|NCT00710684|1349459|P2|Overall Study|Physician Decision|2
402757|NCT00710684|1349460|P1|Overall Study|Physician Decision|0
402758|NCT00710684|1349458|P3|Overall Study|Lost to Follow-up|7
402759|NCT00710684|1349459|P2|Overall Study|Lost to Follow-up|6
402760|NCT00710684|1349460|P1|Overall Study|Lost to Follow-up|4
402761|NCT00710684|1349458|P3|Overall Study|Protocol Violation|5
402762|NCT00710684|1349459|P2|Overall Study|Protocol Violation|5
402763|NCT00710684|1349460|P1|Overall Study|Protocol Violation|5
402764|NCT00710684|1349458|P3|Overall Study|Lack of Efficacy|5
402765|NCT00710684|1349459|P2|Overall Study|Lack of Efficacy|3
402766|NCT00710684|1349460|P1|Overall Study|Lack of Efficacy|4
402767|NCT00710684|1349458|P3|Overall Study|Adverse Event|16
402768|NCT00710684|1349459|P2|Overall Study|Adverse Event|19
402769|NCT00710684|1349460|P1|Overall Study|Adverse Event|11
402770|NCT00710606|1349517|P2|Overall Study|Adverse Event|2
402771|NCT00710606|1349518|P1|Overall Study|Adverse Event|0
402772|NCT00710593|1349530|P2|Overall Study|Prem disc vaccine, completed all visits|2
402773|NCT00710593|1349531|P1|Overall Study|Prem disc vaccine, completed all visits|6
402774|NCT00710593|1349530|P2|Overall Study|Protocol Violation|1
402775|NCT00710593|1349531|P1|Overall Study|Protocol Violation|1
402776|NCT00710593|1349530|P2|Overall Study|Failure to adhere or complete study eval|1
402777|NCT00710593|1349531|P1|Overall Study|Failure to adhere or complete study eval|1
402778|NCT00710593|1349530|P2|Overall Study|Moved out of area|0
402779|NCT00710593|1349531|P1|Overall Study|Moved out of area|1
402780|NCT00710593|1349530|P2|Overall Study|Lost to Follow-up|1
402781|NCT00710593|1349531|P1|Overall Study|Lost to Follow-up|3
402782|NCT00710593|1349530|P2|Overall Study|Unable to complete Wk 48 within window|0
402783|NCT00710593|1349531|P1|Overall Study|Unable to complete Wk 48 within window|2
402784|NCT00710593|1349530|P2|Overall Study|Incarceration|0
402785|NCT00710593|1349531|P1|Overall Study|Incarceration|1
402786|NCT00710554|1349574|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
402787|NCT00710554|1349575|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
402788|NCT00710554|1349574|P2|Overall Study|Lack of Efficacy|12
402789|NCT00710554|1349575|P1|Overall Study|Lack of Efficacy|11
402790|NCT00710554|1349574|P2|Overall Study|Lost to Follow-up|1
402791|NCT00710554|1349575|P1|Overall Study|Lost to Follow-up|7
402792|NCT00710554|1349574|P2|Overall Study|Withdrawal by Subject|3
402793|NCT00710554|1349575|P1|Overall Study|Withdrawal by Subject|7
402794|NCT00710554|1349574|P2|Overall Study|Adverse Event|7
402795|NCT00710554|1349575|P1|Overall Study|Adverse Event|24
402796|NCT00710424|1349603|P2|Overall Study|Felt good so stopped treatment|1
402797|NCT00710424|1349604|P1|Overall Study|Felt good so stopped treatment|0
402798|NCT00710424|1349603|P2|Overall Study|Subject preferred paracetamol|1
402799|NCT00710424|1349604|P1|Overall Study|Subject preferred paracetamol|0
402800|NCT00710424|1349603|P2|Overall Study|Ceased treatment due to travel|0
402801|NCT00710424|1349604|P1|Overall Study|Ceased treatment due to travel|1
402802|NCT00710424|1349603|P2|Overall Study|Subject thought medication changed|0
402803|NCT00710424|1349604|P1|Overall Study|Subject thought medication changed|1
402804|NCT00710424|1349603|P2|Overall Study|Did not meet entry criteria at visit 1|0
402805|NCT00710424|1349604|P1|Overall Study|Did not meet entry criteria at visit 1|1
402806|NCT00710424|1349603|P2|Overall Study|Non-compliance with stable analgesia|0
402807|NCT00710424|1349604|P1|Overall Study|Non-compliance with stable analgesia|1
402808|NCT00710424|1349603|P2|Overall Study|Refused medication, no side effects|0
402809|NCT00710424|1349604|P1|Overall Study|Refused medication, no side effects|1
402810|NCT00710424|1349603|P2|Overall Study|Lost to Follow-up|1
402811|NCT00710424|1349604|P1|Overall Study|Lost to Follow-up|0
402812|NCT00710424|1349603|P2|Overall Study|Withdrawal by Subject|3
402813|NCT00710424|1349604|P1|Overall Study|Withdrawal by Subject|5
402814|NCT00710424|1349603|P2|Overall Study|Lack of Efficacy|5
402815|NCT00710424|1349604|P1|Overall Study|Lack of Efficacy|4
402816|NCT00710424|1349603|P2|Overall Study|Adverse Event|12
402817|NCT00710424|1349604|P1|Overall Study|Adverse Event|30
402818|NCT00710385|1349628|P1|Overall Study|Undisclosed excessive methadone use|1
402819|NCT00710385|1349628|P1|Overall Study|Physician Decision|1
402820|NCT00710385|1349628|P1|Overall Study|Undisclosed back pain|1
402821|NCT00710385|1349628|P1|Overall Study|Withdrawal by Subject|1
402822|NCT00710385|1349628|P1|Overall Study|Did not qualify|1
402823|NCT00710034|1349673|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
402824|NCT00710034|1349674|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
402825|NCT00710034|1349673|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
402826|NCT00710034|1349674|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
402827|NCT00710034|1349673|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
402828|NCT00710034|1349674|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
402829|NCT00710034|1349673|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
402830|NCT00710034|1349674|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
402831|NCT00710034|1349673|P2|Completed 12 Weeks of Treatment|Adverse Event|1
402832|NCT00710034|1349674|P1|Completed 12 Weeks of Treatment|Adverse Event|0
402833|NCT00710034|1349673|P2|Completed 6 Weeks of Treatment|Physician Decision|0
402834|NCT00710034|1349674|P1|Completed 6 Weeks of Treatment|Physician Decision|1
402835|NCT00710034|1349673|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
402836|NCT00710034|1349674|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
402837|NCT00710034|1349673|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
402838|NCT00710034|1349674|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
402839|NCT00710034|1349673|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
402840|NCT00710034|1349674|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
402841|NCT00710034|1349673|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
402842|NCT00710034|1349674|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
402843|NCT00710034|1349673|P2|Completed 6 Weeks of Treatment|Adverse Event|12
402844|NCT00710034|1349674|P1|Completed 6 Weeks of Treatment|Adverse Event|5
402845|NCT00710021|1349691|P3|Overall Study|Physician Decision|0
402846|NCT00710021|1349692|P2|Overall Study|Physician Decision|1
402847|NCT00710021|1349693|P1|Overall Study|Physician Decision|0
402848|NCT00710021|1349691|P3|Overall Study|Subject misrandomized|1
402849|NCT00710021|1349692|P2|Overall Study|Subject misrandomized|1
402850|NCT00710021|1349693|P1|Overall Study|Subject misrandomized|0
402851|NCT00710021|1349691|P3|Overall Study|Subject's Decision|0
402852|NCT00710021|1349692|P2|Overall Study|Subject's Decision|1
402853|NCT00710021|1349693|P1|Overall Study|Subject's Decision|0
402854|NCT00710021|1349691|P3|Overall Study|Lost to Follow-up|0
402855|NCT00710021|1349692|P2|Overall Study|Lost to Follow-up|0
402856|NCT00710021|1349693|P1|Overall Study|Lost to Follow-up|1
402857|NCT00709956|1349808|P2|Overall Study|Inclusion/exclusion criteria violation|3
402858|NCT00709956|1349809|P1|Overall Study|Inclusion/exclusion criteria violation|2
402859|NCT00709956|1349808|P2|Overall Study|Withdrawal by Subject|1
402860|NCT00709956|1349809|P1|Overall Study|Withdrawal by Subject|1
402861|NCT00709852|1349839|P2|Period 2|No 72-hour follow-up|0
402862|NCT00709852|1349840|P1|Period 2|No 72-hour follow-up|3
402863|NCT00709852|1349839|P2|Period 2|Lost to Follow-up|0
402864|NCT00709852|1349840|P1|Period 2|Lost to Follow-up|1
402865|NCT00709852|1349839|P2|Period 2|Adverse Event|1
402866|NCT00709852|1349840|P1|Period 2|Adverse Event|1
402867|NCT00709852|1349839|P2|Period 2|Protocol Violation|1
402868|NCT00709852|1349840|P1|Period 2|Protocol Violation|4
402869|NCT00709852|1349839|P2|Period 1|Lost to Follow-up|0
402870|NCT00709852|1349840|P1|Period 1|Lost to Follow-up|1
402871|NCT00709852|1349839|P2|Period 1|Defective scanner|1
402872|NCT00709852|1349840|P1|Period 1|Defective scanner|0
402873|NCT00709852|1349839|P2|Period 1|Protocol Violation|0
402874|NCT00709852|1349840|P1|Period 1|Protocol Violation|1
402875|NCT00709852|1349839|P2|Period 1|Withdrawal by Subject|2
402876|NCT00709852|1349840|P1|Period 1|Withdrawal by Subject|4
402877|NCT00709852|1349839|P2|Period 1|Adverse Event|0
402878|NCT00709852|1349840|P1|Period 1|Adverse Event|2
402879|NCT00709761|1350004|P1|Overall Study|Ongoing|40
402880|NCT00709761|1350004|P1|Overall Study|Withdrawal by Subject|7
402881|NCT00709735|1350015|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
402882|NCT00709735|1350016|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
402883|NCT00709735|1350015|P2|Overall Study|Relapse into Opioid Abuse|1
402884|NCT00709735|1350016|P1|Overall Study|Relapse into Opioid Abuse|0
402885|NCT00709735|1350015|P2|Overall Study|Lost to Follow-up|1
402886|NCT00709735|1350016|P1|Overall Study|Lost to Follow-up|1
402887|NCT00709722|1350024|P1|Overall Study|Adverse Event|1
402888|NCT00709618|1350039|P1|Overall Study|Study Closed/Terminated|25
402889|NCT00709618|1350039|P1|Overall Study|Lost to Follow-up|1
402890|NCT00709618|1350039|P1|Overall Study|Withdrawal by Subject|4
402891|NCT00709592|1350051|P2|Overall Study|Unable to proceed to transplant|1
402892|NCT00709592|1350052|P1|Overall Study|Unable to proceed to transplant|0
402893|NCT00709319|1350072|P1|Overall Study|Withdrawal by Subject|2
402894|NCT00709319|1350072|P1|Overall Study|Death|4
402895|NCT00709228|1350101|P1|Overall Study|Non-compliance|5
402896|NCT00709228|1350101|P1|Overall Study|Lost to Follow-up|6
402897|NCT00709228|1350101|P1|Overall Study|Disease progression|1
402898|NCT00709228|1350101|P1|Overall Study|Discontinued follow-up|5
402899|NCT00709228|1350101|P1|Overall Study|Did not enter follow-up|4
402900|NCT00709228|1350101|P1|Overall Study|Discontinued treatment|14
402901|NCT00709228|1350101|P1|Overall Study|Adverse events|2
402902|NCT00709228|1350101|P1|Overall Study|Eligibility criteria not met|281
402903|NCT00709228|1350101|P1|Overall Study|Not treated|14
402904|NCT00709124|1350107|P2|Overall Study|encephalopathy; can't do assessment|0
402905|NCT00709124|1350108|P1|Overall Study|encephalopathy; can't do assessment|1
402906|NCT00709124|1350107|P2|Overall Study|Death|1
402907|NCT00709124|1350108|P1|Overall Study|Death|3
402908|NCT00709111|1350142|P1|Overall Study|Unable to attend clinic visits|1
402909|NCT00709111|1350142|P1|Overall Study|Withdrawal by Subject|1
402910|NCT00709098|1350183|P3|Open-label Period|Lost to Follow-up|1
402911|NCT00709098|1350184|P2|Open-label Period|Lost to Follow-up|0
402912|NCT00709098|1350185|P1|Open-label Period|Lost to Follow-up|0
402913|NCT00709098|1350183|P3|Open-label Period|Death|1
402914|NCT00709098|1350184|P2|Open-label Period|Death|0
402915|NCT00709098|1350185|P1|Open-label Period|Death|0
402916|NCT00709098|1350183|P3|Open-label Period|Administrative reason|5
402917|NCT00709098|1350184|P2|Open-label Period|Administrative reason|0
402918|NCT00709098|1350185|P1|Open-label Period|Administrative reason|0
402919|NCT00709098|1350183|P3|Open-label Period|Withdrawal of consent|7
402920|NCT00709098|1350184|P2|Open-label Period|Withdrawal of consent|0
402921|NCT00709098|1350185|P1|Open-label Period|Withdrawal of consent|0
402922|NCT00709098|1350183|P3|Double-blind Period|Lost to Follow-up|0
402923|NCT00709098|1350184|P2|Double-blind Period|Lost to Follow-up|1
402924|NCT00709098|1350185|P1|Double-blind Period|Lost to Follow-up|1
402925|NCT00709098|1350183|P3|Double-blind Period|Death|0
402926|NCT00709098|1350184|P2|Double-blind Period|Death|1
402927|NCT00709098|1350185|P1|Double-blind Period|Death|1
402928|NCT00709098|1350183|P3|Double-blind Period|Administrative reason|0
402929|NCT00709098|1350184|P2|Double-blind Period|Administrative reason|3
402930|NCT00709098|1350185|P1|Double-blind Period|Administrative reason|1
402931|NCT00709098|1350183|P3|Double-blind Period|Withdrawal of consent|0
402932|NCT00709098|1350184|P2|Double-blind Period|Withdrawal of consent|3
402933|NCT00709098|1350185|P1|Double-blind Period|Withdrawal of consent|3
402934|NCT00709059|1350204|P1|Overall Study|Serious side effects|11
402935|NCT00709059|1350204|P1|Overall Study|Side effects|20
402936|NCT00709059|1350204|P1|Overall Study|Disease complication|3
402937|NCT00709059|1350204|P1|Overall Study|Physician Decision|7
402938|NCT00709059|1350204|P1|Overall Study|Withdrawal by Subject|19
402939|NCT00709059|1350204|P1|Overall Study|Lost to Follow-up|34
402940|NCT00708734|1350251|P1|Overall Study|leg fracture|1
402941|NCT00708734|1350251|P1|Overall Study|vertigo|1
402942|NCT00708734|1350251|P1|Overall Study|knee replacement|1
402943|NCT00708734|1350251|P1|Overall Study|leg injury|1
402944|NCT00708734|1350251|P1|Overall Study|moved|1
402945|NCT00708734|1350251|P1|Overall Study|scheduling conflict|2
402946|NCT00708708|1350271|P1|Overall Study|Missing values|392
402947|NCT00708708|1350271|P1|Overall Study|Adverse Event|3
402948|NCT00708708|1350271|P1|Overall Study|Pregnancy|3
402949|NCT00708708|1350271|P1|Overall Study|Lack of compliance|3
402950|NCT00708708|1350271|P1|Overall Study|Lack of effectiveness|4
402951|NCT00708708|1350271|P1|Overall Study|Administrative reasons|7
402952|NCT00708708|1350271|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
402953|NCT00708708|1350271|P1|Overall Study|Good effectiveness|9
402954|NCT00708708|1350271|P1|Overall Study|Other unspecified|11
402955|NCT00708708|1350271|P1|Overall Study|Another therapy along with Enbrel|15
402956|NCT00708708|1350271|P1|Overall Study|Intolerance|42
402957|NCT00708708|1350271|P1|Overall Study|Withdrawal by Subject|51
402958|NCT00708708|1350271|P1|Overall Study|Lost to Follow-up|52
402959|NCT00708708|1350271|P1|Overall Study|Another therapy instead of Enbrel|141
402960|NCT00708682|1350319|P1|Toddler Dose|Failed to Return|4
402961|NCT00708682|1350319|P1|Toddler Dose|Lost to Follow-up|3
402962|NCT00708682|1350319|P1|Toddler Dose|Parent/Legal Guardian Request|1
402963|NCT00708682|1350319|P1|After Infant Series|Parent/Legal Guardian Request|1
402964|NCT00708682|1350319|P1|Infant Series|Not Specified|19
402965|NCT00708682|1350319|P1|Infant Series|Failed to return|2
402966|NCT00708682|1350319|P1|Infant Series|Parent/legal guardian request|6
402967|NCT00708682|1350319|P1|Infant Series|Protocol Violation|1
402968|NCT00708682|1350319|P1|Infant Series|Lost to Follow-up|4
402969|NCT00708682|1350319|P1|Infant Series|Adverse Event|1
402970|NCT00708643|1350340|P2|Overall Study|Adverse Event|1
402971|NCT00708643|1350341|P1|Overall Study|Adverse Event|0
402972|NCT00708552|1350361|P4|Overall Study|Withdrawal by Subject|10
402973|NCT00708552|1350362|P3|Overall Study|Withdrawal by Subject|8
402974|NCT00708552|1350363|P2|Overall Study|Withdrawal by Subject|7
402975|NCT00708552|1350364|P1|Overall Study|Withdrawal by Subject|12
402976|NCT00708552|1350361|P4|Overall Study|Physician Decision|0
402977|NCT00708552|1350362|P3|Overall Study|Physician Decision|0
402978|NCT00708552|1350363|P2|Overall Study|Physician Decision|2
402979|NCT00708552|1350364|P1|Overall Study|Physician Decision|1
402980|NCT00708552|1350361|P4|Overall Study|Lost to Follow-up|1
402981|NCT00708552|1350362|P3|Overall Study|Lost to Follow-up|0
402982|NCT00708552|1350363|P2|Overall Study|Lost to Follow-up|2
402983|NCT00708552|1350364|P1|Overall Study|Lost to Follow-up|4
402984|NCT00708552|1350361|P4|Overall Study|Protocol Violation|4
402985|NCT00708552|1350362|P3|Overall Study|Protocol Violation|2
402986|NCT00708552|1350363|P2|Overall Study|Protocol Violation|0
402987|NCT00708552|1350364|P1|Overall Study|Protocol Violation|0
402988|NCT00708552|1350361|P4|Overall Study|Lack of Efficacy|0
402989|NCT00708552|1350362|P3|Overall Study|Lack of Efficacy|1
402990|NCT00708552|1350363|P2|Overall Study|Lack of Efficacy|4
402991|NCT00708552|1350364|P1|Overall Study|Lack of Efficacy|0
402992|NCT00708552|1350361|P4|Overall Study|Adverse Event|6
402993|NCT00708552|1350362|P3|Overall Study|Adverse Event|4
402994|NCT00708552|1350363|P2|Overall Study|Adverse Event|3
402995|NCT00708552|1350364|P1|Overall Study|Adverse Event|10
402996|NCT00708500|1350526|P3|FOLLOWUP|Non-compliance with protocol|1
402997|NCT00708500|1350527|P2|FOLLOWUP|Non-compliance with protocol|0
402998|NCT00708500|1350528|P1|FOLLOWUP|Non-compliance with protocol|5
402999|NCT00708500|1350526|P3|FOLLOWUP|Subject withdrew consent|5
403000|NCT00708500|1350527|P2|FOLLOWUP|Subject withdrew consent|4
403001|NCT00708500|1350528|P1|FOLLOWUP|Subject withdrew consent|31
403002|NCT00708500|1350526|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
403003|NCT00708500|1350527|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
403004|NCT00708500|1350528|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
403005|NCT00708500|1350526|P3|FOLLOWUP|Lost to Follow-up|4
403006|NCT00708500|1350527|P2|FOLLOWUP|Lost to Follow-up|6
403007|NCT00708500|1350528|P1|FOLLOWUP|Lost to Follow-up|1
403008|NCT00708500|1350526|P3|FOLLOWUP|Adverse Event|0
403009|NCT00708500|1350527|P2|FOLLOWUP|Adverse Event|1
403010|NCT00708500|1350528|P1|FOLLOWUP|Adverse Event|0
403011|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
403012|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
403013|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
403014|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
403015|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
403016|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
403017|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
403018|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
403019|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
403020|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
403021|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
403022|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
403023|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
403024|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
403025|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
403026|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
403027|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
403028|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
403029|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
403030|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
403031|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
403032|NCT00708500|1350526|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
403033|NCT00708500|1350527|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
403034|NCT00708500|1350528|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
403035|NCT00708500|1350526|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
403036|NCT00708500|1350527|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
403037|NCT00708500|1350528|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
403038|NCT00708500|1350526|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
403039|NCT00708500|1350527|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
403040|NCT00708500|1350528|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
403041|NCT00708500|1350526|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
403042|NCT00708500|1350527|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
403043|NCT00708500|1350528|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
403044|NCT00708500|1350526|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
403045|NCT00708500|1350527|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
403046|NCT00708500|1350528|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
403047|NCT00708500|1350526|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
403048|NCT00708500|1350527|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
403049|NCT00708500|1350528|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
403050|NCT00708461|1350547|P2|Overall Study|left workforce|180
403051|NCT00708461|1350548|P1|Overall Study|left workforce|115
403052|NCT00708461|1350547|P2|Overall Study|Withdrawal by Subject|9
403053|NCT00708461|1350548|P1|Overall Study|Withdrawal by Subject|8
403054|NCT00708461|1350547|P2|Overall Study|Lost to Follow-up|11
403055|NCT00708461|1350548|P1|Overall Study|Lost to Follow-up|18
403056|NCT00708435|1350556|P2|Overall Study|Refused hospitalization|0
403057|NCT00708435|1350557|P1|Overall Study|Refused hospitalization|1
403058|NCT00708435|1350556|P2|Overall Study|Intervention by primary care physician|0
403059|NCT00708435|1350557|P1|Overall Study|Intervention by primary care physician|1
403060|NCT00708435|1350556|P2|Overall Study|Protocol Violation|1
403061|NCT00708435|1350557|P1|Overall Study|Protocol Violation|0
403062|NCT00708435|1350556|P2|Overall Study|Adverse Event|0
403063|NCT00708435|1350557|P1|Overall Study|Adverse Event|1
403064|NCT00708435|1350556|P2|Overall Study|Withdrawal by Subject|7
403065|NCT00708435|1350557|P1|Overall Study|Withdrawal by Subject|3
403066|NCT00708435|1350556|P2|Overall Study|Lost to Follow-up|4
403067|NCT00708435|1350557|P1|Overall Study|Lost to Follow-up|9
403068|NCT00708435|1350556|P2|Overall Study|Death / Serious Adverse Event|5
403069|NCT00708435|1350557|P1|Overall Study|Death / Serious Adverse Event|10
403070|NCT00708422|1350584|P2|Overall Study|Withdrawal by Subject|0
403071|NCT00708422|1350585|P1|Overall Study|Withdrawal by Subject|1
403072|NCT00708422|1350584|P2|Overall Study|Adverse Event|1
403073|NCT00708422|1350585|P1|Overall Study|Adverse Event|3
403074|NCT00708305|1350593|P4|Period 3|Other Reason|0
403075|NCT00708305|1350594|P3|Period 3|Other Reason|0
403076|NCT00708305|1350595|P2|Period 3|Other Reason|0
403077|NCT00708305|1350596|P1|Period 3|Other Reason|1
403078|NCT00708305|1350593|P4|Period 3|Protocol Violation|0
403079|NCT00708305|1350594|P3|Period 3|Protocol Violation|0
403080|NCT00708305|1350595|P2|Period 3|Protocol Violation|2
403081|NCT00708305|1350596|P1|Period 3|Protocol Violation|0
403082|NCT00708305|1350593|P4|Period 2|Other Reason|1
403083|NCT00708305|1350594|P3|Period 2|Other Reason|0
403084|NCT00708305|1350595|P2|Period 2|Other Reason|0
403085|NCT00708305|1350596|P1|Period 2|Other Reason|1
403086|NCT00708305|1350593|P4|Period 2|Protocol Violation|0
403087|NCT00708305|1350594|P3|Period 2|Protocol Violation|0
403088|NCT00708305|1350595|P2|Period 2|Protocol Violation|1
403089|NCT00708305|1350596|P1|Period 2|Protocol Violation|0
403090|NCT00708305|1350593|P4|Period 2|Lost to Follow-up|0
403091|NCT00708305|1350594|P3|Period 2|Lost to Follow-up|0
403092|NCT00708305|1350595|P2|Period 2|Lost to Follow-up|1
403093|NCT00708305|1350596|P1|Period 2|Lost to Follow-up|0
403094|NCT00708305|1350593|P4|Period 1|Other Reason|2
403095|NCT00708305|1350594|P3|Period 1|Other Reason|0
403096|NCT00708305|1350595|P2|Period 1|Other Reason|0
403097|NCT00708305|1350596|P1|Period 1|Other Reason|0
403098|NCT00708305|1350593|P4|Period 1|Protocol Violation|0
403099|NCT00708305|1350594|P3|Period 1|Protocol Violation|1
403100|NCT00708305|1350595|P2|Period 1|Protocol Violation|0
403101|NCT00708305|1350596|P1|Period 1|Protocol Violation|1
403102|NCT00708227|1350632|P4|Overall Study|Withdrawal by Subject|1
403103|NCT00708227|1350633|P3|Overall Study|Withdrawal by Subject|0
403104|NCT00708227|1350634|P2|Overall Study|Withdrawal by Subject|2
403105|NCT00708227|1350635|P1|Overall Study|Withdrawal by Subject|1
403106|NCT00708227|1350632|P4|Overall Study|Physician Decision|2
403107|NCT00708227|1350633|P3|Overall Study|Physician Decision|1
403108|NCT00708227|1350634|P2|Overall Study|Physician Decision|3
403109|NCT00708227|1350635|P1|Overall Study|Physician Decision|0
403110|NCT00708214|1350668|P3|Overall Study|Progressive Disease|5
403111|NCT00708214|1350669|P2|Overall Study|Progressive Disease|6
403112|NCT00708214|1350670|P1|Overall Study|Progressive Disease|4
403113|NCT00708214|1350668|P3|Overall Study|Other|1
403114|NCT00708214|1350669|P2|Overall Study|Other|1
403115|NCT00708214|1350670|P1|Overall Study|Other|0
403116|NCT00708214|1350668|P3|Overall Study|Other Adverse Event|2
403117|NCT00708214|1350669|P2|Overall Study|Other Adverse Event|6
403118|NCT00708214|1350670|P1|Overall Study|Other Adverse Event|3
403119|NCT00708201|1350713|P2|Overall Study|Protocol Violation|1
403120|NCT00708201|1350714|P1|Overall Study|Protocol Violation|0
403121|NCT00708201|1350713|P2|Overall Study|Lost to Follow-up|0
403122|NCT00708201|1350714|P1|Overall Study|Lost to Follow-up|2
403123|NCT00708201|1350713|P2|Overall Study|Withdrawal by Subject|1
403124|NCT00708201|1350714|P1|Overall Study|Withdrawal by Subject|1
403125|NCT00708201|1350713|P2|Overall Study|Adverse Event|4
403126|NCT00708201|1350714|P1|Overall Study|Adverse Event|4
403127|NCT00708175|1350738|P2|Overall Study|BMD loss >7%|3
403128|NCT00708175|1350739|P1|Overall Study|BMD loss >7%|2
403129|NCT00708175|1350738|P2|Overall Study|Withdrawal by Subject|7
403130|NCT00708175|1350739|P1|Overall Study|Withdrawal by Subject|5
403131|NCT00708175|1350738|P2|Overall Study|Lost to Follow-up|3
403132|NCT00708175|1350739|P1|Overall Study|Lost to Follow-up|5
403133|NCT00708175|1350738|P2|Overall Study|Protocol Violation|3
403134|NCT00708175|1350739|P1|Overall Study|Protocol Violation|2
403135|NCT00708175|1350738|P2|Overall Study|Adverse Event|5
403136|NCT00708175|1350739|P1|Overall Study|Adverse Event|4
403137|NCT00708162|1350755|P2|Open-Label Phase|Other|0
403138|NCT00708162|1350756|P1|Open-Label Phase|Other|1
403139|NCT00708162|1350755|P2|Open-Label Phase|Adverse Event|2
403140|NCT00708162|1350756|P1|Open-Label Phase|Adverse Event|1
403141|NCT00708162|1350755|P2|Open-Label Phase|Death|1
403142|NCT00708162|1350756|P1|Open-Label Phase|Death|3
403143|NCT00708162|1350755|P2|Open-Label Phase|Investigator's Discretion|2
403144|NCT00708162|1350756|P1|Open-Label Phase|Investigator's Discretion|3
403145|NCT00708162|1350755|P2|Open-Label Phase|Lack of Efficacy|4
403146|NCT00708162|1350756|P1|Open-Label Phase|Lack of Efficacy|7
403147|NCT00708162|1350755|P2|Open-Label Phase|Participant Noncompliance|7
403148|NCT00708162|1350756|P1|Open-Label Phase|Participant Noncompliance|7
403149|NCT00708162|1350755|P2|Open-Label Phase|Withdrew Consent|6
403150|NCT00708162|1350756|P1|Open-Label Phase|Withdrew Consent|12
403151|NCT00708162|1350755|P2|Open-Label Phase|Lost to Follow-up|8
403152|NCT00708162|1350756|P1|Open-Label Phase|Lost to Follow-up|10
403153|NCT00708162|1350755|P2|Randomized Phase|Pregnancy|0
403154|NCT00708162|1350756|P1|Randomized Phase|Pregnancy|3
403155|NCT00708162|1350755|P2|Randomized Phase|Death|9
403156|NCT00708162|1350756|P1|Randomized Phase|Death|2
403157|NCT00708162|1350755|P2|Randomized Phase|Investigator’s Discretion|10
403158|NCT00708162|1350756|P1|Randomized Phase|Investigator’s Discretion|7
403159|NCT00708162|1350755|P2|Randomized Phase|Adverse Event|12
403160|NCT00708162|1350756|P1|Randomized Phase|Adverse Event|8
403161|NCT00708162|1350755|P2|Randomized Phase|Protocol Violation|11
403162|NCT00708162|1350756|P1|Randomized Phase|Protocol Violation|10
403163|NCT00708162|1350755|P2|Randomized Phase|Lack of Efficacy|19
403164|NCT00708162|1350756|P1|Randomized Phase|Lack of Efficacy|14
403165|NCT00708162|1350755|P2|Randomized Phase|Withdrew Consent|22
403166|NCT00708162|1350756|P1|Randomized Phase|Withdrew Consent|31
403167|NCT00708162|1350755|P2|Randomized Phase|Lost to Follow-up|34
403168|NCT00708162|1350756|P1|Randomized Phase|Lost to Follow-up|34
403169|NCT00708162|1350755|P2|Randomized Phase|Participant Noncompliance|32
403170|NCT00708162|1350756|P1|Randomized Phase|Participant Noncompliance|40
403171|NCT00708162|1350755|P2|Randomized Phase|Randomized but Not Treated|5
403172|NCT00708162|1350756|P1|Randomized Phase|Randomized but Not Treated|7
403173|NCT00708123|1350797|P5|Period 4|Protocol Violation|0
403174|NCT00708123|1350798|P4|Period 4|Protocol Violation|0
403175|NCT00708123|1350799|P3|Period 4|Protocol Violation|0
403176|NCT00708123|1350800|P2|Period 4|Protocol Violation|1
403177|NCT00708123|1350801|P1|Period 4|Protocol Violation|0
403178|NCT00708123|1350797|P5|Period 3|Lost to Follow-up|0
403179|NCT00708123|1350798|P4|Period 3|Lost to Follow-up|1
403180|NCT00708123|1350799|P3|Period 3|Lost to Follow-up|1
403181|NCT00708123|1350800|P2|Period 3|Lost to Follow-up|0
403182|NCT00708123|1350801|P1|Period 3|Lost to Follow-up|0
403183|NCT00708123|1350797|P5|Period 2|Other Reason|0
403184|NCT00708123|1350798|P4|Period 2|Other Reason|0
403185|NCT00708123|1350799|P3|Period 2|Other Reason|0
403186|NCT00708123|1350800|P2|Period 2|Other Reason|0
403187|NCT00708123|1350801|P1|Period 2|Other Reason|1
403188|NCT00708123|1350797|P5|Period 2|Protocol Violation|0
403189|NCT00708123|1350798|P4|Period 2|Protocol Violation|1
403190|NCT00708123|1350799|P3|Period 2|Protocol Violation|0
403191|NCT00708123|1350800|P2|Period 2|Protocol Violation|0
403192|NCT00708123|1350801|P1|Period 2|Protocol Violation|0
403193|NCT00708123|1350797|P5|Period 1|Adverse Event|0
403194|NCT00708123|1350798|P4|Period 1|Adverse Event|0
403195|NCT00708123|1350799|P3|Period 1|Adverse Event|1
403196|NCT00708123|1350800|P2|Period 1|Adverse Event|0
403197|NCT00708123|1350801|P1|Period 1|Adverse Event|0
403198|NCT00708123|1350797|P5|Period 1|Protocol Violation|0
403199|NCT00708123|1350798|P4|Period 1|Protocol Violation|1
403200|NCT00708123|1350799|P3|Period 1|Protocol Violation|0
403201|NCT00708123|1350800|P2|Period 1|Protocol Violation|1
403202|NCT00708123|1350801|P1|Period 1|Protocol Violation|0
403203|NCT00708097|1350934|P5|Period 2|Protocol Violation|0
403204|NCT00708097|1350935|P4|Period 2|Protocol Violation|1
403205|NCT00708097|1350936|P3|Period 2|Protocol Violation|1
403206|NCT00708097|1350937|P2|Period 2|Protocol Violation|1
403207|NCT00708097|1350938|P1|Period 2|Protocol Violation|0
403208|NCT00708097|1350934|P5|Period 1|Other Reason|1
403209|NCT00708097|1350935|P4|Period 1|Other Reason|0
403210|NCT00708097|1350936|P3|Period 1|Other Reason|0
403211|NCT00708097|1350937|P2|Period 1|Other Reason|0
403212|NCT00708097|1350938|P1|Period 1|Other Reason|0
403213|NCT00708097|1350934|P5|Period 1|Protocol Violation|0
403214|NCT00708097|1350935|P4|Period 1|Protocol Violation|2
403215|NCT00708097|1350936|P3|Period 1|Protocol Violation|0
403216|NCT00708097|1350937|P2|Period 1|Protocol Violation|1
403217|NCT00708097|1350938|P1|Period 1|Protocol Violation|0
403218|NCT00708032|1351048|P2|Overall Study|Withdrawal by Subject|1
403219|NCT00708032|1351049|P1|Overall Study|Withdrawal by Subject|0
403220|NCT00708032|1351048|P2|Overall Study|Protocol Violation|1
403221|NCT00708032|1351049|P1|Overall Study|Protocol Violation|4
403222|NCT00708032|1351048|P2|Overall Study|Did not meet protocol criteria|2
403223|NCT00708032|1351049|P1|Overall Study|Did not meet protocol criteria|1
403224|NCT00708032|1351048|P2|Overall Study|Visit out of range at month 12|1
403225|NCT00708032|1351049|P1|Overall Study|Visit out of range at month 12|4
403226|NCT00708032|1351048|P2|Overall Study|Poor vision|6
403227|NCT00708032|1351049|P1|Overall Study|Poor vision|0
403228|NCT00708032|1351048|P2|Overall Study|Pregnancy|1
403229|NCT00708032|1351049|P1|Overall Study|Pregnancy|0
403230|NCT00708032|1351048|P2|Overall Study|Lost to Follow-up|2
403231|NCT00708032|1351049|P1|Overall Study|Lost to Follow-up|1
403232|NCT00708032|1351048|P2|Overall Study|Adverse Event|2
403233|NCT00708032|1351049|P1|Overall Study|Adverse Event|0
403234|NCT00707993|1351076|P2|Overall Study|Other|0
403235|NCT00707993|1351077|P1|Overall Study|Other|2
403236|NCT00707993|1351076|P2|Overall Study|Hyperglycemic Rescue|47
403237|NCT00707993|1351077|P1|Overall Study|Hyperglycemic Rescue|55
403238|NCT00707993|1351076|P2|Overall Study|Withdrawal by Subject|16
403239|NCT00707993|1351077|P1|Overall Study|Withdrawal by Subject|12
403240|NCT00707993|1351076|P2|Overall Study|Lost to Follow-up|4
403241|NCT00707993|1351077|P1|Overall Study|Lost to Follow-up|0
403242|NCT00707993|1351076|P2|Overall Study|Protocol Violation|7
403243|NCT00707993|1351077|P1|Overall Study|Protocol Violation|4
403244|NCT00707993|1351076|P2|Overall Study|Adverse Event|20
403245|NCT00707993|1351077|P1|Overall Study|Adverse Event|16
403246|NCT00707980|1351119|P1|Overall Study|Other|39
403247|NCT00707980|1351119|P1|Overall Study|Lost to Follow-up|59
403248|NCT00707980|1351119|P1|Overall Study|Withdrawal of Consent|81
403249|NCT00707980|1351119|P1|Overall Study|Protocol Deviations|19
403250|NCT00707980|1351119|P1|Overall Study|Non-Compliance with Study Drug|28
403251|NCT00707980|1351119|P1|Overall Study|Lack of Efficacy|35
403252|NCT00707980|1351119|P1|Overall Study|Adverse Event|49
403253|NCT00707954|1351203|P5|Overall Study|Physician Decision|1
403254|NCT00707954|1351204|P4|Overall Study|Physician Decision|0
403255|NCT00707954|1351205|P3|Overall Study|Physician Decision|0
403256|NCT00707954|1351206|P2|Overall Study|Physician Decision|0
403257|NCT00707954|1351207|P1|Overall Study|Physician Decision|0
403258|NCT00707746|1351248|P2|Treatment Period|Ineligibility|1
403259|NCT00707746|1351249|P1|Treatment Period|Ineligibility|0
403260|NCT00707746|1351248|P2|Treatment Period|Adverse Event|4
403261|NCT00707746|1351249|P1|Treatment Period|Adverse Event|2
403262|NCT00707577|1351310|P2|Overall Study|Pregnancy|1
403263|NCT00707577|1351311|P1|Overall Study|Pregnancy|4
403264|NCT00707577|1351310|P2|Overall Study|Left employment|10
403265|NCT00707577|1351311|P1|Overall Study|Left employment|13
403266|NCT00707577|1351310|P2|Overall Study|Lost to Follow-up|25
403267|NCT00707577|1351311|P1|Overall Study|Lost to Follow-up|34
403268|NCT00707577|1351310|P2|Overall Study|Withdrawal by Subject|2
403269|NCT00707577|1351311|P1|Overall Study|Withdrawal by Subject|3
403270|NCT00707486|1351317|P1|Overall Study|Withdrawal by Subject|1
403271|NCT00707239|1351360|P3|Overall Study|Other|5
403272|NCT00707239|1351361|P2|Overall Study|Other|3
403273|NCT00707239|1351362|P1|Overall Study|Other|8
403274|NCT00707239|1351360|P3|Overall Study|Randomized, but not treated|1
403275|NCT00707239|1351361|P2|Overall Study|Randomized, but not treated|1
403276|NCT00707239|1351362|P1|Overall Study|Randomized, but not treated|1
403277|NCT00707239|1351360|P3|Overall Study|Lack of Efficacy|0
403278|NCT00707239|1351361|P2|Overall Study|Lack of Efficacy|2
403279|NCT00707239|1351362|P1|Overall Study|Lack of Efficacy|1
403280|NCT00707239|1351360|P3|Overall Study|Protocol Violation|1
403281|NCT00707239|1351361|P2|Overall Study|Protocol Violation|0
403282|NCT00707239|1351362|P1|Overall Study|Protocol Violation|0
403283|NCT00707239|1351360|P3|Overall Study|Physician Decision|2
403284|NCT00707239|1351361|P2|Overall Study|Physician Decision|1
403285|NCT00707239|1351362|P1|Overall Study|Physician Decision|1
403286|NCT00707239|1351360|P3|Overall Study|Death|3
403287|NCT00707239|1351361|P2|Overall Study|Death|1
403288|NCT00707239|1351362|P1|Overall Study|Death|3
403289|NCT00707239|1351360|P3|Overall Study|Adverse Event|2
403290|NCT00707239|1351361|P2|Overall Study|Adverse Event|3
403291|NCT00707239|1351362|P1|Overall Study|Adverse Event|5
403292|NCT00707174|1351410|P2|Overall Study|Withdrawal by Subject|1
403293|NCT00707174|1351411|P1|Overall Study|Withdrawal by Subject|4
403294|NCT00707174|1351410|P2|Overall Study|Adverse Event|6
403295|NCT00707174|1351411|P1|Overall Study|Adverse Event|1
403296|NCT00707161|1351417|P1|Overall Study|Physician Decision|6
403297|NCT00707057|1351423|P2|Overall Study|Dosed incorrectly|1
403298|NCT00707057|1351424|P1|Overall Study|Dosed incorrectly|0
403299|NCT00707057|1351423|P2|Overall Study|Withdrawal by Subject|3
403300|NCT00707057|1351424|P1|Overall Study|Withdrawal by Subject|8
403301|NCT00707031|1351458|P2|Overall Study|Sponsor Decision|8
403302|NCT00707031|1351459|P1|Overall Study|Sponsor Decision|9
403303|NCT00707031|1351458|P2|Overall Study|Serious Noncompliance|3
403304|NCT00707031|1351459|P1|Overall Study|Serious Noncompliance|2
403305|NCT00707031|1351458|P2|Overall Study|Familial or Personal Reasons|15
403306|NCT00707031|1351459|P1|Overall Study|Familial or Personal Reasons|12
403307|NCT00707031|1351458|P2|Overall Study|Poor Compliance to Protocol|13
403308|NCT00707031|1351459|P1|Overall Study|Poor Compliance to Protocol|7
403309|NCT00707031|1351458|P2|Overall Study|Withdrawal by Subject|8
403310|NCT00707031|1351459|P1|Overall Study|Withdrawal by Subject|7
403311|NCT00707031|1351458|P2|Overall Study|Protocol Violation|0
403312|NCT00707031|1351459|P1|Overall Study|Protocol Violation|1
403313|NCT00707031|1351458|P2|Overall Study|Lost to Follow-up|1
403314|NCT00707031|1351459|P1|Overall Study|Lost to Follow-up|2
403315|NCT00707031|1351458|P2|Overall Study|Lack of Efficacy|6
403316|NCT00707031|1351459|P1|Overall Study|Lack of Efficacy|19
403317|NCT00707031|1351458|P2|Overall Study|Adverse Event|45
403318|NCT00707031|1351459|P1|Overall Study|Adverse Event|45
403319|NCT00706992|1351488|P7|Overall Study|Disease progression before treatment|0
403320|NCT00706992|1351489|P6|Overall Study|Disease progression before treatment|0
403321|NCT00706992|1351490|P5|Overall Study|Disease progression before treatment|1
403322|NCT00706992|1351491|P4|Overall Study|Disease progression before treatment|0
403323|NCT00706992|1351492|P3|Overall Study|Disease progression before treatment|0
403324|NCT00706992|1351493|P2|Overall Study|Disease progression before treatment|0
403325|NCT00706992|1351494|P1|Overall Study|Disease progression before treatment|0
403326|NCT00706992|1351488|P7|Overall Study|Study termination|3
403327|NCT00706992|1351489|P6|Overall Study|Study termination|2
403328|NCT00706992|1351490|P5|Overall Study|Study termination|3
403329|NCT00706992|1351491|P4|Overall Study|Study termination|2
403330|NCT00706992|1351492|P3|Overall Study|Study termination|6
403331|NCT00706992|1351493|P2|Overall Study|Study termination|5
403332|NCT00706992|1351494|P1|Overall Study|Study termination|5
403333|NCT00706966|1351526|P1|Overall Study|Adverse Event|1
403334|NCT00706914|1351562|P3|Overall Study|Protocol Violation|1
403335|NCT00706914|1351563|P2|Overall Study|Protocol Violation|1
403336|NCT00706914|1351564|P1|Overall Study|Protocol Violation|3
403337|NCT00706914|1351562|P3|Overall Study|Adverse Event|0
403338|NCT00706914|1351563|P2|Overall Study|Adverse Event|2
403339|NCT00706914|1351564|P1|Overall Study|Adverse Event|2
403340|NCT00706914|1351562|P3|Overall Study|Lost to Follow-up|0
403341|NCT00706914|1351563|P2|Overall Study|Lost to Follow-up|0
403342|NCT00706914|1351564|P1|Overall Study|Lost to Follow-up|1
403343|NCT00706914|1351562|P3|Overall Study|Lack of Efficacy|0
403344|NCT00706914|1351563|P2|Overall Study|Lack of Efficacy|1
403345|NCT00706914|1351564|P1|Overall Study|Lack of Efficacy|0
403346|NCT00706901|1351587|P3|Overall Study|Death|0
403347|NCT00706901|1351588|P2|Overall Study|Death|0
403348|NCT00706901|1351589|P1|Overall Study|Death|1
403349|NCT00706901|1351587|P3|Overall Study|In Jail|1
403350|NCT00706901|1351588|P2|Overall Study|In Jail|0
403351|NCT00706901|1351589|P1|Overall Study|In Jail|1
403352|NCT00706901|1351587|P3|Overall Study|Withdrawal by Subject|5
403353|NCT00706901|1351588|P2|Overall Study|Withdrawal by Subject|2
403354|NCT00706901|1351589|P1|Overall Study|Withdrawal by Subject|4
403355|NCT00706901|1351587|P3|Overall Study|Lost to Follow-up|2
403356|NCT00706901|1351588|P2|Overall Study|Lost to Follow-up|3
403357|NCT00706901|1351589|P1|Overall Study|Lost to Follow-up|2
403358|NCT00706849|1351614|P2|Follow-up Period|Protocol non-compliance|1
403359|NCT00706849|1351615|P1|Follow-up Period|Protocol non-compliance|0
403360|NCT00706849|1351614|P2|Follow-up Period|Withdrawal by Subject|2
403361|NCT00706849|1351615|P1|Follow-up Period|Withdrawal by Subject|0
403362|NCT00706849|1351614|P2|Treatment Period|Other|1
403363|NCT00706849|1351615|P1|Treatment Period|Other|0
403364|NCT00706849|1351614|P2|Treatment Period|Adverse Event|9
403365|NCT00706849|1351615|P1|Treatment Period|Adverse Event|0
403366|NCT00706797|1351693|P2|Overall Study|Other|0
403367|NCT00706797|1351694|P1|Overall Study|Other|1
403368|NCT00706797|1351693|P2|Overall Study|Lost to Follow-up|2
403369|NCT00706797|1351694|P1|Overall Study|Lost to Follow-up|1
403370|NCT00706797|1351693|P2|Overall Study|Protocol Violation|2
403371|NCT00706797|1351694|P1|Overall Study|Protocol Violation|3
403372|NCT00706797|1351693|P2|Overall Study|Discontinuation of study by sponsor|63
403373|NCT00706797|1351694|P1|Overall Study|Discontinuation of study by sponsor|52
403374|NCT00706797|1351693|P2|Overall Study|Death|0
403375|NCT00706797|1351694|P1|Overall Study|Death|1
403376|NCT00706797|1351693|P2|Overall Study|Withdrawal by Subject|1
403377|NCT00706797|1351694|P1|Overall Study|Withdrawal by Subject|8
403378|NCT00706797|1351693|P2|Overall Study|Adverse Event|3
403379|NCT00706797|1351694|P1|Overall Study|Adverse Event|0
403380|NCT00706797|1351693|P2|Overall Study|Lack of Efficacy|0
403381|NCT00706797|1351694|P1|Overall Study|Lack of Efficacy|3
403382|NCT00706706|1351763|P1|Overall Study|Study endpoint had reached|45
403383|NCT00706706|1351763|P1|Overall Study|Lost to Follow-up|7
403384|NCT00706706|1351763|P1|Overall Study|Death|53
403385|NCT00706654|1351773|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
403386|NCT00706654|1351774|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
403387|NCT00706654|1351775|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
403388|NCT00706654|1351776|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
403389|NCT00706654|1351773|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
403390|NCT00706654|1351774|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
403391|NCT00706654|1351775|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
403392|NCT00706654|1351776|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
403393|NCT00706654|1351773|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
403394|NCT00706654|1351774|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
403395|NCT00706654|1351775|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
403396|NCT00706654|1351776|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
403397|NCT00706654|1351773|P4|Depot Maintenance Phase|Protocol Deviation|1
403398|NCT00706654|1351774|P3|Depot Maintenance Phase|Protocol Deviation|3
403399|NCT00706654|1351775|P2|Depot Maintenance Phase|Protocol Deviation|2
403400|NCT00706654|1351776|P1|Depot Maintenance Phase|Protocol Deviation|0
403401|NCT00706654|1351773|P4|Depot Maintenance Phase|Withdrew Consent|14
403402|NCT00706654|1351774|P3|Depot Maintenance Phase|Withdrew Consent|29
403403|NCT00706654|1351775|P2|Depot Maintenance Phase|Withdrew Consent|21
403404|NCT00706654|1351776|P1|Depot Maintenance Phase|Withdrew Consent|0
403405|NCT00706654|1351773|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
403406|NCT00706654|1351774|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
403407|NCT00706654|1351775|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
403408|NCT00706654|1351776|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
403409|NCT00706654|1351773|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
403410|NCT00706654|1351774|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
403411|NCT00706654|1351775|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
403412|NCT00706654|1351776|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
403413|NCT00706654|1351773|P4|Depot Maintenance Phase|Lost to Follow-up|6
403414|NCT00706654|1351774|P3|Depot Maintenance Phase|Lost to Follow-up|10
403415|NCT00706654|1351775|P2|Depot Maintenance Phase|Lost to Follow-up|4
403416|NCT00706654|1351776|P1|Depot Maintenance Phase|Lost to Follow-up|0
403417|NCT00706654|1351773|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
403418|NCT00706654|1351774|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
403419|NCT00706654|1351775|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
403420|NCT00706654|1351776|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
403421|NCT00706654|1351773|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
403422|NCT00706654|1351774|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
403423|NCT00706654|1351775|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
403424|NCT00706654|1351776|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
403425|NCT00706654|1351773|P4|Oral Stabilization Phase|Adverse Event|0
403426|NCT00706654|1351774|P3|Oral Stabilization Phase|Adverse Event|0
403427|NCT00706654|1351775|P2|Oral Stabilization Phase|Adverse Event|0
403428|NCT00706654|1351776|P1|Oral Stabilization Phase|Adverse Event|21
403429|NCT00706654|1351773|P4|Oral Stabilization Phase|Protocol Deviation|0
403430|NCT00706654|1351774|P3|Oral Stabilization Phase|Protocol Deviation|0
403431|NCT00706654|1351775|P2|Oral Stabilization Phase|Protocol Deviation|0
403432|NCT00706654|1351776|P1|Oral Stabilization Phase|Protocol Deviation|2
403433|NCT00706654|1351773|P4|Oral Stabilization Phase|Withdrew consent|0
403434|NCT00706654|1351774|P3|Oral Stabilization Phase|Withdrew consent|0
403435|NCT00706654|1351775|P2|Oral Stabilization Phase|Withdrew consent|0
403436|NCT00706654|1351776|P1|Oral Stabilization Phase|Withdrew consent|55
403437|NCT00706654|1351773|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
403438|NCT00706654|1351774|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
403439|NCT00706654|1351775|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
403440|NCT00706654|1351776|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
403441|NCT00706654|1351773|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
403442|NCT00706654|1351774|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
403443|NCT00706654|1351775|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
403444|NCT00706654|1351776|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
403445|NCT00706654|1351773|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
403446|NCT00706654|1351774|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
403447|NCT00706654|1351775|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
403448|NCT00706654|1351776|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
403449|NCT00706654|1351773|P4|Oral Stabilization Phase|Lost to Follow-up|0
403450|NCT00706654|1351774|P3|Oral Stabilization Phase|Lost to Follow-up|0
403451|NCT00706654|1351775|P2|Oral Stabilization Phase|Lost to Follow-up|0
403452|NCT00706654|1351776|P1|Oral Stabilization Phase|Lost to Follow-up|17
403453|NCT00706654|1351773|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
403454|NCT00706654|1351774|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
403455|NCT00706654|1351775|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
403456|NCT00706654|1351776|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
403457|NCT00706654|1351773|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
403458|NCT00706654|1351774|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
403459|NCT00706654|1351775|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
403460|NCT00706654|1351776|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
403461|NCT00706654|1351773|P4|Conversion Phase|Adverse Event|0
403462|NCT00706654|1351774|P3|Conversion Phase|Adverse Event|0
403463|NCT00706654|1351775|P2|Conversion Phase|Adverse Event|0
403464|NCT00706654|1351776|P1|Conversion Phase|Adverse Event|18
403465|NCT00706654|1351773|P4|Conversion Phase|Withdrew Consent|0
403466|NCT00706654|1351774|P3|Conversion Phase|Withdrew Consent|0
403467|NCT00706654|1351775|P2|Conversion Phase|Withdrew Consent|0
403468|NCT00706654|1351776|P1|Conversion Phase|Withdrew Consent|38
403469|NCT00706654|1351773|P4|Conversion Phase|Withdrawn by Investigator|0
403470|NCT00706654|1351774|P3|Conversion Phase|Withdrawn by Investigator|0
403471|NCT00706654|1351775|P2|Conversion Phase|Withdrawn by Investigator|0
403472|NCT00706654|1351776|P1|Conversion Phase|Withdrawn by Investigator|14
403473|NCT00706654|1351773|P4|Conversion Phase|Met Withdrawal Criteria|0
403474|NCT00706654|1351774|P3|Conversion Phase|Met Withdrawal Criteria|0
403475|NCT00706654|1351775|P2|Conversion Phase|Met Withdrawal Criteria|0
403476|NCT00706654|1351776|P1|Conversion Phase|Met Withdrawal Criteria|2
403477|NCT00706654|1351773|P4|Conversion Phase|Sponsor Discontinued Trial|0
403478|NCT00706654|1351774|P3|Conversion Phase|Sponsor Discontinued Trial|0
403479|NCT00706654|1351775|P2|Conversion Phase|Sponsor Discontinued Trial|0
403480|NCT00706654|1351776|P1|Conversion Phase|Sponsor Discontinued Trial|8
403481|NCT00706654|1351773|P4|Conversion Phase|Lost to Follow-up|0
403482|NCT00706654|1351774|P3|Conversion Phase|Lost to Follow-up|0
403483|NCT00706654|1351775|P2|Conversion Phase|Lost to Follow-up|0
403484|NCT00706654|1351776|P1|Conversion Phase|Lost to Follow-up|4
403485|NCT00706641|1351795|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
403486|NCT00706641|1351795|P1|Dasatinib Administration|Ineligible after start of therapy|1
403487|NCT00706641|1351795|P1|Dasatinib Administration|Withdrawal by Subject|1
403488|NCT00706628|1351809|P4|Overall Study|Not treated|0
403489|NCT00706628|1351810|P3|Overall Study|Not treated|0
403490|NCT00706628|1351811|P2|Overall Study|Not treated|1
403491|NCT00706628|1351812|P1|Overall Study|Not treated|1
403492|NCT00706628|1351809|P4|Overall Study|Other than those stated above|0
403493|NCT00706628|1351810|P3|Overall Study|Other than those stated above|0
403494|NCT00706628|1351811|P2|Overall Study|Other than those stated above|0
403495|NCT00706628|1351812|P1|Overall Study|Other than those stated above|4
403496|NCT00706628|1351809|P4|Overall Study|Progressive disease|1
403497|NCT00706628|1351810|P3|Overall Study|Progressive disease|8
403498|NCT00706628|1351811|P2|Overall Study|Progressive disease|13
403499|NCT00706628|1351812|P1|Overall Study|Progressive disease|20
403500|NCT00706628|1351809|P4|Overall Study|Consent withdrawn|0
403501|NCT00706628|1351810|P3|Overall Study|Consent withdrawn|3
403502|NCT00706628|1351811|P2|Overall Study|Consent withdrawn|1
403503|NCT00706628|1351812|P1|Overall Study|Consent withdrawn|6
403504|NCT00706628|1351809|P4|Overall Study|Non compliant with protocol|0
403505|NCT00706628|1351810|P3|Overall Study|Non compliant with protocol|0
403506|NCT00706628|1351811|P2|Overall Study|Non compliant with protocol|1
403507|NCT00706628|1351812|P1|Overall Study|Non compliant with protocol|0
403508|NCT00706628|1351809|P4|Overall Study|Other Adverse Event|2
403509|NCT00706628|1351810|P3|Overall Study|Other Adverse Event|5
403510|NCT00706628|1351811|P2|Overall Study|Other Adverse Event|5
403511|NCT00706628|1351812|P1|Overall Study|Other Adverse Event|16
403512|NCT00706433|1351972|P4|Overall Study|new job|1
403513|NCT00706433|1351973|P3|Overall Study|new job|0
403514|NCT00706433|1351974|P2|Overall Study|new job|0
403515|NCT00706433|1351975|P1|Overall Study|new job|0
403516|NCT00706433|1351972|P4|Overall Study|Protocol Violation|0
403517|NCT00706433|1351973|P3|Overall Study|Protocol Violation|0
403518|NCT00706433|1351974|P2|Overall Study|Protocol Violation|0
403519|NCT00706433|1351975|P1|Overall Study|Protocol Violation|1
403520|NCT00706433|1351972|P4|Overall Study|Adverse Event|0
403521|NCT00706433|1351973|P3|Overall Study|Adverse Event|1
403522|NCT00706433|1351974|P2|Overall Study|Adverse Event|0
403523|NCT00706433|1351975|P1|Overall Study|Adverse Event|0
403524|NCT00706433|1351972|P4|Overall Study|Withdrawal by Subject|1
403525|NCT00706433|1351973|P3|Overall Study|Withdrawal by Subject|3
403526|NCT00706433|1351974|P2|Overall Study|Withdrawal by Subject|2
403527|NCT00706433|1351975|P1|Overall Study|Withdrawal by Subject|1
403528|NCT00706433|1351972|P4|Overall Study|Lost to Follow-up|0
403529|NCT00706433|1351973|P3|Overall Study|Lost to Follow-up|6
403530|NCT00706433|1351974|P2|Overall Study|Lost to Follow-up|1
403531|NCT00706433|1351975|P1|Overall Study|Lost to Follow-up|3
403532|NCT00706355|1352302|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
403533|NCT00706355|1352303|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
403534|NCT00706355|1352304|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
403535|NCT00706355|1352305|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
403536|NCT00706355|1352302|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
403537|NCT00706355|1352303|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
403538|NCT00706355|1352304|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
403539|NCT00706355|1352305|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
403540|NCT00706355|1352302|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
403541|NCT00706355|1352303|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
403542|NCT00706355|1352304|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
403543|NCT00706355|1352305|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
403544|NCT00706355|1352302|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
403545|NCT00706355|1352303|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
403546|NCT00706355|1352304|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
403547|NCT00706355|1352305|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
403548|NCT00706355|1352302|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
403549|NCT00706355|1352303|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
403550|NCT00706355|1352304|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
403551|NCT00706355|1352305|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
403552|NCT00706355|1352302|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
403553|NCT00706355|1352303|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
403554|NCT00706355|1352304|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
403555|NCT00706355|1352305|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
403556|NCT00706355|1352302|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
403557|NCT00706355|1352303|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
403558|NCT00706355|1352304|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
403559|NCT00706355|1352305|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
403560|NCT00706355|1352302|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
403561|NCT00706355|1352303|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
403562|NCT00706355|1352304|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
403563|NCT00706355|1352305|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
403564|NCT00706355|1352302|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
403565|NCT00706355|1352303|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
403566|NCT00706355|1352304|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
403567|NCT00706355|1352305|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
403568|NCT00706342|1352357|P1|Overall Study|WIthdrawal of consent|1
403569|NCT00706342|1352357|P1|Overall Study|Ongoing|6
403570|NCT00706342|1352357|P1|Overall Study|Non-responder Week 12|1
403571|NCT00706342|1352357|P1|Overall Study|Investigator discretion|2
403572|NCT00706342|1352357|P1|Overall Study|Withdrew from the study on his own.|1
403573|NCT00706342|1352357|P1|Overall Study|Death|1
403574|NCT00706342|1352357|P1|Overall Study|Withdrawn due to failure to respond|1
403575|NCT00706342|1352357|P1|Overall Study|Not responding to treatment|2
403576|NCT00706342|1352357|P1|Overall Study|Adverse Event|3
403577|NCT00706134|1352374|P4|Overall Study|Did not meet study criteria|0
403578|NCT00706134|1352375|P3|Overall Study|Did not meet study criteria|0
403579|NCT00706134|1352376|P2|Overall Study|Did not meet study criteria|0
403580|NCT00706134|1352377|P1|Overall Study|Did not meet study criteria|2
403581|NCT00706134|1352374|P4|Overall Study|Unsatisfactory therapeutic effect|5
403582|NCT00706134|1352375|P3|Overall Study|Unsatisfactory therapeutic effect|3
403583|NCT00706134|1352376|P2|Overall Study|Unsatisfactory therapeutic effect|3
403584|NCT00706134|1352377|P1|Overall Study|Unsatisfactory therapeutic effect|9
403585|NCT00706134|1352374|P4|Overall Study|Withdrawal by Subject|0
403586|NCT00706134|1352375|P3|Overall Study|Withdrawal by Subject|1
403587|NCT00706134|1352376|P2|Overall Study|Withdrawal by Subject|2
403588|NCT00706134|1352377|P1|Overall Study|Withdrawal by Subject|1
403589|NCT00706134|1352374|P4|Overall Study|Protocol Violation|3
403590|NCT00706134|1352375|P3|Overall Study|Protocol Violation|0
403591|NCT00706134|1352376|P2|Overall Study|Protocol Violation|6
403592|NCT00706134|1352377|P1|Overall Study|Protocol Violation|0
403593|NCT00706134|1352374|P4|Overall Study|Lost to Follow-up|0
403594|NCT00706134|1352375|P3|Overall Study|Lost to Follow-up|0
403595|NCT00706134|1352376|P2|Overall Study|Lost to Follow-up|1
403596|NCT00706134|1352377|P1|Overall Study|Lost to Follow-up|0
403597|NCT00706134|1352374|P4|Overall Study|Adverse Event|3
403598|NCT00706134|1352375|P3|Overall Study|Adverse Event|2
403599|NCT00706134|1352376|P2|Overall Study|Adverse Event|7
403600|NCT00706134|1352377|P1|Overall Study|Adverse Event|8
403601|NCT00706095|1352443|P3|Overall Study|Withdrawal by Subject|0
403602|NCT00706095|1352444|P2|Overall Study|Withdrawal by Subject|0
403603|NCT00706095|1352445|P1|Overall Study|Withdrawal by Subject|1
403604|NCT00706095|1352443|P3|Overall Study|Clinical Progression|2
403605|NCT00706095|1352444|P2|Overall Study|Clinical Progression|2
403606|NCT00706095|1352445|P1|Overall Study|Clinical Progression|1
403607|NCT00706095|1352443|P3|Overall Study|Progressive Disease|3
403608|NCT00706095|1352444|P2|Overall Study|Progressive Disease|5
403609|NCT00706095|1352445|P1|Overall Study|Progressive Disease|4
403610|NCT00706030|1352463|P4|Overall Study|Death|0
403611|NCT00706030|1352464|P3|Overall Study|Death|1
403612|NCT00706030|1352465|P2|Overall Study|Death|0
403613|NCT00706030|1352466|P1|Overall Study|Death|0
403614|NCT00706030|1352463|P4|Overall Study|No treatment received|1
403615|NCT00706030|1352464|P3|Overall Study|No treatment received|0
403616|NCT00706030|1352465|P2|Overall Study|No treatment received|0
403617|NCT00706030|1352466|P1|Overall Study|No treatment received|0
403618|NCT00706030|1352463|P4|Overall Study|Symptomatic Deterioration|0
403619|NCT00706030|1352464|P3|Overall Study|Symptomatic Deterioration|1
403620|NCT00706030|1352465|P2|Overall Study|Symptomatic Deterioration|0
403621|NCT00706030|1352466|P1|Overall Study|Symptomatic Deterioration|0
403622|NCT00706030|1352463|P4|Overall Study|Failed to return|0
403623|NCT00706030|1352464|P3|Overall Study|Failed to return|1
403624|NCT00706030|1352465|P2|Overall Study|Failed to return|0
403625|NCT00706030|1352466|P1|Overall Study|Failed to return|0
403626|NCT00706030|1352463|P4|Overall Study|Protocol Violation|1
403627|NCT00706030|1352464|P3|Overall Study|Protocol Violation|1
403628|NCT00706030|1352465|P2|Overall Study|Protocol Violation|0
403629|NCT00706030|1352466|P1|Overall Study|Protocol Violation|0
403630|NCT00706030|1352463|P4|Overall Study|Not recorded|0
403631|NCT00706030|1352464|P3|Overall Study|Not recorded|2
403632|NCT00706030|1352465|P2|Overall Study|Not recorded|0
403633|NCT00706030|1352466|P1|Overall Study|Not recorded|0
403634|NCT00706030|1352463|P4|Overall Study|Physician Decision|0
403635|NCT00706030|1352464|P3|Overall Study|Physician Decision|2
403636|NCT00706030|1352465|P2|Overall Study|Physician Decision|0
403637|NCT00706030|1352466|P1|Overall Study|Physician Decision|0
403638|NCT00706030|1352463|P4|Overall Study|Withdrawal by Subject|0
403639|NCT00706030|1352464|P3|Overall Study|Withdrawal by Subject|2
403640|NCT00706030|1352465|P2|Overall Study|Withdrawal by Subject|0
403641|NCT00706030|1352466|P1|Overall Study|Withdrawal by Subject|1
403642|NCT00706030|1352463|P4|Overall Study|Adverse Event|2
403643|NCT00706030|1352464|P3|Overall Study|Adverse Event|4
403644|NCT00706030|1352465|P2|Overall Study|Adverse Event|0
403645|NCT00706030|1352466|P1|Overall Study|Adverse Event|1
403646|NCT00706030|1352463|P4|Overall Study|Disease Progression|12
403647|NCT00706030|1352464|P3|Overall Study|Disease Progression|46
403648|NCT00706030|1352465|P2|Overall Study|Disease Progression|6
403649|NCT00706030|1352466|P1|Overall Study|Disease Progression|4
403650|NCT00706004|1352481|P1|Overall Study|Did not meet eligibility criteria|2
403651|NCT00705939|1352509|P3|Overall Study|Physician Decision|0
403652|NCT00705939|1352510|P2|Overall Study|Physician Decision|1
403653|NCT00705939|1352511|P1|Overall Study|Physician Decision|0
403654|NCT00705939|1352509|P3|Overall Study|Withdrawal by Subject|3
403655|NCT00705939|1352510|P2|Overall Study|Withdrawal by Subject|1
403656|NCT00705939|1352511|P1|Overall Study|Withdrawal by Subject|0
403657|NCT00705939|1352509|P3|Overall Study|Protocol Violation|1
403658|NCT00705939|1352510|P2|Overall Study|Protocol Violation|0
403659|NCT00705939|1352511|P1|Overall Study|Protocol Violation|0
403660|NCT00705783|1352565|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
403661|NCT00705783|1352566|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
403662|NCT00705783|1352567|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
403663|NCT00705783|1352565|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
403664|NCT00705783|1352566|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
403665|NCT00705783|1352567|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
403666|NCT00705783|1352565|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
403667|NCT00705783|1352566|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
403668|NCT00705783|1352567|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
403669|NCT00705783|1352565|P3|Depot Maintenance Phase|Protocol Deviation|0
403670|NCT00705783|1352566|P2|Depot Maintenance Phase|Protocol Deviation|2
403671|NCT00705783|1352567|P1|Depot Maintenance Phase|Protocol Deviation|0
403672|NCT00705783|1352565|P3|Depot Maintenance Phase|Withdrew Consent|4
403673|NCT00705783|1352566|P2|Depot Maintenance Phase|Withdrew Consent|14
403674|NCT00705783|1352567|P1|Depot Maintenance Phase|Withdrew Consent|0
403675|NCT00705783|1352565|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
403676|NCT00705783|1352566|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
403677|NCT00705783|1352567|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
403678|NCT00705783|1352565|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
403679|NCT00705783|1352566|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
403680|NCT00705783|1352567|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
403681|NCT00705783|1352565|P3|Depot Maintenance Phase|Lost to Follow-up|3
403682|NCT00705783|1352566|P2|Depot Maintenance Phase|Lost to Follow-up|5
403683|NCT00705783|1352567|P1|Depot Maintenance Phase|Lost to Follow-up|0
403684|NCT00705783|1352565|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
403685|NCT00705783|1352566|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
403686|NCT00705783|1352567|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
403687|NCT00705783|1352565|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
403688|NCT00705783|1352566|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
403689|NCT00705783|1352567|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
403690|NCT00705783|1352565|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
403691|NCT00705783|1352566|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
403692|NCT00705783|1352567|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
403693|NCT00705783|1352565|P3|Depot Stabilization Phase|Adverse Event|0
403694|NCT00705783|1352566|P2|Depot Stabilization Phase|Adverse Event|0
403695|NCT00705783|1352567|P1|Depot Stabilization Phase|Adverse Event|17
403696|NCT00705783|1352565|P3|Depot Stabilization Phase|Withdrew Consent|0
403697|NCT00705783|1352566|P2|Depot Stabilization Phase|Withdrew Consent|0
403698|NCT00705783|1352567|P1|Depot Stabilization Phase|Withdrew Consent|29
403699|NCT00705783|1352565|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
403700|NCT00705783|1352566|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
403701|NCT00705783|1352567|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
403702|NCT00705783|1352565|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
403703|NCT00705783|1352566|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
403704|NCT00705783|1352567|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
403705|NCT00705783|1352565|P3|Depot Stabilization Phase|Lost to Follow-up|0
403706|NCT00705783|1352566|P2|Depot Stabilization Phase|Lost to Follow-up|0
403707|NCT00705783|1352567|P1|Depot Stabilization Phase|Lost to Follow-up|11
403708|NCT00705783|1352565|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
403709|NCT00705783|1352566|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
403710|NCT00705783|1352567|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
403711|NCT00705783|1352565|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
403712|NCT00705783|1352566|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
403713|NCT00705783|1352567|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
403714|NCT00705783|1352565|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
403715|NCT00705783|1352566|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
403716|NCT00705783|1352567|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
403717|NCT00705783|1352565|P3|Oral Stabilization Phase|Adverse Event|0
403718|NCT00705783|1352566|P2|Oral Stabilization Phase|Adverse Event|0
403719|NCT00705783|1352567|P1|Oral Stabilization Phase|Adverse Event|14
403720|NCT00705783|1352565|P3|Oral Stabilization Phase|Withdrew Consent|0
403721|NCT00705783|1352566|P2|Oral Stabilization Phase|Withdrew Consent|0
403722|NCT00705783|1352567|P1|Oral Stabilization Phase|Withdrew Consent|29
403723|NCT00705783|1352565|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
403724|NCT00705783|1352566|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
403725|NCT00705783|1352567|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
403726|NCT00705783|1352565|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
403727|NCT00705783|1352566|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
403728|NCT00705783|1352567|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
403729|NCT00705783|1352565|P3|Oral Stabilization Phase|Lost to Follow-up|0
403730|NCT00705783|1352566|P2|Oral Stabilization Phase|Lost to Follow-up|0
403731|NCT00705783|1352567|P1|Oral Stabilization Phase|Lost to Follow-up|7
403732|NCT00705783|1352565|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
403733|NCT00705783|1352566|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
403734|NCT00705783|1352567|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
403735|NCT00705783|1352565|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
403736|NCT00705783|1352566|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
403737|NCT00705783|1352567|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
403738|NCT00705783|1352565|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
403739|NCT00705783|1352566|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
403740|NCT00705783|1352567|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
403741|NCT00705783|1352565|P3|Conversion Phase|Adverse Event|0
403742|NCT00705783|1352566|P2|Conversion Phase|Adverse Event|0
403743|NCT00705783|1352567|P1|Conversion Phase|Adverse Event|11
403744|NCT00705783|1352565|P3|Conversion Phase|Protocol Deviation|0
403745|NCT00705783|1352566|P2|Conversion Phase|Protocol Deviation|0
403746|NCT00705783|1352567|P1|Conversion Phase|Protocol Deviation|2
403747|NCT00705783|1352565|P3|Conversion Phase|Withdrew Consent|0
403748|NCT00705783|1352566|P2|Conversion Phase|Withdrew Consent|0
403749|NCT00705783|1352567|P1|Conversion Phase|Withdrew Consent|24
403750|NCT00705783|1352565|P3|Conversion Phase|Withdrawn by Investigator|0
403751|NCT00705783|1352566|P2|Conversion Phase|Withdrawn by Investigator|0
403752|NCT00705783|1352567|P1|Conversion Phase|Withdrawn by Investigator|4
403753|NCT00705783|1352565|P3|Conversion Phase|Met Withdrawal Criteria|0
403754|NCT00705783|1352566|P2|Conversion Phase|Met Withdrawal Criteria|0
403755|NCT00705783|1352567|P1|Conversion Phase|Met Withdrawal Criteria|4
403756|NCT00705783|1352565|P3|Conversion Phase|Lost to Follow-up|0
403757|NCT00705783|1352566|P2|Conversion Phase|Lost to Follow-up|0
403758|NCT00705783|1352567|P1|Conversion Phase|Lost to Follow-up|13
403759|NCT00705783|1352565|P3|Conversion Phase|Sponsor Discontinued Study|0
403760|NCT00705783|1352566|P2|Conversion Phase|Sponsor Discontinued Study|0
403761|NCT00705783|1352567|P1|Conversion Phase|Sponsor Discontinued Study|54
403762|NCT00705757|1352597|P3|Overall Study|Withdrawal by Subject|2
403763|NCT00705757|1352598|P2|Overall Study|Withdrawal by Subject|1
403764|NCT00705757|1352599|P1|Overall Study|Withdrawal by Subject|1
403765|NCT00705757|1352597|P3|Overall Study|Lost to Follow-up|6
403766|NCT00705757|1352598|P2|Overall Study|Lost to Follow-up|6
403767|NCT00705757|1352599|P1|Overall Study|Lost to Follow-up|7
403768|NCT00705757|1352597|P3|Overall Study|Lack of Efficacy|3
403769|NCT00705757|1352598|P2|Overall Study|Lack of Efficacy|1
403770|NCT00705757|1352599|P1|Overall Study|Lack of Efficacy|5
403771|NCT00705718|1352609|P2|Overall Study|Follow up not done|4
403772|NCT00705718|1352610|P1|Overall Study|Follow up not done|1
403773|NCT00705718|1352609|P2|Overall Study|Not due for Visit|12
403774|NCT00705718|1352610|P1|Overall Study|Not due for Visit|0
403775|NCT00705718|1352609|P2|Overall Study|Death|6
403776|NCT00705718|1352610|P1|Overall Study|Death|6
403777|NCT00705679|1352631|P5|Overall Study|Withdrawal by Subject|33
403778|NCT00705679|1352632|P4|Overall Study|Withdrawal by Subject|47
403779|NCT00705679|1352633|P3|Overall Study|Withdrawal by Subject|68
403780|NCT00705679|1352634|P2|Overall Study|Withdrawal by Subject|77
403781|NCT00705679|1352635|P1|Overall Study|Withdrawal by Subject|32
403782|NCT00705679|1352631|P5|Overall Study|Physician Decision|0
403783|NCT00705679|1352632|P4|Overall Study|Physician Decision|1
403784|NCT00705679|1352633|P3|Overall Study|Physician Decision|0
403785|NCT00705679|1352634|P2|Overall Study|Physician Decision|1
403786|NCT00705679|1352635|P1|Overall Study|Physician Decision|0
403787|NCT00705679|1352631|P5|Overall Study|Lost to Follow-up|35
403788|NCT00705679|1352632|P4|Overall Study|Lost to Follow-up|30
403789|NCT00705679|1352633|P3|Overall Study|Lost to Follow-up|44
403790|NCT00705679|1352634|P2|Overall Study|Lost to Follow-up|60
403791|NCT00705679|1352635|P1|Overall Study|Lost to Follow-up|32
403792|NCT00705679|1352631|P5|Overall Study|Death|1
403793|NCT00705679|1352632|P4|Overall Study|Death|2
403794|NCT00705679|1352633|P3|Overall Study|Death|3
403795|NCT00705679|1352634|P2|Overall Study|Death|0
403796|NCT00705679|1352635|P1|Overall Study|Death|0
403797|NCT00705679|1352631|P5|Overall Study|Adverse Event|0
403798|NCT00705679|1352632|P4|Overall Study|Adverse Event|0
403799|NCT00705679|1352633|P3|Overall Study|Adverse Event|0
403800|NCT00705679|1352634|P2|Overall Study|Adverse Event|1
403801|NCT00705679|1352635|P1|Overall Study|Adverse Event|1
403802|NCT00705666|1352670|P1|Overall Study|Untreated|5
403803|NCT00705666|1352670|P1|Overall Study|Lack of data|3
403804|NCT00705666|1352670|P1|Overall Study|Other|2
403805|NCT00705666|1352670|P1|Overall Study|Not specified|12
403806|NCT00705666|1352670|P1|Overall Study|Adverse Event|4
403807|NCT00705666|1352670|P1|Overall Study|Death|1
403808|NCT00705666|1352670|P1|Overall Study|Lost to Follow-up|5
403809|NCT00705666|1352670|P1|Overall Study|Physician Decision|7
403810|NCT00705666|1352670|P1|Overall Study|Withdrawal by Subject|21
403811|NCT00705666|1352670|P1|Overall Study|No post-treatment questionnaire|279
403812|NCT00705614|1352681|P2|Switch to Remicade|Administrative Reason|9
403813|NCT00705614|1352682|P1|Switch to Remicade|Administrative Reason|0
403814|NCT00705614|1352681|P2|Switch to Remicade|Withdrawal by Subject|12
403815|NCT00705614|1352682|P1|Switch to Remicade|Withdrawal by Subject|0
403816|NCT00705614|1352681|P2|Switch to Remicade|Lost to Follow-up|23
403817|NCT00705614|1352682|P1|Switch to Remicade|Lost to Follow-up|0
403818|NCT00705614|1352681|P2|Switch to Remicade|Adverse Event|5
403819|NCT00705614|1352682|P1|Switch to Remicade|Adverse Event|0
403820|NCT00705614|1352681|P2|Initial Intervention|Status completion unknown|0
403821|NCT00705614|1352682|P1|Initial Intervention|Status completion unknown|3
403822|NCT00705614|1352681|P2|Initial Intervention|Administrative Reason|38
403823|NCT00705614|1352682|P1|Initial Intervention|Administrative Reason|51
403824|NCT00705614|1352681|P2|Initial Intervention|Withdrawal by Subject|71
403825|NCT00705614|1352682|P1|Initial Intervention|Withdrawal by Subject|114
403826|NCT00705614|1352681|P2|Initial Intervention|Lost to Follow-up|191
403827|NCT00705614|1352682|P1|Initial Intervention|Lost to Follow-up|310
403828|NCT00705614|1352681|P2|Initial Intervention|Adverse Event|21
403829|NCT00705614|1352682|P1|Initial Intervention|Adverse Event|40
403830|NCT00705575|1352731|P2|Overall Study|Withdrawal by Subject|10
403831|NCT00705575|1352732|P1|Overall Study|Withdrawal by Subject|5
403832|NCT00705575|1352731|P2|Overall Study|Protocol Violation|2
403833|NCT00705575|1352732|P1|Overall Study|Protocol Violation|2
403834|NCT00705575|1352731|P2|Overall Study|Lost to Follow-up|4
403835|NCT00705575|1352732|P1|Overall Study|Lost to Follow-up|3
403836|NCT00705575|1352731|P2|Overall Study|Adverse Event|15
403837|NCT00705575|1352732|P1|Overall Study|Adverse Event|11
403838|NCT00705575|1352731|P2|Overall Study|Abnormal test procedure result(s)|12
403839|NCT00705575|1352732|P1|Overall Study|Abnormal test procedure result(s)|2
403840|NCT00705575|1352731|P2|Overall Study|Abnormal laboratory value(s)|3
403841|NCT00705575|1352732|P1|Overall Study|Abnormal laboratory value(s)|0
403842|NCT00705536|1352746|P4|Start Period 1|Withdrawal by Subject|1
403843|NCT00705536|1352747|P3|Start Period 1|Withdrawal by Subject|0
403844|NCT00705536|1352748|P2|Start Period 1|Withdrawal by Subject|0
403845|NCT00705536|1352749|P1|Start Period 1|Withdrawal by Subject|0
403846|NCT00705523|1352810|P2|Overall Study|Lost to Follow-up|3
403847|NCT00705523|1352811|P1|Overall Study|Lost to Follow-up|2
403848|NCT00705432|1352825|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
403849|NCT00705432|1352826|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
403850|NCT00705432|1352827|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
403851|NCT00705432|1352828|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
403852|NCT00705432|1352829|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
403853|NCT00705432|1352830|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
403854|NCT00705432|1352825|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
403855|NCT00705432|1352826|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
403856|NCT00705432|1352827|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
403857|NCT00705432|1352828|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
403858|NCT00705432|1352829|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
403859|NCT00705432|1352830|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
403860|NCT00705432|1352825|P6|Treatment Period|Non medical reason|7
403861|NCT00705432|1352826|P5|Treatment Period|Non medical reason|7
403862|NCT00705432|1352827|P4|Treatment Period|Non medical reason|4
403863|NCT00705432|1352828|P3|Treatment Period|Non medical reason|37
403864|NCT00705432|1352829|P2|Treatment Period|Non medical reason|32
403865|NCT00705432|1352830|P1|Treatment Period|Non medical reason|26
403866|NCT00705432|1352825|P6|Treatment Period|Treatment failure|14
403867|NCT00705432|1352826|P5|Treatment Period|Treatment failure|13
403868|NCT00705432|1352827|P4|Treatment Period|Treatment failure|25
403869|NCT00705432|1352828|P3|Treatment Period|Treatment failure|33
403870|NCT00705432|1352829|P2|Treatment Period|Treatment failure|42
403871|NCT00705432|1352830|P1|Treatment Period|Treatment failure|92
403872|NCT00705432|1352825|P6|Treatment Period|Adverse Event|9
403873|NCT00705432|1352826|P5|Treatment Period|Adverse Event|8
403874|NCT00705432|1352827|P4|Treatment Period|Adverse Event|12
403875|NCT00705432|1352828|P3|Treatment Period|Adverse Event|51
403876|NCT00705432|1352829|P2|Treatment Period|Adverse Event|37
403877|NCT00705432|1352830|P1|Treatment Period|Adverse Event|45
403878|NCT00705406|1352867|P2|Overall Study|Did not receive study drug|2
403879|NCT00705406|1352868|P1|Overall Study|Did not receive study drug|1
403880|NCT00705406|1352867|P2|Overall Study|Lost to Follow-up|3
403881|NCT00705406|1352868|P1|Overall Study|Lost to Follow-up|3
403882|NCT00705367|1352892|P2|Long-term Extension Period|Administrative reason by sponsor|0
403883|NCT00705367|1352893|P1|Long-term Extension Period|Administrative reason by sponsor|3
403884|NCT00705367|1352892|P2|Long-term Extension Period|No longer met study criteria|0
403885|NCT00705367|1352893|P1|Long-term Extension Period|No longer met study criteria|1
403886|NCT00705367|1352892|P2|Long-term Extension Period|Lack of Efficacy|0
403887|NCT00705367|1352893|P1|Long-term Extension Period|Lack of Efficacy|1
403888|NCT00705367|1352892|P2|Long-term Extension Period|Withdrawal by Subject|0
403889|NCT00705367|1352893|P1|Long-term Extension Period|Withdrawal by Subject|2
403890|NCT00705367|1352892|P2|Long-term Extension Period|Adverse Event|0
403891|NCT00705367|1352893|P1|Long-term Extension Period|Adverse Event|2
403892|NCT00705341|1352920|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
403893|NCT00705341|1352921|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
403894|NCT00705341|1352922|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
403895|NCT00705341|1352923|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
403896|NCT00705341|1352920|P4|Phase 2: Trial|Withdrawal by Subject|4
403897|NCT00705341|1352921|P3|Phase 2: Trial|Withdrawal by Subject|6
403898|NCT00705341|1352922|P2|Phase 2: Trial|Withdrawal by Subject|0
403899|NCT00705341|1352923|P1|Phase 2: Trial|Withdrawal by Subject|0
403900|NCT00705289|1352931|P1|Overall Study|Subject or treating physician's choice|131
403901|NCT00705263|1352955|P1|Overall Study|Withdrawal by Subject|2
403902|NCT00705250|1352959|P1|Overall Study|Patient died in car accident|1
403903|NCT00705250|1352959|P1|Overall Study|Withdrawal by Subject|1
403904|NCT00705224|1352963|P1|Overall Study|Lost to Follow-up|5
403905|NCT00705224|1352963|P1|Overall Study|Withdrawal by Subject|3
403906|NCT00705224|1352963|P1|Overall Study|Lack of Efficacy|2
403907|NCT00705224|1352963|P1|Overall Study|Adverse Event|1
403908|NCT00705159|1352979|P4|Overall Study|Screen Failure|1
403909|NCT00705159|1352980|P3|Overall Study|Screen Failure|0
403910|NCT00705159|1352981|P2|Overall Study|Screen Failure|0
403911|NCT00705159|1352982|P1|Overall Study|Screen Failure|0
403912|NCT00705159|1352979|P4|Overall Study|Lost to Follow-up|2
403913|NCT00705159|1352980|P3|Overall Study|Lost to Follow-up|3
403914|NCT00705159|1352981|P2|Overall Study|Lost to Follow-up|0
403915|NCT00705159|1352982|P1|Overall Study|Lost to Follow-up|0
403916|NCT00705159|1352979|P4|Overall Study|Adverse Event|0
403917|NCT00705159|1352980|P3|Overall Study|Adverse Event|1
403918|NCT00705159|1352981|P2|Overall Study|Adverse Event|0
403919|NCT00705159|1352982|P1|Overall Study|Adverse Event|0
403920|NCT00705159|1352979|P4|Overall Study|Protocol Violation|0
403921|NCT00705159|1352980|P3|Overall Study|Protocol Violation|0
403922|NCT00705159|1352981|P2|Overall Study|Protocol Violation|1
403923|NCT00705159|1352982|P1|Overall Study|Protocol Violation|0
403924|NCT00705159|1352979|P4|Overall Study|Withdrawal by Subject|1
403925|NCT00705159|1352980|P3|Overall Study|Withdrawal by Subject|1
403926|NCT00705159|1352981|P2|Overall Study|Withdrawal by Subject|1
403927|NCT00705159|1352982|P1|Overall Study|Withdrawal by Subject|0
403928|NCT00705146|1353002|P2|Overall Study|Lost to Follow-up|1
403929|NCT00705146|1353003|P1|Overall Study|Lost to Follow-up|1
403930|NCT00705016|1353032|P3|Overall Study|Other|6
403931|NCT00705016|1353033|P2|Overall Study|Other|6
403932|NCT00705016|1353034|P1|Overall Study|Other|9
403933|NCT00705016|1353032|P3|Overall Study|Symptomatic Deterioration|1
403934|NCT00705016|1353033|P2|Overall Study|Symptomatic Deterioration|1
403935|NCT00705016|1353034|P1|Overall Study|Symptomatic Deterioration|3
403936|NCT00705016|1353032|P3|Overall Study|Progressive Disease|33
403937|NCT00705016|1353033|P2|Overall Study|Progressive Disease|29
403938|NCT00705016|1353034|P1|Overall Study|Progressive Disease|33
403939|NCT00705016|1353032|P3|Overall Study|Withdrawal by Subject|2
403940|NCT00705016|1353033|P2|Overall Study|Withdrawal by Subject|3
403941|NCT00705016|1353034|P1|Overall Study|Withdrawal by Subject|4
403942|NCT00705016|1353032|P3|Overall Study|Protocol Violation|1
403943|NCT00705016|1353033|P2|Overall Study|Protocol Violation|1
403944|NCT00705016|1353034|P1|Overall Study|Protocol Violation|0
403945|NCT00705016|1353032|P3|Overall Study|Death|5
403946|NCT00705016|1353033|P2|Overall Study|Death|7
403947|NCT00705016|1353034|P1|Overall Study|Death|5
403948|NCT00705016|1353032|P3|Overall Study|Adverse Event|10
403949|NCT00705016|1353033|P2|Overall Study|Adverse Event|11
403950|NCT00705016|1353034|P1|Overall Study|Adverse Event|6
403951|NCT00704964|1353085|P1|Overall Study|Not completed on time|328
403952|NCT00704808|1353134|P1|Overall Study|Treatment change|1
403953|NCT00704808|1353134|P1|Overall Study|Lost to Follow-up|1
403954|NCT00704808|1353134|P1|Overall Study|Adverse Event|1
403955|NCT00704808|1353134|P1|Overall Study|Early therapy discontinuation|16
403956|NCT00704808|1353134|P1|Overall Study|Patient's decision|11
403957|NCT00704808|1353134|P1|Overall Study|Tumor progression|80
403958|NCT00704808|1353134|P1|Overall Study|Death|7
403959|NCT00704808|1353134|P1|Overall Study|Discontinued prior to starting treatment|14
403960|NCT00704730|1353145|P2|Overall Study|Withdrawal by Subject|13
403961|NCT00704730|1353146|P1|Overall Study|Withdrawal by Subject|9
403962|NCT00704730|1353145|P2|Overall Study|data unavailable|0
403963|NCT00704730|1353146|P1|Overall Study|data unavailable|1
403964|NCT00704730|1353145|P2|Overall Study|Disease progression per PI|67
403965|NCT00704730|1353146|P1|Overall Study|Disease progression per PI|58
403966|NCT00704730|1353145|P2|Overall Study|Did not receive drug|2
403967|NCT00704730|1353146|P1|Overall Study|Did not receive drug|5
403968|NCT00704730|1353145|P2|Overall Study|Physician Decision|0
403969|NCT00704730|1353146|P1|Overall Study|Physician Decision|2
403970|NCT00704730|1353145|P2|Overall Study|Death|5
403971|NCT00704730|1353146|P1|Overall Study|Death|11
403972|NCT00704730|1353145|P2|Overall Study|Adverse Event|9
403973|NCT00704730|1353146|P1|Overall Study|Adverse Event|35
403974|NCT00704535|1353166|P1|Overall Study|Completed status not on Case Report Form|124
403975|NCT00704535|1353166|P1|Overall Study|Protocol Violation|10
403976|NCT00704535|1353166|P1|Overall Study|Lost to Follow-up|8
403977|NCT00704535|1353166|P1|Overall Study|Death|2
403978|NCT00704535|1353166|P1|Overall Study|Adverse Event|2
403979|NCT00704522|1353179|P2|Overall Study|No information on therapy end|2
403980|NCT00704522|1353180|P1|Overall Study|No information on therapy end|27
403981|NCT00704522|1353179|P2|Overall Study|Undefined causes|7
403982|NCT00704522|1353180|P1|Overall Study|Undefined causes|9
403983|NCT00704522|1353179|P2|Overall Study|Adverse Event|1
403984|NCT00704522|1353180|P1|Overall Study|Adverse Event|9
403985|NCT00704522|1353179|P2|Overall Study|Withdrawal by Subject|8
403986|NCT00704522|1353180|P1|Overall Study|Withdrawal by Subject|17
403987|NCT00704522|1353179|P2|Overall Study|Failure to appear again at hospital|10
403988|NCT00704522|1353180|P1|Overall Study|Failure to appear again at hospital|56
403989|NCT00704522|1353179|P2|Overall Study|Lack of Efficacy|17
403990|NCT00704522|1353180|P1|Overall Study|Lack of Efficacy|65
403991|NCT00704418|1353200|P2|Overall Study|Over-enrolled/surgery postponed|6
403992|NCT00704418|1353201|P1|Overall Study|Over-enrolled/surgery postponed|3
403993|NCT00704418|1353200|P2|Overall Study|Withdrawal by Subject|0
403994|NCT00704418|1353201|P1|Overall Study|Withdrawal by Subject|2
403995|NCT00704405|1353214|P5|Overall Study (C Population)|Lost to Follow-up|0
403996|NCT00704405|1353215|P4|Overall Study (C Population)|Lost to Follow-up|0
403997|NCT00704405|1353216|P3|Overall Study (C Population)|Lost to Follow-up|0
403998|NCT00704405|1353217|P2|Overall Study (C Population)|Lost to Follow-up|2
403999|NCT00704405|1353218|P1|Overall Study (C Population)|Lost to Follow-up|0
404000|NCT00704405|1353214|P5|Overall Study (C Population)|Withdrawal by Subject|0
404001|NCT00704405|1353215|P4|Overall Study (C Population)|Withdrawal by Subject|1
404002|NCT00704405|1353216|P3|Overall Study (C Population)|Withdrawal by Subject|1
404003|NCT00704405|1353217|P2|Overall Study (C Population)|Withdrawal by Subject|1
404004|NCT00704405|1353218|P1|Overall Study (C Population)|Withdrawal by Subject|1
404005|NCT00704405|1353214|P5|Overall Study (NC Population)|Other|1
404006|NCT00704405|1353215|P4|Overall Study (NC Population)|Other|0
404007|NCT00704405|1353216|P3|Overall Study (NC Population)|Other|0
404008|NCT00704405|1353217|P2|Overall Study (NC Population)|Other|0
404009|NCT00704405|1353218|P1|Overall Study (NC Population)|Other|0
404010|NCT00704405|1353214|P5|Overall Study (NC Population)|Withdrawal by Subject|2
404011|NCT00704405|1353215|P4|Overall Study (NC Population)|Withdrawal by Subject|2
404012|NCT00704405|1353216|P3|Overall Study (NC Population)|Withdrawal by Subject|2
404013|NCT00704405|1353217|P2|Overall Study (NC Population)|Withdrawal by Subject|3
404014|NCT00704405|1353218|P1|Overall Study (NC Population)|Withdrawal by Subject|2
404015|NCT00704405|1353214|P5|Overall Study (NC Population)|Lost to Follow-up|2
404016|NCT00704405|1353215|P4|Overall Study (NC Population)|Lost to Follow-up|2
404017|NCT00704405|1353216|P3|Overall Study (NC Population)|Lost to Follow-up|1
404018|NCT00704405|1353217|P2|Overall Study (NC Population)|Lost to Follow-up|1
404019|NCT00704405|1353218|P1|Overall Study (NC Population)|Lost to Follow-up|2
404020|NCT00704405|1353214|P5|Overall Study (NC Population)|Adverse Event|0
404021|NCT00704405|1353215|P4|Overall Study (NC Population)|Adverse Event|0
404022|NCT00704405|1353216|P3|Overall Study (NC Population)|Adverse Event|0
404023|NCT00704405|1353217|P2|Overall Study (NC Population)|Adverse Event|0
404024|NCT00704405|1353218|P1|Overall Study (NC Population)|Adverse Event|1
404025|NCT00704340|1353276|P2|Overall Study|Death|1
404026|NCT00704340|1353277|P1|Overall Study|Death|0
404027|NCT00704340|1353276|P2|Overall Study|Lost to Follow-up|1
404028|NCT00704340|1353277|P1|Overall Study|Lost to Follow-up|2
404029|NCT00704184|1353292|P5|Open-Label Treatment|Withdrawal by Subject|0
404030|NCT00704184|1353293|P4|Open-Label Treatment|Withdrawal by Subject|3
404031|NCT00704184|1353294|P3|Open-Label Treatment|Withdrawal by Subject|0
404032|NCT00704184|1353295|P2|Open-Label Treatment|Withdrawal by Subject|0
404033|NCT00704184|1353296|P1|Open-Label Treatment|Withdrawal by Subject|1
404034|NCT00704184|1353292|P5|Open-Label Treatment|Physician Decision|1
404035|NCT00704184|1353293|P4|Open-Label Treatment|Physician Decision|0
404036|NCT00704184|1353294|P3|Open-Label Treatment|Physician Decision|0
404037|NCT00704184|1353295|P2|Open-Label Treatment|Physician Decision|0
404038|NCT00704184|1353296|P1|Open-Label Treatment|Physician Decision|0
404039|NCT00704184|1353292|P5|Open-Label Treatment|Lack of Efficacy|1
404040|NCT00704184|1353293|P4|Open-Label Treatment|Lack of Efficacy|2
404041|NCT00704184|1353294|P3|Open-Label Treatment|Lack of Efficacy|2
404042|NCT00704184|1353295|P2|Open-Label Treatment|Lack of Efficacy|2
404043|NCT00704184|1353296|P1|Open-Label Treatment|Lack of Efficacy|0
404044|NCT00704184|1353292|P5|Open-Label Treatment|Adverse Event|1
404045|NCT00704184|1353293|P4|Open-Label Treatment|Adverse Event|0
404046|NCT00704184|1353294|P3|Open-Label Treatment|Adverse Event|2
404047|NCT00704184|1353295|P2|Open-Label Treatment|Adverse Event|0
404048|NCT00704184|1353296|P1|Open-Label Treatment|Adverse Event|0
404049|NCT00704184|1353292|P5|Double-Blind Treatment|Withdrawal by Subject|0
404050|NCT00704184|1353293|P4|Double-Blind Treatment|Withdrawal by Subject|0
404051|NCT00704184|1353294|P3|Double-Blind Treatment|Withdrawal by Subject|0
404052|NCT00704184|1353295|P2|Double-Blind Treatment|Withdrawal by Subject|0
404053|NCT00704184|1353296|P1|Double-Blind Treatment|Withdrawal by Subject|1
404054|NCT00704171|1353335|P2|Overall Study|Withdrawal by Subject|0
404055|NCT00704171|1353336|P1|Overall Study|Withdrawal by Subject|1
404056|NCT00704132|1353354|P2|Overall Study|Withdrawal by Subject|1
404057|NCT00704132|1353355|P1|Overall Study|Withdrawal by Subject|0
404058|NCT00704132|1353354|P2|Overall Study|Lack of Efficacy|1
404059|NCT00704132|1353355|P1|Overall Study|Lack of Efficacy|0
404060|NCT00704132|1353354|P2|Overall Study|Clinical Adverse Experience|0
404061|NCT00704132|1353355|P1|Overall Study|Clinical Adverse Experience|1
404062|NCT00703963|1353383|P2|Overall Study|Physician Decision|1
404063|NCT00703963|1353384|P1|Overall Study|Physician Decision|0
404064|NCT00703963|1353383|P2|Overall Study|Withdrawal by Subject|13
404065|NCT00703963|1353384|P1|Overall Study|Withdrawal by Subject|7
404066|NCT00703924|1353405|P2|Overall Study|Withdrawal by Subject|1
404067|NCT00703924|1353406|P1|Overall Study|Withdrawal by Subject|1
404068|NCT00703911|1353422|P1|Overall Study|Withdrawal by Subject|2
404069|NCT00703911|1353422|P1|Overall Study|Lost to Follow-up|1
404070|NCT00703911|1353422|P1|Overall Study|Physician Decision|6
404071|NCT00703911|1353422|P1|Overall Study|Death|1
404072|NCT00703846|1353455|P1|Overall Study|Did Not Receive Study Drug|2
404073|NCT00703846|1353455|P1|Overall Study|Other|14
404074|NCT00703846|1353455|P1|Overall Study|Death|1
404075|NCT00703846|1353455|P1|Overall Study|Withdrawal by Subject|40
404076|NCT00703846|1353455|P1|Overall Study|Noncompliance with Study Treatment|2
404077|NCT00703846|1353455|P1|Overall Study|Lack of Efficacy|15
404078|NCT00703846|1353455|P1|Overall Study|Lost to Follow-up|55
404079|NCT00703846|1353455|P1|Overall Study|Adverse Event|8
404080|NCT00703820|1353471|P2|Overall Study|Withdrawal by Subject|1
404081|NCT00703820|1353472|P1|Overall Study|Withdrawal by Subject|2
404082|NCT00703820|1353471|P2|Overall Study|Physician Decision|5
404083|NCT00703820|1353472|P1|Overall Study|Physician Decision|4
404084|NCT00703820|1353471|P2|Overall Study|Received non-protocol therapy|0
404085|NCT00703820|1353472|P1|Overall Study|Received non-protocol therapy|1
404086|NCT00703820|1353471|P2|Overall Study|Lack of Efficacy|11
404087|NCT00703820|1353472|P1|Overall Study|Lack of Efficacy|11
404088|NCT00703820|1353471|P2|Overall Study|Death|0
404089|NCT00703820|1353472|P1|Overall Study|Death|5
404090|NCT00703820|1353471|P2|Overall Study|Adverse Event|17
404091|NCT00703820|1353472|P1|Overall Study|Adverse Event|12
404092|NCT00703781|1353481|P2|Overall Study|Cancelled surgery|0
404093|NCT00703781|1353482|P1|Overall Study|Cancelled surgery|1
404094|NCT00703781|1353481|P2|Overall Study|Withdrawal by Subject|2
404095|NCT00703781|1353482|P1|Overall Study|Withdrawal by Subject|1
404096|NCT00703677|1353527|P1|Overall Study|Dropout-withdrawal not related to drug|3
404097|NCT00703534|1353542|P2|Overall Study|Severe Non Compliance|5
404098|NCT00703534|1353543|P1|Overall Study|Severe Non Compliance|1
404099|NCT00703534|1353542|P2|Overall Study|Lost to Follow-up|4
404100|NCT00703534|1353543|P1|Overall Study|Lost to Follow-up|1
404101|NCT00703534|1353542|P2|Overall Study|Incorrect Enrollment|6
404102|NCT00703534|1353543|P1|Overall Study|Incorrect Enrollment|6
404103|NCT00703534|1353542|P2|Overall Study|Withdrawal by Subject|7
404104|NCT00703534|1353543|P1|Overall Study|Withdrawal by Subject|8
404105|NCT00703534|1353542|P2|Overall Study|Adverse Event|3
404106|NCT00703534|1353543|P1|Overall Study|Adverse Event|14
404107|NCT00703326|1353615|P2|Overall Study|Withdrawal by Subject|20
404108|NCT00703326|1353616|P1|Overall Study|Withdrawal by Subject|42
404109|NCT00703326|1353615|P2|Overall Study|Lost to Follow-up|8
404110|NCT00703326|1353616|P1|Overall Study|Lost to Follow-up|25
404111|NCT00703326|1353615|P2|Overall Study|Still on study|197
404112|NCT00703326|1353616|P1|Overall Study|Still on study|380
404113|NCT00703157|1353648|P2|Overall Study|source data permanently lost/ other|1
404114|NCT00703157|1353649|P1|Overall Study|source data permanently lost/ other|4
404115|NCT00703157|1353648|P2|Overall Study|Lost to Follow-up|1
404116|NCT00703157|1353649|P1|Overall Study|Lost to Follow-up|0
404117|NCT00703118|1353683|P3|Overall Study|Not specified|1
404118|NCT00703118|1353684|P2|Overall Study|Not specified|0
404119|NCT00703118|1353685|P1|Overall Study|Not specified|0
404120|NCT00703118|1353683|P3|Overall Study|Withdrawal by Subject|13
404121|NCT00703118|1353684|P2|Overall Study|Withdrawal by Subject|7
404122|NCT00703118|1353685|P1|Overall Study|Withdrawal by Subject|8
404123|NCT00703118|1353683|P3|Overall Study|Lost to Follow-up|4
404124|NCT00703118|1353684|P2|Overall Study|Lost to Follow-up|4
404125|NCT00703118|1353685|P1|Overall Study|Lost to Follow-up|6
404126|NCT00703118|1353683|P3|Overall Study|Subject Ineligible To Continue The Trial|2
404127|NCT00703118|1353684|P2|Overall Study|Subject Ineligible To Continue The Trial|3
404128|NCT00703118|1353685|P1|Overall Study|Subject Ineligible To Continue The Trial|6
404129|NCT00703118|1353683|P3|Overall Study|Adverse Event|2
404130|NCT00703118|1353684|P2|Overall Study|Adverse Event|2
404131|NCT00703118|1353685|P1|Overall Study|Adverse Event|1
404132|NCT00703092|1353716|P1|Overall Study|Withdrawal by Subject|2
404133|NCT00703014|1353924|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
404134|NCT00703014|1353925|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
404135|NCT00703014|1353926|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
404136|NCT00703014|1353927|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
404137|NCT00703014|1353924|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
404138|NCT00703014|1353925|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
404139|NCT00703014|1353926|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
404140|NCT00703014|1353927|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
404141|NCT00702949|1353948|P3|Overall Study|Other Medical Reason/unknown|3
404142|NCT00702949|1353949|P2|Overall Study|Other Medical Reason/unknown|1
404143|NCT00702949|1353950|P1|Overall Study|Other Medical Reason/unknown|1
404144|NCT00702949|1353948|P3|Overall Study|Adverse Event|3
404145|NCT00702949|1353949|P2|Overall Study|Adverse Event|6
404146|NCT00702949|1353950|P1|Overall Study|Adverse Event|1
404147|NCT00702949|1353948|P3|Overall Study|Refusal|2
404148|NCT00702949|1353949|P2|Overall Study|Refusal|2
404149|NCT00702949|1353950|P1|Overall Study|Refusal|3
404150|NCT00702923|1353975|P1|Overall Study|Adverse Event|1
404151|NCT00702845|1353998|P2|Overall Study|Not randomized|1
404152|NCT00702845|1353999|P1|Overall Study|Not randomized|0
404153|NCT00702845|1353998|P2|Overall Study|Patient's decision|1
404154|NCT00702845|1353999|P1|Overall Study|Patient's decision|2
404155|NCT00702845|1353998|P2|Overall Study|No or abnormal fertilization|2
404156|NCT00702845|1353999|P1|Overall Study|No or abnormal fertilization|4
404157|NCT00702845|1353998|P2|Overall Study|No/too few/bad quality embryos retrieved|1
404158|NCT00702845|1353999|P1|Overall Study|No/too few/bad quality embryos retrieved|7
404159|NCT00702845|1353998|P2|Overall Study|Insufficient ovarian response|0
404160|NCT00702845|1353999|P1|Overall Study|Insufficient ovarian response|1
404161|NCT00702845|1353998|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
404162|NCT00702845|1353999|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
404163|NCT00702845|1353998|P2|Overall Study|Too high ovarian response|1
404164|NCT00702845|1353999|P1|Overall Study|Too high ovarian response|5
404165|NCT00702845|1353998|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
404166|NCT00702845|1353999|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
404167|NCT00702715|1354061|P2|Overall Study|Lost to Follow-up|0
404168|NCT00702715|1354062|P1|Overall Study|Lost to Follow-up|1
404169|NCT00702702|1354075|P1|Overall Study|Study prematurely terminated|56
404170|NCT00702689|1354083|P1|Overall Study|Adverse Event|1
404171|NCT00702689|1354083|P1|Overall Study|Recurrent malignancy|1
404172|NCT00702689|1354083|P1|Overall Study|Withdrawal by Subject|4
404173|NCT00702650|1354094|P1|Overall Study|Adverse Event|3
404174|NCT00702650|1354094|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
404175|NCT00702650|1354094|P1|Overall Study|Sponsor Request|1
404176|NCT00702650|1354094|P1|Overall Study|Non-Compliance with Site Directives|1
404177|NCT00702650|1354094|P1|Overall Study|Lost to Follow-up|2
404178|NCT00702650|1354094|P1|Overall Study|Non-Compliance of Study Drug|3
404179|NCT00702650|1354094|P1|Overall Study|Withdrawal by Subject|9
404180|NCT00702520|1354156|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
404181|NCT00702520|1354157|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
404182|NCT00702520|1354158|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
404183|NCT00702520|1354159|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
404184|NCT00702520|1354156|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
404185|NCT00702520|1354157|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
404186|NCT00702520|1354158|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
404187|NCT00702520|1354159|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
404188|NCT00702520|1354156|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
404189|NCT00702520|1354157|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
404190|NCT00702520|1354158|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
404191|NCT00702520|1354159|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
404192|NCT00702507|1354175|P1|Follow-up Phase|Late Enrollment|1
404193|NCT00702507|1354175|P1|Follow-up Phase|Lost to Follow-up|23
404194|NCT00702507|1354175|P1|Follow-up Phase|Protocol Violation|2
404195|NCT00702507|1354175|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
404196|NCT00702507|1354175|P1|Initial Treatment Phase|Negative Candida Culture|34
404197|NCT00702507|1354175|P1|Initial Treatment Phase|Lost to Follow-up|2
404198|NCT00702507|1354175|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
404199|NCT00702507|1354175|P1|Initial Treatment Phase|Adverse Event|2
404200|NCT00702403|1354212|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
404201|NCT00702403|1354212|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
404202|NCT00702403|1354212|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
404203|NCT00702403|1354212|P1|From Engraftment to Study Completion|Suicide|1
404204|NCT00702403|1354212|P1|From Engraftment to Study Completion|Liver GVHD|1
404205|NCT00702403|1354212|P1|From Engraftment to Study Completion|Adenocarcinoma|1
404206|NCT00702403|1354212|P1|From Engraftment to Study Completion|Non-compliance|2
404207|NCT00702403|1354212|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
404208|NCT00702403|1354212|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
404209|NCT00702403|1354212|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
404210|NCT00702403|1354212|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
404211|NCT00702403|1354212|P1|From Consent to Engraftment|Myocardial infarction|1
404212|NCT00702403|1354212|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
404213|NCT00702403|1354212|P1|From Consent to Engraftment|Critically ill|2
404214|NCT00702403|1354212|P1|From Consent to Engraftment|Progressive leukemia|6
404215|NCT00702325|1354266|P2|Overall Study|Incorrectly Discontinued|1
404216|NCT00702325|1354267|P1|Overall Study|Incorrectly Discontinued|0
404217|NCT00702325|1354266|P2|Overall Study|Withdrew consent|1
404218|NCT00702325|1354267|P1|Overall Study|Withdrew consent|0
404219|NCT00702325|1354266|P2|Overall Study|Didn't follow study medication dosage|2
404220|NCT00702325|1354267|P1|Overall Study|Didn't follow study medication dosage|0
404221|NCT00702325|1354266|P2|Overall Study|Termination due to lab results|0
404222|NCT00702325|1354267|P1|Overall Study|Termination due to lab results|1
404223|NCT00702325|1354266|P2|Overall Study|Severe noncompliance to protocol|3
404224|NCT00702325|1354267|P1|Overall Study|Severe noncompliance to protocol|3
404225|NCT00702325|1354266|P2|Overall Study|Developed study discontinuation criteria|28
404226|NCT00702325|1354267|P1|Overall Study|Developed study discontinuation criteria|18
404227|NCT00702325|1354266|P2|Overall Study|Incorrect enrollment|7
404228|NCT00702325|1354267|P1|Overall Study|Incorrect enrollment|5
404229|NCT00702325|1354266|P2|Overall Study|Lost to Follow-up|4
404230|NCT00702325|1354267|P1|Overall Study|Lost to Follow-up|3
404231|NCT00702325|1354266|P2|Overall Study|Withdrawal by Subject|7
404232|NCT00702325|1354267|P1|Overall Study|Withdrawal by Subject|7
404233|NCT00702325|1354266|P2|Overall Study|Adverse Event|0
404234|NCT00702325|1354267|P1|Overall Study|Adverse Event|1
404235|NCT00702221|1354363|P2|Overall Study|Adverse Event|3
404236|NCT00702221|1354364|P1|Overall Study|Adverse Event|4
404237|NCT00702208|1354370|P1|Overall Study|Unsatisfactory colposcopy|2
404238|NCT00702208|1354370|P1|Overall Study|Did not self-lavage|1
404239|NCT00702208|1354370|P1|Overall Study|Lost to Follow-up|28
404240|NCT00702143|1354379|P3|Overall Study|Lost to Follow-up|1
404241|NCT00702143|1354380|P2|Overall Study|Lost to Follow-up|0
404242|NCT00702143|1354381|P1|Overall Study|Lost to Follow-up|0
404243|NCT00701805|1354430|P4|Overall Study|Resumption criteria were not met|0
404244|NCT00701805|1354431|P3|Overall Study|Resumption criteria were not met|0
404245|NCT00701805|1354432|P2|Overall Study|Resumption criteria were not met|1
404246|NCT00701805|1354433|P1|Overall Study|Resumption criteria were not met|0
404247|NCT00701805|1354430|P4|Overall Study|Difficult to travel to dialysis site|0
404248|NCT00701805|1354431|P3|Overall Study|Difficult to travel to dialysis site|1
404249|NCT00701805|1354432|P2|Overall Study|Difficult to travel to dialysis site|0
404250|NCT00701805|1354433|P1|Overall Study|Difficult to travel to dialysis site|0
404251|NCT00701805|1354430|P4|Overall Study|Physician decision, change of therapy|1
404252|NCT00701805|1354431|P3|Overall Study|Physician decision, change of therapy|0
404253|NCT00701805|1354432|P2|Overall Study|Physician decision, change of therapy|0
404254|NCT00701805|1354433|P1|Overall Study|Physician decision, change of therapy|0
404255|NCT00701805|1354430|P4|Overall Study|Admitted to hospital for 2 weeks|0
404256|NCT00701805|1354431|P3|Overall Study|Admitted to hospital for 2 weeks|1
404257|NCT00701805|1354432|P2|Overall Study|Admitted to hospital for 2 weeks|0
404258|NCT00701805|1354433|P1|Overall Study|Admitted to hospital for 2 weeks|0
404259|NCT00701805|1354430|P4|Overall Study|Missed 7 consecutive doses|0
404260|NCT00701805|1354431|P3|Overall Study|Missed 7 consecutive doses|0
404261|NCT00701805|1354432|P2|Overall Study|Missed 7 consecutive doses|1
404262|NCT00701805|1354433|P1|Overall Study|Missed 7 consecutive doses|0
404263|NCT00701805|1354430|P4|Overall Study|Adverse Event|0
404264|NCT00701805|1354431|P3|Overall Study|Adverse Event|1
404265|NCT00701805|1354432|P2|Overall Study|Adverse Event|1
404266|NCT00701805|1354433|P1|Overall Study|Adverse Event|0
404267|NCT00701805|1354430|P4|Overall Study|Withdrawal by Subject|3
404268|NCT00701805|1354431|P3|Overall Study|Withdrawal by Subject|4
404269|NCT00701805|1354432|P2|Overall Study|Withdrawal by Subject|1
404270|NCT00701805|1354433|P1|Overall Study|Withdrawal by Subject|3
404271|NCT00701779|1354483|P1|Overall Study|Withdrawal by Subject|2
404272|NCT00701779|1354483|P1|Overall Study|Lost to Follow-up|1
404273|NCT00701779|1354483|P1|Overall Study|Adverse Event|6
404274|NCT00701727|1354492|P2|Second Treatment Period|Withdrawal by Subject|0
404275|NCT00701727|1354493|P1|Second Treatment Period|Withdrawal by Subject|2
404276|NCT00701727|1354492|P2|First Treatment Period|Lost to Follow-up|1
404277|NCT00701727|1354493|P1|First Treatment Period|Lost to Follow-up|0
404278|NCT00701727|1354492|P2|First Treatment Period|sponsor decision|1
404279|NCT00701727|1354493|P1|First Treatment Period|sponsor decision|0
404280|NCT00701727|1354492|P2|First Treatment Period|Withdrawal by Subject|0
404281|NCT00701727|1354493|P1|First Treatment Period|Withdrawal by Subject|1
404282|NCT00701727|1354492|P2|First Treatment Period|Adverse Event|0
404283|NCT00701727|1354493|P1|First Treatment Period|Adverse Event|0
404284|NCT00701662|1354539|P1|Overall Study|Lack of Efficacy|1
404285|NCT00701558|1354564|P1|Overall Study|Lost to Follow-up|8
404286|NCT00701558|1354564|P1|Overall Study|Death|7
404287|NCT00701441|1354572|P2|Overall Study|failure in cpap compliance|4
404288|NCT00701441|1354573|P1|Overall Study|failure in cpap compliance|0
404289|NCT00701415|1354585|P2|Overall Study|Social/family issues and needle phobia|0
404290|NCT00701415|1354586|P1|Overall Study|Social/family issues and needle phobia|1
404291|NCT00701415|1354585|P2|Overall Study|Adverse Event|1
404292|NCT00701415|1354586|P1|Overall Study|Adverse Event|0
404293|NCT00701363|1354621|P4|Treatment Phase 2|Withdrawal by Subject|0
404294|NCT00701363|1354622|P3|Treatment Phase 2|Withdrawal by Subject|1
404295|NCT00701363|1354623|P2|Treatment Phase 2|Withdrawal by Subject|0
404296|NCT00701363|1354624|P1|Treatment Phase 2|Withdrawal by Subject|0
404297|NCT00701363|1354621|P4|Treatment Phase 2|Adverse Event|0
404298|NCT00701363|1354622|P3|Treatment Phase 2|Adverse Event|1
404299|NCT00701363|1354623|P2|Treatment Phase 2|Adverse Event|0
404300|NCT00701363|1354624|P1|Treatment Phase 2|Adverse Event|0
404301|NCT00701363|1354621|P4|Treatment Phase 1|Lack of Efficacy|0
404302|NCT00701363|1354622|P3|Treatment Phase 1|Lack of Efficacy|0
404303|NCT00701363|1354623|P2|Treatment Phase 1|Lack of Efficacy|0
404304|NCT00701363|1354624|P1|Treatment Phase 1|Lack of Efficacy|1
404305|NCT00701363|1354621|P4|Treatment Phase 1|Withdrawal by Subject|0
404306|NCT00701363|1354622|P3|Treatment Phase 1|Withdrawal by Subject|0
404307|NCT00701363|1354623|P2|Treatment Phase 1|Withdrawal by Subject|0
404308|NCT00701363|1354624|P1|Treatment Phase 1|Withdrawal by Subject|5
404309|NCT00701363|1354621|P4|Treatment Phase 1|Protocol Violation|0
404310|NCT00701363|1354622|P3|Treatment Phase 1|Protocol Violation|0
404311|NCT00701363|1354623|P2|Treatment Phase 1|Protocol Violation|0
404312|NCT00701363|1354624|P1|Treatment Phase 1|Protocol Violation|1
404313|NCT00701363|1354621|P4|Treatment Phase 1|Adverse Event|0
404314|NCT00701363|1354622|P3|Treatment Phase 1|Adverse Event|0
404315|NCT00701363|1354623|P2|Treatment Phase 1|Adverse Event|0
404316|NCT00701363|1354624|P1|Treatment Phase 1|Adverse Event|7
404317|NCT00701363|1354621|P4|Treatment Phase 1|Does not meet entry Criteria|0
404318|NCT00701363|1354622|P3|Treatment Phase 1|Does not meet entry Criteria|0
404319|NCT00701363|1354623|P2|Treatment Phase 1|Does not meet entry Criteria|0
404320|NCT00701363|1354624|P1|Treatment Phase 1|Does not meet entry Criteria|1
404321|NCT00701363|1354621|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
404322|NCT00701363|1354622|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
404323|NCT00701363|1354623|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
404324|NCT00701363|1354624|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
404325|NCT00701311|1354664|P1|Overall Study|Withdrawal by Subject|2
404326|NCT00701311|1354664|P1|Overall Study|Adverse Event|3
404327|NCT00701311|1354664|P1|Overall Study|Lack of Efficacy|3
404328|NCT00701129|1354668|P1|Overall Study|Death|2
404329|NCT00701103|1354690|P11|Overall Study|Other|0
404330|NCT00701103|1354691|P10|Overall Study|Other|1
404331|NCT00701103|1354692|P9|Overall Study|Other|1
404332|NCT00701103|1354693|P8|Overall Study|Other|0
404333|NCT00701103|1354694|P7|Overall Study|Other|0
404334|NCT00701103|1354695|P6|Overall Study|Other|0
404335|NCT00701103|1354696|P5|Overall Study|Other|0
404336|NCT00701103|1354697|P4|Overall Study|Other|0
404337|NCT00701103|1354698|P3|Overall Study|Other|0
404338|NCT00701103|1354699|P2|Overall Study|Other|0
404339|NCT00701103|1354700|P1|Overall Study|Other|0
404340|NCT00701103|1354690|P11|Overall Study|Withdrawal by Subject|0
404341|NCT00701103|1354691|P10|Overall Study|Withdrawal by Subject|0
404342|NCT00701103|1354692|P9|Overall Study|Withdrawal by Subject|0
404343|NCT00701103|1354693|P8|Overall Study|Withdrawal by Subject|0
404344|NCT00701103|1354694|P7|Overall Study|Withdrawal by Subject|0
404345|NCT00701103|1354695|P6|Overall Study|Withdrawal by Subject|0
404346|NCT00701103|1354696|P5|Overall Study|Withdrawal by Subject|0
404347|NCT00701103|1354697|P4|Overall Study|Withdrawal by Subject|0
404348|NCT00701103|1354698|P3|Overall Study|Withdrawal by Subject|1
404349|NCT00701103|1354699|P2|Overall Study|Withdrawal by Subject|1
404350|NCT00701103|1354700|P1|Overall Study|Withdrawal by Subject|0
404351|NCT00701103|1354690|P11|Overall Study|Progressive Disease|11
404352|NCT00701103|1354691|P10|Overall Study|Progressive Disease|8
404353|NCT00701103|1354692|P9|Overall Study|Progressive Disease|8
404354|NCT00701103|1354693|P8|Overall Study|Progressive Disease|7
404355|NCT00701103|1354694|P7|Overall Study|Progressive Disease|7
404356|NCT00701103|1354695|P6|Overall Study|Progressive Disease|5
404357|NCT00701103|1354696|P5|Overall Study|Progressive Disease|6
404358|NCT00701103|1354697|P4|Overall Study|Progressive Disease|5
404359|NCT00701103|1354698|P3|Overall Study|Progressive Disease|6
404360|NCT00701103|1354699|P2|Overall Study|Progressive Disease|2
404361|NCT00701103|1354700|P1|Overall Study|Progressive Disease|5
404362|NCT00701103|1354690|P11|Overall Study|Adverse Event|0
404363|NCT00701103|1354691|P10|Overall Study|Adverse Event|2
404364|NCT00701103|1354692|P9|Overall Study|Adverse Event|0
404365|NCT00701103|1354693|P8|Overall Study|Adverse Event|0
404366|NCT00701103|1354694|P7|Overall Study|Adverse Event|1
404367|NCT00701103|1354695|P6|Overall Study|Adverse Event|1
404368|NCT00701103|1354696|P5|Overall Study|Adverse Event|0
404369|NCT00701103|1354697|P4|Overall Study|Adverse Event|1
404370|NCT00701103|1354698|P3|Overall Study|Adverse Event|1
404371|NCT00701103|1354699|P2|Overall Study|Adverse Event|0
404372|NCT00701103|1354700|P1|Overall Study|Adverse Event|0
404373|NCT00701090|1354806|P2|Overall Study|Other|12
404374|NCT00701090|1354807|P1|Overall Study|Other|7
404375|NCT00701090|1354806|P2|Overall Study|Withdrawal by Subject|16
404376|NCT00701090|1354807|P1|Overall Study|Withdrawal by Subject|11
404377|NCT00701090|1354806|P2|Overall Study|Protocol Violation|3
404378|NCT00701090|1354807|P1|Overall Study|Protocol Violation|2
404379|NCT00701090|1354806|P2|Overall Study|Physician Decision|4
404380|NCT00701090|1354807|P1|Overall Study|Physician Decision|3
404381|NCT00701090|1354806|P2|Overall Study|Lost to Follow-up|9
404382|NCT00701090|1354807|P1|Overall Study|Lost to Follow-up|9
404383|NCT00701090|1354806|P2|Overall Study|Lack of Efficacy|4
404384|NCT00701090|1354807|P1|Overall Study|Lack of Efficacy|5
404385|NCT00701090|1354806|P2|Overall Study|Death|1
404386|NCT00701090|1354807|P1|Overall Study|Death|0
404387|NCT00701090|1354806|P2|Overall Study|Adverse Event|2
404388|NCT00701090|1354807|P1|Overall Study|Adverse Event|11
404389|NCT00701064|1354825|P2|Overall Study|initiated other PTSD treatment|2
404390|NCT00701064|1354826|P1|Overall Study|initiated other PTSD treatment|2
404391|NCT00701064|1354825|P2|Overall Study|Withdrawal by Subject|1
404392|NCT00701064|1354826|P1|Overall Study|Withdrawal by Subject|1
404393|NCT00701064|1354825|P2|Overall Study|Protocol Violation|1
404394|NCT00701064|1354826|P1|Overall Study|Protocol Violation|1
404395|NCT00701051|1354834|P3|Exercise Intervention|time conflict; non-study related illness|3
404396|NCT00701051|1354835|P2|Exercise Intervention|time conflict; non-study related illness|5
404397|NCT00701051|1354836|P1|Exercise Intervention|time conflict; non-study related illness|0
404398|NCT00701051|1354834|P3|Screening|Time conflicts|0
404399|NCT00701051|1354835|P2|Screening|Time conflicts|0
404400|NCT00701051|1354836|P1|Screening|Time conflicts|19
404401|NCT00701051|1354834|P3|Screening|Failed Screening|0
404402|NCT00701051|1354835|P2|Screening|Failed Screening|0
404403|NCT00701051|1354836|P1|Screening|Failed Screening|40
404404|NCT00701038|1354854|P2|Overall Study|study amended pilot group of patients|4
404405|NCT00701038|1354855|P1|Overall Study|study amended pilot group of patients|4
404406|NCT00700999|1354863|P2|Overall Study|Withdrawal by Subject|1
404407|NCT00700999|1354864|P1|Overall Study|Withdrawal by Subject|8
404408|NCT00700999|1354863|P2|Overall Study|Excluded - did not meet study criteria|1
404409|NCT00700999|1354864|P1|Overall Study|Excluded - did not meet study criteria|0
404410|NCT00700999|1354863|P2|Overall Study|Lost to Follow-up|7
404411|NCT00700999|1354864|P1|Overall Study|Lost to Follow-up|7
404412|NCT00700817|1354884|P5|Week 52-78 (Extension Period 2)|Unclassified|1
404413|NCT00700817|1354885|P4|Week 52-78 (Extension Period 2)|Unclassified|0
404414|NCT00700817|1354886|P3|Week 52-78 (Extension Period 2)|Unclassified|0
404415|NCT00700817|1354887|P2|Week 52-78 (Extension Period 2)|Unclassified|4
404416|NCT00700817|1354888|P1|Week 52-78 (Extension Period 2)|Unclassified|2
404417|NCT00700817|1354884|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
404418|NCT00700817|1354885|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
404419|NCT00700817|1354886|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
404420|NCT00700817|1354887|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
404421|NCT00700817|1354888|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
404422|NCT00700817|1354884|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
404423|NCT00700817|1354885|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
404424|NCT00700817|1354886|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
404425|NCT00700817|1354887|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
404426|NCT00700817|1354888|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
404427|NCT00700817|1354884|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
404428|NCT00700817|1354885|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
404429|NCT00700817|1354886|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
404430|NCT00700817|1354887|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
404431|NCT00700817|1354888|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
404432|NCT00700817|1354884|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
404433|NCT00700817|1354885|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
404434|NCT00700817|1354886|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
404435|NCT00700817|1354887|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
404436|NCT00700817|1354888|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
404437|NCT00700817|1354884|P5|Week 26-52 (Extension Period 1)|Unclassified|0
404438|NCT00700817|1354885|P4|Week 26-52 (Extension Period 1)|Unclassified|0
404439|NCT00700817|1354886|P3|Week 26-52 (Extension Period 1)|Unclassified|1
404440|NCT00700817|1354887|P2|Week 26-52 (Extension Period 1)|Unclassified|3
404441|NCT00700817|1354888|P1|Week 26-52 (Extension Period 1)|Unclassified|4
404442|NCT00700817|1354884|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
404443|NCT00700817|1354885|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
404444|NCT00700817|1354886|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
404445|NCT00700817|1354887|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
404446|NCT00700817|1354888|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
404447|NCT00700817|1354884|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
404448|NCT00700817|1354885|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
404449|NCT00700817|1354886|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
404450|NCT00700817|1354887|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
404451|NCT00700817|1354888|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
404452|NCT00700817|1354884|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
404453|NCT00700817|1354885|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
404454|NCT00700817|1354886|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
404455|NCT00700817|1354887|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
404456|NCT00700817|1354888|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
404457|NCT00700817|1354884|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
404458|NCT00700817|1354885|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
404459|NCT00700817|1354886|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
404460|NCT00700817|1354887|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
404461|NCT00700817|1354888|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
404462|NCT00700817|1354884|P5|Week 0-26 (Main Period)|Unclassified|0
404463|NCT00700817|1354885|P4|Week 0-26 (Main Period)|Unclassified|0
404464|NCT00700817|1354886|P3|Week 0-26 (Main Period)|Unclassified|8
404465|NCT00700817|1354887|P2|Week 0-26 (Main Period)|Unclassified|4
404466|NCT00700817|1354888|P1|Week 0-26 (Main Period)|Unclassified|14
404467|NCT00700817|1354884|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
404468|NCT00700817|1354885|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
404469|NCT00700817|1354886|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
404470|NCT00700817|1354887|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
404471|NCT00700817|1354888|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
404472|NCT00700817|1354884|P5|Week 0-26 (Main Period)|Protocol Violation|0
404473|NCT00700817|1354885|P4|Week 0-26 (Main Period)|Protocol Violation|0
404474|NCT00700817|1354886|P3|Week 0-26 (Main Period)|Protocol Violation|4
404475|NCT00700817|1354887|P2|Week 0-26 (Main Period)|Protocol Violation|4
404476|NCT00700817|1354888|P1|Week 0-26 (Main Period)|Protocol Violation|14
404477|NCT00700817|1354884|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
404478|NCT00700817|1354885|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
404479|NCT00700817|1354886|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
404480|NCT00700817|1354887|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
404481|NCT00700817|1354888|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
404482|NCT00700817|1354884|P5|Week 0-26 (Main Period)|Adverse Event|0
404483|NCT00700817|1354885|P4|Week 0-26 (Main Period)|Adverse Event|0
404484|NCT00700817|1354886|P3|Week 0-26 (Main Period)|Adverse Event|4
404485|NCT00700817|1354887|P2|Week 0-26 (Main Period)|Adverse Event|15
404486|NCT00700817|1354888|P1|Week 0-26 (Main Period)|Adverse Event|14
404487|NCT00700804|1355270|P2|Overall Study|Loose Stools|1
404488|NCT00700804|1355271|P1|Overall Study|Loose Stools|1
404489|NCT00700804|1355270|P2|Overall Study|Protocol Violation|1
404490|NCT00700804|1355271|P1|Overall Study|Protocol Violation|1
404491|NCT00700804|1355270|P2|Overall Study|Withdrawal by Subject|2
404492|NCT00700804|1355271|P1|Overall Study|Withdrawal by Subject|1
404493|NCT00700752|1355279|P2|First Intervention|Withdrawal by Subject|2
404494|NCT00700752|1355280|P1|First Intervention|Withdrawal by Subject|0
404495|NCT00700739|1355288|P2|Overall Study|Lost to Follow-up|4
404496|NCT00700739|1355289|P1|Overall Study|Lost to Follow-up|4
404497|NCT00700713|1355328|P3|Overall Study|Withdrawal by Subject|1
404498|NCT00700713|1355329|P2|Overall Study|Withdrawal by Subject|0
404499|NCT00700713|1355330|P1|Overall Study|Withdrawal by Subject|0
404500|NCT00700713|1355328|P3|Overall Study|Protocol Violation|1
404501|NCT00700713|1355329|P2|Overall Study|Protocol Violation|0
404502|NCT00700713|1355330|P1|Overall Study|Protocol Violation|1
404503|NCT00700635|1355347|P3|Overall Study|Withdrawal by Subject|1
404504|NCT00700635|1355348|P2|Overall Study|Withdrawal by Subject|3
404505|NCT00700635|1355349|P1|Overall Study|Withdrawal by Subject|7
404506|NCT00700635|1355347|P3|Overall Study|Protocol Violation|0
404507|NCT00700635|1355348|P2|Overall Study|Protocol Violation|2
404508|NCT00700635|1355349|P1|Overall Study|Protocol Violation|2
404509|NCT00700635|1355347|P3|Overall Study|Lost to Follow-up|0
404510|NCT00700635|1355348|P2|Overall Study|Lost to Follow-up|3
404511|NCT00700635|1355349|P1|Overall Study|Lost to Follow-up|1
404512|NCT00700635|1355347|P3|Overall Study|Adverse Event|0
404513|NCT00700635|1355348|P2|Overall Study|Adverse Event|0
404514|NCT00700635|1355349|P1|Overall Study|Adverse Event|1
404515|NCT00700622|1355371|P2|Overall Study|Other|1
404516|NCT00700622|1355372|P1|Overall Study|Other|3
404517|NCT00700622|1355371|P2|Overall Study|Withdrawal by Subject|1
404518|NCT00700622|1355372|P1|Overall Study|Withdrawal by Subject|4
404519|NCT00700622|1355371|P2|Overall Study|Protocol Violation|1
404520|NCT00700622|1355372|P1|Overall Study|Protocol Violation|0
404521|NCT00700622|1355371|P2|Overall Study|Physician Decision|1
404522|NCT00700622|1355372|P1|Overall Study|Physician Decision|2
404523|NCT00700622|1355371|P2|Overall Study|Lost to Follow-up|1
404524|NCT00700622|1355372|P1|Overall Study|Lost to Follow-up|0
404525|NCT00700622|1355371|P2|Overall Study|Adverse Event|0
404526|NCT00700622|1355372|P1|Overall Study|Adverse Event|4
404527|NCT00700570|1355380|P2|Overall Study|Withdrawal by Subject|6
404528|NCT00700570|1355381|P1|Overall Study|Withdrawal by Subject|1
404529|NCT00700570|1355380|P2|Overall Study|Disease Progression|11
404530|NCT00700570|1355381|P1|Overall Study|Disease Progression|8
404531|NCT00700570|1355380|P2|Overall Study|Discretion of Investigator or Sponsor|3
404532|NCT00700570|1355381|P1|Overall Study|Discretion of Investigator or Sponsor|0
404533|NCT00700570|1355380|P2|Overall Study|Adverse Event|6
404534|NCT00700570|1355381|P1|Overall Study|Adverse Event|2
404535|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
404536|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
404537|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
404538|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
404539|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
404540|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
404541|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
404542|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
404543|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
404544|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
404545|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
404546|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
404547|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
404548|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
404549|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
404550|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
404551|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
404552|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
404553|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
404554|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
404555|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
404556|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
404557|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
404558|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
404559|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
404560|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
404561|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
404562|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
404563|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
404564|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
404565|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
404566|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
404567|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
404568|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
404569|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
404570|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Death|1
404571|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Death|0
404572|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Death|0
404573|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Death|0
404574|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Death|0
404575|NCT00700427|1355397|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
404576|NCT00700427|1355398|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
404577|NCT00700427|1355399|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
404578|NCT00700427|1355400|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
404579|NCT00700427|1355401|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
404580|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Death|0
404581|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Death|0
404582|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Death|1
404583|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Death|0
404584|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Death|0
404585|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
404586|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
404587|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
404588|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
404589|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
404590|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
404591|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
404592|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
404593|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
404594|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
404595|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
404596|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
404597|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
404598|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
404599|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
404600|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
404601|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
404602|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
404603|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
404604|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
404605|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
404606|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
404607|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
404608|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
404609|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
404610|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
404611|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
404612|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
404613|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
404614|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
404615|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
404616|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
404617|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
404618|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
404619|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
404620|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
404621|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
404622|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
404623|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
404624|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
404625|NCT00700427|1355397|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
404626|NCT00700427|1355398|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
404627|NCT00700427|1355399|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
404628|NCT00700427|1355400|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
404629|NCT00700427|1355401|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
404630|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
404631|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
404632|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
404633|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
404634|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
404635|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
404636|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
404637|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
404638|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
404639|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
404640|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
404641|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
404642|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
404643|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
404644|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
404645|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
404646|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
404647|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
404648|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
404649|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
404650|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
404651|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
404652|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
404653|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
404654|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
404655|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
404656|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
404657|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
404658|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
404659|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
404660|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
404661|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
404662|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
404663|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
404664|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
404665|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
404666|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
404667|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
404668|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
404669|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
404670|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
404671|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
404672|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
404673|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
404674|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
404675|NCT00700427|1355397|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
404676|NCT00700427|1355398|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
404677|NCT00700427|1355399|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
404678|NCT00700427|1355400|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
404679|NCT00700427|1355401|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
404680|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
404681|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
404682|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
404683|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
404684|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
404685|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
404686|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
404687|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
404688|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
404689|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
404690|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
404691|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
404692|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
404693|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
404694|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
404695|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
404696|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
404697|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
404698|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
404699|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
404700|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
404701|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
404702|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
404703|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
404704|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
404705|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
404706|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
404707|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
404708|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
404709|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
404710|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
404711|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
404712|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
404713|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
404714|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
404715|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
404716|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
404717|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
404718|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
404719|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
404720|NCT00700427|1355397|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
404721|NCT00700427|1355398|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
404722|NCT00700427|1355399|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
404723|NCT00700427|1355400|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
404724|NCT00700427|1355401|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
404725|NCT00700401|1355423|P1|Overall Study|Withdrawal by Subject|2
404726|NCT00700401|1355423|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
404727|NCT00700401|1355423|P1|Overall Study|Treatment never started|1
404728|NCT00700401|1355423|P1|Overall Study|Lost to Follow-up|1
404729|NCT00700401|1355423|P1|Overall Study|Refused Treatment|2
404730|NCT00700401|1355423|P1|Overall Study|Adverse Event|5
404731|NCT00700401|1355423|P1|Overall Study|Detectable HCV RNA after Week 4|82
404732|NCT00700310|1355447|P4|Overall Study|Randomized, Not Treated|2
404733|NCT00700310|1355448|P3|Overall Study|Randomized, Not Treated|2
404734|NCT00700310|1355449|P2|Overall Study|Randomized, Not Treated|0
404735|NCT00700310|1355450|P1|Overall Study|Randomized, Not Treated|2
404736|NCT00700310|1355447|P4|Overall Study|Administrative/Other|3
404737|NCT00700310|1355448|P3|Overall Study|Administrative/Other|1
404738|NCT00700310|1355449|P2|Overall Study|Administrative/Other|3
404739|NCT00700310|1355450|P1|Overall Study|Administrative/Other|1
404740|NCT00700310|1355447|P4|Overall Study|Lack of Efficacy|1
404741|NCT00700310|1355448|P3|Overall Study|Lack of Efficacy|0
404742|NCT00700310|1355449|P2|Overall Study|Lack of Efficacy|3
404743|NCT00700310|1355450|P1|Overall Study|Lack of Efficacy|0
404744|NCT00700310|1355447|P4|Overall Study|Withdrawal by Subject|8
404745|NCT00700310|1355448|P3|Overall Study|Withdrawal by Subject|8
404746|NCT00700310|1355449|P2|Overall Study|Withdrawal by Subject|9
404747|NCT00700310|1355450|P1|Overall Study|Withdrawal by Subject|8
404748|NCT00700310|1355447|P4|Overall Study|Lost to Follow-up|1
404749|NCT00700310|1355448|P3|Overall Study|Lost to Follow-up|0
404750|NCT00700310|1355449|P2|Overall Study|Lost to Follow-up|1
404751|NCT00700310|1355450|P1|Overall Study|Lost to Follow-up|4
404752|NCT00700310|1355447|P4|Overall Study|Adverse Event|11
404753|NCT00700310|1355448|P3|Overall Study|Adverse Event|5
404754|NCT00700310|1355449|P2|Overall Study|Adverse Event|10
404755|NCT00700310|1355450|P1|Overall Study|Adverse Event|6
404756|NCT00700271|1355470|P2|Overall Study|Lost to Follow-up|2
404757|NCT00700271|1355471|P1|Overall Study|Lost to Follow-up|2
404758|NCT00700271|1355470|P2|Overall Study|Withdrawal by Subject|4
404759|NCT00700271|1355471|P1|Overall Study|Withdrawal by Subject|6
404760|NCT00700271|1355470|P2|Overall Study|Administrative Reasons|0
404761|NCT00700271|1355471|P1|Overall Study|Administrative Reasons|1
404762|NCT00700271|1355470|P2|Overall Study|Protocol Violation|0
404763|NCT00700271|1355471|P1|Overall Study|Protocol Violation|1
404764|NCT00700271|1355470|P2|Overall Study|Adverse Event|6
404765|NCT00700271|1355471|P1|Overall Study|Adverse Event|4
404766|NCT00700180|1355499|P2|Overall Study|Lost to Follow-up|5
404767|NCT00700180|1355500|P1|Overall Study|Lost to Follow-up|4
404768|NCT00700180|1355499|P2|Overall Study|Alive in follow-up|27
404769|NCT00700180|1355500|P1|Overall Study|Alive in follow-up|46
404770|NCT00700180|1355499|P2|Overall Study|Alive on treatment|3
404771|NCT00700180|1355500|P1|Overall Study|Alive on treatment|5
404772|NCT00700180|1355499|P2|Overall Study|Death|114
404773|NCT00700180|1355500|P1|Overall Study|Death|99
404774|NCT00700115|1355529|P2|Overall Study|Lost to Follow-up|1
404775|NCT00700115|1355530|P1|Overall Study|Lost to Follow-up|0
404776|NCT00700115|1355529|P2|Overall Study|Withdrawal by Subject|0
404777|NCT00700115|1355530|P1|Overall Study|Withdrawal by Subject|1
404778|NCT00700102|1355540|P2|Overall Study|Lost to Follow-up|10
404779|NCT00700102|1355541|P1|Overall Study|Lost to Follow-up|8
404780|NCT00700102|1355540|P2|Overall Study|Died|385
404781|NCT00700102|1355541|P1|Overall Study|Died|394
404782|NCT00700011|1355680|P2|Overall Study|Death|1
404783|NCT00700011|1355681|P1|Overall Study|Death|0
404784|NCT00699998|1355697|P4|Overall Study|Lost to Follow-up|1
404785|NCT00699998|1355698|P3|Overall Study|Lost to Follow-up|3
404786|NCT00699998|1355699|P2|Overall Study|Lost to Follow-up|1
404787|NCT00699998|1355700|P1|Overall Study|Lost to Follow-up|2
404788|NCT00699998|1355697|P4|Overall Study|Physician Decision|1
404789|NCT00699998|1355698|P3|Overall Study|Physician Decision|1
404790|NCT00699998|1355699|P2|Overall Study|Physician Decision|2
404791|NCT00699998|1355700|P1|Overall Study|Physician Decision|3
404792|NCT00699998|1355697|P4|Overall Study|Withdrawal by Subject|80
404793|NCT00699998|1355698|P3|Overall Study|Withdrawal by Subject|202
404794|NCT00699998|1355699|P2|Overall Study|Withdrawal by Subject|83
404795|NCT00699998|1355700|P1|Overall Study|Withdrawal by Subject|194
404796|NCT00699972|1355745|P3|Overall Study|Randomized, Not Treated|1
404797|NCT00699972|1355746|P2|Overall Study|Randomized, Not Treated|0
404798|NCT00699972|1355747|P1|Overall Study|Randomized, Not Treated|1
404799|NCT00699972|1355745|P3|Overall Study|Administrative/Other|4
404800|NCT00699972|1355746|P2|Overall Study|Administrative/Other|1
404801|NCT00699972|1355747|P1|Overall Study|Administrative/Other|3
404802|NCT00699972|1355745|P3|Overall Study|Lack of Efficacy|2
404803|NCT00699972|1355746|P2|Overall Study|Lack of Efficacy|0
404804|NCT00699972|1355747|P1|Overall Study|Lack of Efficacy|2
404805|NCT00699972|1355745|P3|Overall Study|Withdrawal by Subject|4
404806|NCT00699972|1355746|P2|Overall Study|Withdrawal by Subject|7
404807|NCT00699972|1355747|P1|Overall Study|Withdrawal by Subject|3
404808|NCT00699972|1355745|P3|Overall Study|Lost to Follow-up|0
404809|NCT00699972|1355746|P2|Overall Study|Lost to Follow-up|2
404810|NCT00699972|1355747|P1|Overall Study|Lost to Follow-up|0
404811|NCT00699972|1355745|P3|Overall Study|Adverse Event|24
404812|NCT00699972|1355746|P2|Overall Study|Adverse Event|9
404813|NCT00699972|1355747|P1|Overall Study|Adverse Event|7
404814|NCT00699907|1355764|P3|Overall Study|No usable sample|8
404815|NCT00699907|1355765|P2|Overall Study|No usable sample|9
404816|NCT00699907|1355766|P1|Overall Study|No usable sample|0
404817|NCT00699907|1355764|P3|Overall Study|Withdrawal by Subject|0
404818|NCT00699907|1355765|P2|Overall Study|Withdrawal by Subject|1
404819|NCT00699907|1355766|P1|Overall Study|Withdrawal by Subject|2
404820|NCT00699842|1355801|P3|Overall Study|Death|0
404821|NCT00699842|1355802|P2|Overall Study|Death|1
404822|NCT00699842|1355803|P1|Overall Study|Death|0
404823|NCT00699816|1355816|P2|Overall Study|Protocol Violation|3
404824|NCT00699816|1355817|P1|Overall Study|Protocol Violation|1
404825|NCT00699751|1355835|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
404826|NCT00699751|1355836|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
404827|NCT00699751|1355835|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
404828|NCT00699751|1355836|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
404829|NCT00699751|1355835|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
404830|NCT00699751|1355836|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
404831|NCT00699751|1355835|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
404832|NCT00699751|1355836|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
404833|NCT00699751|1355835|P2|Period 1: Without/Before Drug Switch|Other|20
404834|NCT00699751|1355836|P1|Period 1: Without/Before Drug Switch|Other|30
404835|NCT00699751|1355835|P2|Period 1: Without/Before Drug Switch|Subject Request|23
404836|NCT00699751|1355836|P1|Period 1: Without/Before Drug Switch|Subject Request|43
404837|NCT00699751|1355835|P2|Period 1: Without/Before Drug Switch|Death|29
404838|NCT00699751|1355836|P1|Period 1: Without/Before Drug Switch|Death|28
404839|NCT00699751|1355835|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
404840|NCT00699751|1355836|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
404841|NCT00699699|1355921|P1|Overall Study|Individual different reasons|21
404842|NCT00699699|1355921|P1|Overall Study|Adverse Event|36
404843|NCT00699660|1355930|P2|Overall Study|missing reports and recording failures|6
404844|NCT00699660|1355931|P1|Overall Study|missing reports and recording failures|10
404845|NCT00699660|1355930|P2|Overall Study|Lost to Follow-up|2
404846|NCT00699660|1355931|P1|Overall Study|Lost to Follow-up|4
404847|NCT00699608|1355943|P6|Second Intervention|Withdrawal by Subject|0
404848|NCT00699608|1355944|P5|Second Intervention|Withdrawal by Subject|0
404849|NCT00699608|1355945|P4|Second Intervention|Withdrawal by Subject|1
404850|NCT00699608|1355946|P3|Second Intervention|Withdrawal by Subject|0
404851|NCT00699608|1355947|P2|Second Intervention|Withdrawal by Subject|0
404852|NCT00699608|1355948|P1|Second Intervention|Withdrawal by Subject|0
404853|NCT00699608|1355943|P6|Second Intervention|Adverse Event|0
404854|NCT00699608|1355944|P5|Second Intervention|Adverse Event|0
404855|NCT00699608|1355945|P4|Second Intervention|Adverse Event|0
404856|NCT00699608|1355946|P3|Second Intervention|Adverse Event|1
404857|NCT00699608|1355947|P2|Second Intervention|Adverse Event|0
404858|NCT00699608|1355948|P1|Second Intervention|Adverse Event|0
404859|NCT00699608|1355943|P6|First Intervention|Protocol Violation|0
404860|NCT00699608|1355944|P5|First Intervention|Protocol Violation|1
404861|NCT00699608|1355945|P4|First Intervention|Protocol Violation|0
404862|NCT00699608|1355946|P3|First Intervention|Protocol Violation|0
404863|NCT00699608|1355947|P2|First Intervention|Protocol Violation|0
404864|NCT00699608|1355948|P1|First Intervention|Protocol Violation|0
404865|NCT00699608|1355943|P6|First Intervention|Withdrawal by Subject|0
404866|NCT00699608|1355944|P5|First Intervention|Withdrawal by Subject|0
404867|NCT00699608|1355945|P4|First Intervention|Withdrawal by Subject|0
404868|NCT00699608|1355946|P3|First Intervention|Withdrawal by Subject|1
404869|NCT00699608|1355947|P2|First Intervention|Withdrawal by Subject|0
404870|NCT00699608|1355948|P1|First Intervention|Withdrawal by Subject|0
404871|NCT00699582|1356001|P3|Overall Study|Randomized, Not Treated|0
404872|NCT00699582|1356002|P2|Overall Study|Randomized, Not Treated|1
404873|NCT00699582|1356003|P1|Overall Study|Randomized, Not Treated|2
404874|NCT00699582|1356001|P3|Overall Study|Administrative/Other|0
404875|NCT00699582|1356002|P2|Overall Study|Administrative/Other|3
404876|NCT00699582|1356003|P1|Overall Study|Administrative/Other|4
404877|NCT00699582|1356001|P3|Overall Study|Progressive Disease|0
404878|NCT00699582|1356002|P2|Overall Study|Progressive Disease|0
404879|NCT00699582|1356003|P1|Overall Study|Progressive Disease|1
404880|NCT00699582|1356001|P3|Overall Study|Lack of Efficacy|1
404881|NCT00699582|1356002|P2|Overall Study|Lack of Efficacy|0
404882|NCT00699582|1356003|P1|Overall Study|Lack of Efficacy|1
404883|NCT00699582|1356001|P3|Overall Study|Withdrawal by Subject|4
404884|NCT00699582|1356002|P2|Overall Study|Withdrawal by Subject|7
404885|NCT00699582|1356003|P1|Overall Study|Withdrawal by Subject|6
404886|NCT00699582|1356001|P3|Overall Study|Adverse Event|23
404887|NCT00699582|1356002|P2|Overall Study|Adverse Event|11
404888|NCT00699582|1356003|P1|Overall Study|Adverse Event|4
404889|NCT00699374|1356107|P2|Overall Study|Died 28 days after last dose|9
404890|NCT00699374|1356108|P1|Overall Study|Died 28 days after last dose|5
404891|NCT00699374|1356107|P2|Overall Study|Randomized but not treated|2
404892|NCT00699374|1356108|P1|Overall Study|Randomized but not treated|4
404893|NCT00699374|1356107|P2|Overall Study|Study terminated by sponsor|28
404894|NCT00699374|1356108|P1|Overall Study|Study terminated by sponsor|13
404895|NCT00699374|1356107|P2|Overall Study|Protocol Violation|6
404896|NCT00699374|1356108|P1|Overall Study|Protocol Violation|2
404897|NCT00699374|1356107|P2|Overall Study|Other|15
404898|NCT00699374|1356108|P1|Overall Study|Other|18
404899|NCT00699374|1356107|P2|Overall Study|Objective progression or relapse|277
404900|NCT00699374|1356108|P1|Overall Study|Objective progression or relapse|281
404901|NCT00699374|1356107|P2|Overall Study|Withdrawal by Subject|44
404902|NCT00699374|1356108|P1|Overall Study|Withdrawal by Subject|34
404903|NCT00699374|1356107|P2|Overall Study|Lost to Follow-up|5
404904|NCT00699374|1356108|P1|Overall Study|Lost to Follow-up|3
404905|NCT00699374|1356107|P2|Overall Study|Global deterioration of health status|8
404906|NCT00699374|1356108|P1|Overall Study|Global deterioration of health status|7
404907|NCT00699374|1356107|P2|Overall Study|Adverse Event|67
404908|NCT00699374|1356108|P1|Overall Study|Adverse Event|70
404909|NCT00699374|1356107|P2|Overall Study|Death|83
404910|NCT00699374|1356108|P1|Overall Study|Death|93
404911|NCT00699348|1356120|P1|Overall Study|Other|5
404912|NCT00699348|1356120|P1|Overall Study|Renal transplantation|10
404913|NCT00699348|1356120|P1|Overall Study|Blood transfusion|24
404914|NCT00699348|1356120|P1|Overall Study|Failure to return|1
404915|NCT00699348|1356120|P1|Overall Study|Lack of Efficacy|8
404916|NCT00699348|1356120|P1|Overall Study|Protocol Violation|10
404917|NCT00699348|1356120|P1|Overall Study|Withdrawal by Subject|11
404918|NCT00699348|1356120|P1|Overall Study|Adverse Event|15
404919|NCT00699348|1356120|P1|Overall Study|Death|6
404920|NCT00699335|1356129|P1|Overall Study|Missing data|52
404921|NCT00699335|1356129|P1|Overall Study|Combination of multiple reasons|176
404922|NCT00699283|1356162|P2|Overall Study|AE of unknown type|0
404923|NCT00699283|1356163|P1|Overall Study|AE of unknown type|1
404924|NCT00699283|1356162|P2|Overall Study|AE, non-serious non-fatal|1
404925|NCT00699283|1356163|P1|Overall Study|AE, non-serious non-fatal|8
404926|NCT00699283|1356162|P2|Overall Study|SAE, non-fatal|1
404927|NCT00699283|1356163|P1|Overall Study|SAE, non-fatal|1
404928|NCT00699283|1356162|P2|Overall Study|Other Reason|1
404929|NCT00699283|1356163|P1|Overall Study|Other Reason|5
404930|NCT00699283|1356162|P2|Overall Study|Withdrawal by Subject|0
404931|NCT00699283|1356163|P1|Overall Study|Withdrawal by Subject|1
404932|NCT00699283|1356162|P2|Overall Study|Lost to Follow-up|0
404933|NCT00699283|1356163|P1|Overall Study|Lost to Follow-up|2
404934|NCT00699283|1356162|P2|Overall Study|Lack of Efficacy|5
404935|NCT00699283|1356163|P1|Overall Study|Lack of Efficacy|15
404936|NCT00699192|1356171|P3|Overall Study|Protocol Violation|0
404937|NCT00699192|1356172|P2|Overall Study|Protocol Violation|2
404938|NCT00699192|1356173|P1|Overall Study|Protocol Violation|2
404939|NCT00699192|1356171|P3|Overall Study|Administrative problems|1
404940|NCT00699192|1356172|P2|Overall Study|Administrative problems|3
404941|NCT00699192|1356173|P1|Overall Study|Administrative problems|1
404942|NCT00699192|1356171|P3|Overall Study|Withdrawal by Subject|4
404943|NCT00699192|1356172|P2|Overall Study|Withdrawal by Subject|2
404944|NCT00699192|1356173|P1|Overall Study|Withdrawal by Subject|3
404945|NCT00699192|1356171|P3|Overall Study|Lack of Efficacy|1
404946|NCT00699192|1356172|P2|Overall Study|Lack of Efficacy|0
404947|NCT00699192|1356173|P1|Overall Study|Lack of Efficacy|0
404948|NCT00699192|1356171|P3|Overall Study|Abnormal test procedure result(s)|1
404949|NCT00699192|1356172|P2|Overall Study|Abnormal test procedure result(s)|0
404950|NCT00699192|1356173|P1|Overall Study|Abnormal test procedure result(s)|0
404951|NCT00699192|1356171|P3|Overall Study|Adverse Event|3
404952|NCT00699192|1356172|P2|Overall Study|Adverse Event|4
404953|NCT00699192|1356173|P1|Overall Study|Adverse Event|9
404954|NCT00699192|1356171|P3|Overall Study|Missing|1
404955|NCT00699192|1356172|P2|Overall Study|Missing|1
404956|NCT00699192|1356173|P1|Overall Study|Missing|1
404957|NCT00699153|1356195|P2|Overall Study|Travel Problem|0
404958|NCT00699153|1356196|P1|Overall Study|Travel Problem|1
404959|NCT00699153|1356195|P2|Overall Study|Protocol Violation|0
404960|NCT00699153|1356196|P1|Overall Study|Protocol Violation|1
404961|NCT00699153|1356195|P2|Overall Study|Adverse Event|2
404962|NCT00699153|1356196|P1|Overall Study|Adverse Event|0
404963|NCT00699153|1356195|P2|Overall Study|Lost to Follow-up|0
404964|NCT00699153|1356196|P1|Overall Study|Lost to Follow-up|1
404965|NCT00698932|1356222|P2|Overall Study|Death|0
404966|NCT00698932|1356223|P1|Overall Study|Death|1
404967|NCT00698932|1356222|P2|Overall Study|Safety reasons|2
404968|NCT00698932|1356223|P1|Overall Study|Safety reasons|0
404969|NCT00698932|1356222|P2|Overall Study|Severe non-compliance to protocol|2
404970|NCT00698932|1356223|P1|Overall Study|Severe non-compliance to protocol|1
404971|NCT00698932|1356222|P2|Overall Study|Lost to Follow-up|1
404972|NCT00698932|1356223|P1|Overall Study|Lost to Follow-up|6
404973|NCT00698932|1356222|P2|Overall Study|Withdrawal by Subject|23
404974|NCT00698932|1356223|P1|Overall Study|Withdrawal by Subject|11
404975|NCT00698932|1356222|P2|Overall Study|Study specific discontinuation criteria|4
404976|NCT00698932|1356223|P1|Overall Study|Study specific discontinuation criteria|3
404977|NCT00698932|1356222|P2|Overall Study|Incorrect enrollment|2
404978|NCT00698932|1356223|P1|Overall Study|Incorrect enrollment|0
404979|NCT00698932|1356222|P2|Overall Study|Adverse Event|2
404980|NCT00698932|1356223|P1|Overall Study|Adverse Event|0
404981|NCT00698841|1356249|P1|Overall Study|Other|2
404982|NCT00698841|1356249|P1|Overall Study|Study drug toxicity|2
404983|NCT00698841|1356249|P1|Overall Study|Failure to meet eligibility criteria|2
404984|NCT00698841|1356249|P1|Overall Study|Disease progression|7
404985|NCT00698841|1356249|P1|Overall Study|Adverse Event|3
404986|NCT00698841|1356249|P1|Overall Study|Withdrawal by Subject|2
404987|NCT00698815|1356263|P3|Overall Study|Did not receive protocol treatment|2
404988|NCT00698815|1356264|P2|Overall Study|Did not receive protocol treatment|2
404989|NCT00698815|1356265|P1|Overall Study|Did not receive protocol treatment|1
404990|NCT00698815|1356263|P3|Overall Study|MD discretion|2
404991|NCT00698815|1356264|P2|Overall Study|MD discretion|7
404992|NCT00698815|1356265|P1|Overall Study|MD discretion|2
404993|NCT00698815|1356263|P3|Overall Study|Withdrawal by Subject|2
404994|NCT00698815|1356264|P2|Overall Study|Withdrawal by Subject|3
404995|NCT00698815|1356265|P1|Overall Study|Withdrawal by Subject|6
404996|NCT00698815|1356263|P3|Overall Study|Death|4
404997|NCT00698815|1356264|P2|Overall Study|Death|2
404998|NCT00698815|1356265|P1|Overall Study|Death|1
404999|NCT00698685|1356282|P1|Overall Study|Off study pre transplant by clinic MD|1
405000|NCT00698685|1356282|P1|Overall Study|Sister withdrew as donor|1
405001|NCT00698646|1356290|P3|Overall Study|Administrative problems|1
405002|NCT00698646|1356291|P2|Overall Study|Administrative problems|0
405003|NCT00698646|1356292|P1|Overall Study|Administrative problems|1
405004|NCT00698646|1356290|P3|Overall Study|Lost to Follow-up|2
405005|NCT00698646|1356291|P2|Overall Study|Lost to Follow-up|0
405006|NCT00698646|1356292|P1|Overall Study|Lost to Follow-up|0
405007|NCT00698646|1356290|P3|Overall Study|Withdrawal by Subject|8
405008|NCT00698646|1356291|P2|Overall Study|Withdrawal by Subject|11
405009|NCT00698646|1356292|P1|Overall Study|Withdrawal by Subject|10
405010|NCT00698646|1356290|P3|Overall Study|Protocol Deviation|3
405011|NCT00698646|1356291|P2|Overall Study|Protocol Deviation|2
405012|NCT00698646|1356292|P1|Overall Study|Protocol Deviation|6
405013|NCT00698646|1356290|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
405014|NCT00698646|1356291|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
405015|NCT00698646|1356292|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
405016|NCT00698646|1356290|P3|Overall Study|Adverse Event|8
405017|NCT00698646|1356291|P2|Overall Study|Adverse Event|7
405018|NCT00698646|1356292|P1|Overall Study|Adverse Event|8
405019|NCT00698581|1356317|P2|Overall Study|AE of unknown type|0
405020|NCT00698581|1356318|P1|Overall Study|AE of unknown type|1
405021|NCT00698581|1356317|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
405022|NCT00698581|1356318|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
405023|NCT00698581|1356317|P2|Overall Study|AE, non-serious non-fatal|0
405024|NCT00698581|1356318|P1|Overall Study|AE, non-serious non-fatal|4
405025|NCT00698581|1356317|P2|Overall Study|SAE, non-fatal|0
405026|NCT00698581|1356318|P1|Overall Study|SAE, non-fatal|1
405027|NCT00698581|1356317|P2|Overall Study|Other reason|1
405028|NCT00698581|1356318|P1|Overall Study|Other reason|9
405029|NCT00698581|1356317|P2|Overall Study|Withdrawal by Subject|0
405030|NCT00698581|1356318|P1|Overall Study|Withdrawal by Subject|6
405031|NCT00698581|1356317|P2|Overall Study|Lack of Efficacy|11
405032|NCT00698581|1356318|P1|Overall Study|Lack of Efficacy|23
405033|NCT00698516|1356329|P1|Overall Study|Withdrawal by Subject|3
405034|NCT00698516|1356329|P1|Overall Study|Study Termination|2
405035|NCT00698451|1356347|P1|Overall Study|Disease progression|3
405036|NCT00698451|1356347|P1|Overall Study|Withdrawal by Subject|6
405037|NCT00698451|1356347|P1|Overall Study|Protocol Violation|6
405038|NCT00698451|1356347|P1|Overall Study|Physician Decision|2
405039|NCT00698451|1356347|P1|Overall Study|Adverse Event|22
405040|NCT00698204|1356354|P2|Overall Study|Withdrawal by Subject|0
405041|NCT00698204|1356355|P1|Overall Study|Withdrawal by Subject|1
405042|NCT00698009|1356415|P1|Overall Study|Withdrawal by Subject|1
405043|NCT00697827|1356421|P2|Overall Study|enrolled but not treated|1
405044|NCT00697827|1356422|P1|Overall Study|enrolled but not treated|2
405045|NCT00697788|1356449|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
405046|NCT00697788|1356450|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
405047|NCT00697788|1356451|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
405048|NCT00697788|1356452|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
405049|NCT00697788|1356453|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
405050|NCT00697788|1356454|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
405051|NCT00697788|1356455|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
405052|NCT00697788|1356456|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
405053|NCT00697788|1356449|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
405054|NCT00697788|1356450|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
405055|NCT00697788|1356451|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
405056|NCT00697788|1356452|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
405057|NCT00697788|1356453|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
405058|NCT00697788|1356454|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
405059|NCT00697788|1356455|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
405060|NCT00697788|1356456|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
405061|NCT00697619|1356511|P2|Overall Study|Adverse Event|6
405062|NCT00697619|1356512|P1|Overall Study|Adverse Event|4
405063|NCT00697619|1356511|P2|Overall Study|Lack of Efficacy|2
405064|NCT00697619|1356512|P1|Overall Study|Lack of Efficacy|2
405065|NCT00697593|1356518|P1|Overall Study|Suspension of the study by sponsor|12
405066|NCT00697593|1356518|P1|Overall Study|Lack of Efficacy|3
405067|NCT00697593|1356518|P1|Overall Study|Protocol Violation|1
405068|NCT00697593|1356518|P1|Overall Study|Adverse Event|3
405069|NCT00697515|1356562|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
405070|NCT00697515|1356563|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
405071|NCT00697515|1356562|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
405072|NCT00697515|1356563|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
405073|NCT00697515|1356562|P2|First Intervention (Crossover Period)|Adverse Event|2
405074|NCT00697515|1356563|P1|First Intervention (Crossover Period)|Adverse Event|0
405075|NCT00697515|1356562|P2|First Intervention (Crossover Period)|Natural disaster|9
405076|NCT00697515|1356563|P1|First Intervention (Crossover Period)|Natural disaster|8
405077|NCT00697515|1356562|P2|Dose Optimization Period|elevated QTc|0
405078|NCT00697515|1356563|P1|Dose Optimization Period|elevated QTc|1
405079|NCT00697515|1356562|P2|Dose Optimization Period|called to active duty|0
405080|NCT00697515|1356563|P1|Dose Optimization Period|called to active duty|1
405081|NCT00697515|1356562|P2|Dose Optimization Period|sponsor request|0
405082|NCT00697515|1356563|P1|Dose Optimization Period|sponsor request|2
405083|NCT00697515|1356562|P2|Dose Optimization Period|Lost to Follow-up|0
405084|NCT00697515|1356563|P1|Dose Optimization Period|Lost to Follow-up|2
405085|NCT00697515|1356562|P2|Dose Optimization Period|Withdrawal by Subject|0
405086|NCT00697515|1356563|P1|Dose Optimization Period|Withdrawal by Subject|5
405087|NCT00697515|1356562|P2|Dose Optimization Period|Adverse Event|0
405088|NCT00697515|1356563|P1|Dose Optimization Period|Adverse Event|4
405089|NCT00697255|1356593|P2|Stage 1b|Insufficient ovarian response|1
405090|NCT00697255|1356594|P1|Stage 1b|Insufficient ovarian response|0
405091|NCT00697255|1356593|P2|Stage 1b|Not growing of dominant follicle|1
405092|NCT00697255|1356594|P1|Stage 1b|Not growing of dominant follicle|0
405093|NCT00697255|1356593|P2|Stage 1a|Not growing of dominant follicle|0
405094|NCT00697255|1356594|P1|Stage 1a|Not growing of dominant follicle|1
405095|NCT00697255|1356593|P2|Stage 1a|Multifollicular growth|0
405096|NCT00697255|1356594|P1|Stage 1a|Multifollicular growth|1
405097|NCT00697255|1356593|P2|Stage 1a|Insufficient ovarian response|0
405098|NCT00697255|1356594|P1|Stage 1a|Insufficient ovarian response|1
405099|NCT00697112|1356645|P1|Overall Study|Did not meet inclusion criteria|1
405100|NCT00697112|1356645|P1|Overall Study|Lost to Follow-up|1
405101|NCT00697112|1356645|P1|Overall Study|Adverse Event|8
405102|NCT00697073|1356669|P1|Overall Study|non compliance and other|6
405103|NCT00697073|1356669|P1|Overall Study|Pregnancy|1
405104|NCT00697073|1356669|P1|Overall Study|Withdrawal by Subject|2
405105|NCT00696878|1356673|P1|Overall Study|Other reason (not specified)|55
405106|NCT00696878|1356673|P1|Overall Study|Trial stopped|32
405107|NCT00696878|1356673|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
405108|NCT00696878|1356673|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
405109|NCT00696878|1356673|P1|Overall Study|Withdrawal by Subject|87
405110|NCT00696878|1356673|P1|Overall Study|Adverse Event|8
405111|NCT00696800|1356747|P2|Overall Study|Not treated|2
405112|NCT00696800|1356748|P1|Overall Study|Not treated|1
405113|NCT00696800|1356747|P2|Overall Study|Other Reasons|3
405114|NCT00696800|1356748|P1|Overall Study|Other Reasons|5
405115|NCT00696800|1356747|P2|Overall Study|No/too few/bad quality embryos|18
405116|NCT00696800|1356748|P1|Overall Study|No/too few/bad quality embryos|24
405117|NCT00696800|1356747|P2|Overall Study|No/abnormal fertilization|13
405118|NCT00696800|1356748|P1|Overall Study|No/abnormal fertilization|11
405119|NCT00696800|1356747|P2|Overall Study|No/too few/bad quality oocytes|3
405120|NCT00696800|1356748|P1|Overall Study|No/too few/bad quality oocytes|4
405121|NCT00696800|1356747|P2|Overall Study|Too high ovarian response|1
405122|NCT00696800|1356748|P1|Overall Study|Too high ovarian response|6
405123|NCT00696800|1356747|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
405124|NCT00696800|1356748|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
405125|NCT00696800|1356747|P2|Overall Study|Insufficient ovarian response|1
405126|NCT00696800|1356748|P1|Overall Study|Insufficient ovarian response|4
405127|NCT00696800|1356747|P2|Overall Study|Insufficient ovarian response on Day 8|1
405128|NCT00696800|1356748|P1|Overall Study|Insufficient ovarian response on Day 8|4
405129|NCT00696800|1356747|P2|Overall Study|Insufficient compliance with medication|1
405130|NCT00696800|1356748|P1|Overall Study|Insufficient compliance with medication|2
405131|NCT00696800|1356747|P2|Overall Study|Adverse Event|3
405132|NCT00696800|1356748|P1|Overall Study|Adverse Event|16
405133|NCT00696787|1356801|P3|Overall Study|Failed to return|1
405134|NCT00696787|1356802|P2|Overall Study|Failed to return|3
405135|NCT00696787|1356803|P1|Overall Study|Failed to return|1
405136|NCT00696787|1356801|P3|Overall Study|Withdrawal by Subject|2
405137|NCT00696787|1356802|P2|Overall Study|Withdrawal by Subject|3
405138|NCT00696787|1356803|P1|Overall Study|Withdrawal by Subject|0
405139|NCT00696787|1356801|P3|Overall Study|Lost to Follow-up|3
405140|NCT00696787|1356802|P2|Overall Study|Lost to Follow-up|0
405141|NCT00696787|1356803|P1|Overall Study|Lost to Follow-up|4
405142|NCT00696787|1356801|P3|Overall Study|Lack of Efficacy|0
405143|NCT00696787|1356802|P2|Overall Study|Lack of Efficacy|1
405144|NCT00696787|1356803|P1|Overall Study|Lack of Efficacy|0
405145|NCT00696787|1356801|P3|Overall Study|Discontinuation by Sponsor|14
405146|NCT00696787|1356802|P2|Overall Study|Discontinuation by Sponsor|13
405147|NCT00696787|1356803|P1|Overall Study|Discontinuation by Sponsor|9
405148|NCT00696787|1356801|P3|Overall Study|Adverse Event|6
405149|NCT00696787|1356802|P2|Overall Study|Adverse Event|0
405150|NCT00696787|1356803|P1|Overall Study|Adverse Event|1
405151|NCT00696774|1356817|P3|Period III|Lack of Efficacy|0
405152|NCT00696774|1356818|P2|Period III|Lack of Efficacy|2
405153|NCT00696774|1356819|P1|Period III|Lack of Efficacy|0
405154|NCT00696774|1356817|P3|Period III|Sponsor Decision|0
405155|NCT00696774|1356818|P2|Period III|Sponsor Decision|0
405156|NCT00696774|1356819|P1|Period III|Sponsor Decision|2
405157|NCT00696774|1356817|P3|Period III|Withdrawal by Subject|0
405158|NCT00696774|1356818|P2|Period III|Withdrawal by Subject|2
405159|NCT00696774|1356819|P1|Period III|Withdrawal by Subject|1
405160|NCT00696774|1356817|P3|Period III|Protocol Violation|0
405161|NCT00696774|1356818|P2|Period III|Protocol Violation|1
405162|NCT00696774|1356819|P1|Period III|Protocol Violation|1
405163|NCT00696774|1356817|P3|Period III|Lost to Follow-up|0
405164|NCT00696774|1356818|P2|Period III|Lost to Follow-up|1
405165|NCT00696774|1356819|P1|Period III|Lost to Follow-up|2
405166|NCT00696774|1356817|P3|Period III|Adverse Event|0
405167|NCT00696774|1356818|P2|Period III|Adverse Event|1
405168|NCT00696774|1356819|P1|Period III|Adverse Event|1
405169|NCT00696774|1356817|P3|Period II|Lack of Efficacy|2
405170|NCT00696774|1356818|P2|Period II|Lack of Efficacy|0
405171|NCT00696774|1356819|P1|Period II|Lack of Efficacy|0
405172|NCT00696774|1356817|P3|Period II|Sponsor Decision|0
405173|NCT00696774|1356818|P2|Period II|Sponsor Decision|0
405174|NCT00696774|1356819|P1|Period II|Sponsor Decision|0
405175|NCT00696774|1356817|P3|Period II|Withdrawal by Subject|4
405176|NCT00696774|1356818|P2|Period II|Withdrawal by Subject|0
405177|NCT00696774|1356819|P1|Period II|Withdrawal by Subject|0
405178|NCT00696774|1356817|P3|Period II|Protocol Violation|11
405179|NCT00696774|1356818|P2|Period II|Protocol Violation|0
405180|NCT00696774|1356819|P1|Period II|Protocol Violation|0
405181|NCT00696774|1356817|P3|Period II|Lost to Follow-up|4
405182|NCT00696774|1356818|P2|Period II|Lost to Follow-up|0
405183|NCT00696774|1356819|P1|Period II|Lost to Follow-up|0
405184|NCT00696774|1356817|P3|Period II|Adverse Event|15
405185|NCT00696774|1356818|P2|Period II|Adverse Event|0
405186|NCT00696774|1356819|P1|Period II|Adverse Event|0
405187|NCT00696696|1356874|P1|Overall Study|Death|3
405188|NCT00696696|1356874|P1|Overall Study|Physician Decision|2
405189|NCT00696696|1356874|P1|Overall Study|Withdrawal by Subject|8
405190|NCT00696696|1356874|P1|Overall Study|Adverse Event|5
405191|NCT00696436|1356925|P5|Overall Study|Missing|0
405192|NCT00696436|1356926|P4|Overall Study|Missing|0
405193|NCT00696436|1356927|P3|Overall Study|Missing|1
405194|NCT00696436|1356928|P2|Overall Study|Missing|1
405195|NCT00696436|1356929|P1|Overall Study|Missing|0
405196|NCT00696436|1356925|P5|Overall Study|Administrative Decision|0
405197|NCT00696436|1356926|P4|Overall Study|Administrative Decision|0
405198|NCT00696436|1356927|P3|Overall Study|Administrative Decision|0
405199|NCT00696436|1356928|P2|Overall Study|Administrative Decision|0
405200|NCT00696436|1356929|P1|Overall Study|Administrative Decision|1
405201|NCT00696436|1356925|P5|Overall Study|Participant Non-compliance|0
405202|NCT00696436|1356926|P4|Overall Study|Participant Non-compliance|2
405203|NCT00696436|1356927|P3|Overall Study|Participant Non-compliance|1
405204|NCT00696436|1356928|P2|Overall Study|Participant Non-compliance|0
405205|NCT00696436|1356929|P1|Overall Study|Participant Non-compliance|0
405206|NCT00696436|1356925|P5|Overall Study|Administrative Error|0
405207|NCT00696436|1356926|P4|Overall Study|Administrative Error|0
405208|NCT00696436|1356927|P3|Overall Study|Administrative Error|2
405209|NCT00696436|1356928|P2|Overall Study|Administrative Error|0
405210|NCT00696436|1356929|P1|Overall Study|Administrative Error|2
405211|NCT00696436|1356925|P5|Overall Study|Participant Unavailability|0
405212|NCT00696436|1356926|P4|Overall Study|Participant Unavailability|1
405213|NCT00696436|1356927|P3|Overall Study|Participant Unavailability|2
405214|NCT00696436|1356928|P2|Overall Study|Participant Unavailability|0
405215|NCT00696436|1356929|P1|Overall Study|Participant Unavailability|2
405216|NCT00696436|1356925|P5|Overall Study|Lack of Efficacy|4
405217|NCT00696436|1356926|P4|Overall Study|Lack of Efficacy|2
405218|NCT00696436|1356927|P3|Overall Study|Lack of Efficacy|5
405219|NCT00696436|1356928|P2|Overall Study|Lack of Efficacy|1
405220|NCT00696436|1356929|P1|Overall Study|Lack of Efficacy|3
405221|NCT00696436|1356925|P5|Overall Study|Withdrawal by Subject|1
405222|NCT00696436|1356926|P4|Overall Study|Withdrawal by Subject|7
405223|NCT00696436|1356927|P3|Overall Study|Withdrawal by Subject|5
405224|NCT00696436|1356928|P2|Overall Study|Withdrawal by Subject|11
405225|NCT00696436|1356929|P1|Overall Study|Withdrawal by Subject|4
405226|NCT00696436|1356925|P5|Overall Study|Lost to Follow-up|3
405227|NCT00696436|1356926|P4|Overall Study|Lost to Follow-up|4
405228|NCT00696436|1356927|P3|Overall Study|Lost to Follow-up|2
405229|NCT00696436|1356928|P2|Overall Study|Lost to Follow-up|6
405230|NCT00696436|1356929|P1|Overall Study|Lost to Follow-up|1
405231|NCT00696436|1356925|P5|Overall Study|Protocol Violation|1
405232|NCT00696436|1356926|P4|Overall Study|Protocol Violation|0
405233|NCT00696436|1356927|P3|Overall Study|Protocol Violation|2
405234|NCT00696436|1356928|P2|Overall Study|Protocol Violation|2
405235|NCT00696436|1356929|P1|Overall Study|Protocol Violation|3
405236|NCT00696436|1356925|P5|Overall Study|Adverse Event|4
405237|NCT00696436|1356926|P4|Overall Study|Adverse Event|6
405238|NCT00696436|1356927|P3|Overall Study|Adverse Event|8
405239|NCT00696436|1356928|P2|Overall Study|Adverse Event|9
405240|NCT00696436|1356929|P1|Overall Study|Adverse Event|7
405241|NCT00696423|1357013|P2|Overall Study|Lost to Follow-up|5
405242|NCT00696423|1357014|P1|Overall Study|Lost to Follow-up|0
405243|NCT00696410|1357046|P2|Overall Study|Physician Decision|0
405244|NCT00696410|1357047|P1|Overall Study|Physician Decision|3
405245|NCT00696410|1357046|P2|Overall Study|Withdrawal by Subject|0
405246|NCT00696410|1357047|P1|Overall Study|Withdrawal by Subject|8
405247|NCT00696410|1357046|P2|Overall Study|Lost to Follow-up|0
405248|NCT00696410|1357047|P1|Overall Study|Lost to Follow-up|2
405249|NCT00696384|1357061|P3|Double Blind Phase|Physician Decision|0
405250|NCT00696384|1357062|P2|Double Blind Phase|Physician Decision|2
405251|NCT00696384|1357063|P1|Double Blind Phase|Physician Decision|0
405252|NCT00696384|1357061|P3|Double Blind Phase|Lack of Efficacy|0
405253|NCT00696384|1357062|P2|Double Blind Phase|Lack of Efficacy|1
405254|NCT00696384|1357063|P1|Double Blind Phase|Lack of Efficacy|0
405255|NCT00696384|1357061|P3|Double Blind Phase|Withdrawal by Subject|3
405256|NCT00696384|1357062|P2|Double Blind Phase|Withdrawal by Subject|4
405257|NCT00696384|1357063|P1|Double Blind Phase|Withdrawal by Subject|0
405258|NCT00696384|1357061|P3|Double Blind Phase|Lost to Follow-up|1
405259|NCT00696384|1357062|P2|Double Blind Phase|Lost to Follow-up|2
405260|NCT00696384|1357063|P1|Double Blind Phase|Lost to Follow-up|0
405261|NCT00696384|1357061|P3|Double Blind Phase|Adverse Event|2
405262|NCT00696384|1357062|P2|Double Blind Phase|Adverse Event|2
405263|NCT00696384|1357063|P1|Double Blind Phase|Adverse Event|0
405264|NCT00696384|1357061|P3|Open Label Phase|Physician Decision|0
405265|NCT00696384|1357062|P2|Open Label Phase|Physician Decision|0
405266|NCT00696384|1357063|P1|Open Label Phase|Physician Decision|4
405267|NCT00696384|1357061|P3|Open Label Phase|Lack of Efficacy|0
405268|NCT00696384|1357062|P2|Open Label Phase|Lack of Efficacy|0
405269|NCT00696384|1357063|P1|Open Label Phase|Lack of Efficacy|3
405270|NCT00696384|1357061|P3|Open Label Phase|Other|0
405271|NCT00696384|1357062|P2|Open Label Phase|Other|0
405272|NCT00696384|1357063|P1|Open Label Phase|Other|6
405273|NCT00696384|1357061|P3|Open Label Phase|Withdrawal by Subject|0
405274|NCT00696384|1357062|P2|Open Label Phase|Withdrawal by Subject|0
405275|NCT00696384|1357063|P1|Open Label Phase|Withdrawal by Subject|37
405276|NCT00696384|1357061|P3|Open Label Phase|Lost to Follow-up|0
405277|NCT00696384|1357062|P2|Open Label Phase|Lost to Follow-up|0
405278|NCT00696384|1357063|P1|Open Label Phase|Lost to Follow-up|24
405279|NCT00696384|1357061|P3|Open Label Phase|Protocol Violation|0
405280|NCT00696384|1357062|P2|Open Label Phase|Protocol Violation|0
405281|NCT00696384|1357063|P1|Open Label Phase|Protocol Violation|18
405282|NCT00696384|1357061|P3|Open Label Phase|Adverse Event|0
405283|NCT00696384|1357062|P2|Open Label Phase|Adverse Event|0
405284|NCT00696384|1357063|P1|Open Label Phase|Adverse Event|27
405285|NCT00696241|1357087|P5|Overall Study|Other|1
405286|NCT00696241|1357088|P4|Overall Study|Other|2
405287|NCT00696241|1357089|P3|Overall Study|Other|5
405288|NCT00696241|1357090|P2|Overall Study|Other|1
405289|NCT00696241|1357091|P1|Overall Study|Other|6
405290|NCT00696241|1357087|P5|Overall Study|Lack of Efficacy|3
405291|NCT00696241|1357088|P4|Overall Study|Lack of Efficacy|5
405292|NCT00696241|1357089|P3|Overall Study|Lack of Efficacy|4
405293|NCT00696241|1357090|P2|Overall Study|Lack of Efficacy|5
405294|NCT00696241|1357091|P1|Overall Study|Lack of Efficacy|1
405295|NCT00696241|1357087|P5|Overall Study|Withdrawal by Subject|0
405296|NCT00696241|1357088|P4|Overall Study|Withdrawal by Subject|1
405297|NCT00696241|1357089|P3|Overall Study|Withdrawal by Subject|6
405298|NCT00696241|1357090|P2|Overall Study|Withdrawal by Subject|8
405299|NCT00696241|1357091|P1|Overall Study|Withdrawal by Subject|4
405300|NCT00696241|1357087|P5|Overall Study|Lost to Follow-up|0
405301|NCT00696241|1357088|P4|Overall Study|Lost to Follow-up|2
405302|NCT00696241|1357089|P3|Overall Study|Lost to Follow-up|1
405303|NCT00696241|1357090|P2|Overall Study|Lost to Follow-up|4
405304|NCT00696241|1357091|P1|Overall Study|Lost to Follow-up|1
405305|NCT00696241|1357087|P5|Overall Study|Protocol Violation|3
405306|NCT00696241|1357088|P4|Overall Study|Protocol Violation|0
405307|NCT00696241|1357089|P3|Overall Study|Protocol Violation|2
405308|NCT00696241|1357090|P2|Overall Study|Protocol Violation|1
405309|NCT00696241|1357091|P1|Overall Study|Protocol Violation|1
405310|NCT00696241|1357087|P5|Overall Study|Adverse Event|5
405311|NCT00696241|1357088|P4|Overall Study|Adverse Event|4
405312|NCT00696241|1357089|P3|Overall Study|Adverse Event|6
405313|NCT00696241|1357090|P2|Overall Study|Adverse Event|3
405314|NCT00696241|1357091|P1|Overall Study|Adverse Event|11
405315|NCT00696072|1357175|P2|Overall Study|Non-specified|2
405316|NCT00696072|1357176|P1|Overall Study|Non-specified|1
405317|NCT00696072|1357175|P2|Overall Study|Disease Progression|30
405318|NCT00696072|1357176|P1|Overall Study|Disease Progression|32
405319|NCT00696072|1357175|P2|Overall Study|Sponsor Request|1
405320|NCT00696072|1357176|P1|Overall Study|Sponsor Request|0
405321|NCT00696072|1357175|P2|Overall Study|Investigator Request|4
405322|NCT00696072|1357176|P1|Overall Study|Investigator Request|1
405323|NCT00696072|1357175|P2|Overall Study|Patient Request|7
405324|NCT00696072|1357176|P1|Overall Study|Patient Request|3
405325|NCT00696072|1357175|P2|Overall Study|Adverse Event|6
405326|NCT00696072|1357176|P1|Overall Study|Adverse Event|10
405327|NCT00696072|1357175|P2|Overall Study|continuing active treatment|13
405328|NCT00696072|1357176|P1|Overall Study|continuing active treatment|10
405329|NCT00696020|1357197|P4|Overall Study|Other not stated above|1
405330|NCT00696020|1357198|P3|Overall Study|Other not stated above|1
405331|NCT00696020|1357199|P2|Overall Study|Other not stated above|0
405332|NCT00696020|1357200|P1|Overall Study|Other not stated above|0
405333|NCT00696020|1357197|P4|Overall Study|Withdrawal by Subject|1
405334|NCT00696020|1357198|P3|Overall Study|Withdrawal by Subject|0
405335|NCT00696020|1357199|P2|Overall Study|Withdrawal by Subject|1
405336|NCT00696020|1357200|P1|Overall Study|Withdrawal by Subject|0
405337|NCT00696020|1357197|P4|Overall Study|Protocol Violation|1
405338|NCT00696020|1357198|P3|Overall Study|Protocol Violation|0
405339|NCT00696020|1357199|P2|Overall Study|Protocol Violation|0
405340|NCT00696020|1357200|P1|Overall Study|Protocol Violation|0
405341|NCT00696020|1357197|P4|Overall Study|Lack of Efficacy|0
405342|NCT00696020|1357198|P3|Overall Study|Lack of Efficacy|0
405343|NCT00696020|1357199|P2|Overall Study|Lack of Efficacy|0
405344|NCT00696020|1357200|P1|Overall Study|Lack of Efficacy|1
405345|NCT00696020|1357197|P4|Overall Study|Adverse Event|1
405346|NCT00696020|1357198|P3|Overall Study|Adverse Event|2
405347|NCT00696020|1357199|P2|Overall Study|Adverse Event|1
405348|NCT00696020|1357200|P1|Overall Study|Adverse Event|3
405349|NCT00695955|1357308|P1|Cohort 2|Other|5
405350|NCT00695955|1357308|P1|Cohort 2|Lack of Efficacy|4
405351|NCT00695955|1357308|P1|Cohort 2|Withdrawal by Subject|28
405352|NCT00695955|1357308|P1|Cohort 2|Lost to Follow-up|38
405353|NCT00695955|1357308|P1|Cohort 2|Protocol Violation|5
405354|NCT00695955|1357308|P1|Cohort 2|Adverse Event|24
405355|NCT00695955|1357308|P1|Cohort 1|Other|16
405356|NCT00695955|1357308|P1|Cohort 1|Lack of Efficacy|3
405357|NCT00695955|1357308|P1|Cohort 1|Withdrawal by Subject|25
405358|NCT00695955|1357308|P1|Cohort 1|Lost to Follow-up|30
405359|NCT00695955|1357308|P1|Cohort 1|Protocol Violation|2
405360|NCT00695955|1357308|P1|Cohort 1|Adverse Event|26
405361|NCT00695903|1357320|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
405362|NCT00695903|1357321|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
405363|NCT00695903|1357320|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
405364|NCT00695903|1357321|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
405365|NCT00695903|1357320|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
405366|NCT00695903|1357321|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
405367|NCT00695903|1357320|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
405368|NCT00695903|1357321|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
405369|NCT00695903|1357320|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
405370|NCT00695903|1357321|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
405371|NCT00695903|1357320|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
405372|NCT00695903|1357321|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
405373|NCT00695903|1357320|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
405374|NCT00695903|1357321|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
405375|NCT00695903|1357320|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
405376|NCT00695903|1357321|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
405377|NCT00695903|1357320|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
405378|NCT00695903|1357321|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
405379|NCT00695864|1357333|P1|Placebo|Physician Decision|4
405380|NCT00695864|1357333|P1|Placebo|Withdrawal by Subject|1
405381|NCT00695669|1357343|P4|Overall Study|Lost to Follow-up|4
405382|NCT00695669|1357344|P3|Overall Study|Lost to Follow-up|1
405383|NCT00695669|1357345|P2|Overall Study|Lost to Follow-up|4
405384|NCT00695669|1357346|P1|Overall Study|Lost to Follow-up|4
405385|NCT00695669|1357343|P4|Overall Study|Adverse Event|0
405386|NCT00695669|1357344|P3|Overall Study|Adverse Event|2
405387|NCT00695669|1357345|P2|Overall Study|Adverse Event|0
405388|NCT00695669|1357346|P1|Overall Study|Adverse Event|0
405389|NCT00695565|1357422|P2|Overall Study|Subject did not follow instructions|1
405390|NCT00695565|1357423|P1|Overall Study|Subject did not follow instructions|1
405391|NCT00695565|1357422|P2|Overall Study|Lack of Efficacy|1
405392|NCT00695565|1357423|P1|Overall Study|Lack of Efficacy|1
405393|NCT00695565|1357422|P2|Overall Study|Withdrawal by Subject|1
405394|NCT00695565|1357423|P1|Overall Study|Withdrawal by Subject|1
405395|NCT00695565|1357422|P2|Overall Study|Protocol Violation|1
405396|NCT00695565|1357423|P1|Overall Study|Protocol Violation|3
405397|NCT00695565|1357422|P2|Overall Study|Adverse Event|1
405398|NCT00695565|1357423|P1|Overall Study|Adverse Event|3
405399|NCT00695565|1357422|P2|Overall Study|Lost to Follow-up|4
405400|NCT00695565|1357423|P1|Overall Study|Lost to Follow-up|4
405401|NCT00695396|1357484|P3|Overall Study|Withdrawal by Subject|0
405402|NCT00695396|1357485|P2|Overall Study|Withdrawal by Subject|2
405403|NCT00695396|1357486|P1|Overall Study|Withdrawal by Subject|2
405404|NCT00695396|1357484|P3|Overall Study|Study Closed Prematurely|8
405405|NCT00695396|1357485|P2|Overall Study|Study Closed Prematurely|6
405406|NCT00695396|1357486|P1|Overall Study|Study Closed Prematurely|5
405407|NCT00695318|1357502|P2|Overall Study|Study Terminated|0
405408|NCT00695318|1357503|P1|Overall Study|Study Terminated|1
405409|NCT00695318|1357502|P2|Overall Study|Death|1
405410|NCT00695318|1357503|P1|Overall Study|Death|1
405411|NCT00695318|1357502|P2|Overall Study|Withdrawal by Subject|0
405412|NCT00695318|1357503|P1|Overall Study|Withdrawal by Subject|2
405413|NCT00695318|1357502|P2|Overall Study|Lost to Follow-up|0
405414|NCT00695318|1357503|P1|Overall Study|Lost to Follow-up|1
405415|NCT00695136|1357528|P1|Overall Study|unrelated adverse event|1
405416|NCT00695136|1357528|P1|Overall Study|Withdrawal by Subject|1
405417|NCT00695019|1357544|P3|Overall Study|Various|4
405418|NCT00695019|1357545|P2|Overall Study|Various|5
405419|NCT00695019|1357546|P1|Overall Study|Various|4
405420|NCT00695019|1357544|P3|Overall Study|Lack of Efficacy|1
405421|NCT00695019|1357545|P2|Overall Study|Lack of Efficacy|0
405422|NCT00695019|1357546|P1|Overall Study|Lack of Efficacy|0
405423|NCT00695019|1357544|P3|Overall Study|Protocol Violation|1
405424|NCT00695019|1357545|P2|Overall Study|Protocol Violation|3
405425|NCT00695019|1357546|P1|Overall Study|Protocol Violation|1
405426|NCT00695019|1357544|P3|Overall Study|Withdrawal by Subject|4
405427|NCT00695019|1357545|P2|Overall Study|Withdrawal by Subject|6
405428|NCT00695019|1357546|P1|Overall Study|Withdrawal by Subject|8
405429|NCT00694551|1357587|P3|Overall Study|Disease Progression|1
405430|NCT00694551|1357588|P2|Overall Study|Disease Progression|0
405431|NCT00694551|1357589|P1|Overall Study|Disease Progression|1
405432|NCT00694369|1357618|P5|Overall Study|Withdrawal by Subject|2
405433|NCT00694369|1357619|P4|Overall Study|Withdrawal by Subject|1
405434|NCT00694369|1357620|P3|Overall Study|Withdrawal by Subject|1
405435|NCT00694369|1357621|P2|Overall Study|Withdrawal by Subject|1
405436|NCT00694369|1357622|P1|Overall Study|Withdrawal by Subject|1
405437|NCT00694369|1357618|P5|Overall Study|Protocol Violation|0
405438|NCT00694369|1357619|P4|Overall Study|Protocol Violation|0
405439|NCT00694369|1357620|P3|Overall Study|Protocol Violation|0
405440|NCT00694369|1357621|P2|Overall Study|Protocol Violation|1
405441|NCT00694369|1357622|P1|Overall Study|Protocol Violation|0
405442|NCT00694369|1357618|P5|Overall Study|Physician Decision|1
405443|NCT00694369|1357619|P4|Overall Study|Physician Decision|0
405444|NCT00694369|1357620|P3|Overall Study|Physician Decision|0
405445|NCT00694369|1357621|P2|Overall Study|Physician Decision|0
405446|NCT00694369|1357622|P1|Overall Study|Physician Decision|0
405447|NCT00694369|1357618|P5|Overall Study|Lost to Follow-up|0
405448|NCT00694369|1357619|P4|Overall Study|Lost to Follow-up|1
405449|NCT00694369|1357620|P3|Overall Study|Lost to Follow-up|1
405450|NCT00694369|1357621|P2|Overall Study|Lost to Follow-up|0
405451|NCT00694369|1357622|P1|Overall Study|Lost to Follow-up|0
405452|NCT00694369|1357618|P5|Overall Study|Adverse Event|3
405453|NCT00694369|1357619|P4|Overall Study|Adverse Event|1
405454|NCT00694369|1357620|P3|Overall Study|Adverse Event|0
405455|NCT00694369|1357621|P2|Overall Study|Adverse Event|1
405456|NCT00694369|1357622|P1|Overall Study|Adverse Event|0
405457|NCT00694356|1357642|P3|Overall Study|Progressive Disease|6
405458|NCT00694356|1357643|P2|Overall Study|Progressive Disease|6
405459|NCT00694356|1357644|P1|Overall Study|Progressive Disease|2
405460|NCT00694356|1357642|P3|Overall Study|Adverse Event|0
405461|NCT00694356|1357643|P2|Overall Study|Adverse Event|0
405462|NCT00694356|1357644|P1|Overall Study|Adverse Event|1
405463|NCT00694304|1357679|P1|Overall Study|Administrative or Other Reasons|32
405464|NCT00694304|1357679|P1|Overall Study|Lost to Follow-up|15
405465|NCT00694304|1357679|P1|Overall Study|Withdrawal of Consent|61
405466|NCT00694304|1357679|P1|Overall Study|Protocol Violation|6
405467|NCT00694304|1357679|P1|Overall Study|Non-compliance With Study Product|16
405468|NCT00694304|1357679|P1|Overall Study|Lack of Efficacy|35
405469|NCT00694304|1357679|P1|Overall Study|Adverse Event|42
405470|NCT00694161|1357692|P1|Part 2 (After Week 6 up to Month 12)|Death|1
405471|NCT00694161|1357692|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
405472|NCT00694161|1357692|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
405473|NCT00694122|1357731|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
405474|NCT00694122|1357732|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
405475|NCT00694122|1357731|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
405476|NCT00694122|1357732|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
405477|NCT00694122|1357731|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
405478|NCT00694122|1357732|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
405479|NCT00694109|1357748|P1|Overall Study|Consented but no additional treatment|3
405480|NCT00694109|1357748|P1|Overall Study|Other|2
405481|NCT00694109|1357748|P1|Overall Study|Enrolled but not treated|1
405482|NCT00694109|1357748|P1|Overall Study|Pregnancy|1
405483|NCT00694109|1357748|P1|Overall Study|Withdrawal by Subject|13
405484|NCT00694109|1357748|P1|Overall Study|Lack of Efficacy|2
405485|NCT00694109|1357748|P1|Overall Study|Not consent of more 2 years of treatment|18
405486|NCT00694109|1357748|P1|Overall Study|Adverse Event|74
405487|NCT00694109|1357748|P1|Overall Study|Physician Decision|3
405488|NCT00694096|1357772|P1|Overall Study|Withdrawal by Subject|5
405489|NCT00693784|1357812|P1|Overall Study|Withdrawal by Subject|2
405490|NCT00693784|1357812|P1|Overall Study|Lost to Follow-up|2
405491|NCT00693706|1357825|P2|Overall Study|Protocol Violation|1
405492|NCT00693706|1357826|P1|Overall Study|Protocol Violation|0
405493|NCT00693693|1357853|P3|Overall Study|Lost to Follow-up|2
405494|NCT00693693|1357854|P2|Overall Study|Lost to Follow-up|1
405495|NCT00693693|1357855|P1|Overall Study|Lost to Follow-up|1
405496|NCT00693472|1357914|P4|Part 2|Withdrew - reason unrelated to treatment|2
405497|NCT00693472|1357915|P3|Part 2|Withdrew - reason unrelated to treatment|1
405498|NCT00693472|1357916|P2|Part 2|Withdrew - reason unrelated to treatment|0
405499|NCT00693472|1357917|P1|Part 2|Withdrew - reason unrelated to treatment|0
405500|NCT00693472|1357914|P4|Part 2|Adverse Event|0
405501|NCT00693472|1357915|P3|Part 2|Adverse Event|1
405502|NCT00693472|1357916|P2|Part 2|Adverse Event|0
405503|NCT00693472|1357917|P1|Part 2|Adverse Event|0
405504|NCT00693472|1357914|P4|Part 1|Withdrew - reason unrelated to treatment|0
405505|NCT00693472|1357915|P3|Part 1|Withdrew - reason unrelated to treatment|0
405506|NCT00693472|1357916|P2|Part 1|Withdrew - reason unrelated to treatment|2
405507|NCT00693472|1357917|P1|Part 1|Withdrew - reason unrelated to treatment|5
405508|NCT00693472|1357914|P4|Part 1|Lost to Follow-up|0
405509|NCT00693472|1357915|P3|Part 1|Lost to Follow-up|0
405510|NCT00693472|1357916|P2|Part 1|Lost to Follow-up|1
405511|NCT00693472|1357917|P1|Part 1|Lost to Follow-up|0
405512|NCT00693472|1357914|P4|Part 1|Adverse Event|0
405513|NCT00693472|1357915|P3|Part 1|Adverse Event|0
405514|NCT00693472|1357916|P2|Part 1|Adverse Event|1
405515|NCT00693472|1357917|P1|Part 1|Adverse Event|1
405516|NCT00693420|1357937|P2|Overall Study|Personal Reasons|4
405517|NCT00693420|1357938|P1|Overall Study|Personal Reasons|1
405518|NCT00693420|1357937|P2|Overall Study|Sponsor Request - Conflict of Interest|2
405519|NCT00693420|1357938|P1|Overall Study|Sponsor Request - Conflict of Interest|0
405520|NCT00693420|1357937|P2|Overall Study|Protocol Violation|2
405521|NCT00693420|1357938|P1|Overall Study|Protocol Violation|0
405522|NCT00693420|1357937|P2|Overall Study|Withdrawal by Subject|0
405523|NCT00693420|1357938|P1|Overall Study|Withdrawal by Subject|1
405524|NCT00693420|1357937|P2|Overall Study|Lost to Follow-up|3
405525|NCT00693420|1357938|P1|Overall Study|Lost to Follow-up|0
405526|NCT00693420|1357937|P2|Overall Study|Adverse Event|4
405527|NCT00693420|1357938|P1|Overall Study|Adverse Event|4
405528|NCT00693225|1357977|P2|Overall Study|Adverse Event|3
405529|NCT00693225|1357978|P1|Overall Study|Adverse Event|1
405530|NCT00693225|1357977|P2|Overall Study|Lost to Follow-up|2
405531|NCT00693225|1357978|P1|Overall Study|Lost to Follow-up|1
405532|NCT00693017|1358001|P2|Overall Study|Death|1
405533|NCT00693017|1358002|P1|Overall Study|Death|0
405534|NCT00693017|1358001|P2|Overall Study|Sponsor Decision|1
405535|NCT00693017|1358002|P1|Overall Study|Sponsor Decision|2
405536|NCT00692913|1358012|P2|Overall Study|Withdrawal by Subject|20
405537|NCT00692913|1358013|P1|Overall Study|Withdrawal by Subject|15
405538|NCT00692913|1358012|P2|Overall Study|Protocol Violation|1
405539|NCT00692913|1358013|P1|Overall Study|Protocol Violation|1
405540|NCT00692913|1358012|P2|Overall Study|Physician Decision|0
405541|NCT00692913|1358013|P1|Overall Study|Physician Decision|2
405542|NCT00692913|1358012|P2|Overall Study|Lost to Follow-up|5
405543|NCT00692913|1358013|P1|Overall Study|Lost to Follow-up|3
405544|NCT00692913|1358012|P2|Overall Study|Adverse Event|4
405545|NCT00692913|1358013|P1|Overall Study|Adverse Event|8
405546|NCT00692770|1358035|P2|Overall Study|Randomized but not treated|4
405547|NCT00692770|1358036|P1|Overall Study|Randomized but not treated|3
405548|NCT00692770|1358035|P2|Overall Study|Study terminated by sponsor|2
405549|NCT00692770|1358036|P1|Overall Study|Study terminated by sponsor|2
405550|NCT00692770|1358035|P2|Overall Study|Clinical endpoint reached|43
405551|NCT00692770|1358036|P1|Overall Study|Clinical endpoint reached|16
405552|NCT00692770|1358035|P2|Overall Study|Radiological and clinical progression|8
405553|NCT00692770|1358036|P1|Overall Study|Radiological and clinical progression|8
405554|NCT00692770|1358035|P2|Overall Study|Completed all planned assessments|101
405555|NCT00692770|1358036|P1|Overall Study|Completed all planned assessments|79
405556|NCT00692770|1358035|P2|Overall Study|Protocol driven decision point|7
405557|NCT00692770|1358036|P1|Overall Study|Protocol driven decision point|3
405558|NCT00692770|1358035|P2|Overall Study|Disease progression, recurrence/relapse|279
405559|NCT00692770|1358036|P1|Overall Study|Disease progression, recurrence/relapse|170
405560|NCT00692770|1358035|P2|Overall Study|Physician decision not protocol driven|14
405561|NCT00692770|1358036|P1|Overall Study|Physician decision not protocol driven|10
405562|NCT00692770|1358035|P2|Overall Study|Progression by clinical judgment|3
405563|NCT00692770|1358036|P1|Overall Study|Progression by clinical judgment|2
405564|NCT00692770|1358035|P2|Overall Study|Non-compliant with study medication|5
405565|NCT00692770|1358036|P1|Overall Study|Non-compliant with study medication|11
405566|NCT00692770|1358035|P2|Overall Study|Lost to Follow-up|3
405567|NCT00692770|1358036|P1|Overall Study|Lost to Follow-up|7
405568|NCT00692770|1358035|P2|Overall Study|Death|5
405569|NCT00692770|1358036|P1|Overall Study|Death|10
405570|NCT00692770|1358035|P2|Overall Study|Adverse Event|41
405571|NCT00692770|1358036|P1|Overall Study|Adverse Event|136
405572|NCT00692770|1358035|P2|Overall Study|Withdrawal by Subject|36
405573|NCT00692770|1358036|P1|Overall Study|Withdrawal by Subject|97
405574|NCT00692770|1358035|P2|Overall Study|Protocol Violation|7
405575|NCT00692770|1358036|P1|Overall Study|Protocol Violation|2
405576|NCT00692406|1358082|P1|Overall Study|PI dropped, bad data|57
405577|NCT00692237|1358144|P2|Overall Study|Adverse Event|1
405578|NCT00692237|1358145|P1|Overall Study|Adverse Event|0
405579|NCT00692237|1358144|P2|Overall Study|Withdrawal by Subject|3
405580|NCT00692237|1358145|P1|Overall Study|Withdrawal by Subject|1
405581|NCT00692003|1358209|P2|Overall Study|Sponsor Decision|1
405582|NCT00692003|1358210|P1|Overall Study|Sponsor Decision|5
405583|NCT00691938|1358225|P7|Overall Study|QTc prolongation|0
405584|NCT00691938|1358226|P6|Overall Study|QTc prolongation|0
405585|NCT00691938|1358227|P5|Overall Study|QTc prolongation|0
405586|NCT00691938|1358228|P4|Overall Study|QTc prolongation|0
405587|NCT00691938|1358229|P3|Overall Study|QTc prolongation|0
405588|NCT00691938|1358230|P2|Overall Study|QTc prolongation|0
405589|NCT00691938|1358231|P1|Overall Study|QTc prolongation|1
405590|NCT00691704|1358298|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
405591|NCT00691704|1358298|P1|Two Years of Maintenance Therapy|Physician Decision|4
405592|NCT00691704|1358298|P1|Two Years of Maintenance Therapy|Disease Progression|8
405593|NCT00691704|1358298|P1|Induction Therapy|Active Hepatitis|1
405594|NCT00691704|1358298|P1|Induction Therapy|Disease Progression|1
405595|NCT00691483|1358327|P2|Overall Study|Randomized by not treated|1
405596|NCT00691483|1358328|P1|Overall Study|Randomized by not treated|7
405597|NCT00691483|1358327|P2|Overall Study|Other known cause|1
405598|NCT00691483|1358328|P1|Overall Study|Other known cause|6
405599|NCT00691483|1358327|P2|Overall Study|Withdrawal by Subject|7
405600|NCT00691483|1358328|P1|Overall Study|Withdrawal by Subject|24
405601|NCT00691483|1358327|P2|Overall Study|Lost to Follow-up|10
405602|NCT00691483|1358328|P1|Overall Study|Lost to Follow-up|17
405603|NCT00691483|1358327|P2|Overall Study|Adverse Event|6
405604|NCT00691483|1358328|P1|Overall Study|Adverse Event|14
405605|NCT00691301|1358355|P1|Overall Study|Did not initiate study treatment|1
405606|NCT00691301|1358355|P1|Overall Study|other reason|3
405607|NCT00691301|1358355|P1|Overall Study|Concurrent illness|2
405608|NCT00691301|1358355|P1|Overall Study|Withdrawal by Subject|4
405609|NCT00691301|1358355|P1|Overall Study|Lack of Efficacy|32
405610|NCT00691301|1358355|P1|Overall Study|Death|2
405611|NCT00691301|1358355|P1|Overall Study|Adverse Event|10
405612|NCT00691210|1358375|P8|Overall Study|Lack of Efficacy|0
405613|NCT00691210|1358376|P7|Overall Study|Lack of Efficacy|0
405614|NCT00691210|1358377|P6|Overall Study|Lack of Efficacy|1
405615|NCT00691210|1358378|P5|Overall Study|Lack of Efficacy|0
405616|NCT00691210|1358379|P4|Overall Study|Lack of Efficacy|1
405617|NCT00691210|1358380|P3|Overall Study|Lack of Efficacy|0
405618|NCT00691210|1358381|P2|Overall Study|Lack of Efficacy|0
405619|NCT00691210|1358382|P1|Overall Study|Lack of Efficacy|0
405620|NCT00691210|1358375|P8|Overall Study|Progression of Disease|0
405621|NCT00691210|1358376|P7|Overall Study|Progression of Disease|0
405622|NCT00691210|1358377|P6|Overall Study|Progression of Disease|0
405623|NCT00691210|1358378|P5|Overall Study|Progression of Disease|0
405624|NCT00691210|1358379|P4|Overall Study|Progression of Disease|2
405625|NCT00691210|1358380|P3|Overall Study|Progression of Disease|0
405626|NCT00691210|1358381|P2|Overall Study|Progression of Disease|0
405627|NCT00691210|1358382|P1|Overall Study|Progression of Disease|0
405628|NCT00691132|1358417|P2|Overall Study|Withdrawal by Subject|10
405629|NCT00691132|1358418|P1|Overall Study|Withdrawal by Subject|10
405630|NCT00691132|1358417|P2|Overall Study|Adverse Event|3
405631|NCT00691132|1358418|P1|Overall Study|Adverse Event|2
405632|NCT00691093|1358437|P1|Overall Study|Ongoing at Date of Cut-Off|4
405633|NCT00691093|1358437|P1|Overall Study|Lack of Efficacy|1
405634|NCT00691093|1358437|P1|Overall Study|Lost to Follow-up|1
405635|NCT00691093|1358437|P1|Overall Study|Adverse Event|1
405636|NCT00691054|1358471|P1|Overall Study|Withdrawal by Subject|1
405637|NCT00691028|1358483|P4|Double-blind Period|not come to a hospital.|0
405638|NCT00691028|1358484|P3|Double-blind Period|not come to a hospital.|0
405639|NCT00691028|1358485|P2|Double-blind Period|not come to a hospital.|1
405640|NCT00691028|1358486|P1|Double-blind Period|not come to a hospital.|0
405641|NCT00691028|1358483|P4|Double-blind Period|Withdrawal by Subject|0
405642|NCT00691028|1358484|P3|Double-blind Period|Withdrawal by Subject|1
405643|NCT00691028|1358485|P2|Double-blind Period|Withdrawal by Subject|0
405644|NCT00691028|1358486|P1|Double-blind Period|Withdrawal by Subject|1
405645|NCT00691028|1358483|P4|Double-blind Period|Lack of Efficacy|0
405646|NCT00691028|1358484|P3|Double-blind Period|Lack of Efficacy|2
405647|NCT00691028|1358485|P2|Double-blind Period|Lack of Efficacy|3
405648|NCT00691028|1358486|P1|Double-blind Period|Lack of Efficacy|4
405649|NCT00691028|1358483|P4|Double-blind Period|Adverse Event|0
405650|NCT00691028|1358484|P3|Double-blind Period|Adverse Event|6
405651|NCT00691028|1358485|P2|Double-blind Period|Adverse Event|9
405652|NCT00691028|1358486|P1|Double-blind Period|Adverse Event|8
405653|NCT00691028|1358483|P4|Open-label Period|not come to a hospital|1
405654|NCT00691028|1358484|P3|Open-label Period|not come to a hospital|0
405655|NCT00691028|1358485|P2|Open-label Period|not come to a hospital|0
405656|NCT00691028|1358486|P1|Open-label Period|not come to a hospital|0
405657|NCT00691028|1358483|P4|Open-label Period|Withdrawal by Subject|3
405658|NCT00691028|1358484|P3|Open-label Period|Withdrawal by Subject|0
405659|NCT00691028|1358485|P2|Open-label Period|Withdrawal by Subject|0
405660|NCT00691028|1358486|P1|Open-label Period|Withdrawal by Subject|0
405661|NCT00691028|1358483|P4|Open-label Period|Adverse Event|16
405662|NCT00691028|1358484|P3|Open-label Period|Adverse Event|0
405663|NCT00691028|1358485|P2|Open-label Period|Adverse Event|0
405664|NCT00691028|1358486|P1|Open-label Period|Adverse Event|0
405665|NCT00691015|1358519|P1|Overall Study|Refused further treatment|1
405666|NCT00690898|1358534|P1|TREATMENT|Other (not otherwise specified)|1
405667|NCT00690898|1358534|P1|TREATMENT|Withdrawal by Subject|4
405668|NCT00690898|1358534|P1|TREATMENT|Lack of Efficacy|18
405669|NCT00690898|1358534|P1|TREATMENT|Adverse Event|3
405670|NCT00690898|1358534|P1|SCREENING|Screen failure|18
405671|NCT00690820|1358554|P2|Period 1|Withdrawal by Subject|1
405672|NCT00690820|1358555|P1|Period 1|Withdrawal by Subject|0
405673|NCT00690794|1358577|P2|Overall Study|Other not specified|3
405674|NCT00690794|1358578|P1|Overall Study|Other not specified|1
405675|NCT00690794|1358577|P2|Overall Study|Noncompliance|2
405676|NCT00690794|1358578|P1|Overall Study|Noncompliance|1
405677|NCT00690794|1358577|P2|Overall Study|Protocol Violation|7
405678|NCT00690794|1358578|P1|Overall Study|Protocol Violation|6
405679|NCT00690794|1358577|P2|Overall Study|Withdrawal by Subject|9
405680|NCT00690794|1358578|P1|Overall Study|Withdrawal by Subject|0
405681|NCT00690794|1358577|P2|Overall Study|Lost to Follow-up|4
405682|NCT00690794|1358578|P1|Overall Study|Lost to Follow-up|1
405683|NCT00690794|1358577|P2|Overall Study|Adverse Event|10
405684|NCT00690794|1358578|P1|Overall Study|Adverse Event|12
405685|NCT00690755|1358593|P7|Overall Study|Physician Decision|0
405686|NCT00690755|1358594|P6|Overall Study|Physician Decision|4
405687|NCT00690755|1358595|P5|Overall Study|Physician Decision|0
405688|NCT00690755|1358596|P4|Overall Study|Physician Decision|5
405689|NCT00690755|1358597|P3|Overall Study|Physician Decision|46
405690|NCT00690755|1358598|P2|Overall Study|Physician Decision|0
405691|NCT00690755|1358599|P1|Overall Study|Physician Decision|2
405692|NCT00690612|1358615|P1|Overall Study|Withdrawal by Subject|2
405693|NCT00690612|1358615|P1|Overall Study|Adverse Event|1
405694|NCT00690573|1358620|P1|Overall Study|Withdrawal by Subject|1
405695|NCT00690573|1358620|P1|Overall Study|Lack of Efficacy|8
405696|NCT00690482|1358639|P2|Overall Study|withdrew consent at rand.day|1
405697|NCT00690482|1358640|P1|Overall Study|withdrew consent at rand.day|0
405698|NCT00690482|1358639|P2|Overall Study|Intake of prohibited medicine|0
405699|NCT00690482|1358640|P1|Overall Study|Intake of prohibited medicine|1
405700|NCT00690482|1358639|P2|Overall Study|Study-specific discontinuation criteria|0
405701|NCT00690482|1358640|P1|Overall Study|Study-specific discontinuation criteria|1
405702|NCT00690482|1358639|P2|Overall Study|Incorrect enrolment|1
405703|NCT00690482|1358640|P1|Overall Study|Incorrect enrolment|0
405704|NCT00690482|1358639|P2|Overall Study|Adverse Event|1
405705|NCT00690482|1358640|P1|Overall Study|Adverse Event|2
405706|NCT00690443|1358674|P2|Overall Study|Adverse Event|2
405707|NCT00690443|1358675|P1|Overall Study|Adverse Event|1
405708|NCT00690430|1358685|P3|Extension Phase|Early Termination|3
405709|NCT00690430|1358686|P2|Extension Phase|Early Termination|1
405710|NCT00690430|1358687|P1|Extension Phase|Early Termination|10
405711|NCT00690430|1358685|P3|Extension Phase|Withdrawal by Subject|2
405712|NCT00690430|1358686|P2|Extension Phase|Withdrawal by Subject|0
405713|NCT00690430|1358687|P1|Extension Phase|Withdrawal by Subject|0
405714|NCT00690430|1358685|P3|Extension Phase|Death|1
405715|NCT00690430|1358686|P2|Extension Phase|Death|1
405716|NCT00690430|1358687|P1|Extension Phase|Death|1
405717|NCT00690430|1358685|P3|Extension Phase|Adverse Event|2
405718|NCT00690430|1358686|P2|Extension Phase|Adverse Event|1
405719|NCT00690430|1358687|P1|Extension Phase|Adverse Event|2
405720|NCT00690430|1358685|P3|Extension Phase|Administrative Problems|1
405721|NCT00690430|1358686|P2|Extension Phase|Administrative Problems|1
405722|NCT00690430|1358687|P1|Extension Phase|Administrative Problems|0
405723|NCT00690430|1358685|P3|Extension Phase|Abnormal test procedure results|0
405724|NCT00690430|1358686|P2|Extension Phase|Abnormal test procedure results|0
405725|NCT00690430|1358687|P1|Extension Phase|Abnormal test procedure results|1
405726|NCT00690430|1358685|P3|Extension Phase|Abnormal Lab Values|0
405727|NCT00690430|1358686|P2|Extension Phase|Abnormal Lab Values|0
405728|NCT00690430|1358687|P1|Extension Phase|Abnormal Lab Values|1
405729|NCT00690430|1358685|P3|Extension Phase|Lack of Efficacy|4
405730|NCT00690430|1358686|P2|Extension Phase|Lack of Efficacy|1
405731|NCT00690430|1358687|P1|Extension Phase|Lack of Efficacy|3
405732|NCT00690430|1358685|P3|Core Phase|Early Termination|0
405733|NCT00690430|1358686|P2|Core Phase|Early Termination|5
405734|NCT00690430|1358687|P1|Core Phase|Early Termination|0
405735|NCT00690430|1358685|P3|Core Phase|Administrative Problems|0
405736|NCT00690430|1358686|P2|Core Phase|Administrative Problems|1
405737|NCT00690430|1358687|P1|Core Phase|Administrative Problems|0
405738|NCT00690430|1358685|P3|Core Phase|Lack of Efficacy|0
405739|NCT00690430|1358686|P2|Core Phase|Lack of Efficacy|10
405740|NCT00690430|1358687|P1|Core Phase|Lack of Efficacy|8
405741|NCT00690430|1358685|P3|Core Phase|Subject no longer requires study drug|0
405742|NCT00690430|1358686|P2|Core Phase|Subject no longer requires study drug|0
405743|NCT00690430|1358687|P1|Core Phase|Subject no longer requires study drug|1
405744|NCT00690430|1358685|P3|Core Phase|Withdrawal by Subject|0
405745|NCT00690430|1358686|P2|Core Phase|Withdrawal by Subject|3
405746|NCT00690430|1358687|P1|Core Phase|Withdrawal by Subject|3
405747|NCT00690430|1358685|P3|Core Phase|Protocol Violation|0
405748|NCT00690430|1358686|P2|Core Phase|Protocol Violation|0
405749|NCT00690430|1358687|P1|Core Phase|Protocol Violation|1
405750|NCT00690430|1358685|P3|Core Phase|Death|0
405751|NCT00690430|1358686|P2|Core Phase|Death|2
405752|NCT00690430|1358687|P1|Core Phase|Death|0
405753|NCT00690430|1358685|P3|Core Phase|Adverse Event|0
405754|NCT00690430|1358686|P2|Core Phase|Adverse Event|1
405755|NCT00690430|1358687|P1|Core Phase|Adverse Event|5
405756|NCT00690430|1358685|P3|Core Phase|Abnormal Laboratory value|0
405757|NCT00690430|1358686|P2|Core Phase|Abnormal Laboratory value|1
405758|NCT00690430|1358687|P1|Core Phase|Abnormal Laboratory value|0
405759|NCT00690378|1358716|P2|Overall Study|Social problem|0
405760|NCT00690378|1358717|P1|Overall Study|Social problem|1
405761|NCT00690378|1358716|P2|Overall Study|Did not meet inc/exc criteria|11
405762|NCT00690378|1358717|P1|Overall Study|Did not meet inc/exc criteria|13
405763|NCT00690378|1358716|P2|Overall Study|Lost to Follow-up|3
405764|NCT00690378|1358717|P1|Overall Study|Lost to Follow-up|2
405765|NCT00690378|1358716|P2|Overall Study|Protocol Violation|0
405766|NCT00690378|1358717|P1|Overall Study|Protocol Violation|1
405767|NCT00690378|1358716|P2|Overall Study|Withdrawal by Subject|0
405768|NCT00690378|1358717|P1|Overall Study|Withdrawal by Subject|2
405769|NCT00690378|1358716|P2|Overall Study|Adverse Event|0
405770|NCT00690378|1358717|P1|Overall Study|Adverse Event|1
405771|NCT00689936|1358794|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
405772|NCT00689936|1358795|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
405773|NCT00689936|1358796|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
405774|NCT00689936|1358794|P3|Active Treatment Phase|Miscellaneous|47
405775|NCT00689936|1358795|P2|Active Treatment Phase|Miscellaneous|34
405776|NCT00689936|1358796|P1|Active Treatment Phase|Miscellaneous|52
405777|NCT00689936|1358794|P3|Active Treatment Phase|Study Close Out|21
405778|NCT00689936|1358795|P2|Active Treatment Phase|Study Close Out|26
405779|NCT00689936|1358796|P1|Active Treatment Phase|Study Close Out|64
405780|NCT00689936|1358794|P3|Active Treatment Phase|Protocol Violation|4
405781|NCT00689936|1358795|P2|Active Treatment Phase|Protocol Violation|2
405782|NCT00689936|1358796|P1|Active Treatment Phase|Protocol Violation|2
405783|NCT00689936|1358794|P3|Active Treatment Phase|Lost to Follow-up|2
405784|NCT00689936|1358795|P2|Active Treatment Phase|Lost to Follow-up|2
405785|NCT00689936|1358796|P1|Active Treatment Phase|Lost to Follow-up|0
405786|NCT00689936|1358794|P3|Active Treatment Phase|Death|37
405787|NCT00689936|1358795|P2|Active Treatment Phase|Death|28
405788|NCT00689936|1358796|P1|Active Treatment Phase|Death|60
405789|NCT00689936|1358794|P3|Active Treatment Phase|Withdrawal by Subject|21
405790|NCT00689936|1358795|P2|Active Treatment Phase|Withdrawal by Subject|16
405791|NCT00689936|1358796|P1|Active Treatment Phase|Withdrawal by Subject|16
405792|NCT00689936|1358794|P3|Active Treatment Phase|Disease Progression|339
405793|NCT00689936|1358795|P2|Active Treatment Phase|Disease Progression|362
405794|NCT00689936|1358796|P1|Active Treatment Phase|Disease Progression|273
405795|NCT00689936|1358794|P3|Active Treatment Phase|Adverse Event|76
405796|NCT00689936|1358795|P2|Active Treatment Phase|Adverse Event|71
405797|NCT00689936|1358796|P1|Active Treatment Phase|Adverse Event|68
405798|NCT00689871|1358945|P4|Overall Study|Physician Decision|0
405799|NCT00689871|1358946|P3|Overall Study|Physician Decision|1
405800|NCT00689871|1358947|P2|Overall Study|Physician Decision|1
405801|NCT00689871|1358948|P1|Overall Study|Physician Decision|2
405802|NCT00689871|1358945|P4|Overall Study|Death|2
405803|NCT00689871|1358946|P3|Overall Study|Death|2
405804|NCT00689871|1358947|P2|Overall Study|Death|10
405805|NCT00689871|1358948|P1|Overall Study|Death|1
405806|NCT00689871|1358945|P4|Overall Study|Withdrawal by Subject|1
405807|NCT00689871|1358946|P3|Overall Study|Withdrawal by Subject|4
405808|NCT00689871|1358947|P2|Overall Study|Withdrawal by Subject|3
405809|NCT00689871|1358948|P1|Overall Study|Withdrawal by Subject|13
405810|NCT00689871|1358945|P4|Overall Study|Explanted of All Study Devices|3
405811|NCT00689871|1358946|P3|Overall Study|Explanted of All Study Devices|29
405812|NCT00689871|1358947|P2|Overall Study|Explanted of All Study Devices|25
405813|NCT00689871|1358948|P1|Overall Study|Explanted of All Study Devices|36
405814|NCT00689871|1358945|P4|Overall Study|Lost to Follow-up|1
405815|NCT00689871|1358946|P3|Overall Study|Lost to Follow-up|37
405816|NCT00689871|1358947|P2|Overall Study|Lost to Follow-up|13
405817|NCT00689871|1358948|P1|Overall Study|Lost to Follow-up|123
405818|NCT00689793|1358975|P2|Overall Study|Lost to Follow-up|5
405819|NCT00689793|1358976|P1|Overall Study|Lost to Follow-up|4
405820|NCT00689611|1358994|P2|Overall Study|Lost to Follow-up|28
405821|NCT00689611|1358995|P1|Overall Study|Lost to Follow-up|27
405822|NCT00689611|1358994|P2|Overall Study|Withdrawal by Subject|9
405823|NCT00689611|1358995|P1|Overall Study|Withdrawal by Subject|8
405824|NCT00689611|1358994|P2|Overall Study|Death|9
405825|NCT00689611|1358995|P1|Overall Study|Death|6
405826|NCT00689481|1359005|P2|Overall Study|Subject early term, left on vacation|1
405827|NCT00689481|1359006|P1|Overall Study|Subject early term, left on vacation|0
405828|NCT00689481|1359005|P2|Overall Study|Excluded medication started during study|1
405829|NCT00689481|1359006|P1|Overall Study|Excluded medication started during study|0
405830|NCT00689481|1359005|P2|Overall Study|Withdrawal by Subject|4
405831|NCT00689481|1359006|P1|Overall Study|Withdrawal by Subject|8
405832|NCT00689481|1359005|P2|Overall Study|Non-compliance with study treatment|1
405833|NCT00689481|1359006|P1|Overall Study|Non-compliance with study treatment|1
405834|NCT00689481|1359005|P2|Overall Study|Lack of Efficacy|3
405835|NCT00689481|1359006|P1|Overall Study|Lack of Efficacy|4
405836|NCT00689481|1359005|P2|Overall Study|Lost to Follow-up|3
405837|NCT00689481|1359006|P1|Overall Study|Lost to Follow-up|4
405838|NCT00689481|1359005|P2|Overall Study|Adverse Event|1
405839|NCT00689481|1359006|P1|Overall Study|Adverse Event|7
405840|NCT00689390|1359024|P2|Overall Study|Administrative|0
405841|NCT00689390|1359025|P1|Overall Study|Administrative|37
405842|NCT00689390|1359024|P2|Overall Study|Did Not Meet Protocol Eligibility|0
405843|NCT00689390|1359025|P1|Overall Study|Did Not Meet Protocol Eligibility|1
405844|NCT00689390|1359024|P2|Overall Study|Non-Compliance With Protocol|0
405845|NCT00689390|1359025|P1|Overall Study|Non-Compliance With Protocol|21
405846|NCT00689390|1359024|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
405847|NCT00689390|1359025|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
405848|NCT00689390|1359024|P2|Overall Study|Withdrawal by Subject|3
405849|NCT00689390|1359025|P1|Overall Study|Withdrawal by Subject|117
405850|NCT00689390|1359024|P2|Overall Study|Lost to Follow-up|7
405851|NCT00689390|1359025|P1|Overall Study|Lost to Follow-up|179
405852|NCT00689390|1359024|P2|Overall Study|Adverse Event|0
405853|NCT00689390|1359025|P1|Overall Study|Adverse Event|19
405854|NCT00689351|1359043|P2|After Infant Series|Parent/legal guardian request|0
405855|NCT00689351|1359044|P1|After Infant Series|Parent/legal guardian request|1
405856|NCT00689351|1359043|P2|Infant Series of Dosing|Lost to Follow-up|1
405857|NCT00689351|1359044|P1|Infant Series of Dosing|Lost to Follow-up|0
405858|NCT00689351|1359043|P2|Infant Series of Dosing|Adverse Event|0
405859|NCT00689351|1359044|P1|Infant Series of Dosing|Adverse Event|1
405860|NCT00689351|1359043|P2|Infant Series of Dosing|Parent/legal guardian request|0
405861|NCT00689351|1359044|P1|Infant Series of Dosing|Parent/legal guardian request|5
405862|NCT00689338|1359076|P1|Overall Study|Protocol Violation|15
405863|NCT00689338|1359076|P1|Overall Study|Withdrawal by Subject|3
405864|NCT00689338|1359076|P1|Overall Study|Lost to Follow-up|5
405865|NCT00689338|1359076|P1|Overall Study|Did not Meet Entrance Criteria|27
405866|NCT00689338|1359076|P1|Overall Study|Other|8
405867|NCT00689338|1359076|P1|Overall Study|Lack of Efficacy|6
405868|NCT00689338|1359076|P1|Overall Study|Insufficient Clinical Response|1
405869|NCT00689338|1359076|P1|Overall Study|Adverse Event|13
405870|NCT00689338|1359076|P1|Overall Study|Death|65
405871|NCT00689299|1359089|P3|Overall Study|Protocol Violation|0
405872|NCT00689299|1359090|P2|Overall Study|Protocol Violation|0
405873|NCT00689299|1359091|P1|Overall Study|Protocol Violation|1
405874|NCT00689299|1359089|P3|Overall Study|Withdrawal by Subject|3
405875|NCT00689299|1359090|P2|Overall Study|Withdrawal by Subject|1
405876|NCT00689299|1359091|P1|Overall Study|Withdrawal by Subject|4
405877|NCT00689299|1359089|P3|Overall Study|Lost to Follow-up|1
405878|NCT00689299|1359090|P2|Overall Study|Lost to Follow-up|1
405879|NCT00689299|1359091|P1|Overall Study|Lost to Follow-up|0
405880|NCT00689299|1359089|P3|Overall Study|Adverse Event|1
405881|NCT00689299|1359090|P2|Overall Study|Adverse Event|1
405882|NCT00689299|1359091|P1|Overall Study|Adverse Event|2
405883|NCT00689221|1359120|P2|Overall Study|Ongoing at cut-off date|36
405884|NCT00689221|1359121|P1|Overall Study|Ongoing at cut-off date|39
405885|NCT00689117|1359150|P4|Overall Study|Dispensing Error|0
405886|NCT00689117|1359151|P3|Overall Study|Dispensing Error|0
405887|NCT00689117|1359152|P2|Overall Study|Dispensing Error|1
405888|NCT00689117|1359153|P1|Overall Study|Dispensing Error|0
405889|NCT00689117|1359150|P4|Overall Study|Personal Reason|0
405890|NCT00689117|1359151|P3|Overall Study|Personal Reason|0
405891|NCT00689117|1359152|P2|Overall Study|Personal Reason|1
405892|NCT00689117|1359153|P1|Overall Study|Personal Reason|0
405893|NCT00689117|1359150|P4|Overall Study|Patient Withdrew from Study|1
405894|NCT00689117|1359151|P3|Overall Study|Patient Withdrew from Study|0
405895|NCT00689117|1359152|P2|Overall Study|Patient Withdrew from Study|0
405896|NCT00689117|1359153|P1|Overall Study|Patient Withdrew from Study|0
405897|NCT00689117|1359150|P4|Overall Study|Transportation|0
405898|NCT00689117|1359151|P3|Overall Study|Transportation|0
405899|NCT00689117|1359152|P2|Overall Study|Transportation|0
405900|NCT00689117|1359153|P1|Overall Study|Transportation|1
405901|NCT00689117|1359150|P4|Overall Study|Fear of Birth Defects|0
405902|NCT00689117|1359151|P3|Overall Study|Fear of Birth Defects|1
405903|NCT00689117|1359152|P2|Overall Study|Fear of Birth Defects|0
405904|NCT00689117|1359153|P1|Overall Study|Fear of Birth Defects|0
405905|NCT00689117|1359150|P4|Overall Study|Incarceration|0
405906|NCT00689117|1359151|P3|Overall Study|Incarceration|0
405907|NCT00689117|1359152|P2|Overall Study|Incarceration|0
405908|NCT00689117|1359153|P1|Overall Study|Incarceration|2
405909|NCT00689117|1359150|P4|Overall Study|Pregnancy|2
405910|NCT00689117|1359151|P3|Overall Study|Pregnancy|0
405911|NCT00689117|1359152|P2|Overall Study|Pregnancy|2
405912|NCT00689117|1359153|P1|Overall Study|Pregnancy|0
405913|NCT00689117|1359150|P4|Overall Study|Use of Prohibitive Medication|0
405914|NCT00689117|1359151|P3|Overall Study|Use of Prohibitive Medication|3
405915|NCT00689117|1359152|P2|Overall Study|Use of Prohibitive Medication|1
405916|NCT00689117|1359153|P1|Overall Study|Use of Prohibitive Medication|2
405917|NCT00689117|1359150|P4|Overall Study|Change/Discontinuation of Birth Control|0
405918|NCT00689117|1359151|P3|Overall Study|Change/Discontinuation of Birth Control|1
405919|NCT00689117|1359152|P2|Overall Study|Change/Discontinuation of Birth Control|1
405920|NCT00689117|1359153|P1|Overall Study|Change/Discontinuation of Birth Control|1
405921|NCT00689117|1359150|P4|Overall Study|Non-compliance with Treatment Regimen|0
405922|NCT00689117|1359151|P3|Overall Study|Non-compliance with Treatment Regimen|0
405923|NCT00689117|1359152|P2|Overall Study|Non-compliance with Treatment Regimen|1
405924|NCT00689117|1359153|P1|Overall Study|Non-compliance with Treatment Regimen|0
405925|NCT00689117|1359150|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
405926|NCT00689117|1359151|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
405927|NCT00689117|1359152|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
405928|NCT00689117|1359153|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
405929|NCT00689117|1359150|P4|Overall Study|Unable to Comply with Visit Schedule|1
405930|NCT00689117|1359151|P3|Overall Study|Unable to Comply with Visit Schedule|1
405931|NCT00689117|1359152|P2|Overall Study|Unable to Comply with Visit Schedule|0
405932|NCT00689117|1359153|P1|Overall Study|Unable to Comply with Visit Schedule|0
405933|NCT00689117|1359150|P4|Overall Study|Withdrawal by Subject|13
405934|NCT00689117|1359151|P3|Overall Study|Withdrawal by Subject|26
405935|NCT00689117|1359152|P2|Overall Study|Withdrawal by Subject|18
405936|NCT00689117|1359153|P1|Overall Study|Withdrawal by Subject|19
405937|NCT00689117|1359150|P4|Overall Study|Non-Compliance with Study Treatment|1
405938|NCT00689117|1359151|P3|Overall Study|Non-Compliance with Study Treatment|3
405939|NCT00689117|1359152|P2|Overall Study|Non-Compliance with Study Treatment|3
405940|NCT00689117|1359153|P1|Overall Study|Non-Compliance with Study Treatment|3
405941|NCT00689117|1359150|P4|Overall Study|Lack of Efficacy|2
405942|NCT00689117|1359151|P3|Overall Study|Lack of Efficacy|2
405943|NCT00689117|1359152|P2|Overall Study|Lack of Efficacy|2
405944|NCT00689117|1359153|P1|Overall Study|Lack of Efficacy|1
405945|NCT00689117|1359150|P4|Overall Study|Lost to Follow-up|11
405946|NCT00689117|1359151|P3|Overall Study|Lost to Follow-up|17
405947|NCT00689117|1359152|P2|Overall Study|Lost to Follow-up|19
405948|NCT00689117|1359153|P1|Overall Study|Lost to Follow-up|26
405949|NCT00689117|1359150|P4|Overall Study|Adverse Event|0
405950|NCT00689117|1359151|P3|Overall Study|Adverse Event|5
405951|NCT00689117|1359152|P2|Overall Study|Adverse Event|0
405952|NCT00689117|1359153|P1|Overall Study|Adverse Event|6
405953|NCT00689104|1359183|P4|Overall Study|Non-compliance with study procedures|0
405954|NCT00689104|1359184|P3|Overall Study|Non-compliance with study procedures|1
405955|NCT00689104|1359185|P2|Overall Study|Non-compliance with study procedures|0
405956|NCT00689104|1359186|P1|Overall Study|Non-compliance with study procedures|0
405957|NCT00689104|1359183|P4|Overall Study|Physician Decision|0
405958|NCT00689104|1359184|P3|Overall Study|Physician Decision|0
405959|NCT00689104|1359185|P2|Overall Study|Physician Decision|0
405960|NCT00689104|1359186|P1|Overall Study|Physician Decision|1
405961|NCT00689104|1359183|P4|Overall Study|Randomized but never received study drug|0
405962|NCT00689104|1359184|P3|Overall Study|Randomized but never received study drug|1
405963|NCT00689104|1359185|P2|Overall Study|Randomized but never received study drug|1
405964|NCT00689104|1359186|P1|Overall Study|Randomized but never received study drug|2
405965|NCT00689104|1359183|P4|Overall Study|Protocol Violation|3
405966|NCT00689104|1359184|P3|Overall Study|Protocol Violation|5
405967|NCT00689104|1359185|P2|Overall Study|Protocol Violation|3
405968|NCT00689104|1359186|P1|Overall Study|Protocol Violation|2
405969|NCT00689104|1359183|P4|Overall Study|Lost to Follow-up|5
405970|NCT00689104|1359184|P3|Overall Study|Lost to Follow-up|2
405971|NCT00689104|1359185|P2|Overall Study|Lost to Follow-up|3
405972|NCT00689104|1359186|P1|Overall Study|Lost to Follow-up|4
405973|NCT00689104|1359183|P4|Overall Study|Withdrawal by Subject|11
405974|NCT00689104|1359184|P3|Overall Study|Withdrawal by Subject|18
405975|NCT00689104|1359185|P2|Overall Study|Withdrawal by Subject|11
405976|NCT00689104|1359186|P1|Overall Study|Withdrawal by Subject|12
405977|NCT00689104|1359183|P4|Overall Study|Lack of Efficacy|3
405978|NCT00689104|1359184|P3|Overall Study|Lack of Efficacy|2
405979|NCT00689104|1359185|P2|Overall Study|Lack of Efficacy|6
405980|NCT00689104|1359186|P1|Overall Study|Lack of Efficacy|5
405981|NCT00689104|1359183|P4|Overall Study|Adverse Event|24
405982|NCT00689104|1359184|P3|Overall Study|Adverse Event|16
405983|NCT00689104|1359185|P2|Overall Study|Adverse Event|25
405984|NCT00689104|1359186|P1|Overall Study|Adverse Event|13
405985|NCT00689104|1359183|P4|Overall Study|Eligibility criterion not met|4
405986|NCT00689104|1359184|P3|Overall Study|Eligibility criterion not met|0
405987|NCT00689104|1359185|P2|Overall Study|Eligibility criterion not met|8
405988|NCT00689104|1359186|P1|Overall Study|Eligibility criterion not met|5
405989|NCT00689052|1359339|P2|Overall Study|Early termination of the trial|24
405990|NCT00689052|1359340|P1|Overall Study|Early termination of the trial|22
405991|NCT00689052|1359339|P2|Overall Study|Withdrawal by Subject|0
405992|NCT00689052|1359340|P1|Overall Study|Withdrawal by Subject|2
405993|NCT00689052|1359339|P2|Overall Study|Lost to Follow-up|0
405994|NCT00689052|1359340|P1|Overall Study|Lost to Follow-up|2
405995|NCT00689052|1359339|P2|Overall Study|Protocol Violation|0
405996|NCT00689052|1359340|P1|Overall Study|Protocol Violation|1
405997|NCT00689052|1359339|P2|Overall Study|Adverse Event|6
405998|NCT00689052|1359340|P1|Overall Study|Adverse Event|4
405999|NCT00689026|1359372|P2|Overall Study|Withdrawal by Subject|6
406000|NCT00689026|1359373|P1|Overall Study|Withdrawal by Subject|13
406001|NCT00688870|1359381|P2|Infant Series|Parent or legal guardian request|0
406002|NCT00688870|1359382|P1|Infant Series|Parent or legal guardian request|4
406003|NCT00688844|1359414|P1|Overall Study|Lost to Follow-up|10
406004|NCT00688753|1359424|P1|Overall Study|Lost to Follow-up|3
406005|NCT00688753|1359424|P1|Overall Study|Protocol Violation|1
406006|NCT00688753|1359424|P1|Overall Study|Adverse Event|20
406007|NCT00688753|1359424|P1|Overall Study|Withdrawal by Subject|3
406008|NCT00688753|1359424|P1|Overall Study|Death|9
406009|NCT00688753|1359424|P1|Overall Study|Missing|1
406010|NCT00688753|1359424|P1|Overall Study|Disease progression|55
406011|NCT00688740|1359435|P2|Overall Study|Violation of Inclusion Criteria|3
406012|NCT00688740|1359436|P1|Overall Study|Violation of Inclusion Criteria|1
406013|NCT00688740|1359435|P2|Overall Study|Breast Cancer Relapse|4
406014|NCT00688740|1359436|P1|Overall Study|Breast Cancer Relapse|1
406015|NCT00688740|1359435|P2|Overall Study|Consent Withdrawn|17
406016|NCT00688740|1359436|P1|Overall Study|Consent Withdrawn|17
406017|NCT00688740|1359435|P2|Overall Study|Lost to Follow-up|1
406018|NCT00688740|1359436|P1|Overall Study|Lost to Follow-up|0
406019|NCT00688740|1359435|P2|Overall Study|Death|2
406020|NCT00688740|1359436|P1|Overall Study|Death|2
406021|NCT00688740|1359435|P2|Overall Study|Adverse Event|8
406022|NCT00688740|1359436|P1|Overall Study|Adverse Event|45
406023|NCT00688701|1359449|P4|Overall Study|Poor compliance to protocol|0
406024|NCT00688701|1359450|P3|Overall Study|Poor compliance to protocol|1
406025|NCT00688701|1359451|P2|Overall Study|Poor compliance to protocol|1
406026|NCT00688701|1359452|P1|Overall Study|Poor compliance to protocol|0
406027|NCT00688701|1359449|P4|Overall Study|Withdrawal by Subject|8
406028|NCT00688701|1359450|P3|Overall Study|Withdrawal by Subject|4
406029|NCT00688701|1359451|P2|Overall Study|Withdrawal by Subject|3
406030|NCT00688701|1359452|P1|Overall Study|Withdrawal by Subject|3
406031|NCT00688701|1359449|P4|Overall Study|Lack of Efficacy|0
406032|NCT00688701|1359450|P3|Overall Study|Lack of Efficacy|0
406033|NCT00688701|1359451|P2|Overall Study|Lack of Efficacy|1
406034|NCT00688701|1359452|P1|Overall Study|Lack of Efficacy|0
406035|NCT00688701|1359449|P4|Overall Study|Adverse Event|3
406036|NCT00688701|1359450|P3|Overall Study|Adverse Event|5
406037|NCT00688701|1359451|P2|Overall Study|Adverse Event|0
406038|NCT00688701|1359452|P1|Overall Study|Adverse Event|1
406039|NCT00688688|1359493|P3|Overall Study|Violation of exclusion criterion|0
406040|NCT00688688|1359494|P2|Overall Study|Violation of exclusion criterion|1
406041|NCT00688688|1359495|P1|Overall Study|Violation of exclusion criterion|0
406042|NCT00688688|1359493|P3|Overall Study|Site closure|0
406043|NCT00688688|1359494|P2|Overall Study|Site closure|1
406044|NCT00688688|1359495|P1|Overall Study|Site closure|0
406045|NCT00688688|1359493|P3|Overall Study|Taking exclusionary medications|0
406046|NCT00688688|1359494|P2|Overall Study|Taking exclusionary medications|0
406047|NCT00688688|1359495|P1|Overall Study|Taking exclusionary medications|1
406048|NCT00688688|1359493|P3|Overall Study|Non-compliance with study procedures|4
406049|NCT00688688|1359494|P2|Overall Study|Non-compliance with study procedures|3
406050|NCT00688688|1359495|P1|Overall Study|Non-compliance with study procedures|5
406051|NCT00688688|1359493|P3|Overall Study|Randomized but never received study drug|0
406052|NCT00688688|1359494|P2|Overall Study|Randomized but never received study drug|0
406053|NCT00688688|1359495|P1|Overall Study|Randomized but never received study drug|1
406054|NCT00688688|1359493|P3|Overall Study|Protocol Violation|11
406055|NCT00688688|1359494|P2|Overall Study|Protocol Violation|9
406056|NCT00688688|1359495|P1|Overall Study|Protocol Violation|6
406057|NCT00688688|1359493|P3|Overall Study|Lost to Follow-up|7
406058|NCT00688688|1359494|P2|Overall Study|Lost to Follow-up|7
406059|NCT00688688|1359495|P1|Overall Study|Lost to Follow-up|14
406060|NCT00688688|1359493|P3|Overall Study|Withdrawal by Subject|65
406061|NCT00688688|1359494|P2|Overall Study|Withdrawal by Subject|75
406062|NCT00688688|1359495|P1|Overall Study|Withdrawal by Subject|66
406063|NCT00688688|1359493|P3|Overall Study|Lack of Efficacy|45
406064|NCT00688688|1359494|P2|Overall Study|Lack of Efficacy|25
406065|NCT00688688|1359495|P1|Overall Study|Lack of Efficacy|34
406066|NCT00688688|1359493|P3|Overall Study|Adverse Event|50
406067|NCT00688688|1359494|P2|Overall Study|Adverse Event|51
406068|NCT00688688|1359495|P1|Overall Study|Adverse Event|52
406069|NCT00688688|1359493|P3|Overall Study|Eligibility criterion not met|10
406070|NCT00688688|1359494|P2|Overall Study|Eligibility criterion not met|7
406071|NCT00688688|1359495|P1|Overall Study|Eligibility criterion not met|7
406072|NCT00688636|1359597|P2|Overall Study|Adverse Event|1
406073|NCT00688636|1359598|P1|Overall Study|Adverse Event|2
406074|NCT00688545|1359614|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
406075|NCT00688545|1359615|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
406076|NCT00688545|1359614|P2|Overall Study|Withdrawal by Subject|3
406077|NCT00688545|1359615|P1|Overall Study|Withdrawal by Subject|2
406078|NCT00688545|1359614|P2|Overall Study|Insurance/cost of drug|1
406079|NCT00688545|1359615|P1|Overall Study|Insurance/cost of drug|0
406080|NCT00688545|1359614|P2|Overall Study|Lost to Follow-up|4
406081|NCT00688545|1359615|P1|Overall Study|Lost to Follow-up|1
406082|NCT00688519|1359625|P2|Overall Study|Pregnancy|1
406083|NCT00688519|1359626|P1|Overall Study|Pregnancy|0
406084|NCT00688519|1359625|P2|Overall Study|Subject moved out of area|0
406085|NCT00688519|1359626|P1|Overall Study|Subject moved out of area|1
406086|NCT00688519|1359625|P2|Overall Study|Investigator decision|0
406087|NCT00688519|1359626|P1|Overall Study|Investigator decision|1
406088|NCT00688519|1359625|P2|Overall Study|Subject moved out of state|0
406089|NCT00688519|1359626|P1|Overall Study|Subject moved out of state|1
406090|NCT00688519|1359625|P2|Overall Study|Non-compliance|1
406091|NCT00688519|1359626|P1|Overall Study|Non-compliance|0
406092|NCT00688519|1359625|P2|Overall Study|Prohibited medication|0
406093|NCT00688519|1359626|P1|Overall Study|Prohibited medication|1
406094|NCT00688519|1359625|P2|Overall Study|Withdrawal by Subject|6
406095|NCT00688519|1359626|P1|Overall Study|Withdrawal by Subject|7
406096|NCT00688519|1359625|P2|Overall Study|Lack of Efficacy|1
406097|NCT00688519|1359626|P1|Overall Study|Lack of Efficacy|3
406098|NCT00688519|1359625|P2|Overall Study|Lost to Follow-up|3
406099|NCT00688519|1359626|P1|Overall Study|Lost to Follow-up|3
406100|NCT00688519|1359625|P2|Overall Study|Adverse Event|3
406101|NCT00688519|1359626|P1|Overall Study|Adverse Event|2
406102|NCT00688467|1359644|P2|Treatment Period 2|Adverse Event|1
406103|NCT00688467|1359645|P1|Treatment Period 2|Adverse Event|0
406104|NCT00688467|1359644|P2|Treatment Period 2|Protocol Violation|1
406105|NCT00688467|1359645|P1|Treatment Period 2|Protocol Violation|0
406106|NCT00688467|1359644|P2|Treatment Period 1|Did not meet protocol eligibility|1
406107|NCT00688467|1359645|P1|Treatment Period 1|Did not meet protocol eligibility|0
406108|NCT00688467|1359644|P2|Treatment Period 1|Adverse Event|1
406109|NCT00688467|1359645|P1|Treatment Period 1|Adverse Event|2
406110|NCT00688324|1359675|P1|Overall Study|Lost to Follow-up|1
406111|NCT00688324|1359675|P1|Overall Study|Physician Decision|5
406112|NCT00688324|1359675|P1|Overall Study|Withdrawal by Subject|2
406113|NCT00688259|1359720|P2|Overall Study|Hospitalized at Follow-up|1
406114|NCT00688259|1359721|P1|Overall Study|Hospitalized at Follow-up|0
406115|NCT00688259|1359720|P2|Overall Study|Declined Interview|3
406116|NCT00688259|1359721|P1|Overall Study|Declined Interview|2
406117|NCT00688259|1359720|P2|Overall Study|Withdrawal by Subject|0
406118|NCT00688259|1359721|P1|Overall Study|Withdrawal by Subject|2
406119|NCT00688259|1359720|P2|Overall Study|Physician Decision|0
406120|NCT00688259|1359721|P1|Overall Study|Physician Decision|1
406121|NCT00688259|1359720|P2|Overall Study|Lost to Follow-up|4
406122|NCT00688259|1359721|P1|Overall Study|Lost to Follow-up|2
406123|NCT00688155|1359741|P4|Overall Study|Withdrawal by Subject|1
406124|NCT00688155|1359742|P3|Overall Study|Withdrawal by Subject|1
406125|NCT00688155|1359743|P2|Overall Study|Withdrawal by Subject|2
406126|NCT00688155|1359744|P1|Overall Study|Withdrawal by Subject|2
406127|NCT00688103|1359764|P2|Overall Study|complex reasons|9
406128|NCT00688103|1359765|P1|Overall Study|complex reasons|11
406129|NCT00688103|1359764|P2|Overall Study|Withdrawal by Subject|2
406130|NCT00688103|1359765|P1|Overall Study|Withdrawal by Subject|4
406131|NCT00688103|1359764|P2|Overall Study|Lack of Efficacy|1
406132|NCT00688103|1359765|P1|Overall Study|Lack of Efficacy|11
406133|NCT00688103|1359764|P2|Overall Study|Adverse Event|1
406134|NCT00688103|1359765|P1|Overall Study|Adverse Event|4
406135|NCT00688064|1359777|P2|Overall Study|Any other reasons|3
406136|NCT00688064|1359778|P1|Overall Study|Any other reasons|1
406137|NCT00688064|1359777|P2|Overall Study|Pregnancy|0
406138|NCT00688064|1359778|P1|Overall Study|Pregnancy|1
406139|NCT00688064|1359777|P2|Overall Study|Lack of Efficacy|1
406140|NCT00688064|1359778|P1|Overall Study|Lack of Efficacy|0
406141|NCT00688064|1359777|P2|Overall Study|Lost to Follow-up|10
406142|NCT00688064|1359778|P1|Overall Study|Lost to Follow-up|10
406143|NCT00688064|1359777|P2|Overall Study|Withdrawal by Subject|7
406144|NCT00688064|1359778|P1|Overall Study|Withdrawal by Subject|7
406145|NCT00688064|1359777|P2|Overall Study|Adverse Event|4
406146|NCT00688064|1359778|P1|Overall Study|Adverse Event|2
406147|NCT00688064|1359777|P2|Overall Study|Protocol Violation|1
406148|NCT00688064|1359778|P1|Overall Study|Protocol Violation|0
406149|NCT00687973|1359794|P2|Overall Study|Withdrawal by Subject|3
406150|NCT00687973|1359795|P1|Overall Study|Withdrawal by Subject|3
406151|NCT00687973|1359794|P2|Overall Study|Administrative Reasons|2
406152|NCT00687973|1359795|P1|Overall Study|Administrative Reasons|0
406153|NCT00687973|1359794|P2|Overall Study|Protocol Violation|2
406154|NCT00687973|1359795|P1|Overall Study|Protocol Violation|1
406155|NCT00687973|1359794|P2|Overall Study|Lack of Efficacy|3
406156|NCT00687973|1359795|P1|Overall Study|Lack of Efficacy|2
406157|NCT00687973|1359794|P2|Overall Study|Adverse Event|28
406158|NCT00687973|1359795|P1|Overall Study|Adverse Event|18
406159|NCT00687804|1359857|P3|Open-Label Extension Study|Death|3
406160|NCT00687804|1359858|P2|Open-Label Extension Study|Death|3
406161|NCT00687804|1359859|P1|Open-Label Extension Study|Death|2
406162|NCT00687804|1359857|P3|Open-Label Extension Study|Administrative problems|0
406163|NCT00687804|1359858|P2|Open-Label Extension Study|Administrative problems|1
406164|NCT00687804|1359859|P1|Open-Label Extension Study|Administrative problems|1
406165|NCT00687804|1359857|P3|Open-Label Extension Study|Lost to Follow-up|2
406166|NCT00687804|1359858|P2|Open-Label Extension Study|Lost to Follow-up|1
406167|NCT00687804|1359859|P1|Open-Label Extension Study|Lost to Follow-up|2
406168|NCT00687804|1359857|P3|Open-Label Extension Study|Subject withdrew consent|4
406169|NCT00687804|1359858|P2|Open-Label Extension Study|Subject withdrew consent|4
406170|NCT00687804|1359859|P1|Open-Label Extension Study|Subject withdrew consent|3
406171|NCT00687804|1359857|P3|Open-Label Extension Study|Adverse Event|2
406172|NCT00687804|1359858|P2|Open-Label Extension Study|Adverse Event|2
406173|NCT00687804|1359859|P1|Open-Label Extension Study|Adverse Event|2
406174|NCT00687804|1359857|P3|Core Study|Protocol Violation|0
406175|NCT00687804|1359858|P2|Core Study|Protocol Violation|1
406176|NCT00687804|1359859|P1|Core Study|Protocol Violation|1
406177|NCT00687804|1359857|P3|Core Study|Death|2
406178|NCT00687804|1359858|P2|Core Study|Death|2
406179|NCT00687804|1359859|P1|Core Study|Death|2
406180|NCT00687804|1359857|P3|Core Study|Lost to Follow-up|0
406181|NCT00687804|1359858|P2|Core Study|Lost to Follow-up|1
406182|NCT00687804|1359859|P1|Core Study|Lost to Follow-up|0
406183|NCT00687804|1359857|P3|Core Study|Withdrawal by Subject|7
406184|NCT00687804|1359858|P2|Core Study|Withdrawal by Subject|7
406185|NCT00687804|1359859|P1|Core Study|Withdrawal by Subject|4
406186|NCT00687804|1359857|P3|Core Study|Lack of Efficacy|1
406187|NCT00687804|1359858|P2|Core Study|Lack of Efficacy|1
406188|NCT00687804|1359859|P1|Core Study|Lack of Efficacy|1
406189|NCT00687804|1359857|P3|Core Study|Abnormal laboratory value(s)|0
406190|NCT00687804|1359858|P2|Core Study|Abnormal laboratory value(s)|0
406191|NCT00687804|1359859|P1|Core Study|Abnormal laboratory value(s)|1
406192|NCT00687804|1359857|P3|Core Study|Adverse Event|3
406193|NCT00687804|1359858|P2|Core Study|Adverse Event|3
406194|NCT00687804|1359859|P1|Core Study|Adverse Event|5
406195|NCT00687609|1359920|P1|Overall Study|Withdrawal by Subject|2
406196|NCT00687609|1359920|P1|Overall Study|Physician Decision|1
406197|NCT00687531|1359943|P1|Overall Study|Lost to Follow-up|26
406198|NCT00687531|1359943|P1|Overall Study|Adverse Event|5
406199|NCT00687531|1359943|P1|Overall Study|Did not meet protocol eligibility|104
406200|NCT00687440|1359966|P1|Overall Study|Missing|1
406201|NCT00687440|1359966|P1|Overall Study|Not specified|1
406202|NCT00687440|1359966|P1|Overall Study|Death|2
406203|NCT00687440|1359966|P1|Overall Study|Lack of Efficacy|2
406204|NCT00687440|1359966|P1|Overall Study|Lost to Follow-up|3
406205|NCT00687440|1359966|P1|Overall Study|Adverse Event|3
406206|NCT00687401|1359970|P1|Overall Study|For reasons different from those above|4
406207|NCT00687401|1359970|P1|Overall Study|Did not return for visit|3
406208|NCT00687401|1359970|P1|Overall Study|Withdrawal by Subject|4
406209|NCT00687401|1359970|P1|Overall Study|Lack of Efficacy|6
406210|NCT00687401|1359970|P1|Overall Study|Adverse Event|6
406211|NCT00687401|1359970|P1|Overall Study|Protocol Violation|7
406212|NCT00687362|1359975|P1|Overall Study|Withdrawal by Subject|1
406213|NCT00687362|1359975|P1|Overall Study|Protocol Violation|2
406214|NCT00687323|1359979|P1|Overall Study|Screen failure|148
406215|NCT00687323|1359979|P1|Overall Study|Excluded from efficacy evaluations|6
406216|NCT00687323|1359979|P1|Overall Study|Withdrawal by Subject|1
406217|NCT00687323|1359979|P1|Overall Study|Death|25
406218|NCT00687297|1359995|P2|Induction|Other|1
406219|NCT00687297|1359996|P1|Induction|Other|0
406220|NCT00687297|1359995|P2|Induction|Physician Decision|2
406221|NCT00687297|1359996|P1|Induction|Physician Decision|0
406222|NCT00687297|1359995|P2|Induction|Patient Noncompliance|0
406223|NCT00687297|1359996|P1|Induction|Patient Noncompliance|1
406224|NCT00687297|1359995|P2|Induction|Ineligible|1
406225|NCT00687297|1359996|P1|Induction|Ineligible|0
406226|NCT00687297|1359995|P2|Induction|Lack of Efficacy|21
406227|NCT00687297|1359996|P1|Induction|Lack of Efficacy|17
406228|NCT00687297|1359995|P2|Induction|Death|11
406229|NCT00687297|1359996|P1|Induction|Death|7
406230|NCT00687297|1359995|P2|Induction|Adverse Event|15
406231|NCT00687297|1359996|P1|Induction|Adverse Event|16
406232|NCT00687297|1359995|P2|Induction|Withdrawal by Subject|4
406233|NCT00687297|1359996|P1|Induction|Withdrawal by Subject|4
406234|NCT00687297|1359995|P2|Randomization|Withdrew before treatment, ineligible|1
406235|NCT00687297|1359996|P1|Randomization|Withdrew before treatment, ineligible|1
406236|NCT00687297|1359995|P2|Randomization|Withdrawal by Subject|0
406237|NCT00687297|1359996|P1|Randomization|Withdrawal by Subject|2
406238|NCT00687219|1360006|P1|Overall Study|Lack of Efficacy|1
406239|NCT00687219|1360006|P1|Overall Study|Withdrawal by Subject|1
406240|NCT00687219|1360006|P1|Overall Study|HCV-RNA positive conversion|34
406241|NCT00687219|1360006|P1|Overall Study|Discontinuance criteria met|7
406242|NCT00687219|1360006|P1|Overall Study|Adverse Event|8
406243|NCT00687193|1360018|P6|Overall Study|Protocol Violation|0
406244|NCT00687193|1360019|P5|Overall Study|Protocol Violation|2
406245|NCT00687193|1360020|P4|Overall Study|Protocol Violation|1
406246|NCT00687193|1360021|P3|Overall Study|Protocol Violation|0
406247|NCT00687193|1360022|P2|Overall Study|Protocol Violation|2
406248|NCT00687193|1360023|P1|Overall Study|Protocol Violation|1
406249|NCT00687193|1360018|P6|Overall Study|Lack of Efficacy|2
406250|NCT00687193|1360019|P5|Overall Study|Lack of Efficacy|0
406251|NCT00687193|1360020|P4|Overall Study|Lack of Efficacy|0
406252|NCT00687193|1360021|P3|Overall Study|Lack of Efficacy|0
406253|NCT00687193|1360022|P2|Overall Study|Lack of Efficacy|1
406254|NCT00687193|1360023|P1|Overall Study|Lack of Efficacy|1
406255|NCT00687193|1360018|P6|Overall Study|Adverse Event|2
406256|NCT00687193|1360019|P5|Overall Study|Adverse Event|0
406257|NCT00687193|1360020|P4|Overall Study|Adverse Event|3
406258|NCT00687193|1360021|P3|Overall Study|Adverse Event|2
406259|NCT00687193|1360022|P2|Overall Study|Adverse Event|1
406260|NCT00687193|1360023|P1|Overall Study|Adverse Event|0
406261|NCT00686998|1360233|P3|Overall Study|Safety Reasons|0
406262|NCT00686998|1360234|P2|Overall Study|Safety Reasons|0
406263|NCT00686998|1360235|P1|Overall Study|Safety Reasons|1
406264|NCT00686998|1360233|P3|Overall Study|Not specified|1
406265|NCT00686998|1360234|P2|Overall Study|Not specified|0
406266|NCT00686998|1360235|P1|Overall Study|Not specified|0
406267|NCT00686998|1360233|P3|Overall Study|Lack of Efficacy|0
406268|NCT00686998|1360234|P2|Overall Study|Lack of Efficacy|5
406269|NCT00686998|1360235|P1|Overall Study|Lack of Efficacy|7
406270|NCT00686998|1360233|P3|Overall Study|Withdrawal by Subject|2
406271|NCT00686998|1360234|P2|Overall Study|Withdrawal by Subject|1
406272|NCT00686998|1360235|P1|Overall Study|Withdrawal by Subject|2
406273|NCT00686998|1360233|P3|Overall Study|Adverse Event|1
406274|NCT00686998|1360234|P2|Overall Study|Adverse Event|2
406275|NCT00686998|1360235|P1|Overall Study|Adverse Event|3
406276|NCT00686972|1360243|P1|Overall Study|P.I, Left institution. Study terminated|51
406277|NCT00686959|1360249|P2|Overall Study|Participants censored (no death events)|117
406278|NCT00686959|1360250|P1|Overall Study|Participants censored (no death events)|124
406279|NCT00686894|1360268|P1|Overall Study|Protocol Violation|4
406280|NCT00686894|1360268|P1|Overall Study|Relapse|2
406281|NCT00686881|1360274|P2|Overall Study|Never received study drug|6
406282|NCT00686881|1360275|P1|Overall Study|Never received study drug|2
406283|NCT00686881|1360274|P2|Overall Study|Study discontinuation|32
406284|NCT00686881|1360275|P1|Overall Study|Study discontinuation|35
406285|NCT00686881|1360274|P2|Overall Study|Irregular visits|0
406286|NCT00686881|1360275|P1|Overall Study|Irregular visits|1
406287|NCT00686881|1360274|P2|Overall Study|Did not meet protocol eligibility|0
406288|NCT00686881|1360275|P1|Overall Study|Did not meet protocol eligibility|1
406289|NCT00686881|1360274|P2|Overall Study|Circumstances of site|1
406290|NCT00686881|1360275|P1|Overall Study|Circumstances of site|1
406291|NCT00686881|1360274|P2|Overall Study|Physician Decision|0
406292|NCT00686881|1360275|P1|Overall Study|Physician Decision|1
406293|NCT00686881|1360274|P2|Overall Study|Lack of Efficacy|3
406294|NCT00686881|1360275|P1|Overall Study|Lack of Efficacy|4
406295|NCT00686881|1360274|P2|Overall Study|Onset of malignant tumor|11
406296|NCT00686881|1360275|P1|Overall Study|Onset of malignant tumor|11
406297|NCT00686881|1360274|P2|Overall Study|Met discontinuation criteria|0
406298|NCT00686881|1360275|P1|Overall Study|Met discontinuation criteria|5
406299|NCT00686881|1360274|P2|Overall Study|Treatment-related adverse event|9
406300|NCT00686881|1360275|P1|Overall Study|Treatment-related adverse event|10
406301|NCT00686881|1360274|P2|Overall Study|Lost to Follow-up|1
406302|NCT00686881|1360275|P1|Overall Study|Lost to Follow-up|0
406303|NCT00686881|1360274|P2|Overall Study|Withdrawal by Subject|18
406304|NCT00686881|1360275|P1|Overall Study|Withdrawal by Subject|11
406305|NCT00686855|1360287|P2|Overall Study|Progressive GVHD|1
406306|NCT00686855|1360288|P1|Overall Study|Progressive GVHD|0
406307|NCT00686855|1360287|P2|Overall Study|Lost to Follow-up|0
406308|NCT00686855|1360288|P1|Overall Study|Lost to Follow-up|1
406309|NCT00686790|1360314|P1|Overall Study|Lost to Follow-up|12
406310|NCT00686790|1360314|P1|Overall Study|Death|1
406311|NCT00686790|1360314|P1|Overall Study|Withdrawal by Subject|1
406312|NCT00686790|1360314|P1|Overall Study|Adverse Event|2
406313|NCT00686777|1360322|P1|Overall Study|No Visit|1
406314|NCT00686777|1360322|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
406315|NCT00686777|1360322|P1|Overall Study|Withdrawal by Subject|2
406316|NCT00686777|1360322|P1|Overall Study|Pregnancy|1
406317|NCT00686777|1360322|P1|Overall Study|Adverse Event|2
406318|NCT00686725|1360330|P2|Overall Study|Not Specified|3
406319|NCT00686725|1360331|P1|Overall Study|Not Specified|1
406320|NCT00686725|1360330|P2|Overall Study|Protocol Violation|3
406321|NCT00686725|1360331|P1|Overall Study|Protocol Violation|1
406322|NCT00686725|1360330|P2|Overall Study|Withdrawal by Subject|4
406323|NCT00686725|1360331|P1|Overall Study|Withdrawal by Subject|13
406324|NCT00686725|1360330|P2|Overall Study|Death|3
406325|NCT00686725|1360331|P1|Overall Study|Death|6
406326|NCT00686725|1360330|P2|Overall Study|Lost to Follow-up|5
406327|NCT00686725|1360331|P1|Overall Study|Lost to Follow-up|7
406328|NCT00686725|1360330|P2|Overall Study|Progressive Disease|23
406329|NCT00686725|1360331|P1|Overall Study|Progressive Disease|17
406330|NCT00686725|1360330|P2|Overall Study|Adverse Event|1
406331|NCT00686725|1360331|P1|Overall Study|Adverse Event|1
406332|NCT00686712|1360356|P3|Overall Study|Adverse Event|0
406333|NCT00686712|1360357|P2|Overall Study|Adverse Event|1
406334|NCT00686712|1360358|P1|Overall Study|Adverse Event|1
406335|NCT00686712|1360356|P3|Overall Study|Lost to Follow-up|3
406336|NCT00686712|1360357|P2|Overall Study|Lost to Follow-up|2
406337|NCT00686712|1360358|P1|Overall Study|Lost to Follow-up|1
406338|NCT00686712|1360356|P3|Overall Study|Protocol Violation|10
406339|NCT00686712|1360357|P2|Overall Study|Protocol Violation|8
406340|NCT00686712|1360358|P1|Overall Study|Protocol Violation|8
406341|NCT00686699|1360386|P2|Treatment Period 1|Adverse Event|2
406342|NCT00686699|1360387|P1|Treatment Period 1|Adverse Event|0
406343|NCT00686686|1360411|P1|Overall Study|Lost to Follow-up|3
406344|NCT00686686|1360411|P1|Overall Study|Adverse Event|2
406345|NCT00686686|1360411|P1|Overall Study|Non-compliance|1
406346|NCT00686647|1360419|P1|Overall Study|Death|1
406347|NCT00686647|1360419|P1|Overall Study|Lost to Follow-up|1
406348|NCT00686634|1360425|P1|Overall Study|Protocol Violation|6
406349|NCT00686595|1360432|P1|Overall Study|Poor Compliance|1
406350|NCT00686595|1360432|P1|Overall Study|Lack of Efficacy|1
406351|NCT00686595|1360432|P1|Overall Study|Lost to Follow-up|1
406352|NCT00686595|1360432|P1|Overall Study|Protocol Violation|1
406353|NCT00686595|1360432|P1|Overall Study|Adverse Event|3
406354|NCT00686543|1360461|P4|Overall Study|Protocol Violation|1
406355|NCT00686543|1360462|P3|Overall Study|Protocol Violation|2
406356|NCT00686543|1360463|P2|Overall Study|Protocol Violation|0
406357|NCT00686543|1360464|P1|Overall Study|Protocol Violation|3
406358|NCT00686543|1360461|P4|Overall Study|Withdrawal by Subject|0
406359|NCT00686543|1360462|P3|Overall Study|Withdrawal by Subject|0
406360|NCT00686543|1360463|P2|Overall Study|Withdrawal by Subject|0
406361|NCT00686543|1360464|P1|Overall Study|Withdrawal by Subject|2
406362|NCT00686543|1360461|P4|Overall Study|Adverse Event|2
406363|NCT00686543|1360462|P3|Overall Study|Adverse Event|3
406364|NCT00686543|1360463|P2|Overall Study|Adverse Event|1
406365|NCT00686543|1360464|P1|Overall Study|Adverse Event|9
406366|NCT00686517|1360485|P3|Treatment|Protocol Violation|0
406367|NCT00686517|1360486|P2|Treatment|Protocol Violation|1
406368|NCT00686517|1360487|P1|Treatment|Protocol Violation|2
406369|NCT00686517|1360485|P3|Treatment|Poor Protocol Compliance|0
406370|NCT00686517|1360486|P2|Treatment|Poor Protocol Compliance|0
406371|NCT00686517|1360487|P1|Treatment|Poor Protocol Compliance|1
406372|NCT00686517|1360485|P3|Treatment|Adverse Event|0
406373|NCT00686517|1360486|P2|Treatment|Adverse Event|0
406374|NCT00686517|1360487|P1|Treatment|Adverse Event|2
406375|NCT00686517|1360485|P3|Treatment|Serious Adverse Event|1
406376|NCT00686517|1360486|P2|Treatment|Serious Adverse Event|2
406377|NCT00686517|1360487|P1|Treatment|Serious Adverse Event|1
406378|NCT00686374|1360510|P1|Overall Study|Other, not specified|4
406379|NCT00686374|1360510|P1|Overall Study|Missing reason|33
406380|NCT00686374|1360510|P1|Overall Study|Lost to Follow-up|1
406381|NCT00686374|1360510|P1|Overall Study|Withdrew consent|5
406382|NCT00686374|1360510|P1|Overall Study|Adverse Event|8
406383|NCT00686374|1360510|P1|Overall Study|Lack of Efficacy|10
406384|NCT00686335|1360521|P1|Run-in Period|violation of inclusion/exclusion criteri|3
406385|NCT00686335|1360521|P1|Run-in Period|asthma exacerbation|1
406386|NCT00686335|1360521|P1|Run-in Period|Adverse Event|1
406387|NCT00686205|1360565|P2|Overall Study|Specimens not confirmed HIV positive|981
406388|NCT00686205|1360566|P1|Overall Study|Specimens not confirmed HIV positive|0
406389|NCT00686205|1360565|P2|Overall Study|Specimen handling procedure altered|0
406390|NCT00686205|1360566|P1|Overall Study|Specimen handling procedure altered|5878
406391|NCT00686205|1360565|P2|Overall Study|Withdrawal by Subject|0
406392|NCT00686205|1360566|P1|Overall Study|Withdrawal by Subject|2
406393|NCT00686205|1360565|P2|Overall Study|Protocol Violation|0
406394|NCT00686205|1360566|P1|Overall Study|Protocol Violation|127
406395|NCT00686166|1360572|P1|Overall Study|Did not begin protocol therapy|4
406396|NCT00686166|1360572|P1|Overall Study|Ineligible|5
406397|NCT00686166|1360572|P1|Overall Study|Not Protocol Specified|1
406398|NCT00686166|1360572|P1|Overall Study|Death|1
406399|NCT00686166|1360572|P1|Overall Study|Progression/Relapse|1
406400|NCT00686166|1360572|P1|Overall Study|Withdrawal by Subject|1
406401|NCT00686166|1360572|P1|Overall Study|Adverse Event|7
406402|NCT00686127|1360584|P2|Overall Study|Withdrawal by Subject|6
406403|NCT00686127|1360585|P1|Overall Study|Withdrawal by Subject|14
406404|NCT00686075|1360601|P10|Overall Study|Other|1
406405|NCT00686075|1360602|P9|Overall Study|Other|0
406406|NCT00686075|1360603|P8|Overall Study|Other|0
406407|NCT00686075|1360604|P7|Overall Study|Other|0
406408|NCT00686075|1360605|P6|Overall Study|Other|0
406409|NCT00686075|1360606|P5|Overall Study|Other|0
406410|NCT00686075|1360607|P4|Overall Study|Other|0
406411|NCT00686075|1360608|P3|Overall Study|Other|0
406412|NCT00686075|1360609|P2|Overall Study|Other|1
406413|NCT00686075|1360610|P1|Overall Study|Other|1
406414|NCT00686075|1360601|P10|Overall Study|Lost to Follow-up|3
406415|NCT00686075|1360602|P9|Overall Study|Lost to Follow-up|2
406416|NCT00686075|1360603|P8|Overall Study|Lost to Follow-up|0
406417|NCT00686075|1360604|P7|Overall Study|Lost to Follow-up|0
406418|NCT00686075|1360605|P6|Overall Study|Lost to Follow-up|3
406419|NCT00686075|1360606|P5|Overall Study|Lost to Follow-up|3
406420|NCT00686075|1360607|P4|Overall Study|Lost to Follow-up|2
406421|NCT00686075|1360608|P3|Overall Study|Lost to Follow-up|3
406422|NCT00686075|1360609|P2|Overall Study|Lost to Follow-up|6
406423|NCT00686075|1360610|P1|Overall Study|Lost to Follow-up|3
406424|NCT00686075|1360601|P10|Overall Study|Withdrawal by Subject|6
406425|NCT00686075|1360602|P9|Overall Study|Withdrawal by Subject|4
406426|NCT00686075|1360603|P8|Overall Study|Withdrawal by Subject|2
406427|NCT00686075|1360604|P7|Overall Study|Withdrawal by Subject|0
406428|NCT00686075|1360605|P6|Overall Study|Withdrawal by Subject|0
406429|NCT00686075|1360606|P5|Overall Study|Withdrawal by Subject|1
406430|NCT00686075|1360607|P4|Overall Study|Withdrawal by Subject|7
406431|NCT00686075|1360608|P3|Overall Study|Withdrawal by Subject|3
406432|NCT00686075|1360609|P2|Overall Study|Withdrawal by Subject|3
406433|NCT00686075|1360610|P1|Overall Study|Withdrawal by Subject|4
406434|NCT00686036|1360804|P2|Overall Study|Other reasons not identified|4
406435|NCT00686036|1360805|P1|Overall Study|Other reasons not identified|0
406436|NCT00686036|1360804|P2|Overall Study|PSA ≥ 10ng/mL|0
406437|NCT00686036|1360805|P1|Overall Study|PSA ≥ 10ng/mL|1
406438|NCT00686036|1360804|P2|Overall Study|Study terminated by AstraZeneca|1
406439|NCT00686036|1360805|P1|Overall Study|Study terminated by AstraZeneca|2
406440|NCT00686036|1360804|P2|Overall Study|Withdrawal by Subject|1
406441|NCT00686036|1360805|P1|Overall Study|Withdrawal by Subject|3
406442|NCT00686036|1360804|P2|Overall Study|Adverse Event|0
406443|NCT00686036|1360805|P1|Overall Study|Adverse Event|3
406444|NCT00685945|1360817|P1|L-NMMA + Bradykinin|Physician Decision|1
406445|NCT00685802|1360852|P2|Washout Period of 7 Days|Withdrawal by Subject|1
406446|NCT00685802|1360853|P1|Washout Period of 7 Days|Withdrawal by Subject|0
406447|NCT00685802|1360852|P2|Washout Period of 7 Days|Protocol Violation|0
406448|NCT00685802|1360853|P1|Washout Period of 7 Days|Protocol Violation|2
406449|NCT00685763|1360863|P1|Overall Study|Protocol Violation|1
406450|NCT00685763|1360863|P1|Overall Study|Intercurrent death-incomplete treatment|1
406451|NCT00685698|1360867|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
406452|NCT00685698|1360867|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
406453|NCT00685698|1360867|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
406454|NCT00685698|1360867|P1|Overall Study|Adverse Event|3
406455|NCT00685698|1360867|P1|Overall Study|Protocol Violation|6
406456|NCT00685698|1360867|P1|Overall Study|Withdrawal by Subject|1
406457|NCT00685685|1360902|P2|Washout Period of 7 Days|Withdrawal by Subject|1
406458|NCT00685685|1360903|P1|Washout Period of 7 Days|Withdrawal by Subject|0
406459|NCT00685685|1360902|P2|Washout Period of 7 Days|Adverse Event|0
406460|NCT00685685|1360903|P1|Washout Period of 7 Days|Adverse Event|2
406461|NCT00685399|1361056|P8|Extension|Adverse Event|0
406462|NCT00685399|1361057|P7|Extension|Adverse Event|0
406463|NCT00685399|1361058|P6|Extension|Adverse Event|0
406464|NCT00685399|1361059|P5|Extension|Adverse Event|0
406465|NCT00685399|1361060|P4|Extension|Adverse Event|2
406466|NCT00685399|1361061|P3|Extension|Adverse Event|0
406467|NCT00685399|1361062|P2|Extension|Adverse Event|0
406468|NCT00685399|1361063|P1|Extension|Adverse Event|0
406469|NCT00685399|1361056|P8|Extension|Lack of Efficacy|0
406470|NCT00685399|1361057|P7|Extension|Lack of Efficacy|0
406471|NCT00685399|1361058|P6|Extension|Lack of Efficacy|0
406472|NCT00685399|1361059|P5|Extension|Lack of Efficacy|0
406473|NCT00685399|1361060|P4|Extension|Lack of Efficacy|2
406474|NCT00685399|1361061|P3|Extension|Lack of Efficacy|0
406475|NCT00685399|1361062|P2|Extension|Lack of Efficacy|0
406476|NCT00685399|1361063|P1|Extension|Lack of Efficacy|0
406477|NCT00685399|1361056|P8|Extension|Protocol Violation|0
406478|NCT00685399|1361057|P7|Extension|Protocol Violation|0
406479|NCT00685399|1361058|P6|Extension|Protocol Violation|0
406480|NCT00685399|1361059|P5|Extension|Protocol Violation|0
406481|NCT00685399|1361060|P4|Extension|Protocol Violation|1
406482|NCT00685399|1361061|P3|Extension|Protocol Violation|0
406483|NCT00685399|1361062|P2|Extension|Protocol Violation|0
406484|NCT00685399|1361063|P1|Extension|Protocol Violation|0
406485|NCT00685399|1361056|P8|Extension|Withdrawal by Subject|0
406486|NCT00685399|1361057|P7|Extension|Withdrawal by Subject|0
406487|NCT00685399|1361058|P6|Extension|Withdrawal by Subject|0
406488|NCT00685399|1361059|P5|Extension|Withdrawal by Subject|0
406489|NCT00685399|1361060|P4|Extension|Withdrawal by Subject|1
406490|NCT00685399|1361061|P3|Extension|Withdrawal by Subject|0
406491|NCT00685399|1361062|P2|Extension|Withdrawal by Subject|0
406492|NCT00685399|1361063|P1|Extension|Withdrawal by Subject|0
406493|NCT00685399|1361056|P8|Extension|Administrative Issues|0
406494|NCT00685399|1361057|P7|Extension|Administrative Issues|0
406495|NCT00685399|1361058|P6|Extension|Administrative Issues|0
406496|NCT00685399|1361059|P5|Extension|Administrative Issues|0
406497|NCT00685399|1361060|P4|Extension|Administrative Issues|1
406498|NCT00685399|1361061|P3|Extension|Administrative Issues|0
406499|NCT00685399|1361062|P2|Extension|Administrative Issues|0
406500|NCT00685399|1361063|P1|Extension|Administrative Issues|0
406501|NCT00685399|1361056|P8|Treatment Period 2|Lack of Efficacy|0
406502|NCT00685399|1361057|P7|Treatment Period 2|Lack of Efficacy|0
406503|NCT00685399|1361058|P6|Treatment Period 2|Lack of Efficacy|1
406504|NCT00685399|1361059|P5|Treatment Period 2|Lack of Efficacy|0
406505|NCT00685399|1361060|P4|Treatment Period 2|Lack of Efficacy|0
406506|NCT00685399|1361061|P3|Treatment Period 2|Lack of Efficacy|2
406507|NCT00685399|1361062|P2|Treatment Period 2|Lack of Efficacy|10
406508|NCT00685399|1361063|P1|Treatment Period 2|Lack of Efficacy|0
406509|NCT00685399|1361056|P8|Treatment Period 2|Adverse Event|0
406510|NCT00685399|1361057|P7|Treatment Period 2|Adverse Event|0
406511|NCT00685399|1361058|P6|Treatment Period 2|Adverse Event|1
406512|NCT00685399|1361059|P5|Treatment Period 2|Adverse Event|0
406513|NCT00685399|1361060|P4|Treatment Period 2|Adverse Event|0
406514|NCT00685399|1361061|P3|Treatment Period 2|Adverse Event|0
406515|NCT00685399|1361062|P2|Treatment Period 2|Adverse Event|0
406516|NCT00685399|1361063|P1|Treatment Period 2|Adverse Event|0
406517|NCT00685399|1361056|P8|Treatment Period 2|Withdrawal by Subject|2
406518|NCT00685399|1361057|P7|Treatment Period 2|Withdrawal by Subject|0
406519|NCT00685399|1361058|P6|Treatment Period 2|Withdrawal by Subject|0
406520|NCT00685399|1361059|P5|Treatment Period 2|Withdrawal by Subject|0
406521|NCT00685399|1361060|P4|Treatment Period 2|Withdrawal by Subject|0
406522|NCT00685399|1361061|P3|Treatment Period 2|Withdrawal by Subject|0
406523|NCT00685399|1361062|P2|Treatment Period 2|Withdrawal by Subject|0
406524|NCT00685399|1361063|P1|Treatment Period 2|Withdrawal by Subject|0
406525|NCT00685399|1361056|P8|Treatment Period 2|Administrative Problems|0
406526|NCT00685399|1361057|P7|Treatment Period 2|Administrative Problems|0
406527|NCT00685399|1361058|P6|Treatment Period 2|Administrative Problems|0
406528|NCT00685399|1361059|P5|Treatment Period 2|Administrative Problems|0
406529|NCT00685399|1361060|P4|Treatment Period 2|Administrative Problems|0
406530|NCT00685399|1361061|P3|Treatment Period 2|Administrative Problems|1
406531|NCT00685399|1361062|P2|Treatment Period 2|Administrative Problems|2
406532|NCT00685399|1361063|P1|Treatment Period 2|Administrative Problems|0
406533|NCT00685399|1361056|P8|Treatment Period 1|Lack of Efficacy|0
406534|NCT00685399|1361057|P7|Treatment Period 1|Lack of Efficacy|0
406535|NCT00685399|1361058|P6|Treatment Period 1|Lack of Efficacy|0
406536|NCT00685399|1361059|P5|Treatment Period 1|Lack of Efficacy|0
406537|NCT00685399|1361060|P4|Treatment Period 1|Lack of Efficacy|0
406538|NCT00685399|1361061|P3|Treatment Period 1|Lack of Efficacy|0
406539|NCT00685399|1361062|P2|Treatment Period 1|Lack of Efficacy|0
406540|NCT00685399|1361063|P1|Treatment Period 1|Lack of Efficacy|1
406541|NCT00685399|1361056|P8|Treatment Period 1|Administrative|0
406542|NCT00685399|1361057|P7|Treatment Period 1|Administrative|0
406543|NCT00685399|1361058|P6|Treatment Period 1|Administrative|0
406544|NCT00685399|1361059|P5|Treatment Period 1|Administrative|0
406545|NCT00685399|1361060|P4|Treatment Period 1|Administrative|0
406546|NCT00685399|1361061|P3|Treatment Period 1|Administrative|0
406547|NCT00685399|1361062|P2|Treatment Period 1|Administrative|0
406548|NCT00685399|1361063|P1|Treatment Period 1|Administrative|2
406549|NCT00685399|1361056|P8|Treatment Period 1|Protocol Violation|0
406550|NCT00685399|1361057|P7|Treatment Period 1|Protocol Violation|0
406551|NCT00685399|1361058|P6|Treatment Period 1|Protocol Violation|0
406552|NCT00685399|1361059|P5|Treatment Period 1|Protocol Violation|0
406553|NCT00685399|1361060|P4|Treatment Period 1|Protocol Violation|0
406554|NCT00685399|1361061|P3|Treatment Period 1|Protocol Violation|0
406555|NCT00685399|1361062|P2|Treatment Period 1|Protocol Violation|0
406556|NCT00685399|1361063|P1|Treatment Period 1|Protocol Violation|1
406557|NCT00685399|1361056|P8|Treatment Period 1|Withdrawal by Subject|0
406558|NCT00685399|1361057|P7|Treatment Period 1|Withdrawal by Subject|0
406559|NCT00685399|1361058|P6|Treatment Period 1|Withdrawal by Subject|0
406560|NCT00685399|1361059|P5|Treatment Period 1|Withdrawal by Subject|0
406561|NCT00685399|1361060|P4|Treatment Period 1|Withdrawal by Subject|0
406562|NCT00685399|1361061|P3|Treatment Period 1|Withdrawal by Subject|0
406563|NCT00685399|1361062|P2|Treatment Period 1|Withdrawal by Subject|0
406564|NCT00685399|1361063|P1|Treatment Period 1|Withdrawal by Subject|2
406565|NCT00685373|1361096|P1|Overall Study|Protocol Violation|1
406566|NCT00685373|1361096|P1|Overall Study|Lost to Follow-up|2
406567|NCT00685373|1361096|P1|Overall Study|Condition no longer requires study drug|1
406568|NCT00685373|1361096|P1|Overall Study|Lack of Efficacy|3
406569|NCT00685373|1361096|P1|Overall Study|Withdrawal by Subject|5
406570|NCT00685373|1361096|P1|Overall Study|Adverse Event|3
406571|NCT00685334|1361105|P2|Overall Study|Chose to enter hospital|1
406572|NCT00685334|1361106|P1|Overall Study|Chose to enter hospital|1
406573|NCT00685334|1361105|P2|Overall Study|Lost to Follow-up|0
406574|NCT00685334|1361106|P1|Overall Study|Lost to Follow-up|4
406575|NCT00685334|1361105|P2|Overall Study|Withdrawal by Subject|6
406576|NCT00685334|1361106|P1|Overall Study|Withdrawal by Subject|5
406577|NCT00685178|1361131|P4|Overall Study|Pregnancy|1
406578|NCT00685178|1361132|P3|Overall Study|Pregnancy|0
406579|NCT00685178|1361133|P2|Overall Study|Pregnancy|0
406580|NCT00685178|1361134|P1|Overall Study|Pregnancy|0
406581|NCT00685178|1361131|P4|Overall Study|administrative (disciplinary) discharge|2
406582|NCT00685178|1361132|P3|Overall Study|administrative (disciplinary) discharge|0
406583|NCT00685178|1361133|P2|Overall Study|administrative (disciplinary) discharge|1
406584|NCT00685178|1361134|P1|Overall Study|administrative (disciplinary) discharge|0
406585|NCT00685178|1361131|P4|Overall Study|incarcerated|0
406586|NCT00685178|1361132|P3|Overall Study|incarcerated|7
406587|NCT00685178|1361133|P2|Overall Study|incarcerated|3
406588|NCT00685178|1361134|P1|Overall Study|incarcerated|1
406589|NCT00685178|1361131|P4|Overall Study|voluntary study discharge|1
406590|NCT00685178|1361132|P3|Overall Study|voluntary study discharge|1
406591|NCT00685178|1361133|P2|Overall Study|voluntary study discharge|5
406592|NCT00685178|1361134|P1|Overall Study|voluntary study discharge|4
406593|NCT00685178|1361131|P4|Overall Study|missed 3 consecutive methadone clin days|6
406594|NCT00685178|1361132|P3|Overall Study|missed 3 consecutive methadone clin days|2
406595|NCT00685178|1361133|P2|Overall Study|missed 3 consecutive methadone clin days|5
406596|NCT00685178|1361134|P1|Overall Study|missed 3 consecutive methadone clin days|7
406597|NCT00685178|1361131|P4|Overall Study|Adverse Event|4
406598|NCT00685178|1361132|P3|Overall Study|Adverse Event|2
406599|NCT00685178|1361133|P2|Overall Study|Adverse Event|5
406600|NCT00685178|1361134|P1|Overall Study|Adverse Event|1
406601|NCT00685165|1361148|P2|Washout Period of 14 Days|Adverse Event|0
406602|NCT00685165|1361149|P1|Washout Period of 14 Days|Adverse Event|1
406603|NCT00685035|1361168|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
406604|NCT00685035|1361169|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
406605|NCT00684996|1361193|P1|Overall Study|Other reasons not protocol specified|1
406606|NCT00684996|1361193|P1|Overall Study|Progression/relapse|2
406607|NCT00684996|1361193|P1|Overall Study|Refusal unrelated to adverse event|1
406608|NCT00684996|1361193|P1|Overall Study|Adverse Event|1
406609|NCT00684814|1361225|P2|Second Intervention|Adverse Event|0
406610|NCT00684814|1361226|P1|Second Intervention|Adverse Event|1
406611|NCT00684814|1361225|P2|Washout Period of 7 Days|Withdrawal by Subject|2
406612|NCT00684814|1361226|P1|Washout Period of 7 Days|Withdrawal by Subject|1
406613|NCT00684814|1361225|P2|Washout Period of 7 Days|Adverse Event|2
406614|NCT00684814|1361226|P1|Washout Period of 7 Days|Adverse Event|1
406615|NCT00684762|1361278|P2|Washout Period of 7 Days|Withdrawal by Subject|2
406616|NCT00684762|1361279|P1|Washout Period of 7 Days|Withdrawal by Subject|2
406617|NCT00684671|1361307|P3|Overall Study|Alcoholic dependance|0
406618|NCT00684671|1361308|P2|Overall Study|Alcoholic dependance|0
406619|NCT00684671|1361309|P1|Overall Study|Alcoholic dependance|1
406620|NCT00684671|1361307|P3|Overall Study|Lost to Follow-up|0
406621|NCT00684671|1361308|P2|Overall Study|Lost to Follow-up|0
406622|NCT00684671|1361309|P1|Overall Study|Lost to Follow-up|1
406623|NCT00684671|1361307|P3|Overall Study|Adverse Event|0
406624|NCT00684671|1361308|P2|Overall Study|Adverse Event|0
406625|NCT00684671|1361309|P1|Overall Study|Adverse Event|1
406626|NCT00684645|1361338|P1|Overall Study|Not specified|15
406627|NCT00684645|1361338|P1|Overall Study|Lost to Follow-up|3
406628|NCT00684645|1361338|P1|Overall Study|Adverse Event|27
406629|NCT00684645|1361338|P1|Overall Study|Progressive disease|67
406630|NCT00684645|1361338|P1|Overall Study|Death|2
406631|NCT00684593|1361358|P2|Overall Study|Adverse Event|2
406632|NCT00684593|1361359|P1|Overall Study|Adverse Event|0
406633|NCT00684567|1361371|P1|Monotherapy Period|Progression of primary disease|11
406634|NCT00684567|1361371|P1|Monotherapy Period|Death|1
406635|NCT00684567|1361371|P1|Monotherapy Period|Adverse Event|2
406636|NCT00684567|1361371|P1|Concomitant Radiotherapy Period|Adverse Event|2
406637|NCT00684515|1361404|P3|Overall Study|Protocol-Defined Clinical Event|0
406638|NCT00684515|1361405|P2|Overall Study|Protocol-Defined Clinical Event|0
406639|NCT00684515|1361406|P1|Overall Study|Protocol-Defined Clinical Event|1
406640|NCT00684515|1361404|P3|Overall Study|Adverse Event|1
406641|NCT00684515|1361405|P2|Overall Study|Adverse Event|3
406642|NCT00684515|1361406|P1|Overall Study|Adverse Event|3
406643|NCT00684424|1361429|P1|Overall Study|Not Specified|2
406644|NCT00684424|1361429|P1|Overall Study|Lost to Follow-up|2
406645|NCT00684424|1361429|P1|Overall Study|Adverse Event|1
406646|NCT00684411|1361444|P1|Overall Study|Adverse Event|1
406647|NCT00684411|1361444|P1|Overall Study|Disease Progression|10
406648|NCT00684411|1361444|P1|Overall Study|New Primary Cancer|1
406649|NCT00684307|1361466|P5|Overall Study|Criteria from the CSR|3
406650|NCT00684307|1361467|P4|Overall Study|Criteria from the CSR|3
406651|NCT00684307|1361468|P3|Overall Study|Criteria from the CSR|1
406652|NCT00684307|1361469|P2|Overall Study|Criteria from the CSR|0
406653|NCT00684307|1361470|P1|Overall Study|Criteria from the CSR|0
406654|NCT00684307|1361466|P5|Overall Study|Participant not willing to continue|8
406655|NCT00684307|1361467|P4|Overall Study|Participant not willing to continue|5
406656|NCT00684307|1361468|P3|Overall Study|Participant not willing to continue|11
406657|NCT00684307|1361469|P2|Overall Study|Participant not willing to continue|10
406658|NCT00684307|1361470|P1|Overall Study|Participant not willing to continue|7
406659|NCT00684307|1361466|P5|Overall Study|Severe non compliance to protocol|2
406660|NCT00684307|1361467|P4|Overall Study|Severe non compliance to protocol|1
406661|NCT00684307|1361468|P3|Overall Study|Severe non compliance to protocol|0
406662|NCT00684307|1361469|P2|Overall Study|Severe non compliance to protocol|0
406663|NCT00684307|1361470|P1|Overall Study|Severe non compliance to protocol|1
406664|NCT00684307|1361466|P5|Overall Study|Interupted IP for more than 7 days|3
406665|NCT00684307|1361467|P4|Overall Study|Interupted IP for more than 7 days|3
406666|NCT00684307|1361468|P3|Overall Study|Interupted IP for more than 7 days|1
406667|NCT00684307|1361469|P2|Overall Study|Interupted IP for more than 7 days|4
406668|NCT00684307|1361470|P1|Overall Study|Interupted IP for more than 7 days|0
406669|NCT00684307|1361466|P5|Overall Study|Incorrect enrolment or randomization|0
406670|NCT00684307|1361467|P4|Overall Study|Incorrect enrolment or randomization|0
406671|NCT00684307|1361468|P3|Overall Study|Incorrect enrolment or randomization|0
406672|NCT00684307|1361469|P2|Overall Study|Incorrect enrolment or randomization|0
406673|NCT00684307|1361470|P1|Overall Study|Incorrect enrolment or randomization|4
406674|NCT00684307|1361466|P5|Overall Study|Fullfillment of exclusion criteria|1
406675|NCT00684307|1361467|P4|Overall Study|Fullfillment of exclusion criteria|3
406676|NCT00684307|1361468|P3|Overall Study|Fullfillment of exclusion criteria|0
406677|NCT00684307|1361469|P2|Overall Study|Fullfillment of exclusion criteria|0
406678|NCT00684307|1361470|P1|Overall Study|Fullfillment of exclusion criteria|1
406679|NCT00684307|1361466|P5|Overall Study|Development of increasing Liver Function|0
406680|NCT00684307|1361467|P4|Overall Study|Development of increasing Liver Function|1
406681|NCT00684307|1361468|P3|Overall Study|Development of increasing Liver Function|0
406682|NCT00684307|1361469|P2|Overall Study|Development of increasing Liver Function|2
406683|NCT00684307|1361470|P1|Overall Study|Development of increasing Liver Function|0
406684|NCT00684307|1361466|P5|Overall Study|Adverse Event|8
406685|NCT00684307|1361467|P4|Overall Study|Adverse Event|16
406686|NCT00684307|1361468|P3|Overall Study|Adverse Event|15
406687|NCT00684307|1361469|P2|Overall Study|Adverse Event|6
406688|NCT00684307|1361470|P1|Overall Study|Adverse Event|11
406689|NCT00684203|1361552|P6|Overall Study|Did not meet protocol eligibility|0
406690|NCT00684203|1361553|P5|Overall Study|Did not meet protocol eligibility|0
406691|NCT00684203|1361554|P4|Overall Study|Did not meet protocol eligibility|0
406692|NCT00684203|1361555|P3|Overall Study|Did not meet protocol eligibility|0
406693|NCT00684203|1361556|P2|Overall Study|Did not meet protocol eligibility|1
406694|NCT00684203|1361557|P1|Overall Study|Did not meet protocol eligibility|0
406695|NCT00684203|1361552|P6|Overall Study|Withdrawal by Subject|0
406696|NCT00684203|1361553|P5|Overall Study|Withdrawal by Subject|0
406697|NCT00684203|1361554|P4|Overall Study|Withdrawal by Subject|0
406698|NCT00684203|1361555|P3|Overall Study|Withdrawal by Subject|1
406699|NCT00684203|1361556|P2|Overall Study|Withdrawal by Subject|2
406700|NCT00684203|1361557|P1|Overall Study|Withdrawal by Subject|0
406701|NCT00684203|1361552|P6|Overall Study|Protocol-defined clinical event|0
406702|NCT00684203|1361553|P5|Overall Study|Protocol-defined clinical event|0
406703|NCT00684203|1361554|P4|Overall Study|Protocol-defined clinical event|0
406704|NCT00684203|1361555|P3|Overall Study|Protocol-defined clinical event|0
406705|NCT00684203|1361556|P2|Overall Study|Protocol-defined clinical event|1
406706|NCT00684203|1361557|P1|Overall Study|Protocol-defined clinical event|3
406707|NCT00684203|1361552|P6|Overall Study|Adverse Event|0
406708|NCT00684203|1361553|P5|Overall Study|Adverse Event|0
406709|NCT00684203|1361554|P4|Overall Study|Adverse Event|0
406710|NCT00684203|1361555|P3|Overall Study|Adverse Event|8
406711|NCT00684203|1361556|P2|Overall Study|Adverse Event|4
406712|NCT00684203|1361557|P1|Overall Study|Adverse Event|6
406713|NCT00684177|1361618|P2|Overall Study|Other|2
406714|NCT00684177|1361619|P1|Overall Study|Other|1
406715|NCT00684177|1361618|P2|Overall Study|Withdrawal by Subject|2
406716|NCT00684177|1361619|P1|Overall Study|Withdrawal by Subject|1
406717|NCT00684177|1361618|P2|Overall Study|Physician Decision|0
406718|NCT00684177|1361619|P1|Overall Study|Physician Decision|2
406719|NCT00684177|1361618|P2|Overall Study|Lost to Follow-up|1
406720|NCT00684177|1361619|P1|Overall Study|Lost to Follow-up|2
406721|NCT00684177|1361618|P2|Overall Study|Protocol Violation|0
406722|NCT00684177|1361619|P1|Overall Study|Protocol Violation|1
406723|NCT00684177|1361618|P2|Overall Study|Lack of Efficacy|15
406724|NCT00684177|1361619|P1|Overall Study|Lack of Efficacy|10
406725|NCT00684177|1361618|P2|Overall Study|Adverse Event|3
406726|NCT00684177|1361619|P1|Overall Study|Adverse Event|4
406727|NCT00684073|1361654|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
406728|NCT00684073|1361654|P1|Selection|request of the sponsor|1
406729|NCT00684073|1361654|P1|Selection|Lost to Follow-up|1
406730|NCT00684073|1361654|P1|Selection|noncompliance|1
406731|NCT00684073|1361654|P1|Selection|Death|1
406732|NCT00684073|1361654|P1|Selection|Selection/non-selection criteria|3
406733|NCT00684060|1361664|P2|Overall Study|Death|1
406734|NCT00684060|1361665|P1|Overall Study|Death|0
406735|NCT00684060|1361664|P2|Overall Study|Unable to collect MRI|2
406736|NCT00684060|1361665|P1|Overall Study|Unable to collect MRI|1
406737|NCT00684060|1361664|P2|Overall Study|New stenosis identified|0
406738|NCT00684060|1361665|P1|Overall Study|New stenosis identified|1
406739|NCT00684060|1361664|P2|Overall Study|Lost to Follow-up|0
406740|NCT00684060|1361665|P1|Overall Study|Lost to Follow-up|1
406741|NCT00684021|1361704|P4|Overall Study|Death|0
406742|NCT00684021|1361705|P3|Overall Study|Death|0
406743|NCT00684021|1361706|P2|Overall Study|Death|0
406744|NCT00684021|1361707|P1|Overall Study|Death|1
406745|NCT00684021|1361704|P4|Overall Study|MRI not performed|2
406746|NCT00684021|1361705|P3|Overall Study|MRI not performed|1
406747|NCT00684021|1361706|P2|Overall Study|MRI not performed|1
406748|NCT00684021|1361707|P1|Overall Study|MRI not performed|0
406749|NCT00684021|1361704|P4|Overall Study|MRI Contraindicated|0
406750|NCT00684021|1361705|P3|Overall Study|MRI Contraindicated|1
406751|NCT00684021|1361706|P2|Overall Study|MRI Contraindicated|1
406752|NCT00684021|1361707|P1|Overall Study|MRI Contraindicated|1
406753|NCT00683917|1361768|P1|Overall Study|Study prematurely terminated|10
406754|NCT00683904|1361778|P2|Dose Level 2|Adverse Event|2
406755|NCT00683904|1361779|P1|Dose Level 2|Adverse Event|0
406756|NCT00683904|1361778|P2|Dose Level 1|Adverse Event|0
406757|NCT00683904|1361779|P1|Dose Level 1|Adverse Event|1
406758|NCT00683904|1361778|P2|Dose Level 1|Disease progression|0
406759|NCT00683904|1361779|P1|Dose Level 1|Disease progression|2
406760|NCT00683878|1361815|P3|Overall Study|Non-compliance, not met criteria etc.|0
406761|NCT00683878|1361816|P2|Overall Study|Non-compliance, not met criteria etc.|2
406762|NCT00683878|1361817|P1|Overall Study|Non-compliance, not met criteria etc.|3
406763|NCT00683878|1361815|P3|Overall Study|Lost to Follow-up|4
406764|NCT00683878|1361816|P2|Overall Study|Lost to Follow-up|2
406765|NCT00683878|1361817|P1|Overall Study|Lost to Follow-up|4
406766|NCT00683878|1361815|P3|Overall Study|Death|0
406767|NCT00683878|1361816|P2|Overall Study|Death|1
406768|NCT00683878|1361817|P1|Overall Study|Death|0
406769|NCT00683878|1361815|P3|Overall Study|Withdrawal by Subject|6
406770|NCT00683878|1361816|P2|Overall Study|Withdrawal by Subject|8
406771|NCT00683878|1361817|P1|Overall Study|Withdrawal by Subject|9
406772|NCT00683878|1361815|P3|Overall Study|Adverse Event|3
406773|NCT00683878|1361816|P2|Overall Study|Adverse Event|3
406774|NCT00683878|1361817|P1|Overall Study|Adverse Event|4
406775|NCT00683878|1361815|P3|Overall Study|Lack of Efficacy|1
406776|NCT00683878|1361816|P2|Overall Study|Lack of Efficacy|0
406777|NCT00683878|1361817|P1|Overall Study|Lack of Efficacy|3
406778|NCT00683800|1361891|P2|Overall Study|Randomized, not treated|33
406779|NCT00683800|1361892|P1|Overall Study|Randomized, not treated|35
406780|NCT00683800|1361891|P2|Overall Study|Lack of Efficacy|104
406781|NCT00683800|1361892|P1|Overall Study|Lack of Efficacy|61
406782|NCT00683800|1361891|P2|Overall Study|Withdrawal by Subject|64
406783|NCT00683800|1361892|P1|Overall Study|Withdrawal by Subject|66
406784|NCT00683800|1361891|P2|Overall Study|Protocol Violation|16
406785|NCT00683800|1361892|P1|Overall Study|Protocol Violation|13
406786|NCT00683800|1361891|P2|Overall Study|Other|2
406787|NCT00683800|1361892|P1|Overall Study|Other|5
406788|NCT00683800|1361891|P2|Overall Study|Lost to Follow-up|44
406789|NCT00683800|1361892|P1|Overall Study|Lost to Follow-up|57
406790|NCT00683800|1361891|P2|Overall Study|Death|1
406791|NCT00683800|1361892|P1|Overall Study|Death|0
406792|NCT00683800|1361891|P2|Overall Study|Adverse Event|102
406793|NCT00683800|1361892|P1|Overall Study|Adverse Event|195
406794|NCT00683787|1361959|P3|Overall Study|Adverse Event|2
406795|NCT00683787|1361960|P2|Overall Study|Adverse Event|0
406796|NCT00683787|1361961|P1|Overall Study|Adverse Event|0
406797|NCT00683787|1361959|P3|Overall Study|Progression|0
406798|NCT00683787|1361960|P2|Overall Study|Progression|3
406799|NCT00683787|1361961|P1|Overall Study|Progression|3
406800|NCT00683774|1361980|P2|Overall Study|Physician Decision|0
406801|NCT00683774|1361981|P1|Overall Study|Physician Decision|3
406802|NCT00683774|1361980|P2|Overall Study|Withdrawal by Subject|1
406803|NCT00683774|1361981|P1|Overall Study|Withdrawal by Subject|0
406804|NCT00683696|1361991|P2|Overall Study|Death|30
406805|NCT00683696|1361992|P1|Overall Study|Death|46
406806|NCT00683696|1361991|P2|Overall Study|Vital status follow-up only|3
406807|NCT00683696|1361992|P1|Overall Study|Vital status follow-up only|3
406808|NCT00683696|1361991|P2|Overall Study|Lost to Follow-up|6
406809|NCT00683696|1361992|P1|Overall Study|Lost to Follow-up|5
406810|NCT00683696|1361991|P2|Overall Study|Withdrawn prior to study closure|28
406811|NCT00683696|1361992|P1|Overall Study|Withdrawn prior to study closure|13
406812|NCT00683696|1361991|P2|Overall Study|Withdrawn due to study closure|338
406813|NCT00683696|1361992|P1|Overall Study|Withdrawn due to study closure|337
406814|NCT00683657|1362011|P2|Overall Study|Subject Withdrew Consent|0
406815|NCT00683657|1362012|P1|Overall Study|Subject Withdrew Consent|1
406816|NCT00683657|1362011|P2|Overall Study|Adverse Event|1
406817|NCT00683657|1362012|P1|Overall Study|Adverse Event|0
406818|NCT00683644|1362028|P2|Overall Study|Low copper, other health problems,|6
406819|NCT00683644|1362029|P1|Overall Study|Low copper, other health problems,|7
406820|NCT00683644|1362028|P2|Overall Study|Adverse Event|2
406821|NCT00683644|1362029|P1|Overall Study|Adverse Event|1
406822|NCT00683644|1362028|P2|Overall Study|Lost to Follow-up|4
406823|NCT00683644|1362029|P1|Overall Study|Lost to Follow-up|1
406824|NCT00683644|1362028|P2|Overall Study|Withdrawal by Subject|2
406825|NCT00683644|1362029|P1|Overall Study|Withdrawal by Subject|4
406826|NCT00683618|1362042|P3|Extension Treatment Period|Protocol Violation|0
406827|NCT00683618|1362043|P2|Extension Treatment Period|Protocol Violation|0
406828|NCT00683618|1362044|P1|Extension Treatment Period|Protocol Violation|1
406829|NCT00683618|1362042|P3|Extension Treatment Period|Adverse Event|0
406830|NCT00683618|1362043|P2|Extension Treatment Period|Adverse Event|0
406831|NCT00683618|1362044|P1|Extension Treatment Period|Adverse Event|1
406832|NCT00683618|1362042|P3|Extension Treatment Period|Withdrawal by Subject|0
406833|NCT00683618|1362043|P2|Extension Treatment Period|Withdrawal by Subject|0
406834|NCT00683618|1362044|P1|Extension Treatment Period|Withdrawal by Subject|1
406835|NCT00683618|1362042|P3|Randomised Treatment Period|Reason not provided|2
406836|NCT00683618|1362043|P2|Randomised Treatment Period|Reason not provided|0
406837|NCT00683618|1362044|P1|Randomised Treatment Period|Reason not provided|0
406838|NCT00683618|1362042|P3|Randomised Treatment Period|Adverse Event|2
406839|NCT00683618|1362043|P2|Randomised Treatment Period|Adverse Event|0
406840|NCT00683618|1362044|P1|Randomised Treatment Period|Adverse Event|2
406841|NCT00683618|1362042|P3|Randomised Treatment Period|Protocol Violation|0
406842|NCT00683618|1362043|P2|Randomised Treatment Period|Protocol Violation|1
406843|NCT00683618|1362044|P1|Randomised Treatment Period|Protocol Violation|0
406844|NCT00683618|1362042|P3|Randomised Treatment Period|Withdrawal by Subject|2
406845|NCT00683618|1362043|P2|Randomised Treatment Period|Withdrawal by Subject|1
406846|NCT00683618|1362044|P1|Randomised Treatment Period|Withdrawal by Subject|4
406847|NCT00683592|1362094|P2|Overall Study|Other|1
406848|NCT00683592|1362095|P1|Overall Study|Other|1
406849|NCT00683592|1362094|P2|Overall Study|Non-compliance|5
406850|NCT00683592|1362095|P1|Overall Study|Non-compliance|3
406851|NCT00683592|1362094|P2|Overall Study|Physician Decision|1
406852|NCT00683592|1362095|P1|Overall Study|Physician Decision|0
406853|NCT00683592|1362094|P2|Overall Study|Lack of Efficacy|7
406854|NCT00683592|1362095|P1|Overall Study|Lack of Efficacy|3
406855|NCT00683592|1362094|P2|Overall Study|Lost to Follow-up|17
406856|NCT00683592|1362095|P1|Overall Study|Lost to Follow-up|17
406857|NCT00683592|1362094|P2|Overall Study|Withdrawal by Subject|11
406858|NCT00683592|1362095|P1|Overall Study|Withdrawal by Subject|11
406859|NCT00683592|1362094|P2|Overall Study|Adverse Event|4
406860|NCT00683592|1362095|P1|Overall Study|Adverse Event|12
406861|NCT00683475|1362113|P2|Overall Study|Never Treated: Progressive Disease|0
406862|NCT00683475|1362114|P1|Overall Study|Never Treated: Progressive Disease|1
406863|NCT00683475|1362113|P2|Overall Study|Never Treated: Adverse Event|3
406864|NCT00683475|1362114|P1|Overall Study|Never Treated: Adverse Event|2
406865|NCT00683475|1362113|P2|Overall Study|Withdrawal by Subject|0
406866|NCT00683475|1362114|P1|Overall Study|Withdrawal by Subject|1
406867|NCT00683449|1362149|P5|Overall Study|Lost to Follow-up|0
406868|NCT00683449|1362150|P4|Overall Study|Lost to Follow-up|0
406869|NCT00683449|1362151|P3|Overall Study|Lost to Follow-up|0
406870|NCT00683449|1362152|P2|Overall Study|Lost to Follow-up|1
406871|NCT00683449|1362153|P1|Overall Study|Lost to Follow-up|0
406872|NCT00683384|1362179|P1|Overall Study|Adverse Event|1
406873|NCT00683384|1362179|P1|Overall Study|Death|1
406874|NCT00683293|1362189|P2|Overall Study|Withdrawal by Subject|3
406875|NCT00683293|1362190|P1|Overall Study|Withdrawal by Subject|2
406876|NCT00682929|1362253|P3|Overall Study|lag in DEA renewal|0
406877|NCT00682929|1362254|P2|Overall Study|lag in DEA renewal|0
406878|NCT00682929|1362255|P1|Overall Study|lag in DEA renewal|1
406879|NCT00682929|1362253|P3|Overall Study|dosing compliance < 80%|0
406880|NCT00682929|1362254|P2|Overall Study|dosing compliance < 80%|2
406881|NCT00682929|1362255|P1|Overall Study|dosing compliance < 80%|0
406882|NCT00682929|1362253|P3|Overall Study|Withdrawal by Subject|1
406883|NCT00682929|1362254|P2|Overall Study|Withdrawal by Subject|2
406884|NCT00682929|1362255|P1|Overall Study|Withdrawal by Subject|1
406885|NCT00682929|1362253|P3|Overall Study|Adverse Event|1
406886|NCT00682929|1362254|P2|Overall Study|Adverse Event|1
406887|NCT00682929|1362255|P1|Overall Study|Adverse Event|4
406888|NCT00682890|1362424|P2|Overall Study|heavy menstrual bleeding|0
406889|NCT00682890|1362425|P1|Overall Study|heavy menstrual bleeding|1
406890|NCT00682890|1362424|P2|Overall Study|subject moved away|1
406891|NCT00682890|1362425|P1|Overall Study|subject moved away|0
406892|NCT00682890|1362424|P2|Overall Study|Lost to Follow-up|1
406893|NCT00682890|1362425|P1|Overall Study|Lost to Follow-up|1
406894|NCT00682786|1362467|P2|Overall Study|Did not receive irinotecan|1
406895|NCT00682786|1362468|P1|Overall Study|Did not receive irinotecan|0
406896|NCT00682786|1362467|P2|Overall Study|Withdrawal by Subject|2
406897|NCT00682786|1362468|P1|Overall Study|Withdrawal by Subject|2
406898|NCT00682643|1362517|P2|Overall Study|Did Not Receive Study Drug|1
406899|NCT00682643|1362518|P1|Overall Study|Did Not Receive Study Drug|1
406900|NCT00682643|1362517|P2|Overall Study|Withdrawal by Subject|53
406901|NCT00682643|1362518|P1|Overall Study|Withdrawal by Subject|19
406902|NCT00682643|1362517|P2|Overall Study|Physician Decision|6
406903|NCT00682643|1362518|P1|Overall Study|Physician Decision|2
406904|NCT00682643|1362517|P2|Overall Study|Lost to Follow-up|6
406905|NCT00682643|1362518|P1|Overall Study|Lost to Follow-up|1
406906|NCT00682643|1362517|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
406907|NCT00682643|1362518|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
406908|NCT00682643|1362517|P2|Overall Study|Protocol Violation|76
406909|NCT00682643|1362518|P1|Overall Study|Protocol Violation|38
406910|NCT00682643|1362517|P2|Overall Study|Lack of Efficacy|0
406911|NCT00682643|1362518|P1|Overall Study|Lack of Efficacy|2
406912|NCT00682643|1362517|P2|Overall Study|Adverse Event|23
406913|NCT00682643|1362518|P1|Overall Study|Adverse Event|12
406914|NCT00682539|1362579|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
406915|NCT00682539|1362580|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
406916|NCT00682539|1362581|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
406917|NCT00682539|1362579|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
406918|NCT00682539|1362580|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
406919|NCT00682539|1362581|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
406920|NCT00682461|1362594|P2|Overall Study|Withdrawal by Subject|19
406921|NCT00682461|1362595|P1|Overall Study|Withdrawal by Subject|12
406922|NCT00682461|1362594|P2|Overall Study|Lost to Follow-up|5
406923|NCT00682461|1362595|P1|Overall Study|Lost to Follow-up|8
406924|NCT00682461|1362594|P2|Overall Study|Adverse Event|7
406925|NCT00682461|1362595|P1|Overall Study|Adverse Event|5
406926|NCT00681863|1362635|P1|Overall Study|not specified|18
406927|NCT00681863|1362635|P1|Overall Study|Lack of Efficacy|2
406928|NCT00681863|1362635|P1|Overall Study|Lost to Follow-up|2
406929|NCT00681863|1362635|P1|Overall Study|Adverse Event|1
406930|NCT00681824|1362683|P3|Overall Study|Death|0
406931|NCT00681824|1362684|P2|Overall Study|Death|1
406932|NCT00681824|1362685|P1|Overall Study|Death|0
406933|NCT00681824|1362683|P3|Overall Study|scheduling conflict|0
406934|NCT00681824|1362684|P2|Overall Study|scheduling conflict|0
406935|NCT00681824|1362685|P1|Overall Study|scheduling conflict|1
406936|NCT00681824|1362683|P3|Overall Study|withdrawn by investigator|1
406937|NCT00681824|1362684|P2|Overall Study|withdrawn by investigator|0
406938|NCT00681824|1362685|P1|Overall Study|withdrawn by investigator|0
406939|NCT00681811|1362703|P2|Overall Study|Non-compliance|1
406940|NCT00681811|1362704|P1|Overall Study|Non-compliance|0
406941|NCT00681811|1362703|P2|Overall Study|Withdrawal by Subject|2
406942|NCT00681811|1362704|P1|Overall Study|Withdrawal by Subject|2
406943|NCT00681811|1362703|P2|Overall Study|Adverse Event|1
406944|NCT00681811|1362704|P1|Overall Study|Adverse Event|1
406945|NCT00681668|1362732|P1|Overall Study|Withdrawal by Subject|1
406946|NCT00681668|1362732|P1|Overall Study|Protocol Violation|1
406947|NCT00681629|1362741|P2|Overall Study|Adverse Event|0
406948|NCT00681629|1362742|P1|Overall Study|Adverse Event|1
406949|NCT00681629|1362741|P2|Overall Study|Study termination|2
406950|NCT00681629|1362742|P1|Overall Study|Study termination|4
406951|NCT00681590|1362788|P2|Overall Study|Withdrawal by Subject|12
406952|NCT00681590|1362789|P1|Overall Study|Withdrawal by Subject|2
406953|NCT00681564|1362799|P2|Overall Study|Death|1
406954|NCT00681564|1362800|P1|Overall Study|Death|0
406955|NCT00681564|1362799|P2|Overall Study|Withdrawal by Subject|1
406956|NCT00681564|1362800|P1|Overall Study|Withdrawal by Subject|0
406957|NCT00681564|1362799|P2|Overall Study|Lost to Follow-up|6
406958|NCT00681564|1362800|P1|Overall Study|Lost to Follow-up|6
406959|NCT00681187|1362892|P2|Overall Study|Adverse Event|1
406960|NCT00681187|1362893|P1|Overall Study|Adverse Event|0
406961|NCT00681187|1362892|P2|Overall Study|Death|1
406962|NCT00681187|1362893|P1|Overall Study|Death|0
406963|NCT00681187|1362892|P2|Overall Study|Withdrawal by Subject|0
406964|NCT00681187|1362893|P1|Overall Study|Withdrawal by Subject|1
406965|NCT00681109|1362928|P3|Overall Study|Lost to Follow-up|0
406966|NCT00681109|1362929|P2|Overall Study|Lost to Follow-up|6
406967|NCT00681109|1362930|P1|Overall Study|Lost to Follow-up|2
406968|NCT00680914|1362980|P2|Overall Study|serious adverse event (SAE)|1
406969|NCT00680914|1362981|P1|Overall Study|serious adverse event (SAE)|0
406970|NCT00680914|1362980|P2|Overall Study|Lost to Follow-up|0
406971|NCT00680914|1362981|P1|Overall Study|Lost to Follow-up|4
406972|NCT00680914|1362980|P2|Overall Study|Consent withdrawal|3
406973|NCT00680914|1362981|P1|Overall Study|Consent withdrawal|6
406974|NCT00680901|1363015|P2|Overall Study|Ongoing: In Follow Up|41
406975|NCT00680901|1363016|P1|Overall Study|Ongoing: In Follow Up|45
406976|NCT00680901|1363015|P2|Overall Study|Ongoing: On Study Treatment|13
406977|NCT00680901|1363016|P1|Overall Study|Ongoing: On Study Treatment|16
406978|NCT00680901|1363015|P2|Overall Study|Physician Decision|1
406979|NCT00680901|1363016|P1|Overall Study|Physician Decision|0
406980|NCT00680901|1363015|P2|Overall Study|Withdrawal by Subject|13
406981|NCT00680901|1363016|P1|Overall Study|Withdrawal by Subject|4
406982|NCT00680901|1363015|P2|Overall Study|Lost to Follow-up|8
406983|NCT00680901|1363016|P1|Overall Study|Lost to Follow-up|8
406984|NCT00680836|1363054|P2|Overall Study|Physician Decision|1
406985|NCT00680836|1363055|P1|Overall Study|Physician Decision|2
406986|NCT00680836|1363054|P2|Overall Study|Lost to Follow-up|1
406987|NCT00680836|1363055|P1|Overall Study|Lost to Follow-up|3
406988|NCT00680836|1363054|P2|Overall Study|Withdrawal by Subject|0
406989|NCT00680836|1363055|P1|Overall Study|Withdrawal by Subject|3
406990|NCT00680771|1363109|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
406991|NCT00680771|1363110|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
406992|NCT00680771|1363109|P2|Overall Study|Sleep Apnea suspected after PSG|0
406993|NCT00680771|1363110|P1|Overall Study|Sleep Apnea suspected after PSG|1
406994|NCT00680771|1363109|P2|Overall Study|Withdrawal by Subject|0
406995|NCT00680771|1363110|P1|Overall Study|Withdrawal by Subject|1
406996|NCT00680745|1363120|P4|Overall Study|False Treatment|0
406997|NCT00680745|1363121|P3|Overall Study|False Treatment|3
406998|NCT00680745|1363122|P2|Overall Study|False Treatment|1
406999|NCT00680745|1363123|P1|Overall Study|False Treatment|0
407000|NCT00680745|1363120|P4|Overall Study|Subject No Longer Meets Study Criteria|2
407001|NCT00680745|1363121|P3|Overall Study|Subject No Longer Meets Study Criteria|0
407002|NCT00680745|1363122|P2|Overall Study|Subject No Longer Meets Study Criteria|2
407003|NCT00680745|1363123|P1|Overall Study|Subject No Longer Meets Study Criteria|0
407004|NCT00680745|1363120|P4|Overall Study|Poor/Non-compliance|0
407005|NCT00680745|1363121|P3|Overall Study|Poor/Non-compliance|0
407006|NCT00680745|1363122|P2|Overall Study|Poor/Non-compliance|3
407007|NCT00680745|1363123|P1|Overall Study|Poor/Non-compliance|0
407008|NCT00680745|1363120|P4|Overall Study|Adverse Event|3
407009|NCT00680745|1363121|P3|Overall Study|Adverse Event|3
407010|NCT00680745|1363122|P2|Overall Study|Adverse Event|3
407011|NCT00680745|1363123|P1|Overall Study|Adverse Event|5
407012|NCT00680745|1363120|P4|Overall Study|Death|0
407013|NCT00680745|1363121|P3|Overall Study|Death|1
407014|NCT00680745|1363122|P2|Overall Study|Death|0
407015|NCT00680745|1363123|P1|Overall Study|Death|1
407016|NCT00680745|1363120|P4|Overall Study|Lost to Follow-up|0
407017|NCT00680745|1363121|P3|Overall Study|Lost to Follow-up|1
407018|NCT00680745|1363122|P2|Overall Study|Lost to Follow-up|1
407019|NCT00680745|1363123|P1|Overall Study|Lost to Follow-up|0
407020|NCT00680745|1363120|P4|Overall Study|Withdrawal by Subject|8
407021|NCT00680745|1363121|P3|Overall Study|Withdrawal by Subject|2
407022|NCT00680745|1363122|P2|Overall Study|Withdrawal by Subject|3
407023|NCT00680745|1363123|P1|Overall Study|Withdrawal by Subject|8
407024|NCT00680407|1363197|P3|Overall Study|Withdrawal by Subject|2
407025|NCT00680407|1363198|P2|Overall Study|Withdrawal by Subject|2
407026|NCT00680407|1363199|P1|Overall Study|Withdrawal by Subject|5
407027|NCT00680407|1363197|P3|Overall Study|Lost to Follow-up|1
407028|NCT00680407|1363198|P2|Overall Study|Lost to Follow-up|3
407029|NCT00680407|1363199|P1|Overall Study|Lost to Follow-up|3
407030|NCT00680368|1363213|P1|Overall Study|not supervised, not eligible|15
407031|NCT00680186|1363241|P2|Overall Study|Other|1
407032|NCT00680186|1363242|P1|Overall Study|Other|4
407033|NCT00680186|1363241|P2|Overall Study|Withdrawal by Subject|39
407034|NCT00680186|1363242|P1|Overall Study|Withdrawal by Subject|32
407035|NCT00680186|1363241|P2|Overall Study|Lost to Follow-up|6
407036|NCT00680186|1363242|P1|Overall Study|Lost to Follow-up|11
407037|NCT00680186|1363241|P2|Overall Study|Protocol Violation|26
407038|NCT00680186|1363242|P1|Overall Study|Protocol Violation|31
407039|NCT00680186|1363241|P2|Overall Study|Adverse Event|44
407040|NCT00680186|1363242|P1|Overall Study|Adverse Event|47
407041|NCT00680121|1363268|P2|Overall Study|Lost to Follow-up|23
407042|NCT00680121|1363269|P1|Overall Study|Lost to Follow-up|27
407043|NCT00680056|1363283|P2|Second Intervention|Protocol Violation|1
407044|NCT00680056|1363284|P1|Second Intervention|Protocol Violation|3
407045|NCT00680056|1363283|P2|First Intervention|Mainly Exacerbation of COPD|2
407046|NCT00680056|1363284|P1|First Intervention|Mainly Exacerbation of COPD|1
407047|NCT00680043|1363295|P3|Overall Study|Renal Transplant|4
407048|NCT00680043|1363296|P2|Overall Study|Renal Transplant|0
407049|NCT00680043|1363297|P1|Overall Study|Renal Transplant|1
407050|NCT00680043|1363295|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
407051|NCT00680043|1363296|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
407052|NCT00680043|1363297|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
407053|NCT00680043|1363295|P3|Overall Study|Withdrawal by Subject|0
407054|NCT00680043|1363296|P2|Overall Study|Withdrawal by Subject|0
407055|NCT00680043|1363297|P1|Overall Study|Withdrawal by Subject|1
407056|NCT00680017|1363313|P2|Overall Study|Lost to Follow-up|0
407057|NCT00680017|1363314|P1|Overall Study|Lost to Follow-up|2
407058|NCT00680017|1363313|P2|Overall Study|Withdrawal by Subject|5
407059|NCT00680017|1363314|P1|Overall Study|Withdrawal by Subject|2
407060|NCT00680017|1363313|P2|Overall Study|Adverse Event|7
407061|NCT00680017|1363314|P1|Overall Study|Adverse Event|13
407062|NCT00679939|1363333|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
407063|NCT00679939|1363334|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
407064|NCT00679939|1363333|P2|24-Week Open-Label (OL) Period|Physician Decision|0
407065|NCT00679939|1363334|P1|24-Week Open-Label (OL) Period|Physician Decision|1
407066|NCT00679939|1363333|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
407067|NCT00679939|1363334|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
407068|NCT00679939|1363333|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
407069|NCT00679939|1363334|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
407070|NCT00679939|1363333|P2|24-Week Open-Label (OL) Period|Adverse Event|1
407071|NCT00679939|1363334|P1|24-Week Open-Label (OL) Period|Adverse Event|0
407072|NCT00679939|1363333|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
407073|NCT00679939|1363334|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
407074|NCT00679939|1363333|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
407075|NCT00679939|1363334|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
407076|NCT00679939|1363333|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
407077|NCT00679939|1363334|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
407078|NCT00679939|1363333|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
407079|NCT00679939|1363334|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
407080|NCT00679939|1363333|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
407081|NCT00679939|1363334|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
407082|NCT00679913|1363485|P2|Overall Study|Protocol Violation|13
407083|NCT00679913|1363486|P1|Overall Study|Protocol Violation|18
407084|NCT00679783|1363501|P7|Overall Study|Ongoing at data cut-off|0
407085|NCT00679783|1363502|P6|Overall Study|Ongoing at data cut-off|0
407086|NCT00679783|1363503|P5|Overall Study|Ongoing at data cut-off|1
407087|NCT00679783|1363504|P4|Overall Study|Ongoing at data cut-off|9
407088|NCT00679783|1363505|P3|Overall Study|Ongoing at data cut-off|0
407089|NCT00679783|1363506|P2|Overall Study|Ongoing at data cut-off|2
407090|NCT00679783|1363507|P1|Overall Study|Ongoing at data cut-off|2
407091|NCT00679783|1363501|P7|Overall Study|Not Captured|0
407092|NCT00679783|1363502|P6|Overall Study|Not Captured|0
407093|NCT00679783|1363503|P5|Overall Study|Not Captured|0
407094|NCT00679783|1363504|P4|Overall Study|Not Captured|5
407095|NCT00679783|1363505|P3|Overall Study|Not Captured|0
407096|NCT00679783|1363506|P2|Overall Study|Not Captured|0
407097|NCT00679783|1363507|P1|Overall Study|Not Captured|0
407098|NCT00679783|1363501|P7|Overall Study|Withdrawal by Subject|0
407099|NCT00679783|1363502|P6|Overall Study|Withdrawal by Subject|0
407100|NCT00679783|1363503|P5|Overall Study|Withdrawal by Subject|0
407101|NCT00679783|1363504|P4|Overall Study|Withdrawal by Subject|1
407102|NCT00679783|1363505|P3|Overall Study|Withdrawal by Subject|1
407103|NCT00679783|1363506|P2|Overall Study|Withdrawal by Subject|0
407104|NCT00679783|1363507|P1|Overall Study|Withdrawal by Subject|0
407105|NCT00679783|1363501|P7|Overall Study|Lack of Efficacy|0
407106|NCT00679783|1363502|P6|Overall Study|Lack of Efficacy|0
407107|NCT00679783|1363503|P5|Overall Study|Lack of Efficacy|0
407108|NCT00679783|1363504|P4|Overall Study|Lack of Efficacy|2
407109|NCT00679783|1363505|P3|Overall Study|Lack of Efficacy|0
407110|NCT00679783|1363506|P2|Overall Study|Lack of Efficacy|1
407111|NCT00679783|1363507|P1|Overall Study|Lack of Efficacy|0
407112|NCT00679783|1363501|P7|Overall Study|Adverse Event|1
407113|NCT00679783|1363502|P6|Overall Study|Adverse Event|0
407114|NCT00679783|1363503|P5|Overall Study|Adverse Event|0
407115|NCT00679783|1363504|P4|Overall Study|Adverse Event|3
407116|NCT00679783|1363505|P3|Overall Study|Adverse Event|0
407117|NCT00679783|1363506|P2|Overall Study|Adverse Event|0
407118|NCT00679783|1363507|P1|Overall Study|Adverse Event|0
407119|NCT00679627|1363560|P2|Overall Study|Early Study Closure|405
407120|NCT00679627|1363561|P1|Overall Study|Early Study Closure|425
407121|NCT00679627|1363560|P2|Overall Study|Lost to Follow-up|26
407122|NCT00679627|1363561|P1|Overall Study|Lost to Follow-up|22
407123|NCT00679627|1363560|P2|Overall Study|Withdrawal by Subject|172
407124|NCT00679627|1363561|P1|Overall Study|Withdrawal by Subject|168
407125|NCT00679627|1363560|P2|Overall Study|Adverse Event|53
407126|NCT00679627|1363561|P1|Overall Study|Adverse Event|43
407127|NCT00679627|1363560|P2|Overall Study|Death|29
407128|NCT00679627|1363561|P1|Overall Study|Death|41
407129|NCT00679432|1363587|P4|Overall Study|Randomization error, return to prior Rx|0
407130|NCT00679432|1363588|P3|Overall Study|Randomization error, return to prior Rx|3
407131|NCT00679432|1363589|P2|Overall Study|Randomization error, return to prior Rx|0
407132|NCT00679432|1363590|P1|Overall Study|Randomization error, return to prior Rx|0
407133|NCT00679432|1363587|P4|Overall Study|Infectious colitis, normal histology|3
407134|NCT00679432|1363588|P3|Overall Study|Infectious colitis, normal histology|8
407135|NCT00679432|1363589|P2|Overall Study|Infectious colitis, normal histology|4
407136|NCT00679432|1363590|P1|Overall Study|Infectious colitis, normal histology|5
407137|NCT00679432|1363587|P4|Overall Study|Lack of Efficacy|8
407138|NCT00679432|1363588|P3|Overall Study|Lack of Efficacy|14
407139|NCT00679432|1363589|P2|Overall Study|Lack of Efficacy|9
407140|NCT00679432|1363590|P1|Overall Study|Lack of Efficacy|13
407141|NCT00679432|1363587|P4|Overall Study|Sponsor decision|0
407142|NCT00679432|1363588|P3|Overall Study|Sponsor decision|0
407143|NCT00679432|1363589|P2|Overall Study|Sponsor decision|0
407144|NCT00679432|1363590|P1|Overall Study|Sponsor decision|1
407145|NCT00679432|1363587|P4|Overall Study|Physician Decision|2
407146|NCT00679432|1363588|P3|Overall Study|Physician Decision|2
407147|NCT00679432|1363589|P2|Overall Study|Physician Decision|2
407148|NCT00679432|1363590|P1|Overall Study|Physician Decision|3
407149|NCT00679432|1363587|P4|Overall Study|Lost to Follow-up|2
407150|NCT00679432|1363588|P3|Overall Study|Lost to Follow-up|4
407151|NCT00679432|1363589|P2|Overall Study|Lost to Follow-up|5
407152|NCT00679432|1363590|P1|Overall Study|Lost to Follow-up|1
407153|NCT00679432|1363587|P4|Overall Study|Withdrawal by Subject|9
407154|NCT00679432|1363588|P3|Overall Study|Withdrawal by Subject|10
407155|NCT00679432|1363589|P2|Overall Study|Withdrawal by Subject|11
407156|NCT00679432|1363590|P1|Overall Study|Withdrawal by Subject|8
407157|NCT00679432|1363587|P4|Overall Study|Protocol Violation|1
407158|NCT00679432|1363588|P3|Overall Study|Protocol Violation|2
407159|NCT00679432|1363589|P2|Overall Study|Protocol Violation|1
407160|NCT00679432|1363590|P1|Overall Study|Protocol Violation|1
407161|NCT00679432|1363587|P4|Overall Study|Adverse Event|7
407162|NCT00679432|1363588|P3|Overall Study|Adverse Event|10
407163|NCT00679432|1363589|P2|Overall Study|Adverse Event|6
407164|NCT00679432|1363590|P1|Overall Study|Adverse Event|5
407165|NCT00679367|1363633|P1|Overall Study|Withdrawal by Subject|1
407166|NCT00679367|1363633|P1|Overall Study|Lack of Efficacy|3
407167|NCT00679367|1363633|P1|Overall Study|inability to swallow oral drugs|1
407168|NCT00679367|1363633|P1|Overall Study|Adverse Event|7
407169|NCT00679354|1363639|P1|Overall Study|Ineligible|1
407170|NCT00679354|1363639|P1|Overall Study|Physician Decision|4
407171|NCT00679354|1363639|P1|Overall Study|Lack of Efficacy|22
407172|NCT00679354|1363639|P1|Overall Study|Death|3
407173|NCT00679341|1363645|P2|Overall Study|Physician/patient decision to withdraw|6
407174|NCT00679341|1363646|P1|Overall Study|Physician/patient decision to withdraw|0
407175|NCT00679341|1363645|P2|Overall Study|Not treated|2
407176|NCT00679341|1363646|P1|Overall Study|Not treated|0
407177|NCT00679341|1363645|P2|Overall Study|Physician Decision|0
407178|NCT00679341|1363646|P1|Overall Study|Physician Decision|1
407179|NCT00679341|1363645|P2|Overall Study|Not specified|0
407180|NCT00679341|1363646|P1|Overall Study|Not specified|1
407181|NCT00679341|1363645|P2|Overall Study|Death|1
407182|NCT00679341|1363646|P1|Overall Study|Death|1
407183|NCT00679341|1363645|P2|Overall Study|Subject/guardian decision to discontinue|0
407184|NCT00679341|1363646|P1|Overall Study|Subject/guardian decision to discontinue|3
407185|NCT00679341|1363645|P2|Overall Study|Adverse Event|6
407186|NCT00679341|1363646|P1|Overall Study|Adverse Event|5
407187|NCT00679341|1363645|P2|Overall Study|Disease progression|36
407188|NCT00679341|1363646|P1|Overall Study|Disease progression|42
407189|NCT00679302|1363666|P2|Overall Study|Lost to Follow-up|4
407190|NCT00679302|1363667|P1|Overall Study|Lost to Follow-up|8
407191|NCT00679289|1363678|P3|Overall Study|Physician Decision|1
407192|NCT00679289|1363679|P2|Overall Study|Physician Decision|0
407193|NCT00679289|1363680|P1|Overall Study|Physician Decision|1
407194|NCT00679289|1363678|P3|Overall Study|Adverse Event|3
407195|NCT00679289|1363679|P2|Overall Study|Adverse Event|0
407196|NCT00679289|1363680|P1|Overall Study|Adverse Event|0
407197|NCT00679289|1363678|P3|Overall Study|Withdrawal by Subject|1
407198|NCT00679289|1363679|P2|Overall Study|Withdrawal by Subject|1
407199|NCT00679289|1363680|P1|Overall Study|Withdrawal by Subject|0
407200|NCT00679289|1363678|P3|Overall Study|Progressive disease|18
407201|NCT00679289|1363679|P2|Overall Study|Progressive disease|5
407202|NCT00679289|1363680|P1|Overall Study|Progressive disease|4
407203|NCT00679263|1363702|P3|Visit 2/Dose 1|subject not compliance|0
407204|NCT00679263|1363703|P2|Visit 2/Dose 1|subject not compliance|1
407205|NCT00679263|1363704|P1|Visit 2/Dose 1|subject not compliance|1
407206|NCT00679263|1363702|P3|Visit 2/Dose 1|Adverse Event|0
407207|NCT00679263|1363703|P2|Visit 2/Dose 1|Adverse Event|0
407208|NCT00679263|1363704|P1|Visit 2/Dose 1|Adverse Event|1
407209|NCT00679211|1363715|P1|Overall Study|Other|1
407210|NCT00679211|1363715|P1|Overall Study|Transferred to extension study TDM4529g|12
407211|NCT00679211|1363715|P1|Overall Study|Refused to undergo protocol procedures|1
407212|NCT00679211|1363715|P1|Overall Study|Physician Decision|5
407213|NCT00679211|1363715|P1|Overall Study|Withdrawal by Subject|2
407214|NCT00679211|1363715|P1|Overall Study|Adverse Event|7
407215|NCT00679211|1363715|P1|Overall Study|Progressive disease|82
407216|NCT00679172|1363732|P5|Overall Study|Other not specified|0
407217|NCT00679172|1363733|P4|Overall Study|Other not specified|0
407218|NCT00679172|1363734|P3|Overall Study|Other not specified|1
407219|NCT00679172|1363735|P2|Overall Study|Other not specified|0
407220|NCT00679172|1363736|P1|Overall Study|Other not specified|0
407221|NCT00679172|1363732|P5|Overall Study|Non-compliance|0
407222|NCT00679172|1363733|P4|Overall Study|Non-compliance|1
407223|NCT00679172|1363734|P3|Overall Study|Non-compliance|0
407224|NCT00679172|1363735|P2|Overall Study|Non-compliance|1
407225|NCT00679172|1363736|P1|Overall Study|Non-compliance|1
407226|NCT00679081|1363799|P1|Overall Study|Lost to Follow-up|1
407227|NCT00679055|1363809|P2|Overall Study|Study Terminated|1
407228|NCT00679055|1363810|P1|Overall Study|Study Terminated|2
407229|NCT00679055|1363809|P2|Overall Study|Other|3
407230|NCT00679055|1363810|P1|Overall Study|Other|0
407231|NCT00679055|1363809|P2|Overall Study|Adverse Event|1
407232|NCT00679055|1363810|P1|Overall Study|Adverse Event|0
407233|NCT00678899|1363820|P1|Overall Study|Adverse Event|1
407234|NCT00678886|1363829|P4|Overall Study|Other|0
407235|NCT00678886|1363830|P3|Overall Study|Other|1
407236|NCT00678886|1363831|P2|Overall Study|Other|0
407237|NCT00678886|1363832|P1|Overall Study|Other|0
407238|NCT00678886|1363829|P4|Overall Study|Lost to Follow-up|2
407239|NCT00678886|1363830|P3|Overall Study|Lost to Follow-up|3
407240|NCT00678886|1363831|P2|Overall Study|Lost to Follow-up|0
407241|NCT00678886|1363832|P1|Overall Study|Lost to Follow-up|0
407242|NCT00678886|1363829|P4|Overall Study|Physician Decision|1
407243|NCT00678886|1363830|P3|Overall Study|Physician Decision|1
407244|NCT00678886|1363831|P2|Overall Study|Physician Decision|0
407245|NCT00678886|1363832|P1|Overall Study|Physician Decision|0
407246|NCT00678886|1363829|P4|Overall Study|Withdrawal by Subject|6
407247|NCT00678886|1363830|P3|Overall Study|Withdrawal by Subject|4
407248|NCT00678886|1363831|P2|Overall Study|Withdrawal by Subject|0
407249|NCT00678886|1363832|P1|Overall Study|Withdrawal by Subject|0
407250|NCT00678795|1363901|P2|Overall Study|Lack of Efficacy|1
407251|NCT00678795|1363902|P1|Overall Study|Lack of Efficacy|1
407252|NCT00678795|1363901|P2|Overall Study|Lost to Follow-up|1
407253|NCT00678795|1363902|P1|Overall Study|Lost to Follow-up|0
407254|NCT00678795|1363901|P2|Overall Study|Protocol Violation|1
407255|NCT00678795|1363902|P1|Overall Study|Protocol Violation|0
407256|NCT00678795|1363901|P2|Overall Study|Withdrawal by Subject|0
407257|NCT00678795|1363902|P1|Overall Study|Withdrawal by Subject|3
407258|NCT00678795|1363901|P2|Overall Study|Adverse Event|3
407259|NCT00678795|1363902|P1|Overall Study|Adverse Event|7
407260|NCT00678691|1363924|P2|Overall Study|Adverse Event|4
407261|NCT00678691|1363925|P1|Overall Study|Adverse Event|6
407262|NCT00678652|1363935|P4|Overall Study|Relocation|0
407263|NCT00678652|1363936|P3|Overall Study|Relocation|0
407264|NCT00678652|1363937|P2|Overall Study|Relocation|0
407265|NCT00678652|1363938|P1|Overall Study|Relocation|1
407266|NCT00678652|1363935|P4|Overall Study|Pregnancy|0
407267|NCT00678652|1363936|P3|Overall Study|Pregnancy|1
407268|NCT00678652|1363937|P2|Overall Study|Pregnancy|0
407269|NCT00678652|1363938|P1|Overall Study|Pregnancy|0
407270|NCT00678652|1363935|P4|Overall Study|Protocol Violation|0
407271|NCT00678652|1363936|P3|Overall Study|Protocol Violation|0
407272|NCT00678652|1363937|P2|Overall Study|Protocol Violation|0
407273|NCT00678652|1363938|P1|Overall Study|Protocol Violation|2
407274|NCT00678639|1363962|P2|Overall Study|Lost to Follow-up at 30 days|0
407275|NCT00678639|1363963|P1|Overall Study|Lost to Follow-up at 30 days|2
407276|NCT00678587|1363978|P2|Overall Study|Withdrew Consent|3
407277|NCT00678587|1363979|P1|Overall Study|Withdrew Consent|8
407278|NCT00678587|1363978|P2|Overall Study|Investigator Discretion|6
407279|NCT00678587|1363979|P1|Overall Study|Investigator Discretion|2
407280|NCT00678587|1363978|P2|Overall Study|Lost to Follow-up|5
407281|NCT00678587|1363979|P1|Overall Study|Lost to Follow-up|3
407282|NCT00678587|1363978|P2|Overall Study|Study Closed/Terminated|0
407283|NCT00678587|1363979|P1|Overall Study|Study Closed/Terminated|1
407284|NCT00678587|1363978|P2|Overall Study|Protocol Violation|1
407285|NCT00678587|1363979|P1|Overall Study|Protocol Violation|2
407286|NCT00678587|1363978|P2|Overall Study|Lack of Efficacy|0
407287|NCT00678587|1363979|P1|Overall Study|Lack of Efficacy|1
407288|NCT00678587|1363978|P2|Overall Study|Adverse Event|3
407289|NCT00678587|1363979|P1|Overall Study|Adverse Event|3
407290|NCT00678392|1364062|P2|Overall Study|Other|53
407291|NCT00678392|1364063|P1|Overall Study|Other|56
407292|NCT00678392|1364062|P2|Overall Study|Randomized But Not Treated|7
407293|NCT00678392|1364063|P1|Overall Study|Randomized But Not Treated|2
407294|NCT00678392|1364062|P2|Overall Study|Withdrawal by Subject|4
407295|NCT00678392|1364063|P1|Overall Study|Withdrawal by Subject|4
407296|NCT00678392|1364062|P2|Overall Study|Sponsor's Decision|2
407297|NCT00678392|1364063|P1|Overall Study|Sponsor's Decision|1
407298|NCT00678392|1364062|P2|Overall Study|Objective Progression or Relapse|8
407299|NCT00678392|1364063|P1|Overall Study|Objective Progression or Relapse|3
407300|NCT00678392|1364062|P2|Overall Study|Lost to Follow-up|13
407301|NCT00678392|1364063|P1|Overall Study|Lost to Follow-up|15
407302|NCT00678392|1364062|P2|Overall Study|Death|269
407303|NCT00678392|1364063|P1|Overall Study|Death|280
407304|NCT00678392|1364062|P2|Overall Study|Adverse Event|6
407305|NCT00678392|1364063|P1|Overall Study|Adverse Event|0
407306|NCT00678379|1364098|P3|Overall Study|Incomplete Data|3
407307|NCT00678379|1364099|P2|Overall Study|Incomplete Data|3
407308|NCT00678379|1364100|P1|Overall Study|Incomplete Data|4
407309|NCT00678379|1364098|P3|Overall Study|Injection performed after tonsillectomy|1
407310|NCT00678379|1364099|P2|Overall Study|Injection performed after tonsillectomy|0
407311|NCT00678379|1364100|P1|Overall Study|Injection performed after tonsillectomy|2
407312|NCT00678301|1364128|P2|Overall Study|Lost to Follow-up|1
407313|NCT00678301|1364129|P1|Overall Study|Lost to Follow-up|3
407314|NCT00678301|1364128|P2|Overall Study|Withdrawal by Subject|0
407315|NCT00678301|1364129|P1|Overall Study|Withdrawal by Subject|4
407316|NCT00678301|1364128|P2|Overall Study|Adverse Event|0
407317|NCT00678301|1364129|P1|Overall Study|Adverse Event|1
407318|NCT00678301|1364128|P2|Overall Study|Non-compliance with study procedures|1
407319|NCT00678301|1364129|P1|Overall Study|Non-compliance with study procedures|0
407320|NCT00678288|1364187|P2|Overall Study|Disease progression/recurrence/relapse|1
407321|NCT00678288|1364188|P1|Overall Study|Disease progression/recurrence/relapse|6
407322|NCT00678288|1364187|P2|Overall Study|Reason not reported|0
407323|NCT00678288|1364188|P1|Overall Study|Reason not reported|1
407324|NCT00678288|1364187|P2|Overall Study|Switch to commercial drug|1
407325|NCT00678288|1364188|P1|Overall Study|Switch to commercial drug|0
407326|NCT00678288|1364187|P2|Overall Study|Not compliant with study medication|1
407327|NCT00678288|1364188|P1|Overall Study|Not compliant with study medication|0
407328|NCT00678288|1364187|P2|Overall Study|Study terminated by the sponsor|0
407329|NCT00678288|1364188|P1|Overall Study|Study terminated by the sponsor|2
407330|NCT00678288|1364187|P2|Overall Study|Withdrawal by Subject|1
407331|NCT00678288|1364188|P1|Overall Study|Withdrawal by Subject|1
407332|NCT00678288|1364187|P2|Overall Study|Adverse Event|2
407333|NCT00678288|1364188|P1|Overall Study|Adverse Event|0
407334|NCT00678210|1364243|P4|Overall Study|Other|0
407335|NCT00678210|1364244|P3|Overall Study|Other|1
407336|NCT00678210|1364245|P2|Overall Study|Other|0
407337|NCT00678210|1364246|P1|Overall Study|Other|1
407338|NCT00678210|1364243|P4|Overall Study|Withdrawal by Subject|7
407339|NCT00678210|1364244|P3|Overall Study|Withdrawal by Subject|1
407340|NCT00678210|1364245|P2|Overall Study|Withdrawal by Subject|4
407341|NCT00678210|1364246|P1|Overall Study|Withdrawal by Subject|3
407342|NCT00678210|1364243|P4|Overall Study|Lost to Follow-up|1
407343|NCT00678210|1364244|P3|Overall Study|Lost to Follow-up|0
407344|NCT00678210|1364245|P2|Overall Study|Lost to Follow-up|2
407345|NCT00678210|1364246|P1|Overall Study|Lost to Follow-up|4
407346|NCT00678210|1364243|P4|Overall Study|Lack of Efficacy|9
407347|NCT00678210|1364244|P3|Overall Study|Lack of Efficacy|1
407348|NCT00678210|1364245|P2|Overall Study|Lack of Efficacy|3
407349|NCT00678210|1364246|P1|Overall Study|Lack of Efficacy|2
407350|NCT00678210|1364243|P4|Overall Study|Adverse Event|3
407351|NCT00678210|1364244|P3|Overall Study|Adverse Event|3
407352|NCT00678210|1364245|P2|Overall Study|Adverse Event|2
407353|NCT00678210|1364246|P1|Overall Study|Adverse Event|1
407354|NCT00678041|1364282|P2|Overall Study|Physician Decision|5
407355|NCT00678041|1364283|P1|Overall Study|Physician Decision|5
407356|NCT00677833|1364336|P4|Overall Study|Lost to Follow-up|0
407357|NCT00677833|1364337|P3|Overall Study|Lost to Follow-up|1
407358|NCT00677833|1364338|P2|Overall Study|Lost to Follow-up|0
407359|NCT00677833|1364339|P1|Overall Study|Lost to Follow-up|0
407360|NCT00677833|1364336|P4|Overall Study|Withdrawal by Subject|3
407361|NCT00677833|1364337|P3|Overall Study|Withdrawal by Subject|1
407362|NCT00677833|1364338|P2|Overall Study|Withdrawal by Subject|0
407363|NCT00677833|1364339|P1|Overall Study|Withdrawal by Subject|4
407364|NCT00677820|1364389|P2|Overall Study|Lost to Follow-up|0
407365|NCT00677820|1364390|P1|Overall Study|Lost to Follow-up|1
407366|NCT00677807|1364411|P3|Overall Study|Protocol Deviation|0
407367|NCT00677807|1364412|P2|Overall Study|Protocol Deviation|3
407368|NCT00677807|1364413|P1|Overall Study|Protocol Deviation|1
407369|NCT00677807|1364411|P3|Overall Study|Death|1
407370|NCT00677807|1364412|P2|Overall Study|Death|1
407371|NCT00677807|1364413|P1|Overall Study|Death|0
407372|NCT00677807|1364411|P3|Overall Study|Administrative problems|2
407373|NCT00677807|1364412|P2|Overall Study|Administrative problems|1
407374|NCT00677807|1364413|P1|Overall Study|Administrative problems|1
407375|NCT00677807|1364411|P3|Overall Study|Lost to Follow-up|2
407376|NCT00677807|1364412|P2|Overall Study|Lost to Follow-up|2
407377|NCT00677807|1364413|P1|Overall Study|Lost to Follow-up|2
407378|NCT00677807|1364411|P3|Overall Study|Withdrawal by Subject|6
407379|NCT00677807|1364412|P2|Overall Study|Withdrawal by Subject|3
407380|NCT00677807|1364413|P1|Overall Study|Withdrawal by Subject|10
407381|NCT00677807|1364411|P3|Overall Study|Participant no longer needs study drug|1
407382|NCT00677807|1364412|P2|Overall Study|Participant no longer needs study drug|0
407383|NCT00677807|1364413|P1|Overall Study|Participant no longer needs study drug|0
407384|NCT00677807|1364411|P3|Overall Study|Lack of Efficacy|2
407385|NCT00677807|1364412|P2|Overall Study|Lack of Efficacy|0
407386|NCT00677807|1364413|P1|Overall Study|Lack of Efficacy|0
407387|NCT00677807|1364411|P3|Overall Study|Adverse Event|6
407388|NCT00677807|1364412|P2|Overall Study|Adverse Event|1
407389|NCT00677807|1364413|P1|Overall Study|Adverse Event|4
407390|NCT00677534|1364459|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
407391|NCT00677534|1364459|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
407392|NCT00677534|1364459|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
407393|NCT00677365|1364467|P4|Overall Study|Other reason|1
407394|NCT00677365|1364468|P3|Overall Study|Other reason|0
407395|NCT00677365|1364469|P2|Overall Study|Other reason|0
407396|NCT00677365|1364470|P1|Overall Study|Other reason|0
407397|NCT00677365|1364467|P4|Overall Study|Withdrawal by Subject|0
407398|NCT00677365|1364468|P3|Overall Study|Withdrawal by Subject|1
407399|NCT00677365|1364469|P2|Overall Study|Withdrawal by Subject|0
407400|NCT00677365|1364470|P1|Overall Study|Withdrawal by Subject|0
407401|NCT00677365|1364467|P4|Overall Study|Adverse Event|2
407402|NCT00677365|1364468|P3|Overall Study|Adverse Event|1
407403|NCT00677365|1364469|P2|Overall Study|Adverse Event|1
407404|NCT00677365|1364470|P1|Overall Study|Adverse Event|2
407405|NCT00677352|1364502|P2|Tapering Phase|Job transfer|1
407406|NCT00677352|1364503|P1|Tapering Phase|Job transfer|0
407407|NCT00677352|1364502|P2|Tapering Phase|Pregnancy|1
407408|NCT00677352|1364503|P1|Tapering Phase|Pregnancy|0
407409|NCT00677352|1364502|P2|Tapering Phase|Withdrawal by Subject|3
407410|NCT00677352|1364503|P1|Tapering Phase|Withdrawal by Subject|5
407411|NCT00677352|1364502|P2|Tapering Phase|Adverse Event|5
407412|NCT00677352|1364503|P1|Tapering Phase|Adverse Event|1
407413|NCT00677352|1364502|P2|Treatment Phase|Not treated|2
407414|NCT00677352|1364503|P1|Treatment Phase|Not treated|0
407415|NCT00677352|1364502|P2|Treatment Phase|Transference or work related matter|5
407416|NCT00677352|1364503|P1|Treatment Phase|Transference or work related matter|0
407417|NCT00677352|1364502|P2|Treatment Phase|Protocol Violation|1
407418|NCT00677352|1364503|P1|Treatment Phase|Protocol Violation|1
407419|NCT00677352|1364502|P2|Treatment Phase|Pregnancy|1
407420|NCT00677352|1364503|P1|Treatment Phase|Pregnancy|0
407421|NCT00677352|1364502|P2|Treatment Phase|Physician Decision|0
407422|NCT00677352|1364503|P1|Treatment Phase|Physician Decision|1
407423|NCT00677352|1364502|P2|Treatment Phase|Withdrawal by Subject|7
407424|NCT00677352|1364503|P1|Treatment Phase|Withdrawal by Subject|7
407425|NCT00677352|1364502|P2|Treatment Phase|Lost to Follow-up|1
407426|NCT00677352|1364503|P1|Treatment Phase|Lost to Follow-up|0
407427|NCT00677352|1364502|P2|Treatment Phase|Lack of Efficacy|3
407428|NCT00677352|1364503|P1|Treatment Phase|Lack of Efficacy|2
407429|NCT00677352|1364502|P2|Treatment Phase|Adverse Event|22
407430|NCT00677352|1364503|P1|Treatment Phase|Adverse Event|14
407431|NCT00677235|1364523|P2|Overall Study|Adverse Experience|0
407432|NCT00677235|1364524|P1|Overall Study|Adverse Experience|1
407433|NCT00677235|1364523|P2|Overall Study|Death|36
407434|NCT00677235|1364524|P1|Overall Study|Death|37
407435|NCT00677235|1364523|P2|Overall Study|Lost to Follow-up|1
407436|NCT00677235|1364524|P1|Overall Study|Lost to Follow-up|2
407437|NCT00677235|1364523|P2|Overall Study|Withdrawal by Subject|1
407438|NCT00677235|1364524|P1|Overall Study|Withdrawal by Subject|1
407439|NCT00677092|1364564|P1|Overall Study|Death Prior to Receiving Treatment|1
407440|NCT00677092|1364564|P1|Overall Study|Withdrawal by Subject|3
407441|NCT00677092|1364564|P1|Overall Study|Lost to Follow-up|1
407442|NCT00677092|1364564|P1|Overall Study|Adverse Event|1
407443|NCT00677014|1364581|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
407444|NCT00677014|1364582|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
407445|NCT00677014|1364583|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
407446|NCT00677014|1364581|P3|Overall Study|Death|7
407447|NCT00677014|1364582|P2|Overall Study|Death|15
407448|NCT00677014|1364583|P1|Overall Study|Death|6
407449|NCT00677014|1364581|P3|Overall Study|Lost to Follow-up|24
407450|NCT00677014|1364582|P2|Overall Study|Lost to Follow-up|12
407451|NCT00677014|1364583|P1|Overall Study|Lost to Follow-up|20
407452|NCT00676715|1364636|P4|Overall Study|Participants Ongoing|24
407453|NCT00676715|1364637|P3|Overall Study|Participants Ongoing|17
407454|NCT00676715|1364638|P2|Overall Study|Participants Ongoing|29
407455|NCT00676715|1364639|P1|Overall Study|Participants Ongoing|29
407456|NCT00676715|1364636|P4|Overall Study|Adverse Event|0
407457|NCT00676715|1364637|P3|Overall Study|Adverse Event|2
407458|NCT00676715|1364638|P2|Overall Study|Adverse Event|1
407459|NCT00676715|1364639|P1|Overall Study|Adverse Event|0
407460|NCT00676715|1364636|P4|Overall Study|Death|0
407461|NCT00676715|1364637|P3|Overall Study|Death|1
407462|NCT00676715|1364638|P2|Overall Study|Death|1
407463|NCT00676715|1364639|P1|Overall Study|Death|1
407464|NCT00676715|1364636|P4|Overall Study|Lost to Follow-up|3
407465|NCT00676715|1364637|P3|Overall Study|Lost to Follow-up|7
407466|NCT00676715|1364638|P2|Overall Study|Lost to Follow-up|1
407467|NCT00676715|1364639|P1|Overall Study|Lost to Follow-up|1
407468|NCT00676715|1364636|P4|Overall Study|Other|3
407469|NCT00676715|1364637|P3|Overall Study|Other|4
407470|NCT00676715|1364638|P2|Overall Study|Other|6
407471|NCT00676715|1364639|P1|Overall Study|Other|2
407472|NCT00676715|1364636|P4|Overall Study|Withdrawal by Subject|10
407473|NCT00676715|1364637|P3|Overall Study|Withdrawal by Subject|10
407474|NCT00676715|1364638|P2|Overall Study|Withdrawal by Subject|9
407475|NCT00676715|1364639|P1|Overall Study|Withdrawal by Subject|7
407476|NCT00676689|1364669|P1|Overall Study|Continuing FU|49
407477|NCT00676689|1364669|P1|Overall Study|Withdrawal by Subject|3
407478|NCT00676689|1364669|P1|Overall Study|Physician Decision|1
407479|NCT00676689|1364669|P1|Overall Study|Lost to Follow-up|4
407480|NCT00676689|1364669|P1|Overall Study|Death|2
407481|NCT00676689|1364669|P1|Overall Study|Screen Failure|2
407482|NCT00676650|1364681|P2|Overall Study|Randomized but not treated|4
407483|NCT00676650|1364682|P1|Overall Study|Randomized but not treated|3
407484|NCT00676650|1364681|P2|Overall Study|Withdrawal by Subject|24
407485|NCT00676650|1364682|P1|Overall Study|Withdrawal by Subject|48
407486|NCT00676650|1364681|P2|Overall Study|Study terminated by sponsor|43
407487|NCT00676650|1364682|P1|Overall Study|Study terminated by sponsor|57
407488|NCT00676650|1364681|P2|Overall Study|Protocol Violation|1
407489|NCT00676650|1364682|P1|Overall Study|Protocol Violation|3
407490|NCT00676650|1364681|P2|Overall Study|Other|10
407491|NCT00676650|1364682|P1|Overall Study|Other|14
407492|NCT00676650|1364681|P2|Overall Study|Objective progression or relapse|140
407493|NCT00676650|1364682|P1|Overall Study|Objective progression or relapse|189
407494|NCT00676650|1364681|P2|Overall Study|Lost to Follow-up|1
407495|NCT00676650|1364682|P1|Overall Study|Lost to Follow-up|0
407496|NCT00676650|1364681|P2|Overall Study|Global deterioration of health status|31
407497|NCT00676650|1364682|P1|Overall Study|Global deterioration of health status|66
407498|NCT00676650|1364681|P2|Overall Study|Adverse Event|21
407499|NCT00676650|1364682|P1|Overall Study|Adverse Event|159
407500|NCT00676650|1364681|P2|Overall Study|Death|14
407501|NCT00676650|1364682|P1|Overall Study|Death|45
407502|NCT00676520|1364713|P1|Overall Study|Other Reason|18
407503|NCT00676520|1364713|P1|Overall Study|Ineligible for Randomization to DAPT|209
407504|NCT00676520|1364713|P1|Overall Study|Physician Decision|20
407505|NCT00676520|1364713|P1|Overall Study|Death|159
407506|NCT00676520|1364713|P1|Overall Study|Lost to Follow-up|162
407507|NCT00676520|1364713|P1|Overall Study|Withdrawal by Subject|163
407508|NCT00676494|1364770|P1|Overall Study|Withdrawal by Subject|6
407509|NCT00676494|1364770|P1|Overall Study|Missed Visit|8
407510|NCT00676403|1364787|P6|Overall Study|Withdrawal by Subject|1
407511|NCT00676403|1364788|P5|Overall Study|Withdrawal by Subject|0
407512|NCT00676403|1364789|P4|Overall Study|Withdrawal by Subject|0
407513|NCT00676403|1364790|P3|Overall Study|Withdrawal by Subject|0
407514|NCT00676403|1364791|P2|Overall Study|Withdrawal by Subject|0
407515|NCT00676403|1364792|P1|Overall Study|Withdrawal by Subject|0
407516|NCT00676403|1364787|P6|Overall Study|Reason Unspecified|1
407517|NCT00676403|1364788|P5|Overall Study|Reason Unspecified|0
407518|NCT00676403|1364789|P4|Overall Study|Reason Unspecified|0
407519|NCT00676403|1364790|P3|Overall Study|Reason Unspecified|1
407520|NCT00676403|1364791|P2|Overall Study|Reason Unspecified|0
407521|NCT00676403|1364792|P1|Overall Study|Reason Unspecified|1
407522|NCT00676403|1364787|P6|Overall Study|Lost to Follow-up|1
407523|NCT00676403|1364788|P5|Overall Study|Lost to Follow-up|0
407524|NCT00676403|1364789|P4|Overall Study|Lost to Follow-up|0
407525|NCT00676403|1364790|P3|Overall Study|Lost to Follow-up|0
407526|NCT00676403|1364791|P2|Overall Study|Lost to Follow-up|0
407527|NCT00676403|1364792|P1|Overall Study|Lost to Follow-up|0
407528|NCT00676403|1364787|P6|Overall Study|Adverse Event|2
407529|NCT00676403|1364788|P5|Overall Study|Adverse Event|1
407530|NCT00676403|1364789|P4|Overall Study|Adverse Event|5
407531|NCT00676403|1364790|P3|Overall Study|Adverse Event|0
407532|NCT00676403|1364791|P2|Overall Study|Adverse Event|2
407533|NCT00676403|1364792|P1|Overall Study|Adverse Event|1
407534|NCT00676338|1364935|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
407535|NCT00676338|1364936|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
407536|NCT00676338|1364937|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
407537|NCT00676338|1364938|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
407538|NCT00676338|1364935|P4|Overall Study|Entry Criteria Not Met|1
407539|NCT00676338|1364936|P3|Overall Study|Entry Criteria Not Met|1
407540|NCT00676338|1364937|P2|Overall Study|Entry Criteria Not Met|2
407541|NCT00676338|1364938|P1|Overall Study|Entry Criteria Not Met|0
407542|NCT00676338|1364935|P4|Overall Study|Withdrawal by Subject|6
407543|NCT00676338|1364936|P3|Overall Study|Withdrawal by Subject|12
407544|NCT00676338|1364937|P2|Overall Study|Withdrawal by Subject|9
407545|NCT00676338|1364938|P1|Overall Study|Withdrawal by Subject|17
407546|NCT00676338|1364935|P4|Overall Study|Protocol Violation|5
407547|NCT00676338|1364936|P3|Overall Study|Protocol Violation|2
407548|NCT00676338|1364937|P2|Overall Study|Protocol Violation|9
407549|NCT00676338|1364938|P1|Overall Study|Protocol Violation|5
407550|NCT00676338|1364935|P4|Overall Study|Physician Decision|3
407551|NCT00676338|1364936|P3|Overall Study|Physician Decision|2
407552|NCT00676338|1364937|P2|Overall Study|Physician Decision|3
407553|NCT00676338|1364938|P1|Overall Study|Physician Decision|3
407554|NCT00676338|1364935|P4|Overall Study|Lost to Follow-up|4
407555|NCT00676338|1364936|P3|Overall Study|Lost to Follow-up|3
407556|NCT00676338|1364937|P2|Overall Study|Lost to Follow-up|1
407557|NCT00676338|1364938|P1|Overall Study|Lost to Follow-up|4
407558|NCT00676338|1364935|P4|Overall Study|Adverse Event|1
407559|NCT00676338|1364936|P3|Overall Study|Adverse Event|5
407560|NCT00676338|1364937|P2|Overall Study|Adverse Event|6
407561|NCT00676338|1364938|P1|Overall Study|Adverse Event|6
407562|NCT00676208|1364990|P2|Overall Study|Incomplete data|4
407563|NCT00676208|1364991|P1|Overall Study|Incomplete data|2
407564|NCT00676208|1364990|P2|Overall Study|Lost to Follow-up|2
407565|NCT00676208|1364991|P1|Overall Study|Lost to Follow-up|0
407566|NCT00676195|1364999|P1|Overall Study|Physician Decision|1
407567|NCT00676195|1364999|P1|Overall Study|Adverse Event|1
407568|NCT00676195|1364999|P1|Overall Study|Lost to Follow-up|1
407569|NCT00676143|1365024|P2|Overall Study|Vasogenic edema recurrence|3
407570|NCT00676143|1365025|P1|Overall Study|Vasogenic edema recurrence|1
407571|NCT00676143|1365024|P2|Overall Study|Participant participation unknown|4
407572|NCT00676143|1365025|P1|Overall Study|Participant participation unknown|1
407573|NCT00676143|1365024|P2|Overall Study|Not specified|20
407574|NCT00676143|1365025|P1|Overall Study|Not specified|11
407575|NCT00676143|1365024|P2|Overall Study|Loss of caregiver|3
407576|NCT00676143|1365025|P1|Overall Study|Loss of caregiver|5
407577|NCT00676143|1365024|P2|Overall Study|Failed to return|1
407578|NCT00676143|1365025|P1|Overall Study|Failed to return|2
407579|NCT00676143|1365024|P2|Overall Study|Discontinuation of study by sponsor|88
407580|NCT00676143|1365025|P1|Overall Study|Discontinuation of study by sponsor|65
407581|NCT00676143|1365024|P2|Overall Study|Withdrawal by Subject|42
407582|NCT00676143|1365025|P1|Overall Study|Withdrawal by Subject|24
407583|NCT00676143|1365024|P2|Overall Study|Protocol Violation|8
407584|NCT00676143|1365025|P1|Overall Study|Protocol Violation|4
407585|NCT00676143|1365024|P2|Overall Study|Physician Decision|8
407586|NCT00676143|1365025|P1|Overall Study|Physician Decision|5
407587|NCT00676143|1365024|P2|Overall Study|Lost to Follow-up|13
407588|NCT00676143|1365025|P1|Overall Study|Lost to Follow-up|0
407589|NCT00676143|1365024|P2|Overall Study|Lack of Efficacy|6
407590|NCT00676143|1365025|P1|Overall Study|Lack of Efficacy|0
407591|NCT00676143|1365024|P2|Overall Study|Death|4
407592|NCT00676143|1365025|P1|Overall Study|Death|4
407593|NCT00676143|1365024|P2|Overall Study|Adverse Event|60
407594|NCT00676143|1365025|P1|Overall Study|Adverse Event|34
407595|NCT00676130|1365065|P2|Overall Study|Withdrawal by Subject|1
407596|NCT00676130|1365066|P1|Overall Study|Withdrawal by Subject|0
407597|NCT00676130|1365065|P2|Overall Study|Found ineligible|2
407598|NCT00676130|1365066|P1|Overall Study|Found ineligible|3
407599|NCT00676130|1365065|P2|Overall Study|Lost to Follow-up|1
407600|NCT00676130|1365066|P1|Overall Study|Lost to Follow-up|0
407601|NCT00676091|1365076|P2|Toddler Dose|Parent or legal guardian request|0
407602|NCT00676091|1365077|P1|Toddler Dose|Parent or legal guardian request|1
407603|NCT00676091|1365076|P2|Toddler Dose|Failed to return|0
407604|NCT00676091|1365077|P1|Toddler Dose|Failed to return|2
407605|NCT00676091|1365076|P2|After Infant Series|Failed to return|1
407606|NCT00676091|1365077|P1|After Infant Series|Failed to return|1
407607|NCT00676091|1365076|P2|After Infant Series|Protocol Violation|1
407608|NCT00676091|1365077|P1|After Infant Series|Protocol Violation|0
407609|NCT00676091|1365076|P2|After Infant Series|Adverse Event|1
407610|NCT00676091|1365077|P1|After Infant Series|Adverse Event|0
407611|NCT00676091|1365076|P2|Infant Series|Died prior to receiving 7vPnC|1
407612|NCT00676091|1365077|P1|Infant Series|Died prior to receiving 7vPnC|0
407613|NCT00676091|1365076|P2|Infant Series|Lost to Follow-up|0
407614|NCT00676091|1365077|P1|Infant Series|Lost to Follow-up|1
407615|NCT00676091|1365076|P2|Infant Series|Failed to return|3
407616|NCT00676091|1365077|P1|Infant Series|Failed to return|1
407617|NCT00676091|1365076|P2|Infant Series|Adverse Event|3
407618|NCT00676091|1365077|P1|Infant Series|Adverse Event|2
407619|NCT00676091|1365076|P2|Infant Series|Protocol Violation|3
407620|NCT00676091|1365077|P1|Infant Series|Protocol Violation|6
407621|NCT00676091|1365076|P2|Infant Series|Parent or legal guardian request|8
407622|NCT00676091|1365077|P1|Infant Series|Parent or legal guardian request|10
407623|NCT00676052|1365134|P6|Overall Study|Withdrawal by Subject|0
407624|NCT00676052|1365135|P5|Overall Study|Withdrawal by Subject|0
407625|NCT00676052|1365136|P4|Overall Study|Withdrawal by Subject|0
407626|NCT00676052|1365137|P3|Overall Study|Withdrawal by Subject|1
407627|NCT00676052|1365138|P2|Overall Study|Withdrawal by Subject|0
407628|NCT00676052|1365139|P1|Overall Study|Withdrawal by Subject|1
407629|NCT00676052|1365134|P6|Overall Study|Physician Decision|1
407630|NCT00676052|1365135|P5|Overall Study|Physician Decision|0
407631|NCT00676052|1365136|P4|Overall Study|Physician Decision|0
407632|NCT00676052|1365137|P3|Overall Study|Physician Decision|1
407633|NCT00676052|1365138|P2|Overall Study|Physician Decision|1
407634|NCT00676052|1365139|P1|Overall Study|Physician Decision|1
407635|NCT00676052|1365134|P6|Overall Study|Lost to Follow-up|0
407636|NCT00676052|1365135|P5|Overall Study|Lost to Follow-up|1
407637|NCT00676052|1365136|P4|Overall Study|Lost to Follow-up|0
407638|NCT00676052|1365137|P3|Overall Study|Lost to Follow-up|0
407639|NCT00676052|1365138|P2|Overall Study|Lost to Follow-up|0
407640|NCT00676052|1365139|P1|Overall Study|Lost to Follow-up|0
407641|NCT00676052|1365134|P6|Overall Study|Protocol Violation|2
407642|NCT00676052|1365135|P5|Overall Study|Protocol Violation|1
407643|NCT00676052|1365136|P4|Overall Study|Protocol Violation|2
407644|NCT00676052|1365137|P3|Overall Study|Protocol Violation|2
407645|NCT00676052|1365138|P2|Overall Study|Protocol Violation|3
407646|NCT00676052|1365139|P1|Overall Study|Protocol Violation|5
407647|NCT00676052|1365134|P6|Overall Study|Lack of Efficacy|1
407648|NCT00676052|1365135|P5|Overall Study|Lack of Efficacy|2
407649|NCT00676052|1365136|P4|Overall Study|Lack of Efficacy|1
407650|NCT00676052|1365137|P3|Overall Study|Lack of Efficacy|1
407651|NCT00676052|1365138|P2|Overall Study|Lack of Efficacy|2
407652|NCT00676052|1365139|P1|Overall Study|Lack of Efficacy|2
407653|NCT00676052|1365134|P6|Overall Study|Adverse Event|2
407654|NCT00676052|1365135|P5|Overall Study|Adverse Event|2
407655|NCT00676052|1365136|P4|Overall Study|Adverse Event|2
407656|NCT00676052|1365137|P3|Overall Study|Adverse Event|1
407657|NCT00676052|1365138|P2|Overall Study|Adverse Event|1
407658|NCT00676052|1365139|P1|Overall Study|Adverse Event|0
407659|NCT00675948|1365188|P2|Overall Study|Patient feels unable to take medication|1
407660|NCT00675948|1365189|P1|Overall Study|Patient feels unable to take medication|0
407661|NCT00675948|1365188|P2|Overall Study|Patient unable to comply with diaries|0
407662|NCT00675948|1365189|P1|Overall Study|Patient unable to comply with diaries|1
407663|NCT00675948|1365188|P2|Overall Study|Patient died|0
407664|NCT00675948|1365189|P1|Overall Study|Patient died|1
407665|NCT00675948|1365188|P2|Overall Study|Sponsor decision|1
407666|NCT00675948|1365189|P1|Overall Study|Sponsor decision|0
407667|NCT00675948|1365188|P2|Overall Study|Pain under control|0
407668|NCT00675948|1365189|P1|Overall Study|Pain under control|1
407669|NCT00675948|1365188|P2|Overall Study|Protocol Violation|0
407670|NCT00675948|1365189|P1|Overall Study|Protocol Violation|1
407671|NCT00675948|1365188|P2|Overall Study|Lost to Follow-up|0
407672|NCT00675948|1365189|P1|Overall Study|Lost to Follow-up|2
407673|NCT00675948|1365188|P2|Overall Study|Withdrawal by Subject|0
407674|NCT00675948|1365189|P1|Overall Study|Withdrawal by Subject|7
407675|NCT00675948|1365188|P2|Overall Study|Lack of Efficacy|0
407676|NCT00675948|1365189|P1|Overall Study|Lack of Efficacy|3
407677|NCT00675948|1365188|P2|Overall Study|Adverse Event|1
407678|NCT00675948|1365189|P1|Overall Study|Adverse Event|23
407679|NCT00675766|1365240|P4|Overall Study|Lost to Follow-up|26
407680|NCT00675766|1365241|P3|Overall Study|Lost to Follow-up|21
407681|NCT00675766|1365242|P2|Overall Study|Lost to Follow-up|5
407682|NCT00675766|1365243|P1|Overall Study|Lost to Follow-up|6
407683|NCT00675597|1365253|P1|Overall Study|Withdrawal by Subject|3
407684|NCT00675506|1365307|P2|Overall Study|Schedule conflict|1
407685|NCT00675506|1365308|P1|Overall Study|Schedule conflict|0
407686|NCT00675506|1365307|P2|Overall Study|Declined participation|0
407687|NCT00675506|1365308|P1|Overall Study|Declined participation|1
407688|NCT00675506|1365307|P2|Overall Study|Disclosed history of cancer|0
407689|NCT00675506|1365308|P1|Overall Study|Disclosed history of cancer|1
407690|NCT00675506|1365307|P2|Overall Study|Hypersensitivity Reaction|0
407691|NCT00675506|1365308|P1|Overall Study|Hypersensitivity Reaction|1
407692|NCT00675506|1365307|P2|Overall Study|Elevated IGF-1|0
407693|NCT00675506|1365308|P1|Overall Study|Elevated IGF-1|2
407694|NCT00675506|1365307|P2|Overall Study|Elevated IGF-1 prior to treatment|0
407695|NCT00675506|1365308|P1|Overall Study|Elevated IGF-1 prior to treatment|1
407696|NCT00675506|1365307|P2|Overall Study|Elevated fasting glucose|1
407697|NCT00675506|1365308|P1|Overall Study|Elevated fasting glucose|2
407698|NCT00675506|1365307|P2|Overall Study|Lost interest|5
407699|NCT00675506|1365308|P1|Overall Study|Lost interest|3
407700|NCT00675506|1365307|P2|Overall Study|Lost to Follow-up|5
407701|NCT00675506|1365308|P1|Overall Study|Lost to Follow-up|1
407702|NCT00675441|1365324|P1|Overall Study|Death|1
407703|NCT00675441|1365324|P1|Overall Study|Withdrawal by Subject|2
407704|NCT00675428|1365330|P2|Overall Study|Physician Decision|0
407705|NCT00675428|1365331|P1|Overall Study|Physician Decision|1
407706|NCT00675428|1365330|P2|Overall Study|No Disease Response After Cycle 6|1
407707|NCT00675428|1365331|P1|Overall Study|No Disease Response After Cycle 6|0
407708|NCT00675428|1365330|P2|Overall Study|Disease Progression|2
407709|NCT00675428|1365331|P1|Overall Study|Disease Progression|2
407710|NCT00675103|1365373|P1|Overall Study|Adverse Event|1
407711|NCT00675103|1365373|P1|Overall Study|Lack of Efficacy|2
407712|NCT00674986|1365380|P2|Overall Study|Other reasons|8
407713|NCT00674986|1365381|P1|Overall Study|Other reasons|4
407714|NCT00674986|1365380|P2|Overall Study|Lost to Follow-up|53
407715|NCT00674986|1365381|P1|Overall Study|Lost to Follow-up|25
407716|NCT00674986|1365380|P2|Overall Study|Subject withdrew consent|19
407717|NCT00674986|1365381|P1|Overall Study|Subject withdrew consent|12
407718|NCT00674986|1365380|P2|Overall Study|Adverse Event|1
407719|NCT00674986|1365381|P1|Overall Study|Adverse Event|2
407720|NCT00674973|1365402|P2|Overall Study|Protocol Violation|1
407721|NCT00674973|1365403|P1|Overall Study|Protocol Violation|0
407722|NCT00674973|1365402|P2|Overall Study|Death|15
407723|NCT00674973|1365403|P1|Overall Study|Death|19
407724|NCT00674973|1365402|P2|Overall Study|Adverse Event|9
407725|NCT00674973|1365403|P1|Overall Study|Adverse Event|2
407726|NCT00674973|1365402|P2|Overall Study|Failure to Return|0
407727|NCT00674973|1365403|P1|Overall Study|Failure to Return|1
407728|NCT00674973|1365402|P2|Overall Study|Refused Treatment|5
407729|NCT00674973|1365403|P1|Overall Study|Refused Treatment|1
407730|NCT00674973|1365402|P2|Overall Study|Insufficient Therapeutic Response|72
407731|NCT00674973|1365403|P1|Overall Study|Insufficient Therapeutic Response|77
407732|NCT00674817|1365417|P1|Period 4|Adverse Event|1
407733|NCT00674817|1365417|P1|Period 3|Protocol Violation|1
407734|NCT00674817|1365417|P1|Period 3|Adverse Event|1
407735|NCT00674817|1365417|P1|Period 1|Protocol Violation|1
407736|NCT00674817|1365417|P1|Period 1|Withdrawal by Subject|2
407737|NCT00674700|1365594|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
407738|NCT00674700|1365595|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
407739|NCT00674700|1365596|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
407740|NCT00674700|1365594|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
407741|NCT00674700|1365595|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
407742|NCT00674700|1365596|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
407743|NCT00674700|1365594|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
407744|NCT00674700|1365595|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
407745|NCT00674700|1365596|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
407746|NCT00674700|1365594|P3|Year 1|Any other reason not above-mentioned|6
407747|NCT00674700|1365595|P2|Year 1|Any other reason not above-mentioned|7
407748|NCT00674700|1365596|P1|Year 1|Any other reason not above-mentioned|7
407749|NCT00674700|1365594|P3|Year 1|Withdrawal by Subject|6
407750|NCT00674700|1365595|P2|Year 1|Withdrawal by Subject|7
407751|NCT00674700|1365596|P1|Year 1|Withdrawal by Subject|7
407752|NCT00674700|1365594|P3|Year 1|Adverse Event|5
407753|NCT00674700|1365595|P2|Year 1|Adverse Event|20
407754|NCT00674700|1365596|P1|Year 1|Adverse Event|17
407755|NCT00674661|1365609|P2|Overall Study|Withdrawal by Subject|5
407756|NCT00674661|1365610|P1|Overall Study|Withdrawal by Subject|0
407757|NCT00674661|1365609|P2|Overall Study|Lost to Follow-up|3
407758|NCT00674661|1365610|P1|Overall Study|Lost to Follow-up|6
407759|NCT00674661|1365609|P2|Overall Study|not specified|7
407760|NCT00674661|1365610|P1|Overall Study|not specified|5
407761|NCT00674362|1365730|P2|Open Label|Other: Subject moved to extension study|0
407762|NCT00674362|1365731|P1|Open Label|Other: Subject moved to extension study|1
407763|NCT00674362|1365730|P2|Open Label|Adverse Event|0
407764|NCT00674362|1365731|P1|Open Label|Adverse Event|1
407765|NCT00674362|1365730|P2|Double Blind|Other: Surgery|1
407766|NCT00674362|1365731|P1|Double Blind|Other: Surgery|0
407767|NCT00674362|1365730|P2|Double Blind|Other: Loss of Patient Compliance|1
407768|NCT00674362|1365731|P1|Double Blind|Other: Loss of Patient Compliance|0
407769|NCT00674362|1365730|P2|Double Blind|Withdrawal by Subject|3
407770|NCT00674362|1365731|P1|Double Blind|Withdrawal by Subject|4
407771|NCT00674362|1365730|P2|Double Blind|Loss of efficacy|1
407772|NCT00674362|1365731|P1|Double Blind|Loss of efficacy|0
407773|NCT00674362|1365730|P2|Double Blind|Lack of Efficacy|6
407774|NCT00674362|1365731|P1|Double Blind|Lack of Efficacy|2
407775|NCT00674362|1365730|P2|Double Blind|Adverse Event|6
407776|NCT00674362|1365731|P1|Double Blind|Adverse Event|6
407777|NCT00674323|1365799|P3|Overall Study|Protocol Violation|0
407778|NCT00674323|1365800|P2|Overall Study|Protocol Violation|0
407779|NCT00674323|1365801|P1|Overall Study|Protocol Violation|1
407780|NCT00674323|1365799|P3|Overall Study|Adverse Event|0
407781|NCT00674323|1365800|P2|Overall Study|Adverse Event|1
407782|NCT00674323|1365801|P1|Overall Study|Adverse Event|0
407783|NCT00674154|1365843|P2|Overall Study|Did not want parathyroidectomy|2
407784|NCT00674154|1365844|P1|Overall Study|Did not want parathyroidectomy|0
407785|NCT00674154|1365843|P2|Overall Study|Withdrawal by Subject|1
407786|NCT00674154|1365844|P1|Overall Study|Withdrawal by Subject|3
407787|NCT00674128|1365852|P2|Overall Study|Withdrawal by Subject|23
407788|NCT00674128|1365853|P1|Overall Study|Withdrawal by Subject|25
407789|NCT00673933|1365878|P1|Overall Study|Lost to Follow-up|1
407790|NCT00673933|1365878|P1|Overall Study|Withdrawal by Subject|2
407791|NCT00673881|1365894|P1|Overall Study|Withdrawal by Subject|1
407792|NCT00673816|1365908|P1|Overall Study|Withdrawal by Subject|1
407793|NCT00673816|1365908|P1|Overall Study|Adverse Event|1
407794|NCT00673673|1365943|P1|Overall Study|Investigators' discretion|2
407795|NCT00673673|1365943|P1|Overall Study|Withdrawal by Subject|3
407796|NCT00673673|1365943|P1|Overall Study|Adverse Event|4
407797|NCT00673673|1365943|P1|Overall Study|Progressive disease|27
407798|NCT00673660|1365949|P1|Overall Study|Lost to Follow-up|107
407799|NCT00673465|1365971|P12|Part 1/Period 2 (United States)|Protocol Violation|0
407800|NCT00673465|1365972|P11|Part 1/Period 2 (United States)|Protocol Violation|0
407801|NCT00673465|1365973|P10|Part 1/Period 2 (United States)|Protocol Violation|0
407802|NCT00673465|1365974|P9|Part 1/Period 2 (United States)|Protocol Violation|0
407803|NCT00673465|1365975|P8|Part 1/Period 2 (United States)|Protocol Violation|0
407804|NCT00673465|1365976|P7|Part 1/Period 2 (United States)|Protocol Violation|0
407805|NCT00673465|1365977|P6|Part 1/Period 2 (United States)|Protocol Violation|0
407806|NCT00673465|1365978|P5|Part 1/Period 2 (United States)|Protocol Violation|1
407807|NCT00673465|1365979|P4|Part 1/Period 2 (United States)|Protocol Violation|0
407808|NCT00673465|1365980|P3|Part 1/Period 2 (United States)|Protocol Violation|0
407809|NCT00673465|1365981|P2|Part 1/Period 2 (United States)|Protocol Violation|0
407810|NCT00673465|1365982|P1|Part 1/Period 2 (United States)|Protocol Violation|0
407811|NCT00673465|1365971|P12|Part 1/Period 1 (United States)|Protocol Violation|0
407812|NCT00673465|1365972|P11|Part 1/Period 1 (United States)|Protocol Violation|0
407813|NCT00673465|1365973|P10|Part 1/Period 1 (United States)|Protocol Violation|0
407814|NCT00673465|1365974|P9|Part 1/Period 1 (United States)|Protocol Violation|0
407815|NCT00673465|1365975|P8|Part 1/Period 1 (United States)|Protocol Violation|0
407816|NCT00673465|1365976|P7|Part 1/Period 1 (United States)|Protocol Violation|0
407817|NCT00673465|1365977|P6|Part 1/Period 1 (United States)|Protocol Violation|1
407818|NCT00673465|1365978|P5|Part 1/Period 1 (United States)|Protocol Violation|1
407819|NCT00673465|1365979|P4|Part 1/Period 1 (United States)|Protocol Violation|0
407820|NCT00673465|1365980|P3|Part 1/Period 1 (United States)|Protocol Violation|0
407821|NCT00673465|1365981|P2|Part 1/Period 1 (United States)|Protocol Violation|0
407822|NCT00673465|1365982|P1|Part 1/Period 1 (United States)|Protocol Violation|0
407823|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
407824|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
407825|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Physician Decision|0
407826|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Physician Decision|2
407827|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Sponsor Decision|3
407828|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Sponsor Decision|0
407829|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Protocol Violation|3
407830|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Protocol Violation|2
407831|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
407832|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
407833|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
407834|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
407835|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
407836|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
407837|NCT00673452|1366031|P2|Continuation Double-Blind Phase|Adverse Event|13
407838|NCT00673452|1366032|P1|Continuation Double-Blind Phase|Adverse Event|5
407839|NCT00673452|1366031|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
407840|NCT00673452|1366032|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
407841|NCT00673452|1366031|P2|Acute Double-Blind Phase|Sponsor Decision|1
407842|NCT00673452|1366032|P1|Acute Double-Blind Phase|Sponsor Decision|0
407843|NCT00673452|1366031|P2|Acute Double-Blind Phase|Protocol Violation|3
407844|NCT00673452|1366032|P1|Acute Double-Blind Phase|Protocol Violation|5
407845|NCT00673452|1366031|P2|Acute Double-Blind Phase|Physician Decision|6
407846|NCT00673452|1366032|P1|Acute Double-Blind Phase|Physician Decision|0
407847|NCT00673452|1366031|P2|Acute Double-Blind Phase|Lost to Follow-up|19
407848|NCT00673452|1366032|P1|Acute Double-Blind Phase|Lost to Follow-up|16
407849|NCT00673452|1366031|P2|Acute Double-Blind Phase|Lack of Efficacy|14
407850|NCT00673452|1366032|P1|Acute Double-Blind Phase|Lack of Efficacy|9
407851|NCT00673452|1366031|P2|Acute Double-Blind Phase|Adverse Event|24
407852|NCT00673452|1366032|P1|Acute Double-Blind Phase|Adverse Event|41
407853|NCT00673387|1366095|P8|Overall Study|Lost to Follow-up|5
407854|NCT00673387|1366096|P7|Overall Study|Lost to Follow-up|8
407855|NCT00673387|1366097|P6|Overall Study|Lost to Follow-up|5
407856|NCT00673387|1366098|P5|Overall Study|Lost to Follow-up|6
407857|NCT00673387|1366099|P4|Overall Study|Lost to Follow-up|6
407858|NCT00673387|1366100|P3|Overall Study|Lost to Follow-up|5
407859|NCT00673387|1366101|P2|Overall Study|Lost to Follow-up|6
407860|NCT00673387|1366102|P1|Overall Study|Lost to Follow-up|8
407861|NCT00673387|1366095|P8|Overall Study|Protocol Violation|3
407862|NCT00673387|1366096|P7|Overall Study|Protocol Violation|1
407863|NCT00673387|1366097|P6|Overall Study|Protocol Violation|1
407864|NCT00673387|1366098|P5|Overall Study|Protocol Violation|0
407865|NCT00673387|1366099|P4|Overall Study|Protocol Violation|2
407866|NCT00673387|1366100|P3|Overall Study|Protocol Violation|1
407867|NCT00673387|1366101|P2|Overall Study|Protocol Violation|0
407868|NCT00673387|1366102|P1|Overall Study|Protocol Violation|3
407869|NCT00673387|1366095|P8|Overall Study|Physician Decision|1
407870|NCT00673387|1366096|P7|Overall Study|Physician Decision|1
407871|NCT00673387|1366097|P6|Overall Study|Physician Decision|5
407872|NCT00673387|1366098|P5|Overall Study|Physician Decision|0
407873|NCT00673387|1366099|P4|Overall Study|Physician Decision|0
407874|NCT00673387|1366100|P3|Overall Study|Physician Decision|0
407875|NCT00673387|1366101|P2|Overall Study|Physician Decision|0
407876|NCT00673387|1366102|P1|Overall Study|Physician Decision|0
407877|NCT00673387|1366095|P8|Overall Study|Adverse Event|5
407878|NCT00673387|1366096|P7|Overall Study|Adverse Event|5
407879|NCT00673387|1366097|P6|Overall Study|Adverse Event|2
407880|NCT00673387|1366098|P5|Overall Study|Adverse Event|6
407881|NCT00673387|1366099|P4|Overall Study|Adverse Event|2
407882|NCT00673387|1366100|P3|Overall Study|Adverse Event|5
407883|NCT00673387|1366101|P2|Overall Study|Adverse Event|1
407884|NCT00673387|1366102|P1|Overall Study|Adverse Event|3
407885|NCT00673387|1366095|P8|Overall Study|Withdrawal by Subject|21
407886|NCT00673387|1366096|P7|Overall Study|Withdrawal by Subject|15
407887|NCT00673387|1366097|P6|Overall Study|Withdrawal by Subject|21
407888|NCT00673387|1366098|P5|Overall Study|Withdrawal by Subject|18
407889|NCT00673387|1366099|P4|Overall Study|Withdrawal by Subject|16
407890|NCT00673387|1366100|P3|Overall Study|Withdrawal by Subject|20
407891|NCT00673387|1366101|P2|Overall Study|Withdrawal by Subject|16
407892|NCT00673387|1366102|P1|Overall Study|Withdrawal by Subject|15
407893|NCT00673361|1366318|P1|Overall Study|Screen Failure|2
407894|NCT00673257|1366322|P1|Overall Study|Unable to obtain specimen|1
407895|NCT00673257|1366322|P1|Overall Study|Withdrawal by Subject|4
407896|NCT00673231|1366331|P4|Overall Study|Study criteria,compliance,safety, other|4
407897|NCT00673231|1366332|P3|Overall Study|Study criteria,compliance,safety, other|7
407898|NCT00673231|1366333|P2|Overall Study|Study criteria,compliance,safety, other|5
407899|NCT00673231|1366334|P1|Overall Study|Study criteria,compliance,safety, other|8
407900|NCT00673231|1366331|P4|Overall Study|Death|0
407901|NCT00673231|1366332|P3|Overall Study|Death|1
407902|NCT00673231|1366333|P2|Overall Study|Death|0
407903|NCT00673231|1366334|P1|Overall Study|Death|0
407904|NCT00673231|1366331|P4|Overall Study|Lost to Follow-up|2
407905|NCT00673231|1366332|P3|Overall Study|Lost to Follow-up|1
407906|NCT00673231|1366333|P2|Overall Study|Lost to Follow-up|2
407907|NCT00673231|1366334|P1|Overall Study|Lost to Follow-up|1
407908|NCT00673231|1366331|P4|Overall Study|Adverse Event|6
407909|NCT00673231|1366332|P3|Overall Study|Adverse Event|9
407910|NCT00673231|1366333|P2|Overall Study|Adverse Event|5
407911|NCT00673231|1366334|P1|Overall Study|Adverse Event|6
407912|NCT00673231|1366331|P4|Overall Study|Withdrawal by Subject|6
407913|NCT00673231|1366332|P3|Overall Study|Withdrawal by Subject|8
407914|NCT00673231|1366333|P2|Overall Study|Withdrawal by Subject|10
407915|NCT00673231|1366334|P1|Overall Study|Withdrawal by Subject|14
407916|NCT00673179|1366366|P2|Overall Study|Toxicity/Complications|0
407917|NCT00673179|1366367|P1|Overall Study|Toxicity/Complications|3
407918|NCT00673049|1366416|P4|After Progression on Erlotinib|study terminated by sponsor|4
407919|NCT00673049|1366417|P3|After Progression on Erlotinib|study terminated by sponsor|0
407920|NCT00673049|1366418|P2|After Progression on Erlotinib|study terminated by sponsor|0
407921|NCT00673049|1366419|P1|After Progression on Erlotinib|study terminated by sponsor|0
407922|NCT00673049|1366416|P4|After Progression on Erlotinib|Withdrawal by Subject|5
407923|NCT00673049|1366417|P3|After Progression on Erlotinib|Withdrawal by Subject|0
407924|NCT00673049|1366418|P2|After Progression on Erlotinib|Withdrawal by Subject|0
407925|NCT00673049|1366419|P1|After Progression on Erlotinib|Withdrawal by Subject|0
407926|NCT00673049|1366416|P4|After Progression on Erlotinib|Lost to Follow-up|3
407927|NCT00673049|1366417|P3|After Progression on Erlotinib|Lost to Follow-up|0
407928|NCT00673049|1366418|P2|After Progression on Erlotinib|Lost to Follow-up|0
407929|NCT00673049|1366419|P1|After Progression on Erlotinib|Lost to Follow-up|0
407930|NCT00673049|1366416|P4|After Progression on Erlotinib|Death|71
407931|NCT00673049|1366417|P3|After Progression on Erlotinib|Death|0
407932|NCT00673049|1366418|P2|After Progression on Erlotinib|Death|0
407933|NCT00673049|1366419|P1|After Progression on Erlotinib|Death|0
407934|NCT00673049|1366416|P4|Before Progression on Erlotinib|Switched to figitumumab|0
407935|NCT00673049|1366417|P3|Before Progression on Erlotinib|Switched to figitumumab|0
407936|NCT00673049|1366418|P2|Before Progression on Erlotinib|Switched to figitumumab|83
407937|NCT00673049|1366419|P1|Before Progression on Erlotinib|Switched to figitumumab|0
407938|NCT00673049|1366416|P4|Before Progression on Erlotinib|study terminated by sponsor|0
407939|NCT00673049|1366417|P3|Before Progression on Erlotinib|study terminated by sponsor|0
407940|NCT00673049|1366418|P2|Before Progression on Erlotinib|study terminated by sponsor|14
407941|NCT00673049|1366419|P1|Before Progression on Erlotinib|study terminated by sponsor|18
407942|NCT00673049|1366416|P4|Before Progression on Erlotinib|Other|0
407943|NCT00673049|1366417|P3|Before Progression on Erlotinib|Other|0
407944|NCT00673049|1366418|P2|Before Progression on Erlotinib|Other|2
407945|NCT00673049|1366419|P1|Before Progression on Erlotinib|Other|1
407946|NCT00673049|1366416|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
407947|NCT00673049|1366417|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
407948|NCT00673049|1366418|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
407949|NCT00673049|1366419|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
407950|NCT00673049|1366416|P4|Before Progression on Erlotinib|Lost to Follow-up|0
407951|NCT00673049|1366417|P3|Before Progression on Erlotinib|Lost to Follow-up|0
407952|NCT00673049|1366418|P2|Before Progression on Erlotinib|Lost to Follow-up|5
407953|NCT00673049|1366419|P1|Before Progression on Erlotinib|Lost to Follow-up|9
407954|NCT00673049|1366416|P4|Before Progression on Erlotinib|Death|0
407955|NCT00673049|1366417|P3|Before Progression on Erlotinib|Death|1
407956|NCT00673049|1366418|P2|Before Progression on Erlotinib|Death|167
407957|NCT00673049|1366419|P1|Before Progression on Erlotinib|Death|235
407958|NCT00673049|1366416|P4|Before Progression on Erlotinib|Randomized but not treated|0
407959|NCT00673049|1366417|P3|Before Progression on Erlotinib|Randomized but not treated|0
407960|NCT00673049|1366418|P2|Before Progression on Erlotinib|Randomized but not treated|1
407961|NCT00673049|1366419|P1|Before Progression on Erlotinib|Randomized but not treated|3
407962|NCT00672984|1366443|P3|Third Intervention|Adverse Event|1
407963|NCT00672984|1366444|P2|Third Intervention|Adverse Event|0
407964|NCT00672984|1366445|P1|Third Intervention|Adverse Event|1
407965|NCT00672984|1366443|P3|Second Intervention|Protocol Violation|1
407966|NCT00672984|1366444|P2|Second Intervention|Protocol Violation|1
407967|NCT00672984|1366445|P1|Second Intervention|Protocol Violation|0
407968|NCT00672984|1366443|P3|Second Intervention|Withdrawal by Subject|0
407969|NCT00672984|1366444|P2|Second Intervention|Withdrawal by Subject|3
407970|NCT00672984|1366445|P1|Second Intervention|Withdrawal by Subject|0
407971|NCT00672984|1366443|P3|Second Intervention|Non-compliance with facility policies|0
407972|NCT00672984|1366444|P2|Second Intervention|Non-compliance with facility policies|2
407973|NCT00672984|1366445|P1|Second Intervention|Non-compliance with facility policies|0
407974|NCT00672984|1366443|P3|First Intervention|Sponsor decision|0
407975|NCT00672984|1366444|P2|First Intervention|Sponsor decision|0
407976|NCT00672984|1366445|P1|First Intervention|Sponsor decision|3
407977|NCT00672984|1366443|P3|First Intervention|Withdrawal by Subject|2
407978|NCT00672984|1366444|P2|First Intervention|Withdrawal by Subject|2
407979|NCT00672984|1366445|P1|First Intervention|Withdrawal by Subject|1
407980|NCT00672984|1366443|P3|First Intervention|Adverse Event|0
407981|NCT00672984|1366444|P2|First Intervention|Adverse Event|0
407982|NCT00672984|1366445|P1|First Intervention|Adverse Event|5
407983|NCT00672958|1366496|P2|Overall Study|Reason not specified|3
407984|NCT00672958|1366497|P1|Overall Study|Reason not specified|0
407985|NCT00672958|1366496|P2|Overall Study|Lost to Follow-up|17
407986|NCT00672958|1366497|P1|Overall Study|Lost to Follow-up|22
407987|NCT00672958|1366496|P2|Overall Study|Voluntary withdrawal|8
407988|NCT00672958|1366497|P1|Overall Study|Voluntary withdrawal|12
407989|NCT00672958|1366496|P2|Overall Study|Protocol deviations|5
407990|NCT00672958|1366497|P1|Overall Study|Protocol deviations|11
407991|NCT00672958|1366496|P2|Overall Study|Non-compliance with study drug|3
407992|NCT00672958|1366497|P1|Overall Study|Non-compliance with study drug|2
407993|NCT00672958|1366496|P2|Overall Study|Lack of Efficacy|11
407994|NCT00672958|1366497|P1|Overall Study|Lack of Efficacy|6
407995|NCT00672958|1366496|P2|Overall Study|Adverse Event|9
407996|NCT00672958|1366497|P1|Overall Study|Adverse Event|11
407997|NCT00672841|1366549|P2|Overall Study|Pregnancy|1
407998|NCT00672841|1366550|P1|Overall Study|Pregnancy|0
407999|NCT00672841|1366549|P2|Overall Study|Adverse Event|3
408000|NCT00672841|1366550|P1|Overall Study|Adverse Event|0
408001|NCT00672841|1366549|P2|Overall Study|Antifungal therapy, negative glucan|4
408002|NCT00672841|1366550|P1|Overall Study|Antifungal therapy, negative glucan|0
408003|NCT00672841|1366549|P2|Overall Study|icteric specimens|3
408004|NCT00672841|1366550|P1|Overall Study|icteric specimens|0
408005|NCT00672841|1366549|P2|Overall Study|Comfort care|4
408006|NCT00672841|1366550|P1|Overall Study|Comfort care|1
408007|NCT00672646|1366572|P3|Overall Study|Withdrawal by Subject|1
408008|NCT00672646|1366573|P2|Overall Study|Withdrawal by Subject|0
408009|NCT00672646|1366574|P1|Overall Study|Withdrawal by Subject|0
408010|NCT00672646|1366572|P3|Overall Study|Lost to Follow-up|2
408011|NCT00672646|1366573|P2|Overall Study|Lost to Follow-up|1
408012|NCT00672646|1366574|P1|Overall Study|Lost to Follow-up|0
408013|NCT00672633|1366599|P2|Overall Study|Withdrawal by Subject|1
408014|NCT00672633|1366600|P1|Overall Study|Withdrawal by Subject|0
408015|NCT00672620|1366614|P4|Overall Study|Reason not Specified|1
408016|NCT00672620|1366615|P3|Overall Study|Reason not Specified|2
408017|NCT00672620|1366616|P2|Overall Study|Reason not Specified|3
408018|NCT00672620|1366617|P1|Overall Study|Reason not Specified|3
408019|NCT00672620|1366614|P4|Overall Study|Lost to Follow-up|11
408020|NCT00672620|1366615|P3|Overall Study|Lost to Follow-up|8
408021|NCT00672620|1366616|P2|Overall Study|Lost to Follow-up|19
408022|NCT00672620|1366617|P1|Overall Study|Lost to Follow-up|8
408023|NCT00672620|1366614|P4|Overall Study|Withdrawal of Consent|6
408024|NCT00672620|1366615|P3|Overall Study|Withdrawal of Consent|5
408025|NCT00672620|1366616|P2|Overall Study|Withdrawal of Consent|12
408026|NCT00672620|1366617|P1|Overall Study|Withdrawal of Consent|6
408027|NCT00672620|1366614|P4|Overall Study|Protocol Deviations|5
408028|NCT00672620|1366615|P3|Overall Study|Protocol Deviations|2
408029|NCT00672620|1366616|P2|Overall Study|Protocol Deviations|7
408030|NCT00672620|1366617|P1|Overall Study|Protocol Deviations|5
408031|NCT00672620|1366614|P4|Overall Study|Noncompliance with Study Drug|2
408032|NCT00672620|1366615|P3|Overall Study|Noncompliance with Study Drug|0
408033|NCT00672620|1366616|P2|Overall Study|Noncompliance with Study Drug|4
408034|NCT00672620|1366617|P1|Overall Study|Noncompliance with Study Drug|3
408035|NCT00672620|1366614|P4|Overall Study|Lack of Efficacy|0
408036|NCT00672620|1366615|P3|Overall Study|Lack of Efficacy|2
408037|NCT00672620|1366616|P2|Overall Study|Lack of Efficacy|2
408038|NCT00672620|1366617|P1|Overall Study|Lack of Efficacy|1
408039|NCT00672620|1366614|P4|Overall Study|Adverse Event|17
408040|NCT00672620|1366615|P3|Overall Study|Adverse Event|12
408041|NCT00672620|1366616|P2|Overall Study|Adverse Event|7
408042|NCT00672620|1366617|P1|Overall Study|Adverse Event|7
408043|NCT00672555|1366682|P1|Overall Study|Did not want to answer questionnaire|2
408044|NCT00672555|1366682|P1|Overall Study|Lost to Follow-up|4
408045|NCT00672490|1366693|P2|Overall Study|No reason was provided|2
408046|NCT00672490|1366694|P1|Overall Study|No reason was provided|6
408047|NCT00672490|1366693|P2|Overall Study|Lost to Follow-up|5
408048|NCT00672490|1366694|P1|Overall Study|Lost to Follow-up|1
408049|NCT00672490|1366693|P2|Overall Study|Intolerance|2
408050|NCT00672490|1366694|P1|Overall Study|Intolerance|0
408051|NCT00672490|1366693|P2|Overall Study|Violation of Concomitant Medicine|0
408052|NCT00672490|1366694|P1|Overall Study|Violation of Concomitant Medicine|1
408053|NCT00672490|1366693|P2|Overall Study|Adverse Event|8
408054|NCT00672490|1366694|P1|Overall Study|Adverse Event|5
408055|NCT00672490|1366693|P2|Overall Study|Mismatch Include/Exclude Criteria|0
408056|NCT00672490|1366694|P1|Overall Study|Mismatch Include/Exclude Criteria|1
408057|NCT00672490|1366693|P2|Overall Study|Lack of Compliance|7
408058|NCT00672490|1366694|P1|Overall Study|Lack of Compliance|2
408059|NCT00672490|1366693|P2|Overall Study|Withdrawal by Subject|8
408060|NCT00672490|1366694|P1|Overall Study|Withdrawal by Subject|8
408061|NCT00672477|1366718|P2|Overall Study|no study drug for low GFR, health cond.|3
408062|NCT00672477|1366719|P1|Overall Study|no study drug for low GFR, health cond.|1
408063|NCT00672477|1366718|P2|Overall Study|Lack of Efficacy|1
408064|NCT00672477|1366719|P1|Overall Study|Lack of Efficacy|1
408065|NCT00672477|1366718|P2|Overall Study|Withdrawal by Subject|3
408066|NCT00672477|1366719|P1|Overall Study|Withdrawal by Subject|5
408067|NCT00672477|1366718|P2|Overall Study|Protocol Violation|1
408068|NCT00672477|1366719|P1|Overall Study|Protocol Violation|1
408069|NCT00672477|1366718|P2|Overall Study|Physician Decision|0
408070|NCT00672477|1366719|P1|Overall Study|Physician Decision|2
408071|NCT00672477|1366718|P2|Overall Study|Death|11
408072|NCT00672477|1366719|P1|Overall Study|Death|7
408073|NCT00672477|1366718|P2|Overall Study|Adverse Event|7
408074|NCT00672477|1366719|P1|Overall Study|Adverse Event|10
408075|NCT00672256|1366761|P1|Overall Study|PI dropped, bad data|44
408076|NCT00672139|1366786|P2|Overall Study|hospice discharge, caregiver requests|2
408077|NCT00672139|1366787|P1|Overall Study|hospice discharge, caregiver requests|3
408078|NCT00672139|1366786|P2|Overall Study|Protocol Violation|1
408079|NCT00672139|1366787|P1|Overall Study|Protocol Violation|1
408080|NCT00672139|1366786|P2|Overall Study|Lack of Efficacy|1
408081|NCT00672139|1366787|P1|Overall Study|Lack of Efficacy|4
408082|NCT00672139|1366786|P2|Overall Study|Physician Decision|0
408083|NCT00672139|1366787|P1|Overall Study|Physician Decision|2
408084|NCT00672139|1366786|P2|Overall Study|Adverse Event|7
408085|NCT00672139|1366787|P1|Overall Study|Adverse Event|4
408086|NCT00672139|1366786|P2|Overall Study|Withdrawal by Subject|11
408087|NCT00672139|1366787|P1|Overall Study|Withdrawal by Subject|2
408088|NCT00672139|1366786|P2|Overall Study|Death|23
408089|NCT00672139|1366787|P1|Overall Study|Death|14
408090|NCT00671931|1366844|P5|Overall Study|Physician Decision|1
408091|NCT00671931|1366845|P4|Overall Study|Physician Decision|2
408092|NCT00671931|1366846|P3|Overall Study|Physician Decision|0
408093|NCT00671931|1366847|P2|Overall Study|Physician Decision|0
408094|NCT00671931|1366848|P1|Overall Study|Physician Decision|1
408095|NCT00671879|1366868|P3|Overall Study|Withdrawal by Subject|6
408096|NCT00671879|1366869|P2|Overall Study|Withdrawal by Subject|4
408097|NCT00671879|1366870|P1|Overall Study|Withdrawal by Subject|0
408098|NCT00671853|1366883|P2|Overall Study|Non-adherence with study procedures|4
408099|NCT00671853|1366884|P1|Overall Study|Non-adherence with study procedures|1
408100|NCT00671853|1366883|P2|Overall Study|Physician Decision|2
408101|NCT00671853|1366884|P1|Overall Study|Physician Decision|0
408102|NCT00671853|1366883|P2|Overall Study|Lost to Follow-up|8
408103|NCT00671853|1366884|P1|Overall Study|Lost to Follow-up|8
408104|NCT00671853|1366883|P2|Overall Study|Withdrawal by Subject|5
408105|NCT00671853|1366884|P1|Overall Study|Withdrawal by Subject|1
408106|NCT00671853|1366883|P2|Overall Study|Adverse Event|1
408107|NCT00671853|1366884|P1|Overall Study|Adverse Event|7
408108|NCT00671853|1366883|P2|Overall Study|Lack of Efficacy|7
408109|NCT00671853|1366884|P1|Overall Study|Lack of Efficacy|3
408110|NCT00671788|1366900|P1|Overall Study|Other|1
408111|NCT00671788|1366900|P1|Overall Study|MD Decision|1
408112|NCT00671788|1366900|P1|Overall Study|Ineligible|1
408113|NCT00671788|1366900|P1|Overall Study|Refused further treatment|3
408114|NCT00671788|1366900|P1|Overall Study|Adverse Event|8
408115|NCT00671749|1366907|P1|Overall Study|Lost to Follow-up|1
408116|NCT00671749|1366907|P1|Overall Study|Protocol Violation|1
408117|NCT00671749|1366907|P1|Overall Study|Withdrawal by Subject|4
408118|NCT00671749|1366907|P1|Overall Study|Adverse Event|2
408119|NCT00671554|1366966|P1|Overall Study|Disease progression|3
408120|NCT00671437|1367005|P1|Overall Study|Ineligible post-hoc|1
408121|NCT00671437|1367005|P1|Overall Study|Adverse Event|3
408122|NCT00671437|1367005|P1|Overall Study|Cutaneous SCC of head and neck|3
408123|NCT00671437|1367005|P1|Overall Study|Progressive disease before C1 week 8|8
408124|NCT00671060|1367039|P2|Overall Study|Physician Decision|1
408125|NCT00671060|1367040|P1|Overall Study|Physician Decision|0
408126|NCT00671060|1367039|P2|Overall Study|Protocol Violation|0
408127|NCT00671060|1367040|P1|Overall Study|Protocol Violation|1
408128|NCT00670930|1367066|P2|Overall Study|Lost to Follow-up|0
408129|NCT00670930|1367067|P1|Overall Study|Lost to Follow-up|1
408130|NCT00670930|1367066|P2|Overall Study|Adminstrative Problem|1
408131|NCT00670930|1367067|P1|Overall Study|Adminstrative Problem|0
408132|NCT00670800|1367083|P2|Overall Study|2 controls were insulin resistant|2
408133|NCT00670800|1367084|P1|Overall Study|2 controls were insulin resistant|0
408134|NCT00670748|1367115|P4|Overall Study|Not off study|1
408135|NCT00670748|1367116|P3|Overall Study|Not off study|1
408136|NCT00670748|1367117|P2|Overall Study|Not off study|1
408137|NCT00670748|1367118|P1|Overall Study|Not off study|2
408138|NCT00670748|1367115|P4|Overall Study|Death during treatment|0
408139|NCT00670748|1367116|P3|Overall Study|Death during treatment|1
408140|NCT00670748|1367117|P2|Overall Study|Death during treatment|1
408141|NCT00670748|1367118|P1|Overall Study|Death during treatment|1
408142|NCT00670540|1367153|P1|Overall Study|missing information inclusion criteria|1
408143|NCT00670540|1367153|P1|Overall Study|controls randomised for no follow up|2770
408144|NCT00670540|1367153|P1|Overall Study|refused to participate|189
408145|NCT00670540|1367153|P1|Overall Study|not living in France|348
408146|NCT00670540|1367153|P1|Overall Study|ineligible|17
408147|NCT00670449|1367198|P4|Overall Study|Abnormal Laboratory Value(s)|0
408148|NCT00670449|1367199|P3|Overall Study|Abnormal Laboratory Value(s)|0
408149|NCT00670449|1367200|P2|Overall Study|Abnormal Laboratory Value(s)|2
408150|NCT00670449|1367201|P1|Overall Study|Abnormal Laboratory Value(s)|0
408151|NCT00670449|1367198|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
408152|NCT00670449|1367199|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
408153|NCT00670449|1367200|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
408154|NCT00670449|1367201|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
408155|NCT00670449|1367198|P4|Overall Study|Subject Withdrew Consent|1
408156|NCT00670449|1367199|P3|Overall Study|Subject Withdrew Consent|0
408157|NCT00670449|1367200|P2|Overall Study|Subject Withdrew Consent|2
408158|NCT00670449|1367201|P1|Overall Study|Subject Withdrew Consent|0
408159|NCT00670449|1367198|P4|Overall Study|Administrative Problems|1
408160|NCT00670449|1367199|P3|Overall Study|Administrative Problems|0
408161|NCT00670449|1367200|P2|Overall Study|Administrative Problems|2
408162|NCT00670449|1367201|P1|Overall Study|Administrative Problems|0
408163|NCT00670449|1367198|P4|Overall Study|Protocol Deviation|1
408164|NCT00670449|1367199|P3|Overall Study|Protocol Deviation|0
408165|NCT00670449|1367200|P2|Overall Study|Protocol Deviation|2
408166|NCT00670449|1367201|P1|Overall Study|Protocol Deviation|1
408167|NCT00670449|1367198|P4|Overall Study|Adverse Event|5
408168|NCT00670449|1367199|P3|Overall Study|Adverse Event|8
408169|NCT00670449|1367200|P2|Overall Study|Adverse Event|2
408170|NCT00670449|1367201|P1|Overall Study|Adverse Event|6
408171|NCT00670306|1367225|P1|Overall Study|incl/excl criterias did not meet|19
408172|NCT00670306|1367225|P1|Overall Study|Lost to Follow-up|8
408173|NCT00670306|1367225|P1|Overall Study|Physician Decision|1
408174|NCT00670306|1367225|P1|Overall Study|Withdrawal by Subject|9
408175|NCT00670306|1367225|P1|Overall Study|Lack of Efficacy|10
408176|NCT00670306|1367225|P1|Overall Study|Adverse Event|8
408177|NCT00670228|1367264|P2|Overall Study|Not meeting the selection criteria|0
408178|NCT00670228|1367265|P1|Overall Study|Not meeting the selection criteria|2
408179|NCT00670228|1367264|P2|Overall Study|Not treated|2
408180|NCT00670228|1367265|P1|Overall Study|Not treated|2
408181|NCT00670228|1367264|P2|Overall Study|Death or MACE|1
408182|NCT00670228|1367265|P1|Overall Study|Death or MACE|0
408183|NCT00670228|1367264|P2|Overall Study|Adverse Event|0
408184|NCT00670228|1367265|P1|Overall Study|Adverse Event|1
408185|NCT00670111|1367289|P3|Enrollment to One Month|Physician Decision|0
408186|NCT00670111|1367290|P2|Enrollment to One Month|Physician Decision|0
408187|NCT00670111|1367291|P1|Enrollment to One Month|Physician Decision|1
408188|NCT00670111|1367289|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
408189|NCT00670111|1367290|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
408190|NCT00670111|1367291|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
408191|NCT00670111|1367289|P3|Enrollment to One Month|Testing Failure|13
408192|NCT00670111|1367290|P2|Enrollment to One Month|Testing Failure|0
408193|NCT00670111|1367291|P1|Enrollment to One Month|Testing Failure|0
408194|NCT00670007|1367299|P1|Overall Study|Withdrawal by Subject|4
408195|NCT00670007|1367299|P1|Overall Study|Adverse Event|1
408196|NCT00670007|1367299|P1|Overall Study|Adverse event, serious fatal|1
408197|NCT00670007|1367299|P1|Overall Study|Travel/Vacation|1
408198|NCT00670007|1367299|P1|Overall Study|Lung transplant|1
408199|NCT00670007|1367299|P1|Overall Study|Drug abuse|1
408200|NCT00669955|1367326|P2|Overall Study|not compliant with study drug/visit|3
408201|NCT00669955|1367327|P1|Overall Study|not compliant with study drug/visit|2
408202|NCT00669955|1367326|P2|Overall Study|Investigator Sponsor Judgement|1
408203|NCT00669955|1367327|P1|Overall Study|Investigator Sponsor Judgement|0
408204|NCT00669955|1367326|P2|Overall Study|Protocol Violation|7
408205|NCT00669955|1367327|P1|Overall Study|Protocol Violation|2
408206|NCT00669955|1367326|P2|Overall Study|Lost to Follow-up|7
408207|NCT00669955|1367327|P1|Overall Study|Lost to Follow-up|5
408208|NCT00669955|1367326|P2|Overall Study|Withdrawal by Subject|3
408209|NCT00669955|1367327|P1|Overall Study|Withdrawal by Subject|2
408210|NCT00669955|1367326|P2|Overall Study|Death|1
408211|NCT00669955|1367327|P1|Overall Study|Death|0
408212|NCT00669955|1367326|P2|Overall Study|Adverse Event|5
408213|NCT00669955|1367327|P1|Overall Study|Adverse Event|3
408214|NCT00669942|1367357|P12|Parts 2 and 3|Protocol Violation|0
408215|NCT00669942|1367358|P11|Parts 2 and 3|Protocol Violation|0
408216|NCT00669942|1367359|P10|Parts 2 and 3|Protocol Violation|0
408217|NCT00669942|1367360|P9|Parts 2 and 3|Protocol Violation|0
408218|NCT00669942|1367361|P8|Parts 2 and 3|Protocol Violation|0
408219|NCT00669942|1367362|P7|Parts 2 and 3|Protocol Violation|0
408220|NCT00669942|1367363|P6|Parts 2 and 3|Protocol Violation|1
408221|NCT00669942|1367364|P5|Parts 2 and 3|Protocol Violation|0
408222|NCT00669942|1367365|P4|Parts 2 and 3|Protocol Violation|0
408223|NCT00669942|1367366|P3|Parts 2 and 3|Protocol Violation|0
408224|NCT00669942|1367367|P2|Parts 2 and 3|Protocol Violation|0
408225|NCT00669942|1367368|P1|Parts 2 and 3|Protocol Violation|0
408226|NCT00669942|1367357|P12|Parts 2 and 3|Withdrawal by Subject|0
408227|NCT00669942|1367358|P11|Parts 2 and 3|Withdrawal by Subject|0
408228|NCT00669942|1367359|P10|Parts 2 and 3|Withdrawal by Subject|0
408229|NCT00669942|1367360|P9|Parts 2 and 3|Withdrawal by Subject|2
408230|NCT00669942|1367361|P8|Parts 2 and 3|Withdrawal by Subject|0
408231|NCT00669942|1367362|P7|Parts 2 and 3|Withdrawal by Subject|0
408232|NCT00669942|1367363|P6|Parts 2 and 3|Withdrawal by Subject|1
408233|NCT00669942|1367364|P5|Parts 2 and 3|Withdrawal by Subject|0
408234|NCT00669942|1367365|P4|Parts 2 and 3|Withdrawal by Subject|0
408235|NCT00669942|1367366|P3|Parts 2 and 3|Withdrawal by Subject|0
408236|NCT00669942|1367367|P2|Parts 2 and 3|Withdrawal by Subject|0
408237|NCT00669942|1367368|P1|Parts 2 and 3|Withdrawal by Subject|0
408238|NCT00669942|1367357|P12|Parts 2 and 3|Adverse Event|0
408239|NCT00669942|1367358|P11|Parts 2 and 3|Adverse Event|0
408240|NCT00669942|1367359|P10|Parts 2 and 3|Adverse Event|0
408241|NCT00669942|1367360|P9|Parts 2 and 3|Adverse Event|1
408242|NCT00669942|1367361|P8|Parts 2 and 3|Adverse Event|2
408243|NCT00669942|1367362|P7|Parts 2 and 3|Adverse Event|0
408244|NCT00669942|1367363|P6|Parts 2 and 3|Adverse Event|0
408245|NCT00669942|1367364|P5|Parts 2 and 3|Adverse Event|0
408246|NCT00669942|1367365|P4|Parts 2 and 3|Adverse Event|0
408247|NCT00669942|1367366|P3|Parts 2 and 3|Adverse Event|0
408248|NCT00669942|1367367|P2|Parts 2 and 3|Adverse Event|0
408249|NCT00669942|1367368|P1|Parts 2 and 3|Adverse Event|0
408250|NCT00669903|1367451|P4|Overall Study|Protocol Violation|0
408251|NCT00669903|1367452|P3|Overall Study|Protocol Violation|0
408252|NCT00669903|1367453|P2|Overall Study|Protocol Violation|1
408253|NCT00669903|1367454|P1|Overall Study|Protocol Violation|0
408254|NCT00669903|1367451|P4|Overall Study|Lost to Follow-up|1
408255|NCT00669903|1367452|P3|Overall Study|Lost to Follow-up|0
408256|NCT00669903|1367453|P2|Overall Study|Lost to Follow-up|1
408257|NCT00669903|1367454|P1|Overall Study|Lost to Follow-up|1
408258|NCT00669903|1367451|P4|Overall Study|Withdrawal by Subject|2
408259|NCT00669903|1367452|P3|Overall Study|Withdrawal by Subject|2
408260|NCT00669903|1367453|P2|Overall Study|Withdrawal by Subject|2
408261|NCT00669903|1367454|P1|Overall Study|Withdrawal by Subject|0
408262|NCT00669903|1367451|P4|Overall Study|Adverse Event|1
408263|NCT00669903|1367452|P3|Overall Study|Adverse Event|3
408264|NCT00669903|1367453|P2|Overall Study|Adverse Event|1
408265|NCT00669903|1367454|P1|Overall Study|Adverse Event|0
408266|NCT00669877|1367484|P1|Overall Study|Disease Progression/Death|4
408267|NCT00669864|1367489|P1|Overall Study|Other|2
408268|NCT00669864|1367489|P1|Overall Study|Withdrawal by Subject|3
408269|NCT00669864|1367489|P1|Overall Study|Protocol Violation|2
408270|NCT00669864|1367489|P1|Overall Study|Lost to Follow-up|2
408271|NCT00669617|1367503|P5|Period 3|Lost to Follow-up|0
408272|NCT00669617|1367504|P4|Period 3|Lost to Follow-up|0
408273|NCT00669617|1367505|P3|Period 3|Lost to Follow-up|0
408274|NCT00669617|1367506|P2|Period 3|Lost to Follow-up|0
408275|NCT00669617|1367507|P1|Period 3|Lost to Follow-up|1
408276|NCT00669617|1367503|P5|Period 1|Protocol Deviation|1
408277|NCT00669617|1367504|P4|Period 1|Protocol Deviation|0
408278|NCT00669617|1367505|P3|Period 1|Protocol Deviation|0
408279|NCT00669617|1367506|P2|Period 1|Protocol Deviation|0
408280|NCT00669617|1367507|P1|Period 1|Protocol Deviation|0
408281|NCT00669617|1367503|P5|Period 1|Withdrawal by Subject|0
408282|NCT00669617|1367504|P4|Period 1|Withdrawal by Subject|0
408283|NCT00669617|1367505|P3|Period 1|Withdrawal by Subject|1
408284|NCT00669617|1367506|P2|Period 1|Withdrawal by Subject|0
408285|NCT00669617|1367507|P1|Period 1|Withdrawal by Subject|0
408286|NCT00669396|1367555|P2|Overall Study|Lost to Follow-up|12
408287|NCT00669396|1367556|P1|Overall Study|Lost to Follow-up|10
408288|NCT00669331|1367570|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
408289|NCT00669331|1367571|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
408290|NCT00669331|1367570|P2|Blinded Treatment Period|Physician Decision|3
408291|NCT00669331|1367571|P1|Blinded Treatment Period|Physician Decision|3
408292|NCT00669331|1367570|P2|Blinded Treatment Period|Death|2
408293|NCT00669331|1367571|P1|Blinded Treatment Period|Death|0
408294|NCT00669331|1367570|P2|Blinded Treatment Period|Lost to Follow-up|2
408295|NCT00669331|1367571|P1|Blinded Treatment Period|Lost to Follow-up|3
408296|NCT00669331|1367570|P2|Blinded Treatment Period|Withdrawal by Subject|19
408297|NCT00669331|1367571|P1|Blinded Treatment Period|Withdrawal by Subject|17
408298|NCT00669331|1367570|P2|Blinded Treatment Period|Protocol Violation|1
408299|NCT00669331|1367571|P1|Blinded Treatment Period|Protocol Violation|1
408300|NCT00669331|1367570|P2|Blinded Treatment Period|Adverse Event|10
408301|NCT00669331|1367571|P1|Blinded Treatment Period|Adverse Event|16
408302|NCT00669331|1367570|P2|Randomisation to First Dose|Randomised in error|10
408303|NCT00669331|1367571|P1|Randomisation to First Dose|Randomised in error|3
408304|NCT00669331|1367570|P2|Randomisation to First Dose|Sponsor decision|1
408305|NCT00669331|1367571|P1|Randomisation to First Dose|Sponsor decision|0
408306|NCT00669331|1367570|P2|Randomisation to First Dose|Death|0
408307|NCT00669331|1367571|P1|Randomisation to First Dose|Death|1
408308|NCT00669331|1367570|P2|Randomisation to First Dose|Lost to Follow-up|0
408309|NCT00669331|1367571|P1|Randomisation to First Dose|Lost to Follow-up|2
408310|NCT00669331|1367570|P2|Randomisation to First Dose|Withdrawal by Subject|2
408311|NCT00669331|1367571|P1|Randomisation to First Dose|Withdrawal by Subject|3
408312|NCT00669331|1367570|P2|Randomisation to First Dose|Protocol Violation|0
408313|NCT00669331|1367571|P1|Randomisation to First Dose|Protocol Violation|1
408314|NCT00669331|1367570|P2|Randomisation to First Dose|Adverse Event|0
408315|NCT00669331|1367571|P1|Randomisation to First Dose|Adverse Event|1
408316|NCT00669318|1367613|P1|Overall Study|Withdrawal by Subject|2
408317|NCT00669240|1367630|P1|Overall Study|Enrolled but no dosing record|1
408318|NCT00669240|1367630|P1|Overall Study|Enrolled but not treated|15
408319|NCT00669240|1367630|P1|Overall Study|Other|19
408320|NCT00669240|1367630|P1|Overall Study|Adverse Event|21
408321|NCT00669240|1367630|P1|Overall Study|Lost to Follow-up|34
408322|NCT00669240|1367630|P1|Overall Study|Withdrawal by Subject|42
408323|NCT00669240|1367630|P1|Overall Study|Lack of Efficacy|33
408324|NCT00669110|1367681|P2|Overall Study|Withdrawal by Subject|2
408325|NCT00669110|1367682|P1|Overall Study|Withdrawal by Subject|0
408326|NCT00669110|1367681|P2|Overall Study|Protocol Violation|5
408327|NCT00669110|1367682|P1|Overall Study|Protocol Violation|0
408328|NCT00669110|1367681|P2|Overall Study|Lost to Follow-up|0
408329|NCT00669110|1367682|P1|Overall Study|Lost to Follow-up|1
408330|NCT00669110|1367681|P2|Overall Study|Physician Decision|1
408331|NCT00669110|1367682|P1|Overall Study|Physician Decision|0
408332|NCT00669110|1367681|P2|Overall Study|Caregiver request|2
408333|NCT00669110|1367682|P1|Overall Study|Caregiver request|3
408334|NCT00669110|1367681|P2|Overall Study|Adverse Event|3
408335|NCT00669110|1367682|P1|Overall Study|Adverse Event|4
408336|NCT00669071|1367718|P1|Overall Study|Final visit 40 days out of window|1
408337|NCT00669071|1367718|P1|Overall Study|Lost to Follow-up|3
408338|NCT00669032|1367739|P2|Overall Study|No fulfilment of the selection criteria|5
408339|NCT00669032|1367740|P1|Overall Study|No fulfilment of the selection criteria|5
408340|NCT00669032|1367739|P2|Overall Study|Physician Decision|1
408341|NCT00669032|1367740|P1|Overall Study|Physician Decision|1
408342|NCT00669032|1367739|P2|Overall Study|Adverse Event|16
408343|NCT00669032|1367740|P1|Overall Study|Adverse Event|12
408344|NCT00669032|1367739|P2|Overall Study|Withdrawal by Subject|13
408345|NCT00669032|1367740|P1|Overall Study|Withdrawal by Subject|12
408346|NCT00669032|1367739|P2|Overall Study|Lack of Efficacy|19
408347|NCT00669032|1367740|P1|Overall Study|Lack of Efficacy|8
408348|NCT00669032|1367739|P2|Overall Study|Lost to Follow-up|5
408349|NCT00669032|1367740|P1|Overall Study|Lost to Follow-up|6
408350|NCT00668863|1367786|P1|Overall Study|Physician Decision|1
408351|NCT00668863|1367786|P1|Overall Study|Subject’s work scheduling problem|1
408352|NCT00668863|1367786|P1|Overall Study|Surgery|1
408353|NCT00668863|1367786|P1|Overall Study|Withdrawal by Subject|1
408354|NCT00668863|1367786|P1|Overall Study|Global Deterioration of Health Status|4
408355|NCT00668863|1367786|P1|Overall Study|Study Terminated by Sponsor|8
408356|NCT00668863|1367786|P1|Overall Study|Adverse Event|13
408357|NCT00668863|1367786|P1|Overall Study|Objective Progression or Relapse|42
408358|NCT00668746|1367816|P2|Overall Study|Lost to Follow-up|1
408359|NCT00668746|1367817|P1|Overall Study|Lost to Follow-up|2
408360|NCT00668733|1367837|P2|Overall Study|Withdrawal by Subject|4
408361|NCT00668733|1367838|P1|Overall Study|Withdrawal by Subject|0
408362|NCT00668733|1367837|P2|Overall Study|Lost to Follow-up|3
408363|NCT00668733|1367838|P1|Overall Study|Lost to Follow-up|2
408364|NCT00668395|1367883|P3|Overall Study|Physician Decision|0
408365|NCT00668395|1367884|P2|Overall Study|Physician Decision|1
408366|NCT00668395|1367885|P1|Overall Study|Physician Decision|1
408367|NCT00668395|1367883|P3|Overall Study|Adverse Event|0
408368|NCT00668395|1367884|P2|Overall Study|Adverse Event|1
408369|NCT00668395|1367885|P1|Overall Study|Adverse Event|1
408370|NCT00668395|1367883|P3|Overall Study|Withdrawal by Subject|1
408371|NCT00668395|1367884|P2|Overall Study|Withdrawal by Subject|4
408372|NCT00668395|1367885|P1|Overall Study|Withdrawal by Subject|4
408373|NCT00668317|1367897|P1|Overall Study|Adverse Event|2
408374|NCT00668200|1367912|P1|Overall Study|Lost to Follow-up|1
408375|NCT00668200|1367912|P1|Overall Study|Withdrawal by Subject|2
408376|NCT00667992|1367920|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
408377|NCT00667992|1367921|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
408378|NCT00667992|1367920|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
408379|NCT00667992|1367921|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
408380|NCT00667992|1367920|P2|Wash-out|Withdrawal by Subject|0
408381|NCT00667992|1367921|P1|Wash-out|Withdrawal by Subject|1
408382|NCT00667992|1367920|P2|Wash-out|Failure to wash-out|2
408383|NCT00667992|1367921|P1|Wash-out|Failure to wash-out|2
408384|NCT00667992|1367920|P2|Wash-out|Not within one doubling dilution|3
408385|NCT00667992|1367921|P1|Wash-out|Not within one doubling dilution|4
408386|NCT00667992|1367920|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
408387|NCT00667992|1367921|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
408388|NCT00667992|1367920|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
408389|NCT00667992|1367921|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
408390|NCT00667992|1367920|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
408391|NCT00667992|1367921|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
408392|NCT00667992|1367920|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
408393|NCT00667992|1367921|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
408394|NCT00667992|1367920|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
408395|NCT00667992|1367921|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
408396|NCT00667992|1367920|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
408397|NCT00667992|1367921|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
408398|NCT00667992|1367920|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
408399|NCT00667992|1367921|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
408400|NCT00667992|1367920|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
408401|NCT00667992|1367921|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
408402|NCT00667875|1367978|P3|Overall Study|Withdrawal by Subject|7
408403|NCT00667875|1367979|P2|Overall Study|Withdrawal by Subject|9
408404|NCT00667875|1367980|P1|Overall Study|Withdrawal by Subject|10
408405|NCT00667875|1367978|P3|Overall Study|Adverse Event|6
408406|NCT00667875|1367979|P2|Overall Study|Adverse Event|2
408407|NCT00667875|1367980|P1|Overall Study|Adverse Event|0
408408|NCT00667810|1368014|P4|Overall Study|Not specified|0
408409|NCT00667810|1368015|P3|Overall Study|Not specified|5
408410|NCT00667810|1368016|P2|Overall Study|Not specified|6
408411|NCT00667810|1368017|P1|Overall Study|Not specified|6
408412|NCT00667810|1368014|P4|Overall Study|Vasogenic Edema Recurrence|0
408413|NCT00667810|1368015|P3|Overall Study|Vasogenic Edema Recurrence|0
408414|NCT00667810|1368016|P2|Overall Study|Vasogenic Edema Recurrence|3
408415|NCT00667810|1368017|P1|Overall Study|Vasogenic Edema Recurrence|0
408416|NCT00667810|1368014|P4|Overall Study|Loss of Caregiver|0
408417|NCT00667810|1368015|P3|Overall Study|Loss of Caregiver|3
408418|NCT00667810|1368016|P2|Overall Study|Loss of Caregiver|1
408419|NCT00667810|1368017|P1|Overall Study|Loss of Caregiver|0
408420|NCT00667810|1368014|P4|Overall Study|Failed to Return|0
408421|NCT00667810|1368015|P3|Overall Study|Failed to Return|2
408422|NCT00667810|1368016|P2|Overall Study|Failed to Return|0
408423|NCT00667810|1368017|P1|Overall Study|Failed to Return|0
408424|NCT00667810|1368014|P4|Overall Study|Discontinuation of Study by Sponsor|0
408425|NCT00667810|1368015|P3|Overall Study|Discontinuation of Study by Sponsor|155
408426|NCT00667810|1368016|P2|Overall Study|Discontinuation of Study by Sponsor|118
408427|NCT00667810|1368017|P1|Overall Study|Discontinuation of Study by Sponsor|130
408428|NCT00667810|1368014|P4|Overall Study|Withdrawal by Subject|1
408429|NCT00667810|1368015|P3|Overall Study|Withdrawal by Subject|29
408430|NCT00667810|1368016|P2|Overall Study|Withdrawal by Subject|20
408431|NCT00667810|1368017|P1|Overall Study|Withdrawal by Subject|14
408432|NCT00667810|1368014|P4|Overall Study|Protocol Violation|0
408433|NCT00667810|1368015|P3|Overall Study|Protocol Violation|0
408434|NCT00667810|1368016|P2|Overall Study|Protocol Violation|2
408435|NCT00667810|1368017|P1|Overall Study|Protocol Violation|0
408436|NCT00667810|1368014|P4|Overall Study|Physician Decision|0
408437|NCT00667810|1368015|P3|Overall Study|Physician Decision|2
408438|NCT00667810|1368016|P2|Overall Study|Physician Decision|1
408439|NCT00667810|1368017|P1|Overall Study|Physician Decision|1
408440|NCT00667810|1368014|P4|Overall Study|Lost to Follow-up|0
408441|NCT00667810|1368015|P3|Overall Study|Lost to Follow-up|2
408442|NCT00667810|1368016|P2|Overall Study|Lost to Follow-up|4
408443|NCT00667810|1368017|P1|Overall Study|Lost to Follow-up|1
408444|NCT00667810|1368014|P4|Overall Study|Lack of Efficacy|0
408445|NCT00667810|1368015|P3|Overall Study|Lack of Efficacy|2
408446|NCT00667810|1368016|P2|Overall Study|Lack of Efficacy|0
408447|NCT00667810|1368017|P1|Overall Study|Lack of Efficacy|1
408448|NCT00667810|1368014|P4|Overall Study|Death|0
408449|NCT00667810|1368015|P3|Overall Study|Death|3
408450|NCT00667810|1368016|P2|Overall Study|Death|1
408451|NCT00667810|1368017|P1|Overall Study|Death|1
408452|NCT00667810|1368014|P4|Overall Study|Adverse Event|1
408453|NCT00667810|1368015|P3|Overall Study|Adverse Event|19
408454|NCT00667810|1368016|P2|Overall Study|Adverse Event|14
408455|NCT00667810|1368017|P1|Overall Study|Adverse Event|13
408456|NCT00667732|1368093|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
408457|NCT00667732|1368094|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
408458|NCT00667732|1368095|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
408459|NCT00667732|1368093|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
408460|NCT00667732|1368094|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
408461|NCT00667732|1368095|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
408462|NCT00667732|1368093|P3|Run -In (8 Weeks)|Adverse Event|0
408463|NCT00667732|1368094|P2|Run -In (8 Weeks)|Adverse Event|0
408464|NCT00667732|1368095|P1|Run -In (8 Weeks)|Adverse Event|4
408465|NCT00667602|1368123|P3|Overall Study|Protocol Violation|0
408466|NCT00667602|1368124|P2|Overall Study|Protocol Violation|1
408467|NCT00667602|1368125|P1|Overall Study|Protocol Violation|0
408468|NCT00667602|1368123|P3|Overall Study|Administrative reason|2
408469|NCT00667602|1368124|P2|Overall Study|Administrative reason|0
408470|NCT00667602|1368125|P1|Overall Study|Administrative reason|0
408471|NCT00667602|1368123|P3|Overall Study|Lost to Follow-up|6
408472|NCT00667602|1368124|P2|Overall Study|Lost to Follow-up|5
408473|NCT00667602|1368125|P1|Overall Study|Lost to Follow-up|4
408474|NCT00667602|1368123|P3|Overall Study|Withdrawal by Subject|10
408475|NCT00667602|1368124|P2|Overall Study|Withdrawal by Subject|9
408476|NCT00667602|1368125|P1|Overall Study|Withdrawal by Subject|4
408477|NCT00667576|1368193|P5|Overall Study|Missed Visit|0
408478|NCT00667576|1368194|P4|Overall Study|Missed Visit|1
408479|NCT00667576|1368195|P3|Overall Study|Missed Visit|0
408480|NCT00667576|1368196|P2|Overall Study|Missed Visit|0
408481|NCT00667576|1368197|P1|Overall Study|Missed Visit|0
408482|NCT00667576|1368193|P5|Overall Study|Physician Decision|0
408483|NCT00667576|1368194|P4|Overall Study|Physician Decision|1
408484|NCT00667576|1368195|P3|Overall Study|Physician Decision|0
408485|NCT00667576|1368196|P2|Overall Study|Physician Decision|0
408486|NCT00667576|1368197|P1|Overall Study|Physician Decision|0
408487|NCT00667576|1368193|P5|Overall Study|Protocol Violation|0
408488|NCT00667576|1368194|P4|Overall Study|Protocol Violation|1
408489|NCT00667576|1368195|P3|Overall Study|Protocol Violation|0
408490|NCT00667576|1368196|P2|Overall Study|Protocol Violation|0
408491|NCT00667576|1368197|P1|Overall Study|Protocol Violation|0
408492|NCT00667576|1368193|P5|Overall Study|Lost to Follow-up|0
408493|NCT00667576|1368194|P4|Overall Study|Lost to Follow-up|0
408494|NCT00667576|1368195|P3|Overall Study|Lost to Follow-up|1
408495|NCT00667576|1368196|P2|Overall Study|Lost to Follow-up|0
408496|NCT00667576|1368197|P1|Overall Study|Lost to Follow-up|0
408497|NCT00667576|1368193|P5|Overall Study|Adverse Event|0
408498|NCT00667576|1368194|P4|Overall Study|Adverse Event|0
408499|NCT00667576|1368195|P3|Overall Study|Adverse Event|0
408500|NCT00667576|1368196|P2|Overall Study|Adverse Event|1
408501|NCT00667576|1368197|P1|Overall Study|Adverse Event|1
408502|NCT00667576|1368193|P5|Overall Study|Withdrawal by Subject|1
408503|NCT00667576|1368194|P4|Overall Study|Withdrawal by Subject|1
408504|NCT00667576|1368195|P3|Overall Study|Withdrawal by Subject|1
408505|NCT00667576|1368196|P2|Overall Study|Withdrawal by Subject|0
408506|NCT00667576|1368197|P1|Overall Study|Withdrawal by Subject|1
408507|NCT00667563|1368244|P1|Overall Study|Protocol Violation|24
408508|NCT00667459|1368264|P2|Overall Study|Lost to Follow-up|43
408509|NCT00667459|1368265|P1|Overall Study|Lost to Follow-up|8
408510|NCT00667459|1368264|P2|Overall Study|Death|2
408511|NCT00667459|1368265|P1|Overall Study|Death|0
408512|NCT00667446|1368307|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
408513|NCT00667446|1368308|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
408514|NCT00667446|1368307|P2|Treatment Period (36 Months)|Therapeutic Failure|1
408515|NCT00667446|1368308|P1|Treatment Period (36 Months)|Therapeutic Failure|1
408516|NCT00667446|1368307|P2|Treatment Period (36 Months)|Protocol Violation|1
408517|NCT00667446|1368308|P1|Treatment Period (36 Months)|Protocol Violation|1
408518|NCT00667446|1368307|P2|Treatment Period (36 Months)|Lost to Follow-up|0
408519|NCT00667446|1368308|P1|Treatment Period (36 Months)|Lost to Follow-up|1
408520|NCT00667446|1368307|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
408521|NCT00667446|1368308|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
408522|NCT00667446|1368307|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
408523|NCT00667446|1368308|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
408524|NCT00667446|1368307|P2|Treatment Period (36 Months)|Personal reasons|2
408525|NCT00667446|1368308|P1|Treatment Period (36 Months)|Personal reasons|2
408526|NCT00667446|1368307|P2|Treatment Period (36 Months)|Other|2
408527|NCT00667446|1368308|P1|Treatment Period (36 Months)|Other|2
408528|NCT00667446|1368307|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
408529|NCT00667446|1368308|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
408530|NCT00667420|1368330|P1|Overall Study|Withdrawal by Subject|2
408531|NCT00667420|1368330|P1|Overall Study|Physician Decision|1
408532|NCT00667420|1368330|P1|Overall Study|Lack of Efficacy|5
408533|NCT00667420|1368330|P1|Overall Study|Adverse Event|2
408534|NCT00667394|1368340|P2|Overall Study|Progressive disease|0
408535|NCT00667394|1368341|P1|Overall Study|Progressive disease|1
408536|NCT00667394|1368340|P2|Overall Study|Adverse Event|0
408537|NCT00667394|1368341|P1|Overall Study|Adverse Event|3
408538|NCT00667368|1368368|P2|Overall Study|Discontinued early|17
408539|NCT00667368|1368369|P1|Overall Study|Discontinued early|24
408540|NCT00667368|1368368|P2|Overall Study|Lost to Follow-up|155
408541|NCT00667368|1368369|P1|Overall Study|Lost to Follow-up|176
408542|NCT00667355|1368377|P1|Overall Study|Other reason was not specified|5
408543|NCT00667355|1368377|P1|Overall Study|Lost to Follow-up|1
408544|NCT00667355|1368377|P1|Overall Study|Adverse Event|5
408545|NCT00667342|1368402|P3|Overall Study|Ineligible|1
408546|NCT00667342|1368403|P2|Overall Study|Ineligible|0
408547|NCT00667342|1368404|P1|Overall Study|Ineligible|0
408548|NCT00667342|1368402|P3|Overall Study|Adverse Event|1
408549|NCT00667342|1368403|P2|Overall Study|Adverse Event|0
408550|NCT00667342|1368404|P1|Overall Study|Adverse Event|0
408551|NCT00667342|1368402|P3|Overall Study|Relapse or tumor progression|7
408552|NCT00667342|1368403|P2|Overall Study|Relapse or tumor progression|0
408553|NCT00667342|1368404|P1|Overall Study|Relapse or tumor progression|9
408554|NCT00667342|1368402|P3|Overall Study|Physician Decision|0
408555|NCT00667342|1368403|P2|Overall Study|Physician Decision|0
408556|NCT00667342|1368404|P1|Overall Study|Physician Decision|3
408557|NCT00667342|1368402|P3|Overall Study|Withdrawal by Subject|0
408558|NCT00667342|1368403|P2|Overall Study|Withdrawal by Subject|0
408559|NCT00667342|1368404|P1|Overall Study|Withdrawal by Subject|1
408560|NCT00667342|1368402|P3|Overall Study|Protocol Violation|0
408561|NCT00667342|1368403|P2|Overall Study|Protocol Violation|0
408562|NCT00667342|1368404|P1|Overall Study|Protocol Violation|1
408563|NCT00667277|1368442|P1|Overall Study|Withdrawal by Subject|2
408564|NCT00667251|1368449|P2|Overall Study|Symptomatic progression|2
408565|NCT00667251|1368450|P1|Overall Study|Symptomatic progression|1
408566|NCT00667251|1368449|P2|Overall Study|Intercurrent Illness|3
408567|NCT00667251|1368450|P1|Overall Study|Intercurrent Illness|4
408568|NCT00667251|1368449|P2|Overall Study|Other/missing|84
408569|NCT00667251|1368450|P1|Overall Study|Other/missing|46
408570|NCT00667251|1368449|P2|Overall Study|Withdrawal by Subject|2
408571|NCT00667251|1368450|P1|Overall Study|Withdrawal by Subject|6
408572|NCT00667251|1368449|P2|Overall Study|Adverse Event|4
408573|NCT00667251|1368450|P1|Overall Study|Adverse Event|13
408574|NCT00667225|1368476|P2|Overall Study|Lost to Follow-up|1
408575|NCT00667225|1368477|P1|Overall Study|Lost to Follow-up|0
408576|NCT00667225|1368476|P2|Overall Study|Subject had no more lesions to treat.|0
408577|NCT00667225|1368477|P1|Overall Study|Subject had no more lesions to treat.|1
408578|NCT00667095|1368498|P2|Overall Study|Withdrawal by Subject|1
408579|NCT00667095|1368499|P1|Overall Study|Withdrawal by Subject|0
408580|NCT00666965|1368531|P4|Overall Study|Withdrawal by Subject|2
408581|NCT00666965|1368532|P3|Overall Study|Withdrawal by Subject|0
408582|NCT00666965|1368533|P2|Overall Study|Withdrawal by Subject|0
408583|NCT00666965|1368534|P1|Overall Study|Withdrawal by Subject|0
408584|NCT00666965|1368531|P4|Overall Study|Discontinuation criteria|2
408585|NCT00666965|1368532|P3|Overall Study|Discontinuation criteria|1
408586|NCT00666965|1368533|P2|Overall Study|Discontinuation criteria|1
408587|NCT00666965|1368534|P1|Overall Study|Discontinuation criteria|2
408588|NCT00666965|1368531|P4|Overall Study|Protocol Violation|2
408589|NCT00666965|1368532|P3|Overall Study|Protocol Violation|0
408590|NCT00666965|1368533|P2|Overall Study|Protocol Violation|0
408591|NCT00666965|1368534|P1|Overall Study|Protocol Violation|0
408592|NCT00666965|1368531|P4|Overall Study|Lack of Efficacy|0
408593|NCT00666965|1368532|P3|Overall Study|Lack of Efficacy|0
408594|NCT00666965|1368533|P2|Overall Study|Lack of Efficacy|1
408595|NCT00666965|1368534|P1|Overall Study|Lack of Efficacy|1
408596|NCT00666965|1368531|P4|Overall Study|Adverse Event|9
408597|NCT00666965|1368532|P3|Overall Study|Adverse Event|1
408598|NCT00666965|1368533|P2|Overall Study|Adverse Event|2
408599|NCT00666965|1368534|P1|Overall Study|Adverse Event|0
408600|NCT00666926|1368564|P16|Overall Study|Death|0
408601|NCT00666926|1368565|P15|Overall Study|Death|0
408602|NCT00666926|1368566|P14|Overall Study|Death|0
408603|NCT00666926|1368567|P13|Overall Study|Death|0
408604|NCT00666926|1368568|P12|Overall Study|Death|1
408605|NCT00666926|1368569|P11|Overall Study|Death|0
408606|NCT00666926|1368570|P10|Overall Study|Death|0
408607|NCT00666926|1368571|P9|Overall Study|Death|0
408608|NCT00666926|1368572|P8|Overall Study|Death|0
408609|NCT00666926|1368573|P7|Overall Study|Death|0
408610|NCT00666926|1368574|P6|Overall Study|Death|0
408611|NCT00666926|1368575|P5|Overall Study|Death|0
408612|NCT00666926|1368576|P4|Overall Study|Death|0
408613|NCT00666926|1368577|P3|Overall Study|Death|0
408614|NCT00666926|1368578|P2|Overall Study|Death|0
408615|NCT00666926|1368579|P1|Overall Study|Death|0
408616|NCT00666926|1368564|P16|Overall Study|Withdrawal by Subject|3
408617|NCT00666926|1368565|P15|Overall Study|Withdrawal by Subject|3
408618|NCT00666926|1368566|P14|Overall Study|Withdrawal by Subject|1
408619|NCT00666926|1368567|P13|Overall Study|Withdrawal by Subject|0
408620|NCT00666926|1368568|P12|Overall Study|Withdrawal by Subject|3
408621|NCT00666926|1368569|P11|Overall Study|Withdrawal by Subject|0
408622|NCT00666926|1368570|P10|Overall Study|Withdrawal by Subject|3
408623|NCT00666926|1368571|P9|Overall Study|Withdrawal by Subject|0
408624|NCT00666926|1368572|P8|Overall Study|Withdrawal by Subject|1
408625|NCT00666926|1368573|P7|Overall Study|Withdrawal by Subject|0
408626|NCT00666926|1368574|P6|Overall Study|Withdrawal by Subject|0
408627|NCT00666926|1368575|P5|Overall Study|Withdrawal by Subject|0
408628|NCT00666926|1368576|P4|Overall Study|Withdrawal by Subject|0
408629|NCT00666926|1368577|P3|Overall Study|Withdrawal by Subject|0
408630|NCT00666926|1368578|P2|Overall Study|Withdrawal by Subject|0
408631|NCT00666926|1368579|P1|Overall Study|Withdrawal by Subject|0
408632|NCT00666926|1368564|P16|Overall Study|Other|4
408633|NCT00666926|1368565|P15|Overall Study|Other|4
408634|NCT00666926|1368566|P14|Overall Study|Other|2
408635|NCT00666926|1368567|P13|Overall Study|Other|3
408636|NCT00666926|1368568|P12|Overall Study|Other|26
408637|NCT00666926|1368569|P11|Overall Study|Other|3
408638|NCT00666926|1368570|P10|Overall Study|Other|5
408639|NCT00666926|1368571|P9|Overall Study|Other|3
408640|NCT00666926|1368572|P8|Overall Study|Other|0
408641|NCT00666926|1368573|P7|Overall Study|Other|4
408642|NCT00666926|1368574|P6|Overall Study|Other|3
408643|NCT00666926|1368575|P5|Overall Study|Other|3
408644|NCT00666926|1368576|P4|Overall Study|Other|3
408645|NCT00666926|1368577|P3|Overall Study|Other|3
408646|NCT00666926|1368578|P2|Overall Study|Other|4
408647|NCT00666926|1368579|P1|Overall Study|Other|2
408648|NCT00666926|1368564|P16|Overall Study|Lost to Follow-up|0
408649|NCT00666926|1368565|P15|Overall Study|Lost to Follow-up|0
408650|NCT00666926|1368566|P14|Overall Study|Lost to Follow-up|0
408651|NCT00666926|1368567|P13|Overall Study|Lost to Follow-up|0
408652|NCT00666926|1368568|P12|Overall Study|Lost to Follow-up|0
408653|NCT00666926|1368569|P11|Overall Study|Lost to Follow-up|0
408654|NCT00666926|1368570|P10|Overall Study|Lost to Follow-up|0
408655|NCT00666926|1368571|P9|Overall Study|Lost to Follow-up|0
408656|NCT00666926|1368572|P8|Overall Study|Lost to Follow-up|0
408657|NCT00666926|1368573|P7|Overall Study|Lost to Follow-up|0
408658|NCT00666926|1368574|P6|Overall Study|Lost to Follow-up|0
408659|NCT00666926|1368575|P5|Overall Study|Lost to Follow-up|0
408660|NCT00666926|1368576|P4|Overall Study|Lost to Follow-up|1
408661|NCT00666926|1368577|P3|Overall Study|Lost to Follow-up|0
408662|NCT00666926|1368578|P2|Overall Study|Lost to Follow-up|0
408663|NCT00666926|1368579|P1|Overall Study|Lost to Follow-up|0
408664|NCT00666926|1368564|P16|Overall Study|Lack of Efficacy|0
408665|NCT00666926|1368565|P15|Overall Study|Lack of Efficacy|0
408666|NCT00666926|1368566|P14|Overall Study|Lack of Efficacy|0
408667|NCT00666926|1368567|P13|Overall Study|Lack of Efficacy|0
408668|NCT00666926|1368568|P12|Overall Study|Lack of Efficacy|1
408669|NCT00666926|1368569|P11|Overall Study|Lack of Efficacy|0
408670|NCT00666926|1368570|P10|Overall Study|Lack of Efficacy|0
408671|NCT00666926|1368571|P9|Overall Study|Lack of Efficacy|0
408672|NCT00666926|1368572|P8|Overall Study|Lack of Efficacy|0
408673|NCT00666926|1368573|P7|Overall Study|Lack of Efficacy|0
408674|NCT00666926|1368574|P6|Overall Study|Lack of Efficacy|1
408675|NCT00666926|1368575|P5|Overall Study|Lack of Efficacy|0
408676|NCT00666926|1368576|P4|Overall Study|Lack of Efficacy|0
408677|NCT00666926|1368577|P3|Overall Study|Lack of Efficacy|0
408678|NCT00666926|1368578|P2|Overall Study|Lack of Efficacy|0
408679|NCT00666926|1368579|P1|Overall Study|Lack of Efficacy|0
408680|NCT00666926|1368564|P16|Overall Study|Laboratory abnormality|1
408681|NCT00666926|1368565|P15|Overall Study|Laboratory abnormality|0
408682|NCT00666926|1368566|P14|Overall Study|Laboratory abnormality|0
408683|NCT00666926|1368567|P13|Overall Study|Laboratory abnormality|0
408684|NCT00666926|1368568|P12|Overall Study|Laboratory abnormality|0
408685|NCT00666926|1368569|P11|Overall Study|Laboratory abnormality|1
408686|NCT00666926|1368570|P10|Overall Study|Laboratory abnormality|0
408687|NCT00666926|1368571|P9|Overall Study|Laboratory abnormality|0
408688|NCT00666926|1368572|P8|Overall Study|Laboratory abnormality|0
408689|NCT00666926|1368573|P7|Overall Study|Laboratory abnormality|0
408690|NCT00666926|1368574|P6|Overall Study|Laboratory abnormality|0
408691|NCT00666926|1368575|P5|Overall Study|Laboratory abnormality|0
408692|NCT00666926|1368576|P4|Overall Study|Laboratory abnormality|0
408693|NCT00666926|1368577|P3|Overall Study|Laboratory abnormality|0
408694|NCT00666926|1368578|P2|Overall Study|Laboratory abnormality|0
408695|NCT00666926|1368579|P1|Overall Study|Laboratory abnormality|0
408696|NCT00666926|1368564|P16|Overall Study|Adverse Event|0
408697|NCT00666926|1368565|P15|Overall Study|Adverse Event|0
408698|NCT00666926|1368566|P14|Overall Study|Adverse Event|1
408699|NCT00666926|1368567|P13|Overall Study|Adverse Event|0
408700|NCT00666926|1368568|P12|Overall Study|Adverse Event|2
408701|NCT00666926|1368569|P11|Overall Study|Adverse Event|2
408702|NCT00666926|1368570|P10|Overall Study|Adverse Event|2
408703|NCT00666926|1368571|P9|Overall Study|Adverse Event|0
408704|NCT00666926|1368572|P8|Overall Study|Adverse Event|0
408705|NCT00666926|1368573|P7|Overall Study|Adverse Event|0
408706|NCT00666926|1368574|P6|Overall Study|Adverse Event|0
408707|NCT00666926|1368575|P5|Overall Study|Adverse Event|0
408708|NCT00666926|1368576|P4|Overall Study|Adverse Event|0
408709|NCT00666926|1368577|P3|Overall Study|Adverse Event|0
408710|NCT00666926|1368578|P2|Overall Study|Adverse Event|0
408711|NCT00666926|1368579|P1|Overall Study|Adverse Event|0
408712|NCT00666835|1368888|P2|Overall Study|Physician Decision|2
408713|NCT00666835|1368889|P1|Overall Study|Physician Decision|1
408714|NCT00666835|1368888|P2|Overall Study|Planned operation|0
408715|NCT00666835|1368889|P1|Overall Study|Planned operation|2
408716|NCT00666835|1368888|P2|Overall Study|Hemoglobulin concentration|3
408717|NCT00666835|1368889|P1|Overall Study|Hemoglobulin concentration|4
408718|NCT00666835|1368888|P2|Overall Study|Kidney Transplantation (NTX)|2
408719|NCT00666835|1368889|P1|Overall Study|Kidney Transplantation (NTX)|10
408720|NCT00666835|1368888|P2|Overall Study|Death|4
408721|NCT00666835|1368889|P1|Overall Study|Death|15
408722|NCT00666835|1368888|P2|Overall Study|Protocol Violation|0
408723|NCT00666835|1368889|P1|Overall Study|Protocol Violation|2
408724|NCT00666835|1368888|P2|Overall Study|Adverse Event|6
408725|NCT00666835|1368889|P1|Overall Study|Adverse Event|7
408726|NCT00666835|1368888|P2|Overall Study|Incl./excl. not fulfilled|2
408727|NCT00666835|1368889|P1|Overall Study|Incl./excl. not fulfilled|7
408728|NCT00666835|1368888|P2|Overall Study|Lack of Efficacy|1
408729|NCT00666835|1368889|P1|Overall Study|Lack of Efficacy|0
408730|NCT00666835|1368888|P2|Overall Study|Withdrawal by Subject|2
408731|NCT00666835|1368889|P1|Overall Study|Withdrawal by Subject|5
408732|NCT00666757|1368899|P2|Overall Study|Sponsor decision|1
408733|NCT00666757|1368900|P1|Overall Study|Sponsor decision|0
408734|NCT00666757|1368899|P2|Overall Study|Physician Decision|2
408735|NCT00666757|1368900|P1|Overall Study|Physician Decision|0
408736|NCT00666757|1368899|P2|Overall Study|Lack of Efficacy|6
408737|NCT00666757|1368900|P1|Overall Study|Lack of Efficacy|3
408738|NCT00666757|1368899|P2|Overall Study|Withdrawal by Subject|17
408739|NCT00666757|1368900|P1|Overall Study|Withdrawal by Subject|13
408740|NCT00666757|1368899|P2|Overall Study|Adverse Event|12
408741|NCT00666757|1368900|P1|Overall Study|Adverse Event|22
408742|NCT00666757|1368899|P2|Overall Study|Protocol Violation|24
408743|NCT00666757|1368900|P1|Overall Study|Protocol Violation|23
408744|NCT00666757|1368899|P2|Overall Study|Lost to Follow-up|35
408745|NCT00666757|1368900|P1|Overall Study|Lost to Follow-up|39
408746|NCT00666718|1368959|P2|Overall Study|Physician Decision|2
408747|NCT00666718|1368960|P1|Overall Study|Physician Decision|0
408748|NCT00666718|1368959|P2|Overall Study|Withdrawal by Subject|12
408749|NCT00666718|1368960|P1|Overall Study|Withdrawal by Subject|7
408750|NCT00666718|1368959|P2|Overall Study|Protocol Violation|3
408751|NCT00666718|1368960|P1|Overall Study|Protocol Violation|1
408752|NCT00666718|1368959|P2|Overall Study|Entry Criteria Not Met|0
408753|NCT00666718|1368960|P1|Overall Study|Entry Criteria Not Met|2
408754|NCT00666718|1368959|P2|Overall Study|Lost to Follow-up|0
408755|NCT00666718|1368960|P1|Overall Study|Lost to Follow-up|1
408756|NCT00666718|1368959|P2|Overall Study|Death|0
408757|NCT00666718|1368960|P1|Overall Study|Death|1
408758|NCT00666718|1368959|P2|Overall Study|Adverse Event|1
408759|NCT00666718|1368960|P1|Overall Study|Adverse Event|0
408760|NCT00666705|1368986|P1|Overall Study|Withdrawal by Subject|1
408761|NCT00666679|1369005|P2|Second Intervention|Death|1
408762|NCT00666679|1369006|P1|Second Intervention|Death|0
408763|NCT00666679|1369005|P2|Second Intervention|Adverse Event|0
408764|NCT00666679|1369006|P1|Second Intervention|Adverse Event|1
408765|NCT00666679|1369005|P2|Washout Period of 1 Week|Protocol Violation|1
408766|NCT00666679|1369006|P1|Washout Period of 1 Week|Protocol Violation|0
408767|NCT00666679|1369005|P2|Washout Period of 1 Week|Lost to Follow-up|1
408768|NCT00666679|1369006|P1|Washout Period of 1 Week|Lost to Follow-up|0
408769|NCT00666679|1369005|P2|First Intervention|Randomized did not start treatment|1
408770|NCT00666679|1369006|P1|First Intervention|Randomized did not start treatment|1
408771|NCT00666679|1369005|P2|First Intervention|Withdrawal by Subject|0
408772|NCT00666679|1369006|P1|First Intervention|Withdrawal by Subject|1
408773|NCT00666679|1369005|P2|First Intervention|Protocol Violation|0
408774|NCT00666679|1369006|P1|First Intervention|Protocol Violation|1
408775|NCT00666679|1369005|P2|First Intervention|Lost to Follow-up|0
408776|NCT00666679|1369006|P1|First Intervention|Lost to Follow-up|1
408777|NCT00666588|1369036|P4|Overall Study|inevaluable|0
408778|NCT00666588|1369037|P3|Overall Study|inevaluable|0
408779|NCT00666588|1369038|P2|Overall Study|inevaluable|0
408780|NCT00666588|1369039|P1|Overall Study|inevaluable|2
408781|NCT00666588|1369036|P4|Overall Study|ineligible|2
408782|NCT00666588|1369037|P3|Overall Study|ineligible|0
408783|NCT00666588|1369038|P2|Overall Study|ineligible|0
408784|NCT00666588|1369039|P1|Overall Study|ineligible|2
408785|NCT00666562|1369072|P3|Overall Study|Concomitant Medication|0
408786|NCT00666562|1369073|P2|Overall Study|Concomitant Medication|1
408787|NCT00666562|1369074|P1|Overall Study|Concomitant Medication|0
408788|NCT00666562|1369072|P3|Overall Study|Withdrawal by Subject|0
408789|NCT00666562|1369073|P2|Overall Study|Withdrawal by Subject|1
408790|NCT00666562|1369074|P1|Overall Study|Withdrawal by Subject|0
408791|NCT00666536|1369121|P2|Overall Study|Lost to Follow-up|3
408792|NCT00666536|1369122|P1|Overall Study|Lost to Follow-up|4
408793|NCT00666536|1369121|P2|Overall Study|Withdrawal by Subject|9
408794|NCT00666536|1369122|P1|Overall Study|Withdrawal by Subject|10
408795|NCT00666536|1369121|P2|Overall Study|Protocol deviation(s)|6
408796|NCT00666536|1369122|P1|Overall Study|Protocol deviation(s)|8
408797|NCT00666536|1369121|P2|Overall Study|Unsatisfactory therapeutic effect|0
408798|NCT00666536|1369122|P1|Overall Study|Unsatisfactory therapeutic effect|2
408799|NCT00666536|1369121|P2|Overall Study|Adverse Event|19
408800|NCT00666536|1369122|P1|Overall Study|Adverse Event|9
408801|NCT00666458|1369140|P2|Overall Study|Medical history of anemia|0
408802|NCT00666458|1369141|P1|Overall Study|Medical history of anemia|1
408803|NCT00666458|1369140|P2|Overall Study|Safety reasons|0
408804|NCT00666458|1369141|P1|Overall Study|Safety reasons|1
408805|NCT00666458|1369140|P2|Overall Study|Severe non-compliance to the protocol|1
408806|NCT00666458|1369141|P1|Overall Study|Severe non-compliance to the protocol|1
408807|NCT00666458|1369140|P2|Overall Study|Study specific discontinuation criteria|7
408808|NCT00666458|1369141|P1|Overall Study|Study specific discontinuation criteria|14
408809|NCT00666458|1369140|P2|Overall Study|Incorrect enrollment|1
408810|NCT00666458|1369141|P1|Overall Study|Incorrect enrollment|7
408811|NCT00666458|1369140|P2|Overall Study|Administrative reason by sponsor|1
408812|NCT00666458|1369141|P1|Overall Study|Administrative reason by sponsor|1
408813|NCT00666458|1369140|P2|Overall Study|Lost to Follow-up|3
408814|NCT00666458|1369141|P1|Overall Study|Lost to Follow-up|0
408815|NCT00666458|1369140|P2|Overall Study|Withdrawal by Subject|4
408816|NCT00666458|1369141|P1|Overall Study|Withdrawal by Subject|5
408817|NCT00666458|1369140|P2|Overall Study|Adverse Event|7
408818|NCT00666458|1369141|P1|Overall Study|Adverse Event|8
408819|NCT00666328|1369229|P1|Overall Study|No longer met eligibility criteria|1
408820|NCT00666328|1369229|P1|Overall Study|Lost to Follow-up|2
408821|NCT00666328|1369229|P1|Overall Study|Death|2
408822|NCT00666276|1369242|P1|Overall Study|Protocol Violation|34
408823|NCT00666263|1369266|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
408824|NCT00666263|1369267|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
408825|NCT00666263|1369266|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
408826|NCT00666263|1369267|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
408827|NCT00666263|1369266|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
408828|NCT00666263|1369267|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
408829|NCT00666224|1369411|P2|Open-Label|Undefined/Unknown|1
408830|NCT00666224|1369412|P1|Open-Label|Undefined/Unknown|1
408831|NCT00666224|1369411|P2|Open-Label|Noncompliance|1
408832|NCT00666224|1369412|P1|Open-Label|Noncompliance|2
408833|NCT00666224|1369411|P2|Open-Label|Pregnancy|5
408834|NCT00666224|1369412|P1|Open-Label|Pregnancy|1
408835|NCT00666224|1369411|P2|Open-Label|Physician Decision|5
408836|NCT00666224|1369412|P1|Open-Label|Physician Decision|7
408837|NCT00666224|1369411|P2|Open-Label|Withdrawal by Subject|25
408838|NCT00666224|1369412|P1|Open-Label|Withdrawal by Subject|12
408839|NCT00666224|1369411|P2|Open-Label|Lost to Follow-up|5
408840|NCT00666224|1369412|P1|Open-Label|Lost to Follow-up|4
408841|NCT00666224|1369411|P2|Open-Label|Adverse Event|43
408842|NCT00666224|1369412|P1|Open-Label|Adverse Event|8
408843|NCT00666224|1369411|P2|Double-Blind|Undefined/Unknown|1
408844|NCT00666224|1369412|P1|Double-Blind|Undefined/Unknown|4
408845|NCT00666224|1369411|P2|Double-Blind|Death|0
408846|NCT00666224|1369412|P1|Double-Blind|Death|1
408847|NCT00666224|1369411|P2|Double-Blind|Noncompliance|0
408848|NCT00666224|1369412|P1|Double-Blind|Noncompliance|1
408849|NCT00666224|1369411|P2|Double-Blind|Pregnancy|2
408850|NCT00666224|1369412|P1|Double-Blind|Pregnancy|3
408851|NCT00666224|1369411|P2|Double-Blind|Sponsor decision|0
408852|NCT00666224|1369412|P1|Double-Blind|Sponsor decision|1
408853|NCT00666224|1369411|P2|Double-Blind|Physician Decision|3
408854|NCT00666224|1369412|P1|Double-Blind|Physician Decision|0
408855|NCT00666224|1369411|P2|Double-Blind|Withdrawal by Subject|14
408856|NCT00666224|1369412|P1|Double-Blind|Withdrawal by Subject|18
408857|NCT00666224|1369411|P2|Double-Blind|Lost to Follow-up|2
408858|NCT00666224|1369412|P1|Double-Blind|Lost to Follow-up|2
408859|NCT00666224|1369411|P2|Double-Blind|Adverse Event|5
408860|NCT00666224|1369412|P1|Double-Blind|Adverse Event|15
408861|NCT00666211|1369431|P2|Overall Study|Physician Decision|1
408862|NCT00666211|1369432|P1|Overall Study|Physician Decision|0
408863|NCT00666211|1369431|P2|Overall Study|off tx for other complicating disease|1
408864|NCT00666211|1369432|P1|Overall Study|off tx for other complicating disease|0
408865|NCT00666211|1369431|P2|Overall Study|Death|2
408866|NCT00666211|1369432|P1|Overall Study|Death|0
408867|NCT00666211|1369431|P2|Overall Study|hospital admission|5
408868|NCT00666211|1369432|P1|Overall Study|hospital admission|0
408869|NCT00666211|1369431|P2|Overall Study|toxicity|2
408870|NCT00666211|1369432|P1|Overall Study|toxicity|0
408871|NCT00666211|1369431|P2|Overall Study|Lost to Follow-up|0
408872|NCT00666211|1369432|P1|Overall Study|Lost to Follow-up|2
408873|NCT00666211|1369431|P2|Overall Study|disease progression|8
408874|NCT00666211|1369432|P1|Overall Study|disease progression|1
408875|NCT00666211|1369431|P2|Overall Study|patient non-compliant|6
408876|NCT00666211|1369432|P1|Overall Study|patient non-compliant|6
408877|NCT00666211|1369431|P2|Overall Study|went off medication, no more pain|0
408878|NCT00666211|1369432|P1|Overall Study|went off medication, no more pain|1
408879|NCT00666211|1369431|P2|Overall Study|Withdrawal by Subject|13
408880|NCT00666211|1369432|P1|Overall Study|Withdrawal by Subject|10
408881|NCT00666198|1369450|P1|Overall Study|No Drug Administration|4
408882|NCT00666198|1369450|P1|Overall Study|Safety Not Assessable|6
408883|NCT00666198|1369450|P1|Overall Study|No Visit After First Day of Treatment|13
408884|NCT00666198|1369450|P1|Overall Study|Protocol Violation|10
408885|NCT00665925|1369478|P4|Overall Study|Due to exclusion criteria|0
408886|NCT00665925|1369479|P3|Overall Study|Due to exclusion criteria|0
408887|NCT00665925|1369480|P2|Overall Study|Due to exclusion criteria|0
408888|NCT00665925|1369481|P1|Overall Study|Due to exclusion criteria|1
408889|NCT00665925|1369478|P4|Overall Study|Enrolled by mistake|1
408890|NCT00665925|1369479|P3|Overall Study|Enrolled by mistake|0
408891|NCT00665925|1369480|P2|Overall Study|Enrolled by mistake|0
408892|NCT00665925|1369481|P1|Overall Study|Enrolled by mistake|0
408893|NCT00665925|1369478|P4|Overall Study|Adverse Event|5
408894|NCT00665925|1369479|P3|Overall Study|Adverse Event|10
408895|NCT00665925|1369480|P2|Overall Study|Adverse Event|5
408896|NCT00665925|1369481|P1|Overall Study|Adverse Event|1
408897|NCT00665925|1369478|P4|Overall Study|Severe Non-Compliance to Protocol|1
408898|NCT00665925|1369479|P3|Overall Study|Severe Non-Compliance to Protocol|1
408899|NCT00665925|1369480|P2|Overall Study|Severe Non-Compliance to Protocol|0
408900|NCT00665925|1369481|P1|Overall Study|Severe Non-Compliance to Protocol|0
408901|NCT00665925|1369478|P4|Overall Study|Physician Decision|2
408902|NCT00665925|1369479|P3|Overall Study|Physician Decision|1
408903|NCT00665925|1369480|P2|Overall Study|Physician Decision|0
408904|NCT00665925|1369481|P1|Overall Study|Physician Decision|0
408905|NCT00665925|1369478|P4|Overall Study|Withdrawal by Subject|2
408906|NCT00665925|1369479|P3|Overall Study|Withdrawal by Subject|3
408907|NCT00665925|1369480|P2|Overall Study|Withdrawal by Subject|2
408908|NCT00665925|1369481|P1|Overall Study|Withdrawal by Subject|2
408909|NCT00665925|1369478|P4|Overall Study|Lost to Follow-up|2
408910|NCT00665925|1369479|P3|Overall Study|Lost to Follow-up|2
408911|NCT00665925|1369480|P2|Overall Study|Lost to Follow-up|2
408912|NCT00665925|1369481|P1|Overall Study|Lost to Follow-up|1
408913|NCT00665925|1369478|P4|Overall Study|Lack of Efficacy|8
408914|NCT00665925|1369479|P3|Overall Study|Lack of Efficacy|9
408915|NCT00665925|1369480|P2|Overall Study|Lack of Efficacy|8
408916|NCT00665925|1369481|P1|Overall Study|Lack of Efficacy|10
408917|NCT00665847|1369892|P1|Overall Study|Switch to Commercial Medication|1
408918|NCT00665847|1369892|P1|Overall Study|Subject ineligible to continue the trial|1
408919|NCT00665847|1369892|P1|Overall Study|Resistance to TMC125|1
408920|NCT00665847|1369892|P1|Overall Study|Subject reached a virologic endpoint|4
408921|NCT00665847|1369892|P1|Overall Study|Subject non-compliant|8
408922|NCT00665847|1369892|P1|Overall Study|Withdrawal by Subject|2
408923|NCT00665847|1369892|P1|Overall Study|Adverse Event|8
408924|NCT00665626|1369911|P2|Overall Study|Death|0
408925|NCT00665626|1369912|P1|Overall Study|Death|1
408926|NCT00665626|1369911|P2|Overall Study|Unably to comply with dosing regimen|1
408927|NCT00665626|1369912|P1|Overall Study|Unably to comply with dosing regimen|0
408928|NCT00665626|1369911|P2|Overall Study|Did not fulfil inclusion criteria|1
408929|NCT00665626|1369912|P1|Overall Study|Did not fulfil inclusion criteria|0
408930|NCT00665626|1369911|P2|Overall Study|Due to exclusion criteria|1
408931|NCT00665626|1369912|P1|Overall Study|Due to exclusion criteria|0
408932|NCT00665626|1369911|P2|Overall Study|Adverse Event|9
408933|NCT00665626|1369912|P1|Overall Study|Adverse Event|1
408934|NCT00665626|1369911|P2|Overall Study|Protocol Violation|2
408935|NCT00665626|1369912|P1|Overall Study|Protocol Violation|0
408936|NCT00665626|1369911|P2|Overall Study|Withdrawal by Subject|1
408937|NCT00665626|1369912|P1|Overall Study|Withdrawal by Subject|0
408938|NCT00665626|1369911|P2|Overall Study|Lost to Follow-up|2
408939|NCT00665626|1369912|P1|Overall Study|Lost to Follow-up|0
408940|NCT00665626|1369911|P2|Overall Study|Lack of Efficacy|5
408941|NCT00665626|1369912|P1|Overall Study|Lack of Efficacy|8
408942|NCT00665444|1369989|P1|Overall Study|Study Terminated by Study Sponsor|1
408943|NCT00665444|1369989|P1|Overall Study|Physician Decision|1
408944|NCT00665431|1370001|P3|Overall Study|Other|2
408945|NCT00665431|1370002|P2|Overall Study|Other|7
408946|NCT00665431|1370003|P1|Overall Study|Other|4
408947|NCT00665431|1370001|P3|Overall Study|Lost to Follow-up|1
408948|NCT00665431|1370002|P2|Overall Study|Lost to Follow-up|3
408949|NCT00665431|1370003|P1|Overall Study|Lost to Follow-up|3
408950|NCT00665431|1370001|P3|Overall Study|Withdrawal by Subject|15
408951|NCT00665431|1370002|P2|Overall Study|Withdrawal by Subject|25
408952|NCT00665431|1370003|P1|Overall Study|Withdrawal by Subject|17
408953|NCT00665431|1370001|P3|Overall Study|Adverse Event|6
408954|NCT00665431|1370002|P2|Overall Study|Adverse Event|22
408955|NCT00665431|1370003|P1|Overall Study|Adverse Event|16
408956|NCT00665366|1370046|P2|Overall Study|Other reasons|1
408957|NCT00665366|1370047|P1|Overall Study|Other reasons|4
408958|NCT00665366|1370046|P2|Overall Study|No longer meets study criteria|1
408959|NCT00665366|1370047|P1|Overall Study|No longer meets study criteria|0
408960|NCT00665366|1370046|P2|Overall Study|Pregnancy|0
408961|NCT00665366|1370047|P1|Overall Study|Pregnancy|1
408962|NCT00665366|1370046|P2|Overall Study|Poor compliance/noncompliance|5
408963|NCT00665366|1370047|P1|Overall Study|Poor compliance/noncompliance|3
408964|NCT00665366|1370046|P2|Overall Study|Lost to Follow-up|5
408965|NCT00665366|1370047|P1|Overall Study|Lost to Follow-up|3
408966|NCT00665366|1370046|P2|Overall Study|Withdrawal by Subject|14
408967|NCT00665366|1370047|P1|Overall Study|Withdrawal by Subject|11
408968|NCT00665366|1370046|P2|Overall Study|Adverse Event|23
408969|NCT00665366|1370047|P1|Overall Study|Adverse Event|25
408970|NCT00665366|1370046|P2|Overall Study|Lack of Efficacy|10
408971|NCT00665366|1370047|P1|Overall Study|Lack of Efficacy|11
408972|NCT00665353|1370075|P1|Study Step 2|Lack of Efficacy|12
408973|NCT00665353|1370075|P1|Study Step 2|Lost to Follow-up|2
408974|NCT00665353|1370075|P1|Study Step 1|Withdrawal by Subject|2
408975|NCT00665353|1370075|P1|Study Step 1|Adverse Event|1
408976|NCT00665002|1370092|P1|Overall Study|Cytogenetic resistance|1
408977|NCT00665002|1370092|P1|Overall Study|Progression/relapse during treatment|11
408978|NCT00664742|1370106|P1|Overall Study|Lost to Follow-up|92
408979|NCT00664742|1370106|P1|Overall Study|Withdrawal by Subject|31
408980|NCT00664742|1370106|P1|Overall Study|Withdrawn due to adverse events|3
408981|NCT00664560|1370114|P3|Overall Study|Other|5
408982|NCT00664560|1370115|P2|Overall Study|Other|4
408983|NCT00664560|1370116|P1|Overall Study|Other|11
408984|NCT00664560|1370114|P3|Overall Study|Lost to Follow-up|0
408985|NCT00664560|1370115|P2|Overall Study|Lost to Follow-up|2
408986|NCT00664560|1370116|P1|Overall Study|Lost to Follow-up|0
408987|NCT00664560|1370114|P3|Overall Study|Withdrawal by Subject|7
408988|NCT00664560|1370115|P2|Overall Study|Withdrawal by Subject|13
408989|NCT00664560|1370116|P1|Overall Study|Withdrawal by Subject|9
408990|NCT00664560|1370114|P3|Overall Study|Adverse Event|7
408991|NCT00664560|1370115|P2|Overall Study|Adverse Event|16
408992|NCT00664560|1370116|P1|Overall Study|Adverse Event|19
408993|NCT00664534|1370159|P2|Overall Study|Sponsor decision|6
408994|NCT00664534|1370160|P1|Overall Study|Sponsor decision|8
408995|NCT00664534|1370159|P2|Overall Study|Physician Decision|0
408996|NCT00664534|1370160|P1|Overall Study|Physician Decision|8
408997|NCT00664534|1370159|P2|Overall Study|Withdrawal by Subject|6
408998|NCT00664534|1370160|P1|Overall Study|Withdrawal by Subject|7
408999|NCT00664534|1370159|P2|Overall Study|Protocol Violation|8
409000|NCT00664534|1370160|P1|Overall Study|Protocol Violation|10
409001|NCT00664534|1370159|P2|Overall Study|Lost to Follow-up|10
409002|NCT00664534|1370160|P1|Overall Study|Lost to Follow-up|6
409003|NCT00664534|1370159|P2|Overall Study|Adverse Event|3
409004|NCT00664534|1370160|P1|Overall Study|Adverse Event|2
409005|NCT00664521|1370188|P2|Overall Study|Other|0
409006|NCT00664521|1370189|P1|Overall Study|Other|1
409007|NCT00664521|1370188|P2|Overall Study|Lost to Follow-up|0
409008|NCT00664521|1370189|P1|Overall Study|Lost to Follow-up|1
409009|NCT00664521|1370188|P2|Overall Study|Adverse Event|1
409010|NCT00664521|1370189|P1|Overall Study|Adverse Event|4
409011|NCT00664326|1370215|P1|Overall Study|ongoing with treatment|6
409012|NCT00664326|1370215|P1|Overall Study|Physician Decision|1
409013|NCT00664326|1370215|P1|Overall Study|Withdrawal by Subject|1
409014|NCT00664326|1370215|P1|Overall Study|Noncompliance with study medication|3
409015|NCT00664326|1370215|P1|Overall Study|Adverse Event|13
409016|NCT00664209|1370234|P1|Study Treatment Period|Withdrawal by Subject|2
409017|NCT00664209|1370234|P1|Study Treatment Period|Physician Decision|4
409018|NCT00664209|1370234|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
409019|NCT00664105|1370242|P1|Overall Study|Disease progression|7
409020|NCT00664105|1370242|P1|Overall Study|Adverse Event|9
409021|NCT00664105|1370242|P1|Overall Study|Withdrawal by Subject|5
409022|NCT00664105|1370242|P1|Overall Study|Death|3
409023|NCT00664066|1370249|P1|Overall Study|Study terminated|3
409024|NCT00663962|1370255|P2|Overall Study|somnolence|0
409025|NCT00663962|1370256|P1|Overall Study|somnolence|1
409026|NCT00663923|1370262|P1|Overall Study|Lost to Follow-up|2
409027|NCT00663858|1370279|P3|Overall Study|Other|4
409028|NCT00663858|1370280|P2|Overall Study|Other|2
409029|NCT00663858|1370281|P1|Overall Study|Other|8
409030|NCT00663858|1370279|P3|Overall Study|Protocol Violation|4
409031|NCT00663858|1370280|P2|Overall Study|Protocol Violation|3
409032|NCT00663858|1370281|P1|Overall Study|Protocol Violation|5
409033|NCT00663858|1370279|P3|Overall Study|Withdrawal by Subject|3
409034|NCT00663858|1370280|P2|Overall Study|Withdrawal by Subject|3
409035|NCT00663858|1370281|P1|Overall Study|Withdrawal by Subject|7
409036|NCT00663858|1370279|P3|Overall Study|Lack of Efficacy|3
409037|NCT00663858|1370280|P2|Overall Study|Lack of Efficacy|1
409038|NCT00663858|1370281|P1|Overall Study|Lack of Efficacy|5
409039|NCT00663858|1370279|P3|Overall Study|Adverse Event|6
409040|NCT00663858|1370280|P2|Overall Study|Adverse Event|1
409041|NCT00663858|1370281|P1|Overall Study|Adverse Event|9
409042|NCT00663702|1370319|P2|Overall Study|Lack of Efficacy|3
409043|NCT00663702|1370320|P1|Overall Study|Lack of Efficacy|3
409044|NCT00663702|1370319|P2|Overall Study|Death|1
409045|NCT00663702|1370320|P1|Overall Study|Death|1
409046|NCT00663702|1370319|P2|Overall Study|Lost to Follow-up|0
409047|NCT00663702|1370320|P1|Overall Study|Lost to Follow-up|3
409048|NCT00663702|1370319|P2|Overall Study|Pregnancy|1
409049|NCT00663702|1370320|P1|Overall Study|Pregnancy|0
409050|NCT00663702|1370319|P2|Overall Study|Withdrawal by Subject|1
409051|NCT00663702|1370320|P1|Overall Study|Withdrawal by Subject|3
409052|NCT00663702|1370319|P2|Overall Study|Adverse Event|4
409053|NCT00663702|1370320|P1|Overall Study|Adverse Event|8
409054|NCT00663260|1370356|P3|Overall Study|non-compliance, not met criteria, etc.|3
409055|NCT00663260|1370357|P2|Overall Study|non-compliance, not met criteria, etc.|2
409056|NCT00663260|1370358|P1|Overall Study|non-compliance, not met criteria, etc.|3
409057|NCT00663260|1370356|P3|Overall Study|Lost to Follow-up|0
409058|NCT00663260|1370357|P2|Overall Study|Lost to Follow-up|1
409059|NCT00663260|1370358|P1|Overall Study|Lost to Follow-up|0
409060|NCT00663260|1370356|P3|Overall Study|Death|1
409061|NCT00663260|1370357|P2|Overall Study|Death|0
409062|NCT00663260|1370358|P1|Overall Study|Death|1
409063|NCT00663260|1370356|P3|Overall Study|Withdrawal by Subject|6
409064|NCT00663260|1370357|P2|Overall Study|Withdrawal by Subject|1
409065|NCT00663260|1370358|P1|Overall Study|Withdrawal by Subject|3
409066|NCT00663260|1370356|P3|Overall Study|Adverse Event|6
409067|NCT00663260|1370357|P2|Overall Study|Adverse Event|7
409068|NCT00663260|1370358|P1|Overall Study|Adverse Event|12
409069|NCT00663260|1370356|P3|Overall Study|Lack of Efficacy|0
409070|NCT00663260|1370357|P2|Overall Study|Lack of Efficacy|0
409071|NCT00663260|1370358|P1|Overall Study|Lack of Efficacy|2
409072|NCT00663234|1370372|P1|Overall Study|Not willing to adhere to requirements|1
409073|NCT00663208|1370405|P7|Follow-up Period|Other reason|1
409074|NCT00663208|1370406|P6|Follow-up Period|Other reason|0
409075|NCT00663208|1370407|P5|Follow-up Period|Other reason|0
409076|NCT00663208|1370408|P4|Follow-up Period|Other reason|0
409077|NCT00663208|1370409|P3|Follow-up Period|Other reason|0
409078|NCT00663208|1370410|P2|Follow-up Period|Other reason|0
409079|NCT00663208|1370411|P1|Follow-up Period|Other reason|1
409080|NCT00663208|1370405|P7|Follow-up Period|Lost to Follow-up|0
409081|NCT00663208|1370406|P6|Follow-up Period|Lost to Follow-up|0
409082|NCT00663208|1370407|P5|Follow-up Period|Lost to Follow-up|0
409083|NCT00663208|1370408|P4|Follow-up Period|Lost to Follow-up|2
409084|NCT00663208|1370409|P3|Follow-up Period|Lost to Follow-up|3
409085|NCT00663208|1370410|P2|Follow-up Period|Lost to Follow-up|0
409086|NCT00663208|1370411|P1|Follow-up Period|Lost to Follow-up|2
409087|NCT00663208|1370405|P7|Treatment Period|Lost to Follow-up|0
409088|NCT00663208|1370406|P6|Treatment Period|Lost to Follow-up|0
409089|NCT00663208|1370407|P5|Treatment Period|Lost to Follow-up|0
409090|NCT00663208|1370408|P4|Treatment Period|Lost to Follow-up|0
409091|NCT00663208|1370409|P3|Treatment Period|Lost to Follow-up|0
409092|NCT00663208|1370410|P2|Treatment Period|Lost to Follow-up|1
409093|NCT00663208|1370411|P1|Treatment Period|Lost to Follow-up|0
409094|NCT00663117|1370589|P2|Overall Study|Lack of Efficacy|0
409095|NCT00663117|1370590|P1|Overall Study|Lack of Efficacy|1
409096|NCT00663052|1370604|P2|Overall Study|Other|1
409097|NCT00663052|1370605|P1|Overall Study|Other|0
409098|NCT00663052|1370604|P2|Overall Study|Unsatisfactory Response - Efficacy|1
409099|NCT00663052|1370605|P1|Overall Study|Unsatisfactory Response - Efficacy|1
409100|NCT00663052|1370604|P2|Overall Study|Withdrawal by Subject|5
409101|NCT00663052|1370605|P1|Overall Study|Withdrawal by Subject|2
409102|NCT00663052|1370604|P2|Overall Study|Protocol Violation|0
409103|NCT00663052|1370605|P1|Overall Study|Protocol Violation|1
409104|NCT00663052|1370604|P2|Overall Study|Discontinuation of Study by Sponsor|0
409105|NCT00663052|1370605|P1|Overall Study|Discontinuation of Study by Sponsor|2
409106|NCT00663052|1370604|P2|Overall Study|Adverse Event|3
409107|NCT00663052|1370605|P1|Overall Study|Adverse Event|6
409108|NCT00663026|1370688|P3|Overall Study|Withdrawal by Subject|1
409109|NCT00663026|1370689|P2|Overall Study|Withdrawal by Subject|0
409110|NCT00663026|1370690|P1|Overall Study|Withdrawal by Subject|0
409111|NCT00663026|1370688|P3|Overall Study|Caregiver Request|0
409112|NCT00663026|1370689|P2|Overall Study|Caregiver Request|2
409113|NCT00663026|1370690|P1|Overall Study|Caregiver Request|0
409114|NCT00663026|1370688|P3|Overall Study|Adverse Event|3
409115|NCT00663026|1370689|P2|Overall Study|Adverse Event|2
409116|NCT00663026|1370690|P1|Overall Study|Adverse Event|0
409117|NCT00663026|1370688|P3|Overall Study|Other|0
409118|NCT00663026|1370689|P2|Overall Study|Other|2
409119|NCT00663026|1370690|P1|Overall Study|Other|1
409120|NCT00663026|1370688|P3|Overall Study|Lost to Follow-up|0
409121|NCT00663026|1370689|P2|Overall Study|Lost to Follow-up|0
409122|NCT00663026|1370690|P1|Overall Study|Lost to Follow-up|1
409123|NCT00662909|1370713|P3|Overall Study|Eligibility criterion not met|1
409124|NCT00662909|1370714|P2|Overall Study|Eligibility criterion not met|1
409125|NCT00662909|1370715|P1|Overall Study|Eligibility criterion not met|0
409126|NCT00662909|1370713|P3|Overall Study|Physician Decision|2
409127|NCT00662909|1370714|P2|Overall Study|Physician Decision|1
409128|NCT00662909|1370715|P1|Overall Study|Physician Decision|1
409129|NCT00662909|1370713|P3|Overall Study|Non-compliance with study procedures|2
409130|NCT00662909|1370714|P2|Overall Study|Non-compliance with study procedures|3
409131|NCT00662909|1370715|P1|Overall Study|Non-compliance with study procedures|3
409132|NCT00662909|1370713|P3|Overall Study|Randomized- never received study drug|0
409133|NCT00662909|1370714|P2|Overall Study|Randomized- never received study drug|0
409134|NCT00662909|1370715|P1|Overall Study|Randomized- never received study drug|1
409135|NCT00662909|1370713|P3|Overall Study|Protocol Violation|5
409136|NCT00662909|1370714|P2|Overall Study|Protocol Violation|4
409137|NCT00662909|1370715|P1|Overall Study|Protocol Violation|7
409138|NCT00662909|1370713|P3|Overall Study|Lost to Follow-up|3
409139|NCT00662909|1370714|P2|Overall Study|Lost to Follow-up|9
409140|NCT00662909|1370715|P1|Overall Study|Lost to Follow-up|2
409141|NCT00662909|1370713|P3|Overall Study|Withdrawal by Subject|16
409142|NCT00662909|1370714|P2|Overall Study|Withdrawal by Subject|22
409143|NCT00662909|1370715|P1|Overall Study|Withdrawal by Subject|29
409144|NCT00662909|1370713|P3|Overall Study|Lack of Efficacy|5
409145|NCT00662909|1370714|P2|Overall Study|Lack of Efficacy|1
409146|NCT00662909|1370715|P1|Overall Study|Lack of Efficacy|9
409147|NCT00662909|1370713|P3|Overall Study|Adverse Event|19
409148|NCT00662909|1370714|P2|Overall Study|Adverse Event|18
409149|NCT00662909|1370715|P1|Overall Study|Adverse Event|17
409150|NCT00662857|1370813|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
409151|NCT00662857|1370814|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
409152|NCT00662857|1370813|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
409153|NCT00662857|1370814|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
409154|NCT00662857|1370813|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
409155|NCT00662857|1370814|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
409156|NCT00662831|1370829|P2|Overall Study|Adverse Event|16
409157|NCT00662831|1370830|P1|Overall Study|Adverse Event|23
409158|NCT00662831|1370829|P2|Overall Study|Protocol Violation|4
409159|NCT00662831|1370830|P1|Overall Study|Protocol Violation|8
409160|NCT00662831|1370829|P2|Overall Study|Other|31
409161|NCT00662831|1370830|P1|Overall Study|Other|62
409162|NCT00662831|1370829|P2|Overall Study|Withdrawal by Subject|1
409163|NCT00662831|1370830|P1|Overall Study|Withdrawal by Subject|2
409164|NCT00662831|1370829|P2|Overall Study|Lost to Follow-up|0
409165|NCT00662831|1370830|P1|Overall Study|Lost to Follow-up|1
409166|NCT00662831|1370829|P2|Overall Study|Lack of Efficacy|6
409167|NCT00662831|1370830|P1|Overall Study|Lack of Efficacy|6
409168|NCT00662831|1370829|P2|Overall Study|Death|1
409169|NCT00662831|1370830|P1|Overall Study|Death|4
409170|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
409171|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
409172|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
409173|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
409174|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
409175|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
409176|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
409177|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
409178|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
409179|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
409180|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
409181|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
409182|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
409183|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
409184|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
409185|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
409186|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
409187|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
409188|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
409189|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
409190|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
409191|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
409192|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
409193|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
409194|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
409195|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Adverse Event|10
409196|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Adverse Event|6
409197|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Adverse Event|0
409198|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Adverse Event|9
409199|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Adverse Event|6
409200|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Administrative problems|0
409201|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Administrative problems|1
409202|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Administrative problems|0
409203|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Administrative problems|0
409204|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Administrative problems|0
409205|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
409206|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
409207|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
409208|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
409209|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
409210|NCT00662649|1370910|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
409211|NCT00662649|1370911|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
409212|NCT00662649|1370912|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
409213|NCT00662649|1370913|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
409214|NCT00662649|1370914|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
409215|NCT00662649|1370910|P5|Core Study (24 Months)|Death|0
409216|NCT00662649|1370911|P4|Core Study (24 Months)|Death|0
409217|NCT00662649|1370912|P3|Core Study (24 Months)|Death|2
409218|NCT00662649|1370913|P2|Core Study (24 Months)|Death|0
409219|NCT00662649|1370914|P1|Core Study (24 Months)|Death|1
409220|NCT00662649|1370910|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
409221|NCT00662649|1370911|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
409222|NCT00662649|1370912|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
409223|NCT00662649|1370913|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
409224|NCT00662649|1370914|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
409225|NCT00662649|1370910|P5|Core Study (24 Months)|Protocol Violation|0
409226|NCT00662649|1370911|P4|Core Study (24 Months)|Protocol Violation|0
409227|NCT00662649|1370912|P3|Core Study (24 Months)|Protocol Violation|4
409228|NCT00662649|1370913|P2|Core Study (24 Months)|Protocol Violation|5
409229|NCT00662649|1370914|P1|Core Study (24 Months)|Protocol Violation|5
409230|NCT00662649|1370910|P5|Core Study (24 Months)|Lost to Follow-up|0
409231|NCT00662649|1370911|P4|Core Study (24 Months)|Lost to Follow-up|0
409232|NCT00662649|1370912|P3|Core Study (24 Months)|Lost to Follow-up|7
409233|NCT00662649|1370913|P2|Core Study (24 Months)|Lost to Follow-up|5
409234|NCT00662649|1370914|P1|Core Study (24 Months)|Lost to Follow-up|3
409235|NCT00662649|1370910|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
409236|NCT00662649|1370911|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
409237|NCT00662649|1370912|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
409238|NCT00662649|1370913|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
409239|NCT00662649|1370914|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
409240|NCT00662649|1370910|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
409241|NCT00662649|1370911|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
409242|NCT00662649|1370912|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
409243|NCT00662649|1370913|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
409244|NCT00662649|1370914|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
409245|NCT00662649|1370910|P5|Core Study (24 Months)|Adverse Event|0
409246|NCT00662649|1370911|P4|Core Study (24 Months)|Adverse Event|0
409247|NCT00662649|1370912|P3|Core Study (24 Months)|Adverse Event|18
409248|NCT00662649|1370913|P2|Core Study (24 Months)|Adverse Event|13
409249|NCT00662649|1370914|P1|Core Study (24 Months)|Adverse Event|22
409250|NCT00662649|1370910|P5|Core Study (24 Months)|Withdrawal by Subject|0
409251|NCT00662649|1370911|P4|Core Study (24 Months)|Withdrawal by Subject|0
409252|NCT00662649|1370912|P3|Core Study (24 Months)|Withdrawal by Subject|28
409253|NCT00662649|1370913|P2|Core Study (24 Months)|Withdrawal by Subject|17
409254|NCT00662649|1370914|P1|Core Study (24 Months)|Withdrawal by Subject|31
409255|NCT00662558|1370954|P2|Overall Study|Randomized But Did Not Receive Treatment|8
409256|NCT00662558|1370955|P1|Overall Study|Randomized But Did Not Receive Treatment|2
409257|NCT00662558|1370954|P2|Overall Study|Withdrawal by Subject|12
409258|NCT00662558|1370955|P1|Overall Study|Withdrawal by Subject|7
409259|NCT00662558|1370954|P2|Overall Study|Other|14
409260|NCT00662558|1370955|P1|Overall Study|Other|9
409261|NCT00662558|1370954|P2|Overall Study|Lost to Follow-up|10
409262|NCT00662558|1370955|P1|Overall Study|Lost to Follow-up|13
409263|NCT00662558|1370954|P2|Overall Study|Lack of Efficacy|7
409264|NCT00662558|1370955|P1|Overall Study|Lack of Efficacy|4
409265|NCT00662558|1370954|P2|Overall Study|Adverse Event|59
409266|NCT00662558|1370955|P1|Overall Study|Adverse Event|21
409267|NCT00662532|1371006|P2|Overall Study|Lost to Follow-up|1
409268|NCT00662532|1371007|P1|Overall Study|Lost to Follow-up|0
409269|NCT00662532|1371006|P2|Overall Study|Adverse Event|1
409270|NCT00662532|1371007|P1|Overall Study|Adverse Event|0
409271|NCT00662363|1371022|P2|Overall Study|Protocol Violation|1
409272|NCT00662363|1371023|P1|Overall Study|Protocol Violation|1
409273|NCT00662363|1371022|P2|Overall Study|Discharged early from rehab|1
409274|NCT00662363|1371023|P1|Overall Study|Discharged early from rehab|4
409275|NCT00662363|1371022|P2|Overall Study|Adverse Event|3
409276|NCT00662363|1371023|P1|Overall Study|Adverse Event|0
409277|NCT00662363|1371022|P2|Overall Study|Withdrawal by Subject|5
409278|NCT00662363|1371023|P1|Overall Study|Withdrawal by Subject|6
409279|NCT00662311|1371034|P3|Overall Study|Respiratory Infection|0
409280|NCT00662311|1371035|P2|Overall Study|Respiratory Infection|0
409281|NCT00662311|1371036|P1|Overall Study|Respiratory Infection|1
409282|NCT00662129|1371087|P1|Overall Study|Ineligible|1
409283|NCT00662129|1371087|P1|Overall Study|Cancel prior to beginning treatment|1
409284|NCT00662129|1371087|P1|Overall Study|Protocol Violation|1
409285|NCT00662038|1371097|P1|Overall Study|Continued treatment|5
409286|NCT00662038|1371097|P1|Overall Study|Adverse Event|358
409287|NCT00662038|1371097|P1|Overall Study|Death|95
409288|NCT00662038|1371097|P1|Overall Study|Lost to Follow-up|1
409289|NCT00662038|1371097|P1|Overall Study|Lung transplantation|44
409290|NCT00662038|1371097|P1|Overall Study|Physician Decision|19
409291|NCT00662038|1371097|P1|Overall Study|Sponsor decision|1
409292|NCT00662038|1371097|P1|Overall Study|Withdrawal by Subject|83
409293|NCT00662038|1371097|P1|Overall Study|Withdrawn consent|22
409294|NCT00662038|1371097|P1|Overall Study|Reason not specified|3
409295|NCT00662025|1371101|P1|Overall Study|Domestic circumstances|1
409296|NCT00662025|1371101|P1|Overall Study|Target lesion cannot be evaluated|1
409297|NCT00662025|1371101|P1|Overall Study|Results of other clinical study|2
409298|NCT00662025|1371101|P1|Overall Study|Withdrawal by Subject|1
409299|NCT00662025|1371101|P1|Overall Study|Adverse Event|7
409300|NCT00662025|1371101|P1|Overall Study|Objective progression or relapse|51
409301|NCT00662012|1371121|P1|Overall Study|Withdrawal by Subject|1
409302|NCT00662012|1371121|P1|Overall Study|Death|1
409303|NCT00662012|1371121|P1|Overall Study|Lost to Follow-up|85
409304|NCT00661999|1371129|P3|Overall Study|Other Medical Problems|9
409305|NCT00661999|1371130|P2|Overall Study|Other Medical Problems|4
409306|NCT00661999|1371131|P1|Overall Study|Other Medical Problems|4
409307|NCT00661999|1371129|P3|Overall Study|Alternative Treatment|0
409308|NCT00661999|1371130|P2|Overall Study|Alternative Treatment|0
409309|NCT00661999|1371131|P1|Overall Study|Alternative Treatment|1
409310|NCT00661999|1371129|P3|Overall Study|Withdrawal by Subject|14
409311|NCT00661999|1371130|P2|Overall Study|Withdrawal by Subject|23
409312|NCT00661999|1371131|P1|Overall Study|Withdrawal by Subject|30
409313|NCT00661999|1371129|P3|Overall Study|Other Reasons|23
409314|NCT00661999|1371130|P2|Overall Study|Other Reasons|12
409315|NCT00661999|1371131|P1|Overall Study|Other Reasons|5
409316|NCT00661999|1371129|P3|Overall Study|Death|3
409317|NCT00661999|1371130|P2|Overall Study|Death|6
409318|NCT00661999|1371131|P1|Overall Study|Death|8
409319|NCT00661999|1371129|P3|Overall Study|Adverse Event|8
409320|NCT00661999|1371130|P2|Overall Study|Adverse Event|5
409321|NCT00661999|1371131|P1|Overall Study|Adverse Event|11
409322|NCT00661830|1371208|P2|Overall Study|Other reason|5
409323|NCT00661830|1371209|P1|Overall Study|Other reason|1
409324|NCT00661830|1371208|P2|Overall Study|Withdrawal by Subject|1
409325|NCT00661830|1371209|P1|Overall Study|Withdrawal by Subject|1
409326|NCT00661830|1371208|P2|Overall Study|Lost to Follow-up|3
409327|NCT00661830|1371209|P1|Overall Study|Lost to Follow-up|1
409328|NCT00661830|1371208|P2|Overall Study|Death|33
409329|NCT00661830|1371209|P1|Overall Study|Death|37
409330|NCT00661778|1371221|P1|Overall Study|Withdrawal of Consent|1
409331|NCT00661778|1371221|P1|Overall Study|Protocol Violation|2
409332|NCT00661778|1371221|P1|Overall Study|Reason not Specified|6
409333|NCT00661778|1371221|P1|Overall Study|Adverse Event|18
409334|NCT00661778|1371221|P1|Overall Study|Disease Progression|23
409335|NCT00661726|1371228|P1|Overall Study|Adverse Event|1
409336|NCT00661713|1371251|P8|Overall Study|Inappropriate Enrollment|0
409337|NCT00661713|1371252|P7|Overall Study|Inappropriate Enrollment|1
409338|NCT00661713|1371253|P6|Overall Study|Inappropriate Enrollment|0
409339|NCT00661713|1371254|P5|Overall Study|Inappropriate Enrollment|0
409340|NCT00661713|1371255|P4|Overall Study|Inappropriate Enrollment|0
409341|NCT00661713|1371256|P3|Overall Study|Inappropriate Enrollment|0
409342|NCT00661713|1371257|P2|Overall Study|Inappropriate Enrollment|0
409343|NCT00661713|1371258|P1|Overall Study|Inappropriate Enrollment|0
409344|NCT00661713|1371251|P8|Overall Study|Adverse Event|0
409345|NCT00661713|1371252|P7|Overall Study|Adverse Event|1
409346|NCT00661713|1371253|P6|Overall Study|Adverse Event|0
409347|NCT00661713|1371254|P5|Overall Study|Adverse Event|0
409348|NCT00661713|1371255|P4|Overall Study|Adverse Event|0
409349|NCT00661713|1371256|P3|Overall Study|Adverse Event|0
409350|NCT00661713|1371257|P2|Overall Study|Adverse Event|0
409351|NCT00661713|1371258|P1|Overall Study|Adverse Event|0
409352|NCT00661713|1371251|P8|Overall Study|Administrative Reason|0
409353|NCT00661713|1371252|P7|Overall Study|Administrative Reason|1
409354|NCT00661713|1371253|P6|Overall Study|Administrative Reason|2
409355|NCT00661713|1371254|P5|Overall Study|Administrative Reason|2
409356|NCT00661713|1371255|P4|Overall Study|Administrative Reason|2
409357|NCT00661713|1371256|P3|Overall Study|Administrative Reason|0
409358|NCT00661713|1371257|P2|Overall Study|Administrative Reason|1
409359|NCT00661713|1371258|P1|Overall Study|Administrative Reason|0
409360|NCT00661713|1371251|P8|Overall Study|Lost to Follow-up|1
409361|NCT00661713|1371252|P7|Overall Study|Lost to Follow-up|14
409362|NCT00661713|1371253|P6|Overall Study|Lost to Follow-up|7
409363|NCT00661713|1371254|P5|Overall Study|Lost to Follow-up|5
409364|NCT00661713|1371255|P4|Overall Study|Lost to Follow-up|2
409365|NCT00661713|1371256|P3|Overall Study|Lost to Follow-up|2
409366|NCT00661713|1371257|P2|Overall Study|Lost to Follow-up|7
409367|NCT00661713|1371258|P1|Overall Study|Lost to Follow-up|2
409368|NCT00661713|1371251|P8|Overall Study|Withdrawal by Subject|9
409369|NCT00661713|1371252|P7|Overall Study|Withdrawal by Subject|45
409370|NCT00661713|1371253|P6|Overall Study|Withdrawal by Subject|26
409371|NCT00661713|1371254|P5|Overall Study|Withdrawal by Subject|12
409372|NCT00661713|1371255|P4|Overall Study|Withdrawal by Subject|21
409373|NCT00661713|1371256|P3|Overall Study|Withdrawal by Subject|12
409374|NCT00661713|1371257|P2|Overall Study|Withdrawal by Subject|25
409375|NCT00661713|1371258|P1|Overall Study|Withdrawal by Subject|11
409376|NCT00661713|1371251|P8|Overall Study|Protocol Violation|1
409377|NCT00661713|1371252|P7|Overall Study|Protocol Violation|2
409378|NCT00661713|1371253|P6|Overall Study|Protocol Violation|2
409379|NCT00661713|1371254|P5|Overall Study|Protocol Violation|0
409380|NCT00661713|1371255|P4|Overall Study|Protocol Violation|3
409381|NCT00661713|1371256|P3|Overall Study|Protocol Violation|3
409382|NCT00661713|1371257|P2|Overall Study|Protocol Violation|6
409383|NCT00661713|1371258|P1|Overall Study|Protocol Violation|1
409384|NCT00661713|1371251|P8|Overall Study|Unable to Classify|0
409385|NCT00661713|1371252|P7|Overall Study|Unable to Classify|0
409386|NCT00661713|1371253|P6|Overall Study|Unable to Classify|0
409387|NCT00661713|1371254|P5|Overall Study|Unable to Classify|0
409388|NCT00661713|1371255|P4|Overall Study|Unable to Classify|0
409389|NCT00661713|1371256|P3|Overall Study|Unable to Classify|0
409390|NCT00661713|1371257|P2|Overall Study|Unable to Classify|0
409391|NCT00661713|1371258|P1|Overall Study|Unable to Classify|1
409392|NCT00661713|1371251|P8|Overall Study|Death|0
409393|NCT00661713|1371252|P7|Overall Study|Death|0
409394|NCT00661713|1371253|P6|Overall Study|Death|0
409395|NCT00661713|1371254|P5|Overall Study|Death|1
409396|NCT00661713|1371255|P4|Overall Study|Death|0
409397|NCT00661713|1371256|P3|Overall Study|Death|0
409398|NCT00661713|1371257|P2|Overall Study|Death|0
409399|NCT00661713|1371258|P1|Overall Study|Death|1
409400|NCT00661687|1371348|P1|Overall Study|Adverse Event|2
409401|NCT00661687|1371348|P1|Overall Study|Physician Decision|1
409402|NCT00661687|1371348|P1|Overall Study|Inability to maintain wearing schedule|3
409403|NCT00661687|1371348|P1|Overall Study|Positive slit lamp findings|4
409404|NCT00661687|1371348|P1|Overall Study|Study related symptoms and complaints|5
409405|NCT00661661|1371376|P2|Overall Study|Not assigned treatment|0
409406|NCT00661661|1371377|P1|Overall Study|Not assigned treatment|1
409407|NCT00661661|1371376|P2|Overall Study|Other|7
409408|NCT00661661|1371377|P1|Overall Study|Other|22
409409|NCT00661661|1371376|P2|Overall Study|Withdrawal by Subject|5
409410|NCT00661661|1371377|P1|Overall Study|Withdrawal by Subject|15
409411|NCT00661661|1371376|P2|Overall Study|Lost to Follow-up|1
409412|NCT00661661|1371377|P1|Overall Study|Lost to Follow-up|0
409413|NCT00661661|1371376|P2|Overall Study|Lack of Efficacy|2
409414|NCT00661661|1371377|P1|Overall Study|Lack of Efficacy|3
409415|NCT00661661|1371376|P2|Overall Study|Adverse Event|24
409416|NCT00661661|1371377|P1|Overall Study|Adverse Event|99
409417|NCT00661622|1371453|P2|Overall Study|Protocol Violation|0
409418|NCT00661622|1371454|P1|Overall Study|Protocol Violation|1
409419|NCT00661609|1371468|P1|Overall Study|Disease progression|3
409420|NCT00661609|1371468|P1|Overall Study|Survival follow up stage discontinued|11
409421|NCT00661609|1371468|P1|Overall Study|PI Decision|1
409422|NCT00661609|1371468|P1|Overall Study|Withdrawal by Subject|2
409423|NCT00661609|1371468|P1|Overall Study|Death|20
409424|NCT00661609|1371468|P1|Overall Study|Adverse Event|4
409425|NCT00661531|1371508|P1|Overall Study|Withdrawal by Subject|3
409426|NCT00661505|1371513|P1|Overall Study|Not Specified|2
409427|NCT00661505|1371513|P1|Overall Study|Lost to Follow-up|3
409428|NCT00661505|1371513|P1|Overall Study|Withdrawal by Subject|8
409429|NCT00661505|1371513|P1|Overall Study|Protocol Violation|14
409430|NCT00661505|1371513|P1|Overall Study|Adverse Event|3
409431|NCT00661492|1371541|P2|Overall Study|Other|0
409432|NCT00661492|1371542|P1|Overall Study|Other|1
409433|NCT00661492|1371541|P2|Overall Study|Lost to Follow-up|1
409434|NCT00661492|1371542|P1|Overall Study|Lost to Follow-up|0
409435|NCT00661492|1371541|P2|Overall Study|Investigator Request|0
409436|NCT00661492|1371542|P1|Overall Study|Investigator Request|1
409437|NCT00661492|1371541|P2|Overall Study|Patient Request|1
409438|NCT00661492|1371542|P1|Overall Study|Patient Request|6
409439|NCT00661492|1371541|P2|Overall Study|Disease Progression|14
409440|NCT00661492|1371542|P1|Overall Study|Disease Progression|44
409441|NCT00661492|1371541|P2|Overall Study|Adverse Event|13
409442|NCT00661492|1371542|P1|Overall Study|Adverse Event|16
409443|NCT00661427|1371588|P2|Overall Study|Patient not treated|2
409444|NCT00661427|1371589|P1|Overall Study|Patient not treated|0
409445|NCT00661427|1371588|P2|Overall Study|Adverse Event|5
409446|NCT00661427|1371589|P1|Overall Study|Adverse Event|5
409447|NCT00661388|1371597|P1|Overall Study|Administrative reasons|1
409448|NCT00661388|1371597|P1|Overall Study|Dialysis initiation|1
409449|NCT00661388|1371597|P1|Overall Study|Renal transplantation|1
409450|NCT00661388|1371597|P1|Overall Study|Protocol Violation|7
409451|NCT00661388|1371597|P1|Overall Study|Adverse Event|14
409452|NCT00661362|1371620|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
409453|NCT00661362|1371621|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
409454|NCT00661362|1371620|P2|Overall Study|Safety reasons|0
409455|NCT00661362|1371621|P1|Overall Study|Safety reasons|1
409456|NCT00661362|1371620|P2|Overall Study|Severe non-compliance to protocol|1
409457|NCT00661362|1371621|P1|Overall Study|Severe non-compliance to protocol|0
409458|NCT00661362|1371620|P2|Overall Study|Lost to Follow-up|1
409459|NCT00661362|1371621|P1|Overall Study|Lost to Follow-up|3
409460|NCT00661362|1371620|P2|Overall Study|Withdrawal by Subject|23
409461|NCT00661362|1371621|P1|Overall Study|Withdrawal by Subject|13
409462|NCT00661362|1371620|P2|Overall Study|Study specific discontinuation criteria|11
409463|NCT00661362|1371621|P1|Overall Study|Study specific discontinuation criteria|4
409464|NCT00661362|1371620|P2|Overall Study|Incorrect enrollment|0
409465|NCT00661362|1371621|P1|Overall Study|Incorrect enrollment|2
409466|NCT00661362|1371620|P2|Overall Study|Adverse Event|4
409467|NCT00661362|1371621|P1|Overall Study|Adverse Event|5
409468|NCT00661271|1371639|P2|Overall Study|Lost to Follow-up|25
409469|NCT00661271|1371640|P1|Overall Study|Lost to Follow-up|28
409470|NCT00661258|1371650|P2|Overall Study|caught by police and in detox center|1
409471|NCT00661258|1371651|P1|Overall Study|caught by police and in detox center|2
409472|NCT00661258|1371650|P2|Overall Study|Death|0
409473|NCT00661258|1371651|P1|Overall Study|Death|1
409474|NCT00661193|1371661|P2|Overall Study|Not protocol specified|0
409475|NCT00661193|1371662|P1|Overall Study|Not protocol specified|1
409476|NCT00661193|1371661|P2|Overall Study|Progression|24
409477|NCT00661193|1371662|P1|Overall Study|Progression|27
409478|NCT00661193|1371661|P2|Overall Study|Withdrawal by Subject|1
409479|NCT00661193|1371662|P1|Overall Study|Withdrawal by Subject|3
409480|NCT00661193|1371661|P2|Overall Study|Adverse Event|1
409481|NCT00661193|1371662|P1|Overall Study|Adverse Event|2
409482|NCT00661089|1371887|P2|Overall Study|death at 8 weeks due to new stroke|1
409483|NCT00661089|1371888|P1|Overall Study|death at 8 weeks due to new stroke|0
409484|NCT00661089|1371887|P2|Overall Study|1 subject withdrawal|1
409485|NCT00661089|1371888|P1|Overall Study|1 subject withdrawal|0
409486|NCT00660907|1371936|P2|Overall Study|Various|8
409487|NCT00660907|1371937|P1|Overall Study|Various|11
409488|NCT00660907|1371936|P2|Overall Study|Death|3
409489|NCT00660907|1371937|P1|Overall Study|Death|1
409490|NCT00660907|1371936|P2|Overall Study|Safety|0
409491|NCT00660907|1371937|P1|Overall Study|Safety|1
409492|NCT00660907|1371936|P2|Overall Study|Poor/Non-Compliance|1
409493|NCT00660907|1371937|P1|Overall Study|Poor/Non-Compliance|5
409494|NCT00660907|1371936|P2|Overall Study|Lost to Follow-up|3
409495|NCT00660907|1371937|P1|Overall Study|Lost to Follow-up|3
409496|NCT00660907|1371936|P2|Overall Study|Withdrawal by Subject|32
409497|NCT00660907|1371937|P1|Overall Study|Withdrawal by Subject|23
409498|NCT00660907|1371936|P2|Overall Study|Subject No Longer Meets Study Criteria|27
409499|NCT00660907|1371937|P1|Overall Study|Subject No Longer Meets Study Criteria|6
409500|NCT00660907|1371936|P2|Overall Study|Adverse Event|19
409501|NCT00660907|1371937|P1|Overall Study|Adverse Event|33
409502|NCT00660907|1371936|P2|Overall Study|Incorrect Enrollment|1
409503|NCT00660907|1371937|P1|Overall Study|Incorrect Enrollment|1
409504|NCT00660829|1371951|P2|Overall Study|Other|4
409505|NCT00660829|1371952|P1|Overall Study|Other|9
409506|NCT00660829|1371951|P2|Overall Study|Lost to Follow-up|2
409507|NCT00660829|1371952|P1|Overall Study|Lost to Follow-up|3
409508|NCT00660829|1371951|P2|Overall Study|Withdrawal by Subject|2
409509|NCT00660829|1371952|P1|Overall Study|Withdrawal by Subject|1
409510|NCT00660829|1371951|P2|Overall Study|Non-Compliance|4
409511|NCT00660829|1371952|P1|Overall Study|Non-Compliance|0
409512|NCT00660829|1371951|P2|Overall Study|Lack of Efficacy|3
409513|NCT00660829|1371952|P1|Overall Study|Lack of Efficacy|2
409514|NCT00660829|1371951|P2|Overall Study|Adverse Event|4
409515|NCT00660829|1371952|P1|Overall Study|Adverse Event|3
409516|NCT00660816|1371970|P2|Overall Study|Complicating Disease|1
409517|NCT00660816|1371971|P1|Overall Study|Complicating Disease|0
409518|NCT00660816|1371970|P2|Overall Study|Disease Progression|12
409519|NCT00660816|1371971|P1|Overall Study|Disease Progression|16
409520|NCT00660816|1371970|P2|Overall Study|Protocol Violation|0
409521|NCT00660816|1371971|P1|Overall Study|Protocol Violation|1
409522|NCT00660816|1371970|P2|Overall Study|Physician Decision|2
409523|NCT00660816|1371971|P1|Overall Study|Physician Decision|0
409524|NCT00660816|1371970|P2|Overall Study|Lack of Efficacy|0
409525|NCT00660816|1371971|P1|Overall Study|Lack of Efficacy|1
409526|NCT00660816|1371970|P2|Overall Study|Death|2
409527|NCT00660816|1371971|P1|Overall Study|Death|0
409528|NCT00660816|1371970|P2|Overall Study|Withdrawal by Subject|0
409529|NCT00660816|1371971|P1|Overall Study|Withdrawal by Subject|1
409530|NCT00660816|1371970|P2|Overall Study|Adverse Event|2
409531|NCT00660816|1371971|P1|Overall Study|Adverse Event|1
409532|NCT00660699|1371983|P1|Overall Study|Withdrawal by Subject|2
409533|NCT00660660|1371999|P2|Overall Study|New medication after randomization|0
409534|NCT00660660|1372000|P1|Overall Study|New medication after randomization|1
409535|NCT00660660|1371999|P2|Overall Study|Incorrect enrollment and other|1
409536|NCT00660660|1372000|P1|Overall Study|Incorrect enrollment and other|0
409537|NCT00660660|1371999|P2|Overall Study|Withdrawal by Subject|0
409538|NCT00660660|1372000|P1|Overall Study|Withdrawal by Subject|3
409539|NCT00660660|1371999|P2|Overall Study|Lack of Efficacy|2
409540|NCT00660660|1372000|P1|Overall Study|Lack of Efficacy|0
409541|NCT00660660|1371999|P2|Overall Study|Lost to Follow-up|6
409542|NCT00660660|1372000|P1|Overall Study|Lost to Follow-up|0
409543|NCT00660660|1371999|P2|Overall Study|Adverse Event|0
409544|NCT00660660|1372000|P1|Overall Study|Adverse Event|1
409545|NCT00660595|1372100|P2|Overall Study|Non Specified reasons|0
409546|NCT00660595|1372101|P1|Overall Study|Non Specified reasons|5
409547|NCT00660595|1372100|P2|Overall Study|Participant left hospital|0
409548|NCT00660595|1372101|P1|Overall Study|Participant left hospital|1
409549|NCT00660595|1372100|P2|Overall Study|Did not consent to participate in study|8
409550|NCT00660595|1372101|P1|Overall Study|Did not consent to participate in study|12
409551|NCT00660595|1372100|P2|Overall Study|Lost to Follow-up|1
409552|NCT00660595|1372101|P1|Overall Study|Lost to Follow-up|0
409553|NCT00660400|1372162|P1|Overall Study|Withdrawal by Subject|1
409554|NCT00660400|1372162|P1|Overall Study|Intracranial hemorrhage|1
409555|NCT00660400|1372162|P1|Overall Study|Suboptimal organ function|1
409556|NCT00660400|1372162|P1|Overall Study|Lack of insurance approval|1
409557|NCT00660387|1372171|P2|Overall Study|Protocol Violation|0
409558|NCT00660387|1372172|P1|Overall Study|Protocol Violation|1
409559|NCT00660387|1372171|P2|Overall Study|Lack of Efficacy|1
409560|NCT00660387|1372172|P1|Overall Study|Lack of Efficacy|0
409561|NCT00660387|1372171|P2|Overall Study|Adverse Event|2
409562|NCT00660387|1372172|P1|Overall Study|Adverse Event|1
409563|NCT00660348|1372226|P2|Overall Study|Withdrawal by Subject|0
409564|NCT00660348|1372227|P1|Overall Study|Withdrawal by Subject|1
409565|NCT00660309|1372235|P2|Overall Study|Withdrawal by Subject|3
409566|NCT00660309|1372236|P1|Overall Study|Withdrawal by Subject|0
409567|NCT00660309|1372235|P2|Overall Study|Adverse Event|0
409568|NCT00660309|1372236|P1|Overall Study|Adverse Event|2
409569|NCT00660192|1372277|P2|Overall Study|Lost to Follow-up|3
409570|NCT00660192|1372278|P1|Overall Study|Lost to Follow-up|2
409571|NCT00660179|1372289|P3|Overall Study|Incorrect randomization|0
409572|NCT00660179|1372290|P2|Overall Study|Incorrect randomization|0
409573|NCT00660179|1372291|P1|Overall Study|Incorrect randomization|1
409574|NCT00660179|1372289|P3|Overall Study|Administrative reason|1
409575|NCT00660179|1372290|P2|Overall Study|Administrative reason|0
409576|NCT00660179|1372291|P1|Overall Study|Administrative reason|0
409577|NCT00660179|1372289|P3|Overall Study|Lost to Follow-up|2
409578|NCT00660179|1372290|P2|Overall Study|Lost to Follow-up|5
409579|NCT00660179|1372291|P1|Overall Study|Lost to Follow-up|7
409580|NCT00660179|1372289|P3|Overall Study|Withdrawal of consent|4
409581|NCT00660179|1372290|P2|Overall Study|Withdrawal of consent|6
409582|NCT00660179|1372291|P1|Overall Study|Withdrawal of consent|4
409583|NCT00660179|1372289|P3|Overall Study|Death|34
409584|NCT00660179|1372290|P2|Overall Study|Death|47
409585|NCT00660179|1372291|P1|Overall Study|Death|44
409586|NCT00660023|1372336|P1|Overall Study|Other Screening Failure|9
409587|NCT00660023|1372336|P1|Overall Study|Missed Pregnancy Test|1
409588|NCT00660023|1372336|P1|Overall Study|Withdrawal by Subject|1
409589|NCT00660023|1372336|P1|Overall Study|Renal Transplantation|3
409590|NCT00660023|1372336|P1|Overall Study|Blood Transfusion|5
409591|NCT00660023|1372336|P1|Overall Study|Death|8
409592|NCT00660023|1372336|P1|Overall Study|Adverse Event|2
409593|NCT00660010|1372347|P1|Overall Study|Noncompliance with visit schedule|3
409594|NCT00660010|1372347|P1|Overall Study|Adverse Event|1
409595|NCT00660010|1372347|P1|Overall Study|Lost to Follow-up|3
409596|NCT00660010|1372347|P1|Overall Study|Withdrawal by Subject|2
409597|NCT00659984|1372361|P1|Overall Study|Adverse Event|1
409598|NCT00659880|1372381|P1|Overall Study|Lost to Follow-up|5
409599|NCT00659815|1372388|P2|Overall Study|Withdrawal by Subject|1
409600|NCT00659815|1372389|P1|Overall Study|Withdrawal by Subject|1
409601|NCT00659815|1372388|P2|Overall Study|Inability to maintain wearing schedule|2
409602|NCT00659815|1372389|P1|Overall Study|Inability to maintain wearing schedule|1
409603|NCT00659815|1372388|P2|Overall Study|Study related symptoms and complaints|1
409604|NCT00659815|1372389|P1|Overall Study|Study related symptoms and complaints|2
409605|NCT00659607|1372449|P1|Overall Study|Inconsistent BP measuring date|2
409606|NCT00659607|1372449|P1|Overall Study|No recorded efficacy data|15
409607|NCT00659607|1372449|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
409608|NCT00659607|1372449|P1|Overall Study|Unknown measuring date of blood pressure|85
409609|NCT00659607|1372449|P1|Overall Study|No blood pressure recorded|147
409610|NCT00659581|1372467|P1|Overall Study|Other|6393
409611|NCT00659581|1372467|P1|Overall Study|Lack of Efficacy|1183
409612|NCT00659581|1372467|P1|Overall Study|Adverse Event|1006
409613|NCT00659529|1372479|P1|Overall Study|Screen failure|9
409614|NCT00659529|1372479|P1|Overall Study|Protocol Violation|3
409615|NCT00659529|1372479|P1|Overall Study|Withdrawal by Subject|4
409616|NCT00659490|1372486|P3|Overall Study|Lost to Follow-up|1
409617|NCT00659490|1372487|P2|Overall Study|Lost to Follow-up|0
409618|NCT00659490|1372488|P1|Overall Study|Lost to Follow-up|2
409619|NCT00659438|1372561|P2|Overall Study|Lost to Follow-up|0
409620|NCT00659438|1372562|P1|Overall Study|Lost to Follow-up|1
409621|NCT00659438|1372561|P2|Overall Study|Death|6
409622|NCT00659438|1372562|P1|Overall Study|Death|11
409623|NCT00659438|1372561|P2|Overall Study|Withdrawal by Subject|2
409624|NCT00659438|1372562|P1|Overall Study|Withdrawal by Subject|2
409625|NCT00659425|1372594|P10|Overall Study|Other|6
409626|NCT00659425|1372595|P9|Overall Study|Other|0
409627|NCT00659425|1372596|P8|Overall Study|Other|2
409628|NCT00659425|1372597|P7|Overall Study|Other|3
409629|NCT00659425|1372598|P6|Overall Study|Other|0
409630|NCT00659425|1372599|P5|Overall Study|Other|4
409631|NCT00659425|1372600|P4|Overall Study|Other|2
409632|NCT00659425|1372601|P3|Overall Study|Other|1
409633|NCT00659425|1372602|P2|Overall Study|Other|1
409634|NCT00659425|1372603|P1|Overall Study|Other|0
409635|NCT00659425|1372594|P10|Overall Study|Investigator Discretion|0
409636|NCT00659425|1372595|P9|Overall Study|Investigator Discretion|0
409637|NCT00659425|1372596|P8|Overall Study|Investigator Discretion|3
409638|NCT00659425|1372597|P7|Overall Study|Investigator Discretion|0
409639|NCT00659425|1372598|P6|Overall Study|Investigator Discretion|1
409640|NCT00659425|1372599|P5|Overall Study|Investigator Discretion|0
409641|NCT00659425|1372600|P4|Overall Study|Investigator Discretion|0
409642|NCT00659425|1372601|P3|Overall Study|Investigator Discretion|0
409643|NCT00659425|1372602|P2|Overall Study|Investigator Discretion|0
409644|NCT00659425|1372603|P1|Overall Study|Investigator Discretion|0
409645|NCT00659425|1372594|P10|Overall Study|Adverse Event|4
409646|NCT00659425|1372595|P9|Overall Study|Adverse Event|1
409647|NCT00659425|1372596|P8|Overall Study|Adverse Event|3
409648|NCT00659425|1372597|P7|Overall Study|Adverse Event|0
409649|NCT00659425|1372598|P6|Overall Study|Adverse Event|1
409650|NCT00659425|1372599|P5|Overall Study|Adverse Event|0
409651|NCT00659425|1372600|P4|Overall Study|Adverse Event|0
409652|NCT00659425|1372601|P3|Overall Study|Adverse Event|0
409653|NCT00659425|1372602|P2|Overall Study|Adverse Event|0
409654|NCT00659425|1372603|P1|Overall Study|Adverse Event|0
409655|NCT00659425|1372594|P10|Overall Study|Death|0
409656|NCT00659425|1372595|P9|Overall Study|Death|0
409657|NCT00659425|1372596|P8|Overall Study|Death|0
409658|NCT00659425|1372597|P7|Overall Study|Death|1
409659|NCT00659425|1372598|P6|Overall Study|Death|0
409660|NCT00659425|1372599|P5|Overall Study|Death|0
409661|NCT00659425|1372600|P4|Overall Study|Death|1
409662|NCT00659425|1372601|P3|Overall Study|Death|0
409663|NCT00659425|1372602|P2|Overall Study|Death|0
409664|NCT00659425|1372603|P1|Overall Study|Death|0
409665|NCT00659425|1372594|P10|Overall Study|Disease progression|3
409666|NCT00659425|1372595|P9|Overall Study|Disease progression|5
409667|NCT00659425|1372596|P8|Overall Study|Disease progression|3
409668|NCT00659425|1372597|P7|Overall Study|Disease progression|4
409669|NCT00659425|1372598|P6|Overall Study|Disease progression|2
409670|NCT00659425|1372599|P5|Overall Study|Disease progression|0
409671|NCT00659425|1372600|P4|Overall Study|Disease progression|1
409672|NCT00659425|1372601|P3|Overall Study|Disease progression|0
409673|NCT00659425|1372602|P2|Overall Study|Disease progression|0
409674|NCT00659425|1372603|P1|Overall Study|Disease progression|1
409675|NCT00659373|1372834|P2|Overall Study|Assessment Missed|2
409676|NCT00659373|1372835|P1|Overall Study|Assessment Missed|2
409677|NCT00659373|1372834|P2|Overall Study|Withdrawal by Subject|5
409678|NCT00659373|1372835|P1|Overall Study|Withdrawal by Subject|3
409679|NCT00659334|1372857|P7|Overall Study|Screen Failure|1
409680|NCT00659334|1372858|P6|Overall Study|Screen Failure|0
409681|NCT00659334|1372859|P5|Overall Study|Screen Failure|0
409682|NCT00659334|1372860|P4|Overall Study|Screen Failure|0
409683|NCT00659334|1372861|P3|Overall Study|Screen Failure|0
409684|NCT00659334|1372862|P2|Overall Study|Screen Failure|5
409685|NCT00659334|1372863|P1|Overall Study|Screen Failure|8
409686|NCT00659269|1372890|P2|Overall Study|Physician Decision|1
409687|NCT00659269|1372891|P1|Overall Study|Physician Decision|1
409688|NCT00659230|1372921|P2|Overall Study|Did not return post-randomization|3
409689|NCT00659230|1372922|P1|Overall Study|Did not return post-randomization|2
409690|NCT00659230|1372921|P2|Overall Study|Lost source documentation|4
409691|NCT00659230|1372922|P1|Overall Study|Lost source documentation|5
409692|NCT00659230|1372921|P2|Overall Study|Lost to Follow-up|5
409693|NCT00659230|1372922|P1|Overall Study|Lost to Follow-up|2
409694|NCT00659061|1372945|P2|Overall Study|Migration due to political unrest|15
409695|NCT00659061|1372946|P1|Overall Study|Migration due to political unrest|21
409696|NCT00658996|1372964|P2|Second Intervention|Positive slit lamp finding|1
409697|NCT00658996|1372965|P1|Second Intervention|Positive slit lamp finding|0
409698|NCT00658996|1372964|P2|Second Intervention|Developed a stye on upper lid|0
409699|NCT00658996|1372965|P1|Second Intervention|Developed a stye on upper lid|1
409700|NCT00658996|1372964|P2|Crossover Period|Ineligible|1
409701|NCT00658996|1372965|P1|Crossover Period|Ineligible|1
409702|NCT00658996|1372964|P2|Crossover Period|Physician Decision|0
409703|NCT00658996|1372965|P1|Crossover Period|Physician Decision|1
409704|NCT00658996|1372964|P2|First Intervention|Lack of lenses|1
409705|NCT00658996|1372965|P1|First Intervention|Lack of lenses|0
409706|NCT00658996|1372964|P2|First Intervention|Positive slit lamp finding|0
409707|NCT00658996|1372965|P1|First Intervention|Positive slit lamp finding|1
409708|NCT00658814|1372977|P2|Maintenance Therapy|Not eligible|0
409709|NCT00658814|1372978|P1|Maintenance Therapy|Not eligible|1
409710|NCT00658814|1372977|P2|Maintenance Therapy|Not protocol specified|0
409711|NCT00658814|1372978|P1|Maintenance Therapy|Not protocol specified|1
409712|NCT00658814|1372977|P2|Maintenance Therapy|Adverse Event|1
409713|NCT00658814|1372978|P1|Maintenance Therapy|Adverse Event|1
409714|NCT00658814|1372977|P2|Consolidation Therapy|Not eligible|2
409715|NCT00658814|1372978|P1|Consolidation Therapy|Not eligible|2
409716|NCT00658814|1372977|P2|Consolidation Therapy|Not protocol specified|1
409717|NCT00658814|1372978|P1|Consolidation Therapy|Not protocol specified|0
409718|NCT00658814|1372977|P2|Remission Induction Chemotherapy|Not eligible|2
409719|NCT00658814|1372978|P1|Remission Induction Chemotherapy|Not eligible|1
409720|NCT00658814|1372977|P2|Remission Induction Chemotherapy|Not protocol specified|4
409721|NCT00658814|1372978|P1|Remission Induction Chemotherapy|Not protocol specified|2
409722|NCT00658814|1372977|P2|Remission Induction Chemotherapy|Death|4
409723|NCT00658814|1372978|P1|Remission Induction Chemotherapy|Death|1
409724|NCT00658814|1372977|P2|Remission Induction Chemotherapy|Progression/Relapse|1
409725|NCT00658814|1372978|P1|Remission Induction Chemotherapy|Progression/Relapse|0
409726|NCT00658814|1372977|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
409727|NCT00658814|1372978|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
409728|NCT00658814|1372977|P2|Remission Induction Chemotherapy|Adverse Event|3
409729|NCT00658814|1372978|P1|Remission Induction Chemotherapy|Adverse Event|1
409730|NCT00658788|1372992|P1|Overall Study|Treatment Discontinuation|32
409731|NCT00658788|1372992|P1|Overall Study|Lost to Follow-up|18
409732|NCT00658788|1372992|P1|Overall Study|Withdrawal by Subject|13
409733|NCT00658788|1372992|P1|Overall Study|Adverse Event|11
409734|NCT00658775|1373047|P2|Overall Study|Not specified|8
409735|NCT00658775|1373048|P1|Overall Study|Not specified|7
409736|NCT00658775|1373047|P2|Overall Study|Withdrawal of consent|7
409737|NCT00658775|1373048|P1|Overall Study|Withdrawal of consent|8
409738|NCT00658775|1373047|P2|Overall Study|Withdrawal by Subject|4
409739|NCT00658775|1373048|P1|Overall Study|Withdrawal by Subject|6
409740|NCT00658775|1373047|P2|Overall Study|Lost to Follow-up|18
409741|NCT00658775|1373048|P1|Overall Study|Lost to Follow-up|17
409742|NCT00658775|1373047|P2|Overall Study|Adverse Event|6
409743|NCT00658775|1373048|P1|Overall Study|Adverse Event|4
409744|NCT00658723|1373071|P3|Overall Study|Withdrawal by Subject|1
409745|NCT00658723|1373072|P2|Overall Study|Withdrawal by Subject|0
409746|NCT00658723|1373073|P1|Overall Study|Withdrawal by Subject|1
409747|NCT00658723|1373071|P3|Overall Study|Scheduling Issue|0
409748|NCT00658723|1373072|P2|Overall Study|Scheduling Issue|1
409749|NCT00658723|1373073|P1|Overall Study|Scheduling Issue|1
409750|NCT00658723|1373071|P3|Overall Study|Death|4
409751|NCT00658723|1373072|P2|Overall Study|Death|1
409752|NCT00658723|1373073|P1|Overall Study|Death|2
409753|NCT00658723|1373071|P3|Overall Study|Lost to Follow-up|2
409754|NCT00658723|1373072|P2|Overall Study|Lost to Follow-up|2
409755|NCT00658723|1373073|P1|Overall Study|Lost to Follow-up|0
409756|NCT00658684|1373111|P4|Overall Study|Pregnancy|0
409757|NCT00658684|1373112|P3|Overall Study|Pregnancy|0
409758|NCT00658684|1373113|P2|Overall Study|Pregnancy|1
409759|NCT00658684|1373114|P1|Overall Study|Pregnancy|1
409760|NCT00658684|1373111|P4|Overall Study|Protocol Violation|0
409761|NCT00658684|1373112|P3|Overall Study|Protocol Violation|0
409762|NCT00658684|1373113|P2|Overall Study|Protocol Violation|1
409763|NCT00658684|1373114|P1|Overall Study|Protocol Violation|1
409764|NCT00658684|1373111|P4|Overall Study|Lack of Efficacy|0
409765|NCT00658684|1373112|P3|Overall Study|Lack of Efficacy|0
409766|NCT00658684|1373113|P2|Overall Study|Lack of Efficacy|1
409767|NCT00658684|1373114|P1|Overall Study|Lack of Efficacy|1
409768|NCT00658684|1373111|P4|Overall Study|Withdrawal by Subject|1
409769|NCT00658684|1373112|P3|Overall Study|Withdrawal by Subject|1
409770|NCT00658684|1373113|P2|Overall Study|Withdrawal by Subject|4
409771|NCT00658684|1373114|P1|Overall Study|Withdrawal by Subject|6
409772|NCT00658684|1373111|P4|Overall Study|Adverse Event|0
409773|NCT00658684|1373112|P3|Overall Study|Adverse Event|2
409774|NCT00658684|1373113|P2|Overall Study|Adverse Event|8
409775|NCT00658684|1373114|P1|Overall Study|Adverse Event|10
409776|NCT00658658|1373169|P5|Overall Study|Other|1
409777|NCT00658658|1373170|P4|Overall Study|Other|0
409778|NCT00658658|1373171|P3|Overall Study|Other|0
409779|NCT00658658|1373172|P2|Overall Study|Other|0
409780|NCT00658658|1373173|P1|Overall Study|Other|0
409781|NCT00658658|1373169|P5|Overall Study|Protocol-specified Criteria|0
409782|NCT00658658|1373170|P4|Overall Study|Protocol-specified Criteria|0
409783|NCT00658658|1373171|P3|Overall Study|Protocol-specified Criteria|0
409784|NCT00658658|1373172|P2|Overall Study|Protocol-specified Criteria|0
409785|NCT00658658|1373173|P1|Overall Study|Protocol-specified Criteria|1
409786|NCT00658658|1373169|P5|Overall Study|Disease Progression|3
409787|NCT00658658|1373170|P4|Overall Study|Disease Progression|1
409788|NCT00658658|1373171|P3|Overall Study|Disease Progression|0
409789|NCT00658658|1373172|P2|Overall Study|Disease Progression|1
409790|NCT00658658|1373173|P1|Overall Study|Disease Progression|0
409791|NCT00658658|1373169|P5|Overall Study|Death|1
409792|NCT00658658|1373170|P4|Overall Study|Death|1
409793|NCT00658658|1373171|P3|Overall Study|Death|0
409794|NCT00658658|1373172|P2|Overall Study|Death|0
409795|NCT00658658|1373173|P1|Overall Study|Death|4
409796|NCT00658658|1373169|P5|Overall Study|Withdrawal by Subject|0
409797|NCT00658658|1373170|P4|Overall Study|Withdrawal by Subject|0
409798|NCT00658658|1373171|P3|Overall Study|Withdrawal by Subject|0
409799|NCT00658658|1373172|P2|Overall Study|Withdrawal by Subject|1
409800|NCT00658658|1373173|P1|Overall Study|Withdrawal by Subject|0
409801|NCT00658632|1373232|P2|Overall Study|Not specified|8
409802|NCT00658632|1373233|P1|Overall Study|Not specified|7
409803|NCT00658632|1373232|P2|Overall Study|Pregnancy|1
409804|NCT00658632|1373233|P1|Overall Study|Pregnancy|1
409805|NCT00658632|1373232|P2|Overall Study|Withdrawal of consent|14
409806|NCT00658632|1373233|P1|Overall Study|Withdrawal of consent|8
409807|NCT00658632|1373232|P2|Overall Study|Lack of Efficacy|1
409808|NCT00658632|1373233|P1|Overall Study|Lack of Efficacy|0
409809|NCT00658632|1373232|P2|Overall Study|Withdrawal by Subject|7
409810|NCT00658632|1373233|P1|Overall Study|Withdrawal by Subject|10
409811|NCT00658632|1373232|P2|Overall Study|Lost to Follow-up|23
409812|NCT00658632|1373233|P1|Overall Study|Lost to Follow-up|25
409813|NCT00658632|1373232|P2|Overall Study|Adverse Event|11
409814|NCT00658632|1373233|P1|Overall Study|Adverse Event|13
409815|NCT00658606|1373274|P2|Overall Study|Lack of Compliance|3
409816|NCT00658606|1373275|P1|Overall Study|Lack of Compliance|0
409817|NCT00658606|1373274|P2|Overall Study|Withdrawal by Subject|16
409818|NCT00658606|1373275|P1|Overall Study|Withdrawal by Subject|7
409819|NCT00658606|1373274|P2|Overall Study|Lost to Follow-up|0
409820|NCT00658606|1373275|P1|Overall Study|Lost to Follow-up|1
409821|NCT00658606|1373274|P2|Overall Study|Lack of Efficacy|3
409822|NCT00658606|1373275|P1|Overall Study|Lack of Efficacy|6
409823|NCT00658606|1373274|P2|Overall Study|Adverse Event|1
409824|NCT00658606|1373275|P1|Overall Study|Adverse Event|2
409825|NCT00658567|1373304|P3|Overall Study|At Discretion of Sponsor|1
409826|NCT00658567|1373305|P2|Overall Study|At Discretion of Sponsor|1
409827|NCT00658567|1373306|P1|Overall Study|At Discretion of Sponsor|1
409828|NCT00658567|1373304|P3|Overall Study|Physician Decision|0
409829|NCT00658567|1373305|P2|Overall Study|Physician Decision|1
409830|NCT00658567|1373306|P1|Overall Study|Physician Decision|0
409831|NCT00658567|1373304|P3|Overall Study|Voluntary Withdrawal of Consent|2
409832|NCT00658567|1373305|P2|Overall Study|Voluntary Withdrawal of Consent|0
409833|NCT00658567|1373306|P1|Overall Study|Voluntary Withdrawal of Consent|2
409834|NCT00658567|1373304|P3|Overall Study|Adverse Event|3
409835|NCT00658567|1373305|P2|Overall Study|Adverse Event|2
409836|NCT00658567|1373306|P1|Overall Study|Adverse Event|5
409837|NCT00658541|1373317|P2|Washout Period of 7 Days|Withdrawal by Subject|1
409838|NCT00658541|1373318|P1|Washout Period of 7 Days|Withdrawal by Subject|0
409839|NCT00658541|1373317|P2|Washout Period of 7 Days|Withdrawal by Subject|1
409840|NCT00658541|1373318|P1|Washout Period of 7 Days|Withdrawal by Subject|1
409841|NCT00658528|1373330|P2|Overall Study|Not specified|4
409842|NCT00658528|1373331|P1|Overall Study|Not specified|8
409843|NCT00658528|1373330|P2|Overall Study|Withdrawal of consent|6
409844|NCT00658528|1373331|P1|Overall Study|Withdrawal of consent|5
409845|NCT00658528|1373330|P2|Overall Study|Withdrawal by Subject|6
409846|NCT00658528|1373331|P1|Overall Study|Withdrawal by Subject|8
409847|NCT00658528|1373330|P2|Overall Study|Lost to Follow-up|22
409848|NCT00658528|1373331|P1|Overall Study|Lost to Follow-up|14
409849|NCT00658528|1373330|P2|Overall Study|Adverse Event|7
409850|NCT00658528|1373331|P1|Overall Study|Adverse Event|5
409851|NCT00658359|1373356|P3|Overall Study|Lack of Efficacy|0
409852|NCT00658359|1373357|P2|Overall Study|Lack of Efficacy|1
409853|NCT00658359|1373358|P1|Overall Study|Lack of Efficacy|0
409854|NCT00658359|1373356|P3|Overall Study|Lost to Follow-up|4
409855|NCT00658359|1373357|P2|Overall Study|Lost to Follow-up|2
409856|NCT00658359|1373358|P1|Overall Study|Lost to Follow-up|2
409857|NCT00658359|1373356|P3|Overall Study|Withdrawal by Subject|2
409858|NCT00658359|1373357|P2|Overall Study|Withdrawal by Subject|4
409859|NCT00658359|1373358|P1|Overall Study|Withdrawal by Subject|7
409860|NCT00658359|1373356|P3|Overall Study|Includes protocol Amendments 3 and 4|29
409861|NCT00658359|1373357|P2|Overall Study|Includes protocol Amendments 3 and 4|31
409862|NCT00658359|1373358|P1|Overall Study|Includes protocol Amendments 3 and 4|2
409863|NCT00658359|1373356|P3|Overall Study|Protocol Violation|0
409864|NCT00658359|1373357|P2|Overall Study|Protocol Violation|0
409865|NCT00658359|1373358|P1|Overall Study|Protocol Violation|1
409866|NCT00658359|1373356|P3|Overall Study|Adverse Event|9
409867|NCT00658359|1373357|P2|Overall Study|Adverse Event|6
409868|NCT00658359|1373358|P1|Overall Study|Adverse Event|13
409869|NCT00658359|1373356|P3|Overall Study|Death|2
409870|NCT00658359|1373357|P2|Overall Study|Death|1
409871|NCT00658359|1373358|P1|Overall Study|Death|3
409872|NCT00658333|1373446|P2|Overall Study|Adverse Event|1
409873|NCT00658333|1373447|P1|Overall Study|Adverse Event|2
409874|NCT00658320|1373457|P2|Extension Study: After Month 24|Subject withdrew consent|0
409875|NCT00658320|1373458|P1|Extension Study: After Month 24|Subject withdrew consent|2
409876|NCT00658320|1373457|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
409877|NCT00658320|1373458|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
409878|NCT00658320|1373457|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
409879|NCT00658320|1373458|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
409880|NCT00658320|1373457|P2|Core Study: 12 Months|Subject withdrew consent|3
409881|NCT00658320|1373458|P1|Core Study: 12 Months|Subject withdrew consent|5
409882|NCT00657709|1373495|P5|Overall Study|Protocol Violation|2
409883|NCT00657709|1373496|P4|Overall Study|Protocol Violation|1
409884|NCT00657709|1373497|P3|Overall Study|Protocol Violation|0
409885|NCT00657709|1373498|P2|Overall Study|Protocol Violation|2
409886|NCT00657709|1373499|P1|Overall Study|Protocol Violation|0
409887|NCT00657709|1373495|P5|Overall Study|Lost to Follow-up|21
409888|NCT00657709|1373496|P4|Overall Study|Lost to Follow-up|1
409889|NCT00657709|1373497|P3|Overall Study|Lost to Follow-up|7
409890|NCT00657709|1373498|P2|Overall Study|Lost to Follow-up|9
409891|NCT00657709|1373499|P1|Overall Study|Lost to Follow-up|9
409892|NCT00657709|1373495|P5|Overall Study|Withdrawal by Subject|9
409893|NCT00657709|1373496|P4|Overall Study|Withdrawal by Subject|5
409894|NCT00657709|1373497|P3|Overall Study|Withdrawal by Subject|15
409895|NCT00657709|1373498|P2|Overall Study|Withdrawal by Subject|15
409896|NCT00657709|1373499|P1|Overall Study|Withdrawal by Subject|7
409897|NCT00657709|1373495|P5|Overall Study|AE or Death|1
409898|NCT00657709|1373496|P4|Overall Study|AE or Death|7
409899|NCT00657709|1373497|P3|Overall Study|AE or Death|6
409900|NCT00657709|1373498|P2|Overall Study|AE or Death|7
409901|NCT00657709|1373499|P1|Overall Study|AE or Death|7
409902|NCT00657618|1373548|P1|Overall Study|didn't start due to schedule conflicts|1
409903|NCT00657618|1373548|P1|Overall Study|negative for leishmaniasis|2
409904|NCT00657618|1373548|P1|Overall Study|Withdrawal by Subject|8
409905|NCT00657618|1373548|P1|Overall Study|Adverse Event|32
409906|NCT00657553|1373555|P2|Overall Study|low accrual, no analysis run|5
409907|NCT00657553|1373556|P1|Overall Study|low accrual, no analysis run|5
409908|NCT00657540|1373564|P2|Overall Study|Lost to Follow-up|4
409909|NCT00657540|1373565|P1|Overall Study|Lost to Follow-up|1
409910|NCT00657371|1373579|P1|Overall Study|Pre-existing medical condition|4
409911|NCT00657371|1373579|P1|Overall Study|Device- related reasons|13
409912|NCT00657371|1373579|P1|Overall Study|Protocol Violation|2
409913|NCT00657371|1373579|P1|Overall Study|Unable to intubate the cecum|5
409914|NCT00657371|1373579|P1|Overall Study|Poor bowel preparation|15
409915|NCT00657358|1373584|P1|Overall Study|Lack of Efficacy|6
409916|NCT00657267|1373596|P1|Overall Study|Adverse Event|9
409917|NCT00657267|1373596|P1|Overall Study|Progressive disease|45
409918|NCT00657150|1373606|P2|Treatment|Not Specified|15
409919|NCT00657150|1373607|P1|Treatment|Not Specified|13
409920|NCT00657150|1373606|P2|Treatment|Withdrawal by Subject|20
409921|NCT00657150|1373607|P1|Treatment|Withdrawal by Subject|23
409922|NCT00657150|1373606|P2|Treatment|Lost to Follow-up|0
409923|NCT00657150|1373607|P1|Treatment|Lost to Follow-up|1
409924|NCT00657150|1373606|P2|Treatment|Non-compliant with protocol|9
409925|NCT00657150|1373607|P1|Treatment|Non-compliant with protocol|10
409926|NCT00657150|1373606|P2|Treatment|Adverse Event|53
409927|NCT00657150|1373607|P1|Treatment|Adverse Event|60
409928|NCT00657150|1373606|P2|Overall Study|Not Specified|38
409929|NCT00657150|1373607|P1|Overall Study|Not Specified|38
409930|NCT00657150|1373606|P2|Overall Study|Withdrawal by Subject|36
409931|NCT00657150|1373607|P1|Overall Study|Withdrawal by Subject|51
409932|NCT00657150|1373606|P2|Overall Study|Lost to Follow-up|0
409933|NCT00657150|1373607|P1|Overall Study|Lost to Follow-up|2
409934|NCT00657150|1373606|P2|Overall Study|Non-compliant with protocol|9
409935|NCT00657150|1373607|P1|Overall Study|Non-compliant with protocol|5
409936|NCT00657150|1373606|P2|Overall Study|Adverse Event|10
409937|NCT00657150|1373607|P1|Overall Study|Adverse Event|19
409938|NCT00657046|1373638|P3|Overall Study|Surgery|1
409939|NCT00657046|1373639|P2|Overall Study|Surgery|0
409940|NCT00657046|1373640|P1|Overall Study|Surgery|0
409941|NCT00657046|1373638|P3|Overall Study|Death|1
409942|NCT00657046|1373639|P2|Overall Study|Death|0
409943|NCT00657046|1373640|P1|Overall Study|Death|0
409944|NCT00657046|1373638|P3|Overall Study|Withdrawal by Subject|0
409945|NCT00657046|1373639|P2|Overall Study|Withdrawal by Subject|0
409946|NCT00657046|1373640|P1|Overall Study|Withdrawal by Subject|1
409947|NCT00657046|1373638|P3|Overall Study|Protocol Violation|0
409948|NCT00657046|1373639|P2|Overall Study|Protocol Violation|2
409949|NCT00657046|1373640|P1|Overall Study|Protocol Violation|2
409950|NCT00657046|1373638|P3|Overall Study|Adverse Event|0
409951|NCT00657046|1373639|P2|Overall Study|Adverse Event|1
409952|NCT00657046|1373640|P1|Overall Study|Adverse Event|1
409953|NCT00657020|1373672|P2|PERIOD 1|Adverse Event|1
409954|NCT00657020|1373673|P1|PERIOD 1|Adverse Event|0
409955|NCT00656851|1373723|P2|Overall Study|Withdrawal by Subject|4
409956|NCT00656851|1373724|P1|Overall Study|Withdrawal by Subject|0
409957|NCT00656799|1373746|P1|Overall Study|Death|2
409958|NCT00656669|1373768|P1|AC (Cycles 6-9)|Did not start segment 3|1
409959|NCT00656669|1373768|P1|AC (Cycles 6-9)|Adverse Event|1
409960|NCT00656669|1373768|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
409961|NCT00656669|1373768|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
409962|NCT00656617|1373807|P1|Overall Study|Move to different clinical trial|2
409963|NCT00656617|1373807|P1|Overall Study|Insurance Issues|2
409964|NCT00656617|1373807|P1|Overall Study|Death|2
409965|NCT00656617|1373807|P1|Overall Study|Adverse Event|1
409966|NCT00656513|1373816|P3|Overall Study|Missing baseline form|5
409967|NCT00656513|1373817|P2|Overall Study|Missing baseline form|5
409968|NCT00656513|1373818|P1|Overall Study|Missing baseline form|0
409969|NCT00656513|1373816|P3|Overall Study|Treatment completed outside of timeframe|1
409970|NCT00656513|1373817|P2|Overall Study|Treatment completed outside of timeframe|3
409971|NCT00656513|1373818|P1|Overall Study|Treatment completed outside of timeframe|0
409972|NCT00656513|1373816|P3|Overall Study|Incomplete treatment|0
409973|NCT00656513|1373817|P2|Overall Study|Incomplete treatment|0
409974|NCT00656513|1373818|P1|Overall Study|Incomplete treatment|3
409975|NCT00656513|1373816|P3|Overall Study|Missing data|9
409976|NCT00656513|1373817|P2|Overall Study|Missing data|11
409977|NCT00656513|1373818|P1|Overall Study|Missing data|0
409978|NCT00656513|1373816|P3|Overall Study|Death|1
409979|NCT00656513|1373817|P2|Overall Study|Death|0
409980|NCT00656513|1373818|P1|Overall Study|Death|0
409981|NCT00656513|1373816|P3|Overall Study|Withdrawal by Subject|4
409982|NCT00656513|1373817|P2|Overall Study|Withdrawal by Subject|11
409983|NCT00656513|1373818|P1|Overall Study|Withdrawal by Subject|0
409984|NCT00656513|1373816|P3|Overall Study|Protocol Violation|2
409985|NCT00656513|1373817|P2|Overall Study|Protocol Violation|0
409986|NCT00656513|1373818|P1|Overall Study|Protocol Violation|1
409987|NCT00656474|1373865|P1|Overall Study|Other Reason|1
409988|NCT00656370|1373883|P1|Overall Study|Alternates|3
409989|NCT00656370|1373883|P1|Overall Study|Screen Failures|7
409990|NCT00656292|1373891|P2|Overall Study|Screen failure|2
409991|NCT00656292|1373892|P1|Overall Study|Screen failure|1
409992|NCT00656292|1373891|P2|Overall Study|Withdrawal by Subject|3
409993|NCT00656292|1373892|P1|Overall Study|Withdrawal by Subject|2
409994|NCT00656175|1373919|P2|Overall Study|Transportation issues|1
409995|NCT00656175|1373920|P1|Overall Study|Transportation issues|0
409996|NCT00656175|1373919|P2|Overall Study|Adverse Event|0
409997|NCT00656175|1373920|P1|Overall Study|Adverse Event|1
409998|NCT00656136|1373928|P2|Overall Study|Unknown and others|4
409999|NCT00656136|1373929|P1|Overall Study|Unknown and others|4
410000|NCT00656136|1373928|P2|Overall Study|Patient refused to take study medication|10
410001|NCT00656136|1373929|P1|Overall Study|Patient refused to take study medication|7
410002|NCT00656136|1373928|P2|Overall Study|Protocol Violation|3
410003|NCT00656136|1373929|P1|Overall Study|Protocol Violation|2
410004|NCT00656136|1373928|P2|Overall Study|Other Adverse Event|51
410005|NCT00656136|1373929|P1|Overall Study|Other Adverse Event|5
410006|NCT00656136|1373928|P2|Overall Study|Progressive disease|322
410007|NCT00656136|1373929|P1|Overall Study|Progressive disease|177
410008|NCT00656084|1373939|P1|Overall Study|Investigator Request|1
410009|NCT00656084|1373939|P1|Overall Study|Patient Request|1
410010|NCT00656084|1373939|P1|Overall Study|Withdrawal by Subject|1
410011|NCT00656084|1373939|P1|Overall Study|Adverse Event|4
410012|NCT00656058|1373946|P1|Overall Study|Withdrawal by Subject|4
410013|NCT00656058|1373946|P1|Overall Study|Withdrawal by Subject|2
410014|NCT00656019|1373959|P4|Overall Study|Lost to Follow-up|0
410015|NCT00656019|1373960|P3|Overall Study|Lost to Follow-up|0
410016|NCT00656019|1373961|P2|Overall Study|Lost to Follow-up|1
410017|NCT00656019|1373962|P1|Overall Study|Lost to Follow-up|2
410018|NCT00656019|1373959|P4|Overall Study|Withdrawal by Subject|0
410019|NCT00656019|1373960|P3|Overall Study|Withdrawal by Subject|0
410020|NCT00656019|1373961|P2|Overall Study|Withdrawal by Subject|0
410021|NCT00656019|1373962|P1|Overall Study|Withdrawal by Subject|2
410022|NCT00656019|1373959|P4|Overall Study|Not Eligible|0
410023|NCT00656019|1373960|P3|Overall Study|Not Eligible|0
410024|NCT00656019|1373961|P2|Overall Study|Not Eligible|0
410025|NCT00656019|1373962|P1|Overall Study|Not Eligible|10
410026|NCT00655889|1373972|P1|Overall Study|Protocol Violation|1
410027|NCT00655889|1373972|P1|Overall Study|Inadequate cell growth|1
410028|NCT00655876|1373979|P2|Overall Study|Protocol Violation|7
410029|NCT00655876|1373980|P1|Overall Study|Protocol Violation|9
410030|NCT00655863|1373999|P3|Overall Study|Lost to Follow-up|1
410031|NCT00655863|1374000|P2|Overall Study|Lost to Follow-up|0
410032|NCT00655863|1374001|P1|Overall Study|Lost to Follow-up|0
410033|NCT00655850|1374060|P1|Overall Study|Withdrawal by Subject|1
410034|NCT00655850|1374060|P1|Overall Study|Death|2
410035|NCT00655824|1374067|P1|Overall Study|Deterioration of Trial Disease|2
410036|NCT00655824|1374067|P1|Overall Study|Withdrawal by Subject|4
410037|NCT00655824|1374067|P1|Overall Study|Protocol Violation|1
410038|NCT00655824|1374067|P1|Overall Study|Early Termination of Study by Sponsor|74
410039|NCT00655824|1374067|P1|Overall Study|Adverse Event|3
410040|NCT00655746|1374115|P1|Overall Study|Withdrawal by Subject|1
410041|NCT00655733|1374134|P2|Overall Study|Physician Decision|1
410042|NCT00655733|1374135|P1|Overall Study|Physician Decision|0
410043|NCT00655733|1374134|P2|Overall Study|Withdrawal by Subject|3
410044|NCT00655733|1374135|P1|Overall Study|Withdrawal by Subject|3
410045|NCT00655733|1374134|P2|Overall Study|Adverse Event|2
410046|NCT00655733|1374135|P1|Overall Study|Adverse Event|2
410047|NCT00655733|1374134|P2|Overall Study|Lost to Follow-up|2
410048|NCT00655733|1374135|P1|Overall Study|Lost to Follow-up|2
410049|NCT00655668|1374141|P1|Overall Study|Withdrawal by Subject|2
410050|NCT00655668|1374141|P1|Overall Study|New Lymphoma Treatment Started|4
410051|NCT00655668|1374141|P1|Overall Study|Other|1
410052|NCT00655668|1374141|P1|Overall Study|Study Terminated|9
410053|NCT00655668|1374141|P1|Overall Study|Disease Progression|27
410054|NCT00655668|1374141|P1|Overall Study|Death|5
410055|NCT00655668|1374141|P1|Overall Study|Adverse Event|6
410056|NCT00655629|1374168|P2|Overall Study|consent withdrawn|4
410057|NCT00655629|1374169|P1|Overall Study|consent withdrawn|6
410058|NCT00655629|1374168|P2|Overall Study|Protocol Violation|3
410059|NCT00655629|1374169|P1|Overall Study|Protocol Violation|5
410060|NCT00655629|1374168|P2|Overall Study|Lost to Follow-up|3
410061|NCT00655629|1374169|P1|Overall Study|Lost to Follow-up|4
410062|NCT00655629|1374168|P2|Overall Study|Lack of Efficacy|12
410063|NCT00655629|1374169|P1|Overall Study|Lack of Efficacy|2
410064|NCT00655629|1374168|P2|Overall Study|Adverse Event|1
410065|NCT00655629|1374169|P1|Overall Study|Adverse Event|4
410066|NCT00655564|1374205|P1|Overall Study|Desired Alternate Therapy|1
410067|NCT00655564|1374205|P1|Overall Study|Lost to Follow-up|1
410068|NCT00655564|1374205|P1|Overall Study|Adverse Event|1
410069|NCT00655551|1374213|P3|Period 4 (up to 7 Days)|Adverse Event|0
410070|NCT00655551|1374214|P2|Period 4 (up to 7 Days)|Adverse Event|2
410071|NCT00655551|1374215|P1|Period 4 (up to 7 Days)|Adverse Event|0
410072|NCT00655551|1374213|P3|Period 3 (up to 7 Days)|Adverse Event|4
410073|NCT00655551|1374214|P2|Period 3 (up to 7 Days)|Adverse Event|0
410074|NCT00655551|1374215|P1|Period 3 (up to 7 Days)|Adverse Event|0
410075|NCT00655551|1374213|P3|Period 2 (up to 7 Days)|Adverse Event|0
410076|NCT00655551|1374214|P2|Period 2 (up to 7 Days)|Adverse Event|1
410077|NCT00655551|1374215|P1|Period 2 (up to 7 Days)|Adverse Event|0
410078|NCT00655551|1374213|P3|All Periods Combined|Adverse Event|4
410079|NCT00655551|1374214|P2|All Periods Combined|Adverse Event|3
410080|NCT00655551|1374215|P1|All Periods Combined|Adverse Event|0
410081|NCT00655486|1374229|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
410082|NCT00655486|1374229|P1|Overall Study|Other: Could not tolerate BID dosing|1
410083|NCT00655486|1374229|P1|Overall Study|Other: Pregnancy|1
410084|NCT00655486|1374229|P1|Overall Study|Unsatisfactory compliance|2
410085|NCT00655486|1374229|P1|Overall Study|Protocol Violation|1
410086|NCT00655486|1374229|P1|Overall Study|Withdrawal by Subject|4
410087|NCT00655486|1374229|P1|Overall Study|Lack of Efficacy|8
410088|NCT00655486|1374229|P1|Overall Study|Adverse Event|10
410089|NCT00655356|1374236|P2|Overall Study|Other Reason|0
410090|NCT00655356|1374237|P1|Overall Study|Other Reason|1
410091|NCT00655356|1374236|P2|Overall Study|Protocol Violation|1
410092|NCT00655356|1374237|P1|Overall Study|Protocol Violation|2
410093|NCT00655356|1374236|P2|Overall Study|Adverse Event|1
410094|NCT00655356|1374237|P1|Overall Study|Adverse Event|1
410095|NCT00655356|1374236|P2|Overall Study|Sponsor Request|4
410096|NCT00655356|1374237|P1|Overall Study|Sponsor Request|10
410097|NCT00655356|1374236|P2|Overall Study|Withdrawal by Subject|4
410098|NCT00655356|1374237|P1|Overall Study|Withdrawal by Subject|3
410099|NCT00654940|1374288|P2|Period 1|Intolerable Pain Level|0
410100|NCT00654940|1374289|P1|Period 1|Intolerable Pain Level|1
410101|NCT00654940|1374288|P2|Period 1|Adverse Event|1
410102|NCT00654940|1374289|P1|Period 1|Adverse Event|0
410103|NCT00654901|1374313|P4|Overall Study|Withdrawal by Subject|0
410104|NCT00654901|1374314|P3|Overall Study|Withdrawal by Subject|1
410105|NCT00654901|1374315|P2|Overall Study|Withdrawal by Subject|0
410106|NCT00654901|1374316|P1|Overall Study|Withdrawal by Subject|3
410107|NCT00654901|1374313|P4|Overall Study|Lost to Follow-up|0
410108|NCT00654901|1374314|P3|Overall Study|Lost to Follow-up|1
410109|NCT00654901|1374315|P2|Overall Study|Lost to Follow-up|0
410110|NCT00654901|1374316|P1|Overall Study|Lost to Follow-up|1
410111|NCT00654875|1374336|P2|Overall Study|Administrative Problems|0
410112|NCT00654875|1374337|P1|Overall Study|Administrative Problems|1
410113|NCT00654875|1374336|P2|Overall Study|Abnormal Test Procedure Result(s)|0
410114|NCT00654875|1374337|P1|Overall Study|Abnormal Test Procedure Result(s)|1
410115|NCT00654875|1374336|P2|Overall Study|Lost to Follow-up|3
410116|NCT00654875|1374337|P1|Overall Study|Lost to Follow-up|1
410117|NCT00654875|1374336|P2|Overall Study|Lack of Efficacy|2
410118|NCT00654875|1374337|P1|Overall Study|Lack of Efficacy|2
410119|NCT00654875|1374336|P2|Overall Study|Protocol Violation|3
410120|NCT00654875|1374337|P1|Overall Study|Protocol Violation|3
410121|NCT00654875|1374336|P2|Overall Study|Withdrawal by Subject|4
410122|NCT00654875|1374337|P1|Overall Study|Withdrawal by Subject|4
410123|NCT00654875|1374336|P2|Overall Study|Adverse Event|5
410124|NCT00654875|1374337|P1|Overall Study|Adverse Event|5
410125|NCT00654745|1374370|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
410126|NCT00654745|1374370|P1|Overall Study|Withdrawal by Subject|10
410127|NCT00654745|1374370|P1|Overall Study|Protocol Violation|11
410128|NCT00654745|1374370|P1|Overall Study|Lost to Follow-up|7
410129|NCT00654745|1374370|P1|Overall Study|Adverse Event|12
410130|NCT00654641|1374415|P2|Overall Study|Lost to Follow-up|3
410131|NCT00654641|1374416|P1|Overall Study|Lost to Follow-up|2
410132|NCT00654628|1374422|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
410133|NCT00654628|1374422|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
410134|NCT00654628|1374422|P1|6-week Active Treatment Period|Out of window period|1
410135|NCT00654628|1374422|P1|6-week Active Treatment Period|Transferred to branch hospital|1
410224|NCT00654381|1374533|P6|2nd Stage|Adverse Event|2
410136|NCT00654628|1374422|P1|6-week Active Treatment Period|Lost to Follow-up|10
410137|NCT00654628|1374422|P1|6-week Active Treatment Period|Adverse Event|9
410138|NCT00654498|1374471|P2|Overall Study|Other reason not defined above|5
410139|NCT00654498|1374472|P1|Overall Study|Other reason not defined above|4
410140|NCT00654498|1374471|P2|Overall Study|Withdrawal by Subject|0
410141|NCT00654498|1374472|P1|Overall Study|Withdrawal by Subject|1
410142|NCT00654498|1374471|P2|Overall Study|Lost to Follow-up|5
410143|NCT00654498|1374472|P1|Overall Study|Lost to Follow-up|1
410144|NCT00654498|1374471|P2|Overall Study|Protocol Violation|1
410145|NCT00654498|1374472|P1|Overall Study|Protocol Violation|1
410146|NCT00654498|1374471|P2|Overall Study|Adverse Event|1
410147|NCT00654498|1374472|P1|Overall Study|Adverse Event|6
410148|NCT00654498|1374471|P2|Overall Study|Not Treated|0
410149|NCT00654498|1374472|P1|Overall Study|Not Treated|1
410150|NCT00654420|1374504|P4|Phase II|Missing Disposition Record|0
410151|NCT00654420|1374505|P3|Phase II|Missing Disposition Record|1
410152|NCT00654420|1374506|P2|Phase II|Missing Disposition Record|0
410153|NCT00654420|1374507|P1|Phase II|Missing Disposition Record|0
410154|NCT00654420|1374504|P4|Phase II|Withdrawal by Subject|1
410155|NCT00654420|1374505|P3|Phase II|Withdrawal by Subject|4
410156|NCT00654420|1374506|P2|Phase II|Withdrawal by Subject|0
410157|NCT00654420|1374507|P1|Phase II|Withdrawal by Subject|0
410158|NCT00654420|1374504|P4|Phase II|Progressive Disease|29
410159|NCT00654420|1374505|P3|Phase II|Progressive Disease|29
410160|NCT00654420|1374506|P2|Phase II|Progressive Disease|0
410161|NCT00654420|1374507|P1|Phase II|Progressive Disease|0
410162|NCT00654420|1374504|P4|Phase II|Physician Decision|4
410163|NCT00654420|1374505|P3|Phase II|Physician Decision|0
410164|NCT00654420|1374506|P2|Phase II|Physician Decision|0
410165|NCT00654420|1374507|P1|Phase II|Physician Decision|0
410166|NCT00654420|1374504|P4|Phase II|Lost to Follow-up|1
410167|NCT00654420|1374505|P3|Phase II|Lost to Follow-up|0
410168|NCT00654420|1374506|P2|Phase II|Lost to Follow-up|0
410169|NCT00654420|1374507|P1|Phase II|Lost to Follow-up|0
410170|NCT00654420|1374504|P4|Phase II|Adverse Event|3
410171|NCT00654420|1374505|P3|Phase II|Adverse Event|3
410172|NCT00654420|1374506|P2|Phase II|Adverse Event|0
410173|NCT00654420|1374507|P1|Phase II|Adverse Event|0
410174|NCT00654420|1374504|P4|Phase I (Dose Escalation)|Progressive Disease|0
410175|NCT00654420|1374505|P3|Phase I (Dose Escalation)|Progressive Disease|0
410176|NCT00654420|1374506|P2|Phase I (Dose Escalation)|Progressive Disease|15
410177|NCT00654420|1374507|P1|Phase I (Dose Escalation)|Progressive Disease|4
410178|NCT00654420|1374504|P4|Phase I (Dose Escalation)|Adverse Event|0
410179|NCT00654420|1374505|P3|Phase I (Dose Escalation)|Adverse Event|0
410180|NCT00654420|1374506|P2|Phase I (Dose Escalation)|Adverse Event|1
410181|NCT00654420|1374507|P1|Phase I (Dose Escalation)|Adverse Event|0
410182|NCT00654381|1374533|P6|Extension Stage|Closure of the trial site|1
410183|NCT00654381|1374534|P5|Extension Stage|Closure of the trial site|1
410184|NCT00654381|1374535|P4|Extension Stage|Closure of the trial site|0
410185|NCT00654381|1374536|P3|Extension Stage|Closure of the trial site|0
410186|NCT00654381|1374537|P2|Extension Stage|Closure of the trial site|0
410187|NCT00654381|1374538|P1|Extension Stage|Closure of the trial site|0
410188|NCT00654381|1374533|P6|Extension Stage|Withdrawal by Subject|1
410189|NCT00654381|1374534|P5|Extension Stage|Withdrawal by Subject|1
410190|NCT00654381|1374535|P4|Extension Stage|Withdrawal by Subject|1
410191|NCT00654381|1374536|P3|Extension Stage|Withdrawal by Subject|1
410192|NCT00654381|1374537|P2|Extension Stage|Withdrawal by Subject|0
410193|NCT00654381|1374538|P1|Extension Stage|Withdrawal by Subject|0
410194|NCT00654381|1374533|P6|Extension Stage|Lack of Efficacy|0
410195|NCT00654381|1374534|P5|Extension Stage|Lack of Efficacy|0
410196|NCT00654381|1374535|P4|Extension Stage|Lack of Efficacy|0
410197|NCT00654381|1374536|P3|Extension Stage|Lack of Efficacy|1
410198|NCT00654381|1374537|P2|Extension Stage|Lack of Efficacy|0
410199|NCT00654381|1374538|P1|Extension Stage|Lack of Efficacy|0
410200|NCT00654381|1374533|P6|Extension Stage|Protocol Violation|0
410201|NCT00654381|1374534|P5|Extension Stage|Protocol Violation|0
410202|NCT00654381|1374535|P4|Extension Stage|Protocol Violation|1
410203|NCT00654381|1374536|P3|Extension Stage|Protocol Violation|0
410204|NCT00654381|1374537|P2|Extension Stage|Protocol Violation|0
410205|NCT00654381|1374538|P1|Extension Stage|Protocol Violation|0
410206|NCT00654381|1374533|P6|Extension Stage|Adverse Event|1
410207|NCT00654381|1374534|P5|Extension Stage|Adverse Event|1
410208|NCT00654381|1374535|P4|Extension Stage|Adverse Event|7
410209|NCT00654381|1374536|P3|Extension Stage|Adverse Event|9
410210|NCT00654381|1374537|P2|Extension Stage|Adverse Event|2
410211|NCT00654381|1374538|P1|Extension Stage|Adverse Event|1
410212|NCT00654381|1374533|P6|2nd Stage|Investigator's decision|0
410213|NCT00654381|1374534|P5|2nd Stage|Investigator's decision|0
410214|NCT00654381|1374535|P4|2nd Stage|Investigator's decision|1
410215|NCT00654381|1374536|P3|2nd Stage|Investigator's decision|1
410216|NCT00654381|1374537|P2|2nd Stage|Investigator's decision|0
410217|NCT00654381|1374538|P1|2nd Stage|Investigator's decision|0
410218|NCT00654381|1374533|P6|2nd Stage|Withdrawal by Subject|1
410219|NCT00654381|1374534|P5|2nd Stage|Withdrawal by Subject|1
410220|NCT00654381|1374535|P4|2nd Stage|Withdrawal by Subject|0
410221|NCT00654381|1374536|P3|2nd Stage|Withdrawal by Subject|0
410222|NCT00654381|1374537|P2|2nd Stage|Withdrawal by Subject|0
410223|NCT00654381|1374538|P1|2nd Stage|Withdrawal by Subject|0
410225|NCT00654381|1374534|P5|2nd Stage|Adverse Event|7
410226|NCT00654381|1374535|P4|2nd Stage|Adverse Event|3
410227|NCT00654381|1374536|P3|2nd Stage|Adverse Event|2
410228|NCT00654381|1374537|P2|2nd Stage|Adverse Event|0
410229|NCT00654381|1374538|P1|2nd Stage|Adverse Event|2
410230|NCT00654381|1374533|P6|1st Stage|Investigator's decision|0
410231|NCT00654381|1374534|P5|1st Stage|Investigator's decision|0
410232|NCT00654381|1374535|P4|1st Stage|Investigator's decision|1
410233|NCT00654381|1374536|P3|1st Stage|Investigator's decision|0
410234|NCT00654381|1374537|P2|1st Stage|Investigator's decision|0
410235|NCT00654381|1374538|P1|1st Stage|Investigator's decision|0
410236|NCT00654381|1374533|P6|1st Stage|Withdrawal by Subject|1
410237|NCT00654381|1374534|P5|1st Stage|Withdrawal by Subject|0
410238|NCT00654381|1374535|P4|1st Stage|Withdrawal by Subject|1
410239|NCT00654381|1374536|P3|1st Stage|Withdrawal by Subject|0
410240|NCT00654381|1374537|P2|1st Stage|Withdrawal by Subject|0
410241|NCT00654381|1374538|P1|1st Stage|Withdrawal by Subject|0
410242|NCT00654381|1374533|P6|1st Stage|Adverse Event|1
410243|NCT00654381|1374534|P5|1st Stage|Adverse Event|2
410244|NCT00654381|1374535|P4|1st Stage|Adverse Event|3
410245|NCT00654381|1374536|P3|1st Stage|Adverse Event|3
410246|NCT00654381|1374537|P2|1st Stage|Adverse Event|3
410247|NCT00654381|1374538|P1|1st Stage|Adverse Event|3
410248|NCT00654368|1374575|P3|Overall Study|Adverse Event|6
410249|NCT00654368|1374576|P2|Overall Study|Adverse Event|9
410250|NCT00654368|1374577|P1|Overall Study|Adverse Event|14
410251|NCT00654368|1374575|P3|Overall Study|Other|3
410252|NCT00654368|1374576|P2|Overall Study|Other|2
410253|NCT00654368|1374577|P1|Overall Study|Other|0
410254|NCT00654368|1374575|P3|Overall Study|Pregnancy|2
410255|NCT00654368|1374576|P2|Overall Study|Pregnancy|0
410256|NCT00654368|1374577|P1|Overall Study|Pregnancy|0
410257|NCT00654368|1374575|P3|Overall Study|Death|0
410258|NCT00654368|1374576|P2|Overall Study|Death|0
410259|NCT00654368|1374577|P1|Overall Study|Death|1
410260|NCT00654368|1374575|P3|Overall Study|Physician Decision|2
410261|NCT00654368|1374576|P2|Overall Study|Physician Decision|0
410262|NCT00654368|1374577|P1|Overall Study|Physician Decision|0
410263|NCT00654368|1374575|P3|Overall Study|Requirement for alternative therapy|1
410264|NCT00654368|1374576|P2|Overall Study|Requirement for alternative therapy|1
410265|NCT00654368|1374577|P1|Overall Study|Requirement for alternative therapy|1
410266|NCT00654368|1374575|P3|Overall Study|Disease progression|13
410267|NCT00654368|1374576|P2|Overall Study|Disease progression|31
410268|NCT00654368|1374577|P1|Overall Study|Disease progression|21
410269|NCT00654368|1374575|P3|Overall Study|Withdrawal by Subject|2
410270|NCT00654368|1374576|P2|Overall Study|Withdrawal by Subject|2
410271|NCT00654368|1374577|P1|Overall Study|Withdrawal by Subject|5
410272|NCT00654368|1374575|P3|Overall Study|Non-compliance|2
410273|NCT00654368|1374576|P2|Overall Study|Non-compliance|1
410274|NCT00654368|1374577|P1|Overall Study|Non-compliance|2
410275|NCT00654368|1374575|P3|Overall Study|Protocol deviation|1
410276|NCT00654368|1374576|P2|Overall Study|Protocol deviation|2
410277|NCT00654368|1374577|P1|Overall Study|Protocol deviation|3
410278|NCT00654368|1374575|P3|Overall Study|Ineligibility determined|0
410279|NCT00654368|1374576|P2|Overall Study|Ineligibility determined|0
410280|NCT00654368|1374577|P1|Overall Study|Ineligibility determined|6
410281|NCT00654355|1374610|P2|Overall Study|Lost to Follow-up|2
410282|NCT00654355|1374611|P1|Overall Study|Lost to Follow-up|2
410283|NCT00654186|1374642|P1|Overall Study|Withdrawal by Subject|5
410284|NCT00654095|1374667|P1|Overall Study|Did not meet inclusion criteria|1
410285|NCT00654095|1374667|P1|Overall Study|Adverse reaction did not improve (5)|4
410286|NCT00654095|1374667|P1|Overall Study|Elevated alanine aminotransferase (4)|7
410287|NCT00654095|1374667|P1|Overall Study|Withdrawal by Subject|5
410288|NCT00654095|1374667|P1|Overall Study|Adverse Event|11
410289|NCT00654095|1374667|P1|Overall Study|Elevated alanine aminotransferase (3)|1
410290|NCT00654095|1374667|P1|Overall Study|Elevated triglyceride level (2)|1
410291|NCT00654095|1374667|P1|Overall Study|Drop in low density lipoprotein (1)|2
410292|NCT00654004|1374677|P2|Overall Study|Lost to Follow-up|0
410293|NCT00654004|1374678|P1|Overall Study|Lost to Follow-up|1
410294|NCT00653939|1374694|P2|Overall Study|Not Specified|6
410295|NCT00653939|1374695|P1|Overall Study|Not Specified|2
410296|NCT00653939|1374694|P2|Overall Study|Disease Progression|3
410297|NCT00653939|1374695|P1|Overall Study|Disease Progression|2
410298|NCT00653939|1374694|P2|Overall Study|Physician Decision|0
410299|NCT00653939|1374695|P1|Overall Study|Physician Decision|4
410300|NCT00653939|1374694|P2|Overall Study|Withdrawal by Subject|3
410301|NCT00653939|1374695|P1|Overall Study|Withdrawal by Subject|3
410302|NCT00653939|1374694|P2|Overall Study|Adverse Event|3
410303|NCT00653939|1374695|P1|Overall Study|Adverse Event|1
410304|NCT00653523|1374720|P1|Overall Study|Adverse reaction did not improve (4)|1
410305|NCT00653523|1374720|P1|Overall Study|Elevated alanine aminotransferase (3)|2
410306|NCT00653523|1374720|P1|Overall Study|Withdrawal by Subject|6
410307|NCT00653523|1374720|P1|Overall Study|Adverse Event|7
410308|NCT00653523|1374720|P1|Overall Study|Elevated creatine phosphokinase (2)|1
410309|NCT00653523|1374720|P1|Overall Study|Drop in low density lipoprotein (1)|2
410310|NCT00653328|1374724|P1|Overall Study|Drug manufacturer no longing making drug|2
410311|NCT00653328|1374724|P1|Overall Study|Disease progression|10
410312|NCT00653328|1374724|P1|Overall Study|Adverse Event|2
410313|NCT00653328|1374724|P1|Overall Study|Withdrawal by Subject|1
410314|NCT00653263|1374731|P1|Overall Study|Physician Decision|1
410315|NCT00653263|1374731|P1|Overall Study|Withdrawal by Subject|1
410316|NCT00653224|1374739|P2|Overall Study|Other|4
410317|NCT00653224|1374740|P1|Overall Study|Other|2
410318|NCT00653224|1374739|P2|Overall Study|Lost to Follow-up|0
410319|NCT00653224|1374740|P1|Overall Study|Lost to Follow-up|1
410320|NCT00653224|1374739|P2|Overall Study|Loss of efficacy|0
410321|NCT00653224|1374740|P1|Overall Study|Loss of efficacy|1
410322|NCT00653224|1374739|P2|Overall Study|Lack of Efficacy|2
410323|NCT00653224|1374740|P1|Overall Study|Lack of Efficacy|1
410324|NCT00653224|1374739|P2|Overall Study|Adverse Event|1
410325|NCT00653224|1374740|P1|Overall Study|Adverse Event|2
410326|NCT00653159|1374926|P2|Overall Study|Lost to Follow-up|2
410327|NCT00653159|1374927|P1|Overall Study|Lost to Follow-up|1
410328|NCT00653159|1374926|P2|Overall Study|Adverse Event|1
410329|NCT00653159|1374927|P1|Overall Study|Adverse Event|4
410330|NCT00653068|1374954|P1|Overall Study|Ineligible|2
410331|NCT00653068|1374954|P1|Overall Study|Withdrawal by Subject|1
410332|NCT00653068|1374954|P1|Overall Study|Physician Decision|4
410333|NCT00653068|1374954|P1|Overall Study|Lack of Efficacy|34
410334|NCT00653068|1374954|P1|Overall Study|Death|9
410335|NCT00652938|1374968|P3|Overall Study|fear of blood sampling|0
410336|NCT00652938|1374969|P2|Overall Study|fear of blood sampling|1
410337|NCT00652938|1374970|P1|Overall Study|fear of blood sampling|0
410338|NCT00652938|1374968|P3|Overall Study|Lost to Follow-up|2
410339|NCT00652938|1374969|P2|Overall Study|Lost to Follow-up|0
410340|NCT00652938|1374970|P1|Overall Study|Lost to Follow-up|0
410341|NCT00652938|1374968|P3|Overall Study|Withdrawal by Subject|1
410342|NCT00652938|1374969|P2|Overall Study|Withdrawal by Subject|6
410343|NCT00652938|1374970|P1|Overall Study|Withdrawal by Subject|0
410344|NCT00652938|1374968|P3|Overall Study|Adverse Event|2
410345|NCT00652938|1374969|P2|Overall Study|Adverse Event|0
410346|NCT00652938|1374970|P1|Overall Study|Adverse Event|1
410347|NCT00652899|1375035|P1|Overall Study|Treating physician decision|1
410348|NCT00652899|1375035|P1|Overall Study|Death|1
410349|NCT00652834|1375045|P1|Overall Study|Lost to Follow-up|2
410350|NCT00652834|1375045|P1|Overall Study|Withdrawal by Subject|3
410351|NCT00652626|1375056|P7|Extension Phase|Death|1
410352|NCT00652626|1375057|P6|Extension Phase|Death|1
410353|NCT00652626|1375058|P5|Extension Phase|Death|0
410354|NCT00652626|1375059|P4|Extension Phase|Death|0
410355|NCT00652626|1375060|P3|Extension Phase|Death|0
410356|NCT00652626|1375061|P2|Extension Phase|Death|0
410357|NCT00652626|1375062|P1|Extension Phase|Death|0
410358|NCT00652626|1375056|P7|Extension Phase|Physician Decision|1
410359|NCT00652626|1375057|P6|Extension Phase|Physician Decision|1
410360|NCT00652626|1375058|P5|Extension Phase|Physician Decision|0
410361|NCT00652626|1375059|P4|Extension Phase|Physician Decision|0
410362|NCT00652626|1375060|P3|Extension Phase|Physician Decision|0
410363|NCT00652626|1375061|P2|Extension Phase|Physician Decision|0
410364|NCT00652626|1375062|P1|Extension Phase|Physician Decision|0
410365|NCT00652626|1375056|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
410366|NCT00652626|1375057|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
410367|NCT00652626|1375058|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
410368|NCT00652626|1375059|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
410369|NCT00652626|1375060|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
410370|NCT00652626|1375061|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
410371|NCT00652626|1375062|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
410372|NCT00652626|1375056|P7|Extension Phase|Adverse Event|1
410373|NCT00652626|1375057|P6|Extension Phase|Adverse Event|2
410374|NCT00652626|1375058|P5|Extension Phase|Adverse Event|0
410375|NCT00652626|1375059|P4|Extension Phase|Adverse Event|0
410376|NCT00652626|1375060|P3|Extension Phase|Adverse Event|0
410377|NCT00652626|1375061|P2|Extension Phase|Adverse Event|0
410378|NCT00652626|1375062|P1|Extension Phase|Adverse Event|0
410379|NCT00652626|1375056|P7|Extension Phase|Withdrawal by Subject|0
410380|NCT00652626|1375057|P6|Extension Phase|Withdrawal by Subject|2
410381|NCT00652626|1375058|P5|Extension Phase|Withdrawal by Subject|0
410382|NCT00652626|1375059|P4|Extension Phase|Withdrawal by Subject|0
410383|NCT00652626|1375060|P3|Extension Phase|Withdrawal by Subject|0
410384|NCT00652626|1375061|P2|Extension Phase|Withdrawal by Subject|0
410385|NCT00652626|1375062|P1|Extension Phase|Withdrawal by Subject|0
410386|NCT00652626|1375056|P7|Initial Treatment Phase|Lost to Follow-up|0
410387|NCT00652626|1375057|P6|Initial Treatment Phase|Lost to Follow-up|0
410388|NCT00652626|1375058|P5|Initial Treatment Phase|Lost to Follow-up|1
410389|NCT00652626|1375059|P4|Initial Treatment Phase|Lost to Follow-up|0
410390|NCT00652626|1375060|P3|Initial Treatment Phase|Lost to Follow-up|0
410391|NCT00652626|1375061|P2|Initial Treatment Phase|Lost to Follow-up|0
410392|NCT00652626|1375062|P1|Initial Treatment Phase|Lost to Follow-up|0
410393|NCT00652626|1375056|P7|Initial Treatment Phase|Sponsor Request|0
410394|NCT00652626|1375057|P6|Initial Treatment Phase|Sponsor Request|0
410395|NCT00652626|1375058|P5|Initial Treatment Phase|Sponsor Request|0
410396|NCT00652626|1375059|P4|Initial Treatment Phase|Sponsor Request|0
410397|NCT00652626|1375060|P3|Initial Treatment Phase|Sponsor Request|1
410398|NCT00652626|1375061|P2|Initial Treatment Phase|Sponsor Request|0
410399|NCT00652626|1375062|P1|Initial Treatment Phase|Sponsor Request|0
410400|NCT00652626|1375056|P7|Initial Treatment Phase|Physician Decision|0
410401|NCT00652626|1375057|P6|Initial Treatment Phase|Physician Decision|0
410402|NCT00652626|1375058|P5|Initial Treatment Phase|Physician Decision|1
410403|NCT00652626|1375059|P4|Initial Treatment Phase|Physician Decision|0
410404|NCT00652626|1375060|P3|Initial Treatment Phase|Physician Decision|0
410405|NCT00652626|1375061|P2|Initial Treatment Phase|Physician Decision|0
410406|NCT00652626|1375062|P1|Initial Treatment Phase|Physician Decision|0
410407|NCT00652626|1375056|P7|Initial Treatment Phase|Protocol Violation|0
410408|NCT00652626|1375057|P6|Initial Treatment Phase|Protocol Violation|0
410409|NCT00652626|1375058|P5|Initial Treatment Phase|Protocol Violation|0
410410|NCT00652626|1375059|P4|Initial Treatment Phase|Protocol Violation|1
410411|NCT00652626|1375060|P3|Initial Treatment Phase|Protocol Violation|0
410412|NCT00652626|1375061|P2|Initial Treatment Phase|Protocol Violation|0
410413|NCT00652626|1375062|P1|Initial Treatment Phase|Protocol Violation|0
410414|NCT00652626|1375056|P7|Initial Treatment Phase|Adverse Event|0
410415|NCT00652626|1375057|P6|Initial Treatment Phase|Adverse Event|0
410416|NCT00652626|1375058|P5|Initial Treatment Phase|Adverse Event|1
410417|NCT00652626|1375059|P4|Initial Treatment Phase|Adverse Event|0
410418|NCT00652626|1375060|P3|Initial Treatment Phase|Adverse Event|0
410419|NCT00652626|1375061|P2|Initial Treatment Phase|Adverse Event|0
410420|NCT00652626|1375062|P1|Initial Treatment Phase|Adverse Event|0
410421|NCT00652366|1375131|P5|Overall Study|Not specified|0
410422|NCT00652366|1375132|P4|Overall Study|Not specified|4
410423|NCT00652366|1375133|P3|Overall Study|Not specified|3
410424|NCT00652366|1375134|P2|Overall Study|Not specified|2
410425|NCT00652366|1375135|P1|Overall Study|Not specified|5
410426|NCT00652366|1375131|P5|Overall Study|Refused treatment|5
410427|NCT00652366|1375132|P4|Overall Study|Refused treatment|17
410428|NCT00652366|1375133|P3|Overall Study|Refused treatment|6
410429|NCT00652366|1375134|P2|Overall Study|Refused treatment|7
410430|NCT00652366|1375135|P1|Overall Study|Refused treatment|3
410431|NCT00652366|1375131|P5|Overall Study|Protocol Violation|0
410432|NCT00652366|1375132|P4|Overall Study|Protocol Violation|0
410433|NCT00652366|1375133|P3|Overall Study|Protocol Violation|0
410434|NCT00652366|1375134|P2|Overall Study|Protocol Violation|0
410435|NCT00652366|1375135|P1|Overall Study|Protocol Violation|1
410436|NCT00652366|1375131|P5|Overall Study|Violation of Selection Criteria|0
410437|NCT00652366|1375132|P4|Overall Study|Violation of Selection Criteria|0
410438|NCT00652366|1375133|P3|Overall Study|Violation of Selection Criteria|1
410439|NCT00652366|1375134|P2|Overall Study|Violation of Selection Criteria|0
410440|NCT00652366|1375135|P1|Overall Study|Violation of Selection Criteria|0
410441|NCT00652366|1375131|P5|Overall Study|Lack of Efficacy|13
410442|NCT00652366|1375132|P4|Overall Study|Lack of Efficacy|133
410443|NCT00652366|1375133|P3|Overall Study|Lack of Efficacy|53
410444|NCT00652366|1375134|P2|Overall Study|Lack of Efficacy|58
410445|NCT00652366|1375135|P1|Overall Study|Lack of Efficacy|84
410446|NCT00652366|1375131|P5|Overall Study|Death|5
410447|NCT00652366|1375132|P4|Overall Study|Death|8
410448|NCT00652366|1375133|P3|Overall Study|Death|1
410449|NCT00652366|1375134|P2|Overall Study|Death|4
410450|NCT00652366|1375135|P1|Overall Study|Death|5
410451|NCT00652366|1375131|P5|Overall Study|Adverse Event|13
410452|NCT00652366|1375132|P4|Overall Study|Adverse Event|17
410453|NCT00652366|1375133|P3|Overall Study|Adverse Event|7
410454|NCT00652366|1375134|P2|Overall Study|Adverse Event|4
410455|NCT00652366|1375135|P1|Overall Study|Adverse Event|8
410456|NCT00652340|1375170|P2|Overall Study|Had not progressed.|3
410457|NCT00652340|1375171|P1|Overall Study|Had not progressed.|4
410458|NCT00652327|1375181|P2|Overall Study|Lost to Follow-up|3
410459|NCT00652327|1375182|P1|Overall Study|Lost to Follow-up|0
410460|NCT00652327|1375181|P2|Overall Study|Adverse Event|2
410461|NCT00652327|1375182|P1|Overall Study|Adverse Event|0
410462|NCT00652093|1375224|P6|Overall Study|Physician Decision|0
410463|NCT00652093|1375225|P5|Overall Study|Physician Decision|1
410464|NCT00652093|1375226|P4|Overall Study|Physician Decision|0
410465|NCT00652093|1375227|P3|Overall Study|Physician Decision|0
410466|NCT00652093|1375228|P2|Overall Study|Physician Decision|0
410467|NCT00652093|1375229|P1|Overall Study|Physician Decision|0
410468|NCT00652093|1375224|P6|Overall Study|Withdrawal by Subject|0
410469|NCT00652093|1375225|P5|Overall Study|Withdrawal by Subject|1
410470|NCT00652093|1375226|P4|Overall Study|Withdrawal by Subject|0
410471|NCT00652093|1375227|P3|Overall Study|Withdrawal by Subject|1
410472|NCT00652093|1375228|P2|Overall Study|Withdrawal by Subject|0
410473|NCT00652093|1375229|P1|Overall Study|Withdrawal by Subject|0
410474|NCT00652028|1375313|P4|Overall Study|Physician Decision|0
410475|NCT00652028|1375314|P3|Overall Study|Physician Decision|1
410476|NCT00652028|1375315|P2|Overall Study|Physician Decision|0
410477|NCT00652028|1375316|P1|Overall Study|Physician Decision|0
410478|NCT00652028|1375313|P4|Overall Study|No Longer Meets Entry Criteria|0
410479|NCT00652028|1375314|P3|Overall Study|No Longer Meets Entry Criteria|0
410480|NCT00652028|1375315|P2|Overall Study|No Longer Meets Entry Criteria|1
410481|NCT00652028|1375316|P1|Overall Study|No Longer Meets Entry Criteria|0
410482|NCT00652028|1375313|P4|Overall Study|Adverse Event|0
410483|NCT00652028|1375314|P3|Overall Study|Adverse Event|0
410484|NCT00652028|1375315|P2|Overall Study|Adverse Event|0
410485|NCT00652028|1375316|P1|Overall Study|Adverse Event|1
410486|NCT00651924|1375360|P2|Overall Study|Withdrawal by Subject|5
410487|NCT00651924|1375361|P1|Overall Study|Withdrawal by Subject|0
410488|NCT00651924|1375360|P2|Overall Study|Withdrawal by PI|2
410489|NCT00651924|1375361|P1|Overall Study|Withdrawal by PI|0
410490|NCT00651820|1375367|P1|Overall Study|Lost to Follow-up|2
410491|NCT00651755|1375399|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
410492|NCT00651755|1375400|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
410493|NCT00651755|1375399|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
410494|NCT00651755|1375400|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
410495|NCT00651313|1375445|P2|Overall Study|Adminstrative Discontinuation|3
410496|NCT00651313|1375446|P1|Overall Study|Adminstrative Discontinuation|2
410497|NCT00651313|1375445|P2|Overall Study|Lost to Follow-up|1
410498|NCT00651313|1375446|P1|Overall Study|Lost to Follow-up|1
410499|NCT00651313|1375445|P2|Overall Study|Withdrawal by Subject|1
410500|NCT00651313|1375446|P1|Overall Study|Withdrawal by Subject|3
410501|NCT00651313|1375445|P2|Overall Study|Adverse Event|1
410502|NCT00651313|1375446|P1|Overall Study|Adverse Event|0
410503|NCT00651261|1375454|P2|Overall Study|Never treated|3
410504|NCT00651261|1375455|P1|Overall Study|Never treated|5
410505|NCT00651261|1375454|P2|Overall Study|Other disease or participant decisions|23
410506|NCT00651261|1375455|P1|Overall Study|Other disease or participant decisions|23
410507|NCT00651261|1375454|P2|Overall Study|Alternative therapy|107
410508|NCT00651261|1375455|P1|Overall Study|Alternative therapy|109
410509|NCT00651261|1375454|P2|Overall Study|Disease progression|58
410510|NCT00651261|1375455|P1|Overall Study|Disease progression|58
410511|NCT00651261|1375454|P2|Overall Study|Induction failure|35
410512|NCT00651261|1375455|P1|Overall Study|Induction failure|24
410513|NCT00651261|1375454|P2|Overall Study|Withdrawal by Subject|40
410514|NCT00651261|1375455|P1|Overall Study|Withdrawal by Subject|22
410515|NCT00651261|1375454|P2|Overall Study|Death|18
410516|NCT00651261|1375455|P1|Overall Study|Death|18
410517|NCT00651261|1375454|P2|Overall Study|Adverse Event|22
410518|NCT00651261|1375455|P1|Overall Study|Adverse Event|32
410519|NCT00651183|1375471|P2|Overall Study|missing|0
410520|NCT00651183|1375472|P1|Overall Study|missing|1
410521|NCT00651183|1375471|P2|Overall Study|Other reasons|2
410522|NCT00651183|1375472|P1|Overall Study|Other reasons|4
410523|NCT00651183|1375471|P2|Overall Study|Lost to Follow-up|1
410524|NCT00651183|1375472|P1|Overall Study|Lost to Follow-up|3
410525|NCT00651183|1375471|P2|Overall Study|Withdrawal by Subject|3
410526|NCT00651183|1375472|P1|Overall Study|Withdrawal by Subject|6
410527|NCT00651183|1375471|P2|Overall Study|Tolerability insufficient +Patients wish|1
410528|NCT00651183|1375472|P1|Overall Study|Tolerability insufficient +Patients wish|0
410529|NCT00651183|1375471|P2|Overall Study|Tolerability insufficient|2
410530|NCT00651183|1375472|P1|Overall Study|Tolerability insufficient|5
410531|NCT00651183|1375471|P2|Overall Study|Efficacy insufficient + patients wish|1
410532|NCT00651183|1375472|P1|Overall Study|Efficacy insufficient + patients wish|0
410533|NCT00651183|1375471|P2|Overall Study|Lack of Efficacy|0
410534|NCT00651183|1375472|P1|Overall Study|Lack of Efficacy|1
410535|NCT00651157|1375484|P1|Overall Study|Protocol Violation|1
410536|NCT00651157|1375484|P1|Overall Study|Death|1
410537|NCT00651118|1375494|P4|Overall Study|Withdrawal by Subject|1
410538|NCT00651118|1375495|P3|Overall Study|Withdrawal by Subject|1
410539|NCT00651118|1375496|P2|Overall Study|Withdrawal by Subject|1
410540|NCT00651118|1375497|P1|Overall Study|Withdrawal by Subject|0
410541|NCT00651118|1375494|P4|Overall Study|administrative|1
410542|NCT00651118|1375495|P3|Overall Study|administrative|2
410543|NCT00651118|1375496|P2|Overall Study|administrative|4
410544|NCT00651118|1375497|P1|Overall Study|administrative|1
410545|NCT00651118|1375494|P4|Overall Study|Lost to Follow-up|2
410546|NCT00651118|1375495|P3|Overall Study|Lost to Follow-up|1
410547|NCT00651118|1375496|P2|Overall Study|Lost to Follow-up|0
410548|NCT00651118|1375497|P1|Overall Study|Lost to Follow-up|2
410549|NCT00651118|1375494|P4|Overall Study|Protocol Violation|2
410550|NCT00651118|1375495|P3|Overall Study|Protocol Violation|6
410551|NCT00651118|1375496|P2|Overall Study|Protocol Violation|2
410552|NCT00651118|1375497|P1|Overall Study|Protocol Violation|2
410553|NCT00651118|1375494|P4|Overall Study|Adverse Event|1
410554|NCT00651118|1375495|P3|Overall Study|Adverse Event|1
410555|NCT00651118|1375496|P2|Overall Study|Adverse Event|0
410556|NCT00651118|1375497|P1|Overall Study|Adverse Event|4
410557|NCT00650845|1375560|P2|Overall Study|Protocol Violation|13
410558|NCT00650845|1375561|P1|Overall Study|Protocol Violation|0
410559|NCT00650845|1375560|P2|Overall Study|Withdrawal by Subject|0
410560|NCT00650845|1375561|P1|Overall Study|Withdrawal by Subject|5
410561|NCT00650806|1375581|P4|Overall Study|Not specified|0
410562|NCT00650806|1375582|P3|Overall Study|Not specified|2
410563|NCT00650806|1375583|P2|Overall Study|Not specified|1
410564|NCT00650806|1375584|P1|Overall Study|Not specified|1
410565|NCT00650806|1375581|P4|Overall Study|Study terminated by sponsor|4
410566|NCT00650806|1375582|P3|Overall Study|Study terminated by sponsor|5
410567|NCT00650806|1375583|P2|Overall Study|Study terminated by sponsor|3
410568|NCT00650806|1375584|P1|Overall Study|Study terminated by sponsor|2
410569|NCT00650806|1375581|P4|Overall Study|Noncompliance with study drug regimen|0
410570|NCT00650806|1375582|P3|Overall Study|Noncompliance with study drug regimen|0
410571|NCT00650806|1375583|P2|Overall Study|Noncompliance with study drug regimen|1
410572|NCT00650806|1375584|P1|Overall Study|Noncompliance with study drug regimen|1
410573|NCT00650806|1375581|P4|Overall Study|Withdrawal by Subject|6
410574|NCT00650806|1375582|P3|Overall Study|Withdrawal by Subject|8
410575|NCT00650806|1375583|P2|Overall Study|Withdrawal by Subject|5
410576|NCT00650806|1375584|P1|Overall Study|Withdrawal by Subject|7
410577|NCT00650806|1375581|P4|Overall Study|Pregnancy|1
410578|NCT00650806|1375582|P3|Overall Study|Pregnancy|0
410579|NCT00650806|1375583|P2|Overall Study|Pregnancy|0
410580|NCT00650806|1375584|P1|Overall Study|Pregnancy|0
410581|NCT00650806|1375581|P4|Overall Study|Protocol Violation|1
410582|NCT00650806|1375582|P3|Overall Study|Protocol Violation|0
410583|NCT00650806|1375583|P2|Overall Study|Protocol Violation|0
410584|NCT00650806|1375584|P1|Overall Study|Protocol Violation|0
410585|NCT00650806|1375581|P4|Overall Study|Lost to Follow-up|10
410586|NCT00650806|1375582|P3|Overall Study|Lost to Follow-up|11
410587|NCT00650806|1375583|P2|Overall Study|Lost to Follow-up|6
410588|NCT00650806|1375584|P1|Overall Study|Lost to Follow-up|7
410589|NCT00650806|1375581|P4|Overall Study|Adverse Event|4
410590|NCT00650806|1375582|P3|Overall Study|Adverse Event|3
410591|NCT00650806|1375583|P2|Overall Study|Adverse Event|5
410592|NCT00650806|1375584|P1|Overall Study|Adverse Event|0
410593|NCT00650767|1375626|P4|Overall Study|Other|0
410594|NCT00650767|1375627|P3|Overall Study|Other|0
410595|NCT00650767|1375628|P2|Overall Study|Other|1
410596|NCT00650767|1375629|P1|Overall Study|Other|1
410597|NCT00650767|1375626|P4|Overall Study|Lost to Follow-up|0
410598|NCT00650767|1375627|P3|Overall Study|Lost to Follow-up|1
410599|NCT00650767|1375628|P2|Overall Study|Lost to Follow-up|1
410600|NCT00650767|1375629|P1|Overall Study|Lost to Follow-up|1
410601|NCT00650767|1375626|P4|Overall Study|Withdrawal by Subject|3
410602|NCT00650767|1375627|P3|Overall Study|Withdrawal by Subject|3
410603|NCT00650767|1375628|P2|Overall Study|Withdrawal by Subject|4
410604|NCT00650767|1375629|P1|Overall Study|Withdrawal by Subject|2
410605|NCT00650767|1375626|P4|Overall Study|Death|0
410606|NCT00650767|1375627|P3|Overall Study|Death|0
410607|NCT00650767|1375628|P2|Overall Study|Death|0
410608|NCT00650767|1375629|P1|Overall Study|Death|1
410609|NCT00650767|1375626|P4|Overall Study|Adverse Event|8
410610|NCT00650767|1375627|P3|Overall Study|Adverse Event|10
410611|NCT00650767|1375628|P2|Overall Study|Adverse Event|3
410612|NCT00650767|1375629|P1|Overall Study|Adverse Event|0
410613|NCT00650585|1376133|P2|Overall Study|Excluded/ruled ineligible|129
410614|NCT00650585|1376134|P1|Overall Study|Excluded/ruled ineligible|357
410615|NCT00650585|1376133|P2|Overall Study|No parental consent|866
410616|NCT00650585|1376134|P1|Overall Study|No parental consent|935
410617|NCT00650585|1376133|P2|Overall Study|Lost to Follow-up|482
410618|NCT00650585|1376134|P1|Overall Study|Lost to Follow-up|505
410619|NCT00650104|1376178|P1|Overall Study|Sponsor Terminated Dosing|1
410620|NCT00650104|1376178|P1|Overall Study|Non-compliance|2
410621|NCT00650104|1376178|P1|Overall Study|Lost to Follow-up|1
410622|NCT00650104|1376178|P1|Overall Study|Physician Decision|7
410623|NCT00650104|1376178|P1|Overall Study|Withdrawal by Subject|11
410624|NCT00650104|1376178|P1|Overall Study|Death|2
410625|NCT00650104|1376178|P1|Overall Study|Adverse Event|17
410626|NCT00650091|1376193|P3|Amended Study Design|Not specified|0
410627|NCT00650091|1376194|P2|Amended Study Design|Not specified|3
410628|NCT00650091|1376195|P1|Amended Study Design|Not specified|1
410629|NCT00650091|1376193|P3|Amended Study Design|Lung transplantation|0
410630|NCT00650091|1376194|P2|Amended Study Design|Lung transplantation|2
410631|NCT00650091|1376195|P1|Amended Study Design|Lung transplantation|4
410632|NCT00650091|1376193|P3|Amended Study Design|Adverse Event|0
410633|NCT00650091|1376194|P2|Amended Study Design|Adverse Event|4
410634|NCT00650091|1376195|P1|Amended Study Design|Adverse Event|1
410635|NCT00650091|1376193|P3|Amended Study Design|Physician Decision|0
410636|NCT00650091|1376194|P2|Amended Study Design|Physician Decision|0
410637|NCT00650091|1376195|P1|Amended Study Design|Physician Decision|5
410638|NCT00650091|1376193|P3|Amended Study Design|Withdrawal by Subject|0
410639|NCT00650091|1376194|P2|Amended Study Design|Withdrawal by Subject|11
410640|NCT00650091|1376195|P1|Amended Study Design|Withdrawal by Subject|12
410641|NCT00649428|1376238|P2|Overall Study|Physician Decision|1
410642|NCT00649428|1376239|P1|Overall Study|Physician Decision|0
410643|NCT00649428|1376238|P2|Overall Study|Protocol Violation|2
410644|NCT00649428|1376239|P1|Overall Study|Protocol Violation|6
410645|NCT00649428|1376238|P2|Overall Study|Insufficient manufacturing yield|1
410646|NCT00649428|1376239|P1|Overall Study|Insufficient manufacturing yield|5
410647|NCT00649428|1376238|P2|Overall Study|Lost to Follow-up|3
410648|NCT00649428|1376239|P1|Overall Study|Lost to Follow-up|1
410649|NCT00649428|1376238|P2|Overall Study|Withdrawal by Subject|6
410650|NCT00649428|1376239|P1|Overall Study|Withdrawal by Subject|6
410651|NCT00649428|1376238|P2|Overall Study|Adverse Event|2
410652|NCT00649428|1376239|P1|Overall Study|Adverse Event|2
410653|NCT00649389|1376255|P4|Overall Study|Other|6
410654|NCT00649389|1376256|P3|Overall Study|Other|1
410655|NCT00649389|1376257|P2|Overall Study|Other|9
410656|NCT00649389|1376258|P1|Overall Study|Other|3
410657|NCT00649389|1376255|P4|Overall Study|Withdrawal by Subject|23
410658|NCT00649389|1376256|P3|Overall Study|Withdrawal by Subject|19
410659|NCT00649389|1376257|P2|Overall Study|Withdrawal by Subject|21
410660|NCT00649389|1376258|P1|Overall Study|Withdrawal by Subject|20
410661|NCT00649389|1376255|P4|Overall Study|Protocol Violation|8
410662|NCT00649389|1376256|P3|Overall Study|Protocol Violation|9
410663|NCT00649389|1376257|P2|Overall Study|Protocol Violation|13
410664|NCT00649389|1376258|P1|Overall Study|Protocol Violation|11
410665|NCT00649389|1376255|P4|Overall Study|Lost to Follow-up|26
410666|NCT00649389|1376256|P3|Overall Study|Lost to Follow-up|21
410667|NCT00649389|1376257|P2|Overall Study|Lost to Follow-up|17
410668|NCT00649389|1376258|P1|Overall Study|Lost to Follow-up|15
410669|NCT00649389|1376255|P4|Overall Study|Adverse Event|48
410670|NCT00649389|1376256|P3|Overall Study|Adverse Event|38
410671|NCT00649389|1376257|P2|Overall Study|Adverse Event|46
410672|NCT00649389|1376258|P1|Overall Study|Adverse Event|22
410673|NCT00649220|1376280|P1|Overall Study|Withdrawal by Subject|1
410674|NCT00649220|1376280|P1|Overall Study|Adverse Event|2
410675|NCT00648895|1376301|P2|Overall Study|Lack of Efficacy|1
410676|NCT00648895|1376302|P1|Overall Study|Lack of Efficacy|0
410677|NCT00648167|1376308|P1|Overall Study|unable to swallow tablets|1
410678|NCT00648167|1376308|P1|Overall Study|Adverse Event|6
410679|NCT00648037|1376328|P1|Overall Study|Other|1
410680|NCT00648037|1376328|P1|Overall Study|Relapse|2
410681|NCT00648037|1376328|P1|Overall Study|Adverse Event|11
410682|NCT00648037|1376328|P1|Overall Study|Withdrawal by Subject|1
410683|NCT00648037|1376328|P1|Overall Study|Not Treated|1
410684|NCT00647699|1376347|P2|Overall Study|Withdrawal by Subject|8
410685|NCT00647699|1376348|P1|Overall Study|Withdrawal by Subject|3
410686|NCT00647699|1376347|P2|Overall Study|Lost to Follow-up|4
410687|NCT00647699|1376348|P1|Overall Study|Lost to Follow-up|5
410688|NCT00647556|1376356|P2|Overall Study|Surgery for pre-existing neck pain|0
410689|NCT00647556|1376357|P1|Overall Study|Surgery for pre-existing neck pain|1
410690|NCT00647556|1376356|P2|Overall Study|Withdrawal by Subject|0
410691|NCT00647556|1376357|P1|Overall Study|Withdrawal by Subject|1
410692|NCT00647556|1376356|P2|Overall Study|Protocol Violation|1
410693|NCT00647556|1376357|P1|Overall Study|Protocol Violation|0
410694|NCT00647556|1376356|P2|Overall Study|Lost to Follow-up|0
410695|NCT00647556|1376357|P1|Overall Study|Lost to Follow-up|1
410696|NCT00647556|1376356|P2|Overall Study|Adverse Event|1
410697|NCT00647556|1376357|P1|Overall Study|Adverse Event|0
410698|NCT00647270|1376387|P3|Period 2, Placebo Switched to Adalimumab|Other|0
410699|NCT00647270|1376388|P2|Period 2, Placebo Switched to Adalimumab|Other|6
410700|NCT00647270|1376389|P1|Period 2, Placebo Switched to Adalimumab|Other|2
410701|NCT00647270|1376387|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
410702|NCT00647270|1376388|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
410703|NCT00647270|1376389|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
410704|NCT00647270|1376387|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
410705|NCT00647270|1376388|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
410706|NCT00647270|1376389|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
410707|NCT00647270|1376387|P3|Period 1, Placebo-control (12 Weeks)|Other|8
410708|NCT00647270|1376388|P2|Period 1, Placebo-control (12 Weeks)|Other|4
410709|NCT00647270|1376389|P1|Period 1, Placebo-control (12 Weeks)|Other|4
410710|NCT00647270|1376387|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
410711|NCT00647270|1376388|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
410712|NCT00647270|1376389|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
410713|NCT00647270|1376387|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
410714|NCT00647270|1376388|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
410715|NCT00647270|1376389|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
410716|NCT00647270|1376387|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
410717|NCT00647270|1376388|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
410718|NCT00647270|1376389|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
410719|NCT00646958|1376415|P3|Overall Study|Did not receive study drug|2
410720|NCT00646958|1376416|P2|Overall Study|Did not receive study drug|0
410721|NCT00646958|1376417|P1|Overall Study|Did not receive study drug|2
410722|NCT00646958|1376415|P3|Overall Study|Withdrawal by Subject|0
410723|NCT00646958|1376416|P2|Overall Study|Withdrawal by Subject|2
410724|NCT00646958|1376417|P1|Overall Study|Withdrawal by Subject|1
410725|NCT00646958|1376415|P3|Overall Study|Abnormal screening lab tests|0
410726|NCT00646958|1376416|P2|Overall Study|Abnormal screening lab tests|1
410727|NCT00646958|1376417|P1|Overall Study|Abnormal screening lab tests|1
410728|NCT00646958|1376415|P3|Overall Study|Protocol Violation|0
410729|NCT00646958|1376416|P2|Overall Study|Protocol Violation|1
410730|NCT00646958|1376417|P1|Overall Study|Protocol Violation|1
410731|NCT00646958|1376415|P3|Overall Study|Lost to Follow-up|7
410732|NCT00646958|1376416|P2|Overall Study|Lost to Follow-up|5
410733|NCT00646958|1376417|P1|Overall Study|Lost to Follow-up|1
410734|NCT00646958|1376415|P3|Overall Study|Adverse Event|0
410735|NCT00646958|1376416|P2|Overall Study|Adverse Event|0
410736|NCT00646958|1376417|P1|Overall Study|Adverse Event|4
410737|NCT00646958|1376415|P3|Overall Study|Lack of Efficacy|0
410738|NCT00646958|1376416|P2|Overall Study|Lack of Efficacy|0
410739|NCT00646958|1376417|P1|Overall Study|Lack of Efficacy|1
410740|NCT00646776|1376430|P2|Overall Study|Investigator discretion|4
410741|NCT00646776|1376431|P1|Overall Study|Investigator discretion|0
410742|NCT00646776|1376430|P2|Overall Study|Adverse Event|9
410743|NCT00646776|1376431|P1|Overall Study|Adverse Event|1
410744|NCT00646399|1376529|P2|Overall Study|Other Reason|11
410745|NCT00646399|1376530|P1|Overall Study|Other Reason|11
410746|NCT00646399|1376529|P2|Overall Study|Withdrawal by Subject|10
410747|NCT00646399|1376530|P1|Overall Study|Withdrawal by Subject|9
410748|NCT00646399|1376529|P2|Overall Study|Death|53
410749|NCT00646399|1376530|P1|Overall Study|Death|63
410750|NCT00646282|1376538|P2|Overall Study|Protocol terminated|4
410751|NCT00646282|1376539|P1|Overall Study|Protocol terminated|4
410752|NCT00645944|1376562|P2|Received Medication|Protocol Violation|1
410753|NCT00645944|1376563|P1|Received Medication|Protocol Violation|2
410754|NCT00645944|1376562|P2|Received Medication|Lost to Follow-up|0
410755|NCT00645944|1376563|P1|Received Medication|Lost to Follow-up|1
410756|NCT00645944|1376562|P2|Received Medication|Withdrawal by Subject|1
410757|NCT00645944|1376563|P1|Received Medication|Withdrawal by Subject|1
410758|NCT00645944|1376562|P2|Received Medication|Adverse Event|1
410759|NCT00645944|1376563|P1|Received Medication|Adverse Event|2
410760|NCT00645944|1376562|P2|Randomized|Withdrawal by Subject|2
410761|NCT00645944|1376563|P1|Randomized|Withdrawal by Subject|1
410762|NCT00645853|1376571|P2|Overall Study|recall of ICF, planned operation, death|4
410763|NCT00645853|1376572|P1|Overall Study|recall of ICF, planned operation, death|7
410764|NCT00645853|1376571|P2|Overall Study|Discontinuation criteria|2
410765|NCT00645853|1376572|P1|Overall Study|Discontinuation criteria|2
410766|NCT00645853|1376571|P2|Overall Study|Protocol Violation|2
410767|NCT00645853|1376572|P1|Overall Study|Protocol Violation|0
410768|NCT00645853|1376571|P2|Overall Study|Withdrawal by Subject|2
410769|NCT00645853|1376572|P1|Overall Study|Withdrawal by Subject|5
410770|NCT00645853|1376571|P2|Overall Study|AZ study closure in Hungary|40
410771|NCT00645853|1376572|P1|Overall Study|AZ study closure in Hungary|60
410772|NCT00645853|1376571|P2|Overall Study|Adverse Event|7
410773|NCT00645853|1376572|P1|Overall Study|Adverse Event|18
410774|NCT00645788|1376603|P4|Overall Study|Pulmonary exacerbation|9
410775|NCT00645788|1376604|P3|Overall Study|Pulmonary exacerbation|11
410776|NCT00645788|1376605|P2|Overall Study|Pulmonary exacerbation|16
410777|NCT00645788|1376606|P1|Overall Study|Pulmonary exacerbation|13
410778|NCT00645788|1376603|P4|Overall Study|Withdrawal by Subject|2
410779|NCT00645788|1376604|P3|Overall Study|Withdrawal by Subject|0
410780|NCT00645788|1376605|P2|Overall Study|Withdrawal by Subject|1
410781|NCT00645788|1376606|P1|Overall Study|Withdrawal by Subject|0
410782|NCT00645788|1376603|P4|Overall Study|Protocol Violation|0
410783|NCT00645788|1376604|P3|Overall Study|Protocol Violation|2
410784|NCT00645788|1376605|P2|Overall Study|Protocol Violation|0
410785|NCT00645788|1376606|P1|Overall Study|Protocol Violation|1
410786|NCT00645788|1376603|P4|Overall Study|Lost to Follow-up|0
410787|NCT00645788|1376604|P3|Overall Study|Lost to Follow-up|0
410788|NCT00645788|1376605|P2|Overall Study|Lost to Follow-up|0
410789|NCT00645788|1376606|P1|Overall Study|Lost to Follow-up|1
410790|NCT00645788|1376603|P4|Overall Study|Adverse Event|3
410791|NCT00645788|1376604|P3|Overall Study|Adverse Event|5
410792|NCT00645788|1376605|P2|Overall Study|Adverse Event|9
410793|NCT00645788|1376606|P1|Overall Study|Adverse Event|4
410794|NCT00645788|1376603|P4|Overall Study|Did not receive study drug|0
410795|NCT00645788|1376604|P3|Overall Study|Did not receive study drug|0
410796|NCT00645788|1376605|P2|Overall Study|Did not receive study drug|1
410797|NCT00645788|1376606|P1|Overall Study|Did not receive study drug|1
410798|NCT00645671|1376664|P2|Overall Study|Physician Decision|1
410799|NCT00645671|1376665|P1|Overall Study|Physician Decision|0
410800|NCT00645671|1376664|P2|Overall Study|Adverse Event|1
410801|NCT00645671|1376665|P1|Overall Study|Adverse Event|0
410802|NCT00645671|1376664|P2|Overall Study|Withdrawal by Subject|4
410803|NCT00645671|1376665|P1|Overall Study|Withdrawal by Subject|0
410804|NCT00645671|1376664|P2|Overall Study|Protocol Violation|0
410805|NCT00645671|1376665|P1|Overall Study|Protocol Violation|1
410806|NCT00645593|1376679|P2|Overall Study|Later found to be ineligible|0
410807|NCT00645593|1376680|P1|Overall Study|Later found to be ineligible|1
410808|NCT00645567|1376692|P1|Overall Study|Adverse Event|1
410809|NCT00645528|1376700|P1|Overall Study|Did not show up for Visit 2|7
410810|NCT00645411|1376713|P4|Overall Study|Unable to classify|4
410811|NCT00645411|1376714|P3|Overall Study|Unable to classify|3
410812|NCT00645411|1376715|P2|Overall Study|Unable to classify|0
410813|NCT00645411|1376716|P1|Overall Study|Unable to classify|0
410814|NCT00645411|1376713|P4|Overall Study|Inappropriate enrollment|1
410815|NCT00645411|1376714|P3|Overall Study|Inappropriate enrollment|4
410816|NCT00645411|1376715|P2|Overall Study|Inappropriate enrollment|0
410817|NCT00645411|1376716|P1|Overall Study|Inappropriate enrollment|0
410818|NCT00645411|1376713|P4|Overall Study|Protocol Violation|0
410819|NCT00645411|1376714|P3|Overall Study|Protocol Violation|1
410820|NCT00645411|1376715|P2|Overall Study|Protocol Violation|0
410821|NCT00645411|1376716|P1|Overall Study|Protocol Violation|1
410822|NCT00645411|1376713|P4|Overall Study|Lost to Follow-up|75
410823|NCT00645411|1376714|P3|Overall Study|Lost to Follow-up|124
410824|NCT00645411|1376715|P2|Overall Study|Lost to Follow-up|5
410825|NCT00645411|1376716|P1|Overall Study|Lost to Follow-up|10
410826|NCT00645411|1376713|P4|Overall Study|Withdrawal by Subject|21
410827|NCT00645411|1376714|P3|Overall Study|Withdrawal by Subject|19
410828|NCT00645411|1376715|P2|Overall Study|Withdrawal by Subject|1
410829|NCT00645411|1376716|P1|Overall Study|Withdrawal by Subject|2
410830|NCT00645411|1376713|P4|Overall Study|Adverse Event|2
410831|NCT00645411|1376714|P3|Overall Study|Adverse Event|0
410832|NCT00645411|1376715|P2|Overall Study|Adverse Event|0
410833|NCT00645411|1376716|P1|Overall Study|Adverse Event|0
410834|NCT00645164|1376758|P1|Overall Study|Protocol Violation|1
410835|NCT00645164|1376758|P1|Overall Study|Withdrawal by Subject|4
410836|NCT00645164|1376758|P1|Overall Study|Lost to Follow-up|2
410837|NCT00645099|1376764|P2|Overall Study|Other|5
410838|NCT00645099|1376765|P1|Overall Study|Other|9
410839|NCT00645099|1376764|P2|Overall Study|Adverse Event|5
410840|NCT00645099|1376765|P1|Overall Study|Adverse Event|11
410841|NCT00645099|1376764|P2|Overall Study|Lost to Follow-up|4
410842|NCT00645099|1376765|P1|Overall Study|Lost to Follow-up|6
410843|NCT00645099|1376764|P2|Overall Study|Withdrawal by Subject|22
410844|NCT00645099|1376765|P1|Overall Study|Withdrawal by Subject|30
410845|NCT00645099|1376764|P2|Overall Study|Lack of Efficacy|6
410846|NCT00645099|1376765|P1|Overall Study|Lack of Efficacy|15
410847|NCT00644995|1376834|P2|Overall Study|Refused|0
410848|NCT00644995|1376835|P1|Overall Study|Refused|1
410849|NCT00644995|1376834|P2|Overall Study|Lost to Follow-up|4
410850|NCT00644995|1376835|P1|Overall Study|Lost to Follow-up|1
410851|NCT00644969|1376855|P2|Post Treatment Phase|Other|0
410852|NCT00644969|1376856|P1|Post Treatment Phase|Other|1
410853|NCT00644969|1376855|P2|Post Treatment Phase|Lost to Follow-up|1
410854|NCT00644969|1376856|P1|Post Treatment Phase|Lost to Follow-up|4
410855|NCT00644969|1376855|P2|Post Treatment Phase|Withdrawal by Subject|2
410856|NCT00644969|1376856|P1|Post Treatment Phase|Withdrawal by Subject|4
410857|NCT00644969|1376855|P2|Post Treatment Phase|Death|0
410858|NCT00644969|1376856|P1|Post Treatment Phase|Death|1
410859|NCT00644969|1376855|P2|Treatment Phase|Other|1
410860|NCT00644969|1376856|P1|Treatment Phase|Other|4
410861|NCT00644969|1376855|P2|Treatment Phase|Lost to Follow-up|2
410862|NCT00644969|1376856|P1|Treatment Phase|Lost to Follow-up|2
410863|NCT00644969|1376855|P2|Treatment Phase|Withdrawal by Subject|0
410864|NCT00644969|1376856|P1|Treatment Phase|Withdrawal by Subject|4
410865|NCT00644969|1376855|P2|Treatment Phase|Adverse Event|0
410866|NCT00644969|1376856|P1|Treatment Phase|Adverse Event|3
410867|NCT00644969|1376855|P2|Treatment Phase|Randomized, not treated|0
410868|NCT00644969|1376856|P1|Treatment Phase|Randomized, not treated|1
410869|NCT00644917|1376902|P1|Overall Study|Withdrawal by Subject|2
410870|NCT00644787|1376910|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
410871|NCT00644787|1376911|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
410872|NCT00644787|1376912|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
410873|NCT00644787|1376910|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
410874|NCT00644787|1376911|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
410875|NCT00644787|1376912|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
410876|NCT00644787|1376910|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
410877|NCT00644787|1376911|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
410878|NCT00644787|1376912|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
410879|NCT00644787|1376910|P3|Period 2: Double Blind Phase|Adverse Event|4
410880|NCT00644787|1376911|P2|Period 2: Double Blind Phase|Adverse Event|2
410881|NCT00644787|1376912|P1|Period 2: Double Blind Phase|Adverse Event|0
410882|NCT00644787|1376910|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
410883|NCT00644787|1376911|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
410884|NCT00644787|1376912|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
410885|NCT00644787|1376910|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
410886|NCT00644787|1376911|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
410887|NCT00644787|1376912|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
410888|NCT00644787|1376910|P3|Period 1: Titration Phase|Worsening of symptoms|0
410889|NCT00644787|1376911|P2|Period 1: Titration Phase|Worsening of symptoms|0
410890|NCT00644787|1376912|P1|Period 1: Titration Phase|Worsening of symptoms|1
410891|NCT00644787|1376910|P3|Period 1: Titration Phase|Worsening of complications|0
410892|NCT00644787|1376911|P2|Period 1: Titration Phase|Worsening of complications|0
410893|NCT00644787|1376912|P1|Period 1: Titration Phase|Worsening of complications|1
410894|NCT00644787|1376910|P3|Period 1: Titration Phase|Worsening of underlying disease|0
410895|NCT00644787|1376911|P2|Period 1: Titration Phase|Worsening of underlying disease|0
410896|NCT00644787|1376912|P1|Period 1: Titration Phase|Worsening of underlying disease|5
410897|NCT00644787|1376910|P3|Period 1: Titration Phase|Physician Decision|0
410898|NCT00644787|1376911|P2|Period 1: Titration Phase|Physician Decision|0
410899|NCT00644787|1376912|P1|Period 1: Titration Phase|Physician Decision|1
410900|NCT00644787|1376910|P3|Period 1: Titration Phase|Withdrawal by Subject|0
410901|NCT00644787|1376911|P2|Period 1: Titration Phase|Withdrawal by Subject|0
410902|NCT00644787|1376912|P1|Period 1: Titration Phase|Withdrawal by Subject|2
410903|NCT00644787|1376910|P3|Period 1: Titration Phase|Adverse Event|0
410904|NCT00644787|1376911|P2|Period 1: Titration Phase|Adverse Event|0
410905|NCT00644787|1376912|P1|Period 1: Titration Phase|Adverse Event|11
410906|NCT00644358|1376954|P1|Overall Study|Other Unspecified|11
410907|NCT00644358|1376954|P1|Overall Study|Noncompliance|14
410908|NCT00644358|1376954|P1|Overall Study|Protocol Violation|5
410909|NCT00644358|1376954|P1|Overall Study|Lack of Effectiveness|39
410910|NCT00644358|1376954|P1|Overall Study|Consent Withdrawal|64
410911|NCT00644358|1376954|P1|Overall Study|Lost to Follow-up|105
410912|NCT00644358|1376954|P1|Overall Study|Adverse Event|124
410913|NCT00644332|1376961|P1|Overall Study|Could Not Attend Scheduled Visits|1
410914|NCT00644332|1376961|P1|Overall Study|Did Not Meet Eligibility Requirements|1
410915|NCT00644332|1376961|P1|Overall Study|Completion Status Unknown|2
410916|NCT00644332|1376961|P1|Overall Study|Withdrawal by Subject|6
410917|NCT00644332|1376961|P1|Overall Study|Adverse Event|11
410918|NCT00644228|1376987|P2|Maintenance|On Treatment|40
410919|NCT00644228|1376988|P1|Maintenance|On Treatment|26
410920|NCT00644228|1376987|P2|Maintenance|Not Protocol-Specified|15
410921|NCT00644228|1376988|P1|Maintenance|Not Protocol-Specified|14
410922|NCT00644228|1376987|P2|Maintenance|Death|3
410923|NCT00644228|1376988|P1|Maintenance|Death|3
410924|NCT00644228|1376987|P2|Maintenance|Progression/Relapse|42
410925|NCT00644228|1376988|P1|Maintenance|Progression/Relapse|67
410926|NCT00644228|1376987|P2|Maintenance|Withdrawal by Subject|4
410927|NCT00644228|1376988|P1|Maintenance|Withdrawal by Subject|6
410928|NCT00644228|1376987|P2|Maintenance|Adverse Event|31
410929|NCT00644228|1376988|P1|Maintenance|Adverse Event|27
410930|NCT00644228|1376987|P2|Induction Therapy|Not Protocol-Specified|28
410931|NCT00644228|1376988|P1|Induction Therapy|Not Protocol-Specified|24
410932|NCT00644228|1376987|P2|Induction Therapy|Death|7
410933|NCT00644228|1376988|P1|Induction Therapy|Death|3
410934|NCT00644228|1376987|P2|Induction Therapy|Progression/Relapse|12
410935|NCT00644228|1376988|P1|Induction Therapy|Progression/Relapse|24
410936|NCT00644228|1376987|P2|Induction Therapy|Withdrawal by Subject|3
410937|NCT00644228|1376988|P1|Induction Therapy|Withdrawal by Subject|10
410938|NCT00644228|1376987|P2|Induction Therapy|Adverse Event|55
410939|NCT00644228|1376988|P1|Induction Therapy|Adverse Event|22
410940|NCT00644228|1376987|P2|Randomization & Eligibility|Invalid Consent|1
410941|NCT00644228|1376988|P1|Randomization & Eligibility|Invalid Consent|0
410942|NCT00644228|1376987|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
410943|NCT00644228|1376988|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
410944|NCT00644228|1376987|P2|Randomization & Eligibility|Ineligible|21
410945|NCT00644228|1376988|P1|Randomization & Eligibility|Ineligible|31
410946|NCT00644059|1377017|P3|Overall Study|Unable to classify|3
410947|NCT00644059|1377018|P2|Overall Study|Unable to classify|2
410948|NCT00644059|1377019|P1|Overall Study|Unable to classify|6
410949|NCT00644059|1377017|P3|Overall Study|Protocol Deviation/violation|15
410950|NCT00644059|1377018|P2|Overall Study|Protocol Deviation/violation|19
410951|NCT00644059|1377019|P1|Overall Study|Protocol Deviation/violation|20
410952|NCT00644059|1377017|P3|Overall Study|Inappropriate Enrollment|0
410953|NCT00644059|1377018|P2|Overall Study|Inappropriate Enrollment|3
410954|NCT00644059|1377019|P1|Overall Study|Inappropriate Enrollment|1
410955|NCT00644059|1377017|P3|Overall Study|Adverse Event|1
410956|NCT00644059|1377018|P2|Overall Study|Adverse Event|5
410957|NCT00644059|1377019|P1|Overall Study|Adverse Event|8
410958|NCT00644059|1377017|P3|Overall Study|Withdrawal by Subject|30
410959|NCT00644059|1377018|P2|Overall Study|Withdrawal by Subject|60
410960|NCT00644059|1377019|P1|Overall Study|Withdrawal by Subject|52
410961|NCT00644059|1377017|P3|Overall Study|Lost to Follow-up|16
410962|NCT00644059|1377018|P2|Overall Study|Lost to Follow-up|34
410963|NCT00644059|1377019|P1|Overall Study|Lost to Follow-up|37
410964|NCT00643916|1377109|P6|Overall Study|Not Vaccinated|0
410965|NCT00643916|1377110|P5|Overall Study|Not Vaccinated|2
410966|NCT00643916|1377111|P4|Overall Study|Not Vaccinated|0
410967|NCT00643916|1377112|P3|Overall Study|Not Vaccinated|3
410968|NCT00643916|1377113|P2|Overall Study|Not Vaccinated|2
410969|NCT00643916|1377114|P1|Overall Study|Not Vaccinated|2
410970|NCT00643916|1377109|P6|Overall Study|Withdrawal by Subject|1
410971|NCT00643916|1377110|P5|Overall Study|Withdrawal by Subject|0
410972|NCT00643916|1377111|P4|Overall Study|Withdrawal by Subject|1
410973|NCT00643916|1377112|P3|Overall Study|Withdrawal by Subject|2
410974|NCT00643916|1377113|P2|Overall Study|Withdrawal by Subject|2
410975|NCT00643916|1377114|P1|Overall Study|Withdrawal by Subject|2
410976|NCT00643916|1377109|P6|Overall Study|Lost to Follow-up|0
410977|NCT00643916|1377110|P5|Overall Study|Lost to Follow-up|0
410978|NCT00643916|1377111|P4|Overall Study|Lost to Follow-up|0
410979|NCT00643916|1377112|P3|Overall Study|Lost to Follow-up|0
410980|NCT00643916|1377113|P2|Overall Study|Lost to Follow-up|1
410981|NCT00643916|1377114|P1|Overall Study|Lost to Follow-up|0
410982|NCT00643916|1377109|P6|Overall Study|Protocol Violation|0
410983|NCT00643916|1377110|P5|Overall Study|Protocol Violation|0
410984|NCT00643916|1377111|P4|Overall Study|Protocol Violation|1
410985|NCT00643916|1377112|P3|Overall Study|Protocol Violation|1
410986|NCT00643916|1377113|P2|Overall Study|Protocol Violation|1
410987|NCT00643916|1377114|P1|Overall Study|Protocol Violation|0
410988|NCT00643851|1377137|P3|Overall Study|Non-compl., not met criteria, etc.|6
410989|NCT00643851|1377138|P2|Overall Study|Non-compl., not met criteria, etc.|4
410990|NCT00643851|1377139|P1|Overall Study|Non-compl., not met criteria, etc.|3
410991|NCT00643851|1377137|P3|Overall Study|Withdrawal by Subject|9
410992|NCT00643851|1377138|P2|Overall Study|Withdrawal by Subject|15
410993|NCT00643851|1377139|P1|Overall Study|Withdrawal by Subject|8
410994|NCT00643851|1377137|P3|Overall Study|Lost to Follow-up|9
410995|NCT00643851|1377138|P2|Overall Study|Lost to Follow-up|6
410996|NCT00643851|1377139|P1|Overall Study|Lost to Follow-up|4
410997|NCT00643851|1377137|P3|Overall Study|Adverse Event|6
410998|NCT00643851|1377138|P2|Overall Study|Adverse Event|6
410999|NCT00643851|1377139|P1|Overall Study|Adverse Event|2
411000|NCT00643851|1377137|P3|Overall Study|Lack of Efficacy|0
411001|NCT00643851|1377138|P2|Overall Study|Lack of Efficacy|1
411002|NCT00643851|1377139|P1|Overall Study|Lack of Efficacy|0
411003|NCT00643851|1377137|P3|Overall Study|Death|0
411004|NCT00643851|1377138|P2|Overall Study|Death|1
411005|NCT00643851|1377139|P1|Overall Study|Death|0
411006|NCT00643760|1377167|P5|Overall Study|Withdrawal by Subject|1
411007|NCT00643760|1377168|P4|Overall Study|Withdrawal by Subject|4
411008|NCT00643760|1377169|P3|Overall Study|Withdrawal by Subject|2
411009|NCT00643760|1377170|P2|Overall Study|Withdrawal by Subject|1
411010|NCT00643760|1377171|P1|Overall Study|Withdrawal by Subject|3
411011|NCT00643760|1377167|P5|Overall Study|Investigator Discretion|0
411012|NCT00643760|1377168|P4|Overall Study|Investigator Discretion|2
411013|NCT00643760|1377169|P3|Overall Study|Investigator Discretion|0
411014|NCT00643760|1377170|P2|Overall Study|Investigator Discretion|0
411015|NCT00643760|1377171|P1|Overall Study|Investigator Discretion|0
411016|NCT00643760|1377167|P5|Overall Study|Lost to Follow-up|3
411017|NCT00643760|1377168|P4|Overall Study|Lost to Follow-up|3
411018|NCT00643760|1377169|P3|Overall Study|Lost to Follow-up|1
411019|NCT00643760|1377170|P2|Overall Study|Lost to Follow-up|2
411020|NCT00643760|1377171|P1|Overall Study|Lost to Follow-up|6
411021|NCT00643760|1377167|P5|Overall Study|Protocol Violation|6
411022|NCT00643760|1377168|P4|Overall Study|Protocol Violation|4
411023|NCT00643760|1377169|P3|Overall Study|Protocol Violation|4
411024|NCT00643760|1377170|P2|Overall Study|Protocol Violation|6
411025|NCT00643760|1377171|P1|Overall Study|Protocol Violation|7
411026|NCT00643760|1377167|P5|Overall Study|Lack of Efficacy|3
411027|NCT00643760|1377168|P4|Overall Study|Lack of Efficacy|4
411028|NCT00643760|1377169|P3|Overall Study|Lack of Efficacy|0
411029|NCT00643760|1377170|P2|Overall Study|Lack of Efficacy|1
411030|NCT00643760|1377171|P1|Overall Study|Lack of Efficacy|3
411031|NCT00643760|1377167|P5|Overall Study|Adverse Event|6
411032|NCT00643760|1377168|P4|Overall Study|Adverse Event|21
411033|NCT00643760|1377169|P3|Overall Study|Adverse Event|12
411034|NCT00643760|1377170|P2|Overall Study|Adverse Event|5
411035|NCT00643760|1377171|P1|Overall Study|Adverse Event|11
411036|NCT00643682|1377275|P2|Overall Study|did not keep appointment|509
411037|NCT00643682|1377276|P1|Overall Study|did not keep appointment|522
411038|NCT00643604|1377288|P1|Overall Study|Death|1
411039|NCT00643565|1377316|P2|Overall Study|Lost to Follow-up|0
411040|NCT00643565|1377317|P1|Overall Study|Lost to Follow-up|2
411041|NCT00643565|1377316|P2|Overall Study|Withdrawal by Subject|1
411042|NCT00643565|1377317|P1|Overall Study|Withdrawal by Subject|2
411043|NCT00643565|1377316|P2|Overall Study|Ongoing in Follow-up|39
411044|NCT00643565|1377317|P1|Overall Study|Ongoing in Follow-up|39
411045|NCT00643565|1377316|P2|Overall Study|Death|34
411046|NCT00643565|1377317|P1|Overall Study|Death|37
411047|NCT00643487|1377339|P1|Overall Study|Technical difficulty|3
411048|NCT00643448|1377346|P3|Overall Study|QTcF>550 ms|0
411049|NCT00643448|1377347|P2|Overall Study|QTcF>550 ms|3
411050|NCT00643448|1377348|P1|Overall Study|QTcF>550 ms|0
411051|NCT00643448|1377346|P3|Overall Study|Adverse Event|2
411052|NCT00643448|1377347|P2|Overall Study|Adverse Event|2
411053|NCT00643448|1377348|P1|Overall Study|Adverse Event|2
411054|NCT00643448|1377346|P3|Overall Study|Lack of Efficacy|4
411055|NCT00643448|1377347|P2|Overall Study|Lack of Efficacy|0
411056|NCT00643448|1377348|P1|Overall Study|Lack of Efficacy|2
411057|NCT00643201|1377365|P2|Completed Study Follow Up|non-specified|0
411058|NCT00643201|1377366|P1|Completed Study Follow Up|non-specified|1
411059|NCT00643201|1377365|P2|Completed Study Follow Up|Lost to Follow-up|16
411060|NCT00643201|1377366|P1|Completed Study Follow Up|Lost to Follow-up|18
411061|NCT00643201|1377365|P2|Completed Study Follow Up|Withdrawal by Subject|29
411062|NCT00643201|1377366|P1|Completed Study Follow Up|Withdrawal by Subject|23
411063|NCT00643201|1377365|P2|Completed Study Follow Up|Death|34
411064|NCT00643201|1377366|P1|Completed Study Follow Up|Death|28
411065|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|not specified|107
411066|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|not specified|107
411067|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
411068|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
411069|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
411070|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
411071|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
411072|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
411073|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
411074|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
411075|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
411076|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
411077|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
411078|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
411079|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
411080|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
411081|NCT00643201|1377365|P2|Randomized, Completed 6 Months of Study|Death|26
411082|NCT00643201|1377366|P1|Randomized, Completed 6 Months of Study|Death|20
411083|NCT00643123|1377414|P2|Overall Study|Withdrawal by Subject|1
411084|NCT00643123|1377415|P1|Overall Study|Withdrawal by Subject|1
411085|NCT00643123|1377414|P2|Overall Study|Lost to Follow-up|0
411086|NCT00643123|1377415|P1|Overall Study|Lost to Follow-up|4
411087|NCT00643006|1377445|P2|Overall Study|Lost to Follow-up|4
411088|NCT00643006|1377446|P1|Overall Study|Lost to Follow-up|5
411089|NCT00642993|1377456|P2|Overall Study|Administrative|0
411090|NCT00642993|1377457|P1|Overall Study|Administrative|1
411091|NCT00642993|1377456|P2|Overall Study|Did not meet protocol eligibility|1
411092|NCT00642993|1377457|P1|Overall Study|Did not meet protocol eligibility|0
411093|NCT00642993|1377456|P2|Overall Study|Protocol Violation|4
411094|NCT00642993|1377457|P1|Overall Study|Protocol Violation|1
411095|NCT00642993|1377456|P2|Overall Study|Withdrew - reason unrelated to treatment|3
411096|NCT00642993|1377457|P1|Overall Study|Withdrew - reason unrelated to treatment|11
411097|NCT00642993|1377456|P2|Overall Study|Lost to Follow-up|4
411098|NCT00642993|1377457|P1|Overall Study|Lost to Follow-up|8
411099|NCT00642993|1377456|P2|Overall Study|Adverse Event|4
411100|NCT00642993|1377457|P1|Overall Study|Adverse Event|85
411101|NCT00642902|1377475|P4|Overall Study|Other|4
411102|NCT00642902|1377476|P3|Overall Study|Other|1
411103|NCT00642902|1377477|P2|Overall Study|Other|5
411104|NCT00642902|1377478|P1|Overall Study|Other|1
411105|NCT00642902|1377475|P4|Overall Study|Randomized, but not treated|0
411106|NCT00642902|1377476|P3|Overall Study|Randomized, but not treated|1
411107|NCT00642902|1377477|P2|Overall Study|Randomized, but not treated|0
411108|NCT00642902|1377478|P1|Overall Study|Randomized, but not treated|0
411109|NCT00642902|1377475|P4|Overall Study|Premature termination of clinical trial|35
411110|NCT00642902|1377476|P3|Overall Study|Premature termination of clinical trial|35
411111|NCT00642902|1377477|P2|Overall Study|Premature termination of clinical trial|32
411112|NCT00642902|1377478|P1|Overall Study|Premature termination of clinical trial|37
411113|NCT00642902|1377475|P4|Overall Study|Death|0
411114|NCT00642902|1377476|P3|Overall Study|Death|0
411115|NCT00642902|1377477|P2|Overall Study|Death|0
411116|NCT00642902|1377478|P1|Overall Study|Death|1
411117|NCT00642902|1377475|P4|Overall Study|Lack of Efficacy|0
411118|NCT00642902|1377476|P3|Overall Study|Lack of Efficacy|3
411119|NCT00642902|1377477|P2|Overall Study|Lack of Efficacy|3
411120|NCT00642902|1377478|P1|Overall Study|Lack of Efficacy|0
411121|NCT00642902|1377475|P4|Overall Study|Lost to Follow-up|0
411122|NCT00642902|1377476|P3|Overall Study|Lost to Follow-up|0
411123|NCT00642902|1377477|P2|Overall Study|Lost to Follow-up|1
411124|NCT00642902|1377478|P1|Overall Study|Lost to Follow-up|1
411125|NCT00642902|1377475|P4|Overall Study|Adverse Event|1
411126|NCT00642902|1377476|P3|Overall Study|Adverse Event|3
411127|NCT00642902|1377477|P2|Overall Study|Adverse Event|1
411128|NCT00642902|1377478|P1|Overall Study|Adverse Event|0
411129|NCT00642850|1377500|P1|Overall Study|Other reasons|7
411130|NCT00642850|1377500|P1|Overall Study|Blood transfusion|6
411131|NCT00642850|1377500|P1|Overall Study|Kidney transplantation|8
411132|NCT00642850|1377500|P1|Overall Study|Protocol Violation|2
411133|NCT00642850|1377500|P1|Overall Study|Lack of Efficacy|1
411134|NCT00642850|1377500|P1|Overall Study|Adverse Event|2
411135|NCT00642850|1377500|P1|Overall Study|Death|7
411136|NCT00642811|1377516|P6|Overall Study|Other|0
411137|NCT00642811|1377517|P5|Overall Study|Other|0
411138|NCT00642811|1377518|P4|Overall Study|Other|1
411139|NCT00642811|1377519|P3|Overall Study|Other|0
411140|NCT00642811|1377520|P2|Overall Study|Other|1
411141|NCT00642811|1377521|P1|Overall Study|Other|0
411142|NCT00642811|1377516|P6|Overall Study|Severe Non-compliance to protocol|0
411143|NCT00642811|1377517|P5|Overall Study|Severe Non-compliance to protocol|0
411144|NCT00642811|1377518|P4|Overall Study|Severe Non-compliance to protocol|0
411145|NCT00642811|1377519|P3|Overall Study|Severe Non-compliance to protocol|0
411146|NCT00642811|1377520|P2|Overall Study|Severe Non-compliance to protocol|0
411147|NCT00642811|1377521|P1|Overall Study|Severe Non-compliance to protocol|1
411148|NCT00642811|1377516|P6|Overall Study|Developement of discontinuation criteria|0
411149|NCT00642811|1377517|P5|Overall Study|Developement of discontinuation criteria|1
411150|NCT00642811|1377518|P4|Overall Study|Developement of discontinuation criteria|0
411151|NCT00642811|1377519|P3|Overall Study|Developement of discontinuation criteria|0
411152|NCT00642811|1377520|P2|Overall Study|Developement of discontinuation criteria|0
411153|NCT00642811|1377521|P1|Overall Study|Developement of discontinuation criteria|0
411154|NCT00642811|1377516|P6|Overall Study|Adverse Event|1
411155|NCT00642811|1377517|P5|Overall Study|Adverse Event|0
411156|NCT00642811|1377518|P4|Overall Study|Adverse Event|0
411157|NCT00642811|1377519|P3|Overall Study|Adverse Event|0
411158|NCT00642811|1377520|P2|Overall Study|Adverse Event|3
411159|NCT00642811|1377521|P1|Overall Study|Adverse Event|2
411160|NCT00642772|1377543|P1|Overall Study|Withdrawal by Subject|7
411161|NCT00642772|1377543|P1|Overall Study|Lost to Follow-up|3
411162|NCT00642759|1377547|P1|Overall Study|Protocol Violation|1
411163|NCT00642746|1377556|P2|Overall Study|Patient unevaluable|0
411164|NCT00642746|1377557|P1|Overall Study|Patient unevaluable|1
411165|NCT00642707|1377571|P4|Overall Study|Withdrawal by Subject|0
411166|NCT00642707|1377572|P3|Overall Study|Withdrawal by Subject|0
411167|NCT00642707|1377573|P2|Overall Study|Withdrawal by Subject|0
411168|NCT00642707|1377574|P1|Overall Study|Withdrawal by Subject|1
411169|NCT00642707|1377571|P4|Overall Study|Adverse Event|2
411170|NCT00642707|1377572|P3|Overall Study|Adverse Event|0
411171|NCT00642707|1377573|P2|Overall Study|Adverse Event|0
411172|NCT00642707|1377574|P1|Overall Study|Adverse Event|0
411173|NCT00642668|1377595|P1|Overall Study|Blood Transfusion|2
411174|NCT00642668|1377595|P1|Overall Study|Dialysis Initiation|5
411175|NCT00642668|1377595|P1|Overall Study|Failure to Return|1
411176|NCT00642668|1377595|P1|Overall Study|Insufficient Therapeutic Response|1
411177|NCT00642668|1377595|P1|Overall Study|Death|2
411178|NCT00642668|1377595|P1|Overall Study|Adverse Event|2
411179|NCT00642668|1377595|P1|Overall Study|Lost to Follow-up|1
411180|NCT00642642|1377603|P1|Treatment & Follow Up|Lost to Follow-up|10
411181|NCT00642642|1377603|P1|Treatment & Follow Up|Withdrawal by Subject|5
411182|NCT00642642|1377603|P1|Treatment & Follow Up|Adverse Event|2
411183|NCT00642616|1377620|P4|Overall Study|Physician Decision|1
411184|NCT00642616|1377621|P3|Overall Study|Physician Decision|1
411185|NCT00642616|1377622|P2|Overall Study|Physician Decision|0
411186|NCT00642616|1377623|P1|Overall Study|Physician Decision|0
411187|NCT00642616|1377620|P4|Overall Study|Protocol Violation|0
411188|NCT00642616|1377621|P3|Overall Study|Protocol Violation|2
411189|NCT00642616|1377622|P2|Overall Study|Protocol Violation|0
411190|NCT00642616|1377623|P1|Overall Study|Protocol Violation|0
411191|NCT00642616|1377620|P4|Overall Study|Withdrawal by Subject|1
411192|NCT00642616|1377621|P3|Overall Study|Withdrawal by Subject|1
411193|NCT00642616|1377622|P2|Overall Study|Withdrawal by Subject|1
411194|NCT00642616|1377623|P1|Overall Study|Withdrawal by Subject|0
411195|NCT00642616|1377620|P4|Overall Study|Study Terminated by Sponsor|5
411196|NCT00642616|1377621|P3|Overall Study|Study Terminated by Sponsor|4
411197|NCT00642616|1377622|P2|Overall Study|Study Terminated by Sponsor|6
411198|NCT00642616|1377623|P1|Overall Study|Study Terminated by Sponsor|7
411199|NCT00642616|1377620|P4|Overall Study|Adverse Event|0
411200|NCT00642616|1377621|P3|Overall Study|Adverse Event|1
411201|NCT00642616|1377622|P2|Overall Study|Adverse Event|0
411202|NCT00642616|1377623|P1|Overall Study|Adverse Event|2
411203|NCT00642473|1377656|P2|Overall Study|Other|2
411204|NCT00642473|1377657|P1|Overall Study|Other|2
411205|NCT00642473|1377656|P2|Overall Study|Progression or death|4
411206|NCT00642473|1377657|P1|Overall Study|Progression or death|2
411207|NCT00642473|1377656|P2|Overall Study|Withdrawal by Subject|5
411208|NCT00642473|1377657|P1|Overall Study|Withdrawal by Subject|0
411209|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
411210|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
411211|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
411212|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
411213|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
411214|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
411215|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
411216|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
411217|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
411218|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
411219|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
411220|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
411221|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Death|3
411222|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Death|0
411223|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Death|0
411224|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Death|0
411225|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Death|0
411226|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Death|0
411227|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Other|2
411228|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Other|2
411229|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Other|0
411230|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Other|0
411231|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Other|0
411232|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Other|0
411233|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
411234|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
411235|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
411236|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
411237|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
411238|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
411239|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
411240|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
411241|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
411242|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
411243|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
411244|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
411245|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
411246|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
411247|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
411248|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
411249|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
411250|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
411251|NCT00642460|1377671|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
411252|NCT00642460|1377672|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
411253|NCT00642460|1377673|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
411254|NCT00642460|1377674|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
411255|NCT00642460|1377675|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
411256|NCT00642460|1377676|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
411257|NCT00642460|1377671|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
411258|NCT00642460|1377672|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
411259|NCT00642460|1377673|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
411260|NCT00642460|1377674|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
411261|NCT00642460|1377675|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
411262|NCT00642460|1377676|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
411263|NCT00642460|1377671|P6|Part II: Open-Label Up to Week 92|Failure to return|0
411264|NCT00642460|1377672|P5|Part II: Open-Label Up to Week 92|Failure to return|0
411265|NCT00642460|1377673|P4|Part II: Open-Label Up to Week 92|Failure to return|0
411266|NCT00642460|1377674|P3|Part II: Open-Label Up to Week 92|Failure to return|0
411267|NCT00642460|1377675|P2|Part II: Open-Label Up to Week 92|Failure to return|1
411268|NCT00642460|1377676|P1|Part II: Open-Label Up to Week 92|Failure to return|0
411269|NCT00642460|1377671|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
411270|NCT00642460|1377672|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
411271|NCT00642460|1377673|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
411272|NCT00642460|1377674|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
411273|NCT00642460|1377675|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
411274|NCT00642460|1377676|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
411275|NCT00642460|1377671|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
411276|NCT00642460|1377672|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
411277|NCT00642460|1377673|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
411278|NCT00642460|1377674|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
411279|NCT00642460|1377675|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
411280|NCT00642460|1377676|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
411281|NCT00642460|1377671|P6|Part II: Open-Label Up to Week 92|Death|0
411282|NCT00642460|1377672|P5|Part II: Open-Label Up to Week 92|Death|0
411283|NCT00642460|1377673|P4|Part II: Open-Label Up to Week 92|Death|2
411284|NCT00642460|1377674|P3|Part II: Open-Label Up to Week 92|Death|0
411285|NCT00642460|1377675|P2|Part II: Open-Label Up to Week 92|Death|1
411286|NCT00642460|1377676|P1|Part II: Open-Label Up to Week 92|Death|0
411287|NCT00642460|1377671|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
411288|NCT00642460|1377672|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
411289|NCT00642460|1377673|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
411290|NCT00642460|1377674|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
411291|NCT00642460|1377675|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
411292|NCT00642460|1377676|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
411293|NCT00642460|1377671|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
411294|NCT00642460|1377672|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
411295|NCT00642460|1377673|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
411296|NCT00642460|1377674|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
411297|NCT00642460|1377675|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
411298|NCT00642460|1377676|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
411299|NCT00642460|1377671|P6|Part I: 12 Week Double-Blind|Adverse Event|0
411300|NCT00642460|1377672|P5|Part I: 12 Week Double-Blind|Adverse Event|0
411301|NCT00642460|1377673|P4|Part I: 12 Week Double-Blind|Adverse Event|0
411302|NCT00642460|1377674|P3|Part I: 12 Week Double-Blind|Adverse Event|1
411303|NCT00642460|1377675|P2|Part I: 12 Week Double-Blind|Adverse Event|1
411304|NCT00642460|1377676|P1|Part I: 12 Week Double-Blind|Adverse Event|0
411305|NCT00642369|1377751|P2|Overall Study|Lack of Efficacy|2
411306|NCT00642369|1377752|P1|Overall Study|Lack of Efficacy|2
411307|NCT00642369|1377751|P2|Overall Study|misdiagnosis|1
411308|NCT00642369|1377752|P1|Overall Study|misdiagnosis|0
411309|NCT00642369|1377751|P2|Overall Study|Withdrawal by Subject|0
411310|NCT00642369|1377752|P1|Overall Study|Withdrawal by Subject|1
411311|NCT00642369|1377751|P2|Overall Study|Adverse Event|3
411312|NCT00642369|1377752|P1|Overall Study|Adverse Event|2
411313|NCT00642356|1377762|P2|Overall Study|Lack of Efficacy|0
411314|NCT00642356|1377763|P1|Overall Study|Lack of Efficacy|1
411315|NCT00642356|1377762|P2|Overall Study|Protocol Violation|3
411316|NCT00642356|1377763|P1|Overall Study|Protocol Violation|0
411317|NCT00642356|1377762|P2|Overall Study|Adverse Event|0
411318|NCT00642356|1377763|P1|Overall Study|Adverse Event|1
411319|NCT00642304|1377771|P1|Overall Study|Transplantation|1
411320|NCT00642304|1377771|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
411321|NCT00642304|1377771|P1|Overall Study|Blood transfusion|2
411322|NCT00642304|1377771|P1|Overall Study|Death|1
411323|NCT00642304|1377771|P1|Overall Study|Adverse Event|1
411324|NCT00642278|1377787|P7|Overall Study|Not specified|0
411325|NCT00642278|1377788|P6|Overall Study|Not specified|1
411326|NCT00642278|1377789|P5|Overall Study|Not specified|0
411327|NCT00642278|1377790|P4|Overall Study|Not specified|1
411328|NCT00642278|1377791|P3|Overall Study|Not specified|0
411329|NCT00642278|1377792|P2|Overall Study|Not specified|1
411330|NCT00642278|1377793|P1|Overall Study|Not specified|2
411331|NCT00642278|1377787|P7|Overall Study|Noncompliance with study drug regimen|0
411332|NCT00642278|1377788|P6|Overall Study|Noncompliance with study drug regimen|0
411333|NCT00642278|1377789|P5|Overall Study|Noncompliance with study drug regimen|0
411334|NCT00642278|1377790|P4|Overall Study|Noncompliance with study drug regimen|1
411335|NCT00642278|1377791|P3|Overall Study|Noncompliance with study drug regimen|0
411336|NCT00642278|1377792|P2|Overall Study|Noncompliance with study drug regimen|0
411337|NCT00642278|1377793|P1|Overall Study|Noncompliance with study drug regimen|0
411338|NCT00642278|1377787|P7|Overall Study|Withdrawal by Subject|2
411339|NCT00642278|1377788|P6|Overall Study|Withdrawal by Subject|2
411340|NCT00642278|1377789|P5|Overall Study|Withdrawal by Subject|6
411341|NCT00642278|1377790|P4|Overall Study|Withdrawal by Subject|3
411342|NCT00642278|1377791|P3|Overall Study|Withdrawal by Subject|1
411343|NCT00642278|1377792|P2|Overall Study|Withdrawal by Subject|1
411344|NCT00642278|1377793|P1|Overall Study|Withdrawal by Subject|1
411345|NCT00642278|1377787|P7|Overall Study|Protocol Violation|2
411346|NCT00642278|1377788|P6|Overall Study|Protocol Violation|1
411347|NCT00642278|1377789|P5|Overall Study|Protocol Violation|0
411348|NCT00642278|1377790|P4|Overall Study|Protocol Violation|1
411349|NCT00642278|1377791|P3|Overall Study|Protocol Violation|1
411350|NCT00642278|1377792|P2|Overall Study|Protocol Violation|0
411351|NCT00642278|1377793|P1|Overall Study|Protocol Violation|0
411352|NCT00642278|1377787|P7|Overall Study|Physician Decision|0
411353|NCT00642278|1377788|P6|Overall Study|Physician Decision|0
411354|NCT00642278|1377789|P5|Overall Study|Physician Decision|0
411355|NCT00642278|1377790|P4|Overall Study|Physician Decision|1
411356|NCT00642278|1377791|P3|Overall Study|Physician Decision|0
411357|NCT00642278|1377792|P2|Overall Study|Physician Decision|0
411358|NCT00642278|1377793|P1|Overall Study|Physician Decision|0
411359|NCT00642278|1377787|P7|Overall Study|Lost to Follow-up|1
411360|NCT00642278|1377788|P6|Overall Study|Lost to Follow-up|1
411361|NCT00642278|1377789|P5|Overall Study|Lost to Follow-up|0
411362|NCT00642278|1377790|P4|Overall Study|Lost to Follow-up|1
411363|NCT00642278|1377791|P3|Overall Study|Lost to Follow-up|0
411364|NCT00642278|1377792|P2|Overall Study|Lost to Follow-up|1
411365|NCT00642278|1377793|P1|Overall Study|Lost to Follow-up|5
411366|NCT00642278|1377787|P7|Overall Study|Lack of Efficacy|0
411367|NCT00642278|1377788|P6|Overall Study|Lack of Efficacy|0
411368|NCT00642278|1377789|P5|Overall Study|Lack of Efficacy|0
411369|NCT00642278|1377790|P4|Overall Study|Lack of Efficacy|0
411370|NCT00642278|1377791|P3|Overall Study|Lack of Efficacy|0
411371|NCT00642278|1377792|P2|Overall Study|Lack of Efficacy|1
411372|NCT00642278|1377793|P1|Overall Study|Lack of Efficacy|0
411373|NCT00642278|1377787|P7|Overall Study|Adverse Event|0
411374|NCT00642278|1377788|P6|Overall Study|Adverse Event|2
411375|NCT00642278|1377789|P5|Overall Study|Adverse Event|2
411376|NCT00642278|1377790|P4|Overall Study|Adverse Event|1
411377|NCT00642278|1377791|P3|Overall Study|Adverse Event|3
411378|NCT00642278|1377792|P2|Overall Study|Adverse Event|1
411379|NCT00642278|1377793|P1|Overall Study|Adverse Event|2
411380|NCT00642174|1377846|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
411381|NCT00642174|1377847|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
411382|NCT00641719|1377890|P2|Overall Study|Reason Not Specified|2
411383|NCT00641719|1377891|P1|Overall Study|Reason Not Specified|1
411384|NCT00641719|1377890|P2|Overall Study|Withdrawal by Subject|4
411385|NCT00641719|1377891|P1|Overall Study|Withdrawal by Subject|4
411386|NCT00641719|1377890|P2|Overall Study|Adverse Event|29
411387|NCT00641719|1377891|P1|Overall Study|Adverse Event|24
411388|NCT00641719|1377890|P2|Overall Study|Lack of Efficacy|2
411389|NCT00641719|1377891|P1|Overall Study|Lack of Efficacy|1
411390|NCT00641706|1377915|P2|Overall Study|Lead Investigator Decision|1
411391|NCT00641706|1377916|P1|Overall Study|Lead Investigator Decision|0
411392|NCT00641706|1377915|P2|Overall Study|Clinical Decline|0
411393|NCT00641706|1377916|P1|Overall Study|Clinical Decline|1
411394|NCT00641706|1377915|P2|Overall Study|Withdrawal by Subject|1
411395|NCT00641706|1377916|P1|Overall Study|Withdrawal by Subject|6
411396|NCT00641706|1377915|P2|Overall Study|Adverse Event|1
411397|NCT00641706|1377916|P1|Overall Study|Adverse Event|2
411398|NCT00641667|1377928|P1|Overall Study|Worsening of underlying disease|3
411399|NCT00641667|1377928|P1|Overall Study|Physician Decision|1
411400|NCT00641667|1377928|P1|Overall Study|Adverse Event|1
411401|NCT00641667|1377928|P1|Overall Study|Withdrawal by Subject|1
411402|NCT00641537|1377956|P8|24-Week Supplemental Follow-up Period|Other|1
411403|NCT00641537|1377957|P7|24-Week Supplemental Follow-up Period|Other|1
411404|NCT00641537|1377958|P6|24-Week Supplemental Follow-up Period|Other|0
411405|NCT00641537|1377959|P5|24-Week Supplemental Follow-up Period|Other|3
411406|NCT00641537|1377960|P4|24-Week Supplemental Follow-up Period|Other|1
411407|NCT00641537|1377961|P3|24-Week Supplemental Follow-up Period|Other|2
411408|NCT00641537|1377962|P2|24-Week Supplemental Follow-up Period|Other|2
411409|NCT00641537|1377963|P1|24-Week Supplemental Follow-up Period|Other|0
411410|NCT00641537|1377956|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
411411|NCT00641537|1377957|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
411412|NCT00641537|1377958|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
411413|NCT00641537|1377959|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
411414|NCT00641537|1377960|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
411415|NCT00641537|1377961|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
411416|NCT00641537|1377962|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
411417|NCT00641537|1377963|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
411418|NCT00641537|1377956|P8|96-week Period|Other|6
411419|NCT00641537|1377957|P7|96-week Period|Other|4
411420|NCT00641537|1377958|P6|96-week Period|Other|6
411421|NCT00641537|1377959|P5|96-week Period|Other|12
411422|NCT00641537|1377960|P4|96-week Period|Other|9
411423|NCT00641537|1377961|P3|96-week Period|Other|14
411424|NCT00641537|1377962|P2|96-week Period|Other|7
411425|NCT00641537|1377963|P1|96-week Period|Other|4
411426|NCT00641537|1377956|P8|96-week Period|Death|0
411427|NCT00641537|1377957|P7|96-week Period|Death|0
411428|NCT00641537|1377958|P6|96-week Period|Death|0
411429|NCT00641537|1377959|P5|96-week Period|Death|0
411430|NCT00641537|1377960|P4|96-week Period|Death|0
411431|NCT00641537|1377961|P3|96-week Period|Death|1
411432|NCT00641537|1377962|P2|96-week Period|Death|0
411433|NCT00641537|1377963|P1|96-week Period|Death|2
411434|NCT00641537|1377956|P8|96-week Period|Protocol Violation|0
411435|NCT00641537|1377957|P7|96-week Period|Protocol Violation|0
411436|NCT00641537|1377958|P6|96-week Period|Protocol Violation|1
411437|NCT00641537|1377959|P5|96-week Period|Protocol Violation|0
411438|NCT00641537|1377960|P4|96-week Period|Protocol Violation|1
411439|NCT00641537|1377961|P3|96-week Period|Protocol Violation|0
411440|NCT00641537|1377962|P2|96-week Period|Protocol Violation|1
411441|NCT00641537|1377963|P1|96-week Period|Protocol Violation|0
411442|NCT00641537|1377956|P8|96-week Period|Lost to Follow-up|0
411443|NCT00641537|1377957|P7|96-week Period|Lost to Follow-up|1
411444|NCT00641537|1377958|P6|96-week Period|Lost to Follow-up|0
411445|NCT00641537|1377959|P5|96-week Period|Lost to Follow-up|4
411446|NCT00641537|1377960|P4|96-week Period|Lost to Follow-up|2
411447|NCT00641537|1377961|P3|96-week Period|Lost to Follow-up|2
411448|NCT00641537|1377962|P2|96-week Period|Lost to Follow-up|1
411449|NCT00641537|1377963|P1|96-week Period|Lost to Follow-up|3
411450|NCT00641537|1377956|P8|96-week Period|Adverse Event|0
411451|NCT00641537|1377957|P7|96-week Period|Adverse Event|0
411452|NCT00641537|1377958|P6|96-week Period|Adverse Event|0
411453|NCT00641537|1377959|P5|96-week Period|Adverse Event|2
411454|NCT00641537|1377960|P4|96-week Period|Adverse Event|0
411455|NCT00641537|1377961|P3|96-week Period|Adverse Event|3
411456|NCT00641537|1377962|P2|96-week Period|Adverse Event|1
411457|NCT00641537|1377963|P1|96-week Period|Adverse Event|0
411458|NCT00641147|1378018|P2|Completed 16 Months.|Lost to Follow-up|0
411459|NCT00641147|1378019|P1|Completed 16 Months.|Lost to Follow-up|1
411460|NCT00641147|1378018|P2|Completed 16 Months.|Physician Decision|0
411461|NCT00641147|1378019|P1|Completed 16 Months.|Physician Decision|1
411462|NCT00641147|1378018|P2|Completed 12 Months.|Withdrawal by Subject|1
411463|NCT00641147|1378019|P1|Completed 12 Months.|Withdrawal by Subject|0
411464|NCT00641147|1378018|P2|Completed 12 Months.|Physician Decision|1
411465|NCT00641147|1378019|P1|Completed 12 Months.|Physician Decision|1
411466|NCT00641147|1378018|P2|Completed 8 Months.|Withdrawal by Subject|1
411467|NCT00641147|1378019|P1|Completed 8 Months.|Withdrawal by Subject|0
411468|NCT00641147|1378018|P2|Completed 8 Months.|non compliance|0
411469|NCT00641147|1378019|P1|Completed 8 Months.|non compliance|1
411470|NCT00641147|1378018|P2|Completed 8 Months.|Physician Decision|1
411471|NCT00641147|1378019|P1|Completed 8 Months.|Physician Decision|2
411472|NCT00641147|1378018|P2|Completed 4 Months.|Adverse Event|0
411473|NCT00641147|1378019|P1|Completed 4 Months.|Adverse Event|1
411474|NCT00641147|1378018|P2|Completed 4 Months.|Physician Decision|0
411475|NCT00641147|1378019|P1|Completed 4 Months.|Physician Decision|1
411476|NCT00641056|1378063|P2|Overall Study|Sponsor Decision|2
411477|NCT00641056|1378064|P1|Overall Study|Sponsor Decision|1
411478|NCT00641056|1378063|P2|Overall Study|Subject Decision|19
411479|NCT00641056|1378064|P1|Overall Study|Subject Decision|6
411480|NCT00641056|1378063|P2|Overall Study|Entry Criteria Not Met|0
411481|NCT00641056|1378064|P1|Overall Study|Entry Criteria Not Met|3
411482|NCT00641056|1378063|P2|Overall Study|Protocol Violation|0
411483|NCT00641056|1378064|P1|Overall Study|Protocol Violation|2
411484|NCT00641056|1378063|P2|Overall Study|Physician Decision|1
411485|NCT00641056|1378064|P1|Overall Study|Physician Decision|3
411486|NCT00641056|1378063|P2|Overall Study|Lost to Follow-up|1
411487|NCT00641056|1378064|P1|Overall Study|Lost to Follow-up|2
411488|NCT00641056|1378063|P2|Overall Study|Adverse Event|2
411489|NCT00641056|1378064|P1|Overall Study|Adverse Event|12
411490|NCT00641043|1378092|P2|Overall Study|Other incl. lack of efficacy|2
411491|NCT00641043|1378093|P1|Overall Study|Other incl. lack of efficacy|4
411492|NCT00641043|1378092|P2|Overall Study|Withdrawal by Subject|4
411493|NCT00641043|1378093|P1|Overall Study|Withdrawal by Subject|4
411494|NCT00641043|1378092|P2|Overall Study|Lost to Follow-up|2
411495|NCT00641043|1378093|P1|Overall Study|Lost to Follow-up|3
411496|NCT00641043|1378092|P2|Overall Study|Protocol Violation|3
411497|NCT00641043|1378093|P1|Overall Study|Protocol Violation|2
411498|NCT00641043|1378092|P2|Overall Study|Adverse Event|4
411499|NCT00641043|1378093|P1|Overall Study|Adverse Event|6
411500|NCT00640926|1378130|P3|Overall Study|Withdrawal by Subject|1
411501|NCT00640926|1378131|P2|Overall Study|Withdrawal by Subject|0
411502|NCT00640926|1378132|P1|Overall Study|Withdrawal by Subject|1
411503|NCT00640926|1378130|P3|Overall Study|Lost to Follow-up|2
411504|NCT00640926|1378131|P2|Overall Study|Lost to Follow-up|1
411505|NCT00640926|1378132|P1|Overall Study|Lost to Follow-up|3
411506|NCT00640926|1378130|P3|Overall Study|Protocol Violation|2
411507|NCT00640926|1378131|P2|Overall Study|Protocol Violation|0
411508|NCT00640926|1378132|P1|Overall Study|Protocol Violation|2
411509|NCT00640926|1378130|P3|Overall Study|Lack of Efficacy|1
411510|NCT00640926|1378131|P2|Overall Study|Lack of Efficacy|2
411511|NCT00640926|1378132|P1|Overall Study|Lack of Efficacy|0
411512|NCT00640926|1378130|P3|Overall Study|Adverse Event|2
411513|NCT00640926|1378131|P2|Overall Study|Adverse Event|3
411514|NCT00640926|1378132|P1|Overall Study|Adverse Event|2
411515|NCT00640835|1378145|P2|Overall Study|Other Reason|4
411516|NCT00640835|1378146|P1|Overall Study|Other Reason|19
411517|NCT00640835|1378145|P2|Overall Study|Lost to Follow-up|13
411518|NCT00640835|1378146|P1|Overall Study|Lost to Follow-up|17
411519|NCT00640835|1378145|P2|Overall Study|Protocol Violation|2
411520|NCT00640835|1378146|P1|Overall Study|Protocol Violation|2
411521|NCT00640835|1378145|P2|Overall Study|Sponsor's Decision|7
411522|NCT00640835|1378146|P1|Overall Study|Sponsor's Decision|11
411523|NCT00640835|1378145|P2|Overall Study|Physician Decision|14
411524|NCT00640835|1378146|P1|Overall Study|Physician Decision|10
411525|NCT00640835|1378145|P2|Overall Study|Withdrawal by Subject|14
411526|NCT00640835|1378146|P1|Overall Study|Withdrawal by Subject|12
411527|NCT00640835|1378145|P2|Overall Study|Adverse Event|3
411528|NCT00640835|1378146|P1|Overall Study|Adverse Event|5
411529|NCT00640614|1378210|P2|Overall Study|Lost to Follow-up|0
411530|NCT00640614|1378211|P1|Overall Study|Lost to Follow-up|1
411531|NCT00640601|1378253|P1|Overall Study|treatment naive, combination therapy|10
411532|NCT00640601|1378253|P1|Overall Study|Physician Decision|8
411533|NCT00640601|1378253|P1|Overall Study|Lost to Follow-up|9
411534|NCT00640601|1378253|P1|Overall Study|Lack of Efficacy|16
411535|NCT00640601|1378253|P1|Overall Study|Protocol Violation|6
411536|NCT00640601|1378253|P1|Overall Study|Withdrawal by Subject|20
411537|NCT00640601|1378253|P1|Overall Study|Adverse Event|43
411538|NCT00640562|1378269|P2|Overall Study|Glycosylated Hemoglobin >8|0
411539|NCT00640562|1378270|P1|Overall Study|Glycosylated Hemoglobin >8|1
411540|NCT00640562|1378269|P2|Overall Study|Low study drug dose|1
411541|NCT00640562|1378270|P1|Overall Study|Low study drug dose|0
411542|NCT00640562|1378269|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
411543|NCT00640562|1378270|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
411544|NCT00640562|1378269|P2|Overall Study|Known risperidone intolerance|1
411545|NCT00640562|1378270|P1|Overall Study|Known risperidone intolerance|0
411546|NCT00640562|1378269|P2|Overall Study|Withdrawal by Subject|10
411547|NCT00640562|1378270|P1|Overall Study|Withdrawal by Subject|6
411548|NCT00640562|1378269|P2|Overall Study|Protocol Violation|4
411549|NCT00640562|1378270|P1|Overall Study|Protocol Violation|2
411550|NCT00640562|1378269|P2|Overall Study|Lack of Efficacy|4
411551|NCT00640562|1378270|P1|Overall Study|Lack of Efficacy|1
411552|NCT00640562|1378269|P2|Overall Study|Adverse Event|5
411553|NCT00640562|1378270|P1|Overall Study|Adverse Event|8
411554|NCT00640510|1378298|P2|Overall Study|Physician Decision|1
411555|NCT00640510|1378299|P1|Overall Study|Physician Decision|0
411556|NCT00640510|1378298|P2|Overall Study|Protocol Violation|0
411557|NCT00640510|1378299|P1|Overall Study|Protocol Violation|1
411558|NCT00640510|1378298|P2|Overall Study|Lack of Efficacy|1
411559|NCT00640510|1378299|P1|Overall Study|Lack of Efficacy|0
411560|NCT00640393|1378311|P3|Part 2|Adverse Event|0
411561|NCT00640393|1378312|P2|Part 2|Adverse Event|1
411562|NCT00640393|1378313|P1|Part 2|Adverse Event|0
411563|NCT00640393|1378311|P3|Part 2|Non-adherence|0
411564|NCT00640393|1378312|P2|Part 2|Non-adherence|1
411565|NCT00640393|1378313|P1|Part 2|Non-adherence|0
411566|NCT00640393|1378311|P3|Part 2|Withdrawal by Subject|1
411567|NCT00640393|1378312|P2|Part 2|Withdrawal by Subject|6
411568|NCT00640393|1378313|P1|Part 2|Withdrawal by Subject|0
411569|NCT00640393|1378311|P3|Part 2|Lost to Follow-up|2
411570|NCT00640393|1378312|P2|Part 2|Lost to Follow-up|2
411571|NCT00640393|1378313|P1|Part 2|Lost to Follow-up|0
411572|NCT00640393|1378311|P3|Randomization|Never randomized by site|0
411573|NCT00640393|1378312|P2|Randomization|Never randomized by site|0
411574|NCT00640393|1378313|P1|Randomization|Never randomized by site|2
411575|NCT00640393|1378311|P3|Randomization|Withdrawn per protocol|0
411576|NCT00640393|1378312|P2|Randomization|Withdrawn per protocol|0
411577|NCT00640393|1378313|P1|Randomization|Withdrawn per protocol|17
411578|NCT00640393|1378311|P3|Part 1|Withdrawal by Subject|0
411579|NCT00640393|1378312|P2|Part 1|Withdrawal by Subject|0
411580|NCT00640393|1378313|P1|Part 1|Withdrawal by Subject|3
411581|NCT00640393|1378311|P3|Part 1|Lost to Follow-up|0
411582|NCT00640393|1378312|P2|Part 1|Lost to Follow-up|0
411583|NCT00640393|1378313|P1|Part 1|Lost to Follow-up|2
411584|NCT00640341|1378378|P3|Overall Study|Adverse event and positive slit lamp|0
411585|NCT00640341|1378379|P2|Overall Study|Adverse event and positive slit lamp|0
411586|NCT00640341|1378380|P1|Overall Study|Adverse event and positive slit lamp|1
411587|NCT00640341|1378378|P3|Overall Study|Ineligable at Baseline|2
411588|NCT00640341|1378379|P2|Overall Study|Ineligable at Baseline|3
411589|NCT00640341|1378380|P1|Overall Study|Ineligable at Baseline|5
411590|NCT00640341|1378378|P3|Overall Study|Poor fit/Uncomfortable|0
411591|NCT00640341|1378379|P2|Overall Study|Poor fit/Uncomfortable|0
411592|NCT00640341|1378380|P1|Overall Study|Poor fit/Uncomfortable|4
411593|NCT00640341|1378378|P3|Overall Study|Unacceptable Lens Movement|0
411594|NCT00640341|1378379|P2|Overall Study|Unacceptable Lens Movement|0
411595|NCT00640341|1378380|P1|Overall Study|Unacceptable Lens Movement|1
411596|NCT00640341|1378378|P3|Overall Study|Withdrawal by Subject|1
411597|NCT00640341|1378379|P2|Overall Study|Withdrawal by Subject|0
411598|NCT00640341|1378380|P1|Overall Study|Withdrawal by Subject|4
411599|NCT00640341|1378378|P3|Overall Study|Lost to Follow-up|0
411600|NCT00640341|1378379|P2|Overall Study|Lost to Follow-up|0
411601|NCT00640341|1378380|P1|Overall Study|Lost to Follow-up|2
411602|NCT00640341|1378378|P3|Overall Study|Failure to Follow Subject Instructions|0
411603|NCT00640341|1378379|P2|Overall Study|Failure to Follow Subject Instructions|0
411604|NCT00640341|1378380|P1|Overall Study|Failure to Follow Subject Instructions|1
411605|NCT00640341|1378378|P3|Overall Study|Inability to Maintain Wearing Schedule|0
411606|NCT00640341|1378379|P2|Overall Study|Inability to Maintain Wearing Schedule|1
411607|NCT00640341|1378380|P1|Overall Study|Inability to Maintain Wearing Schedule|1
411608|NCT00640341|1378378|P3|Overall Study|Study Related Symptoms/Complaints|2
411609|NCT00640341|1378379|P2|Overall Study|Study Related Symptoms/Complaints|1
411610|NCT00640341|1378380|P1|Overall Study|Study Related Symptoms/Complaints|2
411611|NCT00640341|1378378|P3|Overall Study|Positive Slit Lamp Findings|1
411612|NCT00640341|1378379|P2|Overall Study|Positive Slit Lamp Findings|0
411613|NCT00640341|1378380|P1|Overall Study|Positive Slit Lamp Findings|0
411614|NCT00640341|1378378|P3|Overall Study|Adverse Event|1
411615|NCT00640341|1378379|P2|Overall Study|Adverse Event|0
411616|NCT00640341|1378380|P1|Overall Study|Adverse Event|0
411617|NCT00640328|1378400|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
411618|NCT00640328|1378401|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
411619|NCT00640328|1378402|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
411620|NCT00640328|1378403|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
411621|NCT00640328|1378404|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
411622|NCT00640328|1378405|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
411623|NCT00640328|1378400|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
411624|NCT00640328|1378401|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
411625|NCT00640328|1378402|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
411626|NCT00640328|1378403|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
411627|NCT00640328|1378404|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
411628|NCT00640328|1378405|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
411629|NCT00640328|1378400|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
411630|NCT00640328|1378401|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
411631|NCT00640328|1378402|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
411632|NCT00640328|1378403|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
411633|NCT00640328|1378404|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
411634|NCT00640328|1378405|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
411635|NCT00640328|1378400|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
411636|NCT00640328|1378401|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
411637|NCT00640328|1378402|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
411638|NCT00640328|1378403|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
411639|NCT00640328|1378404|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
411640|NCT00640328|1378405|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
411641|NCT00640315|1378571|P2|Overall Study|Withdrawal by Subject|1
411642|NCT00640315|1378572|P1|Overall Study|Withdrawal by Subject|0
411643|NCT00640224|1378805|P4|Overall Study|Headaches|0
411644|NCT00640224|1378806|P3|Overall Study|Headaches|0
411645|NCT00640224|1378807|P2|Overall Study|Headaches|1
411646|NCT00640224|1378808|P1|Overall Study|Headaches|0
411647|NCT00640224|1378805|P4|Overall Study|Withdrawal by Subject|0
411648|NCT00640224|1378806|P3|Overall Study|Withdrawal by Subject|0
411649|NCT00640224|1378807|P2|Overall Study|Withdrawal by Subject|0
411650|NCT00640224|1378808|P1|Overall Study|Withdrawal by Subject|1
411651|NCT00640224|1378805|P4|Overall Study|Lost to Follow-up|0
411652|NCT00640224|1378806|P3|Overall Study|Lost to Follow-up|0
411653|NCT00640224|1378807|P2|Overall Study|Lost to Follow-up|2
411654|NCT00640224|1378808|P1|Overall Study|Lost to Follow-up|5
411655|NCT00640042|1378906|P1|Enrollment|Did not receive study drug|83
411656|NCT00640016|1378922|P4|Overall Study|Adverse Event|1
411657|NCT00640016|1378923|P3|Overall Study|Adverse Event|0
411658|NCT00640016|1378924|P2|Overall Study|Adverse Event|0
411659|NCT00640016|1378925|P1|Overall Study|Adverse Event|0
411660|NCT00640016|1378922|P4|Overall Study|Study termination|2
411661|NCT00640016|1378923|P3|Overall Study|Study termination|3
411662|NCT00640016|1378924|P2|Overall Study|Study termination|1
411663|NCT00640016|1378925|P1|Overall Study|Study termination|2
411664|NCT00640016|1378922|P4|Overall Study|Withdrawal by Subject|0
411665|NCT00640016|1378923|P3|Overall Study|Withdrawal by Subject|0
411666|NCT00640016|1378924|P2|Overall Study|Withdrawal by Subject|1
411667|NCT00640016|1378925|P1|Overall Study|Withdrawal by Subject|0
411668|NCT00639769|1378977|P1|Overall Study|Withdrawal by Subject|4
411669|NCT00639769|1378977|P1|Overall Study|Disease progression|26
411670|NCT00639769|1378977|P1|Overall Study|Lack of Efficacy|1
411671|NCT00639769|1378977|P1|Overall Study|Adverse Event|7
411672|NCT00639769|1378977|P1|Overall Study|Death|2
411673|NCT00639678|1378994|P4|Overall Study|Lack of Compliance|0
411674|NCT00639678|1378995|P3|Overall Study|Lack of Compliance|1
411675|NCT00639678|1378996|P2|Overall Study|Lack of Compliance|0
411676|NCT00639678|1378997|P1|Overall Study|Lack of Compliance|0
411677|NCT00639678|1378994|P4|Overall Study|Adverse Event|0
411678|NCT00639678|1378995|P3|Overall Study|Adverse Event|0
411679|NCT00639678|1378996|P2|Overall Study|Adverse Event|1
411680|NCT00639678|1378997|P1|Overall Study|Adverse Event|0
411681|NCT00639678|1378994|P4|Overall Study|Lost to Follow-up|0
411682|NCT00639678|1378995|P3|Overall Study|Lost to Follow-up|6
411683|NCT00639678|1378996|P2|Overall Study|Lost to Follow-up|0
411684|NCT00639678|1378997|P1|Overall Study|Lost to Follow-up|1
411685|NCT00639678|1378994|P4|Overall Study|Withdrawal by Subject|0
411686|NCT00639678|1378995|P3|Overall Study|Withdrawal by Subject|4
411687|NCT00639678|1378996|P2|Overall Study|Withdrawal by Subject|0
411688|NCT00639678|1378997|P1|Overall Study|Withdrawal by Subject|3
411689|NCT00639509|1379062|P1|Overall Study|Death|1
411690|NCT00639457|1379070|P2|Overall Study|Withdrawal by Subject|3
411691|NCT00639457|1379071|P1|Overall Study|Withdrawal by Subject|2
411692|NCT00639379|1379130|P2|Period 1 - 2 Weeks|lens issue|0
411693|NCT00639379|1379131|P1|Period 1 - 2 Weeks|lens issue|3
411694|NCT00639379|1379130|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
411695|NCT00639379|1379131|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
411696|NCT00639223|1379147|P2|Overall Study|Lost to Follow-up|2
411697|NCT00639223|1379148|P1|Overall Study|Lost to Follow-up|0
411698|NCT00639002|1379188|P1|Overall Study|Lack of Efficacy|1
411699|NCT00639002|1379188|P1|Overall Study|Physician Decision|6
411700|NCT00639002|1379188|P1|Overall Study|Disease progression|3
411701|NCT00639002|1379188|P1|Overall Study|Protocol Violation|1
411702|NCT00639002|1379188|P1|Overall Study|Adverse Event|1
411703|NCT00639002|1379188|P1|Overall Study|Death|1
411704|NCT00638989|1379197|P3|Overall Study|Lost to Follow-up|1
411705|NCT00638989|1379198|P2|Overall Study|Lost to Follow-up|0
411706|NCT00638989|1379199|P1|Overall Study|Lost to Follow-up|0
411707|NCT00638963|1379239|P2|Overall Study|Withdrawal by Subject|0
411708|NCT00638963|1379240|P1|Overall Study|Withdrawal by Subject|1
411709|NCT00638846|1379281|P2|Overall Study|lens issue|3
411710|NCT00638846|1379282|P1|Overall Study|lens issue|1
411711|NCT00638846|1379281|P2|Overall Study|Lost to Follow-up|2
411712|NCT00638846|1379282|P1|Overall Study|Lost to Follow-up|3
411713|NCT00638846|1379281|P2|Overall Study|Adverse Event|1
411714|NCT00638846|1379282|P1|Overall Study|Adverse Event|0
411715|NCT00638690|1379326|P2|Overall Study|Lost to Follow-up|2
411716|NCT00638690|1379327|P1|Overall Study|Lost to Follow-up|4
411717|NCT00638690|1379326|P2|Overall Study|Withdrawal by Subject|5
411718|NCT00638690|1379327|P1|Overall Study|Withdrawal by Subject|22
411719|NCT00638690|1379326|P2|Overall Study|Death|335
411720|NCT00638690|1379327|P1|Overall Study|Death|655
411721|NCT00638443|1379345|P2|First Intervention|Adverse Event|1
411722|NCT00638443|1379346|P1|First Intervention|Adverse Event|2
411723|NCT00638378|1379374|P1|Overall Study|Physician Decision|4
411724|NCT00638378|1379374|P1|Overall Study|Disease progression|15
411725|NCT00638378|1379374|P1|Overall Study|Adverse Event|1
411726|NCT00638378|1379374|P1|Overall Study|Death|2
411727|NCT00638235|1379403|P9|Overall Study|Lost to Follow-up|18
411728|NCT00638235|1379404|P8|Overall Study|Lost to Follow-up|1
411729|NCT00638235|1379405|P7|Overall Study|Lost to Follow-up|0
411730|NCT00638235|1379406|P6|Overall Study|Lost to Follow-up|26
411731|NCT00638235|1379407|P5|Overall Study|Lost to Follow-up|13
411732|NCT00638235|1379408|P4|Overall Study|Lost to Follow-up|10
411733|NCT00638235|1379409|P3|Overall Study|Lost to Follow-up|18
411734|NCT00638235|1379410|P2|Overall Study|Lost to Follow-up|3
411735|NCT00638235|1379411|P1|Overall Study|Lost to Follow-up|31
411736|NCT00638183|1379821|P1|Overall Study|Other reason not defined above|27
411737|NCT00638183|1379821|P1|Overall Study|Lost to Follow-up|46
411738|NCT00638183|1379821|P1|Overall Study|Physician Decision|9
411739|NCT00638183|1379821|P1|Overall Study|Lack of Efficacy|14
411740|NCT00638183|1379821|P1|Overall Study|Adverse Event|23
411741|NCT00638157|1379830|P2|Overall Study|Randomized, not treated|0
411742|NCT00638157|1379831|P1|Overall Study|Randomized, not treated|2
411743|NCT00638157|1379830|P2|Overall Study|Not Specified|2
411744|NCT00638157|1379831|P1|Overall Study|Not Specified|1
411745|NCT00638157|1379830|P2|Overall Study|Physician Decision|0
411746|NCT00638157|1379831|P1|Overall Study|Physician Decision|1
411747|NCT00638157|1379830|P2|Overall Study|Lost to Follow-up|0
411748|NCT00638157|1379831|P1|Overall Study|Lost to Follow-up|1
411749|NCT00638157|1379830|P2|Overall Study|Microbiological failure|0
411750|NCT00638157|1379831|P1|Overall Study|Microbiological failure|1
411751|NCT00638157|1379830|P2|Overall Study|Clinical (symptomatic) failure|1
411752|NCT00638157|1379831|P1|Overall Study|Clinical (symptomatic) failure|1
411753|NCT00638157|1379830|P2|Overall Study|Adverse Event|1
411754|NCT00638157|1379831|P1|Overall Study|Adverse Event|0
411755|NCT00638027|1379841|P2|Overall Study|Adverse Event|2
411756|NCT00638027|1379842|P1|Overall Study|Adverse Event|0
411757|NCT00637806|1379889|P4|Extension Phase|Study Discontinued|1
411758|NCT00637806|1379890|P3|Extension Phase|Study Discontinued|0
411759|NCT00637806|1379891|P2|Extension Phase|Study Discontinued|0
411760|NCT00637806|1379892|P1|Extension Phase|Study Discontinued|0
411761|NCT00637806|1379889|P4|Double-blind Phase|Study Discontinued|0
411762|NCT00637806|1379890|P3|Double-blind Phase|Study Discontinued|1
411763|NCT00637806|1379891|P2|Double-blind Phase|Study Discontinued|0
411764|NCT00637806|1379892|P1|Double-blind Phase|Study Discontinued|2
411765|NCT00637728|1379927|P3|Double-blind Phase|Study Discontinued|0
411766|NCT00637728|1379928|P2|Double-blind Phase|Study Discontinued|1
411767|NCT00637728|1379929|P1|Double-blind Phase|Study Discontinued|1
411768|NCT00637728|1379927|P3|Double-blind Phase|Non-compliance|0
411769|NCT00637728|1379928|P2|Double-blind Phase|Non-compliance|0
411770|NCT00637728|1379929|P1|Double-blind Phase|Non-compliance|2
411771|NCT00637728|1379927|P3|Double-blind Phase|Adverse Event|0
411772|NCT00637728|1379928|P2|Double-blind Phase|Adverse Event|0
411773|NCT00637728|1379929|P1|Double-blind Phase|Adverse Event|1
411774|NCT00637572|1379944|P2|Overall Study|Illicit Drug Use|0
411775|NCT00637572|1379945|P1|Overall Study|Illicit Drug Use|1
411776|NCT00637572|1379944|P2|Overall Study|Withdrawal by Subject|2
411777|NCT00637572|1379945|P1|Overall Study|Withdrawal by Subject|0
411778|NCT00637572|1379944|P2|Overall Study|Physician Decision|1
411779|NCT00637572|1379945|P1|Overall Study|Physician Decision|1
411780|NCT00637572|1379944|P2|Overall Study|Lost to Follow-up|1
411781|NCT00637572|1379945|P1|Overall Study|Lost to Follow-up|0
411782|NCT00637572|1379944|P2|Overall Study|Death|1
411783|NCT00637572|1379945|P1|Overall Study|Death|0
411784|NCT00637572|1379944|P2|Overall Study|Adverse Event|2
411785|NCT00637572|1379945|P1|Overall Study|Adverse Event|1
411786|NCT00637416|1379984|P2|Overall Study|Unable to take study drug|1
411787|NCT00637416|1379985|P1|Overall Study|Unable to take study drug|0
411788|NCT00637416|1379984|P2|Overall Study|Lost to Follow-up|1
411789|NCT00637416|1379985|P1|Overall Study|Lost to Follow-up|1
411790|NCT00637377|1379995|P4|Overall Study|Other (no further information available)|5
411791|NCT00637377|1379996|P3|Overall Study|Other (no further information available)|10
411792|NCT00637377|1379997|P2|Overall Study|Other (no further information available)|6
411793|NCT00637377|1379998|P1|Overall Study|Other (no further information available)|7
411794|NCT00637377|1379995|P4|Overall Study|Withdrawal by Subject|11
411795|NCT00637377|1379996|P3|Overall Study|Withdrawal by Subject|13
411796|NCT00637377|1379997|P2|Overall Study|Withdrawal by Subject|15
411797|NCT00637377|1379998|P1|Overall Study|Withdrawal by Subject|11
411798|NCT00637377|1379995|P4|Overall Study|Protocol Violation|0
411799|NCT00637377|1379996|P3|Overall Study|Protocol Violation|1
411800|NCT00637377|1379997|P2|Overall Study|Protocol Violation|1
411801|NCT00637377|1379998|P1|Overall Study|Protocol Violation|2
411802|NCT00637377|1379995|P4|Overall Study|Lost to Follow-up|2
411803|NCT00637377|1379996|P3|Overall Study|Lost to Follow-up|2
411804|NCT00637377|1379997|P2|Overall Study|Lost to Follow-up|1
411805|NCT00637377|1379998|P1|Overall Study|Lost to Follow-up|4
411806|NCT00637377|1379995|P4|Overall Study|Lack of Efficacy|1
411807|NCT00637377|1379996|P3|Overall Study|Lack of Efficacy|1
411808|NCT00637377|1379997|P2|Overall Study|Lack of Efficacy|0
411809|NCT00637377|1379998|P1|Overall Study|Lack of Efficacy|0
411810|NCT00637377|1379995|P4|Overall Study|Death|1
411811|NCT00637377|1379996|P3|Overall Study|Death|2
411812|NCT00637377|1379997|P2|Overall Study|Death|3
411813|NCT00637377|1379998|P1|Overall Study|Death|1
411814|NCT00637377|1379995|P4|Overall Study|Adverse Event|9
411815|NCT00637377|1379996|P3|Overall Study|Adverse Event|8
411816|NCT00637377|1379997|P2|Overall Study|Adverse Event|6
411817|NCT00637377|1379998|P1|Overall Study|Adverse Event|2
411818|NCT00637273|1380047|P3|Overall Study|Loss of Glucose Control|1
411819|NCT00637273|1380048|P2|Overall Study|Loss of Glucose Control|1
411820|NCT00637273|1380049|P1|Overall Study|Loss of Glucose Control|1
411821|NCT00637273|1380047|P3|Overall Study|Administrative|0
411822|NCT00637273|1380048|P2|Overall Study|Administrative|0
411823|NCT00637273|1380049|P1|Overall Study|Administrative|2
411824|NCT00637273|1380047|P3|Overall Study|Investigator Decision|1
411825|NCT00637273|1380048|P2|Overall Study|Investigator Decision|3
411826|NCT00637273|1380049|P1|Overall Study|Investigator Decision|1
411827|NCT00637273|1380047|P3|Overall Study|Withdrawal of Consent|18
411828|NCT00637273|1380048|P2|Overall Study|Withdrawal of Consent|6
411829|NCT00637273|1380049|P1|Overall Study|Withdrawal of Consent|18
411830|NCT00637273|1380047|P3|Overall Study|Protocol Violation|1
411831|NCT00637273|1380048|P2|Overall Study|Protocol Violation|4
411832|NCT00637273|1380049|P1|Overall Study|Protocol Violation|2
411833|NCT00637273|1380047|P3|Overall Study|Lost to Follow-up|13
411834|NCT00637273|1380048|P2|Overall Study|Lost to Follow-up|9
411835|NCT00637273|1380049|P1|Overall Study|Lost to Follow-up|8
411836|NCT00637273|1380047|P3|Overall Study|Adverse Event|7
411837|NCT00637273|1380048|P2|Overall Study|Adverse Event|5
411838|NCT00637273|1380049|P1|Overall Study|Adverse Event|11
411839|NCT00637195|1380105|P2|Overall Study|Withdrawal by Subject|1
411840|NCT00637195|1380106|P1|Overall Study|Withdrawal by Subject|0
411841|NCT00637195|1380105|P2|Overall Study|Other|0
411842|NCT00637195|1380106|P1|Overall Study|Other|2
411843|NCT00637195|1380105|P2|Overall Study|Lost to Follow-up|0
411844|NCT00637195|1380106|P1|Overall Study|Lost to Follow-up|1
411845|NCT00637156|1380142|P2|Overall Study|Lost to Follow-up|16
411846|NCT00637156|1380143|P1|Overall Study|Lost to Follow-up|10
411847|NCT00637156|1380142|P2|Overall Study|Death|1
411848|NCT00637156|1380143|P1|Overall Study|Death|0
411849|NCT00637156|1380142|P2|Overall Study|Withdrawal by Subject|7
411850|NCT00637156|1380143|P1|Overall Study|Withdrawal by Subject|0
411851|NCT00637000|1380185|P2|Overall Study|Withdrawal by Subject|3
411852|NCT00637000|1380186|P1|Overall Study|Withdrawal by Subject|4
411853|NCT00636987|1380226|P1|Overall Study|5 year visit window not complete|69
411854|NCT00636987|1380226|P1|Overall Study|Lost to Follow-up|63
411855|NCT00636987|1380226|P1|Overall Study|Explanted|13
411856|NCT00636987|1380226|P1|Overall Study|Death|44
411857|NCT00636961|1380236|P2|Period 2|Adverse Event|0
411858|NCT00636961|1380237|P1|Period 2|Adverse Event|1
411859|NCT00636961|1380236|P2|Period 1|Administrative problems|1
411860|NCT00636961|1380237|P1|Period 1|Administrative problems|1
411861|NCT00636818|1380251|P1|Overall Study|Withdrawal by Subject|4
411862|NCT00636818|1380251|P1|Overall Study|Protocol Violation|1
411863|NCT00636818|1380251|P1|Overall Study|Entry Criteria Exclusion|3
411864|NCT00636818|1380251|P1|Overall Study|Lost to Follow-up|2
411865|NCT00636818|1380251|P1|Overall Study|Adverse Event|1
411866|NCT00636792|1380276|P1|Overall Study|Other|3
411867|NCT00636792|1380276|P1|Overall Study|Withdrawal by Subject|3
411868|NCT00636792|1380276|P1|Overall Study|Progressive Disease|4
411869|NCT00636792|1380276|P1|Overall Study|Physician Decision|7
411870|NCT00636792|1380276|P1|Overall Study|Adverse Event|16
411871|NCT00636636|1380323|P2|Overall Study|Withdrawal by Subject|9
411872|NCT00636636|1380324|P1|Overall Study|Withdrawal by Subject|4
411873|NCT00636636|1380323|P2|Overall Study|Death|1
411874|NCT00636636|1380324|P1|Overall Study|Death|0
411875|NCT00636636|1380323|P2|Overall Study|Lost to Follow-up|1
411876|NCT00636636|1380324|P1|Overall Study|Lost to Follow-up|0
411877|NCT00636636|1380323|P2|Overall Study|Protocol Violation|2
411878|NCT00636636|1380324|P1|Overall Study|Protocol Violation|2
411879|NCT00636636|1380323|P2|Overall Study|Lack of Efficacy|12
411880|NCT00636636|1380324|P1|Overall Study|Lack of Efficacy|7
411881|NCT00636636|1380323|P2|Overall Study|Adverse Event|8
411882|NCT00636636|1380324|P1|Overall Study|Adverse Event|19
411883|NCT00636636|1380323|P2|Overall Study|Other reason|6
411884|NCT00636636|1380324|P1|Overall Study|Other reason|4
411885|NCT00636610|1380340|P2|Overall Study|Reason for discontinuation not available|2
411886|NCT00636610|1380341|P1|Overall Study|Reason for discontinuation not available|3
411887|NCT00636610|1380340|P2|Overall Study|Disease progression - clinical|3
411888|NCT00636610|1380341|P1|Overall Study|Disease progression - clinical|8
411889|NCT00636610|1380340|P2|Overall Study|Disease progression - radiographic|51
411890|NCT00636610|1380341|P1|Overall Study|Disease progression - radiographic|41
411891|NCT00636610|1380340|P2|Overall Study|Subject decision to withdraw|11
411892|NCT00636610|1380341|P1|Overall Study|Subject decision to withdraw|15
411893|NCT00636610|1380340|P2|Overall Study|Physician decision to withdraw patient|9
411894|NCT00636610|1380341|P1|Overall Study|Physician decision to withdraw patient|15
411895|NCT00636610|1380340|P2|Overall Study|Death|3
411896|NCT00636610|1380341|P1|Overall Study|Death|6
411897|NCT00636610|1380340|P2|Overall Study|Adverse Event|4
411898|NCT00636610|1380341|P1|Overall Study|Adverse Event|4
411899|NCT00636441|1380358|P7|Overall Study|Screen Failure|17
411900|NCT00636441|1380359|P6|Overall Study|Screen Failure|0
411901|NCT00636441|1380360|P5|Overall Study|Screen Failure|0
411902|NCT00636441|1380361|P4|Overall Study|Screen Failure|0
411903|NCT00636441|1380362|P3|Overall Study|Screen Failure|0
411904|NCT00636441|1380363|P2|Overall Study|Screen Failure|0
411905|NCT00636441|1380364|P1|Overall Study|Screen Failure|0
411906|NCT00636441|1380358|P7|Overall Study|Late, ineligible|1
411907|NCT00636441|1380359|P6|Overall Study|Late, ineligible|0
411908|NCT00636441|1380360|P5|Overall Study|Late, ineligible|0
411909|NCT00636441|1380361|P4|Overall Study|Late, ineligible|0
411910|NCT00636441|1380362|P3|Overall Study|Late, ineligible|0
411911|NCT00636441|1380363|P2|Overall Study|Late, ineligible|0
411912|NCT00636441|1380364|P1|Overall Study|Late, ineligible|0
411913|NCT00636441|1380358|P7|Overall Study|Adverse Event|0
411914|NCT00636441|1380359|P6|Overall Study|Adverse Event|1
411915|NCT00636441|1380360|P5|Overall Study|Adverse Event|0
411916|NCT00636441|1380361|P4|Overall Study|Adverse Event|0
411917|NCT00636441|1380362|P3|Overall Study|Adverse Event|1
411918|NCT00636441|1380363|P2|Overall Study|Adverse Event|1
411919|NCT00636441|1380364|P1|Overall Study|Adverse Event|0
411920|NCT00636363|1380407|P3|Overall Study|Withdrawal by Subject|2
411921|NCT00636363|1380408|P2|Overall Study|Withdrawal by Subject|3
411922|NCT00636363|1380409|P1|Overall Study|Withdrawal by Subject|1
411923|NCT00636363|1380407|P3|Overall Study|Lost to Follow-up|2
411924|NCT00636363|1380408|P2|Overall Study|Lost to Follow-up|4
411925|NCT00636363|1380409|P1|Overall Study|Lost to Follow-up|3
411926|NCT00636363|1380407|P3|Overall Study|Protocol Violation|0
411927|NCT00636363|1380408|P2|Overall Study|Protocol Violation|3
411928|NCT00636363|1380409|P1|Overall Study|Protocol Violation|0
411929|NCT00636363|1380407|P3|Overall Study|Lack of motivation|1
411930|NCT00636363|1380408|P2|Overall Study|Lack of motivation|0
411931|NCT00636363|1380409|P1|Overall Study|Lack of motivation|1
411932|NCT00636363|1380407|P3|Overall Study|Missed > 1 visit|3
411933|NCT00636363|1380408|P2|Overall Study|Missed > 1 visit|1
411934|NCT00636363|1380409|P1|Overall Study|Missed > 1 visit|0
411935|NCT00636363|1380407|P3|Overall Study|Met ineligibility criteria|3
411936|NCT00636363|1380408|P2|Overall Study|Met ineligibility criteria|0
411937|NCT00636363|1380409|P1|Overall Study|Met ineligibility criteria|0
411938|NCT00636363|1380407|P3|Overall Study|Study related symptoms/complaints|4
411939|NCT00636363|1380408|P2|Overall Study|Study related symptoms/complaints|7
411940|NCT00636363|1380409|P1|Overall Study|Study related symptoms/complaints|8
411941|NCT00636363|1380407|P3|Overall Study|Positive slit lamp finding|1
411942|NCT00636363|1380408|P2|Overall Study|Positive slit lamp finding|2
411943|NCT00636363|1380409|P1|Overall Study|Positive slit lamp finding|0
411944|NCT00636363|1380407|P3|Overall Study|Adverse Event|1
411945|NCT00636363|1380408|P2|Overall Study|Adverse Event|0
411946|NCT00636363|1380409|P1|Overall Study|Adverse Event|0
411947|NCT00636363|1380407|P3|Overall Study|Conjunctivitis|1
411948|NCT00636363|1380408|P2|Overall Study|Conjunctivitis|0
411949|NCT00636363|1380409|P1|Overall Study|Conjunctivitis|0
411950|NCT00636207|1380430|P7|Overall Study|Withdrawal by Subject|0
411951|NCT00636207|1380431|P6|Overall Study|Withdrawal by Subject|0
411952|NCT00636207|1380432|P5|Overall Study|Withdrawal by Subject|1
411953|NCT00636207|1380433|P4|Overall Study|Withdrawal by Subject|0
411954|NCT00636207|1380434|P3|Overall Study|Withdrawal by Subject|0
411955|NCT00636207|1380435|P2|Overall Study|Withdrawal by Subject|1
411956|NCT00636207|1380436|P1|Overall Study|Withdrawal by Subject|0
411957|NCT00636207|1380430|P7|Overall Study|Adverse Event|0
411958|NCT00636207|1380431|P6|Overall Study|Adverse Event|0
411959|NCT00636207|1380432|P5|Overall Study|Adverse Event|0
411960|NCT00636207|1380433|P4|Overall Study|Adverse Event|0
411961|NCT00636207|1380434|P3|Overall Study|Adverse Event|0
411962|NCT00636207|1380435|P2|Overall Study|Adverse Event|0
411963|NCT00636207|1380436|P1|Overall Study|Adverse Event|1
411964|NCT00636194|1380500|P2|Overall Study|Protocol Violation|0
411965|NCT00636194|1380501|P1|Overall Study|Protocol Violation|2
411966|NCT00636194|1380500|P2|Overall Study|Study related symptoms and complaints|0
411967|NCT00636194|1380501|P1|Overall Study|Study related symptoms and complaints|1
411968|NCT00636168|1380513|P2|Treated With Study Drug|Still remains on treatment|94
411969|NCT00636168|1380514|P1|Treated With Study Drug|Still remains on treatment|48
411970|NCT00636168|1380513|P2|Treated With Study Drug|non-specified|1
411971|NCT00636168|1380514|P1|Treated With Study Drug|non-specified|1
411972|NCT00636168|1380513|P2|Treated With Study Drug|No longer meets criteria|0
411973|NCT00636168|1380514|P1|Treated With Study Drug|No longer meets criteria|1
411974|NCT00636168|1380513|P2|Treated With Study Drug|Pregnancy|0
411975|NCT00636168|1380514|P1|Treated With Study Drug|Pregnancy|1
411976|NCT00636168|1380513|P2|Treated With Study Drug|Death|0
411977|NCT00636168|1380514|P1|Treated With Study Drug|Death|3
411978|NCT00636168|1380513|P2|Treated With Study Drug|Poor or non-compliance|3
411979|NCT00636168|1380514|P1|Treated With Study Drug|Poor or non-compliance|1
411980|NCT00636168|1380513|P2|Treated With Study Drug|Withdrawal by Subject|20
411981|NCT00636168|1380514|P1|Treated With Study Drug|Withdrawal by Subject|16
411982|NCT00636168|1380513|P2|Treated With Study Drug|Adverse Event|20
411983|NCT00636168|1380514|P1|Treated With Study Drug|Adverse Event|244
411984|NCT00636168|1380513|P2|Treated With Study Drug|Recurrence of disease|273
411985|NCT00636168|1380514|P1|Treated With Study Drug|Recurrence of disease|132
411986|NCT00636168|1380513|P2|Randomized to Study Drug|No longer met study criteria|0
411987|NCT00636168|1380514|P1|Randomized to Study Drug|No longer met study criteria|1
411988|NCT00636168|1380513|P2|Randomized to Study Drug|Adverse Event|0
411989|NCT00636168|1380514|P1|Randomized to Study Drug|Adverse Event|1
411990|NCT00636168|1380513|P2|Randomized to Study Drug|Withdrawal by Subject|2
411991|NCT00636168|1380514|P1|Randomized to Study Drug|Withdrawal by Subject|2
411992|NCT00636155|1380534|P1|Overall Study|Physician Decision|5
411993|NCT00636155|1380534|P1|Overall Study|Stem cell transplant|1
411994|NCT00636155|1380534|P1|Overall Study|Withdrawal by Subject|3
411995|NCT00636155|1380534|P1|Overall Study|Lack of Efficacy|1
411996|NCT00636155|1380534|P1|Overall Study|Adverse Event|8
411997|NCT00635999|1380576|P3|Overall Study|Withdrawal by Subject|1
411998|NCT00635999|1380577|P2|Overall Study|Withdrawal by Subject|2
411999|NCT00635999|1380578|P1|Overall Study|Withdrawal by Subject|4
412000|NCT00635882|1380595|P6|Overall Study|Protocol Violation|0
412001|NCT00635882|1380596|P5|Overall Study|Protocol Violation|0
412002|NCT00635882|1380597|P4|Overall Study|Protocol Violation|0
412003|NCT00635882|1380598|P3|Overall Study|Protocol Violation|0
412004|NCT00635882|1380599|P2|Overall Study|Protocol Violation|0
412005|NCT00635882|1380600|P1|Overall Study|Protocol Violation|1
412006|NCT00635804|1380730|P8|Overall Study|Withdrawal by Subject|0
412007|NCT00635804|1380731|P7|Overall Study|Withdrawal by Subject|0
412008|NCT00635804|1380732|P6|Overall Study|Withdrawal by Subject|0
412009|NCT00635804|1380733|P5|Overall Study|Withdrawal by Subject|0
412010|NCT00635804|1380734|P4|Overall Study|Withdrawal by Subject|0
412011|NCT00635804|1380735|P3|Overall Study|Withdrawal by Subject|0
412012|NCT00635804|1380736|P2|Overall Study|Withdrawal by Subject|0
412013|NCT00635804|1380737|P1|Overall Study|Withdrawal by Subject|1
412014|NCT00635804|1380730|P8|Overall Study|Adverse Event|0
412015|NCT00635804|1380731|P7|Overall Study|Adverse Event|0
412016|NCT00635804|1380732|P6|Overall Study|Adverse Event|1
412017|NCT00635804|1380733|P5|Overall Study|Adverse Event|0
412018|NCT00635804|1380734|P4|Overall Study|Adverse Event|0
412019|NCT00635804|1380735|P3|Overall Study|Adverse Event|0
412020|NCT00635804|1380736|P2|Overall Study|Adverse Event|0
412021|NCT00635804|1380737|P1|Overall Study|Adverse Event|0
412022|NCT00635661|1380843|P1|Overall Study|Withdrawal by Subject|4
412023|NCT00635648|1380847|P1|Overall Study|Other reason|2
412024|NCT00635648|1380847|P1|Overall Study|Noncompliance with protocol|1
412025|NCT00635648|1380847|P1|Overall Study|No improvement after 7-10 days treatment|4
412026|NCT00635648|1380847|P1|Overall Study|Use of other antifungal agent needed|1
412027|NCT00635648|1380847|P1|Overall Study|Rapid progression of baseline disease|4
412028|NCT00635648|1380847|P1|Overall Study|Physician Decision|4
412029|NCT00635648|1380847|P1|Overall Study|Withdrawal by Subject|9
412030|NCT00635648|1380847|P1|Overall Study|Adverse Event|12
412031|NCT00635570|1380869|P2|Overall Study|Early termination(No sexual activity)|1
412032|NCT00635570|1380870|P1|Overall Study|Early termination(No sexual activity)|1
412033|NCT00635570|1380869|P2|Overall Study|Did not complete survey|1
412034|NCT00635570|1380870|P1|Overall Study|Did not complete survey|2
412035|NCT00635570|1380869|P2|Overall Study|Physician Decision|0
412036|NCT00635570|1380870|P1|Overall Study|Physician Decision|1
412037|NCT00635570|1380869|P2|Overall Study|Adverse Event|0
412038|NCT00635570|1380870|P1|Overall Study|Adverse Event|2
412039|NCT00635570|1380869|P2|Overall Study|Withdrawal by Subject|1
412040|NCT00635570|1380870|P1|Overall Study|Withdrawal by Subject|1
412041|NCT00635570|1380869|P2|Overall Study|Lost to Follow-up|8
412042|NCT00635570|1380870|P1|Overall Study|Lost to Follow-up|8
412043|NCT00635492|1380884|P2|Overall Study|Withdrawal by Subject|45
412044|NCT00635492|1380885|P1|Overall Study|Withdrawal by Subject|82
412045|NCT00635492|1380884|P2|Overall Study|Sponsor decision|3
412046|NCT00635492|1380885|P1|Overall Study|Sponsor decision|2
412047|NCT00635492|1380884|P2|Overall Study|Physician Decision|22
412048|NCT00635492|1380885|P1|Overall Study|Physician Decision|32
412049|NCT00635492|1380884|P2|Overall Study|Lost to Follow-up|172
412050|NCT00635492|1380885|P1|Overall Study|Lost to Follow-up|151
412051|NCT00635492|1380884|P2|Overall Study|Death|40
412052|NCT00635492|1380885|P1|Overall Study|Death|12
412053|NCT00635427|1380943|P5|Overall Study|Withdrawal Of Consent|2
412054|NCT00635427|1380944|P4|Overall Study|Withdrawal Of Consent|2
412055|NCT00635427|1380945|P3|Overall Study|Withdrawal Of Consent|0
412056|NCT00635427|1380946|P2|Overall Study|Withdrawal Of Consent|0
412057|NCT00635427|1380947|P1|Overall Study|Withdrawal Of Consent|0
412058|NCT00635427|1380943|P5|Overall Study|Termination Of Study By Sponsor|6
412059|NCT00635427|1380944|P4|Overall Study|Termination Of Study By Sponsor|6
412060|NCT00635427|1380945|P3|Overall Study|Termination Of Study By Sponsor|10
412061|NCT00635427|1380946|P2|Overall Study|Termination Of Study By Sponsor|6
412062|NCT00635427|1380947|P1|Overall Study|Termination Of Study By Sponsor|12
412063|NCT00635427|1380943|P5|Overall Study|Death|0
412064|NCT00635427|1380944|P4|Overall Study|Death|1
412065|NCT00635427|1380945|P3|Overall Study|Death|0
412066|NCT00635427|1380946|P2|Overall Study|Death|0
412067|NCT00635427|1380947|P1|Overall Study|Death|0
412068|NCT00635427|1380943|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
412069|NCT00635427|1380944|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
412070|NCT00635427|1380945|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
412071|NCT00635427|1380946|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
412072|NCT00635427|1380947|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
412073|NCT00635349|1380986|P2|Overall Study|Adverse Event|9
412074|NCT00635349|1380987|P1|Overall Study|Adverse Event|11
412075|NCT00635349|1380986|P2|Overall Study|Lost to Follow-up|3
412076|NCT00635349|1380987|P1|Overall Study|Lost to Follow-up|4
412077|NCT00635349|1380986|P2|Overall Study|Withdrawal by Subject|8
412078|NCT00635349|1380987|P1|Overall Study|Withdrawal by Subject|3
412079|NCT00635349|1380986|P2|Overall Study|Protocol Violation|22
412080|NCT00635349|1380987|P1|Overall Study|Protocol Violation|18
412081|NCT00635349|1380986|P2|Overall Study|Other|6
412082|NCT00635349|1380987|P1|Overall Study|Other|8
412083|NCT00635219|1381041|P5|Overall Study|Administrative or Other Reasons|1
412084|NCT00635219|1381042|P4|Overall Study|Administrative or Other Reasons|0
412085|NCT00635219|1381043|P3|Overall Study|Administrative or Other Reasons|1
412086|NCT00635219|1381044|P2|Overall Study|Administrative or Other Reasons|1
412087|NCT00635219|1381045|P1|Overall Study|Administrative or Other Reasons|0
412088|NCT00635219|1381041|P5|Overall Study|Lost to Follow-up|3
412089|NCT00635219|1381042|P4|Overall Study|Lost to Follow-up|0
412090|NCT00635219|1381043|P3|Overall Study|Lost to Follow-up|2
412091|NCT00635219|1381044|P2|Overall Study|Lost to Follow-up|0
412092|NCT00635219|1381045|P1|Overall Study|Lost to Follow-up|0
412093|NCT00635219|1381041|P5|Overall Study|Withdrawal of Consent|8
412094|NCT00635219|1381042|P4|Overall Study|Withdrawal of Consent|11
412095|NCT00635219|1381043|P3|Overall Study|Withdrawal of Consent|8
412096|NCT00635219|1381044|P2|Overall Study|Withdrawal of Consent|6
412097|NCT00635219|1381045|P1|Overall Study|Withdrawal of Consent|8
412098|NCT00635219|1381041|P5|Overall Study|Protocol Violation|4
412099|NCT00635219|1381042|P4|Overall Study|Protocol Violation|2
412100|NCT00635219|1381043|P3|Overall Study|Protocol Violation|3
412101|NCT00635219|1381044|P2|Overall Study|Protocol Violation|2
412102|NCT00635219|1381045|P1|Overall Study|Protocol Violation|0
412103|NCT00635219|1381041|P5|Overall Study|Non-compliance With Study Product|1
412104|NCT00635219|1381042|P4|Overall Study|Non-compliance With Study Product|2
412105|NCT00635219|1381043|P3|Overall Study|Non-compliance With Study Product|0
412106|NCT00635219|1381044|P2|Overall Study|Non-compliance With Study Product|0
412107|NCT00635219|1381045|P1|Overall Study|Non-compliance With Study Product|0
412108|NCT00635219|1381041|P5|Overall Study|Lack of Efficacy|6
412109|NCT00635219|1381042|P4|Overall Study|Lack of Efficacy|4
412110|NCT00635219|1381043|P3|Overall Study|Lack of Efficacy|3
412111|NCT00635219|1381044|P2|Overall Study|Lack of Efficacy|6
412112|NCT00635219|1381045|P1|Overall Study|Lack of Efficacy|5
412113|NCT00635219|1381041|P5|Overall Study|Adverse Event|19
412114|NCT00635219|1381042|P4|Overall Study|Adverse Event|15
412115|NCT00635219|1381043|P3|Overall Study|Adverse Event|18
412116|NCT00635219|1381044|P2|Overall Study|Adverse Event|10
412117|NCT00635219|1381045|P1|Overall Study|Adverse Event|12
412118|NCT00635154|1381102|P1|Overall Study|Still on treatment|21
412119|NCT00635154|1381102|P1|Overall Study|Other|4
412120|NCT00635154|1381102|P1|Overall Study|Alternative Treatment|8
412121|NCT00635102|1381145|P2|Overall Study|Withdrawal by Subject|8
412122|NCT00635102|1381146|P1|Overall Study|Withdrawal by Subject|7
412123|NCT00635089|1381240|P1|Overall Study|Not Specified|31
412124|NCT00635089|1381240|P1|Overall Study|Lost to Follow-up|8
412125|NCT00635089|1381240|P1|Overall Study|Protocol Deviation|4
412126|NCT00635089|1381240|P1|Overall Study|Lack of Efficacy|28
412127|NCT00635089|1381240|P1|Overall Study|Adverse Event|7
412128|NCT00635050|1381267|P1|Overall Study|Withdrawal by Subject|1
412129|NCT00635024|1381274|P1|Overall Study|Adverse Event|1
412130|NCT00634933|1381285|P5|Part B: Week 24 to Week 52|Other|1
412131|NCT00634933|1381286|P4|Part B: Week 24 to Week 52|Other|0
412132|NCT00634933|1381287|P3|Part B: Week 24 to Week 52|Other|5
412133|NCT00634933|1381288|P2|Part B: Week 24 to Week 52|Other|0
412134|NCT00634933|1381289|P1|Part B: Week 24 to Week 52|Other|0
412135|NCT00634933|1381285|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
412136|NCT00634933|1381286|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
412137|NCT00634933|1381287|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
412138|NCT00634933|1381288|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
412139|NCT00634933|1381289|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
412140|NCT00634933|1381285|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
412141|NCT00634933|1381286|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
412142|NCT00634933|1381287|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
412143|NCT00634933|1381288|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
412144|NCT00634933|1381289|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
412145|NCT00634933|1381285|P5|Part B: Week 24 to Week 52|Protocol Violation|1
412146|NCT00634933|1381286|P4|Part B: Week 24 to Week 52|Protocol Violation|0
412147|NCT00634933|1381287|P3|Part B: Week 24 to Week 52|Protocol Violation|0
412148|NCT00634933|1381288|P2|Part B: Week 24 to Week 52|Protocol Violation|0
412149|NCT00634933|1381289|P1|Part B: Week 24 to Week 52|Protocol Violation|0
412150|NCT00634933|1381285|P5|Part B: Week 24 to Week 52|Physician Decision|0
412151|NCT00634933|1381286|P4|Part B: Week 24 to Week 52|Physician Decision|0
412152|NCT00634933|1381287|P3|Part B: Week 24 to Week 52|Physician Decision|1
412153|NCT00634933|1381288|P2|Part B: Week 24 to Week 52|Physician Decision|1
412154|NCT00634933|1381289|P1|Part B: Week 24 to Week 52|Physician Decision|0
412155|NCT00634933|1381285|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
412156|NCT00634933|1381286|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
412157|NCT00634933|1381287|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
412158|NCT00634933|1381288|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
412159|NCT00634933|1381289|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
412160|NCT00634933|1381285|P5|Part B: Week 24 to Week 52|Adverse Event|0
412161|NCT00634933|1381286|P4|Part B: Week 24 to Week 52|Adverse Event|1
412162|NCT00634933|1381287|P3|Part B: Week 24 to Week 52|Adverse Event|1
412163|NCT00634933|1381288|P2|Part B: Week 24 to Week 52|Adverse Event|1
412164|NCT00634933|1381289|P1|Part B: Week 24 to Week 52|Adverse Event|0
412165|NCT00634933|1381285|P5|Between Part A and Part B|Physician Decision|0
412166|NCT00634933|1381286|P4|Between Part A and Part B|Physician Decision|0
412167|NCT00634933|1381287|P3|Between Part A and Part B|Physician Decision|0
412168|NCT00634933|1381288|P2|Between Part A and Part B|Physician Decision|1
412169|NCT00634933|1381289|P1|Between Part A and Part B|Physician Decision|0
412170|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Other|0
412171|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Other|0
412172|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Other|5
412173|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Other|8
412174|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Other|1
412175|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
412176|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
412177|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
412178|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
412179|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
412180|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
412181|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
412182|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
412183|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
412184|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
412185|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
412186|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
412187|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
412188|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
412189|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
412190|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Investigator Request|0
412191|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Investigator Request|0
412192|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Investigator Request|1
412193|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Investigator Request|1
412194|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Investigator Request|1
412195|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Failed to Return|0
412196|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Failed to Return|0
412197|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Failed to Return|0
412198|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Failed to Return|0
412199|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Failed to Return|1
412200|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Death|0
412201|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Death|0
412202|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Death|0
412203|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Death|0
412204|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Death|1
412205|NCT00634933|1381285|P5|Part A: Baseline to Week 24|Adverse Event|0
412206|NCT00634933|1381286|P4|Part A: Baseline to Week 24|Adverse Event|0
412207|NCT00634933|1381287|P3|Part A: Baseline to Week 24|Adverse Event|8
412208|NCT00634933|1381288|P2|Part A: Baseline to Week 24|Adverse Event|4
412209|NCT00634933|1381289|P1|Part A: Baseline to Week 24|Adverse Event|4
412210|NCT00634920|1381358|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
412211|NCT00634920|1381359|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
412212|NCT00634920|1381360|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
412213|NCT00634920|1381358|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
412214|NCT00634920|1381359|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
412215|NCT00634920|1381360|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
412216|NCT00634920|1381358|P3|Period 2 - Post-Randomization|Death|0
412217|NCT00634920|1381359|P2|Period 2 - Post-Randomization|Death|5
412218|NCT00634920|1381360|P1|Period 2 - Post-Randomization|Death|2
412219|NCT00634920|1381358|P3|Period 2 - Post-Randomization|Rejection|0
412220|NCT00634920|1381359|P2|Period 2 - Post-Randomization|Rejection|5
412221|NCT00634920|1381360|P1|Period 2 - Post-Randomization|Rejection|11
412222|NCT00634920|1381358|P3|Period 2 - Post-Randomization|Adverse Event|0
412223|NCT00634920|1381359|P2|Period 2 - Post-Randomization|Adverse Event|9
412224|NCT00634920|1381360|P1|Period 2 - Post-Randomization|Adverse Event|37
412225|NCT00634920|1381358|P3|Period 1 - Pre-Randomization|Other issues|6
412226|NCT00634920|1381359|P2|Period 1 - Pre-Randomization|Other issues|0
412227|NCT00634920|1381360|P1|Period 1 - Pre-Randomization|Other issues|0
412228|NCT00634920|1381358|P3|Period 1 - Pre-Randomization|Non-Compliance|3
412229|NCT00634920|1381359|P2|Period 1 - Pre-Randomization|Non-Compliance|0
412230|NCT00634920|1381360|P1|Period 1 - Pre-Randomization|Non-Compliance|0
412231|NCT00634920|1381358|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
412232|NCT00634920|1381359|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
412233|NCT00634920|1381360|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
412234|NCT00634920|1381358|P3|Period 1 - Pre-Randomization|Rejections|55
412235|NCT00634920|1381359|P2|Period 1 - Pre-Randomization|Rejections|0
412236|NCT00634920|1381360|P1|Period 1 - Pre-Randomization|Rejections|0
412237|NCT00634920|1381358|P3|Period 1 - Pre-Randomization|Wound healing problems|16
412238|NCT00634920|1381359|P2|Period 1 - Pre-Randomization|Wound healing problems|0
412239|NCT00634920|1381360|P1|Period 1 - Pre-Randomization|Wound healing problems|0
412240|NCT00634920|1381358|P3|Period 1 - Pre-Randomization|Adverse Event|36
412241|NCT00634920|1381359|P2|Period 1 - Pre-Randomization|Adverse Event|0
412242|NCT00634920|1381360|P1|Period 1 - Pre-Randomization|Adverse Event|0
412243|NCT00634907|1381404|P2|Overall Study|Withdrawal by Subject|8
412244|NCT00634907|1381405|P1|Overall Study|Withdrawal by Subject|11
412245|NCT00634907|1381404|P2|Overall Study|Physician Decision|9
412246|NCT00634907|1381405|P1|Overall Study|Physician Decision|3
412247|NCT00634907|1381404|P2|Overall Study|Withdrawal by Subject|0
412248|NCT00634907|1381405|P1|Overall Study|Withdrawal by Subject|3
412249|NCT00634842|1381429|P2|Overall Study|Subject off study drug for too long|1
412250|NCT00634842|1381430|P1|Overall Study|Subject off study drug for too long|0
412251|NCT00634842|1381429|P2|Overall Study|No wish to keep taking Avandia|1
412252|NCT00634842|1381430|P1|Overall Study|No wish to keep taking Avandia|0
412253|NCT00634842|1381429|P2|Overall Study|No need of study drug to treat diabetes|1
412254|NCT00634842|1381430|P1|Overall Study|No need of study drug to treat diabetes|0
412255|NCT00634842|1381429|P2|Overall Study|Discontinued due to injection|2
412256|NCT00634842|1381430|P1|Overall Study|Discontinued due to injection|0
412257|NCT00634842|1381429|P2|Overall Study|Lack of time and intolerance to drug|1
412258|NCT00634842|1381430|P1|Overall Study|Lack of time and intolerance to drug|0
412259|NCT00634842|1381429|P2|Overall Study|Withdrawal by Subject|3
412260|NCT00634842|1381430|P1|Overall Study|Withdrawal by Subject|1
412261|NCT00634842|1381429|P2|Overall Study|Physician Decision|0
412262|NCT00634842|1381430|P1|Overall Study|Physician Decision|1
412263|NCT00634842|1381429|P2|Overall Study|Lost to Follow-up|2
412264|NCT00634842|1381430|P1|Overall Study|Lost to Follow-up|1
412265|NCT00634842|1381429|P2|Overall Study|Inclusion criteria were not met|0
412266|NCT00634842|1381430|P1|Overall Study|Inclusion criteria were not met|1
412267|NCT00634842|1381429|P2|Overall Study|Move to another state|0
412268|NCT00634842|1381430|P1|Overall Study|Move to another state|1
412269|NCT00634842|1381429|P2|Overall Study|Protocol Violation|4
412270|NCT00634842|1381430|P1|Overall Study|Protocol Violation|8
412271|NCT00634842|1381429|P2|Overall Study|Adverse Event|3
412272|NCT00634842|1381430|P1|Overall Study|Adverse Event|2
412273|NCT00634751|1381446|P4|Pancreatic and Bilial Tract Cancer|Death|1
412274|NCT00634751|1381447|P3|Pancreatic and Bilial Tract Cancer|Death|1
412275|NCT00634751|1381448|P2|Pancreatic and Bilial Tract Cancer|Death|0
412276|NCT00634751|1381449|P1|Pancreatic and Bilial Tract Cancer|Death|0
412277|NCT00634751|1381446|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
412278|NCT00634751|1381447|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
412279|NCT00634751|1381448|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
412280|NCT00634751|1381449|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
412281|NCT00634751|1381446|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
412282|NCT00634751|1381447|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
412283|NCT00634751|1381448|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
412284|NCT00634751|1381449|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
412285|NCT00634647|1381467|P1|Overall Study|declined to participate before treatment|1
412286|NCT00634647|1381467|P1|Overall Study|refused further treatment|3
412287|NCT00634647|1381467|P1|Overall Study|death on study|5
412288|NCT00634569|1381486|P2|Overall Study|Physician Decision|1
412289|NCT00634569|1381487|P1|Overall Study|Physician Decision|0
412290|NCT00634569|1381486|P2|Overall Study|Withdrawal by Subject|4
412291|NCT00634569|1381487|P1|Overall Study|Withdrawal by Subject|0
412292|NCT00634543|1381501|P2|Overall Study|Lost to Follow-up|1
412293|NCT00634543|1381502|P1|Overall Study|Lost to Follow-up|0
412294|NCT00634543|1381501|P2|Overall Study|Withdrawal by Subject|4
412295|NCT00634543|1381502|P1|Overall Study|Withdrawal by Subject|4
412296|NCT00634543|1381501|P2|Overall Study|Adverse Event|11
412297|NCT00634543|1381502|P1|Overall Study|Adverse Event|11
412298|NCT00634543|1381501|P2|Overall Study|Protocol Violation|3
412299|NCT00634543|1381502|P1|Overall Study|Protocol Violation|3
412300|NCT00634543|1381501|P2|Overall Study|Other|2
412301|NCT00634543|1381502|P1|Overall Study|Other|1
412302|NCT00634504|1381520|P2|Overall Study|Protocol Violation|0
412303|NCT00634504|1381521|P1|Overall Study|Protocol Violation|1
412304|NCT00634244|1381572|P3|Overall Study|Other complicating disease|0
412305|NCT00634244|1381573|P2|Overall Study|Other complicating disease|1
412306|NCT00634244|1381574|P1|Overall Study|Other complicating disease|0
412307|NCT00634244|1381572|P3|Overall Study|Disease progression/relapse|0
412308|NCT00634244|1381573|P2|Overall Study|Disease progression/relapse|1
412309|NCT00634244|1381574|P1|Overall Study|Disease progression/relapse|0
412310|NCT00634244|1381572|P3|Overall Study|Physician Decision|0
412311|NCT00634244|1381573|P2|Overall Study|Physician Decision|1
412312|NCT00634244|1381574|P1|Overall Study|Physician Decision|0
412313|NCT00634244|1381572|P3|Overall Study|Withdrawal by Subject|0
412314|NCT00634244|1381573|P2|Overall Study|Withdrawal by Subject|1
412315|NCT00634244|1381574|P1|Overall Study|Withdrawal by Subject|0
412316|NCT00634244|1381572|P3|Overall Study|Adverse Event|0
412317|NCT00634244|1381573|P2|Overall Study|Adverse Event|2
412318|NCT00634244|1381574|P1|Overall Study|Adverse Event|0
412319|NCT00634244|1381572|P3|Overall Study|Death|0
412320|NCT00634244|1381573|P2|Overall Study|Death|6
412321|NCT00634244|1381574|P1|Overall Study|Death|1
412322|NCT00634244|1381572|P3|Overall Study|Never started treatment|0
412323|NCT00634244|1381573|P2|Overall Study|Never started treatment|1
412324|NCT00634244|1381574|P1|Overall Study|Never started treatment|0
412325|NCT00634179|1381585|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
412326|NCT00634114|1381604|P3|Overall Study|Other reason|1
412327|NCT00634114|1381605|P2|Overall Study|Other reason|1
412328|NCT00634114|1381606|P1|Overall Study|Other reason|1
412329|NCT00634114|1381604|P3|Overall Study|Difficult to continue|1
412330|NCT00634114|1381605|P2|Overall Study|Difficult to continue|1
412331|NCT00634114|1381606|P1|Overall Study|Difficult to continue|3
412332|NCT00634114|1381604|P3|Overall Study|Recurrence of reflux esophagitis|21
412333|NCT00634114|1381605|P2|Overall Study|Recurrence of reflux esophagitis|15
412334|NCT00634114|1381606|P1|Overall Study|Recurrence of reflux esophagitis|5
412335|NCT00634114|1381604|P3|Overall Study|Incorrect enrolment|0
412336|NCT00634114|1381605|P2|Overall Study|Incorrect enrolment|1
412337|NCT00634114|1381606|P1|Overall Study|Incorrect enrolment|0
412338|NCT00634114|1381604|P3|Overall Study|Pregnancy|0
412339|NCT00634114|1381605|P2|Overall Study|Pregnancy|0
412340|NCT00634114|1381606|P1|Overall Study|Pregnancy|1
412341|NCT00634114|1381604|P3|Overall Study|Protocol Violation|1
412342|NCT00634114|1381605|P2|Overall Study|Protocol Violation|3
412343|NCT00634114|1381606|P1|Overall Study|Protocol Violation|3
412344|NCT00634114|1381604|P3|Overall Study|Lost to Follow-up|1
412345|NCT00634114|1381605|P2|Overall Study|Lost to Follow-up|0
412346|NCT00634114|1381606|P1|Overall Study|Lost to Follow-up|0
412347|NCT00634114|1381604|P3|Overall Study|Withdrawal by Subject|11
412348|NCT00634114|1381605|P2|Overall Study|Withdrawal by Subject|6
412349|NCT00634114|1381606|P1|Overall Study|Withdrawal by Subject|9
412350|NCT00634114|1381604|P3|Overall Study|Adverse Event|3
412351|NCT00634114|1381605|P2|Overall Study|Adverse Event|8
412352|NCT00634114|1381606|P1|Overall Study|Adverse Event|6
412353|NCT00634088|1381624|P4|Time Period 3: Dose Level 3|Progressive disease|0
412354|NCT00634088|1381625|P3|Time Period 3: Dose Level 3|Progressive disease|1
412355|NCT00634088|1381626|P2|Time Period 3: Dose Level 3|Progressive disease|0
412356|NCT00634088|1381627|P1|Time Period 3: Dose Level 3|Progressive disease|0
412357|NCT00634088|1381624|P4|Time Period 2: Dose Level 2|Progressive disease|0
412358|NCT00634088|1381625|P3|Time Period 2: Dose Level 2|Progressive disease|0
412359|NCT00634088|1381626|P2|Time Period 2: Dose Level 2|Progressive disease|1
412360|NCT00634088|1381627|P1|Time Period 2: Dose Level 2|Progressive disease|0
412361|NCT00634088|1381624|P4|Time Period 2: Dose Level 2|Adverse Event|0
412362|NCT00634088|1381625|P3|Time Period 2: Dose Level 2|Adverse Event|0
412363|NCT00634088|1381626|P2|Time Period 2: Dose Level 2|Adverse Event|2
412364|NCT00634088|1381627|P1|Time Period 2: Dose Level 2|Adverse Event|0
412365|NCT00634088|1381624|P4|Time Period 1: Dose Level 1|Adverse Event|0
412366|NCT00634088|1381625|P3|Time Period 1: Dose Level 1|Adverse Event|0
412367|NCT00634088|1381626|P2|Time Period 1: Dose Level 1|Adverse Event|0
412368|NCT00634088|1381627|P1|Time Period 1: Dose Level 1|Adverse Event|3
412369|NCT00634088|1381624|P4|Time Period 1: Dose Level 1|Physician Decision|0
412370|NCT00634088|1381625|P3|Time Period 1: Dose Level 1|Physician Decision|0
412371|NCT00634088|1381626|P2|Time Period 1: Dose Level 1|Physician Decision|0
412372|NCT00634088|1381627|P1|Time Period 1: Dose Level 1|Physician Decision|1
412373|NCT00634088|1381624|P4|Time Period 1: Dose Level 1|Disease progression|0
412374|NCT00634088|1381625|P3|Time Period 1: Dose Level 1|Disease progression|0
412375|NCT00634088|1381626|P2|Time Period 1: Dose Level 1|Disease progression|0
412376|NCT00634088|1381627|P1|Time Period 1: Dose Level 1|Disease progression|2
412377|NCT00634049|1381678|P1|Overall Study|Screening failure|1
412378|NCT00634049|1381678|P1|Overall Study|Died prior to receiving study drug|1
412379|NCT00634049|1381678|P1|Overall Study|Never received study drug|1
412380|NCT00634036|1381757|P2|Overall Study|Withdrawal by Subject|1
412381|NCT00634036|1381758|P1|Overall Study|Withdrawal by Subject|1
412382|NCT00634036|1381757|P2|Overall Study|Lost to Follow-up|1
412383|NCT00634036|1381758|P1|Overall Study|Lost to Follow-up|1
412384|NCT00634010|1381772|P2|Overall Study|Non-Compliant|1
412385|NCT00634010|1381773|P1|Overall Study|Non-Compliant|1
412386|NCT00634010|1381772|P2|Overall Study|Disease Progression|1
412387|NCT00634010|1381773|P1|Overall Study|Disease Progression|1
412388|NCT00634010|1381772|P2|Overall Study|Physician Decision|1
412389|NCT00634010|1381773|P1|Overall Study|Physician Decision|1
412390|NCT00634010|1381772|P2|Overall Study|Withdrawal by Subject|6
412391|NCT00634010|1381773|P1|Overall Study|Withdrawal by Subject|5
412392|NCT00634010|1381772|P2|Overall Study|Adverse Event|5
412393|NCT00634010|1381773|P1|Overall Study|Adverse Event|2
412394|NCT00633984|1381781|P2|Overall Study|Hospitalized|0
412395|NCT00633984|1381782|P1|Overall Study|Hospitalized|1
412396|NCT00633984|1381781|P2|Overall Study|Withdrawal by Subject|7
412397|NCT00633984|1381782|P1|Overall Study|Withdrawal by Subject|8
412398|NCT00633984|1381781|P2|Overall Study|Lost to Follow-up|6
412399|NCT00633984|1381782|P1|Overall Study|Lost to Follow-up|0
412400|NCT00633932|1381793|P3|Overall Study|Moved Away|0
412401|NCT00633932|1381794|P2|Overall Study|Moved Away|0
412402|NCT00633932|1381795|P1|Overall Study|Moved Away|1
412403|NCT00633932|1381793|P3|Overall Study|Doctor's judgement|0
412404|NCT00633932|1381794|P2|Overall Study|Doctor's judgement|0
412405|NCT00633932|1381795|P1|Overall Study|Doctor's judgement|1
412406|NCT00633932|1381793|P3|Overall Study|Physician Decision|1
412407|NCT00633932|1381794|P2|Overall Study|Physician Decision|0
412408|NCT00633932|1381795|P1|Overall Study|Physician Decision|0
412409|NCT00633932|1381793|P3|Overall Study|Protocol Violation|3
412410|NCT00633932|1381794|P2|Overall Study|Protocol Violation|2
412411|NCT00633932|1381795|P1|Overall Study|Protocol Violation|5
412412|NCT00633932|1381793|P3|Overall Study|Lost to Follow-up|2
412413|NCT00633932|1381794|P2|Overall Study|Lost to Follow-up|0
412414|NCT00633932|1381795|P1|Overall Study|Lost to Follow-up|1
412415|NCT00633932|1381793|P3|Overall Study|Withdrawal by Subject|1
412416|NCT00633932|1381794|P2|Overall Study|Withdrawal by Subject|9
412417|NCT00633932|1381795|P1|Overall Study|Withdrawal by Subject|3
412418|NCT00633932|1381793|P3|Overall Study|Adverse Event|4
412419|NCT00633932|1381794|P2|Overall Study|Adverse Event|3
412420|NCT00633932|1381795|P1|Overall Study|Adverse Event|1
412421|NCT00633893|1381826|P3|Overall Study|not specified|31
412422|NCT00633893|1381827|P2|Overall Study|not specified|33
412423|NCT00633893|1381828|P1|Overall Study|not specified|28
412424|NCT00633893|1381826|P3|Overall Study|Not meet/no longer meets criteria|4
412425|NCT00633893|1381827|P2|Overall Study|Not meet/no longer meets criteria|6
412426|NCT00633893|1381828|P1|Overall Study|Not meet/no longer meets criteria|4
412427|NCT00633893|1381826|P3|Overall Study|Pregnancy|1
412428|NCT00633893|1381827|P2|Overall Study|Pregnancy|1
412429|NCT00633893|1381828|P1|Overall Study|Pregnancy|2
412430|NCT00633893|1381826|P3|Overall Study|Poor/non-compliance|3
412431|NCT00633893|1381827|P2|Overall Study|Poor/non-compliance|12
412432|NCT00633893|1381828|P1|Overall Study|Poor/non-compliance|5
412433|NCT00633893|1381826|P3|Overall Study|Lost to Follow-up|8
412434|NCT00633893|1381827|P2|Overall Study|Lost to Follow-up|4
412435|NCT00633893|1381828|P1|Overall Study|Lost to Follow-up|2
412436|NCT00633893|1381826|P3|Overall Study|Withdrawal by Subject|6
412437|NCT00633893|1381827|P2|Overall Study|Withdrawal by Subject|12
412438|NCT00633893|1381828|P1|Overall Study|Withdrawal by Subject|7
412439|NCT00633893|1381826|P3|Overall Study|Adverse Event|126
412440|NCT00633893|1381827|P2|Overall Study|Adverse Event|58
412441|NCT00633893|1381828|P1|Overall Study|Adverse Event|65
412442|NCT00633893|1381826|P3|Overall Study|Death|9
412443|NCT00633893|1381827|P2|Overall Study|Death|3
412444|NCT00633893|1381828|P1|Overall Study|Death|1
412445|NCT00633880|1381902|P3|Open Label Titration|Withdrawal by Subject|0
412446|NCT00633880|1381903|P2|Open Label Titration|Withdrawal by Subject|0
412447|NCT00633880|1381904|P1|Open Label Titration|Withdrawal by Subject|4
412448|NCT00633880|1381902|P3|Open Label Titration|Physician Decision|0
412449|NCT00633880|1381903|P2|Open Label Titration|Physician Decision|0
412450|NCT00633880|1381904|P1|Open Label Titration|Physician Decision|1
412451|NCT00633880|1381902|P3|Open Label Titration|Protocol Violation|0
412452|NCT00633880|1381903|P2|Open Label Titration|Protocol Violation|0
412453|NCT00633880|1381904|P1|Open Label Titration|Protocol Violation|6
412454|NCT00633880|1381902|P3|Open Label Titration|Treatment Failure|0
412455|NCT00633880|1381903|P2|Open Label Titration|Treatment Failure|0
412456|NCT00633880|1381904|P1|Open Label Titration|Treatment Failure|55
412457|NCT00633880|1381902|P3|Open Label Titration|Adverse Event|0
412458|NCT00633880|1381903|P2|Open Label Titration|Adverse Event|0
412459|NCT00633880|1381904|P1|Open Label Titration|Adverse Event|13
412460|NCT00633880|1381902|P3|Open Label Titration|Lack of Efficacy|0
412461|NCT00633880|1381903|P2|Open Label Titration|Lack of Efficacy|0
412462|NCT00633880|1381904|P1|Open Label Titration|Lack of Efficacy|1
412463|NCT00633750|1381940|P1|Overall Study|Withdrawal by Subject|3
412464|NCT00633750|1381940|P1|Overall Study|Adverse Event|2
412465|NCT00633594|1381949|P3|Overall Study|Disease Progression|1
412466|NCT00633594|1381950|P2|Overall Study|Disease Progression|0
412467|NCT00633594|1381951|P1|Overall Study|Disease Progression|0
412468|NCT00633594|1381949|P3|Overall Study|Death|2
412469|NCT00633594|1381950|P2|Overall Study|Death|1
412470|NCT00633594|1381951|P1|Overall Study|Death|0
412471|NCT00633594|1381949|P3|Overall Study|Adverse Event|7
412472|NCT00633594|1381950|P2|Overall Study|Adverse Event|4
412473|NCT00633594|1381951|P1|Overall Study|Adverse Event|0
412474|NCT00633477|1381980|P2|Overall Study|Randomized but not treated|0
412475|NCT00633477|1381981|P1|Overall Study|Randomized but not treated|1
412476|NCT00633477|1381980|P2|Overall Study|Death|0
412477|NCT00633477|1381981|P1|Overall Study|Death|1
412478|NCT00633464|1381997|P2|Overall Study|Never Treated (Randomized in error)|1
412479|NCT00633464|1381998|P1|Overall Study|Never Treated (Randomized in error)|0
412480|NCT00633464|1381997|P2|Overall Study|Never Treated (Not met study criteria)|1
412481|NCT00633464|1381998|P1|Overall Study|Never Treated (Not met study criteria)|0
412482|NCT00633360|1382033|P2|Overall Study|Protocol Violation|1
412483|NCT00633360|1382034|P1|Overall Study|Protocol Violation|0
412484|NCT00633360|1382033|P2|Overall Study|Adverse Event|1
412485|NCT00633360|1382034|P1|Overall Study|Adverse Event|3
412486|NCT00633360|1382033|P2|Overall Study|Lost to Follow-up|1
412487|NCT00633360|1382034|P1|Overall Study|Lost to Follow-up|1
412488|NCT00633243|1382057|P2|Overall Study|Couldn't tolerate side-effects|1
412489|NCT00633243|1382058|P1|Overall Study|Couldn't tolerate side-effects|1
412490|NCT00633243|1382057|P2|Overall Study|Mental Health--Depression|1
412491|NCT00633243|1382058|P1|Overall Study|Mental Health--Depression|0
412492|NCT00633243|1382057|P2|Overall Study|Not comfortable with self-injecting|1
412493|NCT00633243|1382058|P1|Overall Study|Not comfortable with self-injecting|0
412494|NCT00633243|1382057|P2|Overall Study|Homeless--no refrigeration for meds|1
412495|NCT00633243|1382058|P1|Overall Study|Homeless--no refrigeration for meds|0
412496|NCT00633243|1382057|P2|Overall Study|incarceration|2
412497|NCT00633243|1382058|P1|Overall Study|incarceration|0
412498|NCT00633243|1382057|P2|Overall Study|Withdrawal by Subject|1
412499|NCT00633243|1382058|P1|Overall Study|Withdrawal by Subject|0
412500|NCT00633217|1382066|P2|Overall Study|Withdrew Consent|3
412501|NCT00633217|1382067|P1|Overall Study|Withdrew Consent|3
412502|NCT00633217|1382066|P2|Overall Study|Investigator Discretion|0
412503|NCT00633217|1382067|P1|Overall Study|Investigator Discretion|2
412504|NCT00633217|1382066|P2|Overall Study|Lost to Follow-up|2
412505|NCT00633217|1382067|P1|Overall Study|Lost to Follow-up|2
412506|NCT00633217|1382066|P2|Overall Study|Protocol Violation|7
412507|NCT00633217|1382067|P1|Overall Study|Protocol Violation|3
412508|NCT00633217|1382066|P2|Overall Study|Lack of Efficacy|2
412509|NCT00633217|1382067|P1|Overall Study|Lack of Efficacy|0
412510|NCT00633217|1382066|P2|Overall Study|Adverse Event|9
412511|NCT00633217|1382067|P1|Overall Study|Adverse Event|5
412512|NCT00633152|1382079|P2|Overall Study|Miscellaneous Other|2
412513|NCT00633152|1382080|P1|Overall Study|Miscellaneous Other|3
412514|NCT00633152|1382079|P2|Overall Study|Lost to Follow-up|1
412515|NCT00633152|1382080|P1|Overall Study|Lost to Follow-up|4
412516|NCT00633152|1382079|P2|Overall Study|Withdrawal by Subject|1
412517|NCT00633152|1382080|P1|Overall Study|Withdrawal by Subject|1
412518|NCT00633152|1382079|P2|Overall Study|Randomized, did not receive study drug|2
412519|NCT00633152|1382080|P1|Overall Study|Randomized, did not receive study drug|5
412520|NCT00633152|1382079|P2|Overall Study|Adverse Event|0
412521|NCT00633152|1382080|P1|Overall Study|Adverse Event|1
412522|NCT00633139|1382091|P3|Overall Study|Withdrawal by Subject|0
412523|NCT00633139|1382092|P2|Overall Study|Withdrawal by Subject|1
412524|NCT00633139|1382093|P1|Overall Study|Withdrawal by Subject|0
412525|NCT00633139|1382091|P3|Overall Study|Non compliance|1
412526|NCT00633139|1382092|P2|Overall Study|Non compliance|0
412527|NCT00633139|1382093|P1|Overall Study|Non compliance|0
412528|NCT00633126|1382107|P1|Overall Study|Did not receive full dose|1
412529|NCT00633074|1382121|P2|Overall Study|Adverse Event|0
412530|NCT00633074|1382122|P1|Overall Study|Adverse Event|1
412531|NCT00632931|1382175|P3|Part 2|Withdrawal by Subject|3
412532|NCT00632931|1382176|P2|Part 2|Withdrawal by Subject|0
412533|NCT00632931|1382177|P1|Part 2|Withdrawal by Subject|0
412534|NCT00632931|1382175|P3|Part 2|Lack of Efficacy|17
412535|NCT00632931|1382176|P2|Part 2|Lack of Efficacy|0
412536|NCT00632931|1382177|P1|Part 2|Lack of Efficacy|0
412537|NCT00632931|1382175|P3|Part 2|Death|1
412538|NCT00632931|1382176|P2|Part 2|Death|0
412539|NCT00632931|1382177|P1|Part 2|Death|0
412540|NCT00632931|1382175|P3|Part 2|Adverse Event|3
412541|NCT00632931|1382176|P2|Part 2|Adverse Event|0
412542|NCT00632931|1382177|P1|Part 2|Adverse Event|0
412543|NCT00632931|1382175|P3|Part 1, Period 1|Withdrawal by Subject|0
412544|NCT00632931|1382176|P2|Part 1, Period 1|Withdrawal by Subject|0
412545|NCT00632931|1382177|P1|Part 1, Period 1|Withdrawal by Subject|1
412546|NCT00632931|1382175|P3|Part 1, Period 1|Protocol Violation|0
412547|NCT00632931|1382176|P2|Part 1, Period 1|Protocol Violation|0
412548|NCT00632931|1382177|P1|Part 1, Period 1|Protocol Violation|1
412549|NCT00632749|1382247|P14|Overall Study|Reason other than those specified above|2
412550|NCT00632749|1382248|P13|Overall Study|Reason other than those specified above|0
412551|NCT00632749|1382249|P12|Overall Study|Reason other than those specified above|1
412552|NCT00632749|1382250|P11|Overall Study|Reason other than those specified above|2
412553|NCT00632749|1382251|P10|Overall Study|Reason other than those specified above|0
412554|NCT00632749|1382252|P9|Overall Study|Reason other than those specified above|0
412555|NCT00632749|1382253|P8|Overall Study|Reason other than those specified above|0
412556|NCT00632749|1382254|P7|Overall Study|Reason other than those specified above|1
412557|NCT00632749|1382255|P6|Overall Study|Reason other than those specified above|0
412558|NCT00632749|1382256|P5|Overall Study|Reason other than those specified above|1
412559|NCT00632749|1382257|P4|Overall Study|Reason other than those specified above|0
412560|NCT00632749|1382258|P3|Overall Study|Reason other than those specified above|0
412561|NCT00632749|1382259|P2|Overall Study|Reason other than those specified above|2
412562|NCT00632749|1382260|P1|Overall Study|Reason other than those specified above|0
412563|NCT00632749|1382247|P14|Overall Study|Refuse to continue medication|0
412564|NCT00632749|1382248|P13|Overall Study|Refuse to continue medication|0
412565|NCT00632749|1382249|P12|Overall Study|Refuse to continue medication|0
412566|NCT00632749|1382250|P11|Overall Study|Refuse to continue medication|0
412567|NCT00632749|1382251|P10|Overall Study|Refuse to continue medication|1
412568|NCT00632749|1382252|P9|Overall Study|Refuse to continue medication|0
412569|NCT00632749|1382253|P8|Overall Study|Refuse to continue medication|0
412570|NCT00632749|1382254|P7|Overall Study|Refuse to continue medication|0
412571|NCT00632749|1382255|P6|Overall Study|Refuse to continue medication|0
412572|NCT00632749|1382256|P5|Overall Study|Refuse to continue medication|0
412573|NCT00632749|1382257|P4|Overall Study|Refuse to continue medication|1
412574|NCT00632749|1382258|P3|Overall Study|Refuse to continue medication|0
412575|NCT00632749|1382259|P2|Overall Study|Refuse to continue medication|0
412576|NCT00632749|1382260|P1|Overall Study|Refuse to continue medication|0
412577|NCT00632749|1382247|P14|Overall Study|Other Adverse event|0
412578|NCT00632749|1382248|P13|Overall Study|Other Adverse event|1
412579|NCT00632749|1382249|P12|Overall Study|Other Adverse event|0
412580|NCT00632749|1382250|P11|Overall Study|Other Adverse event|1
412581|NCT00632749|1382251|P10|Overall Study|Other Adverse event|0
412582|NCT00632749|1382252|P9|Overall Study|Other Adverse event|2
412583|NCT00632749|1382253|P8|Overall Study|Other Adverse event|2
412584|NCT00632749|1382254|P7|Overall Study|Other Adverse event|1
412585|NCT00632749|1382255|P6|Overall Study|Other Adverse event|4
412586|NCT00632749|1382256|P5|Overall Study|Other Adverse event|2
412587|NCT00632749|1382257|P4|Overall Study|Other Adverse event|1
412588|NCT00632749|1382258|P3|Overall Study|Other Adverse event|1
412589|NCT00632749|1382259|P2|Overall Study|Other Adverse event|1
412590|NCT00632749|1382260|P1|Overall Study|Other Adverse event|1
412591|NCT00632749|1382247|P14|Overall Study|Progressive disease|4
412592|NCT00632749|1382248|P13|Overall Study|Progressive disease|2
412593|NCT00632749|1382249|P12|Overall Study|Progressive disease|3
412594|NCT00632749|1382250|P11|Overall Study|Progressive disease|4
412595|NCT00632749|1382251|P10|Overall Study|Progressive disease|2
412596|NCT00632749|1382252|P9|Overall Study|Progressive disease|3
412597|NCT00632749|1382253|P8|Overall Study|Progressive disease|2
412598|NCT00632749|1382254|P7|Overall Study|Progressive disease|3
412599|NCT00632749|1382255|P6|Overall Study|Progressive disease|4
412600|NCT00632749|1382256|P5|Overall Study|Progressive disease|4
412601|NCT00632749|1382257|P4|Overall Study|Progressive disease|2
412602|NCT00632749|1382258|P3|Overall Study|Progressive disease|2
412603|NCT00632749|1382259|P2|Overall Study|Progressive disease|2
412604|NCT00632749|1382260|P1|Overall Study|Progressive disease|3
412605|NCT00632736|1382554|P1|Overall Study|Other|16
412606|NCT00632736|1382554|P1|Overall Study|Non-compliance|10
412607|NCT00632736|1382554|P1|Overall Study|Sponsor terminated study|5
412608|NCT00632736|1382554|P1|Overall Study|Lack of Efficacy|5
412609|NCT00632736|1382554|P1|Overall Study|Withdrawal by Subject|99
412610|NCT00632736|1382554|P1|Overall Study|Protocol Violation|14
412611|NCT00632736|1382554|P1|Overall Study|Lost to Follow-up|15
412612|NCT00632736|1382554|P1|Overall Study|Adverse Event|104
412613|NCT00632541|1382589|P1|Overall Study|Adverse Event|7
412614|NCT00632502|1382598|P2|Overall Study|Randomized not treated|0
412615|NCT00632502|1382599|P1|Overall Study|Randomized not treated|3
412616|NCT00632502|1382598|P2|Overall Study|Adverse Event|1
412617|NCT00632502|1382599|P1|Overall Study|Adverse Event|0
412618|NCT00632463|1382643|P3|Overall Study|Adverse Event|0
412619|NCT00632463|1382644|P2|Overall Study|Adverse Event|1
412620|NCT00632463|1382645|P1|Overall Study|Adverse Event|0
412621|NCT00632424|1382662|P1|Overall Study|Study Drug Toxicity|1
412622|NCT00632424|1382662|P1|Overall Study|Disease Progression|17
412623|NCT00632229|1382700|P2|Overall Study|Undisclosed reasons within the first wee|1
412624|NCT00632229|1382701|P1|Overall Study|Undisclosed reasons within the first wee|0
412625|NCT00632229|1382700|P2|Overall Study|Lack of Efficacy|2
412626|NCT00632229|1382701|P1|Overall Study|Lack of Efficacy|0
412627|NCT00632229|1382700|P2|Overall Study|Lost to Follow-up|3
412628|NCT00632229|1382701|P1|Overall Study|Lost to Follow-up|0
412629|NCT00632229|1382700|P2|Overall Study|Adverse Event|0
412630|NCT00632229|1382701|P1|Overall Study|Adverse Event|6
412631|NCT00632203|1382711|P2|Overall Study|Did not start study treatment|0
412632|NCT00632203|1382712|P1|Overall Study|Did not start study treatment|1
412633|NCT00632125|1382730|P1|Overall Study|Moved to other dialysis unit, etc.|102
412634|NCT00632125|1382730|P1|Overall Study|Development of uncontrolled hypertension|5
412635|NCT00632125|1382730|P1|Overall Study|Non-compliance|8
412636|NCT00632125|1382730|P1|Overall Study|Need for systemic immunosuppressive medi|8
412637|NCT00632125|1382730|P1|Overall Study|Renal transplantation|17
412638|NCT00632125|1382730|P1|Overall Study|Adverse Event|36
412639|NCT00632125|1382730|P1|Overall Study|Withdrawal by Subject|44
412640|NCT00632125|1382730|P1|Overall Study|Death|82
412641|NCT00632099|1382736|P2|Overall Study|Lost to Follow-up|3
412642|NCT00632099|1382737|P1|Overall Study|Lost to Follow-up|3
412643|NCT00632021|1382745|P2|Overall Study|Withdrawal/death|7
412644|NCT00632021|1382746|P1|Overall Study|Withdrawal/death|4
412645|NCT00631969|1382756|P2|Overall Study|No Drug Exposure|2
412646|NCT00631969|1382757|P1|Overall Study|No Drug Exposure|2
412647|NCT00631969|1382756|P2|Overall Study|Noncompliant With Study Medication|1
412648|NCT00631969|1382757|P1|Overall Study|Noncompliant With Study Medication|0
412649|NCT00631969|1382756|P2|Overall Study|Consent Withdrawn|7
412650|NCT00631969|1382757|P1|Overall Study|Consent Withdrawn|5
412651|NCT00631969|1382756|P2|Overall Study|Protocol Violation|1
412652|NCT00631969|1382757|P1|Overall Study|Protocol Violation|1
412653|NCT00631969|1382756|P2|Overall Study|Lost to Follow-up|1
412654|NCT00631969|1382757|P1|Overall Study|Lost to Follow-up|2
412655|NCT00631969|1382756|P2|Overall Study|Lack of Efficacy|8
412656|NCT00631969|1382757|P1|Overall Study|Lack of Efficacy|2
412657|NCT00631969|1382756|P2|Overall Study|Adverse Event|1
412658|NCT00631969|1382757|P1|Overall Study|Adverse Event|3
412659|NCT00631917|1382803|P2|Overall Study|Death|0
412660|NCT00631917|1382804|P1|Overall Study|Death|1
412661|NCT00631917|1382803|P2|Overall Study|Administrative problems|0
412662|NCT00631917|1382804|P1|Overall Study|Administrative problems|2
412663|NCT00631917|1382803|P2|Overall Study|Lost to Follow-up|7
412664|NCT00631917|1382804|P1|Overall Study|Lost to Follow-up|7
412665|NCT00631917|1382803|P2|Overall Study|Subject withdrew consent|33
412666|NCT00631917|1382804|P1|Overall Study|Subject withdrew consent|25
412667|NCT00631917|1382803|P2|Overall Study|Protocol deviation|5
412668|NCT00631917|1382804|P1|Overall Study|Protocol deviation|6
412669|NCT00631917|1382803|P2|Overall Study|No longer required study drug|1
412670|NCT00631917|1382804|P1|Overall Study|No longer required study drug|0
412671|NCT00631917|1382803|P2|Overall Study|Unsatisfactory therapeutic effect|14
412672|NCT00631917|1382804|P1|Overall Study|Unsatisfactory therapeutic effect|8
412673|NCT00631917|1382803|P2|Overall Study|Abnormal test procedure result(s)|2
412674|NCT00631917|1382804|P1|Overall Study|Abnormal test procedure result(s)|3
412675|NCT00631917|1382803|P2|Overall Study|Abnormal laboratory value(s)|1
412676|NCT00631917|1382804|P1|Overall Study|Abnormal laboratory value(s)|2
412677|NCT00631917|1382803|P2|Overall Study|Adverse Event|45
412678|NCT00631917|1382804|P1|Overall Study|Adverse Event|34
412679|NCT00631696|1382831|P2|Overall Study|Adverse Event|0
412680|NCT00631696|1382832|P1|Overall Study|Adverse Event|5
412681|NCT00631696|1382831|P2|Overall Study|Study terminated by sponsor|3
412682|NCT00631696|1382832|P1|Overall Study|Study terminated by sponsor|3
412683|NCT00631696|1382831|P2|Overall Study|Protocol Violation|9
412684|NCT00631696|1382832|P1|Overall Study|Protocol Violation|9
412685|NCT00631696|1382831|P2|Overall Study|Other|8
412686|NCT00631696|1382832|P1|Overall Study|Other|8
412687|NCT00631696|1382831|P2|Overall Study|Withdrawal by Subject|9
412688|NCT00631696|1382832|P1|Overall Study|Withdrawal by Subject|2
412689|NCT00631696|1382831|P2|Overall Study|Lost to Follow-up|10
412690|NCT00631696|1382832|P1|Overall Study|Lost to Follow-up|7
412691|NCT00631696|1382831|P2|Overall Study|Follow up after database release date|0
412692|NCT00631696|1382832|P1|Overall Study|Follow up after database release date|1
412693|NCT00631696|1382831|P2|Overall Study|Discontinued after database release date|0
412694|NCT00631696|1382832|P1|Overall Study|Discontinued after database release date|1
412695|NCT00631696|1382831|P2|Overall Study|Entered, not randomized to treatment|1
412696|NCT00631696|1382832|P1|Overall Study|Entered, not randomized to treatment|1
412697|NCT00631657|1382875|P3|7-Day Discontinuation Period|Other|0
412698|NCT00631657|1382876|P2|7-Day Discontinuation Period|Other|0
412699|NCT00631657|1382877|P1|7-Day Discontinuation Period|Other|1
412700|NCT00631657|1382875|P3|7-Day Discontinuation Period|Not Treated|1
412701|NCT00631657|1382876|P2|7-Day Discontinuation Period|Not Treated|1
412702|NCT00631657|1382877|P1|7-Day Discontinuation Period|Not Treated|1
412703|NCT00631657|1382875|P3|6-Month Treatment Period|Not Treated|1
412704|NCT00631657|1382876|P2|6-Month Treatment Period|Not Treated|0
412705|NCT00631657|1382877|P1|6-Month Treatment Period|Not Treated|2
412706|NCT00631657|1382875|P3|6-Month Treatment Period|Other|4
412707|NCT00631657|1382876|P2|6-Month Treatment Period|Other|0
412708|NCT00631657|1382877|P1|6-Month Treatment Period|Other|16
412709|NCT00631657|1382875|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
412710|NCT00631657|1382876|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
412711|NCT00631657|1382877|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
412712|NCT00631657|1382875|P3|6-Month Treatment Period|Lost to Follow-up|2
412713|NCT00631657|1382876|P2|6-Month Treatment Period|Lost to Follow-up|0
412714|NCT00631657|1382877|P1|6-Month Treatment Period|Lost to Follow-up|7
412715|NCT00631657|1382875|P3|6-Month Treatment Period|Lack of Efficacy|25
412716|NCT00631657|1382876|P2|6-Month Treatment Period|Lack of Efficacy|0
412717|NCT00631657|1382877|P1|6-Month Treatment Period|Lack of Efficacy|34
412718|NCT00631657|1382875|P3|6-Month Treatment Period|Withdrawal by Subject|5
412719|NCT00631657|1382876|P2|6-Month Treatment Period|Withdrawal by Subject|0
412720|NCT00631657|1382877|P1|6-Month Treatment Period|Withdrawal by Subject|14
412721|NCT00631657|1382875|P3|6-Month Treatment Period|Adverse Event|7
412722|NCT00631657|1382876|P2|6-Month Treatment Period|Adverse Event|0
412723|NCT00631657|1382877|P1|6-Month Treatment Period|Adverse Event|47
412724|NCT00631540|1382904|P1|Overall Study|Core Lab Data Unavailable|3
412725|NCT00631540|1382904|P1|Overall Study|Lost to Follow-up|2
412726|NCT00631540|1382904|P1|Overall Study|Death|4
412727|NCT00631540|1382904|P1|Overall Study|Withdrawal by Subject|5
412728|NCT00631488|1382916|P3|Overall Study|Protocol Violation|1
412729|NCT00631488|1382917|P2|Overall Study|Protocol Violation|0
412730|NCT00631488|1382918|P1|Overall Study|Protocol Violation|0
412731|NCT00631488|1382916|P3|Overall Study|Physician Decision|1
412732|NCT00631488|1382917|P2|Overall Study|Physician Decision|0
412733|NCT00631488|1382918|P1|Overall Study|Physician Decision|1
412734|NCT00631488|1382916|P3|Overall Study|Lost to Follow-up|0
412735|NCT00631488|1382917|P2|Overall Study|Lost to Follow-up|2
412736|NCT00631488|1382918|P1|Overall Study|Lost to Follow-up|2
412737|NCT00631488|1382916|P3|Overall Study|Adverse Event|0
412738|NCT00631488|1382917|P2|Overall Study|Adverse Event|0
412739|NCT00631488|1382918|P1|Overall Study|Adverse Event|1
412740|NCT00631475|1382938|P1|Overall Study|Preparation for lung transplant|8
412741|NCT00631475|1382938|P1|Overall Study|Withdrew consent|5
412742|NCT00631475|1382938|P1|Overall Study|Adverse Event|14
412743|NCT00631475|1382938|P1|Overall Study|Death|18
412744|NCT00631410|1382957|P2|Overall Study|Surgery|0
412745|NCT00631410|1382958|P1|Overall Study|Surgery|1
412746|NCT00631410|1382957|P2|Overall Study|Objective Progression or Relapse|3
412747|NCT00631410|1382958|P1|Overall Study|Objective Progression or Relapse|4
412748|NCT00631410|1382957|P2|Overall Study|Adverse Event|3
412749|NCT00631410|1382958|P1|Overall Study|Adverse Event|1
412750|NCT00631371|1382977|P2|Overall Study|Death|239
412751|NCT00631371|1382978|P1|Overall Study|Death|263
412752|NCT00631371|1382977|P2|Overall Study|Discontinuation of study by Sponsor|76
412753|NCT00631371|1382978|P1|Overall Study|Discontinuation of study by Sponsor|70
412754|NCT00631371|1382977|P2|Overall Study|subject request|45
412755|NCT00631371|1382978|P1|Overall Study|subject request|38
412756|NCT00631371|1382977|P2|Overall Study|Other reason|12
412757|NCT00631371|1382978|P1|Overall Study|Other reason|5
412758|NCT00631371|1382977|P2|Overall Study|Lost to Follow-up|19
412759|NCT00631371|1382978|P1|Overall Study|Lost to Follow-up|24
412760|NCT00631189|1383011|P4|Treatment Phase|patient did not take pravastatin|0
412761|NCT00631189|1383012|P3|Treatment Phase|patient did not take pravastatin|1
412762|NCT00631189|1383013|P2|Treatment Phase|patient did not take pravastatin|0
412763|NCT00631189|1383014|P1|Treatment Phase|patient did not take pravastatin|0
412764|NCT00631189|1383011|P4|Treatment Phase|Pregnancy|0
412765|NCT00631189|1383012|P3|Treatment Phase|Pregnancy|1
412766|NCT00631189|1383013|P2|Treatment Phase|Pregnancy|0
412767|NCT00631189|1383014|P1|Treatment Phase|Pregnancy|0
412768|NCT00631189|1383011|P4|Treatment Phase|Lost to Follow-up|0
412769|NCT00631189|1383012|P3|Treatment Phase|Lost to Follow-up|0
412770|NCT00631189|1383013|P2|Treatment Phase|Lost to Follow-up|1
412771|NCT00631189|1383014|P1|Treatment Phase|Lost to Follow-up|0
412772|NCT00631189|1383011|P4|Treatment Phase|Adverse Event|4
412773|NCT00631189|1383012|P3|Treatment Phase|Adverse Event|2
412774|NCT00631189|1383013|P2|Treatment Phase|Adverse Event|3
412775|NCT00631189|1383014|P1|Treatment Phase|Adverse Event|0
412776|NCT00631189|1383011|P4|Treatment Phase|Protocol Violation|2
412777|NCT00631189|1383012|P3|Treatment Phase|Protocol Violation|6
412778|NCT00631189|1383013|P2|Treatment Phase|Protocol Violation|1
412779|NCT00631189|1383014|P1|Treatment Phase|Protocol Violation|0
412780|NCT00631189|1383011|P4|Treatment Phase|Withdrawal by Subject|1
412781|NCT00631189|1383012|P3|Treatment Phase|Withdrawal by Subject|1
412782|NCT00631189|1383013|P2|Treatment Phase|Withdrawal by Subject|2
412783|NCT00631189|1383014|P1|Treatment Phase|Withdrawal by Subject|0
412784|NCT00631189|1383011|P4|Initial Phase|Withdrawal by Subject|0
412785|NCT00631189|1383012|P3|Initial Phase|Withdrawal by Subject|0
412786|NCT00631189|1383013|P2|Initial Phase|Withdrawal by Subject|0
412787|NCT00631189|1383014|P1|Initial Phase|Withdrawal by Subject|4
412788|NCT00631189|1383011|P4|Initial Phase|Protocol Violation|0
412789|NCT00631189|1383012|P3|Initial Phase|Protocol Violation|0
412790|NCT00631189|1383013|P2|Initial Phase|Protocol Violation|0
412791|NCT00631189|1383014|P1|Initial Phase|Protocol Violation|347
412792|NCT00631020|1383056|P1|Overall Study|Incarcerated|1
412793|NCT00631020|1383056|P1|Overall Study|Lost to Follow-up|7
412794|NCT00631007|1383071|P6|Overall Study|Other|0
412795|NCT00631007|1383072|P5|Overall Study|Other|1
412796|NCT00631007|1383073|P4|Overall Study|Other|0
412797|NCT00631007|1383074|P3|Overall Study|Other|0
412798|NCT00631007|1383075|P2|Overall Study|Other|1
412799|NCT00631007|1383076|P1|Overall Study|Other|2
412800|NCT00631007|1383071|P6|Overall Study|Withdrawal by Subject|3
412801|NCT00631007|1383072|P5|Overall Study|Withdrawal by Subject|1
412802|NCT00631007|1383073|P4|Overall Study|Withdrawal by Subject|2
412803|NCT00631007|1383074|P3|Overall Study|Withdrawal by Subject|2
412804|NCT00631007|1383075|P2|Overall Study|Withdrawal by Subject|5
412805|NCT00631007|1383076|P1|Overall Study|Withdrawal by Subject|4
412806|NCT00631007|1383071|P6|Overall Study|Persistent Hyperglycemia|5
412807|NCT00631007|1383072|P5|Overall Study|Persistent Hyperglycemia|2
412808|NCT00631007|1383073|P4|Overall Study|Persistent Hyperglycemia|1
412809|NCT00631007|1383074|P3|Overall Study|Persistent Hyperglycemia|5
412810|NCT00631007|1383075|P2|Overall Study|Persistent Hyperglycemia|2
412811|NCT00631007|1383076|P1|Overall Study|Persistent Hyperglycemia|2
412812|NCT00631007|1383071|P6|Overall Study|Physician Decision|2
412813|NCT00631007|1383072|P5|Overall Study|Physician Decision|0
412814|NCT00631007|1383073|P4|Overall Study|Physician Decision|0
412815|NCT00631007|1383074|P3|Overall Study|Physician Decision|1
412816|NCT00631007|1383075|P2|Overall Study|Physician Decision|0
412817|NCT00631007|1383076|P1|Overall Study|Physician Decision|1
412818|NCT00631007|1383071|P6|Overall Study|Lost to Follow-up|3
412819|NCT00631007|1383072|P5|Overall Study|Lost to Follow-up|5
412820|NCT00631007|1383073|P4|Overall Study|Lost to Follow-up|4
412821|NCT00631007|1383074|P3|Overall Study|Lost to Follow-up|2
412822|NCT00631007|1383075|P2|Overall Study|Lost to Follow-up|1
412823|NCT00631007|1383076|P1|Overall Study|Lost to Follow-up|2
412824|NCT00631007|1383071|P6|Overall Study|Adverse Event|2
412825|NCT00631007|1383072|P5|Overall Study|Adverse Event|3
412826|NCT00631007|1383073|P4|Overall Study|Adverse Event|2
412827|NCT00631007|1383074|P3|Overall Study|Adverse Event|0
412828|NCT00631007|1383075|P2|Overall Study|Adverse Event|2
412829|NCT00631007|1383076|P1|Overall Study|Adverse Event|0
412830|NCT00630994|1383096|P1|Overall Study|Other|1
412831|NCT00630994|1383096|P1|Overall Study|Lack of Efficacy|1
412832|NCT00630994|1383096|P1|Overall Study|Disease Progression|1
412833|NCT00630994|1383096|P1|Overall Study|Adverse Event|1
412834|NCT00630916|1383126|P1|Overall Study|Lack of Efficacy|3
412835|NCT00630916|1383126|P1|Overall Study|Physician Decision|47
412836|NCT00630916|1383126|P1|Overall Study|Protocol Violation|7
412837|NCT00630916|1383126|P1|Overall Study|Withdrawal by Subject|30
412838|NCT00630916|1383126|P1|Overall Study|Lost to Follow-up|5
412839|NCT00630916|1383126|P1|Overall Study|Explant|8
412840|NCT00630916|1383126|P1|Overall Study|Death|110
412841|NCT00630877|1383136|P3|Overall Study|Personal reasons|1
412842|NCT00630877|1383137|P2|Overall Study|Personal reasons|0
412843|NCT00630877|1383138|P1|Overall Study|Personal reasons|0
412844|NCT00630877|1383136|P3|Overall Study|Protocol violation|1
412845|NCT00630877|1383137|P2|Overall Study|Protocol violation|0
412846|NCT00630877|1383138|P1|Overall Study|Protocol violation|1
412847|NCT00630877|1383136|P3|Overall Study|Noncompliance|1
412848|NCT00630877|1383137|P2|Overall Study|Noncompliance|3
412849|NCT00630877|1383138|P1|Overall Study|Noncompliance|2
412850|NCT00630877|1383136|P3|Overall Study|Lost to Follow-up|0
412851|NCT00630877|1383137|P2|Overall Study|Lost to Follow-up|0
412852|NCT00630877|1383138|P1|Overall Study|Lost to Follow-up|2
412853|NCT00630877|1383136|P3|Overall Study|Withdrawal by Subject|0
412854|NCT00630877|1383137|P2|Overall Study|Withdrawal by Subject|4
412855|NCT00630877|1383138|P1|Overall Study|Withdrawal by Subject|3
412856|NCT00630877|1383136|P3|Overall Study|Adverse Event|7
412857|NCT00630877|1383137|P2|Overall Study|Adverse Event|8
412858|NCT00630877|1383138|P1|Overall Study|Adverse Event|11
412859|NCT00630864|1383156|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
412860|NCT00630864|1383156|P1|Part 1 (up to Week 6)|Adverse Event|1
412861|NCT00630838|1383195|P2|Overall Study|Lost to Follow-up|1
412862|NCT00630838|1383196|P1|Overall Study|Lost to Follow-up|0
412863|NCT00630838|1383195|P2|Overall Study|Death|1
412864|NCT00630838|1383196|P1|Overall Study|Death|0
412865|NCT00630825|1383208|P4|Overall Study|Withdrawal by Subject|3
412866|NCT00630825|1383209|P3|Overall Study|Withdrawal by Subject|2
412867|NCT00630825|1383210|P2|Overall Study|Withdrawal by Subject|2
412868|NCT00630825|1383211|P1|Overall Study|Withdrawal by Subject|2
412869|NCT00630825|1383208|P4|Overall Study|Physician Decision|0
412870|NCT00630825|1383209|P3|Overall Study|Physician Decision|0
412871|NCT00630825|1383210|P2|Overall Study|Physician Decision|0
412872|NCT00630825|1383211|P1|Overall Study|Physician Decision|1
412873|NCT00630825|1383208|P4|Overall Study|Lost to Follow-up|1
412874|NCT00630825|1383209|P3|Overall Study|Lost to Follow-up|1
412875|NCT00630825|1383210|P2|Overall Study|Lost to Follow-up|1
412876|NCT00630825|1383211|P1|Overall Study|Lost to Follow-up|1
412877|NCT00630825|1383208|P4|Overall Study|Entry Criteria Not Met|1
412878|NCT00630825|1383209|P3|Overall Study|Entry Criteria Not Met|2
412879|NCT00630825|1383210|P2|Overall Study|Entry Criteria Not Met|0
412880|NCT00630825|1383211|P1|Overall Study|Entry Criteria Not Met|1
412881|NCT00630825|1383208|P4|Overall Study|Adverse Event|1
412882|NCT00630825|1383209|P3|Overall Study|Adverse Event|3
412883|NCT00630825|1383210|P2|Overall Study|Adverse Event|4
412884|NCT00630825|1383211|P1|Overall Study|Adverse Event|4
412885|NCT00630786|1383283|P3|Overall Study|Not specified|0
412886|NCT00630786|1383284|P2|Overall Study|Not specified|0
412887|NCT00630786|1383285|P1|Overall Study|Not specified|1
412888|NCT00630786|1383283|P3|Overall Study|Lost to Follow-up|0
412889|NCT00630786|1383284|P2|Overall Study|Lost to Follow-up|1
412890|NCT00630786|1383285|P1|Overall Study|Lost to Follow-up|0
412891|NCT00630786|1383283|P3|Overall Study|Withdrawal by Subject|1
412892|NCT00630786|1383284|P2|Overall Study|Withdrawal by Subject|1
412893|NCT00630786|1383285|P1|Overall Study|Withdrawal by Subject|0
412894|NCT00630786|1383283|P3|Overall Study|Physician Decision|1
412895|NCT00630786|1383284|P2|Overall Study|Physician Decision|0
412896|NCT00630786|1383285|P1|Overall Study|Physician Decision|0
412897|NCT00630747|1383304|P1|Overall Study|Returned to country of origin|1
412898|NCT00630747|1383304|P1|Overall Study|Transferred to Study TKT031NPU|7
412899|NCT00630747|1383304|P1|Overall Study|Death|1
412900|NCT00630539|1383357|P4|Overall Study|Withdrawal by Subject|1
412901|NCT00630539|1383358|P3|Overall Study|Withdrawal by Subject|0
412902|NCT00630539|1383359|P2|Overall Study|Withdrawal by Subject|1
412903|NCT00630539|1383360|P1|Overall Study|Withdrawal by Subject|0
412904|NCT00630539|1383357|P4|Overall Study|Adverse Event|2
412905|NCT00630539|1383358|P3|Overall Study|Adverse Event|1
412906|NCT00630539|1383359|P2|Overall Study|Adverse Event|3
412907|NCT00630539|1383360|P1|Overall Study|Adverse Event|1
412908|NCT00630396|1383456|P1|Overall Study|Lost to Follow-up|3
412909|NCT00630396|1383456|P1|Overall Study|Death|4
412910|NCT00630344|1383462|P1|Overall Study|Other|1
412911|NCT00630344|1383462|P1|Overall Study|Intercurrent Illness|1
412912|NCT00630344|1383462|P1|Overall Study|Withdrawal by Subject|1
412913|NCT00630344|1383462|P1|Overall Study|Physician Decision|9
412914|NCT00630344|1383462|P1|Overall Study|Progressive Disease|19
412915|NCT00630344|1383462|P1|Overall Study|Adverse Event|5
412916|NCT00630331|1383474|P3|Overall Study|Protocol Violation|6
412917|NCT00630331|1383475|P2|Overall Study|Protocol Violation|5
412918|NCT00630331|1383476|P1|Overall Study|Protocol Violation|4
412919|NCT00630331|1383474|P3|Overall Study|Unable to classify|3
412920|NCT00630331|1383475|P2|Overall Study|Unable to classify|4
412921|NCT00630331|1383476|P1|Overall Study|Unable to classify|9
412922|NCT00630331|1383474|P3|Overall Study|Inappropriate enrollment|3
412923|NCT00630331|1383475|P2|Overall Study|Inappropriate enrollment|6
412924|NCT00630331|1383476|P1|Overall Study|Inappropriate enrollment|3
412925|NCT00630331|1383474|P3|Overall Study|Lost to Follow-up|170
412926|NCT00630331|1383475|P2|Overall Study|Lost to Follow-up|143
412927|NCT00630331|1383476|P1|Overall Study|Lost to Follow-up|175
412928|NCT00630331|1383474|P3|Overall Study|Withdrawal by Subject|5
412929|NCT00630331|1383475|P2|Overall Study|Withdrawal by Subject|7
412930|NCT00630331|1383476|P1|Overall Study|Withdrawal by Subject|12
412931|NCT00630331|1383474|P3|Overall Study|Adverse Event|0
412932|NCT00630331|1383475|P2|Overall Study|Adverse Event|0
412933|NCT00630331|1383476|P1|Overall Study|Adverse Event|1
412934|NCT00630331|1383474|P3|Overall Study|Death|1
412935|NCT00630331|1383475|P2|Overall Study|Death|1
412936|NCT00630331|1383476|P1|Overall Study|Death|2
412937|NCT00630305|1383517|P1|Overall Study|Inability to insert contact lens|1
412938|NCT00630305|1383517|P1|Overall Study|Withdrawal by Subject|1
412939|NCT00630292|1383539|P1|Overall Study|Withdrawal by Subject|1
412940|NCT00630058|1383545|P2|Overall Study|stopping criteria|2
412941|NCT00630058|1383546|P1|Overall Study|stopping criteria|3
412942|NCT00630058|1383545|P2|Overall Study|Withdrawal by Subject|1
412943|NCT00630058|1383546|P1|Overall Study|Withdrawal by Subject|0
412944|NCT00630058|1383545|P2|Overall Study|Adverse Event|1
412945|NCT00630058|1383546|P1|Overall Study|Adverse Event|1
412946|NCT00629772|1383577|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
412947|NCT00629772|1383578|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
412948|NCT00629772|1383577|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
412949|NCT00629772|1383578|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
412950|NCT00629707|1383598|P2|Overall Study|Physician Decision|1
412951|NCT00629707|1383599|P1|Overall Study|Physician Decision|0
412952|NCT00629707|1383598|P2|Overall Study|Withdrawal by Subject|1
412953|NCT00629707|1383599|P1|Overall Study|Withdrawal by Subject|0
412954|NCT00629265|1383619|P2|Overall Study|Unknown Reason|2
412955|NCT00629265|1383620|P1|Overall Study|Unknown Reason|2
412956|NCT00629265|1383619|P2|Overall Study|Unrelated Medical Complications|1
412957|NCT00629265|1383620|P1|Overall Study|Unrelated Medical Complications|3
412958|NCT00629265|1383619|P2|Overall Study|Needed Esophageal Dilation|1
412959|NCT00629265|1383620|P1|Overall Study|Needed Esophageal Dilation|4
412960|NCT00629265|1383619|P2|Overall Study|Other CA Requiring Treatment|3
412961|NCT00629265|1383620|P1|Overall Study|Other CA Requiring Treatment|1
412962|NCT00629265|1383619|P2|Overall Study|HNC Recurrence|0
412963|NCT00629265|1383620|P1|Overall Study|HNC Recurrence|4
412964|NCT00629265|1383619|P2|Overall Study|Adverse Event|0
412965|NCT00629265|1383620|P1|Overall Study|Adverse Event|2
412966|NCT00629265|1383619|P2|Overall Study|Death|0
412967|NCT00629265|1383620|P1|Overall Study|Death|1
412968|NCT00629265|1383619|P2|Overall Study|Withdrawal by Subject|8
412969|NCT00629265|1383620|P1|Overall Study|Withdrawal by Subject|11
412970|NCT00629265|1383619|P2|Overall Study|Lost to Follow-up|5
412971|NCT00629265|1383620|P1|Overall Study|Lost to Follow-up|4
412972|NCT00629239|1383630|P2|Overall Study|Physician Decision|0
412973|NCT00629239|1383631|P1|Overall Study|Physician Decision|1
412974|NCT00629239|1383630|P2|Overall Study|Adverse Event|4
412975|NCT00629239|1383631|P1|Overall Study|Adverse Event|7
412976|NCT00628927|1383695|P2|Overall Study|Equipment failure|0
412977|NCT00628927|1383696|P1|Overall Study|Equipment failure|1
412978|NCT00628927|1383695|P2|Overall Study|Lost to Follow-up|0
412979|NCT00628927|1383696|P1|Overall Study|Lost to Follow-up|1
412980|NCT00628927|1383695|P2|Overall Study|Problems performing blood draw|0
412981|NCT00628927|1383696|P1|Overall Study|Problems performing blood draw|6
412982|NCT00628862|1383741|P3|Overall Study|COPD Exacerbation|0
412983|NCT00628862|1383742|P2|Overall Study|COPD Exacerbation|1
412984|NCT00628862|1383743|P1|Overall Study|COPD Exacerbation|0
412985|NCT00628862|1383741|P3|Overall Study|Protocol Violation|0
412986|NCT00628862|1383742|P2|Overall Study|Protocol Violation|0
412987|NCT00628862|1383743|P1|Overall Study|Protocol Violation|1
412988|NCT00628862|1383741|P3|Overall Study|Lost to Follow-up|1
412989|NCT00628862|1383742|P2|Overall Study|Lost to Follow-up|2
412990|NCT00628862|1383743|P1|Overall Study|Lost to Follow-up|0
412991|NCT00628862|1383741|P3|Overall Study|Withdrawal by Subject|11
412992|NCT00628862|1383742|P2|Overall Study|Withdrawal by Subject|6
412993|NCT00628862|1383743|P1|Overall Study|Withdrawal by Subject|4
412994|NCT00628862|1383741|P3|Overall Study|Adverse Event|10
412995|NCT00628862|1383742|P2|Overall Study|Adverse Event|8
412996|NCT00628862|1383743|P1|Overall Study|Adverse Event|6
412997|NCT00628758|1383789|P2|Overall Study|Treatment Failure|2
412998|NCT00628758|1383790|P1|Overall Study|Treatment Failure|0
412999|NCT00628758|1383789|P2|Overall Study|Investigator Moved|0
413000|NCT00628758|1383790|P1|Overall Study|Investigator Moved|3
413001|NCT00628758|1383789|P2|Overall Study|Pregnancy|2
413002|NCT00628758|1383790|P1|Overall Study|Pregnancy|2
413003|NCT00628758|1383789|P2|Overall Study|Lost to Follow-up|31
413004|NCT00628758|1383790|P1|Overall Study|Lost to Follow-up|25
413005|NCT00628758|1383789|P2|Overall Study|Protocol Violation|1
413006|NCT00628758|1383790|P1|Overall Study|Protocol Violation|5
413007|NCT00628758|1383789|P2|Overall Study|Death|0
413008|NCT00628758|1383790|P1|Overall Study|Death|1
413009|NCT00628758|1383789|P2|Overall Study|Withdrawal by Subject|3
413010|NCT00628758|1383790|P1|Overall Study|Withdrawal by Subject|6
413011|NCT00628758|1383789|P2|Overall Study|Adverse Event|3
413012|NCT00628758|1383790|P1|Overall Study|Adverse Event|2
413013|NCT00628446|1383834|P1|Overall Study|Protocol Violation|3
413014|NCT00628446|1383834|P1|Overall Study|Withdrawal by Subject|1
413015|NCT00628446|1383834|P1|Overall Study|Lost to Follow-up|3
413016|NCT00628355|1383845|P2|Overall Study|Withdrawal by Subject|1
413017|NCT00628355|1383846|P1|Overall Study|Withdrawal by Subject|1
413018|NCT00628251|1383857|P3|Cross-over/ Continuation of Olaparib|Other|0
413019|NCT00628251|1383858|P2|Cross-over/ Continuation of Olaparib|Other|1
413020|NCT00628251|1383859|P1|Cross-over/ Continuation of Olaparib|Other|1
413021|NCT00628251|1383857|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
413022|NCT00628251|1383858|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
413023|NCT00628251|1383859|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
413024|NCT00628251|1383857|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
413025|NCT00628251|1383858|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
413026|NCT00628251|1383859|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
413027|NCT00628251|1383857|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
413028|NCT00628251|1383858|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
413029|NCT00628251|1383859|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
413030|NCT00628251|1383857|P3|Randomised Part|Did not receive cross over treatment|8
413031|NCT00628251|1383858|P2|Randomised Part|Did not receive cross over treatment|0
413032|NCT00628251|1383859|P1|Randomised Part|Did not receive cross over treatment|0
413033|NCT00628212|1383902|P4|Overall Study|Physician Decision|3
413034|NCT00628212|1383903|P3|Overall Study|Physician Decision|2
413035|NCT00628212|1383904|P2|Overall Study|Physician Decision|1
413036|NCT00628212|1383905|P1|Overall Study|Physician Decision|1
413037|NCT00628212|1383902|P4|Overall Study|Adverse Event|2
413038|NCT00628212|1383903|P3|Overall Study|Adverse Event|1
413039|NCT00628212|1383904|P2|Overall Study|Adverse Event|0
413040|NCT00628212|1383905|P1|Overall Study|Adverse Event|2
413041|NCT00628108|1383953|P2|Overall Study|Withdrawal by Subject|0
413042|NCT00628108|1383954|P1|Overall Study|Withdrawal by Subject|1
413043|NCT00628108|1383953|P2|Overall Study|Adverse Event|3
413044|NCT00628108|1383954|P1|Overall Study|Adverse Event|0
413045|NCT00628030|1383986|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
413046|NCT00628030|1383987|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
413047|NCT00628030|1383986|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
413048|NCT00628030|1383987|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
413049|NCT00628030|1383986|P2|Baseline to Post-Assessment|Lost to Follow-up|29
413050|NCT00628030|1383987|P1|Baseline to Post-Assessment|Lost to Follow-up|28
413051|NCT00627926|1384013|P3|Overall Study|Noncompliance/unspecified|17
413052|NCT00627926|1384014|P2|Overall Study|Noncompliance/unspecified|23
413053|NCT00627926|1384015|P1|Overall Study|Noncompliance/unspecified|8
413054|NCT00627926|1384013|P3|Overall Study|Lack of Efficacy|38
413055|NCT00627926|1384014|P2|Overall Study|Lack of Efficacy|40
413056|NCT00627926|1384015|P1|Overall Study|Lack of Efficacy|118
413057|NCT00627926|1384013|P3|Overall Study|Withdrawal by Subject|0
413058|NCT00627926|1384014|P2|Overall Study|Withdrawal by Subject|1
413059|NCT00627926|1384015|P1|Overall Study|Withdrawal by Subject|2
413060|NCT00627926|1384013|P3|Overall Study|Lost to Follow-up|4
413061|NCT00627926|1384014|P2|Overall Study|Lost to Follow-up|3
413062|NCT00627926|1384015|P1|Overall Study|Lost to Follow-up|4
413063|NCT00627926|1384013|P3|Overall Study|Death|0
413064|NCT00627926|1384014|P2|Overall Study|Death|0
413065|NCT00627926|1384015|P1|Overall Study|Death|1
413066|NCT00627926|1384013|P3|Overall Study|Adverse Event|36
413067|NCT00627926|1384014|P2|Overall Study|Adverse Event|37
413068|NCT00627926|1384015|P1|Overall Study|Adverse Event|26
413069|NCT00627705|1384067|P2|Overall Study|Lost to Follow-up|1
413070|NCT00627705|1384068|P1|Overall Study|Lost to Follow-up|0
413071|NCT00627705|1384067|P2|Overall Study|Withdrawal by Subject|2
413072|NCT00627705|1384068|P1|Overall Study|Withdrawal by Subject|0
413073|NCT00627705|1384067|P2|Overall Study|Adverse Event|0
413074|NCT00627705|1384068|P1|Overall Study|Adverse Event|1
413075|NCT00627705|1384067|P2|Overall Study|Unwilling to take the compound (taste)|3
413076|NCT00627705|1384068|P1|Overall Study|Unwilling to take the compound (taste)|1
413077|NCT00627523|1384119|P2|Overall Study|Not specified|0
413078|NCT00627523|1384120|P1|Overall Study|Not specified|1
413079|NCT00627523|1384119|P2|Overall Study|Withdrawal by Subject|2
413080|NCT00627523|1384120|P1|Overall Study|Withdrawal by Subject|0
413081|NCT00627523|1384119|P2|Overall Study|Lack of Efficacy|0
413082|NCT00627523|1384120|P1|Overall Study|Lack of Efficacy|1
413083|NCT00627497|1384148|P4|Overall Study|Lost to Follow-up|0
413084|NCT00627497|1384149|P3|Overall Study|Lost to Follow-up|0
413085|NCT00627497|1384150|P2|Overall Study|Lost to Follow-up|1
413086|NCT00627497|1384151|P1|Overall Study|Lost to Follow-up|1
413087|NCT00627458|1384212|P3|Overall Study|Lost to Follow-up|0
413088|NCT00627458|1384213|P2|Overall Study|Lost to Follow-up|1
413089|NCT00627458|1384214|P1|Overall Study|Lost to Follow-up|1
413090|NCT00627458|1384212|P3|Overall Study|Withdrawal by Subject|5
413091|NCT00627458|1384213|P2|Overall Study|Withdrawal by Subject|6
413092|NCT00627458|1384214|P1|Overall Study|Withdrawal by Subject|2
413093|NCT00627458|1384212|P3|Overall Study|Migrated from study area|1
413094|NCT00627458|1384213|P2|Overall Study|Migrated from study area|0
413095|NCT00627458|1384214|P1|Overall Study|Migrated from study area|1
413096|NCT00627445|1384289|P2|Overall Study|Other|8
413097|NCT00627445|1384290|P1|Overall Study|Other|6
413098|NCT00627445|1384289|P2|Overall Study|Lack of Efficacy|1
413099|NCT00627445|1384290|P1|Overall Study|Lack of Efficacy|0
413100|NCT00627445|1384289|P2|Overall Study|Adverse Event|3
413101|NCT00627445|1384290|P1|Overall Study|Adverse Event|3
413102|NCT00627393|1384333|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
413103|NCT00627393|1384334|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
413104|NCT00627393|1384333|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
413105|NCT00627393|1384334|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
413106|NCT00627393|1384333|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
413107|NCT00627393|1384334|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
413108|NCT00627393|1384333|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
413109|NCT00627393|1384334|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
413110|NCT00627094|1384370|P2|Overall Study|Other reason|0
413111|NCT00627094|1384371|P1|Overall Study|Other reason|1
413112|NCT00627094|1384370|P2|Overall Study|ulcer healed|7
413113|NCT00627094|1384371|P1|Overall Study|ulcer healed|1
413114|NCT00627094|1384370|P2|Overall Study|Withdrawal by Subject|1
413115|NCT00627094|1384371|P1|Overall Study|Withdrawal by Subject|1
413116|NCT00627094|1384370|P2|Overall Study|Lost to Follow-up|0
413117|NCT00627094|1384371|P1|Overall Study|Lost to Follow-up|1
413118|NCT00627094|1384370|P2|Overall Study|Adverse Event|7
413119|NCT00627094|1384371|P1|Overall Study|Adverse Event|8
413120|NCT00627042|1384383|P1|Overall Study|Withdrawal by Subject|2
413121|NCT00627016|1384395|P2|Overall Study|Pregnancy|0
413122|NCT00627016|1384396|P1|Overall Study|Pregnancy|1
413123|NCT00627016|1384395|P2|Overall Study|Placed on Excluded Drugs|0
413124|NCT00627016|1384396|P1|Overall Study|Placed on Excluded Drugs|1
413125|NCT00627016|1384395|P2|Overall Study|Lack of Efficacy|0
413126|NCT00627016|1384396|P1|Overall Study|Lack of Efficacy|1
413127|NCT00627016|1384395|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
413128|NCT00627016|1384396|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
413129|NCT00627016|1384395|P2|Overall Study|Withdrawal by Subject|1
413130|NCT00627016|1384396|P1|Overall Study|Withdrawal by Subject|2
413131|NCT00627016|1384395|P2|Overall Study|Lost to Follow-up|1
413132|NCT00627016|1384396|P1|Overall Study|Lost to Follow-up|0
413133|NCT00627016|1384395|P2|Overall Study|Protocol Violation|2
413134|NCT00627016|1384396|P1|Overall Study|Protocol Violation|0
413135|NCT00627016|1384395|P2|Overall Study|Adverse Event|1
413136|NCT00627016|1384396|P1|Overall Study|Adverse Event|1
413137|NCT00626925|1384408|P2|Overall Study|Time constraints|1
413138|NCT00626925|1384409|P1|Overall Study|Time constraints|3
413139|NCT00626925|1384408|P2|Overall Study|Lack of Efficacy|4
413140|NCT00626925|1384409|P1|Overall Study|Lack of Efficacy|1
413141|NCT00626925|1384408|P2|Overall Study|Adverse effect|2
413142|NCT00626925|1384409|P1|Overall Study|Adverse effect|6
413143|NCT00626925|1384408|P2|Overall Study|relapse|0
413144|NCT00626925|1384409|P1|Overall Study|relapse|1
413145|NCT00626925|1384408|P2|Overall Study|Lost to Follow-up|2
413146|NCT00626925|1384409|P1|Overall Study|Lost to Follow-up|1
413147|NCT00626821|1384441|P1|Overall Study|other/unknown reason|104
413148|NCT00626821|1384441|P1|Overall Study|Product dysfunction|21
413149|NCT00626821|1384441|P1|Overall Study|Physician Decision|9
413150|NCT00626821|1384441|P1|Overall Study|Withdrawal by Subject|10
413151|NCT00626821|1384441|P1|Overall Study|Protocol Violation|33
413152|NCT00626821|1384441|P1|Overall Study|Adverse Event|44
413153|NCT00626639|1384542|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
413154|NCT00626639|1384543|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
413155|NCT00626561|1384583|P1|Overall Study|Disease Progression|2
413156|NCT00626561|1384583|P1|Overall Study|Withdrawal by Subject|2
413157|NCT00626548|1384589|P2|Overall Study|Other termination reason|613
413158|NCT00626548|1384590|P1|Overall Study|Other termination reason|493
413159|NCT00626548|1384589|P2|Overall Study|Lost to Follow-up|2
413160|NCT00626548|1384590|P1|Overall Study|Lost to Follow-up|2
413161|NCT00626548|1384589|P2|Overall Study|Protocol Violation|11
413162|NCT00626548|1384590|P1|Overall Study|Protocol Violation|4
413163|NCT00626548|1384589|P2|Overall Study|Withdrawal by Subject|46
413164|NCT00626548|1384590|P1|Overall Study|Withdrawal by Subject|42
413165|NCT00626548|1384589|P2|Overall Study|Adverse Event|44
413166|NCT00626548|1384590|P1|Overall Study|Adverse Event|164
413167|NCT00626522|1384604|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
413168|NCT00626522|1384605|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
413169|NCT00626522|1384606|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
413170|NCT00626522|1384607|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
413171|NCT00626522|1384608|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
413172|NCT00626522|1384609|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
413173|NCT00626522|1384604|P6|Overall Study|Inconsistent reason reported|0
413174|NCT00626522|1384605|P5|Overall Study|Inconsistent reason reported|0
413175|NCT00626522|1384606|P4|Overall Study|Inconsistent reason reported|0
413176|NCT00626522|1384607|P3|Overall Study|Inconsistent reason reported|0
413177|NCT00626522|1384608|P2|Overall Study|Inconsistent reason reported|0
413178|NCT00626522|1384609|P1|Overall Study|Inconsistent reason reported|1
413179|NCT00626522|1384604|P6|Overall Study|Lost to Follow-up|0
413180|NCT00626522|1384605|P5|Overall Study|Lost to Follow-up|0
413181|NCT00626522|1384606|P4|Overall Study|Lost to Follow-up|0
413182|NCT00626522|1384607|P3|Overall Study|Lost to Follow-up|0
413183|NCT00626522|1384608|P2|Overall Study|Lost to Follow-up|1
413184|NCT00626522|1384609|P1|Overall Study|Lost to Follow-up|0
413185|NCT00626522|1384604|P6|Overall Study|COPD exacerbation|0
413186|NCT00626522|1384605|P5|Overall Study|COPD exacerbation|1
413187|NCT00626522|1384606|P4|Overall Study|COPD exacerbation|1
413188|NCT00626522|1384607|P3|Overall Study|COPD exacerbation|0
413189|NCT00626522|1384608|P2|Overall Study|COPD exacerbation|0
413190|NCT00626522|1384609|P1|Overall Study|COPD exacerbation|0
413191|NCT00626522|1384604|P6|Overall Study|Withdrawal by Subject|1
413192|NCT00626522|1384605|P5|Overall Study|Withdrawal by Subject|4
413193|NCT00626522|1384606|P4|Overall Study|Withdrawal by Subject|0
413194|NCT00626522|1384607|P3|Overall Study|Withdrawal by Subject|5
413195|NCT00626522|1384608|P2|Overall Study|Withdrawal by Subject|5
413196|NCT00626522|1384609|P1|Overall Study|Withdrawal by Subject|2
413197|NCT00626522|1384604|P6|Overall Study|Adverse Event|1
413198|NCT00626522|1384605|P5|Overall Study|Adverse Event|1
413199|NCT00626522|1384606|P4|Overall Study|Adverse Event|0
413200|NCT00626522|1384607|P3|Overall Study|Adverse Event|2
413201|NCT00626522|1384608|P2|Overall Study|Adverse Event|1
413202|NCT00626522|1384609|P1|Overall Study|Adverse Event|2
413203|NCT00626522|1384604|P6|Overall Study|Protocol Violation|0
413204|NCT00626522|1384605|P5|Overall Study|Protocol Violation|1
413205|NCT00626522|1384606|P4|Overall Study|Protocol Violation|0
413206|NCT00626522|1384607|P3|Overall Study|Protocol Violation|0
413207|NCT00626522|1384608|P2|Overall Study|Protocol Violation|0
413208|NCT00626522|1384609|P1|Overall Study|Protocol Violation|0
413209|NCT00626405|1384672|P2|Overall Study|Withdrawal by Subject|1
413210|NCT00626405|1384673|P1|Overall Study|Withdrawal by Subject|0
413211|NCT00626405|1384672|P2|Overall Study|Deemed Ineligible|0
413212|NCT00626405|1384673|P1|Overall Study|Deemed Ineligible|1
413213|NCT00626392|1384689|P6|Coadministration Period|Other|1
413214|NCT00626392|1384690|P5|Coadministration Period|Other|1
413215|NCT00626392|1384691|P4|Coadministration Period|Other|1
413216|NCT00626392|1384692|P3|Coadministration Period|Other|3
413217|NCT00626392|1384693|P2|Coadministration Period|Other|2
413218|NCT00626392|1384694|P1|Coadministration Period|Other|0
413219|NCT00626392|1384689|P6|Coadministration Period|Protocol Violation|0
413220|NCT00626392|1384690|P5|Coadministration Period|Protocol Violation|1
413221|NCT00626392|1384691|P4|Coadministration Period|Protocol Violation|1
413222|NCT00626392|1384692|P3|Coadministration Period|Protocol Violation|0
413223|NCT00626392|1384693|P2|Coadministration Period|Protocol Violation|1
413224|NCT00626392|1384694|P1|Coadministration Period|Protocol Violation|0
413225|NCT00626392|1384689|P6|Coadministration Period|Withdrawal by Subject|1
413226|NCT00626392|1384690|P5|Coadministration Period|Withdrawal by Subject|0
413227|NCT00626392|1384691|P4|Coadministration Period|Withdrawal by Subject|1
413228|NCT00626392|1384692|P3|Coadministration Period|Withdrawal by Subject|0
413229|NCT00626392|1384693|P2|Coadministration Period|Withdrawal by Subject|1
413230|NCT00626392|1384694|P1|Coadministration Period|Withdrawal by Subject|1
413231|NCT00626392|1384689|P6|Coadministration Period|Adverse Event|4
413232|NCT00626392|1384690|P5|Coadministration Period|Adverse Event|3
413233|NCT00626392|1384691|P4|Coadministration Period|Adverse Event|4
413234|NCT00626392|1384692|P3|Coadministration Period|Adverse Event|7
413235|NCT00626392|1384693|P2|Coadministration Period|Adverse Event|1
413236|NCT00626392|1384694|P1|Coadministration Period|Adverse Event|3
413237|NCT00626392|1384689|P6|Run-in Period|Noncompliance|0
413238|NCT00626392|1384690|P5|Run-in Period|Noncompliance|0
413239|NCT00626392|1384691|P4|Run-in Period|Noncompliance|0
413240|NCT00626392|1384692|P3|Run-in Period|Noncompliance|1
413241|NCT00626392|1384693|P2|Run-in Period|Noncompliance|0
413242|NCT00626392|1384694|P1|Run-in Period|Noncompliance|1
413243|NCT00626392|1384689|P6|Run-in Period|Withdrawal by Subject|1
413244|NCT00626392|1384690|P5|Run-in Period|Withdrawal by Subject|3
413245|NCT00626392|1384691|P4|Run-in Period|Withdrawal by Subject|1
413246|NCT00626392|1384692|P3|Run-in Period|Withdrawal by Subject|1
413247|NCT00626392|1384693|P2|Run-in Period|Withdrawal by Subject|1
413248|NCT00626392|1384694|P1|Run-in Period|Withdrawal by Subject|0
413249|NCT00626392|1384689|P6|Run-in Period|Adverse Event|0
413250|NCT00626392|1384690|P5|Run-in Period|Adverse Event|1
413251|NCT00626392|1384691|P4|Run-in Period|Adverse Event|0
413252|NCT00626392|1384692|P3|Run-in Period|Adverse Event|1
413253|NCT00626392|1384693|P2|Run-in Period|Adverse Event|0
413254|NCT00626392|1384694|P1|Run-in Period|Adverse Event|0
413255|NCT00626327|1384713|P3|Overall Study|Protocol Violation|26
413256|NCT00626327|1384714|P2|Overall Study|Protocol Violation|4
413257|NCT00626327|1384715|P1|Overall Study|Protocol Violation|26
413258|NCT00626327|1384713|P3|Overall Study|Administrative Reason|6
413259|NCT00626327|1384714|P2|Overall Study|Administrative Reason|0
413260|NCT00626327|1384715|P1|Overall Study|Administrative Reason|2
413261|NCT00626327|1384713|P3|Overall Study|Inappropriate enrollment|3
413262|NCT00626327|1384714|P2|Overall Study|Inappropriate enrollment|5
413263|NCT00626327|1384715|P1|Overall Study|Inappropriate enrollment|4
413264|NCT00626327|1384713|P3|Overall Study|Lost to Follow-up|23
413265|NCT00626327|1384714|P2|Overall Study|Lost to Follow-up|21
413266|NCT00626327|1384715|P1|Overall Study|Lost to Follow-up|24
413267|NCT00626327|1384713|P3|Overall Study|Adverse Event|0
413268|NCT00626327|1384714|P2|Overall Study|Adverse Event|0
413269|NCT00626327|1384715|P1|Overall Study|Adverse Event|1
413270|NCT00626327|1384713|P3|Overall Study|Withdrawal by Subject|30
413271|NCT00626327|1384714|P2|Overall Study|Withdrawal by Subject|29
413272|NCT00626327|1384715|P1|Overall Study|Withdrawal by Subject|21
413273|NCT00626275|1384741|P8|Part B|Withdrawal by Subject|1
413274|NCT00626275|1384742|P7|Part B|Withdrawal by Subject|0
413275|NCT00626275|1384743|P6|Part B|Withdrawal by Subject|0
413276|NCT00626275|1384744|P5|Part B|Withdrawal by Subject|0
413277|NCT00626275|1384745|P4|Part B|Withdrawal by Subject|0
413278|NCT00626275|1384746|P3|Part B|Withdrawal by Subject|0
413279|NCT00626275|1384747|P2|Part B|Withdrawal by Subject|0
413280|NCT00626275|1384748|P1|Part B|Withdrawal by Subject|0
413281|NCT00626275|1384741|P8|Part B|Lost to Follow-up|0
413282|NCT00626275|1384742|P7|Part B|Lost to Follow-up|1
413283|NCT00626275|1384743|P6|Part B|Lost to Follow-up|0
413284|NCT00626275|1384744|P5|Part B|Lost to Follow-up|0
413285|NCT00626275|1384745|P4|Part B|Lost to Follow-up|0
413286|NCT00626275|1384746|P3|Part B|Lost to Follow-up|0
413287|NCT00626275|1384747|P2|Part B|Lost to Follow-up|0
413288|NCT00626275|1384748|P1|Part B|Lost to Follow-up|0
413289|NCT00626275|1384741|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
413290|NCT00626275|1384742|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
413291|NCT00626275|1384743|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
413292|NCT00626275|1384744|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
413293|NCT00626275|1384745|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
413294|NCT00626275|1384746|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
413295|NCT00626275|1384747|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
413296|NCT00626275|1384748|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
413297|NCT00626275|1384741|P8|Part A - Treatment Period 1|Adverse Event|0
413298|NCT00626275|1384742|P7|Part A - Treatment Period 1|Adverse Event|0
413299|NCT00626275|1384743|P6|Part A - Treatment Period 1|Adverse Event|0
413300|NCT00626275|1384744|P5|Part A - Treatment Period 1|Adverse Event|0
413301|NCT00626275|1384745|P4|Part A - Treatment Period 1|Adverse Event|0
413302|NCT00626275|1384746|P3|Part A - Treatment Period 1|Adverse Event|0
413303|NCT00626275|1384747|P2|Part A - Treatment Period 1|Adverse Event|0
413304|NCT00626275|1384748|P1|Part A - Treatment Period 1|Adverse Event|1
413305|NCT00626093|1384792|P1|Overall Study|One of the required devices not implante|6
413306|NCT00626093|1384792|P1|Overall Study|Protocol Violation|1
413307|NCT00626093|1384792|P1|Overall Study|Withdrawal by Subject|6
413308|NCT00626093|1384792|P1|Overall Study|Physician Decision|4
413309|NCT00626093|1384792|P1|Overall Study|Death|1
413310|NCT00626093|1384792|P1|Overall Study|Lost to Follow-up|5
413311|NCT00626028|1384799|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
413312|NCT00626028|1384800|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
413313|NCT00626028|1384799|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
413314|NCT00626028|1384800|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
413315|NCT00626028|1384799|P2|Treatment 1 NO First, O2 Last|Device Failure|1
413316|NCT00626028|1384800|P1|Treatment 1 NO First, O2 Last|Device Failure|0
413317|NCT00626028|1384799|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
413318|NCT00626028|1384800|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
413319|NCT00625872|1384820|P2|Overall Study|Randomized but not treated|1
413320|NCT00625872|1384821|P1|Overall Study|Randomized but not treated|0
413321|NCT00625872|1384820|P2|Overall Study|Terminated by sponsor|5
413322|NCT00625872|1384821|P1|Overall Study|Terminated by sponsor|2
413323|NCT00625872|1384820|P2|Overall Study|Does not meet inclusion criteria|0
413324|NCT00625872|1384821|P1|Overall Study|Does not meet inclusion criteria|1
413325|NCT00625872|1384820|P2|Overall Study|Withdrawal by Subject|0
413326|NCT00625872|1384821|P1|Overall Study|Withdrawal by Subject|1
413327|NCT00625820|1384931|P1|Overall Study|Withdrawal by Subject|1
413328|NCT00625742|1384937|P1|Overall Study|Ineligible|1
413329|NCT00625742|1384937|P1|Overall Study|Lost to Follow-up|4
413330|NCT00625742|1384937|P1|Overall Study|Adverse Event|4
413331|NCT00625742|1384937|P1|Overall Study|Withdrawal by Subject|1
413332|NCT00625742|1384937|P1|Overall Study|Disease Progression|2
413333|NCT00625586|1384951|P1|Overall Study|Adverse Event|1
413334|NCT00625443|1384964|P3|Overall Study|Not specified|1
413335|NCT00625443|1384965|P2|Overall Study|Not specified|1
413336|NCT00625443|1384966|P1|Overall Study|Not specified|0
413337|NCT00625443|1384964|P3|Overall Study|Physician Decision|2
413338|NCT00625443|1384965|P2|Overall Study|Physician Decision|4
413339|NCT00625443|1384966|P1|Overall Study|Physician Decision|0
413340|NCT00625443|1384964|P3|Overall Study|Withdrawal by Subject|2
413341|NCT00625443|1384965|P2|Overall Study|Withdrawal by Subject|1
413342|NCT00625443|1384966|P1|Overall Study|Withdrawal by Subject|0
413343|NCT00625443|1384964|P3|Overall Study|Platelet count increase >=500,000/mm3|0
413344|NCT00625443|1384965|P2|Overall Study|Platelet count increase >=500,000/mm3|0
413345|NCT00625443|1384966|P1|Overall Study|Platelet count increase >=500,000/mm3|1
413346|NCT00625443|1384964|P3|Overall Study|Non-compliance with protocol|0
413347|NCT00625443|1384965|P2|Overall Study|Non-compliance with protocol|1
413348|NCT00625443|1384966|P1|Overall Study|Non-compliance with protocol|0
413349|NCT00625443|1384964|P3|Overall Study|Adverse Event|0
413350|NCT00625443|1384965|P2|Overall Study|Adverse Event|4
413351|NCT00625443|1384966|P1|Overall Study|Adverse Event|1
413352|NCT00625365|1385046|P1|Overall Study|VSD|1
413353|NCT00625365|1385046|P1|Overall Study|No IV access|5
413354|NCT00625365|1385046|P1|Overall Study|Withdrawal by Subject|1
413355|NCT00625183|1385052|P1|Overall Study|Disease Progression|1
413356|NCT00625131|1385063|P3|Overall Study|Withdrawal by Subject|5
413357|NCT00625131|1385064|P2|Overall Study|Withdrawal by Subject|0
413358|NCT00625131|1385065|P1|Overall Study|Withdrawal by Subject|1
413359|NCT00625131|1385063|P3|Overall Study|Lost to Follow-up|0
413360|NCT00625131|1385064|P2|Overall Study|Lost to Follow-up|2
413361|NCT00625131|1385065|P1|Overall Study|Lost to Follow-up|3
413362|NCT00624832|1385088|P4|Overall Study|Abnormal Laboratory Value|0
413363|NCT00624832|1385089|P3|Overall Study|Abnormal Laboratory Value|0
413364|NCT00624832|1385090|P2|Overall Study|Abnormal Laboratory Value|0
413365|NCT00624832|1385091|P1|Overall Study|Abnormal Laboratory Value|2
413366|NCT00624832|1385088|P4|Overall Study|Adverse Event|1
413367|NCT00624832|1385089|P3|Overall Study|Adverse Event|0
413368|NCT00624832|1385090|P2|Overall Study|Adverse Event|1
413369|NCT00624832|1385091|P1|Overall Study|Adverse Event|0
413370|NCT00624780|1385122|P6|Follow-up (Week 26)|Other|0
413371|NCT00624780|1385123|P5|Follow-up (Week 26)|Other|0
413372|NCT00624780|1385124|P4|Follow-up (Week 26)|Other|0
413373|NCT00624780|1385125|P3|Follow-up (Week 26)|Other|0
413374|NCT00624780|1385126|P2|Follow-up (Week 26)|Other|1
413375|NCT00624780|1385127|P1|Follow-up (Week 26)|Other|1
413376|NCT00624780|1385122|P6|Follow-up (Week 26)|Withdrawal by Subject|0
413377|NCT00624780|1385123|P5|Follow-up (Week 26)|Withdrawal by Subject|0
413378|NCT00624780|1385124|P4|Follow-up (Week 26)|Withdrawal by Subject|0
413379|NCT00624780|1385125|P3|Follow-up (Week 26)|Withdrawal by Subject|0
413380|NCT00624780|1385126|P2|Follow-up (Week 26)|Withdrawal by Subject|0
413381|NCT00624780|1385127|P1|Follow-up (Week 26)|Withdrawal by Subject|1
413382|NCT00624780|1385122|P6|Follow-up (Week 26)|Lost to Follow-up|0
413383|NCT00624780|1385123|P5|Follow-up (Week 26)|Lost to Follow-up|1
413384|NCT00624780|1385124|P4|Follow-up (Week 26)|Lost to Follow-up|0
413385|NCT00624780|1385125|P3|Follow-up (Week 26)|Lost to Follow-up|1
413386|NCT00624780|1385126|P2|Follow-up (Week 26)|Lost to Follow-up|0
413387|NCT00624780|1385127|P1|Follow-up (Week 26)|Lost to Follow-up|0
413388|NCT00624780|1385122|P6|Follow-up (Week 26)|Adverse Event|0
413389|NCT00624780|1385123|P5|Follow-up (Week 26)|Adverse Event|1
413390|NCT00624780|1385124|P4|Follow-up (Week 26)|Adverse Event|0
413391|NCT00624780|1385125|P3|Follow-up (Week 26)|Adverse Event|0
413392|NCT00624780|1385126|P2|Follow-up (Week 26)|Adverse Event|0
413393|NCT00624780|1385127|P1|Follow-up (Week 26)|Adverse Event|0
413394|NCT00624780|1385122|P6|Follow-up (Week 26)|Death|0
413395|NCT00624780|1385123|P5|Follow-up (Week 26)|Death|0
413396|NCT00624780|1385124|P4|Follow-up (Week 26)|Death|0
413397|NCT00624780|1385125|P3|Follow-up (Week 26)|Death|1
413398|NCT00624780|1385126|P2|Follow-up (Week 26)|Death|0
413399|NCT00624780|1385127|P1|Follow-up (Week 26)|Death|0
413400|NCT00624780|1385122|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
413401|NCT00624780|1385123|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
413402|NCT00624780|1385124|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
413403|NCT00624780|1385125|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
413404|NCT00624780|1385126|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
413405|NCT00624780|1385127|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
413406|NCT00624780|1385122|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
413407|NCT00624780|1385123|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
413408|NCT00624780|1385124|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
413409|NCT00624780|1385125|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
413410|NCT00624780|1385126|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
413411|NCT00624780|1385127|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
413412|NCT00624780|1385122|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
413413|NCT00624780|1385123|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
413414|NCT00624780|1385124|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
413415|NCT00624780|1385125|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
413416|NCT00624780|1385126|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
413417|NCT00624780|1385127|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
413418|NCT00624780|1385122|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
413419|NCT00624780|1385123|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
413420|NCT00624780|1385124|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
413421|NCT00624780|1385125|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
413422|NCT00624780|1385126|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
413423|NCT00624780|1385127|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
413424|NCT00624780|1385122|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
413425|NCT00624780|1385123|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
413426|NCT00624780|1385124|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
413427|NCT00624780|1385125|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
413428|NCT00624780|1385126|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
413429|NCT00624780|1385127|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
413430|NCT00624780|1385122|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
413431|NCT00624780|1385123|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
413432|NCT00624780|1385124|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
413433|NCT00624780|1385125|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
413434|NCT00624780|1385126|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
413435|NCT00624780|1385127|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
413436|NCT00624780|1385122|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
413437|NCT00624780|1385123|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
413438|NCT00624780|1385124|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
413439|NCT00624780|1385125|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
413440|NCT00624780|1385126|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
413441|NCT00624780|1385127|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
413442|NCT00624780|1385122|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
413443|NCT00624780|1385123|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
413444|NCT00624780|1385124|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
413445|NCT00624780|1385125|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
413446|NCT00624780|1385126|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
413447|NCT00624780|1385127|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
413448|NCT00624780|1385122|P6|Treatment Optimization (Up to Week 12)|Other|0
413449|NCT00624780|1385123|P5|Treatment Optimization (Up to Week 12)|Other|9
413450|NCT00624780|1385124|P4|Treatment Optimization (Up to Week 12)|Other|2
413451|NCT00624780|1385125|P3|Treatment Optimization (Up to Week 12)|Other|8
413452|NCT00624780|1385126|P2|Treatment Optimization (Up to Week 12)|Other|4
413453|NCT00624780|1385127|P1|Treatment Optimization (Up to Week 12)|Other|10
413454|NCT00624780|1385122|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
413455|NCT00624780|1385123|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
413456|NCT00624780|1385124|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
413457|NCT00624780|1385125|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
413458|NCT00624780|1385126|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
413459|NCT00624780|1385127|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
413460|NCT00624780|1385122|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
413461|NCT00624780|1385123|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
413462|NCT00624780|1385124|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
413463|NCT00624780|1385125|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
413464|NCT00624780|1385126|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
413465|NCT00624780|1385127|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
413466|NCT00624780|1385122|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
413467|NCT00624780|1385123|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
413468|NCT00624780|1385124|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
413469|NCT00624780|1385125|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
413470|NCT00624780|1385126|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
413471|NCT00624780|1385127|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
413472|NCT00624780|1385122|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
413473|NCT00624780|1385123|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
413474|NCT00624780|1385124|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
413475|NCT00624780|1385125|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
413476|NCT00624780|1385126|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
413477|NCT00624780|1385127|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
413478|NCT00624585|1385309|P1|Overall Study|Adverse Event|3
413479|NCT00624585|1385309|P1|Overall Study|Disease Progression|6
413480|NCT00624585|1385309|P1|Overall Study|Death|3
413481|NCT00624520|1385339|P2|Overall Study|Death|1
413482|NCT00624520|1385340|P1|Overall Study|Death|0
413483|NCT00624520|1385339|P2|Overall Study|Withdrawal by Subject|7
413484|NCT00624520|1385340|P1|Overall Study|Withdrawal by Subject|12
413485|NCT00624468|1385367|P4|Safety Follow-up (SFU) Period|Other|1
413486|NCT00624468|1385368|P3|Safety Follow-up (SFU) Period|Other|1
413487|NCT00624468|1385369|P2|Safety Follow-up (SFU) Period|Other|0
413488|NCT00624468|1385370|P1|Safety Follow-up (SFU) Period|Other|0
413489|NCT00624468|1385367|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
413490|NCT00624468|1385368|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
413491|NCT00624468|1385369|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
413492|NCT00624468|1385370|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
413493|NCT00624468|1385367|P4|Double-blind Period|Withdrew Prematurely|0
413494|NCT00624468|1385368|P3|Double-blind Period|Withdrew Prematurely|0
413495|NCT00624468|1385369|P2|Double-blind Period|Withdrew Prematurely|1
413496|NCT00624468|1385370|P1|Double-blind Period|Withdrew Prematurely|1
413497|NCT00624468|1385367|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
413498|NCT00624468|1385368|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
413499|NCT00624468|1385369|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
413500|NCT00624468|1385370|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
413501|NCT00624377|1385437|P1|Overall Study|Non-evaluable population|84
413502|NCT00624377|1385437|P1|Overall Study|Other|91
413503|NCT00624377|1385437|P1|Overall Study|Adverse Event|14
413504|NCT00624377|1385437|P1|Overall Study|Withdrawal by Subject|100
413505|NCT00624377|1385437|P1|Overall Study|Lost to Follow-up|355
413506|NCT00624338|1385451|P3|Overall Study|Randomized but not treated|3
413507|NCT00624338|1385452|P2|Overall Study|Randomized but not treated|1
413508|NCT00624338|1385453|P1|Overall Study|Randomized but not treated|2
413509|NCT00624338|1385451|P3|Overall Study|Other|9
413510|NCT00624338|1385452|P2|Overall Study|Other|5
413511|NCT00624338|1385453|P1|Overall Study|Other|15
413512|NCT00624338|1385451|P3|Overall Study|Termination of 150 mg group by Sponsor|0
413513|NCT00624338|1385452|P2|Overall Study|Termination of 150 mg group by Sponsor|55
413514|NCT00624338|1385453|P1|Overall Study|Termination of 150 mg group by Sponsor|0
413515|NCT00624338|1385451|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
413516|NCT00624338|1385452|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
413517|NCT00624338|1385453|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
413518|NCT00624338|1385451|P3|Overall Study|Death|0
413519|NCT00624338|1385452|P2|Overall Study|Death|2
413520|NCT00624338|1385453|P1|Overall Study|Death|0
413521|NCT00624338|1385451|P3|Overall Study|Protocol Violation|2
413522|NCT00624338|1385452|P2|Overall Study|Protocol Violation|3
413523|NCT00624338|1385453|P1|Overall Study|Protocol Violation|3
413524|NCT00624338|1385451|P3|Overall Study|Lack of Efficacy|14
413525|NCT00624338|1385452|P2|Overall Study|Lack of Efficacy|3
413526|NCT00624338|1385453|P1|Overall Study|Lack of Efficacy|11
413527|NCT00624338|1385451|P3|Overall Study|Lost to Follow-up|0
413528|NCT00624338|1385452|P2|Overall Study|Lost to Follow-up|0
413529|NCT00624338|1385453|P1|Overall Study|Lost to Follow-up|1
413530|NCT00624338|1385451|P3|Overall Study|Adverse Event|18
413531|NCT00624338|1385452|P2|Overall Study|Adverse Event|14
413532|NCT00624338|1385453|P1|Overall Study|Adverse Event|14
413533|NCT00624286|1385475|P2|Overall Study|Death|1
413534|NCT00624286|1385476|P1|Overall Study|Death|0
413535|NCT00624286|1385475|P2|Overall Study|Abnormal test procedure result(s)|1
413536|NCT00624286|1385476|P1|Overall Study|Abnormal test procedure result(s)|0
413537|NCT00624286|1385475|P2|Overall Study|Not stated|1
413538|NCT00624286|1385476|P1|Overall Study|Not stated|0
413539|NCT00624286|1385475|P2|Overall Study|Lack of Efficacy|6
413540|NCT00624286|1385476|P1|Overall Study|Lack of Efficacy|1
413541|NCT00624286|1385475|P2|Overall Study|Administrative problems|0
413542|NCT00624286|1385476|P1|Overall Study|Administrative problems|3
413543|NCT00624286|1385475|P2|Overall Study|Lost to Follow-up|2
413544|NCT00624286|1385476|P1|Overall Study|Lost to Follow-up|3
413545|NCT00624286|1385475|P2|Overall Study|Withdrawal by Subject|4
413546|NCT00624286|1385476|P1|Overall Study|Withdrawal by Subject|5
413547|NCT00624286|1385475|P2|Overall Study|Adverse Event|3
413548|NCT00624286|1385476|P1|Overall Study|Adverse Event|6
413549|NCT00624286|1385475|P2|Overall Study|Protocol Deviation|9
413550|NCT00624286|1385476|P1|Overall Study|Protocol Deviation|7
413551|NCT00624065|1385529|P2|Overall Study|Met protocol-defined stopping criteria|9
413552|NCT00624065|1385530|P1|Overall Study|Met protocol-defined stopping criteria|4
413553|NCT00624065|1385529|P2|Overall Study|Lack of Efficacy|3
413554|NCT00624065|1385530|P1|Overall Study|Lack of Efficacy|0
413555|NCT00624065|1385529|P2|Overall Study|Consent withdrawn|5
413556|NCT00624065|1385530|P1|Overall Study|Consent withdrawn|6
413557|NCT00624065|1385529|P2|Overall Study|Lost to Follow-up|1
413558|NCT00624065|1385530|P1|Overall Study|Lost to Follow-up|4
413559|NCT00624065|1385529|P2|Overall Study|Adverse Event|6
413560|NCT00624065|1385530|P1|Overall Study|Adverse Event|5
413561|NCT00624052|1385542|P4|Overall Study|Changed job/ran out if meds|0
413562|NCT00624052|1385543|P3|Overall Study|Changed job/ran out if meds|0
413563|NCT00624052|1385544|P2|Overall Study|Changed job/ran out if meds|2
413564|NCT00624052|1385545|P1|Overall Study|Changed job/ran out if meds|0
413565|NCT00624052|1385542|P4|Overall Study|Consent withdrawn|0
413566|NCT00624052|1385543|P3|Overall Study|Consent withdrawn|1
413567|NCT00624052|1385544|P2|Overall Study|Consent withdrawn|1
413568|NCT00624052|1385545|P1|Overall Study|Consent withdrawn|3
413569|NCT00624052|1385542|P4|Overall Study|Non compliant with the protocol|1
413570|NCT00624052|1385543|P3|Overall Study|Non compliant with the protocol|1
413571|NCT00624052|1385544|P2|Overall Study|Non compliant with the protocol|1
413572|NCT00624052|1385545|P1|Overall Study|Non compliant with the protocol|2
413573|NCT00624052|1385542|P4|Overall Study|Lost to Follow-up|0
413574|NCT00624052|1385543|P3|Overall Study|Lost to Follow-up|1
413575|NCT00624052|1385544|P2|Overall Study|Lost to Follow-up|3
413576|NCT00624052|1385545|P1|Overall Study|Lost to Follow-up|2
413577|NCT00624052|1385542|P4|Overall Study|Lack of Efficacy|0
413578|NCT00624052|1385543|P3|Overall Study|Lack of Efficacy|0
413579|NCT00624052|1385544|P2|Overall Study|Lack of Efficacy|1
413580|NCT00624052|1385545|P1|Overall Study|Lack of Efficacy|1
413581|NCT00624052|1385542|P4|Overall Study|Adverse Event|3
413582|NCT00624052|1385543|P3|Overall Study|Adverse Event|0
413583|NCT00624052|1385544|P2|Overall Study|Adverse Event|6
413584|NCT00624052|1385545|P1|Overall Study|Adverse Event|7
413585|NCT00623935|1385622|P1|Overall Study|Patient Declined Transplant|1
413586|NCT00623935|1385622|P1|Overall Study|Death|1
413587|NCT00623831|1385629|P2|Overall Study|Progressive Disease|1
413588|NCT00623831|1385630|P1|Overall Study|Progressive Disease|0
413589|NCT00623831|1385629|P2|Overall Study|Withdrawal by Subject|0
413590|NCT00623831|1385630|P1|Overall Study|Withdrawal by Subject|1
413591|NCT00623805|1385642|P2|Overall Study|Reason not Specified|6
413592|NCT00623805|1385643|P1|Overall Study|Reason not Specified|3
413593|NCT00623805|1385642|P2|Overall Study|Protocol Violation|1
413594|NCT00623805|1385643|P1|Overall Study|Protocol Violation|1
413595|NCT00623805|1385642|P2|Overall Study|Lost to Follow-up|2
413596|NCT00623805|1385643|P1|Overall Study|Lost to Follow-up|2
413597|NCT00623805|1385642|P2|Overall Study|Lack of Efficacy|7
413598|NCT00623805|1385643|P1|Overall Study|Lack of Efficacy|3
413599|NCT00623805|1385642|P2|Overall Study|Death|0
413600|NCT00623805|1385643|P1|Overall Study|Death|2
413601|NCT00623805|1385642|P2|Overall Study|Adverse Event|6
413602|NCT00623805|1385643|P1|Overall Study|Adverse Event|9
413603|NCT00623779|1385660|P3|Overall Study|Criteria from CSR|1
413604|NCT00623779|1385661|P2|Overall Study|Criteria from CSR|0
413605|NCT00623779|1385662|P1|Overall Study|Criteria from CSR|2
413606|NCT00623779|1385660|P3|Overall Study|Adverse Event|0
413607|NCT00623779|1385661|P2|Overall Study|Adverse Event|3
413608|NCT00623779|1385662|P1|Overall Study|Adverse Event|1
413609|NCT00623766|1385711|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
413610|NCT00623766|1385712|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
413611|NCT00623766|1385711|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
413612|NCT00623766|1385712|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
413613|NCT00623766|1385711|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
413614|NCT00623766|1385712|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
413615|NCT00623766|1385711|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
413616|NCT00623766|1385712|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
413617|NCT00623766|1385711|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
413618|NCT00623766|1385712|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
413619|NCT00623727|1385736|P2|Open Label Follow-up|Participant convenience|1
413620|NCT00623727|1385737|P1|Open Label Follow-up|Participant convenience|0
413621|NCT00623727|1385736|P2|Open Label Follow-up|Study termination|6
413622|NCT00623727|1385737|P1|Open Label Follow-up|Study termination|0
413623|NCT00623727|1385736|P2|Open Label Follow-up|Withdrawal by Subject|1
413624|NCT00623727|1385737|P1|Open Label Follow-up|Withdrawal by Subject|0
413625|NCT00623727|1385736|P2|Double Blind (DB)|Protocol Violation|2
413626|NCT00623727|1385737|P1|Double Blind (DB)|Protocol Violation|2
413627|NCT00623727|1385736|P2|Double Blind (DB)|Lost to Follow-up|1
413628|NCT00623727|1385737|P1|Double Blind (DB)|Lost to Follow-up|1
413629|NCT00623727|1385736|P2|Double Blind (DB)|Termination of the double-blind period|21
413630|NCT00623727|1385737|P1|Double Blind (DB)|Termination of the double-blind period|22
413631|NCT00623727|1385736|P2|Double Blind (DB)|Lack of Efficacy|2
413632|NCT00623727|1385737|P1|Double Blind (DB)|Lack of Efficacy|2
413633|NCT00623727|1385736|P2|Double Blind (DB)|Withdrawal by Subject|2
413634|NCT00623727|1385737|P1|Double Blind (DB)|Withdrawal by Subject|8
413635|NCT00623727|1385736|P2|Double Blind (DB)|Physician Decision|1
413636|NCT00623727|1385737|P1|Double Blind (DB)|Physician Decision|0
413637|NCT00623727|1385736|P2|Double Blind (DB)|Adverse Event|3
413638|NCT00623727|1385737|P1|Double Blind (DB)|Adverse Event|1
413639|NCT00623597|1385792|P2|Overall Study|Failed to return|0
413640|NCT00623597|1385793|P1|Overall Study|Failed to return|1
413641|NCT00623545|1385856|P1|Overall Study|Withdrawal by Subject|4
413642|NCT00623545|1385856|P1|Overall Study|Adverse Event|6
413643|NCT00623480|1385876|P2|Overall Study|Site closed by sponsor|1
413644|NCT00623480|1385877|P1|Overall Study|Site closed by sponsor|0
413645|NCT00623480|1385876|P2|Overall Study|Protocol Violation|1
413646|NCT00623480|1385877|P1|Overall Study|Protocol Violation|0
413647|NCT00623480|1385876|P2|Overall Study|Non-compliant with study medication|0
413648|NCT00623480|1385877|P1|Overall Study|Non-compliant with study medication|4
413649|NCT00623480|1385876|P2|Overall Study|Lack of Efficacy|0
413650|NCT00623480|1385877|P1|Overall Study|Lack of Efficacy|1
413651|NCT00623480|1385876|P2|Overall Study|Withdrawal by Subject|4
413652|NCT00623480|1385877|P1|Overall Study|Withdrawal by Subject|2
413653|NCT00623480|1385876|P2|Overall Study|Lost to Follow-up|1
413654|NCT00623480|1385877|P1|Overall Study|Lost to Follow-up|0
413655|NCT00623467|1385889|P1|Overall Study|Withdrawal by Subject|2
413656|NCT00623467|1385889|P1|Overall Study|Protocol Violation|4
413657|NCT00623467|1385889|P1|Overall Study|Lost to Follow-up|1
413658|NCT00623428|1385959|P2|Follow-up Period|Death|1
413659|NCT00623428|1385960|P1|Follow-up Period|Death|0
413660|NCT00623428|1385959|P2|Follow-up Period|Reason not specified|1
413661|NCT00623428|1385960|P1|Follow-up Period|Reason not specified|1
413662|NCT00623428|1385959|P2|Follow-up Period|Did not cooperate|3
413663|NCT00623428|1385960|P1|Follow-up Period|Did not cooperate|0
413664|NCT00623428|1385959|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
413665|NCT00623428|1385960|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
413666|NCT00623428|1385959|P2|Follow-up Period|Patient withdrew consent|4
413667|NCT00623428|1385960|P1|Follow-up Period|Patient withdrew consent|5
413668|NCT00623428|1385959|P2|Follow-up Period|Failure to return|2
413669|NCT00623428|1385960|P1|Follow-up Period|Failure to return|10
413670|NCT00623428|1385959|P2|Follow-up Period|Relapse post-treatment|3
413671|NCT00623428|1385960|P1|Follow-up Period|Relapse post-treatment|11
413672|NCT00623428|1385959|P2|Treatment Period|Withdrawal by Subject|1
413673|NCT00623428|1385960|P1|Treatment Period|Withdrawal by Subject|0
413674|NCT00623428|1385959|P2|Treatment Period|Other|1
413675|NCT00623428|1385960|P1|Treatment Period|Other|0
413676|NCT00623428|1385959|P2|Treatment Period|Insufficient therapeutic response|2
413677|NCT00623428|1385960|P1|Treatment Period|Insufficient therapeutic response|0
413678|NCT00623428|1385959|P2|Treatment Period|Did not cooperate / refused treatment|13
413679|NCT00623428|1385960|P1|Treatment Period|Did not cooperate / refused treatment|0
413680|NCT00623428|1385959|P2|Treatment Period|Death|1
413681|NCT00623428|1385960|P1|Treatment Period|Death|0
413682|NCT00623428|1385959|P2|Treatment Period|Adverse event/intercurrent illness|9
413683|NCT00623428|1385960|P1|Treatment Period|Adverse event/intercurrent illness|0
413684|NCT00623233|1385978|P1|Overall Study|Withdrawal by Subject|3
413685|NCT00623233|1385978|P1|Overall Study|Lost to Follow-up|1
413686|NCT00623233|1385978|P1|Overall Study|Physician Decision|10
413687|NCT00623233|1385978|P1|Overall Study|Adverse Event|10
413688|NCT00623194|1385985|P1|Overall Study|Unclassified|1
413689|NCT00623194|1385985|P1|Overall Study|Protocol Violation|3
413690|NCT00623194|1385985|P1|Overall Study|Lack of Efficacy|1
413691|NCT00623103|1386022|P2|Overall Study|Protocol deviation|1
413692|NCT00623103|1386023|P1|Overall Study|Protocol deviation|2
413693|NCT00623103|1386022|P2|Overall Study|Death|11
413694|NCT00623103|1386023|P1|Overall Study|Death|11
413695|NCT00623103|1386022|P2|Overall Study|Administrative problems|4
413696|NCT00623103|1386023|P1|Overall Study|Administrative problems|2
413697|NCT00623103|1386022|P2|Overall Study|Lost to Follow-up|1
413698|NCT00623103|1386023|P1|Overall Study|Lost to Follow-up|4
413699|NCT00623103|1386022|P2|Overall Study|Withdrawal by Subject|24
413700|NCT00623103|1386023|P1|Overall Study|Withdrawal by Subject|18
413701|NCT00623103|1386022|P2|Overall Study|Unsatisfactory therapeutic effect|12
413702|NCT00623103|1386023|P1|Overall Study|Unsatisfactory therapeutic effect|4
413703|NCT00623103|1386022|P2|Overall Study|Adverse Event|60
413704|NCT00623103|1386023|P1|Overall Study|Adverse Event|70
413705|NCT00622908|1386051|P2|Overall Study|Termination by study sponser|1
413706|NCT00622908|1386052|P1|Overall Study|Termination by study sponser|0
413707|NCT00622908|1386051|P2|Overall Study|Refusal|1
413708|NCT00622908|1386052|P1|Overall Study|Refusal|0
413709|NCT00622908|1386051|P2|Overall Study|Lost to Follow-up|0
413710|NCT00622908|1386052|P1|Overall Study|Lost to Follow-up|1
413711|NCT00622908|1386051|P2|Overall Study|Lack of Efficacy|7
413712|NCT00622908|1386052|P1|Overall Study|Lack of Efficacy|1
413713|NCT00622908|1386051|P2|Overall Study|Adverse Event|1
413714|NCT00622908|1386052|P1|Overall Study|Adverse Event|0
413715|NCT00622908|1386051|P2|Overall Study|Protocol Violation|0
413716|NCT00622908|1386052|P1|Overall Study|Protocol Violation|1
413717|NCT00622869|1386082|P3|Overall Study|Missing|1
413718|NCT00622869|1386083|P2|Overall Study|Missing|1
413719|NCT00622869|1386084|P1|Overall Study|Missing|0
413720|NCT00622869|1386082|P3|Overall Study|Graft Loss|2
413721|NCT00622869|1386083|P2|Overall Study|Graft Loss|3
413722|NCT00622869|1386084|P1|Overall Study|Graft Loss|5
413723|NCT00622869|1386082|P3|Overall Study|Lost to Follow-up|2
413724|NCT00622869|1386083|P2|Overall Study|Lost to Follow-up|4
413725|NCT00622869|1386084|P1|Overall Study|Lost to Follow-up|2
413726|NCT00622869|1386082|P3|Overall Study|Death|10
413727|NCT00622869|1386083|P2|Overall Study|Death|15
413728|NCT00622869|1386084|P1|Overall Study|Death|12
413729|NCT00622869|1386082|P3|Overall Study|Administrative Problems|13
413730|NCT00622869|1386083|P2|Overall Study|Administrative Problems|17
413731|NCT00622869|1386084|P1|Overall Study|Administrative Problems|11
413732|NCT00622869|1386082|P3|Overall Study|Subject Withdrew Consent|11
413733|NCT00622869|1386083|P2|Overall Study|Subject Withdrew Consent|17
413734|NCT00622869|1386084|P1|Overall Study|Subject Withdrew Consent|13
413735|NCT00622739|1386103|P2|Overall Study|Lost to Follow-up|1
413736|NCT00622739|1386104|P1|Overall Study|Lost to Follow-up|0
413737|NCT00622739|1386103|P2|Overall Study|Withdrawal by Subject|1
413738|NCT00622739|1386104|P1|Overall Study|Withdrawal by Subject|0
413739|NCT00622739|1386103|P2|Overall Study|Lack of Efficacy|2
413740|NCT00622739|1386104|P1|Overall Study|Lack of Efficacy|0
413741|NCT00622739|1386103|P2|Overall Study|Adverse Event|2
413742|NCT00622739|1386104|P1|Overall Study|Adverse Event|1
413743|NCT00622739|1386103|P2|Overall Study|Physician Decision|0
413744|NCT00622739|1386104|P1|Overall Study|Physician Decision|1
413745|NCT00622726|1386112|P2|August, 2010 to April, 2013|Death|5
413746|NCT00622726|1386113|P1|August, 2010 to April, 2013|Death|1
413747|NCT00622726|1386112|P2|March, 2008 to August, 2010|Death|2
413748|NCT00622726|1386113|P1|March, 2008 to August, 2010|Death|5
413749|NCT00622713|1386123|P1|Overall Study|Did not meet eligibility criteria|1
413750|NCT00622713|1386123|P1|Overall Study|Subject no longer required study drug|1
413751|NCT00622713|1386123|P1|Overall Study|Death|2
413752|NCT00622713|1386123|P1|Overall Study|Lost to Follow-up|5
413753|NCT00622713|1386123|P1|Overall Study|Withdrawal by Subject|11
413754|NCT00622713|1386123|P1|Overall Study|Administrative problems|4
413755|NCT00622713|1386123|P1|Overall Study|Adverse Event|35
413756|NCT00622700|1386134|P7|Extension Treatment Period|Other than specified above|1
413757|NCT00622700|1386135|P6|Extension Treatment Period|Other than specified above|1
413758|NCT00622700|1386136|P5|Extension Treatment Period|Other than specified above|0
413759|NCT00622700|1386137|P4|Extension Treatment Period|Other than specified above|0
413760|NCT00622700|1386138|P3|Extension Treatment Period|Other than specified above|0
413761|NCT00622700|1386139|P2|Extension Treatment Period|Other than specified above|0
413762|NCT00622700|1386140|P1|Extension Treatment Period|Other than specified above|0
413763|NCT00622700|1386134|P7|Extension Treatment Period|Missing|0
413764|NCT00622700|1386135|P6|Extension Treatment Period|Missing|1
413765|NCT00622700|1386136|P5|Extension Treatment Period|Missing|3
413766|NCT00622700|1386137|P4|Extension Treatment Period|Missing|2
413767|NCT00622700|1386138|P3|Extension Treatment Period|Missing|0
413768|NCT00622700|1386139|P2|Extension Treatment Period|Missing|0
413769|NCT00622700|1386140|P1|Extension Treatment Period|Missing|0
413770|NCT00622700|1386134|P7|Extension Treatment Period|Withdrawal by Subject|10
413771|NCT00622700|1386135|P6|Extension Treatment Period|Withdrawal by Subject|6
413772|NCT00622700|1386136|P5|Extension Treatment Period|Withdrawal by Subject|16
413773|NCT00622700|1386137|P4|Extension Treatment Period|Withdrawal by Subject|11
413774|NCT00622700|1386138|P3|Extension Treatment Period|Withdrawal by Subject|0
413775|NCT00622700|1386139|P2|Extension Treatment Period|Withdrawal by Subject|0
413776|NCT00622700|1386140|P1|Extension Treatment Period|Withdrawal by Subject|0
413777|NCT00622700|1386134|P7|Extension Treatment Period|Progressive Disease|2
413778|NCT00622700|1386135|P6|Extension Treatment Period|Progressive Disease|0
413779|NCT00622700|1386136|P5|Extension Treatment Period|Progressive Disease|2
413780|NCT00622700|1386137|P4|Extension Treatment Period|Progressive Disease|1
413781|NCT00622700|1386138|P3|Extension Treatment Period|Progressive Disease|0
413782|NCT00622700|1386139|P2|Extension Treatment Period|Progressive Disease|0
413783|NCT00622700|1386140|P1|Extension Treatment Period|Progressive Disease|0
413784|NCT00622700|1386134|P7|Extension Treatment Period|Lost to Follow-up|0
413785|NCT00622700|1386135|P6|Extension Treatment Period|Lost to Follow-up|0
413786|NCT00622700|1386136|P5|Extension Treatment Period|Lost to Follow-up|1
413787|NCT00622700|1386137|P4|Extension Treatment Period|Lost to Follow-up|0
413788|NCT00622700|1386138|P3|Extension Treatment Period|Lost to Follow-up|0
413789|NCT00622700|1386139|P2|Extension Treatment Period|Lost to Follow-up|0
413790|NCT00622700|1386140|P1|Extension Treatment Period|Lost to Follow-up|0
413791|NCT00622700|1386134|P7|Extension Treatment Period|Protocol Violation|0
413792|NCT00622700|1386135|P6|Extension Treatment Period|Protocol Violation|2
413793|NCT00622700|1386136|P5|Extension Treatment Period|Protocol Violation|0
413794|NCT00622700|1386137|P4|Extension Treatment Period|Protocol Violation|0
413795|NCT00622700|1386138|P3|Extension Treatment Period|Protocol Violation|0
413796|NCT00622700|1386139|P2|Extension Treatment Period|Protocol Violation|0
413797|NCT00622700|1386140|P1|Extension Treatment Period|Protocol Violation|0
413798|NCT00622700|1386134|P7|Extension Treatment Period|Lack of Efficacy|9
413799|NCT00622700|1386135|P6|Extension Treatment Period|Lack of Efficacy|1
413800|NCT00622700|1386136|P5|Extension Treatment Period|Lack of Efficacy|8
413801|NCT00622700|1386137|P4|Extension Treatment Period|Lack of Efficacy|2
413802|NCT00622700|1386138|P3|Extension Treatment Period|Lack of Efficacy|0
413803|NCT00622700|1386139|P2|Extension Treatment Period|Lack of Efficacy|0
413804|NCT00622700|1386140|P1|Extension Treatment Period|Lack of Efficacy|0
413805|NCT00622700|1386134|P7|Extension Treatment Period|Adverse Event|8
413806|NCT00622700|1386135|P6|Extension Treatment Period|Adverse Event|6
413807|NCT00622700|1386136|P5|Extension Treatment Period|Adverse Event|9
413808|NCT00622700|1386137|P4|Extension Treatment Period|Adverse Event|5
413809|NCT00622700|1386138|P3|Extension Treatment Period|Adverse Event|0
413810|NCT00622700|1386139|P2|Extension Treatment Period|Adverse Event|0
413811|NCT00622700|1386140|P1|Extension Treatment Period|Adverse Event|0
413812|NCT00622700|1386134|P7|Core Treatment Period|Other than specified above|0
413813|NCT00622700|1386135|P6|Core Treatment Period|Other than specified above|0
413814|NCT00622700|1386136|P5|Core Treatment Period|Other than specified above|0
413815|NCT00622700|1386137|P4|Core Treatment Period|Other than specified above|0
413816|NCT00622700|1386138|P3|Core Treatment Period|Other than specified above|5
413817|NCT00622700|1386139|P2|Core Treatment Period|Other than specified above|2
413818|NCT00622700|1386140|P1|Core Treatment Period|Other than specified above|2
413819|NCT00622700|1386134|P7|Core Treatment Period|Withdrawal by Subject|0
413820|NCT00622700|1386135|P6|Core Treatment Period|Withdrawal by Subject|0
413821|NCT00622700|1386136|P5|Core Treatment Period|Withdrawal by Subject|0
413822|NCT00622700|1386137|P4|Core Treatment Period|Withdrawal by Subject|0
413823|NCT00622700|1386138|P3|Core Treatment Period|Withdrawal by Subject|15
413824|NCT00622700|1386139|P2|Core Treatment Period|Withdrawal by Subject|18
413825|NCT00622700|1386140|P1|Core Treatment Period|Withdrawal by Subject|12
413826|NCT00622700|1386134|P7|Core Treatment Period|Progressive Disease|0
413827|NCT00622700|1386135|P6|Core Treatment Period|Progressive Disease|0
413828|NCT00622700|1386136|P5|Core Treatment Period|Progressive Disease|0
413829|NCT00622700|1386137|P4|Core Treatment Period|Progressive Disease|0
413830|NCT00622700|1386138|P3|Core Treatment Period|Progressive Disease|0
413831|NCT00622700|1386139|P2|Core Treatment Period|Progressive Disease|1
413832|NCT00622700|1386140|P1|Core Treatment Period|Progressive Disease|3
413833|NCT00622700|1386134|P7|Core Treatment Period|Death|0
413834|NCT00622700|1386135|P6|Core Treatment Period|Death|0
413835|NCT00622700|1386136|P5|Core Treatment Period|Death|0
413836|NCT00622700|1386137|P4|Core Treatment Period|Death|0
413837|NCT00622700|1386138|P3|Core Treatment Period|Death|0
413838|NCT00622700|1386139|P2|Core Treatment Period|Death|0
413839|NCT00622700|1386140|P1|Core Treatment Period|Death|1
413840|NCT00622700|1386134|P7|Core Treatment Period|Lost to Follow-up|0
413841|NCT00622700|1386135|P6|Core Treatment Period|Lost to Follow-up|0
413842|NCT00622700|1386136|P5|Core Treatment Period|Lost to Follow-up|0
413843|NCT00622700|1386137|P4|Core Treatment Period|Lost to Follow-up|0
413844|NCT00622700|1386138|P3|Core Treatment Period|Lost to Follow-up|1
413845|NCT00622700|1386139|P2|Core Treatment Period|Lost to Follow-up|1
413846|NCT00622700|1386140|P1|Core Treatment Period|Lost to Follow-up|1
413847|NCT00622700|1386134|P7|Core Treatment Period|Lack of Efficacy|0
413848|NCT00622700|1386135|P6|Core Treatment Period|Lack of Efficacy|0
413849|NCT00622700|1386136|P5|Core Treatment Period|Lack of Efficacy|0
413850|NCT00622700|1386137|P4|Core Treatment Period|Lack of Efficacy|0
413851|NCT00622700|1386138|P3|Core Treatment Period|Lack of Efficacy|12
413852|NCT00622700|1386139|P2|Core Treatment Period|Lack of Efficacy|6
413853|NCT00622700|1386140|P1|Core Treatment Period|Lack of Efficacy|19
413854|NCT00622700|1386134|P7|Core Treatment Period|Adverse Event|0
413855|NCT00622700|1386135|P6|Core Treatment Period|Adverse Event|0
413856|NCT00622700|1386136|P5|Core Treatment Period|Adverse Event|0
413857|NCT00622700|1386137|P4|Core Treatment Period|Adverse Event|0
413858|NCT00622700|1386138|P3|Core Treatment Period|Adverse Event|18
413859|NCT00622700|1386139|P2|Core Treatment Period|Adverse Event|25
413860|NCT00622700|1386140|P1|Core Treatment Period|Adverse Event|18
413861|NCT00622700|1386134|P7|Core Treatment Period|Randomized but Not Treated|0
413862|NCT00622700|1386135|P6|Core Treatment Period|Randomized but Not Treated|0
413863|NCT00622700|1386136|P5|Core Treatment Period|Randomized but Not Treated|0
413864|NCT00622700|1386137|P4|Core Treatment Period|Randomized but Not Treated|0
413865|NCT00622700|1386138|P3|Core Treatment Period|Randomized but Not Treated|2
413866|NCT00622700|1386139|P2|Core Treatment Period|Randomized but Not Treated|2
413867|NCT00622700|1386140|P1|Core Treatment Period|Randomized but Not Treated|0
413868|NCT00622635|1386199|P6|Treatment Period 3|Withdrawal by Subject|0
413869|NCT00622635|1386200|P5|Treatment Period 3|Withdrawal by Subject|0
413870|NCT00622635|1386201|P4|Treatment Period 3|Withdrawal by Subject|1
413871|NCT00622635|1386202|P3|Treatment Period 3|Withdrawal by Subject|0
413872|NCT00622635|1386203|P2|Treatment Period 3|Withdrawal by Subject|0
413873|NCT00622635|1386204|P1|Treatment Period 3|Withdrawal by Subject|0
413874|NCT00622635|1386199|P6|Treatment Period 3|Adverse Event|0
413875|NCT00622635|1386200|P5|Treatment Period 3|Adverse Event|0
413876|NCT00622635|1386201|P4|Treatment Period 3|Adverse Event|2
413877|NCT00622635|1386202|P3|Treatment Period 3|Adverse Event|0
413878|NCT00622635|1386203|P2|Treatment Period 3|Adverse Event|0
413879|NCT00622635|1386204|P1|Treatment Period 3|Adverse Event|0
413880|NCT00622635|1386199|P6|Treatment Period 2|Adverse Event|0
413881|NCT00622635|1386200|P5|Treatment Period 2|Adverse Event|0
413882|NCT00622635|1386201|P4|Treatment Period 2|Adverse Event|0
413883|NCT00622635|1386202|P3|Treatment Period 2|Adverse Event|0
413884|NCT00622635|1386203|P2|Treatment Period 2|Adverse Event|0
413885|NCT00622635|1386204|P1|Treatment Period 2|Adverse Event|1
413886|NCT00622635|1386199|P6|Treatment Period 1|Abnormal test procedure result(s)|0
413887|NCT00622635|1386200|P5|Treatment Period 1|Abnormal test procedure result(s)|1
413888|NCT00622635|1386201|P4|Treatment Period 1|Abnormal test procedure result(s)|0
413889|NCT00622635|1386202|P3|Treatment Period 1|Abnormal test procedure result(s)|0
413890|NCT00622635|1386203|P2|Treatment Period 1|Abnormal test procedure result(s)|0
413891|NCT00622635|1386204|P1|Treatment Period 1|Abnormal test procedure result(s)|0
413892|NCT00622635|1386199|P6|Treatment Period 1|Withdrawal by Subject|0
413893|NCT00622635|1386200|P5|Treatment Period 1|Withdrawal by Subject|0
413894|NCT00622635|1386201|P4|Treatment Period 1|Withdrawal by Subject|0
413895|NCT00622635|1386202|P3|Treatment Period 1|Withdrawal by Subject|0
413896|NCT00622635|1386203|P2|Treatment Period 1|Withdrawal by Subject|1
413897|NCT00622635|1386204|P1|Treatment Period 1|Withdrawal by Subject|0
413898|NCT00622635|1386199|P6|Treatment Period 1|Adverse Event|0
413899|NCT00622635|1386200|P5|Treatment Period 1|Adverse Event|0
413900|NCT00622635|1386201|P4|Treatment Period 1|Adverse Event|0
413901|NCT00622635|1386202|P3|Treatment Period 1|Adverse Event|1
413902|NCT00622635|1386203|P2|Treatment Period 1|Adverse Event|0
413903|NCT00622635|1386204|P1|Treatment Period 1|Adverse Event|0
413904|NCT00622440|1386282|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
413905|NCT00622440|1386283|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
413906|NCT00622440|1386282|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
413994|NCT00621842|1386508|P1|Overall Study|Adverse Event|6
413907|NCT00622440|1386283|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
413908|NCT00622440|1386282|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
413909|NCT00622440|1386283|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
413910|NCT00622440|1386282|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
413911|NCT00622440|1386283|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
413912|NCT00622401|1386309|P3|Overall Study|Disease progression prior to treatment|0
413913|NCT00622401|1386310|P2|Overall Study|Disease progression prior to treatment|2
413914|NCT00622401|1386311|P1|Overall Study|Disease progression prior to treatment|3
413915|NCT00622388|1386318|P1|Overall Study|Insurance Expired|1
413916|NCT00622388|1386318|P1|Overall Study|Withdrew Consent|1
413917|NCT00622388|1386318|P1|Overall Study|Took Prohibited Medication|2
413918|NCT00622388|1386318|P1|Overall Study|Received Alternate Anticancer Therapy|8
413919|NCT00622388|1386318|P1|Overall Study|Death|3
413920|NCT00622388|1386318|P1|Overall Study|Participant Refusal|1
413921|NCT00622388|1386318|P1|Overall Study|Protocol Violation|3
413922|NCT00622388|1386318|P1|Overall Study|Adverse Event|6
413923|NCT00622388|1386318|P1|Overall Study|Disease Progression|47
413924|NCT00622336|1386336|P1|Extension Phase|Other|9
413925|NCT00622336|1386336|P1|Extension Phase|Lost to Follow-up|1
413926|NCT00622336|1386336|P1|Extension Phase|Withdrawal by Subject|1
413927|NCT00622336|1386336|P1|Extension Phase|Lack of therapeutic effect|2
413928|NCT00622336|1386336|P1|Extension Phase|Progressive Disease|6
413929|NCT00622336|1386336|P1|Extension Phase|Adverse Event|2
413930|NCT00622336|1386336|P1|Treatment Phase|Lost to Follow-up|2
413931|NCT00622336|1386336|P1|Treatment Phase|Withdrawal by Subject|13
413932|NCT00622336|1386336|P1|Treatment Phase|Lack of therapeutic effect|13
413933|NCT00622336|1386336|P1|Treatment Phase|Death|14
413934|NCT00622336|1386336|P1|Treatment Phase|Other|40
413935|NCT00622336|1386336|P1|Treatment Phase|Adverse Event|46
413936|NCT00622336|1386336|P1|Treatment Phase|Progression of Disease|181
413937|NCT00622284|1386347|P2|Overall Study|Other reason (not specified)|24
413938|NCT00622284|1386348|P1|Overall Study|Other reason (not specified)|33
413939|NCT00622284|1386347|P2|Overall Study|Withdrawal by Subject|24
413940|NCT00622284|1386348|P1|Overall Study|Withdrawal by Subject|27
413941|NCT00622284|1386347|P2|Overall Study|Lost to Follow-up|13
413942|NCT00622284|1386348|P1|Overall Study|Lost to Follow-up|11
413943|NCT00622284|1386347|P2|Overall Study|Protocol Violation|5
413944|NCT00622284|1386348|P1|Overall Study|Protocol Violation|12
413945|NCT00622284|1386347|P2|Overall Study|Adverse Event|90
413946|NCT00622284|1386348|P1|Overall Study|Adverse Event|61
413947|NCT00622284|1386347|P2|Overall Study|Lack of Efficacy|15
413948|NCT00622284|1386348|P1|Overall Study|Lack of Efficacy|45
413949|NCT00622167|1386410|P1|Overall Study|Did not meet angiographic criteria|20
413950|NCT00621985|1386414|P1|Dexamethasone Admission|Adverse Event|1
413951|NCT00621959|1386422|P2|Overall Study|Other|3
413952|NCT00621959|1386423|P1|Overall Study|Other|1
413953|NCT00621959|1386422|P2|Overall Study|Withdrawal by Subject|1
413954|NCT00621959|1386423|P1|Overall Study|Withdrawal by Subject|1
413955|NCT00621959|1386422|P2|Overall Study|Lost to Follow-up|2
413956|NCT00621959|1386423|P1|Overall Study|Lost to Follow-up|0
413957|NCT00621959|1386422|P2|Overall Study|Lack of Efficacy|1
413958|NCT00621959|1386423|P1|Overall Study|Lack of Efficacy|1
413959|NCT00621959|1386422|P2|Overall Study|Adverse Event|2
413960|NCT00621959|1386423|P1|Overall Study|Adverse Event|4
413961|NCT00621855|1386462|P5|Overall Study|Patients did not receive study drug|2
413962|NCT00621855|1386463|P4|Overall Study|Patients did not receive study drug|4
413963|NCT00621855|1386464|P3|Overall Study|Patients did not receive study drug|5
413964|NCT00621855|1386465|P2|Overall Study|Patients did not receive study drug|3
413965|NCT00621855|1386466|P1|Overall Study|Patients did not receive study drug|3
413966|NCT00621855|1386462|P5|Overall Study|Other|4
413967|NCT00621855|1386463|P4|Overall Study|Other|5
413968|NCT00621855|1386464|P3|Overall Study|Other|6
413969|NCT00621855|1386465|P2|Overall Study|Other|7
413970|NCT00621855|1386466|P1|Overall Study|Other|9
413971|NCT00621855|1386462|P5|Overall Study|Withdrawal by Subject|9
413972|NCT00621855|1386463|P4|Overall Study|Withdrawal by Subject|13
413973|NCT00621855|1386464|P3|Overall Study|Withdrawal by Subject|13
413974|NCT00621855|1386465|P2|Overall Study|Withdrawal by Subject|11
413975|NCT00621855|1386466|P1|Overall Study|Withdrawal by Subject|16
413976|NCT00621855|1386462|P5|Overall Study|Protocol Violation|8
413977|NCT00621855|1386463|P4|Overall Study|Protocol Violation|7
413978|NCT00621855|1386464|P3|Overall Study|Protocol Violation|6
413979|NCT00621855|1386465|P2|Overall Study|Protocol Violation|8
413980|NCT00621855|1386466|P1|Overall Study|Protocol Violation|16
413981|NCT00621855|1386462|P5|Overall Study|Lost to Follow-up|1
413982|NCT00621855|1386463|P4|Overall Study|Lost to Follow-up|4
413983|NCT00621855|1386464|P3|Overall Study|Lost to Follow-up|3
413984|NCT00621855|1386465|P2|Overall Study|Lost to Follow-up|1
413985|NCT00621855|1386466|P1|Overall Study|Lost to Follow-up|0
413986|NCT00621855|1386462|P5|Overall Study|Adverse Event|31
413987|NCT00621855|1386463|P4|Overall Study|Adverse Event|34
413988|NCT00621855|1386464|P3|Overall Study|Adverse Event|48
413989|NCT00621855|1386465|P2|Overall Study|Adverse Event|31
413990|NCT00621855|1386466|P1|Overall Study|Adverse Event|32
413991|NCT00621842|1386508|P1|Overall Study|Lack of Efficacy|2
413992|NCT00621842|1386508|P1|Overall Study|Protocol Violation|4
413993|NCT00621842|1386508|P1|Overall Study|Withdrawal by Subject|7
413995|NCT00621777|1386525|P2|Randomized Phase|Death|1
413996|NCT00621777|1386526|P1|Randomized Phase|Death|0
413997|NCT00621777|1386525|P2|Randomized Phase|administrative|3
413998|NCT00621777|1386526|P1|Randomized Phase|administrative|0
413999|NCT00621777|1386525|P2|Randomized Phase|Withdrawal by Subject|9
414000|NCT00621777|1386526|P1|Randomized Phase|Withdrawal by Subject|1
414001|NCT00621777|1386525|P2|Randomized Phase|Lost to Follow-up|3
414002|NCT00621777|1386526|P1|Randomized Phase|Lost to Follow-up|3
414003|NCT00621777|1386525|P2|Randomized Phase|Adverse Event|3
414004|NCT00621777|1386526|P1|Randomized Phase|Adverse Event|3
414005|NCT00621777|1386525|P2|Open Phase|Lost to Follow-up|0
414006|NCT00621777|1386526|P1|Open Phase|Lost to Follow-up|10
414007|NCT00621777|1386525|P2|Open Phase|administrative|0
414008|NCT00621777|1386526|P1|Open Phase|administrative|13
414009|NCT00621777|1386525|P2|Open Phase|Withdrawal by Subject|0
414010|NCT00621777|1386526|P1|Open Phase|Withdrawal by Subject|17
414011|NCT00621777|1386525|P2|Open Phase|Did not abstain during open phase|0
414012|NCT00621777|1386526|P1|Open Phase|Did not abstain during open phase|56
414013|NCT00621777|1386525|P2|Open Phase|Adverse Event|0
414014|NCT00621777|1386526|P1|Open Phase|Adverse Event|20
414015|NCT00621764|1386541|P4|Overall Study|Protocol Violation|1
414016|NCT00621764|1386542|P3|Overall Study|Protocol Violation|0
414017|NCT00621764|1386543|P2|Overall Study|Protocol Violation|0
414018|NCT00621764|1386544|P1|Overall Study|Protocol Violation|0
414019|NCT00621621|1386590|P2|Overall Study|Subjects were exited at EP study|0
414020|NCT00621621|1386591|P1|Overall Study|Subjects were exited at EP study|30
414021|NCT00621582|1386599|P1|Overall Study|issues not identified by investigators|18
414022|NCT00621582|1386599|P1|Overall Study|Lost to Follow-up|24
414023|NCT00621582|1386599|P1|Overall Study|Protocol Violation|57
414024|NCT00621582|1386599|P1|Overall Study|Adverse Event|7
414025|NCT00621543|1386606|P1|Overall Study|Lost to Follow-up|23
414026|NCT00621517|1386630|P2|Overall Study|Adverse Event|0
414027|NCT00621517|1386631|P1|Overall Study|Adverse Event|1
414028|NCT00621517|1386630|P2|Overall Study|Withdrawal by Subject|4
414029|NCT00621517|1386631|P1|Overall Study|Withdrawal by Subject|3
414030|NCT00621517|1386630|P2|Overall Study|Lost to Follow-up|3
414031|NCT00621517|1386631|P1|Overall Study|Lost to Follow-up|3
414032|NCT00621504|1386639|P2|Overall Study|Death|6
414033|NCT00621504|1386640|P1|Overall Study|Death|6
414034|NCT00621504|1386639|P2|Overall Study|Other|0
414035|NCT00621504|1386640|P1|Overall Study|Other|1
414036|NCT00621504|1386639|P2|Overall Study|Lost to Follow-up|10
414037|NCT00621504|1386640|P1|Overall Study|Lost to Follow-up|8
414038|NCT00621504|1386639|P2|Overall Study|Withdrew consent|6
414039|NCT00621504|1386640|P1|Overall Study|Withdrew consent|9
414040|NCT00621504|1386639|P2|Overall Study|At the request of sponsor/investigator|0
414041|NCT00621504|1386640|P1|Overall Study|At the request of sponsor/investigator|1
414042|NCT00621504|1386639|P2|Overall Study|Adverse Event|3
414043|NCT00621504|1386640|P1|Overall Study|Adverse Event|1
414044|NCT00621322|1386674|P6|Overall Study|Migrated/moved from study area|2
414045|NCT00621322|1386675|P5|Overall Study|Migrated/moved from study area|0
414046|NCT00621322|1386676|P4|Overall Study|Migrated/moved from study area|1
414047|NCT00621322|1386677|P3|Overall Study|Migrated/moved from study area|1
414048|NCT00621322|1386678|P2|Overall Study|Migrated/moved from study area|0
414049|NCT00621322|1386679|P1|Overall Study|Migrated/moved from study area|1
414050|NCT00621322|1386674|P6|Overall Study|Withdrawal by Subject|2
414051|NCT00621322|1386675|P5|Overall Study|Withdrawal by Subject|0
414052|NCT00621322|1386676|P4|Overall Study|Withdrawal by Subject|1
414053|NCT00621322|1386677|P3|Overall Study|Withdrawal by Subject|0
414054|NCT00621322|1386678|P2|Overall Study|Withdrawal by Subject|0
414055|NCT00621322|1386679|P1|Overall Study|Withdrawal by Subject|0
414056|NCT00621322|1386674|P6|Overall Study|Physician Decision|0
414057|NCT00621322|1386675|P5|Overall Study|Physician Decision|0
414058|NCT00621322|1386676|P4|Overall Study|Physician Decision|1
414059|NCT00621322|1386677|P3|Overall Study|Physician Decision|1
414060|NCT00621322|1386678|P2|Overall Study|Physician Decision|0
414061|NCT00621322|1386679|P1|Overall Study|Physician Decision|0
414062|NCT00621322|1386674|P6|Overall Study|Lost to Follow-up|0
414063|NCT00621322|1386675|P5|Overall Study|Lost to Follow-up|1
414064|NCT00621322|1386676|P4|Overall Study|Lost to Follow-up|0
414065|NCT00621322|1386677|P3|Overall Study|Lost to Follow-up|0
414066|NCT00621322|1386678|P2|Overall Study|Lost to Follow-up|0
414067|NCT00621322|1386679|P1|Overall Study|Lost to Follow-up|0
414068|NCT00621296|1386759|P1|Overall Study|Stopping Criteria|3
414069|NCT00621296|1386759|P1|Overall Study|Unmatch Criteria|1
414070|NCT00621296|1386759|P1|Overall Study|Physician Decision|7
414071|NCT00621296|1386759|P1|Overall Study|Lack of Efficacy|1
414072|NCT00621296|1386759|P1|Overall Study|Adverse Event|2
414073|NCT00621257|1386768|P5|Overall Study|Withdrawal by Subject|1
414074|NCT00621257|1386769|P4|Overall Study|Withdrawal by Subject|1
414075|NCT00621257|1386770|P3|Overall Study|Withdrawal by Subject|0
414076|NCT00621257|1386771|P2|Overall Study|Withdrawal by Subject|0
414077|NCT00621257|1386772|P1|Overall Study|Withdrawal by Subject|0
414078|NCT00621257|1386768|P5|Overall Study|Physician Decision|1
414079|NCT00621257|1386769|P4|Overall Study|Physician Decision|1
414080|NCT00621257|1386770|P3|Overall Study|Physician Decision|0
414081|NCT00621257|1386771|P2|Overall Study|Physician Decision|2
414082|NCT00621257|1386772|P1|Overall Study|Physician Decision|0
414083|NCT00621257|1386768|P5|Overall Study|Adverse Event|0
414084|NCT00621257|1386769|P4|Overall Study|Adverse Event|0
414085|NCT00621257|1386770|P3|Overall Study|Adverse Event|1
414086|NCT00621257|1386771|P2|Overall Study|Adverse Event|1
414087|NCT00621257|1386772|P1|Overall Study|Adverse Event|0
414088|NCT00621257|1386768|P5|Overall Study|Lost to Follow-up|7
414089|NCT00621257|1386769|P4|Overall Study|Lost to Follow-up|4
414090|NCT00621257|1386770|P3|Overall Study|Lost to Follow-up|2
414091|NCT00621257|1386771|P2|Overall Study|Lost to Follow-up|0
414092|NCT00621257|1386772|P1|Overall Study|Lost to Follow-up|4
414093|NCT00621244|1386788|P4|Overall Study|Administrative problems|2
414094|NCT00621244|1386789|P3|Overall Study|Administrative problems|0
414095|NCT00621244|1386790|P2|Overall Study|Administrative problems|1
414096|NCT00621244|1386791|P1|Overall Study|Administrative problems|5
414097|NCT00621244|1386788|P4|Overall Study|Adverse Event|2
414098|NCT00621244|1386789|P3|Overall Study|Adverse Event|9
414099|NCT00621244|1386790|P2|Overall Study|Adverse Event|7
414100|NCT00621244|1386791|P1|Overall Study|Adverse Event|27
414101|NCT00621244|1386788|P4|Overall Study|Death|1
414102|NCT00621244|1386789|P3|Overall Study|Death|1
414103|NCT00621244|1386790|P2|Overall Study|Death|3
414104|NCT00621244|1386791|P1|Overall Study|Death|3
414105|NCT00621244|1386788|P4|Overall Study|Disease progression|15
414106|NCT00621244|1386789|P3|Overall Study|Disease progression|20
414107|NCT00621244|1386790|P2|Overall Study|Disease progression|20
414108|NCT00621244|1386791|P1|Overall Study|Disease progression|44
414109|NCT00621244|1386788|P4|Overall Study|Withdrawal by Subject|3
414110|NCT00621244|1386789|P3|Overall Study|Withdrawal by Subject|3
414111|NCT00621244|1386790|P2|Overall Study|Withdrawal by Subject|3
414112|NCT00621244|1386791|P1|Overall Study|Withdrawal by Subject|7
414113|NCT00621192|1386895|P4|Overall Study|Final Assessments not Completed|1
414114|NCT00621192|1386896|P3|Overall Study|Final Assessments not Completed|3
414115|NCT00621192|1386897|P2|Overall Study|Final Assessments not Completed|0
414116|NCT00621192|1386898|P1|Overall Study|Final Assessments not Completed|0
414117|NCT00621192|1386895|P4|Overall Study|Death|0
414118|NCT00621192|1386896|P3|Overall Study|Death|0
414119|NCT00621192|1386897|P2|Overall Study|Death|5
414120|NCT00621192|1386898|P1|Overall Study|Death|2
414121|NCT00621192|1386895|P4|Overall Study|Adverse Event|1
414122|NCT00621192|1386896|P3|Overall Study|Adverse Event|0
414123|NCT00621192|1386897|P2|Overall Study|Adverse Event|1
414124|NCT00621192|1386898|P1|Overall Study|Adverse Event|0
414125|NCT00621192|1386895|P4|Overall Study|Protocol Violation|1
414126|NCT00621192|1386896|P3|Overall Study|Protocol Violation|0
414127|NCT00621192|1386897|P2|Overall Study|Protocol Violation|0
414128|NCT00621192|1386898|P1|Overall Study|Protocol Violation|1
414129|NCT00621192|1386895|P4|Overall Study|Physician Decision|0
414130|NCT00621192|1386896|P3|Overall Study|Physician Decision|0
414131|NCT00621192|1386897|P2|Overall Study|Physician Decision|3
414132|NCT00621192|1386898|P1|Overall Study|Physician Decision|1
414133|NCT00621192|1386895|P4|Overall Study|Withdrawal by Subject|0
414134|NCT00621192|1386896|P3|Overall Study|Withdrawal by Subject|2
414135|NCT00621192|1386897|P2|Overall Study|Withdrawal by Subject|0
414136|NCT00621192|1386898|P1|Overall Study|Withdrawal by Subject|0
414137|NCT00621153|1386922|P2|Overall Study|Withdrawal by Subject|5
414138|NCT00621153|1386923|P1|Overall Study|Withdrawal by Subject|4
414139|NCT00621153|1386922|P2|Overall Study|Lost to Follow-up|1
414140|NCT00621153|1386923|P1|Overall Study|Lost to Follow-up|5
414141|NCT00621153|1386922|P2|Overall Study|Adverse Event|2
414142|NCT00621153|1386923|P1|Overall Study|Adverse Event|3
414143|NCT00621153|1386922|P2|Overall Study|Safety Reason|7
414144|NCT00621153|1386923|P1|Overall Study|Safety Reason|8
414145|NCT00621140|1386931|P2|Overall Study|Other incl. lack of efficacy|5
414146|NCT00621140|1386932|P1|Overall Study|Other incl. lack of efficacy|6
414147|NCT00621140|1386931|P2|Overall Study|Withdrawal by Subject|6
414148|NCT00621140|1386932|P1|Overall Study|Withdrawal by Subject|4
414149|NCT00621140|1386931|P2|Overall Study|Lost to Follow-up|2
414150|NCT00621140|1386932|P1|Overall Study|Lost to Follow-up|1
414151|NCT00621140|1386931|P2|Overall Study|Adverse Event|5
414152|NCT00621140|1386932|P1|Overall Study|Adverse Event|4
414153|NCT00621023|1386979|P1|Overall Study|Follow up discontinued|1
414154|NCT00621023|1386979|P1|Overall Study|Death|5
414155|NCT00620854|1386996|P6|Washout 1|Withdrawal by Subject|0
414156|NCT00620854|1386997|P5|Washout 1|Withdrawal by Subject|0
414157|NCT00620854|1386998|P4|Washout 1|Withdrawal by Subject|1
414158|NCT00620854|1386999|P3|Washout 1|Withdrawal by Subject|1
414159|NCT00620854|1387000|P2|Washout 1|Withdrawal by Subject|0
414160|NCT00620854|1387001|P1|Washout 1|Withdrawal by Subject|0
414161|NCT00620815|1387032|P3|Overall Study|Protocol Violation|1
414162|NCT00620815|1387033|P2|Overall Study|Protocol Violation|2
414163|NCT00620815|1387034|P1|Overall Study|Protocol Violation|1
414164|NCT00620815|1387032|P3|Overall Study|Inappropriate enrolment|1
414165|NCT00620815|1387033|P2|Overall Study|Inappropriate enrolment|0
414166|NCT00620815|1387034|P1|Overall Study|Inappropriate enrolment|0
414167|NCT00620815|1387032|P3|Overall Study|Lost to Follow-up|3
414168|NCT00620815|1387033|P2|Overall Study|Lost to Follow-up|6
414169|NCT00620815|1387034|P1|Overall Study|Lost to Follow-up|1
414170|NCT00620815|1387032|P3|Overall Study|Withdrawal by Subject|0
414171|NCT00620815|1387033|P2|Overall Study|Withdrawal by Subject|2
414172|NCT00620815|1387034|P1|Overall Study|Withdrawal by Subject|1
414173|NCT00620815|1387032|P3|Overall Study|Adverse Event|2
414174|NCT00620815|1387033|P2|Overall Study|Adverse Event|1
414175|NCT00620815|1387034|P1|Overall Study|Adverse Event|1
414176|NCT00620776|1387074|P2|Overall Study|Withdrawal by Subject|2
414177|NCT00620776|1387075|P1|Overall Study|Withdrawal by Subject|3
414178|NCT00620776|1387074|P2|Overall Study|Lost to Follow-up|5
414179|NCT00620776|1387075|P1|Overall Study|Lost to Follow-up|2
414180|NCT00620776|1387074|P2|Overall Study|Lack of Efficacy|1
414181|NCT00620776|1387075|P1|Overall Study|Lack of Efficacy|2
414182|NCT00620776|1387074|P2|Overall Study|Adverse Event|3
414183|NCT00620776|1387075|P1|Overall Study|Adverse Event|2
414184|NCT00620776|1387074|P2|Overall Study|Did not receive treatment|5
414185|NCT00620776|1387075|P1|Overall Study|Did not receive treatment|3
414186|NCT00620763|1387103|P2|Period: Second Intervention|Withdrawal by Subject|0
414187|NCT00620763|1387104|P1|Period: Second Intervention|Withdrawal by Subject|1
414188|NCT00620763|1387103|P2|Period: First Intervention|Protocol Violation|3
414189|NCT00620763|1387104|P1|Period: First Intervention|Protocol Violation|0
414190|NCT00620763|1387103|P2|Period: First Intervention|Withdrawal by Subject|2
414191|NCT00620763|1387104|P1|Period: First Intervention|Withdrawal by Subject|0
414192|NCT00620750|1387110|P1|Overall Study|Lost to Follow-up|25
414193|NCT00620659|1387125|P6|Treatment Period 3|Withdrawal by Subject|0
414194|NCT00620659|1387126|P5|Treatment Period 3|Withdrawal by Subject|0
414195|NCT00620659|1387127|P4|Treatment Period 3|Withdrawal by Subject|1
414196|NCT00620659|1387128|P3|Treatment Period 3|Withdrawal by Subject|0
414197|NCT00620659|1387129|P2|Treatment Period 3|Withdrawal by Subject|0
414198|NCT00620659|1387130|P1|Treatment Period 3|Withdrawal by Subject|0
414199|NCT00620659|1387125|P6|Treatment Period 3|Adverse Event|0
414200|NCT00620659|1387126|P5|Treatment Period 3|Adverse Event|0
414201|NCT00620659|1387127|P4|Treatment Period 3|Adverse Event|0
414202|NCT00620659|1387128|P3|Treatment Period 3|Adverse Event|0
414203|NCT00620659|1387129|P2|Treatment Period 3|Adverse Event|2
414204|NCT00620659|1387130|P1|Treatment Period 3|Adverse Event|0
414205|NCT00620659|1387125|P6|Placebo Washout Period 2|Adverse Event|0
414206|NCT00620659|1387126|P5|Placebo Washout Period 2|Adverse Event|0
414207|NCT00620659|1387127|P4|Placebo Washout Period 2|Adverse Event|0
414208|NCT00620659|1387128|P3|Placebo Washout Period 2|Adverse Event|0
414209|NCT00620659|1387129|P2|Placebo Washout Period 2|Adverse Event|0
414210|NCT00620659|1387130|P1|Placebo Washout Period 2|Adverse Event|2
414211|NCT00620659|1387125|P6|Treatment Period 2|Withdrawal by Subject|0
414212|NCT00620659|1387126|P5|Treatment Period 2|Withdrawal by Subject|3
414213|NCT00620659|1387127|P4|Treatment Period 2|Withdrawal by Subject|0
414214|NCT00620659|1387128|P3|Treatment Period 2|Withdrawal by Subject|1
414215|NCT00620659|1387129|P2|Treatment Period 2|Withdrawal by Subject|0
414216|NCT00620659|1387130|P1|Treatment Period 2|Withdrawal by Subject|0
414217|NCT00620659|1387125|P6|Treatment Period 2|Adverse Event|0
414218|NCT00620659|1387126|P5|Treatment Period 2|Adverse Event|2
414219|NCT00620659|1387127|P4|Treatment Period 2|Adverse Event|0
414220|NCT00620659|1387128|P3|Treatment Period 2|Adverse Event|0
414221|NCT00620659|1387129|P2|Treatment Period 2|Adverse Event|3
414222|NCT00620659|1387130|P1|Treatment Period 2|Adverse Event|0
414223|NCT00620659|1387125|P6|Placebo Washout Period 1|Withdrawal by Subject|0
414224|NCT00620659|1387126|P5|Placebo Washout Period 1|Withdrawal by Subject|0
414225|NCT00620659|1387127|P4|Placebo Washout Period 1|Withdrawal by Subject|1
414226|NCT00620659|1387128|P3|Placebo Washout Period 1|Withdrawal by Subject|0
414227|NCT00620659|1387129|P2|Placebo Washout Period 1|Withdrawal by Subject|0
414228|NCT00620659|1387130|P1|Placebo Washout Period 1|Withdrawal by Subject|0
414229|NCT00620659|1387125|P6|Treatment Period 1|Withdrawal by Subject|0
414230|NCT00620659|1387126|P5|Treatment Period 1|Withdrawal by Subject|1
414231|NCT00620659|1387127|P4|Treatment Period 1|Withdrawal by Subject|0
414232|NCT00620659|1387128|P3|Treatment Period 1|Withdrawal by Subject|1
414233|NCT00620659|1387129|P2|Treatment Period 1|Withdrawal by Subject|0
414234|NCT00620659|1387130|P1|Treatment Period 1|Withdrawal by Subject|1
414235|NCT00620659|1387125|P6|Treatment Period 1|Protocol Violation|0
414236|NCT00620659|1387126|P5|Treatment Period 1|Protocol Violation|0
414237|NCT00620659|1387127|P4|Treatment Period 1|Protocol Violation|0
414238|NCT00620659|1387128|P3|Treatment Period 1|Protocol Violation|0
414239|NCT00620659|1387129|P2|Treatment Period 1|Protocol Violation|0
414240|NCT00620659|1387130|P1|Treatment Period 1|Protocol Violation|1
414241|NCT00620659|1387125|P6|Treatment Period 1|Adverse Event|0
414242|NCT00620659|1387126|P5|Treatment Period 1|Adverse Event|0
414243|NCT00620659|1387127|P4|Treatment Period 1|Adverse Event|3
414244|NCT00620659|1387128|P3|Treatment Period 1|Adverse Event|0
414245|NCT00620659|1387129|P2|Treatment Period 1|Adverse Event|0
414246|NCT00620659|1387130|P1|Treatment Period 1|Adverse Event|1
414247|NCT00620555|1387148|P1|Overall Study|Visit failure against planned|1
414248|NCT00620555|1387148|P1|Overall Study|Choice of other treatment|1
414249|NCT00620555|1387148|P1|Overall Study|Withdrawal by Subject|1
414250|NCT00620555|1387148|P1|Overall Study|Lack of Efficacy|12
414251|NCT00620555|1387148|P1|Overall Study|Protocol Violation|2
414252|NCT00620555|1387148|P1|Overall Study|Adverse Event|4
414253|NCT00620542|1387157|P4|Part B (2 Year Core Study)|IVUS not available|2
414254|NCT00620542|1387158|P3|Part B (2 Year Core Study)|IVUS not available|3
414255|NCT00620542|1387159|P2|Part B (2 Year Core Study)|IVUS not available|0
414256|NCT00620542|1387160|P1|Part B (2 Year Core Study)|IVUS not available|0
414257|NCT00620542|1387157|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
414258|NCT00620542|1387158|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
414259|NCT00620542|1387159|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
414260|NCT00620542|1387160|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
414261|NCT00620542|1387157|P4|Part B (2 Year Core Study)|Safety reasons|3
414262|NCT00620542|1387158|P3|Part B (2 Year Core Study)|Safety reasons|2
414263|NCT00620542|1387159|P2|Part B (2 Year Core Study)|Safety reasons|0
414264|NCT00620542|1387160|P1|Part B (2 Year Core Study)|Safety reasons|0
414265|NCT00620542|1387157|P4|Part B (2 Year Core Study)|Protocol Violation|16
414266|NCT00620542|1387158|P3|Part B (2 Year Core Study)|Protocol Violation|13
414267|NCT00620542|1387159|P2|Part B (2 Year Core Study)|Protocol Violation|0
414268|NCT00620542|1387160|P1|Part B (2 Year Core Study)|Protocol Violation|0
414269|NCT00620542|1387157|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
414270|NCT00620542|1387158|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
414271|NCT00620542|1387159|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
414272|NCT00620542|1387160|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
414273|NCT00620542|1387157|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
414274|NCT00620542|1387158|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
414275|NCT00620542|1387159|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
414276|NCT00620542|1387160|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
414277|NCT00620542|1387157|P4|Part B (2 Year Core Study)|Protocol Violation|5
414278|NCT00620542|1387158|P3|Part B (2 Year Core Study)|Protocol Violation|3
414279|NCT00620542|1387159|P2|Part B (2 Year Core Study)|Protocol Violation|0
414280|NCT00620542|1387160|P1|Part B (2 Year Core Study)|Protocol Violation|0
414281|NCT00620542|1387157|P4|Part B (2 Year Core Study)|Adverse Event|49
414282|NCT00620542|1387158|P3|Part B (2 Year Core Study)|Adverse Event|46
414283|NCT00620542|1387159|P2|Part B (2 Year Core Study)|Adverse Event|0
414284|NCT00620542|1387160|P1|Part B (2 Year Core Study)|Adverse Event|0
414285|NCT00620542|1387157|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
414286|NCT00620542|1387158|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
414287|NCT00620542|1387159|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
414288|NCT00620542|1387160|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
414289|NCT00620542|1387157|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
414290|NCT00620542|1387158|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
414291|NCT00620542|1387159|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
414292|NCT00620542|1387160|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
414293|NCT00620542|1387157|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
414294|NCT00620542|1387158|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
414295|NCT00620542|1387159|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
414296|NCT00620542|1387160|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
414297|NCT00620542|1387157|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
414298|NCT00620542|1387158|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
414299|NCT00620542|1387159|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
414300|NCT00620542|1387160|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
414301|NCT00620542|1387157|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
414302|NCT00620542|1387158|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
414303|NCT00620542|1387159|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
414304|NCT00620542|1387160|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
414305|NCT00620542|1387157|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
414306|NCT00620542|1387158|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
414307|NCT00620542|1387159|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
414308|NCT00620542|1387160|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
414309|NCT00620542|1387157|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
414310|NCT00620542|1387158|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
414311|NCT00620542|1387159|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
414312|NCT00620542|1387160|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
414313|NCT00620464|1387200|P2|Overall Study|Used prohibited medication|0
414314|NCT00620464|1387201|P1|Overall Study|Used prohibited medication|1
414315|NCT00620464|1387200|P2|Overall Study|Personal|2
414316|NCT00620464|1387201|P1|Overall Study|Personal|2
414317|NCT00620464|1387200|P2|Overall Study|Planning Pregnancy|4
414318|NCT00620464|1387201|P1|Overall Study|Planning Pregnancy|1
414319|NCT00620464|1387200|P2|Overall Study|Lost to Follow-up|1
414320|NCT00620464|1387201|P1|Overall Study|Lost to Follow-up|1
414321|NCT00620464|1387200|P2|Overall Study|Adverse Event|17
414322|NCT00620464|1387201|P1|Overall Study|Adverse Event|15
414323|NCT00620373|1387220|P1|Overall Study|Unverified cancer status|33
414324|NCT00620282|1387239|P3|Overall Study|Withdrawal by Subject|0
414325|NCT00620282|1387240|P2|Overall Study|Withdrawal by Subject|1
414326|NCT00620282|1387241|P1|Overall Study|Withdrawal by Subject|0
414327|NCT00620282|1387239|P3|Overall Study|Arterial line unable to be placed|1
414328|NCT00620282|1387240|P2|Overall Study|Arterial line unable to be placed|0
414329|NCT00620282|1387241|P1|Overall Study|Arterial line unable to be placed|0
414330|NCT00620282|1387239|P3|Overall Study|Adverse Event|0
414331|NCT00620282|1387240|P2|Overall Study|Adverse Event|1
414332|NCT00620282|1387241|P1|Overall Study|Adverse Event|0
414333|NCT00620113|1387305|P4|Overall Study|Withdrawal by Subject|5
414334|NCT00620113|1387306|P3|Overall Study|Withdrawal by Subject|3
414335|NCT00620113|1387307|P2|Overall Study|Withdrawal by Subject|1
414336|NCT00620113|1387308|P1|Overall Study|Withdrawal by Subject|5
414337|NCT00620113|1387305|P4|Overall Study|Protocol Violation|0
414338|NCT00620113|1387306|P3|Overall Study|Protocol Violation|0
414339|NCT00620113|1387307|P2|Overall Study|Protocol Violation|1
414340|NCT00620113|1387308|P1|Overall Study|Protocol Violation|2
414341|NCT00620113|1387305|P4|Overall Study|Physician Decision|2
414342|NCT00620113|1387306|P3|Overall Study|Physician Decision|0
414343|NCT00620113|1387307|P2|Overall Study|Physician Decision|0
414344|NCT00620113|1387308|P1|Overall Study|Physician Decision|1
414345|NCT00620113|1387305|P4|Overall Study|Lack of Efficacy|2
414346|NCT00620113|1387306|P3|Overall Study|Lack of Efficacy|0
414347|NCT00620113|1387307|P2|Overall Study|Lack of Efficacy|3
414348|NCT00620113|1387308|P1|Overall Study|Lack of Efficacy|2
414349|NCT00620113|1387305|P4|Overall Study|Adverse Event|1
414350|NCT00620113|1387306|P3|Overall Study|Adverse Event|2
414351|NCT00620113|1387307|P2|Overall Study|Adverse Event|2
414352|NCT00620113|1387308|P1|Overall Study|Adverse Event|3
414353|NCT00620074|1387358|P1|Overall Study|Adverse Event|1
414354|NCT00620035|1387366|P1|Overall Study|Other Reason|38
414355|NCT00620035|1387366|P1|Overall Study|Withdrawal of Informed Consent|1
414356|NCT00620035|1387366|P1|Overall Study|Adverse Event|106
414357|NCT00620022|1387376|P2|Treatment Period 2|Adverse Event|2
414358|NCT00620022|1387377|P1|Treatment Period 2|Adverse Event|2
414359|NCT00620022|1387376|P2|Treatment Period 1|Subject withdrew consent|0
414360|NCT00620022|1387377|P1|Treatment Period 1|Subject withdrew consent|1
414361|NCT00620022|1387376|P2|Treatment Period 1|Adverse Event|6
414362|NCT00620022|1387377|P1|Treatment Period 1|Adverse Event|4
414363|NCT00619983|1387389|P4|Test Drug Alone|Failure of daily diary device|2
414364|NCT00619983|1387390|P3|Test Drug Alone|Failure of daily diary device|2
414365|NCT00619983|1387391|P2|Test Drug Alone|Failure of daily diary device|1
414366|NCT00619983|1387392|P1|Test Drug Alone|Failure of daily diary device|1
414367|NCT00619983|1387389|P4|Test Drug Alone|Withdrawal by Subject|1
414368|NCT00619983|1387390|P3|Test Drug Alone|Withdrawal by Subject|0
414369|NCT00619983|1387391|P2|Test Drug Alone|Withdrawal by Subject|0
414370|NCT00619983|1387392|P1|Test Drug Alone|Withdrawal by Subject|1
414371|NCT00619957|1387419|P2|Month 48 Open-Label|Withdrawal by Subject|9
414372|NCT00619957|1387420|P1|Month 48 Open-Label|Withdrawal by Subject|6
414373|NCT00619957|1387419|P2|Month 48 Open-Label|Lost to Follow-up|4
414374|NCT00619957|1387420|P1|Month 48 Open-Label|Lost to Follow-up|2
414375|NCT00619957|1387419|P2|Month 48 Open-Label|Adverse Event|4
414376|NCT00619957|1387420|P1|Month 48 Open-Label|Adverse Event|4
414377|NCT00619957|1387419|P2|Month 24 Double-Blind|Did not take any study medication|1
414378|NCT00619957|1387420|P1|Month 24 Double-Blind|Did not take any study medication|0
414379|NCT00619957|1387419|P2|Month 24 Double-Blind|Lost to Follow-up|0
414380|NCT00619957|1387420|P1|Month 24 Double-Blind|Lost to Follow-up|1
414381|NCT00619957|1387419|P2|Month 24 Double-Blind|Withdrawal by Subject|9
414382|NCT00619957|1387420|P1|Month 24 Double-Blind|Withdrawal by Subject|7
414383|NCT00619957|1387419|P2|Month 24 Double-Blind|Protocol Violation|0
414384|NCT00619957|1387420|P1|Month 24 Double-Blind|Protocol Violation|1
414385|NCT00619957|1387419|P2|Month 24 Double-Blind|Adverse Event|7
414386|NCT00619957|1387420|P1|Month 24 Double-Blind|Adverse Event|9
414387|NCT00619918|1387502|P2|Overall Study|Left before receiving first dose|8
414388|NCT00619918|1387503|P1|Overall Study|Left before receiving first dose|5
414389|NCT00619918|1387502|P2|Overall Study|Transfer to outside facility|3
414390|NCT00619918|1387503|P1|Overall Study|Transfer to outside facility|3
414391|NCT00619918|1387502|P2|Overall Study|Physician Decision|8
414392|NCT00619918|1387503|P1|Overall Study|Physician Decision|8
414393|NCT00619918|1387502|P2|Overall Study|Withdrawal by Subject|3
414394|NCT00619918|1387503|P1|Overall Study|Withdrawal by Subject|4
414395|NCT00619892|1387513|P2|Overall Study|Intercurrent illness|1
414396|NCT00619892|1387514|P1|Overall Study|Intercurrent illness|0
414397|NCT00619892|1387513|P2|Overall Study|Lost to Follow-up|1
414398|NCT00619892|1387514|P1|Overall Study|Lost to Follow-up|0
414399|NCT00619892|1387513|P2|Overall Study|Adverse Event|0
414400|NCT00619892|1387514|P1|Overall Study|Adverse Event|3
414401|NCT00619827|1387524|P2|Overall Study|Withdrawal by Subject|2
414402|NCT00619827|1387525|P1|Overall Study|Withdrawal by Subject|2
414403|NCT00619827|1387524|P2|Overall Study|Adverse Event|2
414404|NCT00619827|1387525|P1|Overall Study|Adverse Event|1
414405|NCT00619801|1387533|P2|Overall Study|Loss of efficacy|1
414406|NCT00619801|1387534|P1|Overall Study|Loss of efficacy|0
414407|NCT00619801|1387533|P2|Overall Study|Withdrawal by Subject|1
414408|NCT00619801|1387534|P1|Overall Study|Withdrawal by Subject|1
414409|NCT00619801|1387533|P2|Overall Study|Lack of Efficacy|1
414410|NCT00619801|1387534|P1|Overall Study|Lack of Efficacy|0
414411|NCT00619645|1387591|P1|Overall Study|Adverse Event|1
414412|NCT00619619|1387605|P8|Overall Study|Adverse Event|2
414413|NCT00619619|1387606|P7|Overall Study|Adverse Event|0
414414|NCT00619619|1387607|P6|Overall Study|Adverse Event|0
414415|NCT00619619|1387608|P5|Overall Study|Adverse Event|2
414416|NCT00619619|1387609|P4|Overall Study|Adverse Event|0
414417|NCT00619619|1387610|P3|Overall Study|Adverse Event|0
414418|NCT00619619|1387611|P2|Overall Study|Adverse Event|0
414419|NCT00619619|1387612|P1|Overall Study|Adverse Event|0
414420|NCT00619619|1387605|P8|Overall Study|Protocol Violation|1
414421|NCT00619619|1387606|P7|Overall Study|Protocol Violation|1
414422|NCT00619619|1387607|P6|Overall Study|Protocol Violation|0
414423|NCT00619619|1387608|P5|Overall Study|Protocol Violation|0
414424|NCT00619619|1387609|P4|Overall Study|Protocol Violation|1
414425|NCT00619619|1387610|P3|Overall Study|Protocol Violation|0
414426|NCT00619619|1387611|P2|Overall Study|Protocol Violation|0
414427|NCT00619619|1387612|P1|Overall Study|Protocol Violation|0
414428|NCT00619619|1387605|P8|Overall Study|Physician Decision|0
414429|NCT00619619|1387606|P7|Overall Study|Physician Decision|0
414430|NCT00619619|1387607|P6|Overall Study|Physician Decision|0
414431|NCT00619619|1387608|P5|Overall Study|Physician Decision|0
414432|NCT00619619|1387609|P4|Overall Study|Physician Decision|0
414433|NCT00619619|1387610|P3|Overall Study|Physician Decision|1
414434|NCT00619619|1387611|P2|Overall Study|Physician Decision|0
414435|NCT00619619|1387612|P1|Overall Study|Physician Decision|0
414436|NCT00619502|1387699|P2|Overall Study|Lost to Follow-up|10
414437|NCT00619502|1387700|P1|Overall Study|Lost to Follow-up|8
414438|NCT00619489|1387712|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
414439|NCT00619489|1387713|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
414440|NCT00619489|1387712|P2|Overall Study|Lack of Efficacy|11
414441|NCT00619489|1387713|P1|Overall Study|Lack of Efficacy|0
414442|NCT00619489|1387712|P2|Overall Study|Withdrawal by Subject|1
414443|NCT00619489|1387713|P1|Overall Study|Withdrawal by Subject|1
414444|NCT00619489|1387712|P2|Overall Study|Adverse Event|7
414445|NCT00619489|1387713|P1|Overall Study|Adverse Event|0
414446|NCT00619476|1387735|P4|Overall Study|Withdrawal by Subject|4
414447|NCT00619476|1387736|P3|Overall Study|Withdrawal by Subject|5
414448|NCT00619476|1387737|P2|Overall Study|Withdrawal by Subject|7
414449|NCT00619476|1387738|P1|Overall Study|Withdrawal by Subject|5
414450|NCT00619476|1387735|P4|Overall Study|Investigator Discretion|0
414451|NCT00619476|1387736|P3|Overall Study|Investigator Discretion|2
414452|NCT00619476|1387737|P2|Overall Study|Investigator Discretion|2
414453|NCT00619476|1387738|P1|Overall Study|Investigator Discretion|2
414454|NCT00619476|1387735|P4|Overall Study|Lost to Follow-up|1
414455|NCT00619476|1387736|P3|Overall Study|Lost to Follow-up|0
414456|NCT00619476|1387737|P2|Overall Study|Lost to Follow-up|2
414457|NCT00619476|1387738|P1|Overall Study|Lost to Follow-up|1
414458|NCT00619476|1387735|P4|Overall Study|Protocol Violation|9
414459|NCT00619476|1387736|P3|Overall Study|Protocol Violation|4
414460|NCT00619476|1387737|P2|Overall Study|Protocol Violation|4
414461|NCT00619476|1387738|P1|Overall Study|Protocol Violation|5
414462|NCT00619476|1387735|P4|Overall Study|Lack of Efficacy|4
414463|NCT00619476|1387736|P3|Overall Study|Lack of Efficacy|1
414464|NCT00619476|1387737|P2|Overall Study|Lack of Efficacy|1
414465|NCT00619476|1387738|P1|Overall Study|Lack of Efficacy|6
414466|NCT00619476|1387735|P4|Overall Study|Adverse Event|16
414467|NCT00619476|1387736|P3|Overall Study|Adverse Event|12
414468|NCT00619476|1387737|P2|Overall Study|Adverse Event|6
414469|NCT00619476|1387738|P1|Overall Study|Adverse Event|12
414470|NCT00619385|1387823|P3|Overall Study|Other|1
414471|NCT00619385|1387824|P2|Overall Study|Other|2
414472|NCT00619385|1387825|P1|Overall Study|Other|1
414473|NCT00619385|1387823|P3|Overall Study|Adverse Event|3
414474|NCT00619385|1387824|P2|Overall Study|Adverse Event|0
414475|NCT00619385|1387825|P1|Overall Study|Adverse Event|0
414476|NCT00619359|1387840|P2|Overall Study|Progressive Disease|1
414477|NCT00619359|1387841|P1|Overall Study|Progressive Disease|3
414478|NCT00619359|1387840|P2|Overall Study|Withdrawal by Subject|20
414479|NCT00619359|1387841|P1|Overall Study|Withdrawal by Subject|19
414480|NCT00619359|1387840|P2|Overall Study|Protocol Violation|1
414481|NCT00619359|1387841|P1|Overall Study|Protocol Violation|1
414482|NCT00619359|1387840|P2|Overall Study|Physician Decision|7
414483|NCT00619359|1387841|P1|Overall Study|Physician Decision|0
414484|NCT00619359|1387840|P2|Overall Study|Lost to Follow-up|16
414485|NCT00619359|1387841|P1|Overall Study|Lost to Follow-up|12
414486|NCT00619359|1387840|P2|Overall Study|Adverse Event|36
414487|NCT00619359|1387841|P1|Overall Study|Adverse Event|32
414488|NCT00619307|1387853|P2|Overall Study|MS attack plus steroids|1
414489|NCT00619307|1387854|P1|Overall Study|MS attack plus steroids|0
414490|NCT00619307|1387853|P2|Overall Study|Severe migraine|1
414491|NCT00619307|1387854|P1|Overall Study|Severe migraine|0
414492|NCT00619307|1387853|P2|Overall Study|Withdrew consent|0
414493|NCT00619307|1387854|P1|Overall Study|Withdrew consent|1
414494|NCT00619307|1387853|P2|Overall Study|Protocol Violation|0
414495|NCT00619307|1387854|P1|Overall Study|Protocol Violation|3
414496|NCT00619307|1387853|P2|Overall Study|Lost to Follow-up|1
414497|NCT00619307|1387854|P1|Overall Study|Lost to Follow-up|0
414498|NCT00619307|1387853|P2|Overall Study|Adverse Event|1
414499|NCT00619307|1387854|P1|Overall Study|Adverse Event|0
414500|NCT00619229|1387891|P2|Overall Study|Investigator planned Cataract Operation|0
414501|NCT00619229|1387892|P1|Overall Study|Investigator planned Cataract Operation|1
414502|NCT00619229|1387891|P2|Overall Study|Termination of the Study by the Sponsor|1
414503|NCT00619229|1387892|P1|Overall Study|Termination of the Study by the Sponsor|1
414504|NCT00619229|1387891|P2|Overall Study|Lost to Follow-up|0
414505|NCT00619229|1387892|P1|Overall Study|Lost to Follow-up|1
414506|NCT00619229|1387891|P2|Overall Study|Withdrawal by Subject|1
414507|NCT00619229|1387892|P1|Overall Study|Withdrawal by Subject|1
414508|NCT00619177|1387931|P1|Overall Study|Not specified reasons|6
414509|NCT00619177|1387931|P1|Overall Study|Missing termination information|481
414510|NCT00619177|1387931|P1|Overall Study|Lack of Efficacy|1
414511|NCT00619177|1387931|P1|Overall Study|Lost to Follow-up|2
414512|NCT00619177|1387931|P1|Overall Study|Adverse Event|18
414513|NCT00619151|1387941|P2|Overall Study|Study terminated prior to followup|0
414514|NCT00619151|1387942|P1|Overall Study|Study terminated prior to followup|1
414515|NCT00619112|1387952|P2|Overall Study|Adverse Event|2
414516|NCT00619112|1387953|P1|Overall Study|Adverse Event|1
414517|NCT00619099|1387974|P2|Overall Study|Physician Decision|6
414518|NCT00619099|1387975|P1|Overall Study|Physician Decision|9
414519|NCT00619099|1387974|P2|Overall Study|Withdrawal by Subject|2
414520|NCT00619099|1387975|P1|Overall Study|Withdrawal by Subject|10
414521|NCT00619099|1387974|P2|Overall Study|Emergence of Clinically Significant Lab|2
414522|NCT00619099|1387975|P1|Overall Study|Emergence of Clinically Significant Lab|1
414523|NCT00619099|1387974|P2|Overall Study|Adverse Event|3
414524|NCT00619099|1387975|P1|Overall Study|Adverse Event|4
414525|NCT00619099|1387974|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
414526|NCT00619099|1387975|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
414527|NCT00619099|1387974|P2|Overall Study|Progressive Disease|5
414528|NCT00619099|1387975|P1|Overall Study|Progressive Disease|7
414529|NCT00618995|1387997|P4|Period 4|Adverse Event|0
414530|NCT00618995|1387998|P3|Period 4|Adverse Event|0
414531|NCT00618995|1387999|P2|Period 4|Adverse Event|0
414532|NCT00618995|1388000|P1|Period 4|Adverse Event|1
414533|NCT00618995|1387997|P4|Period 2|Protocol Violation|0
414534|NCT00618995|1387998|P3|Period 2|Protocol Violation|1
414535|NCT00618995|1387999|P2|Period 2|Protocol Violation|0
414536|NCT00618995|1388000|P1|Period 2|Protocol Violation|0
414537|NCT00618995|1387997|P4|Period 1|Protocol Violation|0
414538|NCT00618995|1387998|P3|Period 1|Protocol Violation|1
414539|NCT00618995|1387999|P2|Period 1|Protocol Violation|1
414540|NCT00618995|1388000|P1|Period 1|Protocol Violation|0
414541|NCT00618995|1387997|P4|Period 1|Adverse Event|0
414542|NCT00618995|1387998|P3|Period 1|Adverse Event|1
414543|NCT00618995|1387999|P2|Period 1|Adverse Event|0
414544|NCT00618995|1388000|P1|Period 1|Adverse Event|0
414545|NCT00618982|1388014|P1|Overall Study|ongoing, still treated with study med.|25
414546|NCT00618982|1388014|P1|Overall Study|Protocol Violation|1
414547|NCT00618982|1388014|P1|Overall Study|Withdrawal by Subject|1
414548|NCT00618982|1388014|P1|Overall Study|Adverse Event|23
414549|NCT00618956|1388037|P2|Overall Study|did not meet criteria, non-compliance|1
414550|NCT00618956|1388038|P1|Overall Study|did not meet criteria, non-compliance|2
414551|NCT00618956|1388037|P2|Overall Study|Protocol Violation|2
414552|NCT00618956|1388038|P1|Overall Study|Protocol Violation|2
414553|NCT00618956|1388037|P2|Overall Study|Lost to Follow-up|5
414554|NCT00618956|1388038|P1|Overall Study|Lost to Follow-up|4
414555|NCT00618956|1388037|P2|Overall Study|Withdrawal by Subject|7
414556|NCT00618956|1388038|P1|Overall Study|Withdrawal by Subject|5
414557|NCT00618956|1388037|P2|Overall Study|Lack of Efficacy|1
414558|NCT00618956|1388038|P1|Overall Study|Lack of Efficacy|2
414559|NCT00618956|1388037|P2|Overall Study|Adverse Event|34
414560|NCT00618956|1388038|P1|Overall Study|Adverse Event|10
414561|NCT00618826|1388063|P1|Overall Study|Adverse Event|1
414562|NCT00618813|1388068|P1|Overall Study|Withdrawal by Subject|1
414563|NCT00618813|1388068|P1|Overall Study|Physician Decision|2
414564|NCT00618813|1388068|P1|Overall Study|Lack of Efficacy|1
414565|NCT00618787|1388078|P2|Overall Study|Lost to Follow-up|0
414566|NCT00618787|1388079|P1|Overall Study|Lost to Follow-up|1
414567|NCT00618787|1388078|P2|Overall Study|Withdrawal by Subject|1
414568|NCT00618787|1388079|P1|Overall Study|Withdrawal by Subject|2
414569|NCT00618787|1388078|P2|Overall Study|Adverse Event|1
414570|NCT00618787|1388079|P1|Overall Study|Adverse Event|0
414571|NCT00618774|1388087|P2|Overall Study|Withdrawal by Subject|0
414572|NCT00618774|1388088|P1|Overall Study|Withdrawal by Subject|1
414573|NCT00618774|1388087|P2|Overall Study|Adverse Event|3
414574|NCT00618774|1388088|P1|Overall Study|Adverse Event|5
414575|NCT00618748|1388121|P3|Overall Study|Withdrawal by Subject|5
414576|NCT00618748|1388122|P2|Overall Study|Withdrawal by Subject|1
414577|NCT00618748|1388123|P1|Overall Study|Withdrawal by Subject|4
414578|NCT00618748|1388121|P3|Overall Study|Physician Decision|1
414579|NCT00618748|1388122|P2|Overall Study|Physician Decision|1
414580|NCT00618748|1388123|P1|Overall Study|Physician Decision|3
414581|NCT00618748|1388121|P3|Overall Study|Adverse Event|8
414582|NCT00618748|1388122|P2|Overall Study|Adverse Event|3
414583|NCT00618748|1388123|P1|Overall Study|Adverse Event|4
414584|NCT00618722|1388168|P4|Overall Study|Miscellaneous Reasons|1
414585|NCT00618722|1388169|P3|Overall Study|Miscellaneous Reasons|1
414586|NCT00618722|1388170|P2|Overall Study|Miscellaneous Reasons|0
414587|NCT00618722|1388171|P1|Overall Study|Miscellaneous Reasons|0
414588|NCT00618722|1388168|P4|Overall Study|Lost to Follow-up|2
414589|NCT00618722|1388169|P3|Overall Study|Lost to Follow-up|0
414590|NCT00618722|1388170|P2|Overall Study|Lost to Follow-up|0
414591|NCT00618722|1388171|P1|Overall Study|Lost to Follow-up|2
414592|NCT00618722|1388168|P4|Overall Study|Inability to Complete Study Procedure|0
414593|NCT00618722|1388169|P3|Overall Study|Inability to Complete Study Procedure|0
414594|NCT00618722|1388170|P2|Overall Study|Inability to Complete Study Procedure|1
414595|NCT00618722|1388171|P1|Overall Study|Inability to Complete Study Procedure|0
414596|NCT00618722|1388168|P4|Overall Study|Patient Request|1
414597|NCT00618722|1388169|P3|Overall Study|Patient Request|1
414598|NCT00618722|1388170|P2|Overall Study|Patient Request|1
414599|NCT00618722|1388171|P1|Overall Study|Patient Request|1
414600|NCT00618722|1388168|P4|Overall Study|Refusal of Treatment|0
414601|NCT00618722|1388169|P3|Overall Study|Refusal of Treatment|1
414602|NCT00618722|1388170|P2|Overall Study|Refusal of Treatment|0
414603|NCT00618722|1388171|P1|Overall Study|Refusal of Treatment|0
414604|NCT00618618|1388209|P4|Overall Study|Death|0
414605|NCT00618618|1388210|P3|Overall Study|Death|0
414606|NCT00618618|1388211|P2|Overall Study|Death|1
414607|NCT00618618|1388212|P1|Overall Study|Death|0
414608|NCT00618618|1388209|P4|Overall Study|Did Not Meet Entry Criteria|0
414609|NCT00618618|1388210|P3|Overall Study|Did Not Meet Entry Criteria|1
414610|NCT00618618|1388211|P2|Overall Study|Did Not Meet Entry Criteria|0
414611|NCT00618618|1388212|P1|Overall Study|Did Not Meet Entry Criteria|0
414612|NCT00618618|1388209|P4|Overall Study|Non-compliance|0
414613|NCT00618618|1388210|P3|Overall Study|Non-compliance|0
414614|NCT00618618|1388211|P2|Overall Study|Non-compliance|1
414615|NCT00618618|1388212|P1|Overall Study|Non-compliance|1
414616|NCT00618618|1388209|P4|Overall Study|Lost to Follow-up|1
414617|NCT00618618|1388210|P3|Overall Study|Lost to Follow-up|0
414618|NCT00618618|1388211|P2|Overall Study|Lost to Follow-up|0
414619|NCT00618618|1388212|P1|Overall Study|Lost to Follow-up|3
414620|NCT00618618|1388209|P4|Overall Study|Inability to Complete Study Procedures|0
414621|NCT00618618|1388210|P3|Overall Study|Inability to Complete Study Procedures|0
414622|NCT00618618|1388211|P2|Overall Study|Inability to Complete Study Procedures|1
414623|NCT00618618|1388212|P1|Overall Study|Inability to Complete Study Procedures|0
414624|NCT00618618|1388209|P4|Overall Study|Patient Request|0
414625|NCT00618618|1388210|P3|Overall Study|Patient Request|2
414626|NCT00618618|1388211|P2|Overall Study|Patient Request|0
414627|NCT00618618|1388212|P1|Overall Study|Patient Request|0
414628|NCT00618514|1388271|P3|Overall Study|Lost to Follow-up|4
414629|NCT00618514|1388272|P2|Overall Study|Lost to Follow-up|12
414630|NCT00618514|1388273|P1|Overall Study|Lost to Follow-up|11
414631|NCT00618449|1388293|P2|Overall Study|Lost to Follow-up|110
414632|NCT00618449|1388294|P1|Overall Study|Lost to Follow-up|98
414633|NCT00618410|1388313|P2|Washout Period (2 Weeks)|Physician Decision|1
414634|NCT00618410|1388314|P1|Washout Period (2 Weeks)|Physician Decision|0
414635|NCT00618371|1388330|P1|Overall Study|Withdrawal by Subject|2
414636|NCT00618072|1388363|P3|Overall Study|Physician Decision|1
414637|NCT00618072|1388364|P2|Overall Study|Physician Decision|1
414638|NCT00618072|1388365|P1|Overall Study|Physician Decision|0
414639|NCT00618072|1388363|P3|Overall Study|Lost to Follow-up|3
414640|NCT00618072|1388364|P2|Overall Study|Lost to Follow-up|0
414641|NCT00618072|1388365|P1|Overall Study|Lost to Follow-up|2
414642|NCT00617929|1388421|P1|Overall Study|Physician Decision|1
414643|NCT00617903|1388433|P2|Overall Study|noncompliance|1
414644|NCT00617903|1388434|P1|Overall Study|noncompliance|0
414645|NCT00617903|1388433|P2|Overall Study|Adverse Event|1
414646|NCT00617903|1388434|P1|Overall Study|Adverse Event|0
414647|NCT00617903|1388433|P2|Overall Study|Lack of Efficacy|1
414648|NCT00617903|1388434|P1|Overall Study|Lack of Efficacy|0
414649|NCT00617903|1388433|P2|Overall Study|Lost to Follow-up|1
414650|NCT00617903|1388434|P1|Overall Study|Lost to Follow-up|1
414651|NCT00617903|1388433|P2|Overall Study|Withdrawal by Subject|3
414652|NCT00617903|1388434|P1|Overall Study|Withdrawal by Subject|2
414653|NCT00617890|1388480|P4|Overall Study|Not treated|1
414654|NCT00617890|1388481|P3|Overall Study|Not treated|1
414655|NCT00617890|1388482|P2|Overall Study|Not treated|0
414656|NCT00617890|1388483|P1|Overall Study|Not treated|1
414657|NCT00617890|1388480|P4|Overall Study|Adverse Event|8
414658|NCT00617890|1388481|P3|Overall Study|Adverse Event|3
414659|NCT00617890|1388482|P2|Overall Study|Adverse Event|0
414660|NCT00617890|1388483|P1|Overall Study|Adverse Event|1
414661|NCT00617890|1388480|P4|Overall Study|Protocol Violation|0
414662|NCT00617890|1388481|P3|Overall Study|Protocol Violation|0
414663|NCT00617890|1388482|P2|Overall Study|Protocol Violation|1
414664|NCT00617890|1388483|P1|Overall Study|Protocol Violation|2
414665|NCT00617890|1388480|P4|Overall Study|Withdrawal by Subject|2
414666|NCT00617890|1388481|P3|Overall Study|Withdrawal by Subject|0
414667|NCT00617890|1388482|P2|Overall Study|Withdrawal by Subject|1
414668|NCT00617890|1388483|P1|Overall Study|Withdrawal by Subject|4
414669|NCT00617890|1388480|P4|Overall Study|Lost to Follow-up|2
414670|NCT00617890|1388481|P3|Overall Study|Lost to Follow-up|1
414671|NCT00617890|1388482|P2|Overall Study|Lost to Follow-up|0
414672|NCT00617890|1388483|P1|Overall Study|Lost to Follow-up|0
414673|NCT00617890|1388480|P4|Overall Study|Lack of Efficacy|97
414674|NCT00617890|1388481|P3|Overall Study|Lack of Efficacy|30
414675|NCT00617890|1388482|P2|Overall Study|Lack of Efficacy|26
414676|NCT00617890|1388483|P1|Overall Study|Lack of Efficacy|23
414677|NCT00617890|1388480|P4|Overall Study|Treatment ongoing at data cut-off|5
414678|NCT00617890|1388481|P3|Overall Study|Treatment ongoing at data cut-off|0
414679|NCT00617890|1388482|P2|Overall Study|Treatment ongoing at data cut-off|0
414680|NCT00617890|1388483|P1|Overall Study|Treatment ongoing at data cut-off|0
414681|NCT00617851|1388519|P4|Overall Study|Unable to classify|0
414682|NCT00617851|1388520|P3|Overall Study|Unable to classify|1
414683|NCT00617851|1388521|P2|Overall Study|Unable to classify|0
414684|NCT00617851|1388522|P1|Overall Study|Unable to classify|1
414685|NCT00617851|1388519|P4|Overall Study|Inappropriate Enrollment|1
414686|NCT00617851|1388520|P3|Overall Study|Inappropriate Enrollment|1
414687|NCT00617851|1388521|P2|Overall Study|Inappropriate Enrollment|4
414688|NCT00617851|1388522|P1|Overall Study|Inappropriate Enrollment|5
414689|NCT00617851|1388519|P4|Overall Study|Lost to Follow-up|19
414690|NCT00617851|1388520|P3|Overall Study|Lost to Follow-up|31
414691|NCT00617851|1388521|P2|Overall Study|Lost to Follow-up|29
414692|NCT00617851|1388522|P1|Overall Study|Lost to Follow-up|27
414693|NCT00617851|1388519|P4|Overall Study|Withdrawal by Subject|4
414694|NCT00617851|1388520|P3|Overall Study|Withdrawal by Subject|12
414695|NCT00617851|1388521|P2|Overall Study|Withdrawal by Subject|7
414696|NCT00617851|1388522|P1|Overall Study|Withdrawal by Subject|14
414697|NCT00617851|1388519|P4|Overall Study|Death|1
414698|NCT00617851|1388520|P3|Overall Study|Death|0
414699|NCT00617851|1388521|P2|Overall Study|Death|0
414700|NCT00617851|1388522|P1|Overall Study|Death|0
414701|NCT00617773|1388560|P1|Overall Study|Protocol Violation|1
414702|NCT00617773|1388560|P1|Overall Study|Progressive disease|19
414703|NCT00617773|1388560|P1|Overall Study|Death|1
414704|NCT00617773|1388560|P1|Overall Study|Withdrawal by Subject|1
414705|NCT00617773|1388560|P1|Overall Study|Lack of compliance with the protocol|1
414706|NCT00617773|1388560|P1|Overall Study|Physician Decision|1
414707|NCT00617734|1388577|P2|Overall Study|Lost to Follow-up|1
414708|NCT00617734|1388578|P1|Overall Study|Lost to Follow-up|0
414709|NCT00617734|1388577|P2|Overall Study|Found Ineligible After Randomization|4
414710|NCT00617734|1388578|P1|Overall Study|Found Ineligible After Randomization|1
414711|NCT00617734|1388577|P2|Overall Study|Protocol Violation|0
414712|NCT00617734|1388578|P1|Overall Study|Protocol Violation|1
414713|NCT00617734|1388577|P2|Overall Study|Adverse Event|1
414714|NCT00617734|1388578|P1|Overall Study|Adverse Event|4
414715|NCT00617734|1388577|P2|Overall Study|Withdrew Consent|0
414716|NCT00617734|1388578|P1|Overall Study|Withdrew Consent|2
414717|NCT00617708|1388599|P3|Overall Study|Not eligible|5
414718|NCT00617708|1388600|P2|Overall Study|Not eligible|3
414719|NCT00617708|1388601|P1|Overall Study|Not eligible|1
414720|NCT00617708|1388599|P3|Overall Study|Not protocol specified|2
414721|NCT00617708|1388600|P2|Overall Study|Not protocol specified|4
414722|NCT00617708|1388601|P1|Overall Study|Not protocol specified|1
414723|NCT00617708|1388599|P3|Overall Study|Progression/Relapse|36
414724|NCT00617708|1388600|P2|Overall Study|Progression/Relapse|40
414725|NCT00617708|1388601|P1|Overall Study|Progression/Relapse|7
414726|NCT00617708|1388599|P3|Overall Study|Death|5
414727|NCT00617708|1388600|P2|Overall Study|Death|6
414728|NCT00617708|1388601|P1|Overall Study|Death|0
414729|NCT00617708|1388599|P3|Overall Study|Withdrawal by Subject|7
414730|NCT00617708|1388600|P2|Overall Study|Withdrawal by Subject|1
414731|NCT00617708|1388601|P1|Overall Study|Withdrawal by Subject|1
414732|NCT00617708|1388599|P3|Overall Study|Adverse Event|9
414733|NCT00617708|1388600|P2|Overall Study|Adverse Event|6
414734|NCT00617708|1388601|P1|Overall Study|Adverse Event|0
414735|NCT00617669|1388618|P2|Overall Study|Patients randomized but not treated|3
414736|NCT00617669|1388619|P1|Overall Study|Patients randomized but not treated|2
414737|NCT00617669|1388618|P2|Overall Study|Reason not otherwise captured, eg; death|290
414738|NCT00617669|1388619|P1|Overall Study|Reason not otherwise captured, eg; death|265
414739|NCT00617669|1388618|P2|Overall Study|Protocol Violation|3
414740|NCT00617669|1388619|P1|Overall Study|Protocol Violation|2
414741|NCT00617669|1388618|P2|Overall Study|Adverse Event|76
414742|NCT00617669|1388619|P1|Overall Study|Adverse Event|87
414743|NCT00617669|1388618|P2|Overall Study|Lost to Follow-up|2
414744|NCT00617669|1388619|P1|Overall Study|Lost to Follow-up|3
414745|NCT00617669|1388618|P2|Overall Study|Withdrawal by Subject|77
414746|NCT00617669|1388619|P1|Overall Study|Withdrawal by Subject|71
414747|NCT00617604|1388641|P2|Overall Study|Randomized but Never Received Study Drug|3
414748|NCT00617604|1388642|P1|Overall Study|Randomized but Never Received Study Drug|3
414749|NCT00617604|1388641|P2|Overall Study|Withdrawal by Subject|6
414750|NCT00617604|1388642|P1|Overall Study|Withdrawal by Subject|4
414751|NCT00617604|1388641|P2|Overall Study|Miscellaneous Reasons|10
414752|NCT00617604|1388642|P1|Overall Study|Miscellaneous Reasons|8
414753|NCT00617604|1388641|P2|Overall Study|Lost to Follow-up|0
414754|NCT00617604|1388642|P1|Overall Study|Lost to Follow-up|1
414755|NCT00617604|1388641|P2|Overall Study|Death|1
414756|NCT00617604|1388642|P1|Overall Study|Death|2
414757|NCT00617591|1388686|P1|Overall Study|Withdrew consent during Maintenance|6
414758|NCT00617591|1388686|P1|Overall Study|Withdrew consent during Induction|4
414759|NCT00617461|1388702|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
414760|NCT00617461|1388703|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
414761|NCT00617461|1388702|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
414762|NCT00617461|1388703|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
414763|NCT00617461|1388702|P2|Second Treatment Intervention Period|Lack of Efficacy|3
414764|NCT00617461|1388703|P1|Second Treatment Intervention Period|Lack of Efficacy|0
414765|NCT00617461|1388702|P2|Second Treatment Intervention Period|Adverse Event|1
414766|NCT00617461|1388703|P1|Second Treatment Intervention Period|Adverse Event|0
414767|NCT00617461|1388702|P2|4-Day Crossover Period|Withdrawal by Subject|0
414768|NCT00617461|1388703|P1|4-Day Crossover Period|Withdrawal by Subject|1
414769|NCT00617461|1388702|P2|First Treatment Intervention Period|Withdrawal by Subject|0
414770|NCT00617461|1388703|P1|First Treatment Intervention Period|Withdrawal by Subject|4
414771|NCT00617461|1388702|P2|First Treatment Intervention Period|Investigator Discretion|1
414772|NCT00617461|1388703|P1|First Treatment Intervention Period|Investigator Discretion|1
414773|NCT00617461|1388702|P2|First Treatment Intervention Period|Lost to Follow-up|1
414774|NCT00617461|1388703|P1|First Treatment Intervention Period|Lost to Follow-up|0
414775|NCT00617461|1388702|P2|First Treatment Intervention Period|Protocol Violation|1
414776|NCT00617461|1388703|P1|First Treatment Intervention Period|Protocol Violation|2
414777|NCT00617461|1388702|P2|First Treatment Intervention Period|Lack of Efficacy|0
414778|NCT00617461|1388703|P1|First Treatment Intervention Period|Lack of Efficacy|1
414779|NCT00617461|1388702|P2|First Treatment Intervention Period|Adverse Event|0
414780|NCT00617461|1388703|P1|First Treatment Intervention Period|Adverse Event|2
414781|NCT00617409|1388759|P3|Overall Study|Alternative Therapy|0
414782|NCT00617409|1388760|P2|Overall Study|Alternative Therapy|2
414783|NCT00617409|1388761|P1|Overall Study|Alternative Therapy|1
414784|NCT00617409|1388759|P3|Overall Study|Death|4
414785|NCT00617409|1388760|P2|Overall Study|Death|5
414786|NCT00617409|1388761|P1|Overall Study|Death|3
414787|NCT00617409|1388759|P3|Overall Study|Disease Progression|18
414788|NCT00617409|1388760|P2|Overall Study|Disease Progression|8
414789|NCT00617409|1388761|P1|Overall Study|Disease Progression|8
414790|NCT00617409|1388759|P3|Overall Study|Adverse Event|3
414791|NCT00617409|1388760|P2|Overall Study|Adverse Event|2
414792|NCT00617409|1388761|P1|Overall Study|Adverse Event|0
414793|NCT00617409|1388759|P3|Overall Study|Withdrawal by Subject|2
414794|NCT00617409|1388760|P2|Overall Study|Withdrawal by Subject|1
414795|NCT00617409|1388761|P1|Overall Study|Withdrawal by Subject|4
414796|NCT00617357|1388776|P1|Overall Study|Physician Decision|1
414797|NCT00617357|1388776|P1|Overall Study|Withdrawal by Subject|1
414798|NCT00617357|1388776|P1|Overall Study|insurance concerns|2
414799|NCT00617357|1388776|P1|Overall Study|Death|5
414800|NCT00617357|1388776|P1|Overall Study|Lost to Follow-up|7
414801|NCT00617305|1388789|P3|Overall Study|Withdrawal by Subject|0
414802|NCT00617305|1388790|P2|Overall Study|Withdrawal by Subject|0
414803|NCT00617305|1388791|P1|Overall Study|Withdrawal by Subject|1
414804|NCT00617305|1388789|P3|Overall Study|Protocol Violation|1
414805|NCT00617305|1388790|P2|Overall Study|Protocol Violation|0
414806|NCT00617305|1388791|P1|Overall Study|Protocol Violation|1
414807|NCT00617305|1388789|P3|Overall Study|Physician Decision|0
414808|NCT00617305|1388790|P2|Overall Study|Physician Decision|0
414809|NCT00617305|1388791|P1|Overall Study|Physician Decision|1
414810|NCT00617305|1388789|P3|Overall Study|Death|0
414811|NCT00617305|1388790|P2|Overall Study|Death|0
414812|NCT00617305|1388791|P1|Overall Study|Death|1
414813|NCT00617305|1388789|P3|Overall Study|Adverse Event|0
414814|NCT00617305|1388790|P2|Overall Study|Adverse Event|0
414815|NCT00617305|1388791|P1|Overall Study|Adverse Event|4
414816|NCT00617279|1388847|P2|Overall Study|Death|2
414817|NCT00617279|1388848|P1|Overall Study|Death|1
414818|NCT00617279|1388847|P2|Overall Study|Lost to Follow-up|0
414819|NCT00617279|1388848|P1|Overall Study|Lost to Follow-up|1
414820|NCT00617279|1388847|P2|Overall Study|Graft abandonment|0
414821|NCT00617279|1388848|P1|Overall Study|Graft abandonment|2
414822|NCT00617279|1388847|P2|Overall Study|Study terminated by Sponsor|15
414823|NCT00617279|1388848|P1|Overall Study|Study terminated by Sponsor|10
414824|NCT00617240|1388904|P2|Overall Study|Lack of Efficacy|0
414825|NCT00617240|1388905|P1|Overall Study|Lack of Efficacy|1
414826|NCT00617201|1388925|P2|Overall Study|Lost to Follow-up|13
414827|NCT00617201|1388926|P1|Overall Study|Lost to Follow-up|9
414828|NCT00617123|1388954|P2|Study Treatment Period|Noncompliance with Protocol|1
414829|NCT00617123|1388955|P1|Study Treatment Period|Noncompliance with Protocol|0
414830|NCT00617123|1388954|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
414831|NCT00617123|1388955|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
414832|NCT00617123|1388954|P2|Study Treatment Period|Adverse Event|3
414833|NCT00617123|1388955|P1|Study Treatment Period|Adverse Event|7
414834|NCT00617123|1388954|P2|Study Treatment Period|Withdrawal by Subject|12
414835|NCT00617123|1388955|P1|Study Treatment Period|Withdrawal by Subject|8
414836|NCT00617123|1388954|P2|Referral Screening Period|Adverse Event|1
414837|NCT00617123|1388955|P1|Referral Screening Period|Adverse Event|0
414838|NCT00617123|1388954|P2|Referral Screening Period|Did Not Wish To Continue|1
414839|NCT00617123|1388955|P1|Referral Screening Period|Did Not Wish To Continue|3
414840|NCT00617123|1388954|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
414841|NCT00617123|1388955|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
414842|NCT00617084|1388986|P2|Overall Study|Missed 12 Months visit|19
414843|NCT00617084|1388987|P1|Overall Study|Missed 12 Months visit|16
414844|NCT00617084|1388986|P2|Overall Study|Withdrawal by Subject|7
414845|NCT00617084|1388987|P1|Overall Study|Withdrawal by Subject|5
414846|NCT00616967|1389040|P3|Overall Study|Withdrawal by Subject|1
414847|NCT00616967|1389041|P2|Overall Study|Withdrawal by Subject|0
414848|NCT00616967|1389042|P1|Overall Study|Withdrawal by Subject|0
414849|NCT00616928|1389055|P4|Overall Study|Lost to Follow-up|0
414850|NCT00616928|1389056|P3|Overall Study|Lost to Follow-up|0
414851|NCT00616928|1389057|P2|Overall Study|Lost to Follow-up|7
414852|NCT00616928|1389058|P1|Overall Study|Lost to Follow-up|5
414853|NCT00616928|1389055|P4|Overall Study|Other|5
414854|NCT00616928|1389056|P3|Overall Study|Other|15
414855|NCT00616928|1389057|P2|Overall Study|Other|8
414856|NCT00616928|1389058|P1|Overall Study|Other|51
414857|NCT00616928|1389055|P4|Overall Study|Adverse Event|2
414858|NCT00616928|1389056|P3|Overall Study|Adverse Event|2
414859|NCT00616928|1389057|P2|Overall Study|Adverse Event|3
414860|NCT00616928|1389058|P1|Overall Study|Adverse Event|6
414861|NCT00616902|1389122|P2|Overall Study|Termination of study|6
414862|NCT00616902|1389123|P1|Overall Study|Termination of study|6
414863|NCT00616759|1389166|P2|Overall Study|Withdrawal by Subject|2
414864|NCT00616759|1389167|P1|Overall Study|Withdrawal by Subject|1
414865|NCT00616759|1389166|P2|Overall Study|Physician Decision|0
414866|NCT00616759|1389167|P1|Overall Study|Physician Decision|2
414867|NCT00616655|1389176|P3|Overall Study|Other|5
414868|NCT00616655|1389177|P2|Overall Study|Other|6
414869|NCT00616655|1389178|P1|Overall Study|Other|6
414870|NCT00616655|1389176|P3|Overall Study|Does not meet in/ex criteria|2
414871|NCT00616655|1389177|P2|Overall Study|Does not meet in/ex criteria|0
414872|NCT00616655|1389178|P1|Overall Study|Does not meet in/ex criteria|0
414873|NCT00616655|1389176|P3|Overall Study|Withdrawal by Subject|11
414874|NCT00616655|1389177|P2|Overall Study|Withdrawal by Subject|7
414875|NCT00616655|1389178|P1|Overall Study|Withdrawal by Subject|9
414876|NCT00616655|1389176|P3|Overall Study|Protocol Violation|3
414877|NCT00616655|1389177|P2|Overall Study|Protocol Violation|4
414878|NCT00616655|1389178|P1|Overall Study|Protocol Violation|2
414879|NCT00616655|1389176|P3|Overall Study|Lost to Follow-up|10
414880|NCT00616655|1389177|P2|Overall Study|Lost to Follow-up|12
414881|NCT00616655|1389178|P1|Overall Study|Lost to Follow-up|3
414882|NCT00616655|1389176|P3|Overall Study|Lack of Efficacy|5
414883|NCT00616655|1389177|P2|Overall Study|Lack of Efficacy|5
414884|NCT00616655|1389178|P1|Overall Study|Lack of Efficacy|5
414885|NCT00616655|1389176|P3|Overall Study|Adverse Event|12
414886|NCT00616655|1389177|P2|Overall Study|Adverse Event|7
414887|NCT00616655|1389178|P1|Overall Study|Adverse Event|10
414888|NCT00616642|1389218|P2|Overall Study|Withdrawal by Subject|1
414889|NCT00616642|1389219|P1|Overall Study|Withdrawal by Subject|0
414890|NCT00616629|1389230|P5|Overall Study|AV-block|0
414891|NCT00616629|1389231|P4|Overall Study|AV-block|0
414892|NCT00616629|1389232|P3|Overall Study|AV-block|0
414893|NCT00616629|1389233|P2|Overall Study|AV-block|0
414894|NCT00616629|1389234|P1|Overall Study|AV-block|1
414895|NCT00616629|1389230|P5|Overall Study|Protocol Violation|0
414896|NCT00616629|1389231|P4|Overall Study|Protocol Violation|0
414897|NCT00616629|1389232|P3|Overall Study|Protocol Violation|1
414898|NCT00616629|1389233|P2|Overall Study|Protocol Violation|2
414899|NCT00616629|1389234|P1|Overall Study|Protocol Violation|1
414900|NCT00616603|1389279|P3|Overall Study|Physician Decision|2
414901|NCT00616603|1389280|P2|Overall Study|Physician Decision|0
414902|NCT00616603|1389281|P1|Overall Study|Physician Decision|2
414903|NCT00616434|1389304|P2|Overall Study|Protocol deviation|1
414904|NCT00616434|1389305|P1|Overall Study|Protocol deviation|0
414905|NCT00616434|1389304|P2|Overall Study|Withdrawal by Subject|1
414906|NCT00616434|1389305|P1|Overall Study|Withdrawal by Subject|1
414907|NCT00616434|1389304|P2|Overall Study|Physician Decision|4
414908|NCT00616434|1389305|P1|Overall Study|Physician Decision|0
414909|NCT00616434|1389304|P2|Overall Study|Adverse Event|2
414910|NCT00616434|1389305|P1|Overall Study|Adverse Event|5
414911|NCT00616421|1389318|P3|Overall Study|Unable to classify|0
414912|NCT00616421|1389319|P2|Overall Study|Unable to classify|0
414913|NCT00616421|1389320|P1|Overall Study|Unable to classify|1
414914|NCT00616421|1389318|P3|Overall Study|Protocol Violation|2
414915|NCT00616421|1389319|P2|Overall Study|Protocol Violation|1
414916|NCT00616421|1389320|P1|Overall Study|Protocol Violation|0
414917|NCT00616421|1389318|P3|Overall Study|Administrative reason|0
414918|NCT00616421|1389319|P2|Overall Study|Administrative reason|0
414919|NCT00616421|1389320|P1|Overall Study|Administrative reason|1
414920|NCT00616421|1389318|P3|Overall Study|Inappropriate enrollment|1
414921|NCT00616421|1389319|P2|Overall Study|Inappropriate enrollment|0
414922|NCT00616421|1389320|P1|Overall Study|Inappropriate enrollment|3
414923|NCT00616421|1389318|P3|Overall Study|Lost to Follow-up|30
414924|NCT00616421|1389319|P2|Overall Study|Lost to Follow-up|26
414925|NCT00616421|1389320|P1|Overall Study|Lost to Follow-up|12
414926|NCT00616421|1389318|P3|Overall Study|Withdrawal by Subject|8
414927|NCT00616421|1389319|P2|Overall Study|Withdrawal by Subject|11
414928|NCT00616421|1389320|P1|Overall Study|Withdrawal by Subject|9
414929|NCT00616239|1389361|P1|Overall Study|Withdrawal by Subject|2
414930|NCT00616018|1389385|P1|Overall Study|Protocol Violation|3
414931|NCT00615992|1389390|P1|Overall Study|Protocol Violation|67
414932|NCT00615914|1389416|P1|Overall Study|Irregularly enrolled patients|10
414933|NCT00615914|1389416|P1|Overall Study|No treatment|2
414934|NCT00615914|1389416|P1|Overall Study|No data was collected.|65
414935|NCT00615914|1389416|P1|Overall Study|Physician Decision|4
414936|NCT00615914|1389416|P1|Overall Study|Withdrawal by Subject|16
414937|NCT00615914|1389416|P1|Overall Study|Lost to Follow-up|187
414938|NCT00615914|1389416|P1|Overall Study|Lack of Efficacy|59
414939|NCT00615914|1389416|P1|Overall Study|Death|20
414940|NCT00615914|1389416|P1|Overall Study|Adverse Event|274
414941|NCT00615901|1389423|P1|Overall Study|Adverse Event|7
414942|NCT00615901|1389423|P1|Overall Study|Withdrawal by Subject|2
414943|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
414944|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
414945|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
414946|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
414947|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
414948|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Not reported|0
414949|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Not reported|4
414950|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Not reported|1
414951|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Not reported|4
414952|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Not reported|6
414953|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Not specified|0
414954|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Not specified|8
414955|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Not specified|8
414956|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Not specified|7
414957|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Not specified|10
414958|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
414959|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
414960|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
414961|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
414962|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
414963|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
414964|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
414965|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
414966|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
414967|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
414968|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
414969|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
414970|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
414971|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
414972|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
414973|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
414974|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
414975|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
414976|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
414977|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
414978|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
414979|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
414980|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
414981|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
414982|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
414983|NCT00615836|1389431|P5|Extension Study (FE992026 CS31)|Adverse Event|0
414984|NCT00615836|1389432|P4|Extension Study (FE992026 CS31)|Adverse Event|13
414985|NCT00615836|1389433|P3|Extension Study (FE992026 CS31)|Adverse Event|15
414986|NCT00615836|1389434|P2|Extension Study (FE992026 CS31)|Adverse Event|12
414987|NCT00615836|1389435|P1|Extension Study (FE992026 CS31)|Adverse Event|7
414988|NCT00615719|1389495|P1|Overall Study|Physician Decision|5
414989|NCT00615550|1389509|P2|Overall Study|Lost to Follow-up|1
414990|NCT00615550|1389510|P1|Overall Study|Lost to Follow-up|6
414991|NCT00615459|1389533|P4|Period III|Unsatisfactory therapeutic effect|0
414992|NCT00615459|1389534|P3|Period III|Unsatisfactory therapeutic effect|0
414993|NCT00615459|1389535|P2|Period III|Unsatisfactory therapeutic effect|1
414994|NCT00615459|1389536|P1|Period III|Unsatisfactory therapeutic effect|0
414995|NCT00615459|1389533|P4|Period III|Administrative problems|0
414996|NCT00615459|1389534|P3|Period III|Administrative problems|1
414997|NCT00615459|1389535|P2|Period III|Administrative problems|1
414998|NCT00615459|1389536|P1|Period III|Administrative problems|0
414999|NCT00615459|1389533|P4|Period III|Adverse Event|0
415000|NCT00615459|1389534|P3|Period III|Adverse Event|0
415001|NCT00615459|1389535|P2|Period III|Adverse Event|1
415002|NCT00615459|1389536|P1|Period III|Adverse Event|0
415003|NCT00615459|1389533|P4|Period II|Lost to Follow-up|1
415004|NCT00615459|1389534|P3|Period II|Lost to Follow-up|0
415005|NCT00615459|1389535|P2|Period II|Lost to Follow-up|0
415006|NCT00615459|1389536|P1|Period II|Lost to Follow-up|0
415007|NCT00615459|1389533|P4|Period II|Adverse Event|0
415008|NCT00615459|1389534|P3|Period II|Adverse Event|0
415009|NCT00615459|1389535|P2|Period II|Adverse Event|0
415010|NCT00615459|1389536|P1|Period II|Adverse Event|1
415011|NCT00615459|1389533|P4|Period I|Abnormal test procedure results|0
415012|NCT00615459|1389534|P3|Period I|Abnormal test procedure results|1
415013|NCT00615459|1389535|P2|Period I|Abnormal test procedure results|1
415014|NCT00615459|1389536|P1|Period I|Abnormal test procedure results|1
415015|NCT00615459|1389533|P4|Period I|Subject withdrew consent|1
415016|NCT00615459|1389534|P3|Period I|Subject withdrew consent|0
415017|NCT00615459|1389535|P2|Period I|Subject withdrew consent|0
415018|NCT00615459|1389536|P1|Period I|Subject withdrew consent|1
415019|NCT00615459|1389533|P4|Period I|Adverse Event|0
415020|NCT00615459|1389534|P3|Period I|Adverse Event|1
415021|NCT00615459|1389535|P2|Period I|Adverse Event|0
415022|NCT00615459|1389536|P1|Period I|Adverse Event|2
415023|NCT00615290|1389571|P1|Overall Study|Other|2
415024|NCT00615290|1389571|P1|Overall Study|Withdrawal by Subject|1
415025|NCT00615290|1389571|P1|Overall Study|Lost to Follow-up|3
415026|NCT00615290|1389571|P1|Overall Study|Adverse Event|2
415027|NCT00615264|1389585|P2|Overall Study|Dermal Hypersensitivity|3
415028|NCT00615264|1389586|P1|Overall Study|Dermal Hypersensitivity|0
415029|NCT00615264|1389585|P2|Overall Study|Not defined|4
415030|NCT00615264|1389586|P1|Overall Study|Not defined|7
415031|NCT00615264|1389585|P2|Overall Study|Protocol Violation|7
415032|NCT00615264|1389586|P1|Overall Study|Protocol Violation|11
415033|NCT00615264|1389585|P2|Overall Study|Death|1
415034|NCT00615264|1389586|P1|Overall Study|Death|1
415035|NCT00615264|1389585|P2|Overall Study|Adverse Event|5
415036|NCT00615264|1389586|P1|Overall Study|Adverse Event|8
415037|NCT00615264|1389585|P2|Overall Study|Lost to Follow-up|13
415038|NCT00615264|1389586|P1|Overall Study|Lost to Follow-up|6
415039|NCT00615264|1389585|P2|Overall Study|Withdrawal by Subject|19
415040|NCT00615264|1389586|P1|Overall Study|Withdrawal by Subject|17
415041|NCT00615199|1389598|P4|Overall Study|Withdrawal by Subject|0
415042|NCT00615199|1389599|P3|Overall Study|Withdrawal by Subject|0
415043|NCT00615199|1389600|P2|Overall Study|Withdrawal by Subject|1
415044|NCT00615199|1389601|P1|Overall Study|Withdrawal by Subject|2
415045|NCT00615199|1389598|P4|Overall Study|Other|1
415046|NCT00615199|1389599|P3|Overall Study|Other|0
415047|NCT00615199|1389600|P2|Overall Study|Other|0
415048|NCT00615199|1389601|P1|Overall Study|Other|0
415049|NCT00615199|1389598|P4|Overall Study|Lost to Follow-up|0
415050|NCT00615199|1389599|P3|Overall Study|Lost to Follow-up|0
415051|NCT00615199|1389600|P2|Overall Study|Lost to Follow-up|0
415052|NCT00615199|1389601|P1|Overall Study|Lost to Follow-up|1
415053|NCT00615199|1389598|P4|Overall Study|Lack of Efficacy|1
415054|NCT00615199|1389599|P3|Overall Study|Lack of Efficacy|0
415055|NCT00615199|1389600|P2|Overall Study|Lack of Efficacy|0
415056|NCT00615199|1389601|P1|Overall Study|Lack of Efficacy|2
415057|NCT00615199|1389598|P4|Overall Study|Adverse Event|0
415058|NCT00615199|1389599|P3|Overall Study|Adverse Event|1
415059|NCT00615199|1389600|P2|Overall Study|Adverse Event|1
415060|NCT00615199|1389601|P1|Overall Study|Adverse Event|3
415061|NCT00615108|1389635|P1|Overall Study|Lost to Follow-up|15
415062|NCT00615108|1389635|P1|Overall Study|Other|370
415063|NCT00615108|1389635|P1|Overall Study|Adverse Event|122
415064|NCT00615069|1389650|P1|Overall Study|Withdrawal by Subject|4
415065|NCT00615069|1389650|P1|Overall Study|Physician Decision|2
415066|NCT00615069|1389650|P1|Overall Study|Death|10
415067|NCT00615056|1389659|P4|Overall Study|Randomized but not treated|0
415068|NCT00615056|1389660|P3|Overall Study|Randomized but not treated|0
415069|NCT00615056|1389661|P2|Overall Study|Randomized but not treated|0
415070|NCT00615056|1389662|P1|Overall Study|Randomized but not treated|3
415071|NCT00615056|1389659|P4|Overall Study|Discontinued by Sponsor|0
415072|NCT00615056|1389660|P3|Overall Study|Discontinued by Sponsor|0
415073|NCT00615056|1389661|P2|Overall Study|Discontinued by Sponsor|0
415074|NCT00615056|1389662|P1|Overall Study|Discontinued by Sponsor|1
415075|NCT00615056|1389659|P4|Overall Study|Withdrawal by Subject|0
415076|NCT00615056|1389660|P3|Overall Study|Withdrawal by Subject|1
415077|NCT00615056|1389661|P2|Overall Study|Withdrawal by Subject|1
415078|NCT00615056|1389662|P1|Overall Study|Withdrawal by Subject|0
415079|NCT00615056|1389659|P4|Overall Study|Objective progression or relapse|0
415080|NCT00615056|1389660|P3|Overall Study|Objective progression or relapse|0
415081|NCT00615056|1389661|P2|Overall Study|Objective progression or relapse|2
415082|NCT00615056|1389662|P1|Overall Study|Objective progression or relapse|0
415083|NCT00615056|1389659|P4|Overall Study|Other|7
415084|NCT00615056|1389660|P3|Overall Study|Other|10
415085|NCT00615056|1389661|P2|Overall Study|Other|15
415086|NCT00615056|1389662|P1|Overall Study|Other|13
415087|NCT00615056|1389659|P4|Overall Study|Lost to Follow-up|5
415088|NCT00615056|1389660|P3|Overall Study|Lost to Follow-up|4
415089|NCT00615056|1389661|P2|Overall Study|Lost to Follow-up|2
415090|NCT00615056|1389662|P1|Overall Study|Lost to Follow-up|1
415091|NCT00615056|1389659|P4|Overall Study|Death|23
415092|NCT00615056|1389660|P3|Overall Study|Death|21
415093|NCT00615056|1389661|P2|Overall Study|Death|31
415094|NCT00615056|1389662|P1|Overall Study|Death|31
415095|NCT00615030|1389692|P12|Period III|Administrative problems|0
415096|NCT00615030|1389693|P11|Period III|Administrative problems|0
415097|NCT00615030|1389694|P10|Period III|Administrative problems|0
415098|NCT00615030|1389695|P9|Period III|Administrative problems|0
415099|NCT00615030|1389696|P8|Period III|Administrative problems|0
415100|NCT00615030|1389697|P7|Period III|Administrative problems|0
415101|NCT00615030|1389698|P6|Period III|Administrative problems|0
415102|NCT00615030|1389699|P5|Period III|Administrative problems|0
415103|NCT00615030|1389700|P4|Period III|Administrative problems|1
415104|NCT00615030|1389701|P3|Period III|Administrative problems|0
415105|NCT00615030|1389702|P2|Period III|Administrative problems|0
415106|NCT00615030|1389703|P1|Period III|Administrative problems|1
415107|NCT00615030|1389692|P12|Period II|Subject withdrew consent|0
415108|NCT00615030|1389693|P11|Period II|Subject withdrew consent|0
415109|NCT00615030|1389694|P10|Period II|Subject withdrew consent|0
415110|NCT00615030|1389695|P9|Period II|Subject withdrew consent|0
415111|NCT00615030|1389696|P8|Period II|Subject withdrew consent|0
415112|NCT00615030|1389697|P7|Period II|Subject withdrew consent|1
415113|NCT00615030|1389698|P6|Period II|Subject withdrew consent|0
415114|NCT00615030|1389699|P5|Period II|Subject withdrew consent|0
415115|NCT00615030|1389700|P4|Period II|Subject withdrew consent|1
415116|NCT00615030|1389701|P3|Period II|Subject withdrew consent|0
415117|NCT00615030|1389702|P2|Period II|Subject withdrew consent|0
415118|NCT00615030|1389703|P1|Period II|Subject withdrew consent|0
415119|NCT00615030|1389692|P12|Period II|Adverse Event|0
415120|NCT00615030|1389693|P11|Period II|Adverse Event|0
415121|NCT00615030|1389694|P10|Period II|Adverse Event|0
415122|NCT00615030|1389695|P9|Period II|Adverse Event|1
415123|NCT00615030|1389696|P8|Period II|Adverse Event|0
415124|NCT00615030|1389697|P7|Period II|Adverse Event|0
415125|NCT00615030|1389698|P6|Period II|Adverse Event|0
415126|NCT00615030|1389699|P5|Period II|Adverse Event|0
415127|NCT00615030|1389700|P4|Period II|Adverse Event|0
415128|NCT00615030|1389701|P3|Period II|Adverse Event|1
415129|NCT00615030|1389702|P2|Period II|Adverse Event|0
415130|NCT00615030|1389703|P1|Period II|Adverse Event|0
415131|NCT00615030|1389692|P12|Period I|Abnormal laboratory value(s)|0
415132|NCT00615030|1389693|P11|Period I|Abnormal laboratory value(s)|0
415133|NCT00615030|1389694|P10|Period I|Abnormal laboratory value(s)|0
415134|NCT00615030|1389695|P9|Period I|Abnormal laboratory value(s)|0
415135|NCT00615030|1389696|P8|Period I|Abnormal laboratory value(s)|0
415136|NCT00615030|1389697|P7|Period I|Abnormal laboratory value(s)|0
415137|NCT00615030|1389698|P6|Period I|Abnormal laboratory value(s)|1
415138|NCT00615030|1389699|P5|Period I|Abnormal laboratory value(s)|0
415139|NCT00615030|1389700|P4|Period I|Abnormal laboratory value(s)|0
415140|NCT00615030|1389701|P3|Period I|Abnormal laboratory value(s)|0
415141|NCT00615030|1389702|P2|Period I|Abnormal laboratory value(s)|0
415142|NCT00615030|1389703|P1|Period I|Abnormal laboratory value(s)|0
415143|NCT00615030|1389692|P12|Period I|Subject withdrew consent|1
415144|NCT00615030|1389693|P11|Period I|Subject withdrew consent|1
415145|NCT00615030|1389694|P10|Period I|Subject withdrew consent|0
415146|NCT00615030|1389695|P9|Period I|Subject withdrew consent|1
415147|NCT00615030|1389696|P8|Period I|Subject withdrew consent|0
415148|NCT00615030|1389697|P7|Period I|Subject withdrew consent|0
415149|NCT00615030|1389698|P6|Period I|Subject withdrew consent|0
415150|NCT00615030|1389699|P5|Period I|Subject withdrew consent|0
415151|NCT00615030|1389700|P4|Period I|Subject withdrew consent|0
415152|NCT00615030|1389701|P3|Period I|Subject withdrew consent|0
415153|NCT00615030|1389702|P2|Period I|Subject withdrew consent|0
415154|NCT00615030|1389703|P1|Period I|Subject withdrew consent|0
415155|NCT00615030|1389692|P12|Period I|Protocol deviation|0
415156|NCT00615030|1389693|P11|Period I|Protocol deviation|0
415157|NCT00615030|1389694|P10|Period I|Protocol deviation|0
415158|NCT00615030|1389695|P9|Period I|Protocol deviation|0
415159|NCT00615030|1389696|P8|Period I|Protocol deviation|0
415160|NCT00615030|1389697|P7|Period I|Protocol deviation|0
415161|NCT00615030|1389698|P6|Period I|Protocol deviation|0
415162|NCT00615030|1389699|P5|Period I|Protocol deviation|0
415163|NCT00615030|1389700|P4|Period I|Protocol deviation|0
415164|NCT00615030|1389701|P3|Period I|Protocol deviation|0
415165|NCT00615030|1389702|P2|Period I|Protocol deviation|0
415166|NCT00615030|1389703|P1|Period I|Protocol deviation|1
415167|NCT00615030|1389692|P12|Period I|Administrative problem|0
415168|NCT00615030|1389693|P11|Period I|Administrative problem|0
415169|NCT00615030|1389694|P10|Period I|Administrative problem|0
415170|NCT00615030|1389695|P9|Period I|Administrative problem|0
415171|NCT00615030|1389696|P8|Period I|Administrative problem|0
415172|NCT00615030|1389697|P7|Period I|Administrative problem|0
415173|NCT00615030|1389698|P6|Period I|Administrative problem|0
415174|NCT00615030|1389699|P5|Period I|Administrative problem|1
415175|NCT00615030|1389700|P4|Period I|Administrative problem|0
415176|NCT00615030|1389701|P3|Period I|Administrative problem|0
415177|NCT00615030|1389702|P2|Period I|Administrative problem|0
415178|NCT00615030|1389703|P1|Period I|Administrative problem|0
415179|NCT00615017|1389723|P6|Overall Study|Physician discontinued drug|1
415180|NCT00615017|1389724|P5|Overall Study|Physician discontinued drug|0
415181|NCT00615017|1389725|P4|Overall Study|Physician discontinued drug|0
415182|NCT00615017|1389726|P3|Overall Study|Physician discontinued drug|0
415183|NCT00615017|1389727|P2|Overall Study|Physician discontinued drug|0
415184|NCT00615017|1389728|P1|Overall Study|Physician discontinued drug|0
415185|NCT00615017|1389723|P6|Overall Study|Transferred out of Intensive Care Unit|0
415186|NCT00615017|1389724|P5|Overall Study|Transferred out of Intensive Care Unit|0
415187|NCT00615017|1389725|P4|Overall Study|Transferred out of Intensive Care Unit|1
415188|NCT00615017|1389726|P3|Overall Study|Transferred out of Intensive Care Unit|0
415189|NCT00615017|1389727|P2|Overall Study|Transferred out of Intensive Care Unit|0
415190|NCT00615017|1389728|P1|Overall Study|Transferred out of Intensive Care Unit|0
415191|NCT00615017|1389723|P6|Overall Study|Sepsis resolved|0
415192|NCT00615017|1389724|P5|Overall Study|Sepsis resolved|0
415193|NCT00615017|1389725|P4|Overall Study|Sepsis resolved|0
415194|NCT00615017|1389726|P3|Overall Study|Sepsis resolved|1
415195|NCT00615017|1389727|P2|Overall Study|Sepsis resolved|0
415196|NCT00615017|1389728|P1|Overall Study|Sepsis resolved|0
415197|NCT00615017|1389723|P6|Overall Study|Death|1
415198|NCT00615017|1389724|P5|Overall Study|Death|1
415199|NCT00615017|1389725|P4|Overall Study|Death|0
415200|NCT00615017|1389726|P3|Overall Study|Death|2
415201|NCT00615017|1389727|P2|Overall Study|Death|0
415202|NCT00615017|1389728|P1|Overall Study|Death|0
415203|NCT00615017|1389723|P6|Overall Study|Adverse Event|1
415204|NCT00615017|1389724|P5|Overall Study|Adverse Event|0
415205|NCT00615017|1389725|P4|Overall Study|Adverse Event|0
415206|NCT00615017|1389726|P3|Overall Study|Adverse Event|2
415207|NCT00615017|1389727|P2|Overall Study|Adverse Event|1
415208|NCT00615017|1389728|P1|Overall Study|Adverse Event|0
415209|NCT00614991|1389886|P6|Overall Study|Adverse Event|0
415210|NCT00614991|1389887|P5|Overall Study|Adverse Event|1
415211|NCT00614991|1389888|P4|Overall Study|Adverse Event|0
415212|NCT00614991|1389889|P3|Overall Study|Adverse Event|0
415213|NCT00614991|1389890|P2|Overall Study|Adverse Event|3
415214|NCT00614991|1389891|P1|Overall Study|Adverse Event|3
415215|NCT00614939|1389925|P2|Overall Study|Hospitalized due to kidney transplant|0
415216|NCT00614939|1389926|P1|Overall Study|Hospitalized due to kidney transplant|1
415217|NCT00614939|1389925|P2|Overall Study|Poor/non-compliance|0
415218|NCT00614939|1389926|P1|Overall Study|Poor/non-compliance|4
415219|NCT00614939|1389925|P2|Overall Study|Death|3
415220|NCT00614939|1389926|P1|Overall Study|Death|4
415221|NCT00614939|1389925|P2|Overall Study|Incorrect enrollment|2
415222|NCT00614939|1389926|P1|Overall Study|Incorrect enrollment|1
415223|NCT00614939|1389925|P2|Overall Study|Adverse Event|5
415224|NCT00614939|1389926|P1|Overall Study|Adverse Event|2
415225|NCT00614939|1389925|P2|Overall Study|Study specific discontinuation criteris|16
415226|NCT00614939|1389926|P1|Overall Study|Study specific discontinuation criteris|13
415227|NCT00614939|1389925|P2|Overall Study|Withdrawal by Subject|17
415228|NCT00614939|1389926|P1|Overall Study|Withdrawal by Subject|10
415229|NCT00614926|1389960|P2|Overall Study|Adverse Event|0
415230|NCT00614926|1389961|P1|Overall Study|Adverse Event|3
415231|NCT00614926|1389960|P2|Overall Study|Burden of travel|0
415232|NCT00614926|1389961|P1|Overall Study|Burden of travel|1
415233|NCT00614874|1389974|P1|Overall Study|Withdrawal by Subject|1
415234|NCT00614874|1389974|P1|Overall Study|Protocol Violation|1
415235|NCT00614744|1389983|P2|Overall Study|Incomplete for Behavior Issues|2
415236|NCT00614744|1389984|P1|Overall Study|Incomplete for Behavior Issues|0
415237|NCT00614744|1389983|P2|Overall Study|Lost to Follow-up|4
415238|NCT00614744|1389984|P1|Overall Study|Lost to Follow-up|5
415239|NCT00614614|1390010|P5|Booster Vaccination Phase|Other|1
415240|NCT00614614|1390011|P4|Booster Vaccination Phase|Other|2
415241|NCT00614614|1390012|P3|Booster Vaccination Phase|Other|3
415242|NCT00614614|1390013|P2|Booster Vaccination Phase|Other|1
415243|NCT00614614|1390014|P1|Booster Vaccination Phase|Other|0
415244|NCT00614614|1390010|P5|Booster Vaccination Phase|Protocol Violation|0
415245|NCT00614614|1390011|P4|Booster Vaccination Phase|Protocol Violation|3
415246|NCT00614614|1390012|P3|Booster Vaccination Phase|Protocol Violation|2
415247|NCT00614614|1390013|P2|Booster Vaccination Phase|Protocol Violation|0
415248|NCT00614614|1390014|P1|Booster Vaccination Phase|Protocol Violation|0
415249|NCT00614614|1390010|P5|Booster Vaccination Phase|Lost to Follow-up|8
415250|NCT00614614|1390011|P4|Booster Vaccination Phase|Lost to Follow-up|10
415251|NCT00614614|1390012|P3|Booster Vaccination Phase|Lost to Follow-up|17
415252|NCT00614614|1390013|P2|Booster Vaccination Phase|Lost to Follow-up|5
415253|NCT00614614|1390014|P1|Booster Vaccination Phase|Lost to Follow-up|0
415254|NCT00614614|1390010|P5|Booster Vaccination Phase|Withdrawal by Subject|4
415255|NCT00614614|1390011|P4|Booster Vaccination Phase|Withdrawal by Subject|3
415256|NCT00614614|1390012|P3|Booster Vaccination Phase|Withdrawal by Subject|4
415257|NCT00614614|1390013|P2|Booster Vaccination Phase|Withdrawal by Subject|0
415258|NCT00614614|1390014|P1|Booster Vaccination Phase|Withdrawal by Subject|0
415259|NCT00614614|1390010|P5|Booster Vaccination Phase|Adverse Event|0
415260|NCT00614614|1390011|P4|Booster Vaccination Phase|Adverse Event|1
415261|NCT00614614|1390012|P3|Booster Vaccination Phase|Adverse Event|1
415262|NCT00614614|1390013|P2|Booster Vaccination Phase|Adverse Event|0
415263|NCT00614614|1390014|P1|Booster Vaccination Phase|Adverse Event|0
415264|NCT00614614|1390010|P5|Primary Vaccination Phase|Other|0
415265|NCT00614614|1390011|P4|Primary Vaccination Phase|Other|0
415266|NCT00614614|1390012|P3|Primary Vaccination Phase|Other|0
415267|NCT00614614|1390013|P2|Primary Vaccination Phase|Other|0
415268|NCT00614614|1390014|P1|Primary Vaccination Phase|Other|4
415269|NCT00614614|1390010|P5|Primary Vaccination Phase|Protocol Violation|0
415270|NCT00614614|1390011|P4|Primary Vaccination Phase|Protocol Violation|0
415271|NCT00614614|1390012|P3|Primary Vaccination Phase|Protocol Violation|0
415272|NCT00614614|1390013|P2|Primary Vaccination Phase|Protocol Violation|3
415273|NCT00614614|1390014|P1|Primary Vaccination Phase|Protocol Violation|9
415274|NCT00614614|1390010|P5|Primary Vaccination Phase|Lost to Follow-up|0
415275|NCT00614614|1390011|P4|Primary Vaccination Phase|Lost to Follow-up|0
415276|NCT00614614|1390012|P3|Primary Vaccination Phase|Lost to Follow-up|0
415277|NCT00614614|1390013|P2|Primary Vaccination Phase|Lost to Follow-up|8
415278|NCT00614614|1390014|P1|Primary Vaccination Phase|Lost to Follow-up|26
415279|NCT00614614|1390010|P5|Primary Vaccination Phase|Withdrawal by Subject|0
415280|NCT00614614|1390011|P4|Primary Vaccination Phase|Withdrawal by Subject|0
415281|NCT00614614|1390012|P3|Primary Vaccination Phase|Withdrawal by Subject|0
415282|NCT00614614|1390013|P2|Primary Vaccination Phase|Withdrawal by Subject|6
415283|NCT00614614|1390014|P1|Primary Vaccination Phase|Withdrawal by Subject|45
415284|NCT00614614|1390010|P5|Primary Vaccination Phase|Adverse Event|0
415285|NCT00614614|1390011|P4|Primary Vaccination Phase|Adverse Event|0
415286|NCT00614614|1390012|P3|Primary Vaccination Phase|Adverse Event|0
415287|NCT00614614|1390013|P2|Primary Vaccination Phase|Adverse Event|0
415288|NCT00614614|1390014|P1|Primary Vaccination Phase|Adverse Event|6
415289|NCT00614575|1390137|P1|Overall Study|No treatment|1
415290|NCT00614575|1390137|P1|Overall Study|Irregularly enrolled patients|23
415291|NCT00614575|1390137|P1|Overall Study|No data were collected.|18
415292|NCT00614575|1390137|P1|Overall Study|Physician Decision|2
415293|NCT00614575|1390137|P1|Overall Study|Death|3
415294|NCT00614575|1390137|P1|Overall Study|Withdrawal by Subject|6
415295|NCT00614575|1390137|P1|Overall Study|Lack of Efficacy|14
415296|NCT00614575|1390137|P1|Overall Study|Lost to Follow-up|55
415297|NCT00614575|1390137|P1|Overall Study|Adverse Event|106
415298|NCT00614523|1390148|P2|Overall Study|Administrative Decision|46
415299|NCT00614523|1390149|P1|Overall Study|Administrative Decision|23
415300|NCT00614523|1390148|P2|Overall Study|Disease Progression|8
415301|NCT00614523|1390149|P1|Overall Study|Disease Progression|0
415302|NCT00614523|1390148|P2|Overall Study|Ineligibility Determined|2
415303|NCT00614523|1390149|P1|Overall Study|Ineligibility Determined|1
415304|NCT00614523|1390148|P2|Overall Study|Other|11
415305|NCT00614523|1390149|P1|Overall Study|Other|6
415306|NCT00614523|1390148|P2|Overall Study|Withdrawal by Subject|22
415307|NCT00614523|1390149|P1|Overall Study|Withdrawal by Subject|12
415308|NCT00614523|1390148|P2|Overall Study|Protocol Violation|2
415309|NCT00614523|1390149|P1|Overall Study|Protocol Violation|3
415310|NCT00614523|1390148|P2|Overall Study|Lost to Follow-up|1
415311|NCT00614523|1390149|P1|Overall Study|Lost to Follow-up|0
415312|NCT00614523|1390148|P2|Overall Study|Lack of Efficacy|11
415313|NCT00614523|1390149|P1|Overall Study|Lack of Efficacy|9
415314|NCT00614523|1390148|P2|Overall Study|Death|8
415315|NCT00614523|1390149|P1|Overall Study|Death|5
415316|NCT00614523|1390148|P2|Overall Study|Adverse Event|20
415317|NCT00614523|1390149|P1|Overall Study|Adverse Event|4
415318|NCT00614393|1390205|P5|Overall Study|Not Treated|2
415319|NCT00614393|1390206|P4|Overall Study|Not Treated|0
415320|NCT00614393|1390207|P3|Overall Study|Not Treated|0
415321|NCT00614393|1390208|P2|Overall Study|Not Treated|0
415322|NCT00614393|1390209|P1|Overall Study|Not Treated|0
415323|NCT00614393|1390205|P5|Overall Study|Other|2
415324|NCT00614393|1390206|P4|Overall Study|Other|4
415325|NCT00614393|1390207|P3|Overall Study|Other|0
415326|NCT00614393|1390208|P2|Overall Study|Other|0
415327|NCT00614393|1390209|P1|Overall Study|Other|4
415328|NCT00614393|1390205|P5|Overall Study|Withdrawal by Subject|13
415329|NCT00614393|1390206|P4|Overall Study|Withdrawal by Subject|16
415330|NCT00614393|1390207|P3|Overall Study|Withdrawal by Subject|1
415331|NCT00614393|1390208|P2|Overall Study|Withdrawal by Subject|1
415332|NCT00614393|1390209|P1|Overall Study|Withdrawal by Subject|20
415333|NCT00614393|1390205|P5|Overall Study|Terminated by Sponsor|1
415334|NCT00614393|1390206|P4|Overall Study|Terminated by Sponsor|0
415335|NCT00614393|1390207|P3|Overall Study|Terminated by Sponsor|0
415336|NCT00614393|1390208|P2|Overall Study|Terminated by Sponsor|0
415337|NCT00614393|1390209|P1|Overall Study|Terminated by Sponsor|0
415338|NCT00614393|1390205|P5|Overall Study|Protocol Violation|0
415339|NCT00614393|1390206|P4|Overall Study|Protocol Violation|0
415340|NCT00614393|1390207|P3|Overall Study|Protocol Violation|0
415341|NCT00614393|1390208|P2|Overall Study|Protocol Violation|0
415342|NCT00614393|1390209|P1|Overall Study|Protocol Violation|1
415343|NCT00614393|1390205|P5|Overall Study|Progressive Disease|130
415344|NCT00614393|1390206|P4|Overall Study|Progressive Disease|138
415345|NCT00614393|1390207|P3|Overall Study|Progressive Disease|5
415346|NCT00614393|1390208|P2|Overall Study|Progressive Disease|5
415347|NCT00614393|1390209|P1|Overall Study|Progressive Disease|118
415348|NCT00614393|1390205|P5|Overall Study|Physician Decision|9
415349|NCT00614393|1390206|P4|Overall Study|Physician Decision|8
415350|NCT00614393|1390207|P3|Overall Study|Physician Decision|1
415351|NCT00614393|1390208|P2|Overall Study|Physician Decision|0
415352|NCT00614393|1390209|P1|Overall Study|Physician Decision|17
415353|NCT00614393|1390205|P5|Overall Study|Lost to Follow-up|2
415354|NCT00614393|1390206|P4|Overall Study|Lost to Follow-up|1
415355|NCT00614393|1390207|P3|Overall Study|Lost to Follow-up|0
415356|NCT00614393|1390208|P2|Overall Study|Lost to Follow-up|0
415357|NCT00614393|1390209|P1|Overall Study|Lost to Follow-up|0
415358|NCT00614393|1390205|P5|Overall Study|Adverse Event|21
415359|NCT00614393|1390206|P4|Overall Study|Adverse Event|13
415360|NCT00614393|1390207|P3|Overall Study|Adverse Event|3
415361|NCT00614393|1390208|P2|Overall Study|Adverse Event|2
415362|NCT00614393|1390209|P1|Overall Study|Adverse Event|20
415363|NCT00614380|1390255|P4|Overall Study|Consent withdrawn|0
415364|NCT00614380|1390256|P3|Overall Study|Consent withdrawn|0
415365|NCT00614380|1390257|P2|Overall Study|Consent withdrawn|1
415366|NCT00614380|1390258|P1|Overall Study|Consent withdrawn|3
415367|NCT00614380|1390255|P4|Overall Study|Non compliant with the protocol|2
415368|NCT00614380|1390256|P3|Overall Study|Non compliant with the protocol|1
415369|NCT00614380|1390257|P2|Overall Study|Non compliant with the protocol|2
415370|NCT00614380|1390258|P1|Overall Study|Non compliant with the protocol|12
415371|NCT00614380|1390255|P4|Overall Study|Lost to Follow-up|0
415372|NCT00614380|1390256|P3|Overall Study|Lost to Follow-up|0
415373|NCT00614380|1390257|P2|Overall Study|Lost to Follow-up|1
415374|NCT00614380|1390258|P1|Overall Study|Lost to Follow-up|6
415375|NCT00614380|1390255|P4|Overall Study|Adverse Event|0
415376|NCT00614380|1390256|P3|Overall Study|Adverse Event|0
415377|NCT00614380|1390257|P2|Overall Study|Adverse Event|4
415378|NCT00614380|1390258|P1|Overall Study|Adverse Event|14
415379|NCT00614120|1390325|P4|Overall Study|Lost to Follow-up|4
415380|NCT00614120|1390326|P3|Overall Study|Lost to Follow-up|3
415381|NCT00614120|1390327|P2|Overall Study|Lost to Follow-up|2
415382|NCT00614120|1390328|P1|Overall Study|Lost to Follow-up|1
415383|NCT00614120|1390325|P4|Overall Study|Taken inhibition medication eg Prandin|1
415384|NCT00614120|1390326|P3|Overall Study|Taken inhibition medication eg Prandin|1
415385|NCT00614120|1390327|P2|Overall Study|Taken inhibition medication eg Prandin|0
415386|NCT00614120|1390328|P1|Overall Study|Taken inhibition medication eg Prandin|0
415387|NCT00614120|1390325|P4|Overall Study|Late syphilis, latent|0
415388|NCT00614120|1390326|P3|Overall Study|Late syphilis, latent|0
415389|NCT00614120|1390327|P2|Overall Study|Late syphilis, latent|0
415390|NCT00614120|1390328|P1|Overall Study|Late syphilis, latent|1
415391|NCT00614120|1390325|P4|Overall Study|Lack of trial product|0
415392|NCT00614120|1390326|P3|Overall Study|Lack of trial product|2
415393|NCT00614120|1390327|P2|Overall Study|Lack of trial product|3
415394|NCT00614120|1390328|P1|Overall Study|Lack of trial product|3
415395|NCT00614120|1390325|P4|Overall Study|Hypoglycaemia|1
415396|NCT00614120|1390326|P3|Overall Study|Hypoglycaemia|0
415397|NCT00614120|1390327|P2|Overall Study|Hypoglycaemia|0
415398|NCT00614120|1390328|P1|Overall Study|Hypoglycaemia|0
415399|NCT00614120|1390325|P4|Overall Study|hCG positive (not pregnant)|0
415400|NCT00614120|1390326|P3|Overall Study|hCG positive (not pregnant)|1
415401|NCT00614120|1390327|P2|Overall Study|hCG positive (not pregnant)|0
415402|NCT00614120|1390328|P1|Overall Study|hCG positive (not pregnant)|0
415403|NCT00614120|1390325|P4|Overall Study|Did not meet trial criteria|1
415404|NCT00614120|1390326|P3|Overall Study|Did not meet trial criteria|1
415405|NCT00614120|1390327|P2|Overall Study|Did not meet trial criteria|1
415406|NCT00614120|1390328|P1|Overall Study|Did not meet trial criteria|0
415407|NCT00614120|1390325|P4|Overall Study|Withdrawal by Subject|3
415408|NCT00614120|1390326|P3|Overall Study|Withdrawal by Subject|16
415409|NCT00614120|1390327|P2|Overall Study|Withdrawal by Subject|10
415410|NCT00614120|1390328|P1|Overall Study|Withdrawal by Subject|9
415411|NCT00614120|1390325|P4|Overall Study|Withdrawal criteria|0
415412|NCT00614120|1390326|P3|Overall Study|Withdrawal criteria|0
415413|NCT00614120|1390327|P2|Overall Study|Withdrawal criteria|0
415414|NCT00614120|1390328|P1|Overall Study|Withdrawal criteria|1
415415|NCT00614120|1390325|P4|Overall Study|Protocol Violation|1
415416|NCT00614120|1390326|P3|Overall Study|Protocol Violation|3
415417|NCT00614120|1390327|P2|Overall Study|Protocol Violation|5
415418|NCT00614120|1390328|P1|Overall Study|Protocol Violation|2
415419|NCT00614120|1390325|P4|Overall Study|Lack of Efficacy|2
415420|NCT00614120|1390326|P3|Overall Study|Lack of Efficacy|2
415421|NCT00614120|1390327|P2|Overall Study|Lack of Efficacy|3
415422|NCT00614120|1390328|P1|Overall Study|Lack of Efficacy|3
415423|NCT00614120|1390325|P4|Overall Study|Adverse Event|3
415424|NCT00614120|1390326|P3|Overall Study|Adverse Event|30
415425|NCT00614120|1390327|P2|Overall Study|Adverse Event|22
415426|NCT00614120|1390328|P1|Overall Study|Adverse Event|9
415427|NCT00614055|1390369|P3|Overall Study|Unclassified|2
415428|NCT00614055|1390370|P2|Overall Study|Unclassified|4
415429|NCT00614055|1390371|P1|Overall Study|Unclassified|1
415430|NCT00614055|1390369|P3|Overall Study|Lack of Efficacy|2
415431|NCT00614055|1390370|P2|Overall Study|Lack of Efficacy|0
415432|NCT00614055|1390371|P1|Overall Study|Lack of Efficacy|0
415433|NCT00614055|1390369|P3|Overall Study|Protocol Violation|1
415434|NCT00614055|1390370|P2|Overall Study|Protocol Violation|2
415435|NCT00614055|1390371|P1|Overall Study|Protocol Violation|2
415436|NCT00614055|1390369|P3|Overall Study|Adverse Event|0
415437|NCT00614055|1390370|P2|Overall Study|Adverse Event|0
415438|NCT00614055|1390371|P1|Overall Study|Adverse Event|1
415439|NCT00613951|1390418|P3|Overall Study|Unclassified|2
415440|NCT00613951|1390419|P2|Overall Study|Unclassified|3
415441|NCT00613951|1390420|P1|Overall Study|Unclassified|5
415442|NCT00613951|1390418|P3|Overall Study|Protocol Violation|1
415443|NCT00613951|1390419|P2|Overall Study|Protocol Violation|1
415444|NCT00613951|1390420|P1|Overall Study|Protocol Violation|1
415445|NCT00613951|1390418|P3|Overall Study|Lack of Efficacy|1
415446|NCT00613951|1390419|P2|Overall Study|Lack of Efficacy|1
415447|NCT00613951|1390420|P1|Overall Study|Lack of Efficacy|0
415448|NCT00613951|1390418|P3|Overall Study|Adverse Event|1
415449|NCT00613951|1390419|P2|Overall Study|Adverse Event|0
415450|NCT00613951|1390420|P1|Overall Study|Adverse Event|1
415451|NCT00613938|1390465|P4|Overall Study|Other|3
415452|NCT00613938|1390466|P3|Overall Study|Other|1
415453|NCT00613938|1390467|P2|Overall Study|Other|2
415454|NCT00613938|1390468|P1|Overall Study|Other|1
415455|NCT00613938|1390465|P4|Overall Study|Lack of Efficacy|9
415456|NCT00613938|1390466|P3|Overall Study|Lack of Efficacy|5
415457|NCT00613938|1390467|P2|Overall Study|Lack of Efficacy|18
415458|NCT00613938|1390468|P1|Overall Study|Lack of Efficacy|16
415459|NCT00613938|1390465|P4|Overall Study|Adverse Event|5
415460|NCT00613938|1390466|P3|Overall Study|Adverse Event|8
415461|NCT00613938|1390467|P2|Overall Study|Adverse Event|4
415462|NCT00613938|1390468|P1|Overall Study|Adverse Event|1
415463|NCT00613938|1390465|P4|Overall Study|Withdrawal by Subject|9
415464|NCT00613938|1390466|P3|Overall Study|Withdrawal by Subject|9
415465|NCT00613938|1390467|P2|Overall Study|Withdrawal by Subject|4
415466|NCT00613938|1390468|P1|Overall Study|Withdrawal by Subject|2
415467|NCT00613925|1390500|P2|Overall Study|1 did not tolerate outpatient biopsy|1
415468|NCT00613925|1390501|P1|Overall Study|1 did not tolerate outpatient biopsy|0
415469|NCT00613821|1390511|P2|Overall Study|Physician Decision|1
415470|NCT00613821|1390512|P1|Overall Study|Physician Decision|1
415471|NCT00613821|1390511|P2|Overall Study|Withdrawal by Subject|0
415472|NCT00613821|1390512|P1|Overall Study|Withdrawal by Subject|1
415473|NCT00613730|1390518|P1|Overall Study|Administrative decision|1
415474|NCT00613730|1390518|P1|Overall Study|Disease progression|2
415475|NCT00613626|1390527|P3|Overall Study|Ineligible|0
415476|NCT00613626|1390528|P2|Overall Study|Ineligible|1
415477|NCT00613626|1390529|P1|Overall Study|Ineligible|0
415478|NCT00613574|1390545|P1|Overall Study|Other|1
415479|NCT00613574|1390545|P1|Overall Study|Lost to Follow-up|2
415480|NCT00613574|1390545|P1|Overall Study|Adverse Event|3
415481|NCT00613509|1390557|P2|Cycle 1|Other administrative reason|1
415482|NCT00613509|1390558|P1|Cycle 1|Other administrative reason|0
415483|NCT00613509|1390557|P2|Cycle 1|Unacceptable Toxicity|0
415484|NCT00613509|1390558|P1|Cycle 1|Unacceptable Toxicity|1
415485|NCT00613509|1390557|P2|Cycle 1|Disease Progression|6
415486|NCT00613509|1390558|P1|Cycle 1|Disease Progression|2
415487|NCT00613509|1390557|P2|Cycle 1|Adverse Event|1
415488|NCT00613509|1390558|P1|Cycle 1|Adverse Event|2
415489|NCT00613366|1390604|P2|Overall Study|Withdrawal by Subject|2
415490|NCT00613366|1390605|P1|Overall Study|Withdrawal by Subject|3
415491|NCT00613327|1390613|P1|Overall Study|Other|47
415492|NCT00613327|1390613|P1|Overall Study|Protocol Violation|2
415493|NCT00613327|1390613|P1|Overall Study|Withdrawal by Subject|6
415494|NCT00613327|1390613|P1|Overall Study|Lost to Follow-up|8
415495|NCT00613327|1390613|P1|Overall Study|Adverse Event|38
415496|NCT00613314|1390632|P1|Overall Study|Other reason not defined above|90
415497|NCT00613314|1390632|P1|Overall Study|Lost to Follow-up|46
415498|NCT00613314|1390632|P1|Overall Study|Protocol Violation|14
415499|NCT00613314|1390632|P1|Overall Study|Adverse Event|5
415500|NCT00613301|1390640|P1|Overall Study|Irregularly enrolled patients|12
415501|NCT00613301|1390640|P1|Overall Study|No data was collected|53
415502|NCT00613301|1390640|P1|Overall Study|Physician Decision|2
415503|NCT00613301|1390640|P1|Overall Study|Lack of Efficacy|13
415504|NCT00613301|1390640|P1|Overall Study|Death|6
415505|NCT00613301|1390640|P1|Overall Study|Withdrawal by Subject|5
415506|NCT00613301|1390640|P1|Overall Study|Lost to Follow-up|88
415507|NCT00613301|1390640|P1|Overall Study|Adverse Event|49
415508|NCT00613106|1390649|P2|Overall Study|misc|3
415509|NCT00613106|1390650|P1|Overall Study|misc|4
415510|NCT00613106|1390649|P2|Overall Study|Lost to Follow-up|2
415511|NCT00613106|1390650|P1|Overall Study|Lost to Follow-up|7
415512|NCT00613106|1390649|P2|Overall Study|Withdrawal by Subject|3
415513|NCT00613106|1390650|P1|Overall Study|Withdrawal by Subject|6
415514|NCT00613106|1390649|P2|Overall Study|Adverse Event|1
415515|NCT00613106|1390650|P1|Overall Study|Adverse Event|3
415516|NCT00613080|1390656|P1|Overall Study|Ineligible / no protocol treatment|11
415517|NCT00613015|1390683|P6|Overall Study|Lost to Follow-up|3
415518|NCT00613015|1390684|P5|Overall Study|Lost to Follow-up|2
415519|NCT00613015|1390685|P4|Overall Study|Lost to Follow-up|3
415520|NCT00613015|1390686|P3|Overall Study|Lost to Follow-up|3
415521|NCT00613015|1390687|P2|Overall Study|Lost to Follow-up|1
415522|NCT00613015|1390688|P1|Overall Study|Lost to Follow-up|0
415523|NCT00612807|1390724|P2|Overall Study|Withdrawal by Subject|0
415524|NCT00612807|1390725|P1|Overall Study|Withdrawal by Subject|2
415525|NCT00612690|1390760|P2|Overall Study|Withdrawal by Site|0
415526|NCT00612690|1390761|P1|Overall Study|Withdrawal by Site|11
415527|NCT00612690|1390760|P2|Overall Study|Withdrawal by Subject|20
415528|NCT00612690|1390761|P1|Overall Study|Withdrawal by Subject|32
415529|NCT00612690|1390760|P2|Overall Study|Lost to Follow-up|98
415530|NCT00612690|1390761|P1|Overall Study|Lost to Follow-up|72
415531|NCT00612677|1390769|P1|Overall Study|study closed before treatment started|1
415532|NCT00612534|1390837|P4|Overall Study|Other Reason|0
415533|NCT00612534|1390838|P3|Overall Study|Other Reason|0
415534|NCT00612534|1390839|P2|Overall Study|Other Reason|1
415535|NCT00612534|1390840|P1|Overall Study|Other Reason|0
415536|NCT00612534|1390837|P4|Overall Study|Lack of Efficacy|16
415537|NCT00612534|1390838|P3|Overall Study|Lack of Efficacy|5
415538|NCT00612534|1390839|P2|Overall Study|Lack of Efficacy|12
415539|NCT00612534|1390840|P1|Overall Study|Lack of Efficacy|13
415540|NCT00612534|1390837|P4|Overall Study|Adverse Event|1
415541|NCT00612534|1390838|P3|Overall Study|Adverse Event|2
415542|NCT00612534|1390839|P2|Overall Study|Adverse Event|4
415543|NCT00612534|1390840|P1|Overall Study|Adverse Event|0
415544|NCT00612508|1390852|P2|Overall Study|Withdrawal by Subject|4
415545|NCT00612508|1390853|P1|Overall Study|Withdrawal by Subject|3
415546|NCT00612456|1390864|P3|Overall Study|Withdrawal by Subject|0
415547|NCT00612456|1390865|P2|Overall Study|Withdrawal by Subject|1
415548|NCT00612456|1390866|P1|Overall Study|Withdrawal by Subject|0
415549|NCT00612456|1390864|P3|Overall Study|Lack of Efficacy|0
415550|NCT00612456|1390865|P2|Overall Study|Lack of Efficacy|1
415551|NCT00612456|1390866|P1|Overall Study|Lack of Efficacy|1
415552|NCT00612456|1390864|P3|Overall Study|Adverse Event|0
415553|NCT00612456|1390865|P2|Overall Study|Adverse Event|0
415554|NCT00612456|1390866|P1|Overall Study|Adverse Event|1
415555|NCT00612352|1390929|P2|Overall Study|didn't return calls/show up on test date|1
415556|NCT00612352|1390930|P1|Overall Study|didn't return calls/show up on test date|4
415557|NCT00612352|1390929|P2|Overall Study|moved out of state|0
415558|NCT00612352|1390930|P1|Overall Study|moved out of state|1
415559|NCT00612352|1390929|P2|Overall Study|Withdrawal by Subject|5
415560|NCT00612352|1390930|P1|Overall Study|Withdrawal by Subject|3
415561|NCT00612352|1390929|P2|Overall Study|Adverse Event|0
415562|NCT00612352|1390930|P1|Overall Study|Adverse Event|1
415563|NCT00612313|1391050|P2|Overall Study|Lost to Follow-up|4
415564|NCT00612313|1391051|P1|Overall Study|Lost to Follow-up|11
415565|NCT00612313|1391050|P2|Overall Study|Withdrawal by Subject|9
415566|NCT00612313|1391051|P1|Overall Study|Withdrawal by Subject|6
415567|NCT00612105|1391075|P2|Period Title 3: 3-Week Taper Phase|Other|0
415568|NCT00612105|1391076|P1|Period Title 3: 3-Week Taper Phase|Other|1
415569|NCT00612105|1391075|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
415570|NCT00612105|1391076|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
415571|NCT00612105|1391075|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
415572|NCT00612105|1391076|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
415573|NCT00612105|1391075|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
415574|NCT00612105|1391076|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
415575|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Other|1
415576|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Other|0
415577|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
415578|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
415579|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
415580|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
415581|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
415582|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
415583|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
415584|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
415585|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
415586|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
415587|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
415588|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
415589|NCT00612105|1391075|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
415590|NCT00612105|1391076|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
415591|NCT00612066|1391126|P1|Overall Study|Adverse Event|1
415592|NCT00612040|1391133|P3|Overall Study|Unclassified|5
415593|NCT00612040|1391134|P2|Overall Study|Unclassified|2
415594|NCT00612040|1391135|P1|Overall Study|Unclassified|2
415595|NCT00612040|1391133|P3|Overall Study|Lack of Efficacy|0
415596|NCT00612040|1391134|P2|Overall Study|Lack of Efficacy|1
415597|NCT00612040|1391135|P1|Overall Study|Lack of Efficacy|2
415598|NCT00612040|1391133|P3|Overall Study|Protocol Violation|1
415599|NCT00612040|1391134|P2|Overall Study|Protocol Violation|2
415600|NCT00612040|1391135|P1|Overall Study|Protocol Violation|1
415601|NCT00612040|1391133|P3|Overall Study|Adverse Event|1
415602|NCT00612040|1391134|P2|Overall Study|Adverse Event|2
415603|NCT00612040|1391135|P1|Overall Study|Adverse Event|0
415604|NCT00611884|1391208|P4|Overall Study|Unclassified|3
415605|NCT00611884|1391209|P3|Overall Study|Unclassified|2
415606|NCT00611884|1391210|P2|Overall Study|Unclassified|4
415607|NCT00611884|1391211|P1|Overall Study|Unclassified|7
415608|NCT00611884|1391208|P4|Overall Study|Lack of Efficacy|0
415609|NCT00611884|1391209|P3|Overall Study|Lack of Efficacy|0
415610|NCT00611884|1391210|P2|Overall Study|Lack of Efficacy|1
415611|NCT00611884|1391211|P1|Overall Study|Lack of Efficacy|0
415612|NCT00611884|1391208|P4|Overall Study|Non-Compliance|2
415613|NCT00611884|1391209|P3|Overall Study|Non-Compliance|2
415614|NCT00611884|1391210|P2|Overall Study|Non-Compliance|4
415615|NCT00611884|1391211|P1|Overall Study|Non-Compliance|1
415616|NCT00611884|1391208|P4|Overall Study|Adverse Event|1
415617|NCT00611884|1391209|P3|Overall Study|Adverse Event|0
415618|NCT00611884|1391210|P2|Overall Study|Adverse Event|0
415619|NCT00611884|1391211|P1|Overall Study|Adverse Event|1
415620|NCT00611806|1391267|P2|Overall Study|Lost to Follow-up|0
415621|NCT00611806|1391268|P1|Overall Study|Lost to Follow-up|6
415622|NCT00611806|1391267|P2|Overall Study|Adverse Event|1
415623|NCT00611806|1391268|P1|Overall Study|Adverse Event|2
415624|NCT00611806|1391267|P2|Overall Study|Withdrawal by Subject|2
415625|NCT00611806|1391268|P1|Overall Study|Withdrawal by Subject|8
415626|NCT00611767|1391282|P2|Overall Study|Physician Decision|0
415627|NCT00611767|1391283|P1|Overall Study|Physician Decision|1
415628|NCT00611767|1391282|P2|Overall Study|didn't like the medication|1
415629|NCT00611767|1391283|P1|Overall Study|didn't like the medication|1
415630|NCT00611767|1391282|P2|Overall Study|Thiopental not available|0
415631|NCT00611767|1391283|P1|Overall Study|Thiopental not available|3
415632|NCT00611767|1391282|P2|Overall Study|Withdrawal by Subject|1
415633|NCT00611767|1391283|P1|Overall Study|Withdrawal by Subject|4
415634|NCT00611715|1391445|P2|Overall Study|two patients are still on treatment|0
415635|NCT00611715|1391446|P1|Overall Study|two patients are still on treatment|2
415636|NCT00611715|1391445|P2|Overall Study|Death|0
415637|NCT00611715|1391446|P1|Overall Study|Death|1
415638|NCT00611715|1391445|P2|Overall Study|Adverse Event|1
415639|NCT00611715|1391446|P1|Overall Study|Adverse Event|9
415640|NCT00611715|1391445|P2|Overall Study|Withdrawal by Subject|1
415641|NCT00611715|1391446|P1|Overall Study|Withdrawal by Subject|5
415642|NCT00611715|1391445|P2|Overall Study|Disease Progression|4
415643|NCT00611715|1391446|P1|Overall Study|Disease Progression|24
415644|NCT00611559|1391466|P3|Overall Study|Protocol Violation|1
415645|NCT00611559|1391467|P2|Overall Study|Protocol Violation|0
415646|NCT00611559|1391468|P1|Overall Study|Protocol Violation|1
415647|NCT00611559|1391466|P3|Overall Study|Lost to Follow-up|0
415648|NCT00611559|1391467|P2|Overall Study|Lost to Follow-up|1
415649|NCT00611559|1391468|P1|Overall Study|Lost to Follow-up|0
415650|NCT00611533|1391527|P2|Second Intervention (6 Weeks)|Adverse Event|2
415651|NCT00611533|1391528|P1|Second Intervention (6 Weeks)|Adverse Event|0
415652|NCT00611533|1391527|P2|First Intervention (6 Weeks)|Adverse Event|1
415653|NCT00611533|1391528|P1|First Intervention (6 Weeks)|Adverse Event|0
415654|NCT00611533|1391527|P2|First Intervention (6 Weeks)|Never started study|1
415655|NCT00611533|1391528|P1|First Intervention (6 Weeks)|Never started study|0
415656|NCT00611455|1391562|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
415657|NCT00611455|1391563|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
415658|NCT00611455|1391564|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
415659|NCT00611455|1391562|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
415660|NCT00611455|1391563|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
415661|NCT00611455|1391564|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
415662|NCT00611455|1391562|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
415663|NCT00611455|1391563|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
415664|NCT00611455|1391564|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
415665|NCT00611455|1391562|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
415666|NCT00611455|1391563|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
415667|NCT00611455|1391564|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
415668|NCT00611455|1391562|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
415669|NCT00611455|1391563|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
415670|NCT00611455|1391564|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
415671|NCT00611455|1391562|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
415672|NCT00611455|1391563|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
415673|NCT00611455|1391564|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
415674|NCT00611455|1391562|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
415675|NCT00611455|1391563|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
415676|NCT00611455|1391564|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
415677|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
415678|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
415679|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
415680|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
415681|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
415682|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
415683|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
415684|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
415685|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
415686|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
415687|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
415688|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
415689|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
415690|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
415691|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
415692|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
415693|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
415694|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
415695|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
415696|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
415697|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
415698|NCT00611455|1391562|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
415699|NCT00611455|1391563|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
415700|NCT00611455|1391564|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
415701|NCT00611455|1391562|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
415702|NCT00611455|1391563|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
415703|NCT00611455|1391564|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
415704|NCT00611455|1391562|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
415705|NCT00611455|1391563|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
415706|NCT00611455|1391564|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
415707|NCT00611455|1391562|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
415708|NCT00611455|1391563|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
415709|NCT00611455|1391564|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
415710|NCT00611455|1391562|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
415711|NCT00611455|1391563|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
415712|NCT00611455|1391564|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
415713|NCT00611455|1391562|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
415714|NCT00611455|1391563|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
415715|NCT00611455|1391564|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
415716|NCT00611455|1391562|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
415717|NCT00611455|1391563|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
415718|NCT00611455|1391564|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
415719|NCT00611247|1391744|P2|Overall Study|Lack of Efficacy|16
415720|NCT00611247|1391745|P1|Overall Study|Lack of Efficacy|1
415721|NCT00611247|1391744|P2|Overall Study|Death|5
415722|NCT00611247|1391745|P1|Overall Study|Death|1
415723|NCT00611130|1391757|P2|Overall Study|Death|0
415724|NCT00611130|1391758|P1|Overall Study|Death|1
415725|NCT00611130|1391757|P2|Overall Study|Adverse Event|0
415726|NCT00611130|1391758|P1|Overall Study|Adverse Event|1
415727|NCT00611130|1391757|P2|Overall Study|Administrative|1
415728|NCT00611130|1391758|P1|Overall Study|Administrative|1
415729|NCT00611130|1391757|P2|Overall Study|Incarceration|2
415730|NCT00611130|1391758|P1|Overall Study|Incarceration|3
415731|NCT00611130|1391757|P2|Overall Study|Other|4
415732|NCT00611130|1391758|P1|Overall Study|Other|5
415733|NCT00611130|1391757|P2|Overall Study|Withdrawal by Subject|5
415734|NCT00611130|1391758|P1|Overall Study|Withdrawal by Subject|6
415735|NCT00611130|1391757|P2|Overall Study|Protocol noncompliance|6
415736|NCT00611130|1391758|P1|Overall Study|Protocol noncompliance|7
415737|NCT00611130|1391757|P2|Overall Study|Lost to Follow-up|29
415738|NCT00611130|1391758|P1|Overall Study|Lost to Follow-up|25
415739|NCT00611026|1391768|P3|Double-blind Treatment Period|Other|18
415740|NCT00611026|1391769|P2|Double-blind Treatment Period|Other|20
415741|NCT00611026|1391770|P1|Double-blind Treatment Period|Other|13
415742|NCT00611026|1391768|P3|Double-blind Treatment Period|Withdrawal by Subject|16
415743|NCT00611026|1391769|P2|Double-blind Treatment Period|Withdrawal by Subject|19
415744|NCT00611026|1391770|P1|Double-blind Treatment Period|Withdrawal by Subject|7
415745|NCT00611026|1391768|P3|Double-blind Treatment Period|Lost to Follow-up|14
415746|NCT00611026|1391769|P2|Double-blind Treatment Period|Lost to Follow-up|11
415747|NCT00611026|1391770|P1|Double-blind Treatment Period|Lost to Follow-up|6
415748|NCT00611026|1391768|P3|Double-blind Treatment Period|Lack of Efficacy|4
415749|NCT00611026|1391769|P2|Double-blind Treatment Period|Lack of Efficacy|10
415750|NCT00611026|1391770|P1|Double-blind Treatment Period|Lack of Efficacy|11
415751|NCT00611026|1391768|P3|Double-blind Treatment Period|Adverse Event|46
415752|NCT00611026|1391769|P2|Double-blind Treatment Period|Adverse Event|28
415753|NCT00611026|1391770|P1|Double-blind Treatment Period|Adverse Event|9
415754|NCT00611026|1391768|P3|Double-blind Treatment Period|Death|0
415755|NCT00611026|1391769|P2|Double-blind Treatment Period|Death|0
415756|NCT00611026|1391770|P1|Double-blind Treatment Period|Death|1
415757|NCT00611026|1391768|P3|Randomized to Double-blind Treatment|Not treated|3
415758|NCT00611026|1391769|P2|Randomized to Double-blind Treatment|Not treated|1
415759|NCT00611026|1391770|P1|Randomized to Double-blind Treatment|Not treated|2
415760|NCT00610857|1391847|P1|Overall Study|Not evaluable for response|2
415761|NCT00610714|1391862|P2|Overall Study|Study completion at 120 PFS events|2
415762|NCT00610714|1391863|P1|Overall Study|Study completion at 120 PFS events|2
415763|NCT00610714|1391862|P2|Overall Study|Withdrawal by Subject|3
415764|NCT00610714|1391863|P1|Overall Study|Withdrawal by Subject|9
415765|NCT00610714|1391862|P2|Overall Study|Death|18
415766|NCT00610714|1391863|P1|Overall Study|Death|12
415767|NCT00610714|1391862|P2|Overall Study|Adverse Event|1
415768|NCT00610714|1391863|P1|Overall Study|Adverse Event|3
415769|NCT00610675|1391901|P1|Overall Study|Other reason (not specified)|25
415770|NCT00610675|1391901|P1|Overall Study|Lost to Follow-up|31
415771|NCT00610675|1391901|P1|Overall Study|Lack of Compliance|7
415772|NCT00610675|1391901|P1|Overall Study|Reasons unrelated to trial|27
415773|NCT00610675|1391901|P1|Overall Study|Withdrawal by Subject|28
415774|NCT00610675|1391901|P1|Overall Study|Insufficient Effect|31
415775|NCT00610675|1391901|P1|Overall Study|Adverse Event|67
415776|NCT00610675|1391901|P1|Overall Study|Untreated|4
415777|NCT00610649|1391923|P11|Overall Study|Withdrawal by Subject|0
415778|NCT00610649|1391924|P10|Overall Study|Withdrawal by Subject|1
415779|NCT00610649|1391925|P9|Overall Study|Withdrawal by Subject|0
415780|NCT00610649|1391926|P8|Overall Study|Withdrawal by Subject|0
415781|NCT00610649|1391927|P7|Overall Study|Withdrawal by Subject|0
415782|NCT00610649|1391928|P6|Overall Study|Withdrawal by Subject|0
415783|NCT00610649|1391929|P5|Overall Study|Withdrawal by Subject|0
415784|NCT00610649|1391930|P4|Overall Study|Withdrawal by Subject|0
415785|NCT00610649|1391931|P3|Overall Study|Withdrawal by Subject|0
415786|NCT00610649|1391932|P2|Overall Study|Withdrawal by Subject|0
415787|NCT00610649|1391933|P1|Overall Study|Withdrawal by Subject|0
415788|NCT00610649|1391923|P11|Overall Study|Family Emergency|0
415789|NCT00610649|1391924|P10|Overall Study|Family Emergency|0
415790|NCT00610649|1391925|P9|Overall Study|Family Emergency|0
415791|NCT00610649|1391926|P8|Overall Study|Family Emergency|0
415792|NCT00610649|1391927|P7|Overall Study|Family Emergency|0
415793|NCT00610649|1391928|P6|Overall Study|Family Emergency|0
415794|NCT00610649|1391929|P5|Overall Study|Family Emergency|0
415795|NCT00610649|1391930|P4|Overall Study|Family Emergency|0
415796|NCT00610649|1391931|P3|Overall Study|Family Emergency|0
415797|NCT00610649|1391932|P2|Overall Study|Family Emergency|1
415798|NCT00610649|1391933|P1|Overall Study|Family Emergency|0
415799|NCT00610649|1391923|P11|Overall Study|Adverse Event|1
415800|NCT00610649|1391924|P10|Overall Study|Adverse Event|0
415801|NCT00610649|1391925|P9|Overall Study|Adverse Event|0
415802|NCT00610649|1391926|P8|Overall Study|Adverse Event|0
415803|NCT00610649|1391927|P7|Overall Study|Adverse Event|0
415804|NCT00610649|1391928|P6|Overall Study|Adverse Event|0
415805|NCT00610649|1391929|P5|Overall Study|Adverse Event|0
415806|NCT00610649|1391930|P4|Overall Study|Adverse Event|0
415807|NCT00610649|1391931|P3|Overall Study|Adverse Event|0
415808|NCT00610649|1391932|P2|Overall Study|Adverse Event|0
415809|NCT00610649|1391933|P1|Overall Study|Adverse Event|1
415810|NCT00610441|1391997|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
415811|NCT00610441|1391998|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
415812|NCT00610441|1391999|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
415813|NCT00610441|1392000|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
415814|NCT00610441|1391997|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
415815|NCT00610441|1391998|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
415816|NCT00610441|1391999|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
415817|NCT00610441|1392000|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
415818|NCT00610441|1391997|P4|Treatment Period 2 - 3 Weeks|Other|1
415819|NCT00610441|1391998|P3|Treatment Period 2 - 3 Weeks|Other|0
415820|NCT00610441|1391999|P2|Treatment Period 2 - 3 Weeks|Other|1
415821|NCT00610441|1392000|P1|Treatment Period 2 - 3 Weeks|Other|1
415822|NCT00610441|1391997|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
415823|NCT00610441|1391998|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
415824|NCT00610441|1391999|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
415825|NCT00610441|1392000|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
415826|NCT00610441|1391997|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
415827|NCT00610441|1391998|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
415828|NCT00610441|1391999|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
415829|NCT00610441|1392000|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
415830|NCT00610441|1391997|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
415831|NCT00610441|1391998|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
415832|NCT00610441|1391999|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
415833|NCT00610441|1392000|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
415834|NCT00610441|1391997|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
415835|NCT00610441|1391998|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
415836|NCT00610441|1391999|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
415837|NCT00610441|1392000|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
415838|NCT00610441|1391997|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
415839|NCT00610441|1391998|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
415840|NCT00610441|1391999|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
415841|NCT00610441|1392000|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
415842|NCT00610441|1391997|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
415843|NCT00610441|1391998|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
415844|NCT00610441|1391999|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
415845|NCT00610441|1392000|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
415846|NCT00610363|1392109|P2|Overall Study|Other than specified above|1
415847|NCT00610363|1392110|P1|Overall Study|Other than specified above|1
415848|NCT00610363|1392109|P2|Overall Study|Withdrawal by Subject|0
415849|NCT00610363|1392110|P1|Overall Study|Withdrawal by Subject|1
415850|NCT00610363|1392109|P2|Overall Study|Lost to Follow-up|0
415851|NCT00610363|1392110|P1|Overall Study|Lost to Follow-up|4
415852|NCT00610363|1392109|P2|Overall Study|Lack of Efficacy|0
415853|NCT00610363|1392110|P1|Overall Study|Lack of Efficacy|2
415854|NCT00610363|1392109|P2|Overall Study|Adverse Event|1
415855|NCT00610363|1392110|P1|Overall Study|Adverse Event|3
415856|NCT00610363|1392109|P2|Overall Study|Non-compliance with protocol|1
415857|NCT00610363|1392110|P1|Overall Study|Non-compliance with protocol|0
415858|NCT00610207|1392135|P1|Overall Study|Lost to Follow-up|3
415859|NCT00610168|1392142|P2|Overall Study|Withdrawal by Subject|0
415860|NCT00610168|1392143|P1|Overall Study|Withdrawal by Subject|2
415861|NCT00610155|1392162|P6|Period 3|Adverse Event|0
415862|NCT00610155|1392163|P5|Period 3|Adverse Event|0
415863|NCT00610155|1392164|P4|Period 3|Adverse Event|0
415864|NCT00610155|1392165|P3|Period 3|Adverse Event|0
415865|NCT00610155|1392166|P2|Period 3|Adverse Event|0
415866|NCT00610155|1392167|P1|Period 3|Adverse Event|1
415867|NCT00610155|1392162|P6|Period 1|Withdrawal by Subject|0
415868|NCT00610155|1392163|P5|Period 1|Withdrawal by Subject|0
415869|NCT00610155|1392164|P4|Period 1|Withdrawal by Subject|0
415870|NCT00610155|1392165|P3|Period 1|Withdrawal by Subject|1
415871|NCT00610155|1392166|P2|Period 1|Withdrawal by Subject|0
415872|NCT00610155|1392167|P1|Period 1|Withdrawal by Subject|0
415873|NCT00610129|1392214|P1|Overall Study|Not treated since patients ineligible|3
415874|NCT00609986|1392220|P2|Overall Study|Did not receive transplant or treatment|3
415875|NCT00609986|1392221|P1|Overall Study|Did not receive transplant or treatment|8
415876|NCT00609973|1392235|P2|Overall Study|Withdrawal by Subject|1
415877|NCT00609973|1392236|P1|Overall Study|Withdrawal by Subject|0
415878|NCT00609973|1392235|P2|Overall Study|Lost to Follow-up|1
415879|NCT00609973|1392236|P1|Overall Study|Lost to Follow-up|2
415880|NCT00609973|1392235|P2|Overall Study|Protocol Violation|3
415881|NCT00609973|1392236|P1|Overall Study|Protocol Violation|4
415882|NCT00609973|1392235|P2|Overall Study|Adverse Event|1
415883|NCT00609973|1392236|P1|Overall Study|Adverse Event|2
415884|NCT00609947|1392244|P1|Overall Study|Death|1
415885|NCT00609869|1392249|P1|Overall Study|Mantle cell: not evaluable|4
415886|NCT00609869|1392249|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
415887|NCT00609869|1392249|P1|Overall Study|Hepatitis B infection|1
415888|NCT00609869|1392249|P1|Overall Study|Severe tumor flare reaction|1
415889|NCT00609869|1392249|P1|Overall Study|Seizures|1
415890|NCT00609869|1392249|P1|Overall Study|Withdrawal by Subject|1
415891|NCT00609869|1392249|P1|Overall Study|Severe hematologic toxicity|1
415892|NCT00609869|1392249|P1|Overall Study|Withdrawn, ischemic stroke|1
415893|NCT00609765|1392268|P1|Overall Study|Study ended prior to 12 months|1
415894|NCT00609674|1392282|P2|Overall Study|Withdrew consent|1
415895|NCT00609674|1392283|P1|Overall Study|Withdrew consent|2
415896|NCT00609674|1392282|P2|Overall Study|Lost to Follow-up|0
415897|NCT00609674|1392283|P1|Overall Study|Lost to Follow-up|1
415898|NCT00609674|1392282|P2|Overall Study|Protocol Violation|5
415899|NCT00609674|1392283|P1|Overall Study|Protocol Violation|3
415900|NCT00609674|1392282|P2|Overall Study|Adverse Event|1
415901|NCT00609674|1392283|P1|Overall Study|Adverse Event|1
415902|NCT00609622|1392319|P2|Overall Study|Global deterioration of health status|2
415903|NCT00609622|1392320|P1|Overall Study|Global deterioration of health status|6
415904|NCT00609622|1392319|P2|Overall Study|Other|14
415905|NCT00609622|1392320|P1|Overall Study|Other|7
415906|NCT00609622|1392319|P2|Overall Study|Study terminated by sponsor|3
415907|NCT00609622|1392320|P1|Overall Study|Study terminated by sponsor|16
415908|NCT00609622|1392319|P2|Overall Study|Objective progression or relapse|41
415909|NCT00609622|1392320|P1|Overall Study|Objective progression or relapse|47
415910|NCT00609622|1392319|P2|Overall Study|Protocol Violation|1
415911|NCT00609622|1392320|P1|Overall Study|Protocol Violation|1
415912|NCT00609622|1392319|P2|Overall Study|Death|4
415913|NCT00609622|1392320|P1|Overall Study|Death|1
415914|NCT00609622|1392319|P2|Overall Study|Withdrawal by Subject|20
415915|NCT00609622|1392320|P1|Overall Study|Withdrawal by Subject|4
415916|NCT00609622|1392319|P2|Overall Study|Adverse Event|10
415917|NCT00609622|1392320|P1|Overall Study|Adverse Event|14
415918|NCT00609609|1392342|P2|Overall Study|Progression|2
415919|NCT00609609|1392343|P1|Overall Study|Progression|4
415920|NCT00609609|1392342|P2|Overall Study|Withdrawal by Subject|0
415921|NCT00609609|1392343|P1|Overall Study|Withdrawal by Subject|2
415922|NCT00609518|1392355|P2|Overall Study|Death from Adverse Event|2
415923|NCT00609518|1392356|P1|Overall Study|Death from Adverse Event|2
415924|NCT00609518|1392355|P2|Overall Study|Physician Decision|3
415925|NCT00609518|1392356|P1|Overall Study|Physician Decision|1
415926|NCT00609518|1392355|P2|Overall Study|Lost to Follow-up|0
415927|NCT00609518|1392356|P1|Overall Study|Lost to Follow-up|3
415928|NCT00609518|1392355|P2|Overall Study|Withdrawal by Subject|3
415929|NCT00609518|1392356|P1|Overall Study|Withdrawal by Subject|5
415930|NCT00609518|1392355|P2|Overall Study|Death from Study Disease|32
415931|NCT00609518|1392356|P1|Overall Study|Death from Study Disease|32
415932|NCT00609492|1392371|P3|Overall Study|Lost to Follow-up|4
415933|NCT00609492|1392372|P2|Overall Study|Lost to Follow-up|1
415934|NCT00609492|1392373|P1|Overall Study|Lost to Follow-up|1
415935|NCT00609492|1392371|P3|Overall Study|Withdrawal by Subject|3
415936|NCT00609492|1392372|P2|Overall Study|Withdrawal by Subject|2
415937|NCT00609492|1392373|P1|Overall Study|Withdrawal by Subject|0
415938|NCT00609466|1392458|P3|Overall Study|Lack of Efficacy|2
415939|NCT00609466|1392459|P2|Overall Study|Lack of Efficacy|2
415940|NCT00609466|1392460|P1|Overall Study|Lack of Efficacy|0
415941|NCT00609466|1392458|P3|Overall Study|Adverse Event|1
415942|NCT00609466|1392459|P2|Overall Study|Adverse Event|3
415943|NCT00609466|1392460|P1|Overall Study|Adverse Event|2
415944|NCT00609466|1392458|P3|Overall Study|Withdrawal by Subject|1
415945|NCT00609466|1392459|P2|Overall Study|Withdrawal by Subject|1
415946|NCT00609466|1392460|P1|Overall Study|Withdrawal by Subject|0
415947|NCT00609362|1392488|P2|Overall Study|Adverse Event|0
415948|NCT00609362|1392489|P1|Overall Study|Adverse Event|1
415949|NCT00609362|1392488|P2|Overall Study|Withdrawal by Subject|1
415950|NCT00609362|1392489|P1|Overall Study|Withdrawal by Subject|2
415951|NCT00609336|1392499|P1|Overall Study|LA or Met at Surgery|9
415952|NCT00609336|1392499|P1|Overall Study|Death|1
415953|NCT00609336|1392499|P1|Overall Study|Protocol Violation|3
415954|NCT00609245|1392511|P1|Overall Study|Adverse Event|1
415955|NCT00609167|1392519|P2|Overall Study|Stem Cell Transplant|6
415956|NCT00609167|1392520|P1|Overall Study|Stem Cell Transplant|0
415957|NCT00609167|1392519|P2|Overall Study|Disease Progression|0
415958|NCT00609167|1392520|P1|Overall Study|Disease Progression|1
415959|NCT00609167|1392519|P2|Overall Study|Adverse Event|1
415960|NCT00609167|1392520|P1|Overall Study|Adverse Event|5
415961|NCT00609167|1392519|P2|Overall Study|Lack of Efficacy|0
415962|NCT00609167|1392520|P1|Overall Study|Lack of Efficacy|1
415963|NCT00609167|1392519|P2|Overall Study|Withdrawal by Subject|0
415964|NCT00609167|1392520|P1|Overall Study|Withdrawal by Subject|1
415965|NCT00608985|1392546|P4|Overall Study|Lost to Follow-up|0
415966|NCT00608985|1392547|P3|Overall Study|Lost to Follow-up|0
415967|NCT00608985|1392548|P2|Overall Study|Lost to Follow-up|1
415968|NCT00608985|1392549|P1|Overall Study|Lost to Follow-up|2
415969|NCT00608985|1392546|P4|Overall Study|Withdrawal of Consent|1
415970|NCT00608985|1392547|P3|Overall Study|Withdrawal of Consent|1
415971|NCT00608985|1392548|P2|Overall Study|Withdrawal of Consent|1
415972|NCT00608985|1392549|P1|Overall Study|Withdrawal of Consent|5
415973|NCT00608985|1392546|P4|Overall Study|Administrative/Other|2
415974|NCT00608985|1392547|P3|Overall Study|Administrative/Other|1
415975|NCT00608985|1392548|P2|Overall Study|Administrative/Other|4
415976|NCT00608985|1392549|P1|Overall Study|Administrative/Other|7
415977|NCT00608985|1392546|P4|Overall Study|Adverse Event|6
415978|NCT00608985|1392547|P3|Overall Study|Adverse Event|4
415979|NCT00608985|1392548|P2|Overall Study|Adverse Event|7
415980|NCT00608985|1392549|P1|Overall Study|Adverse Event|2
415981|NCT00608959|1392581|P1|Part 1|Did not meet eligibility criteria|1
415982|NCT00608907|1392594|P3|Overall Study|Progressive Disease|0
415983|NCT00608907|1392595|P2|Overall Study|Progressive Disease|0
415984|NCT00608907|1392596|P1|Overall Study|Progressive Disease|1
415985|NCT00608907|1392594|P3|Overall Study|Withdrawal by Subject|0
415986|NCT00608907|1392595|P2|Overall Study|Withdrawal by Subject|0
415987|NCT00608907|1392596|P1|Overall Study|Withdrawal by Subject|4
415988|NCT00608907|1392594|P3|Overall Study|Death|0
415989|NCT00608907|1392595|P2|Overall Study|Death|0
415990|NCT00608907|1392596|P1|Overall Study|Death|1
415991|NCT00608907|1392594|P3|Overall Study|Adverse Event|1
415992|NCT00608907|1392595|P2|Overall Study|Adverse Event|0
415993|NCT00608907|1392596|P1|Overall Study|Adverse Event|6
415994|NCT00608881|1392606|P2|Overall Study|Institutionalized|2
415995|NCT00608881|1392607|P1|Overall Study|Institutionalized|1
415996|NCT00608881|1392606|P2|Overall Study|Physician Decision|5
415997|NCT00608881|1392607|P1|Overall Study|Physician Decision|5
415998|NCT00608881|1392606|P2|Overall Study|Withdrawal by Subject|29
415999|NCT00608881|1392607|P1|Overall Study|Withdrawal by Subject|18
416000|NCT00608881|1392606|P2|Overall Study|Lost to Follow-up|14
416001|NCT00608881|1392607|P1|Overall Study|Lost to Follow-up|28
416002|NCT00608881|1392606|P2|Overall Study|Adverse Event|3
416003|NCT00608881|1392607|P1|Overall Study|Adverse Event|5
416004|NCT00608881|1392606|P2|Overall Study|Death|13
416005|NCT00608881|1392607|P1|Overall Study|Death|22
416006|NCT00608868|1392641|P1|Overall Study|Physician Decision|2
416007|NCT00608868|1392641|P1|Overall Study|Adverse Event|1
416008|NCT00608868|1392641|P1|Overall Study|Lost to Follow-up|2
416009|NCT00608868|1392641|P1|Overall Study|Protocol Violation|3
416010|NCT00608868|1392641|P1|Overall Study|Withdrawal by Subject|7
416011|NCT00608842|1392652|P4|Overall Study|Lost to Follow-up|0
416012|NCT00608842|1392653|P3|Overall Study|Lost to Follow-up|0
416013|NCT00608842|1392654|P2|Overall Study|Lost to Follow-up|0
416014|NCT00608842|1392655|P1|Overall Study|Lost to Follow-up|1
416015|NCT00608842|1392652|P4|Overall Study|Participant's Request|1
416016|NCT00608842|1392653|P3|Overall Study|Participant's Request|2
416017|NCT00608842|1392654|P2|Overall Study|Participant's Request|1
416018|NCT00608842|1392655|P1|Overall Study|Participant's Request|0
416019|NCT00608829|1392689|P1|Overall Study|Subject refuses to follow up or return.|5
416020|NCT00608829|1392689|P1|Overall Study|Withdrawal by Subject|4
416021|NCT00608829|1392689|P1|Overall Study|Death|6
416022|NCT00608582|1392715|P2|Overall Study|Early stage Design Change|3
416023|NCT00608582|1392716|P1|Overall Study|Early stage Design Change|0
416024|NCT00608582|1392715|P2|Overall Study|Illicit Drug Use|0
416025|NCT00608582|1392716|P1|Overall Study|Illicit Drug Use|1
416026|NCT00608582|1392715|P2|Overall Study|No Best Response in Phase 1 located|1
416027|NCT00608582|1392716|P1|Overall Study|No Best Response in Phase 1 located|1
416028|NCT00608582|1392715|P2|Overall Study|Lost to Follow-up|0
416029|NCT00608582|1392716|P1|Overall Study|Lost to Follow-up|2
416030|NCT00608569|1392726|P2|Overall Study|Unable to adhere with study requirements|1
416031|NCT00608569|1392727|P1|Overall Study|Unable to adhere with study requirements|0
416032|NCT00608569|1392726|P2|Overall Study|Adverse Event|0
416033|NCT00608569|1392727|P1|Overall Study|Adverse Event|1
416034|NCT00608569|1392726|P2|Overall Study|Withdrawal by Subject|0
416035|NCT00608569|1392727|P1|Overall Study|Withdrawal by Subject|1
416036|NCT00608569|1392726|P2|Overall Study|Lost to Follow-up|5
416037|NCT00608569|1392727|P1|Overall Study|Lost to Follow-up|4
416038|NCT00608569|1392726|P2|Overall Study|Death|3
416039|NCT00608569|1392727|P1|Overall Study|Death|4
416040|NCT00608543|1392747|P1|Overall Study|Adverse Event|4
416041|NCT00608530|1392760|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
416042|NCT00608530|1392761|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
416043|NCT00608530|1392762|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
416044|NCT00608530|1392763|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
416045|NCT00608530|1392760|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
416046|NCT00608530|1392761|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
416047|NCT00608530|1392762|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
416048|NCT00608530|1392763|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
416049|NCT00608530|1392760|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
416050|NCT00608530|1392761|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
416051|NCT00608530|1392762|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
416052|NCT00608530|1392763|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
416053|NCT00608530|1392760|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
416054|NCT00608530|1392761|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
416055|NCT00608530|1392762|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
416056|NCT00608530|1392763|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
416057|NCT00608530|1392760|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
416058|NCT00608530|1392761|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
416059|NCT00608530|1392762|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
416060|NCT00608530|1392763|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
416061|NCT00608530|1392760|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
416062|NCT00608530|1392761|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
416063|NCT00608530|1392762|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
416064|NCT00608530|1392763|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
416065|NCT00608517|1392784|P3|Overall Study|Death|0
416066|NCT00608517|1392785|P2|Overall Study|Death|0
416067|NCT00608517|1392786|P1|Overall Study|Death|1
416068|NCT00608426|1392966|P2|Overall Study|refused, health issues, wrong address|348
416069|NCT00608426|1392967|P1|Overall Study|refused, health issues, wrong address|319
416070|NCT00608426|1392966|P2|Overall Study|Lost to Follow-up|521
416071|NCT00608426|1392967|P1|Overall Study|Lost to Follow-up|485
416072|NCT00608426|1392966|P2|Overall Study|Death|36
416073|NCT00608426|1392967|P1|Overall Study|Death|32
416074|NCT00608322|1392979|P2|Overall Study|Death|1
416075|NCT00608322|1392980|P1|Overall Study|Death|2
416076|NCT00608244|1392986|P1|Overall Study|Low trough levels|1
416077|NCT00608244|1392986|P1|Overall Study|Adverse Event|1
416078|NCT00608205|1392997|P2|Overall Study|Patient non-compliant|1
416079|NCT00608205|1392998|P1|Overall Study|Patient non-compliant|0
416080|NCT00608205|1392997|P2|Overall Study|Adverse Event|2
416081|NCT00608205|1392998|P1|Overall Study|Adverse Event|3
416082|NCT00608023|1393115|P3|Overall Study|Unknown reason|0
416083|NCT00608023|1393116|P2|Overall Study|Unknown reason|3
416084|NCT00608023|1393117|P1|Overall Study|Unknown reason|0
416085|NCT00608023|1393115|P3|Overall Study|Protocol Violation|1
416086|NCT00608023|1393116|P2|Overall Study|Protocol Violation|3
416087|NCT00608023|1393117|P1|Overall Study|Protocol Violation|1
416088|NCT00608023|1393115|P3|Overall Study|Lost to Follow-up|1
416089|NCT00608023|1393116|P2|Overall Study|Lost to Follow-up|2
416090|NCT00608023|1393117|P1|Overall Study|Lost to Follow-up|2
416091|NCT00608023|1393115|P3|Overall Study|Adverse Event|5
416092|NCT00608023|1393116|P2|Overall Study|Adverse Event|4
416093|NCT00608023|1393117|P1|Overall Study|Adverse Event|1
416094|NCT00608023|1393115|P3|Overall Study|Withdrawal by Subject|7
416095|NCT00608023|1393116|P2|Overall Study|Withdrawal by Subject|10
416096|NCT00608023|1393117|P1|Overall Study|Withdrawal by Subject|8
416097|NCT00607997|1393141|P4|Overall Study|Other without explanation|1
416098|NCT00607997|1393142|P3|Overall Study|Other without explanation|4
416099|NCT00607997|1393143|P2|Overall Study|Other without explanation|0
416100|NCT00607997|1393144|P1|Overall Study|Other without explanation|2
416101|NCT00607997|1393141|P4|Overall Study|Relapse, recurrent illness|0
416102|NCT00607997|1393142|P3|Overall Study|Relapse, recurrent illness|2
416103|NCT00607997|1393143|P2|Overall Study|Relapse, recurrent illness|0
416104|NCT00607997|1393144|P1|Overall Study|Relapse, recurrent illness|4
416105|NCT00607997|1393141|P4|Overall Study|Physician Decision|0
416106|NCT00607997|1393142|P3|Overall Study|Physician Decision|0
416107|NCT00607997|1393143|P2|Overall Study|Physician Decision|1
416108|NCT00607997|1393144|P1|Overall Study|Physician Decision|4
416109|NCT00607997|1393141|P4|Overall Study|Adverse Event|0
416110|NCT00607997|1393142|P3|Overall Study|Adverse Event|2
416111|NCT00607997|1393143|P2|Overall Study|Adverse Event|1
416112|NCT00607997|1393144|P1|Overall Study|Adverse Event|3
416113|NCT00607997|1393141|P4|Overall Study|Death|5
416114|NCT00607997|1393142|P3|Overall Study|Death|2
416115|NCT00607997|1393143|P2|Overall Study|Death|5
416116|NCT00607997|1393144|P1|Overall Study|Death|8
416117|NCT00607997|1393141|P4|Overall Study|Lack of Efficacy|10
416118|NCT00607997|1393142|P3|Overall Study|Lack of Efficacy|14
416119|NCT00607997|1393143|P2|Overall Study|Lack of Efficacy|20
416120|NCT00607997|1393144|P1|Overall Study|Lack of Efficacy|6
416121|NCT00607919|1393202|P2|Open-Label Phase|Parent/Caregiver Decision|2
416122|NCT00607919|1393203|P1|Open-Label Phase|Parent/Caregiver Decision|1
416123|NCT00607919|1393202|P2|Open-Label Phase|Withdrawal by Subject|2
416124|NCT00607919|1393203|P1|Open-Label Phase|Withdrawal by Subject|2
416125|NCT00607919|1393202|P2|Open-Label Phase|Protocol Violation|2
416126|NCT00607919|1393203|P1|Open-Label Phase|Protocol Violation|2
416127|NCT00607919|1393202|P2|Open-Label Phase|Lost to Follow-up|1
416128|NCT00607919|1393203|P1|Open-Label Phase|Lost to Follow-up|4
416129|NCT00607919|1393202|P2|Open-Label Phase|Adverse Event|5
416130|NCT00607919|1393203|P1|Open-Label Phase|Adverse Event|1
416131|NCT00607919|1393202|P2|Acute Phase|Withdrawal by Subject|3
416132|NCT00607919|1393203|P1|Acute Phase|Withdrawal by Subject|3
416133|NCT00607919|1393202|P2|Acute Phase|Protocol Violation|1
416134|NCT00607919|1393203|P1|Acute Phase|Protocol Violation|5
416135|NCT00607919|1393202|P2|Acute Phase|Parent/Caregiver Decision|4
416136|NCT00607919|1393203|P1|Acute Phase|Parent/Caregiver Decision|6
416137|NCT00607919|1393202|P2|Acute Phase|Lost to Follow-up|3
416138|NCT00607919|1393203|P1|Acute Phase|Lost to Follow-up|9
416139|NCT00607919|1393202|P2|Acute Phase|Lack of Efficacy|2
416140|NCT00607919|1393203|P1|Acute Phase|Lack of Efficacy|1
416141|NCT00607919|1393202|P2|Acute Phase|Entry Criteria Not Met|1
416142|NCT00607919|1393203|P1|Acute Phase|Entry Criteria Not Met|1
416143|NCT00607919|1393202|P2|Acute Phase|Adverse Event|2
416144|NCT00607919|1393203|P1|Acute Phase|Adverse Event|9
416145|NCT00607893|1393261|P2|Overall Study|Withdrew due to hypertensive urgency|1
416146|NCT00607893|1393262|P1|Overall Study|Withdrew due to hypertensive urgency|1
416147|NCT00607893|1393261|P2|Overall Study|Declined to be treated|0
416148|NCT00607893|1393262|P1|Overall Study|Declined to be treated|1
416149|NCT00607893|1393261|P2|Overall Study|withdrew could not tolerate CPAP|1
416150|NCT00607893|1393262|P1|Overall Study|withdrew could not tolerate CPAP|0
416151|NCT00607893|1393261|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
416152|NCT00607893|1393262|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
416153|NCT00607893|1393261|P2|Overall Study|withdrew due to loss of interest|1
416154|NCT00607893|1393262|P1|Overall Study|withdrew due to loss of interest|0
416155|NCT00607893|1393261|P2|Overall Study|Lost to Follow-up|0
416156|NCT00607893|1393262|P1|Overall Study|Lost to Follow-up|4
416157|NCT00607880|1393290|P2|Overall Study|Unable to place port due to occlusion|0
416158|NCT00607880|1393291|P1|Overall Study|Unable to place port due to occlusion|1
416159|NCT00607789|1393341|P2|Overall Study|Withdrawal by Subject|0
416160|NCT00607789|1393342|P1|Overall Study|Withdrawal by Subject|1
416161|NCT00607789|1393341|P2|Overall Study|Lost to Follow-up|5
416162|NCT00607789|1393342|P1|Overall Study|Lost to Follow-up|0
416163|NCT00607789|1393341|P2|Overall Study|Inadequate adherence|0
416164|NCT00607789|1393342|P1|Overall Study|Inadequate adherence|3
416165|NCT00607789|1393341|P2|Overall Study|Lack of Efficacy|1
416166|NCT00607789|1393342|P1|Overall Study|Lack of Efficacy|0
416167|NCT00607789|1393341|P2|Overall Study|Adverse Event|0
416168|NCT00607789|1393342|P1|Overall Study|Adverse Event|3
416169|NCT00607724|1393357|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
416170|NCT00607724|1393358|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
416171|NCT00607724|1393359|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
416172|NCT00607724|1393360|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
416173|NCT00607724|1393361|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
416174|NCT00607724|1393362|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
416175|NCT00607724|1393363|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
416176|NCT00607724|1393357|P7|Stage 2: Expanded Cohort|Physician Decision|0
416177|NCT00607724|1393358|P6|Stage 2: Expanded Cohort|Physician Decision|1
416178|NCT00607724|1393359|P5|Stage 2: Expanded Cohort|Physician Decision|1
416179|NCT00607724|1393360|P4|Stage 2: Expanded Cohort|Physician Decision|0
416180|NCT00607724|1393361|P3|Stage 2: Expanded Cohort|Physician Decision|0
416181|NCT00607724|1393362|P2|Stage 2: Expanded Cohort|Physician Decision|0
416182|NCT00607724|1393363|P1|Stage 2: Expanded Cohort|Physician Decision|0
416183|NCT00607724|1393357|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
416184|NCT00607724|1393358|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
416185|NCT00607724|1393359|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
416186|NCT00607724|1393360|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
416187|NCT00607724|1393361|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
416188|NCT00607724|1393362|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
416189|NCT00607724|1393363|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
416190|NCT00607724|1393357|P7|Stage 2: Expanded Cohort|Adverse Event|1
416191|NCT00607724|1393358|P6|Stage 2: Expanded Cohort|Adverse Event|0
416192|NCT00607724|1393359|P5|Stage 2: Expanded Cohort|Adverse Event|0
416193|NCT00607724|1393360|P4|Stage 2: Expanded Cohort|Adverse Event|0
416194|NCT00607724|1393361|P3|Stage 2: Expanded Cohort|Adverse Event|0
416195|NCT00607724|1393362|P2|Stage 2: Expanded Cohort|Adverse Event|0
416196|NCT00607724|1393363|P1|Stage 2: Expanded Cohort|Adverse Event|0
416197|NCT00607724|1393357|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
416198|NCT00607724|1393358|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
416199|NCT00607724|1393359|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
416200|NCT00607724|1393360|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
416201|NCT00607724|1393361|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
416202|NCT00607724|1393362|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
416203|NCT00607724|1393363|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
416204|NCT00607386|1393521|P1|Overall Study|Physician Decision|1
416205|NCT00607373|1393536|P2|Follow-up Period|Withdrawal by Subject|3
416206|NCT00607373|1393537|P1|Follow-up Period|Withdrawal by Subject|1
416207|NCT00607373|1393536|P2|Follow-up Period|Protocol Violation|1
416208|NCT00607373|1393537|P1|Follow-up Period|Protocol Violation|0
416209|NCT00607373|1393536|P2|Follow-up Period|Not specified|1
416210|NCT00607373|1393537|P1|Follow-up Period|Not specified|0
416211|NCT00607373|1393536|P2|Treatment Period|Withdrawal by Subject|1
416212|NCT00607373|1393537|P1|Treatment Period|Withdrawal by Subject|0
416213|NCT00607373|1393536|P2|Treatment Period|Physician Decision|1
416214|NCT00607373|1393537|P1|Treatment Period|Physician Decision|0
416215|NCT00607373|1393536|P2|Treatment Period|Adverse Event|4
416216|NCT00607373|1393537|P1|Treatment Period|Adverse Event|0
416217|NCT00607087|1393639|P3|Period 3|Adverse Event|0
416218|NCT00607087|1393640|P2|Period 3|Adverse Event|1
416219|NCT00607087|1393641|P1|Period 3|Adverse Event|0
416220|NCT00607087|1393639|P3|Period 3|Withdrawal by Subject|0
416221|NCT00607087|1393640|P2|Period 3|Withdrawal by Subject|1
416222|NCT00607087|1393641|P1|Period 3|Withdrawal by Subject|2
416223|NCT00607087|1393639|P3|Period 2|Poor compliance to protocol|1
416224|NCT00607087|1393640|P2|Period 2|Poor compliance to protocol|0
416225|NCT00607087|1393641|P1|Period 2|Poor compliance to protocol|0
416226|NCT00607087|1393639|P3|Period 2|Adverse Event|3
416227|NCT00607087|1393640|P2|Period 2|Adverse Event|1
416228|NCT00607087|1393641|P1|Period 2|Adverse Event|0
416229|NCT00607087|1393639|P3|Period 2|Other reason|0
416230|NCT00607087|1393640|P2|Period 2|Other reason|1
416231|NCT00607087|1393641|P1|Period 2|Other reason|1
416232|NCT00607087|1393639|P3|Period 2|Withdrawal by Subject|1
416233|NCT00607087|1393640|P2|Period 2|Withdrawal by Subject|1
416234|NCT00607087|1393641|P1|Period 2|Withdrawal by Subject|0
416235|NCT00607087|1393639|P3|Period 1|Other reason|2
416236|NCT00607087|1393640|P2|Period 1|Other reason|4
416237|NCT00607087|1393641|P1|Period 1|Other reason|0
416238|NCT00607087|1393639|P3|Period 1|Lost to Follow-up|0
416239|NCT00607087|1393640|P2|Period 1|Lost to Follow-up|0
416240|NCT00607087|1393641|P1|Period 1|Lost to Follow-up|1
416241|NCT00607087|1393639|P3|Period 1|Poor compliance to protocol|0
416242|NCT00607087|1393640|P2|Period 1|Poor compliance to protocol|0
416243|NCT00607087|1393641|P1|Period 1|Poor compliance to protocol|1
416244|NCT00607087|1393639|P3|Period 1|Adverse Event|0
416245|NCT00607087|1393640|P2|Period 1|Adverse Event|0
416246|NCT00607087|1393641|P1|Period 1|Adverse Event|3
416247|NCT00607087|1393639|P3|Period 1|Withdrawal by Subject|3
416248|NCT00607087|1393640|P2|Period 1|Withdrawal by Subject|2
416249|NCT00607087|1393641|P1|Period 1|Withdrawal by Subject|7
416250|NCT00607087|1393639|P3|Overall Study|Lost to Follow-up|0
416251|NCT00607087|1393640|P2|Overall Study|Lost to Follow-up|0
416252|NCT00607087|1393641|P1|Overall Study|Lost to Follow-up|1
416253|NCT00607087|1393639|P3|Overall Study|Poor compliance to protocol|1
416254|NCT00607087|1393640|P2|Overall Study|Poor compliance to protocol|0
416255|NCT00607087|1393641|P1|Overall Study|Poor compliance to protocol|1
416256|NCT00607087|1393639|P3|Overall Study|Other reason|2
416257|NCT00607087|1393640|P2|Overall Study|Other reason|5
416258|NCT00607087|1393641|P1|Overall Study|Other reason|1
416259|NCT00607087|1393639|P3|Overall Study|Adverse Event|3
416260|NCT00607087|1393640|P2|Overall Study|Adverse Event|2
416261|NCT00607087|1393641|P1|Overall Study|Adverse Event|3
416262|NCT00607087|1393639|P3|Overall Study|Withdrawal by Subject|4
416263|NCT00607087|1393640|P2|Overall Study|Withdrawal by Subject|4
416264|NCT00607087|1393641|P1|Overall Study|Withdrawal by Subject|9
416265|NCT00607048|1393699|P6|Overall Study|Other|1
416266|NCT00607048|1393700|P5|Overall Study|Other|0
416267|NCT00607048|1393701|P4|Overall Study|Other|0
416268|NCT00607048|1393702|P3|Overall Study|Other|0
416269|NCT00607048|1393703|P2|Overall Study|Other|1
416270|NCT00607048|1393704|P1|Overall Study|Other|1
416271|NCT00607048|1393699|P6|Overall Study|Withdrawal by Subject|2
416272|NCT00607048|1393700|P5|Overall Study|Withdrawal by Subject|0
416273|NCT00607048|1393701|P4|Overall Study|Withdrawal by Subject|1
416274|NCT00607048|1393702|P3|Overall Study|Withdrawal by Subject|0
416275|NCT00607048|1393703|P2|Overall Study|Withdrawal by Subject|0
416276|NCT00607048|1393704|P1|Overall Study|Withdrawal by Subject|0
416277|NCT00607048|1393699|P6|Overall Study|Objective disease progression - relapse|2
416278|NCT00607048|1393700|P5|Overall Study|Objective disease progression - relapse|2
416279|NCT00607048|1393701|P4|Overall Study|Objective disease progression - relapse|2
416280|NCT00607048|1393702|P3|Overall Study|Objective disease progression - relapse|4
416281|NCT00607048|1393703|P2|Overall Study|Objective disease progression - relapse|2
416282|NCT00607048|1393704|P1|Overall Study|Objective disease progression - relapse|1
416283|NCT00607048|1393699|P6|Overall Study|Global deterioration of health|0
416284|NCT00607048|1393700|P5|Overall Study|Global deterioration of health|0
416285|NCT00607048|1393701|P4|Overall Study|Global deterioration of health|0
416286|NCT00607048|1393702|P3|Overall Study|Global deterioration of health|0
416287|NCT00607048|1393703|P2|Overall Study|Global deterioration of health|0
416288|NCT00607048|1393704|P1|Overall Study|Global deterioration of health|1
416289|NCT00607048|1393699|P6|Overall Study|Adverse Event|0
416290|NCT00607048|1393700|P5|Overall Study|Adverse Event|4
416291|NCT00607048|1393701|P4|Overall Study|Adverse Event|0
416292|NCT00607048|1393702|P3|Overall Study|Adverse Event|0
416293|NCT00607048|1393703|P2|Overall Study|Adverse Event|1
416294|NCT00607048|1393704|P1|Overall Study|Adverse Event|0
416295|NCT00606931|1393795|P1|Overall Study|Withdrawal by Subject|3
416296|NCT00606905|1393803|P2|Overall Study|Withdrew|5
416297|NCT00606905|1393804|P1|Overall Study|Withdrew|5
416298|NCT00606905|1393803|P2|Overall Study|Non-Index Pregnancy|4
416299|NCT00606905|1393804|P1|Overall Study|Non-Index Pregnancy|1
416300|NCT00606905|1393803|P2|Overall Study|No Pregnancy|6
416301|NCT00606905|1393804|P1|Overall Study|No Pregnancy|9
416302|NCT00606892|1393810|P2|First Intervention|Protocol Violation|4
416303|NCT00606892|1393811|P1|First Intervention|Protocol Violation|1
416304|NCT00606801|1393845|P2|Intervention|Protocol Violation|3
416305|NCT00606801|1393846|P1|Intervention|Protocol Violation|3
416306|NCT00606684|1393874|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
416307|NCT00606684|1393875|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
416308|NCT00606684|1393876|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
416309|NCT00606684|1393877|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
416310|NCT00606684|1393878|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
416311|NCT00606684|1393879|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
416312|NCT00606684|1393880|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
416313|NCT00606684|1393874|P7|Double-Blind Treatment Period|Physician Decision|2
416314|NCT00606684|1393875|P6|Double-Blind Treatment Period|Physician Decision|1
416315|NCT00606684|1393876|P5|Double-Blind Treatment Period|Physician Decision|3
416316|NCT00606684|1393877|P4|Double-Blind Treatment Period|Physician Decision|0
416317|NCT00606684|1393878|P3|Double-Blind Treatment Period|Physician Decision|1
416318|NCT00606684|1393879|P2|Double-Blind Treatment Period|Physician Decision|5
416319|NCT00606684|1393880|P1|Double-Blind Treatment Period|Physician Decision|0
416320|NCT00606684|1393874|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
416321|NCT00606684|1393875|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
416322|NCT00606684|1393876|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
416323|NCT00606684|1393877|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
416324|NCT00606684|1393878|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
416325|NCT00606684|1393879|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
416326|NCT00606684|1393880|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
416327|NCT00606684|1393874|P7|Double-Blind Treatment Period|Protocol Violation|4
416328|NCT00606684|1393875|P6|Double-Blind Treatment Period|Protocol Violation|3
416329|NCT00606684|1393876|P5|Double-Blind Treatment Period|Protocol Violation|0
416330|NCT00606684|1393877|P4|Double-Blind Treatment Period|Protocol Violation|3
416331|NCT00606684|1393878|P3|Double-Blind Treatment Period|Protocol Violation|5
416332|NCT00606684|1393879|P2|Double-Blind Treatment Period|Protocol Violation|5
416333|NCT00606684|1393880|P1|Double-Blind Treatment Period|Protocol Violation|0
416334|NCT00606684|1393874|P7|Double-Blind Treatment Period|Lack of Efficacy|0
416335|NCT00606684|1393875|P6|Double-Blind Treatment Period|Lack of Efficacy|0
416336|NCT00606684|1393876|P5|Double-Blind Treatment Period|Lack of Efficacy|1
416337|NCT00606684|1393877|P4|Double-Blind Treatment Period|Lack of Efficacy|0
416338|NCT00606684|1393878|P3|Double-Blind Treatment Period|Lack of Efficacy|0
416339|NCT00606684|1393879|P2|Double-Blind Treatment Period|Lack of Efficacy|1
416340|NCT00606684|1393880|P1|Double-Blind Treatment Period|Lack of Efficacy|0
416341|NCT00606684|1393874|P7|Double-Blind Treatment Period|Adverse Event|1
416342|NCT00606684|1393875|P6|Double-Blind Treatment Period|Adverse Event|0
416343|NCT00606684|1393876|P5|Double-Blind Treatment Period|Adverse Event|2
416344|NCT00606684|1393877|P4|Double-Blind Treatment Period|Adverse Event|4
416345|NCT00606684|1393878|P3|Double-Blind Treatment Period|Adverse Event|2
416346|NCT00606684|1393879|P2|Double-Blind Treatment Period|Adverse Event|3
416347|NCT00606684|1393880|P1|Double-Blind Treatment Period|Adverse Event|0
416348|NCT00606684|1393874|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
416349|NCT00606684|1393875|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
416350|NCT00606684|1393876|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
416351|NCT00606684|1393877|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
416352|NCT00606684|1393878|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
416353|NCT00606684|1393879|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
416354|NCT00606684|1393880|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
416355|NCT00606684|1393874|P7|2-week Single-Blind Run-in Period|Adverse Event|0
416356|NCT00606684|1393875|P6|2-week Single-Blind Run-in Period|Adverse Event|0
416357|NCT00606684|1393876|P5|2-week Single-Blind Run-in Period|Adverse Event|0
416358|NCT00606684|1393877|P4|2-week Single-Blind Run-in Period|Adverse Event|0
416359|NCT00606684|1393878|P3|2-week Single-Blind Run-in Period|Adverse Event|0
416360|NCT00606684|1393879|P2|2-week Single-Blind Run-in Period|Adverse Event|0
416361|NCT00606684|1393880|P1|2-week Single-Blind Run-in Period|Adverse Event|2
416362|NCT00606684|1393874|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
416363|NCT00606684|1393875|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
416364|NCT00606684|1393876|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
416365|NCT00606684|1393877|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
416366|NCT00606684|1393878|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
416367|NCT00606684|1393879|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
416368|NCT00606684|1393880|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
416369|NCT00606684|1393874|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
416370|NCT00606684|1393875|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
416371|NCT00606684|1393876|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
416372|NCT00606684|1393877|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
416373|NCT00606684|1393878|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
416374|NCT00606684|1393879|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
416375|NCT00606684|1393880|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
416376|NCT00606684|1393874|P7|2-week Single-Blind Run-in Period|Physician Decision|0
416377|NCT00606684|1393875|P6|2-week Single-Blind Run-in Period|Physician Decision|0
416378|NCT00606684|1393876|P5|2-week Single-Blind Run-in Period|Physician Decision|0
416379|NCT00606684|1393877|P4|2-week Single-Blind Run-in Period|Physician Decision|0
416380|NCT00606684|1393878|P3|2-week Single-Blind Run-in Period|Physician Decision|0
416381|NCT00606684|1393879|P2|2-week Single-Blind Run-in Period|Physician Decision|0
416382|NCT00606684|1393880|P1|2-week Single-Blind Run-in Period|Physician Decision|18
416383|NCT00606684|1393874|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
416384|NCT00606684|1393875|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
416385|NCT00606684|1393876|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
416386|NCT00606684|1393877|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
416387|NCT00606684|1393878|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
416388|NCT00606684|1393879|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
416389|NCT00606684|1393880|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
416390|NCT00606684|1393874|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
416391|NCT00606684|1393875|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
416392|NCT00606684|1393876|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
416393|NCT00606684|1393877|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
416394|NCT00606684|1393878|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
416395|NCT00606684|1393879|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
416396|NCT00606684|1393880|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
416397|NCT00606632|1393912|P1|Overall Study|Miscellaneous reasons|9
416398|NCT00606632|1393912|P1|Overall Study|Withdrawal by Subject|13
416399|NCT00606593|1393919|P10|Overall Study|Administrative/Other|0
416400|NCT00606593|1393920|P9|Overall Study|Administrative/Other|0
416401|NCT00606593|1393921|P8|Overall Study|Administrative/Other|0
416402|NCT00606593|1393922|P7|Overall Study|Administrative/Other|0
416403|NCT00606593|1393923|P6|Overall Study|Administrative/Other|0
416404|NCT00606593|1393924|P5|Overall Study|Administrative/Other|0
416405|NCT00606593|1393925|P4|Overall Study|Administrative/Other|0
416406|NCT00606593|1393926|P3|Overall Study|Administrative/Other|1
416407|NCT00606593|1393927|P2|Overall Study|Administrative/Other|0
416408|NCT00606593|1393928|P1|Overall Study|Administrative/Other|0
416409|NCT00606593|1393919|P10|Overall Study|Withdrawal of consent|0
416410|NCT00606593|1393920|P9|Overall Study|Withdrawal of consent|0
416411|NCT00606593|1393921|P8|Overall Study|Withdrawal of consent|0
416412|NCT00606593|1393922|P7|Overall Study|Withdrawal of consent|0
416413|NCT00606593|1393923|P6|Overall Study|Withdrawal of consent|0
416414|NCT00606593|1393924|P5|Overall Study|Withdrawal of consent|0
416415|NCT00606593|1393925|P4|Overall Study|Withdrawal of consent|0
416416|NCT00606593|1393926|P3|Overall Study|Withdrawal of consent|1
416417|NCT00606593|1393927|P2|Overall Study|Withdrawal of consent|0
416418|NCT00606593|1393928|P1|Overall Study|Withdrawal of consent|1
416419|NCT00606593|1393919|P10|Overall Study|Adverse Event|0
416420|NCT00606593|1393920|P9|Overall Study|Adverse Event|1
416421|NCT00606593|1393921|P8|Overall Study|Adverse Event|2
416422|NCT00606593|1393922|P7|Overall Study|Adverse Event|1
416423|NCT00606593|1393923|P6|Overall Study|Adverse Event|0
416424|NCT00606593|1393924|P5|Overall Study|Adverse Event|1
416425|NCT00606593|1393925|P4|Overall Study|Adverse Event|1
416426|NCT00606593|1393926|P3|Overall Study|Adverse Event|0
416427|NCT00606593|1393927|P2|Overall Study|Adverse Event|0
416428|NCT00606593|1393928|P1|Overall Study|Adverse Event|0
416429|NCT00606580|1393949|P3|Overall Study|Withdrawal by Subject|0
416430|NCT00606580|1393950|P2|Overall Study|Withdrawal by Subject|1
416431|NCT00606580|1393951|P1|Overall Study|Withdrawal by Subject|0
416432|NCT00606580|1393949|P3|Overall Study|Withdrawal by investigator|6
416433|NCT00606580|1393950|P2|Overall Study|Withdrawal by investigator|1
416434|NCT00606580|1393951|P1|Overall Study|Withdrawal by investigator|0
416435|NCT00606580|1393949|P3|Overall Study|Clinical failures|12
416436|NCT00606580|1393950|P2|Overall Study|Clinical failures|0
416437|NCT00606580|1393951|P1|Overall Study|Clinical failures|1
416438|NCT00606580|1393949|P3|Overall Study|Lost to Follow-up|4
416439|NCT00606580|1393950|P2|Overall Study|Lost to Follow-up|1
416440|NCT00606580|1393951|P1|Overall Study|Lost to Follow-up|1
416441|NCT00606502|1394017|P2|Treatment|Treatment ongoing at time of data cutoff|3
416442|NCT00606502|1394018|P1|Treatment|Treatment ongoing at time of data cutoff|0
416443|NCT00606502|1394017|P2|Randomization|Randomized but not treated|0
416444|NCT00606502|1394018|P1|Randomization|Randomized but not treated|3
416445|NCT00606320|1394039|P1|Overall Study|Progression to depressive phase|4
416446|NCT00606320|1394039|P1|Overall Study|Withdrawal by Subject|10
416447|NCT00606320|1394039|P1|Overall Study|Protocol Violation|8
416448|NCT00606320|1394039|P1|Overall Study|Physician Decision|7
416449|NCT00606320|1394039|P1|Overall Study|Lack of Efficacy|5
416450|NCT00606320|1394039|P1|Overall Study|Adverse Event|3
416451|NCT00606281|1394046|P2|Overall Study|Change of residence or other commitments|1
416452|NCT00606281|1394047|P1|Overall Study|Change of residence or other commitments|1
416453|NCT00606281|1394046|P2|Overall Study|Progression to depressive phase|1
416454|NCT00606281|1394047|P1|Overall Study|Progression to depressive phase|1
416455|NCT00606281|1394046|P2|Overall Study|Withdrawal by Subject|13
416456|NCT00606281|1394047|P1|Overall Study|Withdrawal by Subject|11
416457|NCT00606281|1394046|P2|Overall Study|Protocol Violation|3
416458|NCT00606281|1394047|P1|Overall Study|Protocol Violation|3
416459|NCT00606281|1394046|P2|Overall Study|Physician Decision|1
416460|NCT00606281|1394047|P1|Overall Study|Physician Decision|0
416461|NCT00606281|1394046|P2|Overall Study|Lack of Efficacy|35
416462|NCT00606281|1394047|P1|Overall Study|Lack of Efficacy|28
416463|NCT00606281|1394046|P2|Overall Study|Death|0
416464|NCT00606281|1394047|P1|Overall Study|Death|1
416465|NCT00606281|1394046|P2|Overall Study|Adverse Event|12
416466|NCT00606281|1394047|P1|Overall Study|Adverse Event|11
416467|NCT00606229|1394055|P1|Overall Study|change of residence or other commitments|2
416468|NCT00606229|1394055|P1|Overall Study|does not meet inclusion criterion 1-3|4
416469|NCT00606229|1394055|P1|Overall Study|Withdrawal by Subject|4
416470|NCT00606229|1394055|P1|Overall Study|Lack of Efficacy|1
416471|NCT00606229|1394055|P1|Overall Study|Adverse Event|11
416472|NCT00606177|1394062|P2|Overall Study|Change of residence or other commitments|1
416473|NCT00606177|1394063|P1|Overall Study|Change of residence or other commitments|1
416474|NCT00606177|1394062|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
416475|NCT00606177|1394063|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
416476|NCT00606177|1394062|P2|Overall Study|Progression to depressive phase|1
416477|NCT00606177|1394063|P1|Overall Study|Progression to depressive phase|6
416478|NCT00606177|1394062|P2|Overall Study|Withdrawal by Subject|6
416479|NCT00606177|1394063|P1|Overall Study|Withdrawal by Subject|5
416480|NCT00606177|1394062|P2|Overall Study|Protocol Violation|4
416481|NCT00606177|1394063|P1|Overall Study|Protocol Violation|1
416482|NCT00606177|1394062|P2|Overall Study|Physician Decision|0
416483|NCT00606177|1394063|P1|Overall Study|Physician Decision|1
416484|NCT00606177|1394062|P2|Overall Study|Lack of Efficacy|7
416485|NCT00606177|1394063|P1|Overall Study|Lack of Efficacy|3
416486|NCT00606177|1394062|P2|Overall Study|Adverse Event|5
416487|NCT00606177|1394063|P1|Overall Study|Adverse Event|9
416488|NCT00606086|1394090|P2|Overall Study|Randomized, not treated|2
416489|NCT00606086|1394091|P1|Overall Study|Randomized, not treated|1
416490|NCT00606086|1394090|P2|Overall Study|Non-compliance|1
416491|NCT00606086|1394091|P1|Overall Study|Non-compliance|0
416492|NCT00606086|1394090|P2|Overall Study|Withdrawal by Subject|3
416493|NCT00606086|1394091|P1|Overall Study|Withdrawal by Subject|5
416494|NCT00606086|1394090|P2|Overall Study|Protocol Violation|0
416495|NCT00606086|1394091|P1|Overall Study|Protocol Violation|1
416496|NCT00606086|1394090|P2|Overall Study|Lost to Follow-up|8
416497|NCT00606086|1394091|P1|Overall Study|Lost to Follow-up|4
416498|NCT00606086|1394090|P2|Overall Study|Adverse Event|1
416499|NCT00606086|1394091|P1|Overall Study|Adverse Event|1
416500|NCT00606034|1394097|P1|Overall Study|incarceration|1
416501|NCT00606021|1394105|P3|Maintenance Phase|Lost to Follow-up|2
416502|NCT00606021|1394106|P2|Maintenance Phase|Lost to Follow-up|5
416503|NCT00606021|1394107|P1|Maintenance Phase|Lost to Follow-up|0
416504|NCT00606021|1394105|P3|Maintenance Phase|Physician Decision|0
416505|NCT00606021|1394106|P2|Maintenance Phase|Physician Decision|1
416506|NCT00606021|1394107|P1|Maintenance Phase|Physician Decision|0
416507|NCT00606021|1394105|P3|Maintenance Phase|Death|15
416508|NCT00606021|1394106|P2|Maintenance Phase|Death|17
416509|NCT00606021|1394107|P1|Maintenance Phase|Death|0
416510|NCT00606021|1394105|P3|Induction Phase|Lost to Follow-up|0
416511|NCT00606021|1394106|P2|Induction Phase|Lost to Follow-up|0
416512|NCT00606021|1394107|P1|Induction Phase|Lost to Follow-up|10
416513|NCT00606021|1394105|P3|Induction Phase|Withdrawal by Subject|0
416514|NCT00606021|1394106|P2|Induction Phase|Withdrawal by Subject|0
416515|NCT00606021|1394107|P1|Induction Phase|Withdrawal by Subject|2
416516|NCT00606021|1394105|P3|Induction Phase|Physician Decision|0
416517|NCT00606021|1394106|P2|Induction Phase|Physician Decision|0
416518|NCT00606021|1394107|P1|Induction Phase|Physician Decision|2
416519|NCT00606021|1394105|P3|Induction Phase|Death|0
416520|NCT00606021|1394106|P2|Induction Phase|Death|0
416521|NCT00606021|1394107|P1|Induction Phase|Death|73
416522|NCT00606008|1394125|P1|Overall Study|Withdrawal by Subject|4
416523|NCT00606008|1394125|P1|Overall Study|Adverse Event|1
416524|NCT00605917|1394139|P1|Overall Study|Protocol Violation|79
416525|NCT00605865|1394191|P1|Overall Study|Protocol Violation|115
416526|NCT00605839|1394233|P3|Overall Study|Protocol Violation|0
416527|NCT00605839|1394234|P2|Overall Study|Protocol Violation|0
416528|NCT00605839|1394235|P1|Overall Study|Protocol Violation|1
416529|NCT00605813|1394243|P1|Overall Study|Protocol Violation|25
416530|NCT00605722|1394256|P1|Overall Study|Failure to return|1
416531|NCT00605722|1394256|P1|Overall Study|Insufficient therapeutic response|44
416532|NCT00605722|1394256|P1|Overall Study|Adverse Event|6
416533|NCT00605657|1394277|P1|Overall Study|Protocol Violation|1
416534|NCT00605657|1394277|P1|Overall Study|Adverse Event|1
416535|NCT00605540|1394282|P1|Overall Study|Lost to Follow-up|23
416536|NCT00605540|1394282|P1|Overall Study|Death|15
416537|NCT00605475|1394300|P10|Overall Study|Withdrawal by Subject|1
416538|NCT00605475|1394301|P9|Overall Study|Withdrawal by Subject|0
416539|NCT00605475|1394302|P8|Overall Study|Withdrawal by Subject|0
416540|NCT00605475|1394303|P7|Overall Study|Withdrawal by Subject|0
416541|NCT00605475|1394304|P6|Overall Study|Withdrawal by Subject|2
416542|NCT00605475|1394305|P5|Overall Study|Withdrawal by Subject|0
416543|NCT00605475|1394306|P4|Overall Study|Withdrawal by Subject|0
416544|NCT00605475|1394307|P3|Overall Study|Withdrawal by Subject|0
416545|NCT00605475|1394308|P2|Overall Study|Withdrawal by Subject|0
416546|NCT00605475|1394309|P1|Overall Study|Withdrawal by Subject|0
416547|NCT00605475|1394300|P10|Overall Study|Protocol Violation|0
416548|NCT00605475|1394301|P9|Overall Study|Protocol Violation|0
416549|NCT00605475|1394302|P8|Overall Study|Protocol Violation|0
416550|NCT00605475|1394303|P7|Overall Study|Protocol Violation|0
416551|NCT00605475|1394304|P6|Overall Study|Protocol Violation|0
416552|NCT00605475|1394305|P5|Overall Study|Protocol Violation|1
416553|NCT00605475|1394306|P4|Overall Study|Protocol Violation|0
416554|NCT00605475|1394307|P3|Overall Study|Protocol Violation|0
416555|NCT00605475|1394308|P2|Overall Study|Protocol Violation|0
416556|NCT00605475|1394309|P1|Overall Study|Protocol Violation|0
416557|NCT00605475|1394300|P10|Overall Study|Lost to Follow-up|1
416558|NCT00605475|1394301|P9|Overall Study|Lost to Follow-up|1
416559|NCT00605475|1394302|P8|Overall Study|Lost to Follow-up|0
416560|NCT00605475|1394303|P7|Overall Study|Lost to Follow-up|0
416561|NCT00605475|1394304|P6|Overall Study|Lost to Follow-up|0
416562|NCT00605475|1394305|P5|Overall Study|Lost to Follow-up|0
416563|NCT00605475|1394306|P4|Overall Study|Lost to Follow-up|0
416564|NCT00605475|1394307|P3|Overall Study|Lost to Follow-up|0
416565|NCT00605475|1394308|P2|Overall Study|Lost to Follow-up|0
416566|NCT00605475|1394309|P1|Overall Study|Lost to Follow-up|0
416567|NCT00605475|1394300|P10|Overall Study|Administrative problems|0
416568|NCT00605475|1394301|P9|Overall Study|Administrative problems|0
416569|NCT00605475|1394302|P8|Overall Study|Administrative problems|0
416570|NCT00605475|1394303|P7|Overall Study|Administrative problems|1
416571|NCT00605475|1394304|P6|Overall Study|Administrative problems|0
416572|NCT00605475|1394305|P5|Overall Study|Administrative problems|0
416573|NCT00605475|1394306|P4|Overall Study|Administrative problems|0
416574|NCT00605475|1394307|P3|Overall Study|Administrative problems|0
416575|NCT00605475|1394308|P2|Overall Study|Administrative problems|0
416576|NCT00605475|1394309|P1|Overall Study|Administrative problems|0
416577|NCT00605475|1394300|P10|Overall Study|Abnormal Laboratory Values|0
416578|NCT00605475|1394301|P9|Overall Study|Abnormal Laboratory Values|1
416579|NCT00605475|1394302|P8|Overall Study|Abnormal Laboratory Values|0
416580|NCT00605475|1394303|P7|Overall Study|Abnormal Laboratory Values|0
416581|NCT00605475|1394304|P6|Overall Study|Abnormal Laboratory Values|0
416582|NCT00605475|1394305|P5|Overall Study|Abnormal Laboratory Values|0
416583|NCT00605475|1394306|P4|Overall Study|Abnormal Laboratory Values|0
416584|NCT00605475|1394307|P3|Overall Study|Abnormal Laboratory Values|0
416585|NCT00605475|1394308|P2|Overall Study|Abnormal Laboratory Values|0
416586|NCT00605475|1394309|P1|Overall Study|Abnormal Laboratory Values|0
416587|NCT00605345|1394486|P2|Overall Study|Protocol Violation|2
416588|NCT00605345|1394487|P1|Overall Study|Protocol Violation|0
416589|NCT00605345|1394486|P2|Overall Study|Adverse Event|1
416590|NCT00605345|1394487|P1|Overall Study|Adverse Event|0
416591|NCT00605345|1394486|P2|Overall Study|Withdrawal by Subject|0
416592|NCT00605345|1394487|P1|Overall Study|Withdrawal by Subject|1
416593|NCT00605319|1394503|P1|Overall Study|Adverse Event|6
416594|NCT00605306|1394515|P2|Overall Study|Adverse Event|1
416595|NCT00605306|1394516|P1|Overall Study|Adverse Event|0
416596|NCT00605293|1394530|P2|Overall Study|Principal Investigator Decision|1
416597|NCT00605293|1394531|P1|Overall Study|Principal Investigator Decision|0
416598|NCT00605293|1394530|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
416599|NCT00605293|1394531|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
416600|NCT00605293|1394530|P2|Overall Study|Incorrect Epoetin Beta Administration|0
416601|NCT00605293|1394531|P1|Overall Study|Incorrect Epoetin Beta Administration|1
416602|NCT00605293|1394530|P2|Overall Study|Renal Transplantation|1
416603|NCT00605293|1394531|P1|Overall Study|Renal Transplantation|3
416604|NCT00605293|1394530|P2|Overall Study|Blood Transfusion|1
416605|NCT00605293|1394531|P1|Overall Study|Blood Transfusion|7
416606|NCT00605293|1394530|P2|Overall Study|Holidays Dialysis Out|0
416607|NCT00605293|1394531|P1|Overall Study|Holidays Dialysis Out|1
416608|NCT00605293|1394530|P2|Overall Study|Adverse Event|0
416609|NCT00605293|1394531|P1|Overall Study|Adverse Event|1
416610|NCT00605293|1394530|P2|Overall Study|Insufficient Therapeutic Response|0
416611|NCT00605293|1394531|P1|Overall Study|Insufficient Therapeutic Response|2
416612|NCT00605293|1394530|P2|Overall Study|Death|1
416613|NCT00605293|1394531|P1|Overall Study|Death|2
416614|NCT00605280|1394551|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
416615|NCT00605280|1394552|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
416616|NCT00605280|1394553|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
416617|NCT00605280|1394554|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
416618|NCT00605280|1394551|P4|Year 3 Extension|Other|0
416619|NCT00605280|1394552|P3|Year 3 Extension|Other|0
416620|NCT00605280|1394553|P2|Year 3 Extension|Other|0
416621|NCT00605280|1394554|P1|Year 3 Extension|Other|2
416622|NCT00605280|1394551|P4|Year 3 Extension|Withdrawal by Subject|5
416623|NCT00605280|1394552|P3|Year 3 Extension|Withdrawal by Subject|0
416624|NCT00605280|1394553|P2|Year 3 Extension|Withdrawal by Subject|0
416625|NCT00605280|1394554|P1|Year 3 Extension|Withdrawal by Subject|2
416626|NCT00605280|1394551|P4|Year 3 Extension|Physician Decision|2
416627|NCT00605280|1394552|P3|Year 3 Extension|Physician Decision|0
416628|NCT00605280|1394553|P2|Year 3 Extension|Physician Decision|0
416629|NCT00605280|1394554|P1|Year 3 Extension|Physician Decision|0
416630|NCT00605280|1394551|P4|Year 3 Extension|Adverse Event|2
416631|NCT00605280|1394552|P3|Year 3 Extension|Adverse Event|0
416632|NCT00605280|1394553|P2|Year 3 Extension|Adverse Event|0
416633|NCT00605280|1394554|P1|Year 3 Extension|Adverse Event|2
416634|NCT00605280|1394551|P4|Year 2|Lost to Follow-up or Patient non-comply|2
416635|NCT00605280|1394552|P3|Year 2|Lost to Follow-up or Patient non-comply|0
416636|NCT00605280|1394553|P2|Year 2|Lost to Follow-up or Patient non-comply|0
416637|NCT00605280|1394554|P1|Year 2|Lost to Follow-up or Patient non-comply|4
416638|NCT00605280|1394551|P4|Year 2|Other|1
416639|NCT00605280|1394552|P3|Year 2|Other|0
416640|NCT00605280|1394553|P2|Year 2|Other|0
416641|NCT00605280|1394554|P1|Year 2|Other|1
416642|NCT00605280|1394551|P4|Year 2|Withdrawal by Subject|4
416643|NCT00605280|1394552|P3|Year 2|Withdrawal by Subject|0
416644|NCT00605280|1394553|P2|Year 2|Withdrawal by Subject|0
416645|NCT00605280|1394554|P1|Year 2|Withdrawal by Subject|4
416646|NCT00605280|1394551|P4|Year 2|Physician Decision|11
416647|NCT00605280|1394552|P3|Year 2|Physician Decision|4
416648|NCT00605280|1394553|P2|Year 2|Physician Decision|6
416649|NCT00605280|1394554|P1|Year 2|Physician Decision|11
416650|NCT00605280|1394551|P4|Year 2|Adverse Event|4
416651|NCT00605280|1394552|P3|Year 2|Adverse Event|2
416652|NCT00605280|1394553|P2|Year 2|Adverse Event|0
416653|NCT00605280|1394554|P1|Year 2|Adverse Event|4
416654|NCT00605280|1394551|P4|Year 1|Lost to Follow-up or Patient non-comply|2
416655|NCT00605280|1394552|P3|Year 1|Lost to Follow-up or Patient non-comply|0
416656|NCT00605280|1394553|P2|Year 1|Lost to Follow-up or Patient non-comply|1
416657|NCT00605280|1394554|P1|Year 1|Lost to Follow-up or Patient non-comply|5
416658|NCT00605280|1394551|P4|Year 1|Other|1
416659|NCT00605280|1394552|P3|Year 1|Other|0
416660|NCT00605280|1394553|P2|Year 1|Other|1
416661|NCT00605280|1394554|P1|Year 1|Other|2
416662|NCT00605280|1394551|P4|Year 1|Withdrawal by Subject|4
416663|NCT00605280|1394552|P3|Year 1|Withdrawal by Subject|0
416664|NCT00605280|1394553|P2|Year 1|Withdrawal by Subject|4
416665|NCT00605280|1394554|P1|Year 1|Withdrawal by Subject|2
416666|NCT00605280|1394551|P4|Year 1|Physician Decision|6
416667|NCT00605280|1394552|P3|Year 1|Physician Decision|0
416668|NCT00605280|1394553|P2|Year 1|Physician Decision|4
416669|NCT00605280|1394554|P1|Year 1|Physician Decision|7
416670|NCT00605280|1394551|P4|Year 1|Adverse Event|5
416671|NCT00605280|1394552|P3|Year 1|Adverse Event|1
416672|NCT00605280|1394553|P2|Year 1|Adverse Event|1
416673|NCT00605280|1394554|P1|Year 1|Adverse Event|3
416674|NCT00605280|1394551|P4|Year 1|Protocol Violation|1
416675|NCT00605280|1394552|P3|Year 1|Protocol Violation|0
416676|NCT00605280|1394553|P2|Year 1|Protocol Violation|0
416677|NCT00605280|1394554|P1|Year 1|Protocol Violation|0
416678|NCT00605267|1394588|P2|Overall Study|Withdrawal by Subject|3
416679|NCT00605267|1394589|P1|Overall Study|Withdrawal by Subject|2
416680|NCT00605267|1394588|P2|Overall Study|Lack of Efficacy|5
416681|NCT00605267|1394589|P1|Overall Study|Lack of Efficacy|1
416682|NCT00605267|1394588|P2|Overall Study|Adverse Event|1
416683|NCT00605267|1394589|P1|Overall Study|Adverse Event|0
416684|NCT00605176|1394637|P3|Overall Study|Other (not due to AE)|0
416685|NCT00605176|1394638|P2|Overall Study|Other (not due to AE)|1
416686|NCT00605176|1394639|P1|Overall Study|Other (not due to AE)|1
416687|NCT00605176|1394637|P3|Overall Study|Use of concomitant therapy|1
416688|NCT00605176|1394638|P2|Overall Study|Use of concomitant therapy|0
416689|NCT00605176|1394639|P1|Overall Study|Use of concomitant therapy|1
416690|NCT00605176|1394637|P3|Overall Study|Non-complicance with study procedures|0
416691|NCT00605176|1394638|P2|Overall Study|Non-complicance with study procedures|0
416692|NCT00605176|1394639|P1|Overall Study|Non-complicance with study procedures|1
416693|NCT00605176|1394637|P3|Overall Study|Lost to Follow-up|1
416694|NCT00605176|1394638|P2|Overall Study|Lost to Follow-up|2
416695|NCT00605176|1394639|P1|Overall Study|Lost to Follow-up|2
416696|NCT00605176|1394637|P3|Overall Study|Withdrawal by Subject|4
416697|NCT00605176|1394638|P2|Overall Study|Withdrawal by Subject|2
416698|NCT00605176|1394639|P1|Overall Study|Withdrawal by Subject|4
416699|NCT00605176|1394637|P3|Overall Study|Adverse Event|3
416700|NCT00605176|1394638|P2|Overall Study|Adverse Event|1
416701|NCT00605176|1394639|P1|Overall Study|Adverse Event|2
416702|NCT00605085|1394662|P2|Overall Study|administrative reasons|8
416703|NCT00605085|1394663|P1|Overall Study|administrative reasons|18
416704|NCT00605085|1394662|P2|Overall Study|Lost to Follow-up|5
416705|NCT00605085|1394663|P1|Overall Study|Lost to Follow-up|10
416706|NCT00605085|1394662|P2|Overall Study|Protocol Violation|2
416707|NCT00605085|1394663|P1|Overall Study|Protocol Violation|3
416708|NCT00605085|1394662|P2|Overall Study|Pregnancy|0
416709|NCT00605085|1394663|P1|Overall Study|Pregnancy|2
416710|NCT00605085|1394662|P2|Overall Study|Adverse Event|5
416711|NCT00605085|1394663|P1|Overall Study|Adverse Event|9
416712|NCT00605085|1394662|P2|Overall Study|Withdrawal by Subject|5
416713|NCT00605085|1394663|P1|Overall Study|Withdrawal by Subject|8
416714|NCT00605033|1394696|P2|Overall Study|Protocol Violation|1
416715|NCT00605033|1394697|P1|Overall Study|Protocol Violation|1
416716|NCT00605033|1394696|P2|Overall Study|Withdrawal by Subject|4
416717|NCT00605033|1394697|P1|Overall Study|Withdrawal by Subject|3
416718|NCT00605033|1394696|P2|Overall Study|Lost to Follow-up|1
416719|NCT00605033|1394697|P1|Overall Study|Lost to Follow-up|1
416720|NCT00605033|1394696|P2|Overall Study|Adverse Event|2
416721|NCT00605033|1394697|P1|Overall Study|Adverse Event|2
416722|NCT00604825|1394720|P4|Overall Study|Exclusion criterion met|1
416723|NCT00604825|1394721|P3|Overall Study|Exclusion criterion met|0
416724|NCT00604825|1394722|P2|Overall Study|Exclusion criterion met|0
416725|NCT00604825|1394723|P1|Overall Study|Exclusion criterion met|0
416726|NCT00604825|1394720|P4|Overall Study|Physician Decision|1
416727|NCT00604825|1394721|P3|Overall Study|Physician Decision|0
416728|NCT00604825|1394722|P2|Overall Study|Physician Decision|0
416729|NCT00604825|1394723|P1|Overall Study|Physician Decision|0
416730|NCT00604825|1394720|P4|Overall Study|Did not meet eligibility criteria|0
416731|NCT00604825|1394721|P3|Overall Study|Did not meet eligibility criteria|2
416732|NCT00604825|1394722|P2|Overall Study|Did not meet eligibility criteria|0
416733|NCT00604825|1394723|P1|Overall Study|Did not meet eligibility criteria|0
416734|NCT00604825|1394720|P4|Overall Study|Lack of Efficacy|0
416735|NCT00604825|1394721|P3|Overall Study|Lack of Efficacy|1
416736|NCT00604825|1394722|P2|Overall Study|Lack of Efficacy|2
416737|NCT00604825|1394723|P1|Overall Study|Lack of Efficacy|3
416738|NCT00604825|1394720|P4|Overall Study|Withdrawal by Subject|5
416739|NCT00604825|1394721|P3|Overall Study|Withdrawal by Subject|5
416740|NCT00604825|1394722|P2|Overall Study|Withdrawal by Subject|3
416741|NCT00604825|1394723|P1|Overall Study|Withdrawal by Subject|4
416742|NCT00604825|1394720|P4|Overall Study|Protocol Violation|0
416743|NCT00604825|1394721|P3|Overall Study|Protocol Violation|0
416744|NCT00604825|1394722|P2|Overall Study|Protocol Violation|1
416745|NCT00604825|1394723|P1|Overall Study|Protocol Violation|0
416746|NCT00604825|1394720|P4|Overall Study|Lost to Follow-up|0
416747|NCT00604825|1394721|P3|Overall Study|Lost to Follow-up|1
416748|NCT00604825|1394722|P2|Overall Study|Lost to Follow-up|3
416749|NCT00604825|1394723|P1|Overall Study|Lost to Follow-up|0
416750|NCT00604825|1394720|P4|Overall Study|Adverse Event|4
416751|NCT00604825|1394721|P3|Overall Study|Adverse Event|7
416752|NCT00604825|1394722|P2|Overall Study|Adverse Event|6
416753|NCT00604825|1394723|P1|Overall Study|Adverse Event|2
416754|NCT00604786|1394951|P2|Overall Study|Lost to Follow-up|0
416755|NCT00604786|1394952|P1|Overall Study|Lost to Follow-up|2
416756|NCT00604721|1394958|P1|Overall Study|Withdrawal by Subject|1
416757|NCT00604721|1394958|P1|Overall Study|Physician Decision|1
416758|NCT00604708|1394966|P2|Overall Study|Adverse Event|6
416759|NCT00604708|1394967|P1|Overall Study|Adverse Event|6
416760|NCT00604708|1394966|P2|Overall Study|administrative reasons|11
416761|NCT00604708|1394967|P1|Overall Study|administrative reasons|9
416762|NCT00604708|1394966|P2|Overall Study|Lost to Follow-up|5
416763|NCT00604708|1394967|P1|Overall Study|Lost to Follow-up|5
416764|NCT00604708|1394966|P2|Overall Study|Protocol Violation|8
416765|NCT00604708|1394967|P1|Overall Study|Protocol Violation|2
416766|NCT00604708|1394966|P2|Overall Study|Withdrawal by Subject|10
416767|NCT00604708|1394967|P1|Overall Study|Withdrawal by Subject|9
416768|NCT00604695|1394977|P2|Overall Study|Did not receive first bolus.|4
416769|NCT00604695|1394978|P1|Overall Study|Did not receive first bolus.|0
416770|NCT00604669|1395000|P1|Overall Study|lack of information in chart|7
416771|NCT00604565|1395006|P2|Overall Study|Study terminated|3
416772|NCT00604565|1395007|P1|Overall Study|Study terminated|0
416773|NCT00604500|1395026|P1|Overall Study|Did not meet protocol eligibility|1
416774|NCT00604500|1395026|P1|Overall Study|Administrative|1
416775|NCT00604500|1395026|P1|Overall Study|Withdrawal by Subject|4
416776|NCT00604500|1395026|P1|Overall Study|Treatment Failure|1
416777|NCT00604500|1395026|P1|Overall Study|Protocol Violation|2
416778|NCT00604500|1395026|P1|Overall Study|Adverse Event|2
416779|NCT00604383|1395040|P2|Overall Study|Physician Decision|3
416780|NCT00604383|1395041|P1|Overall Study|Physician Decision|0
416781|NCT00604383|1395040|P2|Overall Study|Adverse Event|9
416782|NCT00604383|1395041|P1|Overall Study|Adverse Event|16
416783|NCT00604383|1395040|P2|Overall Study|Death|22
416784|NCT00604383|1395041|P1|Overall Study|Death|14
416785|NCT00604383|1395040|P2|Overall Study|Lost to Follow-up|19
416786|NCT00604383|1395041|P1|Overall Study|Lost to Follow-up|24
416787|NCT00604383|1395040|P2|Overall Study|Withdrawal by Subject|31
416788|NCT00604383|1395041|P1|Overall Study|Withdrawal by Subject|33
416789|NCT00604279|1395057|P2|Overall Study|Other|4
416790|NCT00604279|1395058|P1|Overall Study|Other|8
416791|NCT00604279|1395057|P2|Overall Study|Adverse Event|5
416792|NCT00604279|1395058|P1|Overall Study|Adverse Event|4
416793|NCT00604279|1395057|P2|Overall Study|Withdrawal by Subject|5
416794|NCT00604279|1395058|P1|Overall Study|Withdrawal by Subject|16
416795|NCT00604279|1395057|P2|Overall Study|Protocol Violation|1
416796|NCT00604279|1395058|P1|Overall Study|Protocol Violation|3
416797|NCT00604279|1395057|P2|Overall Study|Pregnancy|0
416798|NCT00604279|1395058|P1|Overall Study|Pregnancy|2
416799|NCT00604279|1395057|P2|Overall Study|Lost to Follow-up|14
416800|NCT00604279|1395058|P1|Overall Study|Lost to Follow-up|9
416801|NCT00604279|1395057|P2|Overall Study|Lack of Efficacy|9
416802|NCT00604279|1395058|P1|Overall Study|Lack of Efficacy|22
416803|NCT00604214|1395074|P2|Day 91 to Day 180|Withdrawal by Subject|1
416804|NCT00604214|1395075|P1|Day 91 to Day 180|Withdrawal by Subject|1
416805|NCT00604214|1395074|P2|Day 91 to Day 180|Lost to Follow-up|8
416806|NCT00604214|1395075|P1|Day 91 to Day 180|Lost to Follow-up|6
416807|NCT00604214|1395074|P2|Day 91 to Day 180|Death|23
416808|NCT00604214|1395075|P1|Day 91 to Day 180|Death|19
416809|NCT00604214|1395074|P2|Day 29 to Day 90|Withdrawal by Subject|6
416810|NCT00604214|1395075|P1|Day 29 to Day 90|Withdrawal by Subject|0
416811|NCT00604214|1395074|P2|Day 29 to Day 90|Lost to Follow-up|6
416812|NCT00604214|1395075|P1|Day 29 to Day 90|Lost to Follow-up|4
416813|NCT00604214|1395074|P2|Day 29 to Day 90|Death|67
416814|NCT00604214|1395075|P1|Day 29 to Day 90|Death|64
416815|NCT00604214|1395074|P2|Baseline to Day 28|Withdrawal by Subject|7
416816|NCT00604214|1395075|P1|Baseline to Day 28|Withdrawal by Subject|3
416817|NCT00604214|1395074|P2|Baseline to Day 28|Lost to Follow-up|4
416818|NCT00604214|1395075|P1|Baseline to Day 28|Lost to Follow-up|2
416819|NCT00604214|1395074|P2|Baseline to Day 28|Death|202
416820|NCT00604214|1395075|P1|Baseline to Day 28|Death|223
416821|NCT00604188|1395107|P2|Overall Study|Did not receive study drug|1
416822|NCT00604188|1395108|P1|Overall Study|Did not receive study drug|0
416823|NCT00604188|1395107|P2|Overall Study|Non-compliance with protocol|4
416824|NCT00604188|1395108|P1|Overall Study|Non-compliance with protocol|4
416825|NCT00604188|1395107|P2|Overall Study|Withdrawal by Subject|1
416826|NCT00604188|1395108|P1|Overall Study|Withdrawal by Subject|5
416827|NCT00604188|1395107|P2|Overall Study|Lost to Follow-up|15
416828|NCT00604188|1395108|P1|Overall Study|Lost to Follow-up|17
416829|NCT00604188|1395107|P2|Overall Study|Adverse Event|4
416830|NCT00604188|1395108|P1|Overall Study|Adverse Event|1
416831|NCT00604175|1395131|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
416832|NCT00604175|1395132|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
416833|NCT00604175|1395133|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
416834|NCT00604175|1395131|P3|Week 29 Through Week 72|Site closure|0
416835|NCT00604175|1395132|P2|Week 29 Through Week 72|Site closure|1
416836|NCT00604175|1395133|P1|Week 29 Through Week 72|Site closure|0
416837|NCT00604175|1395131|P3|Week 29 Through Week 72|Lost to Follow-up|2
416838|NCT00604175|1395132|P2|Week 29 Through Week 72|Lost to Follow-up|6
416839|NCT00604175|1395133|P1|Week 29 Through Week 72|Lost to Follow-up|12
416840|NCT00604175|1395131|P3|Week 29 Through Week 72|Death|1
416841|NCT00604175|1395132|P2|Week 29 Through Week 72|Death|0
416842|NCT00604175|1395133|P1|Week 29 Through Week 72|Death|0
416843|NCT00604175|1395131|P3|Entry Through Week 28|Did not start intervention|1
416844|NCT00604175|1395132|P2|Entry Through Week 28|Did not start intervention|0
416845|NCT00604175|1395133|P1|Entry Through Week 28|Did not start intervention|2
416846|NCT00604175|1395131|P3|Entry Through Week 28|Ineligible|0
416847|NCT00604175|1395132|P2|Entry Through Week 28|Ineligible|0
416848|NCT00604175|1395133|P1|Entry Through Week 28|Ineligible|1
416849|NCT00604175|1395131|P3|Entry Through Week 28|Lost to Follow-up|0
416850|NCT00604175|1395132|P2|Entry Through Week 28|Lost to Follow-up|3
416851|NCT00604175|1395133|P1|Entry Through Week 28|Lost to Follow-up|4
416852|NCT00604175|1395131|P3|Entry Through Week 28|Withdrawal by Subject|0
416853|NCT00604175|1395132|P2|Entry Through Week 28|Withdrawal by Subject|0
416854|NCT00604175|1395133|P1|Entry Through Week 28|Withdrawal by Subject|1
416855|NCT00604175|1395131|P3|Entry Through Week 28|Death|0
416856|NCT00604175|1395132|P2|Entry Through Week 28|Death|0
416857|NCT00604175|1395133|P1|Entry Through Week 28|Death|2
416858|NCT00604162|1395186|P1|Overall Study|Withdrawal by Subject|1
416859|NCT00604162|1395186|P1|Overall Study|Physician Decision|3
416860|NCT00603915|1395228|P1|Overall Study|Physician Decision|1
416861|NCT00603837|1395258|P2|Overall Study|Physician Decision|0
416862|NCT00603837|1395259|P1|Overall Study|Physician Decision|3
416863|NCT00603798|1395268|P3|Overall Study|Not due to AE|4
416864|NCT00603798|1395269|P2|Overall Study|Not due to AE|1
416865|NCT00603798|1395270|P1|Overall Study|Not due to AE|1
416866|NCT00603798|1395268|P3|Overall Study|Non-compliance with study procedures|0
416867|NCT00603798|1395269|P2|Overall Study|Non-compliance with study procedures|1
416868|NCT00603798|1395270|P1|Overall Study|Non-compliance with study procedures|0
416869|NCT00603798|1395268|P3|Overall Study|Lost to Follow-up|1
416870|NCT00603798|1395269|P2|Overall Study|Lost to Follow-up|0
416871|NCT00603798|1395270|P1|Overall Study|Lost to Follow-up|1
416872|NCT00603798|1395268|P3|Overall Study|Withdrawal by Subject|4
416873|NCT00603798|1395269|P2|Overall Study|Withdrawal by Subject|3
416874|NCT00603798|1395270|P1|Overall Study|Withdrawal by Subject|4
416875|NCT00603798|1395268|P3|Overall Study|Adverse Event|1
416876|NCT00603798|1395269|P2|Overall Study|Adverse Event|2
416877|NCT00603798|1395270|P1|Overall Study|Adverse Event|4
416878|NCT00603746|1395293|P6|Overall Study|Withdrawal by Subject|1
416879|NCT00603746|1395294|P5|Overall Study|Withdrawal by Subject|3
416880|NCT00603746|1395295|P4|Overall Study|Withdrawal by Subject|1
416881|NCT00603746|1395296|P3|Overall Study|Withdrawal by Subject|0
416882|NCT00603746|1395297|P2|Overall Study|Withdrawal by Subject|0
416883|NCT00603746|1395298|P1|Overall Study|Withdrawal by Subject|1
416884|NCT00603746|1395293|P6|Overall Study|Physician Decision|0
416885|NCT00603746|1395294|P5|Overall Study|Physician Decision|1
416886|NCT00603746|1395295|P4|Overall Study|Physician Decision|0
416887|NCT00603746|1395296|P3|Overall Study|Physician Decision|0
416888|NCT00603746|1395297|P2|Overall Study|Physician Decision|0
416889|NCT00603746|1395298|P1|Overall Study|Physician Decision|1
416890|NCT00603746|1395293|P6|Overall Study|Lost to Follow-up|0
416891|NCT00603746|1395294|P5|Overall Study|Lost to Follow-up|0
416892|NCT00603746|1395295|P4|Overall Study|Lost to Follow-up|0
416893|NCT00603746|1395296|P3|Overall Study|Lost to Follow-up|1
416894|NCT00603746|1395297|P2|Overall Study|Lost to Follow-up|1
416895|NCT00603746|1395298|P1|Overall Study|Lost to Follow-up|0
416896|NCT00603746|1395293|P6|Overall Study|Protocol Violation|0
416897|NCT00603746|1395294|P5|Overall Study|Protocol Violation|1
416898|NCT00603746|1395295|P4|Overall Study|Protocol Violation|0
416899|NCT00603746|1395296|P3|Overall Study|Protocol Violation|1
416900|NCT00603746|1395297|P2|Overall Study|Protocol Violation|3
416901|NCT00603746|1395298|P1|Overall Study|Protocol Violation|0
416902|NCT00603746|1395293|P6|Overall Study|Lack of Efficacy|8
416903|NCT00603746|1395294|P5|Overall Study|Lack of Efficacy|12
416904|NCT00603746|1395295|P4|Overall Study|Lack of Efficacy|11
416905|NCT00603746|1395296|P3|Overall Study|Lack of Efficacy|6
416906|NCT00603746|1395297|P2|Overall Study|Lack of Efficacy|11
416907|NCT00603746|1395298|P1|Overall Study|Lack of Efficacy|34
416908|NCT00603746|1395293|P6|Overall Study|Adverse Event|4
416909|NCT00603746|1395294|P5|Overall Study|Adverse Event|0
416910|NCT00603746|1395295|P4|Overall Study|Adverse Event|1
416911|NCT00603746|1395296|P3|Overall Study|Adverse Event|0
416912|NCT00603746|1395297|P2|Overall Study|Adverse Event|3
416913|NCT00603746|1395298|P1|Overall Study|Adverse Event|2
416914|NCT00603733|1395446|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
416915|NCT00603733|1395447|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
416916|NCT00603733|1395446|P2|Maintenance Phase ITT|Physician Decision|1
416917|NCT00603733|1395447|P1|Maintenance Phase ITT|Physician Decision|0
416918|NCT00603733|1395446|P2|Maintenance Phase ITT|Lack of Efficacy|2
416919|NCT00603733|1395447|P1|Maintenance Phase ITT|Lack of Efficacy|2
416920|NCT00603733|1395446|P2|Maintenance Phase ITT|Lost to Follow-up|1
416921|NCT00603733|1395447|P1|Maintenance Phase ITT|Lost to Follow-up|0
416922|NCT00603733|1395446|P2|Maintenance Phase ITT|Protocol Violation|1
416923|NCT00603733|1395447|P1|Maintenance Phase ITT|Protocol Violation|1
416924|NCT00603733|1395446|P2|Maintenance Phase ITT|Withdrawal by Subject|0
416925|NCT00603733|1395447|P1|Maintenance Phase ITT|Withdrawal by Subject|1
416926|NCT00603733|1395446|P2|Maintenance Phase ITT|Adverse Event|6
416927|NCT00603733|1395447|P1|Maintenance Phase ITT|Adverse Event|3
416928|NCT00603733|1395446|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
416929|NCT00603733|1395447|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
416930|NCT00603733|1395446|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
416931|NCT00603733|1395447|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
416932|NCT00603733|1395446|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
416933|NCT00603733|1395447|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
416934|NCT00603733|1395446|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
416935|NCT00603733|1395447|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
416936|NCT00603733|1395446|P2|Run-In Phase - 4 Weeks|Adverse Event|1
416937|NCT00603733|1395447|P1|Run-In Phase - 4 Weeks|Adverse Event|2
416938|NCT00603733|1395446|P2|Active Phase ITT|Subject moved, site closed|1
416939|NCT00603733|1395447|P1|Active Phase ITT|Subject moved, site closed|1
416940|NCT00603733|1395446|P2|Active Phase ITT|Lack of Efficacy|2
416941|NCT00603733|1395447|P1|Active Phase ITT|Lack of Efficacy|1
416942|NCT00603733|1395446|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
416943|NCT00603733|1395447|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
416944|NCT00603733|1395446|P2|Active Phase ITT|Lost to Follow-up|1
416945|NCT00603733|1395447|P1|Active Phase ITT|Lost to Follow-up|0
416946|NCT00603733|1395446|P2|Active Phase ITT|Withdrawal by Subject|3
416947|NCT00603733|1395447|P1|Active Phase ITT|Withdrawal by Subject|0
416948|NCT00603733|1395446|P2|Active Phase ITT|Adverse Event|7
416949|NCT00603733|1395447|P1|Active Phase ITT|Adverse Event|8
416950|NCT00603590|1395476|P2|Overall Study|Cardiovascular event|1
416951|NCT00603590|1395477|P1|Overall Study|Cardiovascular event|0
416952|NCT00603590|1395476|P2|Overall Study|Lost to Follow-up|4
416953|NCT00603590|1395477|P1|Overall Study|Lost to Follow-up|8
416954|NCT00603590|1395476|P2|Overall Study|Adverse Event|0
416955|NCT00603590|1395477|P1|Overall Study|Adverse Event|2
416956|NCT00603590|1395476|P2|Overall Study|Patient discontinued study drug|15
416957|NCT00603590|1395477|P1|Overall Study|Patient discontinued study drug|22
416958|NCT00603590|1395476|P2|Overall Study|Refused blood test|1
416959|NCT00603590|1395477|P1|Overall Study|Refused blood test|5
416960|NCT00603590|1395476|P2|Overall Study|Did not attend study clinic|30
416961|NCT00603590|1395477|P1|Overall Study|Did not attend study clinic|39
416962|NCT00603538|1395501|P3|Overall Study|Objective progression or relapse|0
416963|NCT00603538|1395502|P2|Overall Study|Objective progression or relapse|0
416964|NCT00603538|1395503|P1|Overall Study|Objective progression or relapse|3
416965|NCT00603538|1395501|P3|Overall Study|Adverse Event|2
416966|NCT00603538|1395502|P2|Overall Study|Adverse Event|4
416967|NCT00603538|1395503|P1|Overall Study|Adverse Event|0
416968|NCT00603525|1395543|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
416969|NCT00603525|1395544|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
416970|NCT00603525|1395545|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
416971|NCT00603525|1395543|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
416972|NCT00603525|1395544|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
416973|NCT00603525|1395545|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
416974|NCT00603525|1395543|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
416975|NCT00603525|1395544|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
416976|NCT00603525|1395545|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
416977|NCT00603525|1395543|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
416978|NCT00603525|1395544|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
416979|NCT00603525|1395545|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
416980|NCT00603525|1395543|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
416981|NCT00603525|1395544|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
416982|NCT00603525|1395545|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
416983|NCT00603525|1395543|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
416984|NCT00603525|1395544|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
416985|NCT00603525|1395545|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
416986|NCT00603525|1395543|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
416987|NCT00603525|1395544|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
416988|NCT00603525|1395545|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
416989|NCT00603525|1395543|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
416990|NCT00603525|1395544|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
416991|NCT00603525|1395545|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
416992|NCT00603525|1395543|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
416993|NCT00603525|1395544|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
416994|NCT00603525|1395545|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
416995|NCT00603525|1395543|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
416996|NCT00603525|1395544|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
416997|NCT00603525|1395545|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
416998|NCT00603525|1395543|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
416999|NCT00603525|1395544|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
417000|NCT00603525|1395545|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
417001|NCT00603525|1395543|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
417002|NCT00603525|1395544|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
417003|NCT00603525|1395545|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
417004|NCT00603525|1395543|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
417005|NCT00603525|1395544|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
417006|NCT00603525|1395545|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
417007|NCT00603525|1395543|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
417008|NCT00603525|1395544|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
417009|NCT00603525|1395545|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
417010|NCT00603525|1395543|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
417011|NCT00603525|1395544|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
417012|NCT00603525|1395545|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
417013|NCT00603512|1395677|P5|Overall Study|Randomized but not treated|0
417014|NCT00603512|1395678|P4|Overall Study|Randomized but not treated|2
417015|NCT00603512|1395679|P3|Overall Study|Randomized but not treated|1
417016|NCT00603512|1395680|P2|Overall Study|Randomized but not treated|1
417017|NCT00603512|1395681|P1|Overall Study|Randomized but not treated|0
417018|NCT00603512|1395677|P5|Overall Study|Withdrawal by Subject|1
417019|NCT00603512|1395678|P4|Overall Study|Withdrawal by Subject|0
417020|NCT00603512|1395679|P3|Overall Study|Withdrawal by Subject|0
417021|NCT00603512|1395680|P2|Overall Study|Withdrawal by Subject|0
417022|NCT00603512|1395681|P1|Overall Study|Withdrawal by Subject|0
417023|NCT00603512|1395677|P5|Overall Study|Other|1
417024|NCT00603512|1395678|P4|Overall Study|Other|1
417025|NCT00603512|1395679|P3|Overall Study|Other|0
417026|NCT00603512|1395680|P2|Overall Study|Other|1
417027|NCT00603512|1395681|P1|Overall Study|Other|2
417028|NCT00603512|1395677|P5|Overall Study|Lack of Efficacy|1
417029|NCT00603512|1395678|P4|Overall Study|Lack of Efficacy|0
417030|NCT00603512|1395679|P3|Overall Study|Lack of Efficacy|0
417031|NCT00603512|1395680|P2|Overall Study|Lack of Efficacy|1
417032|NCT00603512|1395681|P1|Overall Study|Lack of Efficacy|0
417033|NCT00603512|1395677|P5|Overall Study|Adverse Event|2
417034|NCT00603512|1395678|P4|Overall Study|Adverse Event|4
417035|NCT00603512|1395679|P3|Overall Study|Adverse Event|4
417036|NCT00603512|1395680|P2|Overall Study|Adverse Event|2
417037|NCT00603512|1395681|P1|Overall Study|Adverse Event|0
417038|NCT00603473|1395823|P1|Overall Study|Protocol Violation|1
417039|NCT00603473|1395823|P1|Overall Study|Lack of Efficacy|4
417040|NCT00603473|1395823|P1|Overall Study|Adverse Event|4
417041|NCT00603447|1395836|P7|Overall Study|Withdrew Consent|1
417042|NCT00603447|1395837|P6|Overall Study|Withdrew Consent|0
417043|NCT00603447|1395838|P5|Overall Study|Withdrew Consent|1
417044|NCT00603447|1395839|P4|Overall Study|Withdrew Consent|0
417045|NCT00603447|1395840|P3|Overall Study|Withdrew Consent|0
417046|NCT00603447|1395841|P2|Overall Study|Withdrew Consent|2
417047|NCT00603447|1395842|P1|Overall Study|Withdrew Consent|0
417048|NCT00603447|1395836|P7|Overall Study|Other|13
417049|NCT00603447|1395837|P6|Overall Study|Other|0
417050|NCT00603447|1395838|P5|Overall Study|Other|3
417051|NCT00603447|1395839|P4|Overall Study|Other|0
417052|NCT00603447|1395840|P3|Overall Study|Other|1
417053|NCT00603447|1395841|P2|Overall Study|Other|0
417054|NCT00603447|1395842|P1|Overall Study|Other|0
417055|NCT00603447|1395836|P7|Overall Study|Adverse Event|10
417056|NCT00603447|1395837|P6|Overall Study|Adverse Event|2
417057|NCT00603447|1395838|P5|Overall Study|Adverse Event|1
417058|NCT00603447|1395839|P4|Overall Study|Adverse Event|2
417059|NCT00603447|1395840|P3|Overall Study|Adverse Event|1
417060|NCT00603447|1395841|P2|Overall Study|Adverse Event|1
417061|NCT00603447|1395842|P1|Overall Study|Adverse Event|0
417062|NCT00603382|1395881|P6|Overall Study|Withdrawal by Subject|1
417063|NCT00603382|1395882|P5|Overall Study|Withdrawal by Subject|0
417064|NCT00603382|1395883|P4|Overall Study|Withdrawal by Subject|1
417065|NCT00603382|1395884|P3|Overall Study|Withdrawal by Subject|1
417066|NCT00603382|1395885|P2|Overall Study|Withdrawal by Subject|3
417067|NCT00603382|1395886|P1|Overall Study|Withdrawal by Subject|3
417068|NCT00603382|1395881|P6|Overall Study|Physician Decision|3
417069|NCT00603382|1395882|P5|Overall Study|Physician Decision|1
417070|NCT00603382|1395883|P4|Overall Study|Physician Decision|0
417071|NCT00603382|1395884|P3|Overall Study|Physician Decision|2
417072|NCT00603382|1395885|P2|Overall Study|Physician Decision|0
417073|NCT00603382|1395886|P1|Overall Study|Physician Decision|0
417074|NCT00603382|1395881|P6|Overall Study|Lost to Follow-up|1
417075|NCT00603382|1395882|P5|Overall Study|Lost to Follow-up|0
417076|NCT00603382|1395883|P4|Overall Study|Lost to Follow-up|1
417077|NCT00603382|1395884|P3|Overall Study|Lost to Follow-up|1
417078|NCT00603382|1395885|P2|Overall Study|Lost to Follow-up|1
417079|NCT00603382|1395886|P1|Overall Study|Lost to Follow-up|0
417080|NCT00603382|1395881|P6|Overall Study|Protocol Violation|0
417081|NCT00603382|1395882|P5|Overall Study|Protocol Violation|1
417082|NCT00603382|1395883|P4|Overall Study|Protocol Violation|2
417083|NCT00603382|1395884|P3|Overall Study|Protocol Violation|1
417084|NCT00603382|1395885|P2|Overall Study|Protocol Violation|0
417085|NCT00603382|1395886|P1|Overall Study|Protocol Violation|1
417086|NCT00603382|1395881|P6|Overall Study|Lack of Efficacy|11
417087|NCT00603382|1395882|P5|Overall Study|Lack of Efficacy|6
417088|NCT00603382|1395883|P4|Overall Study|Lack of Efficacy|6
417089|NCT00603382|1395884|P3|Overall Study|Lack of Efficacy|3
417090|NCT00603382|1395885|P2|Overall Study|Lack of Efficacy|9
417091|NCT00603382|1395886|P1|Overall Study|Lack of Efficacy|14
417092|NCT00603382|1395881|P6|Overall Study|Adverse Event|2
417093|NCT00603382|1395882|P5|Overall Study|Adverse Event|1
417094|NCT00603382|1395883|P4|Overall Study|Adverse Event|2
417095|NCT00603382|1395884|P3|Overall Study|Adverse Event|1
417096|NCT00603382|1395885|P2|Overall Study|Adverse Event|1
417097|NCT00603382|1395886|P1|Overall Study|Adverse Event|0
417098|NCT00603304|1396034|P2|Overall Study|Patient Decision|0
417099|NCT00603304|1396035|P1|Overall Study|Patient Decision|2
417100|NCT00603304|1396034|P2|Overall Study|Not Specified|0
417101|NCT00603304|1396035|P1|Overall Study|Not Specified|2
417102|NCT00603304|1396034|P2|Overall Study|Moved Away|2
417103|NCT00603304|1396035|P1|Overall Study|Moved Away|0
417104|NCT00603304|1396034|P2|Overall Study|Non-Compliant|1
417105|NCT00603304|1396035|P1|Overall Study|Non-Compliant|0
417106|NCT00603304|1396034|P2|Overall Study|Exclusionary Medication|3
417107|NCT00603304|1396035|P1|Overall Study|Exclusionary Medication|2
417108|NCT00603304|1396034|P2|Overall Study|Crossed Over to Open Label Therapy|3
417109|NCT00603304|1396035|P1|Overall Study|Crossed Over to Open Label Therapy|3
417110|NCT00603304|1396034|P2|Overall Study|Unacceptable Treatment Toxicity|8
417111|NCT00603304|1396035|P1|Overall Study|Unacceptable Treatment Toxicity|5
417112|NCT00603304|1396034|P2|Overall Study|Adverse Event|2
417113|NCT00603304|1396035|P1|Overall Study|Adverse Event|4
417114|NCT00603304|1396034|P2|Overall Study|Protocol Violation|0
417115|NCT00603304|1396035|P1|Overall Study|Protocol Violation|1
417116|NCT00603304|1396034|P2|Overall Study|Withdrawal by Subject|5
417117|NCT00603304|1396035|P1|Overall Study|Withdrawal by Subject|8
417118|NCT00603304|1396034|P2|Overall Study|Lost to Follow-up|7
417119|NCT00603304|1396035|P1|Overall Study|Lost to Follow-up|5
417120|NCT00603278|1396091|P6|Overall Study|Lost to Follow-up|0
417121|NCT00603278|1396092|P5|Overall Study|Lost to Follow-up|1
417122|NCT00603278|1396093|P4|Overall Study|Lost to Follow-up|0
417123|NCT00603278|1396094|P3|Overall Study|Lost to Follow-up|0
417124|NCT00603278|1396095|P2|Overall Study|Lost to Follow-up|0
417125|NCT00603278|1396096|P1|Overall Study|Lost to Follow-up|1
417126|NCT00603278|1396091|P6|Overall Study|Physician Decision|1
417127|NCT00603278|1396092|P5|Overall Study|Physician Decision|2
417128|NCT00603278|1396093|P4|Overall Study|Physician Decision|0
417129|NCT00603278|1396094|P3|Overall Study|Physician Decision|0
417130|NCT00603278|1396095|P2|Overall Study|Physician Decision|1
417131|NCT00603278|1396096|P1|Overall Study|Physician Decision|0
417132|NCT00603278|1396091|P6|Overall Study|Protocol Violation|1
417133|NCT00603278|1396092|P5|Overall Study|Protocol Violation|0
417134|NCT00603278|1396093|P4|Overall Study|Protocol Violation|1
417135|NCT00603278|1396094|P3|Overall Study|Protocol Violation|1
417136|NCT00603278|1396095|P2|Overall Study|Protocol Violation|0
417137|NCT00603278|1396096|P1|Overall Study|Protocol Violation|3
417138|NCT00603278|1396091|P6|Overall Study|Withdrawal by Subject|2
417139|NCT00603278|1396092|P5|Overall Study|Withdrawal by Subject|1
417140|NCT00603278|1396093|P4|Overall Study|Withdrawal by Subject|2
417141|NCT00603278|1396094|P3|Overall Study|Withdrawal by Subject|1
417142|NCT00603278|1396095|P2|Overall Study|Withdrawal by Subject|3
417143|NCT00603278|1396096|P1|Overall Study|Withdrawal by Subject|2
417144|NCT00603278|1396091|P6|Overall Study|Adverse Event|1
417145|NCT00603278|1396092|P5|Overall Study|Adverse Event|2
417146|NCT00603278|1396093|P4|Overall Study|Adverse Event|0
417147|NCT00603278|1396094|P3|Overall Study|Adverse Event|1
417148|NCT00603278|1396095|P2|Overall Study|Adverse Event|3
417149|NCT00603278|1396096|P1|Overall Study|Adverse Event|0
417150|NCT00603278|1396091|P6|Overall Study|Lack of Efficacy|14
417151|NCT00603278|1396092|P5|Overall Study|Lack of Efficacy|7
417152|NCT00603278|1396093|P4|Overall Study|Lack of Efficacy|8
417153|NCT00603278|1396094|P3|Overall Study|Lack of Efficacy|11
417154|NCT00603278|1396095|P2|Overall Study|Lack of Efficacy|10
417155|NCT00603278|1396096|P1|Overall Study|Lack of Efficacy|35
417156|NCT00603265|1396245|P3|Overall Study|Protocol Violation|0
417157|NCT00603265|1396246|P2|Overall Study|Protocol Violation|0
417158|NCT00603265|1396247|P1|Overall Study|Protocol Violation|1
417159|NCT00603265|1396245|P3|Overall Study|Participant Left Country, No Responses|0
417160|NCT00603265|1396246|P2|Overall Study|Participant Left Country, No Responses|1
417161|NCT00603265|1396247|P1|Overall Study|Participant Left Country, No Responses|0
417162|NCT00603265|1396245|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
417163|NCT00603265|1396246|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
417164|NCT00603265|1396247|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
417165|NCT00603265|1396245|P3|Overall Study|Lost to Follow-up|0
417166|NCT00603265|1396246|P2|Overall Study|Lost to Follow-up|1
417167|NCT00603265|1396247|P1|Overall Study|Lost to Follow-up|0
417168|NCT00603265|1396245|P3|Overall Study|Lack of Efficacy|3
417169|NCT00603265|1396246|P2|Overall Study|Lack of Efficacy|0
417170|NCT00603265|1396247|P1|Overall Study|Lack of Efficacy|3
417171|NCT00603265|1396245|P3|Overall Study|Withdrawal by Subject|1
417172|NCT00603265|1396246|P2|Overall Study|Withdrawal by Subject|2
417173|NCT00603265|1396247|P1|Overall Study|Withdrawal by Subject|1
417174|NCT00603265|1396245|P3|Overall Study|Adverse Event|1
417175|NCT00603265|1396246|P2|Overall Study|Adverse Event|11
417176|NCT00603265|1396247|P1|Overall Study|Adverse Event|2
417177|NCT00603239|1396275|P2|Overall Study|Subject decision|1
417178|NCT00603239|1396276|P1|Overall Study|Subject decision|2
417179|NCT00603239|1396275|P2|Overall Study|Protocol Violation|0
417180|NCT00603239|1396276|P1|Overall Study|Protocol Violation|2
417181|NCT00603239|1396275|P2|Overall Study|Physician Decision|0
417182|NCT00603239|1396276|P1|Overall Study|Physician Decision|2
417183|NCT00603239|1396275|P2|Overall Study|Lost to Follow-up|1
417184|NCT00603239|1396276|P1|Overall Study|Lost to Follow-up|2
417185|NCT00603239|1396275|P2|Overall Study|Loss of glucose control|0
417186|NCT00603239|1396276|P1|Overall Study|Loss of glucose control|3
417187|NCT00603239|1396275|P2|Overall Study|Entry criteria not met|1
417188|NCT00603239|1396276|P1|Overall Study|Entry criteria not met|0
417189|NCT00603239|1396275|P2|Overall Study|Adverse Event|1
417190|NCT00603239|1396276|P1|Overall Study|Adverse Event|4
417191|NCT00602979|1396337|P5|Overall Study|Failed Intubation|0
417192|NCT00602979|1396338|P4|Overall Study|Failed Intubation|1
417193|NCT00602979|1396339|P3|Overall Study|Failed Intubation|0
417194|NCT00602979|1396340|P2|Overall Study|Failed Intubation|1
417195|NCT00602979|1396341|P1|Overall Study|Failed Intubation|0
417196|NCT00602979|1396337|P5|Overall Study|Lost to Follow-up|3
417197|NCT00602979|1396338|P4|Overall Study|Lost to Follow-up|2
417198|NCT00602979|1396339|P3|Overall Study|Lost to Follow-up|3
417199|NCT00602979|1396340|P2|Overall Study|Lost to Follow-up|2
417200|NCT00602979|1396341|P1|Overall Study|Lost to Follow-up|3
417201|NCT00602927|1396391|P2|Period 3: 13 Days|MRI data quality|2
417202|NCT00602927|1396392|P1|Period 3: 13 Days|MRI data quality|2
417203|NCT00602927|1396391|P2|Period 3: 13 Days|Protocol Violation|1
417204|NCT00602927|1396392|P1|Period 3: 13 Days|Protocol Violation|0
417205|NCT00602927|1396391|P2|Period 2: 14 Days|Protocol Violation|2
417206|NCT00602927|1396392|P1|Period 2: 14 Days|Protocol Violation|0
417207|NCT00602927|1396391|P2|Period 1: 13 Days|Claustrophobia|1
417208|NCT00602927|1396392|P1|Period 1: 13 Days|Claustrophobia|0
417209|NCT00602927|1396391|P2|Period 1: 13 Days|Time|0
417210|NCT00602927|1396392|P1|Period 1: 13 Days|Time|1
417211|NCT00602927|1396391|P2|Period 1: 13 Days|MRI scanner technical issue|0
417212|NCT00602927|1396392|P1|Period 1: 13 Days|MRI scanner technical issue|1
417213|NCT00602927|1396391|P2|Period 1: 13 Days|Protocol Violation|4
417214|NCT00602927|1396392|P1|Period 1: 13 Days|Protocol Violation|2
417215|NCT00602797|1396404|P1|Overall Study|Adverse Event|1
417216|NCT00602641|1396421|P2|Overall Study|Other|1
417217|NCT00602641|1396422|P1|Overall Study|Other|3
417218|NCT00602641|1396421|P2|Overall Study|Administrative Closure|1
417219|NCT00602641|1396422|P1|Overall Study|Administrative Closure|1
417220|NCT00602641|1396421|P2|Overall Study|Physician Decision|4
417221|NCT00602641|1396422|P1|Overall Study|Physician Decision|5
417222|NCT00602641|1396421|P2|Overall Study|Other Complicating Disease|2
417223|NCT00602641|1396422|P1|Overall Study|Other Complicating Disease|5
417224|NCT00602641|1396421|P2|Overall Study|Alternative therapy|2
417225|NCT00602641|1396422|P1|Overall Study|Alternative therapy|5
417226|NCT00602641|1396421|P2|Overall Study|Withdrawal by Subject|12
417227|NCT00602641|1396422|P1|Overall Study|Withdrawal by Subject|15
417228|NCT00602641|1396421|P2|Overall Study|Death|5
417229|NCT00602641|1396422|P1|Overall Study|Death|6
417230|NCT00602641|1396421|P2|Overall Study|Disease progression|55
417231|NCT00602641|1396422|P1|Overall Study|Disease progression|38
417232|NCT00602641|1396421|P2|Overall Study|Adverse Event|53
417233|NCT00602641|1396422|P1|Overall Study|Adverse Event|62
417234|NCT00602641|1396421|P2|Overall Study|Still on treatment at time of analysis|15
417235|NCT00602641|1396422|P1|Overall Study|Still on treatment at time of analysis|8
417236|NCT00602641|1396421|P2|Overall Study|Never started protocol therapy|2
417237|NCT00602641|1396422|P1|Overall Study|Never started protocol therapy|6
417238|NCT00602537|1396436|P2|Follow Up Study Comparison|Withdrawal by Subject|2
417239|NCT00602537|1396437|P1|Follow Up Study Comparison|Withdrawal by Subject|2
417240|NCT00602537|1396436|P2|Follow Up Study Comparison|Lost to Follow-up|1
417241|NCT00602537|1396437|P1|Follow Up Study Comparison|Lost to Follow-up|8
417242|NCT00602537|1396436|P2|Follow Up Study Comparison|Adverse Event|0
417243|NCT00602537|1396437|P1|Follow Up Study Comparison|Adverse Event|1
417244|NCT00602537|1396436|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
417245|NCT00602537|1396437|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
417246|NCT00602537|1396436|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
417247|NCT00602537|1396437|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
417248|NCT00602537|1396436|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
417249|NCT00602537|1396437|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
417250|NCT00602537|1396436|P2|12 Week Double Blind Comparison|Adverse Event|5
417251|NCT00602537|1396437|P1|12 Week Double Blind Comparison|Adverse Event|2
417252|NCT00602472|1396447|P2|Overall Study|Other incl. lack of efficacy|2
417253|NCT00602472|1396448|P1|Overall Study|Other incl. lack of efficacy|4
417254|NCT00602472|1396447|P2|Overall Study|Withdrawal by Subject|14
417255|NCT00602472|1396448|P1|Overall Study|Withdrawal by Subject|8
417256|NCT00602472|1396447|P2|Overall Study|Protocol Violation|19
417257|NCT00602472|1396448|P1|Overall Study|Protocol Violation|4
417258|NCT00602472|1396447|P2|Overall Study|Adverse Event|23
417259|NCT00602472|1396448|P1|Overall Study|Adverse Event|5
417260|NCT00602420|1396508|P2|Overall Study|Adverse Event|0
417261|NCT00602420|1396509|P1|Overall Study|Adverse Event|1
417262|NCT00602420|1396508|P2|Overall Study|Withdrawal by Subject|17
417263|NCT00602420|1396509|P1|Overall Study|Withdrawal by Subject|18
417264|NCT00602420|1396508|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
417265|NCT00602420|1396509|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
417266|NCT00602420|1396508|P2|Overall Study|Death|4
417267|NCT00602420|1396509|P1|Overall Study|Death|1
417268|NCT00601900|1396617|P2|Overall Study|Withdrawal by Subject|3
417269|NCT00601900|1396618|P1|Overall Study|Withdrawal by Subject|0
417270|NCT00601835|1396634|P2|Overall Study|Relocate|2
417271|NCT00601835|1396635|P1|Overall Study|Relocate|12
417272|NCT00601835|1396634|P2|Overall Study|Adverse Event|1
417273|NCT00601835|1396635|P1|Overall Study|Adverse Event|1
417274|NCT00601835|1396634|P2|Overall Study|Lost to Follow-up|5
417275|NCT00601835|1396635|P1|Overall Study|Lost to Follow-up|37
417276|NCT00601835|1396634|P2|Overall Study|Physician Decision|0
417277|NCT00601835|1396635|P1|Overall Study|Physician Decision|1
417278|NCT00601835|1396634|P2|Overall Study|Withdrawal by Subject|6
417279|NCT00601835|1396635|P1|Overall Study|Withdrawal by Subject|9
417280|NCT00601640|1396727|P3|Overall Study|change in eligibility status|1
417281|NCT00601640|1396728|P2|Overall Study|change in eligibility status|1
417282|NCT00601640|1396729|P1|Overall Study|change in eligibility status|0
417283|NCT00601640|1396727|P3|Overall Study|intercurrent illness|0
417284|NCT00601640|1396728|P2|Overall Study|intercurrent illness|0
417285|NCT00601640|1396729|P1|Overall Study|intercurrent illness|1
417286|NCT00601640|1396727|P3|Overall Study|Adverse Event|2
417287|NCT00601640|1396728|P2|Overall Study|Adverse Event|4
417288|NCT00601640|1396729|P1|Overall Study|Adverse Event|0
417289|NCT00601640|1396727|P3|Overall Study|Death|0
417290|NCT00601640|1396728|P2|Overall Study|Death|0
417291|NCT00601640|1396729|P1|Overall Study|Death|1
417292|NCT00601640|1396727|P3|Overall Study|Withdrawal by Subject|7
417293|NCT00601640|1396728|P2|Overall Study|Withdrawal by Subject|0
417294|NCT00601640|1396729|P1|Overall Study|Withdrawal by Subject|3
417295|NCT00601523|1396754|P2|Overall Study|not specified|1
417296|NCT00601523|1396755|P1|Overall Study|not specified|9
417297|NCT00601523|1396754|P2|Overall Study|Withdrawal by Subject|9
417298|NCT00601523|1396755|P1|Overall Study|Withdrawal by Subject|18
417299|NCT00601523|1396754|P2|Overall Study|Lost to Follow-up|1
417300|NCT00601523|1396755|P1|Overall Study|Lost to Follow-up|0
417301|NCT00601523|1396754|P2|Overall Study|Protocol Violation|1
417302|NCT00601523|1396755|P1|Overall Study|Protocol Violation|5
417303|NCT00601523|1396754|P2|Overall Study|Lack of Efficacy|0
417304|NCT00601523|1396755|P1|Overall Study|Lack of Efficacy|3
417305|NCT00601523|1396754|P2|Overall Study|Adverse Event|14
417306|NCT00601523|1396755|P1|Overall Study|Adverse Event|42
417307|NCT00601458|1396790|P3|Overall Study|Early Termination|1
417308|NCT00601458|1396791|P2|Overall Study|Early Termination|1
417309|NCT00601458|1396792|P1|Overall Study|Early Termination|0
417310|NCT00601458|1396790|P3|Overall Study|Protocol Violation|1
417311|NCT00601458|1396791|P2|Overall Study|Protocol Violation|2
417312|NCT00601458|1396792|P1|Overall Study|Protocol Violation|3
417313|NCT00601458|1396790|P3|Overall Study|Incomplete Data|0
417314|NCT00601458|1396791|P2|Overall Study|Incomplete Data|2
417315|NCT00601458|1396792|P1|Overall Study|Incomplete Data|0
417316|NCT00601458|1396790|P3|Overall Study|Dosing Error|0
417317|NCT00601458|1396791|P2|Overall Study|Dosing Error|0
417318|NCT00601458|1396792|P1|Overall Study|Dosing Error|1
417319|NCT00601419|1396803|P1|Overall Study|Missed Visits|1
417320|NCT00601419|1396803|P1|Overall Study|Lost to Follow-up|3
417321|NCT00601354|1396833|P2|Overall Study|Lost to Follow-up|5
417322|NCT00601354|1396834|P1|Overall Study|Lost to Follow-up|4
417323|NCT00601250|1396846|P2|Overall Study|Other incl. lack of efficacy|9
417324|NCT00601250|1396847|P1|Overall Study|Other incl. lack of efficacy|2
417325|NCT00601250|1396846|P2|Overall Study|Withdrawal by Subject|13
417326|NCT00601250|1396847|P1|Overall Study|Withdrawal by Subject|4
417327|NCT00601250|1396846|P2|Overall Study|Lost to Follow-up|6
417328|NCT00601250|1396847|P1|Overall Study|Lost to Follow-up|2
417329|NCT00601250|1396846|P2|Overall Study|Protocol Violation|2
417330|NCT00601250|1396847|P1|Overall Study|Protocol Violation|3
417331|NCT00601250|1396846|P2|Overall Study|Adverse Event|9
417332|NCT00601250|1396847|P1|Overall Study|Adverse Event|3
417333|NCT00601172|1396883|P2|Overall Study|Did not meet continuation criteria|20
417334|NCT00601172|1396884|P1|Overall Study|Did not meet continuation criteria|19
417335|NCT00601172|1396883|P2|Overall Study|Withdrawal by Subject|27
417336|NCT00601172|1396884|P1|Overall Study|Withdrawal by Subject|35
417337|NCT00601172|1396883|P2|Overall Study|Physician Decision|28
417338|NCT00601172|1396884|P1|Overall Study|Physician Decision|27
417339|NCT00601172|1396883|P2|Overall Study|Lost to Follow-up|3
417340|NCT00601172|1396884|P1|Overall Study|Lost to Follow-up|4
417341|NCT00601172|1396883|P2|Overall Study|Protocol Violation|5
417342|NCT00601172|1396884|P1|Overall Study|Protocol Violation|2
417343|NCT00601172|1396883|P2|Overall Study|Lack of Efficacy|12
417344|NCT00601172|1396884|P1|Overall Study|Lack of Efficacy|11
417345|NCT00601172|1396883|P2|Overall Study|Adverse Event|32
417346|NCT00601172|1396884|P1|Overall Study|Adverse Event|43
417347|NCT00601107|1396941|P4|Overall Study|Undefined|0
417348|NCT00601107|1396942|P3|Overall Study|Undefined|1
417349|NCT00601107|1396943|P2|Overall Study|Undefined|0
417350|NCT00601107|1396944|P1|Overall Study|Undefined|1
417351|NCT00601107|1396941|P4|Overall Study|Worsening of Psoriasis|4
417352|NCT00601107|1396942|P3|Overall Study|Worsening of Psoriasis|1
417353|NCT00601107|1396943|P2|Overall Study|Worsening of Psoriasis|1
417354|NCT00601107|1396944|P1|Overall Study|Worsening of Psoriasis|4
417355|NCT00601107|1396941|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
417356|NCT00601107|1396942|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
417357|NCT00601107|1396943|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
417358|NCT00601107|1396944|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
417359|NCT00601107|1396941|P4|Overall Study|Lost to Follow-up|3
417360|NCT00601107|1396942|P3|Overall Study|Lost to Follow-up|0
417361|NCT00601107|1396943|P2|Overall Study|Lost to Follow-up|3
417362|NCT00601107|1396944|P1|Overall Study|Lost to Follow-up|3
417363|NCT00601107|1396941|P4|Overall Study|Withdrawal by Subject|4
417364|NCT00601107|1396942|P3|Overall Study|Withdrawal by Subject|7
417365|NCT00601107|1396943|P2|Overall Study|Withdrawal by Subject|4
417366|NCT00601107|1396944|P1|Overall Study|Withdrawal by Subject|5
417367|NCT00601107|1396941|P4|Overall Study|Adverse Event|0
417368|NCT00601107|1396942|P3|Overall Study|Adverse Event|3
417369|NCT00601107|1396943|P2|Overall Study|Adverse Event|1
417370|NCT00601107|1396944|P1|Overall Study|Adverse Event|0
417371|NCT00600938|1396964|P4|Extension Study|Death|0
417372|NCT00600938|1396965|P3|Extension Study|Death|0
417373|NCT00600938|1396966|P2|Extension Study|Death|0
417374|NCT00600938|1396967|P1|Extension Study|Death|1
417375|NCT00600938|1396964|P4|Extension Study|Lost to Follow-up|0
417376|NCT00600938|1396965|P3|Extension Study|Lost to Follow-up|2
417377|NCT00600938|1396966|P2|Extension Study|Lost to Follow-up|1
417378|NCT00600938|1396967|P1|Extension Study|Lost to Follow-up|1
417379|NCT00600938|1396964|P4|Extension Study|Withdrawal by Subject|0
417380|NCT00600938|1396965|P3|Extension Study|Withdrawal by Subject|3
417381|NCT00600938|1396966|P2|Extension Study|Withdrawal by Subject|2
417382|NCT00600938|1396967|P1|Extension Study|Withdrawal by Subject|2
417383|NCT00600938|1396964|P4|Extension Study|Unsatisfactory therapeutic effect|0
417384|NCT00600938|1396965|P3|Extension Study|Unsatisfactory therapeutic effect|1
417385|NCT00600938|1396966|P2|Extension Study|Unsatisfactory therapeutic effect|1
417386|NCT00600938|1396967|P1|Extension Study|Unsatisfactory therapeutic effect|4
417387|NCT00600938|1396964|P4|Extension Study|Abnormal test procedure results|1
417388|NCT00600938|1396965|P3|Extension Study|Abnormal test procedure results|1
417389|NCT00600938|1396966|P2|Extension Study|Abnormal test procedure results|1
417390|NCT00600938|1396967|P1|Extension Study|Abnormal test procedure results|0
417391|NCT00600938|1396964|P4|Extension Study|Adverse Event|0
417392|NCT00600938|1396965|P3|Extension Study|Adverse Event|2
417393|NCT00600938|1396966|P2|Extension Study|Adverse Event|0
417394|NCT00600938|1396967|P1|Extension Study|Adverse Event|1
417395|NCT00600938|1396964|P4|Core Study|Protocol Violation|0
417396|NCT00600938|1396965|P3|Core Study|Protocol Violation|0
417397|NCT00600938|1396966|P2|Core Study|Protocol Violation|2
417398|NCT00600938|1396967|P1|Core Study|Protocol Violation|1
417399|NCT00600938|1396964|P4|Core Study|Death|0
417400|NCT00600938|1396965|P3|Core Study|Death|0
417401|NCT00600938|1396966|P2|Core Study|Death|1
417402|NCT00600938|1396967|P1|Core Study|Death|1
417403|NCT00600938|1396964|P4|Core Study|Lost to Follow-up|0
417404|NCT00600938|1396965|P3|Core Study|Lost to Follow-up|0
417405|NCT00600938|1396966|P2|Core Study|Lost to Follow-up|2
417406|NCT00600938|1396967|P1|Core Study|Lost to Follow-up|3
417407|NCT00600938|1396964|P4|Core Study|Patient withdrew consent|0
417408|NCT00600938|1396965|P3|Core Study|Patient withdrew consent|0
417409|NCT00600938|1396966|P2|Core Study|Patient withdrew consent|12
417410|NCT00600938|1396967|P1|Core Study|Patient withdrew consent|7
417411|NCT00600938|1396964|P4|Core Study|Unsatisfactory therapeutic effect|0
417412|NCT00600938|1396965|P3|Core Study|Unsatisfactory therapeutic effect|0
417413|NCT00600938|1396966|P2|Core Study|Unsatisfactory therapeutic effect|2
417414|NCT00600938|1396967|P1|Core Study|Unsatisfactory therapeutic effect|1
417415|NCT00600938|1396964|P4|Core Study|Abnormal test procedure result(s)|0
417416|NCT00600938|1396965|P3|Core Study|Abnormal test procedure result(s)|0
417417|NCT00600938|1396966|P2|Core Study|Abnormal test procedure result(s)|2
417418|NCT00600938|1396967|P1|Core Study|Abnormal test procedure result(s)|3
417419|NCT00600886|1397031|P2|Extension - After Crossover (CAS)|Death|0
417420|NCT00600886|1397032|P1|Extension - After Crossover (CAS)|Death|1
417421|NCT00600886|1397031|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
417422|NCT00600886|1397032|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
417423|NCT00600886|1397031|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
417424|NCT00600886|1397032|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
417425|NCT00600886|1397031|P2|Extension - After Crossover (CAS)|Administrative Problems|4
417426|NCT00600886|1397032|P1|Extension - After Crossover (CAS)|Administrative Problems|4
417427|NCT00600886|1397031|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
417428|NCT00600886|1397032|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
417429|NCT00600886|1397031|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
417430|NCT00600886|1397032|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
417431|NCT00600886|1397031|P2|Extension - After Crossover (CAS)|Adverse Event|1
417432|NCT00600886|1397032|P1|Extension - After Crossover (CAS)|Adverse Event|19
417433|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
417434|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
417435|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Death|1
417436|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Death|1
417437|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
417438|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
417439|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Adverse Event|1
417440|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Adverse Event|4
417441|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
417442|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
417443|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
417444|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
417445|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
417446|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
417447|NCT00600886|1397031|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
417448|NCT00600886|1397032|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
417449|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Death|1
417450|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Death|0
417451|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
417452|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
417453|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
417454|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
417455|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
417456|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
417457|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
417458|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
417459|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
417460|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
417461|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
417462|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
417463|NCT00600886|1397031|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
417464|NCT00600886|1397032|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
417465|NCT00600821|1397096|P2|Overall Study|Other|3
417466|NCT00600821|1397097|P1|Overall Study|Other|2
417467|NCT00600821|1397096|P2|Overall Study|Randomized but not treated|1
417468|NCT00600821|1397097|P1|Overall Study|Randomized but not treated|0
417469|NCT00600821|1397096|P2|Overall Study|Objective progression or relapse|1
417470|NCT00600821|1397097|P1|Overall Study|Objective progression or relapse|0
417471|NCT00600821|1397096|P2|Overall Study|Terminated by sponsor|6
417472|NCT00600821|1397097|P1|Overall Study|Terminated by sponsor|8
417473|NCT00600821|1397096|P2|Overall Study|Withdrawal by Subject|1
417474|NCT00600821|1397097|P1|Overall Study|Withdrawal by Subject|1
417475|NCT00600821|1397096|P2|Overall Study|Lost to Follow-up|2
417476|NCT00600821|1397097|P1|Overall Study|Lost to Follow-up|2
417477|NCT00600821|1397096|P2|Overall Study|Death|46
417478|NCT00600821|1397097|P1|Overall Study|Death|45
417479|NCT00600756|1397125|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
417480|NCT00600756|1397126|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
417481|NCT00600756|1397125|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
417482|NCT00600756|1397126|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
417483|NCT00600756|1397125|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
417484|NCT00600756|1397126|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
417485|NCT00600756|1397125|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
417486|NCT00600756|1397126|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
417487|NCT00600756|1397125|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
417488|NCT00600756|1397126|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
417489|NCT00600756|1397125|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
417490|NCT00600756|1397126|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
417491|NCT00600756|1397125|P2|Overall Study Analysis After 12 Months|Adverse Event|44
417492|NCT00600756|1397126|P1|Overall Study Analysis After 12 Months|Adverse Event|53
417493|NCT00600756|1397125|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
417494|NCT00600756|1397126|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
417495|NCT00600756|1397125|P2|Analysis After 6 Months|Lost to Follow-up|8
417496|NCT00600756|1397126|P1|Analysis After 6 Months|Lost to Follow-up|10
417497|NCT00600756|1397125|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
417498|NCT00600756|1397126|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
417499|NCT00600756|1397125|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
417500|NCT00600756|1397126|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
417501|NCT00600756|1397125|P2|Analysis After 6 Months|Incorrect Enrollment|21
417502|NCT00600756|1397126|P1|Analysis After 6 Months|Incorrect Enrollment|12
417503|NCT00600756|1397125|P2|Analysis After 6 Months|Withdrawal by Subject|30
417504|NCT00600756|1397126|P1|Analysis After 6 Months|Withdrawal by Subject|38
417505|NCT00600756|1397125|P2|Analysis After 6 Months|Adverse Event|33
417506|NCT00600756|1397126|P1|Analysis After 6 Months|Adverse Event|43
417507|NCT00600613|1397235|P1|Overall Study|Protocol Deviation|1
417508|NCT00600353|1397241|P2|Overall Study|History of prepartive regimen|1
417509|NCT00600353|1397242|P1|Overall Study|History of prepartive regimen|0
417510|NCT00600353|1397241|P2|Overall Study|history of malignancy within 5 years|0
417511|NCT00600353|1397242|P1|Overall Study|history of malignancy within 5 years|1
417512|NCT00600171|1397260|P6|Overall Study|Lost to Follow-up|0
417513|NCT00600171|1397261|P5|Overall Study|Lost to Follow-up|0
417514|NCT00600171|1397262|P4|Overall Study|Lost to Follow-up|1
417515|NCT00600171|1397263|P3|Overall Study|Lost to Follow-up|0
417516|NCT00600171|1397264|P2|Overall Study|Lost to Follow-up|0
417517|NCT00600171|1397265|P1|Overall Study|Lost to Follow-up|0
417518|NCT00600171|1397260|P6|Overall Study|Physician Decision|2
417519|NCT00600171|1397261|P5|Overall Study|Physician Decision|0
417520|NCT00600171|1397262|P4|Overall Study|Physician Decision|1
417521|NCT00600171|1397263|P3|Overall Study|Physician Decision|0
417522|NCT00600171|1397264|P2|Overall Study|Physician Decision|1
417523|NCT00600171|1397265|P1|Overall Study|Physician Decision|0
417524|NCT00600171|1397260|P6|Overall Study|Withdrawal by Subject|1
417525|NCT00600171|1397261|P5|Overall Study|Withdrawal by Subject|1
417526|NCT00600171|1397262|P4|Overall Study|Withdrawal by Subject|1
417527|NCT00600171|1397263|P3|Overall Study|Withdrawal by Subject|0
417528|NCT00600171|1397264|P2|Overall Study|Withdrawal by Subject|0
417529|NCT00600171|1397265|P1|Overall Study|Withdrawal by Subject|3
417530|NCT00600171|1397260|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
417531|NCT00600171|1397261|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
417532|NCT00600171|1397262|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
417533|NCT00600171|1397263|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
417534|NCT00600171|1397264|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
417535|NCT00600171|1397265|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
417536|NCT00600171|1397260|P6|Overall Study|Protocol Violation|0
417537|NCT00600171|1397261|P5|Overall Study|Protocol Violation|0
417538|NCT00600171|1397262|P4|Overall Study|Protocol Violation|1
417539|NCT00600171|1397263|P3|Overall Study|Protocol Violation|0
417540|NCT00600171|1397264|P2|Overall Study|Protocol Violation|2
417541|NCT00600171|1397265|P1|Overall Study|Protocol Violation|1
417542|NCT00600171|1397260|P6|Overall Study|Lack of Efficacy|0
417543|NCT00600171|1397261|P5|Overall Study|Lack of Efficacy|4
417544|NCT00600171|1397262|P4|Overall Study|Lack of Efficacy|5
417545|NCT00600171|1397263|P3|Overall Study|Lack of Efficacy|3
417546|NCT00600171|1397264|P2|Overall Study|Lack of Efficacy|12
417547|NCT00600171|1397265|P1|Overall Study|Lack of Efficacy|9
417548|NCT00600171|1397260|P6|Overall Study|Adverse Event|0
417549|NCT00600171|1397261|P5|Overall Study|Adverse Event|1
417550|NCT00600171|1397262|P4|Overall Study|Adverse Event|0
417551|NCT00600171|1397263|P3|Overall Study|Adverse Event|0
417552|NCT00600171|1397264|P2|Overall Study|Adverse Event|1
417553|NCT00600171|1397265|P1|Overall Study|Adverse Event|0
417554|NCT00600119|1397339|P6|Follow-up Period|Other|0
417555|NCT00600119|1397340|P5|Follow-up Period|Other|0
417556|NCT00600119|1397341|P4|Follow-up Period|Other|0
417557|NCT00600119|1397342|P3|Follow-up Period|Other|0
417558|NCT00600119|1397343|P2|Follow-up Period|Other|0
417559|NCT00600119|1397344|P1|Follow-up Period|Other|1
417560|NCT00600119|1397339|P6|Follow-up Period|Adverse Event|1
417561|NCT00600119|1397340|P5|Follow-up Period|Adverse Event|0
417562|NCT00600119|1397341|P4|Follow-up Period|Adverse Event|0
417563|NCT00600119|1397342|P3|Follow-up Period|Adverse Event|0
417564|NCT00600119|1397343|P2|Follow-up Period|Adverse Event|0
417565|NCT00600119|1397344|P1|Follow-up Period|Adverse Event|0
417566|NCT00600119|1397339|P6|Double-blind Treatment Period|Adverse Event|10
417567|NCT00600119|1397340|P5|Double-blind Treatment Period|Adverse Event|2
417568|NCT00600119|1397341|P4|Double-blind Treatment Period|Adverse Event|1
417569|NCT00600119|1397342|P3|Double-blind Treatment Period|Adverse Event|0
417570|NCT00600119|1397343|P2|Double-blind Treatment Period|Adverse Event|1
417571|NCT00600119|1397344|P1|Double-blind Treatment Period|Adverse Event|1
417572|NCT00600119|1397339|P6|Double-blind Treatment Period|Lost to Follow-up|0
417573|NCT00600119|1397340|P5|Double-blind Treatment Period|Lost to Follow-up|0
417574|NCT00600119|1397341|P4|Double-blind Treatment Period|Lost to Follow-up|0
417575|NCT00600119|1397342|P3|Double-blind Treatment Period|Lost to Follow-up|0
417576|NCT00600119|1397343|P2|Double-blind Treatment Period|Lost to Follow-up|1
417577|NCT00600119|1397344|P1|Double-blind Treatment Period|Lost to Follow-up|0
417578|NCT00600119|1397339|P6|Double-blind Treatment Period|Physician Decision|0
417579|NCT00600119|1397340|P5|Double-blind Treatment Period|Physician Decision|0
417580|NCT00600119|1397341|P4|Double-blind Treatment Period|Physician Decision|0
417581|NCT00600119|1397342|P3|Double-blind Treatment Period|Physician Decision|0
417582|NCT00600119|1397343|P2|Double-blind Treatment Period|Physician Decision|0
417583|NCT00600119|1397344|P1|Double-blind Treatment Period|Physician Decision|2
417584|NCT00600119|1397339|P6|Double-blind Treatment Period|Sponsor Decision|0
417585|NCT00600119|1397340|P5|Double-blind Treatment Period|Sponsor Decision|1
417586|NCT00600119|1397341|P4|Double-blind Treatment Period|Sponsor Decision|0
417587|NCT00600119|1397342|P3|Double-blind Treatment Period|Sponsor Decision|0
417588|NCT00600119|1397343|P2|Double-blind Treatment Period|Sponsor Decision|1
417589|NCT00600119|1397344|P1|Double-blind Treatment Period|Sponsor Decision|0
417590|NCT00600119|1397339|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
417756|NCT00598871|1397799|P1|Overall Study|Adverse Event|0
417591|NCT00600119|1397340|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
417592|NCT00600119|1397341|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
417593|NCT00600119|1397342|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
417594|NCT00600119|1397343|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
417595|NCT00600119|1397344|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
417596|NCT00600119|1397339|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
417597|NCT00600119|1397340|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
417598|NCT00600119|1397341|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
417599|NCT00600119|1397342|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
417600|NCT00600119|1397343|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
417601|NCT00600119|1397344|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
417602|NCT00600119|1397339|P6|Double-blind Treatment Period|Other|1
417603|NCT00600119|1397340|P5|Double-blind Treatment Period|Other|2
417604|NCT00600119|1397341|P4|Double-blind Treatment Period|Other|0
417605|NCT00600119|1397342|P3|Double-blind Treatment Period|Other|0
417606|NCT00600119|1397343|P2|Double-blind Treatment Period|Other|0
417607|NCT00600119|1397344|P1|Double-blind Treatment Period|Other|0
417608|NCT00600119|1397339|P6|Double-blind Treatment Period|Withdrawal by Subject|3
417609|NCT00600119|1397340|P5|Double-blind Treatment Period|Withdrawal by Subject|0
417610|NCT00600119|1397341|P4|Double-blind Treatment Period|Withdrawal by Subject|1
417611|NCT00600119|1397342|P3|Double-blind Treatment Period|Withdrawal by Subject|0
417612|NCT00600119|1397343|P2|Double-blind Treatment Period|Withdrawal by Subject|0
417613|NCT00600119|1397344|P1|Double-blind Treatment Period|Withdrawal by Subject|2
417614|NCT00600119|1397339|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
417615|NCT00600119|1397340|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
417616|NCT00600119|1397341|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
417617|NCT00600119|1397342|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
417618|NCT00600119|1397343|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
417619|NCT00600119|1397344|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
417620|NCT00600119|1397339|P6|Single-blind Placebo run-in Period|Adverse Event|1
417621|NCT00600119|1397340|P5|Single-blind Placebo run-in Period|Adverse Event|0
417622|NCT00600119|1397341|P4|Single-blind Placebo run-in Period|Adverse Event|1
417623|NCT00600119|1397342|P3|Single-blind Placebo run-in Period|Adverse Event|0
417624|NCT00600119|1397343|P2|Single-blind Placebo run-in Period|Adverse Event|0
417625|NCT00600119|1397344|P1|Single-blind Placebo run-in Period|Adverse Event|0
417626|NCT00600119|1397339|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
417627|NCT00600119|1397340|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
417628|NCT00600119|1397341|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
417629|NCT00600119|1397342|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
417630|NCT00600119|1397343|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
417631|NCT00600119|1397344|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
417632|NCT00600119|1397339|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
417633|NCT00600119|1397340|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
417634|NCT00600119|1397341|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
417635|NCT00600119|1397342|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
417636|NCT00600119|1397343|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
417637|NCT00600119|1397344|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
417638|NCT00600119|1397339|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
417639|NCT00600119|1397340|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
417640|NCT00600119|1397341|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
417641|NCT00600119|1397342|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
417642|NCT00600119|1397343|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
417643|NCT00600119|1397344|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
417644|NCT00600119|1397339|P6|Single-blind Placebo run-in Period|Other - Not specified|1
417645|NCT00600119|1397340|P5|Single-blind Placebo run-in Period|Other - Not specified|1
417646|NCT00600119|1397341|P4|Single-blind Placebo run-in Period|Other - Not specified|0
417647|NCT00600119|1397342|P3|Single-blind Placebo run-in Period|Other - Not specified|0
417648|NCT00600119|1397343|P2|Single-blind Placebo run-in Period|Other - Not specified|0
417649|NCT00600119|1397344|P1|Single-blind Placebo run-in Period|Other - Not specified|1
417650|NCT00600106|1397378|P2|Overall Study|Withdrawal by Subject|1
417651|NCT00600106|1397379|P1|Overall Study|Withdrawal by Subject|1
417652|NCT00600067|1397426|P2|Overall Study|Lack of Efficacy|0
417653|NCT00600067|1397427|P1|Overall Study|Lack of Efficacy|1
417654|NCT00600067|1397426|P2|Overall Study|protocol non-compliance|3
417655|NCT00600067|1397427|P1|Overall Study|protocol non-compliance|0
417656|NCT00600067|1397426|P2|Overall Study|Lost to Follow-up|3
417657|NCT00600067|1397427|P1|Overall Study|Lost to Follow-up|2
417658|NCT00600067|1397426|P2|Overall Study|Adverse Event|1
417659|NCT00600067|1397427|P1|Overall Study|Adverse Event|0
417660|NCT00600028|1397437|P2|Second Intervention (12 Weeks)|Adverse Event|2
417661|NCT00600028|1397438|P1|Second Intervention (12 Weeks)|Adverse Event|0
417662|NCT00600028|1397437|P2|First Intervention (12 Weeks)|Adverse Event|1
417663|NCT00600028|1397438|P1|First Intervention (12 Weeks)|Adverse Event|0
417664|NCT00600028|1397437|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
417665|NCT00600028|1397438|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
417666|NCT00599924|1397468|P7|Overall Study|Other|2
417667|NCT00599924|1397469|P6|Overall Study|Other|0
417668|NCT00599924|1397470|P5|Overall Study|Other|2
417669|NCT00599924|1397471|P4|Overall Study|Other|1
417670|NCT00599924|1397472|P3|Overall Study|Other|0
417671|NCT00599924|1397473|P2|Overall Study|Other|0
417672|NCT00599924|1397474|P1|Overall Study|Other|0
417673|NCT00599924|1397468|P7|Overall Study|Withdrawal by Subject|0
417674|NCT00599924|1397469|P6|Overall Study|Withdrawal by Subject|0
417675|NCT00599924|1397470|P5|Overall Study|Withdrawal by Subject|1
417676|NCT00599924|1397471|P4|Overall Study|Withdrawal by Subject|0
417677|NCT00599924|1397472|P3|Overall Study|Withdrawal by Subject|1
417678|NCT00599924|1397473|P2|Overall Study|Withdrawal by Subject|0
417679|NCT00599924|1397474|P1|Overall Study|Withdrawal by Subject|0
417680|NCT00599924|1397468|P7|Overall Study|Protocol Violation|0
417681|NCT00599924|1397469|P6|Overall Study|Protocol Violation|0
417682|NCT00599924|1397470|P5|Overall Study|Protocol Violation|0
417683|NCT00599924|1397471|P4|Overall Study|Protocol Violation|1
417684|NCT00599924|1397472|P3|Overall Study|Protocol Violation|0
417685|NCT00599924|1397473|P2|Overall Study|Protocol Violation|0
417686|NCT00599924|1397474|P1|Overall Study|Protocol Violation|0
417687|NCT00599924|1397468|P7|Overall Study|Death|1
417688|NCT00599924|1397469|P6|Overall Study|Death|2
417689|NCT00599924|1397470|P5|Overall Study|Death|0
417690|NCT00599924|1397471|P4|Overall Study|Death|2
417691|NCT00599924|1397472|P3|Overall Study|Death|0
417692|NCT00599924|1397473|P2|Overall Study|Death|0
417693|NCT00599924|1397474|P1|Overall Study|Death|0
417694|NCT00599924|1397468|P7|Overall Study|Adverse Event|2
417695|NCT00599924|1397469|P6|Overall Study|Adverse Event|0
417696|NCT00599924|1397470|P5|Overall Study|Adverse Event|0
417697|NCT00599924|1397471|P4|Overall Study|Adverse Event|2
417698|NCT00599924|1397472|P3|Overall Study|Adverse Event|0
417699|NCT00599924|1397473|P2|Overall Study|Adverse Event|0
417700|NCT00599924|1397474|P1|Overall Study|Adverse Event|0
417701|NCT00599924|1397468|P7|Overall Study|Lack of Efficacy|0
417702|NCT00599924|1397469|P6|Overall Study|Lack of Efficacy|2
417703|NCT00599924|1397470|P5|Overall Study|Lack of Efficacy|3
417704|NCT00599924|1397471|P4|Overall Study|Lack of Efficacy|2
417705|NCT00599924|1397472|P3|Overall Study|Lack of Efficacy|1
417706|NCT00599924|1397473|P2|Overall Study|Lack of Efficacy|5
417707|NCT00599924|1397474|P1|Overall Study|Lack of Efficacy|3
417708|NCT00599755|1397578|P1|Overall Study|No data available|1
417709|NCT00599755|1397578|P1|Overall Study|Other Reason|2
417710|NCT00599755|1397578|P1|Overall Study|Progression of Disease|3
417711|NCT00599755|1397578|P1|Overall Study|Withdrawal by Subject|2
417712|NCT00599755|1397578|P1|Overall Study|Adverse Event|11
417713|NCT00599521|1397589|P2|Overall Study|Pregnancy|2
417714|NCT00599521|1397590|P1|Overall Study|Pregnancy|0
417715|NCT00599521|1397589|P2|Overall Study|Lost to Follow-up|23
417716|NCT00599521|1397590|P1|Overall Study|Lost to Follow-up|23
417717|NCT00599521|1397589|P2|Overall Study|Protocol Violation|1
417718|NCT00599521|1397590|P1|Overall Study|Protocol Violation|1
417719|NCT00599521|1397589|P2|Overall Study|Withdrawal by Subject|34
417720|NCT00599521|1397590|P1|Overall Study|Withdrawal by Subject|28
417721|NCT00599521|1397589|P2|Overall Study|Adverse Event|1
417722|NCT00599521|1397590|P1|Overall Study|Adverse Event|4
417723|NCT00599521|1397589|P2|Overall Study|Lack of Efficacy|8
417724|NCT00599521|1397590|P1|Overall Study|Lack of Efficacy|4
417725|NCT00599339|1397604|P1|Overall Study|Study Termination Status Unknown|12
417726|NCT00599339|1397604|P1|Overall Study|No valid data consent|36
417727|NCT00599339|1397604|P1|Overall Study|Lost to Follow-up|221
417728|NCT00599339|1397604|P1|Overall Study|Other Reason|179
417729|NCT00599339|1397604|P1|Overall Study|Withdrawal by Subject|137
417730|NCT00599339|1397604|P1|Overall Study|Adverse Event|79
417731|NCT00599326|1397706|P1|Overall Study|Noncompliant|1
417732|NCT00599326|1397706|P1|Overall Study|Lost to Follow-up|1
417733|NCT00599313|1397711|P1|Overall Study|Ineligible|1
417734|NCT00599313|1397711|P1|Overall Study|Patient Request|4
417735|NCT00599313|1397711|P1|Overall Study|Disease Progression|12
417736|NCT00599313|1397711|P1|Overall Study|Adverse Event|19
417737|NCT00599196|1397753|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
417738|NCT00599196|1397753|P1|Overall Study|Other: Patient Stopped Due To Moving|1
417739|NCT00599196|1397753|P1|Overall Study|Other: Pt Moved To Australia|1
417740|NCT00599196|1397753|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
417741|NCT00599196|1397753|P1|Overall Study|Other: Spouse Withdrew Consent|1
417742|NCT00599196|1397753|P1|Overall Study|Other: Patient Leaving For Israel|1
417743|NCT00599196|1397753|P1|Overall Study|Lost to Follow-up|17
417744|NCT00599196|1397753|P1|Overall Study|Study ended per sponsor|197
417745|NCT00599196|1397753|P1|Overall Study|Subject withdrew consent|43
417746|NCT00599196|1397753|P1|Overall Study|Unsatisfactory compliance of subject|3
417747|NCT00599196|1397753|P1|Overall Study|Adverse Event|93
417748|NCT00599196|1397753|P1|Overall Study|Lack of Efficacy|22
417749|NCT00599027|1397784|P2|Overall Study|Treatment Failure|1
417750|NCT00599027|1397785|P1|Overall Study|Treatment Failure|0
417751|NCT00599027|1397784|P2|Overall Study|Adverse Event|1
417752|NCT00599027|1397785|P1|Overall Study|Adverse Event|0
417753|NCT00599027|1397784|P2|Overall Study|Withdrawal by Subject|1
417754|NCT00599027|1397785|P1|Overall Study|Withdrawal by Subject|1
417755|NCT00598871|1397798|P2|Overall Study|Adverse Event|1
417757|NCT00598832|1397809|P2|Overall Study|Non compliance|0
417758|NCT00598832|1397810|P1|Overall Study|Non compliance|1
417759|NCT00598832|1397809|P2|Overall Study|Physician Decision|4
417760|NCT00598832|1397810|P1|Overall Study|Physician Decision|1
417761|NCT00598832|1397809|P2|Overall Study|Pregnancy|2
417762|NCT00598832|1397810|P1|Overall Study|Pregnancy|2
417763|NCT00598832|1397809|P2|Overall Study|Lost to Follow-up|29
417764|NCT00598832|1397810|P1|Overall Study|Lost to Follow-up|24
417765|NCT00598832|1397809|P2|Overall Study|Protocol Violation|2
417766|NCT00598832|1397810|P1|Overall Study|Protocol Violation|0
417767|NCT00598832|1397809|P2|Overall Study|Withdrawal by Subject|36
417768|NCT00598832|1397810|P1|Overall Study|Withdrawal by Subject|25
417769|NCT00598832|1397809|P2|Overall Study|Adverse Event|2
417770|NCT00598832|1397810|P1|Overall Study|Adverse Event|6
417771|NCT00598832|1397809|P2|Overall Study|Lack of Efficacy|7
417772|NCT00598832|1397810|P1|Overall Study|Lack of Efficacy|3
417773|NCT00598702|1397863|P8|Overall Study|Dose limiting toxicity|0
417774|NCT00598702|1397864|P7|Overall Study|Dose limiting toxicity|0
417775|NCT00598702|1397865|P6|Overall Study|Dose limiting toxicity|1
417776|NCT00598702|1397866|P5|Overall Study|Dose limiting toxicity|1
417777|NCT00598702|1397867|P4|Overall Study|Dose limiting toxicity|1
417778|NCT00598702|1397868|P3|Overall Study|Dose limiting toxicity|0
417779|NCT00598702|1397869|P2|Overall Study|Dose limiting toxicity|0
417780|NCT00598702|1397870|P1|Overall Study|Dose limiting toxicity|0
417781|NCT00598702|1397863|P8|Overall Study|Physician Decision|0
417782|NCT00598702|1397864|P7|Overall Study|Physician Decision|0
417783|NCT00598702|1397865|P6|Overall Study|Physician Decision|0
417784|NCT00598702|1397866|P5|Overall Study|Physician Decision|1
417785|NCT00598702|1397867|P4|Overall Study|Physician Decision|0
417786|NCT00598702|1397868|P3|Overall Study|Physician Decision|0
417787|NCT00598702|1397869|P2|Overall Study|Physician Decision|0
417788|NCT00598702|1397870|P1|Overall Study|Physician Decision|0
417789|NCT00598702|1397863|P8|Overall Study|Withdrawal by Subject|0
417790|NCT00598702|1397864|P7|Overall Study|Withdrawal by Subject|0
417791|NCT00598702|1397865|P6|Overall Study|Withdrawal by Subject|0
417792|NCT00598702|1397866|P5|Overall Study|Withdrawal by Subject|1
417793|NCT00598702|1397867|P4|Overall Study|Withdrawal by Subject|1
417794|NCT00598702|1397868|P3|Overall Study|Withdrawal by Subject|0
417795|NCT00598702|1397869|P2|Overall Study|Withdrawal by Subject|0
417796|NCT00598702|1397870|P1|Overall Study|Withdrawal by Subject|0
417797|NCT00598702|1397863|P8|Overall Study|Adverse Event|0
417798|NCT00598702|1397864|P7|Overall Study|Adverse Event|0
417799|NCT00598702|1397865|P6|Overall Study|Adverse Event|0
417800|NCT00598702|1397866|P5|Overall Study|Adverse Event|0
417801|NCT00598702|1397867|P4|Overall Study|Adverse Event|1
417802|NCT00598702|1397868|P3|Overall Study|Adverse Event|0
417803|NCT00598702|1397869|P2|Overall Study|Adverse Event|0
417804|NCT00598702|1397870|P1|Overall Study|Adverse Event|0
417805|NCT00598702|1397863|P8|Overall Study|Early discharge from hospital|0
417806|NCT00598702|1397864|P7|Overall Study|Early discharge from hospital|1
417807|NCT00598702|1397865|P6|Overall Study|Early discharge from hospital|10
417808|NCT00598702|1397866|P5|Overall Study|Early discharge from hospital|0
417809|NCT00598702|1397867|P4|Overall Study|Early discharge from hospital|5
417810|NCT00598702|1397868|P3|Overall Study|Early discharge from hospital|2
417811|NCT00598702|1397869|P2|Overall Study|Early discharge from hospital|0
417812|NCT00598702|1397870|P1|Overall Study|Early discharge from hospital|0
417813|NCT00598702|1397863|P8|Overall Study|Not specified|0
417814|NCT00598702|1397864|P7|Overall Study|Not specified|0
417815|NCT00598702|1397865|P6|Overall Study|Not specified|1
417816|NCT00598702|1397866|P5|Overall Study|Not specified|0
417817|NCT00598702|1397867|P4|Overall Study|Not specified|0
417818|NCT00598702|1397868|P3|Overall Study|Not specified|0
417819|NCT00598702|1397869|P2|Overall Study|Not specified|2
417820|NCT00598702|1397870|P1|Overall Study|Not specified|0
417821|NCT00598650|1397925|P1|Overall Study|Physician Decision|2
417822|NCT00598650|1397925|P1|Overall Study|Prohibited Concomitant Medication|2
417823|NCT00598650|1397925|P1|Overall Study|Not eligible|1
417824|NCT00598650|1397925|P1|Overall Study|No treatment for 3 weeks|1
417825|NCT00598650|1397925|P1|Overall Study|Adverse Event|18
417826|NCT00598650|1397925|P1|Overall Study|Withdrawal by Subject|3
417827|NCT00598585|1397934|P2|Overall Study|Lost to Follow-up|0
417828|NCT00598585|1397935|P1|Overall Study|Lost to Follow-up|1
417829|NCT00598559|1397944|P3|Overall Study|Subject unable/unwilling to attend visit|0
417830|NCT00598559|1397945|P2|Overall Study|Subject unable/unwilling to attend visit|7
417831|NCT00598559|1397946|P1|Overall Study|Subject unable/unwilling to attend visit|4
417832|NCT00598559|1397944|P3|Overall Study|Early discharge from hospital|3
417833|NCT00598559|1397945|P2|Overall Study|Early discharge from hospital|12
417834|NCT00598559|1397946|P1|Overall Study|Early discharge from hospital|9
417835|NCT00598559|1397944|P3|Overall Study|Protocol Non-compliance|0
417836|NCT00598559|1397945|P2|Overall Study|Protocol Non-compliance|0
417837|NCT00598559|1397946|P1|Overall Study|Protocol Non-compliance|1
417838|NCT00598559|1397944|P3|Overall Study|Withdrawal by Subject|0
417839|NCT00598559|1397945|P2|Overall Study|Withdrawal by Subject|2
417840|NCT00598559|1397946|P1|Overall Study|Withdrawal by Subject|2
417841|NCT00598559|1397944|P3|Overall Study|Adverse Event|0
417842|NCT00598559|1397945|P2|Overall Study|Adverse Event|7
417843|NCT00598559|1397946|P1|Overall Study|Adverse Event|11
417844|NCT00598442|1397973|P3|Overall Study|Started dialysis|0
417845|NCT00598442|1397974|P2|Overall Study|Started dialysis|0
417846|NCT00598442|1397975|P1|Overall Study|Started dialysis|1
417847|NCT00598442|1397973|P3|Overall Study|Site closed by sponsor|1
417848|NCT00598442|1397974|P2|Overall Study|Site closed by sponsor|2
417849|NCT00598442|1397975|P1|Overall Study|Site closed by sponsor|5
417850|NCT00598442|1397973|P3|Overall Study|Renal transplant|1
417851|NCT00598442|1397974|P2|Overall Study|Renal transplant|0
417852|NCT00598442|1397975|P1|Overall Study|Renal transplant|0
417853|NCT00598442|1397973|P3|Overall Study|Relocation|0
417854|NCT00598442|1397974|P2|Overall Study|Relocation|4
417855|NCT00598442|1397975|P1|Overall Study|Relocation|1
417856|NCT00598442|1397973|P3|Overall Study|Noncompliance|1
417857|NCT00598442|1397974|P2|Overall Study|Noncompliance|2
417858|NCT00598442|1397975|P1|Overall Study|Noncompliance|0
417859|NCT00598442|1397973|P3|Overall Study|Withdrawal by Subject|6
417860|NCT00598442|1397974|P2|Overall Study|Withdrawal by Subject|16
417861|NCT00598442|1397975|P1|Overall Study|Withdrawal by Subject|8
417862|NCT00598442|1397973|P3|Overall Study|Physician Decision|1
417863|NCT00598442|1397974|P2|Overall Study|Physician Decision|1
417864|NCT00598442|1397975|P1|Overall Study|Physician Decision|2
417865|NCT00598442|1397973|P3|Overall Study|Lost to Follow-up|3
417866|NCT00598442|1397974|P2|Overall Study|Lost to Follow-up|3
417867|NCT00598442|1397975|P1|Overall Study|Lost to Follow-up|4
417868|NCT00598442|1397973|P3|Overall Study|Death|11
417869|NCT00598442|1397974|P2|Overall Study|Death|11
417870|NCT00598442|1397975|P1|Overall Study|Death|19
417871|NCT00598442|1397973|P3|Overall Study|Adverse Event|0
417872|NCT00598442|1397974|P2|Overall Study|Adverse Event|0
417873|NCT00598442|1397975|P1|Overall Study|Adverse Event|3
417874|NCT00598273|1397992|P3|Overall Study|Started dialysis|5
417875|NCT00598273|1397993|P2|Overall Study|Started dialysis|4
417876|NCT00598273|1397994|P1|Overall Study|Started dialysis|6
417877|NCT00598273|1397992|P3|Overall Study|Site elected to close|0
417878|NCT00598273|1397993|P2|Overall Study|Site elected to close|0
417879|NCT00598273|1397994|P1|Overall Study|Site elected to close|1
417880|NCT00598273|1397992|P3|Overall Study|Renal transplant|1
417881|NCT00598273|1397993|P2|Overall Study|Renal transplant|0
417882|NCT00598273|1397994|P1|Overall Study|Renal transplant|1
417883|NCT00598273|1397992|P3|Overall Study|Relocation|4
417884|NCT00598273|1397993|P2|Overall Study|Relocation|2
417885|NCT00598273|1397994|P1|Overall Study|Relocation|0
417886|NCT00598273|1397992|P3|Overall Study|Noncompliance|3
417887|NCT00598273|1397993|P2|Overall Study|Noncompliance|2
417888|NCT00598273|1397994|P1|Overall Study|Noncompliance|3
417889|NCT00598273|1397992|P3|Overall Study|Withdrawal by Subject|10
417890|NCT00598273|1397993|P2|Overall Study|Withdrawal by Subject|10
417891|NCT00598273|1397994|P1|Overall Study|Withdrawal by Subject|12
417892|NCT00598273|1397992|P3|Overall Study|Physician Decision|1
417893|NCT00598273|1397993|P2|Overall Study|Physician Decision|0
417894|NCT00598273|1397994|P1|Overall Study|Physician Decision|0
417895|NCT00598273|1397992|P3|Overall Study|Lost to Follow-up|5
417896|NCT00598273|1397993|P2|Overall Study|Lost to Follow-up|3
417897|NCT00598273|1397994|P1|Overall Study|Lost to Follow-up|8
417898|NCT00598273|1397992|P3|Overall Study|Death|8
417899|NCT00598273|1397993|P2|Overall Study|Death|12
417900|NCT00598273|1397994|P1|Overall Study|Death|6
417901|NCT00598273|1397992|P3|Overall Study|Adverse Event|2
417902|NCT00598273|1397993|P2|Overall Study|Adverse Event|5
417903|NCT00598273|1397994|P1|Overall Study|Adverse Event|4
417904|NCT00598078|1398008|P2|Period 2 (Day 2)|Adverse Event|0
417905|NCT00598078|1398009|P1|Period 2 (Day 2)|Adverse Event|1
417906|NCT00597766|1398062|P3|Follow-up 2, Week 8|Lost to Follow-up|1
417907|NCT00597766|1398063|P2|Follow-up 2, Week 8|Lost to Follow-up|0
417908|NCT00597766|1398064|P1|Follow-up 2, Week 8|Lost to Follow-up|0
417909|NCT00597766|1398062|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
417910|NCT00597766|1398063|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
417911|NCT00597766|1398064|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
417912|NCT00597753|1398083|P2|Overall Study|Site elected to close|4
417913|NCT00597753|1398084|P1|Overall Study|Site elected to close|2
417914|NCT00597753|1398083|P2|Overall Study|Site closed by sponsor|7
417915|NCT00597753|1398084|P1|Overall Study|Site closed by sponsor|19
417916|NCT00597753|1398083|P2|Overall Study|Renal transplant|3
417917|NCT00597753|1398084|P1|Overall Study|Renal transplant|10
417918|NCT00597753|1398083|P2|Overall Study|Relocation|6
417919|NCT00597753|1398084|P1|Overall Study|Relocation|17
417920|NCT00597753|1398083|P2|Overall Study|Noncompliance|1
417921|NCT00597753|1398084|P1|Overall Study|Noncompliance|2
417922|NCT00597753|1398083|P2|Overall Study|Never dosed|0
417923|NCT00597753|1398084|P1|Overall Study|Never dosed|2
417924|NCT00597753|1398083|P2|Overall Study|Discontinued Dialysis|1
417925|NCT00597753|1398084|P1|Overall Study|Discontinued Dialysis|0
417926|NCT00597753|1398083|P2|Overall Study|Withdrawal by Subject|12
417927|NCT00597753|1398084|P1|Overall Study|Withdrawal by Subject|35
417928|NCT00597753|1398083|P2|Overall Study|Pregnancy|0
417929|NCT00597753|1398084|P1|Overall Study|Pregnancy|1
417930|NCT00597753|1398083|P2|Overall Study|Physician Decision|1
417931|NCT00597753|1398084|P1|Overall Study|Physician Decision|5
417932|NCT00597753|1398083|P2|Overall Study|Lost to Follow-up|3
417933|NCT00597753|1398084|P1|Overall Study|Lost to Follow-up|10
417934|NCT00597753|1398083|P2|Overall Study|Lack of Efficacy|0
417935|NCT00597753|1398084|P1|Overall Study|Lack of Efficacy|2
417936|NCT00597753|1398083|P2|Overall Study|Death|29
417937|NCT00597753|1398084|P1|Overall Study|Death|55
417938|NCT00597753|1398083|P2|Overall Study|Adverse Event|2
417939|NCT00597753|1398084|P1|Overall Study|Adverse Event|6
417940|NCT00597714|1398118|P3|Overall Study|Recipient death|10
417941|NCT00597714|1398119|P2|Overall Study|Recipient death|0
417942|NCT00597714|1398120|P1|Overall Study|Recipient death|0
417943|NCT00597714|1398118|P3|Overall Study|Death|0
417944|NCT00597714|1398119|P2|Overall Study|Death|46
417945|NCT00597714|1398120|P1|Overall Study|Death|56
417946|NCT00597701|1398132|P2|Overall Study|Did not start intervention (pharmacy er)|2
417947|NCT00597701|1398133|P1|Overall Study|Did not start intervention (pharmacy er)|0
417948|NCT00597701|1398132|P2|Overall Study|Physician Decision|0
417949|NCT00597701|1398133|P1|Overall Study|Physician Decision|2
417950|NCT00597701|1398132|P2|Overall Study|Death|1
417951|NCT00597701|1398133|P1|Overall Study|Death|0
417952|NCT00597701|1398132|P2|Overall Study|Withdrawal by Subject|5
417953|NCT00597701|1398133|P1|Overall Study|Withdrawal by Subject|5
417954|NCT00597584|1398155|P2|Overall Study|Renal transplant|7
417955|NCT00597584|1398156|P1|Overall Study|Renal transplant|9
417956|NCT00597584|1398155|P2|Overall Study|Relocation|6
417957|NCT00597584|1398156|P1|Overall Study|Relocation|8
417958|NCT00597584|1398155|P2|Overall Study|Never dosed|0
417959|NCT00597584|1398156|P1|Overall Study|Never dosed|1
417960|NCT00597584|1398155|P2|Overall Study|Lost ability to consent|1
417961|NCT00597584|1398156|P1|Overall Study|Lost ability to consent|1
417962|NCT00597584|1398155|P2|Overall Study|Discontinued Dialysis|1
417963|NCT00597584|1398156|P1|Overall Study|Discontinued Dialysis|0
417964|NCT00597584|1398155|P2|Overall Study|Withdrawal by Subject|12
417965|NCT00597584|1398156|P1|Overall Study|Withdrawal by Subject|44
417966|NCT00597584|1398155|P2|Overall Study|Pregnancy|0
417967|NCT00597584|1398156|P1|Overall Study|Pregnancy|2
417968|NCT00597584|1398155|P2|Overall Study|Physician Decision|0
417969|NCT00597584|1398156|P1|Overall Study|Physician Decision|3
417970|NCT00597584|1398155|P2|Overall Study|Lost to Follow-up|4
417971|NCT00597584|1398156|P1|Overall Study|Lost to Follow-up|2
417972|NCT00597584|1398155|P2|Overall Study|Lack of Efficacy|0
417973|NCT00597584|1398156|P1|Overall Study|Lack of Efficacy|1
417974|NCT00597584|1398155|P2|Overall Study|Death|30
417975|NCT00597584|1398156|P1|Overall Study|Death|53
417976|NCT00597584|1398155|P2|Overall Study|Adverse Event|2
417977|NCT00597584|1398156|P1|Overall Study|Adverse Event|4
417978|NCT00597519|1398181|P1|Overall Study|Death|1
417979|NCT00597506|1398185|P1|Overall Study|Subject is being followed for survival|1
417980|NCT00597376|1398235|P2|Overall Study|Adverse Event|1
417981|NCT00597376|1398236|P1|Overall Study|Adverse Event|4
417982|NCT00597376|1398235|P2|Overall Study|Withdrawal by Subject|3
417983|NCT00597376|1398236|P1|Overall Study|Withdrawal by Subject|4
417984|NCT00597207|1398277|P2|Overall Study|Lost to Follow-up|7
417985|NCT00597207|1398278|P1|Overall Study|Lost to Follow-up|5
417986|NCT00597116|1398286|P2|Overall Study|Progressive disease|6
417987|NCT00597116|1398287|P1|Overall Study|Progressive disease|11
417988|NCT00597116|1398286|P2|Overall Study|Lost to Follow-up|0
417989|NCT00597116|1398287|P1|Overall Study|Lost to Follow-up|1
417990|NCT00597116|1398286|P2|Overall Study|Death|1
417991|NCT00597116|1398287|P1|Overall Study|Death|0
417992|NCT00597116|1398286|P2|Overall Study|Physician Decision|1
417993|NCT00597116|1398287|P1|Overall Study|Physician Decision|0
417994|NCT00597116|1398286|P2|Overall Study|Withdrawal by Subject|2
417995|NCT00597116|1398287|P1|Overall Study|Withdrawal by Subject|0
417996|NCT00597116|1398286|P2|Overall Study|Adverse Event|1
417997|NCT00597116|1398287|P1|Overall Study|Adverse Event|2
417998|NCT00597012|1398313|P2|Overall Study|Lost to Follow-up|2
417999|NCT00597012|1398314|P1|Overall Study|Lost to Follow-up|0
418000|NCT00597012|1398313|P2|Overall Study|Ineligible|0
418001|NCT00597012|1398314|P1|Overall Study|Ineligible|2
418002|NCT00597012|1398313|P2|Overall Study|Withdrawal by Subject|4
418003|NCT00597012|1398314|P1|Overall Study|Withdrawal by Subject|7
418004|NCT00597012|1398313|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
418005|NCT00597012|1398314|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
418006|NCT00597012|1398313|P2|Overall Study|Death|1
418007|NCT00597012|1398314|P1|Overall Study|Death|1
418008|NCT00596960|1398326|P2|Overall Study|No alcohol use data|1
418009|NCT00596960|1398327|P1|Overall Study|No alcohol use data|0
418010|NCT00596960|1398326|P2|Overall Study|Protocol Violation|1
418011|NCT00596960|1398327|P1|Overall Study|Protocol Violation|0
418012|NCT00596960|1398326|P2|Overall Study|Physician Decision|0
418013|NCT00596960|1398327|P1|Overall Study|Physician Decision|1
418014|NCT00596960|1398326|P2|Overall Study|Incarcerated|0
418015|NCT00596960|1398327|P1|Overall Study|Incarcerated|2
418016|NCT00596960|1398326|P2|Overall Study|Withdrawal by Subject|0
418017|NCT00596960|1398327|P1|Overall Study|Withdrawal by Subject|1
418018|NCT00596960|1398326|P2|Overall Study|Lost to Follow-up|5
418019|NCT00596960|1398327|P1|Overall Study|Lost to Follow-up|6
418020|NCT00596960|1398326|P2|Overall Study|Death|2
418021|NCT00596960|1398327|P1|Overall Study|Death|1
418022|NCT00596947|1398339|P2|Overall Study|Lost to Follow-up|0
418023|NCT00596947|1398340|P1|Overall Study|Lost to Follow-up|1
418024|NCT00596947|1398339|P2|Overall Study|study halted due to low enrollment|3
418025|NCT00596947|1398340|P1|Overall Study|study halted due to low enrollment|5
418026|NCT00596934|1398380|P1|Overall Study|Withdrawal by Subject|1
418027|NCT00596934|1398380|P1|Overall Study|Protocol Violation|1
418028|NCT00596830|1398393|P2|Overall Study|Randomized but not treated|7
418029|NCT00596830|1398394|P1|Overall Study|Randomized but not treated|3
418030|NCT00596830|1398393|P2|Overall Study|Follow-up was discontinued|0
418031|NCT00596830|1398394|P1|Overall Study|Follow-up was discontinued|1
418032|NCT00596830|1398393|P2|Overall Study|Study terminated by sponsor|62
418033|NCT00596830|1398394|P1|Overall Study|Study terminated by sponsor|51
418034|NCT00596830|1398393|P2|Overall Study|Withdrawal by Subject|12
418035|NCT00596830|1398394|P1|Overall Study|Withdrawal by Subject|22
418036|NCT00596830|1398393|P2|Overall Study|Lost to Follow-up|11
418037|NCT00596830|1398394|P1|Overall Study|Lost to Follow-up|7
418038|NCT00596830|1398393|P2|Overall Study|Death|247
418039|NCT00596830|1398394|P1|Overall Study|Death|258
418040|NCT00596817|1398420|P2|Double-blind Period|Other Reasons|18
418041|NCT00596817|1398421|P1|Double-blind Period|Other Reasons|10
418042|NCT00596817|1398420|P2|Double-blind Period|Lost to Follow-up|2
418043|NCT00596817|1398421|P1|Double-blind Period|Lost to Follow-up|0
418044|NCT00596817|1398420|P2|Double-blind Period|Withdrawal of Consent|3
418045|NCT00596817|1398421|P1|Double-blind Period|Withdrawal of Consent|7
418046|NCT00596817|1398420|P2|Double-blind Period|Protocol Violation|8
418047|NCT00596817|1398421|P1|Double-blind Period|Protocol Violation|11
418048|NCT00596817|1398420|P2|Double-blind Period|Non-compliance With Study Product|4
418049|NCT00596817|1398421|P1|Double-blind Period|Non-compliance With Study Product|3
418050|NCT00596817|1398420|P2|Double-blind Period|Lack of Efficacy|28
418051|NCT00596817|1398421|P1|Double-blind Period|Lack of Efficacy|52
418052|NCT00596817|1398420|P2|Double-blind Period|Adverse Event|16
418053|NCT00596817|1398421|P1|Double-blind Period|Adverse Event|5
418054|NCT00596817|1398420|P2|Open-label Period to Double-blind Period|Other Reasons|14
418055|NCT00596817|1398421|P1|Open-label Period to Double-blind Period|Other Reasons|0
418056|NCT00596817|1398420|P2|Open-label Period to Double-blind Period|Not Eligible|49
418057|NCT00596817|1398421|P1|Open-label Period to Double-blind Period|Not Eligible|0
418058|NCT00596817|1398420|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
418059|NCT00596817|1398421|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
418060|NCT00596817|1398420|P2|Open-label Period to Double-blind Period|Adverse Event|5
418061|NCT00596817|1398421|P1|Open-label Period to Double-blind Period|Adverse Event|0
418062|NCT00596817|1398420|P2|Open-label Period|Other Reasons|65
418063|NCT00596817|1398421|P1|Open-label Period|Other Reasons|0
418064|NCT00596817|1398420|P2|Open-label Period|Lack of Efficacy|33
418065|NCT00596817|1398421|P1|Open-label Period|Lack of Efficacy|0
418066|NCT00596817|1398420|P2|Open-label Period|Adverse Event|49
418067|NCT00596817|1398421|P1|Open-label Period|Adverse Event|0
418068|NCT00596752|1398446|P2|Overall Study|Protocol Violation|0
418069|NCT00596752|1398447|P1|Overall Study|Protocol Violation|1
418070|NCT00596752|1398446|P2|Overall Study|Lack of Efficacy|7
418071|NCT00596752|1398447|P1|Overall Study|Lack of Efficacy|4
418072|NCT00596752|1398446|P2|Overall Study|Unsatisfactory Compliance|6
418073|NCT00596752|1398447|P1|Overall Study|Unsatisfactory Compliance|9
418074|NCT00596752|1398446|P2|Overall Study|Withdrawal by Subject|9
418075|NCT00596752|1398447|P1|Overall Study|Withdrawal by Subject|12
418076|NCT00596752|1398446|P2|Overall Study|Lost to Follow-up|38
418077|NCT00596752|1398447|P1|Overall Study|Lost to Follow-up|22
418078|NCT00596752|1398446|P2|Overall Study|Adverse Event|34
418079|NCT00596752|1398447|P1|Overall Study|Adverse Event|34
418080|NCT00596752|1398446|P2|Overall Study|Other Reason|49
418081|NCT00596752|1398447|P1|Overall Study|Other Reason|44
418082|NCT00596687|1398477|P2|Overall Study|cancelled surgery|1
418083|NCT00596687|1398478|P1|Overall Study|cancelled surgery|1
418084|NCT00596687|1398477|P2|Overall Study|Withdrawal by Subject|1
418085|NCT00596687|1398478|P1|Overall Study|Withdrawal by Subject|3
418086|NCT00596687|1398477|P2|Overall Study|continuous insulin infusion during TPN|1
418087|NCT00596687|1398478|P1|Overall Study|continuous insulin infusion during TPN|2
418088|NCT00596687|1398477|P2|Overall Study|< 24 hours of insulin treatment|6
418089|NCT00596687|1398478|P1|Overall Study|< 24 hours of insulin treatment|8
418090|NCT00596635|1398489|P3|Overall Study|Could not provide urine specimen|2
418091|NCT00596635|1398490|P2|Overall Study|Could not provide urine specimen|2
418092|NCT00596635|1398491|P1|Overall Study|Could not provide urine specimen|1
418093|NCT00596635|1398489|P3|Overall Study|Hip fracture|3
418094|NCT00596635|1398490|P2|Overall Study|Hip fracture|3
418095|NCT00596635|1398491|P1|Overall Study|Hip fracture|2
418096|NCT00596635|1398489|P3|Overall Study|Treatment for symptomatic UTI|3
418097|NCT00596635|1398490|P2|Overall Study|Treatment for symptomatic UTI|6
418098|NCT00596635|1398491|P1|Overall Study|Treatment for symptomatic UTI|4
418099|NCT00596635|1398489|P3|Overall Study|Lost to Follow-up|0
418100|NCT00596635|1398490|P2|Overall Study|Lost to Follow-up|2
418101|NCT00596635|1398491|P1|Overall Study|Lost to Follow-up|0
418102|NCT00596466|1398517|P1|Overall Study|Enrolled, not treated|2
418103|NCT00596466|1398517|P1|Overall Study|Unpecified|2
418104|NCT00596466|1398517|P1|Overall Study|Protocol Violation|2
418105|NCT00596466|1398517|P1|Overall Study|Withdrawal by Subject|2
418106|NCT00596466|1398517|P1|Overall Study|Adverse Event|4
418107|NCT00596466|1398517|P1|Overall Study|Lack of Efficacy|5
418108|NCT00596427|1398547|P2|Overall Study|Protocol Violation|0
418109|NCT00596427|1398548|P1|Overall Study|Protocol Violation|1
418110|NCT00596427|1398547|P2|Overall Study|Increased Fasting Triacylglycerol level|0
418111|NCT00596427|1398548|P1|Overall Study|Increased Fasting Triacylglycerol level|1
418112|NCT00596427|1398547|P2|Overall Study|Withdrawal by Subject|2
418113|NCT00596427|1398548|P1|Overall Study|Withdrawal by Subject|2
418114|NCT00596362|1398576|P1|Overall Study|Progressive Disease|1
418119|NCT00595959|1398629|P1|Overall Study|Lost to Follow-up|1
418120|NCT00595959|1398629|P1|Overall Study|Withdrawal by Subject|1
418121|NCT00595920|1398663|P1|Overall Study|The OLTERMS study was discontinued by th|116
418122|NCT00595868|1398674|P2|Overall Study|Lost to Follow-up|50
418123|NCT00595868|1398675|P1|Overall Study|Lost to Follow-up|45
418124|NCT00595764|1398698|P2|Overall Study|Withdrawal by Subject|0
418125|NCT00595764|1398699|P1|Overall Study|Withdrawal by Subject|4
418126|NCT00595764|1398698|P2|Overall Study|Missed 3 PM visits|7
418127|NCT00595764|1398699|P1|Overall Study|Missed 3 PM visits|1
418128|NCT00595764|1398698|P2|Overall Study|Missed Medication >1 week|17
418129|NCT00595764|1398699|P1|Overall Study|Missed Medication >1 week|10
418130|NCT00595764|1398698|P2|Overall Study|Protocol Violation|19
418131|NCT00595764|1398699|P1|Overall Study|Protocol Violation|24
418132|NCT00595582|1398713|P1|Overall Study|Physician Decision|5
418133|NCT00595582|1398713|P1|Overall Study|Adverse Event|2
418134|NCT00595582|1398713|P1|Overall Study|Lost to Follow-up|1
418135|NCT00595582|1398713|P1|Overall Study|Pilot study that PI terminated|2
418136|NCT00595517|1398738|P1|Overall Study|No intention to attend regularly|1
418137|NCT00595517|1398738|P1|Overall Study|usage of prohibited treatment|1
418138|NCT00595517|1398738|P1|Overall Study|Recurrence of ulcer|5
418139|NCT00595517|1398738|P1|Overall Study|Protocol Violation|2
418140|NCT00595517|1398738|P1|Overall Study|Withdrawal by Subject|4
418141|NCT00595517|1398738|P1|Overall Study|Adverse Event|6
418142|NCT00595504|1398747|P2|Overall Study|Physician Decision|0
418143|NCT00595504|1398748|P1|Overall Study|Physician Decision|1
418144|NCT00595504|1398747|P2|Overall Study|Withdrawal by Subject|3
418145|NCT00595504|1398748|P1|Overall Study|Withdrawal by Subject|1
418146|NCT00595478|1398760|P2|36-week Follow-up Period|Withdrawal by Subject|4
418147|NCT00595478|1398761|P1|36-week Follow-up Period|Withdrawal by Subject|4
418148|NCT00595478|1398760|P2|36-week Follow-up Period|Lost to Follow-up|4
418149|NCT00595478|1398761|P1|36-week Follow-up Period|Lost to Follow-up|5
418150|NCT00595465|1398772|P3|Overall Study|administrative reason|1
418151|NCT00595465|1398773|P2|Overall Study|administrative reason|0
418152|NCT00595465|1398774|P1|Overall Study|administrative reason|0
418153|NCT00595465|1398772|P3|Overall Study|Lost to Follow-up|2
418154|NCT00595465|1398773|P2|Overall Study|Lost to Follow-up|0
418155|NCT00595465|1398774|P1|Overall Study|Lost to Follow-up|0
418156|NCT00595465|1398772|P3|Overall Study|Protocol Violation|0
418157|NCT00595465|1398773|P2|Overall Study|Protocol Violation|1
418158|NCT00595465|1398774|P1|Overall Study|Protocol Violation|2
418159|NCT00595465|1398772|P3|Overall Study|Pregnancy|1
418160|NCT00595465|1398773|P2|Overall Study|Pregnancy|0
418161|NCT00595465|1398774|P1|Overall Study|Pregnancy|0
418162|NCT00595465|1398772|P3|Overall Study|Adverse Event|3
418163|NCT00595465|1398773|P2|Overall Study|Adverse Event|3
418164|NCT00595465|1398774|P1|Overall Study|Adverse Event|4
418165|NCT00595413|1398786|P4|Overall Study|Other|0
418166|NCT00595413|1398787|P3|Overall Study|Other|5
418167|NCT00595413|1398788|P2|Overall Study|Other|1
418168|NCT00595413|1398789|P1|Overall Study|Other|5
418169|NCT00595413|1398786|P4|Overall Study|Death|0
418170|NCT00595413|1398787|P3|Overall Study|Death|1
418171|NCT00595413|1398788|P2|Overall Study|Death|0
418172|NCT00595413|1398789|P1|Overall Study|Death|0
418173|NCT00595413|1398786|P4|Overall Study|Lost to Follow-up|3
418174|NCT00595413|1398787|P3|Overall Study|Lost to Follow-up|1
418175|NCT00595413|1398788|P2|Overall Study|Lost to Follow-up|2
418176|NCT00595413|1398789|P1|Overall Study|Lost to Follow-up|2
418177|NCT00595413|1398786|P4|Overall Study|Adverse Event|1
418178|NCT00595413|1398787|P3|Overall Study|Adverse Event|1
418179|NCT00595413|1398788|P2|Overall Study|Adverse Event|2
418180|NCT00595413|1398789|P1|Overall Study|Adverse Event|0
418181|NCT00595335|1398830|P2|Six Months to Twelve Months|Disease Progression|0
418182|NCT00595335|1398831|P1|Six Months to Twelve Months|Disease Progression|1
418183|NCT00595335|1398830|P2|Six Months to Twelve Months|Withdrawal by Subject|1
418184|NCT00595335|1398831|P1|Six Months to Twelve Months|Withdrawal by Subject|0
418185|NCT00595335|1398830|P2|Baseline to Six Months|Adverse Event|0
418186|NCT00595335|1398831|P1|Baseline to Six Months|Adverse Event|1
418187|NCT00595335|1398830|P2|Baseline to Six Months|Disease Progression|1
418188|NCT00595335|1398831|P1|Baseline to Six Months|Disease Progression|1
418189|NCT00595335|1398830|P2|Baseline to Six Months|Withdrawal by Subject|1
418190|NCT00595335|1398831|P1|Baseline to Six Months|Withdrawal by Subject|0
418191|NCT00595309|1398851|P1|Overall Study|personal reason|1
418192|NCT00595309|1398851|P1|Overall Study|acute infection after V0|1
418193|NCT00595309|1398851|P1|Overall Study|planned vaccination against yellow fever|1
418194|NCT00595309|1398851|P1|Overall Study|Lost to Follow-up|1
418195|NCT00595127|1398881|P1|Overall Study|joined another trial|1
418196|NCT00595127|1398881|P1|Overall Study|Relapsed|3
418197|NCT00595127|1398881|P1|Overall Study|Death|6
418198|NCT00595075|1398903|P2|Overall Study|Withdrawal by Subject|0
418199|NCT00595075|1398904|P1|Overall Study|Withdrawal by Subject|1
418200|NCT00594958|1398925|P3|Overall Study|administrative|2
418201|NCT00594958|1398926|P2|Overall Study|administrative|0
418202|NCT00594958|1398927|P1|Overall Study|administrative|3
418203|NCT00594958|1398925|P3|Overall Study|Lost to Follow-up|3
418204|NCT00594958|1398926|P2|Overall Study|Lost to Follow-up|0
418205|NCT00594958|1398927|P1|Overall Study|Lost to Follow-up|5
418206|NCT00594958|1398925|P3|Overall Study|Protocol Violation|2
418207|NCT00594958|1398926|P2|Overall Study|Protocol Violation|0
418208|NCT00594958|1398927|P1|Overall Study|Protocol Violation|1
418209|NCT00594958|1398925|P3|Overall Study|Pregnancy|0
418210|NCT00594958|1398926|P2|Overall Study|Pregnancy|2
418211|NCT00594958|1398927|P1|Overall Study|Pregnancy|0
418212|NCT00594958|1398925|P3|Overall Study|Adverse Event|2
418213|NCT00594958|1398926|P2|Overall Study|Adverse Event|1
418214|NCT00594958|1398927|P1|Overall Study|Adverse Event|4
418215|NCT00594958|1398925|P3|Overall Study|Withdrawal by Subject|1
418216|NCT00594958|1398926|P2|Overall Study|Withdrawal by Subject|0
418217|NCT00594958|1398927|P1|Overall Study|Withdrawal by Subject|1
418218|NCT00594906|1398948|P2|Overall Study|Death|1
418219|NCT00594906|1398949|P1|Overall Study|Death|0
418220|NCT00594906|1398948|P2|Overall Study|Physician Decision|1
418221|NCT00594906|1398949|P1|Overall Study|Physician Decision|0
418222|NCT00594906|1398948|P2|Overall Study|Physician Decision|0
418223|NCT00594906|1398949|P1|Overall Study|Physician Decision|1
418224|NCT00594880|1398957|P2|Overall Study|Lost to Follow-up|0
418225|NCT00594880|1398958|P1|Overall Study|Lost to Follow-up|1
418226|NCT00594880|1398957|P2|Overall Study|Withdrawal by Subject|1
418227|NCT00594880|1398958|P1|Overall Study|Withdrawal by Subject|1
418228|NCT00594854|1398970|P2|Overall Study|Study terminated|10
418229|NCT00594854|1398971|P1|Overall Study|Study terminated|7
418230|NCT00594815|1398981|P1|Overall Study|Toxicity|4
418231|NCT00594815|1398981|P1|Overall Study|Withdrawal by Subject|2
418232|NCT00594815|1398981|P1|Overall Study|Never Treated|3
418233|NCT00594659|1399006|P3|Overall Study|Lost to Follow-up|7
418234|NCT00594659|1399007|P2|Overall Study|Lost to Follow-up|9
418235|NCT00594659|1399008|P1|Overall Study|Lost to Follow-up|13
418236|NCT00594646|1399019|P1|Overall Study|Lost to Follow-up|15
418237|NCT00594646|1399019|P1|Overall Study|Withdrawal by Subject|1
418238|NCT00594568|1399027|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
418239|NCT00594568|1399028|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
418240|NCT00594568|1399029|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
418241|NCT00594568|1399027|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
418242|NCT00594568|1399028|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
418243|NCT00594568|1399029|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
418244|NCT00594568|1399027|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
418245|NCT00594568|1399028|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
418246|NCT00594568|1399029|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
418247|NCT00594568|1399027|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
418248|NCT00594568|1399028|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
418249|NCT00594568|1399029|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
418250|NCT00594568|1399027|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
418251|NCT00594568|1399028|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
418252|NCT00594568|1399029|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
418253|NCT00594568|1399027|P3|Safety Follow Up (SFU)-Optional|Death|0
418254|NCT00594568|1399028|P2|Safety Follow Up (SFU)-Optional|Death|1
418255|NCT00594568|1399029|P1|Safety Follow Up (SFU)-Optional|Death|0
418256|NCT00594568|1399027|P3|Delayed Start|Sponsor Decision|59
418257|NCT00594568|1399028|P2|Delayed Start|Sponsor Decision|66
418258|NCT00594568|1399029|P1|Delayed Start|Sponsor Decision|77
418259|NCT00594568|1399027|P3|Delayed Start|Caregiver Decision|2
418260|NCT00594568|1399028|P2|Delayed Start|Caregiver Decision|6
418261|NCT00594568|1399029|P1|Delayed Start|Caregiver Decision|5
418262|NCT00594568|1399027|P3|Delayed Start|Lost to Follow-up|1
418263|NCT00594568|1399028|P2|Delayed Start|Lost to Follow-up|0
418264|NCT00594568|1399029|P1|Delayed Start|Lost to Follow-up|0
418265|NCT00594568|1399027|P3|Delayed Start|Physician Decision|1
418266|NCT00594568|1399028|P2|Delayed Start|Physician Decision|0
418267|NCT00594568|1399029|P1|Delayed Start|Physician Decision|0
418268|NCT00594568|1399027|P3|Delayed Start|Withdrawal by Subject|0
418269|NCT00594568|1399028|P2|Delayed Start|Withdrawal by Subject|3
418270|NCT00594568|1399029|P1|Delayed Start|Withdrawal by Subject|4
418271|NCT00594568|1399027|P3|Delayed Start|Adverse Event|2
418272|NCT00594568|1399028|P2|Delayed Start|Adverse Event|2
418273|NCT00594568|1399029|P1|Delayed Start|Adverse Event|12
418274|NCT00594568|1399027|P3|Delayed Start|Death|1
418275|NCT00594568|1399028|P2|Delayed Start|Death|0
418276|NCT00594568|1399029|P1|Delayed Start|Death|0
418277|NCT00594568|1399027|P3|Initial Treatment|Entry criteria exclusion|1
418278|NCT00594568|1399028|P2|Initial Treatment|Entry criteria exclusion|1
418279|NCT00594568|1399029|P1|Initial Treatment|Entry criteria exclusion|0
418280|NCT00594568|1399027|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
418281|NCT00594568|1399028|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
418282|NCT00594568|1399029|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
418283|NCT00594568|1399027|P3|Initial Treatment|Caregiver decision|36
418284|NCT00594568|1399028|P2|Initial Treatment|Caregiver decision|36
418285|NCT00594568|1399029|P1|Initial Treatment|Caregiver decision|21
418286|NCT00594568|1399027|P3|Initial Treatment|Sponsor decision|147
418287|NCT00594568|1399028|P2|Initial Treatment|Sponsor decision|142
418288|NCT00594568|1399029|P1|Initial Treatment|Sponsor decision|193
418289|NCT00594568|1399027|P3|Initial Treatment|Withdrawal by Subject|46
418290|NCT00594568|1399028|P2|Initial Treatment|Withdrawal by Subject|31
418291|NCT00594568|1399029|P1|Initial Treatment|Withdrawal by Subject|25
418292|NCT00594568|1399027|P3|Initial Treatment|Protocol Violation|5
418293|NCT00594568|1399028|P2|Initial Treatment|Protocol Violation|2
418294|NCT00594568|1399029|P1|Initial Treatment|Protocol Violation|2
418295|NCT00594568|1399027|P3|Initial Treatment|Physician Decision|4
418296|NCT00594568|1399028|P2|Initial Treatment|Physician Decision|2
418297|NCT00594568|1399029|P1|Initial Treatment|Physician Decision|3
418298|NCT00594568|1399027|P3|Initial Treatment|Lost to Follow-up|4
418299|NCT00594568|1399028|P2|Initial Treatment|Lost to Follow-up|1
418300|NCT00594568|1399029|P1|Initial Treatment|Lost to Follow-up|4
418301|NCT00594568|1399027|P3|Initial Treatment|Death|15
418302|NCT00594568|1399028|P2|Initial Treatment|Death|11
418303|NCT00594568|1399029|P1|Initial Treatment|Death|6
418304|NCT00594568|1399027|P3|Initial Treatment|Adverse Event|144
418305|NCT00594568|1399028|P2|Initial Treatment|Adverse Event|121
418306|NCT00594568|1399029|P1|Initial Treatment|Adverse Event|51
418307|NCT00594516|1399117|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
418308|NCT00594516|1399118|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
418309|NCT00594516|1399119|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
418310|NCT00594516|1399117|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
418311|NCT00594516|1399118|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
418312|NCT00594516|1399119|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
418313|NCT00594516|1399117|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
418314|NCT00594516|1399118|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
418315|NCT00594516|1399119|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
418316|NCT00594516|1399117|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
418317|NCT00594516|1399118|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
418318|NCT00594516|1399119|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
418319|NCT00594516|1399117|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
418320|NCT00594516|1399118|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
418321|NCT00594516|1399119|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
418322|NCT00594516|1399117|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
418323|NCT00594516|1399118|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
418324|NCT00594516|1399119|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
418325|NCT00594516|1399117|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
418326|NCT00594516|1399118|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
418327|NCT00594516|1399119|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
418328|NCT00594516|1399117|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
418329|NCT00594516|1399118|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
418330|NCT00594516|1399119|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
418331|NCT00594516|1399117|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
418332|NCT00594516|1399118|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
418333|NCT00594516|1399119|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
418334|NCT00594464|1399127|P1|Overall Study|Delay in operation|2
418335|NCT00594464|1399127|P1|Overall Study|Withdrawal by Subject|1
418336|NCT00594399|1399256|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
418337|NCT00594399|1399257|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
418338|NCT00594399|1399258|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
418339|NCT00594399|1399256|P3|Rerandomization Arm 1 Only|Death|0
418340|NCT00594399|1399257|P2|Rerandomization Arm 1 Only|Death|1
418341|NCT00594399|1399258|P1|Rerandomization Arm 1 Only|Death|2
418342|NCT00594399|1399256|P3|Initial 3 Month Counseling|Family illness|0
418343|NCT00594399|1399257|P2|Initial 3 Month Counseling|Family illness|0
418344|NCT00594399|1399258|P1|Initial 3 Month Counseling|Family illness|1
418345|NCT00594399|1399256|P3|Initial 3 Month Counseling|Moved|0
418346|NCT00594399|1399257|P2|Initial 3 Month Counseling|Moved|0
418347|NCT00594399|1399258|P1|Initial 3 Month Counseling|Moved|1
418348|NCT00594399|1399256|P3|Initial 3 Month Counseling|Pain|0
418349|NCT00594399|1399257|P2|Initial 3 Month Counseling|Pain|0
418350|NCT00594399|1399258|P1|Initial 3 Month Counseling|Pain|2
418351|NCT00594399|1399256|P3|Initial 3 Month Counseling|Too busy|0
418352|NCT00594399|1399257|P2|Initial 3 Month Counseling|Too busy|1
418353|NCT00594399|1399258|P1|Initial 3 Month Counseling|Too busy|7
418354|NCT00594399|1399256|P3|Initial 3 Month Counseling|Personal issues|0
418355|NCT00594399|1399257|P2|Initial 3 Month Counseling|Personal issues|0
418356|NCT00594399|1399258|P1|Initial 3 Month Counseling|Personal issues|2
418357|NCT00594399|1399256|P3|Initial 3 Month Counseling|Lack of Interest|0
418358|NCT00594399|1399257|P2|Initial 3 Month Counseling|Lack of Interest|3
418359|NCT00594399|1399258|P1|Initial 3 Month Counseling|Lack of Interest|3
418360|NCT00594399|1399256|P3|Initial 3 Month Counseling|Not ready to exercise|0
418361|NCT00594399|1399257|P2|Initial 3 Month Counseling|Not ready to exercise|0
418362|NCT00594399|1399258|P1|Initial 3 Month Counseling|Not ready to exercise|1
418363|NCT00594386|1399280|P1|Overall Study|Other: Loss of drivers license|1
418364|NCT00594386|1399280|P1|Overall Study|Other: Patient wants prescription Neupro|1
418365|NCT00594386|1399280|P1|Overall Study|Other: Site terminated participation|1
418366|NCT00594386|1399280|P1|Overall Study|Other: Sponsor closure of study|1
418367|NCT00594386|1399280|P1|Overall Study|Other: Study terminated per investigator|2
418368|NCT00594386|1399280|P1|Overall Study|Other: Subject admitted to nursing home|1
418369|NCT00594386|1399280|P1|Overall Study|Other: Subject moved to Seattle|1
418370|NCT00594386|1399280|P1|Overall Study|Other: Patient went off patch (hospital)|1
418371|NCT00594386|1399280|P1|Overall Study|Lost to Follow-up|6
418372|NCT00594386|1399280|P1|Overall Study|Study ended per sponsor|115
418373|NCT00594386|1399280|P1|Overall Study|Subject withdrew consent|35
418374|NCT00594386|1399280|P1|Overall Study|Unsatisfactory compliance of subject|11
418375|NCT00594386|1399280|P1|Overall Study|Adverse Event|68
418376|NCT00594386|1399280|P1|Overall Study|Lack of Efficacy|12
418377|NCT00594386|1399280|P1|Overall Study|Major protocol violation|2
418378|NCT00594204|1399313|P2|Overall Study|Randomized but not treated|1
418379|NCT00594204|1399314|P1|Overall Study|Randomized but not treated|4
418380|NCT00594204|1399313|P2|Overall Study|Lack of Efficacy|4
418381|NCT00594204|1399314|P1|Overall Study|Lack of Efficacy|3
418382|NCT00594204|1399313|P2|Overall Study|Other|3
418383|NCT00594204|1399314|P1|Overall Study|Other|4
418384|NCT00594204|1399313|P2|Overall Study|Withdrawal by Subject|29
418385|NCT00594204|1399314|P1|Overall Study|Withdrawal by Subject|23
418386|NCT00594204|1399313|P2|Overall Study|Lost to Follow-up|5
418387|NCT00594204|1399314|P1|Overall Study|Lost to Follow-up|9
418388|NCT00594204|1399313|P2|Overall Study|Adverse Event|3
418389|NCT00594204|1399314|P1|Overall Study|Adverse Event|15
418390|NCT00594178|1399324|P1|Overall Study|Physician Decision|5
418391|NCT00594165|1399329|P1|Overall Study|Other: Site terminated participation|2
418392|NCT00594165|1399329|P1|Overall Study|Other: Subject enrolled in other trial|1
418393|NCT00594165|1399329|P1|Overall Study|Other: House bound; can't get to clinic|1
418394|NCT00594165|1399329|P1|Overall Study|Other: Brain surgery controlled symptoms|1
418395|NCT00594165|1399329|P1|Overall Study|Other: Subject moving|3
418396|NCT00594165|1399329|P1|Overall Study|Other: PI discretion|5
418397|NCT00594165|1399329|P1|Overall Study|Lost to Follow-up|4
418398|NCT00594165|1399329|P1|Overall Study|Study ended per sponsor|102
418399|NCT00594165|1399329|P1|Overall Study|Subject withdrew consent|27
418400|NCT00594165|1399329|P1|Overall Study|Unsatisfactory compliance of subject|6
418401|NCT00594165|1399329|P1|Overall Study|Adverse Event|52
418402|NCT00594165|1399329|P1|Overall Study|Lack of Efficacy|12
418403|NCT00594165|1399329|P1|Overall Study|Major protocol violation|1
418404|NCT00594100|1399335|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
418405|NCT00594100|1399335|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
418406|NCT00594100|1399335|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
418407|NCT00594100|1399335|P1|Procedure|Technical Failure|9
418408|NCT00594035|1399351|P2|Overall Study|Subject couldn't return due to job|1
418409|NCT00594035|1399352|P1|Overall Study|Subject couldn't return due to job|0
418410|NCT00594035|1399351|P2|Overall Study|Subject transferred to nursing home|1
418411|NCT00594035|1399352|P1|Overall Study|Subject transferred to nursing home|0
418412|NCT00594035|1399351|P2|Overall Study|Withdrawal by Subject|0
418413|NCT00594035|1399352|P1|Overall Study|Withdrawal by Subject|1
418414|NCT00594035|1399351|P2|Overall Study|Lost to Follow-up|1
418415|NCT00594035|1399352|P1|Overall Study|Lost to Follow-up|1
418416|NCT00593957|1399378|P3|Overall Study|Physician Decision|2
418417|NCT00593957|1399379|P2|Overall Study|Physician Decision|1
418418|NCT00593957|1399380|P1|Overall Study|Physician Decision|0
418419|NCT00593918|1399404|P2|Overall Study|Withdrawal by Subject|24
418420|NCT00593918|1399405|P1|Overall Study|Withdrawal by Subject|5
418421|NCT00593840|1399418|P1|Overall Study|Withdrawal by Subject|1
418422|NCT00593827|1399430|P2|Overall Study|On Active Treatment/Pending|2
418423|NCT00593827|1399431|P1|Overall Study|On Active Treatment/Pending|0
418424|NCT00593814|1399455|P2|Overall Study|Physician Decision|0
418425|NCT00593814|1399456|P1|Overall Study|Physician Decision|3
418426|NCT00593814|1399455|P2|Overall Study|Lost to Follow-up|0
418427|NCT00593814|1399456|P1|Overall Study|Lost to Follow-up|7
418428|NCT00593814|1399455|P2|Overall Study|Withdrawal by Subject|0
418429|NCT00593814|1399456|P1|Overall Study|Withdrawal by Subject|7
418430|NCT00593814|1399455|P2|Overall Study|Death|0
418431|NCT00593814|1399456|P1|Overall Study|Death|7
418432|NCT00593736|1399468|P4|Treatment Period and Placebo Run-out|Various|0
418433|NCT00593736|1399469|P3|Treatment Period and Placebo Run-out|Various|1
418434|NCT00593736|1399470|P2|Treatment Period and Placebo Run-out|Various|1
418435|NCT00593736|1399471|P1|Treatment Period and Placebo Run-out|Various|1
418436|NCT00593736|1399468|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
418437|NCT00593736|1399469|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
418438|NCT00593736|1399470|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
418439|NCT00593736|1399471|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
418440|NCT00593736|1399468|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
418441|NCT00593736|1399469|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
418442|NCT00593736|1399470|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
418443|NCT00593736|1399471|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
418444|NCT00593736|1399468|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
418445|NCT00593736|1399469|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
418446|NCT00593736|1399470|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
418447|NCT00593736|1399471|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
418448|NCT00593736|1399468|P4|Screening Period and Placebo Run-in|Various|25
418449|NCT00593736|1399469|P3|Screening Period and Placebo Run-in|Various|0
418450|NCT00593736|1399470|P2|Screening Period and Placebo Run-in|Various|0
418451|NCT00593736|1399471|P1|Screening Period and Placebo Run-in|Various|0
418452|NCT00593736|1399468|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
418453|NCT00593736|1399469|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
418454|NCT00593736|1399470|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
418455|NCT00593736|1399471|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
418456|NCT00593736|1399468|P4|Screening Period and Placebo Run-in|Study Termination|15
418457|NCT00593736|1399469|P3|Screening Period and Placebo Run-in|Study Termination|0
418458|NCT00593736|1399470|P2|Screening Period and Placebo Run-in|Study Termination|0
418459|NCT00593736|1399471|P1|Screening Period and Placebo Run-in|Study Termination|0
418460|NCT00593736|1399468|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
418461|NCT00593736|1399469|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
418462|NCT00593736|1399470|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
418463|NCT00593736|1399471|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
418464|NCT00593736|1399468|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
418465|NCT00593736|1399469|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
418466|NCT00593736|1399470|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
418467|NCT00593736|1399471|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
418468|NCT00593736|1399468|P4|Screening Period and Placebo Run-in|Adverse Event|3
418469|NCT00593736|1399469|P3|Screening Period and Placebo Run-in|Adverse Event|0
418470|NCT00593736|1399470|P2|Screening Period and Placebo Run-in|Adverse Event|0
418471|NCT00593736|1399471|P1|Screening Period and Placebo Run-in|Adverse Event|0
418472|NCT00593684|1399719|P2|Overall Study|Death|1
418473|NCT00593684|1399720|P1|Overall Study|Death|2
418474|NCT00593606|1399746|P1|Overall Study|Screen Failure|3
418475|NCT00593606|1399746|P1|Overall Study|Run-In Failure|5
418476|NCT00593606|1399746|P1|Overall Study|Lost to Follow-up|2
418477|NCT00593606|1399746|P1|Overall Study|Protocol Violation|3
418478|NCT00593606|1399746|P1|Overall Study|Withdrawal by Subject|1
418479|NCT00593606|1399746|P1|Overall Study|Adverse Event|13
418480|NCT00593554|1399844|P2|Overall Study|Disease Progression|2
418481|NCT00593554|1399845|P1|Overall Study|Disease Progression|1
418482|NCT00593554|1399844|P2|Overall Study|Withdrawal by Subject|0
418483|NCT00593554|1399845|P1|Overall Study|Withdrawal by Subject|1
418484|NCT00593554|1399844|P2|Overall Study|Physician Decision|1
418485|NCT00593554|1399845|P1|Overall Study|Physician Decision|0
418486|NCT00593554|1399844|P2|Overall Study|Death|2
418487|NCT00593554|1399845|P1|Overall Study|Death|1
418488|NCT00593385|1399940|P1|Overall Study|Withdrawal by Subject|9
418489|NCT00593385|1399940|P1|Overall Study|Lost to Follow-up|17
418490|NCT00593385|1399940|P1|Overall Study|Death|14
418491|NCT00593333|1400001|P2|Overall Study|Lost to Follow-up|11
418492|NCT00593333|1400002|P1|Overall Study|Lost to Follow-up|10
418493|NCT00593112|1400025|P2|Overall Study|Withdrawal by Subject|0
418494|NCT00593112|1400026|P1|Overall Study|Withdrawal by Subject|5
418495|NCT00593112|1400025|P2|Overall Study|Unreadable Scan|0
418496|NCT00593112|1400026|P1|Overall Study|Unreadable Scan|1
418497|NCT00593112|1400025|P2|Overall Study|Abnormal Scan|0
418498|NCT00593112|1400026|P1|Overall Study|Abnormal Scan|1
418499|NCT00593112|1400025|P2|Overall Study|Scan Anxiety|0
418500|NCT00593112|1400026|P1|Overall Study|Scan Anxiety|3
418501|NCT00592904|1400053|P4|Overall Study|Not specified|0
418502|NCT00592904|1400054|P3|Overall Study|Not specified|0
418503|NCT00592904|1400055|P2|Overall Study|Not specified|3
418504|NCT00592904|1400056|P1|Overall Study|Not specified|3
418505|NCT00592904|1400053|P4|Overall Study|Physician Decision|0
418506|NCT00592904|1400054|P3|Overall Study|Physician Decision|1
418507|NCT00592904|1400055|P2|Overall Study|Physician Decision|3
418508|NCT00592904|1400056|P1|Overall Study|Physician Decision|0
418509|NCT00592904|1400053|P4|Overall Study|Lack of Efficacy|3
418510|NCT00592904|1400054|P3|Overall Study|Lack of Efficacy|2
418511|NCT00592904|1400055|P2|Overall Study|Lack of Efficacy|7
418512|NCT00592904|1400056|P1|Overall Study|Lack of Efficacy|2
418513|NCT00592904|1400053|P4|Overall Study|Withdrawal by Subject|2
418514|NCT00592904|1400054|P3|Overall Study|Withdrawal by Subject|1
418515|NCT00592904|1400055|P2|Overall Study|Withdrawal by Subject|16
418516|NCT00592904|1400056|P1|Overall Study|Withdrawal by Subject|4
418517|NCT00592904|1400053|P4|Overall Study|Protocol Violation|1
418518|NCT00592904|1400054|P3|Overall Study|Protocol Violation|0
418519|NCT00592904|1400055|P2|Overall Study|Protocol Violation|1
418520|NCT00592904|1400056|P1|Overall Study|Protocol Violation|1
418521|NCT00592904|1400053|P4|Overall Study|Adverse Event|5
418522|NCT00592904|1400054|P3|Overall Study|Adverse Event|13
418523|NCT00592904|1400055|P2|Overall Study|Adverse Event|25
418524|NCT00592904|1400056|P1|Overall Study|Adverse Event|15
418525|NCT00592852|1400082|P1|Overall Study|Withdrawal by Subject|1
418526|NCT00592852|1400082|P1|Overall Study|Found ineligible|1
418527|NCT00592852|1400082|P1|Overall Study|Adverse Event|3
418528|NCT00592852|1400082|P1|Overall Study|Non-compliance|1
418529|NCT00592839|1400090|P3|Overall Study|Lost to Follow-up|1
418530|NCT00592839|1400091|P2|Overall Study|Lost to Follow-up|1
418531|NCT00592839|1400092|P1|Overall Study|Lost to Follow-up|0
418532|NCT00592839|1400090|P3|Overall Study|Adverse Event|0
418533|NCT00592839|1400091|P2|Overall Study|Adverse Event|1
418534|NCT00592839|1400092|P1|Overall Study|Adverse Event|0
418535|NCT00592839|1400090|P3|Overall Study|Protocol Violation|2
418536|NCT00592839|1400091|P2|Overall Study|Protocol Violation|1
418537|NCT00592839|1400092|P1|Overall Study|Protocol Violation|1
418538|NCT00592839|1400090|P3|Overall Study|Withdrawal by Subject|3
418539|NCT00592839|1400091|P2|Overall Study|Withdrawal by Subject|1
418540|NCT00592839|1400092|P1|Overall Study|Withdrawal by Subject|1
418541|NCT00592774|1400120|P5|Overall Study|Not specified|2
418542|NCT00592774|1400121|P4|Overall Study|Not specified|0
418543|NCT00592774|1400122|P3|Overall Study|Not specified|1
418544|NCT00592774|1400123|P2|Overall Study|Not specified|1
418545|NCT00592774|1400124|P1|Overall Study|Not specified|0
418546|NCT00592774|1400120|P5|Overall Study|Physician Decision|1
418547|NCT00592774|1400121|P4|Overall Study|Physician Decision|0
418548|NCT00592774|1400122|P3|Overall Study|Physician Decision|1
418549|NCT00592774|1400123|P2|Overall Study|Physician Decision|1
418550|NCT00592774|1400124|P1|Overall Study|Physician Decision|0
418551|NCT00592774|1400120|P5|Overall Study|Lack of Efficacy|2
418552|NCT00592774|1400121|P4|Overall Study|Lack of Efficacy|0
418553|NCT00592774|1400122|P3|Overall Study|Lack of Efficacy|0
418554|NCT00592774|1400123|P2|Overall Study|Lack of Efficacy|3
418555|NCT00592774|1400124|P1|Overall Study|Lack of Efficacy|3
418556|NCT00592774|1400120|P5|Overall Study|Withdrawal by Subject|0
418557|NCT00592774|1400121|P4|Overall Study|Withdrawal by Subject|0
418558|NCT00592774|1400122|P3|Overall Study|Withdrawal by Subject|0
418559|NCT00592774|1400123|P2|Overall Study|Withdrawal by Subject|7
418560|NCT00592774|1400124|P1|Overall Study|Withdrawal by Subject|3
418561|NCT00592774|1400120|P5|Overall Study|Protocol Violation|1
418562|NCT00592774|1400121|P4|Overall Study|Protocol Violation|0
418563|NCT00592774|1400122|P3|Overall Study|Protocol Violation|0
418564|NCT00592774|1400123|P2|Overall Study|Protocol Violation|1
418565|NCT00592774|1400124|P1|Overall Study|Protocol Violation|0
418566|NCT00592774|1400120|P5|Overall Study|Adverse Event|8
418567|NCT00592774|1400121|P4|Overall Study|Adverse Event|14
418568|NCT00592774|1400122|P3|Overall Study|Adverse Event|2
418569|NCT00592774|1400123|P2|Overall Study|Adverse Event|19
418570|NCT00592774|1400124|P1|Overall Study|Adverse Event|5
418571|NCT00592683|1400196|P2|Overall Study|Lost to Follow-up|1
418572|NCT00592683|1400197|P1|Overall Study|Lost to Follow-up|0
418573|NCT00592683|1400196|P2|Overall Study|Other|0
418574|NCT00592683|1400197|P1|Overall Study|Other|1
418575|NCT00592683|1400196|P2|Overall Study|Study drug expired|0
418576|NCT00592683|1400197|P1|Overall Study|Study drug expired|1
418577|NCT00592683|1400196|P2|Overall Study|Protocol Violation|0
418578|NCT00592683|1400197|P1|Overall Study|Protocol Violation|1
418579|NCT00592683|1400196|P2|Overall Study|Adverse Event|2
418580|NCT00592683|1400197|P1|Overall Study|Adverse Event|0
418581|NCT00592683|1400196|P2|Overall Study|Withdrawal by Subject|0
418582|NCT00592683|1400197|P1|Overall Study|Withdrawal by Subject|1
418583|NCT00592683|1400196|P2|Overall Study|Found ineligible|1
418584|NCT00592683|1400197|P1|Overall Study|Found ineligible|0
418585|NCT00592631|1400207|P2|Overall Study|Lost to Follow-up|2
418586|NCT00592631|1400208|P1|Overall Study|Lost to Follow-up|0
418587|NCT00592384|1400257|P2|Overall Study|Withdrawal by Subject|6
418588|NCT00592384|1400258|P1|Overall Study|Withdrawal by Subject|5
418589|NCT00592358|1400266|P1|Overall Study|Inability to swallow pills|1
418590|NCT00592358|1400266|P1|Overall Study|Lack of Efficacy|2
418591|NCT00592358|1400266|P1|Overall Study|Adverse Event|1
418592|NCT00592358|1400266|P1|Overall Study|Withdrawal by Subject|2
418593|NCT00592319|1400273|P2|Overall Study|Lost to Follow-up|3
418594|NCT00592319|1400274|P1|Overall Study|Lost to Follow-up|0
418595|NCT00592072|1400349|P2|Wash Out Period|Lost to Follow-up|1
418596|NCT00592072|1400350|P1|Wash Out Period|Lost to Follow-up|1
418597|NCT00592007|1400372|P1|Overall Study|patient ineligible (out of lab range)|1
418598|NCT00592007|1400372|P1|Overall Study|Withdrawal by Subject|1
418599|NCT00591864|1400384|P1|Overall Study|Incomplete Imaging|5
418600|NCT00591851|1400390|P1|Overall Study|Progressive Disease|1
418601|NCT00591851|1400390|P1|Overall Study|Adverse Event|2
418602|NCT00591851|1400390|P1|Overall Study|Withdrawal by Subject|3
418603|NCT00591773|1400430|P3|Overall Study|Other|4
418604|NCT00591773|1400431|P2|Overall Study|Other|1
418605|NCT00591773|1400432|P1|Overall Study|Other|1
418606|NCT00591773|1400430|P3|Overall Study|Lack of Efficacy|2
418607|NCT00591773|1400431|P2|Overall Study|Lack of Efficacy|2
418608|NCT00591773|1400432|P1|Overall Study|Lack of Efficacy|1
418609|NCT00591773|1400430|P3|Overall Study|Withdrawal by Subject|3
418610|NCT00591773|1400431|P2|Overall Study|Withdrawal by Subject|5
418611|NCT00591773|1400432|P1|Overall Study|Withdrawal by Subject|2
418612|NCT00591773|1400430|P3|Overall Study|Lost to Follow-up|1
418613|NCT00591773|1400431|P2|Overall Study|Lost to Follow-up|4
418614|NCT00591773|1400432|P1|Overall Study|Lost to Follow-up|1
418615|NCT00591773|1400430|P3|Overall Study|Protocol Violation|0
418616|NCT00591773|1400431|P2|Overall Study|Protocol Violation|3
418617|NCT00591773|1400432|P1|Overall Study|Protocol Violation|2
418618|NCT00591773|1400430|P3|Overall Study|Adverse Event|6
418619|NCT00591773|1400431|P2|Overall Study|Adverse Event|9
418620|NCT00591773|1400432|P1|Overall Study|Adverse Event|9
418621|NCT00591734|1400491|P1|Overall Study|Intercurrent Illness|8
418622|NCT00591734|1400491|P1|Overall Study|Physician Decision|5
418623|NCT00591734|1400491|P1|Overall Study|Adverse Event|5
418624|NCT00591734|1400491|P1|Overall Study|Lack of Efficacy|35
418625|NCT00591721|1400497|P2|Overall Study|Intervention not received|8
418626|NCT00591721|1400498|P1|Overall Study|Intervention not received|10
418627|NCT00591721|1400497|P2|Overall Study|Lost to Follow-up|4
418628|NCT00591721|1400498|P1|Overall Study|Lost to Follow-up|1
418629|NCT00591721|1400497|P2|Overall Study|Withdrawal by Subject|10
418630|NCT00591721|1400498|P1|Overall Study|Withdrawal by Subject|10
418631|NCT00591591|1400506|P2|Overall Study|Lack of Efficacy|2
418632|NCT00591591|1400507|P1|Overall Study|Lack of Efficacy|10
418633|NCT00591591|1400506|P2|Overall Study|Withdrawal by Subject|37
418634|NCT00591591|1400507|P1|Overall Study|Withdrawal by Subject|1
418635|NCT00591578|1400524|P3|Open-Label Extension Phase|Other|0
418636|NCT00591578|1400525|P2|Open-Label Extension Phase|Other|0
418637|NCT00591578|1400526|P1|Open-Label Extension Phase|Other|1
418638|NCT00591578|1400524|P3|Open-Label Extension Phase|Withdrawal by Subject|0
418639|NCT00591578|1400525|P2|Open-Label Extension Phase|Withdrawal by Subject|1
418640|NCT00591578|1400526|P1|Open-Label Extension Phase|Withdrawal by Subject|1
418641|NCT00591578|1400524|P3|Open-Label Extension Phase|Lost to Follow-up|0
418642|NCT00591578|1400525|P2|Open-Label Extension Phase|Lost to Follow-up|4
418643|NCT00591578|1400526|P1|Open-Label Extension Phase|Lost to Follow-up|1
418644|NCT00591578|1400524|P3|Open-Label Extension Phase|Adverse Event|0
418645|NCT00591578|1400525|P2|Open-Label Extension Phase|Adverse Event|5
418646|NCT00591578|1400526|P1|Open-Label Extension Phase|Adverse Event|3
418647|NCT00591578|1400524|P3|Double-Blind Treatment Phase|Other|4
418648|NCT00591578|1400525|P2|Double-Blind Treatment Phase|Other|9
418649|NCT00591578|1400526|P1|Double-Blind Treatment Phase|Other|4
418650|NCT00591578|1400524|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
418651|NCT00591578|1400525|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
418652|NCT00591578|1400526|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
418653|NCT00591578|1400524|P3|Double-Blind Treatment Phase|Pregnancy|0
418654|NCT00591578|1400525|P2|Double-Blind Treatment Phase|Pregnancy|0
418655|NCT00591578|1400526|P1|Double-Blind Treatment Phase|Pregnancy|1
418656|NCT00591578|1400524|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
418657|NCT00591578|1400525|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
418658|NCT00591578|1400526|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
418659|NCT00591578|1400524|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
418660|NCT00591578|1400525|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
418661|NCT00591578|1400526|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
418662|NCT00591578|1400524|P3|Double-Blind Treatment Phase|Protocol Violation|3
418663|NCT00591578|1400525|P2|Double-Blind Treatment Phase|Protocol Violation|2
418664|NCT00591578|1400526|P1|Double-Blind Treatment Phase|Protocol Violation|3
418665|NCT00591578|1400524|P3|Double-Blind Treatment Phase|Adverse Event|19
418666|NCT00591578|1400525|P2|Double-Blind Treatment Phase|Adverse Event|26
418667|NCT00591578|1400526|P1|Double-Blind Treatment Phase|Adverse Event|20
418668|NCT00591565|1400577|P1|Overall Study|lost follow up, withdrawn|5
418669|NCT00591370|1400581|P1|Overall Study|Not Treated|2
418670|NCT00591344|1400589|P2|Overall Study|Did not want to come off medication|1
418671|NCT00591344|1400590|P1|Overall Study|Did not want to come off medication|0
418672|NCT00591344|1400589|P2|Overall Study|Lost to Follow-up|1
418673|NCT00591344|1400590|P1|Overall Study|Lost to Follow-up|0
418674|NCT00591344|1400589|P2|Overall Study|Death|1
418675|NCT00591344|1400590|P1|Overall Study|Death|0
418676|NCT00591344|1400589|P2|Overall Study|Underwent DBS|2
418677|NCT00591344|1400590|P1|Overall Study|Underwent DBS|2
418678|NCT00591344|1400589|P2|Overall Study|Medical complications|3
418679|NCT00591344|1400590|P1|Overall Study|Medical complications|1
418680|NCT00591344|1400589|P2|Overall Study|Moved out of state|0
418681|NCT00591344|1400590|P1|Overall Study|Moved out of state|1
418682|NCT00591344|1400589|P2|Overall Study|Transportation issues|0
418683|NCT00591344|1400590|P1|Overall Study|Transportation issues|1
418684|NCT00591266|1400616|P3|Overall Study|Other|5
418685|NCT00591266|1400617|P2|Overall Study|Other|4
418686|NCT00591266|1400618|P1|Overall Study|Other|1
418687|NCT00591266|1400616|P3|Overall Study|Lack of Efficacy|0
418688|NCT00591266|1400617|P2|Overall Study|Lack of Efficacy|2
418689|NCT00591266|1400618|P1|Overall Study|Lack of Efficacy|0
418690|NCT00591266|1400616|P3|Overall Study|Withdrawal by Subject|5
418691|NCT00591266|1400617|P2|Overall Study|Withdrawal by Subject|2
418692|NCT00591266|1400618|P1|Overall Study|Withdrawal by Subject|6
418693|NCT00591266|1400616|P3|Overall Study|Protocol Violation|1
418694|NCT00591266|1400617|P2|Overall Study|Protocol Violation|0
418695|NCT00591266|1400618|P1|Overall Study|Protocol Violation|0
418696|NCT00591266|1400616|P3|Overall Study|Lost to Follow-up|0
418697|NCT00591266|1400617|P2|Overall Study|Lost to Follow-up|1
418698|NCT00591266|1400618|P1|Overall Study|Lost to Follow-up|0
418699|NCT00591266|1400616|P3|Overall Study|Adverse Event|3
418700|NCT00591266|1400617|P2|Overall Study|Adverse Event|2
418701|NCT00591266|1400618|P1|Overall Study|Adverse Event|2
418702|NCT00591253|1400671|P3|Overall Study|Other|3
418703|NCT00591253|1400672|P2|Overall Study|Other|5
418704|NCT00591253|1400673|P1|Overall Study|Other|5
418705|NCT00591253|1400671|P3|Overall Study|Lack of Efficacy|3
418706|NCT00591253|1400672|P2|Overall Study|Lack of Efficacy|0
418707|NCT00591253|1400673|P1|Overall Study|Lack of Efficacy|1
418708|NCT00591253|1400671|P3|Overall Study|Withdrawal by Subject|6
418709|NCT00591253|1400672|P2|Overall Study|Withdrawal by Subject|7
418710|NCT00591253|1400673|P1|Overall Study|Withdrawal by Subject|1
418711|NCT00591253|1400671|P3|Overall Study|Lost to Follow-up|0
418712|NCT00591253|1400672|P2|Overall Study|Lost to Follow-up|4
418713|NCT00591253|1400673|P1|Overall Study|Lost to Follow-up|2
418714|NCT00591253|1400671|P3|Overall Study|Protocol Violation|2
418715|NCT00591253|1400672|P2|Overall Study|Protocol Violation|2
418716|NCT00591253|1400673|P1|Overall Study|Protocol Violation|2
418717|NCT00591253|1400671|P3|Overall Study|Adverse Event|1
418718|NCT00591253|1400672|P2|Overall Study|Adverse Event|3
418719|NCT00591253|1400673|P1|Overall Study|Adverse Event|3
418720|NCT00591214|1400741|P1|Overall Study|Withdrawal by Subject|1
418721|NCT00591214|1400741|P1|Overall Study|Physician Decision|7
418722|NCT00591149|1400750|P1|Overall Study|Withdrawal by Subject|1
418723|NCT00591149|1400750|P1|Overall Study|Adverse Event|4
418724|NCT00591006|1400766|P24|Overall Study|Adverse Event|0
418725|NCT00591006|1400767|P23|Overall Study|Adverse Event|1
418726|NCT00591006|1400768|P22|Overall Study|Adverse Event|0
418727|NCT00591006|1400769|P21|Overall Study|Adverse Event|0
418728|NCT00591006|1400770|P20|Overall Study|Adverse Event|0
418729|NCT00591006|1400771|P19|Overall Study|Adverse Event|0
418730|NCT00591006|1400772|P18|Overall Study|Adverse Event|0
418731|NCT00591006|1400773|P17|Overall Study|Adverse Event|0
418732|NCT00591006|1400774|P16|Overall Study|Adverse Event|0
418733|NCT00591006|1400775|P15|Overall Study|Adverse Event|0
418734|NCT00591006|1400776|P14|Overall Study|Adverse Event|0
418735|NCT00591006|1400777|P13|Overall Study|Adverse Event|0
418736|NCT00591006|1400778|P12|Overall Study|Adverse Event|0
418737|NCT00591006|1400779|P11|Overall Study|Adverse Event|0
418738|NCT00591006|1400780|P10|Overall Study|Adverse Event|0
418739|NCT00591006|1400781|P9|Overall Study|Adverse Event|0
418740|NCT00591006|1400782|P8|Overall Study|Adverse Event|0
418741|NCT00591006|1400783|P7|Overall Study|Adverse Event|0
418742|NCT00591006|1400784|P6|Overall Study|Adverse Event|0
418743|NCT00591006|1400785|P5|Overall Study|Adverse Event|0
418744|NCT00591006|1400786|P4|Overall Study|Adverse Event|0
418745|NCT00591006|1400787|P3|Overall Study|Adverse Event|0
418746|NCT00591006|1400788|P2|Overall Study|Adverse Event|0
418747|NCT00591006|1400789|P1|Overall Study|Adverse Event|0
418748|NCT00591006|1400766|P24|Overall Study|Withdrawal by Subject|1
418749|NCT00591006|1400767|P23|Overall Study|Withdrawal by Subject|0
418750|NCT00591006|1400768|P22|Overall Study|Withdrawal by Subject|0
418751|NCT00591006|1400769|P21|Overall Study|Withdrawal by Subject|0
418752|NCT00591006|1400770|P20|Overall Study|Withdrawal by Subject|0
418753|NCT00591006|1400771|P19|Overall Study|Withdrawal by Subject|0
418754|NCT00591006|1400772|P18|Overall Study|Withdrawal by Subject|0
418755|NCT00591006|1400773|P17|Overall Study|Withdrawal by Subject|0
418756|NCT00591006|1400774|P16|Overall Study|Withdrawal by Subject|1
418757|NCT00591006|1400775|P15|Overall Study|Withdrawal by Subject|0
418758|NCT00591006|1400776|P14|Overall Study|Withdrawal by Subject|0
418759|NCT00591006|1400777|P13|Overall Study|Withdrawal by Subject|0
418760|NCT00591006|1400778|P12|Overall Study|Withdrawal by Subject|0
418761|NCT00591006|1400779|P11|Overall Study|Withdrawal by Subject|0
418762|NCT00591006|1400780|P10|Overall Study|Withdrawal by Subject|0
418763|NCT00591006|1400781|P9|Overall Study|Withdrawal by Subject|0
418764|NCT00591006|1400782|P8|Overall Study|Withdrawal by Subject|0
418765|NCT00591006|1400783|P7|Overall Study|Withdrawal by Subject|0
418766|NCT00591006|1400784|P6|Overall Study|Withdrawal by Subject|0
418767|NCT00591006|1400785|P5|Overall Study|Withdrawal by Subject|0
418768|NCT00591006|1400786|P4|Overall Study|Withdrawal by Subject|0
418769|NCT00591006|1400787|P3|Overall Study|Withdrawal by Subject|0
418770|NCT00591006|1400788|P2|Overall Study|Withdrawal by Subject|0
418771|NCT00591006|1400789|P1|Overall Study|Withdrawal by Subject|0
418772|NCT00590980|1400807|P1|Overall Study|Did not meet all inclusion criteria|10
418773|NCT00590967|1400813|P2|Overall Study|Did not receive chemo per protocol|0
418774|NCT00590967|1400814|P1|Overall Study|Did not receive chemo per protocol|1
418775|NCT00590967|1400813|P2|Overall Study|Did not sign consent form|1
418776|NCT00590967|1400814|P1|Overall Study|Did not sign consent form|0
418777|NCT00590967|1400813|P2|Overall Study|Non-compliant|2
418778|NCT00590967|1400814|P1|Overall Study|Non-compliant|0
418779|NCT00590967|1400813|P2|Overall Study|Poor performance status|1
418780|NCT00590967|1400814|P1|Overall Study|Poor performance status|0
418781|NCT00590967|1400813|P2|Overall Study|Ineligible|0
418782|NCT00590967|1400814|P1|Overall Study|Ineligible|1
418783|NCT00590967|1400813|P2|Overall Study|Withdrawal by Subject|1
418784|NCT00590967|1400814|P1|Overall Study|Withdrawal by Subject|1
418785|NCT00590902|1400826|P1|Overall Study|Death|1
418786|NCT00590759|1400861|P1|Overall Study|Lost to Follow-up|28
418787|NCT00590759|1400861|P1|Overall Study|Death|52
418788|NCT00590720|1400868|P2|Overall Study|Withdrawal by Subject|1
418789|NCT00590720|1400869|P1|Overall Study|Withdrawal by Subject|0
418790|NCT00590720|1400868|P2|Overall Study|Lost to Follow-up|0
418791|NCT00590720|1400869|P1|Overall Study|Lost to Follow-up|1
418792|NCT00590590|1400931|P3|Overall Study|Did not complete study|0
418793|NCT00590590|1400932|P2|Overall Study|Did not complete study|1
418794|NCT00590590|1400933|P1|Overall Study|Did not complete study|0
418795|NCT00590590|1400931|P3|Overall Study|Did not complete due to study closure|1
418796|NCT00590590|1400932|P2|Overall Study|Did not complete due to study closure|1
418797|NCT00590590|1400933|P1|Overall Study|Did not complete due to study closure|1
418798|NCT00590590|1400931|P3|Overall Study|Withdrawal by Subject|1
418799|NCT00590590|1400932|P2|Overall Study|Withdrawal by Subject|1
418800|NCT00590590|1400933|P1|Overall Study|Withdrawal by Subject|0
418801|NCT00590590|1400931|P3|Overall Study|Lost to Follow-up|2
418802|NCT00590590|1400932|P2|Overall Study|Lost to Follow-up|1
418803|NCT00590590|1400933|P1|Overall Study|Lost to Follow-up|4
418804|NCT00590590|1400931|P3|Overall Study|Protocol Violation|2
418805|NCT00590590|1400932|P2|Overall Study|Protocol Violation|0
418806|NCT00590590|1400933|P1|Overall Study|Protocol Violation|0
418807|NCT00590590|1400931|P3|Overall Study|Adverse Event|0
418808|NCT00590590|1400932|P2|Overall Study|Adverse Event|0
418809|NCT00590590|1400933|P1|Overall Study|Adverse Event|1
418810|NCT00590590|1400931|P3|Overall Study|Lack of Efficacy|0
418811|NCT00590590|1400932|P2|Overall Study|Lack of Efficacy|2
418812|NCT00590590|1400933|P1|Overall Study|Lack of Efficacy|1
418813|NCT00590577|1400960|P4|Overall Study|Various reasons|2
418814|NCT00590577|1400961|P3|Overall Study|Various reasons|1
418815|NCT00590577|1400962|P2|Overall Study|Various reasons|3
418816|NCT00590577|1400963|P1|Overall Study|Various reasons|1
418817|NCT00590577|1400960|P4|Overall Study|Pregnancy|0
418818|NCT00590577|1400961|P3|Overall Study|Pregnancy|0
418819|NCT00590577|1400962|P2|Overall Study|Pregnancy|1
418820|NCT00590577|1400963|P1|Overall Study|Pregnancy|0
418821|NCT00590577|1400960|P4|Overall Study|Lost to Follow-up|9
418822|NCT00590577|1400961|P3|Overall Study|Lost to Follow-up|6
418823|NCT00590577|1400962|P2|Overall Study|Lost to Follow-up|6
418824|NCT00590577|1400963|P1|Overall Study|Lost to Follow-up|12
418825|NCT00590577|1400960|P4|Overall Study|Adverse Event|11
418826|NCT00590577|1400961|P3|Overall Study|Adverse Event|13
418827|NCT00590577|1400962|P2|Overall Study|Adverse Event|10
418828|NCT00590577|1400963|P1|Overall Study|Adverse Event|10
418829|NCT00590577|1400960|P4|Overall Study|Withdrawal by Subject|26
418830|NCT00590577|1400961|P3|Overall Study|Withdrawal by Subject|30
418831|NCT00590577|1400962|P2|Overall Study|Withdrawal by Subject|28
418832|NCT00590577|1400963|P1|Overall Study|Withdrawal by Subject|23
418833|NCT00590577|1400960|P4|Overall Study|Lack of Efficacy|45
418834|NCT00590577|1400961|P3|Overall Study|Lack of Efficacy|23
418835|NCT00590577|1400962|P2|Overall Study|Lack of Efficacy|28
418836|NCT00590577|1400963|P1|Overall Study|Lack of Efficacy|31
418837|NCT00590564|1400981|P1|Overall Study|Patient Non-compliance|6
418838|NCT00590564|1400981|P1|Overall Study|Patient Found to be Ineligible|1
418839|NCT00590564|1400981|P1|Overall Study|Protocol Violation|1
418840|NCT00590564|1400981|P1|Overall Study|Lost to Follow-up|6
418841|NCT00590564|1400981|P1|Overall Study|Withdrawal by Subject|4
418842|NCT00590538|1400985|P1|Overall Study|Study terminated before completed|2
418843|NCT00590317|1401027|P2|Overall Study|Lack of Efficacy|5
418844|NCT00590317|1401028|P1|Overall Study|Lack of Efficacy|1
418845|NCT00590135|1401058|P1|Overall Study|Primary endpoint measure not obtainable|59
418846|NCT00590044|1401068|P2|Overall Study|Protocol Violation|0
418847|NCT00590044|1401069|P1|Overall Study|Protocol Violation|1
418848|NCT00590044|1401068|P2|Overall Study|wrong insulin arm assigned|0
418849|NCT00590044|1401069|P1|Overall Study|wrong insulin arm assigned|1
418850|NCT00590044|1401068|P2|Overall Study|Withdrawal by Subject|2
418851|NCT00590044|1401069|P1|Overall Study|Withdrawal by Subject|2
418852|NCT00590031|1401075|P1|Overall Study|Admin Hold|1
418853|NCT00590031|1401075|P1|Overall Study|Metastatic Disease|1
418854|NCT00590031|1401075|P1|Overall Study|Withdrawal by Subject|1
418855|NCT00590031|1401075|P1|Overall Study|Adverse Event|3
418856|NCT00589979|1401102|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
418857|NCT00589979|1401103|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
418858|NCT00589979|1401104|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
418859|NCT00589979|1401102|P3|Double-Blind Treatment Period 3|Protocol Violation|0
418860|NCT00589979|1401103|P2|Double-Blind Treatment Period 3|Protocol Violation|1
418861|NCT00589979|1401104|P1|Double-Blind Treatment Period 3|Protocol Violation|0
418862|NCT00589979|1401102|P3|Double-Blind Treatment Period 2|Other|1
418863|NCT00589979|1401103|P2|Double-Blind Treatment Period 2|Other|0
418864|NCT00589979|1401104|P1|Double-Blind Treatment Period 2|Other|0
418865|NCT00589979|1401102|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
418866|NCT00589979|1401103|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
418867|NCT00589979|1401104|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
418868|NCT00589979|1401102|P3|Double-Blind Treatment Period 2|Adverse Event|0
418869|NCT00589979|1401103|P2|Double-Blind Treatment Period 2|Adverse Event|1
418870|NCT00589979|1401104|P1|Double-Blind Treatment Period 2|Adverse Event|0
418871|NCT00589979|1401102|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
418872|NCT00589979|1401103|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
418873|NCT00589979|1401104|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
418874|NCT00589979|1401102|P3|Double-Blind Treatment Period 1|Protocol Violation|1
418875|NCT00589979|1401103|P2|Double-Blind Treatment Period 1|Protocol Violation|1
418876|NCT00589979|1401104|P1|Double-Blind Treatment Period 1|Protocol Violation|0
418877|NCT00589979|1401102|P3|Double-Blind Treatment Period 1|Adverse Event|0
418878|NCT00589979|1401103|P2|Double-Blind Treatment Period 1|Adverse Event|1
418879|NCT00589979|1401104|P1|Double-Blind Treatment Period 1|Adverse Event|0
418880|NCT00589979|1401102|P3|Run-In Period|Informed Consent Withdrawn|0
418881|NCT00589979|1401103|P2|Run-In Period|Informed Consent Withdrawn|0
418882|NCT00589979|1401104|P1|Run-In Period|Informed Consent Withdrawn|4
418883|NCT00589979|1401102|P3|Run-In Period|Withdrawal by Subject|0
418884|NCT00589979|1401103|P2|Run-In Period|Withdrawal by Subject|0
418885|NCT00589979|1401104|P1|Run-In Period|Withdrawal by Subject|10
418886|NCT00589979|1401102|P3|Run-In Period|Did not qualify for randomization|0
418887|NCT00589979|1401103|P2|Run-In Period|Did not qualify for randomization|0
418888|NCT00589979|1401104|P1|Run-In Period|Did not qualify for randomization|54
418889|NCT00589979|1401102|P3|Run-In Period|Protocol Violation|0
418890|NCT00589979|1401103|P2|Run-In Period|Protocol Violation|0
418891|NCT00589979|1401104|P1|Run-In Period|Protocol Violation|3
418892|NCT00589979|1401102|P3|Run-In Period|Adverse Event|0
418893|NCT00589979|1401103|P2|Run-In Period|Adverse Event|0
418894|NCT00589979|1401104|P1|Run-In Period|Adverse Event|5
418895|NCT00589914|1401143|P2|Overall Study|Other|17
418896|NCT00589914|1401144|P1|Overall Study|Other|22
418897|NCT00589914|1401143|P2|Overall Study|Withdrawal by Subject|49
418898|NCT00589914|1401144|P1|Overall Study|Withdrawal by Subject|55
418899|NCT00589914|1401143|P2|Overall Study|Pregnancy|0
418900|NCT00589914|1401144|P1|Overall Study|Pregnancy|1
418901|NCT00589914|1401143|P2|Overall Study|Lost to Follow-up|18
418902|NCT00589914|1401144|P1|Overall Study|Lost to Follow-up|11
418903|NCT00589914|1401143|P2|Overall Study|Lack of Efficacy|43
418904|NCT00589914|1401144|P1|Overall Study|Lack of Efficacy|40
418905|NCT00589914|1401143|P2|Overall Study|Death|0
418906|NCT00589914|1401144|P1|Overall Study|Death|2
418907|NCT00589914|1401143|P2|Overall Study|Adverse Event|10
418908|NCT00589914|1401144|P1|Overall Study|Adverse Event|19
418909|NCT00589784|1401180|P2|Overall Study|Adverse Event|4
418910|NCT00589784|1401181|P1|Overall Study|Adverse Event|0
418911|NCT00589784|1401180|P2|Overall Study|Patient inevaluable|0
418912|NCT00589784|1401181|P1|Overall Study|Patient inevaluable|1
418913|NCT00589784|1401180|P2|Overall Study|Withdrawal by Subject|6
418914|NCT00589784|1401181|P1|Overall Study|Withdrawal by Subject|0
418915|NCT00589693|1401188|P2|Overall Study|Protocol Violation|1
418916|NCT00589693|1401189|P1|Overall Study|Protocol Violation|1
418917|NCT00589693|1401188|P2|Overall Study|Physician Decision|1
418918|NCT00589693|1401189|P1|Overall Study|Physician Decision|0
418919|NCT00589693|1401188|P2|Overall Study|Lost to Follow-up|0
418920|NCT00589693|1401189|P1|Overall Study|Lost to Follow-up|1
418921|NCT00589693|1401188|P2|Overall Study|Lack of Efficacy|1
418922|NCT00589693|1401189|P1|Overall Study|Lack of Efficacy|0
418923|NCT00589693|1401188|P2|Overall Study|Death|16
418924|NCT00589693|1401189|P1|Overall Study|Death|26
418925|NCT00589693|1401188|P2|Overall Study|Adverse Event|4
418926|NCT00589693|1401189|P1|Overall Study|Adverse Event|4
418927|NCT00589693|1401188|P2|Overall Study|randomized in error|6
418928|NCT00589693|1401189|P1|Overall Study|randomized in error|12
418929|NCT00589667|1401203|P1|Overall Study|Withdrawal by Subject|1
418930|NCT00589667|1401203|P1|Overall Study|Adverse Event|2
418931|NCT00589628|1401210|P2|Overall Study|Lost to Follow-up|1
418932|NCT00589628|1401211|P1|Overall Study|Lost to Follow-up|0
418933|NCT00589602|1401217|P1|Overall Study|Did not collect enough CD34+ cells|1
418934|NCT00589472|1401252|P1|Overall Study|Adverse Event|1
418935|NCT00589303|1401264|P2|Overall Study|Withdrawal by Subject|1
418936|NCT00589303|1401265|P1|Overall Study|Withdrawal by Subject|2
418937|NCT00589290|1401271|P1|Overall Study|Withdrawal by Subject|1
418938|NCT00589121|1401294|P2|Overall Study|No protocol treatment received|1
418939|NCT00589121|1401295|P1|Overall Study|No protocol treatment received|0
418940|NCT00589121|1401294|P2|Overall Study|Protocol Violation|6
418941|NCT00589121|1401295|P1|Overall Study|Protocol Violation|2
418942|NCT00589108|1401315|P3|Overall Study|Death|4
418943|NCT00589108|1401316|P2|Overall Study|Death|3
418944|NCT00589108|1401317|P1|Overall Study|Death|3
418945|NCT00589108|1401315|P3|Overall Study|Lost to Follow-up|1
418946|NCT00589108|1401316|P2|Overall Study|Lost to Follow-up|1
418947|NCT00589108|1401317|P1|Overall Study|Lost to Follow-up|1
418948|NCT00588952|1401347|P2|Overall Study|Withdrawal by Subject|5
418949|NCT00588952|1401348|P1|Overall Study|Withdrawal by Subject|3
418950|NCT00588952|1401347|P2|Overall Study|Adverse Event|2
418951|NCT00588952|1401348|P1|Overall Study|Adverse Event|0
418952|NCT00588861|1401376|P2|10 Years|Incomplete due to study termination|114
418953|NCT00588861|1401377|P1|10 Years|Incomplete due to study termination|107
418954|NCT00588861|1401376|P2|8 Years|Patients did not return for follow-up|114
418955|NCT00588861|1401377|P1|8 Years|Patients did not return for follow-up|105
418956|NCT00588861|1401376|P2|6 Years|Patients did not return for follow-up|109
418957|NCT00588861|1401377|P1|6 Years|Patients did not return for follow-up|104
418958|NCT00588861|1401376|P2|4 Years|Patients did not return for follow-up|103
418959|NCT00588861|1401377|P1|4 Years|Patients did not return for follow-up|91
418960|NCT00588861|1401376|P2|2 Years|Patients did not return for follow-up|87
418961|NCT00588861|1401377|P1|2 Years|Patients did not return for follow-up|92
418962|NCT00588861|1401376|P2|1 Year|Patients did not return for follow-up|82
418963|NCT00588861|1401377|P1|1 Year|Patients did not return for follow-up|89
418964|NCT00588861|1401376|P2|6 Months|Patients did not return for follow-up|73
418965|NCT00588861|1401377|P1|6 Months|Patients did not return for follow-up|98
418966|NCT00588861|1401376|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
418967|NCT00588861|1401377|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
418968|NCT00588822|1401398|P1|Overall Study|progression of disease|8
418969|NCT00588731|1401418|P2|Overall Study|Withdrawal by Subject|2
418970|NCT00588731|1401419|P1|Overall Study|Withdrawal by Subject|3
418971|NCT00588692|1401429|P2|Overall Study|Death|0
418972|NCT00588692|1401430|P1|Overall Study|Death|1
418973|NCT00588692|1401429|P2|Overall Study|Cancer|0
418974|NCT00588692|1401430|P1|Overall Study|Cancer|1
418975|NCT00588692|1401429|P2|Overall Study|Severe Peptic Ulcer Disease|0
418976|NCT00588692|1401430|P1|Overall Study|Severe Peptic Ulcer Disease|1
418977|NCT00588692|1401429|P2|Overall Study|Hip Surgery|1
418978|NCT00588692|1401430|P1|Overall Study|Hip Surgery|0
418979|NCT00588692|1401429|P2|Overall Study|Withdrawal by Subject|2
418980|NCT00588692|1401430|P1|Overall Study|Withdrawal by Subject|4
418981|NCT00588666|1401466|P1|Overall Study|Adverse Event|4
418982|NCT00588640|1401471|P1|Overall Study|Ineligible Patient|1
418983|NCT00588640|1401471|P1|Overall Study|Physician Decision|1
418984|NCT00588445|1401490|P1|Overall Study|Not Treated|10
418985|NCT00588445|1401490|P1|Overall Study|Disease Progression|1
418986|NCT00588445|1401490|P1|Overall Study|Withdrawal by Subject|3
418987|NCT00588445|1401490|P1|Overall Study|Protocol Violation|1
418988|NCT00588354|1401514|P2|Baseline to 4 Weeks|Lost to Follow-up|1
418989|NCT00588354|1401515|P1|Baseline to 4 Weeks|Lost to Follow-up|0
418990|NCT00588354|1401514|P2|Baseline to 2 Weeks|Lack of Efficacy|0
418991|NCT00588354|1401515|P1|Baseline to 2 Weeks|Lack of Efficacy|1
418992|NCT00588354|1401514|P2|Baseline to 2 Weeks|Adverse Event|0
418993|NCT00588354|1401515|P1|Baseline to 2 Weeks|Adverse Event|1
418994|NCT00588341|1401535|P1|Overall Study|Patient ineligible|1
418995|NCT00588341|1401535|P1|Overall Study|Not treated due to metastatic disease|1
418996|NCT00588341|1401535|P1|Overall Study|Withdrawal by Subject|3
418997|NCT00588237|1401539|P1|Overall Study|Patien not treated|1
418998|NCT00588237|1401539|P1|Overall Study|Evaluable for toxicity only|3
418999|NCT00588146|1401562|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
419000|NCT00588146|1401563|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
419001|NCT00588094|1401569|P1|Overall Study|Progression of Disease|2
419002|NCT00588094|1401569|P1|Overall Study|Adverse Event|3
419003|NCT00587964|1401592|P1|Overall Study|Progression of Disease|4
419004|NCT00587964|1401592|P1|Overall Study|Patient did not receive intervention|5
419005|NCT00587964|1401592|P1|Overall Study|Patient found to be ineligible|1
419006|NCT00587964|1401592|P1|Overall Study|Lost to Follow-up|1
419007|NCT00587964|1401592|P1|Overall Study|Withdrawal by Subject|1
419008|NCT00587860|1401598|P2|Overall Study|Withdrawal by Subject|3
419009|NCT00587860|1401599|P1|Overall Study|Withdrawal by Subject|3
419010|NCT00587860|1401598|P2|Overall Study|Lost to Follow-up|2
419011|NCT00587860|1401599|P1|Overall Study|Lost to Follow-up|2
419012|NCT00587847|1401619|P1|Overall Study|Adverse Event|2
419013|NCT00587847|1401619|P1|Overall Study|Lack of Efficacy|5
419014|NCT00587795|1401642|P2|Overall Study|Withdrawal by Subject|0
419015|NCT00587795|1401643|P1|Overall Study|Withdrawal by Subject|1
419016|NCT00587639|1401697|P1|Overall Study|Withdrawal by Subject|1
419017|NCT00587587|1401704|P2|Overall Study|Lost to Follow-up|1
419018|NCT00587587|1401705|P1|Overall Study|Lost to Follow-up|6
419019|NCT00587457|1401759|P3|Overall Study|Development of neutralizing Abs|1
419020|NCT00587457|1401760|P2|Overall Study|Development of neutralizing Abs|0
419021|NCT00587457|1401761|P1|Overall Study|Development of neutralizing Abs|0
419022|NCT00587457|1401759|P3|Overall Study|Undefined|1
419023|NCT00587457|1401760|P2|Overall Study|Undefined|0
419024|NCT00587457|1401761|P1|Overall Study|Undefined|0
419025|NCT00587457|1401759|P3|Overall Study|Initiation of alternative therapy|0
419026|NCT00587457|1401760|P2|Overall Study|Initiation of alternative therapy|1
419027|NCT00587457|1401761|P1|Overall Study|Initiation of alternative therapy|0
419028|NCT00587457|1401759|P3|Overall Study|Disease progression|2
419029|NCT00587457|1401760|P2|Overall Study|Disease progression|0
419030|NCT00587457|1401761|P1|Overall Study|Disease progression|2
419031|NCT00587457|1401759|P3|Overall Study|Adverse Event|1
419032|NCT00587457|1401760|P2|Overall Study|Adverse Event|2
419033|NCT00587457|1401761|P1|Overall Study|Adverse Event|1
419034|NCT00587431|1401798|P2|Overall Study|Withdrawal by Subject|1
419035|NCT00587431|1401799|P1|Overall Study|Withdrawal by Subject|0
419036|NCT00587431|1401798|P2|Overall Study|Adverse Event|0
419037|NCT00587431|1401799|P1|Overall Study|Adverse Event|1
419038|NCT00587288|1401810|P2|Overall Study|Protocol Violation|0
419039|NCT00587288|1401811|P1|Overall Study|Protocol Violation|1
419040|NCT00587288|1401810|P2|Overall Study|Lack of Efficacy|8
419041|NCT00587288|1401811|P1|Overall Study|Lack of Efficacy|2
419042|NCT00587288|1401810|P2|Overall Study|Adverse Event|1
419043|NCT00587288|1401811|P1|Overall Study|Adverse Event|0
419044|NCT00587223|1401829|P1|Overall Study|Adverse Event|1
419045|NCT00587171|1401846|P2|Overall Study|Lost to Follow-up|1
419046|NCT00587171|1401847|P1|Overall Study|Lost to Follow-up|1
419047|NCT00587158|1401877|P2|Overall Study|Subject did not want to take study med|1
419048|NCT00587158|1401878|P1|Overall Study|Subject did not want to take study med|0
419049|NCT00587158|1401877|P2|Overall Study|Death|1
419050|NCT00587158|1401878|P1|Overall Study|Death|0
419051|NCT00587158|1401877|P2|Overall Study|Lost to Follow-up|2
419052|NCT00587158|1401878|P1|Overall Study|Lost to Follow-up|1
419053|NCT00587158|1401877|P2|Overall Study|Physician Decision|1
419054|NCT00587158|1401878|P1|Overall Study|Physician Decision|0
419055|NCT00587158|1401877|P2|Overall Study|Did not want to do 24 hr urine collect.|3
419056|NCT00587158|1401878|P1|Overall Study|Did not want to do 24 hr urine collect.|4
419057|NCT00587054|1401931|P1|Overall Study|Patient not treated|9
419058|NCT00586898|1401951|P1|Overall Study|Evaluable for Toxicity Only|5
419059|NCT00586898|1401951|P1|Overall Study|Patiemt Non-compliance|1
419060|NCT00586898|1401951|P1|Overall Study|Adverse Event|1
419061|NCT00586846|1401955|P1|Overall Study|Evaluable for Toxicity Only|4
419062|NCT00586846|1401955|P1|Overall Study|Death|1
419063|NCT00586846|1401955|P1|Overall Study|Physician Decision|1
419064|NCT00586820|1401961|P2|Overall Study|Unsuccessful PCI|0
419065|NCT00586820|1401962|P1|Overall Study|Unsuccessful PCI|1
419066|NCT00586703|1401993|P1|Overall Study|Death|12
419067|NCT00586690|1402000|P2|Overall Study|Lab can't accommodate|0
419068|NCT00586690|1402001|P1|Overall Study|Lab can't accommodate|1
419069|NCT00586690|1402000|P2|Overall Study|Lack of Efficacy|0
419070|NCT00586690|1402001|P1|Overall Study|Lack of Efficacy|2
419071|NCT00586690|1402000|P2|Overall Study|Adverse Event|0
419072|NCT00586690|1402001|P1|Overall Study|Adverse Event|1
419073|NCT00586690|1402000|P2|Overall Study|Disease Progression|0
419074|NCT00586690|1402001|P1|Overall Study|Disease Progression|10
419075|NCT00586690|1402000|P2|Overall Study|Death|0
419076|NCT00586690|1402001|P1|Overall Study|Death|2
419077|NCT00586664|1402011|P3|Overall Study|Exclusion criteria met|0
419078|NCT00586664|1402012|P2|Overall Study|Exclusion criteria met|0
419079|NCT00586664|1402013|P1|Overall Study|Exclusion criteria met|2
419080|NCT00586664|1402011|P3|Overall Study|Withdrawal by Subject|1
419081|NCT00586664|1402012|P2|Overall Study|Withdrawal by Subject|7
419082|NCT00586664|1402013|P1|Overall Study|Withdrawal by Subject|3
419083|NCT00586625|1402059|P2|Overall Study|Subject unable to return for visit|0
419084|NCT00586625|1402060|P1|Overall Study|Subject unable to return for visit|2
419085|NCT00586625|1402059|P2|Overall Study|Subject non-compliance|1
419086|NCT00586625|1402060|P1|Overall Study|Subject non-compliance|0
419087|NCT00586625|1402059|P2|Overall Study|Withdrawal by Subject|10
419088|NCT00586625|1402060|P1|Overall Study|Withdrawal by Subject|32
419089|NCT00586625|1402059|P2|Overall Study|Protocol Violation|0
419090|NCT00586625|1402060|P1|Overall Study|Protocol Violation|3
419091|NCT00586625|1402059|P2|Overall Study|Adverse Event|6
419092|NCT00586625|1402060|P1|Overall Study|Adverse Event|6
419093|NCT00586612|1402068|P2|Booster Phase|Lost to Follow-up|1
419094|NCT00586612|1402069|P1|Booster Phase|Lost to Follow-up|3
419095|NCT00586612|1402068|P2|Primary Phase|Withdrawal by Subject|2
419096|NCT00586612|1402069|P1|Primary Phase|Withdrawal by Subject|0
419097|NCT00586612|1402068|P2|Primary Phase|Lost to Follow-up|1
419098|NCT00586612|1402069|P1|Primary Phase|Lost to Follow-up|0
419099|NCT00586612|1402068|P2|Primary Phase|Protocol Violation|0
419100|NCT00586612|1402069|P1|Primary Phase|Protocol Violation|1
419101|NCT00586521|1402139|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
419102|NCT00586495|1402146|P1|Follow-up|Switch to commercial drug|10
419103|NCT00586495|1402146|P1|Follow-up|Protocol driven decision point|37
419104|NCT00586495|1402146|P1|Follow-up|Withdrawal by Subject|4
419105|NCT00586495|1402146|P1|Follow-up|Lost to Follow-up|1
419106|NCT00586495|1402146|P1|Follow-up|Death|40
419107|NCT00586495|1402146|P1|Treatment Period|Switch to commercial drug|10
419108|NCT00586495|1402146|P1|Treatment Period|Disease progression, recurrence/relapse|71
419109|NCT00586495|1402146|P1|Treatment Period|Withdrawal by Subject|1
419110|NCT00586495|1402146|P1|Treatment Period|Protocol Violation|1
419111|NCT00586495|1402146|P1|Treatment Period|Death|1
419112|NCT00586495|1402146|P1|Treatment Period|Adverse Event|11
419113|NCT00586469|1402175|P2|Overall Study|Adverse Event|1
419114|NCT00586469|1402176|P1|Overall Study|Adverse Event|0
419115|NCT00586339|1402203|P3|Overall Study|Withdrawal by Subject|1
419116|NCT00586339|1402204|P2|Overall Study|Withdrawal by Subject|3
419117|NCT00586339|1402205|P1|Overall Study|Withdrawal by Subject|1
419118|NCT00586339|1402203|P3|Overall Study|Lost to Follow-up|5
419119|NCT00586339|1402204|P2|Overall Study|Lost to Follow-up|4
419120|NCT00586339|1402205|P1|Overall Study|Lost to Follow-up|6
419121|NCT00586326|1402303|P1|Treated Through 5-yr Follow Up-Treated|Other|2
419122|NCT00586326|1402303|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
419123|NCT00586326|1402303|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
419124|NCT00586326|1402303|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
419125|NCT00586326|1402303|P1|Treated Through 5-yr Follow Up-Treated|Death|2
419126|NCT00586326|1402303|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
419127|NCT00586326|1402303|P1|Device Placed toTreatment-ITT|Physician Decision|1
419128|NCT00586326|1402303|P1|Device Placed toTreatment-ITT|Positive Margins|3
419129|NCT00586326|1402303|P1|Device Placed toTreatment-ITT|Microinvasion|1
419130|NCT00586326|1402303|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
419131|NCT00586326|1402303|P1|Device Placed toTreatment-ITT|Skin Distance|7
419132|NCT00586326|1402303|P1|Enrollment to Device Placement-Enrolled|Other|1
419133|NCT00586326|1402303|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
419134|NCT00586326|1402303|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
419135|NCT00586326|1402303|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
419136|NCT00586326|1402303|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
419137|NCT00586326|1402303|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
419138|NCT00586313|1402314|P1|Overall Study|Lack of Efficacy|2
419139|NCT00586157|1402350|P2|Second Intervention|Adverse Event|1
419140|NCT00586157|1402351|P1|Second Intervention|Adverse Event|0
419141|NCT00586157|1402350|P2|Second Intervention|Worsening behavior|0
419142|NCT00586157|1402351|P1|Second Intervention|Worsening behavior|1
419143|NCT00586157|1402350|P2|Second Intervention|Withdrawal by Subject|0
419144|NCT00586157|1402351|P1|Second Intervention|Withdrawal by Subject|1
419145|NCT00586157|1402350|P2|First Intervention|Worsening behavior|0
419146|NCT00586157|1402351|P1|First Intervention|Worsening behavior|1
419147|NCT00586105|1402361|P1|Overall Study|Reason not reported|1
419148|NCT00586105|1402361|P1|Overall Study|Switched to commercial drug|9
419149|NCT00586105|1402361|P1|Overall Study|Disease progression|19
419150|NCT00586105|1402361|P1|Overall Study|Withdrawal by Subject|3
419151|NCT00586105|1402361|P1|Overall Study|Protocol Violation|1
419152|NCT00586105|1402361|P1|Overall Study|Death|2
419153|NCT00586105|1402361|P1|Overall Study|Adverse Event|4
419154|NCT00586066|1402376|P2|Overall Study|Withdrawal of consent|2
419155|NCT00586066|1402377|P1|Overall Study|Withdrawal of consent|4
419156|NCT00586066|1402376|P2|Overall Study|Physician Decision|0
419157|NCT00586066|1402377|P1|Overall Study|Physician Decision|1
419158|NCT00586066|1402376|P2|Overall Study|Adverse Event|2
419159|NCT00586066|1402377|P1|Overall Study|Adverse Event|2
419160|NCT00586066|1402376|P2|Overall Study|Lack of Efficacy|3
419161|NCT00586066|1402377|P1|Overall Study|Lack of Efficacy|5
419162|NCT00586066|1402376|P2|Overall Study|Lost to Follow-up|3
419163|NCT00586066|1402377|P1|Overall Study|Lost to Follow-up|6
419164|NCT00585975|1402389|P2|Overall Study|Enrollment met/over-enrolled|9
419165|NCT00585975|1402390|P1|Overall Study|Enrollment met/over-enrolled|10
419166|NCT00585975|1402389|P2|Overall Study|Lost to Follow-up|1
419167|NCT00585975|1402390|P1|Overall Study|Lost to Follow-up|2
419168|NCT00585975|1402389|P2|Overall Study|Withdrawal by Subject|3
419169|NCT00585975|1402390|P1|Overall Study|Withdrawal by Subject|3
419170|NCT00585923|1402400|P2|Overall Study|Physician decided not to continue|33
419171|NCT00585923|1402401|P1|Overall Study|Physician decided not to continue|31
419172|NCT00585689|1402432|P1|Overall Study|Death|1
419173|NCT00585689|1402432|P1|Overall Study|Patient had unresectable disease|1
419174|NCT00585689|1402432|P1|Overall Study|Patient Declined Surgery|1
419175|NCT00585689|1402432|P1|Overall Study|Adverse Event|1
419176|NCT00585689|1402432|P1|Overall Study|Received different ABI-007 schedule|3
419177|NCT00585585|1402478|P1|Overall Study|Adverse Event|1
419178|NCT00585546|1402482|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
419179|NCT00585546|1402482|P1|Clenbuterol Treatment - up to 12 Months|Death|1
419180|NCT00585533|1402496|P1|Overall Study|objective or symptomatic progression|9
419181|NCT00585468|1402505|P2|First Intervention|Withdrawal by Subject|1
419182|NCT00585468|1402506|P1|First Intervention|Withdrawal by Subject|1
419183|NCT00585351|1402538|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
419184|NCT00585351|1402539|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
419185|NCT00585351|1402540|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
419186|NCT00585351|1402541|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
419187|NCT00585351|1402542|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
419188|NCT00585351|1402543|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
419189|NCT00585351|1402544|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
419190|NCT00585351|1402545|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
419191|NCT00585351|1402538|P8|Enrollment Period (Intervention)|Death|0
419192|NCT00585351|1402539|P7|Enrollment Period (Intervention)|Death|1
419193|NCT00585351|1402540|P6|Enrollment Period (Intervention)|Death|0
419194|NCT00585351|1402541|P5|Enrollment Period (Intervention)|Death|1
419195|NCT00585351|1402542|P4|Enrollment Period (Intervention)|Death|0
419196|NCT00585351|1402543|P3|Enrollment Period (Intervention)|Death|0
419197|NCT00585351|1402544|P2|Enrollment Period (Intervention)|Death|0
419198|NCT00585351|1402545|P1|Enrollment Period (Intervention)|Death|0
419199|NCT00585351|1402538|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
419200|NCT00585351|1402539|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
419201|NCT00585351|1402540|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
419202|NCT00585351|1402541|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
419203|NCT00585351|1402542|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
419204|NCT00585351|1402543|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
419205|NCT00585351|1402544|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
419206|NCT00585351|1402545|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
419207|NCT00585351|1402538|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
419208|NCT00585351|1402539|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
419209|NCT00585351|1402540|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
419210|NCT00585351|1402541|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
419211|NCT00585351|1402542|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
419212|NCT00585351|1402543|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
419213|NCT00585351|1402544|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
419214|NCT00585351|1402545|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
419215|NCT00585351|1402538|P8|Notification Period (Informed Consent)|No study medication on flight|0
419216|NCT00585351|1402539|P7|Notification Period (Informed Consent)|No study medication on flight|0
419217|NCT00585351|1402540|P6|Notification Period (Informed Consent)|No study medication on flight|0
419218|NCT00585351|1402541|P5|Notification Period (Informed Consent)|No study medication on flight|0
419219|NCT00585351|1402542|P4|Notification Period (Informed Consent)|No study medication on flight|0
419220|NCT00585351|1402543|P3|Notification Period (Informed Consent)|No study medication on flight|0
419221|NCT00585351|1402544|P2|Notification Period (Informed Consent)|No study medication on flight|1
419222|NCT00585351|1402545|P1|Notification Period (Informed Consent)|No study medication on flight|0
419223|NCT00585351|1402538|P8|Notification Period (Informed Consent)|Flight aborted|0
419224|NCT00585351|1402539|P7|Notification Period (Informed Consent)|Flight aborted|0
419225|NCT00585351|1402540|P6|Notification Period (Informed Consent)|Flight aborted|0
419226|NCT00585351|1402541|P5|Notification Period (Informed Consent)|Flight aborted|0
419227|NCT00585351|1402542|P4|Notification Period (Informed Consent)|Flight aborted|0
419228|NCT00585351|1402543|P3|Notification Period (Informed Consent)|Flight aborted|0
419229|NCT00585351|1402544|P2|Notification Period (Informed Consent)|Flight aborted|1
419230|NCT00585351|1402545|P1|Notification Period (Informed Consent)|Flight aborted|2
419231|NCT00585351|1402538|P8|Notification Period (Informed Consent)|Physician Decision|0
419232|NCT00585351|1402539|P7|Notification Period (Informed Consent)|Physician Decision|0
419233|NCT00585351|1402540|P6|Notification Period (Informed Consent)|Physician Decision|0
419234|NCT00585351|1402541|P5|Notification Period (Informed Consent)|Physician Decision|0
419235|NCT00585351|1402542|P4|Notification Period (Informed Consent)|Physician Decision|0
419236|NCT00585351|1402543|P3|Notification Period (Informed Consent)|Physician Decision|0
419237|NCT00585351|1402544|P2|Notification Period (Informed Consent)|Physician Decision|2
419238|NCT00585351|1402545|P1|Notification Period (Informed Consent)|Physician Decision|0
419239|NCT00585325|1402561|P2|Overall Study|Withdrawal by Subject|1
419240|NCT00585325|1402562|P1|Overall Study|Withdrawal by Subject|1
419241|NCT00585312|1402570|P2|Overall Study|Study terminated by the sponsor|31
419242|NCT00585312|1402571|P1|Overall Study|Study terminated by the sponsor|34
419243|NCT00585312|1402570|P2|Overall Study|Withdrawal by Subject|1
419244|NCT00585312|1402571|P1|Overall Study|Withdrawal by Subject|5
419245|NCT00585312|1402570|P2|Overall Study|Reason not specified|0
419246|NCT00585312|1402571|P1|Overall Study|Reason not specified|2
419247|NCT00585312|1402570|P2|Overall Study|Lost to Follow-up|1
419248|NCT00585312|1402571|P1|Overall Study|Lost to Follow-up|1
419249|NCT00585312|1402570|P2|Overall Study|Lack of Efficacy|11
419250|NCT00585312|1402571|P1|Overall Study|Lack of Efficacy|6
419251|NCT00585312|1402570|P2|Overall Study|Adverse Event|0
419252|NCT00585312|1402571|P1|Overall Study|Adverse Event|3
419253|NCT00585286|1402583|P1|Overall Study|Lost to Follow-up|1
419254|NCT00585221|1402599|P1|Overall Study|Protocol Violation|8
419255|NCT00585169|1402609|P1|Overall Study|Withdrawal by Subject|1
419256|NCT00585078|1402619|P1|Overall Study|Death|1
419257|NCT00585078|1402619|P1|Overall Study|Adverse Event|10
419258|NCT00585078|1402619|P1|Overall Study|Disease Progression|24
419259|NCT00585078|1402619|P1|Overall Study|Poor performance status|1
419260|NCT00585078|1402619|P1|Overall Study|Withdrawal by Subject|4
419261|NCT00585052|1402626|P1|Overall Study|Withdrawal by Subject|1
419262|NCT00585039|1402633|P2|Overall Study|medication spilled|0
419263|NCT00585039|1402634|P1|Overall Study|medication spilled|2
419264|NCT00584987|1402663|P4|Overall Study|Adverse Event|1
419265|NCT00584987|1402664|P3|Overall Study|Adverse Event|0
419266|NCT00584987|1402665|P2|Overall Study|Adverse Event|0
419267|NCT00584987|1402666|P1|Overall Study|Adverse Event|0
419268|NCT00584987|1402663|P4|Overall Study|Protocol Violation|0
419269|NCT00584987|1402664|P3|Overall Study|Protocol Violation|1
419270|NCT00584987|1402665|P2|Overall Study|Protocol Violation|1
419271|NCT00584987|1402666|P1|Overall Study|Protocol Violation|1
419272|NCT00584909|1402714|P1|Overall Study|Adverse Event|4
419273|NCT00584844|1402724|P1|Overall Study|Screen Failure|20
419274|NCT00584844|1402724|P1|Overall Study|Withdrawal by Subject|59
419275|NCT00584740|1402776|P2|Overall Study|Lost to Follow-up|1
419276|NCT00584740|1402777|P1|Overall Study|Lost to Follow-up|0
419277|NCT00584740|1402776|P2|Overall Study|Withdrawal by Subject|2
419278|NCT00584740|1402777|P1|Overall Study|Withdrawal by Subject|3
419279|NCT00584740|1402776|P2|Overall Study|Lack of Efficacy|2
419280|NCT00584740|1402777|P1|Overall Study|Lack of Efficacy|8
419281|NCT00584740|1402776|P2|Overall Study|Adverse Event|1
419282|NCT00584740|1402777|P1|Overall Study|Adverse Event|1
419283|NCT00584727|1402795|P6|Third Intervention|Protocol Violation|2
419284|NCT00584727|1402796|P5|Third Intervention|Protocol Violation|4
419285|NCT00584727|1402797|P4|Third Intervention|Protocol Violation|0
419286|NCT00584727|1402798|P3|Third Intervention|Protocol Violation|1
419287|NCT00584727|1402799|P2|Third Intervention|Protocol Violation|0
419288|NCT00584727|1402800|P1|Third Intervention|Protocol Violation|0
419289|NCT00584727|1402795|P6|First Intervention|Discontinuation|0
419290|NCT00584727|1402796|P5|First Intervention|Discontinuation|0
419291|NCT00584727|1402797|P4|First Intervention|Discontinuation|0
419292|NCT00584727|1402798|P3|First Intervention|Discontinuation|1
419293|NCT00584727|1402799|P2|First Intervention|Discontinuation|0
419294|NCT00584727|1402800|P1|First Intervention|Discontinuation|0
419295|NCT00584454|1402838|P1|Overall Study|Clinical Hold|2
419296|NCT00584454|1402838|P1|Overall Study|Relocation|1
419297|NCT00584454|1402838|P1|Overall Study|Adverse Event|1
419298|NCT00584415|1402842|P1|Overall Study|Adverse Event|7
419299|NCT00584194|1402861|P1|Overall Study|Not specified|135
419300|NCT00583947|1402875|P2|Cross-over Period|not specified|1
419301|NCT00583947|1402876|P1|Cross-over Period|not specified|1
419302|NCT00583947|1402875|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
419303|NCT00583947|1402876|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
419304|NCT00583947|1402875|P2|Cross-over Period|Withdrawal by Subject|0
419305|NCT00583947|1402876|P1|Cross-over Period|Withdrawal by Subject|2
419306|NCT00583947|1402875|P2|Cross-over Period|Adverse Event|0
419307|NCT00583947|1402876|P1|Cross-over Period|Adverse Event|2
419308|NCT00583596|1403048|P1|Overall Study|Outside f-up window|26
419309|NCT00583596|1403048|P1|Overall Study|Not consented|15
419310|NCT00583596|1403048|P1|Overall Study|Data not complete|1
419311|NCT00583596|1403048|P1|Overall Study|Lost to Follow-up|94
419312|NCT00583596|1403048|P1|Overall Study|Withdrawal by Subject|6
419313|NCT00583596|1403048|P1|Overall Study|Death|2
419314|NCT00583596|1403048|P1|Overall Study|Excluded due to Hurricane Katrina|30
419315|NCT00583596|1403048|P1|Overall Study|Lost to Follow-up|110
419316|NCT00583557|1403053|P1|Overall Study|Did not receive belimumab in LBRA99|2
419317|NCT00583557|1403053|P1|Overall Study|Other|5
419318|NCT00583557|1403053|P1|Overall Study|Lack of Compliance|5
419319|NCT00583557|1403053|P1|Overall Study|Lack of Efficacy|31
419320|NCT00583557|1403053|P1|Overall Study|Adverse Event|9
419321|NCT00583557|1403053|P1|Overall Study|Withdrawal by Subject|18
419322|NCT00583453|1403084|P2|Overall Study|discontinued intervention|2
419323|NCT00583453|1403085|P1|Overall Study|discontinued intervention|0
419324|NCT00583362|1403118|P1|Overall Study|Withdrawal by Subject|57
419325|NCT00583362|1403118|P1|Overall Study|Protocol Violation|2
419326|NCT00583362|1403118|P1|Overall Study|Physician Decision|19
419327|NCT00583362|1403118|P1|Overall Study|Sponsor request due to missed doses|1
419328|NCT00583362|1403118|P1|Overall Study|Behavioral problems and non-compliance|1
419329|NCT00583362|1403118|P1|Overall Study|Misunderstanding of protocol|1
419330|NCT00583362|1403118|P1|Overall Study|Missed visits due to staff changes|1
419331|NCT00583362|1403118|P1|Overall Study|Subject moved out of the country/state|2
419332|NCT00583362|1403118|P1|Overall Study|Subject not dosed in LBSL99|1
419333|NCT00583362|1403118|P1|Overall Study|Current site closed|7
419334|NCT00583362|1403118|P1|Overall Study|Miscommunication of visit window|5
419335|NCT00583362|1403118|P1|Overall Study|Pregnancy|7
419336|NCT00583362|1403118|P1|Overall Study|Non-compliance with study drug|28
419337|NCT00583362|1403118|P1|Overall Study|Lost to Follow-up|4
419338|NCT00583362|1403118|P1|Overall Study|Lack of Efficacy|22
419339|NCT00583362|1403118|P1|Overall Study|Adverse Event|44
419340|NCT00583219|1403142|P1|Phase 2|Withdrawal by Subject|1
419341|NCT00583115|1403159|P1|Overall Study|Death|1
419342|NCT00583102|1403164|P1|Overall Study|Adverse Event|3
419343|NCT00582972|1403168|P1|Overall Study|Protocol Violation|2
419344|NCT00582933|1403177|P1|Overall Study|Physician Decision|3
419345|NCT00582907|1403181|P4|2nd Course|Lack of Efficacy|0
419346|NCT00582907|1403182|P3|2nd Course|Lack of Efficacy|0
419347|NCT00582907|1403183|P2|2nd Course|Lack of Efficacy|0
419348|NCT00582907|1403184|P1|2nd Course|Lack of Efficacy|1
419349|NCT00582907|1403181|P4|1st Course|Lost to Follow-up|1
419350|NCT00582907|1403182|P3|1st Course|Lost to Follow-up|0
419351|NCT00582907|1403183|P2|1st Course|Lost to Follow-up|0
419352|NCT00582907|1403184|P1|1st Course|Lost to Follow-up|0
419353|NCT00582907|1403181|P4|1st Course|Withdrawal by Subject|0
419354|NCT00582907|1403182|P3|1st Course|Withdrawal by Subject|0
419355|NCT00582907|1403183|P2|1st Course|Withdrawal by Subject|0
419356|NCT00582907|1403184|P1|1st Course|Withdrawal by Subject|1
419357|NCT00582816|1403223|P1|Overall Study|Engraftment Failure|3
419358|NCT00582790|1403233|P1|Overall Study|Rapid progression of disease|1
419359|NCT00582738|1403242|P2|Overall Study|Withdrawal by Subject|3
419360|NCT00582738|1403243|P1|Overall Study|Withdrawal by Subject|0
419361|NCT00582738|1403242|P2|Overall Study|Protocol Violation|1
419362|NCT00582738|1403243|P1|Overall Study|Protocol Violation|1
419363|NCT00582738|1403242|P2|Overall Study|Other|0
419364|NCT00582738|1403243|P1|Overall Study|Other|1
419365|NCT00582738|1403242|P2|Overall Study|Graft Lost|1
419366|NCT00582738|1403243|P1|Overall Study|Graft Lost|0
419367|NCT00582738|1403242|P2|Overall Study|Adverse Event|5
419368|NCT00582738|1403243|P1|Overall Study|Adverse Event|0
419369|NCT00582738|1403242|P2|Overall Study|Administrative Problems|8
419370|NCT00582738|1403243|P1|Overall Study|Administrative Problems|7
419371|NCT00582712|1403267|P1|Overall Study|Complicating disease requiring treatment|1
419372|NCT00582712|1403267|P1|Overall Study|Withdrawal by Subject|1
419373|NCT00582712|1403267|P1|Overall Study|Lack of Efficacy|1
419374|NCT00582712|1403267|P1|Overall Study|Adverse Event|1
419375|NCT00582608|1403282|P1|Overall Study|Lack of accrual|4
419376|NCT00582608|1403282|P1|Overall Study|Patient Ineligible|1
419377|NCT00582608|1403282|P1|Overall Study|Not Treated|7
419378|NCT00582556|1403289|P3|Overall Study|Physician Decision|1
419379|NCT00582556|1403290|P2|Overall Study|Physician Decision|0
419380|NCT00582556|1403291|P1|Overall Study|Physician Decision|0
419381|NCT00582556|1403289|P3|Overall Study|Withdrawal by Subject|1
419382|NCT00582556|1403290|P2|Overall Study|Withdrawal by Subject|1
419383|NCT00582556|1403291|P1|Overall Study|Withdrawal by Subject|0
419384|NCT00582491|1403319|P2|Overall Study|Withdrawal by Subject|0
419385|NCT00582491|1403320|P1|Overall Study|Withdrawal by Subject|1
419386|NCT00582426|1403344|P2|Overall Study|Use of illicit drugs|0
419387|NCT00582426|1403345|P1|Overall Study|Use of illicit drugs|1
419388|NCT00582426|1403344|P2|Overall Study|Disease Progression|2
419389|NCT00582426|1403345|P1|Overall Study|Disease Progression|2
419390|NCT00582426|1403344|P2|Overall Study|Withdrawal by Subject|2
419391|NCT00582426|1403345|P1|Overall Study|Withdrawal by Subject|3
419392|NCT00582426|1403344|P2|Overall Study|Death|3
419393|NCT00582426|1403345|P1|Overall Study|Death|4
419394|NCT00582426|1403344|P2|Overall Study|Protocol Violation|2
419395|NCT00582426|1403345|P1|Overall Study|Protocol Violation|6
419396|NCT00582426|1403344|P2|Overall Study|Adverse Event|2
419397|NCT00582426|1403345|P1|Overall Study|Adverse Event|4
419398|NCT00582426|1403344|P2|Overall Study|Lost to Follow-up|2
419399|NCT00582426|1403345|P1|Overall Study|Lost to Follow-up|0
419400|NCT00582309|1403392|P3|Overall Study|Protocol Violation|2
419401|NCT00582309|1403393|P2|Overall Study|Protocol Violation|0
419402|NCT00582309|1403394|P1|Overall Study|Protocol Violation|0
419403|NCT00582114|1403409|P2|Overall Study|Stopped by data safety monitoring board|20
419404|NCT00582114|1403410|P1|Overall Study|Stopped by data safety monitoring board|19
419405|NCT00582114|1403409|P2|Overall Study|Physician Decision|6
419406|NCT00582114|1403410|P1|Overall Study|Physician Decision|0
419407|NCT00582114|1403409|P2|Overall Study|Adverse Event|1
419408|NCT00582114|1403410|P1|Overall Study|Adverse Event|1
419409|NCT00582114|1403409|P2|Overall Study|Withdrawal by Subject|16
419410|NCT00582114|1403410|P1|Overall Study|Withdrawal by Subject|8
419411|NCT00582114|1403409|P2|Overall Study|Lost to Follow-up|6
419412|NCT00582114|1403410|P1|Overall Study|Lost to Follow-up|7
419413|NCT00582114|1403409|P2|Overall Study|Kidney Transplant|1
419414|NCT00582114|1403410|P1|Overall Study|Kidney Transplant|3
419415|NCT00582114|1403409|P2|Overall Study|Death|4
419416|NCT00582114|1403410|P1|Overall Study|Death|4
419417|NCT00582036|1403425|P2|Overall Study|Withdrawal by Subject|1
419418|NCT00582036|1403426|P1|Overall Study|Withdrawal by Subject|0
419419|NCT00582010|1403434|P2|Overall Study|Death|1
419420|NCT00582010|1403435|P1|Overall Study|Death|0
419421|NCT00581945|1403464|P2|Overall Study|Death|0
419422|NCT00581945|1403465|P1|Overall Study|Death|1
419423|NCT00581945|1403464|P2|Overall Study|Withdrawal by Subject|6
419424|NCT00581945|1403465|P1|Overall Study|Withdrawal by Subject|2
419425|NCT00581945|1403464|P2|Overall Study|Unsatisfactory therapeutic effect|0
419426|NCT00581945|1403465|P1|Overall Study|Unsatisfactory therapeutic effect|2
419427|NCT00581945|1403464|P2|Overall Study|Adverse Event|4
419428|NCT00581945|1403465|P1|Overall Study|Adverse Event|4
419429|NCT00581919|1403481|P1|Overall Study|Withdrawal by Subject|1
419430|NCT00581919|1403481|P1|Overall Study|Started Non-Protocol Therapy|2
419431|NCT00581919|1403481|P1|Overall Study|Other Complicating Disease|1
419432|NCT00581919|1403481|P1|Overall Study|Physician Decision|1
419433|NCT00581919|1403481|P1|Overall Study|Disease Progression|10
419434|NCT00581919|1403481|P1|Overall Study|Death|1
419435|NCT00581919|1403481|P1|Overall Study|Adverse Event|8
419436|NCT00581828|1403500|P1|Overall Study|Protocol Violation|1
419437|NCT00581776|1403504|P1|Overall Study|Disease progression or no response|3
419438|NCT00581555|1403522|P2|Overall Study|Other reasons|4
419439|NCT00581555|1403523|P1|Overall Study|Other reasons|16
419440|NCT00581555|1403522|P2|Overall Study|Lost to Follow-up|2
419441|NCT00581555|1403523|P1|Overall Study|Lost to Follow-up|2
419442|NCT00581555|1403522|P2|Overall Study|Withdrawal by Subject|9
419443|NCT00581555|1403523|P1|Overall Study|Withdrawal by Subject|18
419444|NCT00581555|1403522|P2|Overall Study|Physician Decision|2
419445|NCT00581555|1403523|P1|Overall Study|Physician Decision|3
419446|NCT00581555|1403522|P2|Overall Study|Adverse Event|3
419447|NCT00581555|1403523|P1|Overall Study|Adverse Event|4
419448|NCT00581542|1403547|P2|Overall Study|Lost to Follow-up|21
419449|NCT00581542|1403548|P1|Overall Study|Lost to Follow-up|9
419450|NCT00581542|1403547|P2|Overall Study|they met an exclusion criteria|2
419451|NCT00581542|1403548|P1|Overall Study|they met an exclusion criteria|2
419452|NCT00581360|1403602|P1|Overall Study|Withdrawal by Subject|1
419453|NCT00581308|1403621|P1|Month 12|Other|1
419454|NCT00581308|1403621|P1|Month 12|Device Removed|1
419455|NCT00581308|1403621|P1|Month 12|Withdrawal by Subject|3
419456|NCT00581308|1403621|P1|Month 12|Lost to Follow-up|14
419457|NCT00581308|1403621|P1|Month 12|Death|1
419458|NCT00581308|1403621|P1|Month 6|Withdrawal by Subject|2
419459|NCT00581308|1403621|P1|Month 6|Lost to Follow-up|1
419460|NCT00581308|1403621|P1|Month 1|Uknown|1
419461|NCT00581308|1403621|P1|Month 1|Device Removed|2
419462|NCT00581308|1403621|P1|Month 1|Withdrawal by Subject|2
419463|NCT00581308|1403621|P1|Month 1|Lost to Follow-up|3
419464|NCT00581308|1403621|P1|Pre Discharge|Device Removed|1
419465|NCT00581308|1403621|P1|Pre Discharge|Lost to Follow-up|1
419466|NCT00581113|1403652|P2|Overall Study|Withdrawal by Subject|1
419467|NCT00581113|1403653|P1|Overall Study|Withdrawal by Subject|0
419468|NCT00581100|1403663|P2|Overall Study|Other|0
419469|NCT00581100|1403664|P1|Overall Study|Other|3
419470|NCT00581100|1403663|P2|Overall Study|Withdrawal by Subject|4
419471|NCT00581100|1403664|P1|Overall Study|Withdrawal by Subject|1
419472|NCT00581100|1403663|P2|Overall Study|Adverse Event|1
419473|NCT00581100|1403664|P1|Overall Study|Adverse Event|2
419474|NCT00581100|1403663|P2|Overall Study|Death|0
419475|NCT00581100|1403664|P1|Overall Study|Death|1
419476|NCT00580983|1403717|P1|Overall Study|Did not complete 12 mon post RT studies|7
419477|NCT00580970|1403724|P1|Treatment (Lovastatin)|Death|1
419478|NCT00580970|1403724|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
419479|NCT00580970|1403724|P1|Treatment (Lovastatin)|Physician Decision|4
419480|NCT00580970|1403724|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
419481|NCT00580970|1403724|P1|Treatment (Lovastatin)|Non-compliance|6
419482|NCT00580970|1403724|P1|Pre-treatment|Non-compliance|1
419483|NCT00580866|1403739|P2|Overall Study|Lost to Follow-up|2
419484|NCT00580866|1403740|P1|Overall Study|Lost to Follow-up|2
419485|NCT00580840|1403764|P4|Double-Blind|Other: Forbidden Medication|0
419486|NCT00580840|1403765|P3|Double-Blind|Other: Forbidden Medication|1
419487|NCT00580840|1403766|P2|Double-Blind|Other: Forbidden Medication|0
419488|NCT00580840|1403767|P1|Double-Blind|Other: Forbidden Medication|0
419489|NCT00580840|1403764|P4|Double-Blind|Other: Discontinued Methotrexate|0
419490|NCT00580840|1403765|P3|Double-Blind|Other: Discontinued Methotrexate|0
419491|NCT00580840|1403766|P2|Double-Blind|Other: Discontinued Methotrexate|1
419492|NCT00580840|1403767|P1|Double-Blind|Other: Discontinued Methotrexate|0
419493|NCT00580840|1403764|P4|Double-Blind|Withdrawal by Subject|2
419494|NCT00580840|1403765|P3|Double-Blind|Withdrawal by Subject|2
419495|NCT00580840|1403766|P2|Double-Blind|Withdrawal by Subject|1
419496|NCT00580840|1403767|P1|Double-Blind|Withdrawal by Subject|0
419497|NCT00580840|1403764|P4|Double-Blind|Lost to Follow-up|2
419498|NCT00580840|1403765|P3|Double-Blind|Lost to Follow-up|0
419499|NCT00580840|1403766|P2|Double-Blind|Lost to Follow-up|1
419500|NCT00580840|1403767|P1|Double-Blind|Lost to Follow-up|0
419501|NCT00580840|1403764|P4|Double-Blind|Loss of Efficacy|10
419502|NCT00580840|1403765|P3|Double-Blind|Loss of Efficacy|2
419503|NCT00580840|1403766|P2|Double-Blind|Loss of Efficacy|1
419504|NCT00580840|1403767|P1|Double-Blind|Loss of Efficacy|0
419505|NCT00580840|1403764|P4|Double-Blind|Adverse Event|1
419506|NCT00580840|1403765|P3|Double-Blind|Adverse Event|4
419507|NCT00580840|1403766|P2|Double-Blind|Adverse Event|3
419508|NCT00580840|1403767|P1|Double-Blind|Adverse Event|0
419509|NCT00580840|1403764|P4|Run-in|Other: Exclusionary Lab Value|0
419510|NCT00580840|1403765|P3|Run-in|Other: Exclusionary Lab Value|0
419511|NCT00580840|1403766|P2|Run-in|Other: Exclusionary Lab Value|0
419512|NCT00580840|1403767|P1|Run-in|Other: Exclusionary Lab Value|1
419513|NCT00580840|1403764|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
419514|NCT00580840|1403765|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
419515|NCT00580840|1403766|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
419516|NCT00580840|1403767|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
419517|NCT00580840|1403764|P4|Run-in|Other: Per Sponsor Request|0
419518|NCT00580840|1403765|P3|Run-in|Other: Per Sponsor Request|0
419519|NCT00580840|1403766|P2|Run-in|Other: Per Sponsor Request|0
419520|NCT00580840|1403767|P1|Run-in|Other: Per Sponsor Request|2
419521|NCT00580840|1403764|P4|Run-in|Withdrawal by Subject|0
419522|NCT00580840|1403765|P3|Run-in|Withdrawal by Subject|0
419523|NCT00580840|1403766|P2|Run-in|Withdrawal by Subject|0
419524|NCT00580840|1403767|P1|Run-in|Withdrawal by Subject|5
419525|NCT00580840|1403764|P4|Run-in|Lost to Follow-up|0
419526|NCT00580840|1403765|P3|Run-in|Lost to Follow-up|0
419527|NCT00580840|1403766|P2|Run-in|Lost to Follow-up|0
419528|NCT00580840|1403767|P1|Run-in|Lost to Follow-up|4
419529|NCT00580840|1403764|P4|Run-in|Loss of Efficacy|0
419530|NCT00580840|1403765|P3|Run-in|Loss of Efficacy|0
419531|NCT00580840|1403766|P2|Run-in|Loss of Efficacy|0
419532|NCT00580840|1403767|P1|Run-in|Loss of Efficacy|1
419533|NCT00580840|1403764|P4|Run-in|Lack of Efficacy|0
419534|NCT00580840|1403765|P3|Run-in|Lack of Efficacy|0
419535|NCT00580840|1403766|P2|Run-in|Lack of Efficacy|0
419536|NCT00580840|1403767|P1|Run-in|Lack of Efficacy|93
419537|NCT00580840|1403764|P4|Run-in|Adverse Event|0
419538|NCT00580840|1403765|P3|Run-in|Adverse Event|0
419539|NCT00580840|1403766|P2|Run-in|Adverse Event|0
419540|NCT00580840|1403767|P1|Run-in|Adverse Event|17
419541|NCT00580801|1403875|P3|Overall Study|Travel|0
419542|NCT00580801|1403876|P2|Overall Study|Travel|0
419543|NCT00580801|1403877|P1|Overall Study|Travel|1
419544|NCT00580801|1403875|P3|Overall Study|Participant non-compliant|1
419545|NCT00580801|1403876|P2|Overall Study|Participant non-compliant|0
419546|NCT00580801|1403877|P1|Overall Study|Participant non-compliant|0
419547|NCT00580801|1403875|P3|Overall Study|Reached a virologic endpoint|2
419548|NCT00580801|1403876|P2|Overall Study|Reached a virologic endpoint|1
419549|NCT00580801|1403877|P1|Overall Study|Reached a virologic endpoint|0
419550|NCT00580801|1403875|P3|Overall Study|Lost to Follow-up|0
419551|NCT00580801|1403876|P2|Overall Study|Lost to Follow-up|0
419552|NCT00580801|1403877|P1|Overall Study|Lost to Follow-up|2
419553|NCT00580801|1403875|P3|Overall Study|Adverse Event|0
419554|NCT00580801|1403876|P2|Overall Study|Adverse Event|0
419555|NCT00580801|1403877|P1|Overall Study|Adverse Event|2
419556|NCT00580801|1403875|P3|Overall Study|Physician Decision|0
419557|NCT00580801|1403876|P2|Overall Study|Physician Decision|0
419558|NCT00580801|1403877|P1|Overall Study|Physician Decision|1
419559|NCT00580788|1403916|P4|Overall Study|Adverse Event|1
419560|NCT00580788|1403917|P3|Overall Study|Adverse Event|0
419561|NCT00580788|1403918|P2|Overall Study|Adverse Event|0
419562|NCT00580788|1403919|P1|Overall Study|Adverse Event|0
419563|NCT00580723|1403977|P1|Overall Study|Lost to Follow-up|5
419564|NCT00580723|1403977|P1|Overall Study|Did not want to participate in extension|3
419565|NCT00580606|1404020|P2|Open Label (OL)|Needed Prohibited Medication|1
419566|NCT00580606|1404021|P1|Open Label (OL)|Needed Prohibited Medication|0
419567|NCT00580606|1404020|P2|Open Label (OL)|Physician Decision|1
419568|NCT00580606|1404021|P1|Open Label (OL)|Physician Decision|1
419569|NCT00580606|1404020|P2|Open Label (OL)|Non-compliance|0
419570|NCT00580606|1404021|P1|Open Label (OL)|Non-compliance|2
419571|NCT00580606|1404020|P2|Open Label (OL)|Pregnancy|1
419572|NCT00580606|1404021|P1|Open Label (OL)|Pregnancy|0
419573|NCT00580606|1404020|P2|Open Label (OL)|Lost to Follow-up|1
419574|NCT00580606|1404021|P1|Open Label (OL)|Lost to Follow-up|0
419575|NCT00580606|1404020|P2|Open Label (OL)|Dosing Symptoms|1
419576|NCT00580606|1404021|P1|Open Label (OL)|Dosing Symptoms|0
419577|NCT00580606|1404020|P2|Open Label (OL)|Withdrawal by Subject|6
419578|NCT00580606|1404021|P1|Open Label (OL)|Withdrawal by Subject|4
419579|NCT00580606|1404020|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
419580|NCT00580606|1404021|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
419581|NCT00580047|1404100|P3|Overall Study|Withdrawal by Subject|0
419582|NCT00580047|1404101|P2|Overall Study|Withdrawal by Subject|0
419583|NCT00580047|1404102|P1|Overall Study|Withdrawal by Subject|1
419584|NCT00580047|1404100|P3|Overall Study|Withdrawal by Subject|2
419585|NCT00580047|1404101|P2|Overall Study|Withdrawal by Subject|1
419586|NCT00580047|1404102|P1|Overall Study|Withdrawal by Subject|1
419587|NCT00580047|1404100|P3|Overall Study|Lost to Follow-up|0
419588|NCT00580047|1404101|P2|Overall Study|Lost to Follow-up|1
419589|NCT00580047|1404102|P1|Overall Study|Lost to Follow-up|1
419590|NCT00580034|1404113|P2|Overall Study|Toxicity|0
419591|NCT00580034|1404114|P1|Overall Study|Toxicity|10
419592|NCT00579982|1404120|P1|Overall Study|Protocol Violation|4
419593|NCT00579982|1404120|P1|Overall Study|Adverse Event|4
419594|NCT00579826|1404141|P2|Overall Study|Withdrawal by Subject|3
419595|NCT00579826|1404142|P1|Overall Study|Withdrawal by Subject|5
419596|NCT00579670|1404176|P5|Overall Study|Withdrawal by Subject|0
419597|NCT00579670|1404177|P4|Overall Study|Withdrawal by Subject|0
419598|NCT00579670|1404178|P3|Overall Study|Withdrawal by Subject|1
419599|NCT00579670|1404179|P2|Overall Study|Withdrawal by Subject|0
419600|NCT00579670|1404180|P1|Overall Study|Withdrawal by Subject|0
419601|NCT00579670|1404176|P5|Overall Study|Other|0
419602|NCT00579670|1404177|P4|Overall Study|Other|2
419603|NCT00579670|1404178|P3|Overall Study|Other|1
419604|NCT00579670|1404179|P2|Overall Study|Other|0
419605|NCT00579670|1404180|P1|Overall Study|Other|0
419606|NCT00579670|1404176|P5|Overall Study|Lost to Follow-up|0
419607|NCT00579670|1404177|P4|Overall Study|Lost to Follow-up|4
419608|NCT00579670|1404178|P3|Overall Study|Lost to Follow-up|0
419609|NCT00579670|1404179|P2|Overall Study|Lost to Follow-up|1
419610|NCT00579670|1404180|P1|Overall Study|Lost to Follow-up|0
419611|NCT00579670|1404176|P5|Overall Study|Lack of Efficacy|0
419612|NCT00579670|1404177|P4|Overall Study|Lack of Efficacy|14
419613|NCT00579670|1404178|P3|Overall Study|Lack of Efficacy|1
419614|NCT00579670|1404179|P2|Overall Study|Lack of Efficacy|0
419615|NCT00579670|1404180|P1|Overall Study|Lack of Efficacy|0
419616|NCT00579670|1404176|P5|Overall Study|Adverse Event|0
419617|NCT00579670|1404177|P4|Overall Study|Adverse Event|2
419618|NCT00579670|1404178|P3|Overall Study|Adverse Event|1
419619|NCT00579670|1404179|P2|Overall Study|Adverse Event|0
419620|NCT00579670|1404180|P1|Overall Study|Adverse Event|1
419621|NCT00579670|1404176|P5|Overall Study|Death|0
419622|NCT00579670|1404177|P4|Overall Study|Death|0
419623|NCT00579670|1404178|P3|Overall Study|Death|0
419624|NCT00579670|1404179|P2|Overall Study|Death|0
419625|NCT00579670|1404180|P1|Overall Study|Death|1
419626|NCT00579501|1404392|P1|Overall Study|Radiation therapy before surgery|1
419627|NCT00579501|1404392|P1|Overall Study|Secondary lesion|1
419628|NCT00579501|1404392|P1|Overall Study|toxicity|1
419629|NCT00579501|1404392|P1|Overall Study|End of neoadjuvant therapy|25
419630|NCT00579501|1404392|P1|Overall Study|Death|1
419631|NCT00579345|1404420|P8|Overall Study|Death|0
419632|NCT00579345|1404421|P7|Overall Study|Death|0
419633|NCT00579345|1404422|P6|Overall Study|Death|0
419634|NCT00579345|1404423|P5|Overall Study|Death|0
419635|NCT00579345|1404424|P4|Overall Study|Death|1
419636|NCT00579345|1404425|P3|Overall Study|Death|1
419637|NCT00579345|1404426|P2|Overall Study|Death|1
419638|NCT00579345|1404427|P1|Overall Study|Death|1
419639|NCT00579345|1404420|P8|Overall Study|Protocol Violation|1
419640|NCT00579345|1404421|P7|Overall Study|Protocol Violation|0
419641|NCT00579345|1404422|P6|Overall Study|Protocol Violation|0
419642|NCT00579345|1404423|P5|Overall Study|Protocol Violation|0
419643|NCT00579345|1404424|P4|Overall Study|Protocol Violation|0
419644|NCT00579345|1404425|P3|Overall Study|Protocol Violation|0
419645|NCT00579345|1404426|P2|Overall Study|Protocol Violation|0
419646|NCT00579345|1404427|P1|Overall Study|Protocol Violation|1
419647|NCT00579345|1404420|P8|Overall Study|Adverse Event|0
419648|NCT00579345|1404421|P7|Overall Study|Adverse Event|0
419649|NCT00579345|1404422|P6|Overall Study|Adverse Event|0
419650|NCT00579345|1404423|P5|Overall Study|Adverse Event|0
419651|NCT00579345|1404424|P4|Overall Study|Adverse Event|0
419652|NCT00579345|1404425|P3|Overall Study|Adverse Event|1
419653|NCT00579345|1404426|P2|Overall Study|Adverse Event|0
419654|NCT00579345|1404427|P1|Overall Study|Adverse Event|0
419655|NCT00579345|1404420|P8|Overall Study|Lost to Follow-up|0
419656|NCT00579345|1404421|P7|Overall Study|Lost to Follow-up|0
419657|NCT00579345|1404422|P6|Overall Study|Lost to Follow-up|0
419658|NCT00579345|1404423|P5|Overall Study|Lost to Follow-up|0
419659|NCT00579345|1404424|P4|Overall Study|Lost to Follow-up|0
419660|NCT00579345|1404425|P3|Overall Study|Lost to Follow-up|0
419661|NCT00579345|1404426|P2|Overall Study|Lost to Follow-up|0
419662|NCT00579345|1404427|P1|Overall Study|Lost to Follow-up|1
419663|NCT00579345|1404420|P8|Overall Study|Withdrawal by Subject|1
419664|NCT00579345|1404421|P7|Overall Study|Withdrawal by Subject|0
419665|NCT00579345|1404422|P6|Overall Study|Withdrawal by Subject|0
419666|NCT00579345|1404423|P5|Overall Study|Withdrawal by Subject|0
419667|NCT00579345|1404424|P4|Overall Study|Withdrawal by Subject|0
419668|NCT00579345|1404425|P3|Overall Study|Withdrawal by Subject|0
419669|NCT00579345|1404426|P2|Overall Study|Withdrawal by Subject|0
419670|NCT00579345|1404427|P1|Overall Study|Withdrawal by Subject|2
419671|NCT00579254|1404459|P1|Overall Study|Discontinued when study terminated|73
419672|NCT00579254|1404459|P1|Overall Study|Lost to Follow-up|39
419673|NCT00579098|1404483|P2|Overall Study|AF returned after ablation|2
419674|NCT00579098|1404484|P1|Overall Study|AF returned after ablation|3
419675|NCT00579098|1404483|P2|Overall Study|Withdrawal by Subject|3
419676|NCT00579098|1404484|P1|Overall Study|Withdrawal by Subject|2
419677|NCT00579098|1404483|P2|Overall Study|Adverse Event|3
419678|NCT00579098|1404484|P1|Overall Study|Adverse Event|2
419679|NCT00579098|1404483|P2|Overall Study|Lost to Follow-up|0
419680|NCT00579098|1404484|P1|Overall Study|Lost to Follow-up|2
419681|NCT00579059|1404500|P2|Overall Study|Study Canceled at 1 Year|10
419682|NCT00579059|1404501|P1|Overall Study|Study Canceled at 1 Year|21
419683|NCT00578942|1404575|P1|Overall Study|Lost to Follow-up|1
419684|NCT00578877|1404614|P2|Overall Study|did not provide follow-up data|17
419685|NCT00578877|1404615|P1|Overall Study|did not provide follow-up data|12
419686|NCT00578877|1404614|P2|Overall Study|early discontinue|101
419687|NCT00578877|1404615|P1|Overall Study|early discontinue|61
419688|NCT00578877|1404614|P2|Overall Study|Lost to Follow-up|10
419689|NCT00578877|1404615|P1|Overall Study|Lost to Follow-up|8
419690|NCT00578864|1404623|P2|Overall Study|Death|0
419691|NCT00578864|1404624|P1|Overall Study|Death|1
419692|NCT00578812|1404640|P2|Overall Study|Not treated|7
419693|NCT00578812|1404641|P1|Overall Study|Not treated|6
419694|NCT00578786|1404680|P3|Overall Study|Qualified but Not Enrolled in Extension|0
419695|NCT00578786|1404681|P2|Overall Study|Qualified but Not Enrolled in Extension|3
419696|NCT00578786|1404682|P1|Overall Study|Qualified but Not Enrolled in Extension|0
419697|NCT00578786|1404680|P3|Overall Study|Not Otherwise Specified|1
419698|NCT00578786|1404681|P2|Overall Study|Not Otherwise Specified|4
419699|NCT00578786|1404682|P1|Overall Study|Not Otherwise Specified|0
419700|NCT00578786|1404680|P3|Overall Study|Pregnancy|0
419701|NCT00578786|1404681|P2|Overall Study|Pregnancy|1
419702|NCT00578786|1404682|P1|Overall Study|Pregnancy|0
419703|NCT00578786|1404680|P3|Overall Study|Lost to Follow-up|0
419704|NCT00578786|1404681|P2|Overall Study|Lost to Follow-up|4
419705|NCT00578786|1404682|P1|Overall Study|Lost to Follow-up|0
419706|NCT00578786|1404680|P3|Overall Study|Sponsor Decision|1
419707|NCT00578786|1404681|P2|Overall Study|Sponsor Decision|0
419708|NCT00578786|1404682|P1|Overall Study|Sponsor Decision|0
419709|NCT00578786|1404680|P3|Overall Study|Physician Decision|1
419710|NCT00578786|1404681|P2|Overall Study|Physician Decision|0
419711|NCT00578786|1404682|P1|Overall Study|Physician Decision|1
419712|NCT00578786|1404680|P3|Overall Study|Protocol Violation|1
419713|NCT00578786|1404681|P2|Overall Study|Protocol Violation|3
419714|NCT00578786|1404682|P1|Overall Study|Protocol Violation|0
419715|NCT00578786|1404680|P3|Overall Study|Withdrawal by Subject|5
419716|NCT00578786|1404681|P2|Overall Study|Withdrawal by Subject|8
419717|NCT00578786|1404682|P1|Overall Study|Withdrawal by Subject|7
419718|NCT00578786|1404680|P3|Overall Study|Early Escape from Prior Study|2
419719|NCT00578786|1404681|P2|Overall Study|Early Escape from Prior Study|1
419720|NCT00578786|1404682|P1|Overall Study|Early Escape from Prior Study|2
419721|NCT00578786|1404680|P3|Overall Study|Lack of Efficacy|2
419722|NCT00578786|1404681|P2|Overall Study|Lack of Efficacy|5
419723|NCT00578786|1404682|P1|Overall Study|Lack of Efficacy|2
419724|NCT00578786|1404680|P3|Overall Study|Adverse Event|17
419725|NCT00578786|1404681|P2|Overall Study|Adverse Event|37
419726|NCT00578786|1404682|P1|Overall Study|Adverse Event|27
419727|NCT00578565|1404781|P1|Overall Study|Adverse Event|3
419728|NCT00578448|1404811|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
419729|NCT00578448|1404811|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
419730|NCT00578448|1404811|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
419731|NCT00578448|1404811|P1|Day 1 up to 3 Years of Planned Study|Death|1
419732|NCT00578318|1404875|P2|Overall Study|Physician Decision|0
419733|NCT00578318|1404876|P1|Overall Study|Physician Decision|1
419734|NCT00578318|1404875|P2|Overall Study|Lost to Follow-up|0
419735|NCT00578318|1404876|P1|Overall Study|Lost to Follow-up|2
419736|NCT00578227|1404958|P3|Overall Study|Withdrawal by Subject|3
419737|NCT00578227|1404959|P2|Overall Study|Withdrawal by Subject|1
419738|NCT00578227|1404960|P1|Overall Study|Withdrawal by Subject|5
419739|NCT00578227|1404958|P3|Overall Study|Lost to Follow-up|1
419740|NCT00578227|1404959|P2|Overall Study|Lost to Follow-up|1
419741|NCT00578227|1404960|P1|Overall Study|Lost to Follow-up|0
419742|NCT00578136|1405166|P2|Overall Study|Not given intervention|1
419743|NCT00578136|1405167|P1|Overall Study|Not given intervention|1
419744|NCT00577889|1405185|P3|Overall Study|Withdrawal by Subject|0
419745|NCT00577889|1405186|P2|Overall Study|Withdrawal by Subject|0
419746|NCT00577889|1405187|P1|Overall Study|Withdrawal by Subject|1
419747|NCT00577863|1405206|P2|Overall Study|Did Not Receive at Least One Injection|1
419748|NCT00577863|1405207|P1|Overall Study|Did Not Receive at Least One Injection|0
419749|NCT00577863|1405206|P2|Overall Study|Sponsor Decision|7
419750|NCT00577863|1405207|P1|Overall Study|Sponsor Decision|2
419751|NCT00577863|1405206|P2|Overall Study|Withdrawal by Subject|2
419752|NCT00577863|1405207|P1|Overall Study|Withdrawal by Subject|0
419753|NCT00577863|1405206|P2|Overall Study|Entry Criteria Exclusion|0
419754|NCT00577863|1405207|P1|Overall Study|Entry Criteria Exclusion|1
419755|NCT00577863|1405206|P2|Overall Study|Lost to Follow-up|2
419756|NCT00577863|1405207|P1|Overall Study|Lost to Follow-up|2
419757|NCT00577863|1405206|P2|Overall Study|Death|0
419758|NCT00577863|1405207|P1|Overall Study|Death|1
419759|NCT00577863|1405206|P2|Overall Study|Adverse Event|2
419760|NCT00577863|1405207|P1|Overall Study|Adverse Event|4
419761|NCT00577824|1405249|P3|Overall Study|Protocol Violation|0
419762|NCT00577824|1405250|P2|Overall Study|Protocol Violation|1
419763|NCT00577824|1405251|P1|Overall Study|Protocol Violation|1
419764|NCT00577824|1405249|P3|Overall Study|Patient decision|1
419765|NCT00577824|1405250|P2|Overall Study|Patient decision|1
419766|NCT00577824|1405251|P1|Overall Study|Patient decision|0
419767|NCT00577824|1405249|P3|Overall Study|Adverse Event|1
419768|NCT00577824|1405250|P2|Overall Study|Adverse Event|18
419769|NCT00577824|1405251|P1|Overall Study|Adverse Event|6
419770|NCT00577772|1405309|P2|Overall Study|Lost to Follow-up|1
419771|NCT00577772|1405310|P1|Overall Study|Lost to Follow-up|0
419772|NCT00577720|1405320|P4|Overall Study|Withdrawal by Subject|2
419773|NCT00577720|1405321|P3|Overall Study|Withdrawal by Subject|0
419774|NCT00577720|1405322|P2|Overall Study|Withdrawal by Subject|0
419775|NCT00577720|1405323|P1|Overall Study|Withdrawal by Subject|2
419776|NCT00577720|1405320|P4|Overall Study|Protocol Violation|1
419777|NCT00577720|1405321|P3|Overall Study|Protocol Violation|0
419778|NCT00577720|1405322|P2|Overall Study|Protocol Violation|0
419779|NCT00577720|1405323|P1|Overall Study|Protocol Violation|0
419780|NCT00577720|1405320|P4|Overall Study|Lost to Follow-up|0
419781|NCT00577720|1405321|P3|Overall Study|Lost to Follow-up|1
419782|NCT00577720|1405322|P2|Overall Study|Lost to Follow-up|0
419783|NCT00577720|1405323|P1|Overall Study|Lost to Follow-up|0
419784|NCT00577720|1405320|P4|Overall Study|Adverse Event|4
419785|NCT00577720|1405321|P3|Overall Study|Adverse Event|0
419786|NCT00577720|1405322|P2|Overall Study|Adverse Event|1
419787|NCT00577720|1405323|P1|Overall Study|Adverse Event|2
419788|NCT00577707|1405341|P1|Overall Study|Withdrawal by Subject|3
419789|NCT00577655|1405349|P2|Overall Study|Lost to Follow-up|1
419790|NCT00577655|1405350|P1|Overall Study|Lost to Follow-up|1
419791|NCT00577655|1405349|P2|Overall Study|Protocol Violation|1
419792|NCT00577655|1405350|P1|Overall Study|Protocol Violation|0
419793|NCT00577655|1405349|P2|Overall Study|Patient Request|2
419794|NCT00577655|1405350|P1|Overall Study|Patient Request|0
419795|NCT00577642|1405388|P1|Overall Study|Clinical Disease Progression|1
419796|NCT00577629|1405392|P1|Long Term Follow-Up|Physician Decision|1
419797|NCT00577629|1405392|P1|Long Term Follow-Up|Withdrawal by Subject|4
419798|NCT00577629|1405392|P1|Long Term Follow-Up|Lost to Follow-up|5
419799|NCT00577629|1405392|P1|Long Term Follow-Up|Death|15
419800|NCT00577629|1405392|P1|Treatment Period|Death|1
419801|NCT00577473|1405406|P2|Overall Study|Lack of Efficacy|7
419802|NCT00577473|1405407|P1|Overall Study|Lack of Efficacy|8
419803|NCT00577473|1405406|P2|Overall Study|Physician Decision|2
419804|NCT00577473|1405407|P1|Overall Study|Physician Decision|2
419805|NCT00577473|1405406|P2|Overall Study|Withdrawal by Subject|6
419806|NCT00577473|1405407|P1|Overall Study|Withdrawal by Subject|2
419807|NCT00577473|1405406|P2|Overall Study|Adverse Event|5
419808|NCT00577473|1405407|P1|Overall Study|Adverse Event|8
419809|NCT00577473|1405406|P2|Overall Study|Protocol Violation|4
419810|NCT00577473|1405407|P1|Overall Study|Protocol Violation|1
419811|NCT00577460|1405438|P3|Overall Study|not specified|2
419812|NCT00577460|1405439|P2|Overall Study|not specified|3
419813|NCT00577460|1405440|P1|Overall Study|not specified|0
419814|NCT00577460|1405438|P3|Overall Study|Withdrawal by Subject|6
419815|NCT00577460|1405439|P2|Overall Study|Withdrawal by Subject|5
419816|NCT00577460|1405440|P1|Overall Study|Withdrawal by Subject|5
419817|NCT00577460|1405438|P3|Overall Study|Lost to Follow-up|4
419818|NCT00577460|1405439|P2|Overall Study|Lost to Follow-up|3
419819|NCT00577460|1405440|P1|Overall Study|Lost to Follow-up|0
419820|NCT00577460|1405438|P3|Overall Study|Protocol Violation|1
419821|NCT00577460|1405439|P2|Overall Study|Protocol Violation|1
419822|NCT00577460|1405440|P1|Overall Study|Protocol Violation|0
419823|NCT00577460|1405438|P3|Overall Study|Adverse Event|14
419824|NCT00577460|1405439|P2|Overall Study|Adverse Event|7
419825|NCT00577460|1405440|P1|Overall Study|Adverse Event|11
419826|NCT00577408|1405549|P2|Overall Study|Psychiatric hospitalization|1
419827|NCT00577408|1405550|P1|Overall Study|Psychiatric hospitalization|0
419828|NCT00577408|1405549|P2|Overall Study|Death|1
419829|NCT00577408|1405550|P1|Overall Study|Death|0
419830|NCT00577408|1405549|P2|Overall Study|Scheduling Issues|3
419831|NCT00577408|1405550|P1|Overall Study|Scheduling Issues|0
419832|NCT00577408|1405549|P2|Overall Study|Moved out of state|1
419833|NCT00577408|1405550|P1|Overall Study|Moved out of state|0
419834|NCT00577408|1405549|P2|Overall Study|Refused Oral Naltrexone|1
419835|NCT00577408|1405550|P1|Overall Study|Refused Oral Naltrexone|0
419836|NCT00577408|1405549|P2|Overall Study|Non-compliance with study meds|3
419837|NCT00577408|1405550|P1|Overall Study|Non-compliance with study meds|0
419838|NCT00577408|1405549|P2|Overall Study|Continued opioid use|2
419839|NCT00577408|1405550|P1|Overall Study|Continued opioid use|3
419840|NCT00577408|1405549|P2|Overall Study|Stopped attending study visits|11
419841|NCT00577408|1405550|P1|Overall Study|Stopped attending study visits|9
419842|NCT00577395|1405558|P2|Overall Study|Study was terminated early by Sponsor|6
419843|NCT00577395|1405559|P1|Overall Study|Study was terminated early by Sponsor|7
419844|NCT00577382|1405569|P2|Overall Study|Lost to Follow-up|2
419845|NCT00577382|1405570|P1|Overall Study|Lost to Follow-up|2
419846|NCT00577382|1405569|P2|Overall Study|Death|1
419847|NCT00577382|1405570|P1|Overall Study|Death|1
419848|NCT00577382|1405569|P2|Overall Study|Intercurrent Illness|2
419849|NCT00577382|1405570|P1|Overall Study|Intercurrent Illness|1
419850|NCT00577382|1405569|P2|Overall Study|Progressive Disease|19
419851|NCT00577382|1405570|P1|Overall Study|Progressive Disease|17
419852|NCT00577382|1405569|P2|Overall Study|Withdrawal by Subject|1
419853|NCT00577382|1405570|P1|Overall Study|Withdrawal by Subject|0
419854|NCT00577382|1405569|P2|Overall Study|Adverse Event|6
419855|NCT00577382|1405570|P1|Overall Study|Adverse Event|0
419856|NCT00577122|1405713|P2|Overall Study|Alternative Therapy|1
419857|NCT00577122|1405714|P1|Overall Study|Alternative Therapy|0
419858|NCT00577122|1405713|P2|Overall Study|Prog, refract disease during active trt|5
419859|NCT00577122|1405714|P1|Overall Study|Prog, refract disease during active trt|8
419860|NCT00577122|1405713|P2|Overall Study|Progression, relapse during active trt|8
419861|NCT00577122|1405714|P1|Overall Study|Progression, relapse during active trt|6
419862|NCT00577122|1405713|P2|Overall Study|Adverse Event|2
419863|NCT00577122|1405714|P1|Overall Study|Adverse Event|0
419864|NCT00577096|1405728|P2|Short Term Participation|Death|1
419865|NCT00577096|1405729|P1|Short Term Participation|Death|1
419866|NCT00577096|1405728|P2|Short Term Participation|Withdrawal by Subject|5
419867|NCT00577096|1405729|P1|Short Term Participation|Withdrawal by Subject|3
419868|NCT00577096|1405728|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
419869|NCT00577096|1405729|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
419870|NCT00577031|1405762|P1|Overall Study|Death|6
419871|NCT00577031|1405762|P1|Overall Study|Medical decision|14
419872|NCT00577031|1405762|P1|Overall Study|Need for surgery|17
419873|NCT00577031|1405762|P1|Overall Study|Participant non-compliance|5
419874|NCT00577031|1405762|P1|Overall Study|Participant withdrew consent|13
419875|NCT00577031|1405762|P1|Overall Study|Protocol Violation|5
419876|NCT00577031|1405762|P1|Overall Study|Progression of disease|93
419877|NCT00577031|1405762|P1|Overall Study|Adverse Event|52
419878|NCT00577005|1405783|P2|Overall Study|Withdrawal by Subject|1
419879|NCT00577005|1405784|P1|Overall Study|Withdrawal by Subject|2
419880|NCT00577005|1405783|P2|Overall Study|Lost to Follow-up|2
419881|NCT00577005|1405784|P1|Overall Study|Lost to Follow-up|3
419882|NCT00576927|1405798|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
419883|NCT00576927|1405798|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
419884|NCT00576927|1405798|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
419885|NCT00576927|1405798|P1|Sleep Hygiene Behavioral Intervention|Death|1
419886|NCT00576927|1405798|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
419887|NCT00576927|1405798|P1|Baseline|Withdrawal by Subject|3
419888|NCT00576927|1405798|P1|Baseline|Medication Change by PCP of subject|1
419889|NCT00576927|1405798|P1|Baseline|Physician Decision|9
419890|NCT00576927|1405798|P1|Clinical Assessment|Physician Decision|1
419891|NCT00576927|1405798|P1|Clinical Assessment|Withdrawal by Subject|10
419892|NCT00576927|1405798|P1|Clinical Assessment|Death|1
419893|NCT00576927|1405798|P1|Clinical Assessment|Lack of Efficacy|24
419894|NCT00576901|1405810|P1|Overall Study|Protocol Violation|1
419895|NCT00576901|1405810|P1|Overall Study|Disease course|1
419896|NCT00576901|1405810|P1|Overall Study|Withdrawal by Subject|1
419897|NCT00576823|1405821|P3|40-week Safety Extension Phase|Lack of Efficacy|0
419898|NCT00576823|1405822|P2|40-week Safety Extension Phase|Lack of Efficacy|0
419899|NCT00576823|1405823|P1|40-week Safety Extension Phase|Lack of Efficacy|1
419900|NCT00576823|1405821|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
419901|NCT00576823|1405822|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
419902|NCT00576823|1405823|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
419903|NCT00576758|1405839|P2|Follow-up Period|Withdrew consent|1
419904|NCT00576758|1405840|P1|Follow-up Period|Withdrew consent|2
419905|NCT00576758|1405839|P2|Follow-up Period|Insufficient therapeutic response|5
419906|NCT00576758|1405840|P1|Follow-up Period|Insufficient therapeutic response|16
419907|NCT00576758|1405839|P2|Follow-up Period|Death|3
419908|NCT00576758|1405840|P1|Follow-up Period|Death|3
419909|NCT00576758|1405839|P2|Follow-up Period|Administrative/Other|8
419910|NCT00576758|1405840|P1|Follow-up Period|Administrative/Other|6
419911|NCT00576758|1405839|P2|Extension Treatment Period|Administrative/Other|1
419912|NCT00576758|1405840|P1|Extension Treatment Period|Administrative/Other|3
419913|NCT00576758|1405839|P2|Extension Treatment Period|Insufficient therapeutic response|33
419914|NCT00576758|1405840|P1|Extension Treatment Period|Insufficient therapeutic response|30
419915|NCT00576758|1405839|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
419916|NCT00576758|1405840|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
419917|NCT00576758|1405839|P2|Extension Treatment Period|Death|1
419918|NCT00576758|1405840|P1|Extension Treatment Period|Death|1
419919|NCT00576758|1405839|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
419920|NCT00576758|1405840|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
419921|NCT00576758|1405839|P2|Induction Treatment Period|Withdrew consent|0
419922|NCT00576758|1405840|P1|Induction Treatment Period|Withdrew consent|1
419923|NCT00576758|1405839|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
419924|NCT00576758|1405840|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
419925|NCT00576758|1405839|P2|Induction Treatment Period|Death|0
419926|NCT00576758|1405840|P1|Induction Treatment Period|Death|1
419927|NCT00576758|1405839|P2|Induction Treatment Period|Violation of selection criteria at entry|1
419928|NCT00576758|1405840|P1|Induction Treatment Period|Violation of selection criteria at entry|1
419929|NCT00576758|1405839|P2|Induction Treatment Period|Insufficient therapeutic response|0
419930|NCT00576758|1405840|P1|Induction Treatment Period|Insufficient therapeutic response|2
419931|NCT00576758|1405839|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
419932|NCT00576758|1405840|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
419933|NCT00576732|1405886|P6|OPEN LABEL|Protocol Violation|0
419934|NCT00576732|1405887|P5|OPEN LABEL|Protocol Violation|1
419935|NCT00576732|1405888|P4|OPEN LABEL|Protocol Violation|2
419936|NCT00576732|1405889|P3|OPEN LABEL|Protocol Violation|0
419937|NCT00576732|1405890|P2|OPEN LABEL|Protocol Violation|0
419938|NCT00576732|1405891|P1|OPEN LABEL|Protocol Violation|0
419939|NCT00576732|1405886|P6|OPEN LABEL|Lack of Efficacy|3
419940|NCT00576732|1405887|P5|OPEN LABEL|Lack of Efficacy|2
419941|NCT00576732|1405888|P4|OPEN LABEL|Lack of Efficacy|2
419942|NCT00576732|1405889|P3|OPEN LABEL|Lack of Efficacy|0
419943|NCT00576732|1405890|P2|OPEN LABEL|Lack of Efficacy|0
419944|NCT00576732|1405891|P1|OPEN LABEL|Lack of Efficacy|0
419945|NCT00576732|1405886|P6|OPEN LABEL|OTHER|2
419946|NCT00576732|1405887|P5|OPEN LABEL|OTHER|0
419947|NCT00576732|1405888|P4|OPEN LABEL|OTHER|0
419948|NCT00576732|1405889|P3|OPEN LABEL|OTHER|0
419949|NCT00576732|1405890|P2|OPEN LABEL|OTHER|0
419950|NCT00576732|1405891|P1|OPEN LABEL|OTHER|0
419951|NCT00576732|1405886|P6|OPEN LABEL|Withdrawal by Subject|1
419952|NCT00576732|1405887|P5|OPEN LABEL|Withdrawal by Subject|0
419953|NCT00576732|1405888|P4|OPEN LABEL|Withdrawal by Subject|1
419954|NCT00576732|1405889|P3|OPEN LABEL|Withdrawal by Subject|0
419955|NCT00576732|1405890|P2|OPEN LABEL|Withdrawal by Subject|0
419956|NCT00576732|1405891|P1|OPEN LABEL|Withdrawal by Subject|0
419957|NCT00576732|1405886|P6|OPEN LABEL|Lost to Follow-up|1
419958|NCT00576732|1405887|P5|OPEN LABEL|Lost to Follow-up|1
419959|NCT00576732|1405888|P4|OPEN LABEL|Lost to Follow-up|2
419960|NCT00576732|1405889|P3|OPEN LABEL|Lost to Follow-up|0
419961|NCT00576732|1405890|P2|OPEN LABEL|Lost to Follow-up|0
419962|NCT00576732|1405891|P1|OPEN LABEL|Lost to Follow-up|0
419963|NCT00576732|1405886|P6|OPEN LABEL|Adverse Event|1
419964|NCT00576732|1405887|P5|OPEN LABEL|Adverse Event|0
419965|NCT00576732|1405888|P4|OPEN LABEL|Adverse Event|4
419966|NCT00576732|1405889|P3|OPEN LABEL|Adverse Event|0
419967|NCT00576732|1405890|P2|OPEN LABEL|Adverse Event|0
419968|NCT00576732|1405891|P1|OPEN LABEL|Adverse Event|0
419969|NCT00576732|1405886|P6|DOUBLE BLIND|Protocol Violation|0
419970|NCT00576732|1405887|P5|DOUBLE BLIND|Protocol Violation|0
419971|NCT00576732|1405888|P4|DOUBLE BLIND|Protocol Violation|0
419972|NCT00576732|1405889|P3|DOUBLE BLIND|Protocol Violation|0
419973|NCT00576732|1405890|P2|DOUBLE BLIND|Protocol Violation|0
419974|NCT00576732|1405891|P1|DOUBLE BLIND|Protocol Violation|1
419975|NCT00576732|1405886|P6|DOUBLE BLIND|Lack of Efficacy|0
419976|NCT00576732|1405887|P5|DOUBLE BLIND|Lack of Efficacy|0
419977|NCT00576732|1405888|P4|DOUBLE BLIND|Lack of Efficacy|0
419978|NCT00576732|1405889|P3|DOUBLE BLIND|Lack of Efficacy|0
419979|NCT00576732|1405890|P2|DOUBLE BLIND|Lack of Efficacy|1
419980|NCT00576732|1405891|P1|DOUBLE BLIND|Lack of Efficacy|6
419981|NCT00576732|1405886|P6|DOUBLE BLIND|OTHER|0
419982|NCT00576732|1405887|P5|DOUBLE BLIND|OTHER|0
419983|NCT00576732|1405888|P4|DOUBLE BLIND|OTHER|0
419984|NCT00576732|1405889|P3|DOUBLE BLIND|OTHER|1
419985|NCT00576732|1405890|P2|DOUBLE BLIND|OTHER|2
419986|NCT00576732|1405891|P1|DOUBLE BLIND|OTHER|0
419987|NCT00576732|1405886|P6|DOUBLE BLIND|Withdrawal by Subject|0
419988|NCT00576732|1405887|P5|DOUBLE BLIND|Withdrawal by Subject|0
419989|NCT00576732|1405888|P4|DOUBLE BLIND|Withdrawal by Subject|0
419990|NCT00576732|1405889|P3|DOUBLE BLIND|Withdrawal by Subject|3
419991|NCT00576732|1405890|P2|DOUBLE BLIND|Withdrawal by Subject|1
419992|NCT00576732|1405891|P1|DOUBLE BLIND|Withdrawal by Subject|1
419993|NCT00576732|1405886|P6|DOUBLE BLIND|Lost to Follow-up|0
419994|NCT00576732|1405887|P5|DOUBLE BLIND|Lost to Follow-up|0
419995|NCT00576732|1405888|P4|DOUBLE BLIND|Lost to Follow-up|0
419996|NCT00576732|1405889|P3|DOUBLE BLIND|Lost to Follow-up|1
419997|NCT00576732|1405890|P2|DOUBLE BLIND|Lost to Follow-up|1
419998|NCT00576732|1405891|P1|DOUBLE BLIND|Lost to Follow-up|0
419999|NCT00576732|1405886|P6|DOUBLE BLIND|Adverse Event|0
420000|NCT00576732|1405887|P5|DOUBLE BLIND|Adverse Event|0
420001|NCT00576732|1405888|P4|DOUBLE BLIND|Adverse Event|0
420002|NCT00576732|1405889|P3|DOUBLE BLIND|Adverse Event|1
420003|NCT00576732|1405890|P2|DOUBLE BLIND|Adverse Event|0
420004|NCT00576732|1405891|P1|DOUBLE BLIND|Adverse Event|0
420005|NCT00576693|1405923|P2|Overall Study|Withdrawal by Subject|13
420006|NCT00576693|1405924|P1|Overall Study|Withdrawal by Subject|3
420007|NCT00576693|1405923|P2|Overall Study|Lost to Follow-up|11
420008|NCT00576693|1405924|P1|Overall Study|Lost to Follow-up|7
420009|NCT00576628|1405930|P1|Overall Study|Dialysis|15
420010|NCT00576628|1405930|P1|Overall Study|Transplantation|1
420011|NCT00576628|1405930|P1|Overall Study|The patient move into other town|1
420012|NCT00576628|1405930|P1|Overall Study|Progression of Renal Failure|1
420013|NCT00576628|1405930|P1|Overall Study|Progression of Kidney Disease|1
420014|NCT00576628|1405930|P1|Overall Study|RBC transfusion|1
420015|NCT00576628|1405930|P1|Overall Study|Pregnancy|1
420016|NCT00576628|1405930|P1|Overall Study|Refused Treatment|8
420017|NCT00576628|1405930|P1|Overall Study|Failure to return|1
420018|NCT00576628|1405930|P1|Overall Study|Death|2
420019|NCT00576628|1405930|P1|Overall Study|Adverse Event|11
420020|NCT00576576|1405950|P1|Overall Study|Protocol Violation|1
420021|NCT00576576|1405950|P1|Overall Study|Lost to Follow-up|6
420022|NCT00576472|1405984|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
420023|NCT00576472|1405985|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
420024|NCT00576472|1405986|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
420025|NCT00576472|1405987|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
420026|NCT00576472|1405988|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
420027|NCT00576472|1405989|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
420028|NCT00576472|1405990|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
420029|NCT00576472|1405991|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
420030|NCT00576472|1405992|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
420031|NCT00576472|1405993|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
420032|NCT00576472|1405994|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
420033|NCT00576472|1405995|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
420034|NCT00576472|1405996|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
420035|NCT00576472|1405997|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
420036|NCT00576472|1405998|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
420037|NCT00576472|1405984|P15|MPH Home Maintenance Phase|Medical reasons|6
420038|NCT00576472|1405985|P14|MPH Home Maintenance Phase|Medical reasons|0
420039|NCT00576472|1405986|P13|MPH Home Maintenance Phase|Medical reasons|0
420040|NCT00576472|1405987|P12|MPH Home Maintenance Phase|Medical reasons|0
420041|NCT00576472|1405988|P11|MPH Home Maintenance Phase|Medical reasons|0
420042|NCT00576472|1405989|P10|MPH Home Maintenance Phase|Medical reasons|0
420043|NCT00576472|1405990|P9|MPH Home Maintenance Phase|Medical reasons|0
420044|NCT00576472|1405991|P8|MPH Home Maintenance Phase|Medical reasons|0
420045|NCT00576472|1405992|P7|MPH Home Maintenance Phase|Medical reasons|0
420046|NCT00576472|1405993|P6|MPH Home Maintenance Phase|Medical reasons|0
420047|NCT00576472|1405994|P5|MPH Home Maintenance Phase|Medical reasons|0
420048|NCT00576472|1405995|P4|MPH Home Maintenance Phase|Medical reasons|0
420049|NCT00576472|1405996|P3|MPH Home Maintenance Phase|Medical reasons|0
420050|NCT00576472|1405997|P2|MPH Home Maintenance Phase|Medical reasons|0
420051|NCT00576472|1405998|P1|MPH Home Maintenance Phase|Medical reasons|0
420052|NCT00576472|1405984|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
420053|NCT00576472|1405985|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
420054|NCT00576472|1405986|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
420055|NCT00576472|1405987|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
420056|NCT00576472|1405988|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
420057|NCT00576472|1405989|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
420058|NCT00576472|1405990|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
420059|NCT00576472|1405991|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
420060|NCT00576472|1405992|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
420061|NCT00576472|1405993|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
420062|NCT00576472|1405994|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
420063|NCT00576472|1405995|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
420064|NCT00576472|1405996|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
420065|NCT00576472|1405997|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
420066|NCT00576472|1405998|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
420067|NCT00576472|1405984|P15|MPH Home Maintenance Phase|Side effects|8
420068|NCT00576472|1405985|P14|MPH Home Maintenance Phase|Side effects|0
420069|NCT00576472|1405986|P13|MPH Home Maintenance Phase|Side effects|0
420070|NCT00576472|1405987|P12|MPH Home Maintenance Phase|Side effects|0
420071|NCT00576472|1405988|P11|MPH Home Maintenance Phase|Side effects|0
420072|NCT00576472|1405989|P10|MPH Home Maintenance Phase|Side effects|0
420073|NCT00576472|1405990|P9|MPH Home Maintenance Phase|Side effects|0
420074|NCT00576472|1405991|P8|MPH Home Maintenance Phase|Side effects|0
420075|NCT00576472|1405992|P7|MPH Home Maintenance Phase|Side effects|0
420076|NCT00576472|1405993|P6|MPH Home Maintenance Phase|Side effects|0
420077|NCT00576472|1405994|P5|MPH Home Maintenance Phase|Side effects|0
420078|NCT00576472|1405995|P4|MPH Home Maintenance Phase|Side effects|0
420079|NCT00576472|1405996|P3|MPH Home Maintenance Phase|Side effects|0
420080|NCT00576472|1405997|P2|MPH Home Maintenance Phase|Side effects|0
420081|NCT00576472|1405998|P1|MPH Home Maintenance Phase|Side effects|0
420082|NCT00576472|1405984|P15|MPH Home Maintenance Phase|Insufficient data|0
420083|NCT00576472|1405985|P14|MPH Home Maintenance Phase|Insufficient data|4
420084|NCT00576472|1405986|P13|MPH Home Maintenance Phase|Insufficient data|0
420085|NCT00576472|1405987|P12|MPH Home Maintenance Phase|Insufficient data|0
420086|NCT00576472|1405988|P11|MPH Home Maintenance Phase|Insufficient data|0
420087|NCT00576472|1405989|P10|MPH Home Maintenance Phase|Insufficient data|0
420088|NCT00576472|1405990|P9|MPH Home Maintenance Phase|Insufficient data|0
420089|NCT00576472|1405991|P8|MPH Home Maintenance Phase|Insufficient data|0
420090|NCT00576472|1405992|P7|MPH Home Maintenance Phase|Insufficient data|0
420091|NCT00576472|1405993|P6|MPH Home Maintenance Phase|Insufficient data|0
420092|NCT00576472|1405994|P5|MPH Home Maintenance Phase|Insufficient data|0
420093|NCT00576472|1405995|P4|MPH Home Maintenance Phase|Insufficient data|0
420094|NCT00576472|1405996|P3|MPH Home Maintenance Phase|Insufficient data|0
420095|NCT00576472|1405997|P2|MPH Home Maintenance Phase|Insufficient data|0
420096|NCT00576472|1405998|P1|MPH Home Maintenance Phase|Insufficient data|0
420097|NCT00576472|1405984|P15|MPH Home Maintenance Phase|Declined to participate|0
420098|NCT00576472|1405985|P14|MPH Home Maintenance Phase|Declined to participate|7
420099|NCT00576472|1405986|P13|MPH Home Maintenance Phase|Declined to participate|0
420100|NCT00576472|1405987|P12|MPH Home Maintenance Phase|Declined to participate|0
420101|NCT00576472|1405988|P11|MPH Home Maintenance Phase|Declined to participate|0
420102|NCT00576472|1405989|P10|MPH Home Maintenance Phase|Declined to participate|0
420103|NCT00576472|1405990|P9|MPH Home Maintenance Phase|Declined to participate|0
420104|NCT00576472|1405991|P8|MPH Home Maintenance Phase|Declined to participate|0
420105|NCT00576472|1405992|P7|MPH Home Maintenance Phase|Declined to participate|0
420106|NCT00576472|1405993|P6|MPH Home Maintenance Phase|Declined to participate|0
420107|NCT00576472|1405994|P5|MPH Home Maintenance Phase|Declined to participate|0
420108|NCT00576472|1405995|P4|MPH Home Maintenance Phase|Declined to participate|0
420109|NCT00576472|1405996|P3|MPH Home Maintenance Phase|Declined to participate|0
420110|NCT00576472|1405997|P2|MPH Home Maintenance Phase|Declined to participate|0
420111|NCT00576472|1405998|P1|MPH Home Maintenance Phase|Declined to participate|0
420112|NCT00576472|1405984|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
420113|NCT00576472|1405985|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
420114|NCT00576472|1405986|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
420115|NCT00576472|1405987|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
420116|NCT00576472|1405988|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
420117|NCT00576472|1405989|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
420118|NCT00576472|1405990|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
420119|NCT00576472|1405991|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
420120|NCT00576472|1405992|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
420121|NCT00576472|1405993|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
420122|NCT00576472|1405994|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
420123|NCT00576472|1405995|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
420124|NCT00576472|1405996|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
420125|NCT00576472|1405997|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
420126|NCT00576472|1405998|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
420127|NCT00576472|1405984|P15|MPH Cross Over Phase|Did not complete cross over phase|0
420128|NCT00576472|1405985|P14|MPH Cross Over Phase|Did not complete cross over phase|0
420129|NCT00576472|1405986|P13|MPH Cross Over Phase|Did not complete cross over phase|0
420130|NCT00576472|1405987|P12|MPH Cross Over Phase|Did not complete cross over phase|1
420131|NCT00576472|1405988|P11|MPH Cross Over Phase|Did not complete cross over phase|1
420132|NCT00576472|1405989|P10|MPH Cross Over Phase|Did not complete cross over phase|0
420133|NCT00576472|1405990|P9|MPH Cross Over Phase|Did not complete cross over phase|2
420134|NCT00576472|1405991|P8|MPH Cross Over Phase|Did not complete cross over phase|0
420135|NCT00576472|1405992|P7|MPH Cross Over Phase|Did not complete cross over phase|0
420136|NCT00576472|1405993|P6|MPH Cross Over Phase|Did not complete cross over phase|0
420137|NCT00576472|1405994|P5|MPH Cross Over Phase|Did not complete cross over phase|0
420138|NCT00576472|1405995|P4|MPH Cross Over Phase|Did not complete cross over phase|0
420139|NCT00576472|1405996|P3|MPH Cross Over Phase|Did not complete cross over phase|0
420140|NCT00576472|1405997|P2|MPH Cross Over Phase|Did not complete cross over phase|0
420141|NCT00576472|1405998|P1|MPH Cross Over Phase|Did not complete cross over phase|0
420142|NCT00576472|1405984|P15|MPH Cross Over Phase|Physician Decision|0
420143|NCT00576472|1405985|P14|MPH Cross Over Phase|Physician Decision|0
420144|NCT00576472|1405986|P13|MPH Cross Over Phase|Physician Decision|0
420145|NCT00576472|1405987|P12|MPH Cross Over Phase|Physician Decision|0
420146|NCT00576472|1405988|P11|MPH Cross Over Phase|Physician Decision|0
420147|NCT00576472|1405989|P10|MPH Cross Over Phase|Physician Decision|0
420148|NCT00576472|1405990|P9|MPH Cross Over Phase|Physician Decision|0
420149|NCT00576472|1405991|P8|MPH Cross Over Phase|Physician Decision|0
420150|NCT00576472|1405992|P7|MPH Cross Over Phase|Physician Decision|4
420151|NCT00576472|1405993|P6|MPH Cross Over Phase|Physician Decision|0
420152|NCT00576472|1405994|P5|MPH Cross Over Phase|Physician Decision|0
420153|NCT00576472|1405995|P4|MPH Cross Over Phase|Physician Decision|0
420154|NCT00576472|1405996|P3|MPH Cross Over Phase|Physician Decision|0
420155|NCT00576472|1405997|P2|MPH Cross Over Phase|Physician Decision|0
420156|NCT00576472|1405998|P1|MPH Cross Over Phase|Physician Decision|0
420157|NCT00576472|1405984|P15|MPH Cross Over Phase|Ineligible due to disease|0
420158|NCT00576472|1405985|P14|MPH Cross Over Phase|Ineligible due to disease|0
420159|NCT00576472|1405986|P13|MPH Cross Over Phase|Ineligible due to disease|0
420160|NCT00576472|1405987|P12|MPH Cross Over Phase|Ineligible due to disease|0
420161|NCT00576472|1405988|P11|MPH Cross Over Phase|Ineligible due to disease|0
420162|NCT00576472|1405989|P10|MPH Cross Over Phase|Ineligible due to disease|0
420163|NCT00576472|1405990|P9|MPH Cross Over Phase|Ineligible due to disease|0
420164|NCT00576472|1405991|P8|MPH Cross Over Phase|Ineligible due to disease|0
420165|NCT00576472|1405992|P7|MPH Cross Over Phase|Ineligible due to disease|2
420166|NCT00576472|1405993|P6|MPH Cross Over Phase|Ineligible due to disease|0
420167|NCT00576472|1405994|P5|MPH Cross Over Phase|Ineligible due to disease|0
420168|NCT00576472|1405995|P4|MPH Cross Over Phase|Ineligible due to disease|0
420169|NCT00576472|1405996|P3|MPH Cross Over Phase|Ineligible due to disease|0
420170|NCT00576472|1405997|P2|MPH Cross Over Phase|Ineligible due to disease|0
420171|NCT00576472|1405998|P1|MPH Cross Over Phase|Ineligible due to disease|0
420172|NCT00576472|1405984|P15|MPH Cross Over Phase|Withdrawal by Subject|0
420173|NCT00576472|1405985|P14|MPH Cross Over Phase|Withdrawal by Subject|0
420174|NCT00576472|1405986|P13|MPH Cross Over Phase|Withdrawal by Subject|0
420175|NCT00576472|1405987|P12|MPH Cross Over Phase|Withdrawal by Subject|0
420176|NCT00576472|1405988|P11|MPH Cross Over Phase|Withdrawal by Subject|0
420177|NCT00576472|1405989|P10|MPH Cross Over Phase|Withdrawal by Subject|0
420178|NCT00576472|1405990|P9|MPH Cross Over Phase|Withdrawal by Subject|0
420179|NCT00576472|1405991|P8|MPH Cross Over Phase|Withdrawal by Subject|0
420180|NCT00576472|1405992|P7|MPH Cross Over Phase|Withdrawal by Subject|6
420181|NCT00576472|1405993|P6|MPH Cross Over Phase|Withdrawal by Subject|0
420182|NCT00576472|1405994|P5|MPH Cross Over Phase|Withdrawal by Subject|0
420183|NCT00576472|1405995|P4|MPH Cross Over Phase|Withdrawal by Subject|0
420184|NCT00576472|1405996|P3|MPH Cross Over Phase|Withdrawal by Subject|0
420185|NCT00576472|1405997|P2|MPH Cross Over Phase|Withdrawal by Subject|0
420186|NCT00576472|1405998|P1|MPH Cross Over Phase|Withdrawal by Subject|0
420187|NCT00576472|1405984|P15|MPH In-Lab Phase|Psychiatric exclusion|0
420188|NCT00576472|1405985|P14|MPH In-Lab Phase|Psychiatric exclusion|0
420189|NCT00576472|1405986|P13|MPH In-Lab Phase|Psychiatric exclusion|0
420190|NCT00576472|1405987|P12|MPH In-Lab Phase|Psychiatric exclusion|0
420191|NCT00576472|1405988|P11|MPH In-Lab Phase|Psychiatric exclusion|0
420192|NCT00576472|1405989|P10|MPH In-Lab Phase|Psychiatric exclusion|0
420193|NCT00576472|1405990|P9|MPH In-Lab Phase|Psychiatric exclusion|0
420194|NCT00576472|1405991|P8|MPH In-Lab Phase|Psychiatric exclusion|0
420195|NCT00576472|1405992|P7|MPH In-Lab Phase|Psychiatric exclusion|0
420196|NCT00576472|1405993|P6|MPH In-Lab Phase|Psychiatric exclusion|0
420197|NCT00576472|1405994|P5|MPH In-Lab Phase|Psychiatric exclusion|0
420198|NCT00576472|1405995|P4|MPH In-Lab Phase|Psychiatric exclusion|10
420199|NCT00576472|1405996|P3|MPH In-Lab Phase|Psychiatric exclusion|0
420200|NCT00576472|1405997|P2|MPH In-Lab Phase|Psychiatric exclusion|0
420201|NCT00576472|1405998|P1|MPH In-Lab Phase|Psychiatric exclusion|0
420202|NCT00576472|1405984|P15|MPH In-Lab Phase|No attention/academic problems|0
420203|NCT00576472|1405985|P14|MPH In-Lab Phase|No attention/academic problems|0
420204|NCT00576472|1405986|P13|MPH In-Lab Phase|No attention/academic problems|0
420205|NCT00576472|1405987|P12|MPH In-Lab Phase|No attention/academic problems|0
420206|NCT00576472|1405988|P11|MPH In-Lab Phase|No attention/academic problems|0
420207|NCT00576472|1405989|P10|MPH In-Lab Phase|No attention/academic problems|0
420208|NCT00576472|1405990|P9|MPH In-Lab Phase|No attention/academic problems|0
420209|NCT00576472|1405991|P8|MPH In-Lab Phase|No attention/academic problems|0
420210|NCT00576472|1405992|P7|MPH In-Lab Phase|No attention/academic problems|0
420211|NCT00576472|1405993|P6|MPH In-Lab Phase|No attention/academic problems|0
420212|NCT00576472|1405994|P5|MPH In-Lab Phase|No attention/academic problems|0
420213|NCT00576472|1405995|P4|MPH In-Lab Phase|No attention/academic problems|245
420214|NCT00576472|1405996|P3|MPH In-Lab Phase|No attention/academic problems|0
420215|NCT00576472|1405997|P2|MPH In-Lab Phase|No attention/academic problems|0
420216|NCT00576472|1405998|P1|MPH In-Lab Phase|No attention/academic problems|0
420217|NCT00576472|1405984|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420218|NCT00576472|1405985|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420219|NCT00576472|1405986|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420220|NCT00576472|1405987|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420221|NCT00576472|1405988|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420222|NCT00576472|1405989|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420223|NCT00576472|1405990|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420224|NCT00576472|1405991|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420225|NCT00576472|1405992|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420226|NCT00576472|1405993|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420227|NCT00576472|1405994|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420228|NCT00576472|1405995|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
420229|NCT00576472|1405996|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420230|NCT00576472|1405997|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420231|NCT00576472|1405998|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
420232|NCT00576472|1405984|P15|MPH In-Lab Phase|Lost to Follow-up|0
420233|NCT00576472|1405985|P14|MPH In-Lab Phase|Lost to Follow-up|0
420234|NCT00576472|1405986|P13|MPH In-Lab Phase|Lost to Follow-up|0
420235|NCT00576472|1405987|P12|MPH In-Lab Phase|Lost to Follow-up|0
420236|NCT00576472|1405988|P11|MPH In-Lab Phase|Lost to Follow-up|0
420237|NCT00576472|1405989|P10|MPH In-Lab Phase|Lost to Follow-up|0
420238|NCT00576472|1405990|P9|MPH In-Lab Phase|Lost to Follow-up|0
420239|NCT00576472|1405991|P8|MPH In-Lab Phase|Lost to Follow-up|0
420240|NCT00576472|1405992|P7|MPH In-Lab Phase|Lost to Follow-up|0
420241|NCT00576472|1405993|P6|MPH In-Lab Phase|Lost to Follow-up|0
420242|NCT00576472|1405994|P5|MPH In-Lab Phase|Lost to Follow-up|0
420243|NCT00576472|1405995|P4|MPH In-Lab Phase|Lost to Follow-up|1
420244|NCT00576472|1405996|P3|MPH In-Lab Phase|Lost to Follow-up|0
420245|NCT00576472|1405997|P2|MPH In-Lab Phase|Lost to Follow-up|0
420246|NCT00576472|1405998|P1|MPH In-Lab Phase|Lost to Follow-up|0
420247|NCT00576472|1405984|P15|MPH In-Lab Phase|Declined participation in medication pha|0
420248|NCT00576472|1405985|P14|MPH In-Lab Phase|Declined participation in medication pha|0
420249|NCT00576472|1405986|P13|MPH In-Lab Phase|Declined participation in medication pha|0
420250|NCT00576472|1405987|P12|MPH In-Lab Phase|Declined participation in medication pha|0
420251|NCT00576472|1405988|P11|MPH In-Lab Phase|Declined participation in medication pha|0
420252|NCT00576472|1405989|P10|MPH In-Lab Phase|Declined participation in medication pha|0
420253|NCT00576472|1405990|P9|MPH In-Lab Phase|Declined participation in medication pha|0
420254|NCT00576472|1405991|P8|MPH In-Lab Phase|Declined participation in medication pha|0
420255|NCT00576472|1405992|P7|MPH In-Lab Phase|Declined participation in medication pha|0
420256|NCT00576472|1405993|P6|MPH In-Lab Phase|Declined participation in medication pha|0
420257|NCT00576472|1405994|P5|MPH In-Lab Phase|Declined participation in medication pha|0
420258|NCT00576472|1405995|P4|MPH In-Lab Phase|Declined participation in medication pha|75
420259|NCT00576472|1405996|P3|MPH In-Lab Phase|Declined participation in medication pha|0
420260|NCT00576472|1405997|P2|MPH In-Lab Phase|Declined participation in medication pha|0
420261|NCT00576472|1405998|P1|MPH In-Lab Phase|Declined participation in medication pha|0
420262|NCT00576420|1406091|P3|Overall Study|Death|1
420263|NCT00576420|1406092|P2|Overall Study|Death|0
420264|NCT00576420|1406093|P1|Overall Study|Death|0
420265|NCT00576381|1406258|P1|Overall Study|Adverse Event|4
420266|NCT00576381|1406258|P1|Overall Study|Reoperation|3
420267|NCT00576316|1406262|P1|Overall Study|Protocol Violation|9
420268|NCT00576316|1406262|P1|Overall Study|Withdrawal by Subject|2
420269|NCT00576316|1406262|P1|Overall Study|Adverse Event|9
420270|NCT00576303|1406267|P1|Long Term Safety Period|Early withdrawal|16
420271|NCT00576303|1406267|P1|Efficacy Evaluation Period|Early withdrawal|5
420272|NCT00576303|1406267|P1|Dose Titration Period|Early withdrawal|17
420273|NCT00576199|1406285|P1|Overall Study|Reason Unspecified|2
420274|NCT00576199|1406285|P1|Overall Study|Refused Treatment|2
420275|NCT00576199|1406285|P1|Overall Study|Insufficient Therapeutic Response|14
420276|NCT00576199|1406285|P1|Overall Study|Adverse Event|12
420277|NCT00576056|1406298|P1|Overall Study|Physician Decision|1
420278|NCT00576056|1406298|P1|Overall Study|did not meet eligibility criteria|8
420279|NCT00576056|1406298|P1|Overall Study|Withdrawal by Subject|2
420280|NCT00576056|1406298|P1|Overall Study|Lack of Efficacy|1
420281|NCT00576056|1406298|P1|Overall Study|Death|1
420282|NCT00576056|1406298|P1|Overall Study|Adverse Event|1
420283|NCT00575666|1406314|P2|Overall Study|Physician Decision|1
420284|NCT00575666|1406315|P1|Overall Study|Physician Decision|1
420285|NCT00575666|1406314|P2|Overall Study|Withdrawal by Subject|2
420286|NCT00575666|1406315|P1|Overall Study|Withdrawal by Subject|3
420287|NCT00575588|1406355|P2|Overall Study|Impossible to determine HbA1c|1
420288|NCT00575588|1406356|P1|Overall Study|Impossible to determine HbA1c|0
420289|NCT00575588|1406355|P2|Overall Study|Patient moved|3
420290|NCT00575588|1406356|P1|Overall Study|Patient moved|1
420291|NCT00575588|1406355|P2|Overall Study|Elevated triglyceride|0
420292|NCT00575588|1406356|P1|Overall Study|Elevated triglyceride|1
420293|NCT00575588|1406355|P2|Overall Study|Safety reasons|1
420294|NCT00575588|1406356|P1|Overall Study|Safety reasons|2
420295|NCT00575588|1406355|P2|Overall Study|Severe non-compliance to protocol|7
420296|NCT00575588|1406356|P1|Overall Study|Severe non-compliance to protocol|5
420297|NCT00575588|1406355|P2|Overall Study|Study specific discontinuation criteria|218
420298|NCT00575588|1406356|P1|Overall Study|Study specific discontinuation criteria|203
420299|NCT00575588|1406355|P2|Overall Study|Incorrect enrollment|4
420300|NCT00575588|1406356|P1|Overall Study|Incorrect enrollment|8
420301|NCT00575588|1406355|P2|Overall Study|Death|2
420302|NCT00575588|1406356|P1|Overall Study|Death|4
420303|NCT00575588|1406355|P2|Overall Study|Lost to Follow-up|3
420304|NCT00575588|1406356|P1|Overall Study|Lost to Follow-up|1
420305|NCT00575588|1406355|P2|Overall Study|Withdrawal by Subject|31
420306|NCT00575588|1406356|P1|Overall Study|Withdrawal by Subject|27
420307|NCT00575588|1406355|P2|Overall Study|Adverse Event|13
420308|NCT00575588|1406356|P1|Overall Study|Adverse Event|11
420309|NCT00575510|1406379|P3|Overall Study|Pregnancy|1
420310|NCT00575510|1406380|P2|Overall Study|Pregnancy|0
420311|NCT00575510|1406381|P1|Overall Study|Pregnancy|0
420312|NCT00575510|1406379|P3|Overall Study|Clinic Called Patient|7
420313|NCT00575510|1406380|P2|Overall Study|Clinic Called Patient|7
420314|NCT00575510|1406381|P1|Overall Study|Clinic Called Patient|7
420315|NCT00575510|1406379|P3|Overall Study|Withdrawal by Subject|0
420316|NCT00575510|1406380|P2|Overall Study|Withdrawal by Subject|0
420317|NCT00575510|1406381|P1|Overall Study|Withdrawal by Subject|1
420318|NCT00575510|1406379|P3|Overall Study|Lost to Follow-up|9
420319|NCT00575510|1406380|P2|Overall Study|Lost to Follow-up|6
420320|NCT00575510|1406381|P1|Overall Study|Lost to Follow-up|4
420321|NCT00575380|1406394|P2|Overall Study|Various|2
420322|NCT00575380|1406395|P1|Overall Study|Various|0
420323|NCT00575380|1406394|P2|Overall Study|Adverse Event|1
420324|NCT00575380|1406395|P1|Overall Study|Adverse Event|0
420325|NCT00575380|1406394|P2|Overall Study|Withdrawal by Subject|0
420326|NCT00575380|1406395|P1|Overall Study|Withdrawal by Subject|1
420327|NCT00575094|1406537|P1|Overall Study|Withdrawal by Subject|1
420328|NCT00575094|1406537|P1|Overall Study|Adverse Event|2
420329|NCT00575042|1406541|P1|Overall Study|Lost to Follow-up|1
420330|NCT00575042|1406541|P1|Overall Study|Adverse Event|2
420331|NCT00574951|1406592|P1|Overall Study|Ineligible - improper prior treatment|1
420332|NCT00574912|1406600|P1|Overall Study|Physician Decision|2
420333|NCT00574912|1406600|P1|Overall Study|scheduling conflicts|3
420334|NCT00574912|1406600|P1|Overall Study|Could not place IV lines.|3
420335|NCT00574873|1406614|P2|Overall Study|Extension Study|0
420336|NCT00574873|1406615|P1|Overall Study|Extension Study|126
420337|NCT00574873|1406614|P2|Overall Study|Blank, site closed per local regulations|2
420338|NCT00574873|1406615|P1|Overall Study|Blank, site closed per local regulations|2
420339|NCT00574873|1406614|P2|Overall Study|Discontinuation of study by sponsor|199
420340|NCT00574873|1406615|P1|Overall Study|Discontinuation of study by sponsor|5
420341|NCT00574873|1406614|P2|Overall Study|Other|4
420342|NCT00574873|1406615|P1|Overall Study|Other|40
420343|NCT00574873|1406614|P2|Overall Study|Lost to Follow-up|5
420344|NCT00574873|1406615|P1|Overall Study|Lost to Follow-up|14
420345|NCT00574873|1406614|P2|Overall Study|Death|14
420346|NCT00574873|1406615|P1|Overall Study|Death|15
420347|NCT00574873|1406614|P2|Overall Study|Investigator request|8
420348|NCT00574873|1406615|P1|Overall Study|Investigator request|18
420349|NCT00574873|1406614|P2|Overall Study|Withdrawal by Subject|19
420350|NCT00574873|1406615|P1|Overall Study|Withdrawal by Subject|18
420351|NCT00574847|1406633|P2|Overall Study|Did not receive medication (declined)|5
420352|NCT00574847|1406634|P1|Overall Study|Did not receive medication (declined)|2
420353|NCT00574847|1406633|P2|Overall Study|Physician Decision|0
420354|NCT00574847|1406634|P1|Overall Study|Physician Decision|1
420355|NCT00574847|1406633|P2|Overall Study|Withdrawal by Subject|2
420356|NCT00574847|1406634|P1|Overall Study|Withdrawal by Subject|2
420357|NCT00574847|1406633|P2|Overall Study|Death|0
420358|NCT00574847|1406634|P1|Overall Study|Death|1
420359|NCT00574847|1406633|P2|Overall Study|Adverse Event|0
420360|NCT00574847|1406634|P1|Overall Study|Adverse Event|2
420361|NCT00574795|1406679|P1|Toddler Dose|Withdrawal by Subject|1
420362|NCT00574795|1406679|P1|After Infant Series|Adverse Event|2
420363|NCT00574795|1406679|P1|After Infant Series|Withdrawal by Subject|1
420364|NCT00574795|1406679|P1|Infant Series|Adverse Event|1
420365|NCT00574795|1406679|P1|Infant Series|Protocol Violation|2
420366|NCT00574795|1406679|P1|Infant Series|Withdrawal by Subject|2
420367|NCT00574405|1406762|P2|Overall Study|Withdrawal by Subject|2
420368|NCT00574405|1406763|P1|Overall Study|Withdrawal by Subject|3
420369|NCT00574288|1406783|P7|Overall Study|Other|0
420370|NCT00574288|1406784|P6|Overall Study|Other|0
420371|NCT00574288|1406785|P5|Overall Study|Other|0
420372|NCT00574288|1406786|P4|Overall Study|Other|0
420373|NCT00574288|1406787|P3|Overall Study|Other|0
420374|NCT00574288|1406788|P2|Overall Study|Other|1
420375|NCT00574288|1406789|P1|Overall Study|Other|1
420376|NCT00574288|1406783|P7|Overall Study|Progressive Disease|0
420377|NCT00574288|1406784|P6|Overall Study|Progressive Disease|0
420378|NCT00574288|1406785|P5|Overall Study|Progressive Disease|1
420379|NCT00574288|1406786|P4|Overall Study|Progressive Disease|2
420380|NCT00574288|1406787|P3|Overall Study|Progressive Disease|3
420381|NCT00574288|1406788|P2|Overall Study|Progressive Disease|2
420382|NCT00574288|1406789|P1|Overall Study|Progressive Disease|17
420383|NCT00574288|1406783|P7|Overall Study|Study Terminated By Sponsor|5
420384|NCT00574288|1406784|P6|Overall Study|Study Terminated By Sponsor|0
420385|NCT00574288|1406785|P5|Overall Study|Study Terminated By Sponsor|0
420386|NCT00574288|1406786|P4|Overall Study|Study Terminated By Sponsor|0
420387|NCT00574288|1406787|P3|Overall Study|Study Terminated By Sponsor|0
420388|NCT00574288|1406788|P2|Overall Study|Study Terminated By Sponsor|0
420389|NCT00574288|1406789|P1|Overall Study|Study Terminated By Sponsor|0
420390|NCT00574288|1406783|P7|Overall Study|Lost to Follow-up|2
420391|NCT00574288|1406784|P6|Overall Study|Lost to Follow-up|1
420392|NCT00574288|1406785|P5|Overall Study|Lost to Follow-up|0
420393|NCT00574288|1406786|P4|Overall Study|Lost to Follow-up|0
420394|NCT00574288|1406787|P3|Overall Study|Lost to Follow-up|0
420395|NCT00574288|1406788|P2|Overall Study|Lost to Follow-up|0
420396|NCT00574288|1406789|P1|Overall Study|Lost to Follow-up|0
420397|NCT00574288|1406783|P7|Overall Study|Death|21
420398|NCT00574288|1406784|P6|Overall Study|Death|25
420399|NCT00574288|1406785|P5|Overall Study|Death|0
420400|NCT00574288|1406786|P4|Overall Study|Death|0
420401|NCT00574288|1406787|P3|Overall Study|Death|0
420402|NCT00574288|1406788|P2|Overall Study|Death|0
420403|NCT00574288|1406789|P1|Overall Study|Death|0
420404|NCT00574288|1406783|P7|Overall Study|Adverse Event|0
420405|NCT00574288|1406784|P6|Overall Study|Adverse Event|0
420406|NCT00574288|1406785|P5|Overall Study|Adverse Event|1
420407|NCT00574288|1406786|P4|Overall Study|Adverse Event|0
420408|NCT00574288|1406787|P3|Overall Study|Adverse Event|0
420409|NCT00574288|1406788|P2|Overall Study|Adverse Event|0
420410|NCT00574288|1406789|P1|Overall Study|Adverse Event|2
420411|NCT00574275|1406827|P2|Overall Study|Operation for curative intent|1
420412|NCT00574275|1406828|P1|Overall Study|Operation for curative intent|0
420413|NCT00574275|1406827|P2|Overall Study|Insurance change|1
420414|NCT00574275|1406828|P1|Overall Study|Insurance change|0
420415|NCT00574275|1406827|P2|Overall Study|Patient and Investigator decision|1
420416|NCT00574275|1406828|P1|Overall Study|Patient and Investigator decision|0
420417|NCT00574275|1406827|P2|Overall Study|Protocol Violation|1
420418|NCT00574275|1406828|P1|Overall Study|Protocol Violation|0
420419|NCT00574275|1406827|P2|Overall Study|Physician Decision|1
420420|NCT00574275|1406828|P1|Overall Study|Physician Decision|1
420421|NCT00574275|1406827|P2|Overall Study|Error calculating tumor measurement|0
420422|NCT00574275|1406828|P1|Overall Study|Error calculating tumor measurement|1
420423|NCT00574275|1406827|P2|Overall Study|Withdrawal by Subject|17
420424|NCT00574275|1406828|P1|Overall Study|Withdrawal by Subject|15
420425|NCT00574275|1406827|P2|Overall Study|Study stopped based on DMC decision|23
420426|NCT00574275|1406828|P1|Overall Study|Study stopped based on DMC decision|62
420427|NCT00574275|1406827|P2|Overall Study|Lost to Follow-up|1
420428|NCT00574275|1406828|P1|Overall Study|Lost to Follow-up|2
420429|NCT00574275|1406827|P2|Overall Study|Disease progression|146
420430|NCT00574275|1406828|P1|Overall Study|Disease progression|160
420431|NCT00574275|1406827|P2|Overall Study|Adverse Event|76
420432|NCT00574275|1406828|P1|Overall Study|Adverse Event|32
420433|NCT00574275|1406827|P2|Overall Study|Randomized but not treated|3
420434|NCT00574275|1406828|P1|Overall Study|Randomized but not treated|2
420435|NCT00574249|1406846|P2|Overall Study|PPD test taken twice|1
420436|NCT00574249|1406847|P1|Overall Study|PPD test taken twice|0
420437|NCT00574249|1406846|P2|Overall Study|Excluded by company|1
420438|NCT00574249|1406847|P1|Overall Study|Excluded by company|0
420439|NCT00574249|1406846|P2|Overall Study|Pregnancy|0
420440|NCT00574249|1406847|P1|Overall Study|Pregnancy|1
420441|NCT00574249|1406846|P2|Overall Study|Physician Decision|0
420442|NCT00574249|1406847|P1|Overall Study|Physician Decision|1
420443|NCT00574249|1406846|P2|Overall Study|Withdrawal by Subject|0
420444|NCT00574249|1406847|P1|Overall Study|Withdrawal by Subject|3
420445|NCT00574249|1406846|P2|Overall Study|History of carcinoma|0
420446|NCT00574249|1406847|P1|Overall Study|History of carcinoma|1
420447|NCT00574249|1406846|P2|Overall Study|Protocol Violation|2
420448|NCT00574249|1406847|P1|Overall Study|Protocol Violation|5
420449|NCT00574249|1406846|P2|Overall Study|Lost to Follow-up|3
420450|NCT00574249|1406847|P1|Overall Study|Lost to Follow-up|4
420451|NCT00574249|1406846|P2|Overall Study|Lack of Efficacy|3
420452|NCT00574249|1406847|P1|Overall Study|Lack of Efficacy|5
420453|NCT00574249|1406846|P2|Overall Study|Adverse Event|18
420454|NCT00574249|1406847|P1|Overall Study|Adverse Event|6
420455|NCT00574145|1406898|P2|Overall Study|Withdrawal by Subject|1
420456|NCT00574145|1406899|P1|Overall Study|Withdrawal by Subject|2
420457|NCT00574080|1406911|P2|Overall Study|Death|10
420458|NCT00574080|1406912|P1|Overall Study|Death|10
420459|NCT00573937|1406961|P2|Overall Study|Study Terminated|1
420460|NCT00573937|1406962|P1|Overall Study|Study Terminated|0
420461|NCT00573859|1406976|P1|Smoking Versus Abstinence|Scheduling conflicts|12
420462|NCT00573859|1406976|P1|Medication Versus Placebo|Scheduling conflicts|12
420463|NCT00573833|1406982|P1|Overall Study|Not Treated|2
420464|NCT00573794|1406989|P1|Overall Study|Not Specified|46
420465|NCT00573794|1406989|P1|Overall Study|Lack of Efficacy|94
420466|NCT00573794|1406989|P1|Overall Study|Protocol Violation|6
420467|NCT00573794|1406989|P1|Overall Study|Lost to Follow-up|13
420468|NCT00573794|1406989|P1|Overall Study|Withdrew Consent|90
420469|NCT00573794|1406989|P1|Overall Study|Adverse Event|81
420470|NCT00573768|1407020|P3|Overall Study|Lost to Follow-up|1
420471|NCT00573768|1407021|P2|Overall Study|Lost to Follow-up|0
420472|NCT00573768|1407022|P1|Overall Study|Lost to Follow-up|0
420473|NCT00573768|1407020|P3|Overall Study|Withdrawal by Subject|0
420474|NCT00573768|1407021|P2|Overall Study|Withdrawal by Subject|1
420475|NCT00573768|1407022|P1|Overall Study|Withdrawal by Subject|0
420476|NCT00573768|1407020|P3|Overall Study|Protocol Violation|1
420477|NCT00573768|1407021|P2|Overall Study|Protocol Violation|0
420478|NCT00573768|1407022|P1|Overall Study|Protocol Violation|1
420479|NCT00573768|1407020|P3|Overall Study|Adverse Event|2
420480|NCT00573768|1407021|P2|Overall Study|Adverse Event|1
420481|NCT00573768|1407022|P1|Overall Study|Adverse Event|1
420482|NCT00573755|1407032|P2|Overall Study|Still receiving treatment|0
420483|NCT00573755|1407033|P1|Overall Study|Still receiving treatment|1
420484|NCT00573534|1407049|P1|Overall Study|oppositional behavior|3
420485|NCT00573469|1407090|P3|Overall Study|Not Specified|3
420486|NCT00573469|1407091|P2|Overall Study|Not Specified|1
420487|NCT00573469|1407092|P1|Overall Study|Not Specified|5
420488|NCT00573469|1407090|P3|Overall Study|Withdrawal by Subject|0
420489|NCT00573469|1407091|P2|Overall Study|Withdrawal by Subject|2
420490|NCT00573469|1407092|P1|Overall Study|Withdrawal by Subject|0
420491|NCT00573469|1407090|P3|Overall Study|Adverse Event|1
420492|NCT00573469|1407091|P2|Overall Study|Adverse Event|1
420493|NCT00573469|1407092|P1|Overall Study|Adverse Event|1
420494|NCT00573443|1407115|P3|Open-Label Extension Phase|Not Specified|0
420495|NCT00573443|1407116|P2|Open-Label Extension Phase|Not Specified|0
420496|NCT00573443|1407117|P1|Open-Label Extension Phase|Not Specified|2
420497|NCT00573443|1407115|P3|Open-Label Extension Phase|Protocol Violation|0
420498|NCT00573443|1407116|P2|Open-Label Extension Phase|Protocol Violation|0
420499|NCT00573443|1407117|P1|Open-Label Extension Phase|Protocol Violation|2
420500|NCT00573443|1407115|P3|Open-Label Extension Phase|Withdrawal by Subject|0
420501|NCT00573443|1407116|P2|Open-Label Extension Phase|Withdrawal by Subject|0
420502|NCT00573443|1407117|P1|Open-Label Extension Phase|Withdrawal by Subject|3
420503|NCT00573443|1407115|P3|Open-Label Extension Phase|Serious Adverse Event|0
420504|NCT00573443|1407116|P2|Open-Label Extension Phase|Serious Adverse Event|0
420505|NCT00573443|1407117|P1|Open-Label Extension Phase|Serious Adverse Event|5
420506|NCT00573443|1407115|P3|Open-Label Extension Phase|Adverse Event|0
420507|NCT00573443|1407116|P2|Open-Label Extension Phase|Adverse Event|0
420508|NCT00573443|1407117|P1|Open-Label Extension Phase|Adverse Event|3
420509|NCT00573443|1407115|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
420510|NCT00573443|1407116|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
420511|NCT00573443|1407117|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
420512|NCT00573443|1407115|P3|Open-Label Extension Phase|Lost to Follow-up|0
420513|NCT00573443|1407116|P2|Open-Label Extension Phase|Lost to Follow-up|0
420514|NCT00573443|1407117|P1|Open-Label Extension Phase|Lost to Follow-up|1
420515|NCT00573443|1407115|P3|Double-Blind Phase|Not specified|3
420516|NCT00573443|1407116|P2|Double-Blind Phase|Not specified|2
420517|NCT00573443|1407117|P1|Double-Blind Phase|Not specified|0
420518|NCT00573443|1407115|P3|Double-Blind Phase|Protocol Violation|1
420519|NCT00573443|1407116|P2|Double-Blind Phase|Protocol Violation|2
420520|NCT00573443|1407117|P1|Double-Blind Phase|Protocol Violation|0
420521|NCT00573443|1407115|P3|Double-Blind Phase|Withdrawal by Subject|7
420522|NCT00573443|1407116|P2|Double-Blind Phase|Withdrawal by Subject|2
420523|NCT00573443|1407117|P1|Double-Blind Phase|Withdrawal by Subject|2
420524|NCT00573443|1407115|P3|Double-Blind Phase|Medication refusal due to AE|0
420525|NCT00573443|1407116|P2|Double-Blind Phase|Medication refusal due to AE|2
420526|NCT00573443|1407117|P1|Double-Blind Phase|Medication refusal due to AE|2
420527|NCT00573443|1407115|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
420528|NCT00573443|1407116|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
420529|NCT00573443|1407117|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
420530|NCT00573443|1407115|P3|Double-Blind Phase|Adverse Event|0
420531|NCT00573443|1407116|P2|Double-Blind Phase|Adverse Event|5
420532|NCT00573443|1407117|P1|Double-Blind Phase|Adverse Event|1
420533|NCT00573443|1407115|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
420534|NCT00573443|1407116|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
420535|NCT00573443|1407117|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
420536|NCT00573443|1407115|P3|Double-Blind Phase|Lost to Follow-up|2
420537|NCT00573443|1407116|P2|Double-Blind Phase|Lost to Follow-up|3
420538|NCT00573443|1407117|P1|Double-Blind Phase|Lost to Follow-up|1
420539|NCT00573430|1407147|P3|Overall Study|Eligibility criteria not fulfilled|3
420540|NCT00573430|1407148|P2|Overall Study|Eligibility criteria not fulfilled|0
420541|NCT00573430|1407149|P1|Overall Study|Eligibility criteria not fulfilled|0
420542|NCT00573430|1407147|P3|Overall Study|Protocol Violation|1
420543|NCT00573430|1407148|P2|Overall Study|Protocol Violation|1
420544|NCT00573430|1407149|P1|Overall Study|Protocol Violation|0
420545|NCT00573430|1407147|P3|Overall Study|Withdrawal by Subject|1
420546|NCT00573430|1407148|P2|Overall Study|Withdrawal by Subject|0
420547|NCT00573430|1407149|P1|Overall Study|Withdrawal by Subject|1
420548|NCT00573430|1407147|P3|Overall Study|Adverse Event|2
420549|NCT00573430|1407148|P2|Overall Study|Adverse Event|0
420550|NCT00573430|1407149|P1|Overall Study|Adverse Event|0
420551|NCT00573430|1407147|P3|Overall Study|Incorrect enrollment of randomization|3
420552|NCT00573430|1407148|P2|Overall Study|Incorrect enrollment of randomization|4
420553|NCT00573430|1407149|P1|Overall Study|Incorrect enrollment of randomization|0
420554|NCT00573391|1407171|P2|Overall Study|Death|0
420555|NCT00573391|1407172|P1|Overall Study|Death|1
420556|NCT00573391|1407171|P2|Overall Study|study stopped|2
420557|NCT00573391|1407172|P1|Overall Study|study stopped|2
420558|NCT00573313|1407182|P4|Overall Study|Protocol Violation|0
420559|NCT00573313|1407183|P3|Overall Study|Protocol Violation|6
420560|NCT00573313|1407184|P2|Overall Study|Protocol Violation|0
420561|NCT00573313|1407185|P1|Overall Study|Protocol Violation|5
420562|NCT00573248|1407233|P2|Overall Study|scheduling conflicts|11
420563|NCT00573248|1407234|P1|Overall Study|scheduling conflicts|15
420564|NCT00573183|1407248|P2|Overall Study|Other|2
420565|NCT00573183|1407249|P1|Overall Study|Other|5
420566|NCT00573183|1407248|P2|Overall Study|Incarceration|8
420567|NCT00573183|1407249|P1|Overall Study|Incarceration|5
420568|NCT00573183|1407248|P2|Overall Study|Adverse Event|0
420569|NCT00573183|1407249|P1|Overall Study|Adverse Event|2
420570|NCT00573183|1407248|P2|Overall Study|Death|1
420571|NCT00573183|1407249|P1|Overall Study|Death|0
420572|NCT00573183|1407248|P2|Overall Study|Withdrawal by Subject|2
420573|NCT00573183|1407249|P1|Overall Study|Withdrawal by Subject|8
420574|NCT00573183|1407248|P2|Overall Study|Lost to Follow-up|50
420575|NCT00573183|1407249|P1|Overall Study|Lost to Follow-up|52
420576|NCT00573170|1407257|P6|Third Treatment Period|Lost to Follow-up|2
420577|NCT00573170|1407258|P5|Third Treatment Period|Lost to Follow-up|0
420578|NCT00573170|1407259|P4|Third Treatment Period|Lost to Follow-up|0
420579|NCT00573170|1407260|P3|Third Treatment Period|Lost to Follow-up|0
420580|NCT00573170|1407261|P2|Third Treatment Period|Lost to Follow-up|0
420581|NCT00573170|1407262|P1|Third Treatment Period|Lost to Follow-up|0
420582|NCT00573170|1407257|P6|Third Treatment Period|Withdrawal by Subject|0
420583|NCT00573170|1407258|P5|Third Treatment Period|Withdrawal by Subject|0
420584|NCT00573170|1407259|P4|Third Treatment Period|Withdrawal by Subject|0
420585|NCT00573170|1407260|P3|Third Treatment Period|Withdrawal by Subject|0
420586|NCT00573170|1407261|P2|Third Treatment Period|Withdrawal by Subject|0
420587|NCT00573170|1407262|P1|Third Treatment Period|Withdrawal by Subject|1
420588|NCT00573170|1407257|P6|Second Washout Period|Other|2
420589|NCT00573170|1407258|P5|Second Washout Period|Other|6
420590|NCT00573170|1407259|P4|Second Washout Period|Other|4
420591|NCT00573170|1407260|P3|Second Washout Period|Other|1
420592|NCT00573170|1407261|P2|Second Washout Period|Other|2
420593|NCT00573170|1407262|P1|Second Washout Period|Other|1
420594|NCT00573170|1407257|P6|Second Washout Period|Lost to Follow-up|0
420595|NCT00573170|1407258|P5|Second Washout Period|Lost to Follow-up|0
420596|NCT00573170|1407259|P4|Second Washout Period|Lost to Follow-up|1
420597|NCT00573170|1407260|P3|Second Washout Period|Lost to Follow-up|0
420598|NCT00573170|1407261|P2|Second Washout Period|Lost to Follow-up|0
420599|NCT00573170|1407262|P1|Second Washout Period|Lost to Follow-up|0
420600|NCT00573170|1407257|P6|Second Washout Period|Withdrawal by Subject|0
420601|NCT00573170|1407258|P5|Second Washout Period|Withdrawal by Subject|1
420602|NCT00573170|1407259|P4|Second Washout Period|Withdrawal by Subject|0
420603|NCT00573170|1407260|P3|Second Washout Period|Withdrawal by Subject|2
420604|NCT00573170|1407261|P2|Second Washout Period|Withdrawal by Subject|1
420605|NCT00573170|1407262|P1|Second Washout Period|Withdrawal by Subject|1
420606|NCT00573170|1407257|P6|Second Washout Period|Protocol Violation|0
420607|NCT00573170|1407258|P5|Second Washout Period|Protocol Violation|0
420608|NCT00573170|1407259|P4|Second Washout Period|Protocol Violation|0
420609|NCT00573170|1407260|P3|Second Washout Period|Protocol Violation|1
420610|NCT00573170|1407261|P2|Second Washout Period|Protocol Violation|1
420611|NCT00573170|1407262|P1|Second Washout Period|Protocol Violation|2
420612|NCT00573170|1407257|P6|Second Washout Period|Adverse Event|0
420613|NCT00573170|1407258|P5|Second Washout Period|Adverse Event|1
420614|NCT00573170|1407259|P4|Second Washout Period|Adverse Event|0
420615|NCT00573170|1407260|P3|Second Washout Period|Adverse Event|0
420616|NCT00573170|1407261|P2|Second Washout Period|Adverse Event|0
420617|NCT00573170|1407262|P1|Second Washout Period|Adverse Event|1
420618|NCT00573170|1407257|P6|First Washout Period|Other|0
420619|NCT00573170|1407258|P5|First Washout Period|Other|0
420620|NCT00573170|1407259|P4|First Washout Period|Other|1
420621|NCT00573170|1407260|P3|First Washout Period|Other|1
420622|NCT00573170|1407261|P2|First Washout Period|Other|0
420623|NCT00573170|1407262|P1|First Washout Period|Other|4
420624|NCT00573170|1407257|P6|First Washout Period|Withdrawal by Subject|3
420625|NCT00573170|1407258|P5|First Washout Period|Withdrawal by Subject|3
420626|NCT00573170|1407259|P4|First Washout Period|Withdrawal by Subject|2
420627|NCT00573170|1407260|P3|First Washout Period|Withdrawal by Subject|0
420628|NCT00573170|1407261|P2|First Washout Period|Withdrawal by Subject|0
420629|NCT00573170|1407262|P1|First Washout Period|Withdrawal by Subject|2
420630|NCT00573170|1407257|P6|First Washout Period|Lost to Follow-up|2
420631|NCT00573170|1407258|P5|First Washout Period|Lost to Follow-up|0
420632|NCT00573170|1407259|P4|First Washout Period|Lost to Follow-up|2
420633|NCT00573170|1407260|P3|First Washout Period|Lost to Follow-up|0
420634|NCT00573170|1407261|P2|First Washout Period|Lost to Follow-up|1
420635|NCT00573170|1407262|P1|First Washout Period|Lost to Follow-up|1
420636|NCT00573170|1407257|P6|First Washout Period|Lack of Efficacy|1
420637|NCT00573170|1407258|P5|First Washout Period|Lack of Efficacy|0
420638|NCT00573170|1407259|P4|First Washout Period|Lack of Efficacy|0
420639|NCT00573170|1407260|P3|First Washout Period|Lack of Efficacy|0
420640|NCT00573170|1407261|P2|First Washout Period|Lack of Efficacy|0
420641|NCT00573170|1407262|P1|First Washout Period|Lack of Efficacy|0
420642|NCT00573170|1407257|P6|First Washout Period|Adverse Event|1
420643|NCT00573170|1407258|P5|First Washout Period|Adverse Event|0
420644|NCT00573170|1407259|P4|First Washout Period|Adverse Event|0
420645|NCT00573170|1407260|P3|First Washout Period|Adverse Event|0
420646|NCT00573170|1407261|P2|First Washout Period|Adverse Event|1
420647|NCT00573170|1407262|P1|First Washout Period|Adverse Event|1
420648|NCT00573170|1407257|P6|First Treatment Period|Did Not Treat Attack 1|0
420649|NCT00573170|1407258|P5|First Treatment Period|Did Not Treat Attack 1|1
420650|NCT00573170|1407259|P4|First Treatment Period|Did Not Treat Attack 1|0
420651|NCT00573170|1407260|P3|First Treatment Period|Did Not Treat Attack 1|0
420652|NCT00573170|1407261|P2|First Treatment Period|Did Not Treat Attack 1|0
420653|NCT00573170|1407262|P1|First Treatment Period|Did Not Treat Attack 1|0
420654|NCT00573157|1407338|P2|Overall Study|Other|1
420655|NCT00573157|1407339|P1|Overall Study|Other|1
420656|NCT00573157|1407338|P2|Overall Study|Adverse Event|1
420657|NCT00573157|1407339|P1|Overall Study|Adverse Event|3
420658|NCT00573144|1407351|P2|Overall Study|Withdrawal by Subject|3
420659|NCT00573144|1407352|P1|Overall Study|Withdrawal by Subject|2
420660|NCT00573131|1407364|P2|Overall Study|Withdrawal by Subject|8
420661|NCT00573131|1407365|P1|Overall Study|Withdrawal by Subject|10
420662|NCT00573066|1407371|P1|Overall Study|Postoperative bleeding|1
420663|NCT00573066|1407371|P1|Overall Study|IV malfunction|1
420664|NCT00573066|1407371|P1|Overall Study|Exclusion criteria|18
420665|NCT00572910|1407415|P11|Overall Study|Withdrawal by Subject|1
420666|NCT00572910|1407416|P10|Overall Study|Withdrawal by Subject|2
420667|NCT00572910|1407417|P9|Overall Study|Withdrawal by Subject|2
420668|NCT00572910|1407418|P8|Overall Study|Withdrawal by Subject|2
420669|NCT00572910|1407419|P7|Overall Study|Withdrawal by Subject|0
420670|NCT00572910|1407420|P6|Overall Study|Withdrawal by Subject|3
420671|NCT00572910|1407421|P5|Overall Study|Withdrawal by Subject|1
420672|NCT00572910|1407422|P4|Overall Study|Withdrawal by Subject|0
420673|NCT00572910|1407423|P3|Overall Study|Withdrawal by Subject|1
420674|NCT00572910|1407424|P2|Overall Study|Withdrawal by Subject|0
420675|NCT00572910|1407425|P1|Overall Study|Withdrawal by Subject|3
420676|NCT00572910|1407415|P11|Overall Study|Lost to Follow-up|0
420677|NCT00572910|1407416|P10|Overall Study|Lost to Follow-up|1
420678|NCT00572910|1407417|P9|Overall Study|Lost to Follow-up|0
420679|NCT00572910|1407418|P8|Overall Study|Lost to Follow-up|0
420680|NCT00572910|1407419|P7|Overall Study|Lost to Follow-up|0
420681|NCT00572910|1407420|P6|Overall Study|Lost to Follow-up|0
420682|NCT00572910|1407421|P5|Overall Study|Lost to Follow-up|1
420683|NCT00572910|1407422|P4|Overall Study|Lost to Follow-up|2
420684|NCT00572910|1407423|P3|Overall Study|Lost to Follow-up|1
420685|NCT00572910|1407424|P2|Overall Study|Lost to Follow-up|1
420686|NCT00572910|1407425|P1|Overall Study|Lost to Follow-up|0
420687|NCT00572910|1407415|P11|Overall Study|Adverse Event|2
420688|NCT00572910|1407416|P10|Overall Study|Adverse Event|3
420689|NCT00572910|1407417|P9|Overall Study|Adverse Event|1
420690|NCT00572910|1407418|P8|Overall Study|Adverse Event|2
420691|NCT00572910|1407419|P7|Overall Study|Adverse Event|4
420692|NCT00572910|1407420|P6|Overall Study|Adverse Event|0
420693|NCT00572910|1407421|P5|Overall Study|Adverse Event|0
420694|NCT00572910|1407422|P4|Overall Study|Adverse Event|2
420695|NCT00572910|1407423|P3|Overall Study|Adverse Event|0
420696|NCT00572910|1407424|P2|Overall Study|Adverse Event|2
420697|NCT00572910|1407425|P1|Overall Study|Adverse Event|1
420698|NCT00572832|1407492|P2|Overall Study|Pregnancy|1
420699|NCT00572832|1407493|P1|Overall Study|Pregnancy|0
420700|NCT00572832|1407492|P2|Overall Study|Lost to Follow-up|11
420701|NCT00572832|1407493|P1|Overall Study|Lost to Follow-up|0
420702|NCT00572728|1407499|P1|Overall Study|Pathology missing|1
420703|NCT00572728|1407499|P1|Overall Study|FLT2 after second chemotherapy initiated|7
420704|NCT00572728|1407499|P1|Overall Study|Second chemotherapy not initiated|1
420705|NCT00572728|1407499|P1|Overall Study|FLT2 not completed|5
420706|NCT00572728|1407499|P1|Overall Study|First Chemotherapy not initiated|2
420707|NCT00572728|1407499|P1|Overall Study|FLT1 not completed|4
420708|NCT00572728|1407499|P1|Overall Study|Offstudy due to complicating disease|1
420709|NCT00572728|1407499|P1|Overall Study|Enrolled under Amendment 4|5
420710|NCT00572728|1407499|P1|Overall Study|Ineligible|3
420711|NCT00572728|1407499|P1|Overall Study|Withdrawal by Subject|10
420712|NCT00572624|1407513|P2|Overall Study|Health issues unrelated to the study|0
420713|NCT00572624|1407514|P1|Overall Study|Health issues unrelated to the study|1
420714|NCT00572624|1407513|P2|Overall Study|Problem with vascular access|0
420715|NCT00572624|1407514|P1|Overall Study|Problem with vascular access|1
420716|NCT00572624|1407513|P2|Overall Study|Refused to do the stress test|0
420717|NCT00572624|1407514|P1|Overall Study|Refused to do the stress test|1
420718|NCT00572624|1407513|P2|Overall Study|Admitted to being a smoker|0
420719|NCT00572624|1407514|P1|Overall Study|Admitted to being a smoker|1
420720|NCT00572624|1407513|P2|Overall Study|Started a new job-- no time for study|0
420721|NCT00572624|1407514|P1|Overall Study|Started a new job-- no time for study|1
420722|NCT00572624|1407513|P2|Overall Study|Medication change|0
420723|NCT00572624|1407514|P1|Overall Study|Medication change|1
420724|NCT00572624|1407513|P2|Overall Study|Wanted to do a different diet program|0
420725|NCT00572624|1407514|P1|Overall Study|Wanted to do a different diet program|1
420726|NCT00572624|1407513|P2|Overall Study|Lost to Follow-up|4
420727|NCT00572624|1407514|P1|Overall Study|Lost to Follow-up|10
420728|NCT00572572|1407542|P2|Overall Study|Withdrawal by Subject|6
420729|NCT00572572|1407543|P1|Overall Study|Withdrawal by Subject|3
420730|NCT00572533|1407561|P2|Overall Study|Transfer out of Facility|1
420731|NCT00572533|1407562|P1|Overall Study|Transfer out of Facility|0
420732|NCT00572533|1407561|P2|Overall Study|Social Issues|0
420733|NCT00572533|1407562|P1|Overall Study|Social Issues|1
420734|NCT00572533|1407561|P2|Overall Study|Received Kidney Transplant|1
420735|NCT00572533|1407562|P1|Overall Study|Received Kidney Transplant|2
420736|NCT00572533|1407561|P2|Overall Study|Death|1
420737|NCT00572533|1407562|P1|Overall Study|Death|4
420738|NCT00572156|1407601|P4|Overall Study|Sponsor Decision|19
420739|NCT00572156|1407602|P3|Overall Study|Sponsor Decision|17
420740|NCT00572156|1407603|P2|Overall Study|Sponsor Decision|16
420741|NCT00572156|1407604|P1|Overall Study|Sponsor Decision|20
420742|NCT00572156|1407601|P4|Overall Study|Patient/Parent Decision|3
420743|NCT00572156|1407602|P3|Overall Study|Patient/Parent Decision|4
420744|NCT00572156|1407603|P2|Overall Study|Patient/Parent Decision|6
420745|NCT00572156|1407604|P1|Overall Study|Patient/Parent Decision|1
420746|NCT00572156|1407601|P4|Overall Study|Protocol Violation|2
420747|NCT00572156|1407602|P3|Overall Study|Protocol Violation|0
420748|NCT00572156|1407603|P2|Overall Study|Protocol Violation|2
420749|NCT00572156|1407604|P1|Overall Study|Protocol Violation|1
420750|NCT00572156|1407601|P4|Overall Study|Lost to Follow-up|0
420751|NCT00572156|1407602|P3|Overall Study|Lost to Follow-up|1
420752|NCT00572156|1407603|P2|Overall Study|Lost to Follow-up|1
420753|NCT00572156|1407604|P1|Overall Study|Lost to Follow-up|1
420754|NCT00572156|1407601|P4|Overall Study|Adverse Event|1
420755|NCT00572156|1407602|P3|Overall Study|Adverse Event|5
420756|NCT00572156|1407603|P2|Overall Study|Adverse Event|1
420757|NCT00572156|1407604|P1|Overall Study|Adverse Event|3
420758|NCT00572039|1407675|P2|Overall Study|Ill|1
420759|NCT00572039|1407676|P1|Overall Study|Ill|5
420760|NCT00572039|1407675|P2|Overall Study|Death|3
420761|NCT00572039|1407676|P1|Overall Study|Death|2
420762|NCT00572039|1407675|P2|Overall Study|Withdrawal by Subject|6
420763|NCT00572039|1407676|P1|Overall Study|Withdrawal by Subject|9
420764|NCT00571948|1407708|P2|Overall Study|Parent were afraid of blood colection|5
420765|NCT00571948|1407709|P1|Overall Study|Parent were afraid of blood colection|2
420766|NCT00571948|1407708|P2|Overall Study|infant refused study meal|4
420767|NCT00571948|1407709|P1|Overall Study|infant refused study meal|3
420768|NCT00571948|1407708|P2|Overall Study|Protocol Violation|3
420769|NCT00571948|1407709|P1|Overall Study|Protocol Violation|3
420770|NCT00571948|1407708|P2|Overall Study|Withdrawal by Subject|2
420771|NCT00571948|1407709|P1|Overall Study|Withdrawal by Subject|1
420772|NCT00571948|1407708|P2|Overall Study|Lost to Follow-up|0
420773|NCT00571948|1407709|P1|Overall Study|Lost to Follow-up|2
420774|NCT00571922|1407717|P2|Overall Study|Completion unknown|36
420775|NCT00571922|1407718|P1|Overall Study|Completion unknown|36
420776|NCT00571701|1407728|P2|Second Intervention 12 Months|Withdrawal by Subject|0
420777|NCT00571701|1407729|P1|Second Intervention 12 Months|Withdrawal by Subject|3
420778|NCT00571701|1407728|P2|Second Intervention 12 Months|Adverse Event|1
420779|NCT00571701|1407729|P1|Second Intervention 12 Months|Adverse Event|0
420780|NCT00571701|1407728|P2|First Intervention 12 Months|Death|0
420781|NCT00571701|1407729|P1|First Intervention 12 Months|Death|1
420782|NCT00571701|1407728|P2|First Intervention 12 Months|Withdrawal by Subject|1
420783|NCT00571701|1407729|P1|First Intervention 12 Months|Withdrawal by Subject|2
420784|NCT00571688|1407755|P2|Overall Study|subject moved out of the area|0
420785|NCT00571688|1407756|P1|Overall Study|subject moved out of the area|1
420786|NCT00571688|1407755|P2|Overall Study|subject did not tolerate Consta|0
420787|NCT00571688|1407756|P1|Overall Study|subject did not tolerate Consta|1
420788|NCT00571688|1407755|P2|Overall Study|Lost to Follow-up|6
420789|NCT00571688|1407756|P1|Overall Study|Lost to Follow-up|3
420790|NCT00571662|1407762|P1|Overall Study|Adverse Event|5
420791|NCT00571662|1407762|P1|Overall Study|psychiatric instability|1
420792|NCT00571662|1407762|P1|Overall Study|Withdrawal by Subject|2
420793|NCT00571649|1407770|P2|Follow-up Period|Protocol Violation|12
420794|NCT00571649|1407771|P1|Follow-up Period|Protocol Violation|5
420795|NCT00571649|1407770|P2|Follow-up Period|Patient convenience|121
420796|NCT00571649|1407771|P1|Follow-up Period|Patient convenience|136
420797|NCT00571649|1407770|P2|Follow-up Period|Lost to Follow-up|92
420798|NCT00571649|1407771|P1|Follow-up Period|Lost to Follow-up|95
420799|NCT00571649|1407770|P2|Follow-up Period|Physician Decision|13
420800|NCT00571649|1407771|P1|Follow-up Period|Physician Decision|7
420801|NCT00571649|1407770|P2|Follow-up Period|Death|133
420802|NCT00571649|1407771|P1|Follow-up Period|Death|132
420803|NCT00571649|1407770|P2|Follow-up Period|Withdrawal by Subject|115
420804|NCT00571649|1407771|P1|Follow-up Period|Withdrawal by Subject|119
420805|NCT00571649|1407770|P2|Follow-up Period|Clinical endpoint reached|2
420806|NCT00571649|1407771|P1|Follow-up Period|Clinical endpoint reached|5
420807|NCT00571649|1407770|P2|Follow-up Period|Adverse Event|40
420808|NCT00571649|1407771|P1|Follow-up Period|Adverse Event|46
420809|NCT00571649|1407770|P2|Treatment Period|Technical problems|5
420810|NCT00571649|1407771|P1|Treatment Period|Technical problems|3
420811|NCT00571649|1407770|P2|Treatment Period|Protocol Violation|92
420812|NCT00571649|1407771|P1|Treatment Period|Protocol Violation|90
420813|NCT00571649|1407770|P2|Treatment Period|Patient convenience|13
420814|NCT00571649|1407771|P1|Treatment Period|Patient convenience|11
420815|NCT00571649|1407770|P2|Treatment Period|Non-compliant with study medication|89
420816|NCT00571649|1407771|P1|Treatment Period|Non-compliant with study medication|88
420817|NCT00571649|1407770|P2|Treatment Period|Lost to Follow-up|41
420818|NCT00571649|1407771|P1|Treatment Period|Lost to Follow-up|43
420819|NCT00571649|1407770|P2|Treatment Period|Physician Decision|9
420820|NCT00571649|1407771|P1|Treatment Period|Physician Decision|8
420821|NCT00571649|1407770|P2|Treatment Period|Death|59
420822|NCT00571649|1407771|P1|Treatment Period|Death|76
420823|NCT00571649|1407770|P2|Treatment Period|Withdrawal by Subject|255
420824|NCT00571649|1407771|P1|Treatment Period|Withdrawal by Subject|285
420825|NCT00571649|1407770|P2|Treatment Period|Clinical endpoint reached|56
420826|NCT00571649|1407771|P1|Treatment Period|Clinical endpoint reached|50
420827|NCT00571649|1407770|P2|Treatment Period|Adverse Event|385
420828|NCT00571649|1407771|P1|Treatment Period|Adverse Event|438
420829|NCT00571103|1407855|P1|Overall Study|Lost to Follow-up|1
420830|NCT00571103|1407855|P1|Overall Study|Withdrawal by Subject|1
420831|NCT00571064|1407860|P1|Overall Study|Not specified|2
420832|NCT00571064|1407860|P1|Overall Study|Withdrawal by Subject|2
420833|NCT00571064|1407860|P1|Overall Study|Protocol Violation|4
420834|NCT00571064|1407860|P1|Overall Study|Adverse Event|13
420835|NCT00571038|1407875|P2|Overall Study|Moved out of state|2
420836|NCT00571038|1407876|P1|Overall Study|Moved out of state|2
420837|NCT00571038|1407875|P2|Overall Study|Withdrawal by Subject|3
420838|NCT00571038|1407876|P1|Overall Study|Withdrawal by Subject|1
420839|NCT00571038|1407875|P2|Overall Study|Death|5
420840|NCT00571038|1407876|P1|Overall Study|Death|7
420841|NCT00571038|1407875|P2|Overall Study|Lost to Follow-up|4
420842|NCT00571038|1407876|P1|Overall Study|Lost to Follow-up|1
420843|NCT00570921|1407931|P1|Overall Study|Physician Decision|1
420844|NCT00570921|1407931|P1|Overall Study|Protocol Violation|1
420845|NCT00570908|1407937|P1|Overall Study|Withdrawal by Subject|2
420846|NCT00570908|1407937|P1|Overall Study|Adverse Event|5
420847|NCT00570778|1407941|P4|Overall Study|Subject no longer requires study drug|0
420848|NCT00570778|1407942|P3|Overall Study|Subject no longer requires study drug|0
420849|NCT00570778|1407943|P2|Overall Study|Subject no longer requires study drug|1
420850|NCT00570778|1407944|P1|Overall Study|Subject no longer requires study drug|0
420851|NCT00570778|1407941|P4|Overall Study|Lost to Follow-up|0
420852|NCT00570778|1407942|P3|Overall Study|Lost to Follow-up|1
420853|NCT00570778|1407943|P2|Overall Study|Lost to Follow-up|0
420854|NCT00570778|1407944|P1|Overall Study|Lost to Follow-up|0
420855|NCT00570778|1407941|P4|Overall Study|Unsatisfactory therapeutic effect|0
420856|NCT00570778|1407942|P3|Overall Study|Unsatisfactory therapeutic effect|0
420857|NCT00570778|1407943|P2|Overall Study|Unsatisfactory therapeutic effect|0
420858|NCT00570778|1407944|P1|Overall Study|Unsatisfactory therapeutic effect|1
420859|NCT00570778|1407941|P4|Overall Study|Abnormal test procedure|0
420860|NCT00570778|1407942|P3|Overall Study|Abnormal test procedure|0
420861|NCT00570778|1407943|P2|Overall Study|Abnormal test procedure|0
420862|NCT00570778|1407944|P1|Overall Study|Abnormal test procedure|1
420863|NCT00570778|1407941|P4|Overall Study|Subject withdrew consent|1
420864|NCT00570778|1407942|P3|Overall Study|Subject withdrew consent|0
420865|NCT00570778|1407943|P2|Overall Study|Subject withdrew consent|1
420866|NCT00570778|1407944|P1|Overall Study|Subject withdrew consent|0
420867|NCT00570778|1407941|P4|Overall Study|Adverse Event|1
420868|NCT00570778|1407942|P3|Overall Study|Adverse Event|4
420869|NCT00570778|1407943|P2|Overall Study|Adverse Event|1
420870|NCT00570778|1407944|P1|Overall Study|Adverse Event|0
420871|NCT00570778|1407941|P4|Overall Study|Protocol deviation|2
420872|NCT00570778|1407942|P3|Overall Study|Protocol deviation|2
420873|NCT00570778|1407943|P2|Overall Study|Protocol deviation|1
420874|NCT00570778|1407944|P1|Overall Study|Protocol deviation|2
420875|NCT00570739|1407985|P4|Overall Study|Not specified|3
420876|NCT00570739|1407986|P3|Overall Study|Not specified|5
420877|NCT00570739|1407987|P2|Overall Study|Not specified|2
420878|NCT00570739|1407988|P1|Overall Study|Not specified|0
420879|NCT00570739|1407985|P4|Overall Study|Met discontinuation criteria|1
420880|NCT00570739|1407986|P3|Overall Study|Met discontinuation criteria|1
420881|NCT00570739|1407987|P2|Overall Study|Met discontinuation criteria|0
420882|NCT00570739|1407988|P1|Overall Study|Met discontinuation criteria|1
420883|NCT00570739|1407985|P4|Overall Study|Required restricted medication|0
420884|NCT00570739|1407986|P3|Overall Study|Required restricted medication|1
420885|NCT00570739|1407987|P2|Overall Study|Required restricted medication|0
420886|NCT00570739|1407988|P1|Overall Study|Required restricted medication|0
420887|NCT00570739|1407985|P4|Overall Study|Withdrawal by Subject|5
420888|NCT00570739|1407986|P3|Overall Study|Withdrawal by Subject|3
420889|NCT00570739|1407987|P2|Overall Study|Withdrawal by Subject|7
420890|NCT00570739|1407988|P1|Overall Study|Withdrawal by Subject|7
420891|NCT00570739|1407985|P4|Overall Study|Physician Decision|0
420892|NCT00570739|1407986|P3|Overall Study|Physician Decision|0
420893|NCT00570739|1407987|P2|Overall Study|Physician Decision|1
420894|NCT00570739|1407988|P1|Overall Study|Physician Decision|1
420895|NCT00570739|1407985|P4|Overall Study|Lost to Follow-up|1
420896|NCT00570739|1407986|P3|Overall Study|Lost to Follow-up|4
420897|NCT00570739|1407987|P2|Overall Study|Lost to Follow-up|5
420898|NCT00570739|1407988|P1|Overall Study|Lost to Follow-up|4
420899|NCT00570739|1407985|P4|Overall Study|Adverse Event|2
420900|NCT00570739|1407986|P3|Overall Study|Adverse Event|2
420901|NCT00570739|1407987|P2|Overall Study|Adverse Event|6
420902|NCT00570739|1407988|P1|Overall Study|Adverse Event|8
420903|NCT00570713|1408140|P2|Overall Study|Discontinuation of Study by the Sponsor|7
420904|NCT00570713|1408141|P1|Overall Study|Discontinuation of Study by the Sponsor|10
420905|NCT00570713|1408140|P2|Overall Study|Withdrawal by Subject|3
420906|NCT00570713|1408141|P1|Overall Study|Withdrawal by Subject|3
420907|NCT00570713|1408140|P2|Overall Study|Physician Decision|2
420908|NCT00570713|1408141|P1|Overall Study|Physician Decision|2
420909|NCT00570713|1408140|P2|Overall Study|Lack of Efficacy|49
420910|NCT00570713|1408141|P1|Overall Study|Lack of Efficacy|40
420911|NCT00570713|1408140|P2|Overall Study|Death|7
420912|NCT00570713|1408141|P1|Overall Study|Death|7
420913|NCT00570713|1408140|P2|Overall Study|Adverse Event|9
420914|NCT00570713|1408141|P1|Overall Study|Adverse Event|16
420915|NCT00570687|1408159|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420916|NCT00570687|1408160|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420917|NCT00570687|1408161|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420918|NCT00570687|1408162|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
420919|NCT00570687|1408163|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420920|NCT00570687|1408164|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420921|NCT00570687|1408165|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420922|NCT00570687|1408166|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420923|NCT00570687|1408167|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420924|NCT00570687|1408168|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420925|NCT00570687|1408159|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420926|NCT00570687|1408160|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
420927|NCT00570687|1408161|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420928|NCT00570687|1408162|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420929|NCT00570687|1408163|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420930|NCT00570687|1408164|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420931|NCT00570687|1408165|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420932|NCT00570687|1408166|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420933|NCT00570687|1408167|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420934|NCT00570687|1408168|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420935|NCT00570687|1408159|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
420936|NCT00570687|1408160|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
420937|NCT00570687|1408161|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
420938|NCT00570687|1408162|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
420939|NCT00570687|1408163|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
420940|NCT00570687|1408164|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
420941|NCT00570687|1408165|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420942|NCT00570687|1408166|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420943|NCT00570687|1408167|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420944|NCT00570687|1408168|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
420945|NCT00570674|1408194|P7|Overall Study|Withdrawal by Subject|0
420946|NCT00570674|1408195|P6|Overall Study|Withdrawal by Subject|0
420947|NCT00570674|1408196|P5|Overall Study|Withdrawal by Subject|0
420948|NCT00570674|1408197|P4|Overall Study|Withdrawal by Subject|0
420949|NCT00570674|1408198|P3|Overall Study|Withdrawal by Subject|1
420950|NCT00570674|1408199|P2|Overall Study|Withdrawal by Subject|0
420951|NCT00570674|1408200|P1|Overall Study|Withdrawal by Subject|0
420952|NCT00570505|1408223|P1|Overall Study|Other loss to follow-up|4
420953|NCT00570505|1408223|P1|Overall Study|Lost to Follow-up|23
420954|NCT00570505|1408223|P1|Overall Study|Withdrawal by Subject|7
420955|NCT00570505|1408223|P1|Overall Study|Adverse Event|7
420956|NCT00570492|1408236|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
420957|NCT00570492|1408237|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
420958|NCT00570492|1408238|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
420959|NCT00570492|1408236|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
420960|NCT00570492|1408237|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
420961|NCT00570492|1408238|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
420962|NCT00570492|1408236|P3|52-week Double-blind Treatment Period|Physician Decision|4
420963|NCT00570492|1408237|P2|52-week Double-blind Treatment Period|Physician Decision|2
420964|NCT00570492|1408238|P1|52-week Double-blind Treatment Period|Physician Decision|0
420965|NCT00570492|1408236|P3|52-week Double-blind Treatment Period|Adverse Event|5
420966|NCT00570492|1408237|P2|52-week Double-blind Treatment Period|Adverse Event|5
420967|NCT00570492|1408238|P1|52-week Double-blind Treatment Period|Adverse Event|0
420968|NCT00570492|1408236|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
420969|NCT00570492|1408237|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
420970|NCT00570492|1408238|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
420971|NCT00570492|1408236|P3|52-week Double-blind Treatment Period|Protocol Violation|15
420972|NCT00570492|1408237|P2|52-week Double-blind Treatment Period|Protocol Violation|12
420973|NCT00570492|1408238|P1|52-week Double-blind Treatment Period|Protocol Violation|0
420974|NCT00570492|1408236|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
420975|NCT00570492|1408237|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
420976|NCT00570492|1408238|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
420977|NCT00570492|1408236|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
420978|NCT00570492|1408237|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
420979|NCT00570492|1408238|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
420980|NCT00570492|1408236|P3|16-week Single-blind Baseline Period|Adverse Event|0
420981|NCT00570492|1408237|P2|16-week Single-blind Baseline Period|Adverse Event|0
420982|NCT00570492|1408238|P1|16-week Single-blind Baseline Period|Adverse Event|1
420983|NCT00570492|1408236|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
420984|NCT00570492|1408237|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
420985|NCT00570492|1408238|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
420986|NCT00570492|1408236|P3|16-week Single-blind Baseline Period|Protocol Violation|0
420987|NCT00570492|1408237|P2|16-week Single-blind Baseline Period|Protocol Violation|0
420988|NCT00570492|1408238|P1|16-week Single-blind Baseline Period|Protocol Violation|15
420989|NCT00570492|1408236|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
420990|NCT00570492|1408237|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
420991|NCT00570492|1408238|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
420992|NCT00570492|1408236|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
420993|NCT00570492|1408237|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
420994|NCT00570492|1408238|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
420995|NCT00570492|1408236|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
420996|NCT00570492|1408237|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
420997|NCT00570492|1408238|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
420998|NCT00570401|1408276|P1|Overall Study|Adverse Event|2
420999|NCT00570310|1408310|P2|Overall Study|Lack of Efficacy|4
421000|NCT00570310|1408311|P1|Overall Study|Lack of Efficacy|1
421001|NCT00570310|1408310|P2|Overall Study|Adverse Event|2
421002|NCT00570310|1408311|P1|Overall Study|Adverse Event|1
421003|NCT00570232|1408319|P1|Overall Study|discontinued due to noncompliance|2
421004|NCT00570232|1408319|P1|Overall Study|discontinued due to recurrence|8
421005|NCT00570232|1408319|P1|Overall Study|discontinued due to medical condition|3
421006|NCT00570232|1408319|P1|Overall Study|Adverse Event|10
421007|NCT00570141|1408325|P1|Overall Study|Lost to Follow-up|1
421008|NCT00570141|1408325|P1|Overall Study|Missed visits|1
421009|NCT00570141|1408325|P1|Overall Study|Adverse Event|1
421010|NCT00570063|1408341|P2|Overall Study|Sponsor's Decision|3
421011|NCT00570063|1408342|P1|Overall Study|Sponsor's Decision|7
421012|NCT00570063|1408341|P2|Overall Study|Withdrawal by Subject|3
421013|NCT00570063|1408342|P1|Overall Study|Withdrawal by Subject|4
421014|NCT00570063|1408341|P2|Overall Study|Lack of Efficacy|1
421015|NCT00570063|1408342|P1|Overall Study|Lack of Efficacy|0
421016|NCT00570063|1408341|P2|Overall Study|Adverse Event|1
421017|NCT00570063|1408342|P1|Overall Study|Adverse Event|4
421018|NCT00570037|1408408|P2|Overall Study|Could not reach for 6-8 week contact|69
421019|NCT00570037|1408409|P1|Overall Study|Could not reach for 6-8 week contact|44
421020|NCT00569946|1408419|P1|Overall Study|Global Deterioration of Health Status|1
421021|NCT00569946|1408419|P1|Overall Study|Objective Progression or Relapse|42
421022|NCT00569946|1408419|P1|Overall Study|Adverse Event|16
421023|NCT00569803|1408451|P8|Overall Study|Withdrawal by Subject|1
421024|NCT00569803|1408452|P7|Overall Study|Withdrawal by Subject|0
421025|NCT00569803|1408453|P6|Overall Study|Withdrawal by Subject|0
421026|NCT00569803|1408454|P5|Overall Study|Withdrawal by Subject|0
421027|NCT00569803|1408455|P4|Overall Study|Withdrawal by Subject|0
421028|NCT00569803|1408456|P3|Overall Study|Withdrawal by Subject|0
421029|NCT00569803|1408457|P2|Overall Study|Withdrawal by Subject|0
421030|NCT00569803|1408458|P1|Overall Study|Withdrawal by Subject|0
421031|NCT00569803|1408451|P8|Overall Study|injection syringe leaked during dosing|0
421032|NCT00569803|1408452|P7|Overall Study|injection syringe leaked during dosing|0
421033|NCT00569803|1408453|P6|Overall Study|injection syringe leaked during dosing|0
421034|NCT00569803|1408454|P5|Overall Study|injection syringe leaked during dosing|0
421035|NCT00569803|1408455|P4|Overall Study|injection syringe leaked during dosing|1
421036|NCT00569803|1408456|P3|Overall Study|injection syringe leaked during dosing|0
421037|NCT00569803|1408457|P2|Overall Study|injection syringe leaked during dosing|0
421038|NCT00569803|1408458|P1|Overall Study|injection syringe leaked during dosing|0
421039|NCT00569803|1408451|P8|Overall Study|Lost to Follow-up|0
421040|NCT00569803|1408452|P7|Overall Study|Lost to Follow-up|0
421041|NCT00569803|1408453|P6|Overall Study|Lost to Follow-up|0
421042|NCT00569803|1408454|P5|Overall Study|Lost to Follow-up|0
421043|NCT00569803|1408455|P4|Overall Study|Lost to Follow-up|0
421044|NCT00569803|1408456|P3|Overall Study|Lost to Follow-up|0
421045|NCT00569803|1408457|P2|Overall Study|Lost to Follow-up|0
421046|NCT00569803|1408458|P1|Overall Study|Lost to Follow-up|1
421047|NCT00569777|1408585|P2|Overall Study|pregnant|0
421048|NCT00569777|1408586|P1|Overall Study|pregnant|1
421049|NCT00569777|1408585|P2|Overall Study|did not meet exclusion criteria|2
421050|NCT00569777|1408586|P1|Overall Study|did not meet exclusion criteria|1
421051|NCT00569777|1408585|P2|Overall Study|scheduled eye surgery|1
421052|NCT00569777|1408586|P1|Overall Study|scheduled eye surgery|0
421053|NCT00569777|1408585|P2|Overall Study|Lost to Follow-up|0
421054|NCT00569777|1408586|P1|Overall Study|Lost to Follow-up|1
421055|NCT00569777|1408585|P2|Overall Study|Adverse Event|0
421056|NCT00569777|1408586|P1|Overall Study|Adverse Event|3
421057|NCT00569777|1408585|P2|Overall Study|Withdrawal by Subject|0
421058|NCT00569777|1408586|P1|Overall Study|Withdrawal by Subject|4
421059|NCT00569582|1408637|P1|Overall Study|Subject was non-compliant.|1
421060|NCT00569582|1408637|P1|Overall Study|Subject was too ill to travel.|1
421061|NCT00569582|1408637|P1|Overall Study|Adverse Event|7
421062|NCT00569582|1408637|P1|Overall Study|Death|2
421063|NCT00569582|1408637|P1|Overall Study|Withdrawal by Subject|5
421064|NCT00569374|1408653|P1|Overall Study|Withdrawal by Subject|4
421065|NCT00569270|1408672|P2|Period: First Intervention|Protocol Violation|1
421066|NCT00569270|1408673|P1|Period: First Intervention|Protocol Violation|0
421067|NCT00569231|1408708|P1|Overall Study|Non-compliance|2
421068|NCT00569231|1408708|P1|Overall Study|Car accident injury|1
421069|NCT00569231|1408708|P1|Overall Study|Withdrawal by Subject|1
421070|NCT00569231|1408708|P1|Overall Study|Airfare expense|2
421071|NCT00569231|1408708|P1|Overall Study|Study unrelated surgery|1
421072|NCT00569166|1408746|P3|Overall Study|Lost to Follow-up|1
421073|NCT00569166|1408747|P2|Overall Study|Lost to Follow-up|1
421074|NCT00569166|1408748|P1|Overall Study|Lost to Follow-up|2
421075|NCT00569166|1408746|P3|Overall Study|Withdrawal by Subject|3
421076|NCT00569166|1408747|P2|Overall Study|Withdrawal by Subject|5
421077|NCT00569166|1408748|P1|Overall Study|Withdrawal by Subject|7
421078|NCT00569127|1408782|P2|Overall Study|Still on Treatment|3
421079|NCT00569127|1408783|P1|Overall Study|Still on Treatment|7
421080|NCT00569127|1408782|P2|Overall Study|Not Eligible|11
421081|NCT00569127|1408783|P1|Overall Study|Not Eligible|14
421082|NCT00569127|1408782|P2|Overall Study|Lost to Follow-up|3
421083|NCT00569127|1408783|P1|Overall Study|Lost to Follow-up|0
421084|NCT00569127|1408782|P2|Overall Study|Not Specified|19
421085|NCT00569127|1408783|P1|Overall Study|Not Specified|20
421086|NCT00569127|1408782|P2|Overall Study|Death|3
421087|NCT00569127|1408783|P1|Overall Study|Death|4
421088|NCT00569127|1408782|P2|Overall Study|Progression|100
421089|NCT00569127|1408783|P1|Overall Study|Progression|99
421090|NCT00569127|1408782|P2|Overall Study|Withdrawal by Subject|27
421091|NCT00569127|1408783|P1|Overall Study|Withdrawal by Subject|13
421092|NCT00569127|1408782|P2|Overall Study|Adverse Event|47
421093|NCT00569127|1408783|P1|Overall Study|Adverse Event|57
421094|NCT00568958|1408818|P2|Follow-Up|Family Emergency|0
421095|NCT00568958|1408819|P1|Follow-Up|Family Emergency|1
421096|NCT00568958|1408818|P2|Follow-Up|Physician Decision|1
421097|NCT00568958|1408819|P1|Follow-Up|Physician Decision|1
421098|NCT00568958|1408818|P2|Follow-Up|Withdrawal by Subject|3
421099|NCT00568958|1408819|P1|Follow-Up|Withdrawal by Subject|6
421100|NCT00568958|1408818|P2|Allocation|Physician Decision|0
421101|NCT00568958|1408819|P1|Allocation|Physician Decision|2
421102|NCT00568958|1408818|P2|Allocation|Withdrawal by Subject|3
421103|NCT00568958|1408819|P1|Allocation|Withdrawal by Subject|7
421104|NCT00568776|1408852|P4|Overall Study|Miscellaeneous|4
421105|NCT00568776|1408853|P3|Overall Study|Miscellaeneous|1
421106|NCT00568776|1408854|P2|Overall Study|Miscellaeneous|3
421107|NCT00568776|1408855|P1|Overall Study|Miscellaeneous|3
421108|NCT00568776|1408852|P4|Overall Study|Sponsor Decision|42
421109|NCT00568776|1408853|P3|Overall Study|Sponsor Decision|41
421110|NCT00568776|1408854|P2|Overall Study|Sponsor Decision|2
421111|NCT00568776|1408855|P1|Overall Study|Sponsor Decision|2
421112|NCT00568776|1408852|P4|Overall Study|Loss of Caregiver|2
421113|NCT00568776|1408853|P3|Overall Study|Loss of Caregiver|1
421114|NCT00568776|1408854|P2|Overall Study|Loss of Caregiver|2
421115|NCT00568776|1408855|P1|Overall Study|Loss of Caregiver|0
421116|NCT00568776|1408852|P4|Overall Study|Withdrawal by Subject|7
421117|NCT00568776|1408853|P3|Overall Study|Withdrawal by Subject|13
421118|NCT00568776|1408854|P2|Overall Study|Withdrawal by Subject|15
421119|NCT00568776|1408855|P1|Overall Study|Withdrawal by Subject|13
421120|NCT00568776|1408852|P4|Overall Study|Protocol Violation|1
421121|NCT00568776|1408853|P3|Overall Study|Protocol Violation|1
421122|NCT00568776|1408854|P2|Overall Study|Protocol Violation|0
421123|NCT00568776|1408855|P1|Overall Study|Protocol Violation|1
421124|NCT00568776|1408852|P4|Overall Study|Lost to Follow-up|1
421125|NCT00568776|1408853|P3|Overall Study|Lost to Follow-up|1
421126|NCT00568776|1408854|P2|Overall Study|Lost to Follow-up|1
421127|NCT00568776|1408855|P1|Overall Study|Lost to Follow-up|1
421128|NCT00568776|1408852|P4|Overall Study|Lack of Efficacy|4
421129|NCT00568776|1408853|P3|Overall Study|Lack of Efficacy|2
421130|NCT00568776|1408854|P2|Overall Study|Lack of Efficacy|2
421131|NCT00568776|1408855|P1|Overall Study|Lack of Efficacy|2
421132|NCT00568776|1408852|P4|Overall Study|Physician Decision|0
421133|NCT00568776|1408853|P3|Overall Study|Physician Decision|0
421134|NCT00568776|1408854|P2|Overall Study|Physician Decision|2
421135|NCT00568776|1408855|P1|Overall Study|Physician Decision|0
421136|NCT00568776|1408852|P4|Overall Study|Death|3
421137|NCT00568776|1408853|P3|Overall Study|Death|4
421138|NCT00568776|1408854|P2|Overall Study|Death|1
421139|NCT00568776|1408855|P1|Overall Study|Death|0
421140|NCT00568776|1408852|P4|Overall Study|Adverse Event|8
421141|NCT00568776|1408853|P3|Overall Study|Adverse Event|10
421142|NCT00568776|1408854|P2|Overall Study|Adverse Event|8
421143|NCT00568776|1408855|P1|Overall Study|Adverse Event|8
421144|NCT00568685|1408892|P3|Overall Study|Protocol Violation|0
421145|NCT00568685|1408893|P2|Overall Study|Protocol Violation|0
421146|NCT00568685|1408894|P1|Overall Study|Protocol Violation|1
421147|NCT00568685|1408892|P3|Overall Study|Withdrawal by Subject|2
421148|NCT00568685|1408893|P2|Overall Study|Withdrawal by Subject|2
421149|NCT00568685|1408894|P1|Overall Study|Withdrawal by Subject|7
421150|NCT00568685|1408892|P3|Overall Study|Adverse Event|3
421151|NCT00568685|1408893|P2|Overall Study|Adverse Event|3
421152|NCT00568685|1408894|P1|Overall Study|Adverse Event|2
421153|NCT00568555|1408928|P2|Overall Study|Withdrawal by Subject|1
421154|NCT00568555|1408929|P1|Overall Study|Withdrawal by Subject|1
421155|NCT00568451|1408947|P4|Overall Study|Disease Progression|7
421156|NCT00568451|1408948|P3|Overall Study|Disease Progression|2
421157|NCT00568451|1408949|P2|Overall Study|Disease Progression|0
421158|NCT00568451|1408950|P1|Overall Study|Disease Progression|0
421159|NCT00568399|1408966|P1|Overall Study|Withdrawal by Subject|8
421160|NCT00568399|1408966|P1|Overall Study|Adverse Event|5
421161|NCT00568399|1408966|P1|Overall Study|Death|2
421162|NCT00568334|1408981|P2|Overall Study|Lost to Follow-up|0
421163|NCT00568334|1408982|P1|Overall Study|Lost to Follow-up|1
421164|NCT00568334|1408981|P2|Overall Study|Withdrawal by Subject|1
421165|NCT00568334|1408982|P1|Overall Study|Withdrawal by Subject|0
421166|NCT00568178|1409008|P6|Open Label Extension|Withdrawal by Subject|4
421167|NCT00568178|1409009|P5|Open Label Extension|Withdrawal by Subject|4
421168|NCT00568178|1409010|P4|Open Label Extension|Withdrawal by Subject|0
421169|NCT00568178|1409011|P3|Open Label Extension|Withdrawal by Subject|0
421170|NCT00568178|1409012|P2|Open Label Extension|Withdrawal by Subject|0
421171|NCT00568178|1409013|P1|Open Label Extension|Withdrawal by Subject|0
421172|NCT00568178|1409008|P6|Open Label Extension|Termination of Trial|47
421173|NCT00568178|1409009|P5|Open Label Extension|Termination of Trial|45
421174|NCT00568178|1409010|P4|Open Label Extension|Termination of Trial|0
421175|NCT00568178|1409011|P3|Open Label Extension|Termination of Trial|0
421176|NCT00568178|1409012|P2|Open Label Extension|Termination of Trial|0
421177|NCT00568178|1409013|P1|Open Label Extension|Termination of Trial|0
421178|NCT00568178|1409008|P6|Open Label Extension|Progressive Disease|1
421179|NCT00568178|1409009|P5|Open Label Extension|Progressive Disease|3
421180|NCT00568178|1409010|P4|Open Label Extension|Progressive Disease|0
421181|NCT00568178|1409011|P3|Open Label Extension|Progressive Disease|0
421182|NCT00568178|1409012|P2|Open Label Extension|Progressive Disease|0
421183|NCT00568178|1409013|P1|Open Label Extension|Progressive Disease|0
421184|NCT00568178|1409008|P6|Open Label Extension|Pregnancy|1
421185|NCT00568178|1409009|P5|Open Label Extension|Pregnancy|0
421186|NCT00568178|1409010|P4|Open Label Extension|Pregnancy|0
421187|NCT00568178|1409011|P3|Open Label Extension|Pregnancy|0
421188|NCT00568178|1409012|P2|Open Label Extension|Pregnancy|0
421189|NCT00568178|1409013|P1|Open Label Extension|Pregnancy|0
421190|NCT00568178|1409008|P6|Open Label Extension|Physician Decision|8
421191|NCT00568178|1409009|P5|Open Label Extension|Physician Decision|9
421192|NCT00568178|1409010|P4|Open Label Extension|Physician Decision|0
421193|NCT00568178|1409011|P3|Open Label Extension|Physician Decision|0
421194|NCT00568178|1409012|P2|Open Label Extension|Physician Decision|0
421195|NCT00568178|1409013|P1|Open Label Extension|Physician Decision|0
421196|NCT00568178|1409008|P6|Open Label Extension|Lost to Follow-up|11
421197|NCT00568178|1409009|P5|Open Label Extension|Lost to Follow-up|6
421198|NCT00568178|1409010|P4|Open Label Extension|Lost to Follow-up|0
421199|NCT00568178|1409011|P3|Open Label Extension|Lost to Follow-up|0
421200|NCT00568178|1409012|P2|Open Label Extension|Lost to Follow-up|0
421201|NCT00568178|1409013|P1|Open Label Extension|Lost to Follow-up|0
421202|NCT00568178|1409008|P6|Open Label Extension|Protocol Violation|0
421203|NCT00568178|1409009|P5|Open Label Extension|Protocol Violation|1
421204|NCT00568178|1409010|P4|Open Label Extension|Protocol Violation|0
421205|NCT00568178|1409011|P3|Open Label Extension|Protocol Violation|0
421206|NCT00568178|1409012|P2|Open Label Extension|Protocol Violation|0
421207|NCT00568178|1409013|P1|Open Label Extension|Protocol Violation|0
421208|NCT00568178|1409008|P6|Open Label Extension|Adverse Event|8
421209|NCT00568178|1409009|P5|Open Label Extension|Adverse Event|11
421210|NCT00568178|1409010|P4|Open Label Extension|Adverse Event|0
421211|NCT00568178|1409011|P3|Open Label Extension|Adverse Event|0
421212|NCT00568178|1409012|P2|Open Label Extension|Adverse Event|0
421213|NCT00568178|1409013|P1|Open Label Extension|Adverse Event|0
421214|NCT00568178|1409008|P6|Double Blind Base Study|Progressive Disease|0
421215|NCT00568178|1409009|P5|Double Blind Base Study|Progressive Disease|0
421216|NCT00568178|1409010|P4|Double Blind Base Study|Progressive Disease|1
421217|NCT00568178|1409011|P3|Double Blind Base Study|Progressive Disease|0
421218|NCT00568178|1409012|P2|Double Blind Base Study|Progressive Disease|0
421219|NCT00568178|1409013|P1|Double Blind Base Study|Progressive Disease|0
421220|NCT00568178|1409008|P6|Double Blind Base Study|Withdrawal by Subject|0
421221|NCT00568178|1409009|P5|Double Blind Base Study|Withdrawal by Subject|0
421222|NCT00568178|1409010|P4|Double Blind Base Study|Withdrawal by Subject|0
421223|NCT00568178|1409011|P3|Double Blind Base Study|Withdrawal by Subject|0
421224|NCT00568178|1409012|P2|Double Blind Base Study|Withdrawal by Subject|1
421225|NCT00568178|1409013|P1|Double Blind Base Study|Withdrawal by Subject|1
421226|NCT00568178|1409008|P6|Double Blind Base Study|Protocol Violation|0
421227|NCT00568178|1409009|P5|Double Blind Base Study|Protocol Violation|0
421228|NCT00568178|1409010|P4|Double Blind Base Study|Protocol Violation|0
421229|NCT00568178|1409011|P3|Double Blind Base Study|Protocol Violation|0
421230|NCT00568178|1409012|P2|Double Blind Base Study|Protocol Violation|2
421231|NCT00568178|1409013|P1|Double Blind Base Study|Protocol Violation|3
421232|NCT00568178|1409008|P6|Double Blind Base Study|Physician Decision|0
421233|NCT00568178|1409009|P5|Double Blind Base Study|Physician Decision|0
421234|NCT00568178|1409010|P4|Double Blind Base Study|Physician Decision|1
421235|NCT00568178|1409011|P3|Double Blind Base Study|Physician Decision|0
421236|NCT00568178|1409012|P2|Double Blind Base Study|Physician Decision|1
421237|NCT00568178|1409013|P1|Double Blind Base Study|Physician Decision|1
421238|NCT00568178|1409008|P6|Double Blind Base Study|Lost to Follow-up|0
421239|NCT00568178|1409009|P5|Double Blind Base Study|Lost to Follow-up|0
421240|NCT00568178|1409010|P4|Double Blind Base Study|Lost to Follow-up|1
421241|NCT00568178|1409011|P3|Double Blind Base Study|Lost to Follow-up|0
421242|NCT00568178|1409012|P2|Double Blind Base Study|Lost to Follow-up|0
421243|NCT00568178|1409013|P1|Double Blind Base Study|Lost to Follow-up|1
421244|NCT00568178|1409008|P6|Double Blind Base Study|Adverse Event|0
421245|NCT00568178|1409009|P5|Double Blind Base Study|Adverse Event|0
421246|NCT00568178|1409010|P4|Double Blind Base Study|Adverse Event|2
421247|NCT00568178|1409011|P3|Double Blind Base Study|Adverse Event|1
421248|NCT00568178|1409012|P2|Double Blind Base Study|Adverse Event|2
421249|NCT00568178|1409013|P1|Double Blind Base Study|Adverse Event|0
421250|NCT00568061|1409044|P2|Overall Study|Adverse Event|1
421251|NCT00568061|1409045|P1|Overall Study|Adverse Event|0
421252|NCT00568061|1409044|P2|Overall Study|Inclusion / exclusion criteria|1
421253|NCT00568061|1409045|P1|Overall Study|Inclusion / exclusion criteria|5
421254|NCT00567996|1409089|P3|Overall Study|Patient's inability to use the device|0
421255|NCT00567996|1409090|P2|Overall Study|Patient's inability to use the device|1
421256|NCT00567996|1409091|P1|Overall Study|Patient's inability to use the device|0
421257|NCT00567996|1409089|P3|Overall Study|Death|2
421258|NCT00567996|1409090|P2|Overall Study|Death|0
421259|NCT00567996|1409091|P1|Overall Study|Death|1
421260|NCT00567996|1409089|P3|Overall Study|Administrative problems|0
421261|NCT00567996|1409090|P2|Overall Study|Administrative problems|1
421262|NCT00567996|1409091|P1|Overall Study|Administrative problems|1
421263|NCT00567996|1409089|P3|Overall Study|Unsatisfactory therapeutic effect|15
421264|NCT00567996|1409090|P2|Overall Study|Unsatisfactory therapeutic effect|2
421265|NCT00567996|1409091|P1|Overall Study|Unsatisfactory therapeutic effect|1
421266|NCT00567996|1409089|P3|Overall Study|Lost to Follow-up|2
421267|NCT00567996|1409090|P2|Overall Study|Lost to Follow-up|5
421268|NCT00567996|1409091|P1|Overall Study|Lost to Follow-up|2
421269|NCT00567996|1409089|P3|Overall Study|Abnormal test procedure result(s)|1
421270|NCT00567996|1409090|P2|Overall Study|Abnormal test procedure result(s)|1
421271|NCT00567996|1409091|P1|Overall Study|Abnormal test procedure result(s)|2
421272|NCT00567996|1409089|P3|Overall Study|Abnormal Lab value(s)|2
421273|NCT00567996|1409090|P2|Overall Study|Abnormal Lab value(s)|1
421274|NCT00567996|1409091|P1|Overall Study|Abnormal Lab value(s)|2
421275|NCT00567996|1409089|P3|Overall Study|Withdrawal by Subject|22
421276|NCT00567996|1409090|P2|Overall Study|Withdrawal by Subject|12
421277|NCT00567996|1409091|P1|Overall Study|Withdrawal by Subject|8
421278|NCT00567996|1409089|P3|Overall Study|Protocol Deviation|13
421279|NCT00567996|1409090|P2|Overall Study|Protocol Deviation|11
421280|NCT00567996|1409091|P1|Overall Study|Protocol Deviation|9
421281|NCT00567996|1409089|P3|Overall Study|Adverse Event|13
421282|NCT00567996|1409090|P2|Overall Study|Adverse Event|16
421283|NCT00567996|1409091|P1|Overall Study|Adverse Event|18
421284|NCT00567892|1409107|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
421285|NCT00567892|1409108|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
421286|NCT00567892|1409109|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
421287|NCT00567892|1409110|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
421288|NCT00567892|1409107|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
421289|NCT00567892|1409108|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
421290|NCT00567892|1409109|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
421291|NCT00567892|1409110|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
421292|NCT00567879|1409128|P6|Overall Study|Disease progression|3
421293|NCT00567879|1409129|P5|Overall Study|Disease progression|11
421294|NCT00567879|1409130|P4|Overall Study|Disease progression|5
421295|NCT00567879|1409131|P3|Overall Study|Disease progression|15
421296|NCT00567879|1409132|P2|Overall Study|Disease progression|7
421297|NCT00567879|1409133|P1|Overall Study|Disease progression|5
421298|NCT00567879|1409128|P6|Overall Study|New cancer therapy|0
421299|NCT00567879|1409129|P5|Overall Study|New cancer therapy|0
421300|NCT00567879|1409130|P4|Overall Study|New cancer therapy|0
421301|NCT00567879|1409131|P3|Overall Study|New cancer therapy|1
421302|NCT00567879|1409132|P2|Overall Study|New cancer therapy|0
421303|NCT00567879|1409133|P1|Overall Study|New cancer therapy|0
421304|NCT00567879|1409128|P6|Overall Study|Withdrawal by Subject|0
421305|NCT00567879|1409129|P5|Overall Study|Withdrawal by Subject|0
421306|NCT00567879|1409130|P4|Overall Study|Withdrawal by Subject|1
421307|NCT00567879|1409131|P3|Overall Study|Withdrawal by Subject|3
421308|NCT00567879|1409132|P2|Overall Study|Withdrawal by Subject|0
421309|NCT00567879|1409133|P1|Overall Study|Withdrawal by Subject|0
421310|NCT00567879|1409128|P6|Overall Study|Abnormal test procedure(s)|0
421311|NCT00567879|1409129|P5|Overall Study|Abnormal test procedure(s)|0
421312|NCT00567879|1409130|P4|Overall Study|Abnormal test procedure(s)|0
421313|NCT00567879|1409131|P3|Overall Study|Abnormal test procedure(s)|1
421314|NCT00567879|1409132|P2|Overall Study|Abnormal test procedure(s)|0
421315|NCT00567879|1409133|P1|Overall Study|Abnormal test procedure(s)|0
421316|NCT00567879|1409128|P6|Overall Study|Adverse Event|0
421317|NCT00567879|1409129|P5|Overall Study|Adverse Event|1
421318|NCT00567879|1409130|P4|Overall Study|Adverse Event|0
421319|NCT00567879|1409131|P3|Overall Study|Adverse Event|1
421320|NCT00567879|1409132|P2|Overall Study|Adverse Event|0
421321|NCT00567879|1409133|P1|Overall Study|Adverse Event|2
421322|NCT00567593|1409200|P1|Overall Study|Physician Decision|1
421323|NCT00567593|1409200|P1|Overall Study|Adverse Event|1
421324|NCT00567567|1409207|P3|Overall Study|Unable adequate stem cell for transplant|2
421325|NCT00567567|1409208|P2|Overall Study|Unable adequate stem cell for transplant|0
421326|NCT00567567|1409209|P1|Overall Study|Unable adequate stem cell for transplant|0
421327|NCT00567567|1409207|P3|Overall Study|Enrolled another COG therapeutic study|0
421328|NCT00567567|1409208|P2|Overall Study|Enrolled another COG therapeutic study|80
421329|NCT00567567|1409209|P1|Overall Study|Enrolled another COG therapeutic study|99
421330|NCT00567567|1409207|P3|Overall Study|Refusal by patient/parent/guardian|122
421331|NCT00567567|1409208|P2|Overall Study|Refusal by patient/parent/guardian|16
421332|NCT00567567|1409209|P1|Overall Study|Refusal by patient/parent/guardian|9
421333|NCT00567567|1409207|P3|Overall Study|Ineligible|9
421334|NCT00567567|1409208|P2|Overall Study|Ineligible|0
421335|NCT00567567|1409209|P1|Overall Study|Ineligible|4
421336|NCT00567567|1409207|P3|Overall Study|Withdrawal by Subject|2
421337|NCT00567567|1409208|P2|Overall Study|Withdrawal by Subject|0
421338|NCT00567567|1409209|P1|Overall Study|Withdrawal by Subject|0
421339|NCT00567567|1409207|P3|Overall Study|Physician Decision|84
421340|NCT00567567|1409208|P2|Overall Study|Physician Decision|18
421341|NCT00567567|1409209|P1|Overall Study|Physician Decision|16
421342|NCT00567567|1409207|P3|Overall Study|Lost to Follow-up|1
421343|NCT00567567|1409208|P2|Overall Study|Lost to Follow-up|0
421344|NCT00567567|1409209|P1|Overall Study|Lost to Follow-up|0
421345|NCT00567567|1409207|P3|Overall Study|Lack of Efficacy|48
421346|NCT00567567|1409208|P2|Overall Study|Lack of Efficacy|17
421347|NCT00567567|1409209|P1|Overall Study|Lack of Efficacy|16
421348|NCT00567567|1409207|P3|Overall Study|Death|5
421349|NCT00567567|1409208|P2|Overall Study|Death|1
421350|NCT00567567|1409209|P1|Overall Study|Death|8
421351|NCT00567567|1409207|P3|Overall Study|Adverse Event|5
421352|NCT00567567|1409208|P2|Overall Study|Adverse Event|2
421353|NCT00567567|1409209|P1|Overall Study|Adverse Event|0
421354|NCT00567541|1409235|P2|Overall Study|Adverse Event|1
421355|NCT00567541|1409236|P1|Overall Study|Adverse Event|0
421356|NCT00567502|1409246|P4|Overall Study|Never Initiated Treatment|72
421357|NCT00567502|1409247|P3|Overall Study|Never Initiated Treatment|0
421358|NCT00567502|1409248|P2|Overall Study|Never Initiated Treatment|0
421359|NCT00567502|1409249|P1|Overall Study|Never Initiated Treatment|0
421360|NCT00567502|1409246|P4|Overall Study|Sponsor request|1
421361|NCT00567502|1409247|P3|Overall Study|Sponsor request|30
421362|NCT00567502|1409248|P2|Overall Study|Sponsor request|0
421363|NCT00567502|1409249|P1|Overall Study|Sponsor request|9
421364|NCT00567502|1409246|P4|Overall Study|Participant request|1
421365|NCT00567502|1409247|P3|Overall Study|Participant request|33
421366|NCT00567502|1409248|P2|Overall Study|Participant request|1
421367|NCT00567502|1409249|P1|Overall Study|Participant request|12
421368|NCT00567502|1409246|P4|Overall Study|Other|6
421369|NCT00567502|1409247|P3|Overall Study|Other|134
421370|NCT00567502|1409248|P2|Overall Study|Other|2
421371|NCT00567502|1409249|P1|Overall Study|Other|64
421372|NCT00567502|1409246|P4|Overall Study|Death|5
421373|NCT00567502|1409247|P3|Overall Study|Death|360
421374|NCT00567502|1409248|P2|Overall Study|Death|16
421375|NCT00567502|1409249|P1|Overall Study|Death|65
421376|NCT00567502|1409246|P4|Overall Study|Lost to Follow-up|2
421377|NCT00567502|1409247|P3|Overall Study|Lost to Follow-up|351
421378|NCT00567502|1409248|P2|Overall Study|Lost to Follow-up|14
421379|NCT00567502|1409249|P1|Overall Study|Lost to Follow-up|91
421380|NCT00567476|1409286|P2|Overall Study|Non-adherence to protocol|1
421381|NCT00567476|1409287|P1|Overall Study|Non-adherence to protocol|0
421382|NCT00567476|1409286|P2|Overall Study|Medical Decision|1
421383|NCT00567476|1409287|P1|Overall Study|Medical Decision|0
421384|NCT00567476|1409286|P2|Overall Study|Administrative issues|0
421385|NCT00567476|1409287|P1|Overall Study|Administrative issues|1
421386|NCT00567476|1409286|P2|Overall Study|Lost to Follow-up|1
421387|NCT00567476|1409287|P1|Overall Study|Lost to Follow-up|0
421388|NCT00567476|1409286|P2|Overall Study|Protocol Violation|1
421389|NCT00567476|1409287|P1|Overall Study|Protocol Violation|4
421390|NCT00567476|1409286|P2|Overall Study|Pregnancy|0
421391|NCT00567476|1409287|P1|Overall Study|Pregnancy|1
421392|NCT00567476|1409286|P2|Overall Study|Adverse Event|0
421393|NCT00567476|1409287|P1|Overall Study|Adverse Event|2
421394|NCT00567268|1409329|P1|Overall Study|"Safety Evaluation Not Assessable"|1
421395|NCT00567268|1409329|P1|Overall Study|No Drug Administration|4
421396|NCT00567268|1409329|P1|Overall Study|No Visit After First Day of Treatment|2
421397|NCT00567268|1409329|P1|Overall Study|Lost to Follow-up|36
421398|NCT00567268|1409329|P1|Overall Study|Protocol Violation|7
421399|NCT00567255|1409380|P2|Overall Study|Drug noncompliance,moved,other|15
421400|NCT00567255|1409381|P1|Overall Study|Drug noncompliance,moved,other|25
421401|NCT00567255|1409380|P2|Overall Study|Pregnancy|0
421402|NCT00567255|1409381|P1|Overall Study|Pregnancy|6
421403|NCT00567255|1409380|P2|Overall Study|Protocol Violation|8
421404|NCT00567255|1409381|P1|Overall Study|Protocol Violation|20
421405|NCT00567255|1409380|P2|Overall Study|Lack of Efficacy|33
421406|NCT00567255|1409381|P1|Overall Study|Lack of Efficacy|19
421407|NCT00567255|1409380|P2|Overall Study|Withdrawal by Subject|56
421408|NCT00567255|1409381|P1|Overall Study|Withdrawal by Subject|75
421409|NCT00567255|1409380|P2|Overall Study|Lost to Follow-up|48
421410|NCT00567255|1409381|P1|Overall Study|Lost to Follow-up|77
421411|NCT00567255|1409380|P2|Overall Study|Adverse Event|68
421412|NCT00567255|1409381|P1|Overall Study|Adverse Event|241
421413|NCT00567190|1409444|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
421414|NCT00567190|1409445|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
421415|NCT00567190|1409444|P2|Overall Study|Death|221
421416|NCT00567190|1409445|P1|Overall Study|Death|168
421417|NCT00567164|1409465|P3|Overall Study|Missing|0
421418|NCT00567164|1409466|P2|Overall Study|Missing|0
421419|NCT00567164|1409467|P1|Overall Study|Missing|1
421420|NCT00567164|1409465|P3|Overall Study|Primary Reason coded as 'Other'|16
421421|NCT00567164|1409466|P2|Overall Study|Primary Reason coded as 'Other'|8
421422|NCT00567164|1409467|P1|Overall Study|Primary Reason coded as 'Other'|37
421423|NCT00567164|1409465|P3|Overall Study|Pregnancy|6
421424|NCT00567164|1409466|P2|Overall Study|Pregnancy|4
421425|NCT00567164|1409467|P1|Overall Study|Pregnancy|20
421426|NCT00567164|1409465|P3|Overall Study|Lost to Follow-up|21
421427|NCT00567164|1409466|P2|Overall Study|Lost to Follow-up|23
421428|NCT00567164|1409467|P1|Overall Study|Lost to Follow-up|202
421429|NCT00567164|1409465|P3|Overall Study|Death|1
421430|NCT00567164|1409466|P2|Overall Study|Death|0
421431|NCT00567164|1409467|P1|Overall Study|Death|0
421432|NCT00567164|1409465|P3|Overall Study|Adverse Event|9
421433|NCT00567164|1409466|P2|Overall Study|Adverse Event|13
421434|NCT00567164|1409467|P1|Overall Study|Adverse Event|92
421435|NCT00567164|1409465|P3|Overall Study|Protocol Violation|2
421436|NCT00567164|1409466|P2|Overall Study|Protocol Violation|4
421437|NCT00567164|1409467|P1|Overall Study|Protocol Violation|23
421438|NCT00567164|1409465|P3|Overall Study|Withdrawal by Subject|17
421439|NCT00567164|1409466|P2|Overall Study|Withdrawal by Subject|21
421440|NCT00567164|1409467|P1|Overall Study|Withdrawal by Subject|171
421441|NCT00567112|1409539|P3|Washout Period 3 (3 Days)|Protocol Violation|0
421442|NCT00567112|1409540|P2|Washout Period 3 (3 Days)|Protocol Violation|0
421443|NCT00567112|1409541|P1|Washout Period 3 (3 Days)|Protocol Violation|1
421444|NCT00567112|1409539|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
421445|NCT00567112|1409540|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
421446|NCT00567112|1409541|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
421447|NCT00567112|1409539|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
421448|NCT00567112|1409540|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
421449|NCT00567112|1409541|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
421450|NCT00566995|1409572|P1|Overall Study|Withdrew consent|4
421451|NCT00566995|1409572|P1|Overall Study|Physician Decision|1
421452|NCT00566995|1409572|P1|Overall Study|Toxicity|3
421453|NCT00566982|1409579|P2|Overall Study|Other-family problems & doctor's request|2
421454|NCT00566982|1409580|P1|Overall Study|Other-family problems & doctor's request|0
421455|NCT00566982|1409579|P2|Overall Study|Lost to Follow-up|1
421456|NCT00566982|1409580|P1|Overall Study|Lost to Follow-up|0
421457|NCT00566982|1409579|P2|Overall Study|Protocol Violation|4
421458|NCT00566982|1409580|P1|Overall Study|Protocol Violation|1
421459|NCT00566982|1409579|P2|Overall Study|Withdrawal by Subject|14
421460|NCT00566982|1409580|P1|Overall Study|Withdrawal by Subject|1
421461|NCT00566982|1409579|P2|Overall Study|Adverse Event|48
421462|NCT00566982|1409580|P1|Overall Study|Adverse Event|6
421463|NCT00566852|1409645|P2|Overall Study|Missing reason not reported|20
421464|NCT00566852|1409646|P1|Overall Study|Missing reason not reported|16
421465|NCT00566852|1409645|P2|Overall Study|Missing reason not specified|2
421466|NCT00566852|1409646|P1|Overall Study|Missing reason not specified|1
421467|NCT00566852|1409645|P2|Overall Study|Not tested due to disability|12
421468|NCT00566852|1409646|P1|Overall Study|Not tested due to disability|6
421469|NCT00566852|1409645|P2|Overall Study|Patient refusal|37
421470|NCT00566852|1409646|P1|Overall Study|Patient refusal|37
421471|NCT00566852|1409645|P2|Overall Study|Withdrawal by Subject|25
421472|NCT00566852|1409646|P1|Overall Study|Withdrawal by Subject|30
421473|NCT00566852|1409645|P2|Overall Study|Death|78
421474|NCT00566852|1409646|P1|Overall Study|Death|95
421475|NCT00566852|1409645|P2|Overall Study|Protocol Violation|24
421476|NCT00566852|1409646|P1|Overall Study|Protocol Violation|22
421477|NCT00566735|1409664|P2|Overall Study|Switched into a manic episode|1
421478|NCT00566735|1409665|P1|Overall Study|Switched into a manic episode|0
421479|NCT00566735|1409664|P2|Overall Study|Refused neuropsychological testing|5
421480|NCT00566735|1409665|P1|Overall Study|Refused neuropsychological testing|2
421481|NCT00566735|1409664|P2|Overall Study|Withdrawal by Subject|1
421482|NCT00566735|1409665|P1|Overall Study|Withdrawal by Subject|0
421483|NCT00566722|1409678|P3|Overall Study|Noncompliant with drug administration|1
421484|NCT00566722|1409679|P2|Overall Study|Noncompliant with drug administration|0
421485|NCT00566722|1409680|P1|Overall Study|Noncompliant with drug administration|0
421486|NCT00566722|1409678|P3|Overall Study|Serious adverse event|0
421487|NCT00566722|1409679|P2|Overall Study|Serious adverse event|1
421488|NCT00566722|1409680|P1|Overall Study|Serious adverse event|0
421489|NCT00566722|1409678|P3|Overall Study|Did not meet exclusion criteria|2
421490|NCT00566722|1409679|P2|Overall Study|Did not meet exclusion criteria|0
421491|NCT00566722|1409680|P1|Overall Study|Did not meet exclusion criteria|0
421492|NCT00566722|1409678|P3|Overall Study|Lack of Efficacy|4
421493|NCT00566722|1409679|P2|Overall Study|Lack of Efficacy|2
421494|NCT00566722|1409680|P1|Overall Study|Lack of Efficacy|1
421495|NCT00566722|1409678|P3|Overall Study|Lost to Follow-up|1
421496|NCT00566722|1409679|P2|Overall Study|Lost to Follow-up|1
421497|NCT00566722|1409680|P1|Overall Study|Lost to Follow-up|1
421498|NCT00566722|1409678|P3|Overall Study|Withdrawal by Subject|1
421499|NCT00566722|1409679|P2|Overall Study|Withdrawal by Subject|0
421500|NCT00566722|1409680|P1|Overall Study|Withdrawal by Subject|0
421501|NCT00566722|1409678|P3|Overall Study|Adverse Event|0
421502|NCT00566722|1409679|P2|Overall Study|Adverse Event|1
421503|NCT00566722|1409680|P1|Overall Study|Adverse Event|0
421504|NCT00566709|1409726|P2|Overall Study|Protocol Violation|0
421505|NCT00566709|1409727|P1|Overall Study|Protocol Violation|5
421506|NCT00566696|1409743|P1|Overall Study|Non-Patient Donors|37
421507|NCT00566696|1409743|P1|Overall Study|Physician Decision|1
421508|NCT00566696|1409743|P1|Overall Study|Health Status Change|1
421509|NCT00566696|1409743|P1|Overall Study|Muromonab not available|1
421510|NCT00566696|1409743|P1|Overall Study|Met Exclusion Criteria|2
421511|NCT00566631|1409751|P1|Part 2: Extension Phase|Other|5
421512|NCT00566631|1409751|P1|Part 2: Extension Phase|Death|1
421513|NCT00566631|1409751|P1|Part 2: Extension Phase|Lost to Follow-up|6
421514|NCT00566631|1409751|P1|Part 2: Extension Phase|Adverse Event|11
421515|NCT00566631|1409751|P1|Part 2: Extension Phase|Withdrawal by Subject|34
421516|NCT00566631|1409751|P1|Part 2: Extension Phase|Lack of Efficacy|25
421517|NCT00566631|1409751|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
421518|NCT00566631|1409751|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
421519|NCT00566631|1409751|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
421520|NCT00566631|1409751|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
421521|NCT00566631|1409751|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
421522|NCT00566631|1409751|P1|Part 1: Core Treatment Phase|Adverse Event|9
421523|NCT00566631|1409751|P1|Part 1: Core Treatment Phase|Physician Decision|1
421524|NCT00566631|1409751|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
421525|NCT00566527|1409778|P3|Overall Study|Withdrawal by Subject|43
421526|NCT00566527|1409779|P2|Overall Study|Withdrawal by Subject|43
421527|NCT00566527|1409780|P1|Overall Study|Withdrawal by Subject|6
421528|NCT00566527|1409778|P3|Overall Study|Lost to Follow-up|4
421529|NCT00566527|1409779|P2|Overall Study|Lost to Follow-up|4
421530|NCT00566527|1409780|P1|Overall Study|Lost to Follow-up|3
421531|NCT00566527|1409778|P3|Overall Study|Physician Decision|20
421532|NCT00566527|1409779|P2|Overall Study|Physician Decision|8
421533|NCT00566527|1409780|P1|Overall Study|Physician Decision|3
421534|NCT00566527|1409778|P3|Overall Study|Adverse Event|1
421535|NCT00566527|1409779|P2|Overall Study|Adverse Event|0
421536|NCT00566527|1409780|P1|Overall Study|Adverse Event|2
421537|NCT00566527|1409778|P3|Overall Study|Reason not provided|10
421538|NCT00566527|1409779|P2|Overall Study|Reason not provided|11
421539|NCT00566527|1409780|P1|Overall Study|Reason not provided|3
421540|NCT00566254|1409841|P2|Overall Study|Not Specified|2
421541|NCT00566254|1409842|P1|Overall Study|Not Specified|0
421542|NCT00566254|1409841|P2|Overall Study|Lack of Efficacy|6
421543|NCT00566254|1409842|P1|Overall Study|Lack of Efficacy|5
421544|NCT00566254|1409841|P2|Overall Study|Withdrawal by Subject|2
421545|NCT00566254|1409842|P1|Overall Study|Withdrawal by Subject|1
421546|NCT00566254|1409841|P2|Overall Study|Protocol Violation|3
421547|NCT00566254|1409842|P1|Overall Study|Protocol Violation|1
421548|NCT00566254|1409841|P2|Overall Study|Adverse Event|1
421549|NCT00566254|1409842|P1|Overall Study|Adverse Event|3
421550|NCT00566111|1409871|P2|Overall Study|Adverse Event|2
421551|NCT00566111|1409872|P1|Overall Study|Adverse Event|0
421552|NCT00566020|1409886|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
421553|NCT00566020|1409887|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
421554|NCT00566020|1409886|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
421555|NCT00566020|1409887|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
421556|NCT00566020|1409886|P2|46-week Long-term Administration Phase|Physician Decision|7
421557|NCT00566020|1409887|P1|46-week Long-term Administration Phase|Physician Decision|0
421558|NCT00566020|1409886|P2|46-week Long-term Administration Phase|Adverse Event|7
421559|NCT00566020|1409887|P1|46-week Long-term Administration Phase|Adverse Event|0
421560|NCT00566020|1409886|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
421561|NCT00566020|1409887|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
421562|NCT00566020|1409886|P2|6-week Dosage Adjustment Phase|Adverse Event|0
421563|NCT00566020|1409887|P1|6-week Dosage Adjustment Phase|Adverse Event|5
421564|NCT00565812|1409915|P3|Overall Study|Physician Decision|0
421565|NCT00565812|1409916|P2|Overall Study|Physician Decision|0
421566|NCT00565812|1409917|P1|Overall Study|Physician Decision|2
421567|NCT00565812|1409915|P3|Overall Study|Follow-up Visit Not Completed|1
421568|NCT00565812|1409916|P2|Overall Study|Follow-up Visit Not Completed|0
421569|NCT00565812|1409917|P1|Overall Study|Follow-up Visit Not Completed|2
421570|NCT00565812|1409915|P3|Overall Study|Low Compliance|1
421571|NCT00565812|1409916|P2|Overall Study|Low Compliance|0
421572|NCT00565812|1409917|P1|Overall Study|Low Compliance|1
421573|NCT00565812|1409915|P3|Overall Study|Surgical Intervention|2
421574|NCT00565812|1409916|P2|Overall Study|Surgical Intervention|1
421575|NCT00565812|1409917|P1|Overall Study|Surgical Intervention|0
421576|NCT00565812|1409915|P3|Overall Study|Research Site Closure|8
421577|NCT00565812|1409916|P2|Overall Study|Research Site Closure|1
421578|NCT00565812|1409917|P1|Overall Study|Research Site Closure|6
421579|NCT00565812|1409915|P3|Overall Study|Domestic Reasons|3
421580|NCT00565812|1409916|P2|Overall Study|Domestic Reasons|1
421581|NCT00565812|1409917|P1|Overall Study|Domestic Reasons|7
421582|NCT00565812|1409915|P3|Overall Study|Sponsor Decision|1
421583|NCT00565812|1409916|P2|Overall Study|Sponsor Decision|5
421584|NCT00565812|1409917|P1|Overall Study|Sponsor Decision|1
421585|NCT00565812|1409915|P3|Overall Study|Relocated Out of Area|9
421586|NCT00565812|1409916|P2|Overall Study|Relocated Out of Area|8
421587|NCT00565812|1409917|P1|Overall Study|Relocated Out of Area|5
421588|NCT00565812|1409915|P3|Overall Study|Jury Duty|0
421589|NCT00565812|1409916|P2|Overall Study|Jury Duty|0
421590|NCT00565812|1409917|P1|Overall Study|Jury Duty|1
421591|NCT00565812|1409915|P3|Overall Study|Adverse Event|40
421592|NCT00565812|1409916|P2|Overall Study|Adverse Event|54
421593|NCT00565812|1409917|P1|Overall Study|Adverse Event|41
421594|NCT00565812|1409915|P3|Overall Study|Protocol Violation|4
421595|NCT00565812|1409916|P2|Overall Study|Protocol Violation|6
421596|NCT00565812|1409917|P1|Overall Study|Protocol Violation|2
421597|NCT00565812|1409915|P3|Overall Study|Work Schedule|1
421598|NCT00565812|1409916|P2|Overall Study|Work Schedule|3
421599|NCT00565812|1409917|P1|Overall Study|Work Schedule|5
421600|NCT00565812|1409915|P3|Overall Study|Withdrawal by Subject|48
421601|NCT00565812|1409916|P2|Overall Study|Withdrawal by Subject|47
421602|NCT00565812|1409917|P1|Overall Study|Withdrawal by Subject|58
421603|NCT00565812|1409915|P3|Overall Study|Lost to Follow-up|8
421604|NCT00565812|1409916|P2|Overall Study|Lost to Follow-up|8
421605|NCT00565812|1409917|P1|Overall Study|Lost to Follow-up|10
421606|NCT00565812|1409915|P3|Overall Study|Did not Meet Entrance Criteria|1
421607|NCT00565812|1409916|P2|Overall Study|Did not Meet Entrance Criteria|0
421608|NCT00565812|1409917|P1|Overall Study|Did not Meet Entrance Criteria|1
421609|NCT00565812|1409915|P3|Overall Study|Death|3
421610|NCT00565812|1409916|P2|Overall Study|Death|1
421611|NCT00565812|1409917|P1|Overall Study|Death|2
421612|NCT00565747|1410056|P2|Overall Study|No embryo transfer|73
421613|NCT00565747|1410057|P1|Overall Study|No embryo transfer|67
421614|NCT00565721|1410067|P1|Overall Study|Other reasons|6
421615|NCT00565721|1410067|P1|Overall Study|Physician Decision|2
421616|NCT00565721|1410067|P1|Overall Study|Technical Problems|1
421617|NCT00565721|1410067|P1|Overall Study|Lost to Follow-up|6
421618|NCT00565721|1410067|P1|Overall Study|Screen Failure|2
421619|NCT00565617|1410107|P1|Overall Study|Withdrawal by Subject|1
421620|NCT00565604|1410111|P1|Overall Study|Lost to Follow-up|2
421621|NCT00565604|1410111|P1|Overall Study|Failure to treat|2
421622|NCT00565448|1410139|P2|Overall Study|Withdrawal by Subject|0
421623|NCT00565448|1410140|P1|Overall Study|Withdrawal by Subject|1
421624|NCT00565448|1410139|P2|Overall Study|Disease progression|0
421625|NCT00565448|1410140|P1|Overall Study|Disease progression|1
421626|NCT00565448|1410139|P2|Overall Study|Adverse Event|2
421627|NCT00565448|1410140|P1|Overall Study|Adverse Event|1
421628|NCT00565409|1410151|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
421629|NCT00565409|1410152|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
421630|NCT00565409|1410153|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
421631|NCT00565409|1410154|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
421632|NCT00565409|1410151|P4|Period 2 Double-Blind|Other|9
421633|NCT00565409|1410152|P3|Period 2 Double-Blind|Other|5
421634|NCT00565409|1410153|P2|Period 2 Double-Blind|Other|4
421635|NCT00565409|1410154|P1|Period 2 Double-Blind|Other|0
421636|NCT00565409|1410151|P4|Period 2 Double-Blind|Lost to Follow-up|0
421637|NCT00565409|1410152|P3|Period 2 Double-Blind|Lost to Follow-up|1
421638|NCT00565409|1410153|P2|Period 2 Double-Blind|Lost to Follow-up|0
421639|NCT00565409|1410154|P1|Period 2 Double-Blind|Lost to Follow-up|0
421640|NCT00565409|1410151|P4|Period 2 Double-Blind|Protocol Violation|2
421641|NCT00565409|1410152|P3|Period 2 Double-Blind|Protocol Violation|6
421642|NCT00565409|1410153|P2|Period 2 Double-Blind|Protocol Violation|4
421643|NCT00565409|1410154|P1|Period 2 Double-Blind|Protocol Violation|0
421644|NCT00565409|1410151|P4|Period 2 Double-Blind|Death|0
421645|NCT00565409|1410152|P3|Period 2 Double-Blind|Death|0
421646|NCT00565409|1410153|P2|Period 2 Double-Blind|Death|2
421647|NCT00565409|1410154|P1|Period 2 Double-Blind|Death|0
421648|NCT00565409|1410151|P4|Period 2 Double-Blind|Adverse Event|5
421649|NCT00565409|1410152|P3|Period 2 Double-Blind|Adverse Event|4
421650|NCT00565409|1410153|P2|Period 2 Double-Blind|Adverse Event|7
421651|NCT00565409|1410154|P1|Period 2 Double-Blind|Adverse Event|0
421652|NCT00565409|1410151|P4|After Period 1, Prior to Period 2|did not meet criteria|0
421653|NCT00565409|1410152|P3|After Period 1, Prior to Period 2|did not meet criteria|0
421654|NCT00565409|1410153|P2|After Period 1, Prior to Period 2|did not meet criteria|0
421655|NCT00565409|1410154|P1|After Period 1, Prior to Period 2|did not meet criteria|152
421656|NCT00565409|1410151|P4|Period 1 Open Label|no conclusion of participation record|0
421657|NCT00565409|1410152|P3|Period 1 Open Label|no conclusion of participation record|0
421658|NCT00565409|1410153|P2|Period 1 Open Label|no conclusion of participation record|0
421659|NCT00565409|1410154|P1|Period 1 Open Label|no conclusion of participation record|1
421660|NCT00565409|1410151|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
421661|NCT00565409|1410152|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
421662|NCT00565409|1410153|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
421663|NCT00565409|1410154|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
421664|NCT00565409|1410151|P4|Period 1 Open Label|Protocol Violation|0
421665|NCT00565409|1410152|P3|Period 1 Open Label|Protocol Violation|0
421666|NCT00565409|1410153|P2|Period 1 Open Label|Protocol Violation|0
421667|NCT00565409|1410154|P1|Period 1 Open Label|Protocol Violation|14
421668|NCT00565409|1410151|P4|Period 1 Open Label|Other|0
421669|NCT00565409|1410152|P3|Period 1 Open Label|Other|0
421670|NCT00565409|1410153|P2|Period 1 Open Label|Other|0
421671|NCT00565409|1410154|P1|Period 1 Open Label|Other|21
421672|NCT00565409|1410151|P4|Period 1 Open Label|Lost to Follow-up|0
421673|NCT00565409|1410152|P3|Period 1 Open Label|Lost to Follow-up|0
421674|NCT00565409|1410153|P2|Period 1 Open Label|Lost to Follow-up|0
421675|NCT00565409|1410154|P1|Period 1 Open Label|Lost to Follow-up|1
421676|NCT00565409|1410151|P4|Period 1 Open Label|Death|0
421677|NCT00565409|1410152|P3|Period 1 Open Label|Death|0
421678|NCT00565409|1410153|P2|Period 1 Open Label|Death|0
421679|NCT00565409|1410154|P1|Period 1 Open Label|Death|2
421680|NCT00565409|1410151|P4|Period 1 Open Label|Adverse Event|0
421681|NCT00565409|1410152|P3|Period 1 Open Label|Adverse Event|0
421682|NCT00565409|1410153|P2|Period 1 Open Label|Adverse Event|0
421683|NCT00565409|1410154|P1|Period 1 Open Label|Adverse Event|17
421684|NCT00565136|1410290|P1|Overall Study|Protocol Violation|1
421685|NCT00565136|1410290|P1|Overall Study|Withdrawal by Subject|1
421686|NCT00565136|1410290|P1|Overall Study|Lost to Follow-up|1
421687|NCT00565058|1410331|P2|Overall Study|Adverse Event|0
421688|NCT00565058|1410332|P1|Overall Study|Adverse Event|1
421689|NCT00564902|1410379|P3|Overall Study|Death|0
421690|NCT00564902|1410380|P2|Overall Study|Death|1
421691|NCT00564902|1410381|P1|Overall Study|Death|1
421692|NCT00564902|1410379|P3|Overall Study|Withdrawal by Subject|4
421693|NCT00564902|1410380|P2|Overall Study|Withdrawal by Subject|3
421694|NCT00564902|1410381|P1|Overall Study|Withdrawal by Subject|0
421695|NCT00564889|1410413|P1|Overall Study|Other, not specified|4
421696|NCT00564889|1410413|P1|Overall Study|Disease progression|3
421697|NCT00564889|1410413|P1|Overall Study|Alternative treatment|3
421698|NCT00564889|1410413|P1|Overall Study|Adverse Event|12
421699|NCT00564889|1410413|P1|Overall Study|Death|7
421700|NCT00564850|1410428|P1|Overall Study|Protocol Violation|2
421701|NCT00564733|1410446|P1|Overall Study|Ineligible|5
421702|NCT00564733|1410446|P1|Overall Study|Withdrawal by Subject|4
421703|NCT00564629|1410480|P2|Overall Study|Vomited within 2 hours of receiving drug|9
421704|NCT00564629|1410481|P1|Overall Study|Vomited within 2 hours of receiving drug|15
421705|NCT00564486|1410506|P4|Overall Study|Lost to Follow-up|2
421706|NCT00564486|1410507|P3|Overall Study|Lost to Follow-up|2
421707|NCT00564486|1410508|P2|Overall Study|Lost to Follow-up|0
421708|NCT00564486|1410509|P1|Overall Study|Lost to Follow-up|3
421709|NCT00564486|1410506|P4|Overall Study|Subject refused to have blood drawn|0
421710|NCT00564486|1410507|P3|Overall Study|Subject refused to have blood drawn|1
421711|NCT00564486|1410508|P2|Overall Study|Subject refused to have blood drawn|0
421712|NCT00564486|1410509|P1|Overall Study|Subject refused to have blood drawn|0
421713|NCT00564486|1410506|P4|Overall Study|Withdrawal by Subject|5
421714|NCT00564486|1410507|P3|Overall Study|Withdrawal by Subject|0
421715|NCT00564486|1410508|P2|Overall Study|Withdrawal by Subject|0
421716|NCT00564486|1410509|P1|Overall Study|Withdrawal by Subject|4
421717|NCT00564486|1410506|P4|Overall Study|Adverse Event|0
421718|NCT00564486|1410507|P3|Overall Study|Adverse Event|0
421719|NCT00564486|1410508|P2|Overall Study|Adverse Event|1
421720|NCT00564486|1410509|P1|Overall Study|Adverse Event|0
421721|NCT00564278|1410560|P2|Overall Study|Withdrawal by Subject|7
421722|NCT00564278|1410561|P1|Overall Study|Withdrawal by Subject|11
421723|NCT00564278|1410560|P2|Overall Study|Physician Decision|2
421724|NCT00564278|1410561|P1|Overall Study|Physician Decision|1
421725|NCT00564278|1410560|P2|Overall Study|Lost to Follow-up|33
421726|NCT00564278|1410561|P1|Overall Study|Lost to Follow-up|35
421727|NCT00564070|1410583|P2|Overall Study|Worsening depression, referred to care|0
421728|NCT00564070|1410584|P1|Overall Study|Worsening depression, referred to care|3
421729|NCT00564070|1410583|P2|Overall Study|Lost to Follow-up|7
421730|NCT00564070|1410584|P1|Overall Study|Lost to Follow-up|9
421731|NCT00563797|1410610|P2|Overall Study|Lost to Follow-up|2
421732|NCT00563797|1410611|P1|Overall Study|Lost to Follow-up|7
421733|NCT00563706|1410632|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
421734|NCT00563706|1410633|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
421735|NCT00563706|1410634|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
421736|NCT00563706|1410635|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
421737|NCT00563706|1410636|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
421738|NCT00563706|1410637|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
421739|NCT00563706|1410638|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
421740|NCT00563706|1410639|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
421741|NCT00563706|1410640|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
421742|NCT00563706|1410632|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
421743|NCT00563706|1410633|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
421744|NCT00563706|1410634|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
421745|NCT00563706|1410635|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
421746|NCT00563706|1410636|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
421747|NCT00563706|1410637|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
421748|NCT00563706|1410638|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
421749|NCT00563706|1410639|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
421750|NCT00563706|1410640|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
421751|NCT00563706|1410632|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
421752|NCT00563706|1410633|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
421753|NCT00563706|1410634|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
421754|NCT00563706|1410635|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
421755|NCT00563706|1410636|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
421756|NCT00563706|1410637|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
421757|NCT00563706|1410638|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
421758|NCT00563706|1410639|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
421759|NCT00563706|1410640|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
421760|NCT00563706|1410632|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
421761|NCT00563706|1410633|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
421762|NCT00563706|1410634|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
421763|NCT00563706|1410635|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
421764|NCT00563706|1410636|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
421765|NCT00563706|1410637|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
421766|NCT00563706|1410638|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
421767|NCT00563706|1410639|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
421768|NCT00563706|1410640|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
421769|NCT00563706|1410632|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
421770|NCT00563706|1410633|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
421771|NCT00563706|1410634|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
421772|NCT00563706|1410635|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
421773|NCT00563706|1410636|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
421774|NCT00563706|1410637|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
421775|NCT00563706|1410638|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
421776|NCT00563706|1410639|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
421777|NCT00563706|1410640|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
421778|NCT00563381|1410756|P2|Overall Study|Individual different reasons|34
421779|NCT00563381|1410757|P1|Overall Study|Individual different reasons|24
421780|NCT00563381|1410756|P2|Overall Study|Lack of Efficacy|24
421781|NCT00563381|1410757|P1|Overall Study|Lack of Efficacy|32
421782|NCT00563381|1410756|P2|Overall Study|Withdrawal by Subject|209
421783|NCT00563381|1410757|P1|Overall Study|Withdrawal by Subject|192
421784|NCT00563381|1410756|P2|Overall Study|Lost to Follow-up|15
421785|NCT00563381|1410757|P1|Overall Study|Lost to Follow-up|7
421786|NCT00563381|1410756|P2|Overall Study|Protocol Violation|74
421787|NCT00563381|1410757|P1|Overall Study|Protocol Violation|66
421788|NCT00563381|1410756|P2|Overall Study|Adverse Event|292
421789|NCT00563381|1410757|P1|Overall Study|Adverse Event|264
421790|NCT00563368|1410830|P7|Overall Study|not specified|0
421791|NCT00563368|1410831|P6|Overall Study|not specified|4
421792|NCT00563368|1410832|P5|Overall Study|not specified|4
421793|NCT00563368|1410833|P4|Overall Study|not specified|4
421794|NCT00563368|1410834|P3|Overall Study|not specified|3
421795|NCT00563368|1410835|P2|Overall Study|not specified|5
421796|NCT00563368|1410836|P1|Overall Study|not specified|5
421797|NCT00563368|1410830|P7|Overall Study|requirement for restricted medication|0
421798|NCT00563368|1410831|P6|Overall Study|requirement for restricted medication|0
421799|NCT00563368|1410832|P5|Overall Study|requirement for restricted medication|0
421800|NCT00563368|1410833|P4|Overall Study|requirement for restricted medication|0
421801|NCT00563368|1410834|P3|Overall Study|requirement for restricted medication|2
421802|NCT00563368|1410835|P2|Overall Study|requirement for restricted medication|0
421803|NCT00563368|1410836|P1|Overall Study|requirement for restricted medication|0
421804|NCT00563368|1410830|P7|Overall Study|Pregnancy|0
421805|NCT00563368|1410831|P6|Overall Study|Pregnancy|2
421806|NCT00563368|1410832|P5|Overall Study|Pregnancy|1
421807|NCT00563368|1410833|P4|Overall Study|Pregnancy|2
421808|NCT00563368|1410834|P3|Overall Study|Pregnancy|1
421809|NCT00563368|1410835|P2|Overall Study|Pregnancy|0
421810|NCT00563368|1410836|P1|Overall Study|Pregnancy|1
421811|NCT00563368|1410830|P7|Overall Study|protocol non-compliance|3
421812|NCT00563368|1410831|P6|Overall Study|protocol non-compliance|1
421813|NCT00563368|1410832|P5|Overall Study|protocol non-compliance|0
421814|NCT00563368|1410833|P4|Overall Study|protocol non-compliance|1
421815|NCT00563368|1410834|P3|Overall Study|protocol non-compliance|2
421816|NCT00563368|1410835|P2|Overall Study|protocol non-compliance|1
421817|NCT00563368|1410836|P1|Overall Study|protocol non-compliance|1
421818|NCT00563368|1410830|P7|Overall Study|Withdrawal by Subject|4
421819|NCT00563368|1410831|P6|Overall Study|Withdrawal by Subject|5
421820|NCT00563368|1410832|P5|Overall Study|Withdrawal by Subject|8
421821|NCT00563368|1410833|P4|Overall Study|Withdrawal by Subject|7
421822|NCT00563368|1410834|P3|Overall Study|Withdrawal by Subject|5
421823|NCT00563368|1410835|P2|Overall Study|Withdrawal by Subject|6
421824|NCT00563368|1410836|P1|Overall Study|Withdrawal by Subject|11
421825|NCT00563368|1410830|P7|Overall Study|Adverse Event|17
421826|NCT00563368|1410831|P6|Overall Study|Adverse Event|10
421827|NCT00563368|1410832|P5|Overall Study|Adverse Event|6
421828|NCT00563368|1410833|P4|Overall Study|Adverse Event|9
421829|NCT00563368|1410834|P3|Overall Study|Adverse Event|5
421830|NCT00563368|1410835|P2|Overall Study|Adverse Event|4
421831|NCT00563368|1410836|P1|Overall Study|Adverse Event|3
421832|NCT00563368|1410830|P7|Overall Study|Lost to Follow-up|9
421833|NCT00563368|1410831|P6|Overall Study|Lost to Follow-up|8
421834|NCT00563368|1410832|P5|Overall Study|Lost to Follow-up|9
421835|NCT00563368|1410833|P4|Overall Study|Lost to Follow-up|6
421836|NCT00563368|1410834|P3|Overall Study|Lost to Follow-up|12
421837|NCT00563368|1410835|P2|Overall Study|Lost to Follow-up|14
421838|NCT00563368|1410836|P1|Overall Study|Lost to Follow-up|14
421839|NCT00563316|1410859|P1|Overall Study|Other|1
421840|NCT00563316|1410859|P1|Overall Study|On-going in study as of 16 July 2009.|5
421841|NCT00563316|1410859|P1|Overall Study|Death|1
421842|NCT00563316|1410859|P1|Overall Study|Lost to Follow-up|2
421843|NCT00563316|1410859|P1|Overall Study|Physician Decision|1
421844|NCT00563316|1410859|P1|Overall Study|Adverse Event|2
421845|NCT00562965|1410884|P2|Overall Study|Other|1
421846|NCT00562965|1410885|P1|Overall Study|Other|0
421847|NCT00562965|1410884|P2|Overall Study|Lost to Follow-up|0
421848|NCT00562965|1410885|P1|Overall Study|Lost to Follow-up|1
421849|NCT00562965|1410884|P2|Overall Study|Death|4
421850|NCT00562965|1410885|P1|Overall Study|Death|2
421851|NCT00562965|1410884|P2|Overall Study|Withdrawal by Subject|1
421852|NCT00562965|1410885|P1|Overall Study|Withdrawal by Subject|0
421853|NCT00562861|1410906|P2|Overall Study|Lost to Follow-up|3
421854|NCT00562861|1410907|P1|Overall Study|Lost to Follow-up|7
421855|NCT00562861|1410906|P2|Overall Study|noncompliance, moved|2
421856|NCT00562861|1410907|P1|Overall Study|noncompliance, moved|7
421857|NCT00562861|1410906|P2|Overall Study|Lack of Efficacy|5
421858|NCT00562861|1410907|P1|Overall Study|Lack of Efficacy|5
421859|NCT00562861|1410906|P2|Overall Study|Adverse Event|1
421860|NCT00562861|1410907|P1|Overall Study|Adverse Event|1
421861|NCT00562627|1410916|P3|Overall Study|Protocol Violation|1
421862|NCT00562627|1410917|P2|Overall Study|Protocol Violation|1
421863|NCT00562627|1410918|P1|Overall Study|Protocol Violation|1
421864|NCT00562588|1410934|P2|Overall Study|Other|2
421865|NCT00562588|1410935|P1|Overall Study|Other|0
421866|NCT00562588|1410934|P2|Overall Study|Withdrawal by Subject|9
421867|NCT00562588|1410935|P1|Overall Study|Withdrawal by Subject|10
421868|NCT00562588|1410934|P2|Overall Study|Lost to Follow-up|4
421869|NCT00562588|1410935|P1|Overall Study|Lost to Follow-up|12
421870|NCT00562588|1410934|P2|Overall Study|Protocol Violation|26
421871|NCT00562588|1410935|P1|Overall Study|Protocol Violation|30
421872|NCT00562588|1410934|P2|Overall Study|Adverse Event|58
421873|NCT00562588|1410935|P1|Overall Study|Adverse Event|40
421874|NCT00562484|1410965|P2|Overall Study|Reason not provided or not specified|12
421875|NCT00562484|1410966|P1|Overall Study|Reason not provided or not specified|25
421876|NCT00562484|1410965|P2|Overall Study|Lost to Follow-up|71
421877|NCT00562484|1410966|P1|Overall Study|Lost to Follow-up|132
421878|NCT00562484|1410965|P2|Overall Study|Moved away from the study area|9
421879|NCT00562484|1410966|P1|Overall Study|Moved away from the study area|20
421880|NCT00562484|1410965|P2|Overall Study|Withdrawal by Subject|9
421881|NCT00562484|1410966|P1|Overall Study|Withdrawal by Subject|12
421882|NCT00562484|1410965|P2|Overall Study|Protocol Violation|2
421883|NCT00562484|1410966|P1|Overall Study|Protocol Violation|11
421884|NCT00562484|1410965|P2|Overall Study|Adverse Event|1
421885|NCT00562484|1410966|P1|Overall Study|Adverse Event|6
421886|NCT00562354|1410998|P2|Overall Study|Lost to Follow-up|1
421887|NCT00562354|1410999|P1|Overall Study|Lost to Follow-up|0
421888|NCT00562354|1410998|P2|Overall Study|Physician Decision|1
421889|NCT00562354|1410999|P1|Overall Study|Physician Decision|0
421890|NCT00562302|1411061|P2|Overall Study|Not stated|4
421891|NCT00562302|1411062|P1|Overall Study|Not stated|1
421892|NCT00562302|1411061|P2|Overall Study|Lung resection prior to study completion|7
421893|NCT00562302|1411062|P1|Overall Study|Lung resection prior to study completion|7
421894|NCT00562302|1411061|P2|Overall Study|Death|2
421895|NCT00562302|1411062|P1|Overall Study|Death|1
421896|NCT00562302|1411061|P2|Overall Study|Withdrawal by Subject|8
421897|NCT00562302|1411062|P1|Overall Study|Withdrawal by Subject|7
421898|NCT00562302|1411061|P2|Overall Study|Non-compliance|2
421899|NCT00562302|1411062|P1|Overall Study|Non-compliance|1
421900|NCT00562302|1411061|P2|Overall Study|Adverse Event|6
421901|NCT00562302|1411062|P1|Overall Study|Adverse Event|0
421902|NCT00562302|1411061|P2|Overall Study|Lost to Follow-up|3
421903|NCT00562302|1411062|P1|Overall Study|Lost to Follow-up|3
421904|NCT00562159|1411084|P2|Overall Study|Did not meet protocol eligibility|1
421905|NCT00562159|1411085|P1|Overall Study|Did not meet protocol eligibility|1
421906|NCT00562159|1411084|P2|Overall Study|Protocol Violation|12
421907|NCT00562159|1411085|P1|Overall Study|Protocol Violation|12
421908|NCT00562159|1411084|P2|Overall Study|Withdrawal by Subject|8
421909|NCT00562159|1411085|P1|Overall Study|Withdrawal by Subject|9
421910|NCT00562159|1411084|P2|Overall Study|Lost to Follow-up|4
421911|NCT00562159|1411085|P1|Overall Study|Lost to Follow-up|5
421912|NCT00562159|1411084|P2|Overall Study|Adverse Event|8
421913|NCT00562159|1411085|P1|Overall Study|Adverse Event|11
421914|NCT00562120|1411097|P4|First Intervention Period|Randomized but not Treated|0
421915|NCT00562120|1411098|P3|First Intervention Period|Randomized but not Treated|0
421916|NCT00562120|1411099|P2|First Intervention Period|Randomized but not Treated|0
421917|NCT00562120|1411100|P1|First Intervention Period|Randomized but not Treated|1
421918|NCT00562120|1411097|P4|First Intervention Period|Adverse Event|0
421919|NCT00562120|1411098|P3|First Intervention Period|Adverse Event|0
421920|NCT00562120|1411099|P2|First Intervention Period|Adverse Event|0
421921|NCT00562120|1411100|P1|First Intervention Period|Adverse Event|1
421922|NCT00562094|1411132|P1|Overall Study|Lost to Follow-up|62
421923|NCT00561977|1411147|P3|Overall Study|Pregnancy|1
421924|NCT00561977|1411148|P2|Overall Study|Pregnancy|1
421925|NCT00561977|1411149|P1|Overall Study|Pregnancy|0
421926|NCT00561977|1411147|P3|Overall Study|Withdrawal by Subject|1
421927|NCT00561977|1411148|P2|Overall Study|Withdrawal by Subject|2
421928|NCT00561977|1411149|P1|Overall Study|Withdrawal by Subject|0
421929|NCT00561951|1411175|P3|Overall Study|Adverse Event Occured Before Treatment|1
421930|NCT00561951|1411176|P2|Overall Study|Adverse Event Occured Before Treatment|2
421931|NCT00561951|1411177|P1|Overall Study|Adverse Event Occured Before Treatment|1
421932|NCT00561951|1411175|P3|Overall Study|Meet Withdrawal Criterion|1
421933|NCT00561951|1411176|P2|Overall Study|Meet Withdrawal Criterion|1
421934|NCT00561951|1411177|P1|Overall Study|Meet Withdrawal Criterion|0
421935|NCT00561951|1411175|P3|Overall Study|Pregnancy|0
421936|NCT00561951|1411176|P2|Overall Study|Pregnancy|1
421937|NCT00561951|1411177|P1|Overall Study|Pregnancy|0
421938|NCT00561951|1411175|P3|Overall Study|Physician Decision|0
421939|NCT00561951|1411176|P2|Overall Study|Physician Decision|0
421940|NCT00561951|1411177|P1|Overall Study|Physician Decision|1
421941|NCT00561951|1411175|P3|Overall Study|Protocol Violation|4
421942|NCT00561951|1411176|P2|Overall Study|Protocol Violation|3
421943|NCT00561951|1411177|P1|Overall Study|Protocol Violation|4
421944|NCT00561951|1411175|P3|Overall Study|Withdrawal by Subject|10
421945|NCT00561951|1411176|P2|Overall Study|Withdrawal by Subject|9
421946|NCT00561951|1411177|P1|Overall Study|Withdrawal by Subject|10
421947|NCT00561951|1411175|P3|Overall Study|Lost to Follow-up|0
421948|NCT00561951|1411176|P2|Overall Study|Lost to Follow-up|1
421949|NCT00561951|1411177|P1|Overall Study|Lost to Follow-up|1
421950|NCT00561951|1411175|P3|Overall Study|Lack of Efficacy|2
421951|NCT00561951|1411176|P2|Overall Study|Lack of Efficacy|3
421952|NCT00561951|1411177|P1|Overall Study|Lack of Efficacy|5
421953|NCT00561951|1411175|P3|Overall Study|Adverse Event|14
421954|NCT00561951|1411176|P2|Overall Study|Adverse Event|14
421955|NCT00561951|1411177|P1|Overall Study|Adverse Event|11
421956|NCT00561925|1411233|P5|Open-Label Extension Period|Declined entry into extension period|50
421957|NCT00561925|1411234|P4|Open-Label Extension Period|Declined entry into extension period|43
421958|NCT00561925|1411235|P3|Open-Label Extension Period|Declined entry into extension period|0
421959|NCT00561925|1411236|P2|Open-Label Extension Period|Declined entry into extension period|0
421960|NCT00561925|1411237|P1|Open-Label Extension Period|Declined entry into extension period|0
421961|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Other|0
421962|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Other|0
421963|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Other|11
421964|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Other|8
421965|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Other|0
421966|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
421967|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
421968|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
421969|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
421970|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
421971|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Death|0
421972|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Death|0
421973|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Death|3
421974|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Death|6
421975|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Death|0
421976|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Pregnancy|0
421977|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Pregnancy|0
421978|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Pregnancy|9
421979|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Pregnancy|1
421980|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Pregnancy|0
421981|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
421982|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
421983|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
421984|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
421985|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
421986|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
421987|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
421988|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
421989|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
421990|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
421991|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
421992|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
421993|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
421994|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
421995|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
421996|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
421997|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
421998|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
421999|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
422000|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
422001|NCT00561925|1411233|P5|144-week Double-blind, Double-dummy|Adverse Event|0
422002|NCT00561925|1411234|P4|144-week Double-blind, Double-dummy|Adverse Event|0
422003|NCT00561925|1411235|P3|144-week Double-blind, Double-dummy|Adverse Event|43
422004|NCT00561925|1411236|P2|144-week Double-blind, Double-dummy|Adverse Event|48
422005|NCT00561925|1411237|P1|144-week Double-blind, Double-dummy|Adverse Event|0
422006|NCT00561925|1411233|P5|14 Day Lead-In Period|Other|0
422007|NCT00561925|1411234|P4|14 Day Lead-In Period|Other|0
422008|NCT00561925|1411235|P3|14 Day Lead-In Period|Other|0
422009|NCT00561925|1411236|P2|14 Day Lead-In Period|Other|0
422010|NCT00561925|1411237|P1|14 Day Lead-In Period|Other|5
422011|NCT00561925|1411233|P5|14 Day Lead-In Period|Withdrawal by Subject|0
422012|NCT00561925|1411234|P4|14 Day Lead-In Period|Withdrawal by Subject|0
422013|NCT00561925|1411235|P3|14 Day Lead-In Period|Withdrawal by Subject|0
422014|NCT00561925|1411236|P2|14 Day Lead-In Period|Withdrawal by Subject|0
422015|NCT00561925|1411237|P1|14 Day Lead-In Period|Withdrawal by Subject|4
422016|NCT00561925|1411233|P5|14 Day Lead-In Period|Lost to Follow-up|0
422017|NCT00561925|1411234|P4|14 Day Lead-In Period|Lost to Follow-up|0
422018|NCT00561925|1411235|P3|14 Day Lead-In Period|Lost to Follow-up|0
422019|NCT00561925|1411236|P2|14 Day Lead-In Period|Lost to Follow-up|0
422020|NCT00561925|1411237|P1|14 Day Lead-In Period|Lost to Follow-up|4
422021|NCT00561925|1411233|P5|14 Day Lead-In Period|In/Exclusion criteria|0
422022|NCT00561925|1411234|P4|14 Day Lead-In Period|In/Exclusion criteria|0
422023|NCT00561925|1411235|P3|14 Day Lead-In Period|In/Exclusion criteria|0
422024|NCT00561925|1411236|P2|14 Day Lead-In Period|In/Exclusion criteria|0
422025|NCT00561925|1411237|P1|14 Day Lead-In Period|In/Exclusion criteria|4
422026|NCT00561925|1411233|P5|14 Day Lead-In Period|Adverse Event|0
422027|NCT00561925|1411234|P4|14 Day Lead-In Period|Adverse Event|0
422028|NCT00561925|1411235|P3|14 Day Lead-In Period|Adverse Event|0
422029|NCT00561925|1411236|P2|14 Day Lead-In Period|Adverse Event|0
422030|NCT00561925|1411237|P1|14 Day Lead-In Period|Adverse Event|38
422031|NCT00561912|1411286|P1|Overall Study|ineligible|1
422032|NCT00561821|1411298|P4|Overall Study|Adverse Event|1
422033|NCT00561821|1411299|P3|Overall Study|Adverse Event|1
422034|NCT00561821|1411300|P2|Overall Study|Adverse Event|3
422035|NCT00561821|1411301|P1|Overall Study|Adverse Event|2
422036|NCT00561821|1411298|P4|Overall Study|Other (reason not specified)|0
422037|NCT00561821|1411299|P3|Overall Study|Other (reason not specified)|0
422038|NCT00561821|1411300|P2|Overall Study|Other (reason not specified)|1
422039|NCT00561821|1411301|P1|Overall Study|Other (reason not specified)|1
422040|NCT00561821|1411298|P4|Overall Study|Reasons not related to trial|0
422041|NCT00561821|1411299|P3|Overall Study|Reasons not related to trial|0
422042|NCT00561821|1411300|P2|Overall Study|Reasons not related to trial|1
422043|NCT00561821|1411301|P1|Overall Study|Reasons not related to trial|2
422044|NCT00561821|1411298|P4|Overall Study|Withdrawal by Subject|2
422045|NCT00561821|1411299|P3|Overall Study|Withdrawal by Subject|0
422046|NCT00561821|1411300|P2|Overall Study|Withdrawal by Subject|1
422047|NCT00561821|1411301|P1|Overall Study|Withdrawal by Subject|0
422048|NCT00561821|1411298|P4|Overall Study|Not treated|0
422049|NCT00561821|1411299|P3|Overall Study|Not treated|1
422050|NCT00561821|1411300|P2|Overall Study|Not treated|0
422051|NCT00561821|1411301|P1|Overall Study|Not treated|0
422052|NCT00561795|1411377|P4|Overall Study|Physician Decision|0
422053|NCT00561795|1411378|P3|Overall Study|Physician Decision|0
422054|NCT00561795|1411379|P2|Overall Study|Physician Decision|0
422055|NCT00561795|1411380|P1|Overall Study|Physician Decision|1
422056|NCT00561795|1411377|P4|Overall Study|Study Closed/Terminated|0
422057|NCT00561795|1411378|P3|Overall Study|Study Closed/Terminated|0
422058|NCT00561795|1411379|P2|Overall Study|Study Closed/Terminated|3
422059|NCT00561795|1411380|P1|Overall Study|Study Closed/Terminated|0
422060|NCT00561795|1411377|P4|Overall Study|Adverse Event|0
422061|NCT00561795|1411378|P3|Overall Study|Adverse Event|0
422062|NCT00561795|1411379|P2|Overall Study|Adverse Event|3
422063|NCT00561795|1411380|P1|Overall Study|Adverse Event|3
422064|NCT00561730|1411400|P1|Overall Study|Not specified reasons|1
422065|NCT00561730|1411400|P1|Overall Study|Lost to Follow-up|5
422066|NCT00561730|1411400|P1|Overall Study|Handling of the drug|1
422067|NCT00561730|1411400|P1|Overall Study|Adverse Event|2
422068|NCT00561678|1411416|P2|Overall Study|anesthesia provider refusal|0
422069|NCT00561678|1411417|P1|Overall Study|anesthesia provider refusal|1
422070|NCT00561678|1411416|P2|Overall Study|surgery rescheduled to different site|2
422071|NCT00561678|1411417|P1|Overall Study|surgery rescheduled to different site|2
422072|NCT00561678|1411416|P2|Overall Study|surgery cancelled|1
422073|NCT00561678|1411417|P1|Overall Study|surgery cancelled|1
422074|NCT00561678|1411416|P2|Overall Study|Withdrawal by Subject|3
422075|NCT00561678|1411417|P1|Overall Study|Withdrawal by Subject|4
422076|NCT00561652|1411435|P2|Overall Study|Withdrawal by Subject|1
422077|NCT00561652|1411436|P1|Overall Study|Withdrawal by Subject|0
422078|NCT00561574|1411519|P2|Overall Study|Other|7
422079|NCT00561574|1411520|P1|Overall Study|Other|5
422080|NCT00561574|1411519|P2|Overall Study|Lost to Follow-up|0
422081|NCT00561574|1411520|P1|Overall Study|Lost to Follow-up|1
422082|NCT00561574|1411519|P2|Overall Study|Reason Unrelated to Trial|2
422083|NCT00561574|1411520|P1|Overall Study|Reason Unrelated to Trial|6
422084|NCT00561574|1411519|P2|Overall Study|Withdrawal by Subject|4
422085|NCT00561574|1411520|P1|Overall Study|Withdrawal by Subject|4
422086|NCT00561574|1411519|P2|Overall Study|Lack of Efficacy|21
422087|NCT00561574|1411520|P1|Overall Study|Lack of Efficacy|11
422088|NCT00561574|1411519|P2|Overall Study|Adverse Event|24
422089|NCT00561574|1411520|P1|Overall Study|Adverse Event|21
422090|NCT00561470|1411546|P2|Overall Study|Ongoing Treatment|14
422091|NCT00561470|1411547|P1|Overall Study|Ongoing Treatment|11
422092|NCT00561470|1411546|P2|Overall Study|Planning surgery|1
422093|NCT00561470|1411547|P1|Overall Study|Planning surgery|1
422094|NCT00561470|1411546|P2|Overall Study|Missed visit window|4
422095|NCT00561470|1411547|P1|Overall Study|Missed visit window|1
422096|NCT00561470|1411546|P2|Overall Study|Randomized but not treated|5
422097|NCT00561470|1411547|P1|Overall Study|Randomized but not treated|5
422098|NCT00561470|1411546|P2|Overall Study|Unauthorized procedure|1
422099|NCT00561470|1411547|P1|Overall Study|Unauthorized procedure|3
422100|NCT00561470|1411546|P2|Overall Study|Metastatic surgery|12
422101|NCT00561470|1411547|P1|Overall Study|Metastatic surgery|10
422102|NCT00561470|1411546|P2|Overall Study|Subject request|77
422103|NCT00561470|1411547|P1|Overall Study|Subject request|43
422104|NCT00561470|1411546|P2|Overall Study|Consent Withdrawn|6
422105|NCT00561470|1411547|P1|Overall Study|Consent Withdrawn|2
422106|NCT00561470|1411546|P2|Overall Study|Physician Decision|20
422107|NCT00561470|1411547|P1|Overall Study|Physician Decision|21
422108|NCT00561470|1411546|P2|Overall Study|Lost to Follow-up|0
422109|NCT00561470|1411547|P1|Overall Study|Lost to Follow-up|2
422110|NCT00561470|1411546|P2|Overall Study|poor compliance to protocol|4
422111|NCT00561470|1411547|P1|Overall Study|poor compliance to protocol|4
422112|NCT00561470|1411546|P2|Overall Study|Disease progression|305
422113|NCT00561470|1411547|P1|Overall Study|Disease progression|437
422114|NCT00561470|1411546|P2|Overall Study|Adverse Event|163
422115|NCT00561470|1411547|P1|Overall Study|Adverse Event|74
422116|NCT00561392|1411583|P1|Overall Study|Administrative problems|4
422117|NCT00561392|1411583|P1|Overall Study|Withdrawal by Subject|8
422118|NCT00561392|1411583|P1|Overall Study|Protocol Violation|1
422119|NCT00561392|1411583|P1|Overall Study|Lack of Efficacy|2
422120|NCT00561392|1411583|P1|Overall Study|Adverse Event|38
422121|NCT00561353|1411605|P10|Overall Study|Withdrawal by Subject|0
422122|NCT00561353|1411606|P9|Overall Study|Withdrawal by Subject|0
422123|NCT00561353|1411607|P8|Overall Study|Withdrawal by Subject|0
422124|NCT00561353|1411608|P7|Overall Study|Withdrawal by Subject|0
422125|NCT00561353|1411609|P6|Overall Study|Withdrawal by Subject|0
422126|NCT00561353|1411610|P5|Overall Study|Withdrawal by Subject|0
422127|NCT00561353|1411611|P4|Overall Study|Withdrawal by Subject|0
422128|NCT00561353|1411612|P3|Overall Study|Withdrawal by Subject|0
422129|NCT00561353|1411613|P2|Overall Study|Withdrawal by Subject|2
422130|NCT00561353|1411614|P1|Overall Study|Withdrawal by Subject|0
422131|NCT00561353|1411605|P10|Overall Study|Lost to Follow-up|0
422132|NCT00561353|1411606|P9|Overall Study|Lost to Follow-up|0
422133|NCT00561353|1411607|P8|Overall Study|Lost to Follow-up|0
422134|NCT00561353|1411608|P7|Overall Study|Lost to Follow-up|0
422135|NCT00561353|1411609|P6|Overall Study|Lost to Follow-up|0
422136|NCT00561353|1411610|P5|Overall Study|Lost to Follow-up|0
422137|NCT00561353|1411611|P4|Overall Study|Lost to Follow-up|0
422138|NCT00561353|1411612|P3|Overall Study|Lost to Follow-up|1
422139|NCT00561353|1411613|P2|Overall Study|Lost to Follow-up|0
422140|NCT00561353|1411614|P1|Overall Study|Lost to Follow-up|2
422141|NCT00561353|1411605|P10|Overall Study|Adverse Event|1
422142|NCT00561353|1411606|P9|Overall Study|Adverse Event|0
422143|NCT00561353|1411607|P8|Overall Study|Adverse Event|0
422144|NCT00561353|1411608|P7|Overall Study|Adverse Event|1
422145|NCT00561353|1411609|P6|Overall Study|Adverse Event|0
422146|NCT00561353|1411610|P5|Overall Study|Adverse Event|0
422147|NCT00561353|1411611|P4|Overall Study|Adverse Event|2
422148|NCT00561353|1411612|P3|Overall Study|Adverse Event|0
422149|NCT00561353|1411613|P2|Overall Study|Adverse Event|0
422150|NCT00561353|1411614|P1|Overall Study|Adverse Event|0
422151|NCT00561353|1411605|P10|Overall Study|Not specified|0
422152|NCT00561353|1411606|P9|Overall Study|Not specified|0
422153|NCT00561353|1411607|P8|Overall Study|Not specified|0
422154|NCT00561353|1411608|P7|Overall Study|Not specified|0
422155|NCT00561353|1411609|P6|Overall Study|Not specified|2
422156|NCT00561353|1411610|P5|Overall Study|Not specified|0
422157|NCT00561353|1411611|P4|Overall Study|Not specified|0
422158|NCT00561353|1411612|P3|Overall Study|Not specified|1
422159|NCT00561353|1411613|P2|Overall Study|Not specified|0
422160|NCT00561353|1411614|P1|Overall Study|Not specified|1
422161|NCT00561353|1411605|P10|Overall Study|Subject ineligible to continue the trial|1
422162|NCT00561353|1411606|P9|Overall Study|Subject ineligible to continue the trial|2
422163|NCT00561353|1411607|P8|Overall Study|Subject ineligible to continue the trial|0
422164|NCT00561353|1411608|P7|Overall Study|Subject ineligible to continue the trial|1
422165|NCT00561353|1411609|P6|Overall Study|Subject ineligible to continue the trial|1
422166|NCT00561353|1411610|P5|Overall Study|Subject ineligible to continue the trial|0
422167|NCT00561353|1411611|P4|Overall Study|Subject ineligible to continue the trial|0
422168|NCT00561353|1411612|P3|Overall Study|Subject ineligible to continue the trial|0
422169|NCT00561353|1411613|P2|Overall Study|Subject ineligible to continue the trial|0
422170|NCT00561353|1411614|P1|Overall Study|Subject ineligible to continue the trial|0
422171|NCT00561353|1411605|P10|Overall Study|Subject reached a virologic endpoint|0
422172|NCT00561353|1411606|P9|Overall Study|Subject reached a virologic endpoint|5
422173|NCT00561353|1411607|P8|Overall Study|Subject reached a virologic endpoint|4
422174|NCT00561353|1411608|P7|Overall Study|Subject reached a virologic endpoint|4
422175|NCT00561353|1411609|P6|Overall Study|Subject reached a virologic endpoint|3
422176|NCT00561353|1411610|P5|Overall Study|Subject reached a virologic endpoint|1
422177|NCT00561353|1411611|P4|Overall Study|Subject reached a virologic endpoint|4
422178|NCT00561353|1411612|P3|Overall Study|Subject reached a virologic endpoint|1
422179|NCT00561353|1411613|P2|Overall Study|Subject reached a virologic endpoint|1
422180|NCT00561353|1411614|P1|Overall Study|Subject reached a virologic endpoint|2
422181|NCT00561340|1411769|P2|Overall Study|refused to drink pediasure|0
422182|NCT00561340|1411770|P1|Overall Study|refused to drink pediasure|6
422183|NCT00561080|1411790|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
422184|NCT00561080|1411791|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
422185|NCT00561080|1411792|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
422186|NCT00561080|1411790|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
422187|NCT00561080|1411791|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
422188|NCT00561080|1411792|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
422189|NCT00561080|1411790|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
422190|NCT00561080|1411791|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
422191|NCT00561080|1411792|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
422192|NCT00561080|1411790|P3|12-month Post Last Dose Follow-up|Adverse Event|1
422193|NCT00561080|1411791|P2|12-month Post Last Dose Follow-up|Adverse Event|3
422194|NCT00561080|1411792|P1|12-month Post Last Dose Follow-up|Adverse Event|3
422195|NCT00561080|1411790|P3|Vaccination Period (up to Month 4)|Other|1
422196|NCT00561080|1411791|P2|Vaccination Period (up to Month 4)|Other|2
422197|NCT00561080|1411792|P1|Vaccination Period (up to Month 4)|Other|0
422198|NCT00561080|1411790|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
422199|NCT00561080|1411791|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
422200|NCT00561080|1411792|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
422201|NCT00561080|1411790|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
422202|NCT00561080|1411791|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
422203|NCT00561080|1411792|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
422204|NCT00561080|1411790|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
422205|NCT00561080|1411791|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
422206|NCT00561080|1411792|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
422207|NCT00561080|1411790|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
422208|NCT00561080|1411791|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
422209|NCT00561080|1411792|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
422210|NCT00561080|1411790|P3|Vaccination Period (up to Month 4)|Adverse Event|6
422211|NCT00561080|1411791|P2|Vaccination Period (up to Month 4)|Adverse Event|4
422212|NCT00561080|1411792|P1|Vaccination Period (up to Month 4)|Adverse Event|0
422213|NCT00561015|1411869|P6|Overall Study|Participant non-compliance|0
422214|NCT00561015|1411870|P5|Overall Study|Participant non-compliance|0
422215|NCT00561015|1411871|P4|Overall Study|Participant non-compliance|0
422216|NCT00561015|1411872|P3|Overall Study|Participant non-compliance|0
422217|NCT00561015|1411873|P2|Overall Study|Participant non-compliance|0
422218|NCT00561015|1411874|P1|Overall Study|Participant non-compliance|2
422219|NCT00561015|1411869|P6|Overall Study|Lost to Follow-up|3
422220|NCT00561015|1411870|P5|Overall Study|Lost to Follow-up|0
422221|NCT00561015|1411871|P4|Overall Study|Lost to Follow-up|1
422222|NCT00561015|1411872|P3|Overall Study|Lost to Follow-up|0
422223|NCT00561015|1411873|P2|Overall Study|Lost to Follow-up|0
422224|NCT00561015|1411874|P1|Overall Study|Lost to Follow-up|2
422225|NCT00561015|1411869|P6|Overall Study|Adverse Event|0
422226|NCT00561015|1411870|P5|Overall Study|Adverse Event|1
422227|NCT00561015|1411871|P4|Overall Study|Adverse Event|0
422228|NCT00561015|1411872|P3|Overall Study|Adverse Event|0
422229|NCT00561015|1411873|P2|Overall Study|Adverse Event|0
422230|NCT00561015|1411874|P1|Overall Study|Adverse Event|0
422231|NCT00560950|1411965|P2|Overall Study|Lost to Follow-up|0
422232|NCT00560950|1411966|P1|Overall Study|Lost to Follow-up|1
422233|NCT00560937|1412004|P2|Overall Study|Physician Decision|1
422234|NCT00560937|1412005|P1|Overall Study|Physician Decision|1
422235|NCT00560937|1412004|P2|Overall Study|Withdrawal by Subject|1
422236|NCT00560937|1412005|P1|Overall Study|Withdrawal by Subject|0
422237|NCT00560885|1412021|P1|Overall Study|Withdrawal by Subject|1
422238|NCT00560885|1412021|P1|Overall Study|Death|7
422239|NCT00560833|1412046|P5|Overall Study|Never received drug|1
422240|NCT00560833|1412047|P4|Overall Study|Never received drug|0
422241|NCT00560833|1412048|P3|Overall Study|Never received drug|0
422242|NCT00560833|1412049|P2|Overall Study|Never received drug|1
422243|NCT00560833|1412050|P1|Overall Study|Never received drug|0
422244|NCT00560833|1412046|P5|Overall Study|Other|0
422245|NCT00560833|1412047|P4|Overall Study|Other|0
422246|NCT00560833|1412048|P3|Overall Study|Other|3
422247|NCT00560833|1412049|P2|Overall Study|Other|1
422248|NCT00560833|1412050|P1|Overall Study|Other|1
422249|NCT00560833|1412046|P5|Overall Study|Participant uncooperative|2
422250|NCT00560833|1412047|P4|Overall Study|Participant uncooperative|4
422251|NCT00560833|1412048|P3|Overall Study|Participant uncooperative|4
422252|NCT00560833|1412049|P2|Overall Study|Participant uncooperative|5
422253|NCT00560833|1412050|P1|Overall Study|Participant uncooperative|5
422254|NCT00560833|1412046|P5|Overall Study|Lack of Efficacy|4
422255|NCT00560833|1412047|P4|Overall Study|Lack of Efficacy|4
422256|NCT00560833|1412048|P3|Overall Study|Lack of Efficacy|6
422257|NCT00560833|1412049|P2|Overall Study|Lack of Efficacy|9
422258|NCT00560833|1412050|P1|Overall Study|Lack of Efficacy|22
422259|NCT00560833|1412046|P5|Overall Study|Lost to Follow-up|0
422260|NCT00560833|1412047|P4|Overall Study|Lost to Follow-up|0
422261|NCT00560833|1412048|P3|Overall Study|Lost to Follow-up|1
422262|NCT00560833|1412049|P2|Overall Study|Lost to Follow-up|0
422263|NCT00560833|1412050|P1|Overall Study|Lost to Follow-up|0
422264|NCT00560833|1412046|P5|Overall Study|Adverse Event|35
422265|NCT00560833|1412047|P4|Overall Study|Adverse Event|23
422266|NCT00560833|1412048|P3|Overall Study|Adverse Event|25
422267|NCT00560833|1412049|P2|Overall Study|Adverse Event|10
422268|NCT00560833|1412050|P1|Overall Study|Adverse Event|16
422269|NCT00560794|1412082|P1|Overall Study|Received Bone Marrow Transplant|6
422270|NCT00560794|1412082|P1|Overall Study|Hematological Relapse|1
422271|NCT00560794|1412082|P1|Overall Study|Minimal Residual Disease Relapse|1
422272|NCT00560794|1412082|P1|Overall Study|Patient was not Compliant|1
422273|NCT00560794|1412082|P1|Overall Study|Adverse Event|2
422274|NCT00560755|1412099|P1|Overall Study|Physician Decision|2
422275|NCT00560755|1412099|P1|Overall Study|Adverse Event|8
422276|NCT00560755|1412099|P1|Overall Study|Lost to Follow-up|9
422277|NCT00560755|1412099|P1|Overall Study|Withdrawal by Subject|26
422278|NCT00560755|1412099|P1|Overall Study|Protocol Violation|15
422279|NCT00560703|1412120|P2|Overall Study|non-compliance|1
422280|NCT00560703|1412121|P1|Overall Study|non-compliance|0
422281|NCT00560703|1412120|P2|Overall Study|Withdrawal by Subject|1
422282|NCT00560703|1412121|P1|Overall Study|Withdrawal by Subject|0
422283|NCT00560703|1412120|P2|Overall Study|Protocol Violation|2
422284|NCT00560703|1412121|P1|Overall Study|Protocol Violation|0
422285|NCT00560703|1412120|P2|Overall Study|Adverse Event|2
422286|NCT00560703|1412121|P1|Overall Study|Adverse Event|0
422287|NCT00560573|1412138|P6|Overall Study|Enrolled, not treated|0
422288|NCT00560573|1412139|P5|Overall Study|Enrolled, not treated|1
422289|NCT00560573|1412140|P4|Overall Study|Enrolled, not treated|0
422290|NCT00560573|1412141|P3|Overall Study|Enrolled, not treated|0
422291|NCT00560573|1412142|P2|Overall Study|Enrolled, not treated|0
422292|NCT00560573|1412143|P1|Overall Study|Enrolled, not treated|0
422293|NCT00560573|1412138|P6|Overall Study|Other|3
422294|NCT00560573|1412139|P5|Overall Study|Other|3
422295|NCT00560573|1412140|P4|Overall Study|Other|3
422296|NCT00560573|1412141|P3|Overall Study|Other|2
422297|NCT00560573|1412142|P2|Overall Study|Other|2
422298|NCT00560573|1412143|P1|Overall Study|Other|2
422299|NCT00560573|1412138|P6|Overall Study|Withdrawal by Subject|0
422300|NCT00560573|1412139|P5|Overall Study|Withdrawal by Subject|1
422301|NCT00560573|1412140|P4|Overall Study|Withdrawal by Subject|1
422302|NCT00560573|1412141|P3|Overall Study|Withdrawal by Subject|0
422303|NCT00560573|1412142|P2|Overall Study|Withdrawal by Subject|0
422304|NCT00560573|1412143|P1|Overall Study|Withdrawal by Subject|0
422305|NCT00560573|1412138|P6|Overall Study|Lost to Follow-up|0
422306|NCT00560573|1412139|P5|Overall Study|Lost to Follow-up|1
422307|NCT00560573|1412140|P4|Overall Study|Lost to Follow-up|1
422308|NCT00560573|1412141|P3|Overall Study|Lost to Follow-up|0
422309|NCT00560573|1412142|P2|Overall Study|Lost to Follow-up|0
422310|NCT00560573|1412143|P1|Overall Study|Lost to Follow-up|0
422311|NCT00560573|1412138|P6|Overall Study|Death|10
422312|NCT00560573|1412139|P5|Overall Study|Death|1
422313|NCT00560573|1412140|P4|Overall Study|Death|5
422314|NCT00560573|1412141|P3|Overall Study|Death|4
422315|NCT00560573|1412142|P2|Overall Study|Death|1
422316|NCT00560573|1412143|P1|Overall Study|Death|4
422317|NCT00560508|1412220|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
422318|NCT00560508|1412221|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
422319|NCT00560508|1412220|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
422320|NCT00560508|1412221|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
422321|NCT00560508|1412220|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
422322|NCT00560508|1412221|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
422323|NCT00560508|1412220|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
422324|NCT00560508|1412221|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
422325|NCT00560508|1412220|P2|12 Week Double-blind Period|Withdrawal by Subject|1
422326|NCT00560508|1412221|P1|12 Week Double-blind Period|Withdrawal by Subject|1
422327|NCT00560508|1412220|P2|12 Week Double-blind Period|Protocol Violation|0
422328|NCT00560508|1412221|P1|12 Week Double-blind Period|Protocol Violation|1
422329|NCT00560508|1412220|P2|12 Week Double-blind Period|Adverse Event|2
422330|NCT00560508|1412221|P1|12 Week Double-blind Period|Adverse Event|3
422331|NCT00560417|1412280|P2|Overall Study|Withdrawal by Subject|3
422332|NCT00560417|1412281|P1|Overall Study|Withdrawal by Subject|3
422333|NCT00560417|1412280|P2|Overall Study|Sponsor Decision|0
422334|NCT00560417|1412281|P1|Overall Study|Sponsor Decision|2
422335|NCT00560417|1412280|P2|Overall Study|Protocol Violation|5
422336|NCT00560417|1412281|P1|Overall Study|Protocol Violation|6
422337|NCT00560417|1412280|P2|Overall Study|Physician Decision|6
422338|NCT00560417|1412281|P1|Overall Study|Physician Decision|2
422339|NCT00560417|1412280|P2|Overall Study|Lost to Follow-up|1
422340|NCT00560417|1412281|P1|Overall Study|Lost to Follow-up|0
422341|NCT00560417|1412280|P2|Overall Study|Entry Criteria Not Met|0
422342|NCT00560417|1412281|P1|Overall Study|Entry Criteria Not Met|1
422343|NCT00560417|1412280|P2|Overall Study|Adverse Event|2
422344|NCT00560417|1412281|P1|Overall Study|Adverse Event|3
422345|NCT00560404|1412309|P2|Overall Study|Other withdrawal reason|5
422346|NCT00560404|1412310|P1|Overall Study|Other withdrawal reason|13
422347|NCT00560404|1412309|P2|Overall Study|Failure to return|2
422348|NCT00560404|1412310|P1|Overall Study|Failure to return|1
422349|NCT00560404|1412309|P2|Overall Study|Withdrew Consent|0
422350|NCT00560404|1412310|P1|Overall Study|Withdrew Consent|4
422351|NCT00560404|1412309|P2|Overall Study|Administrative Reasons|1
422352|NCT00560404|1412310|P1|Overall Study|Administrative Reasons|1
422353|NCT00560404|1412309|P2|Overall Study|Protocol Violation|7
422354|NCT00560404|1412310|P1|Overall Study|Protocol Violation|12
422355|NCT00560404|1412309|P2|Overall Study|Death|3
422356|NCT00560404|1412310|P1|Overall Study|Death|3
422357|NCT00560404|1412309|P2|Overall Study|Adverse Event|3
422358|NCT00560404|1412310|P1|Overall Study|Adverse Event|2
422359|NCT00560391|1412357|P5|Overall Study|Still on treatment|2
422360|NCT00560391|1412358|P4|Overall Study|Still on treatment|1
422361|NCT00560391|1412359|P3|Overall Study|Still on treatment|0
422362|NCT00560391|1412360|P2|Overall Study|Still on treatment|0
422363|NCT00560391|1412361|P1|Overall Study|Still on treatment|0
422364|NCT00560352|1412417|P3|Overall Study|Maximum clinical benefit|0
422365|NCT00560352|1412418|P2|Overall Study|Maximum clinical benefit|0
422366|NCT00560352|1412419|P1|Overall Study|Maximum clinical benefit|1
422367|NCT00560352|1412417|P3|Overall Study|Withdrawal by Subject|1
422368|NCT00560352|1412418|P2|Overall Study|Withdrawal by Subject|1
422369|NCT00560352|1412419|P1|Overall Study|Withdrawal by Subject|1
422370|NCT00560352|1412417|P3|Overall Study|Disease progression|1
422371|NCT00560352|1412418|P2|Overall Study|Disease progression|1
422372|NCT00560352|1412419|P1|Overall Study|Disease progression|0
422373|NCT00560352|1412417|P3|Overall Study|Study drug toxicity|1
422374|NCT00560352|1412418|P2|Overall Study|Study drug toxicity|0
422375|NCT00560352|1412419|P1|Overall Study|Study drug toxicity|3
422376|NCT00560352|1412417|P3|Overall Study|Adverse event unrelated to study drug|1
422377|NCT00560352|1412418|P2|Overall Study|Adverse event unrelated to study drug|1
422378|NCT00560352|1412419|P1|Overall Study|Adverse event unrelated to study drug|2
422379|NCT00560313|1412436|P1|Overall Study|Protocol Violation|1
422380|NCT00560313|1412436|P1|Overall Study|Lost to Follow-up|1
422381|NCT00560313|1412436|P1|Overall Study|Withdrawal by Subject|2
422382|NCT00560313|1412436|P1|Overall Study|Adverse Events or Death|2
422383|NCT00560235|1412463|P3|Phase 2|Ongoing at Date of Cut-Off|1
422384|NCT00560235|1412464|P2|Phase 2|Ongoing at Date of Cut-Off|0
422385|NCT00560235|1412465|P1|Phase 2|Ongoing at Date of Cut-Off|0
422386|NCT00560235|1412463|P3|Phase 2|Discontinued|96
422387|NCT00560235|1412464|P2|Phase 2|Discontinued|0
422388|NCT00560235|1412465|P1|Phase 2|Discontinued|0
422389|NCT00560235|1412463|P3|Phase 1B|Discontinued|0
422390|NCT00560235|1412464|P2|Phase 1B|Discontinued|19
422391|NCT00560235|1412465|P1|Phase 1B|Discontinued|0
422392|NCT00560235|1412463|P3|Phase 1|Discontinued|0
422393|NCT00560235|1412464|P2|Phase 1|Discontinued|0
422394|NCT00560235|1412465|P1|Phase 1|Discontinued|8
422395|NCT00560105|1412496|P2|Overall Study|musculoskeletal chest discomfort with us|2
422396|NCT00560105|1412497|P1|Overall Study|musculoskeletal chest discomfort with us|1
422397|NCT00560066|1412511|P2|Overall Study|Missing primary reason|2
422398|NCT00560066|1412512|P1|Overall Study|Missing primary reason|0
422399|NCT00560066|1412511|P2|Overall Study|Administrative reason|5
422400|NCT00560066|1412512|P1|Overall Study|Administrative reason|0
422401|NCT00560066|1412511|P2|Overall Study|Protocol Violation|1
422402|NCT00560066|1412512|P1|Overall Study|Protocol Violation|0
422403|NCT00560066|1412511|P2|Overall Study|Lost to Follow-up|10
422404|NCT00560066|1412512|P1|Overall Study|Lost to Follow-up|4
422405|NCT00560066|1412511|P2|Overall Study|Withdrawal by Subject|3
422406|NCT00560066|1412512|P1|Overall Study|Withdrawal by Subject|0
422407|NCT00560066|1412511|P2|Overall Study|Death|1
422408|NCT00560066|1412512|P1|Overall Study|Death|2
422409|NCT00559988|1412544|P2|Overall Study|ICD device explanted|17
422410|NCT00559988|1412545|P1|Overall Study|ICD device explanted|10
422411|NCT00559988|1412544|P2|Overall Study|Lost to Follow-up|56
422412|NCT00559988|1412545|P1|Overall Study|Lost to Follow-up|42
422413|NCT00559988|1412544|P2|Overall Study|Withdrawal by Subject|139
422414|NCT00559988|1412545|P1|Overall Study|Withdrawal by Subject|152
422415|NCT00559988|1412544|P2|Overall Study|Death|140
422416|NCT00559988|1412545|P1|Overall Study|Death|147
422417|NCT00559962|1412575|P8|Overall Study|Inclusion/exclusion criteria not met|0
422418|NCT00559962|1412576|P7|Overall Study|Inclusion/exclusion criteria not met|1
422419|NCT00559962|1412577|P6|Overall Study|Inclusion/exclusion criteria not met|0
422420|NCT00559962|1412578|P5|Overall Study|Inclusion/exclusion criteria not met|0
422421|NCT00559962|1412579|P4|Overall Study|Inclusion/exclusion criteria not met|0
422422|NCT00559962|1412580|P3|Overall Study|Inclusion/exclusion criteria not met|0
422423|NCT00559962|1412581|P2|Overall Study|Inclusion/exclusion criteria not met|0
422424|NCT00559962|1412582|P1|Overall Study|Inclusion/exclusion criteria not met|0
422425|NCT00559962|1412575|P8|Overall Study|Withdrawal by Subject|2
422426|NCT00559962|1412576|P7|Overall Study|Withdrawal by Subject|0
422427|NCT00559962|1412577|P6|Overall Study|Withdrawal by Subject|1
422428|NCT00559962|1412578|P5|Overall Study|Withdrawal by Subject|3
422429|NCT00559962|1412579|P4|Overall Study|Withdrawal by Subject|0
422430|NCT00559962|1412580|P3|Overall Study|Withdrawal by Subject|2
422431|NCT00559962|1412581|P2|Overall Study|Withdrawal by Subject|1
422432|NCT00559962|1412582|P1|Overall Study|Withdrawal by Subject|1
422433|NCT00559962|1412575|P8|Overall Study|Lost to Follow-up|0
422434|NCT00559962|1412576|P7|Overall Study|Lost to Follow-up|0
422435|NCT00559962|1412577|P6|Overall Study|Lost to Follow-up|0
422436|NCT00559962|1412578|P5|Overall Study|Lost to Follow-up|0
422437|NCT00559962|1412579|P4|Overall Study|Lost to Follow-up|0
422438|NCT00559962|1412580|P3|Overall Study|Lost to Follow-up|0
422439|NCT00559962|1412581|P2|Overall Study|Lost to Follow-up|1
422440|NCT00559962|1412582|P1|Overall Study|Lost to Follow-up|0
422441|NCT00559962|1412575|P8|Overall Study|Adverse Event|2
422442|NCT00559962|1412576|P7|Overall Study|Adverse Event|4
422443|NCT00559962|1412577|P6|Overall Study|Adverse Event|4
422444|NCT00559962|1412578|P5|Overall Study|Adverse Event|11
422445|NCT00559962|1412579|P4|Overall Study|Adverse Event|5
422446|NCT00559962|1412580|P3|Overall Study|Adverse Event|8
422447|NCT00559962|1412581|P2|Overall Study|Adverse Event|7
422448|NCT00559962|1412582|P1|Overall Study|Adverse Event|1
422449|NCT00559949|1412602|P1|Overall Study|No disease evaluation per protocol|1
422450|NCT00559949|1412602|P1|Overall Study|Withdrawal by Subject|4
422451|NCT00559949|1412602|P1|Overall Study|Adverse Event|1
422452|NCT00559949|1412602|P1|Overall Study|Progressive Disease during cycle 1|1
422453|NCT00559845|1412618|P1|Overall Study|Premature Surgery-Investigator Decision|1
422454|NCT00559845|1412618|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
422455|NCT00559845|1412618|P1|Overall Study|Adverse Event|3
422456|NCT00559845|1412618|P1|Overall Study|Disease Progression|1
422457|NCT00559845|1412618|P1|Overall Study|Withdrew Consent|1
422458|NCT00559754|1412627|P1|Overall Study|Withdrawal by Subject|2
422459|NCT00559754|1412627|P1|Overall Study|Investigator criteria|2
422460|NCT00559754|1412627|P1|Overall Study|Protocol Violation|1
422461|NCT00559754|1412627|P1|Overall Study|Adverse Event|5
422462|NCT00559754|1412627|P1|Overall Study|Disease progression|1
422463|NCT00559637|1412651|P1|Overall Study|Inclusion or exclusion criteria violated|2
422464|NCT00559637|1412651|P1|Overall Study|Change of home|1
422465|NCT00559637|1412651|P1|Overall Study|Change of center|1
422466|NCT00559637|1412651|P1|Overall Study|Delayed administration of C.E.R.A|1
422467|NCT00559637|1412651|P1|Overall Study|Participation in another study|1
422468|NCT00559637|1412651|P1|Overall Study|Suspected lung cancer|1
422469|NCT00559637|1412651|P1|Overall Study|Started requiring dialysis after month 7|2
422470|NCT00559637|1412651|P1|Overall Study|Insufficient response|3
422471|NCT00559637|1412651|P1|Overall Study|Failure to return|6
422472|NCT00559637|1412651|P1|Overall Study|Withdrawal criteria fulfilled|4
422473|NCT00559637|1412651|P1|Overall Study|Protocol Violation|6
422474|NCT00559637|1412651|P1|Overall Study|Withdrawal by Subject|4
422475|NCT00559637|1412651|P1|Overall Study|Adverse Event|22
422476|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
422477|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
422478|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|non-specified|0
422479|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|non-specified|71
422480|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
422481|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
422482|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
422483|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
422484|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
422485|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
422486|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Death|0
422487|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Death|20
422488|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
422489|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
422490|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
422491|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
422492|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
422493|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
422494|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
422495|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
422496|NCT00559585|1412664|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
422497|NCT00559585|1412665|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
422498|NCT00559585|1412664|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
422499|NCT00559585|1412665|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
422500|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
422501|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
422502|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Investigator Decision|1
422503|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Investigator Decision|0
422504|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
422505|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
422506|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
422507|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
422508|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Early Discontinuation|1
422509|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Early Discontinuation|0
422510|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
422511|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
422512|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
422513|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
422514|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Missed Doses|1
422515|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Missed Doses|0
422516|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
422517|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
422518|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
422519|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
422520|NCT00559585|1412664|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
422521|NCT00559585|1412665|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
422522|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Death|1
422523|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Death|1
422524|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
422525|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
422526|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
422527|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
422528|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
422529|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
422530|NCT00559585|1412664|P2|Double Blind ST Period Main Study|Adverse Event|25
422531|NCT00559585|1412665|P1|Double Blind ST Period Main Study|Adverse Event|17
422532|NCT00559507|1412725|P1|Overall Study|Not treated, patient ineligible|3
422533|NCT00559377|1412731|P1|Overall Study|Withdrawal by Subject|9
422534|NCT00559364|1412741|P2|Overall Study|Inclusion/exclusion criteria failure|0
422535|NCT00559364|1412742|P1|Overall Study|Inclusion/exclusion criteria failure|1
422536|NCT00559273|1412754|P2|Evaluation Period (8 Weeks)|Physician Decision|1
422537|NCT00559273|1412755|P1|Evaluation Period (8 Weeks)|Physician Decision|0
422538|NCT00559273|1412754|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
422539|NCT00559273|1412755|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
422540|NCT00559273|1412754|P2|Evaluation Period (8 Weeks)|Adverse Event|1
422541|NCT00559273|1412755|P1|Evaluation Period (8 Weeks)|Adverse Event|0
422542|NCT00559273|1412754|P2|Evaluation Period (8 Weeks)|Death|3
422543|NCT00559273|1412755|P1|Evaluation Period (8 Weeks)|Death|1
422544|NCT00559273|1412754|P2|Correction Period (20 Weeks)|Did not received study treatment|0
422545|NCT00559273|1412755|P1|Correction Period (20 Weeks)|Did not received study treatment|2
422546|NCT00559273|1412754|P2|Correction Period (20 Weeks)|Participant treated by another center|1
422547|NCT00559273|1412755|P1|Correction Period (20 Weeks)|Participant treated by another center|0
422548|NCT00559273|1412754|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
422549|NCT00559273|1412755|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
422550|NCT00559273|1412754|P2|Correction Period (20 Weeks)|Adverse Event|1
422551|NCT00559273|1412755|P1|Correction Period (20 Weeks)|Adverse Event|2
422552|NCT00559273|1412754|P2|Correction Period (20 Weeks)|Death|4
422553|NCT00559273|1412755|P1|Correction Period (20 Weeks)|Death|3
422554|NCT00559104|1412777|P2|Overall Study|Lack of Efficacy|0
422555|NCT00559104|1412778|P1|Overall Study|Lack of Efficacy|9
422556|NCT00558896|1412799|P7|Overall Study|Continues on treatment|6
422557|NCT00558896|1412800|P6|Overall Study|Continues on treatment|25
422558|NCT00558896|1412801|P5|Overall Study|Continues on treatment|9
422559|NCT00558896|1412802|P4|Overall Study|Continues on treatment|1
422560|NCT00558896|1412803|P3|Overall Study|Continues on treatment|0
422561|NCT00558896|1412804|P2|Overall Study|Continues on treatment|1
422562|NCT00558896|1412805|P1|Overall Study|Continues on treatment|10
422563|NCT00558896|1412799|P7|Overall Study|Physician discretion|3
422564|NCT00558896|1412800|P6|Overall Study|Physician discretion|3
422565|NCT00558896|1412801|P5|Overall Study|Physician discretion|1
422566|NCT00558896|1412802|P4|Overall Study|Physician discretion|2
422567|NCT00558896|1412803|P3|Overall Study|Physician discretion|1
422568|NCT00558896|1412804|P2|Overall Study|Physician discretion|2
422569|NCT00558896|1412805|P1|Overall Study|Physician discretion|3
422570|NCT00558896|1412799|P7|Overall Study|Alternative Treatment|1
422571|NCT00558896|1412800|P6|Overall Study|Alternative Treatment|7
422572|NCT00558896|1412801|P5|Overall Study|Alternative Treatment|6
422573|NCT00558896|1412802|P4|Overall Study|Alternative Treatment|2
422574|NCT00558896|1412803|P3|Overall Study|Alternative Treatment|0
422575|NCT00558896|1412804|P2|Overall Study|Alternative Treatment|2
422576|NCT00558896|1412805|P1|Overall Study|Alternative Treatment|2
422577|NCT00558896|1412799|P7|Overall Study|Withdrawal by Subject|5
422578|NCT00558896|1412800|P6|Overall Study|Withdrawal by Subject|5
422579|NCT00558896|1412801|P5|Overall Study|Withdrawal by Subject|1
422580|NCT00558896|1412802|P4|Overall Study|Withdrawal by Subject|1
422581|NCT00558896|1412803|P3|Overall Study|Withdrawal by Subject|1
422582|NCT00558896|1412804|P2|Overall Study|Withdrawal by Subject|1
422583|NCT00558896|1412805|P1|Overall Study|Withdrawal by Subject|2
422584|NCT00558896|1412799|P7|Overall Study|Death|6
422585|NCT00558896|1412800|P6|Overall Study|Death|2
422586|NCT00558896|1412801|P5|Overall Study|Death|2
422587|NCT00558896|1412802|P4|Overall Study|Death|3
422588|NCT00558896|1412803|P3|Overall Study|Death|2
422589|NCT00558896|1412804|P2|Overall Study|Death|0
422590|NCT00558896|1412805|P1|Overall Study|Death|3
422591|NCT00558896|1412799|P7|Overall Study|Adverse Event|3
422592|NCT00558896|1412800|P6|Overall Study|Adverse Event|10
422593|NCT00558896|1412801|P5|Overall Study|Adverse Event|4
422594|NCT00558896|1412802|P4|Overall Study|Adverse Event|3
422595|NCT00558896|1412803|P3|Overall Study|Adverse Event|1
422596|NCT00558896|1412804|P2|Overall Study|Adverse Event|1
422597|NCT00558896|1412805|P1|Overall Study|Adverse Event|1
422598|NCT00558831|1412846|P1|Overall Study|Lost to Follow-up|1
422599|NCT00558753|1412903|P2|Overall Study|Lost to Follow-up|7
422600|NCT00558753|1412904|P1|Overall Study|Lost to Follow-up|5
422601|NCT00558701|1412916|P2|Overall Study|Protocol Deviations|4
422602|NCT00558701|1412917|P1|Overall Study|Protocol Deviations|1
422603|NCT00558636|1412925|P2|Follow-up|Premature termination of the study|7
422604|NCT00558636|1412926|P1|Follow-up|Premature termination of the study|12
422605|NCT00558636|1412925|P2|Treatment|Disease progression|5
422606|NCT00558636|1412926|P1|Treatment|Disease progression|1
422607|NCT00558636|1412925|P2|Treatment|Premature termination of the study|37
422608|NCT00558636|1412926|P1|Treatment|Premature termination of the study|35
422609|NCT00558636|1412925|P2|Treatment|Withdrawal by Subject|0
422610|NCT00558636|1412926|P1|Treatment|Withdrawal by Subject|2
422611|NCT00558636|1412925|P2|Treatment|Adverse Event|2
422612|NCT00558636|1412926|P1|Treatment|Adverse Event|9
422613|NCT00558558|1413026|P1|Overall Study|Lack of Efficacy|4
422614|NCT00558558|1413026|P1|Overall Study|Withdrawal by Subject|1
422615|NCT00558558|1413026|P1|Overall Study|Unable to swallow|1
422616|NCT00558467|1413032|P2|Overall Study|Patient moving out of state|1
422617|NCT00558467|1413033|P1|Overall Study|Patient moving out of state|0
422618|NCT00558467|1413032|P2|Overall Study|Lack of Efficacy|1
422619|NCT00558467|1413033|P1|Overall Study|Lack of Efficacy|0
422620|NCT00558467|1413032|P2|Overall Study|Adverse Event|2
422621|NCT00558467|1413033|P1|Overall Study|Adverse Event|1
422622|NCT00558428|1413093|P4|Overall Study|Other|1
422623|NCT00558428|1413094|P3|Overall Study|Other|0
422624|NCT00558428|1413095|P2|Overall Study|Other|0
422625|NCT00558428|1413096|P1|Overall Study|Other|3
422626|NCT00558428|1413093|P4|Overall Study|Consent withdrawn|1
422627|NCT00558428|1413094|P3|Overall Study|Consent withdrawn|0
422628|NCT00558428|1413095|P2|Overall Study|Consent withdrawn|1
422629|NCT00558428|1413096|P1|Overall Study|Consent withdrawn|2
422630|NCT00558428|1413093|P4|Overall Study|Non compliant with protocol|3
422631|NCT00558428|1413094|P3|Overall Study|Non compliant with protocol|0
422632|NCT00558428|1413095|P2|Overall Study|Non compliant with protocol|0
422633|NCT00558428|1413096|P1|Overall Study|Non compliant with protocol|1
422634|NCT00558428|1413093|P4|Overall Study|Lack of Efficacy|2
422635|NCT00558428|1413094|P3|Overall Study|Lack of Efficacy|1
422636|NCT00558428|1413095|P2|Overall Study|Lack of Efficacy|0
422637|NCT00558428|1413096|P1|Overall Study|Lack of Efficacy|0
422638|NCT00558428|1413093|P4|Overall Study|Lost to Follow-up|0
422639|NCT00558428|1413094|P3|Overall Study|Lost to Follow-up|0
422640|NCT00558428|1413095|P2|Overall Study|Lost to Follow-up|1
422641|NCT00558428|1413096|P1|Overall Study|Lost to Follow-up|0
422642|NCT00558428|1413093|P4|Overall Study|Adverse Event|4
422643|NCT00558428|1413094|P3|Overall Study|Adverse Event|3
422644|NCT00558428|1413095|P2|Overall Study|Adverse Event|22
422645|NCT00558428|1413096|P1|Overall Study|Adverse Event|6
422646|NCT00558363|1413136|P2|Overall Study|Hospitalized; Unable to Continue|1
422647|NCT00558363|1413137|P1|Overall Study|Hospitalized; Unable to Continue|0
422648|NCT00558363|1413136|P2|Overall Study|Randomized in Error|2
422649|NCT00558363|1413137|P1|Overall Study|Randomized in Error|1
422650|NCT00558363|1413136|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
422651|NCT00558363|1413137|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
422652|NCT00558363|1413136|P2|Overall Study|Lost to Follow-up|1
422653|NCT00558363|1413137|P1|Overall Study|Lost to Follow-up|0
422654|NCT00558363|1413136|P2|Overall Study|Protocol Violation|1
422655|NCT00558363|1413137|P1|Overall Study|Protocol Violation|2
422656|NCT00558363|1413136|P2|Overall Study|Lack of Efficacy|2
422657|NCT00558363|1413137|P1|Overall Study|Lack of Efficacy|2
422658|NCT00558363|1413136|P2|Overall Study|Adverse Event|5
422659|NCT00558363|1413137|P1|Overall Study|Adverse Event|5
422660|NCT00558363|1413136|P2|Overall Study|Withdrawal by Subject|4
422661|NCT00558363|1413137|P1|Overall Study|Withdrawal by Subject|11
422662|NCT00558363|1413136|P2|Overall Study|Physician Decision|4
422663|NCT00558363|1413137|P1|Overall Study|Physician Decision|18
422664|NCT00558285|1413192|P5|Overall Study|Protocol deviation|0
422665|NCT00558285|1413193|P4|Overall Study|Protocol deviation|1
422666|NCT00558285|1413194|P3|Overall Study|Protocol deviation|0
422667|NCT00558285|1413195|P2|Overall Study|Protocol deviation|1
422668|NCT00558285|1413196|P1|Overall Study|Protocol deviation|1
422669|NCT00558285|1413192|P5|Overall Study|Administrative problems|1
422670|NCT00558285|1413193|P4|Overall Study|Administrative problems|1
422671|NCT00558285|1413194|P3|Overall Study|Administrative problems|0
422672|NCT00558285|1413195|P2|Overall Study|Administrative problems|0
422673|NCT00558285|1413196|P1|Overall Study|Administrative problems|0
422674|NCT00558285|1413192|P5|Overall Study|Lost to Follow-up|0
422675|NCT00558285|1413193|P4|Overall Study|Lost to Follow-up|0
422676|NCT00558285|1413194|P3|Overall Study|Lost to Follow-up|0
422677|NCT00558285|1413195|P2|Overall Study|Lost to Follow-up|1
422678|NCT00558285|1413196|P1|Overall Study|Lost to Follow-up|1
422679|NCT00558285|1413192|P5|Overall Study|Subject withdrew consent|1
422680|NCT00558285|1413193|P4|Overall Study|Subject withdrew consent|1
422681|NCT00558285|1413194|P3|Overall Study|Subject withdrew consent|1
422682|NCT00558285|1413195|P2|Overall Study|Subject withdrew consent|0
422683|NCT00558285|1413196|P1|Overall Study|Subject withdrew consent|2
422684|NCT00558285|1413192|P5|Overall Study|Abnormal test procedure result(s)|0
422685|NCT00558285|1413193|P4|Overall Study|Abnormal test procedure result(s)|0
422686|NCT00558285|1413194|P3|Overall Study|Abnormal test procedure result(s)|0
422687|NCT00558285|1413195|P2|Overall Study|Abnormal test procedure result(s)|0
422688|NCT00558285|1413196|P1|Overall Study|Abnormal test procedure result(s)|1
422689|NCT00558285|1413192|P5|Overall Study|Adverse Event|2
422690|NCT00558285|1413193|P4|Overall Study|Adverse Event|1
422691|NCT00558285|1413194|P3|Overall Study|Adverse Event|4
422692|NCT00558285|1413195|P2|Overall Study|Adverse Event|1
422693|NCT00558285|1413196|P1|Overall Study|Adverse Event|1
422694|NCT00558272|1413240|P2|Overall Study|Withdrawal by Subject|1
422695|NCT00558272|1413241|P1|Overall Study|Withdrawal by Subject|0
422696|NCT00558272|1413240|P2|Overall Study|Incorrectly enrolled|0
422697|NCT00558272|1413241|P1|Overall Study|Incorrectly enrolled|1
422698|NCT00558272|1413240|P2|Overall Study|AZ study team decision|1
422699|NCT00558272|1413241|P1|Overall Study|AZ study team decision|0
422700|NCT00558272|1413240|P2|Overall Study|Dev. of study specific discon. criteria|0
422701|NCT00558272|1413241|P1|Overall Study|Dev. of study specific discon. criteria|1
422702|NCT00558272|1413240|P2|Overall Study|Death|0
422703|NCT00558272|1413241|P1|Overall Study|Death|1
422704|NCT00558272|1413240|P2|Overall Study|Adverse Event|0
422705|NCT00558272|1413241|P1|Overall Study|Adverse Event|10
422706|NCT00558259|1413281|P2|Overall Study|Withdrawal by Subject|13
422707|NCT00558259|1413282|P1|Overall Study|Withdrawal by Subject|12
422708|NCT00558259|1413281|P2|Overall Study|Protocol Violation|5
422709|NCT00558259|1413282|P1|Overall Study|Protocol Violation|9
422710|NCT00558259|1413281|P2|Overall Study|Adverse Event|81
422711|NCT00558259|1413282|P1|Overall Study|Adverse Event|50
422712|NCT00558103|1413322|P6|Monotherapy Extension Phase|Disease Progression|8
422713|NCT00558103|1413323|P5|Monotherapy Extension Phase|Disease Progression|0
422714|NCT00558103|1413324|P4|Monotherapy Extension Phase|Disease Progression|0
422715|NCT00558103|1413325|P3|Monotherapy Extension Phase|Disease Progression|0
422716|NCT00558103|1413326|P2|Monotherapy Extension Phase|Disease Progression|0
422717|NCT00558103|1413327|P1|Monotherapy Extension Phase|Disease Progression|0
422718|NCT00558103|1413322|P6|Monotherapy Extension Phase|Protocol Violation|1
422719|NCT00558103|1413323|P5|Monotherapy Extension Phase|Protocol Violation|0
422720|NCT00558103|1413324|P4|Monotherapy Extension Phase|Protocol Violation|0
422721|NCT00558103|1413325|P3|Monotherapy Extension Phase|Protocol Violation|0
422722|NCT00558103|1413326|P2|Monotherapy Extension Phase|Protocol Violation|0
422723|NCT00558103|1413327|P1|Monotherapy Extension Phase|Protocol Violation|0
422724|NCT00558103|1413322|P6|Randomized Treatment Phase|Adverse Event|0
422725|NCT00558103|1413323|P5|Randomized Treatment Phase|Adverse Event|1
422726|NCT00558103|1413324|P4|Randomized Treatment Phase|Adverse Event|1
422727|NCT00558103|1413325|P3|Randomized Treatment Phase|Adverse Event|0
422728|NCT00558103|1413326|P2|Randomized Treatment Phase|Adverse Event|0
422729|NCT00558103|1413327|P1|Randomized Treatment Phase|Adverse Event|0
422730|NCT00558103|1413322|P6|Randomized Treatment Phase|Disease Progression|0
422731|NCT00558103|1413323|P5|Randomized Treatment Phase|Disease Progression|0
422732|NCT00558103|1413324|P4|Randomized Treatment Phase|Disease Progression|0
422733|NCT00558103|1413325|P3|Randomized Treatment Phase|Disease Progression|1
422734|NCT00558103|1413326|P2|Randomized Treatment Phase|Disease Progression|0
422735|NCT00558103|1413327|P1|Randomized Treatment Phase|Disease Progression|1
422736|NCT00558103|1413322|P6|Randomized Treatment Phase|Withdrawal by Subject|0
422737|NCT00558103|1413323|P5|Randomized Treatment Phase|Withdrawal by Subject|1
422738|NCT00558103|1413324|P4|Randomized Treatment Phase|Withdrawal by Subject|0
422739|NCT00558103|1413325|P3|Randomized Treatment Phase|Withdrawal by Subject|0
422740|NCT00558103|1413326|P2|Randomized Treatment Phase|Withdrawal by Subject|2
422741|NCT00558103|1413327|P1|Randomized Treatment Phase|Withdrawal by Subject|2
422742|NCT00558103|1413322|P6|Randomized Treatment Phase|Lost to Follow-up|0
422743|NCT00558103|1413323|P5|Randomized Treatment Phase|Lost to Follow-up|3
422744|NCT00558103|1413324|P4|Randomized Treatment Phase|Lost to Follow-up|1
422745|NCT00558103|1413325|P3|Randomized Treatment Phase|Lost to Follow-up|2
422746|NCT00558103|1413326|P2|Randomized Treatment Phase|Lost to Follow-up|2
422747|NCT00558103|1413327|P1|Randomized Treatment Phase|Lost to Follow-up|2
422748|NCT00558064|1413357|P2|Overall Study|No visit within allowance period|0
422749|NCT00558064|1413358|P1|Overall Study|No visit within allowance period|1
422750|NCT00558064|1413357|P2|Overall Study|Withdrawal by Subject|1
422751|NCT00558064|1413358|P1|Overall Study|Withdrawal by Subject|0
422752|NCT00558064|1413357|P2|Overall Study|Lost to Follow-up|1
422753|NCT00558064|1413358|P1|Overall Study|Lost to Follow-up|0
422754|NCT00558064|1413357|P2|Overall Study|Protocol Violation|0
422755|NCT00558064|1413358|P1|Overall Study|Protocol Violation|1
422756|NCT00558064|1413357|P2|Overall Study|Lack of Efficacy|1
422757|NCT00558064|1413358|P1|Overall Study|Lack of Efficacy|0
422758|NCT00558064|1413357|P2|Overall Study|Adverse Event|2
422759|NCT00558064|1413358|P1|Overall Study|Adverse Event|3
422760|NCT00558025|1413380|P2|Overall Study|Protocol Violation|0
422761|NCT00558025|1413381|P1|Overall Study|Protocol Violation|1
422762|NCT00558025|1413380|P2|Overall Study|Withdrawal by Subject|2
422763|NCT00558025|1413381|P1|Overall Study|Withdrawal by Subject|2
422764|NCT00558025|1413380|P2|Overall Study|Adverse Event|1
422765|NCT00558025|1413381|P1|Overall Study|Adverse Event|1
422766|NCT00557856|1413428|P9|Part 2: Exploratory Phase|global deterioration of health status|1
422767|NCT00557856|1413429|P8|Part 2: Exploratory Phase|global deterioration of health status|0
422768|NCT00557856|1413430|P7|Part 2: Exploratory Phase|global deterioration of health status|0
422769|NCT00557856|1413431|P6|Part 2: Exploratory Phase|global deterioration of health status|0
422770|NCT00557856|1413432|P5|Part 2: Exploratory Phase|global deterioration of health status|0
422771|NCT00557856|1413433|P4|Part 2: Exploratory Phase|global deterioration of health status|0
422772|NCT00557856|1413434|P3|Part 2: Exploratory Phase|global deterioration of health status|0
422773|NCT00557856|1413435|P2|Part 2: Exploratory Phase|global deterioration of health status|0
422774|NCT00557856|1413436|P1|Part 2: Exploratory Phase|global deterioration of health status|0
422775|NCT00557856|1413428|P9|Part 2: Exploratory Phase|Death|2
422776|NCT00557856|1413429|P8|Part 2: Exploratory Phase|Death|0
422777|NCT00557856|1413430|P7|Part 2: Exploratory Phase|Death|0
422778|NCT00557856|1413431|P6|Part 2: Exploratory Phase|Death|0
422779|NCT00557856|1413432|P5|Part 2: Exploratory Phase|Death|0
422780|NCT00557856|1413433|P4|Part 2: Exploratory Phase|Death|0
422781|NCT00557856|1413434|P3|Part 2: Exploratory Phase|Death|0
422782|NCT00557856|1413435|P2|Part 2: Exploratory Phase|Death|0
422783|NCT00557856|1413436|P1|Part 2: Exploratory Phase|Death|0
422784|NCT00557856|1413428|P9|Part 2: Exploratory Phase|Other|1
422785|NCT00557856|1413429|P8|Part 2: Exploratory Phase|Other|0
422786|NCT00557856|1413430|P7|Part 2: Exploratory Phase|Other|0
422787|NCT00557856|1413431|P6|Part 2: Exploratory Phase|Other|0
422788|NCT00557856|1413432|P5|Part 2: Exploratory Phase|Other|0
422789|NCT00557856|1413433|P4|Part 2: Exploratory Phase|Other|0
422790|NCT00557856|1413434|P3|Part 2: Exploratory Phase|Other|0
422791|NCT00557856|1413435|P2|Part 2: Exploratory Phase|Other|0
422792|NCT00557856|1413436|P1|Part 2: Exploratory Phase|Other|0
422793|NCT00557856|1413428|P9|Part 2: Exploratory Phase|Adverse Event|4
422794|NCT00557856|1413429|P8|Part 2: Exploratory Phase|Adverse Event|0
422795|NCT00557856|1413430|P7|Part 2: Exploratory Phase|Adverse Event|0
422796|NCT00557856|1413431|P6|Part 2: Exploratory Phase|Adverse Event|0
422797|NCT00557856|1413432|P5|Part 2: Exploratory Phase|Adverse Event|0
422798|NCT00557856|1413433|P4|Part 2: Exploratory Phase|Adverse Event|0
422799|NCT00557856|1413434|P3|Part 2: Exploratory Phase|Adverse Event|0
422800|NCT00557856|1413435|P2|Part 2: Exploratory Phase|Adverse Event|0
422801|NCT00557856|1413436|P1|Part 2: Exploratory Phase|Adverse Event|0
422802|NCT00557856|1413428|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
422803|NCT00557856|1413429|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
422804|NCT00557856|1413430|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
422805|NCT00557856|1413431|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
422806|NCT00557856|1413432|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
422807|NCT00557856|1413433|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
422808|NCT00557856|1413434|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
422809|NCT00557856|1413435|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
422810|NCT00557856|1413436|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
422811|NCT00557856|1413428|P9|Part 2: Exploratory Phase|objective progression or relapse|15
422812|NCT00557856|1413429|P8|Part 2: Exploratory Phase|objective progression or relapse|0
422813|NCT00557856|1413430|P7|Part 2: Exploratory Phase|objective progression or relapse|0
422814|NCT00557856|1413431|P6|Part 2: Exploratory Phase|objective progression or relapse|0
422815|NCT00557856|1413432|P5|Part 2: Exploratory Phase|objective progression or relapse|0
422816|NCT00557856|1413433|P4|Part 2: Exploratory Phase|objective progression or relapse|0
422817|NCT00557856|1413434|P3|Part 2: Exploratory Phase|objective progression or relapse|0
422818|NCT00557856|1413435|P2|Part 2: Exploratory Phase|objective progression or relapse|0
422819|NCT00557856|1413436|P1|Part 2: Exploratory Phase|objective progression or relapse|0
422820|NCT00557856|1413428|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
422821|NCT00557856|1413429|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
422822|NCT00557856|1413430|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
422823|NCT00557856|1413431|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
422824|NCT00557856|1413432|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
422825|NCT00557856|1413433|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
422826|NCT00557856|1413434|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
422827|NCT00557856|1413435|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
422828|NCT00557856|1413436|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
422829|NCT00557856|1413428|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
422830|NCT00557856|1413429|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
422831|NCT00557856|1413430|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
422832|NCT00557856|1413431|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
422833|NCT00557856|1413432|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
422834|NCT00557856|1413433|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
422835|NCT00557856|1413434|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
422836|NCT00557856|1413435|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
422837|NCT00557856|1413436|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
422838|NCT00557856|1413428|P9|Part 1: Dose Escalation Phase|Death|0
422839|NCT00557856|1413429|P8|Part 1: Dose Escalation Phase|Death|0
422840|NCT00557856|1413430|P7|Part 1: Dose Escalation Phase|Death|0
422841|NCT00557856|1413431|P6|Part 1: Dose Escalation Phase|Death|1
422842|NCT00557856|1413432|P5|Part 1: Dose Escalation Phase|Death|0
422843|NCT00557856|1413433|P4|Part 1: Dose Escalation Phase|Death|0
422844|NCT00557856|1413434|P3|Part 1: Dose Escalation Phase|Death|0
422845|NCT00557856|1413435|P2|Part 1: Dose Escalation Phase|Death|0
422846|NCT00557856|1413436|P1|Part 1: Dose Escalation Phase|Death|0
422847|NCT00557856|1413428|P9|Part 1: Dose Escalation Phase|Other|0
422848|NCT00557856|1413429|P8|Part 1: Dose Escalation Phase|Other|1
422849|NCT00557856|1413430|P7|Part 1: Dose Escalation Phase|Other|0
422850|NCT00557856|1413431|P6|Part 1: Dose Escalation Phase|Other|0
422851|NCT00557856|1413432|P5|Part 1: Dose Escalation Phase|Other|0
422852|NCT00557856|1413433|P4|Part 1: Dose Escalation Phase|Other|1
422853|NCT00557856|1413434|P3|Part 1: Dose Escalation Phase|Other|1
422854|NCT00557856|1413435|P2|Part 1: Dose Escalation Phase|Other|0
422855|NCT00557856|1413436|P1|Part 1: Dose Escalation Phase|Other|0
422856|NCT00557856|1413428|P9|Part 1: Dose Escalation Phase|Adverse Event|0
422857|NCT00557856|1413429|P8|Part 1: Dose Escalation Phase|Adverse Event|2
422858|NCT00557856|1413430|P7|Part 1: Dose Escalation Phase|Adverse Event|1
422859|NCT00557856|1413431|P6|Part 1: Dose Escalation Phase|Adverse Event|3
422860|NCT00557856|1413432|P5|Part 1: Dose Escalation Phase|Adverse Event|1
422861|NCT00557856|1413433|P4|Part 1: Dose Escalation Phase|Adverse Event|1
422862|NCT00557856|1413434|P3|Part 1: Dose Escalation Phase|Adverse Event|1
422863|NCT00557856|1413435|P2|Part 1: Dose Escalation Phase|Adverse Event|0
422864|NCT00557856|1413436|P1|Part 1: Dose Escalation Phase|Adverse Event|1
422865|NCT00557856|1413428|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
422866|NCT00557856|1413429|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
422867|NCT00557856|1413430|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
422868|NCT00557856|1413431|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
422869|NCT00557856|1413432|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
422870|NCT00557856|1413433|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
422871|NCT00557856|1413434|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
422872|NCT00557856|1413435|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
422873|NCT00557856|1413436|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
422874|NCT00557856|1413428|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
422875|NCT00557856|1413429|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
422876|NCT00557856|1413430|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
422877|NCT00557856|1413431|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
422878|NCT00557856|1413432|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
422879|NCT00557856|1413433|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
422880|NCT00557856|1413434|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
422881|NCT00557856|1413435|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
422882|NCT00557856|1413436|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
422883|NCT00557830|1413635|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
422884|NCT00557830|1413636|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
422885|NCT00557830|1413637|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
422886|NCT00557830|1413635|P3|Screening Treatment Phase|Adverse Event|0
422887|NCT00557830|1413636|P2|Screening Treatment Phase|Adverse Event|0
422888|NCT00557830|1413637|P1|Screening Treatment Phase|Adverse Event|2
422889|NCT00557830|1413635|P3|Screening Treatment Phase|Withdrawal by Subject|0
422890|NCT00557830|1413636|P2|Screening Treatment Phase|Withdrawal by Subject|0
422891|NCT00557830|1413637|P1|Screening Treatment Phase|Withdrawal by Subject|1
422892|NCT00557622|1413659|P2|12-Week Treatment Phase|Lost to Follow-up|1
422893|NCT00557622|1413660|P1|12-Week Treatment Phase|Lost to Follow-up|0
422894|NCT00557622|1413659|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
422895|NCT00557622|1413660|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
422896|NCT00557622|1413659|P2|4-Week Run-in Phase|Withdrawal by Subject|0
422897|NCT00557622|1413660|P1|4-Week Run-in Phase|Withdrawal by Subject|1
422898|NCT00557505|1413689|P9|Overall Study|Withdrawal by Subject|1
422899|NCT00557505|1413690|P8|Overall Study|Withdrawal by Subject|0
422900|NCT00557505|1413691|P7|Overall Study|Withdrawal by Subject|0
422901|NCT00557505|1413692|P6|Overall Study|Withdrawal by Subject|0
422902|NCT00557505|1413693|P5|Overall Study|Withdrawal by Subject|0
422903|NCT00557505|1413694|P4|Overall Study|Withdrawal by Subject|1
422904|NCT00557505|1413695|P3|Overall Study|Withdrawal by Subject|0
422905|NCT00557505|1413696|P2|Overall Study|Withdrawal by Subject|0
422906|NCT00557505|1413697|P1|Overall Study|Withdrawal by Subject|0
422907|NCT00557505|1413689|P9|Overall Study|Objective progression or relapse|15
422908|NCT00557505|1413690|P8|Overall Study|Objective progression or relapse|5
422909|NCT00557505|1413691|P7|Overall Study|Objective progression or relapse|2
422910|NCT00557505|1413692|P6|Overall Study|Objective progression or relapse|3
422911|NCT00557505|1413693|P5|Overall Study|Objective progression or relapse|2
422912|NCT00557505|1413694|P4|Overall Study|Objective progression or relapse|2
422913|NCT00557505|1413695|P3|Overall Study|Objective progression or relapse|3
422914|NCT00557505|1413696|P2|Overall Study|Objective progression or relapse|3
422915|NCT00557505|1413697|P1|Overall Study|Objective progression or relapse|2
422916|NCT00557505|1413689|P9|Overall Study|Global deterioration of health|0
422917|NCT00557505|1413690|P8|Overall Study|Global deterioration of health|0
422918|NCT00557505|1413691|P7|Overall Study|Global deterioration of health|0
422919|NCT00557505|1413692|P6|Overall Study|Global deterioration of health|0
422920|NCT00557505|1413693|P5|Overall Study|Global deterioration of health|0
422921|NCT00557505|1413694|P4|Overall Study|Global deterioration of health|0
422922|NCT00557505|1413695|P3|Overall Study|Global deterioration of health|0
422923|NCT00557505|1413696|P2|Overall Study|Global deterioration of health|0
422924|NCT00557505|1413697|P1|Overall Study|Global deterioration of health|1
422925|NCT00557505|1413689|P9|Overall Study|Adverse Event|0
422926|NCT00557505|1413690|P8|Overall Study|Adverse Event|0
422927|NCT00557505|1413691|P7|Overall Study|Adverse Event|1
422928|NCT00557505|1413692|P6|Overall Study|Adverse Event|0
422929|NCT00557505|1413693|P5|Overall Study|Adverse Event|0
422930|NCT00557505|1413694|P4|Overall Study|Adverse Event|0
422931|NCT00557505|1413695|P3|Overall Study|Adverse Event|1
422932|NCT00557505|1413696|P2|Overall Study|Adverse Event|0
422933|NCT00557505|1413697|P1|Overall Study|Adverse Event|0
422934|NCT00557505|1413689|P9|Overall Study|Death|1
422935|NCT00557505|1413690|P8|Overall Study|Death|0
422936|NCT00557505|1413691|P7|Overall Study|Death|0
422937|NCT00557505|1413692|P6|Overall Study|Death|0
422938|NCT00557505|1413693|P5|Overall Study|Death|0
422939|NCT00557505|1413694|P4|Overall Study|Death|0
422940|NCT00557505|1413695|P3|Overall Study|Death|0
422941|NCT00557505|1413696|P2|Overall Study|Death|0
422942|NCT00557505|1413697|P1|Overall Study|Death|0
422943|NCT00557492|1413861|P1|Overall Study|Change in health insurance|1
422944|NCT00557466|1413879|P6|Overall Study|Lost to Follow-up|0
422945|NCT00557466|1413880|P5|Overall Study|Lost to Follow-up|0
422946|NCT00557466|1413881|P4|Overall Study|Lost to Follow-up|1
422947|NCT00557466|1413882|P3|Overall Study|Lost to Follow-up|0
422948|NCT00557466|1413883|P2|Overall Study|Lost to Follow-up|0
422949|NCT00557466|1413884|P1|Overall Study|Lost to Follow-up|0
422950|NCT00557466|1413879|P6|Overall Study|Abnormal test procedure results|0
422951|NCT00557466|1413880|P5|Overall Study|Abnormal test procedure results|0
422952|NCT00557466|1413881|P4|Overall Study|Abnormal test procedure results|0
422953|NCT00557466|1413882|P3|Overall Study|Abnormal test procedure results|1
422954|NCT00557466|1413883|P2|Overall Study|Abnormal test procedure results|0
422955|NCT00557466|1413884|P1|Overall Study|Abnormal test procedure results|0
422956|NCT00557466|1413879|P6|Overall Study|Administrative problems|0
422957|NCT00557466|1413880|P5|Overall Study|Administrative problems|0
422958|NCT00557466|1413881|P4|Overall Study|Administrative problems|0
422959|NCT00557466|1413882|P3|Overall Study|Administrative problems|1
422960|NCT00557466|1413883|P2|Overall Study|Administrative problems|1
422961|NCT00557466|1413884|P1|Overall Study|Administrative problems|0
422962|NCT00557466|1413879|P6|Overall Study|Subject withdrew consent|2
422963|NCT00557466|1413880|P5|Overall Study|Subject withdrew consent|1
422964|NCT00557466|1413881|P4|Overall Study|Subject withdrew consent|0
422965|NCT00557466|1413882|P3|Overall Study|Subject withdrew consent|0
422966|NCT00557466|1413883|P2|Overall Study|Subject withdrew consent|0
422967|NCT00557466|1413884|P1|Overall Study|Subject withdrew consent|0
422968|NCT00557466|1413879|P6|Overall Study|Protocol deviation|0
422969|NCT00557466|1413880|P5|Overall Study|Protocol deviation|0
422970|NCT00557466|1413881|P4|Overall Study|Protocol deviation|2
422971|NCT00557466|1413882|P3|Overall Study|Protocol deviation|0
422972|NCT00557466|1413883|P2|Overall Study|Protocol deviation|1
422973|NCT00557466|1413884|P1|Overall Study|Protocol deviation|0
422974|NCT00557466|1413879|P6|Overall Study|Abnormal laboratory value(s)|0
422975|NCT00557466|1413880|P5|Overall Study|Abnormal laboratory value(s)|0
422976|NCT00557466|1413881|P4|Overall Study|Abnormal laboratory value(s)|0
422977|NCT00557466|1413882|P3|Overall Study|Abnormal laboratory value(s)|0
422978|NCT00557466|1413883|P2|Overall Study|Abnormal laboratory value(s)|2
422979|NCT00557466|1413884|P1|Overall Study|Abnormal laboratory value(s)|1
422980|NCT00557466|1413879|P6|Overall Study|Adverse Event|4
422981|NCT00557466|1413880|P5|Overall Study|Adverse Event|2
422982|NCT00557466|1413881|P4|Overall Study|Adverse Event|1
422983|NCT00557466|1413882|P3|Overall Study|Adverse Event|4
422984|NCT00557466|1413883|P2|Overall Study|Adverse Event|1
422985|NCT00557466|1413884|P1|Overall Study|Adverse Event|3
422986|NCT00557440|1413937|P3|Treatment Period 1|Adverse Event|1
422987|NCT00557440|1413938|P2|Treatment Period 1|Adverse Event|0
422988|NCT00557440|1413939|P1|Treatment Period 1|Adverse Event|0
422989|NCT00557323|1413993|P1|Overall Study|Administrative change|2
422990|NCT00557323|1413993|P1|Overall Study|Withdrawal by Subject|2
422991|NCT00557323|1413993|P1|Overall Study|Death|3
422992|NCT00557310|1413998|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
422993|NCT00557310|1413998|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
422994|NCT00557310|1413998|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
422995|NCT00557310|1413998|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
422996|NCT00557310|1413998|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
422997|NCT00557310|1413998|P1|Main Study (0 - 18 Months)|Adverse Event|4
422998|NCT00557245|1414044|P3|Overall Study|Ineligible|2
422999|NCT00557245|1414045|P2|Overall Study|Ineligible|4
423000|NCT00557245|1414046|P1|Overall Study|Ineligible|5
423001|NCT00557245|1414044|P3|Overall Study|Lost to Follow-up|10
423002|NCT00557245|1414045|P2|Overall Study|Lost to Follow-up|8
423003|NCT00557245|1414046|P1|Overall Study|Lost to Follow-up|7
423004|NCT00557076|1414086|P2|Overall Study|Unblinding|1
423005|NCT00557076|1414087|P1|Overall Study|Unblinding|0
423006|NCT00556998|1414095|P1|Voriconazole Oral|Intolerant of oral treatment|1
423007|NCT00556998|1414095|P1|Voriconazole Oral|Adverse Event|1
423008|NCT00556998|1414095|P1|Voriconazole Intravenous (IV)|Other|4
423009|NCT00556998|1414095|P1|Voriconazole Intravenous (IV)|Adverse Event|1
423010|NCT00556933|1414130|P4|CNI Withdrawal vs. Minimization|Death|1
423011|NCT00556933|1414131|P3|CNI Withdrawal vs. Minimization|Death|0
423012|NCT00556933|1414132|P2|CNI Withdrawal vs. Minimization|Death|0
423013|NCT00556933|1414133|P1|CNI Withdrawal vs. Minimization|Death|0
423014|NCT00556933|1414130|P4|CNI Withdrawal vs. Minimization|Graft loss|0
423015|NCT00556933|1414131|P3|CNI Withdrawal vs. Minimization|Graft loss|2
423016|NCT00556933|1414132|P2|CNI Withdrawal vs. Minimization|Graft loss|1
423017|NCT00556933|1414133|P1|CNI Withdrawal vs. Minimization|Graft loss|0
423018|NCT00556933|1414130|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
423019|NCT00556933|1414131|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
423020|NCT00556933|1414132|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
423021|NCT00556933|1414133|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
423187|NCT00555906|1414591|P2|Phase 2|Objective Progression or Relapse|0
423022|NCT00556933|1414130|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
423023|NCT00556933|1414131|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
423024|NCT00556933|1414132|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
423025|NCT00556933|1414133|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
423026|NCT00556933|1414130|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
423027|NCT00556933|1414131|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
423028|NCT00556933|1414132|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
423029|NCT00556933|1414133|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
423030|NCT00556933|1414130|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
423031|NCT00556933|1414131|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
423032|NCT00556933|1414132|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
423033|NCT00556933|1414133|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
423034|NCT00556933|1414130|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
423035|NCT00556933|1414131|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
423036|NCT00556933|1414132|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
423037|NCT00556933|1414133|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
423038|NCT00556933|1414130|P4|Single vs. Divided-dose rATG Induction|Death|0
423039|NCT00556933|1414131|P3|Single vs. Divided-dose rATG Induction|Death|0
423040|NCT00556933|1414132|P2|Single vs. Divided-dose rATG Induction|Death|1
423041|NCT00556933|1414133|P1|Single vs. Divided-dose rATG Induction|Death|0
423042|NCT00556933|1414130|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
423043|NCT00556933|1414131|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
423044|NCT00556933|1414132|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
423045|NCT00556933|1414133|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
423046|NCT00556933|1414130|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
423047|NCT00556933|1414131|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
423048|NCT00556933|1414132|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
423049|NCT00556933|1414133|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
423050|NCT00556933|1414130|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
423051|NCT00556933|1414131|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
423052|NCT00556933|1414132|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
423053|NCT00556933|1414133|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
423054|NCT00556894|1414190|P3|Overall Study|Withdrawal by Subject|1
423055|NCT00556894|1414191|P2|Overall Study|Withdrawal by Subject|1
423056|NCT00556894|1414192|P1|Overall Study|Withdrawal by Subject|1
423057|NCT00556894|1414190|P3|Overall Study|Change in therapy|2
423058|NCT00556894|1414191|P2|Overall Study|Change in therapy|1
423059|NCT00556894|1414192|P1|Overall Study|Change in therapy|2
423060|NCT00556894|1414190|P3|Overall Study|regulatory decision in Bulgaria|13
423061|NCT00556894|1414191|P2|Overall Study|regulatory decision in Bulgaria|14
423062|NCT00556894|1414192|P1|Overall Study|regulatory decision in Bulgaria|10
423063|NCT00556894|1414190|P3|Overall Study|Death|0
423064|NCT00556894|1414191|P2|Overall Study|Death|0
423065|NCT00556894|1414192|P1|Overall Study|Death|1
423066|NCT00556894|1414190|P3|Overall Study|Adverse Event|3
423067|NCT00556894|1414191|P2|Overall Study|Adverse Event|3
423068|NCT00556894|1414192|P1|Overall Study|Adverse Event|2
423069|NCT00556712|1414202|P2|Overall Study|Ongoing at Data Cutoff|66
423070|NCT00556712|1414203|P1|Overall Study|Ongoing at Data Cutoff|32
423071|NCT00556712|1414202|P2|Overall Study|Not Specified|2
423072|NCT00556712|1414203|P1|Overall Study|Not Specified|2
423073|NCT00556712|1414202|P2|Overall Study|Failure to Return|3
423074|NCT00556712|1414203|P1|Overall Study|Failure to Return|2
423075|NCT00556712|1414202|P2|Overall Study|Refused Treatment|16
423076|NCT00556712|1414203|P1|Overall Study|Refused Treatment|17
423077|NCT00556712|1414202|P2|Overall Study|Protocol Violation|2
423078|NCT00556712|1414203|P1|Overall Study|Protocol Violation|3
423079|NCT00556712|1414202|P2|Overall Study|Progressive Disease|320
423080|NCT00556712|1414203|P1|Overall Study|Progressive Disease|383
423081|NCT00556712|1414202|P2|Overall Study|Death|10
423082|NCT00556712|1414203|P1|Overall Study|Death|5
423083|NCT00556712|1414202|P2|Overall Study|Adverse Event|19
423084|NCT00556712|1414203|P1|Overall Study|Adverse Event|7
423085|NCT00556673|1414281|P2|Overall Study|Protocol deviation|2
423086|NCT00556673|1414282|P1|Overall Study|Protocol deviation|3
423087|NCT00556439|1414418|P4|After Week 12 (Randomized Study Period)|Severe infection|0
423088|NCT00556439|1414419|P3|After Week 12 (Randomized Study Period)|Severe infection|0
423089|NCT00556439|1414420|P2|After Week 12 (Randomized Study Period)|Severe infection|0
423090|NCT00556439|1414421|P1|After Week 12 (Randomized Study Period)|Severe infection|1
423091|NCT00556439|1414418|P4|After Week 12 (Randomized Study Period)|Malignancy|1
423092|NCT00556439|1414419|P3|After Week 12 (Randomized Study Period)|Malignancy|0
423093|NCT00556439|1414420|P2|After Week 12 (Randomized Study Period)|Malignancy|1
423094|NCT00556439|1414421|P1|After Week 12 (Randomized Study Period)|Malignancy|0
423095|NCT00556439|1414418|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
423096|NCT00556439|1414419|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
423097|NCT00556439|1414420|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
423098|NCT00556439|1414421|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
423099|NCT00556439|1414418|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
423100|NCT00556439|1414419|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
423101|NCT00556439|1414420|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
423102|NCT00556439|1414421|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
423103|NCT00556439|1414418|P4|Study Entry to Week 12|Malignancy|0
423104|NCT00556439|1414419|P3|Study Entry to Week 12|Malignancy|1
423105|NCT00556439|1414420|P2|Study Entry to Week 12|Malignancy|0
423106|NCT00556439|1414421|P1|Study Entry to Week 12|Malignancy|0
423107|NCT00556439|1414418|P4|Study Entry to Week 12|Recurrent infection|0
423108|NCT00556439|1414419|P3|Study Entry to Week 12|Recurrent infection|0
423109|NCT00556439|1414420|P2|Study Entry to Week 12|Recurrent infection|0
423110|NCT00556439|1414421|P1|Study Entry to Week 12|Recurrent infection|1
423111|NCT00556439|1414418|P4|Study Entry to Week 12|Withdrawal by Subject|0
423112|NCT00556439|1414419|P3|Study Entry to Week 12|Withdrawal by Subject|1
423113|NCT00556439|1414420|P2|Study Entry to Week 12|Withdrawal by Subject|0
423114|NCT00556439|1414421|P1|Study Entry to Week 12|Withdrawal by Subject|1
423115|NCT00556439|1414418|P4|Study Entry to Week 12|Physician Decision|0
423116|NCT00556439|1414419|P3|Study Entry to Week 12|Physician Decision|0
423117|NCT00556439|1414420|P2|Study Entry to Week 12|Physician Decision|0
423118|NCT00556439|1414421|P1|Study Entry to Week 12|Physician Decision|1
423119|NCT00556439|1414418|P4|Study Entry to Week 12|Lack of Efficacy|0
423120|NCT00556439|1414419|P3|Study Entry to Week 12|Lack of Efficacy|6
423121|NCT00556439|1414420|P2|Study Entry to Week 12|Lack of Efficacy|0
423122|NCT00556439|1414421|P1|Study Entry to Week 12|Lack of Efficacy|5
423123|NCT00556426|1414431|P1|Overall Study|Death|6
423124|NCT00556426|1414431|P1|Overall Study|Withdrawal by Subject|3
423125|NCT00556374|1414453|P2|Overall Study|Lost to Follow-up|5
423126|NCT00556374|1414454|P1|Overall Study|Lost to Follow-up|7
423127|NCT00556374|1414453|P2|Overall Study|Death|43
423128|NCT00556374|1414454|P1|Overall Study|Death|50
423129|NCT00556374|1414453|P2|Overall Study|Withdrawal by Subject|172
423130|NCT00556374|1414454|P1|Overall Study|Withdrawal by Subject|190
423131|NCT00556322|1414472|P2|Overall Study|Death|14
423132|NCT00556322|1414473|P1|Overall Study|Death|20
423133|NCT00556322|1414472|P2|Overall Study|Ongoing at data cutoff|5
423134|NCT00556322|1414473|P1|Overall Study|Ongoing at data cutoff|3
423135|NCT00556322|1414472|P2|Overall Study|Protocol Violation|1
423136|NCT00556322|1414473|P1|Overall Study|Protocol Violation|5
423137|NCT00556322|1414472|P2|Overall Study|Withdrawal by Subject|7
423138|NCT00556322|1414473|P1|Overall Study|Withdrawal by Subject|19
423139|NCT00556322|1414472|P2|Overall Study|Lost to Follow-up|3
423140|NCT00556322|1414473|P1|Overall Study|Lost to Follow-up|5
423141|NCT00556322|1414472|P2|Overall Study|Other|1
423142|NCT00556322|1414473|P1|Overall Study|Other|4
423143|NCT00556322|1414472|P2|Overall Study|Adverse Event|4
423144|NCT00556322|1414473|P1|Overall Study|Adverse Event|7
423145|NCT00556322|1414472|P2|Overall Study|Insufficient therapeutic response|168
423146|NCT00556322|1414473|P1|Overall Study|Insufficient therapeutic response|158
423147|NCT00556166|1414521|P1|Overall Study|Withdrawal by Subject|1
423148|NCT00556075|1414534|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
423149|NCT00556075|1414535|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
423150|NCT00556075|1414536|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
423151|NCT00556075|1414534|P3|Overall Study|Personal issues|0
423152|NCT00556075|1414535|P2|Overall Study|Personal issues|1
423153|NCT00556075|1414536|P1|Overall Study|Personal issues|4
423154|NCT00556075|1414534|P3|Overall Study|Adverse Event|0
423155|NCT00556075|1414535|P2|Overall Study|Adverse Event|2
423156|NCT00556075|1414536|P1|Overall Study|Adverse Event|1
423157|NCT00556075|1414534|P3|Overall Study|Not eligible|2
423158|NCT00556075|1414535|P2|Overall Study|Not eligible|1
423159|NCT00556075|1414536|P1|Overall Study|Not eligible|1
423160|NCT00556075|1414534|P3|Overall Study|Protocol Violation|3
423161|NCT00556075|1414535|P2|Overall Study|Protocol Violation|1
423162|NCT00556075|1414536|P1|Overall Study|Protocol Violation|1
423163|NCT00556075|1414534|P3|Overall Study|Withdrawal by Subject|0
423164|NCT00556075|1414535|P2|Overall Study|Withdrawal by Subject|3
423165|NCT00556075|1414536|P1|Overall Study|Withdrawal by Subject|3
423166|NCT00556075|1414534|P3|Overall Study|Lost to Follow-up|3
423167|NCT00556075|1414535|P2|Overall Study|Lost to Follow-up|0
423168|NCT00556075|1414536|P1|Overall Study|Lost to Follow-up|3
423169|NCT00555906|1414588|P5|Phase 2|Randomized but not Treated|2
423170|NCT00555906|1414589|P4|Phase 2|Randomized but not Treated|0
423171|NCT00555906|1414590|P3|Phase 2|Randomized but not Treated|0
423172|NCT00555906|1414591|P2|Phase 2|Randomized but not Treated|0
423173|NCT00555906|1414592|P1|Phase 2|Randomized but not Treated|0
423174|NCT00555906|1414588|P5|Phase 2|Other|6
423175|NCT00555906|1414589|P4|Phase 2|Other|0
423176|NCT00555906|1414590|P3|Phase 2|Other|0
423177|NCT00555906|1414591|P2|Phase 2|Other|0
423178|NCT00555906|1414592|P1|Phase 2|Other|0
423179|NCT00555906|1414588|P5|Phase 2|Withdrawal by Subject|2
423180|NCT00555906|1414589|P4|Phase 2|Withdrawal by Subject|0
423181|NCT00555906|1414590|P3|Phase 2|Withdrawal by Subject|0
423182|NCT00555906|1414591|P2|Phase 2|Withdrawal by Subject|0
423183|NCT00555906|1414592|P1|Phase 2|Withdrawal by Subject|0
423184|NCT00555906|1414588|P5|Phase 2|Objective Progression or Relapse|16
423185|NCT00555906|1414589|P4|Phase 2|Objective Progression or Relapse|0
423186|NCT00555906|1414590|P3|Phase 2|Objective Progression or Relapse|0
423188|NCT00555906|1414592|P1|Phase 2|Objective Progression or Relapse|0
423189|NCT00555906|1414588|P5|Phase 2|Global Deterioration of Health Status|2
423190|NCT00555906|1414589|P4|Phase 2|Global Deterioration of Health Status|0
423191|NCT00555906|1414590|P3|Phase 2|Global Deterioration of Health Status|0
423192|NCT00555906|1414591|P2|Phase 2|Global Deterioration of Health Status|0
423193|NCT00555906|1414592|P1|Phase 2|Global Deterioration of Health Status|0
423194|NCT00555906|1414588|P5|Phase 2|Adverse Event|4
423195|NCT00555906|1414589|P4|Phase 2|Adverse Event|0
423196|NCT00555906|1414590|P3|Phase 2|Adverse Event|0
423197|NCT00555906|1414591|P2|Phase 2|Adverse Event|0
423198|NCT00555906|1414592|P1|Phase 2|Adverse Event|0
423199|NCT00555906|1414588|P5|Phase 1|Withdrawal by Subject|0
423200|NCT00555906|1414589|P4|Phase 1|Withdrawal by Subject|1
423201|NCT00555906|1414590|P3|Phase 1|Withdrawal by Subject|0
423202|NCT00555906|1414591|P2|Phase 1|Withdrawal by Subject|0
423203|NCT00555906|1414592|P1|Phase 1|Withdrawal by Subject|0
423204|NCT00555906|1414588|P5|Phase 1|Adverse Event|0
423205|NCT00555906|1414589|P4|Phase 1|Adverse Event|2
423206|NCT00555906|1414590|P3|Phase 1|Adverse Event|3
423207|NCT00555906|1414591|P2|Phase 1|Adverse Event|0
423208|NCT00555906|1414592|P1|Phase 1|Adverse Event|0
423209|NCT00555906|1414588|P5|Phase 1|Global Deterioration of Health Status|0
423210|NCT00555906|1414589|P4|Phase 1|Global Deterioration of Health Status|1
423211|NCT00555906|1414590|P3|Phase 1|Global Deterioration of Health Status|1
423212|NCT00555906|1414591|P2|Phase 1|Global Deterioration of Health Status|1
423213|NCT00555906|1414592|P1|Phase 1|Global Deterioration of Health Status|0
423214|NCT00555906|1414588|P5|Phase 1|Objective Progression or Relapse|0
423215|NCT00555906|1414589|P4|Phase 1|Objective Progression or Relapse|1
423216|NCT00555906|1414590|P3|Phase 1|Objective Progression or Relapse|3
423217|NCT00555906|1414591|P2|Phase 1|Objective Progression or Relapse|5
423218|NCT00555906|1414592|P1|Phase 1|Objective Progression or Relapse|3
423219|NCT00555672|1414708|P2|Overall Study|Participant refused|0
423220|NCT00555672|1414709|P1|Overall Study|Participant refused|2
423221|NCT00555672|1414708|P2|Overall Study|Other|1
423222|NCT00555672|1414709|P1|Overall Study|Other|3
423223|NCT00555672|1414708|P2|Overall Study|Objective progression or relapse|5
423224|NCT00555672|1414709|P1|Overall Study|Objective progression or relapse|11
423225|NCT00555672|1414708|P2|Overall Study|Adverse Event|2
423226|NCT00555672|1414709|P1|Overall Study|Adverse Event|8
423227|NCT00555672|1414708|P2|Overall Study|Death|2
423228|NCT00555672|1414709|P1|Overall Study|Death|0
423229|NCT00555620|1414734|P6|Overall Study|Not specified|3
423230|NCT00555620|1414735|P5|Overall Study|Not specified|0
423231|NCT00555620|1414736|P4|Overall Study|Not specified|1
423232|NCT00555620|1414737|P3|Overall Study|Not specified|0
423233|NCT00555620|1414738|P2|Overall Study|Not specified|0
423234|NCT00555620|1414739|P1|Overall Study|Not specified|0
423235|NCT00555620|1414734|P6|Overall Study|Participant refused treatment|1
423236|NCT00555620|1414735|P5|Overall Study|Participant refused treatment|0
423237|NCT00555620|1414736|P4|Overall Study|Participant refused treatment|0
423238|NCT00555620|1414737|P3|Overall Study|Participant refused treatment|1
423239|NCT00555620|1414738|P2|Overall Study|Participant refused treatment|1
423240|NCT00555620|1414739|P1|Overall Study|Participant refused treatment|0
423241|NCT00555620|1414734|P6|Overall Study|Objective progression or relapse|16
423242|NCT00555620|1414735|P5|Overall Study|Objective progression or relapse|3
423243|NCT00555620|1414736|P4|Overall Study|Objective progression or relapse|17
423244|NCT00555620|1414737|P3|Overall Study|Objective progression or relapse|12
423245|NCT00555620|1414738|P2|Overall Study|Objective progression or relapse|5
423246|NCT00555620|1414739|P1|Overall Study|Objective progression or relapse|6
423247|NCT00555620|1414734|P6|Overall Study|Adverse Event|1
423248|NCT00555620|1414735|P5|Overall Study|Adverse Event|0
423249|NCT00555620|1414736|P4|Overall Study|Adverse Event|5
423250|NCT00555620|1414737|P3|Overall Study|Adverse Event|1
423251|NCT00555620|1414738|P2|Overall Study|Adverse Event|0
423252|NCT00555620|1414739|P1|Overall Study|Adverse Event|0
423253|NCT00555620|1414734|P6|Overall Study|Study terminated by sponsor|0
423254|NCT00555620|1414735|P5|Overall Study|Study terminated by sponsor|0
423255|NCT00555620|1414736|P4|Overall Study|Study terminated by sponsor|0
423256|NCT00555620|1414737|P3|Overall Study|Study terminated by sponsor|1
423257|NCT00555620|1414738|P2|Overall Study|Study terminated by sponsor|0
423258|NCT00555620|1414739|P1|Overall Study|Study terminated by sponsor|0
423259|NCT00555620|1414734|P6|Overall Study|Death|1
423260|NCT00555620|1414735|P5|Overall Study|Death|0
423261|NCT00555620|1414736|P4|Overall Study|Death|0
423262|NCT00555620|1414737|P3|Overall Study|Death|0
423263|NCT00555620|1414738|P2|Overall Study|Death|1
423264|NCT00555620|1414739|P1|Overall Study|Death|0
423265|NCT00555568|1414863|P3|Overall Study|Lost to Follow-up|16
423266|NCT00555568|1414864|P2|Overall Study|Lost to Follow-up|16
423267|NCT00555568|1414865|P1|Overall Study|Lost to Follow-up|26
423268|NCT00555477|1414887|P2|Overall Study|Physician Decision|2
423269|NCT00555477|1414888|P1|Overall Study|Physician Decision|1
423270|NCT00555477|1414887|P2|Overall Study|Withdrawal by Subject|2
423271|NCT00555477|1414888|P1|Overall Study|Withdrawal by Subject|1
423272|NCT00555477|1414887|P2|Overall Study|Adverse Event|9
423273|NCT00555477|1414888|P1|Overall Study|Adverse Event|0
423274|NCT00555438|1414904|P1|Between 10 Days and 30 Days Postoperativ|Death|5
423275|NCT00555438|1414904|P1|10 Days Post-operative|Death|4
423276|NCT00555425|1414914|P2|Overall Study|Became pregnant and transferred care|1
423277|NCT00555425|1414915|P1|Overall Study|Became pregnant and transferred care|0
423278|NCT00555425|1414914|P2|Overall Study|Met criteria for protective transfer|3
423279|NCT00555425|1414915|P1|Overall Study|Met criteria for protective transfer|16
423280|NCT00555425|1414914|P2|Overall Study|Missed 3 physician management visits|0
423281|NCT00555425|1414915|P1|Overall Study|Missed 3 physician management visits|1
423282|NCT00555425|1414914|P2|Overall Study|Missed Medication > 1 wk|15
423283|NCT00555425|1414915|P1|Overall Study|Missed Medication > 1 wk|34
423284|NCT00555321|1414951|P5|Long-term Extension Phase|Other Reason|0
423285|NCT00555321|1414952|P4|Long-term Extension Phase|Other Reason|0
423286|NCT00555321|1414953|P3|Long-term Extension Phase|Other Reason|2
423287|NCT00555321|1414954|P2|Long-term Extension Phase|Other Reason|0
423288|NCT00555321|1414955|P1|Long-term Extension Phase|Other Reason|1
423289|NCT00555321|1414951|P5|Long-term Extension Phase|Participant did not meet study criteria|1
423290|NCT00555321|1414952|P4|Long-term Extension Phase|Participant did not meet study criteria|0
423291|NCT00555321|1414953|P3|Long-term Extension Phase|Participant did not meet study criteria|0
423292|NCT00555321|1414954|P2|Long-term Extension Phase|Participant did not meet study criteria|0
423293|NCT00555321|1414955|P1|Long-term Extension Phase|Participant did not meet study criteria|0
423294|NCT00555321|1414951|P5|Long-term Extension Phase|Death|0
423295|NCT00555321|1414952|P4|Long-term Extension Phase|Death|3
423296|NCT00555321|1414953|P3|Long-term Extension Phase|Death|0
423297|NCT00555321|1414954|P2|Long-term Extension Phase|Death|0
423298|NCT00555321|1414955|P1|Long-term Extension Phase|Death|2
423299|NCT00555321|1414951|P5|Long-term Extension Phase|Administrative reason by sponsor|23
423300|NCT00555321|1414952|P4|Long-term Extension Phase|Administrative reason by sponsor|31
423301|NCT00555321|1414953|P3|Long-term Extension Phase|Administrative reason by sponsor|18
423302|NCT00555321|1414954|P2|Long-term Extension Phase|Administrative reason by sponsor|21
423303|NCT00555321|1414955|P1|Long-term Extension Phase|Administrative reason by sponsor|23
423304|NCT00555321|1414951|P5|Long-term Extension Phase|Withdrawal by Subject|2
423305|NCT00555321|1414952|P4|Long-term Extension Phase|Withdrawal by Subject|3
423306|NCT00555321|1414953|P3|Long-term Extension Phase|Withdrawal by Subject|2
423307|NCT00555321|1414954|P2|Long-term Extension Phase|Withdrawal by Subject|1
423308|NCT00555321|1414955|P1|Long-term Extension Phase|Withdrawal by Subject|2
423309|NCT00555321|1414951|P5|Long-term Extension Phase|Adverse Event|0
423310|NCT00555321|1414952|P4|Long-term Extension Phase|Adverse Event|1
423311|NCT00555321|1414953|P3|Long-term Extension Phase|Adverse Event|2
423312|NCT00555321|1414954|P2|Long-term Extension Phase|Adverse Event|5
423313|NCT00555321|1414955|P1|Long-term Extension Phase|Adverse Event|2
423314|NCT00555321|1414951|P5|Treatment Phase up to 12-months|Never treated|4
423315|NCT00555321|1414952|P4|Treatment Phase up to 12-months|Never treated|0
423316|NCT00555321|1414953|P3|Treatment Phase up to 12-months|Never treated|1
423317|NCT00555321|1414954|P2|Treatment Phase up to 12-months|Never treated|3
423318|NCT00555321|1414955|P1|Treatment Phase up to 12-months|Never treated|2
423319|NCT00555321|1414951|P5|Treatment Phase up to 12-months|Other Reason|0
423320|NCT00555321|1414952|P4|Treatment Phase up to 12-months|Other Reason|0
423321|NCT00555321|1414953|P3|Treatment Phase up to 12-months|Other Reason|2
423322|NCT00555321|1414954|P2|Treatment Phase up to 12-months|Other Reason|3
423323|NCT00555321|1414955|P1|Treatment Phase up to 12-months|Other Reason|1
423324|NCT00555321|1414951|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
423325|NCT00555321|1414952|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
423326|NCT00555321|1414953|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
423327|NCT00555321|1414954|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
423328|NCT00555321|1414955|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
423329|NCT00555321|1414951|P5|Treatment Phase up to 12-months|Death|0
423330|NCT00555321|1414952|P4|Treatment Phase up to 12-months|Death|0
423331|NCT00555321|1414953|P3|Treatment Phase up to 12-months|Death|4
423332|NCT00555321|1414954|P2|Treatment Phase up to 12-months|Death|1
423333|NCT00555321|1414955|P1|Treatment Phase up to 12-months|Death|2
423334|NCT00555321|1414951|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
423335|NCT00555321|1414952|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
423336|NCT00555321|1414953|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
423337|NCT00555321|1414954|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
423338|NCT00555321|1414955|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
423339|NCT00555321|1414951|P5|Treatment Phase up to 12-months|Adverse Event|18
423340|NCT00555321|1414952|P4|Treatment Phase up to 12-months|Adverse Event|7
423341|NCT00555321|1414953|P3|Treatment Phase up to 12-months|Adverse Event|11
423342|NCT00555321|1414954|P2|Treatment Phase up to 12-months|Adverse Event|7
423343|NCT00555321|1414955|P1|Treatment Phase up to 12-months|Adverse Event|6
423344|NCT00555217|1415259|P2|Overall Study|close out sites|17
423345|NCT00555217|1415260|P1|Overall Study|close out sites|21
423346|NCT00555217|1415259|P2|Overall Study|Lost to Follow-up|20
423347|NCT00555217|1415260|P1|Overall Study|Lost to Follow-up|19
423348|NCT00555217|1415259|P2|Overall Study|Withdrawal by Subject|31
423349|NCT00555217|1415260|P1|Overall Study|Withdrawal by Subject|35
423350|NCT00555061|1415297|P1|Overall Study|Participant enrolled, but never treated|1
423351|NCT00555061|1415297|P1|Overall Study|Withdrawal by Subject|2
423352|NCT00555061|1415297|P1|Overall Study|Lost to Follow-up|2
423353|NCT00555061|1415297|P1|Overall Study|Protocol Violation|1
423354|NCT00555061|1415297|P1|Overall Study|Adverse Event|3
423355|NCT00555009|1415316|P2|Overall Study|Terminated by Sponsor|5
423356|NCT00555009|1415317|P1|Overall Study|Terminated by Sponsor|2
423357|NCT00555009|1415316|P2|Overall Study|Withdrawal by Subject|1
423358|NCT00555009|1415317|P1|Overall Study|Withdrawal by Subject|0
423359|NCT00554840|1415397|P2|Overall Study|Physician Decision|1
423360|NCT00554840|1415398|P1|Overall Study|Physician Decision|0
423361|NCT00554801|1415416|P2|Overall Study|Withdrawal by Subject|0
423362|NCT00554801|1415417|P1|Overall Study|Withdrawal by Subject|14
423363|NCT00554801|1415416|P2|Overall Study|left area before completion|0
423364|NCT00554801|1415417|P1|Overall Study|left area before completion|5
423365|NCT00554619|1415439|P1|Overall Study|Liver Function Test Abnormality|1
423366|NCT00554619|1415439|P1|Overall Study|Physician Decision|1
423367|NCT00554619|1415439|P1|Overall Study|Adverse Event|1
423368|NCT00554515|1415451|P1|Overall Study|Misc|15
423369|NCT00554515|1415451|P1|Overall Study|Other|1
423370|NCT00554515|1415451|P1|Overall Study|Achieved Stable Disease|7
423371|NCT00554515|1415451|P1|Overall Study|Death|2
423372|NCT00554515|1415451|P1|Overall Study|Adverse Event|9
423373|NCT00554515|1415451|P1|Overall Study|Withdrawal by Subject|11
423374|NCT00554515|1415451|P1|Overall Study|Physician Decision|18
423375|NCT00554515|1415451|P1|Overall Study|Disease progression|52
423376|NCT00554515|1415451|P1|Overall Study|Withdrawal by Subject|3
423377|NCT00554229|1415508|P2|Overall Study|Randomised but no treatment received|0
423378|NCT00554229|1415509|P1|Overall Study|Randomised but no treatment received|1
423379|NCT00554229|1415508|P2|Overall Study|Reason not otherwise captured, eg; death|140
423380|NCT00554229|1415509|P1|Overall Study|Reason not otherwise captured, eg; death|119
423381|NCT00554229|1415508|P2|Overall Study|Protocol Violation|3
423382|NCT00554229|1415509|P1|Overall Study|Protocol Violation|3
423383|NCT00554229|1415508|P2|Overall Study|Adverse Event|39
423384|NCT00554229|1415509|P1|Overall Study|Adverse Event|71
423385|NCT00554229|1415508|P2|Overall Study|Withdrawal by Subject|37
423386|NCT00554229|1415509|P1|Overall Study|Withdrawal by Subject|29
423387|NCT00554229|1415508|P2|Overall Study|Lost to Follow-up|6
423388|NCT00554229|1415509|P1|Overall Study|Lost to Follow-up|3
423389|NCT00554216|1415534|P3|Overall Study|Lack of Efficacy|0
423390|NCT00554216|1415535|P2|Overall Study|Lack of Efficacy|3
423391|NCT00554216|1415536|P1|Overall Study|Lack of Efficacy|15
423392|NCT00554216|1415534|P3|Overall Study|not specified|10
423393|NCT00554216|1415535|P2|Overall Study|not specified|7
423394|NCT00554216|1415536|P1|Overall Study|not specified|12
423395|NCT00554216|1415534|P3|Overall Study|Restricted med|1
423396|NCT00554216|1415535|P2|Overall Study|Restricted med|1
423397|NCT00554216|1415536|P1|Overall Study|Restricted med|3
423398|NCT00554216|1415534|P3|Overall Study|Pregnancy|14
423399|NCT00554216|1415535|P2|Overall Study|Pregnancy|1
423400|NCT00554216|1415536|P1|Overall Study|Pregnancy|2
423401|NCT00554216|1415534|P3|Overall Study|Non compliance|5
423402|NCT00554216|1415535|P2|Overall Study|Non compliance|4
423403|NCT00554216|1415536|P1|Overall Study|Non compliance|10
423404|NCT00554216|1415534|P3|Overall Study|Withdrawal by Subject|43
423405|NCT00554216|1415535|P2|Overall Study|Withdrawal by Subject|31
423406|NCT00554216|1415536|P1|Overall Study|Withdrawal by Subject|92
423407|NCT00554216|1415534|P3|Overall Study|Adverse Event|36
423408|NCT00554216|1415535|P2|Overall Study|Adverse Event|16
423409|NCT00554216|1415536|P1|Overall Study|Adverse Event|16
423410|NCT00554216|1415534|P3|Overall Study|Lost to Follow-up|63
423411|NCT00554216|1415535|P2|Overall Study|Lost to Follow-up|31
423412|NCT00554216|1415536|P1|Overall Study|Lost to Follow-up|92
423413|NCT00554190|1415547|P1|Overall Study|Termination forms not completed|10
423414|NCT00554099|1415556|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
423415|NCT00554099|1415557|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
423416|NCT00554099|1415558|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
423417|NCT00554099|1415556|P3|Non-Treatment Phase (9 Months)|Relapse|1
423418|NCT00554099|1415557|P2|Non-Treatment Phase (9 Months)|Relapse|1
423419|NCT00554099|1415558|P1|Non-Treatment Phase (9 Months)|Relapse|2
423420|NCT00554099|1415556|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
423421|NCT00554099|1415557|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
423422|NCT00554099|1415558|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
423423|NCT00554099|1415556|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
423424|NCT00554099|1415557|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
423425|NCT00554099|1415558|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
423426|NCT00554099|1415556|P3|Treatment Period (12 Weeks)|Protocol Violation|2
423427|NCT00554099|1415557|P2|Treatment Period (12 Weeks)|Protocol Violation|0
423428|NCT00554099|1415558|P1|Treatment Period (12 Weeks)|Protocol Violation|0
423429|NCT00554099|1415556|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
423430|NCT00554099|1415557|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
423431|NCT00554099|1415558|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
423432|NCT00554099|1415556|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
423433|NCT00554099|1415557|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
423434|NCT00554099|1415558|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
423435|NCT00554099|1415556|P3|Treatment Period (12 Weeks)|Physician Decision|0
423436|NCT00554099|1415557|P2|Treatment Period (12 Weeks)|Physician Decision|0
423437|NCT00554099|1415558|P1|Treatment Period (12 Weeks)|Physician Decision|3
423438|NCT00554099|1415556|P3|Treatment Period (12 Weeks)|Adverse Event|1
423439|NCT00554099|1415557|P2|Treatment Period (12 Weeks)|Adverse Event|5
423440|NCT00554099|1415558|P1|Treatment Period (12 Weeks)|Adverse Event|3
423441|NCT00553787|1415613|P3|Overall Study|not specified|13
423442|NCT00553787|1415614|P2|Overall Study|not specified|10
423443|NCT00553787|1415615|P1|Overall Study|not specified|18
423444|NCT00553787|1415613|P3|Overall Study|Requirement for restricted medication|5
423445|NCT00553787|1415614|P2|Overall Study|Requirement for restricted medication|7
423446|NCT00553787|1415615|P1|Overall Study|Requirement for restricted medication|8
423447|NCT00553787|1415613|P3|Overall Study|non compliance|11
423448|NCT00553787|1415614|P2|Overall Study|non compliance|0
423449|NCT00553787|1415615|P1|Overall Study|non compliance|4
423450|NCT00553787|1415613|P3|Overall Study|Pregnancy|2
423451|NCT00553787|1415614|P2|Overall Study|Pregnancy|1
423452|NCT00553787|1415615|P1|Overall Study|Pregnancy|0
423453|NCT00553787|1415613|P3|Overall Study|Lack of Efficacy|3
423454|NCT00553787|1415614|P2|Overall Study|Lack of Efficacy|1
423455|NCT00553787|1415615|P1|Overall Study|Lack of Efficacy|31
423456|NCT00553787|1415613|P3|Overall Study|Withdrawal by Subject|83
423457|NCT00553787|1415614|P2|Overall Study|Withdrawal by Subject|40
423458|NCT00553787|1415615|P1|Overall Study|Withdrawal by Subject|151
423459|NCT00553787|1415613|P3|Overall Study|Lost to Follow-up|78
423460|NCT00553787|1415614|P2|Overall Study|Lost to Follow-up|44
423461|NCT00553787|1415615|P1|Overall Study|Lost to Follow-up|132
423462|NCT00553787|1415613|P3|Overall Study|Adverse Event|67
423463|NCT00553787|1415614|P2|Overall Study|Adverse Event|21
423464|NCT00553787|1415615|P1|Overall Study|Adverse Event|34
423465|NCT00553696|1415647|P4|Overall Study|Withdrawal by Subject|0
423466|NCT00553696|1415648|P3|Overall Study|Withdrawal by Subject|0
423467|NCT00553696|1415649|P2|Overall Study|Withdrawal by Subject|1
423468|NCT00553696|1415650|P1|Overall Study|Withdrawal by Subject|0
423469|NCT00553696|1415647|P4|Overall Study|Objective progression or relapse|0
423470|NCT00553696|1415648|P3|Overall Study|Objective progression or relapse|6
423471|NCT00553696|1415649|P2|Overall Study|Objective progression or relapse|9
423472|NCT00553696|1415650|P1|Overall Study|Objective progression or relapse|2
423473|NCT00553696|1415647|P4|Overall Study|Global deterioration of health status|0
423474|NCT00553696|1415648|P3|Overall Study|Global deterioration of health status|0
423475|NCT00553696|1415649|P2|Overall Study|Global deterioration of health status|2
423476|NCT00553696|1415650|P1|Overall Study|Global deterioration of health status|0
423477|NCT00553696|1415647|P4|Overall Study|Adverse Event|1
423478|NCT00553696|1415648|P3|Overall Study|Adverse Event|0
423479|NCT00553696|1415649|P2|Overall Study|Adverse Event|4
423480|NCT00553696|1415650|P1|Overall Study|Adverse Event|2
423481|NCT00553644|1415688|P1|Overall Study|Alternative therapy|6
423482|NCT00553644|1415688|P1|Overall Study|Physician Decision|1
423483|NCT00553644|1415688|P1|Overall Study|Withdrawal by Subject|4
423484|NCT00553644|1415688|P1|Overall Study|Adverse Event|17
423485|NCT00553631|1415697|P2|Overall Study|Lost to Follow-up|0
423486|NCT00553631|1415698|P1|Overall Study|Lost to Follow-up|1
423487|NCT00553631|1415697|P2|Overall Study|Withdrawal by Subject|1
423488|NCT00553631|1415698|P1|Overall Study|Withdrawal by Subject|0
423489|NCT00553605|1415720|P2|Overall Study|Randomized but not treated|0
423490|NCT00553605|1415721|P1|Overall Study|Randomized but not treated|2
423491|NCT00553605|1415720|P2|Overall Study|Did not receive full dose|0
423492|NCT00553605|1415721|P1|Overall Study|Did not receive full dose|1
423493|NCT00553605|1415720|P2|Overall Study|Did not meet entrance criteria|3
423494|NCT00553605|1415721|P1|Overall Study|Did not meet entrance criteria|1
423495|NCT00553514|1415750|P5|Overall Study|Other|1
423496|NCT00553514|1415751|P4|Overall Study|Other|0
423497|NCT00553514|1415752|P3|Overall Study|Other|0
423498|NCT00553514|1415753|P2|Overall Study|Other|1
423499|NCT00553514|1415754|P1|Overall Study|Other|1
423500|NCT00553514|1415750|P5|Overall Study|Risk of multiple pregnancy|0
423501|NCT00553514|1415751|P4|Overall Study|Risk of multiple pregnancy|1
423502|NCT00553514|1415752|P3|Overall Study|Risk of multiple pregnancy|0
423503|NCT00553514|1415753|P2|Overall Study|Risk of multiple pregnancy|2
423504|NCT00553514|1415754|P1|Overall Study|Risk of multiple pregnancy|0
423505|NCT00553514|1415750|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
423506|NCT00553514|1415751|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
423507|NCT00553514|1415752|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
423508|NCT00553514|1415753|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
423509|NCT00553514|1415754|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
423510|NCT00553514|1415750|P5|Overall Study|Lack of ovarian response|6
423511|NCT00553514|1415751|P4|Overall Study|Lack of ovarian response|5
423512|NCT00553514|1415752|P3|Overall Study|Lack of ovarian response|5
423513|NCT00553514|1415753|P2|Overall Study|Lack of ovarian response|5
423514|NCT00553514|1415754|P1|Overall Study|Lack of ovarian response|4
423515|NCT00553514|1415750|P5|Overall Study|Protocol deviation|0
423516|NCT00553514|1415751|P4|Overall Study|Protocol deviation|1
423517|NCT00553514|1415752|P3|Overall Study|Protocol deviation|0
423518|NCT00553514|1415753|P2|Overall Study|Protocol deviation|0
423519|NCT00553514|1415754|P1|Overall Study|Protocol deviation|0
423520|NCT00553501|1415791|P1|Overall Study|Progression|1
423521|NCT00553501|1415791|P1|Overall Study|Death|1
423522|NCT00553501|1415791|P1|Overall Study|Adverse Event|2
423523|NCT00553475|1415800|P3|Overall Study|Due to moving|0
423524|NCT00553475|1415801|P2|Overall Study|Due to moving|1
423525|NCT00553475|1415802|P1|Overall Study|Due to moving|0
423526|NCT00553475|1415800|P3|Overall Study|Physician Decision|0
423527|NCT00553475|1415801|P2|Overall Study|Physician Decision|0
423528|NCT00553475|1415802|P1|Overall Study|Physician Decision|1
423529|NCT00553475|1415800|P3|Overall Study|Withdrawal by Subject|0
423530|NCT00553475|1415801|P2|Overall Study|Withdrawal by Subject|1
423531|NCT00553475|1415802|P1|Overall Study|Withdrawal by Subject|1
423532|NCT00553475|1415800|P3|Overall Study|Lack of Efficacy|0
423533|NCT00553475|1415801|P2|Overall Study|Lack of Efficacy|1
423534|NCT00553475|1415802|P1|Overall Study|Lack of Efficacy|7
423535|NCT00553475|1415800|P3|Overall Study|Adverse Event|13
423536|NCT00553475|1415801|P2|Overall Study|Adverse Event|17
423537|NCT00553475|1415802|P1|Overall Study|Adverse Event|7
423538|NCT00553462|1415924|P1|Overall Study|Physician Decision|1
423539|NCT00553462|1415924|P1|Overall Study|Withdrawal by Subject|5
423540|NCT00553462|1415924|P1|Overall Study|Progression|4
423541|NCT00553462|1415924|P1|Overall Study|Adverse Event|4
423542|NCT00553436|1415930|P1|Overall Study|Conversion to another procedure|1
423543|NCT00553358|1415939|P3|Overall Study|Other: Reason Not Specified|20
423544|NCT00553358|1415940|P2|Overall Study|Other: Reason Not Specified|4
423545|NCT00553358|1415941|P1|Overall Study|Other: Reason Not Specified|15
423546|NCT00553358|1415939|P3|Overall Study|Missing|1
423547|NCT00553358|1415940|P2|Overall Study|Missing|1
423548|NCT00553358|1415941|P1|Overall Study|Missing|1
423549|NCT00553358|1415939|P3|Overall Study|Participant Withdrawal from Drug|3
423550|NCT00553358|1415940|P2|Overall Study|Participant Withdrawal from Drug|0
423551|NCT00553358|1415941|P1|Overall Study|Participant Withdrawal from Drug|0
423552|NCT00553358|1415939|P3|Overall Study|Recurrence of Disease|1
423553|NCT00553358|1415940|P2|Overall Study|Recurrence of Disease|4
423554|NCT00553358|1415941|P1|Overall Study|Recurrence of Disease|3
423555|NCT00553358|1415939|P3|Overall Study|Withdrawal by Subject|1
423556|NCT00553358|1415940|P2|Overall Study|Withdrawal by Subject|0
423557|NCT00553358|1415941|P1|Overall Study|Withdrawal by Subject|5
423558|NCT00553358|1415939|P3|Overall Study|Protocol Violation|1
423559|NCT00553358|1415940|P2|Overall Study|Protocol Violation|1
423560|NCT00553358|1415941|P1|Overall Study|Protocol Violation|0
423561|NCT00553358|1415939|P3|Overall Study|Lost to Follow-up|1
423562|NCT00553358|1415940|P2|Overall Study|Lost to Follow-up|0
423563|NCT00553358|1415941|P1|Overall Study|Lost to Follow-up|0
423564|NCT00553358|1415939|P3|Overall Study|Adverse Event|32
423565|NCT00553358|1415940|P2|Overall Study|Adverse Event|2
423566|NCT00553358|1415941|P1|Overall Study|Adverse Event|29
423567|NCT00553332|1415967|P1|Overall Study|ineligible, incorrect diagnosis|1
423568|NCT00553319|1415979|P3|Overall Study|moved|1
423569|NCT00553319|1415980|P2|Overall Study|moved|0
423570|NCT00553319|1415981|P1|Overall Study|moved|1
423571|NCT00553319|1415979|P3|Overall Study|incarceration|0
423572|NCT00553319|1415980|P2|Overall Study|incarceration|0
423573|NCT00553319|1415981|P1|Overall Study|incarceration|1
423574|NCT00553319|1415979|P3|Overall Study|non-compliance|2
423575|NCT00553319|1415980|P2|Overall Study|non-compliance|0
423576|NCT00553319|1415981|P1|Overall Study|non-compliance|0
423577|NCT00553319|1415979|P3|Overall Study|wanted treatment elsewhere|1
423578|NCT00553319|1415980|P2|Overall Study|wanted treatment elsewhere|1
423579|NCT00553319|1415981|P1|Overall Study|wanted treatment elsewhere|2
423580|NCT00553319|1415979|P3|Overall Study|Lost to Follow-up|5
423581|NCT00553319|1415980|P2|Overall Study|Lost to Follow-up|9
423582|NCT00553319|1415981|P1|Overall Study|Lost to Follow-up|10
423583|NCT00553280|1415992|P1|Overall Study|Physician Decision|1
423584|NCT00553280|1415992|P1|Overall Study|Withdrawal by Subject|3
423585|NCT00553280|1415992|P1|Overall Study|Lack of Efficacy|3
423586|NCT00553280|1415992|P1|Overall Study|Adverse Event|19
423587|NCT00553267|1416004|P3|Overall Study|Specified category|1
423588|NCT00553267|1416005|P2|Overall Study|Specified category|2
423589|NCT00553267|1416006|P1|Overall Study|Specified category|1
423590|NCT00553267|1416004|P3|Overall Study|Consent withdrawn|1
423591|NCT00553267|1416005|P2|Overall Study|Consent withdrawn|3
423592|NCT00553267|1416006|P1|Overall Study|Consent withdrawn|2
423593|NCT00553267|1416004|P3|Overall Study|Lost to Follow-up|1
423594|NCT00553267|1416005|P2|Overall Study|Lost to Follow-up|0
423595|NCT00553267|1416006|P1|Overall Study|Lost to Follow-up|0
423596|NCT00553267|1416004|P3|Overall Study|Non compliant with protocol|2
423597|NCT00553267|1416005|P2|Overall Study|Non compliant with protocol|3
423598|NCT00553267|1416006|P1|Overall Study|Non compliant with protocol|3
423599|NCT00553267|1416004|P3|Overall Study|Adverse Event|5
423600|NCT00553267|1416005|P2|Overall Study|Adverse Event|10
423601|NCT00553267|1416006|P1|Overall Study|Adverse Event|8
423602|NCT00553202|1416041|P1|Overall Study|Fails to meet organ function|6
423603|NCT00553202|1416041|P1|Overall Study|No donor identified|16
423604|NCT00553202|1416041|P1|Overall Study|Withdrawal by Subject|1
423605|NCT00553202|1416041|P1|Overall Study|Physician Decision|28
423606|NCT00553202|1416041|P1|Overall Study|Lost to Follow-up|1
423607|NCT00553202|1416041|P1|Overall Study|Death|16
423608|NCT00553150|1416051|P4|Overall Study|Ineligible|1
423609|NCT00553150|1416052|P3|Overall Study|Ineligible|0
423610|NCT00553150|1416053|P2|Overall Study|Ineligible|0
423611|NCT00553150|1416054|P1|Overall Study|Ineligible|0
423612|NCT00553150|1416051|P4|Overall Study|Protocol Violation|1
423613|NCT00553150|1416052|P3|Overall Study|Protocol Violation|0
423614|NCT00553150|1416053|P2|Overall Study|Protocol Violation|0
423615|NCT00553150|1416054|P1|Overall Study|Protocol Violation|0
423616|NCT00553150|1416051|P4|Overall Study|Withdrawal by Subject|2
423617|NCT00553150|1416052|P3|Overall Study|Withdrawal by Subject|0
423618|NCT00553150|1416053|P2|Overall Study|Withdrawal by Subject|0
423619|NCT00553150|1416054|P1|Overall Study|Withdrawal by Subject|0
423620|NCT00552760|1416099|P2|Overall Study|Medication Change|0
423621|NCT00552760|1416100|P1|Overall Study|Medication Change|1
423622|NCT00552760|1416099|P2|Overall Study|Withdrawal by Subject|0
423623|NCT00552760|1416100|P1|Overall Study|Withdrawal by Subject|3
423624|NCT00552760|1416099|P2|Overall Study|Medical Condition|1
423625|NCT00552760|1416100|P1|Overall Study|Medical Condition|1
423626|NCT00552760|1416099|P2|Overall Study|Non-compliance|1
423627|NCT00552760|1416100|P1|Overall Study|Non-compliance|1
423628|NCT00552760|1416099|P2|Overall Study|Lost to Follow-up|1
423629|NCT00552760|1416100|P1|Overall Study|Lost to Follow-up|1
423630|NCT00552760|1416099|P2|Overall Study|Protocol Violation|1
423631|NCT00552760|1416100|P1|Overall Study|Protocol Violation|0
423632|NCT00552760|1416099|P2|Overall Study|Relapsed- Mixed Event|5
423633|NCT00552760|1416100|P1|Overall Study|Relapsed- Mixed Event|3
423634|NCT00552760|1416099|P2|Overall Study|Relapse- Manic Event|3
423635|NCT00552760|1416100|P1|Overall Study|Relapse- Manic Event|3
423636|NCT00552760|1416099|P2|Overall Study|Relapsed- Depressed Event|16
423637|NCT00552760|1416100|P1|Overall Study|Relapsed- Depressed Event|10
423638|NCT00552760|1416099|P2|Overall Study|Adverse Event|5
423639|NCT00552760|1416100|P1|Overall Study|Adverse Event|3
423640|NCT00552669|1416127|P2|Overall Study|Death|7
423641|NCT00552669|1416128|P1|Overall Study|Death|3
423642|NCT00552578|1416140|P2|Overall Study|Lost to Follow-up|1
423643|NCT00552578|1416141|P1|Overall Study|Lost to Follow-up|1
423644|NCT00552513|1416153|P2|Overall Study|Lost to Follow-up|1
423645|NCT00552513|1416154|P1|Overall Study|Lost to Follow-up|5
423646|NCT00552396|1416199|P7|Overall Study|protocol withdrawal criteria|9
423647|NCT00552396|1416200|P6|Overall Study|protocol withdrawal criteria|3
423648|NCT00552396|1416201|P5|Overall Study|protocol withdrawal criteria|3
423649|NCT00552396|1416202|P4|Overall Study|protocol withdrawal criteria|6
423650|NCT00552396|1416203|P3|Overall Study|protocol withdrawal criteria|3
423651|NCT00552396|1416204|P2|Overall Study|protocol withdrawal criteria|3
423652|NCT00552396|1416205|P1|Overall Study|protocol withdrawal criteria|3
423653|NCT00552344|1416242|P1|Overall Study|Other Reason|22
423654|NCT00552344|1416242|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
423655|NCT00552344|1416242|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
423656|NCT00552344|1416242|P1|Overall Study|AE, non-serious non-fatal|38
423657|NCT00552344|1416242|P1|Overall Study|SAE, non-fatal|6
423658|NCT00552344|1416242|P1|Overall Study|Withdrawal by Subject|48
423659|NCT00552344|1416242|P1|Overall Study|Lost to Follow-up|8
423660|NCT00552344|1416242|P1|Overall Study|Loss of efficacy|75
423661|NCT00552344|1416242|P1|Overall Study|Lack of Efficacy|55
423662|NCT00552305|1416251|P1|Overall Study|Other: Subject went to rehab|1
423663|NCT00552305|1416251|P1|Overall Study|Other: Subject incarcerated|1
423664|NCT00552305|1416251|P1|Overall Study|Other: Subject moved from area|2
423665|NCT00552305|1416251|P1|Overall Study|Other: Health problems, not drug related|1
423666|NCT00552305|1416251|P1|Overall Study|Other: Subject became pregnant|1
423667|NCT00552305|1416251|P1|Overall Study|Other: Subject underwent surgery|4
423668|NCT00552305|1416251|P1|Overall Study|Other: Unable to attend visits|1
423669|NCT00552305|1416251|P1|Overall Study|Other: Personal problems|1
423670|NCT00552305|1416251|P1|Overall Study|Other: Site closed|4
423671|NCT00552305|1416251|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
423672|NCT00552305|1416251|P1|Overall Study|AE/Other: prohibited drug required|1
423673|NCT00552305|1416251|P1|Overall Study|Poor compliance/lost to follow-up|1
423674|NCT00552305|1416251|P1|Overall Study|Unsatisfactory compliance|11
423675|NCT00552305|1416251|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
423676|NCT00552305|1416251|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
423677|NCT00552305|1416251|P1|Overall Study|Lack of efficacy/withdrew consent|1
423678|NCT00552305|1416251|P1|Overall Study|Withdrawal by Subject|44
423679|NCT00552305|1416251|P1|Overall Study|Protocol Violation|3
423680|NCT00552305|1416251|P1|Overall Study|Lost to Follow-up|4
423681|NCT00552305|1416251|P1|Overall Study|Lack of Efficacy|120
423682|NCT00552305|1416251|P1|Overall Study|Adverse Event|43
423683|NCT00552279|1416261|P2|Overall Study|Other|1
423684|NCT00552279|1416262|P1|Overall Study|Other|1
423685|NCT00552279|1416261|P2|Overall Study|Lost to Follow-up|0
423686|NCT00552279|1416262|P1|Overall Study|Lost to Follow-up|1
423687|NCT00552279|1416261|P2|Overall Study|Withdrawal by Subject|1
423688|NCT00552279|1416262|P1|Overall Study|Withdrawal by Subject|12
423689|NCT00552279|1416261|P2|Overall Study|Adverse Event|1
423690|NCT00552279|1416262|P1|Overall Study|Adverse Event|0
423691|NCT00552240|1416288|P2|Overall Study|not specified|0
423692|NCT00552240|1416289|P1|Overall Study|not specified|1
423693|NCT00552240|1416288|P2|Overall Study|Lack of Efficacy|0
423694|NCT00552240|1416289|P1|Overall Study|Lack of Efficacy|6
423695|NCT00552240|1416288|P2|Overall Study|Withdrawal by Subject|2
423696|NCT00552240|1416289|P1|Overall Study|Withdrawal by Subject|2
423697|NCT00552240|1416288|P2|Overall Study|Lost to Follow-up|6
423698|NCT00552240|1416289|P1|Overall Study|Lost to Follow-up|5
423699|NCT00552240|1416288|P2|Overall Study|Protocol Violation|1
423700|NCT00552240|1416289|P1|Overall Study|Protocol Violation|1
423701|NCT00552240|1416288|P2|Overall Study|Adverse Event|9
423702|NCT00552240|1416289|P1|Overall Study|Adverse Event|9
423703|NCT00552188|1416391|P2|Overall Study|Subject returned to home country|1
423704|NCT00552188|1416392|P1|Overall Study|Subject returned to home country|0
423705|NCT00552188|1416391|P2|Overall Study|Withdrawal of consent|1
423706|NCT00552188|1416392|P1|Overall Study|Withdrawal of consent|0
423707|NCT00552188|1416391|P2|Overall Study|Lost to Follow-up|1
423708|NCT00552188|1416392|P1|Overall Study|Lost to Follow-up|2
423709|NCT00552188|1416391|P2|Overall Study|Adverse Event|2
423710|NCT00552188|1416392|P1|Overall Study|Adverse Event|0
423711|NCT00552175|1416403|P3|Overall Study|Reason Not Specified|1
423712|NCT00552175|1416404|P2|Overall Study|Reason Not Specified|1
423713|NCT00552175|1416405|P1|Overall Study|Reason Not Specified|3
423714|NCT00552175|1416403|P3|Overall Study|Entry Criteria Not Met|0
423715|NCT00552175|1416404|P2|Overall Study|Entry Criteria Not Met|1
423716|NCT00552175|1416405|P1|Overall Study|Entry Criteria Not Met|1
423717|NCT00552175|1416403|P3|Overall Study|Lost to Follow-up|1
423718|NCT00552175|1416404|P2|Overall Study|Lost to Follow-up|0
423719|NCT00552175|1416405|P1|Overall Study|Lost to Follow-up|0
423720|NCT00552175|1416403|P3|Overall Study|Withdrawal by Subject|1
423721|NCT00552175|1416404|P2|Overall Study|Withdrawal by Subject|2
423722|NCT00552175|1416405|P1|Overall Study|Withdrawal by Subject|2
423723|NCT00552175|1416403|P3|Overall Study|Adverse Event|10
423724|NCT00552175|1416404|P2|Overall Study|Adverse Event|9
423725|NCT00552175|1416405|P1|Overall Study|Adverse Event|9
423726|NCT00552175|1416403|P3|Overall Study|Lack of Efficacy|1
423727|NCT00552175|1416404|P2|Overall Study|Lack of Efficacy|0
423728|NCT00552175|1416405|P1|Overall Study|Lack of Efficacy|2
423729|NCT00552110|1416445|P5|Overall Study|Nonserious Adverse Event (AE)|0
423730|NCT00552110|1416446|P4|Overall Study|Nonserious Adverse Event (AE)|1
423731|NCT00552110|1416447|P3|Overall Study|Nonserious Adverse Event (AE)|0
423732|NCT00552110|1416448|P2|Overall Study|Nonserious Adverse Event (AE)|0
423733|NCT00552110|1416449|P1|Overall Study|Nonserious Adverse Event (AE)|1
423734|NCT00552110|1416445|P5|Overall Study|Increased Blood Pressure at Visit 2|0
423735|NCT00552110|1416446|P4|Overall Study|Increased Blood Pressure at Visit 2|1
423736|NCT00552110|1416447|P3|Overall Study|Increased Blood Pressure at Visit 2|0
423737|NCT00552110|1416448|P2|Overall Study|Increased Blood Pressure at Visit 2|0
423738|NCT00552110|1416449|P1|Overall Study|Increased Blood Pressure at Visit 2|0
423739|NCT00552110|1416445|P5|Overall Study|Delay of Study due to Relabeling|0
423740|NCT00552110|1416446|P4|Overall Study|Delay of Study due to Relabeling|1
423741|NCT00552110|1416447|P3|Overall Study|Delay of Study due to Relabeling|0
423742|NCT00552110|1416448|P2|Overall Study|Delay of Study due to Relabeling|0
423743|NCT00552110|1416449|P1|Overall Study|Delay of Study due to Relabeling|0
423744|NCT00552110|1416445|P5|Overall Study|Use of Prohibited Medication|0
423745|NCT00552110|1416446|P4|Overall Study|Use of Prohibited Medication|0
423746|NCT00552110|1416447|P3|Overall Study|Use of Prohibited Medication|0
423747|NCT00552110|1416448|P2|Overall Study|Use of Prohibited Medication|1
423748|NCT00552110|1416449|P1|Overall Study|Use of Prohibited Medication|1
423749|NCT00552110|1416445|P5|Overall Study|Withdrawn per Sponsor|1
423750|NCT00552110|1416446|P4|Overall Study|Withdrawn per Sponsor|0
423751|NCT00552110|1416447|P3|Overall Study|Withdrawn per Sponsor|0
423752|NCT00552110|1416448|P2|Overall Study|Withdrawn per Sponsor|1
423753|NCT00552110|1416449|P1|Overall Study|Withdrawn per Sponsor|0
423754|NCT00552110|1416445|P5|Overall Study|Failed to Comply With Study Requirements|1
423755|NCT00552110|1416446|P4|Overall Study|Failed to Comply With Study Requirements|0
423756|NCT00552110|1416447|P3|Overall Study|Failed to Comply With Study Requirements|1
423757|NCT00552110|1416448|P2|Overall Study|Failed to Comply With Study Requirements|1
423758|NCT00552110|1416449|P1|Overall Study|Failed to Comply With Study Requirements|1
423759|NCT00552110|1416445|P5|Overall Study|Lost to Follow-up|1
423760|NCT00552110|1416446|P4|Overall Study|Lost to Follow-up|1
423761|NCT00552110|1416447|P3|Overall Study|Lost to Follow-up|0
423762|NCT00552110|1416448|P2|Overall Study|Lost to Follow-up|0
423763|NCT00552110|1416449|P1|Overall Study|Lost to Follow-up|0
423764|NCT00552110|1416445|P5|Overall Study|Withdrawal by Subject|2
423765|NCT00552110|1416446|P4|Overall Study|Withdrawal by Subject|3
423766|NCT00552110|1416447|P3|Overall Study|Withdrawal by Subject|0
423767|NCT00552110|1416448|P2|Overall Study|Withdrawal by Subject|2
423768|NCT00552110|1416449|P1|Overall Study|Withdrawal by Subject|0
423769|NCT00552110|1416445|P5|Overall Study|Lack of Efficacy|4
423770|NCT00552110|1416446|P4|Overall Study|Lack of Efficacy|1
423771|NCT00552110|1416447|P3|Overall Study|Lack of Efficacy|0
423772|NCT00552110|1416448|P2|Overall Study|Lack of Efficacy|0
423773|NCT00552110|1416449|P1|Overall Study|Lack of Efficacy|1
423774|NCT00552110|1416445|P5|Overall Study|Serious or Life-Threatening AE|0
423775|NCT00552110|1416446|P4|Overall Study|Serious or Life-Threatening AE|0
423776|NCT00552110|1416447|P3|Overall Study|Serious or Life-Threatening AE|1
423777|NCT00552110|1416448|P2|Overall Study|Serious or Life-Threatening AE|0
423778|NCT00552110|1416449|P1|Overall Study|Serious or Life-Threatening AE|0
423779|NCT00552084|1416468|P2|Overall Study|change in anti-arrythmic drug|1
423780|NCT00552084|1416469|P1|Overall Study|change in anti-arrythmic drug|1
423781|NCT00552084|1416468|P2|Overall Study|Protocol Violation|0
423782|NCT00552084|1416469|P1|Overall Study|Protocol Violation|1
423783|NCT00552084|1416468|P2|Overall Study|Withdrawal by Subject|5
423784|NCT00552084|1416469|P1|Overall Study|Withdrawal by Subject|4
423785|NCT00552084|1416468|P2|Overall Study|Adverse Event|3
423786|NCT00552084|1416469|P1|Overall Study|Adverse Event|2
423787|NCT00552058|1416477|P2|Overall Study|Other: Early Roll Over|0
423788|NCT00552058|1416478|P1|Overall Study|Other: Early Roll Over|1
423789|NCT00552058|1416477|P2|Overall Study|Other: Sponsors Decision|1
423790|NCT00552058|1416478|P1|Overall Study|Other: Sponsors Decision|0
423791|NCT00552058|1416477|P2|Overall Study|Other: Randomized in error|1
423792|NCT00552058|1416478|P1|Overall Study|Other: Randomized in error|0
423793|NCT00552058|1416477|P2|Overall Study|Other: Positive Stool Result|1
423794|NCT00552058|1416478|P1|Overall Study|Other: Positive Stool Result|0
423795|NCT00552058|1416477|P2|Overall Study|Other: Low CDAI score, entry violation|1
423796|NCT00552058|1416478|P1|Overall Study|Other: Low CDAI score, entry violation|0
423797|NCT00552058|1416477|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
423798|NCT00552058|1416478|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
423799|NCT00552058|1416477|P2|Overall Study|Other: Non Compliance|2
423800|NCT00552058|1416478|P1|Overall Study|Other: Non Compliance|1
423801|NCT00552058|1416477|P2|Overall Study|Other: Protocol Violation|1
423802|NCT00552058|1416478|P1|Overall Study|Other: Protocol Violation|0
423803|NCT00552058|1416477|P2|Overall Study|Withdrawal by Subject|4
423804|NCT00552058|1416478|P1|Overall Study|Withdrawal by Subject|4
423805|NCT00552058|1416477|P2|Overall Study|Lost to Follow-up|0
423806|NCT00552058|1416478|P1|Overall Study|Lost to Follow-up|1
423807|NCT00552058|1416477|P2|Overall Study|Lack of Efficacy|5
423808|NCT00552058|1416478|P1|Overall Study|Lack of Efficacy|1
423809|NCT00552058|1416477|P2|Overall Study|Adverse Event|7
423810|NCT00552058|1416478|P1|Overall Study|Adverse Event|8
423811|NCT00552032|1416518|P2|Overall Study|Lost to Follow-up|5
423812|NCT00552032|1416519|P1|Overall Study|Lost to Follow-up|8
423813|NCT00552032|1416518|P2|Overall Study|Protocol Violation|12
423814|NCT00552032|1416519|P1|Overall Study|Protocol Violation|7
423815|NCT00552032|1416518|P2|Overall Study|Withdrawal by Subject|2
423816|NCT00552032|1416519|P1|Overall Study|Withdrawal by Subject|2
423817|NCT00551759|1416563|P1|Overall Study|Ineligible|1
423818|NCT00551759|1416563|P1|Overall Study|Death|5
423819|NCT00551759|1416563|P1|Overall Study|Adverse Event|7
423820|NCT00551642|1416604|P2|Overall Study|Inclusion/Exclusion criteria|4
423821|NCT00551642|1416605|P1|Overall Study|Inclusion/Exclusion criteria|4
423822|NCT00551642|1416604|P2|Overall Study|Delivery device failure|3
423823|NCT00551642|1416605|P1|Overall Study|Delivery device failure|1
423824|NCT00551642|1416604|P2|Overall Study|Physician Decision|1
423825|NCT00551642|1416605|P1|Overall Study|Physician Decision|0
423826|NCT00551642|1416604|P2|Overall Study|Protocol Violation|11
423827|NCT00551642|1416605|P1|Overall Study|Protocol Violation|6
423828|NCT00551642|1416604|P2|Overall Study|Death|31
423829|NCT00551642|1416605|P1|Overall Study|Death|33
423830|NCT00551642|1416604|P2|Overall Study|Adverse Event|12
423831|NCT00551642|1416605|P1|Overall Study|Adverse Event|15
423832|NCT00551642|1416604|P2|Overall Study|Withdrawal by Subject|1
423833|NCT00551642|1416605|P1|Overall Study|Withdrawal by Subject|2
423834|NCT00551525|1416611|P1|Overall Study|Protocol Violation|5
423835|NCT00551460|1416620|P1|Overall Study|Not analyzable (did not start treatment)|4
423836|NCT00551460|1416620|P1|Overall Study|Ineligible|4
423837|NCT00551460|1416620|P1|Overall Study|Death|7
423838|NCT00551460|1416620|P1|Overall Study|Physician Decision|1
423839|NCT00551460|1416620|P1|Overall Study|Withdrawal by Subject|1
423840|NCT00551460|1416620|P1|Overall Study|Adverse Event|1
423841|NCT00551421|1416626|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
423842|NCT00551369|1416633|P1|Overall Study|Not treated per protocol and re|1
423843|NCT00551369|1416633|P1|Overall Study|Withdrawal by Subject|1
423844|NCT00551369|1416633|P1|Overall Study|Protocol Violation|5
423845|NCT00551291|1416641|P1|Overall Study|Physician Decision|1
423846|NCT00551213|1416649|P2|Overall Study|Not Treated|2
423847|NCT00551213|1416650|P1|Overall Study|Not Treated|1
423848|NCT00551213|1416649|P2|Overall Study|Withdrawal by Subject|0
423849|NCT00551213|1416650|P1|Overall Study|Withdrawal by Subject|2
423850|NCT00551213|1416649|P2|Overall Study|Progressive Disease|12
423851|NCT00551213|1416650|P1|Overall Study|Progressive Disease|41
423852|NCT00551213|1416649|P2|Overall Study|Adverse Event|3
423853|NCT00551213|1416650|P1|Overall Study|Adverse Event|6
423854|NCT00551161|1416694|P1|Overall Study|Withdrawal by Subject|1
423855|NCT00551135|1416702|P4|Overall Study|Withdrawal by Subject|1
423856|NCT00551135|1416703|P3|Overall Study|Withdrawal by Subject|3
423857|NCT00551135|1416704|P2|Overall Study|Withdrawal by Subject|0
423858|NCT00551135|1416705|P1|Overall Study|Withdrawal by Subject|1
423859|NCT00551135|1416702|P4|Overall Study|Other|2
423860|NCT00551135|1416703|P3|Overall Study|Other|1
423861|NCT00551135|1416704|P2|Overall Study|Other|2
423862|NCT00551135|1416705|P1|Overall Study|Other|3
423863|NCT00551135|1416702|P4|Overall Study|Lost to Follow-up|1
423864|NCT00551135|1416703|P3|Overall Study|Lost to Follow-up|0
423865|NCT00551135|1416704|P2|Overall Study|Lost to Follow-up|0
423866|NCT00551135|1416705|P1|Overall Study|Lost to Follow-up|0
423867|NCT00551135|1416702|P4|Overall Study|Adverse Event|1
423868|NCT00551135|1416703|P3|Overall Study|Adverse Event|1
423869|NCT00551135|1416704|P2|Overall Study|Adverse Event|0
423870|NCT00551135|1416705|P1|Overall Study|Adverse Event|1
423871|NCT00551031|1416834|P5|Overall Study|Did not receive vaccine|0
423872|NCT00551031|1416835|P4|Overall Study|Did not receive vaccine|0
423873|NCT00551031|1416836|P3|Overall Study|Did not receive vaccine|0
423874|NCT00551031|1416837|P2|Overall Study|Did not receive vaccine|2
423875|NCT00551031|1416838|P1|Overall Study|Did not receive vaccine|1
423876|NCT00551031|1416834|P5|Overall Study|Serious Adverse Event|0
423877|NCT00551031|1416835|P4|Overall Study|Serious Adverse Event|0
423878|NCT00551031|1416836|P3|Overall Study|Serious Adverse Event|1
423879|NCT00551031|1416837|P2|Overall Study|Serious Adverse Event|2
423880|NCT00551031|1416838|P1|Overall Study|Serious Adverse Event|0
423881|NCT00551031|1416834|P5|Overall Study|Withdrawal by Subject|0
423882|NCT00551031|1416835|P4|Overall Study|Withdrawal by Subject|2
423883|NCT00551031|1416836|P3|Overall Study|Withdrawal by Subject|1
423884|NCT00551031|1416837|P2|Overall Study|Withdrawal by Subject|4
423885|NCT00551031|1416838|P1|Overall Study|Withdrawal by Subject|0
423886|NCT00551031|1416834|P5|Overall Study|Lost to Follow-up|1
423887|NCT00551031|1416835|P4|Overall Study|Lost to Follow-up|1
423888|NCT00551031|1416836|P3|Overall Study|Lost to Follow-up|0
423889|NCT00551031|1416837|P2|Overall Study|Lost to Follow-up|1
423890|NCT00551031|1416838|P1|Overall Study|Lost to Follow-up|0
423891|NCT00551031|1416834|P5|Overall Study|Protocol Violation|0
423892|NCT00551031|1416835|P4|Overall Study|Protocol Violation|0
423893|NCT00551031|1416836|P3|Overall Study|Protocol Violation|0
423894|NCT00551031|1416837|P2|Overall Study|Protocol Violation|1
423895|NCT00551031|1416838|P1|Overall Study|Protocol Violation|1
423896|NCT00551031|1416834|P5|Overall Study|Adverse Event|0
423897|NCT00551031|1416835|P4|Overall Study|Adverse Event|0
423898|NCT00551031|1416836|P3|Overall Study|Adverse Event|0
423899|NCT00551031|1416837|P2|Overall Study|Adverse Event|1
423900|NCT00551031|1416838|P1|Overall Study|Adverse Event|0
423901|NCT00550953|1416867|P2|Overall Study|Not able to visit the site|3
423902|NCT00550953|1416868|P1|Overall Study|Not able to visit the site|2
423903|NCT00550953|1416867|P2|Overall Study|Adverse Event|3
423904|NCT00550953|1416868|P1|Overall Study|Adverse Event|4
423905|NCT00550836|1416915|P2|Overall Study|Withdrawal by Subject|9
423906|NCT00550836|1416916|P1|Overall Study|Withdrawal by Subject|3
423907|NCT00550771|1416932|P2|Overall Study|Protocol Violation|5
423908|NCT00550771|1416933|P1|Overall Study|Protocol Violation|4
423909|NCT00550771|1416932|P2|Overall Study|Withdrawal by Subject|1
423910|NCT00550771|1416933|P1|Overall Study|Withdrawal by Subject|0
423911|NCT00550771|1416932|P2|Overall Study|Physician Decision|0
423912|NCT00550771|1416933|P1|Overall Study|Physician Decision|2
423913|NCT00550771|1416932|P2|Overall Study|Discontinued for study-related reasons|1
423914|NCT00550771|1416933|P1|Overall Study|Discontinued for study-related reasons|0
423915|NCT00550771|1416932|P2|Overall Study|Adverse Event|3
423916|NCT00550771|1416933|P1|Overall Study|Adverse Event|11
423917|NCT00550745|1416947|P2|Overall Study|Screen failure|0
423918|NCT00550745|1416948|P1|Overall Study|Screen failure|1
423919|NCT00550745|1416947|P2|Overall Study|Withdrawal by Subject|10
423920|NCT00550745|1416948|P1|Overall Study|Withdrawal by Subject|17
423921|NCT00550745|1416947|P2|Overall Study|Protocol Violation|2
423922|NCT00550745|1416948|P1|Overall Study|Protocol Violation|4
423923|NCT00550745|1416947|P2|Overall Study|Physician Decision|2
423924|NCT00550745|1416948|P1|Overall Study|Physician Decision|0
423925|NCT00550745|1416947|P2|Overall Study|Lost to Follow-up|30
423926|NCT00550745|1416948|P1|Overall Study|Lost to Follow-up|45
423927|NCT00550745|1416947|P2|Overall Study|Death|16
423928|NCT00550745|1416948|P1|Overall Study|Death|20
423929|NCT00550732|1416956|P1|Overall Study|Adverse Event|1
423930|NCT00550732|1416956|P1|Overall Study|Palliative care|1
423931|NCT00550732|1416956|P1|Overall Study|Lost to Follow-up|1
423932|NCT00550732|1416956|P1|Overall Study|Physician Decision|2
423933|NCT00550732|1416956|P1|Overall Study|Withdrawal by Subject|2
423934|NCT00550732|1416956|P1|Overall Study|Death|4
423935|NCT00550680|1416967|P1|Overall Study|Screen Failure|6
423936|NCT00550680|1416967|P1|Overall Study|Refused Treatment|19
423937|NCT00550680|1416967|P1|Overall Study|Protocol Violation|7
423938|NCT00550680|1416967|P1|Overall Study|Not Specified|10
423939|NCT00550680|1416967|P1|Overall Study|Lack of Efficacy|1
423940|NCT00550680|1416967|P1|Overall Study|Lost to Follow-up|3
423941|NCT00550680|1416967|P1|Overall Study|Early Improvement|1
423942|NCT00550680|1416967|P1|Overall Study|Death|3
423943|NCT00550680|1416967|P1|Overall Study|Adverse Event|5
423944|NCT00550680|1416967|P1|Overall Study|Administrative Reasons|1
423945|NCT00550550|1416999|P2|Overall Study|Randomized But Not Treated|0
423946|NCT00550550|1417000|P1|Overall Study|Randomized But Not Treated|1
423947|NCT00550550|1416999|P2|Overall Study|Did Not Meet Protocol Eligibility|1
423948|NCT00550550|1417000|P1|Overall Study|Did Not Meet Protocol Eligibility|1
423949|NCT00550550|1416999|P2|Overall Study|Protocol Violation|14
423950|NCT00550550|1417000|P1|Overall Study|Protocol Violation|5
423951|NCT00550550|1416999|P2|Overall Study|Withdrawal by Subject|8
423952|NCT00550550|1417000|P1|Overall Study|Withdrawal by Subject|10
423953|NCT00550550|1416999|P2|Overall Study|Lost to Follow-up|0
423954|NCT00550550|1417000|P1|Overall Study|Lost to Follow-up|4
423955|NCT00550550|1416999|P2|Overall Study|Treatment Failure|1
423956|NCT00550550|1417000|P1|Overall Study|Treatment Failure|0
423957|NCT00550550|1416999|P2|Overall Study|Adverse Event|5
423958|NCT00550550|1417000|P1|Overall Study|Adverse Event|13
423959|NCT00550537|1417012|P1|Overall Study|Treated closer to home|4
423960|NCT00550537|1417012|P1|Overall Study|Declining performance status|2
423961|NCT00550537|1417012|P1|Overall Study|Other complicating ilness|3
423962|NCT00550537|1417012|P1|Overall Study|Change in treatment plan|4
423963|NCT00550537|1417012|P1|Overall Study|Withdrawal by Subject|7
423964|NCT00550537|1417012|P1|Overall Study|Disease progression before|46
423965|NCT00550537|1417012|P1|Overall Study|Adverse Event|20
423966|NCT00550537|1417012|P1|Overall Study|Death|18
423967|NCT00550459|1417029|P2|Overall Study|Withdrawal by Subject|1
423968|NCT00550459|1417030|P1|Overall Study|Withdrawal by Subject|1
423969|NCT00550459|1417029|P2|Overall Study|Adverse Event|2
423970|NCT00550459|1417030|P1|Overall Study|Adverse Event|0
423971|NCT00550446|1417099|P11|Post Week 12|Other|0
423972|NCT00550446|1417100|P10|Post Week 12|Other|1
423973|NCT00550446|1417101|P9|Post Week 12|Other|1
423974|NCT00550446|1417102|P8|Post Week 12|Other|0
423975|NCT00550446|1417103|P7|Post Week 12|Other|1
423976|NCT00550446|1417104|P6|Post Week 12|Other|0
423977|NCT00550446|1417105|P5|Post Week 12|Other|0
423978|NCT00550446|1417106|P4|Post Week 12|Other|1
423979|NCT00550446|1417107|P3|Post Week 12|Other|0
423980|NCT00550446|1417108|P2|Post Week 12|Other|1
423981|NCT00550446|1417109|P1|Post Week 12|Other|1
423982|NCT00550446|1417099|P11|Post Week 12|Withdrawal by Subject|0
423983|NCT00550446|1417100|P10|Post Week 12|Withdrawal by Subject|0
423984|NCT00550446|1417101|P9|Post Week 12|Withdrawal by Subject|0
423985|NCT00550446|1417102|P8|Post Week 12|Withdrawal by Subject|0
423986|NCT00550446|1417103|P7|Post Week 12|Withdrawal by Subject|0
423987|NCT00550446|1417104|P6|Post Week 12|Withdrawal by Subject|0
423988|NCT00550446|1417105|P5|Post Week 12|Withdrawal by Subject|1
423989|NCT00550446|1417106|P4|Post Week 12|Withdrawal by Subject|0
423990|NCT00550446|1417107|P3|Post Week 12|Withdrawal by Subject|0
423991|NCT00550446|1417108|P2|Post Week 12|Withdrawal by Subject|0
423992|NCT00550446|1417109|P1|Post Week 12|Withdrawal by Subject|0
423993|NCT00550446|1417099|P11|Post Week 12|Lost to Follow-up|0
423994|NCT00550446|1417100|P10|Post Week 12|Lost to Follow-up|0
423995|NCT00550446|1417101|P9|Post Week 12|Lost to Follow-up|0
423996|NCT00550446|1417102|P8|Post Week 12|Lost to Follow-up|0
423997|NCT00550446|1417103|P7|Post Week 12|Lost to Follow-up|1
423998|NCT00550446|1417104|P6|Post Week 12|Lost to Follow-up|0
423999|NCT00550446|1417105|P5|Post Week 12|Lost to Follow-up|0
424000|NCT00550446|1417106|P4|Post Week 12|Lost to Follow-up|1
424001|NCT00550446|1417107|P3|Post Week 12|Lost to Follow-up|1
424002|NCT00550446|1417108|P2|Post Week 12|Lost to Follow-up|0
424003|NCT00550446|1417109|P1|Post Week 12|Lost to Follow-up|0
424004|NCT00550446|1417099|P11|Post Week 12|Lack of Efficacy|1
424005|NCT00550446|1417100|P10|Post Week 12|Lack of Efficacy|2
424006|NCT00550446|1417101|P9|Post Week 12|Lack of Efficacy|1
424007|NCT00550446|1417102|P8|Post Week 12|Lack of Efficacy|1
424008|NCT00550446|1417103|P7|Post Week 12|Lack of Efficacy|0
424009|NCT00550446|1417104|P6|Post Week 12|Lack of Efficacy|0
424010|NCT00550446|1417105|P5|Post Week 12|Lack of Efficacy|0
424011|NCT00550446|1417106|P4|Post Week 12|Lack of Efficacy|0
424012|NCT00550446|1417107|P3|Post Week 12|Lack of Efficacy|1
424013|NCT00550446|1417108|P2|Post Week 12|Lack of Efficacy|0
424014|NCT00550446|1417109|P1|Post Week 12|Lack of Efficacy|0
424015|NCT00550446|1417099|P11|Post Week 12|Adverse Event|0
424016|NCT00550446|1417100|P10|Post Week 12|Adverse Event|4
424017|NCT00550446|1417101|P9|Post Week 12|Adverse Event|0
424018|NCT00550446|1417102|P8|Post Week 12|Adverse Event|0
424019|NCT00550446|1417103|P7|Post Week 12|Adverse Event|0
424020|NCT00550446|1417104|P6|Post Week 12|Adverse Event|1
424021|NCT00550446|1417105|P5|Post Week 12|Adverse Event|1
424022|NCT00550446|1417106|P4|Post Week 12|Adverse Event|1
424023|NCT00550446|1417107|P3|Post Week 12|Adverse Event|1
424024|NCT00550446|1417108|P2|Post Week 12|Adverse Event|1
424025|NCT00550446|1417109|P1|Post Week 12|Adverse Event|2
424026|NCT00550446|1417099|P11|Up To Week 12|Randomized not treated|0
424027|NCT00550446|1417100|P10|Up To Week 12|Randomized not treated|0
424028|NCT00550446|1417101|P9|Up To Week 12|Randomized not treated|0
424029|NCT00550446|1417102|P8|Up To Week 12|Randomized not treated|0
424030|NCT00550446|1417103|P7|Up To Week 12|Randomized not treated|0
424031|NCT00550446|1417104|P6|Up To Week 12|Randomized not treated|0
424032|NCT00550446|1417105|P5|Up To Week 12|Randomized not treated|0
424033|NCT00550446|1417106|P4|Up To Week 12|Randomized not treated|0
424034|NCT00550446|1417107|P3|Up To Week 12|Randomized not treated|1
424035|NCT00550446|1417108|P2|Up To Week 12|Randomized not treated|1
424036|NCT00550446|1417109|P1|Up To Week 12|Randomized not treated|0
424037|NCT00550446|1417099|P11|Up To Week 12|Other|0
424038|NCT00550446|1417100|P10|Up To Week 12|Other|0
424039|NCT00550446|1417101|P9|Up To Week 12|Other|0
424040|NCT00550446|1417102|P8|Up To Week 12|Other|0
424041|NCT00550446|1417103|P7|Up To Week 12|Other|4
424042|NCT00550446|1417104|P6|Up To Week 12|Other|1
424043|NCT00550446|1417105|P5|Up To Week 12|Other|0
424044|NCT00550446|1417106|P4|Up To Week 12|Other|0
424045|NCT00550446|1417107|P3|Up To Week 12|Other|0
424046|NCT00550446|1417108|P2|Up To Week 12|Other|0
424047|NCT00550446|1417109|P1|Up To Week 12|Other|3
424048|NCT00550446|1417099|P11|Up To Week 12|Withdrawal by Subject|0
424049|NCT00550446|1417100|P10|Up To Week 12|Withdrawal by Subject|0
424050|NCT00550446|1417101|P9|Up To Week 12|Withdrawal by Subject|0
424051|NCT00550446|1417102|P8|Up To Week 12|Withdrawal by Subject|0
424052|NCT00550446|1417103|P7|Up To Week 12|Withdrawal by Subject|3
424053|NCT00550446|1417104|P6|Up To Week 12|Withdrawal by Subject|1
424054|NCT00550446|1417105|P5|Up To Week 12|Withdrawal by Subject|0
424055|NCT00550446|1417106|P4|Up To Week 12|Withdrawal by Subject|2
424056|NCT00550446|1417107|P3|Up To Week 12|Withdrawal by Subject|3
424057|NCT00550446|1417108|P2|Up To Week 12|Withdrawal by Subject|0
424058|NCT00550446|1417109|P1|Up To Week 12|Withdrawal by Subject|2
424059|NCT00550446|1417099|P11|Up To Week 12|Lost to Follow-up|0
424060|NCT00550446|1417100|P10|Up To Week 12|Lost to Follow-up|0
424061|NCT00550446|1417101|P9|Up To Week 12|Lost to Follow-up|0
424062|NCT00550446|1417102|P8|Up To Week 12|Lost to Follow-up|0
424063|NCT00550446|1417103|P7|Up To Week 12|Lost to Follow-up|2
424064|NCT00550446|1417104|P6|Up To Week 12|Lost to Follow-up|1
424065|NCT00550446|1417105|P5|Up To Week 12|Lost to Follow-up|1
424066|NCT00550446|1417106|P4|Up To Week 12|Lost to Follow-up|0
424067|NCT00550446|1417107|P3|Up To Week 12|Lost to Follow-up|0
424068|NCT00550446|1417108|P2|Up To Week 12|Lost to Follow-up|1
424069|NCT00550446|1417109|P1|Up To Week 12|Lost to Follow-up|0
424070|NCT00550446|1417099|P11|Up To Week 12|Lack of Efficacy|0
424071|NCT00550446|1417100|P10|Up To Week 12|Lack of Efficacy|0
424072|NCT00550446|1417101|P9|Up To Week 12|Lack of Efficacy|0
424073|NCT00550446|1417102|P8|Up To Week 12|Lack of Efficacy|0
424074|NCT00550446|1417103|P7|Up To Week 12|Lack of Efficacy|3
424075|NCT00550446|1417104|P6|Up To Week 12|Lack of Efficacy|3
424076|NCT00550446|1417105|P5|Up To Week 12|Lack of Efficacy|0
424077|NCT00550446|1417106|P4|Up To Week 12|Lack of Efficacy|1
424078|NCT00550446|1417107|P3|Up To Week 12|Lack of Efficacy|0
424079|NCT00550446|1417108|P2|Up To Week 12|Lack of Efficacy|1
424080|NCT00550446|1417109|P1|Up To Week 12|Lack of Efficacy|3
424081|NCT00550446|1417099|P11|Up To Week 12|Adverse Event|0
424082|NCT00550446|1417100|P10|Up To Week 12|Adverse Event|0
424083|NCT00550446|1417101|P9|Up To Week 12|Adverse Event|0
424084|NCT00550446|1417102|P8|Up To Week 12|Adverse Event|0
424085|NCT00550446|1417103|P7|Up To Week 12|Adverse Event|1
424086|NCT00550446|1417104|P6|Up To Week 12|Adverse Event|2
424087|NCT00550446|1417105|P5|Up To Week 12|Adverse Event|2
424088|NCT00550446|1417106|P4|Up To Week 12|Adverse Event|0
424089|NCT00550446|1417107|P3|Up To Week 12|Adverse Event|0
424090|NCT00550446|1417108|P2|Up To Week 12|Adverse Event|2
424091|NCT00550446|1417109|P1|Up To Week 12|Adverse Event|2
424092|NCT00550420|1417541|P1|Overall Study|Prohibited medicine|1
424093|NCT00550420|1417541|P1|Overall Study|Exclusion criteria|1
424094|NCT00550420|1417541|P1|Overall Study|Out of Electrocardiogram criteria|1
424095|NCT00550420|1417541|P1|Overall Study|Caregiver's decision to withdraw|1
424096|NCT00550420|1417541|P1|Overall Study|Unethical stop of enrollment|2
424097|NCT00550420|1417541|P1|Overall Study|Lack of curative effect|1
424098|NCT00550420|1417541|P1|Overall Study|Investigators opinion|1
424099|NCT00550420|1417541|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
424100|NCT00550420|1417541|P1|Overall Study|Missing|2
424101|NCT00550420|1417541|P1|Overall Study|Still in study at termination|206
424102|NCT00550420|1417541|P1|Overall Study|Withdrawal by Subject|30
424103|NCT00550420|1417541|P1|Overall Study|Protocol Violation|11
424104|NCT00550420|1417541|P1|Overall Study|Lost to Follow-up|8
424105|NCT00550420|1417541|P1|Overall Study|Adverse Event|28
424106|NCT00550407|1417564|P3|26-Week Randomized Phase|Withdrawal by Subject|3
424107|NCT00550407|1417565|P2|26-Week Randomized Phase|Withdrawal by Subject|1
424108|NCT00550407|1417566|P1|26-Week Randomized Phase|Withdrawal by Subject|0
424109|NCT00550407|1417564|P3|26-Week Randomized Phase|Investigator Discretion|0
424110|NCT00550407|1417565|P2|26-Week Randomized Phase|Investigator Discretion|1
424111|NCT00550407|1417566|P1|26-Week Randomized Phase|Investigator Discretion|0
424112|NCT00550407|1417564|P3|26-Week Randomized Phase|Lack of Efficacy|19
424113|NCT00550407|1417565|P2|26-Week Randomized Phase|Lack of Efficacy|36
424114|NCT00550407|1417566|P1|26-Week Randomized Phase|Lack of Efficacy|0
424115|NCT00550407|1417564|P3|26-Week Randomized Phase|Adverse Event|2
424116|NCT00550407|1417565|P2|26-Week Randomized Phase|Adverse Event|5
424117|NCT00550407|1417566|P1|26-Week Randomized Phase|Adverse Event|0
424118|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
424119|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
424120|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
424121|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
424122|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
424123|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
424124|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
424125|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
424126|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
424127|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
424128|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
424129|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
424130|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
424131|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
424132|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
424133|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
424134|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
424135|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
424136|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
424137|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
424138|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
424139|NCT00550407|1417564|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
424140|NCT00550407|1417565|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
424141|NCT00550407|1417566|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
424142|NCT00550173|1417632|P3|Overall Study|Lost to Follow-up|3
424143|NCT00550173|1417633|P2|Overall Study|Lost to Follow-up|4
424144|NCT00550173|1417634|P1|Overall Study|Lost to Follow-up|4
424145|NCT00550173|1417632|P3|Overall Study|Sponsor Decision|1
424146|NCT00550173|1417633|P2|Overall Study|Sponsor Decision|7
424147|NCT00550173|1417634|P1|Overall Study|Sponsor Decision|13
424148|NCT00550173|1417632|P3|Overall Study|Withdrawal by Subject|17
424149|NCT00550173|1417633|P2|Overall Study|Withdrawal by Subject|12
424150|NCT00550173|1417634|P1|Overall Study|Withdrawal by Subject|9
424151|NCT00550173|1417632|P3|Overall Study|Physician Decision|2
424152|NCT00550173|1417633|P2|Overall Study|Physician Decision|2
424153|NCT00550173|1417634|P1|Overall Study|Physician Decision|1
424154|NCT00550173|1417632|P3|Overall Study|Death|50
424155|NCT00550173|1417633|P2|Overall Study|Death|38
424156|NCT00550173|1417634|P1|Overall Study|Death|45
424157|NCT00550147|1417663|P1|Quetiapine Addition Treatment Period|Moved out of state|1
424158|NCT00550147|1417663|P1|Quetiapine Addition Treatment Period|Noncompliance|2
424159|NCT00550147|1417663|P1|Quetiapine Addition Treatment Period|Adverse Event|3
424160|NCT00550147|1417663|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
424161|NCT00550147|1417663|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
424162|NCT00550043|1417686|P5|Overall Study|Other Reasons- Unspecified|0
424163|NCT00550043|1417687|P4|Overall Study|Other Reasons- Unspecified|1
424164|NCT00550043|1417688|P3|Overall Study|Other Reasons- Unspecified|0
424165|NCT00550043|1417689|P2|Overall Study|Other Reasons- Unspecified|1
424166|NCT00550043|1417690|P1|Overall Study|Other Reasons- Unspecified|0
424167|NCT00550043|1417686|P5|Overall Study|Subject Withdrew Consent|0
424168|NCT00550043|1417687|P4|Overall Study|Subject Withdrew Consent|0
424169|NCT00550043|1417688|P3|Overall Study|Subject Withdrew Consent|1
424170|NCT00550043|1417689|P2|Overall Study|Subject Withdrew Consent|2
424171|NCT00550043|1417690|P1|Overall Study|Subject Withdrew Consent|0
424172|NCT00550043|1417686|P5|Overall Study|Adverse Event|1
424173|NCT00550043|1417687|P4|Overall Study|Adverse Event|1
424174|NCT00550043|1417688|P3|Overall Study|Adverse Event|0
424175|NCT00550043|1417689|P2|Overall Study|Adverse Event|0
424176|NCT00550043|1417690|P1|Overall Study|Adverse Event|0
424177|NCT00549939|1417745|P3|40-week Open Label Treatment Period|Other|4
424178|NCT00549939|1417746|P2|40-week Open Label Treatment Period|Other|1
424179|NCT00549939|1417747|P1|40-week Open Label Treatment Period|Other|0
424180|NCT00549939|1417745|P3|40-week Open Label Treatment Period|Protocol Violation|0
424181|NCT00549939|1417746|P2|40-week Open Label Treatment Period|Protocol Violation|1
424182|NCT00549939|1417747|P1|40-week Open Label Treatment Period|Protocol Violation|0
424183|NCT00549939|1417745|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
424184|NCT00549939|1417746|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
424185|NCT00549939|1417747|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
424186|NCT00549939|1417745|P3|40-week Open Label Treatment Period|Adverse Event|1
424187|NCT00549939|1417746|P2|40-week Open Label Treatment Period|Adverse Event|2
424188|NCT00549939|1417747|P1|40-week Open Label Treatment Period|Adverse Event|0
424189|NCT00549939|1417745|P3|12-week Double Blind Treatment Period|Too many blood draws|0
424190|NCT00549939|1417746|P2|12-week Double Blind Treatment Period|Too many blood draws|1
424191|NCT00549939|1417747|P1|12-week Double Blind Treatment Period|Too many blood draws|0
424192|NCT00549939|1417745|P3|12-week Double Blind Treatment Period|Adverse Event|2
424193|NCT00549939|1417746|P2|12-week Double Blind Treatment Period|Adverse Event|1
424194|NCT00549939|1417747|P1|12-week Double Blind Treatment Period|Adverse Event|1
424195|NCT00549900|1417774|P1|Overall Study|Adverse Event|1
424196|NCT00549770|1417830|P8|Overall Study|Adverse Event|4
424197|NCT00549770|1417831|P7|Overall Study|Adverse Event|5
424198|NCT00549770|1417832|P6|Overall Study|Adverse Event|0
424199|NCT00549770|1417833|P5|Overall Study|Adverse Event|1
424200|NCT00549770|1417834|P4|Overall Study|Adverse Event|2
424201|NCT00549770|1417835|P3|Overall Study|Adverse Event|1
424202|NCT00549770|1417836|P2|Overall Study|Adverse Event|3
424203|NCT00549770|1417837|P1|Overall Study|Adverse Event|1
424204|NCT00549770|1417830|P8|Overall Study|Abnormal laboratory values|0
424205|NCT00549770|1417831|P7|Overall Study|Abnormal laboratory values|0
424206|NCT00549770|1417832|P6|Overall Study|Abnormal laboratory values|1
424207|NCT00549770|1417833|P5|Overall Study|Abnormal laboratory values|0
424208|NCT00549770|1417834|P4|Overall Study|Abnormal laboratory values|0
424209|NCT00549770|1417835|P3|Overall Study|Abnormal laboratory values|0
424210|NCT00549770|1417836|P2|Overall Study|Abnormal laboratory values|0
424211|NCT00549770|1417837|P1|Overall Study|Abnormal laboratory values|0
424212|NCT00549770|1417830|P8|Overall Study|Abnormal test procedure results|1
424213|NCT00549770|1417831|P7|Overall Study|Abnormal test procedure results|1
424214|NCT00549770|1417832|P6|Overall Study|Abnormal test procedure results|1
424215|NCT00549770|1417833|P5|Overall Study|Abnormal test procedure results|0
424216|NCT00549770|1417834|P4|Overall Study|Abnormal test procedure results|2
424217|NCT00549770|1417835|P3|Overall Study|Abnormal test procedure results|0
424218|NCT00549770|1417836|P2|Overall Study|Abnormal test procedure results|0
424219|NCT00549770|1417837|P1|Overall Study|Abnormal test procedure results|0
424220|NCT00549770|1417830|P8|Overall Study|Lack of Efficacy|8
424221|NCT00549770|1417831|P7|Overall Study|Lack of Efficacy|3
424222|NCT00549770|1417832|P6|Overall Study|Lack of Efficacy|1
424223|NCT00549770|1417833|P5|Overall Study|Lack of Efficacy|5
424224|NCT00549770|1417834|P4|Overall Study|Lack of Efficacy|3
424225|NCT00549770|1417835|P3|Overall Study|Lack of Efficacy|2
424226|NCT00549770|1417836|P2|Overall Study|Lack of Efficacy|0
424227|NCT00549770|1417837|P1|Overall Study|Lack of Efficacy|1
424228|NCT00549770|1417830|P8|Overall Study|Withdrawal by Subject|9
424229|NCT00549770|1417831|P7|Overall Study|Withdrawal by Subject|4
424230|NCT00549770|1417832|P6|Overall Study|Withdrawal by Subject|6
424231|NCT00549770|1417833|P5|Overall Study|Withdrawal by Subject|6
424232|NCT00549770|1417834|P4|Overall Study|Withdrawal by Subject|5
424233|NCT00549770|1417835|P3|Overall Study|Withdrawal by Subject|4
424234|NCT00549770|1417836|P2|Overall Study|Withdrawal by Subject|6
424235|NCT00549770|1417837|P1|Overall Study|Withdrawal by Subject|4
424236|NCT00549770|1417830|P8|Overall Study|Lost to Follow-up|0
424237|NCT00549770|1417831|P7|Overall Study|Lost to Follow-up|0
424238|NCT00549770|1417832|P6|Overall Study|Lost to Follow-up|2
424239|NCT00549770|1417833|P5|Overall Study|Lost to Follow-up|3
424240|NCT00549770|1417834|P4|Overall Study|Lost to Follow-up|2
424241|NCT00549770|1417835|P3|Overall Study|Lost to Follow-up|2
424242|NCT00549770|1417836|P2|Overall Study|Lost to Follow-up|0
424243|NCT00549770|1417837|P1|Overall Study|Lost to Follow-up|0
424244|NCT00549770|1417830|P8|Overall Study|Administrative problems|1
424245|NCT00549770|1417831|P7|Overall Study|Administrative problems|0
424246|NCT00549770|1417832|P6|Overall Study|Administrative problems|0
424247|NCT00549770|1417833|P5|Overall Study|Administrative problems|0
424248|NCT00549770|1417834|P4|Overall Study|Administrative problems|0
424249|NCT00549770|1417835|P3|Overall Study|Administrative problems|0
424250|NCT00549770|1417836|P2|Overall Study|Administrative problems|1
424251|NCT00549770|1417837|P1|Overall Study|Administrative problems|0
424252|NCT00549770|1417830|P8|Overall Study|Protocol deviation|2
424253|NCT00549770|1417831|P7|Overall Study|Protocol deviation|1
424254|NCT00549770|1417832|P6|Overall Study|Protocol deviation|2
424255|NCT00549770|1417833|P5|Overall Study|Protocol deviation|2
424256|NCT00549770|1417834|P4|Overall Study|Protocol deviation|2
424257|NCT00549770|1417835|P3|Overall Study|Protocol deviation|1
424258|NCT00549770|1417836|P2|Overall Study|Protocol deviation|1
424259|NCT00549770|1417837|P1|Overall Study|Protocol deviation|1
424260|NCT00549757|1417921|P2|Extension Period (in Average 9 Months)|Patient's request|436
424261|NCT00549757|1417922|P1|Extension Period (in Average 9 Months)|Patient's request|421
424262|NCT00549757|1417921|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
424263|NCT00549757|1417922|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
424264|NCT00549757|1417921|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
424265|NCT00549757|1417922|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
424266|NCT00549757|1417921|P2|Extension Period (in Average 9 Months)|Death|136
424267|NCT00549757|1417922|P1|Extension Period (in Average 9 Months)|Death|143
424268|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
424269|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
424270|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
424271|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
424272|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
424273|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
424274|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Death|200
424275|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Death|188
424276|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
424277|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
424278|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
424279|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
424280|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
424281|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
424282|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
424283|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
424284|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
424285|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
424286|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
424287|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
424288|NCT00549757|1417921|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
424289|NCT00549757|1417922|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
424290|NCT00549718|1417984|P4|Overall Study|Administrative|1
424291|NCT00549718|1417985|P3|Overall Study|Administrative|2
424292|NCT00549718|1417986|P2|Overall Study|Administrative|2
424293|NCT00549718|1417987|P1|Overall Study|Administrative|2
424294|NCT00549718|1417984|P4|Overall Study|Withdrawal by Subject|13
424295|NCT00549718|1417985|P3|Overall Study|Withdrawal by Subject|12
424296|NCT00549718|1417986|P2|Overall Study|Withdrawal by Subject|18
424297|NCT00549718|1417987|P1|Overall Study|Withdrawal by Subject|9
424298|NCT00549718|1417984|P4|Overall Study|Lost to Follow-up|6
424299|NCT00549718|1417985|P3|Overall Study|Lost to Follow-up|0
424300|NCT00549718|1417986|P2|Overall Study|Lost to Follow-up|2
424301|NCT00549718|1417987|P1|Overall Study|Lost to Follow-up|4
424302|NCT00549718|1417984|P4|Overall Study|Adverse Event|3
424303|NCT00549718|1417985|P3|Overall Study|Adverse Event|7
424304|NCT00549718|1417986|P2|Overall Study|Adverse Event|8
424305|NCT00549718|1417987|P1|Overall Study|Adverse Event|6
424306|NCT00549718|1417984|P4|Overall Study|Insufficient clinical response|32
424307|NCT00549718|1417985|P3|Overall Study|Insufficient clinical response|18
424308|NCT00549718|1417986|P2|Overall Study|Insufficient clinical response|7
424309|NCT00549718|1417987|P1|Overall Study|Insufficient clinical response|20
424310|NCT00549640|1418003|P2|Overall Study|Lost to Follow-up|4
424311|NCT00549640|1418004|P1|Overall Study|Lost to Follow-up|7
424312|NCT00549640|1418003|P2|Overall Study|Adverse Event|0
424313|NCT00549640|1418004|P1|Overall Study|Adverse Event|5
424314|NCT00549640|1418003|P2|Overall Study|Withdrawal by Subject|12
424315|NCT00549640|1418004|P1|Overall Study|Withdrawal by Subject|6
424316|NCT00549601|1418017|P3|Received Study Drug|Withdrawal by Subject|1
424317|NCT00549601|1418018|P2|Received Study Drug|Withdrawal by Subject|0
424318|NCT00549601|1418019|P1|Received Study Drug|Withdrawal by Subject|2
424319|NCT00549601|1418017|P3|Received Study Drug|Protocol Violation|1
424320|NCT00549601|1418018|P2|Received Study Drug|Protocol Violation|4
424321|NCT00549601|1418019|P1|Received Study Drug|Protocol Violation|3
424322|NCT00549601|1418017|P3|Received Study Drug|Lost to Follow-up|1
424323|NCT00549601|1418018|P2|Received Study Drug|Lost to Follow-up|1
424324|NCT00549601|1418019|P1|Received Study Drug|Lost to Follow-up|0
424325|NCT00549601|1418017|P3|Received Study Drug|Death|0
424326|NCT00549601|1418018|P2|Received Study Drug|Death|1
424327|NCT00549601|1418019|P1|Received Study Drug|Death|0
424328|NCT00549601|1418017|P3|Received Study Drug|Adverse Event|1
424329|NCT00549601|1418018|P2|Received Study Drug|Adverse Event|5
424330|NCT00549601|1418019|P1|Received Study Drug|Adverse Event|2
424331|NCT00549601|1418017|P3|Randomized|Withdrawal by Subject|1
424332|NCT00549601|1418018|P2|Randomized|Withdrawal by Subject|1
424333|NCT00549601|1418019|P1|Randomized|Withdrawal by Subject|0
424334|NCT00549601|1418017|P3|Randomized|Protocol Violation|1
424335|NCT00549601|1418018|P2|Randomized|Protocol Violation|0
424336|NCT00549601|1418019|P1|Randomized|Protocol Violation|0
424337|NCT00549562|1418041|P1|Overall Study|Lack of Efficacy|1
424338|NCT00549562|1418041|P1|Overall Study|Adverse Event|1
424339|NCT00549549|1418053|P4|Overall Study|Randomized but not treated|1
424340|NCT00549549|1418054|P3|Overall Study|Randomized but not treated|1
424341|NCT00549549|1418055|P2|Overall Study|Randomized but not treated|0
424342|NCT00549549|1418056|P1|Overall Study|Randomized but not treated|0
424343|NCT00549549|1418053|P4|Overall Study|Other|11
424344|NCT00549549|1418054|P3|Overall Study|Other|9
424345|NCT00549549|1418055|P2|Overall Study|Other|9
424346|NCT00549549|1418056|P1|Overall Study|Other|9
424347|NCT00549549|1418053|P4|Overall Study|Withdrawal by Subject|0
424348|NCT00549549|1418054|P3|Overall Study|Withdrawal by Subject|1
424349|NCT00549549|1418055|P2|Overall Study|Withdrawal by Subject|4
424350|NCT00549549|1418056|P1|Overall Study|Withdrawal by Subject|0
424351|NCT00549549|1418053|P4|Overall Study|Lost to Follow-up|2
424352|NCT00549549|1418054|P3|Overall Study|Lost to Follow-up|1
424353|NCT00549549|1418055|P2|Overall Study|Lost to Follow-up|0
424354|NCT00549549|1418056|P1|Overall Study|Lost to Follow-up|1
424355|NCT00549549|1418053|P4|Overall Study|Lack of Efficacy|2
424356|NCT00549549|1418054|P3|Overall Study|Lack of Efficacy|4
424357|NCT00549549|1418055|P2|Overall Study|Lack of Efficacy|6
424358|NCT00549549|1418056|P1|Overall Study|Lack of Efficacy|9
424359|NCT00549549|1418053|P4|Overall Study|Adverse Event|9
424360|NCT00549549|1418054|P3|Overall Study|Adverse Event|1
424361|NCT00549549|1418055|P2|Overall Study|Adverse Event|3
424362|NCT00549549|1418056|P1|Overall Study|Adverse Event|5
424363|NCT00549445|1418124|P2|Overall Study|Sputum & Blood Samples Not Available|17
424364|NCT00549445|1418125|P1|Overall Study|Sputum & Blood Samples Not Available|15
424365|NCT00549328|1418144|P1|Overall Study|Use of Prohibited Medication|1
424366|NCT00549328|1418144|P1|Overall Study|Death|1
424367|NCT00549328|1418144|P1|Overall Study|Disease Progression|10
424368|NCT00549328|1418144|P1|Overall Study|Adverse Event|2
424369|NCT00549302|1418155|P3|Open-Label|Withdrawal by Subject|6
424370|NCT00549302|1418156|P2|Open-Label|Withdrawal by Subject|0
424371|NCT00549302|1418157|P1|Open-Label|Withdrawal by Subject|0
424372|NCT00549302|1418155|P3|Open-Label|New drug pulmonary atrial hypertension|2
424373|NCT00549302|1418156|P2|Open-Label|New drug pulmonary atrial hypertension|0
424374|NCT00549302|1418157|P1|Open-Label|New drug pulmonary atrial hypertension|0
424375|NCT00549302|1418155|P3|Open-Label|Other|3
424376|NCT00549302|1418156|P2|Open-Label|Other|0
424377|NCT00549302|1418157|P1|Open-Label|Other|0
424378|NCT00549302|1418155|P3|Open-Label|Lost to Follow-up|2
424379|NCT00549302|1418156|P2|Open-Label|Lost to Follow-up|0
424380|NCT00549302|1418157|P1|Open-Label|Lost to Follow-up|0
424381|NCT00549302|1418155|P3|Open-Label|Investigator Decision|5
424382|NCT00549302|1418156|P2|Open-Label|Investigator Decision|0
424383|NCT00549302|1418157|P1|Open-Label|Investigator Decision|0
424384|NCT00549302|1418155|P3|Open-Label|Death|40
424385|NCT00549302|1418156|P2|Open-Label|Death|0
424386|NCT00549302|1418157|P1|Open-Label|Death|0
424387|NCT00549302|1418155|P3|Open-Label|Adverse Event|11
424388|NCT00549302|1418156|P2|Open-Label|Adverse Event|0
424389|NCT00549302|1418157|P1|Open-Label|Adverse Event|0
424390|NCT00549302|1418155|P3|Double-Blind|New condition or starts new therapy|0
424391|NCT00549302|1418156|P2|Double-Blind|New condition or starts new therapy|2
424392|NCT00549302|1418157|P1|Double-Blind|New condition or starts new therapy|0
424393|NCT00549302|1418155|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
424394|NCT00549302|1418156|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
424395|NCT00549302|1418157|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
424396|NCT00549302|1418155|P3|Double-Blind|Lost to Follow-up|0
424397|NCT00549302|1418156|P2|Double-Blind|Lost to Follow-up|2
424398|NCT00549302|1418157|P1|Double-Blind|Lost to Follow-up|1
424399|NCT00549302|1418155|P3|Double-Blind|Sponsor Decision|0
424400|NCT00549302|1418156|P2|Double-Blind|Sponsor Decision|1
424401|NCT00549302|1418157|P1|Double-Blind|Sponsor Decision|0
424402|NCT00549302|1418155|P3|Double-Blind|Investigator Decision|0
424403|NCT00549302|1418156|P2|Double-Blind|Investigator Decision|5
424404|NCT00549302|1418157|P1|Double-Blind|Investigator Decision|1
424405|NCT00549302|1418155|P3|Double-Blind|Withdrawal by Subject|0
424406|NCT00549302|1418156|P2|Double-Blind|Withdrawal by Subject|8
424407|NCT00549302|1418157|P1|Double-Blind|Withdrawal by Subject|3
424408|NCT00549302|1418155|P3|Double-Blind|Adverse Event|0
424409|NCT00549302|1418156|P2|Double-Blind|Adverse Event|16
424410|NCT00549302|1418157|P1|Double-Blind|Adverse Event|3
424411|NCT00549302|1418155|P3|Double-Blind|Death|0
424412|NCT00549302|1418156|P2|Double-Blind|Death|9
424413|NCT00549302|1418157|P1|Double-Blind|Death|2
424414|NCT00549198|1418169|P2|Overall Study|Not Exposed to Study Drug|4
424415|NCT00549198|1418170|P1|Overall Study|Not Exposed to Study Drug|3
424416|NCT00549198|1418169|P2|Overall Study|Pregnancy|3
424417|NCT00549198|1418170|P1|Overall Study|Pregnancy|0
424418|NCT00549198|1418169|P2|Overall Study|No scan facilities|2
424419|NCT00549198|1418170|P1|Overall Study|No scan facilities|0
424420|NCT00549198|1418169|P2|Overall Study|Participant overweight, no scan possible|0
424421|NCT00549198|1418170|P1|Overall Study|Participant overweight, no scan possible|1
424422|NCT00549198|1418169|P2|Overall Study|Participant planning pregnancy|0
424423|NCT00549198|1418170|P1|Overall Study|Participant planning pregnancy|1
424424|NCT00549198|1418169|P2|Overall Study|Prohibited Medication|2
424425|NCT00549198|1418170|P1|Overall Study|Prohibited Medication|1
424426|NCT00549198|1418169|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
424427|NCT00549198|1418170|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
424428|NCT00549198|1418169|P2|Overall Study|Participant not able to perform Week 96|0
424429|NCT00549198|1418170|P1|Overall Study|Participant not able to perform Week 96|1
424430|NCT00549198|1418169|P2|Overall Study|Participant Moved|0
424431|NCT00549198|1418170|P1|Overall Study|Participant Moved|2
424432|NCT00549198|1418169|P2|Overall Study|Disease Progression|0
424433|NCT00549198|1418170|P1|Overall Study|Disease Progression|1
424434|NCT00549198|1418169|P2|Overall Study|Withdrawal by Subject|7
424435|NCT00549198|1418170|P1|Overall Study|Withdrawal by Subject|7
424436|NCT00549198|1418169|P2|Overall Study|Investigator Decision|3
424437|NCT00549198|1418170|P1|Overall Study|Investigator Decision|4
424438|NCT00549198|1418169|P2|Overall Study|Protocol Violation|2
424439|NCT00549198|1418170|P1|Overall Study|Protocol Violation|7
424440|NCT00549198|1418169|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
424441|NCT00549198|1418170|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
424442|NCT00549198|1418169|P2|Overall Study|Lost to Follow-up|8
424443|NCT00549198|1418170|P1|Overall Study|Lost to Follow-up|7
424444|NCT00549198|1418169|P2|Overall Study|Non-compliance|4
424445|NCT00549198|1418170|P1|Overall Study|Non-compliance|2
424446|NCT00549198|1418169|P2|Overall Study|Protocol-defined Virological Failure|0
424447|NCT00549198|1418170|P1|Overall Study|Protocol-defined Virological Failure|7
424448|NCT00549198|1418169|P2|Overall Study|Insufficient Viral Load Response|2
424449|NCT00549198|1418170|P1|Overall Study|Insufficient Viral Load Response|4
424450|NCT00549198|1418169|P2|Overall Study|Adverse Event|26
424451|NCT00549198|1418170|P1|Overall Study|Adverse Event|28
424452|NCT00549055|1418307|P1|Overall Study|Very low visual acuity (VA)|1
424453|NCT00549055|1418307|P1|Overall Study|Choroidal neovascularization|1
424454|NCT00549055|1418307|P1|Overall Study|Growth choroidal neovascularisation|1
424455|NCT00549055|1418307|P1|Overall Study|Vitreous hemorrhage|1
424456|NCT00549055|1418307|P1|Overall Study|Active choroidal neovascula increased|1
424457|NCT00549055|1418307|P1|Overall Study|Decrease of size|1
424458|NCT00549055|1418307|P1|Overall Study|Progression to fibrosis|2
424459|NCT00549055|1418307|P1|Overall Study|Stabilization|5
424460|NCT00549055|1418307|P1|Overall Study|Lack of efficacy|18
424461|NCT00549055|1418307|P1|Overall Study|Adverse Event|4
424462|NCT00548847|1418331|P1|Overall Study|Disease progression|7
424463|NCT00548808|1418338|P2|Overall Study|Sponsor Decision|1
424464|NCT00548808|1418339|P1|Overall Study|Sponsor Decision|1
424465|NCT00548808|1418338|P2|Overall Study|Lack of Efficacy|0
424466|NCT00548808|1418339|P1|Overall Study|Lack of Efficacy|2
424467|NCT00548808|1418338|P2|Overall Study|Entry Criteria Not Met|2
424468|NCT00548808|1418339|P1|Overall Study|Entry Criteria Not Met|2
424469|NCT00548808|1418338|P2|Overall Study|Death|0
424470|NCT00548808|1418339|P1|Overall Study|Death|2
424471|NCT00548808|1418338|P2|Overall Study|Adverse Event|5
424472|NCT00548808|1418339|P1|Overall Study|Adverse Event|4
424473|NCT00548808|1418338|P2|Overall Study|Physician Decision|3
424474|NCT00548808|1418339|P1|Overall Study|Physician Decision|6
424475|NCT00548808|1418338|P2|Overall Study|Withdrawal by Subject|4
424476|NCT00548808|1418339|P1|Overall Study|Withdrawal by Subject|8
424477|NCT00548808|1418338|P2|Overall Study|Protocol Violation|8
424478|NCT00548808|1418339|P1|Overall Study|Protocol Violation|8
424479|NCT00548808|1418338|P2|Overall Study|Lost to Follow-up|3
424480|NCT00548808|1418339|P1|Overall Study|Lost to Follow-up|9
424481|NCT00548717|1418363|P2|Overall Study|Alternative treatment for GVHD|0
424482|NCT00548717|1418364|P1|Overall Study|Alternative treatment for GVHD|1
424483|NCT00548717|1418363|P2|Overall Study|Relapse|0
424484|NCT00548717|1418364|P1|Overall Study|Relapse|3
424485|NCT00548717|1418363|P2|Overall Study|Death|2
424486|NCT00548717|1418364|P1|Overall Study|Death|5
424487|NCT00548548|1418392|P2|Overall Study|Lost to Follow-up|18
424488|NCT00548548|1418393|P1|Overall Study|Lost to Follow-up|17
424489|NCT00548548|1418392|P2|Overall Study|Death|348
424490|NCT00548548|1418393|P1|Overall Study|Death|345
424491|NCT00548405|1418436|P3|Overall Study|Randomized but not treated|0
424492|NCT00548405|1418437|P2|Overall Study|Randomized but not treated|0
424493|NCT00548405|1418438|P1|Overall Study|Randomized but not treated|1
424494|NCT00548405|1418436|P3|Overall Study|Sponsor decision|0
424495|NCT00548405|1418437|P2|Overall Study|Sponsor decision|0
424496|NCT00548405|1418438|P1|Overall Study|Sponsor decision|1
424497|NCT00548405|1418436|P3|Overall Study|Death|1
424498|NCT00548405|1418437|P2|Overall Study|Death|1
424499|NCT00548405|1418438|P1|Overall Study|Death|0
424500|NCT00548405|1418436|P3|Overall Study|Lost to Follow-up|2
424501|NCT00548405|1418437|P2|Overall Study|Lost to Follow-up|1
424502|NCT00548405|1418438|P1|Overall Study|Lost to Follow-up|1
424503|NCT00548405|1418436|P3|Overall Study|Withdrawal by Subject|5
424504|NCT00548405|1418437|P2|Overall Study|Withdrawal by Subject|12
424505|NCT00548405|1418438|P1|Overall Study|Withdrawal by Subject|36
424506|NCT00548405|1418436|P3|Overall Study|Protocol Violation|0
424507|NCT00548405|1418437|P2|Overall Study|Protocol Violation|0
424508|NCT00548405|1418438|P1|Overall Study|Protocol Violation|1
424509|NCT00548405|1418436|P3|Overall Study|Pregnancy|0
424510|NCT00548405|1418437|P2|Overall Study|Pregnancy|0
424511|NCT00548405|1418438|P1|Overall Study|Pregnancy|1
424512|NCT00548405|1418436|P3|Overall Study|Physician Decision|1
424513|NCT00548405|1418437|P2|Overall Study|Physician Decision|4
424514|NCT00548405|1418438|P1|Overall Study|Physician Decision|3
424515|NCT00548405|1418436|P3|Overall Study|Lack of Efficacy|0
424516|NCT00548405|1418437|P2|Overall Study|Lack of Efficacy|0
424517|NCT00548405|1418438|P1|Overall Study|Lack of Efficacy|6
424518|NCT00548405|1418436|P3|Overall Study|Adverse Event|0
424519|NCT00548405|1418437|P2|Overall Study|Adverse Event|2
424520|NCT00548405|1418438|P1|Overall Study|Adverse Event|6
424521|NCT00548340|1418459|P3|Overall Study|Other|1
424522|NCT00548340|1418460|P2|Overall Study|Other|1
424523|NCT00548340|1418461|P1|Overall Study|Other|1
424524|NCT00548340|1418459|P3|Overall Study|Withdrawal by Subject|3
424525|NCT00548340|1418460|P2|Overall Study|Withdrawal by Subject|4
424526|NCT00548340|1418461|P1|Overall Study|Withdrawal by Subject|2
424527|NCT00548340|1418459|P3|Overall Study|Lost to Follow-up|0
424528|NCT00548340|1418460|P2|Overall Study|Lost to Follow-up|1
424529|NCT00548340|1418461|P1|Overall Study|Lost to Follow-up|1
424530|NCT00548340|1418459|P3|Overall Study|Adverse Event|2
424531|NCT00548340|1418460|P2|Overall Study|Adverse Event|2
424532|NCT00548340|1418461|P1|Overall Study|Adverse Event|2
424533|NCT00548340|1418459|P3|Overall Study|Protocol Violation|3
424534|NCT00548340|1418460|P2|Overall Study|Protocol Violation|3
424535|NCT00548340|1418461|P1|Overall Study|Protocol Violation|2
424536|NCT00548327|1418480|P2|Overall Study|Adverse Event|1
424537|NCT00548327|1418481|P1|Overall Study|Adverse Event|0
424538|NCT00548262|1418499|P1|Overall Study|Withdrawal by Subject|1
424539|NCT00548262|1418499|P1|Overall Study|Other|3
424540|NCT00548262|1418499|P1|Overall Study|Lost to Follow-up|1
424541|NCT00548262|1418499|P1|Overall Study|Lack of Efficacy|4
424542|NCT00548262|1418499|P1|Overall Study|Adverse Event|2
424543|NCT00548262|1418499|P1|Overall Study|Death|21
424544|NCT00548249|1418529|P5|Overall Study|Sponsor's request|0
424545|NCT00548249|1418530|P4|Overall Study|Sponsor's request|1
424546|NCT00548249|1418531|P3|Overall Study|Sponsor's request|0
424547|NCT00548249|1418532|P2|Overall Study|Sponsor's request|0
424548|NCT00548249|1418533|P1|Overall Study|Sponsor's request|0
424549|NCT00548249|1418529|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
424550|NCT00548249|1418530|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
424551|NCT00548249|1418531|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
424552|NCT00548249|1418532|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
424553|NCT00548249|1418533|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
424554|NCT00548249|1418529|P5|Overall Study|Withdrawal by Subject|0
424555|NCT00548249|1418530|P4|Overall Study|Withdrawal by Subject|0
424556|NCT00548249|1418531|P3|Overall Study|Withdrawal by Subject|0
424557|NCT00548249|1418532|P2|Overall Study|Withdrawal by Subject|0
424558|NCT00548249|1418533|P1|Overall Study|Withdrawal by Subject|2
424559|NCT00548249|1418529|P5|Overall Study|Prolonged hospitalization|0
424560|NCT00548249|1418530|P4|Overall Study|Prolonged hospitalization|1
424561|NCT00548249|1418531|P3|Overall Study|Prolonged hospitalization|2
424562|NCT00548249|1418532|P2|Overall Study|Prolonged hospitalization|0
424563|NCT00548249|1418533|P1|Overall Study|Prolonged hospitalization|0
424564|NCT00548249|1418529|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
424565|NCT00548249|1418530|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
424566|NCT00548249|1418531|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
424567|NCT00548249|1418532|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
424568|NCT00548249|1418533|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
424569|NCT00548249|1418529|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
424570|NCT00548249|1418530|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
424571|NCT00548249|1418531|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
424572|NCT00548249|1418532|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
424573|NCT00548249|1418533|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
424574|NCT00548249|1418529|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
424575|NCT00548249|1418530|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
424576|NCT00548249|1418531|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
424577|NCT00548249|1418532|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
424578|NCT00548249|1418533|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
424579|NCT00548249|1418529|P5|Overall Study|Adverse Event|1
424580|NCT00548249|1418530|P4|Overall Study|Adverse Event|1
424581|NCT00548249|1418531|P3|Overall Study|Adverse Event|0
424582|NCT00548249|1418532|P2|Overall Study|Adverse Event|2
424583|NCT00548249|1418533|P1|Overall Study|Adverse Event|2
424584|NCT00548249|1418529|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
424585|NCT00548249|1418530|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
424586|NCT00548249|1418531|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
424587|NCT00548249|1418532|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
424588|NCT00548249|1418533|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
424589|NCT00548249|1418529|P5|Overall Study|Miscellaneous|2
424590|NCT00548249|1418530|P4|Overall Study|Miscellaneous|0
424591|NCT00548249|1418531|P3|Overall Study|Miscellaneous|2
424592|NCT00548249|1418532|P2|Overall Study|Miscellaneous|3
424593|NCT00548249|1418533|P1|Overall Study|Miscellaneous|2
424594|NCT00548249|1418529|P5|Overall Study|Protocol Violation|3
424595|NCT00548249|1418530|P4|Overall Study|Protocol Violation|0
424596|NCT00548249|1418531|P3|Overall Study|Protocol Violation|4
424597|NCT00548249|1418532|P2|Overall Study|Protocol Violation|1
424598|NCT00548249|1418533|P1|Overall Study|Protocol Violation|1
424599|NCT00548249|1418529|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
424600|NCT00548249|1418530|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
424601|NCT00548249|1418531|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
424602|NCT00548249|1418532|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
424603|NCT00548249|1418533|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
424604|NCT00548249|1418529|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
424605|NCT00548249|1418530|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
424606|NCT00548249|1418531|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
424607|NCT00548249|1418532|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
424608|NCT00548249|1418533|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
424609|NCT00548184|1418570|P1|Overall Study|Found Her2 negative|1
424610|NCT00548184|1418570|P1|Overall Study|took other drug|1
424611|NCT00548184|1418570|P1|Overall Study|Adverse Event|3
424612|NCT00548145|1418576|P2|Overall Study|Physician Decision|1
424613|NCT00548145|1418577|P1|Overall Study|Physician Decision|1
424614|NCT00548145|1418576|P2|Overall Study|Withdrawal by Subject|2
424615|NCT00548145|1418577|P1|Overall Study|Withdrawal by Subject|0
424616|NCT00548145|1418576|P2|Overall Study|Death|1
424617|NCT00548145|1418577|P1|Overall Study|Death|0
424618|NCT00547911|1418602|P6|Overall Study|Adverse Event|0
424619|NCT00547911|1418603|P5|Overall Study|Adverse Event|0
424620|NCT00547911|1418604|P4|Overall Study|Adverse Event|1
424621|NCT00547911|1418605|P3|Overall Study|Adverse Event|0
424622|NCT00547911|1418606|P2|Overall Study|Adverse Event|0
424623|NCT00547911|1418607|P1|Overall Study|Adverse Event|0
424624|NCT00547703|1418638|P2|Overall Study|Lost to Follow-up|0
424625|NCT00547703|1418639|P1|Overall Study|Lost to Follow-up|1
424626|NCT00547534|1418664|P1|Overall Study|Disease Progression|4
424627|NCT00547534|1418664|P1|Overall Study|Adverse Event|7
424628|NCT00547521|1418672|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
424629|NCT00547521|1418673|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
424630|NCT00547521|1418672|P2|Long Term Extension (LTE) Study|Not Specified|2
424631|NCT00547521|1418673|P1|Long Term Extension (LTE) Study|Not Specified|0
424632|NCT00547521|1418672|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
424633|NCT00547521|1418673|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
424634|NCT00547521|1418672|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
424635|NCT00547521|1418673|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
424636|NCT00547521|1418672|P2|Long Term Extension (LTE) Study|Adverse Event|9
424637|NCT00547521|1418673|P1|Long Term Extension (LTE) Study|Adverse Event|0
424638|NCT00547521|1418672|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
424639|NCT00547521|1418673|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
424640|NCT00547521|1418672|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
424641|NCT00547521|1418673|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
424642|NCT00547521|1418672|P2|Short Term Study (4 Months)|Withdrawal of consent|1
424643|NCT00547521|1418673|P1|Short Term Study (4 Months)|Withdrawal of consent|0
424644|NCT00547521|1418672|P2|Short Term Study (4 Months)|Lack of Efficacy|2
424645|NCT00547521|1418673|P1|Short Term Study (4 Months)|Lack of Efficacy|0
424646|NCT00547521|1418672|P2|Short Term Study (4 Months)|Adverse Event|0
424647|NCT00547521|1418673|P1|Short Term Study (4 Months)|Adverse Event|1
424648|NCT00547378|1418750|P3|All Implanted Cohort|Other reasons|1
424649|NCT00547378|1418751|P2|All Implanted Cohort|Other reasons|0
424650|NCT00547378|1418752|P1|All Implanted Cohort|Other reasons|1
424651|NCT00547378|1418750|P3|All Implanted Cohort|Site closure|1
424652|NCT00547378|1418751|P2|All Implanted Cohort|Site closure|0
424653|NCT00547378|1418752|P1|All Implanted Cohort|Site closure|2
424654|NCT00547378|1418750|P3|All Implanted Cohort|Physician Decision|6
424655|NCT00547378|1418751|P2|All Implanted Cohort|Physician Decision|2
424656|NCT00547378|1418752|P1|All Implanted Cohort|Physician Decision|0
424657|NCT00547378|1418750|P3|All Implanted Cohort|Death|4
424658|NCT00547378|1418751|P2|All Implanted Cohort|Death|1
424659|NCT00547378|1418752|P1|All Implanted Cohort|Death|3
424660|NCT00547378|1418750|P3|All Implanted Cohort|Lost to Follow-up|14
424661|NCT00547378|1418751|P2|All Implanted Cohort|Lost to Follow-up|1
424662|NCT00547378|1418752|P1|All Implanted Cohort|Lost to Follow-up|0
424663|NCT00547378|1418750|P3|All Implanted Cohort|Adverse Event|17
424664|NCT00547378|1418751|P2|All Implanted Cohort|Adverse Event|10
424665|NCT00547378|1418752|P1|All Implanted Cohort|Adverse Event|4
424666|NCT00547378|1418750|P3|All Implanted Cohort|Withdrawal by Subject|27
424667|NCT00547378|1418751|P2|All Implanted Cohort|Withdrawal by Subject|4
424668|NCT00547378|1418752|P1|All Implanted Cohort|Withdrawal by Subject|5
424669|NCT00547378|1418750|P3|Randomized Cohort|Other reasons|0
424670|NCT00547378|1418751|P2|Randomized Cohort|Other reasons|0
424671|NCT00547378|1418752|P1|Randomized Cohort|Other reasons|2
424672|NCT00547378|1418750|P3|Randomized Cohort|Adverse Event|0
424673|NCT00547378|1418751|P2|Randomized Cohort|Adverse Event|0
424674|NCT00547378|1418752|P1|Randomized Cohort|Adverse Event|1
424675|NCT00547378|1418750|P3|Randomized Cohort|Lost to Follow-up|0
424676|NCT00547378|1418751|P2|Randomized Cohort|Lost to Follow-up|0
424677|NCT00547378|1418752|P1|Randomized Cohort|Lost to Follow-up|1
424678|NCT00547378|1418750|P3|Randomized Cohort|Death|0
424679|NCT00547378|1418751|P2|Randomized Cohort|Death|1
424680|NCT00547378|1418752|P1|Randomized Cohort|Death|0
424681|NCT00547378|1418750|P3|Randomized Cohort|Withdrawal by Subject|0
424682|NCT00547378|1418751|P2|Randomized Cohort|Withdrawal by Subject|5
424683|NCT00547378|1418752|P1|Randomized Cohort|Withdrawal by Subject|7
424684|NCT00547365|1418762|P1|Overall Study|death (not related to study)|4
424685|NCT00547365|1418762|P1|Overall Study|Protocol Violation|2
424686|NCT00547365|1418762|P1|Overall Study|Lost to Follow-up|1
424687|NCT00547365|1418762|P1|Overall Study|Physician Decision|1
424688|NCT00547157|1418769|P2|Overall Study|Lost to Follow-up|2
424689|NCT00547157|1418770|P1|Overall Study|Lost to Follow-up|4
424690|NCT00547157|1418769|P2|Overall Study|Administrative decision|2
424691|NCT00547157|1418770|P1|Overall Study|Administrative decision|3
424692|NCT00547157|1418769|P2|Overall Study|Withdrawal by Subject|1
424693|NCT00547157|1418770|P1|Overall Study|Withdrawal by Subject|3
424694|NCT00547157|1418769|P2|Overall Study|Death|18
424695|NCT00547157|1418770|P1|Overall Study|Death|38
424696|NCT00547157|1418769|P2|Overall Study|Other|0
424697|NCT00547157|1418770|P1|Overall Study|Other|1
424698|NCT00547118|1418788|P2|Overall Study|Study suspended|8
424699|NCT00547118|1418789|P1|Overall Study|Study suspended|7
424700|NCT00547118|1418788|P2|Overall Study|Did not qualify prior to starting drug|1
424701|NCT00547118|1418789|P1|Overall Study|Did not qualify prior to starting drug|1
424702|NCT00546910|1418833|P2|Overall Study|Withdrawal by Subject|0
424703|NCT00546910|1418834|P1|Overall Study|Withdrawal by Subject|2
424704|NCT00546910|1418833|P2|Overall Study|Physician Decision|1
424705|NCT00546910|1418834|P1|Overall Study|Physician Decision|0
424706|NCT00546910|1418833|P2|Overall Study|Lack of Efficacy|7
424707|NCT00546910|1418834|P1|Overall Study|Lack of Efficacy|5
424708|NCT00546910|1418833|P2|Overall Study|Adverse Event|3
424709|NCT00546910|1418834|P1|Overall Study|Adverse Event|2
424710|NCT00546871|1418900|P2|Study Extension Period|Withdrawal by Subject|1
424711|NCT00546871|1418901|P1|Study Extension Period|Withdrawal by Subject|0
424712|NCT00546871|1418900|P2|Study Extension Period|Protocol Violation|0
424713|NCT00546871|1418901|P1|Study Extension Period|Protocol Violation|1
424714|NCT00546871|1418900|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
424715|NCT00546871|1418901|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
424716|NCT00546871|1418900|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
424717|NCT00546871|1418901|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
424718|NCT00546871|1418900|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
424719|NCT00546871|1418901|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
424720|NCT00546819|1419006|P2|Overall Study|Withdrawal by Subject|2
424721|NCT00546819|1419007|P1|Overall Study|Withdrawal by Subject|4
424722|NCT00546819|1419006|P2|Overall Study|Lost to Follow-up|1
424723|NCT00546819|1419007|P1|Overall Study|Lost to Follow-up|2
424724|NCT00546819|1419006|P2|Overall Study|Adverse Event|3
424725|NCT00546819|1419007|P1|Overall Study|Adverse Event|2
424726|NCT00546754|1419019|P2|Overall Study|Missing|7
424727|NCT00546754|1419020|P1|Overall Study|Missing|14
424728|NCT00546754|1419019|P2|Overall Study|Patient's Decision|1
424729|NCT00546754|1419020|P1|Overall Study|Patient's Decision|0
424730|NCT00546754|1419019|P2|Overall Study|Elevated Creatinine and Potassium levels|1
424731|NCT00546754|1419020|P1|Overall Study|Elevated Creatinine and Potassium levels|0
424732|NCT00546754|1419019|P2|Overall Study|Missing Cooperation|0
424733|NCT00546754|1419020|P1|Overall Study|Missing Cooperation|1
424734|NCT00546754|1419019|P2|Overall Study|Suicide|0
424735|NCT00546754|1419020|P1|Overall Study|Suicide|1
424736|NCT00546754|1419019|P2|Overall Study|Hip Replacement|0
424737|NCT00546754|1419020|P1|Overall Study|Hip Replacement|1
424738|NCT00546754|1419019|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
424739|NCT00546754|1419020|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
424740|NCT00546754|1419019|P2|Overall Study|Dyspnea|0
424741|NCT00546754|1419020|P1|Overall Study|Dyspnea|1
424742|NCT00546754|1419019|P2|Overall Study|Withdrawal by Subject|7
424743|NCT00546754|1419020|P1|Overall Study|Withdrawal by Subject|6
424744|NCT00546754|1419019|P2|Overall Study|Protocol Violation|0
424745|NCT00546754|1419020|P1|Overall Study|Protocol Violation|3
424746|NCT00546754|1419019|P2|Overall Study|Lost to Follow-up|15
424747|NCT00546754|1419020|P1|Overall Study|Lost to Follow-up|9
424748|NCT00546754|1419019|P2|Overall Study|Lack of Efficacy|1
424749|NCT00546754|1419020|P1|Overall Study|Lack of Efficacy|1
424750|NCT00546754|1419019|P2|Overall Study|Adverse Event|16
424751|NCT00546754|1419020|P1|Overall Study|Adverse Event|11
424752|NCT00546754|1419019|P2|Overall Study|Serious Adverse Event|1
424753|NCT00546754|1419020|P1|Overall Study|Serious Adverse Event|1
424754|NCT00546715|1419063|P4|Overall Study|Withdrawal by Subject|0
424755|NCT00546715|1419064|P3|Overall Study|Withdrawal by Subject|0
424756|NCT00546715|1419065|P2|Overall Study|Withdrawal by Subject|1
424757|NCT00546715|1419066|P1|Overall Study|Withdrawal by Subject|0
424758|NCT00546637|1419121|P2|Overall Study|Randomized, but not treated|1
424759|NCT00546637|1419122|P1|Overall Study|Randomized, but not treated|3
424760|NCT00546637|1419121|P2|Overall Study|Withdrawal by Subject|9
424761|NCT00546637|1419122|P1|Overall Study|Withdrawal by Subject|7
424762|NCT00546637|1419121|P2|Overall Study|Other|12
424763|NCT00546637|1419122|P1|Overall Study|Other|10
424764|NCT00546637|1419121|P2|Overall Study|Lost to Follow-up|2
424765|NCT00546637|1419122|P1|Overall Study|Lost to Follow-up|2
424766|NCT00546637|1419121|P2|Overall Study|Lack of Efficacy|5
424767|NCT00546637|1419122|P1|Overall Study|Lack of Efficacy|5
424768|NCT00546637|1419121|P2|Overall Study|Adverse Event|20
424769|NCT00546637|1419122|P1|Overall Study|Adverse Event|46
424770|NCT00546572|1419196|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
424771|NCT00546572|1419197|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
424772|NCT00546572|1419196|P2|Vax 2 / Year 1|Adverse Event|0
424773|NCT00546572|1419197|P1|Vax 2 / Year 1|Adverse Event|1
424774|NCT00546572|1419196|P2|Vax 2 / Year 1|Other|1
424775|NCT00546572|1419197|P1|Vax 2 / Year 1|Other|1
424776|NCT00546572|1419196|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
424777|NCT00546572|1419197|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
424778|NCT00546572|1419196|P2|Vax 1 / Year 0|Lost to Follow-up|1
424779|NCT00546572|1419197|P1|Vax 1 / Year 0|Lost to Follow-up|0
424780|NCT00546572|1419196|P2|Vax 1 / Year 0|Adverse Event|1
424781|NCT00546572|1419197|P1|Vax 1 / Year 0|Adverse Event|0
424782|NCT00546572|1419196|P2|Vax 1 / Year 0|Death|2
424783|NCT00546572|1419197|P1|Vax 1 / Year 0|Death|2
424784|NCT00546572|1419196|P2|Vax 1 / Year 0|Protocol Violation|4
424785|NCT00546572|1419197|P1|Vax 1 / Year 0|Protocol Violation|3
424786|NCT00546572|1419196|P2|Vax 1 / Year 0|Withdrawal by Subject|2
424787|NCT00546572|1419197|P1|Vax 1 / Year 0|Withdrawal by Subject|3
424788|NCT00546572|1419196|P2|Vax 1 / Year 0|Randomized, not treated|1
424789|NCT00546572|1419197|P1|Vax 1 / Year 0|Randomized, not treated|1
424790|NCT00546481|1419241|P3|Maintenance Phase (CERA)|Other Reason|1
424791|NCT00546481|1419242|P2|Maintenance Phase (CERA)|Other Reason|0
424792|NCT00546481|1419243|P1|Maintenance Phase (CERA)|Other Reason|0
424793|NCT00546481|1419241|P3|Maintenance Phase (CERA)|Kidney transplantation|1
424794|NCT00546481|1419242|P2|Maintenance Phase (CERA)|Kidney transplantation|0
424795|NCT00546481|1419243|P1|Maintenance Phase (CERA)|Kidney transplantation|0
424796|NCT00546481|1419241|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
424797|NCT00546481|1419242|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
424798|NCT00546481|1419243|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
424799|NCT00546481|1419241|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
424800|NCT00546481|1419242|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
424801|NCT00546481|1419243|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
424802|NCT00546481|1419241|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
424803|NCT00546481|1419242|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
424804|NCT00546481|1419243|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
424805|NCT00546481|1419241|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
424806|NCT00546481|1419242|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
424807|NCT00546481|1419243|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
424808|NCT00546481|1419241|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
424809|NCT00546481|1419242|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
424810|NCT00546481|1419243|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
424811|NCT00546481|1419241|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
424812|NCT00546481|1419242|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
424898|NCT00545753|1419537|P3|Overall Study|Lost to Follow-up|12
424813|NCT00546481|1419243|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
424814|NCT00546481|1419241|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
424815|NCT00546481|1419242|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
424816|NCT00546481|1419243|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
424817|NCT00546377|1419270|P1|Overall Study|Adverse Event|6
424818|NCT00546377|1419270|P1|Overall Study|Deemed ineligible|1
424819|NCT00546364|1419278|P3|Overall Study|Sponsor decision|1
424820|NCT00546364|1419279|P2|Overall Study|Sponsor decision|0
424821|NCT00546364|1419280|P1|Overall Study|Sponsor decision|0
424822|NCT00546364|1419278|P3|Overall Study|Physician Decision|1
424823|NCT00546364|1419279|P2|Overall Study|Physician Decision|0
424824|NCT00546364|1419280|P1|Overall Study|Physician Decision|0
424825|NCT00546364|1419278|P3|Overall Study|Target lesions resected|0
424826|NCT00546364|1419279|P2|Overall Study|Target lesions resected|0
424827|NCT00546364|1419280|P1|Overall Study|Target lesions resected|1
424828|NCT00546364|1419278|P3|Overall Study|Palliative treatment|1
424829|NCT00546364|1419279|P2|Overall Study|Palliative treatment|0
424830|NCT00546364|1419280|P1|Overall Study|Palliative treatment|1
424831|NCT00546364|1419278|P3|Overall Study|Mixed response|0
424832|NCT00546364|1419279|P2|Overall Study|Mixed response|0
424833|NCT00546364|1419280|P1|Overall Study|Mixed response|1
424834|NCT00546364|1419278|P3|Overall Study|Prior taxotere|0
424835|NCT00546364|1419279|P2|Overall Study|Prior taxotere|0
424836|NCT00546364|1419280|P1|Overall Study|Prior taxotere|1
424837|NCT00546364|1419278|P3|Overall Study|Withdrawal by Subject|3
424838|NCT00546364|1419279|P2|Overall Study|Withdrawal by Subject|6
424839|NCT00546364|1419280|P1|Overall Study|Withdrawal by Subject|5
424840|NCT00546364|1419278|P3|Overall Study|No longer meets study criteria|0
424841|NCT00546364|1419279|P2|Overall Study|No longer meets study criteria|1
424842|NCT00546364|1419280|P1|Overall Study|No longer meets study criteria|1
424843|NCT00546364|1419278|P3|Overall Study|Poor compliance/noncompliance|1
424844|NCT00546364|1419279|P2|Overall Study|Poor compliance/noncompliance|0
424845|NCT00546364|1419280|P1|Overall Study|Poor compliance/noncompliance|0
424846|NCT00546364|1419278|P3|Overall Study|Administrative reason by sponsor|0
424847|NCT00546364|1419279|P2|Overall Study|Administrative reason by sponsor|0
424848|NCT00546364|1419280|P1|Overall Study|Administrative reason by sponsor|1
424849|NCT00546364|1419278|P3|Overall Study|Completed and off treatment|2
424850|NCT00546364|1419279|P2|Overall Study|Completed and off treatment|0
424851|NCT00546364|1419280|P1|Overall Study|Completed and off treatment|1
424852|NCT00546364|1419278|P3|Overall Study|Disease progression|8
424853|NCT00546364|1419279|P2|Overall Study|Disease progression|11
424854|NCT00546364|1419280|P1|Overall Study|Disease progression|5
424855|NCT00546351|1419315|P1|Overall Study|Other reasons for premature termination|17
424856|NCT00546351|1419315|P1|Overall Study|Unsatisfactory compliance|9
424857|NCT00546351|1419315|P1|Overall Study|Protocol Deviation|1
424858|NCT00546351|1419315|P1|Overall Study|Lost to Follow-up|9
424859|NCT00546351|1419315|P1|Overall Study|Withdrawal by Subject|109
424860|NCT00546351|1419315|P1|Overall Study|Lack of Efficacy|15
424861|NCT00546351|1419315|P1|Overall Study|Adverse Event|76
424862|NCT00546260|1419361|P2|Overall Study|Drug not given pre diagnostic angiogr|2
424863|NCT00546260|1419362|P1|Overall Study|Drug not given pre diagnostic angiogr|8
424864|NCT00546117|1419384|P2|Overall Study|Inability to schedule follow-up visit|0
424865|NCT00546117|1419385|P1|Overall Study|Inability to schedule follow-up visit|1
424866|NCT00546117|1419384|P2|Overall Study|Withdrawal by Subject|0
424867|NCT00546117|1419385|P1|Overall Study|Withdrawal by Subject|3
424868|NCT00546078|1419410|P2|Overall Study|Other reason|1
424869|NCT00546078|1419411|P1|Overall Study|Other reason|1
424870|NCT00546078|1419410|P2|Overall Study|Withdrawal by Subject|3
424871|NCT00546078|1419411|P1|Overall Study|Withdrawal by Subject|2
424872|NCT00546078|1419410|P2|Overall Study|Lost to Follow-up|3
424873|NCT00546078|1419411|P1|Overall Study|Lost to Follow-up|1
424874|NCT00546052|1419449|P1|Overall Study|Non Compliance|7
424875|NCT00546052|1419449|P1|Overall Study|Withdrawal by Subject|20
424876|NCT00546052|1419449|P1|Overall Study|Protocol Violation|9
424877|NCT00546052|1419449|P1|Overall Study|Lost to Follow-up|144
424878|NCT00546052|1419449|P1|Overall Study|Adverse Event|47
424879|NCT00546000|1419467|P1|Overall Study|Baseline HPA Axis Supression|2
424880|NCT00546000|1419467|P1|Overall Study|Lost to Follow-up|1
424881|NCT00546000|1419467|P1|Overall Study|Adverse Event|1
424882|NCT00545948|1419486|P3|Overall Study|Not Treated|7
424883|NCT00545948|1419487|P2|Overall Study|Not Treated|1
424884|NCT00545948|1419488|P1|Overall Study|Not Treated|1
424885|NCT00545844|1419498|P1|Overall Study|Withdrawal by Subject|2
424886|NCT00545844|1419498|P1|Overall Study|Protocol Violation|1
424887|NCT00545844|1419498|P1|Overall Study|Lost to Follow-up|9
424888|NCT00545792|1419512|P1|Overall Study|Withdrawal by Subject|1
424889|NCT00545779|1419517|P1|Overall Study|Failure to return|3
424890|NCT00545779|1419517|P1|Overall Study|Adverse Event/intercurrent illness|5
424891|NCT00545779|1419517|P1|Overall Study|Withdrawal by Subject|20
424892|NCT00545779|1419517|P1|Overall Study|Did not cooperate|7
424893|NCT00545779|1419517|P1|Overall Study|Other protocol violation|1
424894|NCT00545779|1419517|P1|Overall Study|Violation of selection criteria at entry|8
424895|NCT00545753|1419537|P3|Overall Study|Protocol Violation|4
424896|NCT00545753|1419538|P2|Overall Study|Protocol Violation|1
424897|NCT00545753|1419539|P1|Overall Study|Protocol Violation|3
424899|NCT00545753|1419538|P2|Overall Study|Lost to Follow-up|3
424900|NCT00545753|1419539|P1|Overall Study|Lost to Follow-up|13
424901|NCT00545753|1419537|P3|Overall Study|Withdrawal by Subject|10
424902|NCT00545753|1419538|P2|Overall Study|Withdrawal by Subject|1
424903|NCT00545753|1419539|P1|Overall Study|Withdrawal by Subject|0
424904|NCT00545740|1419552|P4|Overall Study|Husband against study|0
424905|NCT00545740|1419553|P3|Overall Study|Husband against study|1
424906|NCT00545740|1419554|P2|Overall Study|Husband against study|0
424907|NCT00545740|1419555|P1|Overall Study|Husband against study|0
424908|NCT00545740|1419552|P4|Overall Study|Patient difficulties|0
424909|NCT00545740|1419553|P3|Overall Study|Patient difficulties|0
424910|NCT00545740|1419554|P2|Overall Study|Patient difficulties|1
424911|NCT00545740|1419555|P1|Overall Study|Patient difficulties|0
424912|NCT00545740|1419552|P4|Overall Study|Non-adherence to visits|0
424913|NCT00545740|1419553|P3|Overall Study|Non-adherence to visits|0
424914|NCT00545740|1419554|P2|Overall Study|Non-adherence to visits|1
424915|NCT00545740|1419555|P1|Overall Study|Non-adherence to visits|0
424916|NCT00545740|1419552|P4|Overall Study|Lack of time|0
424917|NCT00545740|1419553|P3|Overall Study|Lack of time|0
424918|NCT00545740|1419554|P2|Overall Study|Lack of time|1
424919|NCT00545740|1419555|P1|Overall Study|Lack of time|0
424920|NCT00545740|1419552|P4|Overall Study|Sponsor decision|0
424921|NCT00545740|1419553|P3|Overall Study|Sponsor decision|0
424922|NCT00545740|1419554|P2|Overall Study|Sponsor decision|1
424923|NCT00545740|1419555|P1|Overall Study|Sponsor decision|0
424924|NCT00545740|1419552|P4|Overall Study|Accepted only monthly telephone calls|0
424925|NCT00545740|1419553|P3|Overall Study|Accepted only monthly telephone calls|0
424926|NCT00545740|1419554|P2|Overall Study|Accepted only monthly telephone calls|0
424927|NCT00545740|1419555|P1|Overall Study|Accepted only monthly telephone calls|1
424928|NCT00545740|1419552|P4|Overall Study|Physician Decision|0
424929|NCT00545740|1419553|P3|Overall Study|Physician Decision|3
424930|NCT00545740|1419554|P2|Overall Study|Physician Decision|0
424931|NCT00545740|1419555|P1|Overall Study|Physician Decision|0
424932|NCT00545740|1419552|P4|Overall Study|Missed visit|0
424933|NCT00545740|1419553|P3|Overall Study|Missed visit|0
424934|NCT00545740|1419554|P2|Overall Study|Missed visit|0
424935|NCT00545740|1419555|P1|Overall Study|Missed visit|1
424936|NCT00545740|1419552|P4|Overall Study|Site closure|0
424937|NCT00545740|1419553|P3|Overall Study|Site closure|0
424938|NCT00545740|1419554|P2|Overall Study|Site closure|0
424939|NCT00545740|1419555|P1|Overall Study|Site closure|1
424940|NCT00545740|1419552|P4|Overall Study|Suspected Diverticulitis Recurrence|1
424941|NCT00545740|1419553|P3|Overall Study|Suspected Diverticulitis Recurrence|1
424942|NCT00545740|1419554|P2|Overall Study|Suspected Diverticulitis Recurrence|1
424943|NCT00545740|1419555|P1|Overall Study|Suspected Diverticulitis Recurrence|1
424944|NCT00545740|1419552|P4|Overall Study|Diverticulitis attack|1
424945|NCT00545740|1419553|P3|Overall Study|Diverticulitis attack|1
424946|NCT00545740|1419554|P2|Overall Study|Diverticulitis attack|0
424947|NCT00545740|1419555|P1|Overall Study|Diverticulitis attack|0
424948|NCT00545740|1419552|P4|Overall Study|Moved|0
424949|NCT00545740|1419553|P3|Overall Study|Moved|1
424950|NCT00545740|1419554|P2|Overall Study|Moved|0
424951|NCT00545740|1419555|P1|Overall Study|Moved|2
424952|NCT00545740|1419552|P4|Overall Study|Non-compliance|0
424953|NCT00545740|1419553|P3|Overall Study|Non-compliance|1
424954|NCT00545740|1419554|P2|Overall Study|Non-compliance|2
424955|NCT00545740|1419555|P1|Overall Study|Non-compliance|0
424956|NCT00545740|1419552|P4|Overall Study|Protocol Violation|0
424957|NCT00545740|1419553|P3|Overall Study|Protocol Violation|1
424958|NCT00545740|1419554|P2|Overall Study|Protocol Violation|3
424959|NCT00545740|1419555|P1|Overall Study|Protocol Violation|1
424960|NCT00545740|1419552|P4|Overall Study|Lost to Follow-up|6
424961|NCT00545740|1419553|P3|Overall Study|Lost to Follow-up|5
424962|NCT00545740|1419554|P2|Overall Study|Lost to Follow-up|5
424963|NCT00545740|1419555|P1|Overall Study|Lost to Follow-up|7
424964|NCT00545740|1419552|P4|Overall Study|Adverse Event|9
424965|NCT00545740|1419553|P3|Overall Study|Adverse Event|19
424966|NCT00545740|1419554|P2|Overall Study|Adverse Event|18
424967|NCT00545740|1419555|P1|Overall Study|Adverse Event|10
424968|NCT00545740|1419552|P4|Overall Study|Withdrawal by Subject|18
424969|NCT00545740|1419553|P3|Overall Study|Withdrawal by Subject|16
424970|NCT00545740|1419554|P2|Overall Study|Withdrawal by Subject|15
424971|NCT00545740|1419555|P1|Overall Study|Withdrawal by Subject|17
424972|NCT00545740|1419552|P4|Overall Study|Lack of Efficacy|36
424973|NCT00545740|1419553|P3|Overall Study|Lack of Efficacy|47
424974|NCT00545740|1419554|P2|Overall Study|Lack of Efficacy|35
424975|NCT00545740|1419555|P1|Overall Study|Lack of Efficacy|34
424976|NCT00545688|1419593|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
424977|NCT00545688|1419594|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
424978|NCT00545688|1419595|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
424979|NCT00545688|1419596|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
424980|NCT00545688|1419593|P4|Follow-Up Period|Unspecified Reason|8
424981|NCT00545688|1419594|P3|Follow-Up Period|Unspecified Reason|6
424982|NCT00545688|1419595|P2|Follow-Up Period|Unspecified Reason|5
424983|NCT00545688|1419596|P1|Follow-Up Period|Unspecified Reason|2
424984|NCT00545688|1419593|P4|Follow-Up Period|Lost to Follow-up|1
424985|NCT00545688|1419594|P3|Follow-Up Period|Lost to Follow-up|3
424986|NCT00545688|1419595|P2|Follow-Up Period|Lost to Follow-up|3
424987|NCT00545688|1419596|P1|Follow-Up Period|Lost to Follow-up|3
424988|NCT00545688|1419593|P4|Follow-Up Period|Refused Treatment|2
424989|NCT00545688|1419594|P3|Follow-Up Period|Refused Treatment|0
424990|NCT00545688|1419595|P2|Follow-Up Period|Refused Treatment|2
424991|NCT00545688|1419596|P1|Follow-Up Period|Refused Treatment|6
424992|NCT00545688|1419593|P4|Follow-Up Period|Disease Progression|9
424993|NCT00545688|1419594|P3|Follow-Up Period|Disease Progression|9
424994|NCT00545688|1419595|P2|Follow-Up Period|Disease Progression|5
424995|NCT00545688|1419596|P1|Follow-Up Period|Disease Progression|6
424996|NCT00545688|1419593|P4|Follow-Up Period|Death|6
424997|NCT00545688|1419594|P3|Follow-Up Period|Death|2
424998|NCT00545688|1419595|P2|Follow-Up Period|Death|2
424999|NCT00545688|1419596|P1|Follow-Up Period|Death|4
425000|NCT00545688|1419593|P4|Adjuvant Treatment Period|Unknown Reason|0
425001|NCT00545688|1419594|P3|Adjuvant Treatment Period|Unknown Reason|0
425002|NCT00545688|1419595|P2|Adjuvant Treatment Period|Unknown Reason|1
425003|NCT00545688|1419596|P1|Adjuvant Treatment Period|Unknown Reason|0
425004|NCT00545688|1419593|P4|Adjuvant Treatment Period|Adverse Event|2
425005|NCT00545688|1419594|P3|Adjuvant Treatment Period|Adverse Event|2
425006|NCT00545688|1419595|P2|Adjuvant Treatment Period|Adverse Event|3
425007|NCT00545688|1419596|P1|Adjuvant Treatment Period|Adverse Event|0
425008|NCT00545688|1419593|P4|Adjuvant Treatment Period|Lost to Follow-up|0
425009|NCT00545688|1419594|P3|Adjuvant Treatment Period|Lost to Follow-up|1
425010|NCT00545688|1419595|P2|Adjuvant Treatment Period|Lost to Follow-up|0
425011|NCT00545688|1419596|P1|Adjuvant Treatment Period|Lost to Follow-up|1
425012|NCT00545688|1419593|P4|Adjuvant Treatment Period|Refused Treatment|5
425013|NCT00545688|1419594|P3|Adjuvant Treatment Period|Refused Treatment|1
425014|NCT00545688|1419595|P2|Adjuvant Treatment Period|Refused Treatment|1
425015|NCT00545688|1419596|P1|Adjuvant Treatment Period|Refused Treatment|1
425016|NCT00545688|1419593|P4|Adjuvant Treatment Period|Disease Progression|7
425017|NCT00545688|1419594|P3|Adjuvant Treatment Period|Disease Progression|0
425018|NCT00545688|1419595|P2|Adjuvant Treatment Period|Disease Progression|3
425019|NCT00545688|1419596|P1|Adjuvant Treatment Period|Disease Progression|3
425020|NCT00545688|1419593|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
425021|NCT00545688|1419594|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
425022|NCT00545688|1419595|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
425023|NCT00545688|1419596|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
425024|NCT00545688|1419593|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
425025|NCT00545688|1419594|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
425026|NCT00545688|1419595|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
425027|NCT00545688|1419596|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
425028|NCT00545688|1419593|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
425029|NCT00545688|1419594|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
425030|NCT00545688|1419595|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
425031|NCT00545688|1419596|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
425032|NCT00545688|1419593|P4|Neo-Adjuvant Treatment Period|Death|0
425033|NCT00545688|1419594|P3|Neo-Adjuvant Treatment Period|Death|0
425034|NCT00545688|1419595|P2|Neo-Adjuvant Treatment Period|Death|1
425035|NCT00545688|1419596|P1|Neo-Adjuvant Treatment Period|Death|0
425036|NCT00545688|1419593|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
425037|NCT00545688|1419594|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
425038|NCT00545688|1419595|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
425039|NCT00545688|1419596|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
425040|NCT00545688|1419593|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
425041|NCT00545688|1419594|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
425042|NCT00545688|1419595|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
425043|NCT00545688|1419596|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
425044|NCT00545688|1419593|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
425045|NCT00545688|1419594|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
425046|NCT00545688|1419595|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
425047|NCT00545688|1419596|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
425048|NCT00545584|1419695|P3|Overall Study|Two or more reasons for discontinuation|8
425049|NCT00545584|1419696|P2|Overall Study|Two or more reasons for discontinuation|19
425050|NCT00545584|1419697|P1|Overall Study|Two or more reasons for discontinuation|17
425051|NCT00545584|1419695|P3|Overall Study|Only one reason for discontinuation|48
425052|NCT00545584|1419696|P2|Overall Study|Only one reason for discontinuation|61
425053|NCT00545584|1419697|P1|Overall Study|Only one reason for discontinuation|62
425054|NCT00545571|1419708|P1|Overall Study|Kidney Transplantation|3
425055|NCT00545571|1419708|P1|Overall Study|Early Termination of Study|24
425056|NCT00545571|1419708|P1|Overall Study|Transfusion|12
425057|NCT00545571|1419708|P1|Overall Study|Screen Failure|16
425058|NCT00545571|1419708|P1|Overall Study|Refused Treatment|1
425059|NCT00545571|1419708|P1|Overall Study|Protocol Violation|2
425060|NCT00545571|1419708|P1|Overall Study|Lack of Efficacy|1
425061|NCT00545571|1419708|P1|Overall Study|Death|5
425062|NCT00545571|1419708|P1|Overall Study|Adverse Event|2
425063|NCT00545571|1419708|P1|Overall Study|Administrative Reasons|1
425064|NCT00545441|1419732|P2|Overall Study|Patients were not treated|3
425065|NCT00545441|1419733|P1|Overall Study|Patients were not treated|1
425066|NCT00545441|1419732|P2|Overall Study|Persistence or recurrence of fistula|2
425067|NCT00545441|1419733|P1|Overall Study|Persistence or recurrence of fistula|5
425068|NCT00545441|1419732|P2|Overall Study|Withdrawal by Subject|1
425069|NCT00545441|1419733|P1|Overall Study|Withdrawal by Subject|1
425070|NCT00545441|1419732|P2|Overall Study|Technical failure|1
425071|NCT00545441|1419733|P1|Overall Study|Technical failure|0
425072|NCT00545441|1419732|P2|Overall Study|Lost to Follow-up|5
425073|NCT00545441|1419733|P1|Overall Study|Lost to Follow-up|9
425074|NCT00545441|1419732|P2|Overall Study|Fistula draining at 6 months|4
425075|NCT00545441|1419733|P1|Overall Study|Fistula draining at 6 months|2
425076|NCT00545402|1419741|P2|Overall Study|Reason not specified|1
425077|NCT00545402|1419742|P1|Overall Study|Reason not specified|1
425078|NCT00545402|1419741|P2|Overall Study|Protocol Violation|0
425079|NCT00545402|1419742|P1|Overall Study|Protocol Violation|1
425080|NCT00545402|1419741|P2|Overall Study|Withdrawal by Subject|1
425081|NCT00545402|1419742|P1|Overall Study|Withdrawal by Subject|0
425082|NCT00545402|1419741|P2|Overall Study|Graft loss|4
425083|NCT00545402|1419742|P1|Overall Study|Graft loss|2
425084|NCT00545402|1419741|P2|Overall Study|Death|7
425085|NCT00545402|1419742|P1|Overall Study|Death|5
425086|NCT00545402|1419741|P2|Overall Study|Use of unauthorized immunosuppressant|7
425087|NCT00545402|1419742|P1|Overall Study|Use of unauthorized immunosuppressant|8
425088|NCT00545402|1419741|P2|Overall Study|Discontinuation of treatment|9
425089|NCT00545402|1419742|P1|Overall Study|Discontinuation of treatment|17
425090|NCT00545363|1419760|P2|Overall Study|Other|1
425091|NCT00545363|1419761|P1|Overall Study|Other|1
425092|NCT00545363|1419760|P2|Overall Study|Lost to Follow-up|0
425093|NCT00545363|1419761|P1|Overall Study|Lost to Follow-up|2
425094|NCT00545363|1419760|P2|Overall Study|Did not meet entry criteria|1
425095|NCT00545363|1419761|P1|Overall Study|Did not meet entry criteria|1
425096|NCT00545363|1419760|P2|Overall Study|Non-compliance|1
425097|NCT00545363|1419761|P1|Overall Study|Non-compliance|3
425098|NCT00545363|1419760|P2|Overall Study|Withdrawal by Subject|5
425099|NCT00545363|1419761|P1|Overall Study|Withdrawal by Subject|6
425100|NCT00545363|1419760|P2|Overall Study|Adverse Event|7
425101|NCT00545363|1419761|P1|Overall Study|Adverse Event|6
425102|NCT00545298|1419776|P3|Overall Study|Issues with Standard of Care|1
425103|NCT00545298|1419777|P2|Overall Study|Issues with Standard of Care|0
425104|NCT00545298|1419778|P1|Overall Study|Issues with Standard of Care|2
425105|NCT00545272|1419795|P6|Overall Study|Lost to Follow-up|0
425106|NCT00545272|1419796|P5|Overall Study|Lost to Follow-up|1
425107|NCT00545272|1419797|P4|Overall Study|Lost to Follow-up|0
425108|NCT00545272|1419798|P3|Overall Study|Lost to Follow-up|0
425109|NCT00545272|1419799|P2|Overall Study|Lost to Follow-up|0
425110|NCT00545272|1419800|P1|Overall Study|Lost to Follow-up|0
425111|NCT00545272|1419795|P6|Overall Study|Abnormal test procedure result(s)|0
425112|NCT00545272|1419796|P5|Overall Study|Abnormal test procedure result(s)|1
425113|NCT00545272|1419797|P4|Overall Study|Abnormal test procedure result(s)|0
425114|NCT00545272|1419798|P3|Overall Study|Abnormal test procedure result(s)|0
425115|NCT00545272|1419799|P2|Overall Study|Abnormal test procedure result(s)|0
425116|NCT00545272|1419800|P1|Overall Study|Abnormal test procedure result(s)|0
425117|NCT00545272|1419795|P6|Overall Study|Abnormal laboratory value(s)|1
425118|NCT00545272|1419796|P5|Overall Study|Abnormal laboratory value(s)|0
425119|NCT00545272|1419797|P4|Overall Study|Abnormal laboratory value(s)|0
425120|NCT00545272|1419798|P3|Overall Study|Abnormal laboratory value(s)|0
425121|NCT00545272|1419799|P2|Overall Study|Abnormal laboratory value(s)|0
425122|NCT00545272|1419800|P1|Overall Study|Abnormal laboratory value(s)|0
425123|NCT00545272|1419795|P6|Overall Study|Adverse Event|1
425124|NCT00545272|1419796|P5|Overall Study|Adverse Event|0
425125|NCT00545272|1419797|P4|Overall Study|Adverse Event|0
425126|NCT00545272|1419798|P3|Overall Study|Adverse Event|1
425127|NCT00545272|1419799|P2|Overall Study|Adverse Event|0
425128|NCT00545272|1419800|P1|Overall Study|Adverse Event|0
425129|NCT00545272|1419795|P6|Overall Study|Protocol deviation|1
425130|NCT00545272|1419796|P5|Overall Study|Protocol deviation|0
425131|NCT00545272|1419797|P4|Overall Study|Protocol deviation|1
425132|NCT00545272|1419798|P3|Overall Study|Protocol deviation|0
425133|NCT00545272|1419799|P2|Overall Study|Protocol deviation|1
425134|NCT00545272|1419800|P1|Overall Study|Protocol deviation|0
425135|NCT00545233|1419852|P2|Overall Study|Physician Decision|1
425136|NCT00545233|1419853|P1|Overall Study|Physician Decision|2
425137|NCT00545233|1419852|P2|Overall Study|Insufficient response|15
425138|NCT00545233|1419853|P1|Overall Study|Insufficient response|14
425139|NCT00545233|1419852|P2|Overall Study|Failure to Return|6
425140|NCT00545233|1419853|P1|Overall Study|Failure to Return|4
425141|NCT00545233|1419852|P2|Overall Study|Refused Treatment|7
425142|NCT00545233|1419853|P1|Overall Study|Refused Treatment|9
425143|NCT00545233|1419852|P2|Overall Study|Protocol Violation|0
425144|NCT00545233|1419853|P1|Overall Study|Protocol Violation|2
425145|NCT00545233|1419852|P2|Overall Study|Violation of Selection Criteria at Entry|1
425146|NCT00545233|1419853|P1|Overall Study|Violation of Selection Criteria at Entry|5
425147|NCT00545233|1419852|P2|Overall Study|Adverse Event|5
425148|NCT00545233|1419853|P1|Overall Study|Adverse Event|10
425149|NCT00545168|1419912|P3|Overall Study|Visit for Day 21 was not done in error|2
425150|NCT00545168|1419913|P2|Overall Study|Visit for Day 21 was not done in error|0
425151|NCT00545168|1419914|P1|Overall Study|Visit for Day 21 was not done in error|1
425152|NCT00545168|1419912|P3|Overall Study|Protocol Violation|1
425153|NCT00545168|1419913|P2|Overall Study|Protocol Violation|0
425154|NCT00545168|1419914|P1|Overall Study|Protocol Violation|1
425155|NCT00545168|1419912|P3|Overall Study|Withdrawal by Subject|13
425156|NCT00545168|1419913|P2|Overall Study|Withdrawal by Subject|0
425157|NCT00545168|1419914|P1|Overall Study|Withdrawal by Subject|9
425158|NCT00545168|1419912|P3|Overall Study|Lost to Follow-up|5
425159|NCT00545168|1419913|P2|Overall Study|Lost to Follow-up|5
425160|NCT00545168|1419914|P1|Overall Study|Lost to Follow-up|5
425161|NCT00545103|1419940|P4|Overall Study|Death|0
425162|NCT00545103|1419941|P3|Overall Study|Death|0
425163|NCT00545103|1419942|P2|Overall Study|Death|1
425164|NCT00545103|1419943|P1|Overall Study|Death|0
425165|NCT00545103|1419940|P4|Overall Study|Subject met endpoint under protocol v. 1|0
425166|NCT00545103|1419941|P3|Overall Study|Subject met endpoint under protocol v. 1|1
425167|NCT00545103|1419942|P2|Overall Study|Subject met endpoint under protocol v. 1|0
425168|NCT00545103|1419943|P1|Overall Study|Subject met endpoint under protocol v. 1|0
425169|NCT00545103|1419940|P4|Overall Study|Does not want to take study drug anymore|0
425170|NCT00545103|1419941|P3|Overall Study|Does not want to take study drug anymore|1
425171|NCT00545103|1419942|P2|Overall Study|Does not want to take study drug anymore|0
425172|NCT00545103|1419943|P1|Overall Study|Does not want to take study drug anymore|1
425173|NCT00545103|1419940|P4|Overall Study|Use of prohibited medication|0
425174|NCT00545103|1419941|P3|Overall Study|Use of prohibited medication|1
425175|NCT00545103|1419942|P2|Overall Study|Use of prohibited medication|0
425176|NCT00545103|1419943|P1|Overall Study|Use of prohibited medication|0
425177|NCT00545103|1419940|P4|Overall Study|Subject moved|0
425178|NCT00545103|1419941|P3|Overall Study|Subject moved|0
425179|NCT00545103|1419942|P2|Overall Study|Subject moved|1
425180|NCT00545103|1419943|P1|Overall Study|Subject moved|0
425181|NCT00545103|1419940|P4|Overall Study|Investigator decision|0
425182|NCT00545103|1419941|P3|Overall Study|Investigator decision|1
425183|NCT00545103|1419942|P2|Overall Study|Investigator decision|0
425184|NCT00545103|1419943|P1|Overall Study|Investigator decision|0
425185|NCT00545103|1419940|P4|Overall Study|Noncompliance|0
425186|NCT00545103|1419941|P3|Overall Study|Noncompliance|0
425187|NCT00545103|1419942|P2|Overall Study|Noncompliance|1
425188|NCT00545103|1419943|P1|Overall Study|Noncompliance|0
425189|NCT00545103|1419940|P4|Overall Study|Subject's decision|0
425190|NCT00545103|1419941|P3|Overall Study|Subject's decision|0
425191|NCT00545103|1419942|P2|Overall Study|Subject's decision|0
425192|NCT00545103|1419943|P1|Overall Study|Subject's decision|1
425193|NCT00545103|1419940|P4|Overall Study|Personal reasons|0
425194|NCT00545103|1419941|P3|Overall Study|Personal reasons|0
425195|NCT00545103|1419942|P2|Overall Study|Personal reasons|0
425196|NCT00545103|1419943|P1|Overall Study|Personal reasons|1
425197|NCT00545103|1419940|P4|Overall Study|Diverticulitis crisis|1
425198|NCT00545103|1419941|P3|Overall Study|Diverticulitis crisis|0
425199|NCT00545103|1419942|P2|Overall Study|Diverticulitis crisis|0
425200|NCT00545103|1419943|P1|Overall Study|Diverticulitis crisis|0
425201|NCT00545103|1419940|P4|Overall Study|Wish to start a family|1
425202|NCT00545103|1419941|P3|Overall Study|Wish to start a family|0
425203|NCT00545103|1419942|P2|Overall Study|Wish to start a family|0
425204|NCT00545103|1419943|P1|Overall Study|Wish to start a family|0
425205|NCT00545103|1419940|P4|Overall Study|Investigational product not taken|1
425206|NCT00545103|1419941|P3|Overall Study|Investigational product not taken|0
425207|NCT00545103|1419942|P2|Overall Study|Investigational product not taken|0
425208|NCT00545103|1419943|P1|Overall Study|Investigational product not taken|1
425209|NCT00545103|1419940|P4|Overall Study|Difficult to open package|1
425210|NCT00545103|1419941|P3|Overall Study|Difficult to open package|0
425211|NCT00545103|1419942|P2|Overall Study|Difficult to open package|0
425212|NCT00545103|1419943|P1|Overall Study|Difficult to open package|0
425213|NCT00545103|1419940|P4|Overall Study|Suspected recurrence of diverticulitis|3
425214|NCT00545103|1419941|P3|Overall Study|Suspected recurrence of diverticulitis|0
425215|NCT00545103|1419942|P2|Overall Study|Suspected recurrence of diverticulitis|0
425216|NCT00545103|1419943|P1|Overall Study|Suspected recurrence of diverticulitis|1
425217|NCT00545103|1419940|P4|Overall Study|Protocol Violation|0
425218|NCT00545103|1419941|P3|Overall Study|Protocol Violation|3
425219|NCT00545103|1419942|P2|Overall Study|Protocol Violation|2
425220|NCT00545103|1419943|P1|Overall Study|Protocol Violation|1
425221|NCT00545103|1419940|P4|Overall Study|Lost to Follow-up|4
425222|NCT00545103|1419941|P3|Overall Study|Lost to Follow-up|3
425223|NCT00545103|1419942|P2|Overall Study|Lost to Follow-up|6
425224|NCT00545103|1419943|P1|Overall Study|Lost to Follow-up|4
425225|NCT00545103|1419940|P4|Overall Study|Adverse Event|10
425226|NCT00545103|1419941|P3|Overall Study|Adverse Event|17
425227|NCT00545103|1419942|P2|Overall Study|Adverse Event|12
425228|NCT00545103|1419943|P1|Overall Study|Adverse Event|11
425229|NCT00545103|1419940|P4|Overall Study|Withdrawal by Subject|22
425230|NCT00545103|1419941|P3|Overall Study|Withdrawal by Subject|18
425231|NCT00545103|1419942|P2|Overall Study|Withdrawal by Subject|10
425232|NCT00545103|1419943|P1|Overall Study|Withdrawal by Subject|6
425233|NCT00545103|1419940|P4|Overall Study|Lack of Efficacy|27
425234|NCT00545103|1419941|P3|Overall Study|Lack of Efficacy|31
425235|NCT00545103|1419942|P2|Overall Study|Lack of Efficacy|45
425236|NCT00545103|1419943|P1|Overall Study|Lack of Efficacy|48
425237|NCT00545064|1419977|P1|Overall Study|inclement weather|1
425238|NCT00545064|1419977|P1|Overall Study|cancel all appointments, no rebooking|1
425239|NCT00545064|1419977|P1|Overall Study|did not complete course of treatment|1
425240|NCT00545064|1419977|P1|Overall Study|Withdrawal by Subject|2
425241|NCT00545064|1419977|P1|Overall Study|Lost to Follow-up|3
425242|NCT00545051|1419988|P2|Overall Study|Administrative reasons|1
425243|NCT00545051|1419989|P1|Overall Study|Administrative reasons|0
425244|NCT00545051|1419988|P2|Overall Study|Withdrawal by Subject|1
425245|NCT00545051|1419989|P1|Overall Study|Withdrawal by Subject|0
425246|NCT00545051|1419988|P2|Overall Study|Protocol Violation|0
425247|NCT00545051|1419989|P1|Overall Study|Protocol Violation|1
425248|NCT00545051|1419988|P2|Overall Study|Violation of inclusion/exclusion|2
425249|NCT00545051|1419989|P1|Overall Study|Violation of inclusion/exclusion|0
425250|NCT00545051|1419988|P2|Overall Study|Death|0
425251|NCT00545051|1419989|P1|Overall Study|Death|1
425252|NCT00545051|1419988|P2|Overall Study|Adverse Event|3
425253|NCT00545051|1419989|P1|Overall Study|Adverse Event|7
425254|NCT00544882|1420033|P3|Cycle 3: Follow-up|Pregnancy|0
425255|NCT00544882|1420034|P2|Cycle 3: Follow-up|Pregnancy|1
425256|NCT00544882|1420035|P1|Cycle 3: Follow-up|Pregnancy|0
425257|NCT00544882|1420033|P3|Cycle 3: Follow-up|Noncompliance|0
425258|NCT00544882|1420034|P2|Cycle 3: Follow-up|Noncompliance|1
425259|NCT00544882|1420035|P1|Cycle 3: Follow-up|Noncompliance|0
425260|NCT00544882|1420033|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
425261|NCT00544882|1420034|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
425262|NCT00544882|1420035|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
425263|NCT00544882|1420033|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
425264|NCT00544882|1420034|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
425265|NCT00544882|1420035|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
425266|NCT00544882|1420033|P3|Cycle 1: Run-in Cycle|Adverse Event|0
425267|NCT00544882|1420034|P2|Cycle 1: Run-in Cycle|Adverse Event|0
425268|NCT00544882|1420035|P1|Cycle 1: Run-in Cycle|Adverse Event|1
425269|NCT00544882|1420033|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
425270|NCT00544882|1420034|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
425271|NCT00544882|1420035|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
425272|NCT00544869|1420060|P3|Overall Study|Physician Decision|0
425273|NCT00544869|1420061|P2|Overall Study|Physician Decision|0
425274|NCT00544869|1420062|P1|Overall Study|Physician Decision|2
425275|NCT00544869|1420060|P3|Overall Study|Lack of Efficacy|0
425276|NCT00544869|1420061|P2|Overall Study|Lack of Efficacy|1
425277|NCT00544869|1420062|P1|Overall Study|Lack of Efficacy|1
425278|NCT00544869|1420060|P3|Overall Study|Adverse Event|0
425279|NCT00544869|1420061|P2|Overall Study|Adverse Event|1
425280|NCT00544869|1420062|P1|Overall Study|Adverse Event|6
425281|NCT00544869|1420060|P3|Overall Study|Rsolution of congenitive symptoms|0
425282|NCT00544869|1420061|P2|Overall Study|Rsolution of congenitive symptoms|0
425283|NCT00544869|1420062|P1|Overall Study|Rsolution of congenitive symptoms|3
425284|NCT00544817|1420070|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
425285|NCT00544817|1420070|P1|Follow-up Systemic Therapy|Physician Decision|3
425286|NCT00544817|1420070|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
425287|NCT00544817|1420070|P1|No Treatment Interval|Adverse Event|1
425288|NCT00544817|1420070|P1|No Treatment Interval|Physician Decision|3
425289|NCT00544817|1420070|P1|No Treatment Interval|Lack of Efficacy|8
425290|NCT00544817|1420070|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
425291|NCT00544817|1420070|P1|Combined Modality|Adverse Event|2
425292|NCT00544817|1420070|P1|Combined Modality|Worsening Neurologic Symptoms|2
425293|NCT00544817|1420070|P1|Combined Modality|Lack of Efficacy|2
425294|NCT00544648|1420119|P2|Overall Study|progression of disease|0
425295|NCT00544648|1420120|P1|Overall Study|progression of disease|1
425296|NCT00544648|1420119|P2|Overall Study|Adverse Event|1
425297|NCT00544648|1420120|P1|Overall Study|Adverse Event|1
425298|NCT00544648|1420119|P2|Overall Study|Withdrawal by Subject|0
425299|NCT00544648|1420120|P1|Overall Study|Withdrawal by Subject|1
425300|NCT00544557|1420134|P1|Overall Study|Other|98
425301|NCT00544557|1420134|P1|Overall Study|Lack of Efficacy|196
425302|NCT00544557|1420134|P1|Overall Study|Adverse Event|140
425303|NCT00544544|1420165|P1|Overall Study|Lost to Follow-up|1
425304|NCT00544544|1420165|P1|Overall Study|Adverse Event|1
425305|NCT00544544|1420165|P1|Overall Study|Withdrawal by Subject|1
425306|NCT00544440|1420169|P1|Overall Study|Other|5
425307|NCT00544440|1420169|P1|Overall Study|Progressive Disease|47
425308|NCT00544440|1420169|P1|Overall Study|Subject Non-compliance|1
425309|NCT00544440|1420169|P1|Overall Study|Withdrawal by Subject|2
425310|NCT00544440|1420169|P1|Overall Study|Adverse Event|1
425311|NCT00544440|1420169|P1|Overall Study|Other|1
425312|NCT00544167|1420176|P1|Overall Study|Physician Decision|8
425313|NCT00544167|1420176|P1|Overall Study|Adverse Event|21
425314|NCT00543985|1420180|P1|Overall Study|Withdrawal by Subject|4
425315|NCT00543855|1420191|P4|Overall Study|Protocol Violation|0
425316|NCT00543855|1420192|P3|Overall Study|Protocol Violation|0
425317|NCT00543855|1420193|P2|Overall Study|Protocol Violation|0
425318|NCT00543855|1420194|P1|Overall Study|Protocol Violation|1
425319|NCT00543855|1420191|P4|Overall Study|Withdrawal by Subject|0
425320|NCT00543855|1420192|P3|Overall Study|Withdrawal by Subject|2
425321|NCT00543855|1420193|P2|Overall Study|Withdrawal by Subject|1
425322|NCT00543855|1420194|P1|Overall Study|Withdrawal by Subject|0
425323|NCT00543855|1420191|P4|Overall Study|Lost to Follow-up|0
425324|NCT00543855|1420192|P3|Overall Study|Lost to Follow-up|1
425325|NCT00543855|1420193|P2|Overall Study|Lost to Follow-up|0
425326|NCT00543855|1420194|P1|Overall Study|Lost to Follow-up|0
425327|NCT00543855|1420191|P4|Overall Study|Adverse Event|4
425328|NCT00543855|1420192|P3|Overall Study|Adverse Event|3
425329|NCT00543855|1420193|P2|Overall Study|Adverse Event|1
425330|NCT00543855|1420194|P1|Overall Study|Adverse Event|3
425331|NCT00543803|1420216|P1|Overall Study|not specified|86
425332|NCT00543803|1420216|P1|Overall Study|Lost to Follow-up|20
425333|NCT00543803|1420216|P1|Overall Study|Lack of Efficacy|22
425334|NCT00543803|1420216|P1|Overall Study|Adverse Event|14
425335|NCT00543725|1420244|P2|Overall Study|Not specified|3
425336|NCT00543725|1420245|P1|Overall Study|Not specified|3
425337|NCT00543725|1420244|P2|Overall Study|Lost to Follow-up|11
425338|NCT00543725|1420245|P1|Overall Study|Lost to Follow-up|15
425339|NCT00543725|1420244|P2|Overall Study|Withdrawal by Subject|13
425340|NCT00543725|1420245|P1|Overall Study|Withdrawal by Subject|4
425341|NCT00543725|1420244|P2|Overall Study|Protocol Violation|1
425342|NCT00543725|1420245|P1|Overall Study|Protocol Violation|0
425343|NCT00543725|1420244|P2|Overall Study|Subject Reached A Virologic Endpoint|14
425344|NCT00543725|1420245|P1|Overall Study|Subject Reached A Virologic Endpoint|22
425345|NCT00543725|1420244|P2|Overall Study|Subject Ineligible To Continue The Trial|0
425346|NCT00543725|1420245|P1|Overall Study|Subject Ineligible To Continue The Trial|2
425347|NCT00543725|1420244|P2|Overall Study|Subject Non-Compliant|4
425348|NCT00543725|1420245|P1|Overall Study|Subject Non-Compliant|4
425349|NCT00543725|1420244|P2|Overall Study|Sponsor's Decision|1
425350|NCT00543725|1420245|P1|Overall Study|Sponsor's Decision|0
425351|NCT00543725|1420244|P2|Overall Study|Adverse Event|27
425352|NCT00543725|1420245|P1|Overall Study|Adverse Event|18
425353|NCT00543569|1420271|P4|Overall Study|Randomized but never received study drug|3
425354|NCT00543569|1420272|P3|Overall Study|Randomized but never received study drug|5
425355|NCT00543569|1420273|P2|Overall Study|Randomized but never received study drug|3
425356|NCT00543569|1420274|P1|Overall Study|Randomized but never received study drug|3
425357|NCT00543569|1420271|P4|Overall Study|Miscellaneous Reasons|4
425358|NCT00543569|1420272|P3|Overall Study|Miscellaneous Reasons|11
425359|NCT00543569|1420273|P2|Overall Study|Miscellaneous Reasons|3
425360|NCT00543569|1420274|P1|Overall Study|Miscellaneous Reasons|7
425361|NCT00543569|1420271|P4|Overall Study|Lost to Follow-up|1
425362|NCT00543569|1420272|P3|Overall Study|Lost to Follow-up|1
425363|NCT00543569|1420273|P2|Overall Study|Lost to Follow-up|0
425364|NCT00543569|1420274|P1|Overall Study|Lost to Follow-up|0
425365|NCT00543569|1420271|P4|Overall Study|Death|1
425366|NCT00543569|1420272|P3|Overall Study|Death|3
425367|NCT00543569|1420273|P2|Overall Study|Death|2
425368|NCT00543569|1420274|P1|Overall Study|Death|2
425369|NCT00543543|1420380|P4|Extension Study|Withdrawal by Subject|120
425370|NCT00543543|1420381|P3|Extension Study|Withdrawal by Subject|0
425371|NCT00543543|1420382|P2|Extension Study|Withdrawal by Subject|0
425372|NCT00543543|1420383|P1|Extension Study|Withdrawal by Subject|0
425373|NCT00543543|1420380|P4|Extension Study|Protocol Violation|11
425374|NCT00543543|1420381|P3|Extension Study|Protocol Violation|0
425375|NCT00543543|1420382|P2|Extension Study|Protocol Violation|0
425376|NCT00543543|1420383|P1|Extension Study|Protocol Violation|0
425377|NCT00543543|1420380|P4|Extension Study|Pregnancy|6
425378|NCT00543543|1420381|P3|Extension Study|Pregnancy|0
425379|NCT00543543|1420382|P2|Extension Study|Pregnancy|0
425380|NCT00543543|1420383|P1|Extension Study|Pregnancy|0
425381|NCT00543543|1420380|P4|Extension Study|Physician Decision|7
425382|NCT00543543|1420381|P3|Extension Study|Physician Decision|0
425383|NCT00543543|1420382|P2|Extension Study|Physician Decision|0
425384|NCT00543543|1420383|P1|Extension Study|Physician Decision|0
425385|NCT00543543|1420380|P4|Extension Study|Lost to Follow-up|77
425386|NCT00543543|1420381|P3|Extension Study|Lost to Follow-up|0
425387|NCT00543543|1420382|P2|Extension Study|Lost to Follow-up|0
425388|NCT00543543|1420383|P1|Extension Study|Lost to Follow-up|0
425389|NCT00543543|1420380|P4|Extension Study|Adverse Event|5
425390|NCT00543543|1420381|P3|Extension Study|Adverse Event|0
425391|NCT00543543|1420382|P2|Extension Study|Adverse Event|0
425392|NCT00543543|1420383|P1|Extension Study|Adverse Event|0
425393|NCT00543543|1420380|P4|Base Study|Withdrawal by Subject|503
425394|NCT00543543|1420381|P3|Base Study|Withdrawal by Subject|5
425395|NCT00543543|1420382|P2|Base Study|Withdrawal by Subject|482
425396|NCT00543543|1420383|P1|Base Study|Withdrawal by Subject|7
425397|NCT00543543|1420380|P4|Base Study|Protocol Violation|6
425398|NCT00543543|1420381|P3|Base Study|Protocol Violation|0
425399|NCT00543543|1420382|P2|Base Study|Protocol Violation|6
425400|NCT00543543|1420383|P1|Base Study|Protocol Violation|0
425401|NCT00543543|1420380|P4|Base Study|Physician Decision|7
425402|NCT00543543|1420381|P3|Base Study|Physician Decision|0
425403|NCT00543543|1420382|P2|Base Study|Physician Decision|4
425404|NCT00543543|1420383|P1|Base Study|Physician Decision|0
425405|NCT00543543|1420380|P4|Base Study|Lost to Follow-up|701
425406|NCT00543543|1420381|P3|Base Study|Lost to Follow-up|9
425407|NCT00543543|1420382|P2|Base Study|Lost to Follow-up|749
425408|NCT00543543|1420383|P1|Base Study|Lost to Follow-up|12
425409|NCT00543543|1420380|P4|Base Study|Adverse Event|5
425410|NCT00543543|1420381|P3|Base Study|Adverse Event|0
425411|NCT00543543|1420382|P2|Base Study|Adverse Event|11
425412|NCT00543543|1420383|P1|Base Study|Adverse Event|1
425413|NCT00543309|1420444|P3|Overall Study|Physician Decision|0
425414|NCT00543309|1420445|P2|Overall Study|Physician Decision|1
425415|NCT00543309|1420446|P1|Overall Study|Physician Decision|0
425416|NCT00543296|1420496|P1|Overall Study|Physician Decision|7
425417|NCT00543140|1420503|P1|Overall Study|Conversion to different procedure|1
425418|NCT00543140|1420503|P1|Overall Study|Subject moved|1
425419|NCT00543140|1420503|P1|Overall Study|Death|1
425420|NCT00543140|1420503|P1|Overall Study|SAE leading to explant of SAGB|3
425421|NCT00543140|1420503|P1|Overall Study|Insufficient weight loss|10
425422|NCT00543140|1420503|P1|Overall Study|Protocol Violation|10
425423|NCT00543140|1420503|P1|Overall Study|Withdrawal by Subject|13
425424|NCT00543140|1420503|P1|Overall Study|Lost to Follow-up|33
425425|NCT00542997|1420526|P1|Efficacy Period|Adverse Event|3
425426|NCT00542997|1420526|P1|Wash in / Wash Out Period|Adverse Event|3
425427|NCT00542997|1420526|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
425428|NCT00542880|1420548|P2|Period 3|Adverse Event|2
425429|NCT00542880|1420549|P1|Period 3|Adverse Event|0
425430|NCT00542880|1420548|P2|Period 2|Not specified|1
425431|NCT00542880|1420549|P1|Period 2|Not specified|0
425432|NCT00542880|1420548|P2|Period 2|Severe non-compliance|1
425433|NCT00542880|1420549|P1|Period 2|Severe non-compliance|0
425434|NCT00542880|1420548|P2|Period 2|Discontinuation criteria|0
425435|NCT00542880|1420549|P1|Period 2|Discontinuation criteria|2
425436|NCT00542880|1420548|P2|Period 2|Eligibility not fulfilled|1
425437|NCT00542880|1420549|P1|Period 2|Eligibility not fulfilled|0
425438|NCT00542880|1420548|P2|Period 2|Adverse Event|7
425439|NCT00542880|1420549|P1|Period 2|Adverse Event|5
425440|NCT00542880|1420548|P2|Period 1|Protocol Violation|1
425441|NCT00542880|1420549|P1|Period 1|Protocol Violation|0
425442|NCT00542880|1420548|P2|Period 1|Withdrawal by Subject|1
425443|NCT00542880|1420549|P1|Period 1|Withdrawal by Subject|1
425444|NCT00542880|1420548|P2|Period 1|Development of study-specific criteria|2
425445|NCT00542880|1420549|P1|Period 1|Development of study-specific criteria|1
425446|NCT00542880|1420548|P2|Period 1|Adverse Event|2
425447|NCT00542880|1420549|P1|Period 1|Adverse Event|2
425448|NCT00542880|1420548|P2|Period 1|Eligibility criteria not fulfilled|6
425449|NCT00542880|1420549|P1|Period 1|Eligibility criteria not fulfilled|2
425450|NCT00542828|1420585|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
425451|NCT00542828|1420585|P1|Overall Study|Study Prematurely Discontinued|7
425452|NCT00542828|1420585|P1|Overall Study|Need for Prohibited Treatment|3
425453|NCT00542828|1420585|P1|Overall Study|Physician Decision|1
425454|NCT00542815|1420603|P3|Overall Study|Other reasons|10
425455|NCT00542815|1420604|P2|Overall Study|Other reasons|10
425456|NCT00542815|1420605|P1|Overall Study|Other reasons|24
425457|NCT00542815|1420603|P3|Overall Study|Withdrawal by Subject|8
425458|NCT00542815|1420604|P2|Overall Study|Withdrawal by Subject|5
425459|NCT00542815|1420605|P1|Overall Study|Withdrawal by Subject|41
425460|NCT00542815|1420603|P3|Overall Study|Protocol Violation|2
425461|NCT00542815|1420604|P2|Overall Study|Protocol Violation|1
425462|NCT00542815|1420605|P1|Overall Study|Protocol Violation|1
425463|NCT00542815|1420603|P3|Overall Study|Physician Decision|0
425464|NCT00542815|1420604|P2|Overall Study|Physician Decision|1
425465|NCT00542815|1420605|P1|Overall Study|Physician Decision|2
425466|NCT00542815|1420603|P3|Overall Study|Lack of Efficacy|0
425467|NCT00542815|1420604|P2|Overall Study|Lack of Efficacy|2
425468|NCT00542815|1420605|P1|Overall Study|Lack of Efficacy|9
425469|NCT00542815|1420603|P3|Overall Study|Death|3
425470|NCT00542815|1420604|P2|Overall Study|Death|7
425471|NCT00542815|1420605|P1|Overall Study|Death|10
425472|NCT00542815|1420603|P3|Overall Study|Adverse Event|9
425473|NCT00542815|1420604|P2|Overall Study|Adverse Event|6
425474|NCT00542815|1420605|P1|Overall Study|Adverse Event|19
425475|NCT00542789|1420618|P2|Overall Study|Recurrence of Gastric Ulcer|57
425476|NCT00542789|1420619|P1|Overall Study|Recurrence of Gastric Ulcer|8
425477|NCT00542789|1420618|P2|Overall Study|Protocol Violation|1
425478|NCT00542789|1420619|P1|Overall Study|Protocol Violation|8
425479|NCT00542789|1420618|P2|Overall Study|Withdrawal by Subject|3
425480|NCT00542789|1420619|P1|Overall Study|Withdrawal by Subject|7
425481|NCT00542789|1420618|P2|Overall Study|Adverse Event|17
425482|NCT00542789|1420619|P1|Overall Study|Adverse Event|18
425483|NCT00542425|1420719|P5|Extended 24 Weeks of Treatment|Other|1
425484|NCT00542425|1420720|P4|Extended 24 Weeks of Treatment|Other|0
425485|NCT00542425|1420721|P3|Extended 24 Weeks of Treatment|Other|0
425486|NCT00542425|1420722|P2|Extended 24 Weeks of Treatment|Other|1
425487|NCT00542425|1420723|P1|Extended 24 Weeks of Treatment|Other|1
425488|NCT00542425|1420719|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
425489|NCT00542425|1420720|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
425490|NCT00542425|1420721|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
425491|NCT00542425|1420722|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
425492|NCT00542425|1420723|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
425493|NCT00542425|1420719|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
425494|NCT00542425|1420720|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
425495|NCT00542425|1420721|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
425496|NCT00542425|1420722|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
425497|NCT00542425|1420723|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
425498|NCT00542425|1420719|P5|Extended 24 Weeks of Treatment|Adverse Event|0
425499|NCT00542425|1420720|P4|Extended 24 Weeks of Treatment|Adverse Event|1
425500|NCT00542425|1420721|P3|Extended 24 Weeks of Treatment|Adverse Event|1
425501|NCT00542425|1420722|P2|Extended 24 Weeks of Treatment|Adverse Event|0
425502|NCT00542425|1420723|P1|Extended 24 Weeks of Treatment|Adverse Event|0
425503|NCT00542425|1420719|P5|Initial 24 Weeks|Other|0
425504|NCT00542425|1420720|P4|Initial 24 Weeks|Other|0
425505|NCT00542425|1420721|P3|Initial 24 Weeks|Other|1
425506|NCT00542425|1420722|P2|Initial 24 Weeks|Other|2
425507|NCT00542425|1420723|P1|Initial 24 Weeks|Other|0
425508|NCT00542425|1420719|P5|Initial 24 Weeks|Refusal of treatment|1
425509|NCT00542425|1420720|P4|Initial 24 Weeks|Refusal of treatment|4
425510|NCT00542425|1420721|P3|Initial 24 Weeks|Refusal of treatment|1
425511|NCT00542425|1420722|P2|Initial 24 Weeks|Refusal of treatment|2
425512|NCT00542425|1420723|P1|Initial 24 Weeks|Refusal of treatment|2
425513|NCT00542425|1420719|P5|Initial 24 Weeks|Protocol Violation|0
425514|NCT00542425|1420720|P4|Initial 24 Weeks|Protocol Violation|1
425515|NCT00542425|1420721|P3|Initial 24 Weeks|Protocol Violation|0
425516|NCT00542425|1420722|P2|Initial 24 Weeks|Protocol Violation|0
425517|NCT00542425|1420723|P1|Initial 24 Weeks|Protocol Violation|0
425518|NCT00542425|1420719|P5|Initial 24 Weeks|Non-compliance|1
425519|NCT00542425|1420720|P4|Initial 24 Weeks|Non-compliance|1
425520|NCT00542425|1420721|P3|Initial 24 Weeks|Non-compliance|0
425521|NCT00542425|1420722|P2|Initial 24 Weeks|Non-compliance|0
425522|NCT00542425|1420723|P1|Initial 24 Weeks|Non-compliance|0
425523|NCT00542425|1420719|P5|Initial 24 Weeks|Lost to Follow-up|0
425524|NCT00542425|1420720|P4|Initial 24 Weeks|Lost to Follow-up|0
425525|NCT00542425|1420721|P3|Initial 24 Weeks|Lost to Follow-up|1
425526|NCT00542425|1420722|P2|Initial 24 Weeks|Lost to Follow-up|2
425527|NCT00542425|1420723|P1|Initial 24 Weeks|Lost to Follow-up|2
425528|NCT00542425|1420719|P5|Initial 24 Weeks|Inability to complete procedures|2
425529|NCT00542425|1420720|P4|Initial 24 Weeks|Inability to complete procedures|1
425530|NCT00542425|1420721|P3|Initial 24 Weeks|Inability to complete procedures|2
425531|NCT00542425|1420722|P2|Initial 24 Weeks|Inability to complete procedures|3
425532|NCT00542425|1420723|P1|Initial 24 Weeks|Inability to complete procedures|0
425533|NCT00542425|1420719|P5|Initial 24 Weeks|Adverse Event|2
425534|NCT00542425|1420720|P4|Initial 24 Weeks|Adverse Event|3
425535|NCT00542425|1420721|P3|Initial 24 Weeks|Adverse Event|1
425536|NCT00542425|1420722|P2|Initial 24 Weeks|Adverse Event|1
425537|NCT00542425|1420723|P1|Initial 24 Weeks|Adverse Event|0
425538|NCT00542425|1420719|P5|Initial 24 Weeks|Administrative reasons|0
425539|NCT00542425|1420720|P4|Initial 24 Weeks|Administrative reasons|1
425540|NCT00542425|1420721|P3|Initial 24 Weeks|Administrative reasons|1
425541|NCT00542425|1420722|P2|Initial 24 Weeks|Administrative reasons|0
425542|NCT00542425|1420723|P1|Initial 24 Weeks|Administrative reasons|0
425543|NCT00542386|1420761|P6|Overall Study|Other Reasons|2
425544|NCT00542386|1420762|P5|Overall Study|Other Reasons|4
425545|NCT00542386|1420763|P4|Overall Study|Other Reasons|3
425546|NCT00542386|1420764|P3|Overall Study|Other Reasons|4
425547|NCT00542386|1420765|P2|Overall Study|Other Reasons|1
425548|NCT00542386|1420766|P1|Overall Study|Other Reasons|4
425549|NCT00542386|1420761|P6|Overall Study|Withdrawal by Subject|7
425550|NCT00542386|1420762|P5|Overall Study|Withdrawal by Subject|15
425551|NCT00542386|1420763|P4|Overall Study|Withdrawal by Subject|11
425552|NCT00542386|1420764|P3|Overall Study|Withdrawal by Subject|10
425553|NCT00542386|1420765|P2|Overall Study|Withdrawal by Subject|8
425554|NCT00542386|1420766|P1|Overall Study|Withdrawal by Subject|5
425555|NCT00542386|1420761|P6|Overall Study|Protocol Violation|4
425556|NCT00542386|1420762|P5|Overall Study|Protocol Violation|0
425557|NCT00542386|1420763|P4|Overall Study|Protocol Violation|0
425558|NCT00542386|1420764|P3|Overall Study|Protocol Violation|1
425559|NCT00542386|1420765|P2|Overall Study|Protocol Violation|0
425560|NCT00542386|1420766|P1|Overall Study|Protocol Violation|0
425561|NCT00542386|1420761|P6|Overall Study|Physician Decision|0
425562|NCT00542386|1420762|P5|Overall Study|Physician Decision|0
425563|NCT00542386|1420763|P4|Overall Study|Physician Decision|1
425564|NCT00542386|1420764|P3|Overall Study|Physician Decision|0
425565|NCT00542386|1420765|P2|Overall Study|Physician Decision|0
425566|NCT00542386|1420766|P1|Overall Study|Physician Decision|1
425567|NCT00542386|1420761|P6|Overall Study|Lack of Efficacy|31
425568|NCT00542386|1420762|P5|Overall Study|Lack of Efficacy|7
425569|NCT00542386|1420763|P4|Overall Study|Lack of Efficacy|13
425570|NCT00542386|1420764|P3|Overall Study|Lack of Efficacy|10
425571|NCT00542386|1420765|P2|Overall Study|Lack of Efficacy|12
425572|NCT00542386|1420766|P1|Overall Study|Lack of Efficacy|32
425573|NCT00542386|1420761|P6|Overall Study|Death|2
425574|NCT00542386|1420762|P5|Overall Study|Death|1
425575|NCT00542386|1420763|P4|Overall Study|Death|2
425576|NCT00542386|1420764|P3|Overall Study|Death|1
425577|NCT00542386|1420765|P2|Overall Study|Death|0
425578|NCT00542386|1420766|P1|Overall Study|Death|0
425579|NCT00542386|1420761|P6|Overall Study|Adverse Event|4
425580|NCT00542386|1420762|P5|Overall Study|Adverse Event|13
425581|NCT00542386|1420763|P4|Overall Study|Adverse Event|8
425582|NCT00542386|1420764|P3|Overall Study|Adverse Event|7
425583|NCT00542386|1420765|P2|Overall Study|Adverse Event|7
425584|NCT00542386|1420766|P1|Overall Study|Adverse Event|1
425585|NCT00542321|1420788|P2|Overall Study|Death|1
425586|NCT00542321|1420789|P1|Overall Study|Death|0
425587|NCT00542269|1420811|P3|Overall Study|Administrative problems|1
425588|NCT00542269|1420812|P2|Overall Study|Administrative problems|1
425589|NCT00542269|1420813|P1|Overall Study|Administrative problems|1
425590|NCT00542269|1420811|P3|Overall Study|Withdrawal by Subject|0
425591|NCT00542269|1420812|P2|Overall Study|Withdrawal by Subject|0
425592|NCT00542269|1420813|P1|Overall Study|Withdrawal by Subject|1
425593|NCT00542269|1420811|P3|Overall Study|Protocol Violation|0
425594|NCT00542269|1420812|P2|Overall Study|Protocol Violation|1
425595|NCT00542269|1420813|P1|Overall Study|Protocol Violation|1
425596|NCT00542269|1420811|P3|Overall Study|Adverse Event|5
425597|NCT00542269|1420812|P2|Overall Study|Adverse Event|4
425598|NCT00542269|1420813|P1|Overall Study|Adverse Event|10
425599|NCT00542178|1420848|P8|Overall Study|did not complete year 4 follow-up|85
425600|NCT00542178|1420849|P7|Overall Study|did not complete year 4 follow-up|87
425601|NCT00542178|1420850|P6|Overall Study|did not complete year 4 follow-up|89
425602|NCT00542178|1420851|P5|Overall Study|did not complete year 4 follow-up|64
425603|NCT00542178|1420852|P4|Overall Study|did not complete year 4 follow-up|62
425604|NCT00542178|1420853|P3|Overall Study|did not complete year 4 follow-up|74
425605|NCT00542178|1420854|P2|Overall Study|did not complete year 4 follow-up|80
425606|NCT00542178|1420855|P1|Overall Study|did not complete year 4 follow-up|75
425607|NCT00541970|1420873|P4|Month 60|Protocol Violation|72
425608|NCT00541970|1420874|P3|Month 60|Protocol Violation|82
425609|NCT00541970|1420875|P2|Month 60|Protocol Violation|77
425610|NCT00541970|1420876|P1|Month 60|Protocol Violation|78
425611|NCT00541970|1420873|P4|Month 48|Lost to Follow-up|73
425612|NCT00541970|1420874|P3|Month 48|Lost to Follow-up|68
425613|NCT00541970|1420875|P2|Month 48|Lost to Follow-up|68
425614|NCT00541970|1420876|P1|Month 48|Lost to Follow-up|66
425615|NCT00541970|1420873|P4|Month 48|Other|0
425616|NCT00541970|1420874|P3|Month 48|Other|1
425617|NCT00541970|1420875|P2|Month 48|Other|1
425618|NCT00541970|1420876|P1|Month 48|Other|3
425619|NCT00541970|1420873|P4|Month 48|Withdrawal by Subject|2
425620|NCT00541970|1420874|P3|Month 48|Withdrawal by Subject|4
425621|NCT00541970|1420875|P2|Month 48|Withdrawal by Subject|4
425622|NCT00541970|1420876|P1|Month 48|Withdrawal by Subject|2
425623|NCT00541970|1420873|P4|Month 36|Protocol Violation|60
425624|NCT00541970|1420874|P3|Month 36|Protocol Violation|66
425625|NCT00541970|1420875|P2|Month 36|Protocol Violation|66
425626|NCT00541970|1420876|P1|Month 36|Protocol Violation|61
425627|NCT00541970|1420873|P4|Month 24|Protocol Violation|21
425628|NCT00541970|1420874|P3|Month 24|Protocol Violation|31
425629|NCT00541970|1420875|P2|Month 24|Protocol Violation|31
425630|NCT00541970|1420876|P1|Month 24|Protocol Violation|29
425631|NCT00541970|1420873|P4|Month 24|Adverse Event|1
425632|NCT00541970|1420874|P3|Month 24|Adverse Event|1
425633|NCT00541970|1420875|P2|Month 24|Adverse Event|1
425634|NCT00541970|1420876|P1|Month 24|Adverse Event|0
425635|NCT00541970|1420873|P4|Month 18|Protocol Violation|16
425636|NCT00541970|1420874|P3|Month 18|Protocol Violation|24
425637|NCT00541970|1420875|P2|Month 18|Protocol Violation|23
425638|NCT00541970|1420876|P1|Month 18|Protocol Violation|14
425639|NCT00541970|1420873|P4|Month 18|Adverse Event|1
425640|NCT00541970|1420874|P3|Month 18|Adverse Event|1
425641|NCT00541970|1420875|P2|Month 18|Adverse Event|1
425642|NCT00541970|1420876|P1|Month 18|Adverse Event|0
425643|NCT00541970|1420873|P4|Month 12|Protocol Violation|15
425644|NCT00541970|1420874|P3|Month 12|Protocol Violation|20
425645|NCT00541970|1420875|P2|Month 12|Protocol Violation|21
425646|NCT00541970|1420876|P1|Month 12|Protocol Violation|12
425647|NCT00541970|1420873|P4|Month 12|Adverse Event|1
425648|NCT00541970|1420874|P3|Month 12|Adverse Event|1
425649|NCT00541970|1420875|P2|Month 12|Adverse Event|1
425650|NCT00541970|1420876|P1|Month 12|Adverse Event|0
425651|NCT00541970|1420873|P4|Month 7|Protocol Violation|5
425652|NCT00541970|1420874|P3|Month 7|Protocol Violation|11
425653|NCT00541970|1420875|P2|Month 7|Protocol Violation|13
425654|NCT00541970|1420876|P1|Month 7|Protocol Violation|9
425655|NCT00541931|1421027|P2|Overall Study|Transportation Issue|1
425656|NCT00541931|1421028|P1|Overall Study|Transportation Issue|0
425657|NCT00541931|1421027|P2|Overall Study|Withdrawal by Subject|0
425658|NCT00541931|1421028|P1|Overall Study|Withdrawal by Subject|1
425659|NCT00541931|1421027|P2|Overall Study|Lost to Follow-up|3
425660|NCT00541931|1421028|P1|Overall Study|Lost to Follow-up|3
425661|NCT00541931|1421027|P2|Overall Study|Adverse Event|0
425662|NCT00541931|1421028|P1|Overall Study|Adverse Event|1
425663|NCT00541866|1421041|P5|Overall Study|Physician Decision|0
425664|NCT00541866|1421042|P4|Overall Study|Physician Decision|1
425665|NCT00541866|1421043|P3|Overall Study|Physician Decision|2
425666|NCT00541866|1421044|P2|Overall Study|Physician Decision|0
425667|NCT00541866|1421045|P1|Overall Study|Physician Decision|0
425668|NCT00541866|1421041|P5|Overall Study|Not Reported or Other|1
425669|NCT00541866|1421042|P4|Overall Study|Not Reported or Other|3
425670|NCT00541866|1421043|P3|Overall Study|Not Reported or Other|3
425671|NCT00541866|1421044|P2|Overall Study|Not Reported or Other|3
425672|NCT00541866|1421045|P1|Overall Study|Not Reported or Other|11
425673|NCT00541866|1421041|P5|Overall Study|Lack of Efficacy|14
425674|NCT00541866|1421042|P4|Overall Study|Lack of Efficacy|12
425675|NCT00541866|1421043|P3|Overall Study|Lack of Efficacy|10
425676|NCT00541866|1421044|P2|Overall Study|Lack of Efficacy|15
425677|NCT00541866|1421045|P1|Overall Study|Lack of Efficacy|19
425678|NCT00541866|1421041|P5|Overall Study|Death|0
425679|NCT00541866|1421042|P4|Overall Study|Death|0
425680|NCT00541866|1421043|P3|Overall Study|Death|0
425681|NCT00541866|1421044|P2|Overall Study|Death|0
425682|NCT00541866|1421045|P1|Overall Study|Death|1
425683|NCT00541866|1421041|P5|Overall Study|Adverse Event|0
425684|NCT00541866|1421042|P4|Overall Study|Adverse Event|0
425685|NCT00541866|1421043|P3|Overall Study|Adverse Event|0
425686|NCT00541866|1421044|P2|Overall Study|Adverse Event|0
425687|NCT00541866|1421045|P1|Overall Study|Adverse Event|3
425688|NCT00541775|1421086|P3|Overall Study|Withdrawal by Subject and Other|2
425689|NCT00541775|1421087|P2|Overall Study|Withdrawal by Subject and Other|0
425690|NCT00541775|1421088|P1|Overall Study|Withdrawal by Subject and Other|5
425691|NCT00541775|1421086|P3|Overall Study|Protocol Violation|0
425692|NCT00541775|1421087|P2|Overall Study|Protocol Violation|0
425693|NCT00541775|1421088|P1|Overall Study|Protocol Violation|1
425694|NCT00541775|1421086|P3|Overall Study|Lost to Follow-up|2
425695|NCT00541775|1421087|P2|Overall Study|Lost to Follow-up|0
425696|NCT00541775|1421088|P1|Overall Study|Lost to Follow-up|0
425697|NCT00541775|1421086|P3|Overall Study|Lack of Efficacy|3
425698|NCT00541775|1421087|P2|Overall Study|Lack of Efficacy|0
425699|NCT00541775|1421088|P1|Overall Study|Lack of Efficacy|0
425700|NCT00541775|1421086|P3|Overall Study|Adverse Event|1
425701|NCT00541775|1421087|P2|Overall Study|Adverse Event|2
425702|NCT00541775|1421088|P1|Overall Study|Adverse Event|3
425703|NCT00541658|1421114|P3|Overall Study|Took No Study Drug|0
425704|NCT00541658|1421115|P2|Overall Study|Took No Study Drug|0
425705|NCT00541658|1421116|P1|Overall Study|Took No Study Drug|1
425706|NCT00541658|1421114|P3|Overall Study|Withdrawal by Subject|32
425707|NCT00541658|1421115|P2|Overall Study|Withdrawal by Subject|32
425708|NCT00541658|1421116|P1|Overall Study|Withdrawal by Subject|28
425709|NCT00541658|1421114|P3|Overall Study|Protocol Violation|1
425710|NCT00541658|1421115|P2|Overall Study|Protocol Violation|1
425711|NCT00541658|1421116|P1|Overall Study|Protocol Violation|0
425712|NCT00541658|1421114|P3|Overall Study|Lost to Follow-up|6
425713|NCT00541658|1421115|P2|Overall Study|Lost to Follow-up|3
425714|NCT00541658|1421116|P1|Overall Study|Lost to Follow-up|3
425715|NCT00541658|1421114|P3|Overall Study|Physician Decision|4
425716|NCT00541658|1421115|P2|Overall Study|Physician Decision|0
425717|NCT00541658|1421116|P1|Overall Study|Physician Decision|0
425718|NCT00541658|1421114|P3|Overall Study|Adverse Event|25
425719|NCT00541658|1421115|P2|Overall Study|Adverse Event|37
425720|NCT00541658|1421116|P1|Overall Study|Adverse Event|28
425721|NCT00541450|1421279|P2|Phase B|Withdrawal by Subject|6
425722|NCT00541450|1421280|P1|Phase B|Withdrawal by Subject|8
425723|NCT00541450|1421279|P2|Phase B|Protocol Violation|3
425724|NCT00541450|1421280|P1|Phase B|Protocol Violation|3
425725|NCT00541450|1421279|P2|Phase B|Pregnancy|1
425726|NCT00541450|1421280|P1|Phase B|Pregnancy|0
425727|NCT00541450|1421279|P2|Phase B|Physician Decision|2
425728|NCT00541450|1421280|P1|Phase B|Physician Decision|4
425729|NCT00541450|1421279|P2|Phase B|Lost to Follow-up|4
425730|NCT00541450|1421280|P1|Phase B|Lost to Follow-up|6
425731|NCT00541450|1421279|P2|Phase B|Hyperglycemia|9
425732|NCT00541450|1421280|P1|Phase B|Hyperglycemia|10
425733|NCT00541450|1421279|P2|Phase B|Adverse Event|6
425734|NCT00541450|1421280|P1|Phase B|Adverse Event|6
425735|NCT00541450|1421279|P2|Phase A|Withdrawal by Subject|7
425736|NCT00541450|1421280|P1|Phase A|Withdrawal by Subject|7
425737|NCT00541450|1421279|P2|Phase A|Protocol Violation|3
425738|NCT00541450|1421280|P1|Phase A|Protocol Violation|2
425739|NCT00541450|1421279|P2|Phase A|Physician Decision|0
425740|NCT00541450|1421280|P1|Phase A|Physician Decision|2
425741|NCT00541450|1421279|P2|Phase A|Lost to Follow-up|4
425742|NCT00541450|1421280|P1|Phase A|Lost to Follow-up|6
425743|NCT00541450|1421279|P2|Phase A|Hyperglycemia|1
425744|NCT00541450|1421280|P1|Phase A|Hyperglycemia|0
425745|NCT00541450|1421279|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
425746|NCT00541450|1421280|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
425747|NCT00541450|1421279|P2|Phase A|Adverse Event|0
425748|NCT00541450|1421280|P1|Phase A|Adverse Event|3
425749|NCT00541346|1421298|P1|Follow-up|Adverse Event|1
425750|NCT00541307|1421312|P1|Overall Study|Surgical Bypass|5
425751|NCT00541307|1421312|P1|Overall Study|Subject returned early (outside window)|1
425752|NCT00541307|1421312|P1|Overall Study|Lost to Follow-up|4
425753|NCT00541307|1421312|P1|Overall Study|Withdrawal by Subject|6
425754|NCT00541307|1421312|P1|Overall Study|Physician Decision|3
425755|NCT00541307|1421312|P1|Overall Study|Death|5
425756|NCT00541229|1421337|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
425757|NCT00541229|1421338|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
425758|NCT00541229|1421339|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
425759|NCT00541229|1421340|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
425760|NCT00541229|1421341|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
425761|NCT00541229|1421342|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
425762|NCT00541229|1421337|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
425763|NCT00541229|1421338|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
425764|NCT00541229|1421339|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
425765|NCT00541229|1421340|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
425766|NCT00541229|1421341|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
425767|NCT00541229|1421342|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
425768|NCT00541229|1421337|P6|Treatment Period III (Week 11)|Adverse Event|0
425769|NCT00541229|1421338|P5|Treatment Period III (Week 11)|Adverse Event|1
425770|NCT00541229|1421339|P4|Treatment Period III (Week 11)|Adverse Event|0
425771|NCT00541229|1421340|P3|Treatment Period III (Week 11)|Adverse Event|0
425772|NCT00541229|1421341|P2|Treatment Period III (Week 11)|Adverse Event|0
425773|NCT00541229|1421342|P1|Treatment Period III (Week 11)|Adverse Event|0
425774|NCT00541229|1421337|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
425775|NCT00541229|1421338|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
425776|NCT00541229|1421339|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
425777|NCT00541229|1421340|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
425778|NCT00541229|1421341|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
425779|NCT00541229|1421342|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
425780|NCT00541229|1421337|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
425781|NCT00541229|1421338|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
425782|NCT00541229|1421339|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
425783|NCT00541229|1421340|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
425784|NCT00541229|1421341|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
425785|NCT00541229|1421342|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
425786|NCT00541229|1421337|P6|Washout Period II (Week 7-10)|Protocol Violation|0
425787|NCT00541229|1421338|P5|Washout Period II (Week 7-10)|Protocol Violation|0
425788|NCT00541229|1421339|P4|Washout Period II (Week 7-10)|Protocol Violation|0
425789|NCT00541229|1421340|P3|Washout Period II (Week 7-10)|Protocol Violation|0
425790|NCT00541229|1421341|P2|Washout Period II (Week 7-10)|Protocol Violation|0
425791|NCT00541229|1421342|P1|Washout Period II (Week 7-10)|Protocol Violation|1
425792|NCT00541229|1421337|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
425793|NCT00541229|1421338|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
425794|NCT00541229|1421339|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
425795|NCT00541229|1421340|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
425796|NCT00541229|1421341|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
425797|NCT00541229|1421342|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
425798|NCT00541229|1421337|P6|Treatment Period II (Week 6)|Protocol Violation|1
425799|NCT00541229|1421338|P5|Treatment Period II (Week 6)|Protocol Violation|1
425800|NCT00541229|1421339|P4|Treatment Period II (Week 6)|Protocol Violation|0
425801|NCT00541229|1421340|P3|Treatment Period II (Week 6)|Protocol Violation|0
425802|NCT00541229|1421341|P2|Treatment Period II (Week 6)|Protocol Violation|0
425803|NCT00541229|1421342|P1|Treatment Period II (Week 6)|Protocol Violation|0
425804|NCT00541229|1421337|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
425805|NCT00541229|1421338|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
425806|NCT00541229|1421339|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
425807|NCT00541229|1421340|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
425808|NCT00541229|1421341|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
425809|NCT00541229|1421342|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
425810|NCT00541229|1421337|P6|Washout Period I (Week 2-5)|Protocol Violation|1
425811|NCT00541229|1421338|P5|Washout Period I (Week 2-5)|Protocol Violation|0
425812|NCT00541229|1421339|P4|Washout Period I (Week 2-5)|Protocol Violation|0
425813|NCT00541229|1421340|P3|Washout Period I (Week 2-5)|Protocol Violation|0
425814|NCT00541229|1421341|P2|Washout Period I (Week 2-5)|Protocol Violation|0
425815|NCT00541229|1421342|P1|Washout Period I (Week 2-5)|Protocol Violation|0
425816|NCT00541229|1421337|P6|Washout Period I (Week 2-5)|Physician Decision|0
425817|NCT00541229|1421338|P5|Washout Period I (Week 2-5)|Physician Decision|0
425818|NCT00541229|1421339|P4|Washout Period I (Week 2-5)|Physician Decision|1
425819|NCT00541229|1421340|P3|Washout Period I (Week 2-5)|Physician Decision|0
425820|NCT00541229|1421341|P2|Washout Period I (Week 2-5)|Physician Decision|0
425821|NCT00541229|1421342|P1|Washout Period I (Week 2-5)|Physician Decision|0
425822|NCT00541229|1421337|P6|Washout Period I (Week 2-5)|Adverse Event|0
425823|NCT00541229|1421338|P5|Washout Period I (Week 2-5)|Adverse Event|0
425824|NCT00541229|1421339|P4|Washout Period I (Week 2-5)|Adverse Event|0
425825|NCT00541229|1421340|P3|Washout Period I (Week 2-5)|Adverse Event|1
425826|NCT00541229|1421341|P2|Washout Period I (Week 2-5)|Adverse Event|0
425827|NCT00541229|1421342|P1|Washout Period I (Week 2-5)|Adverse Event|1
425828|NCT00541229|1421337|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
425829|NCT00541229|1421338|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
425830|NCT00541229|1421339|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
425831|NCT00541229|1421340|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
425832|NCT00541229|1421341|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
425833|NCT00541229|1421342|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
425834|NCT00541229|1421337|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
425835|NCT00541229|1421338|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
425836|NCT00541229|1421339|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
425837|NCT00541229|1421340|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
425838|NCT00541229|1421341|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
425839|NCT00541229|1421342|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
425840|NCT00541229|1421337|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
425841|NCT00541229|1421338|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
425842|NCT00541229|1421339|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
425843|NCT00541229|1421340|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
425844|NCT00541229|1421341|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
425845|NCT00541229|1421342|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
425933|NCT00540423|1421735|P2|Open-Label Treatment Period|Lack of Efficacy|0
425846|NCT00541229|1421337|P6|Treatment Period I (Week 1)|Physician Decision|0
425847|NCT00541229|1421338|P5|Treatment Period I (Week 1)|Physician Decision|0
425848|NCT00541229|1421339|P4|Treatment Period I (Week 1)|Physician Decision|0
425849|NCT00541229|1421340|P3|Treatment Period I (Week 1)|Physician Decision|1
425850|NCT00541229|1421341|P2|Treatment Period I (Week 1)|Physician Decision|0
425851|NCT00541229|1421342|P1|Treatment Period I (Week 1)|Physician Decision|0
425852|NCT00541099|1421361|P1|Overall Study|Ineligible|3
425853|NCT00541034|1421367|P1|Overall Study|Non-Compliance|3
425854|NCT00540644|1421394|P2|Overall Study|Noncomplilance|0
425855|NCT00540644|1421395|P1|Overall Study|Noncomplilance|1
425856|NCT00540644|1421394|P2|Overall Study|Withdrawal by Subject|2
425857|NCT00540644|1421395|P1|Overall Study|Withdrawal by Subject|2
425858|NCT00540644|1421394|P2|Overall Study|Physician Decision|5
425859|NCT00540644|1421395|P1|Overall Study|Physician Decision|0
425860|NCT00540644|1421394|P2|Overall Study|Disease Progression|1
425861|NCT00540644|1421395|P1|Overall Study|Disease Progression|3
425862|NCT00540644|1421394|P2|Overall Study|Adverse Event|1
425863|NCT00540644|1421395|P1|Overall Study|Adverse Event|3
425864|NCT00540592|1421415|P10|Overall Study|Withdrawal by Subject|0
425865|NCT00540592|1421416|P9|Overall Study|Withdrawal by Subject|0
425866|NCT00540592|1421417|P8|Overall Study|Withdrawal by Subject|0
425867|NCT00540592|1421418|P7|Overall Study|Withdrawal by Subject|0
425868|NCT00540592|1421419|P6|Overall Study|Withdrawal by Subject|0
425869|NCT00540592|1421420|P5|Overall Study|Withdrawal by Subject|0
425870|NCT00540592|1421421|P4|Overall Study|Withdrawal by Subject|1
425871|NCT00540592|1421422|P3|Overall Study|Withdrawal by Subject|1
425872|NCT00540592|1421423|P2|Overall Study|Withdrawal by Subject|0
425873|NCT00540592|1421424|P1|Overall Study|Withdrawal by Subject|0
425874|NCT00540592|1421415|P10|Overall Study|Lost to Follow-up|0
425875|NCT00540592|1421416|P9|Overall Study|Lost to Follow-up|0
425876|NCT00540592|1421417|P8|Overall Study|Lost to Follow-up|0
425877|NCT00540592|1421418|P7|Overall Study|Lost to Follow-up|0
425878|NCT00540592|1421419|P6|Overall Study|Lost to Follow-up|0
425879|NCT00540592|1421420|P5|Overall Study|Lost to Follow-up|0
425880|NCT00540592|1421421|P4|Overall Study|Lost to Follow-up|0
425881|NCT00540592|1421422|P3|Overall Study|Lost to Follow-up|0
425882|NCT00540592|1421423|P2|Overall Study|Lost to Follow-up|0
425883|NCT00540592|1421424|P1|Overall Study|Lost to Follow-up|2
425884|NCT00540592|1421415|P10|Overall Study|Adverse Event|2
425885|NCT00540592|1421416|P9|Overall Study|Adverse Event|1
425886|NCT00540592|1421417|P8|Overall Study|Adverse Event|1
425887|NCT00540592|1421418|P7|Overall Study|Adverse Event|0
425888|NCT00540592|1421419|P6|Overall Study|Adverse Event|0
425889|NCT00540592|1421420|P5|Overall Study|Adverse Event|1
425890|NCT00540592|1421421|P4|Overall Study|Adverse Event|0
425891|NCT00540592|1421422|P3|Overall Study|Adverse Event|0
425892|NCT00540592|1421423|P2|Overall Study|Adverse Event|1
425893|NCT00540592|1421424|P1|Overall Study|Adverse Event|0
425894|NCT00540514|1421663|P2|Overall Study|Paclitaxel not available|2
425895|NCT00540514|1421664|P1|Overall Study|Paclitaxel not available|0
425896|NCT00540514|1421663|P2|Overall Study|Excluded prior to treatment|7
425897|NCT00540514|1421664|P1|Overall Study|Excluded prior to treatment|7
425898|NCT00540514|1421663|P2|Overall Study|Withdrawal by Subject|67
425899|NCT00540514|1421664|P1|Overall Study|Withdrawal by Subject|65
425900|NCT00540514|1421663|P2|Overall Study|Lost to Follow-up|1
425901|NCT00540514|1421664|P1|Overall Study|Lost to Follow-up|1
425902|NCT00540514|1421663|P2|Overall Study|Protocol Deviation|4
425903|NCT00540514|1421664|P1|Overall Study|Protocol Deviation|3
425904|NCT00540514|1421663|P2|Overall Study|Physician Decision|99
425905|NCT00540514|1421664|P1|Overall Study|Physician Decision|86
425906|NCT00540514|1421663|P2|Overall Study|Adverse Event|24
425907|NCT00540514|1421664|P1|Overall Study|Adverse Event|20
425908|NCT00540514|1421663|P2|Overall Study|Unacceptable Toxicity|62
425909|NCT00540514|1421664|P1|Overall Study|Unacceptable Toxicity|61
425910|NCT00540514|1421663|P2|Overall Study|Still on treatment|0
425911|NCT00540514|1421664|P1|Overall Study|Still on treatment|3
425912|NCT00540449|1421696|P2|Overall Study|Not specified|4
425913|NCT00540449|1421697|P1|Overall Study|Not specified|1
425914|NCT00540449|1421696|P2|Overall Study|Withdrawal by Subject|10
425915|NCT00540449|1421697|P1|Overall Study|Withdrawal by Subject|10
425916|NCT00540449|1421696|P2|Overall Study|Subject Reached A Virologic Endpoint|8
425917|NCT00540449|1421697|P1|Overall Study|Subject Reached A Virologic Endpoint|32
425918|NCT00540449|1421696|P2|Overall Study|Subject Non-Compliant|5
425919|NCT00540449|1421697|P1|Overall Study|Subject Non-Compliant|7
425920|NCT00540449|1421696|P2|Overall Study|Lost to Follow-up|17
425921|NCT00540449|1421697|P1|Overall Study|Lost to Follow-up|19
425922|NCT00540449|1421696|P2|Overall Study|Subject Ineligible To Continue The Trial|1
425923|NCT00540449|1421697|P1|Overall Study|Subject Ineligible To Continue The Trial|2
425924|NCT00540449|1421696|P2|Overall Study|Sponsor's Decision|1
425925|NCT00540449|1421697|P1|Overall Study|Sponsor's Decision|1
425926|NCT00540449|1421696|P2|Overall Study|Adverse Event|32
425927|NCT00540449|1421697|P1|Overall Study|Adverse Event|12
425928|NCT00540436|1421719|P1|Second 12-Week Treatment Period|Adverse Event|1
425929|NCT00540436|1421719|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
425930|NCT00540436|1421719|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
425931|NCT00540436|1421719|P1|First 12-Week Treatment Period|Adverse Event|1
425932|NCT00540423|1421734|P3|Open-Label Treatment Period|Lack of Efficacy|2
425934|NCT00540423|1421736|P1|Open-Label Treatment Period|Lack of Efficacy|0
425935|NCT00540423|1421734|P3|Double-Blind Treatment Period|Adverse Event|0
425936|NCT00540423|1421735|P2|Double-Blind Treatment Period|Adverse Event|1
425937|NCT00540423|1421736|P1|Double-Blind Treatment Period|Adverse Event|0
425938|NCT00540293|1421786|P1|Overall Study|Protocol violation, & subject schedule|12
425939|NCT00540293|1421786|P1|Overall Study|Withdrawal by Subject|6
425940|NCT00540293|1421786|P1|Overall Study|Adverse event not related to study drug|7
425941|NCT00540293|1421786|P1|Overall Study|Adverse event related to study drug|10
425942|NCT00540228|1421834|P5|Overall Study|Lost to Follow-up|0
425943|NCT00540228|1421835|P4|Overall Study|Lost to Follow-up|0
425944|NCT00540228|1421836|P3|Overall Study|Lost to Follow-up|0
425945|NCT00540228|1421837|P2|Overall Study|Lost to Follow-up|1
425946|NCT00540228|1421838|P1|Overall Study|Lost to Follow-up|1
425947|NCT00540228|1421834|P5|Overall Study|Adverse Event|0
425948|NCT00540228|1421835|P4|Overall Study|Adverse Event|0
425949|NCT00540228|1421836|P3|Overall Study|Adverse Event|0
425950|NCT00540228|1421837|P2|Overall Study|Adverse Event|0
425951|NCT00540228|1421838|P1|Overall Study|Adverse Event|2
425952|NCT00540124|1421908|P3|Overall Study|Withdrawal by Subject|0
425953|NCT00540124|1421909|P2|Overall Study|Withdrawal by Subject|1
425954|NCT00540124|1421910|P1|Overall Study|Withdrawal by Subject|1
425955|NCT00540124|1421908|P3|Overall Study|Lack of Efficacy|0
425956|NCT00540124|1421909|P2|Overall Study|Lack of Efficacy|0
425957|NCT00540124|1421910|P1|Overall Study|Lack of Efficacy|1
425958|NCT00540124|1421908|P3|Overall Study|Entry Criteria Not Met|0
425959|NCT00540124|1421909|P2|Overall Study|Entry Criteria Not Met|0
425960|NCT00540124|1421910|P1|Overall Study|Entry Criteria Not Met|2
425961|NCT00540124|1421908|P3|Overall Study|Adverse Event|1
425962|NCT00540124|1421909|P2|Overall Study|Adverse Event|2
425963|NCT00540124|1421910|P1|Overall Study|Adverse Event|0
425964|NCT00540046|1421956|P2|Overall Study|Lost to Follow-up|23
425965|NCT00540046|1421957|P1|Overall Study|Lost to Follow-up|33
425966|NCT00539994|1421993|P3|Overall Study|Physician Decision|1
425967|NCT00539994|1421994|P2|Overall Study|Physician Decision|0
425968|NCT00539994|1421995|P1|Overall Study|Physician Decision|0
425969|NCT00539994|1421993|P3|Overall Study|Withdrawal by Subject|1
425970|NCT00539994|1421994|P2|Overall Study|Withdrawal by Subject|0
425971|NCT00539994|1421995|P1|Overall Study|Withdrawal by Subject|1
425972|NCT00539994|1421993|P3|Overall Study|Lost to Follow-up|0
425973|NCT00539994|1421994|P2|Overall Study|Lost to Follow-up|1
425974|NCT00539994|1421995|P1|Overall Study|Lost to Follow-up|2
425975|NCT00539864|1422045|P2|Overall Study|Withdrawal by Subject|1
425976|NCT00539864|1422046|P1|Overall Study|Withdrawal by Subject|1
425977|NCT00539864|1422045|P2|Overall Study|Lost to Follow-up|1
425978|NCT00539864|1422046|P1|Overall Study|Lost to Follow-up|0
425979|NCT00539734|1422058|P1|Overall Study|Protocol Violation|1
425980|NCT00539591|1422077|P3|Overall Study|Disease progression|3
425981|NCT00539591|1422078|P2|Overall Study|Disease progression|2
425982|NCT00539591|1422079|P1|Overall Study|Disease progression|2
425983|NCT00539591|1422077|P3|Overall Study|Toxicity|0
425984|NCT00539591|1422078|P2|Overall Study|Toxicity|0
425985|NCT00539591|1422079|P1|Overall Study|Toxicity|3
425986|NCT00539513|1422231|P2|Overall Study|Lost to Follow-up|1
425987|NCT00539513|1422232|P1|Overall Study|Lost to Follow-up|0
425988|NCT00539513|1422231|P2|Overall Study|Withdrawal by Subject|1
425989|NCT00539513|1422232|P1|Overall Study|Withdrawal by Subject|2
425990|NCT00539305|1422246|P2|Overall Study|Withdrawal by Subject|1
425991|NCT00539305|1422247|P1|Overall Study|Withdrawal by Subject|0
425992|NCT00539305|1422246|P2|Overall Study|Substance Use|1
425993|NCT00539305|1422247|P1|Overall Study|Substance Use|0
425994|NCT00539305|1422246|P2|Overall Study|Adverse Event|0
425995|NCT00539305|1422247|P1|Overall Study|Adverse Event|1
425996|NCT00539279|1422261|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
425997|NCT00539279|1422262|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
425998|NCT00539279|1422261|P2|Post-Treatment Assessment|Lost to Follow-up|9
425999|NCT00539279|1422262|P1|Post-Treatment Assessment|Lost to Follow-up|12
426000|NCT00539279|1422261|P2|Treatment|Death|0
426001|NCT00539279|1422262|P1|Treatment|Death|1
426002|NCT00539279|1422261|P2|Treatment|Withdrawal by Subject|8
426003|NCT00539279|1422262|P1|Treatment|Withdrawal by Subject|10
426004|NCT00539240|1422288|P3|Overall Study|Adverse Event|10
426005|NCT00539240|1422289|P2|Overall Study|Adverse Event|1
426006|NCT00539240|1422290|P1|Overall Study|Adverse Event|3
426007|NCT00539240|1422288|P3|Overall Study|Lost to Follow-up|1
426008|NCT00539240|1422289|P2|Overall Study|Lost to Follow-up|3
426009|NCT00539240|1422290|P1|Overall Study|Lost to Follow-up|2
426010|NCT00539240|1422288|P3|Overall Study|Protocol Violation|4
426011|NCT00539240|1422289|P2|Overall Study|Protocol Violation|1
426012|NCT00539240|1422290|P1|Overall Study|Protocol Violation|1
426013|NCT00539240|1422288|P3|Overall Study|Withdrawal by Subject|0
426014|NCT00539240|1422289|P2|Overall Study|Withdrawal by Subject|2
426015|NCT00539240|1422290|P1|Overall Study|Withdrawal by Subject|0
426016|NCT00539188|1422309|P2|Overall Study|Lost to Follow-up|1
426017|NCT00539188|1422310|P1|Overall Study|Lost to Follow-up|2
426018|NCT00539188|1422309|P2|Overall Study|Withdrawal by Subject|0
426019|NCT00539188|1422310|P1|Overall Study|Withdrawal by Subject|1
426020|NCT00539032|1422333|P2|Overall Study|Withdrawal by Subject|1
426021|NCT00539032|1422334|P1|Overall Study|Withdrawal by Subject|2
426022|NCT00539006|1422348|P4|Treatment Period 2|Other|0
426023|NCT00539006|1422349|P3|Treatment Period 2|Other|0
426024|NCT00539006|1422350|P2|Treatment Period 2|Other|1
426025|NCT00539006|1422351|P1|Treatment Period 2|Other|0
426026|NCT00539006|1422348|P4|Treatment Period 2|Protocol Violation|0
426027|NCT00539006|1422349|P3|Treatment Period 2|Protocol Violation|0
426028|NCT00539006|1422350|P2|Treatment Period 2|Protocol Violation|0
426029|NCT00539006|1422351|P1|Treatment Period 2|Protocol Violation|1
426030|NCT00539006|1422348|P4|Washout|Other|3
426031|NCT00539006|1422349|P3|Washout|Other|2
426032|NCT00539006|1422350|P2|Washout|Other|1
426033|NCT00539006|1422351|P1|Washout|Other|1
426034|NCT00539006|1422348|P4|Washout|Failed to meet continuation criteria|6
426035|NCT00539006|1422349|P3|Washout|Failed to meet continuation criteria|14
426036|NCT00539006|1422350|P2|Washout|Failed to meet continuation criteria|5
426037|NCT00539006|1422351|P1|Washout|Failed to meet continuation criteria|16
426038|NCT00539006|1422348|P4|Washout|Withdrawal by Subject|0
426039|NCT00539006|1422349|P3|Washout|Withdrawal by Subject|0
426040|NCT00539006|1422350|P2|Washout|Withdrawal by Subject|2
426041|NCT00539006|1422351|P1|Washout|Withdrawal by Subject|0
426042|NCT00539006|1422348|P4|Washout|Protocol Violation|0
426043|NCT00539006|1422349|P3|Washout|Protocol Violation|0
426044|NCT00539006|1422350|P2|Washout|Protocol Violation|1
426045|NCT00539006|1422351|P1|Washout|Protocol Violation|1
426046|NCT00539006|1422348|P4|Washout|Adverse Event|0
426047|NCT00539006|1422349|P3|Washout|Adverse Event|0
426048|NCT00539006|1422350|P2|Washout|Adverse Event|1
426049|NCT00539006|1422351|P1|Washout|Adverse Event|2
426050|NCT00539006|1422348|P4|Treatment Period 1|Lack of Efficacy|1
426051|NCT00539006|1422349|P3|Treatment Period 1|Lack of Efficacy|0
426052|NCT00539006|1422350|P2|Treatment Period 1|Lack of Efficacy|0
426053|NCT00539006|1422351|P1|Treatment Period 1|Lack of Efficacy|0
426054|NCT00539006|1422348|P4|Treatment Period 1|Protocol Violation|0
426055|NCT00539006|1422349|P3|Treatment Period 1|Protocol Violation|1
426056|NCT00539006|1422350|P2|Treatment Period 1|Protocol Violation|0
426057|NCT00539006|1422351|P1|Treatment Period 1|Protocol Violation|0
426058|NCT00539006|1422348|P4|Treatment Period 1|Lost to Follow-up|0
426059|NCT00539006|1422349|P3|Treatment Period 1|Lost to Follow-up|1
426060|NCT00539006|1422350|P2|Treatment Period 1|Lost to Follow-up|0
426061|NCT00539006|1422351|P1|Treatment Period 1|Lost to Follow-up|0
426062|NCT00539006|1422348|P4|Pre-treatment|Other|0
426063|NCT00539006|1422349|P3|Pre-treatment|Other|0
426064|NCT00539006|1422350|P2|Pre-treatment|Other|1
426065|NCT00539006|1422351|P1|Pre-treatment|Other|0
426066|NCT00538902|1422396|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
426067|NCT00538902|1422397|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
426068|NCT00538902|1422398|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
426069|NCT00538902|1422396|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
426070|NCT00538902|1422397|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
426071|NCT00538902|1422398|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
426072|NCT00538902|1422396|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
426073|NCT00538902|1422397|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
426074|NCT00538902|1422398|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
426075|NCT00538902|1422396|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
426076|NCT00538902|1422397|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
426077|NCT00538902|1422398|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
426078|NCT00538902|1422396|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
426079|NCT00538902|1422397|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
426080|NCT00538902|1422398|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
426081|NCT00538902|1422396|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
426082|NCT00538902|1422397|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
426083|NCT00538902|1422398|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
426084|NCT00538902|1422396|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
426085|NCT00538902|1422397|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
426086|NCT00538902|1422398|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
426087|NCT00538902|1422396|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
426088|NCT00538902|1422397|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
426089|NCT00538902|1422398|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
426090|NCT00538785|1422459|P2|Overall Study|Lost to Follow-up|0
426091|NCT00538785|1422460|P1|Overall Study|Lost to Follow-up|1
426092|NCT00538785|1422459|P2|Overall Study|Withdrawal of consent|7
426093|NCT00538785|1422460|P1|Overall Study|Withdrawal of consent|9
426094|NCT00538785|1422459|P2|Overall Study|Death|10
426095|NCT00538785|1422460|P1|Overall Study|Death|9
426096|NCT00538733|1422481|P1|Overall Study|still on therapy|1
426097|NCT00538733|1422481|P1|Overall Study|declined to participate|2
426098|NCT00538733|1422481|P1|Overall Study|Death|1
426099|NCT00538733|1422481|P1|Overall Study|Adverse Event|8
426100|NCT00538629|1422531|P1|Overall Study|Subject's untimely distrust of medicine|1
426101|NCT00538629|1422531|P1|Overall Study|Lost to Follow-up|6
426102|NCT00538629|1422531|P1|Overall Study|Lack of Efficacy|12
426103|NCT00538629|1422531|P1|Overall Study|Adverse Event|2
426104|NCT00538629|1422531|P1|Overall Study|At subject's request|1
426105|NCT00538590|1422587|P2|Overall Study|Death|0
426106|NCT00538590|1422588|P1|Overall Study|Death|1
426107|NCT00538473|1422626|P2|Overall Study|Adverse Event|0
426108|NCT00538473|1422627|P1|Overall Study|Adverse Event|1
426109|NCT00538291|1422707|P1|Overall Study|Withdrawal by Subject|1
426110|NCT00538291|1422707|P1|Overall Study|Adverse Event|2
426111|NCT00537979|1422765|P2|Overall Study|Heart failure|1
426112|NCT00537979|1422766|P1|Overall Study|Heart failure|0
426113|NCT00537979|1422765|P2|Overall Study|Kidney transplant|3
426114|NCT00537979|1422766|P1|Overall Study|Kidney transplant|0
426115|NCT00537979|1422765|P2|Overall Study|Death|3
426116|NCT00537979|1422766|P1|Overall Study|Death|0
426117|NCT00537979|1422765|P2|Overall Study|Non-compliance with treatment/procedure|2
426118|NCT00537979|1422766|P1|Overall Study|Non-compliance with treatment/procedure|2
426119|NCT00537979|1422765|P2|Overall Study|Lack of Efficacy|1
426120|NCT00537979|1422766|P1|Overall Study|Lack of Efficacy|0
426121|NCT00537979|1422765|P2|Overall Study|Lost to Follow-up|4
426122|NCT00537979|1422766|P1|Overall Study|Lost to Follow-up|1
426123|NCT00537979|1422765|P2|Overall Study|Withdrawal by Subject|4
426124|NCT00537979|1422766|P1|Overall Study|Withdrawal by Subject|1
426125|NCT00537979|1422765|P2|Overall Study|Adverse Event|2
426126|NCT00537979|1422766|P1|Overall Study|Adverse Event|2
426127|NCT00537940|1422782|P2|Overall Study|Other|12
426128|NCT00537940|1422783|P1|Overall Study|Other|10
426129|NCT00537940|1422782|P2|Overall Study|Study terminated by sponsor|3
426130|NCT00537940|1422783|P1|Overall Study|Study terminated by sponsor|2
426131|NCT00537940|1422782|P2|Overall Study|Pregnancy|1
426132|NCT00537940|1422783|P1|Overall Study|Pregnancy|1
426133|NCT00537940|1422782|P2|Overall Study|Protocol Violation|4
426134|NCT00537940|1422783|P1|Overall Study|Protocol Violation|6
426135|NCT00537940|1422782|P2|Overall Study|Withdrawal by Subject|95
426136|NCT00537940|1422783|P1|Overall Study|Withdrawal by Subject|113
426137|NCT00537940|1422782|P2|Overall Study|Lost to Follow-up|29
426138|NCT00537940|1422783|P1|Overall Study|Lost to Follow-up|23
426139|NCT00537940|1422782|P2|Overall Study|Lack of Efficacy|16
426140|NCT00537940|1422783|P1|Overall Study|Lack of Efficacy|8
426141|NCT00537940|1422782|P2|Overall Study|Adverse Event|19
426142|NCT00537940|1422783|P1|Overall Study|Adverse Event|20
426143|NCT00537823|1422807|P2|Overall Study|Adverse Event|0
426144|NCT00537823|1422808|P1|Overall Study|Adverse Event|2
426145|NCT00537810|1422834|P4|Overall Study|Medically withdrawn|1
426146|NCT00537810|1422835|P3|Overall Study|Medically withdrawn|0
426147|NCT00537810|1422836|P2|Overall Study|Medically withdrawn|2
426148|NCT00537810|1422837|P1|Overall Study|Medically withdrawn|2
426149|NCT00537810|1422834|P4|Overall Study|Withdrawal by Subject|3
426150|NCT00537810|1422835|P3|Overall Study|Withdrawal by Subject|4
426151|NCT00537810|1422836|P2|Overall Study|Withdrawal by Subject|11
426152|NCT00537810|1422837|P1|Overall Study|Withdrawal by Subject|4
426153|NCT00537771|1422853|P2|Overall Study|Severe Non-Compliance to Protocol|2
426154|NCT00537771|1422854|P1|Overall Study|Severe Non-Compliance to Protocol|4
426155|NCT00537771|1422853|P2|Overall Study|Protocol Violation|6
426156|NCT00537771|1422854|P1|Overall Study|Protocol Violation|2
426157|NCT00537771|1422853|P2|Overall Study|Lost to Follow-up|15
426158|NCT00537771|1422854|P1|Overall Study|Lost to Follow-up|9
426159|NCT00537771|1422853|P2|Overall Study|Adverse Event|15
426160|NCT00537771|1422854|P1|Overall Study|Adverse Event|8
426161|NCT00537771|1422853|P2|Overall Study|Withdrawal by Subject|23
426162|NCT00537771|1422854|P1|Overall Study|Withdrawal by Subject|6
426163|NCT00537745|1422864|P1|Overall Study|Subject unable to provide Interlock info|1
426164|NCT00537745|1422864|P1|Overall Study|Withdrawal by Subject|2
426165|NCT00537745|1422864|P1|Overall Study|Did not meet eligibility criteria|2
426166|NCT00537485|1422909|P2|Overall Study|Physician Decision|0
426167|NCT00537485|1422910|P1|Overall Study|Physician Decision|1
426168|NCT00537485|1422909|P2|Overall Study|Withdrawal by Subject|3
426169|NCT00537485|1422910|P1|Overall Study|Withdrawal by Subject|1
426170|NCT00537485|1422909|P2|Overall Study|Withdrawal by Subject|2
426171|NCT00537485|1422910|P1|Overall Study|Withdrawal by Subject|3
426172|NCT00537485|1422909|P2|Overall Study|Adverse Event|5
426173|NCT00537485|1422910|P1|Overall Study|Adverse Event|10
426174|NCT00537394|1422983|P3|2nd Year of Follow-up|Clinic site closure|0
426175|NCT00537394|1422984|P2|2nd Year of Follow-up|Clinic site closure|0
426176|NCT00537394|1422985|P1|2nd Year of Follow-up|Clinic site closure|1
426177|NCT00537394|1422983|P3|2nd Year of Follow-up|Lost to Follow-up|2
426178|NCT00537394|1422984|P2|2nd Year of Follow-up|Lost to Follow-up|7
426179|NCT00537394|1422985|P1|2nd Year of Follow-up|Lost to Follow-up|6
426180|NCT00537394|1422983|P3|2nd Year of Follow-up|Withdrawal by Subject|2
426181|NCT00537394|1422984|P2|2nd Year of Follow-up|Withdrawal by Subject|1
426182|NCT00537394|1422985|P1|2nd Year of Follow-up|Withdrawal by Subject|0
426183|NCT00537394|1422983|P3|2nd Year of Follow-up|Death|2
426184|NCT00537394|1422984|P2|2nd Year of Follow-up|Death|1
426185|NCT00537394|1422985|P1|2nd Year of Follow-up|Death|4
426186|NCT00537394|1422983|P3|First Year of Follow-up|Lost to Follow-up|1
426187|NCT00537394|1422984|P2|First Year of Follow-up|Lost to Follow-up|5
426188|NCT00537394|1422985|P1|First Year of Follow-up|Lost to Follow-up|1
426189|NCT00537394|1422983|P3|First Year of Follow-up|Withdrawal by Subject|1
426190|NCT00537394|1422984|P2|First Year of Follow-up|Withdrawal by Subject|6
426191|NCT00537394|1422985|P1|First Year of Follow-up|Withdrawal by Subject|3
426192|NCT00537394|1422983|P3|First Year of Follow-up|Severe debilitation|1
426193|NCT00537394|1422984|P2|First Year of Follow-up|Severe debilitation|0
426194|NCT00537394|1422985|P1|First Year of Follow-up|Severe debilitation|1
426195|NCT00537394|1422983|P3|First Year of Follow-up|Death|0
426196|NCT00537394|1422984|P2|First Year of Follow-up|Death|0
426197|NCT00537394|1422985|P1|First Year of Follow-up|Death|7
426198|NCT00537381|1423021|P2|Overall Study|Other|3
426199|NCT00537381|1423022|P1|Overall Study|Other|5
426200|NCT00537381|1423021|P2|Overall Study|Sponsor decision|9
426201|NCT00537381|1423022|P1|Overall Study|Sponsor decision|14
426202|NCT00537381|1423021|P2|Overall Study|Disease Progression|18
426203|NCT00537381|1423022|P1|Overall Study|Disease Progression|9
426204|NCT00537381|1423021|P2|Overall Study|Physician Decision|6
426205|NCT00537381|1423022|P1|Overall Study|Physician Decision|7
426206|NCT00537381|1423021|P2|Overall Study|Withdrawal by Subject|14
426207|NCT00537381|1423022|P1|Overall Study|Withdrawal by Subject|5
426208|NCT00537381|1423021|P2|Overall Study|Death|3
426209|NCT00537381|1423022|P1|Overall Study|Death|3
426210|NCT00537381|1423021|P2|Overall Study|Adverse Event|9
426211|NCT00537381|1423022|P1|Overall Study|Adverse Event|13
426212|NCT00537329|1423042|P1|Overall Study|Other|1
426213|NCT00537329|1423042|P1|Overall Study|Withdrawal by Subject|4
426214|NCT00537329|1423042|P1|Overall Study|Lost to Follow-up|6
426215|NCT00537329|1423042|P1|Overall Study|Lack of Efficacy|2
426216|NCT00537329|1423042|P1|Overall Study|Adverse Event|3
426217|NCT00537329|1423042|P1|Overall Study|Death|10
426218|NCT00537316|1423062|P7|Part 2|Administrative|1
426219|NCT00537316|1423063|P6|Part 2|Administrative|4
426220|NCT00537316|1423064|P5|Part 2|Administrative|1
426221|NCT00537316|1423065|P4|Part 2|Administrative|3
426222|NCT00537316|1423066|P3|Part 2|Administrative|24
426223|NCT00537316|1423067|P2|Part 2|Administrative|8
426224|NCT00537316|1423068|P1|Part 2|Administrative|16
426225|NCT00537316|1423062|P7|Part 2|Withdrawal by Subject|0
426226|NCT00537316|1423063|P6|Part 2|Withdrawal by Subject|0
426227|NCT00537316|1423064|P5|Part 2|Withdrawal by Subject|0
426228|NCT00537316|1423065|P4|Part 2|Withdrawal by Subject|0
426229|NCT00537316|1423066|P3|Part 2|Withdrawal by Subject|4
426230|NCT00537316|1423067|P2|Part 2|Withdrawal by Subject|1
426231|NCT00537316|1423068|P1|Part 2|Withdrawal by Subject|5
426232|NCT00537316|1423062|P7|Part 2|Lost to Follow-up|0
426233|NCT00537316|1423063|P6|Part 2|Lost to Follow-up|0
426234|NCT00537316|1423064|P5|Part 2|Lost to Follow-up|0
426235|NCT00537316|1423065|P4|Part 2|Lost to Follow-up|0
426236|NCT00537316|1423066|P3|Part 2|Lost to Follow-up|2
426237|NCT00537316|1423067|P2|Part 2|Lost to Follow-up|0
426238|NCT00537316|1423068|P1|Part 2|Lost to Follow-up|1
426239|NCT00537316|1423062|P7|Part 2|Adverse Event|0
426240|NCT00537316|1423063|P6|Part 2|Adverse Event|0
426241|NCT00537316|1423064|P5|Part 2|Adverse Event|0
426242|NCT00537316|1423065|P4|Part 2|Adverse Event|0
426243|NCT00537316|1423066|P3|Part 2|Adverse Event|2
426244|NCT00537316|1423067|P2|Part 2|Adverse Event|0
426245|NCT00537316|1423068|P1|Part 2|Adverse Event|4
426246|NCT00537316|1423062|P7|Part 2|Never entered follow-up|1
426247|NCT00537316|1423063|P6|Part 2|Never entered follow-up|0
426248|NCT00537316|1423064|P5|Part 2|Never entered follow-up|0
426249|NCT00537316|1423065|P4|Part 2|Never entered follow-up|0
426250|NCT00537316|1423066|P3|Part 2|Never entered follow-up|0
426251|NCT00537316|1423067|P2|Part 2|Never entered follow-up|0
426252|NCT00537316|1423068|P1|Part 2|Never entered follow-up|0
426253|NCT00537316|1423062|P7|Part 1|Administrative|0
426254|NCT00537316|1423063|P6|Part 1|Administrative|0
426255|NCT00537316|1423064|P5|Part 1|Administrative|0
426256|NCT00537316|1423065|P4|Part 1|Administrative|0
426257|NCT00537316|1423066|P3|Part 1|Administrative|2
426258|NCT00537316|1423067|P2|Part 1|Administrative|0
426259|NCT00537316|1423068|P1|Part 1|Administrative|0
426260|NCT00537316|1423062|P7|Part 1|Did not meet protocol eligibility|0
426261|NCT00537316|1423063|P6|Part 1|Did not meet protocol eligibility|0
426262|NCT00537316|1423064|P5|Part 1|Did not meet protocol eligibility|0
426263|NCT00537316|1423065|P4|Part 1|Did not meet protocol eligibility|0
426264|NCT00537316|1423066|P3|Part 1|Did not meet protocol eligibility|2
426265|NCT00537316|1423067|P2|Part 1|Did not meet protocol eligibility|3
426266|NCT00537316|1423068|P1|Part 1|Did not meet protocol eligibility|1
426267|NCT00537316|1423062|P7|Part 1|Protocol Violation|0
426268|NCT00537316|1423063|P6|Part 1|Protocol Violation|0
426269|NCT00537316|1423064|P5|Part 1|Protocol Violation|0
426270|NCT00537316|1423065|P4|Part 1|Protocol Violation|0
426271|NCT00537316|1423066|P3|Part 1|Protocol Violation|1
426272|NCT00537316|1423067|P2|Part 1|Protocol Violation|5
426273|NCT00537316|1423068|P1|Part 1|Protocol Violation|1
426274|NCT00537316|1423062|P7|Part 1|Withdrawal by Subject|0
426275|NCT00537316|1423063|P6|Part 1|Withdrawal by Subject|0
426276|NCT00537316|1423064|P5|Part 1|Withdrawal by Subject|0
426277|NCT00537316|1423065|P4|Part 1|Withdrawal by Subject|0
426278|NCT00537316|1423066|P3|Part 1|Withdrawal by Subject|4
426279|NCT00537316|1423067|P2|Part 1|Withdrawal by Subject|8
426280|NCT00537316|1423068|P1|Part 1|Withdrawal by Subject|3
426281|NCT00537316|1423062|P7|Part 1|Lost to Follow-up|0
426282|NCT00537316|1423063|P6|Part 1|Lost to Follow-up|0
426283|NCT00537316|1423064|P5|Part 1|Lost to Follow-up|0
426284|NCT00537316|1423065|P4|Part 1|Lost to Follow-up|0
426285|NCT00537316|1423066|P3|Part 1|Lost to Follow-up|0
426286|NCT00537316|1423067|P2|Part 1|Lost to Follow-up|0
426287|NCT00537316|1423068|P1|Part 1|Lost to Follow-up|1
426288|NCT00537316|1423062|P7|Part 1|Protocol defined clinical event|0
426289|NCT00537316|1423063|P6|Part 1|Protocol defined clinical event|0
426290|NCT00537316|1423064|P5|Part 1|Protocol defined clinical event|0
426291|NCT00537316|1423065|P4|Part 1|Protocol defined clinical event|0
426292|NCT00537316|1423066|P3|Part 1|Protocol defined clinical event|0
426293|NCT00537316|1423067|P2|Part 1|Protocol defined clinical event|0
426294|NCT00537316|1423068|P1|Part 1|Protocol defined clinical event|1
426295|NCT00537316|1423062|P7|Part 1|Adverse Event|0
426296|NCT00537316|1423063|P6|Part 1|Adverse Event|0
426297|NCT00537316|1423064|P5|Part 1|Adverse Event|0
426298|NCT00537316|1423065|P4|Part 1|Adverse Event|0
426299|NCT00537316|1423066|P3|Part 1|Adverse Event|8
426300|NCT00537316|1423067|P2|Part 1|Adverse Event|11
426301|NCT00537316|1423068|P1|Part 1|Adverse Event|7
426302|NCT00537303|1423095|P2|Overall Study|Unclassified|7
426303|NCT00537303|1423096|P1|Overall Study|Unclassified|8
426304|NCT00537303|1423095|P2|Overall Study|Withdrawal criteria|3
426305|NCT00537303|1423096|P1|Overall Study|Withdrawal criteria|3
426306|NCT00537303|1423095|P2|Overall Study|Protocol Violation|4
426307|NCT00537303|1423096|P1|Overall Study|Protocol Violation|8
426308|NCT00537303|1423095|P2|Overall Study|Lack of Efficacy|7
426309|NCT00537303|1423096|P1|Overall Study|Lack of Efficacy|6
426310|NCT00537303|1423095|P2|Overall Study|Adverse Event|4
426311|NCT00537303|1423096|P1|Overall Study|Adverse Event|1
426312|NCT00537277|1423117|P1|Overall Study|Non-compliance with trial procedures|15
426313|NCT00537277|1423117|P1|Overall Study|Inability to tolerate trial medication|4
426314|NCT00537277|1423117|P1|Overall Study|Unclassified|4
426315|NCT00537277|1423117|P1|Overall Study|Protocol Violation|11
426316|NCT00537277|1423117|P1|Overall Study|Lost to Follow-up|12
426317|NCT00537277|1423117|P1|Overall Study|Lack of Efficacy|2
426318|NCT00537277|1423117|P1|Overall Study|Adverse Event|1
426319|NCT00537238|1423128|P2|Overall Study|Other|52
426320|NCT00537238|1423129|P1|Overall Study|Other|44
426321|NCT00537238|1423128|P2|Overall Study|Does not meet entrance criteria|2
426322|NCT00537238|1423129|P1|Overall Study|Does not meet entrance criteria|0
426323|NCT00537238|1423128|P2|Overall Study|Protocol Violation|19
426324|NCT00537238|1423129|P1|Overall Study|Protocol Violation|15
426325|NCT00537238|1423128|P2|Overall Study|Withdrawal by Subject|47
426326|NCT00537238|1423129|P1|Overall Study|Withdrawal by Subject|51
426327|NCT00537238|1423128|P2|Overall Study|Lost to Follow-up|8
426328|NCT00537238|1423129|P1|Overall Study|Lost to Follow-up|12
426329|NCT00537238|1423128|P2|Overall Study|Lack of Efficacy|21
426330|NCT00537238|1423129|P1|Overall Study|Lack of Efficacy|20
426331|NCT00537238|1423128|P2|Overall Study|Adverse Event|22
426332|NCT00537238|1423129|P1|Overall Study|Adverse Event|31
426333|NCT00537238|1423128|P2|Overall Study|Death|2
426334|NCT00537238|1423129|P1|Overall Study|Death|1
426335|NCT00537199|1423149|P1|Overall Study|Study Terminated|1
426336|NCT00537095|1423155|P2|Overall Study|Incorrect enrolment|1
426337|NCT00537095|1423156|P1|Overall Study|Incorrect enrolment|0
426338|NCT00537095|1423155|P2|Overall Study|subjective disease progression|1
426339|NCT00537095|1423156|P1|Overall Study|subjective disease progression|0
426340|NCT00537095|1423155|P2|Overall Study|Withdrawal by Subject|2
426341|NCT00537095|1423156|P1|Overall Study|Withdrawal by Subject|2
426342|NCT00537095|1423155|P2|Overall Study|Death|1
426343|NCT00537095|1423156|P1|Overall Study|Death|3
426344|NCT00537095|1423155|P2|Overall Study|disease progression|48
426345|NCT00537095|1423156|P1|Overall Study|disease progression|21
426346|NCT00537095|1423155|P2|Overall Study|Adverse Event|4
426347|NCT00537095|1423156|P1|Overall Study|Adverse Event|24
426348|NCT00537095|1423155|P2|Overall Study|surgery|0
426349|NCT00537095|1423156|P1|Overall Study|surgery|1
426350|NCT00537082|1423171|P3|Overall Study|Discontinued before initiating treatment|0
426351|NCT00537082|1423172|P2|Overall Study|Discontinued before initiating treatment|0
426352|NCT00537082|1423173|P1|Overall Study|Discontinued before initiating treatment|3
426353|NCT00537082|1423171|P3|Overall Study|Withdrawal by Subject|0
426354|NCT00537082|1423172|P2|Overall Study|Withdrawal by Subject|1
426355|NCT00537082|1423173|P1|Overall Study|Withdrawal by Subject|0
426356|NCT00537082|1423171|P3|Overall Study|Lack of Efficacy|2
426357|NCT00537082|1423172|P2|Overall Study|Lack of Efficacy|0
426358|NCT00537082|1423173|P1|Overall Study|Lack of Efficacy|0
426359|NCT00537082|1423171|P3|Overall Study|Protocol Violation|1
426360|NCT00537082|1423172|P2|Overall Study|Protocol Violation|2
426361|NCT00537082|1423173|P1|Overall Study|Protocol Violation|0
426362|NCT00537082|1423171|P3|Overall Study|Adverse Event|3
426363|NCT00537082|1423172|P2|Overall Study|Adverse Event|6
426364|NCT00537082|1423173|P1|Overall Study|Adverse Event|6
426365|NCT00537056|1423190|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
426366|NCT00537030|1423202|P1|Overall Study|Inevaluable|3
426367|NCT00537030|1423202|P1|Overall Study|Confirm patient ineligibility|1
426368|NCT00537030|1423202|P1|Overall Study|Disease progression or relapse during ac|1
426369|NCT00537030|1423202|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
426370|NCT00537030|1423202|P1|Overall Study|Withdrawal by Subject|2
426371|NCT00537030|1423202|P1|Overall Study|Physician Decision|2
426372|NCT00537017|1423206|P1|Follow-up Phase|Withdrawal by Subject|9
426373|NCT00537017|1423206|P1|Treatment Phase|Protocol Violation|2
426374|NCT00537017|1423206|P1|Treatment Phase|Withdrawal by Subject|13
426375|NCT00537017|1423206|P1|Treatment Phase|Adverse Event|19
426376|NCT00536991|1423217|P1|Overall Study|patient ineligible|2
426377|NCT00536991|1423217|P1|Overall Study|Physician Decision|1
426378|NCT00536991|1423217|P1|Overall Study|Withdrawal by Subject|10
426379|NCT00536978|1423224|P1|Overall Study|Not eligible for Adback Infusion|22
426380|NCT00536874|1423253|P1|Overall Study|Withdrawal by Subject|1
426381|NCT00536874|1423253|P1|Overall Study|Death|2
426382|NCT00536874|1423253|P1|Overall Study|Adverse Event|1
426383|NCT00536809|1423263|P1|Phase II|Referred for surgical resection|1
426384|NCT00536809|1423263|P1|Phase II|Adverse Event|1
426385|NCT00536744|1423286|P2|Overall Study|PI tried alternative treatment|3
426386|NCT00536744|1423287|P1|Overall Study|PI tried alternative treatment|1
426387|NCT00536744|1423286|P2|Overall Study|Withdrawal by Subject|8
426388|NCT00536744|1423287|P1|Overall Study|Withdrawal by Subject|7
426389|NCT00536744|1423286|P2|Overall Study|Lost to Follow-up|5
426390|NCT00536744|1423287|P1|Overall Study|Lost to Follow-up|3
426391|NCT00536744|1423286|P2|Overall Study|Physician Decision|1
426392|NCT00536744|1423287|P1|Overall Study|Physician Decision|3
426393|NCT00536744|1423286|P2|Overall Study|Death|1
426394|NCT00536744|1423287|P1|Overall Study|Death|2
426395|NCT00536744|1423286|P2|Overall Study|Adverse Event|10
426396|NCT00536744|1423287|P1|Overall Study|Adverse Event|13
426397|NCT00536731|1423296|P3|Overall Study|Other|0
426398|NCT00536731|1423297|P2|Overall Study|Other|1
426399|NCT00536731|1423298|P1|Overall Study|Other|1
426400|NCT00536731|1423296|P3|Overall Study|Safety reasons|1
426401|NCT00536731|1423297|P2|Overall Study|Safety reasons|0
426402|NCT00536731|1423298|P1|Overall Study|Safety reasons|0
426403|NCT00536731|1423296|P3|Overall Study|Intake of prohibited conc. medication|1
426404|NCT00536731|1423297|P2|Overall Study|Intake of prohibited conc. medication|0
426405|NCT00536731|1423298|P1|Overall Study|Intake of prohibited conc. medication|0
426406|NCT00536731|1423296|P3|Overall Study|Withdrawal by Subject|0
426407|NCT00536731|1423297|P2|Overall Study|Withdrawal by Subject|2
426408|NCT00536731|1423298|P1|Overall Study|Withdrawal by Subject|0
426409|NCT00536731|1423296|P3|Overall Study|Adverse Event|3
426410|NCT00536731|1423297|P2|Overall Study|Adverse Event|2
426411|NCT00536731|1423298|P1|Overall Study|Adverse Event|3
426412|NCT00536575|1423342|P1|Overall Study|Death|1
426413|NCT00536575|1423342|P1|Overall Study|Withdrawal by Subject|1
426414|NCT00536510|1423348|P2|Overall Study|Patient Discontinued for Other Reasons|2
426415|NCT00536510|1423349|P1|Overall Study|Patient Discontinued for Other Reasons|2
426416|NCT00536510|1423348|P2|Overall Study|Laboratory Adverse Event|1
426417|NCT00536510|1423349|P1|Overall Study|Laboratory Adverse Event|2
426418|NCT00536510|1423348|P2|Overall Study|Flushing with Product|0
426419|NCT00536510|1423349|P1|Overall Study|Flushing with Product|20
426420|NCT00536510|1423348|P2|Overall Study|Withdrawal by Subject|9
426421|NCT00536510|1423349|P1|Overall Study|Withdrawal by Subject|16
426422|NCT00536510|1423348|P2|Overall Study|Protocol Violation|5
426423|NCT00536510|1423349|P1|Overall Study|Protocol Violation|4
426424|NCT00536510|1423348|P2|Overall Study|Lost to Follow-up|8
426425|NCT00536510|1423349|P1|Overall Study|Lost to Follow-up|11
426426|NCT00536510|1423348|P2|Overall Study|Adverse Event|4
426427|NCT00536510|1423349|P1|Overall Study|Adverse Event|27
426428|NCT00536484|1423359|P2|Overall Study|Other|0
426429|NCT00536484|1423360|P1|Overall Study|Other|4
426430|NCT00536484|1423359|P2|Overall Study|Lack of Efficacy|5
426431|NCT00536484|1423360|P1|Overall Study|Lack of Efficacy|16
426432|NCT00536484|1423359|P2|Overall Study|Lost to Follow-up|6
426433|NCT00536484|1423360|P1|Overall Study|Lost to Follow-up|8
426434|NCT00536484|1423359|P2|Overall Study|Withdrawal by Subject|11
426435|NCT00536484|1423360|P1|Overall Study|Withdrawal by Subject|11
426436|NCT00536484|1423359|P2|Overall Study|Adverse Event|34
426437|NCT00536484|1423360|P1|Overall Study|Adverse Event|21
426438|NCT00536471|1423394|P4|Overall Study|Sponsor Decision|2
426439|NCT00536471|1423395|P3|Overall Study|Sponsor Decision|3
426440|NCT00536471|1423396|P2|Overall Study|Sponsor Decision|1
426441|NCT00536471|1423397|P1|Overall Study|Sponsor Decision|0
426442|NCT00536471|1423394|P4|Overall Study|Death|2
426443|NCT00536471|1423395|P3|Overall Study|Death|1
426444|NCT00536471|1423396|P2|Overall Study|Death|0
426445|NCT00536471|1423397|P1|Overall Study|Death|0
426446|NCT00536471|1423394|P4|Overall Study|Physician Decision|2
426447|NCT00536471|1423395|P3|Overall Study|Physician Decision|3
426448|NCT00536471|1423396|P2|Overall Study|Physician Decision|1
426449|NCT00536471|1423397|P1|Overall Study|Physician Decision|11
426450|NCT00536471|1423394|P4|Overall Study|Protocol Violation|3
426451|NCT00536471|1423395|P3|Overall Study|Protocol Violation|2
426452|NCT00536471|1423396|P2|Overall Study|Protocol Violation|1
426453|NCT00536471|1423397|P1|Overall Study|Protocol Violation|8
426454|NCT00536471|1423394|P4|Overall Study|Lack of Efficacy|9
426455|NCT00536471|1423395|P3|Overall Study|Lack of Efficacy|11
426456|NCT00536471|1423396|P2|Overall Study|Lack of Efficacy|18
426457|NCT00536471|1423397|P1|Overall Study|Lack of Efficacy|17
426458|NCT00536471|1423394|P4|Overall Study|Withdrawal by Subject|21
426459|NCT00536471|1423395|P3|Overall Study|Withdrawal by Subject|43
426460|NCT00536471|1423396|P2|Overall Study|Withdrawal by Subject|24
426461|NCT00536471|1423397|P1|Overall Study|Withdrawal by Subject|40
426462|NCT00536471|1423394|P4|Overall Study|Adverse Event|13
426463|NCT00536471|1423395|P3|Overall Study|Adverse Event|28
426464|NCT00536471|1423396|P2|Overall Study|Adverse Event|16
426465|NCT00536471|1423397|P1|Overall Study|Adverse Event|32
426466|NCT00536471|1423394|P4|Overall Study|Lost to Follow-up|22
426467|NCT00536471|1423395|P3|Overall Study|Lost to Follow-up|48
426468|NCT00536471|1423396|P2|Overall Study|Lost to Follow-up|23
426469|NCT00536471|1423397|P1|Overall Study|Lost to Follow-up|48
426470|NCT00536380|1423642|P3|Overall Study|Administrative|1
426471|NCT00536380|1423643|P2|Overall Study|Administrative|0
426472|NCT00536380|1423644|P1|Overall Study|Administrative|0
426473|NCT00536380|1423642|P3|Overall Study|Did not meet protocol eligibility|1
426474|NCT00536380|1423643|P2|Overall Study|Did not meet protocol eligibility|0
426475|NCT00536380|1423644|P1|Overall Study|Did not meet protocol eligibility|0
426476|NCT00536380|1423642|P3|Overall Study|Noncompliance with protocol|2
426477|NCT00536380|1423643|P2|Overall Study|Noncompliance with protocol|2
426478|NCT00536380|1423644|P1|Overall Study|Noncompliance with protocol|3
426479|NCT00536380|1423642|P3|Overall Study|Withdrawal related to study drug|2
426480|NCT00536380|1423643|P2|Overall Study|Withdrawal related to study drug|5
426481|NCT00536380|1423644|P1|Overall Study|Withdrawal related to study drug|7
426482|NCT00536380|1423642|P3|Overall Study|Withdrawal unrelated to study drug|1
426483|NCT00536380|1423643|P2|Overall Study|Withdrawal unrelated to study drug|0
426484|NCT00536380|1423644|P1|Overall Study|Withdrawal unrelated to study drug|2
426485|NCT00536380|1423642|P3|Overall Study|Lost to Follow-up|1
426486|NCT00536380|1423643|P2|Overall Study|Lost to Follow-up|0
426487|NCT00536380|1423644|P1|Overall Study|Lost to Follow-up|0
426488|NCT00536380|1423642|P3|Overall Study|Adverse Event|2
426489|NCT00536380|1423643|P2|Overall Study|Adverse Event|2
426490|NCT00536380|1423644|P1|Overall Study|Adverse Event|0
426491|NCT00536263|1423668|P3|Overall Study|Did not meet protocol eligibility|2
426492|NCT00536263|1423669|P2|Overall Study|Did not meet protocol eligibility|2
426493|NCT00536263|1423670|P1|Overall Study|Did not meet protocol eligibility|1
426494|NCT00536263|1423668|P3|Overall Study|Noncompliance with protocol|1
426495|NCT00536263|1423669|P2|Overall Study|Noncompliance with protocol|0
426496|NCT00536263|1423670|P1|Overall Study|Noncompliance with protocol|0
426497|NCT00536263|1423668|P3|Overall Study|Subject withdrew - treatment related|2
426498|NCT00536263|1423669|P2|Overall Study|Subject withdrew - treatment related|3
426499|NCT00536263|1423670|P1|Overall Study|Subject withdrew - treatment related|0
426500|NCT00536263|1423668|P3|Overall Study|Subject withdrew - not treatment related|5
426501|NCT00536263|1423669|P2|Overall Study|Subject withdrew - not treatment related|0
426502|NCT00536263|1423670|P1|Overall Study|Subject withdrew - not treatment related|2
426503|NCT00536263|1423668|P3|Overall Study|Lost to Follow-up|4
426504|NCT00536263|1423669|P2|Overall Study|Lost to Follow-up|4
426505|NCT00536263|1423670|P1|Overall Study|Lost to Follow-up|3
426506|NCT00536263|1423668|P3|Overall Study|Adverse Event|7
426507|NCT00536263|1423669|P2|Overall Study|Adverse Event|5
426508|NCT00536263|1423670|P1|Overall Study|Adverse Event|5
426509|NCT00536198|1423710|P2|Overall Study|Protocol Violation|1
426510|NCT00536198|1423711|P1|Overall Study|Protocol Violation|0
426511|NCT00536198|1423710|P2|Overall Study|Pregnancy|1
426512|NCT00536198|1423711|P1|Overall Study|Pregnancy|1
426513|NCT00536198|1423710|P2|Overall Study|Rescue|9
426514|NCT00536198|1423711|P1|Overall Study|Rescue|3
426515|NCT00536198|1423710|P2|Overall Study|Adverse Event|2
426516|NCT00536198|1423711|P1|Overall Study|Adverse Event|2
426517|NCT00536198|1423710|P2|Overall Study|Withdrawal by Subject|12
426518|NCT00536198|1423711|P1|Overall Study|Withdrawal by Subject|16
426519|NCT00536198|1423710|P2|Overall Study|Lost to Follow-up|14
426520|NCT00536198|1423711|P1|Overall Study|Lost to Follow-up|15
426521|NCT00536120|1423750|P2|Overall Study|Missed Study Visit|1
426522|NCT00536120|1423751|P1|Overall Study|Missed Study Visit|0
426523|NCT00536120|1423750|P2|Overall Study|Steroid Use|2
426524|NCT00536120|1423751|P1|Overall Study|Steroid Use|0
426525|NCT00536120|1423750|P2|Overall Study|Sponsor Decision Due to Lab Values|0
426526|NCT00536120|1423751|P1|Overall Study|Sponsor Decision Due to Lab Values|1
426527|NCT00536120|1423750|P2|Overall Study|Non-compliance|0
426528|NCT00536120|1423751|P1|Overall Study|Non-compliance|1
426529|NCT00536120|1423750|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
426530|NCT00536120|1423751|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
426531|NCT00536120|1423750|P2|Overall Study|Lost to Follow-up|0
426532|NCT00536120|1423751|P1|Overall Study|Lost to Follow-up|1
426533|NCT00536107|1423765|P2|Overall Study|Study Termination|4
426534|NCT00536107|1423766|P1|Overall Study|Study Termination|2
426535|NCT00536107|1423765|P2|Overall Study|Withdrawal by Subject|1
426536|NCT00536107|1423766|P1|Overall Study|Withdrawal by Subject|0
426537|NCT00536107|1423765|P2|Overall Study|Incorrect enrolment|0
426538|NCT00536107|1423766|P1|Overall Study|Incorrect enrolment|1
426539|NCT00536107|1423765|P2|Overall Study|Death|1
426540|NCT00536107|1423766|P1|Overall Study|Death|5
426541|NCT00535847|1423820|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
426542|NCT00535847|1423821|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
426543|NCT00535847|1423822|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
426544|NCT00535847|1423820|P3|Overall Study|Non compliance|0
426545|NCT00535847|1423821|P2|Overall Study|Non compliance|1
426546|NCT00535847|1423822|P1|Overall Study|Non compliance|1
426547|NCT00535847|1423820|P3|Overall Study|Adverse Event|2
426548|NCT00535847|1423821|P2|Overall Study|Adverse Event|3
426549|NCT00535847|1423822|P1|Overall Study|Adverse Event|5
426550|NCT00535730|1423888|P2|Overall Study|Withdrawal by Subject|4
426551|NCT00535730|1423889|P1|Overall Study|Withdrawal by Subject|0
426552|NCT00535730|1423888|P2|Overall Study|Protocol Violation|0
426553|NCT00535730|1423889|P1|Overall Study|Protocol Violation|1
426554|NCT00535730|1423888|P2|Overall Study|Physician Decision|1
426555|NCT00535730|1423889|P1|Overall Study|Physician Decision|0
426556|NCT00535730|1423888|P2|Overall Study|Lost to Follow-up|1
426557|NCT00535730|1423889|P1|Overall Study|Lost to Follow-up|0
426558|NCT00535730|1423888|P2|Overall Study|Adverse Event|1
426559|NCT00535730|1423889|P1|Overall Study|Adverse Event|1
426560|NCT00535626|1423910|P1|Overall Study|Unable to return|2
426561|NCT00535626|1423910|P1|Overall Study|Subject terminated|31
426562|NCT00535626|1423910|P1|Overall Study|Removal/revision of study component|8
426563|NCT00535626|1423910|P1|Overall Study|Withdrawal by Subject|20
426564|NCT00535626|1423910|P1|Overall Study|Lost to Follow-up|29
426565|NCT00535626|1423910|P1|Overall Study|Death|15
426566|NCT00535496|1423937|P4|Overall Study|Not treated with sugammadex|0
426567|NCT00535496|1423938|P3|Overall Study|Not treated with sugammadex|0
426568|NCT00535496|1423939|P2|Overall Study|Not treated with sugammadex|1
426569|NCT00535496|1423940|P1|Overall Study|Not treated with sugammadex|0
426570|NCT00535496|1423937|P4|Overall Study|Lost to Follow-up|0
426571|NCT00535496|1423938|P3|Overall Study|Lost to Follow-up|0
426572|NCT00535496|1423939|P2|Overall Study|Lost to Follow-up|1
426573|NCT00535496|1423940|P1|Overall Study|Lost to Follow-up|0
426574|NCT00535405|1423960|P5|Overall Study|Withdrawal by Subject|8
426575|NCT00535405|1423961|P4|Overall Study|Withdrawal by Subject|10
426576|NCT00535405|1423962|P3|Overall Study|Withdrawal by Subject|10
426577|NCT00535405|1423963|P2|Overall Study|Withdrawal by Subject|11
426578|NCT00535405|1423964|P1|Overall Study|Withdrawal by Subject|5
426579|NCT00535405|1423960|P5|Overall Study|Protocol Violation|0
426580|NCT00535405|1423961|P4|Overall Study|Protocol Violation|1
426581|NCT00535405|1423962|P3|Overall Study|Protocol Violation|2
426582|NCT00535405|1423963|P2|Overall Study|Protocol Violation|2
426583|NCT00535405|1423964|P1|Overall Study|Protocol Violation|2
426584|NCT00535405|1423960|P5|Overall Study|Physician Decision|1
426585|NCT00535405|1423961|P4|Overall Study|Physician Decision|1
426586|NCT00535405|1423962|P3|Overall Study|Physician Decision|0
426587|NCT00535405|1423963|P2|Overall Study|Physician Decision|2
426588|NCT00535405|1423964|P1|Overall Study|Physician Decision|3
426589|NCT00535405|1423960|P5|Overall Study|Lost to Follow-up|1
426590|NCT00535405|1423961|P4|Overall Study|Lost to Follow-up|2
426591|NCT00535405|1423962|P3|Overall Study|Lost to Follow-up|3
426592|NCT00535405|1423963|P2|Overall Study|Lost to Follow-up|3
426593|NCT00535405|1423964|P1|Overall Study|Lost to Follow-up|1
426594|NCT00535405|1423960|P5|Overall Study|Adverse Event|6
426595|NCT00535405|1423961|P4|Overall Study|Adverse Event|8
426596|NCT00535405|1423962|P3|Overall Study|Adverse Event|3
426597|NCT00535405|1423963|P2|Overall Study|Adverse Event|8
426598|NCT00535405|1423964|P1|Overall Study|Adverse Event|6
426599|NCT00535288|1424025|P5|Overall Study|Not specified|1
426600|NCT00535288|1424026|P4|Overall Study|Not specified|2
426601|NCT00535288|1424027|P3|Overall Study|Not specified|1
426602|NCT00535288|1424028|P2|Overall Study|Not specified|1
426603|NCT00535288|1424029|P1|Overall Study|Not specified|2
426604|NCT00535288|1424025|P5|Overall Study|Unwilling to cooperate|4
426605|NCT00535288|1424026|P4|Overall Study|Unwilling to cooperate|3
426606|NCT00535288|1424027|P3|Overall Study|Unwilling to cooperate|3
426607|NCT00535288|1424028|P2|Overall Study|Unwilling to cooperate|6
426608|NCT00535288|1424029|P1|Overall Study|Unwilling to cooperate|6
426609|NCT00535288|1424025|P5|Overall Study|Lack of Efficacy|7
426610|NCT00535288|1424026|P4|Overall Study|Lack of Efficacy|4
426611|NCT00535288|1424027|P3|Overall Study|Lack of Efficacy|4
426612|NCT00535288|1424028|P2|Overall Study|Lack of Efficacy|3
426613|NCT00535288|1424029|P1|Overall Study|Lack of Efficacy|26
426614|NCT00535288|1424025|P5|Overall Study|Lost to Follow-up|0
426615|NCT00535288|1424026|P4|Overall Study|Lost to Follow-up|0
426616|NCT00535288|1424027|P3|Overall Study|Lost to Follow-up|0
426617|NCT00535288|1424028|P2|Overall Study|Lost to Follow-up|3
426618|NCT00535288|1424029|P1|Overall Study|Lost to Follow-up|0
426619|NCT00535288|1424025|P5|Overall Study|Adverse Event|30
426620|NCT00535288|1424026|P4|Overall Study|Adverse Event|20
426621|NCT00535288|1424027|P3|Overall Study|Adverse Event|25
426622|NCT00535288|1424028|P2|Overall Study|Adverse Event|19
426623|NCT00535288|1424029|P1|Overall Study|Adverse Event|20
426624|NCT00535262|1424106|P1|Overall Study|No funding|3
426625|NCT00535223|1424112|P2|Overall Study|Withdrawal by Subject|1
426626|NCT00535223|1424113|P1|Overall Study|Withdrawal by Subject|4
426627|NCT00535145|1424121|P1|Phase II|Subject non-compliance|2
426628|NCT00535145|1424121|P1|Phase II|Withdrawal by Subject|5
426629|NCT00535145|1424121|P1|Phase II|Lost to Follow-up|5
426630|NCT00535145|1424121|P1|Phase II|Lack of Efficacy|1
426631|NCT00535145|1424121|P1|Phase II|Adverse Event|2
426632|NCT00535145|1424121|P1|Phase I|(diagnosis)|3
426633|NCT00535145|1424121|P1|Phase I|(PI decision)|1
426634|NCT00535145|1424121|P1|Phase I|(protocol violation)|1
426635|NCT00535145|1424121|P1|Phase I|(eligibility)|8
426636|NCT00535145|1424121|P1|Phase I|Withdrawal by Subject|6
426637|NCT00535145|1424121|P1|Phase I|Lost to Follow-up|7
426638|NCT00535145|1424121|P1|Phase I|Adverse Event|3
426639|NCT00535132|1424133|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
426640|NCT00535132|1424134|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
426641|NCT00535132|1424133|P2|Safety Analysis Set|Did Not Receive Study Medication|2
426642|NCT00535132|1424134|P1|Safety Analysis Set|Did Not Receive Study Medication|2
426643|NCT00534976|1424215|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
426644|NCT00534976|1424216|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
426645|NCT00534976|1424215|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
426646|NCT00534976|1424216|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
426647|NCT00534976|1424215|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
426648|NCT00534976|1424216|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
426649|NCT00534638|1424277|P2|Overall Study|Refused participation to study|883
426650|NCT00534638|1424278|P1|Overall Study|Refused participation to study|1665
426651|NCT00534638|1424277|P2|Overall Study|Rejected origin of signature|2
426652|NCT00534638|1424278|P1|Overall Study|Rejected origin of signature|0
426653|NCT00534638|1424277|P2|Overall Study|Received without ICF|1
426654|NCT00534638|1424278|P1|Overall Study|Received without ICF|0
426655|NCT00534638|1424277|P2|Overall Study|Subject unable to read|1
426656|NCT00534638|1424278|P1|Overall Study|Subject unable to read|0
426657|NCT00534638|1424277|P2|Overall Study|ICF not returned|1
426658|NCT00534638|1424278|P1|Overall Study|ICF not returned|0
426659|NCT00534638|1424277|P2|Overall Study|Mentally disabled|0
426660|NCT00534638|1424278|P1|Overall Study|Mentally disabled|1
426661|NCT00534638|1424277|P2|Overall Study|Death|5
426662|NCT00534638|1424278|P1|Overall Study|Death|5
426663|NCT00534638|1424277|P2|Overall Study|Pregnancy|4
426664|NCT00534638|1424278|P1|Overall Study|Pregnancy|6
426665|NCT00534638|1424277|P2|Overall Study|Blinded treatment broken|0
426666|NCT00534638|1424278|P1|Overall Study|Blinded treatment broken|2
426667|NCT00534638|1424277|P2|Overall Study|Urticaria|0
426668|NCT00534638|1424278|P1|Overall Study|Urticaria|1
426669|NCT00534638|1424277|P2|Overall Study|Already received HPV vaccine|1
426670|NCT00534638|1424278|P1|Overall Study|Already received HPV vaccine|0
426671|NCT00534638|1424277|P2|Overall Study|Lost to Follow-up|10875
426672|NCT00534638|1424278|P1|Overall Study|Lost to Follow-up|4793
426673|NCT00534638|1424277|P2|Overall Study|Migrated/moved from study area|13
426674|NCT00534638|1424278|P1|Overall Study|Migrated/moved from study area|14
426675|NCT00534638|1424277|P2|Overall Study|Withdrawal by Subject|5
426676|NCT00534638|1424278|P1|Overall Study|Withdrawal by Subject|4
426677|NCT00534599|1424313|P2|Overall Study|Other|0
426678|NCT00534599|1424314|P1|Overall Study|Other|7
426679|NCT00534599|1424313|P2|Overall Study|Withdrawal by Subject|6
426680|NCT00534599|1424314|P1|Overall Study|Withdrawal by Subject|4
426681|NCT00534599|1424313|P2|Overall Study|Lost to Follow-up|14
426682|NCT00534599|1424314|P1|Overall Study|Lost to Follow-up|11
426683|NCT00534599|1424313|P2|Overall Study|Protocol Violation|3
426684|NCT00534599|1424314|P1|Overall Study|Protocol Violation|1
426685|NCT00534599|1424313|P2|Overall Study|Generalized anxiety disorder worsened|1
426686|NCT00534599|1424314|P1|Overall Study|Generalized anxiety disorder worsened|0
426687|NCT00534599|1424313|P2|Overall Study|Lack of Efficacy|1
426688|NCT00534599|1424314|P1|Overall Study|Lack of Efficacy|0
426689|NCT00534599|1424313|P2|Overall Study|Developed study-specific d/c criteria|0
426690|NCT00534599|1424314|P1|Overall Study|Developed study-specific d/c criteria|5
426691|NCT00534599|1424313|P2|Overall Study|Mis-randomization|2
426692|NCT00534599|1424314|P1|Overall Study|Mis-randomization|2
426693|NCT00534599|1424313|P2|Overall Study|Incorrect enrollment|1
426694|NCT00534599|1424314|P1|Overall Study|Incorrect enrollment|2
426695|NCT00534599|1424313|P2|Overall Study|Adverse Event|4
426696|NCT00534599|1424314|P1|Overall Study|Adverse Event|25
426697|NCT00534495|1424350|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
426698|NCT00534495|1424351|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
426699|NCT00534495|1424352|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
426700|NCT00534495|1424350|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
426701|NCT00534495|1424351|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
426702|NCT00534495|1424352|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
426703|NCT00534495|1424350|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
426704|NCT00534495|1424351|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
426705|NCT00534495|1424352|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
426706|NCT00534495|1424350|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
426707|NCT00534495|1424351|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
426708|NCT00534495|1424352|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
426709|NCT00534495|1424350|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
426710|NCT00534495|1424351|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
426711|NCT00534495|1424352|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
426712|NCT00534495|1424350|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
426713|NCT00534495|1424351|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
426714|NCT00534495|1424352|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
426715|NCT00534495|1424350|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
426716|NCT00534495|1424351|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
426717|NCT00534495|1424352|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
426718|NCT00534495|1424350|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
426719|NCT00534495|1424351|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
426720|NCT00534495|1424352|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
426721|NCT00534495|1424350|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
426722|NCT00534495|1424351|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
426723|NCT00534495|1424352|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
426724|NCT00534404|1424390|P3|Overall Study|Lost to Follow-up|201
426725|NCT00534404|1424391|P2|Overall Study|Lost to Follow-up|138
426726|NCT00534404|1424392|P1|Overall Study|Lost to Follow-up|170
426727|NCT00534404|1424390|P3|Overall Study|Removed by study staff|1
426728|NCT00534404|1424391|P2|Overall Study|Removed by study staff|3
426729|NCT00534404|1424392|P1|Overall Study|Removed by study staff|2
426730|NCT00534404|1424390|P3|Overall Study|Withdrawal by Subject|38
426731|NCT00534404|1424391|P2|Overall Study|Withdrawal by Subject|2
426732|NCT00534404|1424392|P1|Overall Study|Withdrawal by Subject|8
426733|NCT00534404|1424390|P3|Overall Study|Death|2
426734|NCT00534404|1424391|P2|Overall Study|Death|0
426735|NCT00534404|1424392|P1|Overall Study|Death|0
426736|NCT00534352|1424423|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
426737|NCT00534352|1424423|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
426738|NCT00534352|1424423|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
426739|NCT00534352|1424423|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
426740|NCT00534352|1424423|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
426741|NCT00534352|1424423|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
426742|NCT00534313|1424467|P4|Long-term Period|Not specified|2
426743|NCT00534313|1424468|P3|Long-term Period|Not specified|2
426744|NCT00534313|1424469|P2|Long-term Period|Not specified|2
426745|NCT00534313|1424470|P1|Long-term Period|Not specified|1
426746|NCT00534313|1424467|P4|Long-term Period|Administrative reason by sponsor|18
426747|NCT00534313|1424468|P3|Long-term Period|Administrative reason by sponsor|26
426748|NCT00534313|1424469|P2|Long-term Period|Administrative reason by sponsor|15
426749|NCT00534313|1424470|P1|Long-term Period|Administrative reason by sponsor|17
426750|NCT00534313|1424467|P4|Long-term Period|Poor compliance/noncompliance|0
426751|NCT00534313|1424468|P3|Long-term Period|Poor compliance/noncompliance|1
426752|NCT00534313|1424469|P2|Long-term Period|Poor compliance/noncompliance|1
426753|NCT00534313|1424470|P1|Long-term Period|Poor compliance/noncompliance|0
426754|NCT00534313|1424467|P4|Long-term Period|No longer meets study criteria|0
426755|NCT00534313|1424468|P3|Long-term Period|No longer meets study criteria|0
426756|NCT00534313|1424469|P2|Long-term Period|No longer meets study criteria|1
426757|NCT00534313|1424470|P1|Long-term Period|No longer meets study criteria|0
426758|NCT00534313|1424467|P4|Long-term Period|Withdrawal by Subject|0
426759|NCT00534313|1424468|P3|Long-term Period|Withdrawal by Subject|0
426760|NCT00534313|1424469|P2|Long-term Period|Withdrawal by Subject|2
426761|NCT00534313|1424470|P1|Long-term Period|Withdrawal by Subject|2
426762|NCT00534313|1424467|P4|Long-term Period|Lost to Follow-up|0
426763|NCT00534313|1424468|P3|Long-term Period|Lost to Follow-up|0
426764|NCT00534313|1424469|P2|Long-term Period|Lost to Follow-up|2
426765|NCT00534313|1424470|P1|Long-term Period|Lost to Follow-up|1
426766|NCT00534313|1424467|P4|Long-term Period|Lack of Efficacy|12
426767|NCT00534313|1424468|P3|Long-term Period|Lack of Efficacy|14
426768|NCT00534313|1424469|P2|Long-term Period|Lack of Efficacy|10
426769|NCT00534313|1424470|P1|Long-term Period|Lack of Efficacy|14
426770|NCT00534313|1424467|P4|Long-term Period|Adverse Event|1
426771|NCT00534313|1424468|P3|Long-term Period|Adverse Event|0
426772|NCT00534313|1424469|P2|Long-term Period|Adverse Event|1
426773|NCT00534313|1424470|P1|Long-term Period|Adverse Event|2
426774|NCT00534313|1424467|P4|Short-term Period|Pregnancy|0
426775|NCT00534313|1424468|P3|Short-term Period|Pregnancy|1
426776|NCT00534313|1424469|P2|Short-term Period|Pregnancy|0
426777|NCT00534313|1424470|P1|Short-term Period|Pregnancy|0
426778|NCT00534313|1424467|P4|Short-term Period|Participant withdrew consent|2
426779|NCT00534313|1424468|P3|Short-term Period|Participant withdrew consent|0
426780|NCT00534313|1424469|P2|Short-term Period|Participant withdrew consent|0
426781|NCT00534313|1424470|P1|Short-term Period|Participant withdrew consent|2
426782|NCT00534313|1424467|P4|Short-term Period|Participant not meeting study criteria|1
426783|NCT00534313|1424468|P3|Short-term Period|Participant not meeting study criteria|0
426784|NCT00534313|1424469|P2|Short-term Period|Participant not meeting study criteria|0
426785|NCT00534313|1424470|P1|Short-term Period|Participant not meeting study criteria|0
426786|NCT00534313|1424467|P4|Short-term Period|Lack of Efficacy|3
426787|NCT00534313|1424468|P3|Short-term Period|Lack of Efficacy|0
426788|NCT00534313|1424469|P2|Short-term Period|Lack of Efficacy|4
426789|NCT00534313|1424470|P1|Short-term Period|Lack of Efficacy|3
426790|NCT00534313|1424467|P4|Short-term Period|Adverse Event|3
426791|NCT00534313|1424468|P3|Short-term Period|Adverse Event|1
426792|NCT00534313|1424469|P2|Short-term Period|Adverse Event|2
426793|NCT00534313|1424470|P1|Short-term Period|Adverse Event|1
426794|NCT00534248|1424565|P2|Overall Study|Withdrawal by Subject|255
426795|NCT00534248|1424566|P1|Overall Study|Withdrawal by Subject|263
426796|NCT00534248|1424565|P2|Overall Study|Protocol Violation|4
426797|NCT00534248|1424566|P1|Overall Study|Protocol Violation|3
426798|NCT00534248|1424565|P2|Overall Study|Physician Decision|7
426799|NCT00534248|1424566|P1|Overall Study|Physician Decision|10
426800|NCT00534248|1424565|P2|Overall Study|Other protocol specified criteria|3
426801|NCT00534248|1424566|P1|Overall Study|Other protocol specified criteria|13
426802|NCT00534248|1424565|P2|Overall Study|Lost to Follow-up|375
426803|NCT00534248|1424566|P1|Overall Study|Lost to Follow-up|353
426804|NCT00534248|1424565|P2|Overall Study|Adverse Event|29
426805|NCT00534248|1424566|P1|Overall Study|Adverse Event|19
426806|NCT00534105|1424596|P2|Overall Study|Lost to Follow-up|39
426807|NCT00534105|1424597|P1|Overall Study|Lost to Follow-up|23
426808|NCT00534092|1424611|P2|Overall Study|personal reasons/family concerns|0
426809|NCT00534092|1424612|P1|Overall Study|personal reasons/family concerns|1
426810|NCT00534092|1424611|P2|Overall Study|Lost to Follow-up|0
426811|NCT00534092|1424612|P1|Overall Study|Lost to Follow-up|1
426812|NCT00533949|1424650|P4|Overall Study|Withdrawal by Subject|1
426813|NCT00533949|1424651|P3|Overall Study|Withdrawal by Subject|1
426814|NCT00533949|1424652|P2|Overall Study|Withdrawal by Subject|2
426815|NCT00533949|1424653|P1|Overall Study|Withdrawal by Subject|3
426816|NCT00533949|1424650|P4|Overall Study|Protocol Violation|9
426817|NCT00533949|1424651|P3|Overall Study|Protocol Violation|9
426818|NCT00533949|1424652|P2|Overall Study|Protocol Violation|12
426819|NCT00533949|1424653|P1|Overall Study|Protocol Violation|12
426820|NCT00533897|1424684|P8|Long Term Extension (LTE)|not specified|6
426821|NCT00533897|1424685|P7|Long Term Extension (LTE)|not specified|1
426822|NCT00533897|1424686|P6|Long Term Extension (LTE)|not specified|0
426823|NCT00533897|1424687|P5|Long Term Extension (LTE)|not specified|0
426824|NCT00533897|1424688|P4|Long Term Extension (LTE)|not specified|0
426825|NCT00533897|1424689|P3|Long Term Extension (LTE)|not specified|0
426826|NCT00533897|1424690|P2|Long Term Extension (LTE)|not specified|0
426827|NCT00533897|1424691|P1|Long Term Extension (LTE)|not specified|0
426828|NCT00533897|1424684|P8|Long Term Extension (LTE)|Lost to Follow-up|1
426829|NCT00533897|1424685|P7|Long Term Extension (LTE)|Lost to Follow-up|1
426830|NCT00533897|1424686|P6|Long Term Extension (LTE)|Lost to Follow-up|0
426831|NCT00533897|1424687|P5|Long Term Extension (LTE)|Lost to Follow-up|0
426832|NCT00533897|1424688|P4|Long Term Extension (LTE)|Lost to Follow-up|0
426833|NCT00533897|1424689|P3|Long Term Extension (LTE)|Lost to Follow-up|0
426834|NCT00533897|1424690|P2|Long Term Extension (LTE)|Lost to Follow-up|0
426835|NCT00533897|1424691|P1|Long Term Extension (LTE)|Lost to Follow-up|0
426836|NCT00533897|1424684|P8|Long Term Extension (LTE)|Pregnancy|2
426837|NCT00533897|1424685|P7|Long Term Extension (LTE)|Pregnancy|0
426838|NCT00533897|1424686|P6|Long Term Extension (LTE)|Pregnancy|0
426839|NCT00533897|1424687|P5|Long Term Extension (LTE)|Pregnancy|0
426840|NCT00533897|1424688|P4|Long Term Extension (LTE)|Pregnancy|0
426841|NCT00533897|1424689|P3|Long Term Extension (LTE)|Pregnancy|0
426842|NCT00533897|1424690|P2|Long Term Extension (LTE)|Pregnancy|0
426843|NCT00533897|1424691|P1|Long Term Extension (LTE)|Pregnancy|0
426844|NCT00533897|1424684|P8|Long Term Extension (LTE)|Adverse Event|5
426845|NCT00533897|1424685|P7|Long Term Extension (LTE)|Adverse Event|2
426846|NCT00533897|1424686|P6|Long Term Extension (LTE)|Adverse Event|0
426847|NCT00533897|1424687|P5|Long Term Extension (LTE)|Adverse Event|0
426848|NCT00533897|1424688|P4|Long Term Extension (LTE)|Adverse Event|0
426849|NCT00533897|1424689|P3|Long Term Extension (LTE)|Adverse Event|0
426850|NCT00533897|1424690|P2|Long Term Extension (LTE)|Adverse Event|0
426851|NCT00533897|1424691|P1|Long Term Extension (LTE)|Adverse Event|0
426852|NCT00533897|1424684|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
426853|NCT00533897|1424685|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
426854|NCT00533897|1424686|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
426855|NCT00533897|1424687|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
426856|NCT00533897|1424688|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
426857|NCT00533897|1424689|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
426858|NCT00533897|1424690|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
426859|NCT00533897|1424691|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
426860|NCT00533897|1424684|P8|Long Term Extension (LTE)|Lack of Efficacy|3
426861|NCT00533897|1424685|P7|Long Term Extension (LTE)|Lack of Efficacy|5
426862|NCT00533897|1424686|P6|Long Term Extension (LTE)|Lack of Efficacy|0
426863|NCT00533897|1424687|P5|Long Term Extension (LTE)|Lack of Efficacy|0
426864|NCT00533897|1424688|P4|Long Term Extension (LTE)|Lack of Efficacy|0
426865|NCT00533897|1424689|P3|Long Term Extension (LTE)|Lack of Efficacy|0
426866|NCT00533897|1424690|P2|Long Term Extension (LTE)|Lack of Efficacy|0
426867|NCT00533897|1424691|P1|Long Term Extension (LTE)|Lack of Efficacy|0
426868|NCT00533897|1424684|P8|Long Term Extension (LTE)|Death|3
426869|NCT00533897|1424685|P7|Long Term Extension (LTE)|Death|1
426870|NCT00533897|1424686|P6|Long Term Extension (LTE)|Death|0
426871|NCT00533897|1424687|P5|Long Term Extension (LTE)|Death|0
426872|NCT00533897|1424688|P4|Long Term Extension (LTE)|Death|0
426873|NCT00533897|1424689|P3|Long Term Extension (LTE)|Death|0
426874|NCT00533897|1424690|P2|Long Term Extension (LTE)|Death|0
426875|NCT00533897|1424691|P1|Long Term Extension (LTE)|Death|0
426876|NCT00533897|1424684|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
426877|NCT00533897|1424685|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
426878|NCT00533897|1424686|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
426879|NCT00533897|1424687|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
426880|NCT00533897|1424688|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
426881|NCT00533897|1424689|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
426882|NCT00533897|1424690|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
426883|NCT00533897|1424691|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
426884|NCT00533897|1424684|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
426885|NCT00533897|1424685|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
426886|NCT00533897|1424686|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
426887|NCT00533897|1424687|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
426888|NCT00533897|1424688|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
426889|NCT00533897|1424689|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
426890|NCT00533897|1424690|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
426891|NCT00533897|1424691|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
426892|NCT00533897|1424684|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
426893|NCT00533897|1424685|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
426894|NCT00533897|1424686|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
426895|NCT00533897|1424687|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
426896|NCT00533897|1424688|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
426897|NCT00533897|1424689|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
426898|NCT00533897|1424690|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
426899|NCT00533897|1424691|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
426900|NCT00533897|1424684|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
426901|NCT00533897|1424685|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
426902|NCT00533897|1424686|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
426903|NCT00533897|1424687|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
426904|NCT00533897|1424688|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
426905|NCT00533897|1424689|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
426906|NCT00533897|1424690|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
426907|NCT00533897|1424691|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
426908|NCT00533897|1424684|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
426909|NCT00533897|1424685|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
426910|NCT00533897|1424686|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
426911|NCT00533897|1424687|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
426912|NCT00533897|1424688|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
426913|NCT00533897|1424689|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
426914|NCT00533897|1424690|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
426915|NCT00533897|1424691|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
426916|NCT00533897|1424684|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
426917|NCT00533897|1424685|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
426918|NCT00533897|1424686|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
426919|NCT00533897|1424687|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
426920|NCT00533897|1424688|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
426921|NCT00533897|1424689|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
426922|NCT00533897|1424690|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
426923|NCT00533897|1424691|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
426924|NCT00533897|1424684|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
426925|NCT00533897|1424685|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
426926|NCT00533897|1424686|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
426927|NCT00533897|1424687|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
426928|NCT00533897|1424688|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
426929|NCT00533897|1424689|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
426930|NCT00533897|1424690|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
426931|NCT00533897|1424691|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
426932|NCT00533897|1424684|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
426933|NCT00533897|1424685|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
426934|NCT00533897|1424686|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
426935|NCT00533897|1424687|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
426936|NCT00533897|1424688|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
426937|NCT00533897|1424689|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
426938|NCT00533897|1424690|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
426939|NCT00533897|1424691|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
426940|NCT00533897|1424684|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
426941|NCT00533897|1424685|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
426942|NCT00533897|1424686|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
426943|NCT00533897|1424687|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
426944|NCT00533897|1424688|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
426945|NCT00533897|1424689|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
426946|NCT00533897|1424690|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
426947|NCT00533897|1424691|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
426948|NCT00533897|1424684|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
426949|NCT00533897|1424685|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
426950|NCT00533897|1424686|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
426951|NCT00533897|1424687|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
426952|NCT00533897|1424688|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
426953|NCT00533897|1424689|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
426954|NCT00533897|1424690|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
426955|NCT00533897|1424691|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
426956|NCT00533897|1424684|P8|Lead-in (LI) Period 1|Adverse Event|0
426957|NCT00533897|1424685|P7|Lead-in (LI) Period 1|Adverse Event|0
426958|NCT00533897|1424686|P6|Lead-in (LI) Period 1|Adverse Event|0
426959|NCT00533897|1424687|P5|Lead-in (LI) Period 1|Adverse Event|0
426960|NCT00533897|1424688|P4|Lead-in (LI) Period 1|Adverse Event|0
426961|NCT00533897|1424689|P3|Lead-in (LI) Period 1|Adverse Event|0
426962|NCT00533897|1424690|P2|Lead-in (LI) Period 1|Adverse Event|0
426963|NCT00533897|1424691|P1|Lead-in (LI) Period 1|Adverse Event|1
426964|NCT00533702|1424831|P2|Overall Study|Found ineligible after randomization|1
426965|NCT00533702|1424832|P1|Overall Study|Found ineligible after randomization|2
426966|NCT00533702|1424831|P2|Overall Study|Withdrawal by Subject|1
426967|NCT00533702|1424832|P1|Overall Study|Withdrawal by Subject|3
426968|NCT00533507|1424863|P1|Overall Study|Withdrawal by Subject|1
426969|NCT00533273|1424908|P2|Open-label|Withdrawal by Subject|0
426970|NCT00533273|1424909|P1|Open-label|Withdrawal by Subject|6
426971|NCT00533273|1424908|P2|Double-blind|Withdrew consent|2
426972|NCT00533273|1424909|P1|Double-blind|Withdrew consent|0
426973|NCT00532948|1424958|P3|Overall Study|Failure to return|0
426974|NCT00532948|1424959|P2|Overall Study|Failure to return|1
426975|NCT00532948|1424960|P1|Overall Study|Failure to return|0
426976|NCT00532948|1424958|P3|Overall Study|Violation of selection criteria at entry|0
426977|NCT00532948|1424959|P2|Overall Study|Violation of selection criteria at entry|1
426978|NCT00532948|1424960|P1|Overall Study|Violation of selection criteria at entry|0
426979|NCT00532948|1424958|P3|Overall Study|Death|4
426980|NCT00532948|1424959|P2|Overall Study|Death|3
426981|NCT00532948|1424960|P1|Overall Study|Death|3
426982|NCT00532948|1424958|P3|Overall Study|Protocol Violation|0
426983|NCT00532948|1424959|P2|Overall Study|Protocol Violation|0
426984|NCT00532948|1424960|P1|Overall Study|Protocol Violation|1
426985|NCT00532935|1424992|P2|Overall Study|Protocol Specific Criteria|15
426986|NCT00532935|1424993|P1|Overall Study|Protocol Specific Criteria|11
426987|NCT00532935|1424992|P2|Overall Study|Withdrawal by Subject|9
426988|NCT00532935|1424993|P1|Overall Study|Withdrawal by Subject|10
426989|NCT00532935|1424992|P2|Overall Study|Protocol Violation|2
426990|NCT00532935|1424993|P1|Overall Study|Protocol Violation|4
426991|NCT00532935|1424992|P2|Overall Study|Pregnancy|0
426992|NCT00532935|1424993|P1|Overall Study|Pregnancy|1
426993|NCT00532935|1424992|P2|Overall Study|Physician Decision|5
426994|NCT00532935|1424993|P1|Overall Study|Physician Decision|4
426995|NCT00532935|1424992|P2|Overall Study|Lost to Follow-up|6
426996|NCT00532935|1424993|P1|Overall Study|Lost to Follow-up|10
426997|NCT00532935|1424992|P2|Overall Study|Lack of Efficacy|3
426998|NCT00532935|1424993|P1|Overall Study|Lack of Efficacy|0
426999|NCT00532935|1424992|P2|Overall Study|Adverse Event|12
427000|NCT00532935|1424993|P1|Overall Study|Adverse Event|11
427001|NCT00532883|1425011|P4|Overall Study|Early Study Termination|4
427002|NCT00532883|1425012|P3|Overall Study|Early Study Termination|1
427003|NCT00532883|1425013|P2|Overall Study|Early Study Termination|4
427004|NCT00532883|1425014|P1|Overall Study|Early Study Termination|4
427005|NCT00532883|1425011|P4|Overall Study|Subject was Nonadherent|0
427006|NCT00532883|1425012|P3|Overall Study|Subject was Nonadherent|1
427007|NCT00532883|1425013|P2|Overall Study|Subject was Nonadherent|1
427008|NCT00532883|1425014|P1|Overall Study|Subject was Nonadherent|0
427009|NCT00532883|1425011|P4|Overall Study|Withdrawal by Subject|0
427010|NCT00532883|1425012|P3|Overall Study|Withdrawal by Subject|1
427011|NCT00532883|1425013|P2|Overall Study|Withdrawal by Subject|1
427012|NCT00532883|1425014|P1|Overall Study|Withdrawal by Subject|0
427013|NCT00532883|1425011|P4|Overall Study|Lost to Follow-up|0
427014|NCT00532883|1425012|P3|Overall Study|Lost to Follow-up|1
427015|NCT00532883|1425013|P2|Overall Study|Lost to Follow-up|1
427016|NCT00532883|1425014|P1|Overall Study|Lost to Follow-up|1
427017|NCT00532883|1425011|P4|Overall Study|Adverse Event|1
427018|NCT00532883|1425012|P3|Overall Study|Adverse Event|0
427019|NCT00532883|1425013|P2|Overall Study|Adverse Event|0
427020|NCT00532883|1425014|P1|Overall Study|Adverse Event|1
427021|NCT00532779|1425027|P3|Overall Study|Drug noncompliance, moved, other|29
427022|NCT00532779|1425028|P2|Overall Study|Drug noncompliance, moved, other|23
427023|NCT00532779|1425029|P1|Overall Study|Drug noncompliance, moved, other|14
427024|NCT00532779|1425027|P3|Overall Study|Death|0
427025|NCT00532779|1425028|P2|Overall Study|Death|1
427026|NCT00532779|1425029|P1|Overall Study|Death|0
427027|NCT00532779|1425027|P3|Overall Study|Pregnancy|3
427028|NCT00532779|1425028|P2|Overall Study|Pregnancy|5
427029|NCT00532779|1425029|P1|Overall Study|Pregnancy|2
427030|NCT00532779|1425027|P3|Overall Study|Protocol Violation|7
427031|NCT00532779|1425028|P2|Overall Study|Protocol Violation|9
427032|NCT00532779|1425029|P1|Overall Study|Protocol Violation|5
427033|NCT00532779|1425027|P3|Overall Study|Lack of Efficacy|40
427034|NCT00532779|1425028|P2|Overall Study|Lack of Efficacy|12
427035|NCT00532779|1425029|P1|Overall Study|Lack of Efficacy|12
427036|NCT00532779|1425027|P3|Overall Study|Withdrawal by Subject|90
427037|NCT00532779|1425028|P2|Overall Study|Withdrawal by Subject|60
427038|NCT00532779|1425029|P1|Overall Study|Withdrawal by Subject|63
427039|NCT00532779|1425027|P3|Overall Study|Lost to Follow-up|66
427040|NCT00532779|1425028|P2|Overall Study|Lost to Follow-up|65
427041|NCT00532779|1425029|P1|Overall Study|Lost to Follow-up|76
427042|NCT00532779|1425027|P3|Overall Study|Adverse Event|56
427043|NCT00532779|1425028|P2|Overall Study|Adverse Event|112
427044|NCT00532779|1425029|P1|Overall Study|Adverse Event|122
427045|NCT00532493|1425090|P2|Overall Study|Contraindicative Medication|0
427046|NCT00532493|1425091|P1|Overall Study|Contraindicative Medication|1
427047|NCT00532493|1425090|P2|Overall Study|Subject Moved Away|1
427048|NCT00532493|1425091|P1|Overall Study|Subject Moved Away|3
427049|NCT00532493|1425090|P2|Overall Study|Protocol Deviation|0
427050|NCT00532493|1425091|P1|Overall Study|Protocol Deviation|1
427051|NCT00532493|1425090|P2|Overall Study|Adverse Event|5
427052|NCT00532493|1425091|P1|Overall Study|Adverse Event|6
427053|NCT00532493|1425090|P2|Overall Study|Physician Decision|6
427054|NCT00532493|1425091|P1|Overall Study|Physician Decision|1
427055|NCT00532493|1425090|P2|Overall Study|Withdrawal by Subject|9
427056|NCT00532493|1425091|P1|Overall Study|Withdrawal by Subject|7
427057|NCT00532493|1425090|P2|Overall Study|Lost to Follow-up|7
427058|NCT00532493|1425091|P1|Overall Study|Lost to Follow-up|10
427059|NCT00532493|1425090|P2|Overall Study|Death|1
427060|NCT00532493|1425091|P1|Overall Study|Death|1
427061|NCT00532441|1425125|P2|Overall Study|Death|0
427062|NCT00532441|1425126|P1|Overall Study|Death|1
427063|NCT00532298|1425141|P6|Overall Study|Lost to Follow-up|1
427064|NCT00532298|1425142|P5|Overall Study|Lost to Follow-up|0
427065|NCT00532298|1425143|P4|Overall Study|Lost to Follow-up|0
427066|NCT00532298|1425144|P3|Overall Study|Lost to Follow-up|1
427067|NCT00532298|1425145|P2|Overall Study|Lost to Follow-up|1
427068|NCT00532298|1425146|P1|Overall Study|Lost to Follow-up|1
427069|NCT00532298|1425141|P6|Overall Study|Adverse Event|1
427070|NCT00532298|1425142|P5|Overall Study|Adverse Event|1
427071|NCT00532298|1425143|P4|Overall Study|Adverse Event|0
427072|NCT00532298|1425144|P3|Overall Study|Adverse Event|0
427073|NCT00532298|1425145|P2|Overall Study|Adverse Event|0
427074|NCT00532298|1425146|P1|Overall Study|Adverse Event|1
427075|NCT00532259|1425226|P1|Overall Study|Protocol Violation|1
427076|NCT00532259|1425226|P1|Overall Study|Physician Decision|3
427077|NCT00532259|1425226|P1|Overall Study|Lost to Follow-up|3
427078|NCT00532259|1425226|P1|Overall Study|Lack of Efficacy|21
427079|NCT00532259|1425226|P1|Overall Study|Death|1
427080|NCT00532259|1425226|P1|Overall Study|Adverse Event|1
427081|NCT00532259|1425226|P1|Overall Study|Withdrawal by Subject|2
427082|NCT00532155|1425233|P2|Overall Study|Did not receive study medication|6
427083|NCT00532155|1425234|P1|Overall Study|Did not receive study medication|2
427084|NCT00532155|1425233|P2|Overall Study|Study termination stop further treatment|0
427085|NCT00532155|1425234|P1|Overall Study|Study termination stop further treatment|4
427086|NCT00532155|1425233|P2|Overall Study|Study terminated by sponsor|0
427087|NCT00532155|1425234|P1|Overall Study|Study terminated by sponsor|1
427088|NCT00532155|1425233|P2|Overall Study|Study stopped|0
427089|NCT00532155|1425234|P1|Overall Study|Study stopped|1
427090|NCT00532155|1425233|P2|Overall Study|Had brain metastasis, was mis-randomized|0
427091|NCT00532155|1425234|P1|Overall Study|Had brain metastasis, was mis-randomized|1
427092|NCT00532155|1425233|P2|Overall Study|Progressive disease (by incorrect scan)|1
427093|NCT00532155|1425234|P1|Overall Study|Progressive disease (by incorrect scan)|0
427094|NCT00532155|1425233|P2|Overall Study|Promotor ended study|0
427095|NCT00532155|1425234|P1|Overall Study|Promotor ended study|1
427096|NCT00532155|1425233|P2|Overall Study|Occurence of a secondary cancer|1
427097|NCT00532155|1425234|P1|Overall Study|Occurence of a secondary cancer|0
427098|NCT00532155|1425233|P2|Overall Study|Occurence of a second cancer|1
427099|NCT00532155|1425234|P1|Overall Study|Occurence of a second cancer|0
427100|NCT00532155|1425233|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
427101|NCT00532155|1425234|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
427102|NCT00532155|1425233|P2|Overall Study|Moved|0
427103|NCT00532155|1425234|P1|Overall Study|Moved|1
427104|NCT00532155|1425233|P2|Overall Study|Consent withdrawn|7
427105|NCT00532155|1425234|P1|Overall Study|Consent withdrawn|5
427106|NCT00532155|1425233|P2|Overall Study|Withdrawal by Subject|44
427107|NCT00532155|1425234|P1|Overall Study|Withdrawal by Subject|23
427108|NCT00532155|1425233|P2|Overall Study|Physician Decision|15
427109|NCT00532155|1425234|P1|Overall Study|Physician Decision|16
427110|NCT00532155|1425233|P2|Overall Study|Lost to Follow-up|0
427111|NCT00532155|1425234|P1|Overall Study|Lost to Follow-up|2
427112|NCT00532155|1425233|P2|Overall Study|Protocol Violation|3
427113|NCT00532155|1425234|P1|Overall Study|Protocol Violation|1
427114|NCT00532155|1425233|P2|Overall Study|Lack of Efficacy|255
427115|NCT00532155|1425234|P1|Overall Study|Lack of Efficacy|332
427116|NCT00532155|1425233|P2|Overall Study|Adverse Event|123
427117|NCT00532155|1425234|P1|Overall Study|Adverse Event|66
427118|NCT00532129|1425248|P1|Follow-up Period|Other|6
427119|NCT00532129|1425248|P1|Follow-up Period|Lost to Follow-up|1
427120|NCT00532129|1425248|P1|Follow-up Period|Disease progression|57
427121|NCT00532129|1425248|P1|Follow-up Period|Adverse event/Serious adverse event|1
427122|NCT00532129|1425248|P1|Treatment Period|Other|5
427123|NCT00532129|1425248|P1|Treatment Period|Protocol Violation|1
427124|NCT00532129|1425248|P1|Treatment Period|Disease progression|3
427125|NCT00532129|1425248|P1|Treatment Period|Physician Decision|15
427126|NCT00532129|1425248|P1|Treatment Period|Adverse event/Serious adverse event|25
427127|NCT00531960|1425268|P2|Overall Study|Not Specified|10
427128|NCT00531960|1425269|P1|Overall Study|Not Specified|4
427129|NCT00531960|1425268|P2|Overall Study|Refused Treatment|6
427130|NCT00531960|1425269|P1|Overall Study|Refused Treatment|5
427131|NCT00531960|1425268|P2|Overall Study|Violation of Selection Criteria|0
427132|NCT00531960|1425269|P1|Overall Study|Violation of Selection Criteria|2
427133|NCT00531960|1425268|P2|Overall Study|Lack of Efficacy|41
427134|NCT00531960|1425269|P1|Overall Study|Lack of Efficacy|42
427135|NCT00531960|1425268|P2|Overall Study|Death|2
427136|NCT00531960|1425269|P1|Overall Study|Death|3
427137|NCT00531960|1425268|P2|Overall Study|Adverse Event|4
427138|NCT00531960|1425269|P1|Overall Study|Adverse Event|5
427139|NCT00531947|1425287|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
427140|NCT00531947|1425288|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
427141|NCT00531947|1425287|P2|Overall Study|Non-Compliance|7
427142|NCT00531947|1425288|P1|Overall Study|Non-Compliance|4
427143|NCT00531947|1425287|P2|Overall Study|Protocol Violation|1
427144|NCT00531947|1425288|P1|Overall Study|Protocol Violation|2
427145|NCT00531947|1425287|P2|Overall Study|Withdrawal by Subject|19
427146|NCT00531947|1425288|P1|Overall Study|Withdrawal by Subject|14
427147|NCT00531947|1425287|P2|Overall Study|Lost to Follow-up|9
427148|NCT00531947|1425288|P1|Overall Study|Lost to Follow-up|12
427149|NCT00531947|1425287|P2|Overall Study|Adverse Event|10
427150|NCT00531947|1425288|P1|Overall Study|Adverse Event|5
427151|NCT00531934|1425332|P2|Overall Study|Not specified|2
427152|NCT00531934|1425333|P1|Overall Study|Not specified|2
427153|NCT00531934|1425332|P2|Overall Study|Withdrawal by Subject|1
427154|NCT00531934|1425333|P1|Overall Study|Withdrawal by Subject|1
427155|NCT00531934|1425332|P2|Overall Study|Death|10
427156|NCT00531934|1425333|P1|Overall Study|Death|7
427157|NCT00531934|1425332|P2|Overall Study|Progression|42
427158|NCT00531934|1425333|P1|Overall Study|Progression|52
427159|NCT00531934|1425332|P2|Overall Study|Adverse Event|8
427160|NCT00531934|1425333|P1|Overall Study|Adverse Event|4
427161|NCT00531752|1425461|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
427162|NCT00531752|1425462|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
427163|NCT00531752|1425463|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
427164|NCT00531752|1425464|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
427165|NCT00531752|1425461|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
427166|NCT00531752|1425462|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
427167|NCT00531752|1425463|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
427168|NCT00531752|1425464|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
427169|NCT00531752|1425461|P4|Second Double-blind Intervention Period|Other|0
427170|NCT00531752|1425462|P3|Second Double-blind Intervention Period|Other|0
427171|NCT00531752|1425463|P2|Second Double-blind Intervention Period|Other|1
427172|NCT00531752|1425464|P1|Second Double-blind Intervention Period|Other|1
427173|NCT00531752|1425461|P4|Second Double-blind Intervention Period|Adverse Event|0
427174|NCT00531752|1425462|P3|Second Double-blind Intervention Period|Adverse Event|0
427175|NCT00531752|1425463|P2|Second Double-blind Intervention Period|Adverse Event|1
427176|NCT00531752|1425464|P1|Second Double-blind Intervention Period|Adverse Event|1
427177|NCT00531752|1425461|P4|First Double-blind Intervention Period|Randomized but not treated|0
427178|NCT00531752|1425462|P3|First Double-blind Intervention Period|Randomized but not treated|0
427179|NCT00531752|1425463|P2|First Double-blind Intervention Period|Randomized but not treated|0
427180|NCT00531752|1425464|P1|First Double-blind Intervention Period|Randomized but not treated|1
427181|NCT00531752|1425461|P4|First Double-blind Intervention Period|Lost to Follow-up|1
427182|NCT00531752|1425462|P3|First Double-blind Intervention Period|Lost to Follow-up|1
427183|NCT00531752|1425463|P2|First Double-blind Intervention Period|Lost to Follow-up|0
427184|NCT00531752|1425464|P1|First Double-blind Intervention Period|Lost to Follow-up|0
427185|NCT00531752|1425461|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
427186|NCT00531752|1425462|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
427187|NCT00531752|1425463|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
427188|NCT00531752|1425464|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
427189|NCT00531752|1425461|P4|First Double-blind Intervention Period|Other|0
427190|NCT00531752|1425462|P3|First Double-blind Intervention Period|Other|4
427191|NCT00531752|1425463|P2|First Double-blind Intervention Period|Other|4
427192|NCT00531752|1425464|P1|First Double-blind Intervention Period|Other|1
427193|NCT00531752|1425461|P4|First Double-blind Intervention Period|Adverse Event|1
427194|NCT00531752|1425462|P3|First Double-blind Intervention Period|Adverse Event|1
427195|NCT00531752|1425463|P2|First Double-blind Intervention Period|Adverse Event|0
427196|NCT00531752|1425464|P1|First Double-blind Intervention Period|Adverse Event|2
427197|NCT00531479|1425575|P2|Overall Study|Did not receive treatment|3
427198|NCT00531479|1425576|P1|Overall Study|Did not receive treatment|2
427199|NCT00531479|1425575|P2|Overall Study|Withdrawal by Subject|6
427200|NCT00531479|1425576|P1|Overall Study|Withdrawal by Subject|6
427201|NCT00531479|1425575|P2|Overall Study|Other|1
427202|NCT00531479|1425576|P1|Overall Study|Other|0
427203|NCT00531479|1425575|P2|Overall Study|Lost to Follow-up|2
427204|NCT00531479|1425576|P1|Overall Study|Lost to Follow-up|0
427205|NCT00531479|1425575|P2|Overall Study|Death|71
427206|NCT00531479|1425576|P1|Overall Study|Death|68
427207|NCT00531427|1425607|P2|Overall Study|Administrative|9
427208|NCT00531427|1425608|P1|Overall Study|Administrative|4
427209|NCT00531427|1425607|P2|Overall Study|Lack of Efficacy|39
427210|NCT00531427|1425608|P1|Overall Study|Lack of Efficacy|14
427211|NCT00531427|1425607|P2|Overall Study|Lost to Follow-up|3
427212|NCT00531427|1425608|P1|Overall Study|Lost to Follow-up|4
427213|NCT00531427|1425607|P2|Overall Study|Adverse Event|30
427214|NCT00531427|1425608|P1|Overall Study|Adverse Event|44
427215|NCT00531427|1425607|P2|Overall Study|Withdrawal by Subject|13
427216|NCT00531427|1425608|P1|Overall Study|Withdrawal by Subject|7
427217|NCT00531284|1425636|P17|Overall Study|Other|0
427218|NCT00531284|1425637|P16|Overall Study|Other|0
427219|NCT00531284|1425638|P15|Overall Study|Other|1
427220|NCT00531284|1425639|P14|Overall Study|Other|0
427221|NCT00531284|1425640|P13|Overall Study|Other|0
427222|NCT00531284|1425641|P12|Overall Study|Other|2
427223|NCT00531284|1425642|P11|Overall Study|Other|0
427224|NCT00531284|1425643|P10|Overall Study|Other|1
427225|NCT00531284|1425644|P9|Overall Study|Other|2
427226|NCT00531284|1425645|P8|Overall Study|Other|0
427227|NCT00531284|1425646|P7|Overall Study|Other|0
427228|NCT00531284|1425647|P6|Overall Study|Other|1
427229|NCT00531284|1425648|P5|Overall Study|Other|2
427230|NCT00531284|1425649|P4|Overall Study|Other|10
427231|NCT00531284|1425650|P3|Overall Study|Other|0
427232|NCT00531284|1425651|P2|Overall Study|Other|0
427233|NCT00531284|1425652|P1|Overall Study|Other|1
427234|NCT00531284|1425636|P17|Overall Study|Withdrawal by Subject|1
427235|NCT00531284|1425637|P16|Overall Study|Withdrawal by Subject|1
427236|NCT00531284|1425638|P15|Overall Study|Withdrawal by Subject|0
427237|NCT00531284|1425639|P14|Overall Study|Withdrawal by Subject|1
427238|NCT00531284|1425640|P13|Overall Study|Withdrawal by Subject|0
427239|NCT00531284|1425641|P12|Overall Study|Withdrawal by Subject|3
427240|NCT00531284|1425642|P11|Overall Study|Withdrawal by Subject|0
427241|NCT00531284|1425643|P10|Overall Study|Withdrawal by Subject|0
427242|NCT00531284|1425644|P9|Overall Study|Withdrawal by Subject|0
427243|NCT00531284|1425645|P8|Overall Study|Withdrawal by Subject|0
427244|NCT00531284|1425646|P7|Overall Study|Withdrawal by Subject|0
427245|NCT00531284|1425647|P6|Overall Study|Withdrawal by Subject|0
427246|NCT00531284|1425648|P5|Overall Study|Withdrawal by Subject|0
427247|NCT00531284|1425649|P4|Overall Study|Withdrawal by Subject|4
427248|NCT00531284|1425650|P3|Overall Study|Withdrawal by Subject|0
427249|NCT00531284|1425651|P2|Overall Study|Withdrawal by Subject|0
427250|NCT00531284|1425652|P1|Overall Study|Withdrawal by Subject|1
427251|NCT00531284|1425636|P17|Overall Study|Adverse Event|2
427252|NCT00531284|1425637|P16|Overall Study|Adverse Event|0
427253|NCT00531284|1425638|P15|Overall Study|Adverse Event|1
427254|NCT00531284|1425639|P14|Overall Study|Adverse Event|1
427255|NCT00531284|1425640|P13|Overall Study|Adverse Event|0
427256|NCT00531284|1425641|P12|Overall Study|Adverse Event|5
427257|NCT00531284|1425642|P11|Overall Study|Adverse Event|0
427258|NCT00531284|1425643|P10|Overall Study|Adverse Event|0
427259|NCT00531284|1425644|P9|Overall Study|Adverse Event|3
427260|NCT00531284|1425645|P8|Overall Study|Adverse Event|2
427261|NCT00531284|1425646|P7|Overall Study|Adverse Event|3
427262|NCT00531284|1425647|P6|Overall Study|Adverse Event|2
427263|NCT00531284|1425648|P5|Overall Study|Adverse Event|0
427264|NCT00531284|1425649|P4|Overall Study|Adverse Event|7
427265|NCT00531284|1425650|P3|Overall Study|Adverse Event|1
427266|NCT00531284|1425651|P2|Overall Study|Adverse Event|1
427267|NCT00531284|1425652|P1|Overall Study|Adverse Event|0
427268|NCT00531284|1425636|P17|Overall Study|Progressive Disease|5
427269|NCT00531284|1425637|P16|Overall Study|Progressive Disease|11
427270|NCT00531284|1425638|P15|Overall Study|Progressive Disease|2
427271|NCT00531284|1425639|P14|Overall Study|Progressive Disease|1
427272|NCT00531284|1425640|P13|Overall Study|Progressive Disease|2
427273|NCT00531284|1425641|P12|Overall Study|Progressive Disease|14
427274|NCT00531284|1425642|P11|Overall Study|Progressive Disease|3
427275|NCT00531284|1425643|P10|Overall Study|Progressive Disease|3
427276|NCT00531284|1425644|P9|Overall Study|Progressive Disease|6
427277|NCT00531284|1425645|P8|Overall Study|Progressive Disease|8
427278|NCT00531284|1425646|P7|Overall Study|Progressive Disease|3
427279|NCT00531284|1425647|P6|Overall Study|Progressive Disease|4
427280|NCT00531284|1425648|P5|Overall Study|Progressive Disease|4
427281|NCT00531284|1425649|P4|Overall Study|Progressive Disease|42
427282|NCT00531284|1425650|P3|Overall Study|Progressive Disease|5
427283|NCT00531284|1425651|P2|Overall Study|Progressive Disease|3
427284|NCT00531284|1425652|P1|Overall Study|Progressive Disease|1
427285|NCT00531206|1425802|P1|Overall Study|including non-related adverse events|8
427286|NCT00531206|1425802|P1|Overall Study|Lost to Follow-up|5
427287|NCT00531206|1425802|P1|Overall Study|Lack of Efficacy|2
427288|NCT00531206|1425802|P1|Overall Study|Adverse Event related|5
427289|NCT00531050|1425832|P6|Part 2: Period 3|Abnormal test procedure|1
427290|NCT00531050|1425833|P5|Part 2: Period 3|Abnormal test procedure|0
427291|NCT00531050|1425834|P4|Part 2: Period 3|Abnormal test procedure|0
427292|NCT00531050|1425835|P3|Part 2: Period 3|Abnormal test procedure|0
427293|NCT00531050|1425836|P2|Part 2: Period 3|Abnormal test procedure|0
427294|NCT00531050|1425837|P1|Part 2: Period 3|Abnormal test procedure|1
427295|NCT00531050|1425832|P6|Part 2: Period 1|Adverse Event|1
427296|NCT00531050|1425833|P5|Part 2: Period 1|Adverse Event|0
427297|NCT00531050|1425834|P4|Part 2: Period 1|Adverse Event|0
427298|NCT00531050|1425835|P3|Part 2: Period 1|Adverse Event|0
427299|NCT00531050|1425836|P2|Part 2: Period 1|Adverse Event|0
427300|NCT00531050|1425837|P1|Part 2: Period 1|Adverse Event|0
427301|NCT00531050|1425832|P6|Part 1: Period 3|Adverse Event|0
427302|NCT00531050|1425833|P5|Part 1: Period 3|Adverse Event|0
427303|NCT00531050|1425834|P4|Part 1: Period 3|Adverse Event|0
427304|NCT00531050|1425835|P3|Part 1: Period 3|Adverse Event|0
427305|NCT00531050|1425836|P2|Part 1: Period 3|Adverse Event|0
427306|NCT00531050|1425837|P1|Part 1: Period 3|Adverse Event|1
427307|NCT00531050|1425832|P6|Part 1: Period 1|Protocol Deviation|0
427308|NCT00531050|1425833|P5|Part 1: Period 1|Protocol Deviation|0
427309|NCT00531050|1425834|P4|Part 1: Period 1|Protocol Deviation|1
427310|NCT00531050|1425835|P3|Part 1: Period 1|Protocol Deviation|0
427311|NCT00531050|1425836|P2|Part 1: Period 1|Protocol Deviation|0
427312|NCT00531050|1425837|P1|Part 1: Period 1|Protocol Deviation|0
427313|NCT00531050|1425832|P6|Part 1: Period 1|Adverse Event|0
427314|NCT00531050|1425833|P5|Part 1: Period 1|Adverse Event|0
427315|NCT00531050|1425834|P4|Part 1: Period 1|Adverse Event|0
427316|NCT00531050|1425835|P3|Part 1: Period 1|Adverse Event|0
427317|NCT00531050|1425836|P2|Part 1: Period 1|Adverse Event|1
427318|NCT00531050|1425837|P1|Part 1: Period 1|Adverse Event|0
427319|NCT00531011|1425866|P2|Overall Study|Physician Decision|3
427320|NCT00531011|1425867|P1|Overall Study|Physician Decision|0
427321|NCT00531011|1425866|P2|Overall Study|Lost to Follow-up|0
427322|NCT00531011|1425867|P1|Overall Study|Lost to Follow-up|1
427323|NCT00531011|1425866|P2|Overall Study|Death|0
427324|NCT00531011|1425867|P1|Overall Study|Death|1
427325|NCT00531011|1425866|P2|Overall Study|Withdrawal by Subject|4
427326|NCT00531011|1425867|P1|Overall Study|Withdrawal by Subject|2
427327|NCT00530946|1425913|P4|Overall Study|Noncompliance|0
427328|NCT00530946|1425914|P3|Overall Study|Noncompliance|0
427329|NCT00530946|1425915|P2|Overall Study|Noncompliance|0
427330|NCT00530946|1425916|P1|Overall Study|Noncompliance|1
427331|NCT00530946|1425913|P4|Overall Study|Protocol Violation|1
427332|NCT00530946|1425914|P3|Overall Study|Protocol Violation|0
427333|NCT00530946|1425915|P2|Overall Study|Protocol Violation|0
427334|NCT00530946|1425916|P1|Overall Study|Protocol Violation|0
427335|NCT00530946|1425913|P4|Overall Study|Adverse Event|1
427336|NCT00530946|1425914|P3|Overall Study|Adverse Event|1
427337|NCT00530946|1425915|P2|Overall Study|Adverse Event|2
427338|NCT00530946|1425916|P1|Overall Study|Adverse Event|1
427339|NCT00530920|1425969|P3|Overall Study|Withdrawal by Subject|1
427340|NCT00530920|1425970|P2|Overall Study|Withdrawal by Subject|0
427341|NCT00530920|1425971|P1|Overall Study|Withdrawal by Subject|0
427342|NCT00530920|1425969|P3|Overall Study|Adverse Event|3
427343|NCT00530920|1425970|P2|Overall Study|Adverse Event|0
427344|NCT00530920|1425971|P1|Overall Study|Adverse Event|0
427345|NCT00530920|1425969|P3|Overall Study|Randomized but not treated|0
427346|NCT00530920|1425970|P2|Overall Study|Randomized but not treated|2
427347|NCT00530920|1425971|P1|Overall Study|Randomized but not treated|0
427348|NCT00530894|1426031|P4|Overall Study|Alive and censored prior to 1 year|0
427349|NCT00530894|1426032|P3|Overall Study|Alive and censored prior to 1 year|0
427350|NCT00530894|1426033|P2|Overall Study|Alive and censored prior to 1 year|0
427351|NCT00530894|1426034|P1|Overall Study|Alive and censored prior to 1 year|2
427352|NCT00530894|1426031|P4|Overall Study|Withdrawal by Subject|5
427353|NCT00530894|1426032|P3|Overall Study|Withdrawal by Subject|0
427354|NCT00530894|1426033|P2|Overall Study|Withdrawal by Subject|23
427355|NCT00530894|1426034|P1|Overall Study|Withdrawal by Subject|1
427356|NCT00530894|1426031|P4|Overall Study|Lost to Follow-up|0
427357|NCT00530894|1426032|P3|Overall Study|Lost to Follow-up|0
427358|NCT00530894|1426033|P2|Overall Study|Lost to Follow-up|3
427359|NCT00530894|1426034|P1|Overall Study|Lost to Follow-up|1
427360|NCT00530894|1426031|P4|Overall Study|Death|89
427361|NCT00530894|1426032|P3|Overall Study|Death|55
427362|NCT00530894|1426033|P2|Overall Study|Death|89
427363|NCT00530894|1426034|P1|Overall Study|Death|84
427364|NCT00530855|1426062|P1|Overall Study|Other reason for premature termination|17
427365|NCT00530855|1426062|P1|Overall Study|Lost to Follow-up|9
427366|NCT00530855|1426062|P1|Overall Study|Unsatisfactory compliance of subject|11
427367|NCT00530855|1426062|P1|Overall Study|Protocol Violation|3
427368|NCT00530855|1426062|P1|Overall Study|Non Fatal Non Serious AE|12
427369|NCT00530855|1426062|P1|Overall Study|Non Fatal Serious AE|7
427370|NCT00530855|1426062|P1|Overall Study|Fatal Serious AE|3
427371|NCT00530855|1426062|P1|Overall Study|Withdrawal by Subject|30
427372|NCT00530855|1426062|P1|Overall Study|Lack of Efficacy|20
427373|NCT00530842|1426071|P2|Period 2|Individual different reasons|0
427374|NCT00530842|1426072|P1|Period 2|Individual different reasons|2
427375|NCT00530842|1426071|P2|Period 2|Withdrawal by Subject|2
427376|NCT00530842|1426072|P1|Period 2|Withdrawal by Subject|1
427377|NCT00530842|1426071|P2|Period 2|Protocol Violation|0
427378|NCT00530842|1426072|P1|Period 2|Protocol Violation|1
427379|NCT00530842|1426071|P2|Period 2|Lost to Follow-up|4
427380|NCT00530842|1426072|P1|Period 2|Lost to Follow-up|0
427381|NCT00530842|1426071|P2|Period 2|Lack of Efficacy|0
427382|NCT00530842|1426072|P1|Period 2|Lack of Efficacy|1
427383|NCT00530842|1426071|P2|Period 2|Adverse Event|3
427384|NCT00530842|1426072|P1|Period 2|Adverse Event|3
427385|NCT00530842|1426071|P2|Period 1|Individual different reasons|3
427386|NCT00530842|1426072|P1|Period 1|Individual different reasons|2
427387|NCT00530842|1426071|P2|Period 1|Withdrawal by Subject|3
427388|NCT00530842|1426072|P1|Period 1|Withdrawal by Subject|2
427389|NCT00530842|1426071|P2|Period 1|Protocol Violation|1
427390|NCT00530842|1426072|P1|Period 1|Protocol Violation|2
427391|NCT00530842|1426071|P2|Period 1|Lack of Efficacy|1
427392|NCT00530842|1426072|P1|Period 1|Lack of Efficacy|1
427393|NCT00530842|1426071|P2|Period 1|Adverse Event|3
427394|NCT00530842|1426072|P1|Period 1|Adverse Event|7
427395|NCT00530842|1426071|P2|Overall Study|Individual different reasons|3
427396|NCT00530842|1426072|P1|Overall Study|Individual different reasons|4
427397|NCT00530842|1426071|P2|Overall Study|Withdrawal by Subject|5
427398|NCT00530842|1426072|P1|Overall Study|Withdrawal by Subject|4
427399|NCT00530842|1426071|P2|Overall Study|Protocol Violation|2
427400|NCT00530842|1426072|P1|Overall Study|Protocol Violation|3
427401|NCT00530842|1426071|P2|Overall Study|Lost to Follow-up|4
427402|NCT00530842|1426072|P1|Overall Study|Lost to Follow-up|0
427403|NCT00530842|1426071|P2|Overall Study|Lack of Efficacy|1
427404|NCT00530842|1426072|P1|Overall Study|Lack of Efficacy|2
427405|NCT00530842|1426071|P2|Overall Study|Adverse Event|6
427406|NCT00530842|1426072|P1|Overall Study|Adverse Event|10
427407|NCT00530816|1426199|P3|Overall Study|Withdrawal by Subject|6
427408|NCT00530816|1426200|P2|Overall Study|Withdrawal by Subject|2
427409|NCT00530816|1426201|P1|Overall Study|Withdrawal by Subject|1
427410|NCT00530816|1426199|P3|Overall Study|Other|4
427411|NCT00530816|1426200|P2|Overall Study|Other|3
427412|NCT00530816|1426201|P1|Overall Study|Other|3
427413|NCT00530816|1426199|P3|Overall Study|Adverse Event|7
427414|NCT00530816|1426200|P2|Overall Study|Adverse Event|13
427415|NCT00530816|1426201|P1|Overall Study|Adverse Event|6
427416|NCT00530816|1426199|P3|Overall Study|Progressive Disease|24
427417|NCT00530816|1426200|P2|Overall Study|Progressive Disease|24
427418|NCT00530816|1426201|P1|Overall Study|Progressive Disease|16
427419|NCT00530790|1426227|P1|Overall Study|Physician Decision|1
427420|NCT00530790|1426227|P1|Overall Study|Withdrawal by Subject|2
427421|NCT00530790|1426227|P1|Overall Study|Adverse Event|2
427422|NCT00530777|1426249|P2|Overall Study|Unable to adhere to visit schedule|1
427423|NCT00530777|1426250|P1|Overall Study|Unable to adhere to visit schedule|5
427424|NCT00530777|1426249|P2|Overall Study|Withdrawal by Subject|1
427425|NCT00530777|1426250|P1|Overall Study|Withdrawal by Subject|0
427426|NCT00530777|1426249|P2|Overall Study|Physician Decision|0
427427|NCT00530777|1426250|P1|Overall Study|Physician Decision|1
427428|NCT00530777|1426249|P2|Overall Study|Death|2
427429|NCT00530777|1426250|P1|Overall Study|Death|1
427430|NCT00530777|1426249|P2|Overall Study|Lost to Follow-up|1
427431|NCT00530777|1426250|P1|Overall Study|Lost to Follow-up|0
427432|NCT00530712|1426307|P1|12 Month Follow-up Visit|Death|9
427433|NCT00530712|1426307|P1|12 Month Follow-up Visit|Lost to Follow-up|7
427434|NCT00530712|1426307|P1|12 Month Follow-up Visit|Missed Visit|3
427435|NCT00530712|1426307|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
427436|NCT00530712|1426307|P1|6 Month Follow-up Visit|Death|2
427437|NCT00530712|1426307|P1|6 Month Follow-up Visit|Lost to Follow-up|3
427438|NCT00530712|1426307|P1|6 Month Follow-up Visit|Missed Visit|3
427439|NCT00530712|1426307|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
427440|NCT00530712|1426307|P1|30 Day Follow-up Visit|Missed Visit|5
427441|NCT00530712|1426307|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
427442|NCT00530504|1426326|P1|Overall Study|Exited study due to other reasons|33
427443|NCT00530504|1426326|P1|Overall Study|Withdrawal by Subject|39
427444|NCT00530504|1426326|P1|Overall Study|Lost to Follow-up|26
427445|NCT00530504|1426326|P1|Overall Study|Death|54
427446|NCT00530439|1426332|P2|Overall Study|Severe malformation/abortion|3
427447|NCT00530439|1426333|P1|Overall Study|Severe malformation/abortion|0
427448|NCT00530439|1426332|P2|Overall Study|Twin pregnancy|2
427449|NCT00530439|1426333|P1|Overall Study|Twin pregnancy|0
427450|NCT00530439|1426332|P2|Overall Study|Misclassification|0
427451|NCT00530439|1426333|P1|Overall Study|Misclassification|2
427452|NCT00530439|1426332|P2|Overall Study|Missed abortion|4
427453|NCT00530439|1426333|P1|Overall Study|Missed abortion|1
427454|NCT00530439|1426332|P2|Overall Study|Withdraw|14
427455|NCT00530439|1426333|P1|Overall Study|Withdraw|18
427456|NCT00530439|1426332|P2|Overall Study|GDM|3
427457|NCT00530439|1426333|P1|Overall Study|GDM|9
427458|NCT00530348|1426341|P2|Overall Study|Noncompliance with inclusion criterion 3|1
427459|NCT00530348|1426342|P1|Overall Study|Noncompliance with inclusion criterion 3|0
427460|NCT00530348|1426341|P2|Overall Study|Randomised in error|0
427461|NCT00530348|1426342|P1|Overall Study|Randomised in error|1
427462|NCT00530348|1426341|P2|Overall Study|Withdrawal by Subject|12
427463|NCT00530348|1426342|P1|Overall Study|Withdrawal by Subject|12
427464|NCT00530348|1426341|P2|Overall Study|Pregnancy|0
427465|NCT00530348|1426342|P1|Overall Study|Pregnancy|1
427466|NCT00530348|1426341|P2|Overall Study|Physician Decision|2
427467|NCT00530348|1426342|P1|Overall Study|Physician Decision|1
427468|NCT00530348|1426341|P2|Overall Study|Lost to Follow-up|2
427469|NCT00530348|1426342|P1|Overall Study|Lost to Follow-up|0
427470|NCT00530348|1426341|P2|Overall Study|Lack of Efficacy|0
427471|NCT00530348|1426342|P1|Overall Study|Lack of Efficacy|2
427472|NCT00530348|1426341|P2|Overall Study|Death|1
427473|NCT00530348|1426342|P1|Overall Study|Death|0
427474|NCT00530348|1426341|P2|Overall Study|Adverse Event|1
427475|NCT00530348|1426342|P1|Overall Study|Adverse Event|5
427476|NCT00530335|1426358|P1|Overall Study|Physician Decision|1
427477|NCT00530335|1426358|P1|Overall Study|Withdrawal by Subject|1
427478|NCT00530335|1426358|P1|Overall Study|Protocol Violation|1
427479|NCT00530335|1426358|P1|Overall Study|Adverse Event|3
427480|NCT00530270|1426375|P2|Overall Study|Protocol Violation|0
427481|NCT00530270|1426376|P1|Overall Study|Protocol Violation|1
427482|NCT00530257|1426390|P1|Overall Study|Lost to Follow-up|1
427483|NCT00530218|1426418|P1|Overall Study|Death|12
427484|NCT00530218|1426418|P1|Overall Study|CMV Not Detected|13
427485|NCT00530088|1426425|P1|Overall Study|Other Not Specified|2
427486|NCT00530088|1426425|P1|Overall Study|Physician Decision|4
427487|NCT00530088|1426425|P1|Overall Study|Disease Progression|4
427488|NCT00530075|1426430|P1|Overall Study|Withdrawal by Subject|1
427489|NCT00530075|1426430|P1|Overall Study|Protocol Violation|1
427490|NCT00530075|1426430|P1|Overall Study|Lack of Efficacy|3
427491|NCT00530075|1426430|P1|Overall Study|Death|1
427492|NCT00530075|1426430|P1|Overall Study|Adverse Event|1
427493|NCT00530023|1426443|P2|Overall Study|Withdrawal by Subject|1
427494|NCT00530023|1426444|P1|Overall Study|Withdrawal by Subject|0
427495|NCT00529802|1426458|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
427496|NCT00529802|1426458|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
427497|NCT00529802|1426458|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
427498|NCT00529802|1426458|P1|Evaluable for Primary Endpoint|Death|1
427499|NCT00529802|1426458|P1|Evaluable for Primary Endpoint|Adverse Event|2
427500|NCT00529802|1426458|P1|Evaluable for Primary Endpoint|Worsening performance status|2
427501|NCT00529802|1426458|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
427502|NCT00529789|1426464|P1|Study Period IV|Lost to Follow-up|3
427503|NCT00529789|1426464|P1|Study Period IV|Lack of Efficacy|1
427504|NCT00529789|1426464|P1|Study Period IV|Adverse Event|1
427505|NCT00529789|1426464|P1|Study Period IV|Parent/Caregiver Decision|1
427506|NCT00529789|1426464|P1|Study Period II/III|Lost to Follow-up|3
427507|NCT00529789|1426464|P1|Study Period II/III|Physician Decision|3
427508|NCT00529789|1426464|P1|Study Period II/III|Protocol Violation|3
427509|NCT00529789|1426464|P1|Study Period II/III|Withdrawal by Subject|1
427510|NCT00529789|1426464|P1|Study Period II/III|Lack of Efficacy|2
427511|NCT00529789|1426464|P1|Study Period II/III|Adverse Event|3
427512|NCT00529789|1426464|P1|Study Period II/III|Parent/Caregiver Decision|9
427513|NCT00529763|1426489|P3|Overall Study|Patient Withdrew Consent|2
427514|NCT00529763|1426490|P2|Overall Study|Patient Withdrew Consent|3
427515|NCT00529763|1426491|P1|Overall Study|Patient Withdrew Consent|2
427516|NCT00529763|1426489|P3|Overall Study|Study Drug Toxicity|1
427517|NCT00529763|1426490|P2|Overall Study|Study Drug Toxicity|6
427518|NCT00529763|1426491|P1|Overall Study|Study Drug Toxicity|1
427519|NCT00529763|1426489|P3|Overall Study|Stem Cell Transplant|0
427520|NCT00529763|1426490|P2|Overall Study|Stem Cell Transplant|3
427521|NCT00529763|1426491|P1|Overall Study|Stem Cell Transplant|0
427522|NCT00529763|1426489|P3|Overall Study|Lost to Follow-up|1
427523|NCT00529763|1426490|P2|Overall Study|Lost to Follow-up|1
427524|NCT00529763|1426491|P1|Overall Study|Lost to Follow-up|0
427525|NCT00529763|1426489|P3|Overall Study|Disease Progression|1
427526|NCT00529763|1426490|P2|Overall Study|Disease Progression|16
427527|NCT00529763|1426491|P1|Overall Study|Disease Progression|6
427528|NCT00529763|1426489|P3|Overall Study|Death|1
427529|NCT00529763|1426490|P2|Overall Study|Death|1
427530|NCT00529763|1426491|P1|Overall Study|Death|0
427531|NCT00529763|1426489|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
427532|NCT00529763|1426490|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
427533|NCT00529763|1426491|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
427534|NCT00529659|1426529|P2|Overall Study|Withdrawal by Subject|6
427535|NCT00529659|1426530|P1|Overall Study|Withdrawal by Subject|1
427536|NCT00529659|1426529|P2|Overall Study|Protocol Violation|6
427537|NCT00529659|1426530|P1|Overall Study|Protocol Violation|2
427538|NCT00529659|1426529|P2|Overall Study|Physician Decision|2
427539|NCT00529659|1426530|P1|Overall Study|Physician Decision|0
427540|NCT00529659|1426529|P2|Overall Study|Lost to Follow-up|2
427541|NCT00529659|1426530|P1|Overall Study|Lost to Follow-up|0
427542|NCT00529659|1426529|P2|Overall Study|Adverse Event|7
427543|NCT00529659|1426530|P1|Overall Study|Adverse Event|8
427544|NCT00529633|1426548|P2|Overall Study|Withdrawal by Subject|1
427545|NCT00529633|1426549|P1|Overall Study|Withdrawal by Subject|1
427546|NCT00529568|1426561|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
427547|NCT00529568|1426562|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
427548|NCT00529568|1426563|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
427549|NCT00529568|1426561|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
427550|NCT00529568|1426562|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
427551|NCT00529568|1426563|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
427552|NCT00529568|1426561|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
427553|NCT00529568|1426562|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
427554|NCT00529568|1426563|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
427555|NCT00529568|1426561|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
427556|NCT00529568|1426562|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
427557|NCT00529568|1426563|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
427558|NCT00529568|1426561|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
427559|NCT00529568|1426562|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
427560|NCT00529568|1426563|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
427561|NCT00529568|1426561|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
427562|NCT00529568|1426562|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
427563|NCT00529568|1426563|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
427564|NCT00529568|1426561|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
427565|NCT00529568|1426562|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
427566|NCT00529568|1426563|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
427567|NCT00529568|1426561|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
427568|NCT00529568|1426562|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
427569|NCT00529568|1426563|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
427570|NCT00529568|1426561|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
427571|NCT00529568|1426562|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
427572|NCT00529568|1426563|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
427573|NCT00529568|1426561|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
427574|NCT00529568|1426562|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
427575|NCT00529568|1426563|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
427576|NCT00529568|1426561|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
427577|NCT00529568|1426562|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
427578|NCT00529568|1426563|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
427579|NCT00529542|1426626|P2|Overall Study|Lost to Follow-up|1
427580|NCT00529542|1426627|P1|Overall Study|Lost to Follow-up|0
427581|NCT00529542|1426626|P2|Overall Study|Withdrawal by Subject|0
427582|NCT00529542|1426627|P1|Overall Study|Withdrawal by Subject|1
427583|NCT00529529|1426670|P3|Overall Study|Administrative problems|3
427584|NCT00529529|1426671|P2|Overall Study|Administrative problems|0
427585|NCT00529529|1426672|P1|Overall Study|Administrative problems|1
427586|NCT00529529|1426670|P3|Overall Study|Abnormal test procedure result(s)|0
427587|NCT00529529|1426671|P2|Overall Study|Abnormal test procedure result(s)|0
427588|NCT00529529|1426672|P1|Overall Study|Abnormal test procedure result(s)|1
427589|NCT00529529|1426670|P3|Overall Study|Death|0
427590|NCT00529529|1426671|P2|Overall Study|Death|0
427591|NCT00529529|1426672|P1|Overall Study|Death|2
427592|NCT00529529|1426670|P3|Overall Study|Unsatisfactory therapeutic effect|2
427593|NCT00529529|1426671|P2|Overall Study|Unsatisfactory therapeutic effect|2
427594|NCT00529529|1426672|P1|Overall Study|Unsatisfactory therapeutic effect|2
427595|NCT00529529|1426670|P3|Overall Study|Lost to Follow-up|1
427596|NCT00529529|1426671|P2|Overall Study|Lost to Follow-up|3
427597|NCT00529529|1426672|P1|Overall Study|Lost to Follow-up|5
427598|NCT00529529|1426670|P3|Overall Study|Protocol deviation|5
427599|NCT00529529|1426671|P2|Overall Study|Protocol deviation|12
427600|NCT00529529|1426672|P1|Overall Study|Protocol deviation|8
427601|NCT00529529|1426670|P3|Overall Study|Subject withdrew consent|12
427602|NCT00529529|1426671|P2|Overall Study|Subject withdrew consent|9
427603|NCT00529529|1426672|P1|Overall Study|Subject withdrew consent|12
427604|NCT00529529|1426670|P3|Overall Study|Adverse Event|8
427605|NCT00529529|1426671|P2|Overall Study|Adverse Event|17
427606|NCT00529529|1426672|P1|Overall Study|Adverse Event|12
427607|NCT00529516|1426731|P3|Overall Study|Lost to Follow-up|1
427608|NCT00529516|1426732|P2|Overall Study|Lost to Follow-up|0
427609|NCT00529516|1426733|P1|Overall Study|Lost to Follow-up|0
427610|NCT00529516|1426731|P3|Overall Study|Withdrawal by Subject|0
427611|NCT00529516|1426732|P2|Overall Study|Withdrawal by Subject|1
427612|NCT00529516|1426733|P1|Overall Study|Withdrawal by Subject|1
427613|NCT00529516|1426731|P3|Overall Study|Adverse Event|0
427614|NCT00529516|1426732|P2|Overall Study|Adverse Event|1
427615|NCT00529516|1426733|P1|Overall Study|Adverse Event|2
427616|NCT00529451|1426818|P4|Overall Study|Administrative problems|2
427617|NCT00529451|1426819|P3|Overall Study|Administrative problems|0
427618|NCT00529451|1426820|P2|Overall Study|Administrative problems|1
427619|NCT00529451|1426821|P1|Overall Study|Administrative problems|1
427620|NCT00529451|1426818|P4|Overall Study|Protocol deviation|1
427621|NCT00529451|1426819|P3|Overall Study|Protocol deviation|4
427622|NCT00529451|1426820|P2|Overall Study|Protocol deviation|1
427623|NCT00529451|1426821|P1|Overall Study|Protocol deviation|1
427624|NCT00529451|1426818|P4|Overall Study|Lost to Follow-up|4
427625|NCT00529451|1426819|P3|Overall Study|Lost to Follow-up|4
427626|NCT00529451|1426820|P2|Overall Study|Lost to Follow-up|7
427627|NCT00529451|1426821|P1|Overall Study|Lost to Follow-up|4
427628|NCT00529451|1426818|P4|Overall Study|Unsatisfactory therapeutic response|4
427629|NCT00529451|1426819|P3|Overall Study|Unsatisfactory therapeutic response|5
427630|NCT00529451|1426820|P2|Overall Study|Unsatisfactory therapeutic response|2
427631|NCT00529451|1426821|P1|Overall Study|Unsatisfactory therapeutic response|6
427632|NCT00529451|1426818|P4|Overall Study|Adverse Event|8
427633|NCT00529451|1426819|P3|Overall Study|Adverse Event|14
427634|NCT00529451|1426820|P2|Overall Study|Adverse Event|16
427635|NCT00529451|1426821|P1|Overall Study|Adverse Event|9
427636|NCT00529451|1426818|P4|Overall Study|Subject withdrew consent|12
427637|NCT00529451|1426819|P3|Overall Study|Subject withdrew consent|13
427638|NCT00529451|1426820|P2|Overall Study|Subject withdrew consent|21
427639|NCT00529451|1426821|P1|Overall Study|Subject withdrew consent|16
427640|NCT00529399|1426848|P3|Overall Study|Non-compliant|0
427641|NCT00529399|1426849|P2|Overall Study|Non-compliant|1
427642|NCT00529399|1426850|P1|Overall Study|Non-compliant|0
427643|NCT00529399|1426848|P3|Overall Study|Withdrawal by Subject|1
427644|NCT00529399|1426849|P2|Overall Study|Withdrawal by Subject|0
427645|NCT00529399|1426850|P1|Overall Study|Withdrawal by Subject|1
427646|NCT00529399|1426848|P3|Overall Study|Lost to Follow-up|1
427647|NCT00529399|1426849|P2|Overall Study|Lost to Follow-up|0
427648|NCT00529399|1426850|P1|Overall Study|Lost to Follow-up|1
427649|NCT00529308|1426860|P2|Overall Study|Withdrawal by Subject|1
427650|NCT00529308|1426861|P1|Overall Study|Withdrawal by Subject|1
427651|NCT00529243|1426890|P1|Overall Study|Relocated|1
427652|NCT00529243|1426890|P1|Overall Study|Death|1
427653|NCT00529243|1426890|P1|Overall Study|Adverse Event|1
427654|NCT00529217|1426895|P1|Overall Study|Unable to adhere to study schedule|2
427655|NCT00529217|1426895|P1|Overall Study|Lack of Efficacy|2
427656|NCT00529152|1426931|P1|Overall Study|Lost to Follow-up|1
427657|NCT00529152|1426931|P1|Overall Study|Withdrawal by Subject|2
427658|NCT00529152|1426931|P1|Overall Study|Adverse Event|2
427659|NCT00529100|1426955|P2|Overall Study|Participant Ineligibility|1
427660|NCT00529100|1426956|P1|Overall Study|Participant Ineligibility|0
427661|NCT00529100|1426955|P2|Overall Study|Withdrawal by Subject|1
427662|NCT00529100|1426956|P1|Overall Study|Withdrawal by Subject|0
427663|NCT00529100|1426955|P2|Overall Study|Progressive Disease|1
427664|NCT00529100|1426956|P1|Overall Study|Progressive Disease|0
427665|NCT00529100|1426955|P2|Overall Study|Protocol Violation|1
427666|NCT00529100|1426956|P1|Overall Study|Protocol Violation|0
427667|NCT00529100|1426955|P2|Overall Study|Adverse Event|5
427668|NCT00529100|1426956|P1|Overall Study|Adverse Event|0
427669|NCT00529087|1426973|P3|Overall Study|Protocol deviation|2
427670|NCT00529087|1426974|P2|Overall Study|Protocol deviation|1
427671|NCT00529087|1426975|P1|Overall Study|Protocol deviation|1
427672|NCT00529087|1426973|P3|Overall Study|Withdrawal by Subject|3
427673|NCT00529087|1426974|P2|Overall Study|Withdrawal by Subject|3
427674|NCT00529087|1426975|P1|Overall Study|Withdrawal by Subject|3
427675|NCT00529087|1426973|P3|Overall Study|Protocol Violation|6
427676|NCT00529087|1426974|P2|Overall Study|Protocol Violation|7
427677|NCT00529087|1426975|P1|Overall Study|Protocol Violation|8
427678|NCT00529087|1426973|P3|Overall Study|Lost to Follow-up|1
427679|NCT00529087|1426974|P2|Overall Study|Lost to Follow-up|4
427680|NCT00529087|1426975|P1|Overall Study|Lost to Follow-up|6
427681|NCT00529087|1426973|P3|Overall Study|Adverse Event|4
427682|NCT00529087|1426974|P2|Overall Study|Adverse Event|13
427683|NCT00529087|1426975|P1|Overall Study|Adverse Event|10
427684|NCT00529035|1427039|P1|Overall Study|Withdrawal by Subject|1
427685|NCT00528957|1427052|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
427686|NCT00528957|1427053|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
427687|NCT00528957|1427052|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
427688|NCT00528957|1427053|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
427689|NCT00528957|1427052|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
427690|NCT00528957|1427053|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
427691|NCT00528957|1427052|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
427692|NCT00528957|1427053|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
427693|NCT00528957|1427052|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
427694|NCT00528957|1427053|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
427695|NCT00528957|1427052|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
427696|NCT00528957|1427053|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
427697|NCT00528957|1427052|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
427698|NCT00528957|1427053|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
427699|NCT00528957|1427052|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
427700|NCT00528957|1427053|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
427701|NCT00528957|1427052|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
427702|NCT00528957|1427053|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
427703|NCT00528957|1427052|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
427704|NCT00528957|1427053|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
427705|NCT00528957|1427052|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
427706|NCT00528957|1427053|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
427707|NCT00528957|1427052|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
427708|NCT00528957|1427053|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
427709|NCT00528957|1427052|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
427710|NCT00528957|1427053|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
427711|NCT00528957|1427052|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
427712|NCT00528957|1427053|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
427713|NCT00528957|1427052|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
427714|NCT00528957|1427053|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
427715|NCT00528957|1427052|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
427716|NCT00528957|1427053|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
427717|NCT00528931|1427194|P1|Overall Study|Lost to Follow-up|1
427718|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
427719|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
427720|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
427721|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
427722|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
427723|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
427724|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
427725|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
427726|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
427727|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
427728|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
427729|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
427730|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
427731|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
427732|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
427733|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
427734|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|Death|0
427735|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|Death|0
427736|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|Death|1
427737|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|Death|0
427738|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
427739|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
427740|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
427741|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
427742|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
427743|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
427744|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
427745|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
427746|NCT00528879|1427206|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
427747|NCT00528879|1427207|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
427748|NCT00528879|1427208|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
427749|NCT00528879|1427209|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
427750|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
427751|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
427752|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
427753|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
427754|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
427755|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
427756|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
427757|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
427758|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
427759|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
427760|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
427761|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
427762|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
427763|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
427764|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
427765|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
427766|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
427767|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
427768|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
427769|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
427770|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
427771|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
427772|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
427773|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
427774|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
427775|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
427776|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
427777|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
427778|NCT00528879|1427206|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
427779|NCT00528879|1427207|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
427780|NCT00528879|1427208|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
427781|NCT00528879|1427209|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
427782|NCT00528866|1427275|P1|Overall Study|Protocol Violation|6
427783|NCT00528840|1427287|P1|Overall Study|Not Specified|2
427784|NCT00528840|1427287|P1|Overall Study|Administrative Reasons|1
427785|NCT00528840|1427287|P1|Overall Study|Death|2
427786|NCT00528840|1427287|P1|Overall Study|Withdrawal by Subject|17
427787|NCT00528840|1427287|P1|Overall Study|Adverse Event|1
427788|NCT00528840|1427287|P1|Overall Study|Lost to Follow-up|10
427789|NCT00528801|1427301|P2|Overall Study|Administrative Reasons|1
427790|NCT00528801|1427302|P1|Overall Study|Administrative Reasons|0
427791|NCT00528801|1427301|P2|Overall Study|Lost to Follow-up|4
427792|NCT00528801|1427302|P1|Overall Study|Lost to Follow-up|15
427793|NCT00528801|1427301|P2|Overall Study|Protocol Violation|5
427794|NCT00528801|1427302|P1|Overall Study|Protocol Violation|11
427795|NCT00528801|1427301|P2|Overall Study|Withdrawal by Subject|1
427796|NCT00528801|1427302|P1|Overall Study|Withdrawal by Subject|1
427797|NCT00528775|1427316|P1|Overall Study|Other not specified|1
427798|NCT00528645|1427324|P1|Overall Study|Adverse Event|3
427799|NCT00528606|1427333|P2|Overall Study|Not specified|0
427800|NCT00528606|1427334|P1|Overall Study|Not specified|2
427801|NCT00528606|1427333|P2|Overall Study|Adverse Event|0
427802|NCT00528606|1427334|P1|Overall Study|Adverse Event|3
427803|NCT00528606|1427333|P2|Overall Study|Lost to Follow-up|1
427804|NCT00528606|1427334|P1|Overall Study|Lost to Follow-up|4
427805|NCT00528606|1427333|P2|Overall Study|Withdrew consent|3
427806|NCT00528606|1427334|P1|Overall Study|Withdrew consent|4
427807|NCT00528567|1427367|P2|Overall Study|Administrative/Other|75
427808|NCT00528567|1427368|P1|Overall Study|Administrative/Other|22
427809|NCT00528567|1427367|P2|Overall Study|Other Protocol Violation|21
427810|NCT00528567|1427368|P1|Overall Study|Other Protocol Violation|5
427811|NCT00528567|1427367|P2|Overall Study|Failure to Return|4
427812|NCT00528567|1427368|P1|Overall Study|Failure to Return|1
427813|NCT00528567|1427367|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
427814|NCT00528567|1427368|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
427815|NCT00528567|1427367|P2|Overall Study|Withdrew Consent|55
427816|NCT00528567|1427368|P1|Overall Study|Withdrew Consent|59
427817|NCT00528567|1427367|P2|Overall Study|Violation Criteria at Entry|17
427818|NCT00528567|1427368|P1|Overall Study|Violation Criteria at Entry|3
427819|NCT00528567|1427367|P2|Overall Study|Adverse Event/Intermittent Illness|29
427820|NCT00528567|1427368|P1|Overall Study|Adverse Event/Intermittent Illness|255
427821|NCT00528567|1427367|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
427822|NCT00528567|1427368|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
427823|NCT00528567|1427367|P2|Overall Study|Death|5
427824|NCT00528567|1427368|P1|Overall Study|Death|4
427825|NCT00528528|1427435|P4|Overall Study|Ongoing participant|0
427826|NCT00528528|1427436|P3|Overall Study|Ongoing participant|1
427827|NCT00528528|1427437|P2|Overall Study|Ongoing participant|0
427828|NCT00528528|1427438|P1|Overall Study|Ongoing participant|0
427829|NCT00528528|1427435|P4|Overall Study|Withdrawal by Subject|1
427830|NCT00528528|1427436|P3|Overall Study|Withdrawal by Subject|1
427831|NCT00528528|1427437|P2|Overall Study|Withdrawal by Subject|2
427832|NCT00528528|1427438|P1|Overall Study|Withdrawal by Subject|3
427833|NCT00528528|1427435|P4|Overall Study|Other|0
427834|NCT00528528|1427436|P3|Overall Study|Other|0
427835|NCT00528528|1427437|P2|Overall Study|Other|1
427836|NCT00528528|1427438|P1|Overall Study|Other|0
427837|NCT00528528|1427435|P4|Overall Study|Ineligible to continue the trial|1
427838|NCT00528528|1427436|P3|Overall Study|Ineligible to continue the trial|0
427839|NCT00528528|1427437|P2|Overall Study|Ineligible to continue the trial|0
427840|NCT00528528|1427438|P1|Overall Study|Ineligible to continue the trial|0
427841|NCT00528528|1427435|P4|Overall Study|Lost to Follow-up|1
427842|NCT00528528|1427436|P3|Overall Study|Lost to Follow-up|1
427843|NCT00528528|1427437|P2|Overall Study|Lost to Follow-up|0
427844|NCT00528528|1427438|P1|Overall Study|Lost to Follow-up|0
427845|NCT00528424|1427476|P1|Overall Study|Not specified|12
427846|NCT00528424|1427476|P1|Overall Study|Administrative reason|2
427847|NCT00528424|1427476|P1|Overall Study|Withdrew consent|2
427848|NCT00528424|1427476|P1|Overall Study|Lost to Follow-up|13
427849|NCT00528411|1427491|P3|Overall Study|Prior commitment medication|0
427850|NCT00528411|1427492|P2|Overall Study|Prior commitment medication|1
427851|NCT00528411|1427493|P1|Overall Study|Prior commitment medication|0
427852|NCT00528411|1427491|P3|Overall Study|Severe non-compliance to protocol|0
427853|NCT00528411|1427492|P2|Overall Study|Severe non-compliance to protocol|1
427854|NCT00528411|1427493|P1|Overall Study|Severe non-compliance to protocol|0
427855|NCT00528411|1427491|P3|Overall Study|Incorrect Enrolment|0
427856|NCT00528411|1427492|P2|Overall Study|Incorrect Enrolment|1
427857|NCT00528411|1427493|P1|Overall Study|Incorrect Enrolment|1
427858|NCT00528411|1427491|P3|Overall Study|Adverse Event|1
427859|NCT00528411|1427492|P2|Overall Study|Adverse Event|0
427860|NCT00528411|1427493|P1|Overall Study|Adverse Event|4
427861|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
427862|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
427863|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
427864|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
427865|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
427866|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
427867|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
427868|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
427869|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
427870|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
427871|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
427872|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
427873|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
427874|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
427875|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
427876|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
427877|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
427878|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
427879|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
427880|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
427881|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
427882|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
427883|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
427884|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
427885|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
427886|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
427887|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
427888|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
427889|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
427890|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
427891|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
427892|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
427893|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
427894|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
427895|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
427896|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
427897|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
427898|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
427899|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
427900|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
427901|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
427902|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
427903|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
427904|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
427905|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
427906|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
427907|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
427908|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
427909|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
427910|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
427911|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
427912|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
427913|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
427914|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
427915|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
427916|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
427917|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
427918|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
427919|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
427920|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
427921|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
427922|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
427923|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
427924|NCT00528372|1427630|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
427925|NCT00528372|1427631|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
427926|NCT00528372|1427632|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
427927|NCT00528372|1427633|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
427928|NCT00528372|1427634|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
427929|NCT00528372|1427635|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
427930|NCT00528372|1427636|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
427931|NCT00528372|1427637|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
427932|NCT00528372|1427638|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
427933|NCT00528372|1427630|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
427934|NCT00528372|1427631|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
427935|NCT00528372|1427632|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
427936|NCT00528372|1427633|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
427937|NCT00528372|1427634|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
427938|NCT00528372|1427635|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
427939|NCT00528372|1427636|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
427940|NCT00528372|1427637|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
427941|NCT00528372|1427638|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
427942|NCT00528372|1427630|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
427943|NCT00528372|1427631|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
427944|NCT00528372|1427632|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
427945|NCT00528372|1427633|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
427946|NCT00528372|1427634|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
427947|NCT00528372|1427635|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
427948|NCT00528372|1427636|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
427949|NCT00528372|1427637|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
427950|NCT00528372|1427638|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
427951|NCT00528372|1427630|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
427952|NCT00528372|1427631|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
428030|NCT00527904|1427886|P1|Overall Study|misc|22
427953|NCT00528372|1427632|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
427954|NCT00528372|1427633|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
427955|NCT00528372|1427634|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
427956|NCT00528372|1427635|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
427957|NCT00528372|1427636|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
427958|NCT00528372|1427637|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
427959|NCT00528372|1427638|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
427960|NCT00528372|1427630|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
427961|NCT00528372|1427631|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
427962|NCT00528372|1427632|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
427963|NCT00528372|1427633|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
427964|NCT00528372|1427634|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
427965|NCT00528372|1427635|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
427966|NCT00528372|1427636|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
427967|NCT00528372|1427637|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
427968|NCT00528372|1427638|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
427969|NCT00528372|1427630|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
427970|NCT00528372|1427631|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
427971|NCT00528372|1427632|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
427972|NCT00528372|1427633|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
427973|NCT00528372|1427634|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
427974|NCT00528372|1427635|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
427975|NCT00528372|1427636|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
427976|NCT00528372|1427637|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
427977|NCT00528372|1427638|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
427978|NCT00528372|1427630|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
427979|NCT00528372|1427631|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
427980|NCT00528372|1427632|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
427981|NCT00528372|1427633|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
427982|NCT00528372|1427634|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
427983|NCT00528372|1427635|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
427984|NCT00528372|1427636|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
427985|NCT00528372|1427637|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
427986|NCT00528372|1427638|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
427987|NCT00528372|1427630|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427988|NCT00528372|1427631|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427989|NCT00528372|1427632|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427990|NCT00528372|1427633|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427991|NCT00528372|1427634|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427992|NCT00528372|1427635|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427993|NCT00528372|1427636|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427994|NCT00528372|1427637|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
427995|NCT00528372|1427638|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
427996|NCT00528112|1427770|P2|Extension Phase|Protocol Violation|2
427997|NCT00528112|1427771|P1|Extension Phase|Protocol Violation|0
427998|NCT00528112|1427770|P2|Extension Phase|Adverse Event|36
427999|NCT00528112|1427771|P1|Extension Phase|Adverse Event|0
428000|NCT00528112|1427770|P2|Extension Phase|Death|1
428001|NCT00528112|1427771|P1|Extension Phase|Death|0
428002|NCT00528112|1427770|P2|Extension Phase|Lost to Follow-up|12
428003|NCT00528112|1427771|P1|Extension Phase|Lost to Follow-up|0
428004|NCT00528112|1427770|P2|Extension Phase|Pregnancy|3
428005|NCT00528112|1427771|P1|Extension Phase|Pregnancy|0
428006|NCT00528112|1427770|P2|Extension Phase|Other reasons|100
428007|NCT00528112|1427771|P1|Extension Phase|Other reasons|0
428008|NCT00528112|1427770|P2|Extension Phase|Withdrawal by Subject|3
428009|NCT00528112|1427771|P1|Extension Phase|Withdrawal by Subject|0
428010|NCT00528112|1427770|P2|Treatment up to 3 Years|Other reasons|186
428011|NCT00528112|1427771|P1|Treatment up to 3 Years|Other reasons|186
428012|NCT00528112|1427770|P2|Treatment up to 3 Years|Pregnancy|10
428013|NCT00528112|1427771|P1|Treatment up to 3 Years|Pregnancy|9
428014|NCT00528112|1427770|P2|Treatment up to 3 Years|Lost to Follow-up|61
428015|NCT00528112|1427771|P1|Treatment up to 3 Years|Lost to Follow-up|63
428016|NCT00528112|1427770|P2|Treatment up to 3 Years|Death|1
428017|NCT00528112|1427771|P1|Treatment up to 3 Years|Death|0
428018|NCT00528112|1427770|P2|Treatment up to 3 Years|Protocol Violation|16
428019|NCT00528112|1427771|P1|Treatment up to 3 Years|Protocol Violation|16
428020|NCT00528112|1427770|P2|Treatment up to 3 Years|Withdrawal by Subject|31
428021|NCT00528112|1427771|P1|Treatment up to 3 Years|Withdrawal by Subject|26
428022|NCT00528112|1427770|P2|Treatment up to 3 Years|Adverse Event|278
428023|NCT00528112|1427771|P1|Treatment up to 3 Years|Adverse Event|313
428024|NCT00528021|1427829|P4|Overall Study|Lack of Efficacy|9
428025|NCT00528021|1427830|P3|Overall Study|Lack of Efficacy|7
428026|NCT00528021|1427831|P2|Overall Study|Lack of Efficacy|13
428027|NCT00528021|1427832|P1|Overall Study|Lack of Efficacy|17
428028|NCT00527982|1427844|P2|Overall Study|Physician Decision|0
428029|NCT00527982|1427845|P1|Overall Study|Physician Decision|1
428031|NCT00527904|1427886|P1|Overall Study|Lost to Follow-up|8
428032|NCT00527904|1427886|P1|Overall Study|Withdrawal by Subject|21
428033|NCT00527904|1427886|P1|Overall Study|Adverse Event|45
428034|NCT00527826|1427905|P2|Overall Study|Participant moved away|1
428035|NCT00527826|1427906|P1|Overall Study|Participant moved away|0
428036|NCT00527826|1427905|P2|Overall Study|Additional Intake of Viani forte|1
428037|NCT00527826|1427906|P1|Overall Study|Additional Intake of Viani forte|0
428038|NCT00527826|1427905|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
428039|NCT00527826|1427906|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
428040|NCT00527826|1427905|P2|Overall Study|Inclusion Criteria Not Met|3
428041|NCT00527826|1427906|P1|Overall Study|Inclusion Criteria Not Met|3
428042|NCT00527826|1427905|P2|Overall Study|Withdrawal by Subject|8
428043|NCT00527826|1427906|P1|Overall Study|Withdrawal by Subject|5
428044|NCT00527826|1427905|P2|Overall Study|Lost to Follow-up|2
428045|NCT00527826|1427906|P1|Overall Study|Lost to Follow-up|3
428046|NCT00527826|1427905|P2|Overall Study|Adverse Event|10
428047|NCT00527826|1427906|P1|Overall Study|Adverse Event|10
428048|NCT00527787|1427955|P2|Overall Study|misc|2
428049|NCT00527787|1427956|P1|Overall Study|misc|5
428050|NCT00527787|1427955|P2|Overall Study|Duodenal Ulcer|10
428051|NCT00527787|1427956|P1|Overall Study|Duodenal Ulcer|1
428052|NCT00527787|1427955|P2|Overall Study|Lost to Follow-up|2
428053|NCT00527787|1427956|P1|Overall Study|Lost to Follow-up|5
428054|NCT00527787|1427955|P2|Overall Study|Withdrawal by Subject|25
428055|NCT00527787|1427956|P1|Overall Study|Withdrawal by Subject|13
428056|NCT00527787|1427955|P2|Overall Study|Adverse Event|24
428057|NCT00527787|1427956|P1|Overall Study|Adverse Event|14
428058|NCT00527748|1427978|P1|Overall Study|Other|3
428059|NCT00527735|1427985|P3|Overall Study|Completed treatment during maintenance|1
428060|NCT00527735|1427986|P2|Overall Study|Completed treatment during maintenance|2
428061|NCT00527735|1427987|P1|Overall Study|Completed treatment during maintenance|2
428062|NCT00527735|1427985|P3|Overall Study|Poor compliance or noncompliance|1
428063|NCT00527735|1427986|P2|Overall Study|Poor compliance or noncompliance|1
428064|NCT00527735|1427987|P1|Overall Study|Poor compliance or noncompliance|0
428065|NCT00527735|1427985|P3|Overall Study|Lost to Follow-up|3
428066|NCT00527735|1427986|P2|Overall Study|Lost to Follow-up|0
428067|NCT00527735|1427987|P1|Overall Study|Lost to Follow-up|0
428068|NCT00527735|1427985|P3|Overall Study|No longer met study criteria|1
428069|NCT00527735|1427986|P2|Overall Study|No longer met study criteria|2
428070|NCT00527735|1427987|P1|Overall Study|No longer met study criteria|2
428071|NCT00527735|1427985|P3|Overall Study|Withdrawal by Subject|3
428072|NCT00527735|1427986|P2|Overall Study|Withdrawal by Subject|4
428073|NCT00527735|1427987|P1|Overall Study|Withdrawal by Subject|5
428074|NCT00527735|1427985|P3|Overall Study|Not identified|5
428075|NCT00527735|1427986|P2|Overall Study|Not identified|5
428076|NCT00527735|1427987|P1|Overall Study|Not identified|5
428077|NCT00527735|1427985|P3|Overall Study|Adverse Event|7
428078|NCT00527735|1427986|P2|Overall Study|Adverse Event|6
428079|NCT00527735|1427987|P1|Overall Study|Adverse Event|10
428080|NCT00527735|1427985|P3|Overall Study|Completed treatment in treatment phase|18
428081|NCT00527735|1427986|P2|Overall Study|Completed treatment in treatment phase|13
428082|NCT00527735|1427987|P1|Overall Study|Completed treatment in treatment phase|14
428083|NCT00527735|1427985|P3|Overall Study|Death|15
428084|NCT00527735|1427986|P2|Overall Study|Death|13
428085|NCT00527735|1427987|P1|Overall Study|Death|23
428086|NCT00527735|1427985|P3|Overall Study|Disease progression|53
428087|NCT00527735|1427986|P2|Overall Study|Disease progression|61
428088|NCT00527735|1427987|P1|Overall Study|Disease progression|47
428089|NCT00527618|1428073|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
428090|NCT00527618|1428074|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
428091|NCT00527618|1428073|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
428092|NCT00527618|1428074|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
428093|NCT00527618|1428073|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
428094|NCT00527618|1428074|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
428095|NCT00527618|1428073|P2|Week 13-14 (Washout)|Lost to Follow-up|0
428096|NCT00527618|1428074|P1|Week 13-14 (Washout)|Lost to Follow-up|1
428097|NCT00527618|1428073|P2|Week 1-12 (First Intervention)|Adverse Event|1
428098|NCT00527618|1428074|P1|Week 1-12 (First Intervention)|Adverse Event|0
428099|NCT00527618|1428073|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
428100|NCT00527618|1428074|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
428101|NCT00527605|1428089|P2|Overall Study|Protocol Violation|2
428102|NCT00527605|1428090|P1|Overall Study|Protocol Violation|1
428103|NCT00527605|1428089|P2|Overall Study|Lost to Follow-up|2
428104|NCT00527605|1428090|P1|Overall Study|Lost to Follow-up|6
428105|NCT00527605|1428089|P2|Overall Study|Withdrawal by Subject|7
428106|NCT00527605|1428090|P1|Overall Study|Withdrawal by Subject|3
428107|NCT00527605|1428089|P2|Overall Study|Adverse Event|0
428108|NCT00527605|1428090|P1|Overall Study|Adverse Event|3
428109|NCT00527514|1428141|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
428110|NCT00527514|1428141|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
428111|NCT00527514|1428141|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
428112|NCT00527514|1428141|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
428113|NCT00527514|1428141|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
428114|NCT00527514|1428141|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
428115|NCT00527514|1428141|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
428116|NCT00527488|1428157|P4|Overall Study|Withdrawn prior to dosing|0
428117|NCT00527488|1428158|P3|Overall Study|Withdrawn prior to dosing|1
428118|NCT00527488|1428159|P2|Overall Study|Withdrawn prior to dosing|1
428119|NCT00527488|1428160|P1|Overall Study|Withdrawn prior to dosing|0
428120|NCT00527423|1428243|P1|Overall Study|Death|9
428121|NCT00527423|1428243|P1|Overall Study|OTHER|4
428122|NCT00527423|1428243|P1|Overall Study|Lost to Follow-up|4
428123|NCT00527423|1428243|P1|Overall Study|Withdrawal by Subject|10
428124|NCT00527423|1428243|P1|Overall Study|Physician Decision|4
428125|NCT00527423|1428243|P1|Overall Study|Adverse Event|5
428126|NCT00527423|1428243|P1|Overall Study|Protocol Violation|1
428127|NCT00527397|1428249|P1|Overall Study|Study terminated by sponsor|13
428128|NCT00527397|1428249|P1|Overall Study|Withdrawal by Subject|6
428129|NCT00527397|1428249|P1|Overall Study|Protocol Violation|1
428130|NCT00527397|1428249|P1|Overall Study|Lack of Efficacy|1
428131|NCT00527397|1428249|P1|Overall Study|Adverse Event|3
428132|NCT00527332|1428275|P2|Overall Study|Withdrew consent|1
428133|NCT00527332|1428276|P1|Overall Study|Withdrew consent|5
428134|NCT00527332|1428275|P2|Overall Study|Protocol Violation|8
428135|NCT00527332|1428276|P1|Overall Study|Protocol Violation|4
428136|NCT00527319|1428285|P3|Overall Study|Adverse Event|1
428137|NCT00527319|1428286|P2|Overall Study|Adverse Event|0
428138|NCT00527319|1428287|P1|Overall Study|Adverse Event|0
428139|NCT00527319|1428285|P3|Overall Study|Intercurrent Medical Illness|3
428140|NCT00527319|1428286|P2|Overall Study|Intercurrent Medical Illness|1
428141|NCT00527319|1428287|P1|Overall Study|Intercurrent Medical Illness|0
428142|NCT00527319|1428285|P3|Overall Study|Death|1
428143|NCT00527319|1428286|P2|Overall Study|Death|3
428144|NCT00527319|1428287|P1|Overall Study|Death|0
428145|NCT00527319|1428285|P3|Overall Study|Lost to Follow-up|0
428146|NCT00527319|1428286|P2|Overall Study|Lost to Follow-up|0
428147|NCT00527319|1428287|P1|Overall Study|Lost to Follow-up|1
428148|NCT00527319|1428285|P3|Overall Study|Withdrawal by Subject|1
428149|NCT00527319|1428286|P2|Overall Study|Withdrawal by Subject|0
428150|NCT00527319|1428287|P1|Overall Study|Withdrawal by Subject|5
428151|NCT00527111|1428317|P2|Overall Study|Other|2
428152|NCT00527111|1428318|P1|Overall Study|Other|2
428153|NCT00527111|1428317|P2|Overall Study|Patient Request|5
428154|NCT00527111|1428318|P1|Overall Study|Patient Request|2
428155|NCT00527111|1428317|P2|Overall Study|Investigator Request|1
428156|NCT00527111|1428318|P1|Overall Study|Investigator Request|2
428157|NCT00527111|1428317|P2|Overall Study|Death|1
428158|NCT00527111|1428318|P1|Overall Study|Death|0
428159|NCT00527111|1428317|P2|Overall Study|Adverse Event|13
428160|NCT00527111|1428318|P1|Overall Study|Adverse Event|14
428161|NCT00527072|1428340|P1|Overall Study|Withdrawal by Subject|7
428162|NCT00527072|1428340|P1|Overall Study|Protocol Violation|2
428163|NCT00527072|1428340|P1|Overall Study|Lost to Follow-up|3
428164|NCT00527072|1428340|P1|Overall Study|Lack of Efficacy|11
428165|NCT00527072|1428340|P1|Overall Study|Adverse Event|13
428166|NCT00526994|1428349|P3|Overall Study|incarcerated, impaired, incomplete|3
428167|NCT00526994|1428350|P2|Overall Study|incarcerated, impaired, incomplete|3
428168|NCT00526994|1428351|P1|Overall Study|incarcerated, impaired, incomplete|4
428169|NCT00526994|1428349|P3|Overall Study|Withdrawal by Subject|5
428170|NCT00526994|1428350|P2|Overall Study|Withdrawal by Subject|7
428171|NCT00526994|1428351|P1|Overall Study|Withdrawal by Subject|2
428172|NCT00526994|1428349|P3|Overall Study|Death|3
428173|NCT00526994|1428350|P2|Overall Study|Death|3
428174|NCT00526994|1428351|P1|Overall Study|Death|4
428175|NCT00526994|1428349|P3|Overall Study|Lost to Follow-up|96
428176|NCT00526994|1428350|P2|Overall Study|Lost to Follow-up|108
428177|NCT00526994|1428351|P1|Overall Study|Lost to Follow-up|98
428178|NCT00526890|1428368|P1|Overall Study|Adverse Event|2
428179|NCT00526799|1428380|P2|Overall Study|Intercurrent Complicating Disease|1
428180|NCT00526799|1428381|P1|Overall Study|Intercurrent Complicating Disease|0
428181|NCT00526799|1428380|P2|Overall Study|Withdrawal by Subject|0
428182|NCT00526799|1428381|P1|Overall Study|Withdrawal by Subject|1
428183|NCT00526669|1428389|P2|Combined Treatment Phase|Death|2
428184|NCT00526669|1428390|P1|Combined Treatment Phase|Death|0
428185|NCT00526669|1428389|P2|Combined Treatment Phase|Sponsor Terminated Study|2
428186|NCT00526669|1428390|P1|Combined Treatment Phase|Sponsor Terminated Study|0
428187|NCT00526669|1428389|P2|Combined Treatment Phase|Withdrawal by Subject|2
428188|NCT00526669|1428390|P1|Combined Treatment Phase|Withdrawal by Subject|0
428189|NCT00526669|1428389|P2|Combined Treatment Phase|Lost to Follow-up|2
428190|NCT00526669|1428390|P1|Combined Treatment Phase|Lost to Follow-up|0
428191|NCT00526630|1428419|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
428192|NCT00526630|1428420|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
428193|NCT00526630|1428419|P2|First Intervention Period - 12 Weeks|Withdrawn|3
428194|NCT00526630|1428420|P1|First Intervention Period - 12 Weeks|Withdrawn|0
428195|NCT00526331|1428519|P1|Overall Study|Sponsor Termination|55
428196|NCT00526227|1428527|P1|Overall Study|Death|1
428197|NCT00526227|1428527|P1|Overall Study|Device not implanted|1
428198|NCT00526162|1428538|P1|Overall Study|Device not implanted|3
428199|NCT00526110|1428568|P2|Overall Study|Poor Tolerance|5
428200|NCT00526110|1428569|P1|Overall Study|Poor Tolerance|0
428201|NCT00526110|1428568|P2|Overall Study|Withdrawal by Subject|2
428202|NCT00526110|1428569|P1|Overall Study|Withdrawal by Subject|0
428203|NCT00526110|1428568|P2|Overall Study|Maximal Response|6
428204|NCT00526110|1428569|P1|Overall Study|Maximal Response|0
428205|NCT00526110|1428568|P2|Overall Study|Disease Progression|19
428206|NCT00526110|1428569|P1|Overall Study|Disease Progression|0
428207|NCT00526110|1428568|P2|Overall Study|Adverse Event|9
428208|NCT00526110|1428569|P1|Overall Study|Adverse Event|2
428209|NCT00526097|1428578|P2|Overall Study|Other|1
428210|NCT00526097|1428579|P1|Overall Study|Other|2
428211|NCT00526097|1428578|P2|Overall Study|Withdrawal by Subject|1
428212|NCT00526097|1428579|P1|Overall Study|Withdrawal by Subject|3
428213|NCT00526097|1428578|P2|Overall Study|Protocol Violation|10
428214|NCT00526097|1428579|P1|Overall Study|Protocol Violation|4
428215|NCT00526097|1428578|P2|Overall Study|Adverse Event|44
428216|NCT00526097|1428579|P1|Overall Study|Adverse Event|6
428217|NCT00525915|1428766|P2|Overall Study|Unrelated illness|0
428218|NCT00525915|1428767|P1|Overall Study|Unrelated illness|1
428219|NCT00525915|1428766|P2|Overall Study|Refused Surgery|2
428220|NCT00525915|1428767|P1|Overall Study|Refused Surgery|1
428221|NCT00525915|1428766|P2|Overall Study|Withdrawal by Subject|0
428222|NCT00525915|1428767|P1|Overall Study|Withdrawal by Subject|1
428223|NCT00525915|1428766|P2|Overall Study|Disease Progression|6
428224|NCT00525915|1428767|P1|Overall Study|Disease Progression|5
428225|NCT00525915|1428766|P2|Overall Study|Non-Compliance|1
428226|NCT00525915|1428767|P1|Overall Study|Non-Compliance|0
428227|NCT00525902|1428773|P1|Overall Study|Lack of Efficacy|1
428228|NCT00525824|1428795|P4|Overall Study|Other|1
428229|NCT00525824|1428796|P3|Overall Study|Other|3
428230|NCT00525824|1428797|P2|Overall Study|Other|3
428231|NCT00525824|1428798|P1|Overall Study|Other|1
428232|NCT00525824|1428795|P4|Overall Study|Safety reasons|0
428233|NCT00525824|1428796|P3|Overall Study|Safety reasons|1
428234|NCT00525824|1428797|P2|Overall Study|Safety reasons|0
428235|NCT00525824|1428798|P1|Overall Study|Safety reasons|1
428236|NCT00525824|1428795|P4|Overall Study|Severe non-compliance|1
428237|NCT00525824|1428796|P3|Overall Study|Severe non-compliance|1
428238|NCT00525824|1428797|P2|Overall Study|Severe non-compliance|1
428239|NCT00525824|1428798|P1|Overall Study|Severe non-compliance|0
428240|NCT00525824|1428795|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
428241|NCT00525824|1428796|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
428242|NCT00525824|1428797|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
428243|NCT00525824|1428798|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
428244|NCT00525824|1428795|P4|Overall Study|Lost to Follow-up|0
428245|NCT00525824|1428796|P3|Overall Study|Lost to Follow-up|4
428246|NCT00525824|1428797|P2|Overall Study|Lost to Follow-up|2
428247|NCT00525824|1428798|P1|Overall Study|Lost to Follow-up|4
428248|NCT00525824|1428795|P4|Overall Study|Withdrawal by Subject|4
428249|NCT00525824|1428796|P3|Overall Study|Withdrawal by Subject|3
428250|NCT00525824|1428797|P2|Overall Study|Withdrawal by Subject|9
428251|NCT00525824|1428798|P1|Overall Study|Withdrawal by Subject|5
428252|NCT00525824|1428795|P4|Overall Study|Adverse Event|7
428253|NCT00525824|1428796|P3|Overall Study|Adverse Event|6
428254|NCT00525824|1428797|P2|Overall Study|Adverse Event|11
428255|NCT00525824|1428798|P1|Overall Study|Adverse Event|7
428256|NCT00525512|1428903|P4|Open-Label Phase|Other reason (not specified)|5
428257|NCT00525512|1428904|P3|Open-Label Phase|Other reason (not specified)|4
428258|NCT00525512|1428905|P2|Open-Label Phase|Other reason (not specified)|0
428259|NCT00525512|1428906|P1|Open-Label Phase|Other reason (not specified)|0
428260|NCT00525512|1428903|P4|Open-Label Phase|Lost to Follow-up|0
428261|NCT00525512|1428904|P3|Open-Label Phase|Lost to Follow-up|1
428262|NCT00525512|1428905|P2|Open-Label Phase|Lost to Follow-up|0
428263|NCT00525512|1428906|P1|Open-Label Phase|Lost to Follow-up|0
428264|NCT00525512|1428903|P4|Open-Label Phase|Adverse Event|0
428265|NCT00525512|1428904|P3|Open-Label Phase|Adverse Event|1
428266|NCT00525512|1428905|P2|Open-Label Phase|Adverse Event|0
428267|NCT00525512|1428906|P1|Open-Label Phase|Adverse Event|0
428268|NCT00525512|1428903|P4|Double-Blind Phase|Other reason (not specified)|0
428269|NCT00525512|1428904|P3|Double-Blind Phase|Other reason (not specified)|0
428270|NCT00525512|1428905|P2|Double-Blind Phase|Other reason (not specified)|13
428271|NCT00525512|1428906|P1|Double-Blind Phase|Other reason (not specified)|12
428272|NCT00525512|1428903|P4|Double-Blind Phase|Lack of Efficacy|0
428273|NCT00525512|1428904|P3|Double-Blind Phase|Lack of Efficacy|0
428274|NCT00525512|1428905|P2|Double-Blind Phase|Lack of Efficacy|5
428275|NCT00525512|1428906|P1|Double-Blind Phase|Lack of Efficacy|13
428276|NCT00525512|1428903|P4|Double-Blind Phase|Withdrawal by Subject|0
428277|NCT00525512|1428904|P3|Double-Blind Phase|Withdrawal by Subject|0
428278|NCT00525512|1428905|P2|Double-Blind Phase|Withdrawal by Subject|12
428279|NCT00525512|1428906|P1|Double-Blind Phase|Withdrawal by Subject|17
428280|NCT00525512|1428903|P4|Double-Blind Phase|Lost to Follow-up|0
428281|NCT00525512|1428904|P3|Double-Blind Phase|Lost to Follow-up|0
428282|NCT00525512|1428905|P2|Double-Blind Phase|Lost to Follow-up|7
428283|NCT00525512|1428906|P1|Double-Blind Phase|Lost to Follow-up|3
428284|NCT00525512|1428903|P4|Double-Blind Phase|Protocol Violation|0
428285|NCT00525512|1428904|P3|Double-Blind Phase|Protocol Violation|0
428286|NCT00525512|1428905|P2|Double-Blind Phase|Protocol Violation|1
428287|NCT00525512|1428906|P1|Double-Blind Phase|Protocol Violation|3
428288|NCT00525512|1428903|P4|Double-Blind Phase|Adverse Event|0
428289|NCT00525512|1428904|P3|Double-Blind Phase|Adverse Event|0
428290|NCT00525512|1428905|P2|Double-Blind Phase|Adverse Event|28
428291|NCT00525512|1428906|P1|Double-Blind Phase|Adverse Event|48
428292|NCT00525499|1429048|P4|Overall Study|Protocol Violation|0
428293|NCT00525499|1429049|P3|Overall Study|Protocol Violation|1
428294|NCT00525499|1429050|P2|Overall Study|Protocol Violation|1
428295|NCT00525499|1429051|P1|Overall Study|Protocol Violation|0
428296|NCT00525499|1429048|P4|Overall Study|Withdrawal by Subject|2
428297|NCT00525499|1429049|P3|Overall Study|Withdrawal by Subject|5
428298|NCT00525499|1429050|P2|Overall Study|Withdrawal by Subject|1
428299|NCT00525499|1429051|P1|Overall Study|Withdrawal by Subject|5
428300|NCT00525499|1429048|P4|Overall Study|Adverse Event|1
428301|NCT00525499|1429049|P3|Overall Study|Adverse Event|0
428302|NCT00525499|1429050|P2|Overall Study|Adverse Event|1
428303|NCT00525499|1429051|P1|Overall Study|Adverse Event|0
428304|NCT00525499|1429048|P4|Overall Study|Lost to Follow-up|4
428305|NCT00525499|1429049|P3|Overall Study|Lost to Follow-up|1
428306|NCT00525499|1429050|P2|Overall Study|Lost to Follow-up|4
428307|NCT00525499|1429051|P1|Overall Study|Lost to Follow-up|2
428308|NCT00525265|1429078|P2|Overall Study|Protocol Violation|0
428309|NCT00525265|1429079|P1|Overall Study|Protocol Violation|1
428310|NCT00525161|1429136|P1|Overall Study|Adverse Event|1
428311|NCT00525148|1429146|P4|Overall Study|Other than stated|3
428312|NCT00525148|1429147|P3|Overall Study|Other than stated|0
428313|NCT00525148|1429148|P2|Overall Study|Other than stated|1
428314|NCT00525148|1429149|P1|Overall Study|Other than stated|2
428315|NCT00525148|1429146|P4|Overall Study|Refused continuation of study medication|1
428316|NCT00525148|1429147|P3|Overall Study|Refused continuation of study medication|0
428317|NCT00525148|1429148|P2|Overall Study|Refused continuation of study medication|2
428318|NCT00525148|1429149|P1|Overall Study|Refused continuation of study medication|0
428319|NCT00525148|1429146|P4|Overall Study|Progressive disease|49
428320|NCT00525148|1429147|P3|Overall Study|Progressive disease|6
428321|NCT00525148|1429148|P2|Overall Study|Progressive disease|30
428322|NCT00525148|1429149|P1|Overall Study|Progressive disease|18
428323|NCT00525148|1429146|P4|Overall Study|Other Adverse Event|8
428324|NCT00525148|1429147|P3|Overall Study|Other Adverse Event|1
428325|NCT00525148|1429148|P2|Overall Study|Other Adverse Event|5
428326|NCT00525148|1429149|P1|Overall Study|Other Adverse Event|3
428327|NCT00525031|1429177|P2|Overall Study|Disease Progression|1
428328|NCT00525031|1429178|P1|Overall Study|Disease Progression|1
428329|NCT00524771|1429192|P2|Overall Study|Protocol Violation|585
428330|NCT00524771|1429193|P1|Overall Study|Protocol Violation|220
428331|NCT00524745|1429207|P4|Overall Study|subject withdrawal or lost to follow up|22
428332|NCT00524745|1429208|P3|Overall Study|subject withdrawal or lost to follow up|29
428333|NCT00524745|1429209|P2|Overall Study|subject withdrawal or lost to follow up|13
428334|NCT00524745|1429210|P1|Overall Study|subject withdrawal or lost to follow up|34
428335|NCT00524680|1429236|P4|Overall Study|Withdrawal by Subject|1
428336|NCT00524680|1429237|P3|Overall Study|Withdrawal by Subject|1
428337|NCT00524680|1429238|P2|Overall Study|Withdrawal by Subject|0
428338|NCT00524680|1429239|P1|Overall Study|Withdrawal by Subject|1
428339|NCT00524680|1429236|P4|Overall Study|not specified|3
428340|NCT00524680|1429237|P3|Overall Study|not specified|2
428341|NCT00524680|1429238|P2|Overall Study|not specified|1
428342|NCT00524680|1429239|P1|Overall Study|not specified|0
428343|NCT00524680|1429236|P4|Overall Study|Adverse Event|1
428344|NCT00524680|1429237|P3|Overall Study|Adverse Event|0
428345|NCT00524680|1429238|P2|Overall Study|Adverse Event|0
428346|NCT00524680|1429239|P1|Overall Study|Adverse Event|2
428347|NCT00524680|1429236|P4|Overall Study|progression|1
428348|NCT00524680|1429237|P3|Overall Study|progression|0
428349|NCT00524680|1429238|P2|Overall Study|progression|0
428350|NCT00524680|1429239|P1|Overall Study|progression|0
428351|NCT00524589|1429261|P1|Overall Study|Disease Progression|16
428352|NCT00524589|1429261|P1|Overall Study|Withdrawal by Subject|2
428353|NCT00524485|1429312|P1|Overall Study|Withdrawal by Subject|5
428354|NCT00524459|1429322|P1|Overall Study|Other|1
428355|NCT00524459|1429322|P1|Overall Study|Withdrawal by Subject|1
428356|NCT00524420|1429332|P2|Overall Study|Lack of Efficacy|0
428357|NCT00524420|1429333|P1|Overall Study|Lack of Efficacy|1
428358|NCT00524368|1429351|P2|Overall Study|Other|2
428359|NCT00524368|1429352|P1|Overall Study|Other|3
428360|NCT00524368|1429351|P2|Overall Study|Ineligible to Continue the study|5
428361|NCT00524368|1429352|P1|Overall Study|Ineligible to Continue the study|2
428362|NCT00524368|1429351|P2|Overall Study|Sponsor's Decision|0
428363|NCT00524368|1429352|P1|Overall Study|Sponsor's Decision|2
428364|NCT00524368|1429351|P2|Overall Study|Reached a Virologic Endpoint|2
428365|NCT00524368|1429352|P1|Overall Study|Reached a Virologic Endpoint|3
428366|NCT00524368|1429351|P2|Overall Study|Non-compliant|9
428367|NCT00524368|1429352|P1|Overall Study|Non-compliant|8
428368|NCT00524368|1429351|P2|Overall Study|Withdrawal by Subject|5
428369|NCT00524368|1429352|P1|Overall Study|Withdrawal by Subject|4
428370|NCT00524368|1429351|P2|Overall Study|Lost to Follow-up|13
428371|NCT00524368|1429352|P1|Overall Study|Lost to Follow-up|9
428372|NCT00524368|1429351|P2|Overall Study|Adverse Event|12
428373|NCT00524368|1429352|P1|Overall Study|Adverse Event|10
428374|NCT00524316|1429386|P1|Overall Study|Disease Progression|7
428375|NCT00524316|1429386|P1|Overall Study|Adverse Event|7
428376|NCT00524316|1429386|P1|Overall Study|Withdrawal by Subject|2
428377|NCT00524303|1429398|P3|Overall Study|Completed 5 years|1
428378|NCT00524303|1429399|P2|Overall Study|Completed 5 years|0
428379|NCT00524303|1429400|P1|Overall Study|Completed 5 years|0
428380|NCT00524303|1429398|P3|Overall Study|Physician Decision|1
428381|NCT00524303|1429399|P2|Overall Study|Physician Decision|0
428382|NCT00524303|1429400|P1|Overall Study|Physician Decision|0
428383|NCT00524303|1429398|P3|Overall Study|Sponsor Request|1
428384|NCT00524303|1429399|P2|Overall Study|Sponsor Request|0
428385|NCT00524303|1429400|P1|Overall Study|Sponsor Request|0
428386|NCT00524303|1429398|P3|Overall Study|Disease Recurrence|0
428387|NCT00524303|1429399|P2|Overall Study|Disease Recurrence|1
428388|NCT00524303|1429400|P1|Overall Study|Disease Recurrence|0
428389|NCT00524303|1429398|P3|Overall Study|Disease Progression|1
428390|NCT00524303|1429399|P2|Overall Study|Disease Progression|4
428391|NCT00524303|1429400|P1|Overall Study|Disease Progression|0
428392|NCT00524303|1429398|P3|Overall Study|Worsening Peripheral Neuropathy|0
428393|NCT00524303|1429399|P2|Overall Study|Worsening Peripheral Neuropathy|0
428394|NCT00524303|1429400|P1|Overall Study|Worsening Peripheral Neuropathy|1
428395|NCT00524303|1429398|P3|Overall Study|Did not Complete Study Dosing|0
428396|NCT00524303|1429399|P2|Overall Study|Did not Complete Study Dosing|0
428397|NCT00524303|1429400|P1|Overall Study|Did not Complete Study Dosing|1
428398|NCT00524303|1429398|P3|Overall Study|Adverse Event|3
428399|NCT00524303|1429399|P2|Overall Study|Adverse Event|2
428400|NCT00524303|1429400|P1|Overall Study|Adverse Event|1
428401|NCT00524303|1429398|P3|Overall Study|Death|3
428402|NCT00524303|1429399|P2|Overall Study|Death|2
428403|NCT00524303|1429400|P1|Overall Study|Death|0
428404|NCT00524303|1429398|P3|Overall Study|Withdrawal by Subject|4
428405|NCT00524303|1429399|P2|Overall Study|Withdrawal by Subject|0
428406|NCT00524303|1429400|P1|Overall Study|Withdrawal by Subject|3
428407|NCT00524303|1429398|P3|Overall Study|Protocol Violation|1
428408|NCT00524303|1429399|P2|Overall Study|Protocol Violation|1
428409|NCT00524303|1429400|P1|Overall Study|Protocol Violation|0
428410|NCT00524303|1429398|P3|Overall Study|Lost to Follow-up|3
428411|NCT00524303|1429399|P2|Overall Study|Lost to Follow-up|0
428412|NCT00524303|1429400|P1|Overall Study|Lost to Follow-up|6
428413|NCT00524173|1429452|P2|Overall Study|Had not reached endpoint at study close|1
428414|NCT00524173|1429453|P1|Overall Study|Had not reached endpoint at study close|4
428415|NCT00524173|1429452|P2|Overall Study|Death|0
428416|NCT00524173|1429453|P1|Overall Study|Death|1
428417|NCT00524173|1429452|P2|Overall Study|Lost to Follow-up|1
428418|NCT00524173|1429453|P1|Overall Study|Lost to Follow-up|0
428419|NCT00524134|1429465|P1|Overall Study|Physician Decision|1
428420|NCT00524134|1429465|P1|Overall Study|Withdrawal by Subject|1
428421|NCT00524121|1429472|P1|Overall Study|Not treated (changed mind)|1
428422|NCT00524121|1429472|P1|Overall Study|Not treated (became ineligible)|4
428423|NCT00524121|1429472|P1|Overall Study|Death|1
428424|NCT00524121|1429472|P1|Overall Study|Other|1
428425|NCT00524121|1429472|P1|Overall Study|Patient refused|2
428426|NCT00524121|1429472|P1|Overall Study|Adverse Event|4
428427|NCT00524121|1429472|P1|Overall Study|Disease progression|6
428428|NCT00524043|1429492|P3|Overall Study|Various (eg, incarceration)|0
428429|NCT00524043|1429493|P2|Overall Study|Various (eg, incarceration)|1
428430|NCT00524043|1429494|P1|Overall Study|Various (eg, incarceration)|2
428431|NCT00524043|1429492|P3|Overall Study|Lost to Follow-up|3
428432|NCT00524043|1429493|P2|Overall Study|Lost to Follow-up|5
428433|NCT00524043|1429494|P1|Overall Study|Lost to Follow-up|3
428434|NCT00524043|1429492|P3|Overall Study|Adverse Event|7
428435|NCT00524043|1429493|P2|Overall Study|Adverse Event|2
428436|NCT00524043|1429494|P1|Overall Study|Adverse Event|5
428437|NCT00524043|1429492|P3|Overall Study|Withdrawal by Subject|7
428438|NCT00524043|1429493|P2|Overall Study|Withdrawal by Subject|7
428439|NCT00524043|1429494|P1|Overall Study|Withdrawal by Subject|5
428440|NCT00524043|1429492|P3|Overall Study|Lack of Efficacy|14
428441|NCT00524043|1429493|P2|Overall Study|Lack of Efficacy|13
428442|NCT00524043|1429494|P1|Overall Study|Lack of Efficacy|15
428443|NCT00524030|1429516|P2|Overall Study|Death|1
428444|NCT00524030|1429517|P1|Overall Study|Death|0
428445|NCT00524030|1429516|P2|Overall Study|Adverse Event|21
428446|NCT00524030|1429517|P1|Overall Study|Adverse Event|3
428447|NCT00524030|1429516|P2|Overall Study|Pregnancy|0
428448|NCT00524030|1429517|P1|Overall Study|Pregnancy|1
428449|NCT00524030|1429516|P2|Overall Study|Protocol Violation|1
428450|NCT00524030|1429517|P1|Overall Study|Protocol Violation|0
428451|NCT00524030|1429516|P2|Overall Study|Noncompliance/Investigator discretion|2
428452|NCT00524030|1429517|P1|Overall Study|Noncompliance/Investigator discretion|0
428453|NCT00524030|1429516|P2|Overall Study|Withdrawal by Subject|8
428454|NCT00524030|1429517|P1|Overall Study|Withdrawal by Subject|3
428455|NCT00524030|1429516|P2|Overall Study|Lost to Follow-up|2
428456|NCT00524030|1429517|P1|Overall Study|Lost to Follow-up|0
428457|NCT00524030|1429516|P2|Overall Study|Lack of Efficacy|24
428458|NCT00524030|1429517|P1|Overall Study|Lack of Efficacy|10
428459|NCT00523991|1429535|P2|Overall Study|Other reason (not specified)|0
428460|NCT00523991|1429536|P1|Overall Study|Other reason (not specified)|3
428461|NCT00523991|1429535|P2|Overall Study|Withdrawal by Subject|17
428462|NCT00523991|1429536|P1|Overall Study|Withdrawal by Subject|7
428463|NCT00523991|1429535|P2|Overall Study|Lost to Follow-up|1
428464|NCT00523991|1429536|P1|Overall Study|Lost to Follow-up|4
428465|NCT00523991|1429535|P2|Overall Study|Protocol Violation|4
428466|NCT00523991|1429536|P1|Overall Study|Protocol Violation|1
428467|NCT00523991|1429535|P2|Overall Study|Adverse Event|5
428468|NCT00523991|1429536|P1|Overall Study|Adverse Event|6
428469|NCT00523978|1429816|P2|Overall Study|Death|0
428470|NCT00523978|1429817|P1|Overall Study|Death|1
428471|NCT00523978|1429816|P2|Overall Study|Screen Failures|1
428472|NCT00523978|1429817|P1|Overall Study|Screen Failures|5
428473|NCT00523978|1429816|P2|Overall Study|Withdrawal by Subject|7
428474|NCT00523978|1429817|P1|Overall Study|Withdrawal by Subject|3
428475|NCT00523848|1429839|P1|Overall Study|Other, unspecified|4
428476|NCT00523848|1429839|P1|Overall Study|Disease Progression|5
428477|NCT00523848|1429839|P1|Overall Study|NOT TREATED (Became ineligible)|2
428478|NCT00523848|1429839|P1|Overall Study|Withdrawal by Subject|2
428479|NCT00523848|1429839|P1|Overall Study|Adverse Event|11
428480|NCT00523744|1429849|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
428481|NCT00523744|1429849|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
428482|NCT00523744|1429849|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
428483|NCT00523744|1429849|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
428484|NCT00523744|1429849|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
428485|NCT00523744|1429849|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
428486|NCT00523718|1429868|P2|Overall Study|Protocol Violation|0
428487|NCT00523718|1429869|P1|Overall Study|Protocol Violation|2
428488|NCT00523718|1429868|P2|Overall Study|Withdrawal by Subject|0
428489|NCT00523718|1429869|P1|Overall Study|Withdrawal by Subject|1
428490|NCT00523705|1429883|P2|Overall Study|No time for study.|1
428491|NCT00523705|1429884|P1|Overall Study|No time for study.|0
428492|NCT00523640|1429896|P1|Overall Study|Death|1
428493|NCT00523549|1429913|P2|Overall Study|Lost to Follow-up|5
428494|NCT00523549|1429914|P1|Overall Study|Lost to Follow-up|3
428495|NCT00523549|1429913|P2|Overall Study|Patient withdrew consent|6
428496|NCT00523549|1429914|P1|Overall Study|Patient withdrew consent|7
428497|NCT00523549|1429913|P2|Overall Study|Protocol Deviation|1
428498|NCT00523549|1429914|P1|Overall Study|Protocol Deviation|3
428499|NCT00523549|1429913|P2|Overall Study|Unsatisfactory therapeutic effect|1
428500|NCT00523549|1429914|P1|Overall Study|Unsatisfactory therapeutic effect|0
428501|NCT00523549|1429913|P2|Overall Study|Adverse Event|3
428502|NCT00523549|1429914|P1|Overall Study|Adverse Event|6
428503|NCT00523419|1429932|P1|Overall Study|Death due to Adverse Event|2
428504|NCT00523419|1429932|P1|Overall Study|Death due to Study Disease|4
428505|NCT00523419|1429932|P1|Overall Study|Progressive Disease|22
428506|NCT00523419|1429932|P1|Overall Study|Physician Decision|2
428507|NCT00523419|1429932|P1|Overall Study|Withdrawal by Subject|1
428508|NCT00523419|1429932|P1|Overall Study|Adverse Event|1
428509|NCT00523367|1429942|P1|Overall Study|4 Withdrawn by PI|4
428510|NCT00523367|1429942|P1|Overall Study|19 screen failures|19
428511|NCT00523341|1429948|P2|Overall Study|Disease Progression|0
428512|NCT00523341|1429949|P1|Overall Study|Disease Progression|1
428513|NCT00523341|1429948|P2|Overall Study|Ineligibility Determined|4
428514|NCT00523341|1429949|P1|Overall Study|Ineligibility Determined|3
428515|NCT00523341|1429948|P2|Overall Study|Protocol Deviation|5
428516|NCT00523341|1429949|P1|Overall Study|Protocol Deviation|6
428517|NCT00523341|1429948|P2|Overall Study|Requirement for Alternative Therapy|14
428518|NCT00523341|1429949|P1|Overall Study|Requirement for Alternative Therapy|4
428519|NCT00523341|1429948|P2|Overall Study|Physician Decision|13
428520|NCT00523341|1429949|P1|Overall Study|Physician Decision|14
428521|NCT00523341|1429948|P2|Overall Study|Non-compliance|13
428522|NCT00523341|1429949|P1|Overall Study|Non-compliance|20
428523|NCT00523341|1429948|P2|Overall Study|Lost to Follow-up|61
428524|NCT00523341|1429949|P1|Overall Study|Lost to Follow-up|73
428525|NCT00523341|1429948|P2|Overall Study|Death|110
428526|NCT00523341|1429949|P1|Overall Study|Death|101
428527|NCT00523341|1429948|P2|Overall Study|Adverse Event|155
428528|NCT00523341|1429949|P1|Overall Study|Adverse Event|122
428529|NCT00523341|1429948|P2|Overall Study|Other|198
428530|NCT00523341|1429949|P1|Overall Study|Other|181
428531|NCT00523341|1429948|P2|Overall Study|Withdrawal by Subject|427
428532|NCT00523341|1429949|P1|Overall Study|Withdrawal by Subject|399
428533|NCT00522951|1430053|P2|Period 2|residual contrast medium|1
428534|NCT00522951|1430054|P1|Period 2|residual contrast medium|1
428535|NCT00522951|1430053|P2|Period 2|Withdrawal by Subject|0
428536|NCT00522951|1430054|P1|Period 2|Withdrawal by Subject|1
428537|NCT00522951|1430053|P2|Washout Period|Death|1
428538|NCT00522951|1430054|P1|Washout Period|Death|0
428539|NCT00522951|1430053|P2|Washout Period|Adverse Event|1
428540|NCT00522951|1430054|P1|Washout Period|Adverse Event|0
428541|NCT00522951|1430053|P2|Period 1|body motion|1
428542|NCT00522951|1430054|P1|Period 1|body motion|0
428543|NCT00522873|1430109|P2|Overall Study|Never Received Medication|0
428544|NCT00522873|1430110|P1|Overall Study|Never Received Medication|1
428545|NCT00522873|1430109|P2|Overall Study|Medication Errors|1
428546|NCT00522873|1430110|P1|Overall Study|Medication Errors|1
428547|NCT00522873|1430109|P2|Overall Study|Personal Reasons|1
428548|NCT00522873|1430110|P1|Overall Study|Personal Reasons|8
428549|NCT00522873|1430109|P2|Overall Study|Lost to Follow-up|3
428550|NCT00522873|1430110|P1|Overall Study|Lost to Follow-up|11
428551|NCT00522873|1430109|P2|Overall Study|Protocol Violation|4
428552|NCT00522873|1430110|P1|Overall Study|Protocol Violation|14
428553|NCT00522873|1430109|P2|Overall Study|Withdrawal by Subject|9
428554|NCT00522873|1430110|P1|Overall Study|Withdrawal by Subject|20
428555|NCT00522873|1430109|P2|Overall Study|Adverse Event|26
428556|NCT00522873|1430110|P1|Overall Study|Adverse Event|41
428557|NCT00522626|1430123|P1|Overall Study|Lost to Follow-up|7
428558|NCT00522548|1430129|P2|Overall Study|Withdrawal by Subject|2
428559|NCT00522548|1430130|P1|Overall Study|Withdrawal by Subject|0
428560|NCT00522548|1430129|P2|Overall Study|Adverse Event|2
428561|NCT00522548|1430130|P1|Overall Study|Adverse Event|2
428562|NCT00522457|1430158|P1|Overall Study|Adverse Event|2
428563|NCT00522457|1430158|P1|Overall Study|Due to disease progression|16
428564|NCT00522431|1430164|P1|Overall Study|Other/unknown|1
428565|NCT00522431|1430164|P1|Overall Study|Subject non-compliance|1
428566|NCT00522431|1430164|P1|Overall Study|Withdrawal by Subject|2
428567|NCT00522431|1430164|P1|Overall Study|Protocol Violation|2
428568|NCT00522431|1430164|P1|Overall Study|Adverse Event|5
428569|NCT00522418|1430171|P2|Overall Study|Lack of Efficacy|1
428570|NCT00522418|1430172|P1|Overall Study|Lack of Efficacy|0
428571|NCT00522418|1430171|P2|Overall Study|Consent Withdraw|2
428572|NCT00522418|1430172|P1|Overall Study|Consent Withdraw|1
428573|NCT00522418|1430171|P2|Overall Study|Reason Not Specified|1
428574|NCT00522418|1430172|P1|Overall Study|Reason Not Specified|3
428575|NCT00522418|1430171|P2|Overall Study|Noncompliance|2
428576|NCT00522418|1430172|P1|Overall Study|Noncompliance|2
428577|NCT00522418|1430171|P2|Overall Study|Early Study Termination|47
428578|NCT00522418|1430172|P1|Overall Study|Early Study Termination|46
428579|NCT00522418|1430171|P2|Overall Study|Local IRB Consent Violation|5
428580|NCT00522418|1430172|P1|Overall Study|Local IRB Consent Violation|5
428581|NCT00522392|1430220|P2|Overall Study|Non-compliance|1
428582|NCT00522392|1430221|P1|Overall Study|Non-compliance|0
428583|NCT00522392|1430220|P2|Overall Study|Physician Decision|1
428584|NCT00522392|1430221|P1|Overall Study|Physician Decision|0
428585|NCT00522392|1430220|P2|Overall Study|Withdrawal by Subject|1
428586|NCT00522392|1430221|P1|Overall Study|Withdrawal by Subject|1
428587|NCT00522392|1430220|P2|Overall Study|Adverse Event|7
428588|NCT00522392|1430221|P1|Overall Study|Adverse Event|7
428589|NCT00522392|1430220|P2|Overall Study|Disease progression|3
428590|NCT00522392|1430221|P1|Overall Study|Disease progression|0
428591|NCT00522379|1430238|P5|Overall Study|Subject Withdrawal|0
428592|NCT00522379|1430239|P4|Overall Study|Subject Withdrawal|1
428593|NCT00522379|1430240|P3|Overall Study|Subject Withdrawal|0
428594|NCT00522379|1430241|P2|Overall Study|Subject Withdrawal|0
428595|NCT00522379|1430242|P1|Overall Study|Subject Withdrawal|0
428596|NCT00522379|1430238|P5|Overall Study|Site Closed|0
428597|NCT00522379|1430239|P4|Overall Study|Site Closed|1
428598|NCT00522379|1430240|P3|Overall Study|Site Closed|0
428599|NCT00522379|1430241|P2|Overall Study|Site Closed|0
428600|NCT00522379|1430242|P1|Overall Study|Site Closed|0
428601|NCT00522379|1430238|P5|Overall Study|Family Problem|0
428602|NCT00522379|1430239|P4|Overall Study|Family Problem|0
428603|NCT00522379|1430240|P3|Overall Study|Family Problem|1
428604|NCT00522379|1430241|P2|Overall Study|Family Problem|0
428605|NCT00522379|1430242|P1|Overall Study|Family Problem|0
428606|NCT00522379|1430238|P5|Overall Study|Sponsor Request|0
428607|NCT00522379|1430239|P4|Overall Study|Sponsor Request|0
428608|NCT00522379|1430240|P3|Overall Study|Sponsor Request|0
428609|NCT00522379|1430241|P2|Overall Study|Sponsor Request|1
428610|NCT00522379|1430242|P1|Overall Study|Sponsor Request|0
428611|NCT00522379|1430238|P5|Overall Study|Subject Moved|0
428612|NCT00522379|1430239|P4|Overall Study|Subject Moved|0
428613|NCT00522379|1430240|P3|Overall Study|Subject Moved|0
428614|NCT00522379|1430241|P2|Overall Study|Subject Moved|1
428615|NCT00522379|1430242|P1|Overall Study|Subject Moved|1
428616|NCT00522379|1430238|P5|Overall Study|Dispensing error|0
428617|NCT00522379|1430239|P4|Overall Study|Dispensing error|1
428618|NCT00522379|1430240|P3|Overall Study|Dispensing error|0
428619|NCT00522379|1430241|P2|Overall Study|Dispensing error|0
428620|NCT00522379|1430242|P1|Overall Study|Dispensing error|1
428621|NCT00522379|1430238|P5|Overall Study|Randomization error|1
428622|NCT00522379|1430239|P4|Overall Study|Randomization error|0
428623|NCT00522379|1430240|P3|Overall Study|Randomization error|0
428624|NCT00522379|1430241|P2|Overall Study|Randomization error|0
428625|NCT00522379|1430242|P1|Overall Study|Randomization error|0
428626|NCT00522379|1430238|P5|Overall Study|Lost to Follow-up|2
428627|NCT00522379|1430239|P4|Overall Study|Lost to Follow-up|2
428628|NCT00522379|1430240|P3|Overall Study|Lost to Follow-up|4
428629|NCT00522379|1430241|P2|Overall Study|Lost to Follow-up|0
428630|NCT00522379|1430242|P1|Overall Study|Lost to Follow-up|1
428631|NCT00522379|1430238|P5|Overall Study|Unsatisfactory Subject Compliance|0
428632|NCT00522379|1430239|P4|Overall Study|Unsatisfactory Subject Compliance|0
428633|NCT00522379|1430240|P3|Overall Study|Unsatisfactory Subject Compliance|0
428634|NCT00522379|1430241|P2|Overall Study|Unsatisfactory Subject Compliance|2
428635|NCT00522379|1430242|P1|Overall Study|Unsatisfactory Subject Compliance|1
428636|NCT00522379|1430238|P5|Overall Study|Protocol Violation|0
428637|NCT00522379|1430239|P4|Overall Study|Protocol Violation|0
428638|NCT00522379|1430240|P3|Overall Study|Protocol Violation|2
428639|NCT00522379|1430241|P2|Overall Study|Protocol Violation|1
428640|NCT00522379|1430242|P1|Overall Study|Protocol Violation|1
428641|NCT00522379|1430238|P5|Overall Study|Withdrawal by Subject|0
428642|NCT00522379|1430239|P4|Overall Study|Withdrawal by Subject|2
428643|NCT00522379|1430240|P3|Overall Study|Withdrawal by Subject|1
428644|NCT00522379|1430241|P2|Overall Study|Withdrawal by Subject|3
428645|NCT00522379|1430242|P1|Overall Study|Withdrawal by Subject|2
428646|NCT00522379|1430238|P5|Overall Study|Lack of Efficacy|7
428647|NCT00522379|1430239|P4|Overall Study|Lack of Efficacy|2
428648|NCT00522379|1430240|P3|Overall Study|Lack of Efficacy|2
428649|NCT00522379|1430241|P2|Overall Study|Lack of Efficacy|0
428650|NCT00522379|1430242|P1|Overall Study|Lack of Efficacy|3
428651|NCT00522379|1430238|P5|Overall Study|Adverse Event|17
428652|NCT00522379|1430239|P4|Overall Study|Adverse Event|5
428653|NCT00522379|1430240|P3|Overall Study|Adverse Event|12
428654|NCT00522379|1430241|P2|Overall Study|Adverse Event|15
428655|NCT00522379|1430242|P1|Overall Study|Adverse Event|12
428656|NCT00522301|1430344|P1|Overall Study|Adverse Event|5
428657|NCT00522301|1430344|P1|Overall Study|Withdrawal by Subject|1
428658|NCT00522275|1430348|P1|Overall Study|Other: Subject had surgery for epilepsy|2
428659|NCT00522275|1430348|P1|Overall Study|Other: Subject ran out of medication|1
428660|NCT00522275|1430348|P1|Overall Study|Other: Sponsor request|2
428661|NCT00522275|1430348|P1|Overall Study|Other: Travel to / from site difficulty|3
428662|NCT00522275|1430348|P1|Overall Study|Other: Site / clinic closed|4
428663|NCT00522275|1430348|P1|Overall Study|Other: Subject arrested|1
428664|NCT00522275|1430348|P1|Overall Study|Other: Subject relocated|2
428665|NCT00522275|1430348|P1|Overall Study|Other: Subject is pregnant|2
428666|NCT00522275|1430348|P1|Overall Study|Other: Subject wants to become pregnant|2
428667|NCT00522275|1430348|P1|Overall Study|Lost to Follow-up|8
428668|NCT00522275|1430348|P1|Overall Study|Unsatisfactory compliance|11
428669|NCT00522275|1430348|P1|Overall Study|Protocol deviation|1
428670|NCT00522275|1430348|P1|Overall Study|Subject withdrew consent|16
428671|NCT00522275|1430348|P1|Overall Study|Lack of Efficacy|80
428672|NCT00522275|1430348|P1|Overall Study|Adverse Event|35
428673|NCT00522041|1430369|P2|Overall Study|Did not receive treatment|1
428674|NCT00522041|1430370|P1|Overall Study|Did not receive treatment|0
428675|NCT00522041|1430369|P2|Overall Study|Voluntary withdrawal|4
428676|NCT00522041|1430370|P1|Overall Study|Voluntary withdrawal|5
428677|NCT00522041|1430369|P2|Overall Study|Lost to Follow-up|4
428678|NCT00522041|1430370|P1|Overall Study|Lost to Follow-up|1
428679|NCT00522041|1430369|P2|Overall Study|Protocol Violation|0
428680|NCT00522041|1430370|P1|Overall Study|Protocol Violation|2
428681|NCT00522041|1430369|P2|Overall Study|Adverse Event|3
428682|NCT00522041|1430370|P1|Overall Study|Adverse Event|9
428683|NCT00521599|1430429|P3|Overall Study|Did not meet protocol eligibility|1
428684|NCT00521599|1430430|P2|Overall Study|Did not meet protocol eligibility|2
428685|NCT00521599|1430431|P1|Overall Study|Did not meet protocol eligibility|2
428686|NCT00521599|1430429|P3|Overall Study|Protocol Violation|2
428687|NCT00521599|1430430|P2|Overall Study|Protocol Violation|4
428688|NCT00521599|1430431|P1|Overall Study|Protocol Violation|2
428689|NCT00521599|1430429|P3|Overall Study|Withdrawal by subject treatment related|2
428690|NCT00521599|1430430|P2|Overall Study|Withdrawal by subject treatment related|1
428691|NCT00521599|1430431|P1|Overall Study|Withdrawal by subject treatment related|3
428692|NCT00521599|1430429|P3|Overall Study|Withdrawal by Subject|1
428693|NCT00521599|1430430|P2|Overall Study|Withdrawal by Subject|5
428694|NCT00521599|1430431|P1|Overall Study|Withdrawal by Subject|3
428695|NCT00521599|1430429|P3|Overall Study|Lost to Follow-up|2
428696|NCT00521599|1430430|P2|Overall Study|Lost to Follow-up|1
428697|NCT00521599|1430431|P1|Overall Study|Lost to Follow-up|2
428698|NCT00521599|1430429|P3|Overall Study|Treatment Failure|22
428699|NCT00521599|1430430|P2|Overall Study|Treatment Failure|9
428700|NCT00521599|1430431|P1|Overall Study|Treatment Failure|8
428701|NCT00521599|1430429|P3|Overall Study|Adverse Event|6
428702|NCT00521599|1430430|P2|Overall Study|Adverse Event|7
428703|NCT00521599|1430431|P1|Overall Study|Adverse Event|5
428704|NCT00521586|1430442|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
428705|NCT00521586|1430443|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
428706|NCT00521586|1430442|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
428707|NCT00521586|1430443|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
428708|NCT00521586|1430442|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
428709|NCT00521586|1430443|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
428710|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
428711|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
428712|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
428713|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
428714|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
428715|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
428716|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
428717|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
428718|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
428719|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
428720|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
428721|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
428722|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
428723|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
428724|NCT00521586|1430442|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
428725|NCT00521586|1430443|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
428726|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Failed to return|1
428727|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Failed to return|0
428728|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Death|0
428729|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Death|1
428730|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Adverse Event|1
428731|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Adverse Event|0
428732|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Investigator request|0
428733|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Investigator request|2
428734|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Other, unspecified|1
428735|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Other, unspecified|3
428736|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Protocol Violation|5
428737|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Protocol Violation|2
428738|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
428739|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
428740|NCT00521586|1430442|P2|Initial Vaccination (Year 0)|Subject request|11
428741|NCT00521586|1430443|P1|Initial Vaccination (Year 0)|Subject request|8
428742|NCT00521365|1430516|P1|Overall Study|Usage of not allowed drugs|6
428743|NCT00521365|1430516|P1|Overall Study|Drug compliance|3
428744|NCT00521365|1430516|P1|Overall Study|Protocol deviation|2
428745|NCT00521365|1430516|P1|Overall Study|Lost to Follow-up|6
428746|NCT00521365|1430516|P1|Overall Study|Adverse Event|3
428747|NCT00521339|1430546|P3|Treatment Extension Phase|Death|1
428748|NCT00521339|1430547|P2|Treatment Extension Phase|Death|0
428749|NCT00521339|1430548|P1|Treatment Extension Phase|Death|0
428750|NCT00521339|1430546|P3|Treatment Extension Phase|Withdrawal by Subject|2
428751|NCT00521339|1430547|P2|Treatment Extension Phase|Withdrawal by Subject|0
428752|NCT00521339|1430548|P1|Treatment Extension Phase|Withdrawal by Subject|0
428753|NCT00521339|1430546|P3|Treatment Phase|Protocol Violation|0
428754|NCT00521339|1430547|P2|Treatment Phase|Protocol Violation|0
428755|NCT00521339|1430548|P1|Treatment Phase|Protocol Violation|1
428756|NCT00521339|1430546|P3|Treatment Phase|Lost to Follow-up|0
428757|NCT00521339|1430547|P2|Treatment Phase|Lost to Follow-up|0
428758|NCT00521339|1430548|P1|Treatment Phase|Lost to Follow-up|1
428759|NCT00521339|1430546|P3|Treatment Phase|Withdrawal by Subject|0
428760|NCT00521339|1430547|P2|Treatment Phase|Withdrawal by Subject|0
428761|NCT00521339|1430548|P1|Treatment Phase|Withdrawal by Subject|3
428762|NCT00521339|1430546|P3|Treatment Phase|Lack of Efficacy|0
428763|NCT00521339|1430547|P2|Treatment Phase|Lack of Efficacy|0
428764|NCT00521339|1430548|P1|Treatment Phase|Lack of Efficacy|3
428765|NCT00521339|1430546|P3|Treatment Phase|Intolerability to study drug|0
428766|NCT00521339|1430547|P2|Treatment Phase|Intolerability to study drug|0
428767|NCT00521339|1430548|P1|Treatment Phase|Intolerability to study drug|2
428768|NCT00521339|1430546|P3|Treatment Phase|Adverse Event|0
428769|NCT00521339|1430547|P2|Treatment Phase|Adverse Event|0
428770|NCT00521339|1430548|P1|Treatment Phase|Adverse Event|2
428771|NCT00521144|1430616|P5|Overall Study|Progressive Disease|6
428772|NCT00521144|1430617|P4|Overall Study|Progressive Disease|0
428773|NCT00521144|1430618|P3|Overall Study|Progressive Disease|2
428774|NCT00521144|1430619|P2|Overall Study|Progressive Disease|2
428775|NCT00521144|1430620|P1|Overall Study|Progressive Disease|4
428776|NCT00521144|1430616|P5|Overall Study|Adverse Event|1
428777|NCT00521144|1430617|P4|Overall Study|Adverse Event|0
428778|NCT00521144|1430618|P3|Overall Study|Adverse Event|0
428779|NCT00521144|1430619|P2|Overall Study|Adverse Event|1
428780|NCT00521144|1430620|P1|Overall Study|Adverse Event|0
428781|NCT00521144|1430616|P5|Overall Study|Not Treated|0
428782|NCT00521144|1430617|P4|Overall Study|Not Treated|1
428783|NCT00521144|1430618|P3|Overall Study|Not Treated|0
428784|NCT00521144|1430619|P2|Overall Study|Not Treated|0
428785|NCT00521144|1430620|P1|Overall Study|Not Treated|0
428786|NCT00521079|1430634|P2|Overall Study|Withdrawal by Subject|3
428787|NCT00521079|1430635|P1|Overall Study|Withdrawal by Subject|5
428788|NCT00521079|1430634|P2|Overall Study|Lost to Follow-up|1
428789|NCT00521079|1430635|P1|Overall Study|Lost to Follow-up|2
428790|NCT00521079|1430634|P2|Overall Study|Adverse Event|1
428791|NCT00521079|1430635|P1|Overall Study|Adverse Event|7
428792|NCT00521053|1430645|P1|Observation Phase|Physician Decision|1
428793|NCT00521053|1430645|P1|Observation Phase|Other non-study melanoma treatment|1
428794|NCT00521053|1430645|P1|Observation Phase|Adverse Event|1
428795|NCT00521053|1430645|P1|Observation Phase|Death|2
428796|NCT00521053|1430645|P1|Observation Phase|Additional PV-10 via alternate protocol|8
428797|NCT00521053|1430645|P1|Observation Phase|Disease Progression|55
428798|NCT00521014|1430655|P1|Overall Study|Inevaluable, not treated|1
428799|NCT00521001|1430659|P1|Overall Study|Ineligible|1
428800|NCT00520975|1430668|P2|Overall Study|Not start protocol therapy|2
428801|NCT00520975|1430669|P1|Overall Study|Not start protocol therapy|1
428802|NCT00520975|1430668|P2|Overall Study|Other reasons|2
428803|NCT00520975|1430669|P1|Overall Study|Other reasons|4
428804|NCT00520975|1430668|P2|Overall Study|Other therapy|4
428805|NCT00520975|1430669|P1|Overall Study|Other therapy|2
428806|NCT00520975|1430668|P2|Overall Study|Withdrawal by Subject|5
428807|NCT00520975|1430669|P1|Overall Study|Withdrawal by Subject|3
428808|NCT00520975|1430668|P2|Overall Study|Death|2
428809|NCT00520975|1430669|P1|Overall Study|Death|0
428810|NCT00520975|1430668|P2|Overall Study|Adverse Event|10
428811|NCT00520975|1430669|P1|Overall Study|Adverse Event|7
428812|NCT00520975|1430668|P2|Overall Study|Disease progression|23
428813|NCT00520975|1430669|P1|Overall Study|Disease progression|31
428814|NCT00520936|1430701|P8|Overall Study|Protocol Violation|0
428815|NCT00520936|1430702|P7|Overall Study|Protocol Violation|1
428816|NCT00520936|1430703|P6|Overall Study|Protocol Violation|0
428817|NCT00520936|1430704|P5|Overall Study|Protocol Violation|1
428818|NCT00520936|1430705|P4|Overall Study|Protocol Violation|0
428819|NCT00520936|1430706|P3|Overall Study|Protocol Violation|1
428820|NCT00520936|1430707|P2|Overall Study|Protocol Violation|1
428821|NCT00520936|1430708|P1|Overall Study|Protocol Violation|0
428822|NCT00520936|1430701|P8|Overall Study|Death|0
428823|NCT00520936|1430702|P7|Overall Study|Death|1
428824|NCT00520936|1430703|P6|Overall Study|Death|0
428825|NCT00520936|1430704|P5|Overall Study|Death|0
428826|NCT00520936|1430705|P4|Overall Study|Death|0
428827|NCT00520936|1430706|P3|Overall Study|Death|0
428828|NCT00520936|1430707|P2|Overall Study|Death|0
428829|NCT00520936|1430708|P1|Overall Study|Death|0
428830|NCT00520936|1430701|P8|Overall Study|Toxicity Requiring Removal from Study|0
428831|NCT00520936|1430702|P7|Overall Study|Toxicity Requiring Removal from Study|2
428832|NCT00520936|1430703|P6|Overall Study|Toxicity Requiring Removal from Study|0
428833|NCT00520936|1430704|P5|Overall Study|Toxicity Requiring Removal from Study|0
428834|NCT00520936|1430705|P4|Overall Study|Toxicity Requiring Removal from Study|0
428835|NCT00520936|1430706|P3|Overall Study|Toxicity Requiring Removal from Study|0
428836|NCT00520936|1430707|P2|Overall Study|Toxicity Requiring Removal from Study|1
428837|NCT00520936|1430708|P1|Overall Study|Toxicity Requiring Removal from Study|0
428838|NCT00520936|1430701|P8|Overall Study|Withdrawal by Subject|1
428839|NCT00520936|1430702|P7|Overall Study|Withdrawal by Subject|0
428840|NCT00520936|1430703|P6|Overall Study|Withdrawal by Subject|0
428841|NCT00520936|1430704|P5|Overall Study|Withdrawal by Subject|0
428842|NCT00520936|1430705|P4|Overall Study|Withdrawal by Subject|0
428843|NCT00520936|1430706|P3|Overall Study|Withdrawal by Subject|0
428844|NCT00520936|1430707|P2|Overall Study|Withdrawal by Subject|0
428845|NCT00520936|1430708|P1|Overall Study|Withdrawal by Subject|0
428846|NCT00520936|1430701|P8|Overall Study|Physician Decision|0
428847|NCT00520936|1430702|P7|Overall Study|Physician Decision|0
428848|NCT00520936|1430703|P6|Overall Study|Physician Decision|0
428849|NCT00520936|1430704|P5|Overall Study|Physician Decision|0
428850|NCT00520936|1430705|P4|Overall Study|Physician Decision|0
428851|NCT00520936|1430706|P3|Overall Study|Physician Decision|1
428852|NCT00520936|1430707|P2|Overall Study|Physician Decision|2
428853|NCT00520936|1430708|P1|Overall Study|Physician Decision|0
428854|NCT00520845|1430735|P1|Overall Study|Alternative Therapy|1
428855|NCT00520845|1430735|P1|Overall Study|Withdrawal by Subject|1
428856|NCT00520845|1430735|P1|Overall Study|Disease Progression, relapse|13
428857|NCT00520845|1430735|P1|Overall Study|Adverse Event|4
428858|NCT00520845|1430735|P1|Overall Study|Death|3
428859|NCT00520767|1430743|P1|Overall Study|Death|2
428860|NCT00520741|1430749|P2|Overall Study|Other reasons for premature termination|6
428861|NCT00520741|1430750|P1|Overall Study|Other reasons for premature termination|0
428862|NCT00520741|1430749|P2|Overall Study|Lost to Follow-up|4
428863|NCT00520741|1430750|P1|Overall Study|Lost to Follow-up|4
428864|NCT00520741|1430749|P2|Overall Study|Unsatisfactory compliance of subject|3
428865|NCT00520741|1430750|P1|Overall Study|Unsatisfactory compliance of subject|4
428866|NCT00520741|1430749|P2|Overall Study|Protocol Violation|15
428867|NCT00520741|1430750|P1|Overall Study|Protocol Violation|2
428868|NCT00520741|1430749|P2|Overall Study|Withdrawal by Subject|11
428869|NCT00520741|1430750|P1|Overall Study|Withdrawal by Subject|0
428870|NCT00520741|1430749|P2|Overall Study|Lack of Efficacy|30
428871|NCT00520741|1430750|P1|Overall Study|Lack of Efficacy|11
428872|NCT00520741|1430749|P2|Overall Study|Adverse Event|56
428873|NCT00520741|1430750|P1|Overall Study|Adverse Event|16
428874|NCT00520676|1430768|P2|Overall Study|Withdrawal by Subject|11
428875|NCT00520676|1430769|P1|Overall Study|Withdrawal by Subject|7
428876|NCT00520676|1430768|P2|Overall Study|Physician Decision|1
428877|NCT00520676|1430769|P1|Overall Study|Physician Decision|4
428878|NCT00520676|1430768|P2|Overall Study|Lost to Follow-up|10
428879|NCT00520676|1430769|P1|Overall Study|Lost to Follow-up|6
428880|NCT00520676|1430768|P2|Overall Study|Death|81
428881|NCT00520676|1430769|P1|Overall Study|Death|84
428882|NCT00520572|1430795|P6|Overall Study|Did not receive Treatment|0
428883|NCT00520572|1430796|P5|Overall Study|Did not receive Treatment|0
428884|NCT00520572|1430797|P4|Overall Study|Did not receive Treatment|0
428885|NCT00520572|1430798|P3|Overall Study|Did not receive Treatment|1
428886|NCT00520572|1430799|P2|Overall Study|Did not receive Treatment|0
428887|NCT00520572|1430800|P1|Overall Study|Did not receive Treatment|1
428888|NCT00520572|1430795|P6|Overall Study|Long break in taking Medication|0
428889|NCT00520572|1430796|P5|Overall Study|Long break in taking Medication|0
428890|NCT00520572|1430797|P4|Overall Study|Long break in taking Medication|1
428891|NCT00520572|1430798|P3|Overall Study|Long break in taking Medication|0
428892|NCT00520572|1430799|P2|Overall Study|Long break in taking Medication|0
428893|NCT00520572|1430800|P1|Overall Study|Long break in taking Medication|0
428894|NCT00520572|1430795|P6|Overall Study|Oral corticotherapy for acute urticaria|0
428895|NCT00520572|1430796|P5|Overall Study|Oral corticotherapy for acute urticaria|0
428896|NCT00520572|1430797|P4|Overall Study|Oral corticotherapy for acute urticaria|0
428897|NCT00520572|1430798|P3|Overall Study|Oral corticotherapy for acute urticaria|0
428898|NCT00520572|1430799|P2|Overall Study|Oral corticotherapy for acute urticaria|1
428899|NCT00520572|1430800|P1|Overall Study|Oral corticotherapy for acute urticaria|0
428900|NCT00520572|1430795|P6|Overall Study|Incorrect enrollment|0
428901|NCT00520572|1430796|P5|Overall Study|Incorrect enrollment|1
428902|NCT00520572|1430797|P4|Overall Study|Incorrect enrollment|0
428903|NCT00520572|1430798|P3|Overall Study|Incorrect enrollment|1
428904|NCT00520572|1430799|P2|Overall Study|Incorrect enrollment|0
428905|NCT00520572|1430800|P1|Overall Study|Incorrect enrollment|1
428906|NCT00520572|1430795|P6|Overall Study|Lost to Follow-up|0
428907|NCT00520572|1430796|P5|Overall Study|Lost to Follow-up|1
428908|NCT00520572|1430797|P4|Overall Study|Lost to Follow-up|0
428909|NCT00520572|1430798|P3|Overall Study|Lost to Follow-up|0
428910|NCT00520572|1430799|P2|Overall Study|Lost to Follow-up|0
428911|NCT00520572|1430800|P1|Overall Study|Lost to Follow-up|0
428912|NCT00520572|1430795|P6|Overall Study|Lack of Efficacy|0
428913|NCT00520572|1430796|P5|Overall Study|Lack of Efficacy|1
428914|NCT00520572|1430797|P4|Overall Study|Lack of Efficacy|2
428915|NCT00520572|1430798|P3|Overall Study|Lack of Efficacy|1
428916|NCT00520572|1430799|P2|Overall Study|Lack of Efficacy|1
428917|NCT00520572|1430800|P1|Overall Study|Lack of Efficacy|1
428918|NCT00520572|1430795|P6|Overall Study|Protocol Violation|0
428919|NCT00520572|1430796|P5|Overall Study|Protocol Violation|0
428920|NCT00520572|1430797|P4|Overall Study|Protocol Violation|0
428921|NCT00520572|1430798|P3|Overall Study|Protocol Violation|1
428922|NCT00520572|1430799|P2|Overall Study|Protocol Violation|0
428923|NCT00520572|1430800|P1|Overall Study|Protocol Violation|0
428924|NCT00520572|1430795|P6|Overall Study|Withdrawal by Subject|0
428925|NCT00520572|1430796|P5|Overall Study|Withdrawal by Subject|2
428926|NCT00520572|1430797|P4|Overall Study|Withdrawal by Subject|2
428927|NCT00520572|1430798|P3|Overall Study|Withdrawal by Subject|5
428928|NCT00520572|1430799|P2|Overall Study|Withdrawal by Subject|9
428929|NCT00520572|1430800|P1|Overall Study|Withdrawal by Subject|0
428930|NCT00520572|1430795|P6|Overall Study|Adverse Event|2
428931|NCT00520572|1430796|P5|Overall Study|Adverse Event|7
428932|NCT00520572|1430797|P4|Overall Study|Adverse Event|9
428933|NCT00520572|1430798|P3|Overall Study|Adverse Event|6
428934|NCT00520572|1430799|P2|Overall Study|Adverse Event|3
428935|NCT00520572|1430800|P1|Overall Study|Adverse Event|9
428936|NCT00520546|1430838|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
428937|NCT00520546|1430838|P1|Overall Study|Withdrawal by Subject|1
428938|NCT00520494|1430853|P1|Overall Study|Withdrawal by Subject|1
428939|NCT00520403|1430880|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
428940|NCT00520403|1430880|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
428941|NCT00520403|1430880|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
428942|NCT00520403|1430880|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
428943|NCT00520403|1430880|P1|Bevacizumab + IFN/Vinblastine|Death|2
428944|NCT00520403|1430880|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
428945|NCT00520403|1430880|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
428946|NCT00520403|1430880|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
428947|NCT00520351|1430889|P2|First Intervention|Withdrawal by Subject|1
428948|NCT00520351|1430890|P1|First Intervention|Withdrawal by Subject|1
428949|NCT00520299|1430905|P3|Overall Study|Progressive disease|4
428950|NCT00520299|1430906|P2|Overall Study|Progressive disease|3
428951|NCT00520299|1430907|P1|Overall Study|Progressive disease|0
428952|NCT00520299|1430905|P3|Overall Study|Withdrawal by Subject|2
428953|NCT00520299|1430906|P2|Overall Study|Withdrawal by Subject|0
428954|NCT00520299|1430907|P1|Overall Study|Withdrawal by Subject|0
428955|NCT00520130|1430962|P2|Overall Study|Physician Decision|1
428956|NCT00520130|1430963|P1|Overall Study|Physician Decision|1
428957|NCT00520130|1430962|P2|Overall Study|Disease progression on study|0
428958|NCT00520130|1430963|P1|Overall Study|Disease progression on study|4
428959|NCT00520039|1431005|P2|Overall Study|Exclusion criteria met at first visit|5
428960|NCT00520039|1431006|P1|Overall Study|Exclusion criteria met at first visit|7
428961|NCT00520013|1431019|P3|Overall Study|Physician Decision|3
428962|NCT00520013|1431020|P2|Overall Study|Physician Decision|0
428963|NCT00520013|1431021|P1|Overall Study|Physician Decision|0
428964|NCT00520013|1431019|P3|Overall Study|Death|0
428965|NCT00520013|1431020|P2|Overall Study|Death|1
428966|NCT00520013|1431021|P1|Overall Study|Death|0
428967|NCT00520013|1431019|P3|Overall Study|Clinical Progression|0
428968|NCT00520013|1431020|P2|Overall Study|Clinical Progression|1
428969|NCT00520013|1431021|P1|Overall Study|Clinical Progression|3
428970|NCT00520013|1431019|P3|Overall Study|Progressive Disease|0
428971|NCT00520013|1431020|P2|Overall Study|Progressive Disease|3
428972|NCT00520013|1431021|P1|Overall Study|Progressive Disease|7
428973|NCT00520013|1431019|P3|Overall Study|Adverse Event|7
428974|NCT00520013|1431020|P2|Overall Study|Adverse Event|10
428975|NCT00520013|1431021|P1|Overall Study|Adverse Event|2
428976|NCT00520013|1431019|P3|Overall Study|Withdrawal by Subject|1
428977|NCT00520013|1431020|P2|Overall Study|Withdrawal by Subject|0
428978|NCT00520013|1431021|P1|Overall Study|Withdrawal by Subject|0
428979|NCT00519896|1431031|P1|Overall Study|Adverse Event|1
428980|NCT00519896|1431031|P1|Overall Study|Protocol Violation|1
428981|NCT00519831|1431037|P1|Overall Study|Adverse Event|3
428982|NCT00519779|1431054|P2|Overall Study|Withdrawal by Subject|1
428983|NCT00519779|1431055|P1|Overall Study|Withdrawal by Subject|0
428984|NCT00519649|1431071|P1|Overall Study|Withdrawal by Subject|1
429067|NCT00519428|1431161|P3|Overall Study|Lost to Follow-up|6
428985|NCT00519636|1431084|P4|Post Study Period|Subject randomized in error|1
428986|NCT00519636|1431085|P3|Post Study Period|Subject randomized in error|0
428987|NCT00519636|1431086|P2|Post Study Period|Subject randomized in error|0
428988|NCT00519636|1431087|P1|Post Study Period|Subject randomized in error|0
428989|NCT00519636|1431084|P4|Treatment Period 2|Subject misrandomized|1
428990|NCT00519636|1431085|P3|Treatment Period 2|Subject misrandomized|0
428991|NCT00519636|1431086|P2|Treatment Period 2|Subject misrandomized|0
428992|NCT00519636|1431087|P1|Treatment Period 2|Subject misrandomized|0
428993|NCT00519636|1431084|P4|Treatment Period 2|Per doctors request|0
428994|NCT00519636|1431085|P3|Treatment Period 2|Per doctors request|1
428995|NCT00519636|1431086|P2|Treatment Period 2|Per doctors request|0
428996|NCT00519636|1431087|P1|Treatment Period 2|Per doctors request|0
428997|NCT00519636|1431084|P4|Treatment Period 2|Subject randomized in error|0
428998|NCT00519636|1431085|P3|Treatment Period 2|Subject randomized in error|0
428999|NCT00519636|1431086|P2|Treatment Period 2|Subject randomized in error|1
429000|NCT00519636|1431087|P1|Treatment Period 2|Subject randomized in error|0
429001|NCT00519636|1431084|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
429002|NCT00519636|1431085|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
429003|NCT00519636|1431086|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
429004|NCT00519636|1431087|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
429005|NCT00519636|1431084|P4|Washout Period|Prohibited medications|0
429006|NCT00519636|1431085|P3|Washout Period|Prohibited medications|1
429007|NCT00519636|1431086|P2|Washout Period|Prohibited medications|0
429008|NCT00519636|1431087|P1|Washout Period|Prohibited medications|0
429009|NCT00519636|1431084|P4|Washout Period|Subject randomized in error|0
429010|NCT00519636|1431085|P3|Washout Period|Subject randomized in error|1
429011|NCT00519636|1431086|P2|Washout Period|Subject randomized in error|0
429012|NCT00519636|1431087|P1|Washout Period|Subject randomized in error|0
429013|NCT00519636|1431084|P4|Washout Period|Per doctors request|0
429014|NCT00519636|1431085|P3|Washout Period|Per doctors request|0
429015|NCT00519636|1431086|P2|Washout Period|Per doctors request|1
429016|NCT00519636|1431087|P1|Washout Period|Per doctors request|0
429017|NCT00519636|1431084|P4|Washout Period|Non-compliant|0
429018|NCT00519636|1431085|P3|Washout Period|Non-compliant|0
429019|NCT00519636|1431086|P2|Washout Period|Non-compliant|1
429020|NCT00519636|1431087|P1|Washout Period|Non-compliant|0
429021|NCT00519636|1431084|P4|Washout Period|Participating in study at another site|0
429022|NCT00519636|1431085|P3|Washout Period|Participating in study at another site|0
429023|NCT00519636|1431086|P2|Washout Period|Participating in study at another site|0
429024|NCT00519636|1431087|P1|Washout Period|Participating in study at another site|1
429025|NCT00519636|1431084|P4|Washout Period|Out of pollen area > 48 hours|0
429026|NCT00519636|1431085|P3|Washout Period|Out of pollen area > 48 hours|0
429027|NCT00519636|1431086|P2|Washout Period|Out of pollen area > 48 hours|0
429028|NCT00519636|1431087|P1|Washout Period|Out of pollen area > 48 hours|1
429029|NCT00519636|1431084|P4|Washout Period|Failed to meet continuation criteria|3
429030|NCT00519636|1431085|P3|Washout Period|Failed to meet continuation criteria|9
429031|NCT00519636|1431086|P2|Washout Period|Failed to meet continuation criteria|11
429032|NCT00519636|1431087|P1|Washout Period|Failed to meet continuation criteria|14
429033|NCT00519636|1431084|P4|Washout Period|Withdrawal by Subject|0
429034|NCT00519636|1431085|P3|Washout Period|Withdrawal by Subject|1
429035|NCT00519636|1431086|P2|Washout Period|Withdrawal by Subject|0
429036|NCT00519636|1431087|P1|Washout Period|Withdrawal by Subject|1
429037|NCT00519636|1431084|P4|Washout Period|Protocol Violation|2
429038|NCT00519636|1431085|P3|Washout Period|Protocol Violation|1
429039|NCT00519636|1431086|P2|Washout Period|Protocol Violation|0
429040|NCT00519636|1431087|P1|Washout Period|Protocol Violation|0
429041|NCT00519636|1431084|P4|Washout Period|Lost to Follow-up|0
429042|NCT00519636|1431085|P3|Washout Period|Lost to Follow-up|0
429043|NCT00519636|1431086|P2|Washout Period|Lost to Follow-up|0
429044|NCT00519636|1431087|P1|Washout Period|Lost to Follow-up|1
429045|NCT00519636|1431084|P4|Washout Period|Adverse Event|0
429046|NCT00519636|1431085|P3|Washout Period|Adverse Event|1
429047|NCT00519636|1431086|P2|Washout Period|Adverse Event|1
429048|NCT00519636|1431087|P1|Washout Period|Adverse Event|2
429049|NCT00519636|1431084|P4|Treatment Period 1|Sponsor request due to missed visit|0
429050|NCT00519636|1431085|P3|Treatment Period 1|Sponsor request due to missed visit|0
429051|NCT00519636|1431086|P2|Treatment Period 1|Sponsor request due to missed visit|0
429052|NCT00519636|1431087|P1|Treatment Period 1|Sponsor request due to missed visit|1
429053|NCT00519636|1431084|P4|Treatment Period 1|Adverse Event|0
429054|NCT00519636|1431085|P3|Treatment Period 1|Adverse Event|1
429055|NCT00519636|1431086|P2|Treatment Period 1|Adverse Event|0
429056|NCT00519636|1431087|P1|Treatment Period 1|Adverse Event|1
429057|NCT00519623|1431117|P1|Overall Study|Adverse Event|1
429058|NCT00519532|1431151|P1|Overall Study|Lost to Follow-up|2
429059|NCT00519532|1431151|P1|Overall Study|Withdrawal by Subject|5
429060|NCT00519532|1431151|P1|Overall Study|Adverse Event|11
429061|NCT00519428|1431161|P3|Overall Study|unstated|2
429062|NCT00519428|1431162|P2|Overall Study|unstated|3
429063|NCT00519428|1431163|P1|Overall Study|unstated|1
429064|NCT00519428|1431161|P3|Overall Study|Withdrawal by Subject|7
429065|NCT00519428|1431162|P2|Overall Study|Withdrawal by Subject|3
429066|NCT00519428|1431163|P1|Overall Study|Withdrawal by Subject|8
429068|NCT00519428|1431162|P2|Overall Study|Lost to Follow-up|7
429069|NCT00519428|1431163|P1|Overall Study|Lost to Follow-up|7
429070|NCT00519428|1431161|P3|Overall Study|Adverse Event|10
429071|NCT00519428|1431162|P2|Overall Study|Adverse Event|2
429072|NCT00519428|1431163|P1|Overall Study|Adverse Event|5
429073|NCT00519376|1431183|P16|Treatment Period 4|Lost to Follow-up|0
429074|NCT00519376|1431184|P15|Treatment Period 4|Lost to Follow-up|0
429075|NCT00519376|1431185|P14|Treatment Period 4|Lost to Follow-up|0
429076|NCT00519376|1431186|P13|Treatment Period 4|Lost to Follow-up|0
429077|NCT00519376|1431187|P12|Treatment Period 4|Lost to Follow-up|0
429078|NCT00519376|1431188|P11|Treatment Period 4|Lost to Follow-up|0
429079|NCT00519376|1431189|P10|Treatment Period 4|Lost to Follow-up|0
429080|NCT00519376|1431190|P9|Treatment Period 4|Lost to Follow-up|0
429081|NCT00519376|1431191|P8|Treatment Period 4|Lost to Follow-up|0
429082|NCT00519376|1431192|P7|Treatment Period 4|Lost to Follow-up|0
429083|NCT00519376|1431193|P6|Treatment Period 4|Lost to Follow-up|0
429084|NCT00519376|1431194|P5|Treatment Period 4|Lost to Follow-up|0
429085|NCT00519376|1431195|P4|Treatment Period 4|Lost to Follow-up|0
429086|NCT00519376|1431196|P3|Treatment Period 4|Lost to Follow-up|1
429087|NCT00519376|1431197|P2|Treatment Period 4|Lost to Follow-up|0
429088|NCT00519376|1431198|P1|Treatment Period 4|Lost to Follow-up|0
429089|NCT00519376|1431183|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429090|NCT00519376|1431184|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429091|NCT00519376|1431185|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429092|NCT00519376|1431186|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
429093|NCT00519376|1431187|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429094|NCT00519376|1431188|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429095|NCT00519376|1431189|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429096|NCT00519376|1431190|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429097|NCT00519376|1431191|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429098|NCT00519376|1431192|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429099|NCT00519376|1431193|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429100|NCT00519376|1431194|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429101|NCT00519376|1431195|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429102|NCT00519376|1431196|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429103|NCT00519376|1431197|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429104|NCT00519376|1431198|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
429105|NCT00519285|1431322|P2|Overall Study|Treatment ongoing|2
429106|NCT00519285|1431323|P1|Overall Study|Treatment ongoing|1
429107|NCT00519285|1431322|P2|Overall Study|Not treated|7
429108|NCT00519285|1431323|P1|Overall Study|Not treated|8
429109|NCT00519285|1431322|P2|Overall Study|Reason unspecified|8
429110|NCT00519285|1431323|P1|Overall Study|Reason unspecified|5
429111|NCT00519285|1431322|P2|Overall Study|Poor compliance to protocol|7
429112|NCT00519285|1431323|P1|Overall Study|Poor compliance to protocol|5
429113|NCT00519285|1431322|P2|Overall Study|Consent withdrawn|5
429114|NCT00519285|1431323|P1|Overall Study|Consent withdrawn|4
429115|NCT00519285|1431322|P2|Overall Study|Participant's request|84
429116|NCT00519285|1431323|P1|Overall Study|Participant's request|53
429117|NCT00519285|1431322|P2|Overall Study|Physician Decision|47
429118|NCT00519285|1431323|P1|Overall Study|Physician Decision|75
429119|NCT00519285|1431322|P2|Overall Study|Disease progression|186
429120|NCT00519285|1431323|P1|Overall Study|Disease progression|334
429121|NCT00519285|1431322|P2|Overall Study|Adverse Event|266
429122|NCT00519285|1431323|P1|Overall Study|Adverse Event|127
429123|NCT00519194|1431349|P1|Overall Study|Lost to Follow-up|3
429124|NCT00519194|1431349|P1|Overall Study|Death|9
429125|NCT00519194|1431349|P1|Overall Study|Withdrawal by Subject|9
429126|NCT00519077|1431364|P1|Overall Study|Other|2
429127|NCT00519077|1431364|P1|Overall Study|Death|6
429128|NCT00518986|1431371|P2|Overall Study|Non-Specific|1
429129|NCT00518986|1431372|P1|Overall Study|Non-Specific|2
429130|NCT00518986|1431371|P2|Overall Study|Withdrawal by Subject|4
429131|NCT00518986|1431372|P1|Overall Study|Withdrawal by Subject|4
429132|NCT00518986|1431371|P2|Overall Study|Protocol Violation|7
429133|NCT00518986|1431372|P1|Overall Study|Protocol Violation|5
429134|NCT00518986|1431371|P2|Overall Study|Physician Decision|3
429135|NCT00518986|1431372|P1|Overall Study|Physician Decision|0
429136|NCT00518986|1431371|P2|Overall Study|Lost to Follow-up|2
429137|NCT00518986|1431372|P1|Overall Study|Lost to Follow-up|3
429138|NCT00518986|1431371|P2|Overall Study|Lack of Efficacy|2
429139|NCT00518986|1431372|P1|Overall Study|Lack of Efficacy|0
429140|NCT00518986|1431371|P2|Overall Study|Adverse Event|7
429141|NCT00518986|1431372|P1|Overall Study|Adverse Event|12
429142|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
429143|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
429144|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Subject decision|0
429145|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Subject decision|2
429146|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
429147|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
429148|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
429149|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
429150|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Creatine increased|0
429151|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Creatine increased|1
429152|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Change in treatment|1
429153|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Change in treatment|1
429154|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
429155|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
429156|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
429157|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
429158|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
429159|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
429160|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
429161|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
429162|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
429163|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
429164|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
429165|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
429166|NCT00518882|1431498|P2|Open-Label Extension, Week 26-78|Adverse Event|9
429167|NCT00518882|1431499|P1|Open-Label Extension, Week 26-78|Adverse Event|3
429168|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Mutual consent|1
429169|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Mutual consent|0
429170|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
429171|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
429172|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
429173|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
429174|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Loss of trust|1
429175|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Loss of trust|0
429176|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
429177|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
429178|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Subject decision|1
429179|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Subject decision|1
429180|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Lost to follow up|1
429181|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Lost to follow up|2
429182|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
429183|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
429184|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Protocol Violation|3
429185|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Protocol Violation|4
429186|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
429187|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
429188|NCT00518882|1431498|P2|Double-Blind, Week 0-26|Adverse Event|31
429189|NCT00518882|1431499|P1|Double-Blind, Week 0-26|Adverse Event|23
429190|NCT00518687|1431680|P2|Overall Study|Withdrawal by Subject|110
429191|NCT00518687|1431681|P1|Overall Study|Withdrawal by Subject|110
429192|NCT00518687|1431680|P2|Overall Study|Study terminated by sponsor|918
429193|NCT00518687|1431681|P1|Overall Study|Study terminated by sponsor|930
429194|NCT00518687|1431680|P2|Overall Study|Protocol Violation|10
429195|NCT00518687|1431681|P1|Overall Study|Protocol Violation|8
429196|NCT00518687|1431680|P2|Overall Study|Progressive disease|2
429197|NCT00518687|1431681|P1|Overall Study|Progressive disease|2
429198|NCT00518687|1431680|P2|Overall Study|Physician Decision|48
429199|NCT00518687|1431681|P1|Overall Study|Physician Decision|42
429200|NCT00518687|1431680|P2|Overall Study|Lost to Follow-up|155
429201|NCT00518687|1431681|P1|Overall Study|Lost to Follow-up|144
429202|NCT00518687|1431680|P2|Overall Study|Adverse Event|177
429203|NCT00518687|1431681|P1|Overall Study|Adverse Event|201
429204|NCT00518622|1431701|P8|Overall Study|Study medication taken incorrectly|0
429205|NCT00518622|1431702|P7|Overall Study|Study medication taken incorrectly|0
429206|NCT00518622|1431703|P6|Overall Study|Study medication taken incorrectly|0
429207|NCT00518622|1431704|P5|Overall Study|Study medication taken incorrectly|0
429208|NCT00518622|1431705|P4|Overall Study|Study medication taken incorrectly|0
429209|NCT00518622|1431706|P3|Overall Study|Study medication taken incorrectly|0
429210|NCT00518622|1431707|P2|Overall Study|Study medication taken incorrectly|1
429211|NCT00518622|1431708|P1|Overall Study|Study medication taken incorrectly|0
429212|NCT00518622|1431701|P8|Overall Study|Lost to Follow-up|0
429213|NCT00518622|1431702|P7|Overall Study|Lost to Follow-up|0
429214|NCT00518622|1431703|P6|Overall Study|Lost to Follow-up|0
429215|NCT00518622|1431704|P5|Overall Study|Lost to Follow-up|0
429216|NCT00518622|1431705|P4|Overall Study|Lost to Follow-up|0
429217|NCT00518622|1431706|P3|Overall Study|Lost to Follow-up|1
429218|NCT00518622|1431707|P2|Overall Study|Lost to Follow-up|0
429219|NCT00518622|1431708|P1|Overall Study|Lost to Follow-up|0
429220|NCT00518531|1431736|P2|Treatment Period 2|Non-compliance|2
429221|NCT00518531|1431737|P1|Treatment Period 2|Non-compliance|1
429222|NCT00518531|1431736|P2|Treatment Period 2|Protocol-specified criteria|1
429223|NCT00518531|1431737|P1|Treatment Period 2|Protocol-specified criteria|0
429224|NCT00518531|1431736|P2|Treatment Period 2|Adverse Event|7
429225|NCT00518531|1431737|P1|Treatment Period 2|Adverse Event|1
429226|NCT00518531|1431736|P2|Treatment Period 2|Complete out of scheduled visit window|2
429227|NCT00518531|1431737|P1|Treatment Period 2|Complete out of scheduled visit window|1
429228|NCT00518531|1431736|P2|Treatment Period 2|Withdrawal by Subject|8
429229|NCT00518531|1431737|P1|Treatment Period 2|Withdrawal by Subject|0
429230|NCT00518531|1431736|P2|Treatment Period 1|Early crossover|3
429231|NCT00518531|1431737|P1|Treatment Period 1|Early crossover|1
429232|NCT00518531|1431736|P2|Treatment Period 1|Withdrawal by Subject|6
429233|NCT00518531|1431737|P1|Treatment Period 1|Withdrawal by Subject|4
429234|NCT00518531|1431736|P2|Treatment Period 1|Protocol Violation|0
429235|NCT00518531|1431737|P1|Treatment Period 1|Protocol Violation|2
429236|NCT00518531|1431736|P2|Treatment Period 1|Physician Decision|0
429237|NCT00518531|1431737|P1|Treatment Period 1|Physician Decision|1
429238|NCT00518531|1431736|P2|Treatment Period 1|Lost to Follow-up|3
429239|NCT00518531|1431737|P1|Treatment Period 1|Lost to Follow-up|5
429240|NCT00518531|1431736|P2|Treatment Period 1|Adverse Event|0
429241|NCT00518531|1431737|P1|Treatment Period 1|Adverse Event|5
429242|NCT00518336|1431782|P2|Year 9|Personal reasons|0
429243|NCT00518336|1431783|P1|Year 9|Personal reasons|1
429244|NCT00518336|1431782|P2|Year 9|Lost to Follow-up|0
429245|NCT00518336|1431783|P1|Year 9|Lost to Follow-up|3
429246|NCT00518336|1431782|P2|Year 9|Migrated/moved from study area|1
429247|NCT00518336|1431783|P1|Year 9|Migrated/moved from study area|1
429248|NCT00518336|1431782|P2|Year 8|Could not attend in time|1
429249|NCT00518336|1431783|P1|Year 8|Could not attend in time|0
429250|NCT00518336|1431782|P2|Year 8|Lost to Follow-up|1
429251|NCT00518336|1431783|P1|Year 8|Lost to Follow-up|1
429252|NCT00518336|1431782|P2|Year 7|Could not attend in time|3
429253|NCT00518336|1431783|P1|Year 7|Could not attend in time|0
429254|NCT00518336|1431782|P2|Year 7|Lost to Follow-up|0
429255|NCT00518336|1431783|P1|Year 7|Lost to Follow-up|2
429256|NCT00518323|1431949|P4|Overall Study|Prohibited medication and others|0
429257|NCT00518323|1431950|P3|Overall Study|Prohibited medication and others|1
429258|NCT00518323|1431951|P2|Overall Study|Prohibited medication and others|1
429259|NCT00518323|1431952|P1|Overall Study|Prohibited medication and others|3
429260|NCT00518323|1431949|P4|Overall Study|Adverse Event|0
429261|NCT00518323|1431950|P3|Overall Study|Adverse Event|1
429262|NCT00518323|1431951|P2|Overall Study|Adverse Event|1
429263|NCT00518323|1431952|P1|Overall Study|Adverse Event|1
429264|NCT00518323|1431949|P4|Overall Study|Lost to Follow-up|3
429265|NCT00518323|1431950|P3|Overall Study|Lost to Follow-up|1
429266|NCT00518323|1431951|P2|Overall Study|Lost to Follow-up|2
429267|NCT00518323|1431952|P1|Overall Study|Lost to Follow-up|0
429268|NCT00518323|1431949|P4|Overall Study|Withdrawal by Subject|2
429269|NCT00518323|1431950|P3|Overall Study|Withdrawal by Subject|4
429270|NCT00518323|1431951|P2|Overall Study|Withdrawal by Subject|2
429271|NCT00518323|1431952|P1|Overall Study|Withdrawal by Subject|1
429272|NCT00518323|1431949|P4|Overall Study|Lack of Efficacy|20
429273|NCT00518323|1431950|P3|Overall Study|Lack of Efficacy|4
429274|NCT00518323|1431951|P2|Overall Study|Lack of Efficacy|2
429275|NCT00518323|1431952|P1|Overall Study|Lack of Efficacy|14
429276|NCT00518284|1431982|P4|Overall Study|Study Termination|2
429277|NCT00518284|1431983|P3|Overall Study|Study Termination|1
429278|NCT00518284|1431984|P2|Overall Study|Study Termination|2
429279|NCT00518284|1431985|P1|Overall Study|Study Termination|0
429280|NCT00518284|1431982|P4|Overall Study|Adverse Event|0
429281|NCT00518284|1431983|P3|Overall Study|Adverse Event|0
429282|NCT00518284|1431984|P2|Overall Study|Adverse Event|1
429283|NCT00518284|1431985|P1|Overall Study|Adverse Event|0
429284|NCT00518206|1432041|P2|Overall Study|Completion Status Unknown|0
429285|NCT00518206|1432042|P1|Overall Study|Completion Status Unknown|1
429286|NCT00518206|1432041|P2|Overall Study|Reason Unknown|0
429287|NCT00518206|1432042|P1|Overall Study|Reason Unknown|1
429288|NCT00518206|1432041|P2|Overall Study|Drug Supply Issue|0
429289|NCT00518206|1432042|P1|Overall Study|Drug Supply Issue|1
429290|NCT00518206|1432041|P2|Overall Study|Withdrawal by Subject|0
429291|NCT00518206|1432042|P1|Overall Study|Withdrawal by Subject|2
429292|NCT00518206|1432041|P2|Overall Study|Disease Progression Requiring Therapy|6
429293|NCT00518206|1432042|P1|Overall Study|Disease Progression Requiring Therapy|6
429294|NCT00518180|1432059|P3|Overall Study|Adverse Event|0
429295|NCT00518180|1432060|P2|Overall Study|Adverse Event|0
429296|NCT00518180|1432061|P1|Overall Study|Adverse Event|1
429297|NCT00518180|1432059|P3|Overall Study|Unable to classify|0
429298|NCT00518180|1432060|P2|Overall Study|Unable to classify|2
429299|NCT00518180|1432061|P1|Overall Study|Unable to classify|0
429300|NCT00518180|1432059|P3|Overall Study|Protocol Violation|4
429301|NCT00518180|1432060|P2|Overall Study|Protocol Violation|7
429302|NCT00518180|1432061|P1|Overall Study|Protocol Violation|5
429303|NCT00518180|1432059|P3|Overall Study|Administrative reason|2
429304|NCT00518180|1432060|P2|Overall Study|Administrative reason|2
429305|NCT00518180|1432061|P1|Overall Study|Administrative reason|0
429306|NCT00518180|1432059|P3|Overall Study|Lost to Follow-up|34
429307|NCT00518180|1432060|P2|Overall Study|Lost to Follow-up|28
429308|NCT00518180|1432061|P1|Overall Study|Lost to Follow-up|30
429309|NCT00518180|1432059|P3|Overall Study|Withdrawal by Subject|42
429310|NCT00518180|1432060|P2|Overall Study|Withdrawal by Subject|30
429311|NCT00518180|1432061|P1|Overall Study|Withdrawal by Subject|29
429312|NCT00518115|1432113|P10|Overall Study|Moved Out of State|1
429313|NCT00518115|1432114|P9|Overall Study|Moved Out of State|0
429314|NCT00518115|1432115|P8|Overall Study|Moved Out of State|0
429315|NCT00518115|1432116|P7|Overall Study|Moved Out of State|0
429316|NCT00518115|1432117|P6|Overall Study|Moved Out of State|0
429317|NCT00518115|1432118|P5|Overall Study|Moved Out of State|0
429318|NCT00518115|1432119|P4|Overall Study|Moved Out of State|0
429319|NCT00518115|1432120|P3|Overall Study|Moved Out of State|0
429320|NCT00518115|1432121|P2|Overall Study|Moved Out of State|0
429321|NCT00518115|1432122|P1|Overall Study|Moved Out of State|0
429322|NCT00518115|1432113|P10|Overall Study|Withdrew Consent|0
429323|NCT00518115|1432114|P9|Overall Study|Withdrew Consent|0
429324|NCT00518115|1432115|P8|Overall Study|Withdrew Consent|0
429325|NCT00518115|1432116|P7|Overall Study|Withdrew Consent|0
429326|NCT00518115|1432117|P6|Overall Study|Withdrew Consent|1
429327|NCT00518115|1432118|P5|Overall Study|Withdrew Consent|0
429328|NCT00518115|1432119|P4|Overall Study|Withdrew Consent|0
429329|NCT00518115|1432120|P3|Overall Study|Withdrew Consent|0
429330|NCT00518115|1432121|P2|Overall Study|Withdrew Consent|0
429331|NCT00518115|1432122|P1|Overall Study|Withdrew Consent|0
429332|NCT00518115|1432113|P10|Overall Study|Family Emergency; Had to Go to England|0
429333|NCT00518115|1432114|P9|Overall Study|Family Emergency; Had to Go to England|0
429334|NCT00518115|1432115|P8|Overall Study|Family Emergency; Had to Go to England|0
429335|NCT00518115|1432116|P7|Overall Study|Family Emergency; Had to Go to England|0
429336|NCT00518115|1432117|P6|Overall Study|Family Emergency; Had to Go to England|0
429337|NCT00518115|1432118|P5|Overall Study|Family Emergency; Had to Go to England|1
429338|NCT00518115|1432119|P4|Overall Study|Family Emergency; Had to Go to England|0
429339|NCT00518115|1432120|P3|Overall Study|Family Emergency; Had to Go to England|0
429340|NCT00518115|1432121|P2|Overall Study|Family Emergency; Had to Go to England|0
429341|NCT00518115|1432122|P1|Overall Study|Family Emergency; Had to Go to England|0
429342|NCT00518115|1432113|P10|Overall Study|Violation of Exclusion Criteria|0
429343|NCT00518115|1432114|P9|Overall Study|Violation of Exclusion Criteria|0
429344|NCT00518115|1432115|P8|Overall Study|Violation of Exclusion Criteria|0
429345|NCT00518115|1432116|P7|Overall Study|Violation of Exclusion Criteria|1
429346|NCT00518115|1432117|P6|Overall Study|Violation of Exclusion Criteria|0
429347|NCT00518115|1432118|P5|Overall Study|Violation of Exclusion Criteria|0
429348|NCT00518115|1432119|P4|Overall Study|Violation of Exclusion Criteria|1
429349|NCT00518115|1432120|P3|Overall Study|Violation of Exclusion Criteria|0
429350|NCT00518115|1432121|P2|Overall Study|Violation of Exclusion Criteria|0
429351|NCT00518115|1432122|P1|Overall Study|Violation of Exclusion Criteria|0
429352|NCT00518115|1432113|P10|Overall Study|Wrong Monotherapy Administered|0
429353|NCT00518115|1432114|P9|Overall Study|Wrong Monotherapy Administered|0
429354|NCT00518115|1432115|P8|Overall Study|Wrong Monotherapy Administered|0
429355|NCT00518115|1432116|P7|Overall Study|Wrong Monotherapy Administered|1
429356|NCT00518115|1432117|P6|Overall Study|Wrong Monotherapy Administered|0
429357|NCT00518115|1432118|P5|Overall Study|Wrong Monotherapy Administered|0
429358|NCT00518115|1432119|P4|Overall Study|Wrong Monotherapy Administered|0
429359|NCT00518115|1432120|P3|Overall Study|Wrong Monotherapy Administered|1
429360|NCT00518115|1432121|P2|Overall Study|Wrong Monotherapy Administered|0
429361|NCT00518115|1432122|P1|Overall Study|Wrong Monotherapy Administered|0
429362|NCT00518115|1432113|P10|Overall Study|Different Monotherapy Diabetic Drug|0
429363|NCT00518115|1432114|P9|Overall Study|Different Monotherapy Diabetic Drug|1
429364|NCT00518115|1432115|P8|Overall Study|Different Monotherapy Diabetic Drug|0
429365|NCT00518115|1432116|P7|Overall Study|Different Monotherapy Diabetic Drug|0
429366|NCT00518115|1432117|P6|Overall Study|Different Monotherapy Diabetic Drug|0
429367|NCT00518115|1432118|P5|Overall Study|Different Monotherapy Diabetic Drug|0
429368|NCT00518115|1432119|P4|Overall Study|Different Monotherapy Diabetic Drug|0
429369|NCT00518115|1432120|P3|Overall Study|Different Monotherapy Diabetic Drug|1
429370|NCT00518115|1432121|P2|Overall Study|Different Monotherapy Diabetic Drug|0
429371|NCT00518115|1432122|P1|Overall Study|Different Monotherapy Diabetic Drug|0
429372|NCT00518115|1432113|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
429373|NCT00518115|1432114|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
429374|NCT00518115|1432115|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
429375|NCT00518115|1432116|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
429376|NCT00518115|1432117|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
429377|NCT00518115|1432118|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
429378|NCT00518115|1432119|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
429379|NCT00518115|1432120|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
429380|NCT00518115|1432121|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
429381|NCT00518115|1432122|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
429382|NCT00518115|1432113|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
429383|NCT00518115|1432114|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
429384|NCT00518115|1432115|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
429385|NCT00518115|1432116|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
429386|NCT00518115|1432117|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
429387|NCT00518115|1432118|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
429388|NCT00518115|1432119|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
429389|NCT00518115|1432120|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
429390|NCT00518115|1432121|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
429391|NCT00518115|1432122|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
429392|NCT00518115|1432113|P10|Overall Study|Non-Compliance|1
429393|NCT00518115|1432114|P9|Overall Study|Non-Compliance|0
429394|NCT00518115|1432115|P8|Overall Study|Non-Compliance|1
429395|NCT00518115|1432116|P7|Overall Study|Non-Compliance|1
429396|NCT00518115|1432117|P6|Overall Study|Non-Compliance|1
429397|NCT00518115|1432118|P5|Overall Study|Non-Compliance|1
429398|NCT00518115|1432119|P4|Overall Study|Non-Compliance|0
429399|NCT00518115|1432120|P3|Overall Study|Non-Compliance|1
429400|NCT00518115|1432121|P2|Overall Study|Non-Compliance|0
429401|NCT00518115|1432122|P1|Overall Study|Non-Compliance|1
429402|NCT00518115|1432113|P10|Overall Study|Lack of Efficacy|0
429403|NCT00518115|1432114|P9|Overall Study|Lack of Efficacy|0
429404|NCT00518115|1432115|P8|Overall Study|Lack of Efficacy|1
429405|NCT00518115|1432116|P7|Overall Study|Lack of Efficacy|0
429406|NCT00518115|1432117|P6|Overall Study|Lack of Efficacy|0
429407|NCT00518115|1432118|P5|Overall Study|Lack of Efficacy|0
429408|NCT00518115|1432119|P4|Overall Study|Lack of Efficacy|1
429409|NCT00518115|1432120|P3|Overall Study|Lack of Efficacy|1
429410|NCT00518115|1432121|P2|Overall Study|Lack of Efficacy|0
429411|NCT00518115|1432122|P1|Overall Study|Lack of Efficacy|1
429412|NCT00518115|1432113|P10|Overall Study|Withdrawal by Subject|3
429413|NCT00518115|1432114|P9|Overall Study|Withdrawal by Subject|1
429414|NCT00518115|1432115|P8|Overall Study|Withdrawal by Subject|2
429415|NCT00518115|1432116|P7|Overall Study|Withdrawal by Subject|0
429416|NCT00518115|1432117|P6|Overall Study|Withdrawal by Subject|1
429417|NCT00518115|1432118|P5|Overall Study|Withdrawal by Subject|2
429418|NCT00518115|1432119|P4|Overall Study|Withdrawal by Subject|0
429419|NCT00518115|1432120|P3|Overall Study|Withdrawal by Subject|5
429420|NCT00518115|1432121|P2|Overall Study|Withdrawal by Subject|1
429421|NCT00518115|1432122|P1|Overall Study|Withdrawal by Subject|1
429422|NCT00518115|1432113|P10|Overall Study|Protocol Violation|0
429423|NCT00518115|1432114|P9|Overall Study|Protocol Violation|0
429424|NCT00518115|1432115|P8|Overall Study|Protocol Violation|0
429425|NCT00518115|1432116|P7|Overall Study|Protocol Violation|0
429426|NCT00518115|1432117|P6|Overall Study|Protocol Violation|0
429427|NCT00518115|1432118|P5|Overall Study|Protocol Violation|0
429428|NCT00518115|1432119|P4|Overall Study|Protocol Violation|0
429429|NCT00518115|1432120|P3|Overall Study|Protocol Violation|1
429430|NCT00518115|1432121|P2|Overall Study|Protocol Violation|3
429431|NCT00518115|1432122|P1|Overall Study|Protocol Violation|1
429432|NCT00518115|1432113|P10|Overall Study|Lost to Follow-up|1
429433|NCT00518115|1432114|P9|Overall Study|Lost to Follow-up|1
429434|NCT00518115|1432115|P8|Overall Study|Lost to Follow-up|1
429435|NCT00518115|1432116|P7|Overall Study|Lost to Follow-up|0
429436|NCT00518115|1432117|P6|Overall Study|Lost to Follow-up|3
429437|NCT00518115|1432118|P5|Overall Study|Lost to Follow-up|1
429438|NCT00518115|1432119|P4|Overall Study|Lost to Follow-up|3
429439|NCT00518115|1432120|P3|Overall Study|Lost to Follow-up|2
429440|NCT00518115|1432121|P2|Overall Study|Lost to Follow-up|0
429441|NCT00518115|1432122|P1|Overall Study|Lost to Follow-up|0
429442|NCT00518115|1432113|P10|Overall Study|Adverse Event|9
429443|NCT00518115|1432114|P9|Overall Study|Adverse Event|2
429444|NCT00518115|1432115|P8|Overall Study|Adverse Event|10
429445|NCT00518115|1432116|P7|Overall Study|Adverse Event|5
429446|NCT00518115|1432117|P6|Overall Study|Adverse Event|5
429447|NCT00518115|1432118|P5|Overall Study|Adverse Event|5
429448|NCT00518115|1432119|P4|Overall Study|Adverse Event|6
429449|NCT00518115|1432120|P3|Overall Study|Adverse Event|5
429450|NCT00518115|1432121|P2|Overall Study|Adverse Event|1
429451|NCT00518115|1432122|P1|Overall Study|Adverse Event|6
429452|NCT00518011|1432297|P2|Overall Study|Withdrawal by Subject|0
429453|NCT00518011|1432298|P1|Overall Study|Withdrawal by Subject|1
429454|NCT00518011|1432297|P2|Overall Study|Other Reasons|2
429455|NCT00518011|1432298|P1|Overall Study|Other Reasons|3
429456|NCT00518011|1432297|P2|Overall Study|Disease Progression|2
429457|NCT00518011|1432298|P1|Overall Study|Disease Progression|2
429458|NCT00518011|1432297|P2|Overall Study|Adverse Event|3
429459|NCT00518011|1432298|P1|Overall Study|Adverse Event|2
429460|NCT00518011|1432297|P2|Overall Study|Death|1
429461|NCT00518011|1432298|P1|Overall Study|Death|1
429462|NCT00517933|1432320|P2|Period 2|Underwent lung transplant|2
429463|NCT00517933|1432321|P1|Period 2|Underwent lung transplant|0
429464|NCT00517933|1432320|P2|Period 2|Withdrawal by Subject|3
429465|NCT00517933|1432321|P1|Period 2|Withdrawal by Subject|1
429466|NCT00517933|1432320|P2|Period 2|Physician Decision|0
429467|NCT00517933|1432321|P1|Period 2|Physician Decision|1
429468|NCT00517933|1432320|P2|Period 2|Adverse Event|4
429469|NCT00517933|1432321|P1|Period 2|Adverse Event|2
429470|NCT00517933|1432320|P2|Period 2|Death|4
429471|NCT00517933|1432321|P1|Period 2|Death|2
429472|NCT00517933|1432320|P2|Period 1|Underwent lung transplant|1
429473|NCT00517933|1432321|P1|Period 1|Underwent lung transplant|0
429474|NCT00517933|1432320|P2|Period 1|Lost to Follow-up|0
429475|NCT00517933|1432321|P1|Period 1|Lost to Follow-up|2
429476|NCT00517933|1432320|P2|Period 1|Adverse Event|4
429477|NCT00517933|1432321|P1|Period 1|Adverse Event|4
429478|NCT00517933|1432320|P2|Period 1|Death|1
429479|NCT00517933|1432321|P1|Period 1|Death|2
429480|NCT00517881|1432385|P1|Overall Study|Renal transplantation|2
429481|NCT00517881|1432385|P1|Overall Study|Adverse Event|1
429482|NCT00517881|1432385|P1|Overall Study|Protocol Violation|2
429483|NCT00517829|1432397|P2|Overall Study|Other|1
429484|NCT00517829|1432398|P1|Overall Study|Other|3
429485|NCT00517829|1432397|P2|Overall Study|Investigator Request|3
429486|NCT00517829|1432398|P1|Overall Study|Investigator Request|5
429487|NCT00517829|1432397|P2|Overall Study|Patient Request|5
429488|NCT00517829|1432398|P1|Overall Study|Patient Request|6
429489|NCT00517829|1432397|P2|Overall Study|Disease Progression|32
429490|NCT00517829|1432398|P1|Overall Study|Disease Progression|39
429491|NCT00517829|1432397|P2|Overall Study|Adverse Event|34
429492|NCT00517829|1432398|P1|Overall Study|Adverse Event|22
429493|NCT00517751|1432412|P1|Overall Study|Missing|3
429494|NCT00517751|1432412|P1|Overall Study|Patient not due for visit|76
429495|NCT00517751|1432412|P1|Overall Study|patient not over due|6
429496|NCT00517751|1432412|P1|Overall Study|Lost to Follow-up|4
429497|NCT00517751|1432412|P1|Overall Study|Withdrawal by Subject|37
429498|NCT00517751|1432412|P1|Overall Study|Death|3
429499|NCT00517699|1432435|P1|Overall Study|Study terminated by Sponsor|2
429500|NCT00517699|1432435|P1|Overall Study|Administrative error|1
429501|NCT00517699|1432435|P1|Overall Study|Lack of Efficacy|1
429502|NCT00517699|1432435|P1|Overall Study|Withdrawal by Subject|1
429503|NCT00517634|1432443|P6|Second Treatment Period|Withdrawal by Subject|0
429504|NCT00517634|1432444|P5|Second Treatment Period|Withdrawal by Subject|1
429505|NCT00517634|1432445|P4|Second Treatment Period|Withdrawal by Subject|0
429506|NCT00517634|1432446|P3|Second Treatment Period|Withdrawal by Subject|0
429507|NCT00517634|1432447|P2|Second Treatment Period|Withdrawal by Subject|0
429508|NCT00517634|1432448|P1|Second Treatment Period|Withdrawal by Subject|0
429509|NCT00517413|1432550|P1|Overall Study|Other-Reasons|23
429510|NCT00517413|1432550|P1|Overall Study|Failure to return|1
429511|NCT00517413|1432550|P1|Overall Study|Withdrawal by Subject|2
429512|NCT00517413|1432550|P1|Overall Study|Protocol Violation|15
429513|NCT00517413|1432550|P1|Overall Study|Death|13
429514|NCT00517413|1432550|P1|Overall Study|Adverse Event|7
429515|NCT00517361|1432571|P1|Overall Study|The study was terminated|5
429516|NCT00517361|1432571|P1|Overall Study|Death|6
429517|NCT00517296|1432580|P2|Overall Study|Withdrawal by Subject|0
429518|NCT00517296|1432581|P1|Overall Study|Withdrawal by Subject|1
429519|NCT00517192|1432593|P2|Overall Study|Early termination of the trial|18
429520|NCT00517192|1432594|P1|Overall Study|Early termination of the trial|16
429521|NCT00517192|1432593|P2|Overall Study|Withdrawal by Subject|0
429522|NCT00517192|1432594|P1|Overall Study|Withdrawal by Subject|1
429523|NCT00517192|1432593|P2|Overall Study|Lost to Follow-up|1
429524|NCT00517192|1432594|P1|Overall Study|Lost to Follow-up|1
429525|NCT00517192|1432593|P2|Overall Study|Adverse Event|1
429526|NCT00517192|1432594|P1|Overall Study|Adverse Event|1
429527|NCT00516906|1432701|P2|Overall Study|Final Dressing Removal Data not captured|2
429528|NCT00516906|1432702|P1|Overall Study|Final Dressing Removal Data not captured|6
429529|NCT00516893|1432712|P1|Overall Study|Received Medication From Another Study|1
429530|NCT00516893|1432712|P1|Overall Study|Pregnancy|1
429531|NCT00516893|1432712|P1|Overall Study|Relocated|1
429532|NCT00516893|1432712|P1|Overall Study|Persistent Antibodies per Protocol|6
429533|NCT00516893|1432712|P1|Overall Study|Death|1
429534|NCT00516893|1432712|P1|Overall Study|Noncompliance|2
429535|NCT00516893|1432712|P1|Overall Study|Withdrawal by Subject|2
429536|NCT00516893|1432712|P1|Overall Study|Adverse Event|3
429537|NCT00516893|1432712|P1|Overall Study|Lost to Follow-up|4
429538|NCT00516737|1432721|P2|Overall Study|Lack of Qualifying Event|6
429539|NCT00516737|1432722|P1|Overall Study|Lack of Qualifying Event|9
429540|NCT00516737|1432721|P2|Overall Study|Withdrawal by Subject|1
429541|NCT00516737|1432722|P1|Overall Study|Withdrawal by Subject|0
429542|NCT00516737|1432721|P2|Overall Study|Physician Decision|1
429543|NCT00516737|1432722|P1|Overall Study|Physician Decision|0
429544|NCT00516737|1432721|P2|Overall Study|Lost to Follow-up|0
429545|NCT00516737|1432722|P1|Overall Study|Lost to Follow-up|2
429546|NCT00516386|1432761|P1|Overall Study|Lost to Follow-up|2
429547|NCT00516386|1432761|P1|Overall Study|not interested in the study|4
429548|NCT00516321|1432768|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
429549|NCT00516321|1432769|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
429550|NCT00516321|1432770|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
429551|NCT00516321|1432768|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
429552|NCT00516321|1432769|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
429553|NCT00516321|1432770|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
429554|NCT00516321|1432768|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
429555|NCT00516321|1432769|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
429556|NCT00516321|1432770|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
429557|NCT00516321|1432768|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
429558|NCT00516321|1432769|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
429559|NCT00516321|1432770|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
429560|NCT00516321|1432768|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
429561|NCT00516321|1432769|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
429562|NCT00516321|1432770|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
429563|NCT00516321|1432768|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
429564|NCT00516321|1432769|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
429565|NCT00516321|1432770|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
429566|NCT00516321|1432768|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
429567|NCT00516321|1432769|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
429568|NCT00516321|1432770|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
429569|NCT00516321|1432768|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
429570|NCT00516321|1432769|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
429571|NCT00516321|1432770|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
429572|NCT00516321|1432768|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
429573|NCT00516321|1432769|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
429574|NCT00516321|1432770|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
429575|NCT00516321|1432768|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
429576|NCT00516321|1432769|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
429577|NCT00516321|1432770|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
429578|NCT00516321|1432768|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
429579|NCT00516321|1432769|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
429580|NCT00516321|1432770|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
429581|NCT00516295|1432821|P3|Overall Study|Ineligible|0
429582|NCT00516295|1432822|P2|Overall Study|Ineligible|0
429583|NCT00516295|1432823|P1|Overall Study|Ineligible|1
429584|NCT00516295|1432821|P3|Overall Study|Lack of Efficacy|0
429585|NCT00516295|1432822|P2|Overall Study|Lack of Efficacy|0
429586|NCT00516295|1432823|P1|Overall Study|Lack of Efficacy|2
429587|NCT00516269|1432836|P2|Overall Study|Protocol Violation|1
429588|NCT00516269|1432837|P1|Overall Study|Protocol Violation|0
429589|NCT00516269|1432836|P2|Overall Study|Lost to Follow-up|1
429590|NCT00516269|1432837|P1|Overall Study|Lost to Follow-up|0
429591|NCT00516269|1432836|P2|Overall Study|Adverse Event|1
429592|NCT00516269|1432837|P1|Overall Study|Adverse Event|2
429593|NCT00516139|1432858|P1|Overall Study|Lack of Efficacy|1
429594|NCT00516139|1432858|P1|Overall Study|Withdrawal by Subject|8
429595|NCT00516139|1432858|P1|Overall Study|Protocol Violation|1
429596|NCT00516139|1432858|P1|Overall Study|Lost to Follow-up|1
429597|NCT00516139|1432858|P1|Overall Study|Adverse Event|27
429598|NCT00516074|1432889|P2|Overall Study|Loss of Glucose Control|0
429599|NCT00516074|1432890|P1|Overall Study|Loss of Glucose Control|2
429600|NCT00516074|1432889|P2|Overall Study|Subject Decision|2
429601|NCT00516074|1432890|P1|Overall Study|Subject Decision|4
429602|NCT00516074|1432889|P2|Overall Study|Adverse Event|1
429603|NCT00516074|1432890|P1|Overall Study|Adverse Event|0
429604|NCT00516048|1432908|P3|Overall Study|Subject Decision|0
429605|NCT00516048|1432909|P2|Overall Study|Subject Decision|2
429606|NCT00516048|1432910|P1|Overall Study|Subject Decision|0
429607|NCT00516048|1432908|P3|Overall Study|Death|1
429608|NCT00516048|1432909|P2|Overall Study|Death|0
429609|NCT00516048|1432910|P1|Overall Study|Death|0
429610|NCT00515827|1432937|P2|Second Intervention (12 Weeks)|Consent withdraw|0
429611|NCT00515827|1432938|P1|Second Intervention (12 Weeks)|Consent withdraw|1
429612|NCT00515827|1432937|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
429613|NCT00515827|1432938|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
429614|NCT00515671|1432973|P2|Overall Study|incarcerated|2
429615|NCT00515671|1432974|P1|Overall Study|incarcerated|1
429616|NCT00515671|1432973|P2|Overall Study|Withdrawal by Subject|5
429617|NCT00515671|1432974|P1|Overall Study|Withdrawal by Subject|3
429618|NCT00515671|1432973|P2|Overall Study|Lost to Follow-up|10
429619|NCT00515671|1432974|P1|Overall Study|Lost to Follow-up|13
429620|NCT00515619|1432982|P1|Overall Study|Other: Subject interested in other AED|1
429621|NCT00515619|1432982|P1|Overall Study|Other: Drug available on license|1
429622|NCT00515619|1432982|P1|Overall Study|Other: Request from sponsor|1
429623|NCT00515619|1432982|P1|Overall Study|Other: Subject became pregnant|1
429624|NCT00515619|1432982|P1|Overall Study|Other: Investigator decision|1
429625|NCT00515619|1432982|P1|Overall Study|Other: Subject moved to another country|1
429626|NCT00515619|1432982|P1|Overall Study|Other: Subject required surgery|1
429627|NCT00515619|1432982|P1|Overall Study|Other: Subject cannot attend visits|2
429628|NCT00515619|1432982|P1|Overall Study|Other: Site discontinuing trials|2
429629|NCT00515619|1432982|P1|Overall Study|Unsatisfactory compliance|6
429630|NCT00515619|1432982|P1|Overall Study|Lost to Follow-up|4
429631|NCT00515619|1432982|P1|Overall Study|Protocol Violation|3
429632|NCT00515619|1432982|P1|Overall Study|Withdrawal by Subject|66
429633|NCT00515619|1432982|P1|Overall Study|Lack of Efficacy|92
429634|NCT00515619|1432982|P1|Overall Study|Adverse Event|34
429635|NCT00515541|1432994|P4|Overall Study|Withdrawal by Subject|2
429636|NCT00515541|1432995|P3|Overall Study|Withdrawal by Subject|0
429637|NCT00515541|1432996|P2|Overall Study|Withdrawal by Subject|2
429638|NCT00515541|1432997|P1|Overall Study|Withdrawal by Subject|0
429639|NCT00515541|1432994|P4|Overall Study|No show for appointments|2
429640|NCT00515541|1432995|P3|Overall Study|No show for appointments|0
429641|NCT00515541|1432996|P2|Overall Study|No show for appointments|1
429642|NCT00515541|1432997|P1|Overall Study|No show for appointments|0
429643|NCT00515541|1432994|P4|Overall Study|Physician Decision|1
429644|NCT00515541|1432995|P3|Overall Study|Physician Decision|0
429645|NCT00515541|1432996|P2|Overall Study|Physician Decision|2
429646|NCT00515541|1432997|P1|Overall Study|Physician Decision|0
429647|NCT00515502|1433019|P12|Treatment Period 2|Adverse Event|0
429648|NCT00515502|1433020|P11|Treatment Period 2|Adverse Event|0
429649|NCT00515502|1433021|P10|Treatment Period 2|Adverse Event|0
429650|NCT00515502|1433022|P9|Treatment Period 2|Adverse Event|0
429651|NCT00515502|1433023|P8|Treatment Period 2|Adverse Event|0
429652|NCT00515502|1433024|P7|Treatment Period 2|Adverse Event|0
429653|NCT00515502|1433025|P6|Treatment Period 2|Adverse Event|0
429654|NCT00515502|1433026|P5|Treatment Period 2|Adverse Event|0
429655|NCT00515502|1433027|P4|Treatment Period 2|Adverse Event|0
429656|NCT00515502|1433028|P3|Treatment Period 2|Adverse Event|0
429657|NCT00515502|1433029|P2|Treatment Period 2|Adverse Event|1
429658|NCT00515502|1433030|P1|Treatment Period 2|Adverse Event|0
429659|NCT00515502|1433019|P12|Treatment Period 1|Adverse Event|1
429660|NCT00515502|1433020|P11|Treatment Period 1|Adverse Event|0
429661|NCT00515502|1433021|P10|Treatment Period 1|Adverse Event|0
429662|NCT00515502|1433022|P9|Treatment Period 1|Adverse Event|1
429663|NCT00515502|1433023|P8|Treatment Period 1|Adverse Event|0
429664|NCT00515502|1433024|P7|Treatment Period 1|Adverse Event|1
429665|NCT00515502|1433025|P6|Treatment Period 1|Adverse Event|0
429666|NCT00515502|1433026|P5|Treatment Period 1|Adverse Event|0
429667|NCT00515502|1433027|P4|Treatment Period 1|Adverse Event|0
429668|NCT00515502|1433028|P3|Treatment Period 1|Adverse Event|0
429669|NCT00515502|1433029|P2|Treatment Period 1|Adverse Event|0
429670|NCT00515502|1433030|P1|Treatment Period 1|Adverse Event|0
429671|NCT00515463|1433190|P2|Overall Study|Other|1
429672|NCT00515463|1433191|P1|Overall Study|Other|0
429673|NCT00515463|1433190|P2|Overall Study|Lost to Follow-up|5
429674|NCT00515463|1433191|P1|Overall Study|Lost to Follow-up|6
429675|NCT00515463|1433190|P2|Overall Study|Withdrawal by Subject|4
429676|NCT00515463|1433191|P1|Overall Study|Withdrawal by Subject|3
429677|NCT00515463|1433190|P2|Overall Study|Adverse Event|2
429678|NCT00515463|1433191|P1|Overall Study|Adverse Event|1
429679|NCT00515463|1433190|P2|Overall Study|Physician Decision|2
429680|NCT00515463|1433191|P1|Overall Study|Physician Decision|4
429681|NCT00515294|1433374|P4|Overall Study|Caffeine amount inaccurate|0
429682|NCT00515294|1433375|P3|Overall Study|Caffeine amount inaccurate|7
429683|NCT00515294|1433376|P2|Overall Study|Caffeine amount inaccurate|0
429684|NCT00515294|1433377|P1|Overall Study|Caffeine amount inaccurate|5
429685|NCT00515294|1433374|P4|Overall Study|Driver simulator problems|3
429686|NCT00515294|1433375|P3|Overall Study|Driver simulator problems|1
429687|NCT00515294|1433376|P2|Overall Study|Driver simulator problems|1
429688|NCT00515294|1433377|P1|Overall Study|Driver simulator problems|1
429689|NCT00515294|1433374|P4|Overall Study|Lost to Follow-up|1
429690|NCT00515294|1433375|P3|Overall Study|Lost to Follow-up|3
429691|NCT00515294|1433376|P2|Overall Study|Lost to Follow-up|2
429692|NCT00515294|1433377|P1|Overall Study|Lost to Follow-up|3
429693|NCT00515216|1433391|P1|Overall Study|Withdrawal by Subject|1
429694|NCT00515112|1433453|P2|Overall Study|The study was terminated|2
429695|NCT00515112|1433454|P1|Overall Study|The study was terminated|3
429696|NCT00515112|1433453|P2|Overall Study|Death|1
429697|NCT00515112|1433454|P1|Overall Study|Death|0
429698|NCT00515099|1433464|P2|Overall Study|IRB Recommendation|0
429699|NCT00515099|1433465|P1|Overall Study|IRB Recommendation|1
429700|NCT00515099|1433464|P2|Overall Study|Withdrawal by Subject|0
429701|NCT00515099|1433465|P1|Overall Study|Withdrawal by Subject|2
429702|NCT00515099|1433464|P2|Overall Study|Lost to Follow-up|4
429703|NCT00515099|1433465|P1|Overall Study|Lost to Follow-up|0
429704|NCT00515086|1433487|P4|Overall Study|Death|0
429705|NCT00515086|1433488|P3|Overall Study|Death|0
429706|NCT00515086|1433489|P2|Overall Study|Death|0
429707|NCT00515086|1433490|P1|Overall Study|Death|2
429708|NCT00515086|1433487|P4|Overall Study|Study drug no longer required|0
429709|NCT00515086|1433488|P3|Overall Study|Study drug no longer required|0
429710|NCT00515086|1433489|P2|Overall Study|Study drug no longer required|1
429711|NCT00515086|1433490|P1|Overall Study|Study drug no longer required|0
429712|NCT00515086|1433487|P4|Overall Study|Lost to Follow-up|0
429713|NCT00515086|1433488|P3|Overall Study|Lost to Follow-up|0
429714|NCT00515086|1433489|P2|Overall Study|Lost to Follow-up|0
429715|NCT00515086|1433490|P1|Overall Study|Lost to Follow-up|1
429716|NCT00515086|1433487|P4|Overall Study|Unsatisfactory therapeutic effect|2
429717|NCT00515086|1433488|P3|Overall Study|Unsatisfactory therapeutic effect|3
429718|NCT00515086|1433489|P2|Overall Study|Unsatisfactory therapeutic effect|3
429719|NCT00515086|1433490|P1|Overall Study|Unsatisfactory therapeutic effect|18
429720|NCT00515086|1433487|P4|Overall Study|Withdrawal by Subject|1
429721|NCT00515086|1433488|P3|Overall Study|Withdrawal by Subject|0
429722|NCT00515086|1433489|P2|Overall Study|Withdrawal by Subject|0
429723|NCT00515086|1433490|P1|Overall Study|Withdrawal by Subject|1
429724|NCT00515086|1433487|P4|Overall Study|Administrative|0
429725|NCT00515086|1433488|P3|Overall Study|Administrative|0
429726|NCT00515086|1433489|P2|Overall Study|Administrative|1
429727|NCT00515086|1433490|P1|Overall Study|Administrative|1
429728|NCT00515086|1433487|P4|Overall Study|Adverse Event|3
429729|NCT00515086|1433488|P3|Overall Study|Adverse Event|2
429730|NCT00515086|1433489|P2|Overall Study|Adverse Event|1
429731|NCT00515086|1433490|P1|Overall Study|Adverse Event|1
429732|NCT00515073|1433517|P1|Overall Study|Physician Decision|1
429733|NCT00515073|1433517|P1|Overall Study|Withdrawal by Subject|1
429734|NCT00515034|1433525|P4|Overall Study|Other|1
429735|NCT00515034|1433526|P3|Overall Study|Other|2
429736|NCT00515034|1433527|P2|Overall Study|Other|0
429737|NCT00515034|1433528|P1|Overall Study|Other|1
429738|NCT00515034|1433525|P4|Overall Study|Physician Decision|1
429739|NCT00515034|1433526|P3|Overall Study|Physician Decision|1
429740|NCT00515034|1433527|P2|Overall Study|Physician Decision|0
429741|NCT00515034|1433528|P1|Overall Study|Physician Decision|0
429742|NCT00515034|1433525|P4|Overall Study|Withdrawal by Subject|0
429743|NCT00515034|1433526|P3|Overall Study|Withdrawal by Subject|3
429744|NCT00515034|1433527|P2|Overall Study|Withdrawal by Subject|0
429745|NCT00515034|1433528|P1|Overall Study|Withdrawal by Subject|1
429746|NCT00515034|1433525|P4|Overall Study|Death|3
429747|NCT00515034|1433526|P3|Overall Study|Death|1
429748|NCT00515034|1433527|P2|Overall Study|Death|2
429749|NCT00515034|1433528|P1|Overall Study|Death|4
429750|NCT00515034|1433525|P4|Overall Study|Adverse Event|0
429751|NCT00515034|1433526|P3|Overall Study|Adverse Event|1
429752|NCT00515034|1433527|P2|Overall Study|Adverse Event|0
429753|NCT00515034|1433528|P1|Overall Study|Adverse Event|2
429754|NCT00515008|1433548|P2|Overall Study|Scheduling conflict|0
429755|NCT00515008|1433549|P1|Overall Study|Scheduling conflict|1
429756|NCT00515008|1433548|P2|Overall Study|Left the Boston Area|1
429757|NCT00515008|1433549|P1|Overall Study|Left the Boston Area|1
429758|NCT00515008|1433548|P2|Overall Study|Declined|3
429759|NCT00515008|1433549|P1|Overall Study|Declined|0
429760|NCT00515008|1433548|P2|Overall Study|Lost to Follow-up|0
429761|NCT00515008|1433549|P1|Overall Study|Lost to Follow-up|1
429762|NCT00514943|1433573|P2|Stage 2|Other than stated above|2
429763|NCT00514943|1433574|P1|Stage 2|Other than stated above|0
429764|NCT00514943|1433573|P2|Stage 2|Patient refused to continue study meds|0
429765|NCT00514943|1433574|P1|Stage 2|Patient refused to continue study meds|2
429766|NCT00514943|1433573|P2|Stage 2|Other Adverse Event|10
429767|NCT00514943|1433574|P1|Stage 2|Other Adverse Event|3
429768|NCT00514943|1433573|P2|Stage 2|Progressive disease|24
429769|NCT00514943|1433574|P1|Stage 2|Progressive disease|27
429770|NCT00514943|1433573|P2|Stage 1|Other than stated above|7
429771|NCT00514943|1433574|P1|Stage 1|Other than stated above|1
429772|NCT00514943|1433573|P2|Stage 1|Patient refused to continue study meds|3
429773|NCT00514943|1433574|P1|Stage 1|Patient refused to continue study meds|8
429774|NCT00514943|1433573|P2|Stage 1|Not treated|2
429775|NCT00514943|1433574|P1|Stage 1|Not treated|1
429776|NCT00514943|1433573|P2|Stage 1|Other Adverse Event|6
429777|NCT00514943|1433574|P1|Stage 1|Other Adverse Event|16
429778|NCT00514943|1433573|P2|Stage 1|Progressive disease|8
429779|NCT00514943|1433574|P1|Stage 1|Progressive disease|4
429780|NCT00514917|1433632|P2|Overall Study|Undefined|5
429781|NCT00514917|1433633|P1|Overall Study|Undefined|11
429782|NCT00514917|1433632|P2|Overall Study|Discontinued due to study closure|81
429783|NCT00514917|1433633|P1|Overall Study|Discontinued due to study closure|88
429784|NCT00514917|1433632|P2|Overall Study|Withdrawal by Subject|16
429785|NCT00514917|1433633|P1|Overall Study|Withdrawal by Subject|18
429786|NCT00514917|1433632|P2|Overall Study|Lost to Follow-up|3
429787|NCT00514917|1433633|P1|Overall Study|Lost to Follow-up|4
429788|NCT00514917|1433632|P2|Overall Study|Protocol Violation|0
429789|NCT00514917|1433633|P1|Overall Study|Protocol Violation|1
429790|NCT00514917|1433632|P2|Overall Study|Death|10
429791|NCT00514917|1433633|P1|Overall Study|Death|4
429792|NCT00514904|1433661|P2|Overall Study|Lost to Follow-up|3
429793|NCT00514904|1433662|P1|Overall Study|Lost to Follow-up|21
429794|NCT00514904|1433661|P2|Overall Study|Withdrawal by Subject|2
429795|NCT00514904|1433662|P1|Overall Study|Withdrawal by Subject|3
429796|NCT00514813|1433727|P4|Overall Study|Death|2
429797|NCT00514813|1433728|P3|Overall Study|Death|3
429798|NCT00514813|1433729|P2|Overall Study|Death|2
429799|NCT00514813|1433730|P1|Overall Study|Death|0
429800|NCT00514813|1433727|P4|Overall Study|Kidney transplant|0
429801|NCT00514813|1433728|P3|Overall Study|Kidney transplant|2
429802|NCT00514813|1433729|P2|Overall Study|Kidney transplant|6
429803|NCT00514813|1433730|P1|Overall Study|Kidney transplant|0
429804|NCT00514813|1433727|P4|Overall Study|Lack of Efficacy|0
429805|NCT00514813|1433728|P3|Overall Study|Lack of Efficacy|0
429806|NCT00514813|1433729|P2|Overall Study|Lack of Efficacy|1
429807|NCT00514813|1433730|P1|Overall Study|Lack of Efficacy|0
429808|NCT00514813|1433727|P4|Overall Study|Withdrawal by Subject|0
429809|NCT00514813|1433728|P3|Overall Study|Withdrawal by Subject|0
429810|NCT00514813|1433729|P2|Overall Study|Withdrawal by Subject|1
429811|NCT00514813|1433730|P1|Overall Study|Withdrawal by Subject|0
429812|NCT00514813|1433727|P4|Overall Study|Protocol Violation|0
429813|NCT00514813|1433728|P3|Overall Study|Protocol Violation|0
429814|NCT00514813|1433729|P2|Overall Study|Protocol Violation|0
429815|NCT00514813|1433730|P1|Overall Study|Protocol Violation|1
429816|NCT00514813|1433727|P4|Overall Study|Adverse Event|0
429817|NCT00514813|1433728|P3|Overall Study|Adverse Event|2
429818|NCT00514813|1433729|P2|Overall Study|Adverse Event|2
429819|NCT00514813|1433730|P1|Overall Study|Adverse Event|0
429820|NCT00514813|1433727|P4|Overall Study|Study terminated|2
429821|NCT00514813|1433728|P3|Overall Study|Study terminated|40
429822|NCT00514813|1433729|P2|Overall Study|Study terminated|74
429823|NCT00514813|1433730|P1|Overall Study|Study terminated|14
429824|NCT00514735|1433750|P2|Overall Study|Lost to Follow-up|1
429825|NCT00514735|1433751|P1|Overall Study|Lost to Follow-up|0
429826|NCT00514735|1433750|P2|Overall Study|Death|0
429827|NCT00514735|1433751|P1|Overall Study|Death|1
429828|NCT00514735|1433750|P2|Overall Study|Withdrawal by Subject|5
429829|NCT00514735|1433751|P1|Overall Study|Withdrawal by Subject|13
429830|NCT00514683|1433787|P5|Overall Study|Reason other than listed above|1
429831|NCT00514683|1433788|P4|Overall Study|Reason other than listed above|0
429832|NCT00514683|1433789|P3|Overall Study|Reason other than listed above|2
429833|NCT00514683|1433790|P2|Overall Study|Reason other than listed above|1
429834|NCT00514683|1433791|P1|Overall Study|Reason other than listed above|0
429835|NCT00514683|1433787|P5|Overall Study|Withdrawal by Subject|4
429836|NCT00514683|1433788|P4|Overall Study|Withdrawal by Subject|0
429837|NCT00514683|1433789|P3|Overall Study|Withdrawal by Subject|1
429838|NCT00514683|1433790|P2|Overall Study|Withdrawal by Subject|2
429839|NCT00514683|1433791|P1|Overall Study|Withdrawal by Subject|2
429840|NCT00514683|1433787|P5|Overall Study|Protocol Violation|0
429841|NCT00514683|1433788|P4|Overall Study|Protocol Violation|1
429842|NCT00514683|1433789|P3|Overall Study|Protocol Violation|0
429843|NCT00514683|1433790|P2|Overall Study|Protocol Violation|1
429844|NCT00514683|1433791|P1|Overall Study|Protocol Violation|1
429845|NCT00514683|1433787|P5|Overall Study|Adverse Event|27
429846|NCT00514683|1433788|P4|Overall Study|Adverse Event|13
429847|NCT00514683|1433789|P3|Overall Study|Adverse Event|15
429848|NCT00514683|1433790|P2|Overall Study|Adverse Event|20
429849|NCT00514683|1433791|P1|Overall Study|Adverse Event|21
429850|NCT00514683|1433787|P5|Overall Study|Not treated|1
429851|NCT00514683|1433788|P4|Overall Study|Not treated|0
429852|NCT00514683|1433789|P3|Overall Study|Not treated|0
429853|NCT00514683|1433790|P2|Overall Study|Not treated|1
429854|NCT00514683|1433791|P1|Overall Study|Not treated|2
429855|NCT00514514|1433990|P3|Extension - 4 Years|Adverse Event|3
429856|NCT00514514|1433991|P2|Extension - 4 Years|Adverse Event|6
429857|NCT00514514|1433992|P1|Extension - 4 Years|Adverse Event|9
429858|NCT00514514|1433990|P3|Extension - 4 Years|Death|6
429859|NCT00514514|1433991|P2|Extension - 4 Years|Death|3
429860|NCT00514514|1433992|P1|Extension - 4 Years|Death|8
429861|NCT00514514|1433990|P3|Extension - 4 Years|Administrative problems|1
429862|NCT00514514|1433991|P2|Extension - 4 Years|Administrative problems|1
429863|NCT00514514|1433992|P1|Extension - 4 Years|Administrative problems|3
429864|NCT00514514|1433990|P3|Extension - 4 Years|Lost to Follow-up|9
429865|NCT00514514|1433991|P2|Extension - 4 Years|Lost to Follow-up|10
429866|NCT00514514|1433992|P1|Extension - 4 Years|Lost to Follow-up|12
429867|NCT00514514|1433990|P3|Extension - 4 Years|Withdrawal by Subject|2
429868|NCT00514514|1433991|P2|Extension - 4 Years|Withdrawal by Subject|2
429869|NCT00514514|1433992|P1|Extension - 4 Years|Withdrawal by Subject|5
429870|NCT00514514|1433990|P3|Randomized - 9 Month|Adverse Event|27
429871|NCT00514514|1433991|P2|Randomized - 9 Month|Adverse Event|44
429872|NCT00514514|1433992|P1|Randomized - 9 Month|Adverse Event|25
429873|NCT00514514|1433990|P3|Randomized - 9 Month|Abnormal laboratory values|1
429874|NCT00514514|1433991|P2|Randomized - 9 Month|Abnormal laboratory values|3
429875|NCT00514514|1433992|P1|Randomized - 9 Month|Abnormal laboratory values|0
429876|NCT00514514|1433990|P3|Randomized - 9 Month|Lack of Efficacy|1
429877|NCT00514514|1433991|P2|Randomized - 9 Month|Lack of Efficacy|3
429878|NCT00514514|1433992|P1|Randomized - 9 Month|Lack of Efficacy|2
429879|NCT00514514|1433990|P3|Randomized - 9 Month|Protocol Violation|0
429880|NCT00514514|1433991|P2|Randomized - 9 Month|Protocol Violation|1
429881|NCT00514514|1433992|P1|Randomized - 9 Month|Protocol Violation|1
429882|NCT00514514|1433990|P3|Randomized - 9 Month|Withdrawal by Subject|5
429883|NCT00514514|1433991|P2|Randomized - 9 Month|Withdrawal by Subject|7
429884|NCT00514514|1433992|P1|Randomized - 9 Month|Withdrawal by Subject|7
429885|NCT00514514|1433990|P3|Randomized - 9 Month|Administrative problems|2
429886|NCT00514514|1433991|P2|Randomized - 9 Month|Administrative problems|1
429887|NCT00514514|1433992|P1|Randomized - 9 Month|Administrative problems|1
429888|NCT00514514|1433990|P3|Randomized - 9 Month|Death|2
429889|NCT00514514|1433991|P2|Randomized - 9 Month|Death|2
429890|NCT00514514|1433992|P1|Randomized - 9 Month|Death|3
429891|NCT00514514|1433990|P3|Pre-phase|Withdrawal by Subject|0
429892|NCT00514514|1433991|P2|Pre-phase|Withdrawal by Subject|0
429893|NCT00514514|1433992|P1|Pre-phase|Withdrawal by Subject|66
429894|NCT00514514|1433990|P3|Pre-phase|Adverse Event|0
429895|NCT00514514|1433991|P2|Pre-phase|Adverse Event|0
429896|NCT00514514|1433992|P1|Pre-phase|Adverse Event|137
429897|NCT00514514|1433990|P3|Pre-phase|Lack of Efficacy|0
429898|NCT00514514|1433991|P2|Pre-phase|Lack of Efficacy|0
429899|NCT00514514|1433992|P1|Pre-phase|Lack of Efficacy|35
429900|NCT00514514|1433990|P3|Pre-phase|abnormal lab values|0
429901|NCT00514514|1433991|P2|Pre-phase|abnormal lab values|0
429902|NCT00514514|1433992|P1|Pre-phase|abnormal lab values|23
429903|NCT00514514|1433990|P3|Pre-phase|Lost to Follow-up|0
429904|NCT00514514|1433991|P2|Pre-phase|Lost to Follow-up|0
429905|NCT00514514|1433992|P1|Pre-phase|Lost to Follow-up|2
429906|NCT00514514|1433990|P3|Pre-phase|abnormal test procedure results|0
429907|NCT00514514|1433991|P2|Pre-phase|abnormal test procedure results|0
429908|NCT00514514|1433992|P1|Pre-phase|abnormal test procedure results|15
429909|NCT00514514|1433990|P3|Pre-phase|condition no longer requires study drug|0
429910|NCT00514514|1433991|P2|Pre-phase|condition no longer requires study drug|0
429911|NCT00514514|1433992|P1|Pre-phase|condition no longer requires study drug|7
429912|NCT00514514|1433990|P3|Pre-phase|Protocol Violation|0
429913|NCT00514514|1433991|P2|Pre-phase|Protocol Violation|0
429914|NCT00514514|1433992|P1|Pre-phase|Protocol Violation|6
429915|NCT00514514|1433990|P3|Pre-phase|administrative problems|0
429916|NCT00514514|1433991|P2|Pre-phase|administrative problems|0
429917|NCT00514514|1433992|P1|Pre-phase|administrative problems|2
429918|NCT00514514|1433990|P3|Pre-phase|Death|0
429919|NCT00514514|1433991|P2|Pre-phase|Death|0
429920|NCT00514514|1433992|P1|Pre-phase|Death|10
429921|NCT00514449|1434044|P2|Overall Study|Lost to Follow-up|0
429922|NCT00514449|1434045|P1|Overall Study|Lost to Follow-up|1
429923|NCT00514449|1434044|P2|Overall Study|Protocol Violation|2
429924|NCT00514449|1434045|P1|Overall Study|Protocol Violation|1
429925|NCT00514449|1434044|P2|Overall Study|Withdrawal by Subject|2
429926|NCT00514449|1434045|P1|Overall Study|Withdrawal by Subject|1
429927|NCT00514020|1434066|P1|Overall Study|"patients moved to the no tx group"|6
429928|NCT00514020|1434066|P1|Overall Study|patient went to radiation treatment|1
429929|NCT00514020|1434066|P1|Overall Study|other complicating disease|2
429930|NCT00514020|1434066|P1|Overall Study|disease progression|9
429931|NCT00514020|1434066|P1|Overall Study|Physician Decision|1
429932|NCT00514020|1434066|P1|Overall Study|Withdrawal by Subject|3
429933|NCT00514020|1434066|P1|Overall Study|Adverse Event|6
429934|NCT00513708|1434098|P3|Overall Study|Lost to Follow-up|4
429935|NCT00513708|1434099|P2|Overall Study|Lost to Follow-up|4
429936|NCT00513708|1434100|P1|Overall Study|Lost to Follow-up|4
429937|NCT00513695|1434114|P1|Overall Study|Progression prior to surgery|3
429938|NCT00513695|1434114|P1|Overall Study|Discontinued therapy|2
429939|NCT00513682|1434123|P1|Washout Phase|Adverse Event|2
429940|NCT00513604|1434153|P5|Overall Study|Death during treatment|0
429941|NCT00513604|1434154|P4|Overall Study|Death during treatment|0
429942|NCT00513604|1434155|P3|Overall Study|Death during treatment|2
429943|NCT00513604|1434156|P2|Overall Study|Death during treatment|3
429944|NCT00513604|1434157|P1|Overall Study|Death during treatment|0
429945|NCT00513604|1434153|P5|Overall Study|Not treated|0
429946|NCT00513604|1434154|P4|Overall Study|Not treated|0
429947|NCT00513604|1434155|P3|Overall Study|Not treated|1
429948|NCT00513604|1434156|P2|Overall Study|Not treated|0
429949|NCT00513604|1434157|P1|Overall Study|Not treated|2
429950|NCT00513500|1434191|P2|Overall Study|Hospitalized|14
429951|NCT00513500|1434192|P1|Overall Study|Hospitalized|4
429952|NCT00513500|1434191|P2|Overall Study|Death|1
429953|NCT00513500|1434192|P1|Overall Study|Death|2
429954|NCT00513500|1434191|P2|Overall Study|Lost to Follow-up|39
429955|NCT00513500|1434192|P1|Overall Study|Lost to Follow-up|35
429956|NCT00513474|1434204|P2|Overall Study|Participant Withdrew Consent|0
429957|NCT00513474|1434205|P1|Overall Study|Participant Withdrew Consent|1
429958|NCT00513474|1434204|P2|Overall Study|Death|9
429959|NCT00513474|1434205|P1|Overall Study|Death|6
429960|NCT00513409|1434224|P2|Overall Study|Visit 3 not done|2
429961|NCT00513409|1434225|P1|Overall Study|Visit 3 not done|1
429962|NCT00513409|1434224|P2|Overall Study|Physician Decision|0
429963|NCT00513409|1434225|P1|Overall Study|Physician Decision|1
429964|NCT00513409|1434224|P2|Overall Study|Lost to Follow-up|1
429965|NCT00513409|1434225|P1|Overall Study|Lost to Follow-up|0
429966|NCT00513409|1434224|P2|Overall Study|Withdrawal by Subject|2
429967|NCT00513409|1434225|P1|Overall Study|Withdrawal by Subject|0
429968|NCT00513409|1434224|P2|Overall Study|Adverse Event|1
429969|NCT00513409|1434225|P1|Overall Study|Adverse Event|0
429970|NCT00513357|1434281|P2|Overall Study|Disease Progression|1
429971|NCT00513357|1434282|P1|Overall Study|Disease Progression|2
429972|NCT00513357|1434281|P2|Overall Study|Withdrawal by Subject|4
429973|NCT00513357|1434282|P1|Overall Study|Withdrawal by Subject|5
429974|NCT00513357|1434281|P2|Overall Study|Death|0
429975|NCT00513357|1434282|P1|Overall Study|Death|2
429976|NCT00513357|1434281|P2|Overall Study|Adverse Event|2
429977|NCT00513357|1434282|P1|Overall Study|Adverse Event|4
429978|NCT00513357|1434281|P2|Overall Study|did not receive allocated placebo|3
429979|NCT00513357|1434282|P1|Overall Study|did not receive allocated placebo|2
429980|NCT00513305|1434301|P2|Overall Study|Sponsor Decision|2
429981|NCT00513305|1434302|P1|Overall Study|Sponsor Decision|0
429982|NCT00513305|1434301|P2|Overall Study|Persistent hypocellularity|1
429983|NCT00513305|1434302|P1|Overall Study|Persistent hypocellularity|0
429984|NCT00513305|1434301|P2|Overall Study|Physician Decision|0
429985|NCT00513305|1434302|P1|Overall Study|Physician Decision|1
429986|NCT00513305|1434301|P2|Overall Study|Hematologic counts did not recover|0
429987|NCT00513305|1434302|P1|Overall Study|Hematologic counts did not recover|1
429988|NCT00513305|1434301|P2|Overall Study|Eligible for stem cell transplant|0
429989|NCT00513305|1434302|P1|Overall Study|Eligible for stem cell transplant|1
429990|NCT00513305|1434301|P2|Overall Study|Disease progression|5
429991|NCT00513305|1434302|P1|Overall Study|Disease progression|8
429992|NCT00513305|1434301|P2|Overall Study|Withdrawal by Subject|2
429993|NCT00513305|1434302|P1|Overall Study|Withdrawal by Subject|1
429994|NCT00513305|1434301|P2|Overall Study|Lack of Efficacy|13
429995|NCT00513305|1434302|P1|Overall Study|Lack of Efficacy|8
429996|NCT00513305|1434301|P2|Overall Study|Death (through Consolidation Treatment)|2
429997|NCT00513305|1434302|P1|Overall Study|Death (through Consolidation Treatment)|2
429998|NCT00513305|1434301|P2|Overall Study|Adverse Event|2
429999|NCT00513305|1434302|P1|Overall Study|Adverse Event|6
430000|NCT00513240|1434339|P2|Overall Study|Withdrawal by Subject|4
430001|NCT00513240|1434340|P1|Overall Study|Withdrawal by Subject|7
430002|NCT00513240|1434339|P2|Overall Study|Death|3
430003|NCT00513240|1434340|P1|Overall Study|Death|3
430004|NCT00513240|1434339|P2|Overall Study|Did not have intended surgery|0
430005|NCT00513240|1434340|P1|Overall Study|Did not have intended surgery|3
430006|NCT00513071|1434347|P1|Overall Study|Physician Decision|3
430007|NCT00513071|1434347|P1|Overall Study|Withdrawal by Subject|1
430008|NCT00513071|1434347|P1|Overall Study|Adverse Event|1
430009|NCT00513019|1434359|P2|Overall Study|Withdrawal by Subject|5
430010|NCT00513019|1434360|P1|Overall Study|Withdrawal by Subject|4
430011|NCT00513019|1434359|P2|Overall Study|Adverse Event|0
430012|NCT00513019|1434360|P1|Overall Study|Adverse Event|1
430013|NCT00512902|1434366|P1|Overall Study|Lost to Follow-up|1
430014|NCT00512902|1434366|P1|Overall Study|Adverse Event|7
430015|NCT00512798|1434381|P2|Overall Study|Withdrawal by Subject|0
430016|NCT00512798|1434382|P1|Overall Study|Withdrawal by Subject|3
430017|NCT00512798|1434381|P2|Overall Study|Progression of disease|20
430018|NCT00512798|1434382|P1|Overall Study|Progression of disease|14
430019|NCT00512798|1434381|P2|Overall Study|Adverse Event|4
430020|NCT00512798|1434382|P1|Overall Study|Adverse Event|2
430021|NCT00512798|1434381|P2|Overall Study|Death|3
430022|NCT00512798|1434382|P1|Overall Study|Death|0
430023|NCT00512707|1434393|P2|Overall Study|Unable to tolerate the smell of the gel|0
430024|NCT00512707|1434394|P1|Overall Study|Unable to tolerate the smell of the gel|1
430025|NCT00512707|1434393|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
430026|NCT00512707|1434394|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
430027|NCT00512707|1434393|P2|Overall Study|Developed skin irritation|1
430028|NCT00512707|1434394|P1|Overall Study|Developed skin irritation|2
430029|NCT00512707|1434393|P2|Overall Study|Lost to Follow-up|11
430030|NCT00512707|1434394|P1|Overall Study|Lost to Follow-up|5
430031|NCT00512252|1434444|P3|Overall Study|Death|1
430032|NCT00512252|1434445|P2|Overall Study|Death|0
430033|NCT00512252|1434446|P1|Overall Study|Death|0
430034|NCT00512252|1434444|P3|Overall Study|Protocol Violation|1
430035|NCT00512252|1434445|P2|Overall Study|Protocol Violation|0
430036|NCT00512252|1434446|P1|Overall Study|Protocol Violation|0
430037|NCT00512252|1434444|P3|Overall Study|Lost to Follow-up|1
430038|NCT00512252|1434445|P2|Overall Study|Lost to Follow-up|0
430039|NCT00512252|1434446|P1|Overall Study|Lost to Follow-up|0
430040|NCT00512148|1434474|P1|Primay Study Period|Withdrawal by Subject|1
430041|NCT00512096|1434479|P1|Overall Study|Lack of Efficacy|3
430042|NCT00512096|1434479|P1|Overall Study|Withdrawal by Subject|2
430043|NCT00512096|1434479|P1|Overall Study|Adverse Event|2
430044|NCT00511901|1434507|P2|Overall Study|Withdrawal by Subject|3
430045|NCT00511901|1434508|P1|Overall Study|Withdrawal by Subject|1
430046|NCT00511836|1434546|P2|Double-blind Period|Lost to Follow-up|0
430047|NCT00511836|1434547|P1|Double-blind Period|Lost to Follow-up|1
430048|NCT00511810|1434564|P2|Overall Study|Refused second scn|1
430049|NCT00511810|1434565|P1|Overall Study|Refused second scn|0
430050|NCT00511810|1434564|P2|Overall Study|Lack of Efficacy|2
430051|NCT00511810|1434565|P1|Overall Study|Lack of Efficacy|0
430052|NCT00511810|1434564|P2|Overall Study|Lost to Follow-up|2
430053|NCT00511810|1434565|P1|Overall Study|Lost to Follow-up|1
430054|NCT00511797|1434575|P4|Overall Study|Other (moving etc)|2
430055|NCT00511797|1434576|P3|Overall Study|Other (moving etc)|1
430056|NCT00511797|1434577|P2|Overall Study|Other (moving etc)|0
430057|NCT00511797|1434578|P1|Overall Study|Other (moving etc)|1
430058|NCT00511797|1434575|P4|Overall Study|Partially missing diary|0
430059|NCT00511797|1434576|P3|Overall Study|Partially missing diary|1
430060|NCT00511797|1434577|P2|Overall Study|Partially missing diary|0
430061|NCT00511797|1434578|P1|Overall Study|Partially missing diary|0
430062|NCT00511797|1434575|P4|Overall Study|Study drug not taken|1
430063|NCT00511797|1434576|P3|Overall Study|Study drug not taken|0
430064|NCT00511797|1434577|P2|Overall Study|Study drug not taken|1
430065|NCT00511797|1434578|P1|Overall Study|Study drug not taken|0
430066|NCT00511797|1434575|P4|Overall Study|Never dispensed|3
430067|NCT00511797|1434576|P3|Overall Study|Never dispensed|1
430068|NCT00511797|1434577|P2|Overall Study|Never dispensed|0
430069|NCT00511797|1434578|P1|Overall Study|Never dispensed|1
430070|NCT00511797|1434575|P4|Overall Study|Withdrawal by Subject|2
430071|NCT00511797|1434576|P3|Overall Study|Withdrawal by Subject|4
430072|NCT00511797|1434577|P2|Overall Study|Withdrawal by Subject|3
430073|NCT00511797|1434578|P1|Overall Study|Withdrawal by Subject|3
430074|NCT00511797|1434575|P4|Overall Study|Protocol Violation|3
430075|NCT00511797|1434576|P3|Overall Study|Protocol Violation|2
430076|NCT00511797|1434577|P2|Overall Study|Protocol Violation|2
430077|NCT00511797|1434578|P1|Overall Study|Protocol Violation|0
430078|NCT00511797|1434575|P4|Overall Study|Pregnancy|1
430079|NCT00511797|1434576|P3|Overall Study|Pregnancy|0
430080|NCT00511797|1434577|P2|Overall Study|Pregnancy|0
430081|NCT00511797|1434578|P1|Overall Study|Pregnancy|0
430082|NCT00511797|1434575|P4|Overall Study|Lost to Follow-up|1
430083|NCT00511797|1434576|P3|Overall Study|Lost to Follow-up|0
430084|NCT00511797|1434577|P2|Overall Study|Lost to Follow-up|0
430085|NCT00511797|1434578|P1|Overall Study|Lost to Follow-up|1
430086|NCT00511797|1434575|P4|Overall Study|Adverse Event|2
430087|NCT00511797|1434576|P3|Overall Study|Adverse Event|2
430088|NCT00511797|1434577|P2|Overall Study|Adverse Event|2
430089|NCT00511797|1434578|P1|Overall Study|Adverse Event|1
430090|NCT00511667|1434697|P2|Overall Study|Other|1
430091|NCT00511667|1434698|P1|Overall Study|Other|2
430092|NCT00511667|1434697|P2|Overall Study|Site terminated|1
430093|NCT00511667|1434698|P1|Overall Study|Site terminated|6
430094|NCT00511667|1434697|P2|Overall Study|Withdrawal by Subject|0
430095|NCT00511667|1434698|P1|Overall Study|Withdrawal by Subject|2
430096|NCT00511667|1434697|P2|Overall Study|Protocol Violation|1
430097|NCT00511667|1434698|P1|Overall Study|Protocol Violation|1
430098|NCT00511667|1434697|P2|Overall Study|Adverse Event|0
430099|NCT00511667|1434698|P1|Overall Study|Adverse Event|1
430100|NCT00511472|1434733|P2|Overall Study|Not reported|2
430101|NCT00511472|1434734|P1|Overall Study|Not reported|2
430102|NCT00511472|1434733|P2|Overall Study|Laboratory Adverse Event|2
430103|NCT00511472|1434734|P1|Overall Study|Laboratory Adverse Event|0
430104|NCT00511472|1434733|P2|Overall Study|Clinical Adverse Event|2
430105|NCT00511472|1434734|P1|Overall Study|Clinical Adverse Event|1
430106|NCT00511433|1434753|P2|Overall Study|Other Reason|1
430107|NCT00511433|1434754|P1|Overall Study|Other Reason|1
430108|NCT00511433|1434753|P2|Overall Study|Adverse Event|0
430109|NCT00511433|1434754|P1|Overall Study|Adverse Event|5
430110|NCT00511355|1434794|P2|Overall Study|Other reason pre-treatment|1
430111|NCT00511355|1434795|P1|Overall Study|Other reason pre-treatment|0
430112|NCT00511355|1434794|P2|Overall Study|Withdrawal of informed consent|1
430113|NCT00511355|1434795|P1|Overall Study|Withdrawal of informed consent|0
430114|NCT00511355|1434794|P2|Overall Study|Pre-treatment (serious) adverse event|1
430115|NCT00511355|1434795|P1|Overall Study|Pre-treatment (serious) adverse event|0
430116|NCT00511355|1434794|P2|Overall Study|Other Reason|1
430117|NCT00511355|1434795|P1|Overall Study|Other Reason|0
430118|NCT00511355|1434794|P2|Overall Study|Lost to Follow-up|1
430119|NCT00511355|1434795|P1|Overall Study|Lost to Follow-up|2
430120|NCT00511355|1434794|P2|Overall Study|Pregnancy Wish|0
430121|NCT00511355|1434795|P1|Overall Study|Pregnancy Wish|1
430122|NCT00511355|1434794|P2|Overall Study|Adverse Event|4
430123|NCT00511355|1434795|P1|Overall Study|Adverse Event|4
430124|NCT00511342|1434895|P2|Overall Study|Other Reason|2
430125|NCT00511342|1434896|P1|Overall Study|Other Reason|2
430126|NCT00511342|1434895|P2|Overall Study|Lost to Follow-up|5
430127|NCT00511342|1434896|P1|Overall Study|Lost to Follow-up|1
430128|NCT00511342|1434895|P2|Overall Study|Pregnancy wish|1
430129|NCT00511342|1434896|P1|Overall Study|Pregnancy wish|0
430130|NCT00511342|1434895|P2|Overall Study|Pregnancy|1
430131|NCT00511342|1434896|P1|Overall Study|Pregnancy|0
430132|NCT00511342|1434895|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
430133|NCT00511342|1434896|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
430134|NCT00511342|1434895|P2|Overall Study|Unacceptable vaginal bleeding|1
430135|NCT00511342|1434896|P1|Overall Study|Unacceptable vaginal bleeding|2
430136|NCT00511238|1434927|P2|Overall Study|various reasons|14
430137|NCT00511238|1434928|P1|Overall Study|various reasons|4
430138|NCT00511238|1434927|P2|Overall Study|Progressive Disease|157
430139|NCT00511238|1434928|P1|Overall Study|Progressive Disease|23
430140|NCT00511238|1434927|P2|Overall Study|Withdrawal by Subject|22
430141|NCT00511238|1434928|P1|Overall Study|Withdrawal by Subject|2
430142|NCT00511238|1434927|P2|Overall Study|Adverse Event|33
430143|NCT00511238|1434928|P1|Overall Study|Adverse Event|13
430144|NCT00511199|1434947|P2|Overall Study|Other Reason|37
430145|NCT00511199|1434948|P1|Overall Study|Other Reason|78
430146|NCT00511199|1434947|P2|Overall Study|Lost to Follow-up|17
430147|NCT00511199|1434948|P1|Overall Study|Lost to Follow-up|40
430148|NCT00511199|1434947|P2|Overall Study|Pregnancy Wish|8
430149|NCT00511199|1434948|P1|Overall Study|Pregnancy Wish|16
430150|NCT00511199|1434947|P2|Overall Study|Pregnancy|3
430151|NCT00511199|1434948|P1|Overall Study|Pregnancy|6
430152|NCT00511199|1434947|P2|Overall Study|Withdrawal of Informed Consent|4
430153|NCT00511199|1434948|P1|Overall Study|Withdrawal of Informed Consent|19
430154|NCT00511199|1434947|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
430155|NCT00511199|1434948|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
430156|NCT00511199|1434947|P2|Overall Study|Unacceptable Vaginal Bleeding|4
430157|NCT00511199|1434948|P1|Overall Study|Unacceptable Vaginal Bleeding|63
430158|NCT00511147|1434977|P1|Overall Study|Required platelet transfusion|1
430159|NCT00511147|1434977|P1|Overall Study|Disease progression|5
430160|NCT00511147|1434977|P1|Overall Study|Withdrawal by Subject|1
430161|NCT00511134|1434986|P2|Overall Study|Withdrawal by Subject|2
430162|NCT00511134|1434987|P1|Overall Study|Withdrawal by Subject|0
430163|NCT00511108|1434999|P4|Overall Study|Withdrawal by Subject|2
430164|NCT00511108|1435000|P3|Overall Study|Withdrawal by Subject|3
430165|NCT00511108|1435001|P2|Overall Study|Withdrawal by Subject|0
430166|NCT00511108|1435002|P1|Overall Study|Withdrawal by Subject|4
430167|NCT00511108|1434999|P4|Overall Study|Physician Decision|1
430168|NCT00511108|1435000|P3|Overall Study|Physician Decision|0
430169|NCT00511108|1435001|P2|Overall Study|Physician Decision|0
430170|NCT00511108|1435002|P1|Overall Study|Physician Decision|0
430171|NCT00511108|1434999|P4|Overall Study|Lost to Follow-up|0
430172|NCT00511108|1435000|P3|Overall Study|Lost to Follow-up|1
430173|NCT00511108|1435001|P2|Overall Study|Lost to Follow-up|2
430174|NCT00511108|1435002|P1|Overall Study|Lost to Follow-up|0
430175|NCT00511108|1434999|P4|Overall Study|Adverse Event|2
430176|NCT00511108|1435000|P3|Overall Study|Adverse Event|1
430177|NCT00511108|1435001|P2|Overall Study|Adverse Event|0
430178|NCT00511108|1435002|P1|Overall Study|Adverse Event|2
430179|NCT00511004|1435029|P3|Overall Study|Lost to Follow-up|4
430180|NCT00511004|1435030|P2|Overall Study|Lost to Follow-up|0
430181|NCT00511004|1435031|P1|Overall Study|Lost to Follow-up|0
430182|NCT00510952|1435050|P2|Overall Study|Did Not Receive Study Drug|0
430183|NCT00510952|1435051|P1|Overall Study|Did Not Receive Study Drug|2
430184|NCT00510952|1435050|P2|Overall Study|Withdrawal by Subject|7
430185|NCT00510952|1435051|P1|Overall Study|Withdrawal by Subject|6
430186|NCT00510952|1435050|P2|Overall Study|Sponsor Decision|0
430187|NCT00510952|1435051|P1|Overall Study|Sponsor Decision|1
430188|NCT00510952|1435050|P2|Overall Study|Protocol Violation|4
430189|NCT00510952|1435051|P1|Overall Study|Protocol Violation|7
430190|NCT00510952|1435050|P2|Overall Study|Physician Decision|1
430191|NCT00510952|1435051|P1|Overall Study|Physician Decision|1
430192|NCT00510952|1435050|P2|Overall Study|Lost to Follow-up|3
430193|NCT00510952|1435051|P1|Overall Study|Lost to Follow-up|5
430194|NCT00510952|1435050|P2|Overall Study|Entry Criteria Not Met|1
430195|NCT00510952|1435051|P1|Overall Study|Entry Criteria Not Met|3
430196|NCT00510952|1435050|P2|Overall Study|Adverse Event|0
430197|NCT00510952|1435051|P1|Overall Study|Adverse Event|1
430198|NCT00510887|1435077|P1|Overall Study|Lost to Follow-up|1
430199|NCT00510874|1435093|P7|Overall Study|Lost to Follow-up|1
430200|NCT00510874|1435094|P6|Overall Study|Lost to Follow-up|0
430201|NCT00510874|1435095|P5|Overall Study|Lost to Follow-up|4
430202|NCT00510874|1435096|P4|Overall Study|Lost to Follow-up|3
430203|NCT00510874|1435097|P3|Overall Study|Lost to Follow-up|1
430204|NCT00510874|1435098|P2|Overall Study|Lost to Follow-up|3
430205|NCT00510874|1435099|P1|Overall Study|Lost to Follow-up|2
430206|NCT00510874|1435093|P7|Overall Study|Withdrawal by Subject|0
430207|NCT00510874|1435094|P6|Overall Study|Withdrawal by Subject|0
430208|NCT00510874|1435095|P5|Overall Study|Withdrawal by Subject|3
430209|NCT00510874|1435096|P4|Overall Study|Withdrawal by Subject|0
430210|NCT00510874|1435097|P3|Overall Study|Withdrawal by Subject|0
430211|NCT00510874|1435098|P2|Overall Study|Withdrawal by Subject|1
430212|NCT00510874|1435099|P1|Overall Study|Withdrawal by Subject|1
430213|NCT00510835|1435202|P3|Overall Study|Withdrawal by Subject|2
430214|NCT00510835|1435203|P2|Overall Study|Withdrawal by Subject|2
430215|NCT00510835|1435204|P1|Overall Study|Withdrawal by Subject|6
430216|NCT00510783|1435230|P2|Overall Study|Protocol Violation|1
430217|NCT00510783|1435231|P1|Overall Study|Protocol Violation|0
430218|NCT00510783|1435230|P2|Overall Study|Withdrawal by Subject|3
430219|NCT00510783|1435231|P1|Overall Study|Withdrawal by Subject|2
430220|NCT00510783|1435230|P2|Overall Study|Lost to Follow-up|25
430221|NCT00510783|1435231|P1|Overall Study|Lost to Follow-up|29
430222|NCT00510692|1435243|P2|Overall Study|Withdrawal by Subject|0
430223|NCT00510692|1435244|P1|Overall Study|Withdrawal by Subject|1
430224|NCT00510692|1435243|P2|Overall Study|Adverse Event|3
430225|NCT00510692|1435244|P1|Overall Study|Adverse Event|1
430226|NCT00510653|1435258|P1|Overall Study|Monetary|3
430227|NCT00510653|1435258|P1|Overall Study|Withdrawal by Subject|8
430228|NCT00510510|1435265|P3|Overall Study|Protocol Violation|4
430229|NCT00510510|1435266|P2|Overall Study|Protocol Violation|3
430230|NCT00510510|1435267|P1|Overall Study|Protocol Violation|0
430231|NCT00510510|1435265|P3|Overall Study|Lost to Follow-up|1
430232|NCT00510510|1435266|P2|Overall Study|Lost to Follow-up|0
430233|NCT00510510|1435267|P1|Overall Study|Lost to Follow-up|0
430234|NCT00510510|1435265|P3|Overall Study|Withdrawal by Subject|3
430235|NCT00510510|1435266|P2|Overall Study|Withdrawal by Subject|2
430236|NCT00510510|1435267|P1|Overall Study|Withdrawal by Subject|1
430237|NCT00510510|1435265|P3|Overall Study|Subjects no longer requires study drug|2
430238|NCT00510510|1435266|P2|Overall Study|Subjects no longer requires study drug|0
430239|NCT00510510|1435267|P1|Overall Study|Subjects no longer requires study drug|0
430240|NCT00510510|1435265|P3|Overall Study|Lack of Efficacy|1
430241|NCT00510510|1435266|P2|Overall Study|Lack of Efficacy|1
430242|NCT00510510|1435267|P1|Overall Study|Lack of Efficacy|0
430243|NCT00510510|1435265|P3|Overall Study|Adverse Event|6
430244|NCT00510510|1435266|P2|Overall Study|Adverse Event|3
430245|NCT00510510|1435267|P1|Overall Study|Adverse Event|4
430246|NCT00510484|1435285|P2|Wash-out Period|Adverse Event|1
430247|NCT00510484|1435286|P1|Wash-out Period|Adverse Event|0
430248|NCT00510458|1435306|P1|Overall Study|Revision|2
430249|NCT00510458|1435306|P1|Overall Study|Withdrawal by Subject|3
430250|NCT00510458|1435306|P1|Overall Study|Lost to Follow-up|6
430251|NCT00510458|1435306|P1|Overall Study|Terminated|14
430252|NCT00510458|1435306|P1|Overall Study|Death|1
430253|NCT00510458|1435306|P1|Overall Study|5 year not evaluable/missed|21
430254|NCT00510289|1435319|P1|Overall Study|Progressed prior to starting drug|2
430255|NCT00510289|1435319|P1|Overall Study|Lost to Follow-up|1
430256|NCT00510289|1435319|P1|Overall Study|Refused bone marrow biopsy|2
430257|NCT00510289|1435319|P1|Overall Study|Withdrawal by Subject|7
430258|NCT00510276|1435329|P2|Extension Open-Label Phase|Subject Decision|9
430259|NCT00510276|1435330|P1|Extension Open-Label Phase|Subject Decision|7
430260|NCT00510276|1435329|P2|Extension Open-Label Phase|Sponsor Decision|0
430261|NCT00510276|1435330|P1|Extension Open-Label Phase|Sponsor Decision|1
430262|NCT00510276|1435329|P2|Extension Open-Label Phase|Protocol Violation|1
430263|NCT00510276|1435330|P1|Extension Open-Label Phase|Protocol Violation|0
430264|NCT00510276|1435329|P2|Extension Open-Label Phase|Physician Decision|3
430265|NCT00510276|1435330|P1|Extension Open-Label Phase|Physician Decision|2
430266|NCT00510276|1435329|P2|Extension Open-Label Phase|Lost to Follow-up|10
430267|NCT00510276|1435330|P1|Extension Open-Label Phase|Lost to Follow-up|12
430268|NCT00510276|1435329|P2|Extension Open-Label Phase|Lack of Efficacy|7
430269|NCT00510276|1435330|P1|Extension Open-Label Phase|Lack of Efficacy|2
430270|NCT00510276|1435329|P2|Extension Open-Label Phase|Adverse Event|18
430271|NCT00510276|1435330|P1|Extension Open-Label Phase|Adverse Event|9
430272|NCT00510276|1435329|P2|Acute Double-Blind Phase|Subject Decision|28
430273|NCT00510276|1435330|P1|Acute Double-Blind Phase|Subject Decision|26
430274|NCT00510276|1435329|P2|Acute Double-Blind Phase|Sponsor Decision|1
430275|NCT00510276|1435330|P1|Acute Double-Blind Phase|Sponsor Decision|2
430276|NCT00510276|1435329|P2|Acute Double-Blind Phase|Protocol Violation|3
430277|NCT00510276|1435330|P1|Acute Double-Blind Phase|Protocol Violation|4
430278|NCT00510276|1435329|P2|Acute Double-Blind Phase|Physician Decision|3
430279|NCT00510276|1435330|P1|Acute Double-Blind Phase|Physician Decision|0
430280|NCT00510276|1435329|P2|Acute Double-Blind Phase|Lost to Follow-up|49
430281|NCT00510276|1435330|P1|Acute Double-Blind Phase|Lost to Follow-up|48
430282|NCT00510276|1435329|P2|Acute Double-Blind Phase|Lack of Efficacy|4
430283|NCT00510276|1435330|P1|Acute Double-Blind Phase|Lack of Efficacy|3
430284|NCT00510276|1435329|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
430285|NCT00510276|1435330|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
430286|NCT00510276|1435329|P2|Acute Double-Blind Phase|Adverse Event|6
430287|NCT00510276|1435330|P1|Acute Double-Blind Phase|Adverse Event|21
430288|NCT00510146|1435424|P2|Open-Label Treatment|Sponsor Decision|0
430289|NCT00510146|1435425|P1|Open-Label Treatment|Sponsor Decision|2
430290|NCT00510146|1435424|P2|Open-Label Treatment|Clinical Relapse|1
430291|NCT00510146|1435425|P1|Open-Label Treatment|Clinical Relapse|1
430292|NCT00510146|1435424|P2|Open-Label Treatment|Withdrawal by Subject|12
430293|NCT00510146|1435425|P1|Open-Label Treatment|Withdrawal by Subject|24
430294|NCT00510146|1435424|P2|Open-Label Treatment|Protocol Violation|2
430295|NCT00510146|1435425|P1|Open-Label Treatment|Protocol Violation|4
430296|NCT00510146|1435424|P2|Open-Label Treatment|Physician Decision|1
430297|NCT00510146|1435425|P1|Open-Label Treatment|Physician Decision|3
430298|NCT00510146|1435424|P2|Open-Label Treatment|Lost to Follow-up|1
430299|NCT00510146|1435425|P1|Open-Label Treatment|Lost to Follow-up|10
430300|NCT00510146|1435424|P2|Open-Label Treatment|Lack of Efficacy|0
430301|NCT00510146|1435425|P1|Open-Label Treatment|Lack of Efficacy|4
430302|NCT00510146|1435424|P2|Open-Label Treatment|Death|1
430303|NCT00510146|1435425|P1|Open-Label Treatment|Death|1
430304|NCT00510146|1435424|P2|Open-Label Treatment|Adverse Event|8
430305|NCT00510146|1435425|P1|Open-Label Treatment|Adverse Event|22
430306|NCT00510146|1435424|P2|Double-Blind Treatment|Entry Criteria Not Met|0
430307|NCT00510146|1435425|P1|Double-Blind Treatment|Entry Criteria Not Met|3
430308|NCT00510146|1435424|P2|Double-Blind Treatment|Clinical Relapse|1
430309|NCT00510146|1435425|P1|Double-Blind Treatment|Clinical Relapse|0
430310|NCT00510146|1435424|P2|Double-Blind Treatment|Withdrawal by Subject|13
430311|NCT00510146|1435425|P1|Double-Blind Treatment|Withdrawal by Subject|27
430312|NCT00510146|1435424|P2|Double-Blind Treatment|Protocol Violation|2
430313|NCT00510146|1435425|P1|Double-Blind Treatment|Protocol Violation|1
430314|NCT00510146|1435424|P2|Double-Blind Treatment|Physician Decision|0
430315|NCT00510146|1435425|P1|Double-Blind Treatment|Physician Decision|6
430316|NCT00510146|1435424|P2|Double-Blind Treatment|Lost to Follow-up|7
430317|NCT00510146|1435425|P1|Double-Blind Treatment|Lost to Follow-up|3
430318|NCT00510146|1435424|P2|Double-Blind Treatment|Lack of Efficacy|13
430319|NCT00510146|1435425|P1|Double-Blind Treatment|Lack of Efficacy|6
430320|NCT00510146|1435424|P2|Double-Blind Treatment|Adverse Event|13
430321|NCT00510146|1435425|P1|Double-Blind Treatment|Adverse Event|30
430322|NCT00510068|1435514|P2|Open-label Period|Abnormal laboratory value (s)|0
430323|NCT00510068|1435515|P1|Open-label Period|Abnormal laboratory value (s)|1
430324|NCT00510068|1435514|P2|Open-label Period|Protocol Violation|0
430325|NCT00510068|1435515|P1|Open-label Period|Protocol Violation|2
430326|NCT00510068|1435514|P2|Open-label Period|New cancer therapy|0
430327|NCT00510068|1435515|P1|Open-label Period|New cancer therapy|7
430328|NCT00510068|1435514|P2|Open-label Period|Death|0
430329|NCT00510068|1435515|P1|Open-label Period|Death|7
430330|NCT00510068|1435514|P2|Open-label Period|Administrative problems|0
430331|NCT00510068|1435515|P1|Open-label Period|Administrative problems|17
430332|NCT00510068|1435514|P2|Open-label Period|Withdrawal by Subject|0
430333|NCT00510068|1435515|P1|Open-label Period|Withdrawal by Subject|21
430334|NCT00510068|1435514|P2|Open-label Period|Adverse Event|0
430335|NCT00510068|1435515|P1|Open-label Period|Adverse Event|46
430336|NCT00510068|1435514|P2|Open-label Period|Disease Progression|0
430337|NCT00510068|1435515|P1|Open-label Period|Disease Progression|124
430338|NCT00510068|1435514|P2|Double-blind Period|Protocol Violation|0
430339|NCT00510068|1435515|P1|Double-blind Period|Protocol Violation|6
430340|NCT00510068|1435514|P2|Double-blind Period|Lost to Follow-up|0
430341|NCT00510068|1435515|P1|Double-blind Period|Lost to Follow-up|1
430342|NCT00510068|1435514|P2|Double-blind Period|Abnormal test result (s)|0
430343|NCT00510068|1435515|P1|Double-blind Period|Abnormal test result (s)|1
430344|NCT00510068|1435514|P2|Double-blind Period|Death|3
430345|NCT00510068|1435515|P1|Double-blind Period|Death|4
430346|NCT00510068|1435514|P2|Double-blind Period|Withdrawal by Subject|6
430347|NCT00510068|1435515|P1|Double-blind Period|Withdrawal by Subject|8
430348|NCT00510068|1435514|P2|Double-blind Period|Adverse Event|7
430349|NCT00510068|1435515|P1|Double-blind Period|Adverse Event|37
430350|NCT00510068|1435514|P2|Double-blind Period|Final primary analysis|18
430351|NCT00510068|1435515|P1|Double-blind Period|Final primary analysis|52
430352|NCT00510068|1435514|P2|Double-blind Period|Disease progression|169
430353|NCT00510068|1435515|P1|Double-blind Period|Disease progression|98
430354|NCT00509925|1435556|P2|Overall Study|Personal reasons|1
430355|NCT00509925|1435557|P1|Overall Study|Personal reasons|0
430356|NCT00509899|1435605|P8|Overall Study|Lack of Efficacy|0
430357|NCT00509899|1435606|P7|Overall Study|Lack of Efficacy|0
430358|NCT00509899|1435607|P6|Overall Study|Lack of Efficacy|1
430359|NCT00509899|1435608|P5|Overall Study|Lack of Efficacy|0
430360|NCT00509899|1435609|P4|Overall Study|Lack of Efficacy|0
430361|NCT00509899|1435610|P3|Overall Study|Lack of Efficacy|2
430362|NCT00509899|1435611|P2|Overall Study|Lack of Efficacy|0
430363|NCT00509899|1435612|P1|Overall Study|Lack of Efficacy|1
430364|NCT00509899|1435605|P8|Overall Study|Death|1
430365|NCT00509899|1435606|P7|Overall Study|Death|1
430366|NCT00509899|1435607|P6|Overall Study|Death|1
430367|NCT00509899|1435608|P5|Overall Study|Death|1
430368|NCT00509899|1435609|P4|Overall Study|Death|0
430369|NCT00509899|1435610|P3|Overall Study|Death|3
430370|NCT00509899|1435611|P2|Overall Study|Death|2
430371|NCT00509899|1435612|P1|Overall Study|Death|2
430372|NCT00509899|1435605|P8|Overall Study|Intercurrent Illness|0
430373|NCT00509899|1435606|P7|Overall Study|Intercurrent Illness|0
430374|NCT00509899|1435607|P6|Overall Study|Intercurrent Illness|1
430375|NCT00509899|1435608|P5|Overall Study|Intercurrent Illness|0
430376|NCT00509899|1435609|P4|Overall Study|Intercurrent Illness|1
430377|NCT00509899|1435610|P3|Overall Study|Intercurrent Illness|0
430378|NCT00509899|1435611|P2|Overall Study|Intercurrent Illness|0
430379|NCT00509899|1435612|P1|Overall Study|Intercurrent Illness|1
430380|NCT00509899|1435605|P8|Overall Study|Physician Decision|0
430381|NCT00509899|1435606|P7|Overall Study|Physician Decision|0
430382|NCT00509899|1435607|P6|Overall Study|Physician Decision|4
430383|NCT00509899|1435608|P5|Overall Study|Physician Decision|1
430384|NCT00509899|1435609|P4|Overall Study|Physician Decision|0
430385|NCT00509899|1435610|P3|Overall Study|Physician Decision|7
430386|NCT00509899|1435611|P2|Overall Study|Physician Decision|2
430387|NCT00509899|1435612|P1|Overall Study|Physician Decision|4
430388|NCT00509899|1435605|P8|Overall Study|Withdrawal by Subject|0
430389|NCT00509899|1435606|P7|Overall Study|Withdrawal by Subject|0
430390|NCT00509899|1435607|P6|Overall Study|Withdrawal by Subject|2
430391|NCT00509899|1435608|P5|Overall Study|Withdrawal by Subject|3
430392|NCT00509899|1435609|P4|Overall Study|Withdrawal by Subject|0
430393|NCT00509899|1435610|P3|Overall Study|Withdrawal by Subject|3
430394|NCT00509899|1435611|P2|Overall Study|Withdrawal by Subject|2
430395|NCT00509899|1435612|P1|Overall Study|Withdrawal by Subject|6
430396|NCT00509899|1435605|P8|Overall Study|Unacceptable Toxicity|0
430397|NCT00509899|1435606|P7|Overall Study|Unacceptable Toxicity|0
430398|NCT00509899|1435607|P6|Overall Study|Unacceptable Toxicity|0
430399|NCT00509899|1435608|P5|Overall Study|Unacceptable Toxicity|0
430400|NCT00509899|1435609|P4|Overall Study|Unacceptable Toxicity|2
430401|NCT00509899|1435610|P3|Overall Study|Unacceptable Toxicity|0
430402|NCT00509899|1435611|P2|Overall Study|Unacceptable Toxicity|0
430403|NCT00509899|1435612|P1|Overall Study|Unacceptable Toxicity|1
430404|NCT00509899|1435605|P8|Overall Study|Progressive disease|0
430405|NCT00509899|1435606|P7|Overall Study|Progressive disease|0
430406|NCT00509899|1435607|P6|Overall Study|Progressive disease|1
430407|NCT00509899|1435608|P5|Overall Study|Progressive disease|0
430408|NCT00509899|1435609|P4|Overall Study|Progressive disease|1
430409|NCT00509899|1435610|P3|Overall Study|Progressive disease|5
430410|NCT00509899|1435611|P2|Overall Study|Progressive disease|3
430411|NCT00509899|1435612|P1|Overall Study|Progressive disease|1
430412|NCT00509795|1435671|P4|Overall Study|Withdrawal by Subject|8
430413|NCT00509795|1435672|P3|Overall Study|Withdrawal by Subject|7
430414|NCT00509795|1435673|P2|Overall Study|Withdrawal by Subject|5
430415|NCT00509795|1435674|P1|Overall Study|Withdrawal by Subject|10
430416|NCT00509795|1435671|P4|Overall Study|Protocol Violation|1
430417|NCT00509795|1435672|P3|Overall Study|Protocol Violation|3
430418|NCT00509795|1435673|P2|Overall Study|Protocol Violation|0
430419|NCT00509795|1435674|P1|Overall Study|Protocol Violation|3
430420|NCT00509795|1435671|P4|Overall Study|OTHER|1
430421|NCT00509795|1435672|P3|Overall Study|OTHER|4
430422|NCT00509795|1435673|P2|Overall Study|OTHER|0
430423|NCT00509795|1435674|P1|Overall Study|OTHER|1
430424|NCT00509795|1435671|P4|Overall Study|Lost to Follow-up|4
430425|NCT00509795|1435672|P3|Overall Study|Lost to Follow-up|4
430426|NCT00509795|1435673|P2|Overall Study|Lost to Follow-up|2
430427|NCT00509795|1435674|P1|Overall Study|Lost to Follow-up|1
430428|NCT00509795|1435671|P4|Overall Study|Lack of Efficacy|2
430429|NCT00509795|1435672|P3|Overall Study|Lack of Efficacy|2
430430|NCT00509795|1435673|P2|Overall Study|Lack of Efficacy|0
430431|NCT00509795|1435674|P1|Overall Study|Lack of Efficacy|0
430432|NCT00509795|1435671|P4|Overall Study|Death|7
430433|NCT00509795|1435672|P3|Overall Study|Death|2
430434|NCT00509795|1435673|P2|Overall Study|Death|1
430435|NCT00509795|1435674|P1|Overall Study|Death|3
430436|NCT00509795|1435671|P4|Overall Study|Adverse Event|4
430437|NCT00509795|1435672|P3|Overall Study|Adverse Event|5
430438|NCT00509795|1435673|P2|Overall Study|Adverse Event|3
430439|NCT00509795|1435674|P1|Overall Study|Adverse Event|4
430440|NCT00509769|1435705|P1|Overall Study|Use of prohibited therapies during study|1
430441|NCT00509769|1435705|P1|Overall Study|Physician Decision|8
430442|NCT00509769|1435705|P1|Overall Study|Patient’s decision|1
430443|NCT00509769|1435705|P1|Overall Study|Adverse Event|4
430444|NCT00509769|1435705|P1|Overall Study|Progressive disease|77
430445|NCT00509600|1435714|P1|Overall Study|Adverse Event|1
430446|NCT00509366|1435792|P5|Overall Study|Not Treated (Screen Failure)|0
430447|NCT00509366|1435793|P4|Overall Study|Not Treated (Screen Failure)|0
430448|NCT00509366|1435794|P3|Overall Study|Not Treated (Screen Failure)|1
430449|NCT00509366|1435795|P2|Overall Study|Not Treated (Screen Failure)|1
430450|NCT00509366|1435796|P1|Overall Study|Not Treated (Screen Failure)|1
430451|NCT00509262|1435820|P2|Overall Study|Withdrawal by Subject|11
430452|NCT00509262|1435821|P1|Overall Study|Withdrawal by Subject|24
430453|NCT00509262|1435820|P2|Overall Study|Protocol Violation|2
430454|NCT00509262|1435821|P1|Overall Study|Protocol Violation|2
430455|NCT00509262|1435820|P2|Overall Study|Physician Decision|3
430456|NCT00509262|1435821|P1|Overall Study|Physician Decision|1
430457|NCT00509262|1435820|P2|Overall Study|Lost to Follow-up|6
430458|NCT00509262|1435821|P1|Overall Study|Lost to Follow-up|1
430459|NCT00509262|1435820|P2|Overall Study|Lack of Efficacy|0
430460|NCT00509262|1435821|P1|Overall Study|Lack of Efficacy|1
430461|NCT00509262|1435820|P2|Overall Study|Not specified|2
430462|NCT00509262|1435821|P1|Overall Study|Not specified|2
430463|NCT00509262|1435820|P2|Overall Study|Adverse Event|18
430464|NCT00509262|1435821|P1|Overall Study|Adverse Event|16
430465|NCT00509236|1435839|P2|Overall Study|Scheduled Kidney Transplant|0
430466|NCT00509236|1435840|P1|Overall Study|Scheduled Kidney Transplant|1
430467|NCT00509236|1435839|P2|Overall Study|Excluded Medication|1
430468|NCT00509236|1435840|P1|Overall Study|Excluded Medication|1
430469|NCT00509236|1435839|P2|Overall Study|Protocol Violation|0
430470|NCT00509236|1435840|P1|Overall Study|Protocol Violation|3
430471|NCT00509236|1435839|P2|Overall Study|Withdrawal by Subject|10
430472|NCT00509236|1435840|P1|Overall Study|Withdrawal by Subject|5
430473|NCT00509236|1435839|P2|Overall Study|Adverse Event|9
430474|NCT00509236|1435840|P1|Overall Study|Adverse Event|7
430475|NCT00509223|1435855|P2|Overall Study|Did not meet revised inclusion criteria|62
430476|NCT00509223|1435856|P1|Overall Study|Did not meet revised inclusion criteria|56
430477|NCT00509223|1435855|P2|Overall Study|Including: subject change of address|2
430478|NCT00509223|1435856|P1|Overall Study|Including: subject change of address|5
430479|NCT00509223|1435855|P2|Overall Study|Withdrawal by Subject|6
430480|NCT00509223|1435856|P1|Overall Study|Withdrawal by Subject|25
430481|NCT00509223|1435855|P2|Overall Study|Adverse Event|1
430482|NCT00509223|1435856|P1|Overall Study|Adverse Event|1
430483|NCT00509223|1435855|P2|Overall Study|Lost to Follow-up|1
430484|NCT00509223|1435856|P1|Overall Study|Lost to Follow-up|1
430485|NCT00509106|1435879|P2|Overall Study|Death|6
430486|NCT00509106|1435880|P1|Overall Study|Death|6
430487|NCT00509106|1435879|P2|Overall Study|Other|0
430488|NCT00509106|1435880|P1|Overall Study|Other|1
430489|NCT00509106|1435879|P2|Overall Study|Lost to Follow-up|10
430490|NCT00509106|1435880|P1|Overall Study|Lost to Follow-up|16
430491|NCT00509106|1435879|P2|Overall Study|Withdrew consent|8
430492|NCT00509106|1435880|P1|Overall Study|Withdrew consent|4
430493|NCT00509106|1435879|P2|Overall Study|At the request of sponsor/investigator|2
430494|NCT00509106|1435880|P1|Overall Study|At the request of sponsor/investigator|1
430495|NCT00509106|1435879|P2|Overall Study|Noncompliance|1
430496|NCT00509106|1435880|P1|Overall Study|Noncompliance|0
430497|NCT00509106|1435879|P2|Overall Study|Adverse Event|2
430498|NCT00509106|1435880|P1|Overall Study|Adverse Event|3
430499|NCT00509067|1435888|P2|Overall Study|Protocol Violation|3
430500|NCT00509067|1435889|P1|Overall Study|Protocol Violation|0
430501|NCT00509067|1435888|P2|Overall Study|Adverse Event|1
430502|NCT00509067|1435889|P1|Overall Study|Adverse Event|3
430503|NCT00509067|1435888|P2|Overall Study|Lost to Follow-up|1
430504|NCT00509067|1435889|P1|Overall Study|Lost to Follow-up|1
430505|NCT00509028|1435908|P2|Overall Study|Non-compliance|1
430506|NCT00509028|1435909|P1|Overall Study|Non-compliance|2
430507|NCT00509028|1435908|P2|Overall Study|Protocol Violation|2
430508|NCT00509028|1435909|P1|Overall Study|Protocol Violation|4
430509|NCT00509028|1435908|P2|Overall Study|Lost to Follow-up|1
430510|NCT00509028|1435909|P1|Overall Study|Lost to Follow-up|0
430511|NCT00509028|1435908|P2|Overall Study|Withdrawal by Subject|3
430512|NCT00509028|1435909|P1|Overall Study|Withdrawal by Subject|4
430513|NCT00509028|1435908|P2|Overall Study|Adverse Event|0
430514|NCT00509028|1435909|P1|Overall Study|Adverse Event|2
430515|NCT00508924|1435949|P4|Overall Study|Protocol Violation|1
430516|NCT00508924|1435950|P3|Overall Study|Protocol Violation|1
430517|NCT00508924|1435951|P2|Overall Study|Protocol Violation|0
430518|NCT00508924|1435952|P1|Overall Study|Protocol Violation|0
430519|NCT00508872|1435966|P1|Overall Study|Physician Decision|1
430520|NCT00508872|1435966|P1|Overall Study|Lost to Follow-up|1
430521|NCT00508820|1435972|P2|Overall Study|Protocol-specified Criteria|12
430522|NCT00508820|1435973|P1|Overall Study|Protocol-specified Criteria|3
430523|NCT00508820|1435972|P2|Overall Study|Requirement for alternative therapy|15
430524|NCT00508820|1435973|P1|Overall Study|Requirement for alternative therapy|7
430525|NCT00508820|1435972|P2|Overall Study|Noncompliance|0
430526|NCT00508820|1435973|P1|Overall Study|Noncompliance|1
430527|NCT00508820|1435972|P2|Overall Study|Other|2
430528|NCT00508820|1435973|P1|Overall Study|Other|11
430529|NCT00508820|1435972|P2|Overall Study|Withdrawal by Subject|12
430530|NCT00508820|1435973|P1|Overall Study|Withdrawal by Subject|10
430531|NCT00508820|1435972|P2|Overall Study|Protocol Violation|0
430532|NCT00508820|1435973|P1|Overall Study|Protocol Violation|2
430533|NCT00508820|1435972|P2|Overall Study|Pregnancy|2
430534|NCT00508820|1435973|P1|Overall Study|Pregnancy|0
430535|NCT00508820|1435972|P2|Overall Study|Physician Decision|2
430536|NCT00508820|1435973|P1|Overall Study|Physician Decision|8
430537|NCT00508820|1435972|P2|Overall Study|Lost to Follow-up|1
430538|NCT00508820|1435973|P1|Overall Study|Lost to Follow-up|1
430539|NCT00508820|1435972|P2|Overall Study|Death|8
430540|NCT00508820|1435973|P1|Overall Study|Death|6
430541|NCT00508820|1435972|P2|Overall Study|Adverse Event|10
430542|NCT00508820|1435973|P1|Overall Study|Adverse Event|6
430543|NCT00508755|1435983|P1|Overall Study|Withdrawal by Subject|1
430544|NCT00508742|1435991|P2|Period 3: Toddler Dose|Other|4
430545|NCT00508742|1435992|P1|Period 3: Toddler Dose|Other|5
430546|NCT00508742|1435991|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
430547|NCT00508742|1435992|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
430548|NCT00508742|1435991|P2|Period 3: Toddler Dose|Lost to Follow-up|3
430549|NCT00508742|1435992|P1|Period 3: Toddler Dose|Lost to Follow-up|2
430550|NCT00508742|1435991|P2|Period 3: Toddler Dose|Adverse Event|0
430551|NCT00508742|1435992|P1|Period 3: Toddler Dose|Adverse Event|1
430552|NCT00508742|1435991|P2|Period 2: After Infant Series|Other|1
430553|NCT00508742|1435992|P1|Period 2: After Infant Series|Other|2
430554|NCT00508742|1435991|P2|Period 2: After Infant Series|Failed to Return|0
430555|NCT00508742|1435992|P1|Period 2: After Infant Series|Failed to Return|1
430556|NCT00508742|1435991|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
430557|NCT00508742|1435992|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
430558|NCT00508742|1435991|P2|Period 2: After Infant Series|Protocol Violation|0
430559|NCT00508742|1435992|P1|Period 2: After Infant Series|Protocol Violation|1
430560|NCT00508742|1435991|P2|Period 2: After Infant Series|Lost to Follow-up|1
430561|NCT00508742|1435992|P1|Period 2: After Infant Series|Lost to Follow-up|1
430562|NCT00508742|1435991|P2|Period 2: After Infant Series|Adverse Event|6
430563|NCT00508742|1435992|P1|Period 2: After Infant Series|Adverse Event|2
430564|NCT00508742|1435991|P2|Period 1: Infant Series|Other|1
430565|NCT00508742|1435992|P1|Period 1: Infant Series|Other|4
430566|NCT00508742|1435991|P2|Period 1: Infant Series|Physician Decision|0
430567|NCT00508742|1435992|P1|Period 1: Infant Series|Physician Decision|1
430568|NCT00508742|1435991|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
430569|NCT00508742|1435992|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
430570|NCT00508742|1435991|P2|Period 1: Infant Series|Protocol Violation|0
430571|NCT00508742|1435992|P1|Period 1: Infant Series|Protocol Violation|1
430572|NCT00508742|1435991|P2|Period 1: Infant Series|Adverse Event|4
430573|NCT00508742|1435992|P1|Period 1: Infant Series|Adverse Event|5
430574|NCT00508651|1436017|P2|Overall Study|Withdrawal by Subject|1
430575|NCT00508651|1436018|P1|Overall Study|Withdrawal by Subject|1
430576|NCT00508651|1436017|P2|Overall Study|Lost to Follow-up|1
430577|NCT00508651|1436018|P1|Overall Study|Lost to Follow-up|3
430578|NCT00508482|1436099|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
430579|NCT00508482|1436100|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
430580|NCT00508482|1436101|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
430581|NCT00508482|1436099|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
430582|NCT00508482|1436100|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
430583|NCT00508482|1436101|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
430584|NCT00508482|1436099|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
430585|NCT00508482|1436100|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
430586|NCT00508482|1436101|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
430587|NCT00508404|1436145|P1|Overall Study|Other - Not Specified|3
430588|NCT00508404|1436145|P1|Overall Study|Lost to Follow-up|2
430589|NCT00508404|1436145|P1|Overall Study|Protocol-specified Criteria|2
430590|NCT00508404|1436145|P1|Overall Study|Withdrawal by Subject|3
430591|NCT00508404|1436145|P1|Overall Study|Physician Decision|2
430592|NCT00508404|1436145|P1|Overall Study|Death|16
430593|NCT00508404|1436145|P1|Overall Study|Adverse Event|2
430594|NCT00508404|1436145|P1|Overall Study|Ongoing at Data Cut-off|12
430595|NCT00508391|1436172|P2|Second Treatment|Withdrawal by Subject|0
430596|NCT00508391|1436173|P1|Second Treatment|Withdrawal by Subject|2
430597|NCT00508391|1436172|P2|First Treatment|Withdrawal by Subject|3
430598|NCT00508391|1436173|P1|First Treatment|Withdrawal by Subject|6
430599|NCT00508274|1436184|P1|Overall Study|Withdrawal by Subject|1
430600|NCT00508274|1436184|P1|Overall Study|Adverse Event|1
430601|NCT00508157|1436212|P2|Overall Study|Other known cause|1
430602|NCT00508157|1436213|P1|Overall Study|Other known cause|0
430603|NCT00508157|1436212|P2|Overall Study|Subject no longer met study criteria|1
430604|NCT00508157|1436213|P1|Overall Study|Subject no longer met study criteria|0
430605|NCT00508157|1436212|P2|Overall Study|Lost to Follow-up|0
430606|NCT00508157|1436213|P1|Overall Study|Lost to Follow-up|1
430607|NCT00508157|1436212|P2|Overall Study|Subject Withdrew Consent|0
430608|NCT00508157|1436213|P1|Overall Study|Subject Withdrew Consent|1
430609|NCT00508157|1436212|P2|Overall Study|Adverse Event|1
430610|NCT00508157|1436213|P1|Overall Study|Adverse Event|0
430611|NCT00508144|1436235|P1|Overall Study|Death|5
430612|NCT00508144|1436235|P1|Overall Study|Not eligible|6
430613|NCT00508027|1436261|P1|Dose Level 2|Withdrawal by Subject|2
430614|NCT00508027|1436261|P1|Dose Level 2|Lost to Follow-up|2
430615|NCT00508027|1436261|P1|Dose Level 1|Physician Decision|2
430616|NCT00508027|1436261|P1|Dose Level 1|Withdrawal by Subject|2
430617|NCT00508027|1436261|P1|Dose Level 1|Lost to Follow-up|4
430618|NCT00508001|1436302|P3|Overall Study|Withdrawal by Subject|1
430619|NCT00508001|1436303|P2|Overall Study|Withdrawal by Subject|4
430620|NCT00508001|1436304|P1|Overall Study|Withdrawal by Subject|4
430621|NCT00508001|1436302|P3|Overall Study|Death|1
430622|NCT00508001|1436303|P2|Overall Study|Death|1
430623|NCT00508001|1436304|P1|Overall Study|Death|0
430624|NCT00508001|1436302|P3|Overall Study|condition under investigation worsened|1
430625|NCT00508001|1436303|P2|Overall Study|condition under investigation worsened|7
430626|NCT00508001|1436304|P1|Overall Study|condition under investigation worsened|13
430627|NCT00508001|1436302|P3|Overall Study|Adverse Event|4
430628|NCT00508001|1436303|P2|Overall Study|Adverse Event|0
430629|NCT00508001|1436304|P1|Overall Study|Adverse Event|2
430630|NCT00507819|1436321|P2|Washout (6 Weeks)|Withdrawal by Subject|0
430631|NCT00507819|1436322|P1|Washout (6 Weeks)|Withdrawal by Subject|1
430632|NCT00507689|1436341|P2|Randomized Period|Withdrawal by Subject|1
430633|NCT00507689|1436342|P1|Randomized Period|Withdrawal by Subject|0
430634|NCT00507689|1436341|P2|Randomized Period|Adverse Event|1
430635|NCT00507689|1436342|P1|Randomized Period|Adverse Event|1
430636|NCT00507689|1436341|P2|Pre-Randomization Period|Withdrawal by Subject|0
430637|NCT00507689|1436342|P1|Pre-Randomization Period|Withdrawal by Subject|1
430638|NCT00507689|1436341|P2|Pre-Randomization Period|Physician Decision|0
430639|NCT00507689|1436342|P1|Pre-Randomization Period|Physician Decision|1
430640|NCT00507689|1436341|P2|Pre-Randomization Period|Adverse Event|0
430641|NCT00507689|1436342|P1|Pre-Randomization Period|Adverse Event|1
430642|NCT00507546|1436374|P2|Overall Study|Physician Decision|1
430643|NCT00507546|1436375|P1|Overall Study|Physician Decision|0
430644|NCT00507546|1436374|P2|Overall Study|Protocol Violation|0
430645|NCT00507546|1436375|P1|Overall Study|Protocol Violation|1
430646|NCT00507546|1436374|P2|Overall Study|Withdrawal by Subject|0
430647|NCT00507546|1436375|P1|Overall Study|Withdrawal by Subject|1
430648|NCT00507507|1436385|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
430649|NCT00507507|1436386|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
430650|NCT00507507|1436385|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
430651|NCT00507507|1436386|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
430652|NCT00507507|1436385|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
430653|NCT00507507|1436386|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
430654|NCT00507507|1436385|P2|Treatment Period|Withdrawal by Subject|47
430655|NCT00507507|1436386|P1|Treatment Period|Withdrawal by Subject|46
430656|NCT00507507|1436385|P2|Treatment Period|Adverse Event|1
430657|NCT00507507|1436386|P1|Treatment Period|Adverse Event|1
430658|NCT00507507|1436385|P2|Treatment Period|Protocol Violation|2
430659|NCT00507507|1436386|P1|Treatment Period|Protocol Violation|1
430660|NCT00507507|1436385|P2|Treatment Period|Physician Decision|1
430661|NCT00507507|1436386|P1|Treatment Period|Physician Decision|4
430662|NCT00507507|1436385|P2|Treatment Period|Lost to Follow-up|2
430663|NCT00507507|1436386|P1|Treatment Period|Lost to Follow-up|0
430664|NCT00507455|1436421|P3|Overall Study|Other - miscellaneous reason|1
430665|NCT00507455|1436422|P2|Overall Study|Other - miscellaneous reason|0
430666|NCT00507455|1436423|P1|Overall Study|Other - miscellaneous reason|1
430667|NCT00507455|1436421|P3|Overall Study|Lack of Efficacy|0
430668|NCT00507455|1436422|P2|Overall Study|Lack of Efficacy|1
430669|NCT00507455|1436423|P1|Overall Study|Lack of Efficacy|0
430670|NCT00507455|1436421|P3|Overall Study|Lost to Follow-up|2
430671|NCT00507455|1436422|P2|Overall Study|Lost to Follow-up|0
430672|NCT00507455|1436423|P1|Overall Study|Lost to Follow-up|2
430673|NCT00507455|1436421|P3|Overall Study|Protocol Violation|1
430674|NCT00507455|1436422|P2|Overall Study|Protocol Violation|1
430675|NCT00507455|1436423|P1|Overall Study|Protocol Violation|4
430676|NCT00507455|1436421|P3|Overall Study|Withdrawal by Subject|2
430677|NCT00507455|1436422|P2|Overall Study|Withdrawal by Subject|1
430678|NCT00507455|1436423|P1|Overall Study|Withdrawal by Subject|2
430679|NCT00507455|1436421|P3|Overall Study|Adverse Event|6
430680|NCT00507455|1436422|P2|Overall Study|Adverse Event|3
430681|NCT00507455|1436423|P1|Overall Study|Adverse Event|3
430682|NCT00507442|1436486|P4|Overall Study|Not Specified|2
430683|NCT00507442|1436487|P3|Overall Study|Not Specified|2
430684|NCT00507442|1436488|P2|Overall Study|Not Specified|5
430685|NCT00507442|1436489|P1|Overall Study|Not Specified|2
430686|NCT00507442|1436486|P4|Overall Study|Withdrawal by Subject|1
430687|NCT00507442|1436487|P3|Overall Study|Withdrawal by Subject|2
430688|NCT00507442|1436488|P2|Overall Study|Withdrawal by Subject|4
430689|NCT00507442|1436489|P1|Overall Study|Withdrawal by Subject|4
430690|NCT00507442|1436486|P4|Overall Study|Progressive Disease|0
430691|NCT00507442|1436487|P3|Overall Study|Progressive Disease|2
430692|NCT00507442|1436488|P2|Overall Study|Progressive Disease|4
430693|NCT00507442|1436489|P1|Overall Study|Progressive Disease|2
430694|NCT00507442|1436486|P4|Overall Study|Physician Decision|1
430695|NCT00507442|1436487|P3|Overall Study|Physician Decision|4
430696|NCT00507442|1436488|P2|Overall Study|Physician Decision|2
430697|NCT00507442|1436489|P1|Overall Study|Physician Decision|0
430698|NCT00507442|1436486|P4|Overall Study|Lost to Follow-up|0
430699|NCT00507442|1436487|P3|Overall Study|Lost to Follow-up|1
430700|NCT00507442|1436488|P2|Overall Study|Lost to Follow-up|0
430701|NCT00507442|1436489|P1|Overall Study|Lost to Follow-up|0
430702|NCT00507442|1436486|P4|Overall Study|Protocol Violation|0
430703|NCT00507442|1436487|P3|Overall Study|Protocol Violation|0
430704|NCT00507442|1436488|P2|Overall Study|Protocol Violation|1
430705|NCT00507442|1436489|P1|Overall Study|Protocol Violation|0
430706|NCT00507442|1436486|P4|Overall Study|Adverse Event|1
430707|NCT00507442|1436487|P3|Overall Study|Adverse Event|4
430708|NCT00507442|1436488|P2|Overall Study|Adverse Event|11
430709|NCT00507442|1436489|P1|Overall Study|Adverse Event|8
430710|NCT00507429|1436541|P2|Maintenance Phase|Progressive Disease|0
430711|NCT00507429|1436542|P1|Maintenance Phase|Progressive Disease|14
430712|NCT00507429|1436541|P2|Treatment Phase|Other|3
430713|NCT00507429|1436542|P1|Treatment Phase|Other|6
430714|NCT00507429|1436541|P2|Treatment Phase|Physician Decision|2
430715|NCT00507429|1436542|P1|Treatment Phase|Physician Decision|4
430716|NCT00507429|1436541|P2|Treatment Phase|Withdrawal by Subject|3
430717|NCT00507429|1436542|P1|Treatment Phase|Withdrawal by Subject|3
430718|NCT00507429|1436541|P2|Treatment Phase|Adverse Event|5
430719|NCT00507429|1436542|P1|Treatment Phase|Adverse Event|12
430720|NCT00507429|1436541|P2|Treatment Phase|Disease Progression|5
430721|NCT00507429|1436542|P1|Treatment Phase|Disease Progression|12
430722|NCT00507416|1436553|P3|Overall Study|Did not Receive Study Treatment|4
430723|NCT00507416|1436554|P2|Overall Study|Did not Receive Study Treatment|9
430724|NCT00507416|1436555|P1|Overall Study|Did not Receive Study Treatment|3
430725|NCT00507416|1436553|P3|Overall Study|Other|13
430726|NCT00507416|1436554|P2|Overall Study|Other|16
430727|NCT00507416|1436555|P1|Overall Study|Other|11
430728|NCT00507416|1436553|P3|Overall Study|Patient declined further treatment|11
430729|NCT00507416|1436554|P2|Overall Study|Patient declined further treatment|14
430730|NCT00507416|1436555|P1|Overall Study|Patient declined further treatment|18
430731|NCT00507416|1436553|P3|Overall Study|Progressive Disease|13
430732|NCT00507416|1436554|P2|Overall Study|Progressive Disease|10
430733|NCT00507416|1436555|P1|Overall Study|Progressive Disease|20
430734|NCT00507416|1436553|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
430735|NCT00507416|1436554|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
430736|NCT00507416|1436555|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
430737|NCT00507416|1436553|P3|Overall Study|Protocol Violation|0
430738|NCT00507416|1436554|P2|Overall Study|Protocol Violation|2
430739|NCT00507416|1436555|P1|Overall Study|Protocol Violation|1
430740|NCT00507416|1436553|P3|Overall Study|Adverse Event|65
430741|NCT00507416|1436554|P2|Overall Study|Adverse Event|67
430742|NCT00507416|1436555|P1|Overall Study|Adverse Event|58
430743|NCT00507130|1436597|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
430744|NCT00507130|1436598|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
430745|NCT00507130|1436599|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
430746|NCT00507130|1436600|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
430747|NCT00507130|1436597|P4|Overall Study|Lost to Follow-up|1
430748|NCT00507130|1436598|P3|Overall Study|Lost to Follow-up|1
430749|NCT00507130|1436599|P2|Overall Study|Lost to Follow-up|0
430750|NCT00507130|1436600|P1|Overall Study|Lost to Follow-up|0
430751|NCT00506948|1436642|P1|Overall Study|Physician Decision|1
430752|NCT00506948|1436642|P1|Overall Study|Adverse Event|5
430753|NCT00506948|1436642|P1|Overall Study|Death|4
430754|NCT00506922|1436651|P5|Overall Study|Withdrawal by Subject|1
430755|NCT00506922|1436652|P4|Overall Study|Withdrawal by Subject|0
430756|NCT00506922|1436653|P3|Overall Study|Withdrawal by Subject|0
430757|NCT00506922|1436654|P2|Overall Study|Withdrawal by Subject|0
430758|NCT00506922|1436655|P1|Overall Study|Withdrawal by Subject|0
430759|NCT00506922|1436651|P5|Overall Study|Physician Decision|0
430760|NCT00506922|1436652|P4|Overall Study|Physician Decision|2
430761|NCT00506922|1436653|P3|Overall Study|Physician Decision|0
430762|NCT00506922|1436654|P2|Overall Study|Physician Decision|0
430763|NCT00506922|1436655|P1|Overall Study|Physician Decision|0
430764|NCT00506883|1436666|P3|Overall Study|Other|1
430765|NCT00506883|1436667|P2|Overall Study|Other|1
430766|NCT00506883|1436668|P1|Overall Study|Other|5
430767|NCT00506883|1436666|P3|Overall Study|Lack of Efficacy|1
430768|NCT00506883|1436667|P2|Overall Study|Lack of Efficacy|1
430769|NCT00506883|1436668|P1|Overall Study|Lack of Efficacy|0
430770|NCT00506883|1436666|P3|Overall Study|Withdrawal by Subject|1
430771|NCT00506883|1436667|P2|Overall Study|Withdrawal by Subject|0
430772|NCT00506883|1436668|P1|Overall Study|Withdrawal by Subject|1
430773|NCT00506883|1436666|P3|Overall Study|Lost to Follow-up|1
430774|NCT00506883|1436667|P2|Overall Study|Lost to Follow-up|1
430775|NCT00506883|1436668|P1|Overall Study|Lost to Follow-up|1
430776|NCT00506831|1436681|P1|Overall Study|Withdrawal by Subject|1
430777|NCT00506831|1436681|P1|Overall Study|Death|1
430778|NCT00506662|1436713|P2|Overall Study|Not recorded|6
430779|NCT00506662|1436714|P1|Overall Study|Not recorded|4
430780|NCT00506662|1436713|P2|Overall Study|Trial terminated|16
430781|NCT00506662|1436714|P1|Overall Study|Trial terminated|10
430782|NCT00506662|1436713|P2|Overall Study|Protocol Violation|4
430783|NCT00506662|1436714|P1|Overall Study|Protocol Violation|2
430784|NCT00506662|1436713|P2|Overall Study|Lack of Efficacy|0
430785|NCT00506662|1436714|P1|Overall Study|Lack of Efficacy|1
430786|NCT00506662|1436713|P2|Overall Study|Adverse Event|2
430787|NCT00506662|1436714|P1|Overall Study|Adverse Event|0
430788|NCT00506493|1436748|P1|Overall Study|Withdrawal by Subject|5
430789|NCT00506493|1436748|P1|Overall Study|Death|6
430790|NCT00506454|1436757|P2|Overall Study|Withdrawal by Subject|1
430791|NCT00506454|1436758|P1|Overall Study|Withdrawal by Subject|1
430792|NCT00506441|1436764|P2|Period 2; Double-blind Period|Other Reason|1
430793|NCT00506441|1436765|P1|Period 2; Double-blind Period|Other Reason|1
430794|NCT00506441|1436764|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
430795|NCT00506441|1436765|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
430796|NCT00506441|1436764|P2|Period 2; Double-blind Period|Physician Decision|1
430797|NCT00506441|1436765|P1|Period 2; Double-blind Period|Physician Decision|1
430798|NCT00506441|1436764|P2|Period 2; Double-blind Period|Lack of Efficacy|2
430799|NCT00506441|1436765|P1|Period 2; Double-blind Period|Lack of Efficacy|0
430800|NCT00506441|1436764|P2|Period 2; Double-blind Period|Adverse Event|1
430801|NCT00506441|1436765|P1|Period 2; Double-blind Period|Adverse Event|0
430802|NCT00506441|1436764|P2|Period 1; Open-label Period|Other Reasons|0
430803|NCT00506441|1436765|P1|Period 1; Open-label Period|Other Reasons|13
430804|NCT00506441|1436764|P2|Period 1; Open-label Period|Withdrawal by Subject|0
430805|NCT00506441|1436765|P1|Period 1; Open-label Period|Withdrawal by Subject|13
430806|NCT00506441|1436764|P2|Period 1; Open-label Period|Protocol Violation|0
430807|NCT00506441|1436765|P1|Period 1; Open-label Period|Protocol Violation|9
430808|NCT00506441|1436764|P2|Period 1; Open-label Period|Physician Decision|0
430809|NCT00506441|1436765|P1|Period 1; Open-label Period|Physician Decision|5
430810|NCT00506441|1436764|P2|Period 1; Open-label Period|Lost to Follow-up|0
430811|NCT00506441|1436765|P1|Period 1; Open-label Period|Lost to Follow-up|2
430812|NCT00506441|1436764|P2|Period 1; Open-label Period|Lack of Efficacy|0
430813|NCT00506441|1436765|P1|Period 1; Open-label Period|Lack of Efficacy|13
430814|NCT00506441|1436764|P2|Period 1; Open-label Period|Adverse Event|0
430815|NCT00506441|1436765|P1|Period 1; Open-label Period|Adverse Event|21
430816|NCT00506415|1436773|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
430817|NCT00506415|1436774|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
430818|NCT00506415|1436775|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
430819|NCT00506415|1436776|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
430820|NCT00506415|1436773|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
430821|NCT00506415|1436774|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
430822|NCT00506415|1436775|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
430823|NCT00506415|1436776|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
430824|NCT00506415|1436773|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
430825|NCT00506415|1436774|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
430826|NCT00506415|1436775|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
430827|NCT00506415|1436776|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
430828|NCT00506415|1436773|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
430829|NCT00506415|1436774|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
430830|NCT00506415|1436775|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
430831|NCT00506415|1436776|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
430832|NCT00506415|1436773|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
430833|NCT00506415|1436774|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
430834|NCT00506415|1436775|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
430835|NCT00506415|1436776|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
430836|NCT00506415|1436773|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
430837|NCT00506415|1436774|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
430838|NCT00506415|1436775|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
430839|NCT00506415|1436776|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
430840|NCT00506415|1436773|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
430841|NCT00506415|1436774|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
430842|NCT00506415|1436775|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
430843|NCT00506415|1436776|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
430844|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
430845|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
430846|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
430847|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
430848|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
430849|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
430850|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
430851|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
430852|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
430853|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
430854|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
430855|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
430856|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
430857|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
430858|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
430859|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
430860|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
430861|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
430862|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
430863|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
430864|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
430865|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
430866|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
430867|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
430868|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Death|0
430869|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Death|3
430870|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Death|5
430871|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Death|0
430872|NCT00506415|1436773|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
430873|NCT00506415|1436774|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
430874|NCT00506415|1436775|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
430875|NCT00506415|1436776|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
430876|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
430877|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
430878|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
430879|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
430880|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
430881|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
430882|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
430883|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
430884|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
430885|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
430886|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
430887|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
430888|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
430889|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
430890|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
430891|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
430892|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
430893|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
430894|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
430895|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
430896|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
430897|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
430898|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
430899|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
430900|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
430901|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
430902|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
430903|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
430904|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
430905|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
430906|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
430907|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
430908|NCT00506415|1436773|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
430909|NCT00506415|1436774|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
430910|NCT00506415|1436775|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
430911|NCT00506415|1436776|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
430912|NCT00506389|1436801|P3|In-treatment Period|Randomized but not treated|1
430913|NCT00506389|1436802|P2|In-treatment Period|Randomized but not treated|1
430914|NCT00506389|1436803|P1|In-treatment Period|Randomized but not treated|4
430915|NCT00506389|1436801|P3|In-treatment Period|Adverse Event|2
430916|NCT00506389|1436802|P2|In-treatment Period|Adverse Event|5
430917|NCT00506389|1436803|P1|In-treatment Period|Adverse Event|11
430918|NCT00506389|1436801|P3|In-treatment Period|Lack of Efficacy|0
430919|NCT00506389|1436802|P2|In-treatment Period|Lack of Efficacy|2
430920|NCT00506389|1436803|P1|In-treatment Period|Lack of Efficacy|0
430921|NCT00506389|1436801|P3|In-treatment Period|Withdrawal by Subject|4
430922|NCT00506389|1436802|P2|In-treatment Period|Withdrawal by Subject|3
430923|NCT00506389|1436803|P1|In-treatment Period|Withdrawal by Subject|3
430924|NCT00506389|1436801|P3|In-treatment Period|Reasons not related to trial|0
430925|NCT00506389|1436802|P2|In-treatment Period|Reasons not related to trial|1
430926|NCT00506389|1436803|P1|In-treatment Period|Reasons not related to trial|4
430927|NCT00506389|1436801|P3|In-treatment Period|Lack of compliance|0
430928|NCT00506389|1436802|P2|In-treatment Period|Lack of compliance|0
430929|NCT00506389|1436803|P1|In-treatment Period|Lack of compliance|1
430930|NCT00506389|1436801|P3|In-treatment Period|Lost to Follow-up|1
430931|NCT00506389|1436802|P2|In-treatment Period|Lost to Follow-up|0
430932|NCT00506389|1436803|P1|In-treatment Period|Lost to Follow-up|0
430933|NCT00506389|1436801|P3|In-treatment Period|Not specified|4
430934|NCT00506389|1436802|P2|In-treatment Period|Not specified|3
430935|NCT00506389|1436803|P1|In-treatment Period|Not specified|3
430936|NCT00506350|1436829|P9|Overall Study|Not specified|2
430937|NCT00506350|1436830|P8|Overall Study|Not specified|2
430938|NCT00506350|1436831|P7|Overall Study|Not specified|0
430939|NCT00506350|1436832|P6|Overall Study|Not specified|0
430940|NCT00506350|1436833|P5|Overall Study|Not specified|3
430941|NCT00506350|1436834|P4|Overall Study|Not specified|0
430942|NCT00506350|1436835|P3|Overall Study|Not specified|3
430943|NCT00506350|1436836|P2|Overall Study|Not specified|1
430944|NCT00506350|1436837|P1|Overall Study|Not specified|1
430945|NCT00506350|1436829|P9|Overall Study|Medical Reason|0
430946|NCT00506350|1436830|P8|Overall Study|Medical Reason|0
430947|NCT00506350|1436831|P7|Overall Study|Medical Reason|0
430948|NCT00506350|1436832|P6|Overall Study|Medical Reason|0
430949|NCT00506350|1436833|P5|Overall Study|Medical Reason|1
430950|NCT00506350|1436834|P4|Overall Study|Medical Reason|0
430951|NCT00506350|1436835|P3|Overall Study|Medical Reason|0
430952|NCT00506350|1436836|P2|Overall Study|Medical Reason|0
430953|NCT00506350|1436837|P1|Overall Study|Medical Reason|0
430954|NCT00506350|1436829|P9|Overall Study|Lost to Follow-up|2
430955|NCT00506350|1436830|P8|Overall Study|Lost to Follow-up|0
430956|NCT00506350|1436831|P7|Overall Study|Lost to Follow-up|0
430957|NCT00506350|1436832|P6|Overall Study|Lost to Follow-up|1
430958|NCT00506350|1436833|P5|Overall Study|Lost to Follow-up|2
430959|NCT00506350|1436834|P4|Overall Study|Lost to Follow-up|1
430960|NCT00506350|1436835|P3|Overall Study|Lost to Follow-up|1
430961|NCT00506350|1436836|P2|Overall Study|Lost to Follow-up|1
430962|NCT00506350|1436837|P1|Overall Study|Lost to Follow-up|1
430963|NCT00506350|1436829|P9|Overall Study|Withdrawal by Subject|0
430964|NCT00506350|1436830|P8|Overall Study|Withdrawal by Subject|2
430965|NCT00506350|1436831|P7|Overall Study|Withdrawal by Subject|1
430966|NCT00506350|1436832|P6|Overall Study|Withdrawal by Subject|1
430967|NCT00506350|1436833|P5|Overall Study|Withdrawal by Subject|4
430968|NCT00506350|1436834|P4|Overall Study|Withdrawal by Subject|1
430969|NCT00506350|1436835|P3|Overall Study|Withdrawal by Subject|1
430970|NCT00506350|1436836|P2|Overall Study|Withdrawal by Subject|1
430971|NCT00506350|1436837|P1|Overall Study|Withdrawal by Subject|0
430972|NCT00506350|1436829|P9|Overall Study|Protocol Violation|0
430973|NCT00506350|1436830|P8|Overall Study|Protocol Violation|0
430974|NCT00506350|1436831|P7|Overall Study|Protocol Violation|1
430975|NCT00506350|1436832|P6|Overall Study|Protocol Violation|0
430976|NCT00506350|1436833|P5|Overall Study|Protocol Violation|0
430977|NCT00506350|1436834|P4|Overall Study|Protocol Violation|0
430978|NCT00506350|1436835|P3|Overall Study|Protocol Violation|1
430979|NCT00506350|1436836|P2|Overall Study|Protocol Violation|0
430980|NCT00506350|1436837|P1|Overall Study|Protocol Violation|0
430981|NCT00506350|1436829|P9|Overall Study|Adverse Event|1
430982|NCT00506350|1436830|P8|Overall Study|Adverse Event|1
430983|NCT00506350|1436831|P7|Overall Study|Adverse Event|0
430984|NCT00506350|1436832|P6|Overall Study|Adverse Event|0
430985|NCT00506350|1436833|P5|Overall Study|Adverse Event|0
430986|NCT00506350|1436834|P4|Overall Study|Adverse Event|0
430987|NCT00506350|1436835|P3|Overall Study|Adverse Event|0
430988|NCT00506350|1436836|P2|Overall Study|Adverse Event|0
430989|NCT00506350|1436837|P1|Overall Study|Adverse Event|0
430990|NCT00506350|1436829|P9|Overall Study|Serious Adverse Event|0
430991|NCT00506350|1436830|P8|Overall Study|Serious Adverse Event|0
430992|NCT00506350|1436831|P7|Overall Study|Serious Adverse Event|0
430993|NCT00506350|1436832|P6|Overall Study|Serious Adverse Event|0
430994|NCT00506350|1436833|P5|Overall Study|Serious Adverse Event|0
430995|NCT00506350|1436834|P4|Overall Study|Serious Adverse Event|0
430996|NCT00506350|1436835|P3|Overall Study|Serious Adverse Event|0
430997|NCT00506350|1436836|P2|Overall Study|Serious Adverse Event|0
430998|NCT00506350|1436837|P1|Overall Study|Serious Adverse Event|1
430999|NCT00506285|1436984|P2|6-month Open Label Phase|Withdrawal by Subject|5
431000|NCT00506285|1436985|P1|6-month Open Label Phase|Withdrawal by Subject|9
431001|NCT00506285|1436984|P2|6-month Open Label Phase|Lost to Follow-up|7
431002|NCT00506285|1436985|P1|6-month Open Label Phase|Lost to Follow-up|1
431003|NCT00506285|1436984|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
431004|NCT00506285|1436985|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
431005|NCT00506285|1436984|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
431006|NCT00506285|1436985|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
431007|NCT00506285|1436984|P2|3 Week Screening Phase|Withdrawal by Subject|10
431008|NCT00506285|1436985|P1|3 Week Screening Phase|Withdrawal by Subject|17
431009|NCT00506077|1437000|P2|Treatment Period 2|Withdrawal by Subject|0
431010|NCT00506077|1437001|P1|Treatment Period 2|Withdrawal by Subject|1
431011|NCT00506077|1437000|P2|Treatment Period 2|Adverse Event|1
431012|NCT00506077|1437001|P1|Treatment Period 2|Adverse Event|0
431013|NCT00506077|1437000|P2|Treatment Period 1|Withdrawal by Subject|0
431014|NCT00506077|1437001|P1|Treatment Period 1|Withdrawal by Subject|2
431015|NCT00506077|1437000|P2|Treatment Period 1|Lost to Follow-up|2
431016|NCT00506077|1437001|P1|Treatment Period 1|Lost to Follow-up|0
431017|NCT00506077|1437000|P2|Treatment Period 1|Adverse Event|1
431018|NCT00506077|1437001|P1|Treatment Period 1|Adverse Event|2
431019|NCT00505934|1437043|P1|Overall Study|Other: IV dose needed to be changed|1
431020|NCT00505934|1437043|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
431021|NCT00505934|1437043|P1|Overall Study|Adverse Event|1
431022|NCT00505921|1437049|P1|Overall Study|Failed to Mobilize|8
431023|NCT00505921|1437049|P1|Overall Study|Ineligible|1
431024|NCT00505778|1437066|P2|Overall Study|Took No Study Drug|2
431025|NCT00505778|1437067|P1|Overall Study|Took No Study Drug|2
431026|NCT00505778|1437066|P2|Overall Study|Relapse|65
431027|NCT00505778|1437067|P1|Overall Study|Relapse|65
431028|NCT00505778|1437066|P2|Overall Study|Withdrawal by Subject|14
431029|NCT00505778|1437067|P1|Overall Study|Withdrawal by Subject|29
431030|NCT00505778|1437066|P2|Overall Study|Protocol Violation|9
431031|NCT00505778|1437067|P1|Overall Study|Protocol Violation|7
431032|NCT00505778|1437066|P2|Overall Study|Unable to Meet Protocol Criteria|1
431033|NCT00505778|1437067|P1|Overall Study|Unable to Meet Protocol Criteria|4
431034|NCT00505778|1437066|P2|Overall Study|Lost to Follow-up|23
431035|NCT00505778|1437067|P1|Overall Study|Lost to Follow-up|17
431036|NCT00505778|1437066|P2|Overall Study|Physician Decision|14
431037|NCT00505778|1437067|P1|Overall Study|Physician Decision|8
431038|NCT00505778|1437066|P2|Overall Study|Adverse Event|7
431039|NCT00505778|1437067|P1|Overall Study|Adverse Event|2
431040|NCT00505765|1437086|P3|Overall Study|Noncompliance|3
431041|NCT00505765|1437087|P2|Overall Study|Noncompliance|1
431042|NCT00505765|1437088|P1|Overall Study|Noncompliance|0
431043|NCT00505765|1437086|P3|Overall Study|Adverse Event|0
431044|NCT00505765|1437087|P2|Overall Study|Adverse Event|2
431045|NCT00505765|1437088|P1|Overall Study|Adverse Event|1
431046|NCT00505765|1437086|P3|Overall Study|Withdrawal by Subject|0
431047|NCT00505765|1437087|P2|Overall Study|Withdrawal by Subject|0
431048|NCT00505765|1437088|P1|Overall Study|Withdrawal by Subject|1
431049|NCT00505752|1437115|P4|Overall Study|Other|2
431050|NCT00505752|1437116|P3|Overall Study|Other|1
431051|NCT00505752|1437117|P2|Overall Study|Other|2
431052|NCT00505752|1437118|P1|Overall Study|Other|1
431053|NCT00505752|1437115|P4|Overall Study|All embryos/blastocysts discarded|1
431054|NCT00505752|1437116|P3|Overall Study|All embryos/blastocysts discarded|1
431055|NCT00505752|1437117|P2|Overall Study|All embryos/blastocysts discarded|0
431056|NCT00505752|1437118|P1|Overall Study|All embryos/blastocysts discarded|0
431057|NCT00505752|1437115|P4|Overall Study|No Fertilization|1
431058|NCT00505752|1437116|P3|Overall Study|No Fertilization|2
431059|NCT00505752|1437117|P2|Overall Study|No Fertilization|1
431060|NCT00505752|1437118|P1|Overall Study|No Fertilization|1
431061|NCT00505752|1437115|P4|Overall Study|No oocytes retrieved|1
431062|NCT00505752|1437116|P3|Overall Study|No oocytes retrieved|0
431063|NCT00505752|1437117|P2|Overall Study|No oocytes retrieved|2
431064|NCT00505752|1437118|P1|Overall Study|No oocytes retrieved|0
431065|NCT00505752|1437115|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
431066|NCT00505752|1437116|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
431067|NCT00505752|1437117|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
431068|NCT00505752|1437118|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
431069|NCT00505752|1437115|P4|Overall Study|Lack of ovarian response|0
431070|NCT00505752|1437116|P3|Overall Study|Lack of ovarian response|0
431071|NCT00505752|1437117|P2|Overall Study|Lack of ovarian response|3
431072|NCT00505752|1437118|P1|Overall Study|Lack of ovarian response|1
431073|NCT00505752|1437115|P4|Overall Study|Lost to Follow-up|0
431074|NCT00505752|1437116|P3|Overall Study|Lost to Follow-up|0
431075|NCT00505752|1437117|P2|Overall Study|Lost to Follow-up|0
431076|NCT00505752|1437118|P1|Overall Study|Lost to Follow-up|1
431077|NCT00505752|1437115|P4|Overall Study|Adverse Event|0
431078|NCT00505752|1437116|P3|Overall Study|Adverse Event|1
431079|NCT00505752|1437117|P2|Overall Study|Adverse Event|0
431080|NCT00505752|1437118|P1|Overall Study|Adverse Event|1
431081|NCT00505687|1437132|P1|Overall Study|Other: As Per Sponsor|8
431082|NCT00505687|1437132|P1|Overall Study|Other: Disease Progression|1
431083|NCT00505687|1437132|P1|Overall Study|Other: Neupro Given In Hospital|1
431084|NCT00505687|1437132|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
431085|NCT00505687|1437132|P1|Overall Study|Other: Prolonged Hospitalization|1
431086|NCT00505687|1437132|P1|Overall Study|Other: Scheduled DBS Surgery|1
431087|NCT00505687|1437132|P1|Overall Study|Other: Underwent Implantation Of DBS|1
431088|NCT00505687|1437132|P1|Overall Study|Lost to Follow-up|1
431089|NCT00505687|1437132|P1|Overall Study|Subject withdrew consent|15
431090|NCT00505687|1437132|P1|Overall Study|Adverse Event|48
431091|NCT00505687|1437132|P1|Overall Study|Lack of Efficacy|15
431092|NCT00505687|1437132|P1|Overall Study|Important protocol violation|2
431093|NCT00505661|1437138|P1|Overall Study|Not Eligible|4
431094|NCT00505622|1437149|P3|Overall Study|Study termination by sponsor|90
431095|NCT00505622|1437150|P2|Overall Study|Study termination by sponsor|98
431096|NCT00505622|1437151|P1|Overall Study|Study termination by sponsor|115
431097|NCT00505622|1437149|P3|Overall Study|Withdrawal by Subject|2
431098|NCT00505622|1437150|P2|Overall Study|Withdrawal by Subject|3
431099|NCT00505622|1437151|P1|Overall Study|Withdrawal by Subject|0
431100|NCT00505622|1437149|P3|Overall Study|Protocol Violation|0
431101|NCT00505622|1437150|P2|Overall Study|Protocol Violation|1
431102|NCT00505622|1437151|P1|Overall Study|Protocol Violation|1
431103|NCT00505622|1437149|P3|Overall Study|Adverse Event|4
431104|NCT00505622|1437150|P2|Overall Study|Adverse Event|6
431105|NCT00505622|1437151|P1|Overall Study|Adverse Event|5
431106|NCT00505414|1437176|P5|Maintenance Phase|underlying disease and therapy required|0
431107|NCT00505414|1437177|P4|Maintenance Phase|underlying disease and therapy required|0
431108|NCT00505414|1437178|P3|Maintenance Phase|underlying disease and therapy required|2
431109|NCT00505414|1437179|P2|Maintenance Phase|underlying disease and therapy required|2
431110|NCT00505414|1437180|P1|Maintenance Phase|underlying disease and therapy required|0
431111|NCT00505414|1437176|P5|Maintenance Phase|Withdrawal by Subject|0
431112|NCT00505414|1437177|P4|Maintenance Phase|Withdrawal by Subject|0
431113|NCT00505414|1437178|P3|Maintenance Phase|Withdrawal by Subject|1
431114|NCT00505414|1437179|P2|Maintenance Phase|Withdrawal by Subject|0
431115|NCT00505414|1437180|P1|Maintenance Phase|Withdrawal by Subject|0
431116|NCT00505414|1437176|P5|Maintenance Phase|Lack of Efficacy|0
431117|NCT00505414|1437177|P4|Maintenance Phase|Lack of Efficacy|0
431118|NCT00505414|1437178|P3|Maintenance Phase|Lack of Efficacy|1
431119|NCT00505414|1437179|P2|Maintenance Phase|Lack of Efficacy|1
431120|NCT00505414|1437180|P1|Maintenance Phase|Lack of Efficacy|2
431121|NCT00505414|1437176|P5|Maintenance Phase|Death|0
431122|NCT00505414|1437177|P4|Maintenance Phase|Death|0
431123|NCT00505414|1437178|P3|Maintenance Phase|Death|1
431124|NCT00505414|1437179|P2|Maintenance Phase|Death|0
431125|NCT00505414|1437180|P1|Maintenance Phase|Death|2
431126|NCT00505414|1437176|P5|Maintenance Phase|Adverse Event|0
431127|NCT00505414|1437177|P4|Maintenance Phase|Adverse Event|0
431128|NCT00505414|1437178|P3|Maintenance Phase|Adverse Event|3
431129|NCT00505414|1437179|P2|Maintenance Phase|Adverse Event|2
431130|NCT00505414|1437180|P1|Maintenance Phase|Adverse Event|2
431131|NCT00505414|1437176|P5|Titration Phase|Underlying disease and therapy required|3
431132|NCT00505414|1437177|P4|Titration Phase|Underlying disease and therapy required|7
431133|NCT00505414|1437178|P3|Titration Phase|Underlying disease and therapy required|0
431134|NCT00505414|1437179|P2|Titration Phase|Underlying disease and therapy required|0
431135|NCT00505414|1437180|P1|Titration Phase|Underlying disease and therapy required|0
431136|NCT00505414|1437176|P5|Titration Phase|Withdrawal by Subject|4
431137|NCT00505414|1437177|P4|Titration Phase|Withdrawal by Subject|3
431138|NCT00505414|1437178|P3|Titration Phase|Withdrawal by Subject|0
431139|NCT00505414|1437179|P2|Titration Phase|Withdrawal by Subject|0
431140|NCT00505414|1437180|P1|Titration Phase|Withdrawal by Subject|0
431141|NCT00505414|1437176|P5|Titration Phase|Protocol Violation|1
431142|NCT00505414|1437177|P4|Titration Phase|Protocol Violation|0
431143|NCT00505414|1437178|P3|Titration Phase|Protocol Violation|0
431144|NCT00505414|1437179|P2|Titration Phase|Protocol Violation|0
431145|NCT00505414|1437180|P1|Titration Phase|Protocol Violation|0
431146|NCT00505414|1437176|P5|Titration Phase|Lack of Efficacy|1
431147|NCT00505414|1437177|P4|Titration Phase|Lack of Efficacy|10
431148|NCT00505414|1437178|P3|Titration Phase|Lack of Efficacy|0
431149|NCT00505414|1437179|P2|Titration Phase|Lack of Efficacy|0
431150|NCT00505414|1437180|P1|Titration Phase|Lack of Efficacy|0
431151|NCT00505414|1437176|P5|Titration Phase|Death|0
431152|NCT00505414|1437177|P4|Titration Phase|Death|2
431153|NCT00505414|1437178|P3|Titration Phase|Death|0
431154|NCT00505414|1437179|P2|Titration Phase|Death|0
431155|NCT00505414|1437180|P1|Titration Phase|Death|0
431156|NCT00505414|1437176|P5|Titration Phase|Adverse Event|3
431157|NCT00505414|1437177|P4|Titration Phase|Adverse Event|8
431158|NCT00505414|1437178|P3|Titration Phase|Adverse Event|0
431159|NCT00505414|1437179|P2|Titration Phase|Adverse Event|0
431160|NCT00505414|1437180|P1|Titration Phase|Adverse Event|0
431161|NCT00505375|1437197|P2|Overall Study|Travel issues|1
431162|NCT00505375|1437198|P1|Overall Study|Travel issues|0
431163|NCT00505375|1437197|P2|Overall Study|Pregnancy|0
431164|NCT00505375|1437198|P1|Overall Study|Pregnancy|1
431165|NCT00505375|1437197|P2|Overall Study|Lost to Follow-up|2
431166|NCT00505375|1437198|P1|Overall Study|Lost to Follow-up|0
431167|NCT00505375|1437197|P2|Overall Study|Withdrawal by Subject|2
431168|NCT00505375|1437198|P1|Overall Study|Withdrawal by Subject|2
431169|NCT00505375|1437197|P2|Overall Study|Death|0
431170|NCT00505375|1437198|P1|Overall Study|Death|1
431171|NCT00505284|1437220|P5|Overall Study|Not specified|4
431172|NCT00505284|1437221|P4|Overall Study|Not specified|4
431173|NCT00505284|1437222|P3|Overall Study|Not specified|0
431174|NCT00505284|1437223|P2|Overall Study|Not specified|0
431175|NCT00505284|1437224|P1|Overall Study|Not specified|5
431176|NCT00505284|1437220|P5|Overall Study|Physician Decision|0
431177|NCT00505284|1437221|P4|Overall Study|Physician Decision|0
431178|NCT00505284|1437222|P3|Overall Study|Physician Decision|0
431179|NCT00505284|1437223|P2|Overall Study|Physician Decision|1
431180|NCT00505284|1437224|P1|Overall Study|Physician Decision|0
431181|NCT00505284|1437220|P5|Overall Study|Lack of Efficacy|1
431182|NCT00505284|1437221|P4|Overall Study|Lack of Efficacy|1
431183|NCT00505284|1437222|P3|Overall Study|Lack of Efficacy|1
431184|NCT00505284|1437223|P2|Overall Study|Lack of Efficacy|1
431185|NCT00505284|1437224|P1|Overall Study|Lack of Efficacy|0
431186|NCT00505284|1437220|P5|Overall Study|Withdrawal by Subject|6
431187|NCT00505284|1437221|P4|Overall Study|Withdrawal by Subject|0
431188|NCT00505284|1437222|P3|Overall Study|Withdrawal by Subject|1
431189|NCT00505284|1437223|P2|Overall Study|Withdrawal by Subject|6
431190|NCT00505284|1437224|P1|Overall Study|Withdrawal by Subject|2
431191|NCT00505284|1437220|P5|Overall Study|Protocol Violation|0
431192|NCT00505284|1437221|P4|Overall Study|Protocol Violation|0
431193|NCT00505284|1437222|P3|Overall Study|Protocol Violation|1
431194|NCT00505284|1437223|P2|Overall Study|Protocol Violation|1
431195|NCT00505284|1437224|P1|Overall Study|Protocol Violation|0
431196|NCT00505284|1437220|P5|Overall Study|Adverse Event|22
431197|NCT00505284|1437221|P4|Overall Study|Adverse Event|14
431198|NCT00505284|1437222|P3|Overall Study|Adverse Event|9
431199|NCT00505284|1437223|P2|Overall Study|Adverse Event|7
431200|NCT00505284|1437224|P1|Overall Study|Adverse Event|3
431201|NCT00505076|1437294|P3|Overall Study|Withdrawal by Subject|2
431202|NCT00505076|1437295|P2|Overall Study|Withdrawal by Subject|1
431203|NCT00505076|1437296|P1|Overall Study|Withdrawal by Subject|0
431204|NCT00505076|1437294|P3|Overall Study|Protocol Violation|2
431205|NCT00505076|1437295|P2|Overall Study|Protocol Violation|1
431206|NCT00505076|1437296|P1|Overall Study|Protocol Violation|2
431207|NCT00505076|1437294|P3|Overall Study|Adverse Event|1
431208|NCT00505076|1437295|P2|Overall Study|Adverse Event|0
431209|NCT00505076|1437296|P1|Overall Study|Adverse Event|1
431210|NCT00504881|1437325|P2|Overall Study|AE of unknown type|0
431211|NCT00504881|1437326|P1|Overall Study|AE of unknown type|1
431212|NCT00504881|1437325|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
431213|NCT00504881|1437326|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
431214|NCT00504881|1437325|P2|Overall Study|AE, non-serious non-fatal|14
431215|NCT00504881|1437326|P1|Overall Study|AE, non-serious non-fatal|4
431216|NCT00504881|1437325|P2|Overall Study|SAE, non-fatal|6
431217|NCT00504881|1437326|P1|Overall Study|SAE, non-fatal|2
431218|NCT00504881|1437325|P2|Overall Study|AE, serious fatal|1
431219|NCT00504881|1437326|P1|Overall Study|AE, serious fatal|0
431220|NCT00504881|1437325|P2|Overall Study|Safety Visit not performed|1
431221|NCT00504881|1437326|P1|Overall Study|Safety Visit not performed|0
431222|NCT00504881|1437325|P2|Overall Study|No Birth Control|1
431223|NCT00504881|1437326|P1|Overall Study|No Birth Control|0
431224|NCT00504881|1437325|P2|Overall Study|Non-Compliance|0
431225|NCT00504881|1437326|P1|Overall Study|Non-Compliance|1
431226|NCT00504881|1437325|P2|Overall Study|Withdrawal by Subject|4
431227|NCT00504881|1437326|P1|Overall Study|Withdrawal by Subject|1
431228|NCT00504881|1437325|P2|Overall Study|Lost to Follow-up|2
431229|NCT00504881|1437326|P1|Overall Study|Lost to Follow-up|0
431230|NCT00504881|1437325|P2|Overall Study|Lack of Efficacy|5
431231|NCT00504881|1437326|P1|Overall Study|Lack of Efficacy|1
431232|NCT00504777|1437376|P1|Overall Study|Adverse Event|1
431233|NCT00504725|1437389|P2|Overall Study|Protocol Violation|0
431234|NCT00504725|1437390|P1|Overall Study|Protocol Violation|1
431235|NCT00504595|1437413|P4|Overall Study|Not specified|0
431236|NCT00504595|1437414|P3|Overall Study|Not specified|2
431237|NCT00504595|1437415|P2|Overall Study|Not specified|0
431238|NCT00504595|1437416|P1|Overall Study|Not specified|0
431239|NCT00504595|1437413|P4|Overall Study|Lack of Efficacy|0
431240|NCT00504595|1437414|P3|Overall Study|Lack of Efficacy|0
431241|NCT00504595|1437415|P2|Overall Study|Lack of Efficacy|0
431242|NCT00504595|1437416|P1|Overall Study|Lack of Efficacy|1
431243|NCT00504556|1437433|P5|Overall Study|not in safety analysis set|1
431244|NCT00504556|1437434|P4|Overall Study|not in safety analysis set|0
431245|NCT00504556|1437435|P3|Overall Study|not in safety analysis set|1
431246|NCT00504556|1437436|P2|Overall Study|not in safety analysis set|1
431247|NCT00504556|1437437|P1|Overall Study|not in safety analysis set|0
431248|NCT00504556|1437433|P5|Overall Study|not specified|0
431249|NCT00504556|1437434|P4|Overall Study|not specified|3
431250|NCT00504556|1437435|P3|Overall Study|not specified|2
431251|NCT00504556|1437436|P2|Overall Study|not specified|2
431252|NCT00504556|1437437|P1|Overall Study|not specified|2
431253|NCT00504556|1437433|P5|Overall Study|data monitor committee decision|0
431254|NCT00504556|1437434|P4|Overall Study|data monitor committee decision|100
431255|NCT00504556|1437435|P3|Overall Study|data monitor committee decision|0
431256|NCT00504556|1437436|P2|Overall Study|data monitor committee decision|0
431257|NCT00504556|1437437|P1|Overall Study|data monitor committee decision|0
431258|NCT00504556|1437433|P5|Overall Study|did not meet entry criteria|0
431259|NCT00504556|1437434|P4|Overall Study|did not meet entry criteria|1
431260|NCT00504556|1437435|P3|Overall Study|did not meet entry criteria|1
431261|NCT00504556|1437436|P2|Overall Study|did not meet entry criteria|0
431262|NCT00504556|1437437|P1|Overall Study|did not meet entry criteria|2
431263|NCT00504556|1437433|P5|Overall Study|administrative reasons|2
431264|NCT00504556|1437434|P4|Overall Study|administrative reasons|1
431265|NCT00504556|1437435|P3|Overall Study|administrative reasons|2
431266|NCT00504556|1437436|P2|Overall Study|administrative reasons|2
431267|NCT00504556|1437437|P1|Overall Study|administrative reasons|0
431268|NCT00504556|1437433|P5|Overall Study|Withdrawal by Subject|12
431269|NCT00504556|1437434|P4|Overall Study|Withdrawal by Subject|8
431270|NCT00504556|1437435|P3|Overall Study|Withdrawal by Subject|7
431271|NCT00504556|1437436|P2|Overall Study|Withdrawal by Subject|16
431272|NCT00504556|1437437|P1|Overall Study|Withdrawal by Subject|16
431273|NCT00504556|1437433|P5|Overall Study|Lost to Follow-up|1
431274|NCT00504556|1437434|P4|Overall Study|Lost to Follow-up|1
431275|NCT00504556|1437435|P3|Overall Study|Lost to Follow-up|1
431276|NCT00504556|1437436|P2|Overall Study|Lost to Follow-up|0
431277|NCT00504556|1437437|P1|Overall Study|Lost to Follow-up|0
431278|NCT00504556|1437433|P5|Overall Study|Protocol Violation|2
431279|NCT00504556|1437434|P4|Overall Study|Protocol Violation|1
431280|NCT00504556|1437435|P3|Overall Study|Protocol Violation|2
431281|NCT00504556|1437436|P2|Overall Study|Protocol Violation|3
431282|NCT00504556|1437437|P1|Overall Study|Protocol Violation|1
431283|NCT00504556|1437433|P5|Overall Study|Death|2
431284|NCT00504556|1437434|P4|Overall Study|Death|0
431285|NCT00504556|1437435|P3|Overall Study|Death|1
431286|NCT00504556|1437436|P2|Overall Study|Death|3
431287|NCT00504556|1437437|P1|Overall Study|Death|3
431288|NCT00504556|1437433|P5|Overall Study|Adverse Event|5
431289|NCT00504556|1437434|P4|Overall Study|Adverse Event|13
431290|NCT00504556|1437435|P3|Overall Study|Adverse Event|14
431291|NCT00504556|1437436|P2|Overall Study|Adverse Event|11
431292|NCT00504556|1437437|P1|Overall Study|Adverse Event|11
431293|NCT00504426|1437505|P4|Overall Study|Withdrawal by Subject|0
431294|NCT00504426|1437506|P3|Overall Study|Withdrawal by Subject|0
431295|NCT00504426|1437507|P2|Overall Study|Withdrawal by Subject|0
431296|NCT00504426|1437508|P1|Overall Study|Withdrawal by Subject|2
431297|NCT00504426|1437505|P4|Overall Study|Protocol Violation|0
431298|NCT00504426|1437506|P3|Overall Study|Protocol Violation|2
431299|NCT00504426|1437507|P2|Overall Study|Protocol Violation|1
431300|NCT00504426|1437508|P1|Overall Study|Protocol Violation|1
431301|NCT00504426|1437505|P4|Overall Study|Adverse Event|0
431302|NCT00504426|1437506|P3|Overall Study|Adverse Event|2
431303|NCT00504426|1437507|P2|Overall Study|Adverse Event|0
431304|NCT00504426|1437508|P1|Overall Study|Adverse Event|0
431305|NCT00504309|1437528|P6|Overall Study|Withdrawal by Subject|0
431306|NCT00504309|1437529|P5|Overall Study|Withdrawal by Subject|0
431307|NCT00504309|1437530|P4|Overall Study|Withdrawal by Subject|0
431308|NCT00504309|1437531|P3|Overall Study|Withdrawal by Subject|1
431309|NCT00504309|1437532|P2|Overall Study|Withdrawal by Subject|0
431310|NCT00504309|1437533|P1|Overall Study|Withdrawal by Subject|0
431311|NCT00504309|1437528|P6|Overall Study|Death|0
431312|NCT00504309|1437529|P5|Overall Study|Death|1
431313|NCT00504309|1437530|P4|Overall Study|Death|0
431314|NCT00504309|1437531|P3|Overall Study|Death|0
431315|NCT00504309|1437532|P2|Overall Study|Death|0
431316|NCT00504309|1437533|P1|Overall Study|Death|0
431317|NCT00504257|1437571|P1|Overall Study|ineligible histology|2
431318|NCT00504257|1437571|P1|Overall Study|Withdrawal by Subject|2
431319|NCT00504231|1437583|P4|Overall Study|Discrepant chart documentation re route|0
431320|NCT00504231|1437584|P3|Overall Study|Discrepant chart documentation re route|1
431321|NCT00504231|1437585|P2|Overall Study|Discrepant chart documentation re route|0
431322|NCT00504231|1437586|P1|Overall Study|Discrepant chart documentation re route|0
431323|NCT00504166|1437606|P2|Overall Study|Lost to Follow-up|3
431324|NCT00504166|1437607|P1|Overall Study|Lost to Follow-up|1
431325|NCT00504166|1437606|P2|Overall Study|Physician Decision|1
431326|NCT00504166|1437607|P1|Overall Study|Physician Decision|1
431327|NCT00504166|1437606|P2|Overall Study|Withdrawal by Subject|6
431328|NCT00504166|1437607|P1|Overall Study|Withdrawal by Subject|3
431329|NCT00504166|1437606|P2|Overall Study|Adverse Event|4
431330|NCT00504166|1437607|P1|Overall Study|Adverse Event|1
431331|NCT00504153|1437613|P1|Overall Study|Death|1
431332|NCT00504153|1437613|P1|Overall Study|Adverse Event|4
431333|NCT00504153|1437613|P1|Overall Study|Withdrawal by Subject|1
431334|NCT00504075|1437621|P1|Overall Study|Required other therapeutic intervention|1
431335|NCT00504075|1437621|P1|Overall Study|Withdrawal by Subject|1
431336|NCT00504075|1437621|P1|Overall Study|Lost to Follow-up|5
431337|NCT00504075|1437621|P1|Overall Study|Adverse Event|1
431338|NCT00503997|1437631|P1|Overall Study|Withdrawal by Subject|1
431339|NCT00503997|1437631|P1|Overall Study|Death|1
431340|NCT00503997|1437631|P1|Overall Study|Adverse Event|5
431341|NCT00503997|1437631|P1|Overall Study|disease progression|1
431342|NCT00503984|1437637|P6|Overall Study|Death|0
431343|NCT00503984|1437638|P5|Overall Study|Death|1
431344|NCT00503984|1437639|P4|Overall Study|Death|0
431345|NCT00503984|1437640|P3|Overall Study|Death|0
431346|NCT00503984|1437641|P2|Overall Study|Death|0
431347|NCT00503984|1437642|P1|Overall Study|Death|0
431348|NCT00503984|1437637|P6|Overall Study|Adverse Event|0
431349|NCT00503984|1437638|P5|Overall Study|Adverse Event|0
431350|NCT00503984|1437639|P4|Overall Study|Adverse Event|0
431351|NCT00503984|1437640|P3|Overall Study|Adverse Event|0
431352|NCT00503984|1437641|P2|Overall Study|Adverse Event|1
431353|NCT00503984|1437642|P1|Overall Study|Adverse Event|0
431354|NCT00503984|1437637|P6|Overall Study|Protocol Violation|0
431355|NCT00503984|1437638|P5|Overall Study|Protocol Violation|0
431356|NCT00503984|1437639|P4|Overall Study|Protocol Violation|0
431357|NCT00503984|1437640|P3|Overall Study|Protocol Violation|0
431358|NCT00503984|1437641|P2|Overall Study|Protocol Violation|1
431359|NCT00503984|1437642|P1|Overall Study|Protocol Violation|0
431360|NCT00503906|1437668|P1|Overall Study|Withdrawal by Subject|1
431361|NCT00503841|1437690|P1|Overall Study|All screen failures|44
431362|NCT00503776|1437698|P4|Overall Study|Physician Decision|1
431363|NCT00503776|1437699|P3|Overall Study|Physician Decision|1
431364|NCT00503776|1437700|P2|Overall Study|Physician Decision|0
431365|NCT00503776|1437701|P1|Overall Study|Physician Decision|0
431366|NCT00503776|1437698|P4|Overall Study|Withdrawal by Subject|1
431367|NCT00503776|1437699|P3|Overall Study|Withdrawal by Subject|1
431368|NCT00503776|1437700|P2|Overall Study|Withdrawal by Subject|0
431369|NCT00503776|1437701|P1|Overall Study|Withdrawal by Subject|1
431370|NCT00503698|1437734|P2|Overall Study|Not exposed to trial drug|6
431371|NCT00503698|1437735|P1|Overall Study|Not exposed to trial drug|11
431372|NCT00503698|1437734|P2|Overall Study|Unclassified|32
431373|NCT00503698|1437735|P1|Overall Study|Unclassified|48
431374|NCT00503698|1437734|P2|Overall Study|Critically ill|0
431375|NCT00503698|1437735|P1|Overall Study|Critically ill|2
431376|NCT00503698|1437734|P2|Overall Study|Move to nonparticipating dialysis center|1
431377|NCT00503698|1437735|P1|Overall Study|Move to nonparticipating dialysis center|2
431378|NCT00503698|1437734|P2|Overall Study|Switch to peritoneal or home dialysis|2
431379|NCT00503698|1437735|P1|Overall Study|Switch to peritoneal or home dialysis|2
431380|NCT00503698|1437734|P2|Overall Study|Any condition in exclusion criteria|6
431381|NCT00503698|1437735|P1|Overall Study|Any condition in exclusion criteria|4
431382|NCT00503698|1437734|P2|Overall Study|Pregnancy/intention to become pregnant|0
431383|NCT00503698|1437735|P1|Overall Study|Pregnancy/intention to become pregnant|1
431384|NCT00503698|1437734|P2|Overall Study|End hemodialysis due to renal transplant|4
431385|NCT00503698|1437735|P1|Overall Study|End hemodialysis due to renal transplant|10
431386|NCT00503698|1437734|P2|Overall Study|Trial terminated|253
431387|NCT00503698|1437735|P1|Overall Study|Trial terminated|216
431388|NCT00503698|1437734|P2|Overall Study|Lack of Efficacy|4
431389|NCT00503698|1437735|P1|Overall Study|Lack of Efficacy|3
431390|NCT00503698|1437734|P2|Overall Study|Death|0
431391|NCT00503698|1437735|P1|Overall Study|Death|1
431392|NCT00503698|1437734|P2|Overall Study|Adverse Event|41
431393|NCT00503698|1437735|P1|Overall Study|Adverse Event|52
431394|NCT00503698|1437734|P2|Overall Study|Protocol Violation|6
431395|NCT00503698|1437735|P1|Overall Study|Protocol Violation|5
431396|NCT00503685|1437752|P3|Overall Study|Eligibility Criteria Not Met|0
431397|NCT00503685|1437753|P2|Overall Study|Eligibility Criteria Not Met|1
431398|NCT00503685|1437754|P1|Overall Study|Eligibility Criteria Not Met|0
431399|NCT00503685|1437752|P3|Overall Study|Protocol Violation|0
431400|NCT00503685|1437753|P2|Overall Study|Protocol Violation|1
431401|NCT00503685|1437754|P1|Overall Study|Protocol Violation|0
431402|NCT00503685|1437752|P3|Overall Study|Withdrawal by Subject|0
431403|NCT00503685|1437753|P2|Overall Study|Withdrawal by Subject|1
431404|NCT00503685|1437754|P1|Overall Study|Withdrawal by Subject|0
431405|NCT00503685|1437752|P3|Overall Study|Adverse Event|2
431406|NCT00503685|1437753|P2|Overall Study|Adverse Event|0
431407|NCT00503685|1437754|P1|Overall Study|Adverse Event|0
431408|NCT00503425|1437796|P1|Overall Study|Missing Data/Unknown|4
431409|NCT00503425|1437796|P1|Overall Study|Death|3
431410|NCT00503425|1437796|P1|Overall Study|Lost to Follow-up|3
431411|NCT00503425|1437796|P1|Overall Study|Withdrawal by Subject|8
431412|NCT00503425|1437796|P1|Overall Study|Lack of Efficacy|25
431413|NCT00503425|1437796|P1|Overall Study|Adverse Event|5
431414|NCT00503425|1437796|P1|Overall Study|Participant files lost|6
431415|NCT00503399|1437806|P2|Overall Study|Lost to Follow-up|2
431416|NCT00503399|1437807|P1|Overall Study|Lost to Follow-up|0
431417|NCT00503399|1437806|P2|Overall Study|Adverse Event|3
431418|NCT00503399|1437807|P1|Overall Study|Adverse Event|0
431419|NCT00503399|1437806|P2|Overall Study|Withdrawal by Subject|2
431420|NCT00503399|1437807|P1|Overall Study|Withdrawal by Subject|4
431421|NCT00503399|1437806|P2|Overall Study|Protocol Violation|0
431422|NCT00503399|1437807|P1|Overall Study|Protocol Violation|1
431423|NCT00503399|1437806|P2|Overall Study|Death|1
431424|NCT00503399|1437807|P1|Overall Study|Death|2
431425|NCT00503308|1437831|P2|Overall Study|Protocol Violation|1
431426|NCT00503308|1437832|P1|Overall Study|Protocol Violation|2
431427|NCT00503139|1437838|P1|Overall Study|Protocol Violation|4
431428|NCT00503139|1437838|P1|Overall Study|Case Report Forms were not collected|4
431429|NCT00503009|1437886|P3|Overall Study|Physician Decision|1
431430|NCT00503009|1437887|P2|Overall Study|Physician Decision|1
431431|NCT00503009|1437888|P1|Overall Study|Physician Decision|0
431432|NCT00503009|1437886|P3|Overall Study|Withdrawal by Subject|1
431433|NCT00503009|1437887|P2|Overall Study|Withdrawal by Subject|1
431434|NCT00503009|1437888|P1|Overall Study|Withdrawal by Subject|0
431435|NCT00503009|1437886|P3|Overall Study|Protocol Violation|1
431436|NCT00503009|1437887|P2|Overall Study|Protocol Violation|0
431437|NCT00503009|1437888|P1|Overall Study|Protocol Violation|1
431438|NCT00502996|1437905|P1|Overall Study|Adverse Event|2
431439|NCT00502996|1437905|P1|Overall Study|Withdrawal Informed Consent|6
431440|NCT00502996|1437905|P1|Overall Study|Treatment failure|25
431441|NCT00502996|1437905|P1|Overall Study|Protocol Violation|2
431442|NCT00502996|1437905|P1|Overall Study|Lost to Follow-up|9
431443|NCT00502840|1437973|P1|Overall Study|Not specified|20
431444|NCT00502840|1437973|P1|Overall Study|Administrative problems|1
431445|NCT00502840|1437973|P1|Overall Study|Lost to Follow-up|6
431446|NCT00502840|1437973|P1|Overall Study|Withdrawal by Subject|5
431447|NCT00502840|1437973|P1|Overall Study|Protocol Violation|4
431448|NCT00502840|1437973|P1|Overall Study|Lack of Efficacy|11
431449|NCT00502840|1437973|P1|Overall Study|Additional or changed therapy|48
431450|NCT00502840|1437973|P1|Overall Study|Adverse Event|5
431451|NCT00502801|1438001|P1|End of Therapy to Test of Cure|OTHER|2
431452|NCT00502801|1438001|P1|End of Therapy to Test of Cure|Death|3
431453|NCT00502801|1438001|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
431454|NCT00502801|1438001|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
431455|NCT00502801|1438001|P1|Treatment Period|OTHER|30
431456|NCT00502801|1438001|P1|Treatment Period|Death|14
431457|NCT00502801|1438001|P1|Treatment Period|Adverse Event|7
431458|NCT00502801|1438001|P1|Treatment Period|Withdrawal by Subject|3
431459|NCT00502775|1438009|P3|Overall Study|Subject took disallowed drug|1
431460|NCT00502775|1438010|P2|Overall Study|Subject took disallowed drug|0
431461|NCT00502775|1438011|P1|Overall Study|Subject took disallowed drug|0
431462|NCT00502775|1438009|P3|Overall Study|Subject in jail|0
431463|NCT00502775|1438010|P2|Overall Study|Subject in jail|1
431464|NCT00502775|1438011|P1|Overall Study|Subject in jail|0
431465|NCT00502775|1438009|P3|Overall Study|Declining pollen counts|1
431466|NCT00502775|1438010|P2|Overall Study|Declining pollen counts|1
431467|NCT00502775|1438011|P1|Overall Study|Declining pollen counts|0
431468|NCT00502775|1438009|P3|Overall Study|Outside pollen area more than 48 hours|0
431469|NCT00502775|1438010|P2|Overall Study|Outside pollen area more than 48 hours|1
431470|NCT00502775|1438011|P1|Overall Study|Outside pollen area more than 48 hours|0
431471|NCT00502775|1438009|P3|Overall Study|Non-compliance|2
431472|NCT00502775|1438010|P2|Overall Study|Non-compliance|2
431473|NCT00502775|1438011|P1|Overall Study|Non-compliance|0
431474|NCT00502775|1438009|P3|Overall Study|Randomized in error|1
431475|NCT00502775|1438010|P2|Overall Study|Randomized in error|1
431476|NCT00502775|1438011|P1|Overall Study|Randomized in error|0
431477|NCT00502775|1438009|P3|Overall Study|Logpad compliance <80%|0
431478|NCT00502775|1438010|P2|Overall Study|Logpad compliance <80%|0
431479|NCT00502775|1438011|P1|Overall Study|Logpad compliance <80%|1
431480|NCT00502775|1438009|P3|Overall Study|Subject unable to swallow capsule|1
431481|NCT00502775|1438010|P2|Overall Study|Subject unable to swallow capsule|0
431482|NCT00502775|1438011|P1|Overall Study|Subject unable to swallow capsule|1
431483|NCT00502775|1438009|P3|Overall Study|Non-compliance with eDiary|1
431484|NCT00502775|1438010|P2|Overall Study|Non-compliance with eDiary|1
431485|NCT00502775|1438011|P1|Overall Study|Non-compliance with eDiary|4
431486|NCT00502775|1438009|P3|Overall Study|Sponsor Terminated Study|1
431487|NCT00502775|1438010|P2|Overall Study|Sponsor Terminated Study|0
431488|NCT00502775|1438011|P1|Overall Study|Sponsor Terminated Study|1
431489|NCT00502775|1438009|P3|Overall Study|Withdrawal by Subject|2
431490|NCT00502775|1438010|P2|Overall Study|Withdrawal by Subject|1
431491|NCT00502775|1438011|P1|Overall Study|Withdrawal by Subject|1
431492|NCT00502775|1438009|P3|Overall Study|Protocol Violation|2
431493|NCT00502775|1438010|P2|Overall Study|Protocol Violation|5
431494|NCT00502775|1438011|P1|Overall Study|Protocol Violation|1
431495|NCT00502775|1438009|P3|Overall Study|Adverse Event|1
431496|NCT00502775|1438010|P2|Overall Study|Adverse Event|2
431497|NCT00502775|1438011|P1|Overall Study|Adverse Event|1
431498|NCT00502697|1438054|P2|Overall Study|did not meet assignment criteria|2
431499|NCT00502697|1438055|P1|Overall Study|did not meet assignment criteria|4
431500|NCT00502697|1438054|P2|Overall Study|found not to meet eligibility criteria|4
431501|NCT00502697|1438055|P1|Overall Study|found not to meet eligibility criteria|3
431502|NCT00502697|1438054|P2|Overall Study|disenrolled due to pregnancy loss|5
431503|NCT00502697|1438055|P1|Overall Study|disenrolled due to pregnancy loss|3
431504|NCT00502697|1438054|P2|Overall Study|Withdrawal by Subject|1
431505|NCT00502697|1438055|P1|Overall Study|Withdrawal by Subject|3
431506|NCT00502671|1438063|P1|Overall Study|Adverse Event|19
431507|NCT00502671|1438063|P1|Overall Study|Protocol Violation|16
431508|NCT00502671|1438063|P1|Overall Study|Lost to Follow-up|7
431509|NCT00502671|1438063|P1|Overall Study|Personal Reasons|22
431510|NCT00502671|1438063|P1|Overall Study|Disease Progression|13
431511|NCT00502593|1438080|P12|Overall Study|Lost to Follow-up|0
431512|NCT00502593|1438081|P11|Overall Study|Lost to Follow-up|1
431513|NCT00502593|1438082|P10|Overall Study|Lost to Follow-up|0
431514|NCT00502593|1438083|P9|Overall Study|Lost to Follow-up|3
431515|NCT00502593|1438084|P8|Overall Study|Lost to Follow-up|0
431516|NCT00502593|1438085|P7|Overall Study|Lost to Follow-up|0
431517|NCT00502593|1438086|P6|Overall Study|Lost to Follow-up|0
431518|NCT00502593|1438087|P5|Overall Study|Lost to Follow-up|0
431519|NCT00502593|1438088|P4|Overall Study|Lost to Follow-up|1
431520|NCT00502593|1438089|P3|Overall Study|Lost to Follow-up|1
431521|NCT00502593|1438090|P2|Overall Study|Lost to Follow-up|1
431522|NCT00502593|1438091|P1|Overall Study|Lost to Follow-up|2
431523|NCT00502593|1438080|P12|Overall Study|Withdrawal by Subject|0
431524|NCT00502593|1438081|P11|Overall Study|Withdrawal by Subject|1
431525|NCT00502593|1438082|P10|Overall Study|Withdrawal by Subject|0
431526|NCT00502593|1438083|P9|Overall Study|Withdrawal by Subject|3
431527|NCT00502593|1438084|P8|Overall Study|Withdrawal by Subject|0
431528|NCT00502593|1438085|P7|Overall Study|Withdrawal by Subject|3
431529|NCT00502593|1438086|P6|Overall Study|Withdrawal by Subject|0
431530|NCT00502593|1438087|P5|Overall Study|Withdrawal by Subject|2
431531|NCT00502593|1438088|P4|Overall Study|Withdrawal by Subject|2
431532|NCT00502593|1438089|P3|Overall Study|Withdrawal by Subject|6
431533|NCT00502593|1438090|P2|Overall Study|Withdrawal by Subject|0
431534|NCT00502593|1438091|P1|Overall Study|Withdrawal by Subject|0
431535|NCT00502593|1438080|P12|Overall Study|Withdrawn unspecified reason|0
431536|NCT00502593|1438081|P11|Overall Study|Withdrawn unspecified reason|0
431537|NCT00502593|1438082|P10|Overall Study|Withdrawn unspecified reason|0
431538|NCT00502593|1438083|P9|Overall Study|Withdrawn unspecified reason|0
431539|NCT00502593|1438084|P8|Overall Study|Withdrawn unspecified reason|0
431540|NCT00502593|1438085|P7|Overall Study|Withdrawn unspecified reason|2
431541|NCT00502593|1438086|P6|Overall Study|Withdrawn unspecified reason|0
431542|NCT00502593|1438087|P5|Overall Study|Withdrawn unspecified reason|2
431543|NCT00502593|1438088|P4|Overall Study|Withdrawn unspecified reason|1
431544|NCT00502593|1438089|P3|Overall Study|Withdrawn unspecified reason|3
431545|NCT00502593|1438090|P2|Overall Study|Withdrawn unspecified reason|1
431546|NCT00502593|1438091|P1|Overall Study|Withdrawn unspecified reason|1
431547|NCT00502320|1438607|P2|Overall Study|Adverse Event|5
431548|NCT00502320|1438608|P1|Overall Study|Adverse Event|3
431549|NCT00502320|1438607|P2|Overall Study|Screen Failure|1
431550|NCT00502320|1438608|P1|Overall Study|Screen Failure|0
431551|NCT00502320|1438607|P2|Overall Study|No longer met criteria|0
431552|NCT00502320|1438608|P1|Overall Study|No longer met criteria|1
431553|NCT00502320|1438607|P2|Overall Study|Withdrew Consent|0
431554|NCT00502320|1438608|P1|Overall Study|Withdrew Consent|1
431555|NCT00502320|1438607|P2|Overall Study|Lost to Follow-up|1
431556|NCT00502320|1438608|P1|Overall Study|Lost to Follow-up|1
431557|NCT00502242|1438620|P2|Overall Study|Withdrawal by Subject|7
431558|NCT00502242|1438621|P1|Overall Study|Withdrawal by Subject|6
431559|NCT00502242|1438620|P2|Overall Study|Protocol Violation|1
431560|NCT00502242|1438621|P1|Overall Study|Protocol Violation|3
431561|NCT00502242|1438620|P2|Overall Study|Other - Unspecified|14
431562|NCT00502242|1438621|P1|Overall Study|Other - Unspecified|8
431563|NCT00502242|1438620|P2|Overall Study|Physician Decision|3
431564|NCT00502242|1438621|P1|Overall Study|Physician Decision|2
431565|NCT00502242|1438620|P2|Overall Study|Adverse Event|20
431566|NCT00502242|1438621|P1|Overall Study|Adverse Event|31
431567|NCT00502242|1438620|P2|Overall Study|Lack of Efficacy|11
431568|NCT00502242|1438621|P1|Overall Study|Lack of Efficacy|1
431569|NCT00502203|1438685|P1|Overall Study|Inevaluable|1
431570|NCT00501969|1438694|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
431571|NCT00501969|1438694|P1|Overall Study|Other: Admin Request from the Sponsor|3
431572|NCT00501969|1438694|P1|Overall Study|Other: As Required by Local EC|2
431573|NCT00501969|1438694|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
431574|NCT00501969|1438694|P1|Overall Study|Other: Pat Pending Surgery for PD|1
431575|NCT00501969|1438694|P1|Overall Study|Other: Patient is Going to Have DBS|1
431576|NCT00501969|1438694|P1|Overall Study|Other: Patients + Investigator Agreement|1
431577|NCT00501969|1438694|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
431578|NCT00501969|1438694|P1|Overall Study|Other: Sponsor Stopped Study|12
431579|NCT00501969|1438694|P1|Overall Study|Other: Sponsor Termination at Site|1
431580|NCT00501969|1438694|P1|Overall Study|Other: Sponsors Request|10
431581|NCT00501969|1438694|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
431582|NCT00501969|1438694|P1|Overall Study|Lost to Follow-up|4
431583|NCT00501969|1438694|P1|Overall Study|Subject withdrew consent|51
431584|NCT00501969|1438694|P1|Overall Study|Unsatisfactory compliance of subject|7
431585|NCT00501969|1438694|P1|Overall Study|Adverse Event|76
431586|NCT00501969|1438694|P1|Overall Study|Lack of Efficacy|29
431587|NCT00501969|1438694|P1|Overall Study|Major Protocol Violation|4
431588|NCT00501852|1438726|P1|Overall Study|Withdrawal by Subject|2
431589|NCT00501852|1438726|P1|Overall Study|Adverse Event|3
431590|NCT00501644|1438746|P1|Overall Study|Withdrawal by Subject|1
431591|NCT00501644|1438746|P1|Overall Study|Adverse Event|4
431592|NCT00501540|1438775|P1|Overall Study|Death|5
431593|NCT00501293|1438787|P2|Maintenance Period|Application site reaction|0
431594|NCT00501293|1438788|P1|Maintenance Period|Application site reaction|1
431595|NCT00501293|1438787|P2|Maintenance Period|Would not wear patch|0
431596|NCT00501293|1438788|P1|Maintenance Period|Would not wear patch|1
431597|NCT00501293|1438787|P2|Maintenance Period|Went into rehabilitation|0
431598|NCT00501293|1438788|P1|Maintenance Period|Went into rehabilitation|1
431599|NCT00501293|1438787|P2|Maintenance Period|Noncompliant with study medication|0
431600|NCT00501293|1438788|P1|Maintenance Period|Noncompliant with study medication|5
431601|NCT00501293|1438787|P2|Maintenance Period|Lack of Efficacy|1
431602|NCT00501293|1438788|P1|Maintenance Period|Lack of Efficacy|4
431603|NCT00501293|1438787|P2|Maintenance Period|Protocol Violation|1
431604|NCT00501293|1438788|P1|Maintenance Period|Protocol Violation|2
431605|NCT00501293|1438787|P2|Maintenance Period|Adverse Event|6
431606|NCT00501293|1438788|P1|Maintenance Period|Adverse Event|6
431607|NCT00501293|1438787|P2|Maintenance Period|Lost to Follow-up|7
431608|NCT00501293|1438788|P1|Maintenance Period|Lost to Follow-up|12
431609|NCT00501293|1438787|P2|Maintenance Period|Withdrawal by Subject|13
431610|NCT00501293|1438788|P1|Maintenance Period|Withdrawal by Subject|14
431611|NCT00501293|1438787|P2|Optimization Period|Enrolled in error|0
431612|NCT00501293|1438788|P1|Optimization Period|Enrolled in error|1
431613|NCT00501228|1438815|P1|Overall Study|Withdrawal by Subject|1
431614|NCT00501085|1438819|P1|Overall Study|Other loss to follow-up|32
431615|NCT00501085|1438819|P1|Overall Study|Study closed by sponsor|109
431616|NCT00501085|1438819|P1|Overall Study|Non-Compliance|24
431617|NCT00501085|1438819|P1|Overall Study|Adverse Event|4
431618|NCT00501085|1438819|P1|Overall Study|Explantation Surgery|26
431619|NCT00501085|1438819|P1|Overall Study|Revision Surgery|7
431620|NCT00501085|1438819|P1|Overall Study|Subject Decision|1
431621|NCT00501085|1438819|P1|Overall Study|Withdrawal by Subject|34
431622|NCT00501085|1438819|P1|Overall Study|Lost to Follow-up|195
431623|NCT00501059|1438829|P2|Overall Study|Not treated|17
431624|NCT00501059|1438830|P1|Overall Study|Not treated|25
431625|NCT00501059|1438829|P2|Overall Study|Lost to Follow-up|198
431626|NCT00501059|1438830|P1|Overall Study|Lost to Follow-up|210
431627|NCT00501059|1438829|P2|Overall Study|Adverse Event|122
431628|NCT00501059|1438830|P1|Overall Study|Adverse Event|129
431629|NCT00501059|1438829|P2|Overall Study|Reason not given|1
431630|NCT00501059|1438830|P1|Overall Study|Reason not given|3
431631|NCT00501059|1438829|P2|Overall Study|Non-compliant with study treatment|16
431632|NCT00501059|1438830|P1|Overall Study|Non-compliant with study treatment|23
431633|NCT00501059|1438829|P2|Overall Study|Consent withdrawn by subject|873
431634|NCT00501059|1438830|P1|Overall Study|Consent withdrawn by subject|817
431635|NCT00501059|1438829|P2|Overall Study|Insufficient therapeutic effect|5
431636|NCT00501059|1438830|P1|Overall Study|Insufficient therapeutic effect|4
431637|NCT00501059|1438829|P2|Overall Study|Clinical endpoint reached|123
431638|NCT00501059|1438830|P1|Overall Study|Clinical endpoint reached|110
431639|NCT00501059|1438829|P2|Overall Study|Missing end-of-study page|92
431640|NCT00501059|1438830|P1|Overall Study|Missing end-of-study page|91
431641|NCT00501059|1438829|P2|Overall Study|Other|239
431642|NCT00501059|1438830|P1|Overall Study|Other|236
431643|NCT00501059|1438829|P2|Overall Study|Death|137
431644|NCT00501059|1438830|P1|Overall Study|Death|140
431645|NCT00501059|1438829|P2|Overall Study|Protocol Violation|69
431646|NCT00501059|1438830|P1|Overall Study|Protocol Violation|80
431647|NCT00501046|1438850|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
431648|NCT00501046|1438851|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
431649|NCT00501046|1438850|P2|Overall Study|Withdrawal by Subject|83
431650|NCT00501046|1438851|P1|Overall Study|Withdrawal by Subject|84
431651|NCT00501046|1438850|P2|Overall Study|Protocol Violation|1
431652|NCT00501046|1438851|P1|Overall Study|Protocol Violation|2
431653|NCT00501046|1438850|P2|Overall Study|Pregnancy|3
431654|NCT00501046|1438851|P1|Overall Study|Pregnancy|0
431655|NCT00501046|1438850|P2|Overall Study|Physician Decision|2
431656|NCT00501046|1438851|P1|Overall Study|Physician Decision|7
431657|NCT00501046|1438850|P2|Overall Study|Lost to Follow-up|13
431658|NCT00501046|1438851|P1|Overall Study|Lost to Follow-up|14
431659|NCT00501046|1438850|P2|Overall Study|Death|30
431660|NCT00501046|1438851|P1|Overall Study|Death|23
431661|NCT00501046|1438850|P2|Overall Study|Adverse Event|25
431662|NCT00501046|1438851|P1|Overall Study|Adverse Event|21
431663|NCT00501007|1438857|P2|Overall Study|Inclusion criteria not met.|25
431664|NCT00501007|1438858|P1|Overall Study|Inclusion criteria not met.|29
431665|NCT00500760|1438866|P2|Overall Study|Other|2
431666|NCT00500760|1438867|P1|Overall Study|Other|1
431667|NCT00500760|1438866|P2|Overall Study|Lost to Follow-up|0
431668|NCT00500760|1438867|P1|Overall Study|Lost to Follow-up|3
431669|NCT00500760|1438866|P2|Overall Study|Administrative decision|0
431670|NCT00500760|1438867|P1|Overall Study|Administrative decision|2
431671|NCT00500760|1438866|P2|Overall Study|Withdrawal by Subject|7
431672|NCT00500760|1438867|P1|Overall Study|Withdrawal by Subject|5
431673|NCT00500760|1438866|P2|Overall Study|Death|15
431674|NCT00500760|1438867|P1|Overall Study|Death|32
431675|NCT00500682|1438887|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
431676|NCT00500682|1438888|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
431677|NCT00500682|1438887|P2|Overall Study|Withdrawal by Subject|74
431678|NCT00500682|1438888|P1|Overall Study|Withdrawal by Subject|80
431679|NCT00500682|1438887|P2|Overall Study|Protocol Violation|3
431680|NCT00500682|1438888|P1|Overall Study|Protocol Violation|1
431681|NCT00500682|1438887|P2|Overall Study|Pregnancy|0
431682|NCT00500682|1438888|P1|Overall Study|Pregnancy|2
431683|NCT00500682|1438887|P2|Overall Study|Physician Decision|10
431684|NCT00500682|1438888|P1|Overall Study|Physician Decision|6
431685|NCT00500682|1438887|P2|Overall Study|Lost to Follow-up|11
431686|NCT00500682|1438888|P1|Overall Study|Lost to Follow-up|11
431687|NCT00500682|1438887|P2|Overall Study|Death|16
431688|NCT00500682|1438888|P1|Overall Study|Death|25
431689|NCT00500682|1438887|P2|Overall Study|Adverse Event|29
431690|NCT00500682|1438888|P1|Overall Study|Adverse Event|37
431691|NCT00500539|1438922|P1|Follow-up Period (16 Weeks)|Missing|3
431692|NCT00500539|1438922|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
431693|NCT00500539|1438922|P1|Follow-up Period (16 Weeks)|Death|1
431694|NCT00500539|1438922|P1|Follow-up Period (16 Weeks)|Administrative problems|1
431695|NCT00500539|1438922|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
431696|NCT00500539|1438922|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
431697|NCT00500539|1438922|P1|Follow-up Period (16 Weeks)|Adverse Event|1
431698|NCT00500539|1438922|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
431699|NCT00500539|1438922|P1|Treatment Period (24 Weeks)|Administrative problems|2
431700|NCT00500539|1438922|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
431701|NCT00500539|1438922|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
431702|NCT00500539|1438922|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
431703|NCT00500539|1438922|P1|Treatment Period (24 Weeks)|Adverse Event|4
431704|NCT00500370|1438948|P2|Overall Study|Subject Decision|17
431705|NCT00500370|1438949|P1|Overall Study|Subject Decision|10
431706|NCT00500370|1438948|P2|Overall Study|Sponsor Decision|0
431707|NCT00500370|1438949|P1|Overall Study|Sponsor Decision|2
431708|NCT00500370|1438948|P2|Overall Study|Protocol Violation|4
431709|NCT00500370|1438949|P1|Overall Study|Protocol Violation|2
431710|NCT00500370|1438948|P2|Overall Study|Lost to Follow-up|10
431711|NCT00500370|1438949|P1|Overall Study|Lost to Follow-up|10
431712|NCT00500370|1438948|P2|Overall Study|Adverse Event|3
431713|NCT00500370|1438949|P1|Overall Study|Adverse Event|9
431714|NCT00500357|1438985|P1|Overall Study|Death|1
431715|NCT00500331|1439011|P7|Overall Study|Protocol violated|0
431716|NCT00500331|1439012|P6|Overall Study|Protocol violated|0
431717|NCT00500331|1439013|P5|Overall Study|Protocol violated|0
431718|NCT00500331|1439014|P4|Overall Study|Protocol violated|1
431719|NCT00500331|1439015|P3|Overall Study|Protocol violated|0
431720|NCT00500331|1439016|P2|Overall Study|Protocol violated|0
431721|NCT00500331|1439017|P1|Overall Study|Protocol violated|0
431722|NCT00500331|1439011|P7|Overall Study|State ban of biological samples export|0
431723|NCT00500331|1439012|P6|Overall Study|State ban of biological samples export|0
431724|NCT00500331|1439013|P5|Overall Study|State ban of biological samples export|0
431725|NCT00500331|1439014|P4|Overall Study|State ban of biological samples export|1
431726|NCT00500331|1439015|P3|Overall Study|State ban of biological samples export|0
431727|NCT00500331|1439016|P2|Overall Study|State ban of biological samples export|0
431728|NCT00500331|1439017|P1|Overall Study|State ban of biological samples export|0
431729|NCT00500331|1439011|P7|Overall Study|Diabetologist nurse in the study|0
431730|NCT00500331|1439012|P6|Overall Study|Diabetologist nurse in the study|0
431731|NCT00500331|1439013|P5|Overall Study|Diabetologist nurse in the study|0
431732|NCT00500331|1439014|P4|Overall Study|Diabetologist nurse in the study|0
431733|NCT00500331|1439015|P3|Overall Study|Diabetologist nurse in the study|1
431734|NCT00500331|1439016|P2|Overall Study|Diabetologist nurse in the study|0
431735|NCT00500331|1439017|P1|Overall Study|Diabetologist nurse in the study|0
431736|NCT00500331|1439011|P7|Overall Study|Participant was randomized by mistake|0
431737|NCT00500331|1439012|P6|Overall Study|Participant was randomized by mistake|0
431738|NCT00500331|1439013|P5|Overall Study|Participant was randomized by mistake|0
431739|NCT00500331|1439014|P4|Overall Study|Participant was randomized by mistake|0
431740|NCT00500331|1439015|P3|Overall Study|Participant was randomized by mistake|0
431741|NCT00500331|1439016|P2|Overall Study|Participant was randomized by mistake|0
431742|NCT00500331|1439017|P1|Overall Study|Participant was randomized by mistake|1
431743|NCT00500331|1439011|P7|Overall Study|Sponsor decided to withdraw participant|0
431744|NCT00500331|1439012|P6|Overall Study|Sponsor decided to withdraw participant|0
431745|NCT00500331|1439013|P5|Overall Study|Sponsor decided to withdraw participant|0
431746|NCT00500331|1439014|P4|Overall Study|Sponsor decided to withdraw participant|0
431747|NCT00500331|1439015|P3|Overall Study|Sponsor decided to withdraw participant|0
431748|NCT00500331|1439016|P2|Overall Study|Sponsor decided to withdraw participant|0
431749|NCT00500331|1439017|P1|Overall Study|Sponsor decided to withdraw participant|1
431750|NCT00500331|1439011|P7|Overall Study|Exclusion citeria not met on Visit 4|0
431751|NCT00500331|1439012|P6|Overall Study|Exclusion citeria not met on Visit 4|0
431752|NCT00500331|1439013|P5|Overall Study|Exclusion citeria not met on Visit 4|0
431753|NCT00500331|1439014|P4|Overall Study|Exclusion citeria not met on Visit 4|0
431754|NCT00500331|1439015|P3|Overall Study|Exclusion citeria not met on Visit 4|0
431755|NCT00500331|1439016|P2|Overall Study|Exclusion citeria not met on Visit 4|0
431756|NCT00500331|1439017|P1|Overall Study|Exclusion citeria not met on Visit 4|1
431757|NCT00500331|1439011|P7|Overall Study|Didn't return for continuation of study|0
431758|NCT00500331|1439012|P6|Overall Study|Didn't return for continuation of study|0
431759|NCT00500331|1439013|P5|Overall Study|Didn't return for continuation of study|0
431760|NCT00500331|1439014|P4|Overall Study|Didn't return for continuation of study|0
431761|NCT00500331|1439015|P3|Overall Study|Didn't return for continuation of study|0
431762|NCT00500331|1439016|P2|Overall Study|Didn't return for continuation of study|0
431763|NCT00500331|1439017|P1|Overall Study|Didn't return for continuation of study|1
431764|NCT00500331|1439011|P7|Overall Study|Increased serum creatinine from Baseline|0
431765|NCT00500331|1439012|P6|Overall Study|Increased serum creatinine from Baseline|1
431766|NCT00500331|1439013|P5|Overall Study|Increased serum creatinine from Baseline|0
431767|NCT00500331|1439014|P4|Overall Study|Increased serum creatinine from Baseline|0
431768|NCT00500331|1439015|P3|Overall Study|Increased serum creatinine from Baseline|0
431769|NCT00500331|1439016|P2|Overall Study|Increased serum creatinine from Baseline|0
431770|NCT00500331|1439017|P1|Overall Study|Increased serum creatinine from Baseline|0
431771|NCT00500331|1439011|P7|Overall Study|Liver function test abnormality|0
431772|NCT00500331|1439012|P6|Overall Study|Liver function test abnormality|0
431773|NCT00500331|1439013|P5|Overall Study|Liver function test abnormality|0
431774|NCT00500331|1439014|P4|Overall Study|Liver function test abnormality|0
431775|NCT00500331|1439015|P3|Overall Study|Liver function test abnormality|1
431776|NCT00500331|1439016|P2|Overall Study|Liver function test abnormality|0
431777|NCT00500331|1439017|P1|Overall Study|Liver function test abnormality|0
431778|NCT00500331|1439011|P7|Overall Study|Lack of Efficacy|0
431779|NCT00500331|1439012|P6|Overall Study|Lack of Efficacy|0
431780|NCT00500331|1439013|P5|Overall Study|Lack of Efficacy|0
431781|NCT00500331|1439014|P4|Overall Study|Lack of Efficacy|0
431782|NCT00500331|1439015|P3|Overall Study|Lack of Efficacy|0
431783|NCT00500331|1439016|P2|Overall Study|Lack of Efficacy|1
431784|NCT00500331|1439017|P1|Overall Study|Lack of Efficacy|3
431785|NCT00500331|1439011|P7|Overall Study|Withdrawal by Subject|1
431786|NCT00500331|1439012|P6|Overall Study|Withdrawal by Subject|1
431787|NCT00500331|1439013|P5|Overall Study|Withdrawal by Subject|0
431788|NCT00500331|1439014|P4|Overall Study|Withdrawal by Subject|5
431789|NCT00500331|1439015|P3|Overall Study|Withdrawal by Subject|1
431790|NCT00500331|1439016|P2|Overall Study|Withdrawal by Subject|0
431791|NCT00500331|1439017|P1|Overall Study|Withdrawal by Subject|4
431792|NCT00500331|1439011|P7|Overall Study|Protocol Violation|1
431793|NCT00500331|1439012|P6|Overall Study|Protocol Violation|1
431794|NCT00500331|1439013|P5|Overall Study|Protocol Violation|1
431795|NCT00500331|1439014|P4|Overall Study|Protocol Violation|0
431796|NCT00500331|1439015|P3|Overall Study|Protocol Violation|1
431797|NCT00500331|1439016|P2|Overall Study|Protocol Violation|1
431798|NCT00500331|1439017|P1|Overall Study|Protocol Violation|3
431799|NCT00500331|1439011|P7|Overall Study|Lost to Follow-up|0
431800|NCT00500331|1439012|P6|Overall Study|Lost to Follow-up|0
431801|NCT00500331|1439013|P5|Overall Study|Lost to Follow-up|1
431802|NCT00500331|1439014|P4|Overall Study|Lost to Follow-up|2
431803|NCT00500331|1439015|P3|Overall Study|Lost to Follow-up|1
431804|NCT00500331|1439016|P2|Overall Study|Lost to Follow-up|1
431805|NCT00500331|1439017|P1|Overall Study|Lost to Follow-up|1
431806|NCT00500331|1439011|P7|Overall Study|Adverse Event|0
431807|NCT00500331|1439012|P6|Overall Study|Adverse Event|2
431808|NCT00500331|1439013|P5|Overall Study|Adverse Event|2
431809|NCT00500331|1439014|P4|Overall Study|Adverse Event|1
431810|NCT00500331|1439015|P3|Overall Study|Adverse Event|0
431811|NCT00500331|1439016|P2|Overall Study|Adverse Event|2
431812|NCT00500331|1439017|P1|Overall Study|Adverse Event|0
431813|NCT00500318|1439154|P2|Overall Study|Other Reason|1
431814|NCT00500318|1439155|P1|Overall Study|Other Reason|0
431815|NCT00500318|1439154|P2|Overall Study|Lack of Efficacy|3
431816|NCT00500318|1439155|P1|Overall Study|Lack of Efficacy|0
431817|NCT00500318|1439154|P2|Overall Study|Withdrawal by Subject|2
431818|NCT00500318|1439155|P1|Overall Study|Withdrawal by Subject|1
431819|NCT00500318|1439154|P2|Overall Study|Protocol Violation|3
431820|NCT00500318|1439155|P1|Overall Study|Protocol Violation|1
431821|NCT00500318|1439154|P2|Overall Study|Adverse Event|8
431822|NCT00500318|1439155|P1|Overall Study|Adverse Event|3
431823|NCT00500292|1439172|P3|Overall Study|Other|4
431824|NCT00500292|1439173|P2|Overall Study|Other|1
431825|NCT00500292|1439174|P1|Overall Study|Other|1
431826|NCT00500292|1439172|P3|Overall Study|Withdrawal by Subject|0
431827|NCT00500292|1439173|P2|Overall Study|Withdrawal by Subject|1
431828|NCT00500292|1439174|P1|Overall Study|Withdrawal by Subject|0
431829|NCT00500292|1439172|P3|Overall Study|Condition under investigation worsened|19
431830|NCT00500292|1439173|P2|Overall Study|Condition under investigation worsened|23
431831|NCT00500292|1439174|P1|Overall Study|Condition under investigation worsened|21
431832|NCT00500292|1439172|P3|Overall Study|Adverse Event|4
431833|NCT00500292|1439173|P2|Overall Study|Adverse Event|6
431834|NCT00500292|1439174|P1|Overall Study|Adverse Event|3
431835|NCT00500149|1439195|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
431836|NCT00500149|1439196|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
431837|NCT00500149|1439195|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
431838|NCT00500149|1439196|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
431839|NCT00500149|1439195|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
431840|NCT00500149|1439196|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
431841|NCT00500149|1439195|P2|First Intervention (Cross-over Phase)|Adverse Event|1
431842|NCT00500149|1439196|P1|First Intervention (Cross-over Phase)|Adverse Event|0
431843|NCT00500149|1439195|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
431844|NCT00500149|1439196|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
431845|NCT00500149|1439195|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
431846|NCT00500149|1439196|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
431847|NCT00500149|1439195|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
431848|NCT00500149|1439196|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
431849|NCT00500110|1439204|P1|Overall Study|Withdrawal by Subject|3
431850|NCT00500071|1439208|P1|30-day Safety Follow-up|Lost to Follow-up|17
431851|NCT00500071|1439208|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
431852|NCT00500071|1439208|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
431853|NCT00500071|1439208|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
431854|NCT00500071|1439208|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
431855|NCT00500071|1439208|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
431856|NCT00500071|1439208|P1|Screening and Washout Phase|Protocol Violation|1
431857|NCT00499889|1439226|P1|Overall Study|Infection prior to treatment|1
431858|NCT00499863|1439234|P2|Overall Study|Lost to Follow-up|1
431859|NCT00499863|1439235|P1|Overall Study|Lost to Follow-up|1
431860|NCT00499863|1439234|P2|Overall Study|Sponsor decision|2
431861|NCT00499863|1439235|P1|Overall Study|Sponsor decision|2
431862|NCT00499863|1439234|P2|Overall Study|Adverse Event|2
431863|NCT00499863|1439235|P1|Overall Study|Adverse Event|8
431864|NCT00499863|1439234|P2|Overall Study|Withdrawal by Subject|4
431865|NCT00499863|1439235|P1|Overall Study|Withdrawal by Subject|6
431866|NCT00499863|1439234|P2|Overall Study|Protocol Violation|7
431867|NCT00499863|1439235|P1|Overall Study|Protocol Violation|12
431868|NCT00499863|1439234|P2|Overall Study|Lack of Efficacy|27
431869|NCT00499863|1439235|P1|Overall Study|Lack of Efficacy|21
431870|NCT00500266|1439263|P1|Overall Study|Assigned, not treated|4
431871|NCT00500266|1439263|P1|Overall Study|Withdrawal by Subject|3
431872|NCT00500266|1439263|P1|Overall Study|Lost to Follow-up|3
431873|NCT00500266|1439263|P1|Overall Study|Death|3
431874|NCT00499746|1439270|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
431875|NCT00499746|1439270|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
431876|NCT00499746|1439270|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
431877|NCT00499746|1439270|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
431878|NCT00499694|1439339|P1|Overall Study|Patient never received treatment.|1
431879|NCT00499681|1439348|P2|Overall Study|disease progression|1
431880|NCT00499681|1439349|P1|Overall Study|disease progression|0
431881|NCT00499681|1439348|P2|Overall Study|toxicity|1
431882|NCT00499681|1439349|P1|Overall Study|toxicity|0
431883|NCT00499616|1439376|P4|Overall Study|Patient/Parent Refusal|0
431884|NCT00499616|1439377|P3|Overall Study|Patient/Parent Refusal|3
431885|NCT00499616|1439378|P2|Overall Study|Patient/Parent Refusal|5
431886|NCT00499616|1439379|P1|Overall Study|Patient/Parent Refusal|1
431887|NCT00499616|1439376|P4|Overall Study|Not evaluable|41
431888|NCT00499616|1439377|P3|Overall Study|Not evaluable|0
431889|NCT00499616|1439378|P2|Overall Study|Not evaluable|0
431890|NCT00499616|1439379|P1|Overall Study|Not evaluable|0
431891|NCT00499616|1439376|P4|Overall Study|Ineligible|15
431892|NCT00499616|1439377|P3|Overall Study|Ineligible|0
431893|NCT00499616|1439378|P2|Overall Study|Ineligible|2
431894|NCT00499616|1439379|P1|Overall Study|Ineligible|1
431895|NCT00499616|1439376|P4|Overall Study|Withdrawal by Subject|0
431896|NCT00499616|1439377|P3|Overall Study|Withdrawal by Subject|1
431897|NCT00499616|1439378|P2|Overall Study|Withdrawal by Subject|0
431898|NCT00499616|1439379|P1|Overall Study|Withdrawal by Subject|1
431899|NCT00499616|1439376|P4|Overall Study|Physician Decision|0
431900|NCT00499616|1439377|P3|Overall Study|Physician Decision|9
431901|NCT00499616|1439378|P2|Overall Study|Physician Decision|16
431902|NCT00499616|1439379|P1|Overall Study|Physician Decision|6
431903|NCT00499616|1439376|P4|Overall Study|Lost to Follow-up|0
431904|NCT00499616|1439377|P3|Overall Study|Lost to Follow-up|1
431905|NCT00499616|1439378|P2|Overall Study|Lost to Follow-up|0
431906|NCT00499616|1439379|P1|Overall Study|Lost to Follow-up|0
431907|NCT00499616|1439376|P4|Overall Study|Lack of Efficacy|0
431908|NCT00499616|1439377|P3|Overall Study|Lack of Efficacy|19
431909|NCT00499616|1439378|P2|Overall Study|Lack of Efficacy|0
431910|NCT00499616|1439379|P1|Overall Study|Lack of Efficacy|5
431911|NCT00499616|1439376|P4|Overall Study|Death|1
431912|NCT00499616|1439377|P3|Overall Study|Death|3
431913|NCT00499616|1439378|P2|Overall Study|Death|5
431914|NCT00499616|1439379|P1|Overall Study|Death|1
431915|NCT00499603|1439416|P2|Overall Study|Adverse Event|1
431916|NCT00499603|1439417|P1|Overall Study|Adverse Event|0
431917|NCT00499590|1439430|P3|Overall Study|Not treated|1
431918|NCT00499590|1439431|P2|Overall Study|Not treated|0
431919|NCT00499590|1439432|P1|Overall Study|Not treated|1
431920|NCT00499590|1439430|P3|Overall Study|Study Terminated|112
431921|NCT00499590|1439431|P2|Overall Study|Study Terminated|112
431922|NCT00499590|1439432|P1|Overall Study|Study Terminated|112
431923|NCT00499486|1439443|P1|Overall Study|Withdrawal by Subject|16
431924|NCT00499460|1439470|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
431925|NCT00499460|1439471|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
431926|NCT00499460|1439470|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
431927|NCT00499460|1439471|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
431928|NCT00499460|1439470|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
431929|NCT00499460|1439471|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
431930|NCT00499369|1439500|P5|Overall Study|Ineligible|0
431931|NCT00499369|1439501|P4|Overall Study|Ineligible|1
431932|NCT00499369|1439502|P3|Overall Study|Ineligible|1
431933|NCT00499369|1439503|P2|Overall Study|Ineligible|2
431934|NCT00499369|1439504|P1|Overall Study|Ineligible|2
431935|NCT00499369|1439500|P5|Overall Study|Not protocol specified|0
431936|NCT00499369|1439501|P4|Overall Study|Not protocol specified|1
431937|NCT00499369|1439502|P3|Overall Study|Not protocol specified|3
431938|NCT00499369|1439503|P2|Overall Study|Not protocol specified|0
431939|NCT00499369|1439504|P1|Overall Study|Not protocol specified|2
431940|NCT00499369|1439500|P5|Overall Study|Death|0
431941|NCT00499369|1439501|P4|Overall Study|Death|0
431942|NCT00499369|1439502|P3|Overall Study|Death|0
431943|NCT00499369|1439503|P2|Overall Study|Death|1
431944|NCT00499369|1439504|P1|Overall Study|Death|0
431945|NCT00499369|1439500|P5|Overall Study|Progression|10
431946|NCT00499369|1439501|P4|Overall Study|Progression|6
431947|NCT00499369|1439502|P3|Overall Study|Progression|9
431948|NCT00499369|1439503|P2|Overall Study|Progression|12
431949|NCT00499369|1439504|P1|Overall Study|Progression|10
431950|NCT00499369|1439500|P5|Overall Study|Withdrawal by Subject|0
431951|NCT00499369|1439501|P4|Overall Study|Withdrawal by Subject|0
431952|NCT00499369|1439502|P3|Overall Study|Withdrawal by Subject|1
431953|NCT00499369|1439503|P2|Overall Study|Withdrawal by Subject|1
431954|NCT00499369|1439504|P1|Overall Study|Withdrawal by Subject|0
431955|NCT00499369|1439500|P5|Overall Study|Adverse Event|2
431956|NCT00499369|1439501|P4|Overall Study|Adverse Event|1
431957|NCT00499369|1439502|P3|Overall Study|Adverse Event|3
431958|NCT00499369|1439503|P2|Overall Study|Adverse Event|2
431959|NCT00499369|1439504|P1|Overall Study|Adverse Event|2
431960|NCT00499252|1439540|P1|Overall Study|<no further label>|3
431961|NCT00499252|1439540|P1|Overall Study|Ineligible|4
431962|NCT00499252|1439540|P1|Overall Study|Refused further treatment|2
431963|NCT00499252|1439540|P1|Overall Study|Adverse Event|3
431964|NCT00499122|1439550|P1|Overall Study|Withdrawal by Subject|2
431965|NCT00499031|1439593|P1|Overall Study|Never treated|1
431966|NCT00499031|1439593|P1|Overall Study|Required test not done|1
431967|NCT00499031|1439593|P1|Overall Study|Improper pre-protocol treatment|1
431968|NCT00498797|1439616|P2|Overall Study|Other|1
431969|NCT00498797|1439617|P1|Overall Study|Other|3
431970|NCT00498797|1439616|P2|Overall Study|Condition under investigation worsened|21
431971|NCT00498797|1439617|P1|Overall Study|Condition under investigation worsened|19
431972|NCT00498797|1439616|P2|Overall Study|Adverse Event|5
431973|NCT00498797|1439617|P1|Overall Study|Adverse Event|12
431974|NCT00498797|1439616|P2|Overall Study|Withdrawal by Subject|2
431975|NCT00498797|1439617|P1|Overall Study|Withdrawal by Subject|4
431976|NCT00498602|1439675|P7|Overall Study|Not specified|0
431977|NCT00498602|1439676|P6|Overall Study|Not specified|3
431978|NCT00498602|1439677|P5|Overall Study|Not specified|0
431979|NCT00498602|1439678|P4|Overall Study|Not specified|0
431980|NCT00498602|1439679|P3|Overall Study|Not specified|1
431981|NCT00498602|1439680|P2|Overall Study|Not specified|3
431982|NCT00498602|1439681|P1|Overall Study|Not specified|2
431983|NCT00498602|1439675|P7|Overall Study|Subject Request|1
431984|NCT00498602|1439676|P6|Overall Study|Subject Request|4
431985|NCT00498602|1439677|P5|Overall Study|Subject Request|1
431986|NCT00498602|1439678|P4|Overall Study|Subject Request|1
431987|NCT00498602|1439679|P3|Overall Study|Subject Request|1
431988|NCT00498602|1439680|P2|Overall Study|Subject Request|0
431989|NCT00498602|1439681|P1|Overall Study|Subject Request|3
431990|NCT00498602|1439675|P7|Overall Study|Investigator Request|0
431991|NCT00498602|1439676|P6|Overall Study|Investigator Request|0
431992|NCT00498602|1439677|P5|Overall Study|Investigator Request|0
431993|NCT00498602|1439678|P4|Overall Study|Investigator Request|0
431994|NCT00498602|1439679|P3|Overall Study|Investigator Request|1
431995|NCT00498602|1439680|P2|Overall Study|Investigator Request|0
431996|NCT00498602|1439681|P1|Overall Study|Investigator Request|0
431997|NCT00498602|1439675|P7|Overall Study|Caregiver Request|0
431998|NCT00498602|1439676|P6|Overall Study|Caregiver Request|2
431999|NCT00498602|1439677|P5|Overall Study|Caregiver Request|1
432000|NCT00498602|1439678|P4|Overall Study|Caregiver Request|0
432001|NCT00498602|1439679|P3|Overall Study|Caregiver Request|2
432002|NCT00498602|1439680|P2|Overall Study|Caregiver Request|2
432003|NCT00498602|1439681|P1|Overall Study|Caregiver Request|2
432004|NCT00498602|1439675|P7|Overall Study|AE not related to Study Drug|1
432005|NCT00498602|1439676|P6|Overall Study|AE not related to Study Drug|2
432006|NCT00498602|1439677|P5|Overall Study|AE not related to Study Drug|2
432007|NCT00498602|1439678|P4|Overall Study|AE not related to Study Drug|0
432008|NCT00498602|1439679|P3|Overall Study|AE not related to Study Drug|0
432009|NCT00498602|1439680|P2|Overall Study|AE not related to Study Drug|3
432010|NCT00498602|1439681|P1|Overall Study|AE not related to Study Drug|1
432011|NCT00498602|1439675|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
432012|NCT00498602|1439676|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
432013|NCT00498602|1439677|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
432014|NCT00498602|1439678|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
432015|NCT00498602|1439679|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
432016|NCT00498602|1439680|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
432017|NCT00498602|1439681|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
432018|NCT00498602|1439675|P7|Overall Study|Lost to Follow-up|0
432019|NCT00498602|1439676|P6|Overall Study|Lost to Follow-up|0
432020|NCT00498602|1439677|P5|Overall Study|Lost to Follow-up|0
432021|NCT00498602|1439678|P4|Overall Study|Lost to Follow-up|2
432022|NCT00498602|1439679|P3|Overall Study|Lost to Follow-up|0
432023|NCT00498602|1439680|P2|Overall Study|Lost to Follow-up|2
432024|NCT00498602|1439681|P1|Overall Study|Lost to Follow-up|0
432025|NCT00498602|1439675|P7|Overall Study|Lack of Efficacy|0
432026|NCT00498602|1439676|P6|Overall Study|Lack of Efficacy|0
432027|NCT00498602|1439677|P5|Overall Study|Lack of Efficacy|0
432028|NCT00498602|1439678|P4|Overall Study|Lack of Efficacy|0
432029|NCT00498602|1439679|P3|Overall Study|Lack of Efficacy|0
432030|NCT00498602|1439680|P2|Overall Study|Lack of Efficacy|0
432031|NCT00498602|1439681|P1|Overall Study|Lack of Efficacy|1
432032|NCT00498602|1439675|P7|Overall Study|Death|0
432033|NCT00498602|1439676|P6|Overall Study|Death|1
432034|NCT00498602|1439677|P5|Overall Study|Death|0
432035|NCT00498602|1439678|P4|Overall Study|Death|0
432036|NCT00498602|1439679|P3|Overall Study|Death|0
432037|NCT00498602|1439680|P2|Overall Study|Death|0
432038|NCT00498602|1439681|P1|Overall Study|Death|0
432039|NCT00498485|1439729|P2|Overall Study|Adverse Event|5
432040|NCT00498485|1439730|P1|Overall Study|Adverse Event|1
432041|NCT00498433|1439741|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
432042|NCT00498433|1439742|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
432043|NCT00498433|1439743|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
432044|NCT00498433|1439741|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
432045|NCT00498433|1439742|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
432046|NCT00498433|1439743|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
432047|NCT00498433|1439741|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
432048|NCT00498433|1439742|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
432049|NCT00498433|1439743|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
432050|NCT00498433|1439741|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
432051|NCT00498433|1439742|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
432052|NCT00498433|1439743|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
432053|NCT00498368|1439788|P2|Overall Study|Withdrawal by Subject|2
432054|NCT00498368|1439789|P1|Overall Study|Withdrawal by Subject|3
432055|NCT00498355|1439801|P1|Overall Study|Lost to Follow-up|1
432056|NCT00498186|1439809|P1|Overall Study|Other|10
432057|NCT00498186|1439809|P1|Overall Study|Lost to Follow-up|3
432058|NCT00498186|1439809|P1|Overall Study|Withdrawal by Subject|18
432059|NCT00498186|1439809|P1|Overall Study|Unsatisfactory compliance of subject|12
432060|NCT00498186|1439809|P1|Overall Study|Adverse Event|89
432061|NCT00498186|1439809|P1|Overall Study|Lack of Efficacy|31
432062|NCT00498186|1439809|P1|Overall Study|Protocol Violation|10
432063|NCT00498173|1439816|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
432064|NCT00498173|1439817|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
432065|NCT00498173|1439818|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
432066|NCT00497874|1439848|P2|Overall Study|Unable to schedule|24
432067|NCT00497874|1439849|P1|Overall Study|Unable to schedule|37
432068|NCT00497874|1439848|P2|Overall Study|Unable to contact|67
432069|NCT00497874|1439849|P1|Overall Study|Unable to contact|52
432070|NCT00497874|1439848|P2|Overall Study|Death|4
432071|NCT00497874|1439849|P1|Overall Study|Death|2
432072|NCT00497874|1439848|P2|Overall Study|Illness|4
432073|NCT00497874|1439849|P1|Overall Study|Illness|8
432074|NCT00497874|1439848|P2|Overall Study|Withdrawal by Subject|17
432075|NCT00497874|1439849|P1|Overall Study|Withdrawal by Subject|48
432076|NCT00497796|1439867|P2|Overall Study|Not applicable (randomized not treated)|4
432077|NCT00497796|1439868|P1|Overall Study|Not applicable (randomized not treated)|0
432078|NCT00497796|1439867|P2|Overall Study|Lost to Follow-up|1
432079|NCT00497796|1439868|P1|Overall Study|Lost to Follow-up|0
432080|NCT00497796|1439867|P2|Overall Study|Investigator/sponsor discretion|34
432081|NCT00497796|1439868|P1|Overall Study|Investigator/sponsor discretion|31
432082|NCT00497796|1439867|P2|Overall Study|Consent withdrawn|3
432083|NCT00497796|1439868|P1|Overall Study|Consent withdrawn|10
432084|NCT00497796|1439867|P2|Overall Study|CMV infection or disease treatment|4
432085|NCT00497796|1439868|P1|Overall Study|CMV infection or disease treatment|30
432086|NCT00497796|1439867|P2|Overall Study|Adverse event (related)|4
432087|NCT00497796|1439868|P1|Overall Study|Adverse event (related)|5
432088|NCT00497796|1439867|P2|Overall Study|Adverse event (not related)|9
432089|NCT00497796|1439868|P1|Overall Study|Adverse event (not related)|9
432090|NCT00497198|1439955|P2|Overall Study|Withdrawal by Subject|1
432091|NCT00497198|1439956|P1|Overall Study|Withdrawal by Subject|0
432092|NCT00497198|1439955|P2|Overall Study|Physician Decision|2
432093|NCT00497198|1439956|P1|Overall Study|Physician Decision|1
432094|NCT00497198|1439955|P2|Overall Study|Adverse Event|2
432095|NCT00497198|1439956|P1|Overall Study|Adverse Event|4
432096|NCT00497146|1439972|P2|Long-term Follow-up Period|Other|1
432097|NCT00497146|1439973|P1|Long-term Follow-up Period|Other|0
432098|NCT00497146|1439972|P2|Long-term Follow-up Period|Lost to Follow-up|1
432099|NCT00497146|1439973|P1|Long-term Follow-up Period|Lost to Follow-up|5
432100|NCT00497146|1439972|P2|Long-term Follow-up Period|Withdrawal by Subject|2
432101|NCT00497146|1439973|P1|Long-term Follow-up Period|Withdrawal by Subject|8
432102|NCT00497146|1439972|P2|Long-term Follow-up Period|Adverse Event|2
432103|NCT00497146|1439973|P1|Long-term Follow-up Period|Adverse Event|2
432104|NCT00497146|1439972|P2|Treatment Period|Other Reason|3
432105|NCT00497146|1439973|P1|Treatment Period|Other Reason|2
432106|NCT00497146|1439972|P2|Treatment Period|Unable to dose reduce per protocol|1
432107|NCT00497146|1439973|P1|Treatment Period|Unable to dose reduce per protocol|4
432108|NCT00497146|1439972|P2|Treatment Period|Change in RAAS inhibitor therapy|2
432109|NCT00497146|1439973|P1|Treatment Period|Change in RAAS inhibitor therapy|5
432110|NCT00497146|1439972|P2|Treatment Period|Required dialysis|1
432111|NCT00497146|1439973|P1|Treatment Period|Required dialysis|4
432112|NCT00497146|1439972|P2|Treatment Period|Lost to Follow-up|3
432113|NCT00497146|1439973|P1|Treatment Period|Lost to Follow-up|1
432114|NCT00497146|1439972|P2|Treatment Period|Withdrawal by Subject|9
432115|NCT00497146|1439973|P1|Treatment Period|Withdrawal by Subject|5
432116|NCT00497146|1439972|P2|Treatment Period|Adverse Event|2
432117|NCT00497146|1439973|P1|Treatment Period|Adverse Event|6
432118|NCT00496964|1440041|P2|Overall Study|Withdrawal by Subject|1
432119|NCT00496964|1440042|P1|Overall Study|Withdrawal by Subject|0
432120|NCT00496873|1440060|P1|Overall Study|Withdrawal by Subject|3
432121|NCT00496873|1440060|P1|Overall Study|Death|2
432122|NCT00496873|1440060|P1|Overall Study|Ineligible|2
432123|NCT00496834|1440093|P2|Overall Study|Blood Pressure control failure|1
432124|NCT00496834|1440094|P1|Overall Study|Blood Pressure control failure|2
432125|NCT00496834|1440093|P2|Overall Study|Lost to Follow-up|0
432126|NCT00496834|1440094|P1|Overall Study|Lost to Follow-up|2
432127|NCT00496834|1440093|P2|Overall Study|IP administration violation|0
432128|NCT00496834|1440094|P1|Overall Study|IP administration violation|2
432129|NCT00496834|1440093|P2|Overall Study|Adverse Event|3
432130|NCT00496834|1440094|P1|Overall Study|Adverse Event|5
432131|NCT00496834|1440093|P2|Overall Study|Inclusion/exclusion criteria not met|2
432132|NCT00496834|1440094|P1|Overall Study|Inclusion/exclusion criteria not met|3
432133|NCT00496834|1440093|P2|Overall Study|Contraindicated medication administered|1
432134|NCT00496834|1440094|P1|Overall Study|Contraindicated medication administered|0
432135|NCT00496834|1440093|P2|Overall Study|Withdrawal by Subject|6
432136|NCT00496834|1440094|P1|Overall Study|Withdrawal by Subject|4
432137|NCT00496782|1440113|P2|Overall Study|Protocol Violation|2
432138|NCT00496782|1440114|P1|Overall Study|Protocol Violation|1
432139|NCT00496769|1440148|P3|Open Label|>=1 reason assigned per patient|1011
432140|NCT00496769|1440149|P2|Open Label|>=1 reason assigned per patient|0
432141|NCT00496769|1440150|P1|Open Label|>=1 reason assigned per patient|0
432142|NCT00496769|1440148|P3|Double Blind|>=1 reason assigned per patient|0
432143|NCT00496769|1440149|P2|Double Blind|>=1 reason assigned per patient|649
432144|NCT00496769|1440150|P1|Double Blind|>=1 reason assigned per patient|558
432145|NCT00496730|1440175|P2|Overall Study|Withdrawal by Subject|2
432146|NCT00496730|1440176|P1|Overall Study|Withdrawal by Subject|2
432147|NCT00496730|1440175|P2|Overall Study|Lost to Follow-up|3
432148|NCT00496730|1440176|P1|Overall Study|Lost to Follow-up|4
432149|NCT00496626|1440188|P2|Overall Study|Relocated|1
432150|NCT00496626|1440189|P1|Overall Study|Relocated|0
432151|NCT00496626|1440188|P2|Overall Study|Withdrawal by Subject|4
432152|NCT00496626|1440189|P1|Overall Study|Withdrawal by Subject|5
432153|NCT00496626|1440188|P2|Overall Study|Protocol Violation|0
432154|NCT00496626|1440189|P1|Overall Study|Protocol Violation|1
432155|NCT00496626|1440188|P2|Overall Study|Lost to Follow-up|1
432156|NCT00496626|1440189|P1|Overall Study|Lost to Follow-up|0
432157|NCT00496587|1440201|P1|Overall Study|Complications unrelated|2
432158|NCT00496587|1440201|P1|Overall Study|Death|1
432159|NCT00496587|1440201|P1|Overall Study|Withdrawal by Subject|2
432160|NCT00496587|1440201|P1|Overall Study|Progressive Disease|24
432161|NCT00496587|1440201|P1|Overall Study|Adverse Event|2
432162|NCT00496483|1440207|P1|Overall Study|Lack of Efficacy|1
432163|NCT00496483|1440207|P1|Overall Study|Adverse Event|2
432164|NCT00496483|1440207|P1|Overall Study|Not dosed|9
432165|NCT00496470|1440224|P2|Overall Study|Other reason|2
432166|NCT00496470|1440225|P1|Overall Study|Other reason|0
432167|NCT00496470|1440224|P2|Overall Study|Incorrectly enrolled|5
432168|NCT00496470|1440225|P1|Overall Study|Incorrectly enrolled|13
432169|NCT00496470|1440224|P2|Overall Study|Withdrawal by Subject|12
432170|NCT00496470|1440225|P1|Overall Study|Withdrawal by Subject|5
432171|NCT00496470|1440224|P2|Overall Study|Adverse Event|10
432172|NCT00496470|1440225|P1|Overall Study|Adverse Event|8
432173|NCT00496366|1440311|P1|Overall Study|Death|1
432174|NCT00496197|1440342|P1|Overall Study|Protocol Violation|8
432175|NCT00496197|1440342|P1|Overall Study|Other|14
432176|NCT00496197|1440342|P1|Overall Study|Pathogen not isolated baseline specimen|4
432177|NCT00496197|1440342|P1|Overall Study|Withdrawal by Subject|11
432178|NCT00496197|1440342|P1|Overall Study|Lost to Follow-up|11
432179|NCT00496197|1440342|P1|Overall Study|Insufficient bacteriological response|10
432180|NCT00496197|1440342|P1|Overall Study|Insufficient clinical response|3
432181|NCT00496197|1440342|P1|Overall Study|Does not meet entrance criteria|5
432182|NCT00496197|1440342|P1|Overall Study|Adverse Event|13
432183|NCT00496197|1440342|P1|Overall Study|Discontinued study due to death|43
432184|NCT00496080|1440369|P1|Overall Study|Physician Decision|6
432185|NCT00496080|1440369|P1|Overall Study|Withdrawal by Subject|5
432186|NCT00496080|1440369|P1|Overall Study|Surgical re-intervention|7
432187|NCT00496080|1440369|P1|Overall Study|Lost to Follow-up|9
432188|NCT00496054|1440379|P1|Overall Study|Lost to Follow-up|7
432189|NCT00496054|1440379|P1|Overall Study|Adverse Event|1
432190|NCT00495820|1440408|P2|Overall Study|Adverse Event|1
432191|NCT00495820|1440409|P1|Overall Study|Adverse Event|1
432192|NCT00495794|1440421|P2|Overall Study|Pharmacist did not activate patient|0
432193|NCT00495794|1440422|P1|Overall Study|Pharmacist did not activate patient|522
432194|NCT00495755|1440432|P1|Overall Study|Adverse Event|3
432195|NCT00495677|1440444|P7|Stage 1 (25 Days)|Adverse Event|0
432196|NCT00495677|1440445|P6|Stage 1 (25 Days)|Adverse Event|0
432197|NCT00495677|1440446|P5|Stage 1 (25 Days)|Adverse Event|0
432198|NCT00495677|1440447|P4|Stage 1 (25 Days)|Adverse Event|0
432199|NCT00495677|1440448|P3|Stage 1 (25 Days)|Adverse Event|1
432200|NCT00495677|1440449|P2|Stage 1 (25 Days)|Adverse Event|0
432201|NCT00495677|1440450|P1|Stage 1 (25 Days)|Adverse Event|0
432202|NCT00495625|1440505|P1|Overall Study|Did not complete at least 1 42 day cycle|10
432203|NCT00495612|1440516|P2|Overall Study|Subject's Decision to Withdraw|0
432204|NCT00495612|1440517|P1|Overall Study|Subject's Decision to Withdraw|3
432205|NCT00495612|1440516|P2|Overall Study|Lost to Follow-up|0
432206|NCT00495612|1440517|P1|Overall Study|Lost to Follow-up|1
432207|NCT00495586|1440535|P2|Overall Study|Withdrawal by Subject|4
432208|NCT00495586|1440536|P1|Overall Study|Withdrawal by Subject|4
432209|NCT00495521|1440546|P2|Overall Study|Physician Decision|1
432210|NCT00495521|1440547|P1|Overall Study|Physician Decision|0
432211|NCT00495495|1440577|P1|Overall Study|Protocol Violation|99
432212|NCT00495469|1440597|P7|Overall Study|ST depression at randomisation in ECG|0
432213|NCT00495469|1440598|P6|Overall Study|ST depression at randomisation in ECG|0
432214|NCT00495469|1440599|P5|Overall Study|ST depression at randomisation in ECG|0
432215|NCT00495469|1440600|P4|Overall Study|ST depression at randomisation in ECG|0
432216|NCT00495469|1440601|P3|Overall Study|ST depression at randomisation in ECG|0
432217|NCT00495469|1440602|P2|Overall Study|ST depression at randomisation in ECG|1
432218|NCT00495469|1440603|P1|Overall Study|ST depression at randomisation in ECG|0
432219|NCT00495469|1440597|P7|Overall Study|Liver function test abnormality|0
432220|NCT00495469|1440598|P6|Overall Study|Liver function test abnormality|0
432221|NCT00495469|1440599|P5|Overall Study|Liver function test abnormality|0
432222|NCT00495469|1440600|P4|Overall Study|Liver function test abnormality|0
432223|NCT00495469|1440601|P3|Overall Study|Liver function test abnormality|0
432224|NCT00495469|1440602|P2|Overall Study|Liver function test abnormality|1
432225|NCT00495469|1440603|P1|Overall Study|Liver function test abnormality|0
432226|NCT00495469|1440597|P7|Overall Study|Lack of Efficacy|1
432227|NCT00495469|1440598|P6|Overall Study|Lack of Efficacy|0
432228|NCT00495469|1440599|P5|Overall Study|Lack of Efficacy|0
432229|NCT00495469|1440600|P4|Overall Study|Lack of Efficacy|0
432230|NCT00495469|1440601|P3|Overall Study|Lack of Efficacy|0
432231|NCT00495469|1440602|P2|Overall Study|Lack of Efficacy|0
432232|NCT00495469|1440603|P1|Overall Study|Lack of Efficacy|0
432233|NCT00495469|1440597|P7|Overall Study|Withdrawal by Subject|3
432234|NCT00495469|1440598|P6|Overall Study|Withdrawal by Subject|2
432235|NCT00495469|1440599|P5|Overall Study|Withdrawal by Subject|3
432236|NCT00495469|1440600|P4|Overall Study|Withdrawal by Subject|3
432237|NCT00495469|1440601|P3|Overall Study|Withdrawal by Subject|1
432238|NCT00495469|1440602|P2|Overall Study|Withdrawal by Subject|3
432239|NCT00495469|1440603|P1|Overall Study|Withdrawal by Subject|5
432240|NCT00495469|1440597|P7|Overall Study|Protocol Violation|0
432241|NCT00495469|1440598|P6|Overall Study|Protocol Violation|2
432242|NCT00495469|1440599|P5|Overall Study|Protocol Violation|1
432243|NCT00495469|1440600|P4|Overall Study|Protocol Violation|0
432244|NCT00495469|1440601|P3|Overall Study|Protocol Violation|0
432245|NCT00495469|1440602|P2|Overall Study|Protocol Violation|0
432246|NCT00495469|1440603|P1|Overall Study|Protocol Violation|0
432247|NCT00495469|1440597|P7|Overall Study|Lost to Follow-up|0
432248|NCT00495469|1440598|P6|Overall Study|Lost to Follow-up|0
432249|NCT00495469|1440599|P5|Overall Study|Lost to Follow-up|0
432250|NCT00495469|1440600|P4|Overall Study|Lost to Follow-up|1
432251|NCT00495469|1440601|P3|Overall Study|Lost to Follow-up|3
432252|NCT00495469|1440602|P2|Overall Study|Lost to Follow-up|1
432253|NCT00495469|1440603|P1|Overall Study|Lost to Follow-up|1
432254|NCT00495469|1440597|P7|Overall Study|Adverse Event|1
432255|NCT00495469|1440598|P6|Overall Study|Adverse Event|1
432256|NCT00495469|1440599|P5|Overall Study|Adverse Event|1
432257|NCT00495469|1440600|P4|Overall Study|Adverse Event|0
432258|NCT00495469|1440601|P3|Overall Study|Adverse Event|3
432259|NCT00495469|1440602|P2|Overall Study|Adverse Event|1
432260|NCT00495469|1440603|P1|Overall Study|Adverse Event|0
432261|NCT00495391|1440747|P2|Overall Study|Withdrawal by Subject|3
432262|NCT00495391|1440748|P1|Overall Study|Withdrawal by Subject|2
432263|NCT00495391|1440747|P2|Overall Study|Lack of Efficacy|18
432264|NCT00495391|1440748|P1|Overall Study|Lack of Efficacy|34
432265|NCT00495131|1440786|P2|Overall Study|Withdrawal by Subject|0
432266|NCT00495131|1440787|P1|Overall Study|Withdrawal by Subject|1
432267|NCT00495131|1440786|P2|Overall Study|Lost to Follow-up|2
432268|NCT00495131|1440787|P1|Overall Study|Lost to Follow-up|0
432269|NCT00495131|1440786|P2|Overall Study|Lack of Efficacy|2
432270|NCT00495131|1440787|P1|Overall Study|Lack of Efficacy|0
432271|NCT00495131|1440786|P2|Overall Study|Adverse Event|2
432272|NCT00495131|1440787|P1|Overall Study|Adverse Event|6
432273|NCT00494871|1440815|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
432274|NCT00494871|1440816|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
432275|NCT00494871|1440815|P2|Follow-up (FU) Period|Withdrawal by Subject|5
432276|NCT00494871|1440816|P1|Follow-up (FU) Period|Withdrawal by Subject|5
432277|NCT00494871|1440815|P2|Follow-up (FU) Period|Protocol Violation|0
432278|NCT00494871|1440816|P1|Follow-up (FU) Period|Protocol Violation|1
432279|NCT00494871|1440815|P2|Follow-up (FU) Period|Physician Decision|1
432280|NCT00494871|1440816|P1|Follow-up (FU) Period|Physician Decision|0
432281|NCT00494871|1440815|P2|Follow-up (FU) Period|Lost to Follow-up|2
432282|NCT00494871|1440816|P1|Follow-up (FU) Period|Lost to Follow-up|6
432283|NCT00494871|1440815|P2|Follow-up (FU) Period|Death|12
432284|NCT00494871|1440816|P1|Follow-up (FU) Period|Death|13
432285|NCT00494871|1440815|P2|Follow-up (FU) Period|Adverse Event|1
432286|NCT00494871|1440816|P1|Follow-up (FU) Period|Adverse Event|1
432287|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
432288|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
432289|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
432290|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
432291|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
432292|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
432293|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
432294|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
432295|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
432296|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
432297|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
432298|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
432299|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
432300|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
432301|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
432302|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
432303|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Physician Decision|13
432304|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Physician Decision|4
432305|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Death|3
432306|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Death|8
432307|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
432308|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
432309|NCT00494871|1440815|P2|Double-blind (DB) Treatment Period|Adverse Event|70
432310|NCT00494871|1440816|P1|Double-blind (DB) Treatment Period|Adverse Event|73
432311|NCT00494780|1440857|P2|Overall Study|Insurance Issues|1
432312|NCT00494780|1440858|P1|Overall Study|Insurance Issues|0
432313|NCT00494780|1440857|P2|Overall Study|Residual Tumour Mass|1
432314|NCT00494780|1440858|P1|Overall Study|Residual Tumour Mass|0
432315|NCT00494780|1440857|P2|Overall Study|Non-compliance|0
432316|NCT00494780|1440858|P1|Overall Study|Non-compliance|1
432317|NCT00494780|1440857|P2|Overall Study|New Treatment|2
432318|NCT00494780|1440858|P1|Overall Study|New Treatment|2
432319|NCT00494780|1440857|P2|Overall Study|Progression of Study Disease|8
432320|NCT00494780|1440858|P1|Overall Study|Progression of Study Disease|7
432321|NCT00494780|1440857|P2|Overall Study|Withdrew before Dosed|1
432322|NCT00494780|1440858|P1|Overall Study|Withdrew before Dosed|0
432323|NCT00494780|1440857|P2|Overall Study|Adverse Event|0
432324|NCT00494780|1440858|P1|Overall Study|Adverse Event|1
432325|NCT00494676|1440896|P2|Second Intervention|Withdrawal by Subject|1
432326|NCT00494676|1440897|P1|Second Intervention|Withdrawal by Subject|1
432327|NCT00494676|1440896|P2|First Intervention|Withdrawal by Subject|3
432328|NCT00494676|1440897|P1|First Intervention|Withdrawal by Subject|1
432329|NCT00494676|1440896|P2|Allocation|Withdrawal by Subject|4
432330|NCT00494676|1440897|P1|Allocation|Withdrawal by Subject|2
432331|NCT00494507|1440912|P4|Open-Label Phase|Worsening Disease|2
432332|NCT00494507|1440913|P3|Open-Label Phase|Worsening Disease|0
432333|NCT00494507|1440914|P2|Open-Label Phase|Worsening Disease|0
432334|NCT00494507|1440915|P1|Open-Label Phase|Worsening Disease|0
432335|NCT00494507|1440912|P4|Open-Label Phase|Adverse Event|3
432336|NCT00494507|1440913|P3|Open-Label Phase|Adverse Event|5
432337|NCT00494507|1440914|P2|Open-Label Phase|Adverse Event|1
432338|NCT00494507|1440915|P1|Open-Label Phase|Adverse Event|0
432339|NCT00494507|1440912|P4|Double-Blind Phase|Negative DNA test|1
432340|NCT00494507|1440913|P3|Double-Blind Phase|Negative DNA test|0
432341|NCT00494507|1440914|P2|Double-Blind Phase|Negative DNA test|0
432342|NCT00494507|1440915|P1|Double-Blind Phase|Negative DNA test|0
432343|NCT00494507|1440912|P4|Double-Blind Phase|Subject Non-compliance|0
432344|NCT00494507|1440913|P3|Double-Blind Phase|Subject Non-compliance|1
432345|NCT00494507|1440914|P2|Double-Blind Phase|Subject Non-compliance|0
432346|NCT00494507|1440915|P1|Double-Blind Phase|Subject Non-compliance|0
432347|NCT00494507|1440912|P4|Double-Blind Phase|Withdrawal by Subject|0
432348|NCT00494507|1440913|P3|Double-Blind Phase|Withdrawal by Subject|0
432349|NCT00494507|1440914|P2|Double-Blind Phase|Withdrawal by Subject|0
432350|NCT00494507|1440915|P1|Double-Blind Phase|Withdrawal by Subject|1
432351|NCT00494507|1440912|P4|Double-Blind Phase|Adverse Event|0
432352|NCT00494507|1440913|P3|Double-Blind Phase|Adverse Event|1
432353|NCT00494507|1440914|P2|Double-Blind Phase|Adverse Event|0
432354|NCT00494507|1440915|P1|Double-Blind Phase|Adverse Event|2
432355|NCT00494481|1440982|P2|Overall Study|Never received IP|0
432356|NCT00494481|1440983|P1|Overall Study|Never received IP|2
432357|NCT00494481|1440982|P2|Overall Study|Other|0
432358|NCT00494481|1440983|P1|Overall Study|Other|1
432359|NCT00494481|1440982|P2|Overall Study|Adverse Event|11
432360|NCT00494481|1440983|P1|Overall Study|Adverse Event|15
432361|NCT00494481|1440982|P2|Overall Study|Condition under investigation worsened|13
432362|NCT00494481|1440983|P1|Overall Study|Condition under investigation worsened|11
432363|NCT00494442|1440991|P2|Overall Study|Intercurrent illness|1
432364|NCT00494442|1440992|P1|Overall Study|Intercurrent illness|0
432365|NCT00494442|1440991|P2|Overall Study|Non-compliance|1
432366|NCT00494442|1440992|P1|Overall Study|Non-compliance|0
432367|NCT00494442|1440991|P2|Overall Study|Physician Decision|1
432368|NCT00494442|1440992|P1|Overall Study|Physician Decision|0
432369|NCT00494442|1440991|P2|Overall Study|Adverse Event|2
432370|NCT00494442|1440992|P1|Overall Study|Adverse Event|0
432371|NCT00494442|1440991|P2|Overall Study|Lack of Efficacy|10
432372|NCT00494442|1440992|P1|Overall Study|Lack of Efficacy|16
432373|NCT00494442|1440991|P2|Overall Study|Death|1
432374|NCT00494442|1440992|P1|Overall Study|Death|1
432375|NCT00494299|1441008|P2|Overall Study|Protocol Driven Decision Point|22
432376|NCT00494299|1441009|P1|Overall Study|Protocol Driven Decision Point|11
432377|NCT00494299|1441008|P2|Overall Study|Site Closed by Sponsor|0
432378|NCT00494299|1441009|P1|Overall Study|Site Closed by Sponsor|6
432379|NCT00494299|1441008|P2|Overall Study|Participant Did Not Take Study Drug|2
432380|NCT00494299|1441009|P1|Overall Study|Participant Did Not Take Study Drug|0
432381|NCT00494299|1441008|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
432382|NCT00494299|1441009|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
432383|NCT00494299|1441008|P2|Overall Study|Withdrawal by Subject|3
432384|NCT00494299|1441009|P1|Overall Study|Withdrawal by Subject|8
432385|NCT00494299|1441008|P2|Overall Study|Protocol Violation|2
432386|NCT00494299|1441009|P1|Overall Study|Protocol Violation|1
432387|NCT00494299|1441008|P2|Overall Study|Physician Decision|2
432388|NCT00494299|1441009|P1|Overall Study|Physician Decision|0
432389|NCT00494299|1441008|P2|Overall Study|Lost to Follow-up|0
432390|NCT00494299|1441009|P1|Overall Study|Lost to Follow-up|1
432391|NCT00494299|1441008|P2|Overall Study|Adverse Event|13
432392|NCT00494299|1441009|P1|Overall Study|Adverse Event|93
432393|NCT00494234|1441021|P2|Overall Study|Death|1
432394|NCT00494234|1441022|P1|Overall Study|Death|2
432395|NCT00494234|1441021|P2|Overall Study|Withdrawal by Subject|0
432396|NCT00494234|1441022|P1|Overall Study|Withdrawal by Subject|1
432397|NCT00494234|1441021|P2|Overall Study|Lack of Efficacy|9
432398|NCT00494234|1441022|P1|Overall Study|Lack of Efficacy|12
432399|NCT00494221|1441041|P3|Overall Study|Withdrawal by Subject|0
432400|NCT00494221|1441042|P2|Overall Study|Withdrawal by Subject|2
432401|NCT00494221|1441043|P1|Overall Study|Withdrawal by Subject|1
432402|NCT00494221|1441041|P3|Overall Study|Death|14
432403|NCT00494221|1441042|P2|Overall Study|Death|9
432404|NCT00494221|1441043|P1|Overall Study|Death|15
432405|NCT00494091|1441084|P2|Overall Study|Withdrawal by Subject|7
432406|NCT00494091|1441085|P1|Overall Study|Withdrawal by Subject|0
432407|NCT00494091|1441084|P2|Overall Study|Not Specified|11
432408|NCT00494091|1441085|P1|Overall Study|Not Specified|1
432409|NCT00494091|1441084|P2|Overall Study|Lost to Follow-up|4
432410|NCT00494091|1441085|P1|Overall Study|Lost to Follow-up|0
432411|NCT00494091|1441084|P2|Overall Study|Death|54
432412|NCT00494091|1441085|P1|Overall Study|Death|5
432413|NCT00494026|1441107|P1|Overall Study|Sponsor Decision|4
432414|NCT00494013|1441117|P2|Overall Study|Sponsor Decision|1
432415|NCT00494013|1441118|P1|Overall Study|Sponsor Decision|0
432416|NCT00494013|1441117|P2|Overall Study|Withdrawal by Subject|14
432417|NCT00494013|1441118|P1|Overall Study|Withdrawal by Subject|13
432418|NCT00494013|1441117|P2|Overall Study|Protocol Violation|5
432419|NCT00494013|1441118|P1|Overall Study|Protocol Violation|8
432420|NCT00494013|1441117|P2|Overall Study|Physician Decision|5
432421|NCT00494013|1441118|P1|Overall Study|Physician Decision|3
432422|NCT00494013|1441117|P2|Overall Study|Lost to Follow-up|6
432423|NCT00494013|1441118|P1|Overall Study|Lost to Follow-up|5
432424|NCT00494013|1441117|P2|Overall Study|Entry Criteria Not Met|4
432425|NCT00494013|1441118|P1|Overall Study|Entry Criteria Not Met|1
432426|NCT00494013|1441117|P2|Overall Study|Adverse Event|1
432427|NCT00494013|1441118|P1|Overall Study|Adverse Event|0
432428|NCT00493974|1441148|P2|Overall Study|Lost to Follow-up|6
432429|NCT00493974|1441149|P1|Overall Study|Lost to Follow-up|4
432430|NCT00493974|1441148|P2|Overall Study|Withdrawal by Subject|6
432431|NCT00493974|1441149|P1|Overall Study|Withdrawal by Subject|8
432432|NCT00493974|1441148|P2|Overall Study|Death|2
432433|NCT00493974|1441149|P1|Overall Study|Death|1
432434|NCT00493779|1441176|P1|Overall Study|Logistical issue at site|1
432435|NCT00493649|1441183|P1|Overall Study|Other|13
432436|NCT00493649|1441183|P1|Overall Study|Lost to Follow-up|1
432437|NCT00493649|1441183|P1|Overall Study|Disease Progression|1
432438|NCT00493649|1441183|P1|Overall Study|Investigator Request|2
432439|NCT00493649|1441183|P1|Overall Study|Patient Request|21
432440|NCT00493649|1441183|P1|Overall Study|Adverse Event|44
432441|NCT00493636|1441196|P2|Overall Study|Mis-randomization|1
432442|NCT00493636|1441197|P1|Overall Study|Mis-randomization|1
432443|NCT00493636|1441196|P2|Overall Study|Disease progression/recurrence/relapse|1
432444|NCT00493636|1441197|P1|Overall Study|Disease progression/recurrence/relapse|0
432445|NCT00493636|1441196|P2|Overall Study|Withdrawal by Subject|0
432446|NCT00493636|1441197|P1|Overall Study|Withdrawal by Subject|1
432447|NCT00493454|1441211|P1|Overall Study|Withdrawal by Subject|1
432448|NCT00493311|1441217|P2|Overall Study|Need for rescue medication|2
432449|NCT00493311|1441218|P1|Overall Study|Need for rescue medication|2
432450|NCT00493285|1441238|P6|Overall Study|Lost to Follow-up|0
432451|NCT00493285|1441239|P5|Overall Study|Lost to Follow-up|1
432452|NCT00493285|1441240|P4|Overall Study|Lost to Follow-up|0
432453|NCT00493285|1441241|P3|Overall Study|Lost to Follow-up|0
432454|NCT00493285|1441242|P2|Overall Study|Lost to Follow-up|0
432455|NCT00493285|1441243|P1|Overall Study|Lost to Follow-up|0
432456|NCT00493246|1441475|P8|Overall Study|Lost to Follow-up|0
432457|NCT00493246|1441476|P7|Overall Study|Lost to Follow-up|1
432458|NCT00493246|1441477|P6|Overall Study|Lost to Follow-up|0
432459|NCT00493246|1441478|P5|Overall Study|Lost to Follow-up|0
432460|NCT00493246|1441479|P4|Overall Study|Lost to Follow-up|0
432461|NCT00493246|1441480|P3|Overall Study|Lost to Follow-up|0
432462|NCT00493246|1441481|P2|Overall Study|Lost to Follow-up|0
432463|NCT00493246|1441482|P1|Overall Study|Lost to Follow-up|0
432464|NCT00493246|1441475|P8|Overall Study|No access to draw blood|0
432465|NCT00493246|1441476|P7|Overall Study|No access to draw blood|0
432466|NCT00493246|1441477|P6|Overall Study|No access to draw blood|1
432467|NCT00493246|1441478|P5|Overall Study|No access to draw blood|0
432468|NCT00493246|1441479|P4|Overall Study|No access to draw blood|0
432469|NCT00493246|1441480|P3|Overall Study|No access to draw blood|0
432470|NCT00493246|1441481|P2|Overall Study|No access to draw blood|0
432471|NCT00493246|1441482|P1|Overall Study|No access to draw blood|0
432472|NCT00493246|1441475|P8|Overall Study|Withdrawal by Subject|0
432473|NCT00493246|1441476|P7|Overall Study|Withdrawal by Subject|0
432474|NCT00493246|1441477|P6|Overall Study|Withdrawal by Subject|0
432475|NCT00493246|1441478|P5|Overall Study|Withdrawal by Subject|1
432476|NCT00493246|1441479|P4|Overall Study|Withdrawal by Subject|0
432477|NCT00493246|1441480|P3|Overall Study|Withdrawal by Subject|0
432478|NCT00493246|1441481|P2|Overall Study|Withdrawal by Subject|0
432479|NCT00493246|1441482|P1|Overall Study|Withdrawal by Subject|0
432480|NCT00493220|1441546|P6|Third Intervention|Withdrawal by Subject|0
432481|NCT00493220|1441547|P5|Third Intervention|Withdrawal by Subject|0
432482|NCT00493220|1441548|P4|Third Intervention|Withdrawal by Subject|0
432483|NCT00493220|1441549|P3|Third Intervention|Withdrawal by Subject|0
432484|NCT00493220|1441550|P2|Third Intervention|Withdrawal by Subject|0
432485|NCT00493220|1441551|P1|Third Intervention|Withdrawal by Subject|1
432486|NCT00493038|1441574|P2|Follow-up|Lost to Follow-up|0
432487|NCT00493038|1441575|P1|Follow-up|Lost to Follow-up|1
432488|NCT00493038|1441574|P2|Treatment|Other|1
432489|NCT00493038|1441575|P1|Treatment|Other|0
432490|NCT00493038|1441574|P2|Treatment|Withdrawal by Subject|12
432491|NCT00493038|1441575|P1|Treatment|Withdrawal by Subject|11
432492|NCT00493038|1441574|P2|Treatment|Lost to Follow-up|3
432493|NCT00493038|1441575|P1|Treatment|Lost to Follow-up|5
432494|NCT00493038|1441574|P2|Treatment|Adverse Event|4
432495|NCT00493038|1441575|P1|Treatment|Adverse Event|8
432496|NCT00493012|1441591|P2|Overall Study|Lost to Follow-up|17
432497|NCT00493012|1441592|P1|Overall Study|Lost to Follow-up|18
432498|NCT00492856|1441635|P4|Post-consolidation|Observation Arm|0
432499|NCT00492856|1441636|P3|Post-consolidation|Observation Arm|27
432500|NCT00492856|1441637|P2|Post-consolidation|Observation Arm|0
432501|NCT00492856|1441638|P1|Post-consolidation|Observation Arm|0
432502|NCT00492856|1441635|P4|Post-consolidation|Lost to Follow-up|0
432503|NCT00492856|1441636|P3|Post-consolidation|Lost to Follow-up|0
432504|NCT00492856|1441637|P2|Post-consolidation|Lost to Follow-up|2
432505|NCT00492856|1441638|P1|Post-consolidation|Lost to Follow-up|0
432506|NCT00492856|1441635|P4|Post-consolidation|Not protocol specified|0
432507|NCT00492856|1441636|P3|Post-consolidation|Not protocol specified|0
432508|NCT00492856|1441637|P2|Post-consolidation|Not protocol specified|1
432509|NCT00492856|1441638|P1|Post-consolidation|Not protocol specified|0
432510|NCT00492856|1441635|P4|Post-consolidation|Death|0
432511|NCT00492856|1441636|P3|Post-consolidation|Death|0
432512|NCT00492856|1441637|P2|Post-consolidation|Death|1
432513|NCT00492856|1441638|P1|Post-consolidation|Death|0
432514|NCT00492856|1441635|P4|Post-consolidation|Withdrawal by Subject|0
432515|NCT00492856|1441636|P3|Post-consolidation|Withdrawal by Subject|0
432516|NCT00492856|1441637|P2|Post-consolidation|Withdrawal by Subject|4
432517|NCT00492856|1441638|P1|Post-consolidation|Withdrawal by Subject|0
432518|NCT00492856|1441635|P4|Post-consolidation|Adverse Event|1
432519|NCT00492856|1441636|P3|Post-consolidation|Adverse Event|0
432520|NCT00492856|1441637|P2|Post-consolidation|Adverse Event|4
432521|NCT00492856|1441638|P1|Post-consolidation|Adverse Event|0
432522|NCT00492856|1441635|P4|Consolidation|Lost to Follow-up|0
432523|NCT00492856|1441636|P3|Consolidation|Lost to Follow-up|0
432524|NCT00492856|1441637|P2|Consolidation|Lost to Follow-up|0
432525|NCT00492856|1441638|P1|Consolidation|Lost to Follow-up|1
432526|NCT00492856|1441635|P4|Consolidation|Not protocol specified|0
432527|NCT00492856|1441636|P3|Consolidation|Not protocol specified|0
432528|NCT00492856|1441637|P2|Consolidation|Not protocol specified|0
432529|NCT00492856|1441638|P1|Consolidation|Not protocol specified|2
432530|NCT00492856|1441635|P4|Consolidation|Adverse Event|0
432531|NCT00492856|1441636|P3|Consolidation|Adverse Event|0
432532|NCT00492856|1441637|P2|Consolidation|Adverse Event|0
432533|NCT00492856|1441638|P1|Consolidation|Adverse Event|6
432534|NCT00492856|1441635|P4|Induction|Death|0
432535|NCT00492856|1441636|P3|Induction|Death|0
432536|NCT00492856|1441637|P2|Induction|Death|0
432537|NCT00492856|1441638|P1|Induction|Death|3
432538|NCT00492856|1441635|P4|Induction|Withdrawal by Subject|0
432539|NCT00492856|1441636|P3|Induction|Withdrawal by Subject|0
432540|NCT00492856|1441637|P2|Induction|Withdrawal by Subject|0
432541|NCT00492856|1441638|P1|Induction|Withdrawal by Subject|1
432542|NCT00492856|1441635|P4|Induction|Adverse Event|0
432543|NCT00492856|1441636|P3|Induction|Adverse Event|0
432544|NCT00492856|1441637|P2|Induction|Adverse Event|0
432545|NCT00492856|1441638|P1|Induction|Adverse Event|2
432546|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
432547|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
432548|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
432549|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
432550|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
432551|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
432552|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
432553|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
432554|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
432555|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
432556|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
432557|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
432558|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
432559|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
432560|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
432561|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
432562|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
432563|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
432564|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
432565|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
432566|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
432567|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
432568|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
432569|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
432570|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Death|1
432571|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Death|45
432572|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Death|5
432573|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Death|75
432574|NCT00492752|1441652|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
432575|NCT00492752|1441653|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
432576|NCT00492752|1441654|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
432577|NCT00492752|1441655|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
432578|NCT00492752|1441652|P4|Double Blind Treatment|Protocol Violation|0
432579|NCT00492752|1441653|P3|Double Blind Treatment|Protocol Violation|1
432580|NCT00492752|1441654|P2|Double Blind Treatment|Protocol Violation|0
432581|NCT00492752|1441655|P1|Double Blind Treatment|Protocol Violation|0
432582|NCT00492752|1441652|P4|Double Blind Treatment|Adverse Event|0
432583|NCT00492752|1441653|P3|Double Blind Treatment|Adverse Event|0
432584|NCT00492752|1441654|P2|Double Blind Treatment|Adverse Event|0
432585|NCT00492752|1441655|P1|Double Blind Treatment|Adverse Event|1
432586|NCT00492752|1441652|P4|Double Blind Treatment|Death|0
432587|NCT00492752|1441653|P3|Double Blind Treatment|Death|2
432588|NCT00492752|1441654|P2|Double Blind Treatment|Death|0
432589|NCT00492752|1441655|P1|Double Blind Treatment|Death|13
432590|NCT00492726|1441690|P2|Overall Study|Non compliant with study medication|3
432591|NCT00492726|1441691|P1|Overall Study|Non compliant with study medication|0
432592|NCT00492726|1441690|P2|Overall Study|Withdrawal by Subject|3
432593|NCT00492726|1441691|P1|Overall Study|Withdrawal by Subject|6
432594|NCT00492726|1441690|P2|Overall Study|Physician Decision|1
432595|NCT00492726|1441691|P1|Overall Study|Physician Decision|0
432596|NCT00492726|1441690|P2|Overall Study|Lost to Follow-up|19
432597|NCT00492726|1441691|P1|Overall Study|Lost to Follow-up|27
432598|NCT00492726|1441690|P2|Overall Study|Lack of Efficacy|2
432599|NCT00492726|1441691|P1|Overall Study|Lack of Efficacy|0
432600|NCT00492726|1441690|P2|Overall Study|Death|2
432601|NCT00492726|1441691|P1|Overall Study|Death|7
432602|NCT00492726|1441690|P2|Overall Study|Adverse Event|6
432603|NCT00492726|1441691|P1|Overall Study|Adverse Event|10
432604|NCT00492557|1441736|P2|Overall Study|Lost to Follow-up|1
432605|NCT00492557|1441737|P1|Overall Study|Lost to Follow-up|0
432606|NCT00492557|1441736|P2|Overall Study|Failed to return|0
432607|NCT00492557|1441737|P1|Overall Study|Failed to return|1
432608|NCT00492557|1441736|P2|Overall Study|Adverse Event|0
432609|NCT00492557|1441737|P1|Overall Study|Adverse Event|1
432610|NCT00492557|1441736|P2|Overall Study|Death|1
432611|NCT00492557|1441737|P1|Overall Study|Death|1
432612|NCT00492557|1441736|P2|Overall Study|Other|2
432613|NCT00492557|1441737|P1|Overall Study|Other|2
432614|NCT00492557|1441736|P2|Overall Study|Protocol Violation|8
432615|NCT00492557|1441737|P1|Overall Study|Protocol Violation|7
432616|NCT00492557|1441736|P2|Overall Study|Subject request|11
432617|NCT00492557|1441737|P1|Overall Study|Subject request|12
432618|NCT00492531|1441767|P2|Overall Study|Withdrawn(More than one reason selected)|23
432619|NCT00492531|1441768|P1|Overall Study|Withdrawn(More than one reason selected)|22
432620|NCT00492297|1441841|P1|Survival Only Follow-up|Study terminated by sponsor|12
432621|NCT00492297|1441841|P1|Survival Only Follow-up|Lack of Efficacy|1
432622|NCT00492297|1441841|P1|Survival Only Follow-up|Death|46
432623|NCT00492297|1441841|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
432624|NCT00492297|1441841|P1|Active Follow-up 30(+4) Days Duration|Death|17
432625|NCT00492297|1441841|P1|Treatment|Study terminated by sponsor|3
432626|NCT00492297|1441841|P1|Treatment|Death|2
432627|NCT00492284|1441859|P4|Overall Study|Withdrawal by Subject|2
432628|NCT00492284|1441860|P3|Overall Study|Withdrawal by Subject|0
432629|NCT00492284|1441861|P2|Overall Study|Withdrawal by Subject|0
432630|NCT00492284|1441862|P1|Overall Study|Withdrawal by Subject|1
432631|NCT00492284|1441859|P4|Overall Study|Death|5
432632|NCT00492284|1441860|P3|Overall Study|Death|2
432633|NCT00492284|1441861|P2|Overall Study|Death|3
432634|NCT00492284|1441862|P1|Overall Study|Death|0
432635|NCT00492284|1441859|P4|Overall Study|Lost to Follow-up|1
432636|NCT00492284|1441860|P3|Overall Study|Lost to Follow-up|3
432637|NCT00492284|1441861|P2|Overall Study|Lost to Follow-up|0
432638|NCT00492284|1441862|P1|Overall Study|Lost to Follow-up|0
432639|NCT00492284|1441859|P4|Overall Study|Adverse Event|2
432640|NCT00492284|1441860|P3|Overall Study|Adverse Event|1
432641|NCT00492284|1441861|P2|Overall Study|Adverse Event|1
432642|NCT00492284|1441862|P1|Overall Study|Adverse Event|0
432643|NCT00492232|1441906|P2|Open-Label Treatment|Withdrawal by Subject|0
432644|NCT00492232|1441907|P1|Open-Label Treatment|Withdrawal by Subject|1
432645|NCT00492232|1441906|P2|Double-Blind Treatment|Randomized not treated|0
432646|NCT00492232|1441907|P1|Double-Blind Treatment|Randomized not treated|1
432647|NCT00492232|1441906|P2|Double-Blind Treatment|Other|5
432648|NCT00492232|1441907|P1|Double-Blind Treatment|Other|6
432649|NCT00492232|1441906|P2|Double-Blind Treatment|Lack of Efficacy|0
432650|NCT00492232|1441907|P1|Double-Blind Treatment|Lack of Efficacy|1
432651|NCT00492232|1441906|P2|Double-Blind Treatment|Withdrawal by Subject|8
432652|NCT00492232|1441907|P1|Double-Blind Treatment|Withdrawal by Subject|4
432653|NCT00492232|1441906|P2|Double-Blind Treatment|Lost to Follow-up|3
432654|NCT00492232|1441907|P1|Double-Blind Treatment|Lost to Follow-up|2
432655|NCT00492232|1441906|P2|Double-Blind Treatment|Protocol Violation|7
432656|NCT00492232|1441907|P1|Double-Blind Treatment|Protocol Violation|3
432657|NCT00492232|1441906|P2|Double-Blind Treatment|Adverse Event|2
432658|NCT00492232|1441907|P1|Double-Blind Treatment|Adverse Event|1
432659|NCT00492232|1441906|P2|Placebo Run-in|Missing|2
432660|NCT00492232|1441907|P1|Placebo Run-in|Missing|0
432661|NCT00492232|1441906|P2|Placebo Run-in|Other|6
432662|NCT00492232|1441907|P1|Placebo Run-in|Other|0
432663|NCT00492232|1441906|P2|Placebo Run-in|Entrance criteria not met|45
432664|NCT00492232|1441907|P1|Placebo Run-in|Entrance criteria not met|0
432665|NCT00492232|1441906|P2|Placebo Run-in|Pregnancy|1
432666|NCT00492232|1441907|P1|Placebo Run-in|Pregnancy|0
432667|NCT00492232|1441906|P2|Placebo Run-in|Withdrawal by Subject|8
432668|NCT00492232|1441907|P1|Placebo Run-in|Withdrawal by Subject|0
432669|NCT00492232|1441906|P2|Placebo Run-in|Lost to Follow-up|3
432670|NCT00492232|1441907|P1|Placebo Run-in|Lost to Follow-up|0
432671|NCT00492232|1441906|P2|Placebo Run-in|Protocol Violation|3
432672|NCT00492232|1441907|P1|Placebo Run-in|Protocol Violation|0
432673|NCT00492232|1441906|P2|Placebo Run-in|Adverse Event|2
432674|NCT00492232|1441907|P1|Placebo Run-in|Adverse Event|0
432675|NCT00492115|1441948|P2|Overall Study|Withdrawal by Subject|4
432676|NCT00492115|1441949|P1|Overall Study|Withdrawal by Subject|3
432677|NCT00492063|1441970|P4|Overall Study|Protocol Violation|1
432678|NCT00492063|1441971|P3|Overall Study|Protocol Violation|0
432679|NCT00492063|1441972|P2|Overall Study|Protocol Violation|0
432680|NCT00492063|1441973|P1|Overall Study|Protocol Violation|0
432681|NCT00492063|1441970|P4|Overall Study|Lost to Follow-up|3
432682|NCT00492063|1441971|P3|Overall Study|Lost to Follow-up|5
432683|NCT00492063|1441972|P2|Overall Study|Lost to Follow-up|11
432684|NCT00492063|1441973|P1|Overall Study|Lost to Follow-up|6
432685|NCT00492063|1441970|P4|Overall Study|Withdrawal by Subject|4
432686|NCT00492063|1441971|P3|Overall Study|Withdrawal by Subject|5
432687|NCT00492063|1441972|P2|Overall Study|Withdrawal by Subject|3
432688|NCT00492063|1441973|P1|Overall Study|Withdrawal by Subject|4
432689|NCT00492063|1441970|P4|Overall Study|Death|2
432690|NCT00492063|1441971|P3|Overall Study|Death|1
432691|NCT00492063|1441972|P2|Overall Study|Death|0
432692|NCT00492063|1441973|P1|Overall Study|Death|0
432693|NCT00492024|1441997|P2|Follow up|Lost to Follow-up|1
432694|NCT00492024|1441998|P1|Follow up|Lost to Follow-up|1
432695|NCT00492024|1441997|P2|Follow up|Lack of Efficacy|1
432696|NCT00492024|1441998|P1|Follow up|Lack of Efficacy|0
432697|NCT00492024|1441997|P2|Treatment|Withdrawal by Subject|0
432698|NCT00492024|1441998|P1|Treatment|Withdrawal by Subject|2
432699|NCT00492024|1441997|P2|Treatment|Lost to Follow-up|1
432700|NCT00492024|1441998|P1|Treatment|Lost to Follow-up|3
432701|NCT00492024|1441997|P2|Treatment|Lack of Efficacy|20
432702|NCT00492024|1441998|P1|Treatment|Lack of Efficacy|21
432703|NCT00492024|1441997|P2|Treatment|Adverse Event|1
432704|NCT00492024|1441998|P1|Treatment|Adverse Event|3
432705|NCT00491894|1442014|P1|Overall Study|Other-Intake of prohibited medication|1
432706|NCT00491894|1442014|P1|Overall Study|Protocol Violation|2
432707|NCT00491894|1442014|P1|Overall Study|Physician Decision|2
432708|NCT00491894|1442014|P1|Overall Study|Other-Failed to meet any criteria|2
432709|NCT00491894|1442014|P1|Overall Study|Lack of Efficacy|2
432710|NCT00491894|1442014|P1|Overall Study|Lost to Follow-up|3
432711|NCT00491894|1442014|P1|Overall Study|Death|3
432712|NCT00491894|1442014|P1|Overall Study|Withdrawal by Subject|5
432713|NCT00491894|1442014|P1|Overall Study|Adverse Event|14
432714|NCT00491764|1442041|P6|Overall Study|Administrative|0
432715|NCT00491764|1442042|P5|Overall Study|Administrative|0
432716|NCT00491764|1442043|P4|Overall Study|Administrative|1
432717|NCT00491764|1442044|P3|Overall Study|Administrative|2
432718|NCT00491764|1442045|P2|Overall Study|Administrative|0
432719|NCT00491764|1442046|P1|Overall Study|Administrative|1
432720|NCT00491764|1442041|P6|Overall Study|Did not Meet Protocol Eligibility|1
432721|NCT00491764|1442042|P5|Overall Study|Did not Meet Protocol Eligibility|1
432722|NCT00491764|1442043|P4|Overall Study|Did not Meet Protocol Eligibility|0
432723|NCT00491764|1442044|P3|Overall Study|Did not Meet Protocol Eligibility|1
432724|NCT00491764|1442045|P2|Overall Study|Did not Meet Protocol Eligibility|1
432725|NCT00491764|1442046|P1|Overall Study|Did not Meet Protocol Eligibility|0
432726|NCT00491764|1442041|P6|Overall Study|Non Compliance with the Protocol|0
432727|NCT00491764|1442042|P5|Overall Study|Non Compliance with the Protocol|0
432728|NCT00491764|1442043|P4|Overall Study|Non Compliance with the Protocol|0
432729|NCT00491764|1442044|P3|Overall Study|Non Compliance with the Protocol|0
432730|NCT00491764|1442045|P2|Overall Study|Non Compliance with the Protocol|0
432731|NCT00491764|1442046|P1|Overall Study|Non Compliance with the Protocol|1
432732|NCT00491764|1442041|P6|Overall Study|Withdrawal by Subject|4
432733|NCT00491764|1442042|P5|Overall Study|Withdrawal by Subject|2
432734|NCT00491764|1442043|P4|Overall Study|Withdrawal by Subject|2
432735|NCT00491764|1442044|P3|Overall Study|Withdrawal by Subject|1
432736|NCT00491764|1442045|P2|Overall Study|Withdrawal by Subject|3
432737|NCT00491764|1442046|P1|Overall Study|Withdrawal by Subject|2
432738|NCT00491764|1442041|P6|Overall Study|Lost to Follow-up|3
432739|NCT00491764|1442042|P5|Overall Study|Lost to Follow-up|0
432740|NCT00491764|1442043|P4|Overall Study|Lost to Follow-up|1
432741|NCT00491764|1442044|P3|Overall Study|Lost to Follow-up|0
432742|NCT00491764|1442045|P2|Overall Study|Lost to Follow-up|1
432743|NCT00491764|1442046|P1|Overall Study|Lost to Follow-up|0
432744|NCT00491764|1442041|P6|Overall Study|Adverse Event|1
432745|NCT00491764|1442042|P5|Overall Study|Adverse Event|0
432746|NCT00491764|1442043|P4|Overall Study|Adverse Event|4
432747|NCT00491764|1442044|P3|Overall Study|Adverse Event|4
432748|NCT00491764|1442045|P2|Overall Study|Adverse Event|2
432749|NCT00491764|1442046|P1|Overall Study|Adverse Event|1
432750|NCT00491608|1442079|P1|Overall Study|Withdrawal by Subject|1
432751|NCT00491608|1442079|P1|Overall Study|Death|2
432752|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
432753|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
432754|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
432755|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
432756|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
432757|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
432758|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
432759|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
432760|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
432761|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
432762|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
432763|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
432764|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
432765|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
432766|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
432767|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
432768|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
432769|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
432770|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
432771|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
432772|NCT00491556|1442090|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
432773|NCT00491556|1442091|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
432774|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
432775|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
432776|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
432777|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
432778|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
432779|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
432780|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
432781|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
432782|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
432783|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
432784|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
432785|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
432786|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
432787|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
432788|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
432789|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
432790|NCT00491556|1442090|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
432791|NCT00491556|1442091|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
432792|NCT00491530|1442150|P3|Overall Study|Use of Prohibited Medication|1
432793|NCT00491530|1442151|P2|Overall Study|Use of Prohibited Medication|0
432794|NCT00491530|1442152|P1|Overall Study|Use of Prohibited Medication|0
432795|NCT00491530|1442150|P3|Overall Study|Patient Request|0
432796|NCT00491530|1442151|P2|Overall Study|Patient Request|1
432797|NCT00491530|1442152|P1|Overall Study|Patient Request|0
432798|NCT00491530|1442150|P3|Overall Study|Investigator Discretion|0
432799|NCT00491530|1442151|P2|Overall Study|Investigator Discretion|1
432800|NCT00491530|1442152|P1|Overall Study|Investigator Discretion|0
432801|NCT00491530|1442150|P3|Overall Study|Lack of Efficacy|0
432802|NCT00491530|1442151|P2|Overall Study|Lack of Efficacy|1
432803|NCT00491530|1442152|P1|Overall Study|Lack of Efficacy|0
432804|NCT00491530|1442150|P3|Overall Study|Lost to Follow-up|2
432805|NCT00491530|1442151|P2|Overall Study|Lost to Follow-up|2
432806|NCT00491530|1442152|P1|Overall Study|Lost to Follow-up|3
432807|NCT00491530|1442150|P3|Overall Study|Withdrawal by Subject|0
432808|NCT00491530|1442151|P2|Overall Study|Withdrawal by Subject|0
432809|NCT00491530|1442152|P1|Overall Study|Withdrawal by Subject|3
432810|NCT00491530|1442150|P3|Overall Study|Adverse Event|2
432811|NCT00491530|1442151|P2|Overall Study|Adverse Event|1
432812|NCT00491530|1442152|P1|Overall Study|Adverse Event|6
432813|NCT00491504|1442182|P4|Overall Study|Protocol Violation|2
432814|NCT00491504|1442183|P3|Overall Study|Protocol Violation|3
432815|NCT00491504|1442184|P2|Overall Study|Protocol Violation|0
432816|NCT00491504|1442185|P1|Overall Study|Protocol Violation|0
432817|NCT00491504|1442182|P4|Overall Study|Withdrawal by Subject|2
432818|NCT00491504|1442183|P3|Overall Study|Withdrawal by Subject|1
432819|NCT00491504|1442184|P2|Overall Study|Withdrawal by Subject|0
432820|NCT00491504|1442185|P1|Overall Study|Withdrawal by Subject|0
432821|NCT00491504|1442182|P4|Overall Study|Adverse Event|0
432822|NCT00491504|1442183|P3|Overall Study|Adverse Event|0
432823|NCT00491504|1442184|P2|Overall Study|Adverse Event|1
432824|NCT00491504|1442185|P1|Overall Study|Adverse Event|0
432825|NCT00491400|1442195|P2|Overall Study|Withdrawal by Subject|4
432826|NCT00491400|1442196|P1|Overall Study|Withdrawal by Subject|5
432827|NCT00491387|1442204|P1|Overall Study|study terminated|20
432828|NCT00491322|1442219|P2|Overall Study|Pregnancy|1
432829|NCT00491322|1442220|P1|Overall Study|Pregnancy|0
432830|NCT00491322|1442219|P2|Overall Study|Protocol Violation|0
432831|NCT00491322|1442220|P1|Overall Study|Protocol Violation|1
432832|NCT00491179|1442239|P2|Overall Study|Withdrawal by Subject|1
432833|NCT00491179|1442240|P1|Overall Study|Withdrawal by Subject|2
432834|NCT00491179|1442239|P2|Overall Study|Adverse Event|1
432835|NCT00491179|1442240|P1|Overall Study|Adverse Event|5
432836|NCT00491075|1442248|P1|Overall Study|Physician Decision|1
432837|NCT00491075|1442248|P1|Overall Study|Withdrawal by Subject|1
432838|NCT00490971|1442254|P5|Maintenance|Not specified|3
432839|NCT00490971|1442255|P4|Maintenance|Not specified|9
432840|NCT00490971|1442256|P3|Maintenance|Not specified|11
432841|NCT00490971|1442257|P2|Maintenance|Not specified|0
432842|NCT00490971|1442258|P1|Maintenance|Not specified|0
432843|NCT00490971|1442254|P5|Maintenance|Withdrawal by Subject|18
432844|NCT00490971|1442255|P4|Maintenance|Withdrawal by Subject|28
432845|NCT00490971|1442256|P3|Maintenance|Withdrawal by Subject|26
432846|NCT00490971|1442257|P2|Maintenance|Withdrawal by Subject|0
432847|NCT00490971|1442258|P1|Maintenance|Withdrawal by Subject|0
432848|NCT00490971|1442254|P5|Maintenance|Protocol Violation|1
432849|NCT00490971|1442255|P4|Maintenance|Protocol Violation|1
432850|NCT00490971|1442256|P3|Maintenance|Protocol Violation|4
432851|NCT00490971|1442257|P2|Maintenance|Protocol Violation|0
432852|NCT00490971|1442258|P1|Maintenance|Protocol Violation|0
432853|NCT00490971|1442254|P5|Maintenance|Pregnancy|0
432854|NCT00490971|1442255|P4|Maintenance|Pregnancy|0
432855|NCT00490971|1442256|P3|Maintenance|Pregnancy|1
432856|NCT00490971|1442257|P2|Maintenance|Pregnancy|0
432857|NCT00490971|1442258|P1|Maintenance|Pregnancy|0
432858|NCT00490971|1442254|P5|Maintenance|Lost to Follow-up|10
432859|NCT00490971|1442255|P4|Maintenance|Lost to Follow-up|8
432860|NCT00490971|1442256|P3|Maintenance|Lost to Follow-up|5
432861|NCT00490971|1442257|P2|Maintenance|Lost to Follow-up|0
432862|NCT00490971|1442258|P1|Maintenance|Lost to Follow-up|0
432863|NCT00490971|1442254|P5|Maintenance|Death|0
432864|NCT00490971|1442255|P4|Maintenance|Death|2
432865|NCT00490971|1442256|P3|Maintenance|Death|0
432866|NCT00490971|1442257|P2|Maintenance|Death|0
432867|NCT00490971|1442258|P1|Maintenance|Death|0
432868|NCT00490971|1442254|P5|Maintenance|Adverse Event|7
432869|NCT00490971|1442255|P4|Maintenance|Adverse Event|5
432870|NCT00490971|1442256|P3|Maintenance|Adverse Event|4
432871|NCT00490971|1442257|P2|Maintenance|Adverse Event|0
432872|NCT00490971|1442258|P1|Maintenance|Adverse Event|0
432873|NCT00490971|1442254|P5|Acute/Continuation|Not specified|0
432874|NCT00490971|1442255|P4|Acute/Continuation|Not specified|0
432875|NCT00490971|1442256|P3|Acute/Continuation|Not specified|0
432876|NCT00490971|1442257|P2|Acute/Continuation|Not specified|4
432877|NCT00490971|1442258|P1|Acute/Continuation|Not specified|11
432878|NCT00490971|1442254|P5|Acute/Continuation|Withdrawal by Subject|0
432879|NCT00490971|1442255|P4|Acute/Continuation|Withdrawal by Subject|0
432880|NCT00490971|1442256|P3|Acute/Continuation|Withdrawal by Subject|0
432881|NCT00490971|1442257|P2|Acute/Continuation|Withdrawal by Subject|24
432882|NCT00490971|1442258|P1|Acute/Continuation|Withdrawal by Subject|92
432883|NCT00490971|1442254|P5|Acute/Continuation|Protocol Violation|0
432884|NCT00490971|1442255|P4|Acute/Continuation|Protocol Violation|0
432885|NCT00490971|1442256|P3|Acute/Continuation|Protocol Violation|0
432886|NCT00490971|1442257|P2|Acute/Continuation|Protocol Violation|2
432887|NCT00490971|1442258|P1|Acute/Continuation|Protocol Violation|10
432888|NCT00490971|1442254|P5|Acute/Continuation|Lost to Follow-up|0
432889|NCT00490971|1442255|P4|Acute/Continuation|Lost to Follow-up|0
432890|NCT00490971|1442256|P3|Acute/Continuation|Lost to Follow-up|0
432891|NCT00490971|1442257|P2|Acute/Continuation|Lost to Follow-up|7
432892|NCT00490971|1442258|P1|Acute/Continuation|Lost to Follow-up|23
432893|NCT00490971|1442254|P5|Acute/Continuation|Lack of Efficacy|0
432894|NCT00490971|1442255|P4|Acute/Continuation|Lack of Efficacy|0
432895|NCT00490971|1442256|P3|Acute/Continuation|Lack of Efficacy|0
432896|NCT00490971|1442257|P2|Acute/Continuation|Lack of Efficacy|12
432897|NCT00490971|1442258|P1|Acute/Continuation|Lack of Efficacy|106
432898|NCT00490971|1442254|P5|Acute/Continuation|Death|0
432899|NCT00490971|1442255|P4|Acute/Continuation|Death|0
432900|NCT00490971|1442256|P3|Acute/Continuation|Death|0
432901|NCT00490971|1442257|P2|Acute/Continuation|Death|0
432902|NCT00490971|1442258|P1|Acute/Continuation|Death|2
432903|NCT00490971|1442254|P5|Acute/Continuation|Adverse Event|0
432904|NCT00490971|1442255|P4|Acute/Continuation|Adverse Event|0
432905|NCT00490971|1442256|P3|Acute/Continuation|Adverse Event|0
432906|NCT00490971|1442257|P2|Acute/Continuation|Adverse Event|13
432907|NCT00490971|1442258|P1|Acute/Continuation|Adverse Event|62
432908|NCT00490945|1442305|P5|Overall Study|Adverse Event|0
432909|NCT00490945|1442306|P4|Overall Study|Adverse Event|0
432910|NCT00490945|1442307|P3|Overall Study|Adverse Event|0
432911|NCT00490945|1442308|P2|Overall Study|Adverse Event|1
432912|NCT00490945|1442309|P1|Overall Study|Adverse Event|0
432913|NCT00490919|1442345|P3|Double-blind Phase|Administrative|6
432914|NCT00490919|1442346|P2|Double-blind Phase|Administrative|6
432915|NCT00490919|1442347|P1|Double-blind Phase|Administrative|0
432916|NCT00490919|1442345|P3|Double-blind Phase|Lack of Efficacy|36
432917|NCT00490919|1442346|P2|Double-blind Phase|Lack of Efficacy|22
432918|NCT00490919|1442347|P1|Double-blind Phase|Lack of Efficacy|0
432919|NCT00490919|1442345|P3|Double-blind Phase|Lost to Follow-up|11
432920|NCT00490919|1442346|P2|Double-blind Phase|Lost to Follow-up|8
432921|NCT00490919|1442347|P1|Double-blind Phase|Lost to Follow-up|0
432922|NCT00490919|1442345|P3|Double-blind Phase|Withdrawal by Subject|11
432923|NCT00490919|1442346|P2|Double-blind Phase|Withdrawal by Subject|10
432924|NCT00490919|1442347|P1|Double-blind Phase|Withdrawal by Subject|0
432925|NCT00490919|1442345|P3|Double-blind Phase|Adverse Event|20
432926|NCT00490919|1442346|P2|Double-blind Phase|Adverse Event|40
432927|NCT00490919|1442347|P1|Double-blind Phase|Adverse Event|0
432928|NCT00490919|1442345|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
432929|NCT00490919|1442346|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
432930|NCT00490919|1442347|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
432931|NCT00490919|1442345|P3|Open-label Run-in Period|Administrative|0
432932|NCT00490919|1442346|P2|Open-label Run-in Period|Administrative|0
432933|NCT00490919|1442347|P1|Open-label Run-in Period|Administrative|40
432934|NCT00490919|1442345|P3|Open-label Run-in Period|Lack of Efficacy|0
432935|NCT00490919|1442346|P2|Open-label Run-in Period|Lack of Efficacy|0
432936|NCT00490919|1442347|P1|Open-label Run-in Period|Lack of Efficacy|143
432937|NCT00490919|1442345|P3|Open-label Run-in Period|Lost to Follow-up|0
432938|NCT00490919|1442346|P2|Open-label Run-in Period|Lost to Follow-up|0
432939|NCT00490919|1442347|P1|Open-label Run-in Period|Lost to Follow-up|21
432940|NCT00490919|1442345|P3|Open-label Run-in Period|Withdrawal by Subject|0
432941|NCT00490919|1442346|P2|Open-label Run-in Period|Withdrawal by Subject|0
432942|NCT00490919|1442347|P1|Open-label Run-in Period|Withdrawal by Subject|37
432943|NCT00490919|1442345|P3|Open-label Run-in Period|Adverse Event|0
432944|NCT00490919|1442346|P2|Open-label Run-in Period|Adverse Event|0
432945|NCT00490919|1442347|P1|Open-label Run-in Period|Adverse Event|239
432946|NCT00490841|1442358|P1|Overall Study|30 day f/u, only non-study stent used|3
432947|NCT00490841|1442358|P1|Overall Study|Lost to Follow-up|1
432948|NCT00490841|1442358|P1|Overall Study|Withdrawal by Subject|4
432949|NCT00490841|1442358|P1|Overall Study|Death|5
432950|NCT00490815|1442380|P2|Overall Study|Death|3
432951|NCT00490815|1442381|P1|Overall Study|Death|1
432952|NCT00490815|1442380|P2|Overall Study|Lost to Follow-up|3
432953|NCT00490815|1442381|P1|Overall Study|Lost to Follow-up|1
432954|NCT00490815|1442380|P2|Overall Study|Withdrawal by Subject|0
432955|NCT00490815|1442381|P1|Overall Study|Withdrawal by Subject|4
432956|NCT00490815|1442380|P2|Overall Study|Adverse Event|3
432957|NCT00490815|1442381|P1|Overall Study|Adverse Event|2
432958|NCT00490724|1442409|P3|Period II|Treatment Discontinuation|3
432959|NCT00490724|1442410|P2|Period II|Treatment Discontinuation|1
432960|NCT00490724|1442411|P1|Period II|Treatment Discontinuation|3
432961|NCT00490724|1442409|P3|Period I|Physician Decision|1
432962|NCT00490724|1442410|P2|Period I|Physician Decision|0
432963|NCT00490724|1442411|P1|Period I|Physician Decision|0
432964|NCT00490698|1442476|P1|Overall Study|Physician Decision|2
432965|NCT00490698|1442476|P1|Overall Study|Disease Progression|7
432966|NCT00490698|1442476|P1|Overall Study|Withdrawal by Subject|1
432967|NCT00490646|1442482|P2|Overall Study|Never Treated (withdrew consent)|1
432968|NCT00490646|1442483|P1|Overall Study|Never Treated (withdrew consent)|0
432969|NCT00490646|1442482|P2|Overall Study|Never Treated (had an adverse event)|0
432970|NCT00490646|1442483|P1|Overall Study|Never Treated (had an adverse event)|1
432971|NCT00490646|1442482|P2|Overall Study|Still on trastuzumab monotherapy|1
432972|NCT00490646|1442483|P1|Overall Study|Still on trastuzumab monotherapy|1
432973|NCT00490568|1442503|P1|Overall Study|Participant withdrawal due to surgery|1
432974|NCT00490568|1442503|P1|Overall Study|Participant died|1
432975|NCT00490568|1442503|P1|Overall Study|Efficacy related|3
432976|NCT00490568|1442503|P1|Overall Study|Non-Compliance|7
432977|NCT00490568|1442503|P1|Overall Study|Investigator decision|3
432978|NCT00490568|1442503|P1|Overall Study|Unmet inclusion-exclusion criteria|5
432979|NCT00490568|1442503|P1|Overall Study|Disease progression|4
432980|NCT00490568|1442503|P1|Overall Study|Legal representative withdrew consent|1
432981|NCT00490568|1442503|P1|Overall Study|Participant refused follow-up|9
432982|NCT00490568|1442503|P1|Overall Study|Abnormal ECG|25
432983|NCT00490568|1442503|P1|Overall Study|Caregiver related|20
432984|NCT00490568|1442503|P1|Overall Study|Exclusion criteria met|1
432985|NCT00490568|1442503|P1|Overall Study|Other|1
432986|NCT00490568|1442503|P1|Overall Study|Still in the study at termination|974
432987|NCT00490568|1442503|P1|Overall Study|Withdrawal by Subject|135
432988|NCT00490568|1442503|P1|Overall Study|Protocol Violation|45
432989|NCT00490568|1442503|P1|Overall Study|Lost to Follow-up|13
432990|NCT00490568|1442503|P1|Overall Study|Adverse Event|116
432991|NCT00490555|1442527|P4|Overall Study|noncompliant with drug administration|0
432992|NCT00490555|1442528|P3|Overall Study|noncompliant with drug administration|2
432993|NCT00490555|1442529|P2|Overall Study|noncompliant with drug administration|0
432994|NCT00490555|1442530|P1|Overall Study|noncompliant with drug administration|0
432995|NCT00490542|1442558|P2|Overall Study|Lack of Efficacy|1
432996|NCT00490542|1442559|P1|Overall Study|Lack of Efficacy|1
432997|NCT00490542|1442558|P2|Overall Study|Adverse Event|3
432998|NCT00490542|1442559|P1|Overall Study|Adverse Event|3
432999|NCT00490542|1442558|P2|Overall Study|Lost to Follow-up|0
433000|NCT00490542|1442559|P1|Overall Study|Lost to Follow-up|3
433001|NCT00490490|1442565|P1|Completed Assessment for TTP|Lost to Follow-up|2
433002|NCT00490490|1442565|P1|Completed Assessment for TTP|Withdrawal by Subject|1
433003|NCT00490451|1442582|P2|Overall Study|Progressive Disease|34
433004|NCT00490451|1442583|P1|Overall Study|Progressive Disease|53
433005|NCT00490451|1442582|P2|Overall Study|Protocol Violation|0
433006|NCT00490451|1442583|P1|Overall Study|Protocol Violation|1
433007|NCT00490451|1442582|P2|Overall Study|Investigator Decision|0
433008|NCT00490451|1442583|P1|Overall Study|Investigator Decision|1
433009|NCT00490451|1442582|P2|Overall Study|Withdrawal by Subject|0
433010|NCT00490451|1442583|P1|Overall Study|Withdrawal by Subject|2
433011|NCT00490451|1442582|P2|Overall Study|Death|1
433012|NCT00490451|1442583|P1|Overall Study|Death|3
433013|NCT00490451|1442582|P2|Overall Study|Adverse Event|3
433014|NCT00490451|1442583|P1|Overall Study|Adverse Event|3
433015|NCT00490139|1442625|P4|Overall Study|Participant Withdrew Consent|116
433016|NCT00490139|1442626|P3|Overall Study|Participant Withdrew Consent|208
433017|NCT00490139|1442627|P2|Overall Study|Participant Withdrew Consent|110
433018|NCT00490139|1442628|P1|Overall Study|Participant Withdrew Consent|146
433019|NCT00490139|1442625|P4|Overall Study|Lost to Follow-up|56
433020|NCT00490139|1442626|P3|Overall Study|Lost to Follow-up|58
433021|NCT00490139|1442627|P2|Overall Study|Lost to Follow-up|46
433022|NCT00490139|1442628|P1|Overall Study|Lost to Follow-up|56
433023|NCT00490139|1442625|P4|Overall Study|Death|135
433024|NCT00490139|1442626|P3|Overall Study|Death|168
433025|NCT00490139|1442627|P2|Overall Study|Death|119
433026|NCT00490139|1442628|P1|Overall Study|Death|106
433027|NCT00490061|1442663|P1|Overall Study|Physician Decision|1
433028|NCT00490035|1442672|P4|Overall Study|AE of unknown type|0
433029|NCT00490035|1442673|P3|Overall Study|AE of unknown type|2
433030|NCT00490035|1442674|P2|Overall Study|AE of unknown type|0
433031|NCT00490035|1442675|P1|Overall Study|AE of unknown type|0
433032|NCT00490035|1442672|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
433033|NCT00490035|1442673|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
433034|NCT00490035|1442674|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
433035|NCT00490035|1442675|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
433036|NCT00490035|1442672|P4|Overall Study|AE, serious fatal|0
433037|NCT00490035|1442673|P3|Overall Study|AE, serious fatal|0
433038|NCT00490035|1442674|P2|Overall Study|AE, serious fatal|0
433039|NCT00490035|1442675|P1|Overall Study|AE, serious fatal|1
433040|NCT00490035|1442672|P4|Overall Study|Other reason|1
433041|NCT00490035|1442673|P3|Overall Study|Other reason|3
433042|NCT00490035|1442674|P2|Overall Study|Other reason|1
433043|NCT00490035|1442675|P1|Overall Study|Other reason|0
433044|NCT00490035|1442672|P4|Overall Study|Withdrawal by Subject|0
433045|NCT00490035|1442673|P3|Overall Study|Withdrawal by Subject|1
433046|NCT00490035|1442674|P2|Overall Study|Withdrawal by Subject|1
433047|NCT00490035|1442675|P1|Overall Study|Withdrawal by Subject|2
433048|NCT00490035|1442672|P4|Overall Study|Lost to Follow-up|0
433049|NCT00490035|1442673|P3|Overall Study|Lost to Follow-up|1
433050|NCT00490035|1442674|P2|Overall Study|Lost to Follow-up|0
433051|NCT00490035|1442675|P1|Overall Study|Lost to Follow-up|2
433052|NCT00490035|1442672|P4|Overall Study|AE, non-serious non-fatal|5
433053|NCT00490035|1442673|P3|Overall Study|AE, non-serious non-fatal|4
433054|NCT00490035|1442674|P2|Overall Study|AE, non-serious non-fatal|4
433055|NCT00490035|1442675|P1|Overall Study|AE, non-serious non-fatal|3
433056|NCT00490022|1442775|P2|Overall Study|Subject failed to disclose concommitant|1
433057|NCT00490022|1442776|P1|Overall Study|Subject failed to disclose concommitant|0
433058|NCT00490022|1442775|P2|Overall Study|Withdrawal by Subject|0
433059|NCT00490022|1442776|P1|Overall Study|Withdrawal by Subject|1
433060|NCT00490022|1442775|P2|Overall Study|Adverse Event|2
433061|NCT00490022|1442776|P1|Overall Study|Adverse Event|0
433062|NCT00489853|1442834|P3|Treatment Period 3|Study specific discontinuation criteria|0
433063|NCT00489853|1442835|P2|Treatment Period 3|Study specific discontinuation criteria|1
433064|NCT00489853|1442836|P1|Treatment Period 3|Study specific discontinuation criteria|0
433065|NCT00489853|1442834|P3|Wash-out Period 2|Study specific discontinuation criteria|2
433066|NCT00489853|1442835|P2|Wash-out Period 2|Study specific discontinuation criteria|2
433067|NCT00489853|1442836|P1|Wash-out Period 2|Study specific discontinuation criteria|3
433068|NCT00489853|1442834|P3|Wash-out Period 2|Adverse Event|0
433069|NCT00489853|1442835|P2|Wash-out Period 2|Adverse Event|1
433070|NCT00489853|1442836|P1|Wash-out Period 2|Adverse Event|1
433071|NCT00489853|1442834|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
433072|NCT00489853|1442835|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
433073|NCT00489853|1442836|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
433074|NCT00489853|1442834|P3|Wash-out Period 1|Protocol Violation|1
433075|NCT00489853|1442835|P2|Wash-out Period 1|Protocol Violation|1
433076|NCT00489853|1442836|P1|Wash-out Period 1|Protocol Violation|0
433077|NCT00489853|1442834|P3|Wash-out Period 1|Adverse Event|1
433078|NCT00489853|1442835|P2|Wash-out Period 1|Adverse Event|1
433079|NCT00489853|1442836|P1|Wash-out Period 1|Adverse Event|0
433080|NCT00489853|1442834|P3|Wash-out Period 1|Withdrawal by Subject|0
433081|NCT00489853|1442835|P2|Wash-out Period 1|Withdrawal by Subject|0
433082|NCT00489853|1442836|P1|Wash-out Period 1|Withdrawal by Subject|1
433083|NCT00489736|1442933|P2|Overall Study|Not coded/ Not pre-specified|8
433084|NCT00489736|1442934|P1|Overall Study|Not coded/ Not pre-specified|5
433085|NCT00489736|1442933|P2|Overall Study|Poor compliance|2
433086|NCT00489736|1442934|P1|Overall Study|Poor compliance|6
433087|NCT00489736|1442933|P2|Overall Study|Adverse Event|45
433088|NCT00489736|1442934|P1|Overall Study|Adverse Event|32
433089|NCT00489736|1442933|P2|Overall Study|Lack of Efficacy|14
433090|NCT00489736|1442934|P1|Overall Study|Lack of Efficacy|53
433091|NCT00489554|1442944|P1|Overall Study|Lost to Follow-up|1
433092|NCT00489554|1442944|P1|Overall Study|Withdrawal by Subject|1
433093|NCT00489554|1442944|P1|Overall Study|Adverse Event|2
433094|NCT00489541|1442964|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
433095|NCT00489541|1442965|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
433096|NCT00489541|1442964|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
433097|NCT00489541|1442965|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
433098|NCT00489541|1442964|P2|12-Month Clinical Follow-up|Death|2
433099|NCT00489541|1442965|P1|12-Month Clinical Follow-up|Death|3
433100|NCT00489541|1442964|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
433101|NCT00489541|1442965|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
433102|NCT00489541|1442964|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
433103|NCT00489541|1442965|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
433104|NCT00489541|1442964|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
433105|NCT00489541|1442965|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
433106|NCT00489489|1442976|P3|Overall Study|Other than above|0
433107|NCT00489489|1442977|P2|Overall Study|Other than above|1
433108|NCT00489489|1442978|P1|Overall Study|Other than above|0
433109|NCT00489489|1442976|P3|Overall Study|Participant did not wish to continue|0
433110|NCT00489489|1442977|P2|Overall Study|Participant did not wish to continue|1
433111|NCT00489489|1442978|P1|Overall Study|Participant did not wish to continue|1
433112|NCT00489489|1442976|P3|Overall Study|Progressive disease|0
433113|NCT00489489|1442977|P2|Overall Study|Progressive disease|1
433114|NCT00489489|1442978|P1|Overall Study|Progressive disease|0
433115|NCT00489489|1442976|P3|Overall Study|Protocol Violation|1
433116|NCT00489489|1442977|P2|Overall Study|Protocol Violation|0
433117|NCT00489489|1442978|P1|Overall Study|Protocol Violation|1
433118|NCT00489489|1442976|P3|Overall Study|Adverse Event|1
433119|NCT00489489|1442977|P2|Overall Study|Adverse Event|1
433120|NCT00489489|1442978|P1|Overall Study|Adverse Event|1
433121|NCT00489489|1442976|P3|Overall Study|Not treated due to protocol violation|1
433122|NCT00489489|1442977|P2|Overall Study|Not treated due to protocol violation|1
433123|NCT00489489|1442978|P1|Overall Study|Not treated due to protocol violation|0
433124|NCT00489476|1443010|P4|Overall Study|Lost to Follow-up|0
433125|NCT00489476|1443011|P3|Overall Study|Lost to Follow-up|0
433126|NCT00489476|1443012|P2|Overall Study|Lost to Follow-up|1
433127|NCT00489476|1443013|P1|Overall Study|Lost to Follow-up|0
433128|NCT00489424|1443034|P3|Overall Study|Administrative problems|1
433129|NCT00489424|1443035|P2|Overall Study|Administrative problems|2
433130|NCT00489424|1443036|P1|Overall Study|Administrative problems|0
433131|NCT00489424|1443034|P3|Overall Study|Lack of Efficacy|0
433132|NCT00489424|1443035|P2|Overall Study|Lack of Efficacy|0
433133|NCT00489424|1443036|P1|Overall Study|Lack of Efficacy|1
433134|NCT00489424|1443034|P3|Overall Study|Adverse Event|4
433135|NCT00489424|1443035|P2|Overall Study|Adverse Event|3
433136|NCT00489424|1443036|P1|Overall Study|Adverse Event|3
433137|NCT00489411|1443067|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
433138|NCT00489411|1443068|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
433139|NCT00489411|1443067|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
433140|NCT00489411|1443068|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
433141|NCT00489411|1443067|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
433142|NCT00489411|1443068|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
433143|NCT00489411|1443067|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
433144|NCT00489411|1443068|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
433145|NCT00489411|1443067|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
433146|NCT00489411|1443068|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
433147|NCT00489359|1443082|P2|Overall Study|Adverse Event|16
433148|NCT00489359|1443083|P1|Overall Study|Adverse Event|0
433149|NCT00489359|1443082|P2|Overall Study|Withdrawal by Subject|5
433150|NCT00489359|1443083|P1|Overall Study|Withdrawal by Subject|1
433151|NCT00489359|1443082|P2|Overall Study|Lost to Follow-up|0
433152|NCT00489359|1443083|P1|Overall Study|Lost to Follow-up|1
433153|NCT00489359|1443082|P2|Overall Study|Progressive Disease|6
433154|NCT00489359|1443083|P1|Overall Study|Progressive Disease|5
433155|NCT00489359|1443082|P2|Overall Study|Death|2
433156|NCT00489359|1443083|P1|Overall Study|Death|0
433157|NCT00489255|1443144|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
433158|NCT00489255|1443145|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
433159|NCT00489255|1443144|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
433160|NCT00489255|1443145|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
433161|NCT00489255|1443144|P2|Period 3: Days 57 to 84|Adverse Event|3
433162|NCT00489255|1443145|P1|Period 3: Days 57 to 84|Adverse Event|3
433163|NCT00489255|1443144|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
433164|NCT00489255|1443145|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
433165|NCT00489255|1443144|P2|Period 2: Days 29 to 56|Adverse Event|1
433166|NCT00489255|1443145|P1|Period 2: Days 29 to 56|Adverse Event|3
433167|NCT00489255|1443144|P2|Period 1: Days 1 to 28|Noncompliance|0
433168|NCT00489255|1443145|P1|Period 1: Days 1 to 28|Noncompliance|2
433169|NCT00489255|1443144|P2|Period 1: Days 1 to 28|Physician Decision|4
433170|NCT00489255|1443145|P1|Period 1: Days 1 to 28|Physician Decision|1
433171|NCT00489255|1443144|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
433172|NCT00489255|1443145|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
433173|NCT00489255|1443144|P2|Period 1: Days 1 to 28|Adverse Event|8
433174|NCT00489255|1443145|P1|Period 1: Days 1 to 28|Adverse Event|21
433175|NCT00489255|1443144|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
433176|NCT00489255|1443145|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
433177|NCT00489216|1443193|P1|Overall Study|Adverse Event|1
433178|NCT00488826|1443215|P3|Overall Study|Protocol Deviations|1
433179|NCT00488826|1443216|P2|Overall Study|Protocol Deviations|1
433180|NCT00488826|1443217|P1|Overall Study|Protocol Deviations|2
433181|NCT00488826|1443215|P3|Overall Study|Lost to Follow-up|0
433182|NCT00488826|1443216|P2|Overall Study|Lost to Follow-up|1
433183|NCT00488826|1443217|P1|Overall Study|Lost to Follow-up|5
433184|NCT00488826|1443215|P3|Overall Study|Adverse Event|4
433185|NCT00488826|1443216|P2|Overall Study|Adverse Event|15
433186|NCT00488826|1443217|P1|Overall Study|Adverse Event|9
433187|NCT00488826|1443215|P3|Overall Study|Protocol Violation|2
433188|NCT00488826|1443216|P2|Overall Study|Protocol Violation|0
433189|NCT00488826|1443217|P1|Overall Study|Protocol Violation|0
433190|NCT00488826|1443215|P3|Overall Study|Withdrawal by Subject|19
433191|NCT00488826|1443216|P2|Overall Study|Withdrawal by Subject|35
433192|NCT00488826|1443217|P1|Overall Study|Withdrawal by Subject|40
433193|NCT00488774|1443232|P4|Overall Study|Lost to Follow-up|1
433194|NCT00488774|1443233|P3|Overall Study|Lost to Follow-up|1
433195|NCT00488774|1443234|P2|Overall Study|Lost to Follow-up|0
433196|NCT00488774|1443235|P1|Overall Study|Lost to Follow-up|0
433197|NCT00488774|1443232|P4|Overall Study|Other|2
433198|NCT00488774|1443233|P3|Overall Study|Other|2
433199|NCT00488774|1443234|P2|Overall Study|Other|3
433200|NCT00488774|1443235|P1|Overall Study|Other|6
433201|NCT00488774|1443232|P4|Overall Study|Withdrawal of consent|0
433202|NCT00488774|1443233|P3|Overall Study|Withdrawal of consent|2
433203|NCT00488774|1443234|P2|Overall Study|Withdrawal of consent|2
433204|NCT00488774|1443235|P1|Overall Study|Withdrawal of consent|2
433205|NCT00488683|1443252|P3|Overall Study|Unable to Classify|0
433206|NCT00488683|1443253|P2|Overall Study|Unable to Classify|0
433207|NCT00488683|1443254|P1|Overall Study|Unable to Classify|1
433208|NCT00488683|1443252|P3|Overall Study|Protocol Violation|0
433209|NCT00488683|1443253|P2|Overall Study|Protocol Violation|1
433210|NCT00488683|1443254|P1|Overall Study|Protocol Violation|5
433211|NCT00488683|1443252|P3|Overall Study|Lost to Follow-up|0
433212|NCT00488683|1443253|P2|Overall Study|Lost to Follow-up|3
433213|NCT00488683|1443254|P1|Overall Study|Lost to Follow-up|5
433214|NCT00488683|1443252|P3|Overall Study|Withdrawal by Subject|2
433215|NCT00488683|1443253|P2|Overall Study|Withdrawal by Subject|2
433216|NCT00488683|1443254|P1|Overall Study|Withdrawal by Subject|1
433217|NCT00488644|1443313|P1|Overall Study|Not Evaluable|1
433218|NCT00488644|1443313|P1|Overall Study|Not Eligible|1
433219|NCT00488631|1443323|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
433220|NCT00488631|1443324|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
433221|NCT00488631|1443325|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
433222|NCT00488631|1443326|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
433223|NCT00488631|1443327|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
433224|NCT00488631|1443328|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
433225|NCT00488631|1443329|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
433226|NCT00488631|1443330|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
433227|NCT00488631|1443331|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
433228|NCT00488631|1443332|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
433229|NCT00488631|1443323|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433230|NCT00488631|1443324|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
433231|NCT00488631|1443325|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433232|NCT00488631|1443326|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
433233|NCT00488631|1443327|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433234|NCT00488631|1443328|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433235|NCT00488631|1443329|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433236|NCT00488631|1443330|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433237|NCT00488631|1443331|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433238|NCT00488631|1443332|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
433239|NCT00488631|1443323|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
433240|NCT00488631|1443324|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
433241|NCT00488631|1443325|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
433242|NCT00488631|1443326|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
433243|NCT00488631|1443327|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
433244|NCT00488631|1443328|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
433245|NCT00488631|1443329|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
433246|NCT00488631|1443330|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
433247|NCT00488631|1443331|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
433248|NCT00488631|1443332|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
433249|NCT00488631|1443323|P10|Open Label Study Extension (Week 54-228)|Death|0
433250|NCT00488631|1443324|P9|Open Label Study Extension (Week 54-228)|Death|1
433251|NCT00488631|1443325|P8|Open Label Study Extension (Week 54-228)|Death|0
433252|NCT00488631|1443326|P7|Open Label Study Extension (Week 54-228)|Death|0
433253|NCT00488631|1443327|P6|Open Label Study Extension (Week 54-228)|Death|0
433254|NCT00488631|1443328|P5|Open Label Study Extension (Week 54-228)|Death|0
433255|NCT00488631|1443329|P4|Open Label Study Extension (Week 54-228)|Death|0
433256|NCT00488631|1443330|P3|Open Label Study Extension (Week 54-228)|Death|0
433257|NCT00488631|1443331|P2|Open Label Study Extension (Week 54-228)|Death|0
433258|NCT00488631|1443332|P1|Open Label Study Extension (Week 54-228)|Death|0
433259|NCT00488631|1443323|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
433260|NCT00488631|1443324|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
433261|NCT00488631|1443325|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
433262|NCT00488631|1443326|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
433263|NCT00488631|1443327|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
433264|NCT00488631|1443328|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
433265|NCT00488631|1443329|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
433266|NCT00488631|1443330|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
433267|NCT00488631|1443331|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
433268|NCT00488631|1443332|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
433269|NCT00488631|1443323|P10|Double Blind Period (Week 0-54)|Other|0
433270|NCT00488631|1443324|P9|Double Blind Period (Week 0-54)|Other|0
433271|NCT00488631|1443325|P8|Double Blind Period (Week 0-54)|Other|0
433272|NCT00488631|1443326|P7|Double Blind Period (Week 0-54)|Other|0
433273|NCT00488631|1443327|P6|Double Blind Period (Week 0-54)|Other|34
433274|NCT00488631|1443328|P5|Double Blind Period (Week 0-54)|Other|14
433275|NCT00488631|1443329|P4|Double Blind Period (Week 0-54)|Other|11
433276|NCT00488631|1443330|P3|Double Blind Period (Week 0-54)|Other|10
433277|NCT00488631|1443331|P2|Double Blind Period (Week 0-54)|Other|12
433278|NCT00488631|1443332|P1|Double Blind Period (Week 0-54)|Other|6
433279|NCT00488631|1443323|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
433280|NCT00488631|1443324|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
433281|NCT00488631|1443325|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
433282|NCT00488631|1443326|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
433283|NCT00488631|1443327|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
433284|NCT00488631|1443328|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
433285|NCT00488631|1443329|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
433286|NCT00488631|1443330|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
433287|NCT00488631|1443331|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
433288|NCT00488631|1443332|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
433289|NCT00488631|1443323|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
433290|NCT00488631|1443324|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
433291|NCT00488631|1443325|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
433292|NCT00488631|1443326|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
433293|NCT00488631|1443327|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
433294|NCT00488631|1443328|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
433295|NCT00488631|1443329|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
433296|NCT00488631|1443330|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
433297|NCT00488631|1443331|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
433298|NCT00488631|1443332|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
433299|NCT00488631|1443323|P10|Double Blind Period (Week 0-54)|Death|0
433300|NCT00488631|1443324|P9|Double Blind Period (Week 0-54)|Death|0
433301|NCT00488631|1443325|P8|Double Blind Period (Week 0-54)|Death|0
433302|NCT00488631|1443326|P7|Double Blind Period (Week 0-54)|Death|0
433303|NCT00488631|1443327|P6|Double Blind Period (Week 0-54)|Death|1
433304|NCT00488631|1443328|P5|Double Blind Period (Week 0-54)|Death|0
433305|NCT00488631|1443329|P4|Double Blind Period (Week 0-54)|Death|0
433306|NCT00488631|1443330|P3|Double Blind Period (Week 0-54)|Death|0
433307|NCT00488631|1443331|P2|Double Blind Period (Week 0-54)|Death|0
433308|NCT00488631|1443332|P1|Double Blind Period (Week 0-54)|Death|0
433309|NCT00488631|1443323|P10|Double Blind Period (Week 0-54)|Adverse Event|0
433310|NCT00488631|1443324|P9|Double Blind Period (Week 0-54)|Adverse Event|0
433311|NCT00488631|1443325|P8|Double Blind Period (Week 0-54)|Adverse Event|0
433312|NCT00488631|1443326|P7|Double Blind Period (Week 0-54)|Adverse Event|0
433313|NCT00488631|1443327|P6|Double Blind Period (Week 0-54)|Adverse Event|50
433314|NCT00488631|1443328|P5|Double Blind Period (Week 0-54)|Adverse Event|30
433315|NCT00488631|1443329|P4|Double Blind Period (Week 0-54)|Adverse Event|12
433316|NCT00488631|1443330|P3|Double Blind Period (Week 0-54)|Adverse Event|12
433317|NCT00488631|1443331|P2|Double Blind Period (Week 0-54)|Adverse Event|12
433318|NCT00488631|1443332|P1|Double Blind Period (Week 0-54)|Adverse Event|17
433319|NCT00488618|1443369|P2|Overall Study|Lost to Follow-up|0
433320|NCT00488618|1443370|P1|Overall Study|Lost to Follow-up|1
433321|NCT00488618|1443369|P2|Overall Study|Withdrawal of Consent|13
433322|NCT00488618|1443370|P1|Overall Study|Withdrawal of Consent|15
433323|NCT00488618|1443369|P2|Overall Study|Protocol Violation|2
433324|NCT00488618|1443370|P1|Overall Study|Protocol Violation|0
433325|NCT00488618|1443369|P2|Overall Study|Insufficient Therapeutic Response|11
433326|NCT00488618|1443370|P1|Overall Study|Insufficient Therapeutic Response|18
433327|NCT00488618|1443369|P2|Overall Study|Adverse Event|17
433328|NCT00488618|1443370|P1|Overall Study|Adverse Event|13
433329|NCT00488592|1443378|P1|Overall Study|Enrolled but not treated|1
433330|NCT00488592|1443378|P1|Overall Study|Disease progression|1
433331|NCT00488592|1443378|P1|Overall Study|Withdrawal by Subject|1
433332|NCT00488514|1443382|P1|Overall Study|Increased use of concomitant medication|1
433333|NCT00488514|1443382|P1|Overall Study|Increase in number of migraines|2
433334|NCT00488514|1443382|P1|Overall Study|Participant had too few migraines|5
433335|NCT00488514|1443382|P1|Overall Study|Investigator decision|1
433336|NCT00488514|1443382|P1|Overall Study|Withdrawn per medical monitor decision|2
433337|NCT00488514|1443382|P1|Overall Study|Postive drug screen|1
433338|NCT00488514|1443382|P1|Overall Study|Did not meet criteria for treatment|30
433339|NCT00488514|1443382|P1|Overall Study|Lack of Efficacy|28
433340|NCT00488514|1443382|P1|Overall Study|Withdrawal by Subject|106
433341|NCT00488514|1443382|P1|Overall Study|Protocol Violation|32
433342|NCT00488514|1443382|P1|Overall Study|Lost to Follow-up|44
433343|NCT00488514|1443382|P1|Overall Study|Adverse Event|41
433344|NCT00488475|1443470|P1|Overall Study|Other|1754
433345|NCT00488345|1443499|P3|Overall Study|Parent/legal guardian request|1
433346|NCT00488345|1443500|P2|Overall Study|Parent/legal guardian request|1
433347|NCT00488345|1443501|P1|Overall Study|Parent/legal guardian request|0
433348|NCT00488345|1443499|P3|Overall Study|Surgical team recommendation|0
433349|NCT00488345|1443500|P2|Overall Study|Surgical team recommendation|1
433350|NCT00488345|1443501|P1|Overall Study|Surgical team recommendation|0
433351|NCT00488345|1443499|P3|Overall Study|Institutional Review Board review|1
433352|NCT00488345|1443500|P2|Overall Study|Institutional Review Board review|0
433353|NCT00488345|1443501|P1|Overall Study|Institutional Review Board review|0
433354|NCT00488345|1443499|P3|Overall Study|Unable to administer antibiotics at home|0
433355|NCT00488345|1443500|P2|Overall Study|Unable to administer antibiotics at home|1
433356|NCT00488345|1443501|P1|Overall Study|Unable to administer antibiotics at home|0
433357|NCT00488345|1443499|P3|Overall Study|Adverse Event|1
433358|NCT00488345|1443500|P2|Overall Study|Adverse Event|1
433359|NCT00488345|1443501|P1|Overall Study|Adverse Event|0
433360|NCT00488319|1443527|P3|Overall Study|Other reasons for withdrawal|12
433361|NCT00488319|1443528|P2|Overall Study|Other reasons for withdrawal|4
433362|NCT00488319|1443529|P1|Overall Study|Other reasons for withdrawal|0
433363|NCT00488319|1443527|P3|Overall Study|Withdrawal by Subject|44
433364|NCT00488319|1443528|P2|Overall Study|Withdrawal by Subject|20
433365|NCT00488319|1443529|P1|Overall Study|Withdrawal by Subject|5
433366|NCT00488319|1443527|P3|Overall Study|Lost to Follow-up|16
433367|NCT00488319|1443528|P2|Overall Study|Lost to Follow-up|5
433368|NCT00488319|1443529|P1|Overall Study|Lost to Follow-up|3
433369|NCT00488319|1443527|P3|Overall Study|Lack of Efficacy|27
433370|NCT00488319|1443528|P2|Overall Study|Lack of Efficacy|12
433371|NCT00488319|1443529|P1|Overall Study|Lack of Efficacy|6
433372|NCT00488319|1443527|P3|Overall Study|Adverse Event|23
433373|NCT00488319|1443528|P2|Overall Study|Adverse Event|2
433374|NCT00488319|1443529|P1|Overall Study|Adverse Event|1
433375|NCT00488293|1443616|P2|Overall Study|Misrandomization/Other Unspecified|1
433376|NCT00488293|1443617|P1|Overall Study|Misrandomization/Other Unspecified|1
433377|NCT00488293|1443616|P2|Overall Study|Death|1
433378|NCT00488293|1443617|P1|Overall Study|Death|2
433379|NCT00488293|1443616|P2|Overall Study|Withdrawal by Subject|3
433380|NCT00488293|1443617|P1|Overall Study|Withdrawal by Subject|5
433381|NCT00488293|1443616|P2|Overall Study|Lost to Follow-up|25
433382|NCT00488293|1443617|P1|Overall Study|Lost to Follow-up|28
433383|NCT00488033|1443662|P2|Overall Study|Withdrawal by Subject|0
433384|NCT00488033|1443663|P1|Overall Study|Withdrawal by Subject|1
433385|NCT00487981|1443679|P1|Overall Study|Hypothyroidism diagnosis|1
433386|NCT00487942|1443687|P4|Overall Study|Withdrawal by Subject|0
433387|NCT00487942|1443688|P3|Overall Study|Withdrawal by Subject|2
433388|NCT00487942|1443689|P2|Overall Study|Withdrawal by Subject|1
433389|NCT00487942|1443690|P1|Overall Study|Withdrawal by Subject|0
433390|NCT00487942|1443687|P4|Overall Study|Protocol Violation|0
433391|NCT00487942|1443688|P3|Overall Study|Protocol Violation|0
433392|NCT00487942|1443689|P2|Overall Study|Protocol Violation|1
433393|NCT00487942|1443690|P1|Overall Study|Protocol Violation|1
433394|NCT00487942|1443687|P4|Overall Study|Lost to Follow-up|1
433395|NCT00487942|1443688|P3|Overall Study|Lost to Follow-up|0
433396|NCT00487942|1443689|P2|Overall Study|Lost to Follow-up|0
433397|NCT00487942|1443690|P1|Overall Study|Lost to Follow-up|1
433398|NCT00487942|1443687|P4|Overall Study|Adverse Event|1
433399|NCT00487942|1443688|P3|Overall Study|Adverse Event|1
433400|NCT00487942|1443689|P2|Overall Study|Adverse Event|1
433401|NCT00487942|1443690|P1|Overall Study|Adverse Event|1
433402|NCT00487825|1444074|P2|Overall Study|not specified|2
433403|NCT00487825|1444075|P1|Overall Study|not specified|3
433404|NCT00487825|1444074|P2|Overall Study|Lack of Efficacy|1
433405|NCT00487825|1444075|P1|Overall Study|Lack of Efficacy|1
433406|NCT00487825|1444074|P2|Overall Study|Adverse Event|2
433407|NCT00487825|1444075|P1|Overall Study|Adverse Event|2
433408|NCT00487747|1444087|P1|Overall Study|Lack of Efficacy|1
433409|NCT00487747|1444087|P1|Overall Study|Lost to Follow-up|9
433410|NCT00487747|1444087|P1|Overall Study|Adverse Event|1
433411|NCT00487695|1444104|P2|Second Procedure|Withdrawal by Subject|2
433412|NCT00487695|1444105|P1|Second Procedure|Withdrawal by Subject|1
433413|NCT00487695|1444104|P2|Second Procedure|active wheezing|1
433414|NCT00487695|1444105|P1|Second Procedure|active wheezing|0
433415|NCT00487695|1444104|P2|First Procedure|esophageal stricture found (excl crit)|0
433416|NCT00487695|1444105|P1|First Procedure|esophageal stricture found (excl crit)|1
433417|NCT00487695|1444104|P2|First Procedure|active wheezing (did not have procedure)|0
433418|NCT00487695|1444105|P1|First Procedure|active wheezing (did not have procedure)|1
433419|NCT00487695|1444104|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
433420|NCT00487695|1444105|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
433421|NCT00487578|1444133|P2|Overall Study|Lost to Follow-up|1
433422|NCT00487578|1444134|P1|Overall Study|Lost to Follow-up|0
433423|NCT00487578|1444133|P2|Overall Study|Lack of Efficacy|1
433424|NCT00487578|1444134|P1|Overall Study|Lack of Efficacy|0
433425|NCT00487578|1444133|P2|Overall Study|Adverse Event|2
433426|NCT00487578|1444134|P1|Overall Study|Adverse Event|1
433427|NCT00487552|1444154|P1|Overall Study|Stent not placed|1
433428|NCT00487552|1444154|P1|Overall Study|Death due to progressive malignancy|2
433429|NCT00487552|1444154|P1|Overall Study|Unsuccessful magnet placements|3
433430|NCT00487539|1444163|P4|Overall Study|Other|2
433431|NCT00487539|1444164|P3|Overall Study|Other|2
433432|NCT00487539|1444165|P2|Overall Study|Other|1
433433|NCT00487539|1444166|P1|Overall Study|Other|3
433434|NCT00487539|1444163|P4|Overall Study|Unsatisfactory therapeutic effect|1
433435|NCT00487539|1444164|P3|Overall Study|Unsatisfactory therapeutic effect|0
433436|NCT00487539|1444165|P2|Overall Study|Unsatisfactory therapeutic effect|0
433437|NCT00487539|1444166|P1|Overall Study|Unsatisfactory therapeutic effect|1
433438|NCT00487539|1444163|P4|Overall Study|Adverse Event|1
433439|NCT00487539|1444164|P3|Overall Study|Adverse Event|1
433440|NCT00487539|1444165|P2|Overall Study|Adverse Event|2
433441|NCT00487539|1444166|P1|Overall Study|Adverse Event|3
433442|NCT00487435|1444200|P1|Overall Study|Other|83
433443|NCT00487435|1444200|P1|Overall Study|Study Medication Non-Compliant|32
433444|NCT00487435|1444200|P1|Overall Study|Resolution Of Pain|1
433445|NCT00487435|1444200|P1|Overall Study|Withdrawal by Subject|132
433446|NCT00487435|1444200|P1|Overall Study|Pregnancy|2
433447|NCT00487435|1444200|P1|Overall Study|Lost to Follow-up|54
433448|NCT00487435|1444200|P1|Overall Study|Lack of Efficacy|33
433449|NCT00487435|1444200|P1|Overall Study|Death|2
433450|NCT00487435|1444200|P1|Overall Study|Adverse Event|146
433451|NCT00487279|1444213|P2|Overall Study|Withdrawal by Subject|2
433452|NCT00487279|1444214|P1|Overall Study|Withdrawal by Subject|0
433453|NCT00487279|1444213|P2|Overall Study|Death|0
433454|NCT00487279|1444214|P1|Overall Study|Death|1
433455|NCT00487240|1444224|P2|Overall Study|Physician Decision|0
433456|NCT00487240|1444225|P1|Overall Study|Physician Decision|2
433457|NCT00487240|1444224|P2|Overall Study|Sponsor Decision|1
433458|NCT00487240|1444225|P1|Overall Study|Sponsor Decision|2
433459|NCT00487240|1444224|P2|Overall Study|Entry Criteria Not Met|4
433460|NCT00487240|1444225|P1|Overall Study|Entry Criteria Not Met|3
433461|NCT00487240|1444224|P2|Overall Study|Protocol Violation|5
433462|NCT00487240|1444225|P1|Overall Study|Protocol Violation|5
433463|NCT00487240|1444224|P2|Overall Study|Adverse Event|4
433464|NCT00487240|1444225|P1|Overall Study|Adverse Event|0
433465|NCT00487240|1444224|P2|Overall Study|Lost to Follow-up|6
433466|NCT00487240|1444225|P1|Overall Study|Lost to Follow-up|7
433467|NCT00487240|1444224|P2|Overall Study|Withdrawal by Subject|6
433468|NCT00487240|1444225|P1|Overall Study|Withdrawal by Subject|12
433469|NCT00487188|1444253|P3|Maintenance Phase|Administrative|1
433470|NCT00487188|1444254|P2|Maintenance Phase|Administrative|0
433471|NCT00487188|1444255|P1|Maintenance Phase|Administrative|0
433472|NCT00487188|1444253|P3|Maintenance Phase|Lost to Follow-up|0
433473|NCT00487188|1444254|P2|Maintenance Phase|Lost to Follow-up|0
433474|NCT00487188|1444255|P1|Maintenance Phase|Lost to Follow-up|1
433475|NCT00487188|1444253|P3|Maintenance Phase|Death|0
433476|NCT00487188|1444254|P2|Maintenance Phase|Death|0
433477|NCT00487188|1444255|P1|Maintenance Phase|Death|1
433478|NCT00487188|1444253|P3|Maintenance Phase|Adverse Event|0
433479|NCT00487188|1444254|P2|Maintenance Phase|Adverse Event|0
433480|NCT00487188|1444255|P1|Maintenance Phase|Adverse Event|1
433481|NCT00487188|1444253|P3|Induction Phase|Administrative|0
433482|NCT00487188|1444254|P2|Induction Phase|Administrative|1
433483|NCT00487188|1444255|P1|Induction Phase|Administrative|0
433484|NCT00487188|1444253|P3|Induction Phase|Lost to Follow-up|0
433485|NCT00487188|1444254|P2|Induction Phase|Lost to Follow-up|2
433486|NCT00487188|1444255|P1|Induction Phase|Lost to Follow-up|2
433487|NCT00487188|1444253|P3|Induction Phase|Refused Treatment|0
433488|NCT00487188|1444254|P2|Induction Phase|Refused Treatment|2
433489|NCT00487188|1444255|P1|Induction Phase|Refused Treatment|1
433490|NCT00487188|1444253|P3|Induction Phase|Protocol Violation|0
433491|NCT00487188|1444254|P2|Induction Phase|Protocol Violation|0
433492|NCT00487188|1444255|P1|Induction Phase|Protocol Violation|1
433493|NCT00487188|1444253|P3|Induction Phase|Lack of Efficacy|0
433494|NCT00487188|1444254|P2|Induction Phase|Lack of Efficacy|1
433495|NCT00487188|1444255|P1|Induction Phase|Lack of Efficacy|0
433496|NCT00487188|1444253|P3|Induction Phase|Adverse Event|0
433497|NCT00487188|1444254|P2|Induction Phase|Adverse Event|0
433498|NCT00487188|1444255|P1|Induction Phase|Adverse Event|5
433499|NCT00487188|1444253|P3|Induction Phase|Abnormality of Laboratory Test|0
433500|NCT00487188|1444254|P2|Induction Phase|Abnormality of Laboratory Test|1
433501|NCT00487188|1444255|P1|Induction Phase|Abnormality of Laboratory Test|0
433502|NCT00487162|1444294|P2|Overall Study|Withdrawal by Subject|3
433503|NCT00487162|1444295|P1|Overall Study|Withdrawal by Subject|2
433504|NCT00487162|1444294|P2|Overall Study|Physician Decision|1
433505|NCT00487162|1444295|P1|Overall Study|Physician Decision|0
433506|NCT00487162|1444294|P2|Overall Study|Adverse Event|1
433507|NCT00487162|1444295|P1|Overall Study|Adverse Event|0
433508|NCT00487084|1444306|P3|Overall Study|Did not receive intervention|5
433509|NCT00487084|1444307|P2|Overall Study|Did not receive intervention|3
433510|NCT00487084|1444308|P1|Overall Study|Did not receive intervention|4
433511|NCT00486954|1444329|P5|Randomized Part|Sponsor Terminated Study|13
433512|NCT00486954|1444330|P4|Randomized Part|Sponsor Terminated Study|19
433513|NCT00486954|1444331|P3|Randomized Part|Sponsor Terminated Study|0
433514|NCT00486954|1444332|P2|Randomized Part|Sponsor Terminated Study|0
433515|NCT00486954|1444333|P1|Randomized Part|Sponsor Terminated Study|0
433516|NCT00486954|1444329|P5|Randomized Part|Withdrawal by Subject|0
433517|NCT00486954|1444330|P4|Randomized Part|Withdrawal by Subject|1
433518|NCT00486954|1444331|P3|Randomized Part|Withdrawal by Subject|0
433519|NCT00486954|1444332|P2|Randomized Part|Withdrawal by Subject|0
433520|NCT00486954|1444333|P1|Randomized Part|Withdrawal by Subject|0
433521|NCT00486954|1444329|P5|Randomized Part|Lost to Follow-up|1
433522|NCT00486954|1444330|P4|Randomized Part|Lost to Follow-up|0
433523|NCT00486954|1444331|P3|Randomized Part|Lost to Follow-up|0
433524|NCT00486954|1444332|P2|Randomized Part|Lost to Follow-up|0
433525|NCT00486954|1444333|P1|Randomized Part|Lost to Follow-up|0
433526|NCT00486954|1444329|P5|Pilot Part|Disease Progression|0
433527|NCT00486954|1444330|P4|Pilot Part|Disease Progression|0
433528|NCT00486954|1444331|P3|Pilot Part|Disease Progression|1
433529|NCT00486954|1444332|P2|Pilot Part|Disease Progression|0
433530|NCT00486954|1444333|P1|Pilot Part|Disease Progression|2
433531|NCT00486954|1444329|P5|Pilot Part|Adverse Event|0
433532|NCT00486954|1444330|P4|Pilot Part|Adverse Event|0
433533|NCT00486954|1444331|P3|Pilot Part|Adverse Event|5
433534|NCT00486954|1444332|P2|Pilot Part|Adverse Event|0
433535|NCT00486954|1444333|P1|Pilot Part|Adverse Event|4
433536|NCT00486902|1444431|P2|Overall Study|No toradol due to hemmorhage or allergy|1
433537|NCT00486902|1444432|P1|Overall Study|No toradol due to hemmorhage or allergy|3
433538|NCT00486902|1444431|P2|Overall Study|Did not meet inclusion criteria|0
433539|NCT00486902|1444432|P1|Overall Study|Did not meet inclusion criteria|1
433540|NCT00486902|1444431|P2|Overall Study|spinal anesthetic protocal violation|1
433541|NCT00486902|1444432|P1|Overall Study|spinal anesthetic protocal violation|1
433542|NCT00486902|1444431|P2|Overall Study|decision for postpartum tubal ligation|1
433543|NCT00486902|1444432|P1|Overall Study|decision for postpartum tubal ligation|3
433544|NCT00486902|1444431|P2|Overall Study|Withdrawal by Subject|2
433545|NCT00486902|1444432|P1|Overall Study|Withdrawal by Subject|1
433546|NCT00486837|1444499|P2|Overall Study|No sputum, devise issues, exacerbation|4
433547|NCT00486837|1444500|P1|Overall Study|No sputum, devise issues, exacerbation|3
433548|NCT00486837|1444499|P2|Overall Study|Protocol Violation|2
433549|NCT00486837|1444500|P1|Overall Study|Protocol Violation|4
433550|NCT00486837|1444499|P2|Overall Study|Adverse Event|1
433551|NCT00486837|1444500|P1|Overall Study|Adverse Event|1
433552|NCT00486837|1444499|P2|Overall Study|Withdrawal by Subject|0
433553|NCT00486837|1444500|P1|Overall Study|Withdrawal by Subject|1
433554|NCT00486811|1444519|P3|Overall Study|All other|7
433555|NCT00486811|1444520|P2|Overall Study|All other|11
433556|NCT00486811|1444521|P1|Overall Study|All other|18
433557|NCT00486811|1444519|P3|Overall Study|Study drug non-compliant|3
433558|NCT00486811|1444520|P2|Overall Study|Study drug non-compliant|6
433559|NCT00486811|1444521|P1|Overall Study|Study drug non-compliant|5
433560|NCT00486811|1444519|P3|Overall Study|Withdrawal by Subject|58
433561|NCT00486811|1444520|P2|Overall Study|Withdrawal by Subject|44
433562|NCT00486811|1444521|P1|Overall Study|Withdrawal by Subject|33
433563|NCT00486811|1444519|P3|Overall Study|Lost to Follow-up|4
433564|NCT00486811|1444520|P2|Overall Study|Lost to Follow-up|6
433565|NCT00486811|1444521|P1|Overall Study|Lost to Follow-up|4
433566|NCT00486811|1444519|P3|Overall Study|Lack of Efficacy|7
433567|NCT00486811|1444520|P2|Overall Study|Lack of Efficacy|14
433568|NCT00486811|1444521|P1|Overall Study|Lack of Efficacy|34
433569|NCT00486811|1444519|P3|Overall Study|Adverse Event|135
433570|NCT00486811|1444520|P2|Overall Study|Adverse Event|60
433571|NCT00486811|1444521|P1|Overall Study|Adverse Event|28
433572|NCT00486759|1444564|P2|Safety Follow-up|Adverse event/intercurrent illness|0
433573|NCT00486759|1444565|P1|Safety Follow-up|Adverse event/intercurrent illness|4
433574|NCT00486759|1444564|P2|Safety Follow-up|Refused treatment/did not cooperate|4
433575|NCT00486759|1444565|P1|Safety Follow-up|Refused treatment/did not cooperate|6
433576|NCT00486759|1444564|P2|Safety Follow-up|Administrative/not specified|6
433577|NCT00486759|1444565|P1|Safety Follow-up|Administrative/not specified|8
433578|NCT00486759|1444564|P2|Safety Follow-up|Failure to return|6
433579|NCT00486759|1444565|P1|Safety Follow-up|Failure to return|9
433580|NCT00486759|1444564|P2|Safety Follow-up|Withdrew consent|23
433581|NCT00486759|1444565|P1|Safety Follow-up|Withdrew consent|32
433582|NCT00486759|1444564|P2|Safety Follow-up|Death|29
433583|NCT00486759|1444565|P1|Safety Follow-up|Death|40
433584|NCT00486759|1444564|P2|Safety Follow-up|Insufficient therapeutic response|50
433585|NCT00486759|1444565|P1|Safety Follow-up|Insufficient therapeutic response|40
433586|NCT00486759|1444564|P2|Treatment|Failure to return|1
433587|NCT00486759|1444565|P1|Treatment|Failure to return|1
433588|NCT00486759|1444564|P2|Treatment|Other protocol violation|5
433589|NCT00486759|1444565|P1|Treatment|Other protocol violation|1
433590|NCT00486759|1444564|P2|Treatment|Violation of selection criteria at entry|3
433591|NCT00486759|1444565|P1|Treatment|Violation of selection criteria at entry|3
433592|NCT00486759|1444564|P2|Treatment|Refused treatment|7
433593|NCT00486759|1444565|P1|Treatment|Refused treatment|10
433594|NCT00486759|1444564|P2|Treatment|Administrative/reason not specified|21
433595|NCT00486759|1444565|P1|Treatment|Administrative/reason not specified|17
433596|NCT00486759|1444564|P2|Treatment|Withdrew consent|12
433597|NCT00486759|1444565|P1|Treatment|Withdrew consent|15
433598|NCT00486759|1444564|P2|Treatment|Death|10
433599|NCT00486759|1444565|P1|Treatment|Death|17
433600|NCT00486759|1444564|P2|Treatment|Insufficient therapeutic response|39
433601|NCT00486759|1444565|P1|Treatment|Insufficient therapeutic response|37
433602|NCT00486759|1444564|P2|Treatment|Adverse event/intercurrent illness|39
433603|NCT00486759|1444565|P1|Treatment|Adverse event/intercurrent illness|86
433604|NCT00486720|1444577|P2|Overall Study|Progressive Disease|1
433605|NCT00486720|1444578|P1|Overall Study|Progressive Disease|0
433606|NCT00486720|1444577|P2|Overall Study|Withdrawal by Subject|1
433607|NCT00486720|1444578|P1|Overall Study|Withdrawal by Subject|3
433608|NCT00486720|1444577|P2|Overall Study|Protocol Violation|0
433609|NCT00486720|1444578|P1|Overall Study|Protocol Violation|1
433610|NCT00486720|1444577|P2|Overall Study|Physician Decision|2
433611|NCT00486720|1444578|P1|Overall Study|Physician Decision|1
433612|NCT00486720|1444577|P2|Overall Study|Lack of Efficacy|6
433613|NCT00486720|1444578|P1|Overall Study|Lack of Efficacy|4
433614|NCT00486720|1444577|P2|Overall Study|Adverse Event|2
433615|NCT00486720|1444578|P1|Overall Study|Adverse Event|1
433616|NCT00486434|1444637|P2|Overall Study|Personal reasons|6
433617|NCT00486434|1444638|P1|Overall Study|Personal reasons|5
433618|NCT00486434|1444637|P2|Overall Study|Death|2
433619|NCT00486434|1444638|P1|Overall Study|Death|1
433620|NCT00486434|1444637|P2|Overall Study|Lost to Follow-up|3
433621|NCT00486434|1444638|P1|Overall Study|Lost to Follow-up|2
433622|NCT00486434|1444637|P2|Overall Study|Lack of Efficacy|19
433623|NCT00486434|1444638|P1|Overall Study|Lack of Efficacy|12
433624|NCT00486434|1444637|P2|Overall Study|Protocol Violation|21
433625|NCT00486434|1444638|P1|Overall Study|Protocol Violation|22
433626|NCT00486434|1444637|P2|Overall Study|Adverse Event|44
433627|NCT00486434|1444638|P1|Overall Study|Adverse Event|118
433628|NCT00486434|1444637|P2|Overall Study|Withdrawal by Subject|39
433629|NCT00486434|1444638|P1|Overall Study|Withdrawal by Subject|34
433630|NCT00486330|1444648|P1|Overall Study|Adverse Event|2
433631|NCT00486291|1444654|P2|Overall Study|requirement for restricted medication|3
433632|NCT00486291|1444655|P1|Overall Study|requirement for restricted medication|0
433633|NCT00486291|1444654|P2|Overall Study|protocol non-compliance|15
433634|NCT00486291|1444655|P1|Overall Study|protocol non-compliance|10
433635|NCT00486291|1444654|P2|Overall Study|Lost to Follow-up|7
433636|NCT00486291|1444655|P1|Overall Study|Lost to Follow-up|3
433637|NCT00486291|1444654|P2|Overall Study|Adverse Event|4
433638|NCT00486291|1444655|P1|Overall Study|Adverse Event|3
433639|NCT00486278|1444663|P1|Overall Study|Physician Decision|2
433640|NCT00486278|1444663|P1|Overall Study|Withdrawal by Subject|2
433641|NCT00486278|1444663|P1|Overall Study|Adverse Event|5
433642|NCT00486265|1444797|P1|Overall Study|Lack of Efficacy|8
433643|NCT00486265|1444797|P1|Overall Study|Adverse Event|1
433644|NCT00486252|1444801|P1|Overall Study|Other|18
433645|NCT00486252|1444801|P1|Overall Study|Lost to Follow-up|24
433646|NCT00486252|1444801|P1|Overall Study|Lack of Efficacy|9
433647|NCT00486252|1444801|P1|Overall Study|Adverse Event|7
433648|NCT00486226|1444816|P1|Overall Study|Lost to Follow-up|8
433649|NCT00486226|1444816|P1|Overall Study|Withdrawal by Subject|1
433650|NCT00486226|1444816|P1|Overall Study|Adverse Event|1
433651|NCT00486226|1444816|P1|Overall Study|Death|3
433652|NCT00486044|1444826|P2|Overall Study|Lost to Follow-up|1
433653|NCT00486044|1444827|P1|Overall Study|Lost to Follow-up|0
433654|NCT00486044|1444826|P2|Overall Study|Adverse Event|1
433655|NCT00486044|1444827|P1|Overall Study|Adverse Event|0
433656|NCT00486044|1444826|P2|Overall Study|Withdrawal by Subject|1
433657|NCT00486044|1444827|P1|Overall Study|Withdrawal by Subject|2
433658|NCT00485758|1444920|P2|Overall Study|Study Terminated by Sponsor|0
433659|NCT00485758|1444921|P1|Overall Study|Study Terminated by Sponsor|3
433660|NCT00485758|1444920|P2|Overall Study|Withdrawal by Subject|27
433661|NCT00485758|1444921|P1|Overall Study|Withdrawal by Subject|32
433662|NCT00485758|1444920|P2|Overall Study|Protocol Violation|2
433663|NCT00485758|1444921|P1|Overall Study|Protocol Violation|11
433664|NCT00485758|1444920|P2|Overall Study|Physician Decision|3
433665|NCT00485758|1444921|P1|Overall Study|Physician Decision|3
433666|NCT00485758|1444920|P2|Overall Study|Lost to Follow-up|1
433667|NCT00485758|1444921|P1|Overall Study|Lost to Follow-up|5
433668|NCT00485758|1444920|P2|Overall Study|Death|1
433669|NCT00485758|1444921|P1|Overall Study|Death|0
433670|NCT00485758|1444920|P2|Overall Study|Adverse Event|31
433671|NCT00485758|1444921|P1|Overall Study|Adverse Event|102
433672|NCT00485732|1444933|P2|Overall Study|Lost to Follow-up|2
433673|NCT00485732|1444934|P1|Overall Study|Lost to Follow-up|2
433674|NCT00485732|1444933|P2|Overall Study|Withdrawal by Subject|4
433675|NCT00485732|1444934|P1|Overall Study|Withdrawal by Subject|5
433676|NCT00485732|1444933|P2|Overall Study|Protocol Violation|3
433677|NCT00485732|1444934|P1|Overall Study|Protocol Violation|1
433678|NCT00485472|1444972|P2|Overall Study|Lost to Follow-up|1
433679|NCT00485472|1444973|P1|Overall Study|Lost to Follow-up|0
433680|NCT00485472|1444972|P2|Overall Study|Other|1
433681|NCT00485472|1444973|P1|Overall Study|Other|2
433682|NCT00485472|1444972|P2|Overall Study|Protocol Violation|1
433683|NCT00485472|1444973|P1|Overall Study|Protocol Violation|0
433684|NCT00485472|1444972|P2|Overall Study|Withdrawal by Subject|0
433685|NCT00485472|1444973|P1|Overall Study|Withdrawal by Subject|1
433686|NCT00485472|1444972|P2|Overall Study|Lack of Efficacy|4
433687|NCT00485472|1444973|P1|Overall Study|Lack of Efficacy|5
433688|NCT00485472|1444972|P2|Overall Study|Adverse Event|5
433689|NCT00485472|1444973|P1|Overall Study|Adverse Event|8
433690|NCT00485303|1445010|P1|Overall Study|Treatment ongoing at cutoff date|2
433691|NCT00485303|1445010|P1|Overall Study|Initiation of new anti-cancer treatment|2
433692|NCT00485303|1445010|P1|Overall Study|Other|3
433693|NCT00485303|1445010|P1|Overall Study|Progressive Disease|44
433694|NCT00485303|1445010|P1|Overall Study|Adverse Event|5
433695|NCT00485264|1445028|P6|Overall Study|Other Reason|0
433696|NCT00485264|1445029|P5|Overall Study|Other Reason|0
433697|NCT00485264|1445030|P4|Overall Study|Other Reason|0
433698|NCT00485264|1445031|P3|Overall Study|Other Reason|0
433699|NCT00485264|1445032|P2|Overall Study|Other Reason|0
433700|NCT00485264|1445033|P1|Overall Study|Other Reason|3
433701|NCT00485264|1445028|P6|Overall Study|Lost to Follow-up|1
433702|NCT00485264|1445029|P5|Overall Study|Lost to Follow-up|0
433703|NCT00485264|1445030|P4|Overall Study|Lost to Follow-up|0
433704|NCT00485264|1445031|P3|Overall Study|Lost to Follow-up|1
433705|NCT00485264|1445032|P2|Overall Study|Lost to Follow-up|1
433706|NCT00485264|1445033|P1|Overall Study|Lost to Follow-up|2
433707|NCT00485264|1445028|P6|Overall Study|Non-Compliant|0
433708|NCT00485264|1445029|P5|Overall Study|Non-Compliant|1
433709|NCT00485264|1445030|P4|Overall Study|Non-Compliant|0
433710|NCT00485264|1445031|P3|Overall Study|Non-Compliant|1
433711|NCT00485264|1445032|P2|Overall Study|Non-Compliant|2
433712|NCT00485264|1445033|P1|Overall Study|Non-Compliant|17
433713|NCT00485264|1445028|P6|Overall Study|Not Able to Attend Clinic|2
433714|NCT00485264|1445029|P5|Overall Study|Not Able to Attend Clinic|1
433715|NCT00485264|1445030|P4|Overall Study|Not Able to Attend Clinic|1
433716|NCT00485264|1445031|P3|Overall Study|Not Able to Attend Clinic|0
433717|NCT00485264|1445032|P2|Overall Study|Not Able to Attend Clinic|0
433718|NCT00485264|1445033|P1|Overall Study|Not Able to Attend Clinic|5
433719|NCT00485264|1445028|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
433720|NCT00485264|1445029|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
433721|NCT00485264|1445030|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
433722|NCT00485264|1445031|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
433723|NCT00485264|1445032|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
433724|NCT00485264|1445033|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
433725|NCT00485264|1445028|P6|Overall Study|Physician Decision|0
433726|NCT00485264|1445029|P5|Overall Study|Physician Decision|0
433727|NCT00485264|1445030|P4|Overall Study|Physician Decision|0
433728|NCT00485264|1445031|P3|Overall Study|Physician Decision|0
433729|NCT00485264|1445032|P2|Overall Study|Physician Decision|2
433730|NCT00485264|1445033|P1|Overall Study|Physician Decision|0
433731|NCT00485264|1445028|P6|Overall Study|Guardian Consent Withdrawn|0
433732|NCT00485264|1445029|P5|Overall Study|Guardian Consent Withdrawn|1
433733|NCT00485264|1445030|P4|Overall Study|Guardian Consent Withdrawn|0
433734|NCT00485264|1445031|P3|Overall Study|Guardian Consent Withdrawn|0
433735|NCT00485264|1445032|P2|Overall Study|Guardian Consent Withdrawn|0
433736|NCT00485264|1445033|P1|Overall Study|Guardian Consent Withdrawn|1
433737|NCT00485264|1445028|P6|Overall Study|Lack of Efficacy|0
433738|NCT00485264|1445029|P5|Overall Study|Lack of Efficacy|0
433739|NCT00485264|1445030|P4|Overall Study|Lack of Efficacy|0
433740|NCT00485264|1445031|P3|Overall Study|Lack of Efficacy|0
433741|NCT00485264|1445032|P2|Overall Study|Lack of Efficacy|1
433742|NCT00485264|1445033|P1|Overall Study|Lack of Efficacy|0
433743|NCT00485264|1445028|P6|Overall Study|Number/Volume/Timing of Study Meds|0
433744|NCT00485264|1445029|P5|Overall Study|Number/Volume/Timing of Study Meds|0
433745|NCT00485264|1445030|P4|Overall Study|Number/Volume/Timing of Study Meds|0
433746|NCT00485264|1445031|P3|Overall Study|Number/Volume/Timing of Study Meds|1
433747|NCT00485264|1445032|P2|Overall Study|Number/Volume/Timing of Study Meds|1
433748|NCT00485264|1445033|P1|Overall Study|Number/Volume/Timing of Study Meds|2
433749|NCT00485264|1445028|P6|Overall Study|Disallowed Medication|1
433750|NCT00485264|1445029|P5|Overall Study|Disallowed Medication|0
433751|NCT00485264|1445030|P4|Overall Study|Disallowed Medication|0
433752|NCT00485264|1445031|P3|Overall Study|Disallowed Medication|0
433753|NCT00485264|1445032|P2|Overall Study|Disallowed Medication|0
433754|NCT00485264|1445033|P1|Overall Study|Disallowed Medication|0
433755|NCT00485264|1445028|P6|Overall Study|Pregnancy|0
433756|NCT00485264|1445029|P5|Overall Study|Pregnancy|0
433757|NCT00485264|1445030|P4|Overall Study|Pregnancy|0
433758|NCT00485264|1445031|P3|Overall Study|Pregnancy|0
433759|NCT00485264|1445032|P2|Overall Study|Pregnancy|0
433760|NCT00485264|1445033|P1|Overall Study|Pregnancy|4
433761|NCT00485264|1445028|P6|Overall Study|Adverse Event|3
433762|NCT00485264|1445029|P5|Overall Study|Adverse Event|1
433763|NCT00485264|1445030|P4|Overall Study|Adverse Event|3
433764|NCT00485264|1445031|P3|Overall Study|Adverse Event|2
433765|NCT00485264|1445032|P2|Overall Study|Adverse Event|0
433766|NCT00485264|1445033|P1|Overall Study|Adverse Event|1
433767|NCT00485264|1445028|P6|Overall Study|Death|0
433768|NCT00485264|1445029|P5|Overall Study|Death|1
433769|NCT00485264|1445030|P4|Overall Study|Death|0
433770|NCT00485264|1445031|P3|Overall Study|Death|0
433771|NCT00485264|1445032|P2|Overall Study|Death|0
433772|NCT00485264|1445033|P1|Overall Study|Death|1
433773|NCT00485264|1445028|P6|Overall Study|Enrolled But Not Given Treatment|0
433774|NCT00485264|1445029|P5|Overall Study|Enrolled But Not Given Treatment|1
433775|NCT00485264|1445030|P4|Overall Study|Enrolled But Not Given Treatment|0
433776|NCT00485264|1445031|P3|Overall Study|Enrolled But Not Given Treatment|0
433777|NCT00485264|1445032|P2|Overall Study|Enrolled But Not Given Treatment|0
433778|NCT00485264|1445033|P1|Overall Study|Enrolled But Not Given Treatment|0
433779|NCT00485173|1445121|P2|Overall Study|Lost to Follow-up|61
433780|NCT00485173|1445122|P1|Overall Study|Lost to Follow-up|32
433781|NCT00485173|1445121|P2|Overall Study|Death|3
433782|NCT00485173|1445122|P1|Overall Study|Death|4
433783|NCT00485134|1445170|P8|Overall Study|Pregnancy|0
433784|NCT00485134|1445171|P7|Overall Study|Pregnancy|1
433785|NCT00485134|1445172|P6|Overall Study|Pregnancy|0
433786|NCT00485134|1445173|P5|Overall Study|Pregnancy|0
433787|NCT00485134|1445174|P4|Overall Study|Pregnancy|0
433788|NCT00485134|1445175|P3|Overall Study|Pregnancy|0
433789|NCT00485134|1445176|P2|Overall Study|Pregnancy|0
433790|NCT00485134|1445177|P1|Overall Study|Pregnancy|0
433791|NCT00485134|1445170|P8|Overall Study|Unable to comply with study schedule|1
433792|NCT00485134|1445171|P7|Overall Study|Unable to comply with study schedule|0
433793|NCT00485134|1445172|P6|Overall Study|Unable to comply with study schedule|0
433794|NCT00485134|1445173|P5|Overall Study|Unable to comply with study schedule|0
433795|NCT00485134|1445174|P4|Overall Study|Unable to comply with study schedule|0
433796|NCT00485134|1445175|P3|Overall Study|Unable to comply with study schedule|0
433797|NCT00485134|1445176|P2|Overall Study|Unable to comply with study schedule|0
433798|NCT00485134|1445177|P1|Overall Study|Unable to comply with study schedule|0
433799|NCT00485134|1445170|P8|Overall Study|Non-compliance|0
433800|NCT00485134|1445171|P7|Overall Study|Non-compliance|2
433801|NCT00485134|1445172|P6|Overall Study|Non-compliance|2
433802|NCT00485134|1445173|P5|Overall Study|Non-compliance|1
433803|NCT00485134|1445174|P4|Overall Study|Non-compliance|0
433804|NCT00485134|1445175|P3|Overall Study|Non-compliance|0
433805|NCT00485134|1445176|P2|Overall Study|Non-compliance|0
433806|NCT00485134|1445177|P1|Overall Study|Non-compliance|0
433807|NCT00485134|1445170|P8|Overall Study|Positive drug test|0
433808|NCT00485134|1445171|P7|Overall Study|Positive drug test|0
433809|NCT00485134|1445172|P6|Overall Study|Positive drug test|1
433810|NCT00485134|1445173|P5|Overall Study|Positive drug test|2
433811|NCT00485134|1445174|P4|Overall Study|Positive drug test|0
433812|NCT00485134|1445175|P3|Overall Study|Positive drug test|0
433813|NCT00485134|1445176|P2|Overall Study|Positive drug test|0
433814|NCT00485134|1445177|P1|Overall Study|Positive drug test|0
433815|NCT00485134|1445170|P8|Overall Study|Withdrew for adverse event|0
433816|NCT00485134|1445171|P7|Overall Study|Withdrew for adverse event|0
433817|NCT00485134|1445172|P6|Overall Study|Withdrew for adverse event|0
433818|NCT00485134|1445173|P5|Overall Study|Withdrew for adverse event|0
433819|NCT00485134|1445174|P4|Overall Study|Withdrew for adverse event|0
433820|NCT00485134|1445175|P3|Overall Study|Withdrew for adverse event|1
433821|NCT00485134|1445176|P2|Overall Study|Withdrew for adverse event|0
433822|NCT00485134|1445177|P1|Overall Study|Withdrew for adverse event|0
433823|NCT00485134|1445170|P8|Overall Study|Change in health status|0
433824|NCT00485134|1445171|P7|Overall Study|Change in health status|0
433825|NCT00485134|1445172|P6|Overall Study|Change in health status|1
433826|NCT00485134|1445173|P5|Overall Study|Change in health status|0
433827|NCT00485134|1445174|P4|Overall Study|Change in health status|1
433828|NCT00485134|1445175|P3|Overall Study|Change in health status|2
433829|NCT00485134|1445176|P2|Overall Study|Change in health status|1
433830|NCT00485134|1445177|P1|Overall Study|Change in health status|0
433831|NCT00485134|1445170|P8|Overall Study|Withdrawal by Subject|0
433832|NCT00485134|1445171|P7|Overall Study|Withdrawal by Subject|0
433833|NCT00485134|1445172|P6|Overall Study|Withdrawal by Subject|0
433834|NCT00485134|1445173|P5|Overall Study|Withdrawal by Subject|0
433835|NCT00485134|1445174|P4|Overall Study|Withdrawal by Subject|0
433836|NCT00485134|1445175|P3|Overall Study|Withdrawal by Subject|0
433837|NCT00485134|1445176|P2|Overall Study|Withdrawal by Subject|1
433838|NCT00485134|1445177|P1|Overall Study|Withdrawal by Subject|0
433839|NCT00485134|1445170|P8|Overall Study|Lost to Follow-up|0
433840|NCT00485134|1445171|P7|Overall Study|Lost to Follow-up|0
433841|NCT00485134|1445172|P6|Overall Study|Lost to Follow-up|0
433842|NCT00485134|1445173|P5|Overall Study|Lost to Follow-up|0
433843|NCT00485134|1445174|P4|Overall Study|Lost to Follow-up|0
433844|NCT00485134|1445175|P3|Overall Study|Lost to Follow-up|0
433845|NCT00485134|1445176|P2|Overall Study|Lost to Follow-up|0
433846|NCT00485134|1445177|P1|Overall Study|Lost to Follow-up|1
433847|NCT00485069|1445199|P2|Overall Study|Withdrawal by Subject|6
433848|NCT00485069|1445200|P1|Overall Study|Withdrawal by Subject|6
433849|NCT00485069|1445199|P2|Overall Study|Protocol Violation|1
433850|NCT00485069|1445200|P1|Overall Study|Protocol Violation|0
433851|NCT00485069|1445199|P2|Overall Study|Lack of Efficacy|1
433852|NCT00485069|1445200|P1|Overall Study|Lack of Efficacy|2
433853|NCT00485069|1445199|P2|Overall Study|Adverse Event|4
433854|NCT00485069|1445200|P1|Overall Study|Adverse Event|10
433855|NCT00484939|1445245|P2|Overall Study|Reason Not Specified|6
433856|NCT00484939|1445246|P1|Overall Study|Reason Not Specified|11
433857|NCT00484939|1445245|P2|Overall Study|Screen Failure|2
433858|NCT00484939|1445246|P1|Overall Study|Screen Failure|2
433859|NCT00484939|1445245|P2|Overall Study|Disease progression|88
433860|NCT00484939|1445246|P1|Overall Study|Disease progression|67
433861|NCT00484939|1445245|P2|Overall Study|Discretion of Investigator or Sponsor|3
433862|NCT00484939|1445246|P1|Overall Study|Discretion of Investigator or Sponsor|7
433863|NCT00484939|1445245|P2|Overall Study|Lost to Follow-up|3
433864|NCT00484939|1445246|P1|Overall Study|Lost to Follow-up|0
433865|NCT00484939|1445245|P2|Overall Study|Protocol Violation|3
433866|NCT00484939|1445246|P1|Overall Study|Protocol Violation|3
433867|NCT00484939|1445245|P2|Overall Study|Patient Withdrew Consent|10
433868|NCT00484939|1445246|P1|Overall Study|Patient Withdrew Consent|19
433869|NCT00484939|1445245|P2|Overall Study|Adverse Event|12
433870|NCT00484939|1445246|P1|Overall Study|Adverse Event|22
433871|NCT00484939|1445245|P2|Overall Study|Death|13
433872|NCT00484939|1445246|P1|Overall Study|Death|9
433874|NCT00484419|1445273|P3|Overall Study|sponsor decision, randomized in error|2
433875|NCT00484419|1445274|P2|Overall Study|sponsor decision, randomized in error|0
433876|NCT00484419|1445275|P1|Overall Study|sponsor decision, randomized in error|0
433877|NCT00484419|1445273|P3|Overall Study|subject relocated|0
433878|NCT00484419|1445274|P2|Overall Study|subject relocated|1
433879|NCT00484419|1445275|P1|Overall Study|subject relocated|0
433880|NCT00484419|1445273|P3|Overall Study|subject unable to receive medication|0
433881|NCT00484419|1445274|P2|Overall Study|subject unable to receive medication|0
433882|NCT00484419|1445275|P1|Overall Study|subject unable to receive medication|1
433883|NCT00484419|1445273|P3|Overall Study|Physician Decision|1
433884|NCT00484419|1445274|P2|Overall Study|Physician Decision|1
433885|NCT00484419|1445275|P1|Overall Study|Physician Decision|1
433886|NCT00484419|1445273|P3|Overall Study|required restricted medication|1
433887|NCT00484419|1445274|P2|Overall Study|required restricted medication|0
433888|NCT00484419|1445275|P1|Overall Study|required restricted medication|1
433889|NCT00484419|1445273|P3|Overall Study|subject met discontinuation criteria|4
433890|NCT00484419|1445274|P2|Overall Study|subject met discontinuation criteria|2
433891|NCT00484419|1445275|P1|Overall Study|subject met discontinuation criteria|2
433892|NCT00484419|1445273|P3|Overall Study|Withdrawal by Subject|1
433893|NCT00484419|1445274|P2|Overall Study|Withdrawal by Subject|1
433894|NCT00484419|1445275|P1|Overall Study|Withdrawal by Subject|3
433895|NCT00484419|1445273|P3|Overall Study|Lost to Follow-up|2
433896|NCT00484419|1445274|P2|Overall Study|Lost to Follow-up|0
433897|NCT00484419|1445275|P1|Overall Study|Lost to Follow-up|1
433898|NCT00484419|1445273|P3|Overall Study|Adverse Event|0
433899|NCT00484419|1445274|P2|Overall Study|Adverse Event|0
433900|NCT00484419|1445275|P1|Overall Study|Adverse Event|3
433901|NCT00484315|1445342|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
433902|NCT00484315|1445343|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
433903|NCT00484315|1445342|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
433904|NCT00484315|1445343|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
433905|NCT00484315|1445342|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
433906|NCT00484315|1445343|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
433907|NCT00484315|1445342|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
433908|NCT00484315|1445343|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
433909|NCT00484315|1445342|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
433910|NCT00484315|1445343|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
433911|NCT00484315|1445342|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
433912|NCT00484315|1445343|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
433913|NCT00484315|1445342|P2|12-Month Clinical Follow-up|Death|2
433914|NCT00484315|1445343|P1|12-Month Clinical Follow-up|Death|6
433915|NCT00484289|1445354|P3|Post Marketing Phase|Adverse Event|0
433916|NCT00484289|1445355|P2|Post Marketing Phase|Adverse Event|1
433917|NCT00484289|1445356|P1|Post Marketing Phase|Adverse Event|0
433918|NCT00484289|1445354|P3|Long Term Phase|Other Reason|1
433919|NCT00484289|1445355|P2|Long Term Phase|Other Reason|5
433920|NCT00484289|1445356|P1|Long Term Phase|Other Reason|0
433921|NCT00484289|1445354|P3|Long Term Phase|Inadequate response|4
433922|NCT00484289|1445355|P2|Long Term Phase|Inadequate response|7
433923|NCT00484289|1445356|P1|Long Term Phase|Inadequate response|2
433924|NCT00484289|1445354|P3|Long Term Phase|Withdrawal by Subject|6
433925|NCT00484289|1445355|P2|Long Term Phase|Withdrawal by Subject|7
433926|NCT00484289|1445356|P1|Long Term Phase|Withdrawal by Subject|0
433927|NCT00484289|1445354|P3|Long Term Phase|Adverse Event|5
433928|NCT00484289|1445355|P2|Long Term Phase|Adverse Event|17
433929|NCT00484289|1445356|P1|Long Term Phase|Adverse Event|1
433930|NCT00484185|1445428|P1|Overall Study|Death|2
433931|NCT00484185|1445428|P1|Overall Study|Randomized but not treated|5
433932|NCT00484185|1445428|P1|Overall Study|Other|20
433933|NCT00484185|1445428|P1|Overall Study|Lost to Follow-up|44
433934|NCT00484159|1445450|P3|Overall Study|Lost to Follow-up|0
433935|NCT00484159|1445451|P2|Overall Study|Lost to Follow-up|1
433936|NCT00484159|1445452|P1|Overall Study|Lost to Follow-up|1
433937|NCT00484094|1445463|P1|Overall Study|Other|3
433938|NCT00484094|1445463|P1|Overall Study|Discontinued|39
433939|NCT00483938|1445479|P7|Overall Study|Other|32
433940|NCT00483938|1445480|P6|Overall Study|Other|4
433941|NCT00483938|1445481|P5|Overall Study|Other|0
433942|NCT00483938|1445482|P4|Overall Study|Other|4
433943|NCT00483938|1445483|P3|Overall Study|Other|0
433944|NCT00483938|1445484|P2|Overall Study|Other|9
433945|NCT00483938|1445485|P1|Overall Study|Other|3
433946|NCT00483938|1445479|P7|Overall Study|Death|0
433947|NCT00483938|1445480|P6|Overall Study|Death|0
433948|NCT00483938|1445481|P5|Overall Study|Death|0
433949|NCT00483938|1445482|P4|Overall Study|Death|0
433950|NCT00483938|1445483|P3|Overall Study|Death|0
433951|NCT00483938|1445484|P2|Overall Study|Death|2
433952|NCT00483938|1445485|P1|Overall Study|Death|0
433953|NCT00483938|1445479|P7|Overall Study|Lost to Follow-up|3
433954|NCT00483938|1445480|P6|Overall Study|Lost to Follow-up|1
433955|NCT00483938|1445481|P5|Overall Study|Lost to Follow-up|1
433956|NCT00483938|1445482|P4|Overall Study|Lost to Follow-up|2
433957|NCT00483938|1445483|P3|Overall Study|Lost to Follow-up|0
433958|NCT00483938|1445484|P2|Overall Study|Lost to Follow-up|2
433959|NCT00483938|1445485|P1|Overall Study|Lost to Follow-up|1
433960|NCT00483938|1445479|P7|Overall Study|Withdrawal by Subject|2
433961|NCT00483938|1445480|P6|Overall Study|Withdrawal by Subject|3
433962|NCT00483938|1445481|P5|Overall Study|Withdrawal by Subject|1
433963|NCT00483938|1445482|P4|Overall Study|Withdrawal by Subject|0
433964|NCT00483938|1445483|P3|Overall Study|Withdrawal by Subject|0
433965|NCT00483938|1445484|P2|Overall Study|Withdrawal by Subject|6
433966|NCT00483938|1445485|P1|Overall Study|Withdrawal by Subject|1
433967|NCT00483938|1445479|P7|Overall Study|Protocol Violation|3
433968|NCT00483938|1445480|P6|Overall Study|Protocol Violation|0
433969|NCT00483938|1445481|P5|Overall Study|Protocol Violation|0
433970|NCT00483938|1445482|P4|Overall Study|Protocol Violation|0
433971|NCT00483938|1445483|P3|Overall Study|Protocol Violation|0
433972|NCT00483938|1445484|P2|Overall Study|Protocol Violation|0
433973|NCT00483938|1445485|P1|Overall Study|Protocol Violation|0
433974|NCT00483756|1445509|P3|Overall Study|Randomized, Not Treated|4
433975|NCT00483756|1445510|P2|Overall Study|Randomized, Not Treated|4
433976|NCT00483756|1445511|P1|Overall Study|Randomized, Not Treated|1
433977|NCT00483756|1445509|P3|Overall Study|Other|3
433978|NCT00483756|1445510|P2|Overall Study|Other|4
433979|NCT00483756|1445511|P1|Overall Study|Other|2
433980|NCT00483756|1445509|P3|Overall Study|Withdrawal by Subject|4
433981|NCT00483756|1445510|P2|Overall Study|Withdrawal by Subject|3
433982|NCT00483756|1445511|P1|Overall Study|Withdrawal by Subject|5
433983|NCT00483756|1445509|P3|Overall Study|Lost to Follow-up|0
433984|NCT00483756|1445510|P2|Overall Study|Lost to Follow-up|1
433985|NCT00483756|1445511|P1|Overall Study|Lost to Follow-up|3
433986|NCT00483756|1445509|P3|Overall Study|Lack of Efficacy|0
433987|NCT00483756|1445510|P2|Overall Study|Lack of Efficacy|0
433988|NCT00483756|1445511|P1|Overall Study|Lack of Efficacy|1
433989|NCT00483756|1445509|P3|Overall Study|Adverse Event|40
433990|NCT00483756|1445510|P2|Overall Study|Adverse Event|38
433991|NCT00483756|1445511|P1|Overall Study|Adverse Event|19
433992|NCT00483756|1445509|P3|Overall Study|Death|1
433993|NCT00483756|1445510|P2|Overall Study|Death|0
433994|NCT00483756|1445511|P1|Overall Study|Death|2
433995|NCT00483717|1445575|P2|Overall Study|Withdrawal by Subject|0
433996|NCT00483717|1445576|P1|Overall Study|Withdrawal by Subject|1
433997|NCT00483717|1445575|P2|Overall Study|Lost to Follow-up|0
433998|NCT00483717|1445576|P1|Overall Study|Lost to Follow-up|1
433999|NCT00483717|1445575|P2|Overall Study|No treatment for migraine|13
434000|NCT00483717|1445576|P1|Overall Study|No treatment for migraine|16
434001|NCT00483717|1445575|P2|Overall Study|Time of dosing missing|1
434002|NCT00483717|1445576|P1|Overall Study|Time of dosing missing|1
434003|NCT00483717|1445575|P2|Overall Study|Protocol Violation|7
434004|NCT00483717|1445576|P1|Overall Study|Protocol Violation|5
434005|NCT00483704|1445599|P3|Treatment|Physician Decision|4
434006|NCT00483704|1445600|P2|Treatment|Physician Decision|1
434007|NCT00483704|1445601|P1|Treatment|Physician Decision|0
434008|NCT00483704|1445599|P3|Treatment|Pregnancy|0
434009|NCT00483704|1445600|P2|Treatment|Pregnancy|1
434010|NCT00483704|1445601|P1|Treatment|Pregnancy|0
434011|NCT00483704|1445599|P3|Treatment|Lack of Efficacy|1
434012|NCT00483704|1445600|P2|Treatment|Lack of Efficacy|1
434013|NCT00483704|1445601|P1|Treatment|Lack of Efficacy|1
434014|NCT00483704|1445599|P3|Treatment|Lost to Follow-up|5
434015|NCT00483704|1445600|P2|Treatment|Lost to Follow-up|7
434016|NCT00483704|1445601|P1|Treatment|Lost to Follow-up|2
434017|NCT00483704|1445599|P3|Treatment|Protocol Violation|5
434018|NCT00483704|1445600|P2|Treatment|Protocol Violation|3
434019|NCT00483704|1445601|P1|Treatment|Protocol Violation|6
434020|NCT00483704|1445599|P3|Treatment|Withdrawal by Subject|21
434021|NCT00483704|1445600|P2|Treatment|Withdrawal by Subject|12
434022|NCT00483704|1445601|P1|Treatment|Withdrawal by Subject|16
434023|NCT00483704|1445599|P3|Treatment|Adverse Event|4
434024|NCT00483704|1445600|P2|Treatment|Adverse Event|5
434025|NCT00483704|1445601|P1|Treatment|Adverse Event|3
434026|NCT00483704|1445599|P3|Treatment|Lack of qualifying migraines|116
434027|NCT00483704|1445600|P2|Treatment|Lack of qualifying migraines|99
434028|NCT00483704|1445601|P1|Treatment|Lack of qualifying migraines|101
434029|NCT00483704|1445599|P3|Randomization|Lack of qualifying migraines|31
434030|NCT00483704|1445600|P2|Randomization|Lack of qualifying migraines|25
434031|NCT00483704|1445601|P1|Randomization|Lack of qualifying migraines|21
434032|NCT00483704|1445599|P3|Randomization|Progressive disease|1
434033|NCT00483704|1445600|P2|Randomization|Progressive disease|0
434034|NCT00483704|1445601|P1|Randomization|Progressive disease|0
434035|NCT00483704|1445599|P3|Randomization|Physician Decision|0
434036|NCT00483704|1445600|P2|Randomization|Physician Decision|4
434037|NCT00483704|1445601|P1|Randomization|Physician Decision|2
434038|NCT00483704|1445599|P3|Randomization|Pregnancy|0
434039|NCT00483704|1445600|P2|Randomization|Pregnancy|0
434040|NCT00483704|1445601|P1|Randomization|Pregnancy|1
434041|NCT00483704|1445599|P3|Randomization|Lost to Follow-up|19
434042|NCT00483704|1445600|P2|Randomization|Lost to Follow-up|14
434043|NCT00483704|1445601|P1|Randomization|Lost to Follow-up|14
434044|NCT00483704|1445599|P3|Randomization|Protocol Violation|22
434045|NCT00483704|1445600|P2|Randomization|Protocol Violation|25
434046|NCT00483704|1445601|P1|Randomization|Protocol Violation|14
434047|NCT00483704|1445599|P3|Randomization|Withdrawal by Subject|18
434048|NCT00483704|1445600|P2|Randomization|Withdrawal by Subject|28
434049|NCT00483704|1445601|P1|Randomization|Withdrawal by Subject|19
434050|NCT00483652|1445647|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
434051|NCT00483652|1445648|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
434052|NCT00483652|1445647|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
434053|NCT00483652|1445648|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
434054|NCT00483652|1445647|P2|Double-blind Treatment Period|Adverse Event|4
434055|NCT00483652|1445648|P1|Double-blind Treatment Period|Adverse Event|3
434056|NCT00483652|1445647|P2|Double-blind Treatment Period|Protocol Violation|1
434057|NCT00483652|1445648|P1|Double-blind Treatment Period|Protocol Violation|2
434058|NCT00483574|1445658|P2|Overall Study|Withdrawal by Subject|0
434059|NCT00483574|1445659|P1|Overall Study|Withdrawal by Subject|52
434060|NCT00483574|1445658|P2|Overall Study|Lost to Follow-up|4
434061|NCT00483574|1445659|P1|Overall Study|Lost to Follow-up|16
434062|NCT00483574|1445658|P2|Overall Study|Protocol Violation|9
434063|NCT00483574|1445659|P1|Overall Study|Protocol Violation|28
434064|NCT00483574|1445658|P2|Overall Study|Adverse Event|0
434065|NCT00483574|1445659|P1|Overall Study|Adverse Event|6
434066|NCT00483548|1445669|P2|Overall Study|Withdrawal by Subject|2
434067|NCT00483548|1445670|P1|Overall Study|Withdrawal by Subject|5
434068|NCT00483548|1445669|P2|Overall Study|Lost to Follow-up|4
434069|NCT00483548|1445670|P1|Overall Study|Lost to Follow-up|3
434070|NCT00483548|1445669|P2|Overall Study|Non-compliance with medication|0
434071|NCT00483548|1445670|P1|Overall Study|Non-compliance with medication|2
434072|NCT00483548|1445669|P2|Overall Study|Unable to comply with protocol schedule|0
434073|NCT00483548|1445670|P1|Overall Study|Unable to comply with protocol schedule|1
434074|NCT00483548|1445669|P2|Overall Study|Protocol required discontinuation|6
434075|NCT00483548|1445670|P1|Overall Study|Protocol required discontinuation|6
434076|NCT00483548|1445669|P2|Overall Study|Pregnancy|0
434077|NCT00483548|1445670|P1|Overall Study|Pregnancy|1
434078|NCT00483548|1445669|P2|Overall Study|Protocol Violation|7
434079|NCT00483548|1445670|P1|Overall Study|Protocol Violation|11
434080|NCT00483548|1445669|P2|Overall Study|Lack of Efficacy|8
434081|NCT00483548|1445670|P1|Overall Study|Lack of Efficacy|4
434082|NCT00483548|1445669|P2|Overall Study|Laboratory abnormality|2
434083|NCT00483548|1445670|P1|Overall Study|Laboratory abnormality|1
434084|NCT00483548|1445669|P2|Overall Study|Adverse Event|14
434085|NCT00483548|1445670|P1|Overall Study|Adverse Event|25
434086|NCT00483548|1445669|P2|Overall Study|Randomized; not treated with study drug|3
434087|NCT00483548|1445670|P1|Overall Study|Randomized; not treated with study drug|1
434088|NCT00483405|1445720|P1|Overall Study|Other complicating disease|1
434089|NCT00483405|1445720|P1|Overall Study|Withdrawal by Subject|2
434090|NCT00483405|1445720|P1|Overall Study|Death|3
434091|NCT00483405|1445720|P1|Overall Study|Lack of Efficacy|14
434092|NCT00483405|1445720|P1|Overall Study|Adverse Event|8
434093|NCT00483379|1445729|P2|Treatment Period|Withdrawal by Subject|0
434094|NCT00483379|1445730|P1|Treatment Period|Withdrawal by Subject|1
434095|NCT00483379|1445729|P2|Treatment Period|Adverse Event|0
434096|NCT00483379|1445730|P1|Treatment Period|Adverse Event|1
434097|NCT00483327|1445766|P1|Overall Study|Patient Non Compliance|2
434098|NCT00483327|1445766|P1|Overall Study|Lost to Follow-up|4
434099|NCT00483327|1445766|P1|Overall Study|Withdrawal by Subject|3
434100|NCT00483327|1445766|P1|Overall Study|Adverse Event|1
434101|NCT00483184|1445798|P3|Overall Study|Protocol Violation|1
434102|NCT00483184|1445799|P2|Overall Study|Protocol Violation|0
434103|NCT00483184|1445800|P1|Overall Study|Protocol Violation|1
434104|NCT00483184|1445798|P3|Overall Study|Adverse Event|2
434105|NCT00483184|1445799|P2|Overall Study|Adverse Event|2
434106|NCT00483184|1445800|P1|Overall Study|Adverse Event|1
434107|NCT00483184|1445798|P3|Overall Study|Lost to Follow-up|0
434108|NCT00483184|1445799|P2|Overall Study|Lost to Follow-up|0
434109|NCT00483184|1445800|P1|Overall Study|Lost to Follow-up|1
434110|NCT00483184|1445798|P3|Overall Study|Withdrawal by Subject|0
434111|NCT00483184|1445799|P2|Overall Study|Withdrawal by Subject|2
434112|NCT00483184|1445800|P1|Overall Study|Withdrawal by Subject|2
434113|NCT00483119|1445810|P2|Overall Study|Physician Decision|0
434114|NCT00483119|1445811|P1|Overall Study|Physician Decision|1
434115|NCT00483119|1445810|P2|Overall Study|Adverse Event|1
434116|NCT00483119|1445811|P1|Overall Study|Adverse Event|0
434117|NCT00483041|1445825|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
434118|NCT00483041|1445826|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
434119|NCT00483002|1445856|P1|Overall Study|Other|967
434120|NCT00483002|1445856|P1|Overall Study|Other|2
434121|NCT00483002|1445856|P1|Overall Study|Lost to Follow-up|962
434122|NCT00483002|1445856|P1|Overall Study|Lack of Efficacy|555
434123|NCT00483002|1445856|P1|Overall Study|Adverse Event|68
434124|NCT00482729|1445881|P2|Overall Study|Withdrawal by Subject|69
434125|NCT00482729|1445882|P1|Overall Study|Withdrawal by Subject|67
434126|NCT00482729|1445881|P2|Overall Study|Protocol Violation|18
434127|NCT00482729|1445882|P1|Overall Study|Protocol Violation|10
434128|NCT00482729|1445881|P2|Overall Study|Pregnancy|2
434129|NCT00482729|1445882|P1|Overall Study|Pregnancy|4
434130|NCT00482729|1445881|P2|Overall Study|Physician Decision|7
434131|NCT00482729|1445882|P1|Overall Study|Physician Decision|10
434132|NCT00482729|1445881|P2|Overall Study|Lost to Follow-up|66
434133|NCT00482729|1445882|P1|Overall Study|Lost to Follow-up|86
434134|NCT00482729|1445881|P2|Overall Study|Lack of Efficacy|16
434135|NCT00482729|1445882|P1|Overall Study|Lack of Efficacy|4
434136|NCT00482729|1445881|P2|Overall Study|Hyperglycemia Criteria|5
434137|NCT00482729|1445882|P1|Overall Study|Hyperglycemia Criteria|7
434138|NCT00482729|1445881|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
434139|NCT00482729|1445882|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
434140|NCT00482729|1445881|P2|Overall Study|Adverse Event|33
434141|NCT00482729|1445882|P1|Overall Study|Adverse Event|29
434142|NCT00482703|1445898|P2|Overall Study|Poor compliance|0
434143|NCT00482703|1445899|P1|Overall Study|Poor compliance|1
434144|NCT00482612|1445970|P4|Follow-up Period|Reasons not related to trial|3
434145|NCT00482612|1445971|P3|Follow-up Period|Reasons not related to trial|1
434146|NCT00482612|1445972|P2|Follow-up Period|Reasons not related to trial|0
434147|NCT00482612|1445973|P1|Follow-up Period|Reasons not related to trial|1
434148|NCT00482612|1445970|P4|Follow-up Period|Withdrawal by Subject|2
434149|NCT00482612|1445971|P3|Follow-up Period|Withdrawal by Subject|7
434150|NCT00482612|1445972|P2|Follow-up Period|Withdrawal by Subject|5
434151|NCT00482612|1445973|P1|Follow-up Period|Withdrawal by Subject|3
434152|NCT00482612|1445970|P4|Follow-up Period|Lack of Efficacy|0
434153|NCT00482612|1445971|P3|Follow-up Period|Lack of Efficacy|1
434154|NCT00482612|1445972|P2|Follow-up Period|Lack of Efficacy|0
434155|NCT00482612|1445973|P1|Follow-up Period|Lack of Efficacy|2
434156|NCT00482612|1445970|P4|Follow-up Period|Adverse Event|0
434157|NCT00482612|1445971|P3|Follow-up Period|Adverse Event|9
434158|NCT00482612|1445972|P2|Follow-up Period|Adverse Event|7
434159|NCT00482612|1445973|P1|Follow-up Period|Adverse Event|4
434160|NCT00482612|1445970|P4|Follow-up Period|Lost to Follow-up|1
434161|NCT00482612|1445971|P3|Follow-up Period|Lost to Follow-up|2
434162|NCT00482612|1445972|P2|Follow-up Period|Lost to Follow-up|4
434163|NCT00482612|1445973|P1|Follow-up Period|Lost to Follow-up|0
434164|NCT00482612|1445970|P4|Follow-up Period|Lack of compliance|0
434165|NCT00482612|1445971|P3|Follow-up Period|Lack of compliance|1
434166|NCT00482612|1445972|P2|Follow-up Period|Lack of compliance|0
434167|NCT00482612|1445973|P1|Follow-up Period|Lack of compliance|0
434168|NCT00482612|1445970|P4|Follow-up Period|Other|2
434169|NCT00482612|1445971|P3|Follow-up Period|Other|1
434170|NCT00482612|1445972|P2|Follow-up Period|Other|2
434171|NCT00482612|1445973|P1|Follow-up Period|Other|4
434172|NCT00482612|1445970|P4|In-treatment Period|No study medication administered|0
434173|NCT00482612|1445971|P3|In-treatment Period|No study medication administered|1
434174|NCT00482612|1445972|P2|In-treatment Period|No study medication administered|0
434175|NCT00482612|1445973|P1|In-treatment Period|No study medication administered|0
434176|NCT00482391|1446022|P1|Overall Study|Death|1
434177|NCT00482391|1446022|P1|Overall Study|Adverse Event|1
434178|NCT00482391|1446022|P1|Overall Study|Withdrawal by Subject|1
434179|NCT00482274|1446027|P1|Overall Study|Adverse Event|1
434180|NCT00482170|1446037|P2|Overall Study|Unspecified reason|2
434181|NCT00482170|1446038|P1|Overall Study|Unspecified reason|0
434182|NCT00482170|1446037|P2|Overall Study|Lost to Follow-up|0
434183|NCT00482170|1446038|P1|Overall Study|Lost to Follow-up|2
434184|NCT00482170|1446037|P2|Overall Study|Protocol Violation|3
434185|NCT00482170|1446038|P1|Overall Study|Protocol Violation|2
434186|NCT00482170|1446037|P2|Overall Study|Withdrawal by Subject|1
434187|NCT00482170|1446038|P1|Overall Study|Withdrawal by Subject|6
434188|NCT00482170|1446037|P2|Overall Study|Adverse Event|14
434189|NCT00482170|1446038|P1|Overall Study|Adverse Event|5
434190|NCT00482053|1446156|P1|Inter-treatment Period|Disease progression|1
434191|NCT00482014|1446170|P4|Overall Study|Sponsor Decision|1
434192|NCT00482014|1446171|P3|Overall Study|Sponsor Decision|1
434193|NCT00482014|1446172|P2|Overall Study|Sponsor Decision|2
434194|NCT00482014|1446173|P1|Overall Study|Sponsor Decision|1
434195|NCT00482014|1446170|P4|Overall Study|Lack of Efficacy|6
434196|NCT00482014|1446171|P3|Overall Study|Lack of Efficacy|4
434197|NCT00482014|1446172|P2|Overall Study|Lack of Efficacy|0
434198|NCT00482014|1446173|P1|Overall Study|Lack of Efficacy|1
434199|NCT00482014|1446170|P4|Overall Study|Death|4
434200|NCT00482014|1446171|P3|Overall Study|Death|1
434201|NCT00482014|1446172|P2|Overall Study|Death|2
434202|NCT00482014|1446173|P1|Overall Study|Death|1
434203|NCT00482014|1446170|P4|Overall Study|Adverse Event|8
434204|NCT00482014|1446171|P3|Overall Study|Adverse Event|2
434205|NCT00482014|1446172|P2|Overall Study|Adverse Event|0
434206|NCT00482014|1446173|P1|Overall Study|Adverse Event|3
434207|NCT00482014|1446170|P4|Overall Study|Withdrawal by Subject|4
434208|NCT00482014|1446171|P3|Overall Study|Withdrawal by Subject|3
434209|NCT00482014|1446172|P2|Overall Study|Withdrawal by Subject|2
434210|NCT00482014|1446173|P1|Overall Study|Withdrawal by Subject|1
434211|NCT00481988|1446197|P2|Overall Study|Withdrawal by Subject|1
434212|NCT00481988|1446198|P1|Overall Study|Withdrawal by Subject|1
434213|NCT00481871|1446211|P5|Overall Study|Progressive Disease - pt withdrew|0
434214|NCT00481871|1446212|P4|Overall Study|Progressive Disease - pt withdrew|0
434215|NCT00481871|1446213|P3|Overall Study|Progressive Disease - pt withdrew|1
434216|NCT00481871|1446214|P2|Overall Study|Progressive Disease - pt withdrew|0
434217|NCT00481871|1446215|P1|Overall Study|Progressive Disease - pt withdrew|0
434218|NCT00481832|1446240|P1|Inter-transplant Period|Lack of allogeneic donor|5
434219|NCT00481832|1446240|P1|Inter-transplant Period|Disease relapse|11
434220|NCT00481832|1446240|P1|Inter-transplant Period|Physician Decision|4
434221|NCT00481832|1446240|P1|Inter-transplant Period|Death|3
434222|NCT00481832|1446240|P1|Inter-transplant Period|Adverse Event|4
434223|NCT00481832|1446240|P1|Enrollment|Unable to collect enough stem cells|2
434224|NCT00481832|1446240|P1|Enrollment|Physician Decision|8
434225|NCT00481767|1446255|P2|Overall Study|Lost to Follow-up|10
434226|NCT00481767|1446256|P1|Overall Study|Lost to Follow-up|16
434227|NCT00481767|1446255|P2|Overall Study|Withdrawal by Subject|11
434228|NCT00481767|1446256|P1|Overall Study|Withdrawal by Subject|16
434229|NCT00481676|1446290|P2|Overall Study|Administrative problem|0
434230|NCT00481676|1446291|P1|Overall Study|Administrative problem|1
434231|NCT00481676|1446290|P2|Overall Study|Unsatisfactory therapeutic effect|4
434232|NCT00481676|1446291|P1|Overall Study|Unsatisfactory therapeutic effect|1
434233|NCT00481676|1446290|P2|Overall Study|Adverse Event|1
434234|NCT00481676|1446291|P1|Overall Study|Adverse Event|0
434235|NCT00481247|1446341|P2|Overall Study|Did not receive treatment|2
434236|NCT00481247|1446342|P1|Overall Study|Did not receive treatment|1
434237|NCT00481247|1446341|P2|Overall Study|Varied|15
434238|NCT00481247|1446342|P1|Overall Study|Varied|6
434239|NCT00481247|1446341|P2|Overall Study|Administrative reason by sponsor|162
434240|NCT00481247|1446342|P1|Overall Study|Administrative reason by sponsor|157
434241|NCT00481247|1446341|P2|Overall Study|Poor compliance/noncompliance|7
434242|NCT00481247|1446342|P1|Overall Study|Poor compliance/noncompliance|1
434243|NCT00481247|1446341|P2|Overall Study|Lost to Follow-up|2
434244|NCT00481247|1446342|P1|Overall Study|Lost to Follow-up|1
434245|NCT00481247|1446341|P2|Overall Study|Pregnancy|1
434246|NCT00481247|1446342|P1|Overall Study|Pregnancy|2
434247|NCT00481247|1446341|P2|Overall Study|Withdrawal by Subject|13
434248|NCT00481247|1446342|P1|Overall Study|Withdrawal by Subject|8
434249|NCT00481247|1446341|P2|Overall Study|AE unrelated to study drug|4
434250|NCT00481247|1446342|P1|Overall Study|AE unrelated to study drug|13
434251|NCT00481247|1446341|P2|Overall Study|Treatment failure|14
434252|NCT00481247|1446342|P1|Overall Study|Treatment failure|10
434253|NCT00481247|1446341|P2|Overall Study|Intolerance|17
434254|NCT00481247|1446342|P1|Overall Study|Intolerance|42
434255|NCT00481247|1446341|P2|Overall Study|Disease progression|22
434256|NCT00481247|1446342|P1|Overall Study|Disease progression|18
434257|NCT00481247|1446341|P2|Overall Study|Death|1
434258|NCT00481247|1446342|P1|Overall Study|Death|0
434259|NCT00481195|1446366|P2|Overall Study|Miscellaneous|2
434260|NCT00481195|1446367|P1|Overall Study|Miscellaneous|2
434261|NCT00481195|1446366|P2|Overall Study|Withdrawal by Subject|9
434262|NCT00481195|1446367|P1|Overall Study|Withdrawal by Subject|3
434263|NCT00481195|1446366|P2|Overall Study|Protocol Violation|7
434264|NCT00481195|1446367|P1|Overall Study|Protocol Violation|10
434265|NCT00481195|1446366|P2|Overall Study|Physician Decision|1
434266|NCT00481195|1446367|P1|Overall Study|Physician Decision|3
434267|NCT00481195|1446366|P2|Overall Study|Lost to Follow-up|6
434268|NCT00481195|1446367|P1|Overall Study|Lost to Follow-up|4
434269|NCT00481195|1446366|P2|Overall Study|Lack of Efficacy|3
434270|NCT00481195|1446367|P1|Overall Study|Lack of Efficacy|1
434271|NCT00481195|1446366|P2|Overall Study|Adverse Event|11
434272|NCT00481195|1446367|P1|Overall Study|Adverse Event|16
434273|NCT00481078|1446453|P2|Overall Study|Brain metastasis|1
434274|NCT00481078|1446454|P1|Overall Study|Brain metastasis|0
434275|NCT00481078|1446453|P2|Overall Study|Received other treatment|1
434276|NCT00481078|1446454|P1|Overall Study|Received other treatment|2
434277|NCT00481078|1446453|P2|Overall Study|Information not available|0
434278|NCT00481078|1446454|P1|Overall Study|Information not available|1
434279|NCT00481078|1446453|P2|Overall Study|Withdrawal by Subject|1
434280|NCT00481078|1446454|P1|Overall Study|Withdrawal by Subject|7
434281|NCT00481078|1446453|P2|Overall Study|Intercurrent illness|0
434282|NCT00481078|1446454|P1|Overall Study|Intercurrent illness|1
434283|NCT00481078|1446453|P2|Overall Study|Death|3
434284|NCT00481078|1446454|P1|Overall Study|Death|5
434285|NCT00481078|1446453|P2|Overall Study|Adverse Event|3
434286|NCT00481078|1446454|P1|Overall Study|Adverse Event|15
434287|NCT00481078|1446453|P2|Overall Study|Progression of disease|11
434288|NCT00481078|1446454|P1|Overall Study|Progression of disease|11
434289|NCT00481065|1446472|P8|Overall Study|Unable to classify|0
434290|NCT00481065|1446473|P7|Overall Study|Unable to classify|0
434291|NCT00481065|1446474|P6|Overall Study|Unable to classify|0
434292|NCT00481065|1446475|P5|Overall Study|Unable to classify|1
434293|NCT00481065|1446476|P4|Overall Study|Unable to classify|0
434294|NCT00481065|1446477|P3|Overall Study|Unable to classify|2
434295|NCT00481065|1446478|P2|Overall Study|Unable to classify|1
434296|NCT00481065|1446479|P1|Overall Study|Unable to classify|0
434297|NCT00481065|1446472|P8|Overall Study|Protocol Violation|2
434298|NCT00481065|1446473|P7|Overall Study|Protocol Violation|3
434299|NCT00481065|1446474|P6|Overall Study|Protocol Violation|6
434300|NCT00481065|1446475|P5|Overall Study|Protocol Violation|2
434301|NCT00481065|1446476|P4|Overall Study|Protocol Violation|1
434302|NCT00481065|1446477|P3|Overall Study|Protocol Violation|1
434303|NCT00481065|1446478|P2|Overall Study|Protocol Violation|1
434304|NCT00481065|1446479|P1|Overall Study|Protocol Violation|2
434305|NCT00481065|1446472|P8|Overall Study|Administrative reason|0
434306|NCT00481065|1446473|P7|Overall Study|Administrative reason|1
434307|NCT00481065|1446474|P6|Overall Study|Administrative reason|2
434308|NCT00481065|1446475|P5|Overall Study|Administrative reason|0
434309|NCT00481065|1446476|P4|Overall Study|Administrative reason|0
434310|NCT00481065|1446477|P3|Overall Study|Administrative reason|0
434311|NCT00481065|1446478|P2|Overall Study|Administrative reason|0
434312|NCT00481065|1446479|P1|Overall Study|Administrative reason|0
434313|NCT00481065|1446472|P8|Overall Study|Inappropriate enrollment|1
434314|NCT00481065|1446473|P7|Overall Study|Inappropriate enrollment|0
434315|NCT00481065|1446474|P6|Overall Study|Inappropriate enrollment|1
434316|NCT00481065|1446475|P5|Overall Study|Inappropriate enrollment|2
434317|NCT00481065|1446476|P4|Overall Study|Inappropriate enrollment|0
434318|NCT00481065|1446477|P3|Overall Study|Inappropriate enrollment|2
434319|NCT00481065|1446478|P2|Overall Study|Inappropriate enrollment|0
434320|NCT00481065|1446479|P1|Overall Study|Inappropriate enrollment|4
434321|NCT00481065|1446472|P8|Overall Study|Lost to Follow-up|5
434322|NCT00481065|1446473|P7|Overall Study|Lost to Follow-up|2
434323|NCT00481065|1446474|P6|Overall Study|Lost to Follow-up|3
434324|NCT00481065|1446475|P5|Overall Study|Lost to Follow-up|3
434325|NCT00481065|1446476|P4|Overall Study|Lost to Follow-up|3
434326|NCT00481065|1446477|P3|Overall Study|Lost to Follow-up|4
434327|NCT00481065|1446478|P2|Overall Study|Lost to Follow-up|2
434328|NCT00481065|1446479|P1|Overall Study|Lost to Follow-up|4
434329|NCT00481065|1446472|P8|Overall Study|Withdrawal by Subject|10
434330|NCT00481065|1446473|P7|Overall Study|Withdrawal by Subject|9
434331|NCT00481065|1446474|P6|Overall Study|Withdrawal by Subject|12
434332|NCT00481065|1446475|P5|Overall Study|Withdrawal by Subject|13
434333|NCT00481065|1446476|P4|Overall Study|Withdrawal by Subject|11
434334|NCT00481065|1446477|P3|Overall Study|Withdrawal by Subject|7
434335|NCT00481065|1446478|P2|Overall Study|Withdrawal by Subject|12
434336|NCT00481065|1446479|P1|Overall Study|Withdrawal by Subject|11
434337|NCT00481065|1446472|P8|Overall Study|Adverse event or death|1
434338|NCT00481065|1446473|P7|Overall Study|Adverse event or death|1
434339|NCT00481065|1446474|P6|Overall Study|Adverse event or death|0
434340|NCT00481065|1446475|P5|Overall Study|Adverse event or death|2
434341|NCT00481065|1446476|P4|Overall Study|Adverse event or death|0
434342|NCT00481065|1446477|P3|Overall Study|Adverse event or death|3
434343|NCT00481065|1446478|P2|Overall Study|Adverse event or death|1
434344|NCT00481065|1446479|P1|Overall Study|Adverse event or death|1
434345|NCT00480857|1446569|P1|Overall Study|Lack of Efficacy|2
434346|NCT00480779|1446579|P2|Overall Study|Job and Health-related|3
434347|NCT00480779|1446580|P1|Overall Study|Job and Health-related|0
434348|NCT00480779|1446579|P2|Overall Study|Other|0
434349|NCT00480779|1446580|P1|Overall Study|Other|2
434350|NCT00480636|1446617|P1|Overall Study|Lost to follow-up; subsequently died|1
434351|NCT00480636|1446617|P1|Overall Study|Other|2
434352|NCT00480636|1446617|P1|Overall Study|Lost to Follow-up|4
434353|NCT00480636|1446617|P1|Overall Study|Death|12
434354|NCT00480532|1446629|P4|Overall Study|Protocol Violation|0
434355|NCT00480532|1446630|P3|Overall Study|Protocol Violation|1
434356|NCT00480532|1446631|P2|Overall Study|Protocol Violation|0
434357|NCT00480532|1446632|P1|Overall Study|Protocol Violation|0
434358|NCT00480532|1446629|P4|Overall Study|Withdrawal by Subject|1
434359|NCT00480532|1446630|P3|Overall Study|Withdrawal by Subject|3
434360|NCT00480532|1446631|P2|Overall Study|Withdrawal by Subject|4
434361|NCT00480532|1446632|P1|Overall Study|Withdrawal by Subject|2
434362|NCT00480493|1446652|P2|Overall Study|moved|7
434363|NCT00480493|1446653|P1|Overall Study|moved|2
434364|NCT00480324|1446665|P2|Overall Study|Subject’s mother pregnant|1
434365|NCT00480324|1446666|P1|Overall Study|Subject’s mother pregnant|0
434366|NCT00480324|1446665|P2|Overall Study|Lost to Follow-up|8
434367|NCT00480324|1446666|P1|Overall Study|Lost to Follow-up|17
434368|NCT00480324|1446665|P2|Overall Study|Withdrawal by Subject|5
434369|NCT00480324|1446666|P1|Overall Study|Withdrawal by Subject|14
434370|NCT00480324|1446665|P2|Overall Study|Protocol Violation|1
434371|NCT00480324|1446666|P1|Overall Study|Protocol Violation|0
434372|NCT00480324|1446665|P2|Overall Study|Adverse Event|1
434373|NCT00480324|1446666|P1|Overall Study|Adverse Event|1
434374|NCT00479882|1446696|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
434375|NCT00479882|1446697|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
434376|NCT00479882|1446698|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
434377|NCT00479882|1446699|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
434378|NCT00479882|1446696|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
434379|NCT00479882|1446697|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
434380|NCT00479882|1446698|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
434381|NCT00479882|1446699|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
434382|NCT00479882|1446696|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
434383|NCT00479882|1446697|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
434384|NCT00479882|1446698|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
434385|NCT00479882|1446699|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
434386|NCT00479882|1446696|P4|Crossover: Period III (Weeks 13-20)|Other|2
434387|NCT00479882|1446697|P3|Crossover: Period III (Weeks 13-20)|Other|2
434388|NCT00479882|1446698|P2|Crossover: Period III (Weeks 13-20)|Other|0
434389|NCT00479882|1446699|P1|Crossover: Period III (Weeks 13-20)|Other|5
434390|NCT00479882|1446696|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
434391|NCT00479882|1446697|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
434392|NCT00479882|1446698|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
434393|NCT00479882|1446699|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
434394|NCT00479882|1446696|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
434395|NCT00479882|1446697|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
434396|NCT00479882|1446698|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
434397|NCT00479882|1446699|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
434398|NCT00479882|1446696|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
434399|NCT00479882|1446697|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
434400|NCT00479882|1446698|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
434401|NCT00479882|1446699|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
434402|NCT00479882|1446696|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
434403|NCT00479882|1446697|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
434404|NCT00479882|1446698|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
434405|NCT00479882|1446699|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
434406|NCT00479882|1446696|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
434407|NCT00479882|1446697|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
434408|NCT00479882|1446698|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
434409|NCT00479882|1446699|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
434410|NCT00479882|1446696|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
434411|NCT00479882|1446697|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
434412|NCT00479882|1446698|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
434413|NCT00479882|1446699|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
434414|NCT00479882|1446696|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
434415|NCT00479882|1446697|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
434416|NCT00479882|1446698|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
434417|NCT00479882|1446699|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
434418|NCT00479882|1446696|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
434419|NCT00479882|1446697|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
434420|NCT00479882|1446698|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
434421|NCT00479882|1446699|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
434422|NCT00479882|1446696|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
434423|NCT00479882|1446697|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
434424|NCT00479882|1446698|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
434425|NCT00479882|1446699|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
434426|NCT00479882|1446696|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
434427|NCT00479882|1446697|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
434428|NCT00479882|1446698|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
434429|NCT00479882|1446699|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
434430|NCT00479856|1446829|P1|Overall Study|Physician Decision|1
434431|NCT00479856|1446829|P1|Overall Study|Withdrawal by Subject|1
434432|NCT00479856|1446829|P1|Overall Study|Adverse Event|1
434433|NCT00479765|1446838|P1|Overall Study|study terminated|4
434434|NCT00479713|1446844|P2|Overall Study|Withdrawal by Subject|1
434435|NCT00479713|1446845|P1|Overall Study|Withdrawal by Subject|4
434436|NCT00479713|1446844|P2|Overall Study|Protocol Violation|1
434437|NCT00479713|1446845|P1|Overall Study|Protocol Violation|0
434438|NCT00479713|1446844|P2|Overall Study|Lost to Follow-up|1
434439|NCT00479713|1446845|P1|Overall Study|Lost to Follow-up|0
434440|NCT00479713|1446844|P2|Overall Study|Death|0
434441|NCT00479713|1446845|P1|Overall Study|Death|1
434442|NCT00479713|1446844|P2|Overall Study|Adverse Event|6
434443|NCT00479713|1446845|P1|Overall Study|Adverse Event|8
434444|NCT00479674|1446869|P1|Overall Study|none provided|3
434445|NCT00479674|1446869|P1|Overall Study|Physician Decision|14
434446|NCT00479674|1446869|P1|Overall Study|Withdrawal by Subject|6
434447|NCT00479674|1446869|P1|Overall Study|Adverse Event|18
434448|NCT00479557|1446884|P7|Overall Study|Not specified|0
434449|NCT00479557|1446885|P6|Overall Study|Not specified|3
434450|NCT00479557|1446886|P5|Overall Study|Not specified|0
434451|NCT00479557|1446887|P4|Overall Study|Not specified|0
434452|NCT00479557|1446888|P3|Overall Study|Not specified|1
434453|NCT00479557|1446889|P2|Overall Study|Not specified|3
434454|NCT00479557|1446890|P1|Overall Study|Not specified|2
434455|NCT00479557|1446884|P7|Overall Study|Subject Request|1
434456|NCT00479557|1446885|P6|Overall Study|Subject Request|4
434457|NCT00479557|1446886|P5|Overall Study|Subject Request|1
434458|NCT00479557|1446887|P4|Overall Study|Subject Request|1
434459|NCT00479557|1446888|P3|Overall Study|Subject Request|1
434460|NCT00479557|1446889|P2|Overall Study|Subject Request|0
434461|NCT00479557|1446890|P1|Overall Study|Subject Request|3
434462|NCT00479557|1446884|P7|Overall Study|Investigator Request|0
434463|NCT00479557|1446885|P6|Overall Study|Investigator Request|0
434464|NCT00479557|1446886|P5|Overall Study|Investigator Request|0
434465|NCT00479557|1446887|P4|Overall Study|Investigator Request|0
434466|NCT00479557|1446888|P3|Overall Study|Investigator Request|1
434467|NCT00479557|1446889|P2|Overall Study|Investigator Request|0
434468|NCT00479557|1446890|P1|Overall Study|Investigator Request|0
434469|NCT00479557|1446884|P7|Overall Study|Caregiver Request|0
434470|NCT00479557|1446885|P6|Overall Study|Caregiver Request|2
434471|NCT00479557|1446886|P5|Overall Study|Caregiver Request|1
434472|NCT00479557|1446887|P4|Overall Study|Caregiver Request|0
434473|NCT00479557|1446888|P3|Overall Study|Caregiver Request|2
434474|NCT00479557|1446889|P2|Overall Study|Caregiver Request|2
434475|NCT00479557|1446890|P1|Overall Study|Caregiver Request|2
434476|NCT00479557|1446884|P7|Overall Study|AE not related to Study Drug|1
434477|NCT00479557|1446885|P6|Overall Study|AE not related to Study Drug|2
434478|NCT00479557|1446886|P5|Overall Study|AE not related to Study Drug|2
434479|NCT00479557|1446887|P4|Overall Study|AE not related to Study Drug|0
434480|NCT00479557|1446888|P3|Overall Study|AE not related to Study Drug|0
434481|NCT00479557|1446889|P2|Overall Study|AE not related to Study Drug|3
434482|NCT00479557|1446890|P1|Overall Study|AE not related to Study Drug|1
434483|NCT00479557|1446884|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
434484|NCT00479557|1446885|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
434485|NCT00479557|1446886|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
434486|NCT00479557|1446887|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
434487|NCT00479557|1446888|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
434488|NCT00479557|1446889|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
434489|NCT00479557|1446890|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
434490|NCT00479557|1446884|P7|Overall Study|Lost to Follow-up|0
434491|NCT00479557|1446885|P6|Overall Study|Lost to Follow-up|0
434492|NCT00479557|1446886|P5|Overall Study|Lost to Follow-up|0
434493|NCT00479557|1446887|P4|Overall Study|Lost to Follow-up|2
434494|NCT00479557|1446888|P3|Overall Study|Lost to Follow-up|0
434495|NCT00479557|1446889|P2|Overall Study|Lost to Follow-up|2
434496|NCT00479557|1446890|P1|Overall Study|Lost to Follow-up|0
434497|NCT00479557|1446884|P7|Overall Study|Lack of Efficacy|0
434498|NCT00479557|1446885|P6|Overall Study|Lack of Efficacy|0
434499|NCT00479557|1446886|P5|Overall Study|Lack of Efficacy|0
434500|NCT00479557|1446887|P4|Overall Study|Lack of Efficacy|0
434501|NCT00479557|1446888|P3|Overall Study|Lack of Efficacy|0
434502|NCT00479557|1446889|P2|Overall Study|Lack of Efficacy|0
434503|NCT00479557|1446890|P1|Overall Study|Lack of Efficacy|1
434504|NCT00479557|1446884|P7|Overall Study|Death|0
434505|NCT00479557|1446885|P6|Overall Study|Death|1
434506|NCT00479557|1446886|P5|Overall Study|Death|0
434507|NCT00479557|1446887|P4|Overall Study|Death|0
434508|NCT00479557|1446888|P3|Overall Study|Death|0
434509|NCT00479557|1446889|P2|Overall Study|Death|0
434510|NCT00479557|1446890|P1|Overall Study|Death|0
434511|NCT00479466|1446933|P6|Overall Study|Withdrawal by Subject|1
434512|NCT00479466|1446934|P5|Overall Study|Withdrawal by Subject|3
434513|NCT00479466|1446935|P4|Overall Study|Withdrawal by Subject|2
434514|NCT00479466|1446936|P3|Overall Study|Withdrawal by Subject|0
434515|NCT00479466|1446937|P2|Overall Study|Withdrawal by Subject|5
434516|NCT00479466|1446938|P1|Overall Study|Withdrawal by Subject|3
434517|NCT00479466|1446933|P6|Overall Study|Protocol Violation|0
434518|NCT00479466|1446934|P5|Overall Study|Protocol Violation|0
434519|NCT00479466|1446935|P4|Overall Study|Protocol Violation|0
434520|NCT00479466|1446936|P3|Overall Study|Protocol Violation|0
434521|NCT00479466|1446937|P2|Overall Study|Protocol Violation|0
434522|NCT00479466|1446938|P1|Overall Study|Protocol Violation|1
434523|NCT00479466|1446933|P6|Overall Study|Pregnancy|0
434524|NCT00479466|1446934|P5|Overall Study|Pregnancy|1
434525|NCT00479466|1446935|P4|Overall Study|Pregnancy|0
434526|NCT00479466|1446936|P3|Overall Study|Pregnancy|0
434527|NCT00479466|1446937|P2|Overall Study|Pregnancy|0
434528|NCT00479466|1446938|P1|Overall Study|Pregnancy|0
434529|NCT00479466|1446933|P6|Overall Study|Physician Decision|0
434530|NCT00479466|1446934|P5|Overall Study|Physician Decision|0
434531|NCT00479466|1446935|P4|Overall Study|Physician Decision|0
434532|NCT00479466|1446936|P3|Overall Study|Physician Decision|1
434533|NCT00479466|1446937|P2|Overall Study|Physician Decision|1
434534|NCT00479466|1446938|P1|Overall Study|Physician Decision|2
434535|NCT00479466|1446933|P6|Overall Study|Lost to Follow-up|2
434536|NCT00479466|1446934|P5|Overall Study|Lost to Follow-up|2
434537|NCT00479466|1446935|P4|Overall Study|Lost to Follow-up|0
434538|NCT00479466|1446936|P3|Overall Study|Lost to Follow-up|1
434539|NCT00479466|1446937|P2|Overall Study|Lost to Follow-up|1
434540|NCT00479466|1446938|P1|Overall Study|Lost to Follow-up|0
434541|NCT00479466|1446933|P6|Overall Study|Lack of Efficacy|0
434542|NCT00479466|1446934|P5|Overall Study|Lack of Efficacy|0
434543|NCT00479466|1446935|P4|Overall Study|Lack of Efficacy|0
434544|NCT00479466|1446936|P3|Overall Study|Lack of Efficacy|1
434545|NCT00479466|1446937|P2|Overall Study|Lack of Efficacy|0
434546|NCT00479466|1446938|P1|Overall Study|Lack of Efficacy|2
434547|NCT00479466|1446933|P6|Overall Study|Hyperglycemia|1
434548|NCT00479466|1446934|P5|Overall Study|Hyperglycemia|0
434549|NCT00479466|1446935|P4|Overall Study|Hyperglycemia|0
434550|NCT00479466|1446936|P3|Overall Study|Hyperglycemia|0
434551|NCT00479466|1446937|P2|Overall Study|Hyperglycemia|0
434552|NCT00479466|1446938|P1|Overall Study|Hyperglycemia|0
434553|NCT00479466|1446933|P6|Overall Study|Adverse Event|0
434554|NCT00479466|1446934|P5|Overall Study|Adverse Event|2
434555|NCT00479466|1446935|P4|Overall Study|Adverse Event|1
434556|NCT00479466|1446936|P3|Overall Study|Adverse Event|0
434557|NCT00479466|1446937|P2|Overall Study|Adverse Event|1
434558|NCT00479466|1446938|P1|Overall Study|Adverse Event|5
434559|NCT00479401|1446967|P3|Overall Study|Exclusion criteria, relocation|0
434560|NCT00479401|1446968|P2|Overall Study|Exclusion criteria, relocation|3
434561|NCT00479401|1446969|P1|Overall Study|Exclusion criteria, relocation|4
434562|NCT00479401|1446967|P3|Overall Study|Withdrawal by Subject|2
434563|NCT00479401|1446968|P2|Overall Study|Withdrawal by Subject|10
434564|NCT00479401|1446969|P1|Overall Study|Withdrawal by Subject|16
434565|NCT00479401|1446967|P3|Overall Study|Lost to Follow-up|1
434566|NCT00479401|1446968|P2|Overall Study|Lost to Follow-up|1
434567|NCT00479401|1446969|P1|Overall Study|Lost to Follow-up|1
434568|NCT00479401|1446967|P3|Overall Study|Protocol Violation|1
434569|NCT00479401|1446968|P2|Overall Study|Protocol Violation|1
434570|NCT00479401|1446969|P1|Overall Study|Protocol Violation|2
434571|NCT00479401|1446967|P3|Overall Study|Lack of Efficacy|4
434572|NCT00479401|1446968|P2|Overall Study|Lack of Efficacy|2
434573|NCT00479401|1446969|P1|Overall Study|Lack of Efficacy|2
434574|NCT00479401|1446967|P3|Overall Study|Adverse Event|4
434575|NCT00479401|1446968|P2|Overall Study|Adverse Event|20
434576|NCT00479401|1446969|P1|Overall Study|Adverse Event|24
434577|NCT00479388|1447024|P2|Overall Study|Withdrawal by Subject|17
434578|NCT00479388|1447025|P1|Overall Study|Withdrawal by Subject|32
434579|NCT00479388|1447024|P2|Overall Study|Protocol Violation|9
434580|NCT00479388|1447025|P1|Overall Study|Protocol Violation|10
434581|NCT00479388|1447024|P2|Overall Study|Lost to Follow-up|2
434582|NCT00479388|1447025|P1|Overall Study|Lost to Follow-up|0
434583|NCT00479388|1447024|P2|Overall Study|Adverse Event|45
434584|NCT00479388|1447025|P1|Overall Study|Adverse Event|90
434585|NCT00479336|1447039|P4|Overall Study|Resolution of all hepatic edema findings|0
434586|NCT00479336|1447040|P3|Overall Study|Resolution of all hepatic edema findings|0
434587|NCT00479336|1447041|P2|Overall Study|Resolution of all hepatic edema findings|1
434588|NCT00479336|1447042|P1|Overall Study|Resolution of all hepatic edema findings|1
434589|NCT00479336|1447039|P4|Overall Study|Physician Decision|2
434590|NCT00479336|1447040|P3|Overall Study|Physician Decision|0
434591|NCT00479336|1447041|P2|Overall Study|Physician Decision|1
434592|NCT00479336|1447042|P1|Overall Study|Physician Decision|0
434593|NCT00479336|1447039|P4|Overall Study|Withdrawal by Subject|0
434594|NCT00479336|1447040|P3|Overall Study|Withdrawal by Subject|0
434595|NCT00479336|1447041|P2|Overall Study|Withdrawal by Subject|2
434596|NCT00479336|1447042|P1|Overall Study|Withdrawal by Subject|1
434597|NCT00479336|1447039|P4|Overall Study|Protocol Violation|0
434598|NCT00479336|1447040|P3|Overall Study|Protocol Violation|0
434599|NCT00479336|1447041|P2|Overall Study|Protocol Violation|1
434600|NCT00479336|1447042|P1|Overall Study|Protocol Violation|0
434601|NCT00479336|1447039|P4|Overall Study|Lack of Efficacy|0
434602|NCT00479336|1447040|P3|Overall Study|Lack of Efficacy|0
434603|NCT00479336|1447041|P2|Overall Study|Lack of Efficacy|0
434604|NCT00479336|1447042|P1|Overall Study|Lack of Efficacy|1
434605|NCT00479336|1447039|P4|Overall Study|Adverse Event|3
434606|NCT00479336|1447040|P3|Overall Study|Adverse Event|1
434607|NCT00479336|1447041|P2|Overall Study|Adverse Event|1
434608|NCT00479336|1447042|P1|Overall Study|Adverse Event|1
434609|NCT00479232|1447065|P6|Overall Study|Withdrew Consent|3
434610|NCT00479232|1447066|P5|Overall Study|Withdrew Consent|1
434611|NCT00479232|1447067|P4|Overall Study|Withdrew Consent|0
434612|NCT00479232|1447068|P3|Overall Study|Withdrew Consent|6
434613|NCT00479232|1447069|P2|Overall Study|Withdrew Consent|2
434614|NCT00479232|1447070|P1|Overall Study|Withdrew Consent|0
434615|NCT00479232|1447065|P6|Overall Study|Progressive Disease|12
434616|NCT00479232|1447066|P5|Overall Study|Progressive Disease|3
434617|NCT00479232|1447067|P4|Overall Study|Progressive Disease|3
434618|NCT00479232|1447068|P3|Overall Study|Progressive Disease|12
434619|NCT00479232|1447069|P2|Overall Study|Progressive Disease|1
434620|NCT00479232|1447070|P1|Overall Study|Progressive Disease|3
434621|NCT00479232|1447065|P6|Overall Study|Physician Decision|1
434622|NCT00479232|1447066|P5|Overall Study|Physician Decision|0
434623|NCT00479232|1447067|P4|Overall Study|Physician Decision|0
434624|NCT00479232|1447068|P3|Overall Study|Physician Decision|2
434625|NCT00479232|1447069|P2|Overall Study|Physician Decision|0
434626|NCT00479232|1447070|P1|Overall Study|Physician Decision|0
434627|NCT00479232|1447065|P6|Overall Study|Lack of Efficacy|4
434628|NCT00479232|1447066|P5|Overall Study|Lack of Efficacy|0
434629|NCT00479232|1447067|P4|Overall Study|Lack of Efficacy|0
434630|NCT00479232|1447068|P3|Overall Study|Lack of Efficacy|2
434631|NCT00479232|1447069|P2|Overall Study|Lack of Efficacy|0
434632|NCT00479232|1447070|P1|Overall Study|Lack of Efficacy|0
434633|NCT00479232|1447065|P6|Overall Study|Deviation from Protocol|0
434634|NCT00479232|1447066|P5|Overall Study|Deviation from Protocol|0
434635|NCT00479232|1447067|P4|Overall Study|Deviation from Protocol|0
434636|NCT00479232|1447068|P3|Overall Study|Deviation from Protocol|1
434637|NCT00479232|1447069|P2|Overall Study|Deviation from Protocol|0
434638|NCT00479232|1447070|P1|Overall Study|Deviation from Protocol|0
434639|NCT00479232|1447065|P6|Overall Study|Adverse Event|10
434640|NCT00479232|1447066|P5|Overall Study|Adverse Event|0
434641|NCT00479232|1447067|P4|Overall Study|Adverse Event|0
434642|NCT00479232|1447068|P3|Overall Study|Adverse Event|5
434643|NCT00479232|1447069|P2|Overall Study|Adverse Event|0
434644|NCT00479232|1447070|P1|Overall Study|Adverse Event|0
434645|NCT00478933|1447123|P1|Overall Study|Inadequate data available|53
434646|NCT00478933|1447123|P1|Overall Study|Informed consent not verified|3
434647|NCT00478933|1447123|P1|Overall Study|Protocol Violation|22
434648|NCT00478881|1447149|P2|Overall Study|Non-Compliance with Study Medication|2
434649|NCT00478881|1447150|P1|Overall Study|Non-Compliance with Study Medication|0
434650|NCT00478881|1447149|P2|Overall Study|Withdrawal by Subject|2
434651|NCT00478881|1447150|P1|Overall Study|Withdrawal by Subject|6
434652|NCT00478881|1447149|P2|Overall Study|Protocol Violation|2
434653|NCT00478881|1447150|P1|Overall Study|Protocol Violation|2
434654|NCT00478881|1447149|P2|Overall Study|Lost to Follow-up|1
434655|NCT00478881|1447150|P1|Overall Study|Lost to Follow-up|0
434656|NCT00478881|1447149|P2|Overall Study|Lack of Efficacy|3
434657|NCT00478881|1447150|P1|Overall Study|Lack of Efficacy|0
434658|NCT00478881|1447149|P2|Overall Study|Adverse Event|12
434659|NCT00478881|1447150|P1|Overall Study|Adverse Event|31
434660|NCT00478777|1447174|P1|Overall Study|Not treated with lenalidomide|6
434661|NCT00478777|1447174|P1|Overall Study|End of therapy|2
434662|NCT00478777|1447174|P1|Overall Study|Lymphocytes infusion|1
434663|NCT00478777|1447174|P1|Overall Study|Lack of compliance|1
434664|NCT00478777|1447174|P1|Overall Study|Intolerance of therapy|1
434665|NCT00478777|1447174|P1|Overall Study|Physician Decision|1
434666|NCT00478777|1447174|P1|Overall Study|Lost to Follow-up|3
434667|NCT00478777|1447174|P1|Overall Study|Protocol Violation|3
434668|NCT00478777|1447174|P1|Overall Study|Death|3
434669|NCT00478777|1447174|P1|Overall Study|Withdrawal by Subject|4
434670|NCT00478777|1447174|P1|Overall Study|Lack of Efficacy|23
434671|NCT00478777|1447174|P1|Overall Study|Adverse Event|29
434672|NCT00478673|1447181|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
434673|NCT00478673|1447181|P1|12-Months Post-Procedure|Missed Visit|25
434674|NCT00478673|1447181|P1|12-Months Post-Procedure|Withdrawal by Subject|6
434675|NCT00478673|1447181|P1|12-Months Post-Procedure|Lost to Follow-up|4
434676|NCT00478673|1447181|P1|12-Months Post-Procedure|Death|23
434677|NCT00478673|1447181|P1|30-Days Post-Procedure|Missed Visit|7
434678|NCT00478673|1447181|P1|30-Days Post-Procedure|Withdrawal by Subject|1
434679|NCT00478673|1447181|P1|30-Days Post-Procedure|Death|2
434680|NCT00478647|1447186|P1|Overall Study|Withdrawal by Subject|1
434681|NCT00478647|1447186|P1|Overall Study|Adverse Event|1
434682|NCT00478608|1447194|P1|Overall Study|Protocol Violation|3
434683|NCT00478608|1447194|P1|Overall Study|Withdrawal by Subject|2
434684|NCT00478608|1447194|P1|Overall Study|Serious Adverse Event|14
434685|NCT00478608|1447194|P1|Overall Study|Adverse Event|1
434686|NCT00478257|1447238|P2|Overall Study|Withdrawal by Subject|3
434687|NCT00478257|1447239|P1|Overall Study|Withdrawal by Subject|8
434688|NCT00478244|1447245|P1|Overall Study|Did not receive transplant|1
434689|NCT00478231|1447258|P1|Overall Study|Randomized, not treated|3
434690|NCT00478231|1447258|P1|Overall Study|Adverse Event|5
434691|NCT00478231|1447258|P1|Overall Study|Other|9
434692|NCT00478231|1447258|P1|Overall Study|Withdrawal by Subject|6
434693|NCT00478231|1447258|P1|Overall Study|Lost to Follow-up|7
434694|NCT00478231|1447258|P1|Overall Study|Lack of Efficacy|47
434695|NCT00478231|1447258|P1|Overall Study|Death|7
434696|NCT00478205|1447294|P2|Overall Study|Not specified|12
434697|NCT00478205|1447295|P1|Overall Study|Not specified|24
434698|NCT00478205|1447294|P2|Overall Study|Lack of Efficacy|0
434699|NCT00478205|1447295|P1|Overall Study|Lack of Efficacy|1
434700|NCT00478205|1447294|P2|Overall Study|Withdrawal by Subject|22
434701|NCT00478205|1447295|P1|Overall Study|Withdrawal by Subject|61
434702|NCT00478205|1447294|P2|Overall Study|Request of Investigator or Sponsor|5
434703|NCT00478205|1447295|P1|Overall Study|Request of Investigator or Sponsor|4
434704|NCT00478205|1447294|P2|Overall Study|Protocol Violation|5
434705|NCT00478205|1447295|P1|Overall Study|Protocol Violation|15
434706|NCT00478205|1447294|P2|Overall Study|Medication Non-compliance|4
434707|NCT00478205|1447295|P1|Overall Study|Medication Non-compliance|9
434708|NCT00478205|1447294|P2|Overall Study|Adverse Event|39
434709|NCT00478205|1447295|P1|Overall Study|Adverse Event|182
434710|NCT00478140|1447339|P1|Overall Study|Disease Progression|3
434711|NCT00478023|1447368|P5|Overall Study|Lack of pain, Technical difficulties|3
434712|NCT00478023|1447369|P4|Overall Study|Lack of pain, Technical difficulties|6
434713|NCT00478023|1447370|P3|Overall Study|Lack of pain, Technical difficulties|5
434714|NCT00478023|1447371|P2|Overall Study|Lack of pain, Technical difficulties|3
434715|NCT00478023|1447372|P1|Overall Study|Lack of pain, Technical difficulties|7
434716|NCT00478023|1447368|P5|Overall Study|Withdrawal by Subject|5
434717|NCT00478023|1447369|P4|Overall Study|Withdrawal by Subject|4
434718|NCT00478023|1447370|P3|Overall Study|Withdrawal by Subject|2
434719|NCT00478023|1447371|P2|Overall Study|Withdrawal by Subject|3
434720|NCT00478023|1447372|P1|Overall Study|Withdrawal by Subject|2
434721|NCT00478023|1447368|P5|Overall Study|Lost to Follow-up|0
434722|NCT00478023|1447369|P4|Overall Study|Lost to Follow-up|1
434723|NCT00478023|1447370|P3|Overall Study|Lost to Follow-up|1
434724|NCT00478023|1447371|P2|Overall Study|Lost to Follow-up|1
434725|NCT00478023|1447372|P1|Overall Study|Lost to Follow-up|3
434726|NCT00478023|1447368|P5|Overall Study|Lack of Efficacy|41
434727|NCT00478023|1447369|P4|Overall Study|Lack of Efficacy|5
434728|NCT00478023|1447370|P3|Overall Study|Lack of Efficacy|4
434729|NCT00478023|1447371|P2|Overall Study|Lack of Efficacy|10
434730|NCT00478023|1447372|P1|Overall Study|Lack of Efficacy|11
434731|NCT00478023|1447368|P5|Overall Study|Death|0
434732|NCT00478023|1447369|P4|Overall Study|Death|0
434733|NCT00478023|1447370|P3|Overall Study|Death|0
434734|NCT00478023|1447371|P2|Overall Study|Death|0
434735|NCT00478023|1447372|P1|Overall Study|Death|1
434736|NCT00478023|1447368|P5|Overall Study|Adverse Event|6
434737|NCT00478023|1447369|P4|Overall Study|Adverse Event|14
434738|NCT00478023|1447370|P3|Overall Study|Adverse Event|8
434739|NCT00478023|1447371|P2|Overall Study|Adverse Event|7
434740|NCT00478023|1447372|P1|Overall Study|Adverse Event|11
434741|NCT00477971|1447391|P2|Overall Study|Alternative treatment|1
434742|NCT00477971|1447392|P1|Overall Study|Alternative treatment|3
434743|NCT00477971|1447391|P2|Overall Study|Death|4
434744|NCT00477971|1447392|P1|Overall Study|Death|2
434745|NCT00477971|1447391|P2|Overall Study|Adverse Event|0
434746|NCT00477971|1447392|P1|Overall Study|Adverse Event|3
434747|NCT00477971|1447391|P2|Overall Study|Withdrawal by Subject|1
434748|NCT00477971|1447392|P1|Overall Study|Withdrawal by Subject|3
434749|NCT00477971|1447391|P2|Overall Study|Disease progression|0
434750|NCT00477971|1447392|P1|Overall Study|Disease progression|6
434751|NCT00477750|1447404|P1|Overall Study|Currently Receiving Treatment|11
434752|NCT00477672|1447416|P3|Overall Study|Discretion of Sponsor|0
434753|NCT00477672|1447417|P2|Overall Study|Discretion of Sponsor|2
434754|NCT00477672|1447418|P1|Overall Study|Discretion of Sponsor|1
434755|NCT00477672|1447416|P3|Overall Study|Consent withdrawn|10
434756|NCT00477672|1447417|P2|Overall Study|Consent withdrawn|5
434757|NCT00477672|1447418|P1|Overall Study|Consent withdrawn|2
434758|NCT00477672|1447416|P3|Overall Study|Protocol noncompliance|0
434759|NCT00477672|1447417|P2|Overall Study|Protocol noncompliance|2
434760|NCT00477672|1447418|P1|Overall Study|Protocol noncompliance|0
434761|NCT00477672|1447416|P3|Overall Study|Physician Decision|0
434762|NCT00477672|1447417|P2|Overall Study|Physician Decision|0
434763|NCT00477672|1447418|P1|Overall Study|Physician Decision|1
434764|NCT00477672|1447416|P3|Overall Study|Disease progression|0
434765|NCT00477672|1447417|P2|Overall Study|Disease progression|1
434766|NCT00477672|1447418|P1|Overall Study|Disease progression|0
434767|NCT00477672|1447416|P3|Overall Study|Death|0
434768|NCT00477672|1447417|P2|Overall Study|Death|1
434769|NCT00477672|1447418|P1|Overall Study|Death|0
434770|NCT00477672|1447416|P3|Overall Study|Adverse Event|6
434771|NCT00477672|1447417|P2|Overall Study|Adverse Event|5
434772|NCT00477672|1447418|P1|Overall Study|Adverse Event|3
434773|NCT00477633|1447429|P1|Overall Study|Various (Moving, Enrollment closed)|75
434774|NCT00477633|1447429|P1|Overall Study|Protocol Violation|25
434775|NCT00477633|1447429|P1|Overall Study|Withdrawal by Subject|149
434776|NCT00477633|1447429|P1|Overall Study|Lost to Follow-up|271
434777|NCT00477633|1447429|P1|Overall Study|Pregnancy|23
434778|NCT00477633|1447429|P1|Overall Study|Adverse Event|143
434779|NCT00477633|1447429|P1|Overall Study|Did not receive treatment|23
434780|NCT00477607|1447437|P2|Overall Study|Lost to Follow-up|7
434781|NCT00477607|1447438|P1|Overall Study|Lost to Follow-up|7
434782|NCT00477594|1447450|P2|Follow-up Period|Other|0
434783|NCT00477594|1447451|P1|Follow-up Period|Other|1
434784|NCT00477594|1447450|P2|Follow-up Period|Withdrawal by Subject|1
434785|NCT00477594|1447451|P1|Follow-up Period|Withdrawal by Subject|2
434786|NCT00477594|1447450|P2|Year 3|Withdrawal by Subject|0
434787|NCT00477594|1447451|P1|Year 3|Withdrawal by Subject|1
434788|NCT00477594|1447450|P2|Year 3|Adverse Event|0
434789|NCT00477594|1447451|P1|Year 3|Adverse Event|1
434790|NCT00477594|1447450|P2|Year 1 and Year 2|Other|0
434791|NCT00477594|1447451|P1|Year 1 and Year 2|Other|1
434792|NCT00477594|1447450|P2|Year 1 and Year 2|Withdrawal by Subject|1
434793|NCT00477594|1447451|P1|Year 1 and Year 2|Withdrawal by Subject|2
434794|NCT00477594|1447450|P2|Year 1 and Year 2|Physician Decision|1
434795|NCT00477594|1447451|P1|Year 1 and Year 2|Physician Decision|2
434796|NCT00477594|1447450|P2|Year 1 and Year 2|Adverse Event|2
434797|NCT00477594|1447451|P1|Year 1 and Year 2|Adverse Event|4
434798|NCT00477490|1447512|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
434799|NCT00477490|1447513|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
434800|NCT00477490|1447514|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
434801|NCT00477490|1447515|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
434802|NCT00477490|1447516|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
434803|NCT00477490|1447517|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
434804|NCT00477490|1447518|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
434805|NCT00477490|1447519|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
434806|NCT00477490|1447520|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
434807|NCT00477490|1447512|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
434808|NCT00477490|1447513|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
434809|NCT00477490|1447514|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
434810|NCT00477490|1447515|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
434811|NCT00477490|1447516|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
434812|NCT00477490|1447517|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
434813|NCT00477490|1447518|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
434814|NCT00477490|1447519|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
434815|NCT00477490|1447520|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
434816|NCT00477490|1447512|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434817|NCT00477490|1447513|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434818|NCT00477490|1447514|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434819|NCT00477490|1447515|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434820|NCT00477490|1447516|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434821|NCT00477490|1447517|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434822|NCT00477490|1447518|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434823|NCT00477490|1447519|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
434824|NCT00477490|1447520|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
434825|NCT00477490|1447512|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
434826|NCT00477490|1447513|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
434827|NCT00477490|1447514|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
434828|NCT00477490|1447515|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
434829|NCT00477490|1447516|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
434830|NCT00477490|1447517|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
434831|NCT00477490|1447518|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
434832|NCT00477490|1447519|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
434833|NCT00477490|1447520|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
434834|NCT00477490|1447512|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
434835|NCT00477490|1447513|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
434836|NCT00477490|1447514|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
434837|NCT00477490|1447515|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
434838|NCT00477490|1447516|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
434839|NCT00477490|1447517|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
434840|NCT00477490|1447518|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
434841|NCT00477490|1447519|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
434842|NCT00477490|1447520|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
434843|NCT00477490|1447512|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
434844|NCT00477490|1447513|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
434845|NCT00477490|1447514|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
434846|NCT00477490|1447515|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
434847|NCT00477490|1447516|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
434848|NCT00477490|1447517|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
434849|NCT00477490|1447518|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
434850|NCT00477490|1447519|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
434851|NCT00477490|1447520|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
434852|NCT00477490|1447512|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
434853|NCT00477490|1447513|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
434854|NCT00477490|1447514|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
434855|NCT00477490|1447515|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
434856|NCT00477490|1447516|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
434857|NCT00477490|1447517|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
434858|NCT00477490|1447518|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
434859|NCT00477490|1447519|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
434860|NCT00477490|1447520|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
434861|NCT00477490|1447512|P9|Part I: 4 Week Efficacy|Not Reported|0
434862|NCT00477490|1447513|P8|Part I: 4 Week Efficacy|Not Reported|0
434863|NCT00477490|1447514|P7|Part I: 4 Week Efficacy|Not Reported|0
434864|NCT00477490|1447515|P6|Part I: 4 Week Efficacy|Not Reported|0
434865|NCT00477490|1447516|P5|Part I: 4 Week Efficacy|Not Reported|1
434866|NCT00477490|1447517|P4|Part I: 4 Week Efficacy|Not Reported|0
434867|NCT00477490|1447518|P3|Part I: 4 Week Efficacy|Not Reported|3
434868|NCT00477490|1447519|P2|Part I: 4 Week Efficacy|Not Reported|2
434869|NCT00477490|1447520|P1|Part I: 4 Week Efficacy|Not Reported|1
434870|NCT00477490|1447512|P9|Part I: 4 Week Efficacy|Other, not specified|0
434871|NCT00477490|1447513|P8|Part I: 4 Week Efficacy|Other, not specified|0
434872|NCT00477490|1447514|P7|Part I: 4 Week Efficacy|Other, not specified|0
434873|NCT00477490|1447515|P6|Part I: 4 Week Efficacy|Other, not specified|0
434874|NCT00477490|1447516|P5|Part I: 4 Week Efficacy|Other, not specified|1
434875|NCT00477490|1447517|P4|Part I: 4 Week Efficacy|Other, not specified|1
434876|NCT00477490|1447518|P3|Part I: 4 Week Efficacy|Other, not specified|0
434877|NCT00477490|1447519|P2|Part I: 4 Week Efficacy|Other, not specified|4
434878|NCT00477490|1447520|P1|Part I: 4 Week Efficacy|Other, not specified|2
434879|NCT00477490|1447512|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
434880|NCT00477490|1447513|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
434881|NCT00477490|1447514|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
434882|NCT00477490|1447515|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
434883|NCT00477490|1447516|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
434884|NCT00477490|1447517|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
434885|NCT00477490|1447518|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
434886|NCT00477490|1447519|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
434887|NCT00477490|1447520|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
434888|NCT00477490|1447512|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
434889|NCT00477490|1447513|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
434890|NCT00477490|1447514|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
434891|NCT00477490|1447515|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
434892|NCT00477490|1447516|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
434893|NCT00477490|1447517|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
434894|NCT00477490|1447518|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
434895|NCT00477490|1447519|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
434896|NCT00477490|1447520|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
434897|NCT00477490|1447512|P9|Part I: 4 Week Efficacy|Protocol Violation|0
434898|NCT00477490|1447513|P8|Part I: 4 Week Efficacy|Protocol Violation|0
434899|NCT00477490|1447514|P7|Part I: 4 Week Efficacy|Protocol Violation|0
434900|NCT00477490|1447515|P6|Part I: 4 Week Efficacy|Protocol Violation|0
434901|NCT00477490|1447516|P5|Part I: 4 Week Efficacy|Protocol Violation|1
434902|NCT00477490|1447517|P4|Part I: 4 Week Efficacy|Protocol Violation|0
434903|NCT00477490|1447518|P3|Part I: 4 Week Efficacy|Protocol Violation|0
434904|NCT00477490|1447519|P2|Part I: 4 Week Efficacy|Protocol Violation|0
434905|NCT00477490|1447520|P1|Part I: 4 Week Efficacy|Protocol Violation|2
434906|NCT00477490|1447512|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
434907|NCT00477490|1447513|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
434908|NCT00477490|1447514|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
434909|NCT00477490|1447515|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
434910|NCT00477490|1447516|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
434911|NCT00477490|1447517|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
434912|NCT00477490|1447518|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
434913|NCT00477490|1447519|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
434914|NCT00477490|1447520|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
434915|NCT00477490|1447512|P9|Part I: 4 Week Efficacy|Adverse Event|0
434916|NCT00477490|1447513|P8|Part I: 4 Week Efficacy|Adverse Event|0
434917|NCT00477490|1447514|P7|Part I: 4 Week Efficacy|Adverse Event|0
434918|NCT00477490|1447515|P6|Part I: 4 Week Efficacy|Adverse Event|0
434919|NCT00477490|1447516|P5|Part I: 4 Week Efficacy|Adverse Event|6
434920|NCT00477490|1447517|P4|Part I: 4 Week Efficacy|Adverse Event|5
434921|NCT00477490|1447518|P3|Part I: 4 Week Efficacy|Adverse Event|0
434922|NCT00477490|1447519|P2|Part I: 4 Week Efficacy|Adverse Event|4
434923|NCT00477490|1447520|P1|Part I: 4 Week Efficacy|Adverse Event|1
434924|NCT00477464|1447604|P1|Overall Study|Completion of protocol-defined follow-up|14
434925|NCT00477464|1447604|P1|Overall Study|Death|36
434926|NCT00477464|1447604|P1|Overall Study|Lost to Follow-up|1
434927|NCT00477386|1447648|P2|Overall Study|Withdrawal by Subject|0
434928|NCT00477386|1447649|P1|Overall Study|Withdrawal by Subject|1
434929|NCT00477386|1447648|P2|Overall Study|Physician Decision|0
434930|NCT00477386|1447649|P1|Overall Study|Physician Decision|1
434931|NCT00477386|1447648|P2|Overall Study|Other|2
434932|NCT00477386|1447649|P1|Overall Study|Other|1
434933|NCT00477386|1447648|P2|Overall Study|Disease progression, refractory|3
434934|NCT00477386|1447649|P1|Overall Study|Disease progression, refractory|1
434935|NCT00477386|1447648|P2|Overall Study|Disease progression, relapse|4
434936|NCT00477386|1447649|P1|Overall Study|Disease progression, relapse|3
434937|NCT00477386|1447648|P2|Overall Study|Adverse Event|8
434938|NCT00477386|1447649|P1|Overall Study|Adverse Event|4
434939|NCT00477334|1447659|P2|Overall Study|Protocol Violation|1
434940|NCT00477334|1447660|P1|Overall Study|Protocol Violation|7
434941|NCT00477334|1447659|P2|Overall Study|Administrative Problems|15
434942|NCT00477334|1447660|P1|Overall Study|Administrative Problems|39
434943|NCT00477334|1447659|P2|Overall Study|Lost to Follow-up|4
434944|NCT00477334|1447660|P1|Overall Study|Lost to Follow-up|15
434945|NCT00477334|1447659|P2|Overall Study|Withdrawal by Subject|1
434946|NCT00477334|1447660|P1|Overall Study|Withdrawal by Subject|2
434947|NCT00477334|1447659|P2|Overall Study|Adverse Event|2
434948|NCT00477334|1447660|P1|Overall Study|Adverse Event|1
434949|NCT00477334|1447659|P2|Overall Study|Discontinued prior to taking study drug|53
434950|NCT00477334|1447660|P1|Overall Study|Discontinued prior to taking study drug|106
434951|NCT00477295|1447686|P2|Overall Study|Not specified|3
434952|NCT00477295|1447687|P1|Overall Study|Not specified|4
434953|NCT00477295|1447686|P2|Overall Study|Lost to Follow-up|11
434954|NCT00477295|1447687|P1|Overall Study|Lost to Follow-up|21
434955|NCT00477295|1447686|P2|Overall Study|Physician Decision|5
434956|NCT00477295|1447687|P1|Overall Study|Physician Decision|4
434957|NCT00477295|1447686|P2|Overall Study|Protocol Violation|8
434958|NCT00477295|1447687|P1|Overall Study|Protocol Violation|3
434959|NCT00477295|1447686|P2|Overall Study|Lack of Efficacy|23
434960|NCT00477295|1447687|P1|Overall Study|Lack of Efficacy|23
434961|NCT00477295|1447686|P2|Overall Study|Withdrawal by Subject|24
434962|NCT00477295|1447687|P1|Overall Study|Withdrawal by Subject|35
434963|NCT00477295|1447686|P2|Overall Study|Adverse Event|35
434964|NCT00477295|1447687|P1|Overall Study|Adverse Event|31
434965|NCT00477269|1447715|P3|Open Label Extension|Death|4
434966|NCT00477269|1447716|P2|Open Label Extension|Death|0
434967|NCT00477269|1447717|P1|Open Label Extension|Death|0
434968|NCT00477269|1447715|P3|Open Label Extension|Adminiatrative problems|2
434969|NCT00477269|1447716|P2|Open Label Extension|Adminiatrative problems|0
434970|NCT00477269|1447717|P1|Open Label Extension|Adminiatrative problems|0
434971|NCT00477269|1447715|P3|Open Label Extension|unsatisfactory therapeutic effects|2
434972|NCT00477269|1447716|P2|Open Label Extension|unsatisfactory therapeutic effects|0
434973|NCT00477269|1447717|P1|Open Label Extension|unsatisfactory therapeutic effects|0
434974|NCT00477269|1447715|P3|Open Label Extension|Abnormal laboratory values|1
434975|NCT00477269|1447716|P2|Open Label Extension|Abnormal laboratory values|0
434976|NCT00477269|1447717|P1|Open Label Extension|Abnormal laboratory values|0
434977|NCT00477269|1447715|P3|Open Label Extension|Adverse Event|4
434978|NCT00477269|1447716|P2|Open Label Extension|Adverse Event|0
434979|NCT00477269|1447717|P1|Open Label Extension|Adverse Event|0
434980|NCT00477269|1447715|P3|Core Study|Withdrawn Consent|0
434981|NCT00477269|1447716|P2|Core Study|Withdrawn Consent|1
434982|NCT00477269|1447717|P1|Core Study|Withdrawn Consent|0
434983|NCT00477269|1447715|P3|Core Study|Death|0
434984|NCT00477269|1447716|P2|Core Study|Death|3
434985|NCT00477269|1447717|P1|Core Study|Death|3
434986|NCT00477269|1447715|P3|Core Study|Adverse Event|0
434987|NCT00477269|1447716|P2|Core Study|Adverse Event|4
434988|NCT00477269|1447717|P1|Core Study|Adverse Event|6
434989|NCT00477165|1447796|P2|Overall Study|Adverse Event|2
434990|NCT00477165|1447797|P1|Overall Study|Adverse Event|7
434991|NCT00477152|1447809|P1|Overall Study|Adverse Event|1
434992|NCT00477152|1447809|P1|Overall Study|Parent withdrew consent|2
434993|NCT00476957|1447824|P2|Overall Study|Lost to Follow-up|193
434994|NCT00476957|1447825|P1|Overall Study|Lost to Follow-up|176
434995|NCT00476593|1447889|P4|Overall Study|Lost to Follow-up|22
434996|NCT00476593|1447890|P3|Overall Study|Lost to Follow-up|8
434997|NCT00476593|1447891|P2|Overall Study|Lost to Follow-up|2
434998|NCT00476593|1447892|P1|Overall Study|Lost to Follow-up|10
434999|NCT00476476|1447904|P2|Overall Study|Progressive Disease|17
435000|NCT00476476|1447905|P1|Overall Study|Progressive Disease|0
435001|NCT00476476|1447904|P2|Overall Study|Adverse Event|7
435002|NCT00476476|1447905|P1|Overall Study|Adverse Event|2
435003|NCT00476229|1447921|P1|Overall Study|Progressive shortness of breath|1
435004|NCT00476151|1447927|P2|Overall Study|Physician Decision|2
435005|NCT00476151|1447928|P1|Overall Study|Physician Decision|0
435006|NCT00476151|1447927|P2|Overall Study|Withdrawal by Subject|0
435007|NCT00476151|1447928|P1|Overall Study|Withdrawal by Subject|2
435008|NCT00476151|1447927|P2|Overall Study|Protocol Violation|3
435009|NCT00476151|1447928|P1|Overall Study|Protocol Violation|1
435010|NCT00476151|1447927|P2|Overall Study|Adverse Event|2
435011|NCT00476151|1447928|P1|Overall Study|Adverse Event|0
435012|NCT00476086|1447934|P1|Overall Study|Progressive Disease|4
435013|NCT00476086|1447934|P1|Overall Study|Alternative therapy|1
435014|NCT00476047|1447940|P1|Overall Study|Lost to Follow-up|1
435015|NCT00476008|1447966|P2|Overall Study|Death|0
435016|NCT00476008|1447967|P1|Overall Study|Death|1
435017|NCT00476008|1447966|P2|Overall Study|Withdrawal by Subject|1
435018|NCT00476008|1447967|P1|Overall Study|Withdrawal by Subject|0
435019|NCT00476008|1447966|P2|Overall Study|Physician Decision: Medication Noncompli|1
435020|NCT00476008|1447967|P1|Overall Study|Physician Decision: Medication Noncompli|2
435021|NCT00476008|1447966|P2|Overall Study|Placebo concerns|2
435022|NCT00476008|1447967|P1|Overall Study|Placebo concerns|2
435023|NCT00476008|1447966|P2|Overall Study|Adverse Event|4
435024|NCT00476008|1447967|P1|Overall Study|Adverse Event|4
435025|NCT00475865|1448021|P3|Overall Study|Other than above|0
435026|NCT00475865|1448022|P2|Overall Study|Other than above|1
435027|NCT00475865|1448023|P1|Overall Study|Other than above|0
435028|NCT00475865|1448021|P3|Overall Study|Participant did not wish to continue|0
435029|NCT00475865|1448022|P2|Overall Study|Participant did not wish to continue|0
435030|NCT00475865|1448023|P1|Overall Study|Participant did not wish to continue|1
435031|NCT00475865|1448021|P3|Overall Study|Progressive disease|2
435032|NCT00475865|1448022|P2|Overall Study|Progressive disease|1
435033|NCT00475865|1448023|P1|Overall Study|Progressive disease|0
435034|NCT00475865|1448021|P3|Overall Study|Lack of Efficacy|0
435035|NCT00475865|1448022|P2|Overall Study|Lack of Efficacy|0
435036|NCT00475865|1448023|P1|Overall Study|Lack of Efficacy|1
435037|NCT00475865|1448021|P3|Overall Study|Adverse Event|4
435038|NCT00475865|1448022|P2|Overall Study|Adverse Event|3
435039|NCT00475865|1448023|P1|Overall Study|Adverse Event|0
435040|NCT00475852|1448053|P2|Overall Study|Lost to Follow-up|68
435041|NCT00475852|1448054|P1|Overall Study|Lost to Follow-up|54
435042|NCT00475852|1448053|P2|Overall Study|Withdrawal by Subject|24
435043|NCT00475852|1448054|P1|Overall Study|Withdrawal by Subject|19
435044|NCT00475852|1448053|P2|Overall Study|Death|456
435045|NCT00475852|1448054|P1|Overall Study|Death|444
435046|NCT00475735|1448105|P6|Treatment Period 2|Withdrawal by Subject|0
435047|NCT00475735|1448106|P5|Treatment Period 2|Withdrawal by Subject|1
435048|NCT00475735|1448107|P4|Treatment Period 2|Withdrawal by Subject|0
435049|NCT00475735|1448108|P3|Treatment Period 2|Withdrawal by Subject|0
435050|NCT00475735|1448109|P2|Treatment Period 2|Withdrawal by Subject|0
435051|NCT00475735|1448110|P1|Treatment Period 2|Withdrawal by Subject|0
435052|NCT00475735|1448105|P6|Treatment Period 2|Lack of Efficacy|1
435053|NCT00475735|1448106|P5|Treatment Period 2|Lack of Efficacy|0
435054|NCT00475735|1448107|P4|Treatment Period 2|Lack of Efficacy|0
435055|NCT00475735|1448108|P3|Treatment Period 2|Lack of Efficacy|0
435056|NCT00475735|1448109|P2|Treatment Period 2|Lack of Efficacy|0
435057|NCT00475735|1448110|P1|Treatment Period 2|Lack of Efficacy|0
435058|NCT00475735|1448105|P6|Treatment Period 2|Adverse Event|0
435059|NCT00475735|1448106|P5|Treatment Period 2|Adverse Event|0
435060|NCT00475735|1448107|P4|Treatment Period 2|Adverse Event|2
435061|NCT00475735|1448108|P3|Treatment Period 2|Adverse Event|0
435062|NCT00475735|1448109|P2|Treatment Period 2|Adverse Event|1
435063|NCT00475735|1448110|P1|Treatment Period 2|Adverse Event|0
435064|NCT00475735|1448105|P6|Treatment Washout|Protocol Violation|0
435065|NCT00475735|1448106|P5|Treatment Washout|Protocol Violation|0
435066|NCT00475735|1448107|P4|Treatment Washout|Protocol Violation|0
435067|NCT00475735|1448108|P3|Treatment Washout|Protocol Violation|0
435068|NCT00475735|1448109|P2|Treatment Washout|Protocol Violation|1
435069|NCT00475735|1448110|P1|Treatment Washout|Protocol Violation|0
435070|NCT00475735|1448105|P6|Treatment Washout|Lost to Follow-up|0
435071|NCT00475735|1448106|P5|Treatment Washout|Lost to Follow-up|0
435072|NCT00475735|1448107|P4|Treatment Washout|Lost to Follow-up|0
435073|NCT00475735|1448108|P3|Treatment Washout|Lost to Follow-up|0
435074|NCT00475735|1448109|P2|Treatment Washout|Lost to Follow-up|1
435075|NCT00475735|1448110|P1|Treatment Washout|Lost to Follow-up|0
435076|NCT00475735|1448105|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
435077|NCT00475735|1448106|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
435078|NCT00475735|1448107|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
435079|NCT00475735|1448108|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
435080|NCT00475735|1448109|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
435081|NCT00475735|1448110|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
435082|NCT00475735|1448105|P6|Treatment Period 1|DC due to AE but continuing|2
435083|NCT00475735|1448106|P5|Treatment Period 1|DC due to AE but continuing|2
435084|NCT00475735|1448107|P4|Treatment Period 1|DC due to AE but continuing|1
435085|NCT00475735|1448108|P3|Treatment Period 1|DC due to AE but continuing|0
435086|NCT00475735|1448109|P2|Treatment Period 1|DC due to AE but continuing|0
435087|NCT00475735|1448110|P1|Treatment Period 1|DC due to AE but continuing|0
435088|NCT00475735|1448105|P6|Treatment Period 1|Withdrawal by Subject|0
435089|NCT00475735|1448106|P5|Treatment Period 1|Withdrawal by Subject|0
435090|NCT00475735|1448107|P4|Treatment Period 1|Withdrawal by Subject|0
435091|NCT00475735|1448108|P3|Treatment Period 1|Withdrawal by Subject|0
435092|NCT00475735|1448109|P2|Treatment Period 1|Withdrawal by Subject|1
435093|NCT00475735|1448110|P1|Treatment Period 1|Withdrawal by Subject|1
435094|NCT00475735|1448105|P6|Treatment Period 1|Protocol Violation|0
435095|NCT00475735|1448106|P5|Treatment Period 1|Protocol Violation|0
435096|NCT00475735|1448107|P4|Treatment Period 1|Protocol Violation|1
435097|NCT00475735|1448108|P3|Treatment Period 1|Protocol Violation|0
435098|NCT00475735|1448109|P2|Treatment Period 1|Protocol Violation|0
435099|NCT00475735|1448110|P1|Treatment Period 1|Protocol Violation|0
435100|NCT00475735|1448105|P6|Treatment Period 1|Lost to Follow-up|1
435101|NCT00475735|1448106|P5|Treatment Period 1|Lost to Follow-up|0
435102|NCT00475735|1448107|P4|Treatment Period 1|Lost to Follow-up|0
435103|NCT00475735|1448108|P3|Treatment Period 1|Lost to Follow-up|0
435104|NCT00475735|1448109|P2|Treatment Period 1|Lost to Follow-up|0
435105|NCT00475735|1448110|P1|Treatment Period 1|Lost to Follow-up|0
435106|NCT00475735|1448105|P6|Treatment Period 1|Lack of Efficacy|0
435107|NCT00475735|1448106|P5|Treatment Period 1|Lack of Efficacy|0
435108|NCT00475735|1448107|P4|Treatment Period 1|Lack of Efficacy|0
435109|NCT00475735|1448108|P3|Treatment Period 1|Lack of Efficacy|0
435110|NCT00475735|1448109|P2|Treatment Period 1|Lack of Efficacy|0
435111|NCT00475735|1448110|P1|Treatment Period 1|Lack of Efficacy|1
435112|NCT00475735|1448105|P6|Treatment Period 1|Adverse Event|0
435113|NCT00475735|1448106|P5|Treatment Period 1|Adverse Event|0
435114|NCT00475735|1448107|P4|Treatment Period 1|Adverse Event|0
435115|NCT00475735|1448108|P3|Treatment Period 1|Adverse Event|0
435116|NCT00475735|1448109|P2|Treatment Period 1|Adverse Event|0
435117|NCT00475735|1448110|P1|Treatment Period 1|Adverse Event|2
435118|NCT00475722|1448123|P2|Overall Study|Protocol Violation|0
435119|NCT00475722|1448124|P1|Overall Study|Protocol Violation|3
435120|NCT00475722|1448123|P2|Overall Study|Withdrawal by Subject|12
435121|NCT00475722|1448124|P1|Overall Study|Withdrawal by Subject|12
435122|NCT00475709|1448130|P1|Overall Study|Lost to Follow-up|21
435123|NCT00475709|1448130|P1|Overall Study|Device Explant|6
435124|NCT00475709|1448130|P1|Overall Study|Death|41
435125|NCT00475709|1448130|P1|Overall Study|Did not meet eligibility criteria|8
435126|NCT00475670|1448138|P2|Overall Study|Not Specified|3
435127|NCT00475670|1448139|P1|Overall Study|Not Specified|0
435128|NCT00475670|1448138|P2|Overall Study|Failure to Return|1
435129|NCT00475670|1448139|P1|Overall Study|Failure to Return|0
435130|NCT00475670|1448138|P2|Overall Study|Refused treatment|2
435131|NCT00475670|1448139|P1|Overall Study|Refused treatment|0
435132|NCT00475670|1448138|P2|Overall Study|Lack of Efficacy|34
435133|NCT00475670|1448139|P1|Overall Study|Lack of Efficacy|3
435134|NCT00475670|1448138|P2|Overall Study|Death|1
435135|NCT00475670|1448139|P1|Overall Study|Death|0
435136|NCT00475657|1448163|P1|Overall Study|Sponsor's Decision|3
435137|NCT00475657|1448163|P1|Overall Study|Death|1
435138|NCT00475423|1448228|P1|Overall Study|Lost to Follow-up|7
435139|NCT00475423|1448228|P1|Overall Study|Reason not specified|1
435140|NCT00475423|1448228|P1|Overall Study|Death|1
435141|NCT00475423|1448228|P1|Overall Study|Lack of Efficacy|8
435142|NCT00475423|1448228|P1|Overall Study|Withdrawal by Subject|6
435143|NCT00475423|1448228|P1|Overall Study|Adverse Event|4
435144|NCT00475423|1448228|P1|Overall Study|Protocol Violation|5
435145|NCT00475306|1448274|P4|Overall Study|Protocol Violation|1
435146|NCT00475306|1448275|P3|Overall Study|Protocol Violation|0
435147|NCT00475306|1448276|P2|Overall Study|Protocol Violation|1
435148|NCT00475306|1448277|P1|Overall Study|Protocol Violation|1
435149|NCT00475228|1448302|P2|Overall Study|Lost to Follow-up|17
435150|NCT00475228|1448303|P1|Overall Study|Lost to Follow-up|17
435151|NCT00475176|1448313|P1|Overall Study|Protocol Violation|1
435152|NCT00475176|1448313|P1|Overall Study|Withdrawal by Subject|1
435153|NCT00475176|1448313|P1|Overall Study|Adverse Event|2
435154|NCT00475033|1448353|P2|Toddler Dose|Lost to Follow-up|0
435155|NCT00475033|1448354|P1|Toddler Dose|Lost to Follow-up|1
435156|NCT00475033|1448353|P2|Toddler Dose|Failed to return|0
435157|NCT00475033|1448354|P1|Toddler Dose|Failed to return|1
435158|NCT00475033|1448353|P2|Toddler Dose|Parent or legal guardian request|0
435159|NCT00475033|1448354|P1|Toddler Dose|Parent or legal guardian request|2
435160|NCT00475033|1448353|P2|After the Infant Series|Other|1
435161|NCT00475033|1448354|P1|After the Infant Series|Other|0
435162|NCT00475033|1448353|P2|After the Infant Series|Lost to Follow-up|0
435163|NCT00475033|1448354|P1|After the Infant Series|Lost to Follow-up|1
435164|NCT00475033|1448353|P2|After the Infant Series|Protocol Violation|0
435165|NCT00475033|1448354|P1|After the Infant Series|Protocol Violation|1
435166|NCT00475033|1448353|P2|After the Infant Series|Failed to return|1
435167|NCT00475033|1448354|P1|After the Infant Series|Failed to return|2
435168|NCT00475033|1448353|P2|After the Infant Series|Parent or legal guardian request|2
435169|NCT00475033|1448354|P1|After the Infant Series|Parent or legal guardian request|2
435170|NCT00475033|1448353|P2|After the Infant Series|Adverse Event|4
435171|NCT00475033|1448354|P1|After the Infant Series|Adverse Event|0
435172|NCT00475033|1448353|P2|Infant Series|Adverse Event|2
435173|NCT00475033|1448354|P1|Infant Series|Adverse Event|0
435174|NCT00475033|1448353|P2|Infant Series|Lost to Follow-up|0
435175|NCT00475033|1448354|P1|Infant Series|Lost to Follow-up|2
435176|NCT00475033|1448353|P2|Infant Series|Protocol Violation|2
435177|NCT00475033|1448354|P1|Infant Series|Protocol Violation|1
435178|NCT00475033|1448353|P2|Infant Series|Parent or legal guardian request|5
435179|NCT00475033|1448354|P1|Infant Series|Parent or legal guardian request|1
435180|NCT00475033|1448353|P2|Infant Series|Failed to return|4
435181|NCT00475033|1448354|P1|Infant Series|Failed to return|3
435182|NCT00474994|1448402|P1|Overall Study|Patient found to be ineligible|1
435183|NCT00474994|1448402|P1|Overall Study|Patient evaluable for toxicity only|3
435184|NCT00474994|1448402|P1|Overall Study|Patient Not treated|1
435185|NCT00474968|1448408|P2|Overall Study|Sample not collected|1
435186|NCT00474968|1448409|P1|Overall Study|Sample not collected|1
435187|NCT00474968|1448408|P2|Overall Study|Protocol Violation|8
435188|NCT00474968|1448409|P1|Overall Study|Protocol Violation|9
435189|NCT00474968|1448408|P2|Overall Study|Withdrawal by Subject|7
435190|NCT00474968|1448409|P1|Overall Study|Withdrawal by Subject|8
435191|NCT00474955|1448419|P1|Overall Study|Personal reasons|5
435192|NCT00474955|1448419|P1|Overall Study|Drug unavailability|1
435193|NCT00474955|1448419|P1|Overall Study|Adverse Event|2
435194|NCT00474929|1448435|P5|Overall Study|Physician Decision|0
435195|NCT00474929|1448436|P4|Overall Study|Physician Decision|2
435196|NCT00474929|1448437|P3|Overall Study|Physician Decision|1
435197|NCT00474929|1448438|P2|Overall Study|Physician Decision|0
435198|NCT00474929|1448439|P1|Overall Study|Physician Decision|0
435199|NCT00474929|1448435|P5|Overall Study|Unrelated medical condition|0
435200|NCT00474929|1448436|P4|Overall Study|Unrelated medical condition|0
435201|NCT00474929|1448437|P3|Overall Study|Unrelated medical condition|1
435202|NCT00474929|1448438|P2|Overall Study|Unrelated medical condition|0
435203|NCT00474929|1448439|P1|Overall Study|Unrelated medical condition|0
435204|NCT00474929|1448435|P5|Overall Study|Withdrawal by Subject|0
435205|NCT00474929|1448436|P4|Overall Study|Withdrawal by Subject|0
435206|NCT00474929|1448437|P3|Overall Study|Withdrawal by Subject|0
435207|NCT00474929|1448438|P2|Overall Study|Withdrawal by Subject|1
435208|NCT00474929|1448439|P1|Overall Study|Withdrawal by Subject|0
435209|NCT00474903|1448456|P3|Overall Study|Protocol Violation|2
435210|NCT00474903|1448457|P2|Overall Study|Protocol Violation|5
435211|NCT00474903|1448458|P1|Overall Study|Protocol Violation|1
435212|NCT00474812|1448480|P1|Overall Study|No Initiation of treatment|2
435213|NCT00474812|1448480|P1|Overall Study|Withdrawal by Subject|5
435214|NCT00474786|1448490|P2|Overall Study|Not specified|0
435215|NCT00474786|1448491|P1|Overall Study|Not specified|5
435216|NCT00474786|1448490|P2|Overall Study|Withdrawal by Subject|15
435217|NCT00474786|1448491|P1|Overall Study|Withdrawal by Subject|15
435218|NCT00474786|1448490|P2|Overall Study|Protocol Violation|0
435219|NCT00474786|1448491|P1|Overall Study|Protocol Violation|2
435220|NCT00474786|1448490|P2|Overall Study|Lost to Follow-up|7
435221|NCT00474786|1448491|P1|Overall Study|Lost to Follow-up|4
435222|NCT00474786|1448490|P2|Overall Study|Discontinuation of Study by Sponsor|59
435223|NCT00474786|1448491|P1|Overall Study|Discontinuation of Study by Sponsor|42
435224|NCT00474786|1448490|P2|Overall Study|Death|170
435225|NCT00474786|1448491|P1|Overall Study|Death|189
435226|NCT00474786|1448490|P2|Overall Study|Investigator Request|1
435227|NCT00474786|1448491|P1|Overall Study|Investigator Request|2
435228|NCT00474786|1448490|P2|Overall Study|Not Meeting Study Criteria|1
435229|NCT00474786|1448491|P1|Overall Study|Not Meeting Study Criteria|0
435230|NCT00474760|1448516|P7|Overall Study|Terminated by sponsor|2
435231|NCT00474760|1448517|P6|Overall Study|Terminated by sponsor|0
435232|NCT00474760|1448518|P5|Overall Study|Terminated by sponsor|0
435233|NCT00474760|1448519|P4|Overall Study|Terminated by sponsor|0
435234|NCT00474760|1448520|P3|Overall Study|Terminated by sponsor|0
435235|NCT00474760|1448521|P2|Overall Study|Terminated by sponsor|0
435236|NCT00474760|1448522|P1|Overall Study|Terminated by sponsor|0
435237|NCT00474760|1448516|P7|Overall Study|Progressive disease|7
435238|NCT00474760|1448517|P6|Overall Study|Progressive disease|20
435239|NCT00474760|1448518|P5|Overall Study|Progressive disease|8
435240|NCT00474760|1448519|P4|Overall Study|Progressive disease|2
435241|NCT00474760|1448520|P3|Overall Study|Progressive disease|3
435242|NCT00474760|1448521|P2|Overall Study|Progressive disease|2
435243|NCT00474760|1448522|P1|Overall Study|Progressive disease|3
435244|NCT00474760|1448516|P7|Overall Study|Other|0
435245|NCT00474760|1448517|P6|Overall Study|Other|0
435246|NCT00474760|1448518|P5|Overall Study|Other|1
435247|NCT00474760|1448519|P4|Overall Study|Other|0
435248|NCT00474760|1448520|P3|Overall Study|Other|0
435249|NCT00474760|1448521|P2|Overall Study|Other|1
435250|NCT00474760|1448522|P1|Overall Study|Other|0
435251|NCT00474760|1448516|P7|Overall Study|Withdrawal by Subject|1
435252|NCT00474760|1448517|P6|Overall Study|Withdrawal by Subject|1
435253|NCT00474760|1448518|P5|Overall Study|Withdrawal by Subject|0
435254|NCT00474760|1448519|P4|Overall Study|Withdrawal by Subject|1
435255|NCT00474760|1448520|P3|Overall Study|Withdrawal by Subject|0
435256|NCT00474760|1448521|P2|Overall Study|Withdrawal by Subject|0
435257|NCT00474760|1448522|P1|Overall Study|Withdrawal by Subject|0
435258|NCT00474760|1448516|P7|Overall Study|Laboratory abnormality|0
435259|NCT00474760|1448517|P6|Overall Study|Laboratory abnormality|1
435260|NCT00474760|1448518|P5|Overall Study|Laboratory abnormality|0
435261|NCT00474760|1448519|P4|Overall Study|Laboratory abnormality|0
435262|NCT00474760|1448520|P3|Overall Study|Laboratory abnormality|0
435263|NCT00474760|1448521|P2|Overall Study|Laboratory abnormality|0
435264|NCT00474760|1448522|P1|Overall Study|Laboratory abnormality|0
435265|NCT00474760|1448516|P7|Overall Study|Adverse Event|0
435266|NCT00474760|1448517|P6|Overall Study|Adverse Event|7
435267|NCT00474760|1448518|P5|Overall Study|Adverse Event|1
435268|NCT00474760|1448519|P4|Overall Study|Adverse Event|0
435269|NCT00474760|1448520|P3|Overall Study|Adverse Event|0
435270|NCT00474760|1448521|P2|Overall Study|Adverse Event|0
435271|NCT00474760|1448522|P1|Overall Study|Adverse Event|0
435272|NCT00474760|1448516|P7|Overall Study|Death|0
435273|NCT00474760|1448517|P6|Overall Study|Death|0
435274|NCT00474760|1448518|P5|Overall Study|Death|2
435275|NCT00474760|1448519|P4|Overall Study|Death|0
435276|NCT00474760|1448520|P3|Overall Study|Death|0
435277|NCT00474760|1448521|P2|Overall Study|Death|0
435278|NCT00474760|1448522|P1|Overall Study|Death|0
435279|NCT00474708|1448629|P2|Overall Study|Physician Decision|6
435280|NCT00474708|1448630|P1|Overall Study|Physician Decision|9
435281|NCT00474708|1448629|P2|Overall Study|Lost to Follow-up|9
435282|NCT00474708|1448630|P1|Overall Study|Lost to Follow-up|18
435283|NCT00474708|1448629|P2|Overall Study|Lack of compliance|4
435284|NCT00474708|1448630|P1|Overall Study|Lack of compliance|12
435285|NCT00474708|1448629|P2|Overall Study|Withdrawal by Subject|0
435286|NCT00474708|1448630|P1|Overall Study|Withdrawal by Subject|7
435287|NCT00474708|1448629|P2|Overall Study|Suicide ideation/behavior|1
435288|NCT00474708|1448630|P1|Overall Study|Suicide ideation/behavior|0
435289|NCT00474708|1448629|P2|Overall Study|Lack of Efficacy|5
435290|NCT00474708|1448630|P1|Overall Study|Lack of Efficacy|11
435291|NCT00474630|1448640|P2|Overall Study|Drug noncompliance, other|4
435292|NCT00474630|1448641|P1|Overall Study|Drug noncompliance, other|11
435293|NCT00474630|1448640|P2|Overall Study|Lack of Efficacy|6
435294|NCT00474630|1448641|P1|Overall Study|Lack of Efficacy|5
435295|NCT00474630|1448640|P2|Overall Study|Protocol Violation|4
435296|NCT00474630|1448641|P1|Overall Study|Protocol Violation|3
435297|NCT00474630|1448640|P2|Overall Study|Withdrawal by Subject|15
435298|NCT00474630|1448641|P1|Overall Study|Withdrawal by Subject|21
435299|NCT00474630|1448640|P2|Overall Study|Lost to Follow-up|15
435300|NCT00474630|1448641|P1|Overall Study|Lost to Follow-up|22
435301|NCT00474630|1448640|P2|Overall Study|Adverse Event|26
435302|NCT00474630|1448641|P1|Overall Study|Adverse Event|98
435303|NCT00474539|1448697|P2|Toddler Dose|Protocol Violation|0
435304|NCT00474539|1448698|P1|Toddler Dose|Protocol Violation|1
435305|NCT00474539|1448697|P2|After Infant Series|Withdrawal by Subject|0
435306|NCT00474539|1448698|P1|After Infant Series|Withdrawal by Subject|1
435307|NCT00474539|1448697|P2|After Infant Series|Lost to Follow-up|0
435308|NCT00474539|1448698|P1|After Infant Series|Lost to Follow-up|3
435309|NCT00474539|1448697|P2|Infant Series|Protocol Violation|1
435310|NCT00474539|1448698|P1|Infant Series|Protocol Violation|0
435311|NCT00474539|1448697|P2|Infant Series|Lost to Follow-up|1
435312|NCT00474539|1448698|P1|Infant Series|Lost to Follow-up|2
435313|NCT00474539|1448697|P2|Infant Series|Randomization error|0
435314|NCT00474539|1448698|P1|Infant Series|Randomization error|5
435315|NCT00474539|1448697|P2|Infant Series|Withdrawal by Subject|4
435316|NCT00474539|1448698|P1|Infant Series|Withdrawal by Subject|3
435317|NCT00474526|1448763|P17|Overall Study|Withdrawal by Subject|1
435318|NCT00474526|1448764|P16|Overall Study|Withdrawal by Subject|1
435319|NCT00474526|1448765|P15|Overall Study|Withdrawal by Subject|22
435320|NCT00474526|1448766|P14|Overall Study|Withdrawal by Subject|37
435321|NCT00474526|1448767|P13|Overall Study|Withdrawal by Subject|4
435322|NCT00474526|1448768|P12|Overall Study|Withdrawal by Subject|4
435323|NCT00474526|1448769|P11|Overall Study|Withdrawal by Subject|5
435324|NCT00474526|1448770|P10|Overall Study|Withdrawal by Subject|13
435325|NCT00474526|1448771|P9|Overall Study|Withdrawal by Subject|4
435326|NCT00474526|1448772|P8|Overall Study|Withdrawal by Subject|4
435327|NCT00474526|1448773|P7|Overall Study|Withdrawal by Subject|12
435328|NCT00474526|1448774|P6|Overall Study|Withdrawal by Subject|6
435329|NCT00474526|1448775|P5|Overall Study|Withdrawal by Subject|38
435330|NCT00474526|1448776|P4|Overall Study|Withdrawal by Subject|52
435331|NCT00474526|1448777|P3|Overall Study|Withdrawal by Subject|21
435332|NCT00474526|1448778|P2|Overall Study|Withdrawal by Subject|24
435333|NCT00474526|1448779|P1|Overall Study|Withdrawal by Subject|9
435334|NCT00474526|1448763|P17|Overall Study|UNABLE TO CLASSIFY|1
435335|NCT00474526|1448764|P16|Overall Study|UNABLE TO CLASSIFY|6
435336|NCT00474526|1448765|P15|Overall Study|UNABLE TO CLASSIFY|12
435337|NCT00474526|1448766|P14|Overall Study|UNABLE TO CLASSIFY|20
435338|NCT00474526|1448767|P13|Overall Study|UNABLE TO CLASSIFY|0
435339|NCT00474526|1448768|P12|Overall Study|UNABLE TO CLASSIFY|0
435340|NCT00474526|1448769|P11|Overall Study|UNABLE TO CLASSIFY|0
435341|NCT00474526|1448770|P10|Overall Study|UNABLE TO CLASSIFY|3
435342|NCT00474526|1448771|P9|Overall Study|UNABLE TO CLASSIFY|0
435343|NCT00474526|1448772|P8|Overall Study|UNABLE TO CLASSIFY|1
435344|NCT00474526|1448773|P7|Overall Study|UNABLE TO CLASSIFY|0
435345|NCT00474526|1448774|P6|Overall Study|UNABLE TO CLASSIFY|2
435346|NCT00474526|1448775|P5|Overall Study|UNABLE TO CLASSIFY|3
435347|NCT00474526|1448776|P4|Overall Study|UNABLE TO CLASSIFY|1
435348|NCT00474526|1448777|P3|Overall Study|UNABLE TO CLASSIFY|0
435349|NCT00474526|1448778|P2|Overall Study|UNABLE TO CLASSIFY|0
435350|NCT00474526|1448779|P1|Overall Study|UNABLE TO CLASSIFY|1
435351|NCT00474526|1448763|P17|Overall Study|Protocol Violation|2
435352|NCT00474526|1448764|P16|Overall Study|Protocol Violation|6
435353|NCT00474526|1448765|P15|Overall Study|Protocol Violation|9
435354|NCT00474526|1448766|P14|Overall Study|Protocol Violation|19
435355|NCT00474526|1448767|P13|Overall Study|Protocol Violation|4
435356|NCT00474526|1448768|P12|Overall Study|Protocol Violation|2
435357|NCT00474526|1448769|P11|Overall Study|Protocol Violation|2
435358|NCT00474526|1448770|P10|Overall Study|Protocol Violation|4
435359|NCT00474526|1448771|P9|Overall Study|Protocol Violation|0
435360|NCT00474526|1448772|P8|Overall Study|Protocol Violation|0
435361|NCT00474526|1448773|P7|Overall Study|Protocol Violation|3
435362|NCT00474526|1448774|P6|Overall Study|Protocol Violation|1
435363|NCT00474526|1448775|P5|Overall Study|Protocol Violation|3
435364|NCT00474526|1448776|P4|Overall Study|Protocol Violation|12
435365|NCT00474526|1448777|P3|Overall Study|Protocol Violation|4
435366|NCT00474526|1448778|P2|Overall Study|Protocol Violation|6
435367|NCT00474526|1448779|P1|Overall Study|Protocol Violation|2
435368|NCT00474526|1448763|P17|Overall Study|Lost to Follow-up|5
435369|NCT00474526|1448764|P16|Overall Study|Lost to Follow-up|4
435370|NCT00474526|1448765|P15|Overall Study|Lost to Follow-up|29
435371|NCT00474526|1448766|P14|Overall Study|Lost to Follow-up|74
435372|NCT00474526|1448767|P13|Overall Study|Lost to Follow-up|6
435373|NCT00474526|1448768|P12|Overall Study|Lost to Follow-up|4
435374|NCT00474526|1448769|P11|Overall Study|Lost to Follow-up|2
435375|NCT00474526|1448770|P10|Overall Study|Lost to Follow-up|6
435376|NCT00474526|1448771|P9|Overall Study|Lost to Follow-up|0
435377|NCT00474526|1448772|P8|Overall Study|Lost to Follow-up|1
435378|NCT00474526|1448773|P7|Overall Study|Lost to Follow-up|8
435379|NCT00474526|1448774|P6|Overall Study|Lost to Follow-up|5
435380|NCT00474526|1448775|P5|Overall Study|Lost to Follow-up|11
435381|NCT00474526|1448776|P4|Overall Study|Lost to Follow-up|29
435382|NCT00474526|1448777|P3|Overall Study|Lost to Follow-up|13
435383|NCT00474526|1448778|P2|Overall Study|Lost to Follow-up|6
435384|NCT00474526|1448779|P1|Overall Study|Lost to Follow-up|8
435385|NCT00474526|1448763|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
435386|NCT00474526|1448764|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
435387|NCT00474526|1448765|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
435388|NCT00474526|1448766|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
435389|NCT00474526|1448767|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
435390|NCT00474526|1448768|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
435391|NCT00474526|1448769|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
435392|NCT00474526|1448770|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
435393|NCT00474526|1448771|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
435394|NCT00474526|1448772|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
435395|NCT00474526|1448773|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
435396|NCT00474526|1448774|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
435397|NCT00474526|1448775|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
435398|NCT00474526|1448776|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
435399|NCT00474526|1448777|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
435400|NCT00474526|1448778|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
435401|NCT00474526|1448779|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
435402|NCT00474526|1448763|P17|Overall Study|Death|0
435403|NCT00474526|1448764|P16|Overall Study|Death|0
435404|NCT00474526|1448765|P15|Overall Study|Death|0
435405|NCT00474526|1448766|P14|Overall Study|Death|3
435406|NCT00474526|1448767|P13|Overall Study|Death|0
435407|NCT00474526|1448768|P12|Overall Study|Death|0
435408|NCT00474526|1448769|P11|Overall Study|Death|0
435409|NCT00474526|1448770|P10|Overall Study|Death|0
435410|NCT00474526|1448771|P9|Overall Study|Death|0
435411|NCT00474526|1448772|P8|Overall Study|Death|0
435412|NCT00474526|1448773|P7|Overall Study|Death|0
435413|NCT00474526|1448774|P6|Overall Study|Death|0
435414|NCT00474526|1448775|P5|Overall Study|Death|0
435415|NCT00474526|1448776|P4|Overall Study|Death|0
435416|NCT00474526|1448777|P3|Overall Study|Death|0
435417|NCT00474526|1448778|P2|Overall Study|Death|0
435418|NCT00474526|1448779|P1|Overall Study|Death|0
435419|NCT00474526|1448763|P17|Overall Study|Adverse Event|0
435420|NCT00474526|1448764|P16|Overall Study|Adverse Event|1
435421|NCT00474526|1448765|P15|Overall Study|Adverse Event|1
435422|NCT00474526|1448766|P14|Overall Study|Adverse Event|0
435423|NCT00474526|1448767|P13|Overall Study|Adverse Event|0
435424|NCT00474526|1448768|P12|Overall Study|Adverse Event|0
435425|NCT00474526|1448769|P11|Overall Study|Adverse Event|0
435426|NCT00474526|1448770|P10|Overall Study|Adverse Event|0
435427|NCT00474526|1448771|P9|Overall Study|Adverse Event|0
435428|NCT00474526|1448772|P8|Overall Study|Adverse Event|0
435429|NCT00474526|1448773|P7|Overall Study|Adverse Event|1
435430|NCT00474526|1448774|P6|Overall Study|Adverse Event|1
435431|NCT00474526|1448775|P5|Overall Study|Adverse Event|2
435432|NCT00474526|1448776|P4|Overall Study|Adverse Event|4
435433|NCT00474526|1448777|P3|Overall Study|Adverse Event|2
435434|NCT00474526|1448778|P2|Overall Study|Adverse Event|0
435435|NCT00474526|1448779|P1|Overall Study|Adverse Event|2
435436|NCT00474526|1448763|P17|Overall Study|ADMINISTRATIVE REASON|0
435437|NCT00474526|1448764|P16|Overall Study|ADMINISTRATIVE REASON|0
435438|NCT00474526|1448765|P15|Overall Study|ADMINISTRATIVE REASON|2
435439|NCT00474526|1448766|P14|Overall Study|ADMINISTRATIVE REASON|1
435440|NCT00474526|1448767|P13|Overall Study|ADMINISTRATIVE REASON|1
435441|NCT00474526|1448768|P12|Overall Study|ADMINISTRATIVE REASON|1
435442|NCT00474526|1448769|P11|Overall Study|ADMINISTRATIVE REASON|1
435443|NCT00474526|1448770|P10|Overall Study|ADMINISTRATIVE REASON|1
435444|NCT00474526|1448771|P9|Overall Study|ADMINISTRATIVE REASON|2
435445|NCT00474526|1448772|P8|Overall Study|ADMINISTRATIVE REASON|0
435446|NCT00474526|1448773|P7|Overall Study|ADMINISTRATIVE REASON|1
435447|NCT00474526|1448774|P6|Overall Study|ADMINISTRATIVE REASON|1
435448|NCT00474526|1448775|P5|Overall Study|ADMINISTRATIVE REASON|9
435449|NCT00474526|1448776|P4|Overall Study|ADMINISTRATIVE REASON|20
435450|NCT00474526|1448777|P3|Overall Study|ADMINISTRATIVE REASON|9
435451|NCT00474526|1448778|P2|Overall Study|ADMINISTRATIVE REASON|9
435452|NCT00474526|1448779|P1|Overall Study|ADMINISTRATIVE REASON|11
435453|NCT00474487|1448944|P4|Overall Study|Death|0
435454|NCT00474487|1448945|P3|Overall Study|Death|0
435455|NCT00474487|1448946|P2|Overall Study|Death|1
435456|NCT00474487|1448947|P1|Overall Study|Death|0
435457|NCT00474487|1448944|P4|Overall Study|Inappropriate enrollment|0
435458|NCT00474487|1448945|P3|Overall Study|Inappropriate enrollment|7
435459|NCT00474487|1448946|P2|Overall Study|Inappropriate enrollment|0
435460|NCT00474487|1448947|P1|Overall Study|Inappropriate enrollment|4
435461|NCT00474487|1448944|P4|Overall Study|Lost to Follow-up|0
435462|NCT00474487|1448945|P3|Overall Study|Lost to Follow-up|7
435463|NCT00474487|1448946|P2|Overall Study|Lost to Follow-up|1
435464|NCT00474487|1448947|P1|Overall Study|Lost to Follow-up|20
435465|NCT00474487|1448944|P4|Overall Study|Withdrawal by Subject|0
435466|NCT00474487|1448945|P3|Overall Study|Withdrawal by Subject|0
435467|NCT00474487|1448946|P2|Overall Study|Withdrawal by Subject|0
435468|NCT00474487|1448947|P1|Overall Study|Withdrawal by Subject|6
435469|NCT00474383|1448967|P2|Extension|Progressive Disease|5
435470|NCT00474383|1448968|P1|Extension|Progressive Disease|0
435471|NCT00474383|1448967|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
435472|NCT00474383|1448968|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
435473|NCT00474383|1448967|P2|Main Study|Other|0
435474|NCT00474383|1448968|P1|Main Study|Other|1
435475|NCT00474383|1448967|P2|Main Study|Progressive Disease|0
435476|NCT00474383|1448968|P1|Main Study|Progressive Disease|23
435477|NCT00474383|1448967|P2|Main Study|Symptomatic Deterioration|0
435478|NCT00474383|1448968|P1|Main Study|Symptomatic Deterioration|1
435479|NCT00474383|1448967|P2|Main Study|Adverse Event|0
435480|NCT00474383|1448968|P1|Main Study|Adverse Event|11
435481|NCT00474266|1448983|P4|Overall Study|Withdrawal by Subject|7
435482|NCT00474266|1448984|P3|Overall Study|Withdrawal by Subject|4
435483|NCT00474266|1448985|P2|Overall Study|Withdrawal by Subject|20
435484|NCT00474266|1448986|P1|Overall Study|Withdrawal by Subject|7
435485|NCT00474240|1449094|P6|Overall Study|Removed due to lab value|1
435486|NCT00474240|1449095|P5|Overall Study|Removed due to lab value|0
435487|NCT00474240|1449096|P4|Overall Study|Removed due to lab value|0
435488|NCT00474240|1449097|P3|Overall Study|Removed due to lab value|0
435489|NCT00474240|1449098|P2|Overall Study|Removed due to lab value|0
435490|NCT00474240|1449099|P1|Overall Study|Removed due to lab value|0
435491|NCT00474240|1449094|P6|Overall Study|Adverse Event|16
435492|NCT00474240|1449095|P5|Overall Study|Adverse Event|5
435493|NCT00474240|1449096|P4|Overall Study|Adverse Event|14
435494|NCT00474240|1449097|P3|Overall Study|Adverse Event|9
435495|NCT00474240|1449098|P2|Overall Study|Adverse Event|0
435496|NCT00474240|1449099|P1|Overall Study|Adverse Event|0
435497|NCT00474240|1449094|P6|Overall Study|Withdrawal by Subject|1
435498|NCT00474240|1449095|P5|Overall Study|Withdrawal by Subject|3
435499|NCT00474240|1449096|P4|Overall Study|Withdrawal by Subject|2
435500|NCT00474240|1449097|P3|Overall Study|Withdrawal by Subject|0
435501|NCT00474240|1449098|P2|Overall Study|Withdrawal by Subject|1
435502|NCT00474240|1449099|P1|Overall Study|Withdrawal by Subject|1
435503|NCT00474188|1449124|P1|Overall Study|Study discontinued by sponsor|5
435504|NCT00474188|1449124|P1|Overall Study|Withdrawal by Subject|1
435505|NCT00474175|1449134|P3|Overall Study|Administrative|0
435506|NCT00474175|1449135|P2|Overall Study|Administrative|1
435507|NCT00474175|1449136|P1|Overall Study|Administrative|0
435508|NCT00474175|1449134|P3|Overall Study|Protocol Violation|1
435509|NCT00474175|1449135|P2|Overall Study|Protocol Violation|2
435510|NCT00474175|1449136|P1|Overall Study|Protocol Violation|0
435511|NCT00474175|1449134|P3|Overall Study|Ineligible|1
435512|NCT00474175|1449135|P2|Overall Study|Ineligible|3
435513|NCT00474175|1449136|P1|Overall Study|Ineligible|1
435514|NCT00474175|1449134|P3|Overall Study|Withdrawal by Subject|1
435515|NCT00474175|1449135|P2|Overall Study|Withdrawal by Subject|1
435516|NCT00474175|1449136|P1|Overall Study|Withdrawal by Subject|0
435517|NCT00474175|1449134|P3|Overall Study|Lack of Efficacy|1
435518|NCT00474175|1449135|P2|Overall Study|Lack of Efficacy|0
435519|NCT00474175|1449136|P1|Overall Study|Lack of Efficacy|0
435520|NCT00474058|1449200|P2|Overall Study|Other|0
435521|NCT00474058|1449201|P1|Overall Study|Other|2
435522|NCT00474058|1449200|P2|Overall Study|Withdrawal by Subject|7
435523|NCT00474058|1449201|P1|Overall Study|Withdrawal by Subject|11
435524|NCT00474058|1449200|P2|Overall Study|Lack of Efficacy|4
435525|NCT00474058|1449201|P1|Overall Study|Lack of Efficacy|0
435526|NCT00474058|1449200|P2|Overall Study|Adverse Event|6
435527|NCT00474058|1449201|P1|Overall Study|Adverse Event|11
435528|NCT00474045|1449215|P2|Overall Study|Withdrawal criteria|50
435529|NCT00474045|1449216|P1|Overall Study|Withdrawal criteria|60
435530|NCT00474045|1449215|P2|Overall Study|Withdrawal by Subject|18
435531|NCT00474045|1449216|P1|Overall Study|Withdrawal by Subject|16
435532|NCT00474045|1449215|P2|Overall Study|Protocol Violation|12
435533|NCT00474045|1449216|P1|Overall Study|Protocol Violation|10
435534|NCT00474045|1449215|P2|Overall Study|Lost to Follow-up|1
435535|NCT00474045|1449216|P1|Overall Study|Lost to Follow-up|1
435536|NCT00474045|1449215|P2|Overall Study|Lack of Efficacy|9
435537|NCT00474045|1449216|P1|Overall Study|Lack of Efficacy|0
435538|NCT00474045|1449215|P2|Overall Study|Unclassified|3
435539|NCT00474045|1449216|P1|Overall Study|Unclassified|1
435540|NCT00474045|1449215|P2|Overall Study|Adverse Event|8
435541|NCT00474045|1449216|P1|Overall Study|Adverse Event|18
435542|NCT00473889|1449316|P2|Overall Study|Withdrawal by Subject|0
435543|NCT00473889|1449317|P1|Overall Study|Withdrawal by Subject|5
435544|NCT00473889|1449316|P2|Overall Study|Trial Terminated|6
435545|NCT00473889|1449317|P1|Overall Study|Trial Terminated|3
435546|NCT00473889|1449316|P2|Overall Study|Physician Decision|5
435547|NCT00473889|1449317|P1|Overall Study|Physician Decision|10
435548|NCT00473889|1449316|P2|Overall Study|Lost to Follow-up|1
435549|NCT00473889|1449317|P1|Overall Study|Lost to Follow-up|2
435550|NCT00473889|1449316|P2|Overall Study|Lack of Efficacy|29
435551|NCT00473889|1449317|P1|Overall Study|Lack of Efficacy|28
435552|NCT00473889|1449316|P2|Overall Study|Protocol Violation|2
435553|NCT00473889|1449317|P1|Overall Study|Protocol Violation|4
435554|NCT00473889|1449316|P2|Overall Study|Adverse Event|17
435555|NCT00473889|1449317|P1|Overall Study|Adverse Event|30
435556|NCT00473889|1449316|P2|Overall Study|Did not receive study medication|4
435557|NCT00473889|1449317|P1|Overall Study|Did not receive study medication|1
435558|NCT00473876|1449329|P2|Overall Study|Lost to Follow-up|1
435559|NCT00473876|1449330|P1|Overall Study|Lost to Follow-up|3
435560|NCT00473824|1449349|P2|Overall Study|Withdrawal by physician|0
435561|NCT00473824|1449350|P1|Overall Study|Withdrawal by physician|1
435562|NCT00473824|1449349|P2|Overall Study|Lost to Follow-up|0
435563|NCT00473824|1449350|P1|Overall Study|Lost to Follow-up|1
435564|NCT00473824|1449349|P2|Overall Study|Death|0
435565|NCT00473824|1449350|P1|Overall Study|Death|1
435566|NCT00473824|1449349|P2|Overall Study|Adverse Event|0
435567|NCT00473824|1449350|P1|Overall Study|Adverse Event|1
435568|NCT00473824|1449349|P2|Overall Study|Virologic Breakthrough|0
435569|NCT00473824|1449350|P1|Overall Study|Virologic Breakthrough|1
435570|NCT00473746|1449361|P5|Period 2 (Phase 2)|Reason not specified|3
435571|NCT00473746|1449362|P4|Period 2 (Phase 2)|Reason not specified|0
435572|NCT00473746|1449363|P3|Period 2 (Phase 2)|Reason not specified|0
435573|NCT00473746|1449364|P2|Period 2 (Phase 2)|Reason not specified|0
435574|NCT00473746|1449365|P1|Period 2 (Phase 2)|Reason not specified|0
435575|NCT00473746|1449361|P5|Period 2 (Phase 2)|Progressive Disease|20
435576|NCT00473746|1449362|P4|Period 2 (Phase 2)|Progressive Disease|0
435577|NCT00473746|1449363|P3|Period 2 (Phase 2)|Progressive Disease|0
435578|NCT00473746|1449364|P2|Period 2 (Phase 2)|Progressive Disease|0
435579|NCT00473746|1449365|P1|Period 2 (Phase 2)|Progressive Disease|0
435580|NCT00473746|1449361|P5|Period 2 (Phase 2)|Death|1
435581|NCT00473746|1449362|P4|Period 2 (Phase 2)|Death|0
435582|NCT00473746|1449363|P3|Period 2 (Phase 2)|Death|0
435583|NCT00473746|1449364|P2|Period 2 (Phase 2)|Death|0
435584|NCT00473746|1449365|P1|Period 2 (Phase 2)|Death|0
435585|NCT00473746|1449361|P5|Period 2 (Phase 2)|Adverse Event|3
435586|NCT00473746|1449362|P4|Period 2 (Phase 2)|Adverse Event|0
435587|NCT00473746|1449363|P3|Period 2 (Phase 2)|Adverse Event|0
435588|NCT00473746|1449364|P2|Period 2 (Phase 2)|Adverse Event|0
435589|NCT00473746|1449365|P1|Period 2 (Phase 2)|Adverse Event|0
435590|NCT00473746|1449361|P5|Period 1 (Phase 1)|Reason not specified|0
435591|NCT00473746|1449362|P4|Period 1 (Phase 1)|Reason not specified|0
435592|NCT00473746|1449363|P3|Period 1 (Phase 1)|Reason not specified|0
435593|NCT00473746|1449364|P2|Period 1 (Phase 1)|Reason not specified|1
435594|NCT00473746|1449365|P1|Period 1 (Phase 1)|Reason not specified|0
435595|NCT00473746|1449361|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
435596|NCT00473746|1449362|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
435597|NCT00473746|1449363|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
435598|NCT00473746|1449364|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
435599|NCT00473746|1449365|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
435600|NCT00473746|1449361|P5|Period 1 (Phase 1)|Progressive Disease|0
435601|NCT00473746|1449362|P4|Period 1 (Phase 1)|Progressive Disease|10
435602|NCT00473746|1449363|P3|Period 1 (Phase 1)|Progressive Disease|6
435603|NCT00473746|1449364|P2|Period 1 (Phase 1)|Progressive Disease|6
435604|NCT00473746|1449365|P1|Period 1 (Phase 1)|Progressive Disease|5
435605|NCT00473746|1449361|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
435606|NCT00473746|1449362|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
435607|NCT00473746|1449363|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
435608|NCT00473746|1449364|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
435609|NCT00473746|1449365|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
435610|NCT00473746|1449361|P5|Period 1 (Phase 1)|Adverse Event|0
435611|NCT00473746|1449362|P4|Period 1 (Phase 1)|Adverse Event|0
435612|NCT00473746|1449363|P3|Period 1 (Phase 1)|Adverse Event|0
435613|NCT00473746|1449364|P2|Period 1 (Phase 1)|Adverse Event|0
435614|NCT00473746|1449365|P1|Period 1 (Phase 1)|Adverse Event|1
435615|NCT00473668|1449413|P3|Overall Study|Other|4
435616|NCT00473668|1449414|P2|Overall Study|Other|3
435617|NCT00473668|1449415|P1|Overall Study|Other|2
435618|NCT00473668|1449413|P3|Overall Study|Lost to Follow-up|6
435619|NCT00473668|1449414|P2|Overall Study|Lost to Follow-up|4
435620|NCT00473668|1449415|P1|Overall Study|Lost to Follow-up|0
435621|NCT00473668|1449413|P3|Overall Study|Migrated/moved from study area|0
435622|NCT00473668|1449414|P2|Overall Study|Migrated/moved from study area|2
435623|NCT00473668|1449415|P1|Overall Study|Migrated/moved from study area|3
435624|NCT00473668|1449413|P3|Overall Study|Withdrawal by Subject|0
435625|NCT00473668|1449414|P2|Overall Study|Withdrawal by Subject|2
435626|NCT00473668|1449415|P1|Overall Study|Withdrawal by Subject|0
435627|NCT00473655|1449468|P3|Overall Study|Lost to Follow-up|8
435628|NCT00473655|1449469|P2|Overall Study|Lost to Follow-up|5
435629|NCT00473655|1449470|P1|Overall Study|Lost to Follow-up|9
435630|NCT00473590|1449517|P2|Overall Study|Other|1
435631|NCT00473590|1449518|P1|Overall Study|Other|0
435632|NCT00473590|1449517|P2|Overall Study|Withdrawal by Subject|3
435633|NCT00473590|1449518|P1|Overall Study|Withdrawal by Subject|5
435634|NCT00473590|1449517|P2|Overall Study|Physician Decision|4
435635|NCT00473590|1449518|P1|Overall Study|Physician Decision|2
435636|NCT00473590|1449517|P2|Overall Study|Non–protocol-specified therapy|5
435637|NCT00473590|1449518|P1|Overall Study|Non–protocol-specified therapy|7
435638|NCT00473590|1449517|P2|Overall Study|Progression not resulting in death|20
435639|NCT00473590|1449518|P1|Overall Study|Progression not resulting in death|24
435640|NCT00473590|1449517|P2|Overall Study|Death|2
435641|NCT00473590|1449518|P1|Overall Study|Death|4
435642|NCT00473590|1449517|P2|Overall Study|Adverse Event|3
435643|NCT00473590|1449518|P1|Overall Study|Adverse Event|3
435644|NCT00473564|1449534|P1|Overall Study|robot surgery aborted in OR|23
435645|NCT00473512|1449544|P5|Period 2 (Phase 2)|Other|0
435646|NCT00473512|1449545|P4|Period 2 (Phase 2)|Other|3
435647|NCT00473512|1449546|P3|Period 2 (Phase 2)|Other|0
435648|NCT00473512|1449547|P2|Period 2 (Phase 2)|Other|0
435649|NCT00473512|1449548|P1|Period 2 (Phase 2)|Other|1
435650|NCT00473512|1449544|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
435651|NCT00473512|1449545|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
435652|NCT00473512|1449546|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
435653|NCT00473512|1449547|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
435654|NCT00473512|1449548|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
435655|NCT00473512|1449544|P5|Period 2 (Phase 2)|Disease Progression|1
435656|NCT00473512|1449545|P4|Period 2 (Phase 2)|Disease Progression|17
435657|NCT00473512|1449546|P3|Period 2 (Phase 2)|Disease Progression|2
435658|NCT00473512|1449547|P2|Period 2 (Phase 2)|Disease Progression|2
435659|NCT00473512|1449548|P1|Period 2 (Phase 2)|Disease Progression|0
435660|NCT00473512|1449544|P5|Period 2 (Phase 2)|Death|1
435661|NCT00473512|1449545|P4|Period 2 (Phase 2)|Death|1
435662|NCT00473512|1449546|P3|Period 2 (Phase 2)|Death|0
435663|NCT00473512|1449547|P2|Period 2 (Phase 2)|Death|0
435664|NCT00473512|1449548|P1|Period 2 (Phase 2)|Death|0
435665|NCT00473512|1449544|P5|Period 2 (Phase 2)|Adverse Event|0
435666|NCT00473512|1449545|P4|Period 2 (Phase 2)|Adverse Event|1
435667|NCT00473512|1449546|P3|Period 2 (Phase 2)|Adverse Event|0
435668|NCT00473512|1449547|P2|Period 2 (Phase 2)|Adverse Event|0
435669|NCT00473512|1449548|P1|Period 2 (Phase 2)|Adverse Event|0
435670|NCT00473512|1449544|P5|Period 1 (Phase 1)|Other|0
435671|NCT00473512|1449545|P4|Period 1 (Phase 1)|Other|1
435672|NCT00473512|1449546|P3|Period 1 (Phase 1)|Other|0
435673|NCT00473512|1449547|P2|Period 1 (Phase 1)|Other|0
435674|NCT00473512|1449548|P1|Period 1 (Phase 1)|Other|0
435675|NCT00473512|1449544|P5|Period 1 (Phase 1)|Disease Progression|1
435676|NCT00473512|1449545|P4|Period 1 (Phase 1)|Disease Progression|10
435677|NCT00473512|1449546|P3|Period 1 (Phase 1)|Disease Progression|0
435678|NCT00473512|1449547|P2|Period 1 (Phase 1)|Disease Progression|1
435679|NCT00473512|1449548|P1|Period 1 (Phase 1)|Disease Progression|1
435680|NCT00473512|1449544|P5|Period 1 (Phase 1)|Death|0
435681|NCT00473512|1449545|P4|Period 1 (Phase 1)|Death|1
435682|NCT00473512|1449546|P3|Period 1 (Phase 1)|Death|0
435683|NCT00473512|1449547|P2|Period 1 (Phase 1)|Death|0
435684|NCT00473512|1449548|P1|Period 1 (Phase 1)|Death|0
435685|NCT00473512|1449544|P5|Period 1 (Phase 1)|Adverse Event|0
435686|NCT00473512|1449545|P4|Period 1 (Phase 1)|Adverse Event|5
435687|NCT00473512|1449546|P3|Period 1 (Phase 1)|Adverse Event|0
435688|NCT00473512|1449547|P2|Period 1 (Phase 1)|Adverse Event|0
435689|NCT00473512|1449548|P1|Period 1 (Phase 1)|Adverse Event|0
435690|NCT00473434|1449606|P1|Overall Study|No longer required|1
435691|NCT00473434|1449606|P1|Overall Study|Switching to trial medication|1
435692|NCT00473434|1449606|P1|Overall Study|Ceased in favor of Paliperidone|1
435693|NCT00473434|1449606|P1|Overall Study|Reason not specified|6
435694|NCT00473434|1449606|P1|Overall Study|Safety evaluation|1
435695|NCT00473434|1449606|P1|Overall Study|Patient was selling medication to others|1
435696|NCT00473434|1449606|P1|Overall Study|Adverse Event|3
435697|NCT00473434|1449606|P1|Overall Study|Lack of Efficacy|3
435698|NCT00473434|1449606|P1|Overall Study|Compliance|3
435699|NCT00473434|1449606|P1|Overall Study|Withdrawal by Subject|9
435700|NCT00473434|1449606|P1|Overall Study|Physician Decision|3
435701|NCT00473382|1449671|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
435702|NCT00473382|1449672|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
435703|NCT00473382|1449673|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
435704|NCT00473382|1449671|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
435705|NCT00473382|1449672|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
435706|NCT00473382|1449673|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
435707|NCT00473382|1449671|P3|Open-label Extension Through Month 60|Subject's Decision|6
435708|NCT00473382|1449672|P2|Open-label Extension Through Month 60|Subject's Decision|1
435709|NCT00473382|1449673|P1|Open-label Extension Through Month 60|Subject's Decision|7
435710|NCT00473382|1449671|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
435711|NCT00473382|1449672|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
435712|NCT00473382|1449673|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
435713|NCT00473382|1449671|P3|Open-label Extension Through Month 60|Death|4
435714|NCT00473382|1449672|P2|Open-label Extension Through Month 60|Death|7
435715|NCT00473382|1449673|P1|Open-label Extension Through Month 60|Death|1
435716|NCT00473382|1449671|P3|Open-label Extension Through Month 60|Adverse Event|2
435717|NCT00473382|1449672|P2|Open-label Extension Through Month 60|Adverse Event|0
435718|NCT00473382|1449673|P1|Open-label Extension Through Month 60|Adverse Event|0
435719|NCT00473382|1449671|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
435720|NCT00473382|1449672|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
435721|NCT00473382|1449673|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
435722|NCT00473382|1449671|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
435723|NCT00473382|1449672|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
435724|NCT00473382|1449673|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
435725|NCT00473382|1449671|P3|Open-label Extension Through Month 48|Subject's Decision|6
435726|NCT00473382|1449672|P2|Open-label Extension Through Month 48|Subject's Decision|1
435727|NCT00473382|1449673|P1|Open-label Extension Through Month 48|Subject's Decision|5
435728|NCT00473382|1449671|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
435729|NCT00473382|1449672|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
435730|NCT00473382|1449673|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
435731|NCT00473382|1449671|P3|Open-label Extension Through Month 48|Death|3
435732|NCT00473382|1449672|P2|Open-label Extension Through Month 48|Death|3
435733|NCT00473382|1449673|P1|Open-label Extension Through Month 48|Death|1
435734|NCT00473382|1449671|P3|Open-label Extension Through Month 48|Adverse Event|1
435735|NCT00473382|1449672|P2|Open-label Extension Through Month 48|Adverse Event|0
435736|NCT00473382|1449673|P1|Open-label Extension Through Month 48|Adverse Event|0
435737|NCT00473382|1449671|P3|Core Study|Subject's decision|10
435738|NCT00473382|1449672|P2|Core Study|Subject's decision|11
435739|NCT00473382|1449673|P1|Core Study|Subject's decision|12
435740|NCT00473382|1449671|P3|Core Study|Subject needed other treatment|2
435741|NCT00473382|1449672|P2|Core Study|Subject needed other treatment|3
435742|NCT00473382|1449673|P1|Core Study|Subject needed other treatment|1
435743|NCT00473382|1449671|P3|Core Study|Subject non-compliance|1
435744|NCT00473382|1449672|P2|Core Study|Subject non-compliance|2
435745|NCT00473382|1449673|P1|Core Study|Subject non-compliance|5
435746|NCT00473382|1449671|P3|Core Study|Physician Decision|2
435747|NCT00473382|1449672|P2|Core Study|Physician Decision|2
435748|NCT00473382|1449673|P1|Core Study|Physician Decision|1
435749|NCT00473382|1449671|P3|Core Study|Lost to Follow-up|3
435750|NCT00473382|1449672|P2|Core Study|Lost to Follow-up|3
435751|NCT00473382|1449673|P1|Core Study|Lost to Follow-up|3
435752|NCT00473382|1449671|P3|Core Study|Death|10
435753|NCT00473382|1449672|P2|Core Study|Death|5
435754|NCT00473382|1449673|P1|Core Study|Death|3
435755|NCT00473382|1449671|P3|Core Study|Adverse Event|1
435756|NCT00473382|1449672|P2|Core Study|Adverse Event|1
435757|NCT00473382|1449673|P1|Core Study|Adverse Event|3
435758|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
435759|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
435760|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
435761|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
435762|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
435763|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
435764|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
435765|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
435766|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
435767|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Subject's Decision|4
435768|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Subject's Decision|3
435769|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Subject's Decision|1
435770|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Physician's Decision|3
435771|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Physician's Decision|1
435772|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Physician's Decision|2
435773|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
435774|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
435775|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
435776|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Death|1
435777|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Death|2
435778|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Death|2
435779|NCT00473330|1449731|P3|Open-label Extension Through Month 60|Adverse Event|2
435780|NCT00473330|1449732|P2|Open-label Extension Through Month 60|Adverse Event|0
435781|NCT00473330|1449733|P1|Open-label Extension Through Month 60|Adverse Event|0
435782|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
435783|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
435784|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
435785|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
435786|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
435787|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
435788|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
435789|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
435790|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
435791|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Subject's Decision|3
435792|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Subject's Decision|3
435793|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Subject's Decision|1
435794|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Physician's Decision|3
435795|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Physician's Decision|1
435796|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Physician's Decision|2
435797|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
435798|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
435799|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
435800|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Death|0
435801|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Death|0
435802|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Death|2
435803|NCT00473330|1449731|P3|Open-label Extension Through Month 48|Adverse Event|2
435804|NCT00473330|1449732|P2|Open-label Extension Through Month 48|Adverse Event|0
435805|NCT00473330|1449733|P1|Open-label Extension Through Month 48|Adverse Event|0
435806|NCT00473330|1449731|P3|Core Study|Subject's Decision|19
435807|NCT00473330|1449732|P2|Core Study|Subject's Decision|8
435808|NCT00473330|1449733|P1|Core Study|Subject's Decision|9
435809|NCT00473330|1449731|P3|Core Study|Subject Required Other Therapy|3
435810|NCT00473330|1449732|P2|Core Study|Subject Required Other Therapy|1
435811|NCT00473330|1449733|P1|Core Study|Subject Required Other Therapy|0
435812|NCT00473330|1449731|P3|Core Study|Subject Non-compliance|1
435813|NCT00473330|1449732|P2|Core Study|Subject Non-compliance|2
435814|NCT00473330|1449733|P1|Core Study|Subject Non-compliance|1
435815|NCT00473330|1449731|P3|Core Study|Physician Decision|3
435816|NCT00473330|1449732|P2|Core Study|Physician Decision|1
435817|NCT00473330|1449733|P1|Core Study|Physician Decision|2
435818|NCT00473330|1449731|P3|Core Study|Lost to Follow-up|10
435819|NCT00473330|1449732|P2|Core Study|Lost to Follow-up|5
435820|NCT00473330|1449733|P1|Core Study|Lost to Follow-up|5
435821|NCT00473330|1449731|P3|Core Study|Death|4
435822|NCT00473330|1449732|P2|Core Study|Death|4
435823|NCT00473330|1449733|P1|Core Study|Death|6
435824|NCT00473330|1449731|P3|Core Study|Adverse Event|1
435825|NCT00473330|1449732|P2|Core Study|Adverse Event|4
435826|NCT00473330|1449733|P1|Core Study|Adverse Event|4
435827|NCT00473265|1449788|P1|Overall Study|Off treatment early|15
435828|NCT00473265|1449788|P1|Overall Study|Unrelated adverse event|5
435829|NCT00473083|1449800|P3|Overall Study|Adverse Event|0
435830|NCT00473083|1449801|P2|Overall Study|Adverse Event|0
435831|NCT00473083|1449802|P1|Overall Study|Adverse Event|1
435832|NCT00472641|1449877|P1|Overall Study|Lost to Follow-up|1
435833|NCT00472641|1449877|P1|Overall Study|Adverse Event|3
435834|NCT00472641|1449877|P1|Overall Study|Lack of Efficacy|3
435835|NCT00472446|1449897|P4|Overall Study|Questionnaires not returned|4
435836|NCT00472446|1449898|P3|Overall Study|Questionnaires not returned|6
435837|NCT00472446|1449899|P2|Overall Study|Questionnaires not returned|6
435838|NCT00472446|1449900|P1|Overall Study|Questionnaires not returned|5
435839|NCT00472446|1449897|P4|Overall Study|Reintervention|1
435840|NCT00472446|1449898|P3|Overall Study|Reintervention|1
435841|NCT00472446|1449899|P2|Overall Study|Reintervention|0
435842|NCT00472446|1449900|P1|Overall Study|Reintervention|0
435843|NCT00472446|1449897|P4|Overall Study|Protocol Violation|1
435844|NCT00472446|1449898|P3|Overall Study|Protocol Violation|0
435845|NCT00472446|1449899|P2|Overall Study|Protocol Violation|0
435846|NCT00472446|1449900|P1|Overall Study|Protocol Violation|0
435847|NCT00472420|1449930|P1|Follow-up Period|Protocol Violation|1
435848|NCT00472420|1449930|P1|Follow-up Period|Lost to Follow-up|2
435849|NCT00472420|1449930|P1|Follow-up Period|Physician Decision|9
435850|NCT00472420|1449930|P1|Follow-up Period|Death|5
435851|NCT00472420|1449930|P1|Induction Treatment Period|Death|3
435852|NCT00472420|1449930|P1|Induction Treatment Period|Non-compliance|1
435853|NCT00472420|1449930|P1|Induction Treatment Period|Adverse Event|3
435854|NCT00472420|1449930|P1|Induction Treatment Period|Physician Decision|9
435855|NCT00472303|1449938|P3|Maintenance Phase|not specified|0
435856|NCT00472303|1449939|P2|Maintenance Phase|not specified|1
435857|NCT00472303|1449940|P1|Maintenance Phase|not specified|1
435858|NCT00472303|1449938|P3|Maintenance Phase|Resolution of pain|1
435859|NCT00472303|1449939|P2|Maintenance Phase|Resolution of pain|0
435860|NCT00472303|1449940|P1|Maintenance Phase|Resolution of pain|0
435861|NCT00472303|1449938|P3|Maintenance Phase|Trial medication non-compliant|1
435862|NCT00472303|1449939|P2|Maintenance Phase|Trial medication non-compliant|0
435863|NCT00472303|1449940|P1|Maintenance Phase|Trial medication non-compliant|0
435864|NCT00472303|1449938|P3|Maintenance Phase|Withdrawal by Subject|3
435865|NCT00472303|1449939|P2|Maintenance Phase|Withdrawal by Subject|7
435866|NCT00472303|1449940|P1|Maintenance Phase|Withdrawal by Subject|6
435867|NCT00472303|1449938|P3|Maintenance Phase|Lack of Efficacy|4
435868|NCT00472303|1449939|P2|Maintenance Phase|Lack of Efficacy|2
435869|NCT00472303|1449940|P1|Maintenance Phase|Lack of Efficacy|2
435870|NCT00472303|1449938|P3|Maintenance Phase|Death|2
435871|NCT00472303|1449939|P2|Maintenance Phase|Death|0
435872|NCT00472303|1449940|P1|Maintenance Phase|Death|3
435873|NCT00472303|1449938|P3|Maintenance Phase|Adverse Event|6
435874|NCT00472303|1449939|P2|Maintenance Phase|Adverse Event|6
435875|NCT00472303|1449940|P1|Maintenance Phase|Adverse Event|5
435876|NCT00472303|1449938|P3|Discontinuations After Titration Phase|not specified|0
435877|NCT00472303|1449939|P2|Discontinuations After Titration Phase|not specified|0
435878|NCT00472303|1449940|P1|Discontinuations After Titration Phase|not specified|5
435879|NCT00472303|1449938|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
435880|NCT00472303|1449939|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
435881|NCT00472303|1449940|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
435882|NCT00472303|1449938|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
435883|NCT00472303|1449939|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
435884|NCT00472303|1449940|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
435885|NCT00472303|1449938|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
435886|NCT00472303|1449939|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
435887|NCT00472303|1449940|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
435888|NCT00472303|1449938|P3|Discontinuations After Titration Phase|Adverse Event|0
435889|NCT00472303|1449939|P2|Discontinuations After Titration Phase|Adverse Event|0
435890|NCT00472303|1449940|P1|Discontinuations After Titration Phase|Adverse Event|6
435891|NCT00472303|1449938|P3|Titration Phase|not specified|0
435892|NCT00472303|1449939|P2|Titration Phase|not specified|1
435893|NCT00472303|1449940|P1|Titration Phase|not specified|3
435894|NCT00472303|1449938|P3|Titration Phase|Trial Medication non-compliant|0
435895|NCT00472303|1449939|P2|Titration Phase|Trial Medication non-compliant|1
435896|NCT00472303|1449940|P1|Titration Phase|Trial Medication non-compliant|4
435897|NCT00472303|1449938|P3|Titration Phase|Withdrawal by Subject|0
435898|NCT00472303|1449939|P2|Titration Phase|Withdrawal by Subject|13
435899|NCT00472303|1449940|P1|Titration Phase|Withdrawal by Subject|16
435900|NCT00472303|1449938|P3|Titration Phase|Lack of Efficacy|0
435901|NCT00472303|1449939|P2|Titration Phase|Lack of Efficacy|0
435902|NCT00472303|1449940|P1|Titration Phase|Lack of Efficacy|10
435903|NCT00472303|1449938|P3|Titration Phase|Death|0
435904|NCT00472303|1449939|P2|Titration Phase|Death|2
435905|NCT00472303|1449940|P1|Titration Phase|Death|4
435906|NCT00472303|1449938|P3|Titration Phase|Adverse Event|0
435907|NCT00472303|1449939|P2|Titration Phase|Adverse Event|12
435908|NCT00472303|1449940|P1|Titration Phase|Adverse Event|22
435909|NCT00472290|1450003|P1|Overall Study|Requirement for alternative therapy|7
435910|NCT00472290|1450003|P1|Overall Study|Adverse Event|6
435911|NCT00472290|1450003|P1|Overall Study|Withdrawal by Subject|5
435912|NCT00472290|1450003|P1|Overall Study|Disease Progression|4
435913|NCT00472290|1450003|P1|Overall Study|Lack of Efficacy|1
435914|NCT00472290|1450003|P1|Overall Study|Lost to Follow-up|1
435915|NCT00472290|1450003|P1|Overall Study|Death|3
435916|NCT00472290|1450003|P1|Overall Study|Administrative Decision|37
435917|NCT00472290|1450003|P1|Overall Study|Protocol Specified Criteria|7
435918|NCT00472290|1450003|P1|Overall Study|Progression of Therapy-Related MDS|1
435919|NCT00472199|1450015|P2|Overall Study|patient was asymptomatic|0
435920|NCT00472199|1450016|P1|Overall Study|patient was asymptomatic|1
435921|NCT00472199|1450015|P2|Overall Study|personal reason|1
435922|NCT00472199|1450016|P1|Overall Study|personal reason|0
435923|NCT00472199|1450015|P2|Overall Study|Withdrawal by Subject|5
435924|NCT00472199|1450016|P1|Overall Study|Withdrawal by Subject|6
435925|NCT00472199|1450015|P2|Overall Study|Protocol Violation|2
435926|NCT00472199|1450016|P1|Overall Study|Protocol Violation|3
435927|NCT00472199|1450015|P2|Overall Study|Lost to Follow-up|4
435928|NCT00472199|1450016|P1|Overall Study|Lost to Follow-up|2
435929|NCT00472199|1450015|P2|Overall Study|Lack of Efficacy|25
435930|NCT00472199|1450016|P1|Overall Study|Lack of Efficacy|4
435931|NCT00472199|1450015|P2|Overall Study|Adverse Event|23
435932|NCT00472199|1450016|P1|Overall Study|Adverse Event|19
435933|NCT00472082|1450082|P1|Overall Study|Study prematurely terminated|5
435934|NCT00472030|1450104|P2|Overall Study|Physician Decision|0
435935|NCT00472030|1450105|P1|Overall Study|Physician Decision|1
435936|NCT00471822|1450121|P1|Overall Study|Protocol Violation|2
435937|NCT00471718|1450129|P1|Overall Study|Withdrawal by Subject|1
435938|NCT00471718|1450129|P1|Overall Study|disease progression|22
435939|NCT00471718|1450129|P1|Overall Study|other complicating disease|1
435940|NCT00471718|1450129|P1|Overall Study|Adverse Event|3
435941|NCT00471536|1450157|P1|Overall Study|Withdrawal by Subject|1
435942|NCT00471497|1450169|P3|Overall Study|Sub optimal response or treat. failure|0
435943|NCT00471497|1450170|P2|Overall Study|Sub optimal response or treat. failure|3
435944|NCT00471497|1450171|P1|Overall Study|Sub optimal response or treat. failure|8
435945|NCT00471497|1450169|P3|Overall Study|Protocol Violation|5
435946|NCT00471497|1450170|P2|Overall Study|Protocol Violation|3
435947|NCT00471497|1450171|P1|Overall Study|Protocol Violation|3
435948|NCT00471497|1450169|P3|Overall Study|Disease Progression|2
435949|NCT00471497|1450170|P2|Overall Study|Disease Progression|2
435950|NCT00471497|1450171|P1|Overall Study|Disease Progression|8
435951|NCT00471497|1450169|P3|Overall Study|Death|0
435952|NCT00471497|1450170|P2|Overall Study|Death|2
435953|NCT00471497|1450171|P1|Overall Study|Death|0
435954|NCT00471497|1450169|P3|Overall Study|Lost to Follow-up|1
435955|NCT00471497|1450170|P2|Overall Study|Lost to Follow-up|2
435956|NCT00471497|1450171|P1|Overall Study|Lost to Follow-up|1
435957|NCT00471497|1450169|P3|Overall Study|Withdrawal by Subject|5
435958|NCT00471497|1450170|P2|Overall Study|Withdrawal by Subject|5
435959|NCT00471497|1450171|P1|Overall Study|Withdrawal by Subject|3
435960|NCT00471497|1450169|P3|Overall Study|Condition no longer requires study drug|0
435961|NCT00471497|1450170|P2|Overall Study|Condition no longer requires study drug|1
435962|NCT00471497|1450171|P1|Overall Study|Condition no longer requires study drug|0
435963|NCT00471497|1450169|P3|Overall Study|Abnormal Test Procedure|1
435964|NCT00471497|1450170|P2|Overall Study|Abnormal Test Procedure|0
435965|NCT00471497|1450171|P1|Overall Study|Abnormal Test Procedure|1
435966|NCT00471497|1450169|P3|Overall Study|Abnormal Laboratory Value|4
435967|NCT00471497|1450170|P2|Overall Study|Abnormal Laboratory Value|6
435968|NCT00471497|1450171|P1|Overall Study|Abnormal Laboratory Value|3
435969|NCT00471497|1450169|P3|Overall Study|Adverse Event|22
435970|NCT00471497|1450170|P2|Overall Study|Adverse Event|11
435971|NCT00471497|1450171|P1|Overall Study|Adverse Event|19
435972|NCT00471445|1450181|P2|Overall Study|Protocol Violation|1
435973|NCT00471445|1450182|P1|Overall Study|Protocol Violation|0
435974|NCT00471445|1450181|P2|Overall Study|Ineligible|0
435975|NCT00471445|1450182|P1|Overall Study|Ineligible|1
435976|NCT00471445|1450181|P2|Overall Study|Withdrawal by Subject|1
435977|NCT00471445|1450182|P1|Overall Study|Withdrawal by Subject|1
435978|NCT00471354|1450195|P1|Overall Study|Patient/Caregiver Decision|12
435979|NCT00471354|1450195|P1|Overall Study|Lack of Efficacy|5
435980|NCT00471354|1450195|P1|Overall Study|Lost to Follow-up|3
435981|NCT00471354|1450195|P1|Overall Study|Sponsor Decision|1
435982|NCT00471354|1450195|P1|Overall Study|Physician Decision|4
435983|NCT00471354|1450195|P1|Overall Study|Withdrawal by Subject|1
435984|NCT00471354|1450195|P1|Overall Study|Protocol Violation|12
435985|NCT00471354|1450195|P1|Overall Study|Adverse Event|13
435986|NCT00471354|1450195|P1|Overall Study|Protocol Entry Criteria Not Met|1
435987|NCT00471328|1450207|P2|Extension Phase|Administrative Problem|0
435988|NCT00471328|1450208|P1|Extension Phase|Administrative Problem|1
435989|NCT00471328|1450207|P2|Extension Phase|New cancer Therapy|0
435990|NCT00471328|1450208|P1|Extension Phase|New cancer Therapy|1
435991|NCT00471328|1450207|P2|Extension Phase|Disease Progression|44
435992|NCT00471328|1450208|P1|Extension Phase|Disease Progression|32
435993|NCT00471328|1450207|P2|Extension Phase|Treatment duration as per protocol|1
435994|NCT00471328|1450208|P1|Extension Phase|Treatment duration as per protocol|0
435995|NCT00471328|1450207|P2|Extension Phase|Protocol Deviation|1
435996|NCT00471328|1450208|P1|Extension Phase|Protocol Deviation|3
435997|NCT00471328|1450207|P2|Extension Phase|Death|7
435998|NCT00471328|1450208|P1|Extension Phase|Death|1
435999|NCT00471328|1450207|P2|Extension Phase|Withdrawal by Subject|2
436000|NCT00471328|1450208|P1|Extension Phase|Withdrawal by Subject|0
436001|NCT00471328|1450207|P2|Extension Phase|Adverse Event|12
436002|NCT00471328|1450208|P1|Extension Phase|Adverse Event|3
436003|NCT00471328|1450207|P2|Core Phase|Protocol Deviation|1
436004|NCT00471328|1450208|P1|Core Phase|Protocol Deviation|0
436005|NCT00471328|1450207|P2|Core Phase|Administrative Problem|1
436006|NCT00471328|1450208|P1|Core Phase|Administrative Problem|0
436007|NCT00471328|1450207|P2|Core Phase|Disease Progression|53
436008|NCT00471328|1450208|P1|Core Phase|Disease Progression|78
436009|NCT00471328|1450207|P2|Core Phase|Abnormal laboratory value|0
436010|NCT00471328|1450208|P1|Core Phase|Abnormal laboratory value|1
436011|NCT00471328|1450207|P2|Core Phase|Withdrawal by Subject|2
436012|NCT00471328|1450208|P1|Core Phase|Withdrawal by Subject|2
436013|NCT00471328|1450207|P2|Core Phase|Death|4
436014|NCT00471328|1450208|P1|Core Phase|Death|8
436015|NCT00471328|1450207|P2|Core Phase|Adverse Event|6
436016|NCT00471328|1450208|P1|Core Phase|Adverse Event|18
436017|NCT00471315|1450227|P1|Overall Study|Withdrawal by Subject|1
436018|NCT00471315|1450227|P1|Overall Study|Adverse Event|7
436019|NCT00471276|1450232|P1|Overall Study|Refused treatment|6
436020|NCT00471276|1450232|P1|Overall Study|Other|3
436021|NCT00471276|1450232|P1|Overall Study|Global deterioration of health status|1
436022|NCT00471276|1450232|P1|Overall Study|Objective progression or relapse|54
436023|NCT00471276|1450232|P1|Overall Study|Protocol Violation|1
436024|NCT00471276|1450232|P1|Overall Study|Adverse Event|16
436025|NCT00471276|1450232|P1|Overall Study|Death|2
436026|NCT00471237|1450262|P7|Overall Study|Participant's decision|0
436027|NCT00471237|1450263|P6|Overall Study|Participant's decision|1
436028|NCT00471237|1450264|P5|Overall Study|Participant's decision|0
436029|NCT00471237|1450265|P4|Overall Study|Participant's decision|0
436030|NCT00471237|1450266|P3|Overall Study|Participant's decision|0
436031|NCT00471237|1450267|P2|Overall Study|Participant's decision|0
436032|NCT00471237|1450268|P1|Overall Study|Participant's decision|0
436033|NCT00471237|1450262|P7|Overall Study|Participant shifted residence|0
436034|NCT00471237|1450263|P6|Overall Study|Participant shifted residence|0
436035|NCT00471237|1450264|P5|Overall Study|Participant shifted residence|1
436036|NCT00471237|1450265|P4|Overall Study|Participant shifted residence|0
436037|NCT00471237|1450266|P3|Overall Study|Participant shifted residence|0
436038|NCT00471237|1450267|P2|Overall Study|Participant shifted residence|0
436039|NCT00471237|1450268|P1|Overall Study|Participant shifted residence|0
436040|NCT00471237|1450262|P7|Overall Study|Administration of prohibited medicine|0
436041|NCT00471237|1450263|P6|Overall Study|Administration of prohibited medicine|0
436042|NCT00471237|1450264|P5|Overall Study|Administration of prohibited medicine|1
436043|NCT00471237|1450265|P4|Overall Study|Administration of prohibited medicine|0
436044|NCT00471237|1450266|P3|Overall Study|Administration of prohibited medicine|0
436045|NCT00471237|1450267|P2|Overall Study|Administration of prohibited medicine|0
436046|NCT00471237|1450268|P1|Overall Study|Administration of prohibited medicine|0
436047|NCT00471237|1450262|P7|Overall Study|Participant lost medication|0
436048|NCT00471237|1450263|P6|Overall Study|Participant lost medication|0
436049|NCT00471237|1450264|P5|Overall Study|Participant lost medication|1
436050|NCT00471237|1450265|P4|Overall Study|Participant lost medication|0
436051|NCT00471237|1450266|P3|Overall Study|Participant lost medication|0
436052|NCT00471237|1450267|P2|Overall Study|Participant lost medication|0
436053|NCT00471237|1450268|P1|Overall Study|Participant lost medication|0
436054|NCT00471237|1450262|P7|Overall Study|High parathyroid hormone|0
436055|NCT00471237|1450263|P6|Overall Study|High parathyroid hormone|0
436056|NCT00471237|1450264|P5|Overall Study|High parathyroid hormone|0
436057|NCT00471237|1450265|P4|Overall Study|High parathyroid hormone|0
436058|NCT00471237|1450266|P3|Overall Study|High parathyroid hormone|1
436059|NCT00471237|1450267|P2|Overall Study|High parathyroid hormone|0
436060|NCT00471237|1450268|P1|Overall Study|High parathyroid hormone|0
436061|NCT00471237|1450262|P7|Overall Study|Participant planned to travel to abraod|0
436062|NCT00471237|1450263|P6|Overall Study|Participant planned to travel to abraod|1
436063|NCT00471237|1450264|P5|Overall Study|Participant planned to travel to abraod|0
436064|NCT00471237|1450265|P4|Overall Study|Participant planned to travel to abraod|0
436065|NCT00471237|1450266|P3|Overall Study|Participant planned to travel to abraod|0
436066|NCT00471237|1450267|P2|Overall Study|Participant planned to travel to abraod|0
436067|NCT00471237|1450268|P1|Overall Study|Participant planned to travel to abraod|1
436068|NCT00471237|1450262|P7|Overall Study|Early stopping due to non-efficacy|0
436069|NCT00471237|1450263|P6|Overall Study|Early stopping due to non-efficacy|0
436070|NCT00471237|1450264|P5|Overall Study|Early stopping due to non-efficacy|1
436071|NCT00471237|1450265|P4|Overall Study|Early stopping due to non-efficacy|0
436072|NCT00471237|1450266|P3|Overall Study|Early stopping due to non-efficacy|0
436073|NCT00471237|1450267|P2|Overall Study|Early stopping due to non-efficacy|0
436074|NCT00471237|1450268|P1|Overall Study|Early stopping due to non-efficacy|1
436075|NCT00471237|1450262|P7|Overall Study|Met serum creatinine withdrawal criteria|0
436076|NCT00471237|1450263|P6|Overall Study|Met serum creatinine withdrawal criteria|0
436077|NCT00471237|1450264|P5|Overall Study|Met serum creatinine withdrawal criteria|0
436078|NCT00471237|1450265|P4|Overall Study|Met serum creatinine withdrawal criteria|2
436079|NCT00471237|1450266|P3|Overall Study|Met serum creatinine withdrawal criteria|2
436080|NCT00471237|1450267|P2|Overall Study|Met serum creatinine withdrawal criteria|0
436081|NCT00471237|1450268|P1|Overall Study|Met serum creatinine withdrawal criteria|1
436082|NCT00471237|1450262|P7|Overall Study|Non-compliance|0
436083|NCT00471237|1450263|P6|Overall Study|Non-compliance|0
436084|NCT00471237|1450264|P5|Overall Study|Non-compliance|0
436085|NCT00471237|1450265|P4|Overall Study|Non-compliance|1
436086|NCT00471237|1450266|P3|Overall Study|Non-compliance|0
436087|NCT00471237|1450267|P2|Overall Study|Non-compliance|1
436088|NCT00471237|1450268|P1|Overall Study|Non-compliance|0
436089|NCT00471237|1450262|P7|Overall Study|Sponsor terminated study|0
436090|NCT00471237|1450263|P6|Overall Study|Sponsor terminated study|24
436091|NCT00471237|1450264|P5|Overall Study|Sponsor terminated study|18
436092|NCT00471237|1450265|P4|Overall Study|Sponsor terminated study|22
436093|NCT00471237|1450266|P3|Overall Study|Sponsor terminated study|19
436094|NCT00471237|1450267|P2|Overall Study|Sponsor terminated study|23
436095|NCT00471237|1450268|P1|Overall Study|Sponsor terminated study|20
436096|NCT00471237|1450262|P7|Overall Study|Withdrawal by Subject|2
436097|NCT00471237|1450263|P6|Overall Study|Withdrawal by Subject|4
436098|NCT00471237|1450264|P5|Overall Study|Withdrawal by Subject|7
436099|NCT00471237|1450265|P4|Overall Study|Withdrawal by Subject|8
436100|NCT00471237|1450266|P3|Overall Study|Withdrawal by Subject|5
436101|NCT00471237|1450267|P2|Overall Study|Withdrawal by Subject|6
436102|NCT00471237|1450268|P1|Overall Study|Withdrawal by Subject|8
436103|NCT00471237|1450262|P7|Overall Study|Protocol Violation|1
436104|NCT00471237|1450263|P6|Overall Study|Protocol Violation|4
436105|NCT00471237|1450264|P5|Overall Study|Protocol Violation|2
436106|NCT00471237|1450265|P4|Overall Study|Protocol Violation|2
436107|NCT00471237|1450266|P3|Overall Study|Protocol Violation|3
436108|NCT00471237|1450267|P2|Overall Study|Protocol Violation|6
436109|NCT00471237|1450268|P1|Overall Study|Protocol Violation|3
436110|NCT00471237|1450262|P7|Overall Study|Lost to Follow-up|0
436111|NCT00471237|1450263|P6|Overall Study|Lost to Follow-up|0
436112|NCT00471237|1450264|P5|Overall Study|Lost to Follow-up|3
436113|NCT00471237|1450265|P4|Overall Study|Lost to Follow-up|2
436114|NCT00471237|1450266|P3|Overall Study|Lost to Follow-up|0
436115|NCT00471237|1450267|P2|Overall Study|Lost to Follow-up|1
436116|NCT00471237|1450268|P1|Overall Study|Lost to Follow-up|1
436117|NCT00471237|1450262|P7|Overall Study|Adverse Event|0
436118|NCT00471237|1450263|P6|Overall Study|Adverse Event|5
436119|NCT00471237|1450264|P5|Overall Study|Adverse Event|7
436120|NCT00471237|1450265|P4|Overall Study|Adverse Event|8
436121|NCT00471237|1450266|P3|Overall Study|Adverse Event|4
436122|NCT00471237|1450267|P2|Overall Study|Adverse Event|5
436123|NCT00471237|1450268|P1|Overall Study|Adverse Event|6
436124|NCT00471146|1450418|P2|Overall Study|Other|5
436125|NCT00471146|1450419|P1|Overall Study|Other|4
436126|NCT00471146|1450418|P2|Overall Study|Randomized but not treated|8
436127|NCT00471146|1450419|P1|Overall Study|Randomized but not treated|9
436128|NCT00471146|1450418|P2|Overall Study|Global deterioration of health status|14
436129|NCT00471146|1450419|P1|Overall Study|Global deterioration of health status|12
436130|NCT00471146|1450418|P2|Overall Study|Objective progression or relapse|87
436131|NCT00471146|1450419|P1|Overall Study|Objective progression or relapse|84
436132|NCT00471146|1450418|P2|Overall Study|Protocol Violation|2
436133|NCT00471146|1450419|P1|Overall Study|Protocol Violation|2
436134|NCT00471146|1450418|P2|Overall Study|Lost to Follow-up|2
436135|NCT00471146|1450419|P1|Overall Study|Lost to Follow-up|4
436136|NCT00471146|1450418|P2|Overall Study|Death|12
436137|NCT00471146|1450419|P1|Overall Study|Death|11
436138|NCT00471146|1450418|P2|Overall Study|Withdrawal by Subject|11
436139|NCT00471146|1450419|P1|Overall Study|Withdrawal by Subject|14
436140|NCT00471146|1450418|P2|Overall Study|Adverse Event|33
436141|NCT00471146|1450419|P1|Overall Study|Adverse Event|32
436142|NCT00471107|1450444|P3|Overall Study|Technical problems/data loss|3
436143|NCT00471107|1450445|P2|Overall Study|Technical problems/data loss|1
436144|NCT00471107|1450446|P1|Overall Study|Technical problems/data loss|3
436145|NCT00470847|1450463|P1|Overall Study|Pt still receiving treatment|1
436146|NCT00470834|1450476|P2|Extension Period (24 Months)|Disease Progression|1
436147|NCT00470834|1450477|P1|Extension Period (24 Months)|Disease Progression|0
436148|NCT00470834|1450476|P2|Extension Period (24 Months)|Non-compliance|1
436149|NCT00470834|1450477|P1|Extension Period (24 Months)|Non-compliance|0
436150|NCT00470834|1450476|P2|Extension Period (24 Months)|Lost to Follow-up|1
436151|NCT00470834|1450477|P1|Extension Period (24 Months)|Lost to Follow-up|0
436152|NCT00470834|1450476|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
436153|NCT00470834|1450477|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
436154|NCT00470834|1450476|P2|Extension Period (24 Months)|Physician Decision|3
436155|NCT00470834|1450477|P1|Extension Period (24 Months)|Physician Decision|4
436156|NCT00470834|1450476|P2|Extension Period (24 Months)|Withdrawal by Subject|5
436157|NCT00470834|1450477|P1|Extension Period (24 Months)|Withdrawal by Subject|2
436158|NCT00470834|1450476|P2|Extension Period (24 Months)|Adverse Event|4
436159|NCT00470834|1450477|P1|Extension Period (24 Months)|Adverse Event|3
436160|NCT00470834|1450476|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
436338|NCT00468585|1451231|P2|Overall Study|Withdrawal by Subject|0
436161|NCT00470834|1450477|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
436162|NCT00470834|1450476|P2|Treatment Period (18 Months)|Lack of Efficacy|0
436163|NCT00470834|1450477|P1|Treatment Period (18 Months)|Lack of Efficacy|1
436164|NCT00470834|1450476|P2|Treatment Period (18 Months)|Non-compliance|0
436165|NCT00470834|1450477|P1|Treatment Period (18 Months)|Non-compliance|1
436166|NCT00470834|1450476|P2|Treatment Period (18 Months)|Lost to Follow-up|0
436167|NCT00470834|1450477|P1|Treatment Period (18 Months)|Lost to Follow-up|1
436168|NCT00470834|1450476|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
436169|NCT00470834|1450477|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
436170|NCT00470834|1450476|P2|Treatment Period (18 Months)|Protocol Violation|1
436171|NCT00470834|1450477|P1|Treatment Period (18 Months)|Protocol Violation|3
436172|NCT00470834|1450476|P2|Treatment Period (18 Months)|Physician Decision|4
436173|NCT00470834|1450477|P1|Treatment Period (18 Months)|Physician Decision|4
436174|NCT00470834|1450476|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
436175|NCT00470834|1450477|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
436176|NCT00470834|1450476|P2|Treatment Period (18 Months)|Adverse Event|6
436177|NCT00470834|1450477|P1|Treatment Period (18 Months)|Adverse Event|7
436178|NCT00470834|1450476|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
436179|NCT00470834|1450477|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
436180|NCT00470626|1450491|P1|Overall Study|Withdrawal by Subject|7
436181|NCT00470626|1450491|P1|Overall Study|Lost to Follow-up|10
436182|NCT00470535|1450533|P1|Overall Study|Other|2
436183|NCT00470535|1450533|P1|Overall Study|Death|1
436184|NCT00470535|1450533|P1|Overall Study|Adverse Event|1
436185|NCT00470535|1450533|P1|Overall Study|Withdrawal by Subject|1
436186|NCT00470535|1450533|P1|Overall Study|Disease Progression|13
436187|NCT00470470|1450542|P1|Overall Study|Not treated|1
436188|NCT00470470|1450542|P1|Overall Study|Death|2
436189|NCT00470470|1450542|P1|Overall Study|Adverse Event|2
436190|NCT00470418|1450549|P2|Overall Study|Withdrawal by Subject|0
436191|NCT00470418|1450550|P1|Overall Study|Withdrawal by Subject|1
436192|NCT00470366|1450571|P1|Overall Study|Poor compliance|1
436193|NCT00470366|1450571|P1|Overall Study|Adverse Event|3
436194|NCT00470275|1450582|P1|Overall Study|Withdrawal by Subject|2
436195|NCT00470275|1450582|P1|Overall Study|Lack of Efficacy|7
436196|NCT00470275|1450582|P1|Overall Study|Death|1
436197|NCT00470262|1450588|P2|Overall Study|Withdrawal by Subject|0
436198|NCT00470262|1450589|P1|Overall Study|Withdrawal by Subject|2
436199|NCT00470184|1450597|P1|Overall Study|recurrence|1
436200|NCT00470184|1450597|P1|Overall Study|other|5
436201|NCT00470184|1450597|P1|Overall Study|Withdrawal by Subject|4
436202|NCT00470184|1450597|P1|Overall Study|Adverse Event|3
436203|NCT00470184|1450597|P1|Overall Study|disease Progression|4
436204|NCT00470184|1450597|P1|Overall Study|Not treated (other)|1
436205|NCT00470184|1450597|P1|Overall Study|Not Treated(became ineligible)|4
436206|NCT00470158|1450609|P5|Overall Study|Protocol Violation|0
436207|NCT00470158|1450610|P4|Overall Study|Protocol Violation|0
436208|NCT00470158|1450611|P3|Overall Study|Protocol Violation|0
436209|NCT00470158|1450612|P2|Overall Study|Protocol Violation|0
436210|NCT00470158|1450613|P1|Overall Study|Protocol Violation|1
436211|NCT00470158|1450609|P5|Overall Study|Lost to Follow-up|4
436212|NCT00470158|1450610|P4|Overall Study|Lost to Follow-up|5
436213|NCT00470158|1450611|P3|Overall Study|Lost to Follow-up|8
436214|NCT00470158|1450612|P2|Overall Study|Lost to Follow-up|8
436215|NCT00470158|1450613|P1|Overall Study|Lost to Follow-up|7
436216|NCT00470158|1450609|P5|Overall Study|Death|2
436217|NCT00470158|1450610|P4|Overall Study|Death|0
436218|NCT00470158|1450611|P3|Overall Study|Death|0
436219|NCT00470158|1450612|P2|Overall Study|Death|0
436220|NCT00470158|1450613|P1|Overall Study|Death|0
436221|NCT00470067|1450646|P1|Overall Study|Disease Progression|6
436222|NCT00470067|1450646|P1|Overall Study|Death|1
436223|NCT00470054|1450650|P1|Overall Study|Ineligible|1
436224|NCT00469898|1450658|P1|Overall Study|Decreased performance status|1
436225|NCT00469898|1450658|P1|Overall Study|Disease progression|9
436226|NCT00469898|1450658|P1|Overall Study|Death|4
436227|NCT00469898|1450658|P1|Overall Study|Withdrawal by Subject|4
436228|NCT00469898|1450658|P1|Overall Study|Adverse Event|7
436229|NCT00469859|1450667|P2|Overall Study|Inevaluable|2
436230|NCT00469859|1450668|P1|Overall Study|Inevaluable|0
436231|NCT00469833|1450676|P1|Overall Study|No IV access|2
436232|NCT00469456|1450703|P2|Overall Study|Withdrawal by Subject|1
436233|NCT00469456|1450704|P1|Overall Study|Withdrawal by Subject|4
436234|NCT00469456|1450703|P2|Overall Study|Protocol Violation|0
436235|NCT00469456|1450704|P1|Overall Study|Protocol Violation|1
436236|NCT00469456|1450703|P2|Overall Study|Adverse Event|3
436237|NCT00469456|1450704|P1|Overall Study|Adverse Event|4
436238|NCT00469209|1450733|P3|Overall Study|Adverse Event|1
436239|NCT00469209|1450734|P2|Overall Study|Adverse Event|0
436240|NCT00469209|1450735|P1|Overall Study|Adverse Event|1
436241|NCT00469092|1450745|P2|Overall Study|Use of Corticosteroid|0
436242|NCT00469092|1450746|P1|Overall Study|Use of Corticosteroid|1
436243|NCT00469092|1450745|P2|Overall Study|Abnormal lab value|0
436244|NCT00469092|1450746|P1|Overall Study|Abnormal lab value|1
436245|NCT00469092|1450745|P2|Overall Study|Hypoglycaemic Episodes|1
436246|NCT00469092|1450746|P1|Overall Study|Hypoglycaemic Episodes|1
436247|NCT00469092|1450745|P2|Overall Study|Use of lipid lowering drug|0
436248|NCT00469092|1450746|P1|Overall Study|Use of lipid lowering drug|1
436249|NCT00469092|1450745|P2|Overall Study|Contraindication metformin/glimepiride|0
436250|NCT00469092|1450746|P1|Overall Study|Contraindication metformin/glimepiride|1
436251|NCT00469092|1450745|P2|Overall Study|Incorrectly Randomised|3
436252|NCT00469092|1450746|P1|Overall Study|Incorrectly Randomised|4
436253|NCT00469092|1450745|P2|Overall Study|Withdrawal Criteria|4
436254|NCT00469092|1450746|P1|Overall Study|Withdrawal Criteria|3
436255|NCT00469092|1450745|P2|Overall Study|Withdrawal by Subject|4
436256|NCT00469092|1450746|P1|Overall Study|Withdrawal by Subject|4
436257|NCT00469092|1450745|P2|Overall Study|Protocol Violation|3
436258|NCT00469092|1450746|P1|Overall Study|Protocol Violation|3
436259|NCT00469092|1450745|P2|Overall Study|Lost to Follow-up|2
436260|NCT00469092|1450746|P1|Overall Study|Lost to Follow-up|1
436261|NCT00469092|1450745|P2|Overall Study|Lack of Efficacy|0
436262|NCT00469092|1450746|P1|Overall Study|Lack of Efficacy|1
436263|NCT00469092|1450745|P2|Overall Study|Adverse Event|4
436264|NCT00469092|1450746|P1|Overall Study|Adverse Event|5
436265|NCT00469079|1450765|P3|Overall Study|Ineligible|0
436266|NCT00469079|1450766|P2|Overall Study|Ineligible|1
436267|NCT00469079|1450767|P1|Overall Study|Ineligible|0
436268|NCT00469079|1450765|P3|Overall Study|Withdrawal by Subject|2
436269|NCT00469079|1450766|P2|Overall Study|Withdrawal by Subject|2
436270|NCT00469079|1450767|P1|Overall Study|Withdrawal by Subject|1
436271|NCT00469079|1450765|P3|Overall Study|Lost to Follow-up|10
436272|NCT00469079|1450766|P2|Overall Study|Lost to Follow-up|8
436273|NCT00469079|1450767|P1|Overall Study|Lost to Follow-up|4
436274|NCT00469079|1450765|P3|Overall Study|Adverse Event|2
436275|NCT00469079|1450766|P2|Overall Study|Adverse Event|3
436276|NCT00469079|1450767|P1|Overall Study|Adverse Event|1
436277|NCT00469079|1450765|P3|Overall Study|Lack of Efficacy|5
436278|NCT00469079|1450766|P2|Overall Study|Lack of Efficacy|8
436279|NCT00469079|1450767|P1|Overall Study|Lack of Efficacy|3
436280|NCT00468910|1450786|P2|Overall Study|Medical Contraindication|1
436281|NCT00468910|1450787|P1|Overall Study|Medical Contraindication|0
436282|NCT00468910|1450786|P2|Overall Study|Withdrawal by Subject|1
436283|NCT00468910|1450787|P1|Overall Study|Withdrawal by Subject|2
436284|NCT00468910|1450786|P2|Overall Study|Lost to Follow-up|1
436285|NCT00468910|1450787|P1|Overall Study|Lost to Follow-up|2
436286|NCT00468858|1450806|P3|Overall Study|Other|1
436287|NCT00468858|1450807|P2|Overall Study|Other|0
436288|NCT00468858|1450808|P1|Overall Study|Other|0
436289|NCT00468858|1450806|P3|Overall Study|Lost to Follow-up|5
436290|NCT00468858|1450807|P2|Overall Study|Lost to Follow-up|2
436291|NCT00468858|1450808|P1|Overall Study|Lost to Follow-up|1
436292|NCT00468858|1450806|P3|Overall Study|Relocation|3
436293|NCT00468858|1450807|P2|Overall Study|Relocation|3
436294|NCT00468858|1450808|P1|Overall Study|Relocation|1
436295|NCT00468858|1450806|P3|Overall Study|Withdrawal by Subject|5
436296|NCT00468858|1450807|P2|Overall Study|Withdrawal by Subject|4
436297|NCT00468858|1450808|P1|Overall Study|Withdrawal by Subject|7
436298|NCT00468858|1450806|P3|Overall Study|Adverse Event|0
436299|NCT00468858|1450807|P2|Overall Study|Adverse Event|1
436300|NCT00468858|1450808|P1|Overall Study|Adverse Event|0
436301|NCT00468845|1450929|P3|Overall Study|Randomized, not treated|2
436302|NCT00468845|1450930|P2|Overall Study|Randomized, not treated|4
436303|NCT00468845|1450931|P1|Overall Study|Randomized, not treated|1
436304|NCT00468845|1450929|P3|Overall Study|No longer willing to participate|10
436305|NCT00468845|1450930|P2|Overall Study|No longer willing to participate|6
436306|NCT00468845|1450931|P1|Overall Study|No longer willing to participate|5
436307|NCT00468845|1450929|P3|Overall Study|Other|5
436308|NCT00468845|1450930|P2|Overall Study|Other|9
436309|NCT00468845|1450931|P1|Overall Study|Other|4
436310|NCT00468845|1450929|P3|Overall Study|Lost to Follow-up|2
436311|NCT00468845|1450930|P2|Overall Study|Lost to Follow-up|1
436312|NCT00468845|1450931|P1|Overall Study|Lost to Follow-up|2
436313|NCT00468845|1450929|P3|Overall Study|Adverse Event|11
436314|NCT00468845|1450930|P2|Overall Study|Adverse Event|14
436315|NCT00468845|1450931|P1|Overall Study|Adverse Event|9
436316|NCT00468819|1451068|P3|Overall Study|Drop-outs (Treatment never received)|0
436317|NCT00468819|1451069|P2|Overall Study|Drop-outs (Treatment never received)|0
436318|NCT00468819|1451070|P1|Overall Study|Drop-outs (Treatment never received)|2
436319|NCT00468819|1451068|P3|Overall Study|Lost to Follow-up|1
436320|NCT00468819|1451069|P2|Overall Study|Lost to Follow-up|0
436321|NCT00468819|1451070|P1|Overall Study|Lost to Follow-up|0
436322|NCT00468819|1451068|P3|Overall Study|Withdrawal by Subject|1
436323|NCT00468819|1451069|P2|Overall Study|Withdrawal by Subject|0
436324|NCT00468819|1451070|P1|Overall Study|Withdrawal by Subject|4
436325|NCT00468728|1451150|P2|Follow-up|mITT failure|31
436326|NCT00468728|1451151|P1|Follow-up|mITT failure|34
436327|NCT00468728|1451150|P2|Treatment|criteria for mITT population|11
436328|NCT00468728|1451151|P1|Treatment|criteria for mITT population|4
436329|NCT00468676|1451163|P2|Overall Study|Death|1
436330|NCT00468676|1451164|P1|Overall Study|Death|2
436331|NCT00468676|1451163|P2|Overall Study|Lost to Follow-up|11
436332|NCT00468676|1451164|P1|Overall Study|Lost to Follow-up|14
436333|NCT00468650|1451181|P1|Overall Study|Protocol Violation|1
436334|NCT00468650|1451181|P1|Overall Study|Withdrawal by Subject|2
436335|NCT00468650|1451181|P1|Overall Study|Lost to Follow-up|4
436336|NCT00468585|1451229|P4|Overall Study|Withdrawal by Subject|1
436337|NCT00468585|1451230|P3|Overall Study|Withdrawal by Subject|2
436339|NCT00468585|1451232|P1|Overall Study|Withdrawal by Subject|0
436340|NCT00468585|1451229|P4|Overall Study|Adverse Event|0
436341|NCT00468585|1451230|P3|Overall Study|Adverse Event|1
436342|NCT00468585|1451231|P2|Overall Study|Adverse Event|0
436343|NCT00468585|1451232|P1|Overall Study|Adverse Event|0
436344|NCT00468585|1451229|P4|Overall Study|Patient found to be ineligible|0
436345|NCT00468585|1451230|P3|Overall Study|Patient found to be ineligible|1
436346|NCT00468585|1451231|P2|Overall Study|Patient found to be ineligible|0
436347|NCT00468585|1451232|P1|Overall Study|Patient found to be ineligible|0
436348|NCT00468585|1451229|P4|Overall Study|Patient not treated|0
436349|NCT00468585|1451230|P3|Overall Study|Patient not treated|1
436350|NCT00468585|1451231|P2|Overall Study|Patient not treated|0
436351|NCT00468585|1451232|P1|Overall Study|Patient not treated|1
436352|NCT00468559|1451244|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
436353|NCT00468559|1451245|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
436354|NCT00468559|1451246|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
436355|NCT00468559|1451244|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
436356|NCT00468559|1451245|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
436357|NCT00468559|1451246|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
436358|NCT00468559|1451244|P3|Open-label Treatment Phase|Withdrawal by Subject|0
436359|NCT00468559|1451245|P2|Open-label Treatment Phase|Withdrawal by Subject|0
436360|NCT00468559|1451246|P1|Open-label Treatment Phase|Withdrawal by Subject|4
436361|NCT00468559|1451244|P3|Open-label Treatment Phase|Lack of Efficacy|0
436362|NCT00468559|1451245|P2|Open-label Treatment Phase|Lack of Efficacy|0
436363|NCT00468559|1451246|P1|Open-label Treatment Phase|Lack of Efficacy|9
436364|NCT00468559|1451244|P3|Open-label Treatment Phase|Adverse Event|0
436365|NCT00468559|1451245|P2|Open-label Treatment Phase|Adverse Event|0
436366|NCT00468559|1451246|P1|Open-label Treatment Phase|Adverse Event|5
436367|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Other|14
436368|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Other|17
436369|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
436370|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
436371|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Failure to return|2
436372|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Failure to return|1
436373|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Refused treatment|7
436374|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Refused treatment|4
436375|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
436376|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
436377|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
436378|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
436379|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Death|0
436380|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Death|1
436381|NCT00468546|1451274|P2|Week 24 to Week 104 Analysis|Adverse Event|5
436382|NCT00468546|1451275|P1|Week 24 to Week 104 Analysis|Adverse Event|2
436383|NCT00468546|1451274|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
436384|NCT00468546|1451275|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
436385|NCT00468546|1451274|P2|Week 24 Analysis|Went onto rescue therapy|0
436386|NCT00468546|1451275|P1|Week 24 Analysis|Went onto rescue therapy|1
436387|NCT00468546|1451274|P2|Week 24 Analysis|Due to clinical hold|0
436388|NCT00468546|1451275|P1|Week 24 Analysis|Due to clinical hold|1
436389|NCT00468546|1451274|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
436390|NCT00468546|1451275|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
436391|NCT00468546|1451274|P2|Week 24 Analysis|Rescue therapy|0
436392|NCT00468546|1451275|P1|Week 24 Analysis|Rescue therapy|2
436393|NCT00468546|1451274|P2|Week 24 Analysis|Failure to return|4
436394|NCT00468546|1451275|P1|Week 24 Analysis|Failure to return|3
436395|NCT00468546|1451274|P2|Week 24 Analysis|Adverse Event|8
436396|NCT00468546|1451275|P1|Week 24 Analysis|Adverse Event|1
436397|NCT00468546|1451274|P2|Week 24 Analysis|Refused treatment|5
436398|NCT00468546|1451275|P1|Week 24 Analysis|Refused treatment|5
436399|NCT00468546|1451274|P2|Week 24 Analysis|Lack of Efficacy|37
436400|NCT00468546|1451275|P1|Week 24 Analysis|Lack of Efficacy|83
436401|NCT00468481|1451305|P2|Overall Study|Other|0
436402|NCT00468481|1451306|P1|Overall Study|Other|6
436403|NCT00468481|1451305|P2|Overall Study|Non-Compliance|0
436404|NCT00468481|1451306|P1|Overall Study|Non-Compliance|5
436405|NCT00468481|1451305|P2|Overall Study|Moved out of area|1
436406|NCT00468481|1451306|P1|Overall Study|Moved out of area|4
436407|NCT00468481|1451305|P2|Overall Study|Egg Donor|0
436408|NCT00468481|1451306|P1|Overall Study|Egg Donor|1
436409|NCT00468481|1451305|P2|Overall Study|Prohibited Medication|1
436410|NCT00468481|1451306|P1|Overall Study|Prohibited Medication|1
436411|NCT00468481|1451305|P2|Overall Study|susp/diag malignant/premalignant disease|0
436412|NCT00468481|1451306|P1|Overall Study|susp/diag malignant/premalignant disease|1
436413|NCT00468481|1451305|P2|Overall Study|Withdrawal by Subject|3
436414|NCT00468481|1451306|P1|Overall Study|Withdrawal by Subject|12
436415|NCT00468481|1451305|P2|Overall Study|Protocol Violation|8
436416|NCT00468481|1451306|P1|Overall Study|Protocol Violation|18
436417|NCT00468481|1451305|P2|Overall Study|Pregnancy|0
436418|NCT00468481|1451306|P1|Overall Study|Pregnancy|2
436419|NCT00468481|1451305|P2|Overall Study|Lost to Follow-up|8
436420|NCT00468481|1451306|P1|Overall Study|Lost to Follow-up|25
436421|NCT00468481|1451305|P2|Overall Study|Adverse Event|3
436422|NCT00468481|1451306|P1|Overall Study|Adverse Event|13
436423|NCT00468312|1451406|P2|Overall Study|Did not meet protocol eligibility|1
436424|NCT00468312|1451407|P1|Overall Study|Did not meet protocol eligibility|0
436425|NCT00468312|1451406|P2|Overall Study|Protocol Violation|1
436426|NCT00468312|1451407|P1|Overall Study|Protocol Violation|2
436427|NCT00468312|1451406|P2|Overall Study|Withdrawal by Subject|1
436428|NCT00468312|1451407|P1|Overall Study|Withdrawal by Subject|0
436429|NCT00468312|1451406|P2|Overall Study|Lack of Efficacy|1
436430|NCT00468312|1451407|P1|Overall Study|Lack of Efficacy|0
436431|NCT00468312|1451406|P2|Overall Study|Adverse Event|1
436432|NCT00468312|1451407|P1|Overall Study|Adverse Event|2
436433|NCT00468299|1451423|P2|Overall Study|Withdrawal by Subject|1
436434|NCT00468299|1451424|P1|Overall Study|Withdrawal by Subject|0
436435|NCT00468286|1451434|P2|Overall Study|Physician Decision|1
436436|NCT00468286|1451435|P1|Overall Study|Physician Decision|0
436437|NCT00468286|1451434|P2|Overall Study|Withdrawal by Subject|3
436438|NCT00468286|1451435|P1|Overall Study|Withdrawal by Subject|4
436439|NCT00468286|1451434|P2|Overall Study|Protocol Violation|2
436440|NCT00468286|1451435|P1|Overall Study|Protocol Violation|2
436441|NCT00468286|1451434|P2|Overall Study|Adverse Event|6
436442|NCT00468286|1451435|P1|Overall Study|Adverse Event|1
436443|NCT00468143|1451465|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
436444|NCT00468143|1451466|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
436445|NCT00468143|1451465|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
436446|NCT00468143|1451466|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
436447|NCT00468104|1451480|P2|Second Intervention|discarded for malposition of chest tube|2
436448|NCT00468104|1451481|P1|Second Intervention|discarded for malposition of chest tube|0
436449|NCT00468104|1451480|P2|Second Intervention|Withdrawal by Subject|2
436450|NCT00468104|1451481|P1|Second Intervention|Withdrawal by Subject|5
436451|NCT00468104|1451480|P2|First Intervention|trapped lung|0
436452|NCT00468104|1451481|P1|First Intervention|trapped lung|1
436453|NCT00468104|1451480|P2|First Intervention|associated prolonged pneumothorax|0
436454|NCT00468104|1451481|P1|First Intervention|associated prolonged pneumothorax|1
436455|NCT00468104|1451480|P2|First Intervention|large lung mass with minimal effusion|0
436456|NCT00468104|1451481|P1|First Intervention|large lung mass with minimal effusion|1
436457|NCT00468104|1451480|P2|First Intervention|malposition/blocked chest tube tube|0
436458|NCT00468104|1451481|P1|First Intervention|malposition/blocked chest tube tube|2
436459|NCT00468104|1451480|P2|First Intervention|died within 3 weeks|0
436460|NCT00468104|1451481|P1|First Intervention|died within 3 weeks|1
436461|NCT00468104|1451480|P2|First Intervention|bleeding at chest tube site--first dose|0
436462|NCT00468104|1451481|P1|First Intervention|bleeding at chest tube site--first dose|1
436463|NCT00468104|1451480|P2|First Intervention|Protocol Violation|1
436464|NCT00468104|1451481|P1|First Intervention|Protocol Violation|2
436465|NCT00468052|1451498|P2|Overall Study|Protocol Violation|8
436466|NCT00468052|1451499|P1|Overall Study|Protocol Violation|7
436467|NCT00467961|1451517|P1|Overall Study|Disease Progression|2
436468|NCT00467961|1451517|P1|Overall Study|Technical Failures|5
436469|NCT00467896|1451521|P1|Overall Study|Patient had no improvement|1
436470|NCT00467896|1451521|P1|Overall Study|Started inhaled Remodulin|1
436471|NCT00467896|1451521|P1|Overall Study|Started intravenous prostacyclin|1
436472|NCT00467896|1451521|P1|Overall Study|Mainly used Prodose not I-neb® device|1
436473|NCT00467896|1451521|P1|Overall Study|Patient weaned off iloprost|1
436474|NCT00467896|1451521|P1|Overall Study|Patient had atrial septostomy|1
436475|NCT00467896|1451521|P1|Overall Study|Patient received transplant|2
436476|NCT00467896|1451521|P1|Overall Study|Changed therapy|2
436477|NCT00467896|1451521|P1|Overall Study|Non-compliance|3
436478|NCT00467896|1451521|P1|Overall Study|Serious Adverse Event|13
436479|NCT00467896|1451521|P1|Overall Study|Adverse Event|7
436480|NCT00467896|1451521|P1|Overall Study|Consent Withdrawal|18
436481|NCT00467870|1451547|P6|Overall Study|Other/Unknown|0
436482|NCT00467870|1451548|P5|Overall Study|Other/Unknown|4
436483|NCT00467870|1451549|P4|Overall Study|Other/Unknown|5
436484|NCT00467870|1451550|P3|Overall Study|Other/Unknown|1
436485|NCT00467870|1451551|P2|Overall Study|Other/Unknown|5
436486|NCT00467870|1451552|P1|Overall Study|Other/Unknown|8
436487|NCT00467870|1451547|P6|Overall Study|Subject Non-compliance|0
436488|NCT00467870|1451548|P5|Overall Study|Subject Non-compliance|5
436489|NCT00467870|1451549|P4|Overall Study|Subject Non-compliance|1
436490|NCT00467870|1451550|P3|Overall Study|Subject Non-compliance|0
436491|NCT00467870|1451551|P2|Overall Study|Subject Non-compliance|4
436492|NCT00467870|1451552|P1|Overall Study|Subject Non-compliance|3
436493|NCT00467870|1451547|P6|Overall Study|Lost to Follow-up|0
436494|NCT00467870|1451548|P5|Overall Study|Lost to Follow-up|3
436495|NCT00467870|1451549|P4|Overall Study|Lost to Follow-up|1
436496|NCT00467870|1451550|P3|Overall Study|Lost to Follow-up|1
436497|NCT00467870|1451551|P2|Overall Study|Lost to Follow-up|3
436498|NCT00467870|1451552|P1|Overall Study|Lost to Follow-up|5
436499|NCT00467870|1451547|P6|Overall Study|Withdrawal by Subject|1
436500|NCT00467870|1451548|P5|Overall Study|Withdrawal by Subject|10
436501|NCT00467870|1451549|P4|Overall Study|Withdrawal by Subject|9
436502|NCT00467870|1451550|P3|Overall Study|Withdrawal by Subject|0
436503|NCT00467870|1451551|P2|Overall Study|Withdrawal by Subject|21
436504|NCT00467870|1451552|P1|Overall Study|Withdrawal by Subject|14
436505|NCT00467870|1451547|P6|Overall Study|Protocol Violation|0
436506|NCT00467870|1451548|P5|Overall Study|Protocol Violation|0
436507|NCT00467870|1451549|P4|Overall Study|Protocol Violation|2
436508|NCT00467870|1451550|P3|Overall Study|Protocol Violation|1
436509|NCT00467870|1451551|P2|Overall Study|Protocol Violation|1
436510|NCT00467870|1451552|P1|Overall Study|Protocol Violation|2
436511|NCT00467870|1451547|P6|Overall Study|Adverse Event|1
436512|NCT00467870|1451548|P5|Overall Study|Adverse Event|15
436513|NCT00467870|1451549|P4|Overall Study|Adverse Event|15
436514|NCT00467870|1451550|P3|Overall Study|Adverse Event|1
436515|NCT00467870|1451551|P2|Overall Study|Adverse Event|9
436516|NCT00467870|1451552|P1|Overall Study|Adverse Event|13
436517|NCT00467857|1451595|P2|Overall Study|Discontinuation reason missing|3
436518|NCT00467857|1451596|P1|Overall Study|Discontinuation reason missing|0
436519|NCT00467857|1451595|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
436520|NCT00467857|1451596|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
436521|NCT00467857|1451595|P2|Overall Study|Emergency care required|1
436522|NCT00467857|1451596|P1|Overall Study|Emergency care required|0
436523|NCT00467857|1451595|P2|Overall Study|Discharged from court service|1
436524|NCT00467857|1451596|P1|Overall Study|Discharged from court service|0
436525|NCT00467857|1451595|P2|Overall Study|Death|1
436526|NCT00467857|1451596|P1|Overall Study|Death|0
436527|NCT00467857|1451595|P2|Overall Study|Withdrew consent|0
436528|NCT00467857|1451596|P1|Overall Study|Withdrew consent|2
436529|NCT00467857|1451595|P2|Overall Study|Adverse Event|0
436530|NCT00467857|1451596|P1|Overall Study|Adverse Event|1
436531|NCT00467831|1451644|P1|Overall Study|Withdrawal by Subject|1
436532|NCT00467831|1451644|P1|Overall Study|Death|2
436533|NCT00467779|1451663|P15|Stage 3|Unspecified Reason|5
436534|NCT00467779|1451664|P14|Stage 3|Unspecified Reason|0
436535|NCT00467779|1451665|P13|Stage 3|Unspecified Reason|0
436536|NCT00467779|1451666|P12|Stage 3|Unspecified Reason|0
436537|NCT00467779|1451667|P11|Stage 3|Unspecified Reason|0
436538|NCT00467779|1451668|P10|Stage 3|Unspecified Reason|0
436539|NCT00467779|1451669|P9|Stage 3|Unspecified Reason|0
436540|NCT00467779|1451670|P8|Stage 3|Unspecified Reason|0
436541|NCT00467779|1451671|P7|Stage 3|Unspecified Reason|0
436542|NCT00467779|1451672|P6|Stage 3|Unspecified Reason|0
436543|NCT00467779|1451673|P5|Stage 3|Unspecified Reason|0
436544|NCT00467779|1451674|P4|Stage 3|Unspecified Reason|0
436545|NCT00467779|1451675|P3|Stage 3|Unspecified Reason|0
436546|NCT00467779|1451676|P2|Stage 3|Unspecified Reason|0
436547|NCT00467779|1451677|P1|Stage 3|Unspecified Reason|0
436548|NCT00467779|1451663|P15|Stage 3|Disease Progression|9
436549|NCT00467779|1451664|P14|Stage 3|Disease Progression|0
436550|NCT00467779|1451665|P13|Stage 3|Disease Progression|0
436551|NCT00467779|1451666|P12|Stage 3|Disease Progression|0
436552|NCT00467779|1451667|P11|Stage 3|Disease Progression|0
436553|NCT00467779|1451668|P10|Stage 3|Disease Progression|0
436554|NCT00467779|1451669|P9|Stage 3|Disease Progression|0
436555|NCT00467779|1451670|P8|Stage 3|Disease Progression|0
436556|NCT00467779|1451671|P7|Stage 3|Disease Progression|0
436557|NCT00467779|1451672|P6|Stage 3|Disease Progression|0
436558|NCT00467779|1451673|P5|Stage 3|Disease Progression|0
436559|NCT00467779|1451674|P4|Stage 3|Disease Progression|0
436560|NCT00467779|1451675|P3|Stage 3|Disease Progression|0
436561|NCT00467779|1451676|P2|Stage 3|Disease Progression|0
436562|NCT00467779|1451677|P1|Stage 3|Disease Progression|0
436563|NCT00467779|1451663|P15|Stage 3|Death|1
436564|NCT00467779|1451664|P14|Stage 3|Death|0
436565|NCT00467779|1451665|P13|Stage 3|Death|0
436566|NCT00467779|1451666|P12|Stage 3|Death|0
436567|NCT00467779|1451667|P11|Stage 3|Death|0
436568|NCT00467779|1451668|P10|Stage 3|Death|0
436569|NCT00467779|1451669|P9|Stage 3|Death|0
436570|NCT00467779|1451670|P8|Stage 3|Death|0
436571|NCT00467779|1451671|P7|Stage 3|Death|0
436572|NCT00467779|1451672|P6|Stage 3|Death|0
436573|NCT00467779|1451673|P5|Stage 3|Death|0
436574|NCT00467779|1451674|P4|Stage 3|Death|0
436575|NCT00467779|1451675|P3|Stage 3|Death|0
436576|NCT00467779|1451676|P2|Stage 3|Death|0
436577|NCT00467779|1451677|P1|Stage 3|Death|0
436578|NCT00467779|1451663|P15|Stage 3|Adverse Event|2
436579|NCT00467779|1451664|P14|Stage 3|Adverse Event|0
436580|NCT00467779|1451665|P13|Stage 3|Adverse Event|0
436581|NCT00467779|1451666|P12|Stage 3|Adverse Event|0
436582|NCT00467779|1451667|P11|Stage 3|Adverse Event|0
436583|NCT00467779|1451668|P10|Stage 3|Adverse Event|0
436584|NCT00467779|1451669|P9|Stage 3|Adverse Event|0
436585|NCT00467779|1451670|P8|Stage 3|Adverse Event|0
436586|NCT00467779|1451671|P7|Stage 3|Adverse Event|0
436587|NCT00467779|1451672|P6|Stage 3|Adverse Event|0
436588|NCT00467779|1451673|P5|Stage 3|Adverse Event|0
436589|NCT00467779|1451674|P4|Stage 3|Adverse Event|0
436590|NCT00467779|1451675|P3|Stage 3|Adverse Event|0
436591|NCT00467779|1451676|P2|Stage 3|Adverse Event|0
436592|NCT00467779|1451677|P1|Stage 3|Adverse Event|0
436593|NCT00467779|1451663|P15|Stage 2A|Withdrawal by Subject|0
436594|NCT00467779|1451664|P14|Stage 2A|Withdrawal by Subject|1
436595|NCT00467779|1451665|P13|Stage 2A|Withdrawal by Subject|0
436596|NCT00467779|1451666|P12|Stage 2A|Withdrawal by Subject|0
436597|NCT00467779|1451667|P11|Stage 2A|Withdrawal by Subject|0
436598|NCT00467779|1451668|P10|Stage 2A|Withdrawal by Subject|0
436599|NCT00467779|1451669|P9|Stage 2A|Withdrawal by Subject|0
436600|NCT00467779|1451670|P8|Stage 2A|Withdrawal by Subject|0
436601|NCT00467779|1451671|P7|Stage 2A|Withdrawal by Subject|0
436602|NCT00467779|1451672|P6|Stage 2A|Withdrawal by Subject|0
436603|NCT00467779|1451673|P5|Stage 2A|Withdrawal by Subject|0
436604|NCT00467779|1451674|P4|Stage 2A|Withdrawal by Subject|0
436605|NCT00467779|1451675|P3|Stage 2A|Withdrawal by Subject|0
436606|NCT00467779|1451676|P2|Stage 2A|Withdrawal by Subject|0
436607|NCT00467779|1451677|P1|Stage 2A|Withdrawal by Subject|0
436608|NCT00467779|1451663|P15|Stage 2A|Unspecified Reason|0
436609|NCT00467779|1451664|P14|Stage 2A|Unspecified Reason|7
436610|NCT00467779|1451665|P13|Stage 2A|Unspecified Reason|0
436611|NCT00467779|1451666|P12|Stage 2A|Unspecified Reason|0
436612|NCT00467779|1451667|P11|Stage 2A|Unspecified Reason|0
436613|NCT00467779|1451668|P10|Stage 2A|Unspecified Reason|0
436614|NCT00467779|1451669|P9|Stage 2A|Unspecified Reason|0
436615|NCT00467779|1451670|P8|Stage 2A|Unspecified Reason|0
436616|NCT00467779|1451671|P7|Stage 2A|Unspecified Reason|0
436617|NCT00467779|1451672|P6|Stage 2A|Unspecified Reason|0
436618|NCT00467779|1451673|P5|Stage 2A|Unspecified Reason|0
436619|NCT00467779|1451674|P4|Stage 2A|Unspecified Reason|0
436620|NCT00467779|1451675|P3|Stage 2A|Unspecified Reason|0
436621|NCT00467779|1451676|P2|Stage 2A|Unspecified Reason|0
436622|NCT00467779|1451677|P1|Stage 2A|Unspecified Reason|0
436623|NCT00467779|1451663|P15|Stage 2A|Disease Progression|0
436624|NCT00467779|1451664|P14|Stage 2A|Disease Progression|10
436625|NCT00467779|1451665|P13|Stage 2A|Disease Progression|0
436626|NCT00467779|1451666|P12|Stage 2A|Disease Progression|0
436627|NCT00467779|1451667|P11|Stage 2A|Disease Progression|0
436628|NCT00467779|1451668|P10|Stage 2A|Disease Progression|0
436629|NCT00467779|1451669|P9|Stage 2A|Disease Progression|0
436630|NCT00467779|1451670|P8|Stage 2A|Disease Progression|0
436631|NCT00467779|1451671|P7|Stage 2A|Disease Progression|0
436632|NCT00467779|1451672|P6|Stage 2A|Disease Progression|0
436633|NCT00467779|1451673|P5|Stage 2A|Disease Progression|0
436634|NCT00467779|1451674|P4|Stage 2A|Disease Progression|0
436635|NCT00467779|1451675|P3|Stage 2A|Disease Progression|0
436636|NCT00467779|1451676|P2|Stage 2A|Disease Progression|0
436637|NCT00467779|1451677|P1|Stage 2A|Disease Progression|0
436638|NCT00467779|1451663|P15|Stage 2A|Death|0
436639|NCT00467779|1451664|P14|Stage 2A|Death|1
436640|NCT00467779|1451665|P13|Stage 2A|Death|0
436641|NCT00467779|1451666|P12|Stage 2A|Death|0
436642|NCT00467779|1451667|P11|Stage 2A|Death|0
436643|NCT00467779|1451668|P10|Stage 2A|Death|0
436644|NCT00467779|1451669|P9|Stage 2A|Death|0
436645|NCT00467779|1451670|P8|Stage 2A|Death|0
436646|NCT00467779|1451671|P7|Stage 2A|Death|0
436647|NCT00467779|1451672|P6|Stage 2A|Death|0
436648|NCT00467779|1451673|P5|Stage 2A|Death|0
436649|NCT00467779|1451674|P4|Stage 2A|Death|0
436650|NCT00467779|1451675|P3|Stage 2A|Death|0
436651|NCT00467779|1451676|P2|Stage 2A|Death|0
436652|NCT00467779|1451677|P1|Stage 2A|Death|0
436653|NCT00467779|1451663|P15|Stage 2A|Adverse Event|0
436654|NCT00467779|1451664|P14|Stage 2A|Adverse Event|2
436655|NCT00467779|1451665|P13|Stage 2A|Adverse Event|0
436656|NCT00467779|1451666|P12|Stage 2A|Adverse Event|0
436657|NCT00467779|1451667|P11|Stage 2A|Adverse Event|0
436658|NCT00467779|1451668|P10|Stage 2A|Adverse Event|0
436659|NCT00467779|1451669|P9|Stage 2A|Adverse Event|0
436660|NCT00467779|1451670|P8|Stage 2A|Adverse Event|0
436661|NCT00467779|1451671|P7|Stage 2A|Adverse Event|0
436662|NCT00467779|1451672|P6|Stage 2A|Adverse Event|0
436663|NCT00467779|1451673|P5|Stage 2A|Adverse Event|0
436664|NCT00467779|1451674|P4|Stage 2A|Adverse Event|0
436665|NCT00467779|1451675|P3|Stage 2A|Adverse Event|0
436666|NCT00467779|1451676|P2|Stage 2A|Adverse Event|0
436667|NCT00467779|1451677|P1|Stage 2A|Adverse Event|0
436668|NCT00467779|1451663|P15|Stage 2|Unspecified Reason|0
436669|NCT00467779|1451664|P14|Stage 2|Unspecified Reason|0
436670|NCT00467779|1451665|P13|Stage 2|Unspecified Reason|0
436671|NCT00467779|1451666|P12|Stage 2|Unspecified Reason|0
436672|NCT00467779|1451667|P11|Stage 2|Unspecified Reason|0
436673|NCT00467779|1451668|P10|Stage 2|Unspecified Reason|0
436674|NCT00467779|1451669|P9|Stage 2|Unspecified Reason|3
436675|NCT00467779|1451670|P8|Stage 2|Unspecified Reason|0
436676|NCT00467779|1451671|P7|Stage 2|Unspecified Reason|0
436677|NCT00467779|1451672|P6|Stage 2|Unspecified Reason|0
436678|NCT00467779|1451673|P5|Stage 2|Unspecified Reason|0
436679|NCT00467779|1451674|P4|Stage 2|Unspecified Reason|0
436680|NCT00467779|1451675|P3|Stage 2|Unspecified Reason|0
436681|NCT00467779|1451676|P2|Stage 2|Unspecified Reason|0
436682|NCT00467779|1451677|P1|Stage 2|Unspecified Reason|0
436683|NCT00467779|1451663|P15|Stage 2|Disease Progression|0
436684|NCT00467779|1451664|P14|Stage 2|Disease Progression|0
436685|NCT00467779|1451665|P13|Stage 2|Disease Progression|0
436686|NCT00467779|1451666|P12|Stage 2|Disease Progression|0
436687|NCT00467779|1451667|P11|Stage 2|Disease Progression|0
436688|NCT00467779|1451668|P10|Stage 2|Disease Progression|0
436689|NCT00467779|1451669|P9|Stage 2|Disease Progression|16
436690|NCT00467779|1451670|P8|Stage 2|Disease Progression|0
436691|NCT00467779|1451671|P7|Stage 2|Disease Progression|0
436692|NCT00467779|1451672|P6|Stage 2|Disease Progression|0
436693|NCT00467779|1451673|P5|Stage 2|Disease Progression|0
436694|NCT00467779|1451674|P4|Stage 2|Disease Progression|0
436695|NCT00467779|1451675|P3|Stage 2|Disease Progression|0
436696|NCT00467779|1451676|P2|Stage 2|Disease Progression|0
436697|NCT00467779|1451677|P1|Stage 2|Disease Progression|0
436698|NCT00467779|1451663|P15|Stage 2|Death|0
436699|NCT00467779|1451664|P14|Stage 2|Death|0
436700|NCT00467779|1451665|P13|Stage 2|Death|0
436701|NCT00467779|1451666|P12|Stage 2|Death|0
436702|NCT00467779|1451667|P11|Stage 2|Death|0
436703|NCT00467779|1451668|P10|Stage 2|Death|0
436704|NCT00467779|1451669|P9|Stage 2|Death|1
436705|NCT00467779|1451670|P8|Stage 2|Death|0
436706|NCT00467779|1451671|P7|Stage 2|Death|0
436707|NCT00467779|1451672|P6|Stage 2|Death|0
436708|NCT00467779|1451673|P5|Stage 2|Death|0
436709|NCT00467779|1451674|P4|Stage 2|Death|0
436710|NCT00467779|1451675|P3|Stage 2|Death|0
436711|NCT00467779|1451676|P2|Stage 2|Death|0
436712|NCT00467779|1451677|P1|Stage 2|Death|0
436713|NCT00467779|1451663|P15|Stage 2|Adverse Event|0
436714|NCT00467779|1451664|P14|Stage 2|Adverse Event|0
436715|NCT00467779|1451665|P13|Stage 2|Adverse Event|0
436716|NCT00467779|1451666|P12|Stage 2|Adverse Event|0
436717|NCT00467779|1451667|P11|Stage 2|Adverse Event|0
436718|NCT00467779|1451668|P10|Stage 2|Adverse Event|0
436719|NCT00467779|1451669|P9|Stage 2|Adverse Event|1
436720|NCT00467779|1451670|P8|Stage 2|Adverse Event|0
436721|NCT00467779|1451671|P7|Stage 2|Adverse Event|0
436722|NCT00467779|1451672|P6|Stage 2|Adverse Event|0
436723|NCT00467779|1451673|P5|Stage 2|Adverse Event|0
436724|NCT00467779|1451674|P4|Stage 2|Adverse Event|0
436725|NCT00467779|1451675|P3|Stage 2|Adverse Event|0
436726|NCT00467779|1451676|P2|Stage 2|Adverse Event|0
436727|NCT00467779|1451677|P1|Stage 2|Adverse Event|0
436728|NCT00467779|1451663|P15|Stage 1A|Unspecified Reason|0
436729|NCT00467779|1451664|P14|Stage 1A|Unspecified Reason|0
436730|NCT00467779|1451665|P13|Stage 1A|Unspecified Reason|1
436731|NCT00467779|1451666|P12|Stage 1A|Unspecified Reason|1
436732|NCT00467779|1451667|P11|Stage 1A|Unspecified Reason|0
436733|NCT00467779|1451668|P10|Stage 1A|Unspecified Reason|0
436734|NCT00467779|1451669|P9|Stage 1A|Unspecified Reason|0
436735|NCT00467779|1451670|P8|Stage 1A|Unspecified Reason|0
436736|NCT00467779|1451671|P7|Stage 1A|Unspecified Reason|0
436737|NCT00467779|1451672|P6|Stage 1A|Unspecified Reason|0
436738|NCT00467779|1451673|P5|Stage 1A|Unspecified Reason|0
436739|NCT00467779|1451674|P4|Stage 1A|Unspecified Reason|0
436740|NCT00467779|1451675|P3|Stage 1A|Unspecified Reason|0
436741|NCT00467779|1451676|P2|Stage 1A|Unspecified Reason|0
436742|NCT00467779|1451677|P1|Stage 1A|Unspecified Reason|0
436743|NCT00467779|1451663|P15|Stage 1A|Withdrawal by Subject|0
436744|NCT00467779|1451664|P14|Stage 1A|Withdrawal by Subject|0
436745|NCT00467779|1451665|P13|Stage 1A|Withdrawal by Subject|1
436746|NCT00467779|1451666|P12|Stage 1A|Withdrawal by Subject|1
436747|NCT00467779|1451667|P11|Stage 1A|Withdrawal by Subject|1
436748|NCT00467779|1451668|P10|Stage 1A|Withdrawal by Subject|0
436749|NCT00467779|1451669|P9|Stage 1A|Withdrawal by Subject|0
436750|NCT00467779|1451670|P8|Stage 1A|Withdrawal by Subject|0
436751|NCT00467779|1451671|P7|Stage 1A|Withdrawal by Subject|0
436752|NCT00467779|1451672|P6|Stage 1A|Withdrawal by Subject|0
436753|NCT00467779|1451673|P5|Stage 1A|Withdrawal by Subject|0
436754|NCT00467779|1451674|P4|Stage 1A|Withdrawal by Subject|0
436755|NCT00467779|1451675|P3|Stage 1A|Withdrawal by Subject|0
436756|NCT00467779|1451676|P2|Stage 1A|Withdrawal by Subject|0
436757|NCT00467779|1451677|P1|Stage 1A|Withdrawal by Subject|0
436758|NCT00467779|1451663|P15|Stage 1A|Physician Decision|0
436759|NCT00467779|1451664|P14|Stage 1A|Physician Decision|0
436760|NCT00467779|1451665|P13|Stage 1A|Physician Decision|0
436761|NCT00467779|1451666|P12|Stage 1A|Physician Decision|0
436762|NCT00467779|1451667|P11|Stage 1A|Physician Decision|0
436763|NCT00467779|1451668|P10|Stage 1A|Physician Decision|1
436764|NCT00467779|1451669|P9|Stage 1A|Physician Decision|0
436765|NCT00467779|1451670|P8|Stage 1A|Physician Decision|0
436766|NCT00467779|1451671|P7|Stage 1A|Physician Decision|0
436767|NCT00467779|1451672|P6|Stage 1A|Physician Decision|0
436768|NCT00467779|1451673|P5|Stage 1A|Physician Decision|0
436769|NCT00467779|1451674|P4|Stage 1A|Physician Decision|0
436770|NCT00467779|1451675|P3|Stage 1A|Physician Decision|0
436771|NCT00467779|1451676|P2|Stage 1A|Physician Decision|0
436772|NCT00467779|1451677|P1|Stage 1A|Physician Decision|0
436773|NCT00467779|1451663|P15|Stage 1A|Disease Progression|0
436774|NCT00467779|1451664|P14|Stage 1A|Disease Progression|0
436775|NCT00467779|1451665|P13|Stage 1A|Disease Progression|2
436776|NCT00467779|1451666|P12|Stage 1A|Disease Progression|5
436777|NCT00467779|1451667|P11|Stage 1A|Disease Progression|2
436778|NCT00467779|1451668|P10|Stage 1A|Disease Progression|2
436779|NCT00467779|1451669|P9|Stage 1A|Disease Progression|0
436780|NCT00467779|1451670|P8|Stage 1A|Disease Progression|0
436781|NCT00467779|1451671|P7|Stage 1A|Disease Progression|0
436782|NCT00467779|1451672|P6|Stage 1A|Disease Progression|0
436783|NCT00467779|1451673|P5|Stage 1A|Disease Progression|0
436784|NCT00467779|1451674|P4|Stage 1A|Disease Progression|0
436785|NCT00467779|1451675|P3|Stage 1A|Disease Progression|0
436786|NCT00467779|1451676|P2|Stage 1A|Disease Progression|0
436787|NCT00467779|1451677|P1|Stage 1A|Disease Progression|0
436788|NCT00467779|1451663|P15|Stage 1A|Death|0
436789|NCT00467779|1451664|P14|Stage 1A|Death|0
436790|NCT00467779|1451665|P13|Stage 1A|Death|1
436791|NCT00467779|1451666|P12|Stage 1A|Death|1
436792|NCT00467779|1451667|P11|Stage 1A|Death|0
436793|NCT00467779|1451668|P10|Stage 1A|Death|0
436794|NCT00467779|1451669|P9|Stage 1A|Death|0
436795|NCT00467779|1451670|P8|Stage 1A|Death|0
436796|NCT00467779|1451671|P7|Stage 1A|Death|0
436797|NCT00467779|1451672|P6|Stage 1A|Death|0
436798|NCT00467779|1451673|P5|Stage 1A|Death|0
436799|NCT00467779|1451674|P4|Stage 1A|Death|0
436800|NCT00467779|1451675|P3|Stage 1A|Death|0
436801|NCT00467779|1451676|P2|Stage 1A|Death|0
436802|NCT00467779|1451677|P1|Stage 1A|Death|0
436803|NCT00467779|1451663|P15|Stage 1A|Adverse Event|0
436804|NCT00467779|1451664|P14|Stage 1A|Adverse Event|0
436805|NCT00467779|1451665|P13|Stage 1A|Adverse Event|1
436806|NCT00467779|1451666|P12|Stage 1A|Adverse Event|0
436807|NCT00467779|1451667|P11|Stage 1A|Adverse Event|0
436808|NCT00467779|1451668|P10|Stage 1A|Adverse Event|0
436809|NCT00467779|1451669|P9|Stage 1A|Adverse Event|0
436810|NCT00467779|1451670|P8|Stage 1A|Adverse Event|0
436811|NCT00467779|1451671|P7|Stage 1A|Adverse Event|0
436812|NCT00467779|1451672|P6|Stage 1A|Adverse Event|0
436813|NCT00467779|1451673|P5|Stage 1A|Adverse Event|0
436814|NCT00467779|1451674|P4|Stage 1A|Adverse Event|0
436815|NCT00467779|1451675|P3|Stage 1A|Adverse Event|0
436816|NCT00467779|1451676|P2|Stage 1A|Adverse Event|0
436817|NCT00467779|1451677|P1|Stage 1A|Adverse Event|0
436818|NCT00467779|1451663|P15|Stage 1|Withdrawal by Subject|0
436819|NCT00467779|1451664|P14|Stage 1|Withdrawal by Subject|0
436820|NCT00467779|1451665|P13|Stage 1|Withdrawal by Subject|0
436821|NCT00467779|1451666|P12|Stage 1|Withdrawal by Subject|0
436822|NCT00467779|1451667|P11|Stage 1|Withdrawal by Subject|0
436823|NCT00467779|1451668|P10|Stage 1|Withdrawal by Subject|0
436824|NCT00467779|1451669|P9|Stage 1|Withdrawal by Subject|0
436825|NCT00467779|1451670|P8|Stage 1|Withdrawal by Subject|1
436826|NCT00467779|1451671|P7|Stage 1|Withdrawal by Subject|1
436827|NCT00467779|1451672|P6|Stage 1|Withdrawal by Subject|0
436828|NCT00467779|1451673|P5|Stage 1|Withdrawal by Subject|0
436829|NCT00467779|1451674|P4|Stage 1|Withdrawal by Subject|0
436830|NCT00467779|1451675|P3|Stage 1|Withdrawal by Subject|0
436831|NCT00467779|1451676|P2|Stage 1|Withdrawal by Subject|0
436832|NCT00467779|1451677|P1|Stage 1|Withdrawal by Subject|0
436833|NCT00467779|1451663|P15|Stage 1|Physician Decision|0
436834|NCT00467779|1451664|P14|Stage 1|Physician Decision|0
436835|NCT00467779|1451665|P13|Stage 1|Physician Decision|0
436836|NCT00467779|1451666|P12|Stage 1|Physician Decision|0
436837|NCT00467779|1451667|P11|Stage 1|Physician Decision|0
436838|NCT00467779|1451668|P10|Stage 1|Physician Decision|0
436839|NCT00467779|1451669|P9|Stage 1|Physician Decision|0
436840|NCT00467779|1451670|P8|Stage 1|Physician Decision|0
436841|NCT00467779|1451671|P7|Stage 1|Physician Decision|0
436842|NCT00467779|1451672|P6|Stage 1|Physician Decision|0
436843|NCT00467779|1451673|P5|Stage 1|Physician Decision|0
436844|NCT00467779|1451674|P4|Stage 1|Physician Decision|0
436845|NCT00467779|1451675|P3|Stage 1|Physician Decision|0
436846|NCT00467779|1451676|P2|Stage 1|Physician Decision|1
436847|NCT00467779|1451677|P1|Stage 1|Physician Decision|0
436848|NCT00467779|1451663|P15|Stage 1|Unspecified Reason|0
436849|NCT00467779|1451664|P14|Stage 1|Unspecified Reason|0
436850|NCT00467779|1451665|P13|Stage 1|Unspecified Reason|0
436851|NCT00467779|1451666|P12|Stage 1|Unspecified Reason|0
436852|NCT00467779|1451667|P11|Stage 1|Unspecified Reason|0
436853|NCT00467779|1451668|P10|Stage 1|Unspecified Reason|0
436854|NCT00467779|1451669|P9|Stage 1|Unspecified Reason|0
436855|NCT00467779|1451670|P8|Stage 1|Unspecified Reason|0
436856|NCT00467779|1451671|P7|Stage 1|Unspecified Reason|0
436857|NCT00467779|1451672|P6|Stage 1|Unspecified Reason|2
436858|NCT00467779|1451673|P5|Stage 1|Unspecified Reason|1
436859|NCT00467779|1451674|P4|Stage 1|Unspecified Reason|0
436860|NCT00467779|1451675|P3|Stage 1|Unspecified Reason|1
436861|NCT00467779|1451676|P2|Stage 1|Unspecified Reason|0
436862|NCT00467779|1451677|P1|Stage 1|Unspecified Reason|1
436863|NCT00467779|1451663|P15|Stage 1|Disease Progression|0
436864|NCT00467779|1451664|P14|Stage 1|Disease Progression|0
436865|NCT00467779|1451665|P13|Stage 1|Disease Progression|0
436866|NCT00467779|1451666|P12|Stage 1|Disease Progression|0
436867|NCT00467779|1451667|P11|Stage 1|Disease Progression|0
436868|NCT00467779|1451668|P10|Stage 1|Disease Progression|0
436869|NCT00467779|1451669|P9|Stage 1|Disease Progression|0
436870|NCT00467779|1451670|P8|Stage 1|Disease Progression|5
436871|NCT00467779|1451671|P7|Stage 1|Disease Progression|4
436872|NCT00467779|1451672|P6|Stage 1|Disease Progression|2
436873|NCT00467779|1451673|P5|Stage 1|Disease Progression|2
436874|NCT00467779|1451674|P4|Stage 1|Disease Progression|3
436875|NCT00467779|1451675|P3|Stage 1|Disease Progression|2
436876|NCT00467779|1451676|P2|Stage 1|Disease Progression|2
436877|NCT00467779|1451677|P1|Stage 1|Disease Progression|2
436878|NCT00467779|1451663|P15|Stage 1|Adverse Event|0
436879|NCT00467779|1451664|P14|Stage 1|Adverse Event|0
436880|NCT00467779|1451665|P13|Stage 1|Adverse Event|0
436881|NCT00467779|1451666|P12|Stage 1|Adverse Event|0
436882|NCT00467779|1451667|P11|Stage 1|Adverse Event|0
436883|NCT00467779|1451668|P10|Stage 1|Adverse Event|0
436884|NCT00467779|1451669|P9|Stage 1|Adverse Event|0
436885|NCT00467779|1451670|P8|Stage 1|Adverse Event|1
436886|NCT00467779|1451671|P7|Stage 1|Adverse Event|2
436887|NCT00467779|1451672|P6|Stage 1|Adverse Event|1
436888|NCT00467779|1451673|P5|Stage 1|Adverse Event|0
436889|NCT00467779|1451674|P4|Stage 1|Adverse Event|0
436890|NCT00467779|1451675|P3|Stage 1|Adverse Event|0
436891|NCT00467779|1451676|P2|Stage 1|Adverse Event|0
436892|NCT00467779|1451677|P1|Stage 1|Adverse Event|1
436893|NCT00467753|1451851|P2|Overall Study|Adverse Event|0
436894|NCT00467753|1451852|P1|Overall Study|Adverse Event|2
436895|NCT00467753|1451851|P2|Overall Study|Lost to Follow-up|2
436896|NCT00467753|1451852|P1|Overall Study|Lost to Follow-up|1
436897|NCT00467740|1451863|P5|Overall Study|Lack of Efficacy|0
436898|NCT00467740|1451864|P4|Overall Study|Lack of Efficacy|0
436899|NCT00467740|1451865|P3|Overall Study|Lack of Efficacy|0
436900|NCT00467740|1451866|P2|Overall Study|Lack of Efficacy|1
436901|NCT00467740|1451867|P1|Overall Study|Lack of Efficacy|0
436902|NCT00467740|1451863|P5|Overall Study|Withdrawal by Subject|0
436903|NCT00467740|1451864|P4|Overall Study|Withdrawal by Subject|1
436904|NCT00467740|1451865|P3|Overall Study|Withdrawal by Subject|0
436905|NCT00467740|1451866|P2|Overall Study|Withdrawal by Subject|1
436906|NCT00467740|1451867|P1|Overall Study|Withdrawal by Subject|1
436907|NCT00467740|1451863|P5|Overall Study|Lost to Follow-up|0
436908|NCT00467740|1451864|P4|Overall Study|Lost to Follow-up|0
436909|NCT00467740|1451865|P3|Overall Study|Lost to Follow-up|0
436910|NCT00467740|1451866|P2|Overall Study|Lost to Follow-up|1
436911|NCT00467740|1451867|P1|Overall Study|Lost to Follow-up|0
436912|NCT00467740|1451863|P5|Overall Study|Protocol Violation|0
436913|NCT00467740|1451864|P4|Overall Study|Protocol Violation|0
436914|NCT00467740|1451865|P3|Overall Study|Protocol Violation|1
436915|NCT00467740|1451866|P2|Overall Study|Protocol Violation|0
436916|NCT00467740|1451867|P1|Overall Study|Protocol Violation|0
436917|NCT00467740|1451863|P5|Overall Study|Adverse Event|0
436918|NCT00467740|1451864|P4|Overall Study|Adverse Event|0
436919|NCT00467740|1451865|P3|Overall Study|Adverse Event|1
436920|NCT00467740|1451866|P2|Overall Study|Adverse Event|0
436921|NCT00467740|1451867|P1|Overall Study|Adverse Event|0
436922|NCT00467649|1452056|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
436923|NCT00467649|1452057|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
436924|NCT00467649|1452058|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
436925|NCT00467649|1452059|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
436926|NCT00467649|1452060|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
436927|NCT00467649|1452061|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
436928|NCT00467649|1452056|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
436929|NCT00467649|1452057|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
436930|NCT00467649|1452058|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
436931|NCT00467649|1452059|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
436932|NCT00467649|1452060|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
436933|NCT00467649|1452061|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
436934|NCT00467649|1452056|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
436935|NCT00467649|1452057|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
436936|NCT00467649|1452058|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
436937|NCT00467649|1452059|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
436938|NCT00467649|1452060|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
436939|NCT00467649|1452061|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
436940|NCT00467649|1452056|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
436941|NCT00467649|1452057|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
436942|NCT00467649|1452058|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
436943|NCT00467649|1452059|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
436944|NCT00467649|1452060|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
436945|NCT00467649|1452061|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
436946|NCT00467649|1452056|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
436947|NCT00467649|1452057|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
436948|NCT00467649|1452058|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
436949|NCT00467649|1452059|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
436950|NCT00467649|1452060|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
436951|NCT00467649|1452061|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
436952|NCT00467649|1452056|P6|Phase 1 (Randomized Population)|Investigator Decision|0
436953|NCT00467649|1452057|P5|Phase 1 (Randomized Population)|Investigator Decision|0
436954|NCT00467649|1452058|P4|Phase 1 (Randomized Population)|Investigator Decision|0
436955|NCT00467649|1452059|P3|Phase 1 (Randomized Population)|Investigator Decision|0
436956|NCT00467649|1452060|P2|Phase 1 (Randomized Population)|Investigator Decision|0
436957|NCT00467649|1452061|P1|Phase 1 (Randomized Population)|Investigator Decision|1
436958|NCT00467649|1452056|P6|Phase 1 (Randomized Population)|Adverse Event|0
436959|NCT00467649|1452057|P5|Phase 1 (Randomized Population)|Adverse Event|0
436960|NCT00467649|1452058|P4|Phase 1 (Randomized Population)|Adverse Event|0
436961|NCT00467649|1452059|P3|Phase 1 (Randomized Population)|Adverse Event|0
436962|NCT00467649|1452060|P2|Phase 1 (Randomized Population)|Adverse Event|0
436963|NCT00467649|1452061|P1|Phase 1 (Randomized Population)|Adverse Event|2
436964|NCT00467610|1452101|P1|Overall Study|Withdrawal by Subject|1
436965|NCT00467597|1452112|P2|Overall Study|Withdrawal by Subject|0
436966|NCT00467597|1452113|P1|Overall Study|Withdrawal by Subject|2
436967|NCT00467584|1452126|P3|Overall Study|Withdrawal by Subject|1
436968|NCT00467584|1452127|P2|Overall Study|Withdrawal by Subject|5
436969|NCT00467584|1452128|P1|Overall Study|Withdrawal by Subject|4
436970|NCT00467558|1452138|P2|Overall Study|Lost to Follow-up|0
436971|NCT00467558|1452139|P1|Overall Study|Lost to Follow-up|2
436972|NCT00467519|1452149|P2|Overall Study|Withdrawal by Subject|10
436973|NCT00467519|1452150|P1|Overall Study|Withdrawal by Subject|4
436974|NCT00467519|1452149|P2|Overall Study|Lost to Follow-up|9
436975|NCT00467519|1452150|P1|Overall Study|Lost to Follow-up|2
436976|NCT00467519|1452149|P2|Overall Study|Protocol Violation|4
436977|NCT00467519|1452150|P1|Overall Study|Protocol Violation|8
436978|NCT00467363|1452179|P2|Overall Study|Lost to Follow-up|70
436979|NCT00467363|1452180|P1|Overall Study|Lost to Follow-up|80
436980|NCT00467285|1452227|P2|Overall Study|Lost to Follow-up|4
436981|NCT00467285|1452228|P1|Overall Study|Lost to Follow-up|4
436982|NCT00467259|1452248|P2|Overall Study|Site Closed|1
436983|NCT00467259|1452249|P1|Overall Study|Site Closed|2
436984|NCT00467259|1452248|P2|Overall Study|Lost to Follow-up|34
436985|NCT00467259|1452249|P1|Overall Study|Lost to Follow-up|14
436986|NCT00467259|1452248|P2|Overall Study|Physician Decision|2
436987|NCT00467259|1452249|P1|Overall Study|Physician Decision|0
436988|NCT00467259|1452248|P2|Overall Study|Withdrawal by Subject|108
436989|NCT00467259|1452249|P1|Overall Study|Withdrawal by Subject|34
436990|NCT00467259|1452248|P2|Overall Study|Protocol Violation|7
436991|NCT00467259|1452249|P1|Overall Study|Protocol Violation|1
436992|NCT00467259|1452248|P2|Overall Study|Adverse Event|90
436993|NCT00467259|1452249|P1|Overall Study|Adverse Event|24
436994|NCT00467051|1452266|P1|Overall Study|Adverse Event|2
436995|NCT00466947|1452293|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
436996|NCT00466947|1452294|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
436997|NCT00466947|1452293|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
436998|NCT00466947|1452294|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
436999|NCT00466947|1452293|P2|Study End Analysis Period|Other – Forbidden vaccination|10
437000|NCT00466947|1452294|P1|Study End Analysis Period|Other – Forbidden vaccination|21
437001|NCT00466947|1452293|P2|Study End Analysis Period|Withdrawal by Subject|1267
437002|NCT00466947|1452294|P1|Study End Analysis Period|Withdrawal by Subject|1264
437003|NCT00466947|1452293|P2|Study End Analysis Period|Protocol Violation|17
437004|NCT00466947|1452294|P1|Study End Analysis Period|Protocol Violation|9
437005|NCT00466947|1452293|P2|Study End Analysis Period|Physician Decision|29
437006|NCT00466947|1452294|P1|Study End Analysis Period|Physician Decision|29
437007|NCT00466947|1452293|P2|Study End Analysis Period|Lost to Follow-up|1167
437008|NCT00466947|1452294|P1|Study End Analysis Period|Lost to Follow-up|1137
437009|NCT00466947|1452293|P2|Study End Analysis Period|Adverse Event|43
437010|NCT00466947|1452294|P1|Study End Analysis Period|Adverse Event|35
437011|NCT00466947|1452293|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
437012|NCT00466947|1452294|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
437013|NCT00466687|1452489|P1|Overall Study|Disease progression|29
437014|NCT00466687|1452489|P1|Overall Study|Withdrawal by Subject|1
437015|NCT00466687|1452489|P1|Overall Study|Other complicating illness|3
437016|NCT00466687|1452489|P1|Overall Study|Adverse Event|1
437017|NCT00466505|1452496|P1|Overall Study|Adverse Event|4
437018|NCT00466505|1452496|P1|Overall Study|disease progression|13
437019|NCT00466193|1452546|P2|Overall Study|Patient refused Visit 4 procedures|0
437020|NCT00466193|1452547|P1|Overall Study|Patient refused Visit 4 procedures|1
437021|NCT00466193|1452546|P2|Overall Study|Withdrawal by Subject|2
437022|NCT00466193|1452547|P1|Overall Study|Withdrawal by Subject|7
437023|NCT00466193|1452546|P2|Overall Study|Protocol Violation|1
437024|NCT00466193|1452547|P1|Overall Study|Protocol Violation|1
437025|NCT00466193|1452546|P2|Overall Study|Physician Decision|0
437026|NCT00466193|1452547|P1|Overall Study|Physician Decision|1
437027|NCT00466193|1452546|P2|Overall Study|Lost to Follow-up|4
437028|NCT00466193|1452547|P1|Overall Study|Lost to Follow-up|2
437029|NCT00466193|1452546|P2|Overall Study|Adverse Event|1
437030|NCT00466193|1452547|P1|Overall Study|Adverse Event|0
437031|NCT00466167|1452574|P3|Overall Study|Not treated|0
437032|NCT00466167|1452575|P2|Overall Study|Not treated|0
437033|NCT00466167|1452576|P1|Overall Study|Not treated|1
437034|NCT00466167|1452574|P3|Overall Study|patient did not meet inclusion criteria|1
437035|NCT00466167|1452575|P2|Overall Study|patient did not meet inclusion criteria|0
437036|NCT00466167|1452576|P1|Overall Study|patient did not meet inclusion criteria|1
437037|NCT00466167|1452574|P3|Overall Study|Withdrawal by Subject|6
437038|NCT00466167|1452575|P2|Overall Study|Withdrawal by Subject|1
437039|NCT00466167|1452576|P1|Overall Study|Withdrawal by Subject|4
437040|NCT00466167|1452574|P3|Overall Study|Lost to Follow-up|2
437041|NCT00466167|1452575|P2|Overall Study|Lost to Follow-up|2
437042|NCT00466167|1452576|P1|Overall Study|Lost to Follow-up|3
437043|NCT00466167|1452574|P3|Overall Study|Protocol Violation|2
437044|NCT00466167|1452575|P2|Overall Study|Protocol Violation|1
437045|NCT00466167|1452576|P1|Overall Study|Protocol Violation|1
437046|NCT00466167|1452574|P3|Overall Study|Lack of Efficacy|3
437047|NCT00466167|1452575|P2|Overall Study|Lack of Efficacy|0
437048|NCT00466167|1452576|P1|Overall Study|Lack of Efficacy|2
437049|NCT00466167|1452574|P3|Overall Study|Adverse Event|7
437050|NCT00466167|1452575|P2|Overall Study|Adverse Event|8
437051|NCT00466167|1452576|P1|Overall Study|Adverse Event|8
437052|NCT00465985|1452637|P2|Part III - Open-label Treatment Period|Adverse Event|0
437053|NCT00465985|1452638|P1|Part III - Open-label Treatment Period|Adverse Event|1
437054|NCT00465985|1452637|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
437055|NCT00465985|1452638|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
437056|NCT00465985|1452637|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
437057|NCT00465985|1452638|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
437058|NCT00465985|1452637|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
437059|NCT00465985|1452638|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
437060|NCT00465972|1452661|P2|Overall Study|Withdrawal by Subject|1
437061|NCT00465972|1452662|P1|Overall Study|Withdrawal by Subject|2
437062|NCT00465816|1452682|P3|Overall Study|Lost to Follow-up|2
437063|NCT00465816|1452683|P2|Overall Study|Lost to Follow-up|0
437064|NCT00465816|1452684|P1|Overall Study|Lost to Follow-up|0
437065|NCT00465738|1452747|P2|Overall Study|Other|5
437066|NCT00465738|1452748|P1|Overall Study|Other|2
437067|NCT00465738|1452747|P2|Overall Study|Withdrawal by Subject|0
437068|NCT00465738|1452748|P1|Overall Study|Withdrawal by Subject|2
437069|NCT00465738|1452747|P2|Overall Study|Adverse Event|1
437070|NCT00465738|1452748|P1|Overall Study|Adverse Event|0
437071|NCT00465738|1452747|P2|Overall Study|Lost to Follow-up|0
437072|NCT00465738|1452748|P1|Overall Study|Lost to Follow-up|2
437073|NCT00465647|1452842|P4|Overall Study|"The other reasons included loss of IV"|2
437074|NCT00465647|1452843|P3|Overall Study|"The other reasons included loss of IV"|3
437075|NCT00465647|1452844|P2|Overall Study|"The other reasons included loss of IV"|4
437076|NCT00465647|1452845|P1|Overall Study|"The other reasons included loss of IV"|8
437077|NCT00465647|1452842|P4|Overall Study|Withdrawal by Subject|7
437078|NCT00465647|1452843|P3|Overall Study|Withdrawal by Subject|2
437079|NCT00465647|1452844|P2|Overall Study|Withdrawal by Subject|2
437080|NCT00465647|1452845|P1|Overall Study|Withdrawal by Subject|1
437081|NCT00465647|1452842|P4|Overall Study|Adverse Event|2
437082|NCT00465647|1452843|P3|Overall Study|Adverse Event|3
437083|NCT00465647|1452844|P2|Overall Study|Adverse Event|0
437084|NCT00465647|1452845|P1|Overall Study|Adverse Event|2
437085|NCT00465647|1452842|P4|Overall Study|Administrative|2
437086|NCT00465647|1452843|P3|Overall Study|Administrative|3
437087|NCT00465647|1452844|P2|Overall Study|Administrative|2
437088|NCT00465647|1452845|P1|Overall Study|Administrative|2
437089|NCT00465569|1452870|P2|Overall Study|persistent eczema during dose escalation|0
437090|NCT00465569|1452871|P1|Overall Study|persistent eczema during dose escalation|1
437091|NCT00465361|1452894|P1|Baseline Assessment|Personal Issues/Scheduling|4
437092|NCT00465179|1452898|P1|Overall Study|Progression of Disease|47
437093|NCT00465179|1452898|P1|Overall Study|Withdrawal by Subject|2
437094|NCT00465179|1452898|P1|Overall Study|Adverse Event|4
437095|NCT00465101|1452904|P1|Overall Study|Withdrew consent prior to procedure|3
437096|NCT00465101|1452904|P1|Overall Study|Physician Decision|1
437097|NCT00465101|1452904|P1|Overall Study|Withdrawal by Subject|25
437098|NCT00465101|1452904|P1|Overall Study|Death|3
437099|NCT00465101|1452904|P1|Overall Study|Unable to obtain IRB approval|1
437100|NCT00465101|1452904|P1|Overall Study|Site closed due to IRB expiration|1
437101|NCT00465101|1452904|P1|Overall Study|Patient postponed procedure|1
437102|NCT00465101|1452904|P1|Overall Study|Pt. Insurance not accepted at center|2
437103|NCT00465101|1452904|P1|Overall Study|Other|6
437104|NCT00465101|1452904|P1|Overall Study|Lost to Follow-up|5
437105|NCT00465101|1452904|P1|Overall Study|Did not meet study criteria|4
437106|NCT00465101|1452904|P1|Overall Study|Change in health precluded follow up|4
437107|NCT00465101|1452904|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
437108|NCT00464945|1452974|P2|Toddler Dose|Lost to Follow-up|1
437109|NCT00464945|1452975|P1|Toddler Dose|Lost to Follow-up|0
437110|NCT00464945|1452974|P2|After Infant Series|Withdrawal by Subject|2
437111|NCT00464945|1452975|P1|After Infant Series|Withdrawal by Subject|0
437112|NCT00464945|1452974|P2|Infant Series|Lost to Follow-up|0
437113|NCT00464945|1452975|P1|Infant Series|Lost to Follow-up|1
437114|NCT00464945|1452974|P2|Infant Series|Protocol Violation|0
437115|NCT00464945|1452975|P1|Infant Series|Protocol Violation|1
437116|NCT00464945|1452974|P2|Infant Series|Withdrawal by parent/guardian request|1
437117|NCT00464945|1452975|P1|Infant Series|Withdrawal by parent/guardian request|2
437118|NCT00464815|1453005|P2|Overall Study|Withdrawal by Subject|3
437119|NCT00464815|1453006|P1|Overall Study|Withdrawal by Subject|6
437120|NCT00464737|1453039|P3|Overall Study|Other: Subject's disability per sponsor|1
437121|NCT00464737|1453040|P2|Overall Study|Other: Subject's disability per sponsor|0
437122|NCT00464737|1453041|P1|Overall Study|Other: Subject's disability per sponsor|0
437123|NCT00464737|1453039|P3|Overall Study|Other: Personal family reasons|1
437124|NCT00464737|1453040|P2|Overall Study|Other: Personal family reasons|0
437125|NCT00464737|1453041|P1|Overall Study|Other: Personal family reasons|0
437126|NCT00464737|1453039|P3|Overall Study|Other: Study demands too great|0
437127|NCT00464737|1453040|P2|Overall Study|Other: Study demands too great|1
437128|NCT00464737|1453041|P1|Overall Study|Other: Study demands too great|0
437129|NCT00464737|1453039|P3|Overall Study|Other: Subject left town; family illness|0
437130|NCT00464737|1453040|P2|Overall Study|Other: Subject left town; family illness|0
437131|NCT00464737|1453041|P1|Overall Study|Other: Subject left town; family illness|1
437132|NCT00464737|1453039|P3|Overall Study|Other: Subject's schedule doesn't permit|0
437133|NCT00464737|1453040|P2|Overall Study|Other: Subject's schedule doesn't permit|0
437134|NCT00464737|1453041|P1|Overall Study|Other: Subject's schedule doesn't permit|1
437135|NCT00464737|1453039|P3|Overall Study|Lost to Follow-up|5
437136|NCT00464737|1453040|P2|Overall Study|Lost to Follow-up|2
437137|NCT00464737|1453041|P1|Overall Study|Lost to Follow-up|5
437138|NCT00464737|1453039|P3|Overall Study|Non-compliance|1
437139|NCT00464737|1453040|P2|Overall Study|Non-compliance|1
437140|NCT00464737|1453041|P1|Overall Study|Non-compliance|0
437141|NCT00464737|1453039|P3|Overall Study|Protocol Violation|5
437142|NCT00464737|1453040|P2|Overall Study|Protocol Violation|1
437143|NCT00464737|1453041|P1|Overall Study|Protocol Violation|1
437144|NCT00464737|1453039|P3|Overall Study|Withdrawal by Subject|5
437145|NCT00464737|1453040|P2|Overall Study|Withdrawal by Subject|3
437146|NCT00464737|1453041|P1|Overall Study|Withdrawal by Subject|5
437147|NCT00464737|1453039|P3|Overall Study|Lack of Efficacy|4
437148|NCT00464737|1453040|P2|Overall Study|Lack of Efficacy|7
437149|NCT00464737|1453041|P1|Overall Study|Lack of Efficacy|7
437150|NCT00464737|1453039|P3|Overall Study|Adverse Event|33
437151|NCT00464737|1453040|P2|Overall Study|Adverse Event|17
437152|NCT00464737|1453041|P1|Overall Study|Adverse Event|12
437153|NCT00464672|1453121|P6|Overall Study|Lost to Follow-up|0
437154|NCT00464672|1453122|P5|Overall Study|Lost to Follow-up|1
437155|NCT00464672|1453123|P4|Overall Study|Lost to Follow-up|0
437156|NCT00464672|1453124|P3|Overall Study|Lost to Follow-up|0
437157|NCT00464672|1453125|P2|Overall Study|Lost to Follow-up|10
437158|NCT00464672|1453126|P1|Overall Study|Lost to Follow-up|25
437159|NCT00464672|1453121|P6|Overall Study|withdrawal of consent|4
437160|NCT00464672|1453122|P5|Overall Study|withdrawal of consent|9
437161|NCT00464672|1453123|P4|Overall Study|withdrawal of consent|1
437162|NCT00464672|1453124|P3|Overall Study|withdrawal of consent|0
437163|NCT00464672|1453125|P2|Overall Study|withdrawal of consent|0
437164|NCT00464672|1453126|P1|Overall Study|withdrawal of consent|0
437165|NCT00464568|1453205|P1|Overall Study|Adverse Event|2
437166|NCT00464542|1453278|P1|Pre-treatment|Withdrawal by Subject|2
437167|NCT00464490|1453285|P2|Overall Study|Physician Decision|11
437168|NCT00464490|1453286|P1|Overall Study|Physician Decision|11
437169|NCT00464334|1453333|P11|Overall Study|Withdrawal by Subject|0
437170|NCT00464334|1453334|P10|Overall Study|Withdrawal by Subject|0
437171|NCT00464334|1453335|P9|Overall Study|Withdrawal by Subject|3
437172|NCT00464334|1453336|P8|Overall Study|Withdrawal by Subject|1
437173|NCT00464334|1453337|P7|Overall Study|Withdrawal by Subject|2
437174|NCT00464334|1453338|P6|Overall Study|Withdrawal by Subject|2
437175|NCT00464334|1453339|P5|Overall Study|Withdrawal by Subject|2
437176|NCT00464334|1453340|P4|Overall Study|Withdrawal by Subject|2
437177|NCT00464334|1453341|P3|Overall Study|Withdrawal by Subject|4
437178|NCT00464334|1453342|P2|Overall Study|Withdrawal by Subject|7
437179|NCT00464334|1453343|P1|Overall Study|Withdrawal by Subject|1
437180|NCT00464334|1453333|P11|Overall Study|Study Terminated by Sponsor|0
437181|NCT00464334|1453334|P10|Overall Study|Study Terminated by Sponsor|0
437182|NCT00464334|1453335|P9|Overall Study|Study Terminated by Sponsor|0
437183|NCT00464334|1453336|P8|Overall Study|Study Terminated by Sponsor|0
437184|NCT00464334|1453337|P7|Overall Study|Study Terminated by Sponsor|0
437185|NCT00464334|1453338|P6|Overall Study|Study Terminated by Sponsor|0
437186|NCT00464334|1453339|P5|Overall Study|Study Terminated by Sponsor|0
437187|NCT00464334|1453340|P4|Overall Study|Study Terminated by Sponsor|1
437188|NCT00464334|1453341|P3|Overall Study|Study Terminated by Sponsor|0
437189|NCT00464334|1453342|P2|Overall Study|Study Terminated by Sponsor|0
437190|NCT00464334|1453343|P1|Overall Study|Study Terminated by Sponsor|0
437191|NCT00464334|1453333|P11|Overall Study|Progressive Disease|0
437192|NCT00464334|1453334|P10|Overall Study|Progressive Disease|0
437193|NCT00464334|1453335|P9|Overall Study|Progressive Disease|1
437194|NCT00464334|1453336|P8|Overall Study|Progressive Disease|0
437195|NCT00464334|1453337|P7|Overall Study|Progressive Disease|0
437196|NCT00464334|1453338|P6|Overall Study|Progressive Disease|1
437197|NCT00464334|1453339|P5|Overall Study|Progressive Disease|0
437198|NCT00464334|1453340|P4|Overall Study|Progressive Disease|0
437199|NCT00464334|1453341|P3|Overall Study|Progressive Disease|0
437200|NCT00464334|1453342|P2|Overall Study|Progressive Disease|0
437201|NCT00464334|1453343|P1|Overall Study|Progressive Disease|0
437202|NCT00464334|1453333|P11|Overall Study|Lost to Follow-up|2
437203|NCT00464334|1453334|P10|Overall Study|Lost to Follow-up|0
437204|NCT00464334|1453335|P9|Overall Study|Lost to Follow-up|0
437205|NCT00464334|1453336|P8|Overall Study|Lost to Follow-up|0
437206|NCT00464334|1453337|P7|Overall Study|Lost to Follow-up|1
437207|NCT00464334|1453338|P6|Overall Study|Lost to Follow-up|0
437208|NCT00464334|1453339|P5|Overall Study|Lost to Follow-up|1
437209|NCT00464334|1453340|P4|Overall Study|Lost to Follow-up|0
437210|NCT00464334|1453341|P3|Overall Study|Lost to Follow-up|1
437211|NCT00464334|1453342|P2|Overall Study|Lost to Follow-up|0
437212|NCT00464334|1453343|P1|Overall Study|Lost to Follow-up|0
437213|NCT00464334|1453333|P11|Overall Study|Lack of Efficacy|0
437214|NCT00464334|1453334|P10|Overall Study|Lack of Efficacy|0
437215|NCT00464334|1453335|P9|Overall Study|Lack of Efficacy|0
437216|NCT00464334|1453336|P8|Overall Study|Lack of Efficacy|0
437217|NCT00464334|1453337|P7|Overall Study|Lack of Efficacy|0
437218|NCT00464334|1453338|P6|Overall Study|Lack of Efficacy|0
437219|NCT00464334|1453339|P5|Overall Study|Lack of Efficacy|0
437220|NCT00464334|1453340|P4|Overall Study|Lack of Efficacy|0
437221|NCT00464334|1453341|P3|Overall Study|Lack of Efficacy|0
437222|NCT00464334|1453342|P2|Overall Study|Lack of Efficacy|1
437223|NCT00464334|1453343|P1|Overall Study|Lack of Efficacy|0
437224|NCT00464334|1453333|P11|Overall Study|Adverse Event|2
437225|NCT00464334|1453334|P10|Overall Study|Adverse Event|1
437226|NCT00464334|1453335|P9|Overall Study|Adverse Event|2
437227|NCT00464334|1453336|P8|Overall Study|Adverse Event|0
437228|NCT00464334|1453337|P7|Overall Study|Adverse Event|0
437229|NCT00464334|1453338|P6|Overall Study|Adverse Event|1
437230|NCT00464334|1453339|P5|Overall Study|Adverse Event|1
437231|NCT00464334|1453340|P4|Overall Study|Adverse Event|1
437232|NCT00464334|1453341|P3|Overall Study|Adverse Event|0
437233|NCT00464334|1453342|P2|Overall Study|Adverse Event|0
437234|NCT00464334|1453343|P1|Overall Study|Adverse Event|0
437235|NCT00464308|1453403|P3|Overall Study|Physician Decision|0
437236|NCT00464308|1453404|P2|Overall Study|Physician Decision|0
437237|NCT00464308|1453405|P1|Overall Study|Physician Decision|1
437238|NCT00464308|1453403|P3|Overall Study|Patient discontinued and other reasons|23
437239|NCT00464308|1453404|P2|Overall Study|Patient discontinued and other reasons|17
437240|NCT00464308|1453405|P1|Overall Study|Patient discontinued and other reasons|17
437241|NCT00464308|1453403|P3|Overall Study|Lost to Follow-up|20
437242|NCT00464308|1453404|P2|Overall Study|Lost to Follow-up|19
437243|NCT00464308|1453405|P1|Overall Study|Lost to Follow-up|29
437244|NCT00464308|1453403|P3|Overall Study|Adverse Event|16
437245|NCT00464308|1453404|P2|Overall Study|Adverse Event|27
437246|NCT00464308|1453405|P1|Overall Study|Adverse Event|22
437247|NCT00464269|1453435|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
437248|NCT00464269|1453436|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
437249|NCT00464269|1453437|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
437250|NCT00464269|1453438|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
437251|NCT00464269|1453435|P4|Overall Study|AE, non-serious non-fatal|4
437252|NCT00464269|1453436|P3|Overall Study|AE, non-serious non-fatal|3
437253|NCT00464269|1453437|P2|Overall Study|AE, non-serious non-fatal|8
437254|NCT00464269|1453438|P1|Overall Study|AE, non-serious non-fatal|2
437255|NCT00464269|1453435|P4|Overall Study|SAE, non-fatal|1
437256|NCT00464269|1453436|P3|Overall Study|SAE, non-fatal|0
437257|NCT00464269|1453437|P2|Overall Study|SAE, non-fatal|0
437258|NCT00464269|1453438|P1|Overall Study|SAE, non-fatal|0
437259|NCT00464269|1453435|P4|Overall Study|AE, serious fatal|1
437260|NCT00464269|1453436|P3|Overall Study|AE, serious fatal|1
437261|NCT00464269|1453437|P2|Overall Study|AE, serious fatal|0
437262|NCT00464269|1453438|P1|Overall Study|AE, serious fatal|0
437263|NCT00464269|1453435|P4|Overall Study|Other reason|1
437264|NCT00464269|1453436|P3|Overall Study|Other reason|1
437265|NCT00464269|1453437|P2|Overall Study|Other reason|3
437266|NCT00464269|1453438|P1|Overall Study|Other reason|3
437267|NCT00464269|1453435|P4|Overall Study|Withdrawal by Subject|1
437268|NCT00464269|1453436|P3|Overall Study|Withdrawal by Subject|1
437269|NCT00464269|1453437|P2|Overall Study|Withdrawal by Subject|2
437270|NCT00464269|1453438|P1|Overall Study|Withdrawal by Subject|0
437271|NCT00464269|1453435|P4|Overall Study|Lost to Follow-up|1
437272|NCT00464269|1453436|P3|Overall Study|Lost to Follow-up|0
437273|NCT00464269|1453437|P2|Overall Study|Lost to Follow-up|4
437274|NCT00464269|1453438|P1|Overall Study|Lost to Follow-up|0
437275|NCT00464269|1453435|P4|Overall Study|Lack of Efficacy|0
437276|NCT00464269|1453436|P3|Overall Study|Lack of Efficacy|0
437277|NCT00464269|1453437|P2|Overall Study|Lack of Efficacy|0
437278|NCT00464269|1453438|P1|Overall Study|Lack of Efficacy|1
437279|NCT00464087|1453576|P3|Overall Study|No PCI per inclusion criteria|29
437280|NCT00464087|1453577|P2|Overall Study|No PCI per inclusion criteria|0
437281|NCT00464087|1453578|P1|Overall Study|No PCI per inclusion criteria|0
437282|NCT00463866|1453596|P2|Overall Study|Other|22
437283|NCT00463866|1453597|P1|Overall Study|Other|22
437284|NCT00463866|1453596|P2|Overall Study|Mis-Randomization of subject|1
437285|NCT00463866|1453597|P1|Overall Study|Mis-Randomization of subject|0
437286|NCT00463866|1453596|P2|Overall Study|Safety Reason|3
437287|NCT00463866|1453597|P1|Overall Study|Safety Reason|1
437288|NCT00463866|1453596|P2|Overall Study|Severe Non-Compliance to Protocol|21
437289|NCT00463866|1453597|P1|Overall Study|Severe Non-Compliance to Protocol|25
437290|NCT00463866|1453596|P2|Overall Study|Incorrect Enrolment|66
437291|NCT00463866|1453597|P1|Overall Study|Incorrect Enrolment|64
437292|NCT00463866|1453596|P2|Overall Study|Lost to Follow-up|55
437293|NCT00463866|1453597|P1|Overall Study|Lost to Follow-up|46
437294|NCT00463866|1453596|P2|Overall Study|Withdrawal by Subject|79
437295|NCT00463866|1453597|P1|Overall Study|Withdrawal by Subject|81
437296|NCT00463866|1453596|P2|Overall Study|Adverse Event|93
437297|NCT00463866|1453597|P1|Overall Study|Adverse Event|70
437298|NCT00463840|1453617|P1|Overall Study|Adverse Event|3
437299|NCT00463840|1453617|P1|Overall Study|Withdrawal by Subject|2
437300|NCT00463840|1453617|P1|Overall Study|Disease progression|7
437301|NCT00463801|1453622|P1|Overall Study|No longer require therapy|1
437302|NCT00463801|1453622|P1|Overall Study|Lost to Follow-up|5
437303|NCT00463801|1453622|P1|Overall Study|Adverse Event|4
437304|NCT00463801|1453622|P1|Overall Study|Lack of Efficacy|2
437305|NCT00463801|1453622|P1|Overall Study|Protocol Violation|1
437306|NCT00463788|1453628|P2|Overall Study|Randomized but not treated|1
437307|NCT00463788|1453629|P1|Overall Study|Randomized but not treated|1
437308|NCT00463788|1453628|P2|Overall Study|Other|0
437309|NCT00463788|1453629|P1|Overall Study|Other|3
437310|NCT00463788|1453628|P2|Overall Study|Protocol Violation|1
437311|NCT00463788|1453629|P1|Overall Study|Protocol Violation|0
437312|NCT00463788|1453628|P2|Overall Study|Lost to Follow-up|0
437313|NCT00463788|1453629|P1|Overall Study|Lost to Follow-up|1
437314|NCT00463788|1453628|P2|Overall Study|Symptomatic Deterioration|3
437315|NCT00463788|1453629|P1|Overall Study|Symptomatic Deterioration|2
437316|NCT00463788|1453628|P2|Overall Study|Death|3
437317|NCT00463788|1453629|P1|Overall Study|Death|4
437318|NCT00463788|1453628|P2|Overall Study|Withdrawal by Subject|2
437319|NCT00463788|1453629|P1|Overall Study|Withdrawal by Subject|6
437320|NCT00463788|1453628|P2|Overall Study|Adverse Event|2
437321|NCT00463788|1453629|P1|Overall Study|Adverse Event|6
437322|NCT00463788|1453628|P2|Overall Study|Progressive Disease|42
437323|NCT00463788|1453629|P1|Overall Study|Progressive Disease|86
437324|NCT00463606|1453647|P3|Overall Study|Protocol Violation|1
437325|NCT00463606|1453648|P2|Overall Study|Protocol Violation|0
437326|NCT00463606|1453649|P1|Overall Study|Protocol Violation|0
437327|NCT00463606|1453647|P3|Overall Study|Participation in another ABT-335 trial|0
437328|NCT00463606|1453648|P2|Overall Study|Participation in another ABT-335 trial|0
437329|NCT00463606|1453649|P1|Overall Study|Participation in another ABT-335 trial|1
437330|NCT00463606|1453647|P3|Overall Study|Patient randomized in error|0
437331|NCT00463606|1453648|P2|Overall Study|Patient randomized in error|0
437332|NCT00463606|1453649|P1|Overall Study|Patient randomized in error|1
437333|NCT00463606|1453647|P3|Overall Study|Coordinator error|0
437334|NCT00463606|1453648|P2|Overall Study|Coordinator error|0
437335|NCT00463606|1453649|P1|Overall Study|Coordinator error|1
437336|NCT00463606|1453647|P3|Overall Study|Exclusion criteria violation|0
437337|NCT00463606|1453648|P2|Overall Study|Exclusion criteria violation|0
437338|NCT00463606|1453649|P1|Overall Study|Exclusion criteria violation|2
437339|NCT00463606|1453647|P3|Overall Study|Sponsor request|0
437340|NCT00463606|1453648|P2|Overall Study|Sponsor request|1
437341|NCT00463606|1453649|P1|Overall Study|Sponsor request|0
437342|NCT00463606|1453647|P3|Overall Study|Physician Decision|0
437343|NCT00463606|1453648|P2|Overall Study|Physician Decision|1
437344|NCT00463606|1453649|P1|Overall Study|Physician Decision|0
437345|NCT00463606|1453647|P3|Overall Study|Subject moved out of town|0
437346|NCT00463606|1453648|P2|Overall Study|Subject moved out of town|0
437347|NCT00463606|1453649|P1|Overall Study|Subject moved out of town|1
437348|NCT00463606|1453647|P3|Overall Study|Subject noncompliance|0
437349|NCT00463606|1453648|P2|Overall Study|Subject noncompliance|1
437350|NCT00463606|1453649|P1|Overall Study|Subject noncompliance|1
437351|NCT00463606|1453647|P3|Overall Study|Lost to Follow-up|3
437352|NCT00463606|1453648|P2|Overall Study|Lost to Follow-up|2
437353|NCT00463606|1453649|P1|Overall Study|Lost to Follow-up|2
437354|NCT00463606|1453647|P3|Overall Study|Withdrawal by Subject|5
437355|NCT00463606|1453648|P2|Overall Study|Withdrawal by Subject|11
437356|NCT00463606|1453649|P1|Overall Study|Withdrawal by Subject|11
437357|NCT00463606|1453647|P3|Overall Study|Adverse Event|11
437358|NCT00463606|1453648|P2|Overall Study|Adverse Event|18
437359|NCT00463606|1453649|P1|Overall Study|Adverse Event|21
437360|NCT00463580|1453674|P2|Overall Study|Medical/psychiatric complications|2
437361|NCT00463580|1453675|P1|Overall Study|Medical/psychiatric complications|0
437362|NCT00463580|1453674|P2|Overall Study|schedule conflict|0
437363|NCT00463580|1453675|P1|Overall Study|schedule conflict|2
437364|NCT00463580|1453674|P2|Overall Study|Lost to Follow-up|0
437365|NCT00463580|1453675|P1|Overall Study|Lost to Follow-up|1
437366|NCT00463567|1453690|P7|Overall Study|Death|0
437367|NCT00463567|1453691|P6|Overall Study|Death|0
437368|NCT00463567|1453692|P5|Overall Study|Death|0
437369|NCT00463567|1453693|P4|Overall Study|Death|0
437370|NCT00463567|1453694|P3|Overall Study|Death|2
437371|NCT00463567|1453695|P2|Overall Study|Death|0
437372|NCT00463567|1453696|P1|Overall Study|Death|1
437373|NCT00463567|1453690|P7|Overall Study|Abnormal test procedure result(s)|0
437374|NCT00463567|1453691|P6|Overall Study|Abnormal test procedure result(s)|2
437375|NCT00463567|1453692|P5|Overall Study|Abnormal test procedure result(s)|0
437376|NCT00463567|1453693|P4|Overall Study|Abnormal test procedure result(s)|2
437377|NCT00463567|1453694|P3|Overall Study|Abnormal test procedure result(s)|6
437378|NCT00463567|1453695|P2|Overall Study|Abnormal test procedure result(s)|1
437379|NCT00463567|1453696|P1|Overall Study|Abnormal test procedure result(s)|1
437380|NCT00463567|1453690|P7|Overall Study|Abnormal lab value(s)|0
437381|NCT00463567|1453691|P6|Overall Study|Abnormal lab value(s)|0
437382|NCT00463567|1453692|P5|Overall Study|Abnormal lab value(s)|1
437383|NCT00463567|1453693|P4|Overall Study|Abnormal lab value(s)|1
437384|NCT00463567|1453694|P3|Overall Study|Abnormal lab value(s)|2
437385|NCT00463567|1453695|P2|Overall Study|Abnormal lab value(s)|1
437386|NCT00463567|1453696|P1|Overall Study|Abnormal lab value(s)|1
437387|NCT00463567|1453690|P7|Overall Study|Lack of Efficacy|1
437388|NCT00463567|1453691|P6|Overall Study|Lack of Efficacy|0
437389|NCT00463567|1453692|P5|Overall Study|Lack of Efficacy|1
437390|NCT00463567|1453693|P4|Overall Study|Lack of Efficacy|17
437391|NCT00463567|1453694|P3|Overall Study|Lack of Efficacy|9
437392|NCT00463567|1453695|P2|Overall Study|Lack of Efficacy|9
437393|NCT00463567|1453696|P1|Overall Study|Lack of Efficacy|4
437394|NCT00463567|1453690|P7|Overall Study|Administrative problems|2
437395|NCT00463567|1453691|P6|Overall Study|Administrative problems|2
437396|NCT00463567|1453692|P5|Overall Study|Administrative problems|3
437397|NCT00463567|1453693|P4|Overall Study|Administrative problems|9
437398|NCT00463567|1453694|P3|Overall Study|Administrative problems|6
437399|NCT00463567|1453695|P2|Overall Study|Administrative problems|3
437400|NCT00463567|1453696|P1|Overall Study|Administrative problems|5
437401|NCT00463567|1453690|P7|Overall Study|Lost to Follow-up|1
437402|NCT00463567|1453691|P6|Overall Study|Lost to Follow-up|1
437403|NCT00463567|1453692|P5|Overall Study|Lost to Follow-up|1
437404|NCT00463567|1453693|P4|Overall Study|Lost to Follow-up|8
437405|NCT00463567|1453694|P3|Overall Study|Lost to Follow-up|13
437406|NCT00463567|1453695|P2|Overall Study|Lost to Follow-up|6
437407|NCT00463567|1453696|P1|Overall Study|Lost to Follow-up|12
437408|NCT00463567|1453690|P7|Overall Study|Protocol Deviation|2
437409|NCT00463567|1453691|P6|Overall Study|Protocol Deviation|1
437410|NCT00463567|1453692|P5|Overall Study|Protocol Deviation|1
437411|NCT00463567|1453693|P4|Overall Study|Protocol Deviation|11
437412|NCT00463567|1453694|P3|Overall Study|Protocol Deviation|14
437413|NCT00463567|1453695|P2|Overall Study|Protocol Deviation|9
437414|NCT00463567|1453696|P1|Overall Study|Protocol Deviation|13
437415|NCT00463567|1453690|P7|Overall Study|Withdrawal by Subject|1
437416|NCT00463567|1453691|P6|Overall Study|Withdrawal by Subject|5
437417|NCT00463567|1453692|P5|Overall Study|Withdrawal by Subject|6
437418|NCT00463567|1453693|P4|Overall Study|Withdrawal by Subject|37
437419|NCT00463567|1453694|P3|Overall Study|Withdrawal by Subject|20
437420|NCT00463567|1453695|P2|Overall Study|Withdrawal by Subject|22
437421|NCT00463567|1453696|P1|Overall Study|Withdrawal by Subject|29
437422|NCT00463567|1453690|P7|Overall Study|Adverse Event|4
437423|NCT00463567|1453691|P6|Overall Study|Adverse Event|10
437424|NCT00463567|1453692|P5|Overall Study|Adverse Event|10
437425|NCT00463567|1453693|P4|Overall Study|Adverse Event|46
437426|NCT00463567|1453694|P3|Overall Study|Adverse Event|17
437427|NCT00463567|1453695|P2|Overall Study|Adverse Event|26
437428|NCT00463567|1453696|P1|Overall Study|Adverse Event|29
437429|NCT00463385|1453800|P4|Overall Study|1 participant received commercial drug|0
437430|NCT00463385|1453801|P3|Overall Study|1 participant received commercial drug|0
437431|NCT00463385|1453802|P2|Overall Study|1 participant received commercial drug|1
437432|NCT00463385|1453803|P1|Overall Study|1 participant received commercial drug|0
437433|NCT00463385|1453800|P4|Overall Study|Missing|2
437434|NCT00463385|1453801|P3|Overall Study|Missing|0
437435|NCT00463385|1453802|P2|Overall Study|Missing|0
437436|NCT00463385|1453803|P1|Overall Study|Missing|2
437437|NCT00463385|1453800|P4|Overall Study|Death|0
437438|NCT00463385|1453801|P3|Overall Study|Death|2
437439|NCT00463385|1453802|P2|Overall Study|Death|1
437440|NCT00463385|1453803|P1|Overall Study|Death|2
437441|NCT00463385|1453800|P4|Overall Study|Lost to Follow-up|1
437442|NCT00463385|1453801|P3|Overall Study|Lost to Follow-up|0
437443|NCT00463385|1453802|P2|Overall Study|Lost to Follow-up|0
437444|NCT00463385|1453803|P1|Overall Study|Lost to Follow-up|0
437445|NCT00463385|1453800|P4|Overall Study|Withdrawal by Subject|4
437446|NCT00463385|1453801|P3|Overall Study|Withdrawal by Subject|3
437447|NCT00463385|1453802|P2|Overall Study|Withdrawal by Subject|3
437448|NCT00463385|1453803|P1|Overall Study|Withdrawal by Subject|3
437449|NCT00463385|1453800|P4|Overall Study|Lack of Efficacy|9
437450|NCT00463385|1453801|P3|Overall Study|Lack of Efficacy|7
437451|NCT00463385|1453802|P2|Overall Study|Lack of Efficacy|6
437452|NCT00463385|1453803|P1|Overall Study|Lack of Efficacy|6
437453|NCT00463385|1453800|P4|Overall Study|Adverse Event|2
437454|NCT00463385|1453801|P3|Overall Study|Adverse Event|4
437455|NCT00463385|1453802|P2|Overall Study|Adverse Event|8
437456|NCT00463385|1453803|P1|Overall Study|Adverse Event|5
437457|NCT00463385|1453800|P4|Overall Study|Other|4
437458|NCT00463385|1453801|P3|Overall Study|Other|6
437459|NCT00463385|1453802|P2|Overall Study|Other|3
437460|NCT00463385|1453803|P1|Overall Study|Other|4
437461|NCT00463346|1453855|P2|Overall Study|Withdrawal by Subject|3
437462|NCT00463346|1453856|P1|Overall Study|Withdrawal by Subject|3
437463|NCT00463229|1453866|P2|Overall Study|Death|3
437464|NCT00463229|1453867|P1|Overall Study|Death|4
437465|NCT00463229|1453866|P2|Overall Study|Lost to Follow-up|7
437466|NCT00463229|1453867|P1|Overall Study|Lost to Follow-up|5
437467|NCT00463047|1453873|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
437468|NCT00463047|1453874|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
437469|NCT00463047|1453873|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
437470|NCT00463047|1453874|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
437471|NCT00463047|1453873|P2|Double-Blind Treatment Period 2|Adverse Event|1
437472|NCT00463047|1453874|P1|Double-Blind Treatment Period 2|Adverse Event|0
437473|NCT00463047|1453873|P2|Double-Blind Treatment Period 1|Not specified|0
437474|NCT00463047|1453874|P1|Double-Blind Treatment Period 1|Not specified|1
437475|NCT00463047|1453873|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
437476|NCT00463047|1453874|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
437477|NCT00463047|1453873|P2|Double-Blind Treatment Period 1|Protocol Violation|2
437478|NCT00463047|1453874|P1|Double-Blind Treatment Period 1|Protocol Violation|1
437479|NCT00463047|1453873|P2|Double-Blind Treatment Period 1|Adverse Event|2
437480|NCT00463047|1453874|P1|Double-Blind Treatment Period 1|Adverse Event|0
437481|NCT00463047|1453873|P2|Titration Period 2|Not specified|2
437482|NCT00463047|1453874|P1|Titration Period 2|Not specified|3
437483|NCT00463047|1453873|P2|Titration Period 2|Non-compliance procedures|1
437484|NCT00463047|1453874|P1|Titration Period 2|Non-compliance procedures|4
437485|NCT00463047|1453873|P2|Titration Period 2|Non-compliance study medication|2
437486|NCT00463047|1453874|P1|Titration Period 2|Non-compliance study medication|4
437487|NCT00463047|1453873|P2|Titration Period 2|Lost to Follow-up|2
437488|NCT00463047|1453874|P1|Titration Period 2|Lost to Follow-up|1
437489|NCT00463047|1453873|P2|Titration Period 2|Protocol Violation|3
437490|NCT00463047|1453874|P1|Titration Period 2|Protocol Violation|2
437491|NCT00463047|1453873|P2|Titration Period 2|Withdrawal by Subject|0
437492|NCT00463047|1453874|P1|Titration Period 2|Withdrawal by Subject|1
437493|NCT00463047|1453873|P2|Titration Period 2|Lack of Efficacy|4
437494|NCT00463047|1453874|P1|Titration Period 2|Lack of Efficacy|6
437495|NCT00463047|1453873|P2|Titration Period 2|Adverse Event|9
437496|NCT00463047|1453874|P1|Titration Period 2|Adverse Event|9
437497|NCT00463047|1453873|P2|Titration Period 1|Not specified|2
437498|NCT00463047|1453874|P1|Titration Period 1|Not specified|0
437499|NCT00463047|1453873|P2|Titration Period 1|Non-compliance procedures|10
437500|NCT00463047|1453874|P1|Titration Period 1|Non-compliance procedures|4
437501|NCT00463047|1453873|P2|Titration Period 1|Withdrawal by Subject|5
437502|NCT00463047|1453874|P1|Titration Period 1|Withdrawal by Subject|3
437503|NCT00463047|1453873|P2|Titration Period 1|Protocol Violation|5
437504|NCT00463047|1453874|P1|Titration Period 1|Protocol Violation|5
437505|NCT00463047|1453873|P2|Titration Period 1|Non-compliance with study medication|5
437506|NCT00463047|1453874|P1|Titration Period 1|Non-compliance with study medication|3
437507|NCT00463047|1453873|P2|Titration Period 1|Lost to Follow-up|0
437508|NCT00463047|1453874|P1|Titration Period 1|Lost to Follow-up|2
437509|NCT00463047|1453873|P2|Titration Period 1|Lack of Efficacy|4
437510|NCT00463047|1453874|P1|Titration Period 1|Lack of Efficacy|10
437511|NCT00463047|1453873|P2|Titration Period 1|Adverse Event|8
437512|NCT00463047|1453874|P1|Titration Period 1|Adverse Event|10
437513|NCT00462982|1453959|P1|Overall Study|Patient Not Treated|2
437514|NCT00462982|1453959|P1|Overall Study|Adverse Event|1
437515|NCT00462943|1453966|P3|Overall Study|Withdrawal by Subject|0
437516|NCT00462943|1453967|P2|Overall Study|Withdrawal by Subject|1
437517|NCT00462943|1453968|P1|Overall Study|Withdrawal by Subject|0
437518|NCT00462943|1453966|P3|Overall Study|Physician Decision|0
437519|NCT00462943|1453967|P2|Overall Study|Physician Decision|0
437520|NCT00462943|1453968|P1|Overall Study|Physician Decision|1
437521|NCT00462943|1453966|P3|Overall Study|Transplant - not specified|1
437522|NCT00462943|1453967|P2|Overall Study|Transplant - not specified|0
437523|NCT00462943|1453968|P1|Overall Study|Transplant - not specified|1
437524|NCT00462943|1453966|P3|Overall Study|Required Lymphocyte Infusion|0
437525|NCT00462943|1453967|P2|Overall Study|Required Lymphocyte Infusion|0
437526|NCT00462943|1453968|P1|Overall Study|Required Lymphocyte Infusion|1
437527|NCT00462943|1453966|P3|Overall Study|Bone Marrow Transplant|0
437528|NCT00462943|1453967|P2|Overall Study|Bone Marrow Transplant|0
437529|NCT00462943|1453968|P1|Overall Study|Bone Marrow Transplant|1
437530|NCT00462943|1453966|P3|Overall Study|Stem Cell Transplant|0
437531|NCT00462943|1453967|P2|Overall Study|Stem Cell Transplant|1
437532|NCT00462943|1453968|P1|Overall Study|Stem Cell Transplant|1
437533|NCT00462943|1453966|P3|Overall Study|Death|7
437534|NCT00462943|1453967|P2|Overall Study|Death|2
437535|NCT00462943|1453968|P1|Overall Study|Death|5
437536|NCT00462943|1453966|P3|Overall Study|Disease Progression|9
437537|NCT00462943|1453967|P2|Overall Study|Disease Progression|15
437538|NCT00462943|1453968|P1|Overall Study|Disease Progression|15
437539|NCT00462943|1453966|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
437540|NCT00462943|1453967|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
437541|NCT00462943|1453968|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
437542|NCT00462943|1453966|P3|Overall Study|Protocol Violation|0
437543|NCT00462943|1453967|P2|Overall Study|Protocol Violation|0
437544|NCT00462943|1453968|P1|Overall Study|Protocol Violation|1
437545|NCT00462943|1453966|P3|Overall Study|Adverse Event|1
437546|NCT00462943|1453967|P2|Overall Study|Adverse Event|4
437547|NCT00462943|1453968|P1|Overall Study|Adverse Event|6
437548|NCT00462943|1453966|P3|Overall Study|Failure to achieve a response|1
437549|NCT00462943|1453967|P2|Overall Study|Failure to achieve a response|5
437550|NCT00462943|1453968|P1|Overall Study|Failure to achieve a response|5
437551|NCT00462865|1454060|P1|Overall Study|Adverse Event|1
437552|NCT00462826|1454079|P1|Overall Study|Never treated|1
437553|NCT00462826|1454079|P1|Overall Study|Ineligible - wrong primary|2
437554|NCT00462826|1454079|P1|Overall Study|Ineligible - wrong cell type|1
437555|NCT00462826|1454079|P1|Overall Study|Ineligible - second primary|1
437556|NCT00462748|1454095|P3|Overall Study|Discontinued after 41 days Rx|0
437557|NCT00462748|1454096|P2|Overall Study|Discontinued after 41 days Rx|0
437558|NCT00462748|1454097|P1|Overall Study|Discontinued after 41 days Rx|1
437559|NCT00462748|1454095|P3|Overall Study|Lost to Follow-up|1
437560|NCT00462748|1454096|P2|Overall Study|Lost to Follow-up|1
437561|NCT00462748|1454097|P1|Overall Study|Lost to Follow-up|1
437562|NCT00462748|1454095|P3|Overall Study|Withdrew consent|0
437563|NCT00462748|1454096|P2|Overall Study|Withdrew consent|3
437564|NCT00462748|1454097|P1|Overall Study|Withdrew consent|3
437565|NCT00462748|1454095|P3|Overall Study|Protocol Violation|1
437566|NCT00462748|1454096|P2|Overall Study|Protocol Violation|2
437567|NCT00462748|1454097|P1|Overall Study|Protocol Violation|0
437568|NCT00462748|1454095|P3|Overall Study|Adverse Event|9
437569|NCT00462748|1454096|P2|Overall Study|Adverse Event|5
437570|NCT00462748|1454097|P1|Overall Study|Adverse Event|7
437571|NCT00462709|1454150|P1|Overall Study|Withdrew to start treatment with Cetor|1
437572|NCT00462709|1454150|P1|Overall Study|Physician Decision|1
437573|NCT00462709|1454150|P1|Overall Study|Logistical reasons|2
437574|NCT00462709|1454150|P1|Overall Study|Death|2
437575|NCT00462709|1454150|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
437576|NCT00462709|1454150|P1|Overall Study|Withdrawal by Subject|8
437577|NCT00462709|1454150|P1|Overall Study|Lost to Follow-up|10
437578|NCT00462709|1454150|P1|Overall Study|Transitioned to commercial C1INH-nf|40
437579|NCT00462670|1454159|P2|Overall Study|Resolution of signs and symptoms|2
437580|NCT00462670|1454160|P1|Overall Study|Resolution of signs and symptoms|0
437581|NCT00462670|1454159|P2|Overall Study|Protocol Violation|0
437582|NCT00462670|1454160|P1|Overall Study|Protocol Violation|1
437583|NCT00462670|1454159|P2|Overall Study|Lack of Efficacy|0
437584|NCT00462670|1454160|P1|Overall Study|Lack of Efficacy|1
437585|NCT00462670|1454159|P2|Overall Study|Adverse Event|5
437586|NCT00462670|1454160|P1|Overall Study|Adverse Event|3
437587|NCT00462501|1454197|P1|Overall Study|Adverse Event|2
437588|NCT00462501|1454197|P1|Overall Study|Not treated|3
437589|NCT00462462|1454203|P2|Overall Study|Physician Decision|1
437590|NCT00462462|1454204|P1|Overall Study|Physician Decision|0
437591|NCT00462384|1454232|P1|Overall Study|Other|4
437592|NCT00462384|1454232|P1|Overall Study|Withdrawal by Subject|1
437593|NCT00462384|1454232|P1|Overall Study|Death|2
437594|NCT00462384|1454232|P1|Overall Study|Adverse Event|2
437595|NCT00462345|1454240|P1|Overall Study|Did not complete second course|1
437596|NCT00462345|1454240|P1|Overall Study|Withdrawal by Subject|2
437597|NCT00462306|1454275|P2|Overall Study|insufficient data|13
437598|NCT00462306|1454276|P1|Overall Study|insufficient data|0
437599|NCT00461981|1454402|P2|Overall Study|Withdrawal by Subject|3
437600|NCT00461981|1454403|P1|Overall Study|Withdrawal by Subject|2
437601|NCT00461981|1454402|P2|Overall Study|Lost to Follow-up|6
437602|NCT00461981|1454403|P1|Overall Study|Lost to Follow-up|9
437603|NCT00461812|1454519|P1|Overall Study|study terminated|10
437604|NCT00461786|1454524|P1|Overall Study|Inevaluable (Never Treated)|1
437605|NCT00461786|1454524|P1|Overall Study|Entry Criteria Not Met|2
437606|NCT00461708|1454569|P2|Overall Study|Death|1
437607|NCT00461708|1454570|P1|Overall Study|Death|8
437608|NCT00461708|1454569|P2|Overall Study|Not specified|4
437609|NCT00461708|1454570|P1|Overall Study|Not specified|4
437610|NCT00461708|1454569|P2|Overall Study|Withdrawal by Subject|2
437611|NCT00461708|1454570|P1|Overall Study|Withdrawal by Subject|8
437612|NCT00461708|1454569|P2|Overall Study|Physician Decision|4
437613|NCT00461708|1454570|P1|Overall Study|Physician Decision|10
437614|NCT00461708|1454569|P2|Overall Study|Lack of Efficacy|20
437615|NCT00461708|1454570|P1|Overall Study|Lack of Efficacy|68
437616|NCT00461708|1454569|P2|Overall Study|Adverse Event|7
437617|NCT00461708|1454570|P1|Overall Study|Adverse Event|17
437618|NCT00461682|1454596|P1|Overall Study|Protocol Violation|1
437619|NCT00461630|1454624|P2|Overall Study|Lost to Follow-up|95
437620|NCT00461630|1454625|P1|Overall Study|Lost to Follow-up|108
437621|NCT00461630|1454624|P2|Overall Study|Death|732
437622|NCT00461630|1454625|P1|Overall Study|Death|798
437623|NCT00461500|1454673|P2|Overall Study|Lost to Follow-up|2
437624|NCT00461500|1454674|P1|Overall Study|Lost to Follow-up|2
437625|NCT00461500|1454673|P2|Overall Study|No Longer Willing to Take Part in Study|0
437626|NCT00461500|1454674|P1|Overall Study|No Longer Willing to Take Part in Study|1
437627|NCT00461500|1454673|P2|Overall Study|Drug Treatment Misuse|0
437628|NCT00461500|1454674|P1|Overall Study|Drug Treatment Misuse|1
437629|NCT00461500|1454673|P2|Overall Study|Study Stopped|2
437630|NCT00461500|1454674|P1|Overall Study|Study Stopped|1
437631|NCT00461500|1454673|P2|Overall Study|Expired Drug Treatment|1
437632|NCT00461500|1454674|P1|Overall Study|Expired Drug Treatment|1
437633|NCT00461500|1454673|P2|Overall Study|Lack of Efficacy|1
437634|NCT00461500|1454674|P1|Overall Study|Lack of Efficacy|0
437635|NCT00461500|1454673|P2|Overall Study|Adverse Event|0
437636|NCT00461500|1454674|P1|Overall Study|Adverse Event|1
437637|NCT00461305|1454717|P2|Continued Treatment|Other (missing drug etc)|0
437638|NCT00461305|1454718|P1|Continued Treatment|Other (missing drug etc)|2
437639|NCT00461305|1454717|P2|Continued Treatment|Partially missing diary|0
437640|NCT00461305|1454718|P1|Continued Treatment|Partially missing diary|2
437641|NCT00461305|1454717|P2|Continued Treatment|Withdrawal by Subject|0
437642|NCT00461305|1454718|P1|Continued Treatment|Withdrawal by Subject|48
437643|NCT00461305|1454717|P2|Continued Treatment|Protocol Violation|0
437644|NCT00461305|1454718|P1|Continued Treatment|Protocol Violation|13
437645|NCT00461305|1454717|P2|Continued Treatment|Lost to Follow-up|0
437646|NCT00461305|1454718|P1|Continued Treatment|Lost to Follow-up|4
437647|NCT00461305|1454717|P2|Continued Treatment|Adverse Event|0
437648|NCT00461305|1454718|P1|Continued Treatment|Adverse Event|26
437649|NCT00461305|1454717|P2|Treatment|Other (missing drug etc)|0
437650|NCT00461305|1454718|P1|Treatment|Other (missing drug etc)|2
437651|NCT00461305|1454717|P2|Treatment|Partially missing diary|0
437652|NCT00461305|1454718|P1|Treatment|Partially missing diary|2
437653|NCT00461305|1454717|P2|Treatment|Study drug not taken|0
437654|NCT00461305|1454718|P1|Treatment|Study drug not taken|1
437655|NCT00461305|1454717|P2|Treatment|Never dispensed|0
437656|NCT00461305|1454718|P1|Treatment|Never dispensed|5
437657|NCT00461305|1454717|P2|Treatment|Withdrawal by Subject|2
437658|NCT00461305|1454718|P1|Treatment|Withdrawal by Subject|48
437659|NCT00461305|1454717|P2|Treatment|Protocol Violation|2
437660|NCT00461305|1454718|P1|Treatment|Protocol Violation|13
437661|NCT00461305|1454717|P2|Treatment|Lost to Follow-up|2
437662|NCT00461305|1454718|P1|Treatment|Lost to Follow-up|4
437663|NCT00461305|1454717|P2|Treatment|Adverse Event|3
437664|NCT00461305|1454718|P1|Treatment|Adverse Event|26
437665|NCT00461253|1454802|P2|Overall Study|administrative|7773
437666|NCT00461253|1454803|P1|Overall Study|administrative|773
437667|NCT00461253|1454802|P2|Overall Study|no response|11789
437668|NCT00461253|1454803|P1|Overall Study|no response|2609
437669|NCT00461253|1454802|P2|Overall Study|Protocol Violation|236
437670|NCT00461253|1454803|P1|Overall Study|Protocol Violation|613
437671|NCT00461253|1454802|P2|Overall Study|Death|0
437672|NCT00461253|1454803|P1|Overall Study|Death|985
437673|NCT00461175|1454811|P2|Overall Study|Protocol Violation|365
437674|NCT00461175|1454812|P1|Overall Study|Protocol Violation|522
437675|NCT00461123|1454822|P2|Overall Study|Withdrawal by Subject|3
437676|NCT00461123|1454823|P1|Overall Study|Withdrawal by Subject|1
437677|NCT00461123|1454822|P2|Overall Study|Protocol Violation|2
437678|NCT00461123|1454823|P1|Overall Study|Protocol Violation|3
437679|NCT00461123|1454822|P2|Overall Study|Lost to Follow-up|1
437680|NCT00461123|1454823|P1|Overall Study|Lost to Follow-up|1
437681|NCT00461123|1454822|P2|Overall Study|Adverse Event|0
437682|NCT00461123|1454823|P1|Overall Study|Adverse Event|1
437683|NCT00461032|1454868|P2|Overall Study|Not Specified|5
437684|NCT00461032|1454869|P1|Overall Study|Not Specified|7
437685|NCT00461032|1454868|P2|Overall Study|Patient Moved or Relocated|1
437686|NCT00461032|1454869|P1|Overall Study|Patient Moved or Relocated|2
437687|NCT00461032|1454868|P2|Overall Study|Withdrawal by Subject|15
437688|NCT00461032|1454869|P1|Overall Study|Withdrawal by Subject|7
437689|NCT00461032|1454868|P2|Overall Study|Protocol Violation|4
437690|NCT00461032|1454869|P1|Overall Study|Protocol Violation|4
437691|NCT00461032|1454868|P2|Overall Study|Lost to Follow-up|12
437692|NCT00461032|1454869|P1|Overall Study|Lost to Follow-up|7
437693|NCT00461032|1454868|P2|Overall Study|Lack of Efficacy|1
437694|NCT00461032|1454869|P1|Overall Study|Lack of Efficacy|5
437695|NCT00461032|1454868|P2|Overall Study|Adverse Event|6
437696|NCT00461032|1454869|P1|Overall Study|Adverse Event|5
437697|NCT00460811|1454895|P5|Overall Study|Lost to Follow-up|6
437698|NCT00460811|1454896|P4|Overall Study|Lost to Follow-up|3
437699|NCT00460811|1454897|P3|Overall Study|Lost to Follow-up|5
437700|NCT00460811|1454898|P2|Overall Study|Lost to Follow-up|2
437701|NCT00460811|1454899|P1|Overall Study|Lost to Follow-up|3
437702|NCT00460811|1454895|P5|Overall Study|Physician Decision|0
437703|NCT00460811|1454896|P4|Overall Study|Physician Decision|0
437704|NCT00460811|1454897|P3|Overall Study|Physician Decision|0
437705|NCT00460811|1454898|P2|Overall Study|Physician Decision|0
437706|NCT00460811|1454899|P1|Overall Study|Physician Decision|1
437707|NCT00460811|1454895|P5|Overall Study|Withdrawal by Subject|11
437708|NCT00460811|1454896|P4|Overall Study|Withdrawal by Subject|3
437709|NCT00460811|1454897|P3|Overall Study|Withdrawal by Subject|6
437710|NCT00460811|1454898|P2|Overall Study|Withdrawal by Subject|7
437711|NCT00460811|1454899|P1|Overall Study|Withdrawal by Subject|7
437712|NCT00460811|1454895|P5|Overall Study|Noncompliance|1
437713|NCT00460811|1454896|P4|Overall Study|Noncompliance|2
437714|NCT00460811|1454897|P3|Overall Study|Noncompliance|0
437715|NCT00460811|1454898|P2|Overall Study|Noncompliance|0
437716|NCT00460811|1454899|P1|Overall Study|Noncompliance|1
437717|NCT00460811|1454895|P5|Overall Study|Adverse Event|2
437718|NCT00460811|1454896|P4|Overall Study|Adverse Event|10
437719|NCT00460811|1454897|P3|Overall Study|Adverse Event|3
437720|NCT00460811|1454898|P2|Overall Study|Adverse Event|6
437721|NCT00460811|1454899|P1|Overall Study|Adverse Event|4
437722|NCT00460798|1454941|P1|Overall Study|Missing/Incomplete Dosing Information|27
437723|NCT00460798|1454941|P1|Overall Study|Ongoing at Date of Cut-Off|82
437724|NCT00460798|1454941|P1|Overall Study|Other|27
437725|NCT00460798|1454941|P1|Overall Study|Progressive Disease|99
437726|NCT00460798|1454941|P1|Overall Study|Lost to Follow-up|19
437727|NCT00460798|1454941|P1|Overall Study|Adverse Event|27
437728|NCT00460798|1454941|P1|Overall Study|Death|59
437729|NCT00460746|1454949|P1|Overall Study|Lost to Follow-up|1
437730|NCT00460746|1454949|P1|Overall Study|Adverse Event|1
437731|NCT00460655|1454964|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
437732|NCT00460655|1454965|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
437733|NCT00460655|1454966|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
437734|NCT00460655|1454967|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
437735|NCT00460655|1454964|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
437736|NCT00460655|1454965|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
437737|NCT00460655|1454966|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437738|NCT00460655|1454967|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437739|NCT00460655|1454964|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
437740|NCT00460655|1454965|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
437741|NCT00460655|1454966|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
437742|NCT00460655|1454967|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
437743|NCT00460655|1454964|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
437744|NCT00460655|1454965|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
437745|NCT00460655|1454966|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
437746|NCT00460655|1454967|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
437747|NCT00460655|1454964|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437748|NCT00460655|1454965|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437749|NCT00460655|1454966|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437750|NCT00460655|1454967|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
437751|NCT00460655|1454964|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
437752|NCT00460655|1454965|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
437753|NCT00460655|1454966|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
437754|NCT00460655|1454967|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
437755|NCT00460603|1455011|P12|Phase 2|Randomized, but not treated|0
437756|NCT00460603|1455012|P11|Phase 2|Randomized, but not treated|0
437757|NCT00460603|1455013|P10|Phase 2|Randomized, but not treated|3
437758|NCT00460603|1455014|P9|Phase 2|Randomized, but not treated|0
437759|NCT00460603|1455015|P8|Phase 2|Randomized, but not treated|0
437760|NCT00460603|1455016|P7|Phase 2|Randomized, but not treated|0
437761|NCT00460603|1455017|P6|Phase 2|Randomized, but not treated|0
437762|NCT00460603|1455018|P5|Phase 2|Randomized, but not treated|0
437763|NCT00460603|1455019|P4|Phase 2|Randomized, but not treated|0
437764|NCT00460603|1455020|P3|Phase 2|Randomized, but not treated|0
437765|NCT00460603|1455021|P2|Phase 2|Randomized, but not treated|0
437766|NCT00460603|1455022|P1|Phase 2|Randomized, but not treated|0
437767|NCT00460603|1455011|P12|Phase 2|Withdrawal by Subject|5
437768|NCT00460603|1455012|P11|Phase 2|Withdrawal by Subject|4
437769|NCT00460603|1455013|P10|Phase 2|Withdrawal by Subject|5
437770|NCT00460603|1455014|P9|Phase 2|Withdrawal by Subject|0
437771|NCT00460603|1455015|P8|Phase 2|Withdrawal by Subject|0
437772|NCT00460603|1455016|P7|Phase 2|Withdrawal by Subject|0
437773|NCT00460603|1455017|P6|Phase 2|Withdrawal by Subject|0
437774|NCT00460603|1455018|P5|Phase 2|Withdrawal by Subject|0
437775|NCT00460603|1455019|P4|Phase 2|Withdrawal by Subject|0
437776|NCT00460603|1455020|P3|Phase 2|Withdrawal by Subject|0
437777|NCT00460603|1455021|P2|Phase 2|Withdrawal by Subject|0
437778|NCT00460603|1455022|P1|Phase 2|Withdrawal by Subject|0
437779|NCT00460603|1455011|P12|Phase 2|Global Deterioration of Health Status|0
437780|NCT00460603|1455012|P11|Phase 2|Global Deterioration of Health Status|1
437781|NCT00460603|1455013|P10|Phase 2|Global Deterioration of Health Status|0
437782|NCT00460603|1455014|P9|Phase 2|Global Deterioration of Health Status|0
437783|NCT00460603|1455015|P8|Phase 2|Global Deterioration of Health Status|0
437784|NCT00460603|1455016|P7|Phase 2|Global Deterioration of Health Status|0
437785|NCT00460603|1455017|P6|Phase 2|Global Deterioration of Health Status|0
437786|NCT00460603|1455018|P5|Phase 2|Global Deterioration of Health Status|0
437787|NCT00460603|1455019|P4|Phase 2|Global Deterioration of Health Status|0
437788|NCT00460603|1455020|P3|Phase 2|Global Deterioration of Health Status|0
437789|NCT00460603|1455021|P2|Phase 2|Global Deterioration of Health Status|0
437790|NCT00460603|1455022|P1|Phase 2|Global Deterioration of Health Status|0
437791|NCT00460603|1455011|P12|Phase 2|Objective Progression or Relapse|17
437792|NCT00460603|1455012|P11|Phase 2|Objective Progression or Relapse|10
437793|NCT00460603|1455013|P10|Phase 2|Objective Progression or Relapse|9
437794|NCT00460603|1455014|P9|Phase 2|Objective Progression or Relapse|0
437795|NCT00460603|1455015|P8|Phase 2|Objective Progression or Relapse|0
437796|NCT00460603|1455016|P7|Phase 2|Objective Progression or Relapse|0
437797|NCT00460603|1455017|P6|Phase 2|Objective Progression or Relapse|0
437798|NCT00460603|1455018|P5|Phase 2|Objective Progression or Relapse|0
437799|NCT00460603|1455019|P4|Phase 2|Objective Progression or Relapse|0
437800|NCT00460603|1455020|P3|Phase 2|Objective Progression or Relapse|0
437801|NCT00460603|1455021|P2|Phase 2|Objective Progression or Relapse|0
437802|NCT00460603|1455022|P1|Phase 2|Objective Progression or Relapse|0
437803|NCT00460603|1455011|P12|Phase 2|Other|7
437804|NCT00460603|1455012|P11|Phase 2|Other|16
437805|NCT00460603|1455013|P10|Phase 2|Other|6
437806|NCT00460603|1455014|P9|Phase 2|Other|0
437807|NCT00460603|1455015|P8|Phase 2|Other|0
437808|NCT00460603|1455016|P7|Phase 2|Other|0
437809|NCT00460603|1455017|P6|Phase 2|Other|0
437810|NCT00460603|1455018|P5|Phase 2|Other|0
437811|NCT00460603|1455019|P4|Phase 2|Other|0
437812|NCT00460603|1455020|P3|Phase 2|Other|0
437813|NCT00460603|1455021|P2|Phase 2|Other|0
437814|NCT00460603|1455022|P1|Phase 2|Other|0
437815|NCT00460603|1455011|P12|Phase 2|Lost to Follow-up|0
437816|NCT00460603|1455012|P11|Phase 2|Lost to Follow-up|0
437817|NCT00460603|1455013|P10|Phase 2|Lost to Follow-up|1
437818|NCT00460603|1455014|P9|Phase 2|Lost to Follow-up|0
437819|NCT00460603|1455015|P8|Phase 2|Lost to Follow-up|0
437820|NCT00460603|1455016|P7|Phase 2|Lost to Follow-up|0
437821|NCT00460603|1455017|P6|Phase 2|Lost to Follow-up|0
437822|NCT00460603|1455018|P5|Phase 2|Lost to Follow-up|0
437823|NCT00460603|1455019|P4|Phase 2|Lost to Follow-up|0
437824|NCT00460603|1455020|P3|Phase 2|Lost to Follow-up|0
437825|NCT00460603|1455021|P2|Phase 2|Lost to Follow-up|0
437826|NCT00460603|1455022|P1|Phase 2|Lost to Follow-up|0
437827|NCT00460603|1455011|P12|Phase 2|Protocol Violation|0
437828|NCT00460603|1455012|P11|Phase 2|Protocol Violation|1
437829|NCT00460603|1455013|P10|Phase 2|Protocol Violation|1
437830|NCT00460603|1455014|P9|Phase 2|Protocol Violation|0
437831|NCT00460603|1455015|P8|Phase 2|Protocol Violation|0
437832|NCT00460603|1455016|P7|Phase 2|Protocol Violation|0
437833|NCT00460603|1455017|P6|Phase 2|Protocol Violation|0
437834|NCT00460603|1455018|P5|Phase 2|Protocol Violation|0
437835|NCT00460603|1455019|P4|Phase 2|Protocol Violation|0
437836|NCT00460603|1455020|P3|Phase 2|Protocol Violation|0
437837|NCT00460603|1455021|P2|Phase 2|Protocol Violation|0
437838|NCT00460603|1455022|P1|Phase 2|Protocol Violation|0
437839|NCT00460603|1455011|P12|Phase 2|Death|2
437840|NCT00460603|1455012|P11|Phase 2|Death|2
437841|NCT00460603|1455013|P10|Phase 2|Death|4
437842|NCT00460603|1455014|P9|Phase 2|Death|0
437843|NCT00460603|1455015|P8|Phase 2|Death|0
437844|NCT00460603|1455016|P7|Phase 2|Death|0
437845|NCT00460603|1455017|P6|Phase 2|Death|0
437846|NCT00460603|1455018|P5|Phase 2|Death|0
437847|NCT00460603|1455019|P4|Phase 2|Death|0
437848|NCT00460603|1455020|P3|Phase 2|Death|0
437849|NCT00460603|1455021|P2|Phase 2|Death|0
437850|NCT00460603|1455022|P1|Phase 2|Death|0
437851|NCT00460603|1455011|P12|Phase 2|Adverse Event|10
437852|NCT00460603|1455012|P11|Phase 2|Adverse Event|9
437853|NCT00460603|1455013|P10|Phase 2|Adverse Event|12
437854|NCT00460603|1455014|P9|Phase 2|Adverse Event|0
437855|NCT00460603|1455015|P8|Phase 2|Adverse Event|0
437856|NCT00460603|1455016|P7|Phase 2|Adverse Event|0
437857|NCT00460603|1455017|P6|Phase 2|Adverse Event|0
437858|NCT00460603|1455018|P5|Phase 2|Adverse Event|0
437859|NCT00460603|1455019|P4|Phase 2|Adverse Event|0
437860|NCT00460603|1455020|P3|Phase 2|Adverse Event|0
437861|NCT00460603|1455021|P2|Phase 2|Adverse Event|0
437862|NCT00460603|1455022|P1|Phase 2|Adverse Event|0
437863|NCT00460603|1455011|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437864|NCT00460603|1455012|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437865|NCT00460603|1455013|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
437866|NCT00460603|1455014|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437867|NCT00460603|1455015|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437868|NCT00460603|1455016|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437869|NCT00460603|1455017|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437870|NCT00460603|1455018|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437871|NCT00460603|1455019|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437872|NCT00460603|1455020|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437873|NCT00460603|1455021|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437874|NCT00460603|1455022|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
437875|NCT00460603|1455011|P12|Phase 1|Other|0
437876|NCT00460603|1455012|P11|Phase 1|Other|0
437877|NCT00460603|1455013|P10|Phase 1|Other|0
437878|NCT00460603|1455014|P9|Phase 1|Other|0
437879|NCT00460603|1455015|P8|Phase 1|Other|1
437880|NCT00460603|1455016|P7|Phase 1|Other|0
437881|NCT00460603|1455017|P6|Phase 1|Other|2
437882|NCT00460603|1455018|P5|Phase 1|Other|1
437883|NCT00460603|1455019|P4|Phase 1|Other|1
437884|NCT00460603|1455020|P3|Phase 1|Other|1
437885|NCT00460603|1455021|P2|Phase 1|Other|3
437886|NCT00460603|1455022|P1|Phase 1|Other|0
437887|NCT00460603|1455011|P12|Phase 1|Withdrawal by Subject|0
437888|NCT00460603|1455012|P11|Phase 1|Withdrawal by Subject|0
437889|NCT00460603|1455013|P10|Phase 1|Withdrawal by Subject|0
437890|NCT00460603|1455014|P9|Phase 1|Withdrawal by Subject|2
437891|NCT00460603|1455015|P8|Phase 1|Withdrawal by Subject|0
437892|NCT00460603|1455016|P7|Phase 1|Withdrawal by Subject|1
437893|NCT00460603|1455017|P6|Phase 1|Withdrawal by Subject|0
437894|NCT00460603|1455018|P5|Phase 1|Withdrawal by Subject|3
437895|NCT00460603|1455019|P4|Phase 1|Withdrawal by Subject|1
437896|NCT00460603|1455020|P3|Phase 1|Withdrawal by Subject|1
437897|NCT00460603|1455021|P2|Phase 1|Withdrawal by Subject|2
437898|NCT00460603|1455022|P1|Phase 1|Withdrawal by Subject|1
437899|NCT00460603|1455011|P12|Phase 1|Lack of Efficacy|0
437900|NCT00460603|1455012|P11|Phase 1|Lack of Efficacy|0
437901|NCT00460603|1455013|P10|Phase 1|Lack of Efficacy|0
437902|NCT00460603|1455014|P9|Phase 1|Lack of Efficacy|11
437903|NCT00460603|1455015|P8|Phase 1|Lack of Efficacy|2
437904|NCT00460603|1455016|P7|Phase 1|Lack of Efficacy|2
437905|NCT00460603|1455017|P6|Phase 1|Lack of Efficacy|2
437906|NCT00460603|1455018|P5|Phase 1|Lack of Efficacy|2
437907|NCT00460603|1455019|P4|Phase 1|Lack of Efficacy|2
437908|NCT00460603|1455020|P3|Phase 1|Lack of Efficacy|1
437909|NCT00460603|1455021|P2|Phase 1|Lack of Efficacy|0
437910|NCT00460603|1455022|P1|Phase 1|Lack of Efficacy|1
437911|NCT00460603|1455011|P12|Phase 1|Adverse Event|0
437912|NCT00460603|1455012|P11|Phase 1|Adverse Event|0
437913|NCT00460603|1455013|P10|Phase 1|Adverse Event|0
437914|NCT00460603|1455014|P9|Phase 1|Adverse Event|4
437915|NCT00460603|1455015|P8|Phase 1|Adverse Event|0
437916|NCT00460603|1455016|P7|Phase 1|Adverse Event|3
437917|NCT00460603|1455017|P6|Phase 1|Adverse Event|0
437918|NCT00460603|1455018|P5|Phase 1|Adverse Event|0
437919|NCT00460603|1455019|P4|Phase 1|Adverse Event|2
437920|NCT00460603|1455020|P3|Phase 1|Adverse Event|1
437921|NCT00460603|1455021|P2|Phase 1|Adverse Event|1
437922|NCT00460603|1455022|P1|Phase 1|Adverse Event|3
437923|NCT00460603|1455011|P12|Phase 1|Death|0
437924|NCT00460603|1455012|P11|Phase 1|Death|0
437925|NCT00460603|1455013|P10|Phase 1|Death|0
437926|NCT00460603|1455014|P9|Phase 1|Death|1
437927|NCT00460603|1455015|P8|Phase 1|Death|0
437928|NCT00460603|1455016|P7|Phase 1|Death|0
437929|NCT00460603|1455017|P6|Phase 1|Death|0
437930|NCT00460603|1455018|P5|Phase 1|Death|0
437931|NCT00460603|1455019|P4|Phase 1|Death|2
437932|NCT00460603|1455020|P3|Phase 1|Death|0
437933|NCT00460603|1455021|P2|Phase 1|Death|0
437934|NCT00460603|1455022|P1|Phase 1|Death|1
437935|NCT00460577|1455116|P2|Overall Study|Protocol Violation|6
437936|NCT00460577|1455117|P1|Overall Study|Protocol Violation|2
437937|NCT00460564|1455135|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
437938|NCT00460564|1455136|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
437939|NCT00460564|1455137|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
437940|NCT00460564|1455138|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
437941|NCT00460564|1455139|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
437942|NCT00460564|1455140|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
437943|NCT00460564|1455141|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
437944|NCT00460564|1455142|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
437945|NCT00460564|1455135|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437946|NCT00460564|1455136|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437947|NCT00460564|1455137|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
437948|NCT00460564|1455138|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
437949|NCT00460564|1455139|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437950|NCT00460564|1455140|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437951|NCT00460564|1455141|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437952|NCT00460564|1455142|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
437953|NCT00460564|1455135|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
437954|NCT00460564|1455136|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
437955|NCT00460564|1455137|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
437956|NCT00460564|1455138|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
437957|NCT00460564|1455139|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
437958|NCT00460564|1455140|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
437959|NCT00460564|1455141|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
437960|NCT00460564|1455142|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
437961|NCT00460564|1455135|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437962|NCT00460564|1455136|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437963|NCT00460564|1455137|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437964|NCT00460564|1455138|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437965|NCT00460564|1455139|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437966|NCT00460564|1455140|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437967|NCT00460564|1455141|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
437968|NCT00460564|1455142|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
437969|NCT00460564|1455135|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
437970|NCT00460564|1455136|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
437971|NCT00460564|1455137|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
437972|NCT00460564|1455138|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
437973|NCT00460564|1455139|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
437974|NCT00460564|1455140|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
437975|NCT00460564|1455141|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
437976|NCT00460564|1455142|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
437977|NCT00460434|1455286|P2|Overall Study|Lost to Follow-up|7
437978|NCT00460434|1455287|P1|Overall Study|Lost to Follow-up|3
437979|NCT00460408|1455366|P4|Overall Study|Other|0
437980|NCT00460408|1455367|P3|Overall Study|Other|0
437981|NCT00460408|1455368|P2|Overall Study|Other|2
437982|NCT00460408|1455369|P1|Overall Study|Other|12
437983|NCT00460408|1455366|P4|Overall Study|Insufficient clinical response|0
437984|NCT00460408|1455367|P3|Overall Study|Insufficient clinical response|5
437985|NCT00460408|1455368|P2|Overall Study|Insufficient clinical response|1
437986|NCT00460408|1455369|P1|Overall Study|Insufficient clinical response|5
437987|NCT00460408|1455366|P4|Overall Study|Withdrawal by Subject|0
437988|NCT00460408|1455367|P3|Overall Study|Withdrawal by Subject|0
437989|NCT00460408|1455368|P2|Overall Study|Withdrawal by Subject|0
437990|NCT00460408|1455369|P1|Overall Study|Withdrawal by Subject|31
437991|NCT00460408|1455366|P4|Overall Study|Lost to Follow-up|0
437992|NCT00460408|1455367|P3|Overall Study|Lost to Follow-up|1
437993|NCT00460408|1455368|P2|Overall Study|Lost to Follow-up|0
437994|NCT00460408|1455369|P1|Overall Study|Lost to Follow-up|11
437995|NCT00460408|1455366|P4|Overall Study|Death|0
437996|NCT00460408|1455367|P3|Overall Study|Death|0
437997|NCT00460408|1455368|P2|Overall Study|Death|0
437998|NCT00460408|1455369|P1|Overall Study|Death|7
437999|NCT00460408|1455366|P4|Overall Study|Adverse Event|0
438000|NCT00460408|1455367|P3|Overall Study|Adverse Event|0
438001|NCT00460408|1455368|P2|Overall Study|Adverse Event|0
438002|NCT00460408|1455369|P1|Overall Study|Adverse Event|1
438003|NCT00460265|1455406|P2|Overall Study|Ongoing|47
438004|NCT00460265|1455407|P1|Overall Study|Ongoing|60
438005|NCT00460265|1455406|P2|Overall Study|Withdrawal by Subject|25
438006|NCT00460265|1455407|P1|Overall Study|Withdrawal by Subject|10
438007|NCT00460265|1455406|P2|Overall Study|Physician Decision|2
438008|NCT00460265|1455407|P1|Overall Study|Physician Decision|1
438009|NCT00460265|1455406|P2|Overall Study|Lost to Follow-up|15
438010|NCT00460265|1455407|P1|Overall Study|Lost to Follow-up|14
438011|NCT00460239|1455423|P9|Overall Study|Withdrawal by Subject|0
438012|NCT00460239|1455424|P8|Overall Study|Withdrawal by Subject|0
438013|NCT00460239|1455425|P7|Overall Study|Withdrawal by Subject|0
438014|NCT00460239|1455426|P6|Overall Study|Withdrawal by Subject|1
438015|NCT00460239|1455427|P5|Overall Study|Withdrawal by Subject|0
438016|NCT00460239|1455428|P4|Overall Study|Withdrawal by Subject|0
438017|NCT00460239|1455429|P3|Overall Study|Withdrawal by Subject|0
438018|NCT00460239|1455430|P2|Overall Study|Withdrawal by Subject|0
438019|NCT00460239|1455431|P1|Overall Study|Withdrawal by Subject|0
438020|NCT00460239|1455423|P9|Overall Study|Physician Decision|0
438021|NCT00460239|1455424|P8|Overall Study|Physician Decision|0
438022|NCT00460239|1455425|P7|Overall Study|Physician Decision|0
438023|NCT00460239|1455426|P6|Overall Study|Physician Decision|2
438024|NCT00460239|1455427|P5|Overall Study|Physician Decision|0
438025|NCT00460239|1455428|P4|Overall Study|Physician Decision|0
438026|NCT00460239|1455429|P3|Overall Study|Physician Decision|0
438027|NCT00460239|1455430|P2|Overall Study|Physician Decision|1
438028|NCT00460239|1455431|P1|Overall Study|Physician Decision|0
438029|NCT00460109|1455500|P1|Overall Study|Death|1
438030|NCT00460031|1455508|P1|Overall Study|Death|1
438031|NCT00460031|1455508|P1|Overall Study|Withdrawal by Subject|5
438032|NCT00460031|1455508|P1|Overall Study|Adverse Event|5
438033|NCT00459979|1455516|P1|Overall Study|Protocol Violation|1
438034|NCT00459979|1455516|P1|Overall Study|Withdrawal by Subject|1
438035|NCT00459953|1455528|P2|Overall Study|not analyzed-household member in study|1
438036|NCT00459953|1455529|P1|Overall Study|not analyzed-household member in study|1
438037|NCT00459875|1455535|P1|Overall Study|Adverse Event|2
438038|NCT00459875|1455535|P1|Overall Study|Ineligible participant|1
438039|NCT00459706|1455571|P2|Overall Study|Other|1
438040|NCT00459706|1455572|P1|Overall Study|Other|0
438041|NCT00459706|1455571|P2|Overall Study|Failed to Return|0
438042|NCT00459706|1455572|P1|Overall Study|Failed to Return|1
438043|NCT00459706|1455571|P2|Overall Study|Protocol Violation|1
438044|NCT00459706|1455572|P1|Overall Study|Protocol Violation|2
438045|NCT00459706|1455571|P2|Overall Study|Discontinuation of Study by Sponsor|0
438046|NCT00459706|1455572|P1|Overall Study|Discontinuation of Study by Sponsor|1
438047|NCT00459706|1455571|P2|Overall Study|Physician Decision|0
438048|NCT00459706|1455572|P1|Overall Study|Physician Decision|2
438049|NCT00459706|1455571|P2|Overall Study|Withdrawal by Subject|6
438050|NCT00459706|1455572|P1|Overall Study|Withdrawal by Subject|1
438051|NCT00459706|1455571|P2|Overall Study|Adverse Event|13
438052|NCT00459706|1455572|P1|Overall Study|Adverse Event|19
438053|NCT00459667|1455715|P3|Overall Study|No treatment administered|1
438054|NCT00459667|1455716|P2|Overall Study|No treatment administered|3
438055|NCT00459667|1455717|P1|Overall Study|No treatment administered|6
438056|NCT00459667|1455715|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
438057|NCT00459667|1455716|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
438058|NCT00459667|1455717|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
438059|NCT00459667|1455715|P3|Overall Study|Other disease modifying treatment|1
438060|NCT00459667|1455716|P2|Overall Study|Other disease modifying treatment|2
438061|NCT00459667|1455717|P1|Overall Study|Other disease modifying treatment|1
438062|NCT00459667|1455715|P3|Overall Study|Withdrawal by Subject|5
438063|NCT00459667|1455716|P2|Overall Study|Withdrawal by Subject|5
438064|NCT00459667|1455717|P1|Overall Study|Withdrawal by Subject|3
438065|NCT00459667|1455715|P3|Overall Study|Protocol Violation|0
438066|NCT00459667|1455716|P2|Overall Study|Protocol Violation|0
438067|NCT00459667|1455717|P1|Overall Study|Protocol Violation|1
438068|NCT00459667|1455715|P3|Overall Study|Pregnancy|1
438069|NCT00459667|1455716|P2|Overall Study|Pregnancy|1
438070|NCT00459667|1455717|P1|Overall Study|Pregnancy|1
438071|NCT00459667|1455715|P3|Overall Study|Lost to Follow-up|3
438072|NCT00459667|1455716|P2|Overall Study|Lost to Follow-up|9
438073|NCT00459667|1455717|P1|Overall Study|Lost to Follow-up|5
438074|NCT00459667|1455715|P3|Overall Study|Adverse Event|8
438075|NCT00459667|1455716|P2|Overall Study|Adverse Event|12
438076|NCT00459667|1455717|P1|Overall Study|Adverse Event|9
438077|NCT00459537|1455739|P2|Overall Study|Missing|0
438078|NCT00459537|1455740|P1|Overall Study|Missing|1
438079|NCT00459537|1455739|P2|Overall Study|Protocol Violation|3
438080|NCT00459537|1455740|P1|Overall Study|Protocol Violation|4
438081|NCT00459537|1455739|P2|Overall Study|Administrative problems|0
438082|NCT00459537|1455740|P1|Overall Study|Administrative problems|3
438083|NCT00459537|1455739|P2|Overall Study|Lost to Follow-up|30
438084|NCT00459537|1455740|P1|Overall Study|Lost to Follow-up|27
438085|NCT00459537|1455739|P2|Overall Study|Withdrawal by Subject|26
438086|NCT00459537|1455740|P1|Overall Study|Withdrawal by Subject|20
438087|NCT00459537|1455739|P2|Overall Study|Lack of Efficacy|11
438088|NCT00459537|1455740|P1|Overall Study|Lack of Efficacy|10
438089|NCT00459537|1455739|P2|Overall Study|Adverse Event|6
438090|NCT00459537|1455740|P1|Overall Study|Adverse Event|1
438091|NCT00459355|1455775|P2|Overall Study|Subject no longer met inc criteria|18
438092|NCT00459355|1455776|P1|Overall Study|Subject no longer met inc criteria|20
438093|NCT00459342|1455788|P1|Overall Study|Not eligible|1
438094|NCT00459316|1455797|P3|Step 3|Withdrawal by Subject|1
438095|NCT00459316|1455798|P2|Step 3|Withdrawal by Subject|0
438096|NCT00459316|1455799|P1|Step 3|Withdrawal by Subject|3
438097|NCT00459316|1455797|P3|Steps 1 & 2|Lost to Follow-up|2
438098|NCT00459316|1455798|P2|Steps 1 & 2|Lost to Follow-up|0
438099|NCT00459316|1455799|P1|Steps 1 & 2|Lost to Follow-up|5
438100|NCT00459316|1455797|P3|Steps 1 & 2|Not willing to adhere to regulations|0
438101|NCT00459316|1455798|P2|Steps 1 & 2|Not willing to adhere to regulations|0
438102|NCT00459316|1455799|P1|Steps 1 & 2|Not willing to adhere to regulations|1
438103|NCT00459316|1455797|P3|Steps 1 & 2|Withdrawal by Subject|0
438104|NCT00459316|1455798|P2|Steps 1 & 2|Withdrawal by Subject|1
438105|NCT00459316|1455799|P1|Steps 1 & 2|Withdrawal by Subject|6
438106|NCT00459316|1455797|P3|Steps 1 & 2|Not able to get to clinic|0
438107|NCT00459316|1455798|P2|Steps 1 & 2|Not able to get to clinic|4
438108|NCT00459316|1455799|P1|Steps 1 & 2|Not able to get to clinic|7
438109|NCT00459316|1455797|P3|Steps 1 & 2|Death|0
438110|NCT00459316|1455798|P2|Steps 1 & 2|Death|1
438111|NCT00459316|1455799|P1|Steps 1 & 2|Death|1
438112|NCT00459316|1455797|P3|Steps 1 & 2|Other eligibility failure|0
438113|NCT00459316|1455798|P2|Steps 1 & 2|Other eligibility failure|1
438114|NCT00459316|1455799|P1|Steps 1 & 2|Other eligibility failure|1
438115|NCT00459290|1455864|P1|Overall Study|Ineligible|2
438116|NCT00459290|1455864|P1|Overall Study|Adverse Event|3
438117|NCT00459186|1455879|P1|PET Imaging and Assessment|Adverse Event|3
438118|NCT00459186|1455879|P1|Single Agent RAD001|Withdrawal by Subject|1
438119|NCT00459134|1455886|P2|Overall Study|Multiple Reasons|3
438120|NCT00459134|1455887|P1|Overall Study|Multiple Reasons|2
438121|NCT00459134|1455886|P2|Overall Study|Progression|0
438122|NCT00459134|1455887|P1|Overall Study|Progression|1
438123|NCT00459134|1455886|P2|Overall Study|Toxicity|5
438124|NCT00459134|1455887|P1|Overall Study|Toxicity|4
438125|NCT00459134|1455886|P2|Overall Study|Surgery|2
438126|NCT00459134|1455887|P1|Overall Study|Surgery|1
438127|NCT00459134|1455886|P2|Overall Study|Lost to Follow-up|7
438128|NCT00459134|1455887|P1|Overall Study|Lost to Follow-up|6
438129|NCT00459134|1455886|P2|Overall Study|Withdrawal by Subject|7
438130|NCT00459134|1455887|P1|Overall Study|Withdrawal by Subject|8
438131|NCT00459134|1455886|P2|Overall Study|Physician Decision|1
438132|NCT00459134|1455887|P1|Overall Study|Physician Decision|1
438133|NCT00459108|1455899|P1|Overall Study|Progression|1
438134|NCT00459108|1455899|P1|Overall Study|Death|2
438135|NCT00459108|1455899|P1|Overall Study|Adverse Event|3
438136|NCT00459108|1455899|P1|Overall Study|Withdrawal by Subject|5
438137|NCT00459056|1455909|P2|First Intervention (First Three Months)|Lost to Follow-up|1
438138|NCT00459056|1455910|P1|First Intervention (First Three Months)|Lost to Follow-up|1
438139|NCT00459043|1455918|P2|Overall Study|Withdrawal by Subject|0
438140|NCT00459043|1455919|P1|Overall Study|Withdrawal by Subject|1
438141|NCT00458705|1455940|P1|Overall Study|Not Treated|1
438142|NCT00458705|1455940|P1|Overall Study|Adverse Event|4
438143|NCT00458536|1455944|P1|Overall Study|Progressive disease during treatment|2
438144|NCT00458536|1455944|P1|Overall Study|Withdrawal by Subject|1
438145|NCT00458536|1455944|P1|Overall Study|Ineligible due to toxicity|1
438146|NCT00458536|1455944|P1|Overall Study|Patient did not have surgery|1
438147|NCT00458536|1455944|P1|Overall Study|Did not have renal cell carcinoma|2
438148|NCT00458536|1455944|P1|Overall Study|No measurable disease after surgery|2
438149|NCT00458536|1455944|P1|Overall Study|Unable to make vaccine|3
438150|NCT00458536|1455944|P1|Overall Study|Disease progression prior to treatment|7
438151|NCT00458393|1455971|P2|Overall Study|Sites marked other on the form.|20
438152|NCT00458393|1455972|P1|Overall Study|Sites marked other on the form.|19
438153|NCT00458393|1455971|P2|Overall Study|Lost to Follow-up|92
438154|NCT00458393|1455972|P1|Overall Study|Lost to Follow-up|115
438155|NCT00458393|1455971|P2|Overall Study|Relocated|81
438156|NCT00458393|1455972|P1|Overall Study|Relocated|77
438157|NCT00458393|1455971|P2|Overall Study|Physician Decision|22
438158|NCT00458393|1455972|P1|Overall Study|Physician Decision|31
438159|NCT00458393|1455971|P2|Overall Study|Withdrawal by Subject|80
438160|NCT00458393|1455972|P1|Overall Study|Withdrawal by Subject|67
438161|NCT00458302|1456020|P2|Overall Study|Other|2
438162|NCT00458302|1456021|P1|Overall Study|Other|4
438163|NCT00458302|1456020|P2|Overall Study|Lost to Follow-up|0
438164|NCT00458302|1456021|P1|Overall Study|Lost to Follow-up|2
438165|NCT00458302|1456020|P2|Overall Study|Study Termination By Sponsor|0
438166|NCT00458302|1456021|P1|Overall Study|Study Termination By Sponsor|1
438167|NCT00458302|1456020|P2|Overall Study|Inc/Exc Criteria Not Met|1
438168|NCT00458302|1456021|P1|Overall Study|Inc/Exc Criteria Not Met|1
438169|NCT00458302|1456020|P2|Overall Study|Withdrawal by Subject|4
438170|NCT00458302|1456021|P1|Overall Study|Withdrawal by Subject|6
438171|NCT00458302|1456020|P2|Overall Study|Protocol Violation|2
438172|NCT00458302|1456021|P1|Overall Study|Protocol Violation|0
438173|NCT00458302|1456020|P2|Overall Study|Pregnancy|1
438174|NCT00458302|1456021|P1|Overall Study|Pregnancy|2
438175|NCT00458302|1456020|P2|Overall Study|Adverse Event|14
438176|NCT00458302|1456021|P1|Overall Study|Adverse Event|4
438177|NCT00458211|1456066|P1|Overall Study|Protocol Violation|2
438178|NCT00458211|1456066|P1|Overall Study|Withdrawal by Subject|2
438179|NCT00458211|1456066|P1|Overall Study|Lack of Efficacy|12
438180|NCT00457821|1456108|P8|Part 2|Withdrawal by Subject|1
438181|NCT00457821|1456109|P7|Part 2|Withdrawal by Subject|0
438182|NCT00457821|1456110|P6|Part 2|Withdrawal by Subject|0
438183|NCT00457821|1456111|P5|Part 2|Withdrawal by Subject|0
438184|NCT00457821|1456112|P4|Part 2|Withdrawal by Subject|0
438185|NCT00457821|1456113|P3|Part 2|Withdrawal by Subject|0
438186|NCT00457821|1456114|P2|Part 2|Withdrawal by Subject|0
438187|NCT00457821|1456115|P1|Part 2|Withdrawal by Subject|0
438188|NCT00457743|1456154|P3|Overall Study|Lack of Efficacy|3
438189|NCT00457743|1456155|P2|Overall Study|Lack of Efficacy|23
438190|NCT00457743|1456156|P1|Overall Study|Lack of Efficacy|3
438191|NCT00457743|1456154|P3|Overall Study|Adverse Event|0
438192|NCT00457743|1456155|P2|Overall Study|Adverse Event|4
438193|NCT00457743|1456156|P1|Overall Study|Adverse Event|0
438194|NCT00457691|1456213|P2|Overall Study|Disease progression, study terminated|196
438195|NCT00457691|1456214|P1|Overall Study|Disease progression, study terminated|180
438196|NCT00457691|1456213|P2|Overall Study|Subject refused (reason other than AE)|19
438197|NCT00457691|1456214|P1|Overall Study|Subject refused (reason other than AE)|14
438198|NCT00457691|1456213|P2|Overall Study|Study terminated by Sponsor|1
438199|NCT00457691|1456214|P1|Overall Study|Study terminated by Sponsor|1
438200|NCT00457691|1456213|P2|Overall Study|Lost to Follow-up|14
438201|NCT00457691|1456214|P1|Overall Study|Lost to Follow-up|23
438202|NCT00457691|1456213|P2|Overall Study|Protocol Violation|3
438203|NCT00457691|1456214|P1|Overall Study|Protocol Violation|1
438204|NCT00457691|1456213|P2|Overall Study|Death|148
438205|NCT00457691|1456214|P1|Overall Study|Death|163
438206|NCT00457691|1456213|P2|Overall Study|Adverse Event|1
438207|NCT00457691|1456214|P1|Overall Study|Adverse Event|4
438208|NCT00457418|1456234|P1|Post PK Maintenance|Lost to Follow-up|1
438209|NCT00457418|1456234|P1|Post PK Maintenance|Withdrawal by Subject|11
438210|NCT00457418|1456234|P1|Post PK Maintenance|Progression of Disease|6
438211|NCT00457418|1456234|P1|Post PK Maintenance|Adverse Event|10
438212|NCT00457418|1456234|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
438213|NCT00457418|1456234|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
438214|NCT00457418|1456234|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
438215|NCT00457392|1456246|P2|Overall Study|Randomized, Not Treated|3
438216|NCT00457392|1456247|P1|Overall Study|Randomized, Not Treated|7
438217|NCT00457392|1456246|P2|Overall Study|Study Terminated by Sponsor|4
438218|NCT00457392|1456247|P1|Overall Study|Study Terminated by Sponsor|1
438219|NCT00457392|1456246|P2|Overall Study|Other|4
438220|NCT00457392|1456247|P1|Overall Study|Other|7
438221|NCT00457392|1456246|P2|Overall Study|Protocol Violation|3
438222|NCT00457392|1456247|P1|Overall Study|Protocol Violation|4
438223|NCT00457392|1456246|P2|Overall Study|Lost to Follow-up|7
438224|NCT00457392|1456247|P1|Overall Study|Lost to Follow-up|6
438225|NCT00457392|1456246|P2|Overall Study|Withdrawal by Subject|8
438226|NCT00457392|1456247|P1|Overall Study|Withdrawal by Subject|14
438227|NCT00457392|1456246|P2|Overall Study|Global Deterioration of Health Status|8
438228|NCT00457392|1456247|P1|Overall Study|Global Deterioration of Health Status|22
438229|NCT00457392|1456246|P2|Overall Study|Adverse Event|41
438230|NCT00457392|1456247|P1|Overall Study|Adverse Event|84
438231|NCT00457392|1456246|P2|Overall Study|Death|106
438232|NCT00457392|1456247|P1|Overall Study|Death|106
438233|NCT00457392|1456246|P2|Overall Study|Objective Progression or Relapse|296
438234|NCT00457392|1456247|P1|Overall Study|Objective Progression or Relapse|229
438235|NCT00457301|1456265|P2|Overall Study|Death|7
438236|NCT00457301|1456266|P1|Overall Study|Death|5
438237|NCT00457301|1456265|P2|Overall Study|Censored out of the study|14
438238|NCT00457301|1456266|P1|Overall Study|Censored out of the study|15
438239|NCT00457301|1456265|P2|Overall Study|Withdrawal by Subject|3
438240|NCT00457301|1456266|P1|Overall Study|Withdrawal by Subject|3
438241|NCT00457249|1456280|P2|Overall Study|Serious Adverse Events|0
438242|NCT00457249|1456281|P1|Overall Study|Serious Adverse Events|2
438243|NCT00457249|1456280|P2|Overall Study|Withdrawal by Subject|1
438244|NCT00457249|1456281|P1|Overall Study|Withdrawal by Subject|3
438245|NCT00457249|1456280|P2|Overall Study|Protocol Violation|1
438246|NCT00457249|1456281|P1|Overall Study|Protocol Violation|4
438247|NCT00457249|1456280|P2|Overall Study|Lost to Follow-up|0
438248|NCT00457249|1456281|P1|Overall Study|Lost to Follow-up|3
438249|NCT00457015|1456320|P2|Overall Study|Left study site against medical advice|1
438250|NCT00457015|1456321|P1|Overall Study|Left study site against medical advice|0
438251|NCT00457002|1456337|P2|Overall Study|treated for 1 day; missing status/reason|0
438252|NCT00457002|1456338|P1|Overall Study|treated for 1 day; missing status/reason|1
438253|NCT00457002|1456337|P2|Overall Study|non-specified|38
438254|NCT00457002|1456338|P1|Overall Study|non-specified|29
438255|NCT00457002|1456337|P2|Overall Study|Administrative reason by Sponsor|0
438256|NCT00457002|1456338|P1|Overall Study|Administrative reason by Sponsor|1
438257|NCT00457002|1456337|P2|Overall Study|No longer met criteria|37
438258|NCT00457002|1456338|P1|Overall Study|No longer met criteria|41
438259|NCT00457002|1456337|P2|Overall Study|Poor/Non-compliance|33
438260|NCT00457002|1456338|P1|Overall Study|Poor/Non-compliance|46
438261|NCT00457002|1456337|P2|Overall Study|Lost to Follow-up|71
438262|NCT00457002|1456338|P1|Overall Study|Lost to Follow-up|72
438263|NCT00457002|1456337|P2|Overall Study|Withdrawal by Subject|271
438264|NCT00457002|1456338|P1|Overall Study|Withdrawal by Subject|299
438265|NCT00457002|1456337|P2|Overall Study|Adverse Event|260
438266|NCT00457002|1456338|P1|Overall Study|Adverse Event|284
438267|NCT00457002|1456337|P2|Overall Study|Death|47
438268|NCT00457002|1456338|P1|Overall Study|Death|40
438269|NCT00456846|1456442|P2|Overall Study|Other|2
438270|NCT00456846|1456443|P1|Overall Study|Other|0
438271|NCT00456846|1456442|P2|Overall Study|Participant Discretion|5
438272|NCT00456846|1456443|P1|Overall Study|Participant Discretion|1
438273|NCT00456846|1456442|P2|Overall Study|Protocol Deviation|0
438274|NCT00456846|1456443|P1|Overall Study|Protocol Deviation|2
438275|NCT00456846|1456442|P2|Overall Study|Physician Decision|6
438276|NCT00456846|1456443|P1|Overall Study|Physician Decision|11
438277|NCT00456846|1456442|P2|Overall Study|Adverse Event|15
438278|NCT00456846|1456443|P1|Overall Study|Adverse Event|2
438279|NCT00456755|1456484|P2|Overall Study|Lost to Follow-up|1
438280|NCT00456755|1456485|P1|Overall Study|Lost to Follow-up|2
438281|NCT00456612|1456499|P1|Overall Study|Withdrawal by Subject|3
438282|NCT00456599|1456504|P1|Overall Study|Withdrawal by Subject|2
438283|NCT00456599|1456504|P1|Overall Study|Non-compliance|1
438284|NCT00456521|1456527|P2|Overall Study|Drug non-compliance, moved, other|11
438285|NCT00456521|1456528|P1|Overall Study|Drug non-compliance, moved, other|26
438286|NCT00456521|1456527|P2|Overall Study|Pregnancy|1
438287|NCT00456521|1456528|P1|Overall Study|Pregnancy|1
438288|NCT00456521|1456527|P2|Overall Study|Protocol Violation|0
438289|NCT00456521|1456528|P1|Overall Study|Protocol Violation|4
438290|NCT00456521|1456527|P2|Overall Study|Lack of Efficacy|6
438291|NCT00456521|1456528|P1|Overall Study|Lack of Efficacy|3
438292|NCT00456521|1456527|P2|Overall Study|Lost to Follow-up|17
438293|NCT00456521|1456528|P1|Overall Study|Lost to Follow-up|22
438294|NCT00456521|1456527|P2|Overall Study|Withdrawal by Subject|24
438295|NCT00456521|1456528|P1|Overall Study|Withdrawal by Subject|43
438296|NCT00456521|1456527|P2|Overall Study|Adverse Event|25
438297|NCT00456521|1456528|P1|Overall Study|Adverse Event|150
438298|NCT00456495|1456574|P1|Overall Study|Physician Decision|2
438299|NCT00456365|1456581|P2|Overall Study|oncologic diagnosis|1
438300|NCT00456365|1456582|P1|Overall Study|oncologic diagnosis|1
438301|NCT00456365|1456581|P2|Overall Study|Pregnancy|1
438302|NCT00456365|1456582|P1|Overall Study|Pregnancy|1
438303|NCT00456365|1456581|P2|Overall Study|Withdrawal by Subject|7
438304|NCT00456365|1456582|P1|Overall Study|Withdrawal by Subject|4
438305|NCT00456365|1456581|P2|Overall Study|Lost to Follow-up|3
438306|NCT00456365|1456582|P1|Overall Study|Lost to Follow-up|1
438307|NCT00455923|1456639|P2|Overall Study|Other|1
438308|NCT00455923|1456640|P1|Overall Study|Other|3
438309|NCT00455923|1456639|P2|Overall Study|Pregnancy|2
438310|NCT00455923|1456640|P1|Overall Study|Pregnancy|0
438311|NCT00455858|1456656|P1|Overall Study|Withdrawal|1
438312|NCT00455858|1456656|P1|Overall Study|Well controlled FPG without insulin|1
438313|NCT00455858|1456656|P1|Overall Study|Lack of Efficacy|1
438314|NCT00455858|1456656|P1|Overall Study|Protocol Violation|1
438315|NCT00455858|1456656|P1|Overall Study|Lost to Follow-up|2
438316|NCT00455741|1456666|P2|Overall Study|Physician Decision|1
438317|NCT00455741|1456667|P1|Overall Study|Physician Decision|0
438318|NCT00455533|1456753|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
438319|NCT00455533|1456754|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
438320|NCT00455533|1456755|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
438321|NCT00455533|1456753|P3|Period Two: Randomized Period|Study Drug Toxicity|0
438322|NCT00455533|1456754|P2|Period Two: Randomized Period|Study Drug Toxicity|2
438323|NCT00455533|1456755|P1|Period Two: Randomized Period|Study Drug Toxicity|0
438324|NCT00455533|1456753|P3|Period Two: Randomized Period|Other - need reasons|0
438325|NCT00455533|1456754|P2|Period Two: Randomized Period|Other - need reasons|1
438326|NCT00455533|1456755|P1|Period Two: Randomized Period|Other - need reasons|0
438327|NCT00455533|1456753|P3|Period Two: Randomized Period|Lost to Follow-up|1
438328|NCT00455533|1456754|P2|Period Two: Randomized Period|Lost to Follow-up|0
438329|NCT00455533|1456755|P1|Period Two: Randomized Period|Lost to Follow-up|0
438330|NCT00455533|1456753|P3|Period Two: Randomized Period|Disease Progression|1
438331|NCT00455533|1456754|P2|Period Two: Randomized Period|Disease Progression|1
438332|NCT00455533|1456755|P1|Period Two: Randomized Period|Disease Progression|0
438333|NCT00455533|1456753|P3|Period Two: Randomized Period|Death|3
438334|NCT00455533|1456754|P2|Period Two: Randomized Period|Death|0
438335|NCT00455533|1456755|P1|Period Two: Randomized Period|Death|0
438336|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
438337|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
438338|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
438339|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
438340|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
438341|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
438342|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
438343|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
438344|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
438345|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
438346|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
438347|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
438348|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
438349|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
438350|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
438351|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Not Reported|0
438352|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Not Reported|0
438353|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Not Reported|1
438354|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
438355|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
438356|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
438357|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Disease Progression|0
438358|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Disease Progression|0
438359|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Disease Progression|5
438360|NCT00455533|1456753|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
438361|NCT00455533|1456754|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
438362|NCT00455533|1456755|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
438363|NCT00455520|1456804|P2|Double Blind Tapentadol ER vs Placebo|All other|6
438364|NCT00455520|1456805|P1|Double Blind Tapentadol ER vs Placebo|All other|4
438365|NCT00455520|1456804|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
438366|NCT00455520|1456805|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
438367|NCT00455520|1456804|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
438368|NCT00455520|1456805|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
438369|NCT00455520|1456804|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
438370|NCT00455520|1456805|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
438371|NCT00455520|1456804|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
438372|NCT00455520|1456805|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
438373|NCT00455520|1456804|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
438374|NCT00455520|1456805|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
438375|NCT00455520|1456804|P2|Open Label Tapentadol Extended Release|All other|0
438376|NCT00455520|1456805|P1|Open Label Tapentadol Extended Release|All other|33
438377|NCT00455520|1456804|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
438378|NCT00455520|1456805|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
438379|NCT00455520|1456804|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
438380|NCT00455520|1456805|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
438381|NCT00455520|1456804|P2|Open Label Tapentadol Extended Release|Adverse Event|0
438382|NCT00455520|1456805|P1|Open Label Tapentadol Extended Release|Adverse Event|100
438383|NCT00455520|1456804|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
438384|NCT00455520|1456805|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
438385|NCT00455520|1456804|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
438386|NCT00455520|1456805|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
438387|NCT00455455|1456821|P2|Washout|Withdrawal by Subject|0
438388|NCT00455455|1456822|P1|Washout|Withdrawal by Subject|1
438389|NCT00455455|1456821|P2|Washout|Withdrawal by Subject|1
438390|NCT00455455|1456822|P1|Washout|Withdrawal by Subject|0
438391|NCT00455429|1456842|P4|Overall Study|Other|1
438392|NCT00455429|1456843|P3|Overall Study|Other|0
438393|NCT00455429|1456844|P2|Overall Study|Other|2
438394|NCT00455429|1456845|P1|Overall Study|Other|0
438395|NCT00455429|1456842|P4|Overall Study|Non-compliance|1
438396|NCT00455429|1456843|P3|Overall Study|Non-compliance|0
438397|NCT00455429|1456844|P2|Overall Study|Non-compliance|0
438398|NCT00455429|1456845|P1|Overall Study|Non-compliance|0
438399|NCT00455429|1456842|P4|Overall Study|Personal Reason|0
438400|NCT00455429|1456843|P3|Overall Study|Personal Reason|0
438401|NCT00455429|1456844|P2|Overall Study|Personal Reason|0
438402|NCT00455429|1456845|P1|Overall Study|Personal Reason|1
438403|NCT00455429|1456842|P4|Overall Study|Randomly assigned but not treated|2
438404|NCT00455429|1456843|P3|Overall Study|Randomly assigned but not treated|0
438405|NCT00455429|1456844|P2|Overall Study|Randomly assigned but not treated|0
438406|NCT00455429|1456845|P1|Overall Study|Randomly assigned but not treated|0
438407|NCT00455429|1456842|P4|Overall Study|Adverse Event|3
438408|NCT00455429|1456843|P3|Overall Study|Adverse Event|0
438409|NCT00455429|1456844|P2|Overall Study|Adverse Event|1
438410|NCT00455429|1456845|P1|Overall Study|Adverse Event|0
438411|NCT00455429|1456842|P4|Overall Study|Lack of Efficacy|1
438412|NCT00455429|1456843|P3|Overall Study|Lack of Efficacy|0
438413|NCT00455429|1456844|P2|Overall Study|Lack of Efficacy|1
438414|NCT00455429|1456845|P1|Overall Study|Lack of Efficacy|0
438415|NCT00455429|1456842|P4|Overall Study|Withdrawal by Subject|0
438416|NCT00455429|1456843|P3|Overall Study|Withdrawal by Subject|1
438417|NCT00455429|1456844|P2|Overall Study|Withdrawal by Subject|1
438418|NCT00455429|1456845|P1|Overall Study|Withdrawal by Subject|0
438419|NCT00455429|1456842|P4|Overall Study|Lost to Follow-up|3
438420|NCT00455429|1456843|P3|Overall Study|Lost to Follow-up|0
438421|NCT00455429|1456844|P2|Overall Study|Lost to Follow-up|0
438422|NCT00455429|1456845|P1|Overall Study|Lost to Follow-up|1
438423|NCT00455429|1456842|P4|Overall Study|Study Terminated by Sponsor|3
438424|NCT00455429|1456843|P3|Overall Study|Study Terminated by Sponsor|0
438425|NCT00455429|1456844|P2|Overall Study|Study Terminated by Sponsor|0
438426|NCT00455429|1456845|P1|Overall Study|Study Terminated by Sponsor|0
438427|NCT00455312|1456904|P2|Overall Study|Death|1
438428|NCT00455312|1456905|P1|Overall Study|Death|0
438429|NCT00455195|1456931|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
438430|NCT00455195|1456932|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
438431|NCT00455195|1456931|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
438432|NCT00455195|1456932|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
438433|NCT00455195|1456931|P2|Double-blind Study AGLU02704|Death|0
438434|NCT00455195|1456932|P1|Double-blind Study AGLU02704|Death|1
438435|NCT00455195|1456931|P2|Double-blind Study AGLU02704|Adverse Event|1
438436|NCT00455195|1456932|P1|Double-blind Study AGLU02704|Adverse Event|2
438437|NCT00455013|1456949|P3|Long Term Extension (LTE)|non-specified|1
438438|NCT00455013|1456950|P2|Long Term Extension (LTE)|non-specified|0
438439|NCT00455013|1456951|P1|Long Term Extension (LTE)|non-specified|0
438440|NCT00455013|1456949|P3|Long Term Extension (LTE)|Poor non-compliance|0
438441|NCT00455013|1456950|P2|Long Term Extension (LTE)|Poor non-compliance|1
438442|NCT00455013|1456951|P1|Long Term Extension (LTE)|Poor non-compliance|0
438443|NCT00455013|1456949|P3|Long Term Extension (LTE)|Subject Request or refused|3
438444|NCT00455013|1456950|P2|Long Term Extension (LTE)|Subject Request or refused|0
438445|NCT00455013|1456951|P1|Long Term Extension (LTE)|Subject Request or refused|0
438446|NCT00455013|1456949|P3|Long Term Extension (LTE)|No longer met criteria|1
438447|NCT00455013|1456950|P2|Long Term Extension (LTE)|No longer met criteria|0
438448|NCT00455013|1456951|P1|Long Term Extension (LTE)|No longer met criteria|0
438449|NCT00455013|1456949|P3|Long Term Extension (LTE)|Death|0
438450|NCT00455013|1456950|P2|Long Term Extension (LTE)|Death|1
438451|NCT00455013|1456951|P1|Long Term Extension (LTE)|Death|1
438452|NCT00455013|1456949|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
438453|NCT00455013|1456950|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
438454|NCT00455013|1456951|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
438455|NCT00455013|1456949|P3|Long Term Extension (LTE)|Adverse Event|1
438456|NCT00455013|1456950|P2|Long Term Extension (LTE)|Adverse Event|1
438457|NCT00455013|1456951|P1|Long Term Extension (LTE)|Adverse Event|0
438458|NCT00455013|1456949|P3|Short Term Period|Other|1
438459|NCT00455013|1456950|P2|Short Term Period|Other|0
438460|NCT00455013|1456951|P1|Short Term Period|Other|0
438461|NCT00455013|1456949|P3|Short Term Period|Lack of Efficacy|0
438462|NCT00455013|1456950|P2|Short Term Period|Lack of Efficacy|0
438463|NCT00455013|1456951|P1|Short Term Period|Lack of Efficacy|4
438464|NCT00455013|1456949|P3|Short Term Period|Withdrawal by Subject|1
438465|NCT00455013|1456950|P2|Short Term Period|Withdrawal by Subject|0
438466|NCT00455013|1456951|P1|Short Term Period|Withdrawal by Subject|0
438467|NCT00455013|1456949|P3|Short Term Period|Adverse Event|0
438468|NCT00455013|1456950|P2|Short Term Period|Adverse Event|5
438469|NCT00455013|1456951|P1|Short Term Period|Adverse Event|2
438470|NCT00454987|1457019|P3|Booster Period|Lost to Follow-up|0
438471|NCT00454987|1457020|P2|Booster Period|Lost to Follow-up|0
438472|NCT00454987|1457021|P1|Booster Period|Lost to Follow-up|1
438473|NCT00454987|1457019|P3|Booster Period|Withdrawal by Subject|0
438474|NCT00454987|1457020|P2|Booster Period|Withdrawal by Subject|1
438475|NCT00454987|1457021|P1|Booster Period|Withdrawal by Subject|0
438476|NCT00454987|1457019|P3|Booster Period|Adverse Event|0
438477|NCT00454987|1457020|P2|Booster Period|Adverse Event|0
438478|NCT00454987|1457021|P1|Booster Period|Adverse Event|1
438479|NCT00454909|1457095|P3|Overall Study|Others|0
438480|NCT00454909|1457096|P2|Overall Study|Others|0
438481|NCT00454909|1457097|P1|Overall Study|Others|1
438482|NCT00454909|1457095|P3|Overall Study|Lost to follow-up (complete vaccination)|1
438483|NCT00454909|1457096|P2|Overall Study|Lost to follow-up (complete vaccination)|3
438484|NCT00454909|1457097|P1|Overall Study|Lost to follow-up (complete vaccination)|5
438485|NCT00454909|1457095|P3|Overall Study|Migrated/moved from study area|1
438486|NCT00454909|1457096|P2|Overall Study|Migrated/moved from study area|0
438487|NCT00454909|1457097|P1|Overall Study|Migrated/moved from study area|0
438488|NCT00454909|1457095|P3|Overall Study|Withdrawal by Subject|0
438489|NCT00454909|1457096|P2|Overall Study|Withdrawal by Subject|0
438490|NCT00454909|1457097|P1|Overall Study|Withdrawal by Subject|1
438491|NCT00454857|1457135|P1|Overall Study|Reason unknown|1
438492|NCT00454857|1457135|P1|Overall Study|Other|11
438493|NCT00454857|1457135|P1|Overall Study|Death|5
438494|NCT00454857|1457135|P1|Overall Study|Noncompliance|6
438495|NCT00454857|1457135|P1|Overall Study|Lost to Follow-up|16
438496|NCT00454857|1457135|P1|Overall Study|Withdrawal by Subject|15
438497|NCT00454818|1457160|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
438498|NCT00454818|1457161|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
438499|NCT00454818|1457162|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
438500|NCT00454818|1457163|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
438501|NCT00454818|1457164|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
438502|NCT00454818|1457160|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
438503|NCT00454818|1457161|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
438504|NCT00454818|1457162|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
438505|NCT00454818|1457163|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
438506|NCT00454818|1457164|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
438507|NCT00454818|1457160|P5|Phase 2: Randomized Double-blind|Death|1
438508|NCT00454818|1457161|P4|Phase 2: Randomized Double-blind|Death|0
438509|NCT00454818|1457162|P3|Phase 2: Randomized Double-blind|Death|0
438510|NCT00454818|1457163|P2|Phase 2: Randomized Double-blind|Death|1
438511|NCT00454818|1457164|P1|Phase 2: Randomized Double-blind|Death|0
438512|NCT00454818|1457160|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
438513|NCT00454818|1457161|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
438514|NCT00454818|1457162|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
438515|NCT00454818|1457163|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
438516|NCT00454818|1457164|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
438517|NCT00454818|1457160|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
438518|NCT00454818|1457161|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
438519|NCT00454818|1457162|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
438520|NCT00454818|1457163|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
438521|NCT00454818|1457164|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
438522|NCT00454818|1457160|P5|Phase I: Open-label Dose-escalation|Death|0
438523|NCT00454818|1457161|P4|Phase I: Open-label Dose-escalation|Death|0
438524|NCT00454818|1457162|P3|Phase I: Open-label Dose-escalation|Death|0
438525|NCT00454818|1457163|P2|Phase I: Open-label Dose-escalation|Death|1
438526|NCT00454818|1457164|P1|Phase I: Open-label Dose-escalation|Death|0
438527|NCT00454818|1457160|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
438528|NCT00454818|1457161|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
438529|NCT00454818|1457162|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
438530|NCT00454818|1457163|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
438531|NCT00454818|1457164|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
438532|NCT00454805|1457243|P2|Overall Study|In order to begin radiotherapy|0
438533|NCT00454805|1457244|P1|Overall Study|In order to begin radiotherapy|1
438534|NCT00454805|1457243|P2|Overall Study|Disease progression|19
438535|NCT00454805|1457244|P1|Overall Study|Disease progression|16
438536|NCT00454805|1457243|P2|Overall Study|Death|2
438537|NCT00454805|1457244|P1|Overall Study|Death|0
438538|NCT00454805|1457243|P2|Overall Study|Withdrawal by Subject|2
438539|NCT00454805|1457244|P1|Overall Study|Withdrawal by Subject|9
438540|NCT00454779|1457260|P2|Second-line Treatment Phase|Ongoing|1
438541|NCT00454779|1457261|P1|Second-line Treatment Phase|Ongoing|0
438542|NCT00454779|1457260|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
438543|NCT00454779|1457261|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
438544|NCT00454779|1457260|P2|Second-line Treatment Phase|Withdrawal by Subject|1
438545|NCT00454779|1457261|P1|Second-line Treatment Phase|Withdrawal by Subject|0
438546|NCT00454779|1457260|P2|First-line Treatment Phase|Ongoing|0
438547|NCT00454779|1457261|P1|First-line Treatment Phase|Ongoing|1
438548|NCT00454779|1457260|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
438549|NCT00454779|1457261|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
438550|NCT00454779|1457260|P2|First-line Treatment Phase|Protocol Violation|1
438551|NCT00454779|1457261|P1|First-line Treatment Phase|Protocol Violation|0
438552|NCT00454779|1457260|P2|First-line Treatment Phase|Lost to Follow-up|0
438553|NCT00454779|1457261|P1|First-line Treatment Phase|Lost to Follow-up|1
438554|NCT00454779|1457260|P2|First-line Treatment Phase|Withdrawal by Subject|4
438555|NCT00454779|1457261|P1|First-line Treatment Phase|Withdrawal by Subject|2
438556|NCT00454779|1457260|P2|First-line Treatment Phase|Lack of Efficacy|2
438557|NCT00454779|1457261|P1|First-line Treatment Phase|Lack of Efficacy|0
438558|NCT00454649|1457299|P10|Overall Study|Withdrawal by Subject|0
438559|NCT00454649|1457300|P9|Overall Study|Withdrawal by Subject|1
438560|NCT00454649|1457301|P8|Overall Study|Withdrawal by Subject|2
438561|NCT00454649|1457302|P7|Overall Study|Withdrawal by Subject|0
438562|NCT00454649|1457303|P6|Overall Study|Withdrawal by Subject|1
438563|NCT00454649|1457304|P5|Overall Study|Withdrawal by Subject|0
438564|NCT00454649|1457305|P4|Overall Study|Withdrawal by Subject|0
438565|NCT00454649|1457306|P3|Overall Study|Withdrawal by Subject|0
438566|NCT00454649|1457307|P2|Overall Study|Withdrawal by Subject|0
438567|NCT00454649|1457308|P1|Overall Study|Withdrawal by Subject|0
438568|NCT00454649|1457299|P10|Overall Study|Other|1
438569|NCT00454649|1457300|P9|Overall Study|Other|3
438570|NCT00454649|1457301|P8|Overall Study|Other|0
438571|NCT00454649|1457302|P7|Overall Study|Other|0
438572|NCT00454649|1457303|P6|Overall Study|Other|0
438573|NCT00454649|1457304|P5|Overall Study|Other|0
438574|NCT00454649|1457305|P4|Overall Study|Other|3
438575|NCT00454649|1457306|P3|Overall Study|Other|5
438576|NCT00454649|1457307|P2|Overall Study|Other|1
438577|NCT00454649|1457308|P1|Overall Study|Other|1
438578|NCT00454649|1457299|P10|Overall Study|Lost to Follow-up|0
438579|NCT00454649|1457300|P9|Overall Study|Lost to Follow-up|0
438580|NCT00454649|1457301|P8|Overall Study|Lost to Follow-up|0
438581|NCT00454649|1457302|P7|Overall Study|Lost to Follow-up|1
438582|NCT00454649|1457303|P6|Overall Study|Lost to Follow-up|0
438583|NCT00454649|1457304|P5|Overall Study|Lost to Follow-up|0
438584|NCT00454649|1457305|P4|Overall Study|Lost to Follow-up|0
438585|NCT00454649|1457306|P3|Overall Study|Lost to Follow-up|1
438586|NCT00454649|1457307|P2|Overall Study|Lost to Follow-up|0
438587|NCT00454649|1457308|P1|Overall Study|Lost to Follow-up|0
438588|NCT00454649|1457299|P10|Overall Study|Adverse Event|2
438589|NCT00454649|1457300|P9|Overall Study|Adverse Event|6
438590|NCT00454649|1457301|P8|Overall Study|Adverse Event|4
438591|NCT00454649|1457302|P7|Overall Study|Adverse Event|3
438592|NCT00454649|1457303|P6|Overall Study|Adverse Event|2
438593|NCT00454649|1457304|P5|Overall Study|Adverse Event|1
438594|NCT00454649|1457305|P4|Overall Study|Adverse Event|0
438595|NCT00454649|1457306|P3|Overall Study|Adverse Event|3
438596|NCT00454649|1457307|P2|Overall Study|Adverse Event|1
438597|NCT00454649|1457308|P1|Overall Study|Adverse Event|0
438598|NCT00454649|1457299|P10|Overall Study|Lack of Efficacy|2
438599|NCT00454649|1457300|P9|Overall Study|Lack of Efficacy|10
438600|NCT00454649|1457301|P8|Overall Study|Lack of Efficacy|13
438601|NCT00454649|1457302|P7|Overall Study|Lack of Efficacy|5
438602|NCT00454649|1457303|P6|Overall Study|Lack of Efficacy|4
438603|NCT00454649|1457304|P5|Overall Study|Lack of Efficacy|0
438604|NCT00454649|1457305|P4|Overall Study|Lack of Efficacy|3
438605|NCT00454649|1457306|P3|Overall Study|Lack of Efficacy|10
438606|NCT00454649|1457307|P2|Overall Study|Lack of Efficacy|2
438607|NCT00454649|1457308|P1|Overall Study|Lack of Efficacy|2
438608|NCT00454636|1457437|P4|Overall Study|Lost to Follow-up|0
438609|NCT00454636|1457438|P3|Overall Study|Lost to Follow-up|0
438610|NCT00454636|1457439|P2|Overall Study|Lost to Follow-up|1
438611|NCT00454636|1457440|P1|Overall Study|Lost to Follow-up|0
438612|NCT00454636|1457437|P4|Overall Study|Patient refusal|2
438613|NCT00454636|1457438|P3|Overall Study|Patient refusal|3
438614|NCT00454636|1457439|P2|Overall Study|Patient refusal|1
438615|NCT00454636|1457440|P1|Overall Study|Patient refusal|1
438616|NCT00454636|1457437|P4|Overall Study|Death|1
438617|NCT00454636|1457438|P3|Overall Study|Death|1
438618|NCT00454636|1457439|P2|Overall Study|Death|1
438619|NCT00454636|1457440|P1|Overall Study|Death|6
438620|NCT00454636|1457437|P4|Overall Study|Protocol Violation|3
438621|NCT00454636|1457438|P3|Overall Study|Protocol Violation|3
438622|NCT00454636|1457439|P2|Overall Study|Protocol Violation|2
438623|NCT00454636|1457440|P1|Overall Study|Protocol Violation|3
438624|NCT00454636|1457437|P4|Overall Study|Disease Progression|11
438625|NCT00454636|1457438|P3|Overall Study|Disease Progression|4
438626|NCT00454636|1457439|P2|Overall Study|Disease Progression|12
438627|NCT00454636|1457440|P1|Overall Study|Disease Progression|11
438628|NCT00454636|1457437|P4|Overall Study|Adverse Event|15
438629|NCT00454636|1457438|P3|Overall Study|Adverse Event|9
438630|NCT00454636|1457439|P2|Overall Study|Adverse Event|6
438631|NCT00454636|1457440|P1|Overall Study|Adverse Event|10
438632|NCT00454584|1457473|P6|After Controlled Period|Other|17
438633|NCT00454584|1457474|P5|After Controlled Period|Other|5
438634|NCT00454584|1457475|P4|After Controlled Period|Other|13
438635|NCT00454584|1457476|P3|After Controlled Period|Other|0
438636|NCT00454584|1457477|P2|After Controlled Period|Other|0
438637|NCT00454584|1457478|P1|After Controlled Period|Other|0
438638|NCT00454584|1457473|P6|After Controlled Period|Other|0
438639|NCT00454584|1457474|P5|After Controlled Period|Other|0
438640|NCT00454584|1457475|P4|After Controlled Period|Other|1
438641|NCT00454584|1457476|P3|After Controlled Period|Other|0
438642|NCT00454584|1457477|P2|After Controlled Period|Other|0
438643|NCT00454584|1457478|P1|After Controlled Period|Other|0
438644|NCT00454584|1457473|P6|After Controlled Period|Lost to Follow-up|6
438645|NCT00454584|1457474|P5|After Controlled Period|Lost to Follow-up|4
438646|NCT00454584|1457475|P4|After Controlled Period|Lost to Follow-up|2
438647|NCT00454584|1457476|P3|After Controlled Period|Lost to Follow-up|0
438648|NCT00454584|1457477|P2|After Controlled Period|Lost to Follow-up|0
438649|NCT00454584|1457478|P1|After Controlled Period|Lost to Follow-up|0
438650|NCT00454584|1457473|P6|After Controlled Period|Lack of Efficacy|0
438651|NCT00454584|1457474|P5|After Controlled Period|Lack of Efficacy|0
438652|NCT00454584|1457475|P4|After Controlled Period|Lack of Efficacy|1
438653|NCT00454584|1457476|P3|After Controlled Period|Lack of Efficacy|0
438654|NCT00454584|1457477|P2|After Controlled Period|Lack of Efficacy|0
438655|NCT00454584|1457478|P1|After Controlled Period|Lack of Efficacy|0
438656|NCT00454584|1457473|P6|After Controlled Period|Adverse Event|9
438657|NCT00454584|1457474|P5|After Controlled Period|Adverse Event|3
438658|NCT00454584|1457475|P4|After Controlled Period|Adverse Event|9
438659|NCT00454584|1457476|P3|After Controlled Period|Adverse Event|0
438660|NCT00454584|1457477|P2|After Controlled Period|Adverse Event|0
438661|NCT00454584|1457478|P1|After Controlled Period|Adverse Event|0
438662|NCT00454584|1457473|P6|Controlled Period|Other|0
438663|NCT00454584|1457474|P5|Controlled Period|Other|0
438664|NCT00454584|1457475|P4|Controlled Period|Other|0
438665|NCT00454584|1457476|P3|Controlled Period|Other|2
438666|NCT00454584|1457477|P2|Controlled Period|Other|4
438667|NCT00454584|1457478|P1|Controlled Period|Other|5
438668|NCT00454584|1457473|P6|Controlled Period|Lost to Follow-up|0
438669|NCT00454584|1457474|P5|Controlled Period|Lost to Follow-up|0
438670|NCT00454584|1457475|P4|Controlled Period|Lost to Follow-up|0
438671|NCT00454584|1457476|P3|Controlled Period|Lost to Follow-up|2
438672|NCT00454584|1457477|P2|Controlled Period|Lost to Follow-up|2
438673|NCT00454584|1457478|P1|Controlled Period|Lost to Follow-up|1
438674|NCT00454584|1457473|P6|Controlled Period|Adverse Event|0
438675|NCT00454584|1457474|P5|Controlled Period|Adverse Event|0
438676|NCT00454584|1457475|P4|Controlled Period|Adverse Event|0
438677|NCT00454584|1457476|P3|Controlled Period|Adverse Event|1
438678|NCT00454584|1457477|P2|Controlled Period|Adverse Event|2
438679|NCT00454584|1457478|P1|Controlled Period|Adverse Event|5
438680|NCT00454571|1457500|P2|Overall Study|Withdrawal by Subject|5
438681|NCT00454571|1457501|P1|Overall Study|Withdrawal by Subject|10
438682|NCT00454571|1457500|P2|Overall Study|Protocol Violation|0
438683|NCT00454571|1457501|P1|Overall Study|Protocol Violation|1
438684|NCT00454571|1457500|P2|Overall Study|Physician Decision|1
438685|NCT00454571|1457501|P1|Overall Study|Physician Decision|0
438686|NCT00454571|1457500|P2|Overall Study|Adverse Event|0
438687|NCT00454571|1457501|P1|Overall Study|Adverse Event|2
438688|NCT00454363|1457536|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
438689|NCT00454363|1457537|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
438690|NCT00454363|1457536|P2|Overall Study|Adverse Event|2
438691|NCT00454363|1457537|P1|Overall Study|Adverse Event|1
438692|NCT00454246|1457562|P3|Overall Study|Early termination of study|9
438693|NCT00454246|1457563|P2|Overall Study|Early termination of study|26
438694|NCT00454246|1457564|P1|Overall Study|Early termination of study|62
438695|NCT00454246|1457562|P3|Overall Study|Failure to return|0
438696|NCT00454246|1457563|P2|Overall Study|Failure to return|0
438697|NCT00454246|1457564|P1|Overall Study|Failure to return|1
438698|NCT00454246|1457562|P3|Overall Study|Refused Treatment|0
438699|NCT00454246|1457563|P2|Overall Study|Refused Treatment|1
438700|NCT00454246|1457564|P1|Overall Study|Refused Treatment|1
438701|NCT00454246|1457562|P3|Overall Study|Protocol Violation|0
438702|NCT00454246|1457563|P2|Overall Study|Protocol Violation|0
438703|NCT00454246|1457564|P1|Overall Study|Protocol Violation|1
438704|NCT00454246|1457562|P3|Overall Study|Violation of selection criteria at entry|0
438705|NCT00454246|1457563|P2|Overall Study|Violation of selection criteria at entry|0
438706|NCT00454246|1457564|P1|Overall Study|Violation of selection criteria at entry|6
438707|NCT00454246|1457562|P3|Overall Study|Adverse Event|0
438708|NCT00454246|1457563|P2|Overall Study|Adverse Event|2
438709|NCT00454246|1457564|P1|Overall Study|Adverse Event|2
438710|NCT00454207|1457580|P2|Overall Study|Protocol Violation|1
438711|NCT00454207|1457581|P1|Overall Study|Protocol Violation|0
438712|NCT00454207|1457580|P2|Overall Study|Lack of Efficacy|0
438713|NCT00454207|1457581|P1|Overall Study|Lack of Efficacy|1
438714|NCT00454207|1457580|P2|Overall Study|Adverse Event|1
438715|NCT00454207|1457581|P1|Overall Study|Adverse Event|3
438716|NCT00454194|1457626|P2|Overall Study|Other Unspecified Reason|2
438717|NCT00454194|1457627|P1|Overall Study|Other Unspecified Reason|2
438718|NCT00454194|1457626|P2|Overall Study|Other Medical Problems|2
438719|NCT00454194|1457627|P1|Overall Study|Other Medical Problems|1
438720|NCT00454194|1457626|P2|Overall Study|Withdrawal by Subject|8
438721|NCT00454194|1457627|P1|Overall Study|Withdrawal by Subject|12
438722|NCT00454194|1457626|P2|Overall Study|Adverse Event|2
438723|NCT00454194|1457627|P1|Overall Study|Adverse Event|7
438724|NCT00454181|1457645|P2|Overall Study|Withdrawal by Subject|0
438725|NCT00454181|1457646|P1|Overall Study|Withdrawal by Subject|2
438726|NCT00454181|1457645|P2|Overall Study|Protocol Violation|1
438727|NCT00454181|1457646|P1|Overall Study|Protocol Violation|1
438728|NCT00454181|1457645|P2|Overall Study|Lost to Follow-up|1
438729|NCT00454181|1457646|P1|Overall Study|Lost to Follow-up|11
438730|NCT00454181|1457645|P2|Overall Study|Adverse Event|1
438731|NCT00454181|1457646|P1|Overall Study|Adverse Event|1
438732|NCT00454142|1457662|P1|Overall Study|Withdrawal by Subject|1
438733|NCT00454116|1457680|P3|Overall Study|Other|0
438734|NCT00454116|1457681|P2|Overall Study|Other|2
438735|NCT00454116|1457682|P1|Overall Study|Other|2
438736|NCT00454116|1457680|P3|Overall Study|Withdrawal by Subject|1
438737|NCT00454116|1457681|P2|Overall Study|Withdrawal by Subject|3
438738|NCT00454116|1457682|P1|Overall Study|Withdrawal by Subject|3
438739|NCT00454116|1457680|P3|Overall Study|Condition under investigation worsened|18
438740|NCT00454116|1457681|P2|Overall Study|Condition under investigation worsened|13
438741|NCT00454116|1457682|P1|Overall Study|Condition under investigation worsened|17
438742|NCT00454116|1457680|P3|Overall Study|Adverse Event|9
438743|NCT00454116|1457681|P2|Overall Study|Adverse Event|11
438744|NCT00454116|1457682|P1|Overall Study|Adverse Event|5
438745|NCT00454051|1457692|P2|Overall Study|Protocol Violation|1
438746|NCT00454051|1457693|P1|Overall Study|Protocol Violation|1
438747|NCT00454051|1457692|P2|Overall Study|Withdrawal by Subject|0
438748|NCT00454051|1457693|P1|Overall Study|Withdrawal by Subject|1
438749|NCT00454051|1457692|P2|Overall Study|Adverse Event|2
438750|NCT00454051|1457693|P1|Overall Study|Adverse Event|1
438751|NCT00453999|1457726|P3|Overall Study|Subject Request|0
438752|NCT00453999|1457727|P2|Overall Study|Subject Request|1
438753|NCT00453999|1457728|P1|Overall Study|Subject Request|2
438754|NCT00453999|1457726|P3|Overall Study|Withdrawal by Subject|1
438755|NCT00453999|1457727|P2|Overall Study|Withdrawal by Subject|1
438756|NCT00453999|1457728|P1|Overall Study|Withdrawal by Subject|2
438757|NCT00453999|1457726|P3|Overall Study|Lost to Follow-up|1
438758|NCT00453999|1457727|P2|Overall Study|Lost to Follow-up|1
438759|NCT00453999|1457728|P1|Overall Study|Lost to Follow-up|0
438760|NCT00453999|1457726|P3|Overall Study|Adverse Event|1
438761|NCT00453999|1457727|P2|Overall Study|Adverse Event|2
438762|NCT00453999|1457728|P1|Overall Study|Adverse Event|1
438763|NCT00453986|1457756|P5|Overall Study|Lost to Follow-up|0
438764|NCT00453986|1457757|P4|Overall Study|Lost to Follow-up|2
438765|NCT00453986|1457758|P3|Overall Study|Lost to Follow-up|6
438766|NCT00453986|1457759|P2|Overall Study|Lost to Follow-up|5
438767|NCT00453986|1457760|P1|Overall Study|Lost to Follow-up|6
438768|NCT00453973|1457855|P2|Overall Study|Sponsor Decision to Terminate Study|30
438769|NCT00453973|1457856|P1|Overall Study|Sponsor Decision to Terminate Study|35
438770|NCT00453973|1457855|P2|Overall Study|Site closed by sponsor|0
438771|NCT00453973|1457856|P1|Overall Study|Site closed by sponsor|3
438772|NCT00453973|1457855|P2|Overall Study|Renal transplant|1
438773|NCT00453973|1457856|P1|Overall Study|Renal transplant|1
438774|NCT00453973|1457855|P2|Overall Study|Relocation|0
438775|NCT00453973|1457856|P1|Overall Study|Relocation|1
438776|NCT00453973|1457855|P2|Overall Study|PI Decision|2
438777|NCT00453973|1457856|P1|Overall Study|PI Decision|0
438778|NCT00453973|1457855|P2|Overall Study|Withdrawal by Subject|6
438779|NCT00453973|1457856|P1|Overall Study|Withdrawal by Subject|7
438780|NCT00453973|1457855|P2|Overall Study|Adverse Event|9
438781|NCT00453973|1457856|P1|Overall Study|Adverse Event|4
438782|NCT00453921|1457866|P4|Overall Study|Lost to Follow-up|0
438783|NCT00453921|1457867|P3|Overall Study|Lost to Follow-up|1
438784|NCT00453921|1457868|P2|Overall Study|Lost to Follow-up|0
438785|NCT00453921|1457869|P1|Overall Study|Lost to Follow-up|0
438786|NCT00453921|1457866|P4|Overall Study|Withdrawal by Subject|1
438787|NCT00453921|1457867|P3|Overall Study|Withdrawal by Subject|1
438788|NCT00453921|1457868|P2|Overall Study|Withdrawal by Subject|1
438789|NCT00453921|1457869|P1|Overall Study|Withdrawal by Subject|1
438790|NCT00453362|1458008|P1|Overall Study|Screening Failure|14
438791|NCT00453362|1458008|P1|Overall Study|Progression of disease|56
438792|NCT00453362|1458008|P1|Overall Study|Withdrawal by Subject|3
438793|NCT00453362|1458008|P1|Overall Study|Physician Decision|2
438794|NCT00453362|1458008|P1|Overall Study|Death|7
438795|NCT00453362|1458008|P1|Overall Study|Adverse Event|5
438796|NCT00453349|1458034|P2|Completed Study|Lost to follow up after study treatment|11
438797|NCT00453349|1458035|P1|Completed Study|Lost to follow up after study treatment|2
438798|NCT00453349|1458034|P2|Completed Study|Withdrawal by Subject|5
438799|NCT00453349|1458035|P1|Completed Study|Withdrawal by Subject|3
438800|NCT00453349|1458034|P2|Completed Study|Protocol Violation|1
438801|NCT00453349|1458035|P1|Completed Study|Protocol Violation|1
438802|NCT00453349|1458034|P2|Completed Study|Lost to Follow-up|5
438803|NCT00453349|1458035|P1|Completed Study|Lost to Follow-up|7
438804|NCT00453349|1458034|P2|Completed Study|Lack of Efficacy|1
438805|NCT00453349|1458035|P1|Completed Study|Lack of Efficacy|2
438806|NCT00453349|1458034|P2|Completed Study|Adverse Event|11
438807|NCT00453349|1458035|P1|Completed Study|Adverse Event|12
438808|NCT00453349|1458034|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
438809|NCT00453349|1458035|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
438810|NCT00453349|1458034|P2|Randomized|Withdrawal by Subject|5
438811|NCT00453349|1458035|P1|Randomized|Withdrawal by Subject|3
438812|NCT00453349|1458034|P2|Randomized|Protocol Violation|1
438813|NCT00453349|1458035|P1|Randomized|Protocol Violation|1
438814|NCT00453349|1458034|P2|Randomized|Lost to Follow-up|5
438815|NCT00453349|1458035|P1|Randomized|Lost to Follow-up|7
438816|NCT00453349|1458034|P2|Randomized|Lack of Efficacy|1
438817|NCT00453349|1458035|P1|Randomized|Lack of Efficacy|2
438818|NCT00453349|1458034|P2|Randomized|Adverse Event|11
438819|NCT00453349|1458035|P1|Randomized|Adverse Event|12
438820|NCT00453310|1458066|P1|Overall Study|Progression of Disease|10
438821|NCT00453206|1458070|P1|Overall Study|Death|1
438822|NCT00453180|1458080|P2|Overall Study|Adverse Event|2
438823|NCT00453180|1458081|P1|Overall Study|Adverse Event|1
438824|NCT00453180|1458080|P2|Overall Study|Lost to Follow-up|1
438825|NCT00453180|1458081|P1|Overall Study|Lost to Follow-up|2
438826|NCT00453154|1458100|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
438827|NCT00453154|1458101|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
438828|NCT00453154|1458102|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
438829|NCT00453154|1458103|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
438830|NCT00453154|1458100|P4|Double BIind Maintenance|Medical Issues|1
438831|NCT00453154|1458101|P3|Double BIind Maintenance|Medical Issues|3
438832|NCT00453154|1458102|P2|Double BIind Maintenance|Medical Issues|0
438833|NCT00453154|1458103|P1|Double BIind Maintenance|Medical Issues|0
438834|NCT00453154|1458100|P4|Double BIind Maintenance|Progression|26
438835|NCT00453154|1458101|P3|Double BIind Maintenance|Progression|29
438836|NCT00453154|1458102|P2|Double BIind Maintenance|Progression|0
438837|NCT00453154|1458103|P1|Double BIind Maintenance|Progression|0
438838|NCT00453154|1458100|P4|Double BIind Maintenance|Withdrawal by Subject|4
438839|NCT00453154|1458101|P3|Double BIind Maintenance|Withdrawal by Subject|4
438840|NCT00453154|1458102|P2|Double BIind Maintenance|Withdrawal by Subject|0
438841|NCT00453154|1458103|P1|Double BIind Maintenance|Withdrawal by Subject|0
438842|NCT00453154|1458100|P4|Double BIind Maintenance|Death|1
438843|NCT00453154|1458101|P3|Double BIind Maintenance|Death|2
438844|NCT00453154|1458102|P2|Double BIind Maintenance|Death|0
438845|NCT00453154|1458103|P1|Double BIind Maintenance|Death|0
438846|NCT00453154|1458100|P4|Double BIind Maintenance|Adverse Event|12
438847|NCT00453154|1458101|P3|Double BIind Maintenance|Adverse Event|3
438848|NCT00453154|1458102|P2|Double BIind Maintenance|Adverse Event|0
438849|NCT00453154|1458103|P1|Double BIind Maintenance|Adverse Event|0
438850|NCT00453102|1458116|P1|Overall Study|Withdrawal by Subject|2
438851|NCT00453063|1458127|P2|Overall Study|Protocol Violation|0
438852|NCT00453063|1458128|P1|Overall Study|Protocol Violation|1
438853|NCT00453063|1458127|P2|Overall Study|Withdrawal by Subject|1
438854|NCT00453063|1458128|P1|Overall Study|Withdrawal by Subject|1
438855|NCT00453063|1458127|P2|Overall Study|Adverse Event|2
438856|NCT00453063|1458128|P1|Overall Study|Adverse Event|1
438857|NCT00452790|1458148|P2|Toddler Dose|Parent/legal guardian request|1
438858|NCT00452790|1458149|P1|Toddler Dose|Parent/legal guardian request|0
438859|NCT00452790|1458148|P2|Toddler Dose|Failed to return|1
438860|NCT00452790|1458149|P1|Toddler Dose|Failed to return|0
438861|NCT00452790|1458148|P2|After Infant Series|Other reasons|0
438862|NCT00452790|1458149|P1|After Infant Series|Other reasons|1
438863|NCT00452790|1458148|P2|After Infant Series|Failed to return|0
438864|NCT00452790|1458149|P1|After Infant Series|Failed to return|1
438865|NCT00452790|1458148|P2|After Infant Series|Lost to Follow-up|0
438866|NCT00452790|1458149|P1|After Infant Series|Lost to Follow-up|4
438867|NCT00452790|1458148|P2|After Infant Series|Parent/legal guardian request|3
438868|NCT00452790|1458149|P1|After Infant Series|Parent/legal guardian request|1
438869|NCT00452790|1458148|P2|After Infant Series|Adverse Event|1
438870|NCT00452790|1458149|P1|After Infant Series|Adverse Event|4
438871|NCT00452790|1458148|P2|After Infant Series|Investigator request|10
438872|NCT00452790|1458149|P1|After Infant Series|Investigator request|10
438873|NCT00452790|1458148|P2|Infant Series|Death|1
438874|NCT00452790|1458149|P1|Infant Series|Death|0
438875|NCT00452790|1458148|P2|Infant Series|Investigator request|1
438876|NCT00452790|1458149|P1|Infant Series|Investigator request|0
438877|NCT00452790|1458148|P2|Infant Series|Other reasons|2
438878|NCT00452790|1458149|P1|Infant Series|Other reasons|1
438879|NCT00452790|1458148|P2|Infant Series|Adverse Event|2
438880|NCT00452790|1458149|P1|Infant Series|Adverse Event|1
438881|NCT00452790|1458148|P2|Infant Series|Lost to Follow-up|2
438882|NCT00452790|1458149|P1|Infant Series|Lost to Follow-up|2
438883|NCT00452790|1458148|P2|Infant Series|Protocol Violation|3
438884|NCT00452790|1458149|P1|Infant Series|Protocol Violation|1
438885|NCT00452790|1458148|P2|Infant Series|Failed to return|1
438886|NCT00452790|1458149|P1|Infant Series|Failed to return|4
438887|NCT00452790|1458148|P2|Infant Series|Parent/legal guardian request|6
438888|NCT00452790|1458149|P1|Infant Series|Parent/legal guardian request|8
438889|NCT00452790|1458148|P2|Infant Series|Clinical hold - consent withdrawn|123
438890|NCT00452790|1458149|P1|Infant Series|Clinical hold - consent withdrawn|118
438891|NCT00452699|1458185|P2|Overall Study|Other|7
438892|NCT00452699|1458186|P1|Overall Study|Other|12
438893|NCT00452699|1458185|P2|Overall Study|Withdrawal by Subject|25
438894|NCT00452699|1458186|P1|Overall Study|Withdrawal by Subject|26
438895|NCT00452699|1458185|P2|Overall Study|Protocol Violation|25
438896|NCT00452699|1458186|P1|Overall Study|Protocol Violation|21
438897|NCT00452699|1458185|P2|Overall Study|Lost to Follow-up|9
438898|NCT00452699|1458186|P1|Overall Study|Lost to Follow-up|6
438899|NCT00452699|1458185|P2|Overall Study|Lack of Efficacy|4
438900|NCT00452699|1458186|P1|Overall Study|Lack of Efficacy|6
438901|NCT00452699|1458185|P2|Overall Study|Adverse Event|3
438902|NCT00452699|1458186|P1|Overall Study|Adverse Event|10
438903|NCT00452673|1458202|P5|Dose Expansion Period|not specified|2
438904|NCT00452673|1458203|P4|Dose Expansion Period|not specified|0
438905|NCT00452673|1458204|P3|Dose Expansion Period|not specified|0
438906|NCT00452673|1458205|P2|Dose Expansion Period|not specified|0
438907|NCT00452673|1458206|P1|Dose Expansion Period|not specified|0
438908|NCT00452673|1458202|P5|Dose Expansion Period|Disease Progression|19
438909|NCT00452673|1458203|P4|Dose Expansion Period|Disease Progression|0
438910|NCT00452673|1458204|P3|Dose Expansion Period|Disease Progression|0
438911|NCT00452673|1458205|P2|Dose Expansion Period|Disease Progression|0
438912|NCT00452673|1458206|P1|Dose Expansion Period|Disease Progression|0
438913|NCT00452673|1458202|P5|Dose Escalation Period|Withdrawal by Subject|0
438914|NCT00452673|1458203|P4|Dose Escalation Period|Withdrawal by Subject|1
438915|NCT00452673|1458204|P3|Dose Escalation Period|Withdrawal by Subject|0
438916|NCT00452673|1458205|P2|Dose Escalation Period|Withdrawal by Subject|0
438917|NCT00452673|1458206|P1|Dose Escalation Period|Withdrawal by Subject|0
438918|NCT00452673|1458202|P5|Dose Escalation Period|Adverse Event|0
438919|NCT00452673|1458203|P4|Dose Escalation Period|Adverse Event|1
438920|NCT00452673|1458204|P3|Dose Escalation Period|Adverse Event|0
438921|NCT00452673|1458205|P2|Dose Escalation Period|Adverse Event|0
438922|NCT00452673|1458206|P1|Dose Escalation Period|Adverse Event|0
438923|NCT00452673|1458202|P5|Dose Escalation Period|not specified|0
438924|NCT00452673|1458203|P4|Dose Escalation Period|not specified|0
438925|NCT00452673|1458204|P3|Dose Escalation Period|not specified|1
438926|NCT00452673|1458205|P2|Dose Escalation Period|not specified|0
438927|NCT00452673|1458206|P1|Dose Escalation Period|not specified|0
438928|NCT00452673|1458202|P5|Dose Escalation Period|study drug toxicity|0
438929|NCT00452673|1458203|P4|Dose Escalation Period|study drug toxicity|1
438930|NCT00452673|1458204|P3|Dose Escalation Period|study drug toxicity|3
438931|NCT00452673|1458205|P2|Dose Escalation Period|study drug toxicity|3
438932|NCT00452673|1458206|P1|Dose Escalation Period|study drug toxicity|1
438933|NCT00452673|1458202|P5|Dose Escalation Period|Disease Progression|0
438934|NCT00452673|1458203|P4|Dose Escalation Period|Disease Progression|6
438935|NCT00452673|1458204|P3|Dose Escalation Period|Disease Progression|2
438936|NCT00452673|1458205|P2|Dose Escalation Period|Disease Progression|6
438937|NCT00452673|1458206|P1|Dose Escalation Period|Disease Progression|6
438938|NCT00452530|1458253|P2|Overall Study|Not specified|11
438939|NCT00452530|1458254|P1|Overall Study|Not specified|7
438940|NCT00452530|1458253|P2|Overall Study|No longer met study criteria|22
438941|NCT00452530|1458254|P1|Overall Study|No longer met study criteria|18
438942|NCT00452530|1458253|P2|Overall Study|Poor compliance/noncompliance|2
438943|NCT00452530|1458254|P1|Overall Study|Poor compliance/noncompliance|1
438944|NCT00452530|1458253|P2|Overall Study|Lost to Follow-up|0
438945|NCT00452530|1458254|P1|Overall Study|Lost to Follow-up|1
438946|NCT00452530|1458253|P2|Overall Study|Withdrawal by Subject|57
438947|NCT00452530|1458254|P1|Overall Study|Withdrawal by Subject|68
438948|NCT00452530|1458253|P2|Overall Study|Adverse Event|44
438949|NCT00452530|1458254|P1|Overall Study|Adverse Event|40
438950|NCT00452530|1458253|P2|Overall Study|Death|0
438951|NCT00452530|1458254|P1|Overall Study|Death|1
438952|NCT00452452|1458275|P3|Overall Study|Lost to Follow-up|0
438953|NCT00452452|1458276|P2|Overall Study|Lost to Follow-up|0
438954|NCT00452452|1458277|P1|Overall Study|Lost to Follow-up|1
438955|NCT00452452|1458275|P3|Overall Study|Withdrawal by Subject|0
438956|NCT00452452|1458276|P2|Overall Study|Withdrawal by Subject|0
438957|NCT00452452|1458277|P1|Overall Study|Withdrawal by Subject|1
438958|NCT00452452|1458275|P3|Overall Study|Protocol Violation|1
438959|NCT00452452|1458276|P2|Overall Study|Protocol Violation|0
438960|NCT00452452|1458277|P1|Overall Study|Protocol Violation|0
438961|NCT00452400|1458322|P5|Overall Study|Other reasons not listed above|1
438962|NCT00452400|1458323|P4|Overall Study|Other reasons not listed above|1
438963|NCT00452400|1458324|P3|Overall Study|Other reasons not listed above|0
438964|NCT00452400|1458325|P2|Overall Study|Other reasons not listed above|0
438965|NCT00452400|1458326|P1|Overall Study|Other reasons not listed above|0
438966|NCT00452400|1458322|P5|Overall Study|Lack of Efficacy|0
438967|NCT00452400|1458323|P4|Overall Study|Lack of Efficacy|0
438968|NCT00452400|1458324|P3|Overall Study|Lack of Efficacy|0
438969|NCT00452400|1458325|P2|Overall Study|Lack of Efficacy|0
438970|NCT00452400|1458326|P1|Overall Study|Lack of Efficacy|2
438971|NCT00452400|1458322|P5|Overall Study|Withdrawal by Subject|0
438972|NCT00452400|1458323|P4|Overall Study|Withdrawal by Subject|0
438973|NCT00452400|1458324|P3|Overall Study|Withdrawal by Subject|1
438974|NCT00452400|1458325|P2|Overall Study|Withdrawal by Subject|0
438975|NCT00452400|1458326|P1|Overall Study|Withdrawal by Subject|1
438976|NCT00452400|1458322|P5|Overall Study|Lost to Follow-up|0
438977|NCT00452400|1458323|P4|Overall Study|Lost to Follow-up|0
438978|NCT00452400|1458324|P3|Overall Study|Lost to Follow-up|0
438979|NCT00452400|1458325|P2|Overall Study|Lost to Follow-up|0
438980|NCT00452400|1458326|P1|Overall Study|Lost to Follow-up|1
438981|NCT00452400|1458322|P5|Overall Study|Protocol Violation|0
438982|NCT00452400|1458323|P4|Overall Study|Protocol Violation|0
438983|NCT00452400|1458324|P3|Overall Study|Protocol Violation|1
438984|NCT00452400|1458325|P2|Overall Study|Protocol Violation|0
438985|NCT00452400|1458326|P1|Overall Study|Protocol Violation|0
438986|NCT00452400|1458322|P5|Overall Study|Adverse Event|2
438987|NCT00452400|1458323|P4|Overall Study|Adverse Event|0
438988|NCT00452400|1458324|P3|Overall Study|Adverse Event|5
438989|NCT00452400|1458325|P2|Overall Study|Adverse Event|1
438990|NCT00452400|1458326|P1|Overall Study|Adverse Event|1
438991|NCT00452361|1458513|P2|Overall Study|Premature termination|9
438992|NCT00452361|1458514|P1|Overall Study|Premature termination|13
438993|NCT00452361|1458513|P2|Overall Study|Withdrawal by Subject|1
438994|NCT00452361|1458514|P1|Overall Study|Withdrawal by Subject|0
438995|NCT00452361|1458513|P2|Overall Study|Adverse Event|0
438996|NCT00452361|1458514|P1|Overall Study|Adverse Event|8
438997|NCT00452348|1458558|P2|Overall Study|Other|9
438998|NCT00452348|1458559|P1|Overall Study|Other|9
438999|NCT00452348|1458558|P2|Overall Study|Withdrawal by Subject|21
439000|NCT00452348|1458559|P1|Overall Study|Withdrawal by Subject|18
439001|NCT00452348|1458558|P2|Overall Study|Protocol Violation|28
439002|NCT00452348|1458559|P1|Overall Study|Protocol Violation|22
439003|NCT00452348|1458558|P2|Overall Study|Lost to Follow-up|8
439004|NCT00452348|1458559|P1|Overall Study|Lost to Follow-up|14
439005|NCT00452348|1458558|P2|Overall Study|Lack of Efficacy|9
439006|NCT00452348|1458559|P1|Overall Study|Lack of Efficacy|10
439007|NCT00452348|1458558|P2|Overall Study|Adverse Event|9
439008|NCT00452348|1458559|P1|Overall Study|Adverse Event|6
439009|NCT00452114|1458613|P2|Overall Study|Physician Decision|3
439010|NCT00452114|1458614|P1|Overall Study|Physician Decision|3
439011|NCT00451958|1458624|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
439012|NCT00451958|1458625|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
439013|NCT00451958|1458626|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
439014|NCT00451958|1458627|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
439015|NCT00451958|1458628|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
439016|NCT00451958|1458624|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
439017|NCT00451958|1458625|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
439018|NCT00451958|1458626|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
439019|NCT00451958|1458627|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
439020|NCT00451958|1458628|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
439021|NCT00451958|1458624|P5|CS21A (NCT00451958)|Physician Decision|0
439022|NCT00451958|1458625|P4|CS21A (NCT00451958)|Physician Decision|4
439023|NCT00451958|1458626|P3|CS21A (NCT00451958)|Physician Decision|4
439024|NCT00451958|1458627|P2|CS21A (NCT00451958)|Physician Decision|4
439025|NCT00451958|1458628|P1|CS21A (NCT00451958)|Physician Decision|2
439026|NCT00451958|1458624|P5|CS21A (NCT00451958)|Protocol Violation|0
439027|NCT00451958|1458625|P4|CS21A (NCT00451958)|Protocol Violation|0
439028|NCT00451958|1458626|P3|CS21A (NCT00451958)|Protocol Violation|2
439029|NCT00451958|1458627|P2|CS21A (NCT00451958)|Protocol Violation|3
439030|NCT00451958|1458628|P1|CS21A (NCT00451958)|Protocol Violation|1
439031|NCT00451958|1458624|P5|CS21A (NCT00451958)|Lost to Follow-up|0
439032|NCT00451958|1458625|P4|CS21A (NCT00451958)|Lost to Follow-up|1
439033|NCT00451958|1458626|P3|CS21A (NCT00451958)|Lost to Follow-up|1
439034|NCT00451958|1458627|P2|CS21A (NCT00451958)|Lost to Follow-up|5
439035|NCT00451958|1458628|P1|CS21A (NCT00451958)|Lost to Follow-up|6
439036|NCT00451958|1458624|P5|CS21A (NCT00451958)|Adverse Event|0
439037|NCT00451958|1458625|P4|CS21A (NCT00451958)|Adverse Event|17
439038|NCT00451958|1458626|P3|CS21A (NCT00451958)|Adverse Event|14
439039|NCT00451958|1458627|P2|CS21A (NCT00451958)|Adverse Event|34
439040|NCT00451958|1458628|P1|CS21A (NCT00451958)|Adverse Event|21
439041|NCT00451906|1458658|P1|Overall Study|Did not complete final visit|4
439042|NCT00451906|1458658|P1|Overall Study|Other Reasons|121
439043|NCT00451906|1458658|P1|Overall Study|Termination of the study|108
439044|NCT00451906|1458658|P1|Overall Study|Progressive disease|1328
439045|NCT00451906|1458658|P1|Overall Study|Protocol Violation|21
439046|NCT00451906|1458658|P1|Overall Study|Withdrawal by Subject|111
439047|NCT00451906|1458658|P1|Overall Study|Lost to Follow-up|31
439048|NCT00451906|1458658|P1|Overall Study|Adverse Event|515
439049|NCT00451451|1458681|P4|Overall Study|Other Reasons for Not Completing Study|14
439050|NCT00451451|1458682|P3|Overall Study|Other Reasons for Not Completing Study|17
439051|NCT00451451|1458683|P2|Overall Study|Other Reasons for Not Completing Study|30
439052|NCT00451451|1458684|P1|Overall Study|Other Reasons for Not Completing Study|34
439053|NCT00451451|1458681|P4|Overall Study|Death|1
439054|NCT00451451|1458682|P3|Overall Study|Death|0
439055|NCT00451451|1458683|P2|Overall Study|Death|0
439056|NCT00451451|1458684|P1|Overall Study|Death|1
439057|NCT00451451|1458681|P4|Overall Study|Subject Non-Compliance|3
439058|NCT00451451|1458682|P3|Overall Study|Subject Non-Compliance|3
439059|NCT00451451|1458683|P2|Overall Study|Subject Non-Compliance|4
439060|NCT00451451|1458684|P1|Overall Study|Subject Non-Compliance|8
439061|NCT00451451|1458681|P4|Overall Study|Investigator Decision|2
439062|NCT00451451|1458682|P3|Overall Study|Investigator Decision|1
439063|NCT00451451|1458683|P2|Overall Study|Investigator Decision|2
439064|NCT00451451|1458684|P1|Overall Study|Investigator Decision|6
439065|NCT00451451|1458681|P4|Overall Study|Consent Withdrawn|17
439066|NCT00451451|1458682|P3|Overall Study|Consent Withdrawn|17
439067|NCT00451451|1458683|P2|Overall Study|Consent Withdrawn|9
439068|NCT00451451|1458684|P1|Overall Study|Consent Withdrawn|14
439069|NCT00451451|1458681|P4|Overall Study|Lost to Follow-up|11
439070|NCT00451451|1458682|P3|Overall Study|Lost to Follow-up|8
439071|NCT00451451|1458683|P2|Overall Study|Lost to Follow-up|9
439072|NCT00451451|1458684|P1|Overall Study|Lost to Follow-up|11
439073|NCT00451451|1458681|P4|Overall Study|Adverse Event|10
439074|NCT00451451|1458682|P3|Overall Study|Adverse Event|26
439075|NCT00451451|1458683|P2|Overall Study|Adverse Event|21
439076|NCT00451451|1458684|P1|Overall Study|Adverse Event|11
439077|NCT00451321|1458719|P8|Overall Study|Sponsor decision to amend protocol|3
439078|NCT00451321|1458720|P7|Overall Study|Sponsor decision to amend protocol|1
439079|NCT00451321|1458721|P6|Overall Study|Sponsor decision to amend protocol|1
439080|NCT00451321|1458722|P5|Overall Study|Sponsor decision to amend protocol|0
439081|NCT00451321|1458723|P4|Overall Study|Sponsor decision to amend protocol|0
439082|NCT00451321|1458724|P3|Overall Study|Sponsor decision to amend protocol|0
439083|NCT00451321|1458725|P2|Overall Study|Sponsor decision to amend protocol|0
439084|NCT00451321|1458726|P1|Overall Study|Sponsor decision to amend protocol|0
439085|NCT00451321|1458719|P8|Overall Study|Study closed/terminated|3
439086|NCT00451321|1458720|P7|Overall Study|Study closed/terminated|5
439087|NCT00451321|1458721|P6|Overall Study|Study closed/terminated|7
439088|NCT00451321|1458722|P5|Overall Study|Study closed/terminated|7
439089|NCT00451321|1458723|P4|Overall Study|Study closed/terminated|5
439090|NCT00451321|1458724|P3|Overall Study|Study closed/terminated|17
439091|NCT00451321|1458725|P2|Overall Study|Study closed/terminated|1
439092|NCT00451321|1458726|P1|Overall Study|Study closed/terminated|1
439093|NCT00451321|1458719|P8|Overall Study|Withdrawal by Subject|0
439094|NCT00451321|1458720|P7|Overall Study|Withdrawal by Subject|0
439095|NCT00451321|1458721|P6|Overall Study|Withdrawal by Subject|0
439096|NCT00451321|1458722|P5|Overall Study|Withdrawal by Subject|0
439097|NCT00451321|1458723|P4|Overall Study|Withdrawal by Subject|4
439098|NCT00451321|1458724|P3|Overall Study|Withdrawal by Subject|0
439099|NCT00451321|1458725|P2|Overall Study|Withdrawal by Subject|1
439100|NCT00451321|1458726|P1|Overall Study|Withdrawal by Subject|3
439101|NCT00451321|1458719|P8|Overall Study|Lost to Follow-up|0
439102|NCT00451321|1458720|P7|Overall Study|Lost to Follow-up|0
439103|NCT00451321|1458721|P6|Overall Study|Lost to Follow-up|1
439104|NCT00451321|1458722|P5|Overall Study|Lost to Follow-up|0
439105|NCT00451321|1458723|P4|Overall Study|Lost to Follow-up|3
439106|NCT00451321|1458724|P3|Overall Study|Lost to Follow-up|1
439107|NCT00451321|1458725|P2|Overall Study|Lost to Follow-up|3
439108|NCT00451321|1458726|P1|Overall Study|Lost to Follow-up|3
439109|NCT00451282|1458898|P2|Overall Study|Lost to Follow-up|5
439110|NCT00451282|1458899|P1|Overall Study|Lost to Follow-up|6
439111|NCT00451204|1458913|P2|Overall Study|Other|2
439112|NCT00451204|1458914|P1|Overall Study|Other|1
439113|NCT00451204|1458913|P2|Overall Study|Patient refusal|4
439114|NCT00451204|1458914|P1|Overall Study|Patient refusal|8
439115|NCT00451204|1458913|P2|Overall Study|Protocol Violation|0
439116|NCT00451204|1458914|P1|Overall Study|Protocol Violation|1
439117|NCT00451204|1458913|P2|Overall Study|Lost to Follow-up|4
439118|NCT00451204|1458914|P1|Overall Study|Lost to Follow-up|4
439119|NCT00451204|1458913|P2|Overall Study|Lack of Efficacy|4
439120|NCT00451204|1458914|P1|Overall Study|Lack of Efficacy|4
439121|NCT00451204|1458913|P2|Overall Study|Adverse Event|6
439122|NCT00451204|1458914|P1|Overall Study|Adverse Event|4
439123|NCT00451191|1458932|P2|Overall Study|withdrawal or received alternate tx|11
439124|NCT00451191|1458933|P1|Overall Study|withdrawal or received alternate tx|15
439125|NCT00450866|1458955|P2|Overall Study|Physician Decision|0
439126|NCT00450866|1458956|P1|Overall Study|Physician Decision|1
439127|NCT00450866|1458955|P2|Overall Study|Death|0
439128|NCT00450866|1458956|P1|Overall Study|Death|1
439129|NCT00450866|1458955|P2|Overall Study|Withdrawal by Subject|2
439130|NCT00450866|1458956|P1|Overall Study|Withdrawal by Subject|5
439131|NCT00450866|1458955|P2|Overall Study|Adverse Event|1
439132|NCT00450866|1458956|P1|Overall Study|Adverse Event|0
439133|NCT00450801|1458966|P1|Overall Study|Death|1
439134|NCT00450749|1458980|P3|Overall Study|Noncompliant|0
439135|NCT00450749|1458981|P2|Overall Study|Noncompliant|1
439136|NCT00450749|1458982|P1|Overall Study|Noncompliant|0
439137|NCT00450749|1458980|P3|Overall Study|Withdrawal by Subject|2
439138|NCT00450749|1458981|P2|Overall Study|Withdrawal by Subject|0
439139|NCT00450749|1458982|P1|Overall Study|Withdrawal by Subject|0
439140|NCT00450723|1458990|P1|Overall Study|Physician Decision|5
439141|NCT00450658|1458998|P2|Overall Study|misc|10
439142|NCT00450658|1458999|P1|Overall Study|misc|21
439143|NCT00450658|1458998|P2|Overall Study|UGI ulcer|34
439144|NCT00450658|1458999|P1|Overall Study|UGI ulcer|33
439145|NCT00450658|1458998|P2|Overall Study|Lost to Follow-up|5
439146|NCT00450658|1458999|P1|Overall Study|Lost to Follow-up|22
439147|NCT00450658|1458998|P2|Overall Study|Withdrawal by Subject|26
439148|NCT00450658|1458999|P1|Overall Study|Withdrawal by Subject|43
439149|NCT00450658|1458998|P2|Overall Study|Adverse Event|15
439150|NCT00450658|1458999|P1|Overall Study|Adverse Event|24
439151|NCT00450619|1459013|P2|Overall Study|Adverse Event|0
439152|NCT00450619|1459014|P1|Overall Study|Adverse Event|1
439153|NCT00450619|1459013|P2|Overall Study|did not progress; refused further trmt|1
439154|NCT00450619|1459014|P1|Overall Study|did not progress; refused further trmt|1
439155|NCT00450619|1459013|P2|Overall Study|refused treatment after randomization|0
439156|NCT00450619|1459014|P1|Overall Study|refused treatment after randomization|2
439157|NCT00450580|1459040|P2|Overall Study|Withdrawal due to pregnancy|1
439158|NCT00450580|1459041|P1|Overall Study|Withdrawal due to pregnancy|0
439159|NCT00450580|1459040|P2|Overall Study|Patient could not swallow Norvir|0
439160|NCT00450580|1459041|P1|Overall Study|Patient could not swallow Norvir|1
439161|NCT00450580|1459040|P2|Overall Study|Patient went to Brazil|0
439162|NCT00450580|1459041|P1|Overall Study|Patient went to Brazil|1
439163|NCT00450580|1459040|P2|Overall Study|Could not comply with scheduled visits|0
439164|NCT00450580|1459041|P1|Overall Study|Could not comply with scheduled visits|1
439165|NCT00450580|1459040|P2|Overall Study|Protocol-defined virologic failure|0
439166|NCT00450580|1459041|P1|Overall Study|Protocol-defined virologic failure|1
439167|NCT00450580|1459040|P2|Overall Study|Protocol Violation|1
439168|NCT00450580|1459041|P1|Overall Study|Protocol Violation|1
439169|NCT00450580|1459040|P2|Overall Study|Withdrawal by Subject|2
439170|NCT00450580|1459041|P1|Overall Study|Withdrawal by Subject|2
439171|NCT00450580|1459040|P2|Overall Study|Lost to Follow-up|5
439172|NCT00450580|1459041|P1|Overall Study|Lost to Follow-up|4
439173|NCT00450580|1459040|P2|Overall Study|Adverse Event|7
439174|NCT00450580|1459041|P1|Overall Study|Adverse Event|5
439175|NCT00450450|1459061|P2|Overall Study|Missing Data|0
439176|NCT00450450|1459062|P1|Overall Study|Missing Data|2
439177|NCT00450450|1459061|P2|Overall Study|Relapse|0
439178|NCT00450450|1459062|P1|Overall Study|Relapse|2
439179|NCT00450450|1459061|P2|Overall Study|Death|3
439180|NCT00450450|1459062|P1|Overall Study|Death|1
439181|NCT00450437|1459086|P4|Overall Study|Unable to Classify|0
439182|NCT00450437|1459087|P3|Overall Study|Unable to Classify|1
439183|NCT00450437|1459088|P2|Overall Study|Unable to Classify|0
439184|NCT00450437|1459089|P1|Overall Study|Unable to Classify|1
439185|NCT00450437|1459086|P4|Overall Study|Administrative reason|0
439186|NCT00450437|1459087|P3|Overall Study|Administrative reason|1
439187|NCT00450437|1459088|P2|Overall Study|Administrative reason|0
439188|NCT00450437|1459089|P1|Overall Study|Administrative reason|0
439189|NCT00450437|1459086|P4|Overall Study|Inappropriate enrollment|0
439190|NCT00450437|1459087|P3|Overall Study|Inappropriate enrollment|3
439191|NCT00450437|1459088|P2|Overall Study|Inappropriate enrollment|1
439192|NCT00450437|1459089|P1|Overall Study|Inappropriate enrollment|4
439193|NCT00450437|1459086|P4|Overall Study|Protocol Violation|1
439194|NCT00450437|1459087|P3|Overall Study|Protocol Violation|0
439195|NCT00450437|1459088|P2|Overall Study|Protocol Violation|1
439196|NCT00450437|1459089|P1|Overall Study|Protocol Violation|0
439197|NCT00450437|1459086|P4|Overall Study|Lost to Follow-up|9
439198|NCT00450437|1459087|P3|Overall Study|Lost to Follow-up|19
439199|NCT00450437|1459088|P2|Overall Study|Lost to Follow-up|12
439200|NCT00450437|1459089|P1|Overall Study|Lost to Follow-up|31
439201|NCT00450437|1459086|P4|Overall Study|Withdrawal by Subject|1
439202|NCT00450437|1459087|P3|Overall Study|Withdrawal by Subject|0
439203|NCT00450437|1459088|P2|Overall Study|Withdrawal by Subject|2
439204|NCT00450437|1459089|P1|Overall Study|Withdrawal by Subject|10
439205|NCT00450411|1459120|P1|Overall Study|No protocol treatment|2
439206|NCT00450411|1459120|P1|Overall Study|Protocol Violation|6
439207|NCT00450385|1459125|P1|Overall Study|Other|3
439208|NCT00450385|1459125|P1|Overall Study|Physician Decision|1
439209|NCT00450385|1459125|P1|Overall Study|Adverse Event|1
439210|NCT00450385|1459125|P1|Overall Study|Lack of Efficacy|2
439211|NCT00450385|1459125|P1|Overall Study|Withdrawal by Subject|2
439212|NCT00450385|1459125|P1|Overall Study|Protocol Violation|1
439213|NCT00450385|1459125|P1|Overall Study|Death|3
439214|NCT00450372|1459134|P1|Overall Study|Physician Decision|1
439215|NCT00450333|1459147|P4|Overall Study|Death|2
439216|NCT00450333|1459148|P3|Overall Study|Death|2
439217|NCT00450333|1459149|P2|Overall Study|Death|2
439218|NCT00450333|1459150|P1|Overall Study|Death|3
439219|NCT00450333|1459147|P4|Overall Study|Kidney transplant|3
439220|NCT00450333|1459148|P3|Overall Study|Kidney transplant|1
439221|NCT00450333|1459149|P2|Overall Study|Kidney transplant|0
439222|NCT00450333|1459150|P1|Overall Study|Kidney transplant|1
439223|NCT00450333|1459147|P4|Overall Study|Withdrawal by Subject|0
439224|NCT00450333|1459148|P3|Overall Study|Withdrawal by Subject|3
439225|NCT00450333|1459149|P2|Overall Study|Withdrawal by Subject|0
439226|NCT00450333|1459150|P1|Overall Study|Withdrawal by Subject|1
439227|NCT00450333|1459147|P4|Overall Study|Protocol Violation|0
439228|NCT00450333|1459148|P3|Overall Study|Protocol Violation|1
439229|NCT00450333|1459149|P2|Overall Study|Protocol Violation|0
439230|NCT00450333|1459150|P1|Overall Study|Protocol Violation|1
439231|NCT00450333|1459147|P4|Overall Study|Adverse Event|2
439232|NCT00450333|1459148|P3|Overall Study|Adverse Event|2
439233|NCT00450333|1459149|P2|Overall Study|Adverse Event|7
439234|NCT00450333|1459150|P1|Overall Study|Adverse Event|1
439235|NCT00450333|1459147|P4|Overall Study|Study terminated|21
439236|NCT00450333|1459148|P3|Overall Study|Study terminated|16
439237|NCT00450333|1459149|P2|Overall Study|Study terminated|54
439238|NCT00450333|1459150|P1|Overall Study|Study terminated|47
439239|NCT00450255|1459173|P1|Overall Study|Prior RFA ablation of liver|1
439240|NCT00450216|1459198|P2|Overall Study|misc|20
439241|NCT00450216|1459199|P1|Overall Study|misc|21
439242|NCT00450216|1459198|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
439243|NCT00450216|1459199|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
439244|NCT00450216|1459198|P2|Overall Study|Lost to Follow-up|9
439245|NCT00450216|1459199|P1|Overall Study|Lost to Follow-up|16
439246|NCT00450216|1459198|P2|Overall Study|Withdrawal by Subject|26
439247|NCT00450216|1459199|P1|Overall Study|Withdrawal by Subject|48
439248|NCT00450216|1459198|P2|Overall Study|Adverse Event|23
439249|NCT00450216|1459199|P1|Overall Study|Adverse Event|38
439250|NCT00450112|1459213|P2|Overall Study|Others|3
439251|NCT00450112|1459214|P1|Overall Study|Others|2
439252|NCT00450112|1459213|P2|Overall Study|Lost to Follow-up|1
439253|NCT00450112|1459214|P1|Overall Study|Lost to Follow-up|2
439254|NCT00450112|1459213|P2|Overall Study|Withdrawal by Subject|1
439255|NCT00450112|1459214|P1|Overall Study|Withdrawal by Subject|4
439256|NCT00450112|1459213|P2|Overall Study|Other Treatment Required|1
439257|NCT00450112|1459214|P1|Overall Study|Other Treatment Required|5
439258|NCT00449956|1459252|P3|Overall Study|Physician Decision|1
439259|NCT00449956|1459253|P2|Overall Study|Physician Decision|1
439260|NCT00449956|1459254|P1|Overall Study|Physician Decision|2
439261|NCT00449956|1459252|P3|Overall Study|Withdrawal by Subject|0
439262|NCT00449956|1459253|P2|Overall Study|Withdrawal by Subject|1
439263|NCT00449956|1459254|P1|Overall Study|Withdrawal by Subject|0
439264|NCT00449956|1459252|P3|Overall Study|Protocol Violation|1
439265|NCT00449956|1459253|P2|Overall Study|Protocol Violation|1
439266|NCT00449956|1459254|P1|Overall Study|Protocol Violation|1
439267|NCT00449956|1459252|P3|Overall Study|Lack of Efficacy|1
439268|NCT00449956|1459253|P2|Overall Study|Lack of Efficacy|0
439269|NCT00449956|1459254|P1|Overall Study|Lack of Efficacy|0
439270|NCT00449956|1459252|P3|Overall Study|Adverse Event|6
439271|NCT00449956|1459253|P2|Overall Study|Adverse Event|1
439272|NCT00449956|1459254|P1|Overall Study|Adverse Event|7
439273|NCT00449930|1459270|P2|Overall Study|Glycemic discontinuation criteria|1
439274|NCT00449930|1459271|P1|Overall Study|Glycemic discontinuation criteria|1
439275|NCT00449930|1459270|P2|Overall Study|Withdrawal by Subject|23
439276|NCT00449930|1459271|P1|Overall Study|Withdrawal by Subject|16
439277|NCT00449930|1459270|P2|Overall Study|Protocol Violation|15
439278|NCT00449930|1459271|P1|Overall Study|Protocol Violation|14
439279|NCT00449930|1459270|P2|Overall Study|Physician Decision|2
439280|NCT00449930|1459271|P1|Overall Study|Physician Decision|1
439281|NCT00449930|1459270|P2|Overall Study|Lost to Follow-up|14
439282|NCT00449930|1459271|P1|Overall Study|Lost to Follow-up|9
439283|NCT00449930|1459270|P2|Overall Study|Lack of Efficacy|1
439284|NCT00449930|1459271|P1|Overall Study|Lack of Efficacy|10
439285|NCT00449930|1459270|P2|Overall Study|Trial Terminated ( Site Closed)|0
439286|NCT00449930|1459271|P1|Overall Study|Trial Terminated ( Site Closed)|1
439287|NCT00449930|1459270|P2|Overall Study|Adverse Event|19
439288|NCT00449930|1459271|P1|Overall Study|Adverse Event|9
439289|NCT00449865|1459287|P2|Overall Study|Study was stopped|328
439290|NCT00449865|1459288|P1|Overall Study|Study was stopped|324
439291|NCT00449865|1459287|P2|Overall Study|Protocol Violation|7
439292|NCT00449865|1459288|P1|Overall Study|Protocol Violation|8
439293|NCT00449865|1459287|P2|Overall Study|Death|40
439294|NCT00449865|1459288|P1|Overall Study|Death|31
439295|NCT00449865|1459287|P2|Overall Study|Physician Decision|12
439296|NCT00449865|1459288|P1|Overall Study|Physician Decision|13
439297|NCT00449865|1459287|P2|Overall Study|Lost to Follow-up|37
439298|NCT00449865|1459288|P1|Overall Study|Lost to Follow-up|36
439299|NCT00449865|1459287|P2|Overall Study|Withdrawal by Subject|110
439300|NCT00449865|1459288|P1|Overall Study|Withdrawal by Subject|110
439301|NCT00449787|1459296|P2|Overall Study|Did not require medication|92
439302|NCT00449787|1459297|P1|Overall Study|Did not require medication|95
439303|NCT00449787|1459296|P2|Overall Study|Lost to Follow-up|8
439304|NCT00449787|1459297|P1|Overall Study|Lost to Follow-up|10
439305|NCT00449696|1459313|P2|Overall Study|Others|0
439306|NCT00449696|1459314|P1|Overall Study|Others|7
439307|NCT00449696|1459313|P2|Overall Study|Lost to Follow-up|3
439308|NCT00449696|1459314|P1|Overall Study|Lost to Follow-up|2
439309|NCT00449696|1459313|P2|Overall Study|Withdrawal by Subject|5
439310|NCT00449696|1459314|P1|Overall Study|Withdrawal by Subject|5
439311|NCT00449696|1459313|P2|Overall Study|Other Treatment Required|1
439312|NCT00449696|1459314|P1|Overall Study|Other Treatment Required|6
439313|NCT00449644|1459340|P4|Overall Study|Rolled-over to treatment with TMC207|1
439314|NCT00449644|1459341|P3|Overall Study|Rolled-over to treatment with TMC207|0
439315|NCT00449644|1459342|P2|Overall Study|Rolled-over to treatment with TMC207|0
439316|NCT00449644|1459343|P1|Overall Study|Rolled-over to treatment with TMC207|0
439317|NCT00449644|1459340|P4|Overall Study|Not specified|0
439318|NCT00449644|1459341|P3|Overall Study|Not specified|1
439319|NCT00449644|1459342|P2|Overall Study|Not specified|4
439320|NCT00449644|1459343|P1|Overall Study|Not specified|1
439321|NCT00449644|1459340|P4|Overall Study|Inclusion/exclusion criteria not met|6
439322|NCT00449644|1459341|P3|Overall Study|Inclusion/exclusion criteria not met|2
439323|NCT00449644|1459342|P2|Overall Study|Inclusion/exclusion criteria not met|0
439324|NCT00449644|1459343|P1|Overall Study|Inclusion/exclusion criteria not met|0
439325|NCT00449644|1459340|P4|Overall Study|Withdrawal by Subject|7
439326|NCT00449644|1459341|P3|Overall Study|Withdrawal by Subject|6
439327|NCT00449644|1459342|P2|Overall Study|Withdrawal by Subject|4
439328|NCT00449644|1459343|P1|Overall Study|Withdrawal by Subject|3
439329|NCT00449644|1459340|P4|Overall Study|Protocol Violation|7
439330|NCT00449644|1459341|P3|Overall Study|Protocol Violation|3
439331|NCT00449644|1459342|P2|Overall Study|Protocol Violation|4
439332|NCT00449644|1459343|P1|Overall Study|Protocol Violation|4
439333|NCT00449644|1459340|P4|Overall Study|Pregnancy|2
439334|NCT00449644|1459341|P3|Overall Study|Pregnancy|3
439335|NCT00449644|1459342|P2|Overall Study|Pregnancy|0
439336|NCT00449644|1459343|P1|Overall Study|Pregnancy|0
439337|NCT00449644|1459340|P4|Overall Study|Lost to Follow-up|3
439338|NCT00449644|1459341|P3|Overall Study|Lost to Follow-up|5
439339|NCT00449644|1459342|P2|Overall Study|Lost to Follow-up|1
439340|NCT00449644|1459343|P1|Overall Study|Lost to Follow-up|1
439341|NCT00449644|1459340|P4|Overall Study|Death|1
439342|NCT00449644|1459341|P3|Overall Study|Death|6
439343|NCT00449644|1459342|P2|Overall Study|Death|0
439344|NCT00449644|1459343|P1|Overall Study|Death|1
439345|NCT00449644|1459340|P4|Overall Study|Adverse Event|5
439346|NCT00449644|1459341|P3|Overall Study|Adverse Event|3
439347|NCT00449644|1459342|P2|Overall Study|Adverse Event|0
439348|NCT00449644|1459343|P1|Overall Study|Adverse Event|0
439349|NCT00449540|1459363|P3|Treatment Phase|did not experience or treat migraine|17
439350|NCT00449540|1459364|P2|Treatment Phase|did not experience or treat migraine|20
439351|NCT00449540|1459365|P1|Treatment Phase|did not experience or treat migraine|0
439352|NCT00449540|1459363|P3|Pretreatment Phase|No migraine experienced|0
439353|NCT00449540|1459364|P2|Pretreatment Phase|No migraine experienced|0
439354|NCT00449540|1459365|P1|Pretreatment Phase|No migraine experienced|66
439355|NCT00449176|1459382|P3|Overall Study|all other|20
439356|NCT00449176|1459383|P2|Overall Study|all other|19
439357|NCT00449176|1459384|P1|Overall Study|all other|22
439358|NCT00449176|1459382|P3|Overall Study|Study drug non-compliant|11
439359|NCT00449176|1459383|P2|Overall Study|Study drug non-compliant|11
439360|NCT00449176|1459384|P1|Overall Study|Study drug non-compliant|14
439361|NCT00449176|1459382|P3|Overall Study|Lack of Efficacy|50
439362|NCT00449176|1459383|P2|Overall Study|Lack of Efficacy|7
439363|NCT00449176|1459384|P1|Overall Study|Lack of Efficacy|13
439364|NCT00449176|1459382|P3|Overall Study|Adverse Event|15
439365|NCT00449176|1459383|P2|Overall Study|Adverse Event|107
439366|NCT00449176|1459384|P1|Overall Study|Adverse Event|51
439367|NCT00449176|1459382|P3|Overall Study|Lost to Follow-up|12
439368|NCT00449176|1459383|P2|Overall Study|Lost to Follow-up|8
439369|NCT00449176|1459384|P1|Overall Study|Lost to Follow-up|13
439370|NCT00449176|1459382|P3|Overall Study|Withdrawal by Subject|59
439371|NCT00449176|1459383|P2|Overall Study|Withdrawal by Subject|43
439372|NCT00449176|1459384|P1|Overall Study|Withdrawal by Subject|39
439373|NCT00449163|1459410|P1|Overall Study|Physician Decision|3
439374|NCT00449150|1459420|P3|Overall Study|Protocol Violation|1
439375|NCT00449150|1459421|P2|Overall Study|Protocol Violation|2
439376|NCT00449150|1459422|P1|Overall Study|Protocol Violation|1
439377|NCT00449150|1459420|P3|Overall Study|Withdrawal by Subject|21
439378|NCT00449150|1459421|P2|Overall Study|Withdrawal by Subject|18
439379|NCT00449150|1459422|P1|Overall Study|Withdrawal by Subject|17
439380|NCT00449150|1459420|P3|Overall Study|Not specified|14
439381|NCT00449150|1459421|P2|Overall Study|Not specified|13
439382|NCT00449150|1459422|P1|Overall Study|Not specified|16
439383|NCT00449150|1459420|P3|Overall Study|Lack of Efficacy|2
439384|NCT00449150|1459421|P2|Overall Study|Lack of Efficacy|2
439385|NCT00449150|1459422|P1|Overall Study|Lack of Efficacy|1
439386|NCT00449150|1459420|P3|Overall Study|Adverse Event|9
439387|NCT00449150|1459421|P2|Overall Study|Adverse Event|18
439388|NCT00449150|1459422|P1|Overall Study|Adverse Event|11
439389|NCT00449072|1459432|P2|Overall Study|Relocation|2
439390|NCT00449072|1459433|P1|Overall Study|Relocation|3
439391|NCT00449072|1459432|P2|Overall Study|Sponsor decision|3
439392|NCT00449072|1459433|P1|Overall Study|Sponsor decision|1
439393|NCT00449072|1459432|P2|Overall Study|Non-compliance|5
439394|NCT00449072|1459433|P1|Overall Study|Non-compliance|2
439395|NCT00449072|1459432|P2|Overall Study|Excluded medication|2
439396|NCT00449072|1459433|P1|Overall Study|Excluded medication|0
439397|NCT00449072|1459432|P2|Overall Study|Not treated|1
439398|NCT00449072|1459433|P1|Overall Study|Not treated|0
439399|NCT00449072|1459432|P2|Overall Study|Physician Decision|0
439400|NCT00449072|1459433|P1|Overall Study|Physician Decision|1
439401|NCT00449072|1459432|P2|Overall Study|Lack of Efficacy|1
439402|NCT00449072|1459433|P1|Overall Study|Lack of Efficacy|1
439403|NCT00449072|1459432|P2|Overall Study|Withdrawal by Subject|8
439404|NCT00449072|1459433|P1|Overall Study|Withdrawal by Subject|11
439405|NCT00449072|1459432|P2|Overall Study|Lost to Follow-up|7
439406|NCT00449072|1459433|P1|Overall Study|Lost to Follow-up|5
439407|NCT00449072|1459432|P2|Overall Study|Protocol Violation|12
439408|NCT00449072|1459433|P1|Overall Study|Protocol Violation|14
439409|NCT00449072|1459432|P2|Overall Study|Adverse Event|1
439410|NCT00449072|1459433|P1|Overall Study|Adverse Event|3
439411|NCT00449033|1459470|P2|Follow-up Period|Reason Missing|113
439412|NCT00449033|1459471|P1|Follow-up Period|Reason Missing|120
439413|NCT00449033|1459470|P2|Follow-up Period|Lost to Follow-up|10
439414|NCT00449033|1459471|P1|Follow-up Period|Lost to Follow-up|6
439415|NCT00449033|1459470|P2|Follow-up Period|Death|311
439416|NCT00449033|1459471|P1|Follow-up Period|Death|299
439417|NCT00449033|1459470|P2|Treatment Period|Treatment Ongoing|4
439418|NCT00449033|1459471|P1|Treatment Period|Treatment Ongoing|6
439419|NCT00449033|1459470|P2|Treatment Period|Reason Missing|4
439420|NCT00449033|1459471|P1|Treatment Period|Reason Missing|0
439421|NCT00449033|1459470|P2|Treatment Period|Second Malignancy|1
439422|NCT00449033|1459471|P1|Treatment Period|Second Malignancy|0
439423|NCT00449033|1459470|P2|Treatment Period|Non-compliance|8
439424|NCT00449033|1459471|P1|Treatment Period|Non-compliance|7
439425|NCT00449033|1459470|P2|Treatment Period|Amended Protocol Criteria|18
439426|NCT00449033|1459471|P1|Treatment Period|Amended Protocol Criteria|22
439427|NCT00449033|1459470|P2|Treatment Period|Consent Withdrawn|20
439428|NCT00449033|1459471|P1|Treatment Period|Consent Withdrawn|36
439429|NCT00449033|1459470|P2|Treatment Period|Disease Progression|288
439430|NCT00449033|1459471|P1|Treatment Period|Disease Progression|231
439431|NCT00449033|1459470|P2|Treatment Period|Protocol Violation|7
439432|NCT00449033|1459471|P1|Treatment Period|Protocol Violation|8
439433|NCT00449033|1459470|P2|Treatment Period|Physician Decision|5
439434|NCT00449033|1459471|P1|Treatment Period|Physician Decision|4
439435|NCT00449033|1459470|P2|Treatment Period|Lost to Follow-up|2
439436|NCT00449033|1459471|P1|Treatment Period|Lost to Follow-up|0
439437|NCT00449033|1459470|P2|Treatment Period|Death|12
439438|NCT00449033|1459471|P1|Treatment Period|Death|21
439439|NCT00449033|1459470|P2|Treatment Period|Adverse Event|83
439440|NCT00449033|1459471|P1|Treatment Period|Adverse Event|117
439441|NCT00448916|1459509|P4|Overall Study|Protocol Violation|1
439442|NCT00448916|1459510|P3|Overall Study|Protocol Violation|0
439443|NCT00448916|1459511|P2|Overall Study|Protocol Violation|0
439444|NCT00448916|1459512|P1|Overall Study|Protocol Violation|0
439445|NCT00448916|1459509|P4|Overall Study|Lost to Follow-up|1
439446|NCT00448916|1459510|P3|Overall Study|Lost to Follow-up|0
439447|NCT00448916|1459511|P2|Overall Study|Lost to Follow-up|1
439448|NCT00448916|1459512|P1|Overall Study|Lost to Follow-up|0
439449|NCT00448916|1459509|P4|Overall Study|Not specified|0
439450|NCT00448916|1459510|P3|Overall Study|Not specified|0
439451|NCT00448916|1459511|P2|Overall Study|Not specified|0
439452|NCT00448916|1459512|P1|Overall Study|Not specified|1
439453|NCT00448916|1459509|P4|Overall Study|Withdrawal by Subject|1
439454|NCT00448916|1459510|P3|Overall Study|Withdrawal by Subject|1
439455|NCT00448916|1459511|P2|Overall Study|Withdrawal by Subject|3
439456|NCT00448916|1459512|P1|Overall Study|Withdrawal by Subject|3
439457|NCT00448916|1459509|P4|Overall Study|Lack of Efficacy|1
439458|NCT00448916|1459510|P3|Overall Study|Lack of Efficacy|2
439459|NCT00448916|1459511|P2|Overall Study|Lack of Efficacy|0
439460|NCT00448916|1459512|P1|Overall Study|Lack of Efficacy|1
439461|NCT00448916|1459509|P4|Overall Study|Adverse Event|2
439462|NCT00448916|1459510|P3|Overall Study|Adverse Event|3
439463|NCT00448916|1459511|P2|Overall Study|Adverse Event|2
439464|NCT00448916|1459512|P1|Overall Study|Adverse Event|2
439465|NCT00448864|1459586|P3|Overall Study|Protocol Violation|0
439466|NCT00448864|1459587|P2|Overall Study|Protocol Violation|2
439467|NCT00448864|1459588|P1|Overall Study|Protocol Violation|0
439468|NCT00448864|1459586|P3|Overall Study|Withdrawal by Subject|0
439469|NCT00448864|1459587|P2|Overall Study|Withdrawal by Subject|2
439470|NCT00448864|1459588|P1|Overall Study|Withdrawal by Subject|0
439471|NCT00448864|1459586|P3|Overall Study|Physician Decision|1
439472|NCT00448864|1459587|P2|Overall Study|Physician Decision|0
439473|NCT00448864|1459588|P1|Overall Study|Physician Decision|1
439474|NCT00448864|1459586|P3|Overall Study|Lost to Follow-up|0
439475|NCT00448864|1459587|P2|Overall Study|Lost to Follow-up|1
439476|NCT00448864|1459588|P1|Overall Study|Lost to Follow-up|3
439477|NCT00448864|1459586|P3|Overall Study|Death|0
439478|NCT00448864|1459587|P2|Overall Study|Death|0
439479|NCT00448864|1459588|P1|Overall Study|Death|1
439480|NCT00448760|1459604|P1|Overall Study|Death|3
439481|NCT00448708|1459613|P2|Overall Study|not listed|2
439482|NCT00448708|1459614|P1|Overall Study|not listed|0
439483|NCT00448708|1459613|P2|Overall Study|Lost to Follow-up|8
439484|NCT00448708|1459614|P1|Overall Study|Lost to Follow-up|6
439485|NCT00448708|1459613|P2|Overall Study|Withdrawal by Subject|4
439486|NCT00448708|1459614|P1|Overall Study|Withdrawal by Subject|8
439487|NCT00448708|1459613|P2|Overall Study|Death|17
439488|NCT00448708|1459614|P1|Overall Study|Death|21
439489|NCT00448591|1459673|P1|Overall Study|Termination of Study|70
439490|NCT00448591|1459673|P1|Overall Study|Not specified|154
439491|NCT00448591|1459673|P1|Overall Study|Treatment Regimen Completed|70
439492|NCT00448591|1459673|P1|Overall Study|Lost to Follow-up|19
439493|NCT00448591|1459673|P1|Overall Study|Protocol Violation|41
439494|NCT00448591|1459673|P1|Overall Study|Adverse Event|382
439495|NCT00448591|1459673|P1|Overall Study|Progressive Disease|1382
439496|NCT00448591|1459673|P1|Overall Study|Withdrawal by Subject|178
439497|NCT00448539|1459684|P2|Overall Study|Lost to Follow-up|3
439498|NCT00448539|1459685|P1|Overall Study|Lost to Follow-up|1
439499|NCT00448539|1459684|P2|Overall Study|Change of meds|3
439500|NCT00448539|1459685|P1|Overall Study|Change of meds|2
439501|NCT00448539|1459684|P2|Overall Study|Miscellaneous|1
439502|NCT00448539|1459685|P1|Overall Study|Miscellaneous|2
439503|NCT00448539|1459684|P2|Overall Study|Lack of Efficacy|40
439504|NCT00448539|1459685|P1|Overall Study|Lack of Efficacy|27
439505|NCT00448539|1459684|P2|Overall Study|Adverse Event|26
439506|NCT00448539|1459685|P1|Overall Study|Adverse Event|9
439507|NCT00448539|1459684|P2|Overall Study|Diary non-compliance|0
439508|NCT00448539|1459685|P1|Overall Study|Diary non-compliance|1
439509|NCT00448539|1459684|P2|Overall Study|Withdrawal by Subject|24
439510|NCT00448539|1459685|P1|Overall Study|Withdrawal by Subject|20
439511|NCT00448539|1459684|P2|Overall Study|Request of the investigator or sponsor|54
439512|NCT00448539|1459685|P1|Overall Study|Request of the investigator or sponsor|67
439513|NCT00448539|1459684|P2|Overall Study|Protocol Violation|0
439514|NCT00448539|1459685|P1|Overall Study|Protocol Violation|1
439515|NCT00448539|1459684|P2|Overall Study|Medication non-compliance|1
439516|NCT00448539|1459685|P1|Overall Study|Medication non-compliance|4
439517|NCT00448448|1459693|P2|Overall Study|Signed consent lost|1
439518|NCT00448448|1459694|P1|Overall Study|Signed consent lost|0
439519|NCT00448448|1459693|P2|Overall Study|Wrong diagnosis (n=3) or other|1
439520|NCT00448448|1459694|P1|Overall Study|Wrong diagnosis (n=3) or other|2
439521|NCT00448448|1459693|P2|Overall Study|Lost to Follow-up|1
439522|NCT00448448|1459694|P1|Overall Study|Lost to Follow-up|2
439523|NCT00448448|1459693|P2|Overall Study|On protocol when study ended|36
439524|NCT00448448|1459694|P1|Overall Study|On protocol when study ended|83
439525|NCT00448448|1459693|P2|Overall Study|Withdrawal by Subject|2
439526|NCT00448448|1459694|P1|Overall Study|Withdrawal by Subject|13
439527|NCT00448435|1459700|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
439528|NCT00448435|1459701|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
439529|NCT00448344|1459752|P2|Overall Study|Physician Decision|2
439530|NCT00448344|1459753|P1|Overall Study|Physician Decision|1
439531|NCT00448344|1459752|P2|Overall Study|Death|4
439532|NCT00448344|1459753|P1|Overall Study|Death|3
439533|NCT00448344|1459752|P2|Overall Study|Withdrawal by Subject|8
439534|NCT00448344|1459753|P1|Overall Study|Withdrawal by Subject|6
439535|NCT00448344|1459752|P2|Overall Study|Lost to Follow-up|22
439536|NCT00448344|1459753|P1|Overall Study|Lost to Follow-up|20
439537|NCT00448279|1459763|P2|Overall Study|Protocol Violation|1
439538|NCT00448279|1459764|P1|Overall Study|Protocol Violation|0
439539|NCT00448279|1459763|P2|Overall Study|Not specified|4
439540|NCT00448279|1459764|P1|Overall Study|Not specified|6
439541|NCT00448279|1459763|P2|Overall Study|Withdrawal by Subject|3
439542|NCT00448279|1459764|P1|Overall Study|Withdrawal by Subject|4
439543|NCT00448279|1459763|P2|Overall Study|Disease progression|18
439544|NCT00448279|1459764|P1|Overall Study|Disease progression|16
439545|NCT00448279|1459763|P2|Overall Study|Adverse Event|1
439546|NCT00448279|1459764|P1|Overall Study|Adverse Event|1
439547|NCT00448279|1459763|P2|Overall Study|Lost to Follow-up|2
439548|NCT00448279|1459764|P1|Overall Study|Lost to Follow-up|2
439549|NCT00448136|1459827|P2|Overall Study|Investigator's decision (progression)|0
439550|NCT00448136|1459828|P1|Overall Study|Investigator's decision (progression)|1
439551|NCT00448136|1459827|P2|Overall Study|Death|8
439552|NCT00448136|1459828|P1|Overall Study|Death|3
439553|NCT00448123|1459866|P2|Overall Study|Physician Decision|6
439554|NCT00448123|1459867|P1|Overall Study|Physician Decision|6
439555|NCT00448123|1459866|P2|Overall Study|Lost to Follow-up|6
439556|NCT00448123|1459867|P1|Overall Study|Lost to Follow-up|9
439557|NCT00448019|1459877|P1|Overall Study|Insurance Issues|1
439558|NCT00448019|1459877|P1|Overall Study|Death|2
439559|NCT00448019|1459877|P1|Overall Study|Disease progression|1
439560|NCT00448019|1459877|P1|Overall Study|Withdrawal by Subject|3
439561|NCT00447902|1459885|P2|Overall Study|Lack of Efficacy|1
439562|NCT00447902|1459886|P1|Overall Study|Lack of Efficacy|2
439563|NCT00447902|1459885|P2|Overall Study|included patients who discontinued|1
439564|NCT00447902|1459886|P1|Overall Study|included patients who discontinued|1
439565|NCT00447902|1459885|P2|Overall Study|Withdrawal by Subject|1
439566|NCT00447902|1459886|P1|Overall Study|Withdrawal by Subject|0
439567|NCT00447902|1459885|P2|Overall Study|Protocol Violation|0
439568|NCT00447902|1459886|P1|Overall Study|Protocol Violation|1
439569|NCT00447902|1459885|P2|Overall Study|Adverse Event|3
439570|NCT00447902|1459886|P1|Overall Study|Adverse Event|0
439571|NCT00447876|1459928|P2|Overall Study|Deterioration of symptomology|0
439572|NCT00447876|1459929|P1|Overall Study|Deterioration of symptomology|1
439573|NCT00447876|1459928|P2|Overall Study|Lost to Follow-up|0
439574|NCT00447876|1459929|P1|Overall Study|Lost to Follow-up|1
439575|NCT00447876|1459928|P2|Overall Study|Withdrawal by Subject|4
439576|NCT00447876|1459929|P1|Overall Study|Withdrawal by Subject|1
439577|NCT00447603|1459959|P3|Filter Period|Study terminated by Sponsor|10
439578|NCT00447603|1459960|P2|Filter Period|Study terminated by Sponsor|1
439579|NCT00447603|1459961|P1|Filter Period|Study terminated by Sponsor|0
439580|NCT00447603|1459959|P3|Filter Period|Screen Failure|4
439581|NCT00447603|1459960|P2|Filter Period|Screen Failure|3
439582|NCT00447603|1459961|P1|Filter Period|Screen Failure|0
439583|NCT00447603|1459959|P3|Filter Period|Adverse Event|1
439584|NCT00447603|1459960|P2|Filter Period|Adverse Event|0
439585|NCT00447603|1459961|P1|Filter Period|Adverse Event|0
439586|NCT00447603|1459959|P3|Screening|Study Terminated by Sponsor|0
439587|NCT00447603|1459960|P2|Screening|Study Terminated by Sponsor|0
439588|NCT00447603|1459961|P1|Screening|Study Terminated by Sponsor|15
439589|NCT00447603|1459959|P3|Screening|Screen Failure|0
439590|NCT00447603|1459960|P2|Screening|Screen Failure|0
439591|NCT00447603|1459961|P1|Screening|Screen Failure|4
439592|NCT00447603|1459959|P3|Screening|Protocol Violation|0
439593|NCT00447603|1459960|P2|Screening|Protocol Violation|0
439594|NCT00447603|1459961|P1|Screening|Protocol Violation|1
439595|NCT00447603|1459959|P3|Screening|Withdrawal by Subject|0
439596|NCT00447603|1459960|P2|Screening|Withdrawal by Subject|0
439597|NCT00447603|1459961|P1|Screening|Withdrawal by Subject|1
439598|NCT00447590|1459981|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
439599|NCT00447590|1459981|P1|Overall Study|Lost to Follow-up|24
439600|NCT00447590|1459981|P1|Overall Study|Withdrawal by Subject|26
439601|NCT00447499|1459990|P1|Overall Study|Physician Decision|1
439602|NCT00447499|1459990|P1|Overall Study|Sponsor Decision|1
439603|NCT00447499|1459990|P1|Overall Study|Patient Decision|4
439604|NCT00447499|1459990|P1|Overall Study|Adverse Event|1
439605|NCT00447421|1460000|P1|Overall Study|Sponsor Decision|2
439606|NCT00447421|1460000|P1|Overall Study|Adverse Event|3
439607|NCT00447421|1460000|P1|Overall Study|Lack of Efficacy|1
439608|NCT00447382|1460012|P2|Overall Study|Unclassified|5
439609|NCT00447382|1460013|P1|Overall Study|Unclassified|2
439610|NCT00447382|1460012|P2|Overall Study|Protocol Violation|0
439611|NCT00447382|1460013|P1|Overall Study|Protocol Violation|2
439612|NCT00447382|1460012|P2|Overall Study|Lack of Efficacy|0
439613|NCT00447382|1460013|P1|Overall Study|Lack of Efficacy|1
439614|NCT00447382|1460012|P2|Overall Study|Adverse Event|1
439615|NCT00447382|1460013|P1|Overall Study|Adverse Event|1
439616|NCT00447278|1460074|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
439617|NCT00447278|1460075|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
439618|NCT00447278|1460074|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
439619|NCT00447278|1460075|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
439620|NCT00447278|1460074|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
439621|NCT00447278|1460075|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
439622|NCT00447278|1460074|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
439623|NCT00447278|1460075|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
439624|NCT00447278|1460074|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
439625|NCT00447278|1460075|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
439626|NCT00447278|1460074|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
439627|NCT00447278|1460075|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
439628|NCT00447278|1460074|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
439629|NCT00447278|1460075|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
439630|NCT00447278|1460074|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
439631|NCT00447278|1460075|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
439632|NCT00447278|1460074|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
439633|NCT00447278|1460075|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
439634|NCT00447278|1460074|P2|Period II (6 Month Open-Label)|Physician Decision|1
439635|NCT00447278|1460075|P1|Period II (6 Month Open-Label)|Physician Decision|4
439636|NCT00447278|1460074|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
439637|NCT00447278|1460075|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
439638|NCT00447278|1460074|P2|Period II (6 Month Open-Label)|Protocol Violation|7
439639|NCT00447278|1460075|P1|Period II (6 Month Open-Label)|Protocol Violation|10
439640|NCT00447278|1460074|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
439641|NCT00447278|1460075|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
439642|NCT00447278|1460074|P2|Period II (6 Month Open-Label)|Adverse Event|3
439643|NCT00447278|1460075|P1|Period II (6 Month Open-Label)|Adverse Event|7
439644|NCT00447265|1460096|P2|Overall Study|Physician Decision|0
439645|NCT00447265|1460097|P1|Overall Study|Physician Decision|1
439646|NCT00447226|1460110|P2|Double-blind Phase|Disease Progression|3
439647|NCT00447226|1460111|P1|Double-blind Phase|Disease Progression|4
439648|NCT00447226|1460110|P2|12-Week Open-label Phase|Physician Decision|1
439649|NCT00447226|1460111|P1|12-Week Open-label Phase|Physician Decision|0
439650|NCT00447226|1460110|P2|12-Week Open-label Phase|Disease Progression|20
439651|NCT00447226|1460111|P1|12-Week Open-label Phase|Disease Progression|0
439652|NCT00447226|1460110|P2|12-Week Open-label Phase|Protocol Violation|1
439653|NCT00447226|1460111|P1|12-Week Open-label Phase|Protocol Violation|0
439654|NCT00447226|1460110|P2|12-Week Open-label Phase|Adverse Event|3
439655|NCT00447226|1460111|P1|12-Week Open-label Phase|Adverse Event|0
439656|NCT00447057|1460137|P4|Overall Study|Death, study drug related|0
439657|NCT00447057|1460138|P3|Overall Study|Death, study drug related|0
439658|NCT00447057|1460139|P2|Overall Study|Death, study drug related|1
439659|NCT00447057|1460140|P1|Overall Study|Death, study drug related|0
439660|NCT00447057|1460137|P4|Overall Study|Death due to adverse event|2
439661|NCT00447057|1460138|P3|Overall Study|Death due to adverse event|1
439662|NCT00447057|1460139|P2|Overall Study|Death due to adverse event|0
439663|NCT00447057|1460140|P1|Overall Study|Death due to adverse event|0
439664|NCT00447057|1460137|P4|Overall Study|Progressive disease|18
439665|NCT00447057|1460138|P3|Overall Study|Progressive disease|13
439666|NCT00447057|1460139|P2|Overall Study|Progressive disease|43
439667|NCT00447057|1460140|P1|Overall Study|Progressive disease|58
439668|NCT00447057|1460137|P4|Overall Study|Sponsor decision|0
439669|NCT00447057|1460138|P3|Overall Study|Sponsor decision|0
439670|NCT00447057|1460139|P2|Overall Study|Sponsor decision|1
439671|NCT00447057|1460140|P1|Overall Study|Sponsor decision|1
439672|NCT00447057|1460137|P4|Overall Study|Physician Decision|1
439673|NCT00447057|1460138|P3|Overall Study|Physician Decision|3
439674|NCT00447057|1460139|P2|Overall Study|Physician Decision|6
439675|NCT00447057|1460140|P1|Overall Study|Physician Decision|9
439676|NCT00447057|1460137|P4|Overall Study|Withdrawal by Subject|1
439677|NCT00447057|1460138|P3|Overall Study|Withdrawal by Subject|1
439678|NCT00447057|1460139|P2|Overall Study|Withdrawal by Subject|5
439679|NCT00447057|1460140|P1|Overall Study|Withdrawal by Subject|4
439680|NCT00447057|1460137|P4|Overall Study|Protocol Violation|0
439681|NCT00447057|1460138|P3|Overall Study|Protocol Violation|0
439682|NCT00447057|1460139|P2|Overall Study|Protocol Violation|1
439683|NCT00447057|1460140|P1|Overall Study|Protocol Violation|0
439684|NCT00447057|1460137|P4|Overall Study|Entry criteria not met|0
439685|NCT00447057|1460138|P3|Overall Study|Entry criteria not met|0
439686|NCT00447057|1460139|P2|Overall Study|Entry criteria not met|1
439687|NCT00447057|1460140|P1|Overall Study|Entry criteria not met|1
439688|NCT00447057|1460137|P4|Overall Study|Lost to Follow-up|0
439689|NCT00447057|1460138|P3|Overall Study|Lost to Follow-up|0
439690|NCT00447057|1460139|P2|Overall Study|Lost to Follow-up|1
439691|NCT00447057|1460140|P1|Overall Study|Lost to Follow-up|0
439692|NCT00447057|1460137|P4|Overall Study|Death due to study disease|1
439693|NCT00447057|1460138|P3|Overall Study|Death due to study disease|1
439694|NCT00447057|1460139|P2|Overall Study|Death due to study disease|4
439695|NCT00447057|1460140|P1|Overall Study|Death due to study disease|6
439696|NCT00447057|1460137|P4|Overall Study|Adverse Event|3
439697|NCT00447057|1460138|P3|Overall Study|Adverse Event|0
439698|NCT00447057|1460139|P2|Overall Study|Adverse Event|10
439699|NCT00447057|1460140|P1|Overall Study|Adverse Event|4
439700|NCT00447005|1460158|P1|Overall Study|Lack of Efficacy|11
439701|NCT00447005|1460158|P1|Overall Study|Adverse Event|1
439702|NCT00446992|1460172|P1|Overall Study|Lost to Follow-up|5
439703|NCT00446992|1460172|P1|Overall Study|Adverse Event|11
439704|NCT00446849|1460184|P1|Maintenance Phase|concomitant medication use|1
439705|NCT00446849|1460184|P1|Maintenance Phase|hydrocodone use|1
439706|NCT00446849|1460184|P1|Maintenance Phase|study closure|1
439707|NCT00446849|1460184|P1|Maintenance Phase|antibiotic use|1
439708|NCT00446849|1460184|P1|Maintenance Phase|prohibited medication use|2
439709|NCT00446849|1460184|P1|Maintenance Phase|noncompliance|2
439710|NCT00446849|1460184|P1|Maintenance Phase|Pregnancy|1
439711|NCT00446849|1460184|P1|Maintenance Phase|Lost to Follow-up|3
439712|NCT00446849|1460184|P1|Maintenance Phase|Consent withdrawn|5
439713|NCT00446849|1460184|P1|Maintenance Phase|Adverse Event|6
439714|NCT00446849|1460184|P1|Maintenance Phase|Protocol Violation|7
439715|NCT00446849|1460184|P1|Maintenance Phase|Lack of Efficacy|40
439716|NCT00446849|1460184|P1|Acute Phase|noncompliance|1
439717|NCT00446849|1460184|P1|Acute Phase|Physician Decision|1
439718|NCT00446849|1460184|P1|Acute Phase|Lost to Follow-up|2
439719|NCT00446849|1460184|P1|Acute Phase|Consent withdrawn|4
439720|NCT00446849|1460184|P1|Acute Phase|Protocol Violation|10
439721|NCT00446849|1460184|P1|Acute Phase|Lack of Efficacy|64
439722|NCT00446797|1460196|P2|Overall Study|did not meet entrance criteria|1
439723|NCT00446797|1460197|P1|Overall Study|did not meet entrance criteria|0
439724|NCT00446797|1460196|P2|Overall Study|subject entered at another site|1
439725|NCT00446797|1460197|P1|Overall Study|subject entered at another site|0
439726|NCT00446797|1460196|P2|Overall Study|Protocol Violation|3
439727|NCT00446797|1460197|P1|Overall Study|Protocol Violation|1
439728|NCT00446797|1460196|P2|Overall Study|Withdrawal by Subject|2
439729|NCT00446797|1460197|P1|Overall Study|Withdrawal by Subject|2
439730|NCT00446797|1460196|P2|Overall Study|Lost to Follow-up|3
439731|NCT00446797|1460197|P1|Overall Study|Lost to Follow-up|5
439732|NCT00446797|1460196|P2|Overall Study|Lack of Efficacy|2
439733|NCT00446797|1460197|P1|Overall Study|Lack of Efficacy|0
439734|NCT00446654|1460243|P2|Overall Study|Adverse Event|0
439735|NCT00446654|1460244|P1|Overall Study|Adverse Event|1
439736|NCT00446654|1460243|P2|Overall Study|Withdrawal by Subject|0
439737|NCT00446654|1460244|P1|Overall Study|Withdrawal by Subject|1
439738|NCT00446641|1460252|P2|Overall Study|Lost to Follow-up|1
439739|NCT00446641|1460253|P1|Overall Study|Lost to Follow-up|1
439740|NCT00446641|1460252|P2|Overall Study|poor compliance|6
439741|NCT00446641|1460253|P1|Overall Study|poor compliance|8
439742|NCT00446641|1460252|P2|Overall Study|Withdrawal by Subject|3
439743|NCT00446641|1460253|P1|Overall Study|Withdrawal by Subject|8
439744|NCT00446563|1460273|P2|Overall Study|Administrative problems|1
439745|NCT00446563|1460274|P1|Overall Study|Administrative problems|0
439746|NCT00446563|1460273|P2|Overall Study|Withdrawal by Subject|1
439747|NCT00446563|1460274|P1|Overall Study|Withdrawal by Subject|2
439748|NCT00446563|1460273|P2|Overall Study|Unsatisfactory therapeutic effect|3
439749|NCT00446563|1460274|P1|Overall Study|Unsatisfactory therapeutic effect|0
439750|NCT00446563|1460273|P2|Overall Study|Abnormal test procedure result(s)|0
439751|NCT00446563|1460274|P1|Overall Study|Abnormal test procedure result(s)|1
439752|NCT00446563|1460273|P2|Overall Study|Abnormal laboratory value(s)|1
439753|NCT00446563|1460274|P1|Overall Study|Abnormal laboratory value(s)|0
439754|NCT00446563|1460273|P2|Overall Study|Adverse Event|3
439755|NCT00446563|1460274|P1|Overall Study|Adverse Event|4
439756|NCT00446511|1460312|P4|Overall Study|Administrative Problems|1
439757|NCT00446511|1460313|P3|Overall Study|Administrative Problems|4
439758|NCT00446511|1460314|P2|Overall Study|Administrative Problems|0
439759|NCT00446511|1460315|P1|Overall Study|Administrative Problems|3
439760|NCT00446511|1460312|P4|Overall Study|Withdrawal by Subject|3
439761|NCT00446511|1460313|P3|Overall Study|Withdrawal by Subject|0
439762|NCT00446511|1460314|P2|Overall Study|Withdrawal by Subject|0
439763|NCT00446511|1460315|P1|Overall Study|Withdrawal by Subject|0
439764|NCT00446511|1460312|P4|Overall Study|Protocol Violation|1
439765|NCT00446511|1460313|P3|Overall Study|Protocol Violation|0
439766|NCT00446511|1460314|P2|Overall Study|Protocol Violation|0
439767|NCT00446511|1460315|P1|Overall Study|Protocol Violation|0
439768|NCT00446511|1460312|P4|Overall Study|Adverse Event|1
439769|NCT00446511|1460313|P3|Overall Study|Adverse Event|3
439770|NCT00446511|1460314|P2|Overall Study|Adverse Event|2
439771|NCT00446511|1460315|P1|Overall Study|Adverse Event|7
439772|NCT00446459|1460339|P1|12 Months|14 subjects to MMF + Rituximab Study|14
439773|NCT00446459|1460339|P1|12 Months|Protocol Violation|4
439774|NCT00446459|1460339|P1|8 Months|Protocol Violation|12
439775|NCT00446446|1460347|P1|Overall Study|On Treatment at Time of Data Cut-off|1
439776|NCT00446446|1460347|P1|Overall Study|Adverse Event|1
439777|NCT00446446|1460347|P1|Overall Study|Disease Progession|2
439778|NCT00446446|1460347|P1|Overall Study|Other|4
439779|NCT00446446|1460347|P1|Overall Study|Withdrawal by Subject|6
439780|NCT00446446|1460347|P1|Overall Study|Death|10
439781|NCT00446251|1460371|P1|Overall Study|Lost to Follow-up|1
439782|NCT00446251|1460371|P1|Overall Study|Rituximab Infusion Reaction|2
439783|NCT00446251|1460371|P1|Overall Study|On-study Transplants|2
439784|NCT00446199|1460381|P4|Overall Study|Move|0
439785|NCT00446199|1460382|P3|Overall Study|Move|0
439786|NCT00446199|1460383|P2|Overall Study|Move|1
439787|NCT00446199|1460384|P1|Overall Study|Move|0
439788|NCT00446199|1460381|P4|Overall Study|In-/Exclusion criterion violated|1
439789|NCT00446199|1460382|P3|Overall Study|In-/Exclusion criterion violated|2
439790|NCT00446199|1460383|P2|Overall Study|In-/Exclusion criterion violated|1
439791|NCT00446199|1460384|P1|Overall Study|In-/Exclusion criterion violated|2
439792|NCT00446199|1460381|P4|Overall Study|Lost interest in study participation|0
439793|NCT00446199|1460382|P3|Overall Study|Lost interest in study participation|0
439794|NCT00446199|1460383|P2|Overall Study|Lost interest in study participation|1
439795|NCT00446199|1460384|P1|Overall Study|Lost interest in study participation|0
439796|NCT00446199|1460381|P4|Overall Study|Hormone fear|1
439797|NCT00446199|1460382|P3|Overall Study|Hormone fear|0
439798|NCT00446199|1460383|P2|Overall Study|Hormone fear|0
439799|NCT00446199|1460384|P1|Overall Study|Hormone fear|0
439800|NCT00446199|1460381|P4|Overall Study|Non-compliant with visit schedule|2
439801|NCT00446199|1460382|P3|Overall Study|Non-compliant with visit schedule|1
439802|NCT00446199|1460383|P2|Overall Study|Non-compliant with visit schedule|1
439803|NCT00446199|1460384|P1|Overall Study|Non-compliant with visit schedule|1
439804|NCT00446199|1460381|P4|Overall Study|Non-compliant with study drug|0
439805|NCT00446199|1460382|P3|Overall Study|Non-compliant with study drug|5
439806|NCT00446199|1460383|P2|Overall Study|Non-compliant with study drug|0
439807|NCT00446199|1460384|P1|Overall Study|Non-compliant with study drug|1
439808|NCT00446199|1460381|P4|Overall Study|Lack of Efficacy|1
439809|NCT00446199|1460382|P3|Overall Study|Lack of Efficacy|0
439810|NCT00446199|1460383|P2|Overall Study|Lack of Efficacy|0
439811|NCT00446199|1460384|P1|Overall Study|Lack of Efficacy|1
439812|NCT00446199|1460381|P4|Overall Study|Randomization in Error|1
439813|NCT00446199|1460382|P3|Overall Study|Randomization in Error|1
439814|NCT00446199|1460383|P2|Overall Study|Randomization in Error|0
439815|NCT00446199|1460384|P1|Overall Study|Randomization in Error|2
439816|NCT00446199|1460381|P4|Overall Study|Site termination|1
439817|NCT00446199|1460382|P3|Overall Study|Site termination|0
439818|NCT00446199|1460383|P2|Overall Study|Site termination|0
439819|NCT00446199|1460384|P1|Overall Study|Site termination|2
439820|NCT00446199|1460381|P4|Overall Study|Withdrawal by Subject|10
439821|NCT00446199|1460382|P3|Overall Study|Withdrawal by Subject|9
439822|NCT00446199|1460383|P2|Overall Study|Withdrawal by Subject|5
439823|NCT00446199|1460384|P1|Overall Study|Withdrawal by Subject|2
439824|NCT00446199|1460381|P4|Overall Study|Protocol Violation|3
439825|NCT00446199|1460382|P3|Overall Study|Protocol Violation|1
439826|NCT00446199|1460383|P2|Overall Study|Protocol Violation|2
439827|NCT00446199|1460384|P1|Overall Study|Protocol Violation|1
439828|NCT00446199|1460381|P4|Overall Study|Lost to Follow-up|6
439829|NCT00446199|1460382|P3|Overall Study|Lost to Follow-up|2
439830|NCT00446199|1460383|P2|Overall Study|Lost to Follow-up|5
439831|NCT00446199|1460384|P1|Overall Study|Lost to Follow-up|4
439832|NCT00446199|1460381|P4|Overall Study|Adverse Event|4
439833|NCT00446199|1460382|P3|Overall Study|Adverse Event|6
439834|NCT00446199|1460383|P2|Overall Study|Adverse Event|4
439835|NCT00446199|1460384|P1|Overall Study|Adverse Event|7
439836|NCT00446134|1460477|P4|Overall Study|Reason Not Completed|2
439837|NCT00446134|1460478|P3|Overall Study|Reason Not Completed|1
439838|NCT00446134|1460479|P2|Overall Study|Reason Not Completed|0
439839|NCT00446134|1460480|P1|Overall Study|Reason Not Completed|3
439840|NCT00446134|1460477|P4|Overall Study|Adverse Event-Diarrhea|0
439841|NCT00446134|1460478|P3|Overall Study|Adverse Event-Diarrhea|2
439842|NCT00446134|1460479|P2|Overall Study|Adverse Event-Diarrhea|1
439843|NCT00446134|1460480|P1|Overall Study|Adverse Event-Diarrhea|1
439844|NCT00446134|1460477|P4|Overall Study|Physician Decision|2
439845|NCT00446134|1460478|P3|Overall Study|Physician Decision|0
439846|NCT00446134|1460479|P2|Overall Study|Physician Decision|0
439847|NCT00446134|1460480|P1|Overall Study|Physician Decision|0
439848|NCT00446134|1460477|P4|Overall Study|Withdrawal by Subject|3
439849|NCT00446134|1460478|P3|Overall Study|Withdrawal by Subject|1
439850|NCT00446134|1460479|P2|Overall Study|Withdrawal by Subject|3
439851|NCT00446134|1460480|P1|Overall Study|Withdrawal by Subject|3
439852|NCT00446134|1460477|P4|Overall Study|Lost to Follow-up|1
439853|NCT00446134|1460478|P3|Overall Study|Lost to Follow-up|1
439854|NCT00446134|1460479|P2|Overall Study|Lost to Follow-up|3
439855|NCT00446134|1460480|P1|Overall Study|Lost to Follow-up|1
439856|NCT00446134|1460477|P4|Overall Study|Protocol Violation|0
439857|NCT00446134|1460478|P3|Overall Study|Protocol Violation|1
439858|NCT00446134|1460479|P2|Overall Study|Protocol Violation|2
439859|NCT00446134|1460480|P1|Overall Study|Protocol Violation|0
439860|NCT00446134|1460477|P4|Overall Study|Lack of Efficacy|19
439861|NCT00446134|1460478|P3|Overall Study|Lack of Efficacy|24
439862|NCT00446134|1460479|P2|Overall Study|Lack of Efficacy|19
439863|NCT00446134|1460480|P1|Overall Study|Lack of Efficacy|19
439864|NCT00446134|1460477|P4|Overall Study|Adverse Event|18
439865|NCT00446134|1460478|P3|Overall Study|Adverse Event|13
439866|NCT00446134|1460479|P2|Overall Study|Adverse Event|17
439867|NCT00446134|1460480|P1|Overall Study|Adverse Event|7
439868|NCT00446095|1460507|P5|Phase I (28 Days)|Lack of Efficacy|3
439869|NCT00446095|1460508|P4|Phase I (28 Days)|Lack of Efficacy|0
439870|NCT00446095|1460509|P3|Phase I (28 Days)|Lack of Efficacy|0
439871|NCT00446095|1460510|P2|Phase I (28 Days)|Lack of Efficacy|0
439872|NCT00446095|1460511|P1|Phase I (28 Days)|Lack of Efficacy|0
439873|NCT00446095|1460507|P5|Phase I (28 Days)|Adverse Event|0
439874|NCT00446095|1460508|P4|Phase I (28 Days)|Adverse Event|1
439875|NCT00446095|1460509|P3|Phase I (28 Days)|Adverse Event|0
439876|NCT00446095|1460510|P2|Phase I (28 Days)|Adverse Event|0
439877|NCT00446095|1460511|P1|Phase I (28 Days)|Adverse Event|0
439878|NCT00446095|1460507|P5|Phase II (8 Weeks)|Ongoing|0
439879|NCT00446095|1460508|P4|Phase II (8 Weeks)|Ongoing|0
439880|NCT00446095|1460509|P3|Phase II (8 Weeks)|Ongoing|1
439881|NCT00446095|1460510|P2|Phase II (8 Weeks)|Ongoing|0
439882|NCT00446095|1460511|P1|Phase II (8 Weeks)|Ongoing|0
439883|NCT00446095|1460507|P5|Phase II (8 Weeks)|Lack of Efficacy|0
439884|NCT00446095|1460508|P4|Phase II (8 Weeks)|Lack of Efficacy|0
439885|NCT00446095|1460509|P3|Phase II (8 Weeks)|Lack of Efficacy|1
439886|NCT00446095|1460510|P2|Phase II (8 Weeks)|Lack of Efficacy|2
439887|NCT00446095|1460511|P1|Phase II (8 Weeks)|Lack of Efficacy|9
439888|NCT00446095|1460507|P5|Phase II (8 Weeks)|Physician Decision|0
439889|NCT00446095|1460508|P4|Phase II (8 Weeks)|Physician Decision|0
439890|NCT00446095|1460509|P3|Phase II (8 Weeks)|Physician Decision|0
439891|NCT00446095|1460510|P2|Phase II (8 Weeks)|Physician Decision|0
439892|NCT00446095|1460511|P1|Phase II (8 Weeks)|Physician Decision|1
439893|NCT00446095|1460507|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
439894|NCT00446095|1460508|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
439895|NCT00446095|1460509|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
439896|NCT00446095|1460510|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
439897|NCT00446095|1460511|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
439898|NCT00446095|1460507|P5|Phase II (8 Weeks)|Adverse Event|0
439899|NCT00446095|1460508|P4|Phase II (8 Weeks)|Adverse Event|0
439900|NCT00446095|1460509|P3|Phase II (8 Weeks)|Adverse Event|1
439901|NCT00446095|1460510|P2|Phase II (8 Weeks)|Adverse Event|1
439902|NCT00446095|1460511|P1|Phase II (8 Weeks)|Adverse Event|0
439903|NCT00446095|1460507|P5|Phase II (8 Weeks)|Lost to Follow-up|0
439904|NCT00446095|1460508|P4|Phase II (8 Weeks)|Lost to Follow-up|0
439905|NCT00446095|1460509|P3|Phase II (8 Weeks)|Lost to Follow-up|0
439906|NCT00446095|1460510|P2|Phase II (8 Weeks)|Lost to Follow-up|0
439907|NCT00446095|1460511|P1|Phase II (8 Weeks)|Lost to Follow-up|1
439908|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
439909|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
439910|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
439911|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
439912|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
439913|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
439914|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
439915|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
439916|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
439917|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
439918|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
439919|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
439920|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
439921|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
439922|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Death|2
439923|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Death|2
439924|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
439925|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
439926|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
439927|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
439928|NCT00446030|1460534|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
439929|NCT00446030|1460535|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
439930|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
439931|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
439932|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
439933|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
439934|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
439935|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
439936|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
439937|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
439938|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
439939|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
439940|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
439941|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
439942|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
439943|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
439944|NCT00446030|1460534|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
439945|NCT00446030|1460535|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
439946|NCT00445939|1460546|P4|Period B - Week 4 - Week 8|Adverse Event|1
439947|NCT00445939|1460547|P3|Period B - Week 4 - Week 8|Adverse Event|0
439948|NCT00445939|1460548|P2|Period B - Week 4 - Week 8|Adverse Event|0
439949|NCT00445939|1460549|P1|Period B - Week 4 - Week 8|Adverse Event|2
439950|NCT00445939|1460546|P4|Period A - Week 0 - Week 4|Adverse Event|0
439951|NCT00445939|1460547|P3|Period A - Week 0 - Week 4|Adverse Event|0
439952|NCT00445939|1460548|P2|Period A - Week 0 - Week 4|Adverse Event|2
439953|NCT00445939|1460549|P1|Period A - Week 0 - Week 4|Adverse Event|1
439954|NCT00445848|1460597|P1|Overall Study|Other-Not protocol specified|5
439955|NCT00445848|1460597|P1|Overall Study|Progression|62
439956|NCT00445848|1460597|P1|Overall Study|Withdrawal by Subject|4
439957|NCT00445848|1460597|P1|Overall Study|Adverse Event|14
439958|NCT00445770|1460607|P3|Overall Study|Not specified|6
439959|NCT00445770|1460608|P2|Overall Study|Not specified|5
439960|NCT00445770|1460609|P1|Overall Study|Not specified|6
439961|NCT00445770|1460607|P3|Overall Study|Lost to Follow-up|0
439962|NCT00445770|1460608|P2|Overall Study|Lost to Follow-up|2
439963|NCT00445770|1460609|P1|Overall Study|Lost to Follow-up|0
439964|NCT00445770|1460607|P3|Overall Study|Lack of Efficacy|6
439965|NCT00445770|1460608|P2|Overall Study|Lack of Efficacy|13
439966|NCT00445770|1460609|P1|Overall Study|Lack of Efficacy|38
439967|NCT00445770|1460607|P3|Overall Study|Adverse Event|19
439968|NCT00445770|1460608|P2|Overall Study|Adverse Event|15
439969|NCT00445770|1460609|P1|Overall Study|Adverse Event|9
439970|NCT00445692|1460710|P1|Overall Study|Lack of Efficacy|5
439971|NCT00445692|1460710|P1|Overall Study|Adverse Event|11
439972|NCT00445679|1460720|P4|Overall Study|Lack of Efficacy|0
439973|NCT00445679|1460721|P3|Overall Study|Lack of Efficacy|2
439974|NCT00445679|1460722|P2|Overall Study|Lack of Efficacy|6
439975|NCT00445679|1460723|P1|Overall Study|Lack of Efficacy|2
439976|NCT00445679|1460720|P4|Overall Study|Withdrawal by Subject|18
439977|NCT00445679|1460721|P3|Overall Study|Withdrawal by Subject|20
439978|NCT00445679|1460722|P2|Overall Study|Withdrawal by Subject|14
439979|NCT00445679|1460723|P1|Overall Study|Withdrawal by Subject|8
439980|NCT00445679|1460720|P4|Overall Study|Protocol Violation|1
439981|NCT00445679|1460721|P3|Overall Study|Protocol Violation|3
439982|NCT00445679|1460722|P2|Overall Study|Protocol Violation|3
439983|NCT00445679|1460723|P1|Overall Study|Protocol Violation|2
439984|NCT00445679|1460720|P4|Overall Study|Withdrawal of Informed Consent|0
439985|NCT00445679|1460721|P3|Overall Study|Withdrawal of Informed Consent|1
439986|NCT00445679|1460722|P2|Overall Study|Withdrawal of Informed Consent|0
439987|NCT00445679|1460723|P1|Overall Study|Withdrawal of Informed Consent|0
439988|NCT00445679|1460720|P4|Overall Study|Compliance|2
439989|NCT00445679|1460721|P3|Overall Study|Compliance|1
439990|NCT00445679|1460722|P2|Overall Study|Compliance|2
439991|NCT00445679|1460723|P1|Overall Study|Compliance|3
439992|NCT00445679|1460720|P4|Overall Study|Lost to Follow-up|5
439993|NCT00445679|1460721|P3|Overall Study|Lost to Follow-up|6
439994|NCT00445679|1460722|P2|Overall Study|Lost to Follow-up|6
439995|NCT00445679|1460723|P1|Overall Study|Lost to Follow-up|10
439996|NCT00445679|1460720|P4|Overall Study|Physician Decision|0
439997|NCT00445679|1460721|P3|Overall Study|Physician Decision|1
439998|NCT00445679|1460722|P2|Overall Study|Physician Decision|0
439999|NCT00445679|1460723|P1|Overall Study|Physician Decision|0
440000|NCT00445679|1460720|P4|Overall Study|Failed to return|2
440001|NCT00445679|1460721|P3|Overall Study|Failed to return|2
440002|NCT00445679|1460722|P2|Overall Study|Failed to return|3
440003|NCT00445679|1460723|P1|Overall Study|Failed to return|1
440004|NCT00445679|1460720|P4|Overall Study|Adverse Event|19
440005|NCT00445679|1460721|P3|Overall Study|Adverse Event|30
440006|NCT00445679|1460722|P2|Overall Study|Adverse Event|12
440007|NCT00445679|1460723|P1|Overall Study|Adverse Event|22
440008|NCT00445601|1460759|P2|Overall Study|Death prior to TURBT|1
440009|NCT00445601|1460760|P1|Overall Study|Death prior to TURBT|0
440010|NCT00445601|1460759|P2|Overall Study|Adverse Event|0
440011|NCT00445601|1460760|P1|Overall Study|Adverse Event|2
440012|NCT00445601|1460759|P2|Overall Study|Drug Delivery Issue|2
440013|NCT00445601|1460760|P1|Overall Study|Drug Delivery Issue|2
440014|NCT00445601|1460759|P2|Overall Study|Incorrect Disease Status|6
440015|NCT00445601|1460760|P1|Overall Study|Incorrect Disease Status|6
440016|NCT00445601|1460759|P2|Overall Study|TURBT Complication|8
440017|NCT00445601|1460760|P1|Overall Study|TURBT Complication|12
440018|NCT00445601|1460759|P2|Overall Study|Withdrawal by Subject|11
440019|NCT00445601|1460760|P1|Overall Study|Withdrawal by Subject|11
440020|NCT00445549|1460777|P1|Overall Study|progressive disease|12
440021|NCT00445458|1460801|P4|Overall Study|Surgery|0
440022|NCT00445458|1460802|P3|Overall Study|Surgery|1
440023|NCT00445458|1460803|P2|Overall Study|Surgery|0
440024|NCT00445458|1460804|P1|Overall Study|Surgery|0
440025|NCT00445458|1460801|P4|Overall Study|Physician Decision|1
440026|NCT00445458|1460802|P3|Overall Study|Physician Decision|1
440027|NCT00445458|1460803|P2|Overall Study|Physician Decision|0
440028|NCT00445458|1460804|P1|Overall Study|Physician Decision|0
440029|NCT00445458|1460801|P4|Overall Study|Death|0
440030|NCT00445458|1460802|P3|Overall Study|Death|2
440031|NCT00445458|1460803|P2|Overall Study|Death|1
440032|NCT00445458|1460804|P1|Overall Study|Death|0
440033|NCT00445458|1460801|P4|Overall Study|Adverse Event|0
440034|NCT00445458|1460802|P3|Overall Study|Adverse Event|3
440035|NCT00445458|1460803|P2|Overall Study|Adverse Event|0
440036|NCT00445458|1460804|P1|Overall Study|Adverse Event|0
440037|NCT00445458|1460801|P4|Overall Study|Withdrawal by Subject|0
440038|NCT00445458|1460802|P3|Overall Study|Withdrawal by Subject|7
440039|NCT00445458|1460803|P2|Overall Study|Withdrawal by Subject|0
440040|NCT00445458|1460804|P1|Overall Study|Withdrawal by Subject|0
440041|NCT00445458|1460801|P4|Overall Study|Disease Progression|27
440042|NCT00445458|1460802|P3|Overall Study|Disease Progression|54
440043|NCT00445458|1460803|P2|Overall Study|Disease Progression|4
440044|NCT00445458|1460804|P1|Overall Study|Disease Progression|3
440045|NCT00445432|1460822|P4|148 Weeks of Adalimumab Treatment|Not specified|9
440046|NCT00445432|1460823|P3|148 Weeks of Adalimumab Treatment|Not specified|0
440047|NCT00445432|1460824|P2|148 Weeks of Adalimumab Treatment|Not specified|0
440048|NCT00445432|1460825|P1|148 Weeks of Adalimumab Treatment|Not specified|0
440049|NCT00445432|1460822|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
440050|NCT00445432|1460823|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
440051|NCT00445432|1460824|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
440052|NCT00445432|1460825|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
440053|NCT00445432|1460822|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
440054|NCT00445432|1460823|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
440055|NCT00445432|1460824|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
440056|NCT00445432|1460825|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
440057|NCT00445432|1460822|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
440058|NCT00445432|1460823|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
440059|NCT00445432|1460824|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
440060|NCT00445432|1460825|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
440061|NCT00445432|1460822|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
440062|NCT00445432|1460823|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
440063|NCT00445432|1460824|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
440064|NCT00445432|1460825|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
440065|NCT00445432|1460822|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
440066|NCT00445432|1460823|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
440067|NCT00445432|1460824|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
440068|NCT00445432|1460825|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
440069|NCT00445432|1460822|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
440070|NCT00445432|1460823|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
440071|NCT00445432|1460824|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
440072|NCT00445432|1460825|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
440073|NCT00445341|1460858|P1|Overall Study|taken off treatment too early|1
440074|NCT00445341|1460858|P1|Overall Study|refused further treatment|1
440075|NCT00445328|1460865|P2|Overall Study|Protocol Violation|0
440076|NCT00445328|1460866|P1|Overall Study|Protocol Violation|1
440077|NCT00445328|1460865|P2|Overall Study|Withdrawal by Subject|0
440078|NCT00445328|1460866|P1|Overall Study|Withdrawal by Subject|2
440079|NCT00445328|1460865|P2|Overall Study|Other|2
440080|NCT00445328|1460866|P1|Overall Study|Other|0
440081|NCT00445328|1460865|P2|Overall Study|Adverse Event|3
440082|NCT00445328|1460866|P1|Overall Study|Adverse Event|0
440083|NCT00445328|1460865|P2|Overall Study|Death|1
440084|NCT00445328|1460866|P1|Overall Study|Death|0
440085|NCT00445224|1461027|P2|Specific Exercises|Withdrawal by Subject|0
440086|NCT00445224|1461028|P1|Specific Exercises|Withdrawal by Subject|1
440087|NCT00445224|1461027|P2|Specific Exercises|Withdrawal by Subject|3
440088|NCT00445224|1461028|P1|Specific Exercises|Withdrawal by Subject|3
440089|NCT00445146|1461055|P1|Overall Study|Pregnancy|1
440090|NCT00445146|1461055|P1|Overall Study|Protocol Violation|4
440091|NCT00445146|1461055|P1|Overall Study|Death|9
440092|NCT00445146|1461055|P1|Overall Study|Lost to Follow-up|13
440093|NCT00445146|1461055|P1|Overall Study|Adverse Event|13
440094|NCT00445146|1461055|P1|Overall Study|Investigator’s Discretion|22
440095|NCT00445146|1461055|P1|Overall Study|Lack of Efficacy|28
440096|NCT00445146|1461055|P1|Overall Study|Withdrew Consent|29
440097|NCT00445003|1461077|P3|Overall Study|Dropped|2
440098|NCT00445003|1461078|P2|Overall Study|Dropped|3
440099|NCT00445003|1461079|P1|Overall Study|Dropped|1
440100|NCT00445003|1461077|P3|Overall Study|Missed Visit|1
440101|NCT00445003|1461078|P2|Overall Study|Missed Visit|5
440102|NCT00445003|1461079|P1|Overall Study|Missed Visit|3
440103|NCT00445003|1461077|P3|Overall Study|Death|1
440104|NCT00445003|1461078|P2|Overall Study|Death|2
440105|NCT00445003|1461079|P1|Overall Study|Death|1
440106|NCT00444951|1461111|P3|Overall Study|Withdrawal by Subject|3
440107|NCT00444951|1461112|P2|Overall Study|Withdrawal by Subject|5
440108|NCT00444951|1461113|P1|Overall Study|Withdrawal by Subject|4
440109|NCT00444951|1461111|P3|Overall Study|Lost to Follow-up|0
440110|NCT00444951|1461112|P2|Overall Study|Lost to Follow-up|1
440111|NCT00444951|1461113|P1|Overall Study|Lost to Follow-up|1
440112|NCT00444925|1461130|P3|Double-blind Treatment Period|Other|12
440113|NCT00444925|1461131|P2|Double-blind Treatment Period|Other|7
440114|NCT00444925|1461132|P1|Double-blind Treatment Period|Other|7
440115|NCT00444925|1461130|P3|Double-blind Treatment Period|Withdrawal by Subject|7
440116|NCT00444925|1461131|P2|Double-blind Treatment Period|Withdrawal by Subject|8
440117|NCT00444925|1461132|P1|Double-blind Treatment Period|Withdrawal by Subject|6
440118|NCT00444925|1461130|P3|Double-blind Treatment Period|Lost to Follow-up|5
440119|NCT00444925|1461131|P2|Double-blind Treatment Period|Lost to Follow-up|8
440120|NCT00444925|1461132|P1|Double-blind Treatment Period|Lost to Follow-up|4
440121|NCT00444925|1461130|P3|Double-blind Treatment Period|Lack of Efficacy|13
440122|NCT00444925|1461131|P2|Double-blind Treatment Period|Lack of Efficacy|5
440123|NCT00444925|1461132|P1|Double-blind Treatment Period|Lack of Efficacy|5
440124|NCT00444925|1461130|P3|Double-blind Treatment Period|Adverse Event|44
440125|NCT00444925|1461131|P2|Double-blind Treatment Period|Adverse Event|28
440126|NCT00444925|1461132|P1|Double-blind Treatment Period|Adverse Event|6
440127|NCT00444925|1461130|P3|Double-blind Treatment Period|Death|0
440128|NCT00444925|1461131|P2|Double-blind Treatment Period|Death|0
440129|NCT00444925|1461132|P1|Double-blind Treatment Period|Death|2
440130|NCT00444925|1461130|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
440131|NCT00444925|1461131|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
440132|NCT00444925|1461132|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
440133|NCT00444912|1461196|P2|Overall Study|Participant Failed Mobilization|0
440134|NCT00444912|1461197|P1|Overall Study|Participant Failed Mobilization|1
440135|NCT00444912|1461196|P2|Overall Study|Lost to Follow-up|0
440136|NCT00444912|1461197|P1|Overall Study|Lost to Follow-up|1
440137|NCT00444912|1461196|P2|Overall Study|Death|2
440138|NCT00444912|1461197|P1|Overall Study|Death|1
440139|NCT00444795|1461238|P1|Overall Study|Treated Prior to the Contract Date|2
440140|NCT00444795|1461238|P1|Overall Study|Not Treated|1
440141|NCT00444626|1461243|P1|Initial Treatment Period|Lost to Follow-up|9
440142|NCT00444626|1461243|P1|Initial Treatment Period|Adverse Event|1
440143|NCT00444626|1461243|P1|Initial Treatment Period|Withdrawal by Subject|2
440144|NCT00444600|1461273|P4|Overall Study|Missed visit|1
440145|NCT00444600|1461274|P3|Overall Study|Missed visit|0
440146|NCT00444600|1461275|P2|Overall Study|Missed visit|0
440147|NCT00444600|1461276|P1|Overall Study|Missed visit|1
440148|NCT00444600|1461273|P4|Overall Study|Dropped|7
440149|NCT00444600|1461274|P3|Overall Study|Dropped|7
440150|NCT00444600|1461275|P2|Overall Study|Dropped|11
440151|NCT00444600|1461276|P1|Overall Study|Dropped|11
440152|NCT00444600|1461273|P4|Overall Study|Death|2
440153|NCT00444600|1461274|P3|Overall Study|Death|3
440154|NCT00444600|1461275|P2|Overall Study|Death|5
440155|NCT00444600|1461276|P1|Overall Study|Death|7
440156|NCT00444587|1461368|P2|Overall Study|Missing|5
440157|NCT00444587|1461369|P1|Overall Study|Missing|0
440158|NCT00444587|1461368|P2|Overall Study|Protocol Violation|0
440159|NCT00444587|1461369|P1|Overall Study|Protocol Violation|1
440160|NCT00444587|1461368|P2|Overall Study|Investigator decision|0
440161|NCT00444587|1461369|P1|Overall Study|Investigator decision|3
440162|NCT00444587|1461368|P2|Overall Study|Refused treatment/did not cooperate|1
440163|NCT00444587|1461369|P1|Overall Study|Refused treatment/did not cooperate|4
440164|NCT00444587|1461368|P2|Overall Study|Progression of the disease|8
440165|NCT00444587|1461369|P1|Overall Study|Progression of the disease|73
440166|NCT00444587|1461368|P2|Overall Study|Death|1
440167|NCT00444587|1461369|P1|Overall Study|Death|2
440168|NCT00444535|1461390|P1|Overall Study|Adverse Event|3
440169|NCT00444535|1461390|P1|Overall Study|Investigator decision|2
440170|NCT00444535|1461390|P1|Overall Study|Withdrawal by Subject|3
440171|NCT00444535|1461390|P1|Overall Study|Treatment is ongoing|16
440172|NCT00444457|1461401|P4|Toddler Dose|Protocol Violation|1
440173|NCT00444457|1461402|P3|Toddler Dose|Protocol Violation|0
440174|NCT00444457|1461403|P2|Toddler Dose|Protocol Violation|0
440175|NCT00444457|1461404|P1|Toddler Dose|Protocol Violation|1
440176|NCT00444457|1461401|P4|Toddler Dose|Parent or legal guardian request|1
440177|NCT00444457|1461402|P3|Toddler Dose|Parent or legal guardian request|2
440178|NCT00444457|1461403|P2|Toddler Dose|Parent or legal guardian request|3
440179|NCT00444457|1461404|P1|Toddler Dose|Parent or legal guardian request|0
440180|NCT00444457|1461401|P4|Toddler Dose|Failed to return|3
440181|NCT00444457|1461402|P3|Toddler Dose|Failed to return|1
440182|NCT00444457|1461403|P2|Toddler Dose|Failed to return|2
440183|NCT00444457|1461404|P1|Toddler Dose|Failed to return|2
440184|NCT00444457|1461401|P4|Toddler Dose|Lost to Follow-up|3
440185|NCT00444457|1461402|P3|Toddler Dose|Lost to Follow-up|1
440186|NCT00444457|1461403|P2|Toddler Dose|Lost to Follow-up|1
440187|NCT00444457|1461404|P1|Toddler Dose|Lost to Follow-up|4
440188|NCT00444457|1461401|P4|After Infant Series|Other|0
440189|NCT00444457|1461402|P3|After Infant Series|Other|0
440190|NCT00444457|1461403|P2|After Infant Series|Other|1
440191|NCT00444457|1461404|P1|After Infant Series|Other|0
440192|NCT00444457|1461401|P4|After Infant Series|Investigator request|1
440193|NCT00444457|1461402|P3|After Infant Series|Investigator request|0
440194|NCT00444457|1461403|P2|After Infant Series|Investigator request|0
440195|NCT00444457|1461404|P1|After Infant Series|Investigator request|0
440196|NCT00444457|1461401|P4|After Infant Series|Adverse Event|0
440197|NCT00444457|1461402|P3|After Infant Series|Adverse Event|0
440198|NCT00444457|1461403|P2|After Infant Series|Adverse Event|2
440199|NCT00444457|1461404|P1|After Infant Series|Adverse Event|2
440200|NCT00444457|1461401|P4|After Infant Series|Protocol Violation|2
440201|NCT00444457|1461402|P3|After Infant Series|Protocol Violation|2
440202|NCT00444457|1461403|P2|After Infant Series|Protocol Violation|4
440203|NCT00444457|1461404|P1|After Infant Series|Protocol Violation|2
440204|NCT00444457|1461401|P4|After Infant Series|Lost to Follow-up|2
440205|NCT00444457|1461402|P3|After Infant Series|Lost to Follow-up|5
440206|NCT00444457|1461403|P2|After Infant Series|Lost to Follow-up|5
440207|NCT00444457|1461404|P1|After Infant Series|Lost to Follow-up|5
440208|NCT00444457|1461401|P4|After Infant Series|Failed to return|1
440209|NCT00444457|1461402|P3|After Infant Series|Failed to return|5
440210|NCT00444457|1461403|P2|After Infant Series|Failed to return|6
440211|NCT00444457|1461404|P1|After Infant Series|Failed to return|7
440212|NCT00444457|1461401|P4|After Infant Series|Parent or legal guardian request|3
440213|NCT00444457|1461402|P3|After Infant Series|Parent or legal guardian request|6
440214|NCT00444457|1461403|P2|After Infant Series|Parent or legal guardian request|11
440215|NCT00444457|1461404|P1|After Infant Series|Parent or legal guardian request|4
440216|NCT00444457|1461401|P4|After Infant Series|Other|1
440217|NCT00444457|1461402|P3|After Infant Series|Other|1
440218|NCT00444457|1461403|P2|After Infant Series|Other|1
440219|NCT00444457|1461404|P1|After Infant Series|Other|0
440220|NCT00444457|1461401|P4|Infant Series|Death|1
440221|NCT00444457|1461402|P3|Infant Series|Death|1
440222|NCT00444457|1461403|P2|Infant Series|Death|1
440223|NCT00444457|1461404|P1|Infant Series|Death|0
440224|NCT00444457|1461401|P4|Infant Series|Adverse Event|0
440225|NCT00444457|1461402|P3|Infant Series|Adverse Event|2
440226|NCT00444457|1461403|P2|Infant Series|Adverse Event|2
440227|NCT00444457|1461404|P1|Infant Series|Adverse Event|1
440228|NCT00444457|1461401|P4|Infant Series|Other|0
440229|NCT00444457|1461402|P3|Infant Series|Other|4
440230|NCT00444457|1461403|P2|Infant Series|Other|2
440231|NCT00444457|1461404|P1|Infant Series|Other|0
440232|NCT00444457|1461401|P4|Infant Series|Investigator request|2
440233|NCT00444457|1461402|P3|Infant Series|Investigator request|3
440234|NCT00444457|1461403|P2|Infant Series|Investigator request|3
440235|NCT00444457|1461404|P1|Infant Series|Investigator request|4
440236|NCT00444457|1461401|P4|Infant Series|Failed to return|2
440237|NCT00444457|1461402|P3|Infant Series|Failed to return|4
440238|NCT00444457|1461403|P2|Infant Series|Failed to return|4
440239|NCT00444457|1461404|P1|Infant Series|Failed to return|5
440240|NCT00444457|1461401|P4|Infant Series|Protocol Violation|3
440241|NCT00444457|1461402|P3|Infant Series|Protocol Violation|6
440242|NCT00444457|1461403|P2|Infant Series|Protocol Violation|8
440243|NCT00444457|1461404|P1|Infant Series|Protocol Violation|16
440244|NCT00444457|1461401|P4|Infant Series|Lost to Follow-up|6
440245|NCT00444457|1461402|P3|Infant Series|Lost to Follow-up|7
440246|NCT00444457|1461403|P2|Infant Series|Lost to Follow-up|11
440247|NCT00444457|1461404|P1|Infant Series|Lost to Follow-up|10
440248|NCT00444457|1461401|P4|Infant Series|Parent or legal guardian request|14
440249|NCT00444457|1461402|P3|Infant Series|Parent or legal guardian request|34
440250|NCT00444457|1461403|P2|Infant Series|Parent or legal guardian request|29
440251|NCT00444457|1461404|P1|Infant Series|Parent or legal guardian request|18
440252|NCT00444457|1461401|P4|Infant Series|Other|0
440253|NCT00444457|1461402|P3|Infant Series|Other|0
440254|NCT00444457|1461403|P2|Infant Series|Other|1
440255|NCT00444457|1461404|P1|Infant Series|Other|0
440256|NCT00444275|1461469|P5|Maintenance Treatment Phase|Ineffectiveness|14
440257|NCT00444275|1461470|P4|Maintenance Treatment Phase|Ineffectiveness|3
440258|NCT00444275|1461471|P3|Maintenance Treatment Phase|Ineffectiveness|5
440259|NCT00444275|1461472|P2|Maintenance Treatment Phase|Ineffectiveness|0
440260|NCT00444275|1461473|P1|Maintenance Treatment Phase|Ineffectiveness|0
440261|NCT00444275|1461469|P5|Maintenance Treatment Phase|Protocol Violation|87
440262|NCT00444275|1461470|P4|Maintenance Treatment Phase|Protocol Violation|88
440263|NCT00444275|1461471|P3|Maintenance Treatment Phase|Protocol Violation|103
440264|NCT00444275|1461472|P2|Maintenance Treatment Phase|Protocol Violation|0
440265|NCT00444275|1461473|P1|Maintenance Treatment Phase|Protocol Violation|0
440266|NCT00444275|1461469|P5|Maintenance Treatment Phase|Patient's wish|20
440267|NCT00444275|1461470|P4|Maintenance Treatment Phase|Patient's wish|9
440268|NCT00444275|1461471|P3|Maintenance Treatment Phase|Patient's wish|19
440269|NCT00444275|1461472|P2|Maintenance Treatment Phase|Patient's wish|0
440270|NCT00444275|1461473|P1|Maintenance Treatment Phase|Patient's wish|0
440271|NCT00444275|1461469|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
440272|NCT00444275|1461470|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
440273|NCT00444275|1461471|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
440274|NCT00444275|1461472|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
440275|NCT00444275|1461473|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
440276|NCT00444275|1461469|P5|Maintenance Treatment Phase|Adverse Event|13
440277|NCT00444275|1461470|P4|Maintenance Treatment Phase|Adverse Event|2
440278|NCT00444275|1461471|P3|Maintenance Treatment Phase|Adverse Event|3
440279|NCT00444275|1461472|P2|Maintenance Treatment Phase|Adverse Event|0
440280|NCT00444275|1461473|P1|Maintenance Treatment Phase|Adverse Event|0
440281|NCT00444275|1461469|P5|Maintenance Treatment Phase|Lost to Follow-up|10
440282|NCT00444275|1461470|P4|Maintenance Treatment Phase|Lost to Follow-up|14
440283|NCT00444275|1461471|P3|Maintenance Treatment Phase|Lost to Follow-up|8
440284|NCT00444275|1461472|P2|Maintenance Treatment Phase|Lost to Follow-up|0
440285|NCT00444275|1461473|P1|Maintenance Treatment Phase|Lost to Follow-up|0
440286|NCT00444275|1461469|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
440287|NCT00444275|1461470|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
440288|NCT00444275|1461471|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
440289|NCT00444275|1461472|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
440290|NCT00444275|1461473|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
440291|NCT00444145|1461523|P1|Overall Study|Screen Failures|5
440292|NCT00444145|1461523|P1|Overall Study|non-compliant|11
440293|NCT00444145|1461523|P1|Overall Study|Lost to Follow-up|1
440294|NCT00444145|1461523|P1|Overall Study|Withdrawal by Subject|2
440295|NCT00444106|1461530|P3|Overall Study|Abnormal Test Procedure Results|1
440296|NCT00444106|1461531|P2|Overall Study|Abnormal Test Procedure Results|0
440297|NCT00444106|1461532|P1|Overall Study|Abnormal Test Procedure Results|0
440298|NCT00444106|1461530|P3|Overall Study|Lost to Follow-up|0
440299|NCT00444106|1461531|P2|Overall Study|Lost to Follow-up|1
440300|NCT00444106|1461532|P1|Overall Study|Lost to Follow-up|2
440301|NCT00444067|1461549|P2|Overall Study|Lost to Follow-up|1
440302|NCT00444067|1461550|P1|Overall Study|Lost to Follow-up|0
440303|NCT00443898|1461564|P4|Overall Study|Death|0
440304|NCT00443898|1461565|P3|Overall Study|Death|0
440305|NCT00443898|1461566|P2|Overall Study|Death|1
440306|NCT00443898|1461567|P1|Overall Study|Death|0
440307|NCT00443898|1461564|P4|Overall Study|Lost to Follow-up|10
440308|NCT00443898|1461565|P3|Overall Study|Lost to Follow-up|14
440309|NCT00443898|1461566|P2|Overall Study|Lost to Follow-up|10
440310|NCT00443898|1461567|P1|Overall Study|Lost to Follow-up|10
440311|NCT00443898|1461564|P4|Overall Study|Withdrawal by Subject|6
440312|NCT00443898|1461565|P3|Overall Study|Withdrawal by Subject|10
440313|NCT00443898|1461566|P2|Overall Study|Withdrawal by Subject|10
440314|NCT00443898|1461567|P1|Overall Study|Withdrawal by Subject|11
440315|NCT00443898|1461564|P4|Overall Study|Protocol Violation|0
440316|NCT00443898|1461565|P3|Overall Study|Protocol Violation|1
440317|NCT00443898|1461566|P2|Overall Study|Protocol Violation|1
440318|NCT00443898|1461567|P1|Overall Study|Protocol Violation|1
440319|NCT00443898|1461564|P4|Overall Study|Lack of Efficacy|1
440320|NCT00443898|1461565|P3|Overall Study|Lack of Efficacy|3
440321|NCT00443898|1461566|P2|Overall Study|Lack of Efficacy|3
440322|NCT00443898|1461567|P1|Overall Study|Lack of Efficacy|2
440323|NCT00443898|1461564|P4|Overall Study|Adverse Event|1
440324|NCT00443898|1461565|P3|Overall Study|Adverse Event|1
440325|NCT00443898|1461566|P2|Overall Study|Adverse Event|0
440326|NCT00443898|1461567|P1|Overall Study|Adverse Event|0
440327|NCT00443872|1461589|P1|Overall Study|Adverse Event|8
440328|NCT00443872|1461589|P1|Overall Study|Lost to Follow-up|2
440329|NCT00443872|1461589|P1|Overall Study|Protocol Violation|7
440330|NCT00443846|1461604|P2|Overall Study|Lost to Follow-up|2
440331|NCT00443846|1461605|P1|Overall Study|Lost to Follow-up|1
440332|NCT00443846|1461604|P2|Overall Study|Personal reason|3
440333|NCT00443846|1461605|P1|Overall Study|Personal reason|8
440334|NCT00443846|1461604|P2|Overall Study|Adverse Event|1
440335|NCT00443846|1461605|P1|Overall Study|Adverse Event|0
440336|NCT00443846|1461604|P2|Overall Study|Not vaccinated, no blood sample drawn|0
440337|NCT00443846|1461605|P1|Overall Study|Not vaccinated, no blood sample drawn|1
440338|NCT00443846|1461604|P2|Overall Study|Withdrawn due to intercurrent disease|0
440339|NCT00443846|1461605|P1|Overall Study|Withdrawn due to intercurrent disease|1
440340|NCT00443820|1461615|P4|Overall Study|Death|0
440341|NCT00443820|1461616|P3|Overall Study|Death|1
440342|NCT00443820|1461617|P2|Overall Study|Death|0
440343|NCT00443820|1461618|P1|Overall Study|Death|0
440344|NCT00443820|1461615|P4|Overall Study|Administrative problems|1
440345|NCT00443820|1461616|P3|Overall Study|Administrative problems|0
440346|NCT00443820|1461617|P2|Overall Study|Administrative problems|0
440347|NCT00443820|1461618|P1|Overall Study|Administrative problems|0
440348|NCT00443820|1461615|P4|Overall Study|Lost to Follow-up|5
440349|NCT00443820|1461616|P3|Overall Study|Lost to Follow-up|6
440350|NCT00443820|1461617|P2|Overall Study|Lost to Follow-up|8
440351|NCT00443820|1461618|P1|Overall Study|Lost to Follow-up|9
440352|NCT00443820|1461615|P4|Overall Study|Withdrawal by Subject|9
440353|NCT00443820|1461616|P3|Overall Study|Withdrawal by Subject|8
440354|NCT00443820|1461617|P2|Overall Study|Withdrawal by Subject|7
440355|NCT00443820|1461618|P1|Overall Study|Withdrawal by Subject|6
440356|NCT00443820|1461615|P4|Overall Study|Protocol Violation|1
440357|NCT00443820|1461616|P3|Overall Study|Protocol Violation|2
440358|NCT00443820|1461617|P2|Overall Study|Protocol Violation|1
440359|NCT00443820|1461618|P1|Overall Study|Protocol Violation|2
440360|NCT00443820|1461615|P4|Overall Study|Lack of Efficacy|1
440361|NCT00443820|1461616|P3|Overall Study|Lack of Efficacy|1
440362|NCT00443820|1461617|P2|Overall Study|Lack of Efficacy|2
440363|NCT00443820|1461618|P1|Overall Study|Lack of Efficacy|3
440364|NCT00443820|1461615|P4|Overall Study|Adverse Event|0
440365|NCT00443820|1461616|P3|Overall Study|Adverse Event|0
440366|NCT00443820|1461617|P2|Overall Study|Adverse Event|1
440367|NCT00443820|1461618|P1|Overall Study|Adverse Event|1
440368|NCT00443781|1461640|P1|Overall Study|PD/FAD not done|1
440369|NCT00443781|1461640|P1|Overall Study|Insurance not covered|2
440370|NCT00443781|1461640|P1|Overall Study|Investigator terminated participation|1
440371|NCT00443781|1461640|P1|Overall Study|Unable to comply with study follow up|2
440372|NCT00443781|1461640|P1|Overall Study|Withdrawal by Subject|6
440373|NCT00443781|1461640|P1|Overall Study|Protocol Violation|1
440374|NCT00443781|1461640|P1|Overall Study|Physician Decision|2
440375|NCT00443781|1461640|P1|Overall Study|Lost to Follow-up|10
440376|NCT00443755|1461646|P2|Overall Study|Withdrawal by Subject|1
440377|NCT00443755|1461647|P1|Overall Study|Withdrawal by Subject|2
440378|NCT00443729|1461681|P2|Overall Study|Withdrawal by Subject|1
440379|NCT00443729|1461682|P1|Overall Study|Withdrawal by Subject|3
440380|NCT00443729|1461681|P2|Overall Study|Protocol Violation|1
440381|NCT00443729|1461682|P1|Overall Study|Protocol Violation|1
440382|NCT00443729|1461681|P2|Overall Study|Physician Decision|1
440383|NCT00443729|1461682|P1|Overall Study|Physician Decision|2
440384|NCT00443729|1461681|P2|Overall Study|Lost to Follow-up|1
440385|NCT00443729|1461682|P1|Overall Study|Lost to Follow-up|0
440386|NCT00443729|1461681|P2|Overall Study|Lack of Efficacy|2
440387|NCT00443729|1461682|P1|Overall Study|Lack of Efficacy|4
440388|NCT00443729|1461681|P2|Overall Study|Never Treated|1
440389|NCT00443729|1461682|P1|Overall Study|Never Treated|0
440390|NCT00443703|1461730|P2|Overall Study|Progressive Disease|0
440391|NCT00443703|1461731|P1|Overall Study|Progressive Disease|1
440392|NCT00443703|1461730|P2|Overall Study|Withdrawal by Subject|6
440393|NCT00443703|1461731|P1|Overall Study|Withdrawal by Subject|9
440394|NCT00443703|1461730|P2|Overall Study|Protocol Violation|1
440395|NCT00443703|1461731|P1|Overall Study|Protocol Violation|1
440396|NCT00443703|1461730|P2|Overall Study|Physician Decision|2
440397|NCT00443703|1461731|P1|Overall Study|Physician Decision|4
440398|NCT00443703|1461730|P2|Overall Study|Lost to Follow-up|4
440399|NCT00443703|1461731|P1|Overall Study|Lost to Follow-up|0
440400|NCT00443703|1461730|P2|Overall Study|Lack of Efficacy|1
440401|NCT00443703|1461731|P1|Overall Study|Lack of Efficacy|3
440402|NCT00443703|1461730|P2|Overall Study|Adverse Event|3
440403|NCT00443703|1461731|P1|Overall Study|Adverse Event|7
440404|NCT00443703|1461730|P2|Overall Study|Never Treated|1
440405|NCT00443703|1461731|P1|Overall Study|Never Treated|3
440406|NCT00443651|1461783|P2|Overall Study|Pregnancy|1
440407|NCT00443651|1461784|P1|Overall Study|Pregnancy|0
440408|NCT00443651|1461783|P2|Overall Study|Physician Decision|4
440409|NCT00443651|1461784|P1|Overall Study|Physician Decision|13
440410|NCT00443651|1461783|P2|Overall Study|Patient's/Guardian's Decision|30
440411|NCT00443651|1461784|P1|Overall Study|Patient's/Guardian's Decision|58
440412|NCT00443651|1461783|P2|Overall Study|Lost to Follow-up|12
440413|NCT00443651|1461784|P1|Overall Study|Lost to Follow-up|18
440414|NCT00443651|1461783|P2|Overall Study|Adverse Event|6
440415|NCT00443651|1461784|P1|Overall Study|Adverse Event|5
440416|NCT00443651|1461783|P2|Overall Study|Death|5
440417|NCT00443651|1461784|P1|Overall Study|Death|1
440418|NCT00443599|1461804|P2|Overall Study|Cardiopulmonary bypass canceled|1
440419|NCT00443599|1461805|P1|Overall Study|Cardiopulmonary bypass canceled|3
440420|NCT00443599|1461804|P2|Overall Study|Death|1
440421|NCT00443599|1461805|P1|Overall Study|Death|1
440422|NCT00443599|1461804|P2|Overall Study|Physician Decision|1
440423|NCT00443599|1461805|P1|Overall Study|Physician Decision|2
440424|NCT00443560|1461839|P2|Overall Study|Multiple pregnancies or fetal demise|4
440425|NCT00443560|1461840|P1|Overall Study|Multiple pregnancies or fetal demise|2
440426|NCT00443560|1461839|P2|Overall Study|No intrathecal dose|26
440427|NCT00443560|1461840|P1|Overall Study|No intrathecal dose|58
440428|NCT00443534|1461850|P1|Overall Study|Enrolled, Not Treated|1
440429|NCT00443534|1461850|P1|Overall Study|Other|10
440430|NCT00443534|1461850|P1|Overall Study|Study Terminated by Sponsor|12
440431|NCT00443534|1461850|P1|Overall Study|Withdrawal by Subject|8
440432|NCT00443534|1461850|P1|Overall Study|Death|9
440433|NCT00443534|1461850|P1|Overall Study|Adverse Event|16
440434|NCT00443534|1461850|P1|Overall Study|Lack of Efficacy|67
440435|NCT00443456|1461857|P1|Overall Study|Withdrawal by Subject|1
440436|NCT00443456|1461857|P1|Overall Study|Move|1
440437|NCT00443456|1461857|P1|Overall Study|Adverse Event|16
440438|NCT00443430|1461892|P2|Overall Study|Adverse Event|1
440439|NCT00443430|1461893|P1|Overall Study|Adverse Event|1
440440|NCT00443430|1461892|P2|Overall Study|Lack of Efficacy|3
440441|NCT00443430|1461893|P1|Overall Study|Lack of Efficacy|3
440442|NCT00443261|1461907|P1|Overall Study|Death|1
440443|NCT00443209|1461913|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
440444|NCT00443209|1461914|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
440445|NCT00443209|1461913|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
440446|NCT00443209|1461914|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
440447|NCT00443209|1461913|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
440448|NCT00443209|1461914|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
440449|NCT00443209|1461913|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
440450|NCT00443209|1461914|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
440451|NCT00443209|1461913|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
440452|NCT00443209|1461914|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
440453|NCT00443209|1461913|P2|Months 13 to 18 Treatment Period|Adverse Event|0
440454|NCT00443209|1461914|P1|Months 13 to 18 Treatment Period|Adverse Event|1
440455|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Not Treated|43
440456|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Not Treated|71
440457|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Missing|1
440458|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Missing|2
440459|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
440460|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
440461|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
440462|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
440463|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Pregnancy|4
440464|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Pregnancy|3
440465|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Physician Decision|4
440466|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Physician Decision|8
440467|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
440468|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
440469|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
440470|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
440471|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
440472|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
440473|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
440474|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
440475|NCT00443209|1461913|P2|Months 1 to 12 Treatment Period|Adverse Event|11
440476|NCT00443209|1461914|P1|Months 1 to 12 Treatment Period|Adverse Event|22
440477|NCT00443118|1461931|P3|Overall Study|Withdrawal by Subject|0
440478|NCT00443118|1461932|P2|Overall Study|Withdrawal by Subject|0
440479|NCT00443118|1461933|P1|Overall Study|Withdrawal by Subject|1
440480|NCT00443118|1461931|P3|Overall Study|unknown primary outcome|0
440481|NCT00443118|1461932|P2|Overall Study|unknown primary outcome|1
440482|NCT00443118|1461933|P1|Overall Study|unknown primary outcome|3
440483|NCT00443053|1461982|P2|Overall Study|Physician Decision|4
440484|NCT00443053|1461983|P1|Overall Study|Physician Decision|0
440485|NCT00443053|1461982|P2|Overall Study|Other|4
440486|NCT00443053|1461983|P1|Overall Study|Other|3
440487|NCT00443053|1461982|P2|Overall Study|Noncompliance|1
440488|NCT00443053|1461983|P1|Overall Study|Noncompliance|2
440489|NCT00443053|1461982|P2|Overall Study|Did Not Meet Eligibility Criteria|0
440490|NCT00443053|1461983|P1|Overall Study|Did Not Meet Eligibility Criteria|1
440491|NCT00443053|1461982|P2|Overall Study|Lost to Follow-up|5
440492|NCT00443053|1461983|P1|Overall Study|Lost to Follow-up|4
440493|NCT00443053|1461982|P2|Overall Study|Withdrawal by Subject|18
440494|NCT00443053|1461983|P1|Overall Study|Withdrawal by Subject|9
440495|NCT00443053|1461982|P2|Overall Study|Adverse Event|1
440496|NCT00443053|1461983|P1|Overall Study|Adverse Event|2
440497|NCT00443040|1462004|P3|Overall Study|Converted to an open laparotomy|1
440498|NCT00443040|1462005|P2|Overall Study|Converted to an open laparotomy|0
440499|NCT00443040|1462006|P1|Overall Study|Converted to an open laparotomy|3
440500|NCT00443040|1462004|P3|Overall Study|Withdrawal by Subject|0
440501|NCT00443040|1462005|P2|Overall Study|Withdrawal by Subject|0
440502|NCT00443040|1462006|P1|Overall Study|Withdrawal by Subject|1
440503|NCT00442962|1462014|P1|Overall Study|Lost to Follow-up|7
440504|NCT00442962|1462014|P1|Overall Study|Pregnancy|1
440505|NCT00442936|1462032|P4|Overall Study|Protocol Violation|1
440506|NCT00442936|1462033|P3|Overall Study|Protocol Violation|1
440507|NCT00442936|1462034|P2|Overall Study|Protocol Violation|0
440508|NCT00442936|1462035|P1|Overall Study|Protocol Violation|1
440509|NCT00442897|1462083|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
440510|NCT00442897|1462084|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
440511|NCT00442897|1462083|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
440512|NCT00442897|1462084|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
440513|NCT00442897|1462083|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
440514|NCT00442897|1462084|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
440515|NCT00442897|1462083|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
440516|NCT00442897|1462084|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
440517|NCT00442897|1462083|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
440518|NCT00442897|1462084|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
440519|NCT00442897|1462083|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
440520|NCT00442897|1462084|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
440521|NCT00442897|1462083|P2|Base Study (12 Week Follow-up)|Death|1
440522|NCT00442897|1462084|P1|Base Study (12 Week Follow-up)|Death|0
440523|NCT00442897|1462083|P2|Base Study (12 Week Follow-up)|Adverse Event|0
440524|NCT00442897|1462084|P1|Base Study (12 Week Follow-up)|Adverse Event|1
440525|NCT00442702|1462094|P2|Evaluation Period|Site closure|1
440526|NCT00442702|1462095|P1|Evaluation Period|Site closure|0
440527|NCT00442702|1462094|P2|Evaluation Period|Failure to return|0
440528|NCT00442702|1462095|P1|Evaluation Period|Failure to return|1
440529|NCT00442702|1462094|P2|Evaluation Period|Renal transplant|1
440530|NCT00442702|1462095|P1|Evaluation Period|Renal transplant|0
440531|NCT00442702|1462094|P2|Evaluation Period|Refused treatment|1
440532|NCT00442702|1462095|P1|Evaluation Period|Refused treatment|1
440533|NCT00442702|1462094|P2|Evaluation Period|Insufficient Therapeutic Response|0
440534|NCT00442702|1462095|P1|Evaluation Period|Insufficient Therapeutic Response|1
440535|NCT00442702|1462094|P2|Evaluation Period|Death|1
440536|NCT00442702|1462095|P1|Evaluation Period|Death|1
440537|NCT00442702|1462094|P2|Evaluation Period|Adverse Event|0
440538|NCT00442702|1462095|P1|Evaluation Period|Adverse Event|1
440539|NCT00442702|1462094|P2|Titration Period|Hospitalized in another hospital|0
440540|NCT00442702|1462095|P1|Titration Period|Hospitalized in another hospital|1
440541|NCT00442702|1462094|P2|Titration Period|Failure to return|0
440542|NCT00442702|1462095|P1|Titration Period|Failure to return|1
440543|NCT00442702|1462094|P2|Titration Period|Refused Treatment|1
440544|NCT00442702|1462095|P1|Titration Period|Refused Treatment|4
440545|NCT00442702|1462094|P2|Titration Period|Insufficient Therapeutic Response|0
440546|NCT00442702|1462095|P1|Titration Period|Insufficient Therapeutic Response|1
440547|NCT00442702|1462094|P2|Titration Period|Death|2
440548|NCT00442702|1462095|P1|Titration Period|Death|3
440549|NCT00442702|1462094|P2|Titration Period|Adverse Event|0
440550|NCT00442702|1462095|P1|Titration Period|Adverse Event|2
440551|NCT00442598|1462160|P3|Overall Study|Death|0
440552|NCT00442598|1462161|P2|Overall Study|Death|1
440553|NCT00442598|1462162|P1|Overall Study|Death|0
440554|NCT00442598|1462160|P3|Overall Study|Reduced creatinine clearance|0
440555|NCT00442598|1462161|P2|Overall Study|Reduced creatinine clearance|0
440556|NCT00442598|1462162|P1|Overall Study|Reduced creatinine clearance|1
440557|NCT00442598|1462160|P3|Overall Study|CA125 progression|0
440558|NCT00442598|1462161|P2|Overall Study|CA125 progression|1
440559|NCT00442598|1462162|P1|Overall Study|CA125 progression|0
440560|NCT00442598|1462160|P3|Overall Study|Clinical deterioration|0
440561|NCT00442598|1462161|P2|Overall Study|Clinical deterioration|2
440562|NCT00442598|1462162|P1|Overall Study|Clinical deterioration|1
440563|NCT00442598|1462160|P3|Overall Study|Tumor progression|0
440564|NCT00442598|1462161|P2|Overall Study|Tumor progression|4
440565|NCT00442598|1462162|P1|Overall Study|Tumor progression|3
440566|NCT00442598|1462160|P3|Overall Study|Adverse Event|0
440567|NCT00442598|1462161|P2|Overall Study|Adverse Event|0
440568|NCT00442598|1462162|P1|Overall Study|Adverse Event|1
440569|NCT00442572|1462180|P2|Overall Study|Withdrawal by Subject|1
440570|NCT00442572|1462181|P1|Overall Study|Withdrawal by Subject|0
440571|NCT00442572|1462180|P2|Overall Study|Lost to Follow-up|1
440572|NCT00442572|1462181|P1|Overall Study|Lost to Follow-up|0
440573|NCT00442572|1462180|P2|Overall Study|Relapse|1
440574|NCT00442572|1462181|P1|Overall Study|Relapse|8
440575|NCT00442559|1462221|P2|Overall Study|Withdrawal by Subject|0
440576|NCT00442559|1462222|P1|Overall Study|Withdrawal by Subject|1
440577|NCT00442559|1462221|P2|Overall Study|Protocol Violation|1
440578|NCT00442559|1462222|P1|Overall Study|Protocol Violation|1
440579|NCT00442559|1462221|P2|Overall Study|Lost to Follow-up|34
440580|NCT00442559|1462222|P1|Overall Study|Lost to Follow-up|32
440581|NCT00442546|1462237|P3|Overall Study|Randomized But Not Treated|6
440582|NCT00442546|1462238|P2|Overall Study|Randomized But Not Treated|4
440583|NCT00442546|1462239|P1|Overall Study|Randomized But Not Treated|5
440584|NCT00442546|1462237|P3|Overall Study|Withdrawal by Subject|7
440585|NCT00442546|1462238|P2|Overall Study|Withdrawal by Subject|5
440586|NCT00442546|1462239|P1|Overall Study|Withdrawal by Subject|5
440587|NCT00442546|1462237|P3|Overall Study|Other|6
440588|NCT00442546|1462238|P2|Overall Study|Other|9
440589|NCT00442546|1462239|P1|Overall Study|Other|4
440590|NCT00442546|1462237|P3|Overall Study|Lost to Follow-up|1
440591|NCT00442546|1462238|P2|Overall Study|Lost to Follow-up|2
440592|NCT00442546|1462239|P1|Overall Study|Lost to Follow-up|1
440593|NCT00442546|1462237|P3|Overall Study|Adverse Event|13
440594|NCT00442546|1462238|P2|Overall Study|Adverse Event|17
440595|NCT00442546|1462239|P1|Overall Study|Adverse Event|11
440596|NCT00442468|1462368|P1|Overall Study|Did not complete all study procedures|88
440597|NCT00442468|1462368|P1|Overall Study|Withdrawal by Subject|91
440598|NCT00442468|1462368|P1|Overall Study|Adverse Event|4
440599|NCT00442416|1462398|P2|Overall Study|Administrative/Other|33
440600|NCT00442416|1462399|P1|Overall Study|Administrative/Other|27
440601|NCT00442416|1462398|P2|Overall Study|Withdrew consent|2
440602|NCT00442416|1462399|P1|Overall Study|Withdrew consent|1
440603|NCT00442416|1462398|P2|Overall Study|Protocol Violation|3
440604|NCT00442416|1462399|P1|Overall Study|Protocol Violation|2
440605|NCT00442416|1462398|P2|Overall Study|Lack of Efficacy|0
440606|NCT00442416|1462399|P1|Overall Study|Lack of Efficacy|2
440607|NCT00442416|1462398|P2|Overall Study|Death|0
440608|NCT00442416|1462399|P1|Overall Study|Death|1
440609|NCT00442416|1462398|P2|Overall Study|Adverse Event|1
440610|NCT00442416|1462399|P1|Overall Study|Adverse Event|4
440611|NCT00442351|1462438|P2|Overall Study|Not specified|1
440612|NCT00442351|1462439|P1|Overall Study|Not specified|0
440613|NCT00442351|1462438|P2|Overall Study|Did not meet protocol eligibility|0
440614|NCT00442351|1462439|P1|Overall Study|Did not meet protocol eligibility|1
440615|NCT00442351|1462438|P2|Overall Study|Administrative|5
440616|NCT00442351|1462439|P1|Overall Study|Administrative|6
440617|NCT00442286|1462461|P2|Overall Study|Patient Injury|0
440618|NCT00442286|1462462|P1|Overall Study|Patient Injury|1
440619|NCT00442286|1462461|P2|Overall Study|System explanted|0
440620|NCT00442286|1462462|P1|Overall Study|System explanted|1
440621|NCT00442286|1462461|P2|Overall Study|Withdrawal by Subject|0
440622|NCT00442286|1462462|P1|Overall Study|Withdrawal by Subject|2
440623|NCT00442286|1462461|P2|Overall Study|Lost to Follow-up|0
440624|NCT00442286|1462462|P1|Overall Study|Lost to Follow-up|1
440625|NCT00442286|1462461|P2|Overall Study|Death|2
440626|NCT00442286|1462462|P1|Overall Study|Death|2
440627|NCT00442117|1462524|P2|Overall Study|Met Withdrawal Criteria|1
440628|NCT00442117|1462525|P1|Overall Study|Met Withdrawal Criteria|2
440629|NCT00442117|1462524|P2|Overall Study|Non compliance with protocol|5
440630|NCT00442117|1462525|P1|Overall Study|Non compliance with protocol|3
440631|NCT00442117|1462524|P2|Overall Study|Major Deviation|20
440632|NCT00442117|1462525|P1|Overall Study|Major Deviation|25
440633|NCT00442117|1462524|P2|Overall Study|Withdrawal by Subject|2
440634|NCT00442117|1462525|P1|Overall Study|Withdrawal by Subject|2
440635|NCT00442117|1462524|P2|Overall Study|Lost to Follow-up|2
440636|NCT00442117|1462525|P1|Overall Study|Lost to Follow-up|1
440637|NCT00442117|1462524|P2|Overall Study|Lack of Efficacy|6
440638|NCT00442117|1462525|P1|Overall Study|Lack of Efficacy|2
440639|NCT00442117|1462524|P2|Overall Study|Adverse Event|2
440640|NCT00442117|1462525|P1|Overall Study|Adverse Event|3
440641|NCT00441974|1462556|P1|Overall Study|Protocol Violation|7
440642|NCT00441974|1462556|P1|Overall Study|Lost to Follow-up|80
440643|NCT00441974|1462556|P1|Overall Study|Consent Withdrawn|35
440644|NCT00441974|1462556|P1|Overall Study|Adverse Event|6
440645|NCT00441792|1462572|P2|Overall Study|Lost to Follow-up|2
440646|NCT00441792|1462573|P1|Overall Study|Lost to Follow-up|0
440647|NCT00441727|1462613|P3|Overall Study|Various reason specified|5
440648|NCT00441727|1462614|P2|Overall Study|Various reason specified|8
440649|NCT00441727|1462615|P1|Overall Study|Various reason specified|6
440650|NCT00441727|1462613|P3|Overall Study|Safety Reasons|3
440651|NCT00441727|1462614|P2|Overall Study|Safety Reasons|1
440652|NCT00441727|1462615|P1|Overall Study|Safety Reasons|3
440653|NCT00441727|1462613|P3|Overall Study|Lost to Follow-up|5
440654|NCT00441727|1462614|P2|Overall Study|Lost to Follow-up|6
440655|NCT00441727|1462615|P1|Overall Study|Lost to Follow-up|5
440656|NCT00441727|1462613|P3|Overall Study|Withdrawal by Subject|47
440657|NCT00441727|1462614|P2|Overall Study|Withdrawal by Subject|34
440658|NCT00441727|1462615|P1|Overall Study|Withdrawal by Subject|40
440659|NCT00441727|1462613|P3|Overall Study|Lack of Efficacy|48
440660|NCT00441727|1462614|P2|Overall Study|Lack of Efficacy|8
440661|NCT00441727|1462615|P1|Overall Study|Lack of Efficacy|7
440662|NCT00441727|1462613|P3|Overall Study|Adverse Event|28
440663|NCT00441727|1462614|P2|Overall Study|Adverse Event|33
440664|NCT00441727|1462615|P1|Overall Study|Adverse Event|26
440665|NCT00441727|1462613|P3|Overall Study|Protocol Violation|32
440666|NCT00441727|1462614|P2|Overall Study|Protocol Violation|28
440667|NCT00441727|1462615|P1|Overall Study|Protocol Violation|19
440668|NCT00441701|1462648|P10|Overall Study|Withdrawal by Subject|0
440669|NCT00441701|1462649|P9|Overall Study|Withdrawal by Subject|0
440670|NCT00441701|1462650|P8|Overall Study|Withdrawal by Subject|0
440671|NCT00441701|1462651|P7|Overall Study|Withdrawal by Subject|0
440672|NCT00441701|1462652|P6|Overall Study|Withdrawal by Subject|0
440673|NCT00441701|1462653|P5|Overall Study|Withdrawal by Subject|0
440674|NCT00441701|1462654|P4|Overall Study|Withdrawal by Subject|1
440675|NCT00441701|1462655|P3|Overall Study|Withdrawal by Subject|1
440676|NCT00441701|1462656|P2|Overall Study|Withdrawal by Subject|2
440677|NCT00441701|1462657|P1|Overall Study|Withdrawal by Subject|0
440678|NCT00441701|1462648|P10|Overall Study|Lack of Efficacy|0
440679|NCT00441701|1462649|P9|Overall Study|Lack of Efficacy|0
440680|NCT00441701|1462650|P8|Overall Study|Lack of Efficacy|0
440681|NCT00441701|1462651|P7|Overall Study|Lack of Efficacy|0
440682|NCT00441701|1462652|P6|Overall Study|Lack of Efficacy|1
440683|NCT00441701|1462653|P5|Overall Study|Lack of Efficacy|0
440684|NCT00441701|1462654|P4|Overall Study|Lack of Efficacy|2
440685|NCT00441701|1462655|P3|Overall Study|Lack of Efficacy|2
440686|NCT00441701|1462656|P2|Overall Study|Lack of Efficacy|0
440687|NCT00441701|1462657|P1|Overall Study|Lack of Efficacy|2
440688|NCT00441701|1462648|P10|Overall Study|Adverse Event|0
440689|NCT00441701|1462649|P9|Overall Study|Adverse Event|0
440690|NCT00441701|1462650|P8|Overall Study|Adverse Event|0
440691|NCT00441701|1462651|P7|Overall Study|Adverse Event|0
440692|NCT00441701|1462652|P6|Overall Study|Adverse Event|2
440693|NCT00441701|1462653|P5|Overall Study|Adverse Event|2
440694|NCT00441701|1462654|P4|Overall Study|Adverse Event|0
440695|NCT00441701|1462655|P3|Overall Study|Adverse Event|1
440696|NCT00441701|1462656|P2|Overall Study|Adverse Event|2
440697|NCT00441701|1462657|P1|Overall Study|Adverse Event|3
440698|NCT00441584|1462739|P1|Overall Study|Failure to meet eligibility criteria|3
440699|NCT00441584|1462739|P1|Overall Study|Lost to Follow-up|4
440700|NCT00441584|1462739|P1|Overall Study|Protocol Violation|5
440701|NCT00441584|1462739|P1|Overall Study|Adverse Event|6
440702|NCT00441584|1462739|P1|Overall Study|Withdrawal by Subject|8
440703|NCT00441584|1462739|P1|Overall Study|Lack of Efficacy|79
440704|NCT00441545|1462747|P2|Second Intervention|Subject moved|1
440705|NCT00441545|1462748|P1|Second Intervention|Subject moved|0
440706|NCT00441545|1462747|P2|Second Intervention|Subject exceeded safety criteria|0
440707|NCT00441545|1462748|P1|Second Intervention|Subject exceeded safety criteria|1
440708|NCT00441545|1462747|P2|Second Intervention|Lack of Efficacy|1
440709|NCT00441545|1462748|P1|Second Intervention|Lack of Efficacy|0
440710|NCT00441545|1462747|P2|Second Intervention|Kidney Transplant|1
440711|NCT00441545|1462748|P1|Second Intervention|Kidney Transplant|1
440712|NCT00441545|1462747|P2|Second Intervention|Withdrawal by Subject|1
440713|NCT00441545|1462748|P1|Second Intervention|Withdrawal by Subject|1
440714|NCT00441545|1462747|P2|Second Intervention|Protocol Violation|1
440715|NCT00441545|1462748|P1|Second Intervention|Protocol Violation|4
440716|NCT00441545|1462747|P2|Second Intervention|Adverse Event|2
440717|NCT00441545|1462748|P1|Second Intervention|Adverse Event|5
440718|NCT00441545|1462747|P2|First Intervention|Sponsor's request|0
440719|NCT00441545|1462748|P1|First Intervention|Sponsor's request|1
440720|NCT00441545|1462747|P2|First Intervention|Site error|0
440721|NCT00441545|1462748|P1|First Intervention|Site error|1
440722|NCT00441545|1462747|P2|First Intervention|Extended hospitalization|0
440723|NCT00441545|1462748|P1|First Intervention|Extended hospitalization|1
440724|NCT00441545|1462747|P2|First Intervention|Subject met an exclusionary criteria|0
440725|NCT00441545|1462748|P1|First Intervention|Subject met an exclusionary criteria|1
440726|NCT00441545|1462747|P2|First Intervention|Subject exceeded safety criteria|1
440727|NCT00441545|1462748|P1|First Intervention|Subject exceeded safety criteria|0
440728|NCT00441545|1462747|P2|First Intervention|Lack of Efficacy|0
440729|NCT00441545|1462748|P1|First Intervention|Lack of Efficacy|2
440730|NCT00441545|1462747|P2|First Intervention|Kidney transplant|1
440731|NCT00441545|1462748|P1|First Intervention|Kidney transplant|1
440732|NCT00441545|1462747|P2|First Intervention|Withdrawal by Subject|3
440733|NCT00441545|1462748|P1|First Intervention|Withdrawal by Subject|3
440734|NCT00441545|1462747|P2|First Intervention|Protocol Violation|2
440735|NCT00441545|1462748|P1|First Intervention|Protocol Violation|2
440736|NCT00441545|1462747|P2|First Intervention|Adverse Event|5
440737|NCT00441545|1462748|P1|First Intervention|Adverse Event|6
440738|NCT00441480|1462762|P2|Overall Study|Withdrawal by Subject|3
440739|NCT00441480|1462763|P1|Overall Study|Withdrawal by Subject|2
440740|NCT00441480|1462762|P2|Overall Study|Protocol Violation|1
440741|NCT00441480|1462763|P1|Overall Study|Protocol Violation|1
440742|NCT00441467|1462795|P1|Overall Study|Progressive disease|9
440743|NCT00441467|1462795|P1|Overall Study|Withdrawal by Subject|3
440744|NCT00441467|1462795|P1|Overall Study|Adverse Event|6
440745|NCT00441441|1462803|P2|Overall Study|Not specified|3
440746|NCT00441441|1462804|P1|Overall Study|Not specified|3
440747|NCT00441441|1462803|P2|Overall Study|Withdrawal by Subject|2
440748|NCT00441441|1462804|P1|Overall Study|Withdrawal by Subject|1
440749|NCT00441441|1462803|P2|Overall Study|Exacerbation of asthma|2
440750|NCT00441441|1462804|P1|Overall Study|Exacerbation of asthma|1
440751|NCT00441441|1462803|P2|Overall Study|Protocol Violation|6
440752|NCT00441441|1462804|P1|Overall Study|Protocol Violation|4
440753|NCT00441441|1462803|P2|Overall Study|Adverse Event|1
440754|NCT00441441|1462804|P1|Overall Study|Adverse Event|2
440755|NCT00441363|1462864|P2|Overall Study|not specified|0
440756|NCT00441363|1462865|P1|Overall Study|not specified|2
440757|NCT00441363|1462864|P2|Overall Study|Lost to Follow-up|2
440758|NCT00441363|1462865|P1|Overall Study|Lost to Follow-up|2
440759|NCT00441363|1462864|P2|Overall Study|Physician Decision|7
440760|NCT00441363|1462865|P1|Overall Study|Physician Decision|6
440761|NCT00441363|1462864|P2|Overall Study|Withdrawal by Subject|4
440762|NCT00441363|1462865|P1|Overall Study|Withdrawal by Subject|3
440763|NCT00441363|1462864|P2|Overall Study|Adverse Event|2
440764|NCT00441363|1462865|P1|Overall Study|Adverse Event|4
440765|NCT00441337|1462877|P4|Overall Study|Did not meet inclusion criteria|0
440766|NCT00441337|1462878|P3|Overall Study|Did not meet inclusion criteria|1
440767|NCT00441337|1462879|P2|Overall Study|Did not meet inclusion criteria|0
440768|NCT00441337|1462880|P1|Overall Study|Did not meet inclusion criteria|0
440769|NCT00441337|1462877|P4|Overall Study|Sponsor Decision|2
440770|NCT00441337|1462878|P3|Overall Study|Sponsor Decision|1
440771|NCT00441337|1462879|P2|Overall Study|Sponsor Decision|0
440772|NCT00441337|1462880|P1|Overall Study|Sponsor Decision|0
440773|NCT00441337|1462877|P4|Overall Study|Lost to Follow-up|1
440774|NCT00441337|1462878|P3|Overall Study|Lost to Follow-up|0
440775|NCT00441337|1462879|P2|Overall Study|Lost to Follow-up|0
440776|NCT00441337|1462880|P1|Overall Study|Lost to Follow-up|0
440777|NCT00441337|1462877|P4|Overall Study|Disease Progression|18
440778|NCT00441337|1462878|P3|Overall Study|Disease Progression|4
440779|NCT00441337|1462879|P2|Overall Study|Disease Progression|6
440780|NCT00441337|1462880|P1|Overall Study|Disease Progression|6
440781|NCT00441272|1462993|P2|Overall Study|Study terminated prior to enrollment|25
440782|NCT00441272|1462994|P1|Overall Study|Study terminated prior to enrollment|25
440783|NCT00441168|1463021|P2|Follow-up Period|Other|3
440784|NCT00441168|1463022|P1|Follow-up Period|Other|1
440785|NCT00441168|1463021|P2|Follow-up Period|Withdrawal by Subject|0
440786|NCT00441168|1463022|P1|Follow-up Period|Withdrawal by Subject|3
440787|NCT00441168|1463021|P2|Follow-up Period|Lost to Follow-up|6
440788|NCT00441168|1463022|P1|Follow-up Period|Lost to Follow-up|5
440789|NCT00441168|1463021|P2|Follow-up Period|Death|0
440790|NCT00441168|1463022|P1|Follow-up Period|Death|3
440791|NCT00441168|1463021|P2|Treatment Period|refractory disease|0
440792|NCT00441168|1463022|P1|Treatment Period|refractory disease|1
440793|NCT00441168|1463021|P2|Treatment Period|qualified for stem-cell transplantation|0
440794|NCT00441168|1463022|P1|Treatment Period|qualified for stem-cell transplantation|3
440795|NCT00441168|1463021|P2|Treatment Period|Withdrawal by Subject|0
440796|NCT00441168|1463022|P1|Treatment Period|Withdrawal by Subject|3
440797|NCT00441168|1463021|P2|Treatment Period|Lost to Follow-up|1
440798|NCT00441168|1463022|P1|Treatment Period|Lost to Follow-up|0
440799|NCT00441168|1463021|P2|Treatment Period|Protocol Violation|1
440800|NCT00441168|1463022|P1|Treatment Period|Protocol Violation|0
440801|NCT00441168|1463021|P2|Treatment Period|Progressive Disease|2
440802|NCT00441168|1463022|P1|Treatment Period|Progressive Disease|0
440803|NCT00441168|1463021|P2|Treatment Period|Adverse Event|2
440804|NCT00441168|1463022|P1|Treatment Period|Adverse Event|1
440805|NCT00441168|1463021|P2|Treatment Period|Death|0
440806|NCT00441168|1463022|P1|Treatment Period|Death|3
440807|NCT00441142|1463036|P4|Overall Study|Death|1
440808|NCT00441142|1463037|P3|Overall Study|Death|0
440809|NCT00441142|1463038|P2|Overall Study|Death|0
440810|NCT00441142|1463039|P1|Overall Study|Death|0
440811|NCT00441142|1463036|P4|Overall Study|Physician Decision|1
440812|NCT00441142|1463037|P3|Overall Study|Physician Decision|0
440813|NCT00441142|1463038|P2|Overall Study|Physician Decision|1
440814|NCT00441142|1463039|P1|Overall Study|Physician Decision|0
440815|NCT00441142|1463036|P4|Overall Study|Patient still receiving active study tx|2
440816|NCT00441142|1463037|P3|Overall Study|Patient still receiving active study tx|0
440817|NCT00441142|1463038|P2|Overall Study|Patient still receiving active study tx|0
440818|NCT00441142|1463039|P1|Overall Study|Patient still receiving active study tx|1
440819|NCT00441142|1463036|P4|Overall Study|Withdrawal by Subject|10
440820|NCT00441142|1463037|P3|Overall Study|Withdrawal by Subject|2
440821|NCT00441142|1463038|P2|Overall Study|Withdrawal by Subject|0
440822|NCT00441142|1463039|P1|Overall Study|Withdrawal by Subject|0
440823|NCT00441142|1463036|P4|Overall Study|Lack of Efficacy|32
440824|NCT00441142|1463037|P3|Overall Study|Lack of Efficacy|17
440825|NCT00441142|1463038|P2|Overall Study|Lack of Efficacy|3
440826|NCT00441142|1463039|P1|Overall Study|Lack of Efficacy|3
440827|NCT00441142|1463036|P4|Overall Study|Adverse Event|22
440828|NCT00441142|1463037|P3|Overall Study|Adverse Event|3
440829|NCT00441142|1463038|P2|Overall Study|Adverse Event|3
440830|NCT00441142|1463039|P1|Overall Study|Adverse Event|2
440831|NCT00441116|1463057|P2|Overall Study|Did not meet Eligibility Criteria|1
440832|NCT00441116|1463058|P1|Overall Study|Did not meet Eligibility Criteria|1
440833|NCT00441116|1463057|P2|Overall Study|Withdrawal by Subject|0
440834|NCT00441116|1463058|P1|Overall Study|Withdrawal by Subject|1
440835|NCT00441116|1463057|P2|Overall Study|Adverse Event|1
440836|NCT00441116|1463058|P1|Overall Study|Adverse Event|1
440837|NCT00441103|1463126|P2|Overall Study|Participant decided to stop|1
440838|NCT00441103|1463127|P1|Overall Study|Participant decided to stop|0
440839|NCT00441103|1463126|P2|Overall Study|Participant's reason|1
440840|NCT00441103|1463127|P1|Overall Study|Participant's reason|0
440841|NCT00441103|1463126|P2|Overall Study|Participant decided to withdraw|0
440842|NCT00441103|1463127|P1|Overall Study|Participant decided to withdraw|1
440843|NCT00441103|1463126|P2|Overall Study|Non-compliant|1
440844|NCT00441103|1463127|P1|Overall Study|Non-compliant|0
440845|NCT00441103|1463126|P2|Overall Study|Inclusion criteria absent|0
440846|NCT00441103|1463127|P1|Overall Study|Inclusion criteria absent|1
440847|NCT00441103|1463126|P2|Overall Study|Participant refused MRI|0
440848|NCT00441103|1463127|P1|Overall Study|Participant refused MRI|1
440849|NCT00441103|1463126|P2|Overall Study|Participant unable to use Rebiject II|0
440850|NCT00441103|1463127|P1|Overall Study|Participant unable to use Rebiject II|1
440851|NCT00441103|1463126|P2|Overall Study|Protocol Violation|0
440852|NCT00441103|1463127|P1|Overall Study|Protocol Violation|1
440853|NCT00441103|1463126|P2|Overall Study|Lost to Follow-up|0
440854|NCT00441103|1463127|P1|Overall Study|Lost to Follow-up|1
440855|NCT00441103|1463126|P2|Overall Study|Disease Progression|0
440856|NCT00441103|1463127|P1|Overall Study|Disease Progression|2
440857|NCT00441103|1463126|P2|Overall Study|Death|0
440858|NCT00441103|1463127|P1|Overall Study|Death|1
440859|NCT00441103|1463126|P2|Overall Study|Adverse Event|1
440860|NCT00441103|1463127|P1|Overall Study|Adverse Event|2
440861|NCT00441090|1463143|P5|Overall Study|Lack of Efficacy|0
440862|NCT00441090|1463144|P4|Overall Study|Lack of Efficacy|0
440863|NCT00441090|1463145|P3|Overall Study|Lack of Efficacy|0
440864|NCT00441090|1463146|P2|Overall Study|Lack of Efficacy|0
440865|NCT00441090|1463147|P1|Overall Study|Lack of Efficacy|1
440866|NCT00441090|1463143|P5|Overall Study|Withdrawal by Subject|0
440867|NCT00441090|1463144|P4|Overall Study|Withdrawal by Subject|0
440868|NCT00441090|1463145|P3|Overall Study|Withdrawal by Subject|1
440869|NCT00441090|1463146|P2|Overall Study|Withdrawal by Subject|0
440870|NCT00441090|1463147|P1|Overall Study|Withdrawal by Subject|1
440871|NCT00441090|1463143|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
440872|NCT00441090|1463144|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
440873|NCT00441090|1463145|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
440874|NCT00441090|1463146|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
440875|NCT00441090|1463147|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
440876|NCT00441090|1463143|P5|Overall Study|Adverse Event|0
440877|NCT00441090|1463144|P4|Overall Study|Adverse Event|0
440878|NCT00441090|1463145|P3|Overall Study|Adverse Event|1
440879|NCT00441090|1463146|P2|Overall Study|Adverse Event|1
440880|NCT00441090|1463147|P1|Overall Study|Adverse Event|0
440881|NCT00441064|1463191|P2|Overall Study|Patient withdrew consent|2
440882|NCT00441064|1463192|P1|Overall Study|Patient withdrew consent|5
440883|NCT00441064|1463191|P2|Overall Study|Protocol Deviation|2
440884|NCT00441064|1463192|P1|Overall Study|Protocol Deviation|3
440885|NCT00441064|1463191|P2|Overall Study|Unsatisfactory therapeutic effect|0
440886|NCT00441064|1463192|P1|Overall Study|Unsatisfactory therapeutic effect|1
440887|NCT00441064|1463191|P2|Overall Study|Abnormal test procedure results|1
440888|NCT00441064|1463192|P1|Overall Study|Abnormal test procedure results|0
440889|NCT00441064|1463191|P2|Overall Study|Abnormal laboratory values|2
440890|NCT00441064|1463192|P1|Overall Study|Abnormal laboratory values|0
440891|NCT00441064|1463191|P2|Overall Study|Adverse Event|0
440892|NCT00441064|1463192|P1|Overall Study|Adverse Event|1
440893|NCT00441012|1463204|P2|Overall Study|Subject Randomized but Not Vaccinated|0
440894|NCT00441012|1463205|P1|Overall Study|Subject Randomized but Not Vaccinated|1
440895|NCT00441012|1463204|P2|Overall Study|Withdrawal by Subject|0
440896|NCT00441012|1463205|P1|Overall Study|Withdrawal by Subject|4
440897|NCT00441012|1463204|P2|Overall Study|Protocol Violation|9
440898|NCT00441012|1463205|P1|Overall Study|Protocol Violation|10
440899|NCT00441012|1463204|P2|Overall Study|Lost to Follow-up|3
440900|NCT00441012|1463205|P1|Overall Study|Lost to Follow-up|3
440901|NCT00441012|1463204|P2|Overall Study|Adverse Event|1
440902|NCT00441012|1463205|P1|Overall Study|Adverse Event|0
440903|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
440904|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
440905|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
440906|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
440907|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
440908|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Physician Decision|1
440909|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Physician Decision|0
440910|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Physician Decision|0
440911|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Physician Decision|0
440912|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Physician Decision|0
440913|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Other|0
440914|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Other|1
440915|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Other|0
440916|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Other|0
440917|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Other|0
440918|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
440919|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
440920|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
440921|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
440922|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
440923|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Sponsor Request|1
440924|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Sponsor Request|1
440925|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Sponsor Request|0
440926|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Sponsor Request|0
440927|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Sponsor Request|0
440928|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Participant Moved|1
440929|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Participant Moved|1
440930|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Participant Moved|0
440931|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Participant Moved|0
440932|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Participant Moved|0
440933|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Pregnancy|0
440934|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Pregnancy|3
440935|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Pregnancy|0
440936|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Pregnancy|0
440937|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Pregnancy|0
440938|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
440939|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
440940|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
440941|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
440942|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
440943|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Protocol Violation|0
440944|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Protocol Violation|1
440945|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Protocol Violation|0
440946|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Protocol Violation|0
440947|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Protocol Violation|0
440948|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
440949|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
440950|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
440951|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
440952|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
440953|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Non-compliance|1
440954|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Non-compliance|1
440955|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Non-compliance|0
440956|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Non-compliance|0
440957|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Non-compliance|0
440958|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
440959|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
440960|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
440961|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
440962|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
440963|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
440964|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
440965|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
440966|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
440967|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
440968|NCT00440947|1463219|P5|Optional 60-Week Extension Phase|Adverse Event|3
440969|NCT00440947|1463220|P4|Optional 60-Week Extension Phase|Adverse Event|1
440970|NCT00440947|1463221|P3|Optional 60-Week Extension Phase|Adverse Event|0
440971|NCT00440947|1463222|P2|Optional 60-Week Extension Phase|Adverse Event|0
440972|NCT00440947|1463223|P1|Optional 60-Week Extension Phase|Adverse Event|0
440973|NCT00440947|1463219|P5|48-Week Randomization Phase|Physician Decision|0
440974|NCT00440947|1463220|P4|48-Week Randomization Phase|Physician Decision|0
440975|NCT00440947|1463221|P3|48-Week Randomization Phase|Physician Decision|0
440976|NCT00440947|1463222|P2|48-Week Randomization Phase|Physician Decision|2
440977|NCT00440947|1463223|P1|48-Week Randomization Phase|Physician Decision|0
440978|NCT00440947|1463219|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
440979|NCT00440947|1463220|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
440980|NCT00440947|1463221|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
440981|NCT00440947|1463222|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
440982|NCT00440947|1463223|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
440983|NCT00440947|1463219|P5|48-Week Randomization Phase|Incarceration|0
440984|NCT00440947|1463220|P4|48-Week Randomization Phase|Incarceration|0
440985|NCT00440947|1463221|P3|48-Week Randomization Phase|Incarceration|0
440986|NCT00440947|1463222|P2|48-Week Randomization Phase|Incarceration|3
440987|NCT00440947|1463223|P1|48-Week Randomization Phase|Incarceration|0
440988|NCT00440947|1463219|P5|48-Week Randomization Phase|Pregnancy|0
440989|NCT00440947|1463220|P4|48-Week Randomization Phase|Pregnancy|0
440990|NCT00440947|1463221|P3|48-Week Randomization Phase|Pregnancy|1
440991|NCT00440947|1463222|P2|48-Week Randomization Phase|Pregnancy|0
440992|NCT00440947|1463223|P1|48-Week Randomization Phase|Pregnancy|0
440993|NCT00440947|1463219|P5|48-Week Randomization Phase|Withdrawal by Subject|0
440994|NCT00440947|1463220|P4|48-Week Randomization Phase|Withdrawal by Subject|0
440995|NCT00440947|1463221|P3|48-Week Randomization Phase|Withdrawal by Subject|4
440996|NCT00440947|1463222|P2|48-Week Randomization Phase|Withdrawal by Subject|2
440997|NCT00440947|1463223|P1|48-Week Randomization Phase|Withdrawal by Subject|0
440998|NCT00440947|1463219|P5|48-Week Randomization Phase|Protocol Violation|0
440999|NCT00440947|1463220|P4|48-Week Randomization Phase|Protocol Violation|0
441000|NCT00440947|1463221|P3|48-Week Randomization Phase|Protocol Violation|1
441001|NCT00440947|1463222|P2|48-Week Randomization Phase|Protocol Violation|0
441002|NCT00440947|1463223|P1|48-Week Randomization Phase|Protocol Violation|0
441003|NCT00440947|1463219|P5|48-Week Randomization Phase|Lost to Follow-up|0
441004|NCT00440947|1463220|P4|48-Week Randomization Phase|Lost to Follow-up|0
441005|NCT00440947|1463221|P3|48-Week Randomization Phase|Lost to Follow-up|8
441006|NCT00440947|1463222|P2|48-Week Randomization Phase|Lost to Follow-up|2
441007|NCT00440947|1463223|P1|48-Week Randomization Phase|Lost to Follow-up|0
441008|NCT00440947|1463219|P5|48-Week Randomization Phase|Non-compliance|0
441009|NCT00440947|1463220|P4|48-Week Randomization Phase|Non-compliance|0
441010|NCT00440947|1463221|P3|48-Week Randomization Phase|Non-compliance|4
441011|NCT00440947|1463222|P2|48-Week Randomization Phase|Non-compliance|3
441012|NCT00440947|1463223|P1|48-Week Randomization Phase|Non-compliance|0
441013|NCT00440947|1463219|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
441014|NCT00440947|1463220|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
441015|NCT00440947|1463221|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
441016|NCT00440947|1463222|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
441017|NCT00440947|1463223|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
441018|NCT00440947|1463219|P5|48-Week Randomization Phase|Adverse Event|0
441019|NCT00440947|1463220|P4|48-Week Randomization Phase|Adverse Event|0
441020|NCT00440947|1463221|P3|48-Week Randomization Phase|Adverse Event|5
441021|NCT00440947|1463222|P2|48-Week Randomization Phase|Adverse Event|2
441022|NCT00440947|1463223|P1|48-Week Randomization Phase|Adverse Event|0
441023|NCT00440947|1463219|P5|36-Week Induction Phase|Pregnancy|0
441024|NCT00440947|1463220|P4|36-Week Induction Phase|Pregnancy|0
441025|NCT00440947|1463221|P3|36-Week Induction Phase|Pregnancy|0
441026|NCT00440947|1463222|P2|36-Week Induction Phase|Pregnancy|0
441027|NCT00440947|1463223|P1|36-Week Induction Phase|Pregnancy|1
441028|NCT00440947|1463219|P5|36-Week Induction Phase|Incarceration|0
441029|NCT00440947|1463220|P4|36-Week Induction Phase|Incarceration|0
441030|NCT00440947|1463221|P3|36-Week Induction Phase|Incarceration|0
441031|NCT00440947|1463222|P2|36-Week Induction Phase|Incarceration|0
441032|NCT00440947|1463223|P1|36-Week Induction Phase|Incarceration|3
441033|NCT00440947|1463219|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
441034|NCT00440947|1463220|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
441035|NCT00440947|1463221|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
441036|NCT00440947|1463222|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
441037|NCT00440947|1463223|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
441038|NCT00440947|1463219|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
441039|NCT00440947|1463220|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
441040|NCT00440947|1463221|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
441041|NCT00440947|1463222|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
441042|NCT00440947|1463223|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
441043|NCT00440947|1463219|P5|36-Week Induction Phase|Took Exclusionary Medications|0
441044|NCT00440947|1463220|P4|36-Week Induction Phase|Took Exclusionary Medications|0
441045|NCT00440947|1463221|P3|36-Week Induction Phase|Took Exclusionary Medications|0
441046|NCT00440947|1463222|P2|36-Week Induction Phase|Took Exclusionary Medications|0
441047|NCT00440947|1463223|P1|36-Week Induction Phase|Took Exclusionary Medications|1
441048|NCT00440947|1463219|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
441049|NCT00440947|1463220|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
441050|NCT00440947|1463221|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
441051|NCT00440947|1463222|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
441052|NCT00440947|1463223|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
441053|NCT00440947|1463219|P5|36-Week Induction Phase|Withdrawal by Subject|0
441054|NCT00440947|1463220|P4|36-Week Induction Phase|Withdrawal by Subject|0
441055|NCT00440947|1463221|P3|36-Week Induction Phase|Withdrawal by Subject|0
441056|NCT00440947|1463222|P2|36-Week Induction Phase|Withdrawal by Subject|0
441057|NCT00440947|1463223|P1|36-Week Induction Phase|Withdrawal by Subject|7
441058|NCT00440947|1463219|P5|36-Week Induction Phase|Lost to Follow-up|0
441059|NCT00440947|1463220|P4|36-Week Induction Phase|Lost to Follow-up|0
441060|NCT00440947|1463221|P3|36-Week Induction Phase|Lost to Follow-up|0
441061|NCT00440947|1463222|P2|36-Week Induction Phase|Lost to Follow-up|0
441062|NCT00440947|1463223|P1|36-Week Induction Phase|Lost to Follow-up|16
441063|NCT00440947|1463219|P5|36-Week Induction Phase|Non-compliance|0
441064|NCT00440947|1463220|P4|36-Week Induction Phase|Non-compliance|0
441065|NCT00440947|1463221|P3|36-Week Induction Phase|Non-compliance|0
441066|NCT00440947|1463222|P2|36-Week Induction Phase|Non-compliance|0
441067|NCT00440947|1463223|P1|36-Week Induction Phase|Non-compliance|10
441068|NCT00440947|1463219|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
441069|NCT00440947|1463220|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
441070|NCT00440947|1463221|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
441071|NCT00440947|1463222|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
441072|NCT00440947|1463223|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
441073|NCT00440947|1463219|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
441074|NCT00440947|1463220|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
441075|NCT00440947|1463221|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
441076|NCT00440947|1463222|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
441077|NCT00440947|1463223|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
441078|NCT00440947|1463219|P5|36-Week Induction Phase|Adverse Event|0
441079|NCT00440947|1463220|P4|36-Week Induction Phase|Adverse Event|0
441080|NCT00440947|1463221|P3|36-Week Induction Phase|Adverse Event|0
441081|NCT00440947|1463222|P2|36-Week Induction Phase|Adverse Event|0
441082|NCT00440947|1463223|P1|36-Week Induction Phase|Adverse Event|16
441083|NCT00440700|1463298|P3|Overall Study|Withdrawal by Subject|4
441084|NCT00440700|1463299|P2|Overall Study|Withdrawal by Subject|8
441085|NCT00440700|1463300|P1|Overall Study|Withdrawal by Subject|8
441086|NCT00440557|1463323|P3|Overall Study|Patient had surgery|0
441087|NCT00440557|1463324|P2|Overall Study|Patient had surgery|0
441088|NCT00440557|1463325|P1|Overall Study|Patient had surgery|1
441089|NCT00440557|1463323|P3|Overall Study|Patient transferred to nursing home|0
441090|NCT00440557|1463324|P2|Overall Study|Patient transferred to nursing home|1
441091|NCT00440557|1463325|P1|Overall Study|Patient transferred to nursing home|0
441092|NCT00440557|1463323|P3|Overall Study|Principal Investigator's office closed|4
441093|NCT00440557|1463324|P2|Overall Study|Principal Investigator's office closed|6
441094|NCT00440557|1463325|P1|Overall Study|Principal Investigator's office closed|3
441095|NCT00440557|1463323|P3|Overall Study|Patient moved|1
441096|NCT00440557|1463324|P2|Overall Study|Patient moved|2
441097|NCT00440557|1463325|P1|Overall Study|Patient moved|1
441098|NCT00440557|1463323|P3|Overall Study|Principal Investigator decision|1
441099|NCT00440557|1463324|P2|Overall Study|Principal Investigator decision|3
441100|NCT00440557|1463325|P1|Overall Study|Principal Investigator decision|0
441101|NCT00440557|1463323|P3|Overall Study|Began Dialysis|4
441102|NCT00440557|1463324|P2|Overall Study|Began Dialysis|1
441103|NCT00440557|1463325|P1|Overall Study|Began Dialysis|4
441104|NCT00440557|1463323|P3|Overall Study|Death|3
441105|NCT00440557|1463324|P2|Overall Study|Death|6
441106|NCT00440557|1463325|P1|Overall Study|Death|2
441107|NCT00440557|1463323|P3|Overall Study|Adverse Event|5
441108|NCT00440557|1463324|P2|Overall Study|Adverse Event|3
441109|NCT00440557|1463325|P1|Overall Study|Adverse Event|3
441110|NCT00440557|1463323|P3|Overall Study|Lost to Follow-up|6
441111|NCT00440557|1463324|P2|Overall Study|Lost to Follow-up|2
441112|NCT00440557|1463325|P1|Overall Study|Lost to Follow-up|1
441113|NCT00440557|1463323|P3|Overall Study|Withdrawal by Subject|11
441114|NCT00440557|1463324|P2|Overall Study|Withdrawal by Subject|5
441115|NCT00440557|1463325|P1|Overall Study|Withdrawal by Subject|10
441116|NCT00440531|1463357|P3|Overall Study|see pre-assignment details|0
441117|NCT00440531|1463358|P2|Overall Study|see pre-assignment details|0
441118|NCT00440531|1463359|P1|Overall Study|see pre-assignment details|2
441119|NCT00440531|1463357|P3|Overall Study|Lost to Follow-up|5
441120|NCT00440531|1463358|P2|Overall Study|Lost to Follow-up|3
441121|NCT00440531|1463359|P1|Overall Study|Lost to Follow-up|4
441122|NCT00440531|1463357|P3|Overall Study|Protocol Violation|0
441123|NCT00440531|1463358|P2|Overall Study|Protocol Violation|2
441124|NCT00440531|1463359|P1|Overall Study|Protocol Violation|1
441125|NCT00440531|1463357|P3|Overall Study|Withdrawal by Subject|0
441126|NCT00440531|1463358|P2|Overall Study|Withdrawal by Subject|0
441127|NCT00440531|1463359|P1|Overall Study|Withdrawal by Subject|2
441128|NCT00440531|1463357|P3|Overall Study|Adverse Event|2
441129|NCT00440531|1463358|P2|Overall Study|Adverse Event|0
441130|NCT00440531|1463359|P1|Overall Study|Adverse Event|1
441131|NCT00440518|1463376|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
441132|NCT00440518|1463377|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
441133|NCT00440518|1463378|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
441134|NCT00440518|1463376|P3|Maintenance and Safety Follow-up Periods|Other|2
441135|NCT00440518|1463377|P2|Maintenance and Safety Follow-up Periods|Other|0
441136|NCT00440518|1463378|P1|Maintenance and Safety Follow-up Periods|Other|0
441137|NCT00440518|1463376|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
441138|NCT00440518|1463377|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
441139|NCT00440518|1463378|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
441140|NCT00440518|1463376|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
441141|NCT00440518|1463377|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
441142|NCT00440518|1463378|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
441143|NCT00440518|1463376|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
441144|NCT00440518|1463377|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
441145|NCT00440518|1463378|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
441146|NCT00440518|1463376|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
441147|NCT00440518|1463377|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
441148|NCT00440518|1463378|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
441149|NCT00440518|1463376|P3|Randomized /Titration Period|Adverse Event|0
441150|NCT00440518|1463377|P2|Randomized /Titration Period|Adverse Event|3
441151|NCT00440518|1463378|P1|Randomized /Titration Period|Adverse Event|2
441152|NCT00440518|1463376|P3|Randomized /Titration Period|Lost to Follow-up|1
441153|NCT00440518|1463377|P2|Randomized /Titration Period|Lost to Follow-up|2
441154|NCT00440518|1463378|P1|Randomized /Titration Period|Lost to Follow-up|2
441155|NCT00440518|1463376|P3|Randomized /Titration Period|Other|0
441156|NCT00440518|1463377|P2|Randomized /Titration Period|Other|0
441157|NCT00440518|1463378|P1|Randomized /Titration Period|Other|1
441158|NCT00440518|1463376|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
441159|NCT00440518|1463377|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
441160|NCT00440518|1463378|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
441161|NCT00440518|1463376|P3|Randomized /Titration Period|Protocol Deviation|0
441162|NCT00440518|1463377|P2|Randomized /Titration Period|Protocol Deviation|0
441163|NCT00440518|1463378|P1|Randomized /Titration Period|Protocol Deviation|1
441164|NCT00440518|1463376|P3|Randomized /Titration Period|Subject Withdrew Consent|0
441165|NCT00440518|1463377|P2|Randomized /Titration Period|Subject Withdrew Consent|1
441166|NCT00440518|1463378|P1|Randomized /Titration Period|Subject Withdrew Consent|4
441167|NCT00440518|1463376|P3|Randomized /Titration Period|Lack of Efficacy|1
441168|NCT00440518|1463377|P2|Randomized /Titration Period|Lack of Efficacy|0
441169|NCT00440518|1463378|P1|Randomized /Titration Period|Lack of Efficacy|1
441170|NCT00440466|1463423|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
441171|NCT00440466|1463424|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
441172|NCT00440466|1463425|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
441173|NCT00440466|1463423|P3|Overall Study|Began Dialysis|1
441174|NCT00440466|1463424|P2|Overall Study|Began Dialysis|0
441175|NCT00440466|1463425|P1|Overall Study|Began Dialysis|0
441176|NCT00440466|1463423|P3|Overall Study|Withdrawal by Subject|9
441177|NCT00440466|1463424|P2|Overall Study|Withdrawal by Subject|5
441178|NCT00440466|1463425|P1|Overall Study|Withdrawal by Subject|2
441179|NCT00440466|1463423|P3|Overall Study|Protocol Violation|4
441180|NCT00440466|1463424|P2|Overall Study|Protocol Violation|0
441181|NCT00440466|1463425|P1|Overall Study|Protocol Violation|2
441182|NCT00440466|1463423|P3|Overall Study|Physician Decision|1
441183|NCT00440466|1463424|P2|Overall Study|Physician Decision|0
441184|NCT00440466|1463425|P1|Overall Study|Physician Decision|2
441185|NCT00440466|1463423|P3|Overall Study|Lost to Follow-up|2
441186|NCT00440466|1463424|P2|Overall Study|Lost to Follow-up|0
441187|NCT00440466|1463425|P1|Overall Study|Lost to Follow-up|1
441188|NCT00440466|1463423|P3|Overall Study|Adverse Event|11
441189|NCT00440466|1463424|P2|Overall Study|Adverse Event|4
441190|NCT00440466|1463425|P1|Overall Study|Adverse Event|3
441191|NCT00440466|1463423|P3|Overall Study|Death|9
441192|NCT00440466|1463424|P2|Overall Study|Death|2
441193|NCT00440466|1463425|P1|Overall Study|Death|3
441194|NCT00440401|1463459|P2|Overall Study|Not specified|5
441195|NCT00440401|1463460|P1|Overall Study|Not specified|2
441196|NCT00440401|1463459|P2|Overall Study|Adverse Event|1
441197|NCT00440401|1463460|P1|Overall Study|Adverse Event|2
441198|NCT00440310|1463470|P2|Overall Study|Status Unknown|3
441199|NCT00440310|1463471|P1|Overall Study|Status Unknown|1
441200|NCT00440310|1463470|P2|Overall Study|Other|0
441201|NCT00440310|1463471|P1|Overall Study|Other|1
441202|NCT00440310|1463470|P2|Overall Study|No Reply at EOS|7
441203|NCT00440310|1463471|P1|Overall Study|No Reply at EOS|7
441204|NCT00440310|1463470|P2|Overall Study|Withdrawal by Subject|14
441205|NCT00440310|1463471|P1|Overall Study|Withdrawal by Subject|15
441206|NCT00440310|1463470|P2|Overall Study|Protocol Violation|1
441207|NCT00440310|1463471|P1|Overall Study|Protocol Violation|0
441208|NCT00440310|1463470|P2|Overall Study|Lost to Follow-up|5
441209|NCT00440310|1463471|P1|Overall Study|Lost to Follow-up|4
441210|NCT00440297|1463479|P2|Overall Study|Randomized by mistake|0
441211|NCT00440297|1463480|P1|Overall Study|Randomized by mistake|1
441212|NCT00440297|1463479|P2|Overall Study|Withdrawal by Subject|6
441213|NCT00440297|1463480|P1|Overall Study|Withdrawal by Subject|1
441214|NCT00440297|1463479|P2|Overall Study|Protocol Violation|7
441215|NCT00440297|1463480|P1|Overall Study|Protocol Violation|11
441216|NCT00440297|1463479|P2|Overall Study|Physician Decision|0
441217|NCT00440297|1463480|P1|Overall Study|Physician Decision|1
441218|NCT00440297|1463479|P2|Overall Study|Lost to Follow-up|0
441219|NCT00440297|1463480|P1|Overall Study|Lost to Follow-up|1
441220|NCT00440297|1463479|P2|Overall Study|Adverse Event|5
441221|NCT00440297|1463480|P1|Overall Study|Adverse Event|8
441222|NCT00440271|1463496|P2|Overall Study|Other|0
441223|NCT00440271|1463497|P1|Overall Study|Other|2
441224|NCT00440271|1463496|P2|Overall Study|Due to closure of trial|10
441225|NCT00440271|1463497|P1|Overall Study|Due to closure of trial|8
441226|NCT00440271|1463496|P2|Overall Study|Lack of Efficacy|1
441227|NCT00440271|1463497|P1|Overall Study|Lack of Efficacy|0
441228|NCT00440271|1463496|P2|Overall Study|Withdrawal by Subject|2
441229|NCT00440271|1463497|P1|Overall Study|Withdrawal by Subject|0
441230|NCT00440271|1463496|P2|Overall Study|Lost to Follow-up|0
441231|NCT00440271|1463497|P1|Overall Study|Lost to Follow-up|1
441232|NCT00440271|1463496|P2|Overall Study|Adverse Event|1
441233|NCT00440271|1463497|P1|Overall Study|Adverse Event|0
441234|NCT00440271|1463496|P2|Overall Study|Protocol Violation|1
441235|NCT00440271|1463497|P1|Overall Study|Protocol Violation|1
441236|NCT00440232|1463531|P2|Overall Study|Onset of headache within 4 hours of fast|2
441237|NCT00440232|1463532|P1|Overall Study|Onset of headache within 4 hours of fast|2
441238|NCT00440232|1463531|P2|Overall Study|Unable to treat within allowed time|1
441239|NCT00440232|1463532|P1|Overall Study|Unable to treat within allowed time|0
441240|NCT00440232|1463531|P2|Overall Study|Lost to Follow-up|1
441241|NCT00440232|1463532|P1|Overall Study|Lost to Follow-up|1
441242|NCT00440193|1463542|P2|Observational Period|Participant convenience|0
441243|NCT00440193|1463543|P1|Observational Period|Participant convenience|2
441244|NCT00440193|1463542|P2|Observational Period|Clinical endpoint reached|0
441245|NCT00440193|1463543|P1|Observational Period|Clinical endpoint reached|1
441246|NCT00440193|1463542|P2|Observational Period|Physician Decision|0
441247|NCT00440193|1463543|P1|Observational Period|Physician Decision|1
441248|NCT00440193|1463542|P2|Observational Period|Withdrawal by Subject|8
441249|NCT00440193|1463543|P1|Observational Period|Withdrawal by Subject|11
441250|NCT00440193|1463542|P2|Observational Period|Protocol Violation|0
441251|NCT00440193|1463543|P1|Observational Period|Protocol Violation|1
441252|NCT00440193|1463542|P2|Observational Period|Lost to Follow-up|8
441253|NCT00440193|1463543|P1|Observational Period|Lost to Follow-up|12
441254|NCT00440193|1463542|P2|Observational Period|Death|20
441255|NCT00440193|1463543|P1|Observational Period|Death|15
441256|NCT00440193|1463542|P2|Observational Period|Adverse Event|2
441257|NCT00440193|1463543|P1|Observational Period|Adverse Event|2
441258|NCT00440193|1463542|P2|Treatment Period|Site closed by investigator|2
441259|NCT00440193|1463543|P1|Treatment Period|Site closed by investigator|0
441260|NCT00440193|1463542|P2|Treatment Period|Participant did not receive treatment|13
441261|NCT00440193|1463543|P1|Treatment Period|Participant did not receive treatment|7
441262|NCT00440193|1463542|P2|Treatment Period|Participant convenience|2
441263|NCT00440193|1463543|P1|Treatment Period|Participant convenience|5
441264|NCT00440193|1463542|P2|Treatment Period|Technical problems|1
441265|NCT00440193|1463543|P1|Treatment Period|Technical problems|1
441266|NCT00440193|1463542|P2|Treatment Period|Switch to commercial drug|2
441267|NCT00440193|1463543|P1|Treatment Period|Switch to commercial drug|0
441268|NCT00440193|1463542|P2|Treatment Period|Protocol driven decision point|2
441269|NCT00440193|1463543|P1|Treatment Period|Protocol driven decision point|2
441270|NCT00440193|1463542|P2|Treatment Period|Study terminated by sponsor|94
441271|NCT00440193|1463543|P1|Treatment Period|Study terminated by sponsor|102
441272|NCT00440193|1463542|P2|Treatment Period|Clinical endpoint reached|25
441273|NCT00440193|1463543|P1|Treatment Period|Clinical endpoint reached|28
441274|NCT00440193|1463542|P2|Treatment Period|Withdrawal by Subject|77
441275|NCT00440193|1463543|P1|Treatment Period|Withdrawal by Subject|36
441276|NCT00440193|1463542|P2|Treatment Period|Protocol Violation|19
441277|NCT00440193|1463543|P1|Treatment Period|Protocol Violation|16
441278|NCT00440193|1463542|P2|Treatment Period|Physician Decision|6
441279|NCT00440193|1463543|P1|Treatment Period|Physician Decision|3
441280|NCT00440193|1463542|P2|Treatment Period|Lost to Follow-up|18
441281|NCT00440193|1463543|P1|Treatment Period|Lost to Follow-up|12
441282|NCT00440193|1463542|P2|Treatment Period|Lack of Efficacy|1
441283|NCT00440193|1463543|P1|Treatment Period|Lack of Efficacy|0
441284|NCT00440193|1463542|P2|Treatment Period|Death|22
441285|NCT00440193|1463543|P1|Treatment Period|Death|19
441286|NCT00440193|1463542|P2|Treatment Period|Adverse Event|67
441287|NCT00440193|1463543|P1|Treatment Period|Adverse Event|74
441288|NCT00440115|1463589|P3|Overall Study|Incarceration|1
441289|NCT00440115|1463590|P2|Overall Study|Incarceration|2
441290|NCT00440115|1463591|P1|Overall Study|Incarceration|0
441291|NCT00440115|1463589|P3|Overall Study|Death|5
441292|NCT00440115|1463590|P2|Overall Study|Death|9
441293|NCT00440115|1463591|P1|Overall Study|Death|7
441294|NCT00440011|1463622|P2|Overall Study|Withdrawal by Subject|0
441295|NCT00440011|1463623|P1|Overall Study|Withdrawal by Subject|1
441296|NCT00440011|1463622|P2|Overall Study|Protocol Violation|1
441297|NCT00440011|1463623|P1|Overall Study|Protocol Violation|1
441298|NCT00440011|1463622|P2|Overall Study|Lost to Follow-up|2
441299|NCT00440011|1463623|P1|Overall Study|Lost to Follow-up|0
441300|NCT00440011|1463622|P2|Overall Study|Adverse Event|0
441301|NCT00440011|1463623|P1|Overall Study|Adverse Event|2
441302|NCT00439777|1463650|P2|Observational Period|Technical problems|1
441303|NCT00439777|1463651|P1|Observational Period|Technical problems|0
441304|NCT00439777|1463650|P2|Observational Period|Lack of Efficacy|0
441305|NCT00439777|1463651|P1|Observational Period|Lack of Efficacy|1
441306|NCT00439777|1463650|P2|Observational Period|Protocol driven decision point|1
441307|NCT00439777|1463651|P1|Observational Period|Protocol driven decision point|0
441308|NCT00439777|1463650|P2|Observational Period|Study terminated by sponsor|1
441309|NCT00439777|1463651|P1|Observational Period|Study terminated by sponsor|3
441310|NCT00439777|1463650|P2|Observational Period|Death|20
441311|NCT00439777|1463651|P1|Observational Period|Death|27
441312|NCT00439777|1463650|P2|Observational Period|Lost to Follow-up|11
441313|NCT00439777|1463651|P1|Observational Period|Lost to Follow-up|1
441314|NCT00439777|1463650|P2|Observational Period|Withdrawal by Subject|5
441315|NCT00439777|1463651|P1|Observational Period|Withdrawal by Subject|9
441316|NCT00439777|1463650|P2|Observational Period|Protocol Violation|2
441317|NCT00439777|1463651|P1|Observational Period|Protocol Violation|0
441318|NCT00439777|1463650|P2|Treatment Period|Participant convenience|8
441319|NCT00439777|1463651|P1|Treatment Period|Participant convenience|12
441320|NCT00439777|1463650|P2|Treatment Period|Technical problems|1
441321|NCT00439777|1463651|P1|Treatment Period|Technical problems|3
441322|NCT00439777|1463650|P2|Treatment Period|Clinical endpoint reached|13
441323|NCT00439777|1463651|P1|Treatment Period|Clinical endpoint reached|26
441324|NCT00439777|1463650|P2|Treatment Period|Physician Decision|18
441325|NCT00439777|1463651|P1|Treatment Period|Physician Decision|7
441326|NCT00439777|1463650|P2|Treatment Period|Protocol driven decision point|3
441327|NCT00439777|1463651|P1|Treatment Period|Protocol driven decision point|1
441328|NCT00439777|1463650|P2|Treatment Period|Lost to Follow-up|10
441329|NCT00439777|1463651|P1|Treatment Period|Lost to Follow-up|8
441330|NCT00439777|1463650|P2|Treatment Period|Lack of Efficacy|4
441331|NCT00439777|1463651|P1|Treatment Period|Lack of Efficacy|1
441332|NCT00439777|1463650|P2|Treatment Period|Withdrawal by Subject|118
441333|NCT00439777|1463651|P1|Treatment Period|Withdrawal by Subject|66
441334|NCT00439777|1463650|P2|Treatment Period|Protocol Violation|30
441335|NCT00439777|1463651|P1|Treatment Period|Protocol Violation|23
441336|NCT00439777|1463650|P2|Treatment Period|Adverse Event|92
441337|NCT00439777|1463651|P1|Treatment Period|Adverse Event|111
441338|NCT00439777|1463650|P2|Treatment Period|Did not take study treatment|8
441339|NCT00439777|1463651|P1|Treatment Period|Did not take study treatment|7
441340|NCT00439777|1463650|P2|Treatment Period|Site closed by investigator|1
441341|NCT00439777|1463651|P1|Treatment Period|Site closed by investigator|0
441342|NCT00439777|1463650|P2|Treatment Period|Study terminated by sponsor|132
441343|NCT00439777|1463651|P1|Treatment Period|Study terminated by sponsor|125
441344|NCT00439777|1463650|P2|Treatment Period|Death|21
441345|NCT00439777|1463651|P1|Treatment Period|Death|29
441346|NCT00439738|1463689|P2|Overall Study|Abnormal Lab Values|0
441347|NCT00439738|1463690|P1|Overall Study|Abnormal Lab Values|1
441348|NCT00439738|1463689|P2|Overall Study|Lack of Efficacy|2
441349|NCT00439738|1463690|P1|Overall Study|Lack of Efficacy|2
441350|NCT00439738|1463689|P2|Overall Study|Protocol Violation|3
441351|NCT00439738|1463690|P1|Overall Study|Protocol Violation|6
441352|NCT00439738|1463689|P2|Overall Study|Lost to Follow-up|6
441353|NCT00439738|1463690|P1|Overall Study|Lost to Follow-up|5
441354|NCT00439738|1463689|P2|Overall Study|Adverse Event|4
441355|NCT00439738|1463690|P1|Overall Study|Adverse Event|6
441356|NCT00439738|1463689|P2|Overall Study|Withdrawal by Subject|13
441357|NCT00439738|1463690|P1|Overall Study|Withdrawal by Subject|16
441358|NCT00439725|1463708|P2|Observational Period|Participant convenience|0
441359|NCT00439725|1463709|P1|Observational Period|Participant convenience|1
441360|NCT00439725|1463708|P2|Observational Period|Technical problems|0
441361|NCT00439725|1463709|P1|Observational Period|Technical problems|1
441362|NCT00439725|1463708|P2|Observational Period|Clinical endpoint reached|1
441363|NCT00439725|1463709|P1|Observational Period|Clinical endpoint reached|3
441364|NCT00439725|1463708|P2|Observational Period|Study termination by sponsor|1
441365|NCT00439725|1463709|P1|Observational Period|Study termination by sponsor|1
441366|NCT00439725|1463708|P2|Observational Period|Death|2
441367|NCT00439725|1463709|P1|Observational Period|Death|0
441368|NCT00439725|1463708|P2|Observational Period|Lost to Follow-up|1
441369|NCT00439725|1463709|P1|Observational Period|Lost to Follow-up|0
441370|NCT00439725|1463708|P2|Observational Period|Withdrawal by Subject|2
441371|NCT00439725|1463709|P1|Observational Period|Withdrawal by Subject|2
441372|NCT00439725|1463708|P2|Treatment Period|Participant did not receive treatment|4
441373|NCT00439725|1463709|P1|Treatment Period|Participant did not receive treatment|4
441374|NCT00439725|1463708|P2|Treatment Period|Death|1
441375|NCT00439725|1463709|P1|Treatment Period|Death|1
441376|NCT00439725|1463708|P2|Treatment Period|Protocol driven decision point|1
441377|NCT00439725|1463709|P1|Treatment Period|Protocol driven decision point|1
441378|NCT00439725|1463708|P2|Treatment Period|Participant convenience|0
441379|NCT00439725|1463709|P1|Treatment Period|Participant convenience|1
441380|NCT00439725|1463708|P2|Treatment Period|Lost to Follow-up|1
441381|NCT00439725|1463709|P1|Treatment Period|Lost to Follow-up|1
441382|NCT00439725|1463708|P2|Treatment Period|Technical problems|0
441383|NCT00439725|1463709|P1|Treatment Period|Technical problems|1
441384|NCT00439725|1463708|P2|Treatment Period|Clinical endpoint reached|50
441385|NCT00439725|1463709|P1|Treatment Period|Clinical endpoint reached|6
441386|NCT00439725|1463708|P2|Treatment Period|Protocol Violation|1
441387|NCT00439725|1463709|P1|Treatment Period|Protocol Violation|2
441388|NCT00439725|1463708|P2|Treatment Period|Physician Decision|1
441389|NCT00439725|1463709|P1|Treatment Period|Physician Decision|1
441390|NCT00439725|1463708|P2|Treatment Period|Adverse Event|18
441391|NCT00439725|1463709|P1|Treatment Period|Adverse Event|39
441392|NCT00439725|1463708|P2|Treatment Period|Site closed by investigator|2
441393|NCT00439725|1463709|P1|Treatment Period|Site closed by investigator|1
441394|NCT00439725|1463708|P2|Treatment Period|Study terminated by sponsor|148
441395|NCT00439725|1463709|P1|Treatment Period|Study terminated by sponsor|156
441396|NCT00439725|1463708|P2|Treatment Period|Withdrawal by Subject|19
441397|NCT00439725|1463709|P1|Treatment Period|Withdrawal by Subject|22
441398|NCT00439647|1463755|P2|Overall Study|Lack of Efficacy|4
441399|NCT00439647|1463756|P1|Overall Study|Lack of Efficacy|0
441400|NCT00439647|1463755|P2|Overall Study|Protocol Violation|4
441401|NCT00439647|1463756|P1|Overall Study|Protocol Violation|3
441402|NCT00439647|1463755|P2|Overall Study|Lost to Follow-up|12
441403|NCT00439647|1463756|P1|Overall Study|Lost to Follow-up|4
441404|NCT00439647|1463755|P2|Overall Study|Adverse Event|11
441405|NCT00439647|1463756|P1|Overall Study|Adverse Event|11
441406|NCT00439647|1463755|P2|Overall Study|Death|18
441407|NCT00439647|1463756|P1|Overall Study|Death|15
441408|NCT00439647|1463755|P2|Overall Study|Withdrawal by Subject|22
441409|NCT00439647|1463756|P1|Overall Study|Withdrawal by Subject|25
441410|NCT00439569|1463792|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
441411|NCT00439569|1463792|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
441412|NCT00439569|1463792|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
441413|NCT00439517|1463805|P2|Overall Study|Subject in survival follow-up|0
441414|NCT00439517|1463806|P1|Overall Study|Subject in survival follow-up|1
441415|NCT00439517|1463805|P2|Overall Study|Subject on treatment|0
441416|NCT00439517|1463806|P1|Overall Study|Subject on treatment|1
441417|NCT00439309|1463874|P2|Follow-Up|Late response by subject|1
441418|NCT00439309|1463875|P1|Follow-Up|Late response by subject|0
441419|NCT00439309|1463874|P2|Follow-Up|Withdrawal by Subject|1
441420|NCT00439309|1463875|P1|Follow-Up|Withdrawal by Subject|0
441421|NCT00439309|1463874|P2|Follow-Up|Lost to Follow-up|0
441422|NCT00439309|1463875|P1|Follow-Up|Lost to Follow-up|2
441423|NCT00439309|1463874|P2|Follow-Up|Death|0
441424|NCT00439309|1463875|P1|Follow-Up|Death|1
441425|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
441426|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
441427|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
441428|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
441429|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
441430|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
441431|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
441432|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
441433|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
441434|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
441435|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
441436|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
441437|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
441438|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
441439|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
441440|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
441441|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
441442|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
441443|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
441444|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
441445|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
441446|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
441447|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
441448|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
441449|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
441450|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
441451|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
441452|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
441453|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
441454|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
441455|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
441456|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
441457|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
441458|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
441459|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
441460|NCT00439270|1463894|P5|Phase 2 (51.6 Months)|Disease progression|0
441461|NCT00439270|1463895|P4|Phase 2 (51.6 Months)|Disease progression|18
441462|NCT00439270|1463896|P3|Phase 2 (51.6 Months)|Disease progression|0
441463|NCT00439270|1463897|P2|Phase 2 (51.6 Months)|Disease progression|0
441464|NCT00439270|1463898|P1|Phase 2 (51.6 Months)|Disease progression|0
441465|NCT00439270|1463894|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
441466|NCT00439270|1463895|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
441467|NCT00439270|1463896|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
441468|NCT00439270|1463897|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
441469|NCT00439270|1463898|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
441470|NCT00439270|1463894|P5|Phase 1 (18.1 Months)|Disease progression|3
441471|NCT00439270|1463895|P4|Phase 1 (18.1 Months)|Disease progression|0
441472|NCT00439270|1463896|P3|Phase 1 (18.1 Months)|Disease progression|3
441473|NCT00439270|1463897|P2|Phase 1 (18.1 Months)|Disease progression|2
441474|NCT00439270|1463898|P1|Phase 1 (18.1 Months)|Disease progression|3
441475|NCT00439244|1463940|P3|Overall Study|Administrative problems|0
441476|NCT00439244|1463941|P2|Overall Study|Administrative problems|0
441477|NCT00439244|1463942|P1|Overall Study|Administrative problems|1
441478|NCT00439244|1463940|P3|Overall Study|Protocol Violation|0
441479|NCT00439244|1463941|P2|Overall Study|Protocol Violation|1
441480|NCT00439244|1463942|P1|Overall Study|Protocol Violation|0
441481|NCT00439244|1463940|P3|Overall Study|Death|0
441482|NCT00439244|1463941|P2|Overall Study|Death|1
441483|NCT00439244|1463942|P1|Overall Study|Death|0
441484|NCT00439244|1463940|P3|Overall Study|Lost to Follow-up|2
441485|NCT00439244|1463941|P2|Overall Study|Lost to Follow-up|1
441486|NCT00439244|1463942|P1|Overall Study|Lost to Follow-up|2
441487|NCT00439244|1463940|P3|Overall Study|Withdrawal by Subject|2
441488|NCT00439244|1463941|P2|Overall Study|Withdrawal by Subject|1
441489|NCT00439244|1463942|P1|Overall Study|Withdrawal by Subject|3
441490|NCT00439244|1463940|P3|Overall Study|Adverse Event|3
441491|NCT00439244|1463941|P2|Overall Study|Adverse Event|2
441492|NCT00439244|1463942|P1|Overall Study|Adverse Event|5
441493|NCT00439231|1463962|P1|Overall Study|Lack of Efficacy|28
441494|NCT00439218|1463966|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
441495|NCT00439179|1463981|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
441496|NCT00439179|1463982|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
441497|NCT00439179|1463983|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
441498|NCT00439179|1463984|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
441499|NCT00439140|1464001|P3|Treatment Cycle 2|Lost to Follow-up|0
441500|NCT00439140|1464002|P2|Treatment Cycle 2|Lost to Follow-up|1
441501|NCT00439140|1464003|P1|Treatment Cycle 2|Lost to Follow-up|1
441502|NCT00439140|1464001|P3|Treatment Cycle 2|Withdrawal by Subject|0
441503|NCT00439140|1464002|P2|Treatment Cycle 2|Withdrawal by Subject|0
441504|NCT00439140|1464003|P1|Treatment Cycle 2|Withdrawal by Subject|1
441505|NCT00439140|1464001|P3|Treatment Cycle 1|Withdrawal by Subject|0
441506|NCT00439140|1464002|P2|Treatment Cycle 1|Withdrawal by Subject|1
441507|NCT00439140|1464003|P1|Treatment Cycle 1|Withdrawal by Subject|0
441508|NCT00439140|1464001|P3|Treatment Cycle 1|Personal reasons|0
441509|NCT00439140|1464002|P2|Treatment Cycle 1|Personal reasons|2
441510|NCT00439140|1464003|P1|Treatment Cycle 1|Personal reasons|0
441511|NCT00439140|1464001|P3|Treatment Cycle 1|Lost to Follow-up|1
441512|NCT00439140|1464002|P2|Treatment Cycle 1|Lost to Follow-up|1
441513|NCT00439140|1464003|P1|Treatment Cycle 1|Lost to Follow-up|1
441514|NCT00438815|1464086|P1|Overall Study|Death|1
441515|NCT00438815|1464086|P1|Overall Study|Withdrawal by Subject|6
441516|NCT00438815|1464086|P1|Overall Study|Lost to Follow-up|6
441517|NCT00438815|1464086|P1|Overall Study|Transitioned to commercial C1INH-nf|6
441518|NCT00438815|1464086|P1|Overall Study|Noncompliance with protocol requirements|9
441519|NCT00438815|1464086|P1|Overall Study|3-month follow-up no longer required|12
441520|NCT00438815|1464086|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
441521|NCT00438672|1464136|P2|Overall Study|Lost to Follow-up|9
441522|NCT00438672|1464137|P1|Overall Study|Lost to Follow-up|7
441523|NCT00438659|1464147|P2|Overall Study|Cancel|2
441524|NCT00438659|1464148|P1|Overall Study|Cancel|5
441525|NCT00438659|1464147|P2|Overall Study|Discontinued Mometasone/Placebo|2
441526|NCT00438659|1464148|P1|Overall Study|Discontinued Mometasone/Placebo|1
441527|NCT00438464|1464187|P2|Overall Study|Incomplete data submission|2
441528|NCT00438464|1464188|P1|Overall Study|Incomplete data submission|0
441529|NCT00438464|1464187|P2|Overall Study|Terminated Early|5
441530|NCT00438464|1464188|P1|Overall Study|Terminated Early|14
441531|NCT00438399|1464289|P6|Overall Study|Patien stopped study at visit 4 by error|0
441532|NCT00438399|1464290|P5|Overall Study|Patien stopped study at visit 4 by error|0
441533|NCT00438399|1464291|P4|Overall Study|Patien stopped study at visit 4 by error|0
441534|NCT00438399|1464292|P3|Overall Study|Patien stopped study at visit 4 by error|0
441535|NCT00438399|1464293|P2|Overall Study|Patien stopped study at visit 4 by error|0
441536|NCT00438399|1464294|P1|Overall Study|Patien stopped study at visit 4 by error|1
441537|NCT00438399|1464289|P6|Overall Study|Pregnancy|1
441538|NCT00438399|1464290|P5|Overall Study|Pregnancy|0
441539|NCT00438399|1464291|P4|Overall Study|Pregnancy|0
441540|NCT00438399|1464292|P3|Overall Study|Pregnancy|0
441541|NCT00438399|1464293|P2|Overall Study|Pregnancy|0
441542|NCT00438399|1464294|P1|Overall Study|Pregnancy|0
441543|NCT00438399|1464289|P6|Overall Study|Subje stopped study|0
441544|NCT00438399|1464290|P5|Overall Study|Subje stopped study|0
441545|NCT00438399|1464291|P4|Overall Study|Subje stopped study|0
441546|NCT00438399|1464292|P3|Overall Study|Subje stopped study|1
441547|NCT00438399|1464293|P2|Overall Study|Subje stopped study|0
441548|NCT00438399|1464294|P1|Overall Study|Subje stopped study|0
441549|NCT00438399|1464289|P6|Overall Study|Protocol Violation|1
441550|NCT00438399|1464290|P5|Overall Study|Protocol Violation|0
441551|NCT00438399|1464291|P4|Overall Study|Protocol Violation|0
441552|NCT00438399|1464292|P3|Overall Study|Protocol Violation|1
441553|NCT00438399|1464293|P2|Overall Study|Protocol Violation|0
441554|NCT00438399|1464294|P1|Overall Study|Protocol Violation|0
441555|NCT00438399|1464289|P6|Overall Study|Withdrawal by Subject|2
441556|NCT00438399|1464290|P5|Overall Study|Withdrawal by Subject|2
441557|NCT00438399|1464291|P4|Overall Study|Withdrawal by Subject|2
441558|NCT00438399|1464292|P3|Overall Study|Withdrawal by Subject|3
441559|NCT00438399|1464293|P2|Overall Study|Withdrawal by Subject|6
441560|NCT00438399|1464294|P1|Overall Study|Withdrawal by Subject|5
441561|NCT00438399|1464289|P6|Overall Study|Adverse Event|1
441562|NCT00438399|1464290|P5|Overall Study|Adverse Event|0
441563|NCT00438399|1464291|P4|Overall Study|Adverse Event|1
441564|NCT00438399|1464292|P3|Overall Study|Adverse Event|1
441565|NCT00438399|1464293|P2|Overall Study|Adverse Event|0
441566|NCT00438399|1464294|P1|Overall Study|Adverse Event|0
441567|NCT00438399|1464289|P6|Overall Study|Lost to Follow-up|1
441568|NCT00438399|1464290|P5|Overall Study|Lost to Follow-up|1
441569|NCT00438399|1464291|P4|Overall Study|Lost to Follow-up|1
441570|NCT00438399|1464292|P3|Overall Study|Lost to Follow-up|1
441571|NCT00438399|1464293|P2|Overall Study|Lost to Follow-up|2
441572|NCT00438399|1464294|P1|Overall Study|Lost to Follow-up|2
441573|NCT00438360|1464305|P2|Overall Study|not specified|15
441574|NCT00438360|1464306|P1|Overall Study|not specified|24
441575|NCT00438360|1464305|P2|Overall Study|Lack of Efficacy|27
441576|NCT00438360|1464306|P1|Overall Study|Lack of Efficacy|42
441577|NCT00438360|1464305|P2|Overall Study|Adverse Event|1
441578|NCT00438360|1464306|P1|Overall Study|Adverse Event|6
441579|NCT00437983|1464354|P2|Overall Study|Withdrawal by Subject|6
441580|NCT00437983|1464355|P1|Overall Study|Withdrawal by Subject|5
441581|NCT00437983|1464354|P2|Overall Study|Protocol Violation|1
441582|NCT00437983|1464355|P1|Overall Study|Protocol Violation|2
441583|NCT00437983|1464354|P2|Overall Study|Adverse Event|6
441584|NCT00437983|1464355|P1|Overall Study|Adverse Event|6
441585|NCT00437645|1464367|P2|Overall Study|Condition no longer requires study drug|1
441586|NCT00437645|1464368|P1|Overall Study|Condition no longer requires study drug|1
441587|NCT00437645|1464367|P2|Overall Study|Lack of Efficacy|1
441588|NCT00437645|1464368|P1|Overall Study|Lack of Efficacy|2
441589|NCT00437645|1464367|P2|Overall Study|Administrative problems|1
441590|NCT00437645|1464368|P1|Overall Study|Administrative problems|2
441591|NCT00437645|1464367|P2|Overall Study|Lost to Follow-up|3
441592|NCT00437645|1464368|P1|Overall Study|Lost to Follow-up|2
441593|NCT00437645|1464367|P2|Overall Study|Protocol Violation|3
441594|NCT00437645|1464368|P1|Overall Study|Protocol Violation|3
441595|NCT00437645|1464367|P2|Overall Study|Withdrawal by Subject|22
441596|NCT00437645|1464368|P1|Overall Study|Withdrawal by Subject|10
441597|NCT00437645|1464367|P2|Overall Study|Adverse Event|84
441598|NCT00437645|1464368|P1|Overall Study|Adverse Event|15
441599|NCT00437489|1464384|P2|Overall Study|Lost to Follow-up|1
441600|NCT00437489|1464385|P1|Overall Study|Lost to Follow-up|0
441601|NCT00437489|1464384|P2|Overall Study|Study terminated by sponsor|21
441602|NCT00437489|1464385|P1|Overall Study|Study terminated by sponsor|23
441603|NCT00437281|1464422|P20|Overall Study|Lost to Follow-up|1
441604|NCT00437281|1464423|P19|Overall Study|Lost to Follow-up|0
441605|NCT00437281|1464424|P18|Overall Study|Lost to Follow-up|0
441606|NCT00437281|1464425|P17|Overall Study|Lost to Follow-up|0
441607|NCT00437281|1464426|P16|Overall Study|Lost to Follow-up|0
441608|NCT00437281|1464427|P15|Overall Study|Lost to Follow-up|0
441609|NCT00437281|1464428|P14|Overall Study|Lost to Follow-up|0
441610|NCT00437281|1464429|P13|Overall Study|Lost to Follow-up|0
441611|NCT00437281|1464430|P12|Overall Study|Lost to Follow-up|0
441612|NCT00437281|1464431|P11|Overall Study|Lost to Follow-up|0
441613|NCT00437281|1464432|P10|Overall Study|Lost to Follow-up|0
441614|NCT00437281|1464433|P9|Overall Study|Lost to Follow-up|0
441615|NCT00437281|1464434|P8|Overall Study|Lost to Follow-up|0
441616|NCT00437281|1464435|P7|Overall Study|Lost to Follow-up|0
441617|NCT00437281|1464436|P6|Overall Study|Lost to Follow-up|0
441618|NCT00437281|1464437|P5|Overall Study|Lost to Follow-up|0
441619|NCT00437281|1464438|P4|Overall Study|Lost to Follow-up|0
441620|NCT00437281|1464439|P3|Overall Study|Lost to Follow-up|0
441621|NCT00437281|1464440|P2|Overall Study|Lost to Follow-up|0
441622|NCT00437281|1464441|P1|Overall Study|Lost to Follow-up|0
441623|NCT00437281|1464422|P20|Overall Study|Adverse Event|0
441624|NCT00437281|1464423|P19|Overall Study|Adverse Event|1
441625|NCT00437281|1464424|P18|Overall Study|Adverse Event|0
441626|NCT00437281|1464425|P17|Overall Study|Adverse Event|0
441627|NCT00437281|1464426|P16|Overall Study|Adverse Event|0
441628|NCT00437281|1464427|P15|Overall Study|Adverse Event|1
441629|NCT00437281|1464428|P14|Overall Study|Adverse Event|1
441630|NCT00437281|1464429|P13|Overall Study|Adverse Event|0
441631|NCT00437281|1464430|P12|Overall Study|Adverse Event|0
441632|NCT00437281|1464431|P11|Overall Study|Adverse Event|0
441633|NCT00437281|1464432|P10|Overall Study|Adverse Event|1
441634|NCT00437281|1464433|P9|Overall Study|Adverse Event|0
441635|NCT00437281|1464434|P8|Overall Study|Adverse Event|0
441636|NCT00437281|1464435|P7|Overall Study|Adverse Event|0
441637|NCT00437281|1464436|P6|Overall Study|Adverse Event|1
441638|NCT00437281|1464437|P5|Overall Study|Adverse Event|0
441639|NCT00437281|1464438|P4|Overall Study|Adverse Event|1
441640|NCT00437281|1464439|P3|Overall Study|Adverse Event|0
441641|NCT00437281|1464440|P2|Overall Study|Adverse Event|0
441642|NCT00437281|1464441|P1|Overall Study|Adverse Event|0
441643|NCT00437203|1464745|P10|Overall Study|Other|0
441644|NCT00437203|1464746|P9|Overall Study|Other|0
441645|NCT00437203|1464747|P8|Overall Study|Other|0
441646|NCT00437203|1464748|P7|Overall Study|Other|1
441647|NCT00437203|1464749|P6|Overall Study|Other|0
441648|NCT00437203|1464750|P5|Overall Study|Other|0
441649|NCT00437203|1464751|P4|Overall Study|Other|0
441650|NCT00437203|1464752|P3|Overall Study|Other|0
441651|NCT00437203|1464753|P2|Overall Study|Other|1
441652|NCT00437203|1464754|P1|Overall Study|Other|0
441653|NCT00437203|1464745|P10|Overall Study|Objective progression or relapse|2
441654|NCT00437203|1464746|P9|Overall Study|Objective progression or relapse|2
441655|NCT00437203|1464747|P8|Overall Study|Objective progression or relapse|1
441656|NCT00437203|1464748|P7|Overall Study|Objective progression or relapse|6
441657|NCT00437203|1464749|P6|Overall Study|Objective progression or relapse|3
441658|NCT00437203|1464750|P5|Overall Study|Objective progression or relapse|3
441659|NCT00437203|1464751|P4|Overall Study|Objective progression or relapse|3
441660|NCT00437203|1464752|P3|Overall Study|Objective progression or relapse|2
441661|NCT00437203|1464753|P2|Overall Study|Objective progression or relapse|6
441662|NCT00437203|1464754|P1|Overall Study|Objective progression or relapse|5
441663|NCT00437203|1464745|P10|Overall Study|Study terminated by sponsor|0
441664|NCT00437203|1464746|P9|Overall Study|Study terminated by sponsor|1
441665|NCT00437203|1464747|P8|Overall Study|Study terminated by sponsor|0
441666|NCT00437203|1464748|P7|Overall Study|Study terminated by sponsor|0
441667|NCT00437203|1464749|P6|Overall Study|Study terminated by sponsor|0
441668|NCT00437203|1464750|P5|Overall Study|Study terminated by sponsor|0
441669|NCT00437203|1464751|P4|Overall Study|Study terminated by sponsor|0
441670|NCT00437203|1464752|P3|Overall Study|Study terminated by sponsor|0
441671|NCT00437203|1464753|P2|Overall Study|Study terminated by sponsor|0
441672|NCT00437203|1464754|P1|Overall Study|Study terminated by sponsor|0
441673|NCT00437203|1464745|P10|Overall Study|Adverse Event|1
441674|NCT00437203|1464746|P9|Overall Study|Adverse Event|0
441675|NCT00437203|1464747|P8|Overall Study|Adverse Event|1
441676|NCT00437203|1464748|P7|Overall Study|Adverse Event|0
441677|NCT00437203|1464749|P6|Overall Study|Adverse Event|0
441678|NCT00437203|1464750|P5|Overall Study|Adverse Event|0
441679|NCT00437203|1464751|P4|Overall Study|Adverse Event|0
441680|NCT00437203|1464752|P3|Overall Study|Adverse Event|0
441681|NCT00437203|1464753|P2|Overall Study|Adverse Event|1
441682|NCT00437203|1464754|P1|Overall Study|Adverse Event|1
441683|NCT00437203|1464745|P10|Overall Study|Death|1
441684|NCT00437203|1464746|P9|Overall Study|Death|0
441685|NCT00437203|1464747|P8|Overall Study|Death|1
441686|NCT00437203|1464748|P7|Overall Study|Death|0
441687|NCT00437203|1464749|P6|Overall Study|Death|0
441688|NCT00437203|1464750|P5|Overall Study|Death|0
441689|NCT00437203|1464751|P4|Overall Study|Death|0
441690|NCT00437203|1464752|P3|Overall Study|Death|1
441691|NCT00437203|1464753|P2|Overall Study|Death|0
441692|NCT00437203|1464754|P1|Overall Study|Death|0
441693|NCT00437125|1464858|P1|Overall Study|Physician Decision|1
441694|NCT00437125|1464858|P1|Overall Study|Withdrawal by Caregiver|2
441695|NCT00437125|1464858|P1|Overall Study|Withdrawal by Subject|13
441696|NCT00437125|1464858|P1|Overall Study|Lost to Follow-up|1
441697|NCT00437125|1464858|P1|Overall Study|Lack of Efficacy|1
441698|NCT00437125|1464858|P1|Overall Study|Clinical Relapse|1
441699|NCT00437125|1464858|P1|Overall Study|Death|1
441700|NCT00437125|1464858|P1|Overall Study|Adverse Event|12
441701|NCT00437073|1464879|P2|Overall Study|Physician Decision|1
441702|NCT00437073|1464880|P1|Overall Study|Physician Decision|0
441703|NCT00437073|1464879|P2|Overall Study|Sponsor Terminated Study|0
441704|NCT00437073|1464880|P1|Overall Study|Sponsor Terminated Study|1
441705|NCT00437034|1464908|P1|Overall Study|Disease progression during treatment|5
441706|NCT00437034|1464908|P1|Overall Study|Adverse Event|1
441707|NCT00436982|1464914|P2|Overall Study|no RSA data|2
441708|NCT00436982|1464915|P1|Overall Study|no RSA data|1
441709|NCT00436982|1464914|P2|Overall Study|Did not receive allocated intervention|1
441710|NCT00436982|1464915|P1|Overall Study|Did not receive allocated intervention|0
441711|NCT00436982|1464914|P2|Overall Study|Withdrawal by Subject|1
441712|NCT00436982|1464915|P1|Overall Study|Withdrawal by Subject|3
441713|NCT00436956|1464986|P2|Overall Study|Not evaluable|0
441714|NCT00436956|1464987|P1|Overall Study|Not evaluable|1
441715|NCT00436917|1464996|P1|Overall Study|Still on treatment|47
441716|NCT00436917|1464996|P1|Overall Study|Adverse Event|1
441717|NCT00436917|1464996|P1|Overall Study|Withdrawal by Subject|6
441718|NCT00436852|1465011|P2|Overall Study|Ineligible|0
441719|NCT00436852|1465012|P1|Overall Study|Ineligible|1
441720|NCT00436852|1465011|P2|Overall Study|Withdrawal by Subject|4
441721|NCT00436852|1465012|P1|Overall Study|Withdrawal by Subject|2
441722|NCT00436852|1465011|P2|Overall Study|Lack of Efficacy|7
441723|NCT00436852|1465012|P1|Overall Study|Lack of Efficacy|9
441724|NCT00436852|1465011|P2|Overall Study|Death|34
441725|NCT00436852|1465012|P1|Overall Study|Death|23
441726|NCT00436826|1465022|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
441727|NCT00436826|1465023|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
441728|NCT00436826|1465024|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
441729|NCT00436826|1465025|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
441730|NCT00436826|1465026|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
441731|NCT00436826|1465027|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
441732|NCT00436826|1465022|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
441733|NCT00436826|1465023|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
441734|NCT00436826|1465024|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
441735|NCT00436826|1465025|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
441736|NCT00436826|1465026|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
441737|NCT00436826|1465027|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
441738|NCT00436826|1465022|P6|Double Blind Period|Other|0
441739|NCT00436826|1465023|P5|Double Blind Period|Other|0
441740|NCT00436826|1465024|P4|Double Blind Period|Other|0
441741|NCT00436826|1465025|P3|Double Blind Period|Other|0
441742|NCT00436826|1465026|P2|Double Blind Period|Other|11
441743|NCT00436826|1465027|P1|Double Blind Period|Other|10
441744|NCT00436826|1465022|P6|Double Blind Period|Protocol Violation|0
441745|NCT00436826|1465023|P5|Double Blind Period|Protocol Violation|0
441746|NCT00436826|1465024|P4|Double Blind Period|Protocol Violation|0
441747|NCT00436826|1465025|P3|Double Blind Period|Protocol Violation|0
441748|NCT00436826|1465026|P2|Double Blind Period|Protocol Violation|0
441749|NCT00436826|1465027|P1|Double Blind Period|Protocol Violation|1
441750|NCT00436826|1465022|P6|Double Blind Period|Adverse Event|0
441751|NCT00436826|1465023|P5|Double Blind Period|Adverse Event|0
441752|NCT00436826|1465024|P4|Double Blind Period|Adverse Event|0
441753|NCT00436826|1465025|P3|Double Blind Period|Adverse Event|0
441754|NCT00436826|1465026|P2|Double Blind Period|Adverse Event|0
441755|NCT00436826|1465027|P1|Double Blind Period|Adverse Event|2
441756|NCT00436748|1465049|P2|Overall Study|Other|0
441757|NCT00436748|1465050|P1|Overall Study|Other|3
441758|NCT00436748|1465049|P2|Overall Study|Protocol-specified Criteria|4
441759|NCT00436748|1465050|P1|Overall Study|Protocol-specified Criteria|5
441760|NCT00436748|1465049|P2|Overall Study|Lost to Follow-up|1
441761|NCT00436748|1465050|P1|Overall Study|Lost to Follow-up|0
441762|NCT00436748|1465049|P2|Overall Study|Administrative Decision|0
441763|NCT00436748|1465050|P1|Overall Study|Administrative Decision|1
441764|NCT00436748|1465049|P2|Overall Study|Consent Withdrawn|4
441765|NCT00436748|1465050|P1|Overall Study|Consent Withdrawn|1
441766|NCT00436748|1465049|P2|Overall Study|Adverse Event|2
441767|NCT00436748|1465050|P1|Overall Study|Adverse Event|0
441768|NCT00436748|1465049|P2|Overall Study|Ineligibility Determined|1
441769|NCT00436748|1465050|P1|Overall Study|Ineligibility Determined|1
441770|NCT00436644|1465084|P1|Overall Study|Death|1
441771|NCT00436644|1465084|P1|Overall Study|Adverse Event|2
441772|NCT00436618|1465094|P3|Overall Study|Still on treatment|7
441773|NCT00436618|1465095|P2|Overall Study|Still on treatment|2
441774|NCT00436618|1465096|P1|Overall Study|Still on treatment|1
441775|NCT00436618|1465094|P3|Overall Study|New Primary or Other Reasons|12
441776|NCT00436618|1465095|P2|Overall Study|New Primary or Other Reasons|2
441777|NCT00436618|1465096|P1|Overall Study|New Primary or Other Reasons|6
441778|NCT00436618|1465094|P3|Overall Study|Death|3
441779|NCT00436618|1465095|P2|Overall Study|Death|2
441780|NCT00436618|1465096|P1|Overall Study|Death|4
441781|NCT00436618|1465094|P3|Overall Study|Other Medical Problems|7
441782|NCT00436618|1465095|P2|Overall Study|Other Medical Problems|1
441783|NCT00436618|1465096|P1|Overall Study|Other Medical Problems|3
441784|NCT00436618|1465094|P3|Overall Study|Alternate Treatment|12
441785|NCT00436618|1465095|P2|Overall Study|Alternate Treatment|4
441786|NCT00436618|1465096|P1|Overall Study|Alternate Treatment|3
441787|NCT00436618|1465094|P3|Overall Study|Adverse Event|9
441788|NCT00436618|1465095|P2|Overall Study|Adverse Event|8
441789|NCT00436618|1465096|P1|Overall Study|Adverse Event|8
441790|NCT00436618|1465094|P3|Overall Study|Withdrawal by Subject|11
441791|NCT00436618|1465095|P2|Overall Study|Withdrawal by Subject|8
441792|NCT00436618|1465096|P1|Overall Study|Withdrawal by Subject|5
441793|NCT00436605|1465113|P1|Overall Study|Protocol Violation|3
441794|NCT00436566|1465118|P1|Overall Study|Protocol Violation|1
441795|NCT00436566|1465118|P1|Overall Study|Withdrawal by Subject|2
441796|NCT00436553|1465125|P3|Overall Study|Withdrawal by Subject|3
441797|NCT00436553|1465126|P2|Overall Study|Withdrawal by Subject|6
441798|NCT00436553|1465127|P1|Overall Study|Withdrawal by Subject|5
441799|NCT00436553|1465125|P3|Overall Study|Protocol Violation|0
441800|NCT00436553|1465126|P2|Overall Study|Protocol Violation|0
441801|NCT00436553|1465127|P1|Overall Study|Protocol Violation|1
441802|NCT00436553|1465125|P3|Overall Study|Lost to Follow-up|0
441803|NCT00436553|1465126|P2|Overall Study|Lost to Follow-up|2
441804|NCT00436553|1465127|P1|Overall Study|Lost to Follow-up|0
441805|NCT00436553|1465125|P3|Overall Study|Death|3
441806|NCT00436553|1465126|P2|Overall Study|Death|1
441807|NCT00436553|1465127|P1|Overall Study|Death|3
441808|NCT00436553|1465125|P3|Overall Study|Adverse Event|4
441809|NCT00436553|1465126|P2|Overall Study|Adverse Event|3
441810|NCT00436553|1465127|P1|Overall Study|Adverse Event|4
441811|NCT00436501|1465148|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
441812|NCT00436501|1465149|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
441813|NCT00436501|1465148|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
441814|NCT00436501|1465149|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
441815|NCT00436436|1465160|P1|Overall Study|Death|6
441816|NCT00436436|1465160|P1|Overall Study|Adverse Event|2
441817|NCT00436436|1465160|P1|Overall Study|Progression|4
441818|NCT00436345|1465171|P2|Overall Study|ICU resident beyond follow-up period|0
441819|NCT00436345|1465172|P1|Overall Study|ICU resident beyond follow-up period|3
441820|NCT00436332|1465225|P1|Overall Study|Never Received Treatment|3
441821|NCT00436332|1465225|P1|Overall Study|Ineligible|2
441822|NCT00436332|1465225|P1|Overall Study|Not Protocol Specified|6
441823|NCT00436332|1465225|P1|Overall Study|Death|2
441824|NCT00436332|1465225|P1|Overall Study|Progression|59
441825|NCT00436332|1465225|P1|Overall Study|Withdrawal by Subject|2
441826|NCT00436332|1465225|P1|Overall Study|Adverse Event|9
441827|NCT00436215|1465232|P1|Overall Study|Small bowel obstruction|1
441828|NCT00436215|1465232|P1|Overall Study|Refused further treatment|3
441829|NCT00436163|1465238|P1|Overall Study|Adverse Event|1
441830|NCT00436163|1465238|P1|Overall Study|Lost to Follow-up|2
441831|NCT00436007|1465286|P3|Overall Study|Other|1
441832|NCT00436007|1465287|P2|Overall Study|Other|0
441833|NCT00436007|1465288|P1|Overall Study|Other|0
441834|NCT00436007|1465286|P3|Overall Study|Death|3
441835|NCT00436007|1465287|P2|Overall Study|Death|1
441836|NCT00436007|1465288|P1|Overall Study|Death|0
441837|NCT00436007|1465286|P3|Overall Study|Physician Decision|2
441838|NCT00436007|1465287|P2|Overall Study|Physician Decision|0
441839|NCT00436007|1465288|P1|Overall Study|Physician Decision|0
441840|NCT00436007|1465286|P3|Overall Study|Lost to Follow-up|13
441841|NCT00436007|1465287|P2|Overall Study|Lost to Follow-up|10
441842|NCT00436007|1465288|P1|Overall Study|Lost to Follow-up|14
441843|NCT00436007|1465286|P3|Overall Study|Withdrawal by Subject|4
441844|NCT00436007|1465287|P2|Overall Study|Withdrawal by Subject|3
441845|NCT00436007|1465288|P1|Overall Study|Withdrawal by Subject|5
441846|NCT00435994|1465336|P3|Overall Study|Lost to Follow-up|0
441847|NCT00435994|1465337|P2|Overall Study|Lost to Follow-up|0
441848|NCT00435994|1465338|P1|Overall Study|Lost to Follow-up|7
441849|NCT00435942|1465349|P2|Overall Study|Other|1
441850|NCT00435942|1465350|P1|Overall Study|Other|0
441851|NCT00435942|1465349|P2|Overall Study|Technical Failure|0
441852|NCT00435942|1465350|P1|Overall Study|Technical Failure|3
441853|NCT00435942|1465349|P2|Overall Study|Conversion to Open Repair|0
441854|NCT00435942|1465350|P1|Overall Study|Conversion to Open Repair|1
441855|NCT00435942|1465349|P2|Overall Study|Lost to Follow-up|16
441856|NCT00435942|1465350|P1|Overall Study|Lost to Follow-up|0
441857|NCT00435942|1465349|P2|Overall Study|Withdrawal by Subject|0
441858|NCT00435942|1465350|P1|Overall Study|Withdrawal by Subject|2
441859|NCT00435942|1465349|P2|Overall Study|Death|10
441860|NCT00435942|1465350|P1|Overall Study|Death|17
441861|NCT00435825|1465390|P4|Overall Study|Did not complete full follow-up period|5
441862|NCT00435825|1465391|P3|Overall Study|Did not complete full follow-up period|4
441863|NCT00435825|1465392|P2|Overall Study|Did not complete full follow-up period|6
441864|NCT00435825|1465393|P1|Overall Study|Did not complete full follow-up period|6
441865|NCT00435825|1465390|P4|Overall Study|Did not enter follow-up|3
441866|NCT00435825|1465391|P3|Overall Study|Did not enter follow-up|1
441867|NCT00435825|1465392|P2|Overall Study|Did not enter follow-up|4
441868|NCT00435825|1465393|P1|Overall Study|Did not enter follow-up|0
441869|NCT00435825|1465390|P4|Overall Study|Did not receive study drug|0
441870|NCT00435825|1465391|P3|Overall Study|Did not receive study drug|2
441871|NCT00435825|1465392|P2|Overall Study|Did not receive study drug|0
441872|NCT00435825|1465393|P1|Overall Study|Did not receive study drug|1
441873|NCT00435825|1465390|P4|Overall Study|Failure to return|0
441874|NCT00435825|1465391|P3|Overall Study|Failure to return|4
441875|NCT00435825|1465392|P2|Overall Study|Failure to return|0
441876|NCT00435825|1465393|P1|Overall Study|Failure to return|5
441877|NCT00435825|1465390|P4|Overall Study|Refused treatment|5
441878|NCT00435825|1465391|P3|Overall Study|Refused treatment|0
441879|NCT00435825|1465392|P2|Overall Study|Refused treatment|0
441880|NCT00435825|1465393|P1|Overall Study|Refused treatment|2
441881|NCT00435825|1465390|P4|Overall Study|Other Protocol Violation|0
441882|NCT00435825|1465391|P3|Overall Study|Other Protocol Violation|0
441883|NCT00435825|1465392|P2|Overall Study|Other Protocol Violation|0
441884|NCT00435825|1465393|P1|Overall Study|Other Protocol Violation|1
441885|NCT00435825|1465390|P4|Overall Study|Insufficient Therapeutic Response|3
441886|NCT00435825|1465391|P3|Overall Study|Insufficient Therapeutic Response|0
441887|NCT00435825|1465392|P2|Overall Study|Insufficient Therapeutic Response|1
441888|NCT00435825|1465393|P1|Overall Study|Insufficient Therapeutic Response|3
441889|NCT00435825|1465390|P4|Overall Study|Abnormality of Laboratory Test|0
441890|NCT00435825|1465391|P3|Overall Study|Abnormality of Laboratory Test|0
441891|NCT00435825|1465392|P2|Overall Study|Abnormality of Laboratory Test|1
441892|NCT00435825|1465393|P1|Overall Study|Abnormality of Laboratory Test|0
441893|NCT00435487|1465516|P2|Overall Study|Received Drug in Other Treatment Group|1
441894|NCT00435487|1465517|P1|Overall Study|Received Drug in Other Treatment Group|0
441895|NCT00435487|1465516|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
441896|NCT00435487|1465517|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
441897|NCT00435487|1465516|P2|Overall Study|Withdrawal by Subject|1
441898|NCT00435487|1465517|P1|Overall Study|Withdrawal by Subject|2
441899|NCT00435487|1465516|P2|Overall Study|Other|2
441900|NCT00435487|1465517|P1|Overall Study|Other|5
441901|NCT00435487|1465516|P2|Overall Study|Lost to Follow-up|2
441902|NCT00435487|1465517|P1|Overall Study|Lost to Follow-up|2
441903|NCT00435487|1465516|P2|Overall Study|Adverse Event|3
441904|NCT00435487|1465517|P1|Overall Study|Adverse Event|0
441905|NCT00435487|1465516|P2|Overall Study|Death|4
441906|NCT00435487|1465517|P1|Overall Study|Death|3
441907|NCT00435461|1465536|P3|Overall Study|Lost to Follow-up|2
441908|NCT00435461|1465537|P2|Overall Study|Lost to Follow-up|1
441909|NCT00435461|1465538|P1|Overall Study|Lost to Follow-up|1
441910|NCT00435461|1465536|P3|Overall Study|Non-Compliance of diary|1
441911|NCT00435461|1465537|P2|Overall Study|Non-Compliance of diary|0
441912|NCT00435461|1465538|P1|Overall Study|Non-Compliance of diary|2
441913|NCT00435461|1465536|P3|Overall Study|Adverse Event|6
441914|NCT00435461|1465537|P2|Overall Study|Adverse Event|2
441915|NCT00435461|1465538|P1|Overall Study|Adverse Event|1
441916|NCT00435461|1465536|P3|Overall Study|Noncompliance with study requirements|1
441917|NCT00435461|1465537|P2|Overall Study|Noncompliance with study requirements|1
441918|NCT00435461|1465538|P1|Overall Study|Noncompliance with study requirements|1
441919|NCT00435461|1465536|P3|Overall Study|Participant ended study one day early|0
441920|NCT00435461|1465537|P2|Overall Study|Participant ended study one day early|0
441921|NCT00435461|1465538|P1|Overall Study|Participant ended study one day early|1
441922|NCT00435461|1465536|P3|Overall Study|Participant moved eDiary,studymedication|0
441923|NCT00435461|1465537|P2|Overall Study|Participant moved eDiary,studymedication|0
441924|NCT00435461|1465538|P1|Overall Study|Participant moved eDiary,studymedication|1
441925|NCT00435461|1465536|P3|Overall Study|Pregnancy|0
441926|NCT00435461|1465537|P2|Overall Study|Pregnancy|0
441927|NCT00435461|1465538|P1|Overall Study|Pregnancy|2
441928|NCT00435461|1465536|P3|Overall Study|Participant could not swallow capsule|1
441929|NCT00435461|1465537|P2|Overall Study|Participant could not swallow capsule|0
441930|NCT00435461|1465538|P1|Overall Study|Participant could not swallow capsule|0
441931|NCT00435461|1465536|P3|Overall Study|Participant could not tolerate symptoms|1
441932|NCT00435461|1465537|P2|Overall Study|Participant could not tolerate symptoms|0
441933|NCT00435461|1465538|P1|Overall Study|Participant could not tolerate symptoms|0
441934|NCT00435461|1465536|P3|Overall Study|Randomized in error|0
441935|NCT00435461|1465537|P2|Overall Study|Randomized in error|0
441936|NCT00435461|1465538|P1|Overall Study|Randomized in error|1
441937|NCT00435461|1465536|P3|Overall Study|Withdrawal by Subject|2
441938|NCT00435461|1465537|P2|Overall Study|Withdrawal by Subject|0
441939|NCT00435461|1465538|P1|Overall Study|Withdrawal by Subject|1
441940|NCT00435461|1465536|P3|Overall Study|Lack of Efficacy|0
441941|NCT00435461|1465537|P2|Overall Study|Lack of Efficacy|1
441942|NCT00435461|1465538|P1|Overall Study|Lack of Efficacy|2
441943|NCT00435461|1465536|P3|Overall Study|In error, two study medications switched|0
441944|NCT00435461|1465537|P2|Overall Study|In error, two study medications switched|0
441945|NCT00435461|1465538|P1|Overall Study|In error, two study medications switched|1
441946|NCT00435461|1465536|P3|Overall Study|Compliance less than 80 percent|0
441947|NCT00435461|1465537|P2|Overall Study|Compliance less than 80 percent|0
441948|NCT00435461|1465538|P1|Overall Study|Compliance less than 80 percent|1
441949|NCT00435461|1465536|P3|Overall Study|Participant randomized(inadequate score)|0
441950|NCT00435461|1465537|P2|Overall Study|Participant randomized(inadequate score)|0
441951|NCT00435461|1465538|P1|Overall Study|Participant randomized(inadequate score)|1
441952|NCT00435461|1465536|P3|Overall Study|Protocol Violation|10
441953|NCT00435461|1465537|P2|Overall Study|Protocol Violation|9
441954|NCT00435461|1465538|P1|Overall Study|Protocol Violation|6
441955|NCT00435461|1465536|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
441956|NCT00435461|1465537|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
441957|NCT00435461|1465538|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
441958|NCT00435409|1465575|P3|Overall Study|Sponsor decision|0
441959|NCT00435409|1465576|P2|Overall Study|Sponsor decision|3
441960|NCT00435409|1465577|P1|Overall Study|Sponsor decision|0
441961|NCT00435409|1465575|P3|Overall Study|Adverse Event|8
441962|NCT00435409|1465576|P2|Overall Study|Adverse Event|0
441963|NCT00435409|1465577|P1|Overall Study|Adverse Event|0
441964|NCT00435409|1465575|P3|Overall Study|Not specified|1
441965|NCT00435409|1465576|P2|Overall Study|Not specified|30
441966|NCT00435409|1465577|P1|Overall Study|Not specified|45
441967|NCT00435409|1465575|P3|Overall Study|Withdrawal by Subject|1
441968|NCT00435409|1465576|P2|Overall Study|Withdrawal by Subject|7
441969|NCT00435409|1465577|P1|Overall Study|Withdrawal by Subject|8
441970|NCT00435409|1465575|P3|Overall Study|Global deterioration of health status|4
441971|NCT00435409|1465576|P2|Overall Study|Global deterioration of health status|0
441972|NCT00435409|1465577|P1|Overall Study|Global deterioration of health status|0
441973|NCT00435409|1465575|P3|Overall Study|Objective progression or relapse|58
441974|NCT00435409|1465576|P2|Overall Study|Objective progression or relapse|93
441975|NCT00435409|1465577|P1|Overall Study|Objective progression or relapse|158
441976|NCT00435409|1465575|P3|Overall Study|Death|6
441977|NCT00435409|1465576|P2|Overall Study|Death|6
441978|NCT00435409|1465577|P1|Overall Study|Death|8
441979|NCT00435409|1465575|P3|Overall Study|Lost to Follow-up|0
441980|NCT00435409|1465576|P2|Overall Study|Lost to Follow-up|2
441981|NCT00435409|1465577|P1|Overall Study|Lost to Follow-up|1
441982|NCT00435409|1465575|P3|Overall Study|Protocol Violation|0
441983|NCT00435409|1465576|P2|Overall Study|Protocol Violation|2
441984|NCT00435409|1465577|P1|Overall Study|Protocol Violation|1
441985|NCT00435370|1465599|P2|Overall Study|Antipsychotic medication changed|2
441986|NCT00435370|1465600|P1|Overall Study|Antipsychotic medication changed|4
441987|NCT00435370|1465599|P2|Overall Study|Withdrawal by Subject|10
441988|NCT00435370|1465600|P1|Overall Study|Withdrawal by Subject|10
441989|NCT00435370|1465599|P2|Overall Study|Adverse Event|8
441990|NCT00435370|1465600|P1|Overall Study|Adverse Event|8
441991|NCT00435188|1465608|P2|Overall Study|Lost to Follow-up|6
441992|NCT00435188|1465609|P1|Overall Study|Lost to Follow-up|5
441993|NCT00435188|1465608|P2|Overall Study|Withdrawal by Subject|11
441994|NCT00435188|1465609|P1|Overall Study|Withdrawal by Subject|16
441995|NCT00435188|1465608|P2|Overall Study|Death|6
441996|NCT00435188|1465609|P1|Overall Study|Death|1
441997|NCT00435162|1465652|P6|Period 2 (2 Weeks)|Adverse Event|0
441998|NCT00435162|1465653|P5|Period 2 (2 Weeks)|Adverse Event|0
441999|NCT00435162|1465654|P4|Period 2 (2 Weeks)|Adverse Event|0
442000|NCT00435162|1465655|P3|Period 2 (2 Weeks)|Adverse Event|0
442001|NCT00435162|1465656|P2|Period 2 (2 Weeks)|Adverse Event|1
442002|NCT00435162|1465657|P1|Period 2 (2 Weeks)|Adverse Event|0
442003|NCT00435045|1465677|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
442004|NCT00435045|1465678|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
442005|NCT00435045|1465677|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
442006|NCT00435045|1465678|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
442007|NCT00435045|1465677|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
442008|NCT00435045|1465678|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
442009|NCT00435045|1465677|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
442010|NCT00435045|1465678|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
442011|NCT00435045|1465677|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
442012|NCT00435045|1465678|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
442013|NCT00435045|1465677|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
442014|NCT00435045|1465678|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
442015|NCT00435045|1465677|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
442016|NCT00435045|1465678|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
442017|NCT00435045|1465677|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
442018|NCT00435045|1465678|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
442019|NCT00435045|1465677|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
442020|NCT00435045|1465678|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
442021|NCT00435045|1465677|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
442022|NCT00435045|1465678|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
442023|NCT00435045|1465677|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
442024|NCT00435045|1465678|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
442025|NCT00435019|1465734|P2|Overall Study|Personal reasons for withdrawal|7
442026|NCT00435019|1465735|P1|Overall Study|Personal reasons for withdrawal|8
442027|NCT00435019|1465734|P2|Overall Study|Protocol Violation|1
442028|NCT00435019|1465735|P1|Overall Study|Protocol Violation|3
442029|NCT00435019|1465734|P2|Overall Study|Lack of Efficacy|2
442030|NCT00435019|1465735|P1|Overall Study|Lack of Efficacy|1
442031|NCT00435019|1465734|P2|Overall Study|Adverse Event|0
442032|NCT00435019|1465735|P1|Overall Study|Adverse Event|1
442033|NCT00434967|1465776|P4|Overall Study|Patient Disposition Challenges|3
442034|NCT00434967|1465777|P3|Overall Study|Patient Disposition Challenges|0
442035|NCT00434967|1465778|P2|Overall Study|Patient Disposition Challenges|0
442036|NCT00434967|1465779|P1|Overall Study|Patient Disposition Challenges|2
442037|NCT00434967|1465776|P4|Overall Study|Physician Decision|0
442038|NCT00434967|1465777|P3|Overall Study|Physician Decision|1
442039|NCT00434967|1465778|P2|Overall Study|Physician Decision|1
442040|NCT00434967|1465779|P1|Overall Study|Physician Decision|1
442041|NCT00434967|1465776|P4|Overall Study|Protocol Violation|1
442042|NCT00434967|1465777|P3|Overall Study|Protocol Violation|0
442043|NCT00434967|1465778|P2|Overall Study|Protocol Violation|1
442044|NCT00434967|1465779|P1|Overall Study|Protocol Violation|0
442045|NCT00434967|1465776|P4|Overall Study|Randomized in error|1
442046|NCT00434967|1465777|P3|Overall Study|Randomized in error|0
442047|NCT00434967|1465778|P2|Overall Study|Randomized in error|0
442048|NCT00434967|1465779|P1|Overall Study|Randomized in error|0
442049|NCT00434967|1465776|P4|Overall Study|Withdrawal by Subject|6
442050|NCT00434967|1465777|P3|Overall Study|Withdrawal by Subject|4
442051|NCT00434967|1465778|P2|Overall Study|Withdrawal by Subject|2
442052|NCT00434967|1465779|P1|Overall Study|Withdrawal by Subject|2
442053|NCT00434967|1465776|P4|Overall Study|Lost to Follow-up|0
442054|NCT00434967|1465777|P3|Overall Study|Lost to Follow-up|1
442055|NCT00434967|1465778|P2|Overall Study|Lost to Follow-up|0
442056|NCT00434967|1465779|P1|Overall Study|Lost to Follow-up|0
442057|NCT00434967|1465776|P4|Overall Study|Adverse Event|3
442058|NCT00434967|1465777|P3|Overall Study|Adverse Event|3
442059|NCT00434967|1465778|P2|Overall Study|Adverse Event|4
442060|NCT00434967|1465779|P1|Overall Study|Adverse Event|2
442061|NCT00434954|1465799|P2|Overall Study|Subject decision|22
442062|NCT00434954|1465800|P1|Overall Study|Subject decision|8
442063|NCT00434954|1465799|P2|Overall Study|Sponsor decision|0
442064|NCT00434954|1465800|P1|Overall Study|Sponsor decision|1
442065|NCT00434954|1465799|P2|Overall Study|Protocol Violation|27
442066|NCT00434954|1465800|P1|Overall Study|Protocol Violation|36
442067|NCT00434954|1465799|P2|Overall Study|Physician Decision|3
442068|NCT00434954|1465800|P1|Overall Study|Physician Decision|6
442069|NCT00434954|1465799|P2|Overall Study|Lost to Follow-up|1
442070|NCT00434954|1465800|P1|Overall Study|Lost to Follow-up|0
442071|NCT00434954|1465799|P2|Overall Study|Entry criteria not met|16
442072|NCT00434954|1465800|P1|Overall Study|Entry criteria not met|14
442073|NCT00434954|1465799|P2|Overall Study|Adverse Event|2
442074|NCT00434954|1465800|P1|Overall Study|Adverse Event|17
442075|NCT00434876|1465830|P2|Overall Study|Lost to Follow-up|1
442076|NCT00434876|1465831|P1|Overall Study|Lost to Follow-up|1
442077|NCT00434759|1465845|P2|Overall Study|family affairs|0
442078|NCT00434759|1465846|P1|Overall Study|family affairs|2
442079|NCT00434759|1465845|P2|Overall Study|Withdrawal by Subject|1
442080|NCT00434759|1465846|P1|Overall Study|Withdrawal by Subject|17
442081|NCT00434759|1465845|P2|Overall Study|Lack of Efficacy|4
442082|NCT00434759|1465846|P1|Overall Study|Lack of Efficacy|5
442083|NCT00434642|1465862|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
442084|NCT00434642|1465863|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
442085|NCT00434642|1465862|P2|Open-label Treatment Phase|Adverse Event|5
442086|NCT00434642|1465863|P1|Open-label Treatment Phase|Adverse Event|0
442087|NCT00434642|1465862|P2|Blinded Treatment Phase|Did not Receive Treatment|1
442088|NCT00434642|1465863|P1|Blinded Treatment Phase|Did not Receive Treatment|4
442089|NCT00434642|1465862|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
442090|NCT00434642|1465863|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
442091|NCT00434642|1465862|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
442092|NCT00434642|1465863|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
442093|NCT00434642|1465862|P2|Blinded Treatment Phase|Physician Decision|27
442094|NCT00434642|1465863|P1|Blinded Treatment Phase|Physician Decision|19
442095|NCT00434642|1465862|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
442096|NCT00434642|1465863|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
442097|NCT00434642|1465862|P2|Blinded Treatment Phase|Clinical Disease Progression|5
442098|NCT00434642|1465863|P1|Blinded Treatment Phase|Clinical Disease Progression|4
442099|NCT00434642|1465862|P2|Blinded Treatment Phase|Adverse Event|58
442100|NCT00434642|1465863|P1|Blinded Treatment Phase|Adverse Event|12
442101|NCT00434590|1465881|P2|Overall Study|Administrative problems|5
442102|NCT00434590|1465882|P1|Overall Study|Administrative problems|5
442103|NCT00434421|1465904|P1|Overall Study|Non-compliance with study treatment|1
442104|NCT00434421|1465904|P1|Overall Study|Withdrawal by Subject|1
442105|NCT00434330|1465932|P6|Overall Study|Subject Not Compliant With Study|0
442106|NCT00434330|1465933|P5|Overall Study|Subject Not Compliant With Study|0
442107|NCT00434330|1465934|P4|Overall Study|Subject Not Compliant With Study|0
442108|NCT00434330|1465935|P3|Overall Study|Subject Not Compliant With Study|1
442109|NCT00434330|1465936|P2|Overall Study|Subject Not Compliant With Study|0
442110|NCT00434330|1465937|P1|Overall Study|Subject Not Compliant With Study|0
442111|NCT00434330|1465932|P6|Overall Study|Renal transplant|0
442112|NCT00434330|1465933|P5|Overall Study|Renal transplant|0
442113|NCT00434330|1465934|P4|Overall Study|Renal transplant|1
442114|NCT00434330|1465935|P3|Overall Study|Renal transplant|0
442115|NCT00434330|1465936|P2|Overall Study|Renal transplant|0
442116|NCT00434330|1465937|P1|Overall Study|Renal transplant|0
442117|NCT00434330|1465932|P6|Overall Study|Withdrawal by Subject|0
442118|NCT00434330|1465933|P5|Overall Study|Withdrawal by Subject|0
442119|NCT00434330|1465934|P4|Overall Study|Withdrawal by Subject|1
442120|NCT00434330|1465935|P3|Overall Study|Withdrawal by Subject|1
442121|NCT00434330|1465936|P2|Overall Study|Withdrawal by Subject|0
442122|NCT00434330|1465937|P1|Overall Study|Withdrawal by Subject|0
442123|NCT00434330|1465932|P6|Overall Study|Death|1
442124|NCT00434330|1465933|P5|Overall Study|Death|1
442125|NCT00434330|1465934|P4|Overall Study|Death|0
442126|NCT00434330|1465935|P3|Overall Study|Death|0
442127|NCT00434330|1465936|P2|Overall Study|Death|0
442128|NCT00434330|1465937|P1|Overall Study|Death|1
442129|NCT00434330|1465932|P6|Overall Study|Adverse Event|0
442130|NCT00434330|1465933|P5|Overall Study|Adverse Event|0
442131|NCT00434330|1465934|P4|Overall Study|Adverse Event|0
442132|NCT00434330|1465935|P3|Overall Study|Adverse Event|1
442133|NCT00434330|1465936|P2|Overall Study|Adverse Event|0
442134|NCT00434330|1465937|P1|Overall Study|Adverse Event|0
442135|NCT00434304|1465969|P1|Overall Study|Withdrawal by Subject|4
442136|NCT00434304|1465969|P1|Overall Study|Lack of Efficacy|2
442137|NCT00434304|1465969|P1|Overall Study|Adverse Event|14
442138|NCT00434252|1466018|P2|Overall Study|Withdrawal by Subject|7
442139|NCT00434252|1466019|P1|Overall Study|Withdrawal by Subject|3
442140|NCT00434252|1466018|P2|Overall Study|Physician Decision|8
442141|NCT00434252|1466019|P1|Overall Study|Physician Decision|4
442142|NCT00434252|1466018|P2|Overall Study|Lost to Follow-up|1
442143|NCT00434252|1466019|P1|Overall Study|Lost to Follow-up|0
442144|NCT00434252|1466018|P2|Overall Study|Death|2
442145|NCT00434252|1466019|P1|Overall Study|Death|1
442146|NCT00434252|1466018|P2|Overall Study|Adverse Event|13
442147|NCT00434252|1466019|P1|Overall Study|Adverse Event|6
442148|NCT00434252|1466018|P2|Overall Study|Lack of Efficacy|100
442149|NCT00434252|1466019|P1|Overall Study|Lack of Efficacy|50
442150|NCT00434213|1466053|P1|Overall Study|Non-compliant to study schedule|1
442151|NCT00434213|1466053|P1|Overall Study|Application site reaction|1
442152|NCT00434213|1466053|P1|Overall Study|Unable to comply with study visit window|2
442153|NCT00434213|1466053|P1|Overall Study|Protocol Violation|3
442154|NCT00434213|1466053|P1|Overall Study|Withdrawal by Subject|7
442155|NCT00434213|1466053|P1|Overall Study|Lost to Follow-up|14
442156|NCT00434213|1466053|P1|Overall Study|Lack of Efficacy|9
442157|NCT00434213|1466053|P1|Overall Study|Adverse Event|12
442158|NCT00434161|1466061|P3|Overall Study|Logistical error study assessments|3
442159|NCT00434161|1466062|P2|Overall Study|Logistical error study assessments|0
442160|NCT00434161|1466063|P1|Overall Study|Logistical error study assessments|1
442161|NCT00434161|1466061|P3|Overall Study|Withdrawal by Subject|3
442162|NCT00434161|1466062|P2|Overall Study|Withdrawal by Subject|0
442163|NCT00434161|1466063|P1|Overall Study|Withdrawal by Subject|2
442164|NCT00434161|1466061|P3|Overall Study|Non-Compliance|0
442165|NCT00434161|1466062|P2|Overall Study|Non-Compliance|1
442166|NCT00434161|1466063|P1|Overall Study|Non-Compliance|1
442167|NCT00434161|1466061|P3|Overall Study|Death|1
442168|NCT00434161|1466062|P2|Overall Study|Death|0
442169|NCT00434161|1466063|P1|Overall Study|Death|1
442170|NCT00434161|1466061|P3|Overall Study|Lost to Follow-up|0
442171|NCT00434161|1466062|P2|Overall Study|Lost to Follow-up|1
442172|NCT00434161|1466063|P1|Overall Study|Lost to Follow-up|0
442173|NCT00434161|1466061|P3|Overall Study|Adverse Event|4
442174|NCT00434161|1466062|P2|Overall Study|Adverse Event|1
442175|NCT00434161|1466063|P1|Overall Study|Adverse Event|5
442176|NCT00434148|1466107|P2|Overall Study|Abnormal test procedure result|1
442177|NCT00434148|1466108|P1|Overall Study|Abnormal test procedure result|0
442178|NCT00434148|1466107|P2|Overall Study|Condition no longer requires study drug|0
442179|NCT00434148|1466108|P1|Overall Study|Condition no longer requires study drug|1
442180|NCT00434148|1466107|P2|Overall Study|Lost to Follow-up|1
442181|NCT00434148|1466108|P1|Overall Study|Lost to Follow-up|0
442182|NCT00434148|1466107|P2|Overall Study|Administrative problems|10
442183|NCT00434148|1466108|P1|Overall Study|Administrative problems|6
442184|NCT00434148|1466107|P2|Overall Study|Protocol Violation|0
442185|NCT00434148|1466108|P1|Overall Study|Protocol Violation|4
442186|NCT00434148|1466107|P2|Overall Study|Withdrawal by Subject|15
442187|NCT00434148|1466108|P1|Overall Study|Withdrawal by Subject|15
442188|NCT00434148|1466107|P2|Overall Study|Lack of Efficacy|28
442189|NCT00434148|1466108|P1|Overall Study|Lack of Efficacy|25
442190|NCT00434148|1466107|P2|Overall Study|Adverse Event|18
442191|NCT00434148|1466108|P1|Overall Study|Adverse Event|18
442192|NCT00434122|1466144|P2|Overall Study|Travelling of subject.|0
442193|NCT00434122|1466145|P1|Overall Study|Travelling of subject.|1
442194|NCT00434122|1466144|P2|Overall Study|Low follicular response.|2
442195|NCT00434122|1466145|P1|Overall Study|Low follicular response.|1
442196|NCT00434122|1466144|P2|Overall Study|Large follicle size|2
442197|NCT00434122|1466145|P1|Overall Study|Large follicle size|2
442198|NCT00434122|1466144|P2|Overall Study|Personal reasons|1
442199|NCT00434122|1466145|P1|Overall Study|Personal reasons|1
442200|NCT00434122|1466144|P2|Overall Study|loss of subject contact|1
442201|NCT00434122|1466145|P1|Overall Study|loss of subject contact|1
442202|NCT00434122|1466144|P2|Overall Study|Non-compliance with protocol|1
442203|NCT00434122|1466145|P1|Overall Study|Non-compliance with protocol|0
442204|NCT00434109|1466154|P1|Overall Study|had embolism, did not receive sunitinib|3
442205|NCT00434109|1466154|P1|Overall Study|Protocol Violation|1
442206|NCT00434109|1466154|P1|Overall Study|Adverse Event|5
442207|NCT00434109|1466154|P1|Overall Study|Physician Decision|9
442208|NCT00434057|1466163|P1|Overall Study|Withdrawal by Subject|1
442209|NCT00433966|1466201|P4|Stent Intervention/Randomization|Lost to Follow-up|47
442210|NCT00433966|1466202|P3|Stent Intervention/Randomization|Lost to Follow-up|113
442211|NCT00433966|1466203|P2|Stent Intervention/Randomization|Lost to Follow-up|0
442212|NCT00433966|1466204|P1|Stent Intervention/Randomization|Lost to Follow-up|0
442213|NCT00433966|1466201|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
442214|NCT00433966|1466202|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
442215|NCT00433966|1466203|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
442216|NCT00433966|1466204|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
442217|NCT00433966|1466201|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
442218|NCT00433966|1466202|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
442219|NCT00433966|1466203|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
442220|NCT00433966|1466204|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
442221|NCT00433966|1466201|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
442222|NCT00433966|1466202|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
442223|NCT00433966|1466203|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
442224|NCT00433966|1466204|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
442225|NCT00433966|1466201|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
442226|NCT00433966|1466202|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
442227|NCT00433966|1466203|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
442228|NCT00433966|1466204|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
442229|NCT00433914|1466226|P2|Overall Study|Lost to Follow-up|1
442230|NCT00433914|1466227|P1|Overall Study|Lost to Follow-up|0
442231|NCT00433914|1466226|P2|Overall Study|Withdrawal by Subject|2
442232|NCT00433914|1466227|P1|Overall Study|Withdrawal by Subject|0
442233|NCT00433836|1466247|P2|Overall Study|Abnormal laboratory values|1
442234|NCT00433836|1466248|P1|Overall Study|Abnormal laboratory values|0
442235|NCT00433836|1466247|P2|Overall Study|Condition no longer requires study drug|1
442236|NCT00433836|1466248|P1|Overall Study|Condition no longer requires study drug|0
442237|NCT00433836|1466247|P2|Overall Study|Protocol Violation|2
442238|NCT00433836|1466248|P1|Overall Study|Protocol Violation|0
442239|NCT00433836|1466247|P2|Overall Study|Unsatisfactory therapeutic effect|1
442240|NCT00433836|1466248|P1|Overall Study|Unsatisfactory therapeutic effect|1
442241|NCT00433836|1466247|P2|Overall Study|Withdrawal by Subject|1
442242|NCT00433836|1466248|P1|Overall Study|Withdrawal by Subject|2
442243|NCT00433836|1466247|P2|Overall Study|Lost to Follow-up|0
442244|NCT00433836|1466248|P1|Overall Study|Lost to Follow-up|3
442245|NCT00433836|1466247|P2|Overall Study|Adverse Event|0
442246|NCT00433836|1466248|P1|Overall Study|Adverse Event|7
442247|NCT00433771|1466260|P1|Overall Study|Failure to deploy stent|1
442248|NCT00433771|1466260|P1|Overall Study|Death|2
442249|NCT00433771|1466260|P1|Overall Study|Treated and later found to be ineligible|2
442250|NCT00433771|1466260|P1|Overall Study|screen fail|14
442251|NCT00433654|1466283|P2|Overall Study|Withdrawal by Subject|2
442252|NCT00433654|1466284|P1|Overall Study|Withdrawal by Subject|1
442253|NCT00433654|1466283|P2|Overall Study|Subject not yet due for visit|0
442254|NCT00433654|1466284|P1|Overall Study|Subject not yet due for visit|4
442255|NCT00433654|1466283|P2|Overall Study|Missed visit|3
442256|NCT00433654|1466284|P1|Overall Study|Missed visit|6
442257|NCT00433654|1466283|P2|Overall Study|Death|0
442258|NCT00433654|1466284|P1|Overall Study|Death|4
442259|NCT00433537|1466330|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
442260|NCT00433537|1466331|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
442261|NCT00433537|1466332|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
442262|NCT00433537|1466330|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
442263|NCT00433537|1466331|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
442264|NCT00433537|1466332|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
442265|NCT00433537|1466330|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
442266|NCT00433537|1466331|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
442267|NCT00433537|1466332|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
442268|NCT00433537|1466330|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
442269|NCT00433537|1466331|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
442270|NCT00433537|1466332|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
442271|NCT00433537|1466330|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
442272|NCT00433537|1466331|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
442273|NCT00433537|1466332|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
442274|NCT00433537|1466330|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
442275|NCT00433537|1466331|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
442276|NCT00433537|1466332|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
442277|NCT00433537|1466330|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
442278|NCT00433537|1466331|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
442279|NCT00433537|1466332|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
442280|NCT00433537|1466330|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
442281|NCT00433537|1466331|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
442282|NCT00433537|1466332|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
442283|NCT00433537|1466330|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
442284|NCT00433537|1466331|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
442285|NCT00433537|1466332|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
442286|NCT00433446|1466341|P1|Overall Study|Ineligible|9
442287|NCT00433446|1466341|P1|Overall Study|Other - Not Protocol specified|3
442288|NCT00433446|1466341|P1|Overall Study|Progression|44
442289|NCT00433446|1466341|P1|Overall Study|Refusal Unrelated to Adverse Event|1
442290|NCT00433446|1466341|P1|Overall Study|Adverse Event|4
442291|NCT00433381|1466351|P2|Overall Study|Lost to follow-up before 6 months|0
442292|NCT00433381|1466352|P1|Overall Study|Lost to follow-up before 6 months|2
442293|NCT00433381|1466351|P2|Overall Study|Ineligible / no protocol treatment|3
442294|NCT00433381|1466352|P1|Overall Study|Ineligible / no protocol treatment|3
442295|NCT00433329|1466358|P1|Overall Study|Physician Decision|1
442296|NCT00433329|1466358|P1|Overall Study|Lost to Follow-up|1
442297|NCT00433329|1466358|P1|Overall Study|Moved out of state|1
442298|NCT00433329|1466358|P1|Overall Study|Discontinued sildenafil|2
442299|NCT00433329|1466358|P1|Overall Study|Withdrew consent|3
442300|NCT00433329|1466358|P1|Overall Study|Death|4
442301|NCT00433329|1466358|P1|Overall Study|Adverse Event|9
442302|NCT00433290|1466364|P2|Overall Study|Lost to Follow-up|0
442303|NCT00433290|1466365|P1|Overall Study|Lost to Follow-up|1
442304|NCT00433290|1466364|P2|Overall Study|Entry Criteria Not Met|1
442305|NCT00433290|1466365|P1|Overall Study|Entry Criteria Not Met|0
442306|NCT00433290|1466364|P2|Overall Study|Physician Decision|0
442307|NCT00433290|1466365|P1|Overall Study|Physician Decision|2
442308|NCT00433290|1466364|P2|Overall Study|Protocol Violation|2
442309|NCT00433290|1466365|P1|Overall Study|Protocol Violation|3
442310|NCT00433290|1466364|P2|Overall Study|Withdrawal by Subject|2
442311|NCT00433290|1466365|P1|Overall Study|Withdrawal by Subject|4
442312|NCT00433290|1466364|P2|Overall Study|Lack of Efficacy|5
442313|NCT00433290|1466365|P1|Overall Study|Lack of Efficacy|1
442314|NCT00433290|1466364|P2|Overall Study|Adverse Event|7
442315|NCT00433290|1466365|P1|Overall Study|Adverse Event|24
442316|NCT00433199|1466434|P2|Open-Label Period|Administrative|1
442317|NCT00433199|1466435|P1|Open-Label Period|Administrative|0
442318|NCT00433199|1466434|P2|Open-Label Period|Protocol Violation|2
442319|NCT00433199|1466435|P1|Open-Label Period|Protocol Violation|0
442320|NCT00433199|1466434|P2|Open-Label Period|Withdrawal by Subject|7
442321|NCT00433199|1466435|P1|Open-Label Period|Withdrawal by Subject|0
442322|NCT00433199|1466434|P2|Open-Label Period|Lost to Follow-up|3
442323|NCT00433199|1466435|P1|Open-Label Period|Lost to Follow-up|0
442324|NCT00433199|1466434|P2|Open-Label Period|Lack of Efficacy|2
442325|NCT00433199|1466435|P1|Open-Label Period|Lack of Efficacy|0
442326|NCT00433199|1466434|P2|Open-Label Period|Adverse Event|19
442327|NCT00433199|1466435|P1|Open-Label Period|Adverse Event|0
442328|NCT00433199|1466434|P2|Double-Blind Period|Administrative|5
442329|NCT00433199|1466435|P1|Double-Blind Period|Administrative|1
442330|NCT00433199|1466434|P2|Double-Blind Period|Protocol Violation|10
442331|NCT00433199|1466435|P1|Double-Blind Period|Protocol Violation|1
442332|NCT00433199|1466434|P2|Double-Blind Period|Withdrawal by Subject|19
442333|NCT00433199|1466435|P1|Double-Blind Period|Withdrawal by Subject|8
442334|NCT00433199|1466434|P2|Double-Blind Period|Lost to Follow-up|5
442335|NCT00433199|1466435|P1|Double-Blind Period|Lost to Follow-up|2
442336|NCT00433199|1466434|P2|Double-Blind Period|Lack of Efficacy|2
442337|NCT00433199|1466435|P1|Double-Blind Period|Lack of Efficacy|0
442338|NCT00433199|1466434|P2|Double-Blind Period|Adverse Event|25
442339|NCT00433199|1466435|P1|Double-Blind Period|Adverse Event|0
442340|NCT00433160|1466455|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
442341|NCT00433160|1466456|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
442342|NCT00433160|1466455|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
442343|NCT00433160|1466456|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
442344|NCT00433160|1466455|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
442345|NCT00433160|1466456|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
442346|NCT00433160|1466455|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
442347|NCT00433160|1466456|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
442348|NCT00433160|1466455|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
442349|NCT00433160|1466456|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
442350|NCT00433160|1466455|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
442351|NCT00433160|1466456|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
442352|NCT00433160|1466455|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
442353|NCT00433160|1466456|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
442354|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
442355|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
442356|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
442357|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
442358|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
442359|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
442360|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
442361|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
442362|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
442363|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
442364|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
442365|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
442366|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
442367|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
442368|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Death|0
442369|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Death|0
442370|NCT00433160|1466455|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
442371|NCT00433160|1466456|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
442372|NCT00433017|1466506|P2|Overall Study|Subject no longer requires study drug|1
442373|NCT00433017|1466507|P1|Overall Study|Subject no longer requires study drug|1
442374|NCT00433017|1466506|P2|Overall Study|Death|2
442375|NCT00433017|1466507|P1|Overall Study|Death|2
442376|NCT00433017|1466506|P2|Overall Study|Protocol Violation|0
442377|NCT00433017|1466507|P1|Overall Study|Protocol Violation|1
442378|NCT00433017|1466506|P2|Overall Study|Administrative problems|86
442379|NCT00433017|1466507|P1|Overall Study|Administrative problems|80
442380|NCT00433017|1466506|P2|Overall Study|Lost to Follow-up|4
442381|NCT00433017|1466507|P1|Overall Study|Lost to Follow-up|3
442382|NCT00433017|1466506|P2|Overall Study|Withdrawal by Subject|5
442383|NCT00433017|1466507|P1|Overall Study|Withdrawal by Subject|4
442384|NCT00433017|1466506|P2|Overall Study|Adverse Event|3
442385|NCT00433017|1466507|P1|Overall Study|Adverse Event|5
442386|NCT00433004|1466523|P2|Overall Study|Lost to Follow-up|7
442387|NCT00433004|1466524|P1|Overall Study|Lost to Follow-up|5
442388|NCT00432991|1466536|P2|Overall Study|Protocol Violation|12
442389|NCT00432991|1466537|P1|Overall Study|Protocol Violation|7
442390|NCT00432965|1466549|P2|Overall Study|Incomplete Data|3
442391|NCT00432965|1466550|P1|Overall Study|Incomplete Data|4
442392|NCT00432965|1466549|P2|Overall Study|Exclusionary Methods|2
442393|NCT00432965|1466550|P1|Overall Study|Exclusionary Methods|1
442394|NCT00432965|1466549|P2|Overall Study|Death|4
442395|NCT00432965|1466550|P1|Overall Study|Death|3
442396|NCT00432965|1466549|P2|Overall Study|Adverse Event|19
442397|NCT00432965|1466550|P1|Overall Study|Adverse Event|22
442398|NCT00432965|1466549|P2|Overall Study|Non-compliance|0
442399|NCT00432965|1466550|P1|Overall Study|Non-compliance|7
442400|NCT00432965|1466549|P2|Overall Study|Lack of Efficacy|13
442401|NCT00432965|1466550|P1|Overall Study|Lack of Efficacy|8
442402|NCT00432965|1466549|P2|Overall Study|Physician Decision|13
442403|NCT00432965|1466550|P1|Overall Study|Physician Decision|14
442404|NCT00432965|1466549|P2|Overall Study|Withdrawal by Subject|13
442405|NCT00432965|1466550|P1|Overall Study|Withdrawal by Subject|13
442406|NCT00432965|1466549|P2|Overall Study|Lost to Follow-up|19
442407|NCT00432965|1466550|P1|Overall Study|Lost to Follow-up|22
442408|NCT00432835|1466558|P2|Overall Study|Adverse event: lead dislodgement.|7
442409|NCT00432835|1466559|P1|Overall Study|Adverse event: lead dislodgement.|6
442410|NCT00432809|1466572|P3|1 Year Follow-up|Withdrawal by Subject|1
442411|NCT00432809|1466573|P2|1 Year Follow-up|Withdrawal by Subject|0
442412|NCT00432809|1466574|P1|1 Year Follow-up|Withdrawal by Subject|7
442413|NCT00432809|1466572|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
442414|NCT00432809|1466573|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
442415|NCT00432809|1466574|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
442416|NCT00432744|1466647|P2|Months 7 - 12|Too disabled to score|1
442417|NCT00432744|1466648|P1|Months 7 - 12|Too disabled to score|0
442418|NCT00432744|1466647|P2|Months 7 - 12|Withdrawal by Subject|0
442419|NCT00432744|1466648|P1|Months 7 - 12|Withdrawal by Subject|1
442420|NCT00432744|1466647|P2|Months 0-6|Too disabled to score|0
442421|NCT00432744|1466648|P1|Months 0-6|Too disabled to score|1
442422|NCT00432744|1466647|P2|Months 0-6|Withdrawal by Subject|4
442423|NCT00432744|1466648|P1|Months 0-6|Withdrawal by Subject|4
442424|NCT00432666|1466660|P2|Open-Label Extension Period|Physician Decision|0
442425|NCT00432666|1466661|P1|Open-Label Extension Period|Physician Decision|3
442426|NCT00432666|1466660|P2|Open-Label Extension Period|Consent withdrawn|0
442427|NCT00432666|1466661|P1|Open-Label Extension Period|Consent withdrawn|10
442428|NCT00432666|1466660|P2|Open-Label Extension Period|Adverse Event|0
442429|NCT00432666|1466661|P1|Open-Label Extension Period|Adverse Event|5
442430|NCT00432666|1466660|P2|Open-Label Extension Period|Lack of Efficacy|0
442431|NCT00432666|1466661|P1|Open-Label Extension Period|Lack of Efficacy|6
442432|NCT00432666|1466660|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
442433|NCT00432666|1466661|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
442434|NCT00432666|1466660|P2|Main Period|Consent Withdrawn|0
442435|NCT00432666|1466661|P1|Main Period|Consent Withdrawn|1
442436|NCT00432666|1466660|P2|Main Period|Adverse Event|1
442437|NCT00432666|1466661|P1|Main Period|Adverse Event|1
442438|NCT00432562|1466834|P2|Overall Study|Death|0
442439|NCT00432562|1466835|P1|Overall Study|Death|3
442440|NCT00432380|1466887|P3|Overall Study|Adverse Event|0
442441|NCT00432380|1466888|P2|Overall Study|Adverse Event|0
442442|NCT00432380|1466889|P1|Overall Study|Adverse Event|1
442443|NCT00432380|1466887|P3|Overall Study|Migrated/moved from study area|1
442444|NCT00432380|1466888|P2|Overall Study|Migrated/moved from study area|4
442445|NCT00432380|1466889|P1|Overall Study|Migrated/moved from study area|3
442446|NCT00432276|1466942|P2|Overall Study|Other|3
442447|NCT00432276|1466943|P1|Overall Study|Other|2
442448|NCT00432276|1466942|P2|Overall Study|Physician Decision|8
442449|NCT00432276|1466943|P1|Overall Study|Physician Decision|6
442450|NCT00432276|1466942|P2|Overall Study|Withdrawal by Subject|20
442451|NCT00432276|1466943|P1|Overall Study|Withdrawal by Subject|25
442452|NCT00432276|1466942|P2|Overall Study|Lost to Follow-up|2
442453|NCT00432276|1466943|P1|Overall Study|Lost to Follow-up|6
442454|NCT00432276|1466942|P2|Overall Study|Protocol Violation|20
442455|NCT00432276|1466943|P1|Overall Study|Protocol Violation|25
442456|NCT00432276|1466942|P2|Overall Study|Adverse Event|16
442457|NCT00432276|1466943|P1|Overall Study|Adverse Event|13
442458|NCT00432276|1466942|P2|Overall Study|Hyperglycemic Rescue|87
442459|NCT00432276|1466943|P1|Overall Study|Hyperglycemic Rescue|44
442460|NCT00432237|1467033|P4|Overall Study|Lack of Qualifying Event|84
442461|NCT00432237|1467034|P3|Overall Study|Lack of Qualifying Event|69
442462|NCT00432237|1467035|P2|Overall Study|Lack of Qualifying Event|71
442463|NCT00432237|1467036|P1|Overall Study|Lack of Qualifying Event|38
442464|NCT00432237|1467033|P4|Overall Study|Withdrawal by Subject|11
442465|NCT00432237|1467034|P3|Overall Study|Withdrawal by Subject|9
442466|NCT00432237|1467035|P2|Overall Study|Withdrawal by Subject|6
442467|NCT00432237|1467036|P1|Overall Study|Withdrawal by Subject|5
442468|NCT00432237|1467033|P4|Overall Study|Protocol Violation|8
442469|NCT00432237|1467034|P3|Overall Study|Protocol Violation|11
442470|NCT00432237|1467035|P2|Overall Study|Protocol Violation|10
442471|NCT00432237|1467036|P1|Overall Study|Protocol Violation|13
442472|NCT00432237|1467033|P4|Overall Study|Pregnancy|0
442473|NCT00432237|1467034|P3|Overall Study|Pregnancy|0
442474|NCT00432237|1467035|P2|Overall Study|Pregnancy|1
442475|NCT00432237|1467036|P1|Overall Study|Pregnancy|0
442476|NCT00432237|1467033|P4|Overall Study|Physician Decision|1
442477|NCT00432237|1467034|P3|Overall Study|Physician Decision|2
442478|NCT00432237|1467035|P2|Overall Study|Physician Decision|3
442479|NCT00432237|1467036|P1|Overall Study|Physician Decision|1
442480|NCT00432237|1467033|P4|Overall Study|Lost to Follow-up|18
442481|NCT00432237|1467034|P3|Overall Study|Lost to Follow-up|18
442482|NCT00432237|1467035|P2|Overall Study|Lost to Follow-up|10
442483|NCT00432237|1467036|P1|Overall Study|Lost to Follow-up|10
442484|NCT00432237|1467033|P4|Overall Study|Lack of Efficacy|1
442485|NCT00432237|1467034|P3|Overall Study|Lack of Efficacy|0
442486|NCT00432237|1467035|P2|Overall Study|Lack of Efficacy|0
442487|NCT00432237|1467036|P1|Overall Study|Lack of Efficacy|0
442488|NCT00432237|1467033|P4|Overall Study|Adverse Event|1
442489|NCT00432237|1467034|P3|Overall Study|Adverse Event|0
442490|NCT00432237|1467035|P2|Overall Study|Adverse Event|0
442491|NCT00432237|1467036|P1|Overall Study|Adverse Event|0
442492|NCT00432159|1467079|P5|Overall Study|Missing NDI and/or neuro. assessment|7
442493|NCT00432159|1467080|P4|Overall Study|Missing NDI and/or neuro. assessment|3
442494|NCT00432159|1467081|P3|Overall Study|Missing NDI and/or neuro. assessment|1
442495|NCT00432159|1467082|P2|Overall Study|Missing NDI and/or neuro. assessment|24
442496|NCT00432159|1467083|P1|Overall Study|Missing NDI and/or neuro. assessment|13
442497|NCT00432159|1467079|P5|Overall Study|Failure|3
442498|NCT00432159|1467080|P4|Overall Study|Failure|2
442499|NCT00432159|1467081|P3|Overall Study|Failure|3
442500|NCT00432159|1467082|P2|Overall Study|Failure|5
442501|NCT00432159|1467083|P1|Overall Study|Failure|9
442502|NCT00432159|1467079|P5|Overall Study|Death|0
442503|NCT00432159|1467080|P4|Overall Study|Death|0
442504|NCT00432159|1467081|P3|Overall Study|Death|0
442505|NCT00432159|1467082|P2|Overall Study|Death|1
442506|NCT00432159|1467083|P1|Overall Study|Death|0
442507|NCT00432042|1467190|P3|Overall Study|Lost to Follow-up|0
442508|NCT00432042|1467191|P2|Overall Study|Lost to Follow-up|1
442509|NCT00432042|1467192|P1|Overall Study|Lost to Follow-up|5
442510|NCT00432042|1467190|P3|Overall Study|Withdrawal by Subject|2
442511|NCT00432042|1467191|P2|Overall Study|Withdrawal by Subject|0
442512|NCT00432042|1467192|P1|Overall Study|Withdrawal by Subject|0
442513|NCT00432042|1467190|P3|Overall Study|Protocol Violation|0
442514|NCT00432042|1467191|P2|Overall Study|Protocol Violation|0
442515|NCT00432042|1467192|P1|Overall Study|Protocol Violation|2
442516|NCT00431964|1467205|P2|Overall Study|Due to Unstable Health|1
442517|NCT00431964|1467206|P1|Overall Study|Due to Unstable Health|0
442518|NCT00431964|1467205|P2|Overall Study|Parental Consent Withdrawn|2
442519|NCT00431964|1467206|P1|Overall Study|Parental Consent Withdrawn|0
442520|NCT00431964|1467205|P2|Overall Study|Withdrawal by Subject|1
442521|NCT00431964|1467206|P1|Overall Study|Withdrawal by Subject|2
442522|NCT00431964|1467205|P2|Overall Study|Physician Decision|2
442523|NCT00431964|1467206|P1|Overall Study|Physician Decision|2
442524|NCT00431964|1467205|P2|Overall Study|Lost to Follow-up|2
442525|NCT00431964|1467206|P1|Overall Study|Lost to Follow-up|1
442526|NCT00431964|1467205|P2|Overall Study|Adverse Event|0
442527|NCT00431964|1467206|P1|Overall Study|Adverse Event|1
442528|NCT00431951|1467216|P4|Overall Study|Adverse Event|0
442529|NCT00431951|1467217|P3|Overall Study|Adverse Event|1
442530|NCT00431951|1467218|P2|Overall Study|Adverse Event|0
442531|NCT00431951|1467219|P1|Overall Study|Adverse Event|0
442532|NCT00431951|1467216|P4|Overall Study|Withdrawal by Subject|0
442533|NCT00431951|1467217|P3|Overall Study|Withdrawal by Subject|0
442534|NCT00431951|1467218|P2|Overall Study|Withdrawal by Subject|1
442535|NCT00431951|1467219|P1|Overall Study|Withdrawal by Subject|0
442536|NCT00431951|1467216|P4|Overall Study|Lost to Follow-up|0
442537|NCT00431951|1467217|P3|Overall Study|Lost to Follow-up|0
442538|NCT00431951|1467218|P2|Overall Study|Lost to Follow-up|1
442539|NCT00431951|1467219|P1|Overall Study|Lost to Follow-up|0
442540|NCT00431951|1467216|P4|Overall Study|Inability to follow study procedures|2
442541|NCT00431951|1467217|P3|Overall Study|Inability to follow study procedures|1
442542|NCT00431951|1467218|P2|Overall Study|Inability to follow study procedures|0
442543|NCT00431951|1467219|P1|Overall Study|Inability to follow study procedures|1
442544|NCT00431847|1467281|P5|Overall Study|Protocol Violation|1
442545|NCT00431847|1467282|P4|Overall Study|Protocol Violation|0
442546|NCT00431847|1467283|P3|Overall Study|Protocol Violation|0
442547|NCT00431847|1467284|P2|Overall Study|Protocol Violation|0
442548|NCT00431847|1467285|P1|Overall Study|Protocol Violation|0
442549|NCT00431847|1467281|P5|Overall Study|completion of less than two study visits|0
442550|NCT00431847|1467282|P4|Overall Study|completion of less than two study visits|14
442551|NCT00431847|1467283|P3|Overall Study|completion of less than two study visits|4
442552|NCT00431847|1467284|P2|Overall Study|completion of less than two study visits|3
442553|NCT00431847|1467285|P1|Overall Study|completion of less than two study visits|6
442554|NCT00431834|1467359|P1|Overall Study|Lost to Follow-up|1
442555|NCT00431834|1467359|P1|Overall Study|Missed Endpoint Visit|2
442556|NCT00431834|1467359|P1|Overall Study|Death|3
442557|NCT00431834|1467359|P1|Overall Study|Withdrawal by Subject|7
442558|NCT00431496|1467375|P1|Overall Study|Protocol-specified criteria|5
442559|NCT00431496|1467375|P1|Overall Study|Withdrawal by Subject|2
442560|NCT00431496|1467375|P1|Overall Study|Lost to Follow-up|1
442561|NCT00431496|1467375|P1|Overall Study|Adverse Event|3
442562|NCT00431444|1467386|P2|Overall Study|Administrative Problems|1
442563|NCT00431444|1467387|P1|Overall Study|Administrative Problems|0
442564|NCT00431444|1467386|P2|Overall Study|Lost to Follow-up|0
442565|NCT00431444|1467387|P1|Overall Study|Lost to Follow-up|1
442566|NCT00431444|1467386|P2|Overall Study|Withdrawal by Subject|1
442567|NCT00431444|1467387|P1|Overall Study|Withdrawal by Subject|1
442568|NCT00431444|1467386|P2|Overall Study|Adverse Event|1
442569|NCT00431444|1467387|P1|Overall Study|Adverse Event|2
442570|NCT00431444|1467386|P2|Overall Study|Protocol Violation|4
442571|NCT00431444|1467387|P1|Overall Study|Protocol Violation|1
442572|NCT00431067|1467427|P1|Overall Study|Non-compliance,lost to follow-up|2
442573|NCT00431067|1467427|P1|Overall Study|Progressive disease|30
442574|NCT00431067|1467427|P1|Overall Study|Other Adverse Event|9
442575|NCT00430950|1467452|P2|Overall Study|concomitant medication,etc.|7
442576|NCT00430950|1467453|P1|Overall Study|concomitant medication,etc.|5
442577|NCT00430950|1467452|P2|Overall Study|Withdrawal by Subject|0
442578|NCT00430950|1467453|P1|Overall Study|Withdrawal by Subject|1
442579|NCT00430950|1467452|P2|Overall Study|Adverse Event|6
442580|NCT00430950|1467453|P1|Overall Study|Adverse Event|7
442581|NCT00430937|1467467|P2|Overall Study|Unable to classify|1
442582|NCT00430937|1467468|P1|Overall Study|Unable to classify|0
442583|NCT00430937|1467467|P2|Overall Study|Protocol discontinuation criteria met|2
442584|NCT00430937|1467468|P1|Overall Study|Protocol discontinuation criteria met|1
442585|NCT00430937|1467467|P2|Overall Study|Administrative reasons|0
442586|NCT00430937|1467468|P1|Overall Study|Administrative reasons|1
442587|NCT00430937|1467467|P2|Overall Study|Inappropriate enrollment|1
442588|NCT00430937|1467468|P1|Overall Study|Inappropriate enrollment|2
442589|NCT00430937|1467467|P2|Overall Study|Lack of Efficacy|5
442590|NCT00430937|1467468|P1|Overall Study|Lack of Efficacy|6
442591|NCT00430937|1467467|P2|Overall Study|Protocol Violation|2
442592|NCT00430937|1467468|P1|Overall Study|Protocol Violation|3
442593|NCT00430937|1467467|P2|Overall Study|Withdrawal by Subject|2
442594|NCT00430937|1467468|P1|Overall Study|Withdrawal by Subject|5
442595|NCT00430937|1467467|P2|Overall Study|Lost to Follow-up|6
442596|NCT00430937|1467468|P1|Overall Study|Lost to Follow-up|6
442597|NCT00430937|1467467|P2|Overall Study|Death|1
442598|NCT00430937|1467468|P1|Overall Study|Death|0
442599|NCT00430937|1467467|P2|Overall Study|Adverse Event|8
442600|NCT00430937|1467468|P1|Overall Study|Adverse Event|3
442601|NCT00430781|1467479|P3|End-of-Study Analysis; 28 July 2011|Other|0
442602|NCT00430781|1467480|P2|End-of-Study Analysis; 28 July 2011|Other|1
442603|NCT00430781|1467481|P1|End-of-Study Analysis; 28 July 2011|Other|4
442604|NCT00430781|1467479|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
442605|NCT00430781|1467480|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
442606|NCT00430781|1467481|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
442607|NCT00430781|1467479|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
442608|NCT00430781|1467480|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
442609|NCT00430781|1467481|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
442610|NCT00430781|1467479|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
442611|NCT00430781|1467480|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
442612|NCT00430781|1467481|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
442613|NCT00430781|1467479|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
442614|NCT00430781|1467480|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
442615|NCT00430781|1467481|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
442616|NCT00430781|1467479|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
442617|NCT00430781|1467480|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
442618|NCT00430781|1467481|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
442619|NCT00430781|1467479|P3|Final Analysis; 31 July 2008|Ongoing|32
442620|NCT00430781|1467480|P2|Final Analysis; 31 July 2008|Ongoing|29
442621|NCT00430781|1467481|P1|Final Analysis; 31 July 2008|Ongoing|0
442622|NCT00430781|1467479|P3|Final Analysis; 31 July 2008|Other|0
442623|NCT00430781|1467480|P2|Final Analysis; 31 July 2008|Other|1
442624|NCT00430781|1467481|P1|Final Analysis; 31 July 2008|Other|0
442625|NCT00430781|1467479|P3|Final Analysis; 31 July 2008|Physician Decision|6
442626|NCT00430781|1467480|P2|Final Analysis; 31 July 2008|Physician Decision|6
442627|NCT00430781|1467481|P1|Final Analysis; 31 July 2008|Physician Decision|0
442628|NCT00430781|1467479|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
442629|NCT00430781|1467480|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
442630|NCT00430781|1467481|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
442631|NCT00430781|1467479|P3|Final Analysis; 31 July 2008|Protocol Violation|0
442632|NCT00430781|1467480|P2|Final Analysis; 31 July 2008|Protocol Violation|1
442633|NCT00430781|1467481|P1|Final Analysis; 31 July 2008|Protocol Violation|0
442634|NCT00430781|1467479|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
442635|NCT00430781|1467480|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
442636|NCT00430781|1467481|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
442637|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Ongoing|25
442638|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Ongoing|20
442639|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Ongoing|23
442640|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Physician Decision|3
442641|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Physician Decision|3
442642|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Physician Decision|2
442643|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
442644|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
442645|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
442646|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Death|0
442647|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Death|1
442648|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Death|0
442649|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Disease Progression|22
442650|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Disease Progression|30
442651|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Disease Progression|16
442652|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
442653|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
442654|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
442655|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
442656|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
442657|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
442658|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
442659|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
442660|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
442661|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
442662|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
442663|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
442664|NCT00430781|1467479|P3|Interim Analysis; 11 February 2008|Adverse Event|7
442665|NCT00430781|1467480|P2|Interim Analysis; 11 February 2008|Adverse Event|3
442666|NCT00430781|1467481|P1|Interim Analysis; 11 February 2008|Adverse Event|10
442667|NCT00430755|1467523|P1|Overall Study|Withdrawal by Subject|53
442668|NCT00430716|1467530|P3|Open Label Phase|Study terminated by sponsor|4
442669|NCT00430716|1467531|P2|Open Label Phase|Study terminated by sponsor|5
442670|NCT00430716|1467532|P1|Open Label Phase|Study terminated by sponsor|4
442671|NCT00430716|1467530|P3|Open Label Phase|Protocol Violation|0
442672|NCT00430716|1467531|P2|Open Label Phase|Protocol Violation|0
442673|NCT00430716|1467532|P1|Open Label Phase|Protocol Violation|1
442674|NCT00430716|1467530|P3|Open Label Phase|Other|1
442675|NCT00430716|1467531|P2|Open Label Phase|Other|1
442676|NCT00430716|1467532|P1|Open Label Phase|Other|3
442677|NCT00430716|1467530|P3|Open Label Phase|No longer willing to participate|1
442678|NCT00430716|1467531|P2|Open Label Phase|No longer willing to participate|1
442679|NCT00430716|1467532|P1|Open Label Phase|No longer willing to participate|0
442680|NCT00430716|1467530|P3|Open Label Phase|Lost to Follow-up|1
442681|NCT00430716|1467531|P2|Open Label Phase|Lost to Follow-up|0
442682|NCT00430716|1467532|P1|Open Label Phase|Lost to Follow-up|1
442683|NCT00430716|1467530|P3|Double Blind Phase|Not met eligibility criteria|0
442684|NCT00430716|1467531|P2|Double Blind Phase|Not met eligibility criteria|0
442685|NCT00430716|1467532|P1|Double Blind Phase|Not met eligibility criteria|1
442686|NCT00430716|1467530|P3|Double Blind Phase|Adverse Event|3
442687|NCT00430716|1467531|P2|Double Blind Phase|Adverse Event|1
442688|NCT00430716|1467532|P1|Double Blind Phase|Adverse Event|1
442689|NCT00430716|1467530|P3|Double Blind Phase|Study terminated by sponsor|2
442690|NCT00430716|1467531|P2|Double Blind Phase|Study terminated by sponsor|1
442691|NCT00430716|1467532|P1|Double Blind Phase|Study terminated by sponsor|1
442692|NCT00430716|1467530|P3|Double Blind Phase|Other|0
442693|NCT00430716|1467531|P2|Double Blind Phase|Other|2
442694|NCT00430716|1467532|P1|Double Blind Phase|Other|0
442695|NCT00430716|1467530|P3|Double Blind Phase|No longer willing to participate|1
442696|NCT00430716|1467531|P2|Double Blind Phase|No longer willing to participate|1
442697|NCT00430716|1467532|P1|Double Blind Phase|No longer willing to participate|2
442698|NCT00430716|1467530|P3|Double Blind Phase|Death|0
442699|NCT00430716|1467531|P2|Double Blind Phase|Death|0
442700|NCT00430716|1467532|P1|Double Blind Phase|Death|1
442701|NCT00430677|1467564|P3|Long-term Extension Period|Poor compliance/noncompliance|0
442702|NCT00430677|1467565|P2|Long-term Extension Period|Poor compliance/noncompliance|0
442703|NCT00430677|1467566|P1|Long-term Extension Period|Poor compliance/noncompliance|1
442704|NCT00430677|1467564|P3|Long-term Extension Period|Not specified|1
442705|NCT00430677|1467565|P2|Long-term Extension Period|Not specified|1
442706|NCT00430677|1467566|P1|Long-term Extension Period|Not specified|2
442707|NCT00430677|1467564|P3|Long-term Extension Period|Administrative reason by sponsor|46
442708|NCT00430677|1467565|P2|Long-term Extension Period|Administrative reason by sponsor|49
442709|NCT00430677|1467566|P1|Long-term Extension Period|Administrative reason by sponsor|41
442710|NCT00430677|1467564|P3|Long-term Extension Period|Pregnancy|0
442711|NCT00430677|1467565|P2|Long-term Extension Period|Pregnancy|1
442712|NCT00430677|1467566|P1|Long-term Extension Period|Pregnancy|1
442713|NCT00430677|1467564|P3|Long-term Extension Period|Withdrawal by Subject|2
442714|NCT00430677|1467565|P2|Long-term Extension Period|Withdrawal by Subject|1
442715|NCT00430677|1467566|P1|Long-term Extension Period|Withdrawal by Subject|5
442716|NCT00430677|1467564|P3|Long-term Extension Period|Lost to Follow-up|1
442717|NCT00430677|1467565|P2|Long-term Extension Period|Lost to Follow-up|1
442718|NCT00430677|1467566|P1|Long-term Extension Period|Lost to Follow-up|1
442719|NCT00430677|1467564|P3|Long-term Extension Period|Lack of Efficacy|8
442720|NCT00430677|1467565|P2|Long-term Extension Period|Lack of Efficacy|3
442721|NCT00430677|1467566|P1|Long-term Extension Period|Lack of Efficacy|5
442722|NCT00430677|1467564|P3|Long-term Extension Period|Adverse Event|5
442723|NCT00430677|1467565|P2|Long-term Extension Period|Adverse Event|2
442724|NCT00430677|1467566|P1|Long-term Extension Period|Adverse Event|3
442725|NCT00430677|1467564|P3|Long-term Extension Period|Death|0
442726|NCT00430677|1467565|P2|Long-term Extension Period|Death|0
442727|NCT00430677|1467566|P1|Long-term Extension Period|Death|1
442728|NCT00430677|1467564|P3|Short-term Period|Pregnancy|0
442729|NCT00430677|1467565|P2|Short-term Period|Pregnancy|2
442730|NCT00430677|1467566|P1|Short-term Period|Pregnancy|0
442731|NCT00430677|1467564|P3|Short-term Period|Poor compliance/ noncompliance|0
442732|NCT00430677|1467565|P2|Short-term Period|Poor compliance/ noncompliance|1
442733|NCT00430677|1467566|P1|Short-term Period|Poor compliance/ noncompliance|0
442734|NCT00430677|1467564|P3|Short-term Period|Participant no longer met study criteria|2
442735|NCT00430677|1467565|P2|Short-term Period|Participant no longer met study criteria|1
442736|NCT00430677|1467566|P1|Short-term Period|Participant no longer met study criteria|1
442737|NCT00430677|1467564|P3|Short-term Period|Withdrawal by Subject|2
442738|NCT00430677|1467565|P2|Short-term Period|Withdrawal by Subject|1
442739|NCT00430677|1467566|P1|Short-term Period|Withdrawal by Subject|1
442740|NCT00430677|1467564|P3|Short-term Period|Lack of Efficacy|4
442741|NCT00430677|1467565|P2|Short-term Period|Lack of Efficacy|6
442742|NCT00430677|1467566|P1|Short-term Period|Lack of Efficacy|5
442743|NCT00430677|1467564|P3|Short-term Period|Adverse Event|9
442744|NCT00430677|1467565|P2|Short-term Period|Adverse Event|13
442745|NCT00430677|1467566|P1|Short-term Period|Adverse Event|15
442746|NCT00430677|1467564|P3|Short-term Period|Death|5
442747|NCT00430677|1467565|P2|Short-term Period|Death|1
442748|NCT00430677|1467566|P1|Short-term Period|Death|1
442749|NCT00430638|1467689|P2|Overall Study|Not specified|2
442750|NCT00430638|1467690|P1|Overall Study|Not specified|2
442751|NCT00430638|1467689|P2|Overall Study|Non-compliant|1
442752|NCT00430638|1467690|P1|Overall Study|Non-compliant|2
442753|NCT00430638|1467689|P2|Overall Study|Withdrawal by Subject|6
442754|NCT00430638|1467690|P1|Overall Study|Withdrawal by Subject|4
442755|NCT00430638|1467689|P2|Overall Study|Protocol Violation|4
442756|NCT00430638|1467690|P1|Overall Study|Protocol Violation|6
442757|NCT00430638|1467689|P2|Overall Study|Lost to Follow-up|7
442758|NCT00430638|1467690|P1|Overall Study|Lost to Follow-up|1
442759|NCT00430638|1467689|P2|Overall Study|Uncontrolled blood pressure|13
442760|NCT00430638|1467690|P1|Overall Study|Uncontrolled blood pressure|48
442761|NCT00430638|1467689|P2|Overall Study|Adverse Event|15
442762|NCT00430638|1467690|P1|Overall Study|Adverse Event|15
442763|NCT00430573|1467725|P1|Overall Study|Withdrawal by Subject|5
442764|NCT00430508|1467734|P4|Overall Study|not specified|0
442765|NCT00430508|1467735|P3|Overall Study|not specified|3
442766|NCT00430508|1467736|P2|Overall Study|not specified|1
442767|NCT00430508|1467737|P1|Overall Study|not specified|1
442768|NCT00430508|1467734|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
442769|NCT00430508|1467735|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
442770|NCT00430508|1467736|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
442771|NCT00430508|1467737|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
442772|NCT00430508|1467734|P4|Overall Study|responder at visit 4|0
442773|NCT00430508|1467735|P3|Overall Study|responder at visit 4|2
442774|NCT00430508|1467736|P2|Overall Study|responder at visit 4|0
442775|NCT00430508|1467737|P1|Overall Study|responder at visit 4|0
442776|NCT00430508|1467734|P4|Overall Study|Withdrawal by Subject|1
442777|NCT00430508|1467735|P3|Overall Study|Withdrawal by Subject|1
442778|NCT00430508|1467736|P2|Overall Study|Withdrawal by Subject|1
442779|NCT00430508|1467737|P1|Overall Study|Withdrawal by Subject|0
442780|NCT00430508|1467734|P4|Overall Study|Adverse Event|3
442781|NCT00430508|1467735|P3|Overall Study|Adverse Event|5
442782|NCT00430508|1467736|P2|Overall Study|Adverse Event|3
442783|NCT00430508|1467737|P1|Overall Study|Adverse Event|2
442784|NCT00430495|1467775|P4|Overall Study|Randomized but not Treated|0
442785|NCT00430495|1467776|P3|Overall Study|Randomized but not Treated|0
442786|NCT00430495|1467777|P2|Overall Study|Randomized but not Treated|0
442787|NCT00430495|1467778|P1|Overall Study|Randomized but not Treated|2
442788|NCT00430495|1467775|P4|Overall Study|Other|4
442789|NCT00430495|1467776|P3|Overall Study|Other|5
442790|NCT00430495|1467777|P2|Overall Study|Other|2
442791|NCT00430495|1467778|P1|Overall Study|Other|8
442792|NCT00430495|1467775|P4|Overall Study|Disease Progression|0
442793|NCT00430495|1467776|P3|Overall Study|Disease Progression|0
442794|NCT00430495|1467777|P2|Overall Study|Disease Progression|1
442795|NCT00430495|1467778|P1|Overall Study|Disease Progression|1
442796|NCT00430495|1467775|P4|Overall Study|Protocol Violation|0
442797|NCT00430495|1467776|P3|Overall Study|Protocol Violation|1
442798|NCT00430495|1467777|P2|Overall Study|Protocol Violation|0
442799|NCT00430495|1467778|P1|Overall Study|Protocol Violation|1
442800|NCT00430495|1467775|P4|Overall Study|Lost to Follow-up|0
442801|NCT00430495|1467776|P3|Overall Study|Lost to Follow-up|4
442802|NCT00430495|1467777|P2|Overall Study|Lost to Follow-up|1
442803|NCT00430495|1467778|P1|Overall Study|Lost to Follow-up|0
442804|NCT00430495|1467775|P4|Overall Study|Death|0
442805|NCT00430495|1467776|P3|Overall Study|Death|1
442806|NCT00430495|1467777|P2|Overall Study|Death|0
442807|NCT00430495|1467778|P1|Overall Study|Death|0
442808|NCT00430495|1467775|P4|Overall Study|Adverse Event|0
442809|NCT00430495|1467776|P3|Overall Study|Adverse Event|2
442810|NCT00430495|1467777|P2|Overall Study|Adverse Event|3
442811|NCT00430495|1467778|P1|Overall Study|Adverse Event|2
442812|NCT00430352|1467816|P1|Overall Study|Not specified|48
442813|NCT00430352|1467816|P1|Overall Study|Death|5
442814|NCT00430352|1467816|P1|Overall Study|Adverse Event|16
442815|NCT00430352|1467816|P1|Overall Study|Withdrawal by Subject|11
442816|NCT00430352|1467816|P1|Overall Study|Disease progression|58
442817|NCT00430300|1467834|P4|Overall Study|Other|1
442818|NCT00430300|1467835|P3|Overall Study|Other|0
442819|NCT00430300|1467836|P2|Overall Study|Other|0
442820|NCT00430300|1467837|P1|Overall Study|Other|0
442821|NCT00430300|1467834|P4|Overall Study|Laboratory abnormality|0
442822|NCT00430300|1467835|P3|Overall Study|Laboratory abnormality|0
442823|NCT00430300|1467836|P2|Overall Study|Laboratory abnormality|0
442824|NCT00430300|1467837|P1|Overall Study|Laboratory abnormality|1
442825|NCT00430300|1467834|P4|Overall Study|Withdrawal by Subject|0
442826|NCT00430300|1467835|P3|Overall Study|Withdrawal by Subject|5
442827|NCT00430300|1467836|P2|Overall Study|Withdrawal by Subject|0
442828|NCT00430300|1467837|P1|Overall Study|Withdrawal by Subject|1
442829|NCT00430300|1467834|P4|Overall Study|Adverse Event|1
442830|NCT00430300|1467835|P3|Overall Study|Adverse Event|1
442831|NCT00430300|1467836|P2|Overall Study|Adverse Event|2
442832|NCT00430300|1467837|P1|Overall Study|Adverse Event|0
442833|NCT00430248|1467942|P3|Overall Study|Reason Not Specified|11
442834|NCT00430248|1467943|P2|Overall Study|Reason Not Specified|8
442835|NCT00430248|1467944|P1|Overall Study|Reason Not Specified|8
442836|NCT00430248|1467942|P3|Overall Study|Gout Flare|2
442837|NCT00430248|1467943|P2|Overall Study|Gout Flare|7
442838|NCT00430248|1467944|P1|Overall Study|Gout Flare|3
442839|NCT00430248|1467942|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
442840|NCT00430248|1467943|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
442841|NCT00430248|1467944|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
442842|NCT00430248|1467942|P3|Overall Study|Withdrawal by Subject|16
442843|NCT00430248|1467943|P2|Overall Study|Withdrawal by Subject|20
442844|NCT00430248|1467944|P1|Overall Study|Withdrawal by Subject|14
442845|NCT00430248|1467942|P3|Overall Study|Therapeutic Failure|1
442846|NCT00430248|1467943|P2|Overall Study|Therapeutic Failure|1
442847|NCT00430248|1467944|P1|Overall Study|Therapeutic Failure|1
442848|NCT00430248|1467942|P3|Overall Study|Lost to Follow-up|28
442849|NCT00430248|1467943|P2|Overall Study|Lost to Follow-up|33
442850|NCT00430248|1467944|P1|Overall Study|Lost to Follow-up|28
442851|NCT00430248|1467942|P3|Overall Study|Personal Reasons|9
442852|NCT00430248|1467943|P2|Overall Study|Personal Reasons|24
442853|NCT00430248|1467944|P1|Overall Study|Personal Reasons|12
442854|NCT00430248|1467942|P3|Overall Study|Protocol Violation|4
442855|NCT00430248|1467943|P2|Overall Study|Protocol Violation|2
442856|NCT00430248|1467944|P1|Overall Study|Protocol Violation|10
442857|NCT00430248|1467942|P3|Overall Study|Adverse Event|64
442858|NCT00430248|1467943|P2|Overall Study|Adverse Event|61
442859|NCT00430248|1467944|P1|Overall Study|Adverse Event|49
442860|NCT00430092|1468003|P3|Overall Study|Withdrawal by Subject|1
442861|NCT00430092|1468004|P2|Overall Study|Withdrawal by Subject|1
442862|NCT00430092|1468005|P1|Overall Study|Withdrawal by Subject|0
442863|NCT00430092|1468003|P3|Overall Study|Protocol Violation|1
442864|NCT00430092|1468004|P2|Overall Study|Protocol Violation|1
442865|NCT00430092|1468005|P1|Overall Study|Protocol Violation|0
442866|NCT00430092|1468003|P3|Overall Study|Lost to Follow-up|0
442867|NCT00430092|1468004|P2|Overall Study|Lost to Follow-up|0
442868|NCT00430092|1468005|P1|Overall Study|Lost to Follow-up|1
442869|NCT00430092|1468003|P3|Overall Study|Lack of Efficacy|54
442870|NCT00430092|1468004|P2|Overall Study|Lack of Efficacy|2
442871|NCT00430092|1468005|P1|Overall Study|Lack of Efficacy|5
442872|NCT00430092|1468003|P3|Overall Study|Adverse Event|1
442873|NCT00430092|1468004|P2|Overall Study|Adverse Event|0
442874|NCT00430092|1468005|P1|Overall Study|Adverse Event|0
442875|NCT00430027|1468010|P1|Overall Study|Study terminated|8
442876|NCT00429923|1468027|P3|Overall Study|Early Termination|0
442877|NCT00429923|1468028|P2|Overall Study|Early Termination|1
442878|NCT00429923|1468029|P1|Overall Study|Early Termination|0
442879|NCT00429923|1468027|P3|Overall Study|Withdrew Consent|1
442880|NCT00429923|1468028|P2|Overall Study|Withdrew Consent|0
442881|NCT00429923|1468029|P1|Overall Study|Withdrew Consent|1
442882|NCT00429923|1468027|P3|Overall Study|Lost to Follow-up|2
442883|NCT00429923|1468028|P2|Overall Study|Lost to Follow-up|0
442884|NCT00429923|1468029|P1|Overall Study|Lost to Follow-up|0
442885|NCT00429923|1468027|P3|Overall Study|Lack of Efficacy|33
442886|NCT00429923|1468028|P2|Overall Study|Lack of Efficacy|1
442887|NCT00429923|1468029|P1|Overall Study|Lack of Efficacy|4
442888|NCT00429923|1468027|P3|Overall Study|Adverse Event|3
442889|NCT00429923|1468028|P2|Overall Study|Adverse Event|2
442890|NCT00429923|1468029|P1|Overall Study|Adverse Event|0
442891|NCT00429793|1468034|P1|Overall Study|Non-measurable|1
442892|NCT00429793|1468034|P1|Overall Study|Never treated|1
442893|NCT00429793|1468034|P1|Overall Study|Required test not done|1
442894|NCT00429793|1468034|P1|Overall Study|Improper pre-protocol treatment|3
442895|NCT00429663|1468061|P2|Overall Study|Death|0
442896|NCT00429663|1468062|P1|Overall Study|Death|4
442897|NCT00429663|1468061|P2|Overall Study|Withdrawal by Subject|5
442898|NCT00429663|1468062|P1|Overall Study|Withdrawal by Subject|2
442899|NCT00429663|1468061|P2|Overall Study|Physician Decision|3
442900|NCT00429663|1468062|P1|Overall Study|Physician Decision|6
442901|NCT00429663|1468061|P2|Overall Study|Lost to Follow-up|31
442902|NCT00429663|1468062|P1|Overall Study|Lost to Follow-up|24
442903|NCT00429572|1468076|P1|Overall Study|Disease progression|1
442904|NCT00429494|1468088|P1|Overall Study|Death|6
442905|NCT00429494|1468088|P1|Overall Study|Withdrawal by Subject|9
442906|NCT00429416|1468092|P1|Overall Study|Death|1
442907|NCT00429364|1468111|P2|Overall Study|Pregnancy|1
442908|NCT00429364|1468112|P1|Overall Study|Pregnancy|0
442909|NCT00429364|1468111|P2|Overall Study|Underwent aortic root surgery|18
442910|NCT00429364|1468112|P1|Overall Study|Underwent aortic root surgery|10
442911|NCT00429364|1468111|P2|Overall Study|Death|1
442912|NCT00429364|1468112|P1|Overall Study|Death|0
442913|NCT00429364|1468111|P2|Overall Study|Lost to Follow-up|6
442914|NCT00429364|1468112|P1|Overall Study|Lost to Follow-up|7
442915|NCT00429364|1468111|P2|Overall Study|Physician Decision|2
442916|NCT00429364|1468112|P1|Overall Study|Physician Decision|4
442917|NCT00429364|1468111|P2|Overall Study|Withdrawal by Subject|5
442918|NCT00429364|1468112|P1|Overall Study|Withdrawal by Subject|11
442919|NCT00429299|1468171|P3|Overall Study|Withdrawal by Subject|3
442920|NCT00429299|1468172|P2|Overall Study|Withdrawal by Subject|1
442921|NCT00429299|1468173|P1|Overall Study|Withdrawal by Subject|0
442922|NCT00429299|1468171|P3|Overall Study|Protocol Violation|0
442923|NCT00429299|1468172|P2|Overall Study|Protocol Violation|0
442924|NCT00429299|1468173|P1|Overall Study|Protocol Violation|1
442925|NCT00429299|1468171|P3|Overall Study|Adverse Event|1
442926|NCT00429299|1468172|P2|Overall Study|Adverse Event|5
442927|NCT00429299|1468173|P1|Overall Study|Adverse Event|2
442928|NCT00429299|1468171|P3|Overall Study|Disease Progression|0
442929|NCT00429299|1468172|P2|Overall Study|Disease Progression|1
442930|NCT00429299|1468173|P1|Overall Study|Disease Progression|1
442931|NCT00429273|1468205|P3|Overall Study|Adverse Event|2
442932|NCT00429273|1468206|P2|Overall Study|Adverse Event|1
442933|NCT00429273|1468207|P1|Overall Study|Adverse Event|1
442934|NCT00429273|1468205|P3|Overall Study|Physician Decision|5
442935|NCT00429273|1468206|P2|Overall Study|Physician Decision|5
442936|NCT00429273|1468207|P1|Overall Study|Physician Decision|6
442937|NCT00429273|1468205|P3|Overall Study|Lost to Follow-up|2
442938|NCT00429273|1468206|P2|Overall Study|Lost to Follow-up|2
442939|NCT00429273|1468207|P1|Overall Study|Lost to Follow-up|1
442940|NCT00429182|1468215|P1|Overall Study|Not eligible|5
442941|NCT00429182|1468215|P1|Overall Study|Not evaluable, Disease Progression|2
442942|NCT00429169|1468222|P2|Overall Study|Ineligibility discovered after entry|1
442943|NCT00429169|1468223|P1|Overall Study|Ineligibility discovered after entry|2
442944|NCT00429169|1468222|P2|Overall Study|Lost to Follow-up|1
442945|NCT00429169|1468223|P1|Overall Study|Lost to Follow-up|0
442946|NCT00429104|1468241|P1|Overall Study|Protocol Violation|1
442947|NCT00429026|1468246|P1|Overall Study|Inevaluable for response.|40
442948|NCT00428948|1468273|P2|Overall Study|Protocol Deviation|1
442949|NCT00428948|1468274|P1|Overall Study|Protocol Deviation|1
442950|NCT00428948|1468273|P2|Overall Study|Subject Withdrew Consent|30
442951|NCT00428948|1468274|P1|Overall Study|Subject Withdrew Consent|50
442952|NCT00428948|1468273|P2|Overall Study|Investigator Withdrew Subject|4
442953|NCT00428948|1468274|P1|Overall Study|Investigator Withdrew Subject|3
442954|NCT00428948|1468273|P2|Overall Study|Subject Met Withdrawal Criteria|0
442955|NCT00428948|1468274|P1|Overall Study|Subject Met Withdrawal Criteria|4
442956|NCT00428948|1468273|P2|Overall Study|Adverse Event|24
442957|NCT00428948|1468274|P1|Overall Study|Adverse Event|148
442958|NCT00428948|1468273|P2|Overall Study|Lost to Follow-up|8
442959|NCT00428948|1468274|P1|Overall Study|Lost to Follow-up|15
442960|NCT00428844|1468302|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
442961|NCT00428844|1468303|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
443045|NCT00428389|1468466|P1|Extension Phase|Adverse Event|17
442962|NCT00428844|1468304|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
442963|NCT00428844|1468302|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
442964|NCT00428844|1468303|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
442965|NCT00428844|1468304|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
442966|NCT00428844|1468302|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
442967|NCT00428844|1468303|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
442968|NCT00428844|1468304|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
442969|NCT00428844|1468302|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
442970|NCT00428844|1468303|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
442971|NCT00428844|1468304|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
442972|NCT00428844|1468302|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
442973|NCT00428844|1468303|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
442974|NCT00428844|1468304|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
442975|NCT00428844|1468302|P3|Completed Study Drug Treatment|Randomized Not Treated|1
442976|NCT00428844|1468303|P2|Completed Study Drug Treatment|Randomized Not Treated|0
442977|NCT00428844|1468304|P1|Completed Study Drug Treatment|Randomized Not Treated|0
442978|NCT00428844|1468302|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
442979|NCT00428844|1468303|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
442980|NCT00428844|1468304|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
442981|NCT00428844|1468302|P3|Completed Study Drug Treatment|Protocol Violation|1
442982|NCT00428844|1468303|P2|Completed Study Drug Treatment|Protocol Violation|1
442983|NCT00428844|1468304|P1|Completed Study Drug Treatment|Protocol Violation|0
442984|NCT00428844|1468302|P3|Completed Study Drug Treatment|Adverse Event|4
442985|NCT00428844|1468303|P2|Completed Study Drug Treatment|Adverse Event|4
442986|NCT00428844|1468304|P1|Completed Study Drug Treatment|Adverse Event|2
442987|NCT00428792|1468327|P2|Overall Study|Lost to Follow-up|1
442988|NCT00428792|1468328|P1|Overall Study|Lost to Follow-up|0
442989|NCT00428792|1468327|P2|Overall Study|Lack of Efficacy|3
442990|NCT00428792|1468328|P1|Overall Study|Lack of Efficacy|1
442991|NCT00428610|1468355|P3|Overall Study|Withdrawal by Subject|0
442992|NCT00428610|1468356|P2|Overall Study|Withdrawal by Subject|0
442993|NCT00428610|1468357|P1|Overall Study|Withdrawal by Subject|4
442994|NCT00428610|1468355|P3|Overall Study|Progressive Disease|22
442995|NCT00428610|1468356|P2|Overall Study|Progressive Disease|14
442996|NCT00428610|1468357|P1|Overall Study|Progressive Disease|42
442997|NCT00428610|1468355|P3|Overall Study|Investigator Decision|1
442998|NCT00428610|1468356|P2|Overall Study|Investigator Decision|1
442999|NCT00428610|1468357|P1|Overall Study|Investigator Decision|2
443000|NCT00428610|1468355|P3|Overall Study|Adverse Event|2
443001|NCT00428610|1468356|P2|Overall Study|Adverse Event|3
443002|NCT00428610|1468357|P1|Overall Study|Adverse Event|2
443003|NCT00428610|1468355|P3|Overall Study|Death Due to Progressive Disease|2
443004|NCT00428610|1468356|P2|Overall Study|Death Due to Progressive Disease|0
443005|NCT00428610|1468357|P1|Overall Study|Death Due to Progressive Disease|0
443006|NCT00428610|1468355|P3|Overall Study|Death Due to Adverse Event|5
443007|NCT00428610|1468356|P2|Overall Study|Death Due to Adverse Event|0
443008|NCT00428610|1468357|P1|Overall Study|Death Due to Adverse Event|3
443009|NCT00428597|1468391|P2|Overall Study|Death|3
443010|NCT00428597|1468392|P1|Overall Study|Death|1
443011|NCT00428597|1468391|P2|Overall Study|Pregnancy|0
443012|NCT00428597|1468392|P1|Overall Study|Pregnancy|1
443013|NCT00428597|1468391|P2|Overall Study|Lost to Follow-up|1
443014|NCT00428597|1468392|P1|Overall Study|Lost to Follow-up|0
443015|NCT00428597|1468391|P2|Overall Study|Other|1
443016|NCT00428597|1468392|P1|Overall Study|Other|1
443017|NCT00428597|1468391|P2|Overall Study|Withdrawal by Subject|1
443018|NCT00428597|1468392|P1|Overall Study|Withdrawal by Subject|2
443019|NCT00428597|1468391|P2|Overall Study|Protocol Violation|1
443020|NCT00428597|1468392|P1|Overall Study|Protocol Violation|2
443021|NCT00428597|1468391|P2|Overall Study|Global Deterioration of Health Status|5
443022|NCT00428597|1468392|P1|Overall Study|Global Deterioration of Health Status|1
443023|NCT00428597|1468391|P2|Overall Study|Adverse Event|7
443024|NCT00428597|1468392|P1|Overall Study|Adverse Event|15
443025|NCT00428597|1468391|P2|Overall Study|Study Terminated by Sponsor|16
443026|NCT00428597|1468392|P1|Overall Study|Study Terminated by Sponsor|41
443027|NCT00428597|1468391|P2|Overall Study|Objective Progression or Relapse|47
443028|NCT00428597|1468392|P1|Overall Study|Objective Progression or Relapse|19
443029|NCT00428597|1468391|P2|Overall Study|Randomized but not treated|3
443030|NCT00428597|1468392|P1|Overall Study|Randomized but not treated|3
443031|NCT00428441|1468459|P1|Overall Study|Lost to Follow-up|1
443032|NCT00428389|1468465|P2|Extension Phase|Administrative problems|1
443033|NCT00428389|1468466|P1|Extension Phase|Administrative problems|1
443034|NCT00428389|1468465|P2|Extension Phase|Protocol Violation|2
443035|NCT00428389|1468466|P1|Extension Phase|Protocol Violation|3
443036|NCT00428389|1468465|P2|Extension Phase|Death|0
443037|NCT00428389|1468466|P1|Extension Phase|Death|1
443038|NCT00428389|1468465|P2|Extension Phase|Lost to Follow-up|3
443039|NCT00428389|1468466|P1|Extension Phase|Lost to Follow-up|0
443040|NCT00428389|1468465|P2|Extension Phase|Withdrawal by Subject|6
443041|NCT00428389|1468466|P1|Extension Phase|Withdrawal by Subject|6
443042|NCT00428389|1468465|P2|Extension Phase|Lack of Efficacy|3
443043|NCT00428389|1468466|P1|Extension Phase|Lack of Efficacy|4
443044|NCT00428389|1468465|P2|Extension Phase|Adverse Event|11
443046|NCT00428389|1468465|P2|Core Phase|Protocol deviation|2
443047|NCT00428389|1468466|P1|Core Phase|Protocol deviation|0
443048|NCT00428389|1468465|P2|Core Phase|Withdrawal by Subject|4
443049|NCT00428389|1468466|P1|Core Phase|Withdrawal by Subject|3
443050|NCT00428389|1468465|P2|Core Phase|Abnormal test procedure result(s)|1
443051|NCT00428389|1468466|P1|Core Phase|Abnormal test procedure result(s)|0
443052|NCT00428389|1468465|P2|Core Phase|Lack of Efficacy|0
443053|NCT00428389|1468466|P1|Core Phase|Lack of Efficacy|2
443054|NCT00428389|1468465|P2|Core Phase|Adverse Event|4
443055|NCT00428389|1468466|P1|Core Phase|Adverse Event|6
443056|NCT00428246|1468500|P3|Overall Study|Adverse Event|0
443057|NCT00428246|1468501|P2|Overall Study|Adverse Event|0
443058|NCT00428246|1468502|P1|Overall Study|Adverse Event|1
443059|NCT00428246|1468500|P3|Overall Study|Withdrawal by Subject|1
443060|NCT00428246|1468501|P2|Overall Study|Withdrawal by Subject|0
443061|NCT00428246|1468502|P1|Overall Study|Withdrawal by Subject|0
443062|NCT00428220|1468510|P1|Overall Study|Other|23
443063|NCT00428220|1468510|P1|Overall Study|Adverse Event|51
443064|NCT00428220|1468510|P1|Overall Study|Participant refused continued treatment|7
443065|NCT00428220|1468510|P1|Overall Study|Objective progression or relapse|123
443066|NCT00428220|1468510|P1|Overall Study|Lost to Follow-up|4
443067|NCT00428220|1468510|P1|Overall Study|Global deterioration of health status|7
443068|NCT00428220|1468510|P1|Overall Study|Participant died|8
443069|NCT00428116|1468535|P2|Overall Study|Lost to Follow-up|0
443070|NCT00428116|1468536|P1|Overall Study|Lost to Follow-up|1
443071|NCT00428116|1468535|P2|Overall Study|Withdrawal by Subject|0
443072|NCT00428116|1468536|P1|Overall Study|Withdrawal by Subject|1
443073|NCT00428116|1468535|P2|Overall Study|Death|0
443074|NCT00428116|1468536|P1|Overall Study|Death|1
443075|NCT00428090|1468548|P4|Overall Study|Raised Creatinine Value|1
443076|NCT00428090|1468549|P3|Overall Study|Raised Creatinine Value|0
443077|NCT00428090|1468550|P2|Overall Study|Raised Creatinine Value|0
443078|NCT00428090|1468551|P1|Overall Study|Raised Creatinine Value|0
443079|NCT00428090|1468548|P4|Overall Study|Excluded for heart insufficiency|0
443080|NCT00428090|1468549|P3|Overall Study|Excluded for heart insufficiency|1
443081|NCT00428090|1468550|P2|Overall Study|Excluded for heart insufficiency|0
443082|NCT00428090|1468551|P1|Overall Study|Excluded for heart insufficiency|0
443083|NCT00428090|1468548|P4|Overall Study|Serious adverse event|0
443084|NCT00428090|1468549|P3|Overall Study|Serious adverse event|1
443085|NCT00428090|1468550|P2|Overall Study|Serious adverse event|0
443086|NCT00428090|1468551|P1|Overall Study|Serious adverse event|0
443087|NCT00428090|1468548|P4|Overall Study|Deterioration of cognitive status|0
443088|NCT00428090|1468549|P3|Overall Study|Deterioration of cognitive status|1
443089|NCT00428090|1468550|P2|Overall Study|Deterioration of cognitive status|0
443090|NCT00428090|1468551|P1|Overall Study|Deterioration of cognitive status|0
443091|NCT00428090|1468548|P4|Overall Study|High MMSE scores|0
443092|NCT00428090|1468549|P3|Overall Study|High MMSE scores|1
443093|NCT00428090|1468550|P2|Overall Study|High MMSE scores|0
443094|NCT00428090|1468551|P1|Overall Study|High MMSE scores|0
443095|NCT00428090|1468548|P4|Overall Study|Insufficient AD documentation|0
443096|NCT00428090|1468549|P3|Overall Study|Insufficient AD documentation|1
443097|NCT00428090|1468550|P2|Overall Study|Insufficient AD documentation|0
443098|NCT00428090|1468551|P1|Overall Study|Insufficient AD documentation|0
443099|NCT00428090|1468548|P4|Overall Study|Excluded for concerning QTc value|0
443100|NCT00428090|1468549|P3|Overall Study|Excluded for concerning QTc value|1
443101|NCT00428090|1468550|P2|Overall Study|Excluded for concerning QTc value|0
443102|NCT00428090|1468551|P1|Overall Study|Excluded for concerning QTc value|0
443103|NCT00428090|1468548|P4|Overall Study|Worsening of AD|0
443104|NCT00428090|1468549|P3|Overall Study|Worsening of AD|1
443105|NCT00428090|1468550|P2|Overall Study|Worsening of AD|0
443106|NCT00428090|1468551|P1|Overall Study|Worsening of AD|0
443107|NCT00428090|1468548|P4|Overall Study|Mental status of par. was|0
443108|NCT00428090|1468549|P3|Overall Study|Mental status of par. was|0
443109|NCT00428090|1468550|P2|Overall Study|Mental status of par. was|1
443110|NCT00428090|1468551|P1|Overall Study|Mental status of par. was|0
443111|NCT00428090|1468548|P4|Overall Study|Medical monitor terminated par.|0
443112|NCT00428090|1468549|P3|Overall Study|Medical monitor terminated par.|0
443113|NCT00428090|1468550|P2|Overall Study|Medical monitor terminated par.|1
443114|NCT00428090|1468551|P1|Overall Study|Medical monitor terminated par.|0
443115|NCT00428090|1468548|P4|Overall Study|Visit 7 exceed the visit window|0
443116|NCT00428090|1468549|P3|Overall Study|Visit 7 exceed the visit window|0
443117|NCT00428090|1468550|P2|Overall Study|Visit 7 exceed the visit window|1
443118|NCT00428090|1468551|P1|Overall Study|Visit 7 exceed the visit window|0
443119|NCT00428090|1468548|P4|Overall Study|Death of par.|0
443120|NCT00428090|1468549|P3|Overall Study|Death of par.|1
443121|NCT00428090|1468550|P2|Overall Study|Death of par.|0
443122|NCT00428090|1468551|P1|Overall Study|Death of par.|1
443123|NCT00428090|1468548|P4|Overall Study|Prohibited medication used for SAE|0
443124|NCT00428090|1468549|P3|Overall Study|Prohibited medication used for SAE|0
443125|NCT00428090|1468550|P2|Overall Study|Prohibited medication used for SAE|0
443126|NCT00428090|1468551|P1|Overall Study|Prohibited medication used for SAE|1
443127|NCT00428090|1468548|P4|Overall Study|Follow-Up visit not possible|0
443128|NCT00428090|1468549|P3|Overall Study|Follow-Up visit not possible|0
443129|NCT00428090|1468550|P2|Overall Study|Follow-Up visit not possible|0
443130|NCT00428090|1468551|P1|Overall Study|Follow-Up visit not possible|1
443131|NCT00428090|1468548|P4|Overall Study|Par. did not returned to visit|1
443132|NCT00428090|1468549|P3|Overall Study|Par. did not returned to visit|0
443133|NCT00428090|1468550|P2|Overall Study|Par. did not returned to visit|0
443134|NCT00428090|1468551|P1|Overall Study|Par. did not returned to visit|1
443135|NCT00428090|1468548|P4|Overall Study|Non-compliance|3
443136|NCT00428090|1468549|P3|Overall Study|Non-compliance|1
443137|NCT00428090|1468550|P2|Overall Study|Non-compliance|0
443138|NCT00428090|1468551|P1|Overall Study|Non-compliance|4
443139|NCT00428090|1468548|P4|Overall Study|Sponsor terminated study|0
443140|NCT00428090|1468549|P3|Overall Study|Sponsor terminated study|0
443141|NCT00428090|1468550|P2|Overall Study|Sponsor terminated study|1
443142|NCT00428090|1468551|P1|Overall Study|Sponsor terminated study|0
443143|NCT00428090|1468548|P4|Overall Study|Withdrawal by Subject|5
443144|NCT00428090|1468549|P3|Overall Study|Withdrawal by Subject|15
443145|NCT00428090|1468550|P2|Overall Study|Withdrawal by Subject|12
443146|NCT00428090|1468551|P1|Overall Study|Withdrawal by Subject|10
443147|NCT00428090|1468548|P4|Overall Study|Protocol Violation|3
443148|NCT00428090|1468549|P3|Overall Study|Protocol Violation|3
443149|NCT00428090|1468550|P2|Overall Study|Protocol Violation|1
443150|NCT00428090|1468551|P1|Overall Study|Protocol Violation|3
443151|NCT00428090|1468548|P4|Overall Study|Lost to Follow-up|4
443152|NCT00428090|1468549|P3|Overall Study|Lost to Follow-up|1
443153|NCT00428090|1468550|P2|Overall Study|Lost to Follow-up|6
443154|NCT00428090|1468551|P1|Overall Study|Lost to Follow-up|3
443155|NCT00428090|1468548|P4|Overall Study|Adverse Event|11
443156|NCT00428090|1468549|P3|Overall Study|Adverse Event|10
443157|NCT00428090|1468550|P2|Overall Study|Adverse Event|8
443158|NCT00428090|1468551|P1|Overall Study|Adverse Event|10
443159|NCT00427999|1468669|P1|Overall Study|Death|1
443160|NCT00427999|1468669|P1|Overall Study|Withdrawal by Subject|9
443161|NCT00427999|1468669|P1|Overall Study|Protocol Violation|2
443162|NCT00427999|1468669|P1|Overall Study|Unsatisfactory therapeutic effect|13
443163|NCT00427999|1468669|P1|Overall Study|Abnormal laboratory values|1
443164|NCT00427999|1468669|P1|Overall Study|Adverse Event|6
443165|NCT00427960|1468687|P2|Overall Study|Not Specified|1
443166|NCT00427960|1468688|P1|Overall Study|Not Specified|0
443167|NCT00427960|1468687|P2|Overall Study|Withdrawal by Subject|3
443168|NCT00427960|1468688|P1|Overall Study|Withdrawal by Subject|0
443169|NCT00427960|1468687|P2|Overall Study|Adverse Event|0
443170|NCT00427960|1468688|P1|Overall Study|Adverse Event|2
443171|NCT00427934|1468726|P4|Overall Study|Withdrawal by Subject|3
443172|NCT00427934|1468727|P3|Overall Study|Withdrawal by Subject|1
443173|NCT00427934|1468728|P2|Overall Study|Withdrawal by Subject|0
443174|NCT00427934|1468729|P1|Overall Study|Withdrawal by Subject|0
443175|NCT00427934|1468726|P4|Overall Study|Other|5
443176|NCT00427934|1468727|P3|Overall Study|Other|11
443177|NCT00427934|1468728|P2|Overall Study|Other|0
443178|NCT00427934|1468729|P1|Overall Study|Other|0
443179|NCT00427934|1468726|P4|Overall Study|Randomized But Did Not Receive Treatment|1
443180|NCT00427934|1468727|P3|Overall Study|Randomized But Did Not Receive Treatment|1
443181|NCT00427934|1468728|P2|Overall Study|Randomized But Did Not Receive Treatment|0
443182|NCT00427934|1468729|P1|Overall Study|Randomized But Did Not Receive Treatment|0
443183|NCT00427934|1468726|P4|Overall Study|Lack of Efficacy|2
443184|NCT00427934|1468727|P3|Overall Study|Lack of Efficacy|5
443185|NCT00427934|1468728|P2|Overall Study|Lack of Efficacy|0
443186|NCT00427934|1468729|P1|Overall Study|Lack of Efficacy|0
443187|NCT00427934|1468726|P4|Overall Study|Adverse Event|4
443188|NCT00427934|1468727|P3|Overall Study|Adverse Event|5
443189|NCT00427934|1468728|P2|Overall Study|Adverse Event|0
443190|NCT00427934|1468729|P1|Overall Study|Adverse Event|1
443191|NCT00427921|1468797|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
443192|NCT00427921|1468797|P1|Overall Study|Adverse Event + Withdrawn from Study|1
443193|NCT00427921|1468797|P1|Overall Study|Adverse Event + Lost Response|1
443194|NCT00427921|1468797|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
443195|NCT00427921|1468797|P1|Overall Study|Adverse Event + Worsening of CD|1
443196|NCT00427921|1468797|P1|Overall Study|Adverse Event + No Response|1
443197|NCT00427921|1468797|P1|Overall Study|Adverse Event + Withdrew Consent|1
443198|NCT00427921|1468797|P1|Overall Study|Adverse Event + Hospitalization|1
443199|NCT00427921|1468797|P1|Overall Study|Other reason not specified|10
443200|NCT00427921|1468797|P1|Overall Study|Lost to Follow-up|2
443201|NCT00427921|1468797|P1|Overall Study|Withdrawal by Subject|4
443202|NCT00427921|1468797|P1|Overall Study|Adverse Event|26
443203|NCT00427908|1468820|P4|Primary Phase|Adverse Event|0
443204|NCT00427908|1468821|P3|Primary Phase|Adverse Event|0
443205|NCT00427908|1468822|P2|Primary Phase|Adverse Event|1
443206|NCT00427908|1468823|P1|Primary Phase|Adverse Event|0
443207|NCT00427908|1468820|P4|Primary Phase|Withdrawal by Subject|0
443208|NCT00427908|1468821|P3|Primary Phase|Withdrawal by Subject|1
443209|NCT00427908|1468822|P2|Primary Phase|Withdrawal by Subject|2
443210|NCT00427908|1468823|P1|Primary Phase|Withdrawal by Subject|1
443211|NCT00427908|1468820|P4|Primary Phase|Lost to Follow-up|0
443212|NCT00427908|1468821|P3|Primary Phase|Lost to Follow-up|2
443213|NCT00427908|1468822|P2|Primary Phase|Lost to Follow-up|0
443214|NCT00427908|1468823|P1|Primary Phase|Lost to Follow-up|4
443215|NCT00427895|1469023|P8|Vax 2/Year 3 to 4|Failed to Return|0
443216|NCT00427895|1469024|P7|Vax 2/Year 3 to 4|Failed to Return|0
443217|NCT00427895|1469025|P6|Vax 2/Year 3 to 4|Failed to Return|0
443218|NCT00427895|1469026|P5|Vax 2/Year 3 to 4|Failed to Return|1
443219|NCT00427895|1469027|P4|Vax 2/Year 3 to 4|Failed to Return|0
443220|NCT00427895|1469028|P3|Vax 2/Year 3 to 4|Failed to Return|0
443221|NCT00427895|1469029|P2|Vax 2/Year 3 to 4|Failed to Return|0
443222|NCT00427895|1469030|P1|Vax 2/Year 3 to 4|Failed to Return|0
443223|NCT00427895|1469023|P8|Vax 2/Year 3 to 4|Protocol Violation|1
443224|NCT00427895|1469024|P7|Vax 2/Year 3 to 4|Protocol Violation|0
443225|NCT00427895|1469025|P6|Vax 2/Year 3 to 4|Protocol Violation|0
443226|NCT00427895|1469026|P5|Vax 2/Year 3 to 4|Protocol Violation|0
443227|NCT00427895|1469027|P4|Vax 2/Year 3 to 4|Protocol Violation|0
443228|NCT00427895|1469028|P3|Vax 2/Year 3 to 4|Protocol Violation|0
443229|NCT00427895|1469029|P2|Vax 2/Year 3 to 4|Protocol Violation|0
443230|NCT00427895|1469030|P1|Vax 2/Year 3 to 4|Protocol Violation|0
443231|NCT00427895|1469023|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
443232|NCT00427895|1469024|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
443233|NCT00427895|1469025|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
443234|NCT00427895|1469026|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
443235|NCT00427895|1469027|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
443236|NCT00427895|1469028|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
443237|NCT00427895|1469029|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
443238|NCT00427895|1469030|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
443239|NCT00427895|1469023|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
443240|NCT00427895|1469024|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
443241|NCT00427895|1469025|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
443242|NCT00427895|1469026|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
443243|NCT00427895|1469027|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
443244|NCT00427895|1469028|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
443245|NCT00427895|1469029|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
443246|NCT00427895|1469030|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
443247|NCT00427895|1469023|P8|Vax 1/Year 1 Follow-up|Other|0
443248|NCT00427895|1469024|P7|Vax 1/Year 1 Follow-up|Other|0
443249|NCT00427895|1469025|P6|Vax 1/Year 1 Follow-up|Other|0
443250|NCT00427895|1469026|P5|Vax 1/Year 1 Follow-up|Other|0
443251|NCT00427895|1469027|P4|Vax 1/Year 1 Follow-up|Other|2
443252|NCT00427895|1469028|P3|Vax 1/Year 1 Follow-up|Other|0
443253|NCT00427895|1469029|P2|Vax 1/Year 1 Follow-up|Other|0
443254|NCT00427895|1469030|P1|Vax 1/Year 1 Follow-up|Other|0
443255|NCT00427895|1469023|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
443256|NCT00427895|1469024|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
443257|NCT00427895|1469025|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
443258|NCT00427895|1469026|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
443259|NCT00427895|1469027|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
443260|NCT00427895|1469028|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
443261|NCT00427895|1469029|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
443262|NCT00427895|1469030|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
443263|NCT00427895|1469023|P8|Vax 1/Year 1 Follow-up|Death|0
443264|NCT00427895|1469024|P7|Vax 1/Year 1 Follow-up|Death|0
443265|NCT00427895|1469025|P6|Vax 1/Year 1 Follow-up|Death|0
443266|NCT00427895|1469026|P5|Vax 1/Year 1 Follow-up|Death|0
443267|NCT00427895|1469027|P4|Vax 1/Year 1 Follow-up|Death|0
443268|NCT00427895|1469028|P3|Vax 1/Year 1 Follow-up|Death|0
443269|NCT00427895|1469029|P2|Vax 1/Year 1 Follow-up|Death|0
443270|NCT00427895|1469030|P1|Vax 1/Year 1 Follow-up|Death|1
443271|NCT00427895|1469023|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
443272|NCT00427895|1469024|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
443273|NCT00427895|1469025|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
443274|NCT00427895|1469026|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
443275|NCT00427895|1469027|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
443276|NCT00427895|1469028|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
443277|NCT00427895|1469029|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
443278|NCT00427895|1469030|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
443279|NCT00427895|1469023|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
443280|NCT00427895|1469024|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
443281|NCT00427895|1469025|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
443282|NCT00427895|1469026|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
443283|NCT00427895|1469027|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
443284|NCT00427895|1469028|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
443285|NCT00427895|1469029|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
443286|NCT00427895|1469030|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
443287|NCT00427895|1469023|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
443288|NCT00427895|1469024|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
443289|NCT00427895|1469025|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
443290|NCT00427895|1469026|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
443291|NCT00427895|1469027|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
443292|NCT00427895|1469028|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
443293|NCT00427895|1469029|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
443294|NCT00427895|1469030|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
443295|NCT00427895|1469023|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
443296|NCT00427895|1469024|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
443297|NCT00427895|1469025|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
443298|NCT00427895|1469026|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
443299|NCT00427895|1469027|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
443300|NCT00427895|1469028|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
443301|NCT00427895|1469029|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
443302|NCT00427895|1469030|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
443303|NCT00427895|1469023|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
443304|NCT00427895|1469024|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
443305|NCT00427895|1469025|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
443306|NCT00427895|1469026|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
443307|NCT00427895|1469027|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
443308|NCT00427895|1469028|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
443309|NCT00427895|1469029|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
443310|NCT00427895|1469030|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
443311|NCT00427895|1469023|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
443312|NCT00427895|1469024|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
443313|NCT00427895|1469025|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
443314|NCT00427895|1469026|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
443315|NCT00427895|1469027|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
443316|NCT00427895|1469028|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
443317|NCT00427895|1469029|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
443318|NCT00427895|1469030|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
443319|NCT00427895|1469023|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
443320|NCT00427895|1469024|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
443321|NCT00427895|1469025|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
443322|NCT00427895|1469026|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
443323|NCT00427895|1469027|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
443324|NCT00427895|1469028|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
443325|NCT00427895|1469029|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
443326|NCT00427895|1469030|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
443327|NCT00427895|1469023|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
443328|NCT00427895|1469024|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
443329|NCT00427895|1469025|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
443330|NCT00427895|1469026|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
443331|NCT00427895|1469027|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
443332|NCT00427895|1469028|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
443333|NCT00427895|1469029|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
443334|NCT00427895|1469030|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
443335|NCT00427895|1469023|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
443336|NCT00427895|1469024|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
443337|NCT00427895|1469025|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
443338|NCT00427895|1469026|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
443339|NCT00427895|1469027|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
443340|NCT00427895|1469028|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
443341|NCT00427895|1469029|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
443342|NCT00427895|1469030|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
443343|NCT00427895|1469023|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
443344|NCT00427895|1469024|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
443345|NCT00427895|1469025|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
443346|NCT00427895|1469026|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
443347|NCT00427895|1469027|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
443348|NCT00427895|1469028|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
443349|NCT00427895|1469029|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
443350|NCT00427895|1469030|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
443351|NCT00427895|1469023|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
443352|NCT00427895|1469024|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
443353|NCT00427895|1469025|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
443354|NCT00427895|1469026|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
443355|NCT00427895|1469027|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
443356|NCT00427895|1469028|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
443357|NCT00427895|1469029|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
443358|NCT00427895|1469030|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
443359|NCT00427895|1469023|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
443360|NCT00427895|1469024|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
443361|NCT00427895|1469025|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
443362|NCT00427895|1469026|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
443363|NCT00427895|1469027|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
443364|NCT00427895|1469028|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
443365|NCT00427895|1469029|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
443366|NCT00427895|1469030|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
443367|NCT00427778|1469105|P2|First Intervention (4 Weeks)|anxious about using ring|0
443368|NCT00427778|1469106|P1|First Intervention (4 Weeks)|anxious about using ring|1
443369|NCT00427778|1469105|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
443370|NCT00427778|1469106|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
443371|NCT00427778|1469105|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
443372|NCT00427778|1469106|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
443373|NCT00427778|1469105|P2|First Intervention (4 Weeks)|no longer interested|0
443374|NCT00427778|1469106|P1|First Intervention (4 Weeks)|no longer interested|1
443375|NCT00427700|1469131|P2|Overall Study|Pregnancy|2
443376|NCT00427700|1469132|P1|Overall Study|Pregnancy|0
443377|NCT00427700|1469131|P2|Overall Study|no induction of menses|4
443378|NCT00427700|1469132|P1|Overall Study|no induction of menses|1
443379|NCT00427700|1469131|P2|Overall Study|Lost to Follow-up|5
443380|NCT00427700|1469132|P1|Overall Study|Lost to Follow-up|2
443381|NCT00427635|1469148|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
443382|NCT00427635|1469149|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
443383|NCT00427635|1469148|P2|Treatment Phase|Withdrawal by Subject|0
443384|NCT00427635|1469149|P1|Treatment Phase|Withdrawal by Subject|1
443385|NCT00427349|1469181|P1|Overall Study|Never started therapy|1
443386|NCT00427349|1469181|P1|Overall Study|Ineligible|1
443387|NCT00427349|1469181|P1|Overall Study|Other|2
443388|NCT00427349|1469181|P1|Overall Study|Alternative therapy|1
443389|NCT00427349|1469181|P1|Overall Study|Withdrawal by Subject|3
443390|NCT00427349|1469181|P1|Overall Study|Death|1
443391|NCT00427349|1469181|P1|Overall Study|Adverse Event|14
443392|NCT00427349|1469181|P1|Overall Study|Lack of Efficacy|23
443393|NCT00427011|1469202|P1|Overall Study|Not specified|12
443394|NCT00427011|1469202|P1|Overall Study|Lack of Efficacy|2
443395|NCT00427011|1469202|P1|Overall Study|Withdrawal by Subject|1
443396|NCT00427011|1469202|P1|Overall Study|Adverse Event|10
443397|NCT00426842|1469217|P1|Overall Study|Lost to Follow-up|1
443398|NCT00426764|1469223|P1|Overall Study|Other|2
443399|NCT00426764|1469223|P1|Overall Study|Protocol Violation|1
443400|NCT00426764|1469223|P1|Overall Study|Physician Decision|1
443401|NCT00426764|1469223|P1|Overall Study|Withdrawal by Subject|3
443402|NCT00426764|1469223|P1|Overall Study|Adverse Event|19
443403|NCT00426764|1469223|P1|Overall Study|Progressive disease|72
443404|NCT00426751|1469239|P2|Overall Study|Other Reasons|12
443405|NCT00426751|1469240|P1|Overall Study|Other Reasons|7
443406|NCT00426751|1469239|P2|Overall Study|Consent Withdrawn|1
443407|NCT00426751|1469240|P1|Overall Study|Consent Withdrawn|0
443408|NCT00426751|1469239|P2|Overall Study|Lost to Follow-up|6
443409|NCT00426751|1469240|P1|Overall Study|Lost to Follow-up|7
443410|NCT00426751|1469239|P2|Overall Study|Adverse Event|1
443411|NCT00426751|1469240|P1|Overall Study|Adverse Event|8
443412|NCT00426660|1469284|P1|Overall Study|Enrolled Not Treated|15
443413|NCT00426660|1469284|P1|Overall Study|Protocol Violation|1
443414|NCT00426660|1469284|P1|Overall Study|Withdrawal by Subject|18
443415|NCT00426660|1469284|P1|Overall Study|Other|23
443416|NCT00426660|1469284|P1|Overall Study|Lost to Follow-up|15
443417|NCT00426660|1469284|P1|Overall Study|Insufficient Clinical Response|22
443418|NCT00426660|1469284|P1|Overall Study|Adverse Event|23
443419|NCT00426660|1469284|P1|Overall Study|Death|14
443420|NCT00426556|1469315|P4|Phase II - Extension Phase|Adverse Event|2
443421|NCT00426556|1469316|P3|Phase II - Extension Phase|Adverse Event|0
443422|NCT00426556|1469317|P2|Phase II - Extension Phase|Adverse Event|0
443423|NCT00426556|1469318|P1|Phase II - Extension Phase|Adverse Event|0
443424|NCT00426556|1469315|P4|Phase II - Extension Phase|Disease Progression|21
443425|NCT00426556|1469316|P3|Phase II - Extension Phase|Disease Progression|0
443426|NCT00426556|1469317|P2|Phase II - Extension Phase|Disease Progression|0
443427|NCT00426556|1469318|P1|Phase II - Extension Phase|Disease Progression|0
443428|NCT00426556|1469315|P4|Phase II - Core Phase|Adverse Event|8
443429|NCT00426556|1469316|P3|Phase II - Core Phase|Adverse Event|0
443430|NCT00426556|1469317|P2|Phase II - Core Phase|Adverse Event|0
443431|NCT00426556|1469318|P1|Phase II - Core Phase|Adverse Event|0
443432|NCT00426556|1469315|P4|Phase II - Core Phase|Disease Progression|16
443433|NCT00426556|1469316|P3|Phase II - Core Phase|Disease Progression|0
443434|NCT00426556|1469317|P2|Phase II - Core Phase|Disease Progression|0
443435|NCT00426556|1469318|P1|Phase II - Core Phase|Disease Progression|0
443436|NCT00426556|1469315|P4|Phase II - Core Phase|Withdrawal by Subject|3
443437|NCT00426556|1469316|P3|Phase II - Core Phase|Withdrawal by Subject|0
443438|NCT00426556|1469317|P2|Phase II - Core Phase|Withdrawal by Subject|0
443439|NCT00426556|1469318|P1|Phase II - Core Phase|Withdrawal by Subject|0
443440|NCT00426556|1469315|P4|Phase I - Extension Phase|Disease Progression|0
443441|NCT00426556|1469316|P3|Phase I - Extension Phase|Disease Progression|6
443442|NCT00426556|1469317|P2|Phase I - Extension Phase|Disease Progression|5
443443|NCT00426556|1469318|P1|Phase I - Extension Phase|Disease Progression|5
443444|NCT00426556|1469315|P4|Phase I - Extension Phase|Adverse Event|0
443445|NCT00426556|1469316|P3|Phase I - Extension Phase|Adverse Event|1
443446|NCT00426556|1469317|P2|Phase I - Extension Phase|Adverse Event|1
443447|NCT00426556|1469318|P1|Phase I - Extension Phase|Adverse Event|0
443448|NCT00426556|1469315|P4|Phase I - Core Phase|Death|0
443449|NCT00426556|1469316|P3|Phase I - Core Phase|Death|0
443450|NCT00426556|1469317|P2|Phase I - Core Phase|Death|1
443451|NCT00426556|1469318|P1|Phase I - Core Phase|Death|0
443452|NCT00426556|1469315|P4|Phase I - Core Phase|Adverse Event|0
443453|NCT00426556|1469316|P3|Phase I - Core Phase|Adverse Event|1
443454|NCT00426556|1469317|P2|Phase I - Core Phase|Adverse Event|3
443455|NCT00426556|1469318|P1|Phase I - Core Phase|Adverse Event|1
443456|NCT00426556|1469315|P4|Phase I - Core Phase|Disease Progression|0
443457|NCT00426556|1469316|P3|Phase I - Core Phase|Disease Progression|2
443458|NCT00426556|1469317|P2|Phase I - Core Phase|Disease Progression|6
443459|NCT00426556|1469318|P1|Phase I - Core Phase|Disease Progression|0
443460|NCT00426361|1469343|P3|Overall Study|Withdrawal by Subject|0
443461|NCT00426361|1469344|P2|Overall Study|Withdrawal by Subject|3
443462|NCT00426361|1469345|P1|Overall Study|Withdrawal by Subject|1
443463|NCT00426361|1469343|P3|Overall Study|Lost to Follow-up|5
443464|NCT00426361|1469344|P2|Overall Study|Lost to Follow-up|2
443465|NCT00426361|1469345|P1|Overall Study|Lost to Follow-up|3
443466|NCT00426270|1469404|P1|Overall Study|Adverse Event|5
443467|NCT00426270|1469404|P1|Overall Study|Incorrectly Enrolled in the Study|1
443468|NCT00426231|1469414|P2|Overall Study|Withdrawal by Subject|12
443469|NCT00426231|1469415|P1|Overall Study|Withdrawal by Subject|9
443470|NCT00426127|1469438|P1|Overall Study|Removed due to disease progression|1
443471|NCT00426127|1469438|P1|Overall Study|Adverse Event|1
443472|NCT00425945|1469446|P2|Overall Study|Moved from area|1
443473|NCT00425945|1469447|P1|Overall Study|Moved from area|0
443474|NCT00425945|1469446|P2|Overall Study|Began cancer treatments|0
443475|NCT00425945|1469447|P1|Overall Study|Began cancer treatments|1
443476|NCT00425945|1469446|P2|Overall Study|Began hypertension medication|0
443477|NCT00425945|1469447|P1|Overall Study|Began hypertension medication|1
443478|NCT00425945|1469446|P2|Overall Study|Lost to Follow-up|2
443479|NCT00425945|1469447|P1|Overall Study|Lost to Follow-up|0
443480|NCT00425945|1469446|P2|Overall Study|Inconvenience|2
443481|NCT00425945|1469447|P1|Overall Study|Inconvenience|0
443482|NCT00425945|1469446|P2|Overall Study|Concern about Supplement|0
443483|NCT00425945|1469447|P1|Overall Study|Concern about Supplement|2
443484|NCT00425854|1469485|P2|Overall Study|Other Adverse Event|2
443485|NCT00425854|1469486|P1|Overall Study|Other Adverse Event|2
443486|NCT00425854|1469485|P2|Overall Study|Dose reduction toxicity AE|7
443487|NCT00425854|1469486|P1|Overall Study|Dose reduction toxicity AE|8
443488|NCT00425854|1469485|P2|Overall Study|Progressive Disease|12
443489|NCT00425854|1469486|P1|Overall Study|Progressive Disease|19
443490|NCT00425750|1469519|P1|Overall Study|Progression of disease|18
443491|NCT00425750|1469519|P1|Overall Study|Adverse Event|3
443492|NCT00425750|1469519|P1|Overall Study|Withdrawal by Subject|3
443493|NCT00425750|1469519|P1|Overall Study|Death|1
443494|NCT00425698|1469527|P2|Overall Study|Withdrawal by Subject|1
443495|NCT00425698|1469528|P1|Overall Study|Withdrawal by Subject|0
443496|NCT00425698|1469527|P2|Overall Study|Adverse Event|1
443497|NCT00425698|1469528|P1|Overall Study|Adverse Event|3
443498|NCT00425607|1469543|P1|Overall Study|Withdrawal by Subject|1
443499|NCT00425607|1469543|P1|Overall Study|Death|1
443500|NCT00425503|1469547|P1|Overall Study|Protocol Violation|1
443501|NCT00425503|1469547|P1|Overall Study|Adverse Event|2
443502|NCT00425438|1469553|P2|Overall Study|Termination by Sponsor|27
443503|NCT00425438|1469554|P1|Overall Study|Termination by Sponsor|25
443504|NCT00425373|1469588|P9|Overall Study|Lack of Efficacy|5
443505|NCT00425373|1469589|P8|Overall Study|Lack of Efficacy|0
443506|NCT00425373|1469590|P7|Overall Study|Lack of Efficacy|3
443507|NCT00425373|1469591|P6|Overall Study|Lack of Efficacy|3
443508|NCT00425373|1469592|P5|Overall Study|Lack of Efficacy|1
443509|NCT00425373|1469593|P4|Overall Study|Lack of Efficacy|0
443510|NCT00425373|1469594|P3|Overall Study|Lack of Efficacy|0
443511|NCT00425373|1469595|P2|Overall Study|Lack of Efficacy|0
443512|NCT00425373|1469596|P1|Overall Study|Lack of Efficacy|0
443513|NCT00425373|1469588|P9|Overall Study|Withdrawal by Subject|2
443514|NCT00425373|1469589|P8|Overall Study|Withdrawal by Subject|2
443515|NCT00425373|1469590|P7|Overall Study|Withdrawal by Subject|2
443516|NCT00425373|1469591|P6|Overall Study|Withdrawal by Subject|0
443517|NCT00425373|1469592|P5|Overall Study|Withdrawal by Subject|4
443518|NCT00425373|1469593|P4|Overall Study|Withdrawal by Subject|1
443519|NCT00425373|1469594|P3|Overall Study|Withdrawal by Subject|2
443520|NCT00425373|1469595|P2|Overall Study|Withdrawal by Subject|0
443521|NCT00425373|1469596|P1|Overall Study|Withdrawal by Subject|2
443522|NCT00425373|1469588|P9|Overall Study|Protocol Violation|3
443523|NCT00425373|1469589|P8|Overall Study|Protocol Violation|5
443524|NCT00425373|1469590|P7|Overall Study|Protocol Violation|0
443525|NCT00425373|1469591|P6|Overall Study|Protocol Violation|0
443526|NCT00425373|1469592|P5|Overall Study|Protocol Violation|0
443527|NCT00425373|1469593|P4|Overall Study|Protocol Violation|0
443528|NCT00425373|1469594|P3|Overall Study|Protocol Violation|1
443529|NCT00425373|1469595|P2|Overall Study|Protocol Violation|0
443530|NCT00425373|1469596|P1|Overall Study|Protocol Violation|1
443531|NCT00425373|1469588|P9|Overall Study|Lost to Follow-up|0
443532|NCT00425373|1469589|P8|Overall Study|Lost to Follow-up|0
443533|NCT00425373|1469590|P7|Overall Study|Lost to Follow-up|0
443534|NCT00425373|1469591|P6|Overall Study|Lost to Follow-up|0
443535|NCT00425373|1469592|P5|Overall Study|Lost to Follow-up|1
443536|NCT00425373|1469593|P4|Overall Study|Lost to Follow-up|0
443537|NCT00425373|1469594|P3|Overall Study|Lost to Follow-up|0
443538|NCT00425373|1469595|P2|Overall Study|Lost to Follow-up|1
443539|NCT00425373|1469596|P1|Overall Study|Lost to Follow-up|0
443540|NCT00425373|1469588|P9|Overall Study|Adverse Event|8
443541|NCT00425373|1469589|P8|Overall Study|Adverse Event|3
443542|NCT00425373|1469590|P7|Overall Study|Adverse Event|2
443543|NCT00425373|1469591|P6|Overall Study|Adverse Event|6
443544|NCT00425373|1469592|P5|Overall Study|Adverse Event|4
443545|NCT00425373|1469593|P4|Overall Study|Adverse Event|1
443546|NCT00425373|1469594|P3|Overall Study|Adverse Event|0
443547|NCT00425373|1469595|P2|Overall Study|Adverse Event|2
443548|NCT00425373|1469596|P1|Overall Study|Adverse Event|2
443549|NCT00425308|1469654|P2|Overall Study|Death|0
443550|NCT00425308|1469655|P1|Overall Study|Death|1
443551|NCT00425308|1469654|P2|Overall Study|Withdrawal by Subject|0
443552|NCT00425308|1469655|P1|Overall Study|Withdrawal by Subject|1
443553|NCT00425308|1469654|P2|Overall Study|Adverse Event|1
443554|NCT00425308|1469655|P1|Overall Study|Adverse Event|2
443555|NCT00425269|1469685|P2|Overall Study|moved or medical reason|4
443556|NCT00425269|1469686|P1|Overall Study|moved or medical reason|5
443557|NCT00425269|1469685|P2|Overall Study|Lost to Follow-up|9
443558|NCT00425269|1469686|P1|Overall Study|Lost to Follow-up|9
443559|NCT00425269|1469685|P2|Overall Study|Pregnancy|7
443560|NCT00425269|1469686|P1|Overall Study|Pregnancy|5
443561|NCT00425113|1469764|P2|Overall Study|Withdrawal by Subject|0
443562|NCT00425113|1469765|P1|Overall Study|Withdrawal by Subject|1
443563|NCT00425113|1469764|P2|Overall Study|missing study drug more than 14 days|1
443564|NCT00425113|1469765|P1|Overall Study|missing study drug more than 14 days|0
443565|NCT00425113|1469764|P2|Overall Study|diagnosis of abdominal TB|1
443566|NCT00425113|1469765|P1|Overall Study|diagnosis of abdominal TB|0
443567|NCT00425113|1469764|P2|Overall Study|uncontrolled diabetes mellitus|0
443568|NCT00425113|1469765|P1|Overall Study|uncontrolled diabetes mellitus|1
443569|NCT00425100|1469773|P1|Overall Study|Withdrawal by Subject|7
443570|NCT00425100|1469773|P1|Overall Study|Protocol Violation|4
443571|NCT00425100|1469773|P1|Overall Study|Lost to Follow-up|2
443572|NCT00425100|1469773|P1|Overall Study|Lack of Efficacy|4
443573|NCT00425100|1469773|P1|Overall Study|Adverse Event|36
443574|NCT00425061|1469817|P7|Overall Study|Other|1
443575|NCT00425061|1469818|P6|Overall Study|Other|0
443576|NCT00425061|1469819|P5|Overall Study|Other|3
443577|NCT00425061|1469820|P4|Overall Study|Other|0
443578|NCT00425061|1469821|P3|Overall Study|Other|0
443579|NCT00425061|1469822|P2|Overall Study|Other|0
443580|NCT00425061|1469823|P1|Overall Study|Other|0
443581|NCT00425061|1469817|P7|Overall Study|Physician Decision|0
443582|NCT00425061|1469818|P6|Overall Study|Physician Decision|0
443583|NCT00425061|1469819|P5|Overall Study|Physician Decision|1
443584|NCT00425061|1469820|P4|Overall Study|Physician Decision|0
443585|NCT00425061|1469821|P3|Overall Study|Physician Decision|0
443586|NCT00425061|1469822|P2|Overall Study|Physician Decision|0
443587|NCT00425061|1469823|P1|Overall Study|Physician Decision|0
443588|NCT00425061|1469817|P7|Overall Study|Sponsor's request|15
443589|NCT00425061|1469818|P6|Overall Study|Sponsor's request|4
443590|NCT00425061|1469819|P5|Overall Study|Sponsor's request|19
443591|NCT00425061|1469820|P4|Overall Study|Sponsor's request|0
443592|NCT00425061|1469821|P3|Overall Study|Sponsor's request|0
443593|NCT00425061|1469822|P2|Overall Study|Sponsor's request|0
443594|NCT00425061|1469823|P1|Overall Study|Sponsor's request|0
443595|NCT00425061|1469817|P7|Overall Study|Withdrawal by Subject|3
443596|NCT00425061|1469818|P6|Overall Study|Withdrawal by Subject|0
443597|NCT00425061|1469819|P5|Overall Study|Withdrawal by Subject|1
443598|NCT00425061|1469820|P4|Overall Study|Withdrawal by Subject|0
443599|NCT00425061|1469821|P3|Overall Study|Withdrawal by Subject|0
443600|NCT00425061|1469822|P2|Overall Study|Withdrawal by Subject|1
443601|NCT00425061|1469823|P1|Overall Study|Withdrawal by Subject|0
443602|NCT00425061|1469817|P7|Overall Study|Protocol Violation|0
443603|NCT00425061|1469818|P6|Overall Study|Protocol Violation|0
443604|NCT00425061|1469819|P5|Overall Study|Protocol Violation|0
443605|NCT00425061|1469820|P4|Overall Study|Protocol Violation|0
443606|NCT00425061|1469821|P3|Overall Study|Protocol Violation|0
443607|NCT00425061|1469822|P2|Overall Study|Protocol Violation|0
443608|NCT00425061|1469823|P1|Overall Study|Protocol Violation|1
443609|NCT00425061|1469817|P7|Overall Study|Lost to Follow-up|0
443610|NCT00425061|1469818|P6|Overall Study|Lost to Follow-up|0
443611|NCT00425061|1469819|P5|Overall Study|Lost to Follow-up|0
443612|NCT00425061|1469820|P4|Overall Study|Lost to Follow-up|0
443613|NCT00425061|1469821|P3|Overall Study|Lost to Follow-up|0
443614|NCT00425061|1469822|P2|Overall Study|Lost to Follow-up|1
443615|NCT00425061|1469823|P1|Overall Study|Lost to Follow-up|0
443616|NCT00425061|1469817|P7|Overall Study|Adverse Event|0
443617|NCT00425061|1469818|P6|Overall Study|Adverse Event|0
443618|NCT00425061|1469819|P5|Overall Study|Adverse Event|2
443619|NCT00425061|1469820|P4|Overall Study|Adverse Event|2
443620|NCT00425061|1469821|P3|Overall Study|Adverse Event|0
443621|NCT00425061|1469822|P2|Overall Study|Adverse Event|0
443622|NCT00425061|1469823|P1|Overall Study|Adverse Event|1
443623|NCT00424827|1469939|P1|Overall Study|Adverse Event|1
443624|NCT00424775|1469947|P2|Overall Study|Lack of Efficacy|0
443625|NCT00424775|1469948|P1|Overall Study|Lack of Efficacy|1
443626|NCT00424775|1469947|P2|Overall Study|Adverse Event|0
443627|NCT00424775|1469948|P1|Overall Study|Adverse Event|2
443628|NCT00424762|1469958|P2|Overall Study|Lost to Follow-up|3
443629|NCT00424762|1469959|P1|Overall Study|Lost to Follow-up|2
443630|NCT00424762|1469958|P2|Overall Study|Withdrawal by Subject|19
443631|NCT00424762|1469959|P1|Overall Study|Withdrawal by Subject|18
443632|NCT00424749|1469969|P1|Overall Study|Withdrawal by Subject|1
443633|NCT00424645|1469976|P2|Overall Study|Death|0
443634|NCT00424645|1469977|P1|Overall Study|Death|1
443635|NCT00424632|1469985|P10|Overall Study|Other|0
443636|NCT00424632|1469986|P9|Overall Study|Other|1
443637|NCT00424632|1469987|P8|Overall Study|Other|0
443638|NCT00424632|1469988|P7|Overall Study|Other|0
443639|NCT00424632|1469989|P6|Overall Study|Other|0
443640|NCT00424632|1469990|P5|Overall Study|Other|0
443641|NCT00424632|1469991|P4|Overall Study|Other|1
443642|NCT00424632|1469992|P3|Overall Study|Other|0
443643|NCT00424632|1469993|P2|Overall Study|Other|0
443644|NCT00424632|1469994|P1|Overall Study|Other|0
443645|NCT00424632|1469985|P10|Overall Study|Objective progression or relapse|4
443646|NCT00424632|1469986|P9|Overall Study|Objective progression or relapse|12
443647|NCT00424632|1469987|P8|Overall Study|Objective progression or relapse|3
443648|NCT00424632|1469988|P7|Overall Study|Objective progression or relapse|7
443649|NCT00424632|1469989|P6|Overall Study|Objective progression or relapse|13
443650|NCT00424632|1469990|P5|Overall Study|Objective progression or relapse|2
443651|NCT00424632|1469991|P4|Overall Study|Objective progression or relapse|2
443652|NCT00424632|1469992|P3|Overall Study|Objective progression or relapse|1
443653|NCT00424632|1469993|P2|Overall Study|Objective progression or relapse|1
443654|NCT00424632|1469994|P1|Overall Study|Objective progression or relapse|1
443655|NCT00424632|1469985|P10|Overall Study|Global deterioration of health status|0
443656|NCT00424632|1469986|P9|Overall Study|Global deterioration of health status|0
443657|NCT00424632|1469987|P8|Overall Study|Global deterioration of health status|0
443658|NCT00424632|1469988|P7|Overall Study|Global deterioration of health status|0
443659|NCT00424632|1469989|P6|Overall Study|Global deterioration of health status|0
443660|NCT00424632|1469990|P5|Overall Study|Global deterioration of health status|1
443661|NCT00424632|1469991|P4|Overall Study|Global deterioration of health status|1
443662|NCT00424632|1469992|P3|Overall Study|Global deterioration of health status|0
443663|NCT00424632|1469993|P2|Overall Study|Global deterioration of health status|0
443664|NCT00424632|1469994|P1|Overall Study|Global deterioration of health status|0
443665|NCT00424632|1469985|P10|Overall Study|Adverse Event|2
443666|NCT00424632|1469986|P9|Overall Study|Adverse Event|3
443667|NCT00424632|1469987|P8|Overall Study|Adverse Event|0
443668|NCT00424632|1469988|P7|Overall Study|Adverse Event|0
443669|NCT00424632|1469989|P6|Overall Study|Adverse Event|0
443670|NCT00424632|1469990|P5|Overall Study|Adverse Event|0
443671|NCT00424632|1469991|P4|Overall Study|Adverse Event|0
443672|NCT00424632|1469992|P3|Overall Study|Adverse Event|0
443673|NCT00424632|1469993|P2|Overall Study|Adverse Event|0
443674|NCT00424632|1469994|P1|Overall Study|Adverse Event|0
443675|NCT00424632|1469985|P10|Overall Study|Death|0
443676|NCT00424632|1469986|P9|Overall Study|Death|0
443677|NCT00424632|1469987|P8|Overall Study|Death|0
443678|NCT00424632|1469988|P7|Overall Study|Death|0
443679|NCT00424632|1469989|P6|Overall Study|Death|2
443680|NCT00424632|1469990|P5|Overall Study|Death|0
443681|NCT00424632|1469991|P4|Overall Study|Death|0
443682|NCT00424632|1469992|P3|Overall Study|Death|0
443683|NCT00424632|1469993|P2|Overall Study|Death|0
443684|NCT00424632|1469994|P1|Overall Study|Death|0
443685|NCT00424593|1470164|P2|Dose-Blind Extension Period|Physician Decision|0
443686|NCT00424593|1470165|P1|Dose-Blind Extension Period|Physician Decision|3
443687|NCT00424593|1470164|P2|Dose-Blind Extension Period|Lost to Follow-up|0
443688|NCT00424593|1470165|P1|Dose-Blind Extension Period|Lost to Follow-up|6
443689|NCT00424593|1470164|P2|Dose-Blind Extension Period|Protocol Violation|0
443690|NCT00424593|1470165|P1|Dose-Blind Extension Period|Protocol Violation|9
443691|NCT00424593|1470164|P2|Dose-Blind Extension Period|Lack of Efficacy|0
443692|NCT00424593|1470165|P1|Dose-Blind Extension Period|Lack of Efficacy|9
443693|NCT00424593|1470164|P2|Dose-Blind Extension Period|Adverse Event|0
443694|NCT00424593|1470165|P1|Dose-Blind Extension Period|Adverse Event|18
443695|NCT00424593|1470164|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
443696|NCT00424593|1470165|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
443697|NCT00424593|1470164|P2|Acute Double-Blind Period|Lack of Efficacy|1
443698|NCT00424593|1470165|P1|Acute Double-Blind Period|Lack of Efficacy|0
443699|NCT00424593|1470164|P2|Acute Double-Blind Period|Lost to Follow-up|1
443700|NCT00424593|1470165|P1|Acute Double-Blind Period|Lost to Follow-up|1
443701|NCT00424593|1470164|P2|Acute Double-Blind Period|Physician Decision|2
443702|NCT00424593|1470165|P1|Acute Double-Blind Period|Physician Decision|1
443703|NCT00424593|1470164|P2|Acute Double-Blind Period|Protocol Violation|2
443704|NCT00424593|1470165|P1|Acute Double-Blind Period|Protocol Violation|2
443705|NCT00424593|1470164|P2|Acute Double-Blind Period|Withdrawal by Subject|10
443706|NCT00424593|1470165|P1|Acute Double-Blind Period|Withdrawal by Subject|11
443707|NCT00424593|1470164|P2|Acute Double-Blind Period|Adverse Event|7
443708|NCT00424593|1470165|P1|Acute Double-Blind Period|Adverse Event|16
443709|NCT00424528|1470229|P3|Overall Study|noncompliance with study requirements|2
443710|NCT00424528|1470230|P2|Overall Study|noncompliance with study requirements|1
443711|NCT00424528|1470231|P1|Overall Study|noncompliance with study requirements|2
443712|NCT00424528|1470229|P3|Overall Study|Lost to Follow-up|0
443713|NCT00424528|1470230|P2|Overall Study|Lost to Follow-up|1
443714|NCT00424528|1470231|P1|Overall Study|Lost to Follow-up|0
443715|NCT00424528|1470229|P3|Overall Study|Protocol Violation|0
443716|NCT00424528|1470230|P2|Overall Study|Protocol Violation|1
443717|NCT00424528|1470231|P1|Overall Study|Protocol Violation|1
443718|NCT00424528|1470229|P3|Overall Study|Adverse Event|2
443719|NCT00424528|1470230|P2|Overall Study|Adverse Event|1
443720|NCT00424528|1470231|P1|Overall Study|Adverse Event|2
443721|NCT00424515|1470286|P2|Overall Study|Withdrawal by Subject|0
443722|NCT00424515|1470287|P1|Overall Study|Withdrawal by Subject|1
443723|NCT00424515|1470286|P2|Overall Study|Intercurrent Illness|1
443724|NCT00424515|1470287|P1|Overall Study|Intercurrent Illness|0
443725|NCT00424515|1470286|P2|Overall Study|Adverse Event|1
443726|NCT00424515|1470287|P1|Overall Study|Adverse Event|0
443727|NCT00424515|1470286|P2|Overall Study|Progressive Disease|11
443728|NCT00424515|1470287|P1|Overall Study|Progressive Disease|10
443729|NCT00424476|1470309|P3|Overall Study|Other|9
443730|NCT00424476|1470310|P2|Overall Study|Other|3
443731|NCT00424476|1470311|P1|Overall Study|Other|4
443732|NCT00424476|1470309|P3|Overall Study|Physician Decision|3
443733|NCT00424476|1470310|P2|Overall Study|Physician Decision|2
443734|NCT00424476|1470311|P1|Overall Study|Physician Decision|3
443735|NCT00424476|1470309|P3|Overall Study|Protocol Violation|3
443736|NCT00424476|1470310|P2|Overall Study|Protocol Violation|2
443737|NCT00424476|1470311|P1|Overall Study|Protocol Violation|7
443738|NCT00424476|1470309|P3|Overall Study|Lost to Follow-up|3
443739|NCT00424476|1470310|P2|Overall Study|Lost to Follow-up|6
443740|NCT00424476|1470311|P1|Overall Study|Lost to Follow-up|4
443741|NCT00424476|1470309|P3|Overall Study|Lack of Compliance|1
443742|NCT00424476|1470310|P2|Overall Study|Lack of Compliance|1
443743|NCT00424476|1470311|P1|Overall Study|Lack of Compliance|1
443744|NCT00424476|1470309|P3|Overall Study|Lack of Efficacy|12
443745|NCT00424476|1470310|P2|Overall Study|Lack of Efficacy|12
443746|NCT00424476|1470311|P1|Overall Study|Lack of Efficacy|16
443747|NCT00424476|1470309|P3|Overall Study|Adverse Event|15
443748|NCT00424476|1470310|P2|Overall Study|Adverse Event|16
443749|NCT00424476|1470311|P1|Overall Study|Adverse Event|19
443750|NCT00424476|1470309|P3|Overall Study|Withdrawal by Subject|3
443751|NCT00424476|1470310|P2|Overall Study|Withdrawal by Subject|6
443752|NCT00424476|1470311|P1|Overall Study|Withdrawal by Subject|7
443753|NCT00424463|1470337|P3|Overall Study|Patient’s convenience|1
443754|NCT00424463|1470338|P2|Overall Study|Patient’s convenience|0
443755|NCT00424463|1470339|P1|Overall Study|Patient’s convenience|0
443756|NCT00424463|1470337|P3|Overall Study|Tracheotomy due to worsening of ALS|6
443757|NCT00424463|1470338|P2|Overall Study|Tracheotomy due to worsening of ALS|7
443758|NCT00424463|1470339|P1|Overall Study|Tracheotomy due to worsening of ALS|1
443759|NCT00424463|1470337|P3|Overall Study|Withdrawal by Subject|5
443760|NCT00424463|1470338|P2|Overall Study|Withdrawal by Subject|2
443761|NCT00424463|1470339|P1|Overall Study|Withdrawal by Subject|4
443762|NCT00424463|1470337|P3|Overall Study|Physician Decision|2
443763|NCT00424463|1470338|P2|Overall Study|Physician Decision|2
443764|NCT00424463|1470339|P1|Overall Study|Physician Decision|0
443765|NCT00424463|1470337|P3|Overall Study|Adverse Event|2
443766|NCT00424463|1470338|P2|Overall Study|Adverse Event|3
443767|NCT00424463|1470339|P1|Overall Study|Adverse Event|2
443768|NCT00424398|1470368|P3|Overall Study|Subject met exclusion criteria|0
443769|NCT00424398|1470369|P2|Overall Study|Subject met exclusion criteria|0
443770|NCT00424398|1470370|P1|Overall Study|Subject met exclusion criteria|1
443771|NCT00424398|1470368|P3|Overall Study|Withdrawal by Subject|0
443772|NCT00424398|1470369|P2|Overall Study|Withdrawal by Subject|1
443773|NCT00424398|1470370|P1|Overall Study|Withdrawal by Subject|2
443774|NCT00424385|1470414|P1|Cohort 1|Withdrawal by Subject|1
443775|NCT00424385|1470414|P1|Cohort 0|Physician Decision|1
443776|NCT00424385|1470414|P1|Cohort 0|Withdrawal by Subject|5
443777|NCT00424372|1470421|P1|Overall Study|Lack of Efficacy|6
443778|NCT00424372|1470421|P1|Overall Study|Protocol Violation|1
443779|NCT00424372|1470421|P1|Overall Study|Withdrawal by Subject|4
443780|NCT00424372|1470421|P1|Overall Study|Health deterioration|1
443781|NCT00424372|1470421|P1|Overall Study|Adverse Event|18
443782|NCT00424372|1470421|P1|Overall Study|Death|1
443783|NCT00424346|1470433|P4|Extension Phase|Protocol Violation|0
443784|NCT00424346|1470434|P3|Extension Phase|Protocol Violation|1
443785|NCT00424346|1470435|P2|Extension Phase|Protocol Violation|1
443786|NCT00424346|1470436|P1|Extension Phase|Protocol Violation|0
443787|NCT00424346|1470433|P4|Extension Phase|Death|1
443788|NCT00424346|1470434|P3|Extension Phase|Death|0
443789|NCT00424346|1470435|P2|Extension Phase|Death|0
443790|NCT00424346|1470436|P1|Extension Phase|Death|0
443791|NCT00424346|1470433|P4|Extension Phase|Administrative Problems|35
443792|NCT00424346|1470434|P3|Extension Phase|Administrative Problems|32
443793|NCT00424346|1470435|P2|Extension Phase|Administrative Problems|69
443794|NCT00424346|1470436|P1|Extension Phase|Administrative Problems|0
443795|NCT00424346|1470433|P4|Extension Phase|Lost to Follow-up|0
443796|NCT00424346|1470434|P3|Extension Phase|Lost to Follow-up|0
443797|NCT00424346|1470435|P2|Extension Phase|Lost to Follow-up|2
443798|NCT00424346|1470436|P1|Extension Phase|Lost to Follow-up|0
443799|NCT00424346|1470433|P4|Extension Phase|Withdrawal by Subject|4
443800|NCT00424346|1470434|P3|Extension Phase|Withdrawal by Subject|3
443801|NCT00424346|1470435|P2|Extension Phase|Withdrawal by Subject|5
443802|NCT00424346|1470436|P1|Extension Phase|Withdrawal by Subject|0
443803|NCT00424346|1470433|P4|Extension Phase|Lack of Efficacy|11
443804|NCT00424346|1470434|P3|Extension Phase|Lack of Efficacy|14
443805|NCT00424346|1470435|P2|Extension Phase|Lack of Efficacy|16
443806|NCT00424346|1470436|P1|Extension Phase|Lack of Efficacy|0
443807|NCT00424346|1470433|P4|Extension Phase|Adverse Event|4
443808|NCT00424346|1470434|P3|Extension Phase|Adverse Event|5
443809|NCT00424346|1470435|P2|Extension Phase|Adverse Event|9
443810|NCT00424346|1470436|P1|Extension Phase|Adverse Event|0
443811|NCT00424346|1470433|P4|Core Study|Protocol Violation|0
443812|NCT00424346|1470434|P3|Core Study|Protocol Violation|2
443813|NCT00424346|1470435|P2|Core Study|Protocol Violation|0
443814|NCT00424346|1470436|P1|Core Study|Protocol Violation|0
443815|NCT00424346|1470433|P4|Core Study|Administrative Problems|0
443816|NCT00424346|1470434|P3|Core Study|Administrative Problems|1
443817|NCT00424346|1470435|P2|Core Study|Administrative Problems|0
443818|NCT00424346|1470436|P1|Core Study|Administrative Problems|1
443819|NCT00424346|1470433|P4|Core Study|Lost to Follow-up|0
443820|NCT00424346|1470434|P3|Core Study|Lost to Follow-up|0
443821|NCT00424346|1470435|P2|Core Study|Lost to Follow-up|1
443822|NCT00424346|1470436|P1|Core Study|Lost to Follow-up|1
443823|NCT00424346|1470433|P4|Core Study|Withdrawal by Subject|2
443824|NCT00424346|1470434|P3|Core Study|Withdrawal by Subject|0
443825|NCT00424346|1470435|P2|Core Study|Withdrawal by Subject|0
443826|NCT00424346|1470436|P1|Core Study|Withdrawal by Subject|1
443827|NCT00424346|1470433|P4|Core Study|Lack of Efficacy|4
443828|NCT00424346|1470434|P3|Core Study|Lack of Efficacy|0
443829|NCT00424346|1470435|P2|Core Study|Lack of Efficacy|3
443830|NCT00424346|1470436|P1|Core Study|Lack of Efficacy|1
443831|NCT00424346|1470433|P4|Core Study|Abnormal Laboratory Values|0
443832|NCT00424346|1470434|P3|Core Study|Abnormal Laboratory Values|0
443833|NCT00424346|1470435|P2|Core Study|Abnormal Laboratory Values|1
443834|NCT00424346|1470436|P1|Core Study|Abnormal Laboratory Values|0
443835|NCT00424346|1470433|P4|Core Study|Adverse Event|1
443836|NCT00424346|1470434|P3|Core Study|Adverse Event|1
443837|NCT00424346|1470435|P2|Core Study|Adverse Event|3
443838|NCT00424346|1470436|P1|Core Study|Adverse Event|5
443839|NCT00424294|1470551|P2|Overall Study|Randomized but not Treated|0
443840|NCT00424294|1470552|P1|Overall Study|Randomized but not Treated|1
443841|NCT00424294|1470551|P2|Overall Study|Other|2
443842|NCT00424294|1470552|P1|Overall Study|Other|0
443843|NCT00424294|1470551|P2|Overall Study|Withdrawal by Subject|2
443844|NCT00424294|1470552|P1|Overall Study|Withdrawal by Subject|1
443845|NCT00424294|1470551|P2|Overall Study|Lack of Efficacy|1
443846|NCT00424294|1470552|P1|Overall Study|Lack of Efficacy|2
443847|NCT00424294|1470551|P2|Overall Study|Adverse Event|10
443848|NCT00424294|1470552|P1|Overall Study|Adverse Event|4
443849|NCT00424255|1470619|P2|Overall Study|Sponsor Terminated Study|167
443850|NCT00424255|1470620|P1|Overall Study|Sponsor Terminated Study|161
443851|NCT00424255|1470619|P2|Overall Study|Disease Progression|2
443852|NCT00424255|1470620|P1|Overall Study|Disease Progression|0
443853|NCT00424255|1470619|P2|Overall Study|Fatigue|0
443854|NCT00424255|1470620|P1|Overall Study|Fatigue|1
443855|NCT00424255|1470619|P2|Overall Study|Non-compliance by Participants|0
443856|NCT00424255|1470620|P1|Overall Study|Non-compliance by Participants|1
443857|NCT00424255|1470619|P2|Overall Study|Cognitive Disturbance|0
443858|NCT00424255|1470620|P1|Overall Study|Cognitive Disturbance|1
443859|NCT00424255|1470619|P2|Overall Study|Physician Decision|7
443860|NCT00424255|1470620|P1|Overall Study|Physician Decision|3
443861|NCT00424255|1470619|P2|Overall Study|Withdrawal by Subject|38
443862|NCT00424255|1470620|P1|Overall Study|Withdrawal by Subject|34
443863|NCT00424255|1470619|P2|Overall Study|Protocol Violation|1
443864|NCT00424255|1470620|P1|Overall Study|Protocol Violation|0
443865|NCT00424255|1470619|P2|Overall Study|Lost to Follow-up|20
443866|NCT00424255|1470620|P1|Overall Study|Lost to Follow-up|26
443867|NCT00424255|1470619|P2|Overall Study|Death|111
443868|NCT00424255|1470620|P1|Overall Study|Death|115
443869|NCT00424190|1470668|P2|Overall Study|Other|21
443870|NCT00424190|1470669|P1|Overall Study|Other|15
443871|NCT00424190|1470668|P2|Overall Study|Diagnosis of osteomyelitis|1
443872|NCT00424190|1470669|P1|Overall Study|Diagnosis of osteomyelitis|0
443873|NCT00424190|1470668|P2|Overall Study|Request of sponsor or investigator|2
443874|NCT00424190|1470669|P1|Overall Study|Request of sponsor or investigator|0
443875|NCT00424190|1470668|P2|Overall Study|Noncompliance|2
443876|NCT00424190|1470669|P1|Overall Study|Noncompliance|1
443877|NCT00424190|1470668|P2|Overall Study|Death|0
443878|NCT00424190|1470669|P1|Overall Study|Death|3
443879|NCT00424190|1470668|P2|Overall Study|Withdrew consent|4
443880|NCT00424190|1470669|P1|Overall Study|Withdrew consent|3
443881|NCT00424177|1470675|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
443882|NCT00424177|1470675|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
443883|NCT00424177|1470675|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
443884|NCT00424177|1470675|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
443885|NCT00424177|1470675|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
443886|NCT00424177|1470675|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
443887|NCT00424177|1470675|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
443888|NCT00424177|1470675|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
443889|NCT00424177|1470675|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
443890|NCT00424177|1470675|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
443891|NCT00424047|1470704|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
443892|NCT00424047|1470705|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
443893|NCT00424047|1470704|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
443894|NCT00424047|1470705|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
443895|NCT00424047|1470704|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
443896|NCT00424047|1470705|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
443897|NCT00424047|1470704|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
443898|NCT00424047|1470705|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
443899|NCT00424047|1470704|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
443900|NCT00424047|1470705|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
443901|NCT00424047|1470704|P2|On Study at Time of Unblinding|Other|4
443902|NCT00424047|1470705|P1|On Study at Time of Unblinding|Other|5
443903|NCT00424047|1470704|P2|On Study at Time of Unblinding|Death|11
443904|NCT00424047|1470705|P1|On Study at Time of Unblinding|Death|11
443905|NCT00424047|1470704|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
443906|NCT00424047|1470705|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
443907|NCT00424047|1470704|P2|On Study at Time of Unblinding|Lack of Efficacy|3
443908|NCT00424047|1470705|P1|On Study at Time of Unblinding|Lack of Efficacy|1
443909|NCT00424047|1470704|P2|On Study at Time of Unblinding|Progression of disease|128
443910|NCT00424047|1470705|P1|On Study at Time of Unblinding|Progression of disease|92
443911|NCT00424047|1470704|P2|On Study at Time of Unblinding|Adverse Event|12
443912|NCT00424047|1470705|P1|On Study at Time of Unblinding|Adverse Event|22
443913|NCT00424047|1470704|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
443914|NCT00424047|1470705|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
443915|NCT00424047|1470704|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
443916|NCT00424047|1470705|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
443917|NCT00424047|1470704|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
443918|NCT00424047|1470705|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
443919|NCT00424047|1470704|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
443920|NCT00424047|1470705|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
443921|NCT00424047|1470704|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
443922|NCT00424047|1470705|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
443923|NCT00424047|1470704|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
443924|NCT00424047|1470705|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
443925|NCT00424021|1470737|P4|AMB-220-E Study Period|Physician Decision|1
443926|NCT00424021|1470738|P3|AMB-220-E Study Period|Physician Decision|0
443927|NCT00424021|1470739|P2|AMB-220-E Study Period|Physician Decision|0
443928|NCT00424021|1470740|P1|AMB-220-E Study Period|Physician Decision|0
443929|NCT00424021|1470737|P4|AMB-220-E Study Period|Lost to Follow-up|1
443930|NCT00424021|1470738|P3|AMB-220-E Study Period|Lost to Follow-up|1
443931|NCT00424021|1470739|P2|AMB-220-E Study Period|Lost to Follow-up|1
443932|NCT00424021|1470740|P1|AMB-220-E Study Period|Lost to Follow-up|0
443933|NCT00424021|1470737|P4|AMB-220-E Study Period|Death|1
443934|NCT00424021|1470738|P3|AMB-220-E Study Period|Death|1
443935|NCT00424021|1470739|P2|AMB-220-E Study Period|Death|0
443936|NCT00424021|1470740|P1|AMB-220-E Study Period|Death|0
443937|NCT00424021|1470737|P4|AMB-220-E Study Period|Adverse Event|7
443938|NCT00424021|1470738|P3|AMB-220-E Study Period|Adverse Event|3
443939|NCT00424021|1470739|P2|AMB-220-E Study Period|Adverse Event|1
443940|NCT00424021|1470740|P1|AMB-220-E Study Period|Adverse Event|1
443941|NCT00424021|1470737|P4|NCT00046319 Study Period|Lost to Follow-up|0
443942|NCT00424021|1470738|P3|NCT00046319 Study Period|Lost to Follow-up|0
443943|NCT00424021|1470739|P2|NCT00046319 Study Period|Lost to Follow-up|1
443944|NCT00424021|1470740|P1|NCT00046319 Study Period|Lost to Follow-up|0
443945|NCT00424021|1470737|P4|NCT00046319 Study Period|Sponsor discretion|0
443946|NCT00424021|1470738|P3|NCT00046319 Study Period|Sponsor discretion|0
443947|NCT00424021|1470739|P2|NCT00046319 Study Period|Sponsor discretion|1
443948|NCT00424021|1470740|P1|NCT00046319 Study Period|Sponsor discretion|0
443949|NCT00424021|1470737|P4|NCT00046319 Study Period|Withdrawal by Subject|0
443950|NCT00424021|1470738|P3|NCT00046319 Study Period|Withdrawal by Subject|0
443951|NCT00424021|1470739|P2|NCT00046319 Study Period|Withdrawal by Subject|1
443952|NCT00424021|1470740|P1|NCT00046319 Study Period|Withdrawal by Subject|0
443953|NCT00424021|1470737|P4|NCT00046319 Study Period|Adverse Event|1
443954|NCT00424021|1470738|P3|NCT00046319 Study Period|Adverse Event|1
443955|NCT00424021|1470739|P2|NCT00046319 Study Period|Adverse Event|0
443956|NCT00424021|1470740|P1|NCT00046319 Study Period|Adverse Event|1
443957|NCT00424008|1470783|P2|Overall Study|Administrative|257
443958|NCT00424008|1470784|P1|Overall Study|Administrative|266
443959|NCT00424008|1470783|P2|Overall Study|Did not meet protocol eligibility|21
443960|NCT00424008|1470784|P1|Overall Study|Did not meet protocol eligibility|16
443961|NCT00424008|1470783|P2|Overall Study|Noncompliance with protocol|7
443962|NCT00424008|1470784|P1|Overall Study|Noncompliance with protocol|13
443963|NCT00424008|1470783|P2|Overall Study|Withdrawal by Subject|8
443964|NCT00424008|1470784|P1|Overall Study|Withdrawal by Subject|5
443965|NCT00424008|1470783|P2|Overall Study|Lost to Follow-up|2
443966|NCT00424008|1470784|P1|Overall Study|Lost to Follow-up|1
443967|NCT00424008|1470783|P2|Overall Study|Lack of Efficacy|34
443968|NCT00424008|1470784|P1|Overall Study|Lack of Efficacy|40
443969|NCT00424008|1470783|P2|Overall Study|Adverse Event|6
443970|NCT00424008|1470784|P1|Overall Study|Adverse Event|8
443971|NCT00423943|1470799|P2|Overall Study|Withdrawal by Subject|1
443972|NCT00423943|1470800|P1|Overall Study|Withdrawal by Subject|3
443973|NCT00423930|1470814|P1|Overall Study|Withdrawal by Subject|2
443974|NCT00423917|1470819|P1|Overall Study|Ineligible|1
443975|NCT00423917|1470819|P1|Overall Study|Cancel|2
443976|NCT00423891|1470832|P3|Post-Dosing Follow Up|Lost to Follow-up|0
443977|NCT00423891|1470833|P2|Post-Dosing Follow Up|Lost to Follow-up|0
443978|NCT00423891|1470834|P1|Post-Dosing Follow Up|Lost to Follow-up|2
443979|NCT00423891|1470832|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
443980|NCT00423891|1470833|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
443981|NCT00423891|1470834|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
443982|NCT00423891|1470832|P3|Treatment|Lost to Follow-up|0
443983|NCT00423891|1470833|P2|Treatment|Lost to Follow-up|0
443984|NCT00423891|1470834|P1|Treatment|Lost to Follow-up|1
443985|NCT00423891|1470832|P3|Treatment|Withdrawal by Subject|0
443986|NCT00423891|1470833|P2|Treatment|Withdrawal by Subject|0
443987|NCT00423891|1470834|P1|Treatment|Withdrawal by Subject|1
443988|NCT00423891|1470832|P3|Enrolled|No longer met criteria|1
443989|NCT00423891|1470833|P2|Enrolled|No longer met criteria|2
443990|NCT00423891|1470834|P1|Enrolled|No longer met criteria|11
443991|NCT00423891|1470832|P3|Enrolled|Lost to Follow-up|1
443992|NCT00423891|1470833|P2|Enrolled|Lost to Follow-up|0
443993|NCT00423891|1470834|P1|Enrolled|Lost to Follow-up|0
443994|NCT00423891|1470832|P3|Enrolled|Withdrawal by Subject|1
443995|NCT00423891|1470833|P2|Enrolled|Withdrawal by Subject|0
443996|NCT00423891|1470834|P1|Enrolled|Withdrawal by Subject|0
443997|NCT00423852|1470912|P1|Overall Study|Removed pior to the high-dose portion|3
443998|NCT00423813|1470920|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
443999|NCT00423813|1470921|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
444000|NCT00423813|1470922|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
444001|NCT00423813|1470920|P3|Overall Study|Will start exclusionary medications|0
444002|NCT00423813|1470921|P2|Overall Study|Will start exclusionary medications|1
444003|NCT00423813|1470922|P1|Overall Study|Will start exclusionary medications|0
444004|NCT00423813|1470920|P3|Overall Study|Subject started night shift work|0
444005|NCT00423813|1470921|P2|Overall Study|Subject started night shift work|0
444006|NCT00423813|1470922|P1|Overall Study|Subject started night shift work|1
444007|NCT00423813|1470920|P3|Overall Study|Pregnancy|1
444008|NCT00423813|1470921|P2|Overall Study|Pregnancy|0
444009|NCT00423813|1470922|P1|Overall Study|Pregnancy|0
444010|NCT00423813|1470920|P3|Overall Study|Protocol Violation|4
444011|NCT00423813|1470921|P2|Overall Study|Protocol Violation|4
444012|NCT00423813|1470922|P1|Overall Study|Protocol Violation|9
444013|NCT00423813|1470920|P3|Overall Study|Sponsor Decision|0
444014|NCT00423813|1470921|P2|Overall Study|Sponsor Decision|1
444015|NCT00423813|1470922|P1|Overall Study|Sponsor Decision|0
444016|NCT00423813|1470920|P3|Overall Study|Physician Decision|0
444017|NCT00423813|1470921|P2|Overall Study|Physician Decision|0
444018|NCT00423813|1470922|P1|Overall Study|Physician Decision|2
444019|NCT00423813|1470920|P3|Overall Study|Lack of Efficacy|19
444020|NCT00423813|1470921|P2|Overall Study|Lack of Efficacy|18
444021|NCT00423813|1470922|P1|Overall Study|Lack of Efficacy|23
444022|NCT00423813|1470920|P3|Overall Study|Lost to Follow-up|4
444023|NCT00423813|1470921|P2|Overall Study|Lost to Follow-up|4
444024|NCT00423813|1470922|P1|Overall Study|Lost to Follow-up|5
444025|NCT00423813|1470920|P3|Overall Study|Withdrawal by Subject|5
444026|NCT00423813|1470921|P2|Overall Study|Withdrawal by Subject|8
444027|NCT00423813|1470922|P1|Overall Study|Withdrawal by Subject|6
444028|NCT00423813|1470920|P3|Overall Study|Adverse Event|40
444029|NCT00423813|1470921|P2|Overall Study|Adverse Event|30
444030|NCT00423813|1470922|P1|Overall Study|Adverse Event|11
444031|NCT00423800|1470932|P2|Overall Study|Protocol Violation|1
444032|NCT00423800|1470933|P1|Overall Study|Protocol Violation|0
444033|NCT00423735|1470945|P3|Overall Study|Ineligible / No protocol treatment|0
444034|NCT00423735|1470946|P2|Overall Study|Ineligible / No protocol treatment|6
444035|NCT00423735|1470947|P1|Overall Study|Ineligible / No protocol treatment|8
444036|NCT00423722|1470970|P2|Overall Study|Withdrawal by Subject|2
444037|NCT00423722|1470971|P1|Overall Study|Withdrawal by Subject|4
444038|NCT00423722|1470970|P2|Overall Study|Unable to complete questionnaires|4
444039|NCT00423722|1470971|P1|Overall Study|Unable to complete questionnaires|4
444040|NCT00423722|1470970|P2|Overall Study|Declined to participate|3
444041|NCT00423722|1470971|P1|Overall Study|Declined to participate|2
444042|NCT00423722|1470970|P2|Overall Study|Death|4
444043|NCT00423722|1470971|P1|Overall Study|Death|4
444044|NCT00423670|1471013|P8|Follow-up Period|Non-compliance with protocol|2
444045|NCT00423670|1471014|P7|Follow-up Period|Non-compliance with protocol|3
444046|NCT00423670|1471015|P6|Follow-up Period|Non-compliance with protocol|0
444047|NCT00423670|1471016|P5|Follow-up Period|Non-compliance with protocol|0
444048|NCT00423670|1471017|P4|Follow-up Period|Non-compliance with protocol|1
444049|NCT00423670|1471018|P3|Follow-up Period|Non-compliance with protocol|1
444050|NCT00423670|1471019|P2|Follow-up Period|Non-compliance with protocol|0
444051|NCT00423670|1471020|P1|Follow-up Period|Non-compliance with protocol|2
444052|NCT00423670|1471013|P8|Follow-up Period|Subject withdrew (not treatment related)|1
444053|NCT00423670|1471014|P7|Follow-up Period|Subject withdrew (not treatment related)|1
444054|NCT00423670|1471015|P6|Follow-up Period|Subject withdrew (not treatment related)|0
444055|NCT00423670|1471016|P5|Follow-up Period|Subject withdrew (not treatment related)|1
444056|NCT00423670|1471017|P4|Follow-up Period|Subject withdrew (not treatment related)|1
444057|NCT00423670|1471018|P3|Follow-up Period|Subject withdrew (not treatment related)|2
444058|NCT00423670|1471019|P2|Follow-up Period|Subject withdrew (not treatment related)|4
444059|NCT00423670|1471020|P1|Follow-up Period|Subject withdrew (not treatment related)|1
444060|NCT00423670|1471013|P8|Follow-up Period|Lost to Follow-up|0
444061|NCT00423670|1471014|P7|Follow-up Period|Lost to Follow-up|5
444062|NCT00423670|1471015|P6|Follow-up Period|Lost to Follow-up|0
444063|NCT00423670|1471016|P5|Follow-up Period|Lost to Follow-up|1
444064|NCT00423670|1471017|P4|Follow-up Period|Lost to Follow-up|3
444065|NCT00423670|1471018|P3|Follow-up Period|Lost to Follow-up|8
444066|NCT00423670|1471019|P2|Follow-up Period|Lost to Follow-up|12
444067|NCT00423670|1471020|P1|Follow-up Period|Lost to Follow-up|0
444068|NCT00423670|1471013|P8|Treatment Period|Non-compliance with protocol|2
444069|NCT00423670|1471014|P7|Treatment Period|Non-compliance with protocol|2
444070|NCT00423670|1471015|P6|Treatment Period|Non-compliance with protocol|0
444071|NCT00423670|1471016|P5|Treatment Period|Non-compliance with protocol|2
444072|NCT00423670|1471017|P4|Treatment Period|Non-compliance with protocol|3
444073|NCT00423670|1471018|P3|Treatment Period|Non-compliance with protocol|1
444074|NCT00423670|1471019|P2|Treatment Period|Non-compliance with protocol|1
444075|NCT00423670|1471020|P1|Treatment Period|Non-compliance with protocol|3
444076|NCT00423670|1471013|P8|Treatment Period|Investigator decision|1
444077|NCT00423670|1471014|P7|Treatment Period|Investigator decision|0
444078|NCT00423670|1471015|P6|Treatment Period|Investigator decision|0
444079|NCT00423670|1471016|P5|Treatment Period|Investigator decision|0
444080|NCT00423670|1471017|P4|Treatment Period|Investigator decision|0
444081|NCT00423670|1471018|P3|Treatment Period|Investigator decision|0
444082|NCT00423670|1471019|P2|Treatment Period|Investigator decision|0
444083|NCT00423670|1471020|P1|Treatment Period|Investigator decision|0
444084|NCT00423670|1471013|P8|Treatment Period|Subject withdrew (not treatment related)|0
444085|NCT00423670|1471014|P7|Treatment Period|Subject withdrew (not treatment related)|3
444086|NCT00423670|1471015|P6|Treatment Period|Subject withdrew (not treatment related)|0
444087|NCT00423670|1471016|P5|Treatment Period|Subject withdrew (not treatment related)|5
444088|NCT00423670|1471017|P4|Treatment Period|Subject withdrew (not treatment related)|4
444089|NCT00423670|1471018|P3|Treatment Period|Subject withdrew (not treatment related)|4
444090|NCT00423670|1471019|P2|Treatment Period|Subject withdrew (not treatment related)|9
444091|NCT00423670|1471020|P1|Treatment Period|Subject withdrew (not treatment related)|3
444092|NCT00423670|1471013|P8|Treatment Period|Lost to Follow-up|1
444093|NCT00423670|1471014|P7|Treatment Period|Lost to Follow-up|3
444094|NCT00423670|1471015|P6|Treatment Period|Lost to Follow-up|0
444095|NCT00423670|1471016|P5|Treatment Period|Lost to Follow-up|6
444096|NCT00423670|1471017|P4|Treatment Period|Lost to Follow-up|1
444097|NCT00423670|1471018|P3|Treatment Period|Lost to Follow-up|3
444098|NCT00423670|1471019|P2|Treatment Period|Lost to Follow-up|1
444099|NCT00423670|1471020|P1|Treatment Period|Lost to Follow-up|2
444100|NCT00423670|1471013|P8|Treatment Period|Protocol-defined clinical event|15
444101|NCT00423670|1471014|P7|Treatment Period|Protocol-defined clinical event|16
444102|NCT00423670|1471015|P6|Treatment Period|Protocol-defined clinical event|4
444103|NCT00423670|1471016|P5|Treatment Period|Protocol-defined clinical event|5
444104|NCT00423670|1471017|P4|Treatment Period|Protocol-defined clinical event|12
444105|NCT00423670|1471018|P3|Treatment Period|Protocol-defined clinical event|4
444106|NCT00423670|1471019|P2|Treatment Period|Protocol-defined clinical event|7
444107|NCT00423670|1471020|P1|Treatment Period|Protocol-defined clinical event|0
444108|NCT00423670|1471013|P8|Treatment Period|Adverse Event|2
444109|NCT00423670|1471014|P7|Treatment Period|Adverse Event|7
444110|NCT00423670|1471015|P6|Treatment Period|Adverse Event|4
444111|NCT00423670|1471016|P5|Treatment Period|Adverse Event|9
444112|NCT00423670|1471017|P4|Treatment Period|Adverse Event|20
444113|NCT00423670|1471018|P3|Treatment Period|Adverse Event|15
444114|NCT00423670|1471019|P2|Treatment Period|Adverse Event|12
444115|NCT00423670|1471020|P1|Treatment Period|Adverse Event|8
444116|NCT00423670|1471013|P8|Treatment Period|Switched to Arm 8 at TW 24|0
444117|NCT00423670|1471014|P7|Treatment Period|Switched to Arm 8 at TW 24|0
444118|NCT00423670|1471015|P6|Treatment Period|Switched to Arm 8 at TW 24|0
444119|NCT00423670|1471016|P5|Treatment Period|Switched to Arm 8 at TW 24|0
444120|NCT00423670|1471017|P4|Treatment Period|Switched to Arm 8 at TW 24|0
444121|NCT00423670|1471018|P3|Treatment Period|Switched to Arm 8 at TW 24|0
444122|NCT00423670|1471019|P2|Treatment Period|Switched to Arm 8 at TW 24|0
444123|NCT00423670|1471020|P1|Treatment Period|Switched to Arm 8 at TW 24|36
444124|NCT00423657|1471078|P2|Overall Study|Request of sponsor/investigator|0
444125|NCT00423657|1471079|P1|Overall Study|Request of sponsor/investigator|1
444126|NCT00423657|1471078|P2|Overall Study|Other|16
444127|NCT00423657|1471079|P1|Overall Study|Other|15
444128|NCT00423657|1471078|P2|Overall Study|Non-compliance|1
444129|NCT00423657|1471079|P1|Overall Study|Non-compliance|0
444130|NCT00423657|1471078|P2|Overall Study|Withdrew consent|8
444131|NCT00423657|1471079|P1|Overall Study|Withdrew consent|10
444132|NCT00423605|1471085|P1|Overall Study|Not one of the pre-specified options|5
444133|NCT00423605|1471085|P1|Overall Study|Protocol Violation|7
444134|NCT00423605|1471085|P1|Overall Study|Physician Decision|8
444135|NCT00423605|1471085|P1|Overall Study|Sponsor Decision|3
444136|NCT00423605|1471085|P1|Overall Study|Lack of Efficacy|38
444137|NCT00423605|1471085|P1|Overall Study|Lost to Follow-up|15
444138|NCT00423605|1471085|P1|Overall Study|Withdrawal by Subject|36
444139|NCT00423605|1471085|P1|Overall Study|Adverse Event|129
444140|NCT00423592|1471089|P1|Overall Study|Adverse Event (post Week 12)|5
444141|NCT00423592|1471089|P1|Overall Study|Adverse Event (through Week 12)|2
444142|NCT00423579|1471110|P2|Overall Study|Diagnosis of diabetes|1
444143|NCT00423579|1471111|P1|Overall Study|Diagnosis of diabetes|0
444144|NCT00423579|1471110|P2|Overall Study|Protocol Violation|3
444145|NCT00423579|1471111|P1|Overall Study|Protocol Violation|1
444146|NCT00423579|1471110|P2|Overall Study|Lost to Follow-up|0
444147|NCT00423579|1471111|P1|Overall Study|Lost to Follow-up|3
444152|NCT00423449|1471126|P5|Overall Study|Protocol Violation|0
444153|NCT00423449|1471127|P4|Overall Study|Protocol Violation|1
444154|NCT00423449|1471128|P3|Overall Study|Protocol Violation|2
444155|NCT00423449|1471129|P2|Overall Study|Protocol Violation|0
444156|NCT00423449|1471130|P1|Overall Study|Protocol Violation|0
444157|NCT00423449|1471126|P5|Overall Study|Not Specified|0
444158|NCT00423449|1471127|P4|Overall Study|Not Specified|1
444159|NCT00423449|1471128|P3|Overall Study|Not Specified|0
444160|NCT00423449|1471129|P2|Overall Study|Not Specified|0
444161|NCT00423449|1471130|P1|Overall Study|Not Specified|0
444162|NCT00423449|1471126|P5|Overall Study|Laboratory Adverse Event|0
444163|NCT00423449|1471127|P4|Overall Study|Laboratory Adverse Event|0
444164|NCT00423449|1471128|P3|Overall Study|Laboratory Adverse Event|2
444165|NCT00423449|1471129|P2|Overall Study|Laboratory Adverse Event|1
444166|NCT00423449|1471130|P1|Overall Study|Laboratory Adverse Event|0
444167|NCT00423449|1471126|P5|Overall Study|Progressive Disease|4
444168|NCT00423449|1471127|P4|Overall Study|Progressive Disease|11
444169|NCT00423449|1471128|P3|Overall Study|Progressive Disease|8
444170|NCT00423449|1471129|P2|Overall Study|Progressive Disease|3
444171|NCT00423449|1471130|P1|Overall Study|Progressive Disease|1
444172|NCT00423449|1471126|P5|Overall Study|Death|1
444173|NCT00423449|1471127|P4|Overall Study|Death|1
444174|NCT00423449|1471128|P3|Overall Study|Death|2
444175|NCT00423449|1471129|P2|Overall Study|Death|0
444176|NCT00423449|1471130|P1|Overall Study|Death|1
444177|NCT00423449|1471126|P5|Overall Study|Clinical Adverse Event|2
444178|NCT00423449|1471127|P4|Overall Study|Clinical Adverse Event|8
444179|NCT00423449|1471128|P3|Overall Study|Clinical Adverse Event|1
444180|NCT00423449|1471129|P2|Overall Study|Clinical Adverse Event|0
444181|NCT00423449|1471130|P1|Overall Study|Clinical Adverse Event|1
444182|NCT00423332|1471177|P2|Overall Study|Unblinded before 12 weeks|3
444183|NCT00423332|1471178|P1|Overall Study|Unblinded before 12 weeks|1
444184|NCT00423332|1471177|P2|Overall Study|Progressive at Week 6|1
444185|NCT00423332|1471178|P1|Overall Study|Progressive at Week 6|0
444186|NCT00423332|1471177|P2|Overall Study|Condition under investigation worsened|1
444187|NCT00423332|1471178|P1|Overall Study|Condition under investigation worsened|1
444188|NCT00423332|1471177|P2|Overall Study|Withdrawal by Subject|0
444189|NCT00423332|1471178|P1|Overall Study|Withdrawal by Subject|1
444190|NCT00423332|1471177|P2|Overall Study|Adverse Event|2
444191|NCT00423332|1471178|P1|Overall Study|Adverse Event|6
444192|NCT00423319|1471197|P2|Overall Study|Not specified|22
444193|NCT00423319|1471198|P1|Overall Study|Not specified|23
444194|NCT00423319|1471197|P2|Overall Study|No longer meets study criteria|15
444195|NCT00423319|1471198|P1|Overall Study|No longer meets study criteria|15
444196|NCT00423319|1471197|P2|Overall Study|Poor compliance or noncompliance|1
444197|NCT00423319|1471198|P1|Overall Study|Poor compliance or noncompliance|1
444198|NCT00423319|1471197|P2|Overall Study|Lost to Follow-up|3
444199|NCT00423319|1471198|P1|Overall Study|Lost to Follow-up|4
444200|NCT00423319|1471197|P2|Overall Study|Withdrawal by Subject|99
444201|NCT00423319|1471198|P1|Overall Study|Withdrawal by Subject|86
444202|NCT00423319|1471197|P2|Overall Study|Adverse Event|112
444203|NCT00423319|1471198|P1|Overall Study|Adverse Event|93
444204|NCT00423319|1471197|P2|Overall Study|Death|0
444205|NCT00423319|1471198|P1|Overall Study|Death|2
444206|NCT00423293|1471230|P1|Overall Study|Ineligible / No protocol treatment|11
444207|NCT00423267|1471236|P2|Period A|Administrative|0
444208|NCT00423267|1471237|P1|Period A|Administrative|1
444209|NCT00423267|1471236|P2|Period A|Non-compliance with protocol|0
444210|NCT00423267|1471237|P1|Period A|Non-compliance with protocol|1
444211|NCT00423267|1471236|P2|Period A|Withdrawal by Subject|1
444212|NCT00423267|1471237|P1|Period A|Withdrawal by Subject|0
444213|NCT00423189|1471257|P3|Overall Study|Death|0
444214|NCT00423189|1471258|P2|Overall Study|Death|1
444215|NCT00423189|1471259|P1|Overall Study|Death|0
444216|NCT00423176|1471281|P2|Overall Study|Did not meet protocol eligibility|4
444217|NCT00423176|1471282|P1|Overall Study|Did not meet protocol eligibility|2
444218|NCT00423176|1471281|P2|Overall Study|Protocol Violation|3
444219|NCT00423176|1471282|P1|Overall Study|Protocol Violation|1
444220|NCT00423176|1471281|P2|Overall Study|Withdrawal by Subject|3
444221|NCT00423176|1471282|P1|Overall Study|Withdrawal by Subject|4
444222|NCT00423176|1471281|P2|Overall Study|Lost to Follow-up|7
444223|NCT00423176|1471282|P1|Overall Study|Lost to Follow-up|4
444224|NCT00423176|1471281|P2|Overall Study|Treatment Failure|6
444225|NCT00423176|1471282|P1|Overall Study|Treatment Failure|1
444226|NCT00423176|1471281|P2|Overall Study|Adverse Event|6
444227|NCT00423176|1471282|P1|Overall Study|Adverse Event|4
444228|NCT00423150|1471290|P1|Overall Study|Administrative|4
444229|NCT00423150|1471290|P1|Overall Study|Non-compliance with protocol|1
444230|NCT00423150|1471290|P1|Overall Study|Withdrawal by Subject|1
444231|NCT00423150|1471290|P1|Overall Study|Progression of disease being studied|69
444232|NCT00423150|1471290|P1|Overall Study|Adverse Event|11
444233|NCT00423098|1471296|P2|Overall Study|Death|0
444234|NCT00423098|1471297|P1|Overall Study|Death|2
444235|NCT00423098|1471296|P2|Overall Study|Administrative problems|1
444236|NCT00423098|1471297|P1|Overall Study|Administrative problems|0
444237|NCT00423098|1471296|P2|Overall Study|Unsatisfactory therapeutic effect|1
444238|NCT00423098|1471297|P1|Overall Study|Unsatisfactory therapeutic effect|0
444239|NCT00423098|1471296|P2|Overall Study|Adverse Event|2
444240|NCT00423098|1471297|P1|Overall Study|Adverse Event|1
444241|NCT00423085|1471324|P4|52-Week Open-Label Extension Phase|Death|2
444242|NCT00423085|1471325|P3|52-Week Open-Label Extension Phase|Death|0
444243|NCT00423085|1471326|P2|52-Week Open-Label Extension Phase|Death|0
444244|NCT00423085|1471327|P1|52-Week Open-Label Extension Phase|Death|0
444245|NCT00423085|1471324|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
444246|NCT00423085|1471325|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
444247|NCT00423085|1471326|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
444248|NCT00423085|1471327|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
444249|NCT00423085|1471324|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
444250|NCT00423085|1471325|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
444251|NCT00423085|1471326|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
444252|NCT00423085|1471327|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
444253|NCT00423085|1471324|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
444254|NCT00423085|1471325|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
444255|NCT00423085|1471326|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
444256|NCT00423085|1471327|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
444257|NCT00423085|1471324|P4|52-Week Open-Label Extension Phase|Adverse Event|97
444258|NCT00423085|1471325|P3|52-Week Open-Label Extension Phase|Adverse Event|0
444259|NCT00423085|1471326|P2|52-Week Open-Label Extension Phase|Adverse Event|0
444260|NCT00423085|1471327|P1|52-Week Open-Label Extension Phase|Adverse Event|0
444261|NCT00423085|1471324|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
444262|NCT00423085|1471325|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
444263|NCT00423085|1471326|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
444264|NCT00423085|1471327|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
444265|NCT00423085|1471324|P4|24-Week Double-Blind Treatment Phase|Death|0
444266|NCT00423085|1471325|P3|24-Week Double-Blind Treatment Phase|Death|0
444267|NCT00423085|1471326|P2|24-Week Double-Blind Treatment Phase|Death|1
444268|NCT00423085|1471327|P1|24-Week Double-Blind Treatment Phase|Death|1
444269|NCT00423085|1471324|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
444270|NCT00423085|1471325|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
444271|NCT00423085|1471326|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
444272|NCT00423085|1471327|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
444273|NCT00423085|1471324|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
444274|NCT00423085|1471325|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
444275|NCT00423085|1471326|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
444276|NCT00423085|1471327|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
444277|NCT00423085|1471324|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
444278|NCT00423085|1471325|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
444279|NCT00423085|1471326|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
444280|NCT00423085|1471327|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
444281|NCT00423085|1471324|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
444282|NCT00423085|1471325|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
444283|NCT00423085|1471326|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
444284|NCT00423085|1471327|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
444285|NCT00423046|1471356|P2|Overall Study|Other|345
444286|NCT00423046|1471357|P1|Overall Study|Other|340
444287|NCT00422942|1471423|P1|Overall Study|Study terminated by Sponsor|3
444288|NCT00422903|1471442|P2|Overall Study|Informed Consent Withdrawn|2
444289|NCT00422903|1471443|P1|Overall Study|Informed Consent Withdrawn|1
444290|NCT00422903|1471442|P2|Overall Study|Adverse Event|2
444291|NCT00422903|1471443|P1|Overall Study|Adverse Event|0
444292|NCT00422903|1471442|P2|Overall Study|Disease Progression|1
444293|NCT00422903|1471443|P1|Overall Study|Disease Progression|3
444294|NCT00422799|1471492|P1|Overall Study|Adverse Event|7
444295|NCT00422799|1471492|P1|Overall Study|Withdrawal by Subject|6
444296|NCT00422734|1471501|P2|Overall Study|Partner Decision|3
444297|NCT00422734|1471502|P1|Overall Study|Partner Decision|0
444298|NCT00422734|1471501|P2|Overall Study|Adverse Event|3
444299|NCT00422734|1471502|P1|Overall Study|Adverse Event|0
444300|NCT00422734|1471501|P2|Overall Study|Withdrawal by Subject|8
444301|NCT00422734|1471502|P1|Overall Study|Withdrawal by Subject|12
444302|NCT00422734|1471501|P2|Overall Study|Protocol Violation|6
444303|NCT00422734|1471502|P1|Overall Study|Protocol Violation|1
444304|NCT00422734|1471501|P2|Overall Study|Physician Decision|1
444305|NCT00422734|1471502|P1|Overall Study|Physician Decision|1
444306|NCT00422669|1471548|P3|Overall Study|The study was terminated early.|7
444307|NCT00422669|1471549|P2|Overall Study|The study was terminated early.|100
444308|NCT00422669|1471550|P1|Overall Study|The study was terminated early.|98
444309|NCT00422591|1471578|P1|Overall Study|Withdrawal by Subject|2
444310|NCT00422591|1471578|P1|Overall Study|Physician Decision|4
444311|NCT00422513|1471586|P2|Overall Study|Death|7
444312|NCT00422513|1471587|P1|Overall Study|Death|3
444313|NCT00422513|1471586|P2|Overall Study|Adverse Event|4
444314|NCT00422513|1471587|P1|Overall Study|Adverse Event|4
444315|NCT00422513|1471586|P2|Overall Study|early termination of the study|80
444316|NCT00422513|1471587|P1|Overall Study|early termination of the study|67
444317|NCT00422513|1471586|P2|Overall Study|Withdrawal by Subject|1
444318|NCT00422513|1471587|P1|Overall Study|Withdrawal by Subject|2
444319|NCT00422513|1471586|P2|Overall Study|Refused Treatment|2
444320|NCT00422513|1471587|P1|Overall Study|Refused Treatment|4
444321|NCT00422513|1471586|P2|Overall Study|Protocol Violation|7
444322|NCT00422513|1471587|P1|Overall Study|Protocol Violation|23
444323|NCT00422513|1471586|P2|Overall Study|Lack of Efficacy|5
444324|NCT00422513|1471587|P1|Overall Study|Lack of Efficacy|4
444325|NCT00422422|1471604|P1|Overall Study|AE, non-serious non-fatal|5
444326|NCT00422422|1471604|P1|Overall Study|SAE, non-fatal|1
444327|NCT00422422|1471604|P1|Overall Study|Withdrawal by Subject|2
444328|NCT00422422|1471604|P1|Overall Study|Protocol Violation|1
444329|NCT00422422|1471604|P1|Overall Study|Lack of Efficacy|1
444330|NCT00422383|1471621|P5|Overall Study|Withdrawal by Subject|1
444331|NCT00422383|1471622|P4|Overall Study|Withdrawal by Subject|0
444332|NCT00422383|1471623|P3|Overall Study|Withdrawal by Subject|0
444333|NCT00422383|1471624|P2|Overall Study|Withdrawal by Subject|5
444334|NCT00422383|1471625|P1|Overall Study|Withdrawal by Subject|5
444335|NCT00422383|1471621|P5|Overall Study|Protocol Violation|0
444336|NCT00422383|1471622|P4|Overall Study|Protocol Violation|0
444337|NCT00422383|1471623|P3|Overall Study|Protocol Violation|1
444338|NCT00422383|1471624|P2|Overall Study|Protocol Violation|1
444339|NCT00422383|1471625|P1|Overall Study|Protocol Violation|1
444340|NCT00422383|1471621|P5|Overall Study|Lost to Follow-up|1
444341|NCT00422383|1471622|P4|Overall Study|Lost to Follow-up|0
444342|NCT00422383|1471623|P3|Overall Study|Lost to Follow-up|0
444343|NCT00422383|1471624|P2|Overall Study|Lost to Follow-up|1
444344|NCT00422383|1471625|P1|Overall Study|Lost to Follow-up|0
444345|NCT00422383|1471621|P5|Overall Study|Lack of Efficacy|1
444346|NCT00422383|1471622|P4|Overall Study|Lack of Efficacy|1
444347|NCT00422383|1471623|P3|Overall Study|Lack of Efficacy|2
444348|NCT00422383|1471624|P2|Overall Study|Lack of Efficacy|4
444349|NCT00422383|1471625|P1|Overall Study|Lack of Efficacy|4
444350|NCT00422383|1471621|P5|Overall Study|Adverse Event|0
444351|NCT00422383|1471622|P4|Overall Study|Adverse Event|1
444352|NCT00422383|1471623|P3|Overall Study|Adverse Event|1
444353|NCT00422383|1471624|P2|Overall Study|Adverse Event|3
444354|NCT00422383|1471625|P1|Overall Study|Adverse Event|5
444355|NCT00422292|1471768|P4|Overall Study|Withdrawal by Subject|13
444356|NCT00422292|1471769|P3|Overall Study|Withdrawal by Subject|7
444357|NCT00422292|1471770|P2|Overall Study|Withdrawal by Subject|25
444358|NCT00422292|1471771|P1|Overall Study|Withdrawal by Subject|6
444359|NCT00422292|1471768|P4|Overall Study|Lost to Follow-up|6
444360|NCT00422292|1471769|P3|Overall Study|Lost to Follow-up|6
444361|NCT00422292|1471770|P2|Overall Study|Lost to Follow-up|12
444362|NCT00422292|1471771|P1|Overall Study|Lost to Follow-up|6
444363|NCT00422292|1471768|P4|Overall Study|Protocol Violation|5
444364|NCT00422292|1471769|P3|Overall Study|Protocol Violation|8
444365|NCT00422292|1471770|P2|Overall Study|Protocol Violation|25
444366|NCT00422292|1471771|P1|Overall Study|Protocol Violation|4
444367|NCT00422292|1471768|P4|Overall Study|Adverse Event|0
444368|NCT00422292|1471769|P3|Overall Study|Adverse Event|1
444369|NCT00422292|1471770|P2|Overall Study|Adverse Event|0
444370|NCT00422292|1471771|P1|Overall Study|Adverse Event|1
444371|NCT00422292|1471768|P4|Overall Study|Serious adverse events|0
444372|NCT00422292|1471769|P3|Overall Study|Serious adverse events|0
444373|NCT00422292|1471770|P2|Overall Study|Serious adverse events|4
444374|NCT00422292|1471771|P1|Overall Study|Serious adverse events|1
444375|NCT00422227|1471810|P2|Overall Study|Withdrawal by Subject|4
444376|NCT00422227|1471811|P1|Overall Study|Withdrawal by Subject|0
444377|NCT00422227|1471810|P2|Overall Study|Lost to Follow-up|3
444378|NCT00422227|1471811|P1|Overall Study|Lost to Follow-up|1
444379|NCT00422227|1471810|P2|Overall Study|Adverse Event|8
444380|NCT00422227|1471811|P1|Overall Study|Adverse Event|3
444381|NCT00422162|1471841|P2|Overall Study|Didn't Receive Treatment|1
444382|NCT00422162|1471842|P1|Overall Study|Didn't Receive Treatment|0
444383|NCT00422162|1471841|P2|Overall Study|Not Specified|1
444384|NCT00422162|1471842|P1|Overall Study|Not Specified|0
444385|NCT00422162|1471841|P2|Overall Study|Non-Compliant with Protocol|1
444386|NCT00422162|1471842|P1|Overall Study|Non-Compliant with Protocol|1
444387|NCT00422162|1471841|P2|Overall Study|Lost to Follow-up|2
444388|NCT00422162|1471842|P1|Overall Study|Lost to Follow-up|1
444389|NCT00422162|1471841|P2|Overall Study|Withdrawal by Subject|6
444390|NCT00422162|1471842|P1|Overall Study|Withdrawal by Subject|7
444391|NCT00422162|1471841|P2|Overall Study|Lack of Efficacy|10
444392|NCT00422162|1471842|P1|Overall Study|Lack of Efficacy|4
444393|NCT00422162|1471841|P2|Overall Study|Adverse Event|9
444394|NCT00422162|1471842|P1|Overall Study|Adverse Event|11
444395|NCT00422097|1471902|P8|Dose Level 2|Still on treatment|0
444396|NCT00422097|1471903|P7|Dose Level 2|Still on treatment|0
444397|NCT00422097|1471904|P6|Dose Level 2|Still on treatment|0
444398|NCT00422097|1471905|P5|Dose Level 2|Still on treatment|0
444399|NCT00422097|1471906|P4|Dose Level 2|Still on treatment|0
444400|NCT00422097|1471907|P3|Dose Level 2|Still on treatment|0
444401|NCT00422097|1471908|P2|Dose Level 2|Still on treatment|1
444402|NCT00422097|1471909|P1|Dose Level 2|Still on treatment|0
444403|NCT00422058|1471974|P6|Open-Label Extension, Week 20-104|Other|18
444404|NCT00422058|1471975|P5|Open-Label Extension, Week 20-104|Other|16
444405|NCT00422058|1471976|P4|Open-Label Extension, Week 20-104|Other|13
444406|NCT00422058|1471977|P3|Open-Label Extension, Week 20-104|Other|6
444407|NCT00422058|1471978|P2|Open-Label Extension, Week 20-104|Other|14
444408|NCT00422058|1471979|P1|Open-Label Extension, Week 20-104|Other|13
444409|NCT00422058|1471974|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
444410|NCT00422058|1471975|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
444411|NCT00422058|1471976|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
444412|NCT00422058|1471977|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
444413|NCT00422058|1471978|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
444414|NCT00422058|1471979|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
444415|NCT00422058|1471974|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
444416|NCT00422058|1471975|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
444417|NCT00422058|1471976|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
444418|NCT00422058|1471977|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
444419|NCT00422058|1471978|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
444420|NCT00422058|1471979|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
444421|NCT00422058|1471974|P6|Open-Label Extension, Week 20-104|Adverse Event|0
444422|NCT00422058|1471975|P5|Open-Label Extension, Week 20-104|Adverse Event|4
444423|NCT00422058|1471976|P4|Open-Label Extension, Week 20-104|Adverse Event|4
444424|NCT00422058|1471977|P3|Open-Label Extension, Week 20-104|Adverse Event|7
444425|NCT00422058|1471978|P2|Open-Label Extension, Week 20-104|Adverse Event|4
444426|NCT00422058|1471979|P1|Open-Label Extension, Week 20-104|Adverse Event|3
444427|NCT00422058|1471974|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
444428|NCT00422058|1471975|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
444429|NCT00422058|1471976|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
444430|NCT00422058|1471977|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
444431|NCT00422058|1471978|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
444432|NCT00422058|1471979|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
444433|NCT00422058|1471974|P6|Double-Blind, Week 0-20|Other|10
444434|NCT00422058|1471975|P5|Double-Blind, Week 0-20|Other|4
444435|NCT00422058|1471976|P4|Double-Blind, Week 0-20|Other|8
444436|NCT00422058|1471977|P3|Double-Blind, Week 0-20|Other|8
444437|NCT00422058|1471978|P2|Double-Blind, Week 0-20|Other|3
444438|NCT00422058|1471979|P1|Double-Blind, Week 0-20|Other|11
444439|NCT00422058|1471974|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
444440|NCT00422058|1471975|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
444441|NCT00422058|1471976|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
444442|NCT00422058|1471977|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
444443|NCT00422058|1471978|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
444444|NCT00422058|1471979|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
444445|NCT00422058|1471974|P6|Double-Blind, Week 0-20|Protocol Violation|2
444446|NCT00422058|1471975|P5|Double-Blind, Week 0-20|Protocol Violation|2
444447|NCT00422058|1471976|P4|Double-Blind, Week 0-20|Protocol Violation|3
444448|NCT00422058|1471977|P3|Double-Blind, Week 0-20|Protocol Violation|2
444449|NCT00422058|1471978|P2|Double-Blind, Week 0-20|Protocol Violation|2
444450|NCT00422058|1471979|P1|Double-Blind, Week 0-20|Protocol Violation|3
444451|NCT00422058|1471974|P6|Double-Blind, Week 0-20|Adverse Event|3
444452|NCT00422058|1471975|P5|Double-Blind, Week 0-20|Adverse Event|5
444453|NCT00422058|1471976|P4|Double-Blind, Week 0-20|Adverse Event|9
444454|NCT00422058|1471977|P3|Double-Blind, Week 0-20|Adverse Event|5
444455|NCT00422058|1471978|P2|Double-Blind, Week 0-20|Adverse Event|4
444456|NCT00422058|1471979|P1|Double-Blind, Week 0-20|Adverse Event|3
444457|NCT00421993|1472120|P4|Overall Study|Subject transportation issues|1
444458|NCT00421993|1472121|P3|Overall Study|Subject transportation issues|0
444459|NCT00421993|1472122|P2|Overall Study|Subject transportation issues|0
444460|NCT00421993|1472123|P1|Overall Study|Subject transportation issues|0
444461|NCT00421993|1472120|P4|Overall Study|Pregnancy|2
444462|NCT00421993|1472121|P3|Overall Study|Pregnancy|1
444463|NCT00421993|1472122|P2|Overall Study|Pregnancy|1
444464|NCT00421993|1472123|P1|Overall Study|Pregnancy|0
444465|NCT00421993|1472120|P4|Overall Study|Lack of Efficacy|5
444466|NCT00421993|1472121|P3|Overall Study|Lack of Efficacy|0
444467|NCT00421993|1472122|P2|Overall Study|Lack of Efficacy|3
444468|NCT00421993|1472123|P1|Overall Study|Lack of Efficacy|0
444469|NCT00421993|1472120|P4|Overall Study|Protocol Violation|1
444470|NCT00421993|1472121|P3|Overall Study|Protocol Violation|0
444471|NCT00421993|1472122|P2|Overall Study|Protocol Violation|2
444472|NCT00421993|1472123|P1|Overall Study|Protocol Violation|2
444473|NCT00421993|1472120|P4|Overall Study|Adverse Event|4
444474|NCT00421993|1472121|P3|Overall Study|Adverse Event|6
444475|NCT00421993|1472122|P2|Overall Study|Adverse Event|1
444476|NCT00421993|1472123|P1|Overall Study|Adverse Event|11
444477|NCT00421993|1472120|P4|Overall Study|Lost to Follow-up|20
444478|NCT00421993|1472121|P3|Overall Study|Lost to Follow-up|22
444479|NCT00421993|1472122|P2|Overall Study|Lost to Follow-up|19
444480|NCT00421993|1472123|P1|Overall Study|Lost to Follow-up|18
444481|NCT00421993|1472120|P4|Overall Study|Withdrawal by Subject|24
444482|NCT00421993|1472121|P3|Overall Study|Withdrawal by Subject|23
444483|NCT00421993|1472122|P2|Overall Study|Withdrawal by Subject|23
444484|NCT00421993|1472123|P1|Overall Study|Withdrawal by Subject|22
444485|NCT00421928|1472160|P3|Overall Study|Death|0
444486|NCT00421928|1472161|P2|Overall Study|Death|1
444487|NCT00421928|1472162|P1|Overall Study|Death|0
444488|NCT00421928|1472160|P3|Overall Study|All other|27
444489|NCT00421928|1472161|P2|Overall Study|All other|21
444490|NCT00421928|1472162|P1|Overall Study|All other|26
444491|NCT00421928|1472160|P3|Overall Study|Study drug non-compliant|4
444492|NCT00421928|1472161|P2|Overall Study|Study drug non-compliant|7
444493|NCT00421928|1472162|P1|Overall Study|Study drug non-compliant|6
444494|NCT00421928|1472160|P3|Overall Study|Lack of Efficacy|35
444495|NCT00421928|1472161|P2|Overall Study|Lack of Efficacy|7
444496|NCT00421928|1472162|P1|Overall Study|Lack of Efficacy|15
444497|NCT00421928|1472160|P3|Overall Study|Withdrawal by Subject|43
444498|NCT00421928|1472161|P2|Overall Study|Withdrawal by Subject|48
444499|NCT00421928|1472162|P1|Overall Study|Withdrawal by Subject|50
444500|NCT00421928|1472160|P3|Overall Study|Lost to Follow-up|3
444501|NCT00421928|1472161|P2|Overall Study|Lost to Follow-up|0
444502|NCT00421928|1472162|P1|Overall Study|Lost to Follow-up|5
444503|NCT00421928|1472160|P3|Overall Study|Adverse Event|22
444504|NCT00421928|1472161|P2|Overall Study|Adverse Event|140
444505|NCT00421928|1472162|P1|Overall Study|Adverse Event|61
444506|NCT00421889|1472197|P9|Overall Study|Lost to Follow-up|1
444507|NCT00421889|1472198|P8|Overall Study|Lost to Follow-up|0
444508|NCT00421889|1472199|P7|Overall Study|Lost to Follow-up|0
444509|NCT00421889|1472200|P6|Overall Study|Lost to Follow-up|0
444510|NCT00421889|1472201|P5|Overall Study|Lost to Follow-up|0
444511|NCT00421889|1472202|P4|Overall Study|Lost to Follow-up|0
444512|NCT00421889|1472203|P3|Overall Study|Lost to Follow-up|0
444513|NCT00421889|1472204|P2|Overall Study|Lost to Follow-up|0
444514|NCT00421889|1472205|P1|Overall Study|Lost to Follow-up|0
444515|NCT00421889|1472197|P9|Overall Study|Patient/Investigator request|3
444516|NCT00421889|1472198|P8|Overall Study|Patient/Investigator request|1
444517|NCT00421889|1472199|P7|Overall Study|Patient/Investigator request|0
444518|NCT00421889|1472200|P6|Overall Study|Patient/Investigator request|9
444519|NCT00421889|1472201|P5|Overall Study|Patient/Investigator request|0
444520|NCT00421889|1472202|P4|Overall Study|Patient/Investigator request|0
444521|NCT00421889|1472203|P3|Overall Study|Patient/Investigator request|0
444522|NCT00421889|1472204|P2|Overall Study|Patient/Investigator request|0
444523|NCT00421889|1472205|P1|Overall Study|Patient/Investigator request|0
444524|NCT00421889|1472197|P9|Overall Study|Progressive disease|5
444525|NCT00421889|1472198|P8|Overall Study|Progressive disease|1
444526|NCT00421889|1472199|P7|Overall Study|Progressive disease|3
444527|NCT00421889|1472200|P6|Overall Study|Progressive disease|21
444528|NCT00421889|1472201|P5|Overall Study|Progressive disease|2
444529|NCT00421889|1472202|P4|Overall Study|Progressive disease|3
444530|NCT00421889|1472203|P3|Overall Study|Progressive disease|2
444531|NCT00421889|1472204|P2|Overall Study|Progressive disease|2
444532|NCT00421889|1472205|P1|Overall Study|Progressive disease|3
444533|NCT00421889|1472197|P9|Overall Study|Death|0
444534|NCT00421889|1472198|P8|Overall Study|Death|0
444535|NCT00421889|1472199|P7|Overall Study|Death|0
444536|NCT00421889|1472200|P6|Overall Study|Death|1
444537|NCT00421889|1472201|P5|Overall Study|Death|1
444538|NCT00421889|1472202|P4|Overall Study|Death|0
444539|NCT00421889|1472203|P3|Overall Study|Death|0
444540|NCT00421889|1472204|P2|Overall Study|Death|0
444541|NCT00421889|1472205|P1|Overall Study|Death|0
444542|NCT00421889|1472197|P9|Overall Study|Withdrawal by Subject|0
444543|NCT00421889|1472198|P8|Overall Study|Withdrawal by Subject|0
444544|NCT00421889|1472199|P7|Overall Study|Withdrawal by Subject|0
444545|NCT00421889|1472200|P6|Overall Study|Withdrawal by Subject|0
444546|NCT00421889|1472201|P5|Overall Study|Withdrawal by Subject|2
444547|NCT00421889|1472202|P4|Overall Study|Withdrawal by Subject|0
444548|NCT00421889|1472203|P3|Overall Study|Withdrawal by Subject|0
444549|NCT00421889|1472204|P2|Overall Study|Withdrawal by Subject|3
444550|NCT00421889|1472205|P1|Overall Study|Withdrawal by Subject|1
444551|NCT00421889|1472197|P9|Overall Study|Adverse Event|2
444552|NCT00421889|1472198|P8|Overall Study|Adverse Event|0
444553|NCT00421889|1472199|P7|Overall Study|Adverse Event|1
444554|NCT00421889|1472200|P6|Overall Study|Adverse Event|4
444555|NCT00421889|1472201|P5|Overall Study|Adverse Event|1
444556|NCT00421889|1472202|P4|Overall Study|Adverse Event|1
444557|NCT00421889|1472203|P3|Overall Study|Adverse Event|1
444558|NCT00421889|1472204|P2|Overall Study|Adverse Event|0
444559|NCT00421889|1472205|P1|Overall Study|Adverse Event|1
444560|NCT00421733|1472250|P3|Overall Study|Protocol deviation|2
444561|NCT00421733|1472251|P2|Overall Study|Protocol deviation|7
444562|NCT00421733|1472252|P1|Overall Study|Protocol deviation|4
444563|NCT00421733|1472250|P3|Overall Study|Sponsor request|3
444564|NCT00421733|1472251|P2|Overall Study|Sponsor request|0
444565|NCT00421733|1472252|P1|Overall Study|Sponsor request|1
444566|NCT00421733|1472250|P3|Overall Study|Did not satisfy entry criteria|2
444567|NCT00421733|1472251|P2|Overall Study|Did not satisfy entry criteria|3
444568|NCT00421733|1472252|P1|Overall Study|Did not satisfy entry criteria|1
444569|NCT00421733|1472250|P3|Overall Study|Administrative|0
444570|NCT00421733|1472251|P2|Overall Study|Administrative|0
444571|NCT00421733|1472252|P1|Overall Study|Administrative|2
444572|NCT00421733|1472250|P3|Overall Study|Required dialysis|0
444573|NCT00421733|1472251|P2|Overall Study|Required dialysis|0
444574|NCT00421733|1472252|P1|Overall Study|Required dialysis|1
444575|NCT00421733|1472250|P3|Overall Study|Death|0
444576|NCT00421733|1472251|P2|Overall Study|Death|3
444577|NCT00421733|1472252|P1|Overall Study|Death|0
444578|NCT00421733|1472250|P3|Overall Study|Withdrawal by Subject|7
444579|NCT00421733|1472251|P2|Overall Study|Withdrawal by Subject|2
444580|NCT00421733|1472252|P1|Overall Study|Withdrawal by Subject|1
444581|NCT00421733|1472250|P3|Overall Study|Lost to Follow-up|4
444582|NCT00421733|1472251|P2|Overall Study|Lost to Follow-up|2
444583|NCT00421733|1472252|P1|Overall Study|Lost to Follow-up|1
444584|NCT00421733|1472250|P3|Overall Study|Adverse Event|2
444585|NCT00421733|1472251|P2|Overall Study|Adverse Event|9
444586|NCT00421733|1472252|P1|Overall Study|Adverse Event|4
444587|NCT00421707|1472272|P2|Period 3:Treatment Period 2|Adverse Event|2
444588|NCT00421707|1472273|P1|Period 3:Treatment Period 2|Adverse Event|0
444589|NCT00421707|1472272|P2|Period 3:Treatment Period 2|Protocol Violation|0
444590|NCT00421707|1472273|P1|Period 3:Treatment Period 2|Protocol Violation|1
444591|NCT00421707|1472272|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
444592|NCT00421707|1472273|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
444593|NCT00421707|1472272|P2|Period 2: Washout|Other: Pregnancy|1
444594|NCT00421707|1472273|P1|Period 2: Washout|Other: Pregnancy|0
444595|NCT00421707|1472272|P2|Period 2: Washout|Lost to Follow-up|1
444596|NCT00421707|1472273|P1|Period 2: Washout|Lost to Follow-up|0
444597|NCT00421707|1472272|P2|Period 2: Washout|Withdrawal by Subject|1
444598|NCT00421707|1472273|P1|Period 2: Washout|Withdrawal by Subject|0
444599|NCT00421707|1472272|P2|Period 2: Washout|Adverse Event|1
444600|NCT00421707|1472273|P1|Period 2: Washout|Adverse Event|1
444601|NCT00421707|1472272|P2|Period 1: Treatment Period 1|Protocol Violation|0
444602|NCT00421707|1472273|P1|Period 1: Treatment Period 1|Protocol Violation|1
444603|NCT00421707|1472272|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
444604|NCT00421707|1472273|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
444605|NCT00421707|1472272|P2|Period 1: Treatment Period 1|Adverse Event|2
444606|NCT00421707|1472273|P1|Period 1: Treatment Period 1|Adverse Event|7
444607|NCT00421707|1472272|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
444608|NCT00421707|1472273|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
444609|NCT00421408|1472324|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
444610|NCT00421408|1472325|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
444611|NCT00421408|1472324|P2|Overall Study|Lost to Follow-up|20
444612|NCT00421408|1472325|P1|Overall Study|Lost to Follow-up|30
444613|NCT00421343|1472343|P1|Overall Study|Lost to follow-up|3
444614|NCT00421343|1472343|P1|Overall Study|Withdrawal by Subject|2
444615|NCT00421343|1472343|P1|Overall Study|Death|1
444616|NCT00421174|1472349|P2|Overall Study|Ineligible due to infection|0
444617|NCT00421174|1472350|P1|Overall Study|Ineligible due to infection|2
444618|NCT00421174|1472349|P2|Overall Study|Withdrawal by Subject|1
444619|NCT00421174|1472350|P1|Overall Study|Withdrawal by Subject|0
444620|NCT00420927|1472395|P7|Period 2|Took prohibited medication|0
444621|NCT00420927|1472396|P6|Period 2|Took prohibited medication|0
444622|NCT00420927|1472397|P5|Period 2|Took prohibited medication|1
444623|NCT00420927|1472398|P4|Period 2|Took prohibited medication|0
444624|NCT00420927|1472399|P3|Period 2|Took prohibited medication|0
444625|NCT00420927|1472400|P2|Period 2|Took prohibited medication|0
444626|NCT00420927|1472401|P1|Period 2|Took prohibited medication|0
444627|NCT00420927|1472395|P7|Period 2|Methotrexate intolerance|1
444628|NCT00420927|1472396|P6|Period 2|Methotrexate intolerance|0
444629|NCT00420927|1472397|P5|Period 2|Methotrexate intolerance|0
444630|NCT00420927|1472398|P4|Period 2|Methotrexate intolerance|0
444631|NCT00420927|1472399|P3|Period 2|Methotrexate intolerance|0
444632|NCT00420927|1472400|P2|Period 2|Methotrexate intolerance|0
444633|NCT00420927|1472401|P1|Period 2|Methotrexate intolerance|0
444634|NCT00420927|1472395|P7|Period 2|Noncompliant with study drug|2
444635|NCT00420927|1472396|P6|Period 2|Noncompliant with study drug|0
444636|NCT00420927|1472397|P5|Period 2|Noncompliant with study drug|0
444637|NCT00420927|1472398|P4|Period 2|Noncompliant with study drug|1
444638|NCT00420927|1472399|P3|Period 2|Noncompliant with study drug|0
444639|NCT00420927|1472400|P2|Period 2|Noncompliant with study drug|0
444640|NCT00420927|1472401|P1|Period 2|Noncompliant with study drug|0
444641|NCT00420927|1472395|P7|Period 2|Randomization error|0
444642|NCT00420927|1472396|P6|Period 2|Randomization error|1
444643|NCT00420927|1472397|P5|Period 2|Randomization error|1
444644|NCT00420927|1472398|P4|Period 2|Randomization error|0
444645|NCT00420927|1472399|P3|Period 2|Randomization error|0
444646|NCT00420927|1472400|P2|Period 2|Randomization error|0
444647|NCT00420927|1472401|P1|Period 2|Randomization error|0
444648|NCT00420927|1472395|P7|Period 2|Sponsor decision|1
444649|NCT00420927|1472396|P6|Period 2|Sponsor decision|0
444650|NCT00420927|1472397|P5|Period 2|Sponsor decision|0
444651|NCT00420927|1472398|P4|Period 2|Sponsor decision|0
444652|NCT00420927|1472399|P3|Period 2|Sponsor decision|1
444653|NCT00420927|1472400|P2|Period 2|Sponsor decision|0
444654|NCT00420927|1472401|P1|Period 2|Sponsor decision|0
444655|NCT00420927|1472395|P7|Period 2|Physician Decision|0
444656|NCT00420927|1472396|P6|Period 2|Physician Decision|1
444657|NCT00420927|1472397|P5|Period 2|Physician Decision|1
444658|NCT00420927|1472398|P4|Period 2|Physician Decision|0
444659|NCT00420927|1472399|P3|Period 2|Physician Decision|0
444660|NCT00420927|1472400|P2|Period 2|Physician Decision|0
444661|NCT00420927|1472401|P1|Period 2|Physician Decision|0
444662|NCT00420927|1472395|P7|Period 2|Subject unable to find transportation|1
444663|NCT00420927|1472396|P6|Period 2|Subject unable to find transportation|0
444664|NCT00420927|1472397|P5|Period 2|Subject unable to find transportation|0
444665|NCT00420927|1472398|P4|Period 2|Subject unable to find transportation|0
444666|NCT00420927|1472399|P3|Period 2|Subject unable to find transportation|0
444667|NCT00420927|1472400|P2|Period 2|Subject unable to find transportation|0
444668|NCT00420927|1472401|P1|Period 2|Subject unable to find transportation|0
444669|NCT00420927|1472395|P7|Period 2|Received wrong treatment/incorrect dose|1
444670|NCT00420927|1472396|P6|Period 2|Received wrong treatment/incorrect dose|0
444671|NCT00420927|1472397|P5|Period 2|Received wrong treatment/incorrect dose|0
444672|NCT00420927|1472398|P4|Period 2|Received wrong treatment/incorrect dose|0
444673|NCT00420927|1472399|P3|Period 2|Received wrong treatment/incorrect dose|0
444674|NCT00420927|1472400|P2|Period 2|Received wrong treatment/incorrect dose|0
444675|NCT00420927|1472401|P1|Period 2|Received wrong treatment/incorrect dose|0
444676|NCT00420927|1472395|P7|Period 2|Lack of efficacy/Loss of efficacy|6
444677|NCT00420927|1472396|P6|Period 2|Lack of efficacy/Loss of efficacy|2
444678|NCT00420927|1472397|P5|Period 2|Lack of efficacy/Loss of efficacy|6
444679|NCT00420927|1472398|P4|Period 2|Lack of efficacy/Loss of efficacy|1
444680|NCT00420927|1472399|P3|Period 2|Lack of efficacy/Loss of efficacy|2
444681|NCT00420927|1472400|P2|Period 2|Lack of efficacy/Loss of efficacy|0
444682|NCT00420927|1472401|P1|Period 2|Lack of efficacy/Loss of efficacy|0
444683|NCT00420927|1472395|P7|Period 2|Lost to Follow-up|9
444684|NCT00420927|1472396|P6|Period 2|Lost to Follow-up|3
444685|NCT00420927|1472397|P5|Period 2|Lost to Follow-up|6
444686|NCT00420927|1472398|P4|Period 2|Lost to Follow-up|2
444687|NCT00420927|1472399|P3|Period 2|Lost to Follow-up|2
444688|NCT00420927|1472400|P2|Period 2|Lost to Follow-up|0
444689|NCT00420927|1472401|P1|Period 2|Lost to Follow-up|0
444690|NCT00420927|1472395|P7|Period 2|Withdrawal by Subject|12
444691|NCT00420927|1472396|P6|Period 2|Withdrawal by Subject|2
444692|NCT00420927|1472397|P5|Period 2|Withdrawal by Subject|11
444693|NCT00420927|1472398|P4|Period 2|Withdrawal by Subject|3
444694|NCT00420927|1472399|P3|Period 2|Withdrawal by Subject|1
444695|NCT00420927|1472400|P2|Period 2|Withdrawal by Subject|0
444696|NCT00420927|1472401|P1|Period 2|Withdrawal by Subject|0
444697|NCT00420927|1472395|P7|Period 2|Adverse Event|20
444698|NCT00420927|1472396|P6|Period 2|Adverse Event|6
444699|NCT00420927|1472397|P5|Period 2|Adverse Event|17
444700|NCT00420927|1472398|P4|Period 2|Adverse Event|3
444701|NCT00420927|1472399|P3|Period 2|Adverse Event|7
444702|NCT00420927|1472400|P2|Period 2|Adverse Event|0
444703|NCT00420927|1472401|P1|Period 2|Adverse Event|0
444704|NCT00420927|1472395|P7|Period 1|Took prohibited medication|0
444705|NCT00420927|1472396|P6|Period 1|Took prohibited medication|0
444706|NCT00420927|1472397|P5|Period 1|Took prohibited medication|0
444707|NCT00420927|1472398|P4|Period 1|Took prohibited medication|0
444708|NCT00420927|1472399|P3|Period 1|Took prohibited medication|0
444709|NCT00420927|1472400|P2|Period 1|Took prohibited medication|3
444710|NCT00420927|1472401|P1|Period 1|Took prohibited medication|1
444711|NCT00420927|1472395|P7|Period 1|Failed to meet entry criteria|0
444712|NCT00420927|1472396|P6|Period 1|Failed to meet entry criteria|0
444713|NCT00420927|1472397|P5|Period 1|Failed to meet entry criteria|0
444714|NCT00420927|1472398|P4|Period 1|Failed to meet entry criteria|0
444715|NCT00420927|1472399|P3|Period 1|Failed to meet entry criteria|0
444716|NCT00420927|1472400|P2|Period 1|Failed to meet entry criteria|7
444717|NCT00420927|1472401|P1|Period 1|Failed to meet entry criteria|8
444718|NCT00420927|1472395|P7|Period 1|Received wrong treatment/incorrect dose|0
444719|NCT00420927|1472396|P6|Period 1|Received wrong treatment/incorrect dose|0
444720|NCT00420927|1472397|P5|Period 1|Received wrong treatment/incorrect dose|0
444721|NCT00420927|1472398|P4|Period 1|Received wrong treatment/incorrect dose|0
444722|NCT00420927|1472399|P3|Period 1|Received wrong treatment/incorrect dose|0
444723|NCT00420927|1472400|P2|Period 1|Received wrong treatment/incorrect dose|1
444724|NCT00420927|1472401|P1|Period 1|Received wrong treatment/incorrect dose|0
444725|NCT00420927|1472395|P7|Period 1|Subject received new diagnosis|0
444726|NCT00420927|1472396|P6|Period 1|Subject received new diagnosis|0
444727|NCT00420927|1472397|P5|Period 1|Subject received new diagnosis|0
444728|NCT00420927|1472398|P4|Period 1|Subject received new diagnosis|0
444729|NCT00420927|1472399|P3|Period 1|Subject received new diagnosis|0
444730|NCT00420927|1472400|P2|Period 1|Subject received new diagnosis|2
444731|NCT00420927|1472401|P1|Period 1|Subject received new diagnosis|0
444732|NCT00420927|1472395|P7|Period 1|Study site closure|0
444733|NCT00420927|1472396|P6|Period 1|Study site closure|0
444734|NCT00420927|1472397|P5|Period 1|Study site closure|0
444735|NCT00420927|1472398|P4|Period 1|Study site closure|0
444736|NCT00420927|1472399|P3|Period 1|Study site closure|0
444737|NCT00420927|1472400|P2|Period 1|Study site closure|1
444738|NCT00420927|1472401|P1|Period 1|Study site closure|0
444739|NCT00420927|1472395|P7|Period 1|Suspected tuberculosis/positive test|0
444740|NCT00420927|1472396|P6|Period 1|Suspected tuberculosis/positive test|0
444741|NCT00420927|1472397|P5|Period 1|Suspected tuberculosis/positive test|0
444742|NCT00420927|1472398|P4|Period 1|Suspected tuberculosis/positive test|0
444743|NCT00420927|1472399|P3|Period 1|Suspected tuberculosis/positive test|0
444744|NCT00420927|1472400|P2|Period 1|Suspected tuberculosis/positive test|1
444745|NCT00420927|1472401|P1|Period 1|Suspected tuberculosis/positive test|1
444746|NCT00420927|1472395|P7|Period 1|Randomization error|0
444747|NCT00420927|1472396|P6|Period 1|Randomization error|0
444748|NCT00420927|1472397|P5|Period 1|Randomization error|0
444749|NCT00420927|1472398|P4|Period 1|Randomization error|0
444750|NCT00420927|1472399|P3|Period 1|Randomization error|0
444751|NCT00420927|1472400|P2|Period 1|Randomization error|0
444752|NCT00420927|1472401|P1|Period 1|Randomization error|1
444753|NCT00420927|1472395|P7|Period 1|Noncompliant with study drug|0
444754|NCT00420927|1472396|P6|Period 1|Noncompliant with study drug|0
444755|NCT00420927|1472397|P5|Period 1|Noncompliant with study drug|0
444756|NCT00420927|1472398|P4|Period 1|Noncompliant with study drug|0
444757|NCT00420927|1472399|P3|Period 1|Noncompliant with study drug|0
444758|NCT00420927|1472400|P2|Period 1|Noncompliant with study drug|1
444759|NCT00420927|1472401|P1|Period 1|Noncompliant with study drug|1
444760|NCT00420927|1472395|P7|Period 1|Subject moved/relocated|0
444761|NCT00420927|1472396|P6|Period 1|Subject moved/relocated|0
444762|NCT00420927|1472397|P5|Period 1|Subject moved/relocated|0
444763|NCT00420927|1472398|P4|Period 1|Subject moved/relocated|0
444764|NCT00420927|1472399|P3|Period 1|Subject moved/relocated|0
444765|NCT00420927|1472400|P2|Period 1|Subject moved/relocated|2
444766|NCT00420927|1472401|P1|Period 1|Subject moved/relocated|0
444767|NCT00420927|1472395|P7|Period 1|Death|0
444768|NCT00420927|1472396|P6|Period 1|Death|0
444769|NCT00420927|1472397|P5|Period 1|Death|0
444770|NCT00420927|1472398|P4|Period 1|Death|0
444771|NCT00420927|1472399|P3|Period 1|Death|0
444772|NCT00420927|1472400|P2|Period 1|Death|0
444773|NCT00420927|1472401|P1|Period 1|Death|2
444774|NCT00420927|1472395|P7|Period 1|Lack of efficacy/Loss of efficacy|0
444775|NCT00420927|1472396|P6|Period 1|Lack of efficacy/Loss of efficacy|0
444776|NCT00420927|1472397|P5|Period 1|Lack of efficacy/Loss of efficacy|0
444777|NCT00420927|1472398|P4|Period 1|Lack of efficacy/Loss of efficacy|0
444778|NCT00420927|1472399|P3|Period 1|Lack of efficacy/Loss of efficacy|0
444779|NCT00420927|1472400|P2|Period 1|Lack of efficacy/Loss of efficacy|6
444780|NCT00420927|1472401|P1|Period 1|Lack of efficacy/Loss of efficacy|1
444781|NCT00420927|1472395|P7|Period 1|Lost to Follow-up|0
444782|NCT00420927|1472396|P6|Period 1|Lost to Follow-up|0
444783|NCT00420927|1472397|P5|Period 1|Lost to Follow-up|0
444784|NCT00420927|1472398|P4|Period 1|Lost to Follow-up|0
444785|NCT00420927|1472399|P3|Period 1|Lost to Follow-up|0
444786|NCT00420927|1472400|P2|Period 1|Lost to Follow-up|6
444787|NCT00420927|1472401|P1|Period 1|Lost to Follow-up|8
444788|NCT00420927|1472395|P7|Period 1|Withdrawal by Subject|0
444789|NCT00420927|1472396|P6|Period 1|Withdrawal by Subject|0
444790|NCT00420927|1472397|P5|Period 1|Withdrawal by Subject|0
444791|NCT00420927|1472398|P4|Period 1|Withdrawal by Subject|0
444792|NCT00420927|1472399|P3|Period 1|Withdrawal by Subject|0
444793|NCT00420927|1472400|P2|Period 1|Withdrawal by Subject|12
444794|NCT00420927|1472401|P1|Period 1|Withdrawal by Subject|7
444795|NCT00420927|1472395|P7|Period 1|Adverse Event|0
444796|NCT00420927|1472396|P6|Period 1|Adverse Event|0
444797|NCT00420927|1472397|P5|Period 1|Adverse Event|0
444798|NCT00420927|1472398|P4|Period 1|Adverse Event|0
444799|NCT00420927|1472399|P3|Period 1|Adverse Event|0
444800|NCT00420927|1472400|P2|Period 1|Adverse Event|15
444801|NCT00420927|1472401|P1|Period 1|Adverse Event|19
444802|NCT00420849|1472505|P1|Overall Study|Lost to Follow-up|1
444803|NCT00420849|1472505|P1|Overall Study|Protocol Violation|1
444804|NCT00420849|1472505|P1|Overall Study|Transplant|8
444805|NCT00420849|1472505|P1|Overall Study|Not specified|14
444806|NCT00420849|1472505|P1|Overall Study|Death|18
444807|NCT00420849|1472505|P1|Overall Study|Withdrawal by Subject|28
444808|NCT00420849|1472505|P1|Overall Study|Adverse Event|107
444809|NCT00420849|1472505|P1|Overall Study|Lack of Efficacy|154
444810|NCT00420784|1472574|P4|Overall Study|Other|5
444811|NCT00420784|1472575|P3|Overall Study|Other|0
444812|NCT00420784|1472576|P2|Overall Study|Other|2
444813|NCT00420784|1472577|P1|Overall Study|Other|1
444814|NCT00420784|1472574|P4|Overall Study|Virologic Stopping Rule|67
444815|NCT00420784|1472575|P3|Overall Study|Virologic Stopping Rule|41
444816|NCT00420784|1472576|P2|Overall Study|Virologic Stopping Rule|26
444817|NCT00420784|1472577|P1|Overall Study|Virologic Stopping Rule|17
444818|NCT00420784|1472574|P4|Overall Study|Lost to Follow-up|1
444819|NCT00420784|1472575|P3|Overall Study|Lost to Follow-up|2
444820|NCT00420784|1472576|P2|Overall Study|Lost to Follow-up|0
444821|NCT00420784|1472577|P1|Overall Study|Lost to Follow-up|0
444822|NCT00420784|1472574|P4|Overall Study|Withdrawal by Subject|0
444823|NCT00420784|1472575|P3|Overall Study|Withdrawal by Subject|0
444824|NCT00420784|1472576|P2|Overall Study|Withdrawal by Subject|1
444825|NCT00420784|1472577|P1|Overall Study|Withdrawal by Subject|0
444826|NCT00420784|1472574|P4|Overall Study|Adverse Event|5
444827|NCT00420784|1472575|P3|Overall Study|Adverse Event|10
444828|NCT00420784|1472576|P2|Overall Study|Adverse Event|29
444829|NCT00420784|1472577|P1|Overall Study|Adverse Event|11
444830|NCT00420745|1472606|P2|Overall Study|Age limit exceeded for Dose 2|0
444831|NCT00420745|1472607|P1|Overall Study|Age limit exceeded for Dose 2|1
444832|NCT00420745|1472606|P2|Overall Study|Recurrent pneumonia & bronchitis|1
444833|NCT00420745|1472607|P1|Overall Study|Recurrent pneumonia & bronchitis|0
444834|NCT00420745|1472606|P2|Overall Study|Physician Decision|1
444835|NCT00420745|1472607|P1|Overall Study|Physician Decision|1
444836|NCT00420745|1472606|P2|Overall Study|Protocol Violation|0
444837|NCT00420745|1472607|P1|Overall Study|Protocol Violation|1
444838|NCT00420745|1472606|P2|Overall Study|Lost to Follow-up|2
444839|NCT00420745|1472607|P1|Overall Study|Lost to Follow-up|10
444840|NCT00420745|1472606|P2|Overall Study|Adverse Event|2
444841|NCT00420745|1472607|P1|Overall Study|Adverse Event|2
444842|NCT00420641|1472626|P3|Overall Study|Other|3
444843|NCT00420641|1472627|P2|Overall Study|Other|4
444844|NCT00420641|1472628|P1|Overall Study|Other|4
444845|NCT00420641|1472626|P3|Overall Study|Non-compliance|4
444846|NCT00420641|1472627|P2|Overall Study|Non-compliance|5
444847|NCT00420641|1472628|P1|Overall Study|Non-compliance|7
444848|NCT00420641|1472626|P3|Overall Study|Lack of Efficacy|4
444849|NCT00420641|1472627|P2|Overall Study|Lack of Efficacy|5
444850|NCT00420641|1472628|P1|Overall Study|Lack of Efficacy|6
444851|NCT00420641|1472626|P3|Overall Study|Withdrawal by Subject|14
444852|NCT00420641|1472627|P2|Overall Study|Withdrawal by Subject|21
444853|NCT00420641|1472628|P1|Overall Study|Withdrawal by Subject|15
444854|NCT00420641|1472626|P3|Overall Study|Protocol Violation|7
444855|NCT00420641|1472627|P2|Overall Study|Protocol Violation|8
444856|NCT00420641|1472628|P1|Overall Study|Protocol Violation|8
444857|NCT00420641|1472626|P3|Overall Study|Lost to Follow-up|2
444858|NCT00420641|1472627|P2|Overall Study|Lost to Follow-up|4
444859|NCT00420641|1472628|P1|Overall Study|Lost to Follow-up|2
444860|NCT00420641|1472626|P3|Overall Study|Adverse Event|10
444861|NCT00420641|1472627|P2|Overall Study|Adverse Event|25
444862|NCT00420641|1472628|P1|Overall Study|Adverse Event|3
444863|NCT00420628|1472704|P2|Overall Study|Adverse Event|0
444864|NCT00420628|1472705|P1|Overall Study|Adverse Event|1
444865|NCT00420628|1472704|P2|Overall Study|Lost to Follow-up|2
444866|NCT00420628|1472705|P1|Overall Study|Lost to Follow-up|3
444867|NCT00420628|1472704|P2|Overall Study|Withdrawn by parent or gaurdian|2
444868|NCT00420628|1472705|P1|Overall Study|Withdrawn by parent or gaurdian|5
444869|NCT00420511|1472721|P2|Overall Study|Lost to Follow-up|0
444870|NCT00420511|1472722|P1|Overall Study|Lost to Follow-up|1
444871|NCT00420511|1472721|P2|Overall Study|Adverse Event|1
444872|NCT00420511|1472722|P1|Overall Study|Adverse Event|1
444873|NCT00420420|1472743|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
444874|NCT00420420|1472744|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
444875|NCT00420420|1472743|P2|Overall Study|Withdrawal by Subject|0
444876|NCT00420420|1472744|P1|Overall Study|Withdrawal by Subject|1
444877|NCT00420420|1472743|P2|Overall Study|Protocol Violation|1
444878|NCT00420420|1472744|P1|Overall Study|Protocol Violation|1
444879|NCT00420420|1472743|P2|Overall Study|Adverse Event|3
444880|NCT00420420|1472744|P1|Overall Study|Adverse Event|5
444881|NCT00420407|1472762|P2|Overall Study|Withdrawal by Subject|2
444882|NCT00420407|1472763|P1|Overall Study|Withdrawal by Subject|0
444883|NCT00420407|1472762|P2|Overall Study|subject identified as Jehovah's witness|0
444884|NCT00420407|1472763|P1|Overall Study|subject identified as Jehovah's witness|1
444885|NCT00420407|1472762|P2|Overall Study|subject identified as detainee|0
444886|NCT00420407|1472763|P1|Overall Study|subject identified as detainee|1
444887|NCT00420407|1472762|P2|Overall Study|Physician Decision|1
444888|NCT00420407|1472763|P1|Overall Study|Physician Decision|2
444889|NCT00420407|1472762|P2|Overall Study|Lost to Follow-up|3
444890|NCT00420407|1472763|P1|Overall Study|Lost to Follow-up|0
444891|NCT00420342|1472772|P3|Overall Study|Withdrawal by Subject|0
444892|NCT00420342|1472773|P2|Overall Study|Withdrawal by Subject|2
444893|NCT00420342|1472774|P1|Overall Study|Withdrawal by Subject|0
444894|NCT00420342|1472772|P3|Overall Study|Lost to Follow-up|1
444895|NCT00420342|1472773|P2|Overall Study|Lost to Follow-up|0
444896|NCT00420342|1472774|P1|Overall Study|Lost to Follow-up|1
444897|NCT00420316|1472817|P2|Overall Study|Lost to Follow-up|8
444898|NCT00420316|1472818|P1|Overall Study|Lost to Follow-up|12
444899|NCT00420316|1472817|P2|Overall Study|Withdrawal by Subject|1
444900|NCT00420316|1472818|P1|Overall Study|Withdrawal by Subject|0
444901|NCT00420303|1472842|P2|Overall Study|Physician Decision|1
444902|NCT00420303|1472843|P1|Overall Study|Physician Decision|0
444903|NCT00420303|1472842|P2|Overall Study|Lack of Efficacy|3
444904|NCT00420303|1472843|P1|Overall Study|Lack of Efficacy|0
444905|NCT00420303|1472842|P2|Overall Study|Serious Adverse Event|0
444906|NCT00420303|1472843|P1|Overall Study|Serious Adverse Event|1
444907|NCT00420290|1472855|P2|Overall Study|did not meet inclusion/exclusion|1
444908|NCT00420290|1472856|P1|Overall Study|did not meet inclusion/exclusion|1
444909|NCT00420290|1472855|P2|Overall Study|Withdrawal by Subject|2
444910|NCT00420290|1472856|P1|Overall Study|Withdrawal by Subject|0
444911|NCT00420290|1472855|P2|Overall Study|Adverse Event|1
444912|NCT00420290|1472856|P1|Overall Study|Adverse Event|3
444913|NCT00420238|1472872|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
444914|NCT00420238|1472873|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
444915|NCT00420238|1472872|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
444916|NCT00420238|1472873|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
444917|NCT00420238|1472872|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
444918|NCT00420238|1472873|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
444919|NCT00420238|1472872|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
444920|NCT00420238|1472873|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
444921|NCT00420238|1472872|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
444922|NCT00420238|1472873|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
444923|NCT00420238|1472872|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
444924|NCT00420238|1472873|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
444925|NCT00420212|1473012|P3|Overall Study|Other-Unspecified|18
444926|NCT00420212|1473013|P2|Overall Study|Other-Unspecified|14
444927|NCT00420212|1473014|P1|Overall Study|Other-Unspecified|21
444928|NCT00420212|1473012|P3|Overall Study|Death|1
444929|NCT00420212|1473013|P2|Overall Study|Death|0
444930|NCT00420212|1473014|P1|Overall Study|Death|0
444931|NCT00420212|1473012|P3|Overall Study|Protocol Violation|8
444932|NCT00420212|1473013|P2|Overall Study|Protocol Violation|4
444933|NCT00420212|1473014|P1|Overall Study|Protocol Violation|4
444934|NCT00420212|1473012|P3|Overall Study|Physician Decision|3
444935|NCT00420212|1473013|P2|Overall Study|Physician Decision|4
444936|NCT00420212|1473014|P1|Overall Study|Physician Decision|4
444937|NCT00420212|1473012|P3|Overall Study|Withdrawal by Subject|19
444938|NCT00420212|1473013|P2|Overall Study|Withdrawal by Subject|22
444939|NCT00420212|1473014|P1|Overall Study|Withdrawal by Subject|31
444940|NCT00420212|1473012|P3|Overall Study|Lost to Follow-up|11
444941|NCT00420212|1473013|P2|Overall Study|Lost to Follow-up|11
444942|NCT00420212|1473014|P1|Overall Study|Lost to Follow-up|9
444943|NCT00420212|1473012|P3|Overall Study|Adverse Event|36
444944|NCT00420212|1473013|P2|Overall Study|Adverse Event|40
444945|NCT00420212|1473014|P1|Overall Study|Adverse Event|22
444946|NCT00420199|1473040|P2|Overall Study|Participant no longer met study criteria|0
444947|NCT00420199|1473041|P1|Overall Study|Participant no longer met study criteria|1
444948|NCT00420095|1473107|P2|Overall Study|Lost to Follow-up|0
444949|NCT00420095|1473108|P1|Overall Study|Lost to Follow-up|1
444950|NCT00420095|1473107|P2|Overall Study|Protocol Violation|1
444951|NCT00420095|1473108|P1|Overall Study|Protocol Violation|1
444952|NCT00420095|1473107|P2|Overall Study|Adverse Event|0
444953|NCT00420095|1473108|P1|Overall Study|Adverse Event|1
444954|NCT00420056|1473126|P1|Overall Study|Objective progression or relapse|17
444955|NCT00420004|1473166|P3|Overall Study|Sponsor Decision|1
444956|NCT00420004|1473167|P2|Overall Study|Sponsor Decision|3
444957|NCT00420004|1473168|P1|Overall Study|Sponsor Decision|3
444958|NCT00420004|1473166|P3|Overall Study|Withdrawal by Subject|14
444959|NCT00420004|1473167|P2|Overall Study|Withdrawal by Subject|42
444960|NCT00420004|1473168|P1|Overall Study|Withdrawal by Subject|67
444961|NCT00420004|1473166|P3|Overall Study|Protocol Violation|3
444962|NCT00420004|1473167|P2|Overall Study|Protocol Violation|4
444963|NCT00420004|1473168|P1|Overall Study|Protocol Violation|5
444964|NCT00420004|1473166|P3|Overall Study|Physician Decision|2
444965|NCT00420004|1473167|P2|Overall Study|Physician Decision|4
444966|NCT00420004|1473168|P1|Overall Study|Physician Decision|14
444967|NCT00420004|1473166|P3|Overall Study|Entry Criteria Not Met|0
444968|NCT00420004|1473167|P2|Overall Study|Entry Criteria Not Met|1
444969|NCT00420004|1473168|P1|Overall Study|Entry Criteria Not Met|0
444970|NCT00420004|1473166|P3|Overall Study|Lost to Follow-up|10
444971|NCT00420004|1473167|P2|Overall Study|Lost to Follow-up|12
444972|NCT00420004|1473168|P1|Overall Study|Lost to Follow-up|31
444973|NCT00420004|1473166|P3|Overall Study|Lack of Efficacy|1
444974|NCT00420004|1473167|P2|Overall Study|Lack of Efficacy|4
444975|NCT00420004|1473168|P1|Overall Study|Lack of Efficacy|5
444976|NCT00420004|1473166|P3|Overall Study|Adverse Event|1
444977|NCT00420004|1473167|P2|Overall Study|Adverse Event|1
444978|NCT00420004|1473168|P1|Overall Study|Adverse Event|4
444979|NCT00419952|1473233|P2|Overall Study|Abnormal ECG|0
444980|NCT00419952|1473234|P1|Overall Study|Abnormal ECG|1
444981|NCT00419952|1473233|P2|Overall Study|Diary or medication non-compliance|4
444982|NCT00419952|1473234|P1|Overall Study|Diary or medication non-compliance|2
444983|NCT00419952|1473233|P2|Overall Study|Occurence of 2 or more exacerbations|0
444984|NCT00419952|1473234|P1|Overall Study|Occurence of 2 or more exacerbations|2
444985|NCT00419952|1473233|P2|Overall Study|Intake of prohibited medication|2
444986|NCT00419952|1473234|P1|Overall Study|Intake of prohibited medication|2
444987|NCT00419952|1473233|P2|Overall Study|Incorrectly enrolled|3
444988|NCT00419952|1473234|P1|Overall Study|Incorrectly enrolled|10
444989|NCT00419952|1473233|P2|Overall Study|Physician Decision|3
444990|NCT00419952|1473234|P1|Overall Study|Physician Decision|1
444991|NCT00419952|1473233|P2|Overall Study|Pregnancy|2
444992|NCT00419952|1473234|P1|Overall Study|Pregnancy|4
444993|NCT00419952|1473233|P2|Overall Study|Protocol Violation|24
444994|NCT00419952|1473234|P1|Overall Study|Protocol Violation|32
444995|NCT00419952|1473233|P2|Overall Study|Lost to Follow-up|34
444996|NCT00419952|1473234|P1|Overall Study|Lost to Follow-up|43
444997|NCT00419952|1473233|P2|Overall Study|Withdrawal by Subject|43
444998|NCT00419952|1473234|P1|Overall Study|Withdrawal by Subject|44
444999|NCT00419952|1473233|P2|Overall Study|Adverse Event|10
445000|NCT00419952|1473234|P1|Overall Study|Adverse Event|8
445001|NCT00419926|1473268|P2|Overall Study|Death|1
445002|NCT00419926|1473269|P1|Overall Study|Death|2
445003|NCT00419926|1473268|P2|Overall Study|Lost to Follow-up|2
445004|NCT00419926|1473269|P1|Overall Study|Lost to Follow-up|1
445005|NCT00419926|1473268|P2|Overall Study|Administrative Problem|4
445006|NCT00419926|1473269|P1|Overall Study|Administrative Problem|4
445007|NCT00419926|1473268|P2|Overall Study|Withdrawal by Subject|3
445008|NCT00419926|1473269|P1|Overall Study|Withdrawal by Subject|7
445009|NCT00419770|1473285|P2|Overall Study|Withdrawal by Subject|1
445010|NCT00419770|1473286|P1|Overall Study|Withdrawal by Subject|5
445011|NCT00419757|1473294|P2|Overall Study|Multiple reasons|1
445012|NCT00419757|1473295|P1|Overall Study|Multiple reasons|3
445013|NCT00419757|1473294|P2|Overall Study|Study specific discontinuation criteria|8
445014|NCT00419757|1473295|P1|Overall Study|Study specific discontinuation criteria|4
445015|NCT00419757|1473294|P2|Overall Study|Protocol Violation|3
445016|NCT00419757|1473295|P1|Overall Study|Protocol Violation|2
445017|NCT00419757|1473294|P2|Overall Study|Withdrawal by Subject|1
445018|NCT00419757|1473295|P1|Overall Study|Withdrawal by Subject|7
445019|NCT00419757|1473294|P2|Overall Study|Lost to Follow-up|4
445020|NCT00419757|1473295|P1|Overall Study|Lost to Follow-up|1
445021|NCT00419757|1473294|P2|Overall Study|Adverse Event|4
445022|NCT00419757|1473295|P1|Overall Study|Adverse Event|1
445023|NCT00419744|1473334|P3|Overall Study|Incorrect medication kit dispensed|1
445024|NCT00419744|1473335|P2|Overall Study|Incorrect medication kit dispensed|0
445025|NCT00419744|1473336|P1|Overall Study|Incorrect medication kit dispensed|0
445026|NCT00419744|1473334|P3|Overall Study|Spirometry mouthpiece issues|2
445027|NCT00419744|1473335|P2|Overall Study|Spirometry mouthpiece issues|1
445028|NCT00419744|1473336|P1|Overall Study|Spirometry mouthpiece issues|0
445029|NCT00419744|1473334|P3|Overall Study|Physician Decision|6
445030|NCT00419744|1473335|P2|Overall Study|Physician Decision|5
445031|NCT00419744|1473336|P1|Overall Study|Physician Decision|10
445032|NCT00419744|1473334|P3|Overall Study|Moving out of state|1
445033|NCT00419744|1473335|P2|Overall Study|Moving out of state|0
445034|NCT00419744|1473336|P1|Overall Study|Moving out of state|2
445035|NCT00419744|1473334|P3|Overall Study|Randomized in error|7
445036|NCT00419744|1473335|P2|Overall Study|Randomized in error|6
445037|NCT00419744|1473336|P1|Overall Study|Randomized in error|9
445038|NCT00419744|1473334|P3|Overall Study|Protocol Violation|8
445039|NCT00419744|1473335|P2|Overall Study|Protocol Violation|7
445040|NCT00419744|1473336|P1|Overall Study|Protocol Violation|4
445041|NCT00419744|1473334|P3|Overall Study|Lost to Follow-up|6
445042|NCT00419744|1473335|P2|Overall Study|Lost to Follow-up|10
445043|NCT00419744|1473336|P1|Overall Study|Lost to Follow-up|8
445044|NCT00419744|1473334|P3|Overall Study|Withdrawal by Subject|52
445045|NCT00419744|1473335|P2|Overall Study|Withdrawal by Subject|49
445046|NCT00419744|1473336|P1|Overall Study|Withdrawal by Subject|45
445047|NCT00419744|1473334|P3|Overall Study|Adverse Event|50
445048|NCT00419744|1473335|P2|Overall Study|Adverse Event|40
445049|NCT00419744|1473336|P1|Overall Study|Adverse Event|39
445050|NCT00419393|1473378|P1|Overall Study|Other: Investigator decision|1
445051|NCT00419393|1473378|P1|Overall Study|Other: Other health problems|1
445052|NCT00419393|1473378|P1|Overall Study|Other: Site closure|1
445053|NCT00419393|1473378|P1|Overall Study|Other: Subject had temporal lobectomy|1
445054|NCT00419393|1473378|P1|Overall Study|Other: Sponsor request|3
445055|NCT00419393|1473378|P1|Overall Study|Withdrawal by Subject|7
445056|NCT00419393|1473378|P1|Overall Study|Protocol Violation|5
445057|NCT00419393|1473378|P1|Overall Study|Adverse Event|5
445058|NCT00419380|1473388|P2|Overall Study|Withdrawal by Subject|1
445059|NCT00419380|1473389|P1|Overall Study|Withdrawal by Subject|0
445060|NCT00419380|1473388|P2|Overall Study|Lost to Follow-up|1
445061|NCT00419380|1473389|P1|Overall Study|Lost to Follow-up|0
445062|NCT00419380|1473388|P2|Overall Study|Physician Decision|1
445063|NCT00419380|1473389|P1|Overall Study|Physician Decision|0
445064|NCT00419380|1473388|P2|Overall Study|Lack of Efficacy|7
445065|NCT00419380|1473389|P1|Overall Study|Lack of Efficacy|1
445066|NCT00419341|1473397|P1|Efficacy Period|Termination of study site|1
445067|NCT00419341|1473397|P1|Efficacy Period|Non-compliance|1
445068|NCT00419341|1473397|P1|Efficacy Period|Lost to Follow-up|1
445069|NCT00419341|1473397|P1|Efficacy Period|Protocol Violation|1
445070|NCT00419341|1473397|P1|Efficacy Period|Withdrawal by Subject|6
445071|NCT00419341|1473397|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
445072|NCT00419341|1473397|P1|Wash in/Wash Out Period|Adverse Event|2
445073|NCT00419341|1473397|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
445074|NCT00419263|1473432|P3|Overall Study|Withdrawal by Subject|1
445075|NCT00419263|1473433|P2|Overall Study|Withdrawal by Subject|0
445076|NCT00419263|1473434|P1|Overall Study|Withdrawal by Subject|0
445077|NCT00419263|1473432|P3|Overall Study|Adverse Event|1
445078|NCT00419263|1473433|P2|Overall Study|Adverse Event|0
445079|NCT00419263|1473434|P1|Overall Study|Adverse Event|0
445080|NCT00419263|1473432|P3|Overall Study|Randomized in Error, Not Treated|0
445081|NCT00419263|1473433|P2|Overall Study|Randomized in Error, Not Treated|1
445082|NCT00419263|1473434|P1|Overall Study|Randomized in Error, Not Treated|1
445083|NCT00419263|1473432|P3|Overall Study|Lost to Follow-up|1
445084|NCT00419263|1473433|P2|Overall Study|Lost to Follow-up|1
445085|NCT00419263|1473434|P1|Overall Study|Lost to Follow-up|2
445086|NCT00419159|1473463|P2|Overall Study|Disease progression|76
445087|NCT00419159|1473464|P1|Overall Study|Disease progression|79
445088|NCT00419159|1473463|P2|Overall Study|Death|2
445089|NCT00419159|1473464|P1|Overall Study|Death|2
445090|NCT00419159|1473463|P2|Overall Study|Lost to Follow-up|1
445091|NCT00419159|1473464|P1|Overall Study|Lost to Follow-up|0
445092|NCT00419159|1473463|P2|Overall Study|Withdrawal by Subject|3
445093|NCT00419159|1473464|P1|Overall Study|Withdrawal by Subject|10
445094|NCT00419159|1473463|P2|Overall Study|Protocol Violation|0
445095|NCT00419159|1473464|P1|Overall Study|Protocol Violation|1
445096|NCT00419159|1473463|P2|Overall Study|Subject's no longer requires study drug|1
445097|NCT00419159|1473464|P1|Overall Study|Subject's no longer requires study drug|0
445098|NCT00419159|1473463|P2|Overall Study|Abnormal laboratory value(s)|2
445099|NCT00419159|1473464|P1|Overall Study|Abnormal laboratory value(s)|0
445100|NCT00419159|1473463|P2|Overall Study|Adverse Event|15
445101|NCT00419159|1473464|P1|Overall Study|Adverse Event|7
445102|NCT00419120|1473478|P1|Long Term Follow up Period|study ongoing|10
445103|NCT00419094|1473485|P2|Overall Study|Other: No contact for extended period|1
445104|NCT00419094|1473486|P1|Overall Study|Other: No contact for extended period|0
445105|NCT00419094|1473485|P2|Overall Study|Other: Patient non-compliant|1
445106|NCT00419094|1473486|P1|Overall Study|Other: Patient non-compliant|0
445107|NCT00419094|1473485|P2|Overall Study|Other: Error determining exit criteria|0
445108|NCT00419094|1473486|P1|Overall Study|Other: Error determining exit criteria|1
445109|NCT00419094|1473485|P2|Overall Study|Withdrawal of consent|5
445110|NCT00419094|1473486|P1|Overall Study|Withdrawal of consent|1
445111|NCT00419094|1473485|P2|Overall Study|Protocol Violation|14
445112|NCT00419094|1473486|P1|Overall Study|Protocol Violation|1
445113|NCT00419094|1473485|P2|Overall Study|Lost to Follow-up|2
445114|NCT00419094|1473486|P1|Overall Study|Lost to Follow-up|0
445115|NCT00419094|1473485|P2|Overall Study|Lack of Efficacy|0
445116|NCT00419094|1473486|P1|Overall Study|Lack of Efficacy|1
445117|NCT00419094|1473485|P2|Overall Study|Adverse Event|7
445118|NCT00419094|1473486|P1|Overall Study|Adverse Event|3
445119|NCT00419003|1473500|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
445120|NCT00419003|1473501|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
445121|NCT00419003|1473500|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
445122|NCT00419003|1473501|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
445123|NCT00418938|1473555|P2|Overall Study|Ineligibility Determined|0
445124|NCT00418938|1473556|P1|Overall Study|Ineligibility Determined|1
445125|NCT00418938|1473555|P2|Overall Study|On-going|1
445126|NCT00418938|1473556|P1|Overall Study|On-going|1
445127|NCT00418938|1473555|P2|Overall Study|Adverse Event|1
445128|NCT00418938|1473556|P1|Overall Study|Adverse Event|1
445129|NCT00418938|1473555|P2|Overall Study|Lost to Follow-up|3
445130|NCT00418938|1473556|P1|Overall Study|Lost to Follow-up|1
445131|NCT00418938|1473555|P2|Overall Study|Withdrawal by Subject|15
445132|NCT00418938|1473556|P1|Overall Study|Withdrawal by Subject|16
445133|NCT00418938|1473555|P2|Overall Study|Administrative decision|3
445134|NCT00418938|1473556|P1|Overall Study|Administrative decision|3
445135|NCT00418938|1473555|P2|Overall Study|Reimbursement|0
445136|NCT00418938|1473556|P1|Overall Study|Reimbursement|1
445137|NCT00418886|1473576|P2|Overall Study|randomised but no treatment received|1
445138|NCT00418886|1473577|P1|Overall Study|randomised but no treatment received|0
445139|NCT00418886|1473576|P2|Overall Study|withdrawn due to other reason|0
445140|NCT00418886|1473577|P1|Overall Study|withdrawn due to other reason|1
445141|NCT00418886|1473576|P2|Overall Study|Lost to Follow-up|6
445142|NCT00418886|1473577|P1|Overall Study|Lost to Follow-up|4
445143|NCT00418886|1473576|P2|Overall Study|Withdrawal by Subject|10
445144|NCT00418886|1473577|P1|Overall Study|Withdrawal by Subject|9
445145|NCT00418886|1473576|P2|Overall Study|Death|147
445146|NCT00418886|1473577|P1|Overall Study|Death|122
445147|NCT00418886|1473576|P2|Overall Study|discontinue treatment survival follow up|91
445148|NCT00418886|1473577|P1|Overall Study|discontinue treatment survival follow up|90
445149|NCT00418834|1473603|P2|Overall Study|Withdrawal by Subject|7
445150|NCT00418834|1473604|P1|Overall Study|Withdrawal by Subject|3
445151|NCT00418834|1473603|P2|Overall Study|Protocol Violation|3
445152|NCT00418834|1473604|P1|Overall Study|Protocol Violation|4
445153|NCT00418834|1473603|P2|Overall Study|Lost to Follow-up|1
445154|NCT00418834|1473604|P1|Overall Study|Lost to Follow-up|0
445155|NCT00418834|1473603|P2|Overall Study|Adverse Event|9
445156|NCT00418834|1473604|P1|Overall Study|Adverse Event|16
445157|NCT00418717|1473664|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
445158|NCT00418717|1473664|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
445159|NCT00418691|1473672|P3|Overall Study|Progressive Disease|1
445160|NCT00418691|1473673|P2|Overall Study|Progressive Disease|0
445161|NCT00418691|1473674|P1|Overall Study|Progressive Disease|1
445162|NCT00418691|1473672|P3|Overall Study|Started new medication voiding entry|1
445163|NCT00418691|1473673|P2|Overall Study|Started new medication voiding entry|0
445164|NCT00418691|1473674|P1|Overall Study|Started new medication voiding entry|0
445165|NCT00418691|1473672|P3|Overall Study|Lost to Follow-up|3
445166|NCT00418691|1473673|P2|Overall Study|Lost to Follow-up|2
445167|NCT00418691|1473674|P1|Overall Study|Lost to Follow-up|1
445168|NCT00418665|1473685|P3|Treatment Extension|Death|1
445169|NCT00418665|1473686|P2|Treatment Extension|Death|0
445170|NCT00418665|1473687|P1|Treatment Extension|Death|0
445171|NCT00418665|1473685|P3|Treatment Extension|Physician Decision|1
445172|NCT00418665|1473686|P2|Treatment Extension|Physician Decision|2
445173|NCT00418665|1473687|P1|Treatment Extension|Physician Decision|2
445174|NCT00418665|1473685|P3|Treatment Extension|Requirement for alternative therapy|0
445175|NCT00418665|1473686|P2|Treatment Extension|Requirement for alternative therapy|2
445176|NCT00418665|1473687|P1|Treatment Extension|Requirement for alternative therapy|2
445177|NCT00418665|1473685|P3|Treatment Extension|Withdrawal by Subject|0
445178|NCT00418665|1473686|P2|Treatment Extension|Withdrawal by Subject|0
445179|NCT00418665|1473687|P1|Treatment Extension|Withdrawal by Subject|1
445180|NCT00418665|1473685|P3|Treatment Extension|Adverse Event|0
445181|NCT00418665|1473686|P2|Treatment Extension|Adverse Event|0
445182|NCT00418665|1473687|P1|Treatment Extension|Adverse Event|1
445183|NCT00418665|1473685|P3|Treatment Period|Physician Decision|3
445184|NCT00418665|1473686|P2|Treatment Period|Physician Decision|0
445185|NCT00418665|1473687|P1|Treatment Period|Physician Decision|1
445186|NCT00418665|1473685|P3|Treatment Period|Requirement for alternative therapy|0
445187|NCT00418665|1473686|P2|Treatment Period|Requirement for alternative therapy|0
445188|NCT00418665|1473687|P1|Treatment Period|Requirement for alternative therapy|1
445189|NCT00418665|1473685|P3|Treatment Period|Withdrawal by Subject|1
445190|NCT00418665|1473686|P2|Treatment Period|Withdrawal by Subject|3
445191|NCT00418665|1473687|P1|Treatment Period|Withdrawal by Subject|0
445192|NCT00418665|1473685|P3|Treatment Period|Adverse Event|0
445193|NCT00418665|1473686|P2|Treatment Period|Adverse Event|2
445194|NCT00418665|1473687|P1|Treatment Period|Adverse Event|2
445195|NCT00418665|1473685|P3|Treatment Period|Ineligibility determined|0
445196|NCT00418665|1473686|P2|Treatment Period|Ineligibility determined|1
445197|NCT00418665|1473687|P1|Treatment Period|Ineligibility determined|1
445198|NCT00418561|1473721|P3|Overall Study|Participant's (guardian's) decision|0
445199|NCT00418561|1473722|P2|Overall Study|Participant's (guardian's) decision|1
445200|NCT00418561|1473723|P1|Overall Study|Participant's (guardian's) decision|0
445201|NCT00418522|1473793|P2|Overall Study|Randomized but did not receive treatment|4
445202|NCT00418522|1473794|P1|Overall Study|Randomized but did not receive treatment|7
445203|NCT00418522|1473793|P2|Overall Study|Other|23
445204|NCT00418522|1473794|P1|Overall Study|Other|27
445205|NCT00418522|1473793|P2|Overall Study|Withdrawal by Subject|7
445206|NCT00418522|1473794|P1|Overall Study|Withdrawal by Subject|31
445207|NCT00418522|1473793|P2|Overall Study|Lost to Follow-up|4
445208|NCT00418522|1473794|P1|Overall Study|Lost to Follow-up|10
445209|NCT00418522|1473793|P2|Overall Study|Lack of Efficacy|3
445210|NCT00418522|1473794|P1|Overall Study|Lack of Efficacy|1
445211|NCT00418522|1473793|P2|Overall Study|Adverse Event|1
445212|NCT00418522|1473794|P1|Overall Study|Adverse Event|7
445213|NCT00418379|1473841|P3|Year 5|Any other reason not above-mentioned|3
445214|NCT00418379|1473842|P2|Year 5|Any other reason not above-mentioned|4
445215|NCT00418379|1473843|P1|Year 5|Any other reason not above-mentioned|2
445216|NCT00418379|1473841|P3|Year 5|Adverse Event|0
445217|NCT00418379|1473842|P2|Year 5|Adverse Event|1
445218|NCT00418379|1473843|P1|Year 5|Adverse Event|0
445219|NCT00418379|1473841|P3|Year 4|Any other reason not above-mentioned|0
445220|NCT00418379|1473842|P2|Year 4|Any other reason not above-mentioned|1
445221|NCT00418379|1473843|P1|Year 4|Any other reason not above-mentioned|1
445222|NCT00418379|1473841|P3|Year 4|Withdrawal by Subject|2
445223|NCT00418379|1473842|P2|Year 4|Withdrawal by Subject|3
445224|NCT00418379|1473843|P1|Year 4|Withdrawal by Subject|2
445225|NCT00418379|1473841|P3|Year 4|Adverse Event|0
445226|NCT00418379|1473842|P2|Year 4|Adverse Event|1
445227|NCT00418379|1473843|P1|Year 4|Adverse Event|0
445228|NCT00418379|1473841|P3|Year 3|Any other reason not above-mentioned|1
445229|NCT00418379|1473842|P2|Year 3|Any other reason not above-mentioned|1
445230|NCT00418379|1473843|P1|Year 3|Any other reason not above-mentioned|2
445231|NCT00418379|1473841|P3|Year 3|Withdrawal by Subject|2
445232|NCT00418379|1473842|P2|Year 3|Withdrawal by Subject|1
445233|NCT00418379|1473843|P1|Year 3|Withdrawal by Subject|1
445234|NCT00418379|1473841|P3|Year 2|Any other reason not above-mentioned|6
445235|NCT00418379|1473842|P2|Year 2|Any other reason not above-mentioned|1
445236|NCT00418379|1473843|P1|Year 2|Any other reason not above-mentioned|2
445237|NCT00418379|1473841|P3|Year 2|Withdrawal by Subject|3
445238|NCT00418379|1473842|P2|Year 2|Withdrawal by Subject|1
445239|NCT00418379|1473843|P1|Year 2|Withdrawal by Subject|1
445240|NCT00418379|1473841|P3|Year 2|Adverse Event|1
445241|NCT00418379|1473842|P2|Year 2|Adverse Event|2
445242|NCT00418379|1473843|P1|Year 2|Adverse Event|5
445243|NCT00418379|1473841|P3|Year 1|Any other reason not above-mentioned|7
445244|NCT00418379|1473842|P2|Year 1|Any other reason not above-mentioned|5
445245|NCT00418379|1473843|P1|Year 1|Any other reason not above-mentioned|2
445246|NCT00418379|1473841|P3|Year 1|Withdrawal by Subject|5
445247|NCT00418379|1473842|P2|Year 1|Withdrawal by Subject|8
445248|NCT00418379|1473843|P1|Year 1|Withdrawal by Subject|7
445249|NCT00418379|1473841|P3|Year 1|Adverse Event|3
445250|NCT00418379|1473842|P2|Year 1|Adverse Event|15
445251|NCT00418379|1473843|P1|Year 1|Adverse Event|9
445252|NCT00418314|1473853|P2|Overall Study|Withdrawal by Subject|2
445253|NCT00418314|1473854|P1|Overall Study|Withdrawal by Subject|1
445254|NCT00418184|1473884|P2|Double-blind Phase|Poor compliance|1
445255|NCT00418184|1473885|P1|Double-blind Phase|Poor compliance|3
445256|NCT00418184|1473884|P2|Double-blind Phase|Adverse Event|1
445257|NCT00418184|1473885|P1|Double-blind Phase|Adverse Event|2
445258|NCT00418184|1473884|P2|Double-blind Phase|Withdrawal by Subject|9
445259|NCT00418184|1473885|P1|Double-blind Phase|Withdrawal by Subject|22
445260|NCT00418145|1473893|P1|Overall Study|study terminated|6
445261|NCT00417989|1473968|P2|Overall Study|Physician Decision|2
445262|NCT00417989|1473969|P1|Overall Study|Physician Decision|5
445263|NCT00417989|1473968|P2|Overall Study|Death|1
445264|NCT00417989|1473969|P1|Overall Study|Death|0
445265|NCT00417989|1473968|P2|Overall Study|Protocol Violation|0
445266|NCT00417989|1473969|P1|Overall Study|Protocol Violation|1
445267|NCT00417989|1473968|P2|Overall Study|Lost to Follow-up|6
445268|NCT00417989|1473969|P1|Overall Study|Lost to Follow-up|1
445269|NCT00417989|1473968|P2|Overall Study|Withdrawal by Subject|13
445270|NCT00417989|1473969|P1|Overall Study|Withdrawal by Subject|13
445271|NCT00417976|1473991|P1|Overall Study|Treatment -related toxicity|2
445272|NCT00417976|1473991|P1|Overall Study|Non compliance unrelated to toxicity|1
445273|NCT00417963|1473996|P1|Overall Study|Study device could not be deployed|3
445274|NCT00417963|1473996|P1|Overall Study|Death|17
445275|NCT00417963|1473996|P1|Overall Study|Withdrawal by Subject|18
445276|NCT00417963|1473996|P1|Overall Study|Lost to Follow-up|3
445277|NCT00417885|1474013|P1|Overall Study|Transferred to Another Sunitinib Study|2
445278|NCT00417885|1474013|P1|Overall Study|Objective Progression or Relapse|3
445279|NCT00417885|1474013|P1|Overall Study|Adverse Event|1
445280|NCT00417612|1474024|P2|Overall Study|Lost to Follow-up|0
445281|NCT00417612|1474025|P1|Overall Study|Lost to Follow-up|1
445282|NCT00417612|1474024|P2|Overall Study|Protocol Violation|2
445283|NCT00417612|1474025|P1|Overall Study|Protocol Violation|0
445284|NCT00417612|1474024|P2|Overall Study|Adverse Event|0
445285|NCT00417612|1474025|P1|Overall Study|Adverse Event|2
445286|NCT00417612|1474024|P2|Overall Study|Errant diagnosis|1
445287|NCT00417612|1474025|P1|Overall Study|Errant diagnosis|0
445288|NCT00417482|1474051|P3|Phase B 2nd 16 Weeks|Death|0
445289|NCT00417482|1474052|P2|Phase B 2nd 16 Weeks|Death|1
445290|NCT00417482|1474053|P1|Phase B 2nd 16 Weeks|Death|1
445291|NCT00417482|1474051|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
445292|NCT00417482|1474052|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
445293|NCT00417482|1474053|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
445294|NCT00417482|1474051|P3|Phase B 2nd 16 Weeks|Adverse Event|1
445295|NCT00417482|1474052|P2|Phase B 2nd 16 Weeks|Adverse Event|0
445296|NCT00417482|1474053|P1|Phase B 2nd 16 Weeks|Adverse Event|0
445297|NCT00417482|1474051|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
445298|NCT00417482|1474052|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
445299|NCT00417482|1474053|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
445300|NCT00417482|1474051|P3|Phase B 1st 16 Weeks|Death|0
445301|NCT00417482|1474052|P2|Phase B 1st 16 Weeks|Death|0
445302|NCT00417482|1474053|P1|Phase B 1st 16 Weeks|Death|1
445303|NCT00417482|1474051|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
445304|NCT00417482|1474052|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
445305|NCT00417482|1474053|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
445306|NCT00417482|1474051|P3|Phase B 1st 16 Weeks|Adverse Event|1
445307|NCT00417482|1474052|P2|Phase B 1st 16 Weeks|Adverse Event|0
445308|NCT00417482|1474053|P1|Phase B 1st 16 Weeks|Adverse Event|2
445309|NCT00417482|1474051|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
445310|NCT00417482|1474052|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
445311|NCT00417482|1474053|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
445312|NCT00417248|1474092|P1|Overall Study|Lack of Efficacy|1
445313|NCT00417248|1474092|P1|Overall Study|Death|1
445314|NCT00417248|1474092|P1|Overall Study|Study Terminated|6
445315|NCT00417170|1474099|P2|Overall Study|Lost to Follow-up|1
445316|NCT00417170|1474100|P1|Overall Study|Lost to Follow-up|0
445317|NCT00417170|1474099|P2|Overall Study|Withdrawal by Subject|1
445318|NCT00417170|1474100|P1|Overall Study|Withdrawal by Subject|1
445319|NCT00417170|1474099|P2|Overall Study|Adverse Event|1
445320|NCT00417170|1474100|P1|Overall Study|Adverse Event|1
445321|NCT00417079|1474116|P2|Overall Study|abnormal liver function tests|1
445322|NCT00417079|1474117|P1|Overall Study|abnormal liver function tests|0
445323|NCT00417079|1474116|P2|Overall Study|Patient unable to come to the clinic|1
445324|NCT00417079|1474117|P1|Overall Study|Patient unable to come to the clinic|0
445325|NCT00417079|1474116|P2|Overall Study|Withdrawal by subject's family|1
445326|NCT00417079|1474117|P1|Overall Study|Withdrawal by subject's family|0
445327|NCT00417079|1474116|P2|Overall Study|Screening error|1
445328|NCT00417079|1474117|P1|Overall Study|Screening error|2
445329|NCT00417079|1474116|P2|Overall Study|Clinical deterioration|0
445330|NCT00417079|1474117|P1|Overall Study|Clinical deterioration|1
445331|NCT00417079|1474116|P2|Overall Study|Non-confirmed Disease progression|1
445332|NCT00417079|1474117|P1|Overall Study|Non-confirmed Disease progression|1
445333|NCT00417079|1474116|P2|Overall Study|Investigator's decision|4
445334|NCT00417079|1474117|P1|Overall Study|Investigator's decision|1
445335|NCT00417079|1474116|P2|Overall Study|Screened failure|1
445336|NCT00417079|1474117|P1|Overall Study|Screened failure|2
445337|NCT00417079|1474116|P2|Overall Study|Not treated|7
445338|NCT00417079|1474117|P1|Overall Study|Not treated|6
445339|NCT00417079|1474116|P2|Overall Study|Withdrawal by Subject|8
445340|NCT00417079|1474117|P1|Overall Study|Withdrawal by Subject|17
445341|NCT00417079|1474116|P2|Overall Study|Lost to Follow-up|0
445342|NCT00417079|1474117|P1|Overall Study|Lost to Follow-up|2
445343|NCT00417079|1474116|P2|Overall Study|Non-compliance to protocol|1
445344|NCT00417079|1474117|P1|Overall Study|Non-compliance to protocol|0
445345|NCT00417079|1474116|P2|Overall Study|Adverse Event|67
445346|NCT00417079|1474117|P1|Overall Study|Adverse Event|32
445347|NCT00417079|1474116|P2|Overall Study|Disease progression|180
445348|NCT00417079|1474117|P1|Overall Study|Disease progression|267
445349|NCT00417027|1474140|P3|Overall Study|Protocol Violation|5
445350|NCT00417027|1474141|P2|Overall Study|Protocol Violation|5
445351|NCT00417027|1474142|P1|Overall Study|Protocol Violation|0
445352|NCT00416884|1474168|P1|Overall Study|Study terminated due to low accrual|1
445353|NCT00416715|1474176|P1|Overall Study|Vitamin D levels not evaluable|8
445354|NCT00416715|1474176|P1|Overall Study|Not evaluable for joint aches|7
445355|NCT00416624|1474187|P4|Overall Study|Cancel|0
445356|NCT00416624|1474188|P3|Overall Study|Cancel|0
445357|NCT00416624|1474189|P2|Overall Study|Cancel|0
445358|NCT00416624|1474190|P1|Overall Study|Cancel|1
445359|NCT00416624|1474187|P4|Overall Study|Not Specified|5
445360|NCT00416624|1474188|P3|Overall Study|Not Specified|5
445361|NCT00416624|1474189|P2|Overall Study|Not Specified|11
445362|NCT00416624|1474190|P1|Overall Study|Not Specified|8
445363|NCT00416624|1474187|P4|Overall Study|Adverse Event|2
445364|NCT00416624|1474188|P3|Overall Study|Adverse Event|2
445365|NCT00416624|1474189|P2|Overall Study|Adverse Event|3
445366|NCT00416624|1474190|P1|Overall Study|Adverse Event|8
445367|NCT00416624|1474187|P4|Overall Study|Death|1
445368|NCT00416624|1474188|P3|Overall Study|Death|7
445369|NCT00416624|1474189|P2|Overall Study|Death|7
445370|NCT00416624|1474190|P1|Overall Study|Death|4
445371|NCT00416624|1474187|P4|Overall Study|Withdrawal by Subject|9
445372|NCT00416624|1474188|P3|Overall Study|Withdrawal by Subject|4
445373|NCT00416624|1474189|P2|Overall Study|Withdrawal by Subject|6
445374|NCT00416624|1474190|P1|Overall Study|Withdrawal by Subject|1
445375|NCT00416598|1474244|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
445376|NCT00416598|1474244|P1|Decitabine Maintenance|Alternative treatment|2
445377|NCT00416598|1474244|P1|Decitabine Maintenance|Progression/relapse|38
445378|NCT00416598|1474244|P1|Decitabine Maintenance|Withdrawal by Subject|18
445379|NCT00416598|1474244|P1|Decitabine Maintenance|Adverse Event|5
445380|NCT00416598|1474244|P1|Induction & Intensification|Failed induction|87
445381|NCT00416598|1474244|P1|Induction & Intensification|Relapse/progression|29
445382|NCT00416598|1474244|P1|Induction & Intensification|Physician discretion/other medical issue|45
445383|NCT00416598|1474244|P1|Induction & Intensification|Alternative Treatment|135
445384|NCT00416598|1474244|P1|Induction & Intensification|Withdrawal by Subject|46
445385|NCT00416598|1474244|P1|Induction & Intensification|Death|32
445386|NCT00416598|1474244|P1|Induction & Intensification|Adverse Event|38
445387|NCT00416520|1474270|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
445388|NCT00416520|1474271|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
445389|NCT00416520|1474272|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
445390|NCT00416520|1474273|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
445391|NCT00416520|1474270|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
445392|NCT00416520|1474271|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
445393|NCT00416520|1474272|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
445394|NCT00416520|1474273|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
445395|NCT00416520|1474270|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
445396|NCT00416520|1474271|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
445397|NCT00416520|1474272|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
445398|NCT00416520|1474273|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
445399|NCT00416520|1474270|P4|Open-label Period|Other Reasons|0
445400|NCT00416520|1474271|P3|Open-label Period|Other Reasons|0
445401|NCT00416520|1474272|P2|Open-label Period|Other Reasons|12
445402|NCT00416520|1474273|P1|Open-label Period|Other Reasons|3
445403|NCT00416520|1474270|P4|Open-label Period|Withdrawal by Subject|0
445404|NCT00416520|1474271|P3|Open-label Period|Withdrawal by Subject|0
445405|NCT00416520|1474272|P2|Open-label Period|Withdrawal by Subject|5
445406|NCT00416520|1474273|P1|Open-label Period|Withdrawal by Subject|16
445407|NCT00416520|1474270|P4|Open-label Period|Protocol Violation|0
445408|NCT00416520|1474271|P3|Open-label Period|Protocol Violation|0
445409|NCT00416520|1474272|P2|Open-label Period|Protocol Violation|3
445410|NCT00416520|1474273|P1|Open-label Period|Protocol Violation|3
445411|NCT00416520|1474270|P4|Open-label Period|Lack of Efficacy|0
445412|NCT00416520|1474271|P3|Open-label Period|Lack of Efficacy|0
445413|NCT00416520|1474272|P2|Open-label Period|Lack of Efficacy|1
445414|NCT00416520|1474273|P1|Open-label Period|Lack of Efficacy|8
445415|NCT00416520|1474270|P4|Open-label Period|Death|0
445416|NCT00416520|1474271|P3|Open-label Period|Death|0
445417|NCT00416520|1474272|P2|Open-label Period|Death|1
445418|NCT00416520|1474273|P1|Open-label Period|Death|2
445419|NCT00416520|1474270|P4|Open-label Period|Adverse Event|0
445420|NCT00416520|1474271|P3|Open-label Period|Adverse Event|0
445421|NCT00416520|1474272|P2|Open-label Period|Adverse Event|10
445422|NCT00416520|1474273|P1|Open-label Period|Adverse Event|28
445423|NCT00416455|1474302|P2|Overall Study|Inadequate pathology|2
445424|NCT00416455|1474303|P1|Overall Study|Inadequate pathology|11
445425|NCT00416455|1474302|P2|Overall Study|PET / CT poor quality|1
445426|NCT00416455|1474303|P1|Overall Study|PET / CT poor quality|2
445427|NCT00416455|1474302|P2|Overall Study|PET / CT not done|5
445428|NCT00416455|1474303|P1|Overall Study|PET / CT not done|3
445429|NCT00416195|1474317|P2|Overall Study|Not Specified|1
445430|NCT00416195|1474318|P1|Overall Study|Not Specified|0
445431|NCT00416195|1474317|P2|Overall Study|Protocol Violation|1
445432|NCT00416195|1474318|P1|Overall Study|Protocol Violation|1
445433|NCT00416195|1474317|P2|Overall Study|Adverse Event|2
445434|NCT00416195|1474318|P1|Overall Study|Adverse Event|1
445435|NCT00416078|1474343|P2|Overall Study|Lost to Follow-up|2
445436|NCT00416078|1474344|P1|Overall Study|Lost to Follow-up|4
445437|NCT00416078|1474343|P2|Overall Study|Physician Decision|0
445438|NCT00416078|1474344|P1|Overall Study|Physician Decision|1
445439|NCT00416078|1474343|P2|Overall Study|Withdrawal by Subject|2
445440|NCT00416078|1474344|P1|Overall Study|Withdrawal by Subject|3
445441|NCT00416078|1474343|P2|Overall Study|Death|4
445442|NCT00416078|1474344|P1|Overall Study|Death|3
445443|NCT00415909|1474360|P1|Overall Study|Death|1
445444|NCT00415909|1474360|P1|Overall Study|Withdrawal by Subject|2
445445|NCT00415623|1474386|P2|Overall Study|Withdrawal by Subject|1
445446|NCT00415623|1474387|P1|Overall Study|Withdrawal by Subject|1
445447|NCT00415623|1474386|P2|Overall Study|Death|0
445448|NCT00415623|1474387|P1|Overall Study|Death|1
445449|NCT00415623|1474386|P2|Overall Study|Adverse Event|4
445450|NCT00415623|1474387|P1|Overall Study|Adverse Event|3
445451|NCT00415610|1474414|P3|Overall Study|Death|5
445452|NCT00415610|1474415|P2|Overall Study|Death|2
445453|NCT00415610|1474416|P1|Overall Study|Death|3
445454|NCT00415597|1474436|P1|Treatment|Multiple Reasons|1
445455|NCT00415597|1474436|P1|Treatment|Sponsor Decision|1
445456|NCT00415597|1474436|P1|Treatment|Administrative|3
445457|NCT00415597|1474436|P1|Treatment|Drug Screen|2
445458|NCT00415597|1474436|P1|Treatment|Lost to Follow-up|28
445459|NCT00415597|1474436|P1|Treatment|Withdrawal by Subject|51
445460|NCT00415597|1474436|P1|Treatment|Physician Decision|3
445461|NCT00415597|1474436|P1|Treatment|Protocol Violation|67
445462|NCT00415597|1474436|P1|Treatment|Lack of Efficacy|39
445463|NCT00415597|1474436|P1|Treatment|Adverse Event|110
445464|NCT00415597|1474436|P1|Enrollment|Protocol Violation|1
445465|NCT00415597|1474436|P1|Enrollment|Withdrawal by Subject|1
445466|NCT00415532|1474444|P2|Safety Follow Up Period|Requirement for alternative therapy|1
445467|NCT00415532|1474445|P1|Safety Follow Up Period|Requirement for alternative therapy|0
445468|NCT00415532|1474444|P2|Safety Follow Up Period|Noncompliance|0
445469|NCT00415532|1474445|P1|Safety Follow Up Period|Noncompliance|1
445470|NCT00415532|1474444|P2|Safety Follow Up Period|Ineligibility determined|1
445471|NCT00415532|1474445|P1|Safety Follow Up Period|Ineligibility determined|1
445472|NCT00415532|1474444|P2|Safety Follow Up Period|Other|4
445473|NCT00415532|1474445|P1|Safety Follow Up Period|Other|1
445474|NCT00415532|1474444|P2|Safety Follow Up Period|Withdrawal by Subject|3
445475|NCT00415532|1474445|P1|Safety Follow Up Period|Withdrawal by Subject|2
445476|NCT00415532|1474444|P2|Safety Follow Up Period|Death|0
445477|NCT00415532|1474445|P1|Safety Follow Up Period|Death|3
445478|NCT00415532|1474444|P2|Safety Follow Up Period|Adverse Event|3
445479|NCT00415532|1474445|P1|Safety Follow Up Period|Adverse Event|1
445480|NCT00415532|1474444|P2|Treatment Period|Requirement for alternative therapy|0
445481|NCT00415532|1474445|P1|Treatment Period|Requirement for alternative therapy|1
445482|NCT00415532|1474444|P2|Treatment Period|Noncompliance|1
445483|NCT00415532|1474445|P1|Treatment Period|Noncompliance|1
445484|NCT00415532|1474444|P2|Treatment Period|Ineligibility determined|1
445485|NCT00415532|1474445|P1|Treatment Period|Ineligibility determined|1
445486|NCT00415532|1474444|P2|Treatment Period|Other|2
445487|NCT00415532|1474445|P1|Treatment Period|Other|2
445488|NCT00415532|1474444|P2|Treatment Period|Withdrawal by Subject|6
445489|NCT00415532|1474445|P1|Treatment Period|Withdrawal by Subject|6
445490|NCT00415532|1474444|P2|Treatment Period|Protocol Violation|0
445491|NCT00415532|1474445|P1|Treatment Period|Protocol Violation|1
445492|NCT00415532|1474444|P2|Treatment Period|Lost to Follow-up|1
445493|NCT00415532|1474445|P1|Treatment Period|Lost to Follow-up|1
445494|NCT00415532|1474444|P2|Treatment Period|Death|1
445495|NCT00415532|1474445|P1|Treatment Period|Death|2
445496|NCT00415532|1474444|P2|Treatment Period|Adverse Event|3
445497|NCT00415532|1474445|P1|Treatment Period|Adverse Event|2
445498|NCT00415519|1474467|P2|Overall Study|Patient’s convenience|0
445499|NCT00415519|1474468|P1|Overall Study|Patient’s convenience|1
445500|NCT00415519|1474467|P2|Overall Study|Withdrawal by Subject|0
445501|NCT00415519|1474468|P1|Overall Study|Withdrawal by Subject|2
445502|NCT00415519|1474467|P2|Overall Study|Adverse Event|0
445503|NCT00415519|1474468|P1|Overall Study|Adverse Event|1
445504|NCT00415194|1474508|P2|Overall Study|Death Due to AE (Other Causes)|15
445505|NCT00415194|1474509|P1|Overall Study|Death Due to AE (Other Causes)|27
445506|NCT00415194|1474508|P2|Overall Study|Death Due to Procedural Related AE|1
445507|NCT00415194|1474509|P1|Overall Study|Death Due to Procedural Related AE|0
445508|NCT00415194|1474508|P2|Overall Study|Death Due to Study Drug Related AE|1
445509|NCT00415194|1474509|P1|Overall Study|Death Due to Study Drug Related AE|11
445510|NCT00415194|1474508|P2|Overall Study|Death Due to Study Disease|29
445511|NCT00415194|1474509|P1|Overall Study|Death Due to Study Disease|26
445512|NCT00415194|1474508|P2|Overall Study|Withdrawal by Subject|21
445513|NCT00415194|1474509|P1|Overall Study|Withdrawal by Subject|28
445514|NCT00415194|1474508|P2|Overall Study|Protocol Violation|2
445515|NCT00415194|1474509|P1|Overall Study|Protocol Violation|4
445516|NCT00415194|1474508|P2|Overall Study|Progressive Disease|217
445517|NCT00415194|1474509|P1|Overall Study|Progressive Disease|180
445518|NCT00415194|1474508|P2|Overall Study|Physician Decision|16
445519|NCT00415194|1474509|P1|Overall Study|Physician Decision|10
445520|NCT00415194|1474508|P2|Overall Study|Lost to Follow-up|0
445521|NCT00415194|1474509|P1|Overall Study|Lost to Follow-up|1
445522|NCT00415194|1474508|P2|Overall Study|Entry Criteria Not Met|8
445523|NCT00415194|1474509|P1|Overall Study|Entry Criteria Not Met|4
445524|NCT00415194|1474508|P2|Overall Study|Adverse Event|32
445525|NCT00415194|1474509|P1|Overall Study|Adverse Event|37
445526|NCT00415168|1474525|P1|Overall Study|Withdrawal by Subject|6
445527|NCT00415168|1474525|P1|Overall Study|Sponsor Decision|4
445528|NCT00415168|1474525|P1|Overall Study|Physician Decision|13
445529|NCT00415168|1474525|P1|Overall Study|Lost to Follow-up|3
445530|NCT00415168|1474525|P1|Overall Study|Death|26
445531|NCT00415051|1474535|P1|Overall Study|Protocol Violation|1
445532|NCT00414973|1474546|P4|Overall Study|Death|0
445533|NCT00414973|1474547|P3|Overall Study|Death|1
445534|NCT00414973|1474548|P2|Overall Study|Death|0
445535|NCT00414973|1474549|P1|Overall Study|Death|0
445536|NCT00414973|1474546|P4|Overall Study|Sponsor Decision|0
445537|NCT00414973|1474547|P3|Overall Study|Sponsor Decision|0
445538|NCT00414973|1474548|P2|Overall Study|Sponsor Decision|0
445539|NCT00414973|1474549|P1|Overall Study|Sponsor Decision|1
445540|NCT00414973|1474546|P4|Overall Study|Lost to Follow-up|0
445541|NCT00414973|1474547|P3|Overall Study|Lost to Follow-up|0
445542|NCT00414973|1474548|P2|Overall Study|Lost to Follow-up|2
445543|NCT00414973|1474549|P1|Overall Study|Lost to Follow-up|0
445544|NCT00414973|1474546|P4|Overall Study|Protocol Violation|0
445545|NCT00414973|1474547|P3|Overall Study|Protocol Violation|0
445546|NCT00414973|1474548|P2|Overall Study|Protocol Violation|4
445547|NCT00414973|1474549|P1|Overall Study|Protocol Violation|3
445548|NCT00414973|1474546|P4|Overall Study|Adverse Event|0
445549|NCT00414973|1474547|P3|Overall Study|Adverse Event|1
445550|NCT00414973|1474548|P2|Overall Study|Adverse Event|0
445551|NCT00414973|1474549|P1|Overall Study|Adverse Event|10
445552|NCT00414973|1474546|P4|Overall Study|Withdrawal by Subject|0
445553|NCT00414973|1474547|P3|Overall Study|Withdrawal by Subject|1
445554|NCT00414973|1474548|P2|Overall Study|Withdrawal by Subject|4
445555|NCT00414973|1474549|P1|Overall Study|Withdrawal by Subject|14
445556|NCT00414908|1474569|P2|Overall Study|Protocol Violation|1
445557|NCT00414908|1474570|P1|Overall Study|Protocol Violation|1
445558|NCT00414726|1474607|P2|Overall Study|Withdrawal by Subject|1
445559|NCT00414726|1474608|P1|Overall Study|Withdrawal by Subject|0
445560|NCT00414661|1474643|P4|Overall Study|Other|0
445561|NCT00414661|1474644|P3|Overall Study|Other|0
445562|NCT00414661|1474645|P2|Overall Study|Other|3
445563|NCT00414661|1474646|P1|Overall Study|Other|6
445564|NCT00414661|1474643|P4|Overall Study|Withdrawal by Subject|2
445565|NCT00414661|1474644|P3|Overall Study|Withdrawal by Subject|2
445566|NCT00414661|1474645|P2|Overall Study|Withdrawal by Subject|2
445567|NCT00414661|1474646|P1|Overall Study|Withdrawal by Subject|5
445568|NCT00414661|1474643|P4|Overall Study|Lost to Follow-up|1
445569|NCT00414661|1474644|P3|Overall Study|Lost to Follow-up|0
445570|NCT00414661|1474645|P2|Overall Study|Lost to Follow-up|4
445571|NCT00414661|1474646|P1|Overall Study|Lost to Follow-up|1
445572|NCT00414661|1474643|P4|Overall Study|Death|0
445573|NCT00414661|1474644|P3|Overall Study|Death|0
445574|NCT00414661|1474645|P2|Overall Study|Death|5
445575|NCT00414661|1474646|P1|Overall Study|Death|2
445576|NCT00414609|1474691|P3|Extension Study|Death|17
445577|NCT00414609|1474692|P2|Extension Study|Death|0
445578|NCT00414609|1474693|P1|Extension Study|Death|0
445579|NCT00414609|1474691|P3|Extension Study|Administrative problems|1
445580|NCT00414609|1474692|P2|Extension Study|Administrative problems|0
445581|NCT00414609|1474693|P1|Extension Study|Administrative problems|0
445582|NCT00414609|1474691|P3|Extension Study|Lost to Follow-up|10
445583|NCT00414609|1474692|P2|Extension Study|Lost to Follow-up|0
445584|NCT00414609|1474693|P1|Extension Study|Lost to Follow-up|0
445585|NCT00414609|1474691|P3|Extension Study|Withdrawal by Subject|13
445586|NCT00414609|1474692|P2|Extension Study|Withdrawal by Subject|0
445587|NCT00414609|1474693|P1|Extension Study|Withdrawal by Subject|0
445588|NCT00414609|1474691|P3|Extension Study|Unsatisfactory therapeutic effect|2
445589|NCT00414609|1474692|P2|Extension Study|Unsatisfactory therapeutic effect|0
445590|NCT00414609|1474693|P1|Extension Study|Unsatisfactory therapeutic effect|0
445591|NCT00414609|1474691|P3|Extension Study|Adverse Event|14
445592|NCT00414609|1474692|P2|Extension Study|Adverse Event|0
445593|NCT00414609|1474693|P1|Extension Study|Adverse Event|0
445594|NCT00414609|1474691|P3|Core Study|Death|0
445595|NCT00414609|1474692|P2|Core Study|Death|14
445596|NCT00414609|1474693|P1|Core Study|Death|7
445597|NCT00414609|1474691|P3|Core Study|Administrative problems|0
445598|NCT00414609|1474692|P2|Core Study|Administrative problems|2
445599|NCT00414609|1474693|P1|Core Study|Administrative problems|0
445600|NCT00414609|1474691|P3|Core Study|Lost to Follow-up|0
445601|NCT00414609|1474692|P2|Core Study|Lost to Follow-up|4
445602|NCT00414609|1474693|P1|Core Study|Lost to Follow-up|7
445603|NCT00414609|1474691|P3|Core Study|Patient withdrew consent|0
445604|NCT00414609|1474692|P2|Core Study|Patient withdrew consent|11
445605|NCT00414609|1474693|P1|Core Study|Patient withdrew consent|10
445606|NCT00414609|1474691|P3|Core Study|Protocol deviation|0
445607|NCT00414609|1474692|P2|Core Study|Protocol deviation|1
445608|NCT00414609|1474693|P1|Core Study|Protocol deviation|0
445609|NCT00414609|1474691|P3|Core Study|Abnormal test procedure results|0
445610|NCT00414609|1474692|P2|Core Study|Abnormal test procedure results|1
445611|NCT00414609|1474693|P1|Core Study|Abnormal test procedure results|1
445612|NCT00414609|1474691|P3|Core Study|Abnormal laboratory values|0
445613|NCT00414609|1474692|P2|Core Study|Abnormal laboratory values|1
445614|NCT00414609|1474693|P1|Core Study|Abnormal laboratory values|0
445615|NCT00414609|1474691|P3|Core Study|Adverse Event|0
445616|NCT00414609|1474692|P2|Core Study|Adverse Event|11
445617|NCT00414609|1474693|P1|Core Study|Adverse Event|9
445618|NCT00414596|1474716|P1|Overall Study|Protocol Violation|2
445619|NCT00414544|1474725|P1|Overall Study|Lost to Follow-up|14
445620|NCT00414466|1474748|P4|Overall Study|Withdrawn by Sponsor|0
445621|NCT00414466|1474749|P3|Overall Study|Withdrawn by Sponsor|0
445622|NCT00414466|1474750|P2|Overall Study|Withdrawn by Sponsor|0
445623|NCT00414466|1474751|P1|Overall Study|Withdrawn by Sponsor|1
445624|NCT00414466|1474748|P4|Overall Study|Lack of Efficacy|0
445625|NCT00414466|1474749|P3|Overall Study|Lack of Efficacy|0
445626|NCT00414466|1474750|P2|Overall Study|Lack of Efficacy|0
445627|NCT00414466|1474751|P1|Overall Study|Lack of Efficacy|1
445628|NCT00414466|1474748|P4|Overall Study|Adverse Event|1
445629|NCT00414466|1474749|P3|Overall Study|Adverse Event|1
445630|NCT00414466|1474750|P2|Overall Study|Adverse Event|0
445631|NCT00414466|1474751|P1|Overall Study|Adverse Event|0
445632|NCT00414453|1474769|P1|Overall Study|Abnormal lab work|16
445633|NCT00414440|1474817|P2|Extension Period|Not included in follow up period|8
445634|NCT00414440|1474818|P1|Extension Period|Not included in follow up period|18
445635|NCT00414440|1474817|P2|Extension Period|Withdrawal by Subject|7
445636|NCT00414440|1474818|P1|Extension Period|Withdrawal by Subject|9
445637|NCT00414440|1474817|P2|Extension Period|Death|2
445638|NCT00414440|1474818|P1|Extension Period|Death|1
445639|NCT00414440|1474817|P2|Extension Period|Administrative|16
445640|NCT00414440|1474818|P1|Extension Period|Administrative|16
445641|NCT00414440|1474817|P2|Extension Period|Other|1
445642|NCT00414440|1474818|P1|Extension Period|Other|1
445643|NCT00414440|1474817|P2|Extension Period|Did not consent to continue follow up|54
445644|NCT00414440|1474818|P1|Extension Period|Did not consent to continue follow up|61
445645|NCT00414440|1474817|P2|Extension Period|Lost to Follow-up|52
445646|NCT00414440|1474818|P1|Extension Period|Lost to Follow-up|44
445647|NCT00414440|1474817|P2|Core Period|Withdrawal by Subject|32
445648|NCT00414440|1474818|P1|Core Period|Withdrawal by Subject|70
445649|NCT00414388|1474832|P1|Overall Study|Adverse Event|1
445650|NCT00414310|1474840|P2|Overall Study|Not treated|0
445651|NCT00414310|1474841|P1|Overall Study|Not treated|1
445652|NCT00414050|1474875|P4|Overall Study|Subject Moved|1
445653|NCT00414050|1474876|P3|Overall Study|Subject Moved|0
445654|NCT00414050|1474877|P2|Overall Study|Subject Moved|0
445655|NCT00414050|1474878|P1|Overall Study|Subject Moved|0
445656|NCT00414050|1474875|P4|Overall Study|Subject discontinued for other reason|1
445657|NCT00414050|1474876|P3|Overall Study|Subject discontinued for other reason|2
445658|NCT00414050|1474877|P2|Overall Study|Subject discontinued for other reason|2
445659|NCT00414050|1474878|P1|Overall Study|Subject discontinued for other reason|1
445660|NCT00414050|1474875|P4|Overall Study|Withdrawal by Subject|4
445661|NCT00414050|1474876|P3|Overall Study|Withdrawal by Subject|2
445662|NCT00414050|1474877|P2|Overall Study|Withdrawal by Subject|3
445663|NCT00414050|1474878|P1|Overall Study|Withdrawal by Subject|5
445664|NCT00414050|1474875|P4|Overall Study|Lost to Follow-up|1
445665|NCT00414050|1474876|P3|Overall Study|Lost to Follow-up|1
445666|NCT00414050|1474877|P2|Overall Study|Lost to Follow-up|2
445667|NCT00414050|1474878|P1|Overall Study|Lost to Follow-up|2
445668|NCT00414050|1474875|P4|Overall Study|Adverse Event|1
445669|NCT00414050|1474876|P3|Overall Study|Adverse Event|1
445670|NCT00414050|1474877|P2|Overall Study|Adverse Event|1
445671|NCT00414050|1474878|P1|Overall Study|Adverse Event|1
445672|NCT00414011|1474892|P1|Overall Study|Withdrawal by Subject|2
445673|NCT00414011|1474892|P1|Overall Study|Physician Decision|3
445674|NCT00413972|1474901|P4|Overall Study|Not Specified|1
445675|NCT00413972|1474902|P3|Overall Study|Not Specified|0
445676|NCT00413972|1474903|P2|Overall Study|Not Specified|0
445677|NCT00413972|1474904|P1|Overall Study|Not Specified|0
445678|NCT00413972|1474901|P4|Overall Study|Protocol Violation|0
445679|NCT00413972|1474902|P3|Overall Study|Protocol Violation|2
445680|NCT00413972|1474903|P2|Overall Study|Protocol Violation|0
445681|NCT00413972|1474904|P1|Overall Study|Protocol Violation|0
445682|NCT00413972|1474901|P4|Overall Study|Withdrawal by Subject|2
445683|NCT00413972|1474902|P3|Overall Study|Withdrawal by Subject|7
445684|NCT00413972|1474903|P2|Overall Study|Withdrawal by Subject|5
445685|NCT00413972|1474904|P1|Overall Study|Withdrawal by Subject|4
445686|NCT00413972|1474901|P4|Overall Study|Lost to Follow-up|0
445687|NCT00413972|1474902|P3|Overall Study|Lost to Follow-up|1
445688|NCT00413972|1474903|P2|Overall Study|Lost to Follow-up|2
445689|NCT00413972|1474904|P1|Overall Study|Lost to Follow-up|1
445690|NCT00413972|1474901|P4|Overall Study|Adverse Event|0
445691|NCT00413972|1474902|P3|Overall Study|Adverse Event|0
445692|NCT00413972|1474903|P2|Overall Study|Adverse Event|1
445693|NCT00413972|1474904|P1|Overall Study|Adverse Event|2
445694|NCT00413959|1474914|P1|Overall Study|Pt had only one cycle.|1
445695|NCT00413920|1474921|P2|Overall Study|Graft Loss|3
445696|NCT00413920|1474922|P1|Overall Study|Graft Loss|5
445697|NCT00413920|1474921|P2|Overall Study|Death|5
445698|NCT00413920|1474922|P1|Overall Study|Death|3
445699|NCT00413920|1474921|P2|Overall Study|Lack of Efficacy|9
445700|NCT00413920|1474922|P1|Overall Study|Lack of Efficacy|11
445701|NCT00413920|1474921|P2|Overall Study|Adverse Event|11
445702|NCT00413920|1474922|P1|Overall Study|Adverse Event|9
445703|NCT00413894|1474937|P1|Overall Study|Other|18
445704|NCT00413894|1474937|P1|Overall Study|Protocol Violation|11
445705|NCT00413894|1474937|P1|Overall Study|Adverse Event|28
445706|NCT00413894|1474937|P1|Overall Study|Hb <10 grams/deciliter|12
445707|NCT00413894|1474937|P1|Overall Study|Administrative Reasons|1
445708|NCT00413894|1474937|P1|Overall Study|Withdrawal by Subject|10
445709|NCT00413777|1474954|P2|Fixed-dose Period|Withdrew Consent|1
445710|NCT00413777|1474955|P1|Fixed-dose Period|Withdrew Consent|0
445711|NCT00413777|1474954|P2|Fixed-dose Period|Met Withdrawal Criteria|0
445712|NCT00413777|1474955|P1|Fixed-dose Period|Met Withdrawal Criteria|1
445713|NCT00413777|1474954|P2|Fixed-dose Period|Adverse Event|1
445714|NCT00413777|1474955|P1|Fixed-dose Period|Adverse Event|2
445715|NCT00413777|1474954|P2|Fixed-dose Period|Lost to Follow-up|1
445716|NCT00413777|1474955|P1|Fixed-dose Period|Lost to Follow-up|1
445717|NCT00413699|1475003|P2|Overall Study|No longer willing to participate|368
445718|NCT00413699|1475004|P1|Overall Study|No longer willing to participate|116
445719|NCT00413699|1475003|P2|Overall Study|Missing end of study page|4
445720|NCT00413699|1475004|P1|Overall Study|Missing end of study page|0
445721|NCT00413699|1475003|P2|Overall Study|Adverse event not related to study drug|248
445722|NCT00413699|1475004|P1|Overall Study|Adverse event not related to study drug|113
445723|NCT00413699|1475003|P2|Overall Study|Adverse event related to study drug|527
445724|NCT00413699|1475004|P1|Overall Study|Adverse event related to study drug|178
445725|NCT00413699|1475003|P2|Overall Study|Not specified|211
445726|NCT00413699|1475004|P1|Overall Study|Not specified|67
445727|NCT00413699|1475003|P2|Overall Study|Study terminated by Sponsor|1
445728|NCT00413699|1475004|P1|Overall Study|Study terminated by Sponsor|0
445729|NCT00413699|1475003|P2|Overall Study|Medication error without adverse event|1
445730|NCT00413699|1475004|P1|Overall Study|Medication error without adverse event|0
445731|NCT00413699|1475003|P2|Overall Study|Did not meet entrance criteria|2
445732|NCT00413699|1475004|P1|Overall Study|Did not meet entrance criteria|2
445733|NCT00413699|1475003|P2|Overall Study|Pregnancy|8
445734|NCT00413699|1475004|P1|Overall Study|Pregnancy|10
445735|NCT00413699|1475003|P2|Overall Study|Protocol Violation|89
445736|NCT00413699|1475004|P1|Overall Study|Protocol Violation|38
445737|NCT00413699|1475003|P2|Overall Study|Lost to Follow-up|101
445738|NCT00413699|1475004|P1|Overall Study|Lost to Follow-up|31
445739|NCT00413699|1475003|P2|Overall Study|Lack of Efficacy|115
445740|NCT00413699|1475004|P1|Overall Study|Lack of Efficacy|59
445741|NCT00413699|1475003|P2|Overall Study|Death|30
445742|NCT00413699|1475004|P1|Overall Study|Death|25
445743|NCT00413660|1475078|P11|Post Week 12|Other|0
445744|NCT00413660|1475079|P10|Post Week 12|Other|0
445745|NCT00413660|1475080|P9|Post Week 12|Other|0
445746|NCT00413660|1475081|P8|Post Week 12|Other|0
445747|NCT00413660|1475082|P7|Post Week 12|Other|1
445748|NCT00413660|1475083|P6|Post Week 12|Other|1
445749|NCT00413660|1475084|P5|Post Week 12|Other|1
445750|NCT00413660|1475085|P4|Post Week 12|Other|0
445751|NCT00413660|1475086|P3|Post Week 12|Other|3
445752|NCT00413660|1475087|P2|Post Week 12|Other|2
445753|NCT00413660|1475088|P1|Post Week 12|Other|1
445754|NCT00413660|1475078|P11|Post Week 12|Withdrawal by Subject|1
445755|NCT00413660|1475079|P10|Post Week 12|Withdrawal by Subject|0
445756|NCT00413660|1475080|P9|Post Week 12|Withdrawal by Subject|0
445757|NCT00413660|1475081|P8|Post Week 12|Withdrawal by Subject|0
445758|NCT00413660|1475082|P7|Post Week 12|Withdrawal by Subject|0
445759|NCT00413660|1475083|P6|Post Week 12|Withdrawal by Subject|0
445760|NCT00413660|1475084|P5|Post Week 12|Withdrawal by Subject|1
445761|NCT00413660|1475085|P4|Post Week 12|Withdrawal by Subject|0
445762|NCT00413660|1475086|P3|Post Week 12|Withdrawal by Subject|1
445763|NCT00413660|1475087|P2|Post Week 12|Withdrawal by Subject|1
445764|NCT00413660|1475088|P1|Post Week 12|Withdrawal by Subject|0
445765|NCT00413660|1475078|P11|Post Week 12|Lost to Follow-up|0
445766|NCT00413660|1475079|P10|Post Week 12|Lost to Follow-up|0
445767|NCT00413660|1475080|P9|Post Week 12|Lost to Follow-up|0
445768|NCT00413660|1475081|P8|Post Week 12|Lost to Follow-up|0
445769|NCT00413660|1475082|P7|Post Week 12|Lost to Follow-up|0
445770|NCT00413660|1475083|P6|Post Week 12|Lost to Follow-up|0
445771|NCT00413660|1475084|P5|Post Week 12|Lost to Follow-up|0
445772|NCT00413660|1475085|P4|Post Week 12|Lost to Follow-up|0
445773|NCT00413660|1475086|P3|Post Week 12|Lost to Follow-up|1
445774|NCT00413660|1475087|P2|Post Week 12|Lost to Follow-up|1
445775|NCT00413660|1475088|P1|Post Week 12|Lost to Follow-up|0
445776|NCT00413660|1475078|P11|Post Week 12|Lack of Efficacy|0
445777|NCT00413660|1475079|P10|Post Week 12|Lack of Efficacy|1
445778|NCT00413660|1475080|P9|Post Week 12|Lack of Efficacy|0
445779|NCT00413660|1475081|P8|Post Week 12|Lack of Efficacy|0
445780|NCT00413660|1475082|P7|Post Week 12|Lack of Efficacy|0
445781|NCT00413660|1475083|P6|Post Week 12|Lack of Efficacy|0
445782|NCT00413660|1475084|P5|Post Week 12|Lack of Efficacy|0
445783|NCT00413660|1475085|P4|Post Week 12|Lack of Efficacy|0
445784|NCT00413660|1475086|P3|Post Week 12|Lack of Efficacy|1
445785|NCT00413660|1475087|P2|Post Week 12|Lack of Efficacy|0
445786|NCT00413660|1475088|P1|Post Week 12|Lack of Efficacy|0
445787|NCT00413660|1475078|P11|Post Week 12|Adverse Event|0
445788|NCT00413660|1475079|P10|Post Week 12|Adverse Event|0
445789|NCT00413660|1475080|P9|Post Week 12|Adverse Event|0
445790|NCT00413660|1475081|P8|Post Week 12|Adverse Event|0
445791|NCT00413660|1475082|P7|Post Week 12|Adverse Event|2
445792|NCT00413660|1475083|P6|Post Week 12|Adverse Event|2
445793|NCT00413660|1475084|P5|Post Week 12|Adverse Event|4
445794|NCT00413660|1475085|P4|Post Week 12|Adverse Event|1
445795|NCT00413660|1475086|P3|Post Week 12|Adverse Event|2
445796|NCT00413660|1475087|P2|Post Week 12|Adverse Event|0
445797|NCT00413660|1475088|P1|Post Week 12|Adverse Event|2
445798|NCT00413660|1475078|P11|Up To Week 12|Other|0
445799|NCT00413660|1475079|P10|Up To Week 12|Other|0
445800|NCT00413660|1475080|P9|Up To Week 12|Other|0
445801|NCT00413660|1475081|P8|Up To Week 12|Other|0
445802|NCT00413660|1475082|P7|Up To Week 12|Other|3
445803|NCT00413660|1475083|P6|Up To Week 12|Other|4
445804|NCT00413660|1475084|P5|Up To Week 12|Other|2
445805|NCT00413660|1475085|P4|Up To Week 12|Other|1
445806|NCT00413660|1475086|P3|Up To Week 12|Other|6
445807|NCT00413660|1475087|P2|Up To Week 12|Other|1
445808|NCT00413660|1475088|P1|Up To Week 12|Other|3
445809|NCT00413660|1475078|P11|Up To Week 12|Randomized, Not Treated|0
445810|NCT00413660|1475079|P10|Up To Week 12|Randomized, Not Treated|0
445811|NCT00413660|1475080|P9|Up To Week 12|Randomized, Not Treated|0
445812|NCT00413660|1475081|P8|Up To Week 12|Randomized, Not Treated|0
445813|NCT00413660|1475082|P7|Up To Week 12|Randomized, Not Treated|0
445814|NCT00413660|1475083|P6|Up To Week 12|Randomized, Not Treated|0
445815|NCT00413660|1475084|P5|Up To Week 12|Randomized, Not Treated|0
445816|NCT00413660|1475085|P4|Up To Week 12|Randomized, Not Treated|1
445817|NCT00413660|1475086|P3|Up To Week 12|Randomized, Not Treated|0
445818|NCT00413660|1475087|P2|Up To Week 12|Randomized, Not Treated|0
445819|NCT00413660|1475088|P1|Up To Week 12|Randomized, Not Treated|1
445820|NCT00413660|1475078|P11|Up To Week 12|Withdrawal by Subject|0
445821|NCT00413660|1475079|P10|Up To Week 12|Withdrawal by Subject|0
445822|NCT00413660|1475080|P9|Up To Week 12|Withdrawal by Subject|0
445823|NCT00413660|1475081|P8|Up To Week 12|Withdrawal by Subject|0
445824|NCT00413660|1475082|P7|Up To Week 12|Withdrawal by Subject|2
445825|NCT00413660|1475083|P6|Up To Week 12|Withdrawal by Subject|2
445826|NCT00413660|1475084|P5|Up To Week 12|Withdrawal by Subject|0
445827|NCT00413660|1475085|P4|Up To Week 12|Withdrawal by Subject|2
445828|NCT00413660|1475086|P3|Up To Week 12|Withdrawal by Subject|0
445829|NCT00413660|1475087|P2|Up To Week 12|Withdrawal by Subject|2
445830|NCT00413660|1475088|P1|Up To Week 12|Withdrawal by Subject|0
445831|NCT00413660|1475078|P11|Up To Week 12|Lost to Follow-up|0
445832|NCT00413660|1475079|P10|Up To Week 12|Lost to Follow-up|0
445833|NCT00413660|1475080|P9|Up To Week 12|Lost to Follow-up|0
445834|NCT00413660|1475081|P8|Up To Week 12|Lost to Follow-up|0
445835|NCT00413660|1475082|P7|Up To Week 12|Lost to Follow-up|0
445836|NCT00413660|1475083|P6|Up To Week 12|Lost to Follow-up|0
445837|NCT00413660|1475084|P5|Up To Week 12|Lost to Follow-up|1
445838|NCT00413660|1475085|P4|Up To Week 12|Lost to Follow-up|0
445839|NCT00413660|1475086|P3|Up To Week 12|Lost to Follow-up|0
445840|NCT00413660|1475087|P2|Up To Week 12|Lost to Follow-up|1
445841|NCT00413660|1475088|P1|Up To Week 12|Lost to Follow-up|0
445842|NCT00413660|1475078|P11|Up To Week 12|Lack of Efficacy|0
445843|NCT00413660|1475079|P10|Up To Week 12|Lack of Efficacy|0
445844|NCT00413660|1475080|P9|Up To Week 12|Lack of Efficacy|0
445845|NCT00413660|1475081|P8|Up To Week 12|Lack of Efficacy|0
445846|NCT00413660|1475082|P7|Up To Week 12|Lack of Efficacy|5
445847|NCT00413660|1475083|P6|Up To Week 12|Lack of Efficacy|0
445848|NCT00413660|1475084|P5|Up To Week 12|Lack of Efficacy|0
445849|NCT00413660|1475085|P4|Up To Week 12|Lack of Efficacy|0
445850|NCT00413660|1475086|P3|Up To Week 12|Lack of Efficacy|0
445851|NCT00413660|1475087|P2|Up To Week 12|Lack of Efficacy|0
445852|NCT00413660|1475088|P1|Up To Week 12|Lack of Efficacy|2
445853|NCT00413660|1475078|P11|Up To Week 12|Adverse Event|0
445854|NCT00413660|1475079|P10|Up To Week 12|Adverse Event|0
445855|NCT00413660|1475080|P9|Up To Week 12|Adverse Event|0
445856|NCT00413660|1475081|P8|Up To Week 12|Adverse Event|0
445857|NCT00413660|1475082|P7|Up To Week 12|Adverse Event|1
445858|NCT00413660|1475083|P6|Up To Week 12|Adverse Event|4
445859|NCT00413660|1475084|P5|Up To Week 12|Adverse Event|6
445860|NCT00413660|1475085|P4|Up To Week 12|Adverse Event|4
445861|NCT00413660|1475086|P3|Up To Week 12|Adverse Event|1
445862|NCT00413660|1475087|P2|Up To Week 12|Adverse Event|3
445863|NCT00413660|1475088|P1|Up To Week 12|Adverse Event|1
445864|NCT00413413|1475491|P3|Double-Blind|Lost to Follow-up|2
445865|NCT00413413|1475492|P2|Double-Blind|Lost to Follow-up|4
445866|NCT00413413|1475493|P1|Double-Blind|Lost to Follow-up|3
445867|NCT00413413|1475491|P3|Double-Blind|Subject withdrew consent|9
445868|NCT00413413|1475492|P2|Double-Blind|Subject withdrew consent|6
445869|NCT00413413|1475493|P1|Double-Blind|Subject withdrew consent|4
445870|NCT00413413|1475491|P3|Double-Blind|Protocol deviation|1
445871|NCT00413413|1475492|P2|Double-Blind|Protocol deviation|2
445872|NCT00413413|1475493|P1|Double-Blind|Protocol deviation|1
445873|NCT00413413|1475491|P3|Double-Blind|Unsatisfactory therapeutic effect|1
445874|NCT00413413|1475492|P2|Double-Blind|Unsatisfactory therapeutic effect|2
445875|NCT00413413|1475493|P1|Double-Blind|Unsatisfactory therapeutic effect|1
445876|NCT00413413|1475491|P3|Double-Blind|Adverse Event|5
445877|NCT00413413|1475492|P2|Double-Blind|Adverse Event|0
445878|NCT00413413|1475493|P1|Double-Blind|Adverse Event|6
445879|NCT00413413|1475491|P3|Single-Blind|Lost to Follow-up|0
445880|NCT00413413|1475492|P2|Single-Blind|Lost to Follow-up|8
445881|NCT00413413|1475493|P1|Single-Blind|Lost to Follow-up|0
445882|NCT00413413|1475491|P3|Single-Blind|Withdrawal by Subject|0
445883|NCT00413413|1475492|P2|Single-Blind|Withdrawal by Subject|27
445884|NCT00413413|1475493|P1|Single-Blind|Withdrawal by Subject|0
445885|NCT00413413|1475491|P3|Single-Blind|Protocol Violation|0
445886|NCT00413413|1475492|P2|Single-Blind|Protocol Violation|16
445887|NCT00413413|1475493|P1|Single-Blind|Protocol Violation|0
445888|NCT00413413|1475491|P3|Single-Blind|Subject no longer requires study drug|0
445889|NCT00413413|1475492|P2|Single-Blind|Subject no longer requires study drug|151
445890|NCT00413413|1475493|P1|Single-Blind|Subject no longer requires study drug|0
445891|NCT00413413|1475491|P3|Single-Blind|Lack of Efficacy|0
445892|NCT00413413|1475492|P2|Single-Blind|Lack of Efficacy|5
445893|NCT00413413|1475493|P1|Single-Blind|Lack of Efficacy|0
445894|NCT00413413|1475491|P3|Single-Blind|Adverse Event|0
445895|NCT00413413|1475492|P2|Single-Blind|Adverse Event|9
445896|NCT00413413|1475493|P1|Single-Blind|Adverse Event|0
445897|NCT00413374|1475546|P2|Overall Study|Surgery|0
445898|NCT00413374|1475547|P1|Overall Study|Surgery|1
445899|NCT00413374|1475546|P2|Overall Study|Lost to Follow-up|0
445900|NCT00413374|1475547|P1|Overall Study|Lost to Follow-up|1
445901|NCT00413374|1475546|P2|Overall Study|Adverse Event|0
445902|NCT00413374|1475547|P1|Overall Study|Adverse Event|1
445903|NCT00413374|1475546|P2|Overall Study|Ineligible due to screening criteria.|0
445904|NCT00413374|1475547|P1|Overall Study|Ineligible due to screening criteria.|3
445905|NCT00413283|1475578|P4|Overall Study|Not specified|0
445906|NCT00413283|1475579|P3|Overall Study|Not specified|1
445907|NCT00413283|1475580|P2|Overall Study|Not specified|0
445908|NCT00413283|1475581|P1|Overall Study|Not specified|0
445909|NCT00413283|1475578|P4|Overall Study|Requirement for alternative therapy|0
445910|NCT00413283|1475579|P3|Overall Study|Requirement for alternative therapy|0
445911|NCT00413283|1475580|P2|Overall Study|Requirement for alternative therapy|2
445912|NCT00413283|1475581|P1|Overall Study|Requirement for alternative therapy|0
445913|NCT00413283|1475578|P4|Overall Study|Protocol deviation|0
445914|NCT00413283|1475579|P3|Overall Study|Protocol deviation|0
445915|NCT00413283|1475580|P2|Overall Study|Protocol deviation|1
445916|NCT00413283|1475581|P1|Overall Study|Protocol deviation|0
445917|NCT00413283|1475578|P4|Overall Study|Ineligibility determined|1
445918|NCT00413283|1475579|P3|Overall Study|Ineligibility determined|0
445919|NCT00413283|1475580|P2|Overall Study|Ineligibility determined|0
445920|NCT00413283|1475581|P1|Overall Study|Ineligibility determined|0
445921|NCT00413283|1475578|P4|Overall Study|Adverse Event|1
445922|NCT00413283|1475579|P3|Overall Study|Adverse Event|0
445923|NCT00413283|1475580|P2|Overall Study|Adverse Event|0
445924|NCT00413283|1475581|P1|Overall Study|Adverse Event|0
445925|NCT00413283|1475578|P4|Overall Study|Death|1
445926|NCT00413283|1475579|P3|Overall Study|Death|1
445927|NCT00413283|1475580|P2|Overall Study|Death|0
445928|NCT00413283|1475581|P1|Overall Study|Death|0
445929|NCT00413283|1475578|P4|Overall Study|Withdrawal by Subject|1
445930|NCT00413283|1475579|P3|Overall Study|Withdrawal by Subject|0
445931|NCT00413283|1475580|P2|Overall Study|Withdrawal by Subject|0
445932|NCT00413283|1475581|P1|Overall Study|Withdrawal by Subject|1
445933|NCT00413244|1475613|P2|Overall Study|Withdrawal by Subject|1
445934|NCT00413244|1475614|P1|Overall Study|Withdrawal by Subject|10
445935|NCT00413231|1475642|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
445936|NCT00413231|1475642|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
445937|NCT00413231|1475642|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
445938|NCT00413231|1475642|P1|365-day to 60-month Post Treatment|Death|36
445939|NCT00413231|1475642|P1|30-day to 365-day Post Treatment|Death|13
445940|NCT00413231|1475642|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
445941|NCT00413231|1475642|P1|0 to 30-day Post Treatment|Death|5
445942|NCT00413218|1475674|P2|Overall Study|Withdrawal by Subject|1
445943|NCT00413218|1475675|P1|Overall Study|Withdrawal by Subject|9
445944|NCT00413218|1475674|P2|Overall Study|Missing|0
445945|NCT00413218|1475675|P1|Overall Study|Missing|1
445946|NCT00413218|1475674|P2|Overall Study|Admin|14
445947|NCT00413218|1475675|P1|Overall Study|Admin|20
445948|NCT00413218|1475674|P2|Overall Study|Lost to Follow-up|17
445949|NCT00413218|1475675|P1|Overall Study|Lost to Follow-up|14
445950|NCT00413218|1475674|P2|Overall Study|Death|56
445951|NCT00413218|1475675|P1|Overall Study|Death|57
445952|NCT00413218|1475674|P2|Overall Study|Randomized but didn't receive study drug|8
445953|NCT00413218|1475675|P1|Overall Study|Randomized but didn't receive study drug|2
445954|NCT00413192|1475701|P4|Overall Study|Not treated|1
445955|NCT00413192|1475702|P3|Overall Study|Not treated|0
445956|NCT00413192|1475703|P2|Overall Study|Not treated|0
445957|NCT00413192|1475704|P1|Overall Study|Not treated|0
445958|NCT00413192|1475701|P4|Overall Study|Not specified|2
445959|NCT00413192|1475702|P3|Overall Study|Not specified|1
445960|NCT00413192|1475703|P2|Overall Study|Not specified|1
445961|NCT00413192|1475704|P1|Overall Study|Not specified|5
445962|NCT00413192|1475701|P4|Overall Study|Intercurrent death|0
445963|NCT00413192|1475702|P3|Overall Study|Intercurrent death|0
445964|NCT00413192|1475703|P2|Overall Study|Intercurrent death|1
445965|NCT00413192|1475704|P1|Overall Study|Intercurrent death|0
445966|NCT00413192|1475701|P4|Overall Study|Intercurrent illness|1
445967|NCT00413192|1475702|P3|Overall Study|Intercurrent illness|0
445968|NCT00413192|1475703|P2|Overall Study|Intercurrent illness|0
445969|NCT00413192|1475704|P1|Overall Study|Intercurrent illness|0
445970|NCT00413192|1475701|P4|Overall Study|Withdrawal by Subject|1
445971|NCT00413192|1475702|P3|Overall Study|Withdrawal by Subject|0
445972|NCT00413192|1475703|P2|Overall Study|Withdrawal by Subject|5
445973|NCT00413192|1475704|P1|Overall Study|Withdrawal by Subject|3
445974|NCT00413192|1475701|P4|Overall Study|Toxicity|2
445975|NCT00413192|1475702|P3|Overall Study|Toxicity|2
445976|NCT00413192|1475703|P2|Overall Study|Toxicity|2
445977|NCT00413192|1475704|P1|Overall Study|Toxicity|3
445978|NCT00413192|1475701|P4|Overall Study|Disease progression|25
445979|NCT00413192|1475702|P3|Overall Study|Disease progression|16
445980|NCT00413192|1475703|P2|Overall Study|Disease progression|31
445981|NCT00413192|1475704|P1|Overall Study|Disease progression|26
445982|NCT00413153|1475744|P2|Overall Study|Adverse Event|0
445983|NCT00413153|1475745|P1|Overall Study|Adverse Event|1
445984|NCT00413153|1475744|P2|Overall Study|Withdrawal by Subject|1
445985|NCT00413153|1475745|P1|Overall Study|Withdrawal by Subject|1
445986|NCT00413062|1475769|P2|Overall Study|Other reason|34
445987|NCT00413062|1475770|P1|Overall Study|Other reason|70
445988|NCT00413062|1475769|P2|Overall Study|Lost to Follow-up|73
445989|NCT00413062|1475770|P1|Overall Study|Lost to Follow-up|175
445990|NCT00413062|1475769|P2|Overall Study|Pregnancy wish|6
445991|NCT00413062|1475770|P1|Overall Study|Pregnancy wish|17
445992|NCT00413062|1475769|P2|Overall Study|Pregnancy|5
445993|NCT00413062|1475770|P1|Overall Study|Pregnancy|15
445994|NCT00413062|1475769|P2|Overall Study|Withdrawal of informed consent|36
445995|NCT00413062|1475770|P1|Overall Study|Withdrawal of informed consent|111
445996|NCT00413062|1475769|P2|Overall Study|Pre-treatment (serious) adverse event|0
445997|NCT00413062|1475770|P1|Overall Study|Pre-treatment (serious) adverse event|1
445998|NCT00413062|1475769|P2|Overall Study|Adverse event/serious adverse event|56
445999|NCT00413062|1475770|P1|Overall Study|Adverse event/serious adverse event|289
446000|NCT00413049|1475796|P2|Overall Study|Lack of Efficacy|0
446001|NCT00413049|1475797|P1|Overall Study|Lack of Efficacy|1
446002|NCT00413049|1475796|P2|Overall Study|Abnormal laboratory value(s)|0
446003|NCT00413049|1475797|P1|Overall Study|Abnormal laboratory value(s)|1
446004|NCT00413049|1475796|P2|Overall Study|Subject no longer requires study drug|1
446005|NCT00413049|1475797|P1|Overall Study|Subject no longer requires study drug|0
446006|NCT00413049|1475796|P2|Overall Study|Protocol Violation|1
446007|NCT00413049|1475797|P1|Overall Study|Protocol Violation|3
446008|NCT00413049|1475796|P2|Overall Study|Lost to Follow-up|3
446009|NCT00413049|1475797|P1|Overall Study|Lost to Follow-up|2
446010|NCT00413049|1475796|P2|Overall Study|Withdrawal by Subject|5
446011|NCT00413049|1475797|P1|Overall Study|Withdrawal by Subject|7
446012|NCT00413049|1475796|P2|Overall Study|Adverse Event|8
446013|NCT00413049|1475797|P1|Overall Study|Adverse Event|10
446014|NCT00413036|1475813|P1|Overall Study|Missing|2
446015|NCT00413036|1475813|P1|Overall Study|Other|26
446016|NCT00413036|1475813|P1|Overall Study|Death|9
446017|NCT00413036|1475813|P1|Overall Study|Withdrawal by Subject|7
446018|NCT00413036|1475813|P1|Overall Study|Lack of Efficacy|129
446019|NCT00413036|1475813|P1|Overall Study|Adverse Event|44
446020|NCT00413010|1475823|P2|Overall Study|Due to termination of the study|52
446021|NCT00413010|1475824|P1|Overall Study|Due to termination of the study|54
446022|NCT00413010|1475823|P2|Overall Study|Withdrawal by Subject|2
446023|NCT00413010|1475824|P1|Overall Study|Withdrawal by Subject|7
446024|NCT00413010|1475823|P2|Overall Study|Lost to Follow-up|0
446025|NCT00413010|1475824|P1|Overall Study|Lost to Follow-up|3
446026|NCT00413010|1475823|P2|Overall Study|Lack of Efficacy|3
446027|NCT00413010|1475824|P1|Overall Study|Lack of Efficacy|0
446028|NCT00413010|1475823|P2|Overall Study|Laboratory abnormality|2
446029|NCT00413010|1475824|P1|Overall Study|Laboratory abnormality|0
446030|NCT00413010|1475823|P2|Overall Study|Adverse Event|4
446031|NCT00413010|1475824|P1|Overall Study|Adverse Event|8
446032|NCT00412984|1475846|P2|Overall Study|Not Reported|12
446033|NCT00412984|1475847|P1|Overall Study|Not Reported|11
446034|NCT00412984|1475846|P2|Overall Study|Other Reason|92
446035|NCT00412984|1475847|P1|Overall Study|Other Reason|80
446036|NCT00412984|1475846|P2|Overall Study|Physician Refused to Continue Treatment|89
446037|NCT00412984|1475847|P1|Overall Study|Physician Refused to Continue Treatment|81
446038|NCT00412984|1475846|P2|Overall Study|Administrative Reason by Sponsor|8
446039|NCT00412984|1475847|P1|Overall Study|Administrative Reason by Sponsor|11
446040|NCT00412984|1475846|P2|Overall Study|Subject No Longer Meets Study Criteria|100
446041|NCT00412984|1475847|P1|Overall Study|Subject No Longer Meets Study Criteria|87
446042|NCT00412984|1475846|P2|Overall Study|Pregnancy|0
446043|NCT00412984|1475847|P1|Overall Study|Pregnancy|1
446044|NCT00412984|1475846|P2|Overall Study|Poor/Noncompliance|77
446045|NCT00412984|1475847|P1|Overall Study|Poor/Noncompliance|57
446046|NCT00412984|1475846|P2|Overall Study|Lost to Follow-up|39
446047|NCT00412984|1475847|P1|Overall Study|Lost to Follow-up|51
446048|NCT00412984|1475846|P2|Overall Study|Withdrawal by Subject|989
446049|NCT00412984|1475847|P1|Overall Study|Withdrawal by Subject|921
446050|NCT00412984|1475846|P2|Overall Study|Adverse Event|738
446051|NCT00412984|1475847|P1|Overall Study|Adverse Event|679
446052|NCT00412984|1475846|P2|Overall Study|Death|349
446053|NCT00412984|1475847|P1|Overall Study|Death|331
446054|NCT00412971|1475891|P2|Overall Study|Protocol Violation|1
446055|NCT00412971|1475892|P1|Overall Study|Protocol Violation|13
446056|NCT00412971|1475891|P2|Overall Study|Lost to Follow-up|9
446057|NCT00412971|1475892|P1|Overall Study|Lost to Follow-up|17
446058|NCT00412958|1475905|P4|Overall Study|Transport issue|0
446059|NCT00412958|1475906|P3|Overall Study|Transport issue|0
446060|NCT00412958|1475907|P2|Overall Study|Transport issue|1
446061|NCT00412958|1475908|P1|Overall Study|Transport issue|0
446062|NCT00412958|1475905|P4|Overall Study|Death|0
446063|NCT00412958|1475906|P3|Overall Study|Death|0
446064|NCT00412958|1475907|P2|Overall Study|Death|1
446065|NCT00412958|1475908|P1|Overall Study|Death|0
446066|NCT00412958|1475905|P4|Overall Study|Lost to Follow-up|0
446067|NCT00412958|1475906|P3|Overall Study|Lost to Follow-up|0
446068|NCT00412958|1475907|P2|Overall Study|Lost to Follow-up|1
446069|NCT00412958|1475908|P1|Overall Study|Lost to Follow-up|0
446070|NCT00412958|1475905|P4|Overall Study|Adverse Event|0
446071|NCT00412958|1475906|P3|Overall Study|Adverse Event|0
446072|NCT00412958|1475907|P2|Overall Study|Adverse Event|1
446073|NCT00412958|1475908|P1|Overall Study|Adverse Event|0
446074|NCT00412958|1475905|P4|Overall Study|Withdrawal by Subject|1
446075|NCT00412958|1475906|P3|Overall Study|Withdrawal by Subject|0
446076|NCT00412958|1475907|P2|Overall Study|Withdrawal by Subject|0
446077|NCT00412958|1475908|P1|Overall Study|Withdrawal by Subject|3
446078|NCT00412932|1475918|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
446079|NCT00412932|1475918|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
446080|NCT00412932|1475918|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
446081|NCT00412932|1475918|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
446082|NCT00412932|1475918|P1|Olmesartan 40 mg|Withdrawal by Subject|1
446083|NCT00412932|1475918|P1|Olmesartan 40 mg|Lack of Efficacy|3
446084|NCT00412932|1475918|P1|Olmesartan 40 mg|Adverse Event|4
446085|NCT00412932|1475918|P1|Olmesartan (Olm) 20 mg|Other|1
446086|NCT00412932|1475918|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
446087|NCT00412932|1475918|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
446088|NCT00412932|1475918|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
446089|NCT00412932|1475918|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
446090|NCT00412893|1475929|P2|Overall Study|Randomized but Never Received Study Drug|6
446091|NCT00412893|1475930|P1|Overall Study|Randomized but Never Received Study Drug|5
446092|NCT00412893|1475929|P2|Overall Study|Administrative Reason|15
446093|NCT00412893|1475930|P1|Overall Study|Administrative Reason|12
446094|NCT00412893|1475929|P2|Overall Study|Did Not Cooperate|9
446095|NCT00412893|1475930|P1|Overall Study|Did Not Cooperate|12
446096|NCT00412893|1475929|P2|Overall Study|Other Protocol Violation|6
446097|NCT00412893|1475930|P1|Overall Study|Other Protocol Violation|10
446098|NCT00412893|1475929|P2|Overall Study|Violation of Selection at Entry|10
446099|NCT00412893|1475930|P1|Overall Study|Violation of Selection at Entry|17
446100|NCT00412893|1475929|P2|Overall Study|Lost to Follow-up|1
446101|NCT00412893|1475930|P1|Overall Study|Lost to Follow-up|2
446102|NCT00412893|1475929|P2|Overall Study|Insufficient Therapeutic Response|23
446103|NCT00412893|1475930|P1|Overall Study|Insufficient Therapeutic Response|39
446104|NCT00412893|1475929|P2|Overall Study|Death|21
446105|NCT00412893|1475930|P1|Overall Study|Death|17
446106|NCT00412893|1475929|P2|Overall Study|Adverse Event|53
446107|NCT00412893|1475930|P1|Overall Study|Adverse Event|31
446108|NCT00412854|1475968|P2|Overall Study|Withdrawn for other reasons|11
446109|NCT00412854|1475969|P1|Overall Study|Withdrawn for other reasons|13
446110|NCT00412854|1475968|P2|Overall Study|Withdrawn due to adverse events|5
446111|NCT00412854|1475969|P1|Overall Study|Withdrawn due to adverse events|1
446112|NCT00412750|1476009|P3|Overall Study|Lack of Efficacy|3
446113|NCT00412750|1476010|P2|Overall Study|Lack of Efficacy|0
446114|NCT00412750|1476011|P1|Overall Study|Lack of Efficacy|0
446115|NCT00412750|1476009|P3|Overall Study|Withdrawal by Subject|2
446116|NCT00412750|1476010|P2|Overall Study|Withdrawal by Subject|1
446117|NCT00412750|1476011|P1|Overall Study|Withdrawal by Subject|0
446118|NCT00412750|1476009|P3|Overall Study|Lost to Follow-up|1
446119|NCT00412750|1476010|P2|Overall Study|Lost to Follow-up|0
446120|NCT00412750|1476011|P1|Overall Study|Lost to Follow-up|1
446121|NCT00412750|1476009|P3|Overall Study|Adverse Event|3
446122|NCT00412750|1476010|P2|Overall Study|Adverse Event|3
446123|NCT00412750|1476011|P1|Overall Study|Adverse Event|8
446124|NCT00412750|1476009|P3|Overall Study|Administrative problems|14
446125|NCT00412750|1476010|P2|Overall Study|Administrative problems|17
446126|NCT00412750|1476011|P1|Overall Study|Administrative problems|21
446127|NCT00412750|1476009|P3|Overall Study|Abnormal laboratory value(s)|0
446128|NCT00412750|1476010|P2|Overall Study|Abnormal laboratory value(s)|0
446129|NCT00412750|1476011|P1|Overall Study|Abnormal laboratory value(s)|1
446130|NCT00412737|1476036|P2|Overall Study|Failure to Return|2
446131|NCT00412737|1476037|P1|Overall Study|Failure to Return|6
446132|NCT00412737|1476036|P2|Overall Study|Refused Treatment|2
446133|NCT00412737|1476037|P1|Overall Study|Refused Treatment|6
446134|NCT00412737|1476036|P2|Overall Study|Adverse Event|2
446135|NCT00412737|1476037|P1|Overall Study|Adverse Event|3
446136|NCT00412737|1476036|P2|Overall Study|Death|0
446137|NCT00412737|1476037|P1|Overall Study|Death|1
446138|NCT00412607|1476055|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
446139|NCT00412607|1476055|P1|Overall Study|Death|61
446140|NCT00412607|1476055|P1|Overall Study|Lost to Follow-up|19
446141|NCT00412607|1476055|P1|Overall Study|Withdrawal by Subject|9
446142|NCT00412542|1476068|P2|Overall Study|Not Eligible|1
446143|NCT00412542|1476069|P1|Overall Study|Not Eligible|0
446144|NCT00412542|1476068|P2|Overall Study|Withdrawal by Subject|2
446145|NCT00412542|1476069|P1|Overall Study|Withdrawal by Subject|0
446146|NCT00412373|1476154|P2|Overall Study|Not Specified|2
446147|NCT00412373|1476155|P1|Overall Study|Not Specified|2
446148|NCT00412373|1476154|P2|Overall Study|Withdrawal by Subject|27
446149|NCT00412373|1476155|P1|Overall Study|Withdrawal by Subject|8
446150|NCT00412373|1476154|P2|Overall Study|Lost to Follow-up|13
446151|NCT00412373|1476155|P1|Overall Study|Lost to Follow-up|7
446152|NCT00412373|1476154|P2|Overall Study|Lack of Efficacy|22
446153|NCT00412373|1476155|P1|Overall Study|Lack of Efficacy|16
446154|NCT00412373|1476154|P2|Overall Study|Adverse Event|13
446155|NCT00412373|1476155|P1|Overall Study|Adverse Event|8
446156|NCT00412360|1476197|P2|Overall Study|Not Transplanted|2
446157|NCT00412360|1476198|P1|Overall Study|Not Transplanted|1
446158|NCT00412360|1476197|P2|Overall Study|Lost to Follow-up|1
446159|NCT00412360|1476198|P1|Overall Study|Lost to Follow-up|0
446160|NCT00412217|1476228|P2|Overall Study|Not Specified|1
446161|NCT00412217|1476229|P1|Overall Study|Not Specified|1
446162|NCT00412217|1476228|P2|Overall Study|Study Terminated by Sponsor|33
446163|NCT00412217|1476229|P1|Overall Study|Study Terminated by Sponsor|26
446164|NCT00412217|1476228|P2|Overall Study|Lost to Follow-up|4
446165|NCT00412217|1476229|P1|Overall Study|Lost to Follow-up|1
446166|NCT00412217|1476228|P2|Overall Study|Withdrawal by Subject|0
446167|NCT00412217|1476229|P1|Overall Study|Withdrawal by Subject|2
446168|NCT00412217|1476228|P2|Overall Study|Investigator Decision|0
446169|NCT00412217|1476229|P1|Overall Study|Investigator Decision|1
446170|NCT00412217|1476228|P2|Overall Study|Disease Progression|3
446171|NCT00412217|1476229|P1|Overall Study|Disease Progression|2
446172|NCT00412217|1476228|P2|Overall Study|Death|4
446173|NCT00412217|1476229|P1|Overall Study|Death|5
446174|NCT00412217|1476228|P2|Overall Study|Insufficient Data Available|3
446175|NCT00412217|1476229|P1|Overall Study|Insufficient Data Available|8
446176|NCT00412113|1476243|P2|Overall Study|did not receive treatment|0
446177|NCT00412113|1476244|P1|Overall Study|did not receive treatment|1
446178|NCT00412113|1476243|P2|Overall Study|Adverse Event|15
446179|NCT00412113|1476244|P1|Overall Study|Adverse Event|11
446180|NCT00412061|1476328|P2|Open Label Phase|New Cancer Therapy|1
446181|NCT00412061|1476329|P1|Open Label Phase|New Cancer Therapy|0
446182|NCT00412061|1476328|P2|Open Label Phase|Lost to Follow-up|2
446183|NCT00412061|1476329|P1|Open Label Phase|Lost to Follow-up|0
446184|NCT00412061|1476328|P2|Open Label Phase|Death|7
446185|NCT00412061|1476329|P1|Open Label Phase|Death|0
446186|NCT00412061|1476328|P2|Open Label Phase|Administrative Problems|13
446187|NCT00412061|1476329|P1|Open Label Phase|Administrative Problems|0
446188|NCT00412061|1476328|P2|Open Label Phase|Withdrawal by Subject|15
446189|NCT00412061|1476329|P1|Open Label Phase|Withdrawal by Subject|0
446190|NCT00412061|1476328|P2|Open Label Phase|Adverse Event|46
446191|NCT00412061|1476329|P1|Open Label Phase|Adverse Event|0
446192|NCT00412061|1476328|P2|Open Label Phase|Disease Progression|86
446193|NCT00412061|1476329|P1|Open Label Phase|Disease Progression|0
446194|NCT00412061|1476328|P2|Double Blind Phase|Lost to Follow-up|1
446195|NCT00412061|1476329|P1|Double Blind Phase|Lost to Follow-up|0
446196|NCT00412061|1476328|P2|Double Blind Phase|New Cander Therapy|1
446197|NCT00412061|1476329|P1|Double Blind Phase|New Cander Therapy|1
446198|NCT00412061|1476328|P2|Double Blind Phase|Protocol Violation|4
446199|NCT00412061|1476329|P1|Double Blind Phase|Protocol Violation|3
446200|NCT00412061|1476328|P2|Double Blind Phase|Death|3
446201|NCT00412061|1476329|P1|Double Blind Phase|Death|6
446202|NCT00412061|1476328|P2|Double Blind Phase|Withdrawal by Subject|20
446203|NCT00412061|1476329|P1|Double Blind Phase|Withdrawal by Subject|18
446204|NCT00412061|1476328|P2|Double Blind Phase|Final Primary Analysis|14
446205|NCT00412061|1476329|P1|Double Blind Phase|Final Primary Analysis|26
446206|NCT00412061|1476328|P2|Double Blind Phase|Adverse Event|16
446207|NCT00412061|1476329|P1|Double Blind Phase|Adverse Event|61
446208|NCT00412061|1476328|P2|Double Blind Phase|Disease Progression|154
446209|NCT00412061|1476329|P1|Double Blind Phase|Disease Progression|101
446210|NCT00411788|1476347|P1|Overall Study|Adverse Event|1
446211|NCT00411788|1476347|P1|Overall Study|Protocol Violation|1
446212|NCT00411762|1476356|P1|Overall Study|Withdrawal by Subject|5
446213|NCT00411671|1476380|P1|Overall Study|Lost to Follow-up|3
446214|NCT00411671|1476380|P1|Overall Study|Death|2
446215|NCT00411671|1476380|P1|Overall Study|Adverse Event|15
446216|NCT00411645|1476388|P2|Overall Study|Lost to Follow-up|0
446217|NCT00411645|1476389|P1|Overall Study|Lost to Follow-up|2
446218|NCT00411645|1476388|P2|Overall Study|Investigator/Sponsor Decision|7
446219|NCT00411645|1476389|P1|Overall Study|Investigator/Sponsor Decision|10
446220|NCT00411645|1476388|P2|Overall Study|Death|135
446221|NCT00411645|1476389|P1|Overall Study|Death|56
446222|NCT00411645|1476388|P2|Overall Study|Consent Withdrawn|22
446223|NCT00411645|1476389|P1|Overall Study|Consent Withdrawn|13
446224|NCT00411554|1476420|P2|Overall Study|Patient Moved|0
446225|NCT00411554|1476421|P1|Overall Study|Patient Moved|1
446226|NCT00411554|1476420|P2|Overall Study|Withdrawal by Subject|0
446227|NCT00411554|1476421|P1|Overall Study|Withdrawal by Subject|3
446228|NCT00411554|1476420|P2|Overall Study|Lack of Efficacy|5
446229|NCT00411554|1476421|P1|Overall Study|Lack of Efficacy|2
446230|NCT00411554|1476420|P2|Overall Study|Adverse Event|4
446231|NCT00411554|1476421|P1|Overall Study|Adverse Event|2
446232|NCT00411450|1476447|P1|Overall Study|Ongoing at time of data cut-off.|3
446233|NCT00411216|1476490|P2|Overall Study|Ten participants were entered into the c|2
446234|NCT00411216|1476491|P1|Overall Study|Ten participants were entered into the c|0
446235|NCT00411151|1476497|P1|Overall Study|Trial prematurely closed|4
446236|NCT00411151|1476497|P1|Overall Study|Protocol Violation|1
446237|NCT00411151|1476497|P1|Overall Study|Lost to Follow-up|2
446238|NCT00411151|1476497|P1|Overall Study|Withdrawal by Subject|2
446239|NCT00411151|1476497|P1|Overall Study|Death|38
446240|NCT00410813|1476541|P2|Overall Study|Death|2
446241|NCT00410813|1476542|P1|Overall Study|Death|0
446242|NCT00410813|1476541|P2|Overall Study|Ineligible|4
446243|NCT00410813|1476542|P1|Overall Study|Ineligible|2
446244|NCT00410813|1476541|P2|Overall Study|Not protocol specified|4
446245|NCT00410813|1476542|P1|Overall Study|Not protocol specified|3
446246|NCT00410813|1476541|P2|Overall Study|Progression|21
446247|NCT00410813|1476542|P1|Overall Study|Progression|32
446248|NCT00410813|1476541|P2|Overall Study|Adverse Event|11
446249|NCT00410813|1476542|P1|Overall Study|Adverse Event|6
446250|NCT00410761|1476579|P2|Overall Study|Never received randomised treatment|1
446251|NCT00410761|1476580|P1|Overall Study|Never received randomised treatment|0
446252|NCT00410761|1476579|P2|Overall Study|Other|9
446253|NCT00410761|1476580|P1|Overall Study|Other|12
446254|NCT00410761|1476579|P2|Overall Study|Withdrawal by Subject|4
446255|NCT00410761|1476580|P1|Overall Study|Withdrawal by Subject|8
446256|NCT00410761|1476579|P2|Overall Study|objective disease progression|55
446257|NCT00410761|1476580|P1|Overall Study|objective disease progression|71
446258|NCT00410761|1476579|P2|Overall Study|Adverse Event|3
446259|NCT00410761|1476580|P1|Overall Study|Adverse Event|29
446260|NCT00410605|1476600|P1|Overall Study|Transferred to another Institution|1
446261|NCT00410605|1476600|P1|Overall Study|Stopped treatmen to collect stem cells|1
446262|NCT00410605|1476600|P1|Overall Study|Started Non-Protocol Therapy|3
446263|NCT00410605|1476600|P1|Overall Study|Withdrawal by Subject|5
446264|NCT00410605|1476600|P1|Overall Study|Physician Decision|3
446265|NCT00410605|1476600|P1|Overall Study|Adverse Event|12
446266|NCT00410514|1476612|P3|Overall Study|Non-compliant with study procedures|2
446267|NCT00410514|1476613|P2|Overall Study|Non-compliant with study procedures|0
446268|NCT00410514|1476614|P1|Overall Study|Non-compliant with study procedures|0
446269|NCT00410514|1476612|P3|Overall Study|Lost to Follow-up|2
446270|NCT00410514|1476613|P2|Overall Study|Lost to Follow-up|0
446271|NCT00410514|1476614|P1|Overall Study|Lost to Follow-up|0
446272|NCT00410514|1476612|P3|Overall Study|Protocol Violation|1
446273|NCT00410514|1476613|P2|Overall Study|Protocol Violation|1
446274|NCT00410514|1476614|P1|Overall Study|Protocol Violation|0
446275|NCT00410514|1476612|P3|Overall Study|Adverse Event|2
446276|NCT00410514|1476613|P2|Overall Study|Adverse Event|2
446277|NCT00410514|1476614|P1|Overall Study|Adverse Event|2
446278|NCT00410410|1476697|P9|Open-Label Period (OL)|not specified|7
446279|NCT00410410|1476698|P8|Open-Label Period (OL)|not specified|0
446280|NCT00410410|1476699|P7|Open-Label Period (OL)|not specified|0
446281|NCT00410410|1476700|P6|Open-Label Period (OL)|not specified|0
446282|NCT00410410|1476701|P5|Open-Label Period (OL)|not specified|0
446283|NCT00410410|1476702|P4|Open-Label Period (OL)|not specified|0
446284|NCT00410410|1476703|P3|Open-Label Period (OL)|not specified|0
446285|NCT00410410|1476704|P2|Open-Label Period (OL)|not specified|0
446286|NCT00410410|1476705|P1|Open-Label Period (OL)|not specified|0
446287|NCT00410410|1476697|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
446288|NCT00410410|1476698|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446289|NCT00410410|1476699|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446290|NCT00410410|1476700|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446291|NCT00410410|1476701|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446292|NCT00410410|1476702|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446293|NCT00410410|1476703|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446294|NCT00410410|1476704|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446295|NCT00410410|1476705|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
446296|NCT00410410|1476697|P9|Open-Label Period (OL)|Pregnancy|1
446297|NCT00410410|1476698|P8|Open-Label Period (OL)|Pregnancy|0
446298|NCT00410410|1476699|P7|Open-Label Period (OL)|Pregnancy|0
446299|NCT00410410|1476700|P6|Open-Label Period (OL)|Pregnancy|0
446300|NCT00410410|1476701|P5|Open-Label Period (OL)|Pregnancy|0
446301|NCT00410410|1476702|P4|Open-Label Period (OL)|Pregnancy|0
446302|NCT00410410|1476703|P3|Open-Label Period (OL)|Pregnancy|0
446303|NCT00410410|1476704|P2|Open-Label Period (OL)|Pregnancy|0
446304|NCT00410410|1476705|P1|Open-Label Period (OL)|Pregnancy|0
446305|NCT00410410|1476697|P9|Open-Label Period (OL)|Withdrawal by Subject|20
446306|NCT00410410|1476698|P8|Open-Label Period (OL)|Withdrawal by Subject|0
446307|NCT00410410|1476699|P7|Open-Label Period (OL)|Withdrawal by Subject|0
446308|NCT00410410|1476700|P6|Open-Label Period (OL)|Withdrawal by Subject|0
446309|NCT00410410|1476701|P5|Open-Label Period (OL)|Withdrawal by Subject|0
446310|NCT00410410|1476702|P4|Open-Label Period (OL)|Withdrawal by Subject|0
446311|NCT00410410|1476703|P3|Open-Label Period (OL)|Withdrawal by Subject|0
446312|NCT00410410|1476704|P2|Open-Label Period (OL)|Withdrawal by Subject|0
446313|NCT00410410|1476705|P1|Open-Label Period (OL)|Withdrawal by Subject|0
446314|NCT00410410|1476697|P9|Open-Label Period (OL)|Lost to Follow-up|4
446315|NCT00410410|1476698|P8|Open-Label Period (OL)|Lost to Follow-up|0
446316|NCT00410410|1476699|P7|Open-Label Period (OL)|Lost to Follow-up|0
446317|NCT00410410|1476700|P6|Open-Label Period (OL)|Lost to Follow-up|0
446318|NCT00410410|1476701|P5|Open-Label Period (OL)|Lost to Follow-up|0
446319|NCT00410410|1476702|P4|Open-Label Period (OL)|Lost to Follow-up|0
446320|NCT00410410|1476703|P3|Open-Label Period (OL)|Lost to Follow-up|0
446321|NCT00410410|1476704|P2|Open-Label Period (OL)|Lost to Follow-up|0
446322|NCT00410410|1476705|P1|Open-Label Period (OL)|Lost to Follow-up|0
446323|NCT00410410|1476697|P9|Open-Label Period (OL)|Lack of Efficacy|161
446324|NCT00410410|1476698|P8|Open-Label Period (OL)|Lack of Efficacy|0
446325|NCT00410410|1476699|P7|Open-Label Period (OL)|Lack of Efficacy|0
446326|NCT00410410|1476700|P6|Open-Label Period (OL)|Lack of Efficacy|0
446327|NCT00410410|1476701|P5|Open-Label Period (OL)|Lack of Efficacy|0
446328|NCT00410410|1476702|P4|Open-Label Period (OL)|Lack of Efficacy|0
446329|NCT00410410|1476703|P3|Open-Label Period (OL)|Lack of Efficacy|0
446330|NCT00410410|1476704|P2|Open-Label Period (OL)|Lack of Efficacy|0
446331|NCT00410410|1476705|P1|Open-Label Period (OL)|Lack of Efficacy|0
446332|NCT00410410|1476697|P9|Open-Label Period (OL)|Adverse Event|10
446333|NCT00410410|1476698|P8|Open-Label Period (OL)|Adverse Event|0
446334|NCT00410410|1476699|P7|Open-Label Period (OL)|Adverse Event|0
446335|NCT00410410|1476700|P6|Open-Label Period (OL)|Adverse Event|0
446336|NCT00410410|1476701|P5|Open-Label Period (OL)|Adverse Event|0
446337|NCT00410410|1476702|P4|Open-Label Period (OL)|Adverse Event|0
446338|NCT00410410|1476703|P3|Open-Label Period (OL)|Adverse Event|0
446339|NCT00410410|1476704|P2|Open-Label Period (OL)|Adverse Event|0
446340|NCT00410410|1476705|P1|Open-Label Period (OL)|Adverse Event|0
446341|NCT00410410|1476697|P9|Open-Label Period (OL)|Death|1
446342|NCT00410410|1476698|P8|Open-Label Period (OL)|Death|0
446343|NCT00410410|1476699|P7|Open-Label Period (OL)|Death|0
446344|NCT00410410|1476700|P6|Open-Label Period (OL)|Death|0
446345|NCT00410410|1476701|P5|Open-Label Period (OL)|Death|0
446346|NCT00410410|1476702|P4|Open-Label Period (OL)|Death|0
446347|NCT00410410|1476703|P3|Open-Label Period (OL)|Death|0
446348|NCT00410410|1476704|P2|Open-Label Period (OL)|Death|0
446349|NCT00410410|1476705|P1|Open-Label Period (OL)|Death|0
446350|NCT00410410|1476697|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
446351|NCT00410410|1476698|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
446352|NCT00410410|1476699|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
446353|NCT00410410|1476700|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
446354|NCT00410410|1476701|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
446355|NCT00410410|1476702|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
446356|NCT00410410|1476703|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
446357|NCT00410410|1476704|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
446358|NCT00410410|1476705|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
446359|NCT00410410|1476697|P9|Maintenance Period (MP)|Withdrawal by Subject|0
446360|NCT00410410|1476698|P8|Maintenance Period (MP)|Withdrawal by Subject|1
446361|NCT00410410|1476699|P7|Maintenance Period (MP)|Withdrawal by Subject|1
446362|NCT00410410|1476700|P6|Maintenance Period (MP)|Withdrawal by Subject|0
446363|NCT00410410|1476701|P5|Maintenance Period (MP)|Withdrawal by Subject|0
446364|NCT00410410|1476702|P4|Maintenance Period (MP)|Withdrawal by Subject|0
446365|NCT00410410|1476703|P3|Maintenance Period (MP)|Withdrawal by Subject|0
446366|NCT00410410|1476704|P2|Maintenance Period (MP)|Withdrawal by Subject|0
446367|NCT00410410|1476705|P1|Maintenance Period (MP)|Withdrawal by Subject|0
446368|NCT00410410|1476697|P9|Maintenance Period (MP)|Lost to Follow-up|0
446369|NCT00410410|1476698|P8|Maintenance Period (MP)|Lost to Follow-up|2
446370|NCT00410410|1476699|P7|Maintenance Period (MP)|Lost to Follow-up|1
446371|NCT00410410|1476700|P6|Maintenance Period (MP)|Lost to Follow-up|0
446372|NCT00410410|1476701|P5|Maintenance Period (MP)|Lost to Follow-up|0
446373|NCT00410410|1476702|P4|Maintenance Period (MP)|Lost to Follow-up|0
446374|NCT00410410|1476703|P3|Maintenance Period (MP)|Lost to Follow-up|0
446375|NCT00410410|1476704|P2|Maintenance Period (MP)|Lost to Follow-up|0
446376|NCT00410410|1476705|P1|Maintenance Period (MP)|Lost to Follow-up|0
446377|NCT00410410|1476697|P9|Maintenance Period (MP)|Lack of Efficacy|0
446378|NCT00410410|1476698|P8|Maintenance Period (MP)|Lack of Efficacy|24
446379|NCT00410410|1476699|P7|Maintenance Period (MP)|Lack of Efficacy|25
446380|NCT00410410|1476700|P6|Maintenance Period (MP)|Lack of Efficacy|0
446381|NCT00410410|1476701|P5|Maintenance Period (MP)|Lack of Efficacy|0
446382|NCT00410410|1476702|P4|Maintenance Period (MP)|Lack of Efficacy|0
446383|NCT00410410|1476703|P3|Maintenance Period (MP)|Lack of Efficacy|0
446384|NCT00410410|1476704|P2|Maintenance Period (MP)|Lack of Efficacy|0
446385|NCT00410410|1476705|P1|Maintenance Period (MP)|Lack of Efficacy|0
446386|NCT00410410|1476697|P9|Maintenance Period (MP)|Adverse Event|0
446387|NCT00410410|1476698|P8|Maintenance Period (MP)|Adverse Event|3
446388|NCT00410410|1476699|P7|Maintenance Period (MP)|Adverse Event|1
446389|NCT00410410|1476700|P6|Maintenance Period (MP)|Adverse Event|0
446390|NCT00410410|1476701|P5|Maintenance Period (MP)|Adverse Event|0
446391|NCT00410410|1476702|P4|Maintenance Period (MP)|Adverse Event|0
446392|NCT00410410|1476703|P3|Maintenance Period (MP)|Adverse Event|0
446393|NCT00410410|1476704|P2|Maintenance Period (MP)|Adverse Event|0
446394|NCT00410410|1476705|P1|Maintenance Period (MP)|Adverse Event|0
446395|NCT00410410|1476697|P9|Maintenance Period (MP)|Death|0
446396|NCT00410410|1476698|P8|Maintenance Period (MP)|Death|0
446397|NCT00410410|1476699|P7|Maintenance Period (MP)|Death|1
446398|NCT00410410|1476700|P6|Maintenance Period (MP)|Death|0
446399|NCT00410410|1476701|P5|Maintenance Period (MP)|Death|0
446400|NCT00410410|1476702|P4|Maintenance Period (MP)|Death|0
446401|NCT00410410|1476703|P3|Maintenance Period (MP)|Death|0
446402|NCT00410410|1476704|P2|Maintenance Period (MP)|Death|0
446403|NCT00410410|1476705|P1|Maintenance Period (MP)|Death|0
446404|NCT00410410|1476697|P9|Induction Period (IP)|not specified|0
446405|NCT00410410|1476698|P8|Induction Period (IP)|not specified|0
446406|NCT00410410|1476699|P7|Induction Period (IP)|not specified|0
446407|NCT00410410|1476700|P6|Induction Period (IP)|not specified|0
446408|NCT00410410|1476701|P5|Induction Period (IP)|not specified|0
446409|NCT00410410|1476702|P4|Induction Period (IP)|not specified|0
446410|NCT00410410|1476703|P3|Induction Period (IP)|not specified|1
446411|NCT00410410|1476704|P2|Induction Period (IP)|not specified|0
446412|NCT00410410|1476705|P1|Induction Period (IP)|not specified|0
446413|NCT00410410|1476697|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
446414|NCT00410410|1476698|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
446415|NCT00410410|1476699|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
446416|NCT00410410|1476700|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
446417|NCT00410410|1476701|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
446418|NCT00410410|1476702|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
446419|NCT00410410|1476703|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
446420|NCT00410410|1476704|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
446421|NCT00410410|1476705|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
446422|NCT00410410|1476697|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446423|NCT00410410|1476698|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446424|NCT00410410|1476699|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446425|NCT00410410|1476700|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446426|NCT00410410|1476701|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446427|NCT00410410|1476702|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446428|NCT00410410|1476703|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
446429|NCT00410410|1476704|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446430|NCT00410410|1476705|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
446431|NCT00410410|1476697|P9|Induction Period (IP)|Withdrawal by Subject|0
446432|NCT00410410|1476698|P8|Induction Period (IP)|Withdrawal by Subject|0
446433|NCT00410410|1476699|P7|Induction Period (IP)|Withdrawal by Subject|0
446434|NCT00410410|1476700|P6|Induction Period (IP)|Withdrawal by Subject|0
446435|NCT00410410|1476701|P5|Induction Period (IP)|Withdrawal by Subject|2
446436|NCT00410410|1476702|P4|Induction Period (IP)|Withdrawal by Subject|5
446437|NCT00410410|1476703|P3|Induction Period (IP)|Withdrawal by Subject|3
446438|NCT00410410|1476704|P2|Induction Period (IP)|Withdrawal by Subject|5
446439|NCT00410410|1476705|P1|Induction Period (IP)|Withdrawal by Subject|3
446440|NCT00410410|1476697|P9|Induction Period (IP)|Lost to Follow-up|0
446441|NCT00410410|1476698|P8|Induction Period (IP)|Lost to Follow-up|0
446442|NCT00410410|1476699|P7|Induction Period (IP)|Lost to Follow-up|0
446443|NCT00410410|1476700|P6|Induction Period (IP)|Lost to Follow-up|1
446444|NCT00410410|1476701|P5|Induction Period (IP)|Lost to Follow-up|0
446445|NCT00410410|1476702|P4|Induction Period (IP)|Lost to Follow-up|3
446446|NCT00410410|1476703|P3|Induction Period (IP)|Lost to Follow-up|2
446447|NCT00410410|1476704|P2|Induction Period (IP)|Lost to Follow-up|2
446448|NCT00410410|1476705|P1|Induction Period (IP)|Lost to Follow-up|2
446449|NCT00410410|1476697|P9|Induction Period (IP)|Lack of Efficacy|0
446450|NCT00410410|1476698|P8|Induction Period (IP)|Lack of Efficacy|0
446451|NCT00410410|1476699|P7|Induction Period (IP)|Lack of Efficacy|0
446452|NCT00410410|1476700|P6|Induction Period (IP)|Lack of Efficacy|7
446453|NCT00410410|1476701|P5|Induction Period (IP)|Lack of Efficacy|7
446454|NCT00410410|1476702|P4|Induction Period (IP)|Lack of Efficacy|8
446455|NCT00410410|1476703|P3|Induction Period (IP)|Lack of Efficacy|8
446456|NCT00410410|1476704|P2|Induction Period (IP)|Lack of Efficacy|24
446457|NCT00410410|1476705|P1|Induction Period (IP)|Lack of Efficacy|26
446458|NCT00410410|1476697|P9|Induction Period (IP)|Adverse Event|0
446459|NCT00410410|1476698|P8|Induction Period (IP)|Adverse Event|0
446460|NCT00410410|1476699|P7|Induction Period (IP)|Adverse Event|0
446461|NCT00410410|1476700|P6|Induction Period (IP)|Adverse Event|0
446462|NCT00410410|1476701|P5|Induction Period (IP)|Adverse Event|1
446463|NCT00410410|1476702|P4|Induction Period (IP)|Adverse Event|4
446464|NCT00410410|1476703|P3|Induction Period (IP)|Adverse Event|2
446465|NCT00410410|1476704|P2|Induction Period (IP)|Adverse Event|4
446466|NCT00410410|1476705|P1|Induction Period (IP)|Adverse Event|3
446467|NCT00410410|1476697|P9|Induction Period (IP)|Death|0
446468|NCT00410410|1476698|P8|Induction Period (IP)|Death|0
446469|NCT00410410|1476699|P7|Induction Period (IP)|Death|0
446470|NCT00410410|1476700|P6|Induction Period (IP)|Death|0
446471|NCT00410410|1476701|P5|Induction Period (IP)|Death|0
446472|NCT00410410|1476702|P4|Induction Period (IP)|Death|0
446473|NCT00410410|1476703|P3|Induction Period (IP)|Death|0
446474|NCT00410410|1476704|P2|Induction Period (IP)|Death|0
446475|NCT00410410|1476705|P1|Induction Period (IP)|Death|1
446476|NCT00410384|1476866|P3|Overall Study|Other|4
446477|NCT00410384|1476867|P2|Overall Study|Other|8
446478|NCT00410384|1476868|P1|Overall Study|Other|3
446479|NCT00410384|1476866|P3|Overall Study|Physician Decision|4
446480|NCT00410384|1476867|P2|Overall Study|Physician Decision|3
446481|NCT00410384|1476868|P1|Overall Study|Physician Decision|3
446482|NCT00410384|1476866|P3|Overall Study|Protocol Violation|6
446483|NCT00410384|1476867|P2|Overall Study|Protocol Violation|6
446484|NCT00410384|1476868|P1|Overall Study|Protocol Violation|6
446485|NCT00410384|1476866|P3|Overall Study|Lost to Follow-up|6
446486|NCT00410384|1476867|P2|Overall Study|Lost to Follow-up|6
446487|NCT00410384|1476868|P1|Overall Study|Lost to Follow-up|4
446488|NCT00410384|1476866|P3|Overall Study|Lack of Compliance|2
446489|NCT00410384|1476867|P2|Overall Study|Lack of Compliance|2
446490|NCT00410384|1476868|P1|Overall Study|Lack of Compliance|2
446491|NCT00410384|1476866|P3|Overall Study|Lack of Efficacy|17
446492|NCT00410384|1476867|P2|Overall Study|Lack of Efficacy|12
446493|NCT00410384|1476868|P1|Overall Study|Lack of Efficacy|20
446494|NCT00410384|1476866|P3|Overall Study|Adverse Event|23
446495|NCT00410384|1476867|P2|Overall Study|Adverse Event|18
446496|NCT00410384|1476868|P1|Overall Study|Adverse Event|23
446497|NCT00410384|1476866|P3|Overall Study|Withdrawal by Subject|20
446498|NCT00410384|1476867|P2|Overall Study|Withdrawal by Subject|17
446499|NCT00410384|1476868|P1|Overall Study|Withdrawal by Subject|28
446500|NCT00410202|1476941|P3|Off-treatment Follow up|Lost to Follow-up|0
446501|NCT00410202|1476942|P2|Off-treatment Follow up|Lost to Follow-up|0
446502|NCT00410202|1476943|P1|Off-treatment Follow up|Lost to Follow-up|1
446503|NCT00410202|1476941|P3|Off-treatment Follow up|Follow up not required per protocol|1
446504|NCT00410202|1476942|P2|Off-treatment Follow up|Follow up not required per protocol|0
446505|NCT00410202|1476943|P1|Off-treatment Follow up|Follow up not required per protocol|3
446506|NCT00410202|1476941|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
446507|NCT00410202|1476942|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
446508|NCT00410202|1476943|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
446509|NCT00410202|1476941|P3|On-Treatment|Other Reason|1
446510|NCT00410202|1476942|P2|On-Treatment|Other Reason|0
446511|NCT00410202|1476943|P1|On-Treatment|Other Reason|0
446512|NCT00410202|1476941|P3|On-Treatment|Withdrawal by Subject|1
446513|NCT00410202|1476942|P2|On-Treatment|Withdrawal by Subject|1
446514|NCT00410202|1476943|P1|On-Treatment|Withdrawal by Subject|2
446515|NCT00410202|1476941|P3|On-Treatment|Lack of Efficacy|0
446516|NCT00410202|1476942|P2|On-Treatment|Lack of Efficacy|4
446517|NCT00410202|1476943|P1|On-Treatment|Lack of Efficacy|1
446518|NCT00410202|1476941|P3|On-Treatment|Lost to Follow-up|1
446519|NCT00410202|1476942|P2|On-Treatment|Lost to Follow-up|0
446520|NCT00410202|1476943|P1|On-Treatment|Lost to Follow-up|1
446521|NCT00410202|1476941|P3|On-Treatment|Death|0
446522|NCT00410202|1476942|P2|On-Treatment|Death|0
446523|NCT00410202|1476943|P1|On-Treatment|Death|1
446524|NCT00410202|1476941|P3|On-Treatment|Adverse Event|2
446525|NCT00410202|1476942|P2|On-Treatment|Adverse Event|3
446526|NCT00410202|1476943|P1|On-Treatment|Adverse Event|1
446527|NCT00410202|1476941|P3|On-Treatment|Continuing treatment|66
446528|NCT00410202|1476942|P2|On-Treatment|Continuing treatment|71
446529|NCT00410202|1476943|P1|On-Treatment|Continuing treatment|69
446530|NCT00410163|1477030|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
446531|NCT00410163|1477031|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
446532|NCT00410163|1477030|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
446533|NCT00410163|1477031|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
446534|NCT00410163|1477030|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
446535|NCT00410163|1477031|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
446536|NCT00410163|1477030|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
446537|NCT00410163|1477031|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
446538|NCT00410163|1477030|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
446539|NCT00410163|1477031|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
446540|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
446541|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
446542|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
446543|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
446544|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
446545|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
446546|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
446547|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
446548|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
446549|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
446550|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
446551|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
446552|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
446553|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
446554|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Death|1
446555|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Death|1
446556|NCT00410163|1477030|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
446557|NCT00410163|1477031|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
446558|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
446559|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
446560|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
446561|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
446562|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
446563|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
446564|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Death|10
446565|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Death|2
446566|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
446567|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
446568|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
446649|NCT00409773|1477265|P3|Overall Study|Withdrawal by Subject|0
446569|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
446570|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
446571|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
446572|NCT00410124|1477084|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
446573|NCT00410124|1477085|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
446574|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
446575|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
446576|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Death|4
446577|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Death|7
446578|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
446579|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
446580|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
446581|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
446582|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
446583|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
446584|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
446585|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
446586|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
446587|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
446588|NCT00410124|1477084|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
446589|NCT00410124|1477085|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
446590|NCT00410072|1477116|P2|After Week 48 to Week 96|Withdrawal by Subject|1
446591|NCT00410072|1477117|P1|After Week 48 to Week 96|Withdrawal by Subject|0
446592|NCT00410072|1477116|P2|After Week 48 to Week 96|Pregnancy|2
446593|NCT00410072|1477117|P1|After Week 48 to Week 96|Pregnancy|0
446594|NCT00410072|1477116|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
446595|NCT00410072|1477117|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
446596|NCT00410072|1477116|P2|After Week 48 to Week 96|Not specified|0
446597|NCT00410072|1477117|P1|After Week 48 to Week 96|Not specified|2
446598|NCT00410072|1477116|P2|After Week 48 to Week 96|Lost to Follow-up|4
446599|NCT00410072|1477117|P1|After Week 48 to Week 96|Lost to Follow-up|2
446600|NCT00410072|1477116|P2|After Week 48 to Week 96|Lack of Efficacy|0
446601|NCT00410072|1477117|P1|After Week 48 to Week 96|Lack of Efficacy|1
446602|NCT00410072|1477116|P2|After Week 48 to Week 96|Death|1
446603|NCT00410072|1477117|P1|After Week 48 to Week 96|Death|0
446604|NCT00410072|1477116|P2|After Week 48 to Week 96|Adverse Event|2
446605|NCT00410072|1477117|P1|After Week 48 to Week 96|Adverse Event|1
446606|NCT00410072|1477116|P2|Day 1 to Week 48|Withdrawal by Subject|2
446607|NCT00410072|1477117|P1|Day 1 to Week 48|Withdrawal by Subject|0
446608|NCT00410072|1477116|P2|Day 1 to Week 48|Pregnancy|2
446609|NCT00410072|1477117|P1|Day 1 to Week 48|Pregnancy|0
446610|NCT00410072|1477116|P2|Day 1 to Week 48|poor compliance/noncompliance|3
446611|NCT00410072|1477117|P1|Day 1 to Week 48|poor compliance/noncompliance|0
446612|NCT00410072|1477116|P2|Day 1 to Week 48|Not specified|1
446613|NCT00410072|1477117|P1|Day 1 to Week 48|Not specified|0
446614|NCT00410072|1477116|P2|Day 1 to Week 48|Lost to Follow-up|2
446615|NCT00410072|1477117|P1|Day 1 to Week 48|Lost to Follow-up|5
446616|NCT00410072|1477116|P2|Day 1 to Week 48|Adverse Event|2
446617|NCT00410072|1477117|P1|Day 1 to Week 48|Adverse Event|1
446618|NCT00410046|1477157|P1|Overall Study|Lost to Follow-up|1
446619|NCT00410046|1477157|P1|Overall Study|Withdrawal by Subject|1
446620|NCT00410046|1477157|P1|Overall Study|Adverse Event|3
446621|NCT00409838|1477188|P2|Long-term Extension Period|Pregnancy|0
446622|NCT00409838|1477189|P1|Long-term Extension Period|Pregnancy|1
446623|NCT00409838|1477188|P2|Long-term Extension Period|Poor compliance/noncompliance|0
446624|NCT00409838|1477189|P1|Long-term Extension Period|Poor compliance/noncompliance|1
446625|NCT00409838|1477188|P2|Long-term Extension Period|Withdrawal by Subject|0
446626|NCT00409838|1477189|P1|Long-term Extension Period|Withdrawal by Subject|3
446627|NCT00409838|1477188|P2|Long-term Extension Period|Lack of Efficacy|0
446628|NCT00409838|1477189|P1|Long-term Extension Period|Lack of Efficacy|2
446629|NCT00409838|1477188|P2|Long-term Extension Period|Death|0
446630|NCT00409838|1477189|P1|Long-term Extension Period|Death|1
446631|NCT00409838|1477188|P2|Long-term Extension Period|Adverse Event|0
446632|NCT00409838|1477189|P1|Long-term Extension Period|Adverse Event|10
446633|NCT00409838|1477188|P2|Short-term Period|Never Treated|0
446634|NCT00409838|1477189|P1|Short-term Period|Never Treated|1
446635|NCT00409838|1477188|P2|Short-term Period|Withdrawal by Subject|3
446636|NCT00409838|1477189|P1|Short-term Period|Withdrawal by Subject|2
446637|NCT00409838|1477188|P2|Short-term Period|Lost to Follow-up|1
446638|NCT00409838|1477189|P1|Short-term Period|Lost to Follow-up|0
446639|NCT00409838|1477188|P2|Short-term Period|Adverse Event|1
446640|NCT00409838|1477189|P1|Short-term Period|Adverse Event|0
446641|NCT00409786|1477254|P1|Overall Study|Withdrawal by Subject|3
446642|NCT00409773|1477263|P5|Overall Study|Lack of Eligibility|1
446643|NCT00409773|1477264|P4|Overall Study|Lack of Eligibility|0
446644|NCT00409773|1477265|P3|Overall Study|Lack of Eligibility|0
446645|NCT00409773|1477266|P2|Overall Study|Lack of Eligibility|0
446646|NCT00409773|1477267|P1|Overall Study|Lack of Eligibility|0
446647|NCT00409773|1477263|P5|Overall Study|Withdrawal by Subject|1
446648|NCT00409773|1477264|P4|Overall Study|Withdrawal by Subject|2
446650|NCT00409773|1477266|P2|Overall Study|Withdrawal by Subject|0
446651|NCT00409773|1477267|P1|Overall Study|Withdrawal by Subject|0
446652|NCT00409773|1477263|P5|Overall Study|Protocol Violation|1
446653|NCT00409773|1477264|P4|Overall Study|Protocol Violation|3
446654|NCT00409773|1477265|P3|Overall Study|Protocol Violation|3
446655|NCT00409773|1477266|P2|Overall Study|Protocol Violation|2
446656|NCT00409773|1477267|P1|Overall Study|Protocol Violation|0
446657|NCT00409773|1477263|P5|Overall Study|Physician Decision|0
446658|NCT00409773|1477264|P4|Overall Study|Physician Decision|2
446659|NCT00409773|1477265|P3|Overall Study|Physician Decision|0
446660|NCT00409773|1477266|P2|Overall Study|Physician Decision|0
446661|NCT00409773|1477267|P1|Overall Study|Physician Decision|0
446662|NCT00409773|1477263|P5|Overall Study|Lost to Follow-up|1
446663|NCT00409773|1477264|P4|Overall Study|Lost to Follow-up|3
446664|NCT00409773|1477265|P3|Overall Study|Lost to Follow-up|2
446665|NCT00409773|1477266|P2|Overall Study|Lost to Follow-up|1
446666|NCT00409773|1477267|P1|Overall Study|Lost to Follow-up|6
446667|NCT00409773|1477263|P5|Overall Study|Adverse Event|6
446668|NCT00409773|1477264|P4|Overall Study|Adverse Event|2
446669|NCT00409773|1477265|P3|Overall Study|Adverse Event|4
446670|NCT00409773|1477266|P2|Overall Study|Adverse Event|4
446671|NCT00409773|1477267|P1|Overall Study|Adverse Event|3
446672|NCT00409747|1477349|P1|Overall Study|Withdrawal by Subject|1
446673|NCT00409708|1477356|P2|Washout|Lost to Follow-up|3
446674|NCT00409708|1477357|P1|Washout|Lost to Follow-up|1
446675|NCT00409708|1477356|P2|Washout|Withdrawal by Subject|5
446676|NCT00409708|1477357|P1|Washout|Withdrawal by Subject|11
446677|NCT00409708|1477356|P2|Washout|Protocol Violation|1
446678|NCT00409708|1477357|P1|Washout|Protocol Violation|0
446679|NCT00409708|1477356|P2|Washout|Lack of Efficacy|1
446680|NCT00409708|1477357|P1|Washout|Lack of Efficacy|9
446681|NCT00409708|1477356|P2|Treatment|Administrative problems|0
446682|NCT00409708|1477357|P1|Treatment|Administrative problems|5
446683|NCT00409708|1477356|P2|Treatment|Lost to Follow-up|6
446684|NCT00409708|1477357|P1|Treatment|Lost to Follow-up|0
446685|NCT00409708|1477356|P2|Treatment|Withdrawal by Subject|8
446686|NCT00409708|1477357|P1|Treatment|Withdrawal by Subject|3
446687|NCT00409708|1477356|P2|Treatment|Protocol Violation|2
446688|NCT00409708|1477357|P1|Treatment|Protocol Violation|6
446689|NCT00409708|1477356|P2|Treatment|Lack of Efficacy|1
446690|NCT00409708|1477357|P1|Treatment|Lack of Efficacy|0
446691|NCT00409708|1477356|P2|Treatment|Abnormal test procedure result(s)|0
446692|NCT00409708|1477357|P1|Treatment|Abnormal test procedure result(s)|1
446693|NCT00409682|1477378|P3|EOW Double-blind Maintenance Period|Non-compliance|1
446694|NCT00409682|1477379|P2|EOW Double-blind Maintenance Period|Non-compliance|0
446695|NCT00409682|1477380|P1|EOW Double-blind Maintenance Period|Non-compliance|0
446696|NCT00409682|1477378|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
446697|NCT00409682|1477379|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
446698|NCT00409682|1477380|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
446699|NCT00409682|1477378|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
446700|NCT00409682|1477379|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
446701|NCT00409682|1477380|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
446702|NCT00409682|1477378|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
446703|NCT00409682|1477379|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
446704|NCT00409682|1477380|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
446705|NCT00409682|1477378|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
446706|NCT00409682|1477379|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
446707|NCT00409682|1477380|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
446708|NCT00409682|1477378|P3|EOW Double-blind Maintenance Period|Adverse Event|12
446709|NCT00409682|1477379|P2|EOW Double-blind Maintenance Period|Adverse Event|10
446710|NCT00409682|1477380|P1|EOW Double-blind Maintenance Period|Adverse Event|0
446711|NCT00409682|1477378|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
446712|NCT00409682|1477379|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
446713|NCT00409682|1477380|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
446714|NCT00409682|1477378|P3|Open-label Induction Period|Protocol Violation|0
446715|NCT00409682|1477379|P2|Open-label Induction Period|Protocol Violation|0
446716|NCT00409682|1477380|P1|Open-label Induction Period|Protocol Violation|1
446717|NCT00409682|1477378|P3|Open-label Induction Period|Lack of Efficacy|0
446718|NCT00409682|1477379|P2|Open-label Induction Period|Lack of Efficacy|0
446719|NCT00409682|1477380|P1|Open-label Induction Period|Lack of Efficacy|1
446720|NCT00409682|1477378|P3|Open-label Induction Period|Adverse Event|0
446721|NCT00409682|1477379|P2|Open-label Induction Period|Adverse Event|0
446722|NCT00409682|1477380|P1|Open-label Induction Period|Adverse Event|1
446723|NCT00409617|1477397|P1|Overall Study|Not described|14
446724|NCT00409617|1477397|P1|Overall Study|Administrative reasons|1
446725|NCT00409617|1477397|P1|Overall Study|Withdrawal by Subject|8
446726|NCT00409617|1477397|P1|Overall Study|Protocol Violation|24
446727|NCT00409617|1477397|P1|Overall Study|Lost to Follow-up|2
446728|NCT00409617|1477397|P1|Overall Study|Lack of Efficacy|54
446729|NCT00409617|1477397|P1|Overall Study|Adverse Event|57
446730|NCT00409578|1477413|P4|Overall Study|Missing|1
446731|NCT00409578|1477414|P3|Overall Study|Missing|0
446732|NCT00409578|1477415|P2|Overall Study|Missing|1
446733|NCT00409578|1477416|P1|Overall Study|Missing|0
446734|NCT00409578|1477413|P4|Overall Study|Protocol Violation|1
446735|NCT00409578|1477414|P3|Overall Study|Protocol Violation|3
446736|NCT00409578|1477415|P2|Overall Study|Protocol Violation|2
446737|NCT00409578|1477416|P1|Overall Study|Protocol Violation|3
446738|NCT00409578|1477413|P4|Overall Study|Death|2
446739|NCT00409578|1477414|P3|Overall Study|Death|4
446740|NCT00409578|1477415|P2|Overall Study|Death|4
446741|NCT00409578|1477416|P1|Overall Study|Death|2
446742|NCT00409578|1477413|P4|Overall Study|Administrative problems|4
446743|NCT00409578|1477414|P3|Overall Study|Administrative problems|2
446744|NCT00409578|1477415|P2|Overall Study|Administrative problems|9
446745|NCT00409578|1477416|P1|Overall Study|Administrative problems|8
446746|NCT00409578|1477413|P4|Overall Study|Lost to Follow-up|2
446747|NCT00409578|1477414|P3|Overall Study|Lost to Follow-up|2
446748|NCT00409578|1477415|P2|Overall Study|Lost to Follow-up|0
446749|NCT00409578|1477416|P1|Overall Study|Lost to Follow-up|2
446750|NCT00409578|1477413|P4|Overall Study|Withdrawal by Subject|17
446751|NCT00409578|1477414|P3|Overall Study|Withdrawal by Subject|16
446752|NCT00409578|1477415|P2|Overall Study|Withdrawal by Subject|15
446753|NCT00409578|1477416|P1|Overall Study|Withdrawal by Subject|8
446754|NCT00409578|1477413|P4|Overall Study|Subject no longer requires study drug|1
446755|NCT00409578|1477414|P3|Overall Study|Subject no longer requires study drug|0
446756|NCT00409578|1477415|P2|Overall Study|Subject no longer requires study drug|0
446757|NCT00409578|1477416|P1|Overall Study|Subject no longer requires study drug|0
446758|NCT00409578|1477413|P4|Overall Study|Lack of Efficacy|2
446759|NCT00409578|1477414|P3|Overall Study|Lack of Efficacy|0
446760|NCT00409578|1477415|P2|Overall Study|Lack of Efficacy|0
446761|NCT00409578|1477416|P1|Overall Study|Lack of Efficacy|0
446762|NCT00409578|1477413|P4|Overall Study|Abnormal laboratory value(s)|4
446763|NCT00409578|1477414|P3|Overall Study|Abnormal laboratory value(s)|2
446764|NCT00409578|1477415|P2|Overall Study|Abnormal laboratory value(s)|2
446765|NCT00409578|1477416|P1|Overall Study|Abnormal laboratory value(s)|2
446766|NCT00409578|1477413|P4|Overall Study|Adverse Event|33
446767|NCT00409578|1477414|P3|Overall Study|Adverse Event|25
446768|NCT00409578|1477415|P2|Overall Study|Adverse Event|37
446769|NCT00409578|1477416|P1|Overall Study|Adverse Event|27
446770|NCT00409409|1477474|P2|Overall Study|Any other reason not above-mentioned|1
446771|NCT00409409|1477475|P1|Overall Study|Any other reason not above-mentioned|0
446772|NCT00409409|1477474|P2|Overall Study|Withdrawal by Subject|1
446773|NCT00409409|1477475|P1|Overall Study|Withdrawal by Subject|1
446774|NCT00409409|1477474|P2|Overall Study|Adverse Event|2
446775|NCT00409409|1477475|P1|Overall Study|Adverse Event|7
446776|NCT00409344|1477483|P2|Overall Study|no enrollment|0
446777|NCT00409344|1477484|P1|Overall Study|no enrollment|0
446778|NCT00409331|1477502|P1|Overall Study|Physician Decision|1
446779|NCT00409188|1477524|P2|Overall Study|Ongoing at data cut-off|175
446780|NCT00409188|1477525|P1|Overall Study|Ongoing at data cut-off|383
446781|NCT00409175|1477541|P2|Overall Study|Liver transplantation|13
446782|NCT00409175|1477542|P1|Overall Study|Liver transplantation|13
446783|NCT00409175|1477541|P2|Overall Study|Negative genotype|1
446784|NCT00409175|1477542|P1|Overall Study|Negative genotype|0
446785|NCT00409175|1477541|P2|Overall Study|Withdrawal by Subject|2
446786|NCT00409175|1477542|P1|Overall Study|Withdrawal by Subject|1
446787|NCT00409175|1477541|P2|Overall Study|Adverse Event|3
446788|NCT00409175|1477542|P1|Overall Study|Adverse Event|4
446789|NCT00409006|1477568|P2|Overall Study|Physician Decision|2
446790|NCT00409006|1477569|P1|Overall Study|Physician Decision|1
446791|NCT00409006|1477568|P2|Overall Study|Withdrawal by Subject|2
446792|NCT00409006|1477569|P1|Overall Study|Withdrawal by Subject|3
446793|NCT00409006|1477568|P2|Overall Study|Lost to Follow-up|2
446794|NCT00409006|1477569|P1|Overall Study|Lost to Follow-up|1
446795|NCT00409006|1477568|P2|Overall Study|Death|6
446796|NCT00409006|1477569|P1|Overall Study|Death|15
446797|NCT00408993|1477585|P2|Overall Study|Withdrawal by Subject|3
446798|NCT00408993|1477586|P1|Overall Study|Withdrawal by Subject|2
446799|NCT00408993|1477585|P2|Overall Study|Lack of Efficacy|4
446800|NCT00408993|1477586|P1|Overall Study|Lack of Efficacy|1
446801|NCT00408993|1477585|P2|Overall Study|Protocol Violation|6
446802|NCT00408993|1477586|P1|Overall Study|Protocol Violation|1
446803|NCT00408993|1477585|P2|Overall Study|Adverse Event|4
446804|NCT00408993|1477586|P1|Overall Study|Adverse Event|15
446805|NCT00408928|1477618|P1|Overall Study|Infection indistinguishable from GVHD|1
446806|NCT00408928|1477618|P1|Overall Study|Death|1
446807|NCT00408928|1477618|P1|Overall Study|Withdrawal by Subject|1
446808|NCT00408902|1477623|P1|Overall Study|Adverse Event|3
446809|NCT00408902|1477623|P1|Overall Study|Lack of Efficacy|7
446810|NCT00408876|1477633|P4|Overall Study|Physician Decision|0
446811|NCT00408876|1477634|P3|Overall Study|Physician Decision|3
446812|NCT00408876|1477635|P2|Overall Study|Physician Decision|0
446813|NCT00408876|1477636|P1|Overall Study|Physician Decision|1
446814|NCT00408876|1477633|P4|Overall Study|Protocol Violation|3
446815|NCT00408876|1477634|P3|Overall Study|Protocol Violation|4
446816|NCT00408876|1477635|P2|Overall Study|Protocol Violation|3
446817|NCT00408876|1477636|P1|Overall Study|Protocol Violation|0
446818|NCT00408876|1477633|P4|Overall Study|Lost to Follow-up|2
446819|NCT00408876|1477634|P3|Overall Study|Lost to Follow-up|5
446820|NCT00408876|1477635|P2|Overall Study|Lost to Follow-up|6
446821|NCT00408876|1477636|P1|Overall Study|Lost to Follow-up|1
446822|NCT00408876|1477633|P4|Overall Study|Lack of Efficacy|6
446823|NCT00408876|1477634|P3|Overall Study|Lack of Efficacy|5
446824|NCT00408876|1477635|P2|Overall Study|Lack of Efficacy|4
446825|NCT00408876|1477636|P1|Overall Study|Lack of Efficacy|2
446826|NCT00408876|1477633|P4|Overall Study|Withdrawal by Subject|14
446827|NCT00408876|1477634|P3|Overall Study|Withdrawal by Subject|6
446828|NCT00408876|1477635|P2|Overall Study|Withdrawal by Subject|6
446829|NCT00408876|1477636|P1|Overall Study|Withdrawal by Subject|3
446830|NCT00408876|1477633|P4|Overall Study|Adverse Event|10
446831|NCT00408876|1477634|P3|Overall Study|Adverse Event|27
446832|NCT00408876|1477635|P2|Overall Study|Adverse Event|17
446833|NCT00408876|1477636|P1|Overall Study|Adverse Event|9
446834|NCT00408694|1477886|P1|Overall Study|No protocol treatment|1
446835|NCT00408694|1477886|P1|Overall Study|Ineligible|1
446836|NCT00408681|1477898|P1|Overall Study|Adverse Event|7
446837|NCT00408681|1477898|P1|Overall Study|Lack of Efficacy|2
446838|NCT00408629|1477917|P2|Overall Study|Miscellaneous|15
446839|NCT00408629|1477918|P1|Overall Study|Miscellaneous|11
446840|NCT00408629|1477917|P2|Overall Study|Protocol Violation|5
446841|NCT00408629|1477918|P1|Overall Study|Protocol Violation|1
446842|NCT00408629|1477917|P2|Overall Study|Lack of Efficacy|73
446843|NCT00408629|1477918|P1|Overall Study|Lack of Efficacy|63
446844|NCT00408629|1477917|P2|Overall Study|Lost to Follow-up|1
446845|NCT00408629|1477918|P1|Overall Study|Lost to Follow-up|1
446846|NCT00408629|1477917|P2|Overall Study|Withdrawal by Subject|4
446847|NCT00408629|1477918|P1|Overall Study|Withdrawal by Subject|8
446848|NCT00408629|1477917|P2|Overall Study|Adverse Event|27
446849|NCT00408629|1477918|P1|Overall Study|Adverse Event|13
446850|NCT00408499|1478005|P5|Phase II- MTD Expansion|treatment delay|3
446851|NCT00408499|1478006|P4|Phase II- MTD Expansion|treatment delay|0
446852|NCT00408499|1478007|P3|Phase II- MTD Expansion|treatment delay|0
446853|NCT00408499|1478008|P2|Phase II- MTD Expansion|treatment delay|0
446854|NCT00408499|1478009|P1|Phase II- MTD Expansion|treatment delay|0
446855|NCT00408499|1478005|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
446856|NCT00408499|1478006|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
446857|NCT00408499|1478007|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
446858|NCT00408499|1478008|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
446859|NCT00408499|1478009|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
446860|NCT00408499|1478005|P5|Phase II- MTD Expansion|Physician Decision|1
446861|NCT00408499|1478006|P4|Phase II- MTD Expansion|Physician Decision|0
446862|NCT00408499|1478007|P3|Phase II- MTD Expansion|Physician Decision|0
446863|NCT00408499|1478008|P2|Phase II- MTD Expansion|Physician Decision|0
446864|NCT00408499|1478009|P1|Phase II- MTD Expansion|Physician Decision|0
446865|NCT00408499|1478005|P5|Phase II- MTD Expansion|Death|2
446866|NCT00408499|1478006|P4|Phase II- MTD Expansion|Death|0
446867|NCT00408499|1478007|P3|Phase II- MTD Expansion|Death|0
446868|NCT00408499|1478008|P2|Phase II- MTD Expansion|Death|0
446869|NCT00408499|1478009|P1|Phase II- MTD Expansion|Death|0
446870|NCT00408499|1478005|P5|Phase II- MTD Expansion|Adverse Event|9
446871|NCT00408499|1478006|P4|Phase II- MTD Expansion|Adverse Event|0
446872|NCT00408499|1478007|P3|Phase II- MTD Expansion|Adverse Event|0
446873|NCT00408499|1478008|P2|Phase II- MTD Expansion|Adverse Event|0
446874|NCT00408499|1478009|P1|Phase II- MTD Expansion|Adverse Event|0
446875|NCT00408499|1478005|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
446876|NCT00408499|1478006|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
446877|NCT00408499|1478007|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
446878|NCT00408499|1478008|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
446879|NCT00408499|1478009|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
446880|NCT00408499|1478005|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
446881|NCT00408499|1478006|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
446882|NCT00408499|1478007|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
446883|NCT00408499|1478008|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
446884|NCT00408499|1478009|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
446885|NCT00408499|1478005|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
446886|NCT00408499|1478006|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
446887|NCT00408499|1478007|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
446888|NCT00408499|1478008|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
446889|NCT00408499|1478009|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
446890|NCT00408421|1478026|P3|Treatment Re-Randomization|Withdrawal by Subject|0
446891|NCT00408421|1478027|P2|Treatment Re-Randomization|Withdrawal by Subject|1
446892|NCT00408421|1478028|P1|Treatment Re-Randomization|Withdrawal by Subject|2
446893|NCT00408421|1478026|P3|Treatment Re-Randomization|Protocol Violation|0
446894|NCT00408421|1478027|P2|Treatment Re-Randomization|Protocol Violation|1
446895|NCT00408421|1478028|P1|Treatment Re-Randomization|Protocol Violation|1
446896|NCT00408421|1478026|P3|Treatment Re-Randomization|Physician Decision|0
446897|NCT00408421|1478027|P2|Treatment Re-Randomization|Physician Decision|3
446898|NCT00408421|1478028|P1|Treatment Re-Randomization|Physician Decision|1
446899|NCT00408421|1478026|P3|Treatment Re-Randomization|Lost to Follow-up|1
446900|NCT00408421|1478027|P2|Treatment Re-Randomization|Lost to Follow-up|0
446901|NCT00408421|1478028|P1|Treatment Re-Randomization|Lost to Follow-up|0
446902|NCT00408421|1478026|P3|Treatment Re-Randomization|Lack of Efficacy|0
446903|NCT00408421|1478027|P2|Treatment Re-Randomization|Lack of Efficacy|0
446904|NCT00408421|1478028|P1|Treatment Re-Randomization|Lack of Efficacy|1
446905|NCT00408421|1478026|P3|Treatment Re-Randomization|Adverse Event|4
446906|NCT00408421|1478027|P2|Treatment Re-Randomization|Adverse Event|2
446907|NCT00408421|1478028|P1|Treatment Re-Randomization|Adverse Event|2
446908|NCT00408421|1478026|P3|Treatment Initial Randomization|Sponsor Decision|0
446909|NCT00408421|1478027|P2|Treatment Initial Randomization|Sponsor Decision|0
446910|NCT00408421|1478028|P1|Treatment Initial Randomization|Sponsor Decision|1
446911|NCT00408421|1478026|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
446912|NCT00408421|1478027|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
446913|NCT00408421|1478028|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
446914|NCT00408421|1478026|P3|Treatment Initial Randomization|Withdrawal by Subject|0
446915|NCT00408421|1478027|P2|Treatment Initial Randomization|Withdrawal by Subject|7
446916|NCT00408421|1478028|P1|Treatment Initial Randomization|Withdrawal by Subject|7
446917|NCT00408421|1478026|P3|Treatment Initial Randomization|Protocol Violation|0
446918|NCT00408421|1478027|P2|Treatment Initial Randomization|Protocol Violation|1
446919|NCT00408421|1478028|P1|Treatment Initial Randomization|Protocol Violation|0
446920|NCT00408421|1478026|P3|Treatment Initial Randomization|Physician Decision|0
446921|NCT00408421|1478027|P2|Treatment Initial Randomization|Physician Decision|0
446922|NCT00408421|1478028|P1|Treatment Initial Randomization|Physician Decision|1
446923|NCT00408421|1478026|P3|Treatment Initial Randomization|Lost to Follow-up|0
446924|NCT00408421|1478027|P2|Treatment Initial Randomization|Lost to Follow-up|3
446925|NCT00408421|1478028|P1|Treatment Initial Randomization|Lost to Follow-up|0
446926|NCT00408421|1478026|P3|Treatment Initial Randomization|Lack of Efficacy|0
446927|NCT00408421|1478027|P2|Treatment Initial Randomization|Lack of Efficacy|2
446928|NCT00408421|1478028|P1|Treatment Initial Randomization|Lack of Efficacy|2
446929|NCT00408421|1478026|P3|Treatment Initial Randomization|Adverse Event|0
446930|NCT00408421|1478027|P2|Treatment Initial Randomization|Adverse Event|9
446931|NCT00408421|1478028|P1|Treatment Initial Randomization|Adverse Event|5
446932|NCT00408408|1478108|P6|Overall Study|No follow up data|3
446933|NCT00408408|1478109|P5|Overall Study|No follow up data|5
446934|NCT00408408|1478110|P4|Overall Study|No follow up data|7
446935|NCT00408408|1478111|P3|Overall Study|No follow up data|0
446936|NCT00408408|1478112|P2|Overall Study|No follow up data|3
446937|NCT00408408|1478113|P1|Overall Study|No follow up data|2
446938|NCT00408317|1478175|P2|Second Intervention Period|Withdrawal of consent|1
446939|NCT00408317|1478176|P1|Second Intervention Period|Withdrawal of consent|0
446940|NCT00408317|1478175|P2|Second Intervention Period|Protocol Violation|1
446941|NCT00408317|1478176|P1|Second Intervention Period|Protocol Violation|0
446942|NCT00408317|1478175|P2|Second Intervention Period|Adverse Event|0
446943|NCT00408317|1478176|P1|Second Intervention Period|Adverse Event|2
446944|NCT00408317|1478175|P2|First Intervention Period|Adverse Event|1
446945|NCT00408317|1478176|P1|First Intervention Period|Adverse Event|0
446946|NCT00407797|1478219|P1|Overall Study|Withdrawal by Subject|3
446947|NCT00407797|1478219|P1|Overall Study|Other|7
446948|NCT00407797|1478219|P1|Overall Study|Adverse Event|6
446949|NCT00407797|1478219|P1|Overall Study|Lost to Follow-up|2
446950|NCT00407758|1478234|P1|Overall Study|ineligible –improper prior treatment|1
446951|NCT00407745|1478247|P2|Overall Study|Randomized, unknown if treated|1
446952|NCT00407745|1478248|P1|Overall Study|Randomized, unknown if treated|0
446953|NCT00407745|1478247|P2|Overall Study|Other|0
446954|NCT00407745|1478248|P1|Overall Study|Other|2
446955|NCT00407745|1478247|P2|Overall Study|Adverse Event|8
446956|NCT00407745|1478248|P1|Overall Study|Adverse Event|8
446957|NCT00407745|1478247|P2|Overall Study|Protocol Violation|3
446958|NCT00407745|1478248|P1|Overall Study|Protocol Violation|5
446959|NCT00407745|1478247|P2|Overall Study|Withdrawal by Subject|3
446960|NCT00407745|1478248|P1|Overall Study|Withdrawal by Subject|3
446961|NCT00407745|1478247|P2|Overall Study|Lack of Efficacy|2
446962|NCT00407745|1478248|P1|Overall Study|Lack of Efficacy|1
446963|NCT00407563|1478332|P1|Overall Study|Patient continues on treatment|1
446964|NCT00407550|1478342|P2|Overall Study|Insurance or Other medical condition|1
446965|NCT00407550|1478343|P1|Overall Study|Insurance or Other medical condition|2
446966|NCT00407550|1478342|P2|Overall Study|Death|0
446967|NCT00407550|1478343|P1|Overall Study|Death|1
446968|NCT00407550|1478342|P2|Overall Study|Withdrawal by Subject|2
446969|NCT00407550|1478343|P1|Overall Study|Withdrawal by Subject|0
446970|NCT00407550|1478342|P2|Overall Study|Adverse Event|1
446971|NCT00407550|1478343|P1|Overall Study|Adverse Event|0
446972|NCT00407537|1478351|P2|Overall Study|Withdrawal by Subject|16
446973|NCT00407537|1478352|P1|Overall Study|Withdrawal by Subject|34
446974|NCT00407537|1478351|P2|Overall Study|Other|7
446975|NCT00407537|1478352|P1|Overall Study|Other|6
446976|NCT00407537|1478351|P2|Overall Study|Lost to Follow-up|19
446977|NCT00407537|1478352|P1|Overall Study|Lost to Follow-up|12
446978|NCT00407537|1478351|P2|Overall Study|Adverse Event|0
446979|NCT00407537|1478352|P1|Overall Study|Adverse Event|36
446980|NCT00407537|1478351|P2|Overall Study|Death|2
446981|NCT00407537|1478352|P1|Overall Study|Death|5
446982|NCT00407511|1478400|P1|Overall Study|Withdrawal by Subject|4
446983|NCT00407511|1478400|P1|Overall Study|Other|5
446984|NCT00407511|1478400|P1|Overall Study|Lost to Follow-up|4
446985|NCT00407511|1478400|P1|Overall Study|Adverse Event|9
446986|NCT00407030|1478446|P3|Extension Period - up to 68 Weeks|Physician Decision|0
446987|NCT00407030|1478447|P2|Extension Period - up to 68 Weeks|Physician Decision|2
446988|NCT00407030|1478448|P1|Extension Period - up to 68 Weeks|Physician Decision|1
446989|NCT00407030|1478446|P3|Extension Period - up to 68 Weeks|Patient Decision|0
446990|NCT00407030|1478447|P2|Extension Period - up to 68 Weeks|Patient Decision|2
446991|NCT00407030|1478448|P1|Extension Period - up to 68 Weeks|Patient Decision|1
446992|NCT00407030|1478446|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
446993|NCT00407030|1478447|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
446994|NCT00407030|1478448|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
446995|NCT00407030|1478446|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
446996|NCT00407030|1478447|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
446997|NCT00407030|1478448|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
446998|NCT00407030|1478446|P3|Extension Period - up to 68 Weeks|Adverse Event|0
446999|NCT00407030|1478447|P2|Extension Period - up to 68 Weeks|Adverse Event|0
447000|NCT00407030|1478448|P1|Extension Period - up to 68 Weeks|Adverse Event|1
447001|NCT00407030|1478446|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
447002|NCT00407030|1478447|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
447003|NCT00407030|1478448|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
447004|NCT00407030|1478446|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
447005|NCT00407030|1478447|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
447006|NCT00407030|1478448|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
447007|NCT00407030|1478446|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
447008|NCT00407030|1478447|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
447009|NCT00407030|1478448|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
447010|NCT00407030|1478446|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
447011|NCT00407030|1478447|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
447012|NCT00407030|1478448|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
447013|NCT00407030|1478446|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
447014|NCT00407030|1478447|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
447015|NCT00407030|1478448|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
447016|NCT00407030|1478446|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
447017|NCT00407030|1478447|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
447018|NCT00407030|1478448|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
447019|NCT00407030|1478446|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
447020|NCT00407030|1478447|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
447021|NCT00407030|1478448|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
447022|NCT00407030|1478446|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
447023|NCT00407030|1478447|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
447024|NCT00407030|1478448|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
447025|NCT00406848|1478476|P2|Overall Study|Sponsor Decision|1
447026|NCT00406848|1478477|P1|Overall Study|Sponsor Decision|1
447027|NCT00406848|1478476|P2|Overall Study|Physician Decision|2
447028|NCT00406848|1478477|P1|Overall Study|Physician Decision|2
447029|NCT00406848|1478476|P2|Overall Study|Lost to Follow-up|2
447030|NCT00406848|1478477|P1|Overall Study|Lost to Follow-up|6
447031|NCT00406848|1478476|P2|Overall Study|Protocol Violation|6
447032|NCT00406848|1478477|P1|Overall Study|Protocol Violation|10
447033|NCT00406848|1478476|P2|Overall Study|Lack of Efficacy|14
447034|NCT00406848|1478477|P1|Overall Study|Lack of Efficacy|9
447035|NCT00406848|1478476|P2|Overall Study|Adverse Event|7
447036|NCT00406848|1478477|P1|Overall Study|Adverse Event|38
447037|NCT00406848|1478476|P2|Overall Study|Withdrawal by Subject|22
447038|NCT00406848|1478477|P1|Overall Study|Withdrawal by Subject|27
447039|NCT00406783|1478541|P2|Overall Study|Protocol Violation|4
447040|NCT00406783|1478542|P1|Overall Study|Protocol Violation|4
447041|NCT00406783|1478541|P2|Overall Study|Withdrawal by Subject|4
447042|NCT00406783|1478542|P1|Overall Study|Withdrawal by Subject|1
447043|NCT00406783|1478541|P2|Overall Study|Lost to Follow-up|0
447044|NCT00406783|1478542|P1|Overall Study|Lost to Follow-up|3
447045|NCT00406783|1478541|P2|Overall Study|Treatment Failure|3
447046|NCT00406783|1478542|P1|Overall Study|Treatment Failure|2
447047|NCT00406783|1478541|P2|Overall Study|Adverse Event|4
447048|NCT00406783|1478542|P1|Overall Study|Adverse Event|4
447049|NCT00406718|1478557|P3|Overall Study|Lost to Follow-up|4
447050|NCT00406718|1478558|P2|Overall Study|Lost to Follow-up|5
447051|NCT00406718|1478559|P1|Overall Study|Lost to Follow-up|2
447052|NCT00406718|1478557|P3|Overall Study|Withdrawal by Subject|4
447053|NCT00406718|1478558|P2|Overall Study|Withdrawal by Subject|9
447054|NCT00406718|1478559|P1|Overall Study|Withdrawal by Subject|2
447055|NCT00406692|1478573|P1|Overall Study|Lack of Efficacy|1
447056|NCT00406692|1478573|P1|Overall Study|Adverse Event|1
447057|NCT00406692|1478573|P1|Overall Study|Physician Decision|1
447058|NCT00406692|1478573|P1|Overall Study|Withdrawal by Subject|4
447059|NCT00406653|1478583|P7|Open-Label Period|Refused followup|1
447060|NCT00406653|1478584|P6|Open-Label Period|Refused followup|0
447061|NCT00406653|1478585|P5|Open-Label Period|Refused followup|0
447062|NCT00406653|1478586|P4|Open-Label Period|Refused followup|0
447063|NCT00406653|1478587|P3|Open-Label Period|Refused followup|0
447064|NCT00406653|1478588|P2|Open-Label Period|Refused followup|0
447065|NCT00406653|1478589|P1|Open-Label Period|Refused followup|0
447066|NCT00406653|1478583|P7|Open-Label Period|Discontinued by Sponsor|1
447067|NCT00406653|1478584|P6|Open-Label Period|Discontinued by Sponsor|0
447068|NCT00406653|1478585|P5|Open-Label Period|Discontinued by Sponsor|0
447069|NCT00406653|1478586|P4|Open-Label Period|Discontinued by Sponsor|0
447070|NCT00406653|1478587|P3|Open-Label Period|Discontinued by Sponsor|0
447071|NCT00406653|1478588|P2|Open-Label Period|Discontinued by Sponsor|0
447072|NCT00406653|1478589|P1|Open-Label Period|Discontinued by Sponsor|0
447073|NCT00406653|1478583|P7|Open-Label Period|Declined participation but followup done|8
447074|NCT00406653|1478584|P6|Open-Label Period|Declined participation but followup done|0
447075|NCT00406653|1478585|P5|Open-Label Period|Declined participation but followup done|0
447076|NCT00406653|1478586|P4|Open-Label Period|Declined participation but followup done|0
447077|NCT00406653|1478587|P3|Open-Label Period|Declined participation but followup done|0
447078|NCT00406653|1478588|P2|Open-Label Period|Declined participation but followup done|0
447079|NCT00406653|1478589|P1|Open-Label Period|Declined participation but followup done|0
447080|NCT00406653|1478583|P7|Open-Label Period|Administrative Reason By Sponsor|115
447081|NCT00406653|1478584|P6|Open-Label Period|Administrative Reason By Sponsor|0
447082|NCT00406653|1478585|P5|Open-Label Period|Administrative Reason By Sponsor|0
447083|NCT00406653|1478586|P4|Open-Label Period|Administrative Reason By Sponsor|0
447084|NCT00406653|1478587|P3|Open-Label Period|Administrative Reason By Sponsor|0
447085|NCT00406653|1478588|P2|Open-Label Period|Administrative Reason By Sponsor|0
447086|NCT00406653|1478589|P1|Open-Label Period|Administrative Reason By Sponsor|0
447087|NCT00406653|1478583|P7|Open-Label Period|Pregnancy|2
447088|NCT00406653|1478584|P6|Open-Label Period|Pregnancy|0
447089|NCT00406653|1478585|P5|Open-Label Period|Pregnancy|0
447090|NCT00406653|1478586|P4|Open-Label Period|Pregnancy|0
447091|NCT00406653|1478587|P3|Open-Label Period|Pregnancy|0
447092|NCT00406653|1478588|P2|Open-Label Period|Pregnancy|0
447093|NCT00406653|1478589|P1|Open-Label Period|Pregnancy|0
447094|NCT00406653|1478583|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
447095|NCT00406653|1478584|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
447096|NCT00406653|1478585|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
447097|NCT00406653|1478586|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
447098|NCT00406653|1478587|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
447099|NCT00406653|1478588|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
447100|NCT00406653|1478589|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
447101|NCT00406653|1478583|P7|Open-Label Period|Withdrawal of Consent|11
447102|NCT00406653|1478584|P6|Open-Label Period|Withdrawal of Consent|0
447103|NCT00406653|1478585|P5|Open-Label Period|Withdrawal of Consent|0
447104|NCT00406653|1478586|P4|Open-Label Period|Withdrawal of Consent|0
447105|NCT00406653|1478587|P3|Open-Label Period|Withdrawal of Consent|0
447106|NCT00406653|1478588|P2|Open-Label Period|Withdrawal of Consent|0
447107|NCT00406653|1478589|P1|Open-Label Period|Withdrawal of Consent|0
447108|NCT00406653|1478583|P7|Open-Label Period|Lost to Follow-up|6
447109|NCT00406653|1478584|P6|Open-Label Period|Lost to Follow-up|0
447110|NCT00406653|1478585|P5|Open-Label Period|Lost to Follow-up|0
447111|NCT00406653|1478586|P4|Open-Label Period|Lost to Follow-up|0
447112|NCT00406653|1478587|P3|Open-Label Period|Lost to Follow-up|0
447113|NCT00406653|1478588|P2|Open-Label Period|Lost to Follow-up|0
447114|NCT00406653|1478589|P1|Open-Label Period|Lost to Follow-up|0
447115|NCT00406653|1478583|P7|Open-Label Period|Lack of Efficacy|160
447116|NCT00406653|1478584|P6|Open-Label Period|Lack of Efficacy|0
447117|NCT00406653|1478585|P5|Open-Label Period|Lack of Efficacy|0
447118|NCT00406653|1478586|P4|Open-Label Period|Lack of Efficacy|0
447119|NCT00406653|1478587|P3|Open-Label Period|Lack of Efficacy|0
447120|NCT00406653|1478588|P2|Open-Label Period|Lack of Efficacy|0
447121|NCT00406653|1478589|P1|Open-Label Period|Lack of Efficacy|0
447122|NCT00406653|1478583|P7|Open-Label Period|Adverse Event|18
447123|NCT00406653|1478584|P6|Open-Label Period|Adverse Event|0
447124|NCT00406653|1478585|P5|Open-Label Period|Adverse Event|0
447125|NCT00406653|1478586|P4|Open-Label Period|Adverse Event|0
447126|NCT00406653|1478587|P3|Open-Label Period|Adverse Event|0
447127|NCT00406653|1478588|P2|Open-Label Period|Adverse Event|0
447128|NCT00406653|1478589|P1|Open-Label Period|Adverse Event|0
447129|NCT00406653|1478583|P7|Open-Label Period|Death|1
447130|NCT00406653|1478584|P6|Open-Label Period|Death|0
447131|NCT00406653|1478585|P5|Open-Label Period|Death|0
447132|NCT00406653|1478586|P4|Open-Label Period|Death|0
447133|NCT00406653|1478587|P3|Open-Label Period|Death|0
447134|NCT00406653|1478588|P2|Open-Label Period|Death|0
447135|NCT00406653|1478589|P1|Open-Label Period|Death|0
447136|NCT00406653|1478583|P7|Maintenance Period|Error in disease score evaluation|0
447137|NCT00406653|1478584|P6|Maintenance Period|Error in disease score evaluation|0
447138|NCT00406653|1478585|P5|Maintenance Period|Error in disease score evaluation|1
447139|NCT00406653|1478586|P4|Maintenance Period|Error in disease score evaluation|0
447140|NCT00406653|1478587|P3|Maintenance Period|Error in disease score evaluation|0
447141|NCT00406653|1478588|P2|Maintenance Period|Error in disease score evaluation|0
447142|NCT00406653|1478589|P1|Maintenance Period|Error in disease score evaluation|0
447143|NCT00406653|1478583|P7|Maintenance Period|Administrative Reason By Sponsor|0
447144|NCT00406653|1478584|P6|Maintenance Period|Administrative Reason By Sponsor|7
447145|NCT00406653|1478585|P5|Maintenance Period|Administrative Reason By Sponsor|4
447146|NCT00406653|1478586|P4|Maintenance Period|Administrative Reason By Sponsor|0
447147|NCT00406653|1478587|P3|Maintenance Period|Administrative Reason By Sponsor|0
447148|NCT00406653|1478588|P2|Maintenance Period|Administrative Reason By Sponsor|0
447149|NCT00406653|1478589|P1|Maintenance Period|Administrative Reason By Sponsor|0
447150|NCT00406653|1478583|P7|Maintenance Period|Pregnancy|0
447151|NCT00406653|1478584|P6|Maintenance Period|Pregnancy|1
447152|NCT00406653|1478585|P5|Maintenance Period|Pregnancy|0
447153|NCT00406653|1478586|P4|Maintenance Period|Pregnancy|0
447154|NCT00406653|1478587|P3|Maintenance Period|Pregnancy|0
447155|NCT00406653|1478588|P2|Maintenance Period|Pregnancy|0
447156|NCT00406653|1478589|P1|Maintenance Period|Pregnancy|0
447157|NCT00406653|1478583|P7|Maintenance Period|Withdrawal of Consent|0
447158|NCT00406653|1478584|P6|Maintenance Period|Withdrawal of Consent|0
447159|NCT00406653|1478585|P5|Maintenance Period|Withdrawal of Consent|2
447160|NCT00406653|1478586|P4|Maintenance Period|Withdrawal of Consent|0
447161|NCT00406653|1478587|P3|Maintenance Period|Withdrawal of Consent|0
447162|NCT00406653|1478588|P2|Maintenance Period|Withdrawal of Consent|0
447163|NCT00406653|1478589|P1|Maintenance Period|Withdrawal of Consent|0
447164|NCT00406653|1478583|P7|Maintenance Period|Lost to Follow-up|0
447165|NCT00406653|1478584|P6|Maintenance Period|Lost to Follow-up|1
447166|NCT00406653|1478585|P5|Maintenance Period|Lost to Follow-up|2
447167|NCT00406653|1478586|P4|Maintenance Period|Lost to Follow-up|0
447168|NCT00406653|1478587|P3|Maintenance Period|Lost to Follow-up|0
447169|NCT00406653|1478588|P2|Maintenance Period|Lost to Follow-up|0
447170|NCT00406653|1478589|P1|Maintenance Period|Lost to Follow-up|0
447171|NCT00406653|1478583|P7|Maintenance Period|Lack of Efficacy|0
447172|NCT00406653|1478584|P6|Maintenance Period|Lack of Efficacy|26
447173|NCT00406653|1478585|P5|Maintenance Period|Lack of Efficacy|20
447174|NCT00406653|1478586|P4|Maintenance Period|Lack of Efficacy|0
447175|NCT00406653|1478587|P3|Maintenance Period|Lack of Efficacy|0
447176|NCT00406653|1478588|P2|Maintenance Period|Lack of Efficacy|0
447177|NCT00406653|1478589|P1|Maintenance Period|Lack of Efficacy|0
447178|NCT00406653|1478583|P7|Maintenance Period|Adverse Event|0
447179|NCT00406653|1478584|P6|Maintenance Period|Adverse Event|1
447180|NCT00406653|1478585|P5|Maintenance Period|Adverse Event|1
447181|NCT00406653|1478586|P4|Maintenance Period|Adverse Event|0
447182|NCT00406653|1478587|P3|Maintenance Period|Adverse Event|0
447183|NCT00406653|1478588|P2|Maintenance Period|Adverse Event|0
447184|NCT00406653|1478589|P1|Maintenance Period|Adverse Event|0
447185|NCT00406653|1478583|P7|Induction Period|Patient relocated|0
447186|NCT00406653|1478584|P6|Induction Period|Patient relocated|0
447187|NCT00406653|1478585|P5|Induction Period|Patient relocated|0
447188|NCT00406653|1478586|P4|Induction Period|Patient relocated|0
447189|NCT00406653|1478587|P3|Induction Period|Patient relocated|1
447190|NCT00406653|1478588|P2|Induction Period|Patient relocated|0
447191|NCT00406653|1478589|P1|Induction Period|Patient relocated|0
447192|NCT00406653|1478583|P7|Induction Period|Incarcerated|0
447193|NCT00406653|1478584|P6|Induction Period|Incarcerated|0
447194|NCT00406653|1478585|P5|Induction Period|Incarcerated|0
447195|NCT00406653|1478586|P4|Induction Period|Incarcerated|0
447196|NCT00406653|1478587|P3|Induction Period|Incarcerated|1
447197|NCT00406653|1478588|P2|Induction Period|Incarcerated|0
447198|NCT00406653|1478589|P1|Induction Period|Incarcerated|0
447199|NCT00406653|1478583|P7|Induction Period|Given prohibited drug|0
447200|NCT00406653|1478584|P6|Induction Period|Given prohibited drug|0
447201|NCT00406653|1478585|P5|Induction Period|Given prohibited drug|0
447202|NCT00406653|1478586|P4|Induction Period|Given prohibited drug|0
447203|NCT00406653|1478587|P3|Induction Period|Given prohibited drug|2
447204|NCT00406653|1478588|P2|Induction Period|Given prohibited drug|1
447205|NCT00406653|1478589|P1|Induction Period|Given prohibited drug|0
447206|NCT00406653|1478583|P7|Induction Period|Declined participation but followup done|0
447207|NCT00406653|1478584|P6|Induction Period|Declined participation but followup done|0
447208|NCT00406653|1478585|P5|Induction Period|Declined participation but followup done|0
447209|NCT00406653|1478586|P4|Induction Period|Declined participation but followup done|1
447210|NCT00406653|1478587|P3|Induction Period|Declined participation but followup done|1
447211|NCT00406653|1478588|P2|Induction Period|Declined participation but followup done|2
447212|NCT00406653|1478589|P1|Induction Period|Declined participation but followup done|0
447213|NCT00406653|1478583|P7|Induction Period|Pregnancy|0
447214|NCT00406653|1478584|P6|Induction Period|Pregnancy|0
447215|NCT00406653|1478585|P5|Induction Period|Pregnancy|0
447216|NCT00406653|1478586|P4|Induction Period|Pregnancy|0
447217|NCT00406653|1478587|P3|Induction Period|Pregnancy|0
447218|NCT00406653|1478588|P2|Induction Period|Pregnancy|0
447219|NCT00406653|1478589|P1|Induction Period|Pregnancy|1
447220|NCT00406653|1478583|P7|Induction Period|Subject No Longer Meets Study Criteria|0
447221|NCT00406653|1478584|P6|Induction Period|Subject No Longer Meets Study Criteria|0
447222|NCT00406653|1478585|P5|Induction Period|Subject No Longer Meets Study Criteria|0
447223|NCT00406653|1478586|P4|Induction Period|Subject No Longer Meets Study Criteria|2
447224|NCT00406653|1478587|P3|Induction Period|Subject No Longer Meets Study Criteria|0
447225|NCT00406653|1478588|P2|Induction Period|Subject No Longer Meets Study Criteria|0
447226|NCT00406653|1478589|P1|Induction Period|Subject No Longer Meets Study Criteria|0
447227|NCT00406653|1478583|P7|Induction Period|Withdrawal of Consent|0
447228|NCT00406653|1478584|P6|Induction Period|Withdrawal of Consent|0
447229|NCT00406653|1478585|P5|Induction Period|Withdrawal of Consent|0
447230|NCT00406653|1478586|P4|Induction Period|Withdrawal of Consent|2
447231|NCT00406653|1478587|P3|Induction Period|Withdrawal of Consent|1
447232|NCT00406653|1478588|P2|Induction Period|Withdrawal of Consent|5
447233|NCT00406653|1478589|P1|Induction Period|Withdrawal of Consent|2
447234|NCT00406653|1478583|P7|Induction Period|Lost to Follow-up|0
447235|NCT00406653|1478584|P6|Induction Period|Lost to Follow-up|0
447236|NCT00406653|1478585|P5|Induction Period|Lost to Follow-up|0
447237|NCT00406653|1478586|P4|Induction Period|Lost to Follow-up|0
447238|NCT00406653|1478587|P3|Induction Period|Lost to Follow-up|0
447239|NCT00406653|1478588|P2|Induction Period|Lost to Follow-up|2
447240|NCT00406653|1478589|P1|Induction Period|Lost to Follow-up|0
447241|NCT00406653|1478583|P7|Induction Period|Lack of Efficacy|0
447242|NCT00406653|1478584|P6|Induction Period|Lack of Efficacy|0
447243|NCT00406653|1478585|P5|Induction Period|Lack of Efficacy|0
447244|NCT00406653|1478586|P4|Induction Period|Lack of Efficacy|10
447245|NCT00406653|1478587|P3|Induction Period|Lack of Efficacy|8
447246|NCT00406653|1478588|P2|Induction Period|Lack of Efficacy|14
447247|NCT00406653|1478589|P1|Induction Period|Lack of Efficacy|11
447248|NCT00406653|1478583|P7|Induction Period|Adverse Event|0
447249|NCT00406653|1478584|P6|Induction Period|Adverse Event|0
447250|NCT00406653|1478585|P5|Induction Period|Adverse Event|0
447251|NCT00406653|1478586|P4|Induction Period|Adverse Event|11
447252|NCT00406653|1478587|P3|Induction Period|Adverse Event|4
447253|NCT00406653|1478588|P2|Induction Period|Adverse Event|10
447254|NCT00406653|1478589|P1|Induction Period|Adverse Event|1
447255|NCT00406640|1478670|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
447256|NCT00406640|1478671|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
447257|NCT00406640|1478670|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
447258|NCT00406640|1478671|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
447259|NCT00406640|1478670|P2|OL Extension Phase for Non-Responders|non-compliance|2
447260|NCT00406640|1478671|P1|OL Extension Phase for Non-Responders|non-compliance|3
447261|NCT00406640|1478670|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
447262|NCT00406640|1478671|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
447263|NCT00406640|1478670|P2|OL Extension Phase for Non-Responders|Physician Decision|0
447264|NCT00406640|1478671|P1|OL Extension Phase for Non-Responders|Physician Decision|1
447265|NCT00406640|1478670|P2|OL Extension Phase for Non-Responders|Failed to Return|0
447266|NCT00406640|1478671|P1|OL Extension Phase for Non-Responders|Failed to Return|1
447267|NCT00406640|1478670|P2|OL Extension Phase for Non-Responders|Adverse Event|6
447268|NCT00406640|1478671|P1|OL Extension Phase for Non-Responders|Adverse Event|6
447269|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
447270|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
447271|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
447272|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
447273|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Protocol Violation|2
447274|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Protocol Violation|2
447275|NCT00406640|1478670|P2|DB Continuation Phase for Responders|non-compliance|5
447276|NCT00406640|1478671|P1|DB Continuation Phase for Responders|non-compliance|7
447277|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
447278|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
447279|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Physician Decision|3
447280|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Physician Decision|2
447281|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Failed to Return|2
447282|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Failed to Return|0
447283|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Death|0
447284|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Death|1
447285|NCT00406640|1478670|P2|DB Continuation Phase for Responders|Adverse Event|11
447286|NCT00406640|1478671|P1|DB Continuation Phase for Responders|Adverse Event|11
447287|NCT00406640|1478670|P2|Acute Phase|Lack of Efficacy|3
447288|NCT00406640|1478671|P1|Acute Phase|Lack of Efficacy|3
447289|NCT00406640|1478670|P2|Acute Phase|Withdrawal by Subject|9
447290|NCT00406640|1478671|P1|Acute Phase|Withdrawal by Subject|11
447291|NCT00406640|1478670|P2|Acute Phase|Protocol Violation|2
447292|NCT00406640|1478671|P1|Acute Phase|Protocol Violation|3
447293|NCT00406640|1478670|P2|Acute Phase|Protocol deviation|10
447294|NCT00406640|1478671|P1|Acute Phase|Protocol deviation|4
447295|NCT00406640|1478670|P2|Acute Phase|Lost to Follow-up|4
447296|NCT00406640|1478671|P1|Acute Phase|Lost to Follow-up|7
447297|NCT00406640|1478670|P2|Acute Phase|Physician Decision|1
447298|NCT00406640|1478671|P1|Acute Phase|Physician Decision|0
447299|NCT00406640|1478670|P2|Acute Phase|Failed to Return|1
447300|NCT00406640|1478671|P1|Acute Phase|Failed to Return|5
447301|NCT00406640|1478670|P2|Acute Phase|Adverse Event|13
447302|NCT00406640|1478671|P1|Acute Phase|Adverse Event|18
447303|NCT00406393|1478703|P2|Overall Study|Did not undergo transplantation|1
447304|NCT00406393|1478704|P1|Overall Study|Did not undergo transplantation|2
447305|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
447306|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
447307|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
447308|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
447309|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
447310|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
447311|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
447312|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
447313|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
447314|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
447315|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
447316|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
447317|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
447318|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
447319|NCT00406367|1478734|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
447320|NCT00406367|1478735|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
447321|NCT00406367|1478734|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
447322|NCT00406367|1478735|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
447323|NCT00406367|1478734|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
447324|NCT00406367|1478735|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
447325|NCT00406367|1478734|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
447326|NCT00406367|1478735|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
447327|NCT00406367|1478734|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
447328|NCT00406367|1478735|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
447329|NCT00406354|1478750|P3|All Randomized and Treated Patients|Physician Decision|1
447330|NCT00406354|1478751|P2|All Randomized and Treated Patients|Physician Decision|0
447331|NCT00406354|1478752|P1|All Randomized and Treated Patients|Physician Decision|0
447332|NCT00406354|1478750|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
447333|NCT00406354|1478751|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
447334|NCT00406354|1478752|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
447335|NCT00406354|1478750|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
447336|NCT00406354|1478751|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
447337|NCT00406354|1478752|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
447338|NCT00406354|1478750|P3|All Randomized and Treated Patients|Adverse Event|1
447339|NCT00406354|1478751|P2|All Randomized and Treated Patients|Adverse Event|2
447340|NCT00406354|1478752|P1|All Randomized and Treated Patients|Adverse Event|6
447341|NCT00406354|1478750|P3|All Randomized and Treated Patients|Lack of Efficacy|17
447342|NCT00406354|1478751|P2|All Randomized and Treated Patients|Lack of Efficacy|4
447343|NCT00406354|1478752|P1|All Randomized and Treated Patients|Lack of Efficacy|7
447344|NCT00406354|1478750|P3|All Randomized Patients|Protocol Violation|1
447345|NCT00406354|1478751|P2|All Randomized Patients|Protocol Violation|0
447346|NCT00406354|1478752|P1|All Randomized Patients|Protocol Violation|0
447347|NCT00406315|1478823|P1|Overall Study|Withdrawal by Subject|30
447348|NCT00406315|1478823|P1|Overall Study|Lost to Follow-up|21
447349|NCT00406315|1478823|P1|Overall Study|Other|33
447350|NCT00406315|1478823|P1|Overall Study|Lack of Efficacy|13
447351|NCT00406315|1478823|P1|Overall Study|Laboratory Abnormality|4
447352|NCT00406315|1478823|P1|Overall Study|Adverse Event|39
447353|NCT00406315|1478823|P1|Overall Study|Death|1
447354|NCT00406029|1478933|P5|Overall Study|Randomized in Error|1
447355|NCT00406029|1478934|P4|Overall Study|Randomized in Error|3
447356|NCT00406029|1478935|P3|Overall Study|Randomized in Error|2
447357|NCT00406029|1478936|P2|Overall Study|Randomized in Error|0
447358|NCT00406029|1478937|P1|Overall Study|Randomized in Error|0
447359|NCT00406029|1478933|P5|Overall Study|Did Not Meet Eligibility Criteria|0
447360|NCT00406029|1478934|P4|Overall Study|Did Not Meet Eligibility Criteria|0
447361|NCT00406029|1478935|P3|Overall Study|Did Not Meet Eligibility Criteria|1
447362|NCT00406029|1478936|P2|Overall Study|Did Not Meet Eligibility Criteria|0
447363|NCT00406029|1478937|P1|Overall Study|Did Not Meet Eligibility Criteria|0
447364|NCT00406029|1478933|P5|Overall Study|Protocol Violation|0
447365|NCT00406029|1478934|P4|Overall Study|Protocol Violation|2
447366|NCT00406029|1478935|P3|Overall Study|Protocol Violation|0
447367|NCT00406029|1478936|P2|Overall Study|Protocol Violation|2
447368|NCT00406029|1478937|P1|Overall Study|Protocol Violation|1
447369|NCT00406029|1478933|P5|Overall Study|Withdrawal by Subject|0
447370|NCT00406029|1478934|P4|Overall Study|Withdrawal by Subject|2
447371|NCT00406029|1478935|P3|Overall Study|Withdrawal by Subject|2
447372|NCT00406029|1478936|P2|Overall Study|Withdrawal by Subject|4
447373|NCT00406029|1478937|P1|Overall Study|Withdrawal by Subject|3
447374|NCT00406029|1478933|P5|Overall Study|Adverse Event|7
447375|NCT00406029|1478934|P4|Overall Study|Adverse Event|10
447376|NCT00406029|1478935|P3|Overall Study|Adverse Event|5
447377|NCT00406029|1478936|P2|Overall Study|Adverse Event|2
447378|NCT00406029|1478937|P1|Overall Study|Adverse Event|12
447379|NCT00405964|1479041|P2|Overall Study|Protocol Violation|6
447380|NCT00405964|1479042|P1|Overall Study|Protocol Violation|11
447381|NCT00405964|1479041|P2|Overall Study|Withdrawal by Subject|23
447382|NCT00405964|1479042|P1|Overall Study|Withdrawal by Subject|19
447383|NCT00405964|1479041|P2|Overall Study|Lost to Follow-up|5
447384|NCT00405964|1479042|P1|Overall Study|Lost to Follow-up|5
447385|NCT00405964|1479041|P2|Overall Study|Adverse Event|16
447386|NCT00405964|1479042|P1|Overall Study|Adverse Event|7
447387|NCT00405964|1479041|P2|Overall Study|Treatment Failure|45
447388|NCT00405964|1479042|P1|Overall Study|Treatment Failure|17
447389|NCT00405912|1479064|P3|Overall Study|Lost to Follow-up|4
447390|NCT00405912|1479065|P2|Overall Study|Lost to Follow-up|8
447391|NCT00405912|1479066|P1|Overall Study|Lost to Follow-up|4
447392|NCT00405912|1479064|P3|Overall Study|Withdrawal by Subject|12
447393|NCT00405912|1479065|P2|Overall Study|Withdrawal by Subject|11
447394|NCT00405912|1479066|P1|Overall Study|Withdrawal by Subject|12
447395|NCT00405821|1479079|P2|Overall Study|initiated ART|8
447396|NCT00405821|1479080|P1|Overall Study|initiated ART|9
447397|NCT00405821|1479079|P2|Overall Study|Protocol Violation|0
447398|NCT00405821|1479080|P1|Overall Study|Protocol Violation|1
447399|NCT00405821|1479079|P2|Overall Study|Lost to Follow-up|7
447400|NCT00405821|1479080|P1|Overall Study|Lost to Follow-up|7
447401|NCT00405821|1479079|P2|Overall Study|Death|7
447402|NCT00405821|1479080|P1|Overall Study|Death|5
447403|NCT00405756|1479093|P3|Follow-up|Lost to Follow-up|4
447404|NCT00405756|1479094|P2|Follow-up|Lost to Follow-up|8
447405|NCT00405756|1479095|P1|Follow-up|Lost to Follow-up|2
447406|NCT00405756|1479093|P3|Follow-up|Death|24
447407|NCT00405756|1479094|P2|Follow-up|Death|31
447408|NCT00405756|1479095|P1|Follow-up|Death|21
447409|NCT00405756|1479093|P3|Follow-up|Ongoing in Follow-up Period|60
447410|NCT00405756|1479094|P2|Follow-up|Ongoing in Follow-up Period|51
447411|NCT00405756|1479095|P1|Follow-up|Ongoing in Follow-up Period|52
447412|NCT00405756|1479093|P3|Open-label Extension|Other|7
447413|NCT00405756|1479094|P2|Open-label Extension|Other|1
447414|NCT00405756|1479095|P1|Open-label Extension|Other|0
447415|NCT00405756|1479093|P3|Open-label Extension|Death|4
447416|NCT00405756|1479094|P2|Open-label Extension|Death|2
447417|NCT00405756|1479095|P1|Open-label Extension|Death|1
447418|NCT00405756|1479093|P3|Open-label Extension|Withdrawal by Subject|3
447419|NCT00405756|1479094|P2|Open-label Extension|Withdrawal by Subject|3
447420|NCT00405756|1479095|P1|Open-label Extension|Withdrawal by Subject|2
447421|NCT00405756|1479093|P3|Open-label Extension|Disease Progression|26
447422|NCT00405756|1479094|P2|Open-label Extension|Disease Progression|23
447423|NCT00405756|1479095|P1|Open-label Extension|Disease Progression|8
447424|NCT00405756|1479093|P3|Open-label Extension|Adverse Event|7
447425|NCT00405756|1479094|P2|Open-label Extension|Adverse Event|3
447426|NCT00405756|1479095|P1|Open-label Extension|Adverse Event|1
447427|NCT00405756|1479093|P3|Open-label Extension|Ongoing in Open Label Period|25
447428|NCT00405756|1479094|P2|Open-label Extension|Ongoing in Open Label Period|15
447429|NCT00405756|1479095|P1|Open-label Extension|Ongoing in Open Label Period|7
447430|NCT00405756|1479093|P3|Double-blind Treatment|Not Specified|4
447431|NCT00405756|1479094|P2|Double-blind Treatment|Not Specified|4
447432|NCT00405756|1479095|P1|Double-blind Treatment|Not Specified|7
447433|NCT00405756|1479093|P3|Double-blind Treatment|Protocol Violation|2
447434|NCT00405756|1479094|P2|Double-blind Treatment|Protocol Violation|0
447435|NCT00405756|1479095|P1|Double-blind Treatment|Protocol Violation|1
447436|NCT00405756|1479093|P3|Double-blind Treatment|Death|4
447437|NCT00405756|1479094|P2|Double-blind Treatment|Death|4
447438|NCT00405756|1479095|P1|Double-blind Treatment|Death|4
447439|NCT00405756|1479093|P3|Double-blind Treatment|Lost to Follow-up|0
447440|NCT00405756|1479094|P2|Double-blind Treatment|Lost to Follow-up|0
447441|NCT00405756|1479095|P1|Double-blind Treatment|Lost to Follow-up|1
447442|NCT00405756|1479093|P3|Double-blind Treatment|Withdrawal by Subject|10
447443|NCT00405756|1479094|P2|Double-blind Treatment|Withdrawal by Subject|9
447444|NCT00405756|1479095|P1|Double-blind Treatment|Withdrawal by Subject|15
447445|NCT00405756|1479093|P3|Double-blind Treatment|Lack of Efficacy|2
447446|NCT00405756|1479094|P2|Double-blind Treatment|Lack of Efficacy|4
447447|NCT00405756|1479095|P1|Double-blind Treatment|Lack of Efficacy|1
447448|NCT00405756|1479093|P3|Double-blind Treatment|Disease Progression|102
447449|NCT00405756|1479094|P2|Double-blind Treatment|Disease Progression|81
447450|NCT00405756|1479095|P1|Double-blind Treatment|Disease Progression|47
447451|NCT00405756|1479093|P3|Double-blind Treatment|Adverse Event|12
447452|NCT00405756|1479094|P2|Double-blind Treatment|Adverse Event|27
447453|NCT00405756|1479095|P1|Double-blind Treatment|Adverse Event|31
447454|NCT00405756|1479093|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
447455|NCT00405756|1479094|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
447456|NCT00405756|1479095|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
447457|NCT00405652|1479206|P1|Overall Study|Adverse Event|4
447458|NCT00405639|1479213|P2|Overall Study|Seizure prior to receiving BNP|0
447459|NCT00405639|1479214|P1|Overall Study|Seizure prior to receiving BNP|1
447460|NCT00405639|1479213|P2|Overall Study|Adverse Event|0
447461|NCT00405639|1479214|P1|Overall Study|Adverse Event|1
447462|NCT00405639|1479213|P2|Overall Study|Withdrawal by Subject|0
447463|NCT00405639|1479214|P1|Overall Study|Withdrawal by Subject|1
447464|NCT00405587|1479230|P4|Overall Study|Participant not dosed|0
447465|NCT00405587|1479231|P3|Overall Study|Participant not dosed|0
447466|NCT00405587|1479232|P2|Overall Study|Participant not dosed|1
447467|NCT00405587|1479233|P1|Overall Study|Participant not dosed|0
447468|NCT00405587|1479230|P4|Overall Study|Withdrawal by Subject|2
447469|NCT00405587|1479231|P3|Overall Study|Withdrawal by Subject|0
447470|NCT00405587|1479232|P2|Overall Study|Withdrawal by Subject|0
447471|NCT00405587|1479233|P1|Overall Study|Withdrawal by Subject|0
447472|NCT00405587|1479230|P4|Overall Study|Radiation induced necrosis|0
447473|NCT00405587|1479231|P3|Overall Study|Radiation induced necrosis|0
447474|NCT00405587|1479232|P2|Overall Study|Radiation induced necrosis|1
447475|NCT00405587|1479233|P1|Overall Study|Radiation induced necrosis|0
447476|NCT00405587|1479230|P4|Overall Study|Lost to Follow-up|0
447477|NCT00405587|1479231|P3|Overall Study|Lost to Follow-up|1
447478|NCT00405587|1479232|P2|Overall Study|Lost to Follow-up|1
447479|NCT00405587|1479233|P1|Overall Study|Lost to Follow-up|0
447480|NCT00405587|1479230|P4|Overall Study|Adverse Event|0
447481|NCT00405587|1479231|P3|Overall Study|Adverse Event|0
447482|NCT00405587|1479232|P2|Overall Study|Adverse Event|0
447483|NCT00405587|1479233|P1|Overall Study|Adverse Event|1
447484|NCT00405587|1479230|P4|Overall Study|Physician Decision|0
447485|NCT00405587|1479231|P3|Overall Study|Physician Decision|0
447486|NCT00405587|1479232|P2|Overall Study|Physician Decision|2
447487|NCT00405587|1479233|P1|Overall Study|Physician Decision|3
447488|NCT00405587|1479230|P4|Overall Study|Disease Progression|17
447489|NCT00405587|1479231|P3|Overall Study|Disease Progression|21
447490|NCT00405587|1479232|P2|Overall Study|Disease Progression|23
447491|NCT00405587|1479233|P1|Overall Study|Disease Progression|22
447492|NCT00405587|1479230|P4|Overall Study|Death|1
447493|NCT00405587|1479231|P3|Overall Study|Death|0
447494|NCT00405587|1479232|P2|Overall Study|Death|0
447495|NCT00405587|1479233|P1|Overall Study|Death|0
447496|NCT00405548|1479351|P2|Overall Study|Withdrawal by Subject|0
447497|NCT00405548|1479352|P1|Overall Study|Withdrawal by Subject|1
447498|NCT00405548|1479351|P2|Overall Study|Venous access failed during study day|0
447499|NCT00405548|1479352|P1|Overall Study|Venous access failed during study day|1
447500|NCT00405548|1479351|P2|Overall Study|Unable to self-administer shots|0
447501|NCT00405548|1479352|P1|Overall Study|Unable to self-administer shots|1
447502|NCT00405548|1479351|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
447503|NCT00405548|1479352|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
447504|NCT00405548|1479351|P2|Overall Study|Cognitive Memory problems on study day|0
447505|NCT00405548|1479352|P1|Overall Study|Cognitive Memory problems on study day|1
447506|NCT00405392|1479383|P2|Overall Study|Other|5
447507|NCT00405392|1479384|P1|Overall Study|Other|1
447508|NCT00405392|1479383|P2|Overall Study|Non-compliance|1
447509|NCT00405392|1479384|P1|Overall Study|Non-compliance|0
447510|NCT00405392|1479383|P2|Overall Study|Data missing|0
447511|NCT00405392|1479384|P1|Overall Study|Data missing|2
447512|NCT00405392|1479383|P2|Overall Study|Lost to Follow-up|2
447513|NCT00405392|1479384|P1|Overall Study|Lost to Follow-up|1
447514|NCT00405392|1479383|P2|Overall Study|Withdrawal by Subject|3
447515|NCT00405392|1479384|P1|Overall Study|Withdrawal by Subject|4
447516|NCT00405392|1479383|P2|Overall Study|Did not meet Eligibility criteria|2
447517|NCT00405392|1479384|P1|Overall Study|Did not meet Eligibility criteria|7
447518|NCT00405392|1479383|P2|Overall Study|Adverse Event|14
447519|NCT00405392|1479384|P1|Overall Study|Adverse Event|15
447520|NCT00405275|1479427|P2|Overall Study|Unwilling to continue|9
447521|NCT00405275|1479428|P1|Overall Study|Unwilling to continue|10
447522|NCT00405275|1479427|P2|Overall Study|Withdrawal by Subject|9
447523|NCT00405275|1479428|P1|Overall Study|Withdrawal by Subject|7
447524|NCT00405275|1479427|P2|Overall Study|Lost to Follow-up|1
447525|NCT00405275|1479428|P1|Overall Study|Lost to Follow-up|5
447526|NCT00405275|1479427|P2|Overall Study|Death|0
447527|NCT00405275|1479428|P1|Overall Study|Death|1
447528|NCT00405067|1479437|P3|Overall Study|Lost to Follow-up|1
447529|NCT00405067|1479438|P2|Overall Study|Lost to Follow-up|0
447530|NCT00405067|1479439|P1|Overall Study|Lost to Follow-up|0
447531|NCT00405067|1479437|P3|Overall Study|Adverse Event|4
447532|NCT00405067|1479438|P2|Overall Study|Adverse Event|9
447533|NCT00405067|1479439|P1|Overall Study|Adverse Event|4
447534|NCT00404924|1479476|P2|Overall Study|Randomised but not received treatment|1
447535|NCT00404924|1479477|P1|Overall Study|Randomised but not received treatment|1
447536|NCT00404924|1479476|P2|Overall Study|Not Specified|11
447537|NCT00404924|1479477|P1|Overall Study|Not Specified|25
447538|NCT00404924|1479476|P2|Overall Study|Withdrawal by Subject|13
447539|NCT00404924|1479477|P1|Overall Study|Withdrawal by Subject|26
447540|NCT00404924|1479476|P2|Overall Study|Lost to Follow-up|1
447541|NCT00404924|1479477|P1|Overall Study|Lost to Follow-up|1
447542|NCT00404924|1479476|P2|Overall Study|Condition under investigation worsened|264
447543|NCT00404924|1479477|P1|Overall Study|Condition under investigation worsened|475
447544|NCT00404924|1479476|P2|Overall Study|Adverse Event|16
447545|NCT00404924|1479477|P1|Overall Study|Adverse Event|75
447546|NCT00404820|1479495|P2|Overall Study|Other|2
447547|NCT00404820|1479496|P1|Overall Study|Other|0
447548|NCT00404820|1479495|P2|Overall Study|Death|0
447549|NCT00404820|1479496|P1|Overall Study|Death|1
447550|NCT00404820|1479495|P2|Overall Study|Administrative problems|0
447551|NCT00404820|1479496|P1|Overall Study|Administrative problems|2
447552|NCT00404820|1479495|P2|Overall Study|Lost to Follow-up|3
447553|NCT00404820|1479496|P1|Overall Study|Lost to Follow-up|7
447554|NCT00404820|1479495|P2|Overall Study|Withdrawal by Subject|3
447555|NCT00404820|1479496|P1|Overall Study|Withdrawal by Subject|5
447556|NCT00404820|1479495|P2|Overall Study|Adverse Event|16
447557|NCT00404820|1479496|P1|Overall Study|Adverse Event|4
447558|NCT00404768|1479518|P4|Part C|Researcher suspended study medication|1
447559|NCT00404768|1479519|P3|Part C|Researcher suspended study medication|0
447560|NCT00404768|1479520|P2|Part C|Researcher suspended study medication|0
447561|NCT00404768|1479521|P1|Part C|Researcher suspended study medication|0
447562|NCT00404768|1479518|P4|Part C|Investigator discretion|1
447563|NCT00404768|1479519|P3|Part C|Investigator discretion|0
447564|NCT00404768|1479520|P2|Part C|Investigator discretion|0
447565|NCT00404768|1479521|P1|Part C|Investigator discretion|0
447566|NCT00404768|1479518|P4|Part C|Treatment failure|1
447567|NCT00404768|1479519|P3|Part C|Treatment failure|0
447568|NCT00404768|1479520|P2|Part C|Treatment failure|0
447569|NCT00404768|1479521|P1|Part C|Treatment failure|0
447570|NCT00404768|1479518|P4|Part C|Lack of Efficacy|2
447571|NCT00404768|1479519|P3|Part C|Lack of Efficacy|0
447572|NCT00404768|1479520|P2|Part C|Lack of Efficacy|0
447573|NCT00404768|1479521|P1|Part C|Lack of Efficacy|0
447574|NCT00404768|1479518|P4|Part C|Active labor|1
447575|NCT00404768|1479519|P3|Part C|Active labor|0
447576|NCT00404768|1479520|P2|Part C|Active labor|0
447577|NCT00404768|1479521|P1|Part C|Active labor|0
447578|NCT00404768|1479518|P4|Part C|Unsatisfactory uterine response to IP|1
447579|NCT00404768|1479519|P3|Part C|Unsatisfactory uterine response to IP|0
447580|NCT00404768|1479520|P2|Part C|Unsatisfactory uterine response to IP|0
447581|NCT00404768|1479521|P1|Part C|Unsatisfactory uterine response to IP|0
447582|NCT00404768|1479518|P4|Part C|Participant delivered baby|1
447583|NCT00404768|1479519|P3|Part C|Participant delivered baby|0
447584|NCT00404768|1479520|P2|Part C|Participant delivered baby|0
447585|NCT00404768|1479521|P1|Part C|Participant delivered baby|0
447586|NCT00404768|1479518|P4|Part C|Physician withdrew the study medication|0
447587|NCT00404768|1479519|P3|Part C|Physician withdrew the study medication|1
447588|NCT00404768|1479520|P2|Part C|Physician withdrew the study medication|0
447589|NCT00404768|1479521|P1|Part C|Physician withdrew the study medication|0
447590|NCT00404768|1479518|P4|Part C|Participant did not respond to therapy|1
447591|NCT00404768|1479519|P3|Part C|Participant did not respond to therapy|1
447592|NCT00404768|1479520|P2|Part C|Participant did not respond to therapy|0
447593|NCT00404768|1479521|P1|Part C|Participant did not respond to therapy|0
447594|NCT00404768|1479518|P4|Part C|Early withdrawal from study medication|0
447595|NCT00404768|1479519|P3|Part C|Early withdrawal from study medication|1
447596|NCT00404768|1479520|P2|Part C|Early withdrawal from study medication|0
447597|NCT00404768|1479521|P1|Part C|Early withdrawal from study medication|0
447598|NCT00404768|1479518|P4|Part C|Withdrawal by Subject|1
447599|NCT00404768|1479519|P3|Part C|Withdrawal by Subject|2
447600|NCT00404768|1479520|P2|Part C|Withdrawal by Subject|0
447601|NCT00404768|1479521|P1|Part C|Withdrawal by Subject|0
447602|NCT00404768|1479518|P4|Part C|Lost to Follow-up|1
447603|NCT00404768|1479519|P3|Part C|Lost to Follow-up|3
447604|NCT00404768|1479520|P2|Part C|Lost to Follow-up|0
447605|NCT00404768|1479521|P1|Part C|Lost to Follow-up|0
447606|NCT00404768|1479518|P4|Part C|Adverse Event|3
447607|NCT00404768|1479519|P3|Part C|Adverse Event|0
447608|NCT00404768|1479520|P2|Part C|Adverse Event|0
447609|NCT00404768|1479521|P1|Part C|Adverse Event|0
447610|NCT00404768|1479518|P4|Part A and B|Withdrawn as delivery imminemnt|0
447611|NCT00404768|1479519|P3|Part A and B|Withdrawn as delivery imminemnt|0
447612|NCT00404768|1479520|P2|Part A and B|Withdrawn as delivery imminemnt|1
447613|NCT00404768|1479521|P1|Part A and B|Withdrawn as delivery imminemnt|0
447614|NCT00404768|1479518|P4|Part A and B|Withdrawn due to labor progression|0
447615|NCT00404768|1479519|P3|Part A and B|Withdrawn due to labor progression|0
447616|NCT00404768|1479520|P2|Part A and B|Withdrawn due to labor progression|0
447617|NCT00404768|1479521|P1|Part A and B|Withdrawn due to labor progression|1
447618|NCT00404755|1479582|P1|Phase II (Escitalopram)|Lost to Follow-up|2
447619|NCT00404755|1479582|P1|Phase I (Bupropion)|Other|1
447620|NCT00404755|1479582|P1|Phase I (Bupropion)|Adverse Event|3
447621|NCT00404651|1479597|P4|Overall Study|Withdrawal by Subject|6
447622|NCT00404651|1479598|P3|Overall Study|Withdrawal by Subject|16
447623|NCT00404651|1479599|P2|Overall Study|Withdrawal by Subject|12
447624|NCT00404651|1479600|P1|Overall Study|Withdrawal by Subject|14
447625|NCT00404651|1479597|P4|Overall Study|Lost to Follow-up|10
447626|NCT00404651|1479598|P3|Overall Study|Lost to Follow-up|13
447627|NCT00404651|1479599|P2|Overall Study|Lost to Follow-up|11
447628|NCT00404651|1479600|P1|Overall Study|Lost to Follow-up|15
447629|NCT00404651|1479597|P4|Overall Study|Protocol Violation|5
447630|NCT00404651|1479598|P3|Overall Study|Protocol Violation|14
447631|NCT00404651|1479599|P2|Overall Study|Protocol Violation|5
447632|NCT00404651|1479600|P1|Overall Study|Protocol Violation|10
447633|NCT00404651|1479597|P4|Overall Study|Serious Adverse Event|0
447634|NCT00404651|1479598|P3|Overall Study|Serious Adverse Event|2
447635|NCT00404651|1479599|P2|Overall Study|Serious Adverse Event|0
447636|NCT00404651|1479600|P1|Overall Study|Serious Adverse Event|0
447637|NCT00404547|1479628|P2|Overall Study|Reason not stated|6
447638|NCT00404547|1479629|P1|Overall Study|Reason not stated|3
447639|NCT00404547|1479628|P2|Overall Study|Other|0
447640|NCT00404547|1479629|P1|Overall Study|Other|4
447641|NCT00404547|1479628|P2|Overall Study|Lack of compliance|1
447642|NCT00404547|1479629|P1|Overall Study|Lack of compliance|5
447643|NCT00404547|1479628|P2|Overall Study|Lost to Follow-up|9
447644|NCT00404547|1479629|P1|Overall Study|Lost to Follow-up|20
447645|NCT00404547|1479628|P2|Overall Study|Protocol Violation|1
447646|NCT00404547|1479629|P1|Overall Study|Protocol Violation|0
447647|NCT00404547|1479628|P2|Overall Study|Withdrawal by Subject|2
447648|NCT00404547|1479629|P1|Overall Study|Withdrawal by Subject|19
447649|NCT00404547|1479628|P2|Overall Study|Adverse Event|6
447650|NCT00404547|1479629|P1|Overall Study|Adverse Event|39
447651|NCT00404495|1479639|P2|Overall Study|Withdrawal by Subject|0
447652|NCT00404495|1479640|P1|Overall Study|Withdrawal by Subject|1
447653|NCT00404495|1479639|P2|Overall Study|Not specified|0
447654|NCT00404495|1479640|P1|Overall Study|Not specified|1
447655|NCT00404495|1479639|P2|Overall Study|Lost to Follow-up|0
447656|NCT00404495|1479640|P1|Overall Study|Lost to Follow-up|5
447657|NCT00404495|1479639|P2|Overall Study|Death|11
447658|NCT00404495|1479640|P1|Overall Study|Death|37
447659|NCT00404352|1479659|P9|Open Label Extension (up to 36 Months)|Other|2
447660|NCT00404352|1479660|P8|Open Label Extension (up to 36 Months)|Other|0
447661|NCT00404352|1479661|P7|Open Label Extension (up to 36 Months)|Other|0
447662|NCT00404352|1479662|P6|Open Label Extension (up to 36 Months)|Other|0
447663|NCT00404352|1479663|P5|Open Label Extension (up to 36 Months)|Other|0
447664|NCT00404352|1479664|P4|Open Label Extension (up to 36 Months)|Other|0
447665|NCT00404352|1479665|P3|Open Label Extension (up to 36 Months)|Other|0
447666|NCT00404352|1479666|P2|Open Label Extension (up to 36 Months)|Other|0
447667|NCT00404352|1479667|P1|Open Label Extension (up to 36 Months)|Other|0
447668|NCT00404352|1479659|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
447669|NCT00404352|1479660|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
447670|NCT00404352|1479661|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
447671|NCT00404352|1479662|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
447672|NCT00404352|1479663|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
447673|NCT00404352|1479664|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
447674|NCT00404352|1479665|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
447675|NCT00404352|1479666|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
447676|NCT00404352|1479667|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
447677|NCT00404352|1479659|P9|Open Label (up to 24 Month)|Disease progression|0
447678|NCT00404352|1479660|P8|Open Label (up to 24 Month)|Disease progression|0
447679|NCT00404352|1479661|P7|Open Label (up to 24 Month)|Disease progression|0
447680|NCT00404352|1479662|P6|Open Label (up to 24 Month)|Disease progression|0
447681|NCT00404352|1479663|P5|Open Label (up to 24 Month)|Disease progression|0
447682|NCT00404352|1479664|P4|Open Label (up to 24 Month)|Disease progression|1
447683|NCT00404352|1479665|P3|Open Label (up to 24 Month)|Disease progression|0
447684|NCT00404352|1479666|P2|Open Label (up to 24 Month)|Disease progression|0
447685|NCT00404352|1479667|P1|Open Label (up to 24 Month)|Disease progression|0
447686|NCT00404352|1479659|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
447687|NCT00404352|1479660|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
447688|NCT00404352|1479661|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
447689|NCT00404352|1479662|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
447690|NCT00404352|1479663|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
447691|NCT00404352|1479664|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
447692|NCT00404352|1479665|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
447693|NCT00404352|1479666|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
447694|NCT00404352|1479667|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
447695|NCT00404352|1479659|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
447696|NCT00404352|1479660|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
447697|NCT00404352|1479661|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
447698|NCT00404352|1479662|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
447699|NCT00404352|1479663|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
447700|NCT00404352|1479664|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
447701|NCT00404352|1479665|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
447702|NCT00404352|1479666|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
447703|NCT00404352|1479667|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
447704|NCT00404352|1479659|P9|Open Label (up to 24 Month)|Pregnancy|0
447705|NCT00404352|1479660|P8|Open Label (up to 24 Month)|Pregnancy|0
447706|NCT00404352|1479661|P7|Open Label (up to 24 Month)|Pregnancy|0
447707|NCT00404352|1479662|P6|Open Label (up to 24 Month)|Pregnancy|1
447708|NCT00404352|1479663|P5|Open Label (up to 24 Month)|Pregnancy|0
447709|NCT00404352|1479664|P4|Open Label (up to 24 Month)|Pregnancy|0
447710|NCT00404352|1479665|P3|Open Label (up to 24 Month)|Pregnancy|0
447711|NCT00404352|1479666|P2|Open Label (up to 24 Month)|Pregnancy|0
447712|NCT00404352|1479667|P1|Open Label (up to 24 Month)|Pregnancy|0
447713|NCT00404352|1479659|P9|Open Label (up to 24 Month)|Adverse Event|0
447714|NCT00404352|1479660|P8|Open Label (up to 24 Month)|Adverse Event|0
447715|NCT00404352|1479661|P7|Open Label (up to 24 Month)|Adverse Event|0
447716|NCT00404352|1479662|P6|Open Label (up to 24 Month)|Adverse Event|1
447717|NCT00404352|1479663|P5|Open Label (up to 24 Month)|Adverse Event|1
447718|NCT00404352|1479664|P4|Open Label (up to 24 Month)|Adverse Event|2
447719|NCT00404352|1479665|P3|Open Label (up to 24 Month)|Adverse Event|0
447720|NCT00404352|1479666|P2|Open Label (up to 24 Month)|Adverse Event|0
447721|NCT00404352|1479667|P1|Open Label (up to 24 Month)|Adverse Event|0
447722|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Other|0
447723|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Other|0
447724|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Other|0
447725|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Other|0
447726|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Other|0
447727|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Other|0
447728|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Other|0
447729|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Other|1
447730|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Other|0
447731|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Physician Decision|0
447732|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Physician Decision|0
447733|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Physician Decision|0
447734|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Physician Decision|0
447735|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Physician Decision|0
447736|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Physician Decision|0
447737|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Physician Decision|1
447738|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Physician Decision|0
447739|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Physician Decision|0
447740|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
447741|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
447742|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
447743|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
447744|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
447745|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
447746|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
447747|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
447748|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
447749|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
447750|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
447751|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
447752|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
447753|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
447754|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
447755|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
447756|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
447757|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
447758|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Poor compliance|0
447759|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Poor compliance|0
447760|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Poor compliance|0
447761|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Poor compliance|0
447762|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Poor compliance|0
447763|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Poor compliance|0
447764|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Poor compliance|0
447765|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Poor compliance|0
447766|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Poor compliance|1
447767|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Disease progression|0
447768|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Disease progression|0
447769|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Disease progression|0
447770|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Disease progression|0
447771|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Disease progression|0
447772|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Disease progression|0
447773|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Disease progression|2
447774|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Disease progression|0
447775|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Disease progression|3
447776|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
447777|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
447778|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
447779|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
447780|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
447781|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
447782|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
447783|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
447784|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
447785|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
447786|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
447787|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
447788|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
447789|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
447790|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
447791|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
447792|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
447793|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
447794|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Death|0
447795|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Death|0
447796|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Death|0
447797|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Death|0
447798|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Death|0
447799|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Death|0
447800|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Death|1
447801|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Death|0
447802|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Death|0
447803|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Pregnancy|0
447804|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Pregnancy|0
447805|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Pregnancy|0
447806|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Pregnancy|0
447807|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Pregnancy|0
447808|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Pregnancy|0
447809|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Pregnancy|2
447810|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Pregnancy|0
447811|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Pregnancy|0
447812|NCT00404352|1479659|P9|Double Blind (up to 24 Month)|Adverse Event|0
447813|NCT00404352|1479660|P8|Double Blind (up to 24 Month)|Adverse Event|0
447814|NCT00404352|1479661|P7|Double Blind (up to 24 Month)|Adverse Event|0
447815|NCT00404352|1479662|P6|Double Blind (up to 24 Month)|Adverse Event|0
447816|NCT00404352|1479663|P5|Double Blind (up to 24 Month)|Adverse Event|0
447817|NCT00404352|1479664|P4|Double Blind (up to 24 Month)|Adverse Event|0
447818|NCT00404352|1479665|P3|Double Blind (up to 24 Month)|Adverse Event|6
447819|NCT00404352|1479666|P2|Double Blind (up to 24 Month)|Adverse Event|4
447820|NCT00404352|1479667|P1|Double Blind (up to 24 Month)|Adverse Event|5
447821|NCT00404248|1479702|P9|Overall Study|pts declining status|0
447822|NCT00404248|1479703|P8|Overall Study|pts declining status|0
447823|NCT00404248|1479704|P7|Overall Study|pts declining status|0
447824|NCT00404248|1479705|P6|Overall Study|pts declining status|0
447825|NCT00404248|1479706|P5|Overall Study|pts declining status|0
447826|NCT00404248|1479707|P4|Overall Study|pts declining status|0
447827|NCT00404248|1479708|P3|Overall Study|pts declining status|0
447828|NCT00404248|1479709|P2|Overall Study|pts declining status|1
447829|NCT00404248|1479710|P1|Overall Study|pts declining status|0
447830|NCT00404092|1479745|P4|Overall Study|Adverse Event|0
447831|NCT00404092|1479746|P3|Overall Study|Adverse Event|1
447832|NCT00404092|1479747|P2|Overall Study|Adverse Event|0
447833|NCT00404092|1479748|P1|Overall Study|Adverse Event|0
447834|NCT00404092|1479745|P4|Overall Study|Death|0
447835|NCT00404092|1479746|P3|Overall Study|Death|0
447836|NCT00404092|1479747|P2|Overall Study|Death|0
447837|NCT00404092|1479748|P1|Overall Study|Death|1
447838|NCT00404079|1479764|P2|Overall Study|Lost to follow up, adverse event etc|20
447839|NCT00404079|1479765|P1|Overall Study|Lost to follow up, adverse event etc|22
447840|NCT00404066|1479771|P1|Overall Study|Withdrawal by Subject - Adverse event|2
447841|NCT00404066|1479771|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
447842|NCT00403845|1479776|P4|Treatment Period 3|Adverse Event|1
447843|NCT00403845|1479777|P3|Treatment Period 3|Adverse Event|0
447844|NCT00403845|1479778|P2|Treatment Period 3|Adverse Event|0
447845|NCT00403845|1479779|P1|Treatment Period 3|Adverse Event|0
447846|NCT00403845|1479776|P4|Treatment Period 3|Subject withdrew consent|1
447847|NCT00403845|1479777|P3|Treatment Period 3|Subject withdrew consent|0
447848|NCT00403845|1479778|P2|Treatment Period 3|Subject withdrew consent|0
447849|NCT00403845|1479779|P1|Treatment Period 3|Subject withdrew consent|0
447850|NCT00403845|1479776|P4|Treatment Period 2|Subject withdrew consent|0
447851|NCT00403845|1479777|P3|Treatment Period 2|Subject withdrew consent|0
447852|NCT00403845|1479778|P2|Treatment Period 2|Subject withdrew consent|0
447853|NCT00403845|1479779|P1|Treatment Period 2|Subject withdrew consent|1
447854|NCT00403845|1479776|P4|Treatment Period 1|Subject no longer needs study drug|1
447855|NCT00403845|1479777|P3|Treatment Period 1|Subject no longer needs study drug|0
447856|NCT00403845|1479778|P2|Treatment Period 1|Subject no longer needs study drug|0
447857|NCT00403845|1479779|P1|Treatment Period 1|Subject no longer needs study drug|0
447858|NCT00403845|1479776|P4|Treatment Period 1|Subject withdrew consent|0
447859|NCT00403845|1479777|P3|Treatment Period 1|Subject withdrew consent|0
447860|NCT00403845|1479778|P2|Treatment Period 1|Subject withdrew consent|0
447861|NCT00403845|1479779|P1|Treatment Period 1|Subject withdrew consent|1
447862|NCT00403767|1479803|P2|Overall Study|Missing/incomplete data|1
447863|NCT00403767|1479804|P1|Overall Study|Missing/incomplete data|1
447864|NCT00403767|1479803|P2|Overall Study|Study terminated by sponsor|69
447865|NCT00403767|1479804|P1|Overall Study|Study terminated by sponsor|82
447866|NCT00403767|1479803|P2|Overall Study|Clinical efficacy endpoint reached|332
447867|NCT00403767|1479804|P1|Overall Study|Clinical efficacy endpoint reached|300
447868|NCT00403767|1479803|P2|Overall Study|Protocol Violation|124
447869|NCT00403767|1479804|P1|Overall Study|Protocol Violation|142
447870|NCT00403767|1479803|P2|Overall Study|Lost to Follow-up|8
447871|NCT00403767|1479804|P1|Overall Study|Lost to Follow-up|6
447872|NCT00403767|1479803|P2|Overall Study|Investigator dec./not protocol-related|178
447873|NCT00403767|1479804|P1|Overall Study|Investigator dec./not protocol-related|191
447874|NCT00403767|1479803|P2|Overall Study|Consent withdrawn|673
447875|NCT00403767|1479804|P1|Overall Study|Consent withdrawn|671
447876|NCT00403767|1479803|P2|Overall Study|Non-compliant with study medication|164
447877|NCT00403767|1479804|P1|Overall Study|Non-compliant with study medication|134
447878|NCT00403767|1479803|P2|Overall Study|Adverse Event|919
447879|NCT00403767|1479804|P1|Overall Study|Adverse Event|993
447880|NCT00403754|1479828|P4|Core Treatment Period 2|Lack of Efficacy|0
447881|NCT00403754|1479829|P3|Core Treatment Period 2|Lack of Efficacy|1
447882|NCT00403754|1479830|P2|Core Treatment Period 2|Lack of Efficacy|0
447883|NCT00403754|1479831|P1|Core Treatment Period 2|Lack of Efficacy|0
447884|NCT00403754|1479828|P4|Core Treatment Period 1|Withdrawal by Subject|0
447885|NCT00403754|1479829|P3|Core Treatment Period 1|Withdrawal by Subject|0
447886|NCT00403754|1479830|P2|Core Treatment Period 1|Withdrawal by Subject|1
447887|NCT00403754|1479831|P1|Core Treatment Period 1|Withdrawal by Subject|0
447888|NCT00403585|1479858|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
447889|NCT00403585|1479858|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
447890|NCT00403585|1479858|P1|Initial Treatment Phase|Lost to Follow-up|2
447891|NCT00403546|1479869|P3|Randomized Trial|Early Terminations|16
447892|NCT00403546|1479870|P2|Randomized Trial|Early Terminations|17
447893|NCT00403546|1479871|P1|Randomized Trial|Early Terminations|0
447894|NCT00403546|1479869|P3|Screening Phase|Terminated Prior to Randomization|0
447895|NCT00403546|1479870|P2|Screening Phase|Terminated Prior to Randomization|0
447896|NCT00403546|1479871|P1|Screening Phase|Terminated Prior to Randomization|5
447897|NCT00403546|1479869|P3|Screening Phase|Adverse Event|0
447898|NCT00403546|1479870|P2|Screening Phase|Adverse Event|0
447899|NCT00403546|1479871|P1|Screening Phase|Adverse Event|1
447900|NCT00403546|1479869|P3|Screening Phase|Screening Failure|0
447901|NCT00403546|1479870|P2|Screening Phase|Screening Failure|0
447902|NCT00403546|1479871|P1|Screening Phase|Screening Failure|22
447903|NCT00403546|1479869|P3|Signed Informed Consent/Open-Label|Adverse Event|0
447904|NCT00403546|1479870|P2|Signed Informed Consent/Open-Label|Adverse Event|0
447905|NCT00403546|1479871|P1|Signed Informed Consent/Open-Label|Adverse Event|5
447906|NCT00403546|1479869|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
447907|NCT00403546|1479870|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
447908|NCT00403546|1479871|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
447909|NCT00403546|1479869|P3|Signed Informed Consent/Open-Label|Early Termination|0
447910|NCT00403546|1479870|P2|Signed Informed Consent/Open-Label|Early Termination|0
447911|NCT00403546|1479871|P1|Signed Informed Consent/Open-Label|Early Termination|8
447912|NCT00403546|1479869|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
447913|NCT00403546|1479870|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
447914|NCT00403546|1479871|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
447915|NCT00403481|1479911|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
447916|NCT00403481|1479911|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
447917|NCT00403481|1479911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
447918|NCT00403481|1479911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
447919|NCT00403481|1479911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
447920|NCT00403481|1479911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
447921|NCT00403481|1479911|P1|Olm 40 mg|Other|1
447922|NCT00403481|1479911|P1|Olm 40 mg|Withdrawal by Subject|1
447923|NCT00403481|1479911|P1|Olm 40 mg|Protocol Violation|1
447924|NCT00403481|1479911|P1|Olm 40 mg|Adverse Event|2
447925|NCT00403481|1479911|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
447926|NCT00403481|1479911|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
447927|NCT00403481|1479911|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
447928|NCT00403481|1479911|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
447929|NCT00403455|1479926|P1|Overall Study|Withdrawal by Subject|1
447930|NCT00403390|1479949|P2|Overall Study|non-compliant|0
447931|NCT00403390|1479950|P1|Overall Study|non-compliant|1
447932|NCT00403390|1479949|P2|Overall Study|samples lost|0
447933|NCT00403390|1479950|P1|Overall Study|samples lost|1
447934|NCT00403390|1479949|P2|Overall Study|Withdrawal by Subject|0
447935|NCT00403390|1479950|P1|Overall Study|Withdrawal by Subject|1
447936|NCT00403273|1479958|P2|Overall Study|pt. wanted to have a surgical procedure|1
447937|NCT00403273|1479959|P1|Overall Study|pt. wanted to have a surgical procedure|0
447938|NCT00403273|1479958|P2|Overall Study|Physician Decision|1
447939|NCT00403273|1479959|P1|Overall Study|Physician Decision|0
447940|NCT00403273|1479958|P2|Overall Study|Lost to Follow-up|2
447941|NCT00403273|1479959|P1|Overall Study|Lost to Follow-up|3
447942|NCT00403234|1480001|P4|Overall Study|Adverse Event|0
447943|NCT00403234|1480002|P3|Overall Study|Adverse Event|1
447944|NCT00403234|1480003|P2|Overall Study|Adverse Event|0
447945|NCT00403234|1480004|P1|Overall Study|Adverse Event|1
447946|NCT00403234|1480001|P4|Overall Study|Withdrawal by Subject|0
447947|NCT00403234|1480002|P3|Overall Study|Withdrawal by Subject|0
447948|NCT00403234|1480003|P2|Overall Study|Withdrawal by Subject|1
447949|NCT00403234|1480004|P1|Overall Study|Withdrawal by Subject|0
447950|NCT00403130|1480014|P1|Overall Study|Withdrawal by Subject|1
447951|NCT00403130|1480014|P1|Overall Study|Lost to Follow up|1
447952|NCT00403130|1480014|P1|Overall Study|Not Eligible|3
447953|NCT00402987|1480067|P4|Overall Study|Lack of Efficacy|0
447954|NCT00402987|1480068|P3|Overall Study|Lack of Efficacy|1
447955|NCT00402987|1480069|P2|Overall Study|Lack of Efficacy|0
447956|NCT00402987|1480070|P1|Overall Study|Lack of Efficacy|0
447957|NCT00402740|1480240|P1|Overall Study|Subject disposition unknown.|1
447958|NCT00402740|1480240|P1|Overall Study|No stent. Completed FU at 30 days.|5
447959|NCT00402740|1480240|P1|Overall Study|Lost to Follow-up|6
447960|NCT00402740|1480240|P1|Overall Study|Death|50
447961|NCT00402740|1480240|P1|Overall Study|Withdrawal by Subject|18
447962|NCT00402727|1480252|P2|Overall Study|non-compliance|1
447963|NCT00402727|1480253|P1|Overall Study|non-compliance|0
447964|NCT00402727|1480252|P2|Overall Study|supply problems|1
447965|NCT00402727|1480253|P1|Overall Study|supply problems|2
447966|NCT00402727|1480252|P2|Overall Study|Withdrawal by Subject|7
447967|NCT00402727|1480253|P1|Overall Study|Withdrawal by Subject|3
447968|NCT00402727|1480252|P2|Overall Study|Protocol Violation|4
447969|NCT00402727|1480253|P1|Overall Study|Protocol Violation|0
447970|NCT00402727|1480252|P2|Overall Study|Physician Decision|1
447971|NCT00402727|1480253|P1|Overall Study|Physician Decision|1
447972|NCT00402727|1480252|P2|Overall Study|Lost to Follow-up|11
447973|NCT00402727|1480253|P1|Overall Study|Lost to Follow-up|24
447974|NCT00402727|1480252|P2|Overall Study|Lack of Efficacy|3
447975|NCT00402727|1480253|P1|Overall Study|Lack of Efficacy|1
447976|NCT00402727|1480252|P2|Overall Study|Death|0
447977|NCT00402727|1480253|P1|Overall Study|Death|1
447978|NCT00402727|1480252|P2|Overall Study|Adverse Event|6
447979|NCT00402727|1480253|P1|Overall Study|Adverse Event|10
447980|NCT00402688|1480295|P3|Overall Study|Patient Left Town and Forgot Medication|1
447981|NCT00402688|1480296|P2|Overall Study|Patient Left Town and Forgot Medication|0
447982|NCT00402688|1480297|P1|Overall Study|Patient Left Town and Forgot Medication|0
447983|NCT00402688|1480295|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
447984|NCT00402688|1480296|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
447985|NCT00402688|1480297|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
447986|NCT00402688|1480295|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
447987|NCT00402688|1480296|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
447988|NCT00402688|1480297|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
447989|NCT00402688|1480295|P3|Overall Study|Lost to Follow-up|2
447990|NCT00402688|1480296|P2|Overall Study|Lost to Follow-up|0
447991|NCT00402688|1480297|P1|Overall Study|Lost to Follow-up|1
447992|NCT00402688|1480295|P3|Overall Study|Protocol Violation|1
447993|NCT00402688|1480296|P2|Overall Study|Protocol Violation|1
447994|NCT00402688|1480297|P1|Overall Study|Protocol Violation|1
447995|NCT00402688|1480295|P3|Overall Study|Lack of Efficacy|5
447996|NCT00402688|1480296|P2|Overall Study|Lack of Efficacy|4
447997|NCT00402688|1480297|P1|Overall Study|Lack of Efficacy|4
447998|NCT00402688|1480295|P3|Overall Study|Physician Decision|1
447999|NCT00402688|1480296|P2|Overall Study|Physician Decision|0
448000|NCT00402688|1480297|P1|Overall Study|Physician Decision|0
448001|NCT00402688|1480295|P3|Overall Study|Withdrawal by Subject|1
448002|NCT00402688|1480296|P2|Overall Study|Withdrawal by Subject|1
448003|NCT00402688|1480297|P1|Overall Study|Withdrawal by Subject|3
448004|NCT00402688|1480295|P3|Overall Study|Adverse Event|3
448005|NCT00402688|1480296|P2|Overall Study|Adverse Event|9
448006|NCT00402688|1480297|P1|Overall Study|Adverse Event|12
448007|NCT00402649|1480320|P1|Overall Study|Withdrawal by Subject|1
448008|NCT00402649|1480320|P1|Overall Study|Lost to Follow-up|1
448009|NCT00402597|1480335|P5|Overall Study|reason not specified|20
448010|NCT00402597|1480336|P4|Overall Study|reason not specified|14
448011|NCT00402597|1480337|P3|Overall Study|reason not specified|27
448012|NCT00402597|1480338|P2|Overall Study|reason not specified|4
448013|NCT00402597|1480339|P1|Overall Study|reason not specified|30
448014|NCT00402597|1480335|P5|Overall Study|Withdrawal by Subject|24
448015|NCT00402597|1480336|P4|Overall Study|Withdrawal by Subject|15
448016|NCT00402597|1480337|P3|Overall Study|Withdrawal by Subject|65
448017|NCT00402597|1480338|P2|Overall Study|Withdrawal by Subject|16
448018|NCT00402597|1480339|P1|Overall Study|Withdrawal by Subject|57
448019|NCT00402597|1480335|P5|Overall Study|Lost to Follow-up|3
448020|NCT00402597|1480336|P4|Overall Study|Lost to Follow-up|2
448021|NCT00402597|1480337|P3|Overall Study|Lost to Follow-up|8
448022|NCT00402597|1480338|P2|Overall Study|Lost to Follow-up|1
448023|NCT00402597|1480339|P1|Overall Study|Lost to Follow-up|8
448024|NCT00402597|1480335|P5|Overall Study|Adverse Event|71
448025|NCT00402597|1480336|P4|Overall Study|Adverse Event|39
448026|NCT00402597|1480337|P3|Overall Study|Adverse Event|106
448027|NCT00402597|1480338|P2|Overall Study|Adverse Event|18
448028|NCT00402597|1480339|P1|Overall Study|Adverse Event|81
448029|NCT00402597|1480335|P5|Overall Study|Death|6
448030|NCT00402597|1480336|P4|Overall Study|Death|4
448031|NCT00402597|1480337|P3|Overall Study|Death|6
448032|NCT00402597|1480338|P2|Overall Study|Death|7
448033|NCT00402597|1480339|P1|Overall Study|Death|15
448034|NCT00402363|1480380|P4|Overall Study|"Captured as Other"|2
448035|NCT00402363|1480381|P3|Overall Study|"Captured as Other"|2
448036|NCT00402363|1480382|P2|Overall Study|"Captured as Other"|2
448037|NCT00402363|1480383|P1|Overall Study|"Captured as Other"|6
448038|NCT00402363|1480380|P4|Overall Study|Lost to Follow-up|2
448039|NCT00402363|1480381|P3|Overall Study|Lost to Follow-up|0
448040|NCT00402363|1480382|P2|Overall Study|Lost to Follow-up|4
448041|NCT00402363|1480383|P1|Overall Study|Lost to Follow-up|5
448042|NCT00402363|1480380|P4|Overall Study|Protocol Violation|3
448043|NCT00402363|1480381|P3|Overall Study|Protocol Violation|0
448044|NCT00402363|1480382|P2|Overall Study|Protocol Violation|5
448045|NCT00402363|1480383|P1|Overall Study|Protocol Violation|3
448046|NCT00402363|1480380|P4|Overall Study|Withdrew Consent|1
448047|NCT00402363|1480381|P3|Overall Study|Withdrew Consent|2
448048|NCT00402363|1480382|P2|Overall Study|Withdrew Consent|5
448049|NCT00402363|1480383|P1|Overall Study|Withdrew Consent|10
448050|NCT00402363|1480380|P4|Overall Study|Adverse Event|2
448051|NCT00402363|1480381|P3|Overall Study|Adverse Event|2
448052|NCT00402363|1480382|P2|Overall Study|Adverse Event|14
448053|NCT00402363|1480383|P1|Overall Study|Adverse Event|9
448054|NCT00402337|1480446|P5|Overall Study|Other Reason|0
448055|NCT00402337|1480447|P4|Overall Study|Other Reason|0
448056|NCT00402337|1480448|P3|Overall Study|Other Reason|0
448057|NCT00402337|1480449|P2|Overall Study|Other Reason|1
448058|NCT00402337|1480450|P1|Overall Study|Other Reason|0
448059|NCT00402337|1480446|P5|Overall Study|Physician Decision|0
448060|NCT00402337|1480447|P4|Overall Study|Physician Decision|1
448061|NCT00402337|1480448|P3|Overall Study|Physician Decision|0
448062|NCT00402337|1480449|P2|Overall Study|Physician Decision|0
448063|NCT00402337|1480450|P1|Overall Study|Physician Decision|0
448064|NCT00402337|1480446|P5|Overall Study|Lost to Follow-up|0
448065|NCT00402337|1480447|P4|Overall Study|Lost to Follow-up|2
448066|NCT00402337|1480448|P3|Overall Study|Lost to Follow-up|1
448067|NCT00402337|1480449|P2|Overall Study|Lost to Follow-up|0
448068|NCT00402337|1480450|P1|Overall Study|Lost to Follow-up|0
448069|NCT00402337|1480446|P5|Overall Study|Withdrawal by Subject|4
448070|NCT00402337|1480447|P4|Overall Study|Withdrawal by Subject|6
448071|NCT00402337|1480448|P3|Overall Study|Withdrawal by Subject|1
448072|NCT00402337|1480449|P2|Overall Study|Withdrawal by Subject|3
448073|NCT00402337|1480450|P1|Overall Study|Withdrawal by Subject|5
448074|NCT00402337|1480446|P5|Overall Study|Noncompliance|2
448075|NCT00402337|1480447|P4|Overall Study|Noncompliance|0
448076|NCT00402337|1480448|P3|Overall Study|Noncompliance|0
448077|NCT00402337|1480449|P2|Overall Study|Noncompliance|0
448078|NCT00402337|1480450|P1|Overall Study|Noncompliance|0
448079|NCT00402337|1480446|P5|Overall Study|Adverse Event|2
448080|NCT00402337|1480447|P4|Overall Study|Adverse Event|3
448081|NCT00402337|1480448|P3|Overall Study|Adverse Event|2
448082|NCT00402337|1480449|P2|Overall Study|Adverse Event|2
448083|NCT00402337|1480450|P1|Overall Study|Adverse Event|0
448084|NCT00402324|1480489|P2|Overall Study|Death|0
448085|NCT00402324|1480490|P1|Overall Study|Death|1
448086|NCT00402324|1480489|P2|Overall Study|Adverse Event|4
448087|NCT00402324|1480490|P1|Overall Study|Adverse Event|6
448088|NCT00402324|1480489|P2|Overall Study|Lack of Efficacy|4
448089|NCT00402324|1480490|P1|Overall Study|Lack of Efficacy|1
448090|NCT00402324|1480489|P2|Overall Study|Sponsor Decision|5
448091|NCT00402324|1480490|P1|Overall Study|Sponsor Decision|4
448092|NCT00402324|1480489|P2|Overall Study|Physician Decision|4
448093|NCT00402324|1480490|P1|Overall Study|Physician Decision|2
448094|NCT00402324|1480489|P2|Overall Study|Withdrawal by Subject|2
448095|NCT00402324|1480490|P1|Overall Study|Withdrawal by Subject|5
448096|NCT00402324|1480489|P2|Overall Study|Protocol Violation|7
448097|NCT00402324|1480490|P1|Overall Study|Protocol Violation|8
448098|NCT00402324|1480489|P2|Overall Study|Protocol Entry Criteria Not Met|4
448099|NCT00402324|1480490|P1|Overall Study|Protocol Entry Criteria Not Met|5
448100|NCT00402324|1480489|P2|Overall Study|Lost to Follow-up|11
448101|NCT00402324|1480490|P1|Overall Study|Lost to Follow-up|11
448102|NCT00402285|1480523|P3|Overall Study|insufficient RNA quality|2
448103|NCT00402285|1480524|P2|Overall Study|insufficient RNA quality|6
448104|NCT00402285|1480525|P1|Overall Study|insufficient RNA quality|7
448105|NCT00402246|1480533|P2|Overall Study|Deterioriating Condition|2
448106|NCT00402246|1480534|P1|Overall Study|Deterioriating Condition|3
448107|NCT00402246|1480533|P2|Overall Study|Center Closure|3
448108|NCT00402246|1480534|P1|Overall Study|Center Closure|5
448109|NCT00402246|1480533|P2|Overall Study|Patient's device explanted|2
448110|NCT00402246|1480534|P1|Overall Study|Patient's device explanted|6
448111|NCT00402246|1480533|P2|Overall Study|Heart Transplant|1
448112|NCT00402246|1480534|P1|Overall Study|Heart Transplant|0
448113|NCT00402246|1480533|P2|Overall Study|Insurance Issues|1
448114|NCT00402246|1480534|P1|Overall Study|Insurance Issues|2
448115|NCT00402246|1480533|P2|Overall Study|Missed Final Visit|2
448116|NCT00402246|1480534|P1|Overall Study|Missed Final Visit|1
448117|NCT00402246|1480533|P2|Overall Study|Protocol Violation|24
448118|NCT00402246|1480534|P1|Overall Study|Protocol Violation|25
448119|NCT00402246|1480533|P2|Overall Study|Physician Decision|26
448120|NCT00402246|1480534|P1|Overall Study|Physician Decision|24
448121|NCT00402246|1480533|P2|Overall Study|Withdrawal by Subject|87
448122|NCT00402246|1480534|P1|Overall Study|Withdrawal by Subject|72
448123|NCT00402246|1480533|P2|Overall Study|Lost to Follow-up|28
448124|NCT00402246|1480534|P1|Overall Study|Lost to Follow-up|20
448125|NCT00402246|1480533|P2|Overall Study|Death|58
448126|NCT00402246|1480534|P1|Overall Study|Death|62
448127|NCT00402233|1480568|P4|Overall Study|Worsening of other pre-existing disease|0
448128|NCT00402233|1480569|P3|Overall Study|Worsening of other pre-existing disease|0
448129|NCT00402233|1480570|P2|Overall Study|Worsening of other pre-existing disease|1
448130|NCT00402233|1480571|P1|Overall Study|Worsening of other pre-existing disease|0
448131|NCT00402233|1480568|P4|Overall Study|Worsening of disease under study|0
448132|NCT00402233|1480569|P3|Overall Study|Worsening of disease under study|0
448133|NCT00402233|1480570|P2|Overall Study|Worsening of disease under study|0
448134|NCT00402233|1480571|P1|Overall Study|Worsening of disease under study|2
448135|NCT00402233|1480568|P4|Overall Study|Withdrawal by Subject|2
448136|NCT00402233|1480569|P3|Overall Study|Withdrawal by Subject|2
448137|NCT00402233|1480570|P2|Overall Study|Withdrawal by Subject|1
448138|NCT00402233|1480571|P1|Overall Study|Withdrawal by Subject|2
448139|NCT00402233|1480568|P4|Overall Study|Protocol Violation|0
448140|NCT00402233|1480569|P3|Overall Study|Protocol Violation|0
448141|NCT00402233|1480570|P2|Overall Study|Protocol Violation|1
448142|NCT00402233|1480571|P1|Overall Study|Protocol Violation|0
448143|NCT00402233|1480568|P4|Overall Study|Adverse Event|9
448144|NCT00402233|1480569|P3|Overall Study|Adverse Event|9
448145|NCT00402233|1480570|P2|Overall Study|Adverse Event|7
448146|NCT00402233|1480571|P1|Overall Study|Adverse Event|1
448147|NCT00402168|1480606|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
448148|NCT00402168|1480607|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
448149|NCT00402168|1480606|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
448150|NCT00402168|1480607|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
448151|NCT00402168|1480606|P2|Long Term (LT)|non-specified|2
448152|NCT00402168|1480607|P1|Long Term (LT)|non-specified|1
448153|NCT00402168|1480606|P2|Long Term (LT)|Lack of Efficacy|2
448154|NCT00402168|1480607|P1|Long Term (LT)|Lack of Efficacy|0
448155|NCT00402168|1480606|P2|Long Term (LT)|Death|0
448156|NCT00402168|1480607|P1|Long Term (LT)|Death|4
448157|NCT00402168|1480606|P2|Long Term (LT)|Lost to Follow-up|0
448158|NCT00402168|1480607|P1|Long Term (LT)|Lost to Follow-up|1
448159|NCT00402168|1480606|P2|Long Term (LT)|Pregnancy|1
448160|NCT00402168|1480607|P1|Long Term (LT)|Pregnancy|0
448161|NCT00402168|1480606|P2|Long Term (LT)|Withdrawal by Subject|7
448162|NCT00402168|1480607|P1|Long Term (LT)|Withdrawal by Subject|4
448163|NCT00402168|1480606|P2|Long Term (LT)|Adverse Event|5
448164|NCT00402168|1480607|P1|Long Term (LT)|Adverse Event|1
448165|NCT00402168|1480606|P2|Treatment (up to 12 Months)|non-specified|1
448166|NCT00402168|1480607|P1|Treatment (up to 12 Months)|non-specified|0
448167|NCT00402168|1480606|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
448168|NCT00402168|1480607|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
448169|NCT00402168|1480606|P2|Treatment (up to 12 Months)|Death|1
448170|NCT00402168|1480607|P1|Treatment (up to 12 Months)|Death|0
448171|NCT00402168|1480606|P2|Randomized|Withdrawal by Subject|1
448172|NCT00402168|1480607|P1|Randomized|Withdrawal by Subject|0
448173|NCT00402168|1480606|P2|Randomized|Lost to Follow-up|0
448174|NCT00402168|1480607|P1|Randomized|Lost to Follow-up|1
448175|NCT00402103|1480664|P2|Overall Study|Administrative problems|0
448176|NCT00402103|1480665|P1|Overall Study|Administrative problems|2
448177|NCT00402103|1480664|P2|Overall Study|Lost to Follow-up|3
448178|NCT00402103|1480665|P1|Overall Study|Lost to Follow-up|6
448179|NCT00402103|1480664|P2|Overall Study|Patient withdrew consent|1
448180|NCT00402103|1480665|P1|Overall Study|Patient withdrew consent|12
448181|NCT00402103|1480664|P2|Overall Study|Protocol Deviation|0
448182|NCT00402103|1480665|P1|Overall Study|Protocol Deviation|8
448183|NCT00402103|1480664|P2|Overall Study|Condition no longer requires study drug|0
448184|NCT00402103|1480665|P1|Overall Study|Condition no longer requires study drug|2
448185|NCT00402103|1480664|P2|Overall Study|Unsatisfactory therapeutic effect|2
448186|NCT00402103|1480665|P1|Overall Study|Unsatisfactory therapeutic effect|1
448187|NCT00402103|1480664|P2|Overall Study|Adverse Event|7
448188|NCT00402103|1480665|P1|Overall Study|Adverse Event|60
448189|NCT00402051|1480681|P2|Overall Study|Lost to Follow-up|0
448190|NCT00402051|1480682|P1|Overall Study|Lost to Follow-up|1
448191|NCT00402051|1480681|P2|Overall Study|Death Due to Adverse Event|2
448192|NCT00402051|1480682|P1|Overall Study|Death Due to Adverse Event|0
448193|NCT00402051|1480681|P2|Overall Study|Death Due to Study Disease|1
448194|NCT00402051|1480682|P1|Overall Study|Death Due to Study Disease|2
448195|NCT00402051|1480681|P2|Overall Study|Death - Related to Study Drug|2
448196|NCT00402051|1480682|P1|Overall Study|Death - Related to Study Drug|1
448197|NCT00402051|1480681|P2|Overall Study|Withdrawal by Subject|3
448198|NCT00402051|1480682|P1|Overall Study|Withdrawal by Subject|3
448199|NCT00402051|1480681|P2|Overall Study|Physician Decision|3
448200|NCT00402051|1480682|P1|Overall Study|Physician Decision|7
448201|NCT00402051|1480681|P2|Overall Study|Adverse Event|4
448202|NCT00402051|1480682|P1|Overall Study|Adverse Event|11
448203|NCT00402051|1480681|P2|Overall Study|Progressive Disease|20
448204|NCT00402051|1480682|P1|Overall Study|Progressive Disease|13
448205|NCT00402025|1480699|P3|Overall Study|Participant Decision|1
448206|NCT00402025|1480700|P2|Overall Study|Participant Decision|0
448207|NCT00402025|1480701|P1|Overall Study|Participant Decision|0
448208|NCT00402025|1480699|P3|Overall Study|Physician Decision|0
448209|NCT00402025|1480700|P2|Overall Study|Physician Decision|1
448210|NCT00402025|1480701|P1|Overall Study|Physician Decision|1
448211|NCT00402025|1480699|P3|Overall Study|Disease Progression|2
448212|NCT00402025|1480700|P2|Overall Study|Disease Progression|1
448213|NCT00402025|1480701|P1|Overall Study|Disease Progression|1
448214|NCT00402025|1480699|P3|Overall Study|Death|5
448215|NCT00402025|1480700|P2|Overall Study|Death|1
448216|NCT00402025|1480701|P1|Overall Study|Death|0
448217|NCT00402025|1480699|P3|Overall Study|Adverse Event|2
448218|NCT00402025|1480700|P2|Overall Study|Adverse Event|0
448219|NCT00402025|1480701|P1|Overall Study|Adverse Event|0
448220|NCT00401973|1480727|P3|Overall Study|Withdrawal by Subject|9
448221|NCT00401973|1480728|P2|Overall Study|Withdrawal by Subject|12
448222|NCT00401973|1480729|P1|Overall Study|Withdrawal by Subject|4
448223|NCT00401973|1480727|P3|Overall Study|Sponsor Decision|0
448224|NCT00401973|1480728|P2|Overall Study|Sponsor Decision|1
448225|NCT00401973|1480729|P1|Overall Study|Sponsor Decision|0
448226|NCT00401973|1480727|P3|Overall Study|Protocol Violation|3
448227|NCT00401973|1480728|P2|Overall Study|Protocol Violation|2
448228|NCT00401973|1480729|P1|Overall Study|Protocol Violation|1
448229|NCT00401973|1480727|P3|Overall Study|Physician Decision|1
448230|NCT00401973|1480728|P2|Overall Study|Physician Decision|0
448231|NCT00401973|1480729|P1|Overall Study|Physician Decision|2
448232|NCT00401973|1480727|P3|Overall Study|Lost to Follow-up|2
448233|NCT00401973|1480728|P2|Overall Study|Lost to Follow-up|2
448234|NCT00401973|1480729|P1|Overall Study|Lost to Follow-up|2
448235|NCT00401973|1480727|P3|Overall Study|Lack of Efficacy|3
448236|NCT00401973|1480728|P2|Overall Study|Lack of Efficacy|0
448237|NCT00401973|1480729|P1|Overall Study|Lack of Efficacy|0
448238|NCT00401973|1480727|P3|Overall Study|Clinical Relapse|1
448239|NCT00401973|1480728|P2|Overall Study|Clinical Relapse|1
448240|NCT00401973|1480729|P1|Overall Study|Clinical Relapse|0
448241|NCT00401973|1480727|P3|Overall Study|Adverse Event|4
448242|NCT00401973|1480728|P2|Overall Study|Adverse Event|8
448243|NCT00401973|1480729|P1|Overall Study|Adverse Event|2
448244|NCT00401960|1480768|P2|Overall Study|Death|0
448245|NCT00401960|1480769|P1|Overall Study|Death|2
448246|NCT00401960|1480768|P2|Overall Study|Lost to Follow-up|0
448247|NCT00401960|1480769|P1|Overall Study|Lost to Follow-up|3
448248|NCT00401843|1480799|P3|Overall Study|Received incorrect treatment|0
448249|NCT00401843|1480800|P2|Overall Study|Received incorrect treatment|3
448250|NCT00401843|1480801|P1|Overall Study|Received incorrect treatment|0
448251|NCT00401843|1480799|P3|Overall Study|Randomized but not Treated|3
448252|NCT00401843|1480800|P2|Overall Study|Randomized but not Treated|2
448253|NCT00401843|1480801|P1|Overall Study|Randomized but not Treated|0
448254|NCT00401843|1480799|P3|Overall Study|Withdrawal of consent to study agent|17
448255|NCT00401843|1480800|P2|Overall Study|Withdrawal of consent to study agent|15
448256|NCT00401843|1480801|P1|Overall Study|Withdrawal of consent to study agent|1
448257|NCT00401843|1480799|P3|Overall Study|Withdrawal by Subject|5
448258|NCT00401843|1480800|P2|Overall Study|Withdrawal by Subject|5
448259|NCT00401843|1480801|P1|Overall Study|Withdrawal by Subject|1
448260|NCT00401843|1480799|P3|Overall Study|Protocol Violation|1
448261|NCT00401843|1480800|P2|Overall Study|Protocol Violation|0
448262|NCT00401843|1480801|P1|Overall Study|Protocol Violation|0
448263|NCT00401843|1480799|P3|Overall Study|Physician Decision|10
448264|NCT00401843|1480800|P2|Overall Study|Physician Decision|16
448265|NCT00401843|1480801|P1|Overall Study|Physician Decision|0
448266|NCT00401843|1480799|P3|Overall Study|Other Unspecified|5
448267|NCT00401843|1480800|P2|Overall Study|Other Unspecified|3
448268|NCT00401843|1480801|P1|Overall Study|Other Unspecified|0
448269|NCT00401843|1480799|P3|Overall Study|Lost to Follow-up|2
448270|NCT00401843|1480800|P2|Overall Study|Lost to Follow-up|0
448271|NCT00401843|1480801|P1|Overall Study|Lost to Follow-up|0
448272|NCT00401843|1480799|P3|Overall Study|End of Study|2
448273|NCT00401843|1480800|P2|Overall Study|End of Study|1
448274|NCT00401843|1480801|P1|Overall Study|End of Study|1
448275|NCT00401843|1480799|P3|Overall Study|Disease progression|49
448276|NCT00401843|1480800|P2|Overall Study|Disease progression|60
448277|NCT00401843|1480801|P1|Overall Study|Disease progression|10
448278|NCT00401843|1480799|P3|Overall Study|Death|10
448279|NCT00401843|1480800|P2|Overall Study|Death|8
448280|NCT00401843|1480801|P1|Overall Study|Death|0
448281|NCT00401843|1480799|P3|Overall Study|Adverse Event|27
448282|NCT00401843|1480800|P2|Overall Study|Adverse Event|26
448283|NCT00401843|1480801|P1|Overall Study|Adverse Event|7
448284|NCT00401843|1480799|P3|Overall Study|Achieved Complete Response|11
448285|NCT00401843|1480800|P2|Overall Study|Achieved Complete Response|5
448286|NCT00401843|1480801|P1|Overall Study|Achieved Complete Response|1
448287|NCT00401830|1480819|P2|Overall Study|Other: Personal / Family problems|0
448288|NCT00401830|1480820|P1|Overall Study|Other: Personal / Family problems|1
448289|NCT00401830|1480819|P2|Overall Study|Lost to Follow-up|3
448290|NCT00401830|1480820|P1|Overall Study|Lost to Follow-up|1
448291|NCT00401830|1480819|P2|Overall Study|Non-compliance with drug study|0
448292|NCT00401830|1480820|P1|Overall Study|Non-compliance with drug study|1
448293|NCT00401830|1480819|P2|Overall Study|Protocol Violation|3
448294|NCT00401830|1480820|P1|Overall Study|Protocol Violation|3
448295|NCT00401830|1480819|P2|Overall Study|Withdrawal by Subject|3
448296|NCT00401830|1480820|P1|Overall Study|Withdrawal by Subject|4
448297|NCT00401830|1480819|P2|Overall Study|Lack of Efficacy|5
448298|NCT00401830|1480820|P1|Overall Study|Lack of Efficacy|11
448299|NCT00401830|1480819|P2|Overall Study|Adverse Event|18
448300|NCT00401830|1480820|P1|Overall Study|Adverse Event|10
448301|NCT00401752|1480878|P2|Overall Study|Physician Decision|1
448302|NCT00401752|1480879|P1|Overall Study|Physician Decision|1
448303|NCT00401752|1480878|P2|Overall Study|Development of any exclusion criteria|2
448304|NCT00401752|1480879|P1|Overall Study|Development of any exclusion criteria|4
448305|NCT00401752|1480878|P2|Overall Study|Lost to Follow-up|4
448306|NCT00401752|1480879|P1|Overall Study|Lost to Follow-up|1
448307|NCT00401752|1480878|P2|Overall Study|Withdrawal by Subject|6
448308|NCT00401752|1480879|P1|Overall Study|Withdrawal by Subject|2
448309|NCT00401752|1480878|P2|Overall Study|Adverse Event|5
448310|NCT00401752|1480879|P1|Overall Study|Adverse Event|2
448311|NCT00401726|1480897|P2|Overall Study|Protocol Deviation|4
448312|NCT00401726|1480898|P1|Overall Study|Protocol Deviation|9
448313|NCT00401726|1480897|P2|Overall Study|Lack of Efficacy|6
448314|NCT00401726|1480898|P1|Overall Study|Lack of Efficacy|4
448315|NCT00401726|1480897|P2|Overall Study|Withdrawal by Subject|24
448316|NCT00401726|1480898|P1|Overall Study|Withdrawal by Subject|18
448317|NCT00401726|1480897|P2|Overall Study|Protocol Violation|3
448318|NCT00401726|1480898|P1|Overall Study|Protocol Violation|6
448319|NCT00401726|1480897|P2|Overall Study|Lost to Follow-up|20
448320|NCT00401726|1480898|P1|Overall Study|Lost to Follow-up|23
448321|NCT00401726|1480897|P2|Overall Study|Physician Decision|6
448322|NCT00401726|1480898|P1|Overall Study|Physician Decision|3
448323|NCT00401726|1480897|P2|Overall Study|Sponsor Request|1
448324|NCT00401726|1480898|P1|Overall Study|Sponsor Request|0
448325|NCT00401726|1480897|P2|Overall Study|Death|3
448326|NCT00401726|1480898|P1|Overall Study|Death|0
448327|NCT00401726|1480897|P2|Overall Study|Adverse Event|45
448328|NCT00401726|1480898|P1|Overall Study|Adverse Event|34
448329|NCT00401544|1480933|P4|Overall Study|Other|2
448330|NCT00401544|1480934|P3|Overall Study|Other|2
448331|NCT00401544|1480935|P2|Overall Study|Other|0
448332|NCT00401544|1480936|P1|Overall Study|Other|0
448333|NCT00401544|1480933|P4|Overall Study|Disease progression|0
448334|NCT00401544|1480934|P3|Overall Study|Disease progression|0
448335|NCT00401544|1480935|P2|Overall Study|Disease progression|1
448336|NCT00401544|1480936|P1|Overall Study|Disease progression|0
448337|NCT00401544|1480933|P4|Overall Study|Ineligibility determined|2
448338|NCT00401544|1480934|P3|Overall Study|Ineligibility determined|0
448339|NCT00401544|1480935|P2|Overall Study|Ineligibility determined|1
448340|NCT00401544|1480936|P1|Overall Study|Ineligibility determined|0
448341|NCT00401544|1480933|P4|Overall Study|Physician Decision|0
448342|NCT00401544|1480934|P3|Overall Study|Physician Decision|0
448343|NCT00401544|1480935|P2|Overall Study|Physician Decision|3
448344|NCT00401544|1480936|P1|Overall Study|Physician Decision|1
448345|NCT00401544|1480933|P4|Overall Study|Withdrawal by Subject|5
448346|NCT00401544|1480934|P3|Overall Study|Withdrawal by Subject|6
448347|NCT00401544|1480935|P2|Overall Study|Withdrawal by Subject|6
448348|NCT00401544|1480936|P1|Overall Study|Withdrawal by Subject|7
448349|NCT00401544|1480933|P4|Overall Study|Lost to Follow-up|1
448350|NCT00401544|1480934|P3|Overall Study|Lost to Follow-up|1
448351|NCT00401544|1480935|P2|Overall Study|Lost to Follow-up|0
448352|NCT00401544|1480936|P1|Overall Study|Lost to Follow-up|2
448353|NCT00401544|1480933|P4|Overall Study|Death|5
448354|NCT00401544|1480934|P3|Overall Study|Death|2
448355|NCT00401544|1480935|P2|Overall Study|Death|6
448356|NCT00401544|1480936|P1|Overall Study|Death|3
448357|NCT00401544|1480933|P4|Overall Study|Adverse Event|1
448358|NCT00401544|1480934|P3|Overall Study|Adverse Event|1
448359|NCT00401544|1480935|P2|Overall Study|Adverse Event|1
448360|NCT00401544|1480936|P1|Overall Study|Adverse Event|5
448361|NCT00401531|1480976|P2|Overall Study|Withdrawal by Subject|2
448362|NCT00401531|1480977|P1|Overall Study|Withdrawal by Subject|3
448363|NCT00401531|1480976|P2|Overall Study|Lost to Follow-up|1
448364|NCT00401531|1480977|P1|Overall Study|Lost to Follow-up|1
448365|NCT00401531|1480976|P2|Overall Study|Protocol Violation|7
448366|NCT00401531|1480977|P1|Overall Study|Protocol Violation|3
448367|NCT00401531|1480976|P2|Overall Study|Adverse Event|0
448368|NCT00401531|1480977|P1|Overall Study|Adverse Event|2
448369|NCT00401258|1481047|P1|Overall Study|Adverse Event|7
448370|NCT00401245|1481062|P8|Double Blind Tapering Phase|Lack of Efficacy|0
448371|NCT00401245|1481063|P7|Double Blind Tapering Phase|Lack of Efficacy|0
448372|NCT00401245|1481064|P6|Double Blind Tapering Phase|Lack of Efficacy|1
448373|NCT00401245|1481065|P5|Double Blind Tapering Phase|Lack of Efficacy|0
448374|NCT00401245|1481066|P4|Double Blind Tapering Phase|Lack of Efficacy|0
448375|NCT00401245|1481067|P3|Double Blind Tapering Phase|Lack of Efficacy|0
448376|NCT00401245|1481068|P2|Double Blind Tapering Phase|Lack of Efficacy|0
448377|NCT00401245|1481069|P1|Double Blind Tapering Phase|Lack of Efficacy|0
448378|NCT00401245|1481062|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
448379|NCT00401245|1481063|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
448380|NCT00401245|1481064|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
448381|NCT00401245|1481065|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
448382|NCT00401245|1481066|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
448383|NCT00401245|1481067|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
448384|NCT00401245|1481068|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
448385|NCT00401245|1481069|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
448386|NCT00401245|1481062|P8|Double Blind Tapering Phase|Other|2
448387|NCT00401245|1481063|P7|Double Blind Tapering Phase|Other|2
448388|NCT00401245|1481064|P6|Double Blind Tapering Phase|Other|0
448389|NCT00401245|1481065|P5|Double Blind Tapering Phase|Other|1
448390|NCT00401245|1481066|P4|Double Blind Tapering Phase|Other|0
448391|NCT00401245|1481067|P3|Double Blind Tapering Phase|Other|0
448392|NCT00401245|1481068|P2|Double Blind Tapering Phase|Other|0
448393|NCT00401245|1481069|P1|Double Blind Tapering Phase|Other|0
448394|NCT00401245|1481062|P8|Double Blind Tapering Phase|Investigator request|1
448395|NCT00401245|1481063|P7|Double Blind Tapering Phase|Investigator request|0
448396|NCT00401245|1481064|P6|Double Blind Tapering Phase|Investigator request|0
448397|NCT00401245|1481065|P5|Double Blind Tapering Phase|Investigator request|0
448398|NCT00401245|1481066|P4|Double Blind Tapering Phase|Investigator request|0
448399|NCT00401245|1481067|P3|Double Blind Tapering Phase|Investigator request|0
448400|NCT00401245|1481068|P2|Double Blind Tapering Phase|Investigator request|0
448401|NCT00401245|1481069|P1|Double Blind Tapering Phase|Investigator request|0
448402|NCT00401245|1481062|P8|Double Blind Tapering Phase|Adverse Event|4
448403|NCT00401245|1481063|P7|Double Blind Tapering Phase|Adverse Event|2
448404|NCT00401245|1481064|P6|Double Blind Tapering Phase|Adverse Event|1
448405|NCT00401245|1481065|P5|Double Blind Tapering Phase|Adverse Event|1
448406|NCT00401245|1481066|P4|Double Blind Tapering Phase|Adverse Event|0
448407|NCT00401245|1481067|P3|Double Blind Tapering Phase|Adverse Event|0
448408|NCT00401245|1481068|P2|Double Blind Tapering Phase|Adverse Event|0
448409|NCT00401245|1481069|P1|Double Blind Tapering Phase|Adverse Event|0
448410|NCT00401245|1481062|P8|Open Label Phase|Lack of Efficacy|0
448411|NCT00401245|1481063|P7|Open Label Phase|Lack of Efficacy|0
448412|NCT00401245|1481064|P6|Open Label Phase|Lack of Efficacy|0
448413|NCT00401245|1481065|P5|Open Label Phase|Lack of Efficacy|0
448414|NCT00401245|1481066|P4|Open Label Phase|Lack of Efficacy|0
448415|NCT00401245|1481067|P3|Open Label Phase|Lack of Efficacy|3
448416|NCT00401245|1481068|P2|Open Label Phase|Lack of Efficacy|2
448417|NCT00401245|1481069|P1|Open Label Phase|Lack of Efficacy|4
448418|NCT00401245|1481062|P8|Open Label Phase|Withdrawal by Subject|0
448419|NCT00401245|1481063|P7|Open Label Phase|Withdrawal by Subject|0
448420|NCT00401245|1481064|P6|Open Label Phase|Withdrawal by Subject|0
448421|NCT00401245|1481065|P5|Open Label Phase|Withdrawal by Subject|0
448422|NCT00401245|1481066|P4|Open Label Phase|Withdrawal by Subject|1
448423|NCT00401245|1481067|P3|Open Label Phase|Withdrawal by Subject|2
448424|NCT00401245|1481068|P2|Open Label Phase|Withdrawal by Subject|3
448425|NCT00401245|1481069|P1|Open Label Phase|Withdrawal by Subject|3
448426|NCT00401245|1481062|P8|Open Label Phase|Protocol Violation|0
448427|NCT00401245|1481063|P7|Open Label Phase|Protocol Violation|0
448428|NCT00401245|1481064|P6|Open Label Phase|Protocol Violation|0
448429|NCT00401245|1481065|P5|Open Label Phase|Protocol Violation|0
448430|NCT00401245|1481066|P4|Open Label Phase|Protocol Violation|1
448431|NCT00401245|1481067|P3|Open Label Phase|Protocol Violation|0
448432|NCT00401245|1481068|P2|Open Label Phase|Protocol Violation|1
448433|NCT00401245|1481069|P1|Open Label Phase|Protocol Violation|0
448434|NCT00401245|1481062|P8|Open Label Phase|Other|0
448435|NCT00401245|1481063|P7|Open Label Phase|Other|0
448436|NCT00401245|1481064|P6|Open Label Phase|Other|0
448437|NCT00401245|1481065|P5|Open Label Phase|Other|0
448438|NCT00401245|1481066|P4|Open Label Phase|Other|8
448439|NCT00401245|1481067|P3|Open Label Phase|Other|7
448440|NCT00401245|1481068|P2|Open Label Phase|Other|8
448441|NCT00401245|1481069|P1|Open Label Phase|Other|4
448442|NCT00401245|1481062|P8|Open Label Phase|Lost to Follow-up|0
448443|NCT00401245|1481063|P7|Open Label Phase|Lost to Follow-up|0
448444|NCT00401245|1481064|P6|Open Label Phase|Lost to Follow-up|0
448445|NCT00401245|1481065|P5|Open Label Phase|Lost to Follow-up|0
448446|NCT00401245|1481066|P4|Open Label Phase|Lost to Follow-up|4
448447|NCT00401245|1481067|P3|Open Label Phase|Lost to Follow-up|5
448448|NCT00401245|1481068|P2|Open Label Phase|Lost to Follow-up|7
448449|NCT00401245|1481069|P1|Open Label Phase|Lost to Follow-up|5
448450|NCT00401245|1481062|P8|Open Label Phase|Adverse Event|0
448451|NCT00401245|1481063|P7|Open Label Phase|Adverse Event|0
448452|NCT00401245|1481064|P6|Open Label Phase|Adverse Event|0
448453|NCT00401245|1481065|P5|Open Label Phase|Adverse Event|0
448454|NCT00401245|1481066|P4|Open Label Phase|Adverse Event|7
448455|NCT00401245|1481067|P3|Open Label Phase|Adverse Event|6
448456|NCT00401245|1481068|P2|Open Label Phase|Adverse Event|14
448457|NCT00401245|1481069|P1|Open Label Phase|Adverse Event|5
448458|NCT00401245|1481062|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
448459|NCT00401245|1481063|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
448460|NCT00401245|1481064|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
448461|NCT00401245|1481065|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
448462|NCT00401245|1481066|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
448463|NCT00401245|1481067|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
448464|NCT00401245|1481068|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
448465|NCT00401245|1481069|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
448466|NCT00401245|1481062|P8|Double Blind Titration Phase|Withdrawal by Subject|0
448467|NCT00401245|1481063|P7|Double Blind Titration Phase|Withdrawal by Subject|0
448468|NCT00401245|1481064|P6|Double Blind Titration Phase|Withdrawal by Subject|0
448469|NCT00401245|1481065|P5|Double Blind Titration Phase|Withdrawal by Subject|0
448470|NCT00401245|1481066|P4|Double Blind Titration Phase|Withdrawal by Subject|2
448471|NCT00401245|1481067|P3|Double Blind Titration Phase|Withdrawal by Subject|0
448472|NCT00401245|1481068|P2|Double Blind Titration Phase|Withdrawal by Subject|1
448473|NCT00401245|1481069|P1|Double Blind Titration Phase|Withdrawal by Subject|1
448474|NCT00401245|1481062|P8|Double Blind Titration Phase|Protocol Violation|0
448475|NCT00401245|1481063|P7|Double Blind Titration Phase|Protocol Violation|0
448476|NCT00401245|1481064|P6|Double Blind Titration Phase|Protocol Violation|0
448477|NCT00401245|1481065|P5|Double Blind Titration Phase|Protocol Violation|0
448478|NCT00401245|1481066|P4|Double Blind Titration Phase|Protocol Violation|1
448479|NCT00401245|1481067|P3|Double Blind Titration Phase|Protocol Violation|0
448480|NCT00401245|1481068|P2|Double Blind Titration Phase|Protocol Violation|0
448481|NCT00401245|1481069|P1|Double Blind Titration Phase|Protocol Violation|0
448482|NCT00401245|1481062|P8|Double Blind Titration Phase|Other|0
448483|NCT00401245|1481063|P7|Double Blind Titration Phase|Other|0
448484|NCT00401245|1481064|P6|Double Blind Titration Phase|Other|0
448485|NCT00401245|1481065|P5|Double Blind Titration Phase|Other|0
448486|NCT00401245|1481066|P4|Double Blind Titration Phase|Other|0
448487|NCT00401245|1481067|P3|Double Blind Titration Phase|Other|1
448488|NCT00401245|1481068|P2|Double Blind Titration Phase|Other|0
448489|NCT00401245|1481069|P1|Double Blind Titration Phase|Other|0
448490|NCT00401245|1481062|P8|Double Blind Titration Phase|Adverse Event|0
448491|NCT00401245|1481063|P7|Double Blind Titration Phase|Adverse Event|0
448492|NCT00401245|1481064|P6|Double Blind Titration Phase|Adverse Event|0
448493|NCT00401245|1481065|P5|Double Blind Titration Phase|Adverse Event|0
448494|NCT00401245|1481066|P4|Double Blind Titration Phase|Adverse Event|12
448495|NCT00401245|1481067|P3|Double Blind Titration Phase|Adverse Event|5
448496|NCT00401245|1481068|P2|Double Blind Titration Phase|Adverse Event|2
448497|NCT00401245|1481069|P1|Double Blind Titration Phase|Adverse Event|3
448498|NCT00401193|1481137|P3|Overall Study|Other Event|2
448499|NCT00401193|1481138|P2|Overall Study|Other Event|2
448500|NCT00401193|1481139|P1|Overall Study|Other Event|3
448501|NCT00401193|1481137|P3|Overall Study|Withdrawal by Subject|1
448502|NCT00401193|1481138|P2|Overall Study|Withdrawal by Subject|0
448503|NCT00401193|1481139|P1|Overall Study|Withdrawal by Subject|2
448504|NCT00401193|1481137|P3|Overall Study|Lost to Follow-up|1
448505|NCT00401193|1481138|P2|Overall Study|Lost to Follow-up|5
448506|NCT00401193|1481139|P1|Overall Study|Lost to Follow-up|6
448507|NCT00401193|1481137|P3|Overall Study|Protocol Violation|1
448508|NCT00401193|1481138|P2|Overall Study|Protocol Violation|1
448509|NCT00401193|1481139|P1|Overall Study|Protocol Violation|3
448510|NCT00401193|1481137|P3|Overall Study|Adverse Event|1
448511|NCT00401193|1481138|P2|Overall Study|Adverse Event|3
448512|NCT00401193|1481139|P1|Overall Study|Adverse Event|1
448513|NCT00400946|1481162|P5|Overall Study|Other|1
448514|NCT00400946|1481163|P4|Overall Study|Other|0
448515|NCT00400946|1481164|P3|Overall Study|Other|0
448516|NCT00400946|1481165|P2|Overall Study|Other|0
448517|NCT00400946|1481166|P1|Overall Study|Other|0
448518|NCT00400946|1481162|P5|Overall Study|Clinical|9
448519|NCT00400946|1481163|P4|Overall Study|Clinical|2
448520|NCT00400946|1481164|P3|Overall Study|Clinical|0
448521|NCT00400946|1481165|P2|Overall Study|Clinical|2
448522|NCT00400946|1481166|P1|Overall Study|Clinical|1
448523|NCT00400946|1481162|P5|Overall Study|Withdrawal by Subject|8
448524|NCT00400946|1481163|P4|Overall Study|Withdrawal by Subject|5
448525|NCT00400946|1481164|P3|Overall Study|Withdrawal by Subject|1
448526|NCT00400946|1481165|P2|Overall Study|Withdrawal by Subject|5
448527|NCT00400946|1481166|P1|Overall Study|Withdrawal by Subject|2
448528|NCT00400946|1481162|P5|Overall Study|Transplant in CR1|1
448529|NCT00400946|1481163|P4|Overall Study|Transplant in CR1|10
448530|NCT00400946|1481164|P3|Overall Study|Transplant in CR1|0
448531|NCT00400946|1481165|P2|Overall Study|Transplant in CR1|0
448532|NCT00400946|1481166|P1|Overall Study|Transplant in CR1|0
448533|NCT00400946|1481162|P5|Overall Study|Relapse|5
448534|NCT00400946|1481163|P4|Overall Study|Relapse|1
448535|NCT00400946|1481164|P3|Overall Study|Relapse|1
448536|NCT00400946|1481165|P2|Overall Study|Relapse|2
448537|NCT00400946|1481166|P1|Overall Study|Relapse|9
448538|NCT00400946|1481162|P5|Overall Study|Remission Death|1
448539|NCT00400946|1481163|P4|Overall Study|Remission Death|0
448540|NCT00400946|1481164|P3|Overall Study|Remission Death|0
448541|NCT00400946|1481165|P2|Overall Study|Remission Death|1
448542|NCT00400946|1481166|P1|Overall Study|Remission Death|1
448543|NCT00400946|1481162|P5|Overall Study|Lost to Follow-up|1
448544|NCT00400946|1481163|P4|Overall Study|Lost to Follow-up|0
448545|NCT00400946|1481164|P3|Overall Study|Lost to Follow-up|0
448546|NCT00400946|1481165|P2|Overall Study|Lost to Follow-up|1
448547|NCT00400946|1481166|P1|Overall Study|Lost to Follow-up|1
448548|NCT00400946|1481162|P5|Overall Study|Induction Death|3
448549|NCT00400946|1481163|P4|Overall Study|Induction Death|13
448550|NCT00400946|1481164|P3|Overall Study|Induction Death|0
448551|NCT00400946|1481165|P2|Overall Study|Induction Death|0
448552|NCT00400946|1481166|P1|Overall Study|Induction Death|0
448553|NCT00400946|1481162|P5|Overall Study|Induction Failure|8
448554|NCT00400946|1481163|P4|Overall Study|Induction Failure|11
448555|NCT00400946|1481164|P3|Overall Study|Induction Failure|0
448556|NCT00400946|1481165|P2|Overall Study|Induction Failure|0
448557|NCT00400946|1481166|P1|Overall Study|Induction Failure|0
448558|NCT00400946|1481162|P5|Overall Study|Ineligible|1
448559|NCT00400946|1481163|P4|Overall Study|Ineligible|5
448560|NCT00400946|1481164|P3|Overall Study|Ineligible|0
448561|NCT00400946|1481165|P2|Overall Study|Ineligible|0
448562|NCT00400946|1481166|P1|Overall Study|Ineligible|0
448563|NCT00400764|1481225|P5|Phase II|Withdrawal by Subject|0
448564|NCT00400764|1481226|P4|Phase II|Withdrawal by Subject|1
448565|NCT00400764|1481227|P3|Phase II|Withdrawal by Subject|1
448566|NCT00400764|1481228|P2|Phase II|Withdrawal by Subject|0
448567|NCT00400764|1481229|P1|Phase II|Withdrawal by Subject|0
448568|NCT00400764|1481225|P5|Phase II|Patient began new, non-protocol, therapy|0
448569|NCT00400764|1481226|P4|Phase II|Patient began new, non-protocol, therapy|0
448570|NCT00400764|1481227|P3|Phase II|Patient began new, non-protocol, therapy|1
448571|NCT00400764|1481228|P2|Phase II|Patient began new, non-protocol, therapy|0
448572|NCT00400764|1481229|P1|Phase II|Patient began new, non-protocol, therapy|0
448573|NCT00400764|1481225|P5|Phase II|Sponsor’s decision to terminate|11
448574|NCT00400764|1481226|P4|Phase II|Sponsor’s decision to terminate|22
448575|NCT00400764|1481227|P3|Phase II|Sponsor’s decision to terminate|18
448576|NCT00400764|1481228|P2|Phase II|Sponsor’s decision to terminate|0
448577|NCT00400764|1481229|P1|Phase II|Sponsor’s decision to terminate|0
448578|NCT00400764|1481225|P5|Phase II|Physician Decision|0
448579|NCT00400764|1481226|P4|Phase II|Physician Decision|1
448580|NCT00400764|1481227|P3|Phase II|Physician Decision|1
448581|NCT00400764|1481228|P2|Phase II|Physician Decision|0
448582|NCT00400764|1481229|P1|Phase II|Physician Decision|0
448583|NCT00400764|1481225|P5|Phase II|Lost to Follow-up|0
448584|NCT00400764|1481226|P4|Phase II|Lost to Follow-up|0
448585|NCT00400764|1481227|P3|Phase II|Lost to Follow-up|1
448586|NCT00400764|1481228|P2|Phase II|Lost to Follow-up|0
448587|NCT00400764|1481229|P1|Phase II|Lost to Follow-up|0
448588|NCT00400764|1481225|P5|Phase II|Death|0
448589|NCT00400764|1481226|P4|Phase II|Death|2
448590|NCT00400764|1481227|P3|Phase II|Death|1
448591|NCT00400764|1481228|P2|Phase II|Death|0
448592|NCT00400764|1481229|P1|Phase II|Death|0
448593|NCT00400764|1481225|P5|Phase Ib|Disease Progression|0
448594|NCT00400764|1481226|P4|Phase Ib|Disease Progression|0
448595|NCT00400764|1481227|P3|Phase Ib|Disease Progression|0
448596|NCT00400764|1481228|P2|Phase Ib|Disease Progression|4
448597|NCT00400764|1481229|P1|Phase Ib|Disease Progression|4
448598|NCT00400764|1481225|P5|Phase Ib|Death|0
448599|NCT00400764|1481226|P4|Phase Ib|Death|0
448600|NCT00400764|1481227|P3|Phase Ib|Death|0
448601|NCT00400764|1481228|P2|Phase Ib|Death|0
448602|NCT00400764|1481229|P1|Phase Ib|Death|1
448603|NCT00400764|1481225|P5|Phase Ib|Adverse Event|0
448604|NCT00400764|1481226|P4|Phase Ib|Adverse Event|0
448605|NCT00400764|1481227|P3|Phase Ib|Adverse Event|0
448606|NCT00400764|1481228|P2|Phase Ib|Adverse Event|0
448607|NCT00400764|1481229|P1|Phase Ib|Adverse Event|1
448608|NCT00400712|1481282|P2|Overall Study|Physician Decision|4
448609|NCT00400712|1481283|P1|Overall Study|Physician Decision|5
448610|NCT00400712|1481282|P2|Overall Study|Withdrawal by Subject|12
448611|NCT00400712|1481283|P1|Overall Study|Withdrawal by Subject|11
448612|NCT00400712|1481282|P2|Overall Study|Death|0
448613|NCT00400712|1481283|P1|Overall Study|Death|1
448614|NCT00400569|1481318|P1|Overall Study|Death|1
448615|NCT00400400|1481331|P2|Overall Study|Did not receive study drug|3
448616|NCT00400400|1481332|P1|Overall Study|Did not receive study drug|1
448617|NCT00400400|1481331|P2|Overall Study|Lost to Follow-up|1
448618|NCT00400400|1481332|P1|Overall Study|Lost to Follow-up|0
448619|NCT00400400|1481331|P2|Overall Study|Administrative Problem|0
448620|NCT00400400|1481332|P1|Overall Study|Administrative Problem|1
448621|NCT00400400|1481331|P2|Overall Study|Withdrawal by Subject|3
448622|NCT00400400|1481332|P1|Overall Study|Withdrawal by Subject|1
448623|NCT00400400|1481331|P2|Overall Study|Protocol Violation|0
448624|NCT00400400|1481332|P1|Overall Study|Protocol Violation|2
448625|NCT00400400|1481331|P2|Overall Study|Adverse Event|8
448626|NCT00400400|1481332|P1|Overall Study|Adverse Event|9
448627|NCT00400179|1481357|P2|Overall Study|Randomization error/patient ineligible|6
448628|NCT00400179|1481358|P1|Overall Study|Randomization error/patient ineligible|1
448629|NCT00400179|1481357|P2|Overall Study|Investigator judgment|1
448630|NCT00400179|1481358|P1|Overall Study|Investigator judgment|0
448631|NCT00400179|1481357|P2|Overall Study|Intercurrent illness|1
448632|NCT00400179|1481358|P1|Overall Study|Intercurrent illness|0
448633|NCT00400179|1481357|P2|Overall Study|Disease progression|1
448634|NCT00400179|1481358|P1|Overall Study|Disease progression|1
448635|NCT00400179|1481357|P2|Overall Study|Withdrew Consent|5
448636|NCT00400179|1481358|P1|Overall Study|Withdrew Consent|1
448637|NCT00400179|1481357|P2|Overall Study|Death|2
448638|NCT00400179|1481358|P1|Overall Study|Death|1
448639|NCT00400179|1481357|P2|Overall Study|Adverse Event|2
448640|NCT00400179|1481358|P1|Overall Study|Adverse Event|2
448641|NCT00400153|1481375|P3|Overall Study|Other reasons - not mentioned above|3
448642|NCT00400153|1481376|P2|Overall Study|Other reasons - not mentioned above|5
448643|NCT00400153|1481377|P1|Overall Study|Other reasons - not mentioned above|8
448644|NCT00400153|1481375|P3|Overall Study|Withdrawal by Subject|10
448645|NCT00400153|1481376|P2|Overall Study|Withdrawal by Subject|11
448646|NCT00400153|1481377|P1|Overall Study|Withdrawal by Subject|12
448647|NCT00400153|1481375|P3|Overall Study|Lost to Follow-up|4
448648|NCT00400153|1481376|P2|Overall Study|Lost to Follow-up|1
448649|NCT00400153|1481377|P1|Overall Study|Lost to Follow-up|2
448650|NCT00400153|1481375|P3|Overall Study|Protocol Violation|9
448651|NCT00400153|1481376|P2|Overall Study|Protocol Violation|4
448652|NCT00400153|1481377|P1|Overall Study|Protocol Violation|7
448653|NCT00400153|1481375|P3|Overall Study|AE due to other condition|15
448654|NCT00400153|1481376|P2|Overall Study|AE due to other condition|14
448655|NCT00400153|1481377|P1|Overall Study|AE due to other condition|3
448656|NCT00400153|1481375|P3|Overall Study|AE due to other disease worsening|0
448657|NCT00400153|1481376|P2|Overall Study|AE due to other disease worsening|1
448658|NCT00400153|1481377|P1|Overall Study|AE due to other disease worsening|2
448659|NCT00400153|1481375|P3|Overall Study|AE due to study disease worsening|20
448660|NCT00400153|1481376|P2|Overall Study|AE due to study disease worsening|19
448661|NCT00400153|1481377|P1|Overall Study|AE due to study disease worsening|14
448662|NCT00399893|1481624|P2|Overall Study|Withdrawal by Subject|0
448663|NCT00399893|1481625|P1|Overall Study|Withdrawal by Subject|1
448664|NCT00399802|1481664|P2|Overall Study|Participant discontinued by mistake|1
448665|NCT00399802|1481665|P1|Overall Study|Participant discontinued by mistake|0
448666|NCT00399802|1481664|P2|Overall Study|Adverse Event|2
448667|NCT00399802|1481665|P1|Overall Study|Adverse Event|0
448668|NCT00399763|1481679|P2|Overall Study|Lost to Follow-up|3
448669|NCT00399763|1481680|P1|Overall Study|Lost to Follow-up|2
448670|NCT00399568|1481692|P2|Overall Study|Lost to Follow-up|2
448671|NCT00399568|1481693|P1|Overall Study|Lost to Follow-up|2
448672|NCT00399568|1481692|P2|Overall Study|Protocol non-compliance|2
448673|NCT00399568|1481693|P1|Overall Study|Protocol non-compliance|2
448674|NCT00399568|1481692|P2|Overall Study|Withdrawal by Subject|3
448675|NCT00399568|1481693|P1|Overall Study|Withdrawal by Subject|7
448676|NCT00399568|1481692|P2|Overall Study|Adverse Event|2
448677|NCT00399568|1481693|P1|Overall Study|Adverse Event|1
448678|NCT00399542|1481707|P2|Overall Study|Physician Decision|1
448679|NCT00399542|1481708|P1|Overall Study|Physician Decision|0
448680|NCT00399542|1481707|P2|Overall Study|Other|0
448681|NCT00399542|1481708|P1|Overall Study|Other|1
448682|NCT00399542|1481707|P2|Overall Study|Lost to Follow-up|6
448683|NCT00399542|1481708|P1|Overall Study|Lost to Follow-up|6
448684|NCT00399542|1481707|P2|Overall Study|Lack of Efficacy|8
448685|NCT00399542|1481708|P1|Overall Study|Lack of Efficacy|18
448686|NCT00399542|1481707|P2|Overall Study|Withdrawal by Subject|10
448687|NCT00399542|1481708|P1|Overall Study|Withdrawal by Subject|28
448688|NCT00399542|1481707|P2|Overall Study|Protocol Violation|3
448689|NCT00399542|1481708|P1|Overall Study|Protocol Violation|13
448690|NCT00399542|1481707|P2|Overall Study|Adverse Event|15
448691|NCT00399542|1481708|P1|Overall Study|Adverse Event|18
448692|NCT00399516|1481770|P1|Overall Study|Lost to Follow-up|2
448693|NCT00399360|1481778|P4|Overall Study|Withdrawal by Subject|2
448694|NCT00399360|1481779|P3|Overall Study|Withdrawal by Subject|0
448695|NCT00399360|1481780|P2|Overall Study|Withdrawal by Subject|2
448696|NCT00399360|1481781|P1|Overall Study|Withdrawal by Subject|0
448697|NCT00399360|1481778|P4|Overall Study|Adverse Event|0
448698|NCT00399360|1481779|P3|Overall Study|Adverse Event|1
448699|NCT00399360|1481780|P2|Overall Study|Adverse Event|0
448700|NCT00399360|1481781|P1|Overall Study|Adverse Event|0
448701|NCT00399360|1481778|P4|Overall Study|Lost to Follow-up|4
448702|NCT00399360|1481779|P3|Overall Study|Lost to Follow-up|2
448703|NCT00399360|1481780|P2|Overall Study|Lost to Follow-up|1
448704|NCT00399360|1481781|P1|Overall Study|Lost to Follow-up|2
448705|NCT00399035|1481852|P3|Overall Study|Severe non-compliance with protocol|0
448706|NCT00399035|1481853|P2|Overall Study|Severe non-compliance with protocol|1
448707|NCT00399035|1481854|P1|Overall Study|Severe non-compliance with protocol|2
448708|NCT00399035|1481852|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
448709|NCT00399035|1481853|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
448710|NCT00399035|1481854|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
448711|NCT00399035|1481852|P3|Overall Study|Withdrawal by Subject|12
448712|NCT00399035|1481853|P2|Overall Study|Withdrawal by Subject|15
448713|NCT00399035|1481854|P1|Overall Study|Withdrawal by Subject|19
448714|NCT00399035|1481852|P3|Overall Study|Lost to Follow-up|5
448715|NCT00399035|1481853|P2|Overall Study|Lost to Follow-up|1
448716|NCT00399035|1481854|P1|Overall Study|Lost to Follow-up|2
448717|NCT00399035|1481852|P3|Overall Study|Death|234
448718|NCT00399035|1481853|P2|Overall Study|Death|141
448719|NCT00399035|1481854|P1|Overall Study|Death|289
448720|NCT00398866|1481890|P3|Overall Study|Unable to complete requirements of study|1
448721|NCT00398866|1481891|P2|Overall Study|Unable to complete requirements of study|1
448722|NCT00398866|1481892|P1|Overall Study|Unable to complete requirements of study|1
448723|NCT00398866|1481890|P3|Overall Study|Withdrawal by Subject|2
448724|NCT00398866|1481891|P2|Overall Study|Withdrawal by Subject|1
448725|NCT00398866|1481892|P1|Overall Study|Withdrawal by Subject|5
448726|NCT00398866|1481890|P3|Overall Study|Lost to Follow-up|4
448727|NCT00398866|1481891|P2|Overall Study|Lost to Follow-up|6
448728|NCT00398866|1481892|P1|Overall Study|Lost to Follow-up|7
448729|NCT00398866|1481890|P3|Overall Study|Lack of Efficacy|1
448730|NCT00398866|1481891|P2|Overall Study|Lack of Efficacy|0
448731|NCT00398866|1481892|P1|Overall Study|Lack of Efficacy|0
448732|NCT00398866|1481890|P3|Overall Study|Adverse Event|0
448733|NCT00398866|1481891|P2|Overall Study|Adverse Event|0
448734|NCT00398866|1481892|P1|Overall Study|Adverse Event|1
448735|NCT00398632|1481903|P1|Overall Study|Lack of Efficacy|1
448736|NCT00398632|1481903|P1|Overall Study|Withdrawal by Subject|1
448737|NCT00398567|1481911|P3|Overall Study|Protocol Violation|1
448738|NCT00398567|1481912|P2|Overall Study|Protocol Violation|0
448739|NCT00398567|1481913|P1|Overall Study|Protocol Violation|0
448740|NCT00398567|1481911|P3|Overall Study|Adverse Event|2
448741|NCT00398567|1481912|P2|Overall Study|Adverse Event|0
448742|NCT00398567|1481913|P1|Overall Study|Adverse Event|0
448743|NCT00398567|1481911|P3|Overall Study|Withdrawal by Subject|4
448744|NCT00398567|1481912|P2|Overall Study|Withdrawal by Subject|0
448745|NCT00398567|1481913|P1|Overall Study|Withdrawal by Subject|1
448746|NCT00398567|1481911|P3|Overall Study|Disease Progression|27
448747|NCT00398567|1481912|P2|Overall Study|Disease Progression|4
448748|NCT00398567|1481913|P1|Overall Study|Disease Progression|3
448749|NCT00398411|1481967|P2|Overall Study|Death|1
448750|NCT00398411|1481968|P1|Overall Study|Death|0
448751|NCT00398320|1481991|P1|Overall Study|Physician Decision|1
448752|NCT00398320|1481991|P1|Overall Study|Adverse Event|4
448753|NCT00398320|1481991|P1|Overall Study|Death|1
448754|NCT00398216|1482004|P5|Overall Study|entrance criteria|2
448755|NCT00398216|1482005|P4|Overall Study|entrance criteria|0
448756|NCT00398216|1482006|P3|Overall Study|entrance criteria|0
448757|NCT00398216|1482007|P2|Overall Study|entrance criteria|0
448758|NCT00398216|1482008|P1|Overall Study|entrance criteria|0
448759|NCT00398216|1482004|P5|Overall Study|administrative reasons|3
448760|NCT00398216|1482005|P4|Overall Study|administrative reasons|3
448761|NCT00398216|1482006|P3|Overall Study|administrative reasons|4
448762|NCT00398216|1482007|P2|Overall Study|administrative reasons|4
448763|NCT00398216|1482008|P1|Overall Study|administrative reasons|3
448764|NCT00398216|1482004|P5|Overall Study|Withdrawal by Subject|2
448765|NCT00398216|1482005|P4|Overall Study|Withdrawal by Subject|1
448766|NCT00398216|1482006|P3|Overall Study|Withdrawal by Subject|3
448767|NCT00398216|1482007|P2|Overall Study|Withdrawal by Subject|0
448768|NCT00398216|1482008|P1|Overall Study|Withdrawal by Subject|1
448769|NCT00398216|1482004|P5|Overall Study|Death|0
448770|NCT00398216|1482005|P4|Overall Study|Death|0
448771|NCT00398216|1482006|P3|Overall Study|Death|0
448772|NCT00398216|1482007|P2|Overall Study|Death|3
448773|NCT00398216|1482008|P1|Overall Study|Death|0
448774|NCT00398216|1482004|P5|Overall Study|Lost to Follow-up|1
448775|NCT00398216|1482005|P4|Overall Study|Lost to Follow-up|4
448776|NCT00398216|1482006|P3|Overall Study|Lost to Follow-up|4
448777|NCT00398216|1482007|P2|Overall Study|Lost to Follow-up|6
448778|NCT00398216|1482008|P1|Overall Study|Lost to Follow-up|1
448779|NCT00398216|1482004|P5|Overall Study|Protocol Violation|5
448780|NCT00398216|1482005|P4|Overall Study|Protocol Violation|7
448781|NCT00398216|1482006|P3|Overall Study|Protocol Violation|5
448782|NCT00398216|1482007|P2|Overall Study|Protocol Violation|4
448783|NCT00398216|1482008|P1|Overall Study|Protocol Violation|2
448784|NCT00398216|1482004|P5|Overall Study|Adverse Event|2
448785|NCT00398216|1482005|P4|Overall Study|Adverse Event|7
448786|NCT00398216|1482006|P3|Overall Study|Adverse Event|5
448787|NCT00398216|1482007|P2|Overall Study|Adverse Event|2
448788|NCT00398216|1482008|P1|Overall Study|Adverse Event|4
448789|NCT00398138|1482035|P1|Overall Study|Adverse Event|2
448790|NCT00398112|1482040|P1|Overall Study|Death|1
448791|NCT00398112|1482040|P1|Overall Study|Withdrawal by Subject|3
448792|NCT00398112|1482040|P1|Overall Study|Alternative treatment|1
448793|NCT00398112|1482040|P1|Overall Study|Disease progression|9
448794|NCT00398112|1482040|P1|Overall Study|Adverse Event|4
448795|NCT00398086|1482051|P3|Overall Study|Withdrawal by Subject|0
448796|NCT00398086|1482052|P2|Overall Study|Withdrawal by Subject|7
448797|NCT00398086|1482053|P1|Overall Study|Withdrawal by Subject|5
448798|NCT00398086|1482051|P3|Overall Study|Physician Decision|0
448799|NCT00398086|1482052|P2|Overall Study|Physician Decision|4
448800|NCT00398086|1482053|P1|Overall Study|Physician Decision|1
448801|NCT00398086|1482051|P3|Overall Study|Adverse Event|0
448802|NCT00398086|1482052|P2|Overall Study|Adverse Event|4
448803|NCT00398086|1482053|P1|Overall Study|Adverse Event|1
448804|NCT00398086|1482051|P3|Overall Study|Unacceptable Toxicity|2
448805|NCT00398086|1482052|P2|Overall Study|Unacceptable Toxicity|8
448806|NCT00398086|1482053|P1|Overall Study|Unacceptable Toxicity|2
448807|NCT00398073|1482087|P2|Overall Study|Withdrawal by Subject|0
448808|NCT00398073|1482088|P1|Overall Study|Withdrawal by Subject|1
448809|NCT00398047|1482098|P1|Overall Study|all patient progressed before completion|3
448810|NCT00397982|1482108|P1|Overall Study|Unrelated health issues|1
448811|NCT00397982|1482108|P1|Overall Study|noncompliance|1
448812|NCT00397982|1482108|P1|Overall Study|Adverse Event|1
448813|NCT00397982|1482108|P1|Overall Study|Withdrawal by Subject|1
448814|NCT00397930|1482119|P2|Overall Study|Missing data|4
448815|NCT00397930|1482120|P1|Overall Study|Missing data|0
448816|NCT00397930|1482119|P2|Overall Study|Withdrawal by Subject|8
448817|NCT00397930|1482120|P1|Overall Study|Withdrawal by Subject|0
448818|NCT00397930|1482119|P2|Overall Study|Did not want to be in control group|1
448819|NCT00397930|1482120|P1|Overall Study|Did not want to be in control group|0
448820|NCT00397930|1482119|P2|Overall Study|Started own yoga program|1
448821|NCT00397930|1482120|P1|Overall Study|Started own yoga program|1
448822|NCT00397930|1482119|P2|Overall Study|Too time-consuming|9
448823|NCT00397930|1482120|P1|Overall Study|Too time-consuming|2
448824|NCT00397930|1482119|P2|Overall Study|Noncompliant|2
448825|NCT00397930|1482120|P1|Overall Study|Noncompliant|3
448826|NCT00397930|1482119|P2|Overall Study|Unknown reasons|14
448827|NCT00397930|1482120|P1|Overall Study|Unknown reasons|9
448828|NCT00397930|1482119|P2|Overall Study|Other medical|4
448829|NCT00397930|1482120|P1|Overall Study|Other medical|9
448830|NCT00397930|1482119|P2|Overall Study|Personal reasons|8
448831|NCT00397930|1482120|P1|Overall Study|Personal reasons|14
448832|NCT00397891|1482135|P5|Overall Study|Withdrawal by Subject|1
448833|NCT00397891|1482136|P4|Overall Study|Withdrawal by Subject|0
448834|NCT00397891|1482137|P3|Overall Study|Withdrawal by Subject|0
448835|NCT00397891|1482138|P2|Overall Study|Withdrawal by Subject|0
448836|NCT00397891|1482139|P1|Overall Study|Withdrawal by Subject|1
448837|NCT00397631|1482260|P2|Overall Study|protocol discontinuation criteria|4
448838|NCT00397631|1482261|P1|Overall Study|protocol discontinuation criteria|1
448839|NCT00397631|1482260|P2|Overall Study|Withdrawal by Subject|14
448840|NCT00397631|1482261|P1|Overall Study|Withdrawal by Subject|7
448841|NCT00397631|1482260|P2|Overall Study|Protocol Violation|1
448842|NCT00397631|1482261|P1|Overall Study|Protocol Violation|0
448843|NCT00397631|1482260|P2|Overall Study|Physician Decision|0
448844|NCT00397631|1482261|P1|Overall Study|Physician Decision|2
448845|NCT00397631|1482260|P2|Overall Study|Lost to Follow-up|9
448846|NCT00397631|1482261|P1|Overall Study|Lost to Follow-up|8
448847|NCT00397631|1482260|P2|Overall Study|Lack of Efficacy|10
448848|NCT00397631|1482261|P1|Overall Study|Lack of Efficacy|7
448849|NCT00397631|1482260|P2|Overall Study|Adverse Event|6
448850|NCT00397631|1482261|P1|Overall Study|Adverse Event|5
448851|NCT00397540|1482273|P2|Overall Study|short follow-up duration < 12 months|0
448852|NCT00397540|1482274|P1|Overall Study|short follow-up duration < 12 months|1
448853|NCT00397514|1482280|P1|Overall Study|poor echocardiographic windows|1
448854|NCT00397514|1482280|P1|Overall Study|early extubation|2
448855|NCT00397514|1482280|P1|Overall Study|Not able to capture & pace LV intraoper.|4
448856|NCT00397514|1482280|P1|Overall Study|Pacing wire malfunction|1
448857|NCT00397514|1482280|P1|Overall Study|Withdrawal by Subject|1
448858|NCT00397488|1482290|P1|Overall Study|Death|1
448859|NCT00397488|1482290|P1|Overall Study|Adverse Event|3
448860|NCT00397488|1482290|P1|Overall Study|Withdrawal by Subject|3
448861|NCT00397254|1482310|P2|Overall Study|Lost to Follow-up|2
448862|NCT00397254|1482311|P1|Overall Study|Lost to Follow-up|2
448863|NCT00397215|1482333|P4|Month 6 (Day 180)|Other|0
448864|NCT00397215|1482334|P3|Month 6 (Day 180)|Other|3
448865|NCT00397215|1482335|P2|Month 6 (Day 180)|Other|0
448866|NCT00397215|1482336|P1|Month 6 (Day 180)|Other|2
448867|NCT00397215|1482333|P4|Month 6 (Day 180)|Adverse Event|0
448868|NCT00397215|1482334|P3|Month 6 (Day 180)|Adverse Event|2
448869|NCT00397215|1482335|P2|Month 6 (Day 180)|Adverse Event|3
448870|NCT00397215|1482336|P1|Month 6 (Day 180)|Adverse Event|0
448871|NCT00397215|1482333|P4|Month 0 (Day 0)|Other|3
448872|NCT00397215|1482334|P3|Month 0 (Day 0)|Other|3
448873|NCT00397215|1482335|P2|Month 0 (Day 0)|Other|1
448874|NCT00397215|1482336|P1|Month 0 (Day 0)|Other|4
448875|NCT00397215|1482333|P4|Month 0 (Day 0)|Withdrawal by Subject|1
448876|NCT00397215|1482334|P3|Month 0 (Day 0)|Withdrawal by Subject|3
448877|NCT00397215|1482335|P2|Month 0 (Day 0)|Withdrawal by Subject|3
448878|NCT00397215|1482336|P1|Month 0 (Day 0)|Withdrawal by Subject|3
448879|NCT00397215|1482333|P4|Month 0 (Day 0)|Adverse Event|0
448880|NCT00397215|1482334|P3|Month 0 (Day 0)|Adverse Event|0
448881|NCT00397215|1482335|P2|Month 0 (Day 0)|Adverse Event|1
448882|NCT00397215|1482336|P1|Month 0 (Day 0)|Adverse Event|0
448883|NCT00397189|1482472|P2|3 Weeks Period|Other|2
448884|NCT00397189|1482473|P1|3 Weeks Period|Other|0
448885|NCT00397189|1482472|P2|3 Weeks Period|Protocol Violation|3
448886|NCT00397189|1482473|P1|3 Weeks Period|Protocol Violation|0
448887|NCT00397189|1482472|P2|3 Weeks Period|Physician Decision|2
448888|NCT00397189|1482473|P1|3 Weeks Period|Physician Decision|0
448889|NCT00397189|1482472|P2|3 Weeks Period|Withdrawal by Subject|9
448890|NCT00397189|1482473|P1|3 Weeks Period|Withdrawal by Subject|13
448891|NCT00397189|1482472|P2|3 Weeks Period|Adverse Event|2
448892|NCT00397189|1482473|P1|3 Weeks Period|Adverse Event|3
448893|NCT00397189|1482472|P2|3 Weeks Period|Lost to Follow-up|4
448894|NCT00397189|1482473|P1|3 Weeks Period|Lost to Follow-up|5
448895|NCT00397046|1482500|P4|Overall Study|Disease Progression|5
448896|NCT00397046|1482501|P3|Overall Study|Disease Progression|10
448897|NCT00397046|1482502|P2|Overall Study|Disease Progression|3
448898|NCT00397046|1482503|P1|Overall Study|Disease Progression|3
448899|NCT00397033|1482524|P3|Overall Study|Other|2
448900|NCT00397033|1482525|P2|Overall Study|Other|5
448901|NCT00397033|1482526|P1|Overall Study|Other|0
448902|NCT00397033|1482524|P3|Overall Study|Withdrawal by Subject|5
448903|NCT00397033|1482525|P2|Overall Study|Withdrawal by Subject|7
448904|NCT00397033|1482526|P1|Overall Study|Withdrawal by Subject|12
448905|NCT00397033|1482524|P3|Overall Study|Lost to Follow-up|3
448906|NCT00397033|1482525|P2|Overall Study|Lost to Follow-up|3
448907|NCT00397033|1482526|P1|Overall Study|Lost to Follow-up|3
448908|NCT00397033|1482524|P3|Overall Study|Lack of Efficacy|9
448909|NCT00397033|1482525|P2|Overall Study|Lack of Efficacy|12
448910|NCT00397033|1482526|P1|Overall Study|Lack of Efficacy|22
448911|NCT00397033|1482524|P3|Overall Study|Adverse Event|4
448912|NCT00397033|1482525|P2|Overall Study|Adverse Event|10
448913|NCT00397033|1482526|P1|Overall Study|Adverse Event|7
448914|NCT00396877|1482608|P2|Overall Study|Parent(s)/guardian(s)'s request|7
448915|NCT00396877|1482609|P1|Overall Study|Parent(s)/guardian(s)'s request|4
448916|NCT00396877|1482608|P2|Overall Study|Lost to Follow-up|1
448917|NCT00396877|1482609|P1|Overall Study|Lost to Follow-up|2
448918|NCT00396812|1482619|P1|Overall Study|Physician Decision|1
448919|NCT00396656|1482631|P2|Second Treatment Period|Adverse Event|1
448920|NCT00396656|1482632|P1|Second Treatment Period|Adverse Event|0
448921|NCT00396656|1482631|P2|First Treatment Period|Withdrawal by Subject|2
448922|NCT00396656|1482632|P1|First Treatment Period|Withdrawal by Subject|0
448923|NCT00396630|1482650|P2|Overall Study|Not vaccinated at Visit 3|3
448924|NCT00396630|1482651|P1|Overall Study|Not vaccinated at Visit 3|3
448925|NCT00396630|1482650|P2|Overall Study|Withdrawal by Subject|1
448926|NCT00396630|1482651|P1|Overall Study|Withdrawal by Subject|1
448927|NCT00396630|1482650|P2|Overall Study|Lost to Follow-up|1
448928|NCT00396630|1482651|P1|Overall Study|Lost to Follow-up|1
448929|NCT00396591|1482671|P1|Overall Study|Participant request|1
448930|NCT00396591|1482671|P1|Overall Study|Adverse Event|2
448931|NCT00396591|1482671|P1|Overall Study|Disease Progression|13
448932|NCT00396565|1482684|P3|Overall Study|Lack of Efficacy|11
448933|NCT00396565|1482685|P2|Overall Study|Lack of Efficacy|64
448934|NCT00396565|1482686|P1|Overall Study|Lack of Efficacy|32
448935|NCT00396565|1482684|P3|Overall Study|Withdrawal by Subject|1
448936|NCT00396565|1482685|P2|Overall Study|Withdrawal by Subject|13
448937|NCT00396565|1482686|P1|Overall Study|Withdrawal by Subject|8
448938|NCT00396565|1482684|P3|Overall Study|Adverse Event|3
448939|NCT00396565|1482685|P2|Overall Study|Adverse Event|13
448940|NCT00396565|1482686|P1|Overall Study|Adverse Event|5
448941|NCT00396565|1482684|P3|Overall Study|Physician Decision|2
448942|NCT00396565|1482685|P2|Overall Study|Physician Decision|1
448943|NCT00396565|1482686|P1|Overall Study|Physician Decision|3
448944|NCT00396409|1482711|P2|Period 2 - 2008|Lost to Follow-up|1
448945|NCT00396409|1482712|P1|Period 2 - 2008|Lost to Follow-up|3
448946|NCT00396409|1482711|P2|Period 2 - 2008|Withdrawal by Subject|1
448947|NCT00396409|1482712|P1|Period 2 - 2008|Withdrawal by Subject|3
448948|NCT00396409|1482711|P2|Period 2 - 2008|Protocol Violation|0
448949|NCT00396409|1482712|P1|Period 2 - 2008|Protocol Violation|1
448950|NCT00396409|1482711|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
448951|NCT00396409|1482712|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
448952|NCT00396409|1482711|P2|Period 1 - 2007|Lost to Follow-up|3
448953|NCT00396409|1482712|P1|Period 1 - 2007|Lost to Follow-up|2
448954|NCT00396409|1482711|P2|Period 1 - 2007|Withdrawal by Subject|1
448955|NCT00396409|1482712|P1|Period 1 - 2007|Withdrawal by Subject|1
448956|NCT00396409|1482711|P2|Period 1 - 2007|Lack of Efficacy|1
448957|NCT00396409|1482712|P1|Period 1 - 2007|Lack of Efficacy|0
448958|NCT00396409|1482711|P2|Period 1 - 2007|Adverse Event|1
448959|NCT00396409|1482712|P1|Period 1 - 2007|Adverse Event|0
448960|NCT00396383|1482742|P1|Overall Study|Lost to Follow-up|1
448961|NCT00396383|1482742|P1|Overall Study|Death|2
448962|NCT00396331|1482755|P1|Overall Study|Death|16
448963|NCT00396331|1482755|P1|Overall Study|Lost to Follow-up|3
448964|NCT00396331|1482755|P1|Overall Study|Did not go on to transplant|5
448965|NCT00396331|1482755|P1|Overall Study|Failed to mobilize - no transplant|8
448966|NCT00396318|1482808|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
448967|NCT00396279|1482828|P1|Overall Study|Physician Decision|1
448968|NCT00396279|1482828|P1|Overall Study|Withdrawal by Subject|1
448969|NCT00396279|1482828|P1|Overall Study|Disease progression|2
448970|NCT00396279|1482828|P1|Overall Study|Ongoing in study|26
448971|NCT00396253|1482861|P1|Overall Study|Change in eligibility status|1
448972|NCT00396253|1482861|P1|Overall Study|Physician Decision|1
448973|NCT00396253|1482861|P1|Overall Study|Death|3
448974|NCT00396253|1482861|P1|Overall Study|Withdrawal by Subject|7
448975|NCT00396253|1482861|P1|Overall Study|Protocol Violation|1
448976|NCT00396162|1482892|P2|Overall Study|Withdrawal by Subject|3
448977|NCT00396162|1482893|P1|Overall Study|Withdrawal by Subject|2
448978|NCT00396136|1482905|P1|Overall Study|Study device explanted|8
448979|NCT00396136|1482905|P1|Overall Study|Lost to Follow-up|15
448980|NCT00396136|1482905|P1|Overall Study|Withdrawal by Subject|59
448981|NCT00396136|1482905|P1|Overall Study|Death|43
448982|NCT00396097|1482912|P2|Overall Study|Insufficient Clinical Response|4
448983|NCT00396097|1482913|P1|Overall Study|Insufficient Clinical Response|1
448984|NCT00396097|1482912|P2|Overall Study|Adverse Event|5
448985|NCT00396097|1482913|P1|Overall Study|Adverse Event|1
448986|NCT00396097|1482912|P2|Overall Study|Protocol Violation|6
448987|NCT00396097|1482913|P1|Overall Study|Protocol Violation|0
448988|NCT00396097|1482912|P2|Overall Study|Not specified|5
448989|NCT00396097|1482913|P1|Overall Study|Not specified|3
448990|NCT00396097|1482912|P2|Overall Study|Lost to Follow-up|9
448991|NCT00396097|1482913|P1|Overall Study|Lost to Follow-up|4
448992|NCT00396097|1482912|P2|Overall Study|Withdrawal by Subject|17
448993|NCT00396097|1482913|P1|Overall Study|Withdrawal by Subject|17
448994|NCT00396084|1482941|P6|Overall Study|Withdrawal by Subject|0
448995|NCT00396084|1482942|P5|Overall Study|Withdrawal by Subject|0
448996|NCT00396084|1482943|P4|Overall Study|Withdrawal by Subject|1
448997|NCT00396084|1482944|P3|Overall Study|Withdrawal by Subject|0
448998|NCT00396084|1482945|P2|Overall Study|Withdrawal by Subject|0
448999|NCT00396084|1482946|P1|Overall Study|Withdrawal by Subject|0
449000|NCT00396084|1482941|P6|Overall Study|Adverse Event|2
449001|NCT00396084|1482942|P5|Overall Study|Adverse Event|1
449002|NCT00396084|1482943|P4|Overall Study|Adverse Event|0
449003|NCT00396084|1482944|P3|Overall Study|Adverse Event|0
449004|NCT00396084|1482945|P2|Overall Study|Adverse Event|0
449005|NCT00396084|1482946|P1|Overall Study|Adverse Event|0
449006|NCT00395967|1483075|P1|Follow-up Period|Lost to Follow-up|1
449007|NCT00395967|1483075|P1|Follow-up Period|Death|1
449008|NCT00395967|1483075|P1|Treatment Period|Failed Mobilization|1
449009|NCT00395863|1483115|P2|Overall Study|Patients did not complete both exams|3
449010|NCT00395863|1483116|P1|Overall Study|Patients did not complete both exams|2
449011|NCT00395850|1483151|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
449012|NCT00395850|1483152|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
449013|NCT00395850|1483153|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
449014|NCT00395850|1483154|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
449015|NCT00395850|1483151|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
449016|NCT00395850|1483152|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
449017|NCT00395850|1483153|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
449018|NCT00395850|1483154|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
449019|NCT00395850|1483151|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
449020|NCT00395850|1483152|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
449021|NCT00395850|1483153|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
449022|NCT00395850|1483154|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
449023|NCT00395850|1483151|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
449024|NCT00395850|1483152|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
449025|NCT00395850|1483153|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
449026|NCT00395850|1483154|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
449027|NCT00395850|1483151|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
449028|NCT00395850|1483152|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
449029|NCT00395850|1483153|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
449030|NCT00395850|1483154|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
449031|NCT00395850|1483151|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
449032|NCT00395850|1483152|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
449033|NCT00395850|1483153|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
449034|NCT00395850|1483154|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
449035|NCT00395850|1483151|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
449036|NCT00395850|1483152|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
449037|NCT00395850|1483153|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
449038|NCT00395850|1483154|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
449039|NCT00395746|1483171|P3|Overall Study|Unable to visit site on schedule|0
449040|NCT00395746|1483172|P2|Overall Study|Unable to visit site on schedule|0
449041|NCT00395746|1483173|P1|Overall Study|Unable to visit site on schedule|1
449042|NCT00395746|1483171|P3|Overall Study|Difficultulty in use of device|1
449043|NCT00395746|1483172|P2|Overall Study|Difficultulty in use of device|0
449044|NCT00395746|1483173|P1|Overall Study|Difficultulty in use of device|0
449045|NCT00395746|1483171|P3|Overall Study|Withdrawal of consent|1
449046|NCT00395746|1483172|P2|Overall Study|Withdrawal of consent|0
449047|NCT00395746|1483173|P1|Overall Study|Withdrawal of consent|0
449048|NCT00395746|1483171|P3|Overall Study|Subject decision|1
449049|NCT00395746|1483172|P2|Overall Study|Subject decision|0
449050|NCT00395746|1483173|P1|Overall Study|Subject decision|0
449051|NCT00395746|1483171|P3|Overall Study|Hypoglycaemia|0
449052|NCT00395746|1483172|P2|Overall Study|Hypoglycaemia|1
449053|NCT00395746|1483173|P1|Overall Study|Hypoglycaemia|2
449054|NCT00395746|1483171|P3|Overall Study|Lack of Efficacy|17
449055|NCT00395746|1483172|P2|Overall Study|Lack of Efficacy|0
449056|NCT00395746|1483173|P1|Overall Study|Lack of Efficacy|2
449057|NCT00395746|1483171|P3|Overall Study|Protocol Violation|0
449058|NCT00395746|1483172|P2|Overall Study|Protocol Violation|1
449059|NCT00395746|1483173|P1|Overall Study|Protocol Violation|0
449060|NCT00395746|1483171|P3|Overall Study|Adverse Event|2
449061|NCT00395746|1483172|P2|Overall Study|Adverse Event|2
449062|NCT00395746|1483173|P1|Overall Study|Adverse Event|5
449063|NCT00395733|1483219|P2|Period 2|Technical problems|0
449064|NCT00395733|1483220|P1|Period 2|Technical problems|1
449065|NCT00395733|1483219|P2|Period 2|Adverse Event|2
449066|NCT00395733|1483220|P1|Period 2|Adverse Event|0
449067|NCT00395733|1483219|P2|Period 2|Protocol Violation|1
449068|NCT00395733|1483220|P1|Period 2|Protocol Violation|0
449069|NCT00395733|1483219|P2|Period 2|Withdrawal by Subject|2
449070|NCT00395733|1483220|P1|Period 2|Withdrawal by Subject|1
449071|NCT00395694|1483244|P2|Continuation Phase|Withdrawal by Subject|2
449072|NCT00395694|1483245|P1|Continuation Phase|Withdrawal by Subject|0
449073|NCT00395694|1483244|P2|Continuation Phase|Poor Compliance|0
449074|NCT00395694|1483245|P1|Continuation Phase|Poor Compliance|1
449075|NCT00395694|1483244|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
449076|NCT00395694|1483245|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
449077|NCT00395694|1483244|P2|Continuation Phase|Lack of Efficacy|11
449078|NCT00395694|1483245|P1|Continuation Phase|Lack of Efficacy|12
449079|NCT00395694|1483244|P2|Continuation Phase|Adverse Event|0
449080|NCT00395694|1483245|P1|Continuation Phase|Adverse Event|1
449081|NCT00395694|1483244|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
449082|NCT00395694|1483245|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
449083|NCT00395642|1483276|P1|Overall Study|Withdrawal by Subject|1
449084|NCT00395642|1483276|P1|Overall Study|Physician Decision|7
449085|NCT00395642|1483276|P1|Overall Study|Lost to Follow-up|1
449086|NCT00395642|1483276|P1|Overall Study|Death|4
449087|NCT00395629|1483283|P3|Extension Study|Administrative problems|1
449088|NCT00395629|1483284|P2|Extension Study|Administrative problems|0
449089|NCT00395629|1483285|P1|Extension Study|Administrative problems|0
449090|NCT00395629|1483283|P3|Extension Study|Adverse Event|2
449091|NCT00395629|1483284|P2|Extension Study|Adverse Event|0
449092|NCT00395629|1483285|P1|Extension Study|Adverse Event|0
449093|NCT00395629|1483283|P3|Core Study|Lost to Follow-up|1
449094|NCT00395629|1483284|P2|Core Study|Lost to Follow-up|0
449095|NCT00395629|1483285|P1|Core Study|Lost to Follow-up|0
449096|NCT00395629|1483283|P3|Core Study|Withdrawal by Subject|1
449097|NCT00395629|1483284|P2|Core Study|Withdrawal by Subject|1
449098|NCT00395629|1483285|P1|Core Study|Withdrawal by Subject|0
449099|NCT00395629|1483283|P3|Core Study|Protocol Violation|0
449100|NCT00395629|1483284|P2|Core Study|Protocol Violation|0
449101|NCT00395629|1483285|P1|Core Study|Protocol Violation|1
449102|NCT00395629|1483283|P3|Core Study|Abnormal laboratory value(s)|1
449103|NCT00395629|1483284|P2|Core Study|Abnormal laboratory value(s)|0
449104|NCT00395629|1483285|P1|Core Study|Abnormal laboratory value(s)|0
449105|NCT00395629|1483283|P3|Core Study|Adverse Event|4
449106|NCT00395629|1483284|P2|Core Study|Adverse Event|3
449107|NCT00395629|1483285|P1|Core Study|Adverse Event|0
449108|NCT00395512|1483303|P4|Overall Study|Hyperglycemic Rescue|6
449109|NCT00395512|1483304|P3|Overall Study|Hyperglycemic Rescue|4
449110|NCT00395512|1483305|P2|Overall Study|Hyperglycemic Rescue|10
449111|NCT00395512|1483306|P1|Overall Study|Hyperglycemic Rescue|18
449112|NCT00395512|1483303|P4|Overall Study|Other|0
449113|NCT00395512|1483304|P3|Overall Study|Other|0
449114|NCT00395512|1483305|P2|Overall Study|Other|1
449115|NCT00395512|1483306|P1|Overall Study|Other|1
449116|NCT00395512|1483303|P4|Overall Study|Physician Decision|2
449117|NCT00395512|1483304|P3|Overall Study|Physician Decision|2
449118|NCT00395512|1483305|P2|Overall Study|Physician Decision|4
449119|NCT00395512|1483306|P1|Overall Study|Physician Decision|6
449120|NCT00395512|1483303|P4|Overall Study|Withdrawal by Subject|12
449121|NCT00395512|1483304|P3|Overall Study|Withdrawal by Subject|5
449122|NCT00395512|1483305|P2|Overall Study|Withdrawal by Subject|5
449123|NCT00395512|1483306|P1|Overall Study|Withdrawal by Subject|6
449124|NCT00395512|1483303|P4|Overall Study|Lost to Follow-up|5
449125|NCT00395512|1483304|P3|Overall Study|Lost to Follow-up|5
449126|NCT00395512|1483305|P2|Overall Study|Lost to Follow-up|6
449127|NCT00395512|1483306|P1|Overall Study|Lost to Follow-up|2
449128|NCT00395512|1483303|P4|Overall Study|Protocol Violation|7
449129|NCT00395512|1483304|P3|Overall Study|Protocol Violation|6
449130|NCT00395512|1483305|P2|Overall Study|Protocol Violation|3
449131|NCT00395512|1483306|P1|Overall Study|Protocol Violation|2
449132|NCT00395512|1483303|P4|Overall Study|Adverse Event|6
449133|NCT00395512|1483304|P3|Overall Study|Adverse Event|6
449134|NCT00395512|1483305|P2|Overall Study|Adverse Event|8
449135|NCT00395512|1483306|P1|Overall Study|Adverse Event|3
449136|NCT00395486|1483478|P2|Overall Study|Lost to Follow-up|1
449137|NCT00395486|1483479|P1|Overall Study|Lost to Follow-up|0
449138|NCT00395486|1483478|P2|Overall Study|Withdrawal by Subject|2
449139|NCT00395486|1483479|P1|Overall Study|Withdrawal by Subject|5
449140|NCT00395486|1483478|P2|Overall Study|Adverse Event|2
449141|NCT00395486|1483479|P1|Overall Study|Adverse Event|1
449142|NCT00395460|1483509|P2|Overall Study|Withdrawal by Subject|0
449143|NCT00395460|1483510|P1|Overall Study|Withdrawal by Subject|1
449144|NCT00395447|1483534|P2|Overall Study|Withdrawl - Other (not subject)|17
449145|NCT00395447|1483535|P1|Overall Study|Withdrawl - Other (not subject)|8
449146|NCT00395447|1483534|P2|Overall Study|Withdrawal by Subject|19
449147|NCT00395447|1483535|P1|Overall Study|Withdrawal by Subject|24
449148|NCT00395447|1483534|P2|Overall Study|Lost to Follow-up|43
449149|NCT00395447|1483535|P1|Overall Study|Lost to Follow-up|52
449150|NCT00395447|1483534|P2|Overall Study|Death|32
449151|NCT00395447|1483535|P1|Overall Study|Death|37
449152|NCT00395343|1483543|P2|Overall Study|Other|2
449153|NCT00395343|1483544|P1|Overall Study|Other|5
449154|NCT00395343|1483543|P2|Overall Study|Withdrawal by Subject|12
449155|NCT00395343|1483544|P1|Overall Study|Withdrawal by Subject|11
449156|NCT00395343|1483543|P2|Overall Study|Protocol Violation|8
449157|NCT00395343|1483544|P1|Overall Study|Protocol Violation|6
449158|NCT00395343|1483543|P2|Overall Study|Physician Decision|4
449159|NCT00395343|1483544|P1|Overall Study|Physician Decision|2
449160|NCT00395343|1483543|P2|Overall Study|Lost to Follow-up|4
449161|NCT00395343|1483544|P1|Overall Study|Lost to Follow-up|4
449162|NCT00395343|1483543|P2|Overall Study|Lack of Efficacy|1
449163|NCT00395343|1483544|P1|Overall Study|Lack of Efficacy|0
449164|NCT00395343|1483543|P2|Overall Study|Adverse Event|5
449165|NCT00395343|1483544|P1|Overall Study|Adverse Event|13
449166|NCT00395304|1483562|P6|Treatment Period 3|Other|0
449167|NCT00395304|1483563|P5|Treatment Period 3|Other|0
449168|NCT00395304|1483564|P4|Treatment Period 3|Other|1
449169|NCT00395304|1483565|P3|Treatment Period 3|Other|0
449170|NCT00395304|1483566|P2|Treatment Period 3|Other|0
449171|NCT00395304|1483567|P1|Treatment Period 3|Other|0
449172|NCT00395304|1483562|P6|Treatment Period 3|Physician Decision|0
449173|NCT00395304|1483563|P5|Treatment Period 3|Physician Decision|0
449174|NCT00395304|1483564|P4|Treatment Period 3|Physician Decision|0
449175|NCT00395304|1483565|P3|Treatment Period 3|Physician Decision|0
449176|NCT00395304|1483566|P2|Treatment Period 3|Physician Decision|1
449177|NCT00395304|1483567|P1|Treatment Period 3|Physician Decision|0
449178|NCT00395304|1483562|P6|Treatment Period 3|Lost to Follow-up|0
449179|NCT00395304|1483563|P5|Treatment Period 3|Lost to Follow-up|0
449180|NCT00395304|1483564|P4|Treatment Period 3|Lost to Follow-up|0
449181|NCT00395304|1483565|P3|Treatment Period 3|Lost to Follow-up|0
449182|NCT00395304|1483566|P2|Treatment Period 3|Lost to Follow-up|1
449183|NCT00395304|1483567|P1|Treatment Period 3|Lost to Follow-up|1
449184|NCT00395304|1483562|P6|Treatment Period 3|Withdrawal by Subject|1
449185|NCT00395304|1483563|P5|Treatment Period 3|Withdrawal by Subject|0
449186|NCT00395304|1483564|P4|Treatment Period 3|Withdrawal by Subject|1
449187|NCT00395304|1483565|P3|Treatment Period 3|Withdrawal by Subject|0
449188|NCT00395304|1483566|P2|Treatment Period 3|Withdrawal by Subject|0
449189|NCT00395304|1483567|P1|Treatment Period 3|Withdrawal by Subject|0
449190|NCT00395304|1483562|P6|Treatment Period 2|Other|0
449191|NCT00395304|1483563|P5|Treatment Period 2|Other|0
449192|NCT00395304|1483564|P4|Treatment Period 2|Other|0
449193|NCT00395304|1483565|P3|Treatment Period 2|Other|0
449194|NCT00395304|1483566|P2|Treatment Period 2|Other|1
449195|NCT00395304|1483567|P1|Treatment Period 2|Other|0
449196|NCT00395304|1483562|P6|Treatment Period 2|Physician Decision|0
449197|NCT00395304|1483563|P5|Treatment Period 2|Physician Decision|0
449198|NCT00395304|1483564|P4|Treatment Period 2|Physician Decision|0
449199|NCT00395304|1483565|P3|Treatment Period 2|Physician Decision|1
449200|NCT00395304|1483566|P2|Treatment Period 2|Physician Decision|0
449201|NCT00395304|1483567|P1|Treatment Period 2|Physician Decision|0
449202|NCT00395304|1483562|P6|Treatment Period 2|Lost to Follow-up|0
449203|NCT00395304|1483563|P5|Treatment Period 2|Lost to Follow-up|0
449204|NCT00395304|1483564|P4|Treatment Period 2|Lost to Follow-up|0
449205|NCT00395304|1483565|P3|Treatment Period 2|Lost to Follow-up|0
449206|NCT00395304|1483566|P2|Treatment Period 2|Lost to Follow-up|3
449207|NCT00395304|1483567|P1|Treatment Period 2|Lost to Follow-up|0
449208|NCT00395304|1483562|P6|Treatment Period 2|Withdrawal by Subject|2
449209|NCT00395304|1483563|P5|Treatment Period 2|Withdrawal by Subject|0
449210|NCT00395304|1483564|P4|Treatment Period 2|Withdrawal by Subject|1
449211|NCT00395304|1483565|P3|Treatment Period 2|Withdrawal by Subject|0
449212|NCT00395304|1483566|P2|Treatment Period 2|Withdrawal by Subject|0
449213|NCT00395304|1483567|P1|Treatment Period 2|Withdrawal by Subject|0
449214|NCT00395304|1483562|P6|Treatment Period 1|Physician Decision|0
449215|NCT00395304|1483563|P5|Treatment Period 1|Physician Decision|0
449216|NCT00395304|1483564|P4|Treatment Period 1|Physician Decision|0
449217|NCT00395304|1483565|P3|Treatment Period 1|Physician Decision|0
449218|NCT00395304|1483566|P2|Treatment Period 1|Physician Decision|1
449219|NCT00395304|1483567|P1|Treatment Period 1|Physician Decision|0
449220|NCT00395304|1483562|P6|Treatment Period 1|Lost to Follow-up|1
449221|NCT00395304|1483563|P5|Treatment Period 1|Lost to Follow-up|0
449222|NCT00395304|1483564|P4|Treatment Period 1|Lost to Follow-up|1
449223|NCT00395304|1483565|P3|Treatment Period 1|Lost to Follow-up|0
449224|NCT00395304|1483566|P2|Treatment Period 1|Lost to Follow-up|0
449225|NCT00395304|1483567|P1|Treatment Period 1|Lost to Follow-up|1
449226|NCT00395304|1483562|P6|Treatment Period 1|Withdrawal by Subject|1
449227|NCT00395304|1483563|P5|Treatment Period 1|Withdrawal by Subject|1
449228|NCT00395304|1483564|P4|Treatment Period 1|Withdrawal by Subject|2
449229|NCT00395304|1483565|P3|Treatment Period 1|Withdrawal by Subject|0
449230|NCT00395304|1483566|P2|Treatment Period 1|Withdrawal by Subject|3
449231|NCT00395304|1483567|P1|Treatment Period 1|Withdrawal by Subject|0
449232|NCT00395226|1483643|P2|Overall Study|Lost to Follow-up|1
449233|NCT00395226|1483644|P1|Overall Study|Lost to Follow-up|0
449234|NCT00395226|1483643|P2|Overall Study|Withdrawal by Subject|1
449235|NCT00395226|1483644|P1|Overall Study|Withdrawal by Subject|0
449236|NCT00395226|1483643|P2|Overall Study|Adverse Event|3
449237|NCT00395226|1483644|P1|Overall Study|Adverse Event|4
449238|NCT00395083|1483691|P2|Overall Study|Developed another disease|3
449239|NCT00395083|1483692|P1|Overall Study|Developed another disease|4
449240|NCT00395083|1483691|P2|Overall Study|Withdrawal by Subject|5
449241|NCT00395083|1483692|P1|Overall Study|Withdrawal by Subject|6
449242|NCT00395018|1483758|P1|Off-Treatment Follow-up|Poor/non-compliance|1
449243|NCT00395018|1483758|P1|Off-Treatment Follow-up|Lost to Follow-up|2
449244|NCT00395018|1483758|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
449245|NCT00395018|1483758|P1|On-Treatment|Subject no longer meets study criteria|2
449246|NCT00395018|1483758|P1|On-Treatment|Poor/non-compliance|2
449247|NCT00395018|1483758|P1|On-Treatment|Other Reason|2
449248|NCT00395018|1483758|P1|On-Treatment|Death|4
449249|NCT00394953|1483779|P2|Second Treatment Period|Not defined|8
449250|NCT00394953|1483780|P1|Second Treatment Period|Not defined|3
449251|NCT00394953|1483779|P2|Second Treatment Period|Renal transplant|6
449252|NCT00394953|1483780|P1|Second Treatment Period|Renal transplant|4
449253|NCT00394953|1483779|P2|Second Treatment Period|Lost to Follow-up|1
449254|NCT00394953|1483780|P1|Second Treatment Period|Lost to Follow-up|0
449255|NCT00394953|1483779|P2|Second Treatment Period|Withdrawal by Subject|3
449256|NCT00394953|1483780|P1|Second Treatment Period|Withdrawal by Subject|3
449257|NCT00394953|1483779|P2|Second Treatment Period|Lack of Efficacy|47
449258|NCT00394953|1483780|P1|Second Treatment Period|Lack of Efficacy|9
449259|NCT00394953|1483779|P2|Second Treatment Period|Death|4
449260|NCT00394953|1483780|P1|Second Treatment Period|Death|8
449261|NCT00394953|1483779|P2|Second Treatment Period|Adverse Event|5
449262|NCT00394953|1483780|P1|Second Treatment Period|Adverse Event|2
449263|NCT00394953|1483779|P2|First Treatment Period|Not defined|1
449264|NCT00394953|1483780|P1|First Treatment Period|Not defined|4
449265|NCT00394953|1483779|P2|First Treatment Period|Renal transplant|7
449266|NCT00394953|1483780|P1|First Treatment Period|Renal transplant|11
449267|NCT00394953|1483779|P2|First Treatment Period|Lost to Follow-up|1
449268|NCT00394953|1483780|P1|First Treatment Period|Lost to Follow-up|0
449269|NCT00394953|1483779|P2|First Treatment Period|Withdrawal by Subject|3
449270|NCT00394953|1483780|P1|First Treatment Period|Withdrawal by Subject|6
449271|NCT00394953|1483779|P2|First Treatment Period|Lack of Efficacy|1
449272|NCT00394953|1483780|P1|First Treatment Period|Lack of Efficacy|1
449273|NCT00394953|1483779|P2|First Treatment Period|Death|7
449274|NCT00394953|1483780|P1|First Treatment Period|Death|6
449275|NCT00394953|1483779|P2|First Treatment Period|Adverse Event|2
449276|NCT00394953|1483780|P1|First Treatment Period|Adverse Event|1
449277|NCT00394914|1483798|P3|Treatment Period|Did not meet protocol eligibility|1
449278|NCT00394914|1483799|P2|Treatment Period|Did not meet protocol eligibility|1
449279|NCT00394914|1483800|P1|Treatment Period|Did not meet protocol eligibility|0
449280|NCT00394914|1483798|P3|Treatment Period|Noncompliance with protocol|2
449281|NCT00394914|1483799|P2|Treatment Period|Noncompliance with protocol|3
449282|NCT00394914|1483800|P1|Treatment Period|Noncompliance with protocol|0
449283|NCT00394914|1483798|P3|Treatment Period|Withdrawal by Subject|2
449284|NCT00394914|1483799|P2|Treatment Period|Withdrawal by Subject|2
449285|NCT00394914|1483800|P1|Treatment Period|Withdrawal by Subject|0
449286|NCT00394914|1483798|P3|Treatment Period|Lost to Follow-up|0
449287|NCT00394914|1483799|P2|Treatment Period|Lost to Follow-up|1
449288|NCT00394914|1483800|P1|Treatment Period|Lost to Follow-up|0
449289|NCT00394914|1483798|P3|Treatment Period|Adverse Event|1
449290|NCT00394914|1483799|P2|Treatment Period|Adverse Event|3
449291|NCT00394914|1483800|P1|Treatment Period|Adverse Event|0
449292|NCT00394901|1483828|P4|Double-blind Phase|Found not to meet entrance criteria|1
449293|NCT00394901|1483829|P3|Double-blind Phase|Found not to meet entrance criteria|0
449294|NCT00394901|1483830|P2|Double-blind Phase|Found not to meet entrance criteria|0
449295|NCT00394901|1483831|P1|Double-blind Phase|Found not to meet entrance criteria|0
449296|NCT00394901|1483828|P4|Double-blind Phase|Entry into another study was found|0
449297|NCT00394901|1483829|P3|Double-blind Phase|Entry into another study was found|1
449298|NCT00394901|1483830|P2|Double-blind Phase|Entry into another study was found|0
449299|NCT00394901|1483831|P1|Double-blind Phase|Entry into another study was found|0
449300|NCT00394901|1483828|P4|Double-blind Phase|Lack of Compliance|0
449301|NCT00394901|1483829|P3|Double-blind Phase|Lack of Compliance|0
449302|NCT00394901|1483830|P2|Double-blind Phase|Lack of Compliance|3
449303|NCT00394901|1483831|P1|Double-blind Phase|Lack of Compliance|0
449304|NCT00394901|1483828|P4|Double-blind Phase|Subject's Personal Reason|1
449305|NCT00394901|1483829|P3|Double-blind Phase|Subject's Personal Reason|0
449306|NCT00394901|1483830|P2|Double-blind Phase|Subject's Personal Reason|0
449307|NCT00394901|1483831|P1|Double-blind Phase|Subject's Personal Reason|1
449308|NCT00394901|1483828|P4|Double-blind Phase|Death|0
449309|NCT00394901|1483829|P3|Double-blind Phase|Death|0
449310|NCT00394901|1483830|P2|Double-blind Phase|Death|0
449311|NCT00394901|1483831|P1|Double-blind Phase|Death|1
449312|NCT00394901|1483828|P4|Double-blind Phase|Protocol Violation|1
449313|NCT00394901|1483829|P3|Double-blind Phase|Protocol Violation|0
449314|NCT00394901|1483830|P2|Double-blind Phase|Protocol Violation|0
449315|NCT00394901|1483831|P1|Double-blind Phase|Protocol Violation|0
449316|NCT00394901|1483828|P4|Double-blind Phase|Lost to Follow-up|1
449317|NCT00394901|1483829|P3|Double-blind Phase|Lost to Follow-up|0
449318|NCT00394901|1483830|P2|Double-blind Phase|Lost to Follow-up|0
449319|NCT00394901|1483831|P1|Double-blind Phase|Lost to Follow-up|0
449320|NCT00394901|1483828|P4|Double-blind Phase|Withdrawal by Subject|0
449321|NCT00394901|1483829|P3|Double-blind Phase|Withdrawal by Subject|0
449322|NCT00394901|1483830|P2|Double-blind Phase|Withdrawal by Subject|0
449323|NCT00394901|1483831|P1|Double-blind Phase|Withdrawal by Subject|2
449324|NCT00394901|1483828|P4|Double-blind Phase|Lack of Efficacy|3
449325|NCT00394901|1483829|P3|Double-blind Phase|Lack of Efficacy|1
449326|NCT00394901|1483830|P2|Double-blind Phase|Lack of Efficacy|4
449327|NCT00394901|1483831|P1|Double-blind Phase|Lack of Efficacy|6
449328|NCT00394901|1483828|P4|Double-blind Phase|Adverse Event|20
449329|NCT00394901|1483829|P3|Double-blind Phase|Adverse Event|16
449330|NCT00394901|1483830|P2|Double-blind Phase|Adverse Event|7
449331|NCT00394901|1483831|P1|Double-blind Phase|Adverse Event|5
449332|NCT00394901|1483828|P4|Baseline Phase|Protocol Violation|0
449333|NCT00394901|1483829|P3|Baseline Phase|Protocol Violation|1
449334|NCT00394901|1483830|P2|Baseline Phase|Protocol Violation|0
449335|NCT00394901|1483831|P1|Baseline Phase|Protocol Violation|0
449336|NCT00394836|1484074|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
449337|NCT00394836|1484075|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
449338|NCT00394836|1484074|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
449339|NCT00394836|1484075|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
449340|NCT00394836|1484074|P2|Extended Follow-up Phase (2-5 Years)|Death|1
449341|NCT00394836|1484075|P1|Extended Follow-up Phase (2-5 Years)|Death|0
449342|NCT00394836|1484074|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
449343|NCT00394836|1484075|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
449344|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Non compliance|1
449345|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Non compliance|0
449346|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
449347|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
449348|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Physician Decision|1
449349|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Physician Decision|0
449350|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
449351|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
449352|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Started alternative treatment|6
449353|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Started alternative treatment|0
449354|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
449355|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
449356|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Death|1
449357|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Death|0
449358|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Patient Refusal|2
449359|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Patient Refusal|1
449360|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Disease Progression|60
449361|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Disease Progression|27
449362|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Protocol Violation|2
449363|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Protocol Violation|0
449364|NCT00394836|1484074|P2|Teatment or Follow-up Phase|Adverse Event|2
449365|NCT00394836|1484075|P1|Teatment or Follow-up Phase|Adverse Event|0
449366|NCT00394771|1484121|P4|Overall Study|Not specified|0
449367|NCT00394771|1484122|P3|Overall Study|Not specified|1
449368|NCT00394771|1484123|P2|Overall Study|Not specified|3
449369|NCT00394771|1484124|P1|Overall Study|Not specified|3
449370|NCT00394771|1484121|P4|Overall Study|Lost to Follow-up|10
449371|NCT00394771|1484122|P3|Overall Study|Lost to Follow-up|13
449372|NCT00394771|1484123|P2|Overall Study|Lost to Follow-up|15
449373|NCT00394771|1484124|P1|Overall Study|Lost to Follow-up|15
449374|NCT00394771|1484121|P4|Overall Study|Participant pregnant|2
449375|NCT00394771|1484122|P3|Overall Study|Participant pregnant|2
449376|NCT00394771|1484123|P2|Overall Study|Participant pregnant|1
449377|NCT00394771|1484124|P1|Overall Study|Participant pregnant|0
449378|NCT00394771|1484121|P4|Overall Study|Adverse Event|8
449379|NCT00394771|1484122|P3|Overall Study|Adverse Event|12
449380|NCT00394771|1484123|P2|Overall Study|Adverse Event|5
449381|NCT00394771|1484124|P1|Overall Study|Adverse Event|10
449382|NCT00394771|1484121|P4|Overall Study|Withdrawal by Subject|12
449383|NCT00394771|1484122|P3|Overall Study|Withdrawal by Subject|8
449384|NCT00394771|1484123|P2|Overall Study|Withdrawal by Subject|6
449385|NCT00394771|1484124|P1|Overall Study|Withdrawal by Subject|10
449386|NCT00394771|1484121|P4|Overall Study|Protocol Violation|7
449387|NCT00394771|1484122|P3|Overall Study|Protocol Violation|9
449388|NCT00394771|1484123|P2|Overall Study|Protocol Violation|4
449389|NCT00394771|1484124|P1|Overall Study|Protocol Violation|2
449390|NCT00394771|1484121|P4|Overall Study|Did not meet protocol requirements|0
449391|NCT00394771|1484122|P3|Overall Study|Did not meet protocol requirements|2
449392|NCT00394771|1484123|P2|Overall Study|Did not meet protocol requirements|0
449393|NCT00394771|1484124|P1|Overall Study|Did not meet protocol requirements|1
449394|NCT00394706|1484194|P8|Overall Study|Lost to Follow-up|0
449395|NCT00394706|1484195|P7|Overall Study|Lost to Follow-up|2
449396|NCT00394706|1484196|P6|Overall Study|Lost to Follow-up|5
449397|NCT00394706|1484197|P5|Overall Study|Lost to Follow-up|2
449398|NCT00394706|1484198|P4|Overall Study|Lost to Follow-up|1
449399|NCT00394706|1484199|P3|Overall Study|Lost to Follow-up|8
449400|NCT00394706|1484200|P2|Overall Study|Lost to Follow-up|2
449401|NCT00394706|1484201|P1|Overall Study|Lost to Follow-up|2
449402|NCT00394706|1484194|P8|Overall Study|Withdrawal by Subject|0
449403|NCT00394706|1484195|P7|Overall Study|Withdrawal by Subject|1
449404|NCT00394706|1484196|P6|Overall Study|Withdrawal by Subject|2
449405|NCT00394706|1484197|P5|Overall Study|Withdrawal by Subject|0
449406|NCT00394706|1484198|P4|Overall Study|Withdrawal by Subject|0
449407|NCT00394706|1484199|P3|Overall Study|Withdrawal by Subject|1
449408|NCT00394706|1484200|P2|Overall Study|Withdrawal by Subject|0
449409|NCT00394706|1484201|P1|Overall Study|Withdrawal by Subject|2
449410|NCT00394654|1484221|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
449411|NCT00394654|1484222|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
449412|NCT00394654|1484221|P2|Overall Study|Lost to Follow-up|0
449413|NCT00394654|1484222|P1|Overall Study|Lost to Follow-up|1
449414|NCT00394589|1484287|P3|Overall Study|Protocol Violation|2
449415|NCT00394589|1484288|P2|Overall Study|Protocol Violation|0
449416|NCT00394589|1484289|P1|Overall Study|Protocol Violation|4
449417|NCT00394589|1484287|P3|Overall Study|Lack of Efficacy|3
449418|NCT00394589|1484288|P2|Overall Study|Lack of Efficacy|2
449419|NCT00394589|1484289|P1|Overall Study|Lack of Efficacy|2
449420|NCT00394589|1484287|P3|Overall Study|Adverse Event|2
449421|NCT00394589|1484288|P2|Overall Study|Adverse Event|1
449422|NCT00394589|1484289|P1|Overall Study|Adverse Event|2
449423|NCT00394524|1484299|P2|Overall Study|Withdrawal by Subject|10
449424|NCT00394524|1484300|P1|Overall Study|Withdrawal by Subject|11
449425|NCT00394472|1484312|P2|Overall Study|Lost to Follow-up|1
449426|NCT00394472|1484313|P1|Overall Study|Lost to Follow-up|0
449427|NCT00394472|1484312|P2|Overall Study|Physician Decision|1
449428|NCT00394472|1484313|P1|Overall Study|Physician Decision|0
449429|NCT00394472|1484312|P2|Overall Study|Withdrawal by Subject|2
449430|NCT00394472|1484313|P1|Overall Study|Withdrawal by Subject|0
449431|NCT00394472|1484312|P2|Overall Study|Adverse Event|2
449432|NCT00394472|1484313|P1|Overall Study|Adverse Event|4
449433|NCT00394472|1484312|P2|Overall Study|incorrect enrolment|2
449434|NCT00394472|1484313|P1|Overall Study|incorrect enrolment|4
449435|NCT00394472|1484312|P2|Overall Study|Protocol Violation|3
449436|NCT00394472|1484313|P1|Overall Study|Protocol Violation|1
449437|NCT00394433|1484321|P1|Overall Study|Alternative Therapy|1
449438|NCT00394433|1484321|P1|Overall Study|Adverse Event|2
449439|NCT00394355|1484332|P4|Overall Study|Lack of Efficacy|3
449440|NCT00394355|1484333|P3|Overall Study|Lack of Efficacy|2
449441|NCT00394355|1484334|P2|Overall Study|Lack of Efficacy|0
449442|NCT00394355|1484335|P1|Overall Study|Lack of Efficacy|0
449443|NCT00394355|1484332|P4|Overall Study|Administrative|1
449444|NCT00394355|1484333|P3|Overall Study|Administrative|1
449445|NCT00394355|1484334|P2|Overall Study|Administrative|1
449446|NCT00394355|1484335|P1|Overall Study|Administrative|0
449447|NCT00394355|1484332|P4|Overall Study|Noncompliance with protocol|8
449448|NCT00394355|1484333|P3|Overall Study|Noncompliance with protocol|10
449449|NCT00394355|1484334|P2|Overall Study|Noncompliance with protocol|3
449450|NCT00394355|1484335|P1|Overall Study|Noncompliance with protocol|4
449451|NCT00394355|1484332|P4|Overall Study|Lost to Follow-up|3
449452|NCT00394355|1484333|P3|Overall Study|Lost to Follow-up|4
449453|NCT00394355|1484334|P2|Overall Study|Lost to Follow-up|5
449454|NCT00394355|1484335|P1|Overall Study|Lost to Follow-up|7
449455|NCT00394355|1484332|P4|Overall Study|Subject withdrawal - related to drug|0
449456|NCT00394355|1484333|P3|Overall Study|Subject withdrawal - related to drug|0
449457|NCT00394355|1484334|P2|Overall Study|Subject withdrawal - related to drug|0
449458|NCT00394355|1484335|P1|Overall Study|Subject withdrawal - related to drug|1
449459|NCT00394355|1484332|P4|Overall Study|Subject withdrawal - unrelated to drug|6
449460|NCT00394355|1484333|P3|Overall Study|Subject withdrawal - unrelated to drug|10
449461|NCT00394355|1484334|P2|Overall Study|Subject withdrawal - unrelated to drug|14
449462|NCT00394355|1484335|P1|Overall Study|Subject withdrawal - unrelated to drug|12
449463|NCT00394355|1484332|P4|Overall Study|Did not meet protocol eligibility|2
449464|NCT00394355|1484333|P3|Overall Study|Did not meet protocol eligibility|4
449465|NCT00394355|1484334|P2|Overall Study|Did not meet protocol eligibility|5
449466|NCT00394355|1484335|P1|Overall Study|Did not meet protocol eligibility|1
449467|NCT00394355|1484332|P4|Overall Study|Adverse Event|8
449468|NCT00394355|1484333|P3|Overall Study|Adverse Event|7
449469|NCT00394355|1484334|P2|Overall Study|Adverse Event|6
449470|NCT00394355|1484335|P1|Overall Study|Adverse Event|10
449471|NCT00394251|1484441|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
449472|NCT00394251|1484442|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
449473|NCT00394251|1484441|P2|Overall Study|Withdrawal by Subject|11
449474|NCT00394251|1484442|P1|Overall Study|Withdrawal by Subject|7
449475|NCT00394251|1484441|P2|Overall Study|Protocol Violation|1
449476|NCT00394251|1484442|P1|Overall Study|Protocol Violation|0
449477|NCT00394251|1484441|P2|Overall Study|Physician Decision|1
449478|NCT00394251|1484442|P1|Overall Study|Physician Decision|1
449479|NCT00394251|1484441|P2|Overall Study|Unacceptable Toxicity|18
449480|NCT00394251|1484442|P1|Overall Study|Unacceptable Toxicity|20
449481|NCT00394251|1484441|P2|Overall Study|Adverse Event|5
449482|NCT00394251|1484442|P1|Overall Study|Adverse Event|7
449483|NCT00394212|1484470|P2|Overall Study|Withdrawal by Subject|1
449484|NCT00394212|1484471|P1|Overall Study|Withdrawal by Subject|4
449485|NCT00394212|1484470|P2|Overall Study|Lost to Follow-up|0
449486|NCT00394212|1484471|P1|Overall Study|Lost to Follow-up|3
449487|NCT00394095|1484485|P2|Overall Study|Adverse Event|0
449488|NCT00394095|1484486|P1|Overall Study|Adverse Event|1
449489|NCT00394082|1484494|P1|Overall Study|Not specified|1
449490|NCT00394082|1484494|P1|Overall Study|Withdrawal by Subject|2
449491|NCT00394082|1484494|P1|Overall Study|Physician Decision|4
449492|NCT00394082|1484494|P1|Overall Study|Adverse Event|4
449493|NCT00394082|1484494|P1|Overall Study|Unacceptable toxicity|15
449494|NCT00393939|1484516|P2|Overall Study|Not specified|45
449495|NCT00393939|1484517|P1|Overall Study|Not specified|37
449496|NCT00393939|1484516|P2|Overall Study|Withdrawal by Subject|7
449497|NCT00393939|1484517|P1|Overall Study|Withdrawal by Subject|2
449498|NCT00393939|1484516|P2|Overall Study|Objective progression or relapse|223
449499|NCT00393939|1484517|P1|Overall Study|Objective progression or relapse|239
449500|NCT00393939|1484516|P2|Overall Study|Sponsor|13
449501|NCT00393939|1484517|P1|Overall Study|Sponsor|5
449502|NCT00393939|1484516|P2|Overall Study|Death|4
449503|NCT00393939|1484517|P1|Overall Study|Death|10
449504|NCT00393939|1484516|P2|Overall Study|Lost to Follow-up|4
449505|NCT00393939|1484517|P1|Overall Study|Lost to Follow-up|2
449506|NCT00393939|1484516|P2|Overall Study|Protocol Violation|1
449507|NCT00393939|1484517|P1|Overall Study|Protocol Violation|1
449508|NCT00393913|1484535|P1|CPAP|TEchnical problem with CPAP|3
449509|NCT00393913|1484535|P1|CPAP|Physician Decision|1
449510|NCT00393913|1484535|P1|CPAP|Withdrawal by Subject|3
449511|NCT00393913|1484535|P1|Initial Assessment|Withdrawal by Subject|16
449512|NCT00393913|1484535|P1|Initial Assessment|diagnosed with other sleep disorder|21
449513|NCT00393887|1484543|P2|Overall Study|Lost to Follow-up|9
449514|NCT00393887|1484544|P1|Overall Study|Lost to Follow-up|11
449515|NCT00393887|1484543|P2|Overall Study|Physician Decision|0
449516|NCT00393887|1484544|P1|Overall Study|Physician Decision|5
449517|NCT00393861|1484572|P1|Overall Study|Disease Progression|24
449518|NCT00393861|1484572|P1|Overall Study|Adverse Event|2
449519|NCT00393848|1484583|P4|Overall Study|Personal reasons|0
449520|NCT00393848|1484584|P3|Overall Study|Personal reasons|2
449521|NCT00393848|1484585|P2|Overall Study|Personal reasons|0
449522|NCT00393848|1484586|P1|Overall Study|Personal reasons|0
449523|NCT00393848|1484583|P4|Overall Study|Surgical schedule|1
449524|NCT00393848|1484584|P3|Overall Study|Surgical schedule|0
449525|NCT00393848|1484585|P2|Overall Study|Surgical schedule|0
449526|NCT00393848|1484586|P1|Overall Study|Surgical schedule|0
449527|NCT00393718|1484609|P2|Overall Study|Move|0
449528|NCT00393718|1484610|P1|Overall Study|Move|1
449529|NCT00393718|1484609|P2|Overall Study|Missed measurement|0
449530|NCT00393718|1484610|P1|Overall Study|Missed measurement|1
449531|NCT00393718|1484609|P2|Overall Study|Withdrawal of consent|1
449532|NCT00393718|1484610|P1|Overall Study|Withdrawal of consent|2
449533|NCT00393718|1484609|P2|Overall Study|Subject decision|0
449534|NCT00393718|1484610|P1|Overall Study|Subject decision|5
449535|NCT00393718|1484609|P2|Overall Study|Hypoglycaemia|2
449536|NCT00393718|1484610|P1|Overall Study|Hypoglycaemia|3
449537|NCT00393718|1484609|P2|Overall Study|Lack of Efficacy|9
449538|NCT00393718|1484610|P1|Overall Study|Lack of Efficacy|10
449539|NCT00393718|1484609|P2|Overall Study|Protocol Violation|2
449540|NCT00393718|1484610|P1|Overall Study|Protocol Violation|1
449541|NCT00393718|1484609|P2|Overall Study|Adverse Event|8
449542|NCT00393718|1484610|P1|Overall Study|Adverse Event|20
449543|NCT00393705|1484642|P2|Overall Study|Physician Decision|2
449544|NCT00393705|1484643|P1|Overall Study|Physician Decision|2
449545|NCT00393705|1484642|P2|Overall Study|Withdrawal by Subject|3
449546|NCT00393705|1484643|P1|Overall Study|Withdrawal by Subject|5
449547|NCT00393705|1484642|P2|Overall Study|Protocol Violation|3
449548|NCT00393705|1484643|P1|Overall Study|Protocol Violation|4
449549|NCT00393705|1484642|P2|Overall Study|Entry Criteria Not Met|10
449550|NCT00393705|1484643|P1|Overall Study|Entry Criteria Not Met|10
449551|NCT00393705|1484642|P2|Overall Study|Lost to Follow-up|2
449552|NCT00393705|1484643|P1|Overall Study|Lost to Follow-up|2
449553|NCT00393705|1484642|P2|Overall Study|Death|1
449554|NCT00393705|1484643|P1|Overall Study|Death|0
449555|NCT00393705|1484642|P2|Overall Study|Adverse Event|2
449556|NCT00393705|1484643|P1|Overall Study|Adverse Event|0
449557|NCT00393523|1484672|P5|Overall Study|Vaccine supply issue|0
449558|NCT00393523|1484673|P4|Overall Study|Vaccine supply issue|0
449559|NCT00393523|1484674|P3|Overall Study|Vaccine supply issue|1
449560|NCT00393523|1484675|P2|Overall Study|Vaccine supply issue|0
449561|NCT00393523|1484676|P1|Overall Study|Vaccine supply issue|0
449562|NCT00393523|1484672|P5|Overall Study|Difficulties in specimen collection|0
449563|NCT00393523|1484673|P4|Overall Study|Difficulties in specimen collection|0
449564|NCT00393523|1484674|P3|Overall Study|Difficulties in specimen collection|1
449565|NCT00393523|1484675|P2|Overall Study|Difficulties in specimen collection|0
449566|NCT00393523|1484676|P1|Overall Study|Difficulties in specimen collection|0
449567|NCT00393523|1484672|P5|Overall Study|Withdrawal by Subject|0
449568|NCT00393523|1484673|P4|Overall Study|Withdrawal by Subject|3
449569|NCT00393523|1484674|P3|Overall Study|Withdrawal by Subject|2
449570|NCT00393523|1484675|P2|Overall Study|Withdrawal by Subject|7
449571|NCT00393523|1484676|P1|Overall Study|Withdrawal by Subject|6
449572|NCT00393523|1484672|P5|Overall Study|Protocol Violation|0
449573|NCT00393523|1484673|P4|Overall Study|Protocol Violation|1
449574|NCT00393523|1484674|P3|Overall Study|Protocol Violation|0
449575|NCT00393523|1484675|P2|Overall Study|Protocol Violation|2
449576|NCT00393523|1484676|P1|Overall Study|Protocol Violation|6
449577|NCT00393523|1484672|P5|Overall Study|Lost to Follow-up|1
449578|NCT00393523|1484673|P4|Overall Study|Lost to Follow-up|2
449579|NCT00393523|1484674|P3|Overall Study|Lost to Follow-up|0
449580|NCT00393523|1484675|P2|Overall Study|Lost to Follow-up|0
449581|NCT00393523|1484676|P1|Overall Study|Lost to Follow-up|0
449582|NCT00393510|1484693|P2|Overall Study|Physician Decision|9
449583|NCT00393510|1484694|P1|Overall Study|Physician Decision|3
449584|NCT00393484|1484706|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
449585|NCT00393484|1484707|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
449586|NCT00393484|1484706|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
449587|NCT00393484|1484707|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
449588|NCT00393484|1484706|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
449589|NCT00393484|1484707|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
449590|NCT00393484|1484706|P2|Open-label Period (Weeks 96 to 240)|Death|0
449591|NCT00393484|1484707|P1|Open-label Period (Weeks 96 to 240)|Death|1
449592|NCT00393484|1484706|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
449593|NCT00393484|1484707|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
449594|NCT00393484|1484706|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
449595|NCT00393484|1484707|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
449596|NCT00393484|1484706|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
449597|NCT00393484|1484707|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
449598|NCT00393484|1484706|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
449599|NCT00393484|1484707|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
449600|NCT00393484|1484706|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
449601|NCT00393484|1484707|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
449602|NCT00393484|1484706|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
449603|NCT00393484|1484707|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
449604|NCT00393458|1484743|P4|Overall Study|Subject no longer requires study drug|0
449605|NCT00393458|1484744|P3|Overall Study|Subject no longer requires study drug|0
449606|NCT00393458|1484745|P2|Overall Study|Subject no longer requires study drug|1
449607|NCT00393458|1484746|P1|Overall Study|Subject no longer requires study drug|0
449608|NCT00393458|1484743|P4|Overall Study|Abnormal test procedure result(s)|2
449609|NCT00393458|1484744|P3|Overall Study|Abnormal test procedure result(s)|1
449610|NCT00393458|1484745|P2|Overall Study|Abnormal test procedure result(s)|1
449611|NCT00393458|1484746|P1|Overall Study|Abnormal test procedure result(s)|0
449612|NCT00393458|1484743|P4|Overall Study|Death|5
449613|NCT00393458|1484744|P3|Overall Study|Death|5
449614|NCT00393458|1484745|P2|Overall Study|Death|1
449615|NCT00393458|1484746|P1|Overall Study|Death|1
449616|NCT00393458|1484743|P4|Overall Study|Abnormal laboratory value(s)|0
449617|NCT00393458|1484744|P3|Overall Study|Abnormal laboratory value(s)|0
449618|NCT00393458|1484745|P2|Overall Study|Abnormal laboratory value(s)|1
449619|NCT00393458|1484746|P1|Overall Study|Abnormal laboratory value(s)|1
449620|NCT00393458|1484743|P4|Overall Study|Lost to Follow-up|3
449621|NCT00393458|1484744|P3|Overall Study|Lost to Follow-up|5
449622|NCT00393458|1484745|P2|Overall Study|Lost to Follow-up|6
449623|NCT00393458|1484746|P1|Overall Study|Lost to Follow-up|5
449624|NCT00393458|1484743|P4|Overall Study|Administrative problems|2
449625|NCT00393458|1484744|P3|Overall Study|Administrative problems|5
449626|NCT00393458|1484745|P2|Overall Study|Administrative problems|8
449627|NCT00393458|1484746|P1|Overall Study|Administrative problems|7
449628|NCT00393458|1484743|P4|Overall Study|Protocol deviation|10
449629|NCT00393458|1484744|P3|Overall Study|Protocol deviation|11
449630|NCT00393458|1484745|P2|Overall Study|Protocol deviation|11
449631|NCT00393458|1484746|P1|Overall Study|Protocol deviation|11
449632|NCT00393458|1484743|P4|Overall Study|Unsatisfactory therapeutic effect|30
449633|NCT00393458|1484744|P3|Overall Study|Unsatisfactory therapeutic effect|12
449634|NCT00393458|1484745|P2|Overall Study|Unsatisfactory therapeutic effect|9
449635|NCT00393458|1484746|P1|Overall Study|Unsatisfactory therapeutic effect|12
449636|NCT00393458|1484743|P4|Overall Study|Subject withdrew consent|50
449637|NCT00393458|1484744|P3|Overall Study|Subject withdrew consent|33
449638|NCT00393458|1484745|P2|Overall Study|Subject withdrew consent|40
449639|NCT00393458|1484746|P1|Overall Study|Subject withdrew consent|27
449640|NCT00393458|1484743|P4|Overall Study|Adverse Event|35
449641|NCT00393458|1484744|P3|Overall Study|Adverse Event|40
449642|NCT00393458|1484745|P2|Overall Study|Adverse Event|24
449643|NCT00393458|1484746|P1|Overall Study|Adverse Event|35
449644|NCT00393367|1484773|P2|Overall Study|Withdrawal by Subject|2
449645|NCT00393367|1484774|P1|Overall Study|Withdrawal by Subject|0
449646|NCT00393367|1484773|P2|Overall Study|Protocol Violation|5
449647|NCT00393367|1484774|P1|Overall Study|Protocol Violation|2
449648|NCT00393094|1484802|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
449649|NCT00393094|1484802|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
449650|NCT00393042|1484813|P2|Second Intervetion|Protocol Violation|1
449651|NCT00393042|1484814|P1|Second Intervetion|Protocol Violation|1
449652|NCT00393042|1484813|P2|Second Intervetion|Lost to Follow-up|2
449653|NCT00393042|1484814|P1|Second Intervetion|Lost to Follow-up|0
449654|NCT00393042|1484813|P2|Second Intervetion|Lack of Efficacy|0
449655|NCT00393042|1484814|P1|Second Intervetion|Lack of Efficacy|1
449656|NCT00393042|1484813|P2|Second Intervetion|Withdrawal by Subject|2
449657|NCT00393042|1484814|P1|Second Intervetion|Withdrawal by Subject|0
449658|NCT00393042|1484813|P2|Second Intervetion|Adverse Event|3
449659|NCT00393042|1484814|P1|Second Intervetion|Adverse Event|0
449660|NCT00393042|1484813|P2|First Intervention|Adverse Event|1
449661|NCT00393042|1484814|P1|First Intervention|Adverse Event|0
449662|NCT00393042|1484813|P2|First Intervention|Protocol Violation|0
449663|NCT00393042|1484814|P1|First Intervention|Protocol Violation|1
449664|NCT00393042|1484813|P2|First Intervention|Lost to Follow-up|3
449665|NCT00393042|1484814|P1|First Intervention|Lost to Follow-up|3
449666|NCT00393042|1484813|P2|First Intervention|Withdrawal by Subject|2
449667|NCT00393042|1484814|P1|First Intervention|Withdrawal by Subject|1
449668|NCT00393029|1484886|P2|Overall Study|Not treated|1
449669|NCT00393029|1484887|P1|Overall Study|Not treated|0
449670|NCT00392925|1484908|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
449671|NCT00392925|1484909|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
449672|NCT00392925|1484910|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
449673|NCT00392925|1484911|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
449674|NCT00392925|1484908|P4|Randomization to Treatment Group Period|Protocol Violation|1
449675|NCT00392925|1484909|P3|Randomization to Treatment Group Period|Protocol Violation|2
449676|NCT00392925|1484910|P2|Randomization to Treatment Group Period|Protocol Violation|0
449677|NCT00392925|1484911|P1|Randomization to Treatment Group Period|Protocol Violation|0
449678|NCT00392925|1484908|P4|Randomization to Treatment Group Period|Adverse Event|5
449679|NCT00392925|1484909|P3|Randomization to Treatment Group Period|Adverse Event|3
449680|NCT00392925|1484910|P2|Randomization to Treatment Group Period|Adverse Event|3
449681|NCT00392925|1484911|P1|Randomization to Treatment Group Period|Adverse Event|0
449682|NCT00392925|1484908|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
449683|NCT00392925|1484909|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
449684|NCT00392925|1484910|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
449685|NCT00392925|1484911|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
449686|NCT00392925|1484908|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
449687|NCT00392925|1484909|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
449688|NCT00392925|1484910|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
449689|NCT00392925|1484911|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
449690|NCT00392925|1484908|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
449691|NCT00392925|1484909|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
449692|NCT00392925|1484910|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
449693|NCT00392925|1484911|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
449694|NCT00392925|1484908|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
449695|NCT00392925|1484909|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
449696|NCT00392925|1484910|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
449697|NCT00392925|1484911|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
449698|NCT00392925|1484908|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
449699|NCT00392925|1484909|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
449700|NCT00392925|1484910|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
449701|NCT00392925|1484911|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
449702|NCT00392925|1484908|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
449703|NCT00392925|1484909|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
449704|NCT00392925|1484910|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
449705|NCT00392925|1484911|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
449706|NCT00392808|1485025|P4|Overall Study|Unable to withdraw blood|2
449707|NCT00392808|1485026|P3|Overall Study|Unable to withdraw blood|1
449708|NCT00392808|1485027|P2|Overall Study|Unable to withdraw blood|1
449709|NCT00392808|1485028|P1|Overall Study|Unable to withdraw blood|3
449710|NCT00392808|1485025|P4|Overall Study|Lost to Follow-up|2
449711|NCT00392808|1485026|P3|Overall Study|Lost to Follow-up|1
449712|NCT00392808|1485027|P2|Overall Study|Lost to Follow-up|2
449713|NCT00392808|1485028|P1|Overall Study|Lost to Follow-up|3
449714|NCT00392769|1485052|P1|Overall Study|Adverse Event|1
449715|NCT00392769|1485052|P1|Overall Study|Clinical Deterioration|9
449716|NCT00392665|1485104|P2|Overall Study|Lost to Follow-up|1
449717|NCT00392665|1485105|P1|Overall Study|Lost to Follow-up|1
449718|NCT00392665|1485104|P2|Overall Study|Death|14
449719|NCT00392665|1485105|P1|Overall Study|Death|16
449720|NCT00392379|1485131|P2|Overall Study|Adverse Event|1
449721|NCT00392379|1485132|P1|Overall Study|Adverse Event|1
449722|NCT00392379|1485131|P2|Overall Study|Lost to Follow-up|9
449723|NCT00392379|1485132|P1|Overall Study|Lost to Follow-up|4
449724|NCT00392379|1485131|P2|Overall Study|Withdrawal by Subject|28
449725|NCT00392379|1485132|P1|Overall Study|Withdrawal by Subject|17
449726|NCT00392288|1485145|P3|Overall Study|Other|1
449727|NCT00392288|1485146|P2|Overall Study|Other|4
449728|NCT00392288|1485147|P1|Overall Study|Other|3
449729|NCT00392288|1485145|P3|Overall Study|Parent/legal guardian withdrawal|1
449730|NCT00392288|1485146|P2|Overall Study|Parent/legal guardian withdrawal|2
449731|NCT00392288|1485147|P1|Overall Study|Parent/legal guardian withdrawal|1
449732|NCT00392288|1485145|P3|Overall Study|Withdrawal by Subject|2
449733|NCT00392288|1485146|P2|Overall Study|Withdrawal by Subject|0
449734|NCT00392288|1485147|P1|Overall Study|Withdrawal by Subject|1
449735|NCT00392288|1485145|P3|Overall Study|Lost to Follow-up|1
449736|NCT00392288|1485146|P2|Overall Study|Lost to Follow-up|1
449737|NCT00392288|1485147|P1|Overall Study|Lost to Follow-up|1
449738|NCT00392288|1485145|P3|Overall Study|Protocol Violation|1
449739|NCT00392288|1485146|P2|Overall Study|Protocol Violation|3
449740|NCT00392288|1485147|P1|Overall Study|Protocol Violation|1
449741|NCT00392288|1485145|P3|Overall Study|Lack of Efficacy|3
449742|NCT00392288|1485146|P2|Overall Study|Lack of Efficacy|5
449743|NCT00392288|1485147|P1|Overall Study|Lack of Efficacy|8
449744|NCT00392288|1485145|P3|Overall Study|Adverse Event|8
449745|NCT00392288|1485146|P2|Overall Study|Adverse Event|7
449746|NCT00392288|1485147|P1|Overall Study|Adverse Event|17
449747|NCT00392223|1485172|P2|Overall Study|Withdrawal by Subject|2
449748|NCT00392223|1485173|P1|Overall Study|Withdrawal by Subject|3
449749|NCT00392223|1485172|P2|Overall Study|Protocol Violation|3
449750|NCT00392223|1485173|P1|Overall Study|Protocol Violation|0
449751|NCT00392223|1485172|P2|Overall Study|Lost to Follow-up|4
449752|NCT00392223|1485173|P1|Overall Study|Lost to Follow-up|1
449753|NCT00392223|1485172|P2|Overall Study|Adverse Event|4
449754|NCT00392223|1485173|P1|Overall Study|Adverse Event|5
449755|NCT00392210|1485191|P2|First Voiding Trial|Physician Decision|2
449756|NCT00392210|1485192|P1|First Voiding Trial|Physician Decision|2
449757|NCT00392197|1485200|P2|Overall Study|Withdrawal by Subject|6
449758|NCT00392197|1485201|P1|Overall Study|Withdrawal by Subject|4
449759|NCT00392197|1485200|P2|Overall Study|Protocol Violation|5
449760|NCT00392197|1485201|P1|Overall Study|Protocol Violation|7
449761|NCT00392197|1485200|P2|Overall Study|Physician Decision|2
449762|NCT00392197|1485201|P1|Overall Study|Physician Decision|3
449763|NCT00392197|1485200|P2|Overall Study|Lost to Follow-up|1
449764|NCT00392197|1485201|P1|Overall Study|Lost to Follow-up|0
449765|NCT00392197|1485200|P2|Overall Study|Lack of Efficacy|4
449766|NCT00392197|1485201|P1|Overall Study|Lack of Efficacy|3
449767|NCT00392197|1485200|P2|Overall Study|Adverse Event|12
449768|NCT00392197|1485201|P1|Overall Study|Adverse Event|4
449769|NCT00392171|1485209|P1|Overall Study|Disease progression|101
449770|NCT00392171|1485209|P1|Overall Study|Did not meet inclusion criteria|4
449771|NCT00391976|1485220|P3|Overall Study|Positive P. aeruginosa antibody test|31
449772|NCT00391976|1485221|P2|Overall Study|Positive P. aeruginosa antibody test|0
449773|NCT00391976|1485222|P1|Overall Study|Positive P. aeruginosa antibody test|0
449774|NCT00391976|1485220|P3|Overall Study|Unable to classify|1
449775|NCT00391976|1485221|P2|Overall Study|Unable to classify|0
449776|NCT00391976|1485222|P1|Overall Study|Unable to classify|0
449777|NCT00391976|1485220|P3|Overall Study|Recurrence/no eradication of infection|0
449778|NCT00391976|1485221|P2|Overall Study|Recurrence/no eradication of infection|19
449779|NCT00391976|1485222|P1|Overall Study|Recurrence/no eradication of infection|21
449780|NCT00391976|1485220|P3|Overall Study|Protocol deviation/violation|1
449781|NCT00391976|1485221|P2|Overall Study|Protocol deviation/violation|2
449782|NCT00391976|1485222|P1|Overall Study|Protocol deviation/violation|4
449783|NCT00391976|1485220|P3|Overall Study|Inappropriate enrollment|0
449784|NCT00391976|1485221|P2|Overall Study|Inappropriate enrollment|1
449785|NCT00391976|1485222|P1|Overall Study|Inappropriate enrollment|1
449786|NCT00391976|1485220|P3|Overall Study|Lost to Follow-up|0
449787|NCT00391976|1485221|P2|Overall Study|Lost to Follow-up|2
449788|NCT00391976|1485222|P1|Overall Study|Lost to Follow-up|1
449789|NCT00391976|1485220|P3|Overall Study|Withdrawal of consent|1
449790|NCT00391976|1485221|P2|Overall Study|Withdrawal of consent|1
449791|NCT00391976|1485222|P1|Overall Study|Withdrawal of consent|0
449792|NCT00391976|1485220|P3|Overall Study|Adverse Event|1
449793|NCT00391976|1485221|P2|Overall Study|Adverse Event|0
449794|NCT00391976|1485222|P1|Overall Study|Adverse Event|0
449795|NCT00391898|1485246|P2|Overall Study|Other|10
449796|NCT00391898|1485247|P1|Overall Study|Other|8
449797|NCT00391898|1485246|P2|Overall Study|Adverse Event|0
449798|NCT00391898|1485247|P1|Overall Study|Adverse Event|3
449799|NCT00391872|1485267|P2|Overall Study|Lost to Follow-up|0
449800|NCT00391872|1485268|P1|Overall Study|Lost to Follow-up|2
449801|NCT00391872|1485267|P2|Overall Study|Reason unknown|4
449802|NCT00391872|1485268|P1|Overall Study|Reason unknown|2
449803|NCT00391872|1485267|P2|Overall Study|Withdrawal by Subject|249
449804|NCT00391872|1485268|P1|Overall Study|Withdrawal by Subject|296
449805|NCT00391872|1485267|P2|Overall Study|Protocol Violation|2
449806|NCT00391872|1485268|P1|Overall Study|Protocol Violation|7
449807|NCT00391846|1485306|P2|Overall Study|Developed study specific DC criteria|1
449808|NCT00391846|1485307|P1|Overall Study|Developed study specific DC criteria|0
449809|NCT00391846|1485306|P2|Overall Study|Withdrawal by Subject|3
449810|NCT00391846|1485307|P1|Overall Study|Withdrawal by Subject|2
449811|NCT00391846|1485306|P2|Overall Study|Did not meet the required elig. crit|2
449812|NCT00391846|1485307|P1|Overall Study|Did not meet the required elig. crit|2
449813|NCT00391846|1485306|P2|Overall Study|Adverse Event|1
449814|NCT00391846|1485307|P1|Overall Study|Adverse Event|4
449815|NCT00391807|1485327|P1|Overall Study|Various|96
449816|NCT00391807|1485327|P1|Overall Study|Protocol Violation|20
449817|NCT00391807|1485327|P1|Overall Study|Withdrawal by Subject|147
449818|NCT00391807|1485327|P1|Overall Study|Lost to Follow-up|227
449819|NCT00391807|1485327|P1|Overall Study|Pregnancy|25
449820|NCT00391807|1485327|P1|Overall Study|Adverse Event|177
449821|NCT00391807|1485327|P1|Overall Study|Did not receive study medication|23
449822|NCT00391768|1485354|P7|Overall Study|Lost to Follow-up|3
449823|NCT00391768|1485355|P6|Overall Study|Lost to Follow-up|2
449824|NCT00391768|1485356|P5|Overall Study|Lost to Follow-up|2
449825|NCT00391768|1485357|P4|Overall Study|Lost to Follow-up|1
449826|NCT00391768|1485358|P3|Overall Study|Lost to Follow-up|0
449827|NCT00391768|1485359|P2|Overall Study|Lost to Follow-up|0
449828|NCT00391768|1485360|P1|Overall Study|Lost to Follow-up|0
449829|NCT00391768|1485354|P7|Overall Study|Withdrawal by Subject|1
449830|NCT00391768|1485355|P6|Overall Study|Withdrawal by Subject|1
449831|NCT00391768|1485356|P5|Overall Study|Withdrawal by Subject|0
449832|NCT00391768|1485357|P4|Overall Study|Withdrawal by Subject|0
449833|NCT00391768|1485358|P3|Overall Study|Withdrawal by Subject|1
449834|NCT00391768|1485359|P2|Overall Study|Withdrawal by Subject|0
449835|NCT00391768|1485360|P1|Overall Study|Withdrawal by Subject|0
449836|NCT00391625|1485447|P1|Month 50|Physician Decision|1
449837|NCT00391625|1485447|P1|Month 14|Withdrawal by Subject|1
449838|NCT00391586|1485500|P1|Overall Study|Death|4
449839|NCT00391586|1485500|P1|Overall Study|Physician Decision|2
449840|NCT00391586|1485500|P1|Overall Study|Adverse Event|5
449841|NCT00391586|1485500|P1|Overall Study|Progressive disease|13
449842|NCT00391391|1485537|P4|Overall Study|Withdrawal by Subject|7
449843|NCT00391391|1485538|P3|Overall Study|Withdrawal by Subject|10
449844|NCT00391391|1485539|P2|Overall Study|Withdrawal by Subject|4
449845|NCT00391391|1485540|P1|Overall Study|Withdrawal by Subject|6
449846|NCT00391391|1485537|P4|Overall Study|Protocol Violation|7
449847|NCT00391391|1485538|P3|Overall Study|Protocol Violation|6
449848|NCT00391391|1485539|P2|Overall Study|Protocol Violation|3
449849|NCT00391391|1485540|P1|Overall Study|Protocol Violation|2
449850|NCT00391391|1485537|P4|Overall Study|Lost to Follow-up|4
449851|NCT00391391|1485538|P3|Overall Study|Lost to Follow-up|7
449852|NCT00391391|1485539|P2|Overall Study|Lost to Follow-up|3
449853|NCT00391391|1485540|P1|Overall Study|Lost to Follow-up|1
449854|NCT00391391|1485537|P4|Overall Study|Adverse Event|1
449855|NCT00391391|1485538|P3|Overall Study|Adverse Event|0
449856|NCT00391391|1485539|P2|Overall Study|Adverse Event|0
449857|NCT00391391|1485540|P1|Overall Study|Adverse Event|0
449858|NCT00391274|1485585|P2|Overall Study|Death Not Study Related|1
449859|NCT00391274|1485586|P1|Overall Study|Death Not Study Related|0
449860|NCT00391274|1485585|P2|Overall Study|Death Due to Indeterminate Cause|0
449861|NCT00391274|1485586|P1|Overall Study|Death Due to Indeterminate Cause|1
449862|NCT00391274|1485585|P2|Overall Study|Death Due to Adverse Event|3
449863|NCT00391274|1485586|P1|Overall Study|Death Due to Adverse Event|1
449864|NCT00391274|1485585|P2|Overall Study|Withdrawal by Subject|3
449865|NCT00391274|1485586|P1|Overall Study|Withdrawal by Subject|0
449866|NCT00391274|1485585|P2|Overall Study|Physician Decision|2
449867|NCT00391274|1485586|P1|Overall Study|Physician Decision|4
449868|NCT00391274|1485585|P2|Overall Study|Lost to Follow-up|3
449869|NCT00391274|1485586|P1|Overall Study|Lost to Follow-up|0
449870|NCT00391274|1485585|P2|Overall Study|Death Due to Study Disease|45
449871|NCT00391274|1485586|P1|Overall Study|Death Due to Study Disease|55
449872|NCT00391222|1485605|P4|Period III (Double-Blind Treatment)|Other|0
449873|NCT00391222|1485606|P3|Period III (Double-Blind Treatment)|Other|6
449874|NCT00391222|1485607|P2|Period III (Double-Blind Treatment)|Other|1
449875|NCT00391222|1485608|P1|Period III (Double-Blind Treatment)|Other|6
449876|NCT00391222|1485605|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
449877|NCT00391222|1485606|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
449878|NCT00391222|1485607|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
449879|NCT00391222|1485608|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
449880|NCT00391222|1485605|P4|Period III (Double-Blind Treatment)|Pregnancy|0
449881|NCT00391222|1485606|P3|Period III (Double-Blind Treatment)|Pregnancy|0
449882|NCT00391222|1485607|P2|Period III (Double-Blind Treatment)|Pregnancy|2
449883|NCT00391222|1485608|P1|Period III (Double-Blind Treatment)|Pregnancy|0
449884|NCT00391222|1485605|P4|Period III (Double-Blind Treatment)|Adverse Event|0
449885|NCT00391222|1485606|P3|Period III (Double-Blind Treatment)|Adverse Event|4
449886|NCT00391222|1485607|P2|Period III (Double-Blind Treatment)|Adverse Event|2
449887|NCT00391222|1485608|P1|Period III (Double-Blind Treatment)|Adverse Event|5
449888|NCT00391222|1485605|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
449889|NCT00391222|1485606|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
449890|NCT00391222|1485607|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
449891|NCT00391222|1485608|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
449892|NCT00391222|1485605|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
449893|NCT00391222|1485606|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
449894|NCT00391222|1485607|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
449895|NCT00391222|1485608|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
449896|NCT00391222|1485605|P4|Period II (Open-label Risperidone LAI)|Other|24
449897|NCT00391222|1485606|P3|Period II (Open-label Risperidone LAI)|Other|0
449898|NCT00391222|1485607|P2|Period II (Open-label Risperidone LAI)|Other|0
449899|NCT00391222|1485608|P1|Period II (Open-label Risperidone LAI)|Other|0
449900|NCT00391222|1485605|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
449901|NCT00391222|1485606|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
449902|NCT00391222|1485607|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
449903|NCT00391222|1485608|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
449904|NCT00391222|1485605|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
449905|NCT00391222|1485606|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
449906|NCT00391222|1485607|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
449907|NCT00391222|1485608|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
449908|NCT00391222|1485605|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
449909|NCT00391222|1485606|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
449910|NCT00391222|1485607|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
449911|NCT00391222|1485608|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
449912|NCT00391222|1485605|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
449913|NCT00391222|1485606|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
449914|NCT00391222|1485607|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
449915|NCT00391222|1485608|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
449916|NCT00391092|1485634|P2|Overall Study|Alive in follow-up|84
449917|NCT00391092|1485635|P1|Overall Study|Alive in follow-up|88
449918|NCT00391092|1485634|P2|Overall Study|Alive on treatment|33
449919|NCT00391092|1485635|P1|Overall Study|Alive on treatment|29
449920|NCT00391092|1485634|P2|Overall Study|Lost to Follow-up|18
449921|NCT00391092|1485635|P1|Overall Study|Lost to Follow-up|13
449922|NCT00391092|1485634|P2|Overall Study|Death|81
449923|NCT00391092|1485635|P1|Overall Study|Death|78
449924|NCT00391053|1485678|P4|Overall Study|Withdrawal by Subject|1
449925|NCT00391053|1485679|P3|Overall Study|Withdrawal by Subject|1
449926|NCT00391053|1485680|P2|Overall Study|Withdrawal by Subject|1
449927|NCT00391053|1485681|P1|Overall Study|Withdrawal by Subject|5
449928|NCT00391053|1485678|P4|Overall Study|Lost to Follow-up|5
449929|NCT00391053|1485679|P3|Overall Study|Lost to Follow-up|0
449930|NCT00391053|1485680|P2|Overall Study|Lost to Follow-up|0
449931|NCT00391053|1485681|P1|Overall Study|Lost to Follow-up|1
449932|NCT00391053|1485678|P4|Overall Study|Protocol Violation|0
449933|NCT00391053|1485679|P3|Overall Study|Protocol Violation|0
449934|NCT00391053|1485680|P2|Overall Study|Protocol Violation|0
449935|NCT00391053|1485681|P1|Overall Study|Protocol Violation|2
449936|NCT00391053|1485678|P4|Overall Study|Serious Adverse Events|4
449937|NCT00391053|1485679|P3|Overall Study|Serious Adverse Events|1
449938|NCT00391053|1485680|P2|Overall Study|Serious Adverse Events|0
449939|NCT00391053|1485681|P1|Overall Study|Serious Adverse Events|1
449940|NCT00391027|1485705|P2|Overall Study|Other|3
449941|NCT00391027|1485706|P1|Overall Study|Other|4
449942|NCT00391027|1485705|P2|Overall Study|Withdrawal by Subject|1
449943|NCT00391027|1485706|P1|Overall Study|Withdrawal by Subject|10
449944|NCT00391027|1485705|P2|Overall Study|Lack of Efficacy|0
449945|NCT00391027|1485706|P1|Overall Study|Lack of Efficacy|3
449946|NCT00391027|1485705|P2|Overall Study|Adverse Event|8
449947|NCT00391027|1485706|P1|Overall Study|Adverse Event|8
449948|NCT00390884|1485746|P2|Overall Study|Withdrawal by Subject|2
449949|NCT00390884|1485747|P1|Overall Study|Withdrawal by Subject|2
449950|NCT00390858|1485759|P2|Overall Study|Withdrawal by Subject|4
449951|NCT00390858|1485760|P1|Overall Study|Withdrawal by Subject|3
449952|NCT00390858|1485759|P2|Overall Study|Lack of Efficacy|1
449953|NCT00390858|1485760|P1|Overall Study|Lack of Efficacy|0
449954|NCT00390858|1485759|P2|Overall Study|Adverse Event|2
449955|NCT00390858|1485760|P1|Overall Study|Adverse Event|6
449956|NCT00390806|1485774|P2|Overall Study|Ongoing|2
449957|NCT00390806|1485775|P1|Overall Study|Ongoing|4
449958|NCT00390806|1485774|P2|Overall Study|Physician Decision|1
449959|NCT00390806|1485775|P1|Overall Study|Physician Decision|0
449960|NCT00390806|1485774|P2|Overall Study|Death|0
449961|NCT00390806|1485775|P1|Overall Study|Death|1
449962|NCT00390806|1485774|P2|Overall Study|Investigator Decision|6
449963|NCT00390806|1485775|P1|Overall Study|Investigator Decision|4
449964|NCT00390806|1485774|P2|Overall Study|Withdrawal by Subject|15
449965|NCT00390806|1485775|P1|Overall Study|Withdrawal by Subject|12
449966|NCT00390806|1485774|P2|Overall Study|Protocol Violation|2
449967|NCT00390806|1485775|P1|Overall Study|Protocol Violation|2
449968|NCT00390806|1485774|P2|Overall Study|Lost to Follow-up|6
449969|NCT00390806|1485775|P1|Overall Study|Lost to Follow-up|7
449970|NCT00390780|1485843|P2|Overall Study|SAE, death|1
449971|NCT00390780|1485844|P1|Overall Study|SAE, death|0
449972|NCT00390780|1485843|P2|Overall Study|Investigator decision, SAE, other reason|1
449973|NCT00390780|1485844|P1|Overall Study|Investigator decision, SAE, other reason|0
449974|NCT00390780|1485843|P2|Overall Study|Lost to follow up and other reasons|1
449975|NCT00390780|1485844|P1|Overall Study|Lost to follow up and other reasons|0
449976|NCT00390780|1485843|P2|Overall Study|Inclusion criteria not satisfied|2
449977|NCT00390780|1485844|P1|Overall Study|Inclusion criteria not satisfied|0
449978|NCT00390780|1485843|P2|Overall Study|Withdrawal by Subject|2
449979|NCT00390780|1485844|P1|Overall Study|Withdrawal by Subject|1
449980|NCT00390780|1485843|P2|Overall Study|Death|3
449981|NCT00390780|1485844|P1|Overall Study|Death|1
449982|NCT00390780|1485843|P2|Overall Study|Adverse Event|3
449983|NCT00390780|1485844|P1|Overall Study|Adverse Event|2
449984|NCT00390780|1485843|P2|Overall Study|Lost to Follow-up|6
449985|NCT00390780|1485844|P1|Overall Study|Lost to Follow-up|3
449986|NCT00390780|1485843|P2|Overall Study|Protocol Violation|4
449987|NCT00390780|1485844|P1|Overall Study|Protocol Violation|6
449988|NCT00390780|1485843|P2|Overall Study|Not completed|4
449989|NCT00390780|1485844|P1|Overall Study|Not completed|10
449990|NCT00390689|1485877|P3|Overall Study|Investigator's judgement|0
449991|NCT00390689|1485878|P2|Overall Study|Investigator's judgement|0
449992|NCT00390689|1485879|P1|Overall Study|Investigator's judgement|2
449993|NCT00390689|1485877|P3|Overall Study|Protocol Violation|0
449994|NCT00390689|1485878|P2|Overall Study|Protocol Violation|0
449995|NCT00390689|1485879|P1|Overall Study|Protocol Violation|1
449996|NCT00390689|1485877|P3|Overall Study|Lack of Efficacy|1
449997|NCT00390689|1485878|P2|Overall Study|Lack of Efficacy|0
449998|NCT00390689|1485879|P1|Overall Study|Lack of Efficacy|0
449999|NCT00390689|1485877|P3|Overall Study|Adverse Event|2
450000|NCT00390689|1485878|P2|Overall Study|Adverse Event|5
450001|NCT00390689|1485879|P1|Overall Study|Adverse Event|2
450002|NCT00390572|1485954|P2|Overall Study|health condition|1
450003|NCT00390572|1485955|P1|Overall Study|health condition|0
450004|NCT00390572|1485954|P2|Overall Study|Lost to Follow-up|4
450005|NCT00390572|1485955|P1|Overall Study|Lost to Follow-up|8
450006|NCT00390546|1485981|P2|Overall Study|Physician Decision|5
450007|NCT00390546|1485982|P1|Overall Study|Physician Decision|5
450008|NCT00390546|1485981|P2|Overall Study|Renal impairment|0
450009|NCT00390546|1485982|P1|Overall Study|Renal impairment|1
450010|NCT00390468|1485992|P1|Overall Study|Lack of Efficacy|1
450011|NCT00390468|1485992|P1|Overall Study|Protocol Violation|2
450012|NCT00390455|1485998|P2|Overall Study|Other Medical Reasons|11
450013|NCT00390455|1485999|P1|Overall Study|Other Medical Reasons|7
450014|NCT00390455|1485998|P2|Overall Study|Alternate Treatment|1
450015|NCT00390455|1485999|P1|Overall Study|Alternate Treatment|0
450016|NCT00390455|1485998|P2|Overall Study|Withdrawal by Subject|8
450017|NCT00390455|1485999|P1|Overall Study|Withdrawal by Subject|8
450018|NCT00390455|1485998|P2|Overall Study|Adverse Event|3
450019|NCT00390455|1485999|P1|Overall Study|Adverse Event|17
450020|NCT00390416|1486039|P1|Overall Study|Not treated|3
450021|NCT00390416|1486039|P1|Overall Study|Withdrawal by Subject|1
450022|NCT00390221|1486060|P3|Overall Study|Not Specified|2
450023|NCT00390221|1486061|P2|Overall Study|Not Specified|4
450024|NCT00390221|1486062|P1|Overall Study|Not Specified|3
450025|NCT00390221|1486060|P3|Overall Study|Subject Non-compliance|2
450026|NCT00390221|1486061|P2|Overall Study|Subject Non-compliance|0
450027|NCT00390221|1486062|P1|Overall Study|Subject Non-compliance|1
450028|NCT00390221|1486060|P3|Overall Study|Withdrawal by Subject|7
450029|NCT00390221|1486061|P2|Overall Study|Withdrawal by Subject|9
450030|NCT00390221|1486062|P1|Overall Study|Withdrawal by Subject|13
450031|NCT00390221|1486060|P3|Overall Study|Investigator Decision|1
450032|NCT00390221|1486061|P2|Overall Study|Investigator Decision|0
450033|NCT00390221|1486062|P1|Overall Study|Investigator Decision|0
450034|NCT00390221|1486060|P3|Overall Study|Adverse Event|3
450035|NCT00390221|1486061|P2|Overall Study|Adverse Event|4
450036|NCT00390221|1486062|P1|Overall Study|Adverse Event|1
450037|NCT00390221|1486060|P3|Overall Study|Lost to Follow-up|0
450038|NCT00390221|1486061|P2|Overall Study|Lost to Follow-up|3
450039|NCT00390221|1486062|P1|Overall Study|Lost to Follow-up|0
450040|NCT00390013|1486092|P4|Phase 2 First Treatment|Withdrawal by Subject|0
450041|NCT00390013|1486093|P3|Phase 2 First Treatment|Withdrawal by Subject|0
450042|NCT00390013|1486094|P2|Phase 2 First Treatment|Withdrawal by Subject|1
450043|NCT00390013|1486095|P1|Phase 2 First Treatment|Withdrawal by Subject|0
450044|NCT00390013|1486092|P4|Phase 2 First Treatment|tired|0
450045|NCT00390013|1486093|P3|Phase 2 First Treatment|tired|0
450046|NCT00390013|1486094|P2|Phase 2 First Treatment|tired|0
450047|NCT00390013|1486095|P1|Phase 2 First Treatment|tired|1
450048|NCT00390013|1486092|P4|Phase 1|tired|1
450049|NCT00390013|1486093|P3|Phase 1|tired|0
450050|NCT00390013|1486094|P2|Phase 1|tired|0
450051|NCT00390013|1486095|P1|Phase 1|tired|0
450052|NCT00389831|1486120|P2|Overall Study|Lost to Follow-up|1
450053|NCT00389831|1486121|P1|Overall Study|Lost to Follow-up|0
450054|NCT00389831|1486120|P2|Overall Study|Other reasons|2
450055|NCT00389831|1486121|P1|Overall Study|Other reasons|0
450056|NCT00389831|1486120|P2|Overall Study|Did not receive treatment.|2
450057|NCT00389831|1486121|P1|Overall Study|Did not receive treatment.|0
450058|NCT00389831|1486120|P2|Overall Study|Lack of Efficacy|2
450059|NCT00389831|1486121|P1|Overall Study|Lack of Efficacy|0
450060|NCT00389597|1486184|P4|Overall Study|Lost to Follow-up|6
450061|NCT00389597|1486185|P3|Overall Study|Lost to Follow-up|4
450062|NCT00389597|1486186|P2|Overall Study|Lost to Follow-up|6
450063|NCT00389597|1486187|P1|Overall Study|Lost to Follow-up|8
450064|NCT00389519|1486212|P4|Treated|Reason not specified|2
450065|NCT00389519|1486213|P3|Treated|Reason not specified|0
450066|NCT00389519|1486214|P2|Treated|Reason not specified|1
450067|NCT00389519|1486215|P1|Treated|Reason not specified|1
450068|NCT00389519|1486212|P4|Treated|Adverse Event|2
450069|NCT00389519|1486213|P3|Treated|Adverse Event|0
450070|NCT00389519|1486214|P2|Treated|Adverse Event|0
450071|NCT00389519|1486215|P1|Treated|Adverse Event|1
450072|NCT00389519|1486212|P4|Randomized|Did not receive study drug|0
450073|NCT00389519|1486213|P3|Randomized|Did not receive study drug|0
450074|NCT00389519|1486214|P2|Randomized|Did not receive study drug|0
450075|NCT00389519|1486215|P1|Randomized|Did not receive study drug|2
450076|NCT00389519|1486212|P4|Placebo Run-In|Reason not specified|0
450077|NCT00389519|1486213|P3|Placebo Run-In|Reason not specified|0
450078|NCT00389519|1486214|P2|Placebo Run-In|Reason not specified|0
450079|NCT00389519|1486215|P1|Placebo Run-In|Reason not specified|40
450080|NCT00389519|1486212|P4|Placebo Run-In|Withdrawal by Subject|0
450081|NCT00389519|1486213|P3|Placebo Run-In|Withdrawal by Subject|0
450082|NCT00389519|1486214|P2|Placebo Run-In|Withdrawal by Subject|0
450083|NCT00389519|1486215|P1|Placebo Run-In|Withdrawal by Subject|19
450084|NCT00389519|1486212|P4|Placebo Run-In|Did not meet blood pressure criteria|0
450085|NCT00389519|1486213|P3|Placebo Run-In|Did not meet blood pressure criteria|0
450086|NCT00389519|1486214|P2|Placebo Run-In|Did not meet blood pressure criteria|0
450087|NCT00389519|1486215|P1|Placebo Run-In|Did not meet blood pressure criteria|119
450088|NCT00389441|1486292|P1|Overall Study|Clinical progression|1
450089|NCT00389441|1486292|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
450090|NCT00389441|1486292|P1|Overall Study|Objective progression or relapse|26
450091|NCT00389441|1486292|P1|Overall Study|Global deterioration of health status|4
450092|NCT00389441|1486292|P1|Overall Study|Protocol Violation|1
450093|NCT00389441|1486292|P1|Overall Study|Physician Decision|1
450094|NCT00389441|1486292|P1|Overall Study|Withdrawal by Subject|4
450095|NCT00389441|1486292|P1|Overall Study|Lost to Follow-up|2
450096|NCT00389441|1486292|P1|Overall Study|Death|4
450097|NCT00389441|1486292|P1|Overall Study|Adverse Event|7
450098|NCT00389324|1486301|P1|Subcutaneous Phase|Lost to Follow-up|1
450099|NCT00389324|1486301|P1|Subcutaneous Phase|Withdrawal by Subject|2
450100|NCT00389324|1486301|P1|Subcutaneous Phase|Non-compliance with study medication|2
450101|NCT00389324|1486301|P1|Subcutaneous Phase|Adverse Event|2
450102|NCT00389324|1486301|P1|Run-In Phase|Withdrawal by Subject|1
450103|NCT00389324|1486301|P1|Run-In Phase|Lost to Follow-up|1
450104|NCT00389324|1486301|P1|Run-In Phase|Adverse Event|1
450105|NCT00389207|1486311|P3|Overall Study|Not specified|9
450106|NCT00389207|1486312|P2|Overall Study|Not specified|23
450107|NCT00389207|1486313|P1|Overall Study|Not specified|17
450108|NCT00389207|1486311|P3|Overall Study|Withdrawal by Subject|11
450109|NCT00389207|1486312|P2|Overall Study|Withdrawal by Subject|7
450110|NCT00389207|1486313|P1|Overall Study|Withdrawal by Subject|5
450111|NCT00389207|1486311|P3|Overall Study|Lost to Follow-up|7
450112|NCT00389207|1486312|P2|Overall Study|Lost to Follow-up|9
450113|NCT00389207|1486313|P1|Overall Study|Lost to Follow-up|12
450114|NCT00389207|1486311|P3|Overall Study|Protocol Violation|4
450115|NCT00389207|1486312|P2|Overall Study|Protocol Violation|1
450116|NCT00389207|1486313|P1|Overall Study|Protocol Violation|3
450117|NCT00389207|1486311|P3|Overall Study|Adverse Event|10
450118|NCT00389207|1486312|P2|Overall Study|Adverse Event|32
450119|NCT00389207|1486313|P1|Overall Study|Adverse Event|26
450120|NCT00389064|1486436|P2|Overall Study|Multiple Reasons|11
450121|NCT00389064|1486437|P1|Overall Study|Multiple Reasons|9
450122|NCT00389064|1486436|P2|Overall Study|Protocol Violation|0
450123|NCT00389064|1486437|P1|Overall Study|Protocol Violation|2
450124|NCT00389064|1486436|P2|Overall Study|Lost to Follow-up|2
450125|NCT00389064|1486437|P1|Overall Study|Lost to Follow-up|1
450126|NCT00389064|1486436|P2|Overall Study|Physician Decision|2
450127|NCT00389064|1486437|P1|Overall Study|Physician Decision|2
450128|NCT00389064|1486436|P2|Overall Study|Withdrawal by Subject|27
450129|NCT00389064|1486437|P1|Overall Study|Withdrawal by Subject|17
450130|NCT00389064|1486436|P2|Overall Study|Lack of Efficacy|14
450131|NCT00389064|1486437|P1|Overall Study|Lack of Efficacy|3
450132|NCT00389064|1486436|P2|Overall Study|Adverse Event|3
450133|NCT00389064|1486437|P1|Overall Study|Adverse Event|11
450222|NCT00387764|1486663|P1|Overall Study|Adverse Event|12
450134|NCT00388973|1486465|P2|Overall Study|Did not complete 2-week follow-up visit|17
450135|NCT00388973|1486466|P1|Overall Study|Did not complete 2-week follow-up visit|17
450136|NCT00388973|1486465|P2|Overall Study|Left region|1
450137|NCT00388973|1486466|P1|Overall Study|Left region|0
450138|NCT00388973|1486465|P2|Overall Study|Did not complete 61 days of treatment|4
450139|NCT00388973|1486466|P1|Overall Study|Did not complete 61 days of treatment|5
450140|NCT00388973|1486465|P2|Overall Study|Study specific Discontinuation Criteria|1
450141|NCT00388973|1486466|P1|Overall Study|Study specific Discontinuation Criteria|0
450142|NCT00388973|1486465|P2|Overall Study|Withdrawal by Subject|17
450143|NCT00388973|1486466|P1|Overall Study|Withdrawal by Subject|14
450144|NCT00388973|1486465|P2|Overall Study|Protocol Violation|0
450145|NCT00388973|1486466|P1|Overall Study|Protocol Violation|3
450146|NCT00388973|1486465|P2|Overall Study|Lack of Efficacy|12
450147|NCT00388973|1486466|P1|Overall Study|Lack of Efficacy|1
450148|NCT00388973|1486465|P2|Overall Study|Adverse Event|6
450149|NCT00388973|1486466|P1|Overall Study|Adverse Event|16
450150|NCT00388947|1486486|P1|Overall Study|Protocol Violation|47
450151|NCT00388726|1486502|P2|Overall Study|Death|2
450152|NCT00388726|1486503|P1|Overall Study|Death|3
450153|NCT00388726|1486502|P2|Overall Study|Physician Decision|13
450154|NCT00388726|1486503|P1|Overall Study|Physician Decision|18
450155|NCT00388726|1486502|P2|Overall Study|Administrative|9
450156|NCT00388726|1486503|P1|Overall Study|Administrative|6
450157|NCT00388726|1486502|P2|Overall Study|Withdrawal by Subject|7
450158|NCT00388726|1486503|P1|Overall Study|Withdrawal by Subject|10
450159|NCT00388726|1486502|P2|Overall Study|Clinical Progression|36
450160|NCT00388726|1486503|P1|Overall Study|Clinical Progression|61
450161|NCT00388726|1486502|P2|Overall Study|Progressive Disease|153
450162|NCT00388726|1486503|P1|Overall Study|Progressive Disease|336
450163|NCT00388726|1486502|P2|Overall Study|Adverse Event|24
450164|NCT00388726|1486503|P1|Overall Study|Adverse Event|50
450165|NCT00388583|1486517|P2|Overall Study|Did not receive vaccine|1
450166|NCT00388583|1486518|P1|Overall Study|Did not receive vaccine|0
450167|NCT00388583|1486517|P2|Overall Study|Serious Adverse Event|0
450168|NCT00388583|1486518|P1|Overall Study|Serious Adverse Event|2
450169|NCT00388583|1486517|P2|Overall Study|Withdrawal by Subject|3
450170|NCT00388583|1486518|P1|Overall Study|Withdrawal by Subject|3
450171|NCT00388583|1486517|P2|Overall Study|Protocol Violation|0
450172|NCT00388583|1486518|P1|Overall Study|Protocol Violation|1
450173|NCT00388505|1486532|P2|Overall Study|Unable to classify|3
450174|NCT00388505|1486533|P1|Overall Study|Unable to classify|4
450175|NCT00388505|1486532|P2|Overall Study|Protocol Violation|5
450176|NCT00388505|1486533|P1|Overall Study|Protocol Violation|6
450177|NCT00388505|1486532|P2|Overall Study|Administrative Reason|0
450178|NCT00388505|1486533|P1|Overall Study|Administrative Reason|1
450179|NCT00388505|1486532|P2|Overall Study|Inappropriate Enrollment|1
450180|NCT00388505|1486533|P1|Overall Study|Inappropriate Enrollment|0
450181|NCT00388505|1486532|P2|Overall Study|Lost to Follow-up|3
450182|NCT00388505|1486533|P1|Overall Study|Lost to Follow-up|5
450183|NCT00388505|1486532|P2|Overall Study|Withdrawal by Subject|9
450184|NCT00388505|1486533|P1|Overall Study|Withdrawal by Subject|24
450185|NCT00388505|1486532|P2|Overall Study|Adverse Event or Death|17
450186|NCT00388505|1486533|P1|Overall Study|Adverse Event or Death|43
450187|NCT00388362|1486588|P1|Remained on Study Median of 514 Days|Death|2
450188|NCT00388362|1486588|P1|Enrolled|Withdrawal by Subject|1
450189|NCT00388362|1486588|P1|Enrolled|Loss insurance|1
450190|NCT00388362|1486588|P1|Enrolled|Death|1
450191|NCT00388362|1486588|P1|Enrolled|Adverse Event|9
450192|NCT00388362|1486588|P1|Enrolled|Ineligible|1
450193|NCT00388349|1486593|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
450194|NCT00388349|1486594|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
450195|NCT00388154|1486603|P1|Overall Study|Withdrawal by Subject|1
450196|NCT00388037|1486608|P1|Overall Study|Protocol Violation|1
450197|NCT00387894|1486616|P1|Overall Study|Withdrawal by Subject|1
450198|NCT00387881|1486623|P2|Overall Study|Not otherwise specified|7
450199|NCT00387881|1486624|P1|Overall Study|Not otherwise specified|11
450200|NCT00387881|1486623|P2|Overall Study|No opportunity to treat headache|34
450201|NCT00387881|1486624|P1|Overall Study|No opportunity to treat headache|32
450202|NCT00387881|1486623|P2|Overall Study|Not eligible|7
450203|NCT00387881|1486624|P1|Overall Study|Not eligible|6
450204|NCT00387881|1486623|P2|Overall Study|Sponsor terminated Study|1
450205|NCT00387881|1486624|P1|Overall Study|Sponsor terminated Study|0
450206|NCT00387881|1486623|P2|Overall Study|Withdrawal by Subject|18
450207|NCT00387881|1486624|P1|Overall Study|Withdrawal by Subject|15
450208|NCT00387881|1486623|P2|Overall Study|Protocol Violation|12
450209|NCT00387881|1486624|P1|Overall Study|Protocol Violation|2
450210|NCT00387881|1486623|P2|Overall Study|Lost to Follow-up|23
450211|NCT00387881|1486624|P1|Overall Study|Lost to Follow-up|23
450212|NCT00387790|1486657|P1|Overall Study|Ineligible for study|2
450213|NCT00387790|1486657|P1|Overall Study|Withdrawal by Subject|3
450214|NCT00387790|1486657|P1|Overall Study|Physician Decision|2
450215|NCT00387790|1486657|P1|Overall Study|Lack of Efficacy|2
450216|NCT00387790|1486657|P1|Overall Study|Adverse Event|5
450217|NCT00387764|1486663|P1|Overall Study|Death|7
450218|NCT00387764|1486663|P1|Overall Study|Other|2
450219|NCT00387764|1486663|P1|Overall Study|Physician Decision|1
450220|NCT00387764|1486663|P1|Overall Study|Sponsor Terminated Study|1
450221|NCT00387764|1486663|P1|Overall Study|Withdrawal by Subject|8
450223|NCT00387725|1486691|P4|Overall Study|Parent/legal guardian request|1
450224|NCT00387725|1486692|P3|Overall Study|Parent/legal guardian request|1
450225|NCT00387725|1486693|P2|Overall Study|Parent/legal guardian request|0
450226|NCT00387725|1486694|P1|Overall Study|Parent/legal guardian request|0
450227|NCT00387725|1486691|P4|Overall Study|Withdrawal by Subject|0
450228|NCT00387725|1486692|P3|Overall Study|Withdrawal by Subject|1
450229|NCT00387725|1486693|P2|Overall Study|Withdrawal by Subject|0
450230|NCT00387725|1486694|P1|Overall Study|Withdrawal by Subject|1
450231|NCT00387725|1486691|P4|Overall Study|Protocol Violation|0
450232|NCT00387725|1486692|P3|Overall Study|Protocol Violation|0
450233|NCT00387725|1486693|P2|Overall Study|Protocol Violation|1
450234|NCT00387725|1486694|P1|Overall Study|Protocol Violation|0
450235|NCT00387725|1486691|P4|Overall Study|Adverse Event|1
450236|NCT00387725|1486692|P3|Overall Study|Adverse Event|0
450237|NCT00387725|1486693|P2|Overall Study|Adverse Event|0
450238|NCT00387725|1486694|P1|Overall Study|Adverse Event|0
450239|NCT00387712|1486714|P2|Overall Study|Withdrawal by Subject|12
450240|NCT00387712|1486715|P1|Overall Study|Withdrawal by Subject|6
450241|NCT00387712|1486714|P2|Overall Study|Lost to Follow-up|20
450242|NCT00387712|1486715|P1|Overall Study|Lost to Follow-up|17
450243|NCT00387712|1486714|P2|Overall Study|Physician Decision|4
450244|NCT00387712|1486715|P1|Overall Study|Physician Decision|6
450245|NCT00387647|1486746|P1|Overall Study|Death|18
450246|NCT00387426|1486786|P1|Overall Study|Disease Progression|3
450247|NCT00387426|1486786|P1|Overall Study|Toxicities|4
450248|NCT00387426|1486786|P1|Overall Study|Lack of Response|7
450249|NCT00387348|1486793|P3|Overall Study|Adverse Event|1
450250|NCT00387348|1486794|P2|Overall Study|Adverse Event|0
450251|NCT00387348|1486795|P1|Overall Study|Adverse Event|1
450252|NCT00387348|1486793|P3|Overall Study|Withdrawal by Subject|2
450253|NCT00387348|1486794|P2|Overall Study|Withdrawal by Subject|2
450254|NCT00387348|1486795|P1|Overall Study|Withdrawal by Subject|0
450255|NCT00387348|1486793|P3|Overall Study|Physician Decision|1
450256|NCT00387348|1486794|P2|Overall Study|Physician Decision|0
450257|NCT00387348|1486795|P1|Overall Study|Physician Decision|1
450258|NCT00387348|1486793|P3|Overall Study|Death|0
450259|NCT00387348|1486794|P2|Overall Study|Death|1
450260|NCT00387348|1486795|P1|Overall Study|Death|1
450261|NCT00387153|1486824|P1|Overall Study|Lack of Response|4
450262|NCT00387153|1486824|P1|Overall Study|Disease Progression|3
450263|NCT00387153|1486824|P1|Overall Study|Adverse Event|1
450264|NCT00387127|1486830|P2|Overall Study|Sponsor Unblinded|0
450265|NCT00387127|1486831|P1|Overall Study|Sponsor Unblinded|1
450266|NCT00387127|1486830|P2|Overall Study|Serious Adverse Event|1
450267|NCT00387127|1486831|P1|Overall Study|Serious Adverse Event|1
450268|NCT00387127|1486830|P2|Overall Study|Required by Protocol Amendment #4|10
450269|NCT00387127|1486831|P1|Overall Study|Required by Protocol Amendment #4|12
450270|NCT00387127|1486830|P2|Overall Study|Withdrawal by Subject|2
450271|NCT00387127|1486831|P1|Overall Study|Withdrawal by Subject|3
450272|NCT00387127|1486830|P2|Overall Study|Physician Decision|1
450273|NCT00387127|1486831|P1|Overall Study|Physician Decision|0
450274|NCT00387127|1486830|P2|Overall Study|Death|16
450275|NCT00387127|1486831|P1|Overall Study|Death|16
450276|NCT00387127|1486830|P2|Overall Study|Lost to Follow-up|4
450277|NCT00387127|1486831|P1|Overall Study|Lost to Follow-up|0
450278|NCT00387088|1486873|P2|Overall Study|Other|52
450279|NCT00387088|1486874|P1|Overall Study|Other|58
450280|NCT00387088|1486873|P2|Overall Study|Lost to Follow-up|28
450281|NCT00387088|1486874|P1|Overall Study|Lost to Follow-up|22
450282|NCT00387088|1486873|P2|Overall Study|Lack of Efficacy|67
450283|NCT00387088|1486874|P1|Overall Study|Lack of Efficacy|28
450284|NCT00387088|1486873|P2|Overall Study|Withdrawal by Subject|35
450285|NCT00387088|1486874|P1|Overall Study|Withdrawal by Subject|20
450286|NCT00387088|1486873|P2|Overall Study|Protocol Violation|35
450287|NCT00387088|1486874|P1|Overall Study|Protocol Violation|47
450288|NCT00387088|1486873|P2|Overall Study|Adverse Event|156
450289|NCT00387088|1486874|P1|Overall Study|Adverse Event|143
450290|NCT00387010|1486931|P1|Treatment Period|Participant reported study drug stolen|1
450291|NCT00387010|1486931|P1|Treatment Period|Noncompliance with study procedures|3
450292|NCT00387010|1486931|P1|Treatment Period|Noncompliance with study medication|2
450293|NCT00387010|1486931|P1|Treatment Period|Withdrawal by Subject|1
450294|NCT00387010|1486931|P1|Treatment Period|Adverse Event|4
450295|NCT00387010|1486931|P1|Dose Titration Period|Noncompliance with study procedures|7
450296|NCT00387010|1486931|P1|Dose Titration Period|Noncompliance with study medication|8
450297|NCT00387010|1486931|P1|Dose Titration Period|Lost to Follow-up|2
450298|NCT00387010|1486931|P1|Dose Titration Period|Protocol Violation|1
450299|NCT00387010|1486931|P1|Dose Titration Period|Withdrawal by Subject|3
450300|NCT00387010|1486931|P1|Dose Titration Period|Lack of Efficacy|5
450301|NCT00387010|1486931|P1|Dose Titration Period|Adverse Event|12
450302|NCT00386776|1486958|P1|Overall Study|Withdrawal by Subject|8
450303|NCT00386607|1486968|P2|Extension|Unsatisfactory therapeutic effect|1
450304|NCT00386607|1486969|P1|Extension|Unsatisfactory therapeutic effect|0
450305|NCT00386607|1486968|P2|Extension|Patient withdrew consent|5
450306|NCT00386607|1486969|P1|Extension|Patient withdrew consent|0
450307|NCT00386607|1486968|P2|Extension|Lost to Follow-up|3
450308|NCT00386607|1486969|P1|Extension|Lost to Follow-up|0
450309|NCT00386607|1486968|P2|Extension|Administrative problems|1
450310|NCT00386607|1486969|P1|Extension|Administrative problems|0
450311|NCT00386607|1486968|P2|Extension|Abnormal laboratory value(s)|1
450312|NCT00386607|1486969|P1|Extension|Abnormal laboratory value(s)|0
450313|NCT00386607|1486968|P2|Extension|Adverse Event|6
450314|NCT00386607|1486969|P1|Extension|Adverse Event|0
450315|NCT00386607|1486968|P2|Core|Protocol Deviation|0
450316|NCT00386607|1486969|P1|Core|Protocol Deviation|6
450317|NCT00386607|1486968|P2|Core|Administrative problems|0
450318|NCT00386607|1486969|P1|Core|Administrative problems|1
450319|NCT00386607|1486968|P2|Core|Lost to Follow-up|0
450320|NCT00386607|1486969|P1|Core|Lost to Follow-up|23
450321|NCT00386607|1486968|P2|Core|Patient withdrew consent|0
450322|NCT00386607|1486969|P1|Core|Patient withdrew consent|15
450323|NCT00386607|1486968|P2|Core|Condition no longer requires study drug|0
450324|NCT00386607|1486969|P1|Core|Condition no longer requires study drug|4
450325|NCT00386607|1486968|P2|Core|Unsatisfactory therapeutic effect|0
450326|NCT00386607|1486969|P1|Core|Unsatisfactory therapeutic effect|23
450327|NCT00386607|1486968|P2|Core|Abnormal laboratory value(s)|0
450328|NCT00386607|1486969|P1|Core|Abnormal laboratory value(s)|3
450329|NCT00386607|1486968|P2|Core|Adverse Event|0
450330|NCT00386607|1486969|P1|Core|Adverse Event|40
450331|NCT00386425|1486997|P3|Overall Study|Withdrawal by Subject|0
450332|NCT00386425|1486998|P2|Overall Study|Withdrawal by Subject|1
450333|NCT00386425|1486999|P1|Overall Study|Withdrawal by Subject|0
450334|NCT00386425|1486997|P3|Overall Study|Physician Decision|0
450335|NCT00386425|1486998|P2|Overall Study|Physician Decision|0
450336|NCT00386425|1486999|P1|Overall Study|Physician Decision|3
450337|NCT00386360|1487025|P2|Overall Study|Did not take any study medication|2
450338|NCT00386360|1487026|P1|Overall Study|Did not take any study medication|0
450339|NCT00386360|1487025|P2|Overall Study|Withdrawal by Subject|6
450340|NCT00386360|1487026|P1|Overall Study|Withdrawal by Subject|3
450341|NCT00386360|1487025|P2|Overall Study|Protocol Violation|3
450342|NCT00386360|1487026|P1|Overall Study|Protocol Violation|0
450343|NCT00386360|1487025|P2|Overall Study|Lost to Follow-up|2
450344|NCT00386360|1487026|P1|Overall Study|Lost to Follow-up|0
450345|NCT00386360|1487025|P2|Overall Study|Physician Decision|2
450346|NCT00386360|1487026|P1|Overall Study|Physician Decision|2
450347|NCT00386360|1487025|P2|Overall Study|Adverse Event|2
450348|NCT00386360|1487026|P1|Overall Study|Adverse Event|4
450349|NCT00386334|1487060|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
450350|NCT00386334|1487061|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
450351|NCT00386334|1487060|P2|Double Blind Period|Other|3
450352|NCT00386334|1487061|P1|Double Blind Period|Other|3
450353|NCT00386334|1487060|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
450354|NCT00386334|1487061|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
450355|NCT00386334|1487060|P2|Double Blind Period|Lack of Efficacy|11
450356|NCT00386334|1487061|P1|Double Blind Period|Lack of Efficacy|20
450357|NCT00386334|1487060|P2|Double Blind Period|Withdrawal by Subject|13
450358|NCT00386334|1487061|P1|Double Blind Period|Withdrawal by Subject|9
450359|NCT00386334|1487060|P2|Double Blind Period|Protocol Violation|1
450360|NCT00386334|1487061|P1|Double Blind Period|Protocol Violation|1
450361|NCT00386334|1487060|P2|Double Blind Period|Adverse Event|14
450362|NCT00386334|1487061|P1|Double Blind Period|Adverse Event|9
450363|NCT00386308|1487205|P2|Overall Study|Other Event|1
450364|NCT00386308|1487206|P1|Overall Study|Other Event|8
450365|NCT00386308|1487205|P2|Overall Study|Withdrawal by Subject|2
450366|NCT00386308|1487206|P1|Overall Study|Withdrawal by Subject|6
450367|NCT00386308|1487205|P2|Overall Study|Lost to Follow-up|6
450368|NCT00386308|1487206|P1|Overall Study|Lost to Follow-up|10
450369|NCT00386308|1487205|P2|Overall Study|Lack of Efficacy|2
450370|NCT00386308|1487206|P1|Overall Study|Lack of Efficacy|0
450371|NCT00386308|1487205|P2|Overall Study|Protocol Violation|5
450372|NCT00386308|1487206|P1|Overall Study|Protocol Violation|2
450373|NCT00386308|1487205|P2|Overall Study|Adverse Event|3
450374|NCT00386308|1487206|P1|Overall Study|Adverse Event|3
450375|NCT00386152|1487253|P3|Overall Study|Withdrawal by Subject|10
450376|NCT00386152|1487254|P2|Overall Study|Withdrawal by Subject|6
450377|NCT00386152|1487255|P1|Overall Study|Withdrawal by Subject|3
450378|NCT00386152|1487253|P3|Overall Study|Protocol Violation|2
450379|NCT00386152|1487254|P2|Overall Study|Protocol Violation|5
450380|NCT00386152|1487255|P1|Overall Study|Protocol Violation|3
450381|NCT00386152|1487253|P3|Overall Study|Completed chemotherapy|1
450382|NCT00386152|1487254|P2|Overall Study|Completed chemotherapy|5
450383|NCT00386152|1487255|P1|Overall Study|Completed chemotherapy|4
450384|NCT00386152|1487253|P3|Overall Study|Lost to Follow-up|0
450385|NCT00386152|1487254|P2|Overall Study|Lost to Follow-up|0
450386|NCT00386152|1487255|P1|Overall Study|Lost to Follow-up|1
450387|NCT00386152|1487253|P3|Overall Study|Physician Decision|4
450388|NCT00386152|1487254|P2|Overall Study|Physician Decision|10
450389|NCT00386152|1487255|P1|Overall Study|Physician Decision|13
450390|NCT00386152|1487253|P3|Overall Study|Disease progression|5
450391|NCT00386152|1487254|P2|Overall Study|Disease progression|4
450392|NCT00386152|1487255|P1|Overall Study|Disease progression|7
450393|NCT00386152|1487253|P3|Overall Study|Death|1
450394|NCT00386152|1487254|P2|Overall Study|Death|0
450395|NCT00386152|1487255|P1|Overall Study|Death|3
450396|NCT00386152|1487253|P3|Overall Study|Chang from original chemo stratification|6
450397|NCT00386152|1487254|P2|Overall Study|Chang from original chemo stratification|5
450648|NCT00385203|1487937|P2|Overall Study|Adverse Event|4
450398|NCT00386152|1487255|P1|Overall Study|Chang from original chemo stratification|4
450399|NCT00386152|1487253|P3|Overall Study|Adverse Event|4
450400|NCT00386152|1487254|P2|Overall Study|Adverse Event|5
450401|NCT00386152|1487255|P1|Overall Study|Adverse Event|6
450402|NCT00386100|1487274|P2|Overall Study|Participant randomized in error|0
450403|NCT00386100|1487275|P1|Overall Study|Participant randomized in error|1
450404|NCT00386100|1487274|P2|Overall Study|Hb1Ac >8%|1
450405|NCT00386100|1487275|P1|Overall Study|Hb1Ac >8%|0
450406|NCT00386100|1487274|P2|Overall Study|Out of country for 5 months|0
450407|NCT00386100|1487275|P1|Overall Study|Out of country for 5 months|1
450408|NCT00386100|1487274|P2|Overall Study|Positive pregnancy test|3
450409|NCT00386100|1487275|P1|Overall Study|Positive pregnancy test|1
450410|NCT00386100|1487274|P2|Overall Study|Osteoporosis|1
450411|NCT00386100|1487275|P1|Overall Study|Osteoporosis|0
450412|NCT00386100|1487274|P2|Overall Study|7.6% bone loss|0
450413|NCT00386100|1487275|P1|Overall Study|7.6% bone loss|1
450414|NCT00386100|1487274|P2|Overall Study|DBP 93 mmHg at randomization|0
450415|NCT00386100|1487275|P1|Overall Study|DBP 93 mmHg at randomization|1
450416|NCT00386100|1487274|P2|Overall Study|Bone loss by DXA bone scan|0
450417|NCT00386100|1487275|P1|Overall Study|Bone loss by DXA bone scan|1
450418|NCT00386100|1487274|P2|Overall Study|Bad metabolic control & patient security|0
450419|NCT00386100|1487275|P1|Overall Study|Bad metabolic control & patient security|1
450420|NCT00386100|1487274|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
450421|NCT00386100|1487275|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
450422|NCT00386100|1487274|P2|Overall Study|Participant's PCP wanted to stop drug|0
450423|NCT00386100|1487275|P1|Overall Study|Participant's PCP wanted to stop drug|1
450424|NCT00386100|1487274|P2|Overall Study|Didn't meet entry criteria|1
450425|NCT00386100|1487275|P1|Overall Study|Didn't meet entry criteria|1
450426|NCT00386100|1487274|P2|Overall Study|Excessive bone loss vs. baseline value|1
450427|NCT00386100|1487275|P1|Overall Study|Excessive bone loss vs. baseline value|0
450428|NCT00386100|1487274|P2|Overall Study|Participant moving out of state|0
450429|NCT00386100|1487275|P1|Overall Study|Participant moving out of state|2
450430|NCT00386100|1487274|P2|Overall Study|Participant's concern due to CPK levels|0
450431|NCT00386100|1487275|P1|Overall Study|Participant's concern due to CPK levels|1
450432|NCT00386100|1487274|P2|Overall Study|Laboratory findings|0
450433|NCT00386100|1487275|P1|Overall Study|Laboratory findings|1
450434|NCT00386100|1487274|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
450435|NCT00386100|1487275|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
450436|NCT00386100|1487274|P2|Overall Study|Consecutive elevated Hba1C|0
450437|NCT00386100|1487275|P1|Overall Study|Consecutive elevated Hba1C|1
450438|NCT00386100|1487274|P2|Overall Study|BMD <2.5|0
450439|NCT00386100|1487275|P1|Overall Study|BMD <2.5|1
450440|NCT00386100|1487274|P2|Overall Study|Bone mass density (BMD) loss >6%|4
450441|NCT00386100|1487275|P1|Overall Study|Bone mass density (BMD) loss >6%|4
450442|NCT00386100|1487274|P2|Overall Study|Withdrawal by Subject|31
450443|NCT00386100|1487275|P1|Overall Study|Withdrawal by Subject|32
450444|NCT00386100|1487274|P2|Overall Study|Protocol Violation|3
450445|NCT00386100|1487275|P1|Overall Study|Protocol Violation|5
450446|NCT00386100|1487274|P2|Overall Study|Non-compliance|19
450447|NCT00386100|1487275|P1|Overall Study|Non-compliance|18
450448|NCT00386100|1487274|P2|Overall Study|Lost to Follow-up|29
450449|NCT00386100|1487275|P1|Overall Study|Lost to Follow-up|29
450450|NCT00386100|1487274|P2|Overall Study|Insufficient therapeutic effect|6
450451|NCT00386100|1487275|P1|Overall Study|Insufficient therapeutic effect|30
450452|NCT00386100|1487274|P2|Overall Study|Death|1
450453|NCT00386100|1487275|P1|Overall Study|Death|0
450454|NCT00386100|1487274|P2|Overall Study|Adverse Event|25
450455|NCT00386100|1487275|P1|Overall Study|Adverse Event|15
450456|NCT00386100|1487274|P2|Overall Study|Did not receive study medication|4
450457|NCT00386100|1487275|P1|Overall Study|Did not receive study medication|6
450458|NCT00386022|1487339|P2|Plus Estrogen|Adverse Event|1
450459|NCT00386022|1487340|P1|Plus Estrogen|Adverse Event|0
450460|NCT00386022|1487339|P2|Plus Estrogen|Lost to Follow-up|0
450461|NCT00386022|1487340|P1|Plus Estrogen|Lost to Follow-up|2
450462|NCT00386009|1487350|P2|Overall Study|Withdrawal by Subject|4
450463|NCT00386009|1487351|P1|Overall Study|Withdrawal by Subject|5
450464|NCT00386009|1487350|P2|Overall Study|Sponsor Decision|1
450465|NCT00386009|1487351|P1|Overall Study|Sponsor Decision|1
450466|NCT00386009|1487350|P2|Overall Study|Protocol Violation|0
450467|NCT00386009|1487351|P1|Overall Study|Protocol Violation|1
450468|NCT00386009|1487350|P2|Overall Study|Lost to Follow-up|1
450469|NCT00386009|1487351|P1|Overall Study|Lost to Follow-up|1
450470|NCT00386009|1487350|P2|Overall Study|Entry Criteria Not Met|2
450471|NCT00386009|1487351|P1|Overall Study|Entry Criteria Not Met|0
450472|NCT00386009|1487350|P2|Overall Study|Death|0
450473|NCT00386009|1487351|P1|Overall Study|Death|1
450474|NCT00386009|1487350|P2|Overall Study|Adverse Event|2
450475|NCT00386009|1487351|P1|Overall Study|Adverse Event|0
450476|NCT00385944|1487396|P3|2nd Maintenance Dose Period|Invalid PD Data|0
450477|NCT00385944|1487397|P2|2nd Maintenance Dose Period|Invalid PD Data|3
450478|NCT00385944|1487398|P1|2nd Maintenance Dose Period|Invalid PD Data|2
450479|NCT00385944|1487396|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
450480|NCT00385944|1487397|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
450481|NCT00385944|1487398|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
450482|NCT00385944|1487396|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
450483|NCT00385944|1487397|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
450484|NCT00385944|1487398|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
450485|NCT00385944|1487396|P3|1st Maintenance Dose Period|Physician Decision|0
450486|NCT00385944|1487397|P2|1st Maintenance Dose Period|Physician Decision|0
450487|NCT00385944|1487398|P1|1st Maintenance Dose Period|Physician Decision|1
450488|NCT00385918|1487441|P3|Intervention Phase After Randomization|Lost to Follow-up|0
450489|NCT00385918|1487442|P2|Intervention Phase After Randomization|Lost to Follow-up|0
450490|NCT00385918|1487443|P1|Intervention Phase After Randomization|Lost to Follow-up|1
450491|NCT00385918|1487441|P3|Intervention Phase After Randomization|Physician Decision|0
450492|NCT00385918|1487442|P2|Intervention Phase After Randomization|Physician Decision|0
450493|NCT00385918|1487443|P1|Intervention Phase After Randomization|Physician Decision|1
450494|NCT00385918|1487441|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
450495|NCT00385918|1487442|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
450496|NCT00385918|1487443|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
450497|NCT00385918|1487441|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
450498|NCT00385918|1487442|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
450499|NCT00385918|1487443|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
450500|NCT00385918|1487441|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
450501|NCT00385918|1487442|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
450502|NCT00385918|1487443|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
450503|NCT00385918|1487441|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
450504|NCT00385918|1487442|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
450505|NCT00385918|1487443|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
450506|NCT00385840|1487467|P2|Overall Study|Lost to Follow-up|13
450507|NCT00385840|1487468|P1|Overall Study|Lost to Follow-up|3
450508|NCT00385840|1487467|P2|Overall Study|Adverse Event|1
450509|NCT00385840|1487468|P1|Overall Study|Adverse Event|1
450510|NCT00385827|1487491|P3|Part 2|Other|21
450511|NCT00385827|1487492|P2|Part 2|Other|11
450512|NCT00385827|1487493|P1|Part 2|Other|0
450513|NCT00385827|1487491|P3|Part 2|Randomized but not treated|2
450514|NCT00385827|1487492|P2|Part 2|Randomized but not treated|2
450515|NCT00385827|1487493|P1|Part 2|Randomized but not treated|0
450516|NCT00385827|1487491|P3|Part 2|Lack of Efficacy|13
450517|NCT00385827|1487492|P2|Part 2|Lack of Efficacy|14
450518|NCT00385827|1487493|P1|Part 2|Lack of Efficacy|0
450519|NCT00385827|1487491|P3|Part 2|Death|2
450520|NCT00385827|1487492|P2|Part 2|Death|0
450521|NCT00385827|1487493|P1|Part 2|Death|0
450522|NCT00385827|1487491|P3|Part 2|Adverse Event|10
450523|NCT00385827|1487492|P2|Part 2|Adverse Event|6
450524|NCT00385827|1487493|P1|Part 2|Adverse Event|0
450525|NCT00385827|1487491|P3|Part 1|Other|0
450526|NCT00385827|1487492|P2|Part 1|Other|0
450527|NCT00385827|1487493|P1|Part 1|Other|1
450528|NCT00385827|1487491|P3|Part 1|Lack of Efficacy|0
450529|NCT00385827|1487492|P2|Part 1|Lack of Efficacy|0
450530|NCT00385827|1487493|P1|Part 1|Lack of Efficacy|5
450531|NCT00385827|1487491|P3|Part 1|Death|0
450532|NCT00385827|1487492|P2|Part 1|Death|0
450533|NCT00385827|1487493|P1|Part 1|Death|2
450534|NCT00385827|1487491|P3|Part 1|Adverse Event|0
450535|NCT00385827|1487492|P2|Part 1|Adverse Event|0
450536|NCT00385827|1487493|P1|Part 1|Adverse Event|1
450537|NCT00385762|1487537|P1|Overall Study|Lost to Follow-up|1
450538|NCT00385762|1487537|P1|Overall Study|Adverse Event|1
450539|NCT00385736|1487547|P3|Safety Analysis Set|Other|4
450540|NCT00385736|1487548|P2|Safety Analysis Set|Other|4
450541|NCT00385736|1487549|P1|Safety Analysis Set|Other|1
450542|NCT00385736|1487547|P3|Safety Analysis Set|Protocol Violation|6
450543|NCT00385736|1487548|P2|Safety Analysis Set|Protocol Violation|1
450544|NCT00385736|1487549|P1|Safety Analysis Set|Protocol Violation|2
450545|NCT00385736|1487547|P3|Safety Analysis Set|Lack of Efficacy|31
450546|NCT00385736|1487548|P2|Safety Analysis Set|Lack of Efficacy|16
450547|NCT00385736|1487549|P1|Safety Analysis Set|Lack of Efficacy|38
450548|NCT00385736|1487547|P3|Safety Analysis Set|Lost to Follow-up|2
450549|NCT00385736|1487548|P2|Safety Analysis Set|Lost to Follow-up|2
450550|NCT00385736|1487549|P1|Safety Analysis Set|Lost to Follow-up|0
450551|NCT00385736|1487547|P3|Safety Analysis Set|Withdrawal by Subject|14
450552|NCT00385736|1487548|P2|Safety Analysis Set|Withdrawal by Subject|6
450553|NCT00385736|1487549|P1|Safety Analysis Set|Withdrawal by Subject|6
450554|NCT00385736|1487547|P3|Safety Analysis Set|Adverse Event|23
450555|NCT00385736|1487548|P2|Safety Analysis Set|Adverse Event|15
450556|NCT00385736|1487549|P1|Safety Analysis Set|Adverse Event|23
450557|NCT00385736|1487547|P3|Efficacy Analysis Set - Maintenance|Other|4
450558|NCT00385736|1487548|P2|Efficacy Analysis Set - Maintenance|Other|4
450559|NCT00385736|1487549|P1|Efficacy Analysis Set - Maintenance|Other|0
450560|NCT00385736|1487547|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
450561|NCT00385736|1487548|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
450562|NCT00385736|1487549|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
450563|NCT00385736|1487547|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
450564|NCT00385736|1487548|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
450565|NCT00385736|1487549|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
450649|NCT00385203|1487938|P1|Overall Study|Adverse Event|5
450566|NCT00385736|1487547|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
450567|NCT00385736|1487548|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
450568|NCT00385736|1487549|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
450569|NCT00385736|1487547|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
450570|NCT00385736|1487548|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
450571|NCT00385736|1487549|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
450572|NCT00385736|1487547|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
450573|NCT00385736|1487548|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
450574|NCT00385736|1487549|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
450575|NCT00385736|1487547|P3|Efficacy Analysis Set - Induction|Other|1
450576|NCT00385736|1487548|P2|Efficacy Analysis Set - Induction|Other|0
450577|NCT00385736|1487549|P1|Efficacy Analysis Set - Induction|Other|0
450578|NCT00385736|1487547|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
450579|NCT00385736|1487548|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
450580|NCT00385736|1487549|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
450581|NCT00385736|1487547|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
450582|NCT00385736|1487548|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
450583|NCT00385736|1487549|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
450584|NCT00385736|1487547|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
450585|NCT00385736|1487548|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
450586|NCT00385736|1487549|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
450587|NCT00385736|1487547|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
450588|NCT00385736|1487548|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
450589|NCT00385736|1487549|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
450590|NCT00385736|1487547|P3|Efficacy Analysis Set - Induction|Adverse Event|4
450591|NCT00385736|1487548|P2|Efficacy Analysis Set - Induction|Adverse Event|6
450592|NCT00385736|1487549|P1|Efficacy Analysis Set - Induction|Adverse Event|5
450593|NCT00385723|1487594|P3|Overall Study|Withdrawal by Subject|2
450594|NCT00385723|1487595|P2|Overall Study|Withdrawal by Subject|0
450595|NCT00385723|1487596|P1|Overall Study|Withdrawal by Subject|1
450596|NCT00385723|1487594|P3|Overall Study|Lost to Follow-up|0
450597|NCT00385723|1487595|P2|Overall Study|Lost to Follow-up|1
450598|NCT00385723|1487596|P1|Overall Study|Lost to Follow-up|1
450599|NCT00385684|1487610|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
450600|NCT00385684|1487611|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
450601|NCT00385684|1487610|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
450602|NCT00385684|1487611|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
450603|NCT00385684|1487610|P2|FIRST INTERVENTION OF PHASE A|Death|0
450604|NCT00385684|1487611|P1|FIRST INTERVENTION OF PHASE A|Death|1
450605|NCT00385671|1487620|P3|Overall Study|Withdrawal by Subject|4
450606|NCT00385671|1487621|P2|Overall Study|Withdrawal by Subject|4
450607|NCT00385671|1487622|P1|Overall Study|Withdrawal by Subject|4
450608|NCT00385671|1487620|P3|Overall Study|Sponsor Decision|1
450609|NCT00385671|1487621|P2|Overall Study|Sponsor Decision|2
450610|NCT00385671|1487622|P1|Overall Study|Sponsor Decision|2
450611|NCT00385671|1487620|P3|Overall Study|Protocol Violation|1
450612|NCT00385671|1487621|P2|Overall Study|Protocol Violation|2
450613|NCT00385671|1487622|P1|Overall Study|Protocol Violation|5
450614|NCT00385671|1487620|P3|Overall Study|Physician Decision|2
450615|NCT00385671|1487621|P2|Overall Study|Physician Decision|1
450616|NCT00385671|1487622|P1|Overall Study|Physician Decision|2
450617|NCT00385671|1487620|P3|Overall Study|Lost to Follow-up|5
450618|NCT00385671|1487621|P2|Overall Study|Lost to Follow-up|6
450619|NCT00385671|1487622|P1|Overall Study|Lost to Follow-up|6
450620|NCT00385671|1487620|P3|Overall Study|Lack of Efficacy|5
450621|NCT00385671|1487621|P2|Overall Study|Lack of Efficacy|9
450622|NCT00385671|1487622|P1|Overall Study|Lack of Efficacy|5
450623|NCT00385671|1487620|P3|Overall Study|Adverse Event|18
450624|NCT00385671|1487621|P2|Overall Study|Adverse Event|27
450625|NCT00385671|1487622|P1|Overall Study|Adverse Event|14
450626|NCT00385593|1487778|P2|Overall Study|Incorrect randomization|1
450627|NCT00385593|1487779|P1|Overall Study|Incorrect randomization|0
450628|NCT00385593|1487778|P2|Overall Study|Incorrect inclusion|0
450629|NCT00385593|1487779|P1|Overall Study|Incorrect inclusion|2
450630|NCT00385593|1487778|P2|Overall Study|Several reasons|15
450631|NCT00385593|1487779|P1|Overall Study|Several reasons|17
450632|NCT00385593|1487778|P2|Overall Study|Protocol Violation|4
450633|NCT00385593|1487779|P1|Overall Study|Protocol Violation|7
450634|NCT00385593|1487778|P2|Overall Study|Lost to Follow-up|8
450635|NCT00385593|1487779|P1|Overall Study|Lost to Follow-up|12
450636|NCT00385593|1487778|P2|Overall Study|Withdrawal by Subject|7
450637|NCT00385593|1487779|P1|Overall Study|Withdrawal by Subject|17
450638|NCT00385593|1487778|P2|Overall Study|Adverse Event|2
450639|NCT00385593|1487779|P1|Overall Study|Adverse Event|3
450640|NCT00385541|1487889|P2|Overall Study|severe pain, clinician requested unblind|1
450641|NCT00385541|1487890|P1|Overall Study|severe pain, clinician requested unblind|0
450642|NCT00385203|1487937|P2|Overall Study|Incorrect enrollment|0
450643|NCT00385203|1487938|P1|Overall Study|Incorrect enrollment|2
450644|NCT00385203|1487937|P2|Overall Study|Condition under investigation worsened|3
450645|NCT00385203|1487938|P1|Overall Study|Condition under investigation worsened|18
450646|NCT00385203|1487937|P2|Overall Study|Death|0
450647|NCT00385203|1487938|P1|Overall Study|Death|1
450650|NCT00384956|1488026|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
450651|NCT00384930|1488043|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
450652|NCT00384930|1488044|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
450653|NCT00384930|1488045|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
450654|NCT00384930|1488046|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
450655|NCT00384930|1488047|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
450656|NCT00384930|1488043|P5|Overall Study|Withdrawal by Subject|16
450657|NCT00384930|1488044|P4|Overall Study|Withdrawal by Subject|6
450658|NCT00384930|1488045|P3|Overall Study|Withdrawal by Subject|7
450659|NCT00384930|1488046|P2|Overall Study|Withdrawal by Subject|7
450660|NCT00384930|1488047|P1|Overall Study|Withdrawal by Subject|9
450661|NCT00384930|1488043|P5|Overall Study|Sponsor Decision|0
450662|NCT00384930|1488044|P4|Overall Study|Sponsor Decision|5
450663|NCT00384930|1488045|P3|Overall Study|Sponsor Decision|0
450664|NCT00384930|1488046|P2|Overall Study|Sponsor Decision|4
450665|NCT00384930|1488047|P1|Overall Study|Sponsor Decision|3
450666|NCT00384930|1488043|P5|Overall Study|Protocol Violation|4
450667|NCT00384930|1488044|P4|Overall Study|Protocol Violation|6
450668|NCT00384930|1488045|P3|Overall Study|Protocol Violation|1
450669|NCT00384930|1488046|P2|Overall Study|Protocol Violation|0
450670|NCT00384930|1488047|P1|Overall Study|Protocol Violation|1
450671|NCT00384930|1488043|P5|Overall Study|Physician Decision|1
450672|NCT00384930|1488044|P4|Overall Study|Physician Decision|0
450673|NCT00384930|1488045|P3|Overall Study|Physician Decision|1
450674|NCT00384930|1488046|P2|Overall Study|Physician Decision|1
450675|NCT00384930|1488047|P1|Overall Study|Physician Decision|0
450676|NCT00384930|1488043|P5|Overall Study|Lost to Follow-up|6
450677|NCT00384930|1488044|P4|Overall Study|Lost to Follow-up|4
450678|NCT00384930|1488045|P3|Overall Study|Lost to Follow-up|0
450679|NCT00384930|1488046|P2|Overall Study|Lost to Follow-up|3
450680|NCT00384930|1488047|P1|Overall Study|Lost to Follow-up|5
450681|NCT00384930|1488043|P5|Overall Study|Lack of Efficacy|2
450682|NCT00384930|1488044|P4|Overall Study|Lack of Efficacy|1
450683|NCT00384930|1488045|P3|Overall Study|Lack of Efficacy|2
450684|NCT00384930|1488046|P2|Overall Study|Lack of Efficacy|1
450685|NCT00384930|1488047|P1|Overall Study|Lack of Efficacy|1
450686|NCT00384930|1488043|P5|Overall Study|Entry Criteria Not Met|4
450687|NCT00384930|1488044|P4|Overall Study|Entry Criteria Not Met|8
450688|NCT00384930|1488045|P3|Overall Study|Entry Criteria Not Met|7
450689|NCT00384930|1488046|P2|Overall Study|Entry Criteria Not Met|6
450690|NCT00384930|1488047|P1|Overall Study|Entry Criteria Not Met|2
450691|NCT00384930|1488043|P5|Overall Study|Adverse Event|14
450692|NCT00384930|1488044|P4|Overall Study|Adverse Event|11
450693|NCT00384930|1488045|P3|Overall Study|Adverse Event|12
450694|NCT00384930|1488046|P2|Overall Study|Adverse Event|4
450695|NCT00384930|1488047|P1|Overall Study|Adverse Event|5
450696|NCT00384397|1488157|P3|Overall Study|Withdrawal by Subject|15
450697|NCT00384397|1488158|P2|Overall Study|Withdrawal by Subject|17
450698|NCT00384397|1488159|P1|Overall Study|Withdrawal by Subject|14
450699|NCT00384397|1488157|P3|Overall Study|Lost to Follow-up|3
450700|NCT00384397|1488158|P2|Overall Study|Lost to Follow-up|13
450701|NCT00384397|1488159|P1|Overall Study|Lost to Follow-up|11
450702|NCT00384397|1488157|P3|Overall Study|Protocol Violation|13
450703|NCT00384397|1488158|P2|Overall Study|Protocol Violation|15
450704|NCT00384397|1488159|P1|Overall Study|Protocol Violation|7
450705|NCT00384397|1488157|P3|Overall Study|Adverse Event|2
450706|NCT00384397|1488158|P2|Overall Study|Adverse Event|1
450707|NCT00384397|1488159|P1|Overall Study|Adverse Event|0
450708|NCT00384332|1488178|P2|Overall Study|Lost to Follow-up|0
450709|NCT00384332|1488179|P1|Overall Study|Lost to Follow-up|4
450710|NCT00384293|1488189|P3|Post-randomization Period|Patient Randomized in Error|1
450711|NCT00384293|1488190|P2|Post-randomization Period|Patient Randomized in Error|0
450712|NCT00384293|1488191|P1|Post-randomization Period|Patient Randomized in Error|0
450713|NCT00384293|1488189|P3|Post-randomization Period|Trial Termination|204
450714|NCT00384293|1488190|P2|Post-randomization Period|Trial Termination|180
450715|NCT00384293|1488191|P1|Post-randomization Period|Trial Termination|0
450716|NCT00384293|1488189|P3|Post-randomization Period|Withdrawal by Subject|6
450717|NCT00384293|1488190|P2|Post-randomization Period|Withdrawal by Subject|8
450718|NCT00384293|1488191|P1|Post-randomization Period|Withdrawal by Subject|0
450719|NCT00384293|1488189|P3|Post-randomization Period|Protocol Violation|0
450720|NCT00384293|1488190|P2|Post-randomization Period|Protocol Violation|1
450721|NCT00384293|1488191|P1|Post-randomization Period|Protocol Violation|0
450722|NCT00384293|1488189|P3|Post-randomization Period|Lost to Follow-up|1
450723|NCT00384293|1488190|P2|Post-randomization Period|Lost to Follow-up|2
450724|NCT00384293|1488191|P1|Post-randomization Period|Lost to Follow-up|0
450725|NCT00384293|1488189|P3|Post-randomization Period|Adverse Event|7
450726|NCT00384293|1488190|P2|Post-randomization Period|Adverse Event|23
450727|NCT00384293|1488191|P1|Post-randomization Period|Adverse Event|0
450728|NCT00384293|1488189|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
450729|NCT00384293|1488190|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
450730|NCT00384293|1488191|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
450731|NCT00384293|1488189|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
450732|NCT00384293|1488190|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
450733|NCT00384293|1488191|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
450734|NCT00384293|1488189|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
450735|NCT00384293|1488190|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
450736|NCT00384293|1488191|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
450737|NCT00384293|1488189|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
450738|NCT00384293|1488190|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
450739|NCT00384293|1488191|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
450740|NCT00384293|1488189|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
450741|NCT00384293|1488190|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
450742|NCT00384293|1488191|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
450743|NCT00384293|1488189|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
450744|NCT00384293|1488190|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
450745|NCT00384293|1488191|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
450746|NCT00384293|1488189|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
450747|NCT00384293|1488190|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
450748|NCT00384293|1488191|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
450749|NCT00384189|1488215|P4|Overall Study|Reason Not Specified|40
450750|NCT00384189|1488216|P3|Overall Study|Reason Not Specified|58
450751|NCT00384189|1488217|P2|Overall Study|Reason Not Specified|57
450752|NCT00384189|1488218|P1|Overall Study|Reason Not Specified|50
450753|NCT00384176|1488279|P3|Overall Study|Liver metastases, colon resec. planned|0
450754|NCT00384176|1488280|P2|Overall Study|Liver metastases, colon resec. planned|0
450755|NCT00384176|1488281|P1|Overall Study|Liver metastases, colon resec. planned|1
450756|NCT00384176|1488279|P3|Overall Study|Physician Decision|0
450757|NCT00384176|1488280|P2|Overall Study|Physician Decision|2
450758|NCT00384176|1488281|P1|Overall Study|Physician Decision|0
450759|NCT00384176|1488279|P3|Overall Study|Did not receive study treatment|1
450760|NCT00384176|1488280|P2|Overall Study|Did not receive study treatment|1
450761|NCT00384176|1488281|P1|Overall Study|Did not receive study treatment|0
450762|NCT00384176|1488279|P3|Overall Study|Toxicity of treatment|0
450763|NCT00384176|1488280|P2|Overall Study|Toxicity of treatment|0
450764|NCT00384176|1488281|P1|Overall Study|Toxicity of treatment|1
450765|NCT00384176|1488279|P3|Overall Study|Longer QTC as Visit 1|0
450766|NCT00384176|1488280|P2|Overall Study|Longer QTC as Visit 1|0
450767|NCT00384176|1488281|P1|Overall Study|Longer QTC as Visit 1|1
450768|NCT00384176|1488279|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
450769|NCT00384176|1488280|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
450770|NCT00384176|1488281|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
450771|NCT00384176|1488279|P3|Overall Study|Lost to Follow-up|4
450772|NCT00384176|1488280|P2|Overall Study|Lost to Follow-up|18
450773|NCT00384176|1488281|P1|Overall Study|Lost to Follow-up|16
450774|NCT00384176|1488279|P3|Overall Study|Withdrawal by Subject|22
450775|NCT00384176|1488280|P2|Overall Study|Withdrawal by Subject|48
450776|NCT00384176|1488281|P1|Overall Study|Withdrawal by Subject|52
450777|NCT00384176|1488279|P3|Overall Study|Death|105
450778|NCT00384176|1488280|P2|Overall Study|Death|247
450779|NCT00384176|1488281|P1|Overall Study|Death|239
450780|NCT00384085|1488307|P3|Overall Study|Patient required surgery|0
450781|NCT00384085|1488308|P2|Overall Study|Patient required surgery|1
450782|NCT00384085|1488309|P1|Overall Study|Patient required surgery|0
450783|NCT00384085|1488307|P3|Overall Study|Patient moved|1
450784|NCT00384085|1488308|P2|Overall Study|Patient moved|0
450785|NCT00384085|1488309|P1|Overall Study|Patient moved|1
450786|NCT00384085|1488307|P3|Overall Study|Sponsor decision|1
450787|NCT00384085|1488308|P2|Overall Study|Sponsor decision|2
450788|NCT00384085|1488309|P1|Overall Study|Sponsor decision|1
450789|NCT00384085|1488307|P3|Overall Study|Loss of site personnel|1
450790|NCT00384085|1488308|P2|Overall Study|Loss of site personnel|0
450791|NCT00384085|1488309|P1|Overall Study|Loss of site personnel|1
450792|NCT00384085|1488307|P3|Overall Study|Physician Decision|0
450793|NCT00384085|1488308|P2|Overall Study|Physician Decision|0
450794|NCT00384085|1488309|P1|Overall Study|Physician Decision|1
450795|NCT00384085|1488307|P3|Overall Study|Patient non-compliant|5
450796|NCT00384085|1488308|P2|Overall Study|Patient non-compliant|4
450797|NCT00384085|1488309|P1|Overall Study|Patient non-compliant|4
450798|NCT00384085|1488307|P3|Overall Study|Withdrawal by Subject|29
450799|NCT00384085|1488308|P2|Overall Study|Withdrawal by Subject|19
450800|NCT00384085|1488309|P1|Overall Study|Withdrawal by Subject|14
450801|NCT00384085|1488307|P3|Overall Study|Progressive Disease|0
450802|NCT00384085|1488308|P2|Overall Study|Progressive Disease|1
450803|NCT00384085|1488309|P1|Overall Study|Progressive Disease|0
450804|NCT00384085|1488307|P3|Overall Study|Lost to Follow-up|10
450805|NCT00384085|1488308|P2|Overall Study|Lost to Follow-up|9
450806|NCT00384085|1488309|P1|Overall Study|Lost to Follow-up|9
450807|NCT00384085|1488307|P3|Overall Study|Protocol Violation|2
450808|NCT00384085|1488308|P2|Overall Study|Protocol Violation|2
450809|NCT00384085|1488309|P1|Overall Study|Protocol Violation|2
450810|NCT00384085|1488307|P3|Overall Study|No longer Requires Study Treatment|1
450811|NCT00384085|1488308|P2|Overall Study|No longer Requires Study Treatment|0
450812|NCT00384085|1488309|P1|Overall Study|No longer Requires Study Treatment|1
450813|NCT00384085|1488307|P3|Overall Study|Lack of Efficacy|2
450814|NCT00384085|1488308|P2|Overall Study|Lack of Efficacy|3
450815|NCT00384085|1488309|P1|Overall Study|Lack of Efficacy|0
450816|NCT00384085|1488307|P3|Overall Study|Adverse Event|4
450817|NCT00384085|1488308|P2|Overall Study|Adverse Event|5
450818|NCT00384085|1488309|P1|Overall Study|Adverse Event|5
450819|NCT00384059|1488335|P2|Toddler Dose|Failed to return|1
450820|NCT00384059|1488336|P1|Toddler Dose|Failed to return|0
450821|NCT00384059|1488335|P2|Toddler Dose|Lost to Follow-up|1
450822|NCT00384059|1488336|P1|Toddler Dose|Lost to Follow-up|1
450823|NCT00384059|1488335|P2|After Infant Series|Lost to Follow-up|1
450824|NCT00384059|1488336|P1|After Infant Series|Lost to Follow-up|0
450825|NCT00384059|1488335|P2|After Infant Series|Physician Decision|1
450826|NCT00384059|1488336|P1|After Infant Series|Physician Decision|0
450827|NCT00384059|1488335|P2|After Infant Series|Adverse Event|1
450828|NCT00384059|1488336|P1|After Infant Series|Adverse Event|0
450829|NCT00384059|1488335|P2|After Infant Series|Failed to Return|2
450830|NCT00384059|1488336|P1|After Infant Series|Failed to Return|0
450831|NCT00384059|1488335|P2|After Infant Series|Withdrawal by Subject|2
450832|NCT00384059|1488336|P1|After Infant Series|Withdrawal by Subject|2
450833|NCT00384059|1488335|P2|After Infant Series|Protocol Violation|3
450834|NCT00384059|1488336|P1|After Infant Series|Protocol Violation|2
450835|NCT00384059|1488335|P2|Infant Series|Lost to Follow-up|1
450836|NCT00384059|1488336|P1|Infant Series|Lost to Follow-up|0
450837|NCT00384059|1488335|P2|Infant Series|Protocol Violation|2
450838|NCT00384059|1488336|P1|Infant Series|Protocol Violation|1
450839|NCT00384059|1488335|P2|Infant Series|Adverse Event|2
450840|NCT00384059|1488336|P1|Infant Series|Adverse Event|1
450841|NCT00384059|1488335|P2|Infant Series|Withdrawal by Subject|2
450842|NCT00384059|1488336|P1|Infant Series|Withdrawal by Subject|2
450843|NCT00384059|1488335|P2|Infant Series|Not consented|6
450844|NCT00384059|1488336|P1|Infant Series|Not consented|2
450845|NCT00384033|1488386|P4|Overall Study|Randomized but not treated|2
450846|NCT00384033|1488387|P3|Overall Study|Randomized but not treated|10
450847|NCT00384033|1488388|P2|Overall Study|Randomized but not treated|7
450848|NCT00384033|1488389|P1|Overall Study|Randomized but not treated|3
450849|NCT00384033|1488386|P4|Overall Study|Lack of Efficacy|1
450850|NCT00384033|1488387|P3|Overall Study|Lack of Efficacy|3
450851|NCT00384033|1488388|P2|Overall Study|Lack of Efficacy|3
450852|NCT00384033|1488389|P1|Overall Study|Lack of Efficacy|7
450853|NCT00384033|1488386|P4|Overall Study|Withdrawal by Subject|2
450854|NCT00384033|1488387|P3|Overall Study|Withdrawal by Subject|5
450855|NCT00384033|1488388|P2|Overall Study|Withdrawal by Subject|2
450856|NCT00384033|1488389|P1|Overall Study|Withdrawal by Subject|6
450857|NCT00384033|1488386|P4|Overall Study|Protocol Violation|6
450858|NCT00384033|1488387|P3|Overall Study|Protocol Violation|5
450859|NCT00384033|1488388|P2|Overall Study|Protocol Violation|0
450860|NCT00384033|1488389|P1|Overall Study|Protocol Violation|5
450861|NCT00384033|1488386|P4|Overall Study|Other|0
450862|NCT00384033|1488387|P3|Overall Study|Other|0
450863|NCT00384033|1488388|P2|Overall Study|Other|0
450864|NCT00384033|1488389|P1|Overall Study|Other|2
450865|NCT00384033|1488386|P4|Overall Study|Lost to Follow-up|7
450866|NCT00384033|1488387|P3|Overall Study|Lost to Follow-up|7
450867|NCT00384033|1488388|P2|Overall Study|Lost to Follow-up|12
450868|NCT00384033|1488389|P1|Overall Study|Lost to Follow-up|6
450869|NCT00384033|1488386|P4|Overall Study|Physician Decision|0
450870|NCT00384033|1488387|P3|Overall Study|Physician Decision|0
450871|NCT00384033|1488388|P2|Overall Study|Physician Decision|0
450872|NCT00384033|1488389|P1|Overall Study|Physician Decision|1
450873|NCT00384033|1488386|P4|Overall Study|Failed to return|2
450874|NCT00384033|1488387|P3|Overall Study|Failed to return|2
450875|NCT00384033|1488388|P2|Overall Study|Failed to return|3
450876|NCT00384033|1488389|P1|Overall Study|Failed to return|1
450877|NCT00384033|1488386|P4|Overall Study|Adverse Event|20
450878|NCT00384033|1488387|P3|Overall Study|Adverse Event|11
450879|NCT00384033|1488388|P2|Overall Study|Adverse Event|8
450880|NCT00384033|1488389|P1|Overall Study|Adverse Event|10
450881|NCT00383786|1488442|P2|Overall Study|Physician Decision|1
450882|NCT00383786|1488443|P1|Overall Study|Physician Decision|0
450883|NCT00383786|1488442|P2|Overall Study|Withdrawal by Subject|5
450884|NCT00383786|1488443|P1|Overall Study|Withdrawal by Subject|2
450885|NCT00383786|1488442|P2|Overall Study|Protocol Violation|6
450886|NCT00383786|1488443|P1|Overall Study|Protocol Violation|2
450887|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Administrative|0
450888|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Administrative|1
450889|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Administrative|3
450890|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Administrative|2
450891|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Administrative|1
450892|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
450893|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
450894|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
450895|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
450896|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
450897|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
450898|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
451286|NCT00382174|1489166|P2|Overall Study|Failed to meet criteria|1
450899|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
450900|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
450901|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
450902|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
450903|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
450904|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
450905|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
450906|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
450907|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
450908|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
450909|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
450910|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
450911|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
450912|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
450913|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
450914|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
450915|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
450916|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
450917|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
450918|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
450919|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
450920|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
450921|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
450922|NCT00383721|1488493|P5|26-Week Treatment Safety Extension|Adverse Event|0
450923|NCT00383721|1488494|P4|26-Week Treatment Safety Extension|Adverse Event|1
450924|NCT00383721|1488495|P3|26-Week Treatment Safety Extension|Adverse Event|10
450925|NCT00383721|1488496|P2|26-Week Treatment Safety Extension|Adverse Event|7
450926|NCT00383721|1488497|P1|26-Week Treatment Safety Extension|Adverse Event|6
450927|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Ongoing|0
450928|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Ongoing|0
450929|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Ongoing|0
450930|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Ongoing|0
450931|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Ongoing|1
450932|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Administrative|3
450933|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Administrative|3
450934|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Administrative|3
450935|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Administrative|3
450936|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Administrative|1
450937|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
450938|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
450939|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
450940|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
450941|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
450942|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
450943|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
450944|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
450945|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
450946|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
450947|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
450948|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
450949|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
450950|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
450951|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
450952|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
450953|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
450954|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
450955|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
450956|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
450957|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
450958|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
450959|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
450960|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
450961|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
450962|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
450963|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
450964|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
450965|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
450966|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
450967|NCT00383721|1488493|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
450968|NCT00383721|1488494|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
450969|NCT00383721|1488495|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
450970|NCT00383721|1488496|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
450971|NCT00383721|1488497|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
450972|NCT00383552|1488569|P4|Overall Study|Administrative|1
450973|NCT00383552|1488570|P3|Overall Study|Administrative|1
450974|NCT00383552|1488571|P2|Overall Study|Administrative|0
450975|NCT00383552|1488572|P1|Overall Study|Administrative|1
450976|NCT00383552|1488569|P4|Overall Study|Did not meet protocol eligibility|3
450977|NCT00383552|1488570|P3|Overall Study|Did not meet protocol eligibility|2
450978|NCT00383552|1488571|P2|Overall Study|Did not meet protocol eligibility|6
450979|NCT00383552|1488572|P1|Overall Study|Did not meet protocol eligibility|8
450980|NCT00383552|1488569|P4|Overall Study|Noncompliance with the protocol|10
450981|NCT00383552|1488570|P3|Overall Study|Noncompliance with the protocol|8
450982|NCT00383552|1488571|P2|Overall Study|Noncompliance with the protocol|6
450983|NCT00383552|1488572|P1|Overall Study|Noncompliance with the protocol|11
450984|NCT00383552|1488569|P4|Overall Study|Did not wish to continue (related)|3
450985|NCT00383552|1488570|P3|Overall Study|Did not wish to continue (related)|2
450986|NCT00383552|1488571|P2|Overall Study|Did not wish to continue (related)|0
450987|NCT00383552|1488572|P1|Overall Study|Did not wish to continue (related)|1
450988|NCT00383552|1488569|P4|Overall Study|Did not wish to continue (unrelated)|6
450989|NCT00383552|1488570|P3|Overall Study|Did not wish to continue (unrelated)|5
450990|NCT00383552|1488571|P2|Overall Study|Did not wish to continue (unrelated)|9
450991|NCT00383552|1488572|P1|Overall Study|Did not wish to continue (unrelated)|4
450992|NCT00383552|1488569|P4|Overall Study|Lost to Follow-up|1
450993|NCT00383552|1488570|P3|Overall Study|Lost to Follow-up|5
450994|NCT00383552|1488571|P2|Overall Study|Lost to Follow-up|1
450995|NCT00383552|1488572|P1|Overall Study|Lost to Follow-up|0
450996|NCT00383552|1488569|P4|Overall Study|Lack of Efficacy|42
450997|NCT00383552|1488570|P3|Overall Study|Lack of Efficacy|29
450998|NCT00383552|1488571|P2|Overall Study|Lack of Efficacy|13
450999|NCT00383552|1488572|P1|Overall Study|Lack of Efficacy|4
451000|NCT00383552|1488569|P4|Overall Study|Adverse Event|6
451001|NCT00383552|1488570|P3|Overall Study|Adverse Event|9
451002|NCT00383552|1488571|P2|Overall Study|Adverse Event|6
451003|NCT00383552|1488572|P1|Overall Study|Adverse Event|7
451004|NCT00383500|1488614|P3|Overall Study|Lost to Follow-up|2
451005|NCT00383500|1488615|P2|Overall Study|Lost to Follow-up|0
451006|NCT00383500|1488616|P1|Overall Study|Lost to Follow-up|0
451007|NCT00383500|1488614|P3|Overall Study|Withdrawal by Subject|0
451008|NCT00383500|1488615|P2|Overall Study|Withdrawal by Subject|3
451009|NCT00383500|1488616|P1|Overall Study|Withdrawal by Subject|8
451010|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Administrative|0
451011|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Administrative|1
451012|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Administrative|0
451013|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Administrative|1
451014|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Administrative|1
451015|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
451016|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
451017|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
451018|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
451019|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
451020|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
451021|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
451022|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
451023|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
451024|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
451025|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
451026|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
451027|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
451028|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
451029|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
451030|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
451031|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
451032|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
451033|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
451034|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
451035|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
451036|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
451037|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
451038|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
451039|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
451040|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
451041|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
451042|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
451043|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
451044|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
451045|NCT00383435|1488632|P5|26-Week Treatment Safety Extension|Adverse Event|1
451046|NCT00383435|1488633|P4|26-Week Treatment Safety Extension|Adverse Event|5
451047|NCT00383435|1488634|P3|26-Week Treatment Safety Extension|Adverse Event|5
451048|NCT00383435|1488635|P2|26-Week Treatment Safety Extension|Adverse Event|2
451049|NCT00383435|1488636|P1|26-Week Treatment Safety Extension|Adverse Event|4
451050|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Administrative|1
451051|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Administrative|1
451052|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Administrative|1
451053|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Administrative|3
451054|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Administrative|5
451055|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
451056|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
451057|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
451058|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
451059|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
451060|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
451061|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
451062|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
451063|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
451064|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
451065|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
451066|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
451067|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
451068|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
451069|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
451070|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
451071|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
451072|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
451073|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
451074|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
451075|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
451076|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
451077|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
451078|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
451079|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
451080|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
451081|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
451082|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
451083|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
451084|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
451085|NCT00383435|1488632|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
451086|NCT00383435|1488633|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
451087|NCT00383435|1488634|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
451088|NCT00383435|1488635|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
451089|NCT00383435|1488636|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
451090|NCT00383331|1488675|P2|Overall Study|Protocol Violation|1
451091|NCT00383331|1488676|P1|Overall Study|Protocol Violation|0
451092|NCT00383292|1488695|P3|Overall Study|Other|0
451093|NCT00383292|1488696|P2|Overall Study|Other|0
451094|NCT00383292|1488697|P1|Overall Study|Other|1
451095|NCT00383292|1488695|P3|Overall Study|Withdrawal by Subject|2
451096|NCT00383292|1488696|P2|Overall Study|Withdrawal by Subject|2
451097|NCT00383292|1488697|P1|Overall Study|Withdrawal by Subject|3
451098|NCT00383292|1488695|P3|Overall Study|Physician Decision|1
451099|NCT00383292|1488696|P2|Overall Study|Physician Decision|0
451100|NCT00383292|1488697|P1|Overall Study|Physician Decision|4
451101|NCT00383292|1488695|P3|Overall Study|Death|3
451102|NCT00383292|1488696|P2|Overall Study|Death|3
451103|NCT00383292|1488697|P1|Overall Study|Death|3
451104|NCT00383292|1488695|P3|Overall Study|Adverse Event|2
451105|NCT00383292|1488696|P2|Overall Study|Adverse Event|1
451106|NCT00383292|1488697|P1|Overall Study|Adverse Event|4
451107|NCT00383240|1488738|P4|Overall Study|Administrative|0
451108|NCT00383240|1488739|P3|Overall Study|Administrative|0
451109|NCT00383240|1488740|P2|Overall Study|Administrative|1
451110|NCT00383240|1488741|P1|Overall Study|Administrative|1
451111|NCT00383240|1488738|P4|Overall Study|Did not meet protocol eligibility|3
451112|NCT00383240|1488739|P3|Overall Study|Did not meet protocol eligibility|9
451113|NCT00383240|1488740|P2|Overall Study|Did not meet protocol eligibility|4
451114|NCT00383240|1488741|P1|Overall Study|Did not meet protocol eligibility|9
451115|NCT00383240|1488738|P4|Overall Study|Protocol Violation|6
451116|NCT00383240|1488739|P3|Overall Study|Protocol Violation|9
451117|NCT00383240|1488740|P2|Overall Study|Protocol Violation|5
451118|NCT00383240|1488741|P1|Overall Study|Protocol Violation|4
451119|NCT00383240|1488738|P4|Overall Study|Withdrawal by subjects, reasons related|5
451120|NCT00383240|1488739|P3|Overall Study|Withdrawal by subjects, reasons related|3
451121|NCT00383240|1488740|P2|Overall Study|Withdrawal by subjects, reasons related|1
451122|NCT00383240|1488741|P1|Overall Study|Withdrawal by subjects, reasons related|0
451123|NCT00383240|1488738|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
451124|NCT00383240|1488739|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
451125|NCT00383240|1488740|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
451126|NCT00383240|1488741|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
451127|NCT00383240|1488738|P4|Overall Study|Lost to Follow-up|2
451128|NCT00383240|1488739|P3|Overall Study|Lost to Follow-up|0
451129|NCT00383240|1488740|P2|Overall Study|Lost to Follow-up|0
451130|NCT00383240|1488741|P1|Overall Study|Lost to Follow-up|3
451131|NCT00383240|1488738|P4|Overall Study|Treatment Failure|46
451132|NCT00383240|1488739|P3|Overall Study|Treatment Failure|47
451133|NCT00383240|1488740|P2|Overall Study|Treatment Failure|13
451134|NCT00383240|1488741|P1|Overall Study|Treatment Failure|8
451135|NCT00383240|1488738|P4|Overall Study|Adverse Event|7
451136|NCT00383240|1488739|P3|Overall Study|Adverse Event|9
451137|NCT00383240|1488740|P2|Overall Study|Adverse Event|6
451138|NCT00383240|1488741|P1|Overall Study|Adverse Event|4
451139|NCT00383162|1488772|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
451140|NCT00383162|1488773|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
451141|NCT00383162|1488772|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
451142|NCT00383162|1488773|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
451143|NCT00383162|1488772|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
451144|NCT00383162|1488773|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
451145|NCT00383162|1488772|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
451146|NCT00383162|1488773|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
451147|NCT00383162|1488772|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
451148|NCT00383162|1488773|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
451149|NCT00383162|1488772|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
451150|NCT00383162|1488773|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
451151|NCT00383162|1488772|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
451152|NCT00383162|1488773|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
451153|NCT00383162|1488772|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
451154|NCT00383162|1488773|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
451155|NCT00383162|1488772|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
451156|NCT00383162|1488773|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
451157|NCT00383149|1488815|P1|Overall Study|Participant Withdrew Consent|1
451158|NCT00383149|1488815|P1|Overall Study|Request to Discontinue Treatment|4
451159|NCT00383149|1488815|P1|Overall Study|Study Drug Toxicity|4
451160|NCT00383149|1488815|P1|Overall Study|Other|1
451161|NCT00383149|1488815|P1|Overall Study|Lost to Follow-up|1
451162|NCT00383149|1488815|P1|Overall Study|Disease Progression|38
451163|NCT00383149|1488815|P1|Overall Study|Death|2
451164|NCT00383149|1488815|P1|Overall Study|Adverse Event not Related to Study Drug|3
451165|NCT00383123|1488834|P2|Overall Study|Other reason|6
451166|NCT00383123|1488835|P1|Overall Study|Other reason|10
451167|NCT00383123|1488834|P2|Overall Study|Withdrawal by Subject|18
451168|NCT00383123|1488835|P1|Overall Study|Withdrawal by Subject|27
451169|NCT00383123|1488834|P2|Overall Study|Protocol Violation|1
451170|NCT00383123|1488835|P1|Overall Study|Protocol Violation|5
451171|NCT00383123|1488834|P2|Overall Study|Lost to Follow-up|61
451172|NCT00383123|1488835|P1|Overall Study|Lost to Follow-up|68
451173|NCT00383123|1488834|P2|Overall Study|Adverse Event|0
451174|NCT00383123|1488835|P1|Overall Study|Adverse Event|1
451175|NCT00383084|1488876|P2|Overall Study|Withdrawal by Subject|10
451176|NCT00383084|1488877|P1|Overall Study|Withdrawal by Subject|12
451177|NCT00383019|1488908|P2|Overall Study|Withdrawal by Subject|1
451178|NCT00383019|1488909|P1|Overall Study|Withdrawal by Subject|0
451179|NCT00383019|1488908|P2|Overall Study|Adverse Event|1
451180|NCT00383019|1488909|P1|Overall Study|Adverse Event|5
451181|NCT00382993|1488931|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
451182|NCT00382993|1488932|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
451183|NCT00382993|1488931|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
451184|NCT00382993|1488932|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
451185|NCT00382993|1488931|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
451186|NCT00382993|1488932|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
451187|NCT00382993|1488931|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
451188|NCT00382993|1488932|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
451189|NCT00382993|1488931|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
451190|NCT00382993|1488932|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
451191|NCT00382993|1488931|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
451192|NCT00382993|1488932|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
451193|NCT00382993|1488931|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
451194|NCT00382993|1488932|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
451195|NCT00382993|1488931|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
451196|NCT00382993|1488932|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
451197|NCT00382993|1488931|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
451198|NCT00382993|1488932|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
451199|NCT00382993|1488931|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
451200|NCT00382993|1488932|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
451201|NCT00382967|1488976|P2|Overall Study|Protocol Violation|1
451202|NCT00382967|1488977|P1|Overall Study|Protocol Violation|1
451203|NCT00382863|1489002|P2|Overall Study|Withdrawal by Subject|25
451204|NCT00382863|1489003|P1|Overall Study|Withdrawal by Subject|5
451205|NCT00382863|1489002|P2|Overall Study|Lost to Follow-up|2
451206|NCT00382863|1489003|P1|Overall Study|Lost to Follow-up|1
451207|NCT00382863|1489002|P2|Overall Study|Death|9
451208|NCT00382863|1489003|P1|Overall Study|Death|9
451209|NCT00382733|1489070|P5|Overall Study|Withdrawal by Subject|0
451210|NCT00382733|1489071|P4|Overall Study|Withdrawal by Subject|0
451211|NCT00382733|1489072|P3|Overall Study|Withdrawal by Subject|0
451212|NCT00382733|1489073|P2|Overall Study|Withdrawal by Subject|1
451213|NCT00382733|1489074|P1|Overall Study|Withdrawal by Subject|0
451214|NCT00382720|1489095|P3|Overall Study|Discontinued at end of study|2
451215|NCT00382720|1489096|P2|Overall Study|Discontinued at end of study|1
451216|NCT00382720|1489097|P1|Overall Study|Discontinued at end of study|0
451217|NCT00382720|1489095|P3|Overall Study|Investigator/Clinical decision|6
451218|NCT00382720|1489096|P2|Overall Study|Investigator/Clinical decision|6
451219|NCT00382720|1489097|P1|Overall Study|Investigator/Clinical decision|5
451220|NCT00382720|1489095|P3|Overall Study|Good prognosis|0
451221|NCT00382720|1489096|P2|Overall Study|Good prognosis|1
451222|NCT00382720|1489097|P1|Overall Study|Good prognosis|0
451223|NCT00382720|1489095|P3|Overall Study|Clinically progressive disease|0
451224|NCT00382720|1489096|P2|Overall Study|Clinically progressive disease|1
451225|NCT00382720|1489097|P1|Overall Study|Clinically progressive disease|0
451226|NCT00382720|1489095|P3|Overall Study|Patient did not receive study medication|4
451227|NCT00382720|1489096|P2|Overall Study|Patient did not receive study medication|1
451228|NCT00382720|1489097|P1|Overall Study|Patient did not receive study medication|1
451229|NCT00382720|1489095|P3|Overall Study|Surgery|4
451230|NCT00382720|1489096|P2|Overall Study|Surgery|1
451231|NCT00382720|1489097|P1|Overall Study|Surgery|1
451232|NCT00382720|1489095|P3|Overall Study|Withdrawal by Subject|12
451233|NCT00382720|1489096|P2|Overall Study|Withdrawal by Subject|20
451234|NCT00382720|1489097|P1|Overall Study|Withdrawal by Subject|11
451235|NCT00382720|1489095|P3|Overall Study|Withdrew consent|2
451236|NCT00382720|1489096|P2|Overall Study|Withdrew consent|1
451237|NCT00382720|1489097|P1|Overall Study|Withdrew consent|1
451238|NCT00382720|1489095|P3|Overall Study|Progressive disease|38
451239|NCT00382720|1489096|P2|Overall Study|Progressive disease|28
451240|NCT00382720|1489097|P1|Overall Study|Progressive disease|37
451241|NCT00382720|1489095|P3|Overall Study|Death|2
451242|NCT00382720|1489096|P2|Overall Study|Death|1
451243|NCT00382720|1489097|P1|Overall Study|Death|0
451244|NCT00382720|1489095|P3|Overall Study|Protocol Violation|1
451245|NCT00382720|1489096|P2|Overall Study|Protocol Violation|5
451246|NCT00382720|1489097|P1|Overall Study|Protocol Violation|2
451247|NCT00382720|1489095|P3|Overall Study|Adverse Event|15
451248|NCT00382720|1489096|P2|Overall Study|Adverse Event|23
451249|NCT00382720|1489097|P1|Overall Study|Adverse Event|21
451250|NCT00382408|1489122|P2|Overall Study|Not specified|35
451251|NCT00382408|1489123|P1|Overall Study|Not specified|100
451252|NCT00382408|1489122|P2|Overall Study|Lost to Follow-up|8
451253|NCT00382408|1489123|P1|Overall Study|Lost to Follow-up|19
451254|NCT00382408|1489122|P2|Overall Study|Pregnancy|0
451255|NCT00382408|1489123|P1|Overall Study|Pregnancy|2
451256|NCT00382408|1489122|P2|Overall Study|Withdrawal by Subject|6
451257|NCT00382408|1489123|P1|Overall Study|Withdrawal by Subject|17
451258|NCT00382408|1489122|P2|Overall Study|Physician Decision|0
451259|NCT00382408|1489123|P1|Overall Study|Physician Decision|1
451260|NCT00382408|1489122|P2|Overall Study|Protocol Violation|2
451261|NCT00382408|1489123|P1|Overall Study|Protocol Violation|2
451262|NCT00382408|1489122|P2|Overall Study|Did not meet protocol requirement|3
451263|NCT00382408|1489123|P1|Overall Study|Did not meet protocol requirement|3
451264|NCT00382291|1489150|P3|Overall Study|Lack of Efficacy|1
451265|NCT00382291|1489151|P2|Overall Study|Lack of Efficacy|0
451266|NCT00382291|1489152|P1|Overall Study|Lack of Efficacy|0
451267|NCT00382291|1489150|P3|Overall Study|Physician Decision|0
451268|NCT00382291|1489151|P2|Overall Study|Physician Decision|1
451269|NCT00382291|1489152|P1|Overall Study|Physician Decision|0
451270|NCT00382291|1489150|P3|Overall Study|Withdrawal by Subject|0
451271|NCT00382291|1489151|P2|Overall Study|Withdrawal by Subject|2
451272|NCT00382291|1489152|P1|Overall Study|Withdrawal by Subject|0
451273|NCT00382291|1489150|P3|Overall Study|Temporary study suspension|5
451274|NCT00382291|1489151|P2|Overall Study|Temporary study suspension|2
451275|NCT00382291|1489152|P1|Overall Study|Temporary study suspension|2
451276|NCT00382291|1489150|P3|Overall Study|Protocol Violation|0
451277|NCT00382291|1489151|P2|Overall Study|Protocol Violation|0
451278|NCT00382291|1489152|P1|Overall Study|Protocol Violation|1
451279|NCT00382291|1489150|P3|Overall Study|Adverse Event|2
451280|NCT00382291|1489151|P2|Overall Study|Adverse Event|2
451281|NCT00382291|1489152|P1|Overall Study|Adverse Event|1
451282|NCT00382174|1489165|P3|Overall Study|Wounds merged|2
451283|NCT00382174|1489166|P2|Overall Study|Wounds merged|2
451284|NCT00382174|1489167|P1|Overall Study|Wounds merged|0
451285|NCT00382174|1489165|P3|Overall Study|Failed to meet criteria|1
451287|NCT00382174|1489167|P1|Overall Study|Failed to meet criteria|0
451288|NCT00382174|1489165|P3|Overall Study|Physician Decision|2
451289|NCT00382174|1489166|P2|Overall Study|Physician Decision|2
451290|NCT00382174|1489167|P1|Overall Study|Physician Decision|0
451291|NCT00382174|1489165|P3|Overall Study|Non compliance|1
451292|NCT00382174|1489166|P2|Overall Study|Non compliance|0
451293|NCT00382174|1489167|P1|Overall Study|Non compliance|1
451294|NCT00382174|1489165|P3|Overall Study|Withdrawal by Subject|5
451295|NCT00382174|1489166|P2|Overall Study|Withdrawal by Subject|4
451296|NCT00382174|1489167|P1|Overall Study|Withdrawal by Subject|1
451297|NCT00382174|1489165|P3|Overall Study|Adverse Event|5
451298|NCT00382174|1489166|P2|Overall Study|Adverse Event|4
451299|NCT00382174|1489167|P1|Overall Study|Adverse Event|1
451300|NCT00382174|1489165|P3|Overall Study|Lost to Follow-up|5
451301|NCT00382174|1489166|P2|Overall Study|Lost to Follow-up|4
451302|NCT00382174|1489167|P1|Overall Study|Lost to Follow-up|1
451303|NCT00382109|1489195|P2|Overall Study|consent withdrawal|1
451304|NCT00382109|1489196|P1|Overall Study|consent withdrawal|0
451305|NCT00382109|1489195|P2|Overall Study|Other|2
451306|NCT00382109|1489196|P1|Overall Study|Other|0
451307|NCT00382109|1489195|P2|Overall Study|ineligible|0
451308|NCT00382109|1489196|P1|Overall Study|ineligible|2
451309|NCT00382109|1489195|P2|Overall Study|Withdrawal by Subject|0
451310|NCT00382109|1489196|P1|Overall Study|Withdrawal by Subject|1
451311|NCT00382109|1489195|P2|Overall Study|Physician Decision|1
451312|NCT00382109|1489196|P1|Overall Study|Physician Decision|6
451313|NCT00382109|1489195|P2|Overall Study|Adverse Event|0
451314|NCT00382109|1489196|P1|Overall Study|Adverse Event|3
451315|NCT00382018|1489235|P4|Overall Study|Other, not protocol specified|1
451316|NCT00382018|1489236|P3|Overall Study|Other, not protocol specified|3
451317|NCT00382018|1489237|P2|Overall Study|Other, not protocol specified|16
451318|NCT00382018|1489238|P1|Overall Study|Other, not protocol specified|0
451319|NCT00382018|1489235|P4|Overall Study|Withdrawal by Subject|4
451320|NCT00382018|1489236|P3|Overall Study|Withdrawal by Subject|3
451321|NCT00382018|1489237|P2|Overall Study|Withdrawal by Subject|4
451322|NCT00382018|1489238|P1|Overall Study|Withdrawal by Subject|0
451323|NCT00382018|1489235|P4|Overall Study|Death|11
451324|NCT00382018|1489236|P3|Overall Study|Death|7
451325|NCT00382018|1489237|P2|Overall Study|Death|9
451326|NCT00382018|1489238|P1|Overall Study|Death|0
451327|NCT00382018|1489235|P4|Overall Study|Progression|43
451328|NCT00382018|1489236|P3|Overall Study|Progression|51
451329|NCT00382018|1489237|P2|Overall Study|Progression|136
451330|NCT00382018|1489238|P1|Overall Study|Progression|0
451331|NCT00381940|1489261|P1|Overall Study|Ineligible|1
451332|NCT00381940|1489261|P1|Overall Study|Protocol Violation|1
451333|NCT00381940|1489261|P1|Overall Study|Lack of Efficacy|3
451334|NCT00381888|1489265|P1|Overall Study|Adverse Event|1
451335|NCT00381888|1489265|P1|Overall Study|Surgery was cancelled|2
451336|NCT00381888|1489265|P1|Overall Study|Had laparoscopic surgery|2
451337|NCT00381888|1489265|P1|Overall Study|Protocol Violation|9
451338|NCT00381888|1489265|P1|Overall Study|Physician Decision|1
451339|NCT00381888|1489265|P1|Overall Study|Withdrawal by Subject|1
451340|NCT00381888|1489265|P1|Overall Study|Death|1
451341|NCT00381849|1489276|P2|Wash Out|Withdrawal by Subject|1
451342|NCT00381849|1489277|P1|Wash Out|Withdrawal by Subject|0
451343|NCT00381797|1489304|P5|Overall Study|Ineligible|0
451344|NCT00381797|1489305|P4|Overall Study|Ineligible|1
451345|NCT00381797|1489306|P3|Overall Study|Ineligible|0
451346|NCT00381797|1489307|P2|Overall Study|Ineligible|0
451347|NCT00381797|1489308|P1|Overall Study|Ineligible|0
451348|NCT00381797|1489304|P5|Overall Study|Withdrawal by Subject|2
451349|NCT00381797|1489305|P4|Overall Study|Withdrawal by Subject|0
451350|NCT00381797|1489306|P3|Overall Study|Withdrawal by Subject|0
451351|NCT00381797|1489307|P2|Overall Study|Withdrawal by Subject|1
451352|NCT00381797|1489308|P1|Overall Study|Withdrawal by Subject|1
451353|NCT00381706|1489383|P3|Overall Study|Never treated|1
451354|NCT00381706|1489384|P2|Overall Study|Never treated|2
451355|NCT00381706|1489385|P1|Overall Study|Never treated|7
451356|NCT00381693|1489408|P1|Overall Study|Progression|2
451357|NCT00381693|1489408|P1|Overall Study|Patient Choice|1
451358|NCT00381693|1489408|P1|Overall Study|Adverse Event|4
451359|NCT00381693|1489408|P1|Overall Study|Death|1
451360|NCT00381680|1489417|P2|Overall Study|Ineligible|1
451361|NCT00381680|1489418|P1|Overall Study|Ineligible|3
451362|NCT00381680|1489417|P2|Overall Study|Other not otherwise specified|2
451363|NCT00381680|1489418|P1|Overall Study|Other not otherwise specified|7
451364|NCT00381680|1489417|P2|Overall Study|Progression|1
451365|NCT00381680|1489418|P1|Overall Study|Progression|1
451366|NCT00381680|1489417|P2|Overall Study|Induction Failure|1
451367|NCT00381680|1489418|P1|Overall Study|Induction Failure|4
451368|NCT00381680|1489417|P2|Overall Study|Relapse|9
451369|NCT00381680|1489418|P1|Overall Study|Relapse|18
451370|NCT00381680|1489417|P2|Overall Study|Stem Cell Transplant|10
451371|NCT00381680|1489418|P1|Overall Study|Stem Cell Transplant|26
451372|NCT00381680|1489417|P2|Overall Study|Delay initiation|0
451373|NCT00381680|1489418|P1|Overall Study|Delay initiation|1
451374|NCT00381680|1489417|P2|Overall Study|Secondary Malignancy|0
451375|NCT00381680|1489418|P1|Overall Study|Secondary Malignancy|3
451376|NCT00381680|1489417|P2|Overall Study|Alternative Therapy|5
451377|NCT00381680|1489418|P1|Overall Study|Alternative Therapy|11
451378|NCT00381680|1489417|P2|Overall Study|Entry onto another COG Trial|2
451379|NCT00381680|1489418|P1|Overall Study|Entry onto another COG Trial|1
451380|NCT00381680|1489417|P2|Overall Study|Withdrawal by Subject|1
451381|NCT00381680|1489418|P1|Overall Study|Withdrawal by Subject|3
451382|NCT00381680|1489417|P2|Overall Study|Physician Decision|6
451383|NCT00381680|1489418|P1|Overall Study|Physician Decision|25
451384|NCT00381680|1489417|P2|Overall Study|Lost to Follow-up|2
451385|NCT00381680|1489418|P1|Overall Study|Lost to Follow-up|3
451386|NCT00381680|1489417|P2|Overall Study|Death|7
451387|NCT00381680|1489418|P1|Overall Study|Death|10
451388|NCT00381680|1489417|P2|Overall Study|Adverse Event|3
451389|NCT00381680|1489418|P1|Overall Study|Adverse Event|9
451390|NCT00381641|1489435|P2|Overall Study|Withdrawal by Subject|2
451391|NCT00381641|1489436|P1|Overall Study|Withdrawal by Subject|0
451392|NCT00381615|1489469|P4|Overall Study|Protocol Violation|0
451393|NCT00381615|1489470|P3|Overall Study|Protocol Violation|1
451394|NCT00381615|1489471|P2|Overall Study|Protocol Violation|0
451395|NCT00381615|1489472|P1|Overall Study|Protocol Violation|0
451396|NCT00381615|1489469|P4|Overall Study|Lost to Follow-up|1
451397|NCT00381615|1489470|P3|Overall Study|Lost to Follow-up|0
451398|NCT00381615|1489471|P2|Overall Study|Lost to Follow-up|2
451399|NCT00381615|1489472|P1|Overall Study|Lost to Follow-up|3
451400|NCT00381615|1489469|P4|Overall Study|Withdrawal by Subject|1
451401|NCT00381615|1489470|P3|Overall Study|Withdrawal by Subject|0
451402|NCT00381615|1489471|P2|Overall Study|Withdrawal by Subject|3
451403|NCT00381615|1489472|P1|Overall Study|Withdrawal by Subject|1
451404|NCT00381563|1489524|P2|Overall Study|Protocol Violation|1
451405|NCT00381563|1489525|P1|Overall Study|Protocol Violation|0
451406|NCT00381563|1489524|P2|Overall Study|Lost to Follow-up|0
451407|NCT00381563|1489525|P1|Overall Study|Lost to Follow-up|2
451408|NCT00381563|1489524|P2|Overall Study|Withdrawal by Subject|5
451409|NCT00381563|1489525|P1|Overall Study|Withdrawal by Subject|5
451410|NCT00381485|1489540|P4|Double-Blind Treatment Period|Administrative|1
451411|NCT00381485|1489541|P3|Double-Blind Treatment Period|Administrative|0
451412|NCT00381485|1489542|P2|Double-Blind Treatment Period|Administrative|1
451413|NCT00381485|1489543|P1|Double-Blind Treatment Period|Administrative|0
451414|NCT00381485|1489540|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
451415|NCT00381485|1489541|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
451416|NCT00381485|1489542|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
451417|NCT00381485|1489543|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
451418|NCT00381485|1489540|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
451419|NCT00381485|1489541|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
451420|NCT00381485|1489542|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
451421|NCT00381485|1489543|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
451422|NCT00381485|1489540|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
451423|NCT00381485|1489541|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
451424|NCT00381485|1489542|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
451425|NCT00381485|1489543|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
451426|NCT00381485|1489540|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
451427|NCT00381485|1489541|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
451428|NCT00381485|1489542|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
451429|NCT00381485|1489543|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
451430|NCT00381485|1489540|P4|Double-Blind Treatment Period|Lost to Follow-up|1
451431|NCT00381485|1489541|P3|Double-Blind Treatment Period|Lost to Follow-up|1
451432|NCT00381485|1489542|P2|Double-Blind Treatment Period|Lost to Follow-up|0
451433|NCT00381485|1489543|P1|Double-Blind Treatment Period|Lost to Follow-up|0
451434|NCT00381485|1489540|P4|Double-Blind Treatment Period|Lack of Efficacy|13
451435|NCT00381485|1489541|P3|Double-Blind Treatment Period|Lack of Efficacy|11
451436|NCT00381485|1489542|P2|Double-Blind Treatment Period|Lack of Efficacy|8
451437|NCT00381485|1489543|P1|Double-Blind Treatment Period|Lack of Efficacy|0
451438|NCT00381485|1489540|P4|Double-Blind Treatment Period|Adverse Event|5
451439|NCT00381485|1489541|P3|Double-Blind Treatment Period|Adverse Event|2
451440|NCT00381485|1489542|P2|Double-Blind Treatment Period|Adverse Event|2
451441|NCT00381485|1489543|P1|Double-Blind Treatment Period|Adverse Event|0
451442|NCT00381485|1489540|P4|Open-Label Run-In Period|Treatment failure|0
451443|NCT00381485|1489541|P3|Open-Label Run-In Period|Treatment failure|0
451444|NCT00381485|1489542|P2|Open-Label Run-In Period|Treatment failure|0
451445|NCT00381485|1489543|P1|Open-Label Run-In Period|Treatment failure|1
451446|NCT00381485|1489540|P4|Open-Label Run-In Period|Lost to Follow-up|0
451447|NCT00381485|1489541|P3|Open-Label Run-In Period|Lost to Follow-up|0
451448|NCT00381485|1489542|P2|Open-Label Run-In Period|Lost to Follow-up|0
451449|NCT00381485|1489543|P1|Open-Label Run-In Period|Lost to Follow-up|3
451450|NCT00381485|1489540|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
451451|NCT00381485|1489541|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
451452|NCT00381485|1489542|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
451453|NCT00381485|1489543|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
451454|NCT00381485|1489540|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
451455|NCT00381485|1489541|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
451456|NCT00381485|1489542|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
451457|NCT00381485|1489543|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
451458|NCT00381485|1489540|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
451459|NCT00381485|1489541|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
451460|NCT00381485|1489542|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
451461|NCT00381485|1489543|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
451462|NCT00381485|1489540|P4|Open-Label Run-In Period|Adverse Event|0
451463|NCT00381485|1489541|P3|Open-Label Run-In Period|Adverse Event|0
451464|NCT00381485|1489542|P2|Open-Label Run-In Period|Adverse Event|0
451465|NCT00381485|1489543|P1|Open-Label Run-In Period|Adverse Event|9
451466|NCT00381381|1489561|P1|Overall Study|Withdrawal by Subject|9
451467|NCT00381381|1489561|P1|Overall Study|Lost to Follow-up|52
451468|NCT00381381|1489561|P1|Overall Study|Adverse Event|3
451469|NCT00381303|1489570|P2|Overall Study|Subject primary physician's decision|0
451470|NCT00381303|1489571|P1|Overall Study|Subject primary physician's decision|1
451471|NCT00381303|1489570|P2|Overall Study|Subject did not continue visits|0
451472|NCT00381303|1489571|P1|Overall Study|Subject did not continue visits|1
451473|NCT00381303|1489570|P2|Overall Study|Subject was too busy for appointments|0
451474|NCT00381303|1489571|P1|Overall Study|Subject was too busy for appointments|1
451475|NCT00381303|1489570|P2|Overall Study|No virologic response by week 12|0
451476|NCT00381303|1489571|P1|Overall Study|No virologic response by week 12|1
451477|NCT00381303|1489570|P2|Overall Study|Subject taking too many different meds|0
451478|NCT00381303|1489571|P1|Overall Study|Subject taking too many different meds|1
451479|NCT00381303|1489570|P2|Overall Study|Subject moved out of state|0
451480|NCT00381303|1489571|P1|Overall Study|Subject moved out of state|2
451481|NCT00381303|1489570|P2|Overall Study|Physician's decision to close the site|1
451482|NCT00381303|1489571|P1|Overall Study|Physician's decision to close the site|3
451483|NCT00381303|1489570|P2|Overall Study|Physician Decision|0
451484|NCT00381303|1489571|P1|Overall Study|Physician Decision|1
451485|NCT00381303|1489570|P2|Overall Study|Pregnancy|0
451486|NCT00381303|1489571|P1|Overall Study|Pregnancy|2
451487|NCT00381303|1489570|P2|Overall Study|Ineligible to continue the trial|1
451488|NCT00381303|1489571|P1|Overall Study|Ineligible to continue the trial|2
451489|NCT00381303|1489570|P2|Overall Study|Virologic failure|4
451490|NCT00381303|1489571|P1|Overall Study|Virologic failure|6
451491|NCT00381303|1489570|P2|Overall Study|Withdrawal by Subject|6
451492|NCT00381303|1489571|P1|Overall Study|Withdrawal by Subject|13
451493|NCT00381303|1489570|P2|Overall Study|Non-Adherence|6
451494|NCT00381303|1489571|P1|Overall Study|Non-Adherence|13
451495|NCT00381303|1489570|P2|Overall Study|AE/HIV-related event|6
451496|NCT00381303|1489571|P1|Overall Study|AE/HIV-related event|22
451497|NCT00381303|1489570|P2|Overall Study|Lost to Follow-up|9
451498|NCT00381303|1489571|P1|Overall Study|Lost to Follow-up|25
451499|NCT00381238|1489631|P1|Overall Study|Disease progression|1
451500|NCT00381238|1489631|P1|Overall Study|Withdrew by physician|1
451501|NCT00381238|1489631|P1|Overall Study|Lack of Efficacy|2
451502|NCT00381238|1489631|P1|Overall Study|Withdrawal by Subject|4
451503|NCT00381238|1489631|P1|Overall Study|Protocol Violation|1
451504|NCT00381238|1489631|P1|Overall Study|Adverse Event|3
451505|NCT00381095|1489647|P2|Overall Study|Adverse Event|7
451506|NCT00381095|1489648|P1|Overall Study|Adverse Event|2
451507|NCT00381095|1489647|P2|Overall Study|Withdrawal by Subject|3
451508|NCT00381095|1489648|P1|Overall Study|Withdrawal by Subject|3
451509|NCT00381095|1489647|P2|Overall Study|Protocol Violation|1
451510|NCT00381095|1489648|P1|Overall Study|Protocol Violation|1
451511|NCT00381095|1489647|P2|Overall Study|Other|2
451512|NCT00381095|1489648|P1|Overall Study|Other|2
451513|NCT00381095|1489647|P2|Overall Study|Lack of Efficacy|4
451514|NCT00381095|1489648|P1|Overall Study|Lack of Efficacy|2
451515|NCT00381095|1489647|P2|Overall Study|Death|4
451516|NCT00381095|1489648|P1|Overall Study|Death|3
451517|NCT00381043|1489680|P2|Overall Study|incarcerated|0
451518|NCT00381043|1489681|P1|Overall Study|incarcerated|1
451519|NCT00381043|1489680|P2|Overall Study|wanted more care|1
451520|NCT00381043|1489681|P1|Overall Study|wanted more care|0
451521|NCT00381043|1489680|P2|Overall Study|Withdrawal by Subject|1
451522|NCT00381043|1489681|P1|Overall Study|Withdrawal by Subject|3
451523|NCT00381043|1489680|P2|Overall Study|Lost to Follow-up|6
451524|NCT00381043|1489681|P1|Overall Study|Lost to Follow-up|8
451525|NCT00380978|1489707|P2|Overall Study|Parous patient|0
451526|NCT00380978|1489708|P1|Overall Study|Parous patient|1
451527|NCT00380978|1489707|P2|Overall Study|Allocation prior to analgesia request|2
451528|NCT00380978|1489708|P1|Overall Study|Allocation prior to analgesia request|1
451529|NCT00380978|1489707|P2|Overall Study|Wrong study envelope|2
451530|NCT00380978|1489708|P1|Overall Study|Wrong study envelope|0
451531|NCT00380978|1489707|P2|Overall Study|Refused allocated intervention|6
451532|NCT00380978|1489708|P1|Overall Study|Refused allocated intervention|0
451533|NCT00380874|1489730|P2|Overall Study|Not related to study drug|2
451534|NCT00380874|1489731|P1|Overall Study|Not related to study drug|3
451535|NCT00380874|1489730|P2|Overall Study|Withdrawal by Subject|1
451536|NCT00380874|1489731|P1|Overall Study|Withdrawal by Subject|2
451537|NCT00380874|1489730|P2|Overall Study|Death|0
451538|NCT00380874|1489731|P1|Overall Study|Death|1
451539|NCT00380874|1489730|P2|Overall Study|Adverse Event|7
451540|NCT00380874|1489731|P1|Overall Study|Adverse Event|7
451541|NCT00380718|1489756|P1|Overall Study|Death after 30-day post-therapy followup|17
451542|NCT00380718|1489756|P1|Overall Study|Adverse Event|1
451543|NCT00380692|1489768|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
451544|NCT00380692|1489769|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
451545|NCT00380692|1489768|P2|Study Period III - Open Label|Lack of Efficacy|4
451546|NCT00380692|1489769|P1|Study Period III - Open Label|Lack of Efficacy|0
451547|NCT00380692|1489768|P2|Study Period III - Open Label|Physician Decision|3
451548|NCT00380692|1489769|P1|Study Period III - Open Label|Physician Decision|0
451549|NCT00380692|1489768|P2|Study Period III - Open Label|Withdrawal by Subject|1
451550|NCT00380692|1489769|P1|Study Period III - Open Label|Withdrawal by Subject|0
451551|NCT00380692|1489768|P2|Study Period III - Open Label|Protocol Violation|0
451552|NCT00380692|1489769|P1|Study Period III - Open Label|Protocol Violation|0
451553|NCT00380692|1489768|P2|Study Period III - Open Label|Adverse Event|3
451554|NCT00380692|1489769|P1|Study Period III - Open Label|Adverse Event|5
451555|NCT00380692|1489768|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
451556|NCT00380692|1489769|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
451557|NCT00380692|1489768|P2|Study Period II - Double Blind|Lack of Efficacy|0
451558|NCT00380692|1489769|P1|Study Period II - Double Blind|Lack of Efficacy|1
451559|NCT00380692|1489768|P2|Study Period II - Double Blind|Physician Decision|1
451560|NCT00380692|1489769|P1|Study Period II - Double Blind|Physician Decision|0
451561|NCT00380692|1489768|P2|Study Period II - Double Blind|Withdrawal by Subject|0
451562|NCT00380692|1489769|P1|Study Period II - Double Blind|Withdrawal by Subject|0
451563|NCT00380692|1489768|P2|Study Period II - Double Blind|Protocol Violation|2
451564|NCT00380692|1489769|P1|Study Period II - Double Blind|Protocol Violation|2
451565|NCT00380692|1489768|P2|Study Period II - Double Blind|Adverse Event|0
451566|NCT00380692|1489769|P1|Study Period II - Double Blind|Adverse Event|1
451567|NCT00380588|1489817|P2|Overall Study|Physician Decision|0
451568|NCT00380588|1489818|P1|Overall Study|Physician Decision|2
451569|NCT00380588|1489817|P2|Overall Study|Withdrawal by Subject|3
451570|NCT00380588|1489818|P1|Overall Study|Withdrawal by Subject|1
451571|NCT00380588|1489817|P2|Overall Study|Adverse Event|3
451572|NCT00380588|1489818|P1|Overall Study|Adverse Event|7
451573|NCT00380588|1489817|P2|Overall Study|Next Cycle Not Started|0
451574|NCT00380588|1489818|P1|Overall Study|Next Cycle Not Started|4
451575|NCT00380588|1489817|P2|Overall Study|Unequivocal Disease Progression|34
451576|NCT00380588|1489818|P1|Overall Study|Unequivocal Disease Progression|25
451577|NCT00380367|1489830|P1|Overall Study|Withdrawal by Subject|1
451578|NCT00380367|1489830|P1|Overall Study|Lost to Follow-up|1
451579|NCT00380250|1489837|P2|Overall Study|Physician Decision|0
451580|NCT00380250|1489838|P1|Overall Study|Physician Decision|1
451581|NCT00380250|1489837|P2|Overall Study|Lost to Follow-up|5
451582|NCT00380250|1489838|P1|Overall Study|Lost to Follow-up|14
451583|NCT00380250|1489837|P2|Overall Study|Protocol Violation|5
451584|NCT00380250|1489838|P1|Overall Study|Protocol Violation|15
451585|NCT00380250|1489837|P2|Overall Study|Lack of Efficacy|8
451586|NCT00380250|1489838|P1|Overall Study|Lack of Efficacy|10
451587|NCT00380250|1489837|P2|Overall Study|Adverse Event|9
451588|NCT00380250|1489838|P1|Overall Study|Adverse Event|20
451589|NCT00380250|1489837|P2|Overall Study|Withdrawal by Subject|28
451590|NCT00380250|1489838|P1|Overall Study|Withdrawal by Subject|39
451591|NCT00380081|1489906|P6|Overall Study|Family Emergency|1
451592|NCT00380081|1489907|P5|Overall Study|Family Emergency|0
451593|NCT00380081|1489908|P4|Overall Study|Family Emergency|0
451594|NCT00380081|1489909|P3|Overall Study|Family Emergency|0
451595|NCT00380081|1489910|P2|Overall Study|Family Emergency|0
451596|NCT00380081|1489911|P1|Overall Study|Family Emergency|0
451597|NCT00380081|1489906|P6|Overall Study|Withdrawal by Subject|0
451598|NCT00380081|1489907|P5|Overall Study|Withdrawal by Subject|1
451599|NCT00380081|1489908|P4|Overall Study|Withdrawal by Subject|0
451600|NCT00380081|1489909|P3|Overall Study|Withdrawal by Subject|0
451601|NCT00380081|1489910|P2|Overall Study|Withdrawal by Subject|0
451602|NCT00380081|1489911|P1|Overall Study|Withdrawal by Subject|0
451603|NCT00380068|1489961|P1|Overall Study|Lack of Efficacy|5
451604|NCT00380068|1489961|P1|Overall Study|Partipant moved away|1
451605|NCT00380068|1489961|P1|Overall Study|Physician Decision|2
451606|NCT00380068|1489961|P1|Overall Study|Lung transplant|3
451607|NCT00380068|1489961|P1|Overall Study|Addition of other PAH therapeutic agent|1
451608|NCT00380068|1489961|P1|Overall Study|Lost to Follow-up|1
451609|NCT00380068|1489961|P1|Overall Study|Not compliant|6
451610|NCT00380068|1489961|P1|Overall Study|Withdrawal by Subject|10
451611|NCT00380068|1489961|P1|Overall Study|Adverse Event|40
451612|NCT00379912|1489993|P2|Overall Study|Lack of Efficacy|0
451613|NCT00379912|1489994|P1|Overall Study|Lack of Efficacy|1
451614|NCT00379899|1490016|P2|Overall Study|Other|1
451615|NCT00379899|1490017|P1|Overall Study|Other|3
451616|NCT00379899|1490016|P2|Overall Study|Other protocol-specified criteria|4
451617|NCT00379899|1490017|P1|Overall Study|Other protocol-specified criteria|3
451618|NCT00379899|1490016|P2|Overall Study|Coronary artery bypass graft|1
451619|NCT00379899|1490017|P1|Overall Study|Coronary artery bypass graft|1
451620|NCT00379899|1490016|P2|Overall Study|Renal transplantation|4
451621|NCT00379899|1490017|P1|Overall Study|Renal transplantation|5
451622|NCT00379899|1490016|P2|Overall Study|Parathyroidectomy|2
451623|NCT00379899|1490017|P1|Overall Study|Parathyroidectomy|0
451624|NCT00379899|1490016|P2|Overall Study|Noncompliance|1
451625|NCT00379899|1490017|P1|Overall Study|Noncompliance|1
451626|NCT00379899|1490016|P2|Overall Study|Ineligibility determined|1
451627|NCT00379899|1490017|P1|Overall Study|Ineligibility determined|0
451628|NCT00379899|1490016|P2|Overall Study|Withdrawal by Subject|5
451629|NCT00379899|1490017|P1|Overall Study|Withdrawal by Subject|5
451630|NCT00379899|1490016|P2|Overall Study|Physician Decision|4
451631|NCT00379899|1490017|P1|Overall Study|Physician Decision|3
451632|NCT00379899|1490016|P2|Overall Study|Lost to Follow-up|4
451633|NCT00379899|1490017|P1|Overall Study|Lost to Follow-up|2
451634|NCT00379899|1490016|P2|Overall Study|Death|10
451635|NCT00379899|1490017|P1|Overall Study|Death|10
451636|NCT00379899|1490016|P2|Overall Study|Adverse Event|3
451637|NCT00379899|1490017|P1|Overall Study|Adverse Event|7
451638|NCT00379834|1490045|P1|Overall Study|Time constraints|2
451639|NCT00379808|1490197|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
451640|NCT00379808|1490198|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
451641|NCT00379795|1490219|P5|Overall Study|Sponsor's decision|10
451642|NCT00379795|1490220|P4|Overall Study|Sponsor's decision|47
451643|NCT00379795|1490221|P3|Overall Study|Sponsor's decision|54
451644|NCT00379795|1490222|P2|Overall Study|Sponsor's decision|17
451645|NCT00379795|1490223|P1|Overall Study|Sponsor's decision|257
451646|NCT00379795|1490219|P5|Overall Study|Subjects condition mandated intervention|7
451647|NCT00379795|1490220|P4|Overall Study|Subjects condition mandated intervention|5
451648|NCT00379795|1490221|P3|Overall Study|Subjects condition mandated intervention|7
451649|NCT00379795|1490222|P2|Overall Study|Subjects condition mandated intervention|9
451650|NCT00379795|1490223|P1|Overall Study|Subjects condition mandated intervention|34
451651|NCT00379795|1490219|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
451652|NCT00379795|1490220|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
451653|NCT00379795|1490221|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
451654|NCT00379795|1490222|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
451655|NCT00379795|1490223|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
451656|NCT00379795|1490219|P5|Overall Study|Subject non-compliance|1
451657|NCT00379795|1490220|P4|Overall Study|Subject non-compliance|0
451658|NCT00379795|1490221|P3|Overall Study|Subject non-compliance|0
451659|NCT00379795|1490222|P2|Overall Study|Subject non-compliance|2
451660|NCT00379795|1490223|P1|Overall Study|Subject non-compliance|7
451661|NCT00379795|1490219|P5|Overall Study|Withdrawal by Subject|14
451662|NCT00379795|1490220|P4|Overall Study|Withdrawal by Subject|7
451663|NCT00379795|1490221|P3|Overall Study|Withdrawal by Subject|19
451664|NCT00379795|1490222|P2|Overall Study|Withdrawal by Subject|11
451665|NCT00379795|1490223|P1|Overall Study|Withdrawal by Subject|94
451666|NCT00379795|1490219|P5|Overall Study|Physician Decision|2
451667|NCT00379795|1490220|P4|Overall Study|Physician Decision|2
451668|NCT00379795|1490221|P3|Overall Study|Physician Decision|2
451669|NCT00379795|1490222|P2|Overall Study|Physician Decision|0
451670|NCT00379795|1490223|P1|Overall Study|Physician Decision|25
451671|NCT00379795|1490219|P5|Overall Study|Lost to Follow-up|4
451672|NCT00379795|1490220|P4|Overall Study|Lost to Follow-up|1
451673|NCT00379795|1490221|P3|Overall Study|Lost to Follow-up|2
451674|NCT00379795|1490222|P2|Overall Study|Lost to Follow-up|1
451675|NCT00379795|1490223|P1|Overall Study|Lost to Follow-up|8
451676|NCT00379795|1490219|P5|Overall Study|Adverse Event|4
451677|NCT00379795|1490220|P4|Overall Study|Adverse Event|1
451678|NCT00379795|1490221|P3|Overall Study|Adverse Event|3
451679|NCT00379795|1490222|P2|Overall Study|Adverse Event|3
451680|NCT00379795|1490223|P1|Overall Study|Adverse Event|17
451681|NCT00379795|1490219|P5|Overall Study|Death|7
451682|NCT00379795|1490220|P4|Overall Study|Death|4
451683|NCT00379795|1490221|P3|Overall Study|Death|6
451684|NCT00379795|1490222|P2|Overall Study|Death|8
451685|NCT00379795|1490223|P1|Overall Study|Death|31
451686|NCT00379769|1490253|P6|Observational Follow-up|Unknown; Reason Not Provided|1
451687|NCT00379769|1490254|P5|Observational Follow-up|Unknown; Reason Not Provided|1
451688|NCT00379769|1490255|P4|Observational Follow-up|Unknown; Reason Not Provided|0
451689|NCT00379769|1490256|P3|Observational Follow-up|Unknown; Reason Not Provided|0
451690|NCT00379769|1490257|P2|Observational Follow-up|Unknown; Reason Not Provided|0
451691|NCT00379769|1490258|P1|Observational Follow-up|Unknown; Reason Not Provided|0
451692|NCT00379769|1490253|P6|Observational Follow-up|Participant Moved|1
451693|NCT00379769|1490254|P5|Observational Follow-up|Participant Moved|0
451694|NCT00379769|1490255|P4|Observational Follow-up|Participant Moved|0
451695|NCT00379769|1490256|P3|Observational Follow-up|Participant Moved|0
451696|NCT00379769|1490257|P2|Observational Follow-up|Participant Moved|0
451697|NCT00379769|1490258|P1|Observational Follow-up|Participant Moved|0
451698|NCT00379769|1490253|P6|Observational Follow-up|Site Closed Early|7
451699|NCT00379769|1490254|P5|Observational Follow-up|Site Closed Early|6
451700|NCT00379769|1490255|P4|Observational Follow-up|Site Closed Early|0
451701|NCT00379769|1490256|P3|Observational Follow-up|Site Closed Early|0
451702|NCT00379769|1490257|P2|Observational Follow-up|Site Closed Early|0
451703|NCT00379769|1490258|P1|Observational Follow-up|Site Closed Early|0
451704|NCT00379769|1490253|P6|Observational Follow-up|Physician Decision|8
451705|NCT00379769|1490254|P5|Observational Follow-up|Physician Decision|8
451706|NCT00379769|1490255|P4|Observational Follow-up|Physician Decision|0
451707|NCT00379769|1490256|P3|Observational Follow-up|Physician Decision|0
451708|NCT00379769|1490257|P2|Observational Follow-up|Physician Decision|0
451709|NCT00379769|1490258|P1|Observational Follow-up|Physician Decision|0
451710|NCT00379769|1490253|P6|Observational Follow-up|Entered into Another Clinical Trial|22
451711|NCT00379769|1490254|P5|Observational Follow-up|Entered into Another Clinical Trial|18
451712|NCT00379769|1490255|P4|Observational Follow-up|Entered into Another Clinical Trial|0
451713|NCT00379769|1490256|P3|Observational Follow-up|Entered into Another Clinical Trial|0
451714|NCT00379769|1490257|P2|Observational Follow-up|Entered into Another Clinical Trial|0
451715|NCT00379769|1490258|P1|Observational Follow-up|Entered into Another Clinical Trial|0
451716|NCT00379769|1490253|P6|Observational Follow-up|Withdrawal by Subject|12
451717|NCT00379769|1490254|P5|Observational Follow-up|Withdrawal by Subject|12
451718|NCT00379769|1490255|P4|Observational Follow-up|Withdrawal by Subject|0
451719|NCT00379769|1490256|P3|Observational Follow-up|Withdrawal by Subject|0
451720|NCT00379769|1490257|P2|Observational Follow-up|Withdrawal by Subject|0
451721|NCT00379769|1490258|P1|Observational Follow-up|Withdrawal by Subject|0
451722|NCT00379769|1490253|P6|Observational Follow-up|Lost to Follow-up|27
451723|NCT00379769|1490254|P5|Observational Follow-up|Lost to Follow-up|25
451724|NCT00379769|1490255|P4|Observational Follow-up|Lost to Follow-up|0
451725|NCT00379769|1490256|P3|Observational Follow-up|Lost to Follow-up|0
451726|NCT00379769|1490257|P2|Observational Follow-up|Lost to Follow-up|0
451727|NCT00379769|1490258|P1|Observational Follow-up|Lost to Follow-up|0
451728|NCT00379769|1490253|P6|Observational Follow-up|Adverse Event|0
451729|NCT00379769|1490254|P5|Observational Follow-up|Adverse Event|1
451730|NCT00379769|1490255|P4|Observational Follow-up|Adverse Event|0
451731|NCT00379769|1490256|P3|Observational Follow-up|Adverse Event|0
451732|NCT00379769|1490257|P2|Observational Follow-up|Adverse Event|0
451733|NCT00379769|1490258|P1|Observational Follow-up|Adverse Event|0
451734|NCT00379769|1490253|P6|Observational Follow-up|Death|70
451735|NCT00379769|1490254|P5|Observational Follow-up|Death|78
451736|NCT00379769|1490255|P4|Observational Follow-up|Death|0
451737|NCT00379769|1490256|P3|Observational Follow-up|Death|0
451738|NCT00379769|1490257|P2|Observational Follow-up|Death|0
451739|NCT00379769|1490258|P1|Observational Follow-up|Death|0
451740|NCT00379769|1490253|P6|Main Study|Reason unspecified|0
451741|NCT00379769|1490254|P5|Main Study|Reason unspecified|0
451742|NCT00379769|1490255|P4|Main Study|Reason unspecified|0
451743|NCT00379769|1490256|P3|Main Study|Reason unspecified|1
451744|NCT00379769|1490257|P2|Main Study|Reason unspecified|0
451745|NCT00379769|1490258|P1|Main Study|Reason unspecified|0
451746|NCT00379769|1490253|P6|Main Study|Investigator refused to log temperature|0
451747|NCT00379769|1490254|P5|Main Study|Investigator refused to log temperature|0
451748|NCT00379769|1490255|P4|Main Study|Investigator refused to log temperature|0
451749|NCT00379769|1490256|P3|Main Study|Investigator refused to log temperature|1
451750|NCT00379769|1490257|P2|Main Study|Investigator refused to log temperature|0
451751|NCT00379769|1490258|P1|Main Study|Investigator refused to log temperature|0
451752|NCT00379769|1490253|P6|Main Study|Risk of heart failure|0
451753|NCT00379769|1490254|P5|Main Study|Risk of heart failure|0
451754|NCT00379769|1490255|P4|Main Study|Risk of heart failure|0
451755|NCT00379769|1490256|P3|Main Study|Risk of heart failure|0
451756|NCT00379769|1490257|P2|Main Study|Risk of heart failure|1
451757|NCT00379769|1490258|P1|Main Study|Risk of heart failure|0
451758|NCT00379769|1490253|P6|Main Study|Personal reasons|0
451759|NCT00379769|1490254|P5|Main Study|Personal reasons|0
451760|NCT00379769|1490255|P4|Main Study|Personal reasons|0
451761|NCT00379769|1490256|P3|Main Study|Personal reasons|0
451762|NCT00379769|1490257|P2|Main Study|Personal reasons|0
451763|NCT00379769|1490258|P1|Main Study|Personal reasons|1
451764|NCT00379769|1490253|P6|Main Study|Participant completed study at visit 27|0
451765|NCT00379769|1490254|P5|Main Study|Participant completed study at visit 27|0
451766|NCT00379769|1490255|P4|Main Study|Participant completed study at visit 27|0
451767|NCT00379769|1490256|P3|Main Study|Participant completed study at visit 27|0
451768|NCT00379769|1490257|P2|Main Study|Participant completed study at visit 27|0
451769|NCT00379769|1490258|P1|Main Study|Participant completed study at visit 27|1
451770|NCT00379769|1490253|P6|Main Study|Physician Decision|0
451771|NCT00379769|1490254|P5|Main Study|Physician Decision|0
451772|NCT00379769|1490255|P4|Main Study|Physician Decision|1
451773|NCT00379769|1490256|P3|Main Study|Physician Decision|1
451774|NCT00379769|1490257|P2|Main Study|Physician Decision|2
451775|NCT00379769|1490258|P1|Main Study|Physician Decision|2
451776|NCT00379769|1490253|P6|Main Study|Participant did not take study drug|0
451777|NCT00379769|1490254|P5|Main Study|Participant did not take study drug|0
451778|NCT00379769|1490255|P4|Main Study|Participant did not take study drug|0
451779|NCT00379769|1490256|P3|Main Study|Participant did not take study drug|1
451780|NCT00379769|1490257|P2|Main Study|Participant did not take study drug|0
451781|NCT00379769|1490258|P1|Main Study|Participant did not take study drug|0
451782|NCT00379769|1490253|P6|Main Study|Entry criteria violation|0
451783|NCT00379769|1490254|P5|Main Study|Entry criteria violation|0
451784|NCT00379769|1490255|P4|Main Study|Entry criteria violation|1
451785|NCT00379769|1490256|P3|Main Study|Entry criteria violation|1
451786|NCT00379769|1490257|P2|Main Study|Entry criteria violation|0
451787|NCT00379769|1490258|P1|Main Study|Entry criteria violation|0
451788|NCT00379769|1490253|P6|Main Study|Site closed|0
451789|NCT00379769|1490254|P5|Main Study|Site closed|0
451790|NCT00379769|1490255|P4|Main Study|Site closed|8
451791|NCT00379769|1490256|P3|Main Study|Site closed|4
451792|NCT00379769|1490257|P2|Main Study|Site closed|4
451793|NCT00379769|1490258|P1|Main Study|Site closed|4
451794|NCT00379769|1490253|P6|Main Study|Prohibited glucose lowering medication|0
451795|NCT00379769|1490254|P5|Main Study|Prohibited glucose lowering medication|0
451796|NCT00379769|1490255|P4|Main Study|Prohibited glucose lowering medication|1
451797|NCT00379769|1490256|P3|Main Study|Prohibited glucose lowering medication|0
451798|NCT00379769|1490257|P2|Main Study|Prohibited glucose lowering medication|3
451799|NCT00379769|1490258|P1|Main Study|Prohibited glucose lowering medication|0
451800|NCT00379769|1490253|P6|Main Study|Poor compliance|0
451801|NCT00379769|1490254|P5|Main Study|Poor compliance|0
451802|NCT00379769|1490255|P4|Main Study|Poor compliance|1
451803|NCT00379769|1490256|P3|Main Study|Poor compliance|2
451804|NCT00379769|1490257|P2|Main Study|Poor compliance|2
451805|NCT00379769|1490258|P1|Main Study|Poor compliance|3
451806|NCT00379769|1490253|P6|Main Study|Participant moved|0
451807|NCT00379769|1490254|P5|Main Study|Participant moved|0
451808|NCT00379769|1490255|P4|Main Study|Participant moved|3
451809|NCT00379769|1490256|P3|Main Study|Participant moved|3
451810|NCT00379769|1490257|P2|Main Study|Participant moved|2
451811|NCT00379769|1490258|P1|Main Study|Participant moved|3
451812|NCT00379769|1490253|P6|Main Study|Moved to survival status follow-up only|0
451813|NCT00379769|1490254|P5|Main Study|Moved to survival status follow-up only|0
451814|NCT00379769|1490255|P4|Main Study|Moved to survival status follow-up only|36
451815|NCT00379769|1490256|P3|Main Study|Moved to survival status follow-up only|32
451816|NCT00379769|1490257|P2|Main Study|Moved to survival status follow-up only|25
451817|NCT00379769|1490258|P1|Main Study|Moved to survival status follow-up only|27
451818|NCT00379769|1490253|P6|Main Study|Withdrawal by Subject|0
451819|NCT00379769|1490254|P5|Main Study|Withdrawal by Subject|0
451820|NCT00379769|1490255|P4|Main Study|Withdrawal by Subject|70
451821|NCT00379769|1490256|P3|Main Study|Withdrawal by Subject|72
451822|NCT00379769|1490257|P2|Main Study|Withdrawal by Subject|56
451823|NCT00379769|1490258|P1|Main Study|Withdrawal by Subject|46
451824|NCT00379769|1490253|P6|Main Study|Lost to Follow-up|0
451825|NCT00379769|1490254|P5|Main Study|Lost to Follow-up|0
451826|NCT00379769|1490255|P4|Main Study|Lost to Follow-up|26
451827|NCT00379769|1490256|P3|Main Study|Lost to Follow-up|25
451828|NCT00379769|1490257|P2|Main Study|Lost to Follow-up|29
451829|NCT00379769|1490258|P1|Main Study|Lost to Follow-up|29
451830|NCT00379769|1490253|P6|Main Study|Adverse Event|0
451831|NCT00379769|1490254|P5|Main Study|Adverse Event|0
451832|NCT00379769|1490255|P4|Main Study|Adverse Event|11
451833|NCT00379769|1490256|P3|Main Study|Adverse Event|10
451834|NCT00379769|1490257|P2|Main Study|Adverse Event|8
451835|NCT00379769|1490258|P1|Main Study|Adverse Event|5
451836|NCT00379769|1490253|P6|Main Study|Death|0
451837|NCT00379769|1490254|P5|Main Study|Death|0
451838|NCT00379769|1490255|P4|Main Study|Death|72
451839|NCT00379769|1490256|P3|Main Study|Death|54
451840|NCT00379769|1490257|P2|Main Study|Death|67
451841|NCT00379769|1490258|P1|Main Study|Death|57
451842|NCT00379639|1490417|P5|Overall Study|Other|0
451843|NCT00379639|1490418|P4|Overall Study|Other|0
451844|NCT00379639|1490419|P3|Overall Study|Other|3
451845|NCT00379639|1490420|P2|Overall Study|Other|0
451846|NCT00379639|1490421|P1|Overall Study|Other|0
451847|NCT00379639|1490417|P5|Overall Study|Lost to Follow-up|0
451848|NCT00379639|1490418|P4|Overall Study|Lost to Follow-up|1
451849|NCT00379639|1490419|P3|Overall Study|Lost to Follow-up|0
451850|NCT00379639|1490420|P2|Overall Study|Lost to Follow-up|0
451851|NCT00379639|1490421|P1|Overall Study|Lost to Follow-up|0
451852|NCT00379639|1490417|P5|Overall Study|Adverse Event|1
451853|NCT00379639|1490418|P4|Overall Study|Adverse Event|0
451854|NCT00379639|1490419|P3|Overall Study|Adverse Event|1
451855|NCT00379639|1490420|P2|Overall Study|Adverse Event|0
451856|NCT00379639|1490421|P1|Overall Study|Adverse Event|0
451857|NCT00379639|1490417|P5|Overall Study|Symptomatic Deterioration|1
451858|NCT00379639|1490418|P4|Overall Study|Symptomatic Deterioration|0
451859|NCT00379639|1490419|P3|Overall Study|Symptomatic Deterioration|1
451860|NCT00379639|1490420|P2|Overall Study|Symptomatic Deterioration|0
451861|NCT00379639|1490421|P1|Overall Study|Symptomatic Deterioration|0
451862|NCT00379639|1490417|P5|Overall Study|Physician Decision|0
451863|NCT00379639|1490418|P4|Overall Study|Physician Decision|1
451864|NCT00379639|1490419|P3|Overall Study|Physician Decision|1
451865|NCT00379639|1490420|P2|Overall Study|Physician Decision|2
451866|NCT00379639|1490421|P1|Overall Study|Physician Decision|0
451867|NCT00379639|1490417|P5|Overall Study|Disease Progression|4
451868|NCT00379639|1490418|P4|Overall Study|Disease Progression|4
451869|NCT00379639|1490419|P3|Overall Study|Disease Progression|3
451870|NCT00379639|1490420|P2|Overall Study|Disease Progression|3
451871|NCT00379639|1490421|P1|Overall Study|Disease Progression|3
451872|NCT00379587|1490443|P1|Overall Study|Lost to Follow-up|2
451873|NCT00379353|1490457|P2|Overall Study|Conflicting drug treatment|1
451874|NCT00379353|1490458|P1|Overall Study|Conflicting drug treatment|0
451875|NCT00379353|1490457|P2|Overall Study|Non-compliance|0
451876|NCT00379353|1490458|P1|Overall Study|Non-compliance|1
451877|NCT00379353|1490457|P2|Overall Study|Cardiac Tamponade|0
451878|NCT00379353|1490458|P1|Overall Study|Cardiac Tamponade|1
451879|NCT00379353|1490457|P2|Overall Study|Death|0
451880|NCT00379353|1490458|P1|Overall Study|Death|1
451881|NCT00379353|1490457|P2|Overall Study|Withdrawal by Subject|2
451882|NCT00379353|1490458|P1|Overall Study|Withdrawal by Subject|5
451883|NCT00379353|1490457|P2|Overall Study|Hospitalization|3
451884|NCT00379353|1490458|P1|Overall Study|Hospitalization|3
451885|NCT00379340|1490493|P5|Overall Study|Delayed nephrectomy and anaplasia|1
451886|NCT00379340|1490494|P4|Overall Study|Delayed nephrectomy and anaplasia|1
451887|NCT00379340|1490495|P3|Overall Study|Delayed nephrectomy and anaplasia|0
451888|NCT00379340|1490496|P2|Overall Study|Delayed nephrectomy and anaplasia|0
451889|NCT00379340|1490497|P1|Overall Study|Delayed nephrectomy and anaplasia|0
451890|NCT00379340|1490493|P5|Overall Study|On more than 1 tumor therapeutic study|0
451891|NCT00379340|1490494|P4|Overall Study|On more than 1 tumor therapeutic study|2
451892|NCT00379340|1490495|P3|Overall Study|On more than 1 tumor therapeutic study|0
451893|NCT00379340|1490496|P2|Overall Study|On more than 1 tumor therapeutic study|0
451894|NCT00379340|1490497|P1|Overall Study|On more than 1 tumor therapeutic study|0
451895|NCT00379340|1490493|P5|Overall Study|Refusal of further protocol therapy|7
451896|NCT00379340|1490494|P4|Overall Study|Refusal of further protocol therapy|1
451897|NCT00379340|1490495|P3|Overall Study|Refusal of further protocol therapy|1
451898|NCT00379340|1490496|P2|Overall Study|Refusal of further protocol therapy|0
451899|NCT00379340|1490497|P1|Overall Study|Refusal of further protocol therapy|1
451900|NCT00379340|1490493|P5|Overall Study|Withdrawal by Subject|0
451901|NCT00379340|1490494|P4|Overall Study|Withdrawal by Subject|1
451902|NCT00379340|1490495|P3|Overall Study|Withdrawal by Subject|0
451903|NCT00379340|1490496|P2|Overall Study|Withdrawal by Subject|0
451904|NCT00379340|1490497|P1|Overall Study|Withdrawal by Subject|0
451905|NCT00379340|1490493|P5|Overall Study|Physician Decision|3
451906|NCT00379340|1490494|P4|Overall Study|Physician Decision|2
451907|NCT00379340|1490495|P3|Overall Study|Physician Decision|1
451908|NCT00379340|1490496|P2|Overall Study|Physician Decision|2
451909|NCT00379340|1490497|P1|Overall Study|Physician Decision|6
451910|NCT00379340|1490493|P5|Overall Study|Lack of Efficacy|3
451911|NCT00379340|1490494|P4|Overall Study|Lack of Efficacy|4
451912|NCT00379340|1490495|P3|Overall Study|Lack of Efficacy|0
451913|NCT00379340|1490496|P2|Overall Study|Lack of Efficacy|1
451914|NCT00379340|1490497|P1|Overall Study|Lack of Efficacy|6
451915|NCT00379340|1490493|P5|Overall Study|Death|0
451916|NCT00379340|1490494|P4|Overall Study|Death|2
451917|NCT00379340|1490495|P3|Overall Study|Death|0
451918|NCT00379340|1490496|P2|Overall Study|Death|0
451919|NCT00379340|1490497|P1|Overall Study|Death|0
451920|NCT00379288|1490514|P4|Overall Study|Administrative|1
451921|NCT00379288|1490515|P3|Overall Study|Administrative|0
451922|NCT00379288|1490516|P2|Overall Study|Administrative|2
451923|NCT00379288|1490517|P1|Overall Study|Administrative|2
451924|NCT00379288|1490514|P4|Overall Study|Did not meet protocol eligibility|2
451925|NCT00379288|1490515|P3|Overall Study|Did not meet protocol eligibility|0
451926|NCT00379288|1490516|P2|Overall Study|Did not meet protocol eligibility|1
451927|NCT00379288|1490517|P1|Overall Study|Did not meet protocol eligibility|0
451928|NCT00379288|1490514|P4|Overall Study|Noncompliance with protocol|1
451929|NCT00379288|1490515|P3|Overall Study|Noncompliance with protocol|2
451930|NCT00379288|1490516|P2|Overall Study|Noncompliance with protocol|6
451931|NCT00379288|1490517|P1|Overall Study|Noncompliance with protocol|8
451932|NCT00379288|1490514|P4|Overall Study|Subject withdrew-related to study drug|1
451933|NCT00379288|1490515|P3|Overall Study|Subject withdrew-related to study drug|0
451934|NCT00379288|1490516|P2|Overall Study|Subject withdrew-related to study drug|0
451935|NCT00379288|1490517|P1|Overall Study|Subject withdrew-related to study drug|1
451936|NCT00379288|1490514|P4|Overall Study|Subject withdrew-unrelated to study drug|2
451937|NCT00379288|1490515|P3|Overall Study|Subject withdrew-unrelated to study drug|4
451938|NCT00379288|1490516|P2|Overall Study|Subject withdrew-unrelated to study drug|3
451939|NCT00379288|1490517|P1|Overall Study|Subject withdrew-unrelated to study drug|0
451940|NCT00379288|1490514|P4|Overall Study|Lost to Follow-up|0
451941|NCT00379288|1490515|P3|Overall Study|Lost to Follow-up|2
451942|NCT00379288|1490516|P2|Overall Study|Lost to Follow-up|3
451943|NCT00379288|1490517|P1|Overall Study|Lost to Follow-up|3
451944|NCT00379288|1490514|P4|Overall Study|Treatment Failure|1
451945|NCT00379288|1490515|P3|Overall Study|Treatment Failure|0
451946|NCT00379288|1490516|P2|Overall Study|Treatment Failure|1
451947|NCT00379288|1490517|P1|Overall Study|Treatment Failure|0
451948|NCT00379288|1490514|P4|Overall Study|Adverse Event|0
451949|NCT00379288|1490515|P3|Overall Study|Adverse Event|2
451950|NCT00379288|1490516|P2|Overall Study|Adverse Event|6
451951|NCT00379288|1490517|P1|Overall Study|Adverse Event|5
451952|NCT00379236|1490529|P3|Open-label Extension|Not specified|7
451953|NCT00379236|1490530|P2|Open-label Extension|Not specified|0
451954|NCT00379236|1490531|P1|Open-label Extension|Not specified|0
451955|NCT00379236|1490529|P3|Open-label Extension|Use of exclusionary medication|3
451956|NCT00379236|1490530|P2|Open-label Extension|Use of exclusionary medication|0
451957|NCT00379236|1490531|P1|Open-label Extension|Use of exclusionary medication|0
451958|NCT00379236|1490529|P3|Open-label Extension|Lost to Follow-up|12
451959|NCT00379236|1490530|P2|Open-label Extension|Lost to Follow-up|0
451960|NCT00379236|1490531|P1|Open-label Extension|Lost to Follow-up|0
451961|NCT00379236|1490529|P3|Open-label Extension|Withdrawal by Subject|13
451962|NCT00379236|1490530|P2|Open-label Extension|Withdrawal by Subject|0
451963|NCT00379236|1490531|P1|Open-label Extension|Withdrawal by Subject|0
451964|NCT00379236|1490529|P3|Open-label Extension|Protocol Violation|7
451965|NCT00379236|1490530|P2|Open-label Extension|Protocol Violation|0
451966|NCT00379236|1490531|P1|Open-label Extension|Protocol Violation|0
451967|NCT00379236|1490529|P3|Open-label Extension|Adverse Event|13
451968|NCT00379236|1490530|P2|Open-label Extension|Adverse Event|0
451969|NCT00379236|1490531|P1|Open-label Extension|Adverse Event|0
451970|NCT00379236|1490529|P3|Double-blind|Data could not be retrieved|0
451971|NCT00379236|1490530|P2|Double-blind|Data could not be retrieved|2
451972|NCT00379236|1490531|P1|Double-blind|Data could not be retrieved|2
451973|NCT00379236|1490529|P3|Double-blind|Not specified|0
451974|NCT00379236|1490530|P2|Double-blind|Not specified|7
451975|NCT00379236|1490531|P1|Double-blind|Not specified|3
451976|NCT00379236|1490529|P3|Double-blind|Use of exclusionary medication|0
451977|NCT00379236|1490530|P2|Double-blind|Use of exclusionary medication|2
451978|NCT00379236|1490531|P1|Double-blind|Use of exclusionary medication|1
451979|NCT00379236|1490529|P3|Double-blind|Lost to Follow-up|0
451980|NCT00379236|1490530|P2|Double-blind|Lost to Follow-up|3
451981|NCT00379236|1490531|P1|Double-blind|Lost to Follow-up|4
451982|NCT00379236|1490529|P3|Double-blind|Withdrawal by Subject|0
451983|NCT00379236|1490530|P2|Double-blind|Withdrawal by Subject|13
451984|NCT00379236|1490531|P1|Double-blind|Withdrawal by Subject|12
451985|NCT00379236|1490529|P3|Double-blind|Protocol Violation|0
451986|NCT00379236|1490530|P2|Double-blind|Protocol Violation|3
451987|NCT00379236|1490531|P1|Double-blind|Protocol Violation|3
451988|NCT00379236|1490529|P3|Double-blind|Adverse Event|0
451989|NCT00379236|1490530|P2|Double-blind|Adverse Event|6
451990|NCT00379236|1490531|P1|Double-blind|Adverse Event|11
451991|NCT00379210|1490576|P2|Overall Study|Withdrawal by Subject|7
451992|NCT00379210|1490577|P1|Overall Study|Withdrawal by Subject|10
451993|NCT00379080|1490600|P3|Overall Study|Withdrawal by Subject|0
451994|NCT00379080|1490601|P2|Overall Study|Withdrawal by Subject|4
451995|NCT00379080|1490602|P1|Overall Study|Withdrawal by Subject|0
451996|NCT00378898|1490647|P2|Overall Study|Protocol Violation|1
451997|NCT00378898|1490648|P1|Overall Study|Protocol Violation|1
451998|NCT00378898|1490647|P2|Overall Study|Withdrawal by Subject|5
451999|NCT00378898|1490648|P1|Overall Study|Withdrawal by Subject|10
452000|NCT00378703|1490660|P4|Overall Study|Other|3
452001|NCT00378703|1490661|P3|Overall Study|Other|2
452002|NCT00378703|1490662|P2|Overall Study|Other|1
452003|NCT00378703|1490663|P1|Overall Study|Other|1
452004|NCT00378703|1490660|P4|Overall Study|Never started treatment|0
452005|NCT00378703|1490661|P3|Overall Study|Never started treatment|0
452006|NCT00378703|1490662|P2|Overall Study|Never started treatment|4
452007|NCT00378703|1490663|P1|Overall Study|Never started treatment|1
452008|NCT00378703|1490660|P4|Overall Study|Ineligible|7
452009|NCT00378703|1490661|P3|Overall Study|Ineligible|7
452010|NCT00378703|1490662|P2|Overall Study|Ineligible|7
452011|NCT00378703|1490663|P1|Overall Study|Ineligible|4
452012|NCT00378703|1490660|P4|Overall Study|Relocation|0
452013|NCT00378703|1490661|P3|Overall Study|Relocation|1
452014|NCT00378703|1490662|P2|Overall Study|Relocation|0
452015|NCT00378703|1490663|P1|Overall Study|Relocation|0
452016|NCT00378703|1490660|P4|Overall Study|Adverse events and progressive disease|1
452017|NCT00378703|1490661|P3|Overall Study|Adverse events and progressive disease|0
452018|NCT00378703|1490662|P2|Overall Study|Adverse events and progressive disease|0
452019|NCT00378703|1490663|P1|Overall Study|Adverse events and progressive disease|0
452020|NCT00378703|1490660|P4|Overall Study|Joint decision of physician and patient|0
452021|NCT00378703|1490661|P3|Overall Study|Joint decision of physician and patient|0
452022|NCT00378703|1490662|P2|Overall Study|Joint decision of physician and patient|0
452023|NCT00378703|1490663|P1|Overall Study|Joint decision of physician and patient|1
452024|NCT00378703|1490660|P4|Overall Study|Surgery|1
452025|NCT00378703|1490661|P3|Overall Study|Surgery|0
452026|NCT00378703|1490662|P2|Overall Study|Surgery|0
452027|NCT00378703|1490663|P1|Overall Study|Surgery|1
452028|NCT00378703|1490660|P4|Overall Study|Symptomatic deterioration|2
452029|NCT00378703|1490661|P3|Overall Study|Symptomatic deterioration|0
452030|NCT00378703|1490662|P2|Overall Study|Symptomatic deterioration|1
452031|NCT00378703|1490663|P1|Overall Study|Symptomatic deterioration|0
452032|NCT00378703|1490660|P4|Overall Study|Other complicated disease|0
452033|NCT00378703|1490661|P3|Overall Study|Other complicated disease|2
452034|NCT00378703|1490662|P2|Overall Study|Other complicated disease|2
452035|NCT00378703|1490663|P1|Overall Study|Other complicated disease|0
452036|NCT00378703|1490660|P4|Overall Study|Alternative therapy|0
452037|NCT00378703|1490661|P3|Overall Study|Alternative therapy|0
452038|NCT00378703|1490662|P2|Overall Study|Alternative therapy|2
452039|NCT00378703|1490663|P1|Overall Study|Alternative therapy|4
452040|NCT00378703|1490660|P4|Overall Study|Physician Decision|0
452041|NCT00378703|1490661|P3|Overall Study|Physician Decision|1
452042|NCT00378703|1490662|P2|Overall Study|Physician Decision|4
452043|NCT00378703|1490663|P1|Overall Study|Physician Decision|1
452044|NCT00378703|1490660|P4|Overall Study|Withdrawal by Subject|7
452045|NCT00378703|1490661|P3|Overall Study|Withdrawal by Subject|5
452046|NCT00378703|1490662|P2|Overall Study|Withdrawal by Subject|8
452047|NCT00378703|1490663|P1|Overall Study|Withdrawal by Subject|4
452048|NCT00378703|1490660|P4|Overall Study|Death|3
452049|NCT00378703|1490661|P3|Overall Study|Death|4
452050|NCT00378703|1490662|P2|Overall Study|Death|2
452051|NCT00378703|1490663|P1|Overall Study|Death|2
452052|NCT00378703|1490660|P4|Overall Study|Adverse Event|18
452053|NCT00378703|1490661|P3|Overall Study|Adverse Event|20
452054|NCT00378703|1490662|P2|Overall Study|Adverse Event|17
452055|NCT00378703|1490663|P1|Overall Study|Adverse Event|11
452056|NCT00378703|1490660|P4|Overall Study|Disease progression|49
452057|NCT00378703|1490661|P3|Overall Study|Disease progression|48
452058|NCT00378703|1490662|P2|Overall Study|Disease progression|43
452059|NCT00378703|1490663|P1|Overall Study|Disease progression|59
452060|NCT00378599|1490685|P1|Overall Study|Withdrawal by Subject|5
452061|NCT00378599|1490685|P1|Overall Study|Treatment failure|7
452062|NCT00378599|1490685|P1|Overall Study|Protocol Violation|2
452063|NCT00378599|1490685|P1|Overall Study|Adverse Event|38
452064|NCT00378573|1490689|P1|Follow-up|Withdrawal by Subject|1
452065|NCT00378573|1490689|P1|Follow-up|Lost to Follow-up|1
452066|NCT00378573|1490689|P1|Follow-up|Death|12
452067|NCT00378573|1490689|P1|Treatment Period|Sponsor decision to close study|1
452068|NCT00378573|1490689|P1|Treatment Period|Disease Progression|4
452069|NCT00378573|1490689|P1|Treatment Period|Withdrawal by Subject|2
452070|NCT00378573|1490689|P1|Treatment Period|Physician Decision|1
452071|NCT00378573|1490689|P1|Treatment Period|Adverse Event|9
452072|NCT00378560|1490697|P2|Overall Study|Laboratory test values abnormal|0
452073|NCT00378560|1490698|P1|Overall Study|Laboratory test values abnormal|1
452074|NCT00378560|1490697|P2|Overall Study|Pregnancy|5
452075|NCT00378560|1490698|P1|Overall Study|Pregnancy|7
452076|NCT00378560|1490697|P2|Overall Study|Moved|3
452077|NCT00378560|1490698|P1|Overall Study|Moved|4
452078|NCT00378560|1490697|P2|Overall Study|Withdrawal by Subject|21
452079|NCT00378560|1490698|P1|Overall Study|Withdrawal by Subject|17
452080|NCT00378560|1490697|P2|Overall Study|Protocol Violation|0
452081|NCT00378560|1490698|P1|Overall Study|Protocol Violation|2
452082|NCT00378560|1490697|P2|Overall Study|Lost to Follow-up|29
452083|NCT00378560|1490698|P1|Overall Study|Lost to Follow-up|24
452084|NCT00378560|1490697|P2|Overall Study|Adverse Event|0
452085|NCT00378560|1490698|P1|Overall Study|Adverse Event|1
452086|NCT00378534|1490712|P1|Overall Study|Subjects did not receive a transplant|3
452087|NCT00378534|1490712|P1|Overall Study|Donors|57
452088|NCT00378508|1490718|P2|Overall Study|Lost to Follow-up|0
452089|NCT00378508|1490719|P1|Overall Study|Lost to Follow-up|1
452090|NCT00378508|1490718|P2|Overall Study|Withdrawal by Subject|3
452091|NCT00378508|1490719|P1|Overall Study|Withdrawal by Subject|1
452092|NCT00378378|1490738|P3|Overall Study|Non-compliance with protocol|1
452093|NCT00378378|1490739|P2|Overall Study|Non-compliance with protocol|0
452094|NCT00378378|1490740|P1|Overall Study|Non-compliance with protocol|0
452095|NCT00378378|1490738|P3|Overall Study|Treatment Failure|1
452096|NCT00378378|1490739|P2|Overall Study|Treatment Failure|0
452097|NCT00378378|1490740|P1|Overall Study|Treatment Failure|0
452098|NCT00378378|1490738|P3|Overall Study|Withdrawal by Subject|0
452099|NCT00378378|1490739|P2|Overall Study|Withdrawal by Subject|1
452100|NCT00378378|1490740|P1|Overall Study|Withdrawal by Subject|0
452101|NCT00378209|1490786|P1|Overall Study|Treatment delay|1
452102|NCT00378209|1490786|P1|Overall Study|Death|1
452103|NCT00378209|1490786|P1|Overall Study|Physician Decision|3
452104|NCT00378209|1490786|P1|Overall Study|Initiation of non-protocol therapy|3
452105|NCT00378209|1490786|P1|Overall Study|Adverse Event|3
452106|NCT00378209|1490786|P1|Overall Study|Progressive disease|11
452107|NCT00378105|1490796|P2|Overall Study|necessity to increase lenalidomide dose|1
452108|NCT00378105|1490797|P1|Overall Study|necessity to increase lenalidomide dose|0
452109|NCT00378105|1490796|P2|Overall Study|Going non-protocol therapy|1
452110|NCT00378105|1490797|P1|Overall Study|Going non-protocol therapy|0
452111|NCT00378105|1490796|P2|Overall Study|Physician Decision|2
452112|NCT00378105|1490797|P1|Overall Study|Physician Decision|0
452113|NCT00378105|1490796|P2|Overall Study|remain on study|11
452114|NCT00378105|1490797|P1|Overall Study|remain on study|3
452115|NCT00378105|1490796|P2|Overall Study|Progressive disease|3
452116|NCT00378105|1490797|P1|Overall Study|Progressive disease|3
452117|NCT00378105|1490796|P2|Overall Study|Going to transplant|8
452118|NCT00378105|1490797|P1|Overall Study|Going to transplant|7
452119|NCT00378105|1490796|P2|Overall Study|Death|0
452120|NCT00378105|1490797|P1|Overall Study|Death|1
452121|NCT00378105|1490796|P2|Overall Study|Withdrawal by Subject|3
452122|NCT00378105|1490797|P1|Overall Study|Withdrawal by Subject|3
452123|NCT00378105|1490796|P2|Overall Study|Adverse Event|1
452124|NCT00378105|1490797|P1|Overall Study|Adverse Event|3
452125|NCT00378079|1490809|P3|Overall Study|Lost to Follow-up|0
452126|NCT00378079|1490810|P2|Overall Study|Lost to Follow-up|1
452127|NCT00378079|1490811|P1|Overall Study|Lost to Follow-up|6
452128|NCT00378014|1490833|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
452129|NCT00378014|1490834|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
452130|NCT00378014|1490833|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
452131|NCT00378014|1490834|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
452132|NCT00378014|1490833|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
452133|NCT00378014|1490834|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
452134|NCT00378014|1490833|P2|Extension (Month 12 to Month 59)|Administrative problems|0
452135|NCT00378014|1490834|P1|Extension (Month 12 to Month 59)|Administrative problems|1
452136|NCT00378014|1490833|P2|Extension (Month 12 to Month 59)|Death|2
452137|NCT00378014|1490834|P1|Extension (Month 12 to Month 59)|Death|1
452138|NCT00378014|1490833|P2|Extension (Month 12 to Month 59)|Adverse Event|7
452139|NCT00378014|1490834|P1|Extension (Month 12 to Month 59)|Adverse Event|8
452140|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
452141|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
452142|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Protocol deviation|1
452143|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Protocol deviation|0
452144|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
452145|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
452146|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
452147|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
452148|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Administrative Problems|2
452149|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Administrative Problems|2
452150|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Death|3
452151|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Death|5
452152|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Graft loss|2
452153|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Graft loss|1
452154|NCT00378014|1490833|P2|Core (Randomization to Month 11)|Adverse Event|0
452155|NCT00378014|1490834|P1|Core (Randomization to Month 11)|Adverse Event|1
452156|NCT00377962|1490860|P2|Extension Study: 12-24 Months|Unspecified reason|3
452157|NCT00377962|1490861|P1|Extension Study: 12-24 Months|Unspecified reason|0
452158|NCT00377962|1490860|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
452159|NCT00377962|1490861|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
452160|NCT00377962|1490860|P2|Extension Study: 12-24 Months|Adverse Event|0
452161|NCT00377962|1490861|P1|Extension Study: 12-24 Months|Adverse Event|8
452162|NCT00377962|1490860|P2|Extension Study: 12-24 Months|Death|1
452163|NCT00377962|1490861|P1|Extension Study: 12-24 Months|Death|1
452164|NCT00377962|1490860|P2|Core Study: 0-12 Months|Unspecified reasons|4
452165|NCT00377962|1490861|P1|Core Study: 0-12 Months|Unspecified reasons|1
452166|NCT00377962|1490860|P2|Core Study: 0-12 Months|Administrative Reason|1
452167|NCT00377962|1490861|P1|Core Study: 0-12 Months|Administrative Reason|1
452168|NCT00377962|1490860|P2|Core Study: 0-12 Months|Withdrew Consent|2
452169|NCT00377962|1490861|P1|Core Study: 0-12 Months|Withdrew Consent|5
452170|NCT00377962|1490860|P2|Core Study: 0-12 Months|Death|0
452171|NCT00377962|1490861|P1|Core Study: 0-12 Months|Death|3
452172|NCT00377962|1490860|P2|Core Study: 0-12 Months|Adverse Event|2
452173|NCT00377962|1490861|P1|Core Study: 0-12 Months|Adverse Event|18
452174|NCT00377858|1490897|P2|Overall Study|Death|3
452175|NCT00377858|1490898|P1|Overall Study|Death|0
452176|NCT00377858|1490897|P2|Overall Study|Sponsor Decision|2
452177|NCT00377858|1490898|P1|Overall Study|Sponsor Decision|1
452178|NCT00377858|1490897|P2|Overall Study|Entry Criteria Not Met|0
452179|NCT00377858|1490898|P1|Overall Study|Entry Criteria Not Met|2
452180|NCT00377858|1490897|P2|Overall Study|Adverse Event|1
452181|NCT00377858|1490898|P1|Overall Study|Adverse Event|2
452182|NCT00377858|1490897|P2|Overall Study|Protocol Violation|4
452183|NCT00377858|1490898|P1|Overall Study|Protocol Violation|3
452184|NCT00377858|1490897|P2|Overall Study|Physician Decision|5
452185|NCT00377858|1490898|P1|Overall Study|Physician Decision|5
452186|NCT00377858|1490897|P2|Overall Study|Lost to Follow-up|1
452187|NCT00377858|1490898|P1|Overall Study|Lost to Follow-up|6
452188|NCT00377858|1490897|P2|Overall Study|Withdrawal by Subject|11
452189|NCT00377858|1490898|P1|Overall Study|Withdrawal by Subject|12
452190|NCT00377819|1490951|P2|Overall Study|Protocol Violation|1
452191|NCT00377819|1490952|P1|Overall Study|Protocol Violation|1
452192|NCT00377819|1490951|P2|Overall Study|Lost to Follow-up|1
452193|NCT00377819|1490952|P1|Overall Study|Lost to Follow-up|0
452194|NCT00377819|1490951|P2|Overall Study|Death|1
452195|NCT00377819|1490952|P1|Overall Study|Death|0
452196|NCT00377819|1490951|P2|Overall Study|Withdrawal by Subject|4
452197|NCT00377819|1490952|P1|Overall Study|Withdrawal by Subject|10
452198|NCT00377819|1490951|P2|Overall Study|Adverse Event|3
452199|NCT00377819|1490952|P1|Overall Study|Adverse Event|2
452200|NCT00377676|1490981|P2|Overall Study|not specified|58
452201|NCT00377676|1490982|P1|Overall Study|not specified|118
452202|NCT00377676|1490981|P2|Overall Study|Lost to Follow-up|56
452203|NCT00377676|1490982|P1|Overall Study|Lost to Follow-up|120
452204|NCT00377676|1490981|P2|Overall Study|Withdrawal by Subject|72
452205|NCT00377676|1490982|P1|Overall Study|Withdrawal by Subject|187
452206|NCT00377676|1490981|P2|Overall Study|Death|2
452207|NCT00377676|1490982|P1|Overall Study|Death|5
452208|NCT00377676|1490981|P2|Overall Study|Protocol Violation|27
452209|NCT00377676|1490982|P1|Overall Study|Protocol Violation|33
452210|NCT00377676|1490981|P2|Overall Study|Adverse Event|107
452211|NCT00377676|1490982|P1|Overall Study|Adverse Event|498
452212|NCT00377637|1490998|P4|Maintenance Phase|Death|1
452213|NCT00377637|1490999|P3|Maintenance Phase|Death|0
452214|NCT00377637|1491000|P2|Maintenance Phase|Death|0
452215|NCT00377637|1491001|P1|Maintenance Phase|Death|0
452216|NCT00377637|1490998|P4|Maintenance Phase|Study medication stopped > 14 days|1
452217|NCT00377637|1490999|P3|Maintenance Phase|Study medication stopped > 14 days|0
452218|NCT00377637|1491000|P2|Maintenance Phase|Study medication stopped > 14 days|0
452219|NCT00377637|1491001|P1|Maintenance Phase|Study medication stopped > 14 days|0
452220|NCT00377637|1490998|P4|Maintenance Phase|Non-compliance|1
452221|NCT00377637|1490999|P3|Maintenance Phase|Non-compliance|1
452222|NCT00377637|1491000|P2|Maintenance Phase|Non-compliance|0
452223|NCT00377637|1491001|P1|Maintenance Phase|Non-compliance|0
452224|NCT00377637|1490998|P4|Maintenance Phase|Sponsor decision|3
452225|NCT00377637|1490999|P3|Maintenance Phase|Sponsor decision|2
452226|NCT00377637|1491000|P2|Maintenance Phase|Sponsor decision|0
452227|NCT00377637|1491001|P1|Maintenance Phase|Sponsor decision|0
452228|NCT00377637|1490998|P4|Maintenance Phase|Withdrawal by Subject|3
452229|NCT00377637|1490999|P3|Maintenance Phase|Withdrawal by Subject|3
452230|NCT00377637|1491000|P2|Maintenance Phase|Withdrawal by Subject|0
452231|NCT00377637|1491001|P1|Maintenance Phase|Withdrawal by Subject|0
452232|NCT00377637|1490998|P4|Maintenance Phase|Lost to Follow-up|1
452233|NCT00377637|1490999|P3|Maintenance Phase|Lost to Follow-up|3
452234|NCT00377637|1491000|P2|Maintenance Phase|Lost to Follow-up|0
452235|NCT00377637|1491001|P1|Maintenance Phase|Lost to Follow-up|0
452236|NCT00377637|1490998|P4|Maintenance Phase|Physician Decision|4
452237|NCT00377637|1490999|P3|Maintenance Phase|Physician Decision|5
452238|NCT00377637|1491000|P2|Maintenance Phase|Physician Decision|0
452239|NCT00377637|1491001|P1|Maintenance Phase|Physician Decision|0
452240|NCT00377637|1490998|P4|Maintenance Phase|Adverse Event|43
452241|NCT00377637|1490999|P3|Maintenance Phase|Adverse Event|29
452242|NCT00377637|1491000|P2|Maintenance Phase|Adverse Event|0
452243|NCT00377637|1491001|P1|Maintenance Phase|Adverse Event|0
452244|NCT00377637|1490998|P4|Induction Phase|Reason for withdrawal is not noted|0
452245|NCT00377637|1490999|P3|Induction Phase|Reason for withdrawal is not noted|0
452246|NCT00377637|1491000|P2|Induction Phase|Reason for withdrawal is not noted|0
452247|NCT00377637|1491001|P1|Induction Phase|Reason for withdrawal is not noted|2
452248|NCT00377637|1490998|P4|Induction Phase|Non-Compliance|0
452249|NCT00377637|1490999|P3|Induction Phase|Non-Compliance|0
452250|NCT00377637|1491000|P2|Induction Phase|Non-Compliance|0
452251|NCT00377637|1491001|P1|Induction Phase|Non-Compliance|1
452252|NCT00377637|1490998|P4|Induction Phase|Sponsor decision|0
452253|NCT00377637|1490999|P3|Induction Phase|Sponsor decision|0
452254|NCT00377637|1491000|P2|Induction Phase|Sponsor decision|2
452255|NCT00377637|1491001|P1|Induction Phase|Sponsor decision|1
452256|NCT00377637|1490998|P4|Induction Phase|Physician Decision|0
452257|NCT00377637|1490999|P3|Induction Phase|Physician Decision|0
452258|NCT00377637|1491000|P2|Induction Phase|Physician Decision|1
452259|NCT00377637|1491001|P1|Induction Phase|Physician Decision|3
452260|NCT00377637|1490998|P4|Induction Phase|Withdrawal by Subject|0
452261|NCT00377637|1490999|P3|Induction Phase|Withdrawal by Subject|0
452262|NCT00377637|1491000|P2|Induction Phase|Withdrawal by Subject|6
452263|NCT00377637|1491001|P1|Induction Phase|Withdrawal by Subject|5
452264|NCT00377637|1490998|P4|Induction Phase|Death|0
452265|NCT00377637|1490999|P3|Induction Phase|Death|0
452266|NCT00377637|1491000|P2|Induction Phase|Death|3
452267|NCT00377637|1491001|P1|Induction Phase|Death|1
452268|NCT00377637|1490998|P4|Induction Phase|Lost to Follow-up|0
452269|NCT00377637|1490999|P3|Induction Phase|Lost to Follow-up|0
452270|NCT00377637|1491000|P2|Induction Phase|Lost to Follow-up|1
452271|NCT00377637|1491001|P1|Induction Phase|Lost to Follow-up|2
452272|NCT00377637|1490998|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
452273|NCT00377637|1490999|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
452274|NCT00377637|1491000|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
452275|NCT00377637|1491001|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
452276|NCT00377637|1490998|P4|Induction Phase|Deterioration/serum creatinine|0
452277|NCT00377637|1490999|P3|Induction Phase|Deterioration/serum creatinine|0
452278|NCT00377637|1491000|P2|Induction Phase|Deterioration/serum creatinine|0
452279|NCT00377637|1491001|P1|Induction Phase|Deterioration/serum creatinine|2
452280|NCT00377637|1490998|P4|Induction Phase|Adverse Event|0
452281|NCT00377637|1490999|P3|Induction Phase|Adverse Event|0
452282|NCT00377637|1491000|P2|Induction Phase|Adverse Event|21
452283|NCT00377637|1491001|P1|Induction Phase|Adverse Event|12
452284|NCT00377520|1491076|P1|Overall Study|Ineligible (Prior radiation)|1
452285|NCT00377455|1491081|P1|Overall Study|Withdrawal by Subject|1
452286|NCT00377429|1491089|P1|Overall Study|Patient non-compliance|1
452287|NCT00377429|1491089|P1|Overall Study|Physician Decision|1
452288|NCT00377429|1491089|P1|Overall Study|Adverse Event|8
452289|NCT00377429|1491089|P1|Overall Study|Withdrawal by Subject|5
452290|NCT00377403|1491100|P2|Overall Study|Unable to contact for telephone intervie|7
452291|NCT00377403|1491101|P1|Overall Study|Unable to contact for telephone intervie|4
452292|NCT00377364|1491109|P2|Overall Study|Withdrawal by Subject|0
452293|NCT00377364|1491110|P1|Overall Study|Withdrawal by Subject|1
452294|NCT00377364|1491109|P2|Overall Study|Lost to Follow-up|0
452295|NCT00377364|1491110|P1|Overall Study|Lost to Follow-up|1
452296|NCT00377312|1491136|P2|Overall Study|Adverse Event|1
452297|NCT00377312|1491137|P1|Overall Study|Adverse Event|1
452298|NCT00377299|1491169|P2|Overall Study|Withdrawal by Subject|4
452299|NCT00377299|1491170|P1|Overall Study|Withdrawal by Subject|5
452300|NCT00377299|1491169|P2|Overall Study|Adverse Event|1
452301|NCT00377299|1491170|P1|Overall Study|Adverse Event|0
452302|NCT00377299|1491169|P2|Overall Study|Lost to Follow-up|19
452303|NCT00377299|1491170|P1|Overall Study|Lost to Follow-up|14
452304|NCT00377260|1491186|P2|Overall Study|Withdrawal by Subject|4
452305|NCT00377260|1491187|P1|Overall Study|Withdrawal by Subject|2
452306|NCT00377260|1491186|P2|Overall Study|Lost to Follow-up|1
452307|NCT00377260|1491187|P1|Overall Study|Lost to Follow-up|0
452308|NCT00377234|1491241|P2|Overall Study|Not assigned|2
452309|NCT00377234|1491242|P1|Overall Study|Not assigned|3
452310|NCT00377234|1491241|P2|Overall Study|Administrative|1
452311|NCT00377234|1491242|P1|Overall Study|Administrative|2
452312|NCT00377234|1491241|P2|Overall Study|Lost to Follow-up|2
452313|NCT00377234|1491242|P1|Overall Study|Lost to Follow-up|4
452314|NCT00377234|1491241|P2|Overall Study|Withdrawal by Subject|9
452315|NCT00377234|1491242|P1|Overall Study|Withdrawal by Subject|11
452316|NCT00377234|1491241|P2|Overall Study|Adverse Event|17
452317|NCT00377234|1491242|P1|Overall Study|Adverse Event|14
452318|NCT00377156|1491260|P2|Overall Study|Other|2
452319|NCT00377156|1491261|P1|Overall Study|Other|5
452320|NCT00377156|1491260|P2|Overall Study|Disability or language problem|1
452321|NCT00377156|1491261|P1|Overall Study|Disability or language problem|0
452322|NCT00377156|1491260|P2|Overall Study|Ineligible|1
452323|NCT00377156|1491261|P1|Overall Study|Ineligible|0
452324|NCT00377156|1491260|P2|Overall Study|Refused testing|1
452325|NCT00377156|1491261|P1|Overall Study|Refused testing|0
452326|NCT00377156|1491260|P2|Overall Study|Cancellation|0
452327|NCT00377156|1491261|P1|Overall Study|Cancellation|1
452328|NCT00377156|1491260|P2|Overall Study|Had follow-up <90 d|6
452329|NCT00377156|1491261|P1|Overall Study|Had follow-up <90 d|3
452330|NCT00377156|1491260|P2|Overall Study|Withdrawal by Subject|24
452331|NCT00377156|1491261|P1|Overall Study|Withdrawal by Subject|16
452332|NCT00377156|1491260|P2|Overall Study|Death|19
452333|NCT00377156|1491261|P1|Overall Study|Death|23
452334|NCT00376961|1491275|P2|Maintenance|Ineligible|3
452335|NCT00376961|1491276|P1|Maintenance|Ineligible|0
452336|NCT00376961|1491275|P2|Maintenance|Progression/relapse|18
452337|NCT00376961|1491276|P1|Maintenance|Progression/relapse|0
452338|NCT00376961|1491275|P2|Maintenance|Refusal Unrelated to Adverse Event|1
452339|NCT00376961|1491276|P1|Maintenance|Refusal Unrelated to Adverse Event|0
452340|NCT00376961|1491275|P2|Maintenance|Adverse Event|1
452341|NCT00376961|1491276|P1|Maintenance|Adverse Event|0
452342|NCT00376961|1491275|P2|Initial Registration|Ineligible|0
452343|NCT00376961|1491276|P1|Initial Registration|Ineligible|3
452344|NCT00376961|1491275|P2|Initial Registration|Progression/relapse|0
452345|NCT00376961|1491276|P1|Initial Registration|Progression/relapse|1
452346|NCT00376961|1491275|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
452347|NCT00376961|1491276|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
452348|NCT00376961|1491275|P2|Initial Registration|Adverse Event|0
452349|NCT00376961|1491276|P1|Initial Registration|Adverse Event|1
452350|NCT00376688|1491342|P1|Overall Study|Death|1
452351|NCT00376688|1491342|P1|Overall Study|Adverse Event|3
452352|NCT00376675|1491348|P2|Overall Study|Other Reason|7
452353|NCT00376675|1491349|P1|Overall Study|Other Reason|1
452354|NCT00376675|1491348|P2|Overall Study|Adverse Event|5
452355|NCT00376675|1491349|P1|Overall Study|Adverse Event|10
452356|NCT00376675|1491348|P2|Overall Study|Withdrawal by Subject|2
452357|NCT00376675|1491349|P1|Overall Study|Withdrawal by Subject|9
452358|NCT00376532|1491398|P2|Overall Study|Lack sufficient blood sample|6
452359|NCT00376532|1491399|P1|Overall Study|Lack sufficient blood sample|6
452360|NCT00376506|1491409|P2|Overall Study|Death|2
452361|NCT00376506|1491410|P1|Overall Study|Death|0
452362|NCT00376259|1491441|P2|Overall Study|Patient request|0
452363|NCT00376259|1491442|P1|Overall Study|Patient request|1
452364|NCT00376259|1491441|P2|Overall Study|Sponsor request - study termination|21
452365|NCT00376259|1491442|P1|Overall Study|Sponsor request - study termination|21
452366|NCT00376220|1491456|P2|Overall Study|Withdrawal by Subject|2
452367|NCT00376220|1491457|P1|Overall Study|Withdrawal by Subject|3
452368|NCT00376220|1491456|P2|Overall Study|Lost to Follow-up|10
452369|NCT00376220|1491457|P1|Overall Study|Lost to Follow-up|7
452370|NCT00376168|1491465|P2|Overall Study|Pregnancy|0
452371|NCT00376168|1491466|P1|Overall Study|Pregnancy|1
452372|NCT00376168|1491465|P2|Overall Study|Adverse Event|1
452373|NCT00376168|1491466|P1|Overall Study|Adverse Event|1
452374|NCT00375934|1491507|P2|Overall Study|Physician Decision|1
452375|NCT00375934|1491508|P1|Overall Study|Physician Decision|0
452376|NCT00375934|1491507|P2|Overall Study|Lack of Efficacy|2
452377|NCT00375934|1491508|P1|Overall Study|Lack of Efficacy|0
452378|NCT00375934|1491507|P2|Overall Study|Withdrawal by Subject|2
452379|NCT00375934|1491508|P1|Overall Study|Withdrawal by Subject|2
452380|NCT00375934|1491507|P2|Overall Study|Adverse Event|1
452381|NCT00375934|1491508|P1|Overall Study|Adverse Event|1
452382|NCT00375752|1491536|P2|Overall Study|Administrative Problems|1
452383|NCT00375752|1491537|P1|Overall Study|Administrative Problems|0
452384|NCT00375752|1491536|P2|Overall Study|Protocol Violation|2
452385|NCT00375752|1491537|P1|Overall Study|Protocol Violation|0
452386|NCT00375752|1491536|P2|Overall Study|Abnormal Laboratory Value(s)|1
452387|NCT00375752|1491537|P1|Overall Study|Abnormal Laboratory Value(s)|1
452388|NCT00375752|1491536|P2|Overall Study|Withdrawal by Subject|1
452389|NCT00375752|1491537|P1|Overall Study|Withdrawal by Subject|6
452390|NCT00375752|1491536|P2|Overall Study|Adverse Event|6
452391|NCT00375752|1491537|P1|Overall Study|Adverse Event|1
452392|NCT00375752|1491536|P2|Overall Study|Lack of Efficacy|4
452393|NCT00375752|1491537|P1|Overall Study|Lack of Efficacy|4
452394|NCT00375674|1491568|P2|Overall Study|Lost to Follow-up|12
452395|NCT00375674|1491569|P1|Overall Study|Lost to Follow-up|14
452396|NCT00375674|1491568|P2|Overall Study|Subject refused further follow-up|23
452397|NCT00375674|1491569|P1|Overall Study|Subject refused further follow-up|24
452398|NCT00375674|1491568|P2|Overall Study|Death|64
452399|NCT00375674|1491569|P1|Overall Study|Death|61
452400|NCT00375674|1491568|P2|Overall Study|Not specified|16
452401|NCT00375674|1491569|P1|Overall Study|Not specified|24
452402|NCT00375609|1491598|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
452403|NCT00375609|1491599|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
452404|NCT00375609|1491600|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
452405|NCT00375609|1491598|P3|Overall Study|Withdrawal by Subject|0
452406|NCT00375609|1491599|P2|Overall Study|Withdrawal by Subject|4
452407|NCT00375609|1491600|P1|Overall Study|Withdrawal by Subject|1
452408|NCT00375609|1491598|P3|Overall Study|Physician Decision|1
452409|NCT00375609|1491599|P2|Overall Study|Physician Decision|0
452410|NCT00375609|1491600|P1|Overall Study|Physician Decision|0
452411|NCT00375609|1491598|P3|Overall Study|Lost to Follow-up|0
452412|NCT00375609|1491599|P2|Overall Study|Lost to Follow-up|0
452413|NCT00375609|1491600|P1|Overall Study|Lost to Follow-up|1
452414|NCT00375609|1491598|P3|Overall Study|Adverse Event|0
452415|NCT00375609|1491599|P2|Overall Study|Adverse Event|3
452416|NCT00375609|1491600|P1|Overall Study|Adverse Event|0
452417|NCT00375609|1491598|P3|Overall Study|Did not receive treatment|0
452418|NCT00375609|1491599|P2|Overall Study|Did not receive treatment|0
452419|NCT00375609|1491600|P1|Overall Study|Did not receive treatment|1
452420|NCT00375518|1491616|P2|Overall Study|Death|1
452421|NCT00375518|1491617|P1|Overall Study|Death|0
452422|NCT00375518|1491616|P2|Overall Study|Patient Not Treated|6
452423|NCT00375518|1491617|P1|Overall Study|Patient Not Treated|6
452424|NCT00375518|1491616|P2|Overall Study|Withdrawal by Subject|10
452425|NCT00375518|1491617|P1|Overall Study|Withdrawal by Subject|2
452426|NCT00375505|1491625|P2|Overall Study|Adverse Event|2
452427|NCT00375505|1491626|P1|Overall Study|Adverse Event|1
452428|NCT00375492|1491670|P2|Overall Study|Withdrawal by Subject|6
452429|NCT00375492|1491671|P1|Overall Study|Withdrawal by Subject|6
452430|NCT00375492|1491670|P2|Overall Study|Sponsor Decision|1
452431|NCT00375492|1491671|P1|Overall Study|Sponsor Decision|0
452432|NCT00375492|1491670|P2|Overall Study|Protocol Violation|3
452433|NCT00375492|1491671|P1|Overall Study|Protocol Violation|6
452434|NCT00375492|1491670|P2|Overall Study|Physician Decision|4
452435|NCT00375492|1491671|P1|Overall Study|Physician Decision|0
452436|NCT00375492|1491670|P2|Overall Study|Lost to Follow-up|5
452437|NCT00375492|1491671|P1|Overall Study|Lost to Follow-up|10
452438|NCT00375492|1491670|P2|Overall Study|Loss of Glucose Control|1
452439|NCT00375492|1491671|P1|Overall Study|Loss of Glucose Control|0
452440|NCT00375492|1491670|P2|Overall Study|Entry Criteria Not Met|1
452441|NCT00375492|1491671|P1|Overall Study|Entry Criteria Not Met|0
452442|NCT00375492|1491670|P2|Overall Study|Adverse Event|5
452443|NCT00375492|1491671|P1|Overall Study|Adverse Event|4
452444|NCT00375427|1491701|P2|Overall Study|Death|10
452445|NCT00375427|1491702|P1|Overall Study|Death|11
452446|NCT00375427|1491701|P2|Overall Study|Administrative reasons|1
452447|NCT00375427|1491702|P1|Overall Study|Administrative reasons|0
452448|NCT00375427|1491701|P2|Overall Study|Lost to Follow-up|1
452449|NCT00375427|1491702|P1|Overall Study|Lost to Follow-up|1
452450|NCT00375427|1491701|P2|Overall Study|Withdrawal by Subject|13
452451|NCT00375427|1491702|P1|Overall Study|Withdrawal by Subject|9
452452|NCT00375427|1491701|P2|Overall Study|Protocol Violation|8
452453|NCT00375427|1491702|P1|Overall Study|Protocol Violation|10
452454|NCT00375427|1491701|P2|Overall Study|Patient no longer requires study drug|7
452455|NCT00375427|1491702|P1|Overall Study|Patient no longer requires study drug|3
452456|NCT00375427|1491701|P2|Overall Study|Unsatisfactory therapeutic effect|4
452457|NCT00375427|1491702|P1|Overall Study|Unsatisfactory therapeutic effect|4
452458|NCT00375427|1491701|P2|Overall Study|Abnormal laboratory value(s)|2
452459|NCT00375427|1491702|P1|Overall Study|Abnormal laboratory value(s)|1
452460|NCT00375427|1491701|P2|Overall Study|Abnormal test procedure result(s)|1
452461|NCT00375427|1491702|P1|Overall Study|Abnormal test procedure result(s)|0
452462|NCT00375427|1491701|P2|Overall Study|Adverse Event|27
452463|NCT00375427|1491702|P1|Overall Study|Adverse Event|21
452464|NCT00375219|1491727|P3|Overall Study|Withdrawal by Subject|0
452465|NCT00375219|1491728|P2|Overall Study|Withdrawal by Subject|0
452466|NCT00375219|1491729|P1|Overall Study|Withdrawal by Subject|1
452467|NCT00375219|1491727|P3|Overall Study|Cord blood transplantation|0
452468|NCT00375219|1491728|P2|Overall Study|Cord blood transplantation|0
452469|NCT00375219|1491729|P1|Overall Study|Cord blood transplantation|1
452470|NCT00375219|1491727|P3|Overall Study|Allograft|0
452471|NCT00375219|1491728|P2|Overall Study|Allograft|0
452472|NCT00375219|1491729|P1|Overall Study|Allograft|2
452473|NCT00375219|1491727|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
452474|NCT00375219|1491728|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
452475|NCT00375219|1491729|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
452476|NCT00375219|1491727|P3|Overall Study|Hematologic resistance|0
452477|NCT00375219|1491728|P2|Overall Study|Hematologic resistance|0
452478|NCT00375219|1491729|P1|Overall Study|Hematologic resistance|1
452479|NCT00375219|1491727|P3|Overall Study|Death|7
452480|NCT00375219|1491728|P2|Overall Study|Death|3
452481|NCT00375219|1491729|P1|Overall Study|Death|4
452482|NCT00375219|1491727|P3|Overall Study|Disease progression|12
452483|NCT00375219|1491728|P2|Overall Study|Disease progression|9
452484|NCT00375219|1491729|P1|Overall Study|Disease progression|18
452485|NCT00375219|1491727|P3|Overall Study|Lost to Follow-up|0
452486|NCT00375219|1491728|P2|Overall Study|Lost to Follow-up|1
452487|NCT00375219|1491729|P1|Overall Study|Lost to Follow-up|1
452488|NCT00375219|1491727|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
452489|NCT00375219|1491728|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
452490|NCT00375219|1491729|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
452491|NCT00375219|1491727|P3|Overall Study|Protocol Violation|1
452492|NCT00375219|1491728|P2|Overall Study|Protocol Violation|0
452493|NCT00375219|1491729|P1|Overall Study|Protocol Violation|1
452494|NCT00375219|1491727|P3|Overall Study|Adverse Event|1
452495|NCT00375219|1491728|P2|Overall Study|Adverse Event|2
452496|NCT00375219|1491729|P1|Overall Study|Adverse Event|8
452497|NCT00375219|1491727|P3|Overall Study|Failure to achieve a response|0
452498|NCT00375219|1491728|P2|Overall Study|Failure to achieve a response|2
452499|NCT00375219|1491729|P1|Overall Study|Failure to achieve a response|16
452500|NCT00374907|1491797|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
452501|NCT00374907|1491798|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
452502|NCT00374907|1491797|P2|116-Week Short-term + Long-term Period|Adverse Event|2
452503|NCT00374907|1491798|P1|116-Week Short-term + Long-term Period|Adverse Event|0
452504|NCT00374907|1491797|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
452505|NCT00374907|1491798|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
452506|NCT00374907|1491797|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
452507|NCT00374907|1491798|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
452508|NCT00374907|1491797|P2|12-Week Short-term Period|Subject Withdrew Consent|1
452509|NCT00374907|1491798|P1|12-Week Short-term Period|Subject Withdrew Consent|3
452510|NCT00374868|1491810|P1|Overall Study|Other - Not Specified|1
452511|NCT00374868|1491810|P1|Overall Study|Death|2
452512|NCT00374868|1491810|P1|Overall Study|Lost to Follow-up|1
452513|NCT00374868|1491810|P1|Overall Study|Physician Decision|13
452514|NCT00374868|1491810|P1|Overall Study|Progressive Disease|7
452515|NCT00374868|1491810|P1|Overall Study|Adverse Event|12
452516|NCT00374556|1491874|P2|Overall Study|excluded at baseline due to medical cond|1
452517|NCT00374556|1491875|P1|Overall Study|excluded at baseline due to medical cond|0
452518|NCT00374556|1491874|P2|Overall Study|Lost to Follow-up|0
452519|NCT00374556|1491875|P1|Overall Study|Lost to Follow-up|1
452520|NCT00374452|1491936|P2|Overall Study|Withdrawal by Subject|2
452521|NCT00374452|1491937|P1|Overall Study|Withdrawal by Subject|0
452522|NCT00374452|1491936|P2|Overall Study|Left clinic after intervention started|1
452523|NCT00374452|1491937|P1|Overall Study|Left clinic after intervention started|1
452524|NCT00374452|1491936|P2|Overall Study|Change in job role before intervention|1
452525|NCT00374452|1491937|P1|Overall Study|Change in job role before intervention|0
452526|NCT00374452|1491936|P2|Overall Study|Left clinic before intervention started|1
452527|NCT00374452|1491937|P1|Overall Study|Left clinic before intervention started|4
452528|NCT00374322|1491950|P2|Overall Study|Did Not Receive Study Medication|6
452529|NCT00374322|1491951|P1|Overall Study|Did Not Receive Study Medication|8
452530|NCT00374322|1491950|P2|Overall Study|Withdrew Consent During Follow-up|5
452531|NCT00374322|1491951|P1|Overall Study|Withdrew Consent During Follow-up|0
452532|NCT00374322|1491950|P2|Overall Study|Noncompliance with Study Requirements|1
452533|NCT00374322|1491951|P1|Overall Study|Noncompliance with Study Requirements|0
452534|NCT00374322|1491950|P2|Overall Study|Started Another Chemotherapy Regimen|1
452535|NCT00374322|1491951|P1|Overall Study|Started Another Chemotherapy Regimen|0
452536|NCT00374322|1491950|P2|Overall Study|Participant Changed Physician|0
452537|NCT00374322|1491951|P1|Overall Study|Participant Changed Physician|1
452538|NCT00374322|1491950|P2|Overall Study|Site Closed|2
452539|NCT00374322|1491951|P1|Overall Study|Site Closed|2
452540|NCT00374322|1491950|P2|Overall Study|Severe Toxicity|0
452541|NCT00374322|1491951|P1|Overall Study|Severe Toxicity|1
452542|NCT00374322|1491950|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
452543|NCT00374322|1491951|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
452544|NCT00374322|1491950|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
452545|NCT00374322|1491951|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
452546|NCT00374322|1491950|P2|Overall Study|Sponsor Decision|3
452547|NCT00374322|1491951|P1|Overall Study|Sponsor Decision|2
452548|NCT00374322|1491950|P2|Overall Study|Par. Consented to Survival FU Only|1
452549|NCT00374322|1491951|P1|Overall Study|Par. Consented to Survival FU Only|3
452550|NCT00374322|1491950|P2|Overall Study|Physician Decision|32
452551|NCT00374322|1491951|P1|Overall Study|Physician Decision|36
452552|NCT00374322|1491950|P2|Overall Study|Sponsor Terminated Study|990
452553|NCT00374322|1491951|P1|Overall Study|Sponsor Terminated Study|866
452554|NCT00374322|1491950|P2|Overall Study|Withdrawal by Subject|167
452555|NCT00374322|1491951|P1|Overall Study|Withdrawal by Subject|235
452556|NCT00374322|1491950|P2|Overall Study|Protocol Violation|3
452557|NCT00374322|1491951|P1|Overall Study|Protocol Violation|8
452558|NCT00374322|1491950|P2|Overall Study|Lost to Follow-up|90
452559|NCT00374322|1491951|P1|Overall Study|Lost to Follow-up|92
452560|NCT00374140|1492042|P1|Overall Study|Protocol Violation|1
452561|NCT00374140|1492042|P1|Overall Study|Lost to Follow-up|1
452562|NCT00374127|1492049|P1|Overall Study|Pregnancy|1
452563|NCT00374127|1492049|P1|Overall Study|Protocol Violation|5
452564|NCT00374127|1492049|P1|Overall Study|Blood could not be drawn.|2
452565|NCT00374127|1492049|P1|Overall Study|Did not inhale during smoking procedure.|3
452566|NCT00373958|1492098|P2|Toddler Dose|Withdrawn after infant series|25
452567|NCT00373958|1492099|P1|Toddler Dose|Withdrawn after infant series|22
452568|NCT00373958|1492098|P2|Toddler Dose|Protocol Violation|1
452569|NCT00373958|1492099|P1|Toddler Dose|Protocol Violation|0
452570|NCT00373958|1492098|P2|Toddler Dose|Failed to return|2
452571|NCT00373958|1492099|P1|Toddler Dose|Failed to return|1
452572|NCT00373958|1492098|P2|Toddler Dose|Withdrawal by Subject|2
452573|NCT00373958|1492099|P1|Toddler Dose|Withdrawal by Subject|2
452574|NCT00373958|1492098|P2|Toddler Dose|Lost to Follow-up|8
452575|NCT00373958|1492099|P1|Toddler Dose|Lost to Follow-up|5
452576|NCT00373958|1492098|P2|Infant Series|Physician Decision|1
452577|NCT00373958|1492099|P1|Infant Series|Physician Decision|1
452578|NCT00373958|1492098|P2|Infant Series|Adverse Event|1
452579|NCT00373958|1492099|P1|Infant Series|Adverse Event|3
452580|NCT00373958|1492098|P2|Infant Series|Consent was not received|0
452581|NCT00373958|1492099|P1|Infant Series|Consent was not received|1
452582|NCT00373958|1492098|P2|Infant Series|Child relocated|0
452583|NCT00373958|1492099|P1|Infant Series|Child relocated|1
452584|NCT00373958|1492098|P2|Infant Series|Lost Kaiser coverage|0
452585|NCT00373958|1492099|P1|Infant Series|Lost Kaiser coverage|4
452586|NCT00373958|1492098|P2|Infant Series|Protocol Violation|7
452587|NCT00373958|1492099|P1|Infant Series|Protocol Violation|3
452588|NCT00373958|1492098|P2|Infant Series|Lost to Follow-up|5
452589|NCT00373958|1492099|P1|Infant Series|Lost to Follow-up|6
452590|NCT00373958|1492098|P2|Infant Series|Failed to return|13
452591|NCT00373958|1492099|P1|Infant Series|Failed to return|8
452592|NCT00373958|1492098|P2|Infant Series|Withdrawal by Subject|15
452593|NCT00373958|1492099|P1|Infant Series|Withdrawal by Subject|13
452594|NCT00373880|1492147|P1|Overall Study|Protocol Violation|14
452595|NCT00373880|1492147|P1|Overall Study|Arrested|1
452596|NCT00373880|1492147|P1|Overall Study|Physician Decision|3
452597|NCT00373685|1492192|P2|Overall Study|Randomized, not treated|77
452598|NCT00373685|1492193|P1|Overall Study|Randomized, not treated|51
452599|NCT00373685|1492192|P2|Overall Study|Final Status Unknown|4
452600|NCT00373685|1492193|P1|Overall Study|Final Status Unknown|12
452601|NCT00373685|1492192|P2|Overall Study|Protocol Violation|182
452602|NCT00373685|1492193|P1|Overall Study|Protocol Violation|191
452603|NCT00373685|1492192|P2|Overall Study|Other|146
452604|NCT00373685|1492193|P1|Overall Study|Other|149
452605|NCT00373685|1492192|P2|Overall Study|No longer willing to participate|352
452606|NCT00373685|1492193|P1|Overall Study|No longer willing to participate|337
452607|NCT00373685|1492192|P2|Overall Study|Lost to follow up|103
452608|NCT00373685|1492193|P1|Overall Study|Lost to follow up|83
452609|NCT00373685|1492192|P2|Overall Study|Did not meet entrance criteria|184
452610|NCT00373685|1492193|P1|Overall Study|Did not meet entrance criteria|167
452611|NCT00373685|1492192|P2|Overall Study|Insufficient clinical response|119
452612|NCT00373685|1492193|P1|Overall Study|Insufficient clinical response|169
452613|NCT00373685|1492192|P2|Overall Study|Adverse Event|253
452614|NCT00373685|1492193|P1|Overall Study|Adverse Event|278
452615|NCT00373685|1492192|P2|Overall Study|Death|1
452616|NCT00373685|1492193|P1|Overall Study|Death|2
452617|NCT00373529|1492227|P1|Overall Study|Consent violation|1
452618|NCT00373529|1492227|P1|Overall Study|Failed independent confirmation of AML|3
452619|NCT00373529|1492227|P1|Overall Study|Not specified|8
452620|NCT00373529|1492227|P1|Overall Study|Need for treatment prohibited by study|1
452621|NCT00373529|1492227|P1|Overall Study|Death|16
452622|NCT00373529|1492227|P1|Overall Study|Disease recurrence|10
452623|NCT00373529|1492227|P1|Overall Study|Treatment failure|36
452624|NCT00373529|1492227|P1|Overall Study|Adverse Event|7
452625|NCT00373529|1492227|P1|Overall Study|Withdrawal by Subject|7
452626|NCT00373529|1492227|P1|Overall Study|Physician Decision|19
452627|NCT00373490|1492239|P2|Overall Study|Withdrawal by Subject|1
452628|NCT00373490|1492240|P1|Overall Study|Withdrawal by Subject|0
452629|NCT00373490|1492239|P2|Overall Study|Lack of Efficacy|4
452630|NCT00373490|1492240|P1|Overall Study|Lack of Efficacy|9
452631|NCT00373490|1492239|P2|Overall Study|Adverse Event|1
452632|NCT00373490|1492240|P1|Overall Study|Adverse Event|0
452633|NCT00373425|1492263|P5|Overall Study|Death|0
452634|NCT00373425|1492264|P4|Overall Study|Death|1
452635|NCT00373425|1492265|P3|Overall Study|Death|3
452636|NCT00373425|1492266|P2|Overall Study|Death|0
452637|NCT00373425|1492267|P1|Overall Study|Death|7
452638|NCT00373425|1492263|P5|Overall Study|Medical/ethical/noncompliance reason|5
452639|NCT00373425|1492264|P4|Overall Study|Medical/ethical/noncompliance reason|2
452640|NCT00373425|1492265|P3|Overall Study|Medical/ethical/noncompliance reason|10
452641|NCT00373425|1492266|P2|Overall Study|Medical/ethical/noncompliance reason|9
452642|NCT00373425|1492267|P1|Overall Study|Medical/ethical/noncompliance reason|21
452643|NCT00373425|1492263|P5|Overall Study|Patient request|7
452644|NCT00373425|1492264|P4|Overall Study|Patient request|6
452645|NCT00373425|1492265|P3|Overall Study|Patient request|43
452646|NCT00373425|1492266|P2|Overall Study|Patient request|18
452647|NCT00373425|1492267|P1|Overall Study|Patient request|35
452648|NCT00373425|1492263|P5|Overall Study|Adverse Event|34
452649|NCT00373425|1492264|P4|Overall Study|Adverse Event|0
452650|NCT00373425|1492265|P3|Overall Study|Adverse Event|59
452651|NCT00373425|1492266|P2|Overall Study|Adverse Event|22
452652|NCT00373425|1492267|P1|Overall Study|Adverse Event|191
452653|NCT00373425|1492263|P5|Overall Study|Relapse of NSCLC|26
452654|NCT00373425|1492264|P4|Overall Study|Relapse of NSCLC|2
452655|NCT00373425|1492265|P3|Overall Study|Relapse of NSCLC|19
452656|NCT00373425|1492266|P2|Overall Study|Relapse of NSCLC|104
452657|NCT00373425|1492267|P1|Overall Study|Relapse of NSCLC|116
452658|NCT00373295|1492349|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
452659|NCT00373295|1492350|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
452660|NCT00373295|1492351|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
452661|NCT00373295|1492352|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
452662|NCT00373295|1492353|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
452663|NCT00373295|1492354|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
452664|NCT00373256|1492375|P2|Overall Study|Study Terminated by Sponsor|13
452665|NCT00373256|1492376|P1|Overall Study|Study Terminated by Sponsor|41
452666|NCT00373256|1492375|P2|Overall Study|Protocol Violation|2
452667|NCT00373256|1492376|P1|Overall Study|Protocol Violation|0
452668|NCT00373256|1492375|P2|Overall Study|Other|107
452669|NCT00373256|1492376|P1|Overall Study|Other|73
452670|NCT00373256|1492375|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
452671|NCT00373256|1492376|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
452672|NCT00373256|1492375|P2|Overall Study|Objective Progression or Relapse|104
452673|NCT00373256|1492376|P1|Overall Study|Objective Progression or Relapse|111
452674|NCT00373256|1492375|P2|Overall Study|Death|8
452675|NCT00373256|1492376|P1|Overall Study|Death|9
452676|NCT00373256|1492375|P2|Overall Study|Lost to Follow-up|1
452677|NCT00373256|1492376|P1|Overall Study|Lost to Follow-up|2
452678|NCT00373256|1492375|P2|Overall Study|Adverse Event (AE)|5
452679|NCT00373256|1492376|P1|Overall Study|Adverse Event (AE)|1
452680|NCT00373113|1492402|P2|Overall Study|Withdrawal by Subject|15
452681|NCT00373113|1492403|P1|Overall Study|Withdrawal by Subject|10
452682|NCT00373113|1492402|P2|Overall Study|Protocol Violation|1
452683|NCT00373113|1492403|P1|Overall Study|Protocol Violation|5
452684|NCT00373113|1492402|P2|Overall Study|Other|17
452685|NCT00373113|1492403|P1|Overall Study|Other|14
452686|NCT00373113|1492402|P2|Overall Study|Objective progression or relapse|169
452687|NCT00373113|1492403|P1|Overall Study|Objective progression or relapse|150
452688|NCT00373113|1492402|P2|Overall Study|Lost to Follow-up|3
452689|NCT00373113|1492403|P1|Overall Study|Lost to Follow-up|1
452690|NCT00373113|1492402|P2|Overall Study|Global deterioration of health status|7
452691|NCT00373113|1492403|P1|Overall Study|Global deterioration of health status|10
452692|NCT00373113|1492402|P2|Overall Study|Study terminated by sponsor|1
452693|NCT00373113|1492403|P1|Overall Study|Study terminated by sponsor|9
452694|NCT00373113|1492402|P2|Overall Study|Adverse Event|24
452695|NCT00373113|1492403|P1|Overall Study|Adverse Event|38
452696|NCT00373113|1492402|P2|Overall Study|Death|7
452697|NCT00373113|1492403|P1|Overall Study|Death|1
452698|NCT00372996|1492425|P4|Overall Study|Not specified|7
452699|NCT00372996|1492426|P3|Overall Study|Not specified|7
452700|NCT00372996|1492427|P2|Overall Study|Not specified|2
452701|NCT00372996|1492428|P1|Overall Study|Not specified|10
452702|NCT00372996|1492425|P4|Overall Study|Study Terminated by Sponsor|0
452703|NCT00372996|1492426|P3|Overall Study|Study Terminated by Sponsor|4
452704|NCT00372996|1492427|P2|Overall Study|Study Terminated by Sponsor|0
452705|NCT00372996|1492428|P1|Overall Study|Study Terminated by Sponsor|4
452706|NCT00372996|1492425|P4|Overall Study|Withdrawal by Subject|5
452707|NCT00372996|1492426|P3|Overall Study|Withdrawal by Subject|9
452708|NCT00372996|1492427|P2|Overall Study|Withdrawal by Subject|6
452709|NCT00372996|1492428|P1|Overall Study|Withdrawal by Subject|12
452710|NCT00372996|1492425|P4|Overall Study|Lost to Follow-up|1
452711|NCT00372996|1492426|P3|Overall Study|Lost to Follow-up|0
452712|NCT00372996|1492427|P2|Overall Study|Lost to Follow-up|2
452713|NCT00372996|1492428|P1|Overall Study|Lost to Follow-up|0
452714|NCT00372996|1492425|P4|Overall Study|Death|7
452715|NCT00372996|1492426|P3|Overall Study|Death|8
452716|NCT00372996|1492427|P2|Overall Study|Death|4
452717|NCT00372996|1492428|P1|Overall Study|Death|11
452718|NCT00372775|1492513|P1|Overall Study|Not Treated|2
452719|NCT00372775|1492513|P1|Overall Study|Not specified|1
452720|NCT00372775|1492513|P1|Overall Study|Withdrawal by Subject|1
452721|NCT00372775|1492513|P1|Overall Study|Global deterioration of health status|6
452722|NCT00372775|1492513|P1|Overall Study|Objective progression or relapse|30
452723|NCT00372775|1492513|P1|Overall Study|Death|15
452724|NCT00372775|1492513|P1|Overall Study|Adverse Event|8
452725|NCT00372697|1492535|P2|Overall Study|Protocol Violation|1
452726|NCT00372697|1492536|P1|Overall Study|Protocol Violation|1
452727|NCT00372619|1492561|P7|Overall Study|Inevaluable|0
452728|NCT00372619|1492562|P6|Overall Study|Inevaluable|1
452729|NCT00372619|1492563|P5|Overall Study|Inevaluable|0
452730|NCT00372619|1492564|P4|Overall Study|Inevaluable|0
452731|NCT00372619|1492565|P3|Overall Study|Inevaluable|0
452732|NCT00372619|1492566|P2|Overall Study|Inevaluable|0
452733|NCT00372619|1492567|P1|Overall Study|Inevaluable|0
452734|NCT00372619|1492561|P7|Overall Study|Ineligible|0
452735|NCT00372619|1492562|P6|Overall Study|Ineligible|2
452736|NCT00372619|1492563|P5|Overall Study|Ineligible|0
452737|NCT00372619|1492564|P4|Overall Study|Ineligible|0
452738|NCT00372619|1492565|P3|Overall Study|Ineligible|0
452739|NCT00372619|1492566|P2|Overall Study|Ineligible|0
452740|NCT00372619|1492567|P1|Overall Study|Ineligible|0
452741|NCT00372593|1492600|P3|Overall Study|Ineligible|1
452742|NCT00372593|1492601|P2|Overall Study|Ineligible|21
452743|NCT00372593|1492602|P1|Overall Study|Ineligible|20
452744|NCT00372593|1492600|P3|Overall Study|Physician Decision|0
452745|NCT00372593|1492601|P2|Overall Study|Physician Decision|41
452746|NCT00372593|1492602|P1|Overall Study|Physician Decision|42
452747|NCT00372593|1492600|P3|Overall Study|Lost to Follow-up|0
452748|NCT00372593|1492601|P2|Overall Study|Lost to Follow-up|0
452749|NCT00372593|1492602|P1|Overall Study|Lost to Follow-up|1
452750|NCT00372593|1492600|P3|Overall Study|Lack of Efficacy|2
452751|NCT00372593|1492601|P2|Overall Study|Lack of Efficacy|71
452752|NCT00372593|1492602|P1|Overall Study|Lack of Efficacy|82
452753|NCT00372593|1492600|P3|Overall Study|Death|1
452754|NCT00372593|1492601|P2|Overall Study|Death|20
452755|NCT00372593|1492602|P1|Overall Study|Death|16
452756|NCT00372593|1492600|P3|Overall Study|Adverse Event|0
452757|NCT00372593|1492601|P2|Overall Study|Adverse Event|45
452758|NCT00372593|1492602|P1|Overall Study|Adverse Event|43
452759|NCT00372567|1492631|P3|Phase 3 Study|study terminated by sponsor|5
452760|NCT00372567|1492632|P2|Phase 3 Study|study terminated by sponsor|8
452761|NCT00372567|1492633|P1|Phase 3 Study|study terminated by sponsor|13
452762|NCT00372567|1492631|P3|Phase 3 Study|not specified|1
452763|NCT00372567|1492632|P2|Phase 3 Study|not specified|2
452764|NCT00372567|1492633|P1|Phase 3 Study|not specified|2
452765|NCT00372567|1492631|P3|Phase 3 Study|Global deterioration of health status|0
452766|NCT00372567|1492632|P2|Phase 3 Study|Global deterioration of health status|1
452767|NCT00372567|1492633|P1|Phase 3 Study|Global deterioration of health status|0
452768|NCT00372567|1492631|P3|Phase 3 Study|Objective progression or relapse|4
452769|NCT00372567|1492632|P2|Phase 3 Study|Objective progression or relapse|13
452770|NCT00372567|1492633|P1|Phase 3 Study|Objective progression or relapse|10
452771|NCT00372567|1492631|P3|Phase 3 Study|Protocol Violation|1
452772|NCT00372567|1492632|P2|Phase 3 Study|Protocol Violation|0
452773|NCT00372567|1492633|P1|Phase 3 Study|Protocol Violation|0
452774|NCT00372567|1492631|P3|Phase 3 Study|Death|0
452775|NCT00372567|1492632|P2|Phase 3 Study|Death|1
452776|NCT00372567|1492633|P1|Phase 3 Study|Death|1
452777|NCT00372567|1492631|P3|Phase 3 Study|Adverse Event|1
452778|NCT00372567|1492632|P2|Phase 3 Study|Adverse Event|1
452779|NCT00372567|1492633|P1|Phase 3 Study|Adverse Event|5
452780|NCT00372528|1492661|P1|Overall Study|Other|1
452781|NCT00372528|1492661|P1|Overall Study|Study Terminated by Sponsor|18
452782|NCT00372528|1492661|P1|Overall Study|Adverse Event|1
452783|NCT00372528|1492661|P1|Overall Study|Lack of Efficacy|1
452784|NCT00372489|1492666|P1|Overall Study|Sponsor Decision to Terminate Study|41
452785|NCT00372489|1492666|P1|Overall Study|Renal transplant|6
452786|NCT00372489|1492666|P1|Overall Study|Patient Relocation|2
452787|NCT00372489|1492666|P1|Overall Study|Withdrawal by Subject|5
452788|NCT00372489|1492666|P1|Overall Study|Physician Decision|3
452789|NCT00372489|1492666|P1|Overall Study|Lost to Follow-up|3
452790|NCT00372489|1492666|P1|Overall Study|Lack of Efficacy|1
452791|NCT00372489|1492666|P1|Overall Study|Adverse Event|18
452792|NCT00372424|1492670|P1|Overall Study|Enrolled, Not Treated|1
452793|NCT00372424|1492670|P1|Overall Study|Other|7
452794|NCT00372424|1492670|P1|Overall Study|Objective Progression or Relapse|14
452795|NCT00372424|1492670|P1|Overall Study|Death|1
452796|NCT00372424|1492670|P1|Overall Study|Withdrawal by Subject|1
452797|NCT00372424|1492670|P1|Overall Study|Adverse Event|2
452798|NCT00372411|1492684|P3|Overall Study|Adverse Event|0
452799|NCT00372411|1492685|P2|Overall Study|Adverse Event|1
452800|NCT00372411|1492686|P1|Overall Study|Adverse Event|1
452801|NCT00372411|1492684|P3|Overall Study|Lost to Follow-up|1
452802|NCT00372411|1492685|P2|Overall Study|Lost to Follow-up|1
452803|NCT00372411|1492686|P1|Overall Study|Lost to Follow-up|1
452804|NCT00372411|1492684|P3|Overall Study|Death|1
452805|NCT00372411|1492685|P2|Overall Study|Death|2
452806|NCT00372411|1492686|P1|Overall Study|Death|0
452807|NCT00372411|1492684|P3|Overall Study|Withdrawal by Subject|1
452808|NCT00372411|1492685|P2|Overall Study|Withdrawal by Subject|4
452809|NCT00372411|1492686|P1|Overall Study|Withdrawal by Subject|3
452810|NCT00372385|1492710|P4|Overall Study|Virologic Stopping Rule|0
452811|NCT00372385|1492711|P3|Overall Study|Virologic Stopping Rule|0
452812|NCT00372385|1492712|P2|Overall Study|Virologic Stopping Rule|0
452813|NCT00372385|1492713|P1|Overall Study|Virologic Stopping Rule|17
452814|NCT00372385|1492710|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
452815|NCT00372385|1492711|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
452816|NCT00372385|1492712|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
452817|NCT00372385|1492713|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
452818|NCT00372385|1492710|P4|Overall Study|No Response|0
452819|NCT00372385|1492711|P3|Overall Study|No Response|0
452820|NCT00372385|1492712|P2|Overall Study|No Response|1
452821|NCT00372385|1492713|P1|Overall Study|No Response|1
452822|NCT00372385|1492710|P4|Overall Study|Refusal of Treatment|0
452823|NCT00372385|1492711|P3|Overall Study|Refusal of Treatment|0
452824|NCT00372385|1492712|P2|Overall Study|Refusal of Treatment|6
452825|NCT00372385|1492713|P1|Overall Study|Refusal of Treatment|3
452826|NCT00372385|1492710|P4|Overall Study|Withdrawal by Subject|0
452827|NCT00372385|1492711|P3|Overall Study|Withdrawal by Subject|0
452828|NCT00372385|1492712|P2|Overall Study|Withdrawal by Subject|1
452829|NCT00372385|1492713|P1|Overall Study|Withdrawal by Subject|2
452830|NCT00372385|1492710|P4|Overall Study|Lost to Follow-up|0
452831|NCT00372385|1492711|P3|Overall Study|Lost to Follow-up|0
452832|NCT00372385|1492712|P2|Overall Study|Lost to Follow-up|0
452833|NCT00372385|1492713|P1|Overall Study|Lost to Follow-up|2
452834|NCT00372385|1492710|P4|Overall Study|Physician Decision|0
452835|NCT00372385|1492711|P3|Overall Study|Physician Decision|0
452836|NCT00372385|1492712|P2|Overall Study|Physician Decision|0
452837|NCT00372385|1492713|P1|Overall Study|Physician Decision|1
452838|NCT00372385|1492710|P4|Overall Study|Noncompliance|1
452839|NCT00372385|1492711|P3|Overall Study|Noncompliance|1
452840|NCT00372385|1492712|P2|Overall Study|Noncompliance|1
452841|NCT00372385|1492713|P1|Overall Study|Noncompliance|0
452842|NCT00372385|1492710|P4|Overall Study|Adverse Event|7
452843|NCT00372385|1492711|P3|Overall Study|Adverse Event|9
452844|NCT00372385|1492712|P2|Overall Study|Adverse Event|11
452845|NCT00372385|1492713|P1|Overall Study|Adverse Event|6
452846|NCT00372190|1492742|P2|Overall Study|Lost to Follow-up|1
452847|NCT00372190|1492743|P1|Overall Study|Lost to Follow-up|3
452848|NCT00372112|1492759|P4|Overall Study|Other-protocol violation|0
452849|NCT00372112|1492760|P3|Overall Study|Other-protocol violation|1
452850|NCT00372112|1492761|P2|Overall Study|Other-protocol violation|0
452851|NCT00372112|1492762|P1|Overall Study|Other-protocol violation|0
452852|NCT00372112|1492759|P4|Overall Study|Hepatitis B|0
452853|NCT00372112|1492760|P3|Overall Study|Hepatitis B|0
452854|NCT00372112|1492761|P2|Overall Study|Hepatitis B|0
452855|NCT00372112|1492762|P1|Overall Study|Hepatitis B|1
452856|NCT00372112|1492759|P4|Overall Study|PR >240 at Visit 3|1
452857|NCT00372112|1492760|P3|Overall Study|PR >240 at Visit 3|0
452858|NCT00372112|1492761|P2|Overall Study|PR >240 at Visit 3|0
452859|NCT00372112|1492762|P1|Overall Study|PR >240 at Visit 3|0
452860|NCT00372112|1492759|P4|Overall Study|Exacerbation|1
452861|NCT00372112|1492760|P3|Overall Study|Exacerbation|0
452862|NCT00372112|1492761|P2|Overall Study|Exacerbation|0
452863|NCT00372112|1492762|P1|Overall Study|Exacerbation|0
452864|NCT00372112|1492759|P4|Overall Study|Withdrawal by Subject|1
452865|NCT00372112|1492760|P3|Overall Study|Withdrawal by Subject|2
452866|NCT00372112|1492761|P2|Overall Study|Withdrawal by Subject|0
452867|NCT00372112|1492762|P1|Overall Study|Withdrawal by Subject|0
452868|NCT00372112|1492759|P4|Overall Study|Adverse Event|1
452869|NCT00372112|1492760|P3|Overall Study|Adverse Event|1
452870|NCT00372112|1492761|P2|Overall Study|Adverse Event|1
452871|NCT00372112|1492762|P1|Overall Study|Adverse Event|0
452872|NCT00372060|1492893|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
452873|NCT00372060|1492894|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
452874|NCT00372060|1492893|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
452875|NCT00372060|1492894|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
452876|NCT00372060|1492893|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
452877|NCT00372060|1492894|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
452878|NCT00372060|1492893|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
452879|NCT00372060|1492894|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
452880|NCT00372060|1492893|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
452881|NCT00372060|1492894|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
452882|NCT00372060|1492893|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
452883|NCT00372060|1492894|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
452884|NCT00371865|1492909|P2|Overall Study|Withdrawal by Subject|10
452885|NCT00371865|1492910|P1|Overall Study|Withdrawal by Subject|12
452886|NCT00371865|1492909|P2|Overall Study|Protocol Violation|2
452887|NCT00371865|1492910|P1|Overall Study|Protocol Violation|3
452888|NCT00371865|1492909|P2|Overall Study|Lack of Efficacy|2
452889|NCT00371865|1492910|P1|Overall Study|Lack of Efficacy|0
452890|NCT00371839|1492927|P3|Overall Study|Lost to Follow-up|2
452891|NCT00371839|1492928|P2|Overall Study|Lost to Follow-up|3
452892|NCT00371839|1492929|P1|Overall Study|Lost to Follow-up|6
452893|NCT00371839|1492927|P3|Overall Study|Withdrawal by Subject|0
452894|NCT00371839|1492928|P2|Overall Study|Withdrawal by Subject|4
452895|NCT00371839|1492929|P1|Overall Study|Withdrawal by Subject|7
452896|NCT00371839|1492927|P3|Overall Study|Death|0
452897|NCT00371839|1492928|P2|Overall Study|Death|0
452898|NCT00371839|1492929|P1|Overall Study|Death|4
452899|NCT00371826|1492938|P3|Extension Phase (24 Months)|Administrative problems|2
452900|NCT00371826|1492939|P2|Extension Phase (24 Months)|Administrative problems|0
452901|NCT00371826|1492940|P1|Extension Phase (24 Months)|Administrative problems|0
452902|NCT00371826|1492938|P3|Extension Phase (24 Months)|Subject withdrew consent|0
452903|NCT00371826|1492939|P2|Extension Phase (24 Months)|Subject withdrew consent|2
452904|NCT00371826|1492940|P1|Extension Phase (24 Months)|Subject withdrew consent|1
452905|NCT00371826|1492938|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
452906|NCT00371826|1492939|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
452907|NCT00371826|1492940|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
452908|NCT00371826|1492938|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
452909|NCT00371826|1492939|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
452910|NCT00371826|1492940|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
452911|NCT00371826|1492938|P3|Extension Phase (24 Months)|Adverse Event|0
452912|NCT00371826|1492939|P2|Extension Phase (24 Months)|Adverse Event|5
452913|NCT00371826|1492940|P1|Extension Phase (24 Months)|Adverse Event|4
452914|NCT00371826|1492938|P3|Core Phase (12 Months)|Graft Loss|0
452915|NCT00371826|1492939|P2|Core Phase (12 Months)|Graft Loss|1
452916|NCT00371826|1492940|P1|Core Phase (12 Months)|Graft Loss|0
452917|NCT00371826|1492938|P3|Core Phase (12 Months)|Administrative problems|8
452918|NCT00371826|1492939|P2|Core Phase (12 Months)|Administrative problems|0
452919|NCT00371826|1492940|P1|Core Phase (12 Months)|Administrative problems|1
452920|NCT00371826|1492938|P3|Core Phase (12 Months)|Subject withdrew consent|3
452921|NCT00371826|1492939|P2|Core Phase (12 Months)|Subject withdrew consent|0
452922|NCT00371826|1492940|P1|Core Phase (12 Months)|Subject withdrew consent|0
452923|NCT00371826|1492938|P3|Core Phase (12 Months)|Protocol Violation|1
452924|NCT00371826|1492939|P2|Core Phase (12 Months)|Protocol Violation|0
452925|NCT00371826|1492940|P1|Core Phase (12 Months)|Protocol Violation|1
452926|NCT00371826|1492938|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
452927|NCT00371826|1492939|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
452928|NCT00371826|1492940|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
452929|NCT00371826|1492938|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
452930|NCT00371826|1492939|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
452931|NCT00371826|1492940|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
452932|NCT00371826|1492938|P3|Core Phase (12 Months)|Adverse Event|9
452933|NCT00371826|1492939|P2|Core Phase (12 Months)|Adverse Event|4
452934|NCT00371826|1492940|P1|Core Phase (12 Months)|Adverse Event|15
452935|NCT00371787|1493064|P2|Overall Study|Withdrawal by Subject|1
452936|NCT00371787|1493065|P1|Overall Study|Withdrawal by Subject|3
452937|NCT00371761|1493079|P2|Overall Study|Study termination|3
452938|NCT00371761|1493080|P1|Overall Study|Study termination|4
452939|NCT00371761|1493079|P2|Overall Study|Investigator Judgment|3
452940|NCT00371761|1493080|P1|Overall Study|Investigator Judgment|2
452941|NCT00371761|1493079|P2|Overall Study|Withdrawal by Subject|3
452942|NCT00371761|1493080|P1|Overall Study|Withdrawal by Subject|1
452943|NCT00371761|1493079|P2|Overall Study|Adverse Event|1
452944|NCT00371761|1493080|P1|Overall Study|Adverse Event|1
452945|NCT00371683|1493088|P2|Follow-Up Period - Randomized Patients|non-specified|12
452946|NCT00371683|1493089|P1|Follow-Up Period - Randomized Patients|non-specified|6
452947|NCT00371683|1493088|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
452948|NCT00371683|1493089|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
452949|NCT00371683|1493088|P2|Follow-Up Period - Randomized Patients|Death|2
452950|NCT00371683|1493089|P1|Follow-Up Period - Randomized Patients|Death|0
452951|NCT00371683|1493088|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
452952|NCT00371683|1493089|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
452953|NCT00371683|1493088|P2|DB Treatment Period-Randomized Patients|non-specified|8
452954|NCT00371683|1493089|P1|DB Treatment Period-Randomized Patients|non-specified|9
452955|NCT00371683|1493088|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
452956|NCT00371683|1493089|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
452957|NCT00371683|1493088|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
452958|NCT00371683|1493089|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
452959|NCT00371683|1493088|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
452960|NCT00371683|1493089|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
452961|NCT00371683|1493088|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
452962|NCT00371683|1493089|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
452963|NCT00371683|1493088|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
452964|NCT00371683|1493089|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
452965|NCT00371683|1493088|P2|DB Treatment Period-Randomized Patients|Death|1
452966|NCT00371683|1493089|P1|DB Treatment Period-Randomized Patients|Death|1
452967|NCT00371566|1493157|P2|Follow Up Phase|Lost to Follow-up|0
452968|NCT00371566|1493158|P1|Follow Up Phase|Lost to Follow-up|1
452969|NCT00371566|1493157|P2|Follow Up Phase|Physician Decision|1
452970|NCT00371566|1493158|P1|Follow Up Phase|Physician Decision|1
452971|NCT00371566|1493157|P2|Follow Up Phase|Withdrawal by Subject|1
452972|NCT00371566|1493158|P1|Follow Up Phase|Withdrawal by Subject|0
452973|NCT00371566|1493157|P2|Follow Up Phase|Disease progression|0
452974|NCT00371566|1493158|P1|Follow Up Phase|Disease progression|1
452975|NCT00371566|1493157|P2|Follow Up Phase|Death|5
452976|NCT00371566|1493158|P1|Follow Up Phase|Death|0
452977|NCT00371566|1493157|P2|Chemoradiation Phase|Death|0
452978|NCT00371566|1493158|P1|Chemoradiation Phase|Death|2
452979|NCT00371566|1493157|P2|Chemoradiation Phase|Progressive Disease|1
452980|NCT00371566|1493158|P1|Chemoradiation Phase|Progressive Disease|1
452981|NCT00371566|1493157|P2|Chemoradiation Phase|Non compliant|1
452982|NCT00371566|1493158|P1|Chemoradiation Phase|Non compliant|0
452983|NCT00371566|1493157|P2|Chemoradiation Phase|Withdrawal by Subject|1
452984|NCT00371566|1493158|P1|Chemoradiation Phase|Withdrawal by Subject|0
452985|NCT00371566|1493157|P2|Chemoradiation Phase|Physician Decision|0
452986|NCT00371566|1493158|P1|Chemoradiation Phase|Physician Decision|2
452987|NCT00371566|1493157|P2|Treatment Phase|Protocol Violation|1
452988|NCT00371566|1493158|P1|Treatment Phase|Protocol Violation|0
452989|NCT00371566|1493157|P2|Treatment Phase|Adverse Event|1
452990|NCT00371566|1493158|P1|Treatment Phase|Adverse Event|0
452991|NCT00371566|1493157|P2|Treatment Phase|Withdrawal by Subject|1
452992|NCT00371566|1493158|P1|Treatment Phase|Withdrawal by Subject|0
452993|NCT00371462|1493243|P2|Overall Study|Other|8
452994|NCT00371462|1493244|P1|Overall Study|Other|7
452995|NCT00371462|1493243|P2|Overall Study|Withdrawal by Subject|0
452996|NCT00371462|1493244|P1|Overall Study|Withdrawal by Subject|1
452997|NCT00371397|1493268|P12|Session 1|Withdrawal by Subject|0
452998|NCT00371397|1493269|P11|Session 1|Withdrawal by Subject|0
452999|NCT00371397|1493270|P10|Session 1|Withdrawal by Subject|0
453000|NCT00371397|1493271|P9|Session 1|Withdrawal by Subject|0
453001|NCT00371397|1493272|P8|Session 1|Withdrawal by Subject|1
453002|NCT00371397|1493273|P7|Session 1|Withdrawal by Subject|0
453003|NCT00371397|1493274|P6|Session 1|Withdrawal by Subject|0
453004|NCT00371397|1493275|P5|Session 1|Withdrawal by Subject|0
453005|NCT00371397|1493276|P4|Session 1|Withdrawal by Subject|0
453006|NCT00371397|1493277|P3|Session 1|Withdrawal by Subject|0
453007|NCT00371397|1493278|P2|Session 1|Withdrawal by Subject|0
453008|NCT00371397|1493279|P1|Session 1|Withdrawal by Subject|1
453009|NCT00371345|1493287|P2|Overall Study|Participant Withdrew Consent|1
453010|NCT00371345|1493288|P1|Overall Study|Participant Withdrew Consent|0
453011|NCT00371345|1493287|P2|Overall Study|Participant Request|1
453012|NCT00371345|1493288|P1|Overall Study|Participant Request|1
453013|NCT00371345|1493287|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
453014|NCT00371345|1493288|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
453015|NCT00371345|1493287|P2|Overall Study|Study Drug Toxicity|7
453016|NCT00371345|1493288|P1|Overall Study|Study Drug Toxicity|1
453017|NCT00371345|1493287|P2|Overall Study|Disease Progression|35
453018|NCT00371345|1493288|P1|Overall Study|Disease Progression|21
453019|NCT00371254|1493389|P2|Overall Study|Withdrawal by Subject|1
453020|NCT00371254|1493390|P1|Overall Study|Withdrawal by Subject|0
453021|NCT00371254|1493389|P2|Overall Study|Lost to Follow-up|1
453022|NCT00371254|1493390|P1|Overall Study|Lost to Follow-up|0
453023|NCT00371254|1493389|P2|Overall Study|Adverse event unrelated to study drug|1
453024|NCT00371254|1493390|P1|Overall Study|Adverse event unrelated to study drug|0
453025|NCT00371254|1493389|P2|Overall Study|Investigator Decision|0
453026|NCT00371254|1493390|P1|Overall Study|Investigator Decision|2
453027|NCT00371254|1493389|P2|Overall Study|Subject request|0
453028|NCT00371254|1493390|P1|Overall Study|Subject request|5
453029|NCT00371254|1493389|P2|Overall Study|Study drug toxicity|5
453030|NCT00371254|1493390|P1|Overall Study|Study drug toxicity|3
453031|NCT00371254|1493389|P2|Overall Study|Disease progression|13
453032|NCT00371254|1493390|P1|Overall Study|Disease progression|13
453033|NCT00371150|1493473|P2|Overall Study|Lost to Follow-up|2
453034|NCT00371150|1493474|P1|Overall Study|Lost to Follow-up|3
453035|NCT00371137|1493509|P3|Overall Study|Protocol Violation|1
453036|NCT00371137|1493510|P2|Overall Study|Protocol Violation|1
453037|NCT00371137|1493511|P1|Overall Study|Protocol Violation|2
453038|NCT00371137|1493509|P3|Overall Study|Physician Decision|1
453039|NCT00371137|1493510|P2|Overall Study|Physician Decision|1
453040|NCT00371137|1493511|P1|Overall Study|Physician Decision|1
453041|NCT00371137|1493509|P3|Overall Study|Sponsor Decision|2
453042|NCT00371137|1493510|P2|Overall Study|Sponsor Decision|1
453043|NCT00371137|1493511|P1|Overall Study|Sponsor Decision|2
453044|NCT00371137|1493509|P3|Overall Study|Lack of Efficacy|13
453045|NCT00371137|1493510|P2|Overall Study|Lack of Efficacy|12
453046|NCT00371137|1493511|P1|Overall Study|Lack of Efficacy|30
453047|NCT00371137|1493509|P3|Overall Study|Lost to Follow-up|5
453048|NCT00371137|1493510|P2|Overall Study|Lost to Follow-up|3
453049|NCT00371137|1493511|P1|Overall Study|Lost to Follow-up|6
453050|NCT00371137|1493509|P3|Overall Study|Withdrawal by Subject|15
453051|NCT00371137|1493510|P2|Overall Study|Withdrawal by Subject|10
453052|NCT00371137|1493511|P1|Overall Study|Withdrawal by Subject|11
453053|NCT00371137|1493509|P3|Overall Study|Adverse Event|42
453054|NCT00371137|1493510|P2|Overall Study|Adverse Event|35
453055|NCT00371137|1493511|P1|Overall Study|Adverse Event|20
453056|NCT00370682|1493554|P3|Overall Study|Lost to Follow-up|1
453057|NCT00370682|1493555|P2|Overall Study|Lost to Follow-up|1
453058|NCT00370682|1493556|P1|Overall Study|Lost to Follow-up|0
453059|NCT00370682|1493554|P3|Overall Study|Moved from area|0
453060|NCT00370682|1493555|P2|Overall Study|Moved from area|2
453061|NCT00370682|1493556|P1|Overall Study|Moved from area|0
453062|NCT00370552|1493598|P3|Overall Study|Planned radiation for palliation|0
453063|NCT00370552|1493599|P2|Overall Study|Planned radiation for palliation|1
453064|NCT00370552|1493600|P1|Overall Study|Planned radiation for palliation|0
453065|NCT00370552|1493598|P3|Overall Study|High risk of allergic reaction|0
453066|NCT00370552|1493599|P2|Overall Study|High risk of allergic reaction|1
453067|NCT00370552|1493600|P1|Overall Study|High risk of allergic reaction|0
453068|NCT00370552|1493598|P3|Overall Study|Investigator decision|0
453069|NCT00370552|1493599|P2|Overall Study|Investigator decision|1
453070|NCT00370552|1493600|P1|Overall Study|Investigator decision|2
453071|NCT00370552|1493598|P3|Overall Study|Physician Decision|0
453072|NCT00370552|1493599|P2|Overall Study|Physician Decision|1
453073|NCT00370552|1493600|P1|Overall Study|Physician Decision|1
453074|NCT00370552|1493598|P3|Overall Study|Never treated|0
453075|NCT00370552|1493599|P2|Overall Study|Never treated|0
453076|NCT00370552|1493600|P1|Overall Study|Never treated|1
453077|NCT00370552|1493598|P3|Overall Study|Still on treatment|2
453078|NCT00370552|1493599|P2|Overall Study|Still on treatment|3
453079|NCT00370552|1493600|P1|Overall Study|Still on treatment|1
453080|NCT00370552|1493598|P3|Overall Study|Withdrawal by Subject|1
453081|NCT00370552|1493599|P2|Overall Study|Withdrawal by Subject|0
453082|NCT00370552|1493600|P1|Overall Study|Withdrawal by Subject|2
453083|NCT00370552|1493598|P3|Overall Study|Study drug toxicity|6
453084|NCT00370552|1493599|P2|Overall Study|Study drug toxicity|8
453085|NCT00370552|1493600|P1|Overall Study|Study drug toxicity|11
453086|NCT00370552|1493598|P3|Overall Study|Poor or noncompliance|1
453087|NCT00370552|1493599|P2|Overall Study|Poor or noncompliance|0
453088|NCT00370552|1493600|P1|Overall Study|Poor or noncompliance|0
453089|NCT00370552|1493598|P3|Overall Study|Maximum clinical benefit|5
453090|NCT00370552|1493599|P2|Overall Study|Maximum clinical benefit|5
453091|NCT00370552|1493600|P1|Overall Study|Maximum clinical benefit|3
453092|NCT00370552|1493598|P3|Overall Study|Disease progression|15
453093|NCT00370552|1493599|P2|Overall Study|Disease progression|23
453094|NCT00370552|1493600|P1|Overall Study|Disease progression|23
453095|NCT00370552|1493598|P3|Overall Study|Adverse Event|2
453096|NCT00370552|1493599|P2|Overall Study|Adverse Event|2
453097|NCT00370552|1493600|P1|Overall Study|Adverse Event|2
453098|NCT00370331|1493640|P2|Overall Study|Protocol Violation|1
453099|NCT00370331|1493641|P1|Overall Study|Protocol Violation|1
453100|NCT00370331|1493640|P2|Overall Study|Non-compliance|1
453101|NCT00370331|1493641|P1|Overall Study|Non-compliance|0
453102|NCT00370331|1493640|P2|Overall Study|Lack of Efficacy|1
453103|NCT00370331|1493641|P1|Overall Study|Lack of Efficacy|0
453104|NCT00370331|1493640|P2|Overall Study|Lost to Follow-up|3
453105|NCT00370331|1493641|P1|Overall Study|Lost to Follow-up|0
453106|NCT00370331|1493640|P2|Overall Study|Withdrawal by Subject|4
453107|NCT00370331|1493641|P1|Overall Study|Withdrawal by Subject|2
453108|NCT00370331|1493640|P2|Overall Study|Adverse Event|13
453109|NCT00370331|1493641|P1|Overall Study|Adverse Event|4
453110|NCT00370292|1493667|P1|Overall Study|Physician Decision|2
453111|NCT00370292|1493667|P1|Overall Study|Adverse Event|7
453112|NCT00370292|1493667|P1|Overall Study|Disease Progression|4
453113|NCT00370149|1493680|P2|Overall Study|Antibiotic coated dressing placed|1
453114|NCT00370149|1493681|P1|Overall Study|Antibiotic coated dressing placed|0
453115|NCT00370149|1493680|P2|Overall Study|Pre-existing infection|1
453116|NCT00370149|1493681|P1|Overall Study|Pre-existing infection|0
453117|NCT00370149|1493680|P2|Overall Study|Catheter inserted in wrong vessel-|1
453118|NCT00370149|1493681|P1|Overall Study|Catheter inserted in wrong vessel-|2
453119|NCT00370149|1493680|P2|Overall Study|Protocol Violation|0
453120|NCT00370149|1493681|P1|Overall Study|Protocol Violation|1
453121|NCT00370149|1493680|P2|Overall Study|Physician Decision|16
453122|NCT00370149|1493681|P1|Overall Study|Physician Decision|16
453123|NCT00370071|1493691|P1|Overall Study|Withdrawal by Subject|2
453124|NCT00370032|1493708|P2|Follow-up Period|Withdrawal by Subject|0
453125|NCT00370032|1493709|P1|Follow-up Period|Withdrawal by Subject|1
453126|NCT00370032|1493708|P2|Washout Period|Adverse Event|0
453127|NCT00370032|1493709|P1|Washout Period|Adverse Event|1
453128|NCT00370032|1493708|P2|Washout Period|Lost to Follow-up|1
453129|NCT00370032|1493709|P1|Washout Period|Lost to Follow-up|0
453130|NCT00370032|1493708|P2|Washout Period|Withdrawal by Subject|1
453131|NCT00370032|1493709|P1|Washout Period|Withdrawal by Subject|0
453132|NCT00370032|1493708|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
453133|NCT00370032|1493709|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
453134|NCT00369967|1493729|P2|Overall Study|Lost to Follow-up|12
453135|NCT00369967|1493730|P1|Overall Study|Lost to Follow-up|23
453136|NCT00369941|1493748|P2|Overall Study|Miscellaneous|3
453137|NCT00369941|1493749|P1|Overall Study|Miscellaneous|3
453138|NCT00369941|1493748|P2|Overall Study|Study Site Terminated|0
453139|NCT00369941|1493749|P1|Overall Study|Study Site Terminated|2
453140|NCT00369941|1493748|P2|Overall Study|Employment Interfered with Study Visits|0
453141|NCT00369941|1493749|P1|Overall Study|Employment Interfered with Study Visits|1
453142|NCT00369941|1493748|P2|Overall Study|Treatment with Prohibited Medication|1
453143|NCT00369941|1493749|P1|Overall Study|Treatment with Prohibited Medication|3
453144|NCT00369941|1493748|P2|Overall Study|Moved|5
453145|NCT00369941|1493749|P1|Overall Study|Moved|11
453146|NCT00369941|1493748|P2|Overall Study|Completed, Did Not Enter Extension|6
453147|NCT00369941|1493749|P1|Overall Study|Completed, Did Not Enter Extension|5
453148|NCT00369941|1493748|P2|Overall Study|Pregnancy|2
453149|NCT00369941|1493749|P1|Overall Study|Pregnancy|4
453150|NCT00369941|1493748|P2|Overall Study|Withdrawal by Subject|18
453151|NCT00369941|1493749|P1|Overall Study|Withdrawal by Subject|5
453152|NCT00369941|1493748|P2|Overall Study|Protocol Violation|3
453153|NCT00369941|1493749|P1|Overall Study|Protocol Violation|5
453154|NCT00369941|1493748|P2|Overall Study|Lost to Follow-up|22
453155|NCT00369941|1493749|P1|Overall Study|Lost to Follow-up|12
453156|NCT00369941|1493748|P2|Overall Study|Lack of Efficacy|10
453157|NCT00369941|1493749|P1|Overall Study|Lack of Efficacy|6
453158|NCT00369941|1493748|P2|Overall Study|Adverse Event|28
453159|NCT00369941|1493749|P1|Overall Study|Adverse Event|14
453160|NCT00369941|1493748|P2|Overall Study|Never Treated|2
453161|NCT00369941|1493749|P1|Overall Study|Never Treated|1
453162|NCT00369915|1493914|P2|Overall Study|W/drawl by investigators|1
453163|NCT00369915|1493915|P1|Overall Study|W/drawl by investigators|0
453164|NCT00369915|1493914|P2|Overall Study|Withdrawal by Subject|1
453165|NCT00369915|1493915|P1|Overall Study|Withdrawal by Subject|4
453166|NCT00369915|1493914|P2|Overall Study|expected side effects|1
453167|NCT00369915|1493915|P1|Overall Study|expected side effects|2
453168|NCT00369824|1493929|P6|Overall Study|Other|3
453169|NCT00369824|1493930|P5|Overall Study|Other|1
453170|NCT00369824|1493931|P4|Overall Study|Other|2
453171|NCT00369824|1493932|P3|Overall Study|Other|0
453172|NCT00369824|1493933|P2|Overall Study|Other|0
453173|NCT00369824|1493934|P1|Overall Study|Other|0
453174|NCT00369824|1493929|P6|Overall Study|Lost to Follow-up|6
453175|NCT00369824|1493930|P5|Overall Study|Lost to Follow-up|9
453176|NCT00369824|1493931|P4|Overall Study|Lost to Follow-up|8
453177|NCT00369824|1493932|P3|Overall Study|Lost to Follow-up|7
453178|NCT00369824|1493933|P2|Overall Study|Lost to Follow-up|11
453179|NCT00369824|1493934|P1|Overall Study|Lost to Follow-up|6
453180|NCT00369824|1493929|P6|Overall Study|Withdrawal by Subject|2
453181|NCT00369824|1493930|P5|Overall Study|Withdrawal by Subject|6
453182|NCT00369824|1493931|P4|Overall Study|Withdrawal by Subject|4
453183|NCT00369824|1493932|P3|Overall Study|Withdrawal by Subject|5
453184|NCT00369824|1493933|P2|Overall Study|Withdrawal by Subject|5
453185|NCT00369824|1493934|P1|Overall Study|Withdrawal by Subject|9
453186|NCT00369824|1493929|P6|Overall Study|Protocol Violation|0
453187|NCT00369824|1493930|P5|Overall Study|Protocol Violation|1
453188|NCT00369824|1493931|P4|Overall Study|Protocol Violation|1
453189|NCT00369824|1493932|P3|Overall Study|Protocol Violation|0
453190|NCT00369824|1493933|P2|Overall Study|Protocol Violation|1
453191|NCT00369824|1493934|P1|Overall Study|Protocol Violation|0
453192|NCT00369824|1493929|P6|Overall Study|Adverse Event|0
453193|NCT00369824|1493930|P5|Overall Study|Adverse Event|1
453194|NCT00369824|1493931|P4|Overall Study|Adverse Event|0
453195|NCT00369824|1493932|P3|Overall Study|Adverse Event|0
453196|NCT00369824|1493933|P2|Overall Study|Adverse Event|2
453197|NCT00369824|1493934|P1|Overall Study|Adverse Event|0
453198|NCT00369785|1494034|P2|Overall Study|Multiple reasons|5
453199|NCT00369785|1494035|P1|Overall Study|Multiple reasons|6
453200|NCT00369785|1494034|P2|Overall Study|Progression|4
453201|NCT00369785|1494035|P1|Overall Study|Progression|4
453202|NCT00369785|1494034|P2|Overall Study|Never started|2
453203|NCT00369785|1494035|P1|Overall Study|Never started|0
453204|NCT00369785|1494034|P2|Overall Study|Toxicity|4
453205|NCT00369785|1494035|P1|Overall Study|Toxicity|6
453206|NCT00369785|1494034|P2|Overall Study|Withdrawal by Subject|6
453207|NCT00369785|1494035|P1|Overall Study|Withdrawal by Subject|7
453208|NCT00369785|1494034|P2|Overall Study|Death|2
453209|NCT00369785|1494035|P1|Overall Study|Death|1
453210|NCT00369785|1494034|P2|Overall Study|Physician Decision|2
453211|NCT00369785|1494035|P1|Overall Study|Physician Decision|3
453212|NCT00369681|1494056|P1|Overall Study|Inevaluable|1
453213|NCT00369668|1494065|P3|Overall Study|Lack of Efficacy|7
453214|NCT00369668|1494066|P2|Overall Study|Lack of Efficacy|5
453215|NCT00369668|1494067|P1|Overall Study|Lack of Efficacy|4
453216|NCT00369655|1494081|P1|Overall Study|Refusal of further treatment|2
453217|NCT00369577|1494111|P3|Overall Study|Withdrawal by Subject|1
453218|NCT00369577|1494112|P2|Overall Study|Withdrawal by Subject|0
453219|NCT00369577|1494113|P1|Overall Study|Withdrawal by Subject|0
453220|NCT00369486|1494150|P5|34-Week Visit|Dropped|3
453221|NCT00369486|1494151|P4|34-Week Visit|Dropped|3
453222|NCT00369486|1494152|P3|34-Week Visit|Dropped|1
453223|NCT00369486|1494153|P2|34-Week Visit|Dropped|1
453224|NCT00369486|1494154|P1|34-Week Visit|Dropped|0
453225|NCT00369486|1494150|P5|17-Week Visit|Missed visit|1
453226|NCT00369486|1494151|P4|17-Week Visit|Missed visit|1
453227|NCT00369486|1494152|P3|17-Week Visit|Missed visit|1
453228|NCT00369486|1494153|P2|17-Week Visit|Missed visit|0
453229|NCT00369486|1494154|P1|17-Week Visit|Missed visit|0
453230|NCT00369486|1494150|P5|8-Week Visit|Dropped|0
453231|NCT00369486|1494151|P4|8-Week Visit|Dropped|1
453232|NCT00369486|1494152|P3|8-Week Visit|Dropped|0
453233|NCT00369486|1494153|P2|8-Week Visit|Dropped|0
453234|NCT00369486|1494154|P1|8-Week Visit|Dropped|0
453235|NCT00369486|1494150|P5|8-Week Visit|Missed visit|1
453236|NCT00369486|1494151|P4|8-Week Visit|Missed visit|0
453237|NCT00369486|1494152|P3|8-Week Visit|Missed visit|0
453238|NCT00369486|1494153|P2|8-Week Visit|Missed visit|1
453239|NCT00369486|1494154|P1|8-Week Visit|Missed visit|0
453240|NCT00369486|1494150|P5|4-Week Visit|Dropped|0
453241|NCT00369486|1494151|P4|4-Week Visit|Dropped|0
453242|NCT00369486|1494152|P3|4-Week Visit|Dropped|1
453243|NCT00369486|1494153|P2|4-Week Visit|Dropped|0
453244|NCT00369486|1494154|P1|4-Week Visit|Dropped|0
453245|NCT00369486|1494150|P5|4-Week Visit|Missed visit|1
453246|NCT00369486|1494151|P4|4-Week Visit|Missed visit|2
453247|NCT00369486|1494152|P3|4-Week Visit|Missed visit|0
453248|NCT00369486|1494153|P2|4-Week Visit|Missed visit|2
453249|NCT00369486|1494154|P1|4-Week Visit|Missed visit|2
453250|NCT00369382|1494193|P2|Overall Study|Other|0
453251|NCT00369382|1494194|P1|Overall Study|Other|1
453252|NCT00369382|1494193|P2|Overall Study|Randomized, not treated|0
453253|NCT00369382|1494194|P1|Overall Study|Randomized, not treated|2
453254|NCT00369382|1494193|P2|Overall Study|Withdrawal by Subject|0
453255|NCT00369382|1494194|P1|Overall Study|Withdrawal by Subject|5
453256|NCT00369382|1494193|P2|Overall Study|Physician Decision|1
453257|NCT00369382|1494194|P1|Overall Study|Physician Decision|2
453258|NCT00369382|1494193|P2|Overall Study|Death|2
453259|NCT00369382|1494194|P1|Overall Study|Death|0
453260|NCT00369343|1494227|P2|Open-label Phase|did not take study drug|2
453261|NCT00369343|1494228|P1|Open-label Phase|did not take study drug|1
453262|NCT00369343|1494227|P2|Open-label Phase|Lack of continuance tolerability|4
453263|NCT00369343|1494228|P1|Open-label Phase|Lack of continuance tolerability|3
453264|NCT00369343|1494227|P2|Open-label Phase|Lack of Efficacy|3
453265|NCT00369343|1494228|P1|Open-label Phase|Lack of Efficacy|4
453266|NCT00369343|1494227|P2|Open-label Phase|Withdrawal by Subject|6
453267|NCT00369343|1494228|P1|Open-label Phase|Withdrawal by Subject|15
453268|NCT00369343|1494227|P2|Open-label Phase|Protocol Violation|3
453269|NCT00369343|1494228|P1|Open-label Phase|Protocol Violation|1
453270|NCT00369343|1494227|P2|Open-label Phase|inadvertently reported study completers|2
453271|NCT00369343|1494228|P1|Open-label Phase|inadvertently reported study completers|3
453272|NCT00369343|1494227|P2|Open-label Phase|Lost to Follow-up|3
453273|NCT00369343|1494228|P1|Open-label Phase|Lost to Follow-up|5
453274|NCT00369343|1494227|P2|Open-label Phase|Physician Decision|0
453275|NCT00369343|1494228|P1|Open-label Phase|Physician Decision|2
453276|NCT00369343|1494227|P2|Open-label Phase|Failed to return|0
453277|NCT00369343|1494228|P1|Open-label Phase|Failed to return|4
453278|NCT00369343|1494227|P2|Open-label Phase|Adverse Event|7
453279|NCT00369343|1494228|P1|Open-label Phase|Adverse Event|19
453280|NCT00369343|1494227|P2|Double-blind Phase|Protocol deviation|0
453281|NCT00369343|1494228|P1|Double-blind Phase|Protocol deviation|4
453282|NCT00369343|1494227|P2|Double-blind Phase|Lack of Efficacy|4
453283|NCT00369343|1494228|P1|Double-blind Phase|Lack of Efficacy|0
453284|NCT00369343|1494227|P2|Double-blind Phase|Withdrawal by Subject|6
453285|NCT00369343|1494228|P1|Double-blind Phase|Withdrawal by Subject|8
453286|NCT00369343|1494227|P2|Double-blind Phase|Protocol Violation|0
453287|NCT00369343|1494228|P1|Double-blind Phase|Protocol Violation|2
453288|NCT00369343|1494227|P2|Double-blind Phase|Lost to Follow-up|2
453289|NCT00369343|1494228|P1|Double-blind Phase|Lost to Follow-up|9
453290|NCT00369343|1494227|P2|Double-blind Phase|Failed to return|0
453291|NCT00369343|1494228|P1|Double-blind Phase|Failed to return|2
453292|NCT00369343|1494227|P2|Double-blind Phase|Adverse Event|4
453293|NCT00369343|1494228|P1|Double-blind Phase|Adverse Event|19
453294|NCT00369317|1494261|P1|Overall Study|Ineligible|1
453295|NCT00369317|1494261|P1|Overall Study|Withdrawal by Subject|8
453296|NCT00369317|1494261|P1|Overall Study|Physician Decision|2
453297|NCT00369317|1494261|P1|Overall Study|Lack of Efficacy|5
453298|NCT00369317|1494261|P1|Overall Study|Death|1
453299|NCT00369317|1494261|P1|Overall Study|Adverse Event|3
453300|NCT00369278|1494277|P2|Overall Study|Graft loss|2
453301|NCT00369278|1494278|P1|Overall Study|Graft loss|1
453302|NCT00369278|1494277|P2|Overall Study|Lost to Follow-up|0
453303|NCT00369278|1494278|P1|Overall Study|Lost to Follow-up|1
453304|NCT00369278|1494277|P2|Overall Study|Withdrawal by Subject|2
453305|NCT00369278|1494278|P1|Overall Study|Withdrawal by Subject|2
453306|NCT00369278|1494277|P2|Overall Study|Protocol Violation|1
453307|NCT00369278|1494278|P1|Overall Study|Protocol Violation|2
453308|NCT00369278|1494277|P2|Overall Study|Unsatisfactory therapeutic effect|5
453309|NCT00369278|1494278|P1|Overall Study|Unsatisfactory therapeutic effect|4
453310|NCT00369278|1494277|P2|Overall Study|Adverse Event|11
453311|NCT00369278|1494278|P1|Overall Study|Adverse Event|14
453312|NCT00369265|1494294|P2|Overall Study|Study terminated|7
453313|NCT00369265|1494295|P1|Overall Study|Study terminated|4
453314|NCT00369161|1494316|P2|Overall Study|Administrative Problem|2
453315|NCT00369161|1494317|P1|Overall Study|Administrative Problem|2
453316|NCT00369161|1494316|P2|Overall Study|Graft loss|0
453317|NCT00369161|1494317|P1|Overall Study|Graft loss|4
453318|NCT00369161|1494316|P2|Overall Study|Death|2
453319|NCT00369161|1494317|P1|Overall Study|Death|1
453320|NCT00369161|1494316|P2|Overall Study|Withdrawal by Subject|3
453321|NCT00369161|1494317|P1|Overall Study|Withdrawal by Subject|2
453322|NCT00369161|1494316|P2|Overall Study|Protocol Violation|2
453323|NCT00369161|1494317|P1|Overall Study|Protocol Violation|0
453324|NCT00369161|1494316|P2|Overall Study|Lack of Efficacy|1
453325|NCT00369161|1494317|P1|Overall Study|Lack of Efficacy|3
453326|NCT00369161|1494316|P2|Overall Study|Abnormal laboratory value|1
453327|NCT00369161|1494317|P1|Overall Study|Abnormal laboratory value|0
453328|NCT00369161|1494316|P2|Overall Study|Adverse Event|13
453329|NCT00369161|1494317|P1|Overall Study|Adverse Event|15
453330|NCT00369122|1494327|P1|Overall Study|No protocol treatment|1
453331|NCT00369122|1494327|P1|Overall Study|Ineligible|10
453332|NCT00368992|1494334|P1|Overall Study|Not Specified|9
453333|NCT00368992|1494334|P1|Overall Study|Death|4
453334|NCT00368992|1494334|P1|Overall Study|Adverse Event|26
453335|NCT00368992|1494334|P1|Overall Study|Lack of Efficacy|63
453336|NCT00368992|1494334|P1|Overall Study|Refused treatment|3
453337|NCT00368992|1494334|P1|Overall Study|Ineligible|5
453338|NCT00368979|1494343|P2|Overall Study|Withdrawal by Subject|9
453339|NCT00368979|1494344|P1|Overall Study|Withdrawal by Subject|5
453340|NCT00368979|1494343|P2|Overall Study|Protocol Violation|1
453341|NCT00368979|1494344|P1|Overall Study|Protocol Violation|2
453342|NCT00368979|1494343|P2|Overall Study|Lost to Follow-up|0
453343|NCT00368979|1494344|P1|Overall Study|Lost to Follow-up|1
453344|NCT00368979|1494343|P2|Overall Study|Not specified|1
453345|NCT00368979|1494344|P1|Overall Study|Not specified|3
453346|NCT00368979|1494343|P2|Overall Study|Lack of Efficacy|3
453347|NCT00368979|1494344|P1|Overall Study|Lack of Efficacy|5
453348|NCT00368979|1494343|P2|Overall Study|Adverse Event|16
453349|NCT00368979|1494344|P1|Overall Study|Adverse Event|9
453350|NCT00368966|1494360|P2|Toddler Dose|Lost to Follow-up|2
453351|NCT00368966|1494361|P1|Toddler Dose|Lost to Follow-up|0
453352|NCT00368966|1494360|P2|Toddler Dose|Withdrawal by Subject|1
453353|NCT00368966|1494361|P1|Toddler Dose|Withdrawal by Subject|1
453354|NCT00368966|1494360|P2|After Infant|Lost to Follow-up|1
453355|NCT00368966|1494361|P1|After Infant|Lost to Follow-up|0
453356|NCT00368966|1494360|P2|After Infant|Death|0
453357|NCT00368966|1494361|P1|After Infant|Death|1
453358|NCT00368966|1494360|P2|After Infant|Withdrawal by Subject|1
453359|NCT00368966|1494361|P1|After Infant|Withdrawal by Subject|1
453360|NCT00368966|1494360|P2|After Infant|Adverse Event|2
453361|NCT00368966|1494361|P1|After Infant|Adverse Event|1
453362|NCT00368966|1494360|P2|After Infant|Failed to return|1
453363|NCT00368966|1494361|P1|After Infant|Failed to return|3
453364|NCT00368966|1494360|P2|Infant Series|Failed to return|0
453365|NCT00368966|1494361|P1|Infant Series|Failed to return|1
453366|NCT00368966|1494360|P2|Infant Series|Adverse Event|1
453367|NCT00368966|1494361|P1|Infant Series|Adverse Event|0
453368|NCT00368966|1494360|P2|Infant Series|Failed to meet eligibility criteria|1
453369|NCT00368966|1494361|P1|Infant Series|Failed to meet eligibility criteria|0
453370|NCT00368966|1494360|P2|Infant Series|Randomization error|1
453371|NCT00368966|1494361|P1|Infant Series|Randomization error|0
453372|NCT00368966|1494360|P2|Infant Series|Lost to Follow-up|0
453373|NCT00368966|1494361|P1|Infant Series|Lost to Follow-up|2
453374|NCT00368966|1494360|P2|Infant Series|Protocol Violation|1
453375|NCT00368966|1494361|P1|Infant Series|Protocol Violation|2
453376|NCT00368966|1494360|P2|Infant Series|Withdrawal by Subject|6
453377|NCT00368966|1494361|P1|Infant Series|Withdrawal by Subject|11
453378|NCT00368927|1494432|P2|Overall Study|Physician Decision|0
453379|NCT00368927|1494433|P1|Overall Study|Physician Decision|1
453380|NCT00368927|1494432|P2|Overall Study|Withdrawal by Subject|2
453381|NCT00368927|1494433|P1|Overall Study|Withdrawal by Subject|1
453382|NCT00368927|1494432|P2|Overall Study|Adverse Event|1
453383|NCT00368927|1494433|P1|Overall Study|Adverse Event|1
453384|NCT00368927|1494432|P2|Overall Study|Lost to Follow-up|0
453385|NCT00368927|1494433|P1|Overall Study|Lost to Follow-up|2
453386|NCT00368875|1494441|P2|Overall Study|Alternative Therapy|1
453387|NCT00368875|1494442|P1|Overall Study|Alternative Therapy|1
453388|NCT00368875|1494441|P2|Overall Study|Other Reason|2
453389|NCT00368875|1494442|P1|Overall Study|Other Reason|0
453390|NCT00368875|1494441|P2|Overall Study|Withdrawal by Subject|6
453391|NCT00368875|1494442|P1|Overall Study|Withdrawal by Subject|2
453392|NCT00368875|1494441|P2|Overall Study|Progressive disease|27
453393|NCT00368875|1494442|P1|Overall Study|Progressive disease|3
453394|NCT00368875|1494441|P2|Overall Study|Adverse Event|12
453395|NCT00368875|1494442|P1|Overall Study|Adverse Event|0
453396|NCT00368849|1494450|P2|Overall Study|Physician Decision|1
453397|NCT00368849|1494451|P1|Overall Study|Physician Decision|0
453398|NCT00368849|1494450|P2|Overall Study|Withdrawal by Subject|1
453399|NCT00368849|1494451|P1|Overall Study|Withdrawal by Subject|0
453400|NCT00368745|1494467|P2|Double-blind Treatment Period|Other|6
453401|NCT00368745|1494468|P1|Double-blind Treatment Period|Other|7
453402|NCT00368745|1494467|P2|Double-blind Treatment Period|Withdrawal by Subject|3
453403|NCT00368745|1494468|P1|Double-blind Treatment Period|Withdrawal by Subject|5
453404|NCT00368745|1494467|P2|Double-blind Treatment Period|Lost to Follow-up|0
453405|NCT00368745|1494468|P1|Double-blind Treatment Period|Lost to Follow-up|1
453406|NCT00368745|1494467|P2|Double-blind Treatment Period|Lack of Efficacy|16
453407|NCT00368745|1494468|P1|Double-blind Treatment Period|Lack of Efficacy|7
453408|NCT00368745|1494467|P2|Double-blind Treatment Period|Adverse Event|6
453409|NCT00368745|1494468|P1|Double-blind Treatment Period|Adverse Event|6
453410|NCT00368641|1494521|P2|Overall Study|Sponsor decision to terminate study|5
453411|NCT00368641|1494522|P1|Overall Study|Sponsor decision to terminate study|2
453412|NCT00368641|1494521|P2|Overall Study|Withdrawal by Subject|0
453413|NCT00368641|1494522|P1|Overall Study|Withdrawal by Subject|1
453414|NCT00368641|1494521|P2|Overall Study|Death|0
453415|NCT00368641|1494522|P1|Overall Study|Death|1
453416|NCT00368641|1494521|P2|Overall Study|Adverse Event|1
453417|NCT00368641|1494522|P1|Overall Study|Adverse Event|2
453418|NCT00368550|1494530|P2|Overall Study|Withdrawal by Subject|10
453419|NCT00368550|1494531|P1|Overall Study|Withdrawal by Subject|17
453420|NCT00368550|1494530|P2|Overall Study|Lack of Efficacy|9
453421|NCT00368550|1494531|P1|Overall Study|Lack of Efficacy|4
453422|NCT00368550|1494530|P2|Overall Study|Adverse Event|4
453423|NCT00368550|1494531|P1|Overall Study|Adverse Event|7
453424|NCT00368537|1494543|P2|Baseline Participants|Patient uncompliant|1
453425|NCT00368537|1494544|P1|Baseline Participants|Patient uncompliant|0
453426|NCT00368537|1494543|P2|Baseline Participants|No susceptibility|0
453427|NCT00368537|1494544|P1|Baseline Participants|No susceptibility|1
453428|NCT00368537|1494543|P2|Baseline Participants|Death|2
453429|NCT00368537|1494544|P1|Baseline Participants|Death|1
453430|NCT00368537|1494543|P2|Baseline Participants|Withdrawal by Subject|4
453431|NCT00368537|1494544|P1|Baseline Participants|Withdrawal by Subject|6
453432|NCT00368537|1494543|P2|Baseline Participants|Lost to Follow-up|17
453433|NCT00368537|1494544|P1|Baseline Participants|Lost to Follow-up|16
453434|NCT00368537|1494543|P2|Randomization|No study drug dosed|6
453435|NCT00368537|1494544|P1|Randomization|No study drug dosed|13
453436|NCT00368472|1494558|P1|Overall Study|Missing Final Disposition Date|1
453437|NCT00368472|1494558|P1|Overall Study|Not Specified|32
453438|NCT00368472|1494558|P1|Overall Study|Diary non-compliance|1
453439|NCT00368472|1494558|P1|Overall Study|Withdrawal by Subject|40
453440|NCT00368472|1494558|P1|Overall Study|Request of Investigator or Sponsor|3
453441|NCT00368472|1494558|P1|Overall Study|Protocol Violation|2
453442|NCT00368472|1494558|P1|Overall Study|Medication non-compliance|4
453443|NCT00368472|1494558|P1|Overall Study|Adverse Event|22
453444|NCT00368277|1494617|P2|Overall Study|Lost to Follow-up|6
453445|NCT00368277|1494618|P1|Overall Study|Lost to Follow-up|8
453446|NCT00368277|1494617|P2|Overall Study|Patient withdrew consent|28
453447|NCT00368277|1494618|P1|Overall Study|Patient withdrew consent|32
453448|NCT00368277|1494617|P2|Overall Study|Protocol deviation|0
453449|NCT00368277|1494618|P1|Overall Study|Protocol deviation|7
453450|NCT00368277|1494617|P2|Overall Study|Unsatisfactory therapeutic effect|24
453451|NCT00368277|1494618|P1|Overall Study|Unsatisfactory therapeutic effect|31
453452|NCT00368277|1494617|P2|Overall Study|Death|1
453453|NCT00368277|1494618|P1|Overall Study|Death|2
453454|NCT00368277|1494617|P2|Overall Study|Adverse Event|49
453455|NCT00368277|1494618|P1|Overall Study|Adverse Event|33
453456|NCT00368251|1494633|P3|Overall Study|AE, non-serious non-fatal|1
453457|NCT00368251|1494634|P2|Overall Study|AE, non-serious non-fatal|0
453458|NCT00368251|1494635|P1|Overall Study|AE, non-serious non-fatal|0
453459|NCT00368251|1494633|P3|Overall Study|SAE, non-fatal|0
453460|NCT00368251|1494634|P2|Overall Study|SAE, non-fatal|0
453461|NCT00368251|1494635|P1|Overall Study|SAE, non-fatal|1
453462|NCT00368108|1494658|P3|Overall Study|Not Specified|1
453463|NCT00368108|1494659|P2|Overall Study|Not Specified|7
453464|NCT00368108|1494660|P1|Overall Study|Not Specified|3
453465|NCT00368108|1494658|P3|Overall Study|Physician Decision|1
453466|NCT00368108|1494659|P2|Overall Study|Physician Decision|0
453467|NCT00368108|1494660|P1|Overall Study|Physician Decision|2
453468|NCT00368108|1494658|P3|Overall Study|Lack of Efficacy|5
453469|NCT00368108|1494659|P2|Overall Study|Lack of Efficacy|8
453470|NCT00368108|1494660|P1|Overall Study|Lack of Efficacy|7
453471|NCT00368108|1494658|P3|Overall Study|Withdrawal by Subject|5
453472|NCT00368108|1494659|P2|Overall Study|Withdrawal by Subject|3
453473|NCT00368108|1494660|P1|Overall Study|Withdrawal by Subject|9
453474|NCT00368108|1494658|P3|Overall Study|Protocol Violation|9
453475|NCT00368108|1494659|P2|Overall Study|Protocol Violation|9
453476|NCT00368108|1494660|P1|Overall Study|Protocol Violation|5
453477|NCT00368108|1494658|P3|Overall Study|Abnormal Laboratory Value|3
453478|NCT00368108|1494659|P2|Overall Study|Abnormal Laboratory Value|0
453479|NCT00368108|1494660|P1|Overall Study|Abnormal Laboratory Value|0
453480|NCT00368108|1494658|P3|Overall Study|Adverse Event|44
453481|NCT00368108|1494659|P2|Overall Study|Adverse Event|26
453482|NCT00368108|1494660|P1|Overall Study|Adverse Event|38
453483|NCT00368069|1494679|P2|Overall Study|no blood sampling possible|1
453484|NCT00368069|1494680|P1|Overall Study|no blood sampling possible|0
453485|NCT00368069|1494679|P2|Overall Study|Withdrawal of Consent|1
453486|NCT00368069|1494680|P1|Overall Study|Withdrawal of Consent|2
453487|NCT00368069|1494679|P2|Overall Study|Protocol Violation|2
453488|NCT00368069|1494680|P1|Overall Study|Protocol Violation|0
453489|NCT00368069|1494679|P2|Overall Study|Lost to Follow-up|0
453490|NCT00368069|1494680|P1|Overall Study|Lost to Follow-up|1
453491|NCT00368069|1494679|P2|Overall Study|Lack of Efficacy|1
453492|NCT00368069|1494680|P1|Overall Study|Lack of Efficacy|0
453493|NCT00368069|1494679|P2|Overall Study|Adverse Event|2
453494|NCT00368069|1494680|P1|Overall Study|Adverse Event|5
453495|NCT00367991|1494698|P2|Overall Study|Adverse Event|1
453496|NCT00367991|1494699|P1|Overall Study|Adverse Event|1
453497|NCT00367991|1494698|P2|Overall Study|Withdrawal by Subject|1
453498|NCT00367991|1494699|P1|Overall Study|Withdrawal by Subject|1
453499|NCT00367835|1494717|P2|Overall Study|History of lead poisoning|1
453500|NCT00367835|1494718|P1|Overall Study|History of lead poisoning|0
453501|NCT00367835|1494717|P2|Overall Study|Did not respond to calls|0
453502|NCT00367835|1494718|P1|Overall Study|Did not respond to calls|1
453503|NCT00367835|1494717|P2|Overall Study|refused blood collection|0
453504|NCT00367835|1494718|P1|Overall Study|refused blood collection|1
453505|NCT00367835|1494717|P2|Overall Study|Subject in juvenile detention center|0
453506|NCT00367835|1494718|P1|Overall Study|Subject in juvenile detention center|1
453507|NCT00367835|1494717|P2|Overall Study|Lack of Efficacy|12
453508|NCT00367835|1494718|P1|Overall Study|Lack of Efficacy|3
453509|NCT00367835|1494717|P2|Overall Study|Lost to Follow-up|4
453510|NCT00367835|1494718|P1|Overall Study|Lost to Follow-up|1
453511|NCT00367835|1494717|P2|Overall Study|Withdrawal by Subject|6
453512|NCT00367835|1494718|P1|Overall Study|Withdrawal by Subject|7
453513|NCT00367835|1494717|P2|Overall Study|Protocol Violation|7
453514|NCT00367835|1494718|P1|Overall Study|Protocol Violation|1
453515|NCT00367835|1494717|P2|Overall Study|Adverse Event|1
453516|NCT00367835|1494718|P1|Overall Study|Adverse Event|14
453517|NCT00367770|1494744|P1|Overall Study|Withdrawal by Subject|1
453518|NCT00367770|1494744|P1|Overall Study|Adverse Event|1
453519|NCT00367744|1494752|P2|Overall Study|Lost to Follow-up|5
453520|NCT00367744|1494753|P1|Overall Study|Lost to Follow-up|4
453521|NCT00367640|1494782|P4|Overall Study|Any other reason not above-mentioned|4
453522|NCT00367640|1494783|P3|Overall Study|Any other reason not above-mentioned|3
453523|NCT00367640|1494784|P2|Overall Study|Any other reason not above-mentioned|5
453524|NCT00367640|1494785|P1|Overall Study|Any other reason not above-mentioned|7
453525|NCT00367640|1494782|P4|Overall Study|Withdrawal by Subject|6
453526|NCT00367640|1494783|P3|Overall Study|Withdrawal by Subject|8
453527|NCT00367640|1494784|P2|Overall Study|Withdrawal by Subject|11
453528|NCT00367640|1494785|P1|Overall Study|Withdrawal by Subject|8
453529|NCT00367640|1494782|P4|Overall Study|Adverse Event|0
453530|NCT00367640|1494783|P3|Overall Study|Adverse Event|8
453531|NCT00367640|1494784|P2|Overall Study|Adverse Event|6
453532|NCT00367640|1494785|P1|Overall Study|Adverse Event|3
453533|NCT00367484|1494801|P1|Overall Study|Lack of Efficacy|1
453534|NCT00367484|1494801|P1|Overall Study|The choice of the patient|1
453535|NCT00367484|1494801|P1|Overall Study|Protocol Violation|1
453536|NCT00367484|1494801|P1|Overall Study|Lost to Follow-up|1
453537|NCT00367484|1494801|P1|Overall Study|Travel to USA|1
453538|NCT00367484|1494801|P1|Overall Study|Withdrew informed consent|5
453539|NCT00367484|1494801|P1|Overall Study|Adverse Event|7
453540|NCT00367432|1494805|P2|Second Period (up to 54 Months)|Other Reason|2
453541|NCT00367432|1494806|P1|Second Period (up to 54 Months)|Other Reason|6
453542|NCT00367432|1494805|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
453543|NCT00367432|1494806|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
453544|NCT00367432|1494805|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
453545|NCT00367432|1494806|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
453546|NCT00367432|1494805|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
453547|NCT00367432|1494806|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
453548|NCT00367432|1494805|P2|Second Period (up to 54 Months)|Adverse Event|3
453549|NCT00367432|1494806|P1|Second Period (up to 54 Months)|Adverse Event|14
453550|NCT00367432|1494805|P2|First Period (16 Weeks)|Other Reason|0
453551|NCT00367432|1494806|P1|First Period (16 Weeks)|Other Reason|2
453552|NCT00367432|1494805|P2|First Period (16 Weeks)|Withdrawal by Subject|0
453553|NCT00367432|1494806|P1|First Period (16 Weeks)|Withdrawal by Subject|6
453554|NCT00367432|1494805|P2|First Period (16 Weeks)|Lack of Efficacy|0
453555|NCT00367432|1494806|P1|First Period (16 Weeks)|Lack of Efficacy|24
453556|NCT00367432|1494805|P2|First Period (16 Weeks)|Adverse Event|0
453557|NCT00367432|1494806|P1|First Period (16 Weeks)|Adverse Event|6
453558|NCT00367341|1494833|P2|Overall Study|Protocol Violation|0
453559|NCT00367341|1494834|P1|Overall Study|Protocol Violation|1
453560|NCT00367341|1494833|P2|Overall Study|Physician Decision|0
453561|NCT00367341|1494834|P1|Overall Study|Physician Decision|1
453562|NCT00367237|1494844|P2|Overall Study|Protocol Violation|5
453563|NCT00367237|1494845|P1|Overall Study|Protocol Violation|2
453564|NCT00367237|1494844|P2|Overall Study|Withdrawal by Subject|4
453565|NCT00367237|1494845|P1|Overall Study|Withdrawal by Subject|0
453566|NCT00367237|1494844|P2|Overall Study|Lost to Follow-up|0
453567|NCT00367237|1494845|P1|Overall Study|Lost to Follow-up|1
453568|NCT00367237|1494844|P2|Overall Study|Adverse Event|2
453569|NCT00367237|1494845|P1|Overall Study|Adverse Event|7
453570|NCT00367133|1494854|P3|2 Years|Missed visit|4
453571|NCT00367133|1494855|P2|2 Years|Missed visit|5
453572|NCT00367133|1494856|P1|2 Years|Missed visit|4
453573|NCT00367133|1494854|P3|2 Years|Dropped|33
453574|NCT00367133|1494855|P2|2 Years|Dropped|19
453575|NCT00367133|1494856|P1|2 Years|Dropped|34
453576|NCT00367133|1494854|P3|2 Years|Death|12
453577|NCT00367133|1494855|P2|2 Years|Death|12
453578|NCT00367133|1494856|P1|2 Years|Death|20
453579|NCT00367055|1494908|P2|Overall Study|Participant Living too Far from Hospital|1
453580|NCT00367055|1494909|P1|Overall Study|Participant Living too Far from Hospital|0
453581|NCT00367055|1494908|P2|Overall Study|Stopping Criterion Met|1
453582|NCT00367055|1494909|P1|Overall Study|Stopping Criterion Met|0
453583|NCT00367055|1494908|P2|Overall Study|Protocol Violation|1
453584|NCT00367055|1494909|P1|Overall Study|Protocol Violation|0
453585|NCT00367055|1494908|P2|Overall Study|Lost to Follow-up|1
453586|NCT00367055|1494909|P1|Overall Study|Lost to Follow-up|1
453587|NCT00367055|1494908|P2|Overall Study|Lack of Efficacy|2
453588|NCT00367055|1494909|P1|Overall Study|Lack of Efficacy|1
453589|NCT00367055|1494908|P2|Overall Study|Patient's Willing|2
453590|NCT00367055|1494909|P1|Overall Study|Patient's Willing|3
453591|NCT00367055|1494908|P2|Overall Study|Adverse Event|3
453592|NCT00367055|1494909|P1|Overall Study|Adverse Event|6
453593|NCT00366899|1494925|P2|Toddler Dose|Protocol Violation|0
453594|NCT00366899|1494926|P1|Toddler Dose|Protocol Violation|1
453595|NCT00366899|1494925|P2|Toddler Dose|Withdrawal by Subject|1
453596|NCT00366899|1494926|P1|Toddler Dose|Withdrawal by Subject|1
453597|NCT00366899|1494925|P2|After Infant Series|Protocol Violation|0
453598|NCT00366899|1494926|P1|After Infant Series|Protocol Violation|1
453599|NCT00366899|1494925|P2|After Infant Series|Adverse Event|2
453600|NCT00366899|1494926|P1|After Infant Series|Adverse Event|1
453601|NCT00366899|1494925|P2|After Infant Series|Withdrawal by Subject|4
453602|NCT00366899|1494926|P1|After Infant Series|Withdrawal by Subject|1
453603|NCT00366899|1494925|P2|After Infant Series|Lost to Follow-up|3
453604|NCT00366899|1494926|P1|After Infant Series|Lost to Follow-up|4
453605|NCT00366899|1494925|P2|Infant Series|Randomized but not consented|0
453606|NCT00366899|1494926|P1|Infant Series|Randomized but not consented|1
453607|NCT00366899|1494925|P2|Infant Series|Physician Decision|0
453608|NCT00366899|1494926|P1|Infant Series|Physician Decision|1
453609|NCT00366899|1494925|P2|Infant Series|Adverse Event|1
453610|NCT00366899|1494926|P1|Infant Series|Adverse Event|0
453611|NCT00366899|1494925|P2|Infant Series|Lost to Follow-up|2
453612|NCT00366899|1494926|P1|Infant Series|Lost to Follow-up|0
453613|NCT00366899|1494925|P2|Infant Series|Failed to return|1
453614|NCT00366899|1494926|P1|Infant Series|Failed to return|1
453615|NCT00366899|1494925|P2|Infant Series|Protocol Violation|1
453616|NCT00366899|1494926|P1|Infant Series|Protocol Violation|2
453617|NCT00366899|1494925|P2|Infant Series|Withdrawal by Subject|7
453618|NCT00366899|1494926|P1|Infant Series|Withdrawal by Subject|4
453619|NCT00366678|1494986|P3|Toddler Dose|protocol deviation|0
453620|NCT00366678|1494987|P2|Toddler Dose|protocol deviation|0
453621|NCT00366678|1494988|P1|Toddler Dose|protocol deviation|1
453622|NCT00366678|1494986|P3|Toddler Dose|Withdrawal by Subject|0
453623|NCT00366678|1494987|P2|Toddler Dose|Withdrawal by Subject|0
453624|NCT00366678|1494988|P1|Toddler Dose|Withdrawal by Subject|1
453625|NCT00366678|1494986|P3|Toddler Dose|Failed to return|0
453626|NCT00366678|1494987|P2|Toddler Dose|Failed to return|0
453627|NCT00366678|1494988|P1|Toddler Dose|Failed to return|1
453628|NCT00366678|1494986|P3|Toddler Dose|Protocol Violation|0
453629|NCT00366678|1494987|P2|Toddler Dose|Protocol Violation|1
453630|NCT00366678|1494988|P1|Toddler Dose|Protocol Violation|2
453631|NCT00366678|1494986|P3|After Infant|Protocol Violation|0
453632|NCT00366678|1494987|P2|After Infant|Protocol Violation|0
453633|NCT00366678|1494988|P1|After Infant|Protocol Violation|1
453634|NCT00366678|1494986|P3|After Infant|Adverse Event|0
453635|NCT00366678|1494987|P2|After Infant|Adverse Event|0
453636|NCT00366678|1494988|P1|After Infant|Adverse Event|1
453637|NCT00366678|1494986|P3|After Infant|Failed to return|0
453638|NCT00366678|1494987|P2|After Infant|Failed to return|5
453639|NCT00366678|1494988|P1|After Infant|Failed to return|5
453640|NCT00366678|1494986|P3|After Infant|Lost to Follow-up|0
453641|NCT00366678|1494987|P2|After Infant|Lost to Follow-up|1
453642|NCT00366678|1494988|P1|After Infant|Lost to Follow-up|2
453643|NCT00366678|1494986|P3|After Infant|Withdrawal by Subject|0
453644|NCT00366678|1494987|P2|After Infant|Withdrawal by Subject|4
453645|NCT00366678|1494988|P1|After Infant|Withdrawal by Subject|8
453646|NCT00366678|1494986|P3|Infant Series|Adverse Event|0
453647|NCT00366678|1494987|P2|Infant Series|Adverse Event|0
453648|NCT00366678|1494988|P1|Infant Series|Adverse Event|1
453649|NCT00366678|1494986|P3|Infant Series|Failed to return|0
453650|NCT00366678|1494987|P2|Infant Series|Failed to return|1
453651|NCT00366678|1494988|P1|Infant Series|Failed to return|1
453652|NCT00366678|1494986|P3|Infant Series|Protocol Violation|0
453653|NCT00366678|1494987|P2|Infant Series|Protocol Violation|3
453654|NCT00366678|1494988|P1|Infant Series|Protocol Violation|4
453655|NCT00366678|1494986|P3|Infant Series|Withdrawal by Subject|0
453656|NCT00366678|1494987|P2|Infant Series|Withdrawal by Subject|6
453657|NCT00366678|1494988|P1|Infant Series|Withdrawal by Subject|8
453658|NCT00366548|1495070|P2|After Infant Series|Lost to Follow-up|0
453659|NCT00366548|1495071|P1|After Infant Series|Lost to Follow-up|1
453660|NCT00366548|1495070|P2|After Infant Series|Adverse Event|0
453661|NCT00366548|1495071|P1|After Infant Series|Adverse Event|2
453662|NCT00366548|1495070|P2|After Infant Series|Withdrawal by Subject|1
453663|NCT00366548|1495071|P1|After Infant Series|Withdrawal by Subject|3
453664|NCT00366548|1495070|P2|Infant Series|Withdrawal by Subject|1
453665|NCT00366548|1495071|P1|Infant Series|Withdrawal by Subject|3
453666|NCT00366548|1495070|P2|Infant Series|Protocol Violation|1
453667|NCT00366548|1495071|P1|Infant Series|Protocol Violation|0
453668|NCT00366548|1495070|P2|Infant Series|Adverse Event|3
453669|NCT00366548|1495071|P1|Infant Series|Adverse Event|1
453670|NCT00366535|1495107|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
453671|NCT00366535|1495108|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
453672|NCT00366535|1495107|P2|Second Phase: 12 Weeks|Adverse Event|1
453673|NCT00366535|1495108|P1|Second Phase: 12 Weeks|Adverse Event|1
453674|NCT00366535|1495107|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
453675|NCT00366535|1495108|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
453676|NCT00366535|1495107|P2|First Phase: 12 Weeks|Adverse Event|3
453677|NCT00366535|1495108|P1|First Phase: 12 Weeks|Adverse Event|1
453678|NCT00366457|1495122|P1|Overall Study|never began study therapy|2
453679|NCT00366444|1495131|P2|Overall Study|Lack of Efficacy|1
453680|NCT00366444|1495132|P1|Overall Study|Lack of Efficacy|0
453681|NCT00366444|1495131|P2|Overall Study|Withdrawal by Subject|1
453682|NCT00366444|1495132|P1|Overall Study|Withdrawal by Subject|1
453683|NCT00366340|1495160|P2|Toddler Dose|Parent/legal guardian request|1
453684|NCT00366340|1495161|P1|Toddler Dose|Parent/legal guardian request|0
453685|NCT00366340|1495160|P2|Toddler Dose|Failed to return|0
453686|NCT00366340|1495161|P1|Toddler Dose|Failed to return|1
453687|NCT00366340|1495160|P2|After the Infant Series|Lost to Follow-up|1
453688|NCT00366340|1495161|P1|After the Infant Series|Lost to Follow-up|0
453689|NCT00366340|1495160|P2|After the Infant Series|Adverse Event|1
453690|NCT00366340|1495161|P1|After the Infant Series|Adverse Event|0
453691|NCT00366340|1495160|P2|After the Infant Series|Protocol Violation|2
453692|NCT00366340|1495161|P1|After the Infant Series|Protocol Violation|2
453693|NCT00366340|1495160|P2|After the Infant Series|Failed to return|1
453694|NCT00366340|1495161|P1|After the Infant Series|Failed to return|0
453695|NCT00366340|1495160|P2|After the Infant Series|Parent/legal guardian request|1
453696|NCT00366340|1495161|P1|After the Infant Series|Parent/legal guardian request|1
453697|NCT00366340|1495160|P2|Infant Series|Failure to return|0
453698|NCT00366340|1495161|P1|Infant Series|Failure to return|1
453699|NCT00366340|1495160|P2|Infant Series|Lost to Follow-up|1
453700|NCT00366340|1495161|P1|Infant Series|Lost to Follow-up|1
453701|NCT00366340|1495160|P2|Infant Series|Adverse Event|2
453702|NCT00366340|1495161|P1|Infant Series|Adverse Event|0
453703|NCT00366340|1495160|P2|Infant Series|Withdrawal by Subject|3
453704|NCT00366340|1495161|P1|Infant Series|Withdrawal by Subject|3
453705|NCT00366340|1495160|P2|Infant Series|Protocol Violation|4
453706|NCT00366340|1495161|P1|Infant Series|Protocol Violation|3
453707|NCT00366301|1495219|P4|Overall Study|Withdrawal by Subject|1
453708|NCT00366301|1495220|P3|Overall Study|Withdrawal by Subject|1
453709|NCT00366301|1495221|P2|Overall Study|Withdrawal by Subject|2
453710|NCT00366301|1495222|P1|Overall Study|Withdrawal by Subject|4
453711|NCT00366301|1495219|P4|Overall Study|Lost to Follow-up|7
453712|NCT00366301|1495220|P3|Overall Study|Lost to Follow-up|3
453713|NCT00366301|1495221|P2|Overall Study|Lost to Follow-up|4
453714|NCT00366301|1495222|P1|Overall Study|Lost to Follow-up|4
453715|NCT00366249|1495238|P2|Overall Study|Most due to osteomylitis status|20
453716|NCT00366249|1495239|P1|Overall Study|Most due to osteomylitis status|31
453717|NCT00366249|1495238|P2|Overall Study|Lack of Efficacy|21
453718|NCT00366249|1495239|P1|Overall Study|Lack of Efficacy|21
453719|NCT00366249|1495238|P2|Overall Study|Withdrawal by Subject|4
453720|NCT00366249|1495239|P1|Overall Study|Withdrawal by Subject|18
453721|NCT00366249|1495238|P2|Overall Study|Protocol Violation|2
453722|NCT00366249|1495239|P1|Overall Study|Protocol Violation|1
453723|NCT00366249|1495238|P2|Overall Study|Lost to Follow-up|0
453724|NCT00366249|1495239|P1|Overall Study|Lost to Follow-up|2
453725|NCT00366249|1495238|P2|Overall Study|Physician Decision|2
453726|NCT00366249|1495239|P1|Overall Study|Physician Decision|5
453727|NCT00366249|1495238|P2|Overall Study|Death|1
453728|NCT00366249|1495239|P1|Overall Study|Death|0
453729|NCT00366249|1495238|P2|Overall Study|Adverse Event|28
453730|NCT00366249|1495239|P1|Overall Study|Adverse Event|53
453731|NCT00365976|1495273|P2|Overall Study|Withdrawal by Subject|5
453732|NCT00365976|1495274|P1|Overall Study|Withdrawal by Subject|1
453733|NCT00365846|1495412|P1|Overall Study|Lost to Follow-up|1
453734|NCT00365716|1495437|P7|Extension 2|Withdrawal by Subject|5
453735|NCT00365716|1495438|P6|Extension 2|Withdrawal by Subject|0
453736|NCT00365716|1495439|P5|Extension 2|Withdrawal by Subject|0
453737|NCT00365716|1495440|P4|Extension 2|Withdrawal by Subject|0
453738|NCT00365716|1495441|P3|Extension 2|Withdrawal by Subject|0
453739|NCT00365716|1495442|P2|Extension 2|Withdrawal by Subject|0
453740|NCT00365716|1495443|P1|Extension 2|Withdrawal by Subject|0
453741|NCT00365716|1495437|P7|Extension 2|Other|3
453742|NCT00365716|1495438|P6|Extension 2|Other|0
453743|NCT00365716|1495439|P5|Extension 2|Other|0
453744|NCT00365716|1495440|P4|Extension 2|Other|0
453745|NCT00365716|1495441|P3|Extension 2|Other|0
453746|NCT00365716|1495442|P2|Extension 2|Other|0
453747|NCT00365716|1495443|P1|Extension 2|Other|0
453748|NCT00365716|1495437|P7|Extension 2|Lost to Follow-up|2
453749|NCT00365716|1495438|P6|Extension 2|Lost to Follow-up|0
453750|NCT00365716|1495439|P5|Extension 2|Lost to Follow-up|0
453751|NCT00365716|1495440|P4|Extension 2|Lost to Follow-up|0
453752|NCT00365716|1495441|P3|Extension 2|Lost to Follow-up|0
453753|NCT00365716|1495442|P2|Extension 2|Lost to Follow-up|0
453754|NCT00365716|1495443|P1|Extension 2|Lost to Follow-up|0
453755|NCT00365716|1495437|P7|Extension 1|Protocol Violation|0
453756|NCT00365716|1495438|P6|Extension 1|Protocol Violation|1
453757|NCT00365716|1495439|P5|Extension 1|Protocol Violation|0
453758|NCT00365716|1495440|P4|Extension 1|Protocol Violation|0
453759|NCT00365716|1495441|P3|Extension 1|Protocol Violation|0
453760|NCT00365716|1495442|P2|Extension 1|Protocol Violation|0
453761|NCT00365716|1495443|P1|Extension 1|Protocol Violation|0
453762|NCT00365716|1495437|P7|Extension 1|Pregnancy|0
453763|NCT00365716|1495438|P6|Extension 1|Pregnancy|4
453764|NCT00365716|1495439|P5|Extension 1|Pregnancy|0
453765|NCT00365716|1495440|P4|Extension 1|Pregnancy|0
453766|NCT00365716|1495441|P3|Extension 1|Pregnancy|0
453767|NCT00365716|1495442|P2|Extension 1|Pregnancy|0
453768|NCT00365716|1495443|P1|Extension 1|Pregnancy|0
453769|NCT00365716|1495437|P7|Extension 1|Withdrawal by Subject|0
453770|NCT00365716|1495438|P6|Extension 1|Withdrawal by Subject|3
453771|NCT00365716|1495439|P5|Extension 1|Withdrawal by Subject|0
453772|NCT00365716|1495440|P4|Extension 1|Withdrawal by Subject|0
453773|NCT00365716|1495441|P3|Extension 1|Withdrawal by Subject|0
453774|NCT00365716|1495442|P2|Extension 1|Withdrawal by Subject|0
453775|NCT00365716|1495443|P1|Extension 1|Withdrawal by Subject|0
453776|NCT00365716|1495437|P7|Extension 1|Moved|0
453777|NCT00365716|1495438|P6|Extension 1|Moved|4
453778|NCT00365716|1495439|P5|Extension 1|Moved|0
453779|NCT00365716|1495440|P4|Extension 1|Moved|0
453780|NCT00365716|1495441|P3|Extension 1|Moved|0
453781|NCT00365716|1495442|P2|Extension 1|Moved|0
453782|NCT00365716|1495443|P1|Extension 1|Moved|0
453783|NCT00365716|1495437|P7|Extension 1|Other|0
453784|NCT00365716|1495438|P6|Extension 1|Other|9
453785|NCT00365716|1495439|P5|Extension 1|Other|0
453786|NCT00365716|1495440|P4|Extension 1|Other|0
453787|NCT00365716|1495441|P3|Extension 1|Other|0
453788|NCT00365716|1495442|P2|Extension 1|Other|0
453789|NCT00365716|1495443|P1|Extension 1|Other|0
453790|NCT00365716|1495437|P7|Extension 1|Lost to Follow-up|0
453791|NCT00365716|1495438|P6|Extension 1|Lost to Follow-up|1
453792|NCT00365716|1495439|P5|Extension 1|Lost to Follow-up|0
453793|NCT00365716|1495440|P4|Extension 1|Lost to Follow-up|0
453794|NCT00365716|1495441|P3|Extension 1|Lost to Follow-up|0
453795|NCT00365716|1495442|P2|Extension 1|Lost to Follow-up|0
453796|NCT00365716|1495443|P1|Extension 1|Lost to Follow-up|0
453797|NCT00365716|1495437|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
453798|NCT00365716|1495438|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
453799|NCT00365716|1495439|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
453800|NCT00365716|1495440|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
453801|NCT00365716|1495441|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
453802|NCT00365716|1495442|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
453803|NCT00365716|1495443|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
453804|NCT00365716|1495437|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
453805|NCT00365716|1495438|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
453806|NCT00365716|1495439|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
453807|NCT00365716|1495440|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
453808|NCT00365716|1495441|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
453809|NCT00365716|1495442|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
453810|NCT00365716|1495443|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
453811|NCT00365716|1495437|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
453812|NCT00365716|1495438|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
453813|NCT00365716|1495439|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
453814|NCT00365716|1495440|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
453815|NCT00365716|1495441|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
453816|NCT00365716|1495442|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
453817|NCT00365716|1495443|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
453818|NCT00365716|1495437|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
453819|NCT00365716|1495438|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
453820|NCT00365716|1495439|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
453821|NCT00365716|1495440|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
453822|NCT00365716|1495441|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
453823|NCT00365716|1495442|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
453824|NCT00365716|1495443|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
453825|NCT00365716|1495437|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
453826|NCT00365716|1495438|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
453827|NCT00365716|1495439|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
453828|NCT00365716|1495440|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
453829|NCT00365716|1495441|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
453830|NCT00365716|1495442|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
453831|NCT00365716|1495443|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
453832|NCT00365716|1495437|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
453833|NCT00365716|1495438|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
453834|NCT00365716|1495439|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
453835|NCT00365716|1495440|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
453836|NCT00365716|1495441|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
453837|NCT00365716|1495442|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
453838|NCT00365716|1495443|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
453839|NCT00365716|1495437|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
453840|NCT00365716|1495438|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
453841|NCT00365716|1495439|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
453842|NCT00365716|1495440|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
453843|NCT00365716|1495441|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
453844|NCT00365716|1495442|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
453845|NCT00365716|1495443|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
453846|NCT00365716|1495437|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
453847|NCT00365716|1495438|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
453848|NCT00365716|1495439|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
453849|NCT00365716|1495440|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
453850|NCT00365716|1495441|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
453851|NCT00365716|1495442|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
453852|NCT00365716|1495443|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
453853|NCT00365716|1495437|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
453854|NCT00365716|1495438|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
453855|NCT00365716|1495439|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
453856|NCT00365716|1495440|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
453857|NCT00365716|1495441|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
453858|NCT00365716|1495442|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
453859|NCT00365716|1495443|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
453860|NCT00365716|1495437|P7|Base Study (Day 1 to Month 7)|Other|0
453861|NCT00365716|1495438|P6|Base Study (Day 1 to Month 7)|Other|0
453862|NCT00365716|1495439|P5|Base Study (Day 1 to Month 7)|Other|0
453863|NCT00365716|1495440|P4|Base Study (Day 1 to Month 7)|Other|0
453864|NCT00365716|1495441|P3|Base Study (Day 1 to Month 7)|Other|0
453865|NCT00365716|1495442|P2|Base Study (Day 1 to Month 7)|Other|1
453866|NCT00365716|1495443|P1|Base Study (Day 1 to Month 7)|Other|0
453867|NCT00365716|1495437|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
453868|NCT00365716|1495438|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
453869|NCT00365716|1495439|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
453870|NCT00365716|1495440|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
453871|NCT00365716|1495441|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
453872|NCT00365716|1495442|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
453873|NCT00365716|1495443|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
453874|NCT00365716|1495437|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
453875|NCT00365716|1495438|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
453876|NCT00365716|1495439|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
453877|NCT00365716|1495440|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
453878|NCT00365716|1495441|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
453879|NCT00365716|1495442|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
453880|NCT00365716|1495443|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
453881|NCT00365716|1495437|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
453882|NCT00365716|1495438|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
453883|NCT00365716|1495439|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
453884|NCT00365716|1495440|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
453885|NCT00365716|1495441|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
453886|NCT00365716|1495442|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
453887|NCT00365716|1495443|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
453888|NCT00365547|1495464|P1|Overall Study|Withdrawal by Subject|1
453889|NCT00365547|1495464|P1|Overall Study|Screen failure|1
453890|NCT00365547|1495464|P1|Overall Study|Insurance did not cover Avastin|1
453891|NCT00365508|1495474|P2|Overall Study|Lost to Follow-up|154
453892|NCT00365508|1495475|P1|Overall Study|Lost to Follow-up|139
453893|NCT00365456|1495483|P2|Trial Period III (12 Months)|Other|1
453894|NCT00365456|1495484|P1|Trial Period III (12 Months)|Other|1
453895|NCT00365456|1495483|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
453896|NCT00365456|1495484|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
453897|NCT00365456|1495483|P2|Trial Period III (12 Months)|Adverse Event|3
453898|NCT00365456|1495484|P1|Trial Period III (12 Months)|Adverse Event|13
453899|NCT00365456|1495483|P2|Trial Period II (12 Months)|Other|1
453900|NCT00365456|1495484|P1|Trial Period II (12 Months)|Other|0
453901|NCT00365456|1495483|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
453902|NCT00365456|1495484|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
453903|NCT00365456|1495483|P2|Trial Period II (12 Months)|Non-compliance|2
453904|NCT00365456|1495484|P1|Trial Period II (12 Months)|Non-compliance|0
453905|NCT00365456|1495483|P2|Trial Period II (12 Months)|Adverse Event|6
453906|NCT00365456|1495484|P1|Trial Period II (12 Months)|Adverse Event|0
453907|NCT00365456|1495483|P2|Trial Period I (12 Months)|Other|0
453908|NCT00365456|1495484|P1|Trial Period I (12 Months)|Other|11
453909|NCT00365456|1495483|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
453910|NCT00365456|1495484|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
453911|NCT00365456|1495483|P2|Trial Period I (12 Months)|Non-compliance|0
453912|NCT00365456|1495484|P1|Trial Period I (12 Months)|Non-compliance|3
453913|NCT00365456|1495483|P2|Trial Period I (12 Months)|Adverse Event|0
453914|NCT00365456|1495484|P1|Trial Period I (12 Months)|Adverse Event|84
453915|NCT00365378|1495506|P3|Extension|Other|31
453916|NCT00365378|1495507|P2|Extension|Other|0
453917|NCT00365378|1495508|P1|Extension|Other|0
453918|NCT00365378|1495506|P3|Extension|Withdrawal by Subject|98
453919|NCT00365378|1495507|P2|Extension|Withdrawal by Subject|0
453920|NCT00365378|1495508|P1|Extension|Withdrawal by Subject|0
453921|NCT00365378|1495506|P3|Extension|Protocol Violation|2
453922|NCT00365378|1495507|P2|Extension|Protocol Violation|0
453923|NCT00365378|1495508|P1|Extension|Protocol Violation|0
453924|NCT00365378|1495506|P3|Extension|Lost to Follow-up|57
453925|NCT00365378|1495507|P2|Extension|Lost to Follow-up|0
453926|NCT00365378|1495508|P1|Extension|Lost to Follow-up|0
453927|NCT00365378|1495506|P3|Extension|Moved|8
453928|NCT00365378|1495507|P2|Extension|Moved|0
453929|NCT00365378|1495508|P1|Extension|Moved|0
453930|NCT00365378|1495506|P3|Extension|Adverse Event|1
453931|NCT00365378|1495507|P2|Extension|Adverse Event|0
453932|NCT00365378|1495508|P1|Extension|Adverse Event|0
453933|NCT00365378|1495506|P3|Follow-up (Month 7 Though Month 48)|Other|0
453934|NCT00365378|1495507|P2|Follow-up (Month 7 Though Month 48)|Other|21
453935|NCT00365378|1495508|P1|Follow-up (Month 7 Though Month 48)|Other|11
453936|NCT00365378|1495506|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
453937|NCT00365378|1495507|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
453938|NCT00365378|1495508|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
453939|NCT00365378|1495506|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
453940|NCT00365378|1495507|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
453941|NCT00365378|1495508|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
453942|NCT00365378|1495506|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
453943|NCT00365378|1495507|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
453944|NCT00365378|1495508|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
453945|NCT00365378|1495506|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
453946|NCT00365378|1495507|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
453947|NCT00365378|1495508|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
453948|NCT00365378|1495506|P3|Follow-up (Month 7 Though Month 48)|Moved|0
453949|NCT00365378|1495507|P2|Follow-up (Month 7 Though Month 48)|Moved|5
453950|NCT00365378|1495508|P1|Follow-up (Month 7 Though Month 48)|Moved|6
453951|NCT00365378|1495506|P3|Vaccination (Day 1 to Month 7)|Other|0
453952|NCT00365378|1495507|P2|Vaccination (Day 1 to Month 7)|Other|9
453953|NCT00365378|1495508|P1|Vaccination (Day 1 to Month 7)|Other|17
453954|NCT00365378|1495506|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
453955|NCT00365378|1495507|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
453956|NCT00365378|1495508|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
453957|NCT00365378|1495506|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
453958|NCT00365378|1495507|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
453959|NCT00365378|1495508|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
453960|NCT00365378|1495506|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
453961|NCT00365378|1495507|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
453962|NCT00365378|1495508|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
453963|NCT00365378|1495506|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
453964|NCT00365378|1495507|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
453965|NCT00365378|1495508|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
453966|NCT00365378|1495506|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
453967|NCT00365378|1495507|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
453968|NCT00365378|1495508|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
453969|NCT00365378|1495506|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
453970|NCT00365378|1495507|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
453971|NCT00365378|1495508|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
453972|NCT00365365|1495522|P3|Overall Study|Patient/physician decision|1
453973|NCT00365365|1495523|P2|Overall Study|Patient/physician decision|0
453974|NCT00365365|1495524|P1|Overall Study|Patient/physician decision|0
453975|NCT00365365|1495522|P3|Overall Study|Second malignancy|0
453976|NCT00365365|1495523|P2|Overall Study|Second malignancy|1
453977|NCT00365365|1495524|P1|Overall Study|Second malignancy|0
453978|NCT00365365|1495522|P3|Overall Study|Withdrew consent|0
453979|NCT00365365|1495523|P2|Overall Study|Withdrew consent|1
453980|NCT00365365|1495524|P1|Overall Study|Withdrew consent|1
453981|NCT00365365|1495522|P3|Overall Study|New cancer|0
453982|NCT00365365|1495523|P2|Overall Study|New cancer|0
453983|NCT00365365|1495524|P1|Overall Study|New cancer|1
453984|NCT00365365|1495522|P3|Overall Study|Moved|0
453985|NCT00365365|1495523|P2|Overall Study|Moved|0
453986|NCT00365365|1495524|P1|Overall Study|Moved|2
453987|NCT00365365|1495522|P3|Overall Study|Adverse Event|3
453988|NCT00365365|1495523|P2|Overall Study|Adverse Event|6
453989|NCT00365365|1495524|P1|Overall Study|Adverse Event|6
453990|NCT00365365|1495522|P3|Overall Study|Disease progression/relapse|7
453991|NCT00365365|1495523|P2|Overall Study|Disease progression/relapse|6
453992|NCT00365365|1495524|P1|Overall Study|Disease progression/relapse|9
453993|NCT00365365|1495522|P3|Overall Study|Subject's request|1
453994|NCT00365365|1495523|P2|Overall Study|Subject's request|13
453995|NCT00365365|1495524|P1|Overall Study|Subject's request|11
453996|NCT00365365|1495522|P3|Overall Study|Death|0
453997|NCT00365365|1495523|P2|Overall Study|Death|3
453998|NCT00365365|1495524|P1|Overall Study|Death|1
453999|NCT00365365|1495522|P3|Overall Study|Lost to Follow-up|3
454000|NCT00365365|1495523|P2|Overall Study|Lost to Follow-up|3
454001|NCT00365365|1495524|P1|Overall Study|Lost to Follow-up|3
454002|NCT00365365|1495522|P3|Overall Study|Poor compliance to protocol|0
454003|NCT00365365|1495523|P2|Overall Study|Poor compliance to protocol|1
454004|NCT00365365|1495524|P1|Overall Study|Poor compliance to protocol|0
454005|NCT00365365|1495522|P3|Overall Study|Randomized but not treated|0
454006|NCT00365365|1495523|P2|Overall Study|Randomized but not treated|2
454007|NCT00365365|1495524|P1|Overall Study|Randomized but not treated|0
454008|NCT00365352|1495541|P3|Overall Study|Withdrawal of Participant by Sponsor|0
454009|NCT00365352|1495542|P2|Overall Study|Withdrawal of Participant by Sponsor|0
454010|NCT00365352|1495543|P1|Overall Study|Withdrawal of Participant by Sponsor|1
454011|NCT00365352|1495541|P3|Overall Study|Lost to Follow-up|0
454012|NCT00365352|1495542|P2|Overall Study|Lost to Follow-up|1
454013|NCT00365352|1495543|P1|Overall Study|Lost to Follow-up|1
454014|NCT00365352|1495541|P3|Overall Study|Non-Compliance (after Randomization)|1
454015|NCT00365352|1495542|P2|Overall Study|Non-Compliance (after Randomization)|0
454016|NCT00365352|1495543|P1|Overall Study|Non-Compliance (after Randomization)|1
454017|NCT00365352|1495541|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
454018|NCT00365352|1495542|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
454019|NCT00365352|1495543|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
454020|NCT00365352|1495541|P3|Overall Study|Lack of Efficacy|0
454021|NCT00365352|1495542|P2|Overall Study|Lack of Efficacy|0
454022|NCT00365352|1495543|P1|Overall Study|Lack of Efficacy|3
454023|NCT00365352|1495541|P3|Overall Study|Participant Withdrew Consent|4
454024|NCT00365352|1495542|P2|Overall Study|Participant Withdrew Consent|3
454025|NCT00365352|1495543|P1|Overall Study|Participant Withdrew Consent|8
454026|NCT00365352|1495541|P3|Overall Study|Adverse Event|8
454027|NCT00365352|1495542|P2|Overall Study|Adverse Event|7
454028|NCT00365352|1495543|P1|Overall Study|Adverse Event|6
454029|NCT00365300|1495627|P2|Double-blind Phase|Lack of Efficacy|6
454030|NCT00365300|1495628|P1|Double-blind Phase|Lack of Efficacy|6
454031|NCT00365300|1495627|P2|Double-blind Phase|Protocol Violation|1
454032|NCT00365300|1495628|P1|Double-blind Phase|Protocol Violation|3
454033|NCT00365300|1495627|P2|Double-blind Phase|Withdrawal by Subject|1
454034|NCT00365300|1495628|P1|Double-blind Phase|Withdrawal by Subject|0
454035|NCT00365300|1495627|P2|Double-blind Phase|Noncompliance|1
454036|NCT00365300|1495628|P1|Double-blind Phase|Noncompliance|1
454037|NCT00365300|1495627|P2|Double-blind Phase|Failed to return|0
454038|NCT00365300|1495628|P1|Double-blind Phase|Failed to return|1
454039|NCT00365300|1495627|P2|Open-label Phase|Patient skipped open label phase|0
454040|NCT00365300|1495628|P1|Open-label Phase|Patient skipped open label phase|1
454041|NCT00365300|1495627|P2|Open-label Phase|Lack of Efficacy|0
454042|NCT00365300|1495628|P1|Open-label Phase|Lack of Efficacy|1
454043|NCT00365300|1495627|P2|Open-label Phase|Protocol Violation|0
454044|NCT00365300|1495628|P1|Open-label Phase|Protocol Violation|1
454045|NCT00365300|1495627|P2|Open-label Phase|Parent/Legal Guardian Request|0
454046|NCT00365300|1495628|P1|Open-label Phase|Parent/Legal Guardian Request|4
454047|NCT00365300|1495627|P2|Open-label Phase|Noncompliance|0
454048|NCT00365300|1495628|P1|Open-label Phase|Noncompliance|9
454049|NCT00365300|1495627|P2|Open-label Phase|Physician Decision|0
454050|NCT00365300|1495628|P1|Open-label Phase|Physician Decision|1
454051|NCT00365300|1495627|P2|Open-label Phase|Failed to Return|0
454052|NCT00365300|1495628|P1|Open-label Phase|Failed to Return|1
454053|NCT00365300|1495627|P2|Open-label Phase|Adverse Event|0
454054|NCT00365300|1495628|P1|Open-label Phase|Adverse Event|4
454055|NCT00365105|1495693|P2|Overall Study|Lost to Follow-up|0
454056|NCT00365105|1495694|P1|Overall Study|Lost to Follow-up|1
454057|NCT00365105|1495693|P2|Overall Study|Withdrawal by Subject|1
454058|NCT00365105|1495694|P1|Overall Study|Withdrawal by Subject|1
454059|NCT00365105|1495693|P2|Overall Study|Protocol Violation|3
454060|NCT00365105|1495694|P1|Overall Study|Protocol Violation|4
454061|NCT00364923|1495730|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
454062|NCT00364923|1495730|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
454063|NCT00364858|1495739|P2|Overall Study|Clinical baseline issue|1
454064|NCT00364858|1495740|P1|Overall Study|Clinical baseline issue|0
454065|NCT00364858|1495739|P2|Overall Study|Return to Q2 regimen|1
454066|NCT00364858|1495740|P1|Overall Study|Return to Q2 regimen|0
454067|NCT00364858|1495739|P2|Overall Study|Non-compliant|0
454068|NCT00364858|1495740|P1|Overall Study|Non-compliant|1
454069|NCT00364858|1495739|P2|Overall Study|Discontinuation at baseline|0
454070|NCT00364858|1495740|P1|Overall Study|Discontinuation at baseline|1
454071|NCT00364858|1495739|P2|Overall Study|Clinical failure|13
454072|NCT00364858|1495740|P1|Overall Study|Clinical failure|2
454073|NCT00364858|1495739|P2|Overall Study|Pregnancy|1
454074|NCT00364858|1495740|P1|Overall Study|Pregnancy|1
454075|NCT00364858|1495739|P2|Overall Study|Withdrawal by Subject|1
454076|NCT00364858|1495740|P1|Overall Study|Withdrawal by Subject|1
454077|NCT00364858|1495739|P2|Overall Study|Adverse Event|5
454078|NCT00364858|1495740|P1|Overall Study|Adverse Event|1
454079|NCT00364845|1495755|P2|Overall Study|Death|1
454080|NCT00364845|1495756|P1|Overall Study|Death|0
454081|NCT00364845|1495755|P2|Overall Study|Lost to Follow-up|1
454082|NCT00364845|1495756|P1|Overall Study|Lost to Follow-up|0
454083|NCT00364845|1495755|P2|Overall Study|Physician Decision|8
454084|NCT00364845|1495756|P1|Overall Study|Physician Decision|8
454085|NCT00364845|1495755|P2|Overall Study|Withdrawal by Subject|1
454086|NCT00364845|1495756|P1|Overall Study|Withdrawal by Subject|2
454087|NCT00364845|1495755|P2|Overall Study|Adverse Event|0
454088|NCT00364845|1495756|P1|Overall Study|Adverse Event|1
454089|NCT00364832|1495777|P12|Extension Year 2|Early Withdrawals|3
454090|NCT00364832|1495778|P11|Extension Year 2|Early Withdrawals|5
454091|NCT00364832|1495779|P10|Extension Year 2|Early Withdrawals|5
454092|NCT00364832|1495780|P9|Extension Year 2|Early Withdrawals|0
454093|NCT00364832|1495781|P8|Extension Year 2|Early Withdrawals|0
454094|NCT00364832|1495782|P7|Extension Year 2|Early Withdrawals|0
454095|NCT00364832|1495783|P6|Extension Year 2|Early Withdrawals|0
454096|NCT00364832|1495784|P5|Extension Year 2|Early Withdrawals|0
454097|NCT00364832|1495785|P4|Extension Year 2|Early Withdrawals|0
454098|NCT00364832|1495786|P3|Extension Year 2|Early Withdrawals|0
454099|NCT00364832|1495787|P2|Extension Year 2|Early Withdrawals|0
454100|NCT00364832|1495788|P1|Extension Year 2|Early Withdrawals|0
454101|NCT00364832|1495777|P12|Extension Year 1|Early Withdrawals|10
454102|NCT00364832|1495778|P11|Extension Year 1|Early Withdrawals|2
454103|NCT00364832|1495779|P10|Extension Year 1|Early Withdrawals|4
454104|NCT00364832|1495780|P9|Extension Year 1|Early Withdrawals|0
454105|NCT00364832|1495781|P8|Extension Year 1|Early Withdrawals|0
454106|NCT00364832|1495782|P7|Extension Year 1|Early Withdrawals|0
454107|NCT00364832|1495783|P6|Extension Year 1|Early Withdrawals|0
454108|NCT00364832|1495784|P5|Extension Year 1|Early Withdrawals|0
454109|NCT00364832|1495785|P4|Extension Year 1|Early Withdrawals|0
454110|NCT00364832|1495786|P3|Extension Year 1|Early Withdrawals|0
454111|NCT00364832|1495787|P2|Extension Year 1|Early Withdrawals|0
454112|NCT00364832|1495788|P1|Extension Year 1|Early Withdrawals|0
454113|NCT00364832|1495777|P12|Core Period|Early Withdrawals|0
454114|NCT00364832|1495778|P11|Core Period|Early Withdrawals|0
454115|NCT00364832|1495779|P10|Core Period|Early Withdrawals|0
454116|NCT00364832|1495780|P9|Core Period|Early Withdrawals|0
454117|NCT00364832|1495781|P8|Core Period|Early Withdrawals|1
454118|NCT00364832|1495782|P7|Core Period|Early Withdrawals|4
454119|NCT00364832|1495783|P6|Core Period|Early Withdrawals|0
454120|NCT00364832|1495784|P5|Core Period|Early Withdrawals|0
454121|NCT00364832|1495785|P4|Core Period|Early Withdrawals|1
454122|NCT00364832|1495786|P3|Core Period|Early Withdrawals|1
454123|NCT00364832|1495787|P2|Core Period|Early Withdrawals|2
454124|NCT00364832|1495788|P1|Core Period|Early Withdrawals|2
454125|NCT00364793|1495853|P4|Overall Study|Withdrawal by Subject|0
454126|NCT00364793|1495854|P3|Overall Study|Withdrawal by Subject|0
454127|NCT00364793|1495855|P2|Overall Study|Withdrawal by Subject|1
454128|NCT00364793|1495856|P1|Overall Study|Withdrawal by Subject|0
454129|NCT00364793|1495853|P4|Overall Study|No longer meets criteria|1
454130|NCT00364793|1495854|P3|Overall Study|No longer meets criteria|0
454131|NCT00364793|1495855|P2|Overall Study|No longer meets criteria|0
454132|NCT00364793|1495856|P1|Overall Study|No longer meets criteria|0
454133|NCT00364793|1495853|P4|Overall Study|Poor or non-compliance|1
454134|NCT00364793|1495854|P3|Overall Study|Poor or non-compliance|0
454135|NCT00364793|1495855|P2|Overall Study|Poor or non-compliance|1
454136|NCT00364793|1495856|P1|Overall Study|Poor or non-compliance|1
454137|NCT00364793|1495853|P4|Overall Study|Lost to Follow-up|0
454138|NCT00364793|1495854|P3|Overall Study|Lost to Follow-up|2
454139|NCT00364793|1495855|P2|Overall Study|Lost to Follow-up|0
454140|NCT00364793|1495856|P1|Overall Study|Lost to Follow-up|1
454141|NCT00364793|1495853|P4|Overall Study|Lack of Efficacy|1
454142|NCT00364793|1495854|P3|Overall Study|Lack of Efficacy|1
454143|NCT00364793|1495855|P2|Overall Study|Lack of Efficacy|3
454144|NCT00364793|1495856|P1|Overall Study|Lack of Efficacy|3
454145|NCT00364793|1495853|P4|Overall Study|Death|0
454146|NCT00364793|1495854|P3|Overall Study|Death|1
454147|NCT00364793|1495855|P2|Overall Study|Death|0
454148|NCT00364793|1495856|P1|Overall Study|Death|1
454149|NCT00364793|1495853|P4|Overall Study|Adverse Event|0
454150|NCT00364793|1495854|P3|Overall Study|Adverse Event|0
454151|NCT00364793|1495855|P2|Overall Study|Adverse Event|0
454152|NCT00364793|1495856|P1|Overall Study|Adverse Event|2
454153|NCT00364611|1495992|P2|Overall Study|Receiving Liver Ablation|1
454154|NCT00364611|1495993|P1|Overall Study|Receiving Liver Ablation|0
454155|NCT00364611|1495992|P2|Overall Study|Presumed CR on Study|1
454156|NCT00364611|1495993|P1|Overall Study|Presumed CR on Study|0
454157|NCT00364611|1495992|P2|Overall Study|Found Ineligible|0
454158|NCT00364611|1495993|P1|Overall Study|Found Ineligible|1
454159|NCT00364611|1495992|P2|Overall Study|Investigator decision|2
454160|NCT00364611|1495993|P1|Overall Study|Investigator decision|2
454161|NCT00364611|1495992|P2|Overall Study|Disease Progression|8
454162|NCT00364611|1495993|P1|Overall Study|Disease Progression|38
454163|NCT00364611|1495992|P2|Overall Study|Participant's Request|4
454164|NCT00364611|1495993|P1|Overall Study|Participant's Request|3
454165|NCT00364611|1495992|P2|Overall Study|Adverse Event|4
454166|NCT00364611|1495993|P1|Overall Study|Adverse Event|7
454167|NCT00364611|1495992|P2|Overall Study|Did not receive study medication|1
454168|NCT00364611|1495993|P1|Overall Study|Did not receive study medication|0
454169|NCT00364533|1496016|P5|Overall Study|Protocol Violation|0
454170|NCT00364533|1496017|P4|Overall Study|Protocol Violation|0
454171|NCT00364533|1496018|P3|Overall Study|Protocol Violation|0
454172|NCT00364533|1496019|P2|Overall Study|Protocol Violation|1
454173|NCT00364533|1496020|P1|Overall Study|Protocol Violation|1
454174|NCT00364533|1496016|P5|Overall Study|Non-compliance|0
454175|NCT00364533|1496017|P4|Overall Study|Non-compliance|0
454176|NCT00364533|1496018|P3|Overall Study|Non-compliance|0
454177|NCT00364533|1496019|P2|Overall Study|Non-compliance|0
454178|NCT00364533|1496020|P1|Overall Study|Non-compliance|1
454179|NCT00364533|1496016|P5|Overall Study|Variations in drug compliance|0
454180|NCT00364533|1496017|P4|Overall Study|Variations in drug compliance|0
454181|NCT00364533|1496018|P3|Overall Study|Variations in drug compliance|1
454182|NCT00364533|1496019|P2|Overall Study|Variations in drug compliance|1
454183|NCT00364533|1496020|P1|Overall Study|Variations in drug compliance|2
454184|NCT00364533|1496016|P5|Overall Study|Subject discharged from hospital|1
454185|NCT00364533|1496017|P4|Overall Study|Subject discharged from hospital|3
454186|NCT00364533|1496018|P3|Overall Study|Subject discharged from hospital|2
454187|NCT00364533|1496019|P2|Overall Study|Subject discharged from hospital|1
454188|NCT00364533|1496020|P1|Overall Study|Subject discharged from hospital|4
454189|NCT00364533|1496016|P5|Overall Study|Lack of Efficacy|42
454190|NCT00364533|1496017|P4|Overall Study|Lack of Efficacy|17
454191|NCT00364533|1496018|P3|Overall Study|Lack of Efficacy|21
454192|NCT00364533|1496019|P2|Overall Study|Lack of Efficacy|22
454193|NCT00364533|1496020|P1|Overall Study|Lack of Efficacy|22
454194|NCT00364533|1496016|P5|Overall Study|Withdrawal by Subject|6
454195|NCT00364533|1496017|P4|Overall Study|Withdrawal by Subject|6
454196|NCT00364533|1496018|P3|Overall Study|Withdrawal by Subject|6
454197|NCT00364533|1496019|P2|Overall Study|Withdrawal by Subject|8
454198|NCT00364533|1496020|P1|Overall Study|Withdrawal by Subject|4
454199|NCT00364533|1496016|P5|Overall Study|Adverse Event|2
454200|NCT00364533|1496017|P4|Overall Study|Adverse Event|5
454201|NCT00364533|1496018|P3|Overall Study|Adverse Event|15
454202|NCT00364533|1496019|P2|Overall Study|Adverse Event|7
454203|NCT00364533|1496020|P1|Overall Study|Adverse Event|8
454204|NCT00364351|1496053|P2|Overall Study|Randomised treatment not started|3
454205|NCT00364351|1496054|P1|Overall Study|Randomised treatment not started|0
454206|NCT00364351|1496053|P2|Overall Study|Patient could not travel to site|1
454207|NCT00364351|1496054|P1|Overall Study|Patient could not travel to site|0
454208|NCT00364351|1496053|P2|Overall Study|Investigator error|2
454209|NCT00364351|1496054|P1|Overall Study|Investigator error|0
454210|NCT00364351|1496053|P2|Overall Study|Poor treatment compliance|3
454211|NCT00364351|1496054|P1|Overall Study|Poor treatment compliance|0
454212|NCT00364351|1496053|P2|Overall Study|Sponsor decision|0
454213|NCT00364351|1496054|P1|Overall Study|Sponsor decision|1
454214|NCT00364351|1496053|P2|Overall Study|Incorrect enrollment|1
454215|NCT00364351|1496054|P1|Overall Study|Incorrect enrollment|1
454216|NCT00364351|1496053|P2|Overall Study|Withdrawal by Subject|29
454217|NCT00364351|1496054|P1|Overall Study|Withdrawal by Subject|30
454218|NCT00364351|1496053|P2|Overall Study|Lost to Follow-up|1
454219|NCT00364351|1496054|P1|Overall Study|Lost to Follow-up|1
454220|NCT00364351|1496053|P2|Overall Study|Prohibited concomitant medication|2
454221|NCT00364351|1496054|P1|Overall Study|Prohibited concomitant medication|0
454222|NCT00364351|1496053|P2|Overall Study|Condition under investigation worsened|497
454223|NCT00364351|1496054|P1|Overall Study|Condition under investigation worsened|469
454224|NCT00364351|1496053|P2|Overall Study|Adverse Event|44
454225|NCT00364351|1496054|P1|Overall Study|Adverse Event|90
454226|NCT00364286|1496072|P1|Overall Study|Adverse Event|2
454227|NCT00364286|1496072|P1|Overall Study|Withdrawal by Subject|1
454228|NCT00364182|1496079|P3|Third Intervention|Lost to Follow-up|1
454229|NCT00364182|1496080|P2|Third Intervention|Lost to Follow-up|0
454230|NCT00364182|1496081|P1|Third Intervention|Lost to Follow-up|0
454231|NCT00364182|1496079|P3|Third Intervention|non-compliance|0
454232|NCT00364182|1496080|P2|Third Intervention|non-compliance|1
454233|NCT00364182|1496081|P1|Third Intervention|non-compliance|0
454234|NCT00364182|1496079|P3|Second Intervention|Adverse Event|1
454235|NCT00364182|1496080|P2|Second Intervention|Adverse Event|0
454236|NCT00364182|1496081|P1|Second Intervention|Adverse Event|0
454237|NCT00364182|1496079|P3|Second Intervention|Protocol Violation|0
454238|NCT00364182|1496080|P2|Second Intervention|Protocol Violation|1
454239|NCT00364182|1496081|P1|Second Intervention|Protocol Violation|0
454240|NCT00364182|1496079|P3|Second Intervention|non-compliance|1
454241|NCT00364182|1496080|P2|Second Intervention|non-compliance|1
454242|NCT00364182|1496081|P1|Second Intervention|non-compliance|0
454243|NCT00364182|1496079|P3|First Intervention|Withdrawal by Subject|0
454244|NCT00364182|1496080|P2|First Intervention|Withdrawal by Subject|0
454245|NCT00364182|1496081|P1|First Intervention|Withdrawal by Subject|2
454246|NCT00364182|1496079|P3|First Intervention|Secondary prophylaxis|0
454247|NCT00364182|1496080|P2|First Intervention|Secondary prophylaxis|0
454248|NCT00364182|1496081|P1|First Intervention|Secondary prophylaxis|1
454249|NCT00364156|1496115|P2|Overall Study|Protocol Violation|1
454250|NCT00364156|1496116|P1|Overall Study|Protocol Violation|6
454251|NCT00364156|1496115|P2|Overall Study|Withdrawal by Subject|80
454252|NCT00364156|1496116|P1|Overall Study|Withdrawal by Subject|73
454253|NCT00364130|1496124|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
454254|NCT00364130|1496125|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
454255|NCT00364130|1496124|P2|Intervention Period|Withdrawal by Subject|5
454256|NCT00364130|1496125|P1|Intervention Period|Withdrawal by Subject|4
454257|NCT00364130|1496124|P2|Intervention Period|Pregnancy|0
454258|NCT00364130|1496125|P1|Intervention Period|Pregnancy|1
454259|NCT00364130|1496124|P2|Intervention Period|Lost to Follow-up|3
454260|NCT00364130|1496125|P1|Intervention Period|Lost to Follow-up|4
454261|NCT00364013|1496147|P2|Overall Study|Ongoing|13
454262|NCT00364013|1496148|P1|Overall Study|Ongoing|20
454263|NCT00364013|1496147|P2|Overall Study|Other|47
454264|NCT00364013|1496148|P1|Overall Study|Other|41
454265|NCT00364013|1496147|P2|Overall Study|Protocol-specified criteria|6
454266|NCT00364013|1496148|P1|Overall Study|Protocol-specified criteria|6
454267|NCT00364013|1496147|P2|Overall Study|Lost to Follow-up|3
454268|NCT00364013|1496148|P1|Overall Study|Lost to Follow-up|10
454269|NCT00364013|1496147|P2|Overall Study|Physician Decision|3
454270|NCT00364013|1496148|P1|Overall Study|Physician Decision|3
454271|NCT00364013|1496147|P2|Overall Study|Withdrawal by Subject|18
454272|NCT00364013|1496148|P1|Overall Study|Withdrawal by Subject|13
454273|NCT00364013|1496147|P2|Overall Study|Adverse Event|3
454274|NCT00364013|1496148|P1|Overall Study|Adverse Event|4
454275|NCT00364013|1496147|P2|Overall Study|Ineligibility determined|2
454276|NCT00364013|1496148|P1|Overall Study|Ineligibility determined|4
454277|NCT00363896|1496176|P2|Overall Study|Other|2
454278|NCT00363896|1496177|P1|Overall Study|Other|1
454279|NCT00363896|1496176|P2|Overall Study|Non-fulfilment of entry criteria|0
454280|NCT00363896|1496177|P1|Overall Study|Non-fulfilment of entry criteria|1
454281|NCT00363896|1496176|P2|Overall Study|Lost to Follow-up|0
454282|NCT00363896|1496177|P1|Overall Study|Lost to Follow-up|3
454283|NCT00363896|1496176|P2|Overall Study|Protocol Violation|1
454284|NCT00363896|1496177|P1|Overall Study|Protocol Violation|6
454285|NCT00363896|1496176|P2|Overall Study|Lack of Efficacy|8
454286|NCT00363896|1496177|P1|Overall Study|Lack of Efficacy|12
454287|NCT00363896|1496176|P2|Overall Study|COPD exacerbation|7
454288|NCT00363896|1496177|P1|Overall Study|COPD exacerbation|13
454289|NCT00363896|1496176|P2|Overall Study|Adverse Event|13
454290|NCT00363896|1496177|P1|Overall Study|Adverse Event|24
454291|NCT00363896|1496176|P2|Overall Study|Withdrawal by Subject|16
454292|NCT00363896|1496177|P1|Overall Study|Withdrawal by Subject|29
454293|NCT00363545|1496225|P2|Overall Study|Others|0
454294|NCT00363545|1496226|P1|Overall Study|Others|1
454295|NCT00363545|1496225|P2|Overall Study|Lost to follow-up (complete vaccination)|17
454296|NCT00363545|1496226|P1|Overall Study|Lost to follow-up (complete vaccination)|14
454297|NCT00363545|1496225|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
454298|NCT00363545|1496226|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
454299|NCT00363545|1496225|P2|Overall Study|Migrated/moved from study area|6
454300|NCT00363545|1496226|P1|Overall Study|Migrated/moved from study area|3
454301|NCT00363545|1496225|P2|Overall Study|Withdrawal by Subject|15
454302|NCT00363545|1496226|P1|Overall Study|Withdrawal by Subject|12
454303|NCT00363545|1496225|P2|Overall Study|Serious Adverse Event|1
454304|NCT00363545|1496226|P1|Overall Study|Serious Adverse Event|0
454305|NCT00363480|1496244|P1|Overall Study|Participant discontinued on its own|1
454306|NCT00363480|1496244|P1|Overall Study|Non-compliance of subject|1
454307|NCT00363480|1496244|P1|Overall Study|Withdrawal by Subject|5
454308|NCT00363480|1496244|P1|Overall Study|Lost to Follow-up|5
454309|NCT00363480|1496244|P1|Overall Study|Adverse Event|4
454310|NCT00363480|1496244|P1|Overall Study|Criteria for treatment period not fulfil|1
454311|NCT00363467|1496264|P1|Overall Study|Physician Decision|1
454312|NCT00363415|1496274|P2|Overall Study|Protocol Violation|4
454313|NCT00363415|1496275|P1|Overall Study|Protocol Violation|1
454314|NCT00363415|1496274|P2|Overall Study|Lost to Follow-up|3
454315|NCT00363415|1496275|P1|Overall Study|Lost to Follow-up|3
454316|NCT00363415|1496274|P2|Overall Study|Withdrawal by Subject|15
454317|NCT00363415|1496275|P1|Overall Study|Withdrawal by Subject|9
454318|NCT00363415|1496274|P2|Overall Study|Entry Criteria Not Met|10
454319|NCT00363415|1496275|P1|Overall Study|Entry Criteria Not Met|11
454320|NCT00363415|1496274|P2|Overall Study|Physician Decision|35
454321|NCT00363415|1496275|P1|Overall Study|Physician Decision|18
454322|NCT00363415|1496274|P2|Overall Study|Adverse Event|15
454323|NCT00363415|1496275|P1|Overall Study|Adverse Event|24
454324|NCT00363415|1496274|P2|Overall Study|Death|29
454325|NCT00363415|1496275|P1|Overall Study|Death|32
454326|NCT00363415|1496274|P2|Overall Study|Sponsor Decision|31
454327|NCT00363415|1496275|P1|Overall Study|Sponsor Decision|67
454328|NCT00363415|1496274|P2|Overall Study|Progressive Disease|107
454329|NCT00363415|1496275|P1|Overall Study|Progressive Disease|196
454330|NCT00363311|1496293|P2|Overall Study|Participant Moved to Louisiana|1
454331|NCT00363311|1496294|P1|Overall Study|Participant Moved to Louisiana|0
454332|NCT00363311|1496293|P2|Overall Study|Withdrawn per Instructions of Monitor|1
454333|NCT00363311|1496294|P1|Overall Study|Withdrawn per Instructions of Monitor|0
454334|NCT00363311|1496293|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
454335|NCT00363311|1496294|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
454336|NCT00363311|1496293|P2|Overall Study|Participant Moved to Another Country|0
454337|NCT00363311|1496294|P1|Overall Study|Participant Moved to Another Country|1
454338|NCT00363311|1496293|P2|Overall Study|Participant Opted for Treatment|0
454339|NCT00363311|1496294|P1|Overall Study|Participant Opted for Treatment|1
454340|NCT00363311|1496293|P2|Overall Study|Prostate Volume/PSA Doubled|0
454341|NCT00363311|1496294|P1|Overall Study|Prostate Volume/PSA Doubled|1
454342|NCT00363311|1496293|P2|Overall Study|Participant Refused Biopsy|0
454343|NCT00363311|1496294|P1|Overall Study|Participant Refused Biopsy|1
454344|NCT00363311|1496293|P2|Overall Study|Non-Compliance|1
454345|NCT00363311|1496294|P1|Overall Study|Non-Compliance|1
454346|NCT00363311|1496293|P2|Overall Study|Disease Progression|26
454347|NCT00363311|1496294|P1|Overall Study|Disease Progression|46
454348|NCT00363311|1496293|P2|Overall Study|Sponsor Terminated Study|2
454349|NCT00363311|1496294|P1|Overall Study|Sponsor Terminated Study|2
454350|NCT00363311|1496293|P2|Overall Study|Physician Decision|1
454351|NCT00363311|1496294|P1|Overall Study|Physician Decision|1
454352|NCT00363311|1496293|P2|Overall Study|Withdrawal by Subject|6
454353|NCT00363311|1496294|P1|Overall Study|Withdrawal by Subject|12
454354|NCT00363311|1496293|P2|Overall Study|Protocol Violation|2
454355|NCT00363311|1496294|P1|Overall Study|Protocol Violation|1
454356|NCT00363311|1496293|P2|Overall Study|Lost to Follow-up|0
454357|NCT00363311|1496294|P1|Overall Study|Lost to Follow-up|3
454358|NCT00363311|1496293|P2|Overall Study|Adverse Event|4
454359|NCT00363311|1496294|P1|Overall Study|Adverse Event|6
454360|NCT00363298|1496360|P2|4-week Study Continuation Phase|Lack of Efficacy|0
454361|NCT00363298|1496361|P1|4-week Study Continuation Phase|Lack of Efficacy|1
454362|NCT00363298|1496360|P2|First Study Week|Lack of Efficacy|5
454363|NCT00363298|1496361|P1|First Study Week|Lack of Efficacy|6
454364|NCT00363246|1496369|P1|Overall Study|Eligibility changed due to Hospice move|5
454365|NCT00363246|1496369|P1|Overall Study|Subject expressed security concerns|2
454366|NCT00363246|1496369|P1|Overall Study|Stopped using wheelchair|11
454367|NCT00363246|1496369|P1|Overall Study|Bad health|6
454368|NCT00363246|1496369|P1|Overall Study|Lost to Follow-up|14
454369|NCT00363246|1496369|P1|Overall Study|Withdrawal by Subject|19
454370|NCT00363246|1496369|P1|Overall Study|Death|40
454371|NCT00363142|1496387|P2|Overall Study|Withdrawal by Subject|1
454372|NCT00363142|1496388|P1|Overall Study|Withdrawal by Subject|3
454373|NCT00363142|1496387|P2|Overall Study|Non-compliance|1
454374|NCT00363142|1496388|P1|Overall Study|Non-compliance|1
454375|NCT00363142|1496387|P2|Overall Study|Lost to Follow-up|0
454376|NCT00363142|1496388|P1|Overall Study|Lost to Follow-up|1
454377|NCT00363142|1496387|P2|Overall Study|Lack of Efficacy|1
454378|NCT00363142|1496388|P1|Overall Study|Lack of Efficacy|0
454379|NCT00363142|1496387|P2|Overall Study|Adverse Event|0
454380|NCT00363142|1496388|P1|Overall Study|Adverse Event|2
454381|NCT00363129|1496417|P2|Overall Study|Other Reasons|3
454382|NCT00363129|1496418|P1|Overall Study|Other Reasons|6
454383|NCT00363129|1496417|P2|Overall Study|Death|1
454384|NCT00363129|1496418|P1|Overall Study|Death|0
454385|NCT00363129|1496417|P2|Overall Study|Other Medical Problems|4
454386|NCT00363129|1496418|P1|Overall Study|Other Medical Problems|2
454387|NCT00363129|1496417|P2|Overall Study|Alternate Treatment|4
454388|NCT00363129|1496418|P1|Overall Study|Alternate Treatment|2
454389|NCT00363129|1496417|P2|Overall Study|Adverse Event|3
454390|NCT00363129|1496418|P1|Overall Study|Adverse Event|8
454391|NCT00363129|1496417|P2|Overall Study|Withdrawal by Subject|18
454392|NCT00363129|1496418|P1|Overall Study|Withdrawal by Subject|11
454393|NCT00363051|1496461|P2|Overall Study|Death|2
454394|NCT00363051|1496462|P1|Overall Study|Death|3
454395|NCT00363051|1496461|P2|Overall Study|Protocol Violation|2
454396|NCT00363051|1496462|P1|Overall Study|Protocol Violation|0
454397|NCT00363051|1496461|P2|Overall Study|Lost to Follow-up|1
454398|NCT00363051|1496462|P1|Overall Study|Lost to Follow-up|0
454399|NCT00363051|1496461|P2|Overall Study|Withdrawal by Subject|3
454400|NCT00363051|1496462|P1|Overall Study|Withdrawal by Subject|11
454401|NCT00363051|1496461|P2|Overall Study|New Cancer Therapy|1
454402|NCT00363051|1496462|P1|Overall Study|New Cancer Therapy|2
454403|NCT00363051|1496461|P2|Overall Study|Adverse Event|12
454404|NCT00363051|1496462|P1|Overall Study|Adverse Event|21
454405|NCT00363051|1496461|P2|Overall Study|Adminstrative problems|1
454406|NCT00363051|1496462|P1|Overall Study|Adminstrative problems|1
454407|NCT00362648|1496511|P4|Overall Study|Withdrawal by Subject|6
454408|NCT00362648|1496512|P3|Overall Study|Withdrawal by Subject|2
454409|NCT00362648|1496513|P2|Overall Study|Withdrawal by Subject|42
454410|NCT00362648|1496514|P1|Overall Study|Withdrawal by Subject|48
454411|NCT00362648|1496511|P4|Overall Study|Protocol Violation|2
454412|NCT00362648|1496512|P3|Overall Study|Protocol Violation|2
454413|NCT00362648|1496513|P2|Overall Study|Protocol Violation|2
454414|NCT00362648|1496514|P1|Overall Study|Protocol Violation|4
454415|NCT00362648|1496511|P4|Overall Study|Lost to Follow-up|3
454416|NCT00362648|1496512|P3|Overall Study|Lost to Follow-up|4
454417|NCT00362648|1496513|P2|Overall Study|Lost to Follow-up|69
454418|NCT00362648|1496514|P1|Overall Study|Lost to Follow-up|62
454419|NCT00362648|1496511|P4|Overall Study|Adverse Event|0
454420|NCT00362648|1496512|P3|Overall Study|Adverse Event|1
454421|NCT00362648|1496513|P2|Overall Study|Adverse Event|21
454422|NCT00362648|1496514|P1|Overall Study|Adverse Event|12
454423|NCT00362609|1496532|P2|Overall Study|Protocol Violation|1
454424|NCT00362609|1496533|P1|Overall Study|Protocol Violation|0
454425|NCT00362609|1496532|P2|Overall Study|Withdrawal by Subject|1
454426|NCT00362609|1496533|P1|Overall Study|Withdrawal by Subject|0
454427|NCT00362414|1496614|P1|Overall Study|Adverse Event|1
454428|NCT00362414|1496614|P1|Overall Study|Death|2
454429|NCT00362375|1496643|P2|Overall Study|Lost to Follow-up|35
454430|NCT00362375|1496644|P1|Overall Study|Lost to Follow-up|40
454431|NCT00362336|1496661|P3|Overall Study|Withdrawal by Subject|1
454432|NCT00362336|1496662|P2|Overall Study|Withdrawal by Subject|3
454433|NCT00362336|1496663|P1|Overall Study|Withdrawal by Subject|3
454434|NCT00362336|1496661|P3|Overall Study|Lost to Follow-up|0
454435|NCT00362336|1496662|P2|Overall Study|Lost to Follow-up|4
454436|NCT00362336|1496663|P1|Overall Study|Lost to Follow-up|6
454437|NCT00362336|1496661|P3|Overall Study|Protocol Violation|1
454438|NCT00362336|1496662|P2|Overall Study|Protocol Violation|0
454439|NCT00362336|1496663|P1|Overall Study|Protocol Violation|0
454440|NCT00362336|1496661|P3|Overall Study|Serious Adverse Event|1
454441|NCT00362336|1496662|P2|Overall Study|Serious Adverse Event|0
454442|NCT00362336|1496663|P1|Overall Study|Serious Adverse Event|1
454443|NCT00362297|1496691|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
454444|NCT00362297|1496692|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
454445|NCT00362232|1496700|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
454446|NCT00362232|1496701|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
454447|NCT00362232|1496700|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
454448|NCT00362232|1496701|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
454449|NCT00362232|1496700|P2|Follow-up (30 (+ 5) Days)|Death|1
454450|NCT00362232|1496701|P1|Follow-up (30 (+ 5) Days)|Death|1
454451|NCT00362232|1496700|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
454452|NCT00362232|1496701|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
454453|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
454454|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
454455|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
454456|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
454457|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
454458|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
454459|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
454460|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
454461|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
454462|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
454463|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
454464|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
454465|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
454466|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
454467|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Death|3
454468|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Death|1
454469|NCT00362232|1496700|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
454470|NCT00362232|1496701|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
454471|NCT00362180|1496746|P9|Treated Period|Adverse Event|0
454472|NCT00362180|1496747|P8|Treated Period|Adverse Event|1
454473|NCT00362180|1496748|P7|Treated Period|Adverse Event|0
454474|NCT00362180|1496749|P6|Treated Period|Adverse Event|1
454475|NCT00362180|1496750|P5|Treated Period|Adverse Event|0
454476|NCT00362180|1496751|P4|Treated Period|Adverse Event|0
454477|NCT00362180|1496752|P3|Treated Period|Adverse Event|0
454478|NCT00362180|1496753|P2|Treated Period|Adverse Event|0
454479|NCT00362180|1496754|P1|Treated Period|Adverse Event|0
454480|NCT00362180|1496746|P9|Treated Period|Withdrawal by Subject|0
454481|NCT00362180|1496747|P8|Treated Period|Withdrawal by Subject|0
454482|NCT00362180|1496748|P7|Treated Period|Withdrawal by Subject|0
454483|NCT00362180|1496749|P6|Treated Period|Withdrawal by Subject|0
454484|NCT00362180|1496750|P5|Treated Period|Withdrawal by Subject|0
454485|NCT00362180|1496751|P4|Treated Period|Withdrawal by Subject|0
454486|NCT00362180|1496752|P3|Treated Period|Withdrawal by Subject|0
454487|NCT00362180|1496753|P2|Treated Period|Withdrawal by Subject|0
454488|NCT00362180|1496754|P1|Treated Period|Withdrawal by Subject|1
454489|NCT00362115|1496826|P7|Overall Study|Other|0
454490|NCT00362115|1496827|P6|Overall Study|Other|1
454491|NCT00362115|1496828|P5|Overall Study|Other|0
454492|NCT00362115|1496829|P4|Overall Study|Other|1
454493|NCT00362115|1496830|P3|Overall Study|Other|0
454494|NCT00362115|1496831|P2|Overall Study|Other|1
454495|NCT00362115|1496832|P1|Overall Study|Other|0
454496|NCT00362115|1496826|P7|Overall Study|Physician Decision|3
454497|NCT00362115|1496827|P6|Overall Study|Physician Decision|0
454498|NCT00362115|1496828|P5|Overall Study|Physician Decision|0
454499|NCT00362115|1496829|P4|Overall Study|Physician Decision|0
454500|NCT00362115|1496830|P3|Overall Study|Physician Decision|0
454501|NCT00362115|1496831|P2|Overall Study|Physician Decision|0
454502|NCT00362115|1496832|P1|Overall Study|Physician Decision|0
454503|NCT00362115|1496826|P7|Overall Study|Lack of Efficacy|3
454504|NCT00362115|1496827|P6|Overall Study|Lack of Efficacy|0
454505|NCT00362115|1496828|P5|Overall Study|Lack of Efficacy|2
454506|NCT00362115|1496829|P4|Overall Study|Lack of Efficacy|2
454507|NCT00362115|1496830|P3|Overall Study|Lack of Efficacy|5
454508|NCT00362115|1496831|P2|Overall Study|Lack of Efficacy|0
454509|NCT00362115|1496832|P1|Overall Study|Lack of Efficacy|1
454510|NCT00362115|1496826|P7|Overall Study|Withdrawal by Subject|4
454511|NCT00362115|1496827|P6|Overall Study|Withdrawal by Subject|3
454512|NCT00362115|1496828|P5|Overall Study|Withdrawal by Subject|1
454513|NCT00362115|1496829|P4|Overall Study|Withdrawal by Subject|0
454514|NCT00362115|1496830|P3|Overall Study|Withdrawal by Subject|1
454515|NCT00362115|1496831|P2|Overall Study|Withdrawal by Subject|3
454516|NCT00362115|1496832|P1|Overall Study|Withdrawal by Subject|1
454517|NCT00362115|1496826|P7|Overall Study|Lost to Follow-up|1
454518|NCT00362115|1496827|P6|Overall Study|Lost to Follow-up|0
454519|NCT00362115|1496828|P5|Overall Study|Lost to Follow-up|2
454520|NCT00362115|1496829|P4|Overall Study|Lost to Follow-up|0
454521|NCT00362115|1496830|P3|Overall Study|Lost to Follow-up|0
454522|NCT00362115|1496831|P2|Overall Study|Lost to Follow-up|1
454523|NCT00362115|1496832|P1|Overall Study|Lost to Follow-up|0
454524|NCT00362115|1496826|P7|Overall Study|Protocol Violation|0
454525|NCT00362115|1496827|P6|Overall Study|Protocol Violation|1
454526|NCT00362115|1496828|P5|Overall Study|Protocol Violation|0
454527|NCT00362115|1496829|P4|Overall Study|Protocol Violation|0
454528|NCT00362115|1496830|P3|Overall Study|Protocol Violation|0
454529|NCT00362115|1496831|P2|Overall Study|Protocol Violation|0
454530|NCT00362115|1496832|P1|Overall Study|Protocol Violation|0
454531|NCT00362115|1496826|P7|Overall Study|Adverse Event|1
454532|NCT00362115|1496827|P6|Overall Study|Adverse Event|2
454533|NCT00362115|1496828|P5|Overall Study|Adverse Event|2
454534|NCT00362115|1496829|P4|Overall Study|Adverse Event|1
454535|NCT00362115|1496830|P3|Overall Study|Adverse Event|1
454536|NCT00362115|1496831|P2|Overall Study|Adverse Event|1
454537|NCT00362115|1496832|P1|Overall Study|Adverse Event|0
454538|NCT00361634|1497005|P1|Overall Study|Withdrawal by Subject|1
454539|NCT00361634|1497005|P1|Overall Study|Lost to Follow-up|1
454540|NCT00361569|1497034|P4|Overall Study|Not specified by investigator|1
454541|NCT00361569|1497035|P3|Overall Study|Not specified by investigator|0
454542|NCT00361569|1497036|P2|Overall Study|Not specified by investigator|0
454543|NCT00361569|1497037|P1|Overall Study|Not specified by investigator|2
454544|NCT00361569|1497034|P4|Overall Study|Lost to Follow-up|2
454545|NCT00361569|1497035|P3|Overall Study|Lost to Follow-up|3
454546|NCT00361569|1497036|P2|Overall Study|Lost to Follow-up|3
454547|NCT00361569|1497037|P1|Overall Study|Lost to Follow-up|2
454548|NCT00361569|1497034|P4|Overall Study|Adverse Event|2
454549|NCT00361569|1497035|P3|Overall Study|Adverse Event|2
454550|NCT00361569|1497036|P2|Overall Study|Adverse Event|5
454551|NCT00361569|1497037|P1|Overall Study|Adverse Event|3
454552|NCT00361569|1497034|P4|Overall Study|Withdrawal by Subject|14
454553|NCT00361569|1497035|P3|Overall Study|Withdrawal by Subject|9
454554|NCT00361569|1497036|P2|Overall Study|Withdrawal by Subject|1
454555|NCT00361569|1497037|P1|Overall Study|Withdrawal by Subject|2
454556|NCT00361569|1497034|P4|Overall Study|Protocol Violation|2
454557|NCT00361569|1497035|P3|Overall Study|Protocol Violation|4
454558|NCT00361569|1497036|P2|Overall Study|Protocol Violation|2
454559|NCT00361569|1497037|P1|Overall Study|Protocol Violation|3
454560|NCT00361504|1497061|P2|Overall Study|All other|3
454561|NCT00361504|1497062|P1|Overall Study|All other|28
454562|NCT00361504|1497061|P2|Overall Study|Study medication non compliant|15
454563|NCT00361504|1497062|P1|Overall Study|Study medication non compliant|42
454564|NCT00361504|1497061|P2|Overall Study|Resolution of Pain|0
454565|NCT00361504|1497062|P1|Overall Study|Resolution of Pain|2
454566|NCT00361504|1497061|P2|Overall Study|Lack of Efficacy|7
454567|NCT00361504|1497062|P1|Overall Study|Lack of Efficacy|72
454568|NCT00361504|1497061|P2|Overall Study|Adverse Event|82
454569|NCT00361504|1497062|P1|Overall Study|Adverse Event|203
454570|NCT00361504|1497061|P2|Overall Study|Lost to Follow-up|7
454571|NCT00361504|1497062|P1|Overall Study|Lost to Follow-up|40
454572|NCT00361504|1497061|P2|Overall Study|Withdrawal by Subject|31
454573|NCT00361504|1497062|P1|Overall Study|Withdrawal by Subject|94
454574|NCT00361335|1497103|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
454575|NCT00361335|1497104|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
454576|NCT00361335|1497105|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
454577|NCT00361335|1497106|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
454578|NCT00361335|1497107|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
454579|NCT00361335|1497108|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
454580|NCT00361335|1497109|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
454581|NCT00361335|1497103|P7|SC Period: Week E0 to Week E24|Not specified|2
454582|NCT00361335|1497104|P6|SC Period: Week E0 to Week E24|Not specified|1
454583|NCT00361335|1497105|P5|SC Period: Week E0 to Week E24|Not specified|0
454584|NCT00361335|1497106|P4|SC Period: Week E0 to Week E24|Not specified|1
454585|NCT00361335|1497107|P3|SC Period: Week E0 to Week E24|Not specified|0
454586|NCT00361335|1497108|P2|SC Period: Week E0 to Week E24|Not specified|0
454587|NCT00361335|1497109|P1|SC Period: Week E0 to Week E24|Not specified|1
454588|NCT00361335|1497103|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
454589|NCT00361335|1497104|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
454590|NCT00361335|1497105|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
454591|NCT00361335|1497106|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
454592|NCT00361335|1497107|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
454593|NCT00361335|1497108|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
454594|NCT00361335|1497109|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
454595|NCT00361335|1497103|P7|SC Period: Week E0 to Week E24|Death|1
454596|NCT00361335|1497104|P6|SC Period: Week E0 to Week E24|Death|0
454597|NCT00361335|1497105|P5|SC Period: Week E0 to Week E24|Death|0
454598|NCT00361335|1497106|P4|SC Period: Week E0 to Week E24|Death|0
454599|NCT00361335|1497107|P3|SC Period: Week E0 to Week E24|Death|0
454600|NCT00361335|1497108|P2|SC Period: Week E0 to Week E24|Death|0
454601|NCT00361335|1497109|P1|SC Period: Week E0 to Week E24|Death|0
454602|NCT00361335|1497103|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
454603|NCT00361335|1497104|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
454604|NCT00361335|1497105|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
454605|NCT00361335|1497106|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
454606|NCT00361335|1497107|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
454607|NCT00361335|1497108|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
454608|NCT00361335|1497109|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
454609|NCT00361335|1497103|P7|SC Period: Week E0 to Week E24|Adverse Event|2
454610|NCT00361335|1497104|P6|SC Period: Week E0 to Week E24|Adverse Event|0
454611|NCT00361335|1497105|P5|SC Period: Week E0 to Week E24|Adverse Event|0
454612|NCT00361335|1497106|P4|SC Period: Week E0 to Week E24|Adverse Event|2
454613|NCT00361335|1497107|P3|SC Period: Week E0 to Week E24|Adverse Event|1
454614|NCT00361335|1497108|P2|SC Period: Week E0 to Week E24|Adverse Event|2
454615|NCT00361335|1497109|P1|SC Period: Week E0 to Week E24|Adverse Event|0
454616|NCT00361335|1497103|P7|IV Period: Baseline to E0|Lack of Efficacy|0
454617|NCT00361335|1497104|P6|IV Period: Baseline to E0|Lack of Efficacy|0
454618|NCT00361335|1497105|P5|IV Period: Baseline to E0|Lack of Efficacy|8
454619|NCT00361335|1497106|P4|IV Period: Baseline to E0|Lack of Efficacy|7
454620|NCT00361335|1497107|P3|IV Period: Baseline to E0|Lack of Efficacy|3
454621|NCT00361335|1497108|P2|IV Period: Baseline to E0|Lack of Efficacy|9
454622|NCT00361335|1497109|P1|IV Period: Baseline to E0|Lack of Efficacy|5
454623|NCT00361335|1497103|P7|IV Period: Baseline to E0|Not specified|0
454624|NCT00361335|1497104|P6|IV Period: Baseline to E0|Not specified|0
454625|NCT00361335|1497105|P5|IV Period: Baseline to E0|Not specified|2
454626|NCT00361335|1497106|P4|IV Period: Baseline to E0|Not specified|3
454627|NCT00361335|1497107|P3|IV Period: Baseline to E0|Not specified|9
454628|NCT00361335|1497108|P2|IV Period: Baseline to E0|Not specified|9
454629|NCT00361335|1497109|P1|IV Period: Baseline to E0|Not specified|2
454630|NCT00361335|1497103|P7|IV Period: Baseline to E0|Worsening of RA|0
454631|NCT00361335|1497104|P6|IV Period: Baseline to E0|Worsening of RA|0
454632|NCT00361335|1497105|P5|IV Period: Baseline to E0|Worsening of RA|2
454633|NCT00361335|1497106|P4|IV Period: Baseline to E0|Worsening of RA|4
454634|NCT00361335|1497107|P3|IV Period: Baseline to E0|Worsening of RA|1
454635|NCT00361335|1497108|P2|IV Period: Baseline to E0|Worsening of RA|5
454636|NCT00361335|1497109|P1|IV Period: Baseline to E0|Worsening of RA|0
454637|NCT00361335|1497103|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
454638|NCT00361335|1497104|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
454639|NCT00361335|1497105|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
454640|NCT00361335|1497106|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
454641|NCT00361335|1497107|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
454642|NCT00361335|1497108|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
454643|NCT00361335|1497109|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
454644|NCT00361335|1497103|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
454645|NCT00361335|1497104|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
454646|NCT00361335|1497105|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
454647|NCT00361335|1497106|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
454648|NCT00361335|1497107|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
454649|NCT00361335|1497108|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
454650|NCT00361335|1497109|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
454651|NCT00361335|1497103|P7|IV Period: Baseline to E0|Death|0
454652|NCT00361335|1497104|P6|IV Period: Baseline to E0|Death|0
454653|NCT00361335|1497105|P5|IV Period: Baseline to E0|Death|0
454654|NCT00361335|1497106|P4|IV Period: Baseline to E0|Death|1
454655|NCT00361335|1497107|P3|IV Period: Baseline to E0|Death|1
454656|NCT00361335|1497108|P2|IV Period: Baseline to E0|Death|1
454657|NCT00361335|1497109|P1|IV Period: Baseline to E0|Death|1
454658|NCT00361335|1497103|P7|IV Period: Baseline to E0|Lost to Follow-up|0
454659|NCT00361335|1497104|P6|IV Period: Baseline to E0|Lost to Follow-up|0
454660|NCT00361335|1497105|P5|IV Period: Baseline to E0|Lost to Follow-up|2
454661|NCT00361335|1497106|P4|IV Period: Baseline to E0|Lost to Follow-up|2
454662|NCT00361335|1497107|P3|IV Period: Baseline to E0|Lost to Follow-up|0
454663|NCT00361335|1497108|P2|IV Period: Baseline to E0|Lost to Follow-up|0
454664|NCT00361335|1497109|P1|IV Period: Baseline to E0|Lost to Follow-up|1
454665|NCT00361335|1497103|P7|IV Period: Baseline to E0|Adverse Event|0
454666|NCT00361335|1497104|P6|IV Period: Baseline to E0|Adverse Event|0
454667|NCT00361335|1497105|P5|IV Period: Baseline to E0|Adverse Event|8
454668|NCT00361335|1497106|P4|IV Period: Baseline to E0|Adverse Event|9
454669|NCT00361335|1497107|P3|IV Period: Baseline to E0|Adverse Event|5
454670|NCT00361335|1497108|P2|IV Period: Baseline to E0|Adverse Event|4
454671|NCT00361335|1497109|P1|IV Period: Baseline to E0|Adverse Event|9
454672|NCT00361283|1497153|P1|Overall Study|Lost to Follow-up|27
454673|NCT00361270|1497161|P4|Overall Study|Adverse Event|0
454674|NCT00361270|1497162|P3|Overall Study|Adverse Event|1
454675|NCT00361270|1497163|P2|Overall Study|Adverse Event|1
454676|NCT00361270|1497164|P1|Overall Study|Adverse Event|0
454677|NCT00361270|1497161|P4|Overall Study|Problems with Transportation|0
454678|NCT00361270|1497162|P3|Overall Study|Problems with Transportation|0
454679|NCT00361270|1497163|P2|Overall Study|Problems with Transportation|0
454680|NCT00361270|1497164|P1|Overall Study|Problems with Transportation|4
454681|NCT00361270|1497161|P4|Overall Study|Afraid of Hypnosis|0
454682|NCT00361270|1497162|P3|Overall Study|Afraid of Hypnosis|0
454683|NCT00361270|1497163|P2|Overall Study|Afraid of Hypnosis|2
454684|NCT00361270|1497164|P1|Overall Study|Afraid of Hypnosis|1
454685|NCT00361270|1497161|P4|Overall Study|Withdrawal by Subject|7
454686|NCT00361270|1497162|P3|Overall Study|Withdrawal by Subject|3
454687|NCT00361270|1497163|P2|Overall Study|Withdrawal by Subject|6
454688|NCT00361270|1497164|P1|Overall Study|Withdrawal by Subject|6
454689|NCT00361270|1497161|P4|Overall Study|Protocol Violation|4
454690|NCT00361270|1497162|P3|Overall Study|Protocol Violation|5
454691|NCT00361270|1497163|P2|Overall Study|Protocol Violation|4
454692|NCT00361270|1497164|P1|Overall Study|Protocol Violation|9
454693|NCT00361270|1497161|P4|Overall Study|Physician Decision|0
454694|NCT00361270|1497162|P3|Overall Study|Physician Decision|1
454695|NCT00361270|1497163|P2|Overall Study|Physician Decision|0
454696|NCT00361270|1497164|P1|Overall Study|Physician Decision|0
454697|NCT00361270|1497161|P4|Overall Study|Lost to Follow-up|0
454698|NCT00361270|1497162|P3|Overall Study|Lost to Follow-up|0
454699|NCT00361270|1497163|P2|Overall Study|Lost to Follow-up|1
454700|NCT00361270|1497164|P1|Overall Study|Lost to Follow-up|4
454701|NCT00361270|1497161|P4|Overall Study|Death|2
454702|NCT00361270|1497162|P3|Overall Study|Death|0
454703|NCT00361270|1497163|P2|Overall Study|Death|0
454704|NCT00361270|1497164|P1|Overall Study|Death|0
454705|NCT00361231|1497237|P1|Overall Study|Adverse Event|6
454706|NCT00361231|1497237|P1|Overall Study|Withdrawal by Subject|4
454707|NCT00361231|1497237|P1|Overall Study|Radiographic disease progression|16
454708|NCT00361231|1497237|P1|Overall Study|Symptomatic deterioration|5
454709|NCT00361231|1497237|P1|Overall Study|Physician Decision|3
454710|NCT00361218|1497242|P1|Overall Study|terminated / withdrawn due to toxicity /|5
454711|NCT00361218|1497242|P1|Overall Study|Personal Reasons|7
454712|NCT00361218|1497242|P1|Overall Study|Lost to Follow-up|11
454713|NCT00360698|1497321|P2|Treatment Period|Early termination by error|1
454714|NCT00360698|1497322|P1|Treatment Period|Early termination by error|0
454715|NCT00360698|1497321|P2|Treatment Period|Non compliance with treatment procedure|0
454716|NCT00360698|1497322|P1|Treatment Period|Non compliance with treatment procedure|1
454717|NCT00360698|1497321|P2|Run-In|Need of insulin with meals|1
454718|NCT00360698|1497322|P1|Run-In|Need of insulin with meals|0
454719|NCT00360698|1497321|P2|Run-In|Patient personal reasons|2
454720|NCT00360698|1497322|P1|Run-In|Patient personal reasons|0
454721|NCT00360698|1497321|P2|Run-In|Patient did not meet inclusion criteria|1
454722|NCT00360698|1497322|P1|Run-In|Patient did not meet inclusion criteria|0
454723|NCT00360698|1497321|P2|Run-In|Sponsor request|2
454724|NCT00360698|1497322|P1|Run-In|Sponsor request|0
454725|NCT00360698|1497321|P2|Run-In|Non compliance with treatment procedure|1
454726|NCT00360698|1497322|P1|Run-In|Non compliance with treatment procedure|0
454727|NCT00360698|1497321|P2|Run-In|Withdrawal by Subject|2
454728|NCT00360698|1497322|P1|Run-In|Withdrawal by Subject|0
454729|NCT00360698|1497321|P2|Run-In|Physician Decision|1
454730|NCT00360698|1497322|P1|Run-In|Physician Decision|0
454731|NCT00360568|1497367|P2|Overall Study|Withdrawal by Subject|3
454732|NCT00360568|1497368|P1|Overall Study|Withdrawal by Subject|0
454733|NCT00360568|1497367|P2|Overall Study|Lack of Efficacy|0
454734|NCT00360568|1497368|P1|Overall Study|Lack of Efficacy|1
454735|NCT00360568|1497367|P2|Overall Study|Adverse Event|2
454736|NCT00360568|1497368|P1|Overall Study|Adverse Event|1
454737|NCT00360529|1497499|P3|Overall Study|Reason discontinued not explained above|11
454738|NCT00360529|1497500|P2|Overall Study|Reason discontinued not explained above|9
454739|NCT00360529|1497501|P1|Overall Study|Reason discontinued not explained above|4
454740|NCT00360529|1497499|P3|Overall Study|Lack of Efficacy|5
454741|NCT00360529|1497500|P2|Overall Study|Lack of Efficacy|6
454742|NCT00360529|1497501|P1|Overall Study|Lack of Efficacy|8
454743|NCT00360529|1497499|P3|Overall Study|Withdrawal by Subject|18
454744|NCT00360529|1497500|P2|Overall Study|Withdrawal by Subject|14
454745|NCT00360529|1497501|P1|Overall Study|Withdrawal by Subject|22
454746|NCT00360529|1497499|P3|Overall Study|Lost to Follow-up|13
454747|NCT00360529|1497500|P2|Overall Study|Lost to Follow-up|10
454748|NCT00360529|1497501|P1|Overall Study|Lost to Follow-up|14
454749|NCT00360529|1497499|P3|Overall Study|Protocol Violation|11
454750|NCT00360529|1497500|P2|Overall Study|Protocol Violation|3
454751|NCT00360529|1497501|P1|Overall Study|Protocol Violation|3
454752|NCT00360529|1497499|P3|Overall Study|Adverse Event|33
454753|NCT00360529|1497500|P2|Overall Study|Adverse Event|23
454754|NCT00360529|1497501|P1|Overall Study|Adverse Event|10
454755|NCT00360490|1497529|P2|Overall Study|Withdrawal by Subject|3
454756|NCT00360490|1497530|P1|Overall Study|Withdrawal by Subject|1
454757|NCT00360490|1497529|P2|Overall Study|Protocol Violation|4
454758|NCT00360490|1497530|P1|Overall Study|Protocol Violation|0
454759|NCT00360490|1497529|P2|Overall Study|Physician Decision|1
454760|NCT00360490|1497530|P1|Overall Study|Physician Decision|2
454761|NCT00360490|1497529|P2|Overall Study|Lost to Follow-up|1
454762|NCT00360490|1497530|P1|Overall Study|Lost to Follow-up|2
454763|NCT00360490|1497529|P2|Overall Study|Adverse Event|2
454764|NCT00360490|1497530|P1|Overall Study|Adverse Event|4
454765|NCT00360412|1497565|P2|Overall Study|Study termination by Sponsor|469
454766|NCT00360412|1497566|P1|Overall Study|Study termination by Sponsor|214
454767|NCT00360412|1497565|P2|Overall Study|Not specified|6
454768|NCT00360412|1497566|P1|Overall Study|Not specified|5
454769|NCT00360412|1497565|P2|Overall Study|Physician Decision|4
454770|NCT00360412|1497566|P1|Overall Study|Physician Decision|2
454771|NCT00360412|1497565|P2|Overall Study|Lack of therapeutic efficacy|61
454772|NCT00360412|1497566|P1|Overall Study|Lack of therapeutic efficacy|46
454773|NCT00360412|1497565|P2|Overall Study|Patient withdrew consent|52
454774|NCT00360412|1497566|P1|Overall Study|Patient withdrew consent|27
454775|NCT00360412|1497565|P2|Overall Study|Protocol Violation|5
454776|NCT00360412|1497566|P1|Overall Study|Protocol Violation|2
454777|NCT00360412|1497565|P2|Overall Study|Adverse Event|65
454778|NCT00360412|1497566|P1|Overall Study|Adverse Event|37
454779|NCT00360334|1497613|P2|Overall Study|Subject decision|2
454780|NCT00360334|1497614|P1|Overall Study|Subject decision|8
454781|NCT00360334|1497613|P2|Overall Study|Entry criterion not met|2
454782|NCT00360334|1497614|P1|Overall Study|Entry criterion not met|1
454783|NCT00360334|1497613|P2|Overall Study|Lack of Efficacy|1
454784|NCT00360334|1497614|P1|Overall Study|Lack of Efficacy|0
454785|NCT00360334|1497613|P2|Overall Study|Physician Decision|3
454786|NCT00360334|1497614|P1|Overall Study|Physician Decision|2
454787|NCT00360334|1497613|P2|Overall Study|Protocol Violation|1
454788|NCT00360334|1497614|P1|Overall Study|Protocol Violation|1
454789|NCT00360334|1497613|P2|Overall Study|Adverse Event|4
454790|NCT00360334|1497614|P1|Overall Study|Adverse Event|7
454791|NCT00360308|1497677|P3|Overall Study|Study termination by sponsor|44
454792|NCT00360308|1497678|P2|Overall Study|Study termination by sponsor|55
454793|NCT00360308|1497679|P1|Overall Study|Study termination by sponsor|43
454794|NCT00360308|1497677|P3|Overall Study|Not Specified|1
454795|NCT00360308|1497678|P2|Overall Study|Not Specified|1
454796|NCT00360308|1497679|P1|Overall Study|Not Specified|2
454797|NCT00360308|1497677|P3|Overall Study|Lack of Efficacy|2
454798|NCT00360308|1497678|P2|Overall Study|Lack of Efficacy|0
454799|NCT00360308|1497679|P1|Overall Study|Lack of Efficacy|3
454800|NCT00360308|1497677|P3|Overall Study|Withdrawal by Subject|14
454801|NCT00360308|1497678|P2|Overall Study|Withdrawal by Subject|7
454802|NCT00360308|1497679|P1|Overall Study|Withdrawal by Subject|11
454803|NCT00360308|1497677|P3|Overall Study|Protocol Violation|2
454804|NCT00360308|1497678|P2|Overall Study|Protocol Violation|1
454805|NCT00360308|1497679|P1|Overall Study|Protocol Violation|2
454806|NCT00360308|1497677|P3|Overall Study|Abnormal Laboratory Value(s)|0
454807|NCT00360308|1497678|P2|Overall Study|Abnormal Laboratory Value(s)|1
454808|NCT00360308|1497679|P1|Overall Study|Abnormal Laboratory Value(s)|0
454809|NCT00360308|1497677|P3|Overall Study|Adverse Event|25
454810|NCT00360308|1497678|P2|Overall Study|Adverse Event|14
454811|NCT00360308|1497679|P1|Overall Study|Adverse Event|15
454812|NCT00360282|1497696|P4|Second Intervention|Adverse Event|0
454813|NCT00360282|1497697|P3|Second Intervention|Adverse Event|0
454814|NCT00360282|1497698|P2|Second Intervention|Adverse Event|1
454815|NCT00360282|1497699|P1|Second Intervention|Adverse Event|0
454816|NCT00360282|1497696|P4|Washout 1-3 Weeks|Lost to Follow-up|0
454817|NCT00360282|1497697|P3|Washout 1-3 Weeks|Lost to Follow-up|1
454818|NCT00360282|1497698|P2|Washout 1-3 Weeks|Lost to Follow-up|0
454819|NCT00360282|1497699|P1|Washout 1-3 Weeks|Lost to Follow-up|0
454820|NCT00360269|1497711|P2|Overall Study|Withdrawal by Subject|1
454821|NCT00360269|1497712|P1|Overall Study|Withdrawal by Subject|1
454822|NCT00360269|1497711|P2|Overall Study|Adverse Event|0
454823|NCT00360269|1497712|P1|Overall Study|Adverse Event|1
454824|NCT00360269|1497711|P2|Overall Study|Physician Decision|2
454825|NCT00360269|1497712|P1|Overall Study|Physician Decision|1
454826|NCT00360269|1497711|P2|Overall Study|Lost to Follow-up|9
454827|NCT00360269|1497712|P1|Overall Study|Lost to Follow-up|7
454828|NCT00360230|1497754|P7|Overall Study|Death|1
454829|NCT00360230|1497755|P6|Overall Study|Death|1
454830|NCT00360230|1497756|P5|Overall Study|Death|0
454831|NCT00360230|1497757|P4|Overall Study|Death|0
454832|NCT00360230|1497758|P3|Overall Study|Death|0
454833|NCT00360230|1497759|P2|Overall Study|Death|1
454834|NCT00360230|1497760|P1|Overall Study|Death|0
454835|NCT00360230|1497754|P7|Overall Study|Protocol Violation|0
454836|NCT00360230|1497755|P6|Overall Study|Protocol Violation|1
454837|NCT00360230|1497756|P5|Overall Study|Protocol Violation|0
454838|NCT00360230|1497757|P4|Overall Study|Protocol Violation|0
454839|NCT00360230|1497758|P3|Overall Study|Protocol Violation|0
454840|NCT00360230|1497759|P2|Overall Study|Protocol Violation|0
454841|NCT00360230|1497760|P1|Overall Study|Protocol Violation|0
454842|NCT00360230|1497754|P7|Overall Study|Not specified|0
454843|NCT00360230|1497755|P6|Overall Study|Not specified|0
454844|NCT00360230|1497756|P5|Overall Study|Not specified|0
454845|NCT00360230|1497757|P4|Overall Study|Not specified|0
454846|NCT00360230|1497758|P3|Overall Study|Not specified|0
454847|NCT00360230|1497759|P2|Overall Study|Not specified|0
454848|NCT00360230|1497760|P1|Overall Study|Not specified|1
454849|NCT00360230|1497754|P7|Overall Study|Migrated|1
454850|NCT00360230|1497755|P6|Overall Study|Migrated|1
454851|NCT00360230|1497756|P5|Overall Study|Migrated|4
454852|NCT00360230|1497757|P4|Overall Study|Migrated|1
454853|NCT00360230|1497758|P3|Overall Study|Migrated|3
454854|NCT00360230|1497759|P2|Overall Study|Migrated|1
454855|NCT00360230|1497760|P1|Overall Study|Migrated|4
454856|NCT00360230|1497754|P7|Overall Study|Withdrawal by Subject|0
454857|NCT00360230|1497755|P6|Overall Study|Withdrawal by Subject|1
454858|NCT00360230|1497756|P5|Overall Study|Withdrawal by Subject|1
454859|NCT00360230|1497757|P4|Overall Study|Withdrawal by Subject|1
454860|NCT00360230|1497758|P3|Overall Study|Withdrawal by Subject|0
454861|NCT00360230|1497759|P2|Overall Study|Withdrawal by Subject|1
454862|NCT00360230|1497760|P1|Overall Study|Withdrawal by Subject|1
454863|NCT00359801|1497916|P2|Overall Study|Sponsor Decision|16
454864|NCT00359801|1497917|P1|Overall Study|Sponsor Decision|17
454865|NCT00359801|1497916|P2|Overall Study|Final Status Unknown: missing data|4
454866|NCT00359801|1497917|P1|Overall Study|Final Status Unknown: missing data|7
454867|NCT00359801|1497916|P2|Overall Study|Other|46
454868|NCT00359801|1497917|P1|Overall Study|Other|66
454869|NCT00359801|1497916|P2|Overall Study|Withdrawal by Subject|96
454870|NCT00359801|1497917|P1|Overall Study|Withdrawal by Subject|143
454871|NCT00359801|1497916|P2|Overall Study|Lost to Follow-up|58
454872|NCT00359801|1497917|P1|Overall Study|Lost to Follow-up|72
454873|NCT00359788|1497951|P2|Overall Study|Protocol Violation|2
454874|NCT00359788|1497952|P1|Overall Study|Protocol Violation|4
454875|NCT00359788|1497951|P2|Overall Study|Withdrawal by Subject|1
454876|NCT00359788|1497952|P1|Overall Study|Withdrawal by Subject|4
454877|NCT00359788|1497951|P2|Overall Study|Lost to Follow-up|2
454878|NCT00359788|1497952|P1|Overall Study|Lost to Follow-up|3
454879|NCT00359788|1497951|P2|Overall Study|Lack of Efficacy|2
454880|NCT00359788|1497952|P1|Overall Study|Lack of Efficacy|1
454881|NCT00359788|1497951|P2|Overall Study|Adverse Event|10
454882|NCT00359788|1497952|P1|Overall Study|Adverse Event|11
454883|NCT00359762|1498186|P5|Period III|Subject Decision|0
454884|NCT00359762|1498187|P4|Period III|Subject Decision|20
454885|NCT00359762|1498188|P3|Period III|Subject Decision|8
454886|NCT00359762|1498189|P2|Period III|Subject Decision|7
454887|NCT00359762|1498190|P1|Period III|Subject Decision|0
454888|NCT00359762|1498186|P5|Period III|Entry Criteria Not Met|0
454889|NCT00359762|1498187|P4|Period III|Entry Criteria Not Met|1
454890|NCT00359762|1498188|P3|Period III|Entry Criteria Not Met|0
454891|NCT00359762|1498189|P2|Period III|Entry Criteria Not Met|1
454892|NCT00359762|1498190|P1|Period III|Entry Criteria Not Met|0
454893|NCT00359762|1498186|P5|Period III|Lost to follow up|0
454894|NCT00359762|1498187|P4|Period III|Lost to follow up|2
454895|NCT00359762|1498188|P3|Period III|Lost to follow up|1
454896|NCT00359762|1498189|P2|Period III|Lost to follow up|1
454897|NCT00359762|1498190|P1|Period III|Lost to follow up|0
454898|NCT00359762|1498186|P5|Period III|Lack of Efficacy|0
454899|NCT00359762|1498187|P4|Period III|Lack of Efficacy|9
454900|NCT00359762|1498188|P3|Period III|Lack of Efficacy|5
454901|NCT00359762|1498189|P2|Period III|Lack of Efficacy|7
454902|NCT00359762|1498190|P1|Period III|Lack of Efficacy|0
454903|NCT00359762|1498186|P5|Period III|Physician Decision|0
454904|NCT00359762|1498187|P4|Period III|Physician Decision|15
454905|NCT00359762|1498188|P3|Period III|Physician Decision|9
454906|NCT00359762|1498189|P2|Period III|Physician Decision|5
454907|NCT00359762|1498190|P1|Period III|Physician Decision|0
454908|NCT00359762|1498186|P5|Period III|Adverse Event|0
454909|NCT00359762|1498187|P4|Period III|Adverse Event|10
454910|NCT00359762|1498188|P3|Period III|Adverse Event|4
454911|NCT00359762|1498189|P2|Period III|Adverse Event|3
454912|NCT00359762|1498190|P1|Period III|Adverse Event|0
454913|NCT00359762|1498186|P5|Period III|Protocol Violation|0
454914|NCT00359762|1498187|P4|Period III|Protocol Violation|8
454915|NCT00359762|1498188|P3|Period III|Protocol Violation|3
454916|NCT00359762|1498189|P2|Period III|Protocol Violation|5
454917|NCT00359762|1498190|P1|Period III|Protocol Violation|0
454918|NCT00359762|1498186|P5|Period II|Subject Decision|70
454919|NCT00359762|1498187|P4|Period II|Subject Decision|0
454920|NCT00359762|1498188|P3|Period II|Subject Decision|0
454921|NCT00359762|1498189|P2|Period II|Subject Decision|0
454922|NCT00359762|1498190|P1|Period II|Subject Decision|50
454923|NCT00359762|1498186|P5|Period II|Entry Criteria Not Met|4
454924|NCT00359762|1498187|P4|Period II|Entry Criteria Not Met|0
454925|NCT00359762|1498188|P3|Period II|Entry Criteria Not Met|0
454926|NCT00359762|1498189|P2|Period II|Entry Criteria Not Met|0
454927|NCT00359762|1498190|P1|Period II|Entry Criteria Not Met|8
454928|NCT00359762|1498186|P5|Period II|Lost to follow up|5
454929|NCT00359762|1498187|P4|Period II|Lost to follow up|0
454930|NCT00359762|1498188|P3|Period II|Lost to follow up|0
454931|NCT00359762|1498189|P2|Period II|Lost to follow up|0
454932|NCT00359762|1498190|P1|Period II|Lost to follow up|5
454933|NCT00359762|1498186|P5|Period II|Lack of Efficacy|8
454934|NCT00359762|1498187|P4|Period II|Lack of Efficacy|0
454935|NCT00359762|1498188|P3|Period II|Lack of Efficacy|0
454936|NCT00359762|1498189|P2|Period II|Lack of Efficacy|0
454937|NCT00359762|1498190|P1|Period II|Lack of Efficacy|11
454938|NCT00359762|1498186|P5|Period II|Death|4
454939|NCT00359762|1498187|P4|Period II|Death|0
454940|NCT00359762|1498188|P3|Period II|Death|0
454941|NCT00359762|1498189|P2|Period II|Death|0
454942|NCT00359762|1498190|P1|Period II|Death|2
454943|NCT00359762|1498186|P5|Period II|Physician Decision|23
454944|NCT00359762|1498187|P4|Period II|Physician Decision|0
454945|NCT00359762|1498188|P3|Period II|Physician Decision|0
454946|NCT00359762|1498189|P2|Period II|Physician Decision|0
454947|NCT00359762|1498190|P1|Period II|Physician Decision|17
454948|NCT00359762|1498186|P5|Period II|Protocol Violation|11
454949|NCT00359762|1498187|P4|Period II|Protocol Violation|0
454950|NCT00359762|1498188|P3|Period II|Protocol Violation|0
454951|NCT00359762|1498189|P2|Period II|Protocol Violation|0
454952|NCT00359762|1498190|P1|Period II|Protocol Violation|18
454953|NCT00359762|1498186|P5|Period II|Adverse Event|49
454954|NCT00359762|1498187|P4|Period II|Adverse Event|0
454955|NCT00359762|1498188|P3|Period II|Adverse Event|0
454956|NCT00359762|1498189|P2|Period II|Adverse Event|0
454957|NCT00359762|1498190|P1|Period II|Adverse Event|17
454958|NCT00359632|1498264|P2|Overall Study|Non-compliance with visit schedule|0
454959|NCT00359632|1498265|P1|Overall Study|Non-compliance with visit schedule|1
454960|NCT00359632|1498264|P2|Overall Study|Adverse Event|0
454961|NCT00359632|1498265|P1|Overall Study|Adverse Event|1
454962|NCT00359632|1498264|P2|Overall Study|Death|0
454963|NCT00359632|1498265|P1|Overall Study|Death|2
454964|NCT00359619|1498279|P7|Overall Study|Lost to Follow-up|0
454965|NCT00359619|1498280|P6|Overall Study|Lost to Follow-up|5
454966|NCT00359619|1498281|P5|Overall Study|Lost to Follow-up|1
454967|NCT00359619|1498282|P4|Overall Study|Lost to Follow-up|1
454968|NCT00359619|1498283|P3|Overall Study|Lost to Follow-up|2
454969|NCT00359619|1498284|P2|Overall Study|Lost to Follow-up|4
454970|NCT00359619|1498285|P1|Overall Study|Lost to Follow-up|4
454971|NCT00359619|1498279|P7|Overall Study|Other|0
454972|NCT00359619|1498280|P6|Overall Study|Other|0
454973|NCT00359619|1498281|P5|Overall Study|Other|0
454974|NCT00359619|1498282|P4|Overall Study|Other|0
454975|NCT00359619|1498283|P3|Overall Study|Other|0
454976|NCT00359619|1498284|P2|Overall Study|Other|0
454977|NCT00359619|1498285|P1|Overall Study|Other|1
454978|NCT00359619|1498279|P7|Overall Study|Withdrawal by Subject|3
454979|NCT00359619|1498280|P6|Overall Study|Withdrawal by Subject|0
454980|NCT00359619|1498281|P5|Overall Study|Withdrawal by Subject|2
454981|NCT00359619|1498282|P4|Overall Study|Withdrawal by Subject|2
454982|NCT00359619|1498283|P3|Overall Study|Withdrawal by Subject|4
454983|NCT00359619|1498284|P2|Overall Study|Withdrawal by Subject|1
454984|NCT00359619|1498285|P1|Overall Study|Withdrawal by Subject|3
454985|NCT00359619|1498279|P7|Overall Study|Adverse Event|1
454986|NCT00359619|1498280|P6|Overall Study|Adverse Event|0
454987|NCT00359619|1498281|P5|Overall Study|Adverse Event|0
454988|NCT00359619|1498282|P4|Overall Study|Adverse Event|0
454989|NCT00359619|1498283|P3|Overall Study|Adverse Event|1
454990|NCT00359619|1498284|P2|Overall Study|Adverse Event|0
454991|NCT00359619|1498285|P1|Overall Study|Adverse Event|0
454992|NCT00359424|1498415|P2|Overall Study|follow up not conducted|0
454993|NCT00359424|1498416|P1|Overall Study|follow up not conducted|2
454994|NCT00359424|1498415|P2|Overall Study|Withdrawal by Subject|2
454995|NCT00359424|1498416|P1|Overall Study|Withdrawal by Subject|10
454996|NCT00359424|1498415|P2|Overall Study|Lost to Follow-up|7
454997|NCT00359424|1498416|P1|Overall Study|Lost to Follow-up|19
454998|NCT00359424|1498415|P2|Overall Study|Death|58
454999|NCT00359424|1498416|P1|Overall Study|Death|99
455000|NCT00359281|1498455|P9|Overall Study|Withdrawal by Subject|0
455001|NCT00359281|1498456|P8|Overall Study|Withdrawal by Subject|0
455002|NCT00359281|1498457|P7|Overall Study|Withdrawal by Subject|1
455003|NCT00359281|1498458|P6|Overall Study|Withdrawal by Subject|0
455004|NCT00359281|1498459|P5|Overall Study|Withdrawal by Subject|0
455005|NCT00359281|1498460|P4|Overall Study|Withdrawal by Subject|0
455006|NCT00359281|1498461|P3|Overall Study|Withdrawal by Subject|0
455007|NCT00359281|1498462|P2|Overall Study|Withdrawal by Subject|0
455008|NCT00359281|1498463|P1|Overall Study|Withdrawal by Subject|0
455009|NCT00359281|1498455|P9|Overall Study|Adverse Event|0
455010|NCT00359281|1498456|P8|Overall Study|Adverse Event|0
455011|NCT00359281|1498457|P7|Overall Study|Adverse Event|1
455012|NCT00359281|1498458|P6|Overall Study|Adverse Event|0
455013|NCT00359281|1498459|P5|Overall Study|Adverse Event|0
455014|NCT00359281|1498460|P4|Overall Study|Adverse Event|0
455015|NCT00359281|1498461|P3|Overall Study|Adverse Event|0
455016|NCT00359281|1498462|P2|Overall Study|Adverse Event|0
455017|NCT00359281|1498463|P1|Overall Study|Adverse Event|1
455018|NCT00359073|1498526|P2|Overall Study|developed RV16 antibody|1
455019|NCT00359073|1498527|P1|Overall Study|developed RV16 antibody|0
455020|NCT00359073|1498526|P2|Overall Study|Eligibility criteria no longer met|0
455021|NCT00359073|1498527|P1|Overall Study|Eligibility criteria no longer met|3
455022|NCT00359073|1498526|P2|Overall Study|Withdrawal by Subject|1
455023|NCT00359073|1498527|P1|Overall Study|Withdrawal by Subject|1
455024|NCT00359021|1498539|P2|Overall Study|Pregnancy|0
455025|NCT00359021|1498540|P1|Overall Study|Pregnancy|1
455026|NCT00359021|1498539|P2|Overall Study|Not specified|1
455027|NCT00359021|1498540|P1|Overall Study|Not specified|4
455028|NCT00359021|1498539|P2|Overall Study|Lost to Follow-up|0
455029|NCT00359021|1498540|P1|Overall Study|Lost to Follow-up|1
455030|NCT00359021|1498539|P2|Overall Study|Withdrawal by Subject|9
455031|NCT00359021|1498540|P1|Overall Study|Withdrawal by Subject|2
455032|NCT00359021|1498539|P2|Overall Study|Subject Reached A Virologic Endpoint|32
455033|NCT00359021|1498540|P1|Overall Study|Subject Reached A Virologic Endpoint|45
455034|NCT00359021|1498539|P2|Overall Study|Subject Ineligible To Continue The Trial|0
455035|NCT00359021|1498540|P1|Overall Study|Subject Ineligible To Continue The Trial|1
455036|NCT00359021|1498539|P2|Overall Study|Subject Non-Compliant|2
455037|NCT00359021|1498540|P1|Overall Study|Subject Non-Compliant|1
455038|NCT00359021|1498539|P2|Overall Study|Adverse Event|8
455039|NCT00359021|1498540|P1|Overall Study|Adverse Event|26
455040|NCT00358956|1498552|P1|Overall Study|Withdrawal by Subject|1
455041|NCT00358956|1498552|P1|Overall Study|condition under investigation worsened|4
455042|NCT00358956|1498552|P1|Overall Study|Adverse Event|3
455043|NCT00358917|1498564|P2|Overall Study|Unable to Continue Participation|2
455044|NCT00358917|1498565|P1|Overall Study|Unable to Continue Participation|2
455045|NCT00358917|1498564|P2|Overall Study|Virologic failure|8
455046|NCT00358917|1498565|P1|Overall Study|Virologic failure|11
455047|NCT00358917|1498564|P2|Overall Study|Death|3
455048|NCT00358917|1498565|P1|Overall Study|Death|2
455049|NCT00358917|1498564|P2|Overall Study|Noncompliance|11
455050|NCT00358917|1498565|P1|Overall Study|Noncompliance|12
455051|NCT00358917|1498564|P2|Overall Study|Lost to Follow-up|17
455052|NCT00358917|1498565|P1|Overall Study|Lost to Follow-up|20
455053|NCT00358917|1498564|P2|Overall Study|Withdrawal by Subject|7
455054|NCT00358917|1498565|P1|Overall Study|Withdrawal by Subject|5
455055|NCT00358917|1498564|P2|Overall Study|Adverse Event|21
455056|NCT00358917|1498565|P1|Overall Study|Adverse Event|14
455057|NCT00358826|1498583|P8|MDCT Substudy|Withdrawal by Subject|0
455058|NCT00358826|1498584|P7|MDCT Substudy|Withdrawal by Subject|0
455059|NCT00358826|1498585|P6|MDCT Substudy|Withdrawal by Subject|1
455060|NCT00358826|1498586|P5|MDCT Substudy|Withdrawal by Subject|0
455061|NCT00358826|1498587|P4|MDCT Substudy|Withdrawal by Subject|0
455062|NCT00358826|1498588|P3|MDCT Substudy|Withdrawal by Subject|0
455063|NCT00358826|1498589|P2|MDCT Substudy|Withdrawal by Subject|0
455064|NCT00358826|1498590|P1|MDCT Substudy|Withdrawal by Subject|0
455065|NCT00358826|1498583|P8|MDCT Substudy|Lost to Follow-up|0
455066|NCT00358826|1498584|P7|MDCT Substudy|Lost to Follow-up|0
455067|NCT00358826|1498585|P6|MDCT Substudy|Lost to Follow-up|1
455068|NCT00358826|1498586|P5|MDCT Substudy|Lost to Follow-up|0
455069|NCT00358826|1498587|P4|MDCT Substudy|Lost to Follow-up|0
455070|NCT00358826|1498588|P3|MDCT Substudy|Lost to Follow-up|0
455071|NCT00358826|1498589|P2|MDCT Substudy|Lost to Follow-up|0
455072|NCT00358826|1498590|P1|MDCT Substudy|Lost to Follow-up|0
455073|NCT00358826|1498583|P8|MDCT Substudy|Adverse Event|0
455074|NCT00358826|1498584|P7|MDCT Substudy|Adverse Event|0
455075|NCT00358826|1498585|P6|MDCT Substudy|Adverse Event|0
455076|NCT00358826|1498586|P5|MDCT Substudy|Adverse Event|1
455077|NCT00358826|1498587|P4|MDCT Substudy|Adverse Event|0
455078|NCT00358826|1498588|P3|MDCT Substudy|Adverse Event|0
455079|NCT00358826|1498589|P2|MDCT Substudy|Adverse Event|0
455080|NCT00358826|1498590|P1|MDCT Substudy|Adverse Event|0
455081|NCT00358826|1498583|P8|Core Study|Physician Decision|0
455082|NCT00358826|1498584|P7|Core Study|Physician Decision|0
455083|NCT00358826|1498585|P6|Core Study|Physician Decision|0
455084|NCT00358826|1498586|P5|Core Study|Physician Decision|0
455085|NCT00358826|1498587|P4|Core Study|Physician Decision|0
455086|NCT00358826|1498588|P3|Core Study|Physician Decision|1
455087|NCT00358826|1498589|P2|Core Study|Physician Decision|0
455088|NCT00358826|1498590|P1|Core Study|Physician Decision|0
455089|NCT00358826|1498583|P8|Core Study|Lost to Follow-up|0
455090|NCT00358826|1498584|P7|Core Study|Lost to Follow-up|0
455091|NCT00358826|1498585|P6|Core Study|Lost to Follow-up|0
455092|NCT00358826|1498586|P5|Core Study|Lost to Follow-up|0
455093|NCT00358826|1498587|P4|Core Study|Lost to Follow-up|1
455094|NCT00358826|1498588|P3|Core Study|Lost to Follow-up|0
455095|NCT00358826|1498589|P2|Core Study|Lost to Follow-up|0
455096|NCT00358826|1498590|P1|Core Study|Lost to Follow-up|0
455097|NCT00358826|1498583|P8|Core Study|Withdrawal by Subject|0
455098|NCT00358826|1498584|P7|Core Study|Withdrawal by Subject|0
455099|NCT00358826|1498585|P6|Core Study|Withdrawal by Subject|0
455100|NCT00358826|1498586|P5|Core Study|Withdrawal by Subject|0
455101|NCT00358826|1498587|P4|Core Study|Withdrawal by Subject|0
455102|NCT00358826|1498588|P3|Core Study|Withdrawal by Subject|0
455103|NCT00358826|1498589|P2|Core Study|Withdrawal by Subject|2
455104|NCT00358826|1498590|P1|Core Study|Withdrawal by Subject|2
455105|NCT00358826|1498583|P8|Core Study|Adverse Event|0
455106|NCT00358826|1498584|P7|Core Study|Adverse Event|0
455107|NCT00358826|1498585|P6|Core Study|Adverse Event|0
455108|NCT00358826|1498586|P5|Core Study|Adverse Event|0
455109|NCT00358826|1498587|P4|Core Study|Adverse Event|1
455110|NCT00358826|1498588|P3|Core Study|Adverse Event|1
455111|NCT00358826|1498589|P2|Core Study|Adverse Event|3
455112|NCT00358826|1498590|P1|Core Study|Adverse Event|1
455113|NCT00358670|1498657|P2|Overall Study|Administrative|125
455114|NCT00358670|1498658|P1|Overall Study|Administrative|153
455115|NCT00358670|1498657|P2|Overall Study|Did Not Meet Protocol Eligibility|3
455116|NCT00358670|1498658|P1|Overall Study|Did Not Meet Protocol Eligibility|0
455117|NCT00358670|1498657|P2|Overall Study|Protocol Defined Clinical Event|1
455118|NCT00358670|1498658|P1|Overall Study|Protocol Defined Clinical Event|0
455119|NCT00358670|1498657|P2|Overall Study|Withdrawal by Subject|24
455120|NCT00358670|1498658|P1|Overall Study|Withdrawal by Subject|13
455121|NCT00358670|1498657|P2|Overall Study|Lost to Follow-up|5
455122|NCT00358670|1498658|P1|Overall Study|Lost to Follow-up|4
455123|NCT00358670|1498657|P2|Overall Study|Protocol Violation|9
455124|NCT00358670|1498658|P1|Overall Study|Protocol Violation|6
455125|NCT00358670|1498657|P2|Overall Study|Lack of Efficacy|23
455126|NCT00358670|1498658|P1|Overall Study|Lack of Efficacy|20
455127|NCT00358670|1498657|P2|Overall Study|Adverse Event|29
455128|NCT00358670|1498658|P1|Overall Study|Adverse Event|26
455129|NCT00358644|1498672|P1|Overall Study|Patient not eligible for study|1
455130|NCT00358644|1498672|P1|Overall Study|Physician Decision|6
455131|NCT00358644|1498672|P1|Overall Study|Withdrawal by Subject|4
455132|NCT00358644|1498672|P1|Overall Study|Death|11
455133|NCT00358644|1498672|P1|Overall Study|Adverse Event|7
455134|NCT00358644|1498672|P1|Overall Study|Progressive Disease|21
455135|NCT00358527|1498695|P2|Overall Study|Administrative|1
455136|NCT00358527|1498696|P1|Overall Study|Administrative|2
455137|NCT00358527|1498695|P2|Overall Study|Non-compliance with protocol|1
455138|NCT00358527|1498696|P1|Overall Study|Non-compliance with protocol|6
455139|NCT00358527|1498695|P2|Overall Study|Withdrawal by Subject|1
455140|NCT00358527|1498696|P1|Overall Study|Withdrawal by Subject|1
455141|NCT00358527|1498695|P2|Overall Study|Adverse Event|0
455142|NCT00358527|1498696|P1|Overall Study|Adverse Event|4
455143|NCT00358449|1498734|P3|Overall Study|Steriod Inhaler was Increased|1
455144|NCT00358449|1498735|P2|Overall Study|Steriod Inhaler was Increased|0
455145|NCT00358449|1498736|P1|Overall Study|Steriod Inhaler was Increased|0
455146|NCT00358449|1498734|P3|Overall Study|Lack of Efficacy|0
455147|NCT00358449|1498735|P2|Overall Study|Lack of Efficacy|1
455148|NCT00358449|1498736|P1|Overall Study|Lack of Efficacy|0
455149|NCT00358449|1498734|P3|Overall Study|Withdrawal by Subject|0
455150|NCT00358449|1498735|P2|Overall Study|Withdrawal by Subject|0
455151|NCT00358449|1498736|P1|Overall Study|Withdrawal by Subject|2
455152|NCT00358449|1498734|P3|Overall Study|Lost to Follow-up|0
455153|NCT00358449|1498735|P2|Overall Study|Lost to Follow-up|0
455154|NCT00358449|1498736|P1|Overall Study|Lost to Follow-up|1
455155|NCT00358449|1498734|P3|Overall Study|Adverse Event|1
455156|NCT00358449|1498735|P2|Overall Study|Adverse Event|0
455157|NCT00358449|1498736|P1|Overall Study|Adverse Event|1
455158|NCT00358436|1498839|P2|Overall Study|Other|1
455159|NCT00358436|1498840|P1|Overall Study|Other|6
455160|NCT00358436|1498839|P2|Overall Study|COPD exacerbation|10
455161|NCT00358436|1498840|P1|Overall Study|COPD exacerbation|22
455162|NCT00358436|1498839|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
455163|NCT00358436|1498840|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
455164|NCT00358436|1498839|P2|Overall Study|Withdrawal by Subject|17
455165|NCT00358436|1498840|P1|Overall Study|Withdrawal by Subject|40
455166|NCT00358436|1498839|P2|Overall Study|Protocol Violation|3
455167|NCT00358436|1498840|P1|Overall Study|Protocol Violation|8
455168|NCT00358436|1498839|P2|Overall Study|Lost to Follow-up|6
455169|NCT00358436|1498840|P1|Overall Study|Lost to Follow-up|11
455170|NCT00358436|1498839|P2|Overall Study|Lack of Efficacy|36
455171|NCT00358436|1498840|P1|Overall Study|Lack of Efficacy|34
455172|NCT00358436|1498839|P2|Overall Study|Adverse Event|13
455173|NCT00358436|1498840|P1|Overall Study|Adverse Event|29
455174|NCT00358215|1498911|P2|Overall Study|Did not receive investigational product|3
455175|NCT00358215|1498912|P1|Overall Study|Did not receive investigational product|2
455176|NCT00358215|1498911|P2|Overall Study|Other|14
455177|NCT00358215|1498912|P1|Overall Study|Other|21
455178|NCT00358215|1498911|P2|Overall Study|Pregnancy|0
455179|NCT00358215|1498912|P1|Overall Study|Pregnancy|1
455180|NCT00358215|1498911|P2|Overall Study|Protocol Violation|59
455181|NCT00358215|1498912|P1|Overall Study|Protocol Violation|64
455182|NCT00358215|1498911|P2|Overall Study|Death|281
455183|NCT00358215|1498912|P1|Overall Study|Death|265
455184|NCT00358215|1498911|P2|Overall Study|Lost to Follow-up|22
455185|NCT00358215|1498912|P1|Overall Study|Lost to Follow-up|16
455186|NCT00358215|1498911|P2|Overall Study|Physician Decision|39
455187|NCT00358215|1498912|P1|Overall Study|Physician Decision|47
455188|NCT00358215|1498911|P2|Overall Study|Participant request|64
455189|NCT00358215|1498912|P1|Overall Study|Participant request|65
455190|NCT00358215|1498911|P2|Overall Study|Withdrawal by Subject|102
455191|NCT00358215|1498912|P1|Overall Study|Withdrawal by Subject|111
455192|NCT00358215|1498911|P2|Overall Study|Adverse Event|65
455193|NCT00358215|1498912|P1|Overall Study|Adverse Event|83
455194|NCT00358215|1498911|P2|Overall Study|Ineligibility determined|3
455195|NCT00358215|1498912|P1|Overall Study|Ineligibility determined|4
455196|NCT00358150|1498926|P1|Overall Study|Undefined|3
455197|NCT00358150|1498926|P1|Overall Study|Withdrawal by Subject|1
455198|NCT00358150|1498926|P1|Overall Study|Adverse Event|3
455199|NCT00357994|1498955|P2|Overall Study|Protocol Violation|0
455200|NCT00357994|1498956|P1|Overall Study|Protocol Violation|1
455201|NCT00357994|1498955|P2|Overall Study|Lack of Efficacy|1
455202|NCT00357994|1498956|P1|Overall Study|Lack of Efficacy|0
455203|NCT00357994|1498955|P2|Overall Study|Adverse Event|2
455204|NCT00357994|1498956|P1|Overall Study|Adverse Event|1
455205|NCT00357968|1499010|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
455206|NCT00357968|1499011|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
455207|NCT00357968|1499010|P2|First Maintenance Dose Phase|Not a PCI patient|42
455208|NCT00357968|1499011|P1|First Maintenance Dose Phase|Not a PCI patient|47
455209|NCT00357903|1499064|P2|Overall Study|Other|10
455210|NCT00357903|1499065|P1|Overall Study|Other|49
455211|NCT00357903|1499064|P2|Overall Study|Response status|9
455212|NCT00357903|1499065|P1|Overall Study|Response status|61
455213|NCT00357903|1499064|P2|Overall Study|Protocol issues|3
455214|NCT00357903|1499065|P1|Overall Study|Protocol issues|14
455215|NCT00357903|1499064|P2|Overall Study|Completed month 12 only|1
455216|NCT00357903|1499065|P1|Overall Study|Completed month 12 only|0
455217|NCT00357903|1499064|P2|Overall Study|Withdrawal by Subject|7
455218|NCT00357903|1499065|P1|Overall Study|Withdrawal by Subject|57
455219|NCT00357903|1499064|P2|Overall Study|Physician Decision|5
455220|NCT00357903|1499065|P1|Overall Study|Physician Decision|39
455221|NCT00357903|1499064|P2|Overall Study|Lost to Follow-up|4
455222|NCT00357903|1499065|P1|Overall Study|Lost to Follow-up|23
455223|NCT00357903|1499064|P2|Overall Study|Death|0
455224|NCT00357903|1499065|P1|Overall Study|Death|33
455225|NCT00357903|1499064|P2|Overall Study|Adverse Event|4
455226|NCT00357903|1499065|P1|Overall Study|Adverse Event|87
455227|NCT00357877|1499105|P2|Overall Study|Other|2
455228|NCT00357877|1499106|P1|Overall Study|Other|0
455229|NCT00357877|1499105|P2|Overall Study|Administrative withdrawal|1
455230|NCT00357877|1499106|P1|Overall Study|Administrative withdrawal|1
455231|NCT00357877|1499105|P2|Overall Study|Withdrawal by Subject|3
455232|NCT00357877|1499106|P1|Overall Study|Withdrawal by Subject|3
455233|NCT00357877|1499105|P2|Overall Study|Lost to Follow-up|23
455234|NCT00357877|1499106|P1|Overall Study|Lost to Follow-up|20
455235|NCT00357877|1499105|P2|Overall Study|Death|1
455236|NCT00357877|1499106|P1|Overall Study|Death|2
455237|NCT00357760|1499120|P2|Overall Study|To receive hospice care|1
455238|NCT00357760|1499121|P1|Overall Study|To receive hospice care|0
455239|NCT00357760|1499120|P2|Overall Study|Protocol Violation|1
455240|NCT00357760|1499121|P1|Overall Study|Protocol Violation|0
455241|NCT00357760|1499120|P2|Overall Study|Physician Decision|1
455242|NCT00357760|1499121|P1|Overall Study|Physician Decision|2
455243|NCT00357760|1499120|P2|Overall Study|Ineligible|2
455244|NCT00357760|1499121|P1|Overall Study|Ineligible|0
455245|NCT00357760|1499120|P2|Overall Study|Never started treatment|1
455246|NCT00357760|1499121|P1|Overall Study|Never started treatment|2
455247|NCT00357760|1499120|P2|Overall Study|Withdrawal by Subject|2
455248|NCT00357760|1499121|P1|Overall Study|Withdrawal by Subject|0
455249|NCT00357760|1499120|P2|Overall Study|Alternative therapy|0
455250|NCT00357760|1499121|P1|Overall Study|Alternative therapy|1
455251|NCT00357760|1499120|P2|Overall Study|Death|3
455252|NCT00357760|1499121|P1|Overall Study|Death|0
455253|NCT00357760|1499120|P2|Overall Study|Adverse Event|7
455254|NCT00357760|1499121|P1|Overall Study|Adverse Event|10
455255|NCT00357760|1499120|P2|Overall Study|Disease progression|17
455256|NCT00357760|1499121|P1|Overall Study|Disease progression|44
455257|NCT00357656|1499142|P2|Overall Study|Other, No surgery performed|3
455258|NCT00357656|1499143|P1|Overall Study|Other, No surgery performed|0
455259|NCT00357552|1499194|P1|Weeks 24 to 104|Not able to get to clinic|2
455260|NCT00357552|1499194|P1|Weeks 24 to 104|Death|3
455261|NCT00357552|1499194|P1|Weeks 0 to 24|Death|1
455262|NCT00357552|1499194|P1|Screening|Did not meet eligibility criteria|84
455263|NCT00357500|1499209|P1|Overall Study|Not Started Protocol Therapy|4
455264|NCT00357500|1499209|P1|Overall Study|Progressive Disease|65
455265|NCT00357500|1499209|P1|Overall Study|Withdrawal by Subject|5
455266|NCT00357500|1499209|P1|Overall Study|Adverse Event|3
455267|NCT00357396|1499218|P2|Overall Study|Adverse Event|0
455268|NCT00357396|1499219|P1|Overall Study|Adverse Event|1
455269|NCT00357370|1499227|P3|Cohort 2|Withdrawal by Subject|0
455270|NCT00357370|1499228|P2|Cohort 2|Withdrawal by Subject|2
455271|NCT00357370|1499229|P1|Cohort 2|Withdrawal by Subject|0
455272|NCT00357370|1499227|P3|Cohort 2|non-compliance, not met criteria, etc|0
455273|NCT00357370|1499228|P2|Cohort 2|non-compliance, not met criteria, etc|1
455274|NCT00357370|1499229|P1|Cohort 2|non-compliance, not met criteria, etc|1
455275|NCT00357370|1499227|P3|Cohort 2|Lost to Follow-up|0
455276|NCT00357370|1499228|P2|Cohort 2|Lost to Follow-up|1
455277|NCT00357370|1499229|P1|Cohort 2|Lost to Follow-up|0
455278|NCT00357370|1499227|P3|Cohort 2|Adverse Event|1
455279|NCT00357370|1499228|P2|Cohort 2|Adverse Event|1
455280|NCT00357370|1499229|P1|Cohort 2|Adverse Event|1
455281|NCT00357370|1499227|P3|Cohort 2|Lack of Efficacy|1
455282|NCT00357370|1499228|P2|Cohort 2|Lack of Efficacy|2
455283|NCT00357370|1499229|P1|Cohort 2|Lack of Efficacy|0
455284|NCT00357110|1499275|P2|Overall Study|Early study termination|5
455285|NCT00357110|1499276|P1|Overall Study|Early study termination|5
455286|NCT00357097|1499284|P2|Overall Study|Increase of RLS Symptoms|1
455287|NCT00357097|1499285|P1|Overall Study|Increase of RLS Symptoms|0
455288|NCT00357097|1499284|P2|Overall Study|Other|1
455289|NCT00357097|1499285|P1|Overall Study|Other|1
455290|NCT00357097|1499284|P2|Overall Study|Met Exclusion Criteria|1
455291|NCT00357097|1499285|P1|Overall Study|Met Exclusion Criteria|3
455292|NCT00357097|1499284|P2|Overall Study|Lack of Efficacy|8
455293|NCT00357097|1499285|P1|Overall Study|Lack of Efficacy|2
455294|NCT00357097|1499284|P2|Overall Study|Non-compliance|2
455295|NCT00357097|1499285|P1|Overall Study|Non-compliance|1
455296|NCT00357097|1499284|P2|Overall Study|Withdrawal by Subject|7
455297|NCT00357097|1499285|P1|Overall Study|Withdrawal by Subject|8
455298|NCT00357097|1499284|P2|Overall Study|Adverse Event|6
455299|NCT00357097|1499285|P1|Overall Study|Adverse Event|34
455300|NCT00357097|1499284|P2|Overall Study|Did not meet inclusion criteria|3
455301|NCT00357097|1499285|P1|Overall Study|Did not meet inclusion criteria|5
455302|NCT00357006|1499339|P3|Overall Study|Withdrawal by Subject|2
455303|NCT00357006|1499340|P2|Overall Study|Withdrawal by Subject|3
455304|NCT00357006|1499341|P1|Overall Study|Withdrawal by Subject|1
455305|NCT00357006|1499339|P3|Overall Study|Lost to Follow-up|1
455306|NCT00357006|1499340|P2|Overall Study|Lost to Follow-up|2
455307|NCT00357006|1499341|P1|Overall Study|Lost to Follow-up|1
455308|NCT00356915|1499352|P3|Overall Study|Miscellaneous reasons|3
455309|NCT00356915|1499353|P2|Overall Study|Miscellaneous reasons|8
455310|NCT00356915|1499354|P1|Overall Study|Miscellaneous reasons|11
455311|NCT00356915|1499352|P3|Overall Study|Adverse Event|8
455312|NCT00356915|1499353|P2|Overall Study|Adverse Event|31
455313|NCT00356915|1499354|P1|Overall Study|Adverse Event|21
455314|NCT00356915|1499352|P3|Overall Study|Physician Decision|0
455315|NCT00356915|1499353|P2|Overall Study|Physician Decision|2
455316|NCT00356915|1499354|P1|Overall Study|Physician Decision|0
455317|NCT00356915|1499352|P3|Overall Study|Administrative Decision|1
455318|NCT00356915|1499353|P2|Overall Study|Administrative Decision|0
455319|NCT00356915|1499354|P1|Overall Study|Administrative Decision|0
455320|NCT00356915|1499352|P3|Overall Study|Lost to Follow-up|14
455321|NCT00356915|1499353|P2|Overall Study|Lost to Follow-up|34
455322|NCT00356915|1499354|P1|Overall Study|Lost to Follow-up|27
455323|NCT00356915|1499352|P3|Overall Study|Lack of Efficacy|3
455324|NCT00356915|1499353|P2|Overall Study|Lack of Efficacy|0
455325|NCT00356915|1499354|P1|Overall Study|Lack of Efficacy|0
455326|NCT00356915|1499352|P3|Overall Study|Withdrawal by Subject|10
455327|NCT00356915|1499353|P2|Overall Study|Withdrawal by Subject|14
455328|NCT00356915|1499354|P1|Overall Study|Withdrawal by Subject|14
455329|NCT00356915|1499352|P3|Overall Study|Protocol Violation|2
455330|NCT00356915|1499353|P2|Overall Study|Protocol Violation|3
455331|NCT00356915|1499354|P1|Overall Study|Protocol Violation|2
455332|NCT00356915|1499352|P3|Overall Study|Non compliance|1
455333|NCT00356915|1499353|P2|Overall Study|Non compliance|2
455334|NCT00356915|1499354|P1|Overall Study|Non compliance|1
455335|NCT00356889|1499371|P1|Overall Study|Adverse Event|1
455336|NCT00356889|1499371|P1|Overall Study|Protocol Violation|2
455337|NCT00356863|1499380|P2|Overall Study|Lost to Follow-up|43
455338|NCT00356863|1499381|P1|Overall Study|Lost to Follow-up|76
455339|NCT00356863|1499380|P2|Overall Study|Death|32
455340|NCT00356863|1499381|P1|Overall Study|Death|16
455341|NCT00356811|1499407|P1|Overall Study|Site Closed during Follow-up|2
455342|NCT00356811|1499407|P1|Overall Study|Study Is Terminating|3
455343|NCT00356811|1499407|P1|Overall Study|Participant Could Not Make a Checkup|1
455344|NCT00356811|1499407|P1|Overall Study|Withdrawal by Subject|6
455345|NCT00356811|1499407|P1|Overall Study|Lost to Follow-up|2
455346|NCT00356811|1499407|P1|Overall Study|Death|35
455347|NCT00356603|1499422|P2|Overall Study|Other|3
455348|NCT00356603|1499423|P1|Overall Study|Other|6
455349|NCT00356590|1499437|P1|Overall Study|Other|52
455350|NCT00356590|1499437|P1|Overall Study|Response status|28
455351|NCT00356590|1499437|P1|Overall Study|Protocol issues|6
455352|NCT00356590|1499437|P1|Overall Study|Completed month 12 only|2
455353|NCT00356590|1499437|P1|Overall Study|Withdrawal by Subject|41
455354|NCT00356590|1499437|P1|Overall Study|Physician Decision|46
455355|NCT00356590|1499437|P1|Overall Study|Lost to Follow-up|35
455356|NCT00356590|1499437|P1|Overall Study|Death|10
455357|NCT00356590|1499437|P1|Overall Study|Adverse Event|54
455358|NCT00356525|1499473|P4|Overall Study|Sponsor Decision|1
455359|NCT00356525|1499474|P3|Overall Study|Sponsor Decision|0
455360|NCT00356525|1499475|P2|Overall Study|Sponsor Decision|0
455361|NCT00356525|1499476|P1|Overall Study|Sponsor Decision|0
455362|NCT00356525|1499473|P4|Overall Study|Death|1
455363|NCT00356525|1499474|P3|Overall Study|Death|0
455364|NCT00356525|1499475|P2|Overall Study|Death|0
455365|NCT00356525|1499476|P1|Overall Study|Death|0
455366|NCT00356525|1499473|P4|Overall Study|Withdrawal by Subject|3
455367|NCT00356525|1499474|P3|Overall Study|Withdrawal by Subject|0
455368|NCT00356525|1499475|P2|Overall Study|Withdrawal by Subject|1
455369|NCT00356525|1499476|P1|Overall Study|Withdrawal by Subject|1
455370|NCT00356525|1499473|P4|Overall Study|Protocol Entry Criteria Not Met|0
455371|NCT00356525|1499474|P3|Overall Study|Protocol Entry Criteria Not Met|0
455372|NCT00356525|1499475|P2|Overall Study|Protocol Entry Criteria Not Met|0
455373|NCT00356525|1499476|P1|Overall Study|Protocol Entry Criteria Not Met|1
455374|NCT00356525|1499473|P4|Overall Study|Physician Decision|1
455375|NCT00356525|1499474|P3|Overall Study|Physician Decision|2
455376|NCT00356525|1499475|P2|Overall Study|Physician Decision|2
455377|NCT00356525|1499476|P1|Overall Study|Physician Decision|2
455378|NCT00356525|1499473|P4|Overall Study|Lost to Follow-up|0
455379|NCT00356525|1499474|P3|Overall Study|Lost to Follow-up|0
455380|NCT00356525|1499475|P2|Overall Study|Lost to Follow-up|0
455381|NCT00356525|1499476|P1|Overall Study|Lost to Follow-up|1
455382|NCT00356525|1499473|P4|Overall Study|Adverse Event|1
455383|NCT00356525|1499474|P3|Overall Study|Adverse Event|1
455384|NCT00356525|1499475|P2|Overall Study|Adverse Event|3
455385|NCT00356525|1499476|P1|Overall Study|Adverse Event|1
455386|NCT00356525|1499473|P4|Overall Study|Progressive Disease|2
455387|NCT00356525|1499474|P3|Overall Study|Progressive Disease|4
455388|NCT00356525|1499475|P2|Overall Study|Progressive Disease|5
455389|NCT00356525|1499476|P1|Overall Study|Progressive Disease|8
455390|NCT00356421|1499517|P2|Overall Study|Not related to study drug|3
455391|NCT00356421|1499518|P1|Overall Study|Not related to study drug|5
455392|NCT00356421|1499517|P2|Overall Study|Related to study drug|12
455393|NCT00356421|1499518|P1|Overall Study|Related to study drug|15
455394|NCT00356421|1499517|P2|Overall Study|Withdrawal by Subject|2
455395|NCT00356421|1499518|P1|Overall Study|Withdrawal by Subject|9
455396|NCT00356421|1499517|P2|Overall Study|Lack of Efficacy|0
455397|NCT00356421|1499518|P1|Overall Study|Lack of Efficacy|3
455398|NCT00356408|1499558|P1|Overall Study|Other: Subject chose commerical dosing|1
455399|NCT00356408|1499558|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
455400|NCT00356408|1499558|P1|Overall Study|Other: Azathioprine stopped|1
455401|NCT00356408|1499558|P1|Overall Study|Other: Sponsor request|1
455402|NCT00356408|1499558|P1|Overall Study|Other: Principal investigator discretion|3
455403|NCT00356408|1499558|P1|Overall Study|Withdrawal by Subject|6
455404|NCT00356408|1499558|P1|Overall Study|Lost to Follow-up|2
455405|NCT00356408|1499558|P1|Overall Study|Lack of Efficacy|36
455406|NCT00356408|1499558|P1|Overall Study|Adverse Event|9
455407|NCT00356369|1499575|P2|Active Phase|Withdrawal by Subject|1
455408|NCT00356369|1499576|P1|Active Phase|Withdrawal by Subject|2
455409|NCT00356278|1499658|P3|Overall Study|Withdrawal by Subject|19
455410|NCT00356278|1499659|P2|Overall Study|Withdrawal by Subject|15
455411|NCT00356278|1499660|P1|Overall Study|Withdrawal by Subject|25
455412|NCT00356265|1499698|P3|Overall Study|Withdrawal by Subject|1
455413|NCT00356265|1499699|P2|Overall Study|Withdrawal by Subject|0
455414|NCT00356265|1499700|P1|Overall Study|Withdrawal by Subject|0
455415|NCT00356200|1499712|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
455416|NCT00356200|1499713|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
455417|NCT00356200|1499712|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
455418|NCT00356200|1499713|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
455419|NCT00356148|1499742|P2|Overall Study|Reoperation within 30 days|1
455420|NCT00356148|1499743|P1|Overall Study|Reoperation within 30 days|2
455421|NCT00356135|1499754|P3|Overall Study|Subject non-compliance|3
455422|NCT00356135|1499755|P2|Overall Study|Subject non-compliance|1
455423|NCT00356135|1499756|P1|Overall Study|Subject non-compliance|1
455424|NCT00356135|1499754|P3|Overall Study|Physician Decision|1
455425|NCT00356135|1499755|P2|Overall Study|Physician Decision|1
455426|NCT00356135|1499756|P1|Overall Study|Physician Decision|1
455427|NCT00356135|1499754|P3|Overall Study|Lost to Follow-up|1
455428|NCT00356135|1499755|P2|Overall Study|Lost to Follow-up|0
455429|NCT00356135|1499756|P1|Overall Study|Lost to Follow-up|0
455430|NCT00356135|1499754|P3|Overall Study|Adverse Event|0
455431|NCT00356135|1499755|P2|Overall Study|Adverse Event|0
455432|NCT00356135|1499756|P1|Overall Study|Adverse Event|1
455433|NCT00356135|1499754|P3|Overall Study|Protocol Violation|0
455434|NCT00356135|1499755|P2|Overall Study|Protocol Violation|0
455435|NCT00356135|1499756|P1|Overall Study|Protocol Violation|1
455436|NCT00356122|1499778|P1|FOLLOW-UP|Other|2
455437|NCT00356122|1499778|P1|FOLLOW-UP|Lost to Follow-up|2
455438|NCT00356122|1499778|P1|FOLLOW-UP|Death|37
455439|NCT00356122|1499778|P1|TREATMENT|Did not receive study medication|1
455440|NCT00356122|1499778|P1|TREATMENT|Other|4
455441|NCT00356122|1499778|P1|TREATMENT|Subject's request|4
455442|NCT00356122|1499778|P1|TREATMENT|Adverse Event|10
455443|NCT00356122|1499778|P1|TREATMENT|Lack of Efficacy|26
455444|NCT00355784|1499886|P3|Overall Study|Withdrawal by Subject|2
455445|NCT00355784|1499887|P2|Overall Study|Withdrawal by Subject|0
455446|NCT00355784|1499888|P1|Overall Study|Withdrawal by Subject|0
455447|NCT00355615|1499937|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
455448|NCT00355615|1499938|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
455449|NCT00355615|1499939|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
455450|NCT00355615|1499940|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
455451|NCT00355615|1499941|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
455452|NCT00355615|1499937|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
455453|NCT00355615|1499938|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
455454|NCT00355615|1499939|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
455455|NCT00355615|1499940|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
455456|NCT00355615|1499941|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
455457|NCT00355615|1499937|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
455458|NCT00355615|1499938|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
455459|NCT00355615|1499939|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
455460|NCT00355615|1499940|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
455461|NCT00355615|1499941|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
455462|NCT00355615|1499937|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
455463|NCT00355615|1499938|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
455464|NCT00355615|1499939|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
455465|NCT00355615|1499940|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
455466|NCT00355615|1499941|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
455467|NCT00355615|1499937|P5|Randomized Double Blind Period|Protocol Violation|0
455468|NCT00355615|1499938|P4|Randomized Double Blind Period|Protocol Violation|1
455469|NCT00355615|1499939|P3|Randomized Double Blind Period|Protocol Violation|1
455470|NCT00355615|1499940|P2|Randomized Double Blind Period|Protocol Violation|0
455471|NCT00355615|1499941|P1|Randomized Double Blind Period|Protocol Violation|0
455472|NCT00355615|1499937|P5|Randomized Double Blind Period|Adverse Event|0
455473|NCT00355615|1499938|P4|Randomized Double Blind Period|Adverse Event|0
455474|NCT00355615|1499939|P3|Randomized Double Blind Period|Adverse Event|0
455475|NCT00355615|1499940|P2|Randomized Double Blind Period|Adverse Event|0
455476|NCT00355615|1499941|P1|Randomized Double Blind Period|Adverse Event|1
455477|NCT00355472|1500000|P1|Overall Study|Physician Decision|1
455478|NCT00355368|1500046|P2|Overall Study|cardiac arrest prior to intubation|2
455479|NCT00355368|1500047|P1|Overall Study|cardiac arrest prior to intubation|2
455480|NCT00355368|1500046|P2|Overall Study|Protocol Violation|7
455481|NCT00355368|1500047|P1|Overall Study|Protocol Violation|8
455482|NCT00355342|1500061|P2|Overall Study|Use of protocol excluded medication|1
455483|NCT00355342|1500062|P1|Overall Study|Use of protocol excluded medication|0
455484|NCT00355342|1500061|P2|Overall Study|Protocol Violation|1
455485|NCT00355342|1500062|P1|Overall Study|Protocol Violation|0
455486|NCT00355342|1500061|P2|Overall Study|Study management|1
455487|NCT00355342|1500062|P1|Overall Study|Study management|0
455488|NCT00355342|1500061|P2|Overall Study|Participant discontinued study drug|1
455489|NCT00355342|1500062|P1|Overall Study|Participant discontinued study drug|0
455490|NCT00355342|1500061|P2|Overall Study|Participant relocated|1
455491|NCT00355342|1500062|P1|Overall Study|Participant relocated|0
455492|NCT00355342|1500061|P2|Overall Study|Withdrawal by participant and physician|0
455493|NCT00355342|1500062|P1|Overall Study|Withdrawal by participant and physician|1
455494|NCT00355342|1500061|P2|Overall Study|Non-compliance with Dexa scans|0
455495|NCT00355342|1500062|P1|Overall Study|Non-compliance with Dexa scans|1
455496|NCT00355342|1500061|P2|Overall Study|Dispensed wrong study drug kit|0
455497|NCT00355342|1500062|P1|Overall Study|Dispensed wrong study drug kit|1
455498|NCT00355342|1500061|P2|Overall Study|COPD exacerbation|1
455499|NCT00355342|1500062|P1|Overall Study|COPD exacerbation|1
455500|NCT00355342|1500061|P2|Overall Study|Use of prohibited medication|0
455501|NCT00355342|1500062|P1|Overall Study|Use of prohibited medication|1
455502|NCT00355342|1500061|P2|Overall Study|Overcompliant-PL discretion|0
455503|NCT00355342|1500062|P1|Overall Study|Overcompliant-PL discretion|1
455504|NCT00355342|1500061|P2|Overall Study|Sponsor terminated study|2
455505|NCT00355342|1500062|P1|Overall Study|Sponsor terminated study|2
455506|NCT00355342|1500061|P2|Overall Study|Withdrawal by Subject|11
455507|NCT00355342|1500062|P1|Overall Study|Withdrawal by Subject|14
455508|NCT00355342|1500061|P2|Overall Study|Lost to Follow-up|2
455509|NCT00355342|1500062|P1|Overall Study|Lost to Follow-up|4
455510|NCT00355342|1500061|P2|Overall Study|Adverse Event|15
455511|NCT00355342|1500062|P1|Overall Study|Adverse Event|13
455512|NCT00355147|1500089|P2|Overall Study|Withdrawal by Subject|12
455513|NCT00355147|1500090|P1|Overall Study|Withdrawal by Subject|8
455514|NCT00355147|1500089|P2|Overall Study|Lost to Follow-up|8
455515|NCT00355147|1500090|P1|Overall Study|Lost to Follow-up|10
455516|NCT00355134|1500109|P5|Extension Phase|Protocol Violation|0
455517|NCT00355134|1500110|P4|Extension Phase|Protocol Violation|1
455518|NCT00355134|1500111|P3|Extension Phase|Protocol Violation|0
455519|NCT00355134|1500112|P2|Extension Phase|Protocol Violation|0
455520|NCT00355134|1500113|P1|Extension Phase|Protocol Violation|0
455521|NCT00355134|1500109|P5|Extension Phase|Abnormal test procedure result(s)|1
455522|NCT00355134|1500110|P4|Extension Phase|Abnormal test procedure result(s)|0
455523|NCT00355134|1500111|P3|Extension Phase|Abnormal test procedure result(s)|0
455524|NCT00355134|1500112|P2|Extension Phase|Abnormal test procedure result(s)|1
455525|NCT00355134|1500113|P1|Extension Phase|Abnormal test procedure result(s)|0
455526|NCT00355134|1500109|P5|Extension Phase|Unsatisfactory therapeutic effect|1
455527|NCT00355134|1500110|P4|Extension Phase|Unsatisfactory therapeutic effect|0
455528|NCT00355134|1500111|P3|Extension Phase|Unsatisfactory therapeutic effect|0
455529|NCT00355134|1500112|P2|Extension Phase|Unsatisfactory therapeutic effect|4
455530|NCT00355134|1500113|P1|Extension Phase|Unsatisfactory therapeutic effect|3
455531|NCT00355134|1500109|P5|Extension Phase|Administrative problems|1
455532|NCT00355134|1500110|P4|Extension Phase|Administrative problems|1
455533|NCT00355134|1500111|P3|Extension Phase|Administrative problems|0
455534|NCT00355134|1500112|P2|Extension Phase|Administrative problems|4
455535|NCT00355134|1500113|P1|Extension Phase|Administrative problems|2
455536|NCT00355134|1500109|P5|Extension Phase|Abnormal laboratory value(s)|2
455537|NCT00355134|1500110|P4|Extension Phase|Abnormal laboratory value(s)|2
455538|NCT00355134|1500111|P3|Extension Phase|Abnormal laboratory value(s)|0
455539|NCT00355134|1500112|P2|Extension Phase|Abnormal laboratory value(s)|2
455540|NCT00355134|1500113|P1|Extension Phase|Abnormal laboratory value(s)|4
455541|NCT00355134|1500109|P5|Extension Phase|Lost to Follow-up|4
455542|NCT00355134|1500110|P4|Extension Phase|Lost to Follow-up|2
455543|NCT00355134|1500111|P3|Extension Phase|Lost to Follow-up|0
455544|NCT00355134|1500112|P2|Extension Phase|Lost to Follow-up|6
455545|NCT00355134|1500113|P1|Extension Phase|Lost to Follow-up|2
455546|NCT00355134|1500109|P5|Extension Phase|Adverse Event|5
455547|NCT00355134|1500110|P4|Extension Phase|Adverse Event|3
455548|NCT00355134|1500111|P3|Extension Phase|Adverse Event|0
455549|NCT00355134|1500112|P2|Extension Phase|Adverse Event|9
455550|NCT00355134|1500113|P1|Extension Phase|Adverse Event|13
455551|NCT00355134|1500109|P5|Extension Phase|Withdrawal by Subject|5
455552|NCT00355134|1500110|P4|Extension Phase|Withdrawal by Subject|7
455553|NCT00355134|1500111|P3|Extension Phase|Withdrawal by Subject|0
455554|NCT00355134|1500112|P2|Extension Phase|Withdrawal by Subject|11
455555|NCT00355134|1500113|P1|Extension Phase|Withdrawal by Subject|7
455556|NCT00355134|1500109|P5|Core Phase|Condition no longer requires study drug|0
455557|NCT00355134|1500110|P4|Core Phase|Condition no longer requires study drug|0
455558|NCT00355134|1500111|P3|Core Phase|Condition no longer requires study drug|1
455559|NCT00355134|1500112|P2|Core Phase|Condition no longer requires study drug|0
455560|NCT00355134|1500113|P1|Core Phase|Condition no longer requires study drug|1
455561|NCT00355134|1500109|P5|Core Phase|Abnormal test procedure result(s)|0
455562|NCT00355134|1500110|P4|Core Phase|Abnormal test procedure result(s)|0
455563|NCT00355134|1500111|P3|Core Phase|Abnormal test procedure result(s)|1
455564|NCT00355134|1500112|P2|Core Phase|Abnormal test procedure result(s)|2
455565|NCT00355134|1500113|P1|Core Phase|Abnormal test procedure result(s)|1
455566|NCT00355134|1500109|P5|Core Phase|Protocol Violation|0
455567|NCT00355134|1500110|P4|Core Phase|Protocol Violation|0
455568|NCT00355134|1500111|P3|Core Phase|Protocol Violation|2
455569|NCT00355134|1500112|P2|Core Phase|Protocol Violation|2
455570|NCT00355134|1500113|P1|Core Phase|Protocol Violation|3
455571|NCT00355134|1500109|P5|Core Phase|Administrative problems|0
455572|NCT00355134|1500110|P4|Core Phase|Administrative problems|0
455573|NCT00355134|1500111|P3|Core Phase|Administrative problems|5
455574|NCT00355134|1500112|P2|Core Phase|Administrative problems|3
455575|NCT00355134|1500113|P1|Core Phase|Administrative problems|5
455576|NCT00355134|1500109|P5|Core Phase|Unsatisfactory therapeutic effect|0
455577|NCT00355134|1500110|P4|Core Phase|Unsatisfactory therapeutic effect|0
455578|NCT00355134|1500111|P3|Core Phase|Unsatisfactory therapeutic effect|17
455579|NCT00355134|1500112|P2|Core Phase|Unsatisfactory therapeutic effect|6
455580|NCT00355134|1500113|P1|Core Phase|Unsatisfactory therapeutic effect|10
455581|NCT00355134|1500109|P5|Core Phase|Abnormal laboratory value(s)|0
455582|NCT00355134|1500110|P4|Core Phase|Abnormal laboratory value(s)|0
455583|NCT00355134|1500111|P3|Core Phase|Abnormal laboratory value(s)|2
455584|NCT00355134|1500112|P2|Core Phase|Abnormal laboratory value(s)|14
455585|NCT00355134|1500113|P1|Core Phase|Abnormal laboratory value(s)|19
455586|NCT00355134|1500109|P5|Core Phase|Lost to Follow-up|0
455587|NCT00355134|1500110|P4|Core Phase|Lost to Follow-up|0
455588|NCT00355134|1500111|P3|Core Phase|Lost to Follow-up|21
455589|NCT00355134|1500112|P2|Core Phase|Lost to Follow-up|13
455590|NCT00355134|1500113|P1|Core Phase|Lost to Follow-up|17
455591|NCT00355134|1500109|P5|Core Phase|Adverse Event|0
455592|NCT00355134|1500110|P4|Core Phase|Adverse Event|0
455593|NCT00355134|1500111|P3|Core Phase|Adverse Event|16
455594|NCT00355134|1500112|P2|Core Phase|Adverse Event|22
455595|NCT00355134|1500113|P1|Core Phase|Adverse Event|28
455596|NCT00355134|1500109|P5|Core Phase|Withdrawal by Subject|0
455597|NCT00355134|1500110|P4|Core Phase|Withdrawal by Subject|0
455598|NCT00355134|1500111|P3|Core Phase|Withdrawal by Subject|35
455599|NCT00355134|1500112|P2|Core Phase|Withdrawal by Subject|24
455600|NCT00355134|1500113|P1|Core Phase|Withdrawal by Subject|35
455601|NCT00355121|1500156|P3|Overall Study|Serious adverse events|0
455602|NCT00355121|1500157|P2|Overall Study|Serious adverse events|2
455603|NCT00355121|1500158|P1|Overall Study|Serious adverse events|0
455604|NCT00355121|1500156|P3|Overall Study|Withdrawal by Subject|2
455605|NCT00355121|1500157|P2|Overall Study|Withdrawal by Subject|10
455606|NCT00355121|1500158|P1|Overall Study|Withdrawal by Subject|9
455607|NCT00355121|1500156|P3|Overall Study|Lost to Follow-up|1
455608|NCT00355121|1500157|P2|Overall Study|Lost to Follow-up|7
455609|NCT00355121|1500158|P1|Overall Study|Lost to Follow-up|4
455610|NCT00355121|1500156|P3|Overall Study|Protocol Violation|1
455611|NCT00355121|1500157|P2|Overall Study|Protocol Violation|9
455612|NCT00355121|1500158|P1|Overall Study|Protocol Violation|7
455613|NCT00355121|1500156|P3|Overall Study|Adverse Event|0
455614|NCT00355121|1500157|P2|Overall Study|Adverse Event|1
455615|NCT00355121|1500158|P1|Overall Study|Adverse Event|0
455616|NCT00355121|1500156|P3|Overall Study|Did not receive study vaccine|1
455617|NCT00355121|1500157|P2|Overall Study|Did not receive study vaccine|0
455618|NCT00355121|1500158|P1|Overall Study|Did not receive study vaccine|1
455619|NCT00355082|1500189|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
455620|NCT00355082|1500190|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
455621|NCT00355082|1500191|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
455622|NCT00355082|1500189|P3|Continuation Phase|Scheduling Error|0
455623|NCT00355082|1500190|P2|Continuation Phase|Scheduling Error|0
455624|NCT00355082|1500191|P1|Continuation Phase|Scheduling Error|1
455625|NCT00355082|1500189|P3|Continuation Phase|Site Closed by Sponsor|0
455626|NCT00355082|1500190|P2|Continuation Phase|Site Closed by Sponsor|0
455627|NCT00355082|1500191|P1|Continuation Phase|Site Closed by Sponsor|8
455628|NCT00355082|1500189|P3|Continuation Phase|Lack of Efficacy|0
455629|NCT00355082|1500190|P2|Continuation Phase|Lack of Efficacy|0
455630|NCT00355082|1500191|P1|Continuation Phase|Lack of Efficacy|5
455631|NCT00355082|1500189|P3|Continuation Phase|Withdrawal by Subject|0
455632|NCT00355082|1500190|P2|Continuation Phase|Withdrawal by Subject|0
455633|NCT00355082|1500191|P1|Continuation Phase|Withdrawal by Subject|4
455634|NCT00355082|1500189|P3|Continuation Phase|Protocol Violation|1
455635|NCT00355082|1500190|P2|Continuation Phase|Protocol Violation|0
455636|NCT00355082|1500191|P1|Continuation Phase|Protocol Violation|1
455637|NCT00355082|1500189|P3|Continuation Phase|Lost to Follow-up|1
455638|NCT00355082|1500190|P2|Continuation Phase|Lost to Follow-up|0
455639|NCT00355082|1500191|P1|Continuation Phase|Lost to Follow-up|2
455640|NCT00355082|1500189|P3|Continuation Phase|Adverse Event|1
455641|NCT00355082|1500190|P2|Continuation Phase|Adverse Event|0
455642|NCT00355082|1500191|P1|Continuation Phase|Adverse Event|2
455643|NCT00355082|1500189|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
455644|NCT00355082|1500190|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
455645|NCT00355082|1500191|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
455646|NCT00355082|1500189|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
455647|NCT00355082|1500190|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
455648|NCT00355082|1500191|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
455649|NCT00355082|1500189|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
455650|NCT00355082|1500190|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
455651|NCT00355082|1500191|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
455652|NCT00355082|1500189|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
455653|NCT00355082|1500190|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
455654|NCT00355082|1500191|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
455655|NCT00355082|1500189|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
455656|NCT00355082|1500190|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
455657|NCT00355082|1500191|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
455658|NCT00355082|1500189|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
455659|NCT00355082|1500190|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
455660|NCT00355082|1500191|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
455661|NCT00355030|1500213|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
455662|NCT00355030|1500214|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
455663|NCT00355030|1500213|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
455664|NCT00355030|1500214|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
455665|NCT00355030|1500213|P2|Study Period 1 Treatment|Other|6
455666|NCT00355030|1500214|P1|Study Period 1 Treatment|Other|2
455667|NCT00355030|1500213|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
455668|NCT00355030|1500214|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
455669|NCT00355030|1500213|P2|Study Period 1 Treatment|Sponsor Decision|32
455670|NCT00355030|1500214|P1|Study Period 1 Treatment|Sponsor Decision|34
455671|NCT00355030|1500213|P2|Study Period 1 Treatment|Physician Decision|1
455672|NCT00355030|1500214|P1|Study Period 1 Treatment|Physician Decision|0
455673|NCT00355030|1500213|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
455674|NCT00355030|1500214|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
455675|NCT00355030|1500213|P2|Study Period 1 Treatment|Withdrawal by Subject|1
455676|NCT00355030|1500214|P1|Study Period 1 Treatment|Withdrawal by Subject|4
455677|NCT00355030|1500213|P2|Study Period 1 Treatment|Lost to Follow-up|0
455678|NCT00355030|1500214|P1|Study Period 1 Treatment|Lost to Follow-up|3
455679|NCT00355030|1500213|P2|Study Period 1 Treatment|Adverse Event|1
455680|NCT00355030|1500214|P1|Study Period 1 Treatment|Adverse Event|1
455681|NCT00354835|1500253|P2|Overall Study|Refusal of further therapy|8
455682|NCT00354835|1500254|P1|Overall Study|Refusal of further therapy|3
455683|NCT00354835|1500253|P2|Overall Study|Adverse Event|0
455684|NCT00354835|1500254|P1|Overall Study|Adverse Event|6
455685|NCT00354835|1500253|P2|Overall Study|Disease progression or relapse|22
455686|NCT00354835|1500254|P1|Overall Study|Disease progression or relapse|15
455687|NCT00354835|1500253|P2|Overall Study|Ineligible|16
455688|NCT00354835|1500254|P1|Overall Study|Ineligible|17
455689|NCT00354835|1500253|P2|Overall Study|Withdrawal by Subject|1
455690|NCT00354835|1500254|P1|Overall Study|Withdrawal by Subject|2
455691|NCT00354835|1500253|P2|Overall Study|Physician Decision|13
455692|NCT00354835|1500254|P1|Overall Study|Physician Decision|8
455693|NCT00354835|1500253|P2|Overall Study|Death|1
455694|NCT00354835|1500254|P1|Overall Study|Death|1
455695|NCT00354744|1500293|P1|Overall Study|Withdrawal by Subject|14
455696|NCT00354744|1500293|P1|Overall Study|Physician Decision|11
455697|NCT00354744|1500293|P1|Overall Study|Lost to Follow-up|2
455698|NCT00354744|1500293|P1|Overall Study|Lack of Efficacy|11
455699|NCT00354744|1500293|P1|Overall Study|Death|2
455700|NCT00354744|1500293|P1|Overall Study|Adverse Event|2
455701|NCT00354679|1500298|P1|Overall Study|Patient Not Treated|1
455702|NCT00354614|1500307|P1|Overall Study|Lack of Efficacy|28
455703|NCT00354601|1500311|P1|Overall Study|progression|1
455704|NCT00354601|1500311|P1|Overall Study|Protocol Violation|1
455705|NCT00354432|1500331|P4|Overall Study|Off/Toxicity|5
455706|NCT00354432|1500332|P3|Overall Study|Off/Toxicity|5
455707|NCT00354432|1500333|P2|Overall Study|Off/Toxicity|7
455708|NCT00354432|1500334|P1|Overall Study|Off/Toxicity|3
455709|NCT00354432|1500331|P4|Overall Study|Adverse Event|5
455710|NCT00354432|1500332|P3|Overall Study|Adverse Event|5
455711|NCT00354432|1500333|P2|Overall Study|Adverse Event|1
455712|NCT00354432|1500334|P1|Overall Study|Adverse Event|3
455713|NCT00354341|1500350|P2|Overall Study|Other|2
455714|NCT00354341|1500351|P1|Overall Study|Other|1
455715|NCT00354341|1500350|P2|Overall Study|Failure to return|1
455716|NCT00354341|1500351|P1|Overall Study|Failure to return|0
455717|NCT00354341|1500350|P2|Overall Study|Refused treatment|2
455718|NCT00354341|1500351|P1|Overall Study|Refused treatment|1
455719|NCT00354341|1500350|P2|Overall Study|Death|2
455720|NCT00354341|1500351|P1|Overall Study|Death|0
455721|NCT00354341|1500350|P2|Overall Study|Adverse Event|0
455722|NCT00354341|1500351|P1|Overall Study|Adverse Event|1
455723|NCT00354172|1500367|P1|Overall Study|Did not receive transplant|1
455724|NCT00354159|1500387|P2|Long-term Follow-up|Study Closed|34
455725|NCT00354159|1500388|P1|Long-term Follow-up|Study Closed|29
455726|NCT00354159|1500387|P2|Long-term Follow-up|Death|11
455727|NCT00354159|1500388|P1|Long-term Follow-up|Death|14
455728|NCT00354159|1500387|P2|Long-term Follow-up|Lost to Follow-up|0
455729|NCT00354159|1500388|P1|Long-term Follow-up|Lost to Follow-up|1
455730|NCT00354159|1500387|P2|Long-term Follow-up|Physician Decision|122
455731|NCT00354159|1500388|P1|Long-term Follow-up|Physician Decision|127
455732|NCT00354159|1500387|P2|Long-term Follow-up|Withdrawal by Subject|9
455733|NCT00354159|1500388|P1|Long-term Follow-up|Withdrawal by Subject|9
455734|NCT00354159|1500387|P2|Randomized Study Period|Death|9
455735|NCT00354159|1500388|P1|Randomized Study Period|Death|7
455736|NCT00354159|1500387|P2|Randomized Study Period|Lost to Follow-up|0
455737|NCT00354159|1500388|P1|Randomized Study Period|Lost to Follow-up|4
455738|NCT00354159|1500387|P2|Randomized Study Period|Physician Decision|10
455739|NCT00354159|1500388|P1|Randomized Study Period|Physician Decision|6
455740|NCT00354159|1500387|P2|Randomized Study Period|Withdrawal by Subject|3
455741|NCT00354159|1500388|P1|Randomized Study Period|Withdrawal by Subject|5
455742|NCT00354107|1500431|P1|Overall Study|Withdrawal by Subject|1
455743|NCT00354107|1500431|P1|Overall Study|Physician Decision|2
455744|NCT00354107|1500431|P1|Overall Study|Adverse Event|2
455745|NCT00354029|1500441|P2|Overall Study|Protocol Violation|2
455746|NCT00354029|1500442|P1|Overall Study|Protocol Violation|4
455747|NCT00353873|1500454|P2|Overall Study|Withdrawal by Subject|1
455748|NCT00353873|1500455|P1|Overall Study|Withdrawal by Subject|1
455749|NCT00353873|1500454|P2|Overall Study|Physician Decision|0
455750|NCT00353873|1500455|P1|Overall Study|Physician Decision|2
455751|NCT00353873|1500454|P2|Overall Study|Adverse Event|0
455752|NCT00353873|1500455|P1|Overall Study|Adverse Event|1
455753|NCT00353873|1500454|P2|Overall Study|Exacerbation|0
455754|NCT00353873|1500455|P1|Overall Study|Exacerbation|1
455755|NCT00353873|1500454|P2|Overall Study|Protocol Violation|2
455756|NCT00353873|1500455|P1|Overall Study|Protocol Violation|1
455757|NCT00353704|1500484|P2|Overall Study|Protocol Violation|1
455758|NCT00353704|1500485|P1|Overall Study|Protocol Violation|3
455759|NCT00353496|1500520|P2|Overall Study|Not otherwise specified|2
455760|NCT00353496|1500521|P1|Overall Study|Not otherwise specified|4
455761|NCT00353496|1500520|P2|Overall Study|Physician Decision|9
455762|NCT00353496|1500521|P1|Overall Study|Physician Decision|6
455763|NCT00353496|1500520|P2|Overall Study|Withdrawal by Subject|4
455764|NCT00353496|1500521|P1|Overall Study|Withdrawal by Subject|3
455765|NCT00353496|1500520|P2|Overall Study|Protocol Violation|2
455766|NCT00353496|1500521|P1|Overall Study|Protocol Violation|2
455767|NCT00353496|1500520|P2|Overall Study|Adverse Event|0
455768|NCT00353496|1500521|P1|Overall Study|Adverse Event|1
455769|NCT00353366|1500574|P1|Overall Study|Other|135
455770|NCT00353366|1500574|P1|Overall Study|Adverse Event|8
455771|NCT00353262|1500595|P1|Overall Study|Break from Chemotherapy|1
455772|NCT00353262|1500595|P1|Overall Study|Surgery|4
455773|NCT00353262|1500595|P1|Overall Study|Progression|1
455774|NCT00353262|1500595|P1|Overall Study|Insufficient Therapeutic Response|13
455775|NCT00353262|1500595|P1|Overall Study|Withdrawal by Subject|2
455776|NCT00353262|1500595|P1|Overall Study|Adverse Event|8
455777|NCT00352846|1500645|P2|Overall Study|Death|1
455778|NCT00352846|1500646|P1|Overall Study|Death|0
455779|NCT00352846|1500645|P2|Overall Study|Non-compliance|0
455780|NCT00352846|1500646|P1|Overall Study|Non-compliance|2
455781|NCT00352846|1500645|P2|Overall Study|Ineligible|2
455782|NCT00352846|1500646|P1|Overall Study|Ineligible|3
455783|NCT00352846|1500645|P2|Overall Study|Withdrawal by Subject|8
455784|NCT00352846|1500646|P1|Overall Study|Withdrawal by Subject|3
455785|NCT00352846|1500645|P2|Overall Study|Disease progression|2
455786|NCT00352846|1500646|P1|Overall Study|Disease progression|0
455787|NCT00352755|1500657|P1|Overall Study|Adverse Event|1
455788|NCT00352755|1500657|P1|Overall Study|Physician Decision|1
455789|NCT00352690|1500667|P2|Overall Study|Determined to be ineligible|0
455790|NCT00352690|1500668|P1|Overall Study|Determined to be ineligible|2
455791|NCT00352664|1500688|P2|Overall Study|Withdrawal by Subject|0
455792|NCT00352664|1500689|P1|Overall Study|Withdrawal by Subject|7
455793|NCT00352534|1500706|P7|Final Risk Group Assignment|Death|0
455794|NCT00352534|1500707|P6|Final Risk Group Assignment|Death|2
455795|NCT00352534|1500708|P5|Final Risk Group Assignment|Death|0
455796|NCT00352534|1500709|P4|Final Risk Group Assignment|Death|0
455797|NCT00352534|1500710|P3|Final Risk Group Assignment|Death|0
455798|NCT00352534|1500711|P2|Final Risk Group Assignment|Death|0
455799|NCT00352534|1500712|P1|Final Risk Group Assignment|Death|0
455800|NCT00352534|1500706|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
455801|NCT00352534|1500707|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
455802|NCT00352534|1500708|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
455803|NCT00352534|1500709|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
455804|NCT00352534|1500710|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
455805|NCT00352534|1500711|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
455806|NCT00352534|1500712|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
455807|NCT00352534|1500706|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
455808|NCT00352534|1500707|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
455809|NCT00352534|1500708|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
455810|NCT00352534|1500709|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
455811|NCT00352534|1500710|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
455812|NCT00352534|1500711|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
455813|NCT00352534|1500712|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
455814|NCT00352534|1500706|P7|Final Risk Group Assignment|Ineligible|0
455815|NCT00352534|1500707|P6|Final Risk Group Assignment|Ineligible|13
455816|NCT00352534|1500708|P5|Final Risk Group Assignment|Ineligible|0
455817|NCT00352534|1500709|P4|Final Risk Group Assignment|Ineligible|1
455818|NCT00352534|1500710|P3|Final Risk Group Assignment|Ineligible|3
455819|NCT00352534|1500711|P2|Final Risk Group Assignment|Ineligible|0
455820|NCT00352534|1500712|P1|Final Risk Group Assignment|Ineligible|0
455821|NCT00352534|1500706|P7|Final Risk Group Assignment|Withdrawal by Subject|0
455822|NCT00352534|1500707|P6|Final Risk Group Assignment|Withdrawal by Subject|3
455823|NCT00352534|1500708|P5|Final Risk Group Assignment|Withdrawal by Subject|0
455824|NCT00352534|1500709|P4|Final Risk Group Assignment|Withdrawal by Subject|0
455825|NCT00352534|1500710|P3|Final Risk Group Assignment|Withdrawal by Subject|0
455826|NCT00352534|1500711|P2|Final Risk Group Assignment|Withdrawal by Subject|0
455827|NCT00352534|1500712|P1|Final Risk Group Assignment|Withdrawal by Subject|0
455828|NCT00352534|1500706|P7|Final Risk Group Assignment|Physician Decision|0
455829|NCT00352534|1500707|P6|Final Risk Group Assignment|Physician Decision|8
455830|NCT00352534|1500708|P5|Final Risk Group Assignment|Physician Decision|0
455831|NCT00352534|1500709|P4|Final Risk Group Assignment|Physician Decision|0
455832|NCT00352534|1500710|P3|Final Risk Group Assignment|Physician Decision|0
455833|NCT00352534|1500711|P2|Final Risk Group Assignment|Physician Decision|0
455834|NCT00352534|1500712|P1|Final Risk Group Assignment|Physician Decision|0
455835|NCT00352534|1500706|P7|Final Risk Group Assignment|Lack of Efficacy|0
455836|NCT00352534|1500707|P6|Final Risk Group Assignment|Lack of Efficacy|19
455837|NCT00352534|1500708|P5|Final Risk Group Assignment|Lack of Efficacy|1
455838|NCT00352534|1500709|P4|Final Risk Group Assignment|Lack of Efficacy|2
455839|NCT00352534|1500710|P3|Final Risk Group Assignment|Lack of Efficacy|0
455840|NCT00352534|1500711|P2|Final Risk Group Assignment|Lack of Efficacy|0
455841|NCT00352534|1500712|P1|Final Risk Group Assignment|Lack of Efficacy|0
455842|NCT00352534|1500706|P7|Initial Staging|Ineligible|0
455843|NCT00352534|1500707|P6|Initial Staging|Ineligible|0
455844|NCT00352534|1500708|P5|Initial Staging|Ineligible|0
455845|NCT00352534|1500709|P4|Initial Staging|Ineligible|0
455846|NCT00352534|1500710|P3|Initial Staging|Ineligible|0
455847|NCT00352534|1500711|P2|Initial Staging|Ineligible|9
455848|NCT00352534|1500712|P1|Initial Staging|Ineligible|8
455849|NCT00352417|1500729|P2|Overall Study|Schedule Change|1
455850|NCT00352417|1500730|P1|Overall Study|Schedule Change|2
455851|NCT00352417|1500729|P2|Overall Study|Lost to Follow-up|0
455852|NCT00352417|1500730|P1|Overall Study|Lost to Follow-up|1
455853|NCT00352417|1500729|P2|Overall Study|Withdrawal by Subject|2
455854|NCT00352417|1500730|P1|Overall Study|Withdrawal by Subject|1
455855|NCT00352417|1500729|P2|Overall Study|Protocol Violation|2
455856|NCT00352417|1500730|P1|Overall Study|Protocol Violation|0
455857|NCT00352417|1500729|P2|Overall Study|Adverse Event|0
455858|NCT00352417|1500730|P1|Overall Study|Adverse Event|1
455859|NCT00352365|1500744|P1|Maintenance Therapy|Not eligible|4
455860|NCT00352365|1500744|P1|Maintenance Therapy|Not protocol specified|3
455861|NCT00352365|1500744|P1|Maintenance Therapy|Death|2
455862|NCT00352365|1500744|P1|Maintenance Therapy|Progression/Relapse|3
455863|NCT00352365|1500744|P1|Induction Therapy|Death before starting protocol therapy|1
455864|NCT00352365|1500744|P1|Induction Therapy|Not eligible|3
455865|NCT00352365|1500744|P1|Induction Therapy|Not protocol specified|1
455866|NCT00352365|1500744|P1|Induction Therapy|Death|7
455867|NCT00352365|1500744|P1|Induction Therapy|Progression/Relapse|8
455868|NCT00352365|1500744|P1|Induction Therapy|Adverse Event|7
455869|NCT00352118|1500754|P1|Overall Study|Physician Decision|4
455870|NCT00352105|1500764|P1|Overall Study|Protocol Violation|2
455871|NCT00352105|1500764|P1|Overall Study|Adverse Event|19
455872|NCT00352105|1500764|P1|Overall Study|Lack of Efficacy|9
455873|NCT00352105|1500764|P1|Overall Study|Withdrawal by Subject|5
455874|NCT00352105|1500764|P1|Overall Study|Death|5
455875|NCT00352053|1500775|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
455876|NCT00352053|1500776|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
455877|NCT00352053|1500775|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
455878|NCT00352053|1500776|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
455879|NCT00352053|1500775|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
455880|NCT00352053|1500776|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
455881|NCT00352053|1500775|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
455882|NCT00352053|1500776|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
455883|NCT00352053|1500775|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
455884|NCT00352053|1500776|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
455885|NCT00352053|1500775|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
455886|NCT00352053|1500776|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
455887|NCT00352053|1500775|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
455888|NCT00352053|1500776|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
455889|NCT00352053|1500775|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
455890|NCT00352053|1500776|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
455891|NCT00352053|1500775|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
455892|NCT00352053|1500776|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
455893|NCT00352053|1500775|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
455894|NCT00352053|1500776|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
455895|NCT00352053|1500775|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
455896|NCT00352053|1500776|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
455897|NCT00352053|1500775|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
455898|NCT00352053|1500776|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
455899|NCT00352053|1500775|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
455900|NCT00352053|1500776|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
455901|NCT00352027|1500943|P1|Overall Study|Progressive disease|3
455902|NCT00351819|1501231|P2|Overall Study|Enrolled in another trial|1
455903|NCT00351819|1501232|P1|Overall Study|Enrolled in another trial|0
455904|NCT00351819|1501231|P2|Overall Study|Incarcerated|1
455905|NCT00351819|1501232|P1|Overall Study|Incarcerated|0
455906|NCT00351819|1501231|P2|Overall Study|Non-compliance|1
455907|NCT00351819|1501232|P1|Overall Study|Non-compliance|0
455908|NCT00351819|1501231|P2|Overall Study|Unprofessional behavior|0
455909|NCT00351819|1501232|P1|Overall Study|Unprofessional behavior|1
455910|NCT00351819|1501231|P2|Overall Study|Traumatic ankle fracture|0
455911|NCT00351819|1501232|P1|Overall Study|Traumatic ankle fracture|1
455912|NCT00351819|1501231|P2|Overall Study|Elevated PSA|1
455913|NCT00351819|1501232|P1|Overall Study|Elevated PSA|1
455914|NCT00351819|1501231|P2|Overall Study|Withdrawal by Subject|4
455915|NCT00351819|1501232|P1|Overall Study|Withdrawal by Subject|0
455916|NCT00351819|1501231|P2|Overall Study|Lost to Follow-up|4
455917|NCT00351819|1501232|P1|Overall Study|Lost to Follow-up|4
455918|NCT00351533|1501303|P2|Overall Study|Withdrawal by Subject|1
455919|NCT00351533|1501304|P1|Overall Study|Withdrawal by Subject|0
455920|NCT00351533|1501303|P2|Overall Study|Physician Decision|1
455921|NCT00351533|1501304|P1|Overall Study|Physician Decision|0
455922|NCT00351533|1501303|P2|Overall Study|Lost to Follow-up|3
455923|NCT00351533|1501304|P1|Overall Study|Lost to Follow-up|1
455924|NCT00351533|1501303|P2|Overall Study|Extubated before first BAL|0
455925|NCT00351533|1501304|P1|Overall Study|Extubated before first BAL|1
455926|NCT00351468|1501364|P1|Overall Study|Protocol Violation|3
455927|NCT00351468|1501364|P1|Overall Study|Lost to Follow-up|4
455928|NCT00351468|1501364|P1|Overall Study|Non-compliance|8
455929|NCT00351468|1501364|P1|Overall Study|Lack of Efficacy|32
455930|NCT00351468|1501364|P1|Overall Study|Various -follow up w clinical team|39
455931|NCT00351468|1501364|P1|Overall Study|Withdrawal by Subject|39
455932|NCT00351468|1501364|P1|Overall Study|Adverse Event|42
455933|NCT00351377|1501388|P1|Overall Study|Unsatisfactory therapeutic effect|1
455934|NCT00351377|1501388|P1|Overall Study|Death|1
455935|NCT00351377|1501388|P1|Overall Study|Adverse Event|5
455936|NCT00351351|1501402|P2|Overall Study|surgical access pbs; device issues|4
455937|NCT00351351|1501403|P1|Overall Study|surgical access pbs; device issues|9
455938|NCT00351273|1501429|P3|Overall Study|Lost to Follow-up|5
455939|NCT00351273|1501430|P2|Overall Study|Lost to Follow-up|2
455940|NCT00351273|1501431|P1|Overall Study|Lost to Follow-up|1
455941|NCT00350870|1501459|P4|Overall Study|Physician Decision|1
455942|NCT00350870|1501460|P3|Overall Study|Physician Decision|1
455943|NCT00350870|1501461|P2|Overall Study|Physician Decision|0
455944|NCT00350870|1501462|P1|Overall Study|Physician Decision|1
455945|NCT00350870|1501459|P4|Overall Study|Withdrawal by Subject|14
455946|NCT00350870|1501460|P3|Overall Study|Withdrawal by Subject|15
455947|NCT00350870|1501461|P2|Overall Study|Withdrawal by Subject|17
455948|NCT00350870|1501462|P1|Overall Study|Withdrawal by Subject|21
455949|NCT00350844|1501476|P1|Overall Study|Lost to Follow-up|1
455950|NCT00350792|1501480|P1|Overall Study|Lack of Efficacy|11
455951|NCT00350792|1501480|P1|Overall Study|Physician Decision|2
455952|NCT00350792|1501480|P1|Overall Study|Withdrawal by Subject|4
455953|NCT00350792|1501480|P1|Overall Study|Protocol Violation|1
455954|NCT00350792|1501480|P1|Overall Study|Death Not Study Drug Related|2
455955|NCT00350792|1501480|P1|Overall Study|Death from Study Drug Toxicity|1
455956|NCT00350792|1501480|P1|Overall Study|Death from Study Disease|1
455957|NCT00350792|1501480|P1|Overall Study|Adverse Event|11
455958|NCT00350779|1501490|P2|Overall Study|Non-compliance with study procedures|1
455959|NCT00350779|1501491|P1|Overall Study|Non-compliance with study procedures|0
455960|NCT00350779|1501490|P2|Overall Study|Patient Moved|1
455961|NCT00350779|1501491|P1|Overall Study|Patient Moved|2
455962|NCT00350779|1501490|P2|Overall Study|Withdrawal by Subject|8
455963|NCT00350779|1501491|P1|Overall Study|Withdrawal by Subject|9
455964|NCT00350779|1501490|P2|Overall Study|Protocol Violation|1
455965|NCT00350779|1501491|P1|Overall Study|Protocol Violation|3
455966|NCT00350779|1501490|P2|Overall Study|Physician Decision|4
455967|NCT00350779|1501491|P1|Overall Study|Physician Decision|2
455968|NCT00350779|1501490|P2|Overall Study|Lost to Follow-up|0
455969|NCT00350779|1501491|P1|Overall Study|Lost to Follow-up|2
455970|NCT00350779|1501490|P2|Overall Study|Lack of Efficacy|4
455971|NCT00350779|1501491|P1|Overall Study|Lack of Efficacy|0
455972|NCT00350779|1501490|P2|Overall Study|Adverse Event|2
455973|NCT00350779|1501491|P1|Overall Study|Adverse Event|4
455974|NCT00350727|1501512|P3|Phase II|Enrolled in Rollover Study|1
455975|NCT00350727|1501513|P2|Phase II|Enrolled in Rollover Study|0
455976|NCT00350727|1501514|P1|Phase II|Enrolled in Rollover Study|0
455977|NCT00350727|1501512|P3|Phase II|Sponsor Terminated Study|1
455978|NCT00350727|1501513|P2|Phase II|Sponsor Terminated Study|0
455979|NCT00350727|1501514|P1|Phase II|Sponsor Terminated Study|0
455980|NCT00350727|1501512|P3|Phase II|Death|2
455981|NCT00350727|1501513|P2|Phase II|Death|0
455982|NCT00350727|1501514|P1|Phase II|Death|0
455983|NCT00350727|1501512|P3|Phase II|Adverse Event|1
455984|NCT00350727|1501513|P2|Phase II|Adverse Event|1
455985|NCT00350727|1501514|P1|Phase II|Adverse Event|0
455986|NCT00350727|1501512|P3|Phase II|Withdrawal by Subject|1
455987|NCT00350727|1501513|P2|Phase II|Withdrawal by Subject|2
455988|NCT00350727|1501514|P1|Phase II|Withdrawal by Subject|0
455989|NCT00350727|1501512|P3|Phase II|Clinical Deterioration|0
455990|NCT00350727|1501513|P2|Phase II|Clinical Deterioration|1
455991|NCT00350727|1501514|P1|Phase II|Clinical Deterioration|0
455992|NCT00350727|1501512|P3|Phase II|Disease Progression|16
455993|NCT00350727|1501513|P2|Phase II|Disease Progression|15
455994|NCT00350727|1501514|P1|Phase II|Disease Progression|0
455995|NCT00350727|1501512|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
455996|NCT00350727|1501513|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
455997|NCT00350727|1501514|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
455998|NCT00350727|1501512|P3|Phase I: Dose Escalation|Physician Decision|0
455999|NCT00350727|1501513|P2|Phase I: Dose Escalation|Physician Decision|0
456000|NCT00350727|1501514|P1|Phase I: Dose Escalation|Physician Decision|1
456001|NCT00350727|1501512|P3|Phase I: Dose Escalation|Death|0
456002|NCT00350727|1501513|P2|Phase I: Dose Escalation|Death|0
456003|NCT00350727|1501514|P1|Phase I: Dose Escalation|Death|1
456004|NCT00350727|1501512|P3|Phase I: Dose Escalation|Lack of Efficacy|0
456005|NCT00350727|1501513|P2|Phase I: Dose Escalation|Lack of Efficacy|0
456006|NCT00350727|1501514|P1|Phase I: Dose Escalation|Lack of Efficacy|25
456007|NCT00350727|1501512|P3|Phase I: Dose Escalation|Adverse Event|0
456008|NCT00350727|1501513|P2|Phase I: Dose Escalation|Adverse Event|0
456009|NCT00350727|1501514|P1|Phase I: Dose Escalation|Adverse Event|4
456010|NCT00350636|1501658|P2|Overall Study|Other|2
456011|NCT00350636|1501659|P1|Overall Study|Other|1
456012|NCT00350636|1501658|P2|Overall Study|Physician Decision|2
456013|NCT00350636|1501659|P1|Overall Study|Physician Decision|0
456014|NCT00350636|1501658|P2|Overall Study|Lost to Follow-up|8
456015|NCT00350636|1501659|P1|Overall Study|Lost to Follow-up|9
456016|NCT00350636|1501658|P2|Overall Study|Withdrawal by Subject|17
456017|NCT00350636|1501659|P1|Overall Study|Withdrawal by Subject|13
456018|NCT00350636|1501658|P2|Overall Study|Protocol Violation|3
456019|NCT00350636|1501659|P1|Overall Study|Protocol Violation|1
456020|NCT00350636|1501658|P2|Overall Study|Adverse Event|13
456021|NCT00350636|1501659|P1|Overall Study|Adverse Event|19
456022|NCT00350623|1501678|P3|Overall Study|patient traveling outside the country|1
456023|NCT00350623|1501679|P2|Overall Study|patient traveling outside the country|0
456024|NCT00350623|1501680|P1|Overall Study|patient traveling outside the country|0
456025|NCT00350623|1501678|P3|Overall Study|Withdrawal by Subject|1
456026|NCT00350623|1501679|P2|Overall Study|Withdrawal by Subject|1
456027|NCT00350623|1501680|P1|Overall Study|Withdrawal by Subject|0
456028|NCT00350623|1501678|P3|Overall Study|Lost to Follow-up|4
456029|NCT00350623|1501679|P2|Overall Study|Lost to Follow-up|3
456030|NCT00350623|1501680|P1|Overall Study|Lost to Follow-up|8
456031|NCT00350545|1501688|P1|Overall Study|Withdrawal by Subject|2
456032|NCT00350519|1501707|P2|Overall Study|Withdrawal by Subject|2
456033|NCT00350519|1501708|P1|Overall Study|Withdrawal by Subject|3
456034|NCT00350519|1501707|P2|Overall Study|Protocol Violation|2
456035|NCT00350519|1501708|P1|Overall Study|Protocol Violation|1
456036|NCT00350519|1501707|P2|Overall Study|Physician Decision|1
456037|NCT00350519|1501708|P1|Overall Study|Physician Decision|0
456038|NCT00350519|1501707|P2|Overall Study|Death|1
456039|NCT00350519|1501708|P1|Overall Study|Death|0
456040|NCT00350402|1501722|P2|Overall Study|Lost to Follow-up|1
456041|NCT00350402|1501723|P1|Overall Study|Lost to Follow-up|1
456042|NCT00350272|1501741|P2|Open-Label 84 Week Treatment|Sponsor decision|1
456043|NCT00350272|1501742|P1|Open-Label 84 Week Treatment|Sponsor decision|2
456044|NCT00350272|1501741|P2|Open-Label 84 Week Treatment|Physician Decision|2
456045|NCT00350272|1501742|P1|Open-Label 84 Week Treatment|Physician Decision|1
456046|NCT00350272|1501741|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
456047|NCT00350272|1501742|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
456048|NCT00350272|1501741|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
456049|NCT00350272|1501742|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
456050|NCT00350272|1501741|P2|Open-Label 84 Week Treatment|Adverse Event|1
456051|NCT00350272|1501742|P1|Open-Label 84 Week Treatment|Adverse Event|2
456052|NCT00350272|1501741|P2|Blinded 12 Week Treatment|Sponsor decision|1
456053|NCT00350272|1501742|P1|Blinded 12 Week Treatment|Sponsor decision|0
456054|NCT00350272|1501741|P2|Blinded 12 Week Treatment|Physician Decision|1
456055|NCT00350272|1501742|P1|Blinded 12 Week Treatment|Physician Decision|2
456056|NCT00350272|1501741|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
456057|NCT00350272|1501742|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
456058|NCT00350272|1501741|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
456059|NCT00350272|1501742|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
456060|NCT00350272|1501741|P2|Blinded 12 Week Treatment|Death|0
456061|NCT00350272|1501742|P1|Blinded 12 Week Treatment|Death|1
456062|NCT00350272|1501741|P2|Blinded 12 Week Treatment|Adverse Event|0
456063|NCT00350272|1501742|P1|Blinded 12 Week Treatment|Adverse Event|1
456064|NCT00350207|1501764|P3|Overall Study|Other|1
456065|NCT00350207|1501765|P2|Overall Study|Other|3
456066|NCT00350207|1501766|P1|Overall Study|Other|1
456067|NCT00350207|1501764|P3|Overall Study|Withdrawal by Subject|1
456068|NCT00350207|1501765|P2|Overall Study|Withdrawal by Subject|1
456069|NCT00350207|1501766|P1|Overall Study|Withdrawal by Subject|0
456070|NCT00350207|1501764|P3|Overall Study|Lost to Follow-up|1
456071|NCT00350207|1501765|P2|Overall Study|Lost to Follow-up|0
456072|NCT00350207|1501766|P1|Overall Study|Lost to Follow-up|1
456073|NCT00350207|1501764|P3|Overall Study|Lack of Efficacy|2
456074|NCT00350207|1501765|P2|Overall Study|Lack of Efficacy|0
456075|NCT00350207|1501766|P1|Overall Study|Lack of Efficacy|1
456076|NCT00350207|1501764|P3|Overall Study|Adverse Event|2
456077|NCT00350207|1501765|P2|Overall Study|Adverse Event|2
456078|NCT00350207|1501766|P1|Overall Study|Adverse Event|5
456079|NCT00349921|1501980|P4|First Spinal Injection|Adverse Event|0
456080|NCT00349921|1501981|P3|First Spinal Injection|Adverse Event|1
456081|NCT00349921|1501982|P2|First Spinal Injection|Adverse Event|0
456082|NCT00349921|1501983|P1|First Spinal Injection|Adverse Event|0
456083|NCT00349921|1501980|P4|First Spinal Injection|Physician Decision|0
456084|NCT00349921|1501981|P3|First Spinal Injection|Physician Decision|0
456085|NCT00349921|1501982|P2|First Spinal Injection|Physician Decision|0
456086|NCT00349921|1501983|P1|First Spinal Injection|Physician Decision|1
456087|NCT00349908|1501994|P2|Overall Study|Withdrawal by Subject|4
456088|NCT00349908|1501995|P1|Overall Study|Withdrawal by Subject|0
456089|NCT00349752|1502021|P2|Overall Study|Other:History of squamous cell carcinoma|0
456090|NCT00349752|1502022|P1|Overall Study|Other:History of squamous cell carcinoma|1
456091|NCT00349752|1502021|P2|Overall Study|Other: Inadvertently unblinded|0
456092|NCT00349752|1502022|P1|Overall Study|Other: Inadvertently unblinded|1
456093|NCT00349752|1502021|P2|Overall Study|Other: Ineligible|0
456094|NCT00349752|1502022|P1|Overall Study|Other: Ineligible|1
456095|NCT00349752|1502021|P2|Overall Study|Other: Patient's steroid use|0
456096|NCT00349752|1502022|P1|Overall Study|Other: Patient's steroid use|1
456097|NCT00349752|1502021|P2|Overall Study|Other: Patient stopped steroids|1
456098|NCT00349752|1502022|P1|Overall Study|Other: Patient stopped steroids|0
456099|NCT00349752|1502021|P2|Overall Study|Other: Non compliance|1
456100|NCT00349752|1502022|P1|Overall Study|Other: Non compliance|0
456101|NCT00349752|1502021|P2|Overall Study|Other: Required exclusionary medication|1
456102|NCT00349752|1502022|P1|Overall Study|Other: Required exclusionary medication|0
456103|NCT00349752|1502021|P2|Overall Study|Personal reasons|5
456104|NCT00349752|1502022|P1|Overall Study|Personal reasons|6
456105|NCT00349752|1502021|P2|Overall Study|Lost to Follow-up|2
456106|NCT00349752|1502022|P1|Overall Study|Lost to Follow-up|4
456107|NCT00349752|1502021|P2|Overall Study|Lack of Efficacy|42
456108|NCT00349752|1502022|P1|Overall Study|Lack of Efficacy|37
456109|NCT00349752|1502021|P2|Overall Study|Adverse Event|12
456110|NCT00349752|1502022|P1|Overall Study|Adverse Event|8
456111|NCT00349622|1502075|P2|Overall Study|Withdrawal by Subject|9
456112|NCT00349622|1502076|P1|Overall Study|Withdrawal by Subject|5
456113|NCT00349622|1502075|P2|Overall Study|Lost to Follow-up|1
456114|NCT00349622|1502076|P1|Overall Study|Lost to Follow-up|5
456115|NCT00349622|1502075|P2|Overall Study|Death|86
456116|NCT00349622|1502076|P1|Overall Study|Death|168
456117|NCT00349349|1502113|P3|Overall Study|New Malignancy (Bladder Cancer)|0
456118|NCT00349349|1502114|P2|Overall Study|New Malignancy (Bladder Cancer)|1
456119|NCT00349349|1502115|P1|Overall Study|New Malignancy (Bladder Cancer)|0
456120|NCT00349349|1502113|P3|Overall Study|No Response|0
456121|NCT00349349|1502114|P2|Overall Study|No Response|3
456122|NCT00349349|1502115|P1|Overall Study|No Response|0
456123|NCT00349349|1502113|P3|Overall Study|Physician Decision|1
456124|NCT00349349|1502114|P2|Overall Study|Physician Decision|2
456125|NCT00349349|1502115|P1|Overall Study|Physician Decision|1
456126|NCT00349349|1502113|P3|Overall Study|Participant Reduced General Condition|0
456127|NCT00349349|1502114|P2|Overall Study|Participant Reduced General Condition|1
456128|NCT00349349|1502115|P1|Overall Study|Participant Reduced General Condition|0
456129|NCT00349349|1502113|P3|Overall Study|Other Treatment Selected|0
456130|NCT00349349|1502114|P2|Overall Study|Other Treatment Selected|0
456131|NCT00349349|1502115|P1|Overall Study|Other Treatment Selected|2
456132|NCT00349349|1502113|P3|Overall Study|Death|1
456133|NCT00349349|1502114|P2|Overall Study|Death|10
456134|NCT00349349|1502115|P1|Overall Study|Death|13
456135|NCT00349349|1502113|P3|Overall Study|Withdrawn due to Disease Progression|1
456136|NCT00349349|1502114|P2|Overall Study|Withdrawn due to Disease Progression|37
456137|NCT00349349|1502115|P1|Overall Study|Withdrawn due to Disease Progression|27
456138|NCT00349349|1502113|P3|Overall Study|Withdrawal by Subject|1
456139|NCT00349349|1502114|P2|Overall Study|Withdrawal by Subject|2
456140|NCT00349349|1502115|P1|Overall Study|Withdrawal by Subject|5
456141|NCT00349349|1502113|P3|Overall Study|Adverse Event|2
456142|NCT00349349|1502114|P2|Overall Study|Adverse Event|6
456143|NCT00349349|1502115|P1|Overall Study|Adverse Event|5
456144|NCT00348933|1502204|P1|Overall Study|Adverse Event|7
456145|NCT00348933|1502204|P1|Overall Study|Protocol Violation|2
456146|NCT00348933|1502204|P1|Overall Study|Lost to Follow-up|6
456147|NCT00348933|1502204|P1|Overall Study|Withdrawal by Subject|10
456148|NCT00348881|1502212|P2|Overall Study|Serious Adverse Event|2
456149|NCT00348881|1502213|P1|Overall Study|Serious Adverse Event|0
456150|NCT00348881|1502212|P2|Overall Study|Adverse Event|0
456151|NCT00348881|1502213|P1|Overall Study|Adverse Event|2
456152|NCT00348881|1502212|P2|Overall Study|Withdrawal by Subject|4
456153|NCT00348881|1502213|P1|Overall Study|Withdrawal by Subject|3
456154|NCT00348881|1502212|P2|Overall Study|Lost to Follow-up|6
456155|NCT00348881|1502213|P1|Overall Study|Lost to Follow-up|12
456156|NCT00348816|1502225|P1|Overall Study|Noncompliance with radiation treatment|1
456157|NCT00348790|1502232|P1|Completed Treatment|Unable to travel to study site|1
456158|NCT00348790|1502232|P1|Completed Treatment|Required surgery|2
456159|NCT00348790|1502232|P1|Completed Treatment|Adverse Event|4
456160|NCT00348790|1502232|P1|Completed Treatment|Disease progression|14
456161|NCT00348790|1502232|P1|Completed Treatment|Withdrawal by Subject|4
456162|NCT00348686|1502237|P1|Overall Study|Multiple Reasons|8
456163|NCT00348686|1502237|P1|Overall Study|Lost to Follow-up|2
456164|NCT00348686|1502237|P1|Overall Study|Protocol Violation|6
456165|NCT00348686|1502237|P1|Overall Study|Adverse Event|5
456166|NCT00348686|1502237|P1|Overall Study|Withdrawal by Subject|45
456167|NCT00348673|1502254|P9|Stage 1|Randomized but not Treated|0
456168|NCT00348673|1502255|P8|Stage 1|Randomized but not Treated|0
456169|NCT00348673|1502256|P7|Stage 1|Randomized but not Treated|0
456170|NCT00348673|1502257|P6|Stage 1|Randomized but not Treated|0
456171|NCT00348673|1502258|P5|Stage 1|Randomized but not Treated|0
456172|NCT00348673|1502259|P4|Stage 1|Randomized but not Treated|0
456173|NCT00348673|1502260|P3|Stage 1|Randomized but not Treated|1
456174|NCT00348673|1502261|P2|Stage 1|Randomized but not Treated|0
456175|NCT00348673|1502262|P1|Stage 1|Randomized but not Treated|0
456176|NCT00348556|1502309|P1|Overall Study|Adverse Event|1
456177|NCT00348374|1502316|P2|Overall Study|randomized but did not receive treatment|7
456178|NCT00348374|1502317|P1|Overall Study|randomized but did not receive treatment|0
456179|NCT00348374|1502316|P2|Overall Study|ongoing at date of cutoff|1
456180|NCT00348374|1502317|P1|Overall Study|ongoing at date of cutoff|1
456181|NCT00348374|1502316|P2|Overall Study|Other|12
456182|NCT00348374|1502317|P1|Overall Study|Other|11
456183|NCT00348374|1502316|P2|Overall Study|Withdrawal by Subject|5
456184|NCT00348374|1502317|P1|Overall Study|Withdrawal by Subject|5
456185|NCT00348374|1502316|P2|Overall Study|Lost to Follow-up|3
456186|NCT00348374|1502317|P1|Overall Study|Lost to Follow-up|1
456187|NCT00348374|1502316|P2|Overall Study|Adverse Event|4
456188|NCT00348374|1502317|P1|Overall Study|Adverse Event|1
456189|NCT00348348|1502364|P2|Overall Study|Adverse event probably related to study|0
456190|NCT00348348|1502365|P1|Overall Study|Adverse event probably related to study|1
456191|NCT00348348|1502364|P2|Overall Study|Worsening of BC - Unlikely related|2
456192|NCT00348348|1502365|P1|Overall Study|Worsening of BC - Unlikely related|1
456193|NCT00348348|1502364|P2|Overall Study|Worsening of BC - Unrelated to study|3
456194|NCT00348348|1502365|P1|Overall Study|Worsening of BC - Unrelated to study|0
456195|NCT00348348|1502364|P2|Overall Study|Dissallowed Meds - possibly releated|1
456196|NCT00348348|1502365|P1|Overall Study|Dissallowed Meds - possibly releated|1
456197|NCT00348348|1502364|P2|Overall Study|Dissallowed Meds - unlikley related|1
456198|NCT00348348|1502365|P1|Overall Study|Dissallowed Meds - unlikley related|1
456199|NCT00348348|1502364|P2|Overall Study|Dissallowed Meds - unrelated to study|3
456200|NCT00348348|1502365|P1|Overall Study|Dissallowed Meds - unrelated to study|1
456201|NCT00348348|1502364|P2|Overall Study|Not specified|4
456202|NCT00348348|1502365|P1|Overall Study|Not specified|7
456203|NCT00348348|1502364|P2|Overall Study|Withdrawal by Subject|1
456204|NCT00348348|1502365|P1|Overall Study|Withdrawal by Subject|4
456205|NCT00348348|1502364|P2|Overall Study|Lost to Follow-up|10
456206|NCT00348348|1502365|P1|Overall Study|Lost to Follow-up|8
456207|NCT00348348|1502364|P2|Overall Study|Lack of Efficacy|1
456208|NCT00348348|1502365|P1|Overall Study|Lack of Efficacy|1
456209|NCT00348348|1502364|P2|Overall Study|Adverse event - unrelated to study drug|1
456210|NCT00348348|1502365|P1|Overall Study|Adverse event - unrelated to study drug|0
456211|NCT00348309|1502380|P3|Overall Study|HCV career|1
456212|NCT00348309|1502381|P2|Overall Study|HCV career|0
456213|NCT00348309|1502382|P1|Overall Study|HCV career|0
456214|NCT00348309|1502380|P3|Overall Study|Cardiologist recommendations|1
456215|NCT00348309|1502381|P2|Overall Study|Cardiologist recommendations|0
456216|NCT00348309|1502382|P1|Overall Study|Cardiologist recommendations|0
456217|NCT00348309|1502380|P3|Overall Study|ECG abnormal|2
456218|NCT00348309|1502381|P2|Overall Study|ECG abnormal|0
456219|NCT00348309|1502382|P1|Overall Study|ECG abnormal|0
456220|NCT00348309|1502380|P3|Overall Study|Adverse event not attended|1
456221|NCT00348309|1502381|P2|Overall Study|Adverse event not attended|0
456222|NCT00348309|1502382|P1|Overall Study|Adverse event not attended|0
456223|NCT00348309|1502380|P3|Overall Study|Site closure|1
456224|NCT00348309|1502381|P2|Overall Study|Site closure|0
456225|NCT00348309|1502382|P1|Overall Study|Site closure|0
456226|NCT00348309|1502380|P3|Overall Study|Increased dose of Aricept|1
456227|NCT00348309|1502381|P2|Overall Study|Increased dose of Aricept|0
456228|NCT00348309|1502382|P1|Overall Study|Increased dose of Aricept|0
456229|NCT00348309|1502380|P3|Overall Study|Medical Monitor decision|1
456230|NCT00348309|1502381|P2|Overall Study|Medical Monitor decision|0
456231|NCT00348309|1502382|P1|Overall Study|Medical Monitor decision|0
456232|NCT00348309|1502380|P3|Overall Study|Forgot often medication|0
456233|NCT00348309|1502381|P2|Overall Study|Forgot often medication|1
456234|NCT00348309|1502382|P1|Overall Study|Forgot often medication|0
456235|NCT00348309|1502380|P3|Overall Study|Sponsor refuseal|1
456236|NCT00348309|1502381|P2|Overall Study|Sponsor refuseal|1
456237|NCT00348309|1502382|P1|Overall Study|Sponsor refuseal|0
456238|NCT00348309|1502380|P3|Overall Study|Participant was hospitalized|0
456239|NCT00348309|1502381|P2|Overall Study|Participant was hospitalized|1
456240|NCT00348309|1502382|P1|Overall Study|Participant was hospitalized|0
456241|NCT00348309|1502380|P3|Overall Study|A foul of exclusion criteria|0
456242|NCT00348309|1502381|P2|Overall Study|A foul of exclusion criteria|1
456243|NCT00348309|1502382|P1|Overall Study|A foul of exclusion criteria|0
456244|NCT00348309|1502380|P3|Overall Study|Ineffectiveness of treatment|0
456245|NCT00348309|1502381|P2|Overall Study|Ineffectiveness of treatment|1
456246|NCT00348309|1502382|P1|Overall Study|Ineffectiveness of treatment|0
456247|NCT00348309|1502380|P3|Overall Study|Decision of sponsor|0
456248|NCT00348309|1502381|P2|Overall Study|Decision of sponsor|0
456249|NCT00348309|1502382|P1|Overall Study|Decision of sponsor|1
456250|NCT00348309|1502380|P3|Overall Study|Participant died|1
456251|NCT00348309|1502381|P2|Overall Study|Participant died|1
456252|NCT00348309|1502382|P1|Overall Study|Participant died|2
456253|NCT00348309|1502380|P3|Overall Study|Did not appear in time for Visit 3|0
456254|NCT00348309|1502381|P2|Overall Study|Did not appear in time for Visit 3|0
456255|NCT00348309|1502382|P1|Overall Study|Did not appear in time for Visit 3|1
456256|NCT00348309|1502380|P3|Overall Study|Worsening of alzheimer|1
456257|NCT00348309|1502381|P2|Overall Study|Worsening of alzheimer|0
456258|NCT00348309|1502382|P1|Overall Study|Worsening of alzheimer|1
456259|NCT00348309|1502380|P3|Overall Study|Cognitive and behaviour worsening|0
456260|NCT00348309|1502381|P2|Overall Study|Cognitive and behaviour worsening|0
456261|NCT00348309|1502382|P1|Overall Study|Cognitive and behaviour worsening|2
456262|NCT00348309|1502380|P3|Overall Study|Worsened neurodegenerative disease|0
456263|NCT00348309|1502381|P2|Overall Study|Worsened neurodegenerative disease|0
456264|NCT00348309|1502382|P1|Overall Study|Worsened neurodegenerative disease|1
456265|NCT00348309|1502380|P3|Overall Study|No disponibility of medication|0
456266|NCT00348309|1502381|P2|Overall Study|No disponibility of medication|0
456267|NCT00348309|1502382|P1|Overall Study|No disponibility of medication|1
456268|NCT00348309|1502380|P3|Overall Study|Principal investigator's decision|0
456269|NCT00348309|1502381|P2|Overall Study|Principal investigator's decision|0
456270|NCT00348309|1502382|P1|Overall Study|Principal investigator's decision|1
456271|NCT00348309|1502380|P3|Overall Study|PI closing medical practice|0
456272|NCT00348309|1502381|P2|Overall Study|PI closing medical practice|0
456273|NCT00348309|1502382|P1|Overall Study|PI closing medical practice|1
456274|NCT00348309|1502380|P3|Overall Study|Unable to complete ET visit|0
456275|NCT00348309|1502381|P2|Overall Study|Unable to complete ET visit|0
456276|NCT00348309|1502382|P1|Overall Study|Unable to complete ET visit|1
456277|NCT00348309|1502380|P3|Overall Study|Caregiver withdrawal|7
456278|NCT00348309|1502381|P2|Overall Study|Caregiver withdrawal|0
456279|NCT00348309|1502382|P1|Overall Study|Caregiver withdrawal|3
456280|NCT00348309|1502380|P3|Overall Study|Use of prohibited medication|2
456281|NCT00348309|1502381|P2|Overall Study|Use of prohibited medication|2
456282|NCT00348309|1502382|P1|Overall Study|Use of prohibited medication|5
456283|NCT00348309|1502380|P3|Overall Study|Caregiver sick|0
456284|NCT00348309|1502381|P2|Overall Study|Caregiver sick|0
456285|NCT00348309|1502382|P1|Overall Study|Caregiver sick|1
456286|NCT00348309|1502380|P3|Overall Study|Wrong bottle allocated|0
456287|NCT00348309|1502381|P2|Overall Study|Wrong bottle allocated|0
456288|NCT00348309|1502382|P1|Overall Study|Wrong bottle allocated|1
456289|NCT00348309|1502380|P3|Overall Study|Lack of insight, dementia|0
456290|NCT00348309|1502381|P2|Overall Study|Lack of insight, dementia|0
456291|NCT00348309|1502382|P1|Overall Study|Lack of insight, dementia|1
456292|NCT00348309|1502380|P3|Overall Study|Death of caregiver|1
456293|NCT00348309|1502381|P2|Overall Study|Death of caregiver|0
456294|NCT00348309|1502382|P1|Overall Study|Death of caregiver|1
456295|NCT00348309|1502380|P3|Overall Study|Non-compliance|8
456296|NCT00348309|1502381|P2|Overall Study|Non-compliance|6
456297|NCT00348309|1502382|P1|Overall Study|Non-compliance|8
456298|NCT00348309|1502380|P3|Overall Study|Withdrawal by Subject|40
456299|NCT00348309|1502381|P2|Overall Study|Withdrawal by Subject|37
456300|NCT00348309|1502382|P1|Overall Study|Withdrawal by Subject|33
456301|NCT00348309|1502380|P3|Overall Study|Protocol Violation|7
456302|NCT00348309|1502381|P2|Overall Study|Protocol Violation|12
456303|NCT00348309|1502382|P1|Overall Study|Protocol Violation|7
456304|NCT00348309|1502380|P3|Overall Study|Lost to Follow-up|4
456305|NCT00348309|1502381|P2|Overall Study|Lost to Follow-up|7
456306|NCT00348309|1502382|P1|Overall Study|Lost to Follow-up|6
456307|NCT00348309|1502380|P3|Overall Study|Adverse Event|63
456308|NCT00348309|1502381|P2|Overall Study|Adverse Event|28
456309|NCT00348309|1502382|P1|Overall Study|Adverse Event|56
456310|NCT00348283|1502455|P2|Open Label|Sponsor decision|1
456311|NCT00348283|1502456|P1|Open Label|Sponsor decision|0
456312|NCT00348283|1502455|P2|Open Label|Pregnancy|1
456313|NCT00348283|1502456|P1|Open Label|Pregnancy|0
456314|NCT00348283|1502455|P2|Open Label|Subject moved to the United States|1
456315|NCT00348283|1502456|P1|Open Label|Subject moved to the United States|0
456316|NCT00348283|1502455|P2|Open Label|Administrative reasons|5
456317|NCT00348283|1502456|P1|Open Label|Administrative reasons|0
456318|NCT00348283|1502455|P2|Open Label|Lack of Efficacy|13
456319|NCT00348283|1502456|P1|Open Label|Lack of Efficacy|0
456320|NCT00348283|1502455|P2|Open Label|Lost to Follow-up|1
456321|NCT00348283|1502456|P1|Open Label|Lost to Follow-up|0
456322|NCT00348283|1502455|P2|Open Label|Withdrawal by Subject|4
456323|NCT00348283|1502456|P1|Open Label|Withdrawal by Subject|0
456324|NCT00348283|1502455|P2|Open Label|Adverse Event|8
456325|NCT00348283|1502456|P1|Open Label|Adverse Event|0
456326|NCT00348283|1502455|P2|Double Blind|Pregnancy|1
456327|NCT00348283|1502456|P1|Double Blind|Pregnancy|0
456328|NCT00348283|1502455|P2|Double Blind|Lack of Efficacy|2
456329|NCT00348283|1502456|P1|Double Blind|Lack of Efficacy|2
456330|NCT00348283|1502455|P2|Double Blind|Protocol Violation|1
456331|NCT00348283|1502456|P1|Double Blind|Protocol Violation|0
456332|NCT00348283|1502455|P2|Double Blind|Withdrawal by Subject|1
456333|NCT00348283|1502456|P1|Double Blind|Withdrawal by Subject|1
456334|NCT00348283|1502455|P2|Double Blind|Adverse Event|5
456335|NCT00348283|1502456|P1|Double Blind|Adverse Event|2
456336|NCT00348283|1502455|P2|Induction|Protocol Violation|4
456337|NCT00348283|1502456|P1|Induction|Protocol Violation|0
456338|NCT00348283|1502455|P2|Induction|Adverse Event|2
456339|NCT00348283|1502456|P1|Induction|Adverse Event|0
456340|NCT00348140|1502475|P3|Overall Study|Memory declined|1
456341|NCT00348140|1502476|P2|Overall Study|Memory declined|0
456342|NCT00348140|1502477|P1|Overall Study|Memory declined|0
456343|NCT00348140|1502475|P3|Overall Study|Exclusion criteria met|1
456344|NCT00348140|1502476|P2|Overall Study|Exclusion criteria met|0
456345|NCT00348140|1502477|P1|Overall Study|Exclusion criteria met|0
456346|NCT00348140|1502475|P3|Overall Study|Participant died|0
456347|NCT00348140|1502476|P2|Overall Study|Participant died|1
456348|NCT00348140|1502477|P1|Overall Study|Participant died|0
456349|NCT00348140|1502475|P3|Overall Study|Abnormal ECG|3
456350|NCT00348140|1502476|P2|Overall Study|Abnormal ECG|1
456351|NCT00348140|1502477|P1|Overall Study|Abnormal ECG|0
456352|NCT00348140|1502475|P3|Overall Study|Serious adverse event|0
456353|NCT00348140|1502476|P2|Overall Study|Serious adverse event|1
456354|NCT00348140|1502477|P1|Overall Study|Serious adverse event|0
456355|NCT00348140|1502475|P3|Overall Study|Increased risk of cardiac infarction|0
456356|NCT00348140|1502476|P2|Overall Study|Increased risk of cardiac infarction|1
456357|NCT00348140|1502477|P1|Overall Study|Increased risk of cardiac infarction|0
456358|NCT00348140|1502475|P3|Overall Study|Disease progression|5
456359|NCT00348140|1502476|P2|Overall Study|Disease progression|2
456360|NCT00348140|1502477|P1|Overall Study|Disease progression|1
456361|NCT00348140|1502475|P3|Overall Study|Use of prohibited drug|2
456362|NCT00348140|1502476|P2|Overall Study|Use of prohibited drug|0
456363|NCT00348140|1502477|P1|Overall Study|Use of prohibited drug|1
456364|NCT00348140|1502475|P3|Overall Study|Decided to discontinue on their own|1
456365|NCT00348140|1502476|P2|Overall Study|Decided to discontinue on their own|4
456366|NCT00348140|1502477|P1|Overall Study|Decided to discontinue on their own|1
456367|NCT00348140|1502475|P3|Overall Study|Investigator decided to discontinue|4
456368|NCT00348140|1502476|P2|Overall Study|Investigator decided to discontinue|1
456369|NCT00348140|1502477|P1|Overall Study|Investigator decided to discontinue|4
456370|NCT00348140|1502475|P3|Overall Study|Screen failure|0
456371|NCT00348140|1502476|P2|Overall Study|Screen failure|0
456372|NCT00348140|1502477|P1|Overall Study|Screen failure|1
456373|NCT00348140|1502475|P3|Overall Study|Participant unwell|0
456374|NCT00348140|1502476|P2|Overall Study|Participant unwell|0
456375|NCT00348140|1502477|P1|Overall Study|Participant unwell|1
456376|NCT00348140|1502475|P3|Overall Study|Unmet inclusion-exclusion criteria|1
456377|NCT00348140|1502476|P2|Overall Study|Unmet inclusion-exclusion criteria|0
456466|NCT00347776|1502627|P1|1.5 Month Follow-up|Death|2
456378|NCT00348140|1502477|P1|Overall Study|Unmet inclusion-exclusion criteria|1
456379|NCT00348140|1502475|P3|Overall Study|Administration related|1
456380|NCT00348140|1502476|P2|Overall Study|Administration related|1
456381|NCT00348140|1502477|P1|Overall Study|Administration related|3
456382|NCT00348140|1502475|P3|Overall Study|Efficacy related|0
456383|NCT00348140|1502476|P2|Overall Study|Efficacy related|1
456384|NCT00348140|1502477|P1|Overall Study|Efficacy related|1
456385|NCT00348140|1502475|P3|Overall Study|Participant hospitalised|0
456386|NCT00348140|1502476|P2|Overall Study|Participant hospitalised|0
456387|NCT00348140|1502477|P1|Overall Study|Participant hospitalised|3
456388|NCT00348140|1502475|P3|Overall Study|Caregiver related|3
456389|NCT00348140|1502476|P2|Overall Study|Caregiver related|7
456390|NCT00348140|1502477|P1|Overall Study|Caregiver related|4
456391|NCT00348140|1502475|P3|Overall Study|Conditional medication increased dose|0
456392|NCT00348140|1502476|P2|Overall Study|Conditional medication increased dose|0
456393|NCT00348140|1502477|P1|Overall Study|Conditional medication increased dose|1
456394|NCT00348140|1502475|P3|Overall Study|Participant at risk due to study drug|0
456395|NCT00348140|1502476|P2|Overall Study|Participant at risk due to study drug|0
456396|NCT00348140|1502477|P1|Overall Study|Participant at risk due to study drug|2
456397|NCT00348140|1502475|P3|Overall Study|Non-compliance|5
456398|NCT00348140|1502476|P2|Overall Study|Non-compliance|13
456399|NCT00348140|1502477|P1|Overall Study|Non-compliance|8
456400|NCT00348140|1502475|P3|Overall Study|Withdrawal by Subject|40
456401|NCT00348140|1502476|P2|Overall Study|Withdrawal by Subject|40
456402|NCT00348140|1502477|P1|Overall Study|Withdrawal by Subject|32
456403|NCT00348140|1502475|P3|Overall Study|Protocol Violation|14
456404|NCT00348140|1502476|P2|Overall Study|Protocol Violation|13
456405|NCT00348140|1502477|P1|Overall Study|Protocol Violation|12
456406|NCT00348140|1502475|P3|Overall Study|Lost to Follow-up|4
456407|NCT00348140|1502476|P2|Overall Study|Lost to Follow-up|4
456408|NCT00348140|1502477|P1|Overall Study|Lost to Follow-up|4
456409|NCT00348140|1502475|P3|Overall Study|Adverse Event|78
456410|NCT00348140|1502476|P2|Overall Study|Adverse Event|49
456411|NCT00348140|1502477|P1|Overall Study|Adverse Event|46
456412|NCT00347958|1502575|P1|Overall Study|Withdrawal by Subject|1
456413|NCT00347958|1502575|P1|Overall Study|Protocol Violation|2
456414|NCT00347958|1502575|P1|Overall Study|Adverse Event|1
456415|NCT00347932|1502584|P2|Overall Study|Did not meet inclusion criteria|8
456416|NCT00347932|1502585|P1|Overall Study|Did not meet inclusion criteria|4
456417|NCT00347932|1502584|P2|Overall Study|Withdrawal by Subject|16
456418|NCT00347932|1502585|P1|Overall Study|Withdrawal by Subject|10
456419|NCT00347932|1502584|P2|Overall Study|Lost to Follow-up|9
456420|NCT00347932|1502585|P1|Overall Study|Lost to Follow-up|10
456421|NCT00347932|1502584|P2|Overall Study|Lack of Efficacy|14
456422|NCT00347932|1502585|P1|Overall Study|Lack of Efficacy|3
456423|NCT00347932|1502584|P2|Overall Study|Adverse Event|5
456424|NCT00347932|1502585|P1|Overall Study|Adverse Event|4
456425|NCT00347919|1502600|P3|Overall Study|Missing|2
456426|NCT00347919|1502601|P2|Overall Study|Missing|1
456427|NCT00347919|1502602|P1|Overall Study|Missing|2
456428|NCT00347919|1502600|P3|Overall Study|Par. Started Other Treatment|1
456429|NCT00347919|1502601|P2|Overall Study|Par. Started Other Treatment|1
456430|NCT00347919|1502602|P1|Overall Study|Par. Started Other Treatment|1
456431|NCT00347919|1502600|P3|Overall Study|Death|19
456432|NCT00347919|1502601|P2|Overall Study|Death|42
456433|NCT00347919|1502602|P1|Overall Study|Death|35
456434|NCT00347919|1502600|P3|Overall Study|Sponsor terminated study|16
456435|NCT00347919|1502601|P2|Overall Study|Sponsor terminated study|10
456436|NCT00347919|1502602|P1|Overall Study|Sponsor terminated study|15
456437|NCT00347919|1502600|P3|Overall Study|Physician Decision|0
456438|NCT00347919|1502601|P2|Overall Study|Physician Decision|1
456439|NCT00347919|1502602|P1|Overall Study|Physician Decision|1
456440|NCT00347919|1502600|P3|Overall Study|Withdrawal by Subject|0
456441|NCT00347919|1502601|P2|Overall Study|Withdrawal by Subject|8
456442|NCT00347919|1502602|P1|Overall Study|Withdrawal by Subject|6
456443|NCT00347919|1502600|P3|Overall Study|Lost to Follow-up|0
456444|NCT00347919|1502601|P2|Overall Study|Lost to Follow-up|13
456445|NCT00347919|1502602|P1|Overall Study|Lost to Follow-up|11
456446|NCT00347776|1502625|P3|12 Month Follow-up|Reached endpoint|9
456447|NCT00347776|1502626|P2|12 Month Follow-up|Reached endpoint|6
456448|NCT00347776|1502627|P1|12 Month Follow-up|Reached endpoint|13
456449|NCT00347776|1502625|P3|12 Month Follow-up|Death|4
456450|NCT00347776|1502626|P2|12 Month Follow-up|Death|4
456451|NCT00347776|1502627|P1|12 Month Follow-up|Death|3
456452|NCT00347776|1502625|P3|12 Month Follow-up|Lost to Follow-up|6
456453|NCT00347776|1502626|P2|12 Month Follow-up|Lost to Follow-up|6
456454|NCT00347776|1502627|P1|12 Month Follow-up|Lost to Follow-up|7
456455|NCT00347776|1502625|P3|6 Month Follow-up|reached endpont|15
456456|NCT00347776|1502626|P2|6 Month Follow-up|reached endpont|12
456457|NCT00347776|1502627|P1|6 Month Follow-up|reached endpont|20
456458|NCT00347776|1502625|P3|6 Month Follow-up|Death|3
456459|NCT00347776|1502626|P2|6 Month Follow-up|Death|1
456460|NCT00347776|1502627|P1|6 Month Follow-up|Death|2
456461|NCT00347776|1502625|P3|1.5 Month Follow-up|reached the endpoint|12
456462|NCT00347776|1502626|P2|1.5 Month Follow-up|reached the endpoint|8
456463|NCT00347776|1502627|P1|1.5 Month Follow-up|reached the endpoint|12
456464|NCT00347776|1502625|P3|1.5 Month Follow-up|Death|0
456465|NCT00347776|1502626|P2|1.5 Month Follow-up|Death|0
456467|NCT00347438|1502639|P1|Overall Study|Physician Decision|1
456468|NCT00347438|1502639|P1|Overall Study|Withdrawal by Subject|1
456469|NCT00347360|1502661|P15|Overall Study|Visits conflicted with new job|0
456470|NCT00347360|1502662|P14|Overall Study|Visits conflicted with new job|0
456471|NCT00347360|1502663|P13|Overall Study|Visits conflicted with new job|0
456472|NCT00347360|1502664|P12|Overall Study|Visits conflicted with new job|0
456473|NCT00347360|1502665|P11|Overall Study|Visits conflicted with new job|0
456474|NCT00347360|1502666|P10|Overall Study|Visits conflicted with new job|0
456475|NCT00347360|1502667|P9|Overall Study|Visits conflicted with new job|0
456476|NCT00347360|1502668|P8|Overall Study|Visits conflicted with new job|0
456477|NCT00347360|1502669|P7|Overall Study|Visits conflicted with new job|1
456478|NCT00347360|1502670|P6|Overall Study|Visits conflicted with new job|0
456479|NCT00347360|1502671|P5|Overall Study|Visits conflicted with new job|0
456480|NCT00347360|1502672|P4|Overall Study|Visits conflicted with new job|0
456481|NCT00347360|1502673|P3|Overall Study|Visits conflicted with new job|0
456482|NCT00347360|1502674|P2|Overall Study|Visits conflicted with new job|0
456483|NCT00347360|1502675|P1|Overall Study|Visits conflicted with new job|0
456484|NCT00347360|1502661|P15|Overall Study|Subject refuse to sign updated consent|1
456485|NCT00347360|1502662|P14|Overall Study|Subject refuse to sign updated consent|0
456486|NCT00347360|1502663|P13|Overall Study|Subject refuse to sign updated consent|0
456487|NCT00347360|1502664|P12|Overall Study|Subject refuse to sign updated consent|0
456488|NCT00347360|1502665|P11|Overall Study|Subject refuse to sign updated consent|0
456489|NCT00347360|1502666|P10|Overall Study|Subject refuse to sign updated consent|0
456490|NCT00347360|1502667|P9|Overall Study|Subject refuse to sign updated consent|0
456491|NCT00347360|1502668|P8|Overall Study|Subject refuse to sign updated consent|0
456492|NCT00347360|1502669|P7|Overall Study|Subject refuse to sign updated consent|0
456493|NCT00347360|1502670|P6|Overall Study|Subject refuse to sign updated consent|0
456494|NCT00347360|1502671|P5|Overall Study|Subject refuse to sign updated consent|0
456495|NCT00347360|1502672|P4|Overall Study|Subject refuse to sign updated consent|0
456496|NCT00347360|1502673|P3|Overall Study|Subject refuse to sign updated consent|0
456497|NCT00347360|1502674|P2|Overall Study|Subject refuse to sign updated consent|0
456498|NCT00347360|1502675|P1|Overall Study|Subject refuse to sign updated consent|0
456499|NCT00347360|1502661|P15|Overall Study|Subject left town, ran out of study drug|0
456500|NCT00347360|1502662|P14|Overall Study|Subject left town, ran out of study drug|1
456501|NCT00347360|1502663|P13|Overall Study|Subject left town, ran out of study drug|0
456502|NCT00347360|1502664|P12|Overall Study|Subject left town, ran out of study drug|0
456503|NCT00347360|1502665|P11|Overall Study|Subject left town, ran out of study drug|0
456504|NCT00347360|1502666|P10|Overall Study|Subject left town, ran out of study drug|0
456505|NCT00347360|1502667|P9|Overall Study|Subject left town, ran out of study drug|0
456506|NCT00347360|1502668|P8|Overall Study|Subject left town, ran out of study drug|0
456507|NCT00347360|1502669|P7|Overall Study|Subject left town, ran out of study drug|0
456508|NCT00347360|1502670|P6|Overall Study|Subject left town, ran out of study drug|0
456509|NCT00347360|1502671|P5|Overall Study|Subject left town, ran out of study drug|0
456510|NCT00347360|1502672|P4|Overall Study|Subject left town, ran out of study drug|0
456511|NCT00347360|1502673|P3|Overall Study|Subject left town, ran out of study drug|0
456512|NCT00347360|1502674|P2|Overall Study|Subject left town, ran out of study drug|0
456513|NCT00347360|1502675|P1|Overall Study|Subject left town, ran out of study drug|0
456514|NCT00347360|1502661|P15|Overall Study|Prolonged duration between visits|0
456515|NCT00347360|1502662|P14|Overall Study|Prolonged duration between visits|0
456516|NCT00347360|1502663|P13|Overall Study|Prolonged duration between visits|1
456517|NCT00347360|1502664|P12|Overall Study|Prolonged duration between visits|0
456518|NCT00347360|1502665|P11|Overall Study|Prolonged duration between visits|0
456519|NCT00347360|1502666|P10|Overall Study|Prolonged duration between visits|0
456520|NCT00347360|1502667|P9|Overall Study|Prolonged duration between visits|0
456521|NCT00347360|1502668|P8|Overall Study|Prolonged duration between visits|0
456522|NCT00347360|1502669|P7|Overall Study|Prolonged duration between visits|0
456523|NCT00347360|1502670|P6|Overall Study|Prolonged duration between visits|0
456524|NCT00347360|1502671|P5|Overall Study|Prolonged duration between visits|0
456525|NCT00347360|1502672|P4|Overall Study|Prolonged duration between visits|0
456526|NCT00347360|1502673|P3|Overall Study|Prolonged duration between visits|0
456527|NCT00347360|1502674|P2|Overall Study|Prolonged duration between visits|0
456528|NCT00347360|1502675|P1|Overall Study|Prolonged duration between visits|0
456529|NCT00347360|1502661|P15|Overall Study|Failed inclusion criteria #4|0
456530|NCT00347360|1502662|P14|Overall Study|Failed inclusion criteria #4|0
456531|NCT00347360|1502663|P13|Overall Study|Failed inclusion criteria #4|0
456532|NCT00347360|1502664|P12|Overall Study|Failed inclusion criteria #4|1
456533|NCT00347360|1502665|P11|Overall Study|Failed inclusion criteria #4|0
456534|NCT00347360|1502666|P10|Overall Study|Failed inclusion criteria #4|0
456535|NCT00347360|1502667|P9|Overall Study|Failed inclusion criteria #4|0
456536|NCT00347360|1502668|P8|Overall Study|Failed inclusion criteria #4|0
456537|NCT00347360|1502669|P7|Overall Study|Failed inclusion criteria #4|0
456538|NCT00347360|1502670|P6|Overall Study|Failed inclusion criteria #4|0
456539|NCT00347360|1502671|P5|Overall Study|Failed inclusion criteria #4|0
456540|NCT00347360|1502672|P4|Overall Study|Failed inclusion criteria #4|0
456541|NCT00347360|1502673|P3|Overall Study|Failed inclusion criteria #4|0
456542|NCT00347360|1502674|P2|Overall Study|Failed inclusion criteria #4|0
456543|NCT00347360|1502675|P1|Overall Study|Failed inclusion criteria #4|0
456544|NCT00347360|1502661|P15|Overall Study|Randomized in error|0
456545|NCT00347360|1502662|P14|Overall Study|Randomized in error|0
456546|NCT00347360|1502663|P13|Overall Study|Randomized in error|0
456547|NCT00347360|1502664|P12|Overall Study|Randomized in error|1
456548|NCT00347360|1502665|P11|Overall Study|Randomized in error|0
456549|NCT00347360|1502666|P10|Overall Study|Randomized in error|0
456550|NCT00347360|1502667|P9|Overall Study|Randomized in error|0
456551|NCT00347360|1502668|P8|Overall Study|Randomized in error|0
456552|NCT00347360|1502669|P7|Overall Study|Randomized in error|0
456553|NCT00347360|1502670|P6|Overall Study|Randomized in error|0
456554|NCT00347360|1502671|P5|Overall Study|Randomized in error|0
456555|NCT00347360|1502672|P4|Overall Study|Randomized in error|0
456556|NCT00347360|1502673|P3|Overall Study|Randomized in error|0
456557|NCT00347360|1502674|P2|Overall Study|Randomized in error|0
456558|NCT00347360|1502675|P1|Overall Study|Randomized in error|0
456559|NCT00347360|1502661|P15|Overall Study|Did not meet criteria before ABPM|0
456560|NCT00347360|1502662|P14|Overall Study|Did not meet criteria before ABPM|0
456561|NCT00347360|1502663|P13|Overall Study|Did not meet criteria before ABPM|0
456562|NCT00347360|1502664|P12|Overall Study|Did not meet criteria before ABPM|0
456563|NCT00347360|1502665|P11|Overall Study|Did not meet criteria before ABPM|1
456564|NCT00347360|1502666|P10|Overall Study|Did not meet criteria before ABPM|0
456565|NCT00347360|1502667|P9|Overall Study|Did not meet criteria before ABPM|0
456566|NCT00347360|1502668|P8|Overall Study|Did not meet criteria before ABPM|0
456567|NCT00347360|1502669|P7|Overall Study|Did not meet criteria before ABPM|0
456568|NCT00347360|1502670|P6|Overall Study|Did not meet criteria before ABPM|0
456569|NCT00347360|1502671|P5|Overall Study|Did not meet criteria before ABPM|0
456570|NCT00347360|1502672|P4|Overall Study|Did not meet criteria before ABPM|0
456571|NCT00347360|1502673|P3|Overall Study|Did not meet criteria before ABPM|0
456572|NCT00347360|1502674|P2|Overall Study|Did not meet criteria before ABPM|0
456573|NCT00347360|1502675|P1|Overall Study|Did not meet criteria before ABPM|0
456574|NCT00347360|1502661|P15|Overall Study|PI recommended early withdrawal|0
456575|NCT00347360|1502662|P14|Overall Study|PI recommended early withdrawal|0
456576|NCT00347360|1502663|P13|Overall Study|PI recommended early withdrawal|0
456577|NCT00347360|1502664|P12|Overall Study|PI recommended early withdrawal|0
456578|NCT00347360|1502665|P11|Overall Study|PI recommended early withdrawal|0
456579|NCT00347360|1502666|P10|Overall Study|PI recommended early withdrawal|1
456580|NCT00347360|1502667|P9|Overall Study|PI recommended early withdrawal|0
456581|NCT00347360|1502668|P8|Overall Study|PI recommended early withdrawal|0
456582|NCT00347360|1502669|P7|Overall Study|PI recommended early withdrawal|0
456583|NCT00347360|1502670|P6|Overall Study|PI recommended early withdrawal|0
456584|NCT00347360|1502671|P5|Overall Study|PI recommended early withdrawal|0
456585|NCT00347360|1502672|P4|Overall Study|PI recommended early withdrawal|0
456586|NCT00347360|1502673|P3|Overall Study|PI recommended early withdrawal|0
456587|NCT00347360|1502674|P2|Overall Study|PI recommended early withdrawal|0
456588|NCT00347360|1502675|P1|Overall Study|PI recommended early withdrawal|0
456589|NCT00347360|1502661|P15|Overall Study|Abnormal lab values|0
456590|NCT00347360|1502662|P14|Overall Study|Abnormal lab values|0
456591|NCT00347360|1502663|P13|Overall Study|Abnormal lab values|0
456592|NCT00347360|1502664|P12|Overall Study|Abnormal lab values|0
456593|NCT00347360|1502665|P11|Overall Study|Abnormal lab values|0
456594|NCT00347360|1502666|P10|Overall Study|Abnormal lab values|0
456595|NCT00347360|1502667|P9|Overall Study|Abnormal lab values|0
456596|NCT00347360|1502668|P8|Overall Study|Abnormal lab values|0
456597|NCT00347360|1502669|P7|Overall Study|Abnormal lab values|1
456598|NCT00347360|1502670|P6|Overall Study|Abnormal lab values|0
456599|NCT00347360|1502671|P5|Overall Study|Abnormal lab values|0
456600|NCT00347360|1502672|P4|Overall Study|Abnormal lab values|0
456601|NCT00347360|1502673|P3|Overall Study|Abnormal lab values|0
456602|NCT00347360|1502674|P2|Overall Study|Abnormal lab values|0
456603|NCT00347360|1502675|P1|Overall Study|Abnormal lab values|0
456604|NCT00347360|1502661|P15|Overall Study|Subject did not meet end of study ABPM|0
456605|NCT00347360|1502662|P14|Overall Study|Subject did not meet end of study ABPM|1
456606|NCT00347360|1502663|P13|Overall Study|Subject did not meet end of study ABPM|1
456607|NCT00347360|1502664|P12|Overall Study|Subject did not meet end of study ABPM|0
456608|NCT00347360|1502665|P11|Overall Study|Subject did not meet end of study ABPM|1
456609|NCT00347360|1502666|P10|Overall Study|Subject did not meet end of study ABPM|0
456610|NCT00347360|1502667|P9|Overall Study|Subject did not meet end of study ABPM|0
456611|NCT00347360|1502668|P8|Overall Study|Subject did not meet end of study ABPM|0
456612|NCT00347360|1502669|P7|Overall Study|Subject did not meet end of study ABPM|1
456613|NCT00347360|1502670|P6|Overall Study|Subject did not meet end of study ABPM|0
456614|NCT00347360|1502671|P5|Overall Study|Subject did not meet end of study ABPM|0
456615|NCT00347360|1502672|P4|Overall Study|Subject did not meet end of study ABPM|0
456616|NCT00347360|1502673|P3|Overall Study|Subject did not meet end of study ABPM|0
456617|NCT00347360|1502674|P2|Overall Study|Subject did not meet end of study ABPM|0
456618|NCT00347360|1502675|P1|Overall Study|Subject did not meet end of study ABPM|0
456619|NCT00347360|1502661|P15|Overall Study|P.I. recommended due to blood pressure|0
456620|NCT00347360|1502662|P14|Overall Study|P.I. recommended due to blood pressure|0
456621|NCT00347360|1502663|P13|Overall Study|P.I. recommended due to blood pressure|0
456622|NCT00347360|1502664|P12|Overall Study|P.I. recommended due to blood pressure|0
456623|NCT00347360|1502665|P11|Overall Study|P.I. recommended due to blood pressure|0
456624|NCT00347360|1502666|P10|Overall Study|P.I. recommended due to blood pressure|0
456625|NCT00347360|1502667|P9|Overall Study|P.I. recommended due to blood pressure|0
456626|NCT00347360|1502668|P8|Overall Study|P.I. recommended due to blood pressure|0
456627|NCT00347360|1502669|P7|Overall Study|P.I. recommended due to blood pressure|0
456628|NCT00347360|1502670|P6|Overall Study|P.I. recommended due to blood pressure|0
456629|NCT00347360|1502671|P5|Overall Study|P.I. recommended due to blood pressure|1
456630|NCT00347360|1502672|P4|Overall Study|P.I. recommended due to blood pressure|0
456631|NCT00347360|1502673|P3|Overall Study|P.I. recommended due to blood pressure|0
456632|NCT00347360|1502674|P2|Overall Study|P.I. recommended due to blood pressure|0
456633|NCT00347360|1502675|P1|Overall Study|P.I. recommended due to blood pressure|0
456634|NCT00347360|1502661|P15|Overall Study|Per sponsors instruction|0
456635|NCT00347360|1502662|P14|Overall Study|Per sponsors instruction|0
456636|NCT00347360|1502663|P13|Overall Study|Per sponsors instruction|0
456637|NCT00347360|1502664|P12|Overall Study|Per sponsors instruction|0
456638|NCT00347360|1502665|P11|Overall Study|Per sponsors instruction|0
456639|NCT00347360|1502666|P10|Overall Study|Per sponsors instruction|0
456640|NCT00347360|1502667|P9|Overall Study|Per sponsors instruction|0
456641|NCT00347360|1502668|P8|Overall Study|Per sponsors instruction|0
456642|NCT00347360|1502669|P7|Overall Study|Per sponsors instruction|0
456643|NCT00347360|1502670|P6|Overall Study|Per sponsors instruction|0
456644|NCT00347360|1502671|P5|Overall Study|Per sponsors instruction|0
456645|NCT00347360|1502672|P4|Overall Study|Per sponsors instruction|0
456646|NCT00347360|1502673|P3|Overall Study|Per sponsors instruction|0
456647|NCT00347360|1502674|P2|Overall Study|Per sponsors instruction|1
456648|NCT00347360|1502675|P1|Overall Study|Per sponsors instruction|0
456649|NCT00347360|1502661|P15|Overall Study|Reason not listed/blank|0
456650|NCT00347360|1502662|P14|Overall Study|Reason not listed/blank|1
456651|NCT00347360|1502663|P13|Overall Study|Reason not listed/blank|0
456652|NCT00347360|1502664|P12|Overall Study|Reason not listed/blank|0
456653|NCT00347360|1502665|P11|Overall Study|Reason not listed/blank|0
456654|NCT00347360|1502666|P10|Overall Study|Reason not listed/blank|0
456655|NCT00347360|1502667|P9|Overall Study|Reason not listed/blank|0
456656|NCT00347360|1502668|P8|Overall Study|Reason not listed/blank|0
456657|NCT00347360|1502669|P7|Overall Study|Reason not listed/blank|1
456658|NCT00347360|1502670|P6|Overall Study|Reason not listed/blank|0
456659|NCT00347360|1502671|P5|Overall Study|Reason not listed/blank|0
456660|NCT00347360|1502672|P4|Overall Study|Reason not listed/blank|0
456661|NCT00347360|1502673|P3|Overall Study|Reason not listed/blank|0
456662|NCT00347360|1502674|P2|Overall Study|Reason not listed/blank|0
456663|NCT00347360|1502675|P1|Overall Study|Reason not listed/blank|1
456664|NCT00347360|1502661|P15|Overall Study|Lack of Efficacy|0
456665|NCT00347360|1502662|P14|Overall Study|Lack of Efficacy|0
456666|NCT00347360|1502663|P13|Overall Study|Lack of Efficacy|0
456667|NCT00347360|1502664|P12|Overall Study|Lack of Efficacy|0
456668|NCT00347360|1502665|P11|Overall Study|Lack of Efficacy|0
456669|NCT00347360|1502666|P10|Overall Study|Lack of Efficacy|0
456670|NCT00347360|1502667|P9|Overall Study|Lack of Efficacy|1
456671|NCT00347360|1502668|P8|Overall Study|Lack of Efficacy|1
456672|NCT00347360|1502669|P7|Overall Study|Lack of Efficacy|0
456673|NCT00347360|1502670|P6|Overall Study|Lack of Efficacy|1
456674|NCT00347360|1502671|P5|Overall Study|Lack of Efficacy|0
456675|NCT00347360|1502672|P4|Overall Study|Lack of Efficacy|1
456676|NCT00347360|1502673|P3|Overall Study|Lack of Efficacy|3
456677|NCT00347360|1502674|P2|Overall Study|Lack of Efficacy|1
456678|NCT00347360|1502675|P1|Overall Study|Lack of Efficacy|1
456679|NCT00347360|1502661|P15|Overall Study|Withdrawal by Subject|1
456680|NCT00347360|1502662|P14|Overall Study|Withdrawal by Subject|2
456681|NCT00347360|1502663|P13|Overall Study|Withdrawal by Subject|4
456682|NCT00347360|1502664|P12|Overall Study|Withdrawal by Subject|3
456683|NCT00347360|1502665|P11|Overall Study|Withdrawal by Subject|0
456684|NCT00347360|1502666|P10|Overall Study|Withdrawal by Subject|1
456685|NCT00347360|1502667|P9|Overall Study|Withdrawal by Subject|1
456686|NCT00347360|1502668|P8|Overall Study|Withdrawal by Subject|1
456687|NCT00347360|1502669|P7|Overall Study|Withdrawal by Subject|1
456688|NCT00347360|1502670|P6|Overall Study|Withdrawal by Subject|2
456689|NCT00347360|1502671|P5|Overall Study|Withdrawal by Subject|1
456690|NCT00347360|1502672|P4|Overall Study|Withdrawal by Subject|4
456691|NCT00347360|1502673|P3|Overall Study|Withdrawal by Subject|2
456692|NCT00347360|1502674|P2|Overall Study|Withdrawal by Subject|1
456693|NCT00347360|1502675|P1|Overall Study|Withdrawal by Subject|0
456694|NCT00347360|1502661|P15|Overall Study|Protocol Violation|0
456695|NCT00347360|1502662|P14|Overall Study|Protocol Violation|1
456696|NCT00347360|1502663|P13|Overall Study|Protocol Violation|0
456697|NCT00347360|1502664|P12|Overall Study|Protocol Violation|0
456698|NCT00347360|1502665|P11|Overall Study|Protocol Violation|0
456699|NCT00347360|1502666|P10|Overall Study|Protocol Violation|2
456700|NCT00347360|1502667|P9|Overall Study|Protocol Violation|1
456701|NCT00347360|1502668|P8|Overall Study|Protocol Violation|0
456702|NCT00347360|1502669|P7|Overall Study|Protocol Violation|0
456703|NCT00347360|1502670|P6|Overall Study|Protocol Violation|2
456704|NCT00347360|1502671|P5|Overall Study|Protocol Violation|1
456705|NCT00347360|1502672|P4|Overall Study|Protocol Violation|2
456706|NCT00347360|1502673|P3|Overall Study|Protocol Violation|1
456707|NCT00347360|1502674|P2|Overall Study|Protocol Violation|3
456708|NCT00347360|1502675|P1|Overall Study|Protocol Violation|2
456709|NCT00347360|1502661|P15|Overall Study|Lost to Follow-up|0
456710|NCT00347360|1502662|P14|Overall Study|Lost to Follow-up|0
456711|NCT00347360|1502663|P13|Overall Study|Lost to Follow-up|1
456712|NCT00347360|1502664|P12|Overall Study|Lost to Follow-up|0
456713|NCT00347360|1502665|P11|Overall Study|Lost to Follow-up|0
456714|NCT00347360|1502666|P10|Overall Study|Lost to Follow-up|2
456715|NCT00347360|1502667|P9|Overall Study|Lost to Follow-up|1
456716|NCT00347360|1502668|P8|Overall Study|Lost to Follow-up|1
456717|NCT00347360|1502669|P7|Overall Study|Lost to Follow-up|0
456718|NCT00347360|1502670|P6|Overall Study|Lost to Follow-up|1
456719|NCT00347360|1502671|P5|Overall Study|Lost to Follow-up|1
456720|NCT00347360|1502672|P4|Overall Study|Lost to Follow-up|2
456721|NCT00347360|1502673|P3|Overall Study|Lost to Follow-up|0
456722|NCT00347360|1502674|P2|Overall Study|Lost to Follow-up|0
456723|NCT00347360|1502675|P1|Overall Study|Lost to Follow-up|0
456724|NCT00347360|1502661|P15|Overall Study|Adverse Event|2
456725|NCT00347360|1502662|P14|Overall Study|Adverse Event|2
456726|NCT00347360|1502663|P13|Overall Study|Adverse Event|3
456727|NCT00347360|1502664|P12|Overall Study|Adverse Event|1
456728|NCT00347360|1502665|P11|Overall Study|Adverse Event|3
456729|NCT00347360|1502666|P10|Overall Study|Adverse Event|3
456730|NCT00347360|1502667|P9|Overall Study|Adverse Event|2
456731|NCT00347360|1502668|P8|Overall Study|Adverse Event|0
456732|NCT00347360|1502669|P7|Overall Study|Adverse Event|2
456733|NCT00347360|1502670|P6|Overall Study|Adverse Event|2
456734|NCT00347360|1502671|P5|Overall Study|Adverse Event|1
456735|NCT00347360|1502672|P4|Overall Study|Adverse Event|4
456736|NCT00347360|1502673|P3|Overall Study|Adverse Event|0
456737|NCT00347360|1502674|P2|Overall Study|Adverse Event|2
456738|NCT00347360|1502675|P1|Overall Study|Adverse Event|1
456739|NCT00347269|1502863|P2|Overall Study|Death|3
456740|NCT00347269|1502864|P1|Overall Study|Death|2
456741|NCT00347269|1502863|P2|Overall Study|Withdrawal by Subject|38
456742|NCT00347269|1502864|P1|Overall Study|Withdrawal by Subject|18
456743|NCT00347269|1502863|P2|Overall Study|Lost to Follow-up|65
456744|NCT00347269|1502864|P1|Overall Study|Lost to Follow-up|74
456745|NCT00347009|1502879|P1|Overall Study|Serious Adverse Event|1
456746|NCT00347009|1502879|P1|Overall Study|Increased ALT/HBV DNA|1
456747|NCT00347009|1502879|P1|Overall Study|Insufficient Viral Suppression|3
456748|NCT00347009|1502879|P1|Overall Study|Adverse Laboratory Experience|1
456749|NCT00347009|1502879|P1|Overall Study|Protocol Violation|2
456750|NCT00347009|1502879|P1|Overall Study|Lost to Follow-up|4
456751|NCT00347009|1502879|P1|Overall Study|Physician Decision|5
456752|NCT00347009|1502879|P1|Overall Study|Withdrawal by Subject|3
456753|NCT00347009|1502879|P1|Overall Study|Adverse Event|6
456754|NCT00347009|1502879|P1|Overall Study|Death|1
456755|NCT00346775|1502900|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
456756|NCT00346775|1502901|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
456757|NCT00346775|1502900|P2|Period 1: Intervention Period 1|Protocol Violation|2
456758|NCT00346775|1502901|P1|Period 1: Intervention Period 1|Protocol Violation|3
456759|NCT00346775|1502900|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
456760|NCT00346775|1502901|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
456761|NCT00346697|1502913|P2|Overall Study|Lost to Follow-up|1
456762|NCT00346697|1502914|P1|Overall Study|Lost to Follow-up|0
456763|NCT00346632|1502950|P10|Overall Study|Not Stated|1
456764|NCT00346632|1502951|P9|Overall Study|Not Stated|2
456765|NCT00346632|1502952|P8|Overall Study|Not Stated|2
456766|NCT00346632|1502953|P7|Overall Study|Not Stated|0
456767|NCT00346632|1502954|P6|Overall Study|Not Stated|0
456768|NCT00346632|1502955|P5|Overall Study|Not Stated|0
456769|NCT00346632|1502956|P4|Overall Study|Not Stated|0
456770|NCT00346632|1502957|P3|Overall Study|Not Stated|0
456771|NCT00346632|1502958|P2|Overall Study|Not Stated|1
456772|NCT00346632|1502959|P1|Overall Study|Not Stated|1
456773|NCT00346632|1502950|P10|Overall Study|Switched to alternative treatment|0
456774|NCT00346632|1502951|P9|Overall Study|Switched to alternative treatment|0
456775|NCT00346632|1502952|P8|Overall Study|Switched to alternative treatment|0
456776|NCT00346632|1502953|P7|Overall Study|Switched to alternative treatment|0
456777|NCT00346632|1502954|P6|Overall Study|Switched to alternative treatment|0
456778|NCT00346632|1502955|P5|Overall Study|Switched to alternative treatment|0
456779|NCT00346632|1502956|P4|Overall Study|Switched to alternative treatment|0
456780|NCT00346632|1502957|P3|Overall Study|Switched to alternative treatment|1
456781|NCT00346632|1502958|P2|Overall Study|Switched to alternative treatment|0
456782|NCT00346632|1502959|P1|Overall Study|Switched to alternative treatment|0
456783|NCT00346632|1502950|P10|Overall Study|Withdrawal by Subject|0
456784|NCT00346632|1502951|P9|Overall Study|Withdrawal by Subject|0
456785|NCT00346632|1502952|P8|Overall Study|Withdrawal by Subject|0
456786|NCT00346632|1502953|P7|Overall Study|Withdrawal by Subject|1
456787|NCT00346632|1502954|P6|Overall Study|Withdrawal by Subject|0
456788|NCT00346632|1502955|P5|Overall Study|Withdrawal by Subject|0
456789|NCT00346632|1502956|P4|Overall Study|Withdrawal by Subject|0
456790|NCT00346632|1502957|P3|Overall Study|Withdrawal by Subject|0
456791|NCT00346632|1502958|P2|Overall Study|Withdrawal by Subject|0
456792|NCT00346632|1502959|P1|Overall Study|Withdrawal by Subject|0
456793|NCT00346632|1502950|P10|Overall Study|Protocol Violation|0
456794|NCT00346632|1502951|P9|Overall Study|Protocol Violation|0
456795|NCT00346632|1502952|P8|Overall Study|Protocol Violation|0
456796|NCT00346632|1502953|P7|Overall Study|Protocol Violation|1
456797|NCT00346632|1502954|P6|Overall Study|Protocol Violation|0
456798|NCT00346632|1502955|P5|Overall Study|Protocol Violation|0
456799|NCT00346632|1502956|P4|Overall Study|Protocol Violation|0
456800|NCT00346632|1502957|P3|Overall Study|Protocol Violation|0
456801|NCT00346632|1502958|P2|Overall Study|Protocol Violation|0
456802|NCT00346632|1502959|P1|Overall Study|Protocol Violation|0
456803|NCT00346632|1502950|P10|Overall Study|Death|0
456804|NCT00346632|1502951|P9|Overall Study|Death|0
456805|NCT00346632|1502952|P8|Overall Study|Death|0
456806|NCT00346632|1502953|P7|Overall Study|Death|0
456807|NCT00346632|1502954|P6|Overall Study|Death|0
456808|NCT00346632|1502955|P5|Overall Study|Death|0
456809|NCT00346632|1502956|P4|Overall Study|Death|0
456810|NCT00346632|1502957|P3|Overall Study|Death|1
456811|NCT00346632|1502958|P2|Overall Study|Death|0
456812|NCT00346632|1502959|P1|Overall Study|Death|0
456813|NCT00346632|1502950|P10|Overall Study|Adverse Event|0
456814|NCT00346632|1502951|P9|Overall Study|Adverse Event|0
456815|NCT00346632|1502952|P8|Overall Study|Adverse Event|0
456816|NCT00346632|1502953|P7|Overall Study|Adverse Event|1
456817|NCT00346632|1502954|P6|Overall Study|Adverse Event|1
456818|NCT00346632|1502955|P5|Overall Study|Adverse Event|1
456819|NCT00346632|1502956|P4|Overall Study|Adverse Event|0
456820|NCT00346632|1502957|P3|Overall Study|Adverse Event|0
456821|NCT00346632|1502958|P2|Overall Study|Adverse Event|0
456822|NCT00346632|1502959|P1|Overall Study|Adverse Event|0
456823|NCT00346632|1502950|P10|Overall Study|Progressive Disease|2
456824|NCT00346632|1502951|P9|Overall Study|Progressive Disease|2
456825|NCT00346632|1502952|P8|Overall Study|Progressive Disease|2
456826|NCT00346632|1502953|P7|Overall Study|Progressive Disease|2
456827|NCT00346632|1502954|P6|Overall Study|Progressive Disease|1
456828|NCT00346632|1502955|P5|Overall Study|Progressive Disease|3
456829|NCT00346632|1502956|P4|Overall Study|Progressive Disease|3
456830|NCT00346632|1502957|P3|Overall Study|Progressive Disease|4
456831|NCT00346632|1502958|P2|Overall Study|Progressive Disease|2
456832|NCT00346632|1502959|P1|Overall Study|Progressive Disease|2
456833|NCT00346398|1503109|P2|Overall Study|Withdrawal by Subject|2
456834|NCT00346398|1503110|P1|Overall Study|Withdrawal by Subject|0
456835|NCT00346398|1503109|P2|Overall Study|Lost to Follow-up|0
456836|NCT00346398|1503110|P1|Overall Study|Lost to Follow-up|3
456837|NCT00346333|1503122|P2|Overall Study|unwilling or unable to continue|8
456838|NCT00346333|1503123|P1|Overall Study|unwilling or unable to continue|4
456839|NCT00346333|1503122|P2|Overall Study|Death|0
456840|NCT00346333|1503123|P1|Overall Study|Death|1
456841|NCT00346268|1503139|P2|Overall Study|Participant refused|3
456842|NCT00346268|1503140|P1|Overall Study|Participant refused|0
456843|NCT00346268|1503139|P2|Overall Study|Protocol Violation|0
456844|NCT00346268|1503140|P1|Overall Study|Protocol Violation|1
456845|NCT00346268|1503139|P2|Overall Study|Adverse Event|0
456846|NCT00346268|1503140|P1|Overall Study|Adverse Event|1
456847|NCT00346216|1503175|P3|Overall Study|Missing Subject Summary Status|62
456848|NCT00346216|1503176|P2|Overall Study|Missing Subject Summary Status|61
456849|NCT00346216|1503177|P1|Overall Study|Missing Subject Summary Status|62
456850|NCT00346216|1503175|P3|Overall Study|Study terminated by sponsor|8
456851|NCT00346216|1503176|P2|Overall Study|Study terminated by sponsor|4
456852|NCT00346216|1503177|P1|Overall Study|Study terminated by sponsor|11
456853|NCT00346216|1503175|P3|Overall Study|Death|228
456854|NCT00346216|1503176|P2|Overall Study|Death|192
456855|NCT00346216|1503177|P1|Overall Study|Death|189
456856|NCT00346216|1503175|P3|Overall Study|Does not meet entrance criteria|8
456857|NCT00346216|1503176|P2|Overall Study|Does not meet entrance criteria|10
456858|NCT00346216|1503177|P1|Overall Study|Does not meet entrance criteria|13
456859|NCT00346216|1503175|P3|Overall Study|Physician Decision|59
456860|NCT00346216|1503176|P2|Overall Study|Physician Decision|76
456861|NCT00346216|1503177|P1|Overall Study|Physician Decision|80
456862|NCT00346216|1503175|P3|Overall Study|Lost to Follow-up|542
456863|NCT00346216|1503176|P2|Overall Study|Lost to Follow-up|588
456864|NCT00346216|1503177|P1|Overall Study|Lost to Follow-up|611
456865|NCT00346216|1503175|P3|Overall Study|Withdrawal by Subject|651
456866|NCT00346216|1503176|P2|Overall Study|Withdrawal by Subject|692
456867|NCT00346216|1503177|P1|Overall Study|Withdrawal by Subject|661
456868|NCT00346216|1503175|P3|Overall Study|No longer willing to participate|585
456869|NCT00346216|1503176|P2|Overall Study|No longer willing to participate|606
456870|NCT00346216|1503177|P1|Overall Study|No longer willing to participate|600
456871|NCT00346216|1503175|P3|Overall Study|Not specified|205
456872|NCT00346216|1503176|P2|Overall Study|Not specified|231
456873|NCT00346216|1503177|P1|Overall Study|Not specified|181
456874|NCT00346164|1503198|P4|Overall Study|Inability to start week 16 tx on time|11
456875|NCT00346164|1503199|P3|Overall Study|Inability to start week 16 tx on time|0
456876|NCT00346164|1503200|P2|Overall Study|Inability to start week 16 tx on time|0
456877|NCT00346164|1503201|P1|Overall Study|Inability to start week 16 tx on time|0
456878|NCT00346164|1503198|P4|Overall Study|Refusal of further protocol therapy|15
456879|NCT00346164|1503199|P3|Overall Study|Refusal of further protocol therapy|3
456880|NCT00346164|1503200|P2|Overall Study|Refusal of further protocol therapy|1
456881|NCT00346164|1503201|P1|Overall Study|Refusal of further protocol therapy|0
456882|NCT00346164|1503198|P4|Overall Study|Ineligible|23
456883|NCT00346164|1503199|P3|Overall Study|Ineligible|2
456884|NCT00346164|1503200|P2|Overall Study|Ineligible|2
456885|NCT00346164|1503201|P1|Overall Study|Ineligible|11
456886|NCT00346164|1503198|P4|Overall Study|Withdrawal by Subject|0
456887|NCT00346164|1503199|P3|Overall Study|Withdrawal by Subject|2
456888|NCT00346164|1503200|P2|Overall Study|Withdrawal by Subject|0
456889|NCT00346164|1503201|P1|Overall Study|Withdrawal by Subject|0
456890|NCT00346164|1503198|P4|Overall Study|Protocol Violation|4
456891|NCT00346164|1503199|P3|Overall Study|Protocol Violation|10
456892|NCT00346164|1503200|P2|Overall Study|Protocol Violation|2
456893|NCT00346164|1503201|P1|Overall Study|Protocol Violation|6
456894|NCT00346164|1503198|P4|Overall Study|Physician Decision|27
456895|NCT00346164|1503199|P3|Overall Study|Physician Decision|2
456896|NCT00346164|1503200|P2|Overall Study|Physician Decision|1
456897|NCT00346164|1503201|P1|Overall Study|Physician Decision|0
456898|NCT00346164|1503198|P4|Overall Study|Lack of Efficacy|25
456899|NCT00346164|1503199|P3|Overall Study|Lack of Efficacy|7
456900|NCT00346164|1503200|P2|Overall Study|Lack of Efficacy|1
456901|NCT00346164|1503201|P1|Overall Study|Lack of Efficacy|0
456902|NCT00346164|1503198|P4|Overall Study|Adverse Event|1
456903|NCT00346164|1503199|P3|Overall Study|Adverse Event|0
456904|NCT00346164|1503200|P2|Overall Study|Adverse Event|0
456905|NCT00346164|1503201|P1|Overall Study|Adverse Event|0
456906|NCT00346151|1503236|P1|Overall Study|Withdrawal by Subject|3
456907|NCT00346034|1503254|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
456908|NCT00346034|1503254|P1|Overall Study|Patient Stopped Taking Study Drug|1
456909|NCT00346034|1503254|P1|Overall Study|Withdrawal by Subject|13
456910|NCT00346034|1503254|P1|Overall Study|Lack of Efficacy|8
456911|NCT00346034|1503254|P1|Overall Study|Adverse Event|34
456912|NCT00345878|1503294|P2|Overall Study|Other|0
456913|NCT00345878|1503295|P1|Overall Study|Other|1
456914|NCT00345878|1503294|P2|Overall Study|Lost to Follow-up|1
456915|NCT00345878|1503295|P1|Overall Study|Lost to Follow-up|2
456916|NCT00345878|1503294|P2|Overall Study|Adverse Event|0
456917|NCT00345878|1503295|P1|Overall Study|Adverse Event|1
456918|NCT00345839|1503313|P2|Overall Study|Lost to Follow-up|61
456919|NCT00345839|1503314|P1|Overall Study|Lost to Follow-up|58
456920|NCT00345839|1503313|P2|Overall Study|Withdrawal by Subject|98
456921|NCT00345839|1503314|P1|Overall Study|Withdrawal by Subject|91
456922|NCT00345683|1503340|P2|Overall Study|Other|2
456923|NCT00345683|1503341|P1|Overall Study|Other|6
456924|NCT00345683|1503340|P2|Overall Study|Lost to Follow-up|7
456925|NCT00345683|1503341|P1|Overall Study|Lost to Follow-up|19
456926|NCT00345631|1503364|P3|Overall Study|Other reasons|1
456927|NCT00345631|1503365|P2|Overall Study|Other reasons|0
456928|NCT00345631|1503366|P1|Overall Study|Other reasons|0
456929|NCT00345631|1503364|P3|Overall Study|Lost to Follow-up|4
456930|NCT00345631|1503365|P2|Overall Study|Lost to Follow-up|7
456931|NCT00345631|1503366|P1|Overall Study|Lost to Follow-up|3
456932|NCT00345631|1503364|P3|Overall Study|Adverse Event|0
456933|NCT00345631|1503365|P2|Overall Study|Adverse Event|1
456934|NCT00345631|1503366|P1|Overall Study|Adverse Event|0
456935|NCT00345631|1503364|P3|Overall Study|Withdrawal by Subject|1
456936|NCT00345631|1503365|P2|Overall Study|Withdrawal by Subject|0
456937|NCT00345631|1503366|P1|Overall Study|Withdrawal by Subject|1
456938|NCT00345605|1503398|P2|Arm 2, Opposite Treatment|Adverse Event|0
456939|NCT00345605|1503399|P1|Arm 2, Opposite Treatment|Adverse Event|1
456940|NCT00345605|1503398|P2|Arm 1|Adverse Event|1
456941|NCT00345605|1503399|P1|Arm 1|Adverse Event|0
456942|NCT00345592|1503419|P2|Overall Study|Withdrawal by Subject|8
456943|NCT00345592|1503420|P1|Overall Study|Withdrawal by Subject|11
456944|NCT00345592|1503419|P2|Overall Study|Death|16
456945|NCT00345592|1503420|P1|Overall Study|Death|14
456946|NCT00345579|1503428|P2|Overall Study|Other|1
456947|NCT00345579|1503429|P1|Overall Study|Other|9
456948|NCT00345579|1503428|P2|Overall Study|Lost to Follow-up|36
456949|NCT00345579|1503429|P1|Overall Study|Lost to Follow-up|82
456950|NCT00345579|1503428|P2|Overall Study|Withdrawal by Subject|17
456951|NCT00345579|1503429|P1|Overall Study|Withdrawal by Subject|50
456952|NCT00345579|1503428|P2|Overall Study|Protocol Violation|5
456953|NCT00345579|1503429|P1|Overall Study|Protocol Violation|14
456954|NCT00345579|1503428|P2|Overall Study|Adverse Event|6
456955|NCT00345579|1503429|P1|Overall Study|Adverse Event|9
456956|NCT00345540|1503449|P1|Overall Study|Withdrawal by Subject|1
456957|NCT00345397|1503455|P1|Overall Study|Death|1
456958|NCT00345293|1503493|P2|Overall Study|Withdrawal by Subject|0
456959|NCT00345293|1503494|P1|Overall Study|Withdrawal by Subject|1
456960|NCT00345293|1503493|P2|Overall Study|Unable to access line for sample|0
456961|NCT00345293|1503494|P1|Overall Study|Unable to access line for sample|1
456962|NCT00345046|1503540|P3|Overall Study|Protocol Violation|2
456963|NCT00345046|1503541|P2|Overall Study|Protocol Violation|1
456964|NCT00345046|1503542|P1|Overall Study|Protocol Violation|1
456965|NCT00344968|1503572|P3|Overall Study|Other|0
456966|NCT00344968|1503573|P2|Overall Study|Other|1
456967|NCT00344968|1503574|P1|Overall Study|Other|0
456968|NCT00344968|1503572|P3|Overall Study|Death|31
456969|NCT00344968|1503573|P2|Overall Study|Death|27
456970|NCT00344968|1503574|P1|Overall Study|Death|11
456971|NCT00344968|1503572|P3|Overall Study|Lost to Follow-up|37
456972|NCT00344968|1503573|P2|Overall Study|Lost to Follow-up|37
456973|NCT00344968|1503574|P1|Overall Study|Lost to Follow-up|24
456974|NCT00344968|1503572|P3|Overall Study|Withdrawal by Subject|27
456975|NCT00344968|1503573|P2|Overall Study|Withdrawal by Subject|31
456976|NCT00344968|1503574|P1|Overall Study|Withdrawal by Subject|14
456977|NCT00344968|1503572|P3|Overall Study|Protocol Violation|5
456978|NCT00344968|1503573|P2|Overall Study|Protocol Violation|2
456979|NCT00344968|1503574|P1|Overall Study|Protocol Violation|2
456980|NCT00344968|1503572|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
456981|NCT00344968|1503573|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
456982|NCT00344968|1503574|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
456983|NCT00344968|1503572|P3|Overall Study|Adverse Event|15
456984|NCT00344968|1503573|P2|Overall Study|Adverse Event|4
456985|NCT00344968|1503574|P1|Overall Study|Adverse Event|5
456986|NCT00344773|1503585|P1|Overall Study|Not Eligible for the study|2
456987|NCT00344773|1503585|P1|Overall Study|Withdrawal by Subject|1
456988|NCT00344773|1503585|P1|Overall Study|Objective Disease Progression|16
456989|NCT00344773|1503585|P1|Overall Study|Adverse Event|2
456990|NCT00344500|1503608|P3|Overall Study|Not Noted|0
456991|NCT00344500|1503609|P2|Overall Study|Not Noted|3
456992|NCT00344500|1503610|P1|Overall Study|Not Noted|1
456993|NCT00344500|1503608|P3|Overall Study|Protocol Violation|1
456994|NCT00344500|1503609|P2|Overall Study|Protocol Violation|7
456995|NCT00344500|1503610|P1|Overall Study|Protocol Violation|4
456996|NCT00344500|1503608|P3|Overall Study|Withdrawal by Subject|0
456997|NCT00344500|1503609|P2|Overall Study|Withdrawal by Subject|10
456998|NCT00344500|1503610|P1|Overall Study|Withdrawal by Subject|7
456999|NCT00344500|1503608|P3|Overall Study|Lost to Follow-up|1
457000|NCT00344500|1503609|P2|Overall Study|Lost to Follow-up|13
457001|NCT00344500|1503610|P1|Overall Study|Lost to Follow-up|5
457002|NCT00344500|1503608|P3|Overall Study|Adverse Event|0
457003|NCT00344500|1503609|P2|Overall Study|Adverse Event|2
457004|NCT00344500|1503610|P1|Overall Study|Adverse Event|6
457005|NCT00344487|1503621|P1|Overall Study|immunologic failure|1
457006|NCT00344461|1503625|P1|Overall Study|Withdrawal by Subject|2
457007|NCT00344461|1503625|P1|Overall Study|Protocol Violation|6
457008|NCT00344461|1503625|P1|Overall Study|Physician Decision|2
457009|NCT00344461|1503625|P1|Overall Study|Lost to Follow-up|2
457010|NCT00344461|1503625|P1|Overall Study|Lack of Efficacy|2
457011|NCT00344461|1503625|P1|Overall Study|Death|1
457012|NCT00344461|1503625|P1|Overall Study|Adverse Event|6
457013|NCT00344448|1503636|P2|Open Label|Study terminated|0
457014|NCT00344448|1503637|P1|Open Label|Study terminated|1
457015|NCT00344448|1503636|P2|Open Label|Withdrawal by Subject|1
457016|NCT00344448|1503637|P1|Open Label|Withdrawal by Subject|1
457017|NCT00344448|1503636|P2|Double Blind, Placebo Controlled|Study terminated|0
457018|NCT00344448|1503637|P1|Double Blind, Placebo Controlled|Study terminated|1
457019|NCT00344448|1503636|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
457020|NCT00344448|1503637|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
457021|NCT00344448|1503636|P2|Screening|Withdrawal by Subject|1
457022|NCT00344448|1503637|P1|Screening|Withdrawal by Subject|0
457023|NCT00344305|1503656|P2|Overall Study|Participant was not contacted in window|1
457024|NCT00344305|1503657|P1|Overall Study|Participant was not contacted in window|0
457025|NCT00344305|1503656|P2|Overall Study|Lost to Follow-up|0
457026|NCT00344305|1503657|P1|Overall Study|Lost to Follow-up|2
457027|NCT00344032|1503707|P2|Overall Study|Physician Decision|1
457028|NCT00344032|1503708|P1|Overall Study|Physician Decision|4
457029|NCT00344032|1503707|P2|Overall Study|Lost to Follow-up|6
457030|NCT00344032|1503708|P1|Overall Study|Lost to Follow-up|4
457031|NCT00344032|1503707|P2|Overall Study|Withdrawal by Subject|2
457032|NCT00344032|1503708|P1|Overall Study|Withdrawal by Subject|6
457033|NCT00344032|1503707|P2|Overall Study|Adverse Event|1
457034|NCT00344032|1503708|P1|Overall Study|Adverse Event|0
457035|NCT00344019|1503727|P3|Overall Study|did not meet final inclusion criteria|74
457036|NCT00344019|1503728|P2|Overall Study|did not meet final inclusion criteria|0
457037|NCT00344019|1503729|P1|Overall Study|did not meet final inclusion criteria|0
457038|NCT00343915|1503747|P2|Primary Study|Other|0
457039|NCT00343915|1503748|P1|Primary Study|Other|1
457040|NCT00343915|1503747|P2|Primary Study|Lost to Follow-up|3
457041|NCT00343915|1503748|P1|Primary Study|Lost to Follow-up|2
457042|NCT00343915|1503747|P2|Primary Study|Withdrawal by Subject|0
457043|NCT00343915|1503748|P1|Primary Study|Withdrawal by Subject|1
457044|NCT00343889|1503774|P2|Overall Study|Protocol Violation|0
457045|NCT00343889|1503775|P1|Overall Study|Protocol Violation|1
457046|NCT00343889|1503774|P2|Overall Study|Withdrawal by Subject|1
457047|NCT00343889|1503775|P1|Overall Study|Withdrawal by Subject|0
457048|NCT00343889|1503774|P2|Overall Study|Lost to Follow-up|0
457049|NCT00343889|1503775|P1|Overall Study|Lost to Follow-up|2
457050|NCT00343512|1503858|P1|Overall Study|Withdrawal by Subject|2
457051|NCT00343382|1503946|P3|Overall Study|Other Reason Not Specified|4
457052|NCT00343382|1503947|P2|Overall Study|Other Reason Not Specified|2
457053|NCT00343382|1503948|P1|Overall Study|Other Reason Not Specified|1
457054|NCT00343382|1503946|P3|Overall Study|Withdrawal by Subject|6
457055|NCT00343382|1503947|P2|Overall Study|Withdrawal by Subject|2
457056|NCT00343382|1503948|P1|Overall Study|Withdrawal by Subject|1
457057|NCT00343382|1503946|P3|Overall Study|Adverse Event|7
457058|NCT00343382|1503947|P2|Overall Study|Adverse Event|10
457059|NCT00343382|1503948|P1|Overall Study|Adverse Event|2
457060|NCT00343291|1503967|P2|Overall Study|Other|5
457061|NCT00343291|1503968|P1|Overall Study|Other|8
457062|NCT00343291|1503967|P2|Overall Study|Withdrawal by Subject|2
457063|NCT00343291|1503968|P1|Overall Study|Withdrawal by Subject|0
457064|NCT00343291|1503967|P2|Overall Study|Progressive disease|34
457065|NCT00343291|1503968|P1|Overall Study|Progressive disease|33
457066|NCT00343291|1503967|P2|Overall Study|Death|2
457067|NCT00343291|1503968|P1|Overall Study|Death|3
457068|NCT00343291|1503967|P2|Overall Study|Adverse Event|13
457069|NCT00343291|1503968|P1|Overall Study|Adverse Event|13
457070|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
457071|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
457072|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Sponsor Decision|5
457073|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Sponsor Decision|8
457074|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Protocol Violation|3
457075|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Protocol Violation|3
457076|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Physician Decision|7
457077|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Physician Decision|4
457078|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
457079|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
457080|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
457081|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
457082|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
457083|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
457084|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Death|5
457085|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Death|4
457086|NCT00343252|1503984|P2|18 Months (All Treated Participants)|Adverse Event|23
457087|NCT00343252|1503985|P1|18 Months (All Treated Participants)|Adverse Event|31
457088|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
457089|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
457090|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Sponsor Decision|6
457091|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Sponsor Decision|9
457092|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Protocol Violation|2
457093|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Protocol Violation|3
457094|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Physician Decision|5
457095|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Physician Decision|4
457096|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
457097|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
457098|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
457099|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
457100|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
457101|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
457102|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Death|3
457103|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Death|3
457104|NCT00343252|1503984|P2|12 Months (All Treated Participants)|Adverse Event|20
457105|NCT00343252|1503985|P1|12 Months (All Treated Participants)|Adverse Event|22
457106|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
457107|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
457108|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Sponsor Decision|4
457109|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Sponsor Decision|7
457110|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Protocol Violation|2
457111|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Protocol Violation|2
457112|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Physician Decision|3
457113|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Physician Decision|1
457114|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
457115|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
457116|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
457117|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
457118|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
457119|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
457120|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Death|2
457121|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Death|0
457122|NCT00343252|1503984|P2|6 Months (All Treated Participants)|Adverse Event|11
457123|NCT00343252|1503985|P1|6 Months (All Treated Participants)|Adverse Event|17
457124|NCT00342628|1504050|P3|Overall Study|moved residence|1
457125|NCT00342628|1504051|P2|Overall Study|moved residence|1
457126|NCT00342628|1504052|P1|Overall Study|moved residence|0
457127|NCT00342628|1504050|P3|Overall Study|Death|0
457128|NCT00342628|1504051|P2|Overall Study|Death|1
457129|NCT00342628|1504052|P1|Overall Study|Death|1
457130|NCT00342628|1504050|P3|Overall Study|Withdrawal by Subject|18
457131|NCT00342628|1504051|P2|Overall Study|Withdrawal by Subject|19
457132|NCT00342628|1504052|P1|Overall Study|Withdrawal by Subject|19
457133|NCT00340834|1504118|P5|Extension Phase of Study|Death|1
457134|NCT00340834|1504119|P4|Extension Phase of Study|Death|0
457135|NCT00340834|1504120|P3|Extension Phase of Study|Death|0
457136|NCT00340834|1504121|P2|Extension Phase of Study|Death|0
457137|NCT00340834|1504122|P1|Extension Phase of Study|Death|0
457138|NCT00340834|1504118|P5|Extension Phase of Study|Protocol Violation|0
457139|NCT00340834|1504119|P4|Extension Phase of Study|Protocol Violation|0
457140|NCT00340834|1504120|P3|Extension Phase of Study|Protocol Violation|0
457141|NCT00340834|1504121|P2|Extension Phase of Study|Protocol Violation|0
457142|NCT00340834|1504122|P1|Extension Phase of Study|Protocol Violation|3
457143|NCT00340834|1504118|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
457144|NCT00340834|1504119|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
457145|NCT00340834|1504120|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
457146|NCT00340834|1504121|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
457147|NCT00340834|1504122|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
457148|NCT00340834|1504118|P5|Extension Phase of Study|Administrative problems|1
457149|NCT00340834|1504119|P4|Extension Phase of Study|Administrative problems|1
457150|NCT00340834|1504120|P3|Extension Phase of Study|Administrative problems|0
457151|NCT00340834|1504121|P2|Extension Phase of Study|Administrative problems|0
457152|NCT00340834|1504122|P1|Extension Phase of Study|Administrative problems|3
457153|NCT00340834|1504118|P5|Extension Phase of Study|Subject no longer requires study drug|2
457154|NCT00340834|1504119|P4|Extension Phase of Study|Subject no longer requires study drug|0
457155|NCT00340834|1504120|P3|Extension Phase of Study|Subject no longer requires study drug|0
457156|NCT00340834|1504121|P2|Extension Phase of Study|Subject no longer requires study drug|0
457157|NCT00340834|1504122|P1|Extension Phase of Study|Subject no longer requires study drug|4
457158|NCT00340834|1504118|P5|Extension Phase of Study|Lost to Follow-up|3
457159|NCT00340834|1504119|P4|Extension Phase of Study|Lost to Follow-up|2
457160|NCT00340834|1504120|P3|Extension Phase of Study|Lost to Follow-up|0
457161|NCT00340834|1504121|P2|Extension Phase of Study|Lost to Follow-up|1
457162|NCT00340834|1504122|P1|Extension Phase of Study|Lost to Follow-up|1
457163|NCT00340834|1504118|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
457164|NCT00340834|1504119|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
457165|NCT00340834|1504120|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
457166|NCT00340834|1504121|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
457167|NCT00340834|1504122|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
457168|NCT00340834|1504118|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
457169|NCT00340834|1504119|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
457170|NCT00340834|1504120|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
457171|NCT00340834|1504121|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
457172|NCT00340834|1504122|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
457173|NCT00340834|1504118|P5|Extension Phase of Study|Adverse Event|7
457174|NCT00340834|1504119|P4|Extension Phase of Study|Adverse Event|19
457175|NCT00340834|1504120|P3|Extension Phase of Study|Adverse Event|0
457176|NCT00340834|1504121|P2|Extension Phase of Study|Adverse Event|22
457177|NCT00340834|1504122|P1|Extension Phase of Study|Adverse Event|21
457178|NCT00340834|1504118|P5|Extension Phase of Study|Subject withdrew consent|15
457179|NCT00340834|1504119|P4|Extension Phase of Study|Subject withdrew consent|12
457180|NCT00340834|1504120|P3|Extension Phase of Study|Subject withdrew consent|0
457181|NCT00340834|1504121|P2|Extension Phase of Study|Subject withdrew consent|31
457182|NCT00340834|1504122|P1|Extension Phase of Study|Subject withdrew consent|26
457183|NCT00340834|1504118|P5|Extension Phase of Study|Subject did not receive study drug|0
457184|NCT00340834|1504119|P4|Extension Phase of Study|Subject did not receive study drug|2
457185|NCT00340834|1504120|P3|Extension Phase of Study|Subject did not receive study drug|0
457186|NCT00340834|1504121|P2|Extension Phase of Study|Subject did not receive study drug|1
457187|NCT00340834|1504122|P1|Extension Phase of Study|Subject did not receive study drug|0
457188|NCT00340834|1504118|P5|Core Phase of Study|Protocol Violation|0
457189|NCT00340834|1504119|P4|Core Phase of Study|Protocol Violation|0
457190|NCT00340834|1504120|P3|Core Phase of Study|Protocol Violation|2
457191|NCT00340834|1504121|P2|Core Phase of Study|Protocol Violation|0
457192|NCT00340834|1504122|P1|Core Phase of Study|Protocol Violation|0
457193|NCT00340834|1504118|P5|Core Phase of Study|Death|0
457194|NCT00340834|1504119|P4|Core Phase of Study|Death|0
457195|NCT00340834|1504120|P3|Core Phase of Study|Death|0
457196|NCT00340834|1504121|P2|Core Phase of Study|Death|0
457197|NCT00340834|1504122|P1|Core Phase of Study|Death|2
457198|NCT00340834|1504118|P5|Core Phase of Study|Lost to Follow-up|0
457199|NCT00340834|1504119|P4|Core Phase of Study|Lost to Follow-up|0
457200|NCT00340834|1504120|P3|Core Phase of Study|Lost to Follow-up|4
457201|NCT00340834|1504121|P2|Core Phase of Study|Lost to Follow-up|1
457202|NCT00340834|1504122|P1|Core Phase of Study|Lost to Follow-up|1
457203|NCT00340834|1504118|P5|Core Phase of Study|Abnormal test procedure result(s)|0
457204|NCT00340834|1504119|P4|Core Phase of Study|Abnormal test procedure result(s)|0
457205|NCT00340834|1504120|P3|Core Phase of Study|Abnormal test procedure result(s)|3
457206|NCT00340834|1504121|P2|Core Phase of Study|Abnormal test procedure result(s)|3
457207|NCT00340834|1504122|P1|Core Phase of Study|Abnormal test procedure result(s)|4
457208|NCT00340834|1504118|P5|Core Phase of Study|Abnormal laboratory value(s)|0
457209|NCT00340834|1504119|P4|Core Phase of Study|Abnormal laboratory value(s)|0
457210|NCT00340834|1504120|P3|Core Phase of Study|Abnormal laboratory value(s)|1
457211|NCT00340834|1504121|P2|Core Phase of Study|Abnormal laboratory value(s)|6
457212|NCT00340834|1504122|P1|Core Phase of Study|Abnormal laboratory value(s)|4
457213|NCT00340834|1504118|P5|Core Phase of Study|Lack of Efficacy|0
457214|NCT00340834|1504119|P4|Core Phase of Study|Lack of Efficacy|0
457215|NCT00340834|1504120|P3|Core Phase of Study|Lack of Efficacy|7
457216|NCT00340834|1504121|P2|Core Phase of Study|Lack of Efficacy|3
457217|NCT00340834|1504122|P1|Core Phase of Study|Lack of Efficacy|3
457218|NCT00340834|1504118|P5|Core Phase of Study|Administrative Problems|0
457219|NCT00340834|1504119|P4|Core Phase of Study|Administrative Problems|0
457220|NCT00340834|1504120|P3|Core Phase of Study|Administrative Problems|7
457221|NCT00340834|1504121|P2|Core Phase of Study|Administrative Problems|2
457222|NCT00340834|1504122|P1|Core Phase of Study|Administrative Problems|6
457223|NCT00340834|1504118|P5|Core Phase of Study|Withdrawal by Subject|0
457224|NCT00340834|1504119|P4|Core Phase of Study|Withdrawal by Subject|0
457225|NCT00340834|1504120|P3|Core Phase of Study|Withdrawal by Subject|16
457226|NCT00340834|1504121|P2|Core Phase of Study|Withdrawal by Subject|9
457227|NCT00340834|1504122|P1|Core Phase of Study|Withdrawal by Subject|11
457228|NCT00340834|1504118|P5|Core Phase of Study|Adverse Event|0
457229|NCT00340834|1504119|P4|Core Phase of Study|Adverse Event|0
457230|NCT00340834|1504120|P3|Core Phase of Study|Adverse Event|9
457231|NCT00340834|1504121|P2|Core Phase of Study|Adverse Event|9
457232|NCT00340834|1504122|P1|Core Phase of Study|Adverse Event|26
457233|NCT00340704|1504156|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
457234|NCT00340704|1504157|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
457235|NCT00340704|1504158|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
457236|NCT00340704|1504159|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
457237|NCT00340704|1504160|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
457238|NCT00340704|1504161|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
457239|NCT00340704|1504162|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
457240|NCT00340704|1504163|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
457241|NCT00340704|1504164|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
457242|NCT00340704|1504156|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
457243|NCT00340704|1504157|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
457244|NCT00340704|1504158|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
457245|NCT00340704|1504159|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
457246|NCT00340704|1504160|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
457247|NCT00340704|1504161|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
457248|NCT00340704|1504162|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
457249|NCT00340704|1504163|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
457250|NCT00340704|1504164|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
457251|NCT00340704|1504156|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457252|NCT00340704|1504157|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457253|NCT00340704|1504158|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457254|NCT00340704|1504159|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
457255|NCT00340704|1504160|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457256|NCT00340704|1504161|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457257|NCT00340704|1504162|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457258|NCT00340704|1504163|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457259|NCT00340704|1504164|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
457260|NCT00340704|1504156|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
457261|NCT00340704|1504157|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
457262|NCT00340704|1504158|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
457263|NCT00340704|1504159|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
457264|NCT00340704|1504160|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
457265|NCT00340704|1504161|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
457266|NCT00340704|1504162|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
457267|NCT00340704|1504163|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
457268|NCT00340704|1504164|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
457269|NCT00340704|1504156|P9|PK Study|Not treated|0
457270|NCT00340704|1504157|P8|PK Study|Not treated|0
457271|NCT00340704|1504158|P7|PK Study|Not treated|0
457272|NCT00340704|1504159|P6|PK Study|Not treated|0
457273|NCT00340704|1504160|P5|PK Study|Not treated|0
457274|NCT00340704|1504161|P4|PK Study|Not treated|0
457275|NCT00340704|1504162|P3|PK Study|Not treated|1
457276|NCT00340704|1504163|P2|PK Study|Not treated|0
457277|NCT00340704|1504164|P1|PK Study|Not treated|0
457278|NCT00340704|1504156|P9|PK Study|Adverse Event|0
457279|NCT00340704|1504157|P8|PK Study|Adverse Event|0
457280|NCT00340704|1504158|P7|PK Study|Adverse Event|0
457281|NCT00340704|1504159|P6|PK Study|Adverse Event|0
457282|NCT00340704|1504160|P5|PK Study|Adverse Event|0
457283|NCT00340704|1504161|P4|PK Study|Adverse Event|0
457284|NCT00340704|1504162|P3|PK Study|Adverse Event|0
457285|NCT00340704|1504163|P2|PK Study|Adverse Event|1
457286|NCT00340704|1504164|P1|PK Study|Adverse Event|0
457287|NCT00340678|1504270|P4|Overall Study|Lost to Follow-up|0
457288|NCT00340678|1504271|P3|Overall Study|Lost to Follow-up|0
457289|NCT00340678|1504272|P2|Overall Study|Lost to Follow-up|0
457290|NCT00340678|1504273|P1|Overall Study|Lost to Follow-up|1
457291|NCT00339833|1504300|P2|Overall Study|Error in data records|0
457292|NCT00339833|1504301|P1|Overall Study|Error in data records|1
457293|NCT00339833|1504300|P2|Overall Study|anaemia or excess drop in glycaemia|0
457294|NCT00339833|1504301|P1|Overall Study|anaemia or excess drop in glycaemia|2
457295|NCT00339833|1504300|P2|Overall Study|Poor venous access|2
457296|NCT00339833|1504301|P1|Overall Study|Poor venous access|2
457297|NCT00339833|1504300|P2|Overall Study|minor infection|1
457298|NCT00339833|1504301|P1|Overall Study|minor infection|0
457299|NCT00339833|1504300|P2|Overall Study|Chest pain|1
457300|NCT00339833|1504301|P1|Overall Study|Chest pain|0
457301|NCT00339833|1504300|P2|Overall Study|indigestion|1
457302|NCT00339833|1504301|P1|Overall Study|indigestion|0
457303|NCT00339833|1504300|P2|Overall Study|toothache|1
457304|NCT00339833|1504301|P1|Overall Study|toothache|0
457305|NCT00339833|1504300|P2|Overall Study|Withdrawal by Subject|2
457306|NCT00339833|1504301|P1|Overall Study|Withdrawal by Subject|1
457307|NCT00339183|1504311|P2|Overall Study|Ongoing|13
457308|NCT00339183|1504312|P1|Overall Study|Ongoing|20
457309|NCT00339183|1504311|P2|Overall Study|Other|40
457310|NCT00339183|1504312|P1|Overall Study|Other|46
457311|NCT00339183|1504311|P2|Overall Study|Missing reason|1
457312|NCT00339183|1504312|P1|Overall Study|Missing reason|3
457313|NCT00339183|1504311|P2|Overall Study|Protocol-specified criteria|8
457314|NCT00339183|1504312|P1|Overall Study|Protocol-specified criteria|12
457315|NCT00339183|1504311|P2|Overall Study|Lost to Follow-up|17
457316|NCT00339183|1504312|P1|Overall Study|Lost to Follow-up|17
457317|NCT00339183|1504311|P2|Overall Study|Physician Decision|4
457318|NCT00339183|1504312|P1|Overall Study|Physician Decision|2
457319|NCT00339183|1504311|P2|Overall Study|Withdrawal by Subject|19
457320|NCT00339183|1504312|P1|Overall Study|Withdrawal by Subject|16
457321|NCT00339183|1504311|P2|Overall Study|Adverse Event|3
457322|NCT00339183|1504312|P1|Overall Study|Adverse Event|5
457323|NCT00339144|1504341|P3|Overall Study|Participant's request to discontinuation|1
457324|NCT00339144|1504342|P2|Overall Study|Participant's request to discontinuation|0
457325|NCT00339144|1504343|P1|Overall Study|Participant's request to discontinuation|1
457326|NCT00339144|1504341|P3|Overall Study|Study drug toxicity|1
457327|NCT00339144|1504342|P2|Overall Study|Study drug toxicity|1
457328|NCT00339144|1504343|P1|Overall Study|Study drug toxicity|3
457329|NCT00339144|1504341|P3|Overall Study|Disease progression|2
457330|NCT00339144|1504342|P2|Overall Study|Disease progression|2
457331|NCT00339144|1504343|P1|Overall Study|Disease progression|5
457332|NCT00339040|1504448|P2|Stage II|Site closing|0
457333|NCT00339040|1504449|P1|Stage II|Site closing|2
457334|NCT00339040|1504448|P2|Stage II|Not able to attend clinic|0
457335|NCT00339040|1504449|P1|Stage II|Not able to attend clinic|1
457336|NCT00339040|1504448|P2|Stage II|Protocol Violation|0
457337|NCT00339040|1504449|P1|Stage II|Protocol Violation|3
457338|NCT00339040|1504448|P2|Stage II|Withdrawal by Subject|2
457339|NCT00339040|1504449|P1|Stage II|Withdrawal by Subject|1
457340|NCT00339040|1504448|P2|Stage II|Lost to Follow-up|0
457341|NCT00339040|1504449|P1|Stage II|Lost to Follow-up|3
457342|NCT00339040|1504448|P2|Stage I|Protocol Violation|1
457343|NCT00339040|1504449|P1|Stage I|Protocol Violation|1
457344|NCT00339040|1504448|P2|Stage I|Not able to attend clinic|0
457345|NCT00339040|1504449|P1|Stage I|Not able to attend clinic|1
457346|NCT00338962|1504476|P4|Overall Study|Poor Compliance|0
457347|NCT00338962|1504477|P3|Overall Study|Poor Compliance|2
457348|NCT00338962|1504478|P2|Overall Study|Poor Compliance|0
457349|NCT00338962|1504479|P1|Overall Study|Poor Compliance|0
457350|NCT00338962|1504476|P4|Overall Study|Adverse Event|0
457351|NCT00338962|1504477|P3|Overall Study|Adverse Event|2
457352|NCT00338962|1504478|P2|Overall Study|Adverse Event|0
457353|NCT00338962|1504479|P1|Overall Study|Adverse Event|0
457354|NCT00338962|1504476|P4|Overall Study|Moved|0
457355|NCT00338962|1504477|P3|Overall Study|Moved|0
457356|NCT00338962|1504478|P2|Overall Study|Moved|1
457357|NCT00338962|1504479|P1|Overall Study|Moved|0
457358|NCT00338962|1504476|P4|Overall Study|Time Constraint|0
457359|NCT00338962|1504477|P3|Overall Study|Time Constraint|0
457360|NCT00338962|1504478|P2|Overall Study|Time Constraint|0
457361|NCT00338962|1504479|P1|Overall Study|Time Constraint|2
457362|NCT00338962|1504476|P4|Overall Study|No Transportation|0
457363|NCT00338962|1504477|P3|Overall Study|No Transportation|0
457364|NCT00338962|1504478|P2|Overall Study|No Transportation|0
457365|NCT00338962|1504479|P1|Overall Study|No Transportation|2
457366|NCT00338962|1504476|P4|Overall Study|Withdrawal by Subject|0
457367|NCT00338962|1504477|P3|Overall Study|Withdrawal by Subject|0
457368|NCT00338962|1504478|P2|Overall Study|Withdrawal by Subject|0
457369|NCT00338962|1504479|P1|Overall Study|Withdrawal by Subject|1
457370|NCT00338962|1504476|P4|Overall Study|Lost to Follow-up|3
457371|NCT00338962|1504477|P3|Overall Study|Lost to Follow-up|2
457372|NCT00338962|1504478|P2|Overall Study|Lost to Follow-up|3
457373|NCT00338962|1504479|P1|Overall Study|Lost to Follow-up|3
457374|NCT00338884|1504501|P1|Overall Study|Randomized But Did Not Receive Treatment|1
457375|NCT00338884|1504501|P1|Overall Study|Lost to Follow-up|1
457376|NCT00338884|1504501|P1|Overall Study|Withdrawal by Subject|3
457377|NCT00338884|1504501|P1|Overall Study|Global Deterioration of Health Status|3
457378|NCT00338884|1504501|P1|Overall Study|Other|4
457379|NCT00338884|1504501|P1|Overall Study|Death|8
457380|NCT00338884|1504501|P1|Overall Study|Adverse Event|14
457381|NCT00338884|1504501|P1|Overall Study|Objective Disease Progression or Relapse|44
457382|NCT00338806|1504535|P2|Follow-up|Lost to Follow-up|3
457383|NCT00338806|1504536|P1|Follow-up|Lost to Follow-up|1
457384|NCT00338806|1504535|P2|Acute Phase|Withdrawal by Subject|1
457385|NCT00338806|1504536|P1|Acute Phase|Withdrawal by Subject|0
457386|NCT00338741|1504598|P2|Overall Study|Lost to Follow-up|0
457387|NCT00338741|1504599|P1|Overall Study|Lost to Follow-up|2
457388|NCT00338455|1504630|P2|Overall Study|Physician Decision|0
457389|NCT00338455|1504631|P1|Overall Study|Physician Decision|1
457390|NCT00338455|1504630|P2|Overall Study|Death|1
457391|NCT00338455|1504631|P1|Overall Study|Death|2
457392|NCT00338286|1504645|P2|Overall Study|Other|93
457393|NCT00338286|1504646|P1|Overall Study|Other|103
457394|NCT00338286|1504645|P2|Overall Study|Lost to Follow-up|66
457395|NCT00338286|1504646|P1|Overall Study|Lost to Follow-up|80
457396|NCT00338286|1504645|P2|Overall Study|Withdrawal by Subject|54
457397|NCT00338286|1504646|P1|Overall Study|Withdrawal by Subject|50
457398|NCT00338104|1504663|P3|Overall Study|Protocol Violation|3
457399|NCT00338104|1504664|P2|Overall Study|Protocol Violation|1
457400|NCT00338104|1504665|P1|Overall Study|Protocol Violation|2
457401|NCT00337935|1504688|P2|Overall Study|Lack of Efficacy|1
457402|NCT00337935|1504689|P1|Overall Study|Lack of Efficacy|0
457403|NCT00337935|1504688|P2|Overall Study|Other|1
457404|NCT00337935|1504689|P1|Overall Study|Other|0
457405|NCT00337935|1504688|P2|Overall Study|Withdrawal by Subject|7
457406|NCT00337935|1504689|P1|Overall Study|Withdrawal by Subject|1
457407|NCT00337935|1504688|P2|Overall Study|Protocol Violation|3
457408|NCT00337935|1504689|P1|Overall Study|Protocol Violation|4
457409|NCT00337935|1504688|P2|Overall Study|Lost to Follow-up|1
457410|NCT00337935|1504689|P1|Overall Study|Lost to Follow-up|0
457411|NCT00337935|1504688|P2|Overall Study|Physician Decision|1
457412|NCT00337935|1504689|P1|Overall Study|Physician Decision|1
457413|NCT00337935|1504688|P2|Overall Study|Death|8
457414|NCT00337935|1504689|P1|Overall Study|Death|2
457415|NCT00337935|1504688|P2|Overall Study|Adverse Event|5
457416|NCT00337935|1504689|P1|Overall Study|Adverse Event|2
457417|NCT00337818|1504702|P3|Overall Study|Lost to Follow-up|107
457418|NCT00337818|1504703|P2|Overall Study|Lost to Follow-up|91
457419|NCT00337818|1504704|P1|Overall Study|Lost to Follow-up|289
457420|NCT00337779|1504726|P2|Overall Study|Death|1
457421|NCT00337779|1504727|P1|Overall Study|Death|0
457422|NCT00337779|1504726|P2|Overall Study|Pregnancy|2
457423|NCT00337779|1504727|P1|Overall Study|Pregnancy|3
457424|NCT00337779|1504726|P2|Overall Study|Adverse Event|51
457425|NCT00337779|1504727|P1|Overall Study|Adverse Event|28
457426|NCT00337779|1504726|P2|Overall Study|Lost to Follow-up|5
457427|NCT00337779|1504727|P1|Overall Study|Lost to Follow-up|6
457428|NCT00337779|1504726|P2|Overall Study|Protocol Violation|1
457429|NCT00337779|1504727|P1|Overall Study|Protocol Violation|1
457430|NCT00337779|1504726|P2|Overall Study|Physician Decision|6
457431|NCT00337779|1504727|P1|Overall Study|Physician Decision|3
457432|NCT00337779|1504726|P2|Overall Study|Sponsor decision|1
457433|NCT00337779|1504727|P1|Overall Study|Sponsor decision|1
457434|NCT00337779|1504726|P2|Overall Study|Withdrawal by Subject|12
457435|NCT00337779|1504727|P1|Overall Study|Withdrawal by Subject|10
457436|NCT00337727|1504739|P2|Overall Study|Withdrawal by Subject|5
457437|NCT00337727|1504740|P1|Overall Study|Withdrawal by Subject|3
457438|NCT00337727|1504739|P2|Overall Study|Protocol Violation|0
457439|NCT00337727|1504740|P1|Overall Study|Protocol Violation|4
457440|NCT00337727|1504739|P2|Overall Study|Physician Decision|0
457441|NCT00337727|1504740|P1|Overall Study|Physician Decision|1
457442|NCT00337727|1504739|P2|Overall Study|Lost to Follow-up|4
457443|NCT00337727|1504740|P1|Overall Study|Lost to Follow-up|5
457444|NCT00337727|1504739|P2|Overall Study|Adverse Event|3
457445|NCT00337727|1504740|P1|Overall Study|Adverse Event|5
457446|NCT00337675|1504751|P3|Overall Study|Trial Terminated|2
457447|NCT00337675|1504752|P2|Overall Study|Trial Terminated|0
457448|NCT00337675|1504753|P1|Overall Study|Trial Terminated|0
457449|NCT00337675|1504751|P3|Overall Study|Progressive Disease|0
457450|NCT00337675|1504752|P2|Overall Study|Progressive Disease|2
457451|NCT00337675|1504753|P1|Overall Study|Progressive Disease|0
457452|NCT00337675|1504751|P3|Overall Study|Withdrawal by Subject|19
457453|NCT00337675|1504752|P2|Overall Study|Withdrawal by Subject|25
457454|NCT00337675|1504753|P1|Overall Study|Withdrawal by Subject|25
457455|NCT00337675|1504751|P3|Overall Study|Protocol Violation|19
457456|NCT00337675|1504752|P2|Overall Study|Protocol Violation|24
457457|NCT00337675|1504753|P1|Overall Study|Protocol Violation|21
457458|NCT00337675|1504751|P3|Overall Study|Physician Decision|14
457459|NCT00337675|1504752|P2|Overall Study|Physician Decision|17
457460|NCT00337675|1504753|P1|Overall Study|Physician Decision|9
457461|NCT00337675|1504751|P3|Overall Study|Lost to Follow-up|17
457462|NCT00337675|1504752|P2|Overall Study|Lost to Follow-up|19
457463|NCT00337675|1504753|P1|Overall Study|Lost to Follow-up|22
457464|NCT00337675|1504751|P3|Overall Study|Lack of Efficacy|9
457465|NCT00337675|1504752|P2|Overall Study|Lack of Efficacy|7
457466|NCT00337675|1504753|P1|Overall Study|Lack of Efficacy|10
457467|NCT00337675|1504751|P3|Overall Study|Adverse Event|19
457468|NCT00337675|1504752|P2|Overall Study|Adverse Event|9
457469|NCT00337675|1504753|P1|Overall Study|Adverse Event|10
457470|NCT00337662|1504770|P4|Study Period III|Clinical Relapse|0
457471|NCT00337662|1504771|P3|Study Period III|Clinical Relapse|0
457472|NCT00337662|1504772|P2|Study Period III|Clinical Relapse|0
457473|NCT00337662|1504773|P1|Study Period III|Clinical Relapse|1
457474|NCT00337662|1504770|P4|Study Period III|Sponsor Decision|0
457475|NCT00337662|1504771|P3|Study Period III|Sponsor Decision|1
457476|NCT00337662|1504772|P2|Study Period III|Sponsor Decision|0
457477|NCT00337662|1504773|P1|Study Period III|Sponsor Decision|1
457478|NCT00337662|1504770|P4|Study Period III|Parent/Caregiver Decision|0
457479|NCT00337662|1504771|P3|Study Period III|Parent/Caregiver Decision|2
457480|NCT00337662|1504772|P2|Study Period III|Parent/Caregiver Decision|0
457481|NCT00337662|1504773|P1|Study Period III|Parent/Caregiver Decision|0
457482|NCT00337662|1504770|P4|Study Period III|Lack of Efficacy|0
457483|NCT00337662|1504771|P3|Study Period III|Lack of Efficacy|2
457484|NCT00337662|1504772|P2|Study Period III|Lack of Efficacy|4
457485|NCT00337662|1504773|P1|Study Period III|Lack of Efficacy|4
457486|NCT00337662|1504770|P4|Study Period III|Entry Criteria Not Met|0
457487|NCT00337662|1504771|P3|Study Period III|Entry Criteria Not Met|3
457488|NCT00337662|1504772|P2|Study Period III|Entry Criteria Not Met|1
457489|NCT00337662|1504773|P1|Study Period III|Entry Criteria Not Met|4
457490|NCT00337662|1504770|P4|Study Period III|Physician Decision|0
457491|NCT00337662|1504771|P3|Study Period III|Physician Decision|0
457492|NCT00337662|1504772|P2|Study Period III|Physician Decision|5
457493|NCT00337662|1504773|P1|Study Period III|Physician Decision|6
457494|NCT00337662|1504770|P4|Study Period III|Protocol Violation|0
457495|NCT00337662|1504771|P3|Study Period III|Protocol Violation|2
457496|NCT00337662|1504772|P2|Study Period III|Protocol Violation|8
457497|NCT00337662|1504773|P1|Study Period III|Protocol Violation|3
457498|NCT00337662|1504770|P4|Study Period III|Adverse Event|0
457499|NCT00337662|1504771|P3|Study Period III|Adverse Event|8
457500|NCT00337662|1504772|P2|Study Period III|Adverse Event|10
457501|NCT00337662|1504773|P1|Study Period III|Adverse Event|9
457502|NCT00337662|1504770|P4|Study Period III|Withdrawal by Subject|0
457503|NCT00337662|1504771|P3|Study Period III|Withdrawal by Subject|12
457504|NCT00337662|1504772|P2|Study Period III|Withdrawal by Subject|14
457505|NCT00337662|1504773|P1|Study Period III|Withdrawal by Subject|18
457506|NCT00337662|1504770|P4|Study Period III|Lost to Follow-up|0
457507|NCT00337662|1504771|P3|Study Period III|Lost to Follow-up|14
457508|NCT00337662|1504772|P2|Study Period III|Lost to Follow-up|16
457509|NCT00337662|1504773|P1|Study Period III|Lost to Follow-up|14
457510|NCT00337662|1504770|P4|Study Period II|Parent/Caregiver Decision|1
457511|NCT00337662|1504771|P3|Study Period II|Parent/Caregiver Decision|0
457512|NCT00337662|1504772|P2|Study Period II|Parent/Caregiver Decision|0
457513|NCT00337662|1504773|P1|Study Period II|Parent/Caregiver Decision|0
457514|NCT00337662|1504770|P4|Study Period II|Sponsor Decision|2
457515|NCT00337662|1504771|P3|Study Period II|Sponsor Decision|0
457516|NCT00337662|1504772|P2|Study Period II|Sponsor Decision|0
457517|NCT00337662|1504773|P1|Study Period II|Sponsor Decision|0
457518|NCT00337662|1504770|P4|Study Period II|Lack of Efficacy|7
457519|NCT00337662|1504771|P3|Study Period II|Lack of Efficacy|0
457520|NCT00337662|1504772|P2|Study Period II|Lack of Efficacy|0
457521|NCT00337662|1504773|P1|Study Period II|Lack of Efficacy|0
457522|NCT00337662|1504770|P4|Study Period II|Protocol Violation|6
457523|NCT00337662|1504771|P3|Study Period II|Protocol Violation|0
457524|NCT00337662|1504772|P2|Study Period II|Protocol Violation|0
457525|NCT00337662|1504773|P1|Study Period II|Protocol Violation|0
457526|NCT00337662|1504770|P4|Study Period II|Entry Criteria Not Met|6
457527|NCT00337662|1504771|P3|Study Period II|Entry Criteria Not Met|0
457528|NCT00337662|1504772|P2|Study Period II|Entry Criteria Not Met|0
457529|NCT00337662|1504773|P1|Study Period II|Entry Criteria Not Met|0
457530|NCT00337662|1504770|P4|Study Period II|Physician Decision|13
457531|NCT00337662|1504771|P3|Study Period II|Physician Decision|0
457532|NCT00337662|1504772|P2|Study Period II|Physician Decision|0
457533|NCT00337662|1504773|P1|Study Period II|Physician Decision|0
457534|NCT00337662|1504770|P4|Study Period II|Adverse Event|16
457535|NCT00337662|1504771|P3|Study Period II|Adverse Event|0
457536|NCT00337662|1504772|P2|Study Period II|Adverse Event|0
457537|NCT00337662|1504773|P1|Study Period II|Adverse Event|0
457538|NCT00337662|1504770|P4|Study Period II|Withdrawal by Subject|20
457539|NCT00337662|1504771|P3|Study Period II|Withdrawal by Subject|0
457540|NCT00337662|1504772|P2|Study Period II|Withdrawal by Subject|0
457541|NCT00337662|1504773|P1|Study Period II|Withdrawal by Subject|0
457542|NCT00337662|1504770|P4|Study Period II|Lost to Follow-up|35
457543|NCT00337662|1504771|P3|Study Period II|Lost to Follow-up|0
457544|NCT00337662|1504772|P2|Study Period II|Lost to Follow-up|0
457545|NCT00337662|1504773|P1|Study Period II|Lost to Follow-up|0
457546|NCT00337610|1504827|P2|Overall Study|Withdrawal by Subject|5
457547|NCT00337610|1504828|P1|Overall Study|Withdrawal by Subject|6
457548|NCT00337610|1504827|P2|Overall Study|Lost to Follow-up|3
457549|NCT00337610|1504828|P1|Overall Study|Lost to Follow-up|3
457550|NCT00337610|1504827|P2|Overall Study|Lack of Efficacy|3
457551|NCT00337610|1504828|P1|Overall Study|Lack of Efficacy|6
457552|NCT00337610|1504827|P2|Overall Study|Death|1
457553|NCT00337610|1504828|P1|Overall Study|Death|0
457554|NCT00337610|1504827|P2|Overall Study|Adverse Event|2
457555|NCT00337610|1504828|P1|Overall Study|Adverse Event|2
457556|NCT00337571|1504844|P4|Overall Study|High Potassium level|1
457557|NCT00337571|1504845|P3|Overall Study|High Potassium level|0
457558|NCT00337571|1504846|P2|Overall Study|High Potassium level|0
457559|NCT00337571|1504847|P1|Overall Study|High Potassium level|0
457560|NCT00337571|1504844|P4|Overall Study|No longer met study criteria|0
457561|NCT00337571|1504845|P3|Overall Study|No longer met study criteria|0
457562|NCT00337571|1504846|P2|Overall Study|No longer met study criteria|0
457563|NCT00337571|1504847|P1|Overall Study|No longer met study criteria|1
457564|NCT00337571|1504844|P4|Overall Study|Poor/noncompliance|1
457565|NCT00337571|1504845|P3|Overall Study|Poor/noncompliance|1
457566|NCT00337571|1504846|P2|Overall Study|Poor/noncompliance|1
457567|NCT00337571|1504847|P1|Overall Study|Poor/noncompliance|1
457568|NCT00337571|1504844|P4|Overall Study|Lost to Follow-up|1
457569|NCT00337571|1504845|P3|Overall Study|Lost to Follow-up|0
457570|NCT00337571|1504846|P2|Overall Study|Lost to Follow-up|1
457571|NCT00337571|1504847|P1|Overall Study|Lost to Follow-up|3
457572|NCT00337571|1504844|P4|Overall Study|Withdrawal by Subject|0
457573|NCT00337571|1504845|P3|Overall Study|Withdrawal by Subject|1
457574|NCT00337571|1504846|P2|Overall Study|Withdrawal by Subject|2
457575|NCT00337571|1504847|P1|Overall Study|Withdrawal by Subject|2
457576|NCT00337571|1504844|P4|Overall Study|Adverse Event|4
457577|NCT00337571|1504845|P3|Overall Study|Adverse Event|8
457578|NCT00337571|1504846|P2|Overall Study|Adverse Event|5
457579|NCT00337571|1504847|P1|Overall Study|Adverse Event|4
457580|NCT00337571|1504844|P4|Overall Study|Lack of Efficacy|0
457581|NCT00337571|1504845|P3|Overall Study|Lack of Efficacy|0
457582|NCT00337571|1504846|P2|Overall Study|Lack of Efficacy|0
457583|NCT00337571|1504847|P1|Overall Study|Lack of Efficacy|3
457584|NCT00337467|1504885|P1|Overall Study|Subject No Longer Met Study Criteria|2
457585|NCT00337467|1504885|P1|Overall Study|Lost to Follow-up|2
457586|NCT00337467|1504885|P1|Overall Study|Pregnancy|1
457587|NCT00337467|1504885|P1|Overall Study|Subject Withdrew Consent|2
457588|NCT00337467|1504885|P1|Overall Study|Adverse Event|3
457589|NCT00337428|1504904|P2|Overall Study|Anorexia|0
457590|NCT00337428|1504905|P1|Overall Study|Anorexia|1
457591|NCT00337428|1504904|P2|Overall Study|Unwilling to Continue|0
457592|NCT00337428|1504905|P1|Overall Study|Unwilling to Continue|1
457593|NCT00337428|1504904|P2|Overall Study|Lack of Time|1
457594|NCT00337428|1504905|P1|Overall Study|Lack of Time|1
457595|NCT00337428|1504904|P2|Overall Study|Withdrawal by Subject|2
457596|NCT00337428|1504905|P1|Overall Study|Withdrawal by Subject|1
457597|NCT00337285|1504956|P1|Overall Study|Lack of protocol compliance|7
457598|NCT00337285|1504956|P1|Overall Study|Physician Decision|1
457599|NCT00337285|1504956|P1|Overall Study|Death|1
457600|NCT00337285|1504956|P1|Overall Study|Lack of Efficacy|11
457601|NCT00337285|1504956|P1|Overall Study|Protocol Violation|27
457602|NCT00337285|1504956|P1|Overall Study|Adverse Event|28
457603|NCT00337285|1504956|P1|Overall Study|Lost to Follow-up|41
457604|NCT00337285|1504956|P1|Overall Study|Withdrawal by Subject|42
457605|NCT00337272|1504964|P2|Withdrawal Period|Non-compliance|1
457606|NCT00337272|1504965|P1|Withdrawal Period|Non-compliance|0
457607|NCT00337272|1504964|P2|Treatment Period|Withdrawal by Subject|1
457608|NCT00337272|1504965|P1|Treatment Period|Withdrawal by Subject|0
457609|NCT00337272|1504964|P2|Treatment Period|Non-compliance|1
457610|NCT00337272|1504965|P1|Treatment Period|Non-compliance|1
457611|NCT00337272|1504964|P2|Screening Period (Pre-randomization)|Screen failure|0
457612|NCT00337272|1504965|P1|Screening Period (Pre-randomization)|Screen failure|3
457613|NCT00337272|1504964|P2|Screening Period (Pre-randomization)|Non-compliance|0
457614|NCT00337272|1504965|P1|Screening Period (Pre-randomization)|Non-compliance|1
457615|NCT00337272|1504964|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
457616|NCT00337272|1504965|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
457617|NCT00337207|1504985|P1|Overall Study|Withdrawal by Subject|3
457618|NCT00337194|1504991|P2|Overall Study|Subsequent non-protocol therapy|1
457619|NCT00337194|1504992|P1|Overall Study|Subsequent non-protocol therapy|3
457620|NCT00337194|1504991|P2|Overall Study|Disease progression|2
457621|NCT00337194|1504992|P1|Overall Study|Disease progression|1
457622|NCT00337194|1504991|P2|Overall Study|Withdrawal by Subject|0
457623|NCT00337194|1504992|P1|Overall Study|Withdrawal by Subject|1
457624|NCT00337194|1504991|P2|Overall Study|Death|0
457625|NCT00337194|1504992|P1|Overall Study|Death|2
457626|NCT00337194|1504991|P2|Overall Study|Adverse Event|1
457627|NCT00337194|1504992|P1|Overall Study|Adverse Event|5
457628|NCT00337168|1505007|P1|Overall Study|Did not start therapy|1
457629|NCT00337168|1505007|P1|Overall Study|Not protocol specified|2
457630|NCT00337168|1505007|P1|Overall Study|Death|5
457631|NCT00337129|1505014|P1|Overall Study|not protocol specified|1
457632|NCT00337129|1505014|P1|Overall Study|Death|2
457633|NCT00337129|1505014|P1|Overall Study|Lack of Efficacy|32
457634|NCT00337129|1505014|P1|Overall Study|Withdrawal by Subject|1
457635|NCT00337129|1505014|P1|Overall Study|Adverse Event|4
457636|NCT00337103|1505023|P2|Overall Study|Death|0
457637|NCT00337103|1505024|P1|Overall Study|Death|1
457638|NCT00337103|1505023|P2|Overall Study|Lost to Follow-up|2
457639|NCT00337103|1505024|P1|Overall Study|Lost to Follow-up|1
457640|NCT00337103|1505023|P2|Overall Study|Entry Criteria Not Met|1
457641|NCT00337103|1505024|P1|Overall Study|Entry Criteria Not Met|4
457642|NCT00337103|1505023|P2|Overall Study|Not specified|6
457643|NCT00337103|1505024|P1|Overall Study|Not specified|5
457644|NCT00337103|1505023|P2|Overall Study|Withdrawal by Subject|5
457645|NCT00337103|1505024|P1|Overall Study|Withdrawal by Subject|8
457646|NCT00337103|1505023|P2|Overall Study|Physician Decision|14
457647|NCT00337103|1505024|P1|Overall Study|Physician Decision|15
457648|NCT00337103|1505023|P2|Overall Study|Clinical Progression|24
457649|NCT00337103|1505024|P1|Overall Study|Clinical Progression|27
457650|NCT00337103|1505023|P2|Overall Study|Subject Choice|27
457651|NCT00337103|1505024|P1|Overall Study|Subject Choice|34
457652|NCT00337103|1505023|P2|Overall Study|Adverse Event|59
457653|NCT00337103|1505024|P1|Overall Study|Adverse Event|45
457654|NCT00337103|1505023|P2|Overall Study|Progressive Disease|405
457655|NCT00337103|1505024|P1|Overall Study|Progressive Disease|409
457656|NCT00337077|1505035|P3|Overall Study|Ineligible|1
457657|NCT00337077|1505036|P2|Overall Study|Ineligible|1
457658|NCT00337077|1505037|P1|Overall Study|Ineligible|1
457659|NCT00337077|1505035|P3|Overall Study|Never started treatment|0
457660|NCT00337077|1505036|P2|Overall Study|Never started treatment|1
457661|NCT00337077|1505037|P1|Overall Study|Never started treatment|1
457662|NCT00337077|1505035|P3|Overall Study|Physician Decision|2
457663|NCT00337077|1505036|P2|Overall Study|Physician Decision|4
457664|NCT00337077|1505037|P1|Overall Study|Physician Decision|1
457665|NCT00337077|1505035|P3|Overall Study|Alternative therapy|0
457666|NCT00337077|1505036|P2|Overall Study|Alternative therapy|0
457667|NCT00337077|1505037|P1|Overall Study|Alternative therapy|1
457668|NCT00337077|1505035|P3|Overall Study|Withdrawal by Subject|2
457669|NCT00337077|1505036|P2|Overall Study|Withdrawal by Subject|2
457670|NCT00337077|1505037|P1|Overall Study|Withdrawal by Subject|7
457671|NCT00337077|1505035|P3|Overall Study|Death|0
457672|NCT00337077|1505036|P2|Overall Study|Death|1
457673|NCT00337077|1505037|P1|Overall Study|Death|0
457674|NCT00337077|1505035|P3|Overall Study|Adverse Event|1
457675|NCT00337077|1505036|P2|Overall Study|Adverse Event|7
457676|NCT00337077|1505037|P1|Overall Study|Adverse Event|7
457677|NCT00337077|1505035|P3|Overall Study|Progressive disease|19
457678|NCT00337077|1505036|P2|Overall Study|Progressive disease|37
457679|NCT00337077|1505037|P1|Overall Study|Progressive disease|25
457680|NCT00336895|1505052|P1|Overall Study|screen failed|1
457681|NCT00336895|1505052|P1|Overall Study|Physician Decision|1
457682|NCT00336895|1505052|P1|Overall Study|nausea and upset stomach|1
457683|NCT00336895|1505052|P1|Overall Study|diarrhea|1
457684|NCT00336856|1505058|P1|Overall Study|Found ineligible at time of analysis|1
457685|NCT00336856|1505058|P1|Overall Study|Withdrawal by Subject|3
457686|NCT00336583|1505106|P1|Overall Study|Death|1
457687|NCT00336583|1505106|P1|Overall Study|Lost to Follow-up|1
457688|NCT00336544|1505113|P2|Overall Study|Other|5
457689|NCT00336544|1505114|P1|Overall Study|Other|3
457690|NCT00336544|1505113|P2|Overall Study|Withdrawal by Subject|3
457691|NCT00336544|1505114|P1|Overall Study|Withdrawal by Subject|4
457692|NCT00336544|1505113|P2|Overall Study|Adverse Event|9
457693|NCT00336544|1505114|P1|Overall Study|Adverse Event|4
457694|NCT00336544|1505113|P2|Overall Study|Lack of Efficacy|5
457695|NCT00336544|1505114|P1|Overall Study|Lack of Efficacy|8
457696|NCT00336505|1505128|P2|Overall Study|Other|7
457697|NCT00336505|1505129|P1|Overall Study|Other|7
457698|NCT00336505|1505128|P2|Overall Study|Withdrawal by Subject|3
457699|NCT00336505|1505129|P1|Overall Study|Withdrawal by Subject|5
457700|NCT00336505|1505128|P2|Overall Study|Lost to Follow-up|4
457701|NCT00336505|1505129|P1|Overall Study|Lost to Follow-up|7
457702|NCT00336505|1505128|P2|Overall Study|Lack of Efficacy|4
457703|NCT00336505|1505129|P1|Overall Study|Lack of Efficacy|8
457704|NCT00336505|1505128|P2|Overall Study|Adverse Event|9
457705|NCT00336505|1505129|P1|Overall Study|Adverse Event|10
457706|NCT00336492|1505144|P3|Overall Study|Other|1
457707|NCT00336492|1505145|P2|Overall Study|Other|0
457708|NCT00336492|1505146|P1|Overall Study|Other|5
457709|NCT00336492|1505144|P3|Overall Study|Lack of Efficacy|4
457710|NCT00336492|1505145|P2|Overall Study|Lack of Efficacy|1
457711|NCT00336492|1505146|P1|Overall Study|Lack of Efficacy|6
457712|NCT00336492|1505144|P3|Overall Study|Adverse Event|6
457713|NCT00336492|1505145|P2|Overall Study|Adverse Event|3
457714|NCT00336492|1505146|P1|Overall Study|Adverse Event|4
457715|NCT00336479|1505158|P4|Overall Study|Virologic Stopping Rule|0
457716|NCT00336479|1505159|P3|Overall Study|Virologic Stopping Rule|0
457717|NCT00336479|1505160|P2|Overall Study|Virologic Stopping Rule|0
457718|NCT00336479|1505161|P1|Overall Study|Virologic Stopping Rule|20
457719|NCT00336479|1505158|P4|Overall Study|Other|0
457720|NCT00336479|1505159|P3|Overall Study|Other|1
457721|NCT00336479|1505160|P2|Overall Study|Other|0
457722|NCT00336479|1505161|P1|Overall Study|Other|0
457723|NCT00336479|1505158|P4|Overall Study|Withdrawal by Subject|0
457724|NCT00336479|1505159|P3|Overall Study|Withdrawal by Subject|3
457725|NCT00336479|1505160|P2|Overall Study|Withdrawal by Subject|2
457726|NCT00336479|1505161|P1|Overall Study|Withdrawal by Subject|3
457727|NCT00336479|1505158|P4|Overall Study|Lost to Follow-up|0
457728|NCT00336479|1505159|P3|Overall Study|Lost to Follow-up|0
457729|NCT00336479|1505160|P2|Overall Study|Lost to Follow-up|2
457730|NCT00336479|1505161|P1|Overall Study|Lost to Follow-up|3
457731|NCT00336479|1505158|P4|Overall Study|Physician Decision|0
457732|NCT00336479|1505159|P3|Overall Study|Physician Decision|1
457733|NCT00336479|1505160|P2|Overall Study|Physician Decision|3
457734|NCT00336479|1505161|P1|Overall Study|Physician Decision|2
457735|NCT00336479|1505158|P4|Overall Study|Noncompliant|0
457736|NCT00336479|1505159|P3|Overall Study|Noncompliant|3
457737|NCT00336479|1505160|P2|Overall Study|Noncompliant|7
457738|NCT00336479|1505161|P1|Overall Study|Noncompliant|1
457739|NCT00336479|1505158|P4|Overall Study|Adverse Event|4
457740|NCT00336479|1505159|P3|Overall Study|Adverse Event|18
457741|NCT00336479|1505160|P2|Overall Study|Adverse Event|11
457742|NCT00336479|1505161|P1|Overall Study|Adverse Event|8
457743|NCT00336284|1505250|P2|Overall Study|Withdrawal by Physician or Subject|64
457744|NCT00336284|1505251|P1|Overall Study|Withdrawal by Physician or Subject|102
457745|NCT00336284|1505250|P2|Overall Study|Lost to Follow-up|61
457746|NCT00336284|1505251|P1|Overall Study|Lost to Follow-up|82
457747|NCT00336284|1505250|P2|Overall Study|Death|26
457748|NCT00336284|1505251|P1|Overall Study|Death|52
457749|NCT00335972|1505269|P2|Overall Study|not given treatments|3
457750|NCT00335972|1505270|P1|Overall Study|not given treatments|0
457751|NCT00335959|1505280|P1|Overall Study|Ineligible|1
457752|NCT00335959|1505280|P1|Overall Study|Adverse Event|2
457753|NCT00335829|1505285|P1|Overall Study|Adverse Event|1
457754|NCT00335829|1505285|P1|Overall Study|Lost to Follow-up|1
457755|NCT00335829|1505285|P1|Overall Study|Withdrawal by Subject|1
457756|NCT00335777|1505299|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
457757|NCT00335777|1505299|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
457758|NCT00335777|1505299|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
457759|NCT00335777|1505299|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
457760|NCT00335777|1505299|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
457761|NCT00335738|1505306|P2|Overall Study|Ineligible|4
457762|NCT00335738|1505307|P1|Overall Study|Ineligible|3
457763|NCT00335738|1505306|P2|Overall Study|Withdrawal by Subject|0
457764|NCT00335738|1505307|P1|Overall Study|Withdrawal by Subject|2
457765|NCT00335738|1505306|P2|Overall Study|Physician Decision|0
457766|NCT00335738|1505307|P1|Overall Study|Physician Decision|6
457767|NCT00335556|1505339|P6|Overall Study|Refusal of further protocol therapy|0
457768|NCT00335556|1505340|P5|Overall Study|Refusal of further protocol therapy|0
457769|NCT00335556|1505341|P4|Overall Study|Refusal of further protocol therapy|1
457770|NCT00335556|1505342|P3|Overall Study|Refusal of further protocol therapy|0
457771|NCT00335556|1505343|P2|Overall Study|Refusal of further protocol therapy|4
457772|NCT00335556|1505344|P1|Overall Study|Refusal of further protocol therapy|0
457773|NCT00335556|1505339|P6|Overall Study|Ineligible|0
457774|NCT00335556|1505340|P5|Overall Study|Ineligible|0
457775|NCT00335556|1505341|P4|Overall Study|Ineligible|0
457776|NCT00335556|1505342|P3|Overall Study|Ineligible|0
457777|NCT00335556|1505343|P2|Overall Study|Ineligible|0
457778|NCT00335556|1505344|P1|Overall Study|Ineligible|2
457779|NCT00335556|1505339|P6|Overall Study|Physician Decision|0
457780|NCT00335556|1505340|P5|Overall Study|Physician Decision|0
457781|NCT00335556|1505341|P4|Overall Study|Physician Decision|1
457782|NCT00335556|1505342|P3|Overall Study|Physician Decision|2
457783|NCT00335556|1505343|P2|Overall Study|Physician Decision|6
457784|NCT00335556|1505344|P1|Overall Study|Physician Decision|0
457785|NCT00335556|1505339|P6|Overall Study|Lack of Efficacy|1
457786|NCT00335556|1505340|P5|Overall Study|Lack of Efficacy|0
457787|NCT00335556|1505341|P4|Overall Study|Lack of Efficacy|3
457788|NCT00335556|1505342|P3|Overall Study|Lack of Efficacy|3
457789|NCT00335556|1505343|P2|Overall Study|Lack of Efficacy|19
457790|NCT00335556|1505344|P1|Overall Study|Lack of Efficacy|0
457791|NCT00335556|1505339|P6|Overall Study|Death|0
457792|NCT00335556|1505340|P5|Overall Study|Death|1
457793|NCT00335556|1505341|P4|Overall Study|Death|0
457794|NCT00335556|1505342|P3|Overall Study|Death|0
457795|NCT00335556|1505343|P2|Overall Study|Death|5
457796|NCT00335556|1505344|P1|Overall Study|Death|0
457797|NCT00335452|1505406|P4|Overall Study|Lost to Follow-up|2
457798|NCT00335452|1505407|P3|Overall Study|Lost to Follow-up|1
457799|NCT00335452|1505408|P2|Overall Study|Lost to Follow-up|3
457800|NCT00335452|1505409|P1|Overall Study|Lost to Follow-up|2
457801|NCT00335452|1505406|P4|Overall Study|Death|129
457802|NCT00335452|1505407|P3|Overall Study|Death|158
457803|NCT00335452|1505408|P2|Overall Study|Death|144
457804|NCT00335452|1505409|P1|Overall Study|Death|156
457805|NCT00335322|1505434|P3|Overall Study|Randomised but withdrew prior to ART sta|2
457806|NCT00335322|1505435|P2|Overall Study|Randomised but withdrew prior to ART sta|2
457807|NCT00335322|1505436|P1|Overall Study|Randomised but withdrew prior to ART sta|1
457808|NCT00335153|1505481|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
457809|NCT00335153|1505481|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
457810|NCT00335153|1505481|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
457811|NCT00335153|1505481|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
457812|NCT00335153|1505481|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
457813|NCT00335153|1505481|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
457814|NCT00335153|1505481|P1|Nasojejunal (NJ) Test Period|Administrative|1
457815|NCT00335153|1505481|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
457816|NCT00335153|1505481|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
457817|NCT00335153|1505481|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
457818|NCT00335140|1505518|P1|Overall Study|Ineligible|1
457819|NCT00334958|1505524|P2|Overall Study|Not specified|2
457820|NCT00334958|1505525|P1|Overall Study|Not specified|1
457821|NCT00334958|1505524|P2|Overall Study|Adverse Event|12
457822|NCT00334958|1505525|P1|Overall Study|Adverse Event|27
457823|NCT00334958|1505524|P2|Overall Study|Withdrawal by Subject|4
457824|NCT00334958|1505525|P1|Overall Study|Withdrawal by Subject|7
457825|NCT00334958|1505524|P2|Overall Study|Request of the investigator or sponsor|1
457826|NCT00334958|1505525|P1|Overall Study|Request of the investigator or sponsor|0
457827|NCT00334958|1505524|P2|Overall Study|Protocol Violation|2
457828|NCT00334958|1505525|P1|Overall Study|Protocol Violation|2
457829|NCT00334958|1505524|P2|Overall Study|Medication Noncompliance|3
457830|NCT00334958|1505525|P1|Overall Study|Medication Noncompliance|0
457831|NCT00334893|1505539|P2|Overall Study|Not Treated|0
457832|NCT00334893|1505540|P1|Overall Study|Not Treated|1
457833|NCT00334815|1505550|P2|Overall Study|Physician Decision|4
457834|NCT00334815|1505551|P1|Overall Study|Physician Decision|2
457835|NCT00334815|1505550|P2|Overall Study|patient refused treatment|1
457836|NCT00334815|1505551|P1|Overall Study|patient refused treatment|0
457837|NCT00334815|1505550|P2|Overall Study|ineligible|1
457838|NCT00334815|1505551|P1|Overall Study|ineligible|1
457839|NCT00334815|1505550|P2|Overall Study|Progression|0
457840|NCT00334815|1505551|P1|Overall Study|Progression|1
457841|NCT00334815|1505550|P2|Overall Study|Death|2
457842|NCT00334815|1505551|P1|Overall Study|Death|0
457843|NCT00334815|1505550|P2|Overall Study|Adverse Event|2
457844|NCT00334815|1505551|P1|Overall Study|Adverse Event|3
457845|NCT00334802|1505565|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
457846|NCT00334802|1505566|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
457847|NCT00334802|1505565|P2|Overall Study|Adverse Event|3
457848|NCT00334802|1505566|P1|Overall Study|Adverse Event|0
457849|NCT00334802|1505565|P2|Overall Study|Withdrawal by Subject|4
457850|NCT00334802|1505566|P1|Overall Study|Withdrawal by Subject|0
457851|NCT00334802|1505565|P2|Overall Study|Physician Decision|0
457852|NCT00334802|1505566|P1|Overall Study|Physician Decision|1
457853|NCT00334802|1505565|P2|Overall Study|Patient Condition Aggrevated|0
457854|NCT00334802|1505566|P1|Overall Study|Patient Condition Aggrevated|1
457855|NCT00334802|1505565|P2|Overall Study|Lack of Efficacy|3
457856|NCT00334802|1505566|P1|Overall Study|Lack of Efficacy|1
457857|NCT00334802|1505565|P2|Overall Study|Toxicity|5
457858|NCT00334802|1505566|P1|Overall Study|Toxicity|1
457859|NCT00334802|1505565|P2|Overall Study|Progressive Disease|24
457860|NCT00334802|1505566|P1|Overall Study|Progressive Disease|2
457861|NCT00334542|1505599|P1|Overall Study|New cancer diagnosis|1
457862|NCT00334542|1505599|P1|Overall Study|Withdrawal by Subject|1
457863|NCT00334542|1505599|P1|Overall Study|Adverse Event|3
457864|NCT00334295|1505604|P1|Overall Study|Patients received fewer than 3 injection|5
457865|NCT00334282|1505614|P2|Overall Study|Death|100
457866|NCT00334282|1505615|P1|Overall Study|Death|194
457867|NCT00334282|1505614|P2|Overall Study|Withdrawal by Subject|3
457868|NCT00334282|1505615|P1|Overall Study|Withdrawal by Subject|17
457869|NCT00334282|1505614|P2|Overall Study|Lost to Follow-up|5
457870|NCT00334282|1505615|P1|Overall Study|Lost to Follow-up|11
457871|NCT00334113|1505646|P2|Overall Study|Withdrawal by Subject|1
457872|NCT00334113|1505647|P1|Overall Study|Withdrawal by Subject|0
457873|NCT00334113|1505646|P2|Overall Study|Lost to Follow-up|2
457874|NCT00334113|1505647|P1|Overall Study|Lost to Follow-up|2
457875|NCT00333983|1505670|P3|Overall Study|Withdrawal by Subject|1
457876|NCT00333983|1505671|P2|Overall Study|Withdrawal by Subject|3
457877|NCT00333983|1505672|P1|Overall Study|Withdrawal by Subject|0
457878|NCT00333983|1505670|P3|Overall Study|Adverse Event|1
457879|NCT00333983|1505671|P2|Overall Study|Adverse Event|1
457880|NCT00333983|1505672|P1|Overall Study|Adverse Event|1
457881|NCT00333983|1505670|P3|Overall Study|Lost to Follow-up|0
457882|NCT00333983|1505671|P2|Overall Study|Lost to Follow-up|1
457883|NCT00333983|1505672|P1|Overall Study|Lost to Follow-up|2
457884|NCT00333970|1505682|P2|Overall Study|Withdrawal by Subject|7
457885|NCT00333970|1505683|P1|Overall Study|Withdrawal by Subject|13
457886|NCT00333866|1505698|P4|Overall Study|Randomized but not Treated|1
457887|NCT00333866|1505699|P3|Overall Study|Randomized but not Treated|2
457888|NCT00333866|1505700|P2|Overall Study|Randomized but not Treated|3
457889|NCT00333866|1505701|P1|Overall Study|Randomized but not Treated|5
457890|NCT00333866|1505698|P4|Overall Study|Withdrawal by Subject|9
457891|NCT00333866|1505699|P3|Overall Study|Withdrawal by Subject|4
457892|NCT00333866|1505700|P2|Overall Study|Withdrawal by Subject|14
457893|NCT00333866|1505701|P1|Overall Study|Withdrawal by Subject|8
457894|NCT00333866|1505698|P4|Overall Study|Lost to Follow-up|2
457895|NCT00333866|1505699|P3|Overall Study|Lost to Follow-up|2
457896|NCT00333866|1505700|P2|Overall Study|Lost to Follow-up|2
457897|NCT00333866|1505701|P1|Overall Study|Lost to Follow-up|1
457898|NCT00333866|1505698|P4|Overall Study|Lack of Efficacy|5
457899|NCT00333866|1505699|P3|Overall Study|Lack of Efficacy|3
457900|NCT00333866|1505700|P2|Overall Study|Lack of Efficacy|6
457901|NCT00333866|1505701|P1|Overall Study|Lack of Efficacy|8
457902|NCT00333866|1505698|P4|Overall Study|Other|2
457903|NCT00333866|1505699|P3|Overall Study|Other|2
457904|NCT00333866|1505700|P2|Overall Study|Other|2
457905|NCT00333866|1505701|P1|Overall Study|Other|3
457906|NCT00333866|1505698|P4|Overall Study|Adverse Event|47
457907|NCT00333866|1505699|P3|Overall Study|Adverse Event|38
457908|NCT00333866|1505700|P2|Overall Study|Adverse Event|37
457909|NCT00333866|1505701|P1|Overall Study|Adverse Event|23
457910|NCT00333840|1505761|P4|Second-line Treatment Period|Death|9
457911|NCT00333840|1505762|P3|Second-line Treatment Period|Death|0
457912|NCT00333840|1505763|P2|Second-line Treatment Period|Death|0
457913|NCT00333840|1505764|P1|Second-line Treatment Period|Death|0
457914|NCT00333840|1505761|P4|Second-line Treatment Period|Administrative problems|7
457915|NCT00333840|1505762|P3|Second-line Treatment Period|Administrative problems|0
457916|NCT00333840|1505763|P2|Second-line Treatment Period|Administrative problems|0
457917|NCT00333840|1505764|P1|Second-line Treatment Period|Administrative problems|0
457918|NCT00333840|1505761|P4|Second-line Treatment Period|Lost to Follow-up|6
457919|NCT00333840|1505762|P3|Second-line Treatment Period|Lost to Follow-up|0
457920|NCT00333840|1505763|P2|Second-line Treatment Period|Lost to Follow-up|0
457921|NCT00333840|1505764|P1|Second-line Treatment Period|Lost to Follow-up|0
457922|NCT00333840|1505761|P4|Second-line Treatment Period|Subject withdrew consent|34
457923|NCT00333840|1505762|P3|Second-line Treatment Period|Subject withdrew consent|0
457924|NCT00333840|1505763|P2|Second-line Treatment Period|Subject withdrew consent|0
457925|NCT00333840|1505764|P1|Second-line Treatment Period|Subject withdrew consent|0
457926|NCT00333840|1505761|P4|Second-line Treatment Period|Protocol Violation|10
457927|NCT00333840|1505762|P3|Second-line Treatment Period|Protocol Violation|1
457928|NCT00333840|1505763|P2|Second-line Treatment Period|Protocol Violation|0
457929|NCT00333840|1505764|P1|Second-line Treatment Period|Protocol Violation|0
457930|NCT00333840|1505761|P4|Second-line Treatment Period|No longer required study drug|14
457931|NCT00333840|1505762|P3|Second-line Treatment Period|No longer required study drug|1
457932|NCT00333840|1505763|P2|Second-line Treatment Period|No longer required study drug|0
457933|NCT00333840|1505764|P1|Second-line Treatment Period|No longer required study drug|0
457934|NCT00333840|1505761|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
457935|NCT00333840|1505762|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
457936|NCT00333840|1505763|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
457937|NCT00333840|1505764|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
457938|NCT00333840|1505761|P4|Second-line Treatment Period|Abnormal procedure|1
457939|NCT00333840|1505762|P3|Second-line Treatment Period|Abnormal procedure|0
457940|NCT00333840|1505763|P2|Second-line Treatment Period|Abnormal procedure|0
457941|NCT00333840|1505764|P1|Second-line Treatment Period|Abnormal procedure|0
457942|NCT00333840|1505761|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
457943|NCT00333840|1505762|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
457944|NCT00333840|1505763|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
457945|NCT00333840|1505764|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
457946|NCT00333840|1505761|P4|Second-line Treatment Period|Adverse Event|34
457947|NCT00333840|1505762|P3|Second-line Treatment Period|Adverse Event|3
457948|NCT00333840|1505763|P2|Second-line Treatment Period|Adverse Event|0
457949|NCT00333840|1505764|P1|Second-line Treatment Period|Adverse Event|0
457950|NCT00333840|1505761|P4|First-line Treatment Period|Crossed over to other treatment arm|0
457951|NCT00333840|1505762|P3|First-line Treatment Period|Crossed over to other treatment arm|0
457952|NCT00333840|1505763|P2|First-line Treatment Period|Crossed over to other treatment arm|363
457953|NCT00333840|1505764|P1|First-line Treatment Period|Crossed over to other treatment arm|14
457954|NCT00333840|1505761|P4|First-line Treatment Period|Death|0
457955|NCT00333840|1505762|P3|First-line Treatment Period|Death|0
457956|NCT00333840|1505763|P2|First-line Treatment Period|Death|2
457957|NCT00333840|1505764|P1|First-line Treatment Period|Death|19
457958|NCT00333840|1505761|P4|First-line Treatment Period|Administrative problems|0
457959|NCT00333840|1505762|P3|First-line Treatment Period|Administrative problems|0
457960|NCT00333840|1505763|P2|First-line Treatment Period|Administrative problems|6
457961|NCT00333840|1505764|P1|First-line Treatment Period|Administrative problems|12
457962|NCT00333840|1505761|P4|First-line Treatment Period|Lost to Follow-up|0
457963|NCT00333840|1505762|P3|First-line Treatment Period|Lost to Follow-up|0
457964|NCT00333840|1505763|P2|First-line Treatment Period|Lost to Follow-up|6
457965|NCT00333840|1505764|P1|First-line Treatment Period|Lost to Follow-up|15
457966|NCT00333840|1505761|P4|First-line Treatment Period|Subject withdrew consent|0
457967|NCT00333840|1505762|P3|First-line Treatment Period|Subject withdrew consent|0
457968|NCT00333840|1505763|P2|First-line Treatment Period|Subject withdrew consent|77
457969|NCT00333840|1505764|P1|First-line Treatment Period|Subject withdrew consent|57
457970|NCT00333840|1505761|P4|First-line Treatment Period|Protocol Violation|0
457971|NCT00333840|1505762|P3|First-line Treatment Period|Protocol Violation|0
457972|NCT00333840|1505763|P2|First-line Treatment Period|Protocol Violation|17
457973|NCT00333840|1505764|P1|First-line Treatment Period|Protocol Violation|17
457974|NCT00333840|1505761|P4|First-line Treatment Period|No longer required study drug|0
457975|NCT00333840|1505762|P3|First-line Treatment Period|No longer required study drug|0
457976|NCT00333840|1505763|P2|First-line Treatment Period|No longer required study drug|8
457977|NCT00333840|1505764|P1|First-line Treatment Period|No longer required study drug|21
457978|NCT00333840|1505761|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
457979|NCT00333840|1505762|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
457980|NCT00333840|1505763|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
457981|NCT00333840|1505764|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
457982|NCT00333840|1505761|P4|First-line Treatment Period|Abnormal procedure|0
457983|NCT00333840|1505762|P3|First-line Treatment Period|Abnormal procedure|0
457984|NCT00333840|1505763|P2|First-line Treatment Period|Abnormal procedure|0
457985|NCT00333840|1505764|P1|First-line Treatment Period|Abnormal procedure|2
457986|NCT00333840|1505761|P4|First-line Treatment Period|Abnormal laboratory values|0
457987|NCT00333840|1505762|P3|First-line Treatment Period|Abnormal laboratory values|0
457988|NCT00333840|1505763|P2|First-line Treatment Period|Abnormal laboratory values|1
457989|NCT00333840|1505764|P1|First-line Treatment Period|Abnormal laboratory values|3
457990|NCT00333840|1505761|P4|First-line Treatment Period|Adverse Event|0
457991|NCT00333840|1505762|P3|First-line Treatment Period|Adverse Event|0
457992|NCT00333840|1505763|P2|First-line Treatment Period|Adverse Event|37
457993|NCT00333840|1505764|P1|First-line Treatment Period|Adverse Event|38
457994|NCT00333801|1505810|P2|Overall Study|Withdrawal by Subject|1
457995|NCT00333801|1505811|P1|Overall Study|Withdrawal by Subject|0
457996|NCT00333801|1505810|P2|Overall Study|Incarcerated|2
457997|NCT00333801|1505811|P1|Overall Study|Incarcerated|1
457998|NCT00333801|1505810|P2|Overall Study|Lost to Follow-up|0
457999|NCT00333801|1505811|P1|Overall Study|Lost to Follow-up|2
458000|NCT00333801|1505810|P2|Overall Study|Moved to another state|3
458001|NCT00333801|1505811|P1|Overall Study|Moved to another state|5
458002|NCT00333788|1505829|P1|Overall Study|Other: Signed consent for another study|1
458003|NCT00333788|1505829|P1|Overall Study|Other: Physician decision|1
458004|NCT00333788|1505829|P1|Overall Study|Other: Medical monitor decision|1
458005|NCT00333788|1505829|P1|Overall Study|Other: Subject in need of an Entocort|1
458006|NCT00333788|1505829|P1|Overall Study|Other: Sponsor decision|1
458007|NCT00333788|1505829|P1|Overall Study|Other: Quality of life concern|1
458008|NCT00333788|1505829|P1|Overall Study|Other: Investigator decision|1
458009|NCT00333788|1505829|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
458010|NCT00333788|1505829|P1|Overall Study|Other: Moved|2
458011|NCT00333788|1505829|P1|Overall Study|Other: Non-compliance|2
458012|NCT00333788|1505829|P1|Overall Study|Withdrawal by Subject|24
458013|NCT00333788|1505829|P1|Overall Study|Lost to Follow-up|2
458014|NCT00333788|1505829|P1|Overall Study|Lack of Efficacy|80
458015|NCT00333788|1505829|P1|Overall Study|Adverse Event|44
458016|NCT00333775|1505859|P3|Overall Study|Lost to Follow-up|8
458017|NCT00333775|1505860|P2|Overall Study|Lost to Follow-up|7
458018|NCT00333775|1505861|P1|Overall Study|Lost to Follow-up|10
458019|NCT00333775|1505859|P3|Overall Study|In Follow−up When Study Stopped|96
458020|NCT00333775|1505860|P2|Overall Study|In Follow−up When Study Stopped|92
458021|NCT00333775|1505861|P1|Overall Study|In Follow−up When Study Stopped|87
458022|NCT00333775|1505859|P3|Overall Study|Death|143
458023|NCT00333775|1505860|P2|Overall Study|Death|149
458024|NCT00333775|1505861|P1|Overall Study|Death|144
458025|NCT00333619|1505900|P2|Overall Study|Lost to Follow-up|3
458026|NCT00333619|1505901|P1|Overall Study|Lost to Follow-up|3
458027|NCT00333619|1505900|P2|Overall Study|Withdrawal by Subject|1
458028|NCT00333619|1505901|P1|Overall Study|Withdrawal by Subject|6
458029|NCT00333619|1505900|P2|Overall Study|Death|6
458030|NCT00333619|1505901|P1|Overall Study|Death|12
458031|NCT00333359|1505919|P2|Overall Study|Withdrew before Receiving One Dose|6
458032|NCT00333359|1505920|P1|Overall Study|Withdrew before Receiving One Dose|2
458033|NCT00333359|1505919|P2|Overall Study|Treatment Failure|8
458034|NCT00333359|1505920|P1|Overall Study|Treatment Failure|3
458035|NCT00333359|1505919|P2|Overall Study|Termination or Withdrawal by Sponsor|1
458036|NCT00333359|1505920|P1|Overall Study|Termination or Withdrawal by Sponsor|1
458037|NCT00333359|1505919|P2|Overall Study|Lost to Follow-up|25
458038|NCT00333359|1505920|P1|Overall Study|Lost to Follow-up|15
458039|NCT00333359|1505919|P2|Overall Study|Protocol Non-compliance|8
458040|NCT00333359|1505920|P1|Overall Study|Protocol Non-compliance|2
458041|NCT00333359|1505919|P2|Overall Study|Physician Decision|2
458042|NCT00333359|1505920|P1|Overall Study|Physician Decision|2
458043|NCT00333359|1505919|P2|Overall Study|Withdrawal by Subject|37
458044|NCT00333359|1505920|P1|Overall Study|Withdrawal by Subject|19
458045|NCT00333359|1505919|P2|Overall Study|Adverse Event|35
458046|NCT00333359|1505920|P1|Overall Study|Adverse Event|29
458047|NCT00333229|1505963|P2|Overall Study|Lack of Efficacy|1
458048|NCT00333229|1505964|P1|Overall Study|Lack of Efficacy|0
458049|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Death|0
458050|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Death|1
458051|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Death|0
458052|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
458053|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
458054|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
458055|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
458056|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
458057|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
458058|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
458059|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
458060|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
458061|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
458062|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
458063|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
458064|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
458065|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
458066|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
458067|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
458068|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
458069|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
458070|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
458071|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
458072|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
458073|NCT00333138|1505981|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
458074|NCT00333138|1505982|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
458075|NCT00333138|1505983|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
458076|NCT00333138|1505981|P3|Core Study (6 Months)|Laboratory abnormality|1
458077|NCT00333138|1505982|P2|Core Study (6 Months)|Laboratory abnormality|0
458078|NCT00333138|1505983|P1|Core Study (6 Months)|Laboratory abnormality|0
458079|NCT00333138|1505981|P3|Core Study (6 Months)|Protocol Violation|1
458080|NCT00333138|1505982|P2|Core Study (6 Months)|Protocol Violation|0
458081|NCT00333138|1505983|P1|Core Study (6 Months)|Protocol Violation|1
458082|NCT00333138|1505981|P3|Core Study (6 Months)|Lack of Efficacy|0
458083|NCT00333138|1505982|P2|Core Study (6 Months)|Lack of Efficacy|0
458084|NCT00333138|1505983|P1|Core Study (6 Months)|Lack of Efficacy|1
458085|NCT00333138|1505981|P3|Core Study (6 Months)|Withdrawal by Subject|2
458086|NCT00333138|1505982|P2|Core Study (6 Months)|Withdrawal by Subject|1
458087|NCT00333138|1505983|P1|Core Study (6 Months)|Withdrawal by Subject|1
458088|NCT00333138|1505981|P3|Core Study (6 Months)|Adverse Event|8
458089|NCT00333138|1505982|P2|Core Study (6 Months)|Adverse Event|5
458090|NCT00333138|1505983|P1|Core Study (6 Months)|Adverse Event|4
458091|NCT00332839|1506022|P2|Follow-up (Months 12 - 60)|Death|1
458092|NCT00332839|1506023|P1|Follow-up (Months 12 - 60)|Death|1
458093|NCT00332839|1506022|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
458094|NCT00332839|1506023|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
458095|NCT00332839|1506022|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
458096|NCT00332839|1506023|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
458097|NCT00332839|1506022|P2|Core (Months 0 - 12)|Adverse Event|15
458098|NCT00332839|1506023|P1|Core (Months 0 - 12)|Adverse Event|5
458099|NCT00332839|1506022|P2|Core (Months 0 - 12)|Protocol deviation|1
458100|NCT00332839|1506023|P1|Core (Months 0 - 12)|Protocol deviation|1
458101|NCT00332839|1506022|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
458102|NCT00332839|1506023|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
458103|NCT00332839|1506022|P2|Core (Months 0 - 12)|Administrative problems|1
458104|NCT00332839|1506023|P1|Core (Months 0 - 12)|Administrative problems|1
458105|NCT00332709|1506054|P2|Overall Study|Abnormal test procedure result|0
458106|NCT00332709|1506055|P1|Overall Study|Abnormal test procedure result|1
458107|NCT00332709|1506054|P2|Overall Study|Administrative Problems|3
458108|NCT00332709|1506055|P1|Overall Study|Administrative Problems|0
458109|NCT00332709|1506054|P2|Overall Study|Lost to Follow-up|0
458110|NCT00332709|1506055|P1|Overall Study|Lost to Follow-up|2
458111|NCT00332709|1506054|P2|Overall Study|Withdrawal by Subject|3
458112|NCT00332709|1506055|P1|Overall Study|Withdrawal by Subject|2
458113|NCT00332709|1506054|P2|Overall Study|Adverse Event|14
458114|NCT00332709|1506055|P1|Overall Study|Adverse Event|11
458115|NCT00332696|1506079|P2|Overall Study|Withdrawal by Subject|0
458116|NCT00332696|1506080|P1|Overall Study|Withdrawal by Subject|1
458117|NCT00332696|1506079|P2|Overall Study|Lost to Follow-up|1
458118|NCT00332696|1506080|P1|Overall Study|Lost to Follow-up|0
458119|NCT00332696|1506079|P2|Overall Study|Condition does not justify treatment|2
458120|NCT00332696|1506080|P1|Overall Study|Condition does not justify treatment|0
458121|NCT00332696|1506079|P2|Overall Study|Adverse Event|2
458122|NCT00332696|1506080|P1|Overall Study|Adverse Event|1
458123|NCT00332696|1506079|P2|Overall Study|Insufficient therapeutic effect|11
458124|NCT00332696|1506080|P1|Overall Study|Insufficient therapeutic effect|4
458125|NCT00332696|1506079|P2|Overall Study|Death|14
458126|NCT00332696|1506080|P1|Overall Study|Death|24
458127|NCT00332488|1506156|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
458128|NCT00332488|1506157|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
458129|NCT00332488|1506158|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
458130|NCT00332488|1506156|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
458131|NCT00332488|1506157|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
458132|NCT00332488|1506158|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
458133|NCT00332488|1506156|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
458134|NCT00332488|1506157|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
458135|NCT00332488|1506158|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
458136|NCT00332488|1506156|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
458137|NCT00332488|1506157|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
458138|NCT00332488|1506158|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
458139|NCT00332488|1506156|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
458140|NCT00332488|1506157|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
458141|NCT00332488|1506158|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
458142|NCT00332488|1506156|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
458143|NCT00332488|1506157|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
458144|NCT00332488|1506158|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
458145|NCT00332488|1506156|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
458146|NCT00332488|1506157|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
458147|NCT00332488|1506158|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
458148|NCT00332488|1506156|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
458149|NCT00332488|1506157|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
458150|NCT00332488|1506158|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
458151|NCT00332488|1506156|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
458152|NCT00332488|1506157|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
458153|NCT00332488|1506158|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
458154|NCT00332488|1506156|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
458155|NCT00332488|1506157|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
458156|NCT00332488|1506158|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
458157|NCT00332488|1506156|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
458158|NCT00332488|1506157|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
458159|NCT00332488|1506158|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
458160|NCT00332488|1506156|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
458161|NCT00332488|1506157|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
458162|NCT00332488|1506158|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
458163|NCT00332462|1506170|P1|Overall Study|Graft Loss|2
458164|NCT00332462|1506170|P1|Overall Study|Death|3
458165|NCT00332462|1506170|P1|Overall Study|no longer requires study drug|1
458166|NCT00332462|1506170|P1|Overall Study|Unsatisfactory therapeutic effect|4
458167|NCT00332462|1506170|P1|Overall Study|Abnormal Lab Value|1
458168|NCT00332462|1506170|P1|Overall Study|Adverse Event|5
458169|NCT00332332|1506177|P1|Overall Study|Did not receive study treatment|16
458170|NCT00332332|1506177|P1|Overall Study|Not specified|18
458171|NCT00332332|1506177|P1|Overall Study|Disease progression|2
458172|NCT00332332|1506177|P1|Overall Study|Noncompliance|2
458173|NCT00332332|1506177|P1|Overall Study|Protocol deviation|4
458174|NCT00332332|1506177|P1|Overall Study|Lost to Follow-up|3
458175|NCT00332332|1506177|P1|Overall Study|Physician Decision|1
458176|NCT00332332|1506177|P1|Overall Study|Withdrawal by Subject|8
458177|NCT00332332|1506177|P1|Overall Study|Death|1
458178|NCT00332332|1506177|P1|Overall Study|Adverse Event|13
458179|NCT00332241|1506186|P2|Overall Study|Lost to Follow-up|1
458180|NCT00332241|1506187|P1|Overall Study|Lost to Follow-up|4
458181|NCT00332241|1506186|P2|Overall Study|Withdrawal by Subject|1
458182|NCT00332241|1506187|P1|Overall Study|Withdrawal by Subject|2
458183|NCT00332241|1506186|P2|Overall Study|Adverse Event|5
458184|NCT00332241|1506187|P1|Overall Study|Adverse Event|3
458185|NCT00332241|1506186|P2|Overall Study|Lack of Efficacy|1
458186|NCT00332241|1506187|P1|Overall Study|Lack of Efficacy|6
458187|NCT00332189|1506207|P1|Overall Study|Moved out of country|2
458188|NCT00332189|1506207|P1|Overall Study|Lack of Efficacy|4
458189|NCT00332189|1506207|P1|Overall Study|Withdrawal by Subject|9
458190|NCT00332189|1506207|P1|Overall Study|Uncooperative/Noncompliant|3
458191|NCT00332189|1506207|P1|Overall Study|Adverse Event|3
458192|NCT00331864|1506249|P2|Overall Study|Death|0
458193|NCT00331864|1506250|P1|Overall Study|Death|6
458194|NCT00331864|1506249|P2|Overall Study|Administrative Problems|0
458195|NCT00331864|1506250|P1|Overall Study|Administrative Problems|1
458196|NCT00331864|1506249|P2|Overall Study|Lost to Follow-up|3
458197|NCT00331864|1506250|P1|Overall Study|Lost to Follow-up|4
458198|NCT00331864|1506249|P2|Overall Study|Withdrawal by Subject|0
458199|NCT00331864|1506250|P1|Overall Study|Withdrawal by Subject|10
458200|NCT00331864|1506249|P2|Overall Study|Protocol Violation|0
458201|NCT00331864|1506250|P1|Overall Study|Protocol Violation|3
458202|NCT00331864|1506249|P2|Overall Study|Lack of Efficacy|0
458203|NCT00331864|1506250|P1|Overall Study|Lack of Efficacy|4
458204|NCT00331864|1506249|P2|Overall Study|Adverse Event|1
458205|NCT00331864|1506250|P1|Overall Study|Adverse Event|30
458206|NCT00331799|1506269|P1|Overall Study|Sedation|1
458207|NCT00331799|1506269|P1|Overall Study|Withdrawal by Subject|2
458208|NCT00331773|1506275|P2|Overall Study|Protocol Violation|3
458209|NCT00331773|1506276|P1|Overall Study|Protocol Violation|10
458210|NCT00331773|1506275|P2|Overall Study|Withdrawal by Subject|4
458211|NCT00331773|1506276|P1|Overall Study|Withdrawal by Subject|6
458212|NCT00331760|1506304|P2|Overall Study|Ineligible / no protocol treatment|8
458213|NCT00331760|1506305|P1|Overall Study|Ineligible / no protocol treatment|15
458214|NCT00331682|1506311|P1|Overall Study|Adverse Event|1
458215|NCT00331552|1506319|P2|Period 3: Phase II|Severe Nausea|0
458216|NCT00331552|1506320|P1|Period 3: Phase II|Severe Nausea|1
458217|NCT00331552|1506319|P2|Period 3: Phase II|Neurological Symptoms|0
458218|NCT00331552|1506320|P1|Period 3: Phase II|Neurological Symptoms|1
458219|NCT00331422|1506334|P1|Overall Study|Did not receive entire study regimen|5
458220|NCT00331409|1506343|P1|Overall Study|Lack of Efficacy|4
458221|NCT00331344|1506351|P9|Phase II|Death|4
458222|NCT00331344|1506352|P8|Phase II|Death|0
458223|NCT00331344|1506353|P7|Phase II|Death|0
458224|NCT00331344|1506354|P6|Phase II|Death|0
458225|NCT00331344|1506355|P5|Phase II|Death|0
458226|NCT00331344|1506356|P4|Phase II|Death|0
458227|NCT00331344|1506357|P3|Phase II|Death|0
458228|NCT00331344|1506358|P2|Phase II|Death|0
458229|NCT00331344|1506359|P1|Phase II|Death|0
458230|NCT00331344|1506351|P9|Phase I|Adverse Event|0
458231|NCT00331344|1506352|P8|Phase I|Adverse Event|1
458232|NCT00331344|1506353|P7|Phase I|Adverse Event|0
458233|NCT00331344|1506354|P6|Phase I|Adverse Event|2
458234|NCT00331344|1506355|P5|Phase I|Adverse Event|2
458235|NCT00331344|1506356|P4|Phase I|Adverse Event|1
458236|NCT00331344|1506357|P3|Phase I|Adverse Event|0
458237|NCT00331344|1506358|P2|Phase I|Adverse Event|0
458238|NCT00331344|1506359|P1|Phase I|Adverse Event|0
458239|NCT00331006|1506396|P1|Follow-Up Phase II|Lost to Follow-up|3
458240|NCT00331006|1506396|P1|Follow-Up Phase I|Lost to Follow-up|1
458241|NCT00331006|1506396|P1|Treatment Phase|Withdrawal by Subject|1
458242|NCT00331006|1506396|P1|Screening Phase|Ineligible for treatment phase|4
458243|NCT00331006|1506396|P1|Screening Phase|Lost to Follow-up|1
458244|NCT00331006|1506396|P1|Screening Phase|enrollment halted|1
458245|NCT00331006|1506396|P1|Screening Phase|Withdrawal by Subject|1
458246|NCT00330967|1506409|P2|Overall Study|Physician Decision|9
458247|NCT00330967|1506410|P1|Overall Study|Physician Decision|0
458248|NCT00330967|1506409|P2|Overall Study|Withdrawal by Subject|5
458249|NCT00330967|1506410|P1|Overall Study|Withdrawal by Subject|0
458250|NCT00330928|1506421|P1|Overall Study|IVUS could not be performed.|1
458251|NCT00330928|1506421|P1|Overall Study|Death|1
458252|NCT00330928|1506421|P1|Overall Study|Physician Decision|9
458253|NCT00330928|1506421|P1|Overall Study|Lost to Follow-up|6
458254|NCT00330759|1506444|P2|Overall Study|Other|44
458255|NCT00330759|1506445|P1|Overall Study|Other|36
458256|NCT00330759|1506444|P2|Overall Study|Ineligibility determined|1
458257|NCT00330759|1506445|P1|Overall Study|Ineligibility determined|2
458258|NCT00330759|1506444|P2|Overall Study|Protocol deviation|2
458259|NCT00330759|1506445|P1|Overall Study|Protocol deviation|0
458260|NCT00330759|1506444|P2|Overall Study|Physician Decision|2
458261|NCT00330759|1506445|P1|Overall Study|Physician Decision|1
458262|NCT00330759|1506444|P2|Overall Study|Noncompliance|17
458263|NCT00330759|1506445|P1|Overall Study|Noncompliance|15
458264|NCT00330759|1506444|P2|Overall Study|Lost to Follow-up|22
458265|NCT00330759|1506445|P1|Overall Study|Lost to Follow-up|16
458266|NCT00330759|1506444|P2|Overall Study|Participant request|22
458267|NCT00330759|1506445|P1|Overall Study|Participant request|31
458268|NCT00330759|1506444|P2|Overall Study|Adverse Event|36
458269|NCT00330759|1506445|P1|Overall Study|Adverse Event|48
458270|NCT00330759|1506444|P2|Overall Study|Withdrawal by Subject|124
458271|NCT00330759|1506445|P1|Overall Study|Withdrawal by Subject|143
458272|NCT00330759|1506444|P2|Overall Study|Disease progression|126
458273|NCT00330759|1506445|P1|Overall Study|Disease progression|104
458274|NCT00330759|1506444|P2|Overall Study|Death|310
458275|NCT00330759|1506445|P1|Overall Study|Death|316
458276|NCT00330681|1506466|P2|Overall Study|Tracheotomy due to worsening of ALS|2
458277|NCT00330681|1506467|P1|Overall Study|Tracheotomy due to worsening of ALS|1
458278|NCT00330681|1506466|P2|Overall Study|Withdrawal by Subject|5
458279|NCT00330681|1506467|P1|Overall Study|Withdrawal by Subject|5
458280|NCT00330681|1506466|P2|Overall Study|Protocol Violation|1
458281|NCT00330681|1506467|P1|Overall Study|Protocol Violation|0
458282|NCT00330681|1506466|P2|Overall Study|Adverse Event|6
458283|NCT00330681|1506467|P1|Overall Study|Adverse Event|3
458284|NCT00330668|1506489|P1|Overall Study|Patient started Lupron|1
458285|NCT00330668|1506489|P1|Overall Study|Use of exclusionary medication|1
458286|NCT00330668|1506489|P1|Overall Study|Lack of Efficacy|1
458287|NCT00330668|1506489|P1|Overall Study|Sponsor's decision|76
458288|NCT00330668|1506489|P1|Overall Study|Withdrawal by Subject|20
458289|NCT00330668|1506489|P1|Overall Study|Non-Compliance|5
458290|NCT00330668|1506489|P1|Overall Study|Lost to Follow-up|9
458291|NCT00330668|1506489|P1|Overall Study|Adverse Event|1
458292|NCT00330616|1506496|P1|Overall Study|Not specified|1
458293|NCT00330616|1506496|P1|Overall Study|Withdrawal by Subject|4
458294|NCT00330616|1506496|P1|Overall Study|Lost to Follow-up|2
458295|NCT00330616|1506496|P1|Overall Study|Lack of Efficacy|1
458296|NCT00330616|1506496|P1|Overall Study|Adverse Event|13
458297|NCT00330460|1506522|P2|Overall Study|Other|0
458298|NCT00330460|1506523|P1|Overall Study|Other|1
458299|NCT00330460|1506522|P2|Overall Study|Noncompliance|1
458300|NCT00330460|1506523|P1|Overall Study|Noncompliance|2
458301|NCT00330460|1506522|P2|Overall Study|Lost to Follow-up|3
458302|NCT00330460|1506523|P1|Overall Study|Lost to Follow-up|8
458303|NCT00330460|1506522|P2|Overall Study|Ineligibility determined|3
458304|NCT00330460|1506523|P1|Overall Study|Ineligibility determined|1
458305|NCT00330460|1506522|P2|Overall Study|Death|1
458306|NCT00330460|1506523|P1|Overall Study|Death|1
458307|NCT00330460|1506522|P2|Overall Study|Withdrawal by Subject|17
458308|NCT00330460|1506523|P1|Overall Study|Withdrawal by Subject|18
458309|NCT00330460|1506522|P2|Overall Study|Adverse Event|8
458310|NCT00330460|1506523|P1|Overall Study|Adverse Event|10
458311|NCT00330460|1506522|P2|Overall Study|Physician Decision|0
458312|NCT00330460|1506523|P1|Overall Study|Physician Decision|1
458313|NCT00330343|1506566|P1|Overall Study|Lost to Follow-up|5
458314|NCT00330174|1506572|P2|Overall Study|Miscellaneous reasons|1
458315|NCT00330174|1506573|P1|Overall Study|Miscellaneous reasons|7
458316|NCT00330174|1506572|P2|Overall Study|Excessive missed visits|8
458317|NCT00330174|1506573|P1|Overall Study|Excessive missed visits|3
458318|NCT00330174|1506572|P2|Overall Study|Clinical deterioration|2
458319|NCT00330174|1506573|P1|Overall Study|Clinical deterioration|1
458320|NCT00330174|1506572|P2|Overall Study|Lost to Follow-up|1
458321|NCT00330174|1506573|P1|Overall Study|Lost to Follow-up|4
458322|NCT00330174|1506572|P2|Overall Study|Withdrawal by Subject|7
458323|NCT00330174|1506573|P1|Overall Study|Withdrawal by Subject|7
458324|NCT00329901|1506597|P3|Overall Study|Unable to classify|0
458325|NCT00329901|1506598|P2|Overall Study|Unable to classify|2
458326|NCT00329901|1506599|P1|Overall Study|Unable to classify|2
458327|NCT00329901|1506597|P3|Overall Study|Protocol Violation|1
458328|NCT00329901|1506598|P2|Overall Study|Protocol Violation|0
458329|NCT00329901|1506599|P1|Overall Study|Protocol Violation|1
458330|NCT00329901|1506597|P3|Overall Study|Lost to Follow-up|1
458331|NCT00329901|1506598|P2|Overall Study|Lost to Follow-up|0
458332|NCT00329901|1506599|P1|Overall Study|Lost to Follow-up|2
458333|NCT00329901|1506597|P3|Overall Study|Withdrawal by Subject|2
458334|NCT00329901|1506598|P2|Overall Study|Withdrawal by Subject|3
458335|NCT00329901|1506599|P1|Overall Study|Withdrawal by Subject|4
458336|NCT00329849|1506629|P2|Overall Study|Withdrawal by Subject|4
458337|NCT00329849|1506630|P1|Overall Study|Withdrawal by Subject|6
458338|NCT00329797|1506656|P2|Overall Study|Withdrawal by Subject|6
458339|NCT00329797|1506657|P1|Overall Study|Withdrawal by Subject|6
458340|NCT00329797|1506656|P2|Overall Study|Protocol Violation|0
458341|NCT00329797|1506657|P1|Overall Study|Protocol Violation|1
458342|NCT00329784|1506673|P4|Overall Study|Other|0
458343|NCT00329784|1506674|P3|Overall Study|Other|0
458344|NCT00329784|1506675|P2|Overall Study|Other|2
458345|NCT00329784|1506676|P1|Overall Study|Other|1
458346|NCT00329784|1506673|P4|Overall Study|Withdrawal by Subject|0
458347|NCT00329784|1506674|P3|Overall Study|Withdrawal by Subject|0
458348|NCT00329784|1506675|P2|Overall Study|Withdrawal by Subject|2
458349|NCT00329784|1506676|P1|Overall Study|Withdrawal by Subject|4
458350|NCT00329784|1506673|P4|Overall Study|Lost to Follow-up|0
458351|NCT00329784|1506674|P3|Overall Study|Lost to Follow-up|0
458352|NCT00329784|1506675|P2|Overall Study|Lost to Follow-up|1
458353|NCT00329784|1506676|P1|Overall Study|Lost to Follow-up|0
458354|NCT00329745|1506704|P2|Overall Study|Lost to Follow-up|101
458355|NCT00329745|1506705|P1|Overall Study|Lost to Follow-up|86
458356|NCT00329745|1506704|P2|Overall Study|Withdrawal by Subject|1
458357|NCT00329745|1506705|P1|Overall Study|Withdrawal by Subject|0
458358|NCT00329745|1506704|P2|Overall Study|Protocol Violation|0
458359|NCT00329745|1506705|P1|Overall Study|Protocol Violation|1
458360|NCT00329719|1506725|P4|Overall Study|Lost to Follow-up|1
458361|NCT00329719|1506726|P3|Overall Study|Lost to Follow-up|0
458362|NCT00329719|1506727|P2|Overall Study|Lost to Follow-up|0
458363|NCT00329719|1506728|P1|Overall Study|Lost to Follow-up|0
458364|NCT00329641|1506750|P1|Overall Study|Other reason, not protocol specified|1
458365|NCT00329641|1506750|P1|Overall Study|Adverse Event|3
458366|NCT00329641|1506750|P1|Overall Study|Not eligible|1
458367|NCT00329641|1506750|P1|Overall Study|Did not start treatment|1
458368|NCT00329602|1506759|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
458369|NCT00329602|1506760|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
458370|NCT00329602|1506761|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
458371|NCT00329602|1506759|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
458372|NCT00329602|1506760|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
458373|NCT00329602|1506761|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
458374|NCT00329602|1506759|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
458375|NCT00329602|1506760|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
458376|NCT00329602|1506761|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
458377|NCT00329602|1506759|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
458378|NCT00329602|1506760|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
458379|NCT00329602|1506761|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
458380|NCT00329602|1506759|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
458381|NCT00329602|1506760|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
458382|NCT00329602|1506761|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
458383|NCT00329602|1506759|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
458384|NCT00329602|1506760|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
458385|NCT00329602|1506761|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
458386|NCT00329550|1506799|P3|Overall Study|Due to Relocation|1
458387|NCT00329550|1506800|P2|Overall Study|Due to Relocation|0
458388|NCT00329550|1506801|P1|Overall Study|Due to Relocation|0
458389|NCT00329550|1506799|P3|Overall Study|Withdrawal of Consent|1
458390|NCT00329550|1506800|P2|Overall Study|Withdrawal of Consent|0
458391|NCT00329550|1506801|P1|Overall Study|Withdrawal of Consent|1
458392|NCT00329550|1506799|P3|Overall Study|Adverse Event|2
458393|NCT00329550|1506800|P2|Overall Study|Adverse Event|4
458394|NCT00329550|1506801|P1|Overall Study|Adverse Event|3
458395|NCT00329420|1507066|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
458396|NCT00329420|1507067|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
458397|NCT00329420|1507068|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
458398|NCT00329420|1507066|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
458399|NCT00329420|1507067|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
458400|NCT00329420|1507068|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
458401|NCT00329420|1507066|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
458402|NCT00329420|1507067|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
458403|NCT00329420|1507068|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
458404|NCT00329420|1507066|P3|Re-induction Phase|Did not respond to re-induction|7
458405|NCT00329420|1507067|P2|Re-induction Phase|Did not respond to re-induction|5
458406|NCT00329420|1507068|P1|Re-induction Phase|Did not respond to re-induction|6
458407|NCT00329420|1507066|P3|Re-induction Phase|Withdrawal of Consent|1
458408|NCT00329420|1507067|P2|Re-induction Phase|Withdrawal of Consent|0
458409|NCT00329420|1507068|P1|Re-induction Phase|Withdrawal of Consent|0
458410|NCT00329420|1507066|P3|Re-induction Phase|Lack of Efficacy|0
458411|NCT00329420|1507067|P2|Re-induction Phase|Lack of Efficacy|1
458412|NCT00329420|1507068|P1|Re-induction Phase|Lack of Efficacy|0
458413|NCT00329407|1507447|P1|Overall Study|Withdrawal by Subject|1
458414|NCT00329238|1507454|P2|Overall Study|Other reason (not specified)|54
458415|NCT00329238|1507455|P1|Overall Study|Other reason (not specified)|40
458416|NCT00329238|1507454|P2|Overall Study|Withdrawal by Subject|58
458417|NCT00329238|1507455|P1|Overall Study|Withdrawal by Subject|64
458418|NCT00329238|1507454|P2|Overall Study|Lost to Follow-up|6
458419|NCT00329238|1507455|P1|Overall Study|Lost to Follow-up|2
458420|NCT00329238|1507454|P2|Overall Study|Protocol Violation|34
458421|NCT00329238|1507455|P1|Overall Study|Protocol Violation|23
458422|NCT00329238|1507454|P2|Overall Study|Adverse Event|129
458423|NCT00329238|1507455|P1|Overall Study|Adverse Event|147
458424|NCT00329160|1507491|P1|Overall Study|Incomplete IVUS|45
458425|NCT00329160|1507491|P1|Overall Study|Did not Receive Study Drug|1
458426|NCT00329160|1507491|P1|Overall Study|Protocol Violation|2
458427|NCT00329160|1507491|P1|Overall Study|Withdrawal by Subject|13
458428|NCT00329160|1507491|P1|Overall Study|Adverse Event|27
458429|NCT00329108|1507500|P2|Overall Study|Protocol Violation|2
458430|NCT00329108|1507501|P1|Overall Study|Protocol Violation|0
458431|NCT00329108|1507500|P2|Overall Study|withdrew patient after SAE resolved|0
458432|NCT00329108|1507501|P1|Overall Study|withdrew patient after SAE resolved|1
458433|NCT00329108|1507500|P2|Overall Study|study terminated by sponsor|0
458434|NCT00329108|1507501|P1|Overall Study|study terminated by sponsor|1
458435|NCT00329108|1507500|P2|Overall Study|Subject no longer willing to participate|2
458436|NCT00329108|1507501|P1|Overall Study|Subject no longer willing to participate|2
458437|NCT00329108|1507500|P2|Overall Study|symptomatic deterioration|1
458438|NCT00329108|1507501|P1|Overall Study|symptomatic deterioration|1
458439|NCT00329108|1507500|P2|Overall Study|Withdrawal by Subject|2
458440|NCT00329108|1507501|P1|Overall Study|Withdrawal by Subject|0
458441|NCT00329108|1507500|P2|Overall Study|Lack of Efficacy|3
458442|NCT00329108|1507501|P1|Overall Study|Lack of Efficacy|3
458443|NCT00329108|1507500|P2|Overall Study|Adverse Event|2
458444|NCT00329108|1507501|P1|Overall Study|Adverse Event|2
458445|NCT00329030|1507509|P2|Overall Study|Ineligible Pathology|1
458446|NCT00329030|1507510|P1|Overall Study|Ineligible Pathology|1
458447|NCT00329030|1507509|P2|Overall Study|Progressive Disease|2
458448|NCT00329030|1507510|P1|Overall Study|Progressive Disease|6
458449|NCT00329030|1507509|P2|Overall Study|Withdrawal by Subject|3
458450|NCT00329030|1507510|P1|Overall Study|Withdrawal by Subject|1
458451|NCT00328926|1507541|P3|Overall Study|Lack of ovarian response|0
458452|NCT00328926|1507542|P2|Overall Study|Lack of ovarian response|1
458453|NCT00328926|1507543|P1|Overall Study|Lack of ovarian response|0
458454|NCT00328926|1507541|P3|Overall Study|In vitro fertilization treatment|1
458455|NCT00328926|1507542|P2|Overall Study|In vitro fertilization treatment|0
458456|NCT00328926|1507543|P1|Overall Study|In vitro fertilization treatment|0
458457|NCT00328926|1507541|P3|Overall Study|Death|1
458458|NCT00328926|1507542|P2|Overall Study|Death|0
458459|NCT00328926|1507543|P1|Overall Study|Death|0
458460|NCT00328926|1507541|P3|Overall Study|Lost to Follow-up|0
458461|NCT00328926|1507542|P2|Overall Study|Lost to Follow-up|1
458462|NCT00328926|1507543|P1|Overall Study|Lost to Follow-up|0
458463|NCT00328926|1507541|P3|Overall Study|Pregnancy|0
458464|NCT00328926|1507542|P2|Overall Study|Pregnancy|1
458465|NCT00328926|1507543|P1|Overall Study|Pregnancy|2
458466|NCT00328783|1507568|P1|Overall Study|Withdrawal by Subject|1
458467|NCT00328783|1507568|P1|Overall Study|No heart in RT field|4
458468|NCT00328783|1507568|P1|Overall Study|Could not tolerate ABC|21
458469|NCT00328627|1507594|P12|Overall Study|Other|0
458470|NCT00328627|1507595|P11|Overall Study|Other|1
458471|NCT00328627|1507596|P10|Overall Study|Other|1
458472|NCT00328627|1507597|P9|Overall Study|Other|0
458473|NCT00328627|1507598|P8|Overall Study|Other|0
458474|NCT00328627|1507599|P7|Overall Study|Other|1
458475|NCT00328627|1507600|P6|Overall Study|Other|0
458476|NCT00328627|1507601|P5|Overall Study|Other|0
458477|NCT00328627|1507602|P4|Overall Study|Other|1
458478|NCT00328627|1507603|P3|Overall Study|Other|0
458479|NCT00328627|1507604|P2|Overall Study|Other|0
458480|NCT00328627|1507605|P1|Overall Study|Other|0
458481|NCT00328627|1507594|P12|Overall Study|Physician Decision|0
458482|NCT00328627|1507595|P11|Overall Study|Physician Decision|1
458483|NCT00328627|1507596|P10|Overall Study|Physician Decision|2
458484|NCT00328627|1507597|P9|Overall Study|Physician Decision|3
458485|NCT00328627|1507598|P8|Overall Study|Physician Decision|0
458486|NCT00328627|1507599|P7|Overall Study|Physician Decision|1
458487|NCT00328627|1507600|P6|Overall Study|Physician Decision|1
458488|NCT00328627|1507601|P5|Overall Study|Physician Decision|1
458489|NCT00328627|1507602|P4|Overall Study|Physician Decision|2
458490|NCT00328627|1507603|P3|Overall Study|Physician Decision|1
458491|NCT00328627|1507604|P2|Overall Study|Physician Decision|3
458492|NCT00328627|1507605|P1|Overall Study|Physician Decision|4
458493|NCT00328627|1507594|P12|Overall Study|Pregnancy|0
458494|NCT00328627|1507595|P11|Overall Study|Pregnancy|0
458495|NCT00328627|1507596|P10|Overall Study|Pregnancy|0
458496|NCT00328627|1507597|P9|Overall Study|Pregnancy|0
458497|NCT00328627|1507598|P8|Overall Study|Pregnancy|0
458498|NCT00328627|1507599|P7|Overall Study|Pregnancy|0
458499|NCT00328627|1507600|P6|Overall Study|Pregnancy|0
458500|NCT00328627|1507601|P5|Overall Study|Pregnancy|0
458501|NCT00328627|1507602|P4|Overall Study|Pregnancy|0
458502|NCT00328627|1507603|P3|Overall Study|Pregnancy|0
458503|NCT00328627|1507604|P2|Overall Study|Pregnancy|1
458504|NCT00328627|1507605|P1|Overall Study|Pregnancy|0
458505|NCT00328627|1507594|P12|Overall Study|Withdrawal by Subject|7
458506|NCT00328627|1507595|P11|Overall Study|Withdrawal by Subject|2
458507|NCT00328627|1507596|P10|Overall Study|Withdrawal by Subject|5
458508|NCT00328627|1507597|P9|Overall Study|Withdrawal by Subject|4
458509|NCT00328627|1507598|P8|Overall Study|Withdrawal by Subject|4
458510|NCT00328627|1507599|P7|Overall Study|Withdrawal by Subject|4
458511|NCT00328627|1507600|P6|Overall Study|Withdrawal by Subject|5
458512|NCT00328627|1507601|P5|Overall Study|Withdrawal by Subject|2
458513|NCT00328627|1507602|P4|Overall Study|Withdrawal by Subject|6
458514|NCT00328627|1507603|P3|Overall Study|Withdrawal by Subject|5
458515|NCT00328627|1507604|P2|Overall Study|Withdrawal by Subject|4
458516|NCT00328627|1507605|P1|Overall Study|Withdrawal by Subject|5
458517|NCT00328627|1507594|P12|Overall Study|Lost to Follow-up|1
458518|NCT00328627|1507595|P11|Overall Study|Lost to Follow-up|0
458519|NCT00328627|1507596|P10|Overall Study|Lost to Follow-up|2
458520|NCT00328627|1507597|P9|Overall Study|Lost to Follow-up|3
458521|NCT00328627|1507598|P8|Overall Study|Lost to Follow-up|0
458522|NCT00328627|1507599|P7|Overall Study|Lost to Follow-up|3
458523|NCT00328627|1507600|P6|Overall Study|Lost to Follow-up|2
458524|NCT00328627|1507601|P5|Overall Study|Lost to Follow-up|0
458525|NCT00328627|1507602|P4|Overall Study|Lost to Follow-up|4
458526|NCT00328627|1507603|P3|Overall Study|Lost to Follow-up|2
458527|NCT00328627|1507604|P2|Overall Study|Lost to Follow-up|2
458528|NCT00328627|1507605|P1|Overall Study|Lost to Follow-up|4
458529|NCT00328627|1507594|P12|Overall Study|Protocol Violation|2
458530|NCT00328627|1507595|P11|Overall Study|Protocol Violation|6
458531|NCT00328627|1507596|P10|Overall Study|Protocol Violation|4
458532|NCT00328627|1507597|P9|Overall Study|Protocol Violation|1
458533|NCT00328627|1507598|P8|Overall Study|Protocol Violation|2
458534|NCT00328627|1507599|P7|Overall Study|Protocol Violation|6
458535|NCT00328627|1507600|P6|Overall Study|Protocol Violation|5
458536|NCT00328627|1507601|P5|Overall Study|Protocol Violation|5
458537|NCT00328627|1507602|P4|Overall Study|Protocol Violation|8
458538|NCT00328627|1507603|P3|Overall Study|Protocol Violation|2
458539|NCT00328627|1507604|P2|Overall Study|Protocol Violation|2
458540|NCT00328627|1507605|P1|Overall Study|Protocol Violation|2
458541|NCT00328627|1507594|P12|Overall Study|Adverse Event|4
458542|NCT00328627|1507595|P11|Overall Study|Adverse Event|5
458543|NCT00328627|1507596|P10|Overall Study|Adverse Event|7
458544|NCT00328627|1507597|P9|Overall Study|Adverse Event|0
458545|NCT00328627|1507598|P8|Overall Study|Adverse Event|2
458546|NCT00328627|1507599|P7|Overall Study|Adverse Event|1
458547|NCT00328627|1507600|P6|Overall Study|Adverse Event|2
458548|NCT00328627|1507601|P5|Overall Study|Adverse Event|1
458549|NCT00328627|1507602|P4|Overall Study|Adverse Event|3
458550|NCT00328627|1507603|P3|Overall Study|Adverse Event|2
458551|NCT00328627|1507604|P2|Overall Study|Adverse Event|1
458552|NCT00328627|1507605|P1|Overall Study|Adverse Event|3
458553|NCT00328627|1507594|P12|Overall Study|Hyperglycemic Rescue|2
458554|NCT00328627|1507595|P11|Overall Study|Hyperglycemic Rescue|3
458555|NCT00328627|1507596|P10|Overall Study|Hyperglycemic Rescue|11
458556|NCT00328627|1507597|P9|Overall Study|Hyperglycemic Rescue|6
458557|NCT00328627|1507598|P8|Overall Study|Hyperglycemic Rescue|6
458558|NCT00328627|1507599|P7|Overall Study|Hyperglycemic Rescue|19
458559|NCT00328627|1507600|P6|Overall Study|Hyperglycemic Rescue|5
458560|NCT00328627|1507601|P5|Overall Study|Hyperglycemic Rescue|6
458561|NCT00328627|1507602|P4|Overall Study|Hyperglycemic Rescue|13
458562|NCT00328627|1507603|P3|Overall Study|Hyperglycemic Rescue|16
458563|NCT00328627|1507604|P2|Overall Study|Hyperglycemic Rescue|18
458564|NCT00328627|1507605|P1|Overall Study|Hyperglycemic Rescue|41
458565|NCT00328562|1509142|P1|Overall Study|Disease progression|1
458566|NCT00328510|1509151|P2|Overall Study|Treatment changed to a single fraction|1
458567|NCT00328510|1509152|P1|Overall Study|Treatment changed to a single fraction|1
458568|NCT00328510|1509151|P2|Overall Study|Severe kyphosis, could not use mask|1
458569|NCT00328510|1509152|P1|Overall Study|Severe kyphosis, could not use mask|0
458570|NCT00328510|1509151|P2|Overall Study|Withdrawal by Subject|2
458571|NCT00328510|1509152|P1|Overall Study|Withdrawal by Subject|4
458572|NCT00328510|1509151|P2|Overall Study|Dentition problems, could not use frame|0
458573|NCT00328510|1509152|P1|Overall Study|Dentition problems, could not use frame|1
458574|NCT00328510|1509151|P2|Overall Study|Gag disorder, could not use frame|0
458575|NCT00328510|1509152|P1|Overall Study|Gag disorder, could not use frame|4
458576|NCT00328198|1509167|P1|Follow-up|Death|31
458577|NCT00328198|1509167|P1|Follow-up|Lost to Follow-up|4
458578|NCT00328198|1509167|P1|Treatment|Confirmed complete response, MRD -|3
458579|NCT00328198|1509167|P1|Treatment|Non-compliance|1
458580|NCT00328198|1509167|P1|Treatment|Evidence of disease progression|2
458581|NCT00328198|1509167|P1|Treatment|Withdrawal by Subject|5
458582|NCT00328198|1509167|P1|Treatment|Physician Decision|5
458583|NCT00328198|1509167|P1|Treatment|Death|1
458584|NCT00328198|1509167|P1|Treatment|Adverse Event|21
458585|NCT00328172|1509182|P5|Overall Study|Other reason (not specified)|0
458586|NCT00328172|1509183|P4|Overall Study|Other reason (not specified)|0
458587|NCT00328172|1509184|P3|Overall Study|Other reason (not specified)|1
458588|NCT00328172|1509185|P2|Overall Study|Other reason (not specified)|0
458589|NCT00328172|1509186|P1|Overall Study|Other reason (not specified)|3
458590|NCT00328172|1509182|P5|Overall Study|Lack of Efficacy|3
458591|NCT00328172|1509183|P4|Overall Study|Lack of Efficacy|4
458592|NCT00328172|1509184|P3|Overall Study|Lack of Efficacy|4
458593|NCT00328172|1509185|P2|Overall Study|Lack of Efficacy|9
458594|NCT00328172|1509186|P1|Overall Study|Lack of Efficacy|14
458595|NCT00328172|1509182|P5|Overall Study|Withdrawal by Subject|0
458596|NCT00328172|1509183|P4|Overall Study|Withdrawal by Subject|6
458597|NCT00328172|1509184|P3|Overall Study|Withdrawal by Subject|1
458598|NCT00328172|1509185|P2|Overall Study|Withdrawal by Subject|1
458599|NCT00328172|1509186|P1|Overall Study|Withdrawal by Subject|1
458600|NCT00328172|1509182|P5|Overall Study|Lost to Follow-up|1
458601|NCT00328172|1509183|P4|Overall Study|Lost to Follow-up|1
458602|NCT00328172|1509184|P3|Overall Study|Lost to Follow-up|2
458603|NCT00328172|1509185|P2|Overall Study|Lost to Follow-up|1
458604|NCT00328172|1509186|P1|Overall Study|Lost to Follow-up|1
458605|NCT00328172|1509182|P5|Overall Study|Protocol Violation|0
458606|NCT00328172|1509183|P4|Overall Study|Protocol Violation|0
458607|NCT00328172|1509184|P3|Overall Study|Protocol Violation|1
458608|NCT00328172|1509185|P2|Overall Study|Protocol Violation|1
458609|NCT00328172|1509186|P1|Overall Study|Protocol Violation|0
458610|NCT00328172|1509182|P5|Overall Study|Adverse Event|1
458611|NCT00328172|1509183|P4|Overall Study|Adverse Event|2
458612|NCT00328172|1509184|P3|Overall Study|Adverse Event|1
458613|NCT00328172|1509185|P2|Overall Study|Adverse Event|2
458614|NCT00328172|1509186|P1|Overall Study|Adverse Event|3
458615|NCT00328094|1509210|P2|Overall Study|Physician Decision|3
458616|NCT00328094|1509211|P1|Overall Study|Physician Decision|3
458617|NCT00327717|1509245|P2|Overall Study|Withdrawal by Subject|7
458618|NCT00327717|1509246|P1|Overall Study|Withdrawal by Subject|3
458619|NCT00327717|1509245|P2|Overall Study|Lack of Efficacy|1
458620|NCT00327717|1509246|P1|Overall Study|Lack of Efficacy|0
458621|NCT00327717|1509245|P2|Overall Study|Adverse Event|6
458622|NCT00327717|1509246|P1|Overall Study|Adverse Event|6
458623|NCT00327470|1509272|P2|Overall Study|Death|4
458624|NCT00327470|1509273|P1|Overall Study|Death|1
458625|NCT00327470|1509272|P2|Overall Study|Withdrawal by Subject|12
458626|NCT00327470|1509273|P1|Overall Study|Withdrawal by Subject|6
458627|NCT00327470|1509272|P2|Overall Study|Lost to Follow-up|3
458628|NCT00327470|1509273|P1|Overall Study|Lost to Follow-up|1
458629|NCT00327470|1509272|P2|Overall Study|Other|9
458630|NCT00327470|1509273|P1|Overall Study|Other|5
458631|NCT00327470|1509272|P2|Overall Study|Lack of Efficacy|19
458632|NCT00327470|1509273|P1|Overall Study|Lack of Efficacy|7
458633|NCT00327470|1509272|P2|Overall Study|Adverse Event|14
458634|NCT00327470|1509273|P1|Overall Study|Adverse Event|9
458635|NCT00327470|1509272|P2|Overall Study|Randomized, but not treated|2
458636|NCT00327470|1509273|P1|Overall Study|Randomized, but not treated|0
458637|NCT00327444|1509293|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
458638|NCT00327444|1509294|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
458639|NCT00327444|1509293|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
458640|NCT00327444|1509294|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
458641|NCT00327444|1509293|P2|Open Label Treatment (OL) Period|Adverse Event|2
458642|NCT00327444|1509294|P1|Open Label Treatment (OL) Period|Adverse Event|2
458643|NCT00327444|1509293|P2|Open Label Treatment (OL) Period|Disease progression|7
458644|NCT00327444|1509294|P1|Open Label Treatment (OL) Period|Disease progression|8
458645|NCT00327444|1509293|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
458646|NCT00327444|1509294|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
458647|NCT00327444|1509293|P2|Double Blind Treatment (DB) Period|Subject request|1
458648|NCT00327444|1509294|P1|Double Blind Treatment (DB) Period|Subject request|0
458649|NCT00327444|1509293|P2|Double Blind Treatment (DB) Period|Adverse Event|5
458650|NCT00327444|1509294|P1|Double Blind Treatment (DB) Period|Adverse Event|5
458651|NCT00327444|1509293|P2|Double Blind Treatment (DB) Period|Disease progression|13
458652|NCT00327444|1509294|P1|Double Blind Treatment (DB) Period|Disease progression|10
458653|NCT00327340|1509312|P2|Overall Study|Adverse Event|3
458654|NCT00327340|1509313|P1|Overall Study|Adverse Event|3
458655|NCT00327340|1509312|P2|Overall Study|Symptomatic Disease|2
458656|NCT00327340|1509313|P1|Overall Study|Symptomatic Disease|0
458657|NCT00327340|1509312|P2|Overall Study|Disease Progression|19
458658|NCT00327340|1509313|P1|Overall Study|Disease Progression|10
458659|NCT00327340|1509312|P2|Overall Study|Physician Decision|1
458660|NCT00327340|1509313|P1|Overall Study|Physician Decision|1
458661|NCT00327340|1509312|P2|Overall Study|Withdrawal by Subject|5
458662|NCT00327340|1509313|P1|Overall Study|Withdrawal by Subject|1
458663|NCT00327171|1509327|P2|Overall Study|Other|0
458664|NCT00327171|1509328|P1|Overall Study|Other|1
458665|NCT00327171|1509327|P2|Overall Study|Undisclosed history of ischemia|1
458666|NCT00327171|1509328|P1|Overall Study|Undisclosed history of ischemia|0
458667|NCT00327171|1509327|P2|Overall Study|Clinical progression|8
458668|NCT00327171|1509328|P1|Overall Study|Clinical progression|12
458669|NCT00327171|1509327|P2|Overall Study|Investigator/participant request|8
458670|NCT00327171|1509328|P1|Overall Study|Investigator/participant request|1
458671|NCT00327171|1509327|P2|Overall Study|Disease progression/lack of efficacy|69
458672|NCT00327171|1509328|P1|Overall Study|Disease progression/lack of efficacy|68
458673|NCT00327171|1509327|P2|Overall Study|Adverse Event|23
458674|NCT00327171|1509328|P1|Overall Study|Adverse Event|23
458675|NCT00327171|1509327|P2|Overall Study|Did not receive study medication|0
458676|NCT00327171|1509328|P1|Overall Study|Did not receive study medication|3
458677|NCT00327015|1509360|P4|Overall Study|Administrative Reason by Sponsor|1
458678|NCT00327015|1509361|P3|Overall Study|Administrative Reason by Sponsor|2
458679|NCT00327015|1509362|P2|Overall Study|Administrative Reason by Sponsor|2
458680|NCT00327015|1509363|P1|Overall Study|Administrative Reason by Sponsor|1
458681|NCT00327015|1509360|P4|Overall Study|Pregnancy|1
458682|NCT00327015|1509361|P3|Overall Study|Pregnancy|1
458683|NCT00327015|1509362|P2|Overall Study|Pregnancy|2
458684|NCT00327015|1509363|P1|Overall Study|Pregnancy|0
458685|NCT00327015|1509360|P4|Overall Study|Death|3
458686|NCT00327015|1509361|P3|Overall Study|Death|2
458687|NCT00327015|1509362|P2|Overall Study|Death|2
458688|NCT00327015|1509363|P1|Overall Study|Death|1
458689|NCT00327015|1509360|P4|Overall Study|Physician Decision|2
458690|NCT00327015|1509361|P3|Overall Study|Physician Decision|3
458691|NCT00327015|1509362|P2|Overall Study|Physician Decision|1
458692|NCT00327015|1509363|P1|Overall Study|Physician Decision|0
458693|NCT00327015|1509360|P4|Overall Study|Poor/Noncompliance|5
458694|NCT00327015|1509361|P3|Overall Study|Poor/Noncompliance|4
458695|NCT00327015|1509362|P2|Overall Study|Poor/Noncompliance|8
458696|NCT00327015|1509363|P1|Overall Study|Poor/Noncompliance|11
458697|NCT00327015|1509360|P4|Overall Study|Subject no longer meets study criteria|7
458698|NCT00327015|1509361|P3|Overall Study|Subject no longer meets study criteria|8
458699|NCT00327015|1509362|P2|Overall Study|Subject no longer meets study criteria|2
458700|NCT00327015|1509363|P1|Overall Study|Subject no longer meets study criteria|4
458701|NCT00327015|1509360|P4|Overall Study|Adverse Event|14
458702|NCT00327015|1509361|P3|Overall Study|Adverse Event|14
458703|NCT00327015|1509362|P2|Overall Study|Adverse Event|10
458704|NCT00327015|1509363|P1|Overall Study|Adverse Event|14
458705|NCT00327015|1509360|P4|Overall Study|Lost to Follow-up|22
458706|NCT00327015|1509361|P3|Overall Study|Lost to Follow-up|29
458707|NCT00327015|1509362|P2|Overall Study|Lost to Follow-up|23
458708|NCT00327015|1509363|P1|Overall Study|Lost to Follow-up|22
458709|NCT00327015|1509360|P4|Overall Study|Withdrawal of Consent by Subject|25
458710|NCT00327015|1509361|P3|Overall Study|Withdrawal of Consent by Subject|28
458711|NCT00327015|1509362|P2|Overall Study|Withdrawal of Consent by Subject|24
458712|NCT00327015|1509363|P1|Overall Study|Withdrawal of Consent by Subject|20
458713|NCT00327015|1509360|P4|Overall Study|Lack of Efficacy|29
458714|NCT00327015|1509361|P3|Overall Study|Lack of Efficacy|35
458715|NCT00327015|1509362|P2|Overall Study|Lack of Efficacy|18
458716|NCT00327015|1509363|P1|Overall Study|Lack of Efficacy|18
458717|NCT00326963|1509405|P1|Overall Study|Administrative / other|1
458718|NCT00326963|1509405|P1|Overall Study|Other protocol violation|1
458719|NCT00326963|1509405|P1|Overall Study|Violation of selection criteria at entry|2
458720|NCT00326963|1509405|P1|Overall Study|Refused treatment / did not cooperate|5
458721|NCT00326963|1509405|P1|Overall Study|Withdrawal by Subject|10
458722|NCT00326963|1509405|P1|Overall Study|Failure to return|10
458723|NCT00326963|1509405|P1|Overall Study|Death|1
458724|NCT00326963|1509405|P1|Overall Study|Injection site reaction|1
458725|NCT00326963|1509405|P1|Overall Study|Adverse Event|2
458726|NCT00326950|1509425|P1|Overall Study|Progressive Disease|1
458727|NCT00326911|1509447|P2|Overall Study|Withdrawal by subject prior to treatment|1
458728|NCT00326911|1509448|P1|Overall Study|Withdrawal by subject prior to treatment|0
458729|NCT00326911|1509447|P2|Overall Study|Physician decision prior to treatment|0
458730|NCT00326911|1509448|P1|Overall Study|Physician decision prior to treatment|1
458731|NCT00326911|1509447|P2|Overall Study|Hospitalization prior to treatment|1
458732|NCT00326911|1509448|P1|Overall Study|Hospitalization prior to treatment|0
458733|NCT00326898|1509501|P3|Overall Study|Other/Missing/Unknown|32
458734|NCT00326898|1509502|P2|Overall Study|Other/Missing/Unknown|28
458735|NCT00326898|1509503|P1|Overall Study|Other/Missing/Unknown|33
458736|NCT00326898|1509501|P3|Overall Study|Other complicating disease|4
458737|NCT00326898|1509502|P2|Overall Study|Other complicating disease|5
458738|NCT00326898|1509503|P1|Overall Study|Other complicating disease|5
458739|NCT00326898|1509501|P3|Overall Study|Alternative therapy|0
458740|NCT00326898|1509502|P2|Overall Study|Alternative therapy|0
458741|NCT00326898|1509503|P1|Overall Study|Alternative therapy|1
458742|NCT00326898|1509501|P3|Overall Study|Withdrawal by Subject|32
458743|NCT00326898|1509502|P2|Overall Study|Withdrawal by Subject|128
458744|NCT00326898|1509503|P1|Overall Study|Withdrawal by Subject|134
458745|NCT00326898|1509501|P3|Overall Study|Death|0
458746|NCT00326898|1509502|P2|Overall Study|Death|0
458747|NCT00326898|1509503|P1|Overall Study|Death|2
458748|NCT00326898|1509501|P3|Overall Study|Adverse Event|33
458749|NCT00326898|1509502|P2|Overall Study|Adverse Event|128
458750|NCT00326898|1509503|P1|Overall Study|Adverse Event|124
458751|NCT00326898|1509501|P3|Overall Study|Disease progression|102
458752|NCT00326898|1509502|P2|Overall Study|Disease progression|54
458753|NCT00326898|1509503|P1|Overall Study|Disease progression|52
458754|NCT00326885|1509520|P1|Overall Study|Hospice withdrew consent|2
458755|NCT00326885|1509520|P1|Overall Study|Physician Decision|1
458756|NCT00326885|1509520|P1|Overall Study|Withdrawal by Subject|3
458757|NCT00326885|1509520|P1|Overall Study|Adverse Event|1
458758|NCT00326716|1509551|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
458759|NCT00326716|1509552|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
458760|NCT00326716|1509553|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
458761|NCT00326716|1509554|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
458762|NCT00326612|1509626|P2|Overall Study|They did not have a seizure requiring tx|137
458763|NCT00326612|1509627|P1|Overall Study|They did not have a seizure requiring tx|129
458764|NCT00326599|1509649|P4|Overall Study|Other Unspecified Reason|1
458765|NCT00326599|1509650|P3|Overall Study|Other Unspecified Reason|2
458766|NCT00326599|1509651|P2|Overall Study|Other Unspecified Reason|0
458767|NCT00326599|1509652|P1|Overall Study|Other Unspecified Reason|0
458768|NCT00326599|1509649|P4|Overall Study|Death|2
458769|NCT00326599|1509650|P3|Overall Study|Death|1
458770|NCT00326599|1509651|P2|Overall Study|Death|0
458771|NCT00326599|1509652|P1|Overall Study|Death|0
458772|NCT00326599|1509649|P4|Overall Study|Alternate Treatment|0
458773|NCT00326599|1509650|P3|Overall Study|Alternate Treatment|0
458774|NCT00326599|1509651|P2|Overall Study|Alternate Treatment|0
458775|NCT00326599|1509652|P1|Overall Study|Alternate Treatment|1
458776|NCT00326599|1509649|P4|Overall Study|Disease Progression|11
458777|NCT00326599|1509650|P3|Overall Study|Disease Progression|13
458778|NCT00326599|1509651|P2|Overall Study|Disease Progression|1
458779|NCT00326599|1509652|P1|Overall Study|Disease Progression|3
458780|NCT00326599|1509649|P4|Overall Study|Adverse Event|3
458781|NCT00326599|1509650|P3|Overall Study|Adverse Event|32
458782|NCT00326599|1509651|P2|Overall Study|Adverse Event|0
458783|NCT00326599|1509652|P1|Overall Study|Adverse Event|1
458784|NCT00326599|1509649|P4|Overall Study|Withdrawal by Subject|2
458785|NCT00326599|1509650|P3|Overall Study|Withdrawal by Subject|5
458786|NCT00326599|1509651|P2|Overall Study|Withdrawal by Subject|0
458787|NCT00326599|1509652|P1|Overall Study|Withdrawal by Subject|1
458788|NCT00326495|1509671|P1|Overall Study|Subject off study before assessment|1
458789|NCT00326495|1509671|P1|Overall Study|Refused further treatment|2
458790|NCT00326495|1509671|P1|Overall Study|Disease progression before treatment|1
458791|NCT00326495|1509671|P1|Overall Study|Switched to alternative treatment|1
458792|NCT00326417|1509678|P4|Overall Study|Death|0
458793|NCT00326417|1509679|P3|Overall Study|Death|0
458794|NCT00326417|1509680|P2|Overall Study|Death|0
458795|NCT00326417|1509681|P1|Overall Study|Death|7
458796|NCT00326417|1509678|P4|Overall Study|Arm Closed|3
458797|NCT00326417|1509679|P3|Overall Study|Arm Closed|0
458798|NCT00326417|1509680|P2|Overall Study|Arm Closed|0
458799|NCT00326417|1509681|P1|Overall Study|Arm Closed|7
458800|NCT00326417|1509678|P4|Overall Study|Withdrawal by Subject|0
458801|NCT00326417|1509679|P3|Overall Study|Withdrawal by Subject|1
458802|NCT00326417|1509680|P2|Overall Study|Withdrawal by Subject|0
458803|NCT00326417|1509681|P1|Overall Study|Withdrawal by Subject|0
458804|NCT00326183|1509708|P2|Overall Study|Adverse Event|0
458805|NCT00326183|1509709|P1|Overall Study|Adverse Event|1
458806|NCT00326183|1509708|P2|Overall Study|Other|13
458807|NCT00326183|1509709|P1|Overall Study|Other|47
458808|NCT00326183|1509708|P2|Overall Study|Subject Moved|4
458809|NCT00326183|1509709|P1|Overall Study|Subject Moved|7
458810|NCT00326183|1509708|P2|Overall Study|Withdrawal by Subject|7
458811|NCT00326183|1509709|P1|Overall Study|Withdrawal by Subject|35
458812|NCT00326183|1509708|P2|Overall Study|Protocol Violation|3
458813|NCT00326183|1509709|P1|Overall Study|Protocol Violation|6
458814|NCT00326183|1509708|P2|Overall Study|Lost to Follow-up|56
458815|NCT00326183|1509709|P1|Overall Study|Lost to Follow-up|104
458816|NCT00326118|1509741|P2|Active Phase|Withdrawal by Subject|1
458817|NCT00326118|1509742|P1|Active Phase|Withdrawal by Subject|4
458818|NCT00326001|1509778|P2|Overall Study|Physician Decision|3
458819|NCT00326001|1509779|P1|Overall Study|Physician Decision|3
458820|NCT00326001|1509778|P2|Overall Study|Adverse Event|5
458821|NCT00326001|1509779|P1|Overall Study|Adverse Event|4
458822|NCT00325897|1509793|P2|Overall Study|Lost to Follow-up|13
458823|NCT00325897|1509794|P1|Overall Study|Lost to Follow-up|12
458824|NCT00325819|1509814|P2|Overall Study|Lost to Follow-up|3
458825|NCT00325819|1509815|P1|Overall Study|Lost to Follow-up|3
458826|NCT00325819|1509814|P2|Overall Study|Did not take a dose of study product|9
458827|NCT00325819|1509815|P1|Overall Study|Did not take a dose of study product|4
458828|NCT00325819|1509814|P2|Overall Study|Study product lost in mail|1
458829|NCT00325819|1509815|P1|Overall Study|Study product lost in mail|2
458830|NCT00325754|1509842|P2|Overall Study|Adverse Event|1
458831|NCT00325754|1509843|P1|Overall Study|Adverse Event|4
458832|NCT00325468|1509889|P5|Overall Study|site closure etc|1
458833|NCT00325468|1509890|P4|Overall Study|site closure etc|8
458834|NCT00325468|1509891|P3|Overall Study|site closure etc|1
458835|NCT00325468|1509892|P2|Overall Study|site closure etc|2
458836|NCT00325468|1509893|P1|Overall Study|site closure etc|4
458837|NCT00325468|1509889|P5|Overall Study|Withdrawal by Subject|4
458838|NCT00325468|1509890|P4|Overall Study|Withdrawal by Subject|14
458839|NCT00325468|1509891|P3|Overall Study|Withdrawal by Subject|0
458840|NCT00325468|1509892|P2|Overall Study|Withdrawal by Subject|1
458841|NCT00325468|1509893|P1|Overall Study|Withdrawal by Subject|3
458842|NCT00325468|1509889|P5|Overall Study|Physician Decision|0
458843|NCT00325468|1509890|P4|Overall Study|Physician Decision|1
458844|NCT00325468|1509891|P3|Overall Study|Physician Decision|0
458845|NCT00325468|1509892|P2|Overall Study|Physician Decision|1
458846|NCT00325468|1509893|P1|Overall Study|Physician Decision|1
458847|NCT00325468|1509889|P5|Overall Study|Lost to Follow-up|2
458848|NCT00325468|1509890|P4|Overall Study|Lost to Follow-up|2
458849|NCT00325468|1509891|P3|Overall Study|Lost to Follow-up|1
458850|NCT00325468|1509892|P2|Overall Study|Lost to Follow-up|0
458851|NCT00325468|1509893|P1|Overall Study|Lost to Follow-up|0
458852|NCT00325468|1509889|P5|Overall Study|Death|0
458853|NCT00325468|1509890|P4|Overall Study|Death|4
458854|NCT00325468|1509891|P3|Overall Study|Death|2
458855|NCT00325468|1509892|P2|Overall Study|Death|0
458856|NCT00325468|1509893|P1|Overall Study|Death|2
458857|NCT00325468|1509889|P5|Overall Study|Adverse Event|1
458858|NCT00325468|1509890|P4|Overall Study|Adverse Event|5
458859|NCT00325468|1509891|P3|Overall Study|Adverse Event|0
458860|NCT00325468|1509892|P2|Overall Study|Adverse Event|1
458861|NCT00325468|1509893|P1|Overall Study|Adverse Event|1
458862|NCT00325416|1509976|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
458863|NCT00325416|1509977|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
458864|NCT00325416|1509976|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
458865|NCT00325416|1509977|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
458866|NCT00325416|1509976|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
458867|NCT00325416|1509977|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
458868|NCT00325416|1509976|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
458869|NCT00325416|1509977|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
458870|NCT00325416|1509976|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
458871|NCT00325416|1509977|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
458872|NCT00325416|1509976|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
458873|NCT00325416|1509977|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
458874|NCT00325234|1510030|P2|Overall Study|Progressive Disease|37
458875|NCT00325234|1510031|P1|Overall Study|Progressive Disease|34
458876|NCT00325234|1510030|P2|Overall Study|Physician Decision|12
458877|NCT00325234|1510031|P1|Overall Study|Physician Decision|17
458878|NCT00325234|1510030|P2|Overall Study|Subject Decision|8
458879|NCT00325234|1510031|P1|Overall Study|Subject Decision|6
458880|NCT00325234|1510030|P2|Overall Study|Entry Criteria Not Met|2
458881|NCT00325234|1510031|P1|Overall Study|Entry Criteria Not Met|1
458882|NCT00325234|1510030|P2|Overall Study|Death due to Study Disease|0
458883|NCT00325234|1510031|P1|Overall Study|Death due to Study Disease|1
458884|NCT00325234|1510030|P2|Overall Study|Adverse Event|7
458885|NCT00325234|1510031|P1|Overall Study|Adverse Event|10
458886|NCT00325195|1510050|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
458887|NCT00325195|1510051|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
458888|NCT00325195|1510052|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
458889|NCT00325195|1510050|P3|Received Intervention: ITT Population|Lost to Follow-up|2
458890|NCT00325195|1510051|P2|Received Intervention: ITT Population|Lost to Follow-up|0
458891|NCT00325195|1510052|P1|Received Intervention: ITT Population|Lost to Follow-up|0
458892|NCT00325195|1510050|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
458893|NCT00325195|1510051|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
458894|NCT00325195|1510052|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
458895|NCT00325195|1510050|P3|Received Intervention: ITT Population|Death|0
458896|NCT00325195|1510051|P2|Received Intervention: ITT Population|Death|1
458897|NCT00325195|1510052|P1|Received Intervention: ITT Population|Death|3
458898|NCT00325195|1510050|P3|Received Intervention: ITT Population|Adverse Event|1
458899|NCT00325195|1510051|P2|Received Intervention: ITT Population|Adverse Event|17
458900|NCT00325195|1510052|P1|Received Intervention: ITT Population|Adverse Event|15
458901|NCT00325195|1510050|P3|Randomized|Not dosed|3
458902|NCT00325195|1510051|P2|Randomized|Not dosed|5
458903|NCT00325195|1510052|P1|Randomized|Not dosed|5
458904|NCT00325156|1510075|P1|Overall Study|Withdrawal by Subject|31
458905|NCT00325156|1510075|P1|Overall Study|Other|1
458906|NCT00325156|1510075|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
458907|NCT00325156|1510075|P1|Overall Study|Adverse event, non-fatal|3
458908|NCT00325156|1510075|P1|Overall Study|Migrated/moved from study area|12
458909|NCT00325156|1510075|P1|Overall Study|Lost to follow-up (complete vaccination)|41
458910|NCT00325156|1510075|P1|Overall Study|Protocol Violation|8
458911|NCT00325143|1510082|P1|Overall Study|Withdrawal by Subject|8
458912|NCT00325143|1510082|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
458913|NCT00325143|1510082|P1|Overall Study|Migrated/moved from study area|1
458914|NCT00325143|1510082|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
458915|NCT00325130|1510092|P2|Overall Study|Patient Discontinued for Other|0
458916|NCT00325130|1510093|P1|Overall Study|Patient Discontinued for Other|1
458917|NCT00325130|1510092|P2|Overall Study|Moved|1
458918|NCT00325130|1510093|P1|Overall Study|Moved|0
458919|NCT00325130|1510092|P2|Overall Study|Protocol Deviation|1
458920|NCT00325130|1510093|P1|Overall Study|Protocol Deviation|0
458921|NCT00325130|1510092|P2|Overall Study|Withdrawal by Subject|14
458922|NCT00325130|1510093|P1|Overall Study|Withdrawal by Subject|12
458923|NCT00325130|1510092|P2|Overall Study|Lost to Follow-up|14
458924|NCT00325130|1510093|P1|Overall Study|Lost to Follow-up|6
458925|NCT00325039|1510150|P2|Overall Study|Lost to Follow-up|14
458926|NCT00325039|1510151|P1|Overall Study|Lost to Follow-up|18
458927|NCT00324987|1510167|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
458928|NCT00324987|1510168|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
458929|NCT00324987|1510167|P2|Overall Study|Progression|1
458930|NCT00324987|1510168|P1|Overall Study|Progression|1
458931|NCT00324987|1510167|P2|Overall Study|Withdrawal by Subject|1
458932|NCT00324987|1510168|P1|Overall Study|Withdrawal by Subject|1
458933|NCT00324987|1510167|P2|Overall Study|Adverse Event|1
458934|NCT00324987|1510168|P1|Overall Study|Adverse Event|2
458935|NCT00324961|1510182|P1|Overall Study|Other|2
458936|NCT00324961|1510182|P1|Overall Study|Protocol Violation|3
458937|NCT00324961|1510182|P1|Overall Study|Lost to Follow-up|22
458938|NCT00324961|1510182|P1|Overall Study|Consent Withdrawn|11
458939|NCT00324961|1510182|P1|Overall Study|Adverse Event|5
458940|NCT00324805|1510229|P2|Overall Study|Did not start therapy|17
458941|NCT00324805|1510230|P1|Overall Study|Did not start therapy|12
458942|NCT00324805|1510229|P2|Overall Study|Other|2
458943|NCT00324805|1510230|P1|Overall Study|Other|0
458944|NCT00324805|1510229|P2|Overall Study|Other reasons|26
458945|NCT00324805|1510230|P1|Overall Study|Other reasons|7
458946|NCT00324805|1510229|P2|Overall Study|Other complicating disease|9
458947|NCT00324805|1510230|P1|Overall Study|Other complicating disease|1
458948|NCT00324805|1510229|P2|Overall Study|Alternative therapy|8
458949|NCT00324805|1510230|P1|Overall Study|Alternative therapy|4
458950|NCT00324805|1510229|P2|Overall Study|Death|9
458951|NCT00324805|1510230|P1|Overall Study|Death|6
458952|NCT00324805|1510229|P2|Overall Study|Withdrawal by Subject|174
458953|NCT00324805|1510230|P1|Overall Study|Withdrawal by Subject|51
458954|NCT00324805|1510229|P2|Overall Study|Progression|35
458955|NCT00324805|1510230|P1|Overall Study|Progression|7
458956|NCT00324805|1510229|P2|Overall Study|Adverse Event|203
458957|NCT00324805|1510230|P1|Overall Study|Adverse Event|62
458958|NCT00324740|1510242|P3|Overall Study|Withdrawal by Subject|1
458959|NCT00324740|1510243|P2|Overall Study|Withdrawal by Subject|0
458960|NCT00324740|1510244|P1|Overall Study|Withdrawal by Subject|1
458961|NCT00324675|1510264|P2|Overall Study|Adverse Event|0
458962|NCT00324675|1510265|P1|Overall Study|Adverse Event|1
458963|NCT00324649|1510273|P2|Overall Study|Noncompliance|0
458964|NCT00324649|1510274|P1|Overall Study|Noncompliance|1
458965|NCT00324649|1510273|P2|Overall Study|Withdrawal by Subject|1
458966|NCT00324649|1510274|P1|Overall Study|Withdrawal by Subject|0
458967|NCT00324649|1510273|P2|Overall Study|Adverse Event|4
458968|NCT00324649|1510274|P1|Overall Study|Adverse Event|1
458969|NCT00324233|1510405|P2|Second Period|Protocol Violation|6
458970|NCT00324233|1510406|P1|Second Period|Protocol Violation|4
458971|NCT00324233|1510405|P2|Second Period|unable to insert catheter|1
458972|NCT00324233|1510406|P1|Second Period|unable to insert catheter|1
458973|NCT00324233|1510405|P2|First Period|unable to insert catheter|0
458974|NCT00324233|1510406|P1|First Period|unable to insert catheter|1
458975|NCT00324168|1510414|P2|Overall Study|Patient did not visit in f/u window|9
458976|NCT00324168|1510415|P1|Overall Study|Patient did not visit in f/u window|6
458977|NCT00324168|1510414|P2|Overall Study|Death|3
458978|NCT00324168|1510415|P1|Overall Study|Death|3
458979|NCT00324168|1510414|P2|Overall Study|Lost to Follow-up|18
458980|NCT00324168|1510415|P1|Overall Study|Lost to Follow-up|19
458981|NCT00324155|1510443|P2|Follow-up Phase|On-going participants still on drug|6
458982|NCT00324155|1510444|P1|Follow-up Phase|On-going participants still on drug|11
458983|NCT00324155|1510443|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
458984|NCT00324155|1510444|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
458985|NCT00324155|1510443|P2|Received Treatment in Maintenance Phase|Adverse Event|3
458986|NCT00324155|1510444|P1|Received Treatment in Maintenance Phase|Adverse Event|0
458987|NCT00324155|1510443|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
458988|NCT00324155|1510444|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
458989|NCT00324155|1510443|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
458990|NCT00324155|1510444|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
458991|NCT00324155|1510443|P2|Received Treatment in Maintenance Phase|Disease Progression|41
458992|NCT00324155|1510444|P1|Received Treatment in Maintenance Phase|Disease Progression|26
458993|NCT00324155|1510443|P2|Received Treatment in Induction Phase|Physician Decision|0
458994|NCT00324155|1510444|P1|Received Treatment in Induction Phase|Physician Decision|2
458995|NCT00324155|1510443|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
458996|NCT00324155|1510444|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
458997|NCT00324155|1510443|P2|Received Treatment in Induction Phase|Adverse Event|7
458998|NCT00324155|1510444|P1|Received Treatment in Induction Phase|Adverse Event|6
458999|NCT00324155|1510443|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
459000|NCT00324155|1510444|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
459001|NCT00324155|1510443|P2|Received Treatment in Induction Phase|Death|15
459002|NCT00324155|1510444|P1|Received Treatment in Induction Phase|Death|8
459003|NCT00324155|1510443|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
459004|NCT00324155|1510444|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
459005|NCT00324155|1510443|P2|Received Treatment in Induction Phase|Disease Progression|152
459006|NCT00324155|1510444|P1|Received Treatment in Induction Phase|Disease Progression|88
459007|NCT00324155|1510443|P2|Enrolled and Randomized|Lost to Follow-up|1
459008|NCT00324155|1510444|P1|Enrolled and Randomized|Lost to Follow-up|0
459009|NCT00324155|1510443|P2|Enrolled and Randomized|No longer met study criteria|0
459010|NCT00324155|1510444|P1|Enrolled and Randomized|No longer met study criteria|3
459011|NCT00324116|1510474|P1|Overall Study|Other|5
459012|NCT00324116|1510474|P1|Overall Study|Withdrawal by Subject|5
459013|NCT00324116|1510474|P1|Overall Study|Lack of Efficacy|17
459014|NCT00324116|1510474|P1|Overall Study|Adverse Event|5
459015|NCT00324038|1510486|P2|Overall Study|Other|13
459016|NCT00324038|1510487|P1|Overall Study|Other|6
459017|NCT00324038|1510486|P2|Overall Study|Lost to Follow-up|2
459018|NCT00324038|1510487|P1|Overall Study|Lost to Follow-up|0
459019|NCT00324038|1510486|P2|Overall Study|Lack of Efficacy|13
459020|NCT00324038|1510487|P1|Overall Study|Lack of Efficacy|5
459021|NCT00324038|1510486|P2|Overall Study|Adverse Event|23
459022|NCT00324038|1510487|P1|Overall Study|Adverse Event|38
459023|NCT00323882|1510498|P5|Overall Study|Not Specified|1
459024|NCT00323882|1510499|P4|Overall Study|Not Specified|1
459025|NCT00323882|1510500|P3|Overall Study|Not Specified|0
459026|NCT00323882|1510501|P2|Overall Study|Not Specified|0
459027|NCT00323882|1510502|P1|Overall Study|Not Specified|0
459028|NCT00323882|1510498|P5|Overall Study|Lost to Follow-up|1
459029|NCT00323882|1510499|P4|Overall Study|Lost to Follow-up|0
459030|NCT00323882|1510500|P3|Overall Study|Lost to Follow-up|1
459031|NCT00323882|1510501|P2|Overall Study|Lost to Follow-up|0
459032|NCT00323882|1510502|P1|Overall Study|Lost to Follow-up|0
459033|NCT00323882|1510498|P5|Overall Study|Death|5
459034|NCT00323882|1510499|P4|Overall Study|Death|0
459035|NCT00323882|1510500|P3|Overall Study|Death|1
459036|NCT00323882|1510501|P2|Overall Study|Death|1
459037|NCT00323882|1510502|P1|Overall Study|Death|0
459038|NCT00323882|1510498|P5|Overall Study|Disease Progression|22
459039|NCT00323882|1510499|P4|Overall Study|Disease Progression|5
459040|NCT00323882|1510500|P3|Overall Study|Disease Progression|10
459041|NCT00323882|1510501|P2|Overall Study|Disease Progression|4
459042|NCT00323882|1510502|P1|Overall Study|Disease Progression|6
459043|NCT00323882|1510498|P5|Overall Study|Adverse Event|3
459044|NCT00323882|1510499|P4|Overall Study|Adverse Event|1
459045|NCT00323882|1510500|P3|Overall Study|Adverse Event|1
459046|NCT00323882|1510501|P2|Overall Study|Adverse Event|1
459047|NCT00323882|1510502|P1|Overall Study|Adverse Event|2
459048|NCT00323869|1510573|P1|Overall Study|Death|1
459049|NCT00323622|1510629|P8|Overall Study|Death|2
459050|NCT00323622|1510630|P7|Overall Study|Death|0
459051|NCT00323622|1510631|P6|Overall Study|Death|0
459052|NCT00323622|1510632|P5|Overall Study|Death|7
459053|NCT00323622|1510633|P4|Overall Study|Death|0
459054|NCT00323622|1510634|P3|Overall Study|Death|0
459055|NCT00323622|1510635|P2|Overall Study|Death|1
459056|NCT00323622|1510636|P1|Overall Study|Death|1
459057|NCT00323622|1510629|P8|Overall Study|Other|13
459058|NCT00323622|1510630|P7|Overall Study|Other|5
459059|NCT00323622|1510631|P6|Overall Study|Other|74
459060|NCT00323622|1510632|P5|Overall Study|Other|32
459061|NCT00323622|1510633|P4|Overall Study|Other|12
459062|NCT00323622|1510634|P3|Overall Study|Other|4
459063|NCT00323622|1510635|P2|Overall Study|Other|91
459064|NCT00323622|1510636|P1|Overall Study|Other|30
459065|NCT00323609|1510678|P4|Overall Study|Other reason|9
459066|NCT00323609|1510679|P3|Overall Study|Other reason|4
459067|NCT00323609|1510680|P2|Overall Study|Other reason|8
459068|NCT00323609|1510681|P1|Overall Study|Other reason|11
459069|NCT00323609|1510678|P4|Overall Study|Logistical withdrawal|1
459070|NCT00323609|1510679|P3|Overall Study|Logistical withdrawal|0
459071|NCT00323609|1510680|P2|Overall Study|Logistical withdrawal|5
459072|NCT00323609|1510681|P1|Overall Study|Logistical withdrawal|9
459073|NCT00323609|1510678|P4|Overall Study|Unrelenting or severe back pain|0
459074|NCT00323609|1510679|P3|Overall Study|Unrelenting or severe back pain|0
459075|NCT00323609|1510680|P2|Overall Study|Unrelenting or severe back pain|1
459076|NCT00323609|1510681|P1|Overall Study|Unrelenting or severe back pain|1
459077|NCT00323609|1510678|P4|Overall Study|Sponsor discontinued trial|0
459078|NCT00323609|1510679|P3|Overall Study|Sponsor discontinued trial|0
459079|NCT00323609|1510680|P2|Overall Study|Sponsor discontinued trial|29
459080|NCT00323609|1510681|P1|Overall Study|Sponsor discontinued trial|29
459081|NCT00323609|1510678|P4|Overall Study|Other non-VCF-related medical condition|0
459082|NCT00323609|1510679|P3|Overall Study|Other non-VCF-related medical condition|0
459083|NCT00323609|1510680|P2|Overall Study|Other non-VCF-related medical condition|2
459084|NCT00323609|1510681|P1|Overall Study|Other non-VCF-related medical condition|3
459085|NCT00323609|1510678|P4|Overall Study|Withdrawal by Subject|4
459086|NCT00323609|1510679|P3|Overall Study|Withdrawal by Subject|4
459087|NCT00323609|1510680|P2|Overall Study|Withdrawal by Subject|23
459088|NCT00323609|1510681|P1|Overall Study|Withdrawal by Subject|11
459089|NCT00323609|1510678|P4|Overall Study|Physician Decision|1
459090|NCT00323609|1510679|P3|Overall Study|Physician Decision|0
459091|NCT00323609|1510680|P2|Overall Study|Physician Decision|0
459092|NCT00323609|1510681|P1|Overall Study|Physician Decision|2
459093|NCT00323609|1510678|P4|Overall Study|Lost to Follow-up|0
459094|NCT00323609|1510679|P3|Overall Study|Lost to Follow-up|0
459095|NCT00323609|1510680|P2|Overall Study|Lost to Follow-up|10
459096|NCT00323609|1510681|P1|Overall Study|Lost to Follow-up|9
459097|NCT00323609|1510678|P4|Overall Study|Death|0
459098|NCT00323609|1510679|P3|Overall Study|Death|0
459099|NCT00323609|1510680|P2|Overall Study|Death|21
459100|NCT00323609|1510681|P1|Overall Study|Death|16
459101|NCT00323557|1510717|P2|Overall Study|Physician Decision|0
459102|NCT00323557|1510718|P1|Overall Study|Physician Decision|1
459103|NCT00323492|1510727|P3|Study Phase 2|Protocol Violation|0
459104|NCT00323492|1510728|P2|Study Phase 2|Protocol Violation|0
459105|NCT00323492|1510729|P1|Study Phase 2|Protocol Violation|1
459106|NCT00323492|1510727|P3|Study Phase 2|Noncompliance with study schedule|1
459107|NCT00323492|1510728|P2|Study Phase 2|Noncompliance with study schedule|0
459108|NCT00323492|1510729|P1|Study Phase 2|Noncompliance with study schedule|0
459109|NCT00323492|1510727|P3|Study Phase 2|Withdrawal by Subject|0
459110|NCT00323492|1510728|P2|Study Phase 2|Withdrawal by Subject|1
459111|NCT00323492|1510729|P1|Study Phase 2|Withdrawal by Subject|0
459112|NCT00323492|1510727|P3|Study Phase 2|Lost to Follow-up|0
459113|NCT00323492|1510728|P2|Study Phase 2|Lost to Follow-up|0
459114|NCT00323492|1510729|P1|Study Phase 2|Lost to Follow-up|1
459115|NCT00323492|1510727|P3|Study Phase 2|Physician Decision|0
459116|NCT00323492|1510728|P2|Study Phase 2|Physician Decision|0
459117|NCT00323492|1510729|P1|Study Phase 2|Physician Decision|1
459118|NCT00323492|1510727|P3|Study Phase 2|Adverse Event|0
459119|NCT00323492|1510728|P2|Study Phase 2|Adverse Event|0
459120|NCT00323492|1510729|P1|Study Phase 2|Adverse Event|1
459121|NCT00323492|1510727|P3|Study Phase 1|Adverse Event|0
459122|NCT00323492|1510728|P2|Study Phase 1|Adverse Event|0
459123|NCT00323492|1510729|P1|Study Phase 1|Adverse Event|2
459124|NCT00323479|1510760|P1|Overall Study|house moving|1
459125|NCT00323479|1510760|P1|Overall Study|Protocol Violation|3
459126|NCT00323479|1510760|P1|Overall Study|Withdrawal by Subject|2
459127|NCT00323479|1510760|P1|Overall Study|Adverse Event|2
459128|NCT00323414|1510784|P2|Overall Study|Withdrawal by Subject|1
459129|NCT00323414|1510785|P1|Overall Study|Withdrawal by Subject|0
459130|NCT00323310|1510807|P1|Overall Study|did not complete the 24-hr f-up visit|1
459131|NCT00323310|1510807|P1|Overall Study|a parent refused blood draw|1
459132|NCT00323310|1510807|P1|Overall Study|Withdrawal by Subject|1
459133|NCT00323297|1510822|P2|Part B (Open-label)|Protocol Violation|1
459134|NCT00323297|1510823|P1|Part B (Open-label)|Protocol Violation|0
459135|NCT00323297|1510822|P2|Part B (Open-label)|Adverse Event|5
459136|NCT00323297|1510823|P1|Part B (Open-label)|Adverse Event|5
459137|NCT00323297|1510822|P2|Part B (Open-label)|Lack of Efficacy|1
459138|NCT00323297|1510823|P1|Part B (Open-label)|Lack of Efficacy|3
459139|NCT00323297|1510822|P2|Part B (Open-label)|Withdrawal by Subject|3
459140|NCT00323297|1510823|P1|Part B (Open-label)|Withdrawal by Subject|1
459141|NCT00323297|1510822|P2|Part B (Open-label)|Reason unspecified|1
459142|NCT00323297|1510823|P1|Part B (Open-label)|Reason unspecified|0
459143|NCT00323297|1510822|P2|Part B (Open-label)|Death|1
459144|NCT00323297|1510823|P1|Part B (Open-label)|Death|0
459145|NCT00323297|1510822|P2|Part A (Double Blind Randomized)|Related adverse event|2
459146|NCT00323297|1510823|P1|Part A (Double Blind Randomized)|Related adverse event|2
459147|NCT00323297|1510822|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
459148|NCT00323297|1510823|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
459149|NCT00323297|1510822|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
459150|NCT00323297|1510823|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
459151|NCT00323297|1510822|P2|Part A (Double Blind Randomized)|Protocol Violation|3
459152|NCT00323297|1510823|P1|Part A (Double Blind Randomized)|Protocol Violation|1
459153|NCT00323297|1510822|P2|Part A (Double Blind Randomized)|Death|1
459154|NCT00323297|1510823|P1|Part A (Double Blind Randomized)|Death|0
459155|NCT00323297|1510822|P2|Part A (Double Blind Randomized)|Reason unspecified|1
459156|NCT00323297|1510823|P1|Part A (Double Blind Randomized)|Reason unspecified|0
459157|NCT00323258|1510863|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
459158|NCT00323258|1510864|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
459159|NCT00323258|1510863|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
459160|NCT00323258|1510864|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
459161|NCT00323258|1510863|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
459162|NCT00323258|1510864|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
459163|NCT00323258|1510863|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
459164|NCT00323258|1510864|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
459165|NCT00323258|1510863|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
459166|NCT00323258|1510864|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
459167|NCT00323258|1510863|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
459168|NCT00323258|1510864|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
459169|NCT00323258|1510863|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
459170|NCT00323258|1510864|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
459171|NCT00323115|1510889|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
459172|NCT00323115|1510889|P1|Vaccine Administration|Adverse Event|1
459173|NCT00323063|1510896|P2|Overall Study|brain mets discovered prior to treatment|0
459174|NCT00323063|1510897|P1|Overall Study|brain mets discovered prior to treatment|1
459175|NCT00323063|1510896|P2|Overall Study|Adverse Event|0
459176|NCT00323063|1510897|P1|Overall Study|Adverse Event|1
459177|NCT00322881|1510914|P1|Overall Study|Disease Progression|2
459178|NCT00322881|1510914|P1|Overall Study|Adverse Event|1
459179|NCT00322881|1510914|P1|Overall Study|Death|2
459180|NCT00322868|1510918|P1|Overall Study|disease progression|1
459181|NCT00322842|1510943|P2|Overall Study|Death|0
459182|NCT00322842|1510944|P1|Overall Study|Death|1
459183|NCT00322842|1510943|P2|Overall Study|Refused transplant|0
459184|NCT00322842|1510944|P1|Overall Study|Refused transplant|1
459185|NCT00322842|1510943|P2|Overall Study|Lost to Follow-up|1
459186|NCT00322842|1510944|P1|Overall Study|Lost to Follow-up|0
459187|NCT00322842|1510943|P2|Overall Study|Withdrawal by Subject|1
459188|NCT00322842|1510944|P1|Overall Study|Withdrawal by Subject|0
459189|NCT00322712|1510982|P1|Overall Study|treated with bevacizumab not cetuximab|1
459190|NCT00322621|1510986|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
459191|NCT00322621|1510987|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
459192|NCT00322621|1510988|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
459193|NCT00322621|1510986|P3|Period III - Maintenance / Rescue Phase|Death|0
459194|NCT00322621|1510987|P2|Period III - Maintenance / Rescue Phase|Death|1
459195|NCT00322621|1510988|P1|Period III - Maintenance / Rescue Phase|Death|0
459196|NCT00322621|1510986|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
459197|NCT00322621|1510987|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
459198|NCT00322621|1510988|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
459199|NCT00322621|1510986|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
459200|NCT00322621|1510987|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
459201|NCT00322621|1510988|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
459202|NCT00322621|1510986|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
459203|NCT00322621|1510987|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
459204|NCT00322621|1510988|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
459205|NCT00322621|1510986|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
459206|NCT00322621|1510987|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
459207|NCT00322621|1510988|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
459208|NCT00322621|1510986|P3|Period II - Acute Therapy Phase|Physician Decision|0
459209|NCT00322621|1510987|P2|Period II - Acute Therapy Phase|Physician Decision|0
459210|NCT00322621|1510988|P1|Period II - Acute Therapy Phase|Physician Decision|1
459211|NCT00322621|1510986|P3|Period II - Acute Therapy Phase|Protocol Violation|0
459212|NCT00322621|1510987|P2|Period II - Acute Therapy Phase|Protocol Violation|0
459213|NCT00322621|1510988|P1|Period II - Acute Therapy Phase|Protocol Violation|2
459214|NCT00322621|1510986|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
459215|NCT00322621|1510987|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
459216|NCT00322621|1510988|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
459217|NCT00322621|1510986|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
459218|NCT00322621|1510987|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
459219|NCT00322621|1510988|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
459220|NCT00322621|1510986|P3|Period II - Acute Therapy Phase|Adverse Event|0
459221|NCT00322621|1510987|P2|Period II - Acute Therapy Phase|Adverse Event|0
459222|NCT00322621|1510988|P1|Period II - Acute Therapy Phase|Adverse Event|20
459223|NCT00322556|1511040|P1|Overall Study|Other Reason|7
459224|NCT00322556|1511040|P1|Overall Study|Lost to Follow-up|3
459225|NCT00322556|1511040|P1|Overall Study|Withdrawal by Subject|1
459226|NCT00322556|1511040|P1|Overall Study|Adverse Event|1
459227|NCT00322491|1511056|P2|Overall Study|Death|2
459228|NCT00322491|1511057|P1|Overall Study|Death|1
459229|NCT00322491|1511056|P2|Overall Study|Adverse Event|0
459230|NCT00322491|1511057|P1|Overall Study|Adverse Event|1
459231|NCT00322452|1511147|P2|Overall Study|Death|227
459232|NCT00322452|1511148|P1|Overall Study|Death|223
459233|NCT00322452|1511147|P2|Overall Study|Withdrawal by Subject|46
459234|NCT00322452|1511148|P1|Overall Study|Withdrawal by Subject|19
459235|NCT00322452|1511147|P2|Overall Study|Lost to Follow-up|2
459236|NCT00322452|1511148|P1|Overall Study|Lost to Follow-up|5
459237|NCT00322452|1511147|P2|Overall Study|Eligibility criteria not fulfilled|1
459238|NCT00322452|1511148|P1|Overall Study|Eligibility criteria not fulfilled|0
459239|NCT00322387|1511199|P2|Follow-up Period|Death|0
459240|NCT00322387|1511200|P1|Follow-up Period|Death|1
459241|NCT00322387|1511199|P2|Follow-up Period|Final assessment not done|3
459242|NCT00322387|1511200|P1|Follow-up Period|Final assessment not done|1
459243|NCT00322387|1511199|P2|Treatment Period|Adverse Event|1
459244|NCT00322387|1511200|P1|Treatment Period|Adverse Event|0
459245|NCT00322374|1511234|P4|Second Escalation|Study Drug Toxicity|0
459246|NCT00322374|1511235|P3|Second Escalation|Study Drug Toxicity|1
459247|NCT00322374|1511236|P2|Second Escalation|Study Drug Toxicity|0
459248|NCT00322374|1511237|P1|Second Escalation|Study Drug Toxicity|0
459249|NCT00322374|1511234|P4|Second Escalation|Physician Decision|0
459250|NCT00322374|1511235|P3|Second Escalation|Physician Decision|5
459251|NCT00322374|1511236|P2|Second Escalation|Physician Decision|0
459252|NCT00322374|1511237|P1|Second Escalation|Physician Decision|0
459253|NCT00322374|1511234|P4|First Escalation|Participant Request|0
459254|NCT00322374|1511235|P3|First Escalation|Participant Request|0
459255|NCT00322374|1511236|P2|First Escalation|Participant Request|1
459256|NCT00322374|1511237|P1|First Escalation|Participant Request|0
459257|NCT00322374|1511234|P4|First Escalation|Study Drug Toxicity|0
459258|NCT00322374|1511235|P3|First Escalation|Study Drug Toxicity|0
459259|NCT00322374|1511236|P2|First Escalation|Study Drug Toxicity|11
459260|NCT00322374|1511237|P1|First Escalation|Study Drug Toxicity|0
459261|NCT00322374|1511234|P4|First Escalation|Physician Decision|0
459262|NCT00322374|1511235|P3|First Escalation|Physician Decision|0
459263|NCT00322374|1511236|P2|First Escalation|Physician Decision|12
459264|NCT00322374|1511237|P1|First Escalation|Physician Decision|0
459265|NCT00322374|1511234|P4|First Escalation|Documented Disease Progression|0
459266|NCT00322374|1511235|P3|First Escalation|Documented Disease Progression|0
459267|NCT00322374|1511236|P2|First Escalation|Documented Disease Progression|6
459268|NCT00322374|1511237|P1|First Escalation|Documented Disease Progression|0
459269|NCT00322374|1511234|P4|Starting Dose|Study Drug Toxicity|0
459270|NCT00322374|1511235|P3|Starting Dose|Study Drug Toxicity|0
459271|NCT00322374|1511236|P2|Starting Dose|Study Drug Toxicity|0
459272|NCT00322374|1511237|P1|Starting Dose|Study Drug Toxicity|4
459273|NCT00322374|1511234|P4|Starting Dose|Physician Decision|0
459274|NCT00322374|1511235|P3|Starting Dose|Physician Decision|0
459275|NCT00322374|1511236|P2|Starting Dose|Physician Decision|0
459276|NCT00322374|1511237|P1|Starting Dose|Physician Decision|2
459277|NCT00322348|1511287|P2|Overall Study|Reasons not specified|1
459278|NCT00322348|1511288|P1|Overall Study|Reasons not specified|5
459279|NCT00322348|1511287|P2|Overall Study|Disease Progression|25
459280|NCT00322348|1511288|P1|Overall Study|Disease Progression|30
459281|NCT00322348|1511287|P2|Overall Study|Death|2
459282|NCT00322348|1511288|P1|Overall Study|Death|0
459283|NCT00322348|1511287|P2|Overall Study|Lost to Follow-up|0
459284|NCT00322348|1511288|P1|Overall Study|Lost to Follow-up|1
459285|NCT00322348|1511287|P2|Overall Study|Withdrawal by Subject|4
459286|NCT00322348|1511288|P1|Overall Study|Withdrawal by Subject|1
459287|NCT00322348|1511287|P2|Overall Study|Adverse Event|1
459288|NCT00322348|1511288|P1|Overall Study|Adverse Event|0
459289|NCT00322153|1511379|P2|Overall Study|Withdrawn for other reasons|4
459290|NCT00322153|1511380|P1|Overall Study|Withdrawn for other reasons|5
459291|NCT00322153|1511379|P2|Overall Study|Lost to Follow-up|4
459292|NCT00322153|1511380|P1|Overall Study|Lost to Follow-up|5
459293|NCT00322153|1511379|P2|Overall Study|Lack of Efficacy|3
459294|NCT00322153|1511380|P1|Overall Study|Lack of Efficacy|8
459295|NCT00322153|1511379|P2|Overall Study|Withdrawal by Subject|10
459296|NCT00322153|1511380|P1|Overall Study|Withdrawal by Subject|18
459297|NCT00322153|1511379|P2|Overall Study|Protocol Violation|14
459298|NCT00322153|1511380|P1|Overall Study|Protocol Violation|6
459299|NCT00322153|1511379|P2|Overall Study|Adverse Event|34
459300|NCT00322153|1511380|P1|Overall Study|Adverse Event|21
459301|NCT00322049|1511413|P4|Overall Study|Infected with Dengue during study|0
459302|NCT00322049|1511414|P3|Overall Study|Infected with Dengue during study|0
459303|NCT00322049|1511415|P2|Overall Study|Infected with Dengue during study|1
459304|NCT00322049|1511416|P1|Overall Study|Infected with Dengue during study|0
459305|NCT00322049|1511413|P4|Overall Study|Moved out of area|1
459306|NCT00322049|1511414|P3|Overall Study|Moved out of area|0
459307|NCT00322049|1511415|P2|Overall Study|Moved out of area|0
459308|NCT00322049|1511416|P1|Overall Study|Moved out of area|0
459309|NCT00321984|1511449|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
459310|NCT00321984|1511450|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
459311|NCT00321984|1511451|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
459312|NCT00321984|1511449|P3|Overall Study|Per Investigator Request|0
459313|NCT00321984|1511450|P2|Overall Study|Per Investigator Request|0
459314|NCT00321984|1511451|P1|Overall Study|Per Investigator Request|1
459315|NCT00321984|1511449|P3|Overall Study|Per Subject Request|0
459316|NCT00321984|1511450|P2|Overall Study|Per Subject Request|0
459317|NCT00321984|1511451|P1|Overall Study|Per Subject Request|1
459318|NCT00321984|1511449|P3|Overall Study|Pregnancy|0
459319|NCT00321984|1511450|P2|Overall Study|Pregnancy|1
459320|NCT00321984|1511451|P1|Overall Study|Pregnancy|0
459321|NCT00321984|1511449|P3|Overall Study|Noncompliant|2
459322|NCT00321984|1511450|P2|Overall Study|Noncompliant|0
459323|NCT00321984|1511451|P1|Overall Study|Noncompliant|0
459324|NCT00321984|1511449|P3|Overall Study|Lack of Efficacy|3
459325|NCT00321984|1511450|P2|Overall Study|Lack of Efficacy|1
459326|NCT00321984|1511451|P1|Overall Study|Lack of Efficacy|3
459327|NCT00321984|1511449|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
459328|NCT00321984|1511450|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
459329|NCT00321984|1511451|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
459330|NCT00321984|1511449|P3|Overall Study|Withdrawal by Subject|5
459331|NCT00321984|1511450|P2|Overall Study|Withdrawal by Subject|6
459332|NCT00321984|1511451|P1|Overall Study|Withdrawal by Subject|8
459333|NCT00321984|1511449|P3|Overall Study|Lost to Follow-up|2
459334|NCT00321984|1511450|P2|Overall Study|Lost to Follow-up|4
459335|NCT00321984|1511451|P1|Overall Study|Lost to Follow-up|2
459336|NCT00321984|1511449|P3|Overall Study|Protocol Violation|1
459337|NCT00321984|1511450|P2|Overall Study|Protocol Violation|1
459338|NCT00321984|1511451|P1|Overall Study|Protocol Violation|0
459339|NCT00321984|1511449|P3|Overall Study|Adverse Event|8
459340|NCT00321984|1511450|P2|Overall Study|Adverse Event|6
459341|NCT00321984|1511451|P1|Overall Study|Adverse Event|9
459342|NCT00321932|1511479|P2|Overall Study|Missing data|1
459343|NCT00321932|1511480|P1|Overall Study|Missing data|2
459344|NCT00321932|1511479|P2|Overall Study|Early relapse|8
459345|NCT00321932|1511480|P1|Overall Study|Early relapse|2
459346|NCT00321932|1511479|P2|Overall Study|Withdrawal by Subject|6
459347|NCT00321932|1511480|P1|Overall Study|Withdrawal by Subject|3
459348|NCT00321932|1511479|P2|Overall Study|Death|6
459349|NCT00321932|1511480|P1|Overall Study|Death|3
459350|NCT00321919|1511504|P2|Overall Study|Other withdrawal reason|6
459351|NCT00321919|1511505|P1|Overall Study|Other withdrawal reason|7
459352|NCT00321919|1511504|P2|Overall Study|Failure to Return|1
459353|NCT00321919|1511505|P1|Overall Study|Failure to Return|3
459354|NCT00321919|1511504|P2|Overall Study|Other Protocol Violation|3
459355|NCT00321919|1511505|P1|Overall Study|Other Protocol Violation|2
459356|NCT00321919|1511504|P2|Overall Study|Refused Treatment|14
459357|NCT00321919|1511505|P1|Overall Study|Refused Treatment|23
459358|NCT00321919|1511504|P2|Overall Study|Violation of Selection Criteria at Entry|1
459359|NCT00321919|1511505|P1|Overall Study|Violation of Selection Criteria at Entry|1
459360|NCT00321919|1511504|P2|Overall Study|Insufficient Therapeutic Response|0
459361|NCT00321919|1511505|P1|Overall Study|Insufficient Therapeutic Response|1
459362|NCT00321919|1511504|P2|Overall Study|Death|17
459363|NCT00321919|1511505|P1|Overall Study|Death|21
459364|NCT00321919|1511504|P2|Overall Study|Adverse Event|10
459365|NCT00321919|1511505|P1|Overall Study|Adverse Event|17
459366|NCT00321906|1511547|P2|Overall Study|Withdrawal by Subject|4
459367|NCT00321906|1511548|P1|Overall Study|Withdrawal by Subject|0
459368|NCT00321906|1511547|P2|Overall Study|Lost to Follow-up|2
459369|NCT00321906|1511548|P1|Overall Study|Lost to Follow-up|1
459370|NCT00321906|1511547|P2|Overall Study|Death|6
459371|NCT00321906|1511548|P1|Overall Study|Death|9
459372|NCT00321906|1511547|P2|Overall Study|Adverse Event|44
459373|NCT00321906|1511548|P1|Overall Study|Adverse Event|36
459374|NCT00321893|1511570|P2|Overall Study|Adverse Event|3
459375|NCT00321893|1511571|P1|Overall Study|Adverse Event|6
459376|NCT00321893|1511570|P2|Overall Study|Lost to Follow-up|1
459377|NCT00321893|1511571|P1|Overall Study|Lost to Follow-up|2
459378|NCT00321893|1511570|P2|Overall Study|Non-Compliance/Refusal|10
459379|NCT00321893|1511571|P1|Overall Study|Non-Compliance/Refusal|16
459380|NCT00321854|1511585|P2|Overall Study|Other|1
459381|NCT00321854|1511586|P1|Overall Study|Other|1
459382|NCT00321854|1511585|P2|Overall Study|Withdrawal by Subject|17
459383|NCT00321854|1511586|P1|Overall Study|Withdrawal by Subject|6
459384|NCT00321854|1511585|P2|Overall Study|Lost to Follow-up|2
459385|NCT00321854|1511586|P1|Overall Study|Lost to Follow-up|0
459386|NCT00321854|1511585|P2|Overall Study|Protocol Violation|5
459387|NCT00321854|1511586|P1|Overall Study|Protocol Violation|6
459388|NCT00321854|1511585|P2|Overall Study|Lack of Efficacy|14
459389|NCT00321854|1511586|P1|Overall Study|Lack of Efficacy|9
459390|NCT00321854|1511585|P2|Overall Study|Adverse Event|43
459391|NCT00321854|1511586|P1|Overall Study|Adverse Event|41
459392|NCT00321828|1511704|P1|Overall Study|No follow up data|1
459393|NCT00321828|1511704|P1|Overall Study|Ineligible|3
459394|NCT00321789|1511710|P2|Overall Study|Protocol Violation|3
459395|NCT00321789|1511711|P1|Overall Study|Protocol Violation|5
459396|NCT00321789|1511710|P2|Overall Study|Withdrawal by Subject|6
459397|NCT00321789|1511711|P1|Overall Study|Withdrawal by Subject|6
459398|NCT00321789|1511710|P2|Overall Study|Lost to Follow-up|7
459399|NCT00321789|1511711|P1|Overall Study|Lost to Follow-up|4
459400|NCT00321763|1511743|P4|Overall Study|Lost to Follow-up|4
459401|NCT00321763|1511744|P3|Overall Study|Lost to Follow-up|5
459402|NCT00321763|1511745|P2|Overall Study|Lost to Follow-up|1
459403|NCT00321763|1511746|P1|Overall Study|Lost to Follow-up|3
459404|NCT00321763|1511743|P4|Overall Study|Withdrawal by Subject|0
459405|NCT00321763|1511744|P3|Overall Study|Withdrawal by Subject|1
459406|NCT00321763|1511745|P2|Overall Study|Withdrawal by Subject|0
459407|NCT00321763|1511746|P1|Overall Study|Withdrawal by Subject|2
459408|NCT00321763|1511743|P4|Overall Study|Adverse Event|1
459409|NCT00321763|1511744|P3|Overall Study|Adverse Event|0
459410|NCT00321763|1511745|P2|Overall Study|Adverse Event|1
459411|NCT00321763|1511746|P1|Overall Study|Adverse Event|1
459412|NCT00321737|1511806|P3|Overall Study|Subject Request/ Subject Unavailable|2
459413|NCT00321737|1511807|P2|Overall Study|Subject Request/ Subject Unavailable|0
459414|NCT00321737|1511808|P1|Overall Study|Subject Request/ Subject Unavailable|0
459415|NCT00321737|1511806|P3|Overall Study|Noncompliance|0
459416|NCT00321737|1511807|P2|Overall Study|Noncompliance|0
459417|NCT00321737|1511808|P1|Overall Study|Noncompliance|2
459418|NCT00321737|1511806|P3|Overall Study|Pregnancy|0
459419|NCT00321737|1511807|P2|Overall Study|Pregnancy|2
459420|NCT00321737|1511808|P1|Overall Study|Pregnancy|0
459421|NCT00321737|1511806|P3|Overall Study|Therapeutic Failure|2
459422|NCT00321737|1511807|P2|Overall Study|Therapeutic Failure|0
459423|NCT00321737|1511808|P1|Overall Study|Therapeutic Failure|6
459424|NCT00321737|1511806|P3|Overall Study|Possible Barrett's Esophagus|1
459425|NCT00321737|1511807|P2|Overall Study|Possible Barrett's Esophagus|1
459426|NCT00321737|1511808|P1|Overall Study|Possible Barrett's Esophagus|2
459427|NCT00321737|1511806|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
459428|NCT00321737|1511807|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
459429|NCT00321737|1511808|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
459430|NCT00321737|1511806|P3|Overall Study|Protocol Violation|1
459431|NCT00321737|1511807|P2|Overall Study|Protocol Violation|0
459432|NCT00321737|1511808|P1|Overall Study|Protocol Violation|0
459433|NCT00321737|1511806|P3|Overall Study|Withdrawal by Subject|17
459434|NCT00321737|1511807|P2|Overall Study|Withdrawal by Subject|12
459435|NCT00321737|1511808|P1|Overall Study|Withdrawal by Subject|19
459436|NCT00321737|1511806|P3|Overall Study|Lost to Follow-up|6
459437|NCT00321737|1511807|P2|Overall Study|Lost to Follow-up|5
459438|NCT00321737|1511808|P1|Overall Study|Lost to Follow-up|5
459439|NCT00321737|1511806|P3|Overall Study|Adverse Event|6
459440|NCT00321737|1511807|P2|Overall Study|Adverse Event|3
459441|NCT00321737|1511808|P1|Overall Study|Adverse Event|11
459442|NCT00321737|1511806|P3|Overall Study|Relapse of Erosive Esophagitis|19
459443|NCT00321737|1511807|P2|Overall Study|Relapse of Erosive Esophagitis|25
459444|NCT00321737|1511808|P1|Overall Study|Relapse of Erosive Esophagitis|76
459445|NCT00321711|1511836|P5|Part B|Death|1
459446|NCT00321711|1511837|P4|Part B|Death|2
459447|NCT00321711|1511838|P3|Part B|Death|0
459448|NCT00321711|1511839|P2|Part B|Death|0
459449|NCT00321711|1511840|P1|Part B|Death|0
459450|NCT00321711|1511836|P5|Part B|Physician Decision|2
459451|NCT00321711|1511837|P4|Part B|Physician Decision|1
459452|NCT00321711|1511838|P3|Part B|Physician Decision|0
459453|NCT00321711|1511839|P2|Part B|Physician Decision|0
459454|NCT00321711|1511840|P1|Part B|Physician Decision|0
459455|NCT00321711|1511836|P5|Part B|Disease progression|0
459456|NCT00321711|1511837|P4|Part B|Disease progression|1
459457|NCT00321711|1511838|P3|Part B|Disease progression|0
459458|NCT00321711|1511839|P2|Part B|Disease progression|0
459459|NCT00321711|1511840|P1|Part B|Disease progression|0
459460|NCT00321711|1511836|P5|Part B|Adverse Event|1
459461|NCT00321711|1511837|P4|Part B|Adverse Event|2
459462|NCT00321711|1511838|P3|Part B|Adverse Event|0
459463|NCT00321711|1511839|P2|Part B|Adverse Event|0
459464|NCT00321711|1511840|P1|Part B|Adverse Event|0
459465|NCT00321711|1511836|P5|Part B|Noncompliance|1
459466|NCT00321711|1511837|P4|Part B|Noncompliance|0
459467|NCT00321711|1511838|P3|Part B|Noncompliance|0
459468|NCT00321711|1511839|P2|Part B|Noncompliance|0
459469|NCT00321711|1511840|P1|Part B|Noncompliance|0
459470|NCT00321711|1511836|P5|Part A|Protocol deviation|0
459471|NCT00321711|1511837|P4|Part A|Protocol deviation|0
459472|NCT00321711|1511838|P3|Part A|Protocol deviation|1
459473|NCT00321711|1511839|P2|Part A|Protocol deviation|0
459474|NCT00321711|1511840|P1|Part A|Protocol deviation|0
459475|NCT00321711|1511836|P5|Part A|Other|0
459476|NCT00321711|1511837|P4|Part A|Other|0
459477|NCT00321711|1511838|P3|Part A|Other|3
459478|NCT00321711|1511839|P2|Part A|Other|2
459479|NCT00321711|1511840|P1|Part A|Other|1
459480|NCT00321711|1511836|P5|Part A|Physician Decision|0
459481|NCT00321711|1511837|P4|Part A|Physician Decision|0
459482|NCT00321711|1511838|P3|Part A|Physician Decision|3
459483|NCT00321711|1511839|P2|Part A|Physician Decision|1
459484|NCT00321711|1511840|P1|Part A|Physician Decision|0
459485|NCT00321711|1511836|P5|Part A|Requirement for alternative therapy|0
459486|NCT00321711|1511837|P4|Part A|Requirement for alternative therapy|0
459487|NCT00321711|1511838|P3|Part A|Requirement for alternative therapy|1
459488|NCT00321711|1511839|P2|Part A|Requirement for alternative therapy|2
459489|NCT00321711|1511840|P1|Part A|Requirement for alternative therapy|0
459490|NCT00321711|1511836|P5|Part A|Disease progression|0
459491|NCT00321711|1511837|P4|Part A|Disease progression|0
459492|NCT00321711|1511838|P3|Part A|Disease progression|0
459493|NCT00321711|1511839|P2|Part A|Disease progression|1
459494|NCT00321711|1511840|P1|Part A|Disease progression|0
459495|NCT00321711|1511836|P5|Part A|Withdrawal by Subject|0
459496|NCT00321711|1511837|P4|Part A|Withdrawal by Subject|0
459497|NCT00321711|1511838|P3|Part A|Withdrawal by Subject|1
459498|NCT00321711|1511839|P2|Part A|Withdrawal by Subject|1
459499|NCT00321711|1511840|P1|Part A|Withdrawal by Subject|1
459500|NCT00321711|1511836|P5|Part A|Adverse Event|0
459501|NCT00321711|1511837|P4|Part A|Adverse Event|0
459502|NCT00321711|1511838|P3|Part A|Adverse Event|2
459503|NCT00321711|1511839|P2|Part A|Adverse Event|3
459504|NCT00321711|1511840|P1|Part A|Adverse Event|3
459505|NCT00321685|1511890|P1|Overall Study|Ineligible|2
459506|NCT00321685|1511890|P1|Overall Study|Not start protocol therapy|2
459507|NCT00321685|1511890|P1|Overall Study|Other|5
459508|NCT00321685|1511890|P1|Overall Study|Complicating disese|1
459509|NCT00321685|1511890|P1|Overall Study|Alternative therapy|1
459510|NCT00321685|1511890|P1|Overall Study|Withdrawal by Subject|8
459511|NCT00321685|1511890|P1|Overall Study|Death|2
459512|NCT00321685|1511890|P1|Overall Study|Adverse Event|18
459513|NCT00321672|1511902|P4|Overall Study|Extensive travel required for new job|0
459514|NCT00321672|1511903|P3|Overall Study|Extensive travel required for new job|0
459515|NCT00321672|1511904|P2|Overall Study|Extensive travel required for new job|1
459516|NCT00321672|1511905|P1|Overall Study|Extensive travel required for new job|0
459517|NCT00321672|1511902|P4|Overall Study|Diagnosis of testicular cancer|0
459518|NCT00321672|1511903|P3|Overall Study|Diagnosis of testicular cancer|0
459519|NCT00321672|1511904|P2|Overall Study|Diagnosis of testicular cancer|1
459520|NCT00321672|1511905|P1|Overall Study|Diagnosis of testicular cancer|0
459521|NCT00321672|1511902|P4|Overall Study|Protocol Violation|0
459522|NCT00321672|1511903|P3|Overall Study|Protocol Violation|1
459523|NCT00321672|1511904|P2|Overall Study|Protocol Violation|0
459524|NCT00321672|1511905|P1|Overall Study|Protocol Violation|0
459525|NCT00321672|1511902|P4|Overall Study|Moved out of state|0
459526|NCT00321672|1511903|P3|Overall Study|Moved out of state|1
459527|NCT00321672|1511904|P2|Overall Study|Moved out of state|1
459528|NCT00321672|1511905|P1|Overall Study|Moved out of state|0
459529|NCT00321672|1511902|P4|Overall Study|Incarcerated|0
459530|NCT00321672|1511903|P3|Overall Study|Incarcerated|2
459531|NCT00321672|1511904|P2|Overall Study|Incarcerated|0
459532|NCT00321672|1511905|P1|Overall Study|Incarcerated|0
459533|NCT00321672|1511902|P4|Overall Study|Too far to travel for visits|0
459534|NCT00321672|1511903|P3|Overall Study|Too far to travel for visits|0
459535|NCT00321672|1511904|P2|Overall Study|Too far to travel for visits|0
459536|NCT00321672|1511905|P1|Overall Study|Too far to travel for visits|1
459537|NCT00321672|1511902|P4|Overall Study|Death|0
459538|NCT00321672|1511903|P3|Overall Study|Death|0
459539|NCT00321672|1511904|P2|Overall Study|Death|0
459540|NCT00321672|1511905|P1|Overall Study|Death|1
459541|NCT00321672|1511902|P4|Overall Study|Lost to Follow-up|2
459542|NCT00321672|1511903|P3|Overall Study|Lost to Follow-up|4
459543|NCT00321672|1511904|P2|Overall Study|Lost to Follow-up|0
459544|NCT00321672|1511905|P1|Overall Study|Lost to Follow-up|2
459545|NCT00321672|1511902|P4|Overall Study|Lack of Efficacy|0
459546|NCT00321672|1511903|P3|Overall Study|Lack of Efficacy|0
459547|NCT00321672|1511904|P2|Overall Study|Lack of Efficacy|1
459548|NCT00321672|1511905|P1|Overall Study|Lack of Efficacy|1
459549|NCT00321672|1511902|P4|Overall Study|Adverse Event|0
459550|NCT00321672|1511903|P3|Overall Study|Adverse Event|0
459551|NCT00321672|1511904|P2|Overall Study|Adverse Event|1
459552|NCT00321672|1511905|P1|Overall Study|Adverse Event|1
459553|NCT00321672|1511902|P4|Overall Study|Noncompliance|0
459554|NCT00321672|1511903|P3|Overall Study|Noncompliance|1
459555|NCT00321672|1511904|P2|Overall Study|Noncompliance|2
459556|NCT00321672|1511905|P1|Overall Study|Noncompliance|1
459557|NCT00321672|1511902|P4|Overall Study|Withdrawal by Subject|0
459558|NCT00321672|1511903|P3|Overall Study|Withdrawal by Subject|2
459559|NCT00321672|1511904|P2|Overall Study|Withdrawal by Subject|1
459560|NCT00321672|1511905|P1|Overall Study|Withdrawal by Subject|5
459561|NCT00321646|1511931|P1|Neoadjuvant Chemotherapy|Disease progression|1
459562|NCT00321646|1511931|P1|Neoadjuvant Chemotherapy|Adverse Event|2
459563|NCT00321646|1511931|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
459564|NCT00321620|1511938|P2|Overall Study|Other|33
459565|NCT00321620|1511939|P1|Overall Study|Other|42
459566|NCT00321620|1511938|P2|Overall Study|Participant request|52
459567|NCT00321620|1511939|P1|Overall Study|Participant request|75
459568|NCT00321620|1511938|P2|Overall Study|Ineligibility determined|3
459569|NCT00321620|1511939|P1|Overall Study|Ineligibility determined|2
459570|NCT00321620|1511938|P2|Overall Study|Protocol deviation|3
459571|NCT00321620|1511939|P1|Overall Study|Protocol deviation|4
459572|NCT00321620|1511938|P2|Overall Study|Noncompliance|7
459573|NCT00321620|1511939|P1|Overall Study|Noncompliance|14
459574|NCT00321620|1511938|P2|Overall Study|Physician Decision|1
459575|NCT00321620|1511939|P1|Overall Study|Physician Decision|4
459576|NCT00321620|1511938|P2|Overall Study|Lost to Follow-up|9
459577|NCT00321620|1511939|P1|Overall Study|Lost to Follow-up|13
459578|NCT00321620|1511938|P2|Overall Study|Adverse Event|56
459579|NCT00321620|1511939|P1|Overall Study|Adverse Event|43
459580|NCT00321620|1511938|P2|Overall Study|Disease progression|117
459581|NCT00321620|1511939|P1|Overall Study|Disease progression|113
459582|NCT00321620|1511938|P2|Overall Study|Withdrawal by Subject|147
459583|NCT00321620|1511939|P1|Overall Study|Withdrawal by Subject|164
459584|NCT00321620|1511938|P2|Overall Study|Death|294
459585|NCT00321620|1511939|P1|Overall Study|Death|269
459586|NCT00321464|1511969|P2|Overall Study|Other|18
459587|NCT00321464|1511970|P1|Overall Study|Other|21
459588|NCT00321464|1511969|P2|Overall Study|Ineligibility determined|1
459589|NCT00321464|1511970|P1|Overall Study|Ineligibility determined|2
459590|NCT00321464|1511969|P2|Overall Study|Protocol deviation|2
459591|NCT00321464|1511970|P1|Overall Study|Protocol deviation|0
459592|NCT00321464|1511969|P2|Overall Study|Lost to Follow-up|8
459593|NCT00321464|1511970|P1|Overall Study|Lost to Follow-up|7
459594|NCT00321464|1511969|P2|Overall Study|Noncompliance|10
459595|NCT00321464|1511970|P1|Overall Study|Noncompliance|4
459596|NCT00321464|1511969|P2|Overall Study|Physician Decision|14
459597|NCT00321464|1511970|P1|Overall Study|Physician Decision|15
459598|NCT00321464|1511969|P2|Overall Study|Adverse Event|28
459599|NCT00321464|1511970|P1|Overall Study|Adverse Event|43
459600|NCT00321464|1511969|P2|Overall Study|Participant request|61
459601|NCT00321464|1511970|P1|Overall Study|Participant request|57
459602|NCT00321464|1511969|P2|Overall Study|Withdrawal by Subject|118
459603|NCT00321464|1511970|P1|Overall Study|Withdrawal by Subject|117
459604|NCT00321464|1511969|P2|Overall Study|Disease progression|124
459605|NCT00321464|1511970|P1|Overall Study|Disease progression|124
459606|NCT00321464|1511969|P2|Overall Study|Death|174
459607|NCT00321464|1511970|P1|Overall Study|Death|169
459608|NCT00321373|1511983|P3|Overall Study|Other|1
459609|NCT00321373|1511984|P2|Overall Study|Other|0
459610|NCT00321373|1511985|P1|Overall Study|Other|0
459611|NCT00321373|1511983|P3|Overall Study|Withdrawal by Subject|0
459612|NCT00321373|1511984|P2|Overall Study|Withdrawal by Subject|0
459613|NCT00321373|1511985|P1|Overall Study|Withdrawal by Subject|1
459614|NCT00321373|1511983|P3|Overall Study|Lost to Follow-up|1
459615|NCT00321373|1511984|P2|Overall Study|Lost to Follow-up|0
459616|NCT00321373|1511985|P1|Overall Study|Lost to Follow-up|1
459617|NCT00321373|1511983|P3|Overall Study|Adverse Event|1
459618|NCT00321373|1511984|P2|Overall Study|Adverse Event|0
459619|NCT00321373|1511985|P1|Overall Study|Adverse Event|0
459620|NCT00320801|1512025|P4|Extension Phase|Lost to Follow-up|3
459621|NCT00320801|1512026|P3|Extension Phase|Lost to Follow-up|0
459622|NCT00320801|1512027|P2|Extension Phase|Lost to Follow-up|0
459623|NCT00320801|1512028|P1|Extension Phase|Lost to Follow-up|0
459624|NCT00320801|1512025|P4|Extension Phase|Lack of Efficacy|2
459625|NCT00320801|1512026|P3|Extension Phase|Lack of Efficacy|0
459626|NCT00320801|1512027|P2|Extension Phase|Lack of Efficacy|0
459627|NCT00320801|1512028|P1|Extension Phase|Lack of Efficacy|0
459628|NCT00320801|1512025|P4|Extension Phase|Administrative|29
459629|NCT00320801|1512026|P3|Extension Phase|Administrative|0
459630|NCT00320801|1512027|P2|Extension Phase|Administrative|0
459631|NCT00320801|1512028|P1|Extension Phase|Administrative|0
459632|NCT00320801|1512025|P4|Extension Phase|Adverse Event|8
459633|NCT00320801|1512026|P3|Extension Phase|Adverse Event|0
459634|NCT00320801|1512027|P2|Extension Phase|Adverse Event|0
459635|NCT00320801|1512028|P1|Extension Phase|Adverse Event|0
459636|NCT00320801|1512025|P4|Extension Phase|Withdrawal by Subject|6
459637|NCT00320801|1512026|P3|Extension Phase|Withdrawal by Subject|0
459638|NCT00320801|1512027|P2|Extension Phase|Withdrawal by Subject|0
459639|NCT00320801|1512028|P1|Extension Phase|Withdrawal by Subject|0
459640|NCT00320801|1512025|P4|Double-blind Phase|Lack of Efficacy|0
459641|NCT00320801|1512026|P3|Double-blind Phase|Lack of Efficacy|1
459642|NCT00320801|1512027|P2|Double-blind Phase|Lack of Efficacy|9
459643|NCT00320801|1512028|P1|Double-blind Phase|Lack of Efficacy|0
459644|NCT00320801|1512025|P4|Double-blind Phase|Administrative|0
459645|NCT00320801|1512026|P3|Double-blind Phase|Administrative|4
459646|NCT00320801|1512027|P2|Double-blind Phase|Administrative|0
459647|NCT00320801|1512028|P1|Double-blind Phase|Administrative|0
459648|NCT00320801|1512025|P4|Double-blind Phase|Adverse Event|0
459649|NCT00320801|1512026|P3|Double-blind Phase|Adverse Event|8
459650|NCT00320801|1512027|P2|Double-blind Phase|Adverse Event|2
459651|NCT00320801|1512028|P1|Double-blind Phase|Adverse Event|0
459652|NCT00320801|1512025|P4|Double-blind Phase|Withdrawal by Subject|0
459653|NCT00320801|1512026|P3|Double-blind Phase|Withdrawal by Subject|1
459654|NCT00320801|1512027|P2|Double-blind Phase|Withdrawal by Subject|0
459655|NCT00320801|1512028|P1|Double-blind Phase|Withdrawal by Subject|0
459656|NCT00320801|1512025|P4|Open-label Run-in Period|Did not qualify|0
459657|NCT00320801|1512026|P3|Open-label Run-in Period|Did not qualify|0
459658|NCT00320801|1512027|P2|Open-label Run-in Period|Did not qualify|0
459659|NCT00320801|1512028|P1|Open-label Run-in Period|Did not qualify|1
459660|NCT00320801|1512025|P4|Open-label Run-in Period|Lost to Follow-up|0
459661|NCT00320801|1512026|P3|Open-label Run-in Period|Lost to Follow-up|0
459662|NCT00320801|1512027|P2|Open-label Run-in Period|Lost to Follow-up|0
459663|NCT00320801|1512028|P1|Open-label Run-in Period|Lost to Follow-up|2
459664|NCT00320801|1512025|P4|Open-label Run-in Period|Lack of Efficacy|0
459665|NCT00320801|1512026|P3|Open-label Run-in Period|Lack of Efficacy|0
459666|NCT00320801|1512027|P2|Open-label Run-in Period|Lack of Efficacy|0
459667|NCT00320801|1512028|P1|Open-label Run-in Period|Lack of Efficacy|44
459668|NCT00320801|1512025|P4|Open-label Run-in Period|Administrative|0
459669|NCT00320801|1512026|P3|Open-label Run-in Period|Administrative|0
459670|NCT00320801|1512027|P2|Open-label Run-in Period|Administrative|0
459671|NCT00320801|1512028|P1|Open-label Run-in Period|Administrative|10
459672|NCT00320801|1512025|P4|Open-label Run-in Period|Adverse Event|0
459673|NCT00320801|1512026|P3|Open-label Run-in Period|Adverse Event|0
459674|NCT00320801|1512027|P2|Open-label Run-in Period|Adverse Event|0
459675|NCT00320801|1512028|P1|Open-label Run-in Period|Adverse Event|33
459676|NCT00320801|1512025|P4|Open-label Run-in Period|Withdrawal by Subject|0
459677|NCT00320801|1512026|P3|Open-label Run-in Period|Withdrawal by Subject|0
459678|NCT00320801|1512027|P2|Open-label Run-in Period|Withdrawal by Subject|0
459679|NCT00320801|1512028|P1|Open-label Run-in Period|Withdrawal by Subject|2
459680|NCT00320788|1512043|P5|Overall Study|Withdrawal by Subject|1
459681|NCT00320788|1512044|P4|Overall Study|Withdrawal by Subject|3
459682|NCT00320788|1512045|P3|Overall Study|Withdrawal by Subject|0
459683|NCT00320788|1512046|P2|Overall Study|Withdrawal by Subject|0
459684|NCT00320788|1512047|P1|Overall Study|Withdrawal by Subject|3
459685|NCT00320788|1512043|P5|Overall Study|Protocol Violation|1
459686|NCT00320788|1512044|P4|Overall Study|Protocol Violation|0
459687|NCT00320788|1512045|P3|Overall Study|Protocol Violation|0
459688|NCT00320788|1512046|P2|Overall Study|Protocol Violation|0
459689|NCT00320788|1512047|P1|Overall Study|Protocol Violation|0
459690|NCT00320788|1512043|P5|Overall Study|Physician Decision|0
459691|NCT00320788|1512044|P4|Overall Study|Physician Decision|0
459692|NCT00320788|1512045|P3|Overall Study|Physician Decision|0
459693|NCT00320788|1512046|P2|Overall Study|Physician Decision|1
459694|NCT00320788|1512047|P1|Overall Study|Physician Decision|1
459695|NCT00320788|1512043|P5|Overall Study|Other|1
459696|NCT00320788|1512044|P4|Overall Study|Other|1
459697|NCT00320788|1512045|P3|Overall Study|Other|1
459698|NCT00320788|1512046|P2|Overall Study|Other|2
459699|NCT00320788|1512047|P1|Overall Study|Other|1
459700|NCT00320788|1512043|P5|Overall Study|Decision by the Sponsor|1
459701|NCT00320788|1512044|P4|Overall Study|Decision by the Sponsor|0
459702|NCT00320788|1512045|P3|Overall Study|Decision by the Sponsor|0
459703|NCT00320788|1512046|P2|Overall Study|Decision by the Sponsor|1
459704|NCT00320788|1512047|P1|Overall Study|Decision by the Sponsor|1
459705|NCT00320788|1512043|P5|Overall Study|Lost to Follow-up|0
459706|NCT00320788|1512044|P4|Overall Study|Lost to Follow-up|0
459707|NCT00320788|1512045|P3|Overall Study|Lost to Follow-up|1
459708|NCT00320788|1512046|P2|Overall Study|Lost to Follow-up|2
459709|NCT00320788|1512047|P1|Overall Study|Lost to Follow-up|0
459710|NCT00320788|1512043|P5|Overall Study|Death|1
459711|NCT00320788|1512044|P4|Overall Study|Death|0
459712|NCT00320788|1512045|P3|Overall Study|Death|1
459713|NCT00320788|1512046|P2|Overall Study|Death|0
459714|NCT00320788|1512047|P1|Overall Study|Death|0
459715|NCT00320788|1512043|P5|Overall Study|Adverse Event|0
459716|NCT00320788|1512044|P4|Overall Study|Adverse Event|1
459717|NCT00320788|1512045|P3|Overall Study|Adverse Event|0
459718|NCT00320788|1512046|P2|Overall Study|Adverse Event|0
459719|NCT00320788|1512047|P1|Overall Study|Adverse Event|0
459720|NCT00320710|1512101|P3|Overall Study|Lost to Follow-up|0
459721|NCT00320710|1512102|P2|Overall Study|Lost to Follow-up|0
459722|NCT00320710|1512103|P1|Overall Study|Lost to Follow-up|1
459723|NCT00320710|1512101|P3|Overall Study|Adverse Event|1
459724|NCT00320710|1512102|P2|Overall Study|Adverse Event|14
459725|NCT00320710|1512103|P1|Overall Study|Adverse Event|18
459726|NCT00320710|1512101|P3|Overall Study|Abnormal laboratory value(s)|0
459727|NCT00320710|1512102|P2|Overall Study|Abnormal laboratory value(s)|3
459728|NCT00320710|1512103|P1|Overall Study|Abnormal laboratory value(s)|12
459729|NCT00320710|1512101|P3|Overall Study|Abnormal test procedure result(s)|0
459730|NCT00320710|1512102|P2|Overall Study|Abnormal test procedure result(s)|0
459731|NCT00320710|1512103|P1|Overall Study|Abnormal test procedure result(s)|2
459732|NCT00320710|1512101|P3|Overall Study|Protocol Violation|0
459733|NCT00320710|1512102|P2|Overall Study|Protocol Violation|5
459734|NCT00320710|1512103|P1|Overall Study|Protocol Violation|6
459735|NCT00320710|1512101|P3|Overall Study|Withdrawal by Subject|1
459736|NCT00320710|1512102|P2|Overall Study|Withdrawal by Subject|26
459737|NCT00320710|1512103|P1|Overall Study|Withdrawal by Subject|20
459738|NCT00320710|1512101|P3|Overall Study|Administrative problems|0
459739|NCT00320710|1512102|P2|Overall Study|Administrative problems|2
459740|NCT00320710|1512103|P1|Overall Study|Administrative problems|1
459741|NCT00320710|1512101|P3|Overall Study|Death|1
459742|NCT00320710|1512102|P2|Overall Study|Death|7
459743|NCT00320710|1512103|P1|Overall Study|Death|10
459744|NCT00320710|1512101|P3|Overall Study|Disease progression|2
459745|NCT00320710|1512102|P2|Overall Study|Disease progression|19
459746|NCT00320710|1512103|P1|Overall Study|Disease progression|24
459747|NCT00320606|1512133|P1|Overall Study|Ongoing in study|12
459748|NCT00320606|1512133|P1|Overall Study|Protocol Violation|1
459749|NCT00320606|1512133|P1|Overall Study|Adverse Event|1
459750|NCT00320593|1512139|P2|Overall Study|Withdrawal by clinical center|0
459751|NCT00320593|1512140|P1|Overall Study|Withdrawal by clinical center|1
459752|NCT00320593|1512139|P2|Overall Study|Withdrawal by Subject|1
459753|NCT00320593|1512140|P1|Overall Study|Withdrawal by Subject|2
459754|NCT00320593|1512139|P2|Overall Study|Moved to another state|0
459755|NCT00320593|1512140|P1|Overall Study|Moved to another state|1
459756|NCT00320593|1512139|P2|Overall Study|Lost to Follow-up|0
459757|NCT00320593|1512140|P1|Overall Study|Lost to Follow-up|3
459758|NCT00320541|1512164|P2|Overall Study|Protocol Entry Criterion Not Met|0
459759|NCT00320541|1512165|P1|Overall Study|Protocol Entry Criterion Not Met|1
459760|NCT00320541|1512164|P2|Overall Study|Death due to Adverse Event(s)|0
459761|NCT00320541|1512165|P1|Overall Study|Death due to Adverse Event(s)|1
459762|NCT00320541|1512164|P2|Overall Study|Death due to Study Disease|3
459763|NCT00320541|1512165|P1|Overall Study|Death due to Study Disease|1
459764|NCT00320541|1512164|P2|Overall Study|Sponsor Decision|1
459765|NCT00320541|1512165|P1|Overall Study|Sponsor Decision|2
459766|NCT00320541|1512164|P2|Overall Study|Other|4
459767|NCT00320541|1512165|P1|Overall Study|Other|3
459768|NCT00320541|1512164|P2|Overall Study|Physician Decision|13
459769|NCT00320541|1512165|P1|Overall Study|Physician Decision|9
459770|NCT00320541|1512164|P2|Overall Study|Withdrawal by Subject|16
459771|NCT00320541|1512165|P1|Overall Study|Withdrawal by Subject|12
459772|NCT00320541|1512164|P2|Overall Study|Protocol Violation|1
459773|NCT00320541|1512165|P1|Overall Study|Protocol Violation|0
459774|NCT00320541|1512164|P2|Overall Study|Adverse Event|19
459775|NCT00320541|1512165|P1|Overall Study|Adverse Event|21
459776|NCT00320528|1512192|P3|Study Period III|Atomoxetine Commercially Available|90
459777|NCT00320528|1512193|P2|Study Period III|Atomoxetine Commercially Available|25
459778|NCT00320528|1512194|P1|Study Period III|Atomoxetine Commercially Available|68
459779|NCT00320528|1512192|P3|Study Period III|Sponsor Decision|1
459780|NCT00320528|1512193|P2|Study Period III|Sponsor Decision|0
459781|NCT00320528|1512194|P1|Study Period III|Sponsor Decision|0
459782|NCT00320528|1512192|P3|Study Period III|Physician Decision|2
459783|NCT00320528|1512193|P2|Study Period III|Physician Decision|1
459784|NCT00320528|1512194|P1|Study Period III|Physician Decision|0
459785|NCT00320528|1512192|P3|Study Period III|Protocol Violation|0
459786|NCT00320528|1512193|P2|Study Period III|Protocol Violation|1
459787|NCT00320528|1512194|P1|Study Period III|Protocol Violation|0
459788|NCT00320528|1512192|P3|Study Period III|Parent/Caregiver Decision|11
459789|NCT00320528|1512193|P2|Study Period III|Parent/Caregiver Decision|3
459790|NCT00320528|1512194|P1|Study Period III|Parent/Caregiver Decision|14
459791|NCT00320528|1512192|P3|Study Period III|Lack of Efficacy|0
459792|NCT00320528|1512193|P2|Study Period III|Lack of Efficacy|0
459793|NCT00320528|1512194|P1|Study Period III|Lack of Efficacy|2
459794|NCT00320528|1512192|P3|Study Period III|Withdrawal by Subject|2
459795|NCT00320528|1512193|P2|Study Period III|Withdrawal by Subject|1
459796|NCT00320528|1512194|P1|Study Period III|Withdrawal by Subject|1
459797|NCT00320528|1512192|P3|Study Period III|Lost to Follow-up|0
459798|NCT00320528|1512193|P2|Study Period III|Lost to Follow-up|0
459799|NCT00320528|1512194|P1|Study Period III|Lost to Follow-up|1
459800|NCT00320528|1512192|P3|Study Period III|Adverse Event|0
459801|NCT00320528|1512193|P2|Study Period III|Adverse Event|0
459802|NCT00320528|1512194|P1|Study Period III|Adverse Event|1
459803|NCT00320528|1512192|P3|Study Period II|Entry Criteria Exclusion|2
459804|NCT00320528|1512193|P2|Study Period II|Entry Criteria Exclusion|2
459805|NCT00320528|1512194|P1|Study Period II|Entry Criteria Exclusion|0
459806|NCT00320528|1512192|P3|Study Period II|Withdrawal by Subject|1
459807|NCT00320528|1512193|P2|Study Period II|Withdrawal by Subject|1
459808|NCT00320528|1512194|P1|Study Period II|Withdrawal by Subject|0
459809|NCT00320528|1512192|P3|Study Period II|Parent/Caregiver Decision|11
459810|NCT00320528|1512193|P2|Study Period II|Parent/Caregiver Decision|3
459811|NCT00320528|1512194|P1|Study Period II|Parent/Caregiver Decision|8
459812|NCT00320528|1512192|P3|Study Period II|Adverse Event|8
459813|NCT00320528|1512193|P2|Study Period II|Adverse Event|4
459814|NCT00320528|1512194|P1|Study Period II|Adverse Event|3
459815|NCT00320515|1512229|P1|Overall Study|Withdrawal by Subject|8
459816|NCT00320515|1512229|P1|Overall Study|Physician Decision|2
459817|NCT00320515|1512229|P1|Overall Study|Lost to Follow-up|6
459818|NCT00320515|1512229|P1|Overall Study|Death|33
459819|NCT00320489|1512238|P2|Overall Study|Withdrawal by Subject|41
459820|NCT00320489|1512239|P1|Overall Study|Withdrawal by Subject|39
459821|NCT00320489|1512238|P2|Overall Study|Sponsor Decision|3
459822|NCT00320489|1512239|P1|Overall Study|Sponsor Decision|3
459823|NCT00320489|1512238|P2|Overall Study|Protocol Violation|4
459824|NCT00320489|1512239|P1|Overall Study|Protocol Violation|4
459825|NCT00320489|1512238|P2|Overall Study|Physician Decision|8
459826|NCT00320489|1512239|P1|Overall Study|Physician Decision|8
459827|NCT00320489|1512238|P2|Overall Study|Lost to Follow-up|22
459828|NCT00320489|1512239|P1|Overall Study|Lost to Follow-up|21
459829|NCT00320489|1512238|P2|Overall Study|Lack of Efficacy|7
459830|NCT00320489|1512239|P1|Overall Study|Lack of Efficacy|16
459831|NCT00320489|1512238|P2|Overall Study|Entry Criteria Exclusion|4
459832|NCT00320489|1512239|P1|Overall Study|Entry Criteria Exclusion|2
459833|NCT00320489|1512238|P2|Overall Study|Death|2
459834|NCT00320489|1512239|P1|Overall Study|Death|0
459835|NCT00320489|1512238|P2|Overall Study|Clinical Relapse|20
459836|NCT00320489|1512239|P1|Overall Study|Clinical Relapse|26
459837|NCT00320489|1512238|P2|Overall Study|Adverse Event|25
459838|NCT00320489|1512239|P1|Overall Study|Adverse Event|26
459839|NCT00320424|1512295|P1|Overall Study|Other|3
459840|NCT00320424|1512295|P1|Overall Study|Adverse Event|3
459841|NCT00320411|1512309|P1|Overall Study|No investigational product admin.|4
459842|NCT00320398|1512332|P2|Overall Study|Other|0
459843|NCT00320398|1512333|P1|Overall Study|Other|1
459844|NCT00320398|1512332|P2|Overall Study|Adverse Event|4
459845|NCT00320398|1512333|P1|Overall Study|Adverse Event|1
459846|NCT00320385|1512361|P2|Overall Study|Adverse Event|1
459847|NCT00320385|1512362|P1|Overall Study|Adverse Event|0
459848|NCT00320385|1512361|P2|Overall Study|Withdrew Consent|0
459849|NCT00320385|1512362|P1|Overall Study|Withdrew Consent|1
459850|NCT00320385|1512361|P2|Overall Study|Serious Adverse Event|0
459851|NCT00320385|1512362|P1|Overall Study|Serious Adverse Event|1
459852|NCT00320385|1512361|P2|Overall Study|Death|2
459853|NCT00320385|1512362|P1|Overall Study|Death|1
459854|NCT00320385|1512361|P2|Overall Study|Investigator Decision|1
459855|NCT00320385|1512362|P1|Overall Study|Investigator Decision|0
459856|NCT00320385|1512361|P2|Overall Study|Sponsor Terminated Study|1
459857|NCT00320385|1512362|P1|Overall Study|Sponsor Terminated Study|2
459858|NCT00320385|1512361|P2|Overall Study|Withdrawal by Subject|7
459859|NCT00320385|1512362|P1|Overall Study|Withdrawal by Subject|6
459860|NCT00320385|1512361|P2|Overall Study|Lost to Follow-up|10
459861|NCT00320385|1512362|P1|Overall Study|Lost to Follow-up|7
459862|NCT00320372|1512385|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
459863|NCT00320372|1512386|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
459864|NCT00320372|1512385|P2|Overall Study|Did not Meet (I/E)|1
459865|NCT00320372|1512386|P1|Overall Study|Did not Meet (I/E)|3
459866|NCT00320372|1512385|P2|Overall Study|Non-Compliance|39
459867|NCT00320372|1512386|P1|Overall Study|Non-Compliance|40
459868|NCT00320372|1512385|P2|Overall Study|Withdrawal by Subject|37
459869|NCT00320372|1512386|P1|Overall Study|Withdrawal by Subject|55
459870|NCT00320372|1512385|P2|Overall Study|Death|8
459871|NCT00320372|1512386|P1|Overall Study|Death|7
459872|NCT00320372|1512385|P2|Overall Study|Physician Decision|7
459873|NCT00320372|1512386|P1|Overall Study|Physician Decision|4
459874|NCT00320255|1512426|P6|Overall Study|Not specified|0
459875|NCT00320255|1512427|P5|Overall Study|Not specified|0
459876|NCT00320255|1512428|P4|Overall Study|Not specified|0
459877|NCT00320255|1512429|P3|Overall Study|Not specified|1
459878|NCT00320255|1512430|P2|Overall Study|Not specified|2
459879|NCT00320255|1512431|P1|Overall Study|Not specified|3
459880|NCT00320255|1512426|P6|Overall Study|No longer meets study criteria|0
459881|NCT00320255|1512427|P5|Overall Study|No longer meets study criteria|0
459882|NCT00320255|1512428|P4|Overall Study|No longer meets study criteria|1
459883|NCT00320255|1512429|P3|Overall Study|No longer meets study criteria|0
459884|NCT00320255|1512430|P2|Overall Study|No longer meets study criteria|0
459885|NCT00320255|1512431|P1|Overall Study|No longer meets study criteria|0
459886|NCT00320255|1512426|P6|Overall Study|Poor compliance/noncompliance|0
459887|NCT00320255|1512427|P5|Overall Study|Poor compliance/noncompliance|0
459888|NCT00320255|1512428|P4|Overall Study|Poor compliance/noncompliance|1
459889|NCT00320255|1512429|P3|Overall Study|Poor compliance/noncompliance|0
459890|NCT00320255|1512430|P2|Overall Study|Poor compliance/noncompliance|1
459891|NCT00320255|1512431|P1|Overall Study|Poor compliance/noncompliance|1
459892|NCT00320255|1512426|P6|Overall Study|Withdrawal by Subject|0
459893|NCT00320255|1512427|P5|Overall Study|Withdrawal by Subject|0
459894|NCT00320255|1512428|P4|Overall Study|Withdrawal by Subject|4
459895|NCT00320255|1512429|P3|Overall Study|Withdrawal by Subject|2
459896|NCT00320255|1512430|P2|Overall Study|Withdrawal by Subject|2
459897|NCT00320255|1512431|P1|Overall Study|Withdrawal by Subject|1
459898|NCT00320255|1512426|P6|Overall Study|Adverse Event|0
459899|NCT00320255|1512427|P5|Overall Study|Adverse Event|0
459900|NCT00320255|1512428|P4|Overall Study|Adverse Event|2
459901|NCT00320255|1512429|P3|Overall Study|Adverse Event|3
459902|NCT00320255|1512430|P2|Overall Study|Adverse Event|2
459903|NCT00320255|1512431|P1|Overall Study|Adverse Event|5
459904|NCT00320255|1512426|P6|Overall Study|Lack of Efficacy|0
459905|NCT00320255|1512427|P5|Overall Study|Lack of Efficacy|0
459906|NCT00320255|1512428|P4|Overall Study|Lack of Efficacy|0
459907|NCT00320255|1512429|P3|Overall Study|Lack of Efficacy|0
459908|NCT00320255|1512430|P2|Overall Study|Lack of Efficacy|0
459909|NCT00320255|1512431|P1|Overall Study|Lack of Efficacy|1
459910|NCT00320216|1512524|P5|Overall Study|Other|3
459911|NCT00320216|1512525|P4|Overall Study|Other|1
459912|NCT00320216|1512526|P3|Overall Study|Other|5
459913|NCT00320216|1512527|P2|Overall Study|Other|2
459914|NCT00320216|1512528|P1|Overall Study|Other|7
459915|NCT00320216|1512524|P5|Overall Study|Lost to Follow-up|0
459916|NCT00320216|1512525|P4|Overall Study|Lost to Follow-up|0
459917|NCT00320216|1512526|P3|Overall Study|Lost to Follow-up|0
459918|NCT00320216|1512527|P2|Overall Study|Lost to Follow-up|0
459919|NCT00320216|1512528|P1|Overall Study|Lost to Follow-up|3
459920|NCT00320216|1512524|P5|Overall Study|Lack of Efficacy|1
459921|NCT00320216|1512525|P4|Overall Study|Lack of Efficacy|0
459922|NCT00320216|1512526|P3|Overall Study|Lack of Efficacy|1
459923|NCT00320216|1512527|P2|Overall Study|Lack of Efficacy|2
459924|NCT00320216|1512528|P1|Overall Study|Lack of Efficacy|6
459925|NCT00320216|1512524|P5|Overall Study|Adverse Event|2
459926|NCT00320216|1512525|P4|Overall Study|Adverse Event|2
459927|NCT00320216|1512526|P3|Overall Study|Adverse Event|0
459928|NCT00320216|1512527|P2|Overall Study|Adverse Event|6
459929|NCT00320216|1512528|P1|Overall Study|Adverse Event|0
459930|NCT00320190|1512562|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
459931|NCT00320190|1512563|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
459932|NCT00320190|1512562|P2|Long-term (12-month) Extension|Lack of major molecular response|2
459933|NCT00320190|1512563|P1|Long-term (12-month) Extension|Lack of major molecular response|1
459934|NCT00320190|1512562|P2|Long-term (12-month) Extension|Sponsor terminated study|0
459935|NCT00320190|1512563|P1|Long-term (12-month) Extension|Sponsor terminated study|7
459936|NCT00320190|1512562|P2|First 12 Months|Withdrawal by Subject|1
459937|NCT00320190|1512563|P1|First 12 Months|Withdrawal by Subject|0
459938|NCT00320190|1512562|P2|First 12 Months|Study drug toxicity|1
459939|NCT00320190|1512563|P1|First 12 Months|Study drug toxicity|0
459940|NCT00320190|1512562|P2|First 12 Months|Investigator request|1
459941|NCT00320190|1512563|P1|First 12 Months|Investigator request|0
459942|NCT00320190|1512562|P2|First 12 Months|Adverse event unrelated to study drug|0
459943|NCT00320190|1512563|P1|First 12 Months|Adverse event unrelated to study drug|1
459944|NCT00320190|1512562|P2|First 12 Months|Enrollment failure|1
459945|NCT00320190|1512563|P1|First 12 Months|Enrollment failure|0
459946|NCT00320190|1512562|P2|First 12 Months|Lost to Follow-up|1
459947|NCT00320190|1512563|P1|First 12 Months|Lost to Follow-up|0
459948|NCT00320190|1512562|P2|First 12 Months|Sponsor terminated study|2
459949|NCT00320190|1512563|P1|First 12 Months|Sponsor terminated study|2
459950|NCT00320190|1512562|P2|First 12 Months|Completed but did not enter extension|3
459951|NCT00320190|1512563|P1|First 12 Months|Completed but did not enter extension|5
459952|NCT00320112|1512583|P2|Overall Study|Death|1
459953|NCT00320112|1512584|P1|Overall Study|Death|2
459954|NCT00320112|1512583|P2|Overall Study|Withdrawal by Subject|0
459955|NCT00320112|1512584|P1|Overall Study|Withdrawal by Subject|3
459956|NCT00320112|1512583|P2|Overall Study|Lost to Follow-up|4
459957|NCT00320112|1512584|P1|Overall Study|Lost to Follow-up|3
459958|NCT00319982|1512598|P2|Overall Study|Withdrawal by Subject|0
459959|NCT00319982|1512599|P1|Overall Study|Withdrawal by Subject|1
459960|NCT00319956|1512619|P2|Overall Study|Death|24
459961|NCT00319956|1512620|P1|Overall Study|Death|20
459962|NCT00319839|1512632|P1|Overall Study|Withdrawal by Subject|1
459963|NCT00319839|1512632|P1|Overall Study|Adverse Event|5
459964|NCT00319735|1512648|P1|Overall Study|Death|2
459965|NCT00319696|1512661|P1|Overall Study|Lost to Follow-up|3
459966|NCT00319696|1512661|P1|Overall Study|administrative|7
459967|NCT00319696|1512661|P1|Overall Study|withdrawal of consent|14
459968|NCT00319696|1512661|P1|Overall Study|Adverse Event|36
459969|NCT00319592|1512698|P2|Overall Study|Physician Decision|1
459970|NCT00319592|1512699|P1|Overall Study|Physician Decision|0
459971|NCT00319592|1512698|P2|Overall Study|Protocol Violation|0
459972|NCT00319592|1512699|P1|Overall Study|Protocol Violation|1
459973|NCT00319553|1512715|P2|Overall Study|Withdrawal by Subject|1
459974|NCT00319553|1512716|P1|Overall Study|Withdrawal by Subject|1
459975|NCT00319553|1512715|P2|Overall Study|Lost to Follow-up|1
459976|NCT00319553|1512716|P1|Overall Study|Lost to Follow-up|2
459977|NCT00319553|1512715|P2|Overall Study|Protocol Violation|2
459978|NCT00319553|1512716|P1|Overall Study|Protocol Violation|1
459979|NCT00319501|1512730|P2|Open-label Extension Period|Withdrawal by Subject|0
459980|NCT00319501|1512731|P1|Open-label Extension Period|Withdrawal by Subject|2
459981|NCT00319501|1512730|P2|Open-label Extension Period|Sponsor request|0
459982|NCT00319501|1512731|P1|Open-label Extension Period|Sponsor request|26
459983|NCT00319501|1512730|P2|Open-label Extension Period|Principal investigator decision|0
459984|NCT00319501|1512731|P1|Open-label Extension Period|Principal investigator decision|2
459985|NCT00319501|1512730|P2|Open-label Extension Period|Not specified|0
459986|NCT00319501|1512731|P1|Open-label Extension Period|Not specified|1
459987|NCT00319501|1512730|P2|Open-label Extension Period|Did not receive treatment|0
459988|NCT00319501|1512731|P1|Open-label Extension Period|Did not receive treatment|18
459989|NCT00319501|1512730|P2|Open-label Extension Period|Adverse Event|0
459990|NCT00319501|1512731|P1|Open-label Extension Period|Adverse Event|2
459991|NCT00319501|1512730|P2|Open-label Period|Not specified|0
459992|NCT00319501|1512731|P1|Open-label Period|Not specified|11
459993|NCT00319501|1512730|P2|Open-label Period|Did not receive treatment|0
459994|NCT00319501|1512731|P1|Open-label Period|Did not receive treatment|33
459995|NCT00319501|1512730|P2|Open-label Period|Lost to Follow-up|0
459996|NCT00319501|1512731|P1|Open-label Period|Lost to Follow-up|5
459997|NCT00319501|1512730|P2|Open-label Period|Sponsor request|0
459998|NCT00319501|1512731|P1|Open-label Period|Sponsor request|12
459999|NCT00319501|1512730|P2|Open-label Period|Principal Investigator decision|0
460000|NCT00319501|1512731|P1|Open-label Period|Principal Investigator decision|6
460001|NCT00319501|1512730|P2|Open-label Period|Withdrawal by Subject|0
460002|NCT00319501|1512731|P1|Open-label Period|Withdrawal by Subject|38
460003|NCT00319501|1512730|P2|Open-label Period|Protocol Violation|0
460004|NCT00319501|1512731|P1|Open-label Period|Protocol Violation|6
460005|NCT00319501|1512730|P2|Open-label Period|Adverse Event|0
460006|NCT00319501|1512731|P1|Open-label Period|Adverse Event|5
460007|NCT00319501|1512730|P2|Double-blind Period|Did not receive treatment|29
460008|NCT00319501|1512731|P1|Double-blind Period|Did not receive treatment|42
460009|NCT00319501|1512730|P2|Double-blind Period|Sponsor Request|0
460010|NCT00319501|1512731|P1|Double-blind Period|Sponsor Request|1
460011|NCT00319501|1512730|P2|Double-blind Period|Withdrawal by Subject|3
460012|NCT00319501|1512731|P1|Double-blind Period|Withdrawal by Subject|0
460013|NCT00319449|1512757|P2|Overall Study|Noncompliance with the protocol|0
460014|NCT00319449|1512758|P1|Overall Study|Noncompliance with the protocol|1
460015|NCT00319449|1512757|P2|Overall Study|Subject did not wish to continue|0
460016|NCT00319449|1512758|P1|Overall Study|Subject did not wish to continue|1
460017|NCT00319436|1512770|P2|Overall Study|Withdrawal by Subject|7
460018|NCT00319436|1512771|P1|Overall Study|Withdrawal by Subject|6
460019|NCT00319254|1512789|P1|Overall Study|Enrolled, Not Treated|2
460020|NCT00319254|1512789|P1|Overall Study|Lost to Follow-up|2
460021|NCT00319254|1512789|P1|Overall Study|Death|46
460022|NCT00319254|1512789|P1|Overall Study|Withdrawal by Subject|4
460023|NCT00319111|1512802|P1|Overall Study|Treatment failure|1
460024|NCT00319111|1512802|P1|Overall Study|Administrative|2
460025|NCT00319111|1512802|P1|Overall Study|Lack of clinical improvement|4
460026|NCT00319111|1512802|P1|Overall Study|Death|9
460027|NCT00319111|1512802|P1|Overall Study|Withdrawal of consent|11
460028|NCT00319111|1512802|P1|Overall Study|Adverse Event|20
460029|NCT00319098|1512816|P2|Overall Study|Protocol Violation|1
460030|NCT00319098|1512817|P1|Overall Study|Protocol Violation|3
460031|NCT00319098|1512816|P2|Overall Study|Others|8
460032|NCT00319098|1512817|P1|Overall Study|Others|33
460033|NCT00319098|1512816|P2|Overall Study|Lost to Follow-up|13
460034|NCT00319098|1512817|P1|Overall Study|Lost to Follow-up|37
460035|NCT00319098|1512816|P2|Overall Study|Migrated/moved from study area|1
460036|NCT00319098|1512817|P1|Overall Study|Migrated/moved from study area|2
460037|NCT00319098|1512816|P2|Overall Study|Withdrawal by Subject|8
460038|NCT00319098|1512817|P1|Overall Study|Withdrawal by Subject|37
460039|NCT00319098|1512816|P2|Overall Study|Adverse Event|1
460040|NCT00319098|1512817|P1|Overall Study|Adverse Event|20
460041|NCT00319098|1512816|P2|Overall Study|Serious adverse event|0
460042|NCT00319098|1512817|P1|Overall Study|Serious adverse event|3
460043|NCT00319046|1512875|P1|Overall Study|administrative reason|1
460044|NCT00319046|1512875|P1|Overall Study|withdrawal of subject's consent|7
460045|NCT00319020|1512884|P2|Overall Study|Adverse Event|1
460046|NCT00319020|1512885|P1|Overall Study|Adverse Event|0
460047|NCT00319020|1512884|P2|Overall Study|Treatment failure|1
460048|NCT00319020|1512885|P1|Overall Study|Treatment failure|0
460049|NCT00319020|1512884|P2|Overall Study|Transplant|1
460050|NCT00319020|1512885|P1|Overall Study|Transplant|0
460051|NCT00319020|1512884|P2|Overall Study|Disease progression|2
460052|NCT00319020|1512885|P1|Overall Study|Disease progression|0
460053|NCT00319020|1512884|P2|Overall Study|Administrative reason|5
460054|NCT00319020|1512885|P1|Overall Study|Administrative reason|0
460055|NCT00319020|1512884|P2|Overall Study|F-1 completed but not enrolled in F-2|0
460056|NCT00319020|1512885|P1|Overall Study|F-1 completed but not enrolled in F-2|1
460057|NCT00319020|1512884|P2|Overall Study|Withdrawal by Subject|1
460058|NCT00319020|1512885|P1|Overall Study|Withdrawal by Subject|4
460059|NCT00319020|1512884|P2|Overall Study|Death|2
460060|NCT00319020|1512885|P1|Overall Study|Death|2
460061|NCT00318656|1512957|P2|Overall Study|Did not receive any treatment|1
460062|NCT00318656|1512958|P1|Overall Study|Did not receive any treatment|0
460063|NCT00318656|1512957|P2|Overall Study|Took Avandamet instead of Glim/Met|1
460064|NCT00318656|1512958|P1|Overall Study|Took Avandamet instead of Glim/Met|0
460065|NCT00318565|1513015|P1|Overall Study|Excluded per protocol|24
460066|NCT00318474|1513022|P2|Overall Study|Trial terminated|7
460067|NCT00318474|1513023|P1|Overall Study|Trial terminated|10
460068|NCT00318474|1513022|P2|Overall Study|Post-therapy hyperflycemia|1
460069|NCT00318474|1513023|P1|Overall Study|Post-therapy hyperflycemia|0
460070|NCT00318474|1513022|P2|Overall Study|Fall in GFR|3
460071|NCT00318474|1513023|P1|Overall Study|Fall in GFR|3
460072|NCT00318474|1513022|P2|Overall Study|Withdrawal by Subject|2
460073|NCT00318474|1513023|P1|Overall Study|Withdrawal by Subject|3
460074|NCT00318474|1513022|P2|Overall Study|Protocol Violation|0
460075|NCT00318474|1513023|P1|Overall Study|Protocol Violation|1
460076|NCT00318474|1513022|P2|Overall Study|Pregnancy|2
460077|NCT00318474|1513023|P1|Overall Study|Pregnancy|0
460078|NCT00318474|1513022|P2|Overall Study|Lost to Follow-up|1
460079|NCT00318474|1513023|P1|Overall Study|Lost to Follow-up|0
460080|NCT00318474|1513022|P2|Overall Study|Adverse Event|1
460081|NCT00318474|1513023|P1|Overall Study|Adverse Event|1
460082|NCT00318461|1513034|P5|Open-Label Extension, 18 Months|Protocol Violation|6
460083|NCT00318461|1513035|P4|Open-Label Extension, 18 Months|Protocol Violation|4
460084|NCT00318461|1513036|P3|Open-Label Extension, 18 Months|Protocol Violation|3
460085|NCT00318461|1513037|P2|Open-Label Extension, 18 Months|Protocol Violation|5
460086|NCT00318461|1513038|P1|Open-Label Extension, 18 Months|Protocol Violation|7
460087|NCT00318461|1513034|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
460088|NCT00318461|1513035|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
460089|NCT00318461|1513036|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
460090|NCT00318461|1513037|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
460091|NCT00318461|1513038|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
460092|NCT00318461|1513034|P5|Open-Label Extension, 18 Months|Adverse Event|6
460093|NCT00318461|1513035|P4|Open-Label Extension, 18 Months|Adverse Event|1
460094|NCT00318461|1513036|P3|Open-Label Extension, 18 Months|Adverse Event|6
460095|NCT00318461|1513037|P2|Open-Label Extension, 18 Months|Adverse Event|8
460096|NCT00318461|1513038|P1|Open-Label Extension, 18 Months|Adverse Event|11
460097|NCT00318461|1513034|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
460098|NCT00318461|1513035|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
460099|NCT00318461|1513036|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
460100|NCT00318461|1513037|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
460101|NCT00318461|1513038|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
460102|NCT00318461|1513034|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
460103|NCT00318461|1513035|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
460104|NCT00318461|1513036|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
460105|NCT00318461|1513037|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
460106|NCT00318461|1513038|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
460107|NCT00318461|1513034|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
460108|NCT00318461|1513035|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
460109|NCT00318461|1513036|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
460110|NCT00318461|1513037|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
460111|NCT00318461|1513038|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
460112|NCT00318461|1513034|P5|Double-Blind, 6 Months|Hyperglicaemia|0
460113|NCT00318461|1513035|P4|Double-Blind, 6 Months|Hyperglicaemia|1
460114|NCT00318461|1513036|P3|Double-Blind, 6 Months|Hyperglicaemia|0
460115|NCT00318461|1513037|P2|Double-Blind, 6 Months|Hyperglicaemia|0
460116|NCT00318461|1513038|P1|Double-Blind, 6 Months|Hyperglicaemia|0
460117|NCT00318461|1513034|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
460118|NCT00318461|1513035|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
460119|NCT00318461|1513036|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
460120|NCT00318461|1513037|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
460121|NCT00318461|1513038|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
460122|NCT00318461|1513034|P5|Double-Blind, 6 Months|Lack of time|0
460123|NCT00318461|1513035|P4|Double-Blind, 6 Months|Lack of time|0
460124|NCT00318461|1513036|P3|Double-Blind, 6 Months|Lack of time|0
460125|NCT00318461|1513037|P2|Double-Blind, 6 Months|Lack of time|0
460126|NCT00318461|1513038|P1|Double-Blind, 6 Months|Lack of time|1
460127|NCT00318461|1513034|P5|Double-Blind, 6 Months|Investigator decision|1
460128|NCT00318461|1513035|P4|Double-Blind, 6 Months|Investigator decision|0
460129|NCT00318461|1513036|P3|Double-Blind, 6 Months|Investigator decision|0
460130|NCT00318461|1513037|P2|Double-Blind, 6 Months|Investigator decision|0
460131|NCT00318461|1513038|P1|Double-Blind, 6 Months|Investigator decision|0
460132|NCT00318461|1513034|P5|Double-Blind, 6 Months|Work commitment|1
460133|NCT00318461|1513035|P4|Double-Blind, 6 Months|Work commitment|0
460134|NCT00318461|1513036|P3|Double-Blind, 6 Months|Work commitment|0
460135|NCT00318461|1513037|P2|Double-Blind, 6 Months|Work commitment|0
460136|NCT00318461|1513038|P1|Double-Blind, 6 Months|Work commitment|0
460137|NCT00318461|1513034|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
460138|NCT00318461|1513035|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
460139|NCT00318461|1513036|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
460140|NCT00318461|1513037|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
460141|NCT00318461|1513038|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
460142|NCT00318461|1513034|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
460143|NCT00318461|1513035|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
460144|NCT00318461|1513036|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
460145|NCT00318461|1513037|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
460146|NCT00318461|1513038|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
460147|NCT00318461|1513034|P5|Double-Blind, 6 Months|Move|0
460148|NCT00318461|1513035|P4|Double-Blind, 6 Months|Move|0
460149|NCT00318461|1513036|P3|Double-Blind, 6 Months|Move|0
460150|NCT00318461|1513037|P2|Double-Blind, 6 Months|Move|1
460151|NCT00318461|1513038|P1|Double-Blind, 6 Months|Move|0
460152|NCT00318461|1513034|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
460153|NCT00318461|1513035|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
460154|NCT00318461|1513036|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
460155|NCT00318461|1513037|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
460156|NCT00318461|1513038|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
460157|NCT00318461|1513034|P5|Double-Blind, 6 Months|Consent withdrawn|4
460158|NCT00318461|1513035|P4|Double-Blind, 6 Months|Consent withdrawn|10
460159|NCT00318461|1513036|P3|Double-Blind, 6 Months|Consent withdrawn|4
460160|NCT00318461|1513037|P2|Double-Blind, 6 Months|Consent withdrawn|3
460161|NCT00318461|1513038|P1|Double-Blind, 6 Months|Consent withdrawn|0
460162|NCT00318461|1513034|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
460163|NCT00318461|1513035|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
460164|NCT00318461|1513036|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
460165|NCT00318461|1513037|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
460166|NCT00318461|1513038|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
460167|NCT00318461|1513034|P5|Double-Blind, 6 Months|Lost to follow up|0
460168|NCT00318461|1513035|P4|Double-Blind, 6 Months|Lost to follow up|0
460169|NCT00318461|1513036|P3|Double-Blind, 6 Months|Lost to follow up|0
460170|NCT00318461|1513037|P2|Double-Blind, 6 Months|Lost to follow up|1
460171|NCT00318461|1513038|P1|Double-Blind, 6 Months|Lost to follow up|0
460172|NCT00318461|1513034|P5|Double-Blind, 6 Months|Protocol Violation|5
460173|NCT00318461|1513035|P4|Double-Blind, 6 Months|Protocol Violation|4
460174|NCT00318461|1513036|P3|Double-Blind, 6 Months|Protocol Violation|4
460175|NCT00318461|1513037|P2|Double-Blind, 6 Months|Protocol Violation|4
460176|NCT00318461|1513038|P1|Double-Blind, 6 Months|Protocol Violation|2
460177|NCT00318461|1513034|P5|Double-Blind, 6 Months|Lack of Efficacy|9
460178|NCT00318461|1513035|P4|Double-Blind, 6 Months|Lack of Efficacy|29
460179|NCT00318461|1513036|P3|Double-Blind, 6 Months|Lack of Efficacy|13
460180|NCT00318461|1513037|P2|Double-Blind, 6 Months|Lack of Efficacy|8
460181|NCT00318461|1513038|P1|Double-Blind, 6 Months|Lack of Efficacy|19
460182|NCT00318461|1513034|P5|Double-Blind, 6 Months|Adverse Event|8
460183|NCT00318461|1513035|P4|Double-Blind, 6 Months|Adverse Event|2
460184|NCT00318461|1513036|P3|Double-Blind, 6 Months|Adverse Event|29
460185|NCT00318461|1513037|P2|Double-Blind, 6 Months|Adverse Event|23
460186|NCT00318461|1513038|P1|Double-Blind, 6 Months|Adverse Event|11
460187|NCT00318370|1513137|P3|Period 3|Other|3
460188|NCT00318370|1513138|P2|Period 3|Other|0
460189|NCT00318370|1513139|P1|Period 3|Other|0
460190|NCT00318370|1513137|P3|Period 3|Withdrawal by Subject|3
460191|NCT00318370|1513138|P2|Period 3|Withdrawal by Subject|0
460192|NCT00318370|1513139|P1|Period 3|Withdrawal by Subject|0
460193|NCT00318370|1513137|P3|Period 3|Physician Decision|1
460194|NCT00318370|1513138|P2|Period 3|Physician Decision|0
460195|NCT00318370|1513139|P1|Period 3|Physician Decision|0
460196|NCT00318370|1513137|P3|Period 3|Death|1
460197|NCT00318370|1513138|P2|Period 3|Death|0
460198|NCT00318370|1513139|P1|Period 3|Death|0
460199|NCT00318370|1513137|P3|Period 3|Lack of Efficacy|24
460200|NCT00318370|1513138|P2|Period 3|Lack of Efficacy|0
460201|NCT00318370|1513139|P1|Period 3|Lack of Efficacy|0
460202|NCT00318370|1513137|P3|Period 3|Adverse Event|1
460203|NCT00318370|1513138|P2|Period 3|Adverse Event|0
460204|NCT00318370|1513139|P1|Period 3|Adverse Event|0
460205|NCT00318370|1513137|P3|Period 2|Other|0
460206|NCT00318370|1513138|P2|Period 2|Other|1
460207|NCT00318370|1513139|P1|Period 2|Other|0
460208|NCT00318370|1513137|P3|Period 2|Withdrawal by Subject|0
460209|NCT00318370|1513138|P2|Period 2|Withdrawal by Subject|1
460210|NCT00318370|1513139|P1|Period 2|Withdrawal by Subject|0
460211|NCT00318370|1513137|P3|Period 2|Physician Decision|0
460212|NCT00318370|1513138|P2|Period 2|Physician Decision|1
460213|NCT00318370|1513139|P1|Period 2|Physician Decision|0
460214|NCT00318370|1513137|P3|Period 2|Lack of Efficacy|0
460215|NCT00318370|1513138|P2|Period 2|Lack of Efficacy|5
460216|NCT00318370|1513139|P1|Period 2|Lack of Efficacy|0
460217|NCT00318370|1513137|P3|Period 2|Adverse Event|0
460218|NCT00318370|1513138|P2|Period 2|Adverse Event|3
460219|NCT00318370|1513139|P1|Period 2|Adverse Event|0
460220|NCT00318370|1513137|P3|Period 1|Withdrawal by Subject|0
460221|NCT00318370|1513138|P2|Period 1|Withdrawal by Subject|0
460222|NCT00318370|1513139|P1|Period 1|Withdrawal by Subject|1
460223|NCT00318370|1513137|P3|Period 1|Physician Decision|0
460224|NCT00318370|1513138|P2|Period 1|Physician Decision|0
460225|NCT00318370|1513139|P1|Period 1|Physician Decision|1
460226|NCT00318370|1513137|P3|Period 1|Lack of Efficacy|0
460227|NCT00318370|1513138|P2|Period 1|Lack of Efficacy|0
460228|NCT00318370|1513139|P1|Period 1|Lack of Efficacy|5
460229|NCT00317642|1513218|P2|Overall Study|AML Not Centrally Confirmed|5
460230|NCT00317642|1513219|P1|Overall Study|AML Not Centrally Confirmed|1
460231|NCT00317642|1513218|P2|Overall Study|Referred For Transplantation|0
460232|NCT00317642|1513219|P1|Overall Study|Referred For Transplantation|1
460233|NCT00317642|1513218|P2|Overall Study|Withdrawal by Subject|1
460234|NCT00317642|1513219|P1|Overall Study|Withdrawal by Subject|0
460235|NCT00317642|1513218|P2|Overall Study|Not Continue to Consolidation|0
460236|NCT00317642|1513219|P1|Overall Study|Not Continue to Consolidation|2
460237|NCT00317642|1513218|P2|Overall Study|Death|7
460238|NCT00317642|1513219|P1|Overall Study|Death|14
460239|NCT00317642|1513218|P2|Overall Study|Disease Recurrence|2
460240|NCT00317642|1513219|P1|Overall Study|Disease Recurrence|1
460241|NCT00317642|1513218|P2|Overall Study|Treatment Failure|102
460242|NCT00317642|1513219|P1|Overall Study|Treatment Failure|56
460243|NCT00317642|1513218|P2|Overall Study|Adverse Event|5
460244|NCT00317642|1513219|P1|Overall Study|Adverse Event|17
460245|NCT00317642|1513218|P2|Overall Study|Participant declined treatment|3
460246|NCT00317642|1513219|P1|Overall Study|Participant declined treatment|14
460247|NCT00317642|1513218|P2|Overall Study|Physician Decision|7
460248|NCT00317642|1513219|P1|Overall Study|Physician Decision|15
460249|NCT00317642|1513218|P2|Overall Study|Not Received Either Study Drug|3
460250|NCT00317642|1513219|P1|Overall Study|Not Received Either Study Drug|1
460251|NCT00317473|1513298|P6|Overall Study|Other|0
460252|NCT00317473|1513299|P5|Overall Study|Other|0
460253|NCT00317473|1513300|P4|Overall Study|Other|0
460254|NCT00317473|1513301|P3|Overall Study|Other|0
460255|NCT00317473|1513302|P2|Overall Study|Other|2
460256|NCT00317473|1513303|P1|Overall Study|Other|0
460257|NCT00317473|1513298|P6|Overall Study|Death|0
460258|NCT00317473|1513299|P5|Overall Study|Death|0
460259|NCT00317473|1513300|P4|Overall Study|Death|0
460260|NCT00317473|1513301|P3|Overall Study|Death|0
460261|NCT00317473|1513302|P2|Overall Study|Death|0
460262|NCT00317473|1513303|P1|Overall Study|Death|1
460263|NCT00317473|1513298|P6|Overall Study|Relocation|2
460264|NCT00317473|1513299|P5|Overall Study|Relocation|5
460265|NCT00317473|1513300|P4|Overall Study|Relocation|1
460266|NCT00317473|1513301|P3|Overall Study|Relocation|1
460267|NCT00317473|1513302|P2|Overall Study|Relocation|0
460268|NCT00317473|1513303|P1|Overall Study|Relocation|1
460269|NCT00317473|1513298|P6|Overall Study|Withdrawal by Subject|1
460270|NCT00317473|1513299|P5|Overall Study|Withdrawal by Subject|3
460271|NCT00317473|1513300|P4|Overall Study|Withdrawal by Subject|1
460272|NCT00317473|1513301|P3|Overall Study|Withdrawal by Subject|2
460273|NCT00317473|1513302|P2|Overall Study|Withdrawal by Subject|1
460274|NCT00317473|1513303|P1|Overall Study|Withdrawal by Subject|2
460275|NCT00317109|1513342|P2|Overall Study|Migated/moved from study area|0
460276|NCT00317109|1513343|P1|Overall Study|Migated/moved from study area|1
460277|NCT00317109|1513342|P2|Overall Study|Withdrawal by Subject|0
460278|NCT00317109|1513343|P1|Overall Study|Withdrawal by Subject|2
460279|NCT00317044|1513380|P3|Overall Study|Multiple Reasons|6
460280|NCT00317044|1513381|P2|Overall Study|Multiple Reasons|2
460281|NCT00317044|1513382|P1|Overall Study|Multiple Reasons|6
460282|NCT00317044|1513380|P3|Overall Study|Lost to Follow-up|3
460283|NCT00317044|1513381|P2|Overall Study|Lost to Follow-up|2
460284|NCT00317044|1513382|P1|Overall Study|Lost to Follow-up|0
460285|NCT00317044|1513380|P3|Overall Study|Withdrawal by Subject|12
460286|NCT00317044|1513381|P2|Overall Study|Withdrawal by Subject|7
460287|NCT00317044|1513382|P1|Overall Study|Withdrawal by Subject|10
460288|NCT00317044|1513380|P3|Overall Study|Adverse Event|4
460289|NCT00317044|1513381|P2|Overall Study|Adverse Event|7
460290|NCT00317044|1513382|P1|Overall Study|Adverse Event|4
460291|NCT00317044|1513380|P3|Overall Study|Protocol Violation|20
460292|NCT00317044|1513381|P2|Overall Study|Protocol Violation|22
460293|NCT00317044|1513382|P1|Overall Study|Protocol Violation|28
460294|NCT00316914|1513428|P2|Overall Study|Missing end of treatment documentation|15
460295|NCT00316914|1513429|P1|Overall Study|Missing end of treatment documentation|14
460296|NCT00316914|1513428|P2|Overall Study|Other Problems|11
460297|NCT00316914|1513429|P1|Overall Study|Other Problems|6
460298|NCT00316914|1513428|P2|Overall Study|Adverse Event|7
460299|NCT00316914|1513429|P1|Overall Study|Adverse Event|8
460300|NCT00316914|1513428|P2|Overall Study|Withdrawal by Subject|3
460301|NCT00316914|1513429|P1|Overall Study|Withdrawal by Subject|5
460302|NCT00316888|1513459|P2|Overall Study|Not start protocol therapy|1
460303|NCT00316888|1513460|P1|Overall Study|Not start protocol therapy|0
460304|NCT00316888|1513459|P2|Overall Study|Withdrawal by Subject|2
460305|NCT00316888|1513460|P1|Overall Study|Withdrawal by Subject|2
460306|NCT00316888|1513459|P2|Overall Study|Adverse Event|5
460307|NCT00316888|1513460|P1|Overall Study|Adverse Event|4
460308|NCT00316719|1513482|P2|Overall Study|Consent withdrawn|0
460309|NCT00316719|1513483|P1|Overall Study|Consent withdrawn|2
460310|NCT00316719|1513482|P2|Overall Study|Adverse Event|6
460311|NCT00316719|1513483|P1|Overall Study|Adverse Event|0
460312|NCT00316706|1513509|P2|Overall Study|Lost to Follow-up|48
460313|NCT00316706|1513510|P1|Overall Study|Lost to Follow-up|38
460314|NCT00316693|1513526|P2|Overall Study|Other|44
460315|NCT00316693|1513527|P1|Overall Study|Other|38
460316|NCT00316693|1513526|P2|Overall Study|Lost to Follow-up|34
460317|NCT00316693|1513527|P1|Overall Study|Lost to Follow-up|26
460318|NCT00316693|1513526|P2|Overall Study|Withdrawal by Subject|6
460319|NCT00316693|1513527|P1|Overall Study|Withdrawal by Subject|6
460320|NCT00316693|1513526|P2|Overall Study|Protocol Violation|0
460321|NCT00316693|1513527|P1|Overall Study|Protocol Violation|1
460322|NCT00316693|1513526|P2|Overall Study|Adverse Event|1
460323|NCT00316693|1513527|P1|Overall Study|Adverse Event|6
460324|NCT00316303|1513580|P2|Overall Study|Lost to Follow-up|16
460325|NCT00316303|1513581|P1|Overall Study|Lost to Follow-up|11
460326|NCT00316277|1513597|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
460327|NCT00316277|1513598|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
460328|NCT00316277|1513597|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
460329|NCT00316277|1513598|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
460330|NCT00316277|1513597|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
460331|NCT00316277|1513598|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
460332|NCT00316277|1513597|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
460333|NCT00316277|1513598|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
460334|NCT00316277|1513597|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
460335|NCT00316277|1513598|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
460336|NCT00316264|1513619|P3|Overall Study|not specified|0
460337|NCT00316264|1513620|P2|Overall Study|not specified|1
460338|NCT00316264|1513621|P1|Overall Study|not specified|1
460339|NCT00316264|1513619|P3|Overall Study|Death|0
460340|NCT00316264|1513620|P2|Overall Study|Death|0
460341|NCT00316264|1513621|P1|Overall Study|Death|2
460342|NCT00316264|1513619|P3|Overall Study|Withdrawal of Consent|6
460343|NCT00316264|1513620|P2|Overall Study|Withdrawal of Consent|5
460344|NCT00316264|1513621|P1|Overall Study|Withdrawal of Consent|3
460345|NCT00316264|1513619|P3|Overall Study|Lost to Follow-up|0
460346|NCT00316264|1513620|P2|Overall Study|Lost to Follow-up|1
460347|NCT00316264|1513621|P1|Overall Study|Lost to Follow-up|0
460348|NCT00316225|1513689|P1|Overall Study|Death|2
460349|NCT00316225|1513689|P1|Overall Study|Withdrawal by Subject|3
460350|NCT00316225|1513689|P1|Overall Study|Progressive Disease|15
460351|NCT00316225|1513689|P1|Overall Study|Physician Decision|3
460352|NCT00316225|1513689|P1|Overall Study|Adverse Event|2
460353|NCT00316199|1513698|P1|Overall Study|Lost to Follow-up|2
460354|NCT00316199|1513698|P1|Overall Study|Death|8
460355|NCT00316199|1513698|P1|Overall Study|Adverse Event|2
460356|NCT00316186|1513706|P1|Overall Study|Other|1
460357|NCT00316186|1513706|P1|Overall Study|Lost to Follow-up|1
460358|NCT00316186|1513706|P1|Overall Study|Disease Progression|4
460359|NCT00316186|1513706|P1|Overall Study|Adverse Event|6
460360|NCT00316173|1513720|P2|Treatment Phase|Study Follow-up Stopped|34
460361|NCT00316173|1513721|P1|Treatment Phase|Study Follow-up Stopped|0
460362|NCT00316173|1513720|P2|Treatment Phase|Withdrawal by Subject|1
460363|NCT00316173|1513721|P1|Treatment Phase|Withdrawal by Subject|0
460364|NCT00316173|1513720|P2|Treatment Phase|Lost to Follow-up|3
460365|NCT00316173|1513721|P1|Treatment Phase|Lost to Follow-up|0
460366|NCT00316173|1513720|P2|Treatment Phase|Lack of Efficacy|3
460367|NCT00316173|1513721|P1|Treatment Phase|Lack of Efficacy|0
460368|NCT00316173|1513720|P2|Treatment Phase|Adverse Event|1
460369|NCT00316173|1513721|P1|Treatment Phase|Adverse Event|0
460370|NCT00316173|1513720|P2|Run-in Phase|Study Follow-up Stopped|0
460371|NCT00316173|1513721|P1|Run-in Phase|Study Follow-up Stopped|5
460372|NCT00316173|1513720|P2|Run-in Phase|Protocol Violation|0
460373|NCT00316173|1513721|P1|Run-in Phase|Protocol Violation|1
460374|NCT00316173|1513720|P2|Run-in Phase|Adverse Event|0
460375|NCT00316173|1513721|P1|Run-in Phase|Adverse Event|1
460376|NCT00316121|1513734|P2|Overall Study|Subject did not have 24 month visit|0
460377|NCT00316121|1513735|P1|Overall Study|Subject did not have 24 month visit|1
460378|NCT00316121|1513734|P2|Overall Study|Subject no show for visit x 3|0
460379|NCT00316121|1513735|P1|Overall Study|Subject no show for visit x 3|1
460380|NCT00316121|1513734|P2|Overall Study|Subject refused to return|0
460381|NCT00316121|1513735|P1|Overall Study|Subject refused to return|1
460382|NCT00316121|1513734|P2|Overall Study|Subject relocated|1
460383|NCT00316121|1513735|P1|Overall Study|Subject relocated|1
460384|NCT00316121|1513734|P2|Overall Study|Reason is missing|0
460385|NCT00316121|1513735|P1|Overall Study|Reason is missing|1
460386|NCT00316121|1513734|P2|Overall Study|Withdrawal by Subject|0
460387|NCT00316121|1513735|P1|Overall Study|Withdrawal by Subject|2
460388|NCT00316121|1513734|P2|Overall Study|Lost to Follow-up|8
460389|NCT00316121|1513735|P1|Overall Study|Lost to Follow-up|14
460390|NCT00316121|1513734|P2|Overall Study|Death|0
460391|NCT00316121|1513735|P1|Overall Study|Death|1
460392|NCT00316082|1513746|P5|Overall Study|Administrative reason by sponsor|0
460393|NCT00316082|1513747|P4|Overall Study|Administrative reason by sponsor|0
460394|NCT00316082|1513748|P3|Overall Study|Administrative reason by sponsor|1
460395|NCT00316082|1513749|P2|Overall Study|Administrative reason by sponsor|0
460396|NCT00316082|1513750|P1|Overall Study|Administrative reason by sponsor|0
460397|NCT00316082|1513746|P5|Overall Study|Death|0
460398|NCT00316082|1513747|P4|Overall Study|Death|0
460399|NCT00316082|1513748|P3|Overall Study|Death|1
460400|NCT00316082|1513749|P2|Overall Study|Death|0
460401|NCT00316082|1513750|P1|Overall Study|Death|0
460402|NCT00316082|1513746|P5|Overall Study|Physician Decision|1
460403|NCT00316082|1513747|P4|Overall Study|Physician Decision|1
460404|NCT00316082|1513748|P3|Overall Study|Physician Decision|2
460405|NCT00316082|1513749|P2|Overall Study|Physician Decision|1
460406|NCT00316082|1513750|P1|Overall Study|Physician Decision|1
460407|NCT00316082|1513746|P5|Overall Study|Subject no longer meets study criteria|1
460408|NCT00316082|1513747|P4|Overall Study|Subject no longer meets study criteria|2
460409|NCT00316082|1513748|P3|Overall Study|Subject no longer meets study criteria|2
460410|NCT00316082|1513749|P2|Overall Study|Subject no longer meets study criteria|1
460411|NCT00316082|1513750|P1|Overall Study|Subject no longer meets study criteria|3
460412|NCT00316082|1513746|P5|Overall Study|Adverse Event|3
460413|NCT00316082|1513747|P4|Overall Study|Adverse Event|1
460414|NCT00316082|1513748|P3|Overall Study|Adverse Event|5
460415|NCT00316082|1513749|P2|Overall Study|Adverse Event|2
460416|NCT00316082|1513750|P1|Overall Study|Adverse Event|4
460417|NCT00316082|1513746|P5|Overall Study|Poor/noncompliance|4
460418|NCT00316082|1513747|P4|Overall Study|Poor/noncompliance|1
460419|NCT00316082|1513748|P3|Overall Study|Poor/noncompliance|4
460420|NCT00316082|1513749|P2|Overall Study|Poor/noncompliance|1
460421|NCT00316082|1513750|P1|Overall Study|Poor/noncompliance|6
460422|NCT00316082|1513746|P5|Overall Study|Lost to Follow-up|6
460423|NCT00316082|1513747|P4|Overall Study|Lost to Follow-up|8
460424|NCT00316082|1513748|P3|Overall Study|Lost to Follow-up|7
460425|NCT00316082|1513749|P2|Overall Study|Lost to Follow-up|6
460426|NCT00316082|1513750|P1|Overall Study|Lost to Follow-up|7
460427|NCT00316082|1513746|P5|Overall Study|Withdrawal of Consent by Subject|5
460428|NCT00316082|1513747|P4|Overall Study|Withdrawal of Consent by Subject|9
460429|NCT00316082|1513748|P3|Overall Study|Withdrawal of Consent by Subject|2
460430|NCT00316082|1513749|P2|Overall Study|Withdrawal of Consent by Subject|8
460431|NCT00316082|1513750|P1|Overall Study|Withdrawal of Consent by Subject|10
460432|NCT00316082|1513746|P5|Overall Study|Lack of Efficacy|6
460433|NCT00316082|1513747|P4|Overall Study|Lack of Efficacy|4
460434|NCT00316082|1513748|P3|Overall Study|Lack of Efficacy|3
460435|NCT00316082|1513749|P2|Overall Study|Lack of Efficacy|3
460436|NCT00316082|1513750|P1|Overall Study|Lack of Efficacy|2
460437|NCT00316017|1513781|P3|Overall Study|Protocol Violation|19
460438|NCT00316017|1513782|P2|Overall Study|Protocol Violation|13
460439|NCT00316017|1513783|P1|Overall Study|Protocol Violation|11
460440|NCT00316004|1513857|P3|Overall Study|Subject was not given study fluid.|21
460441|NCT00316004|1513858|P2|Overall Study|Subject was not given study fluid.|14
460442|NCT00316004|1513859|P1|Overall Study|Subject was not given study fluid.|14
460443|NCT00315731|1513930|P1|Overall Study|Death|5
460444|NCT00315731|1513930|P1|Overall Study|Lost to Follow-up|1
460445|NCT00315705|1513958|P1|Phase 2|Death|7
460446|NCT00315705|1513958|P1|Phase 2|Other|1
460447|NCT00315705|1513958|P1|Phase 2|Scheduled for transplant|8
460448|NCT00315705|1513958|P1|Phase 2|Disease relapse|1
460449|NCT00315705|1513958|P1|Phase 2|Failure to achieve response|3
460450|NCT00315705|1513958|P1|Phase 2|Adverse Event|1
460451|NCT00315705|1513958|P1|Phase 2|Physician Decision|4
460452|NCT00315705|1513958|P1|Phase 1|Death|3
460453|NCT00315705|1513958|P1|Phase 1|Scheduled for transplant|9
460454|NCT00315705|1513958|P1|Phase 1|Disease relapse|4
460455|NCT00315705|1513958|P1|Phase 1|Failure to achieve response|8
460456|NCT00315705|1513958|P1|Phase 1|Refused further treatment|1
460457|NCT00315458|1514019|P4|Overall Study|Did not qualify|0
460458|NCT00315458|1514020|P3|Overall Study|Did not qualify|1
460459|NCT00315458|1514021|P2|Overall Study|Did not qualify|0
460460|NCT00315458|1514022|P1|Overall Study|Did not qualify|0
460461|NCT00315458|1514019|P4|Overall Study|Lack of Efficacy|1
460462|NCT00315458|1514020|P3|Overall Study|Lack of Efficacy|20
460463|NCT00315458|1514021|P2|Overall Study|Lack of Efficacy|0
460464|NCT00315458|1514022|P1|Overall Study|Lack of Efficacy|0
460465|NCT00315458|1514019|P4|Overall Study|Withdrawal by Subject|2
460466|NCT00315458|1514020|P3|Overall Study|Withdrawal by Subject|0
460467|NCT00315458|1514021|P2|Overall Study|Withdrawal by Subject|3
460468|NCT00315458|1514022|P1|Overall Study|Withdrawal by Subject|0
460469|NCT00315458|1514019|P4|Overall Study|Lost to Follow-up|2
460470|NCT00315458|1514020|P3|Overall Study|Lost to Follow-up|0
460471|NCT00315458|1514021|P2|Overall Study|Lost to Follow-up|2
460472|NCT00315458|1514022|P1|Overall Study|Lost to Follow-up|1
460473|NCT00315458|1514019|P4|Overall Study|Adverse Event|3
460474|NCT00315458|1514020|P3|Overall Study|Adverse Event|23
460475|NCT00315458|1514021|P2|Overall Study|Adverse Event|4
460476|NCT00315458|1514022|P1|Overall Study|Adverse Event|2
460477|NCT00315458|1514019|P4|Overall Study|Administrative|21
460478|NCT00315458|1514020|P3|Overall Study|Administrative|8
460479|NCT00315458|1514021|P2|Overall Study|Administrative|3
460480|NCT00315458|1514022|P1|Overall Study|Administrative|0
460481|NCT00315445|1514035|P3|Overall Study|Other|0
460482|NCT00315445|1514036|P2|Overall Study|Other|3
460483|NCT00315445|1514037|P1|Overall Study|Other|1
460484|NCT00315445|1514035|P3|Overall Study|Protocol Violation|1
460485|NCT00315445|1514036|P2|Overall Study|Protocol Violation|0
460486|NCT00315445|1514037|P1|Overall Study|Protocol Violation|2
460487|NCT00315445|1514035|P3|Overall Study|Lost to Follow-up|1
460488|NCT00315445|1514036|P2|Overall Study|Lost to Follow-up|0
460489|NCT00315445|1514037|P1|Overall Study|Lost to Follow-up|1
460490|NCT00315445|1514035|P3|Overall Study|Lack of Efficacy|7
460491|NCT00315445|1514036|P2|Overall Study|Lack of Efficacy|1
460492|NCT00315445|1514037|P1|Overall Study|Lack of Efficacy|16
460493|NCT00315445|1514035|P3|Overall Study|Adverse Event|15
460494|NCT00315445|1514036|P2|Overall Study|Adverse Event|12
460495|NCT00315445|1514037|P1|Overall Study|Adverse Event|7
460496|NCT00315055|1514327|P2|Overall Study|Lost to Follow-up|1
460497|NCT00315055|1514328|P1|Overall Study|Lost to Follow-up|1
460498|NCT00315055|1514327|P2|Overall Study|Protocol Violation|4
460499|NCT00315055|1514328|P1|Overall Study|Protocol Violation|2
460500|NCT00314951|1514346|P2|Follow-up|mITT failure|34
460501|NCT00314951|1514347|P1|Follow-up|mITT failure|44
460502|NCT00314951|1514346|P2|Treatment|Didn't meet criteria for mITT population|11
460503|NCT00314951|1514347|P1|Treatment|Didn't meet criteria for mITT population|16
460504|NCT00314808|1514357|P1|Overall Study|Withdrawal by Subject/PI without AE|4
460505|NCT00314808|1514357|P1|Overall Study|Disease Progression without AE|4
460506|NCT00314574|1514367|P2|Overall Study|Data unknown at database lock|1
460507|NCT00314574|1514368|P1|Overall Study|Data unknown at database lock|0
460508|NCT00314574|1514367|P2|Overall Study|Pregnancy|4
460509|NCT00314574|1514368|P1|Overall Study|Pregnancy|6
460510|NCT00314574|1514367|P2|Overall Study|Physician Decision|15
460511|NCT00314574|1514368|P1|Overall Study|Physician Decision|22
460512|NCT00314574|1514367|P2|Overall Study|Withdrawal by Subject|22
460513|NCT00314574|1514368|P1|Overall Study|Withdrawal by Subject|33
460514|NCT00314574|1514367|P2|Overall Study|Lost to Follow-up|25
460515|NCT00314574|1514368|P1|Overall Study|Lost to Follow-up|19
460516|NCT00314574|1514367|P2|Overall Study|Adverse Event|16
460517|NCT00314574|1514368|P1|Overall Study|Adverse Event|11
460518|NCT00314574|1514367|P2|Overall Study|Death|0
460519|NCT00314574|1514368|P1|Overall Study|Death|3
460520|NCT00314366|1514384|P2|Overall Study|not treated due to patient medical condi|0
460521|NCT00314366|1514385|P1|Overall Study|not treated due to patient medical condi|1
460522|NCT00314340|1514430|P1|Overall Study|lost interest|1
460523|NCT00314327|1514436|P1|Overall Study|Withdrawal by Subject|1
460524|NCT00314262|1514441|P1|Overall Study|Physician Decision|1
460525|NCT00314262|1514441|P1|Overall Study|Withdrawal by Subject|2
460526|NCT00314262|1514441|P1|Overall Study|Adverse Event|2
460527|NCT00314249|1514449|P2|Overall Study|Non-Compliant|6
460528|NCT00314249|1514450|P1|Overall Study|Non-Compliant|5
460529|NCT00314249|1514449|P2|Overall Study|Withdrawn for other reasons|1
460530|NCT00314249|1514450|P1|Overall Study|Withdrawn for other reasons|4
460531|NCT00314249|1514449|P2|Overall Study|Physician Decision|1
460532|NCT00314249|1514450|P1|Overall Study|Physician Decision|1
460533|NCT00314249|1514449|P2|Overall Study|Lost to Follow-up|9
460534|NCT00314249|1514450|P1|Overall Study|Lost to Follow-up|15
460535|NCT00314249|1514449|P2|Overall Study|Withdrawal by Subject|28
460536|NCT00314249|1514450|P1|Overall Study|Withdrawal by Subject|21
460537|NCT00314249|1514449|P2|Overall Study|Lack of Efficacy|24
460538|NCT00314249|1514450|P1|Overall Study|Lack of Efficacy|33
460539|NCT00314249|1514449|P2|Overall Study|Adverse Event|94
460540|NCT00314249|1514450|P1|Overall Study|Adverse Event|73
460541|NCT00314145|1514483|P2|Overall Study|Sponsor Decision|0
460542|NCT00314145|1514484|P1|Overall Study|Sponsor Decision|2
460543|NCT00314145|1514483|P2|Overall Study|Protocol Violation|0
460544|NCT00314145|1514484|P1|Overall Study|Protocol Violation|3
460545|NCT00314145|1514483|P2|Overall Study|Adverse Event|3
460546|NCT00314145|1514484|P1|Overall Study|Adverse Event|0
460547|NCT00314145|1514483|P2|Overall Study|Physician Decision|4
460548|NCT00314145|1514484|P1|Overall Study|Physician Decision|3
460549|NCT00314145|1514483|P2|Overall Study|Lost to Follow-up|12
460550|NCT00314145|1514484|P1|Overall Study|Lost to Follow-up|5
460551|NCT00314145|1514483|P2|Overall Study|Withdrawal by Subject|10
460552|NCT00314145|1514484|P1|Overall Study|Withdrawal by Subject|8
460553|NCT00314132|1514498|P2|Overall Study|Physician Decision|0
460554|NCT00314132|1514499|P1|Overall Study|Physician Decision|1
460555|NCT00314132|1514498|P2|Overall Study|Adverse Event|0
460556|NCT00314132|1514499|P1|Overall Study|Adverse Event|1
460557|NCT00314132|1514498|P2|Overall Study|Withdrawal by Subject|5
460558|NCT00314132|1514499|P1|Overall Study|Withdrawal by Subject|3
460559|NCT00314132|1514498|P2|Overall Study|Lost to Follow-up|13
460560|NCT00314132|1514499|P1|Overall Study|Lost to Follow-up|3
460561|NCT00313911|1514520|P2|Overall Study|Did not meet age criteria|1
460562|NCT00313911|1514521|P1|Overall Study|Did not meet age criteria|1
460563|NCT00313911|1514520|P2|Overall Study|Withdrawal by Subject|12
460564|NCT00313911|1514521|P1|Overall Study|Withdrawal by Subject|39
460565|NCT00313911|1514520|P2|Overall Study|Lost to Follow-up|14
460566|NCT00313911|1514521|P1|Overall Study|Lost to Follow-up|27
460567|NCT00313911|1514520|P2|Overall Study|Protocol Violation|10
460568|NCT00313911|1514521|P1|Overall Study|Protocol Violation|19
460569|NCT00313911|1514520|P2|Overall Study|Adverse Event|3
460570|NCT00313911|1514521|P1|Overall Study|Adverse Event|2
460571|NCT00313911|1514520|P2|Overall Study|Serious adverse event|1
460572|NCT00313911|1514521|P1|Overall Study|Serious adverse event|6
460573|NCT00313846|1514535|P2|Overall Study|Administrative|3
460574|NCT00313846|1514536|P1|Overall Study|Administrative|2
460575|NCT00313846|1514535|P2|Overall Study|Adverse Event|8
460576|NCT00313846|1514536|P1|Overall Study|Adverse Event|1
460577|NCT00313846|1514535|P2|Overall Study|Withdrawal by Subject|0
460578|NCT00313846|1514536|P1|Overall Study|Withdrawal by Subject|2
460579|NCT00313820|1514547|P2|Pregabalin or Placebo Treatment Period|Other|3
460580|NCT00313820|1514548|P1|Pregabalin or Placebo Treatment Period|Other|2
460581|NCT00313820|1514547|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
460582|NCT00313820|1514548|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
460583|NCT00313820|1514547|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
460584|NCT00313820|1514548|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
460585|NCT00313820|1514547|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
460586|NCT00313820|1514548|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
460587|NCT00313820|1514547|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
460588|NCT00313820|1514548|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
460589|NCT00313820|1514547|P2|Assigned to Treatment|Other|0
460590|NCT00313820|1514548|P1|Assigned to Treatment|Other|1
460591|NCT00313781|1514586|P3|After Crossover|Other|18
460592|NCT00313781|1514587|P2|After Crossover|Other|0
460593|NCT00313781|1514588|P1|After Crossover|Other|0
460594|NCT00313781|1514586|P3|After Crossover|Withdrawal by Subject|3
460595|NCT00313781|1514587|P2|After Crossover|Withdrawal by Subject|0
460596|NCT00313781|1514588|P1|After Crossover|Withdrawal by Subject|0
460597|NCT00313781|1514586|P3|After Crossover|Death|6
460598|NCT00313781|1514587|P2|After Crossover|Death|0
460599|NCT00313781|1514588|P1|After Crossover|Death|0
460600|NCT00313781|1514586|P3|Before Crossover|Randomized, not treated|0
460601|NCT00313781|1514587|P2|Before Crossover|Randomized, not treated|0
460602|NCT00313781|1514588|P1|Before Crossover|Randomized, not treated|5
460603|NCT00313781|1514586|P3|Before Crossover|Crossover|0
460604|NCT00313781|1514587|P2|Before Crossover|Crossover|37
460605|NCT00313781|1514588|P1|Before Crossover|Crossover|0
460606|NCT00313781|1514586|P3|Before Crossover|Other|0
460607|NCT00313781|1514587|P2|Before Crossover|Other|30
460608|NCT00313781|1514588|P1|Before Crossover|Other|45
460609|NCT00313781|1514586|P3|Before Crossover|Withdrawal by Subject|0
460610|NCT00313781|1514587|P2|Before Crossover|Withdrawal by Subject|1
460611|NCT00313781|1514588|P1|Before Crossover|Withdrawal by Subject|3
460612|NCT00313781|1514586|P3|Before Crossover|Lost to Follow-up|0
460613|NCT00313781|1514587|P2|Before Crossover|Lost to Follow-up|3
460614|NCT00313781|1514588|P1|Before Crossover|Lost to Follow-up|0
460615|NCT00313781|1514586|P3|Before Crossover|Death|0
460616|NCT00313781|1514587|P2|Before Crossover|Death|8
460617|NCT00313781|1514588|P1|Before Crossover|Death|22
460618|NCT00313716|1514628|P6|Overall Study|Withdrawal by Subject|0
460619|NCT00313716|1514629|P5|Overall Study|Withdrawal by Subject|1
460620|NCT00313716|1514630|P4|Overall Study|Withdrawal by Subject|0
460621|NCT00313716|1514631|P3|Overall Study|Withdrawal by Subject|1
460622|NCT00313716|1514632|P2|Overall Study|Withdrawal by Subject|1
460623|NCT00313716|1514633|P1|Overall Study|Withdrawal by Subject|0
460624|NCT00313716|1514628|P6|Overall Study|Lost to Follow-up|4
460625|NCT00313716|1514629|P5|Overall Study|Lost to Follow-up|0
460626|NCT00313716|1514630|P4|Overall Study|Lost to Follow-up|1
460627|NCT00313716|1514631|P3|Overall Study|Lost to Follow-up|2
460628|NCT00313716|1514632|P2|Overall Study|Lost to Follow-up|5
460629|NCT00313716|1514633|P1|Overall Study|Lost to Follow-up|2
460630|NCT00313716|1514628|P6|Overall Study|Death|9
460631|NCT00313716|1514629|P5|Overall Study|Death|5
460632|NCT00313716|1514630|P4|Overall Study|Death|3
460633|NCT00313716|1514631|P3|Overall Study|Death|9
460634|NCT00313716|1514632|P2|Overall Study|Death|2
460635|NCT00313716|1514633|P1|Overall Study|Death|3
460636|NCT00313703|1514660|P4|Overall Study|Lost to Follow-up|12
460637|NCT00313703|1514661|P3|Overall Study|Lost to Follow-up|5
460638|NCT00313703|1514662|P2|Overall Study|Lost to Follow-up|2
460639|NCT00313703|1514663|P1|Overall Study|Lost to Follow-up|11
460640|NCT00313612|1514679|P2|Overall Study|Patient never received treatment|1
460641|NCT00313612|1514680|P1|Overall Study|Patient never received treatment|0
460642|NCT00313586|1514692|P4|Overall Study|Death before starting treatment|0
460643|NCT00313586|1514693|P3|Overall Study|Death before starting treatment|0
460644|NCT00313586|1514694|P2|Overall Study|Death before starting treatment|0
460645|NCT00313586|1514695|P1|Overall Study|Death before starting treatment|1
460646|NCT00313586|1514692|P4|Overall Study|Moved|0
460647|NCT00313586|1514693|P3|Overall Study|Moved|0
460648|NCT00313586|1514694|P2|Overall Study|Moved|1
460649|NCT00313586|1514695|P1|Overall Study|Moved|0
460650|NCT00313586|1514692|P4|Overall Study|Lost insurance|0
460651|NCT00313586|1514693|P3|Overall Study|Lost insurance|0
460652|NCT00313586|1514694|P2|Overall Study|Lost insurance|1
460653|NCT00313586|1514695|P1|Overall Study|Lost insurance|0
460654|NCT00313586|1514692|P4|Overall Study|Absolute neutrophil count not recovered|0
460655|NCT00313586|1514693|P3|Overall Study|Absolute neutrophil count not recovered|0
460656|NCT00313586|1514694|P2|Overall Study|Absolute neutrophil count not recovered|1
460657|NCT00313586|1514695|P1|Overall Study|Absolute neutrophil count not recovered|2
460658|NCT00313586|1514692|P4|Overall Study|Physician Decision|0
460659|NCT00313586|1514693|P3|Overall Study|Physician Decision|0
460660|NCT00313586|1514694|P2|Overall Study|Physician Decision|1
460661|NCT00313586|1514695|P1|Overall Study|Physician Decision|2
460662|NCT00313586|1514692|P4|Overall Study|Did not achieve HI-major/better response|1
460663|NCT00313586|1514693|P3|Overall Study|Did not achieve HI-major/better response|2
460664|NCT00313586|1514694|P2|Overall Study|Did not achieve HI-major/better response|7
460665|NCT00313586|1514695|P1|Overall Study|Did not achieve HI-major/better response|10
460666|NCT00313586|1514692|P4|Overall Study|Other complicating disease|0
460667|NCT00313586|1514693|P3|Overall Study|Other complicating disease|0
460668|NCT00313586|1514694|P2|Overall Study|Other complicating disease|2
460669|NCT00313586|1514695|P1|Overall Study|Other complicating disease|2
460670|NCT00313586|1514692|P4|Overall Study|Alternative therapy|0
460671|NCT00313586|1514693|P3|Overall Study|Alternative therapy|2
460672|NCT00313586|1514694|P2|Overall Study|Alternative therapy|6
460673|NCT00313586|1514695|P1|Overall Study|Alternative therapy|3
460674|NCT00313586|1514692|P4|Overall Study|Withdrawal by Subject|2
460675|NCT00313586|1514693|P3|Overall Study|Withdrawal by Subject|6
460676|NCT00313586|1514694|P2|Overall Study|Withdrawal by Subject|6
460677|NCT00313586|1514695|P1|Overall Study|Withdrawal by Subject|13
460678|NCT00313586|1514692|P4|Overall Study|Death|7
460679|NCT00313586|1514693|P3|Overall Study|Death|1
460680|NCT00313586|1514694|P2|Overall Study|Death|8
460681|NCT00313586|1514695|P1|Overall Study|Death|11
460682|NCT00313586|1514692|P4|Overall Study|Adverse Event|10
460683|NCT00313586|1514693|P3|Overall Study|Adverse Event|3
460684|NCT00313586|1514694|P2|Overall Study|Adverse Event|18
460685|NCT00313586|1514695|P1|Overall Study|Adverse Event|12
460686|NCT00313586|1514692|P4|Overall Study|Disease progression|3
460687|NCT00313586|1514693|P3|Overall Study|Disease progression|10
460688|NCT00313586|1514694|P2|Overall Study|Disease progression|19
460689|NCT00313586|1514695|P1|Overall Study|Disease progression|14
460690|NCT00313313|1514714|P3|Overall Study|Subject No Longer Meets Study Criteria|2
460691|NCT00313313|1514715|P2|Overall Study|Subject No Longer Meets Study Criteria|3
460692|NCT00313313|1514716|P1|Overall Study|Subject No Longer Meets Study Criteria|0
460693|NCT00313313|1514714|P3|Overall Study|Death|2
460694|NCT00313313|1514715|P2|Overall Study|Death|0
460695|NCT00313313|1514716|P1|Overall Study|Death|0
460696|NCT00313313|1514714|P3|Overall Study|Pregnancy|0
460697|NCT00313313|1514715|P2|Overall Study|Pregnancy|2
460698|NCT00313313|1514716|P1|Overall Study|Pregnancy|1
460699|NCT00313313|1514714|P3|Overall Study|Poor/Noncompliance|2
460700|NCT00313313|1514715|P2|Overall Study|Poor/Noncompliance|6
460701|NCT00313313|1514716|P1|Overall Study|Poor/Noncompliance|3
460702|NCT00313313|1514714|P3|Overall Study|Physician Decision|4
460703|NCT00313313|1514715|P2|Overall Study|Physician Decision|6
460704|NCT00313313|1514716|P1|Overall Study|Physician Decision|2
460705|NCT00313313|1514714|P3|Overall Study|Adverse Event|12
460706|NCT00313313|1514715|P2|Overall Study|Adverse Event|16
460707|NCT00313313|1514716|P1|Overall Study|Adverse Event|15
460708|NCT00313313|1514714|P3|Overall Study|Lost to Follow-up|9
460709|NCT00313313|1514715|P2|Overall Study|Lost to Follow-up|7
460710|NCT00313313|1514716|P1|Overall Study|Lost to Follow-up|10
460711|NCT00313313|1514714|P3|Overall Study|Withdrawal of consent by subject|31
460712|NCT00313313|1514715|P2|Overall Study|Withdrawal of consent by subject|17
460713|NCT00313313|1514716|P1|Overall Study|Withdrawal of consent by subject|18
460714|NCT00313313|1514714|P3|Overall Study|Lack of Efficacy|20
460715|NCT00313313|1514715|P2|Overall Study|Lack of Efficacy|9
460716|NCT00313313|1514716|P1|Overall Study|Lack of Efficacy|14
460717|NCT00313300|1514738|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
460718|NCT00313300|1514739|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
460719|NCT00313300|1514740|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
460720|NCT00313300|1514741|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
460721|NCT00313300|1514742|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
460722|NCT00313300|1514738|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
460723|NCT00313300|1514739|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
460724|NCT00313300|1514740|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
460725|NCT00313300|1514741|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
460726|NCT00313300|1514742|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
460727|NCT00313300|1514738|P5|Follow-Up(30days)-Randomized Phase B|Death|0
460728|NCT00313300|1514739|P4|Follow-Up(30days)-Randomized Phase B|Death|0
460729|NCT00313300|1514740|P3|Follow-Up(30days)-Randomized Phase B|Death|0
460730|NCT00313300|1514741|P2|Follow-Up(30days)-Randomized Phase B|Death|0
460731|NCT00313300|1514742|P1|Follow-Up(30days)-Randomized Phase B|Death|1
460732|NCT00313300|1514738|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
460733|NCT00313300|1514739|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
460734|NCT00313300|1514740|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
460735|NCT00313300|1514741|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
460736|NCT00313300|1514742|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
460737|NCT00313300|1514738|P5|Follow-Up(30days)-Randomized Phase A|Death|0
460738|NCT00313300|1514739|P4|Follow-Up(30days)-Randomized Phase A|Death|0
460739|NCT00313300|1514740|P3|Follow-Up(30days)-Randomized Phase A|Death|0
460740|NCT00313300|1514741|P2|Follow-Up(30days)-Randomized Phase A|Death|1
460741|NCT00313300|1514742|P1|Follow-Up(30days)-Randomized Phase A|Death|0
460742|NCT00313300|1514738|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
460743|NCT00313300|1514739|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
460744|NCT00313300|1514740|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
460745|NCT00313300|1514741|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
460746|NCT00313300|1514742|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
460747|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|non-specified|0
460748|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|non-specified|0
460749|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|non-specified|0
460750|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|non-specified|0
460751|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|non-specified|1
460752|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
460753|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
460754|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
460755|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
460756|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
460757|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
460758|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
460759|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
460760|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
460761|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
460762|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
460763|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
460764|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
460765|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
460766|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
460767|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
460768|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
460769|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
460770|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
460771|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
460772|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|Death|1
460773|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|Death|0
460774|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|Death|1
460775|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|Death|3
460776|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|Death|5
460777|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
460778|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
460779|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
460780|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
460781|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
460782|NCT00313300|1514738|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
460783|NCT00313300|1514739|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
460784|NCT00313300|1514740|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
460785|NCT00313300|1514741|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
460786|NCT00313300|1514742|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
460787|NCT00313300|1514738|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
460788|NCT00313300|1514739|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
460789|NCT00313300|1514740|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
460790|NCT00313300|1514741|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
460791|NCT00313300|1514742|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
460792|NCT00313300|1514738|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
460793|NCT00313300|1514739|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
460794|NCT00313300|1514740|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
460795|NCT00313300|1514741|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
460796|NCT00313300|1514742|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
460797|NCT00313300|1514738|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
460798|NCT00313300|1514739|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
460799|NCT00313300|1514740|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
460800|NCT00313300|1514741|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
460801|NCT00313300|1514742|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
460802|NCT00313300|1514738|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
460803|NCT00313300|1514739|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
460804|NCT00313300|1514740|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
460805|NCT00313300|1514741|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
460806|NCT00313300|1514742|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
460807|NCT00313300|1514738|P5|Randomized in Phase A (26 Weeks)|Death|0
460808|NCT00313300|1514739|P4|Randomized in Phase A (26 Weeks)|Death|0
460809|NCT00313300|1514740|P3|Randomized in Phase A (26 Weeks)|Death|0
460810|NCT00313300|1514741|P2|Randomized in Phase A (26 Weeks)|Death|4
460811|NCT00313300|1514742|P1|Randomized in Phase A (26 Weeks)|Death|3
460812|NCT00313300|1514738|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
460813|NCT00313300|1514739|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
460814|NCT00313300|1514740|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
460815|NCT00313300|1514741|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
460816|NCT00313300|1514742|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
460817|NCT00313300|1514738|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
460818|NCT00313300|1514739|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
460819|NCT00313300|1514740|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
460820|NCT00313300|1514741|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
460821|NCT00313300|1514742|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
460822|NCT00313170|1514812|P3|Overall Study|brain mets. after randomisation|1
460823|NCT00313170|1514813|P2|Overall Study|brain mets. after randomisation|0
460824|NCT00313170|1514814|P1|Overall Study|brain mets. after randomisation|0
460825|NCT00313170|1514812|P3|Overall Study|dosing error|1
460826|NCT00313170|1514813|P2|Overall Study|dosing error|0
460827|NCT00313170|1514814|P1|Overall Study|dosing error|0
460828|NCT00313170|1514812|P3|Overall Study|Clinical progression|0
460829|NCT00313170|1514813|P2|Overall Study|Clinical progression|0
460830|NCT00313170|1514814|P1|Overall Study|Clinical progression|1
460831|NCT00313170|1514812|P3|Overall Study|Lost to Follow-up|1
460832|NCT00313170|1514813|P2|Overall Study|Lost to Follow-up|0
460833|NCT00313170|1514814|P1|Overall Study|Lost to Follow-up|0
460834|NCT00313170|1514812|P3|Overall Study|Incorrect enrollment|1
460835|NCT00313170|1514813|P2|Overall Study|Incorrect enrollment|1
460836|NCT00313170|1514814|P1|Overall Study|Incorrect enrollment|0
460837|NCT00313170|1514812|P3|Overall Study|Withdrawal by Subject|1
460838|NCT00313170|1514813|P2|Overall Study|Withdrawal by Subject|1
460839|NCT00313170|1514814|P1|Overall Study|Withdrawal by Subject|1
460840|NCT00313170|1514812|P3|Overall Study|Disease progression|27
460841|NCT00313170|1514813|P2|Overall Study|Disease progression|26
460842|NCT00313170|1514814|P1|Overall Study|Disease progression|31
460843|NCT00313170|1514812|P3|Overall Study|Adverse Event|0
460844|NCT00313170|1514813|P2|Overall Study|Adverse Event|2
460845|NCT00313170|1514814|P1|Overall Study|Adverse Event|2
460846|NCT00313170|1514812|P3|Overall Study|Death|0
460847|NCT00313170|1514813|P2|Overall Study|Death|4
460848|NCT00313170|1514814|P1|Overall Study|Death|1
460849|NCT00313144|1514830|P1|Overall Study|Due to termination of the study|66
460850|NCT00313144|1514830|P1|Overall Study|Change to different product|1
460851|NCT00313144|1514830|P1|Overall Study|Insurance (homecare provider) change|1
460852|NCT00313144|1514830|P1|Overall Study|Liver transplant|1
460853|NCT00313144|1514830|P1|Overall Study|Adverse event - transient|5
460854|NCT00313144|1514830|P1|Overall Study|Physician Decision|4
460855|NCT00313144|1514830|P1|Overall Study|Terminated by sponsor/ homecare provider|4
460856|NCT00313144|1514830|P1|Overall Study|Withdrawal by Subject|4
460857|NCT00313144|1514830|P1|Overall Study|Lost to Follow-up|5
460858|NCT00313144|1514830|P1|Overall Study|Death|7
460859|NCT00313144|1514830|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
460860|NCT00313014|1514917|P3|Overall Study|Lack of Efficacy|16
460861|NCT00313014|1514918|P2|Overall Study|Lack of Efficacy|25
460862|NCT00313014|1514919|P1|Overall Study|Lack of Efficacy|52
460863|NCT00313014|1514917|P3|Overall Study|Administrative|14
460864|NCT00313014|1514918|P2|Overall Study|Administrative|6
460865|NCT00313014|1514919|P1|Overall Study|Administrative|9
460866|NCT00313014|1514917|P3|Overall Study|Lost to Follow-up|10
460867|NCT00313014|1514918|P2|Overall Study|Lost to Follow-up|6
460868|NCT00313014|1514919|P1|Overall Study|Lost to Follow-up|7
460869|NCT00313014|1514917|P3|Overall Study|Adverse Event|16
460870|NCT00313014|1514918|P2|Overall Study|Adverse Event|29
460871|NCT00313014|1514919|P1|Overall Study|Adverse Event|14
460872|NCT00313014|1514917|P3|Overall Study|Withdrawal by Subject|5
460873|NCT00313014|1514918|P2|Overall Study|Withdrawal by Subject|7
460874|NCT00313014|1514919|P1|Overall Study|Withdrawal by Subject|11
460875|NCT00312897|1514950|P2|Overall Study|discontinued prior to getting treatment|3
460876|NCT00312897|1514951|P1|Overall Study|discontinued prior to getting treatment|0
460877|NCT00312897|1514950|P2|Overall Study|Pregnancy|0
460878|NCT00312897|1514951|P1|Overall Study|Pregnancy|1
460879|NCT00312897|1514950|P2|Overall Study|Withdrawal by Subject|3
460880|NCT00312897|1514951|P1|Overall Study|Withdrawal by Subject|1
460881|NCT00312897|1514950|P2|Overall Study|Physician Decision|0
460882|NCT00312897|1514951|P1|Overall Study|Physician Decision|1
460883|NCT00312897|1514950|P2|Overall Study|Lost to Follow-up|0
460884|NCT00312897|1514951|P1|Overall Study|Lost to Follow-up|2
460885|NCT00312897|1514950|P2|Overall Study|Adverse Event|0
460886|NCT00312897|1514951|P1|Overall Study|Adverse Event|1
460887|NCT00312858|1514976|P2|Overall Study|Other|12
460888|NCT00312858|1514977|P1|Overall Study|Other|9
460889|NCT00312858|1514976|P2|Overall Study|Participant Moved|10
460890|NCT00312858|1514977|P1|Overall Study|Participant Moved|11
460891|NCT00312858|1514976|P2|Overall Study|Withdraw by Participant|20
460892|NCT00312858|1514977|P1|Overall Study|Withdraw by Participant|20
460893|NCT00312858|1514976|P2|Overall Study|Protocol Violation|8
460894|NCT00312858|1514977|P1|Overall Study|Protocol Violation|3
460895|NCT00312858|1514976|P2|Overall Study|Lost to Follow-up|42
460896|NCT00312858|1514977|P1|Overall Study|Lost to Follow-up|25
460897|NCT00312858|1514976|P2|Overall Study|Adverse Event|1
460898|NCT00312858|1514977|P1|Overall Study|Adverse Event|0
460899|NCT00312845|1515031|P2|Overall Study|Other|5
460900|NCT00312845|1515032|P1|Overall Study|Other|6
460901|NCT00312845|1515031|P2|Overall Study|Lost to Follow-up|0
460902|NCT00312845|1515032|P1|Overall Study|Lost to Follow-up|2
460903|NCT00312845|1515031|P2|Overall Study|Disease Progression|77
460904|NCT00312845|1515032|P1|Overall Study|Disease Progression|56
460905|NCT00312845|1515031|P2|Overall Study|Withdrawal by Subject|6
460906|NCT00312845|1515032|P1|Overall Study|Withdrawal by Subject|14
460907|NCT00312845|1515031|P2|Overall Study|Death|2
460908|NCT00312845|1515032|P1|Overall Study|Death|2
460909|NCT00312845|1515031|P2|Overall Study|Adverse Event|5
460910|NCT00312845|1515032|P1|Overall Study|Adverse Event|19
460911|NCT00312728|1515040|P1|Overall Study|Other|1
460912|NCT00312728|1515040|P1|Overall Study|Other|10
460913|NCT00312728|1515040|P1|Overall Study|Protocol Violation|2
460914|NCT00312728|1515040|P1|Overall Study|Required non-protocol cancer treatment|2
460915|NCT00312728|1515040|P1|Overall Study|Withdrawal by Subject|10
460916|NCT00312728|1515040|P1|Overall Study|Adverse Event|32
460917|NCT00312728|1515040|P1|Overall Study|Progressive disease|53
460918|NCT00312572|1515051|P2|Overall Study|Lack of Efficacy|2
460919|NCT00312572|1515052|P1|Overall Study|Lack of Efficacy|1
460920|NCT00312572|1515051|P2|Overall Study|Administrative|2
460921|NCT00312572|1515052|P1|Overall Study|Administrative|4
460922|NCT00312572|1515051|P2|Overall Study|Lost to Follow-up|1
460923|NCT00312572|1515052|P1|Overall Study|Lost to Follow-up|1
460924|NCT00312572|1515051|P2|Overall Study|Adverse Event|16
460925|NCT00312572|1515052|P1|Overall Study|Adverse Event|10
460926|NCT00312494|1515063|P3|Overall Study|Other|1
460927|NCT00312494|1515064|P2|Overall Study|Other|10
460928|NCT00312494|1515065|P1|Overall Study|Other|10
460929|NCT00312494|1515063|P3|Overall Study|Withdrawal by Subject|10
460930|NCT00312494|1515064|P2|Overall Study|Withdrawal by Subject|9
460931|NCT00312494|1515065|P1|Overall Study|Withdrawal by Subject|6
460932|NCT00312494|1515063|P3|Overall Study|Lost to Follow-up|8
460933|NCT00312494|1515064|P2|Overall Study|Lost to Follow-up|8
460934|NCT00312494|1515065|P1|Overall Study|Lost to Follow-up|8
460935|NCT00312494|1515063|P3|Overall Study|Laboratory abnormality|0
460936|NCT00312494|1515064|P2|Overall Study|Laboratory abnormality|0
460937|NCT00312494|1515065|P1|Overall Study|Laboratory abnormality|1
460938|NCT00312494|1515063|P3|Overall Study|Lack of Efficacy|8
460939|NCT00312494|1515064|P2|Overall Study|Lack of Efficacy|6
460940|NCT00312494|1515065|P1|Overall Study|Lack of Efficacy|4
460941|NCT00312494|1515063|P3|Overall Study|Adverse Event|11
460942|NCT00312494|1515064|P2|Overall Study|Adverse Event|15
460943|NCT00312494|1515065|P1|Overall Study|Adverse Event|33
460944|NCT00312494|1515063|P3|Overall Study|Randomized; not treated with study drug|5
460945|NCT00312494|1515064|P2|Overall Study|Randomized; not treated with study drug|10
460946|NCT00312494|1515065|P1|Overall Study|Randomized; not treated with study drug|9
460947|NCT00312377|1515099|P2|Overall Study|Site ended participation in study|0
460948|NCT00312377|1515100|P1|Overall Study|Site ended participation in study|1
460949|NCT00312377|1515099|P2|Overall Study|Discontinue treatment survival follow up|200
460950|NCT00312377|1515100|P1|Overall Study|Discontinue treatment survival follow up|202
460951|NCT00312377|1515099|P2|Overall Study|Randomised but never received treatment|6
460952|NCT00312377|1515100|P1|Overall Study|Randomised but never received treatment|6
460953|NCT00312377|1515099|P2|Overall Study|Non-compliance|2
460954|NCT00312377|1515100|P1|Overall Study|Non-compliance|0
460955|NCT00312377|1515099|P2|Overall Study|Lost to Follow-up|12
460956|NCT00312377|1515100|P1|Overall Study|Lost to Follow-up|9
460957|NCT00312377|1515099|P2|Overall Study|Withdrawal by Subject|30
460958|NCT00312377|1515100|P1|Overall Study|Withdrawal by Subject|23
460959|NCT00312377|1515099|P2|Overall Study|Death|418
460960|NCT00312377|1515100|P1|Overall Study|Death|403
460961|NCT00312338|1515124|P2|Overall Study|Subsequent infection|0
460962|NCT00312338|1515125|P1|Overall Study|Subsequent infection|2
460963|NCT00312338|1515124|P2|Overall Study|Withdrawal by Subject|0
460964|NCT00312338|1515125|P1|Overall Study|Withdrawal by Subject|4
460965|NCT00312338|1515124|P2|Overall Study|Lost to Follow-up|1
460966|NCT00312338|1515125|P1|Overall Study|Lost to Follow-up|9
460967|NCT00312338|1515124|P2|Overall Study|Adverse Event|2
460968|NCT00312338|1515125|P1|Overall Study|Adverse Event|7
460969|NCT00312221|1515138|P4|Double-blind Phase|Lack of Efficacy|10
460970|NCT00312221|1515139|P3|Double-blind Phase|Lack of Efficacy|6
460971|NCT00312221|1515140|P2|Double-blind Phase|Lack of Efficacy|17
460972|NCT00312221|1515141|P1|Double-blind Phase|Lack of Efficacy|0
460973|NCT00312221|1515138|P4|Double-blind Phase|Administrative|33
460974|NCT00312221|1515139|P3|Double-blind Phase|Administrative|37
460975|NCT00312221|1515140|P2|Double-blind Phase|Administrative|26
460976|NCT00312221|1515141|P1|Double-blind Phase|Administrative|0
460977|NCT00312221|1515138|P4|Double-blind Phase|Lost to Follow-up|2
460978|NCT00312221|1515139|P3|Double-blind Phase|Lost to Follow-up|2
460979|NCT00312221|1515140|P2|Double-blind Phase|Lost to Follow-up|0
460980|NCT00312221|1515141|P1|Double-blind Phase|Lost to Follow-up|0
460981|NCT00312221|1515138|P4|Double-blind Phase|Adverse Event|18
460982|NCT00312221|1515139|P3|Double-blind Phase|Adverse Event|19
460983|NCT00312221|1515140|P2|Double-blind Phase|Adverse Event|10
460984|NCT00312221|1515141|P1|Double-blind Phase|Adverse Event|0
460985|NCT00312221|1515138|P4|Double-blind Phase|Withdrawal by Subject|7
460986|NCT00312221|1515139|P3|Double-blind Phase|Withdrawal by Subject|8
460987|NCT00312221|1515140|P2|Double-blind Phase|Withdrawal by Subject|6
460988|NCT00312221|1515141|P1|Double-blind Phase|Withdrawal by Subject|0
460989|NCT00312221|1515138|P4|Open-label Run-in Period|Did not qualify|0
460990|NCT00312221|1515139|P3|Open-label Run-in Period|Did not qualify|0
460991|NCT00312221|1515140|P2|Open-label Run-in Period|Did not qualify|0
460992|NCT00312221|1515141|P1|Open-label Run-in Period|Did not qualify|5
460993|NCT00312221|1515138|P4|Open-label Run-in Period|Lack of Efficacy|0
460994|NCT00312221|1515139|P3|Open-label Run-in Period|Lack of Efficacy|0
460995|NCT00312221|1515140|P2|Open-label Run-in Period|Lack of Efficacy|0
460996|NCT00312221|1515141|P1|Open-label Run-in Period|Lack of Efficacy|102
460997|NCT00312221|1515138|P4|Open-label Run-in Period|Administrative|0
460998|NCT00312221|1515139|P3|Open-label Run-in Period|Administrative|0
460999|NCT00312221|1515140|P2|Open-label Run-in Period|Administrative|0
461000|NCT00312221|1515141|P1|Open-label Run-in Period|Administrative|42
461001|NCT00312221|1515138|P4|Open-label Run-in Period|Lost to Follow-up|0
461002|NCT00312221|1515139|P3|Open-label Run-in Period|Lost to Follow-up|0
461003|NCT00312221|1515140|P2|Open-label Run-in Period|Lost to Follow-up|0
461004|NCT00312221|1515141|P1|Open-label Run-in Period|Lost to Follow-up|5
461005|NCT00312221|1515138|P4|Open-label Run-in Period|Adverse Event|0
461006|NCT00312221|1515139|P3|Open-label Run-in Period|Adverse Event|0
461007|NCT00312221|1515140|P2|Open-label Run-in Period|Adverse Event|0
461008|NCT00312221|1515141|P1|Open-label Run-in Period|Adverse Event|74
461009|NCT00312221|1515138|P4|Open-label Run-in Period|Withdrawal by Subject|0
461010|NCT00312221|1515139|P3|Open-label Run-in Period|Withdrawal by Subject|0
461011|NCT00312221|1515140|P2|Open-label Run-in Period|Withdrawal by Subject|0
461012|NCT00312221|1515141|P1|Open-label Run-in Period|Withdrawal by Subject|6
461013|NCT00312208|1515161|P2|Overall Study|Not specified|7
461014|NCT00312208|1515162|P1|Overall Study|Not specified|5
461015|NCT00312208|1515161|P2|Overall Study|Withdrawal by Subject|42
461016|NCT00312208|1515162|P1|Overall Study|Withdrawal by Subject|53
461017|NCT00312208|1515161|P2|Overall Study|Lost to Follow-up|5
461018|NCT00312208|1515162|P1|Overall Study|Lost to Follow-up|3
461019|NCT00312208|1515161|P2|Overall Study|Lack of Efficacy|4
461020|NCT00312208|1515162|P1|Overall Study|Lack of Efficacy|7
461021|NCT00312208|1515161|P2|Overall Study|Death|1
461022|NCT00312208|1515162|P1|Overall Study|Death|2
461023|NCT00312208|1515161|P2|Overall Study|Protocol Violation|3
461024|NCT00312208|1515162|P1|Overall Study|Protocol Violation|5
461025|NCT00312208|1515161|P2|Overall Study|Adverse Event|61
461026|NCT00312208|1515162|P1|Overall Study|Adverse Event|97
461027|NCT00312195|1515172|P2|Overall Study|Protocol Violation|0
461028|NCT00312195|1515173|P1|Overall Study|Protocol Violation|1
461029|NCT00312195|1515172|P2|Overall Study|Lost to Follow-up|0
461030|NCT00312195|1515173|P1|Overall Study|Lost to Follow-up|1
461031|NCT00312195|1515172|P2|Overall Study|Adverse Event|6
461032|NCT00312195|1515173|P1|Overall Study|Adverse Event|4
461033|NCT00311584|1515200|P2|Overall Study|ineligible|2
461034|NCT00311584|1515201|P1|Overall Study|ineligible|2
461035|NCT00311584|1515200|P2|Overall Study|Withdrawal by Subject|1
461036|NCT00311584|1515201|P1|Overall Study|Withdrawal by Subject|1
461037|NCT00311584|1515200|P2|Overall Study|Physician Decision|5
461038|NCT00311584|1515201|P1|Overall Study|Physician Decision|4
461039|NCT00311584|1515200|P2|Overall Study|Lack of Efficacy|15
461040|NCT00311584|1515201|P1|Overall Study|Lack of Efficacy|12
461041|NCT00311584|1515200|P2|Overall Study|Death|0
461042|NCT00311584|1515201|P1|Overall Study|Death|1
461043|NCT00311402|1515209|P2|Overall Study|IRB's rejection etc.|3
461044|NCT00311402|1515210|P1|Overall Study|IRB's rejection etc.|10
461045|NCT00311402|1515209|P2|Overall Study|Protocol Violation|6
461046|NCT00311402|1515210|P1|Overall Study|Protocol Violation|7
461047|NCT00311402|1515209|P2|Overall Study|Lack of Efficacy|42
461048|NCT00311402|1515210|P1|Overall Study|Lack of Efficacy|58
461049|NCT00311402|1515209|P2|Overall Study|Withdrawal by Subject|18
461050|NCT00311402|1515210|P1|Overall Study|Withdrawal by Subject|17
461051|NCT00311402|1515209|P2|Overall Study|Lost to Follow-up|3
461052|NCT00311402|1515210|P1|Overall Study|Lost to Follow-up|0
461053|NCT00311402|1515209|P2|Overall Study|Adverse Event|105
461054|NCT00311402|1515210|P1|Overall Study|Adverse Event|118
461055|NCT00311363|1515259|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
461056|NCT00311363|1515260|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
461057|NCT00311363|1515261|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
461058|NCT00311363|1515259|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
461059|NCT00311363|1515260|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
461060|NCT00311363|1515261|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
461061|NCT00311363|1515259|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
461062|NCT00311363|1515260|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
461063|NCT00311363|1515261|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
461064|NCT00311363|1515259|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
461065|NCT00311363|1515260|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
461066|NCT00311363|1515261|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
461067|NCT00311363|1515259|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
461068|NCT00311363|1515260|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
461069|NCT00311363|1515261|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
461070|NCT00311363|1515259|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
461071|NCT00311363|1515260|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
461072|NCT00311363|1515261|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
461073|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Death|0
461074|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Death|0
461075|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Death|1
461076|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
461077|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
461078|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
461079|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
461080|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
461081|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
461082|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
461083|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
461084|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
461085|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
461086|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
461087|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
461088|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
461089|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
461090|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
461091|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
461092|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
461093|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
461094|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
461095|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
461096|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
461097|NCT00311363|1515259|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
461098|NCT00311363|1515260|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
461099|NCT00311363|1515261|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
461100|NCT00311311|1515321|P2|Overall Study|Lack of ancillary assistance|1
461101|NCT00311311|1515322|P1|Overall Study|Lack of ancillary assistance|0
461102|NCT00311311|1515321|P2|Overall Study|Death|0
461103|NCT00311311|1515322|P1|Overall Study|Death|1
461104|NCT00311311|1515321|P2|Overall Study|Study Termination by Sponsor|4
461105|NCT00311311|1515322|P1|Overall Study|Study Termination by Sponsor|3
461106|NCT00311311|1515321|P2|Overall Study|Noncompliance|1
461107|NCT00311311|1515322|P1|Overall Study|Noncompliance|0
461108|NCT00311311|1515321|P2|Overall Study|Withdrawal by Subject|1
461109|NCT00311311|1515322|P1|Overall Study|Withdrawal by Subject|1
461110|NCT00311311|1515321|P2|Overall Study|Adverse Event|2
461111|NCT00311311|1515322|P1|Overall Study|Adverse Event|3
461112|NCT00311181|1515372|P1|Overall Study|Final DFTs were not obtained|96
461113|NCT00311155|1515378|P1|Overall Study|Did not meet entry criteria|55
461114|NCT00311155|1515378|P1|Overall Study|Withdrawal by Subject|17
461115|NCT00311155|1515378|P1|Overall Study|Adverse Event|21
461116|NCT00310856|1515390|P3|Overall Study|Unable to classify|0
461117|NCT00310856|1515391|P2|Overall Study|Unable to classify|0
461118|NCT00310856|1515392|P1|Overall Study|Unable to classify|1
461119|NCT00310856|1515390|P3|Overall Study|Inappropriate enrollment|0
461120|NCT00310856|1515391|P2|Overall Study|Inappropriate enrollment|1
461121|NCT00310856|1515392|P1|Overall Study|Inappropriate enrollment|1
461122|NCT00310856|1515390|P3|Overall Study|Lost to Follow-up|6
461123|NCT00310856|1515391|P2|Overall Study|Lost to Follow-up|2
461124|NCT00310856|1515392|P1|Overall Study|Lost to Follow-up|1
461125|NCT00310856|1515390|P3|Overall Study|Withdrawal by Subject|2
461126|NCT00310856|1515391|P2|Overall Study|Withdrawal by Subject|2
461127|NCT00310856|1515392|P1|Overall Study|Withdrawal by Subject|2
461128|NCT00310817|1515416|P4|Overall Study|Unable to classify|0
461129|NCT00310817|1515417|P3|Overall Study|Unable to classify|0
461130|NCT00310817|1515418|P2|Overall Study|Unable to classify|1
461131|NCT00310817|1515419|P1|Overall Study|Unable to classify|3
461132|NCT00310817|1515416|P4|Overall Study|Protocol Violation|1
461133|NCT00310817|1515417|P3|Overall Study|Protocol Violation|1
461134|NCT00310817|1515418|P2|Overall Study|Protocol Violation|1
461135|NCT00310817|1515419|P1|Overall Study|Protocol Violation|1
461136|NCT00310817|1515416|P4|Overall Study|Inappropriate Enrollment|0
461137|NCT00310817|1515417|P3|Overall Study|Inappropriate Enrollment|1
461138|NCT00310817|1515418|P2|Overall Study|Inappropriate Enrollment|0
461139|NCT00310817|1515419|P1|Overall Study|Inappropriate Enrollment|1
461140|NCT00310817|1515416|P4|Overall Study|Lost to Follow-up|0
461141|NCT00310817|1515417|P3|Overall Study|Lost to Follow-up|0
461142|NCT00310817|1515418|P2|Overall Study|Lost to Follow-up|1
461143|NCT00310817|1515419|P1|Overall Study|Lost to Follow-up|2
461144|NCT00310817|1515416|P4|Overall Study|Withdrawal by Subject|7
461145|NCT00310817|1515417|P3|Overall Study|Withdrawal by Subject|6
461146|NCT00310817|1515418|P2|Overall Study|Withdrawal by Subject|4
461147|NCT00310817|1515419|P1|Overall Study|Withdrawal by Subject|1
461148|NCT00310817|1515416|P4|Overall Study|AE or Death|0
461149|NCT00310817|1515417|P3|Overall Study|AE or Death|0
461150|NCT00310817|1515418|P2|Overall Study|AE or Death|1
461151|NCT00310817|1515419|P1|Overall Study|AE or Death|3
461152|NCT00310804|1515507|P2|Overall Study|Withdrawal by Subject|0
461153|NCT00310804|1515508|P1|Overall Study|Withdrawal by Subject|3
461154|NCT00310804|1515507|P2|Overall Study|Lost to Follow-up|0
461155|NCT00310804|1515508|P1|Overall Study|Lost to Follow-up|2
461156|NCT00310440|1515567|P2|Overall Study|Missed 12 Month Visit|4
461157|NCT00310440|1515568|P1|Overall Study|Missed 12 Month Visit|7
461158|NCT00310440|1515567|P2|Overall Study|Withdrawal by Subject|1
461159|NCT00310440|1515568|P1|Overall Study|Withdrawal by Subject|2
461160|NCT00310440|1515567|P2|Overall Study|Lost to Follow-up|8
461161|NCT00310440|1515568|P1|Overall Study|Lost to Follow-up|17
461162|NCT00310388|1515632|P1|Overall Study|Other|1
461163|NCT00310388|1515632|P1|Overall Study|Missing|1
461164|NCT00310388|1515632|P1|Overall Study|Participant retired the informed consent|1
461165|NCT00310388|1515632|P1|Overall Study|Participant passed away|1
461166|NCT00310388|1515632|P1|Overall Study|Due to pigmentation risk concerns|2
461167|NCT00310388|1515632|P1|Overall Study|Ongoing SAE from parent study|1
461168|NCT00310388|1515632|P1|Overall Study|Termination of study at sponsor request|3
461169|NCT00310388|1515632|P1|Overall Study|Participant Immigrated to New Zealand|1
461170|NCT00310388|1515632|P1|Overall Study|Discontinuation of study|1
461171|NCT00310388|1515632|P1|Overall Study|Ministry of Health decision|25
461172|NCT00310388|1515632|P1|Overall Study|Participant request|2
461173|NCT00310388|1515632|P1|Overall Study|Participant request unrelated to study|2
461174|NCT00310388|1515632|P1|Overall Study|Failed to return|8
461175|NCT00310388|1515632|P1|Overall Study|Request of the sponsor|19
461176|NCT00310388|1515632|P1|Overall Study|Physician Decision|2
461177|NCT00310388|1515632|P1|Overall Study|ALT/AST levels above 5 times the ULN|3
461178|NCT00310388|1515632|P1|Overall Study|Persistent ALT/AST above 3 times the ULN|3
461179|NCT00310388|1515632|P1|Overall Study|Change in participant medical condition|3
461180|NCT00310388|1515632|P1|Overall Study|Pregnancy|3
461181|NCT00310388|1515632|P1|Overall Study|Protocol Violation|10
461182|NCT00310388|1515632|P1|Overall Study|Withdrawal by Subject|97
461183|NCT00310388|1515632|P1|Overall Study|Lack of Efficacy|56
461184|NCT00310388|1515632|P1|Overall Study|Adverse Event|101
461185|NCT00310375|1515670|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
461186|NCT00310375|1515671|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
461187|NCT00310375|1515672|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
461188|NCT00310375|1515670|P3|Primary Reporting Phase|Request of Ethics Committee|0
461189|NCT00310375|1515671|P2|Primary Reporting Phase|Request of Ethics Committee|1
461190|NCT00310375|1515672|P1|Primary Reporting Phase|Request of Ethics Committee|0
461191|NCT00310375|1515670|P3|Primary Reporting Phase|Par. switched to commercial product|0
461192|NCT00310375|1515671|P2|Primary Reporting Phase|Par. switched to commercial product|1
461193|NCT00310375|1515672|P1|Primary Reporting Phase|Par. switched to commercial product|0
461194|NCT00310375|1515670|P3|Primary Reporting Phase|Missed study drug for 2 months|0
461195|NCT00310375|1515671|P2|Primary Reporting Phase|Missed study drug for 2 months|0
461196|NCT00310375|1515672|P1|Primary Reporting Phase|Missed study drug for 2 months|1
461197|NCT00310375|1515670|P3|Primary Reporting Phase|Site closure|0
461198|NCT00310375|1515671|P2|Primary Reporting Phase|Site closure|0
461199|NCT00310375|1515672|P1|Primary Reporting Phase|Site closure|3
461200|NCT00310375|1515670|P3|Primary Reporting Phase|Missed study drug >5 days|0
461201|NCT00310375|1515671|P2|Primary Reporting Phase|Missed study drug >5 days|0
461202|NCT00310375|1515672|P1|Primary Reporting Phase|Missed study drug >5 days|1
461203|NCT00310375|1515670|P3|Primary Reporting Phase|Going for temporal lobectomy|0
461204|NCT00310375|1515671|P2|Primary Reporting Phase|Going for temporal lobectomy|0
461205|NCT00310375|1515672|P1|Primary Reporting Phase|Going for temporal lobectomy|1
461206|NCT00310375|1515670|P3|Primary Reporting Phase|Participant request unrelated to study|0
461207|NCT00310375|1515671|P2|Primary Reporting Phase|Participant request unrelated to study|2
461208|NCT00310375|1515672|P1|Primary Reporting Phase|Participant request unrelated to study|1
461209|NCT00310375|1515670|P3|Primary Reporting Phase|Failed to return|0
461210|NCT00310375|1515671|P2|Primary Reporting Phase|Failed to return|3
461211|NCT00310375|1515672|P1|Primary Reporting Phase|Failed to return|1
461212|NCT00310375|1515670|P3|Primary Reporting Phase|Request of the sponsor|0
461213|NCT00310375|1515671|P2|Primary Reporting Phase|Request of the sponsor|2
461214|NCT00310375|1515672|P1|Primary Reporting Phase|Request of the sponsor|2
461215|NCT00310375|1515670|P3|Primary Reporting Phase|Physician Decision|0
461216|NCT00310375|1515671|P2|Primary Reporting Phase|Physician Decision|3
461217|NCT00310375|1515672|P1|Primary Reporting Phase|Physician Decision|5
461218|NCT00310375|1515670|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
461219|NCT00310375|1515671|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
461220|NCT00310375|1515672|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
461221|NCT00310375|1515670|P3|Primary Reporting Phase|Change in Par medical condition|0
461222|NCT00310375|1515671|P2|Primary Reporting Phase|Change in Par medical condition|0
461223|NCT00310375|1515672|P1|Primary Reporting Phase|Change in Par medical condition|2
461224|NCT00310375|1515670|P3|Primary Reporting Phase|Protocol Violation|0
461225|NCT00310375|1515671|P2|Primary Reporting Phase|Protocol Violation|5
461226|NCT00310375|1515672|P1|Primary Reporting Phase|Protocol Violation|8
461227|NCT00310375|1515670|P3|Primary Reporting Phase|Withdrawal by Subject|0
461228|NCT00310375|1515671|P2|Primary Reporting Phase|Withdrawal by Subject|7
461229|NCT00310375|1515672|P1|Primary Reporting Phase|Withdrawal by Subject|10
461230|NCT00310375|1515670|P3|Primary Reporting Phase|Pregnancy|0
461231|NCT00310375|1515671|P2|Primary Reporting Phase|Pregnancy|2
461232|NCT00310375|1515672|P1|Primary Reporting Phase|Pregnancy|2
461233|NCT00310375|1515670|P3|Primary Reporting Phase|Lack of Efficacy|0
461234|NCT00310375|1515671|P2|Primary Reporting Phase|Lack of Efficacy|19
461235|NCT00310375|1515672|P1|Primary Reporting Phase|Lack of Efficacy|24
461236|NCT00310375|1515670|P3|Primary Reporting Phase|Adverse Event|0
461237|NCT00310375|1515671|P2|Primary Reporting Phase|Adverse Event|22
461238|NCT00310375|1515672|P1|Primary Reporting Phase|Adverse Event|28
461239|NCT00309985|1515760|P2|Overall Study|Chemotherapy discontinued only|0
461240|NCT00309985|1515761|P1|Overall Study|Chemotherapy discontinued only|1
461241|NCT00309985|1515760|P2|Overall Study|Non-compliance|0
461242|NCT00309985|1515761|P1|Overall Study|Non-compliance|1
461243|NCT00309985|1515760|P2|Overall Study|Complicating disease|0
461244|NCT00309985|1515761|P1|Overall Study|Complicating disease|1
461245|NCT00309985|1515760|P2|Overall Study|Never started treatment|0
461246|NCT00309985|1515761|P1|Overall Study|Never started treatment|7
461247|NCT00309985|1515760|P2|Overall Study|Physician Decision|0
461248|NCT00309985|1515761|P1|Overall Study|Physician Decision|3
461249|NCT00309985|1515760|P2|Overall Study|Withdrawal by Subject|1
461250|NCT00309985|1515761|P1|Overall Study|Withdrawal by Subject|5
461251|NCT00309985|1515760|P2|Overall Study|Death|0
461252|NCT00309985|1515761|P1|Overall Study|Death|2
461253|NCT00309985|1515760|P2|Overall Study|Adverse Event|0
461254|NCT00309985|1515761|P1|Overall Study|Adverse Event|30
461255|NCT00309985|1515760|P2|Overall Study|Disease progression|0
461256|NCT00309985|1515761|P1|Overall Study|Disease progression|12
461257|NCT00309946|1515777|P1|Overall Study|Withdrawal by Subject|1
461258|NCT00309907|1515783|P1|Overall Study|Major infectious event|4
461259|NCT00309907|1515783|P1|Overall Study|Ineligible|11
461260|NCT00309907|1515783|P1|Overall Study|Physician Decision|1
461261|NCT00309907|1515783|P1|Overall Study|Death|4
461262|NCT00309777|1515796|P4|Overall Study|Death|0
461263|NCT00309777|1515797|P3|Overall Study|Death|0
461264|NCT00309777|1515798|P2|Overall Study|Death|1
461265|NCT00309777|1515799|P1|Overall Study|Death|0
461266|NCT00309777|1515796|P4|Overall Study|Lost to Follow-up|0
461267|NCT00309777|1515797|P3|Overall Study|Lost to Follow-up|1
461268|NCT00309777|1515798|P2|Overall Study|Lost to Follow-up|0
461269|NCT00309777|1515799|P1|Overall Study|Lost to Follow-up|0
461270|NCT00309777|1515796|P4|Overall Study|Withdrawal by Subject|2
461271|NCT00309777|1515797|P3|Overall Study|Withdrawal by Subject|7
461272|NCT00309777|1515798|P2|Overall Study|Withdrawal by Subject|5
461273|NCT00309777|1515799|P1|Overall Study|Withdrawal by Subject|6
461274|NCT00309777|1515796|P4|Overall Study|Protocol Violation|1
461275|NCT00309777|1515797|P3|Overall Study|Protocol Violation|3
461276|NCT00309777|1515798|P2|Overall Study|Protocol Violation|1
461277|NCT00309777|1515799|P1|Overall Study|Protocol Violation|4
461278|NCT00309777|1515796|P4|Overall Study|Adverse Event|1
461279|NCT00309777|1515797|P3|Overall Study|Adverse Event|8
461280|NCT00309777|1515798|P2|Overall Study|Adverse Event|2
461281|NCT00309777|1515799|P1|Overall Study|Adverse Event|13
461282|NCT00309608|1515840|P5|Overall Study|Other incl. Lack of efficacy|0
461283|NCT00309608|1515841|P4|Overall Study|Other incl. Lack of efficacy|4
461284|NCT00309608|1515842|P3|Overall Study|Other incl. Lack of efficacy|3
461285|NCT00309608|1515843|P2|Overall Study|Other incl. Lack of efficacy|4
461286|NCT00309608|1515844|P1|Overall Study|Other incl. Lack of efficacy|10
461287|NCT00309608|1515840|P5|Overall Study|Withdrawal by Subject|0
461288|NCT00309608|1515841|P4|Overall Study|Withdrawal by Subject|0
461289|NCT00309608|1515842|P3|Overall Study|Withdrawal by Subject|2
461290|NCT00309608|1515843|P2|Overall Study|Withdrawal by Subject|4
461291|NCT00309608|1515844|P1|Overall Study|Withdrawal by Subject|1
461292|NCT00309608|1515840|P5|Overall Study|Lost to Follow-up|1
461293|NCT00309608|1515841|P4|Overall Study|Lost to Follow-up|0
461294|NCT00309608|1515842|P3|Overall Study|Lost to Follow-up|2
461295|NCT00309608|1515843|P2|Overall Study|Lost to Follow-up|0
461296|NCT00309608|1515844|P1|Overall Study|Lost to Follow-up|0
461297|NCT00309608|1515840|P5|Overall Study|Protocol Violation|0
461298|NCT00309608|1515841|P4|Overall Study|Protocol Violation|0
461299|NCT00309608|1515842|P3|Overall Study|Protocol Violation|0
461300|NCT00309608|1515843|P2|Overall Study|Protocol Violation|0
461301|NCT00309608|1515844|P1|Overall Study|Protocol Violation|2
461302|NCT00309608|1515840|P5|Overall Study|Adverse Event|3
461303|NCT00309608|1515841|P4|Overall Study|Adverse Event|2
461304|NCT00309608|1515842|P3|Overall Study|Adverse Event|3
461305|NCT00309608|1515843|P2|Overall Study|Adverse Event|5
461306|NCT00309608|1515844|P1|Overall Study|Adverse Event|1
461307|NCT00309452|1515892|P2|Overall Study|Withdrawal by Subject|0
461308|NCT00309452|1515893|P1|Overall Study|Withdrawal by Subject|3
461309|NCT00309387|1515921|P2|Overall Study|Lost to Follow-up|86
461310|NCT00309387|1515922|P1|Overall Study|Lost to Follow-up|70
461311|NCT00309387|1515921|P2|Overall Study|Death|73
461312|NCT00309387|1515922|P1|Overall Study|Death|72
461313|NCT00309244|1515940|P2|Overall Study|Death|1
461314|NCT00309244|1515941|P1|Overall Study|Death|4
461315|NCT00309244|1515940|P2|Overall Study|Randomized but not dosed|12
461316|NCT00309244|1515941|P1|Overall Study|Randomized but not dosed|11
461317|NCT00309244|1515940|P2|Overall Study|Various|7
461318|NCT00309244|1515941|P1|Overall Study|Various|7
461319|NCT00309244|1515940|P2|Overall Study|Withdrawal by Subject|32
461320|NCT00309244|1515941|P1|Overall Study|Withdrawal by Subject|50
461321|NCT00309244|1515940|P2|Overall Study|Protocol Violation|3
461322|NCT00309244|1515941|P1|Overall Study|Protocol Violation|6
461323|NCT00309244|1515940|P2|Overall Study|Physician Decision|8
461324|NCT00309244|1515941|P1|Overall Study|Physician Decision|5
461325|NCT00309244|1515940|P2|Overall Study|Lost to Follow-up|22
461326|NCT00309244|1515941|P1|Overall Study|Lost to Follow-up|6
461327|NCT00309244|1515940|P2|Overall Study|Adverse Event|12
461328|NCT00309244|1515941|P1|Overall Study|Adverse Event|29
461329|NCT00308997|1515963|P2|Overall Study|Unable to tolerate intervention|0
461330|NCT00308997|1515964|P1|Overall Study|Unable to tolerate intervention|1
461331|NCT00308997|1515963|P2|Overall Study|Subject feigned clinical data|1
461332|NCT00308997|1515964|P1|Overall Study|Subject feigned clinical data|0
461333|NCT00308737|1515983|P3|Overall Study|Various|8
461334|NCT00308737|1515984|P2|Overall Study|Various|20
461335|NCT00308737|1515985|P1|Overall Study|Various|32
461336|NCT00308737|1515983|P3|Overall Study|Withdrawal by Subject|18
461337|NCT00308737|1515984|P2|Overall Study|Withdrawal by Subject|166
461338|NCT00308737|1515985|P1|Overall Study|Withdrawal by Subject|218
461339|NCT00308737|1515983|P3|Overall Study|Protocol Violation|5
461340|NCT00308737|1515984|P2|Overall Study|Protocol Violation|9
461341|NCT00308737|1515985|P1|Overall Study|Protocol Violation|34
461342|NCT00308737|1515983|P3|Overall Study|Physician Decision|1
461343|NCT00308737|1515984|P2|Overall Study|Physician Decision|2
461344|NCT00308737|1515985|P1|Overall Study|Physician Decision|15
461345|NCT00308737|1515983|P3|Overall Study|Lost to Follow-up|5
461346|NCT00308737|1515984|P2|Overall Study|Lost to Follow-up|80
461347|NCT00308737|1515985|P1|Overall Study|Lost to Follow-up|56
461348|NCT00308737|1515983|P3|Overall Study|Death|0
461349|NCT00308737|1515984|P2|Overall Study|Death|3
461350|NCT00308737|1515985|P1|Overall Study|Death|4
461351|NCT00308737|1515983|P3|Overall Study|Adverse Event|0
461352|NCT00308737|1515984|P2|Overall Study|Adverse Event|9
461353|NCT00308737|1515985|P1|Overall Study|Adverse Event|104
461354|NCT00308711|1516025|P3|Overall Study|Subject incarcerated, data not allowed|1
461355|NCT00308711|1516026|P2|Overall Study|Subject incarcerated, data not allowed|0
461356|NCT00308711|1516027|P1|Overall Study|Subject incarcerated, data not allowed|0
461357|NCT00308711|1516025|P3|Overall Study|Baby not born within 7 days of treatment|2
461358|NCT00308711|1516026|P2|Overall Study|Baby not born within 7 days of treatment|2
461359|NCT00308711|1516027|P1|Overall Study|Baby not born within 7 days of treatment|1
461360|NCT00308711|1516025|P3|Overall Study|Lost to Follow-up|0
461361|NCT00308711|1516026|P2|Overall Study|Lost to Follow-up|1
461362|NCT00308711|1516027|P1|Overall Study|Lost to Follow-up|0
461363|NCT00308711|1516025|P3|Overall Study|Protocol Violation|1
461364|NCT00308711|1516026|P2|Overall Study|Protocol Violation|1
461365|NCT00308711|1516027|P1|Overall Study|Protocol Violation|0
461366|NCT00308711|1516025|P3|Overall Study|Withdrawal by Subject|1
461367|NCT00308711|1516026|P2|Overall Study|Withdrawal by Subject|0
461368|NCT00308711|1516027|P1|Overall Study|Withdrawal by Subject|1
461369|NCT00308620|1516062|P3|Overall Study|Lost to Follow-up|1
461370|NCT00308620|1516063|P2|Overall Study|Lost to Follow-up|0
461371|NCT00308620|1516064|P1|Overall Study|Lost to Follow-up|0
461372|NCT00308620|1516062|P3|Overall Study|Death|0
461373|NCT00308620|1516063|P2|Overall Study|Death|1
461374|NCT00308620|1516064|P1|Overall Study|Death|1
461375|NCT00308581|1516073|P3|Randomized Maintenance Phase|Unknown reason|0
461376|NCT00308581|1516074|P2|Randomized Maintenance Phase|Unknown reason|0
461377|NCT00308581|1516075|P1|Randomized Maintenance Phase|Unknown reason|3
461378|NCT00308581|1516073|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
461379|NCT00308581|1516074|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
461380|NCT00308581|1516075|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
461381|NCT00308581|1516073|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
461382|NCT00308581|1516074|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
461383|NCT00308581|1516075|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
461384|NCT00308581|1516073|P3|Randomized Maintenance Phase|Lost to Follow-up|0
461385|NCT00308581|1516074|P2|Randomized Maintenance Phase|Lost to Follow-up|2
461386|NCT00308581|1516075|P1|Randomized Maintenance Phase|Lost to Follow-up|0
461387|NCT00308581|1516073|P3|Randomized Maintenance Phase|Lack of Efficacy|0
461388|NCT00308581|1516074|P2|Randomized Maintenance Phase|Lack of Efficacy|21
461389|NCT00308581|1516075|P1|Randomized Maintenance Phase|Lack of Efficacy|9
461390|NCT00308581|1516073|P3|Randomized Maintenance Phase|Adverse Event|0
461391|NCT00308581|1516074|P2|Randomized Maintenance Phase|Adverse Event|17
461392|NCT00308581|1516075|P1|Randomized Maintenance Phase|Adverse Event|10
461393|NCT00308581|1516073|P3|Induction Phase|Unknown reason|3
461394|NCT00308581|1516074|P2|Induction Phase|Unknown reason|0
461395|NCT00308581|1516075|P1|Induction Phase|Unknown reason|0
461396|NCT00308581|1516073|P3|Induction Phase|Withdrawal by Subject|5
461397|NCT00308581|1516074|P2|Induction Phase|Withdrawal by Subject|0
461398|NCT00308581|1516075|P1|Induction Phase|Withdrawal by Subject|0
461399|NCT00308581|1516073|P3|Induction Phase|Lack of Efficacy|121
461400|NCT00308581|1516074|P2|Induction Phase|Lack of Efficacy|0
461401|NCT00308581|1516075|P1|Induction Phase|Lack of Efficacy|0
461402|NCT00308581|1516073|P3|Induction Phase|Adverse Event|37
461403|NCT00308581|1516074|P2|Induction Phase|Adverse Event|0
461404|NCT00308581|1516075|P1|Induction Phase|Adverse Event|0
461405|NCT00308555|1516201|P2|Overall Study|Physician Decision|0
461406|NCT00308555|1516202|P1|Overall Study|Physician Decision|2
461407|NCT00308555|1516201|P2|Overall Study|Withdrawal by Subject|0
461408|NCT00308555|1516202|P1|Overall Study|Withdrawal by Subject|1
461409|NCT00308308|1516219|P2|Overall Study|Other|0
461410|NCT00308308|1516220|P1|Overall Study|Other|1
461411|NCT00308308|1516219|P2|Overall Study|Randomized but not dosed|16
461412|NCT00308308|1516220|P1|Overall Study|Randomized but not dosed|8
461413|NCT00308308|1516219|P2|Overall Study|Various|5
461414|NCT00308308|1516220|P1|Overall Study|Various|7
461415|NCT00308308|1516219|P2|Overall Study|Withdrawal by Subject|19
461416|NCT00308308|1516220|P1|Overall Study|Withdrawal by Subject|47
461417|NCT00308308|1516219|P2|Overall Study|Protocol Violation|14
461418|NCT00308308|1516220|P1|Overall Study|Protocol Violation|3
461419|NCT00308308|1516219|P2|Overall Study|Physician Decision|7
461420|NCT00308308|1516220|P1|Overall Study|Physician Decision|15
461421|NCT00308308|1516219|P2|Overall Study|Lost to Follow-up|5
461422|NCT00308308|1516220|P1|Overall Study|Lost to Follow-up|5
461423|NCT00308308|1516219|P2|Overall Study|Adverse Event|2
461424|NCT00308308|1516220|P1|Overall Study|Adverse Event|17
461425|NCT00308139|1516255|P2|Overall Study|Other|0
461426|NCT00308139|1516256|P1|Overall Study|Other|1
461427|NCT00308139|1516255|P2|Overall Study|Administrative|4
461428|NCT00308139|1516256|P1|Overall Study|Administrative|1
461429|NCT00308139|1516255|P2|Overall Study|Loss of Glucose Control|7
461430|NCT00308139|1516256|P1|Overall Study|Loss of Glucose Control|5
461431|NCT00308139|1516255|P2|Overall Study|Investigator Decision|10
461432|NCT00308139|1516256|P1|Overall Study|Investigator Decision|11
461433|NCT00308139|1516255|P2|Overall Study|Withdrawal of Consent|42
461434|NCT00308139|1516256|P1|Overall Study|Withdrawal of Consent|40
461435|NCT00308139|1516255|P2|Overall Study|Protocol Violation|2
461436|NCT00308139|1516256|P1|Overall Study|Protocol Violation|3
461437|NCT00308139|1516255|P2|Overall Study|Lost to Follow-up|8
461438|NCT00308139|1516256|P1|Overall Study|Lost to Follow-up|13
461439|NCT00308139|1516255|P2|Overall Study|Adverse Event|14
461440|NCT00308139|1516256|P1|Overall Study|Adverse Event|20
461441|NCT00308113|1516330|P4|Overall Study|Protocol closure|1
461442|NCT00308113|1516331|P3|Overall Study|Protocol closure|0
461443|NCT00308113|1516332|P2|Overall Study|Protocol closure|0
461444|NCT00308113|1516333|P1|Overall Study|Protocol closure|0
461445|NCT00308087|1516353|P2|Overall Study|Not Specified|3
461446|NCT00308087|1516354|P1|Overall Study|Not Specified|4
461447|NCT00308087|1516353|P2|Overall Study|Withdrawal by Subject|1
461448|NCT00308087|1516354|P1|Overall Study|Withdrawal by Subject|2
461449|NCT00308087|1516353|P2|Overall Study|Study Closure|12
461450|NCT00308087|1516354|P1|Overall Study|Study Closure|11
461451|NCT00308087|1516353|P2|Overall Study|Progressive Disease|21
461452|NCT00308087|1516354|P1|Overall Study|Progressive Disease|19
461453|NCT00308074|1516370|P1|Overall Study|Withdrawal by Subject|1
461454|NCT00307931|1516387|P1|Overall Study|Adverse Event|1
461455|NCT00307801|1516404|P2|Overall Study|Pregnancy|1
461456|NCT00307801|1516405|P1|Overall Study|Pregnancy|0
461457|NCT00307801|1516404|P2|Overall Study|No reason specified|0
461458|NCT00307801|1516405|P1|Overall Study|No reason specified|2
461459|NCT00307801|1516404|P2|Overall Study|Protocol Violation|2
461460|NCT00307801|1516405|P1|Overall Study|Protocol Violation|3
461461|NCT00307801|1516404|P2|Overall Study|Frustration with e-diary|0
461462|NCT00307801|1516405|P1|Overall Study|Frustration with e-diary|1
461463|NCT00307801|1516404|P2|Overall Study|Lost to Follow-up, moved abroad|1
461464|NCT00307801|1516405|P1|Overall Study|Lost to Follow-up, moved abroad|1
461465|NCT00307801|1516404|P2|Overall Study|Lack of Efficacy|2
461466|NCT00307801|1516405|P1|Overall Study|Lack of Efficacy|0
461467|NCT00307801|1516404|P2|Overall Study|Wrong Randomization|0
461468|NCT00307801|1516405|P1|Overall Study|Wrong Randomization|1
461469|NCT00307801|1516404|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
461470|NCT00307801|1516405|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
461471|NCT00307801|1516404|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
461472|NCT00307801|1516405|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
461473|NCT00307801|1516404|P2|Overall Study|Non-compliance, not taken all tablets|2
461474|NCT00307801|1516405|P1|Overall Study|Non-compliance, not taken all tablets|1
461475|NCT00307801|1516404|P2|Overall Study|Withdrawal by Subject|4
461476|NCT00307801|1516405|P1|Overall Study|Withdrawal by Subject|9
461477|NCT00307801|1516404|P2|Overall Study|Adverse Event|4
461478|NCT00307801|1516405|P1|Overall Study|Adverse Event|12
461479|NCT00307736|1516517|P4|Overall Study|Withdrawal by Subject|0
461480|NCT00307736|1516518|P3|Overall Study|Withdrawal by Subject|2
461481|NCT00307736|1516519|P2|Overall Study|Withdrawal by Subject|0
461482|NCT00307736|1516520|P1|Overall Study|Withdrawal by Subject|0
461483|NCT00307736|1516517|P4|Overall Study|Adverse Event|3
461484|NCT00307736|1516518|P3|Overall Study|Adverse Event|1
461485|NCT00307736|1516519|P2|Overall Study|Adverse Event|0
461486|NCT00307736|1516520|P1|Overall Study|Adverse Event|0
461487|NCT00307684|1516531|P3|Double Blind Phase|Lack of Efficacy|0
461488|NCT00307684|1516532|P2|Double Blind Phase|Lack of Efficacy|5
461489|NCT00307684|1516533|P1|Double Blind Phase|Lack of Efficacy|2
461490|NCT00307684|1516531|P3|Open Label Phase|other|6
461491|NCT00307684|1516532|P2|Open Label Phase|other|0
461492|NCT00307684|1516533|P1|Open Label Phase|other|0
461493|NCT00307684|1516531|P3|Open Label Phase|non compliance|5
461494|NCT00307684|1516532|P2|Open Label Phase|non compliance|0
461495|NCT00307684|1516533|P1|Open Label Phase|non compliance|0
461496|NCT00307684|1516531|P3|Open Label Phase|Lost to Follow-up|11
461497|NCT00307684|1516532|P2|Open Label Phase|Lost to Follow-up|0
461498|NCT00307684|1516533|P1|Open Label Phase|Lost to Follow-up|0
461499|NCT00307684|1516531|P3|Open Label Phase|Withdrawal by Subject|15
461500|NCT00307684|1516532|P2|Open Label Phase|Withdrawal by Subject|0
461501|NCT00307684|1516533|P1|Open Label Phase|Withdrawal by Subject|0
461502|NCT00307684|1516531|P3|Open Label Phase|Adverse Event|16
461503|NCT00307684|1516532|P2|Open Label Phase|Adverse Event|0
461504|NCT00307684|1516533|P1|Open Label Phase|Adverse Event|0
461505|NCT00307684|1516531|P3|Open Label Phase|Lack of Efficacy|3
461506|NCT00307684|1516532|P2|Open Label Phase|Lack of Efficacy|0
461507|NCT00307684|1516533|P1|Open Label Phase|Lack of Efficacy|0
461508|NCT00307489|1516561|P2|Week 48 Through Week 168|Seroconversion|0
461509|NCT00307489|1516562|P1|Week 48 Through Week 168|Seroconversion|1
461510|NCT00307489|1516561|P2|Week 48 Through Week 168|Lost to Follow-up|1
461511|NCT00307489|1516562|P1|Week 48 Through Week 168|Lost to Follow-up|0
461512|NCT00307489|1516561|P2|Week 48 Through Week 168|Death|1
461513|NCT00307489|1516562|P1|Week 48 Through Week 168|Death|0
461514|NCT00307489|1516561|P2|Week 48 Through Week 168|Lack of Efficacy|2
461515|NCT00307489|1516562|P1|Week 48 Through Week 168|Lack of Efficacy|2
461516|NCT00307489|1516561|P2|Week 48 Through Week 168|Withdrawal by Subject|2
461517|NCT00307489|1516562|P1|Week 48 Through Week 168|Withdrawal by Subject|1
461518|NCT00307489|1516561|P2|Week 48 Through Week 168|Physician Decision|0
461519|NCT00307489|1516562|P1|Week 48 Through Week 168|Physician Decision|1
461520|NCT00307489|1516561|P2|Week 48 Through Week 168|Adverse Event|0
461521|NCT00307489|1516562|P1|Week 48 Through Week 168|Adverse Event|1
461522|NCT00307489|1516561|P2|Baseline Through Week 48|Withdrawal by Subject|1
461523|NCT00307489|1516562|P1|Baseline Through Week 48|Withdrawal by Subject|0
461524|NCT00307489|1516561|P2|Baseline Through Week 48|Physician Decision|0
461525|NCT00307489|1516562|P1|Baseline Through Week 48|Physician Decision|1
461526|NCT00307489|1516561|P2|Baseline Through Week 48|Lost to Follow-up|1
461527|NCT00307489|1516562|P1|Baseline Through Week 48|Lost to Follow-up|0
461528|NCT00307437|1516607|P7|After Controlled Period|Other|28
461529|NCT00307437|1516608|P6|After Controlled Period|Other|40
461530|NCT00307437|1516609|P5|After Controlled Period|Other|9
461531|NCT00307437|1516610|P4|After Controlled Period|Other|15
461532|NCT00307437|1516611|P3|After Controlled Period|Other|0
461533|NCT00307437|1516612|P2|After Controlled Period|Other|0
461534|NCT00307437|1516613|P1|After Controlled Period|Other|0
461535|NCT00307437|1516607|P7|After Controlled Period|Lost to Follow-up|18
461536|NCT00307437|1516608|P6|After Controlled Period|Lost to Follow-up|13
461537|NCT00307437|1516609|P5|After Controlled Period|Lost to Follow-up|12
461538|NCT00307437|1516610|P4|After Controlled Period|Lost to Follow-up|7
461539|NCT00307437|1516611|P3|After Controlled Period|Lost to Follow-up|0
461540|NCT00307437|1516612|P2|After Controlled Period|Lost to Follow-up|0
461541|NCT00307437|1516613|P1|After Controlled Period|Lost to Follow-up|0
461542|NCT00307437|1516607|P7|After Controlled Period|Lack of Efficacy|24
461543|NCT00307437|1516608|P6|After Controlled Period|Lack of Efficacy|37
461544|NCT00307437|1516609|P5|After Controlled Period|Lack of Efficacy|17
461545|NCT00307437|1516610|P4|After Controlled Period|Lack of Efficacy|15
461546|NCT00307437|1516611|P3|After Controlled Period|Lack of Efficacy|0
461547|NCT00307437|1516612|P2|After Controlled Period|Lack of Efficacy|0
461548|NCT00307437|1516613|P1|After Controlled Period|Lack of Efficacy|0
461549|NCT00307437|1516607|P7|After Controlled Period|Death|3
461550|NCT00307437|1516608|P6|After Controlled Period|Death|1
461551|NCT00307437|1516609|P5|After Controlled Period|Death|1
461552|NCT00307437|1516610|P4|After Controlled Period|Death|3
461553|NCT00307437|1516611|P3|After Controlled Period|Death|0
461554|NCT00307437|1516612|P2|After Controlled Period|Death|0
461555|NCT00307437|1516613|P1|After Controlled Period|Death|0
461556|NCT00307437|1516607|P7|After Controlled Period|Adverse Event|40
461557|NCT00307437|1516608|P6|After Controlled Period|Adverse Event|31
461558|NCT00307437|1516609|P5|After Controlled Period|Adverse Event|16
461559|NCT00307437|1516610|P4|After Controlled Period|Adverse Event|18
461560|NCT00307437|1516611|P3|After Controlled Period|Adverse Event|0
461561|NCT00307437|1516612|P2|After Controlled Period|Adverse Event|0
461562|NCT00307437|1516613|P1|After Controlled Period|Adverse Event|0
461563|NCT00307437|1516607|P7|Controlled Period|Other|0
461564|NCT00307437|1516608|P6|Controlled Period|Other|0
461565|NCT00307437|1516609|P5|Controlled Period|Other|0
461566|NCT00307437|1516610|P4|Controlled Period|Other|0
461567|NCT00307437|1516611|P3|Controlled Period|Other|3
461568|NCT00307437|1516612|P2|Controlled Period|Other|1
461569|NCT00307437|1516613|P1|Controlled Period|Other|5
461570|NCT00307437|1516607|P7|Controlled Period|Lost to Follow-up|0
461571|NCT00307437|1516608|P6|Controlled Period|Lost to Follow-up|0
461572|NCT00307437|1516609|P5|Controlled Period|Lost to Follow-up|0
461573|NCT00307437|1516610|P4|Controlled Period|Lost to Follow-up|0
461574|NCT00307437|1516611|P3|Controlled Period|Lost to Follow-up|0
461575|NCT00307437|1516612|P2|Controlled Period|Lost to Follow-up|3
461576|NCT00307437|1516613|P1|Controlled Period|Lost to Follow-up|2
461577|NCT00307437|1516607|P7|Controlled Period|Lack of Efficacy|0
461578|NCT00307437|1516608|P6|Controlled Period|Lack of Efficacy|0
461579|NCT00307437|1516609|P5|Controlled Period|Lack of Efficacy|0
461580|NCT00307437|1516610|P4|Controlled Period|Lack of Efficacy|0
461581|NCT00307437|1516611|P3|Controlled Period|Lack of Efficacy|0
461582|NCT00307437|1516612|P2|Controlled Period|Lack of Efficacy|0
461583|NCT00307437|1516613|P1|Controlled Period|Lack of Efficacy|2
461584|NCT00307437|1516607|P7|Controlled Period|Death|0
461585|NCT00307437|1516608|P6|Controlled Period|Death|0
461586|NCT00307437|1516609|P5|Controlled Period|Death|0
461587|NCT00307437|1516610|P4|Controlled Period|Death|0
461588|NCT00307437|1516611|P3|Controlled Period|Death|1
461589|NCT00307437|1516612|P2|Controlled Period|Death|0
461590|NCT00307437|1516613|P1|Controlled Period|Death|0
461591|NCT00307437|1516607|P7|Controlled Period|Adverse Event|0
461592|NCT00307437|1516608|P6|Controlled Period|Adverse Event|0
461593|NCT00307437|1516609|P5|Controlled Period|Adverse Event|0
461594|NCT00307437|1516610|P4|Controlled Period|Adverse Event|0
461595|NCT00307437|1516611|P3|Controlled Period|Adverse Event|5
461596|NCT00307437|1516612|P2|Controlled Period|Adverse Event|2
461597|NCT00307437|1516613|P1|Controlled Period|Adverse Event|7
461598|NCT00307333|1516639|P2|Overall Study|Lost to Follow-up|3
461599|NCT00307333|1516640|P1|Overall Study|Lost to Follow-up|11
461600|NCT00307294|1516652|P1|Overall Study|Withdrawal by Subject|1
461601|NCT00307164|1516661|P2|Overall Study|Lost to Follow-up|1
461602|NCT00307164|1516662|P1|Overall Study|Lost to Follow-up|6
461603|NCT00307164|1516661|P2|Overall Study|Not compliant with requirements|4
461604|NCT00307164|1516662|P1|Overall Study|Not compliant with requirements|4
461605|NCT00307164|1516661|P2|Overall Study|Withdrawal by Subject|8
461606|NCT00307164|1516662|P1|Overall Study|Withdrawal by Subject|1
461607|NCT00307164|1516661|P2|Overall Study|Subject/parent not able to get to clinic|1
461608|NCT00307164|1516662|P1|Overall Study|Subject/parent not able to get to clinic|2
461609|NCT00307164|1516661|P2|Overall Study|Severe debilitation, unable to continue|0
461610|NCT00307164|1516662|P1|Overall Study|Severe debilitation, unable to continue|1
461611|NCT00307164|1516661|P2|Overall Study|Death|0
461612|NCT00307164|1516662|P1|Overall Study|Death|1
461613|NCT00307151|1516702|P4|Overall Study|Clinic unable to contact subject|1
461614|NCT00307151|1516703|P3|Overall Study|Clinic unable to contact subject|1
461615|NCT00307151|1516704|P2|Overall Study|Clinic unable to contact subject|3
461616|NCT00307151|1516705|P1|Overall Study|Clinic unable to contact subject|3
461617|NCT00307151|1516702|P4|Overall Study|Not willing to adhere to study reqs|2
461618|NCT00307151|1516703|P3|Overall Study|Not willing to adhere to study reqs|2
461619|NCT00307151|1516704|P2|Overall Study|Not willing to adhere to study reqs|0
461620|NCT00307151|1516705|P1|Overall Study|Not willing to adhere to study reqs|2
461621|NCT00307151|1516702|P4|Overall Study|Withdrew consent|3
461622|NCT00307151|1516703|P3|Overall Study|Withdrew consent|1
461623|NCT00307151|1516704|P2|Overall Study|Withdrew consent|1
461624|NCT00307151|1516705|P1|Overall Study|Withdrew consent|0
461625|NCT00307151|1516702|P4|Overall Study|Subject unable to get to clinic|2
461626|NCT00307151|1516703|P3|Overall Study|Subject unable to get to clinic|6
461627|NCT00307151|1516704|P2|Overall Study|Subject unable to get to clinic|0
461628|NCT00307151|1516705|P1|Overall Study|Subject unable to get to clinic|1
461629|NCT00307151|1516702|P4|Overall Study|Severe debilitation, unable to continue|0
461630|NCT00307151|1516703|P3|Overall Study|Severe debilitation, unable to continue|0
461631|NCT00307151|1516704|P2|Overall Study|Severe debilitation, unable to continue|0
461632|NCT00307151|1516705|P1|Overall Study|Severe debilitation, unable to continue|1
461633|NCT00307151|1516702|P4|Overall Study|Death|3
461634|NCT00307151|1516703|P3|Overall Study|Death|10
461635|NCT00307151|1516704|P2|Overall Study|Death|3
461636|NCT00307151|1516705|P1|Overall Study|Death|4
461637|NCT00307125|1516749|P3|Pilot Phase|Withdrawal by Subject|1
461638|NCT00307125|1516750|P2|Pilot Phase|Withdrawal by Subject|1
461639|NCT00307125|1516751|P1|Pilot Phase|Withdrawal by Subject|0
461640|NCT00307125|1516749|P3|Pilot Phase|Lost to Follow-up|0
461641|NCT00307125|1516750|P2|Pilot Phase|Lost to Follow-up|1
461642|NCT00307125|1516751|P1|Pilot Phase|Lost to Follow-up|0
461643|NCT00307125|1516749|P3|Screening Phase|Coronary artery bypass|0
461644|NCT00307125|1516750|P2|Screening Phase|Coronary artery bypass|0
461645|NCT00307125|1516751|P1|Screening Phase|Coronary artery bypass|1
461646|NCT00307125|1516749|P3|Screening Phase|AMR and treated with rituximab|0
461647|NCT00307125|1516750|P2|Screening Phase|AMR and treated with rituximab|0
461648|NCT00307125|1516751|P1|Screening Phase|AMR and treated with rituximab|1
461649|NCT00307125|1516749|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
461650|NCT00307125|1516750|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
461651|NCT00307125|1516751|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
461652|NCT00307125|1516749|P3|Screening Phase|Screen Error|0
461653|NCT00307125|1516750|P2|Screening Phase|Screen Error|0
461654|NCT00307125|1516751|P1|Screening Phase|Screen Error|1
461655|NCT00307125|1516749|P3|Screening Phase|Ineligible|0
461656|NCT00307125|1516750|P2|Screening Phase|Ineligible|0
461657|NCT00307125|1516751|P1|Screening Phase|Ineligible|1
461658|NCT00307125|1516749|P3|Screening Phase|PAK|0
461659|NCT00307125|1516750|P2|Screening Phase|PAK|0
461660|NCT00307125|1516751|P1|Screening Phase|PAK|1
461661|NCT00307125|1516749|P3|Screening Phase|Malignancy|0
461662|NCT00307125|1516750|P2|Screening Phase|Malignancy|0
461663|NCT00307125|1516751|P1|Screening Phase|Malignancy|1
461664|NCT00307125|1516749|P3|Screening Phase|Metastatic colon cancer|0
461665|NCT00307125|1516750|P2|Screening Phase|Metastatic colon cancer|0
461666|NCT00307125|1516751|P1|Screening Phase|Metastatic colon cancer|1
461667|NCT00307125|1516749|P3|Screening Phase|Developed acute leukemia|0
461668|NCT00307125|1516750|P2|Screening Phase|Developed acute leukemia|0
461669|NCT00307125|1516751|P1|Screening Phase|Developed acute leukemia|1
461670|NCT00307125|1516749|P3|Screening Phase|Try to get pregnant|0
461671|NCT00307125|1516750|P2|Screening Phase|Try to get pregnant|0
461672|NCT00307125|1516751|P1|Screening Phase|Try to get pregnant|1
461673|NCT00307125|1516749|P3|Screening Phase|Ineligible for pilot|0
461674|NCT00307125|1516750|P2|Screening Phase|Ineligible for pilot|0
461675|NCT00307125|1516751|P1|Screening Phase|Ineligible for pilot|4
461676|NCT00307125|1516749|P3|Screening Phase|Received Pancreas Transplant|0
461677|NCT00307125|1516750|P2|Screening Phase|Received Pancreas Transplant|0
461678|NCT00307125|1516751|P1|Screening Phase|Received Pancreas Transplant|8
461679|NCT00307125|1516749|P3|Screening Phase|Moved or transferred facilities|0
461680|NCT00307125|1516750|P2|Screening Phase|Moved or transferred facilities|0
461681|NCT00307125|1516751|P1|Screening Phase|Moved or transferred facilities|34
461682|NCT00307125|1516749|P3|Screening Phase|Scheduling issues/Non-compliance|0
461683|NCT00307125|1516750|P2|Screening Phase|Scheduling issues/Non-compliance|0
461684|NCT00307125|1516751|P1|Screening Phase|Scheduling issues/Non-compliance|55
461685|NCT00307125|1516749|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
461686|NCT00307125|1516750|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
461687|NCT00307125|1516751|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
461688|NCT00307125|1516749|P3|Screening Phase|Graft Failure|0
461689|NCT00307125|1516750|P2|Screening Phase|Graft Failure|0
461690|NCT00307125|1516751|P1|Screening Phase|Graft Failure|8
461691|NCT00307125|1516749|P3|Screening Phase|Graft Loss|0
461692|NCT00307125|1516750|P2|Screening Phase|Graft Loss|0
461693|NCT00307125|1516751|P1|Screening Phase|Graft Loss|3
461694|NCT00307125|1516749|P3|Screening Phase|Study Terminated|0
461695|NCT00307125|1516750|P2|Screening Phase|Study Terminated|0
461696|NCT00307125|1516751|P1|Screening Phase|Study Terminated|17
461697|NCT00307125|1516749|P3|Screening Phase|Sponsor Decision|0
461698|NCT00307125|1516750|P2|Screening Phase|Sponsor Decision|0
461699|NCT00307125|1516751|P1|Screening Phase|Sponsor Decision|4
461700|NCT00307125|1516749|P3|Screening Phase|Physician Decision|0
461701|NCT00307125|1516750|P2|Screening Phase|Physician Decision|0
461702|NCT00307125|1516751|P1|Screening Phase|Physician Decision|26
461703|NCT00307125|1516749|P3|Screening Phase|Withdrawal by Subject|0
461704|NCT00307125|1516750|P2|Screening Phase|Withdrawal by Subject|0
461705|NCT00307125|1516751|P1|Screening Phase|Withdrawal by Subject|77
461706|NCT00307125|1516749|P3|Screening Phase|Death|0
461707|NCT00307125|1516750|P2|Screening Phase|Death|0
461708|NCT00307125|1516751|P1|Screening Phase|Death|10
461709|NCT00307125|1516749|P3|Screening Phase|Lost to Follow-up|0
461710|NCT00307125|1516750|P2|Screening Phase|Lost to Follow-up|0
461711|NCT00307125|1516751|P1|Screening Phase|Lost to Follow-up|87
461712|NCT00307125|1516749|P3|Screening Phase|Protocol Violation|0
461713|NCT00307125|1516750|P2|Screening Phase|Protocol Violation|0
461714|NCT00307125|1516751|P1|Screening Phase|Protocol Violation|27
461715|NCT00307125|1516749|P3|Screening Phase|Adverse Event|0
461716|NCT00307125|1516750|P2|Screening Phase|Adverse Event|0
461717|NCT00307125|1516751|P1|Screening Phase|Adverse Event|1
461718|NCT00307086|1516773|P1|Overall Study|ineligible|5
461719|NCT00307047|1516779|P2|Overall Study|All death, all MI, all Revascularization|16
461720|NCT00307047|1516780|P1|Overall Study|All death, all MI, all Revascularization|27
461721|NCT00307047|1516779|P2|Overall Study|Lost to follow-up for other reasons|1
461722|NCT00307047|1516780|P1|Overall Study|Lost to follow-up for other reasons|0
461723|NCT00307047|1516779|P2|Overall Study|Physician Decision|2
461724|NCT00307047|1516780|P1|Overall Study|Physician Decision|1
461725|NCT00307047|1516779|P2|Overall Study|Withdrawal by Subject|6
461726|NCT00307047|1516780|P1|Overall Study|Withdrawal by Subject|6
461727|NCT00307047|1516779|P2|Overall Study|Lost to Follow-up|24
461728|NCT00307047|1516780|P1|Overall Study|Lost to Follow-up|35
461729|NCT00307034|1516918|P2|Overall Study|Lost to Follow-up|3
461730|NCT00307034|1516919|P1|Overall Study|Lost to Follow-up|0
461731|NCT00307034|1516918|P2|Overall Study|Withdrawal by Subject|2
461732|NCT00307034|1516919|P1|Overall Study|Withdrawal by Subject|1
461733|NCT00307034|1516918|P2|Overall Study|Adverse Event|2
461734|NCT00307034|1516919|P1|Overall Study|Adverse Event|1
461735|NCT00306891|1516970|P4|Part B|Development of study specific disc crit.|1
461736|NCT00306891|1516971|P3|Part B|Development of study specific disc crit.|0
461737|NCT00306891|1516972|P2|Part B|Development of study specific disc crit.|0
461738|NCT00306891|1516973|P1|Part B|Development of study specific disc crit.|0
461739|NCT00306891|1516970|P4|Part B|Condition under investigation worsened|8
461740|NCT00306891|1516971|P3|Part B|Condition under investigation worsened|2
461741|NCT00306891|1516972|P2|Part B|Condition under investigation worsened|0
461742|NCT00306891|1516973|P1|Part B|Condition under investigation worsened|0
461743|NCT00306891|1516970|P4|Part B|Withdrawal by Subject|1
461744|NCT00306891|1516971|P3|Part B|Withdrawal by Subject|3
461745|NCT00306891|1516972|P2|Part B|Withdrawal by Subject|0
461746|NCT00306891|1516973|P1|Part B|Withdrawal by Subject|0
461747|NCT00306891|1516970|P4|Part B|Adverse Event|5
461748|NCT00306891|1516971|P3|Part B|Adverse Event|5
461749|NCT00306891|1516972|P2|Part B|Adverse Event|0
461750|NCT00306891|1516973|P1|Part B|Adverse Event|0
461751|NCT00306891|1516970|P4|Part B|Death|2
461752|NCT00306891|1516971|P3|Part B|Death|1
461753|NCT00306891|1516972|P2|Part B|Death|0
461754|NCT00306891|1516973|P1|Part B|Death|0
461755|NCT00306891|1516970|P4|Part A|QTC interval outwith elig. criteria|0
461756|NCT00306891|1516971|P3|Part A|QTC interval outwith elig. criteria|0
461757|NCT00306891|1516972|P2|Part A|QTC interval outwith elig. criteria|0
461758|NCT00306891|1516973|P1|Part A|QTC interval outwith elig. criteria|1
461759|NCT00306891|1516970|P4|Part A|Suspicion of second malignancy|0
461760|NCT00306891|1516971|P3|Part A|Suspicion of second malignancy|0
461761|NCT00306891|1516972|P2|Part A|Suspicion of second malignancy|1
461762|NCT00306891|1516973|P1|Part A|Suspicion of second malignancy|0
461763|NCT00306891|1516970|P4|Part A|Reaccumul. of ascites following drainage|0
461764|NCT00306891|1516971|P3|Part A|Reaccumul. of ascites following drainage|0
461765|NCT00306891|1516972|P2|Part A|Reaccumul. of ascites following drainage|1
461766|NCT00306891|1516973|P1|Part A|Reaccumul. of ascites following drainage|0
461767|NCT00306891|1516970|P4|Part A|Partial bowel obstruction|0
461768|NCT00306891|1516971|P3|Part A|Partial bowel obstruction|0
461769|NCT00306891|1516972|P2|Part A|Partial bowel obstruction|0
461770|NCT00306891|1516973|P1|Part A|Partial bowel obstruction|1
461771|NCT00306891|1516970|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
461772|NCT00306891|1516971|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
461773|NCT00306891|1516972|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
461774|NCT00306891|1516973|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
461775|NCT00306891|1516970|P4|Part A|Condition under investigation worsened|0
461776|NCT00306891|1516971|P3|Part A|Condition under investigation worsened|0
461777|NCT00306891|1516972|P2|Part A|Condition under investigation worsened|2
461778|NCT00306891|1516973|P1|Part A|Condition under investigation worsened|2
461779|NCT00306891|1516970|P4|Part A|Withdrawal by Subject|0
461780|NCT00306891|1516971|P3|Part A|Withdrawal by Subject|0
461781|NCT00306891|1516972|P2|Part A|Withdrawal by Subject|1
461782|NCT00306891|1516973|P1|Part A|Withdrawal by Subject|1
461783|NCT00306852|1516996|P2|Overall Study|Lost to Follow-up|24
461784|NCT00306852|1516997|P1|Overall Study|Lost to Follow-up|15
461785|NCT00306852|1516996|P2|Overall Study|Death|14
461786|NCT00306852|1516997|P1|Overall Study|Death|14
461787|NCT00306787|1517015|P2|Overall Study|Abnormal laboratory value(s)|0
461788|NCT00306787|1517016|P1|Overall Study|Abnormal laboratory value(s)|1
461789|NCT00306787|1517015|P2|Overall Study|Administrative problems|0
461790|NCT00306787|1517016|P1|Overall Study|Administrative problems|4
461791|NCT00306787|1517015|P2|Overall Study|Lost to Follow-up|6
461792|NCT00306787|1517016|P1|Overall Study|Lost to Follow-up|9
461793|NCT00306787|1517015|P2|Overall Study|Withdrawal by Subject|9
461794|NCT00306787|1517016|P1|Overall Study|Withdrawal by Subject|2
461795|NCT00306787|1517015|P2|Overall Study|Protocol Violation|10
461796|NCT00306787|1517016|P1|Overall Study|Protocol Violation|8
461797|NCT00306787|1517015|P2|Overall Study|Lack of Efficacy|0
461798|NCT00306787|1517016|P1|Overall Study|Lack of Efficacy|1
461799|NCT00306787|1517015|P2|Overall Study|Adverse Event|1
461800|NCT00306787|1517016|P1|Overall Study|Adverse Event|1
461801|NCT00306787|1517015|P2|Overall Study|Discontinued without taking study drug|215
461802|NCT00306787|1517016|P1|Overall Study|Discontinued without taking study drug|208
461803|NCT00306670|1517034|P2|Overall Study|patients recruited; Genentech, the st|2
461804|NCT00306670|1517035|P1|Overall Study|patients recruited; Genentech, the st|0
461805|NCT00306592|1517041|P2|Overall Study|48-week Treatment Period Ongoing|20
461806|NCT00306592|1517042|P1|Overall Study|48-week Treatment Period Ongoing|0
461807|NCT00306592|1517041|P2|Overall Study|Other|2
461808|NCT00306592|1517042|P1|Overall Study|Other|1
461809|NCT00306592|1517041|P2|Overall Study|Not Specified|10
461810|NCT00306592|1517042|P1|Overall Study|Not Specified|5
461811|NCT00306592|1517041|P2|Overall Study|Voluntary|6
461812|NCT00306592|1517042|P1|Overall Study|Voluntary|10
461813|NCT00306592|1517041|P2|Overall Study|Persistent Antibodies|3
461814|NCT00306592|1517042|P1|Overall Study|Persistent Antibodies|6
461815|NCT00306592|1517041|P2|Overall Study|Noncompliance|2
461816|NCT00306592|1517042|P1|Overall Study|Noncompliance|0
461817|NCT00306592|1517041|P2|Overall Study|Lost to Follow-up|0
461818|NCT00306592|1517042|P1|Overall Study|Lost to Follow-up|1
461819|NCT00306592|1517041|P2|Overall Study|Adverse Event|15
461820|NCT00306592|1517042|P1|Overall Study|Adverse Event|8
461821|NCT00306527|1517052|P4|Overall Study|Death|2
461822|NCT00306527|1517053|P3|Overall Study|Death|1
461823|NCT00306527|1517054|P2|Overall Study|Death|0
461824|NCT00306527|1517055|P1|Overall Study|Death|1
461825|NCT00306527|1517052|P4|Overall Study|Adverse Event|1
461826|NCT00306527|1517053|P3|Overall Study|Adverse Event|1
461827|NCT00306527|1517054|P2|Overall Study|Adverse Event|0
461828|NCT00306527|1517055|P1|Overall Study|Adverse Event|0
461829|NCT00306527|1517052|P4|Overall Study|Withdrawal by Subject|3
461830|NCT00306527|1517053|P3|Overall Study|Withdrawal by Subject|0
461831|NCT00306527|1517054|P2|Overall Study|Withdrawal by Subject|3
461832|NCT00306527|1517055|P1|Overall Study|Withdrawal by Subject|2
461833|NCT00306527|1517052|P4|Overall Study|Lost to Follow-up|0
461834|NCT00306527|1517053|P3|Overall Study|Lost to Follow-up|3
461835|NCT00306527|1517054|P2|Overall Study|Lost to Follow-up|4
461836|NCT00306527|1517055|P1|Overall Study|Lost to Follow-up|3
461837|NCT00306384|1517124|P3|Overall Study|Site closure|0
461838|NCT00306384|1517125|P2|Overall Study|Site closure|0
461839|NCT00306384|1517126|P1|Overall Study|Site closure|2
461840|NCT00306384|1517124|P3|Overall Study|Other|32
461841|NCT00306384|1517125|P2|Overall Study|Other|70
461842|NCT00306384|1517126|P1|Overall Study|Other|80
461843|NCT00306384|1517124|P3|Overall Study|Investigator discretion|21
461844|NCT00306384|1517125|P2|Overall Study|Investigator discretion|31
461845|NCT00306384|1517126|P1|Overall Study|Investigator discretion|28
461846|NCT00306384|1517124|P3|Overall Study|Lack of Efficacy|38
461847|NCT00306384|1517125|P2|Overall Study|Lack of Efficacy|40
461848|NCT00306384|1517126|P1|Overall Study|Lack of Efficacy|26
461849|NCT00306384|1517124|P3|Overall Study|Pregnancy|1
461850|NCT00306384|1517125|P2|Overall Study|Pregnancy|1
461851|NCT00306384|1517126|P1|Overall Study|Pregnancy|3
461852|NCT00306384|1517124|P3|Overall Study|Study termination|1
461853|NCT00306384|1517125|P2|Overall Study|Study termination|0
461854|NCT00306384|1517126|P1|Overall Study|Study termination|1
461855|NCT00306384|1517124|P3|Overall Study|Voluntary withdrawal|91
461856|NCT00306384|1517125|P2|Overall Study|Voluntary withdrawal|187
461857|NCT00306384|1517126|P1|Overall Study|Voluntary withdrawal|199
461858|NCT00306384|1517124|P3|Overall Study|Lost to Follow-up|35
461859|NCT00306384|1517125|P2|Overall Study|Lost to Follow-up|41
461860|NCT00306384|1517126|P1|Overall Study|Lost to Follow-up|57
461861|NCT00306384|1517124|P3|Overall Study|Major protocol deviation|18
461862|NCT00306384|1517125|P2|Overall Study|Major protocol deviation|51
461863|NCT00306384|1517126|P1|Overall Study|Major protocol deviation|43
461864|NCT00306384|1517124|P3|Overall Study|Adverse Event|40
461865|NCT00306384|1517125|P2|Overall Study|Adverse Event|87
461866|NCT00306384|1517126|P1|Overall Study|Adverse Event|103
461867|NCT00306293|1517158|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
461868|NCT00306293|1517159|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
461869|NCT00306293|1517158|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
461870|NCT00306293|1517159|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
461871|NCT00306293|1517158|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
461872|NCT00306293|1517159|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
461873|NCT00306293|1517158|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
461874|NCT00306293|1517159|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
461875|NCT00306293|1517158|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
461876|NCT00306293|1517159|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
461877|NCT00306293|1517158|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
461878|NCT00306293|1517159|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
461879|NCT00306293|1517158|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
461880|NCT00306293|1517159|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
461881|NCT00306293|1517158|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
461882|NCT00306293|1517159|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
461883|NCT00306202|1517180|P3|Overall Study|Still on treatment|0
461884|NCT00306202|1517181|P2|Overall Study|Still on treatment|1
461885|NCT00306202|1517182|P1|Overall Study|Still on treatment|6
461886|NCT00306189|1517342|P4|Overall Study|Other|0
461887|NCT00306189|1517343|P3|Overall Study|Other|0
461888|NCT00306189|1517344|P2|Overall Study|Other|0
461889|NCT00306189|1517345|P1|Overall Study|Other|1
461890|NCT00306189|1517342|P4|Overall Study|Ineligibility determined|1
461891|NCT00306189|1517343|P3|Overall Study|Ineligibility determined|1
461892|NCT00306189|1517344|P2|Overall Study|Ineligibility determined|1
461893|NCT00306189|1517345|P1|Overall Study|Ineligibility determined|1
461894|NCT00306189|1517342|P4|Overall Study|Withdrawal by Subject|1
461895|NCT00306189|1517343|P3|Overall Study|Withdrawal by Subject|8
461896|NCT00306189|1517344|P2|Overall Study|Withdrawal by Subject|2
461897|NCT00306189|1517345|P1|Overall Study|Withdrawal by Subject|4
461898|NCT00306189|1517342|P4|Overall Study|Adverse Event|2
461899|NCT00306189|1517343|P3|Overall Study|Adverse Event|2
461900|NCT00306189|1517344|P2|Overall Study|Adverse Event|3
461901|NCT00306189|1517345|P1|Overall Study|Adverse Event|3
461902|NCT00306189|1517342|P4|Overall Study|Physician Decision|1
461903|NCT00306189|1517343|P3|Overall Study|Physician Decision|0
461904|NCT00306189|1517344|P2|Overall Study|Physician Decision|0
461905|NCT00306189|1517345|P1|Overall Study|Physician Decision|0
461906|NCT00305877|1517372|P2|Overall Study|Transportation issue with daily RT|1
461907|NCT00305877|1517373|P1|Overall Study|Transportation issue with daily RT|0
461908|NCT00305877|1517372|P2|Overall Study|Ineligible|1
461909|NCT00305877|1517373|P1|Overall Study|Ineligible|2
461910|NCT00305877|1517372|P2|Overall Study|Never start treatment|5
461911|NCT00305877|1517373|P1|Overall Study|Never start treatment|2
461912|NCT00305877|1517372|P2|Overall Study|Physician Decision|1
461913|NCT00305877|1517373|P1|Overall Study|Physician Decision|1
461914|NCT00305877|1517372|P2|Overall Study|Withdrawal by Subject|2
461915|NCT00305877|1517373|P1|Overall Study|Withdrawal by Subject|4
461916|NCT00305877|1517372|P2|Overall Study|Death|1
461917|NCT00305877|1517373|P1|Overall Study|Death|0
461918|NCT00305877|1517372|P2|Overall Study|Adverse Event|14
461919|NCT00305877|1517373|P1|Overall Study|Adverse Event|9
461920|NCT00305877|1517372|P2|Overall Study|Lack of Efficacy|9
461921|NCT00305877|1517373|P1|Overall Study|Lack of Efficacy|6
461922|NCT00305864|1517387|P4|Overall Study|Ineligible / No protocol treatment|13
461923|NCT00305864|1517388|P3|Overall Study|Ineligible / No protocol treatment|1
461924|NCT00305864|1517389|P2|Overall Study|Ineligible / No protocol treatment|1
461925|NCT00305864|1517390|P1|Overall Study|Ineligible / No protocol treatment|0
461926|NCT00305773|1517403|P2|Overall Study|All other reasons|2
461927|NCT00305773|1517404|P1|Overall Study|All other reasons|3
461928|NCT00305773|1517403|P2|Overall Study|Disease Progression|3
461929|NCT00305773|1517404|P1|Overall Study|Disease Progression|1
461930|NCT00305773|1517403|P2|Overall Study|Withdrawal by Subject|4
461931|NCT00305773|1517404|P1|Overall Study|Withdrawal by Subject|1
461932|NCT00305773|1517403|P2|Overall Study|Physician Decision|1
461933|NCT00305773|1517404|P1|Overall Study|Physician Decision|1
461934|NCT00305773|1517403|P2|Overall Study|Alternative Treatment|4
461935|NCT00305773|1517404|P1|Overall Study|Alternative Treatment|4
461936|NCT00305773|1517403|P2|Overall Study|Adverse Event|2
461937|NCT00305773|1517404|P1|Overall Study|Adverse Event|1
461938|NCT00305773|1517403|P2|Overall Study|Death|2
461939|NCT00305773|1517404|P1|Overall Study|Death|3
461940|NCT00305604|1517435|P2|Overall Study|Patient moved|0
461941|NCT00305604|1517436|P1|Overall Study|Patient moved|1
461942|NCT00305604|1517435|P2|Overall Study|Withdrawal by Subject|21
461943|NCT00305604|1517436|P1|Overall Study|Withdrawal by Subject|12
461944|NCT00305604|1517435|P2|Overall Study|Protocol Violation|1
461945|NCT00305604|1517436|P1|Overall Study|Protocol Violation|2
461946|NCT00305604|1517435|P2|Overall Study|Lost to Follow-up|4
461947|NCT00305604|1517436|P1|Overall Study|Lost to Follow-up|0
461948|NCT00305604|1517435|P2|Overall Study|Lack of Efficacy|18
461949|NCT00305604|1517436|P1|Overall Study|Lack of Efficacy|11
461950|NCT00305604|1517435|P2|Overall Study|Adverse Event|3
461951|NCT00305604|1517436|P1|Overall Study|Adverse Event|6
461952|NCT00305448|1517580|P3|Overall Study|Tumor Marker Elevation|1
461953|NCT00305448|1517581|P2|Overall Study|Tumor Marker Elevation|0
461954|NCT00305448|1517582|P1|Overall Study|Tumor Marker Elevation|0
461955|NCT00305448|1517580|P3|Overall Study|Subjective Disease Progression|2
461956|NCT00305448|1517581|P2|Overall Study|Subjective Disease Progression|2
461957|NCT00305448|1517582|P1|Overall Study|Subjective Disease Progression|1
461958|NCT00305448|1517580|P3|Overall Study|Disease Progression|28
461959|NCT00305448|1517581|P2|Overall Study|Disease Progression|31
461960|NCT00305448|1517582|P1|Overall Study|Disease Progression|27
461961|NCT00305448|1517580|P3|Overall Study|Adverse Event|1
461962|NCT00305448|1517581|P2|Overall Study|Adverse Event|0
461963|NCT00305448|1517582|P1|Overall Study|Adverse Event|1
461964|NCT00305448|1517580|P3|Overall Study|Withdrawal by Subject|1
461965|NCT00305448|1517581|P2|Overall Study|Withdrawal by Subject|0
461966|NCT00305448|1517582|P1|Overall Study|Withdrawal by Subject|2
461967|NCT00305448|1517580|P3|Overall Study|Protocol Violation|0
461968|NCT00305448|1517581|P2|Overall Study|Protocol Violation|1
461969|NCT00305448|1517582|P1|Overall Study|Protocol Violation|0
461970|NCT00305253|1517604|P2|Overall Study|Withdrawal by Subject|1
461971|NCT00305253|1517605|P1|Overall Study|Withdrawal by Subject|0
461972|NCT00305227|1517617|P2|Overall Study|Lost to Follow-up|6
461973|NCT00305227|1517618|P1|Overall Study|Lost to Follow-up|7
461974|NCT00304954|1517669|P4|Overall Study|Adverse Event|0
461975|NCT00304954|1517670|P3|Overall Study|Adverse Event|0
461976|NCT00304954|1517671|P2|Overall Study|Adverse Event|0
461977|NCT00304954|1517672|P1|Overall Study|Adverse Event|1
461978|NCT00304954|1517669|P4|Overall Study|Withdrawal by Subject|0
461979|NCT00304954|1517670|P3|Overall Study|Withdrawal by Subject|1
461980|NCT00304954|1517671|P2|Overall Study|Withdrawal by Subject|0
461981|NCT00304954|1517672|P1|Overall Study|Withdrawal by Subject|0
461982|NCT00304915|1517692|P2|Overall Study|Withdrawal by Subject|0
461983|NCT00304915|1517693|P1|Overall Study|Withdrawal by Subject|3
461984|NCT00304915|1517692|P2|Overall Study|Death|5
461985|NCT00304915|1517693|P1|Overall Study|Death|4
461986|NCT00304915|1517692|P2|Overall Study|Lost to Follow-up|11
461987|NCT00304915|1517693|P1|Overall Study|Lost to Follow-up|11
461988|NCT00304356|1517719|P1|Nitazoxanide|Physician Decision|1
461989|NCT00304356|1517719|P1|Nitazoxanide|Physician Decision|1
461990|NCT00304356|1517719|P1|Nitazoxanide|Physician Decision|1
461991|NCT00304356|1517719|P1|Nitazoxanide|number is 0|1
461992|NCT00304356|1517719|P1|Nitazoxanide|Physician Decision|1
461993|NCT00304356|1517719|P1|Nitazoxanide|Physician Decision|5
461994|NCT00304278|1517723|P1|Overall Study|PT had medical condition preventing TX|1
461995|NCT00304278|1517723|P1|Overall Study|lack of insurance coverage for chemoRT|1
461996|NCT00304083|1517770|P2|Overall Study|Other|2
461997|NCT00304083|1517771|P1|Overall Study|Other|5
461998|NCT00304083|1517770|P2|Overall Study|Disease Progression|1
461999|NCT00304083|1517771|P1|Overall Study|Disease Progression|5
462000|NCT00304083|1517770|P2|Overall Study|Physician Decision|3
462001|NCT00304083|1517771|P1|Overall Study|Physician Decision|8
462002|NCT00304083|1517770|P2|Overall Study|Withdrawal by Subject|2
462003|NCT00304083|1517771|P1|Overall Study|Withdrawal by Subject|4
462004|NCT00304070|1517779|P3|Overall Study|Progressive Disease|4
462005|NCT00304070|1517780|P2|Overall Study|Progressive Disease|7
462006|NCT00304070|1517781|P1|Overall Study|Progressive Disease|3
462007|NCT00304070|1517779|P3|Overall Study|Withdrawal by Subject|1
462008|NCT00304070|1517780|P2|Overall Study|Withdrawal by Subject|0
462009|NCT00304070|1517781|P1|Overall Study|Withdrawal by Subject|0
462010|NCT00304070|1517779|P3|Overall Study|Physician Decision|3
462011|NCT00304070|1517780|P2|Overall Study|Physician Decision|0
462012|NCT00304070|1517781|P1|Overall Study|Physician Decision|0
462013|NCT00304070|1517779|P3|Overall Study|Lost to Follow-up|1
462014|NCT00304070|1517780|P2|Overall Study|Lost to Follow-up|0
462015|NCT00304070|1517781|P1|Overall Study|Lost to Follow-up|0
462016|NCT00304070|1517779|P3|Overall Study|Death|3
462017|NCT00304070|1517780|P2|Overall Study|Death|0
462018|NCT00304070|1517781|P1|Overall Study|Death|0
462019|NCT00304031|1517796|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
462020|NCT00304031|1517797|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
462021|NCT00304031|1517798|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
462022|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
462023|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
462024|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
462025|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
462026|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
462027|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
462028|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
462029|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
462030|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
462031|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
462032|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
462033|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
462034|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Death|0
462035|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Death|0
462036|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Death|18
462037|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
462038|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
462039|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
462040|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
462041|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
462042|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
462043|NCT00304031|1517796|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
462044|NCT00304031|1517797|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
462045|NCT00304031|1517798|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
462046|NCT00304031|1517796|P3|Registration|Ineligible|0
462047|NCT00304031|1517797|P2|Registration|Ineligible|0
462048|NCT00304031|1517798|P1|Registration|Ineligible|48
462049|NCT00303953|1517829|P1|Overall Study|Physician Decision|1
462050|NCT00303953|1517829|P1|Overall Study|Lack of Efficacy|12
462051|NCT00303953|1517829|P1|Overall Study|Adverse Event|4
462052|NCT00303953|1517829|P1|Overall Study|Death|1
462053|NCT00303953|1517829|P1|Overall Study|Ineligible|1
462054|NCT00303667|1517864|P2|Overall Study|Death|4
462055|NCT00303667|1517865|P1|Overall Study|Death|0
462056|NCT00303628|1517889|P2|Overall Study|Other|9
462057|NCT00303628|1517890|P1|Overall Study|Other|8
462058|NCT00303628|1517889|P2|Overall Study|Not start protocol therapy|5
462059|NCT00303628|1517890|P1|Overall Study|Not start protocol therapy|3
462060|NCT00303628|1517889|P2|Overall Study|Other complicating disease|1
462061|NCT00303628|1517890|P1|Overall Study|Other complicating disease|0
462062|NCT00303628|1517889|P2|Overall Study|Alternative therapy|0
462063|NCT00303628|1517890|P1|Overall Study|Alternative therapy|2
462064|NCT00303628|1517889|P2|Overall Study|Withdrawal by Subject|20
462065|NCT00303628|1517890|P1|Overall Study|Withdrawal by Subject|11
462066|NCT00303628|1517889|P2|Overall Study|Death|1
462067|NCT00303628|1517890|P1|Overall Study|Death|0
462068|NCT00303628|1517889|P2|Overall Study|Adverse Event|36
462069|NCT00303628|1517890|P1|Overall Study|Adverse Event|26
462070|NCT00303628|1517889|P2|Overall Study|Disease progression|1
462071|NCT00303628|1517890|P1|Overall Study|Disease progression|0
462072|NCT00303602|1517908|P2|Overall Study|Protocol Violation|0
462073|NCT00303602|1517909|P1|Overall Study|Protocol Violation|1
462074|NCT00303602|1517908|P2|Overall Study|Noncompliance|2
462075|NCT00303602|1517909|P1|Overall Study|Noncompliance|2
462076|NCT00303602|1517908|P2|Overall Study|Physician Decision|1
462077|NCT00303602|1517909|P1|Overall Study|Physician Decision|2
462078|NCT00303602|1517908|P2|Overall Study|Protocol entry criteria not met|2
462079|NCT00303602|1517909|P1|Overall Study|Protocol entry criteria not met|2
462080|NCT00303602|1517908|P2|Overall Study|Lost to Follow-up|2
462081|NCT00303602|1517909|P1|Overall Study|Lost to Follow-up|5
462082|NCT00303602|1517908|P2|Overall Study|Withdrawal by Subject|6
462083|NCT00303602|1517909|P1|Overall Study|Withdrawal by Subject|5
462084|NCT00303602|1517908|P2|Overall Study|Adverse Event|2
462085|NCT00303602|1517909|P1|Overall Study|Adverse Event|2
462086|NCT00303485|1517955|P2|Overall Study|Withdrawal by Subject|0
462087|NCT00303485|1517956|P1|Overall Study|Withdrawal by Subject|1
462088|NCT00303485|1517955|P2|Overall Study|Failure to return|1
462089|NCT00303485|1517956|P1|Overall Study|Failure to return|0
462090|NCT00303485|1517955|P2|Overall Study|Adverse Event/Intercurrent Illness|1
462091|NCT00303485|1517956|P1|Overall Study|Adverse Event/Intercurrent Illness|0
462092|NCT00303472|1517987|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
462093|NCT00303472|1517988|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
462094|NCT00303472|1517989|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
462095|NCT00303472|1517990|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
462096|NCT00303472|1517991|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
462097|NCT00303472|1517992|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
462098|NCT00303472|1517993|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
462099|NCT00303472|1517987|P7|Treatment Extension (Optional)|Not specified|0
462100|NCT00303472|1517988|P6|Treatment Extension (Optional)|Not specified|0
462101|NCT00303472|1517989|P5|Treatment Extension (Optional)|Not specified|1
462102|NCT00303472|1517990|P4|Treatment Extension (Optional)|Not specified|2
462103|NCT00303472|1517991|P3|Treatment Extension (Optional)|Not specified|4
462104|NCT00303472|1517992|P2|Treatment Extension (Optional)|Not specified|2
462105|NCT00303472|1517993|P1|Treatment Extension (Optional)|Not specified|0
462106|NCT00303472|1517987|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
462107|NCT00303472|1517988|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
462108|NCT00303472|1517989|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
462109|NCT00303472|1517990|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
462110|NCT00303472|1517991|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
462111|NCT00303472|1517992|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
462112|NCT00303472|1517993|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
462113|NCT00303472|1517987|P7|Treatment Extension (Optional)|Physician Decision|0
462114|NCT00303472|1517988|P6|Treatment Extension (Optional)|Physician Decision|0
462115|NCT00303472|1517989|P5|Treatment Extension (Optional)|Physician Decision|2
462116|NCT00303472|1517990|P4|Treatment Extension (Optional)|Physician Decision|3
462117|NCT00303472|1517991|P3|Treatment Extension (Optional)|Physician Decision|2
462118|NCT00303472|1517992|P2|Treatment Extension (Optional)|Physician Decision|4
462119|NCT00303472|1517993|P1|Treatment Extension (Optional)|Physician Decision|0
462120|NCT00303472|1517987|P7|Treatment Extension (Optional)|Lost to Follow-up|0
462121|NCT00303472|1517988|P6|Treatment Extension (Optional)|Lost to Follow-up|0
462122|NCT00303472|1517989|P5|Treatment Extension (Optional)|Lost to Follow-up|0
462123|NCT00303472|1517990|P4|Treatment Extension (Optional)|Lost to Follow-up|1
462124|NCT00303472|1517991|P3|Treatment Extension (Optional)|Lost to Follow-up|0
462125|NCT00303472|1517992|P2|Treatment Extension (Optional)|Lost to Follow-up|0
462126|NCT00303472|1517993|P1|Treatment Extension (Optional)|Lost to Follow-up|0
462127|NCT00303472|1517987|P7|Treatment Extension (Optional)|Death|0
462128|NCT00303472|1517988|P6|Treatment Extension (Optional)|Death|0
462129|NCT00303472|1517989|P5|Treatment Extension (Optional)|Death|0
462130|NCT00303472|1517990|P4|Treatment Extension (Optional)|Death|0
462131|NCT00303472|1517991|P3|Treatment Extension (Optional)|Death|1
462132|NCT00303472|1517992|P2|Treatment Extension (Optional)|Death|0
462133|NCT00303472|1517993|P1|Treatment Extension (Optional)|Death|2
462134|NCT00303472|1517987|P7|Treatment Extension (Optional)|Adverse Event|0
462135|NCT00303472|1517988|P6|Treatment Extension (Optional)|Adverse Event|0
462136|NCT00303472|1517989|P5|Treatment Extension (Optional)|Adverse Event|0
462137|NCT00303472|1517990|P4|Treatment Extension (Optional)|Adverse Event|0
462138|NCT00303472|1517991|P3|Treatment Extension (Optional)|Adverse Event|1
462139|NCT00303472|1517992|P2|Treatment Extension (Optional)|Adverse Event|0
462140|NCT00303472|1517993|P1|Treatment Extension (Optional)|Adverse Event|1
462141|NCT00303472|1517987|P7|Treatment Period|Disease Progression (to AML)|0
462142|NCT00303472|1517988|P6|Treatment Period|Disease Progression (to AML)|0
462143|NCT00303472|1517989|P5|Treatment Period|Disease Progression (to AML)|1
462144|NCT00303472|1517990|P4|Treatment Period|Disease Progression (to AML)|0
462145|NCT00303472|1517991|P3|Treatment Period|Disease Progression (to AML)|0
462146|NCT00303472|1517992|P2|Treatment Period|Disease Progression (to AML)|0
462147|NCT00303472|1517993|P1|Treatment Period|Disease Progression (to AML)|0
462148|NCT00303472|1517987|P7|Treatment Period|Not specified|1
462149|NCT00303472|1517988|P6|Treatment Period|Not specified|0
462150|NCT00303472|1517989|P5|Treatment Period|Not specified|1
462151|NCT00303472|1517990|P4|Treatment Period|Not specified|0
462152|NCT00303472|1517991|P3|Treatment Period|Not specified|0
462153|NCT00303472|1517992|P2|Treatment Period|Not specified|0
462154|NCT00303472|1517993|P1|Treatment Period|Not specified|0
462155|NCT00303472|1517987|P7|Treatment Period|Withdrawal by Subject|0
462156|NCT00303472|1517988|P6|Treatment Period|Withdrawal by Subject|1
462157|NCT00303472|1517989|P5|Treatment Period|Withdrawal by Subject|0
462158|NCT00303472|1517990|P4|Treatment Period|Withdrawal by Subject|1
462159|NCT00303472|1517991|P3|Treatment Period|Withdrawal by Subject|0
462160|NCT00303472|1517992|P2|Treatment Period|Withdrawal by Subject|0
462161|NCT00303472|1517993|P1|Treatment Period|Withdrawal by Subject|0
462162|NCT00303472|1517987|P7|Treatment Period|Death|1
462163|NCT00303472|1517988|P6|Treatment Period|Death|0
462164|NCT00303472|1517989|P5|Treatment Period|Death|0
462165|NCT00303472|1517990|P4|Treatment Period|Death|1
462166|NCT00303472|1517991|P3|Treatment Period|Death|0
462167|NCT00303472|1517992|P2|Treatment Period|Death|0
462168|NCT00303472|1517993|P1|Treatment Period|Death|0
462169|NCT00303472|1517987|P7|Treatment Period|Adverse Event|0
462170|NCT00303472|1517988|P6|Treatment Period|Adverse Event|0
462171|NCT00303472|1517989|P5|Treatment Period|Adverse Event|1
462172|NCT00303472|1517990|P4|Treatment Period|Adverse Event|0
462173|NCT00303472|1517991|P3|Treatment Period|Adverse Event|0
462174|NCT00303472|1517992|P2|Treatment Period|Adverse Event|0
462175|NCT00303472|1517993|P1|Treatment Period|Adverse Event|0
462176|NCT00303459|1518053|P2|Overall Study|Lung transplantation|1
462177|NCT00303459|1518054|P1|Overall Study|Lung transplantation|1
462178|NCT00303459|1518053|P2|Overall Study|Decision by the investigator|7
462179|NCT00303459|1518054|P1|Overall Study|Decision by the investigator|5
462180|NCT00303459|1518053|P2|Overall Study|Administrative reason|7
462181|NCT00303459|1518054|P1|Overall Study|Administrative reason|7
462182|NCT00303459|1518053|P2|Overall Study|Lost to Follow-up|4
462183|NCT00303459|1518054|P1|Overall Study|Lost to Follow-up|5
462184|NCT00303459|1518053|P2|Overall Study|Withdrawal of consent|26
462185|NCT00303459|1518054|P1|Overall Study|Withdrawal of consent|32
462186|NCT00303459|1518053|P2|Overall Study|Death|44
462187|NCT00303459|1518054|P1|Overall Study|Death|33
462188|NCT00303446|1518080|P2|Overall Study|Physician Decision|1
462189|NCT00303446|1518081|P1|Overall Study|Physician Decision|0
462190|NCT00303446|1518080|P2|Overall Study|Death|1
462191|NCT00303446|1518081|P1|Overall Study|Death|0
462192|NCT00303446|1518080|P2|Overall Study|Withdrawal by Subject|2
462193|NCT00303446|1518081|P1|Overall Study|Withdrawal by Subject|2
462194|NCT00303329|1518117|P2|Overall Study|Stopped at end of extension 1|0
462195|NCT00303329|1518118|P1|Overall Study|Stopped at end of extension 1|1
462196|NCT00303329|1518117|P2|Overall Study|Stopped at end of core|9
462197|NCT00303329|1518118|P1|Overall Study|Stopped at end of core|3
462198|NCT00303329|1518117|P2|Overall Study|Death|12
462199|NCT00303329|1518118|P1|Overall Study|Death|2
462200|NCT00303329|1518117|P2|Overall Study|Administrative problems|0
462201|NCT00303329|1518118|P1|Overall Study|Administrative problems|1
462202|NCT00303329|1518117|P2|Overall Study|Lost to Follow-up|1
462203|NCT00303329|1518118|P1|Overall Study|Lost to Follow-up|0
462204|NCT00303329|1518117|P2|Overall Study|Withdrawal by Subject|15
462205|NCT00303329|1518118|P1|Overall Study|Withdrawal by Subject|9
462206|NCT00303329|1518117|P2|Overall Study|Protocol Violation|0
462207|NCT00303329|1518118|P1|Overall Study|Protocol Violation|3
462208|NCT00303329|1518117|P2|Overall Study|Condition no longer requires study drug|8
462209|NCT00303329|1518118|P1|Overall Study|Condition no longer requires study drug|0
462210|NCT00303329|1518117|P2|Overall Study|Unsatisfactory therapeutic effect|2
462211|NCT00303329|1518118|P1|Overall Study|Unsatisfactory therapeutic effect|9
462212|NCT00303329|1518117|P2|Overall Study|Abnormal Laboratory Values|1
462213|NCT00303329|1518118|P1|Overall Study|Abnormal Laboratory Values|0
462214|NCT00303329|1518117|P2|Overall Study|Adverse Event|14
462215|NCT00303329|1518118|P1|Overall Study|Adverse Event|7
462216|NCT00303316|1518132|P2|Overall Study|Withdrawal by Subject|2
462217|NCT00303316|1518133|P1|Overall Study|Withdrawal by Subject|1
462218|NCT00303316|1518132|P2|Overall Study|Lost to Follow-up|1
462219|NCT00303316|1518133|P1|Overall Study|Lost to Follow-up|0
462220|NCT00303316|1518132|P2|Overall Study|Protocol Violation|0
462221|NCT00303316|1518133|P1|Overall Study|Protocol Violation|1
462222|NCT00303186|1518145|P1|Overall Study|Other|52
462223|NCT00303108|1518179|P3|Overall Study|ineligible|0
462224|NCT00303108|1518180|P2|Overall Study|ineligible|1
462225|NCT00303108|1518181|P1|Overall Study|ineligible|2
462226|NCT00303108|1518179|P3|Overall Study|Failed Entry|1
462227|NCT00303108|1518180|P2|Overall Study|Failed Entry|0
462228|NCT00303108|1518181|P1|Overall Study|Failed Entry|1
462229|NCT00303108|1518179|P3|Overall Study|Patient Request|8
462230|NCT00303108|1518180|P2|Overall Study|Patient Request|2
462231|NCT00303108|1518181|P1|Overall Study|Patient Request|4
462232|NCT00303108|1518179|P3|Overall Study|Adverse Event|7
462233|NCT00303108|1518180|P2|Overall Study|Adverse Event|6
462234|NCT00303108|1518181|P1|Overall Study|Adverse Event|5
462235|NCT00303069|1518201|P4|Overall Study|Recruitment into Army Reserves|0
462236|NCT00303069|1518202|P3|Overall Study|Recruitment into Army Reserves|1
462237|NCT00303069|1518203|P2|Overall Study|Recruitment into Army Reserves|0
462238|NCT00303069|1518204|P1|Overall Study|Recruitment into Army Reserves|0
462239|NCT00303069|1518201|P4|Overall Study|subject moved|0
462240|NCT00303069|1518202|P3|Overall Study|subject moved|0
462241|NCT00303069|1518203|P2|Overall Study|subject moved|0
462242|NCT00303069|1518204|P1|Overall Study|subject moved|1
462243|NCT00303069|1518201|P4|Overall Study|Lost to Follow-up|2
462244|NCT00303069|1518202|P3|Overall Study|Lost to Follow-up|0
462245|NCT00303069|1518203|P2|Overall Study|Lost to Follow-up|0
462246|NCT00303069|1518204|P1|Overall Study|Lost to Follow-up|1
462247|NCT00302952|1518224|P2|Overall Study|Elevated SGOT (AST) lab value|1
462248|NCT00302952|1518225|P1|Overall Study|Elevated SGOT (AST) lab value|0
462249|NCT00302952|1518224|P2|Overall Study|Withdrawal by Subject|3
462250|NCT00302952|1518225|P1|Overall Study|Withdrawal by Subject|2
462251|NCT00302952|1518224|P2|Overall Study|Physician Decision|1
462252|NCT00302952|1518225|P1|Overall Study|Physician Decision|1
462253|NCT00302731|1518275|P4|Overall Study|cancer unrelated to study discovered|0
462254|NCT00302731|1518276|P3|Overall Study|cancer unrelated to study discovered|1
462255|NCT00302731|1518277|P2|Overall Study|cancer unrelated to study discovered|0
462256|NCT00302731|1518278|P1|Overall Study|cancer unrelated to study discovered|1
462257|NCT00302731|1518275|P4|Overall Study|Protocol Violation|0
462258|NCT00302731|1518276|P3|Overall Study|Protocol Violation|0
462259|NCT00302731|1518277|P2|Overall Study|Protocol Violation|0
462260|NCT00302731|1518278|P1|Overall Study|Protocol Violation|1
462261|NCT00302731|1518275|P4|Overall Study|Withdrawal by Subject|0
462262|NCT00302731|1518276|P3|Overall Study|Withdrawal by Subject|0
462263|NCT00302731|1518277|P2|Overall Study|Withdrawal by Subject|1
462264|NCT00302731|1518278|P1|Overall Study|Withdrawal by Subject|1
462265|NCT00302731|1518275|P4|Overall Study|Adverse Event|0
462266|NCT00302731|1518276|P3|Overall Study|Adverse Event|2
462267|NCT00302731|1518277|P2|Overall Study|Adverse Event|2
462268|NCT00302731|1518278|P1|Overall Study|Adverse Event|0
462269|NCT00302731|1518275|P4|Overall Study|Lost to Follow-up|0
462270|NCT00302731|1518276|P3|Overall Study|Lost to Follow-up|0
462271|NCT00302731|1518277|P2|Overall Study|Lost to Follow-up|2
462272|NCT00302731|1518278|P1|Overall Study|Lost to Follow-up|1
462273|NCT00302718|1518304|P4|Overall Study|Participant left primary care setting|1
462274|NCT00302718|1518305|P3|Overall Study|Participant left primary care setting|2
462275|NCT00302718|1518306|P2|Overall Study|Participant left primary care setting|0
462276|NCT00302718|1518307|P1|Overall Study|Participant left primary care setting|0
462277|NCT00302718|1518304|P4|Overall Study|Withdrawal by Subject|0
462278|NCT00302718|1518305|P3|Overall Study|Withdrawal by Subject|0
462279|NCT00302718|1518306|P2|Overall Study|Withdrawal by Subject|1
462280|NCT00302718|1518307|P1|Overall Study|Withdrawal by Subject|0
462281|NCT00302718|1518304|P4|Overall Study|Participant left the hospital|1
462282|NCT00302718|1518305|P3|Overall Study|Participant left the hospital|0
462283|NCT00302718|1518306|P2|Overall Study|Participant left the hospital|0
462284|NCT00302718|1518307|P1|Overall Study|Participant left the hospital|1
462285|NCT00302458|1518339|P1|Overall Study|Withdrawal by Subject|1
462286|NCT00302458|1518339|P1|Overall Study|Ineligible after screening|1
462287|NCT00302458|1518339|P1|Overall Study|Lost to Follow-up|1
462288|NCT00302328|1518350|P3|Overall Study|Physician Decision|0
462289|NCT00302328|1518351|P2|Overall Study|Physician Decision|1
462290|NCT00302328|1518352|P1|Overall Study|Physician Decision|0
462291|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
462292|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
462293|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
462294|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
462295|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
462296|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
462297|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
462298|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
462299|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
462300|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
462301|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
462302|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
462303|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
462304|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
462305|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
462306|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|Death|1
462307|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|Death|1
462308|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|Death|0
462309|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|Death|0
462310|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|Death|0
462311|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|Disease progression|2
462312|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|Disease progression|1
462313|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|Disease progression|0
462314|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|Disease progression|0
462315|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|Disease progression|0
462316|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
462317|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
462318|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
462319|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
462320|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
462321|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|Adverse Event|0
462322|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|Adverse Event|1
462323|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|Adverse Event|0
462324|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|Adverse Event|0
462325|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|Adverse Event|0
462326|NCT00302211|1518369|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
462327|NCT00302211|1518370|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
462328|NCT00302211|1518371|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
462329|NCT00302211|1518372|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
462330|NCT00302211|1518373|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
462331|NCT00302211|1518369|P5|Double Blind Period (New Patients)|Disease progression|0
462332|NCT00302211|1518370|P4|Double Blind Period (New Patients)|Disease progression|0
462333|NCT00302211|1518371|P3|Double Blind Period (New Patients)|Disease progression|1
462334|NCT00302211|1518372|P2|Double Blind Period (New Patients)|Disease progression|1
462335|NCT00302211|1518373|P1|Double Blind Period (New Patients)|Disease progression|0
462336|NCT00302211|1518369|P5|Double Blind Period (New Patients)|Investigator's judgement|0
462337|NCT00302211|1518370|P4|Double Blind Period (New Patients)|Investigator's judgement|0
462338|NCT00302211|1518371|P3|Double Blind Period (New Patients)|Investigator's judgement|0
462339|NCT00302211|1518372|P2|Double Blind Period (New Patients)|Investigator's judgement|0
462340|NCT00302211|1518373|P1|Double Blind Period (New Patients)|Investigator's judgement|1
462341|NCT00302211|1518369|P5|Double Blind Period (New Patients)|Adverse Event|0
462342|NCT00302211|1518370|P4|Double Blind Period (New Patients)|Adverse Event|0
462343|NCT00302211|1518371|P3|Double Blind Period (New Patients)|Adverse Event|3
462344|NCT00302211|1518372|P2|Double Blind Period (New Patients)|Adverse Event|0
462345|NCT00302211|1518373|P1|Double Blind Period (New Patients)|Adverse Event|0
462346|NCT00302211|1518369|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
462347|NCT00302211|1518370|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
462348|NCT00302211|1518371|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
462349|NCT00302211|1518372|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
462350|NCT00302211|1518373|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
462351|NCT00302159|1518385|P1|Overall Study|pt started Avastin|1
462352|NCT00302159|1518385|P1|Overall Study|pt declined before treatment started|1
462353|NCT00302107|1518407|P2|Overall Study|Adverse Event|0
462354|NCT00302107|1518408|P1|Overall Study|Adverse Event|1
462355|NCT00302107|1518407|P2|Overall Study|Withdrawal by Subject|3
462356|NCT00302107|1518408|P1|Overall Study|Withdrawal by Subject|0
462357|NCT00302107|1518407|P2|Overall Study|Relocation|1
462358|NCT00302107|1518408|P1|Overall Study|Relocation|0
462359|NCT00302107|1518407|P2|Overall Study|Protocol Violation|0
462360|NCT00302107|1518408|P1|Overall Study|Protocol Violation|1
462361|NCT00302107|1518407|P2|Overall Study|Lost to Follow-up|5
462362|NCT00302107|1518408|P1|Overall Study|Lost to Follow-up|6
462363|NCT00302081|1518417|P3|Overall Study|Other|5
462364|NCT00302081|1518418|P2|Overall Study|Other|6
462365|NCT00302081|1518419|P1|Overall Study|Other|13
462366|NCT00302081|1518417|P3|Overall Study|Death|0
462367|NCT00302081|1518418|P2|Overall Study|Death|1
462368|NCT00302081|1518419|P1|Overall Study|Death|2
462369|NCT00302081|1518417|P3|Overall Study|Lack of Efficacy|5
462370|NCT00302081|1518418|P2|Overall Study|Lack of Efficacy|0
462371|NCT00302081|1518419|P1|Overall Study|Lack of Efficacy|1
462372|NCT00302081|1518417|P3|Overall Study|Protocol Violation|2
462373|NCT00302081|1518418|P2|Overall Study|Protocol Violation|1
462374|NCT00302081|1518419|P1|Overall Study|Protocol Violation|5
462375|NCT00302081|1518417|P3|Overall Study|Withdrawal by Subject|8
462376|NCT00302081|1518418|P2|Overall Study|Withdrawal by Subject|12
462377|NCT00302081|1518419|P1|Overall Study|Withdrawal by Subject|8
462378|NCT00302081|1518417|P3|Overall Study|Lost to Follow-up|28
462379|NCT00302081|1518418|P2|Overall Study|Lost to Follow-up|18
462380|NCT00302081|1518419|P1|Overall Study|Lost to Follow-up|21
462381|NCT00302081|1518417|P3|Overall Study|Adverse Event|4
462382|NCT00302081|1518418|P2|Overall Study|Adverse Event|5
462383|NCT00302081|1518419|P1|Overall Study|Adverse Event|6
462384|NCT00302003|1518476|P1|Overall Study|Protocol Violation|1
462385|NCT00302003|1518476|P1|Overall Study|Ineligible|9
462386|NCT00302003|1518476|P1|Overall Study|Withdrawal by Subject|5
462387|NCT00302003|1518476|P1|Overall Study|Physician Decision|2
462388|NCT00302003|1518476|P1|Overall Study|Lost to Follow-up|1
462389|NCT00302003|1518476|P1|Overall Study|Lack of Efficacy|62
462390|NCT00301964|1518483|P1|Overall Study|Inadequate pathology|1
462391|NCT00301964|1518483|P1|Overall Study|Wrong primary|1
462392|NCT00301964|1518483|P1|Overall Study|Second primary|2
462393|NCT00301834|1518504|P1|Overall Study|Death|1
462394|NCT00301821|1518513|P1|Overall Study|Cancel|1
462395|NCT00301821|1518513|P1|Overall Study|Ineligible|25
462396|NCT00301808|1518520|P1|Overall Study|Lack of Efficacy|4
462397|NCT00301808|1518520|P1|Overall Study|Death|3
462398|NCT00301808|1518520|P1|Overall Study|Adverse Event|5
462399|NCT00301366|1518542|P1|Overall Study|Adverse Event|1
462400|NCT00301262|1518548|P2|Open Label Phase (OL)|Other|0
462401|NCT00301262|1518549|P1|Open Label Phase (OL)|Other|2
462402|NCT00301262|1518548|P2|Open Label Phase (OL)|Lost to Follow-up|2
462403|NCT00301262|1518549|P1|Open Label Phase (OL)|Lost to Follow-up|1
462404|NCT00301262|1518548|P2|Open Label Phase (OL)|Adverse Event|0
462405|NCT00301262|1518549|P1|Open Label Phase (OL)|Adverse Event|1
462406|NCT00301262|1518548|P2|Double Blind Phase (DB)|Other|4
462407|NCT00301262|1518549|P1|Double Blind Phase (DB)|Other|1
462408|NCT00301262|1518548|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
462409|NCT00301262|1518549|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
462410|NCT00301262|1518548|P2|Double Blind Phase (DB)|Lost to Follow-up|3
462411|NCT00301262|1518549|P1|Double Blind Phase (DB)|Lost to Follow-up|3
462412|NCT00301262|1518548|P2|Double Blind Phase (DB)|Lack of Efficacy|1
462413|NCT00301262|1518549|P1|Double Blind Phase (DB)|Lack of Efficacy|0
462414|NCT00301262|1518548|P2|Double Blind Phase (DB)|Adverse Event|0
462415|NCT00301262|1518549|P1|Double Blind Phase (DB)|Adverse Event|1
462416|NCT00301080|1518707|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
462417|NCT00301080|1518708|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
462418|NCT00301080|1518709|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
462419|NCT00301080|1518710|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
462420|NCT00301080|1518711|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
462421|NCT00300885|1518746|P2|Follow-up|Withdrawal by Subject|25
462422|NCT00300885|1518747|P1|Follow-up|Withdrawal by Subject|26
462423|NCT00300885|1518746|P2|Follow-up|Lost to Follow-up|7
462424|NCT00300885|1518747|P1|Follow-up|Lost to Follow-up|11
462425|NCT00300885|1518746|P2|Follow-up|Death|163
462426|NCT00300885|1518747|P1|Follow-up|Death|141
462427|NCT00300885|1518746|P2|Treatment|Non-compliant with study medication|4
462428|NCT00300885|1518747|P1|Treatment|Non-compliant with study medication|3
462429|NCT00300885|1518746|P2|Treatment|Random code broken (subject died)|1
462430|NCT00300885|1518747|P1|Treatment|Random code broken (subject died)|0
462431|NCT00300885|1518746|P2|Treatment|Disease progression|238
462432|NCT00300885|1518747|P1|Treatment|Disease progression|171
462433|NCT00300885|1518746|P2|Treatment|Withdrawal by Subject|23
462434|NCT00300885|1518747|P1|Treatment|Withdrawal by Subject|26
462435|NCT00300885|1518746|P2|Treatment|Protocol Violation|11
462436|NCT00300885|1518747|P1|Treatment|Protocol Violation|11
462437|NCT00300885|1518746|P2|Treatment|Physician Decision|5
462438|NCT00300885|1518747|P1|Treatment|Physician Decision|4
462439|NCT00300885|1518746|P2|Treatment|Lost to Follow-up|2
462440|NCT00300885|1518747|P1|Treatment|Lost to Follow-up|3
462441|NCT00300885|1518746|P2|Treatment|Lack of Efficacy|1
462442|NCT00300885|1518747|P1|Treatment|Lack of Efficacy|1
462443|NCT00300885|1518746|P2|Treatment|Death|7
462444|NCT00300885|1518747|P1|Treatment|Death|20
462445|NCT00300885|1518746|P2|Treatment|Adverse Event|82
462446|NCT00300885|1518747|P1|Treatment|Adverse Event|134
462447|NCT00300781|1518765|P2|Overall Study|Lost to Follow-up|1
462448|NCT00300781|1518766|P1|Overall Study|Lost to Follow-up|0
462449|NCT00300781|1518765|P2|Overall Study|Symptomatic Deterioration|0
462450|NCT00300781|1518766|P1|Overall Study|Symptomatic Deterioration|1
462451|NCT00300781|1518765|P2|Overall Study|Not Recorded|1
462452|NCT00300781|1518766|P1|Overall Study|Not Recorded|0
462453|NCT00300781|1518765|P2|Overall Study|Physician Decision|0
462454|NCT00300781|1518766|P1|Overall Study|Physician Decision|1
462455|NCT00300781|1518765|P2|Overall Study|Withdrawal by Subject|2
462456|NCT00300781|1518766|P1|Overall Study|Withdrawal by Subject|1
462457|NCT00300781|1518765|P2|Overall Study|Adverse Event|6
462458|NCT00300781|1518766|P1|Overall Study|Adverse Event|5
462459|NCT00300781|1518765|P2|Overall Study|Disease Progression|52
462460|NCT00300781|1518766|P1|Overall Study|Disease Progression|55
462461|NCT00300755|1518781|P3|Overall Study|Protocol Violation|1
462462|NCT00300755|1518782|P2|Overall Study|Protocol Violation|0
462463|NCT00300755|1518783|P1|Overall Study|Protocol Violation|0
462464|NCT00300755|1518781|P3|Overall Study|Withdrawal by Subject|0
462465|NCT00300755|1518782|P2|Overall Study|Withdrawal by Subject|2
462466|NCT00300755|1518783|P1|Overall Study|Withdrawal by Subject|0
462467|NCT00300755|1518781|P3|Overall Study|Adverse Event|1
462468|NCT00300755|1518782|P2|Overall Study|Adverse Event|2
462469|NCT00300755|1518783|P1|Overall Study|Adverse Event|1
462470|NCT00300495|1518817|P2|Overall Study|Protocol Violation|1
462471|NCT00300495|1518818|P1|Overall Study|Protocol Violation|4
462472|NCT00300365|1519085|P2|Overall Study|Adverse Event|2
462473|NCT00300365|1519086|P1|Overall Study|Adverse Event|0
462474|NCT00300365|1519085|P2|Overall Study|Withdrawal by Subject|0
462475|NCT00300365|1519086|P1|Overall Study|Withdrawal by Subject|1
462476|NCT00300365|1519085|P2|Overall Study|Physician Decision|0
462477|NCT00300365|1519086|P1|Overall Study|Physician Decision|2
462478|NCT00300365|1519085|P2|Overall Study|Lost to Follow-up|0
462479|NCT00300365|1519086|P1|Overall Study|Lost to Follow-up|1
462480|NCT00300274|1519095|P3|Overall Study|Re-transplant|1
462481|NCT00300274|1519096|P2|Overall Study|Re-transplant|0
462482|NCT00300274|1519097|P1|Overall Study|Re-transplant|0
462483|NCT00300274|1519095|P3|Overall Study|Death|25
462484|NCT00300274|1519096|P2|Overall Study|Death|20
462485|NCT00300274|1519097|P1|Overall Study|Death|31
462486|NCT00300274|1519095|P3|Overall Study|Lost to Follow-up|5
462487|NCT00300274|1519096|P2|Overall Study|Lost to Follow-up|4
462488|NCT00300274|1519097|P1|Overall Study|Lost to Follow-up|3
462489|NCT00300274|1519095|P3|Overall Study|Withdrawal by Subject|14
462490|NCT00300274|1519096|P2|Overall Study|Withdrawal by Subject|3
462491|NCT00300274|1519097|P1|Overall Study|Withdrawal by Subject|12
462492|NCT00299975|1519156|P3|Overall Study|Physician Decision|1
462493|NCT00299975|1519157|P2|Overall Study|Physician Decision|0
462494|NCT00299975|1519158|P1|Overall Study|Physician Decision|0
462495|NCT00299975|1519156|P3|Overall Study|Withdrawal by Subject|3
462496|NCT00299975|1519157|P2|Overall Study|Withdrawal by Subject|1
462497|NCT00299975|1519158|P1|Overall Study|Withdrawal by Subject|0
462498|NCT00299975|1519156|P3|Overall Study|Lost to Follow-up|0
462499|NCT00299975|1519157|P2|Overall Study|Lost to Follow-up|0
462500|NCT00299975|1519158|P1|Overall Study|Lost to Follow-up|1
462501|NCT00299975|1519156|P3|Overall Study|Lack of Efficacy|1
462502|NCT00299975|1519157|P2|Overall Study|Lack of Efficacy|0
462503|NCT00299975|1519158|P1|Overall Study|Lack of Efficacy|1
462504|NCT00299975|1519156|P3|Overall Study|Pregnancy|1
462505|NCT00299975|1519157|P2|Overall Study|Pregnancy|0
462506|NCT00299975|1519158|P1|Overall Study|Pregnancy|0
462507|NCT00299975|1519156|P3|Overall Study|Adverse Event|2
462508|NCT00299975|1519157|P2|Overall Study|Adverse Event|0
462509|NCT00299975|1519158|P1|Overall Study|Adverse Event|1
462510|NCT00299702|1519215|P2|Overall Study|Admin issues, sponsor decision, etc.|9
462511|NCT00299702|1519216|P1|Overall Study|Admin issues, sponsor decision, etc.|5
462512|NCT00299702|1519215|P2|Overall Study|Insufficient Response|3
462513|NCT00299702|1519216|P1|Overall Study|Insufficient Response|4
462514|NCT00299702|1519215|P2|Overall Study|Pregnancy|1
462515|NCT00299702|1519216|P1|Overall Study|Pregnancy|0
462516|NCT00299702|1519215|P2|Overall Study|Withdrawal by Subject|23
462517|NCT00299702|1519216|P1|Overall Study|Withdrawal by Subject|25
462518|NCT00299702|1519215|P2|Overall Study|Lost to Follow-up|10
462519|NCT00299702|1519216|P1|Overall Study|Lost to Follow-up|18
462520|NCT00299702|1519215|P2|Overall Study|Adverse Event|4
462521|NCT00299702|1519216|P1|Overall Study|Adverse Event|0
462522|NCT00299702|1519215|P2|Overall Study|Death|0
462523|NCT00299702|1519216|P1|Overall Study|Death|1
462524|NCT00299546|1519231|P3|Overall Study|Not treated|1
462525|NCT00299546|1519232|P2|Overall Study|Not treated|1
462526|NCT00299546|1519233|P1|Overall Study|Not treated|0
462527|NCT00299546|1519231|P3|Overall Study|Not specified|19
462528|NCT00299546|1519232|P2|Overall Study|Not specified|26
462529|NCT00299546|1519233|P1|Overall Study|Not specified|24
462530|NCT00299546|1519231|P3|Overall Study|Unsatisfactory therapeutic effect|34
462531|NCT00299546|1519232|P2|Overall Study|Unsatisfactory therapeutic effect|39
462532|NCT00299546|1519233|P1|Overall Study|Unsatisfactory therapeutic effect|34
462533|NCT00299546|1519231|P3|Overall Study|Adverse Event|27
462534|NCT00299546|1519232|P2|Overall Study|Adverse Event|22
462535|NCT00299546|1519233|P1|Overall Study|Adverse Event|37
462536|NCT00299546|1519231|P3|Overall Study|Lost to Follow-up|5
462537|NCT00299546|1519232|P2|Overall Study|Lost to Follow-up|2
462538|NCT00299546|1519233|P1|Overall Study|Lost to Follow-up|2
462539|NCT00299546|1519231|P3|Overall Study|Death|0
462540|NCT00299546|1519232|P2|Overall Study|Death|2
462541|NCT00299546|1519233|P1|Overall Study|Death|3
462542|NCT00299494|1519264|P6|Overall Study|Other - site closure|1
462543|NCT00299494|1519265|P5|Overall Study|Other - site closure|1
462544|NCT00299494|1519266|P4|Overall Study|Other - site closure|1
462545|NCT00299494|1519267|P3|Overall Study|Other - site closure|0
462546|NCT00299494|1519268|P2|Overall Study|Other - site closure|0
462547|NCT00299494|1519269|P1|Overall Study|Other - site closure|0
462548|NCT00299494|1519264|P6|Overall Study|Other - Unspecified|1
462549|NCT00299494|1519265|P5|Overall Study|Other - Unspecified|3
462550|NCT00299494|1519266|P4|Overall Study|Other - Unspecified|0
462551|NCT00299494|1519267|P3|Overall Study|Other - Unspecified|0
462552|NCT00299494|1519268|P2|Overall Study|Other - Unspecified|0
462553|NCT00299494|1519269|P1|Overall Study|Other - Unspecified|0
462554|NCT00299494|1519264|P6|Overall Study|Lost to Follow-up|1
462555|NCT00299494|1519265|P5|Overall Study|Lost to Follow-up|3
462556|NCT00299494|1519266|P4|Overall Study|Lost to Follow-up|0
462557|NCT00299494|1519267|P3|Overall Study|Lost to Follow-up|0
462558|NCT00299494|1519268|P2|Overall Study|Lost to Follow-up|0
462559|NCT00299494|1519269|P1|Overall Study|Lost to Follow-up|0
462560|NCT00299494|1519264|P6|Overall Study|Death|19
462561|NCT00299494|1519265|P5|Overall Study|Death|18
462562|NCT00299494|1519266|P4|Overall Study|Death|6
462563|NCT00299494|1519267|P3|Overall Study|Death|4
462564|NCT00299494|1519268|P2|Overall Study|Death|1
462565|NCT00299494|1519269|P1|Overall Study|Death|3
462566|NCT00299494|1519264|P6|Overall Study|Physician Decision|0
462567|NCT00299494|1519265|P5|Overall Study|Physician Decision|1
462568|NCT00299494|1519266|P4|Overall Study|Physician Decision|0
462569|NCT00299494|1519267|P3|Overall Study|Physician Decision|0
462570|NCT00299494|1519268|P2|Overall Study|Physician Decision|0
462571|NCT00299494|1519269|P1|Overall Study|Physician Decision|0
462572|NCT00299494|1519264|P6|Overall Study|Withdrawal by Subject|4
462573|NCT00299494|1519265|P5|Overall Study|Withdrawal by Subject|1
462574|NCT00299494|1519266|P4|Overall Study|Withdrawal by Subject|3
462575|NCT00299494|1519267|P3|Overall Study|Withdrawal by Subject|0
462576|NCT00299494|1519268|P2|Overall Study|Withdrawal by Subject|0
462577|NCT00299494|1519269|P1|Overall Study|Withdrawal by Subject|0
462578|NCT00299156|1519398|P3|Period 2 (Randomized)|Screen Failure|0
462579|NCT00299156|1519399|P2|Period 2 (Randomized)|Screen Failure|1
462580|NCT00299156|1519400|P1|Period 2 (Randomized)|Screen Failure|0
462581|NCT00299130|1519411|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
462582|NCT00299130|1519412|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
462583|NCT00299130|1519413|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
462584|NCT00299130|1519411|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
462585|NCT00299130|1519412|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
462586|NCT00299130|1519413|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
462587|NCT00299130|1519411|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
462588|NCT00299130|1519412|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
462589|NCT00299130|1519413|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
462590|NCT00299130|1519411|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
462591|NCT00299130|1519412|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
462592|NCT00299130|1519413|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
462593|NCT00299130|1519411|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
462594|NCT00299130|1519412|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
462595|NCT00299130|1519413|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
462596|NCT00299130|1519411|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
462597|NCT00299130|1519412|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
462598|NCT00299130|1519413|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
462599|NCT00299130|1519411|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
462600|NCT00299130|1519412|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
462601|NCT00299130|1519413|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
462602|NCT00299130|1519411|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
462603|NCT00299130|1519412|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
462604|NCT00299130|1519413|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
462605|NCT00299130|1519411|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
462606|NCT00299130|1519412|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
462607|NCT00299130|1519413|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
462608|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
462609|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
462610|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
462611|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
462612|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
462613|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
462614|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Failure to Return|6
462615|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Failure to Return|6
462616|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Failure to Return|4
462617|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
462618|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
462619|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
462620|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
462621|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
462622|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
462623|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
462624|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
462625|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
462626|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Death|1
462627|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Death|3
462628|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Death|1
462629|NCT00299130|1519411|P3|Treatment Period (up to 5 Years)|Adverse Event|13
462630|NCT00299130|1519412|P2|Treatment Period (up to 5 Years)|Adverse Event|8
462631|NCT00299130|1519413|P1|Treatment Period (up to 5 Years)|Adverse Event|13
462632|NCT00299104|1519518|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
462633|NCT00299104|1519519|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
462634|NCT00299104|1519520|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
462635|NCT00299104|1519518|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
462636|NCT00299104|1519519|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
462637|NCT00299104|1519520|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
462638|NCT00299104|1519518|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
462639|NCT00299104|1519519|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
462640|NCT00299104|1519520|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
462641|NCT00299104|1519518|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
462642|NCT00299104|1519519|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
462643|NCT00299104|1519520|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
462644|NCT00299104|1519518|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
462645|NCT00299104|1519519|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
462646|NCT00299104|1519520|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
462647|NCT00299104|1519518|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
462648|NCT00299104|1519519|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
462649|NCT00299104|1519520|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
462650|NCT00299104|1519518|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
462651|NCT00299104|1519519|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
462652|NCT00299104|1519520|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
462653|NCT00299104|1519518|P3|Safety Follow-Up (SFU) Period|Death|1
462654|NCT00299104|1519519|P2|Safety Follow-Up (SFU) Period|Death|2
462655|NCT00299104|1519520|P1|Safety Follow-Up (SFU) Period|Death|3
462656|NCT00299104|1519518|P3|Treatment Period|Administrative reasons|137
462657|NCT00299104|1519519|P2|Treatment Period|Administrative reasons|120
462658|NCT00299104|1519520|P1|Treatment Period|Administrative reasons|106
462659|NCT00299104|1519518|P3|Treatment Period|Withdrew consent|9
462660|NCT00299104|1519519|P2|Treatment Period|Withdrew consent|19
462661|NCT00299104|1519520|P1|Treatment Period|Withdrew consent|14
462662|NCT00299104|1519518|P3|Treatment Period|Refused treatment|2
462663|NCT00299104|1519519|P2|Treatment Period|Refused treatment|2
462664|NCT00299104|1519520|P1|Treatment Period|Refused treatment|9
462665|NCT00299104|1519518|P3|Treatment Period|Protocol Violation|0
462666|NCT00299104|1519519|P2|Treatment Period|Protocol Violation|1
462667|NCT00299104|1519520|P1|Treatment Period|Protocol Violation|1
462668|NCT00299104|1519518|P3|Treatment Period|Violation of selection criteria|0
462669|NCT00299104|1519519|P2|Treatment Period|Violation of selection criteria|2
462670|NCT00299104|1519520|P1|Treatment Period|Violation of selection criteria|1
462671|NCT00299104|1519518|P3|Treatment Period|Failure to return|8
462672|NCT00299104|1519519|P2|Treatment Period|Failure to return|8
462673|NCT00299104|1519520|P1|Treatment Period|Failure to return|9
462674|NCT00299104|1519518|P3|Treatment Period|Insufficient therapeutic response|8
462675|NCT00299104|1519519|P2|Treatment Period|Insufficient therapeutic response|13
462676|NCT00299104|1519520|P1|Treatment Period|Insufficient therapeutic response|34
462677|NCT00299104|1519518|P3|Treatment Period|Death|1
462678|NCT00299104|1519519|P2|Treatment Period|Death|1
462679|NCT00299104|1519520|P1|Treatment Period|Death|1
462680|NCT00299104|1519518|P3|Treatment Period|Adverse Event|7
462681|NCT00299104|1519519|P2|Treatment Period|Adverse Event|9
462682|NCT00299104|1519520|P1|Treatment Period|Adverse Event|14
462683|NCT00298766|1519630|P1|Overall Study|Other|4
462684|NCT00298766|1519630|P1|Overall Study|Subjects overall condition deterioration|4
462685|NCT00298766|1519630|P1|Overall Study|Deterioration in KPS and organ function|1
462686|NCT00298766|1519630|P1|Overall Study|Progression of amyloid markers|4
462687|NCT00298766|1519630|P1|Overall Study|Treatment ongoing|4
462688|NCT00298766|1519630|P1|Overall Study|Withdrawal by Subject|9
462689|NCT00298766|1519630|P1|Overall Study|Death|2
462690|NCT00298766|1519630|P1|Overall Study|Adverse Event|18
462691|NCT00298740|1519639|P1|Overall Study|Withdrawal by Subject|3
462692|NCT00298740|1519639|P1|Overall Study|Lack of Efficacy|6
462693|NCT00298363|1519693|P3|Overall Study|Lack of Efficacy|0
462694|NCT00298363|1519694|P2|Overall Study|Lack of Efficacy|3
462695|NCT00298363|1519695|P1|Overall Study|Lack of Efficacy|2
462696|NCT00298363|1519693|P3|Overall Study|Adverse Event|2
462697|NCT00298363|1519694|P2|Overall Study|Adverse Event|2
462698|NCT00298363|1519695|P1|Overall Study|Adverse Event|5
462699|NCT00298363|1519693|P3|Overall Study|Withdrawal by Subject|3
462700|NCT00298363|1519694|P2|Overall Study|Withdrawal by Subject|1
462701|NCT00298363|1519695|P1|Overall Study|Withdrawal by Subject|5
462702|NCT00298363|1519693|P3|Overall Study|Protocol Violation|0
462703|NCT00298363|1519694|P2|Overall Study|Protocol Violation|1
462704|NCT00298363|1519695|P1|Overall Study|Protocol Violation|1
462705|NCT00298363|1519693|P3|Overall Study|Physician Decision|0
462706|NCT00298363|1519694|P2|Overall Study|Physician Decision|1
462707|NCT00298363|1519695|P1|Overall Study|Physician Decision|4
462708|NCT00298363|1519693|P3|Overall Study|Lost to Follow-up|1
462709|NCT00298363|1519694|P2|Overall Study|Lost to Follow-up|0
462710|NCT00298363|1519695|P1|Overall Study|Lost to Follow-up|0
462711|NCT00298272|1519853|P2|Safety Follow-up Phase|Administrative/Other Reason|1
462712|NCT00298272|1519854|P1|Safety Follow-up Phase|Administrative/Other Reason|1
462713|NCT00298272|1519853|P2|Safety Follow-up Phase|Withdrawal by Subject|2
462714|NCT00298272|1519854|P1|Safety Follow-up Phase|Withdrawal by Subject|2
462715|NCT00298272|1519853|P2|Safety Follow-up Phase|Failure to Return|1
462716|NCT00298272|1519854|P1|Safety Follow-up Phase|Failure to Return|1
462717|NCT00298272|1519853|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
462718|NCT00298272|1519854|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
462719|NCT00298272|1519853|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
462720|NCT00298272|1519854|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
462721|NCT00298272|1519853|P2|Open Label Retreatment Phase|Protocol Violation|1
462722|NCT00298272|1519854|P1|Open Label Retreatment Phase|Protocol Violation|2
462723|NCT00298272|1519853|P2|Open Label Retreatment Phase|Failure to Return|0
462724|NCT00298272|1519854|P1|Open Label Retreatment Phase|Failure to Return|1
462725|NCT00298272|1519853|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
462726|NCT00298272|1519854|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
462727|NCT00298272|1519853|P2|Open Label Retreatment Phase|Adverse Event|2
462728|NCT00298272|1519854|P1|Open Label Retreatment Phase|Adverse Event|1
462729|NCT00298272|1519853|P2|Double-blind Phase|Withdrawal by Subject|0
462730|NCT00298272|1519854|P1|Double-blind Phase|Withdrawal by Subject|2
462731|NCT00298272|1519853|P2|Double-blind Phase|Protocol Violation|0
462732|NCT00298272|1519854|P1|Double-blind Phase|Protocol Violation|2
462733|NCT00298272|1519853|P2|Double-blind Phase|Failure to Return|0
462734|NCT00298272|1519854|P1|Double-blind Phase|Failure to Return|2
462735|NCT00298272|1519853|P2|Double-blind Phase|Adverse Event|0
462736|NCT00298272|1519854|P1|Double-blind Phase|Adverse Event|2
462737|NCT00297830|1519919|P3|12 Month Visit|Withdrawal by Subject|0
462738|NCT00297830|1519920|P2|12 Month Visit|Withdrawal by Subject|3
462739|NCT00297830|1519921|P1|12 Month Visit|Withdrawal by Subject|0
462740|NCT00297830|1519919|P3|12 Month Visit|Adverse Event|0
462741|NCT00297830|1519920|P2|12 Month Visit|Adverse Event|3
462742|NCT00297830|1519921|P1|12 Month Visit|Adverse Event|0
462743|NCT00297830|1519919|P3|12 Month Visit|Lost to Follow-up|0
462744|NCT00297830|1519920|P2|12 Month Visit|Lost to Follow-up|0
462745|NCT00297830|1519921|P1|12 Month Visit|Lost to Follow-up|1
462746|NCT00297830|1519919|P3|6 Month Visit|Adverse Event|0
462747|NCT00297830|1519920|P2|6 Month Visit|Adverse Event|1
462748|NCT00297830|1519921|P1|6 Month Visit|Adverse Event|0
462749|NCT00297830|1519919|P3|6 Month Visit|Withdrawal by Subject|1
462750|NCT00297830|1519920|P2|6 Month Visit|Withdrawal by Subject|1
462751|NCT00297830|1519921|P1|6 Month Visit|Withdrawal by Subject|2
462752|NCT00297830|1519919|P3|6 Month Visit|Death|2
462753|NCT00297830|1519920|P2|6 Month Visit|Death|0
462754|NCT00297830|1519921|P1|6 Month Visit|Death|1
462755|NCT00297778|1519940|P2|Overall Study|Other|1
462756|NCT00297778|1519941|P1|Overall Study|Other|0
462757|NCT00297778|1519940|P2|Overall Study|Non-compliant with trial protocol|3
462758|NCT00297778|1519941|P1|Overall Study|Non-compliant with trial protocol|0
462759|NCT00297778|1519940|P2|Overall Study|Lack of Efficacy|1
462760|NCT00297778|1519941|P1|Overall Study|Lack of Efficacy|2
462761|NCT00297778|1519940|P2|Overall Study|Withdrawal by Subject|5
462762|NCT00297778|1519941|P1|Overall Study|Withdrawal by Subject|1
462763|NCT00297778|1519940|P2|Overall Study|Adverse Event|10
462764|NCT00297778|1519941|P1|Overall Study|Adverse Event|16
462765|NCT00297648|1519975|P1|Overall Study|Other: Incompliance|1
462766|NCT00297648|1519975|P1|Overall Study|Withdrawal by Subject|3
462767|NCT00297648|1519975|P1|Overall Study|Lost to Follow-up|1
462768|NCT00297648|1519975|P1|Overall Study|Lack of Efficacy|18
462769|NCT00297648|1519975|P1|Overall Study|Adverse Event|13
462770|NCT00297492|1520021|P3|6 Month Follow-up|Lost to Follow-up|27
462771|NCT00297492|1520022|P2|6 Month Follow-up|Lost to Follow-up|49
462772|NCT00297492|1520023|P1|6 Month Follow-up|Lost to Follow-up|63
462773|NCT00297492|1520021|P3|Set Quit Date|Lost to Follow-up|5
462774|NCT00297492|1520022|P2|Set Quit Date|Lost to Follow-up|13
462775|NCT00297492|1520023|P1|Set Quit Date|Lost to Follow-up|7
462776|NCT00297427|1520033|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
462777|NCT00297427|1520034|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
462778|NCT00297427|1520033|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
462779|NCT00297427|1520034|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
462780|NCT00297427|1520033|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
462781|NCT00297427|1520034|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
462782|NCT00297427|1520033|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
462783|NCT00297427|1520034|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
462784|NCT00297427|1520033|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
462785|NCT00297427|1520034|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
462786|NCT00297427|1520033|P2|Phase 1: Initial Intervention|Death|1
462787|NCT00297427|1520034|P1|Phase 1: Initial Intervention|Death|0
462788|NCT00297427|1520033|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
462789|NCT00297427|1520034|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
462790|NCT00297427|1520033|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
462791|NCT00297427|1520034|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
462792|NCT00297258|1520075|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
462793|NCT00297258|1520075|P1|Overall Study|Switch to Commercial Treatment|1
462794|NCT00297258|1520075|P1|Overall Study|Surgery Performed on Target Lesion|1
462795|NCT00297258|1520075|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
462796|NCT00297258|1520075|P1|Overall Study|Deteriorization of General Condition|1
462797|NCT00297258|1520075|P1|Overall Study|Intercurrent Death|2
462798|NCT00297258|1520075|P1|Overall Study|Intercurrent Illness|3
462799|NCT00297258|1520075|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
462800|NCT00297258|1520075|P1|Overall Study|Toxicity (or Toxic Death)|10
462801|NCT00297258|1520075|P1|Overall Study|Disease Progression, Relapse, Death|120
462802|NCT00297232|1520094|P1|Overall Study|Other|1
462803|NCT00297232|1520094|P1|Overall Study|No data available after Week 264|161
462804|NCT00297232|1520094|P1|Overall Study|Did Not Enroll to Week 480|17
462805|NCT00297232|1520094|P1|Overall Study|Did Not Enroll to Week 264|34
462806|NCT00297232|1520094|P1|Overall Study|Investigator Withdrew From Program|19
462807|NCT00297232|1520094|P1|Overall Study|Persistently Positive Antibodies|11
462808|NCT00297232|1520094|P1|Overall Study|Subject Withdrew Consent|37
462809|NCT00297232|1520094|P1|Overall Study|Subject Relocated|7
462810|NCT00297232|1520094|P1|Overall Study|Sponsor Decision|34
462811|NCT00297232|1520094|P1|Overall Study|Miscellaneous|5
462812|NCT00297232|1520094|P1|Overall Study|Anti-JCV Antibody Positive|13
462813|NCT00297232|1520094|P1|Overall Study|Fear of PML|10
462814|NCT00297232|1520094|P1|Overall Study|Disease Progression|8
462815|NCT00297232|1520094|P1|Overall Study|Switched to Commercial Tysabri|22
462816|NCT00297232|1520094|P1|Overall Study|Anti-natalizumab Positive|8
462817|NCT00297232|1520094|P1|Overall Study|Death|9
462818|NCT00297232|1520094|P1|Overall Study|Subject was Noncompliant|9
462819|NCT00297232|1520094|P1|Overall Study|Voluntary Withdrawal|120
462820|NCT00297232|1520094|P1|Overall Study|Adverse Event|63
462821|NCT00297232|1520094|P1|Overall Study|Lost to Follow-up|10
462822|NCT00297232|1520094|P1|Overall Study|Lack of Efficacy|7
462823|NCT00297167|1520100|P3|Second Double-blind Intervention Period|Protocol Violation|0
462824|NCT00297167|1520101|P2|Second Double-blind Intervention Period|Protocol Violation|0
462825|NCT00297167|1520102|P1|Second Double-blind Intervention Period|Protocol Violation|1
462826|NCT00297167|1520100|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
462827|NCT00297167|1520101|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
462828|NCT00297167|1520102|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
462829|NCT00297037|1520166|P2|Overall Study|Withdrawal by Subject|0
462830|NCT00297037|1520167|P1|Overall Study|Withdrawal by Subject|2
462831|NCT00296816|1520179|P1|Overall Study|ineligibility due to radiation treatment|1
462832|NCT00296816|1520179|P1|Overall Study|Proteinuria|1
462833|NCT00296816|1520179|P1|Overall Study|Neuropathy/patient preference|1
462834|NCT00296816|1520179|P1|Overall Study|Urine protein/creatinine ratio delay|1
462835|NCT00296816|1520179|P1|Overall Study|Noncompliance/decision to discontinue|1
462836|NCT00296816|1520179|P1|Overall Study|Relocation to Florida|1
462837|NCT00296816|1520179|P1|Overall Study|Poor performance status|1
462838|NCT00296816|1520179|P1|Overall Study|Progression based on CA-125 (biomarker)|2
462839|NCT00296816|1520179|P1|Overall Study|Missing for end of treatment|4
462840|NCT00296816|1520179|P1|Overall Study|Non-compliance|1
462841|NCT00296816|1520179|P1|Overall Study|Investigator/Participant request|5
462842|NCT00296816|1520179|P1|Overall Study|Adverse Event|18
462843|NCT00296816|1520179|P1|Overall Study|Disease Progression|37
462844|NCT00296647|1520196|P5|Overall Study|Withdrawal by Subject|19
462845|NCT00296647|1520197|P4|Overall Study|Withdrawal by Subject|16
462846|NCT00296647|1520198|P3|Overall Study|Withdrawal by Subject|32
462847|NCT00296647|1520199|P2|Overall Study|Withdrawal by Subject|27
462848|NCT00296647|1520200|P1|Overall Study|Withdrawal by Subject|28
462849|NCT00296647|1520196|P5|Overall Study|Death|1
462850|NCT00296647|1520197|P4|Overall Study|Death|1
462851|NCT00296647|1520198|P3|Overall Study|Death|2
462852|NCT00296647|1520199|P2|Overall Study|Death|1
462853|NCT00296647|1520200|P1|Overall Study|Death|4
462854|NCT00296517|1520214|P2|Dose Level 3 - Weeks 3-12|Not specified|2
462855|NCT00296517|1520215|P1|Dose Level 3 - Weeks 3-12|Not specified|0
462856|NCT00296517|1520214|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
462857|NCT00296517|1520215|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
462858|NCT00296517|1520214|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
462859|NCT00296517|1520215|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
462860|NCT00296517|1520214|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
462861|NCT00296517|1520215|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
462862|NCT00296517|1520214|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
462863|NCT00296517|1520215|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
462864|NCT00296517|1520214|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
462865|NCT00296517|1520215|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
462866|NCT00296517|1520214|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
462867|NCT00296517|1520215|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
462868|NCT00296517|1520214|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
462869|NCT00296517|1520215|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
462870|NCT00296517|1520214|P2|Dose Level 2 - Week 2|Adverse Event|5
462871|NCT00296517|1520215|P1|Dose Level 2 - Week 2|Adverse Event|1
462872|NCT00296504|1520251|P9|Final Analysis|Poor Adherence|1
462873|NCT00296504|1520252|P8|Final Analysis|Poor Adherence|0
462874|NCT00296504|1520253|P7|Final Analysis|Poor Adherence|0
462875|NCT00296504|1520254|P6|Final Analysis|Poor Adherence|0
462876|NCT00296504|1520255|P5|Final Analysis|Poor Adherence|0
462877|NCT00296504|1520256|P4|Final Analysis|Poor Adherence|0
462878|NCT00296504|1520257|P3|Final Analysis|Poor Adherence|0
462879|NCT00296504|1520258|P2|Final Analysis|Poor Adherence|0
462880|NCT00296504|1520259|P1|Final Analysis|Poor Adherence|0
462881|NCT00296504|1520251|P9|Final Analysis|Participant Moved to Another Country|1
462882|NCT00296504|1520252|P8|Final Analysis|Participant Moved to Another Country|0
462883|NCT00296504|1520253|P7|Final Analysis|Participant Moved to Another Country|0
462884|NCT00296504|1520254|P6|Final Analysis|Participant Moved to Another Country|0
462885|NCT00296504|1520255|P5|Final Analysis|Participant Moved to Another Country|0
462886|NCT00296504|1520256|P4|Final Analysis|Participant Moved to Another Country|0
462887|NCT00296504|1520257|P3|Final Analysis|Participant Moved to Another Country|0
462888|NCT00296504|1520258|P2|Final Analysis|Participant Moved to Another Country|0
462889|NCT00296504|1520259|P1|Final Analysis|Participant Moved to Another Country|0
462890|NCT00296504|1520251|P9|Final Analysis|Tuberculosis|1
462891|NCT00296504|1520252|P8|Final Analysis|Tuberculosis|0
462892|NCT00296504|1520253|P7|Final Analysis|Tuberculosis|0
462893|NCT00296504|1520254|P6|Final Analysis|Tuberculosis|0
462894|NCT00296504|1520255|P5|Final Analysis|Tuberculosis|0
462895|NCT00296504|1520256|P4|Final Analysis|Tuberculosis|0
462896|NCT00296504|1520257|P3|Final Analysis|Tuberculosis|0
462897|NCT00296504|1520258|P2|Final Analysis|Tuberculosis|0
462898|NCT00296504|1520259|P1|Final Analysis|Tuberculosis|0
462899|NCT00296504|1520251|P9|Final Analysis|Pregnancy|4
462900|NCT00296504|1520252|P8|Final Analysis|Pregnancy|0
462901|NCT00296504|1520253|P7|Final Analysis|Pregnancy|0
462902|NCT00296504|1520254|P6|Final Analysis|Pregnancy|0
462903|NCT00296504|1520255|P5|Final Analysis|Pregnancy|0
462904|NCT00296504|1520256|P4|Final Analysis|Pregnancy|0
462905|NCT00296504|1520257|P3|Final Analysis|Pregnancy|0
462906|NCT00296504|1520258|P2|Final Analysis|Pregnancy|0
462907|NCT00296504|1520259|P1|Final Analysis|Pregnancy|0
462908|NCT00296504|1520251|P9|Final Analysis|Adverse Event|2
462909|NCT00296504|1520252|P8|Final Analysis|Adverse Event|0
462910|NCT00296504|1520253|P7|Final Analysis|Adverse Event|0
462911|NCT00296504|1520254|P6|Final Analysis|Adverse Event|0
462912|NCT00296504|1520255|P5|Final Analysis|Adverse Event|0
462913|NCT00296504|1520256|P4|Final Analysis|Adverse Event|0
462914|NCT00296504|1520257|P3|Final Analysis|Adverse Event|0
462915|NCT00296504|1520258|P2|Final Analysis|Adverse Event|0
462916|NCT00296504|1520259|P1|Final Analysis|Adverse Event|0
462917|NCT00296504|1520251|P9|Final Analysis|Insufficient Viral Load Response|6
462918|NCT00296504|1520252|P8|Final Analysis|Insufficient Viral Load Response|0
462919|NCT00296504|1520253|P7|Final Analysis|Insufficient Viral Load Response|0
462920|NCT00296504|1520254|P6|Final Analysis|Insufficient Viral Load Response|0
462921|NCT00296504|1520255|P5|Final Analysis|Insufficient Viral Load Response|0
462922|NCT00296504|1520256|P4|Final Analysis|Insufficient Viral Load Response|0
462923|NCT00296504|1520257|P3|Final Analysis|Insufficient Viral Load Response|0
462924|NCT00296504|1520258|P2|Final Analysis|Insufficient Viral Load Response|0
462925|NCT00296504|1520259|P1|Final Analysis|Insufficient Viral Load Response|0
462926|NCT00296504|1520251|P9|Final Analysis|Lost to Follow-up|5
462927|NCT00296504|1520252|P8|Final Analysis|Lost to Follow-up|0
462928|NCT00296504|1520253|P7|Final Analysis|Lost to Follow-up|0
462929|NCT00296504|1520254|P6|Final Analysis|Lost to Follow-up|0
462930|NCT00296504|1520255|P5|Final Analysis|Lost to Follow-up|0
462931|NCT00296504|1520256|P4|Final Analysis|Lost to Follow-up|0
462932|NCT00296504|1520257|P3|Final Analysis|Lost to Follow-up|0
462933|NCT00296504|1520258|P2|Final Analysis|Lost to Follow-up|0
462934|NCT00296504|1520259|P1|Final Analysis|Lost to Follow-up|0
462935|NCT00296504|1520251|P9|Final Analysis|Withdrawal by Subject|1
462936|NCT00296504|1520252|P8|Final Analysis|Withdrawal by Subject|0
462937|NCT00296504|1520253|P7|Final Analysis|Withdrawal by Subject|0
462938|NCT00296504|1520254|P6|Final Analysis|Withdrawal by Subject|0
462939|NCT00296504|1520255|P5|Final Analysis|Withdrawal by Subject|0
462940|NCT00296504|1520256|P4|Final Analysis|Withdrawal by Subject|0
462941|NCT00296504|1520257|P3|Final Analysis|Withdrawal by Subject|0
462942|NCT00296504|1520258|P2|Final Analysis|Withdrawal by Subject|0
462943|NCT00296504|1520259|P1|Final Analysis|Withdrawal by Subject|0
462944|NCT00296504|1520251|P9|Interim Analysis|Ongoing|0
462945|NCT00296504|1520252|P8|Interim Analysis|Ongoing|1
462946|NCT00296504|1520253|P7|Interim Analysis|Ongoing|30
462947|NCT00296504|1520254|P6|Interim Analysis|Ongoing|0
462948|NCT00296504|1520255|P5|Interim Analysis|Ongoing|0
462949|NCT00296504|1520256|P4|Interim Analysis|Ongoing|22
462950|NCT00296504|1520257|P3|Interim Analysis|Ongoing|16
462951|NCT00296504|1520258|P2|Interim Analysis|Ongoing|12
462952|NCT00296504|1520259|P1|Interim Analysis|Ongoing|32
462953|NCT00296504|1520251|P9|Interim Analysis|Participant Needed Interferon|0
462954|NCT00296504|1520252|P8|Interim Analysis|Participant Needed Interferon|1
462955|NCT00296504|1520253|P7|Interim Analysis|Participant Needed Interferon|0
462956|NCT00296504|1520254|P6|Interim Analysis|Participant Needed Interferon|0
462957|NCT00296504|1520255|P5|Interim Analysis|Participant Needed Interferon|0
462958|NCT00296504|1520256|P4|Interim Analysis|Participant Needed Interferon|0
462959|NCT00296504|1520257|P3|Interim Analysis|Participant Needed Interferon|0
462960|NCT00296504|1520258|P2|Interim Analysis|Participant Needed Interferon|0
462961|NCT00296504|1520259|P1|Interim Analysis|Participant Needed Interferon|0
462962|NCT00296504|1520251|P9|Interim Analysis|Study Ended|0
462963|NCT00296504|1520252|P8|Interim Analysis|Study Ended|0
462964|NCT00296504|1520253|P7|Interim Analysis|Study Ended|1
462965|NCT00296504|1520254|P6|Interim Analysis|Study Ended|0
462966|NCT00296504|1520255|P5|Interim Analysis|Study Ended|0
462967|NCT00296504|1520256|P4|Interim Analysis|Study Ended|0
462968|NCT00296504|1520257|P3|Interim Analysis|Study Ended|0
462969|NCT00296504|1520258|P2|Interim Analysis|Study Ended|0
462970|NCT00296504|1520259|P1|Interim Analysis|Study Ended|0
462971|NCT00296504|1520251|P9|Interim Analysis|Participant Stopped HIV Medications|0
462972|NCT00296504|1520252|P8|Interim Analysis|Participant Stopped HIV Medications|0
462973|NCT00296504|1520253|P7|Interim Analysis|Participant Stopped HIV Medications|1
462974|NCT00296504|1520254|P6|Interim Analysis|Participant Stopped HIV Medications|0
462975|NCT00296504|1520255|P5|Interim Analysis|Participant Stopped HIV Medications|0
462976|NCT00296504|1520256|P4|Interim Analysis|Participant Stopped HIV Medications|0
462977|NCT00296504|1520257|P3|Interim Analysis|Participant Stopped HIV Medications|0
462978|NCT00296504|1520258|P2|Interim Analysis|Participant Stopped HIV Medications|0
462979|NCT00296504|1520259|P1|Interim Analysis|Participant Stopped HIV Medications|0
462980|NCT00296504|1520251|P9|Interim Analysis|Physician and Participant Decision|0
462981|NCT00296504|1520252|P8|Interim Analysis|Physician and Participant Decision|0
462982|NCT00296504|1520253|P7|Interim Analysis|Physician and Participant Decision|0
462983|NCT00296504|1520254|P6|Interim Analysis|Physician and Participant Decision|1
462984|NCT00296504|1520255|P5|Interim Analysis|Physician and Participant Decision|0
462985|NCT00296504|1520256|P4|Interim Analysis|Physician and Participant Decision|0
462986|NCT00296504|1520257|P3|Interim Analysis|Physician and Participant Decision|0
462987|NCT00296504|1520258|P2|Interim Analysis|Physician and Participant Decision|0
462988|NCT00296504|1520259|P1|Interim Analysis|Physician and Participant Decision|0
462989|NCT00296504|1520251|P9|Interim Analysis|Participant Stopped|0
462990|NCT00296504|1520252|P8|Interim Analysis|Participant Stopped|0
462991|NCT00296504|1520253|P7|Interim Analysis|Participant Stopped|0
462992|NCT00296504|1520254|P6|Interim Analysis|Participant Stopped|0
462993|NCT00296504|1520255|P5|Interim Analysis|Participant Stopped|1
462994|NCT00296504|1520256|P4|Interim Analysis|Participant Stopped|0
462995|NCT00296504|1520257|P3|Interim Analysis|Participant Stopped|0
462996|NCT00296504|1520258|P2|Interim Analysis|Participant Stopped|0
462997|NCT00296504|1520259|P1|Interim Analysis|Participant Stopped|0
462998|NCT00296504|1520251|P9|Interim Analysis|Inclusion in Other Protocol|0
462999|NCT00296504|1520252|P8|Interim Analysis|Inclusion in Other Protocol|0
463000|NCT00296504|1520253|P7|Interim Analysis|Inclusion in Other Protocol|0
463001|NCT00296504|1520254|P6|Interim Analysis|Inclusion in Other Protocol|0
463002|NCT00296504|1520255|P5|Interim Analysis|Inclusion in Other Protocol|0
463003|NCT00296504|1520256|P4|Interim Analysis|Inclusion in Other Protocol|1
463004|NCT00296504|1520257|P3|Interim Analysis|Inclusion in Other Protocol|0
463005|NCT00296504|1520258|P2|Interim Analysis|Inclusion in Other Protocol|0
463006|NCT00296504|1520259|P1|Interim Analysis|Inclusion in Other Protocol|0
463007|NCT00296504|1520251|P9|Interim Analysis|Missed Schedule Date|0
463008|NCT00296504|1520252|P8|Interim Analysis|Missed Schedule Date|0
463009|NCT00296504|1520253|P7|Interim Analysis|Missed Schedule Date|0
463010|NCT00296504|1520254|P6|Interim Analysis|Missed Schedule Date|0
463011|NCT00296504|1520255|P5|Interim Analysis|Missed Schedule Date|0
463012|NCT00296504|1520256|P4|Interim Analysis|Missed Schedule Date|0
463013|NCT00296504|1520257|P3|Interim Analysis|Missed Schedule Date|0
463014|NCT00296504|1520258|P2|Interim Analysis|Missed Schedule Date|0
463015|NCT00296504|1520259|P1|Interim Analysis|Missed Schedule Date|1
463016|NCT00296504|1520251|P9|Interim Analysis|Lack of Personnel at Site|0
463017|NCT00296504|1520252|P8|Interim Analysis|Lack of Personnel at Site|0
463018|NCT00296504|1520253|P7|Interim Analysis|Lack of Personnel at Site|0
463019|NCT00296504|1520254|P6|Interim Analysis|Lack of Personnel at Site|0
463020|NCT00296504|1520255|P5|Interim Analysis|Lack of Personnel at Site|0
463021|NCT00296504|1520256|P4|Interim Analysis|Lack of Personnel at Site|0
463022|NCT00296504|1520257|P3|Interim Analysis|Lack of Personnel at Site|0
463023|NCT00296504|1520258|P2|Interim Analysis|Lack of Personnel at Site|0
463024|NCT00296504|1520259|P1|Interim Analysis|Lack of Personnel at Site|1
463025|NCT00296504|1520251|P9|Interim Analysis|Site Closing|0
463026|NCT00296504|1520252|P8|Interim Analysis|Site Closing|0
463027|NCT00296504|1520253|P7|Interim Analysis|Site Closing|2
463028|NCT00296504|1520254|P6|Interim Analysis|Site Closing|1
463029|NCT00296504|1520255|P5|Interim Analysis|Site Closing|0
463030|NCT00296504|1520256|P4|Interim Analysis|Site Closing|0
463031|NCT00296504|1520257|P3|Interim Analysis|Site Closing|0
463032|NCT00296504|1520258|P2|Interim Analysis|Site Closing|0
463033|NCT00296504|1520259|P1|Interim Analysis|Site Closing|1
463034|NCT00296504|1520251|P9|Interim Analysis|Non-adherence|0
463035|NCT00296504|1520252|P8|Interim Analysis|Non-adherence|1
463036|NCT00296504|1520253|P7|Interim Analysis|Non-adherence|0
463037|NCT00296504|1520254|P6|Interim Analysis|Non-adherence|0
463038|NCT00296504|1520255|P5|Interim Analysis|Non-adherence|1
463039|NCT00296504|1520256|P4|Interim Analysis|Non-adherence|0
463040|NCT00296504|1520257|P3|Interim Analysis|Non-adherence|0
463041|NCT00296504|1520258|P2|Interim Analysis|Non-adherence|0
463042|NCT00296504|1520259|P1|Interim Analysis|Non-adherence|2
463043|NCT00296504|1520251|P9|Interim Analysis|Principle Investigator Terminated Study|0
463044|NCT00296504|1520252|P8|Interim Analysis|Principle Investigator Terminated Study|0
463045|NCT00296504|1520253|P7|Interim Analysis|Principle Investigator Terminated Study|0
463046|NCT00296504|1520254|P6|Interim Analysis|Principle Investigator Terminated Study|0
463047|NCT00296504|1520255|P5|Interim Analysis|Principle Investigator Terminated Study|0
463048|NCT00296504|1520256|P4|Interim Analysis|Principle Investigator Terminated Study|0
463049|NCT00296504|1520257|P3|Interim Analysis|Principle Investigator Terminated Study|1
463050|NCT00296504|1520258|P2|Interim Analysis|Principle Investigator Terminated Study|0
463051|NCT00296504|1520259|P1|Interim Analysis|Principle Investigator Terminated Study|0
463052|NCT00296504|1520251|P9|Interim Analysis|Principle Investigator Discretion|0
463053|NCT00296504|1520252|P8|Interim Analysis|Principle Investigator Discretion|0
463054|NCT00296504|1520253|P7|Interim Analysis|Principle Investigator Discretion|0
463055|NCT00296504|1520254|P6|Interim Analysis|Principle Investigator Discretion|0
463056|NCT00296504|1520255|P5|Interim Analysis|Principle Investigator Discretion|0
463057|NCT00296504|1520256|P4|Interim Analysis|Principle Investigator Discretion|1
463058|NCT00296504|1520257|P3|Interim Analysis|Principle Investigator Discretion|1
463059|NCT00296504|1520258|P2|Interim Analysis|Principle Investigator Discretion|0
463060|NCT00296504|1520259|P1|Interim Analysis|Principle Investigator Discretion|2
463061|NCT00296504|1520251|P9|Interim Analysis|Physician Decision|0
463062|NCT00296504|1520252|P8|Interim Analysis|Physician Decision|0
463063|NCT00296504|1520253|P7|Interim Analysis|Physician Decision|0
463064|NCT00296504|1520254|P6|Interim Analysis|Physician Decision|0
463065|NCT00296504|1520255|P5|Interim Analysis|Physician Decision|0
463066|NCT00296504|1520256|P4|Interim Analysis|Physician Decision|0
463067|NCT00296504|1520257|P3|Interim Analysis|Physician Decision|1
463068|NCT00296504|1520258|P2|Interim Analysis|Physician Decision|0
463069|NCT00296504|1520259|P1|Interim Analysis|Physician Decision|0
463070|NCT00296504|1520251|P9|Interim Analysis|Resistance to FPV|0
463071|NCT00296504|1520252|P8|Interim Analysis|Resistance to FPV|0
463072|NCT00296504|1520253|P7|Interim Analysis|Resistance to FPV|0
463073|NCT00296504|1520254|P6|Interim Analysis|Resistance to FPV|0
463074|NCT00296504|1520255|P5|Interim Analysis|Resistance to FPV|0
463075|NCT00296504|1520256|P4|Interim Analysis|Resistance to FPV|0
463076|NCT00296504|1520257|P3|Interim Analysis|Resistance to FPV|1
463077|NCT00296504|1520258|P2|Interim Analysis|Resistance to FPV|0
463078|NCT00296504|1520259|P1|Interim Analysis|Resistance to FPV|0
463079|NCT00296504|1520251|P9|Interim Analysis|Participant Was Incarcerated|0
463080|NCT00296504|1520252|P8|Interim Analysis|Participant Was Incarcerated|0
463081|NCT00296504|1520253|P7|Interim Analysis|Participant Was Incarcerated|0
463082|NCT00296504|1520254|P6|Interim Analysis|Participant Was Incarcerated|0
463083|NCT00296504|1520255|P5|Interim Analysis|Participant Was Incarcerated|0
463084|NCT00296504|1520256|P4|Interim Analysis|Participant Was Incarcerated|0
463085|NCT00296504|1520257|P3|Interim Analysis|Participant Was Incarcerated|1
463086|NCT00296504|1520258|P2|Interim Analysis|Participant Was Incarcerated|0
463087|NCT00296504|1520259|P1|Interim Analysis|Participant Was Incarcerated|2
463088|NCT00296504|1520251|P9|Interim Analysis|Participant Moved|0
463089|NCT00296504|1520252|P8|Interim Analysis|Participant Moved|0
463090|NCT00296504|1520253|P7|Interim Analysis|Participant Moved|1
463091|NCT00296504|1520254|P6|Interim Analysis|Participant Moved|1
463092|NCT00296504|1520255|P5|Interim Analysis|Participant Moved|0
463093|NCT00296504|1520256|P4|Interim Analysis|Participant Moved|0
463094|NCT00296504|1520257|P3|Interim Analysis|Participant Moved|1
463095|NCT00296504|1520258|P2|Interim Analysis|Participant Moved|0
463096|NCT00296504|1520259|P1|Interim Analysis|Participant Moved|1
463097|NCT00296504|1520251|P9|Interim Analysis|Participant Had Problems with Alcohol|0
463098|NCT00296504|1520252|P8|Interim Analysis|Participant Had Problems with Alcohol|0
463099|NCT00296504|1520253|P7|Interim Analysis|Participant Had Problems with Alcohol|0
463100|NCT00296504|1520254|P6|Interim Analysis|Participant Had Problems with Alcohol|0
463101|NCT00296504|1520255|P5|Interim Analysis|Participant Had Problems with Alcohol|0
463102|NCT00296504|1520256|P4|Interim Analysis|Participant Had Problems with Alcohol|0
463103|NCT00296504|1520257|P3|Interim Analysis|Participant Had Problems with Alcohol|1
463104|NCT00296504|1520258|P2|Interim Analysis|Participant Had Problems with Alcohol|0
463105|NCT00296504|1520259|P1|Interim Analysis|Participant Had Problems with Alcohol|0
463106|NCT00296504|1520251|P9|Interim Analysis|To Simplify Treatment|0
463107|NCT00296504|1520252|P8|Interim Analysis|To Simplify Treatment|0
463108|NCT00296504|1520253|P7|Interim Analysis|To Simplify Treatment|2
463109|NCT00296504|1520254|P6|Interim Analysis|To Simplify Treatment|0
463110|NCT00296504|1520255|P5|Interim Analysis|To Simplify Treatment|0
463111|NCT00296504|1520256|P4|Interim Analysis|To Simplify Treatment|0
463112|NCT00296504|1520257|P3|Interim Analysis|To Simplify Treatment|1
463113|NCT00296504|1520258|P2|Interim Analysis|To Simplify Treatment|0
463114|NCT00296504|1520259|P1|Interim Analysis|To Simplify Treatment|0
463115|NCT00296504|1520251|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
463116|NCT00296504|1520252|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
463117|NCT00296504|1520253|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
463118|NCT00296504|1520254|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
463119|NCT00296504|1520255|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
463120|NCT00296504|1520256|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
463121|NCT00296504|1520257|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
463122|NCT00296504|1520258|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
463123|NCT00296504|1520259|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
463124|NCT00296504|1520251|P9|Interim Analysis|Participant Non-compliant|0
463125|NCT00296504|1520252|P8|Interim Analysis|Participant Non-compliant|2
463126|NCT00296504|1520253|P7|Interim Analysis|Participant Non-compliant|6
463127|NCT00296504|1520254|P6|Interim Analysis|Participant Non-compliant|3
463128|NCT00296504|1520255|P5|Interim Analysis|Participant Non-compliant|1
463129|NCT00296504|1520256|P4|Interim Analysis|Participant Non-compliant|1
463130|NCT00296504|1520257|P3|Interim Analysis|Participant Non-compliant|2
463131|NCT00296504|1520258|P2|Interim Analysis|Participant Non-compliant|1
463132|NCT00296504|1520259|P1|Interim Analysis|Participant Non-compliant|0
463133|NCT00296504|1520251|P9|Interim Analysis|Death|0
463134|NCT00296504|1520252|P8|Interim Analysis|Death|0
463135|NCT00296504|1520253|P7|Interim Analysis|Death|0
463136|NCT00296504|1520254|P6|Interim Analysis|Death|0
463137|NCT00296504|1520255|P5|Interim Analysis|Death|0
463138|NCT00296504|1520256|P4|Interim Analysis|Death|0
463139|NCT00296504|1520257|P3|Interim Analysis|Death|3
463140|NCT00296504|1520258|P2|Interim Analysis|Death|0
463141|NCT00296504|1520259|P1|Interim Analysis|Death|1
463142|NCT00296504|1520251|P9|Interim Analysis|Pregnancy|0
463143|NCT00296504|1520252|P8|Interim Analysis|Pregnancy|1
463144|NCT00296504|1520253|P7|Interim Analysis|Pregnancy|1
463145|NCT00296504|1520254|P6|Interim Analysis|Pregnancy|1
463146|NCT00296504|1520255|P5|Interim Analysis|Pregnancy|0
463147|NCT00296504|1520256|P4|Interim Analysis|Pregnancy|2
463148|NCT00296504|1520257|P3|Interim Analysis|Pregnancy|4
463149|NCT00296504|1520258|P2|Interim Analysis|Pregnancy|1
463150|NCT00296504|1520259|P1|Interim Analysis|Pregnancy|4
463151|NCT00296504|1520251|P9|Interim Analysis|Switched to Commercially Available Drug|0
463152|NCT00296504|1520252|P8|Interim Analysis|Switched to Commercially Available Drug|4
463153|NCT00296504|1520253|P7|Interim Analysis|Switched to Commercially Available Drug|3
463154|NCT00296504|1520254|P6|Interim Analysis|Switched to Commercially Available Drug|5
463155|NCT00296504|1520255|P5|Interim Analysis|Switched to Commercially Available Drug|0
463156|NCT00296504|1520256|P4|Interim Analysis|Switched to Commercially Available Drug|1
463157|NCT00296504|1520257|P3|Interim Analysis|Switched to Commercially Available Drug|4
463158|NCT00296504|1520258|P2|Interim Analysis|Switched to Commercially Available Drug|0
463159|NCT00296504|1520259|P1|Interim Analysis|Switched to Commercially Available Drug|2
463160|NCT00296504|1520251|P9|Interim Analysis|Insufficient CD4 Response|0
463161|NCT00296504|1520252|P8|Interim Analysis|Insufficient CD4 Response|0
463162|NCT00296504|1520253|P7|Interim Analysis|Insufficient CD4 Response|0
463163|NCT00296504|1520254|P6|Interim Analysis|Insufficient CD4 Response|1
463164|NCT00296504|1520255|P5|Interim Analysis|Insufficient CD4 Response|1
463165|NCT00296504|1520256|P4|Interim Analysis|Insufficient CD4 Response|0
463166|NCT00296504|1520257|P3|Interim Analysis|Insufficient CD4 Response|0
463167|NCT00296504|1520258|P2|Interim Analysis|Insufficient CD4 Response|0
463168|NCT00296504|1520259|P1|Interim Analysis|Insufficient CD4 Response|0
463169|NCT00296504|1520251|P9|Interim Analysis|Protocol Violation|0
463170|NCT00296504|1520252|P8|Interim Analysis|Protocol Violation|1
463171|NCT00296504|1520253|P7|Interim Analysis|Protocol Violation|0
463172|NCT00296504|1520254|P6|Interim Analysis|Protocol Violation|0
463173|NCT00296504|1520255|P5|Interim Analysis|Protocol Violation|1
463174|NCT00296504|1520256|P4|Interim Analysis|Protocol Violation|0
463175|NCT00296504|1520257|P3|Interim Analysis|Protocol Violation|2
463176|NCT00296504|1520258|P2|Interim Analysis|Protocol Violation|0
463177|NCT00296504|1520259|P1|Interim Analysis|Protocol Violation|0
463178|NCT00296504|1520251|P9|Interim Analysis|Adverse Event|0
463179|NCT00296504|1520252|P8|Interim Analysis|Adverse Event|5
463180|NCT00296504|1520253|P7|Interim Analysis|Adverse Event|4
463181|NCT00296504|1520254|P6|Interim Analysis|Adverse Event|3
463182|NCT00296504|1520255|P5|Interim Analysis|Adverse Event|6
463183|NCT00296504|1520256|P4|Interim Analysis|Adverse Event|4
463184|NCT00296504|1520257|P3|Interim Analysis|Adverse Event|13
463185|NCT00296504|1520258|P2|Interim Analysis|Adverse Event|0
463186|NCT00296504|1520259|P1|Interim Analysis|Adverse Event|0
463187|NCT00296504|1520251|P9|Interim Analysis|Insufficient Viral Load Response|0
463188|NCT00296504|1520252|P8|Interim Analysis|Insufficient Viral Load Response|24
463189|NCT00296504|1520253|P7|Interim Analysis|Insufficient Viral Load Response|2
463190|NCT00296504|1520254|P6|Interim Analysis|Insufficient Viral Load Response|9
463191|NCT00296504|1520255|P5|Interim Analysis|Insufficient Viral Load Response|7
463192|NCT00296504|1520256|P4|Interim Analysis|Insufficient Viral Load Response|2
463193|NCT00296504|1520257|P3|Interim Analysis|Insufficient Viral Load Response|12
463194|NCT00296504|1520258|P2|Interim Analysis|Insufficient Viral Load Response|1
463195|NCT00296504|1520259|P1|Interim Analysis|Insufficient Viral Load Response|5
463196|NCT00296504|1520251|P9|Interim Analysis|Clinical Progression|0
463197|NCT00296504|1520252|P8|Interim Analysis|Clinical Progression|2
463198|NCT00296504|1520253|P7|Interim Analysis|Clinical Progression|1
463199|NCT00296504|1520254|P6|Interim Analysis|Clinical Progression|2
463200|NCT00296504|1520255|P5|Interim Analysis|Clinical Progression|0
463201|NCT00296504|1520256|P4|Interim Analysis|Clinical Progression|1
463202|NCT00296504|1520257|P3|Interim Analysis|Clinical Progression|1
463203|NCT00296504|1520258|P2|Interim Analysis|Clinical Progression|0
463204|NCT00296504|1520259|P1|Interim Analysis|Clinical Progression|1
463205|NCT00296504|1520251|P9|Interim Analysis|Lost to Follow-up|0
463206|NCT00296504|1520252|P8|Interim Analysis|Lost to Follow-up|4
463207|NCT00296504|1520253|P7|Interim Analysis|Lost to Follow-up|11
463208|NCT00296504|1520254|P6|Interim Analysis|Lost to Follow-up|4
463209|NCT00296504|1520255|P5|Interim Analysis|Lost to Follow-up|14
463210|NCT00296504|1520256|P4|Interim Analysis|Lost to Follow-up|8
463211|NCT00296504|1520257|P3|Interim Analysis|Lost to Follow-up|26
463212|NCT00296504|1520258|P2|Interim Analysis|Lost to Follow-up|3
463213|NCT00296504|1520259|P1|Interim Analysis|Lost to Follow-up|13
463214|NCT00296504|1520251|P9|Interim Analysis|Withdrawal by Subject|0
463215|NCT00296504|1520252|P8|Interim Analysis|Withdrawal by Subject|3
463216|NCT00296504|1520253|P7|Interim Analysis|Withdrawal by Subject|9
463217|NCT00296504|1520254|P6|Interim Analysis|Withdrawal by Subject|5
463218|NCT00296504|1520255|P5|Interim Analysis|Withdrawal by Subject|5
463219|NCT00296504|1520256|P4|Interim Analysis|Withdrawal by Subject|0
463220|NCT00296504|1520257|P3|Interim Analysis|Withdrawal by Subject|12
463221|NCT00296504|1520258|P2|Interim Analysis|Withdrawal by Subject|0
463222|NCT00296504|1520259|P1|Interim Analysis|Withdrawal by Subject|8
463223|NCT00296491|1520352|P4|Overall Study|Lost to Follow-up|0
463224|NCT00296491|1520353|P3|Overall Study|Lost to Follow-up|2
463225|NCT00296491|1520354|P2|Overall Study|Lost to Follow-up|2
463226|NCT00296491|1520355|P1|Overall Study|Lost to Follow-up|0
463227|NCT00296491|1520352|P4|Overall Study|Non-Compliance|14
463228|NCT00296491|1520353|P3|Overall Study|Non-Compliance|10
463229|NCT00296491|1520354|P2|Overall Study|Non-Compliance|13
463230|NCT00296491|1520355|P1|Overall Study|Non-Compliance|12
463231|NCT00296491|1520352|P4|Overall Study|Withdrawal by Subject|2
463232|NCT00296491|1520353|P3|Overall Study|Withdrawal by Subject|3
463233|NCT00296491|1520354|P2|Overall Study|Withdrawal by Subject|3
463234|NCT00296491|1520355|P1|Overall Study|Withdrawal by Subject|7
463235|NCT00296491|1520352|P4|Overall Study|Withdrawn due to Asthma|4
463236|NCT00296491|1520353|P3|Overall Study|Withdrawn due to Asthma|0
463237|NCT00296491|1520354|P2|Overall Study|Withdrawn due to Asthma|0
463238|NCT00296491|1520355|P1|Overall Study|Withdrawn due to Asthma|0
463239|NCT00296491|1520352|P4|Overall Study|Adverse Event|4
463240|NCT00296491|1520353|P3|Overall Study|Adverse Event|1
463241|NCT00296491|1520354|P2|Overall Study|Adverse Event|3
463242|NCT00296491|1520355|P1|Overall Study|Adverse Event|1
463243|NCT00296491|1520352|P4|Overall Study|Protocol Violation|3
463244|NCT00296491|1520353|P3|Overall Study|Protocol Violation|2
463245|NCT00296491|1520354|P2|Overall Study|Protocol Violation|6
463246|NCT00296491|1520355|P1|Overall Study|Protocol Violation|4
463247|NCT00296491|1520352|P4|Overall Study|Low Pollen Counts|16
463248|NCT00296491|1520353|P3|Overall Study|Low Pollen Counts|25
463249|NCT00296491|1520354|P2|Overall Study|Low Pollen Counts|26
463250|NCT00296491|1520355|P1|Overall Study|Low Pollen Counts|18
463251|NCT00296400|1520384|P3|Overall Study|Pregnancy|0
463252|NCT00296400|1520385|P2|Overall Study|Pregnancy|2
463253|NCT00296400|1520386|P1|Overall Study|Pregnancy|1
463254|NCT00296400|1520384|P3|Overall Study|Visit 10 was performed earlier|0
463255|NCT00296400|1520385|P2|Overall Study|Visit 10 was performed earlier|1
463256|NCT00296400|1520386|P1|Overall Study|Visit 10 was performed earlier|0
463257|NCT00296400|1520384|P3|Overall Study|Study specific discontinuation criteria|1
463258|NCT00296400|1520385|P2|Overall Study|Study specific discontinuation criteria|0
463259|NCT00296400|1520386|P1|Overall Study|Study specific discontinuation criteria|0
463260|NCT00296400|1520384|P3|Overall Study|Lost to Follow-up|2
463261|NCT00296400|1520385|P2|Overall Study|Lost to Follow-up|1
463262|NCT00296400|1520386|P1|Overall Study|Lost to Follow-up|1
463263|NCT00296400|1520384|P3|Overall Study|Protocol Violation|1
463264|NCT00296400|1520385|P2|Overall Study|Protocol Violation|1
463265|NCT00296400|1520386|P1|Overall Study|Protocol Violation|1
463266|NCT00296400|1520384|P3|Overall Study|Incorrect enrollment|0
463267|NCT00296400|1520385|P2|Overall Study|Incorrect enrollment|0
463268|NCT00296400|1520386|P1|Overall Study|Incorrect enrollment|2
463269|NCT00296400|1520384|P3|Overall Study|Withdrawal by Subject|2
463270|NCT00296400|1520385|P2|Overall Study|Withdrawal by Subject|6
463271|NCT00296400|1520386|P1|Overall Study|Withdrawal by Subject|5
463272|NCT00296400|1520384|P3|Overall Study|Adverse Event|7
463273|NCT00296400|1520385|P2|Overall Study|Adverse Event|7
463274|NCT00296400|1520386|P1|Overall Study|Adverse Event|7
463275|NCT00296374|1520610|P3|Overall Study|Not specified|1
463276|NCT00296374|1520611|P2|Overall Study|Not specified|0
463277|NCT00296374|1520612|P1|Overall Study|Not specified|0
463278|NCT00296374|1520610|P3|Overall Study|Pregnancy|2
463279|NCT00296374|1520611|P2|Overall Study|Pregnancy|0
463280|NCT00296374|1520612|P1|Overall Study|Pregnancy|0
463281|NCT00296374|1520610|P3|Overall Study|Nephrologist introduced ACE|0
463282|NCT00296374|1520611|P2|Overall Study|Nephrologist introduced ACE|1
463283|NCT00296374|1520612|P1|Overall Study|Nephrologist introduced ACE|0
463284|NCT00296374|1520610|P3|Overall Study|Stopped drug before end of study visit|0
463285|NCT00296374|1520611|P2|Overall Study|Stopped drug before end of study visit|1
463286|NCT00296374|1520612|P1|Overall Study|Stopped drug before end of study visit|0
463287|NCT00296374|1520610|P3|Overall Study|Relocated to another state|0
463288|NCT00296374|1520611|P2|Overall Study|Relocated to another state|0
463289|NCT00296374|1520612|P1|Overall Study|Relocated to another state|1
463290|NCT00296374|1520610|P3|Overall Study|Lost to Follow-up|1
463291|NCT00296374|1520611|P2|Overall Study|Lost to Follow-up|1
463292|NCT00296374|1520612|P1|Overall Study|Lost to Follow-up|3
463293|NCT00296374|1520610|P3|Overall Study|Protocol Violation|3
463294|NCT00296374|1520611|P2|Overall Study|Protocol Violation|2
463295|NCT00296374|1520612|P1|Overall Study|Protocol Violation|1
463296|NCT00296374|1520610|P3|Overall Study|Incorrect enrollment|4
463297|NCT00296374|1520611|P2|Overall Study|Incorrect enrollment|3
463298|NCT00296374|1520612|P1|Overall Study|Incorrect enrollment|3
463299|NCT00296374|1520610|P3|Overall Study|Withdrawal by Subject|11
463300|NCT00296374|1520611|P2|Overall Study|Withdrawal by Subject|5
463301|NCT00296374|1520612|P1|Overall Study|Withdrawal by Subject|3
463302|NCT00296374|1520610|P3|Overall Study|Adverse Event|7
463303|NCT00296374|1520611|P2|Overall Study|Adverse Event|10
463304|NCT00296374|1520612|P1|Overall Study|Adverse Event|14
463305|NCT00296335|1520835|P2|Overall Study|Physician Decision|11
463306|NCT00296335|1520836|P1|Overall Study|Physician Decision|3
463307|NCT00296335|1520835|P2|Overall Study|Lost to Follow-up|33
463308|NCT00296335|1520836|P1|Overall Study|Lost to Follow-up|7
463309|NCT00296335|1520835|P2|Overall Study|Adverse Event|27
463310|NCT00296335|1520836|P1|Overall Study|Adverse Event|17
463311|NCT00296335|1520835|P2|Overall Study|Recurrence|51
463312|NCT00296335|1520836|P1|Overall Study|Recurrence|3
463313|NCT00296244|1520876|P2|Overall Study|Underwent retransplant|1
463314|NCT00296244|1520877|P1|Overall Study|Underwent retransplant|0
463315|NCT00296036|1520941|P6|Overall Study|Protocol Violation|3
463316|NCT00296036|1520942|P5|Overall Study|Protocol Violation|0
463317|NCT00296036|1520943|P4|Overall Study|Protocol Violation|0
463318|NCT00296036|1520944|P3|Overall Study|Protocol Violation|0
463319|NCT00296036|1520945|P2|Overall Study|Protocol Violation|0
463320|NCT00296036|1520946|P1|Overall Study|Protocol Violation|0
463321|NCT00296036|1520941|P6|Overall Study|Withdrawal by Subject|1
463322|NCT00296036|1520942|P5|Overall Study|Withdrawal by Subject|2
463323|NCT00296036|1520943|P4|Overall Study|Withdrawal by Subject|1
463324|NCT00296036|1520944|P3|Overall Study|Withdrawal by Subject|2
463325|NCT00296036|1520945|P2|Overall Study|Withdrawal by Subject|0
463326|NCT00296036|1520946|P1|Overall Study|Withdrawal by Subject|1
463327|NCT00295880|1520972|P1|Overall Study|Unit randomization did not occur|1
463328|NCT00295880|1520972|P1|Overall Study|IBMI unit could not be volume reduced|1
463329|NCT00295854|1520986|P3|Overall Study|not specified|1
463330|NCT00295854|1520987|P2|Overall Study|not specified|5
463331|NCT00295854|1520988|P1|Overall Study|not specified|3
463332|NCT00295854|1520986|P3|Overall Study|required a prohibited medication|0
463333|NCT00295854|1520987|P2|Overall Study|required a prohibited medication|0
463334|NCT00295854|1520988|P1|Overall Study|required a prohibited medication|1
463335|NCT00295854|1520986|P3|Overall Study|did not continue to meet criteria|2
463336|NCT00295854|1520987|P2|Overall Study|did not continue to meet criteria|1
463337|NCT00295854|1520988|P1|Overall Study|did not continue to meet criteria|1
463338|NCT00295854|1520986|P3|Overall Study|Withdrawal by Subject|4
463339|NCT00295854|1520987|P2|Overall Study|Withdrawal by Subject|7
463340|NCT00295854|1520988|P1|Overall Study|Withdrawal by Subject|3
463341|NCT00295854|1520986|P3|Overall Study|Lost to Follow-up|1
463342|NCT00295854|1520987|P2|Overall Study|Lost to Follow-up|0
463343|NCT00295854|1520988|P1|Overall Study|Lost to Follow-up|2
463344|NCT00295854|1520986|P3|Overall Study|Protocol Violation|1
463345|NCT00295854|1520987|P2|Overall Study|Protocol Violation|1
463346|NCT00295854|1520988|P1|Overall Study|Protocol Violation|1
463347|NCT00295854|1520986|P3|Overall Study|Adverse Event|6
463348|NCT00295854|1520987|P2|Overall Study|Adverse Event|7
463349|NCT00295854|1520988|P1|Overall Study|Adverse Event|7
463350|NCT00295750|1521002|P3|Overall Study|Protocol Violation|2
463351|NCT00295750|1521003|P2|Overall Study|Protocol Violation|4
463352|NCT00295750|1521004|P1|Overall Study|Protocol Violation|2
463353|NCT00295750|1521002|P3|Overall Study|Withdrawal by Subject|7
463354|NCT00295750|1521003|P2|Overall Study|Withdrawal by Subject|4
463355|NCT00295750|1521004|P1|Overall Study|Withdrawal by Subject|9
463356|NCT00295750|1521002|P3|Overall Study|Randomized but never received trial drug|3
463357|NCT00295750|1521003|P2|Overall Study|Randomized but never received trial drug|3
463358|NCT00295750|1521004|P1|Overall Study|Randomized but never received trial drug|4
463359|NCT00295750|1521002|P3|Overall Study|Personal reasons|0
463360|NCT00295750|1521003|P2|Overall Study|Personal reasons|1
463361|NCT00295750|1521004|P1|Overall Study|Personal reasons|0
463362|NCT00295750|1521002|P3|Overall Study|Disease progression|0
463363|NCT00295750|1521003|P2|Overall Study|Disease progression|1
463364|NCT00295750|1521004|P1|Overall Study|Disease progression|2
463365|NCT00295750|1521002|P3|Overall Study|Trial drug errors|0
463366|NCT00295750|1521003|P2|Overall Study|Trial drug errors|1
463367|NCT00295750|1521004|P1|Overall Study|Trial drug errors|1
463368|NCT00295750|1521002|P3|Overall Study|Administrative errors|5
463369|NCT00295750|1521003|P2|Overall Study|Administrative errors|4
463370|NCT00295750|1521004|P1|Overall Study|Administrative errors|2
463371|NCT00295750|1521002|P3|Overall Study|Taking prohibited therapy|2
463372|NCT00295750|1521003|P2|Overall Study|Taking prohibited therapy|3
463373|NCT00295750|1521004|P1|Overall Study|Taking prohibited therapy|2
463374|NCT00295750|1521002|P3|Overall Study|Lost to Follow-up|1
463375|NCT00295750|1521003|P2|Overall Study|Lost to Follow-up|4
463376|NCT00295750|1521004|P1|Overall Study|Lost to Follow-up|1
463377|NCT00295750|1521002|P3|Overall Study|Lack of Efficacy|0
463378|NCT00295750|1521003|P2|Overall Study|Lack of Efficacy|1
463379|NCT00295750|1521004|P1|Overall Study|Lack of Efficacy|1
463380|NCT00295750|1521002|P3|Overall Study|Adverse Event|12
463381|NCT00295750|1521003|P2|Overall Study|Adverse Event|15
463382|NCT00295750|1521004|P1|Overall Study|Adverse Event|19
463383|NCT00295633|1521039|P3|Overall Study|Administrative reason by sponsor|1
463384|NCT00295633|1521040|P2|Overall Study|Administrative reason by sponsor|0
463385|NCT00295633|1521041|P1|Overall Study|Administrative reason by sponsor|0
463386|NCT00295633|1521039|P3|Overall Study|Death|0
463387|NCT00295633|1521040|P2|Overall Study|Death|1
463388|NCT00295633|1521041|P1|Overall Study|Death|1
463389|NCT00295633|1521039|P3|Overall Study|Subject No Longer Meets Study Criteria|3
463390|NCT00295633|1521040|P2|Overall Study|Subject No Longer Meets Study Criteria|3
463391|NCT00295633|1521041|P1|Overall Study|Subject No Longer Meets Study Criteria|0
463392|NCT00295633|1521039|P3|Overall Study|Poor/Noncompliance|6
463393|NCT00295633|1521040|P2|Overall Study|Poor/Noncompliance|2
463394|NCT00295633|1521041|P1|Overall Study|Poor/Noncompliance|2
463395|NCT00295633|1521039|P3|Overall Study|Physician Decision|8
463396|NCT00295633|1521040|P2|Overall Study|Physician Decision|10
463397|NCT00295633|1521041|P1|Overall Study|Physician Decision|9
463398|NCT00295633|1521039|P3|Overall Study|Lost to Follow-up|7
463399|NCT00295633|1521040|P2|Overall Study|Lost to Follow-up|11
463400|NCT00295633|1521041|P1|Overall Study|Lost to Follow-up|6
463401|NCT00295633|1521039|P3|Overall Study|Adverse Event|9
463402|NCT00295633|1521040|P2|Overall Study|Adverse Event|17
463403|NCT00295633|1521041|P1|Overall Study|Adverse Event|9
463404|NCT00295633|1521039|P3|Overall Study|Withdrawal of consent by subject|26
463405|NCT00295633|1521040|P2|Overall Study|Withdrawal of consent by subject|16
463406|NCT00295633|1521041|P1|Overall Study|Withdrawal of consent by subject|16
463407|NCT00295633|1521039|P3|Overall Study|Lack of Efficacy|16
463408|NCT00295633|1521040|P2|Overall Study|Lack of Efficacy|7
463409|NCT00295633|1521041|P1|Overall Study|Lack of Efficacy|19
463410|NCT00295490|1521068|P4|Overall Study|Other|1
463411|NCT00295490|1521069|P3|Overall Study|Other|0
463412|NCT00295490|1521070|P2|Overall Study|Other|2
463413|NCT00295490|1521071|P1|Overall Study|Other|0
463414|NCT00295490|1521068|P4|Overall Study|Adverse Event|0
463415|NCT00295490|1521069|P3|Overall Study|Adverse Event|0
463416|NCT00295490|1521070|P2|Overall Study|Adverse Event|0
463417|NCT00295490|1521071|P1|Overall Study|Adverse Event|1
463418|NCT00295490|1521068|P4|Overall Study|Lost to Follow-up|0
463419|NCT00295490|1521069|P3|Overall Study|Lost to Follow-up|1
463420|NCT00295490|1521070|P2|Overall Study|Lost to Follow-up|0
463421|NCT00295490|1521071|P1|Overall Study|Lost to Follow-up|0
463422|NCT00295490|1521068|P4|Overall Study|Withdrawal by Subject|1
463423|NCT00295490|1521069|P3|Overall Study|Withdrawal by Subject|0
463424|NCT00295490|1521070|P2|Overall Study|Withdrawal by Subject|2
463425|NCT00295490|1521071|P1|Overall Study|Withdrawal by Subject|0
463426|NCT00295490|1521068|P4|Overall Study|Protocol Violation|3
463427|NCT00295490|1521069|P3|Overall Study|Protocol Violation|3
463428|NCT00295490|1521070|P2|Overall Study|Protocol Violation|0
463429|NCT00295490|1521071|P1|Overall Study|Protocol Violation|0
463430|NCT00294762|1521151|P2|Overall Study|Did not receive study treatment|3
463431|NCT00294762|1521152|P1|Overall Study|Did not receive study treatment|3
463432|NCT00294723|1521171|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
463433|NCT00294723|1521172|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
463434|NCT00294723|1521173|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
463435|NCT00294723|1521171|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
463436|NCT00294723|1521172|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
463437|NCT00294723|1521173|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
463438|NCT00294723|1521171|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
463439|NCT00294723|1521172|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
463440|NCT00294723|1521173|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
463441|NCT00294723|1521171|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
463442|NCT00294723|1521172|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
463443|NCT00294723|1521173|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
463444|NCT00294723|1521171|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
463445|NCT00294723|1521172|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
463446|NCT00294723|1521173|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
463447|NCT00294723|1521171|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
463448|NCT00294723|1521172|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
463449|NCT00294723|1521173|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
463450|NCT00294723|1521171|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
463451|NCT00294723|1521172|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
463452|NCT00294723|1521173|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
463453|NCT00294723|1521171|P3|Open-Label Extension 52 Weeks|Adverse Event|2
463454|NCT00294723|1521172|P2|Open-Label Extension 52 Weeks|Adverse Event|5
463455|NCT00294723|1521173|P1|Open-Label Extension 52 Weeks|Adverse Event|5
463456|NCT00294723|1521171|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
463457|NCT00294723|1521172|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
463458|NCT00294723|1521173|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
463459|NCT00294723|1521171|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
463460|NCT00294723|1521172|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
463461|NCT00294723|1521173|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
463462|NCT00294723|1521171|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
463463|NCT00294723|1521172|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
463464|NCT00294723|1521173|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
463465|NCT00294723|1521171|P3|Double-Blind Period 52 Weeks|Adverse Event|15
463466|NCT00294723|1521172|P2|Double-Blind Period 52 Weeks|Adverse Event|25
463467|NCT00294723|1521173|P1|Double-Blind Period 52 Weeks|Adverse Event|18
463468|NCT00294684|1521234|P2|Overall Study|Lost to Follow-up|8
463469|NCT00294684|1521235|P1|Overall Study|Lost to Follow-up|5
463470|NCT00294671|1521275|P2|Overall Study|Death|1
463471|NCT00294671|1521276|P1|Overall Study|Death|0
463472|NCT00294671|1521275|P2|Overall Study|Non-compliance|0
463473|NCT00294671|1521276|P1|Overall Study|Non-compliance|1
463474|NCT00294671|1521275|P2|Overall Study|Lost to Follow-up|3
463475|NCT00294671|1521276|P1|Overall Study|Lost to Follow-up|1
463476|NCT00294671|1521275|P2|Overall Study|Non-drug related AE|2
463477|NCT00294671|1521276|P1|Overall Study|Non-drug related AE|3
463478|NCT00294671|1521275|P2|Overall Study|Drug related adverse event (AE)|2
463479|NCT00294671|1521276|P1|Overall Study|Drug related adverse event (AE)|4
463480|NCT00294671|1521275|P2|Overall Study|Liver transplant|9
463481|NCT00294671|1521276|P1|Overall Study|Liver transplant|7
463482|NCT00294671|1521275|P2|Overall Study|Lack of Efficacy|23
463483|NCT00294671|1521276|P1|Overall Study|Lack of Efficacy|11
463484|NCT00294658|1521292|P2|Overall Study|Patient and family were not satisfied|1
463485|NCT00294658|1521293|P1|Overall Study|Patient and family were not satisfied|0
463486|NCT00294658|1521292|P2|Overall Study|Found to have invasive thymoma|0
463487|NCT00294658|1521293|P1|Overall Study|Found to have invasive thymoma|1
463488|NCT00294658|1521292|P2|Overall Study|Withdrawal by Subject|4
463489|NCT00294658|1521293|P1|Overall Study|Withdrawal by Subject|0
463490|NCT00294658|1521292|P2|Overall Study|Pregnancy|1
463491|NCT00294658|1521293|P1|Overall Study|Pregnancy|0
463492|NCT00294658|1521292|P2|Overall Study|Physician Decision|2
463493|NCT00294658|1521293|P1|Overall Study|Physician Decision|1
463494|NCT00294658|1521292|P2|Overall Study|Lost to Follow-up|0
463495|NCT00294658|1521293|P1|Overall Study|Lost to Follow-up|4
463496|NCT00294658|1521292|P2|Overall Study|Death|1
463497|NCT00294658|1521293|P1|Overall Study|Death|0
463498|NCT00294645|1521357|P2|Overall Study|Other|10
463499|NCT00294645|1521358|P1|Overall Study|Other|4
463500|NCT00294645|1521357|P2|Overall Study|Physician Decision|20
463501|NCT00294645|1521358|P1|Overall Study|Physician Decision|15
463502|NCT00294645|1521357|P2|Overall Study|Withdrawal by Subject|34
463503|NCT00294645|1521358|P1|Overall Study|Withdrawal by Subject|18
463504|NCT00294645|1521357|P2|Overall Study|Lost to Follow-up|10
463505|NCT00294645|1521358|P1|Overall Study|Lost to Follow-up|1
463506|NCT00294645|1521357|P2|Overall Study|Death|18
463507|NCT00294645|1521358|P1|Overall Study|Death|10
463508|NCT00294554|1521392|P2|Overall Study|Physician Decision|1
463509|NCT00294554|1521393|P1|Overall Study|Physician Decision|0
463510|NCT00294554|1521392|P2|Overall Study|Lack of Efficacy|1
463511|NCT00294554|1521393|P1|Overall Study|Lack of Efficacy|0
463512|NCT00294398|1521420|P2|Overall Study|Lost to Follow-up|26
463513|NCT00294398|1521421|P1|Overall Study|Lost to Follow-up|21
463514|NCT00294060|1521429|P1|Overall Study|Device explanted/not replaced|23
463515|NCT00294060|1521429|P1|Overall Study|Medical condition|3
463516|NCT00294060|1521429|P1|Overall Study|Physician Decision|797
463517|NCT00294060|1521429|P1|Overall Study|Withdrawal by Subject|11
463518|NCT00294060|1521429|P1|Overall Study|Lost to Follow-up|55
463519|NCT00294060|1521429|P1|Overall Study|Other|59
463520|NCT00294060|1521429|P1|Overall Study|Death|225
463521|NCT00294047|1521437|P2|Month 84|No consent for Month 84 Follow-up|754
463522|NCT00294047|1521438|P1|Month 84|No consent for Month 84 Follow-up|731
463523|NCT00294047|1521437|P2|Month 84|Visit missed|1
463524|NCT00294047|1521438|P1|Month 84|Visit missed|0
463525|NCT00294047|1521437|P2|Month 84|Under investigation locally|0
463526|NCT00294047|1521438|P1|Month 84|Under investigation locally|1
463527|NCT00294047|1521437|P2|Month 84|Unable to reach study site|0
463528|NCT00294047|1521438|P1|Month 84|Unable to reach study site|1
463529|NCT00294047|1521437|P2|Month 84|Transport reimbursement delayed|1
463530|NCT00294047|1521438|P1|Month 84|Transport reimbursement delayed|0
463531|NCT00294047|1521437|P2|Month 84|Subject does not want male physician|0
463532|NCT00294047|1521438|P1|Month 84|Subject does not want male physician|1
463533|NCT00294047|1521437|P2|Month 84|Personal reason|4
463534|NCT00294047|1521438|P1|Month 84|Personal reason|2
463535|NCT00294047|1521437|P2|Month 84|Lack of time|1
463536|NCT00294047|1521438|P1|Month 84|Lack of time|3
463537|NCT00294047|1521437|P2|Month 84|Family problems|2
463538|NCT00294047|1521438|P1|Month 84|Family problems|2
463539|NCT00294047|1521437|P2|Month 84|Center closed, subject did not transfer|0
463540|NCT00294047|1521438|P1|Month 84|Center closed, subject did not transfer|1
463541|NCT00294047|1521437|P2|Month 84|Work related reasons|2
463542|NCT00294047|1521438|P1|Month 84|Work related reasons|4
463543|NCT00294047|1521437|P2|Month 84|Absent Cervix|0
463544|NCT00294047|1521438|P1|Month 84|Absent Cervix|2
463545|NCT00294047|1521437|P2|Month 84|Lost to Follow-up|190
463546|NCT00294047|1521438|P1|Month 84|Lost to Follow-up|187
463547|NCT00294047|1521437|P2|Month 84|Withdrawal by Subject|31
463548|NCT00294047|1521438|P1|Month 84|Withdrawal by Subject|33
463549|NCT00294047|1521437|P2|Month 84|Protocol Violation|1
463550|NCT00294047|1521438|P1|Month 84|Protocol Violation|1
463551|NCT00294047|1521437|P2|Month 84|Adverse Event|2
463552|NCT00294047|1521438|P1|Month 84|Adverse Event|4
463553|NCT00294047|1521437|P2|Month 48|Other|14
463554|NCT00294047|1521438|P1|Month 48|Other|10
463555|NCT00294047|1521437|P2|Month 48|Lost to Follow-up|287
463556|NCT00294047|1521438|P1|Month 48|Lost to Follow-up|272
463557|NCT00294047|1521437|P2|Month 48|Withdrawal by Subject|115
463558|NCT00294047|1521438|P1|Month 48|Withdrawal by Subject|111
463559|NCT00294047|1521437|P2|Month 48|Protocol Violation|4
463560|NCT00294047|1521438|P1|Month 48|Protocol Violation|4
463561|NCT00294047|1521437|P2|Month 48|Adverse Event|13
463562|NCT00294047|1521438|P1|Month 48|Adverse Event|28
463563|NCT00293813|1521543|P3|Overall Study|Noncompliance|0
463564|NCT00293813|1521544|P2|Overall Study|Noncompliance|1
463565|NCT00293813|1521545|P1|Overall Study|Noncompliance|0
463566|NCT00293813|1521543|P3|Overall Study|Lost to Follow-up|3
463567|NCT00293813|1521544|P2|Overall Study|Lost to Follow-up|2
463568|NCT00293813|1521545|P1|Overall Study|Lost to Follow-up|3
463569|NCT00293813|1521543|P3|Overall Study|Withdrawal by Subject|4
463570|NCT00293813|1521544|P2|Overall Study|Withdrawal by Subject|4
463571|NCT00293813|1521545|P1|Overall Study|Withdrawal by Subject|7
463572|NCT00293813|1521543|P3|Overall Study|Adverse Event|1
463573|NCT00293813|1521544|P2|Overall Study|Adverse Event|1
463574|NCT00293813|1521545|P1|Overall Study|Adverse Event|3
463575|NCT00293813|1521543|P3|Overall Study|Physician Decision|0
463576|NCT00293813|1521544|P2|Overall Study|Physician Decision|1
463577|NCT00293813|1521545|P1|Overall Study|Physician Decision|0
463578|NCT00293722|1521556|P1|Overall Study|Other|427
463579|NCT00293709|1521570|P1|Overall Study|Other|47
463580|NCT00293579|1521584|P1|Overall Study|Withdrawal by Subject|1
463581|NCT00293462|1521603|P3|Overall Study|Physician Decision|0
463582|NCT00293462|1521604|P2|Overall Study|Physician Decision|1
463583|NCT00293462|1521605|P1|Overall Study|Physician Decision|0
463584|NCT00293462|1521603|P3|Overall Study|Low radiation dose in oral cavity|0
463585|NCT00293462|1521604|P2|Overall Study|Low radiation dose in oral cavity|1
463586|NCT00293462|1521605|P1|Overall Study|Low radiation dose in oral cavity|0
463587|NCT00293462|1521603|P3|Overall Study|Possible Tracheostomy leakage|0
463588|NCT00293462|1521604|P2|Overall Study|Possible Tracheostomy leakage|1
463589|NCT00293462|1521605|P1|Overall Study|Possible Tracheostomy leakage|0
463590|NCT00293462|1521603|P3|Overall Study|Ischemic stroke after chemotherapy|1
463591|NCT00293462|1521604|P2|Overall Study|Ischemic stroke after chemotherapy|0
463592|NCT00293462|1521605|P1|Overall Study|Ischemic stroke after chemotherapy|0
463593|NCT00293462|1521603|P3|Overall Study|Blood clot after chemotherapy|1
463594|NCT00293462|1521604|P2|Overall Study|Blood clot after chemotherapy|0
463595|NCT00293462|1521605|P1|Overall Study|Blood clot after chemotherapy|0
463596|NCT00293462|1521603|P3|Overall Study|Went back to his home country|1
463597|NCT00293462|1521604|P2|Overall Study|Went back to his home country|0
463598|NCT00293462|1521605|P1|Overall Study|Went back to his home country|0
463599|NCT00293462|1521603|P3|Overall Study|No Show|1
463600|NCT00293462|1521604|P2|Overall Study|No Show|0
463601|NCT00293462|1521605|P1|Overall Study|No Show|0
463602|NCT00293462|1521603|P3|Overall Study|Refuse Radiation Treatment|0
463603|NCT00293462|1521604|P2|Overall Study|Refuse Radiation Treatment|0
463604|NCT00293462|1521605|P1|Overall Study|Refuse Radiation Treatment|1
463605|NCT00293462|1521603|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
463606|NCT00293462|1521604|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
463607|NCT00293462|1521605|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
463608|NCT00293462|1521603|P3|Overall Study|Change Treatment Regimen (ineligible)|0
463609|NCT00293462|1521604|P2|Overall Study|Change Treatment Regimen (ineligible)|0
463610|NCT00293462|1521605|P1|Overall Study|Change Treatment Regimen (ineligible)|1
463611|NCT00293462|1521603|P3|Overall Study|Lost to Follow-up|0
463612|NCT00293462|1521604|P2|Overall Study|Lost to Follow-up|1
463613|NCT00293462|1521605|P1|Overall Study|Lost to Follow-up|0
463614|NCT00293462|1521603|P3|Overall Study|Death|0
463615|NCT00293462|1521604|P2|Overall Study|Death|0
463616|NCT00293462|1521605|P1|Overall Study|Death|1
463617|NCT00293462|1521603|P3|Overall Study|Withdrawal by Subject|6
463618|NCT00293462|1521604|P2|Overall Study|Withdrawal by Subject|3
463619|NCT00293462|1521605|P1|Overall Study|Withdrawal by Subject|4
463620|NCT00293384|1521624|P1|Overall Study|Ineligible|2
463621|NCT00293384|1521624|P1|Overall Study|Missed dosage/study drug|1
463622|NCT00293384|1521624|P1|Overall Study|Non-compliance|2
463623|NCT00293293|1521633|P2|Overall Study|Patient discontinued chemotherapy|1
463624|NCT00293293|1521634|P1|Overall Study|Patient discontinued chemotherapy|0
463625|NCT00293293|1521633|P2|Overall Study|"Patient too anxious to complete trial"|0
463626|NCT00293293|1521634|P1|Overall Study|"Patient too anxious to complete trial"|1
463627|NCT00293293|1521633|P2|Overall Study|Withdrawal by Subject|1
463628|NCT00293293|1521634|P1|Overall Study|Withdrawal by Subject|1
463629|NCT00293267|1521662|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
463630|NCT00293267|1521663|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
463631|NCT00293267|1521662|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
463632|NCT00293267|1521663|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
463633|NCT00293267|1521662|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
463634|NCT00293267|1521663|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
463635|NCT00293267|1521662|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
463636|NCT00293267|1521663|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
463637|NCT00293267|1521662|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
463638|NCT00293267|1521663|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
463639|NCT00293267|1521662|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
463640|NCT00293267|1521663|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
463641|NCT00293267|1521662|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
463642|NCT00293267|1521663|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
463643|NCT00293267|1521662|P2|Extension - Open-Label Week 157-240|Other Reason|1
463644|NCT00293267|1521663|P1|Extension - Open-Label Week 157-240|Other Reason|3
463645|NCT00293267|1521662|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
463646|NCT00293267|1521663|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
463647|NCT00293267|1521662|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
463648|NCT00293267|1521663|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
463649|NCT00293267|1521662|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
463650|NCT00293267|1521663|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
463651|NCT00293267|1521662|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
463652|NCT00293267|1521663|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
463653|NCT00293267|1521662|P2|Extension - Open-Label Week 157-240|Adverse Event|0
463654|NCT00293267|1521663|P1|Extension - Open-Label Week 157-240|Adverse Event|5
463655|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
463656|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
463657|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Other Reason|0
463658|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Other Reason|7
463659|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
463660|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
463661|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Death|0
463662|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Death|3
463663|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
463664|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
463665|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
463666|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
463667|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
463668|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
463669|NCT00293267|1521662|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
463670|NCT00293267|1521663|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
463671|NCT00293267|1521662|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
463672|NCT00293267|1521663|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
463673|NCT00293267|1521662|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
463674|NCT00293267|1521663|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
463675|NCT00293267|1521662|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
463676|NCT00293267|1521663|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
463677|NCT00293267|1521662|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
463678|NCT00293267|1521663|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
463679|NCT00293267|1521662|P2|Primary Study - Double-Blind Week 0-48|Death|3
463680|NCT00293267|1521663|P1|Primary Study - Double-Blind Week 0-48|Death|3
463681|NCT00293267|1521662|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
463682|NCT00293267|1521663|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
463683|NCT00293267|1521662|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
463684|NCT00293267|1521663|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
463685|NCT00293254|1521703|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
463686|NCT00293254|1521704|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
463687|NCT00293254|1521703|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
463688|NCT00293254|1521704|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
463689|NCT00293254|1521703|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
463690|NCT00293254|1521704|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
463691|NCT00293254|1521703|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
463692|NCT00293254|1521704|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
463693|NCT00293254|1521703|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
463694|NCT00293254|1521704|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
463695|NCT00293254|1521703|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
463696|NCT00293254|1521704|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
463697|NCT00293254|1521703|P2|Extension - Open-Label Week 157-240|Other Reason|0
463698|NCT00293254|1521704|P1|Extension - Open-Label Week 157-240|Other Reason|4
463699|NCT00293254|1521703|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
463700|NCT00293254|1521704|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
463701|NCT00293254|1521703|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
463702|NCT00293254|1521704|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
463703|NCT00293254|1521703|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
463704|NCT00293254|1521704|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
463705|NCT00293254|1521703|P2|Extension - Open-Label Week 157-240|Adverse Event|1
463706|NCT00293254|1521704|P1|Extension - Open-Label Week 157-240|Adverse Event|2
463707|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
463708|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
463709|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Other Reason|2
463710|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Other Reason|10
463711|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
463712|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
463713|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
463714|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
463715|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
463716|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
463717|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
463718|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
463719|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Death|1
463720|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Death|4
463721|NCT00293254|1521703|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
463722|NCT00293254|1521704|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
463723|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
463724|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
463725|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
463726|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
463727|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
463728|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
463729|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
463730|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
463731|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
463732|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
463733|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Death|2
463734|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Death|5
463735|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
463736|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
463737|NCT00293254|1521703|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
463738|NCT00293254|1521704|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
463739|NCT00293241|1521744|P2|Overall Study|Withdrawal by Subject|8
463740|NCT00293241|1521745|P1|Overall Study|Withdrawal by Subject|4
463741|NCT00293241|1521744|P2|Overall Study|Physician Decision|17
463742|NCT00293241|1521745|P1|Overall Study|Physician Decision|23
463743|NCT00293241|1521744|P2|Overall Study|Lost to Follow-up|16
463744|NCT00293241|1521745|P1|Overall Study|Lost to Follow-up|9
463745|NCT00293059|1521789|P2|Overall Study|missing|5
463746|NCT00293059|1521790|P1|Overall Study|missing|3
463747|NCT00293059|1521789|P2|Overall Study|Noncompliant - sanitary pads collection|1
463748|NCT00293059|1521790|P1|Overall Study|Noncompliant - sanitary pads collection|0
463749|NCT00293059|1521789|P2|Overall Study|Participant stopped study drug|0
463750|NCT00293059|1521790|P1|Overall Study|Participant stopped study drug|1
463751|NCT00293059|1521789|P2|Overall Study|Participant moved out of state|0
463752|NCT00293059|1521790|P1|Overall Study|Participant moved out of state|1
463753|NCT00293059|1521789|P2|Overall Study|Withdrawal by Subject|5
463754|NCT00293059|1521790|P1|Overall Study|Withdrawal by Subject|11
463755|NCT00293059|1521789|P2|Overall Study|Protocol Violation|0
463756|NCT00293059|1521790|P1|Overall Study|Protocol Violation|2
463757|NCT00293059|1521789|P2|Overall Study|Pregnancy|1
463758|NCT00293059|1521790|P1|Overall Study|Pregnancy|1
463759|NCT00293059|1521789|P2|Overall Study|Lost to Follow-up|3
463760|NCT00293059|1521790|P1|Overall Study|Lost to Follow-up|2
463761|NCT00293059|1521789|P2|Overall Study|Lack of Efficacy|0
463762|NCT00293059|1521790|P1|Overall Study|Lack of Efficacy|2
463763|NCT00293059|1521789|P2|Overall Study|Adverse Event|4
463764|NCT00293059|1521790|P1|Overall Study|Adverse Event|12
463765|NCT00293020|1521902|P1|Overall Study|No dose taken|1
463766|NCT00293020|1521902|P1|Overall Study|Other Reason|22
463767|NCT00293020|1521902|P1|Overall Study|Physician Decision|21
463768|NCT00293020|1521902|P1|Overall Study|Protocol Violation|6
463769|NCT00293020|1521902|P1|Overall Study|Lost to Follow-up|4
463770|NCT00293020|1521902|P1|Overall Study|Lack of Efficacy|12
463771|NCT00293020|1521902|P1|Overall Study|Death|32
463772|NCT00293020|1521902|P1|Overall Study|Adverse Event|30
463773|NCT00293020|1521902|P1|Overall Study|Withdrawal by Subject|34
463774|NCT00292981|1521906|P1|Overall Study|Not specified|3
463775|NCT00292981|1521906|P1|Overall Study|Withdrawal by Subject|22
463776|NCT00292981|1521906|P1|Overall Study|Lost to Follow-up|13
463777|NCT00292981|1521906|P1|Overall Study|Adverse Event|1
463778|NCT00292461|1521928|P2|Overall Study|Lost to Follow-up|0
463779|NCT00292461|1521929|P1|Overall Study|Lost to Follow-up|1
463780|NCT00292461|1521928|P2|Overall Study|Protocol Violation|3
463781|NCT00292461|1521929|P1|Overall Study|Protocol Violation|4
463782|NCT00292461|1521928|P2|Overall Study|Withdrawal by Subject|1
463783|NCT00292461|1521929|P1|Overall Study|Withdrawal by Subject|0
463784|NCT00292461|1521928|P2|Overall Study|Lack of Efficacy|0
463785|NCT00292461|1521929|P1|Overall Study|Lack of Efficacy|1
463786|NCT00292461|1521928|P2|Overall Study|Adverse Event|2
463787|NCT00292461|1521929|P1|Overall Study|Adverse Event|4
463788|NCT00292370|1521944|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
463789|NCT00292370|1521945|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
463790|NCT00292370|1521946|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
463791|NCT00292370|1521944|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
463792|NCT00292370|1521945|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
463793|NCT00292370|1521946|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
463794|NCT00292370|1521944|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
463795|NCT00292370|1521945|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
463796|NCT00292370|1521946|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
463797|NCT00292370|1521944|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
463798|NCT00292370|1521945|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
463799|NCT00292370|1521946|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
463800|NCT00292370|1521944|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
463801|NCT00292370|1521945|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
463802|NCT00292370|1521946|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
463803|NCT00292370|1521944|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
463804|NCT00292370|1521945|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
463805|NCT00292370|1521946|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
463806|NCT00292318|1521955|P2|Overall Study|Study terminated by officials|1
463807|NCT00292318|1521956|P1|Overall Study|Study terminated by officials|2
463808|NCT00292227|1521966|P3|Patch Period|Withdrawal by Subject|1
463809|NCT00292227|1521967|P2|Patch Period|Withdrawal by Subject|0
463810|NCT00292227|1521968|P1|Patch Period|Withdrawal by Subject|0
463811|NCT00292227|1521966|P3|Patch Period|Adverse Event|2
463812|NCT00292227|1521967|P2|Patch Period|Adverse Event|0
463813|NCT00292227|1521968|P1|Patch Period|Adverse Event|1
463814|NCT00292188|1522050|P3|Double-Blind|Laboratory Abnormality|1
463815|NCT00292188|1522051|P2|Double-Blind|Laboratory Abnormality|0
463816|NCT00292188|1522052|P1|Double-Blind|Laboratory Abnormality|0
463817|NCT00292188|1522050|P3|Double-Blind|Withdrawal by Subject|3
463818|NCT00292188|1522051|P2|Double-Blind|Withdrawal by Subject|0
463819|NCT00292188|1522052|P1|Double-Blind|Withdrawal by Subject|0
463820|NCT00292188|1522050|P3|Double-Blind|Other|4
463821|NCT00292188|1522051|P2|Double-Blind|Other|3
463822|NCT00292188|1522052|P1|Double-Blind|Other|0
463823|NCT00292188|1522050|P3|Double-Blind|Lost to Follow-up|0
463824|NCT00292188|1522051|P2|Double-Blind|Lost to Follow-up|1
463825|NCT00292188|1522052|P1|Double-Blind|Lost to Follow-up|0
463826|NCT00292188|1522050|P3|Double-Blind|Lack of Efficacy|12
463827|NCT00292188|1522051|P2|Double-Blind|Lack of Efficacy|2
463828|NCT00292188|1522052|P1|Double-Blind|Lack of Efficacy|0
463829|NCT00292188|1522050|P3|Double-Blind|Adverse Event|9
463830|NCT00292188|1522051|P2|Double-Blind|Adverse Event|25
463831|NCT00292188|1522052|P1|Double-Blind|Adverse Event|0
463832|NCT00292188|1522050|P3|Single-Blind|Did not receive treatment|0
463833|NCT00292188|1522051|P2|Single-Blind|Did not receive treatment|0
463834|NCT00292188|1522052|P1|Single-Blind|Did not receive treatment|1
463835|NCT00292188|1522050|P3|Single-Blind|Withdrawal by Subject|0
463836|NCT00292188|1522051|P2|Single-Blind|Withdrawal by Subject|0
463837|NCT00292188|1522052|P1|Single-Blind|Withdrawal by Subject|12
463838|NCT00292188|1522050|P3|Single-Blind|Other|0
463839|NCT00292188|1522051|P2|Single-Blind|Other|0
463840|NCT00292188|1522052|P1|Single-Blind|Other|77
463841|NCT00292188|1522050|P3|Single-Blind|Lost to Follow-up|0
463842|NCT00292188|1522051|P2|Single-Blind|Lost to Follow-up|0
463843|NCT00292188|1522052|P1|Single-Blind|Lost to Follow-up|3
463844|NCT00292188|1522050|P3|Single-Blind|Laboratory Abnormality|0
463845|NCT00292188|1522051|P2|Single-Blind|Laboratory Abnormality|0
463846|NCT00292188|1522052|P1|Single-Blind|Laboratory Abnormality|5
463847|NCT00292188|1522050|P3|Single-Blind|Lack of Efficacy|0
463848|NCT00292188|1522051|P2|Single-Blind|Lack of Efficacy|0
463849|NCT00292188|1522052|P1|Single-Blind|Lack of Efficacy|2
463850|NCT00292188|1522050|P3|Single-Blind|Adverse Event|0
463851|NCT00292188|1522051|P2|Single-Blind|Adverse Event|0
463852|NCT00292188|1522052|P1|Single-Blind|Adverse Event|14
463853|NCT00291577|1522164|P1|Overall Study|Lack of Efficacy|14
463854|NCT00291577|1522164|P1|Overall Study|Withdrawal by Subject|2
463855|NCT00291577|1522164|P1|Overall Study|Other|4
463856|NCT00291577|1522164|P1|Overall Study|Adverse Event|1
463857|NCT00291551|1522183|P1|Overall Study|Withdrawal by Subject|6
463858|NCT00291551|1522183|P1|Overall Study|Death|7
463859|NCT00291330|1522231|P2|Overall Study|Other|1
463860|NCT00291330|1522232|P1|Overall Study|Other|3
463861|NCT00291330|1522231|P2|Overall Study|Withdrawal by Subject|25
463862|NCT00291330|1522232|P1|Overall Study|Withdrawal by Subject|22
463863|NCT00291330|1522231|P2|Overall Study|Lost to Follow-up|11
463864|NCT00291330|1522232|P1|Overall Study|Lost to Follow-up|16
463865|NCT00291330|1522231|P2|Overall Study|Protocol Violation|20
463866|NCT00291330|1522232|P1|Overall Study|Protocol Violation|13
463867|NCT00291330|1522231|P2|Overall Study|Adverse Event|40
463868|NCT00291330|1522232|P1|Overall Study|Adverse Event|47
463869|NCT00291187|1522274|P4|Overall Study|Protocol Violation- No Drug Administered|0
463870|NCT00291187|1522275|P3|Overall Study|Protocol Violation- No Drug Administered|1
463871|NCT00291187|1522276|P2|Overall Study|Protocol Violation- No Drug Administered|0
463872|NCT00291187|1522277|P1|Overall Study|Protocol Violation- No Drug Administered|0
463873|NCT00291018|1522321|P3|Overall Study|Lost to Follow-up|18
463874|NCT00291018|1522322|P2|Overall Study|Lost to Follow-up|4
463875|NCT00291018|1522323|P1|Overall Study|Lost to Follow-up|3
463876|NCT00291018|1522321|P3|Overall Study|Failures|5
463877|NCT00291018|1522322|P2|Overall Study|Failures|12
463878|NCT00291018|1522323|P1|Overall Study|Failures|5
463879|NCT00291018|1522321|P3|Overall Study|Withdrawal by Subject|1
463880|NCT00291018|1522322|P2|Overall Study|Withdrawal by Subject|8
463881|NCT00291018|1522323|P1|Overall Study|Withdrawal by Subject|2
463882|NCT00291018|1522321|P3|Overall Study|Death|4
463883|NCT00291018|1522322|P2|Overall Study|Death|3
463884|NCT00291018|1522323|P1|Overall Study|Death|3
463885|NCT00291018|1522321|P3|Overall Study|Not Consented or Declined PAS|15
463886|NCT00291018|1522322|P2|Overall Study|Not Consented or Declined PAS|15
463887|NCT00291018|1522323|P1|Overall Study|Not Consented or Declined PAS|12
463888|NCT00290888|1522363|P2|Overall Study|Physician Decision|1
463889|NCT00290888|1522364|P1|Overall Study|Physician Decision|3
463890|NCT00290771|1522381|P2|Overall Study|Lost to Follow-up|1
463891|NCT00290771|1522382|P1|Overall Study|Lost to Follow-up|0
463892|NCT00290771|1522381|P2|Overall Study|Protocol Violation|0
463893|NCT00290771|1522382|P1|Overall Study|Protocol Violation|2
463894|NCT00290771|1522381|P2|Overall Study|Administrative problems|1
463895|NCT00290771|1522382|P1|Overall Study|Administrative problems|2
463896|NCT00290771|1522381|P2|Overall Study|Withdrawal by Subject|6
463897|NCT00290771|1522382|P1|Overall Study|Withdrawal by Subject|5
463898|NCT00290771|1522381|P2|Overall Study|Adverse Event|6
463899|NCT00290771|1522382|P1|Overall Study|Adverse Event|12
463900|NCT00290771|1522381|P2|Overall Study|Death|10
463901|NCT00290771|1522382|P1|Overall Study|Death|11
463902|NCT00290771|1522381|P2|Overall Study|Disease progression|73
463903|NCT00290771|1522382|P1|Overall Study|Disease progression|95
463904|NCT00290758|1522406|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
463905|NCT00290758|1522407|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
463906|NCT00290758|1522406|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
463907|NCT00290758|1522407|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
463908|NCT00290758|1522406|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
463909|NCT00290758|1522407|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
463910|NCT00290758|1522406|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
463911|NCT00290758|1522407|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
463912|NCT00290758|1522406|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
463913|NCT00290758|1522407|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
463914|NCT00290758|1522406|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
463915|NCT00290758|1522407|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
463916|NCT00290758|1522406|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
463917|NCT00290758|1522407|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
463918|NCT00290758|1522406|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
463919|NCT00290758|1522407|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
463920|NCT00290732|1522429|P5|Overall Study|Inability to instill drug intraductally.|0
463921|NCT00290732|1522430|P4|Overall Study|Inability to instill drug intraductally.|0
463922|NCT00290732|1522431|P3|Overall Study|Inability to instill drug intraductally.|1
463923|NCT00290732|1522432|P2|Overall Study|Inability to instill drug intraductally.|1
463924|NCT00290732|1522433|P1|Overall Study|Inability to instill drug intraductally.|0
463925|NCT00290693|1522451|P1|Overall Study|Withdrawal by Subject|2
463926|NCT00290407|1522500|P1|Overall Study|Physician Decision|2
463927|NCT00290290|1522532|P2|Overall Study|Underwent clean surgical procedure|12
463928|NCT00290290|1522533|P1|Overall Study|Underwent clean surgical procedure|13
463929|NCT00290290|1522532|P2|Overall Study|Withdrawal by Subject|2
463930|NCT00290290|1522533|P1|Overall Study|Withdrawal by Subject|2
463931|NCT00290290|1522532|P2|Overall Study|Death|4
463932|NCT00290290|1522533|P1|Overall Study|Death|3
463933|NCT00290251|1522539|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
463934|NCT00290251|1522540|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
463935|NCT00290251|1522541|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
463936|NCT00290251|1522539|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
463937|NCT00290251|1522540|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
463938|NCT00290251|1522541|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
463939|NCT00290251|1522539|P3|Treatment 1 (Months 1 - 3)|headache|0
463940|NCT00290251|1522540|P2|Treatment 1 (Months 1 - 3)|headache|1
463941|NCT00290251|1522541|P1|Treatment 1 (Months 1 - 3)|headache|0
463942|NCT00290251|1522539|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
463943|NCT00290251|1522540|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
463944|NCT00290251|1522541|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
463945|NCT00290238|1522553|P2|Overall Study|Withdrawal by Subject|13
463946|NCT00290238|1522554|P1|Overall Study|Withdrawal by Subject|15
463947|NCT00290238|1522553|P2|Overall Study|Lost to Follow-up|1
463948|NCT00290238|1522554|P1|Overall Study|Lost to Follow-up|0
463949|NCT00290238|1522553|P2|Overall Study|Study terminated|27
463950|NCT00290238|1522554|P1|Overall Study|Study terminated|27
463951|NCT00290186|1522579|P2|Overall Study|Withdrawal by Subject|1
463952|NCT00290186|1522580|P1|Overall Study|Withdrawal by Subject|0
463953|NCT00290186|1522579|P2|Overall Study|Study was terminated prior to 3-month te|1
463954|NCT00290186|1522580|P1|Overall Study|Study was terminated prior to 3-month te|1
463955|NCT00290186|1522579|P2|Overall Study|Lost to Follow-up|2
463956|NCT00290186|1522580|P1|Overall Study|Lost to Follow-up|3
463957|NCT00290186|1522579|P2|Overall Study|Adverse Event|1
463958|NCT00290186|1522580|P1|Overall Study|Adverse Event|1
463959|NCT00289991|1522631|P2|Overall Study|Other|14
463960|NCT00289991|1522632|P1|Overall Study|Other|5
463961|NCT00289991|1522631|P2|Overall Study|Withdrawal by Subject|12
463962|NCT00289991|1522632|P1|Overall Study|Withdrawal by Subject|2
463963|NCT00289991|1522631|P2|Overall Study|Lost to Follow-up|1
463964|NCT00289991|1522632|P1|Overall Study|Lost to Follow-up|0
463965|NCT00289991|1522631|P2|Overall Study|Fungal breakthrough infection|1
463966|NCT00289991|1522632|P1|Overall Study|Fungal breakthrough infection|0
463967|NCT00289991|1522631|P2|Overall Study|Failure of prophylaxis|1
463968|NCT00289991|1522632|P1|Overall Study|Failure of prophylaxis|1
463969|NCT00289991|1522631|P2|Overall Study|Adverse Event|13
463970|NCT00289991|1522632|P1|Overall Study|Adverse Event|15
463971|NCT00289991|1522631|P2|Overall Study|Death|38
463972|NCT00289991|1522632|P1|Overall Study|Death|35
463973|NCT00289978|1522657|P3|Overall Study|Death|2
463974|NCT00289978|1522658|P2|Overall Study|Death|0
463975|NCT00289978|1522659|P1|Overall Study|Death|1
463976|NCT00289978|1522657|P3|Overall Study|Abnormal test procedure result(s)|1
463977|NCT00289978|1522658|P2|Overall Study|Abnormal test procedure result(s)|1
463978|NCT00289978|1522659|P1|Overall Study|Abnormal test procedure result(s)|2
463979|NCT00289978|1522657|P3|Overall Study|Protocol Violation|4
463980|NCT00289978|1522658|P2|Overall Study|Protocol Violation|5
463981|NCT00289978|1522659|P1|Overall Study|Protocol Violation|5
463982|NCT00289978|1522657|P3|Overall Study|Lost to Follow-up|7
463983|NCT00289978|1522658|P2|Overall Study|Lost to Follow-up|5
463984|NCT00289978|1522659|P1|Overall Study|Lost to Follow-up|3
463985|NCT00289978|1522657|P3|Overall Study|Abnormal laboratory value(s)|1
463986|NCT00289978|1522658|P2|Overall Study|Abnormal laboratory value(s)|9
463987|NCT00289978|1522659|P1|Overall Study|Abnormal laboratory value(s)|20
463988|NCT00289978|1522657|P3|Overall Study|Lack of Efficacy|25
463989|NCT00289978|1522658|P2|Overall Study|Lack of Efficacy|6
463990|NCT00289978|1522659|P1|Overall Study|Lack of Efficacy|13
463991|NCT00289978|1522657|P3|Overall Study|Adverse Event|18
463992|NCT00289978|1522658|P2|Overall Study|Adverse Event|13
463993|NCT00289978|1522659|P1|Overall Study|Adverse Event|22
463994|NCT00289978|1522657|P3|Overall Study|Withdrawal by Subject|28
463995|NCT00289978|1522658|P2|Overall Study|Withdrawal by Subject|17
463996|NCT00289978|1522659|P1|Overall Study|Withdrawal by Subject|31
463997|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
463998|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
463999|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
464000|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
464001|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
464002|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
464003|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
464004|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
464005|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
464006|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
464007|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
464008|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
464009|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
464010|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
464011|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
464012|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
464013|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
464014|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
464015|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
464016|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
464017|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
464018|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
464019|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
464020|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
464021|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
464022|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
464023|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
464024|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
464025|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
464026|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
464027|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
464028|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
464029|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
464030|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
464031|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
464032|NCT00289913|1522678|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464033|NCT00289913|1522679|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464034|NCT00289913|1522680|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464035|NCT00289913|1522681|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
464036|NCT00289913|1522682|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464037|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
464038|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
464039|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
464040|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
464041|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
464042|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
464043|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
464044|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
464045|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
464046|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
464047|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
464048|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
464049|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
464050|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
464051|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
464052|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
464053|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
464054|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
464055|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
464056|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
464057|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
464058|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
464059|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
464060|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
464061|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
464062|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
464063|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
464064|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
464065|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
464066|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
464067|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
464068|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
464069|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
464070|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
464071|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
464072|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
464073|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
464074|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
464075|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
464076|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
464077|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
464078|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
464079|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
464080|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
464081|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
464082|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
464083|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
464084|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
464085|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
464086|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
464087|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
464088|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
464089|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
464090|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
464091|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
464092|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
464093|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
464094|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
464095|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
464096|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
464097|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
464098|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
464099|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
464100|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
464101|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
464102|NCT00289913|1522678|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464103|NCT00289913|1522679|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464104|NCT00289913|1522680|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
464105|NCT00289913|1522681|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464106|NCT00289913|1522682|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464107|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
464108|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
464109|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
464110|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
464111|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
464112|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
464113|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
464114|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
464115|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
464116|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
464117|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
464118|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
464119|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
464120|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
464121|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
464122|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
464123|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
464124|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
464125|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
464126|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
464127|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
464128|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
464129|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
464130|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
464131|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
464132|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
464133|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
464134|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
464135|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
464136|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
464137|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
464138|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
464139|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
464140|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
464141|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
464142|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
464143|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
464144|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
464145|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
464146|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
464147|NCT00289913|1522678|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464148|NCT00289913|1522679|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464149|NCT00289913|1522680|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464150|NCT00289913|1522681|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
464151|NCT00289913|1522682|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
464152|NCT00289900|1522713|P6|Overall Study|Not treated|0
464153|NCT00289900|1522714|P5|Overall Study|Not treated|0
464154|NCT00289900|1522715|P4|Overall Study|Not treated|0
464155|NCT00289900|1522716|P3|Overall Study|Not treated|0
464156|NCT00289900|1522717|P2|Overall Study|Not treated|1
464157|NCT00289900|1522718|P1|Overall Study|Not treated|0
464158|NCT00289900|1522713|P6|Overall Study|site terminated|0
464159|NCT00289900|1522714|P5|Overall Study|site terminated|0
464160|NCT00289900|1522715|P4|Overall Study|site terminated|0
464161|NCT00289900|1522716|P3|Overall Study|site terminated|1
464162|NCT00289900|1522717|P2|Overall Study|site terminated|0
464163|NCT00289900|1522718|P1|Overall Study|site terminated|1
464164|NCT00289900|1522713|P6|Overall Study|Protocol Violation|4
464165|NCT00289900|1522714|P5|Overall Study|Protocol Violation|7
464166|NCT00289900|1522715|P4|Overall Study|Protocol Violation|6
464167|NCT00289900|1522716|P3|Overall Study|Protocol Violation|2
464168|NCT00289900|1522717|P2|Overall Study|Protocol Violation|9
464169|NCT00289900|1522718|P1|Overall Study|Protocol Violation|3
464170|NCT00289900|1522713|P6|Overall Study|Withdrawal by Subject|11
464171|NCT00289900|1522714|P5|Overall Study|Withdrawal by Subject|12
464172|NCT00289900|1522715|P4|Overall Study|Withdrawal by Subject|18
464173|NCT00289900|1522716|P3|Overall Study|Withdrawal by Subject|8
464174|NCT00289900|1522717|P2|Overall Study|Withdrawal by Subject|21
464175|NCT00289900|1522718|P1|Overall Study|Withdrawal by Subject|10
464176|NCT00289900|1522713|P6|Overall Study|Participant moved|1
464177|NCT00289900|1522714|P5|Overall Study|Participant moved|1
464178|NCT00289900|1522715|P4|Overall Study|Participant moved|1
464179|NCT00289900|1522716|P3|Overall Study|Participant moved|0
464180|NCT00289900|1522717|P2|Overall Study|Participant moved|0
464181|NCT00289900|1522718|P1|Overall Study|Participant moved|1
464182|NCT00289900|1522713|P6|Overall Study|Other|0
464183|NCT00289900|1522714|P5|Overall Study|Other|1
464184|NCT00289900|1522715|P4|Overall Study|Other|5
464185|NCT00289900|1522716|P3|Overall Study|Other|0
464186|NCT00289900|1522717|P2|Overall Study|Other|0
464187|NCT00289900|1522718|P1|Overall Study|Other|0
464188|NCT00289900|1522713|P6|Overall Study|Participant had flushing|4
464189|NCT00289900|1522714|P5|Overall Study|Participant had flushing|0
464190|NCT00289900|1522715|P4|Overall Study|Participant had flushing|2
464191|NCT00289900|1522716|P3|Overall Study|Participant had flushing|1
464192|NCT00289900|1522717|P2|Overall Study|Participant had flushing|42
464193|NCT00289900|1522718|P1|Overall Study|Participant had flushing|18
464194|NCT00289900|1522713|P6|Overall Study|Lost to Follow-up|8
464195|NCT00289900|1522714|P5|Overall Study|Lost to Follow-up|4
464196|NCT00289900|1522715|P4|Overall Study|Lost to Follow-up|8
464197|NCT00289900|1522716|P3|Overall Study|Lost to Follow-up|8
464198|NCT00289900|1522717|P2|Overall Study|Lost to Follow-up|7
464199|NCT00289900|1522718|P1|Overall Study|Lost to Follow-up|7
464200|NCT00289900|1522713|P6|Overall Study|Adverse Event|33
464201|NCT00289900|1522714|P5|Overall Study|Adverse Event|20
464202|NCT00289900|1522715|P4|Overall Study|Adverse Event|19
464203|NCT00289900|1522716|P3|Overall Study|Adverse Event|13
464204|NCT00289900|1522717|P2|Overall Study|Adverse Event|40
464205|NCT00289900|1522718|P1|Overall Study|Adverse Event|28
464206|NCT00289887|1522822|P2|Overall Study|Other|3
464207|NCT00289887|1522823|P1|Overall Study|Other|7
464208|NCT00289887|1522822|P2|Overall Study|Withdrawal by Subject|8
464209|NCT00289887|1522823|P1|Overall Study|Withdrawal by Subject|3
464210|NCT00289887|1522822|P2|Overall Study|Protocol Violation|1
464211|NCT00289887|1522823|P1|Overall Study|Protocol Violation|3
464212|NCT00289887|1522822|P2|Overall Study|Lost to Follow-up|3
464213|NCT00289887|1522823|P1|Overall Study|Lost to Follow-up|3
464214|NCT00289887|1522822|P2|Overall Study|Lack of Efficacy|11
464215|NCT00289887|1522823|P1|Overall Study|Lack of Efficacy|3
464216|NCT00289887|1522822|P2|Overall Study|Adverse Event|3
464217|NCT00289887|1522823|P1|Overall Study|Adverse Event|3
464218|NCT00289874|1522841|P2|Overall Study|Did not meet eligibility|0
464219|NCT00289874|1522842|P1|Overall Study|Did not meet eligibility|1
464220|NCT00289874|1522841|P2|Overall Study|Protocol Violation|2
464221|NCT00289874|1522842|P1|Overall Study|Protocol Violation|3
464222|NCT00289874|1522841|P2|Overall Study|Lost to Follow-up|1
464223|NCT00289874|1522842|P1|Overall Study|Lost to Follow-up|1
464224|NCT00289874|1522841|P2|Overall Study|Adverse Event|5
464225|NCT00289874|1522842|P1|Overall Study|Adverse Event|1
464226|NCT00289848|1522852|P2|Overall Study|Open-Label AHA Treatment Requested|1
464227|NCT00289848|1522853|P1|Overall Study|Open-Label AHA Treatment Requested|0
464228|NCT00289848|1522852|P2|Overall Study|Patient Moved|2
464229|NCT00289848|1522853|P1|Overall Study|Patient Moved|6
464230|NCT00289848|1522852|P2|Overall Study|Withdrawal by Subject|11
464231|NCT00289848|1522853|P1|Overall Study|Withdrawal by Subject|5
464232|NCT00289848|1522852|P2|Overall Study|Protocol Violation|2
464233|NCT00289848|1522853|P1|Overall Study|Protocol Violation|5
464234|NCT00289848|1522852|P2|Overall Study|Lost to Follow-up|1
464235|NCT00289848|1522853|P1|Overall Study|Lost to Follow-up|3
464236|NCT00289848|1522852|P2|Overall Study|Lack of Efficacy|24
464237|NCT00289848|1522853|P1|Overall Study|Lack of Efficacy|20
464238|NCT00289848|1522852|P2|Overall Study|Death|0
464239|NCT00289848|1522853|P1|Overall Study|Death|1
464240|NCT00289848|1522852|P2|Overall Study|Adverse Event|4
464241|NCT00289848|1522853|P1|Overall Study|Adverse Event|6
464242|NCT00289783|1522865|P2|Fourth Dose Phase|Other|10
464243|NCT00289783|1522866|P1|Fourth Dose Phase|Other|22
464244|NCT00289783|1522865|P2|Fourth Dose Phase|Migration from the study area|1
464245|NCT00289783|1522866|P1|Fourth Dose Phase|Migration from the study area|1
464246|NCT00289783|1522865|P2|Fourth Dose Phase|Lost to Follow-up|12
464247|NCT00289783|1522866|P1|Fourth Dose Phase|Lost to Follow-up|53
464248|NCT00289783|1522865|P2|Fourth Dose Phase|Withdrawal by Subject|1
464249|NCT00289783|1522866|P1|Fourth Dose Phase|Withdrawal by Subject|10
464250|NCT00289783|1522865|P2|Fourth Dose Phase|Adverse Event|0
464251|NCT00289783|1522866|P1|Fourth Dose Phase|Adverse Event|1
464252|NCT00289783|1522865|P2|Primary Phase|Other|12
464253|NCT00289783|1522866|P1|Primary Phase|Other|32
464254|NCT00289783|1522865|P2|Primary Phase|Migration from the study area|10
464255|NCT00289783|1522866|P1|Primary Phase|Migration from the study area|26
464256|NCT00289783|1522865|P2|Primary Phase|Lost to Follow-up|14
464257|NCT00289783|1522866|P1|Primary Phase|Lost to Follow-up|60
464258|NCT00289783|1522865|P2|Primary Phase|Withdrawal by Subject|40
464259|NCT00289783|1522866|P1|Primary Phase|Withdrawal by Subject|93
464260|NCT00289783|1522865|P2|Primary Phase|Protocol Violation|6
464261|NCT00289783|1522866|P1|Primary Phase|Protocol Violation|27
464262|NCT00289783|1522865|P2|Primary Phase|Adverse Event|1
464263|NCT00289783|1522866|P1|Primary Phase|Adverse Event|10
464264|NCT00289770|1523044|P1|Year 15|Withdrawal by Subject|1
464265|NCT00289536|1523102|P3|Period 3|Lost to Follow-up|1
464266|NCT00289536|1523103|P2|Period 3|Lost to Follow-up|0
464267|NCT00289536|1523104|P1|Period 3|Lost to Follow-up|0
464268|NCT00289458|1523150|P3|Overall Study|Withdrawal by Subject|4
464269|NCT00289458|1523151|P2|Overall Study|Withdrawal by Subject|2
464270|NCT00289458|1523152|P1|Overall Study|Withdrawal by Subject|2
464271|NCT00289458|1523150|P3|Overall Study|Physician Decision|2
464272|NCT00289458|1523151|P2|Overall Study|Physician Decision|4
464273|NCT00289458|1523152|P1|Overall Study|Physician Decision|3
464274|NCT00289458|1523150|P3|Overall Study|Death|0
464275|NCT00289458|1523151|P2|Overall Study|Death|0
464276|NCT00289458|1523152|P1|Overall Study|Death|1
464277|NCT00289289|1523213|P3|Overall Study|Other Exit Reason|12
464278|NCT00289289|1523214|P2|Overall Study|Other Exit Reason|4
464279|NCT00289289|1523215|P1|Overall Study|Other Exit Reason|6
464280|NCT00289289|1523213|P3|Overall Study|Did not meet inclusion/exclusion|6
464281|NCT00289289|1523214|P2|Overall Study|Did not meet inclusion/exclusion|0
464282|NCT00289289|1523215|P1|Overall Study|Did not meet inclusion/exclusion|0
464283|NCT00289289|1523213|P3|Overall Study|Non-study device implanted|3
464284|NCT00289289|1523214|P2|Overall Study|Non-study device implanted|1
464285|NCT00289289|1523215|P1|Overall Study|Non-study device implanted|2
464286|NCT00289289|1523213|P3|Overall Study|Physician Decision|6
464287|NCT00289289|1523214|P2|Overall Study|Physician Decision|0
464288|NCT00289289|1523215|P1|Overall Study|Physician Decision|1
464289|NCT00289289|1523213|P3|Overall Study|No implant attempted|1
464290|NCT00289289|1523214|P2|Overall Study|No implant attempted|0
464291|NCT00289289|1523215|P1|Overall Study|No implant attempted|0
464292|NCT00289289|1523213|P3|Overall Study|Death|5
464293|NCT00289289|1523214|P2|Overall Study|Death|2
464294|NCT00289289|1523215|P1|Overall Study|Death|4
464295|NCT00289289|1523213|P3|Overall Study|Lost to Follow-up|1
464296|NCT00289289|1523214|P2|Overall Study|Lost to Follow-up|0
464297|NCT00289289|1523215|P1|Overall Study|Lost to Follow-up|1
464298|NCT00289289|1523213|P3|Overall Study|Withdrawal by Subject|15
464299|NCT00289289|1523214|P2|Overall Study|Withdrawal by Subject|3
464300|NCT00289289|1523215|P1|Overall Study|Withdrawal by Subject|5
464301|NCT00289276|1523230|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
464302|NCT00289276|1523231|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
464303|NCT00289276|1523230|P2|Second Part of FAST Study (Expansion)|Death|2
464304|NCT00289276|1523231|P1|Second Part of FAST Study (Expansion)|Death|0
464305|NCT00289198|1523266|P2|Overall Study|Other: Impossible to come on visit|1
464306|NCT00289198|1523267|P1|Overall Study|Other: Impossible to come on visit|0
464307|NCT00289198|1523266|P2|Overall Study|Other: Miscalculation of the visit date|22
464308|NCT00289198|1523267|P1|Overall Study|Other: Miscalculation of the visit date|21
464309|NCT00289198|1523266|P2|Overall Study|Other: Unable to attend on schedule|1
464310|NCT00289198|1523267|P1|Overall Study|Other: Unable to attend on schedule|2
464311|NCT00289198|1523266|P2|Overall Study|Other: Physician's decision|1
464312|NCT00289198|1523267|P1|Overall Study|Other: Physician's decision|0
464313|NCT00289198|1523266|P2|Overall Study|Other: Low compliance|1
464314|NCT00289198|1523267|P1|Overall Study|Other: Low compliance|0
464315|NCT00289198|1523266|P2|Overall Study|Lack of Efficacy|0
464316|NCT00289198|1523267|P1|Overall Study|Lack of Efficacy|2
464317|NCT00289198|1523266|P2|Overall Study|Withdrawal by Subject|1
464318|NCT00289198|1523267|P1|Overall Study|Withdrawal by Subject|4
464319|NCT00289198|1523266|P2|Overall Study|Protocol Violation|1
464320|NCT00289198|1523267|P1|Overall Study|Protocol Violation|2
464321|NCT00289198|1523266|P2|Overall Study|Adverse Event|2
464322|NCT00289198|1523267|P1|Overall Study|Adverse Event|0
464323|NCT00289185|1523317|P2|Overall Study|Death|1
464324|NCT00289185|1523318|P1|Overall Study|Death|1
464325|NCT00289185|1523317|P2|Overall Study|Lost to Follow-up|17
464326|NCT00289185|1523318|P1|Overall Study|Lost to Follow-up|23
464327|NCT00289185|1523317|P2|Overall Study|Withdrawal by Subject|8
464328|NCT00289185|1523318|P1|Overall Study|Withdrawal by Subject|4
464329|NCT00289133|1523365|P2|Overall Study|Lost to Follow-up|115
464330|NCT00289133|1523366|P1|Overall Study|Lost to Follow-up|92
464331|NCT00289133|1523365|P2|Overall Study|Revision|6
464332|NCT00289133|1523366|P1|Overall Study|Revision|8
464333|NCT00289133|1523365|P2|Overall Study|Physician Decision|45
464334|NCT00289133|1523366|P1|Overall Study|Physician Decision|41
464418|NCT00288509|1523614|P1|Treatment Cycle 1|Adverse Event|1
464335|NCT00289133|1523365|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
464336|NCT00289133|1523366|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
464337|NCT00289133|1523365|P2|Overall Study|Death|10
464338|NCT00289133|1523366|P1|Overall Study|Death|5
464339|NCT00289133|1523365|P2|Overall Study|Withdrawal by Subject|10
464340|NCT00289133|1523366|P1|Overall Study|Withdrawal by Subject|9
464341|NCT00289133|1523365|P2|Overall Study|Protocol Violation|38
464342|NCT00289133|1523366|P1|Overall Study|Protocol Violation|32
464343|NCT00289133|1523365|P2|Overall Study|Non-study device implanted|0
464344|NCT00289133|1523366|P1|Overall Study|Non-study device implanted|12
464345|NCT00289016|1523422|P1|Overall Study|Other|1
464346|NCT00289016|1523422|P1|Overall Study|Adverse Event|1
464347|NCT00289016|1523422|P1|Overall Study|Withdrawal by Subject|2
464348|NCT00289016|1523422|P1|Overall Study|Unrelated Medical Condition or Accident|2
464349|NCT00289016|1523422|P1|Overall Study|Death|2
464350|NCT00289016|1523422|P1|Overall Study|Disease Progression|29
464351|NCT00288912|1523434|P3|Overall Study|Withdrawal by Subject|12
464352|NCT00288912|1523435|P2|Overall Study|Withdrawal by Subject|5
464353|NCT00288912|1523436|P1|Overall Study|Withdrawal by Subject|4
464354|NCT00288912|1523434|P3|Overall Study|Lost to Follow-up|9
464355|NCT00288912|1523435|P2|Overall Study|Lost to Follow-up|6
464356|NCT00288912|1523436|P1|Overall Study|Lost to Follow-up|9
464357|NCT00288912|1523434|P3|Overall Study|Developed exclusion criterion|7
464358|NCT00288912|1523435|P2|Overall Study|Developed exclusion criterion|6
464359|NCT00288912|1523436|P1|Overall Study|Developed exclusion criterion|4
464360|NCT00288860|1523476|P2|Overall Study|Lost to Follow-up|71
464361|NCT00288860|1523477|P1|Overall Study|Lost to Follow-up|74
464362|NCT00288860|1523476|P2|Overall Study|Withdrawal by Subject|15
464363|NCT00288860|1523477|P1|Overall Study|Withdrawal by Subject|20
464364|NCT00288860|1523476|P2|Overall Study|Death|3
464365|NCT00288860|1523477|P1|Overall Study|Death|4
464366|NCT00288860|1523476|P2|Overall Study|Did not complete intake|8
464367|NCT00288860|1523477|P1|Overall Study|Did not complete intake|4
464368|NCT00288704|1523490|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
464369|NCT00288704|1523491|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
464370|NCT00288704|1523492|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
464371|NCT00288704|1523490|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
464372|NCT00288704|1523491|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
464373|NCT00288704|1523492|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
464374|NCT00288704|1523490|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
464375|NCT00288704|1523491|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
464376|NCT00288704|1523492|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
464377|NCT00288704|1523490|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
464378|NCT00288704|1523491|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
464379|NCT00288704|1523492|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
464380|NCT00288704|1523490|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
464381|NCT00288704|1523491|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
464382|NCT00288704|1523492|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
464383|NCT00288704|1523490|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
464384|NCT00288704|1523491|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
464385|NCT00288704|1523492|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
464386|NCT00288704|1523490|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
464387|NCT00288704|1523491|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
464388|NCT00288704|1523492|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
464389|NCT00288639|1523519|P1|Overall Study|Other|1
464390|NCT00288639|1523519|P1|Overall Study|Withdrawal by Subject|2
464391|NCT00288639|1523519|P1|Overall Study|Lack of Efficacy|4
464392|NCT00288639|1523519|P1|Overall Study|Adverse Event|5
464393|NCT00288626|1523536|P1|Overall Study|Withdrawal by Subject|4
464394|NCT00288626|1523536|P1|Overall Study|Death|3
464395|NCT00288587|1523570|P2|Overall Study|Severe Aortic Stenosis|0
464396|NCT00288587|1523571|P1|Overall Study|Severe Aortic Stenosis|1
464397|NCT00288587|1523570|P2|Overall Study|Physician Decision|2
464398|NCT00288587|1523571|P1|Overall Study|Physician Decision|0
464399|NCT00288587|1523570|P2|Overall Study|Adverse Event|1
464400|NCT00288587|1523571|P1|Overall Study|Adverse Event|0
464401|NCT00288587|1523570|P2|Overall Study|Transplant|3
464402|NCT00288587|1523571|P1|Overall Study|Transplant|0
464403|NCT00288587|1523570|P2|Overall Study|Death|4
464404|NCT00288587|1523571|P1|Overall Study|Death|4
464405|NCT00288509|1523614|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
464406|NCT00288509|1523614|P1|Treatment Cycle 4|Physician Decision|4
464407|NCT00288509|1523614|P1|Treatment Cycle 4|Withdrawal by Subject|3
464408|NCT00288509|1523614|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
464409|NCT00288509|1523614|P1|Treatment Cycle 3|Lost to Follow-up|2
464410|NCT00288509|1523614|P1|Treatment Cycle 3|Withdrawal by Subject|1
464411|NCT00288509|1523614|P1|Treatment Cycle 3|Lack of Efficacy|1
464412|NCT00288509|1523614|P1|Treatment Cycle 2|Withdrawal by Subject|2
464413|NCT00288509|1523614|P1|Treatment Cycle 2|Lack of Efficacy|1
464414|NCT00288509|1523614|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
464415|NCT00288509|1523614|P1|Treatment Cycle 1|Lost to Follow-up|2
464416|NCT00288509|1523614|P1|Treatment Cycle 1|Withdrawal by Subject|1
464417|NCT00288509|1523614|P1|Treatment Cycle 1|Lack of Efficacy|1
464419|NCT00288080|1523623|P2|Overall Study|Protocol Violation|20
464420|NCT00288080|1523624|P1|Overall Study|Protocol Violation|25
464421|NCT00288080|1523623|P2|Overall Study|Withdrawal by Subject|3
464422|NCT00288080|1523624|P1|Overall Study|Withdrawal by Subject|1
464423|NCT00288054|1523646|P1|Overall Study|Not protocol specified|2
464424|NCT00288054|1523646|P1|Overall Study|Withdrawal by Subject|1
464425|NCT00288054|1523646|P1|Overall Study|Adverse Event|3
464426|NCT00288054|1523646|P1|Overall Study|Lack of Efficacy|16
464427|NCT00288054|1523646|P1|Overall Study|Protocol Violation|2
464428|NCT00288015|1523654|P1|Follow up for Survival x 2 Years|Other|9
464429|NCT00288015|1523654|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
464430|NCT00288015|1523654|P1|Follow up for Survival x 2 Years|Death|13
464431|NCT00288015|1523654|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
464432|NCT00288015|1523654|P1|First Response Assessment|Physician Decision|2
464433|NCT00288015|1523654|P1|First Response Assessment|Death|1
464434|NCT00288015|1523654|P1|First Response Assessment|Withdrawal by Subject|1
464435|NCT00288015|1523654|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
464436|NCT00288015|1523654|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
464437|NCT00287586|1523730|P2|Overall Study|Recurrent Melanoma|1
464438|NCT00287586|1523731|P1|Overall Study|Recurrent Melanoma|0
464439|NCT00287586|1523730|P2|Overall Study|Itchy Swollen Eyes|1
464440|NCT00287586|1523731|P1|Overall Study|Itchy Swollen Eyes|0
464441|NCT00287586|1523730|P2|Overall Study|Bradycardia|1
464442|NCT00287586|1523731|P1|Overall Study|Bradycardia|0
464443|NCT00287586|1523730|P2|Overall Study|Mood Swings and Irritability|1
464444|NCT00287586|1523731|P1|Overall Study|Mood Swings and Irritability|0
464445|NCT00287586|1523730|P2|Overall Study|Mastodynia and Gynecomastia|1
464446|NCT00287586|1523731|P1|Overall Study|Mastodynia and Gynecomastia|0
464447|NCT00287586|1523730|P2|Overall Study|Retroperitoneal Cancer|1
464448|NCT00287586|1523731|P1|Overall Study|Retroperitoneal Cancer|0
464449|NCT00287586|1523730|P2|Overall Study|Elevated IPSS Score|1
464450|NCT00287586|1523731|P1|Overall Study|Elevated IPSS Score|0
464451|NCT00287586|1523730|P2|Overall Study|Lung Cancer|2
464452|NCT00287586|1523731|P1|Overall Study|Lung Cancer|0
464453|NCT00287586|1523730|P2|Overall Study|Major Depression|2
464454|NCT00287586|1523731|P1|Overall Study|Major Depression|0
464455|NCT00287586|1523730|P2|Overall Study|Enrolled in Another Study|0
464456|NCT00287586|1523731|P1|Overall Study|Enrolled in Another Study|1
464457|NCT00287586|1523730|P2|Overall Study|Nonadherence|1
464458|NCT00287586|1523731|P1|Overall Study|Nonadherence|1
464459|NCT00287586|1523730|P2|Overall Study|Inappropriate Behaviour with Staff|0
464460|NCT00287586|1523731|P1|Overall Study|Inappropriate Behaviour with Staff|1
464461|NCT00287586|1523730|P2|Overall Study|Shoulder Pain|0
464462|NCT00287586|1523731|P1|Overall Study|Shoulder Pain|1
464463|NCT00287586|1523730|P2|Overall Study|Sleep Apnea|0
464464|NCT00287586|1523731|P1|Overall Study|Sleep Apnea|1
464465|NCT00287586|1523730|P2|Overall Study|Pancreatic Cancer|3
464466|NCT00287586|1523731|P1|Overall Study|Pancreatic Cancer|1
464467|NCT00287586|1523730|P2|Overall Study|Cognitive Impairment|0
464468|NCT00287586|1523731|P1|Overall Study|Cognitive Impairment|1
464469|NCT00287586|1523730|P2|Overall Study|Lower Urinary Tract Symptoms|0
464470|NCT00287586|1523731|P1|Overall Study|Lower Urinary Tract Symptoms|1
464471|NCT00287586|1523730|P2|Overall Study|Myocardial Infarction|0
464472|NCT00287586|1523731|P1|Overall Study|Myocardial Infarction|1
464473|NCT00287586|1523730|P2|Overall Study|Stroke|0
464474|NCT00287586|1523731|P1|Overall Study|Stroke|2
464475|NCT00287586|1523730|P2|Overall Study|Elevated Prostate Specific Antigen|0
464476|NCT00287586|1523731|P1|Overall Study|Elevated Prostate Specific Antigen|2
464477|NCT00287586|1523730|P2|Overall Study|Rash|0
464478|NCT00287586|1523731|P1|Overall Study|Rash|3
464479|NCT00287586|1523730|P2|Overall Study|Elevated Hematocrit|0
464480|NCT00287586|1523731|P1|Overall Study|Elevated Hematocrit|3
464481|NCT00287586|1523730|P2|Overall Study|Death|3
464482|NCT00287586|1523731|P1|Overall Study|Death|2
464483|NCT00287586|1523730|P2|Overall Study|Lost to Follow-up|4
464484|NCT00287586|1523731|P1|Overall Study|Lost to Follow-up|5
464485|NCT00287586|1523730|P2|Overall Study|Withdrew Consent|30
464486|NCT00287586|1523731|P1|Overall Study|Withdrew Consent|19
464487|NCT00287365|1523767|P1|Overall Study|sample not acquired|13
464488|NCT00287118|1523789|P1|Overall Study|Not specified|7
464489|NCT00287118|1523789|P1|Overall Study|Protocol Violation|2
464490|NCT00287118|1523789|P1|Overall Study|Lost to Follow-up|1
464491|NCT00287118|1523789|P1|Overall Study|Lack of Efficacy|11
464492|NCT00287118|1523789|P1|Overall Study|Death|1
464493|NCT00287118|1523789|P1|Overall Study|Adverse Event|30
464494|NCT00287079|1523795|P2|Overall Study|Other|0
464495|NCT00287079|1523796|P1|Overall Study|Other|3
464496|NCT00287079|1523795|P2|Overall Study|Protocol Violation|0
464497|NCT00287079|1523796|P1|Overall Study|Protocol Violation|1
464498|NCT00287079|1523795|P2|Overall Study|Adverse Event|0
464499|NCT00287079|1523796|P1|Overall Study|Adverse Event|5
464500|NCT00287079|1523795|P2|Overall Study|Non-qualifying relapse|0
464501|NCT00287079|1523796|P1|Overall Study|Non-qualifying relapse|1
464502|NCT00287079|1523795|P2|Overall Study|Qualifying relapse|1
464503|NCT00287079|1523796|P1|Overall Study|Qualifying relapse|12
464504|NCT00286754|1523824|P3|Overall Study|Moved out of state|1
464505|NCT00286754|1523825|P2|Overall Study|Moved out of state|0
464506|NCT00286754|1523826|P1|Overall Study|Moved out of state|0
464507|NCT00286754|1523824|P3|Overall Study|Lost to Follow-up|6
464508|NCT00286754|1523825|P2|Overall Study|Lost to Follow-up|14
464509|NCT00286754|1523826|P1|Overall Study|Lost to Follow-up|12
464510|NCT00286754|1523824|P3|Overall Study|Withdrawal by Subject|0
464511|NCT00286754|1523825|P2|Overall Study|Withdrawal by Subject|2
464512|NCT00286754|1523826|P1|Overall Study|Withdrawal by Subject|6
464513|NCT00286754|1523824|P3|Overall Study|Adverse Event|3
464514|NCT00286754|1523825|P2|Overall Study|Adverse Event|2
464515|NCT00286754|1523826|P1|Overall Study|Adverse Event|2
464516|NCT00286494|1523881|P3|Overall Study|Protocol Violation|2
464517|NCT00286494|1523882|P2|Overall Study|Protocol Violation|1
464518|NCT00286494|1523883|P1|Overall Study|Protocol Violation|1
464519|NCT00286494|1523881|P3|Overall Study|Lost to Follow-up|3
464520|NCT00286494|1523882|P2|Overall Study|Lost to Follow-up|1
464521|NCT00286494|1523883|P1|Overall Study|Lost to Follow-up|3
464522|NCT00286494|1523881|P3|Overall Study|Physician Decision|1
464523|NCT00286494|1523882|P2|Overall Study|Physician Decision|5
464524|NCT00286494|1523883|P1|Overall Study|Physician Decision|5
464525|NCT00286494|1523881|P3|Overall Study|Adverse Event|6
464526|NCT00286494|1523882|P2|Overall Study|Adverse Event|8
464527|NCT00286494|1523883|P1|Overall Study|Adverse Event|3
464528|NCT00286494|1523881|P3|Overall Study|Withdrawal by Subject|9
464529|NCT00286494|1523882|P2|Overall Study|Withdrawal by Subject|10
464530|NCT00286494|1523883|P1|Overall Study|Withdrawal by Subject|2
464531|NCT00286494|1523881|P3|Overall Study|Hyperglycemic rescue|18
464532|NCT00286494|1523882|P2|Overall Study|Hyperglycemic rescue|19
464533|NCT00286494|1523883|P1|Overall Study|Hyperglycemic rescue|12
464534|NCT00286468|1524044|P3|Overall Study|Physician Decision|1
464535|NCT00286468|1524045|P2|Overall Study|Physician Decision|2
464536|NCT00286468|1524046|P1|Overall Study|Physician Decision|3
464537|NCT00286468|1524044|P3|Overall Study|Withdrawal by Subject|11
464538|NCT00286468|1524045|P2|Overall Study|Withdrawal by Subject|8
464539|NCT00286468|1524046|P1|Overall Study|Withdrawal by Subject|3
464540|NCT00286468|1524044|P3|Overall Study|Lost to Follow-up|2
464541|NCT00286468|1524045|P2|Overall Study|Lost to Follow-up|1
464542|NCT00286468|1524046|P1|Overall Study|Lost to Follow-up|1
464543|NCT00286468|1524044|P3|Overall Study|Protocol Violation|1
464544|NCT00286468|1524045|P2|Overall Study|Protocol Violation|3
464545|NCT00286468|1524046|P1|Overall Study|Protocol Violation|0
464546|NCT00286468|1524044|P3|Overall Study|Adverse Event|4
464547|NCT00286468|1524045|P2|Overall Study|Adverse Event|6
464548|NCT00286468|1524046|P1|Overall Study|Adverse Event|2
464549|NCT00286468|1524044|P3|Overall Study|Hyperglycemic Rescue|31
464550|NCT00286468|1524045|P2|Overall Study|Hyperglycemic Rescue|30
464551|NCT00286468|1524046|P1|Overall Study|Hyperglycemic Rescue|28
464552|NCT00286455|1524207|P3|Overall Study|Withdrawal by Subject|7
464553|NCT00286455|1524208|P2|Overall Study|Withdrawal by Subject|8
464554|NCT00286455|1524209|P1|Overall Study|Withdrawal by Subject|0
464555|NCT00286455|1524207|P3|Overall Study|Participant Non-compliance|0
464556|NCT00286455|1524208|P2|Overall Study|Participant Non-compliance|0
464557|NCT00286455|1524209|P1|Overall Study|Participant Non-compliance|1
464558|NCT00286455|1524207|P3|Overall Study|Protocol Violation|0
464559|NCT00286455|1524208|P2|Overall Study|Protocol Violation|1
464560|NCT00286455|1524209|P1|Overall Study|Protocol Violation|1
464561|NCT00286455|1524207|P3|Overall Study|Physician Decision|2
464562|NCT00286455|1524208|P2|Overall Study|Physician Decision|0
464563|NCT00286455|1524209|P1|Overall Study|Physician Decision|3
464564|NCT00286455|1524207|P3|Overall Study|Lost to Follow-up|3
464565|NCT00286455|1524208|P2|Overall Study|Lost to Follow-up|3
464566|NCT00286455|1524209|P1|Overall Study|Lost to Follow-up|0
464567|NCT00286455|1524207|P3|Overall Study|Adverse Event|2
464568|NCT00286455|1524208|P2|Overall Study|Adverse Event|3
464569|NCT00286455|1524209|P1|Overall Study|Adverse Event|1
464570|NCT00286455|1524207|P3|Overall Study|Hyperglycemia rescue|10
464571|NCT00286455|1524208|P2|Overall Study|Hyperglycemia rescue|13
464572|NCT00286455|1524209|P1|Overall Study|Hyperglycemia rescue|19
464573|NCT00286442|1524388|P3|Overall Study|Withdrawal by Subject|2
464574|NCT00286442|1524389|P2|Overall Study|Withdrawal by Subject|14
464575|NCT00286442|1524390|P1|Overall Study|Withdrawal by Subject|2
464576|NCT00286442|1524388|P3|Overall Study|Administrative Error|0
464577|NCT00286442|1524389|P2|Overall Study|Administrative Error|1
464578|NCT00286442|1524390|P1|Overall Study|Administrative Error|1
464579|NCT00286442|1524388|P3|Overall Study|Physician Decision|1
464580|NCT00286442|1524389|P2|Overall Study|Physician Decision|1
464581|NCT00286442|1524390|P1|Overall Study|Physician Decision|1
464582|NCT00286442|1524388|P3|Overall Study|Lost to Follow-up|1
464583|NCT00286442|1524389|P2|Overall Study|Lost to Follow-up|2
464584|NCT00286442|1524390|P1|Overall Study|Lost to Follow-up|5
464585|NCT00286442|1524388|P3|Overall Study|Protocol Violation|2
464586|NCT00286442|1524389|P2|Overall Study|Protocol Violation|4
464587|NCT00286442|1524390|P1|Overall Study|Protocol Violation|2
464588|NCT00286442|1524388|P3|Overall Study|Adverse Event|1
464589|NCT00286442|1524389|P2|Overall Study|Adverse Event|6
464590|NCT00286442|1524390|P1|Overall Study|Adverse Event|7
464591|NCT00286442|1524388|P3|Overall Study|Hyperglycemic Rescue|25
464592|NCT00286442|1524389|P2|Overall Study|Hyperglycemic Rescue|17
464593|NCT00286442|1524390|P1|Overall Study|Hyperglycemic Rescue|19
464594|NCT00286429|1524551|P3|Overall Study|Administrative Decision|0
464595|NCT00286429|1524552|P2|Overall Study|Administrative Decision|1
464596|NCT00286429|1524553|P1|Overall Study|Administrative Decision|0
464597|NCT00286429|1524551|P3|Overall Study|Administrative Error|1
464598|NCT00286429|1524552|P2|Overall Study|Administrative Error|1
464599|NCT00286429|1524553|P1|Overall Study|Administrative Error|1
464600|NCT00286429|1524551|P3|Overall Study|Withdrawal by Subject|6
464601|NCT00286429|1524552|P2|Overall Study|Withdrawal by Subject|2
464602|NCT00286429|1524553|P1|Overall Study|Withdrawal by Subject|3
464603|NCT00286429|1524551|P3|Overall Study|Protocol Violation|4
464604|NCT00286429|1524552|P2|Overall Study|Protocol Violation|5
464605|NCT00286429|1524553|P1|Overall Study|Protocol Violation|3
464606|NCT00286429|1524551|P3|Overall Study|Physician Decision|7
464607|NCT00286429|1524552|P2|Overall Study|Physician Decision|7
464608|NCT00286429|1524553|P1|Overall Study|Physician Decision|10
464609|NCT00286429|1524551|P3|Overall Study|Lost to Follow-up|3
464610|NCT00286429|1524552|P2|Overall Study|Lost to Follow-up|4
464611|NCT00286429|1524553|P1|Overall Study|Lost to Follow-up|2
464612|NCT00286429|1524551|P3|Overall Study|Lack of Efficacy|25
464613|NCT00286429|1524552|P2|Overall Study|Lack of Efficacy|27
464614|NCT00286429|1524553|P1|Overall Study|Lack of Efficacy|52
464615|NCT00286429|1524551|P3|Overall Study|Adverse Event|6
464616|NCT00286429|1524552|P2|Overall Study|Adverse Event|1
464617|NCT00286429|1524553|P1|Overall Study|Adverse Event|4
464618|NCT00286221|1524669|P4|Overall Study|Unrecognized exclusion criteria met|0
464619|NCT00286221|1524670|P3|Overall Study|Unrecognized exclusion criteria met|0
464620|NCT00286221|1524671|P2|Overall Study|Unrecognized exclusion criteria met|1
464621|NCT00286221|1524672|P1|Overall Study|Unrecognized exclusion criteria met|0
464622|NCT00286221|1524669|P4|Overall Study|Inability to trigger PCA|0
464623|NCT00286221|1524670|P3|Overall Study|Inability to trigger PCA|0
464624|NCT00286221|1524671|P2|Overall Study|Inability to trigger PCA|0
464625|NCT00286221|1524672|P1|Overall Study|Inability to trigger PCA|2
464626|NCT00286221|1524669|P4|Overall Study|Unanticipated Neurosurgical Complication|2
464627|NCT00286221|1524670|P3|Overall Study|Unanticipated Neurosurgical Complication|3
464628|NCT00286221|1524671|P2|Overall Study|Unanticipated Neurosurgical Complication|3
464629|NCT00286221|1524672|P1|Overall Study|Unanticipated Neurosurgical Complication|6
464630|NCT00286221|1524669|P4|Overall Study|Protocol Violation|4
464631|NCT00286221|1524670|P3|Overall Study|Protocol Violation|6
464632|NCT00286221|1524671|P2|Overall Study|Protocol Violation|1
464633|NCT00286221|1524672|P1|Overall Study|Protocol Violation|2
464634|NCT00286156|1524698|P3|Overall Study|AE: pneumonia|0
464635|NCT00286156|1524699|P2|Overall Study|AE: pneumonia|0
464636|NCT00286156|1524700|P1|Overall Study|AE: pneumonia|1
464637|NCT00286156|1524698|P3|Overall Study|AE: nephrotic-range proteinuruia|0
464638|NCT00286156|1524699|P2|Overall Study|AE: nephrotic-range proteinuruia|0
464639|NCT00286156|1524700|P1|Overall Study|AE: nephrotic-range proteinuruia|1
464640|NCT00286156|1524698|P3|Overall Study|AE: pulmonary embolus|0
464641|NCT00286156|1524699|P2|Overall Study|AE: pulmonary embolus|1
464642|NCT00286156|1524700|P1|Overall Study|AE: pulmonary embolus|0
464643|NCT00286156|1524698|P3|Overall Study|Missed 12 month visit|1
464644|NCT00286156|1524699|P2|Overall Study|Missed 12 month visit|0
464645|NCT00286156|1524700|P1|Overall Study|Missed 12 month visit|0
464646|NCT00286091|1524713|P2|Open-label Treatment Phase|Missing End of Study Information|1
464647|NCT00286091|1524714|P1|Open-label Treatment Phase|Missing End of Study Information|0
464648|NCT00286091|1524713|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
464649|NCT00286091|1524714|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
464650|NCT00286091|1524713|P2|Open-label Treatment Phase|Lost to Follow-up|1
464651|NCT00286091|1524714|P1|Open-label Treatment Phase|Lost to Follow-up|0
464652|NCT00286091|1524713|P2|Open-label Treatment Phase|Noncompliance|1
464653|NCT00286091|1524714|P1|Open-label Treatment Phase|Noncompliance|3
464654|NCT00286091|1524713|P2|Open-label Treatment Phase|Disease Progression|3
464655|NCT00286091|1524714|P1|Open-label Treatment Phase|Disease Progression|9
464656|NCT00286091|1524713|P2|Open-label Treatment Phase|Death|7
464657|NCT00286091|1524714|P1|Open-label Treatment Phase|Death|10
464658|NCT00286091|1524713|P2|Open-label Treatment Phase|Withdrawal by Subject|10
464659|NCT00286091|1524714|P1|Open-label Treatment Phase|Withdrawal by Subject|14
464660|NCT00286091|1524713|P2|Open-label Treatment Phase|Other|11
464661|NCT00286091|1524714|P1|Open-label Treatment Phase|Other|11
464662|NCT00286091|1524713|P2|Open-label Treatment Phase|Adverse Event|16
464663|NCT00286091|1524714|P1|Open-label Treatment Phase|Adverse Event|5
464664|NCT00286091|1524713|P2|Open-label Treatment Phase|Physician Decision|21
464665|NCT00286091|1524714|P1|Open-label Treatment Phase|Physician Decision|24
464666|NCT00286091|1524713|P2|Double-blind Treatment Phase|Ineligibility Determined|2
464667|NCT00286091|1524714|P1|Double-blind Treatment Phase|Ineligibility Determined|1
464668|NCT00286091|1524713|P2|Double-blind Treatment Phase|Protocol Deviation|3
464669|NCT00286091|1524714|P1|Double-blind Treatment Phase|Protocol Deviation|1
464670|NCT00286091|1524713|P2|Double-blind Treatment Phase|Lost to Follow-up|4
464671|NCT00286091|1524714|P1|Double-blind Treatment Phase|Lost to Follow-up|11
464672|NCT00286091|1524713|P2|Double-blind Treatment Phase|Noncompliance|8
464673|NCT00286091|1524714|P1|Double-blind Treatment Phase|Noncompliance|8
464674|NCT00286091|1524713|P2|Double-blind Treatment Phase|Administrative Decision|21
464675|NCT00286091|1524714|P1|Double-blind Treatment Phase|Administrative Decision|20
464676|NCT00286091|1524713|P2|Double-blind Treatment Phase|Other|33
464677|NCT00286091|1524714|P1|Double-blind Treatment Phase|Other|25
464678|NCT00286091|1524713|P2|Double-blind Treatment Phase|Disease Progression|35
464679|NCT00286091|1524714|P1|Double-blind Treatment Phase|Disease Progression|22
464680|NCT00286091|1524713|P2|Double-blind Treatment Phase|Adverse Event|40
464681|NCT00286091|1524714|P1|Double-blind Treatment Phase|Adverse Event|28
464682|NCT00286091|1524713|P2|Double-blind Treatment Phase|Death|65
464683|NCT00286091|1524714|P1|Double-blind Treatment Phase|Death|58
464684|NCT00286091|1524713|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
464685|NCT00286091|1524714|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
464686|NCT00286091|1524713|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
464687|NCT00286091|1524714|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
464688|NCT00285857|1524737|P1|Overall Study|Adverse Event|1
464689|NCT00285857|1524737|P1|Overall Study|Inadequate initial breast cytology|1
464690|NCT00285857|1524737|P1|Overall Study|Withdrawal by Subject|2
464691|NCT00285818|1524750|P2|Overall Study|Lost to Follow-up|0
464692|NCT00285818|1524751|P1|Overall Study|Lost to Follow-up|1
464693|NCT00285818|1524750|P2|Overall Study|Withdrawal by Subject|2
464694|NCT00285818|1524751|P1|Overall Study|Withdrawal by Subject|3
464695|NCT00285649|1524796|P3|Overall Study|Withdrawal by Subject|2
464696|NCT00285649|1524797|P2|Overall Study|Withdrawal by Subject|2
464697|NCT00285649|1524798|P1|Overall Study|Withdrawal by Subject|3
464698|NCT00285649|1524796|P3|Overall Study|Lost to Follow-up|4
464699|NCT00285649|1524797|P2|Overall Study|Lost to Follow-up|4
464700|NCT00285649|1524798|P1|Overall Study|Lost to Follow-up|6
464701|NCT00285584|1524808|P2|Month 6|Lost to Follow-up|1
464702|NCT00285584|1524809|P1|Month 6|Lost to Follow-up|0
464703|NCT00285584|1524808|P2|Month 3|Withdrawal by Subject|0
464704|NCT00285584|1524809|P1|Month 3|Withdrawal by Subject|1
464705|NCT00285584|1524808|P2|Month 3|Lost to Follow-up|3
464706|NCT00285584|1524809|P1|Month 3|Lost to Follow-up|3
464707|NCT00285207|1524841|P2|Overall Study|non-compliance|1
464708|NCT00285207|1524842|P1|Overall Study|non-compliance|0
464709|NCT00285207|1524841|P2|Overall Study|Pregnancy|1
464710|NCT00285207|1524842|P1|Overall Study|Pregnancy|1
464711|NCT00285207|1524841|P2|Overall Study|Withdrawal by Subject|2
464712|NCT00285207|1524842|P1|Overall Study|Withdrawal by Subject|5
464713|NCT00285207|1524841|P2|Overall Study|Lost to Follow-up|2
464714|NCT00285207|1524842|P1|Overall Study|Lost to Follow-up|3
464715|NCT00285012|1524850|P2|Received Study Tx|Other|5
464716|NCT00285012|1524851|P1|Received Study Tx|Other|5
464717|NCT00285012|1524850|P2|Received Study Tx|Withdrawal by Subject|43
464718|NCT00285012|1524851|P1|Received Study Tx|Withdrawal by Subject|31
464719|NCT00285012|1524850|P2|Received Study Tx|Lost to Follow-up|31
464720|NCT00285012|1524851|P1|Received Study Tx|Lost to Follow-up|29
464721|NCT00285012|1524850|P2|Received Study Tx|Lack of Efficacy|3
464722|NCT00285012|1524851|P1|Received Study Tx|Lack of Efficacy|0
464723|NCT00285012|1524850|P2|Received Study Tx|Adverse Event|11
464724|NCT00285012|1524851|P1|Received Study Tx|Adverse Event|5
464725|NCT00285012|1524850|P2|Received Study Tx|Death|1
464726|NCT00285012|1524851|P1|Received Study Tx|Death|2
464727|NCT00285012|1524850|P2|Assigned to Study Treatment (Tx)|Other|3
464728|NCT00285012|1524851|P1|Assigned to Study Treatment (Tx)|Other|2
464729|NCT00284934|1524877|P2|Overall Study|Other reasons|1
464730|NCT00284934|1524878|P1|Overall Study|Other reasons|3
464731|NCT00284934|1524877|P2|Overall Study|Adverse Event|2
464732|NCT00284934|1524878|P1|Overall Study|Adverse Event|1
464733|NCT00284856|1524893|P3|Overall Study|Other|4
464734|NCT00284856|1524894|P2|Overall Study|Other|5
464735|NCT00284856|1524895|P1|Overall Study|Other|4
464736|NCT00284856|1524893|P3|Overall Study|Withdrawal by Subject|18
464737|NCT00284856|1524894|P2|Overall Study|Withdrawal by Subject|16
464738|NCT00284856|1524895|P1|Overall Study|Withdrawal by Subject|12
464739|NCT00284856|1524893|P3|Overall Study|Protocol Violation|5
464740|NCT00284856|1524894|P2|Overall Study|Protocol Violation|4
464741|NCT00284856|1524895|P1|Overall Study|Protocol Violation|5
464742|NCT00284856|1524893|P3|Overall Study|Lost to Follow-up|22
464743|NCT00284856|1524894|P2|Overall Study|Lost to Follow-up|21
464744|NCT00284856|1524895|P1|Overall Study|Lost to Follow-up|25
464745|NCT00284856|1524893|P3|Overall Study|Lack of Efficacy|8
464746|NCT00284856|1524894|P2|Overall Study|Lack of Efficacy|1
464747|NCT00284856|1524895|P1|Overall Study|Lack of Efficacy|2
464748|NCT00284856|1524893|P3|Overall Study|Adverse Event|3
464749|NCT00284856|1524894|P2|Overall Study|Adverse Event|3
464750|NCT00284856|1524895|P1|Overall Study|Adverse Event|3
464751|NCT00284141|1524994|P1|Overall Study|Ongoing treatment|2
464752|NCT00284141|1524994|P1|Overall Study|Did not take study medication|2
464753|NCT00284141|1524994|P1|Overall Study|Pneumonia|1
464754|NCT00284141|1524994|P1|Overall Study|General decline|1
464755|NCT00284141|1524994|P1|Overall Study|Clinical deterioration / death|2
464756|NCT00284141|1524994|P1|Overall Study|Symptomatic / Clinical Progression|11
464757|NCT00284141|1524994|P1|Overall Study|Participant's request|9
464758|NCT00284141|1524994|P1|Overall Study|Adverse Event|19
464759|NCT00284141|1524994|P1|Overall Study|Disease Progression / Lack of efficacy|51
464760|NCT00284089|1525017|P4|Extension Phase|Withdrawal by Subject|3
464761|NCT00284089|1525018|P3|Extension Phase|Withdrawal by Subject|1
464762|NCT00284089|1525019|P2|Extension Phase|Withdrawal by Subject|0
464763|NCT00284089|1525020|P1|Extension Phase|Withdrawal by Subject|0
464764|NCT00284089|1525017|P4|Extension Phase|Protocol Violation|0
464765|NCT00284089|1525018|P3|Extension Phase|Protocol Violation|1
464766|NCT00284089|1525019|P2|Extension Phase|Protocol Violation|0
464767|NCT00284089|1525020|P1|Extension Phase|Protocol Violation|0
464768|NCT00284089|1525017|P4|Extension Phase|condition no longer requires study drug|7
464769|NCT00284089|1525018|P3|Extension Phase|condition no longer requires study drug|2
464770|NCT00284089|1525019|P2|Extension Phase|condition no longer requires study drug|0
464771|NCT00284089|1525020|P1|Extension Phase|condition no longer requires study drug|2
464772|NCT00284089|1525017|P4|Extension Phase|Adverse Event|2
464773|NCT00284089|1525018|P3|Extension Phase|Adverse Event|2
464774|NCT00284089|1525019|P2|Extension Phase|Adverse Event|0
464775|NCT00284089|1525020|P1|Extension Phase|Adverse Event|0
464776|NCT00284089|1525017|P4|Multiple Dose Phase|Death|1
464777|NCT00284089|1525018|P3|Multiple Dose Phase|Death|1
464778|NCT00284089|1525019|P2|Multiple Dose Phase|Death|0
464779|NCT00284089|1525020|P1|Multiple Dose Phase|Death|0
464780|NCT00284089|1525017|P4|Multiple Dose Phase|Withdrawal by Subject|2
464781|NCT00284089|1525018|P3|Multiple Dose Phase|Withdrawal by Subject|1
464782|NCT00284089|1525019|P2|Multiple Dose Phase|Withdrawal by Subject|0
464783|NCT00284089|1525020|P1|Multiple Dose Phase|Withdrawal by Subject|0
464784|NCT00284089|1525017|P4|Multiple Dose Phase|Protocol Violation|0
464785|NCT00284089|1525018|P3|Multiple Dose Phase|Protocol Violation|1
464786|NCT00284089|1525019|P2|Multiple Dose Phase|Protocol Violation|0
464787|NCT00284089|1525020|P1|Multiple Dose Phase|Protocol Violation|0
464788|NCT00284089|1525017|P4|Multiple Dose Phase|Adverse Event|1
464789|NCT00284089|1525018|P3|Multiple Dose Phase|Adverse Event|1
464790|NCT00284089|1525019|P2|Multiple Dose Phase|Adverse Event|0
464791|NCT00284089|1525020|P1|Multiple Dose Phase|Adverse Event|1
464792|NCT00284050|1525049|P3|Overall Study|Death|0
464793|NCT00284050|1525050|P2|Overall Study|Death|0
464794|NCT00284050|1525051|P1|Overall Study|Death|1
464795|NCT00284050|1525049|P3|Overall Study|Lost to Follow-up|1
464796|NCT00284050|1525050|P2|Overall Study|Lost to Follow-up|0
464797|NCT00284050|1525051|P1|Overall Study|Lost to Follow-up|1
464798|NCT00284050|1525049|P3|Overall Study|Withdrawal by Subject|2
464799|NCT00284050|1525050|P2|Overall Study|Withdrawal by Subject|2
464800|NCT00284050|1525051|P1|Overall Study|Withdrawal by Subject|2
464801|NCT00284050|1525049|P3|Overall Study|Protocol Violation|2
464802|NCT00284050|1525050|P2|Overall Study|Protocol Violation|1
464803|NCT00284050|1525051|P1|Overall Study|Protocol Violation|0
464804|NCT00284050|1525049|P3|Overall Study|Lack of Efficacy|3
464805|NCT00284050|1525050|P2|Overall Study|Lack of Efficacy|1
464806|NCT00284050|1525051|P1|Overall Study|Lack of Efficacy|0
464807|NCT00284050|1525049|P3|Overall Study|Adverse Event|1
464808|NCT00284050|1525050|P2|Overall Study|Adverse Event|1
464809|NCT00284050|1525051|P1|Overall Study|Adverse Event|1
464810|NCT00283868|1525067|P2|Overall Study|Lost to Follow-up|8
464811|NCT00283868|1525068|P1|Overall Study|Lost to Follow-up|7
464812|NCT00283842|1525085|P5|Overall Study|Lost to Follow-up|1
464813|NCT00283842|1525086|P4|Overall Study|Lost to Follow-up|1
464814|NCT00283842|1525087|P3|Overall Study|Lost to Follow-up|4
464815|NCT00283842|1525088|P2|Overall Study|Lost to Follow-up|2
464816|NCT00283842|1525089|P1|Overall Study|Lost to Follow-up|0
464817|NCT00283842|1525085|P5|Overall Study|Lack of Efficacy|3
464818|NCT00283842|1525086|P4|Overall Study|Lack of Efficacy|0
464819|NCT00283842|1525087|P3|Overall Study|Lack of Efficacy|1
464820|NCT00283842|1525088|P2|Overall Study|Lack of Efficacy|3
464821|NCT00283842|1525089|P1|Overall Study|Lack of Efficacy|1
464822|NCT00283842|1525085|P5|Overall Study|Withdrawal by Subject|4
464823|NCT00283842|1525086|P4|Overall Study|Withdrawal by Subject|5
464824|NCT00283842|1525087|P3|Overall Study|Withdrawal by Subject|1
464825|NCT00283842|1525088|P2|Overall Study|Withdrawal by Subject|1
464826|NCT00283842|1525089|P1|Overall Study|Withdrawal by Subject|2
464827|NCT00283842|1525085|P5|Overall Study|Protocol deviation|2
464828|NCT00283842|1525086|P4|Overall Study|Protocol deviation|0
464829|NCT00283842|1525087|P3|Overall Study|Protocol deviation|0
464830|NCT00283842|1525088|P2|Overall Study|Protocol deviation|0
464831|NCT00283842|1525089|P1|Overall Study|Protocol deviation|0
464832|NCT00283842|1525085|P5|Overall Study|Protocol Violation|0
464833|NCT00283842|1525086|P4|Overall Study|Protocol Violation|0
464834|NCT00283842|1525087|P3|Overall Study|Protocol Violation|4
464835|NCT00283842|1525088|P2|Overall Study|Protocol Violation|5
464836|NCT00283842|1525089|P1|Overall Study|Protocol Violation|1
464837|NCT00283842|1525085|P5|Overall Study|Adverse Event|5
464838|NCT00283842|1525086|P4|Overall Study|Adverse Event|21
464839|NCT00283842|1525087|P3|Overall Study|Adverse Event|21
464840|NCT00283842|1525088|P2|Overall Study|Adverse Event|7
464841|NCT00283842|1525089|P1|Overall Study|Adverse Event|8
464842|NCT00283803|1525121|P1|Overall Study|Withdrawal by Subject|4
464843|NCT00283803|1525121|P1|Overall Study|Physician Decision|9
464844|NCT00283712|1525129|P2|Overall Study|Death|1
464845|NCT00283712|1525130|P1|Overall Study|Death|0
464846|NCT00283686|1525168|P4|Overall Study|Less than full participation|12
464847|NCT00283686|1525169|P3|Overall Study|Less than full participation|6
464848|NCT00283686|1525170|P2|Overall Study|Less than full participation|9
464849|NCT00283686|1525171|P1|Overall Study|Less than full participation|7
464850|NCT00283686|1525168|P4|Overall Study|Lost to Follow-up|20
464851|NCT00283686|1525169|P3|Overall Study|Lost to Follow-up|26
464852|NCT00283686|1525170|P2|Overall Study|Lost to Follow-up|31
464853|NCT00283686|1525171|P1|Overall Study|Lost to Follow-up|21
464854|NCT00283686|1525168|P4|Overall Study|Death|0
464855|NCT00283686|1525169|P3|Overall Study|Death|1
464856|NCT00283686|1525170|P2|Overall Study|Death|1
464857|NCT00283686|1525171|P1|Overall Study|Death|1
464858|NCT00283595|1525215|P2|Overall Study|Withdrawal by Subject|2
464859|NCT00283595|1525216|P1|Overall Study|Withdrawal by Subject|1
464860|NCT00283439|1525241|P4|Overall Study|Not specified|0
464861|NCT00283439|1525242|P3|Overall Study|Not specified|0
464862|NCT00283439|1525243|P2|Overall Study|Not specified|0
464863|NCT00283439|1525244|P1|Overall Study|Not specified|1
464864|NCT00283439|1525241|P4|Overall Study|Treatment discontinued|3
464865|NCT00283439|1525242|P3|Overall Study|Treatment discontinued|1
464866|NCT00283439|1525243|P2|Overall Study|Treatment discontinued|2
464867|NCT00283439|1525244|P1|Overall Study|Treatment discontinued|0
464868|NCT00283439|1525241|P4|Overall Study|Stem cell transplant|3
464869|NCT00283439|1525242|P3|Overall Study|Stem cell transplant|4
464870|NCT00283439|1525243|P2|Overall Study|Stem cell transplant|6
464871|NCT00283439|1525244|P1|Overall Study|Stem cell transplant|6
464872|NCT00283439|1525241|P4|Overall Study|Requirement for alternative therapy|2
464873|NCT00283439|1525242|P3|Overall Study|Requirement for alternative therapy|5
464874|NCT00283439|1525243|P2|Overall Study|Requirement for alternative therapy|2
464875|NCT00283439|1525244|P1|Overall Study|Requirement for alternative therapy|1
464876|NCT00283439|1525241|P4|Overall Study|Disease progression|0
464877|NCT00283439|1525242|P3|Overall Study|Disease progression|0
464878|NCT00283439|1525243|P2|Overall Study|Disease progression|1
464879|NCT00283439|1525244|P1|Overall Study|Disease progression|0
464880|NCT00283439|1525241|P4|Overall Study|Death|0
464881|NCT00283439|1525242|P3|Overall Study|Death|1
464882|NCT00283439|1525243|P2|Overall Study|Death|0
464883|NCT00283439|1525244|P1|Overall Study|Death|0
464884|NCT00283439|1525241|P4|Overall Study|Adverse Event|1
464885|NCT00283439|1525242|P3|Overall Study|Adverse Event|0
464886|NCT00283439|1525243|P2|Overall Study|Adverse Event|0
464887|NCT00283439|1525244|P1|Overall Study|Adverse Event|0
464888|NCT00283400|1525270|P4|Overall Study|Death|0
464889|NCT00283400|1525271|P3|Overall Study|Death|1
464890|NCT00283400|1525272|P2|Overall Study|Death|0
464891|NCT00283400|1525273|P1|Overall Study|Death|1
464892|NCT00283400|1525270|P4|Overall Study|Withdrawal by Subject|0
464893|NCT00283400|1525271|P3|Overall Study|Withdrawal by Subject|0
464894|NCT00283400|1525272|P2|Overall Study|Withdrawal by Subject|1
464895|NCT00283400|1525273|P1|Overall Study|Withdrawal by Subject|1
464896|NCT00283387|1525291|P2|First Intervention|Withdrawal by Subject|1
464897|NCT00283387|1525292|P1|First Intervention|Withdrawal by Subject|0
464898|NCT00283387|1525291|P2|First Intervention|Subject non-compliant|1
464899|NCT00283387|1525292|P1|First Intervention|Subject non-compliant|1
464900|NCT00283296|1525298|P1|Overall Study|in-home trial not completed|5
464901|NCT00283244|1525307|P3|Overall Study|Clinical deterioration|3
464902|NCT00283244|1525308|P2|Overall Study|Clinical deterioration|3
464903|NCT00283244|1525309|P1|Overall Study|Clinical deterioration|1
464904|NCT00283244|1525307|P3|Overall Study|Medical illness (other complicating dz)|6
464905|NCT00283244|1525308|P2|Overall Study|Medical illness (other complicating dz)|3
464906|NCT00283244|1525309|P1|Overall Study|Medical illness (other complicating dz)|4
464907|NCT00283244|1525307|P3|Overall Study|Physician Decision|1
464908|NCT00283244|1525308|P2|Overall Study|Physician Decision|0
464909|NCT00283244|1525309|P1|Overall Study|Physician Decision|0
464910|NCT00283244|1525307|P3|Overall Study|Withdrawal by Subject|2
464911|NCT00283244|1525308|P2|Overall Study|Withdrawal by Subject|2
464912|NCT00283244|1525309|P1|Overall Study|Withdrawal by Subject|1
464913|NCT00283244|1525307|P3|Overall Study|Lack of Efficacy|26
464914|NCT00283244|1525308|P2|Overall Study|Lack of Efficacy|32
464915|NCT00283244|1525309|P1|Overall Study|Lack of Efficacy|8
464916|NCT00283244|1525307|P3|Overall Study|Death|2
464917|NCT00283244|1525308|P2|Overall Study|Death|3
464918|NCT00283244|1525309|P1|Overall Study|Death|4
464919|NCT00283244|1525307|P3|Overall Study|Adverse Event|11
464920|NCT00283244|1525308|P2|Overall Study|Adverse Event|8
464921|NCT00283244|1525309|P1|Overall Study|Adverse Event|0
464922|NCT00283062|1525345|P4|Overall Study|chemotherapy not completed (cycle 6)|0
464923|NCT00283062|1525346|P3|Overall Study|chemotherapy not completed (cycle 6)|0
464924|NCT00283062|1525347|P2|Overall Study|chemotherapy not completed (cycle 6)|0
464925|NCT00283062|1525348|P1|Overall Study|chemotherapy not completed (cycle 6)|1
464926|NCT00283062|1525345|P4|Overall Study|Undefined|4
464927|NCT00283062|1525346|P3|Overall Study|Undefined|1
464928|NCT00283062|1525347|P2|Overall Study|Undefined|1
464929|NCT00283062|1525348|P1|Overall Study|Undefined|0
464930|NCT00283062|1525345|P4|Overall Study|Participant did not wish to continue|0
464931|NCT00283062|1525346|P3|Overall Study|Participant did not wish to continue|1
464932|NCT00283062|1525347|P2|Overall Study|Participant did not wish to continue|2
464933|NCT00283062|1525348|P1|Overall Study|Participant did not wish to continue|3
464934|NCT00283062|1525345|P4|Overall Study|Progressive disease|0
464935|NCT00283062|1525346|P3|Overall Study|Progressive disease|1
464936|NCT00283062|1525347|P2|Overall Study|Progressive disease|0
464937|NCT00283062|1525348|P1|Overall Study|Progressive disease|0
464938|NCT00283062|1525345|P4|Overall Study|Lost to Follow-up|0
464939|NCT00283062|1525346|P3|Overall Study|Lost to Follow-up|1
464940|NCT00283062|1525347|P2|Overall Study|Lost to Follow-up|0
464941|NCT00283062|1525348|P1|Overall Study|Lost to Follow-up|1
464942|NCT00283062|1525345|P4|Overall Study|Adverse Event|0
464943|NCT00283062|1525346|P3|Overall Study|Adverse Event|1
464944|NCT00283062|1525347|P2|Overall Study|Adverse Event|0
464945|NCT00283062|1525348|P1|Overall Study|Adverse Event|2
464946|NCT00283062|1525345|P4|Overall Study|Did not receive any study medication|45
464947|NCT00283062|1525346|P3|Overall Study|Did not receive any study medication|36
464948|NCT00283062|1525347|P2|Overall Study|Did not receive any study medication|4
464949|NCT00283062|1525348|P1|Overall Study|Did not receive any study medication|5
464950|NCT00283049|1525381|P3|Overall Study|No longer requires study treatment|1
464951|NCT00283049|1525382|P2|Overall Study|No longer requires study treatment|0
464952|NCT00283049|1525383|P1|Overall Study|No longer requires study treatment|0
464953|NCT00283049|1525381|P3|Overall Study|Discontinuation of Study|20
464954|NCT00283049|1525382|P2|Overall Study|Discontinuation of Study|16
464955|NCT00283049|1525383|P1|Overall Study|Discontinuation of Study|18
464956|NCT00283049|1525381|P3|Overall Study|Withdrawal by Subject|19
464957|NCT00283049|1525382|P2|Overall Study|Withdrawal by Subject|24
464958|NCT00283049|1525383|P1|Overall Study|Withdrawal by Subject|26
464959|NCT00283049|1525381|P3|Overall Study|Lost to Follow-up|5
464960|NCT00283049|1525382|P2|Overall Study|Lost to Follow-up|2
464961|NCT00283049|1525383|P1|Overall Study|Lost to Follow-up|4
464962|NCT00283049|1525381|P3|Overall Study|Lack of Efficacy|1
464963|NCT00283049|1525382|P2|Overall Study|Lack of Efficacy|1
464964|NCT00283049|1525383|P1|Overall Study|Lack of Efficacy|0
464965|NCT00283049|1525381|P3|Overall Study|Death|1
464966|NCT00283049|1525382|P2|Overall Study|Death|1
464967|NCT00283049|1525383|P1|Overall Study|Death|1
464968|NCT00283049|1525381|P3|Overall Study|Protocol Violation|3
464969|NCT00283049|1525382|P2|Overall Study|Protocol Violation|0
464970|NCT00283049|1525383|P1|Overall Study|Protocol Violation|3
464971|NCT00283049|1525381|P3|Overall Study|Adverse Event|4
464972|NCT00283049|1525382|P2|Overall Study|Adverse Event|1
464973|NCT00283049|1525383|P1|Overall Study|Adverse Event|6
464974|NCT00282984|1525411|P2|Overall Study|Protocol Violation|0
464975|NCT00282984|1525412|P1|Overall Study|Protocol Violation|2
464976|NCT00282984|1525411|P2|Overall Study|in prison|1
464977|NCT00282984|1525412|P1|Overall Study|in prison|0
464978|NCT00282984|1525411|P2|Overall Study|lack of motivation|0
464979|NCT00282984|1525412|P1|Overall Study|lack of motivation|1
464980|NCT00282984|1525411|P2|Overall Study|Participant used antipsychosis meds|1
464981|NCT00282984|1525412|P1|Overall Study|Participant used antipsychosis meds|0
464982|NCT00282984|1525411|P2|Overall Study|Participant only allowed phone follow-up|1
464983|NCT00282984|1525412|P1|Overall Study|Participant only allowed phone follow-up|0
464984|NCT00282984|1525411|P2|Overall Study|Participant stopped study medication|2
464985|NCT00282984|1525412|P1|Overall Study|Participant stopped study medication|2
464986|NCT00282984|1525411|P2|Overall Study|Withdrawal by Participant|34
464987|NCT00282984|1525412|P1|Overall Study|Withdrawal by Participant|22
464988|NCT00282984|1525411|P2|Overall Study|Lost to Follow-up|10
464989|NCT00282984|1525412|P1|Overall Study|Lost to Follow-up|14
464990|NCT00282984|1525411|P2|Overall Study|Lack of Efficacy|2
464991|NCT00282984|1525412|P1|Overall Study|Lack of Efficacy|0
464992|NCT00282984|1525411|P2|Overall Study|Adverse Event|5
464993|NCT00282984|1525412|P1|Overall Study|Adverse Event|8
464994|NCT00282984|1525411|P2|Overall Study|Death|5
464995|NCT00282984|1525412|P1|Overall Study|Death|2
464996|NCT00282919|1525449|P1|Overall Study|Asymptomatic Parasitemia|2
464997|NCT00282919|1525449|P1|Overall Study|Withdrawal by Subject|1
464998|NCT00282919|1525449|P1|Overall Study|Lack of Efficacy|4
464999|NCT00282867|1525464|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
465000|NCT00282867|1525465|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
465001|NCT00282867|1525466|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
465002|NCT00282568|1525563|P1|Extended Treatment Period|Lost to Follow-up|2
465003|NCT00282568|1525563|P1|Extended Treatment Period|Physician Decision|1
465004|NCT00282568|1525563|P1|Extended Treatment Period|Non-compliance|4
465005|NCT00282568|1525563|P1|Extended Treatment Period|Adverse Event|17
465006|NCT00282568|1525563|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
465007|NCT00282568|1525563|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
465008|NCT00282464|1525589|P2|Overall Study|dropped due to missed visits|1
465009|NCT00282464|1525590|P1|Overall Study|dropped due to missed visits|0
465010|NCT00282464|1525589|P2|Overall Study|dispensed wrong kit|1
465011|NCT00282464|1525590|P1|Overall Study|dispensed wrong kit|0
465012|NCT00282464|1525589|P2|Overall Study|family crisis|1
465013|NCT00282464|1525590|P1|Overall Study|family crisis|0
465014|NCT00282464|1525589|P2|Overall Study|patient incarcerated|1
465015|NCT00282464|1525590|P1|Overall Study|patient incarcerated|0
465016|NCT00282464|1525589|P2|Overall Study|patient no show|1
465017|NCT00282464|1525590|P1|Overall Study|patient no show|0
465018|NCT00282464|1525589|P2|Overall Study|patient non-compliant|0
465019|NCT00282464|1525590|P1|Overall Study|patient non-compliant|3
465020|NCT00282464|1525589|P2|Overall Study|Patient moved|0
465021|NCT00282464|1525590|P1|Overall Study|Patient moved|1
465022|NCT00282464|1525589|P2|Overall Study|Protocol Violation|7
465023|NCT00282464|1525590|P1|Overall Study|Protocol Violation|0
465024|NCT00282464|1525589|P2|Overall Study|laboratory abnormality|2
465025|NCT00282464|1525590|P1|Overall Study|laboratory abnormality|1
465026|NCT00282464|1525589|P2|Overall Study|Withdrawal by Subject|10
465027|NCT00282464|1525590|P1|Overall Study|Withdrawal by Subject|24
465028|NCT00282464|1525589|P2|Overall Study|Lost to Follow-up|10
465029|NCT00282464|1525590|P1|Overall Study|Lost to Follow-up|10
465030|NCT00282464|1525589|P2|Overall Study|Lack of Efficacy|8
465031|NCT00282464|1525590|P1|Overall Study|Lack of Efficacy|8
465032|NCT00282464|1525589|P2|Overall Study|Adverse Event|20
465033|NCT00282464|1525590|P1|Overall Study|Adverse Event|26
465034|NCT00282438|1525640|P2|Overall Study|Death|1
465035|NCT00282438|1525641|P1|Overall Study|Death|0
465036|NCT00282438|1525640|P2|Overall Study|Lack of Efficacy|0
465037|NCT00282438|1525641|P1|Overall Study|Lack of Efficacy|1
465038|NCT00282347|1525649|P2|B Cell Follow-up Period|Reason Not Specified|0
465039|NCT00282347|1525650|P1|B Cell Follow-up Period|Reason Not Specified|2
465040|NCT00282347|1525649|P2|B Cell Follow-up Period|Physician Decision|0
465041|NCT00282347|1525650|P1|B Cell Follow-up Period|Physician Decision|1
465042|NCT00282347|1525649|P2|B Cell Follow-up Period|Withdrawal by Subject|0
465043|NCT00282347|1525650|P1|B Cell Follow-up Period|Withdrawal by Subject|2
465044|NCT00282347|1525649|P2|Safety Follow-up Period|Protocol Deviation|2
465045|NCT00282347|1525650|P1|Safety Follow-up Period|Protocol Deviation|0
465046|NCT00282347|1525649|P2|Safety Follow-up Period|Physician Decision|1
465047|NCT00282347|1525650|P1|Safety Follow-up Period|Physician Decision|1
465048|NCT00282347|1525649|P2|Safety Follow-up Period|Withdrawal by Subject|1
465049|NCT00282347|1525650|P1|Safety Follow-up Period|Withdrawal by Subject|2
465050|NCT00282347|1525649|P2|Safety Follow-up Period|Lost to Follow-up|2
465051|NCT00282347|1525650|P1|Safety Follow-up Period|Lost to Follow-up|0
465052|NCT00282347|1525649|P2|Treatment Period|Physician Decision|1
465053|NCT00282347|1525650|P1|Treatment Period|Physician Decision|0
465054|NCT00282347|1525649|P2|Treatment Period|Withdrawal by Subject|3
465055|NCT00282347|1525650|P1|Treatment Period|Withdrawal by Subject|1
465056|NCT00282347|1525649|P2|Treatment Period|Lost to Follow-up|5
465057|NCT00282347|1525650|P1|Treatment Period|Lost to Follow-up|2
465058|NCT00282347|1525649|P2|Treatment Period|Death|0
465059|NCT00282347|1525650|P1|Treatment Period|Death|2
465060|NCT00282334|1525676|P2|Overall Study|Withdrawal by Subject|5
465061|NCT00282334|1525677|P1|Overall Study|Withdrawal by Subject|8
465062|NCT00282308|1525685|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
465063|NCT00282308|1525686|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
465064|NCT00282308|1525687|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
465065|NCT00282308|1525685|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
465066|NCT00282308|1525686|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
465067|NCT00282308|1525687|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
465068|NCT00282308|1525685|P3|Safety Follow-up Period|Lost to Follow-up|5
465069|NCT00282308|1525686|P2|Safety Follow-up Period|Lost to Follow-up|0
465070|NCT00282308|1525687|P1|Safety Follow-up Period|Lost to Follow-up|0
465071|NCT00282308|1525685|P3|Safety Follow-up Period|Adverse Event|1
465072|NCT00282308|1525686|P2|Safety Follow-up Period|Adverse Event|0
465073|NCT00282308|1525687|P1|Safety Follow-up Period|Adverse Event|0
465074|NCT00282308|1525685|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
465075|NCT00282308|1525686|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
465076|NCT00282308|1525687|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
465077|NCT00282308|1525685|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
465078|NCT00282308|1525686|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
465079|NCT00282308|1525687|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
465080|NCT00282308|1525685|P3|Optional Extension Re-treatment Period|Adverse Event|4
465081|NCT00282308|1525686|P2|Optional Extension Re-treatment Period|Adverse Event|0
465082|NCT00282308|1525687|P1|Optional Extension Re-treatment Period|Adverse Event|0
465083|NCT00282308|1525685|P3|Treatment Period|Not Treated with Study Drug|0
465084|NCT00282308|1525686|P2|Treatment Period|Not Treated with Study Drug|0
465085|NCT00282308|1525687|P1|Treatment Period|Not Treated with Study Drug|1
465086|NCT00282308|1525685|P3|Treatment Period|Adverse Event|0
465087|NCT00282308|1525686|P2|Treatment Period|Adverse Event|2
465088|NCT00282308|1525687|P1|Treatment Period|Adverse Event|0
465089|NCT00282308|1525685|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
465090|NCT00282308|1525686|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
465091|NCT00282308|1525687|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
465092|NCT00282308|1525685|P3|Treatment Period|Lost to Follow-up|0
465093|NCT00282308|1525686|P2|Treatment Period|Lost to Follow-up|0
465094|NCT00282308|1525687|P1|Treatment Period|Lost to Follow-up|1
465095|NCT00282295|1525717|P3|Overall Study|Other|0
465096|NCT00282295|1525718|P2|Overall Study|Other|1
465097|NCT00282295|1525719|P1|Overall Study|Other|0
465098|NCT00282295|1525717|P3|Overall Study|Lost to Follow-up|2
465099|NCT00282295|1525718|P2|Overall Study|Lost to Follow-up|7
465100|NCT00282295|1525719|P1|Overall Study|Lost to Follow-up|1
465101|NCT00282295|1525717|P3|Overall Study|Withdrawal by Subject|4
465102|NCT00282295|1525718|P2|Overall Study|Withdrawal by Subject|6
465103|NCT00282295|1525719|P1|Overall Study|Withdrawal by Subject|2
465104|NCT00282295|1525717|P3|Overall Study|Protocol Violation|1
465105|NCT00282295|1525718|P2|Overall Study|Protocol Violation|2
465106|NCT00282295|1525719|P1|Overall Study|Protocol Violation|0
465107|NCT00282295|1525717|P3|Overall Study|Serious Adverse Events|1
465108|NCT00282295|1525718|P2|Overall Study|Serious Adverse Events|0
465109|NCT00282295|1525719|P1|Overall Study|Serious Adverse Events|0
465110|NCT00282295|1525717|P3|Overall Study|Adverse Event|0
465111|NCT00282295|1525718|P2|Overall Study|Adverse Event|1
465112|NCT00282295|1525719|P1|Overall Study|Adverse Event|0
465113|NCT00282256|1525774|P1|Extension Treatment Period|Adverse Event|2
465114|NCT00282256|1525774|P1|Pharmacokinetic Treatment Period|Poor venous access|1
465115|NCT00282243|1525795|P1|Extension Treatment Period|Physician Decision|1
465116|NCT00282243|1525795|P1|Extension Treatment Period|Non-compliance|2
465117|NCT00282243|1525795|P1|Extension Treatment Period|Withdrawal by Subject|4
465118|NCT00282243|1525795|P1|Extension Treatment Period|Adverse Event|15
465119|NCT00282243|1525795|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
465120|NCT00282243|1525795|P1|Pharmacokinetic Treatment Period|Adverse Event|3
465121|NCT00282152|1525821|P2|Overall Study|Withdrawal by Subject|0
465122|NCT00282152|1525822|P1|Overall Study|Withdrawal by Subject|1
465123|NCT00282113|1525843|P3|Overall Study|Removed at parents request|0
465124|NCT00282113|1525844|P2|Overall Study|Removed at parents request|0
465125|NCT00282113|1525845|P1|Overall Study|Removed at parents request|1
465126|NCT00282087|1525859|P1|Overall Study|Death|1
465127|NCT00282048|1525872|P1|Overall Study|Ongoing|1
465128|NCT00282048|1525872|P1|Overall Study|Other|8
465129|NCT00282048|1525872|P1|Overall Study|Withdrawal by Subject|1
465130|NCT00282048|1525872|P1|Overall Study|Adverse Event|22
465131|NCT00282048|1525872|P1|Overall Study|Lack of Efficacy|30
465132|NCT00281957|1525886|P2|Overall Study|Refusal unrelated to adverse events|1
465133|NCT00281957|1525887|P1|Overall Study|Refusal unrelated to adverse events|0
465134|NCT00281957|1525886|P2|Overall Study|Did not start treatment|1
465135|NCT00281957|1525887|P1|Overall Study|Did not start treatment|3
465136|NCT00281957|1525886|P2|Overall Study|Not eligible|2
465137|NCT00281957|1525887|P1|Overall Study|Not eligible|1
465138|NCT00281957|1525886|P2|Overall Study|Not protocol specified|1
465139|NCT00281957|1525887|P1|Overall Study|Not protocol specified|8
465140|NCT00281957|1525886|P2|Overall Study|Progression/relapse|35
465141|NCT00281957|1525887|P1|Overall Study|Progression/relapse|47
465142|NCT00281957|1525886|P2|Overall Study|Death|0
465143|NCT00281957|1525887|P1|Overall Study|Death|1
465144|NCT00281957|1525886|P2|Overall Study|Adverse Event|2
465145|NCT00281957|1525887|P1|Overall Study|Adverse Event|7
465146|NCT00281840|1525961|P1|Overall Study|Complicating Disease|1
465147|NCT00281840|1525961|P1|Overall Study|exceed maximum delay in treatment|1
465148|NCT00281840|1525961|P1|Overall Study|Disease Progression|2
465149|NCT00281840|1525961|P1|Overall Study|Withdrawal by Subject|3
465150|NCT00281840|1525961|P1|Overall Study|Physician Decision|6
465151|NCT00281840|1525961|P1|Overall Study|Adverse Event|12
465152|NCT00281697|1525977|P2|Overall Study|Did not receive study drug|2
465153|NCT00281697|1525978|P1|Overall Study|Did not receive study drug|3
465154|NCT00281697|1525977|P2|Overall Study|Subject/guardian's decision to withdraw|6
465155|NCT00281697|1525978|P1|Overall Study|Subject/guardian's decision to withdraw|33
465156|NCT00281697|1525977|P2|Overall Study|Physician's decision to withdraw|12
465157|NCT00281697|1525978|P1|Overall Study|Physician's decision to withdraw|15
465158|NCT00281697|1525977|P2|Overall Study|Not specified|6
465159|NCT00281697|1525978|P1|Overall Study|Not specified|5
465160|NCT00281697|1525977|P2|Overall Study|Disease progression|149
465161|NCT00281697|1525978|P1|Overall Study|Disease progression|279
465162|NCT00281697|1525977|P2|Overall Study|Death|3
465163|NCT00281697|1525978|P1|Overall Study|Death|8
465164|NCT00281697|1525977|P2|Overall Study|Adverse Event|15
465165|NCT00281697|1525978|P1|Overall Study|Adverse Event|54
465166|NCT00281697|1525977|P2|Overall Study|> 60 days since last dose of study drug|4
465167|NCT00281697|1525978|P1|Overall Study|> 60 days since last dose of study drug|4
465168|NCT00281658|1525996|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
465169|NCT00281658|1525997|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
465170|NCT00281658|1525998|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
465171|NCT00281658|1525996|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
465172|NCT00281658|1525997|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
465173|NCT00281658|1525998|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
465174|NCT00281658|1525996|P3|Open-label Monotherapy Extension Phase|Death|97
465175|NCT00281658|1525997|P2|Open-label Monotherapy Extension Phase|Death|0
465176|NCT00281658|1525998|P1|Open-label Monotherapy Extension Phase|Death|0
465177|NCT00281658|1525996|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
465178|NCT00281658|1525997|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
465179|NCT00281658|1525998|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
465180|NCT00281658|1525996|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
465181|NCT00281658|1525997|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
465182|NCT00281658|1525998|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
465183|NCT00281658|1525996|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
465184|NCT00281658|1525997|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
465185|NCT00281658|1525998|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
465186|NCT00281658|1525996|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
465187|NCT00281658|1525997|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
465188|NCT00281658|1525998|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
465189|NCT00281658|1525996|P3|Double-blind, Randomized Phase|Death|0
465190|NCT00281658|1525997|P2|Double-blind, Randomized Phase|Death|46
465191|NCT00281658|1525998|P1|Double-blind, Randomized Phase|Death|120
465192|NCT00281632|1526015|P1|Overall Study|Ongoing|3
465193|NCT00281632|1526015|P1|Overall Study|Physician Decision|1
465194|NCT00281632|1526015|P1|Overall Study|Death|1
465195|NCT00281632|1526015|P1|Overall Study|Disease Progression|22
465196|NCT00281632|1526015|P1|Overall Study|Withdrawal by Subject|2
465197|NCT00281632|1526015|P1|Overall Study|Adverse Event|7
465198|NCT00281580|1526057|P16|Overall Study|Randomised in error; pregnancy; moving|2
465199|NCT00281580|1526058|P15|Overall Study|Randomised in error; pregnancy; moving|1
465200|NCT00281580|1526059|P14|Overall Study|Randomised in error; pregnancy; moving|0
465201|NCT00281580|1526060|P13|Overall Study|Randomised in error; pregnancy; moving|2
465202|NCT00281580|1526061|P12|Overall Study|Randomised in error; pregnancy; moving|1
465203|NCT00281580|1526062|P11|Overall Study|Randomised in error; pregnancy; moving|1
465204|NCT00281580|1526063|P10|Overall Study|Randomised in error; pregnancy; moving|1
465205|NCT00281580|1526064|P9|Overall Study|Randomised in error; pregnancy; moving|2
465206|NCT00281580|1526065|P8|Overall Study|Randomised in error; pregnancy; moving|0
465207|NCT00281580|1526066|P7|Overall Study|Randomised in error; pregnancy; moving|1
465208|NCT00281580|1526067|P6|Overall Study|Randomised in error; pregnancy; moving|0
465209|NCT00281580|1526068|P5|Overall Study|Randomised in error; pregnancy; moving|0
465210|NCT00281580|1526069|P4|Overall Study|Randomised in error; pregnancy; moving|2
465211|NCT00281580|1526070|P3|Overall Study|Randomised in error; pregnancy; moving|0
465212|NCT00281580|1526071|P2|Overall Study|Randomised in error; pregnancy; moving|0
465213|NCT00281580|1526072|P1|Overall Study|Randomised in error; pregnancy; moving|0
465214|NCT00281580|1526057|P16|Overall Study|Lost to Follow-up|0
465215|NCT00281580|1526058|P15|Overall Study|Lost to Follow-up|0
465216|NCT00281580|1526059|P14|Overall Study|Lost to Follow-up|0
465217|NCT00281580|1526060|P13|Overall Study|Lost to Follow-up|1
465218|NCT00281580|1526061|P12|Overall Study|Lost to Follow-up|0
465219|NCT00281580|1526062|P11|Overall Study|Lost to Follow-up|1
465220|NCT00281580|1526063|P10|Overall Study|Lost to Follow-up|1
465221|NCT00281580|1526064|P9|Overall Study|Lost to Follow-up|2
465222|NCT00281580|1526065|P8|Overall Study|Lost to Follow-up|1
465223|NCT00281580|1526066|P7|Overall Study|Lost to Follow-up|0
465224|NCT00281580|1526067|P6|Overall Study|Lost to Follow-up|1
465225|NCT00281580|1526068|P5|Overall Study|Lost to Follow-up|0
465226|NCT00281580|1526069|P4|Overall Study|Lost to Follow-up|3
465227|NCT00281580|1526070|P3|Overall Study|Lost to Follow-up|0
465228|NCT00281580|1526071|P2|Overall Study|Lost to Follow-up|0
465229|NCT00281580|1526072|P1|Overall Study|Lost to Follow-up|0
465230|NCT00281580|1526057|P16|Overall Study|Lack of Efficacy|0
465231|NCT00281580|1526058|P15|Overall Study|Lack of Efficacy|1
465232|NCT00281580|1526059|P14|Overall Study|Lack of Efficacy|2
465233|NCT00281580|1526060|P13|Overall Study|Lack of Efficacy|0
465234|NCT00281580|1526061|P12|Overall Study|Lack of Efficacy|1
465235|NCT00281580|1526062|P11|Overall Study|Lack of Efficacy|0
465236|NCT00281580|1526063|P10|Overall Study|Lack of Efficacy|0
465237|NCT00281580|1526064|P9|Overall Study|Lack of Efficacy|0
465238|NCT00281580|1526065|P8|Overall Study|Lack of Efficacy|0
465239|NCT00281580|1526066|P7|Overall Study|Lack of Efficacy|0
465240|NCT00281580|1526067|P6|Overall Study|Lack of Efficacy|0
465241|NCT00281580|1526068|P5|Overall Study|Lack of Efficacy|2
465242|NCT00281580|1526069|P4|Overall Study|Lack of Efficacy|6
465243|NCT00281580|1526070|P3|Overall Study|Lack of Efficacy|1
465244|NCT00281580|1526071|P2|Overall Study|Lack of Efficacy|1
465245|NCT00281580|1526072|P1|Overall Study|Lack of Efficacy|2
465246|NCT00281580|1526057|P16|Overall Study|Withdrawal by Subject|5
465247|NCT00281580|1526058|P15|Overall Study|Withdrawal by Subject|1
465248|NCT00281580|1526059|P14|Overall Study|Withdrawal by Subject|2
465249|NCT00281580|1526060|P13|Overall Study|Withdrawal by Subject|2
465250|NCT00281580|1526061|P12|Overall Study|Withdrawal by Subject|1
465251|NCT00281580|1526062|P11|Overall Study|Withdrawal by Subject|1
465252|NCT00281580|1526063|P10|Overall Study|Withdrawal by Subject|4
465253|NCT00281580|1526064|P9|Overall Study|Withdrawal by Subject|1
465254|NCT00281580|1526065|P8|Overall Study|Withdrawal by Subject|0
465255|NCT00281580|1526066|P7|Overall Study|Withdrawal by Subject|2
465256|NCT00281580|1526067|P6|Overall Study|Withdrawal by Subject|2
465257|NCT00281580|1526068|P5|Overall Study|Withdrawal by Subject|1
465258|NCT00281580|1526069|P4|Overall Study|Withdrawal by Subject|1
465259|NCT00281580|1526070|P3|Overall Study|Withdrawal by Subject|1
465260|NCT00281580|1526071|P2|Overall Study|Withdrawal by Subject|0
465261|NCT00281580|1526072|P1|Overall Study|Withdrawal by Subject|3
465262|NCT00281580|1526057|P16|Overall Study|Protocol Violation|3
465263|NCT00281580|1526058|P15|Overall Study|Protocol Violation|1
465264|NCT00281580|1526059|P14|Overall Study|Protocol Violation|1
465265|NCT00281580|1526060|P13|Overall Study|Protocol Violation|0
465266|NCT00281580|1526061|P12|Overall Study|Protocol Violation|2
465267|NCT00281580|1526062|P11|Overall Study|Protocol Violation|1
465268|NCT00281580|1526063|P10|Overall Study|Protocol Violation|0
465269|NCT00281580|1526064|P9|Overall Study|Protocol Violation|2
465270|NCT00281580|1526065|P8|Overall Study|Protocol Violation|0
465271|NCT00281580|1526066|P7|Overall Study|Protocol Violation|1
465272|NCT00281580|1526067|P6|Overall Study|Protocol Violation|0
465273|NCT00281580|1526068|P5|Overall Study|Protocol Violation|0
465274|NCT00281580|1526069|P4|Overall Study|Protocol Violation|1
465275|NCT00281580|1526070|P3|Overall Study|Protocol Violation|1
465276|NCT00281580|1526071|P2|Overall Study|Protocol Violation|0
465277|NCT00281580|1526072|P1|Overall Study|Protocol Violation|0
465278|NCT00281580|1526057|P16|Overall Study|Adverse Event|3
465279|NCT00281580|1526058|P15|Overall Study|Adverse Event|3
465280|NCT00281580|1526059|P14|Overall Study|Adverse Event|2
465281|NCT00281580|1526060|P13|Overall Study|Adverse Event|8
465282|NCT00281580|1526061|P12|Overall Study|Adverse Event|5
465283|NCT00281580|1526062|P11|Overall Study|Adverse Event|0
465284|NCT00281580|1526063|P10|Overall Study|Adverse Event|6
465285|NCT00281580|1526064|P9|Overall Study|Adverse Event|1
465286|NCT00281580|1526065|P8|Overall Study|Adverse Event|0
465287|NCT00281580|1526066|P7|Overall Study|Adverse Event|1
465288|NCT00281580|1526067|P6|Overall Study|Adverse Event|0
465289|NCT00281580|1526068|P5|Overall Study|Adverse Event|1
465290|NCT00281580|1526069|P4|Overall Study|Adverse Event|4
465291|NCT00281580|1526070|P3|Overall Study|Adverse Event|2
465292|NCT00281580|1526071|P2|Overall Study|Adverse Event|0
465293|NCT00281580|1526072|P1|Overall Study|Adverse Event|2
465294|NCT00281528|1526419|P3|Overall Study|Other|5
465295|NCT00281528|1526420|P2|Overall Study|Other|3
465296|NCT00281528|1526421|P1|Overall Study|Other|6
465297|NCT00281528|1526419|P3|Overall Study|Withdrawal by Subject|7
465298|NCT00281528|1526420|P2|Overall Study|Withdrawal by Subject|5
465299|NCT00281528|1526421|P1|Overall Study|Withdrawal by Subject|5
465300|NCT00281528|1526419|P3|Overall Study|Protocol Violation|1
465301|NCT00281528|1526420|P2|Overall Study|Protocol Violation|0
465302|NCT00281528|1526421|P1|Overall Study|Protocol Violation|1
465303|NCT00281528|1526419|P3|Overall Study|Physician Decision|5
465304|NCT00281528|1526420|P2|Overall Study|Physician Decision|4
465305|NCT00281528|1526421|P1|Overall Study|Physician Decision|11
465306|NCT00281528|1526419|P3|Overall Study|Adverse Event-unrelated to treatment|2
465307|NCT00281528|1526420|P2|Overall Study|Adverse Event-unrelated to treatment|0
465308|NCT00281528|1526421|P1|Overall Study|Adverse Event-unrelated to treatment|3
465309|NCT00281528|1526419|P3|Overall Study|Unacceptable Toxicity-related to trt|32
465310|NCT00281528|1526420|P2|Overall Study|Unacceptable Toxicity-related to trt|24
465311|NCT00281528|1526421|P1|Overall Study|Unacceptable Toxicity-related to trt|21
465312|NCT00281528|1526419|P3|Overall Study|Progressive Disease|27
465313|NCT00281528|1526420|P2|Overall Study|Progressive Disease|18
465314|NCT00281528|1526421|P1|Overall Study|Progressive Disease|28
465315|NCT00281320|1526472|P2|Overall Study|Not specified|1
465316|NCT00281320|1526473|P1|Overall Study|Not specified|3
465317|NCT00281320|1526472|P2|Overall Study|Lost to Follow-up|2
465318|NCT00281320|1526473|P1|Overall Study|Lost to Follow-up|1
465319|NCT00281320|1526472|P2|Overall Study|Withdrawal by Subject|6
465320|NCT00281320|1526473|P1|Overall Study|Withdrawal by Subject|5
465321|NCT00281320|1526472|P2|Overall Study|Lack of Efficacy|3
465322|NCT00281320|1526473|P1|Overall Study|Lack of Efficacy|4
465323|NCT00281320|1526472|P2|Overall Study|Adverse Event|9
465324|NCT00281320|1526473|P1|Overall Study|Adverse Event|12
465325|NCT00281099|1526495|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
465326|NCT00281099|1526496|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
465327|NCT00281099|1526495|P2|Overall Study|Physician Decision|72
465328|NCT00281099|1526496|P1|Overall Study|Physician Decision|79
465329|NCT00281099|1526495|P2|Overall Study|Withdrawal by Subject|70
465330|NCT00281099|1526496|P1|Overall Study|Withdrawal by Subject|65
465331|NCT00281099|1526495|P2|Overall Study|Lost to Follow-up|19
465332|NCT00281099|1526496|P1|Overall Study|Lost to Follow-up|10
465333|NCT00281099|1526495|P2|Overall Study|Death|57
465334|NCT00281099|1526496|P1|Overall Study|Death|46
465335|NCT00280917|1526545|P4|Overall Study|Noncompliance|0
465336|NCT00280917|1526546|P3|Overall Study|Noncompliance|2
465337|NCT00280917|1526547|P2|Overall Study|Noncompliance|1
465338|NCT00280917|1526548|P1|Overall Study|Noncompliance|0
465339|NCT00280917|1526545|P4|Overall Study|Withdrawal by Subject|1
465340|NCT00280917|1526546|P3|Overall Study|Withdrawal by Subject|0
465341|NCT00280917|1526547|P2|Overall Study|Withdrawal by Subject|2
465342|NCT00280917|1526548|P1|Overall Study|Withdrawal by Subject|0
465343|NCT00280917|1526545|P4|Overall Study|Change Therapy|0
465344|NCT00280917|1526546|P3|Overall Study|Change Therapy|0
465345|NCT00280917|1526547|P2|Overall Study|Change Therapy|2
465346|NCT00280917|1526548|P1|Overall Study|Change Therapy|1
465347|NCT00280917|1526545|P4|Overall Study|Adverse Event|1
465348|NCT00280917|1526546|P3|Overall Study|Adverse Event|4
465349|NCT00280917|1526547|P2|Overall Study|Adverse Event|1
465350|NCT00280917|1526548|P1|Overall Study|Adverse Event|1
465351|NCT00280748|1526571|P1|Overall Study|Extra-cranial disease progression|1
465352|NCT00280748|1526571|P1|Overall Study|Decline in performance|3
465353|NCT00280735|1526581|P1|Overall Study|Intercurrent Illness|2
465354|NCT00280735|1526581|P1|Overall Study|Withdrawal by Subject|8
465355|NCT00280735|1526581|P1|Overall Study|Lack of Efficacy|3
465356|NCT00280735|1526581|P1|Overall Study|Adverse Event|5
465357|NCT00280683|1526593|P2|Overall Study|Adverse Event|1
465358|NCT00280683|1526594|P1|Overall Study|Adverse Event|1
465359|NCT00280683|1526593|P2|Overall Study|Withdrawal by Subject|2
465360|NCT00280683|1526594|P1|Overall Study|Withdrawal by Subject|1
465361|NCT00280566|1526604|P3|Period 2 Double Blind|miscellaneous|5
465362|NCT00280566|1526605|P2|Period 2 Double Blind|miscellaneous|10
465363|NCT00280566|1526606|P1|Period 2 Double Blind|miscellaneous|0
465364|NCT00280566|1526604|P3|Period 2 Double Blind|Withdrawal by Subject|9
465365|NCT00280566|1526605|P2|Period 2 Double Blind|Withdrawal by Subject|9
465366|NCT00280566|1526606|P1|Period 2 Double Blind|Withdrawal by Subject|0
465367|NCT00280566|1526604|P3|Period 2 Double Blind|Lost to Follow-up|6
465368|NCT00280566|1526605|P2|Period 2 Double Blind|Lost to Follow-up|3
465369|NCT00280566|1526606|P1|Period 2 Double Blind|Lost to Follow-up|0
465370|NCT00280566|1526604|P3|Period 2 Double Blind|Adverse Event|15
465371|NCT00280566|1526605|P2|Period 2 Double Blind|Adverse Event|11
465372|NCT00280566|1526606|P1|Period 2 Double Blind|Adverse Event|0
465373|NCT00280566|1526604|P3|Period 2 Double Blind|Laboratory Abnormality|0
465374|NCT00280566|1526605|P2|Period 2 Double Blind|Laboratory Abnormality|1
465375|NCT00280566|1526606|P1|Period 2 Double Blind|Laboratory Abnormality|0
465376|NCT00280566|1526604|P3|Period 2 Double Blind|Lack of Efficacy|22
465377|NCT00280566|1526605|P2|Period 2 Double Blind|Lack of Efficacy|9
465378|NCT00280566|1526606|P1|Period 2 Double Blind|Lack of Efficacy|0
465379|NCT00280566|1526604|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
465380|NCT00280566|1526605|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
465381|NCT00280566|1526606|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
465382|NCT00280566|1526604|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
465383|NCT00280566|1526605|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
465384|NCT00280566|1526606|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
465385|NCT00280566|1526604|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
465386|NCT00280566|1526605|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
465387|NCT00280566|1526606|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
465388|NCT00280566|1526604|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
465389|NCT00280566|1526605|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
465390|NCT00280566|1526606|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
465391|NCT00280566|1526604|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
465392|NCT00280566|1526605|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
465393|NCT00280566|1526606|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
465394|NCT00280566|1526604|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
465395|NCT00280566|1526605|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
465396|NCT00280566|1526606|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
465397|NCT00280397|1526631|P1|Overall Study|Adverse Event|1
465398|NCT00280293|1526697|P2|Overall Study|Adverse Event|1
465399|NCT00280293|1526698|P1|Overall Study|Adverse Event|0
465400|NCT00280293|1526697|P2|Overall Study|Incarceration/Legal Reasons|1
465401|NCT00280293|1526698|P1|Overall Study|Incarceration/Legal Reasons|1
465402|NCT00280293|1526697|P2|Overall Study|Withdrawal by Subject|5
465403|NCT00280293|1526698|P1|Overall Study|Withdrawal by Subject|3
465404|NCT00280293|1526697|P2|Overall Study|Lost to Follow-up|12
465405|NCT00280293|1526698|P1|Overall Study|Lost to Follow-up|14
465406|NCT00280293|1526697|P2|Overall Study|Physician Decision|4
465407|NCT00280293|1526698|P1|Overall Study|Physician Decision|5
465408|NCT00280293|1526697|P2|Overall Study|Protocol Violation|0
465409|NCT00280293|1526698|P1|Overall Study|Protocol Violation|3
465410|NCT00280150|1526721|P4|Overall Study|Declining Performance Status|1
465411|NCT00280150|1526722|P3|Overall Study|Declining Performance Status|0
465412|NCT00280150|1526723|P2|Overall Study|Declining Performance Status|0
465413|NCT00280150|1526724|P1|Overall Study|Declining Performance Status|0
465414|NCT00280150|1526721|P4|Overall Study|Did not get consolidation therapy|0
465415|NCT00280150|1526722|P3|Overall Study|Did not get consolidation therapy|3
465416|NCT00280150|1526723|P2|Overall Study|Did not get consolidation therapy|0
465417|NCT00280150|1526724|P1|Overall Study|Did not get consolidation therapy|3
465418|NCT00280150|1526721|P4|Overall Study|Withdrawal by Subject|1
465419|NCT00280150|1526722|P3|Overall Study|Withdrawal by Subject|0
465420|NCT00280150|1526723|P2|Overall Study|Withdrawal by Subject|0
465421|NCT00280150|1526724|P1|Overall Study|Withdrawal by Subject|0
465422|NCT00280150|1526721|P4|Overall Study|Protocol Violation|1
465423|NCT00280150|1526722|P3|Overall Study|Protocol Violation|0
465424|NCT00280150|1526723|P2|Overall Study|Protocol Violation|0
465425|NCT00280150|1526724|P1|Overall Study|Protocol Violation|0
465426|NCT00280150|1526721|P4|Overall Study|Physician Decision|1
465427|NCT00280150|1526722|P3|Overall Study|Physician Decision|0
465428|NCT00280150|1526723|P2|Overall Study|Physician Decision|0
465429|NCT00280150|1526724|P1|Overall Study|Physician Decision|0
465430|NCT00280150|1526721|P4|Overall Study|Lack of Efficacy|3
465431|NCT00280150|1526722|P3|Overall Study|Lack of Efficacy|0
465432|NCT00280150|1526723|P2|Overall Study|Lack of Efficacy|0
465433|NCT00280150|1526724|P1|Overall Study|Lack of Efficacy|0
465434|NCT00280150|1526721|P4|Overall Study|Adverse Event|3
465435|NCT00280150|1526722|P3|Overall Study|Adverse Event|2
465436|NCT00280150|1526723|P2|Overall Study|Adverse Event|1
465437|NCT00280150|1526724|P1|Overall Study|Adverse Event|0
465438|NCT00280059|1526739|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
465439|NCT00280059|1526740|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
465440|NCT00280059|1526739|P2|Efficacy Assessment Phase|Other|8
465441|NCT00280059|1526740|P1|Efficacy Assessment Phase|Other|7
465442|NCT00280059|1526739|P2|Efficacy Assessment Phase|Lost to Follow-up|13
465443|NCT00280059|1526740|P1|Efficacy Assessment Phase|Lost to Follow-up|6
465444|NCT00280059|1526739|P2|Efficacy Assessment Phase|Lack of Efficacy|3
465445|NCT00280059|1526740|P1|Efficacy Assessment Phase|Lack of Efficacy|19
465446|NCT00280059|1526739|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
465447|NCT00280059|1526740|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
465448|NCT00280059|1526739|P2|Efficacy Assessment Phase|Adverse Event|31
465449|NCT00280059|1526740|P1|Efficacy Assessment Phase|Adverse Event|33
465450|NCT00280059|1526739|P2|Efficacy Assessment Phase|Death|0
465451|NCT00280059|1526740|P1|Efficacy Assessment Phase|Death|2
465452|NCT00279916|1526804|P2|Overall Study|Lost to Follow-up|2
465453|NCT00279916|1526805|P1|Overall Study|Lost to Follow-up|3
465454|NCT00279916|1526804|P2|Overall Study|Withdrawal by Subject|3
465455|NCT00279916|1526805|P1|Overall Study|Withdrawal by Subject|4
465456|NCT00279708|1526827|P2|Overall Study|Adverse Event|1
465457|NCT00279708|1526828|P1|Overall Study|Adverse Event|1
465458|NCT00279708|1526827|P2|Overall Study|Withdrawal by Subject|3
465459|NCT00279708|1526828|P1|Overall Study|Withdrawal by Subject|2
465460|NCT00279305|1526857|P2|Overall Study|FDA Safety Alert|1
465461|NCT00279305|1526858|P1|Overall Study|FDA Safety Alert|4
465462|NCT00279305|1526857|P2|Overall Study|Dificulting establishing IV|0
465463|NCT00279305|1526858|P1|Overall Study|Dificulting establishing IV|1
465464|NCT00279305|1526857|P2|Overall Study|Withdrawal by Subject|0
465465|NCT00279305|1526858|P1|Overall Study|Withdrawal by Subject|2
465466|NCT00279305|1526857|P2|Overall Study|Pregnancy|0
465467|NCT00279305|1526858|P1|Overall Study|Pregnancy|1
465468|NCT00279214|1526866|P2|Overall Study|Physician Decision|2
465469|NCT00279214|1526867|P1|Overall Study|Physician Decision|3
465470|NCT00279201|1526897|P6|Intensification Addendum|Death|0
465471|NCT00279201|1526898|P5|Intensification Addendum|Death|1
465472|NCT00279201|1526899|P4|Intensification Addendum|Death|0
465473|NCT00279201|1526900|P3|Intensification Addendum|Death|0
465474|NCT00279201|1526901|P2|Intensification Addendum|Death|0
465475|NCT00279201|1526902|P1|Intensification Addendum|Death|0
465476|NCT00279201|1526897|P6|Intensification Addendum|Lack of Efficacy|0
465477|NCT00279201|1526898|P5|Intensification Addendum|Lack of Efficacy|1
465478|NCT00279201|1526899|P4|Intensification Addendum|Lack of Efficacy|1
465479|NCT00279201|1526900|P3|Intensification Addendum|Lack of Efficacy|0
465480|NCT00279201|1526901|P2|Intensification Addendum|Lack of Efficacy|0
465481|NCT00279201|1526902|P1|Intensification Addendum|Lack of Efficacy|0
465482|NCT00279201|1526897|P6|Intensification Addendum|Entry Criteria Exclusion|0
465483|NCT00279201|1526898|P5|Intensification Addendum|Entry Criteria Exclusion|0
465484|NCT00279201|1526899|P4|Intensification Addendum|Entry Criteria Exclusion|0
465485|NCT00279201|1526900|P3|Intensification Addendum|Entry Criteria Exclusion|1
465486|NCT00279201|1526901|P2|Intensification Addendum|Entry Criteria Exclusion|0
465487|NCT00279201|1526902|P1|Intensification Addendum|Entry Criteria Exclusion|0
465488|NCT00279201|1526897|P6|Intensification Addendum|Sponsor Decision|1
465489|NCT00279201|1526898|P5|Intensification Addendum|Sponsor Decision|1
465490|NCT00279201|1526899|P4|Intensification Addendum|Sponsor Decision|0
465491|NCT00279201|1526900|P3|Intensification Addendum|Sponsor Decision|0
465492|NCT00279201|1526901|P2|Intensification Addendum|Sponsor Decision|0
465493|NCT00279201|1526902|P1|Intensification Addendum|Sponsor Decision|0
465494|NCT00279201|1526897|P6|Intensification Addendum|Physician Decision|2
465495|NCT00279201|1526898|P5|Intensification Addendum|Physician Decision|3
465496|NCT00279201|1526899|P4|Intensification Addendum|Physician Decision|1
465497|NCT00279201|1526900|P3|Intensification Addendum|Physician Decision|4
465498|NCT00279201|1526901|P2|Intensification Addendum|Physician Decision|0
465499|NCT00279201|1526902|P1|Intensification Addendum|Physician Decision|0
465500|NCT00279201|1526897|P6|Intensification Addendum|Adverse Event|3
465501|NCT00279201|1526898|P5|Intensification Addendum|Adverse Event|1
465502|NCT00279201|1526899|P4|Intensification Addendum|Adverse Event|4
465503|NCT00279201|1526900|P3|Intensification Addendum|Adverse Event|0
465504|NCT00279201|1526901|P2|Intensification Addendum|Adverse Event|0
465505|NCT00279201|1526902|P1|Intensification Addendum|Adverse Event|0
465506|NCT00279201|1526897|P6|Intensification Addendum|Protocol Violation|6
465507|NCT00279201|1526898|P5|Intensification Addendum|Protocol Violation|6
465508|NCT00279201|1526899|P4|Intensification Addendum|Protocol Violation|2
465509|NCT00279201|1526900|P3|Intensification Addendum|Protocol Violation|2
465510|NCT00279201|1526901|P2|Intensification Addendum|Protocol Violation|0
465511|NCT00279201|1526902|P1|Intensification Addendum|Protocol Violation|0
465512|NCT00279201|1526897|P6|Intensification Addendum|Lost to Follow-up|7
465513|NCT00279201|1526898|P5|Intensification Addendum|Lost to Follow-up|7
465514|NCT00279201|1526899|P4|Intensification Addendum|Lost to Follow-up|6
465515|NCT00279201|1526900|P3|Intensification Addendum|Lost to Follow-up|4
465516|NCT00279201|1526901|P2|Intensification Addendum|Lost to Follow-up|0
465517|NCT00279201|1526902|P1|Intensification Addendum|Lost to Follow-up|0
465518|NCT00279201|1526897|P6|Intensification Addendum|Withdrawal by Subject|18
465519|NCT00279201|1526898|P5|Intensification Addendum|Withdrawal by Subject|9
465520|NCT00279201|1526899|P4|Intensification Addendum|Withdrawal by Subject|14
465521|NCT00279201|1526900|P3|Intensification Addendum|Withdrawal by Subject|12
465522|NCT00279201|1526901|P2|Intensification Addendum|Withdrawal by Subject|0
465523|NCT00279201|1526902|P1|Intensification Addendum|Withdrawal by Subject|0
465524|NCT00279201|1526897|P6|Maintenance|HbA1c>7.5%|0
465525|NCT00279201|1526898|P5|Maintenance|HbA1c>7.5%|0
465526|NCT00279201|1526899|P4|Maintenance|HbA1c>7.5%|0
465527|NCT00279201|1526900|P3|Maintenance|HbA1c>7.5%|0
465528|NCT00279201|1526901|P2|Maintenance|HbA1c>7.5%|126
465529|NCT00279201|1526902|P1|Maintenance|HbA1c>7.5%|123
465530|NCT00279201|1526897|P6|Maintenance|Sponsor Decision|0
465531|NCT00279201|1526898|P5|Maintenance|Sponsor Decision|0
465532|NCT00279201|1526899|P4|Maintenance|Sponsor Decision|0
465533|NCT00279201|1526900|P3|Maintenance|Sponsor Decision|0
465534|NCT00279201|1526901|P2|Maintenance|Sponsor Decision|0
465535|NCT00279201|1526902|P1|Maintenance|Sponsor Decision|4
465536|NCT00279201|1526897|P6|Maintenance|Physician Decision|0
465537|NCT00279201|1526898|P5|Maintenance|Physician Decision|0
465538|NCT00279201|1526899|P4|Maintenance|Physician Decision|0
465539|NCT00279201|1526900|P3|Maintenance|Physician Decision|0
465540|NCT00279201|1526901|P2|Maintenance|Physician Decision|9
465541|NCT00279201|1526902|P1|Maintenance|Physician Decision|9
465542|NCT00279201|1526897|P6|Maintenance|Withdrawal by Subject|0
465543|NCT00279201|1526898|P5|Maintenance|Withdrawal by Subject|0
465544|NCT00279201|1526899|P4|Maintenance|Withdrawal by Subject|0
465545|NCT00279201|1526900|P3|Maintenance|Withdrawal by Subject|0
465546|NCT00279201|1526901|P2|Maintenance|Withdrawal by Subject|18
465547|NCT00279201|1526902|P1|Maintenance|Withdrawal by Subject|18
465548|NCT00279201|1526897|P6|Maintenance|Protocol Violation|0
465549|NCT00279201|1526898|P5|Maintenance|Protocol Violation|0
465550|NCT00279201|1526899|P4|Maintenance|Protocol Violation|0
465551|NCT00279201|1526900|P3|Maintenance|Protocol Violation|0
465552|NCT00279201|1526901|P2|Maintenance|Protocol Violation|24
465553|NCT00279201|1526902|P1|Maintenance|Protocol Violation|16
465554|NCT00279201|1526897|P6|Maintenance|Entry Criteria Exclusion|0
465555|NCT00279201|1526898|P5|Maintenance|Entry Criteria Exclusion|0
465556|NCT00279201|1526899|P4|Maintenance|Entry Criteria Exclusion|0
465557|NCT00279201|1526900|P3|Maintenance|Entry Criteria Exclusion|0
465558|NCT00279201|1526901|P2|Maintenance|Entry Criteria Exclusion|4
465559|NCT00279201|1526902|P1|Maintenance|Entry Criteria Exclusion|1
465560|NCT00279201|1526897|P6|Maintenance|Lost to Follow-up|0
465561|NCT00279201|1526898|P5|Maintenance|Lost to Follow-up|0
465562|NCT00279201|1526899|P4|Maintenance|Lost to Follow-up|0
465563|NCT00279201|1526900|P3|Maintenance|Lost to Follow-up|0
465564|NCT00279201|1526901|P2|Maintenance|Lost to Follow-up|13
465565|NCT00279201|1526902|P1|Maintenance|Lost to Follow-up|17
465566|NCT00279201|1526897|P6|Maintenance|Death|0
465567|NCT00279201|1526898|P5|Maintenance|Death|0
465568|NCT00279201|1526899|P4|Maintenance|Death|0
465569|NCT00279201|1526900|P3|Maintenance|Death|0
465570|NCT00279201|1526901|P2|Maintenance|Death|4
465571|NCT00279201|1526902|P1|Maintenance|Death|4
465572|NCT00279201|1526897|P6|Maintenance|Adverse Event|0
465573|NCT00279201|1526898|P5|Maintenance|Adverse Event|0
465574|NCT00279201|1526899|P4|Maintenance|Adverse Event|0
465575|NCT00279201|1526900|P3|Maintenance|Adverse Event|0
465576|NCT00279201|1526901|P2|Maintenance|Adverse Event|4
465577|NCT00279201|1526902|P1|Maintenance|Adverse Event|4
465578|NCT00279201|1526897|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
465579|NCT00279201|1526898|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
465580|NCT00279201|1526899|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
465581|NCT00279201|1526900|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
465582|NCT00279201|1526901|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
465583|NCT00279201|1526902|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
465584|NCT00279201|1526897|P6|Maintenance|Lack of Efficacy|0
465585|NCT00279201|1526898|P5|Maintenance|Lack of Efficacy|0
465586|NCT00279201|1526899|P4|Maintenance|Lack of Efficacy|0
465587|NCT00279201|1526900|P3|Maintenance|Lack of Efficacy|0
465588|NCT00279201|1526901|P2|Maintenance|Lack of Efficacy|30
465589|NCT00279201|1526902|P1|Maintenance|Lack of Efficacy|32
465590|NCT00279201|1526897|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
465591|NCT00279201|1526898|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
465592|NCT00279201|1526899|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
465593|NCT00279201|1526900|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
465594|NCT00279201|1526901|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
465595|NCT00279201|1526902|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
465596|NCT00279201|1526897|P6|Initiation|Sponsor Decision|0
465597|NCT00279201|1526898|P5|Initiation|Sponsor Decision|0
465598|NCT00279201|1526899|P4|Initiation|Sponsor Decision|0
465599|NCT00279201|1526900|P3|Initiation|Sponsor Decision|0
465600|NCT00279201|1526901|P2|Initiation|Sponsor Decision|5
465601|NCT00279201|1526902|P1|Initiation|Sponsor Decision|13
465602|NCT00279201|1526897|P6|Initiation|Physician Decision|0
465603|NCT00279201|1526898|P5|Initiation|Physician Decision|0
465604|NCT00279201|1526899|P4|Initiation|Physician Decision|0
465605|NCT00279201|1526900|P3|Initiation|Physician Decision|0
465606|NCT00279201|1526901|P2|Initiation|Physician Decision|18
465607|NCT00279201|1526902|P1|Initiation|Physician Decision|15
465608|NCT00279201|1526897|P6|Initiation|Withdrawal by Subject|0
465609|NCT00279201|1526898|P5|Initiation|Withdrawal by Subject|0
465610|NCT00279201|1526899|P4|Initiation|Withdrawal by Subject|0
465611|NCT00279201|1526900|P3|Initiation|Withdrawal by Subject|0
465612|NCT00279201|1526901|P2|Initiation|Withdrawal by Subject|41
465613|NCT00279201|1526902|P1|Initiation|Withdrawal by Subject|35
465614|NCT00279201|1526897|P6|Initiation|Protocol Violation|0
465615|NCT00279201|1526898|P5|Initiation|Protocol Violation|0
465616|NCT00279201|1526899|P4|Initiation|Protocol Violation|0
465617|NCT00279201|1526900|P3|Initiation|Protocol Violation|0
465618|NCT00279201|1526901|P2|Initiation|Protocol Violation|10
465619|NCT00279201|1526902|P1|Initiation|Protocol Violation|9
465620|NCT00279201|1526897|P6|Initiation|Entry Criteria Exclusion|0
465621|NCT00279201|1526898|P5|Initiation|Entry Criteria Exclusion|0
465622|NCT00279201|1526899|P4|Initiation|Entry Criteria Exclusion|0
465623|NCT00279201|1526900|P3|Initiation|Entry Criteria Exclusion|0
465624|NCT00279201|1526901|P2|Initiation|Entry Criteria Exclusion|9
465625|NCT00279201|1526902|P1|Initiation|Entry Criteria Exclusion|7
465626|NCT00279201|1526897|P6|Initiation|Lost to Follow-up|0
465627|NCT00279201|1526898|P5|Initiation|Lost to Follow-up|0
465628|NCT00279201|1526899|P4|Initiation|Lost to Follow-up|0
465629|NCT00279201|1526900|P3|Initiation|Lost to Follow-up|0
465630|NCT00279201|1526901|P2|Initiation|Lost to Follow-up|41
465631|NCT00279201|1526902|P1|Initiation|Lost to Follow-up|42
465632|NCT00279201|1526897|P6|Initiation|Adverse Event|0
465633|NCT00279201|1526898|P5|Initiation|Adverse Event|0
465634|NCT00279201|1526899|P4|Initiation|Adverse Event|0
465635|NCT00279201|1526900|P3|Initiation|Adverse Event|0
465636|NCT00279201|1526901|P2|Initiation|Adverse Event|15
465637|NCT00279201|1526902|P1|Initiation|Adverse Event|6
465638|NCT00279201|1526897|P6|Initiation|Death|0
465639|NCT00279201|1526898|P5|Initiation|Death|0
465640|NCT00279201|1526899|P4|Initiation|Death|0
465641|NCT00279201|1526900|P3|Initiation|Death|0
465642|NCT00279201|1526901|P2|Initiation|Death|5
465643|NCT00279201|1526902|P1|Initiation|Death|1
465644|NCT00278993|1527046|P1|Overall Study|Not Otherwise Specified|4
465645|NCT00278993|1527046|P1|Overall Study|Physician Decision|9
465646|NCT00278993|1527046|P1|Overall Study|Progressive Disease|65
465647|NCT00278993|1527046|P1|Overall Study|Withdrawal by Subject|5
465648|NCT00278993|1527046|P1|Overall Study|Adverse Event|24
465649|NCT00278954|1527054|P1|Overall Study|Withdrawal by Subject|1
465650|NCT00278954|1527054|P1|Overall Study|Lost to Follow-up|1
465651|NCT00278954|1527054|P1|Overall Study|Adverse Event|3
465652|NCT00278915|1527062|P1|Overall Study|Lack of Efficacy|1
465653|NCT00278889|1527098|P3|Overall Study|Death|17
465654|NCT00278889|1527099|P2|Overall Study|Death|21
465655|NCT00278889|1527100|P1|Overall Study|Death|24
465656|NCT00278889|1527098|P3|Overall Study|Lost to Follow-up|0
465657|NCT00278889|1527099|P2|Overall Study|Lost to Follow-up|1
465658|NCT00278889|1527100|P1|Overall Study|Lost to Follow-up|1
465659|NCT00278889|1527098|P3|Overall Study|Withdrawal by Subject|3
465660|NCT00278889|1527099|P2|Overall Study|Withdrawal by Subject|5
465661|NCT00278889|1527100|P1|Overall Study|Withdrawal by Subject|0
465662|NCT00278473|1527161|P2|Overall Study|drop out|3
465663|NCT00278473|1527162|P1|Overall Study|drop out|4
465664|NCT00278395|1527178|P1|Overall Study|Nonevaluable|1
465665|NCT00278395|1527178|P1|Overall Study|Adverse Event|2
465666|NCT00277355|1527234|P2|Overall Study|Physician Decision|0
465667|NCT00277355|1527235|P1|Overall Study|Physician Decision|1
465668|NCT00277355|1527234|P2|Overall Study|Death|0
465669|NCT00277355|1527235|P1|Overall Study|Death|3
465670|NCT00277355|1527234|P2|Overall Study|Adverse Event|0
465671|NCT00277355|1527235|P1|Overall Study|Adverse Event|5
465672|NCT00277355|1527234|P2|Overall Study|Lost to Follow-up|2
465673|NCT00277355|1527235|P1|Overall Study|Lost to Follow-up|2
465674|NCT00277355|1527234|P2|Overall Study|Withdrawal by Subject|3
465675|NCT00277355|1527235|P1|Overall Study|Withdrawal by Subject|3
465676|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
465677|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
465678|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
465679|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
465680|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
465681|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
465682|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
465683|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
465684|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
465685|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
465686|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
465687|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
465688|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
465689|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
465690|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
465691|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
465692|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
465693|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
465694|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
465695|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
465696|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
465697|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
465698|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
465699|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
465700|NCT00277212|1527243|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
465701|NCT00277212|1527244|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
465702|NCT00277212|1527245|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
465703|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
465704|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
465705|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
465706|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
465707|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
465708|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
465709|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
465710|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
465711|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
465712|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
465713|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
465714|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
465715|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
465716|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
465717|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
465718|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
465719|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
465720|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
465721|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
465722|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
465723|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
465724|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
465725|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
465726|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
465727|NCT00277212|1527243|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
465728|NCT00277212|1527244|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
465729|NCT00277212|1527245|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
465730|NCT00277095|1527283|P1|Overall Study|Physician Decision|1
465731|NCT00277095|1527283|P1|Overall Study|Missed Follow-up|9
465732|NCT00277095|1527283|P1|Overall Study|Lost to Follow-up|2
465733|NCT00277095|1527283|P1|Overall Study|Explanted|7
465734|NCT00277095|1527283|P1|Overall Study|Death|2
465735|NCT00276614|1527292|P1|Overall Study|Progression of disease under study|3
465736|NCT00276484|1527303|P2|Overall Study|Could not take time off work|1
465737|NCT00276484|1527304|P1|Overall Study|Could not take time off work|0
465738|NCT00276484|1527303|P2|Overall Study|Withdrawal by Subject|3
465739|NCT00276484|1527304|P1|Overall Study|Withdrawal by Subject|4
465740|NCT00276484|1527303|P2|Overall Study|Protocol Violation|1
465741|NCT00276484|1527304|P1|Overall Study|Protocol Violation|0
465742|NCT00276484|1527303|P2|Overall Study|Lost to Follow-up|1
465743|NCT00276484|1527304|P1|Overall Study|Lost to Follow-up|1
465744|NCT00276484|1527303|P2|Overall Study|Adverse Event|7
465745|NCT00276484|1527304|P1|Overall Study|Adverse Event|4
465746|NCT00276458|1527336|P2|Overall Study|Protocol Violation|3
465747|NCT00276458|1527337|P1|Overall Study|Protocol Violation|4
465748|NCT00276458|1527336|P2|Overall Study|Lost to Follow-up|2
465749|NCT00276458|1527337|P1|Overall Study|Lost to Follow-up|2
465750|NCT00276458|1527336|P2|Overall Study|Adverse Event|2
465751|NCT00276458|1527337|P1|Overall Study|Adverse Event|0
465752|NCT00276419|1527371|P2|First Intervention|Withdrawal by Subject|2
465753|NCT00276419|1527372|P1|First Intervention|Withdrawal by Subject|0
465754|NCT00276419|1527371|P2|First Intervention|Adverse Event|0
465755|NCT00276419|1527372|P1|First Intervention|Adverse Event|1
465756|NCT00276380|1527415|P2|Overall Study|Abnormal aPPT Levels|1
465757|NCT00276380|1527416|P1|Overall Study|Abnormal aPPT Levels|0
465758|NCT00276380|1527415|P2|Overall Study|Death|3
465759|NCT00276380|1527416|P1|Overall Study|Death|5
465760|NCT00276380|1527415|P2|Overall Study|Withdrawal by Subject|6
465761|NCT00276380|1527416|P1|Overall Study|Withdrawal by Subject|3
465762|NCT00276380|1527415|P2|Overall Study|Lost to Follow-up|1
465763|NCT00276380|1527416|P1|Overall Study|Lost to Follow-up|1
465764|NCT00276380|1527415|P2|Overall Study|Adverse Event|3
465765|NCT00276380|1527416|P1|Overall Study|Adverse Event|5
465766|NCT00276159|1527471|P1|Overall Study|Did not receive all 24 doses of 852A|6
465767|NCT00276094|1527481|P3|Overall Study|Other-Study medication lost|1
465768|NCT00276094|1527482|P2|Overall Study|Other-Study medication lost|0
465769|NCT00276094|1527483|P1|Overall Study|Other-Study medication lost|0
465770|NCT00276094|1527481|P3|Overall Study|Other-Relocation|0
465771|NCT00276094|1527482|P2|Overall Study|Other-Relocation|1
465772|NCT00276094|1527483|P1|Overall Study|Other-Relocation|0
465773|NCT00276094|1527481|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
465774|NCT00276094|1527482|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
465775|NCT00276094|1527483|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
465776|NCT00276094|1527481|P3|Overall Study|Other-Refused follow-up visit|0
465777|NCT00276094|1527482|P2|Overall Study|Other-Refused follow-up visit|0
465778|NCT00276094|1527483|P1|Overall Study|Other-Refused follow-up visit|1
465779|NCT00276094|1527481|P3|Overall Study|Other-Lack of efficacy|0
465780|NCT00276094|1527482|P2|Overall Study|Other-Lack of efficacy|0
465781|NCT00276094|1527483|P1|Overall Study|Other-Lack of efficacy|1
465782|NCT00276094|1527481|P3|Overall Study|Other-Scheduled gastroplasty|0
465783|NCT00276094|1527482|P2|Overall Study|Other-Scheduled gastroplasty|0
465784|NCT00276094|1527483|P1|Overall Study|Other-Scheduled gastroplasty|1
465785|NCT00276094|1527481|P3|Overall Study|Other-Subject moved out of country|0
465786|NCT00276094|1527482|P2|Overall Study|Other-Subject moved out of country|0
465787|NCT00276094|1527483|P1|Overall Study|Other-Subject moved out of country|1
465788|NCT00276094|1527481|P3|Overall Study|Lost to Follow-up|4
465789|NCT00276094|1527482|P2|Overall Study|Lost to Follow-up|6
465790|NCT00276094|1527483|P1|Overall Study|Lost to Follow-up|8
465791|NCT00276094|1527481|P3|Overall Study|Protocol Violation|10
465792|NCT00276094|1527482|P2|Overall Study|Protocol Violation|7
465793|NCT00276094|1527483|P1|Overall Study|Protocol Violation|16
465794|NCT00276094|1527481|P3|Overall Study|Withdrawal by Subject|12
465795|NCT00276094|1527482|P2|Overall Study|Withdrawal by Subject|14
465796|NCT00276094|1527483|P1|Overall Study|Withdrawal by Subject|14
465797|NCT00276094|1527481|P3|Overall Study|Adverse Event|11
465798|NCT00276094|1527482|P2|Overall Study|Adverse Event|13
465799|NCT00276094|1527483|P1|Overall Study|Adverse Event|15
465800|NCT00276016|1527536|P6|Intervention 1|Withdrawal by Subject|0
465801|NCT00276016|1527537|P5|Intervention 1|Withdrawal by Subject|0
465802|NCT00276016|1527538|P4|Intervention 1|Withdrawal by Subject|0
465803|NCT00276016|1527539|P3|Intervention 1|Withdrawal by Subject|0
465804|NCT00276016|1527540|P2|Intervention 1|Withdrawal by Subject|1
465805|NCT00276016|1527541|P1|Intervention 1|Withdrawal by Subject|0
465806|NCT00275821|1527587|P3|Overall Study|Protocol Violation|0
465807|NCT00275821|1527588|P2|Overall Study|Protocol Violation|1
465808|NCT00275821|1527589|P1|Overall Study|Protocol Violation|5
465809|NCT00275821|1527587|P3|Overall Study|Lack of Efficacy|0
465810|NCT00275821|1527588|P2|Overall Study|Lack of Efficacy|1
465811|NCT00275821|1527589|P1|Overall Study|Lack of Efficacy|2
465812|NCT00275821|1527587|P3|Overall Study|Death|1
465813|NCT00275821|1527588|P2|Overall Study|Death|2
465814|NCT00275821|1527589|P1|Overall Study|Death|0
465815|NCT00275821|1527587|P3|Overall Study|Lost to Follow-up|1
465816|NCT00275821|1527588|P2|Overall Study|Lost to Follow-up|1
465817|NCT00275821|1527589|P1|Overall Study|Lost to Follow-up|0
465818|NCT00275821|1527587|P3|Overall Study|Withdrawal by Subject|1
465819|NCT00275821|1527588|P2|Overall Study|Withdrawal by Subject|2
465820|NCT00275821|1527589|P1|Overall Study|Withdrawal by Subject|0
465821|NCT00275821|1527587|P3|Overall Study|Administrative problems|4
465822|NCT00275821|1527588|P2|Overall Study|Administrative problems|4
465823|NCT00275821|1527589|P1|Overall Study|Administrative problems|3
465824|NCT00275821|1527587|P3|Overall Study|Adverse Event|5
465825|NCT00275821|1527588|P2|Overall Study|Adverse Event|12
465826|NCT00275821|1527589|P1|Overall Study|Adverse Event|4
465827|NCT00275561|1527608|P2|Overall Study|Family Issues|2
465828|NCT00275561|1527609|P1|Overall Study|Family Issues|0
465829|NCT00275561|1527608|P2|Overall Study|Scheduling|2
465830|NCT00275561|1527609|P1|Overall Study|Scheduling|1
465831|NCT00275561|1527608|P2|Overall Study|Travel|1
465832|NCT00275561|1527609|P1|Overall Study|Travel|1
465833|NCT00275561|1527608|P2|Overall Study|Withdrawal by Subject|1
465834|NCT00275561|1527609|P1|Overall Study|Withdrawal by Subject|0
465835|NCT00275509|1527621|P2|Overall Study|graft thrombosis, post-operative day #8|1
465836|NCT00275509|1527622|P1|Overall Study|graft thrombosis, post-operative day #8|0
465837|NCT00275340|1527645|P2|Overall Study|Lost to Follow-up|4
465838|NCT00275340|1527646|P1|Overall Study|Lost to Follow-up|2
465839|NCT00275301|1527650|P1|Overall Study|Adverse Event|5
465840|NCT00275262|1527669|P2|Overall Study|Started Chemotherapy|0
465841|NCT00275262|1527670|P1|Overall Study|Started Chemotherapy|1
465842|NCT00275262|1527669|P2|Overall Study|Death|0
465843|NCT00275262|1527670|P1|Overall Study|Death|1
465844|NCT00275262|1527669|P2|Overall Study|Protocol Violation|2
465845|NCT00275262|1527670|P1|Overall Study|Protocol Violation|0
465846|NCT00275262|1527669|P2|Overall Study|Lost to Follow-up|2
465847|NCT00275262|1527670|P1|Overall Study|Lost to Follow-up|0
465848|NCT00275262|1527669|P2|Overall Study|Disease progression|5
465849|NCT00275262|1527670|P1|Overall Study|Disease progression|2
465850|NCT00275262|1527669|P2|Overall Study|Adverse Event|0
465851|NCT00275262|1527670|P1|Overall Study|Adverse Event|2
465852|NCT00275028|1527684|P1|Overall Study|Physician Decision|2
465853|NCT00275028|1527684|P1|Overall Study|Progressive Disease|30
465854|NCT00275028|1527684|P1|Overall Study|Adverse Event|9
465855|NCT00275028|1527684|P1|Overall Study|Withdrawal by Subject|5
465856|NCT00275028|1527684|P1|Overall Study|Withdrew consent before treatment began|1
465857|NCT00275002|1527691|P2|Overall Study|Adverse Event|1
465858|NCT00275002|1527692|P1|Overall Study|Adverse Event|0
465859|NCT00275002|1527691|P2|Overall Study|Disease progression|15
465860|NCT00275002|1527692|P1|Overall Study|Disease progression|21
465861|NCT00275002|1527691|P2|Overall Study|Death|0
465862|NCT00275002|1527692|P1|Overall Study|Death|1
465863|NCT00274937|1527700|P1|Overall Study|Progressive Disease|4
465864|NCT00274937|1527700|P1|Overall Study|Withdrawal by Subject|6
465865|NCT00274937|1527700|P1|Overall Study|Physician Decision|10
465866|NCT00274924|1527710|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
465867|NCT00274924|1527711|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
465868|NCT00274924|1527712|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
465869|NCT00274924|1527710|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
465870|NCT00274924|1527711|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
465871|NCT00274924|1527712|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
465872|NCT00274924|1527710|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
465873|NCT00274924|1527711|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
465874|NCT00274924|1527712|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
465875|NCT00274924|1527710|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
465876|NCT00274924|1527711|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
465963|NCT00274716|1527791|P3|Phase B|Protocol Violation|0
465877|NCT00274924|1527712|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
465878|NCT00274924|1527710|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
465879|NCT00274924|1527711|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
465880|NCT00274924|1527712|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
465881|NCT00274924|1527710|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
465882|NCT00274924|1527711|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
465883|NCT00274924|1527712|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
465884|NCT00274924|1527710|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
465885|NCT00274924|1527711|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
465886|NCT00274924|1527712|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
465887|NCT00274924|1527710|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
465888|NCT00274924|1527711|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
465889|NCT00274924|1527712|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
465890|NCT00274924|1527710|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
465891|NCT00274924|1527711|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
465892|NCT00274924|1527712|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
465893|NCT00274924|1527710|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
465894|NCT00274924|1527711|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
465895|NCT00274924|1527712|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
465896|NCT00274924|1527710|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
465897|NCT00274924|1527711|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
465898|NCT00274924|1527712|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
465899|NCT00274924|1527710|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
465900|NCT00274924|1527711|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
465901|NCT00274924|1527712|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
465902|NCT00274924|1527710|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
465903|NCT00274924|1527711|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
465904|NCT00274924|1527712|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
465905|NCT00274846|1527721|P1|Overall Study|Did not receive adequate NK cells|1
465906|NCT00274742|1527745|P6|Overall Study|Other|0
465907|NCT00274742|1527746|P5|Overall Study|Other|2
465908|NCT00274742|1527747|P4|Overall Study|Other|0
465909|NCT00274742|1527748|P3|Overall Study|Other|0
465910|NCT00274742|1527749|P2|Overall Study|Other|3
465911|NCT00274742|1527750|P1|Overall Study|Other|0
465912|NCT00274742|1527745|P6|Overall Study|Disease Progression|0
465913|NCT00274742|1527746|P5|Overall Study|Disease Progression|1
465914|NCT00274742|1527747|P4|Overall Study|Disease Progression|0
465915|NCT00274742|1527748|P3|Overall Study|Disease Progression|1
465916|NCT00274742|1527749|P2|Overall Study|Disease Progression|1
465917|NCT00274742|1527750|P1|Overall Study|Disease Progression|0
465918|NCT00274742|1527745|P6|Overall Study|End of Study|0
465919|NCT00274742|1527746|P5|Overall Study|End of Study|0
465920|NCT00274742|1527747|P4|Overall Study|End of Study|1
465921|NCT00274742|1527748|P3|Overall Study|End of Study|0
465922|NCT00274742|1527749|P2|Overall Study|End of Study|0
465923|NCT00274742|1527750|P1|Overall Study|End of Study|0
465924|NCT00274742|1527745|P6|Overall Study|Lost to Follow-up|0
465925|NCT00274742|1527746|P5|Overall Study|Lost to Follow-up|1
465926|NCT00274742|1527747|P4|Overall Study|Lost to Follow-up|0
465927|NCT00274742|1527748|P3|Overall Study|Lost to Follow-up|0
465928|NCT00274742|1527749|P2|Overall Study|Lost to Follow-up|0
465929|NCT00274742|1527750|P1|Overall Study|Lost to Follow-up|0
465930|NCT00274742|1527745|P6|Overall Study|Adverse Event|3
465931|NCT00274742|1527746|P5|Overall Study|Adverse Event|12
465932|NCT00274742|1527747|P4|Overall Study|Adverse Event|4
465933|NCT00274742|1527748|P3|Overall Study|Adverse Event|1
465934|NCT00274742|1527749|P2|Overall Study|Adverse Event|4
465935|NCT00274742|1527750|P1|Overall Study|Adverse Event|0
465936|NCT00274716|1527788|P6|Phase B|Lost to Follow-up|0
465937|NCT00274716|1527789|P5|Phase B|Lost to Follow-up|0
465938|NCT00274716|1527790|P4|Phase B|Lost to Follow-up|0
465939|NCT00274716|1527791|P3|Phase B|Lost to Follow-up|0
465940|NCT00274716|1527792|P2|Phase B|Lost to Follow-up|1
465941|NCT00274716|1527793|P1|Phase B|Lost to Follow-up|0
465942|NCT00274716|1527788|P6|Phase B|Other non-reported reason|0
465943|NCT00274716|1527789|P5|Phase B|Other non-reported reason|0
465944|NCT00274716|1527790|P4|Phase B|Other non-reported reason|1
465945|NCT00274716|1527791|P3|Phase B|Other non-reported reason|1
465946|NCT00274716|1527792|P2|Phase B|Other non-reported reason|0
465947|NCT00274716|1527793|P1|Phase B|Other non-reported reason|0
465948|NCT00274716|1527788|P6|Phase B|Participant moved|0
465949|NCT00274716|1527789|P5|Phase B|Participant moved|0
465950|NCT00274716|1527790|P4|Phase B|Participant moved|0
465951|NCT00274716|1527791|P3|Phase B|Participant moved|0
465952|NCT00274716|1527792|P2|Phase B|Participant moved|0
465953|NCT00274716|1527793|P1|Phase B|Participant moved|1
465954|NCT00274716|1527788|P6|Phase B|Withdrawal by Subject|0
465955|NCT00274716|1527789|P5|Phase B|Withdrawal by Subject|0
465956|NCT00274716|1527790|P4|Phase B|Withdrawal by Subject|0
465957|NCT00274716|1527791|P3|Phase B|Withdrawal by Subject|0
465958|NCT00274716|1527792|P2|Phase B|Withdrawal by Subject|1
465959|NCT00274716|1527793|P1|Phase B|Withdrawal by Subject|0
465960|NCT00274716|1527788|P6|Phase B|Protocol Violation|0
465961|NCT00274716|1527789|P5|Phase B|Protocol Violation|0
465962|NCT00274716|1527790|P4|Phase B|Protocol Violation|0
465964|NCT00274716|1527792|P2|Phase B|Protocol Violation|2
465965|NCT00274716|1527793|P1|Phase B|Protocol Violation|0
465966|NCT00274716|1527788|P6|Phase B|Adverse Event|1
465967|NCT00274716|1527789|P5|Phase B|Adverse Event|0
465968|NCT00274716|1527790|P4|Phase B|Adverse Event|0
465969|NCT00274716|1527791|P3|Phase B|Adverse Event|2
465970|NCT00274716|1527792|P2|Phase B|Adverse Event|0
465971|NCT00274716|1527793|P1|Phase B|Adverse Event|0
465972|NCT00274716|1527788|P6|Phase A|Completed but did not enter Phase B|1
465973|NCT00274716|1527789|P5|Phase A|Completed but did not enter Phase B|1
465974|NCT00274716|1527790|P4|Phase A|Completed but did not enter Phase B|2
465975|NCT00274716|1527791|P3|Phase A|Completed but did not enter Phase B|2
465976|NCT00274716|1527792|P2|Phase A|Completed but did not enter Phase B|2
465977|NCT00274716|1527793|P1|Phase A|Completed but did not enter Phase B|1
465978|NCT00274716|1527788|P6|Phase A|Adverse Event|0
465979|NCT00274716|1527789|P5|Phase A|Adverse Event|2
465980|NCT00274716|1527790|P4|Phase A|Adverse Event|0
465981|NCT00274716|1527791|P3|Phase A|Adverse Event|3
465982|NCT00274716|1527792|P2|Phase A|Adverse Event|3
465983|NCT00274716|1527793|P1|Phase A|Adverse Event|2
465984|NCT00274716|1527788|P6|Phase A|Withdrawal by Subject|1
465985|NCT00274716|1527789|P5|Phase A|Withdrawal by Subject|0
465986|NCT00274716|1527790|P4|Phase A|Withdrawal by Subject|3
465987|NCT00274716|1527791|P3|Phase A|Withdrawal by Subject|1
465988|NCT00274716|1527792|P2|Phase A|Withdrawal by Subject|2
465989|NCT00274716|1527793|P1|Phase A|Withdrawal by Subject|2
465990|NCT00274716|1527788|P6|Phase A|Met criteria for discontinuation|0
465991|NCT00274716|1527789|P5|Phase A|Met criteria for discontinuation|0
465992|NCT00274716|1527790|P4|Phase A|Met criteria for discontinuation|0
465993|NCT00274716|1527791|P3|Phase A|Met criteria for discontinuation|0
465994|NCT00274716|1527792|P2|Phase A|Met criteria for discontinuation|1
465995|NCT00274716|1527793|P1|Phase A|Met criteria for discontinuation|1
465996|NCT00274716|1527788|P6|Phase A|Protocol Violation|0
465997|NCT00274716|1527789|P5|Phase A|Protocol Violation|0
465998|NCT00274716|1527790|P4|Phase A|Protocol Violation|1
465999|NCT00274716|1527791|P3|Phase A|Protocol Violation|0
466000|NCT00274716|1527792|P2|Phase A|Protocol Violation|0
466001|NCT00274716|1527793|P1|Phase A|Protocol Violation|1
466002|NCT00274716|1527788|P6|Phase A|Site Terminated|0
466003|NCT00274716|1527789|P5|Phase A|Site Terminated|0
466004|NCT00274716|1527790|P4|Phase A|Site Terminated|1
466005|NCT00274716|1527791|P3|Phase A|Site Terminated|0
466006|NCT00274716|1527792|P2|Phase A|Site Terminated|0
466007|NCT00274716|1527793|P1|Phase A|Site Terminated|0
466008|NCT00274716|1527788|P6|Phase A|Participant moved|1
466009|NCT00274716|1527789|P5|Phase A|Participant moved|0
466010|NCT00274716|1527790|P4|Phase A|Participant moved|0
466011|NCT00274716|1527791|P3|Phase A|Participant moved|1
466012|NCT00274716|1527792|P2|Phase A|Participant moved|0
466013|NCT00274716|1527793|P1|Phase A|Participant moved|0
466014|NCT00274716|1527788|P6|Phase A|Other non-reported reason|1
466015|NCT00274716|1527789|P5|Phase A|Other non-reported reason|0
466016|NCT00274716|1527790|P4|Phase A|Other non-reported reason|2
466017|NCT00274716|1527791|P3|Phase A|Other non-reported reason|1
466018|NCT00274716|1527792|P2|Phase A|Other non-reported reason|2
466019|NCT00274716|1527793|P1|Phase A|Other non-reported reason|4
466020|NCT00274651|1527855|P2|Overall Study|Physician Decision|7
466021|NCT00274651|1527856|P1|Overall Study|Physician Decision|8
466022|NCT00274651|1527855|P2|Overall Study|Withdrawal by Subject|1
466023|NCT00274651|1527856|P1|Overall Study|Withdrawal by Subject|0
466024|NCT00274651|1527855|P2|Overall Study|Death|3
466025|NCT00274651|1527856|P1|Overall Study|Death|1
466026|NCT00274651|1527855|P2|Overall Study|Lack of Efficacy|6
466027|NCT00274651|1527856|P1|Overall Study|Lack of Efficacy|13
466028|NCT00274651|1527855|P2|Overall Study|Adverse Event|3
466029|NCT00274651|1527856|P1|Overall Study|Adverse Event|6
466030|NCT00274625|1527871|P2|Overall Study|Excluded from analysis|8
466031|NCT00274625|1527872|P1|Overall Study|Excluded from analysis|14
466032|NCT00274625|1527871|P2|Overall Study|Lost to Follow-up|54
466033|NCT00274625|1527872|P1|Overall Study|Lost to Follow-up|46
466034|NCT00274469|1527880|P2|Overall Study|Reasons not specified|8
466035|NCT00274469|1527881|P1|Overall Study|Reasons not specified|5
466036|NCT00274469|1527880|P2|Overall Study|Withdrawal by Subject|0
466037|NCT00274469|1527881|P1|Overall Study|Withdrawal by Subject|2
466038|NCT00274469|1527880|P2|Overall Study|Condition under investigation worsened|38
466039|NCT00274469|1527881|P1|Overall Study|Condition under investigation worsened|28
466040|NCT00274469|1527880|P2|Overall Study|Adverse Event|3
466041|NCT00274469|1527881|P1|Overall Study|Adverse Event|2
466042|NCT00274469|1527880|P2|Overall Study|Death|1
466043|NCT00274469|1527881|P1|Overall Study|Death|1
466044|NCT00274456|1527899|P4|Overall Study|Withdrawal by Subject|13
466045|NCT00274456|1527900|P3|Overall Study|Withdrawal by Subject|9
466046|NCT00274456|1527901|P2|Overall Study|Withdrawal by Subject|13
466047|NCT00274456|1527902|P1|Overall Study|Withdrawal by Subject|18
466048|NCT00274456|1527899|P4|Overall Study|Lost to Follow-up|0
466049|NCT00274456|1527900|P3|Overall Study|Lost to Follow-up|1
466050|NCT00274456|1527901|P2|Overall Study|Lost to Follow-up|0
466051|NCT00274456|1527902|P1|Overall Study|Lost to Follow-up|0
466052|NCT00274456|1527899|P4|Overall Study|Physician Decision|13
466053|NCT00274456|1527900|P3|Overall Study|Physician Decision|6
466054|NCT00274456|1527901|P2|Overall Study|Physician Decision|5
466055|NCT00274456|1527902|P1|Overall Study|Physician Decision|7
466056|NCT00274456|1527899|P4|Overall Study|Adverse Event|2
466057|NCT00274456|1527900|P3|Overall Study|Adverse Event|2
466058|NCT00274456|1527901|P2|Overall Study|Adverse Event|1
466059|NCT00274456|1527902|P1|Overall Study|Adverse Event|0
466060|NCT00274456|1527899|P4|Overall Study|Unacceptable toxicity|16
466061|NCT00274456|1527900|P3|Overall Study|Unacceptable toxicity|12
466062|NCT00274456|1527901|P2|Overall Study|Unacceptable toxicity|5
466063|NCT00274456|1527902|P1|Overall Study|Unacceptable toxicity|10
466064|NCT00274456|1527899|P4|Overall Study|Still on treatment|1
466065|NCT00274456|1527900|P3|Overall Study|Still on treatment|5
466066|NCT00274456|1527901|P2|Overall Study|Still on treatment|3
466067|NCT00274456|1527902|P1|Overall Study|Still on treatment|2
466068|NCT00274287|1527944|P1|Overall Study|subject non-compliance|1
466069|NCT00274287|1527944|P1|Overall Study|Withdrawal by Subject|1
466070|NCT00274261|1527950|P2|Overall Study|Lost to Follow-up|75
466071|NCT00274261|1527951|P1|Overall Study|Lost to Follow-up|106
466072|NCT00274261|1527950|P2|Overall Study|Protocol Violation|42
466073|NCT00274261|1527951|P1|Overall Study|Protocol Violation|71
466074|NCT00274261|1527950|P2|Overall Study|Withdrawal by Subject|126
466075|NCT00274261|1527951|P1|Overall Study|Withdrawal by Subject|179
466076|NCT00274261|1527950|P2|Overall Study|Pregnancy|83
466077|NCT00274261|1527951|P1|Overall Study|Pregnancy|114
466078|NCT00274261|1527950|P2|Overall Study|Adverse Event|11
466079|NCT00274261|1527951|P1|Overall Study|Adverse Event|19
466080|NCT00273858|1527990|P1|Overall Study|Adverse Event|81
466081|NCT00273858|1527990|P1|Overall Study|Withdrawal by Subject|21
466082|NCT00273858|1527990|P1|Overall Study|Lost to Follow-up|101
466083|NCT00273858|1527990|P1|Overall Study|Not completed 24 month observation time|334
466084|NCT00273182|1528049|P1|Overall Study|Site exit, system change, 36 m FU missed|36
466085|NCT00273182|1528049|P1|Overall Study|Device/System Explant|154
466086|NCT00273182|1528049|P1|Overall Study|Withdrawal by Subject|257
466087|NCT00273182|1528049|P1|Overall Study|Lost to Follow-up|88
466088|NCT00273182|1528049|P1|Overall Study|Death|450
466089|NCT00273052|1528059|P2|Overall Study|Worsening serum lipid levels|2
466090|NCT00273052|1528060|P1|Overall Study|Worsening serum lipid levels|0
466091|NCT00273052|1528059|P2|Overall Study|Not specified|0
466092|NCT00273052|1528060|P1|Overall Study|Not specified|2
466093|NCT00273052|1528059|P2|Overall Study|Non-Compliance|1
466094|NCT00273052|1528060|P1|Overall Study|Non-Compliance|3
466095|NCT00273052|1528059|P2|Overall Study|Lack of Efficacy|4
466096|NCT00273052|1528060|P1|Overall Study|Lack of Efficacy|6
466097|NCT00273052|1528059|P2|Overall Study|Lost to Follow-up|25
466098|NCT00273052|1528060|P1|Overall Study|Lost to Follow-up|7
466099|NCT00273052|1528059|P2|Overall Study|Protocol Violation|18
466100|NCT00273052|1528060|P1|Overall Study|Protocol Violation|14
466101|NCT00273052|1528059|P2|Overall Study|Adverse Event|19
466102|NCT00273052|1528060|P1|Overall Study|Adverse Event|21
466103|NCT00273052|1528059|P2|Overall Study|Withdrawal by Subject|19
466104|NCT00273052|1528060|P1|Overall Study|Withdrawal by Subject|16
466105|NCT00272987|1528095|P3|Overall Study|Ongoing|15
466106|NCT00272987|1528096|P2|Overall Study|Ongoing|14
466107|NCT00272987|1528097|P1|Overall Study|Ongoing|20
466108|NCT00272987|1528095|P3|Overall Study|Missed >3 Visits|1
466109|NCT00272987|1528096|P2|Overall Study|Missed >3 Visits|0
466110|NCT00272987|1528097|P1|Overall Study|Missed >3 Visits|0
466111|NCT00272987|1528095|P3|Overall Study|Withdrawal by Subject|3
466112|NCT00272987|1528096|P2|Overall Study|Withdrawal by Subject|0
466113|NCT00272987|1528097|P1|Overall Study|Withdrawal by Subject|0
466114|NCT00272987|1528095|P3|Overall Study|Adverse Event|0
466115|NCT00272987|1528096|P2|Overall Study|Adverse Event|0
466116|NCT00272987|1528097|P1|Overall Study|Adverse Event|1
466117|NCT00272961|1528161|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
466118|NCT00272961|1528162|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
466119|NCT00272961|1528163|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
466120|NCT00272961|1528164|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
466121|NCT00272961|1528165|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
466122|NCT00272961|1528161|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
466123|NCT00272961|1528162|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
466124|NCT00272961|1528163|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
466125|NCT00272961|1528164|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
466126|NCT00272961|1528165|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
466127|NCT00272961|1528161|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
466128|NCT00272961|1528162|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
466129|NCT00272961|1528163|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
466130|NCT00272961|1528164|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
466131|NCT00272961|1528165|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
466132|NCT00272961|1528161|P5|Placebo Run-in Phase: Up to Week 2|Other|0
466133|NCT00272961|1528162|P4|Placebo Run-in Phase: Up to Week 2|Other|0
466134|NCT00272961|1528163|P3|Placebo Run-in Phase: Up to Week 2|Other|0
466135|NCT00272961|1528164|P2|Placebo Run-in Phase: Up to Week 2|Other|0
466136|NCT00272961|1528165|P1|Placebo Run-in Phase: Up to Week 2|Other|2
466137|NCT00272961|1528161|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
466138|NCT00272961|1528162|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
466139|NCT00272961|1528163|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
466140|NCT00272961|1528164|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
466141|NCT00272961|1528165|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
466142|NCT00272961|1528161|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
466143|NCT00272961|1528162|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
466144|NCT00272961|1528163|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
466145|NCT00272961|1528164|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
466146|NCT00272961|1528165|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
466147|NCT00272961|1528161|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
466148|NCT00272961|1528162|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
466149|NCT00272961|1528163|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
466150|NCT00272961|1528164|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
466151|NCT00272961|1528165|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
466152|NCT00272961|1528161|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
466153|NCT00272961|1528162|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
466154|NCT00272961|1528163|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
466155|NCT00272961|1528164|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
466156|NCT00272961|1528165|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
466157|NCT00272844|1528222|P1|Overall Study|Withdrawal by Subject|5
466158|NCT00272792|1528230|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
466159|NCT00272792|1528231|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
466160|NCT00272792|1528230|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
466161|NCT00272792|1528231|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
466162|NCT00272792|1528230|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
466163|NCT00272792|1528231|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
466164|NCT00272792|1528230|P2|Part 1: Responsiveness|Lost to Follow-up|0
466165|NCT00272792|1528231|P1|Part 1: Responsiveness|Lost to Follow-up|1
466166|NCT00272779|1528241|P2|Baseline Through Week 96|Continuing on treatment|38
466167|NCT00272779|1528242|P1|Baseline Through Week 96|Continuing on treatment|61
466168|NCT00272779|1528241|P2|Baseline Through Week 96|Never treated|3
466169|NCT00272779|1528242|P1|Baseline Through Week 96|Never treated|2
466170|NCT00272779|1528241|P2|Baseline Through Week 96|Pregnancy at Week 96|0
466171|NCT00272779|1528242|P1|Baseline Through Week 96|Pregnancy at Week 96|1
466172|NCT00272779|1528241|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
466173|NCT00272779|1528242|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
466174|NCT00272779|1528241|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
466175|NCT00272779|1528242|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
466176|NCT00272779|1528241|P2|Baseline Through Week 96|Changed address before Week 96|1
466177|NCT00272779|1528242|P1|Baseline Through Week 96|Changed address before Week 96|0
466178|NCT00272779|1528241|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
466179|NCT00272779|1528242|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
466180|NCT00272779|1528241|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
466181|NCT00272779|1528242|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
466182|NCT00272779|1528241|P2|Baseline Through Week 96|Pregnancy before Week 96|7
466183|NCT00272779|1528242|P1|Baseline Through Week 96|Pregnancy before Week 96|5
466184|NCT00272779|1528241|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
466185|NCT00272779|1528242|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
466186|NCT00272779|1528241|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
466187|NCT00272779|1528242|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
466188|NCT00272779|1528241|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
466189|NCT00272779|1528242|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
466190|NCT00272779|1528241|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
466191|NCT00272779|1528242|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
466192|NCT00272779|1528241|P2|Baseline Through Week 96|Death before Week 96|5
466193|NCT00272779|1528242|P1|Baseline Through Week 96|Death before Week 96|6
466194|NCT00272779|1528241|P2|Baseline Through Week 96|Adverse event before Week 96|22
466195|NCT00272779|1528242|P1|Baseline Through Week 96|Adverse event before Week 96|13
466196|NCT00272779|1528241|P2|Baseline Through Week 48|Never treated|3
466197|NCT00272779|1528242|P1|Baseline Through Week 48|Never treated|2
466198|NCT00272779|1528241|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
466199|NCT00272779|1528242|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
466200|NCT00272779|1528241|P2|Baseline Through Week 48|Continuing treatment|368
466201|NCT00272779|1528242|P1|Baseline Through Week 48|Continuing treatment|385
466202|NCT00272779|1528241|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
466203|NCT00272779|1528242|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
466204|NCT00272779|1528241|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
466205|NCT00272779|1528242|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
466206|NCT00272779|1528241|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
466207|NCT00272779|1528242|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
466208|NCT00272779|1528241|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
466209|NCT00272779|1528242|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
466210|NCT00272779|1528241|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
466211|NCT00272779|1528242|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
466212|NCT00272779|1528241|P2|Baseline Through Week 48|Death on/after Week 48|1
466213|NCT00272779|1528242|P1|Baseline Through Week 48|Death on/after Week 48|1
466214|NCT00272779|1528241|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
466215|NCT00272779|1528242|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
466216|NCT00272779|1528241|P2|Baseline Through Week 48|Chose different site before wk 48|1
466217|NCT00272779|1528242|P1|Baseline Through Week 48|Chose different site before wk 48|0
466218|NCT00272779|1528241|P2|Baseline Through Week 48|Participant's decision before wk 48|1
466219|NCT00272779|1528242|P1|Baseline Through Week 48|Participant's decision before wk 48|0
466220|NCT00272779|1528241|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
466221|NCT00272779|1528242|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
466222|NCT00272779|1528241|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
466223|NCT00272779|1528242|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
466224|NCT00272779|1528241|P2|Baseline Through Week 48|Pregnancy before Week 48|2
466225|NCT00272779|1528242|P1|Baseline Through Week 48|Pregnancy before Week 48|2
466226|NCT00272779|1528241|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
466227|NCT00272779|1528242|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
466228|NCT00272779|1528241|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
466229|NCT00272779|1528242|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
466230|NCT00272779|1528241|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
466231|NCT00272779|1528242|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
466232|NCT00272779|1528241|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
466233|NCT00272779|1528242|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
466234|NCT00272779|1528241|P2|Baseline Through Week 48|Death before Week 48|4
466235|NCT00272779|1528242|P1|Baseline Through Week 48|Death before Week 48|4
466236|NCT00272779|1528241|P2|Baseline Through Week 48|Adverse event before Week 48|14
466237|NCT00272779|1528242|P1|Baseline Through Week 48|Adverse event before Week 48|10
466238|NCT00272038|1528482|P1|Overall Study|withdrew before they received 2 cycles|7
466239|NCT00271947|1528488|P1|Overall Study|Lost to Follow-up|1
466240|NCT00271856|1528494|P2|Overall Study|Lost to Follow-up|11
466241|NCT00271856|1528495|P1|Overall Study|Lost to Follow-up|10
466242|NCT00271856|1528494|P2|Overall Study|Withdrawal by Subject|7
466243|NCT00271856|1528495|P1|Overall Study|Withdrawal by Subject|1
466244|NCT00271817|1528514|P3|Part 2|LDL < 50 mg/dL|4
466245|NCT00271817|1528515|P2|Part 2|LDL < 50 mg/dL|3
466246|NCT00271817|1528516|P1|Part 2|LDL < 50 mg/dL|0
466247|NCT00271817|1528514|P3|Part 2|Withdrawal by Subject|13
466248|NCT00271817|1528515|P2|Part 2|Withdrawal by Subject|2
466249|NCT00271817|1528516|P1|Part 2|Withdrawal by Subject|0
466250|NCT00271817|1528514|P3|Part 2|Patient Moved|5
466251|NCT00271817|1528515|P2|Part 2|Patient Moved|0
466252|NCT00271817|1528516|P1|Part 2|Patient Moved|0
466253|NCT00271817|1528514|P3|Part 2|Protocol Violation|5
466254|NCT00271817|1528515|P2|Part 2|Protocol Violation|3
466255|NCT00271817|1528516|P1|Part 2|Protocol Violation|0
466256|NCT00271817|1528514|P3|Part 2|Lost to Follow-up|18
466257|NCT00271817|1528515|P2|Part 2|Lost to Follow-up|6
466258|NCT00271817|1528516|P1|Part 2|Lost to Follow-up|0
466259|NCT00271817|1528514|P3|Part 2|Lack of Efficacy|6
466260|NCT00271817|1528515|P2|Part 2|Lack of Efficacy|1
466261|NCT00271817|1528516|P1|Part 2|Lack of Efficacy|0
466262|NCT00271817|1528514|P3|Part 2|Adverse Event|33
466263|NCT00271817|1528515|P2|Part 2|Adverse Event|17
466264|NCT00271817|1528516|P1|Part 2|Adverse Event|0
466265|NCT00271817|1528514|P3|Part 1|LDL < 50 mg/dL|48
466266|NCT00271817|1528515|P2|Part 1|LDL < 50 mg/dL|4
466267|NCT00271817|1528516|P1|Part 1|LDL < 50 mg/dL|1
466268|NCT00271817|1528514|P3|Part 1|Withdrawal by Subject|45
466269|NCT00271817|1528515|P2|Part 1|Withdrawal by Subject|17
466270|NCT00271817|1528516|P1|Part 1|Withdrawal by Subject|23
466271|NCT00271817|1528514|P3|Part 1|Patient Moved|5
466272|NCT00271817|1528515|P2|Part 1|Patient Moved|1
466273|NCT00271817|1528516|P1|Part 1|Patient Moved|3
466274|NCT00271817|1528514|P3|Part 1|Protocol Violation|7
466275|NCT00271817|1528515|P2|Part 1|Protocol Violation|4
466276|NCT00271817|1528516|P1|Part 1|Protocol Violation|5
466277|NCT00271817|1528514|P3|Part 1|Lost to Follow-up|24
466278|NCT00271817|1528515|P2|Part 1|Lost to Follow-up|8
466279|NCT00271817|1528516|P1|Part 1|Lost to Follow-up|6
466280|NCT00271817|1528514|P3|Part 1|Adverse Event|156
466281|NCT00271817|1528515|P2|Part 1|Adverse Event|25
466282|NCT00271817|1528516|P1|Part 1|Adverse Event|68
466283|NCT00271609|1528558|P2|Overall Study|Withdrawal by Subject|0
466284|NCT00271609|1528559|P1|Overall Study|Withdrawal by Subject|2
466285|NCT00271609|1528558|P2|Overall Study|Adverse Event|3
466286|NCT00271609|1528559|P1|Overall Study|Adverse Event|11
466287|NCT00271596|1528569|P2|Overall Study|Withdrawal by Subject|1
466288|NCT00271596|1528570|P1|Overall Study|Withdrawal by Subject|0
466289|NCT00271596|1528569|P2|Overall Study|Protocol Violation|0
466290|NCT00271596|1528570|P1|Overall Study|Protocol Violation|1
466291|NCT00271544|1528605|P1|Overall Study|Implant not attempted|4
466292|NCT00271544|1528605|P1|Overall Study|Model 4196 lead not attempted|9
466293|NCT00271544|1528605|P1|Overall Study|Subjects did not receive a 4196 lead|7
466294|NCT00271024|1528710|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
466295|NCT00271024|1528711|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
466296|NCT00271024|1528712|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
466297|NCT00271024|1528713|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
466298|NCT00271024|1528710|P4|Overall Study|Unpleasant Reaction To Tablet|2
466299|NCT00271024|1528711|P3|Overall Study|Unpleasant Reaction To Tablet|4
466300|NCT00271024|1528712|P2|Overall Study|Unpleasant Reaction To Tablet|3
466301|NCT00271024|1528713|P1|Overall Study|Unpleasant Reaction To Tablet|1
466302|NCT00271024|1528710|P4|Overall Study|Protocol Violation|11
466303|NCT00271024|1528711|P3|Overall Study|Protocol Violation|5
466304|NCT00271024|1528712|P2|Overall Study|Protocol Violation|6
466305|NCT00271024|1528713|P1|Overall Study|Protocol Violation|1
466306|NCT00271024|1528710|P4|Overall Study|Unknown/Unspecified|4
466307|NCT00271024|1528711|P3|Overall Study|Unknown/Unspecified|8
466308|NCT00271024|1528712|P2|Overall Study|Unknown/Unspecified|11
466309|NCT00271024|1528713|P1|Overall Study|Unknown/Unspecified|11
466310|NCT00271024|1528710|P4|Overall Study|Lost Interest|3
466311|NCT00271024|1528711|P3|Overall Study|Lost Interest|2
466312|NCT00271024|1528712|P2|Overall Study|Lost Interest|4
466313|NCT00271024|1528713|P1|Overall Study|Lost Interest|3
466314|NCT00270998|1528763|P3|12 Month Follow-up|Received/desired alternate treatment|1
466315|NCT00270998|1528764|P2|12 Month Follow-up|Received/desired alternate treatment|4
466316|NCT00270998|1528765|P1|12 Month Follow-up|Received/desired alternate treatment|1
466317|NCT00270998|1528763|P3|12 Month Follow-up|Personal/family health|1
466318|NCT00270998|1528764|P2|12 Month Follow-up|Personal/family health|5
466319|NCT00270998|1528765|P1|12 Month Follow-up|Personal/family health|0
466320|NCT00270998|1528763|P3|12 Month Follow-up|Pessary did not fit|0
466321|NCT00270998|1528764|P2|12 Month Follow-up|Pessary did not fit|0
466322|NCT00270998|1528765|P1|12 Month Follow-up|Pessary did not fit|1
466323|NCT00270998|1528763|P3|12 Month Follow-up|Withdrawal by Subject|16
466324|NCT00270998|1528764|P2|12 Month Follow-up|Withdrawal by Subject|12
466325|NCT00270998|1528765|P1|12 Month Follow-up|Withdrawal by Subject|7
466326|NCT00270998|1528763|P3|12 Month Follow-up|Lack of Efficacy|3
466327|NCT00270998|1528764|P2|12 Month Follow-up|Lack of Efficacy|4
466328|NCT00270998|1528765|P1|12 Month Follow-up|Lack of Efficacy|5
466329|NCT00270998|1528763|P3|3 Month Follow-up|Received/desired alternate treatment|2
466330|NCT00270998|1528764|P2|3 Month Follow-up|Received/desired alternate treatment|5
466331|NCT00270998|1528765|P1|3 Month Follow-up|Received/desired alternate treatment|13
466332|NCT00270998|1528763|P3|3 Month Follow-up|Personal/family health|0
466333|NCT00270998|1528764|P2|3 Month Follow-up|Personal/family health|1
466334|NCT00270998|1528765|P1|3 Month Follow-up|Personal/family health|1
466335|NCT00270998|1528763|P3|3 Month Follow-up|Pessary did not fit|0
466336|NCT00270998|1528764|P2|3 Month Follow-up|Pessary did not fit|0
466337|NCT00270998|1528765|P1|3 Month Follow-up|Pessary did not fit|12
466338|NCT00270998|1528763|P3|3 Month Follow-up|Withdrawal by Subject|15
466339|NCT00270998|1528764|P2|3 Month Follow-up|Withdrawal by Subject|14
466340|NCT00270998|1528765|P1|3 Month Follow-up|Withdrawal by Subject|11
466341|NCT00270998|1528763|P3|3 Month Follow-up|Lack of Efficacy|1
466342|NCT00270998|1528764|P2|3 Month Follow-up|Lack of Efficacy|2
466343|NCT00270998|1528765|P1|3 Month Follow-up|Lack of Efficacy|1
466344|NCT00270998|1528763|P3|3 Month Follow-up|Adverse Event|0
466345|NCT00270998|1528764|P2|3 Month Follow-up|Adverse Event|0
466346|NCT00270998|1528765|P1|3 Month Follow-up|Adverse Event|1
466347|NCT00270894|1528794|P1|Overall Study|Withdrawal by Subject|1
466348|NCT00270894|1528794|P1|Overall Study|Adverse Event|1
466349|NCT00270855|1528806|P2|Overall Study|Withdrawal by Subject|8
466350|NCT00270855|1528807|P1|Overall Study|Withdrawal by Subject|8
466351|NCT00270257|1528943|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
466352|NCT00270257|1528944|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
466353|NCT00270231|1528962|P2|Second Intervention|Lost to Follow-up|1
466354|NCT00270231|1528963|P1|Second Intervention|Lost to Follow-up|0
466355|NCT00270231|1528962|P2|Washout Period|Lost to Follow-up|0
466356|NCT00270231|1528963|P1|Washout Period|Lost to Follow-up|1
466357|NCT00270231|1528962|P2|First Intervention|Lost to Follow-up|1
466358|NCT00270231|1528963|P1|First Intervention|Lost to Follow-up|1
466359|NCT00270205|1528973|P4|Overall Study|Lost to Follow-up|1
466360|NCT00270205|1528974|P3|Overall Study|Lost to Follow-up|0
466361|NCT00270205|1528975|P2|Overall Study|Lost to Follow-up|0
466362|NCT00270205|1528976|P1|Overall Study|Lost to Follow-up|1
466363|NCT00269919|1529094|P1|Overall Study|Started but not treated|1
466364|NCT00269919|1529094|P1|Overall Study|Other|26
466365|NCT00269633|1529113|P2|Overall Study|Withdrawal by Subject|0
466366|NCT00269633|1529114|P1|Overall Study|Withdrawal by Subject|1
466367|NCT00269477|1529124|P4|Overall Study|Missed post-vaccination blood draw|0
466368|NCT00269477|1529125|P3|Overall Study|Missed post-vaccination blood draw|0
466369|NCT00269477|1529126|P2|Overall Study|Missed post-vaccination blood draw|1
466370|NCT00269477|1529127|P1|Overall Study|Missed post-vaccination blood draw|0
466371|NCT00269477|1529124|P4|Overall Study|Protocol Violation|0
466372|NCT00269477|1529125|P3|Overall Study|Protocol Violation|1
466373|NCT00269477|1529126|P2|Overall Study|Protocol Violation|5
466374|NCT00269477|1529127|P1|Overall Study|Protocol Violation|5
466375|NCT00269152|1529143|P2|Overall Study|Protocol Violation|1
466376|NCT00269152|1529144|P1|Overall Study|Protocol Violation|0
466377|NCT00269152|1529143|P2|Overall Study|Physician Decision|3
466378|NCT00269152|1529144|P1|Overall Study|Physician Decision|2
466379|NCT00269152|1529143|P2|Overall Study|Withdrawal by Subject|3
466380|NCT00269152|1529144|P1|Overall Study|Withdrawal by Subject|7
466381|NCT00269152|1529143|P2|Overall Study|Adverse Event|3
466382|NCT00269152|1529144|P1|Overall Study|Adverse Event|9
466383|NCT00269113|1529160|P2|Overall Study|Not specified|2
466384|NCT00269113|1529161|P1|Overall Study|Not specified|0
466385|NCT00269113|1529160|P2|Overall Study|Protocol Violation|5
466386|NCT00269113|1529161|P1|Overall Study|Protocol Violation|15
466387|NCT00269113|1529160|P2|Overall Study|Lost to Follow-up|1
466388|NCT00269113|1529161|P1|Overall Study|Lost to Follow-up|2
466389|NCT00269113|1529160|P2|Overall Study|Death|2
466390|NCT00269113|1529161|P1|Overall Study|Death|6
466391|NCT00269113|1529160|P2|Overall Study|Withdrawal by Subject|2
466392|NCT00269113|1529161|P1|Overall Study|Withdrawal by Subject|0
466393|NCT00269113|1529160|P2|Overall Study|Early Improvement|0
466394|NCT00269113|1529161|P1|Overall Study|Early Improvement|2
466395|NCT00269113|1529160|P2|Overall Study|Lack of Efficacy|18
466396|NCT00269113|1529161|P1|Overall Study|Lack of Efficacy|35
466397|NCT00269113|1529160|P2|Overall Study|Adverse Event|7
466398|NCT00269113|1529161|P1|Overall Study|Adverse Event|14
466399|NCT00268996|1529181|P2|Overall Study|Other|1
466400|NCT00268996|1529182|P1|Overall Study|Other|1
466401|NCT00268996|1529181|P2|Overall Study|Non-compliance|0
466402|NCT00268996|1529182|P1|Overall Study|Non-compliance|1
466403|NCT00268996|1529181|P2|Overall Study|Withdrawal by Subject|11
466404|NCT00268996|1529182|P1|Overall Study|Withdrawal by Subject|5
466405|NCT00268996|1529181|P2|Overall Study|Lost to Follow-up|1
466406|NCT00268996|1529182|P1|Overall Study|Lost to Follow-up|3
466407|NCT00268996|1529181|P2|Overall Study|Adverse Event|7
466408|NCT00268996|1529182|P1|Overall Study|Adverse Event|11
466409|NCT00268983|1529226|P2|Overall Study|Death|0
466410|NCT00268983|1529227|P1|Overall Study|Death|3
466411|NCT00268905|1529270|P3|Overall Study|Clinical Progression|1
466412|NCT00268905|1529271|P2|Overall Study|Clinical Progression|4
466413|NCT00268905|1529272|P1|Overall Study|Clinical Progression|9
466414|NCT00268905|1529270|P3|Overall Study|Physician Decision|1
466415|NCT00268905|1529271|P2|Overall Study|Physician Decision|0
466416|NCT00268905|1529272|P1|Overall Study|Physician Decision|3
466417|NCT00268905|1529270|P3|Overall Study|Progressive Disease|3
466418|NCT00268905|1529271|P2|Overall Study|Progressive Disease|4
466419|NCT00268905|1529272|P1|Overall Study|Progressive Disease|28
466420|NCT00268905|1529270|P3|Overall Study|Withdrawal by Subject|3
466421|NCT00268905|1529271|P2|Overall Study|Withdrawal by Subject|0
466422|NCT00268905|1529272|P1|Overall Study|Withdrawal by Subject|0
466423|NCT00268905|1529270|P3|Overall Study|Lost to Follow-up|0
466424|NCT00268905|1529271|P2|Overall Study|Lost to Follow-up|1
466425|NCT00268905|1529272|P1|Overall Study|Lost to Follow-up|0
466426|NCT00268905|1529270|P3|Overall Study|Adverse Event|4
466427|NCT00268905|1529271|P2|Overall Study|Adverse Event|0
466428|NCT00268905|1529272|P1|Overall Study|Adverse Event|3
466429|NCT00268892|1529289|P3|Overall Study|Trial Site Closed|2
466430|NCT00268892|1529290|P2|Overall Study|Trial Site Closed|2
466431|NCT00268892|1529291|P1|Overall Study|Trial Site Closed|4
466432|NCT00268892|1529289|P3|Overall Study|Disease Progression|0
466433|NCT00268892|1529290|P2|Overall Study|Disease Progression|1
466434|NCT00268892|1529291|P1|Overall Study|Disease Progression|1
466435|NCT00268892|1529289|P3|Overall Study|Protocol Violation|0
466436|NCT00268892|1529290|P2|Overall Study|Protocol Violation|1
466437|NCT00268892|1529291|P1|Overall Study|Protocol Violation|0
466438|NCT00268892|1529289|P3|Overall Study|Lost to Follow-up|4
466439|NCT00268892|1529290|P2|Overall Study|Lost to Follow-up|2
466440|NCT00268892|1529291|P1|Overall Study|Lost to Follow-up|5
466441|NCT00268892|1529289|P3|Overall Study|Physician Decision|0
466442|NCT00268892|1529290|P2|Overall Study|Physician Decision|1
466443|NCT00268892|1529291|P1|Overall Study|Physician Decision|0
466444|NCT00268892|1529289|P3|Overall Study|Withdrawal by Subject|13
466445|NCT00268892|1529290|P2|Overall Study|Withdrawal by Subject|15
466446|NCT00268892|1529291|P1|Overall Study|Withdrawal by Subject|14
466447|NCT00268892|1529289|P3|Overall Study|Lack of Efficacy|0
466448|NCT00268892|1529290|P2|Overall Study|Lack of Efficacy|3
466449|NCT00268892|1529291|P1|Overall Study|Lack of Efficacy|1
466450|NCT00268892|1529289|P3|Overall Study|Adverse Event|20
466451|NCT00268892|1529290|P2|Overall Study|Adverse Event|17
466452|NCT00268892|1529291|P1|Overall Study|Adverse Event|14
466453|NCT00268463|1529310|P2|Overall Study|study terminated due to low accrual|12
466454|NCT00268463|1529311|P1|Overall Study|study terminated due to low accrual|10
466455|NCT00268437|1529317|P1|Overall Study|Ineligible|1
466456|NCT00268346|1529324|P2|Overall Study|Withdrawal by Subject|1
466457|NCT00268346|1529325|P1|Overall Study|Withdrawal by Subject|0
466458|NCT00268346|1529324|P2|Overall Study|Death|1
466459|NCT00268346|1529325|P1|Overall Study|Death|0
466460|NCT00268346|1529324|P2|Overall Study|Adverse Event|1
466461|NCT00268346|1529325|P1|Overall Study|Adverse Event|0
466462|NCT00268242|1529331|P1|Overall Study|Death|1
466463|NCT00268203|1529340|P1|Overall Study|Completed 2 Years of Follow-up|62
466464|NCT00268203|1529340|P1|Overall Study|Reason Not Specified|34
466465|NCT00268203|1529340|P1|Overall Study|Death|84
466466|NCT00268203|1529340|P1|Overall Study|Progressive Disease|359
466467|NCT00268203|1529340|P1|Overall Study|Received Other NHL Therapy|7
466468|NCT00268203|1529340|P1|Overall Study|Withdrawal by Subject|9
466469|NCT00268203|1529340|P1|Overall Study|Lost to Follow-up|92
466470|NCT00267969|1529354|P7|After Controlled Period|Not specified|25
466471|NCT00267969|1529355|P6|After Controlled Period|Not specified|22
466472|NCT00267969|1529356|P5|After Controlled Period|Not specified|11
466473|NCT00267969|1529357|P4|After Controlled Period|Not specified|13
466474|NCT00267969|1529358|P3|After Controlled Period|Not specified|0
466475|NCT00267969|1529359|P2|After Controlled Period|Not specified|0
466476|NCT00267969|1529360|P1|After Controlled Period|Not specified|0
466477|NCT00267969|1529354|P7|After Controlled Period|Lost to Follow-up|10
466478|NCT00267969|1529355|P6|After Controlled Period|Lost to Follow-up|9
466479|NCT00267969|1529356|P5|After Controlled Period|Lost to Follow-up|8
466480|NCT00267969|1529357|P4|After Controlled Period|Lost to Follow-up|5
466481|NCT00267969|1529358|P3|After Controlled Period|Lost to Follow-up|0
466482|NCT00267969|1529359|P2|After Controlled Period|Lost to Follow-up|0
466483|NCT00267969|1529360|P1|After Controlled Period|Lost to Follow-up|0
466484|NCT00267969|1529354|P7|After Controlled Period|Lack of Efficacy|15
466485|NCT00267969|1529355|P6|After Controlled Period|Lack of Efficacy|28
466486|NCT00267969|1529356|P5|After Controlled Period|Lack of Efficacy|6
466487|NCT00267969|1529357|P4|After Controlled Period|Lack of Efficacy|10
466488|NCT00267969|1529358|P3|After Controlled Period|Lack of Efficacy|0
466489|NCT00267969|1529359|P2|After Controlled Period|Lack of Efficacy|0
466490|NCT00267969|1529360|P1|After Controlled Period|Lack of Efficacy|0
466491|NCT00267969|1529354|P7|After Controlled Period|Death|1
466492|NCT00267969|1529355|P6|After Controlled Period|Death|0
466493|NCT00267969|1529356|P5|After Controlled Period|Death|2
466494|NCT00267969|1529357|P4|After Controlled Period|Death|1
466495|NCT00267969|1529358|P3|After Controlled Period|Death|0
466496|NCT00267969|1529359|P2|After Controlled Period|Death|0
466497|NCT00267969|1529360|P1|After Controlled Period|Death|0
466498|NCT00267969|1529354|P7|After Controlled Period|Adverse Event|21
466499|NCT00267969|1529355|P6|After Controlled Period|Adverse Event|23
466500|NCT00267969|1529356|P5|After Controlled Period|Adverse Event|8
466501|NCT00267969|1529357|P4|After Controlled Period|Adverse Event|7
466502|NCT00267969|1529358|P3|After Controlled Period|Adverse Event|0
466503|NCT00267969|1529359|P2|After Controlled Period|Adverse Event|0
466504|NCT00267969|1529360|P1|After Controlled Period|Adverse Event|0
466505|NCT00267969|1529354|P7|Controlled Period|Not specified|0
466506|NCT00267969|1529355|P6|Controlled Period|Not specified|0
466507|NCT00267969|1529356|P5|Controlled Period|Not specified|0
466508|NCT00267969|1529357|P4|Controlled Period|Not specified|0
466509|NCT00267969|1529358|P3|Controlled Period|Not specified|6
466510|NCT00267969|1529359|P2|Controlled Period|Not specified|1
466511|NCT00267969|1529360|P1|Controlled Period|Not specified|2
466512|NCT00267969|1529354|P7|Controlled Period|Randomized but not treated|0
466513|NCT00267969|1529355|P6|Controlled Period|Randomized but not treated|0
466514|NCT00267969|1529356|P5|Controlled Period|Randomized but not treated|0
466515|NCT00267969|1529357|P4|Controlled Period|Randomized but not treated|0
466516|NCT00267969|1529358|P3|Controlled Period|Randomized but not treated|1
466517|NCT00267969|1529359|P2|Controlled Period|Randomized but not treated|0
466518|NCT00267969|1529360|P1|Controlled Period|Randomized but not treated|0
466519|NCT00267969|1529354|P7|Controlled Period|Lost to Follow-up|0
466520|NCT00267969|1529355|P6|Controlled Period|Lost to Follow-up|0
466521|NCT00267969|1529356|P5|Controlled Period|Lost to Follow-up|0
466522|NCT00267969|1529357|P4|Controlled Period|Lost to Follow-up|0
466523|NCT00267969|1529358|P3|Controlled Period|Lost to Follow-up|1
466524|NCT00267969|1529359|P2|Controlled Period|Lost to Follow-up|0
466525|NCT00267969|1529360|P1|Controlled Period|Lost to Follow-up|1
466526|NCT00267969|1529354|P7|Controlled Period|Lack of Efficacy|0
466527|NCT00267969|1529355|P6|Controlled Period|Lack of Efficacy|0
466528|NCT00267969|1529356|P5|Controlled Period|Lack of Efficacy|0
466529|NCT00267969|1529357|P4|Controlled Period|Lack of Efficacy|0
466530|NCT00267969|1529358|P3|Controlled Period|Lack of Efficacy|1
466531|NCT00267969|1529359|P2|Controlled Period|Lack of Efficacy|0
466532|NCT00267969|1529360|P1|Controlled Period|Lack of Efficacy|3
466533|NCT00267969|1529354|P7|Controlled Period|Adverse Event|0
466534|NCT00267969|1529355|P6|Controlled Period|Adverse Event|0
466535|NCT00267969|1529356|P5|Controlled Period|Adverse Event|0
466536|NCT00267969|1529357|P4|Controlled Period|Adverse Event|0
466537|NCT00267969|1529358|P3|Controlled Period|Adverse Event|2
466538|NCT00267969|1529359|P2|Controlled Period|Adverse Event|0
466539|NCT00267969|1529360|P1|Controlled Period|Adverse Event|6
466540|NCT00267956|1529386|P4|After Controlled Period|Withdrew consent|0
466541|NCT00267956|1529387|P3|After Controlled Period|Withdrew consent|1
466542|NCT00267956|1529388|P2|After Controlled Period|Withdrew consent|0
466543|NCT00267956|1529389|P1|After Controlled Period|Withdrew consent|0
466544|NCT00267956|1529386|P4|After Controlled Period|Lost to Follow-up|0
466545|NCT00267956|1529387|P3|After Controlled Period|Lost to Follow-up|1
466546|NCT00267956|1529388|P2|After Controlled Period|Lost to Follow-up|0
466547|NCT00267956|1529389|P1|After Controlled Period|Lost to Follow-up|0
466548|NCT00267956|1529386|P4|After Controlled Period|Lack of Efficacy|1
466549|NCT00267956|1529387|P3|After Controlled Period|Lack of Efficacy|1
466550|NCT00267956|1529388|P2|After Controlled Period|Lack of Efficacy|0
466551|NCT00267956|1529389|P1|After Controlled Period|Lack of Efficacy|0
466552|NCT00267956|1529386|P4|After Controlled Period|Adverse Event|1
466553|NCT00267956|1529387|P3|After Controlled Period|Adverse Event|2
466554|NCT00267956|1529388|P2|After Controlled Period|Adverse Event|0
466555|NCT00267956|1529389|P1|After Controlled Period|Adverse Event|0
466556|NCT00267956|1529386|P4|Controlled Period|Withdrew consent|0
466557|NCT00267956|1529387|P3|Controlled Period|Withdrew consent|0
466558|NCT00267956|1529388|P2|Controlled Period|Withdrew consent|1
466559|NCT00267956|1529389|P1|Controlled Period|Withdrew consent|3
466560|NCT00267956|1529386|P4|Controlled Period|Lost to Follow-up|0
466561|NCT00267956|1529387|P3|Controlled Period|Lost to Follow-up|0
466562|NCT00267956|1529388|P2|Controlled Period|Lost to Follow-up|0
466563|NCT00267956|1529389|P1|Controlled Period|Lost to Follow-up|2
466564|NCT00267956|1529386|P4|Controlled Period|Lack of Efficacy|0
466565|NCT00267956|1529387|P3|Controlled Period|Lack of Efficacy|0
466566|NCT00267956|1529388|P2|Controlled Period|Lack of Efficacy|2
466567|NCT00267956|1529389|P1|Controlled Period|Lack of Efficacy|4
466568|NCT00267956|1529386|P4|Controlled Period|Adverse Event|0
466569|NCT00267956|1529387|P3|Controlled Period|Adverse Event|0
466570|NCT00267956|1529388|P2|Controlled Period|Adverse Event|1
466571|NCT00267956|1529389|P1|Controlled Period|Adverse Event|4
466572|NCT00267748|1529421|P3|Randomized Period|randomized but not treated|3
466573|NCT00267748|1529422|P2|Randomized Period|randomized but not treated|0
466574|NCT00267748|1529423|P1|Randomized Period|randomized but not treated|0
466575|NCT00267748|1529421|P3|Randomized Period|Other|6
466576|NCT00267748|1529422|P2|Randomized Period|Other|9
466577|NCT00267748|1529423|P1|Randomized Period|Other|0
466578|NCT00267748|1529421|P3|Randomized Period|Withdrawal by Subject|2
466579|NCT00267748|1529422|P2|Randomized Period|Withdrawal by Subject|9
466580|NCT00267748|1529423|P1|Randomized Period|Withdrawal by Subject|0
466581|NCT00267748|1529421|P3|Randomized Period|Objective progression or relapse|86
466582|NCT00267748|1529422|P2|Randomized Period|Objective progression or relapse|77
466583|NCT00267748|1529423|P1|Randomized Period|Objective progression or relapse|0
466584|NCT00267748|1529421|P3|Randomized Period|Lost to Follow-up|0
466585|NCT00267748|1529422|P2|Randomized Period|Lost to Follow-up|1
466586|NCT00267748|1529423|P1|Randomized Period|Lost to Follow-up|0
466587|NCT00267748|1529421|P3|Randomized Period|Global deterioration of health status|7
466588|NCT00267748|1529422|P2|Randomized Period|Global deterioration of health status|6
466589|NCT00267748|1529423|P1|Randomized Period|Global deterioration of health status|0
466590|NCT00267748|1529421|P3|Randomized Period|Adverse Event|25
466591|NCT00267748|1529422|P2|Randomized Period|Adverse Event|23
466592|NCT00267748|1529423|P1|Randomized Period|Adverse Event|0
466593|NCT00267748|1529421|P3|Randomized Period|Death|3
466594|NCT00267748|1529422|P2|Randomized Period|Death|2
466595|NCT00267748|1529423|P1|Randomized Period|Death|0
466596|NCT00267748|1529421|P3|Non-randomized Period|Other|0
466597|NCT00267748|1529422|P2|Non-randomized Period|Other|0
466598|NCT00267748|1529423|P1|Non-randomized Period|Other|3
466599|NCT00267748|1529421|P3|Non-randomized Period|Participant not willing to participate|0
466600|NCT00267748|1529422|P2|Non-randomized Period|Participant not willing to participate|0
466601|NCT00267748|1529423|P1|Non-randomized Period|Participant not willing to participate|1
466602|NCT00267748|1529421|P3|Non-randomized Period|Death|0
466603|NCT00267748|1529422|P2|Non-randomized Period|Death|0
466604|NCT00267748|1529423|P1|Non-randomized Period|Death|1
466605|NCT00267748|1529421|P3|Non-randomized Period|Adverse Event|0
466606|NCT00267748|1529422|P2|Non-randomized Period|Adverse Event|0
466607|NCT00267748|1529423|P1|Non-randomized Period|Adverse Event|8
466608|NCT00267748|1529421|P3|Non-randomized Period|Progressive disease|0
466609|NCT00267748|1529422|P2|Non-randomized Period|Progressive disease|0
466610|NCT00267748|1529423|P1|Non-randomized Period|Progressive disease|10
466611|NCT00267488|1529480|P1|Overall Study|Other (Disease Progression)|1
466612|NCT00267488|1529480|P1|Overall Study|Protocol Violation|1
466613|NCT00267488|1529480|P1|Overall Study|Sponsor Terminated Study|9
466614|NCT00267202|1529504|P2|Overall Study|Lost to Follow-up|0
466615|NCT00267202|1529505|P1|Overall Study|Lost to Follow-up|3
466616|NCT00267202|1529504|P2|Overall Study|Administrative problems|1
466617|NCT00267202|1529505|P1|Overall Study|Administrative problems|2
466618|NCT00267202|1529504|P2|Overall Study|Protocol Violation|3
466619|NCT00267202|1529505|P1|Overall Study|Protocol Violation|2
466620|NCT00267202|1529504|P2|Overall Study|Adverse Event|7
466621|NCT00267202|1529505|P1|Overall Study|Adverse Event|13
466622|NCT00267202|1529504|P2|Overall Study|Withdrawal by Subject|15
466623|NCT00267202|1529505|P1|Overall Study|Withdrawal by Subject|12
466624|NCT00267202|1529504|P2|Overall Study|Unsatisfactory therapeutic effect|8
466625|NCT00267202|1529505|P1|Overall Study|Unsatisfactory therapeutic effect|21
466626|NCT00267189|1529526|P2|Overall Study|Missing|0
466627|NCT00267189|1529527|P1|Overall Study|Missing|3
466628|NCT00267189|1529526|P2|Overall Study|Death|0
466629|NCT00267189|1529527|P1|Overall Study|Death|1
466630|NCT00267189|1529526|P2|Overall Study|Patient withdrew consent|1
466631|NCT00267189|1529527|P1|Overall Study|Patient withdrew consent|1
466632|NCT00267150|1529537|P1|Overall Study|Adverse Event|1
466633|NCT00267098|1529561|P8|Overall Study|Sponsor withdrew subject|0
466634|NCT00267098|1529562|P7|Overall Study|Sponsor withdrew subject|0
466635|NCT00267098|1529563|P6|Overall Study|Sponsor withdrew subject|0
466636|NCT00267098|1529564|P5|Overall Study|Sponsor withdrew subject|0
466637|NCT00267098|1529565|P4|Overall Study|Sponsor withdrew subject|1
466638|NCT00267098|1529566|P3|Overall Study|Sponsor withdrew subject|0
466639|NCT00267098|1529567|P2|Overall Study|Sponsor withdrew subject|0
466640|NCT00267098|1529568|P1|Overall Study|Sponsor withdrew subject|0
466641|NCT00267098|1529561|P8|Overall Study|Subject listed for heart transplant|0
466642|NCT00267098|1529562|P7|Overall Study|Subject listed for heart transplant|1
466643|NCT00267098|1529563|P6|Overall Study|Subject listed for heart transplant|0
466644|NCT00267098|1529564|P5|Overall Study|Subject listed for heart transplant|0
466645|NCT00267098|1529565|P4|Overall Study|Subject listed for heart transplant|0
466646|NCT00267098|1529566|P3|Overall Study|Subject listed for heart transplant|0
466647|NCT00267098|1529567|P2|Overall Study|Subject listed for heart transplant|0
466648|NCT00267098|1529568|P1|Overall Study|Subject listed for heart transplant|0
466649|NCT00267098|1529561|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
466650|NCT00267098|1529562|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
466651|NCT00267098|1529563|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
466652|NCT00267098|1529564|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
466653|NCT00267098|1529565|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
466654|NCT00267098|1529566|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
466655|NCT00267098|1529567|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
466656|NCT00267098|1529568|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
466657|NCT00267098|1529561|P8|Overall Study|Explanted Medtronic device|0
466658|NCT00267098|1529562|P7|Overall Study|Explanted Medtronic device|0
466659|NCT00267098|1529563|P6|Overall Study|Explanted Medtronic device|0
466660|NCT00267098|1529564|P5|Overall Study|Explanted Medtronic device|0
466661|NCT00267098|1529565|P4|Overall Study|Explanted Medtronic device|1
466662|NCT00267098|1529566|P3|Overall Study|Explanted Medtronic device|0
466663|NCT00267098|1529567|P2|Overall Study|Explanted Medtronic device|0
466664|NCT00267098|1529568|P1|Overall Study|Explanted Medtronic device|0
466665|NCT00267098|1529561|P8|Overall Study|Site closure|0
466666|NCT00267098|1529562|P7|Overall Study|Site closure|1
466667|NCT00267098|1529563|P6|Overall Study|Site closure|1
466668|NCT00267098|1529564|P5|Overall Study|Site closure|0
466669|NCT00267098|1529565|P4|Overall Study|Site closure|1
466670|NCT00267098|1529566|P3|Overall Study|Site closure|0
466671|NCT00267098|1529567|P2|Overall Study|Site closure|0
466672|NCT00267098|1529568|P1|Overall Study|Site closure|0
466673|NCT00267098|1529561|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
466674|NCT00267098|1529562|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
466675|NCT00267098|1529563|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
466676|NCT00267098|1529564|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
466677|NCT00267098|1529565|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
466678|NCT00267098|1529566|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
466679|NCT00267098|1529567|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
466680|NCT00267098|1529568|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
466681|NCT00267098|1529561|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
466682|NCT00267098|1529562|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
466683|NCT00267098|1529563|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
466684|NCT00267098|1529564|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
466685|NCT00267098|1529565|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
466686|NCT00267098|1529566|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
466687|NCT00267098|1529567|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
466688|NCT00267098|1529568|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
466689|NCT00267098|1529561|P8|Overall Study|Physician Decision|0
466690|NCT00267098|1529562|P7|Overall Study|Physician Decision|3
466691|NCT00267098|1529563|P6|Overall Study|Physician Decision|4
466692|NCT00267098|1529564|P5|Overall Study|Physician Decision|5
466693|NCT00267098|1529565|P4|Overall Study|Physician Decision|11
466694|NCT00267098|1529566|P3|Overall Study|Physician Decision|7
466695|NCT00267098|1529567|P2|Overall Study|Physician Decision|0
466696|NCT00267098|1529568|P1|Overall Study|Physician Decision|5
466697|NCT00267098|1529561|P8|Overall Study|Withdrawal by Subject|5
466698|NCT00267098|1529562|P7|Overall Study|Withdrawal by Subject|12
466699|NCT00267098|1529563|P6|Overall Study|Withdrawal by Subject|9
466700|NCT00267098|1529564|P5|Overall Study|Withdrawal by Subject|12
466701|NCT00267098|1529565|P4|Overall Study|Withdrawal by Subject|21
466702|NCT00267098|1529566|P3|Overall Study|Withdrawal by Subject|24
466703|NCT00267098|1529567|P2|Overall Study|Withdrawal by Subject|0
466704|NCT00267098|1529568|P1|Overall Study|Withdrawal by Subject|8
466705|NCT00267098|1529561|P8|Overall Study|Lost to Follow-up|1
466706|NCT00267098|1529562|P7|Overall Study|Lost to Follow-up|1
466707|NCT00267098|1529563|P6|Overall Study|Lost to Follow-up|3
466708|NCT00267098|1529564|P5|Overall Study|Lost to Follow-up|2
466709|NCT00267098|1529565|P4|Overall Study|Lost to Follow-up|5
466710|NCT00267098|1529566|P3|Overall Study|Lost to Follow-up|6
466711|NCT00267098|1529567|P2|Overall Study|Lost to Follow-up|0
466712|NCT00267098|1529568|P1|Overall Study|Lost to Follow-up|0
466713|NCT00267098|1529561|P8|Overall Study|Death|9
466714|NCT00267098|1529562|P7|Overall Study|Death|28
466715|NCT00267098|1529563|P6|Overall Study|Death|23
466716|NCT00267098|1529564|P5|Overall Study|Death|14
466717|NCT00267098|1529565|P4|Overall Study|Death|66
466718|NCT00267098|1529566|P3|Overall Study|Death|57
466719|NCT00267098|1529567|P2|Overall Study|Death|0
466720|NCT00267098|1529568|P1|Overall Study|Death|0
466721|NCT00267046|1529711|P2|Overall Study|Radiation|1
466722|NCT00267046|1529712|P1|Overall Study|Radiation|0
466723|NCT00267046|1529711|P2|Overall Study|Withdrawal by Subject|0
466724|NCT00267046|1529712|P1|Overall Study|Withdrawal by Subject|1
466725|NCT00267046|1529711|P2|Overall Study|Surgery|1
466726|NCT00267046|1529712|P1|Overall Study|Surgery|3
466727|NCT00267046|1529711|P2|Overall Study|Open-label palifermin|7
466728|NCT00267046|1529712|P1|Overall Study|Open-label palifermin|2
466729|NCT00267046|1529711|P2|Overall Study|Chemotoxicity|0
466730|NCT00267046|1529712|P1|Overall Study|Chemotoxicity|2
466731|NCT00267046|1529711|P2|Overall Study|Disease progression|2
466732|NCT00267046|1529712|P1|Overall Study|Disease progression|4
466733|NCT00267007|1529722|P2|Overall Study|Adverse Event|0
466734|NCT00267007|1529723|P1|Overall Study|Adverse Event|1
466735|NCT00267007|1529722|P2|Overall Study|Non-compliance|1
466736|NCT00267007|1529723|P1|Overall Study|Non-compliance|0
466737|NCT00267007|1529722|P2|Overall Study|Lost to Follow-up|0
466738|NCT00267007|1529723|P1|Overall Study|Lost to Follow-up|1
466739|NCT00267007|1529722|P2|Overall Study|Withdrawal by Subject|0
466740|NCT00267007|1529723|P1|Overall Study|Withdrawal by Subject|6
466741|NCT00266877|1529734|P3|Overall Study|Concomitant Radiotherapy|0
466742|NCT00266877|1529735|P2|Overall Study|Concomitant Radiotherapy|1
466743|NCT00266877|1529736|P1|Overall Study|Concomitant Radiotherapy|0
466744|NCT00266877|1529734|P3|Overall Study|Hospitalization|0
466745|NCT00266877|1529735|P2|Overall Study|Hospitalization|0
466746|NCT00266877|1529736|P1|Overall Study|Hospitalization|1
466747|NCT00266877|1529734|P3|Overall Study|Symptomatic Deterioration|1
466748|NCT00266877|1529735|P2|Overall Study|Symptomatic Deterioration|3
466749|NCT00266877|1529736|P1|Overall Study|Symptomatic Deterioration|6
466750|NCT00266877|1529734|P3|Overall Study|Disease Progression|23
466751|NCT00266877|1529735|P2|Overall Study|Disease Progression|37
466752|NCT00266877|1529736|P1|Overall Study|Disease Progression|72
466753|NCT00266877|1529734|P3|Overall Study|Withdrawal by Subject|1
466754|NCT00266877|1529735|P2|Overall Study|Withdrawal by Subject|1
466755|NCT00266877|1529736|P1|Overall Study|Withdrawal by Subject|3
466756|NCT00266877|1529734|P3|Overall Study|Physician Decision|1
466757|NCT00266877|1529735|P2|Overall Study|Physician Decision|1
466758|NCT00266877|1529736|P1|Overall Study|Physician Decision|2
466759|NCT00266877|1529734|P3|Overall Study|Adverse Event|1
466760|NCT00266877|1529735|P2|Overall Study|Adverse Event|4
466761|NCT00266877|1529736|P1|Overall Study|Adverse Event|6
466762|NCT00266877|1529734|P3|Overall Study|Death|1
466763|NCT00266877|1529735|P2|Overall Study|Death|1
466764|NCT00266877|1529736|P1|Overall Study|Death|1
466765|NCT00266864|1529755|P2|Overall Study|Withdrawal by Subject|1
466766|NCT00266864|1529756|P1|Overall Study|Withdrawal by Subject|1
466767|NCT00266864|1529755|P2|Overall Study|Lost to Follow-up|1
466768|NCT00266864|1529756|P1|Overall Study|Lost to Follow-up|4
466769|NCT00266825|1529765|P2|Completed Follow-Up|Withdrawal by Subject|5
466770|NCT00266825|1529766|P1|Completed Follow-Up|Withdrawal by Subject|11
466771|NCT00266825|1529765|P2|Completed Follow-Up|Lost to Follow-up|19
466772|NCT00266825|1529766|P1|Completed Follow-Up|Lost to Follow-up|14
466773|NCT00266812|1529792|P2|Overall Study|Discontinued before starting study drug|0
466774|NCT00266812|1529793|P1|Overall Study|Discontinued before starting study drug|4
466775|NCT00266812|1529792|P2|Overall Study|Withdrawal by Subject|2
466776|NCT00266812|1529793|P1|Overall Study|Withdrawal by Subject|0
466777|NCT00266812|1529792|P2|Overall Study|Protocol Violation|1
466778|NCT00266812|1529793|P1|Overall Study|Protocol Violation|0
466779|NCT00266812|1529792|P2|Overall Study|Adverse Event|1
466780|NCT00266812|1529793|P1|Overall Study|Adverse Event|3
466781|NCT00266812|1529792|P2|Overall Study|Death|4
466782|NCT00266812|1529793|P1|Overall Study|Death|5
466783|NCT00266812|1529792|P2|Overall Study|Disease Progression|3
466784|NCT00266812|1529793|P1|Overall Study|Disease Progression|9
466785|NCT00266695|1529816|P1|Overall Study|Withdrawal by Subject|15
466786|NCT00266695|1529816|P1|Overall Study|Lost to Follow-up|3
466787|NCT00266695|1529816|P1|Overall Study|Physician Decision|1
466788|NCT00266695|1529816|P1|Overall Study|Death|9
466789|NCT00266695|1529816|P1|Overall Study|Adverse Event|1
466790|NCT00266656|1529828|P2|Overall Study|Parent/Caregiver Decision|2
466791|NCT00266656|1529829|P1|Overall Study|Parent/Caregiver Decision|1
466792|NCT00266656|1529828|P2|Overall Study|Did Not Reach Final Height|8
466793|NCT00266656|1529829|P1|Overall Study|Did Not Reach Final Height|4
466794|NCT00266656|1529828|P2|Overall Study|Withdrawal by Subject|2
466795|NCT00266656|1529829|P1|Overall Study|Withdrawal by Subject|4
466796|NCT00266656|1529828|P2|Overall Study|Lost to Follow-up|1
466797|NCT00266656|1529829|P1|Overall Study|Lost to Follow-up|4
466798|NCT00266656|1529828|P2|Overall Study|Death|0
466799|NCT00266656|1529829|P1|Overall Study|Death|1
466800|NCT00266630|1529853|P2|Overall Study|Not Specified|11
466801|NCT00266630|1529854|P1|Overall Study|Not Specified|19
466802|NCT00266630|1529853|P2|Overall Study|Lost to Follow-up|0
466803|NCT00266630|1529854|P1|Overall Study|Lost to Follow-up|1
466804|NCT00266630|1529853|P2|Overall Study|Withdrawal by Subject|2
466805|NCT00266630|1529854|P1|Overall Study|Withdrawal by Subject|10
466806|NCT00266630|1529853|P2|Overall Study|Physician Decision|2
466807|NCT00266630|1529854|P1|Overall Study|Physician Decision|1
466808|NCT00266630|1529853|P2|Overall Study|Protocol Violation|3
466809|NCT00266630|1529854|P1|Overall Study|Protocol Violation|1
466810|NCT00266630|1529853|P2|Overall Study|Entry Criteria not met|0
466811|NCT00266630|1529854|P1|Overall Study|Entry Criteria not met|1
466812|NCT00266630|1529853|P2|Overall Study|Lack of Efficacy|4
466813|NCT00266630|1529854|P1|Overall Study|Lack of Efficacy|1
466814|NCT00266630|1529853|P2|Overall Study|Adverse Event|6
466815|NCT00266630|1529854|P1|Overall Study|Adverse Event|8
466816|NCT00266409|1529896|P4|Overall Study|Other|0
466817|NCT00266409|1529897|P3|Overall Study|Other|2
466818|NCT00266409|1529898|P2|Overall Study|Other|4
466819|NCT00266409|1529899|P1|Overall Study|Other|7
466820|NCT00266409|1529896|P4|Overall Study|Protocol Violation|2
466821|NCT00266409|1529897|P3|Overall Study|Protocol Violation|4
466822|NCT00266409|1529898|P2|Overall Study|Protocol Violation|3
466823|NCT00266409|1529899|P1|Overall Study|Protocol Violation|5
466824|NCT00266409|1529896|P4|Overall Study|Withdrawal by Subject|9
466825|NCT00266409|1529897|P3|Overall Study|Withdrawal by Subject|3
466826|NCT00266409|1529898|P2|Overall Study|Withdrawal by Subject|10
466827|NCT00266409|1529899|P1|Overall Study|Withdrawal by Subject|6
466828|NCT00266409|1529896|P4|Overall Study|Lost to Follow-up|8
466829|NCT00266409|1529897|P3|Overall Study|Lost to Follow-up|6
466830|NCT00266409|1529898|P2|Overall Study|Lost to Follow-up|21
466831|NCT00266409|1529899|P1|Overall Study|Lost to Follow-up|18
466832|NCT00266409|1529896|P4|Overall Study|Adverse Event|1
466833|NCT00266409|1529897|P3|Overall Study|Adverse Event|1
466834|NCT00266409|1529898|P2|Overall Study|Adverse Event|2
466835|NCT00266409|1529899|P1|Overall Study|Adverse Event|7
466836|NCT00266409|1529896|P4|Overall Study|Lack of Efficacy|2
466837|NCT00266409|1529897|P3|Overall Study|Lack of Efficacy|1
466838|NCT00266409|1529898|P2|Overall Study|Lack of Efficacy|6
466839|NCT00266409|1529899|P1|Overall Study|Lack of Efficacy|2
466840|NCT00266227|1530187|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
466841|NCT00266227|1530188|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
466842|NCT00266227|1530189|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
466843|NCT00266227|1530187|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
466844|NCT00266227|1530188|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
466845|NCT00266227|1530189|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
466846|NCT00266227|1530187|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
466847|NCT00266227|1530188|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
466848|NCT00266227|1530189|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
466849|NCT00266227|1530187|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
466850|NCT00266227|1530188|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
466851|NCT00266227|1530189|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
466852|NCT00266227|1530187|P3|Retreatment: Week 48 to Week 72|Death|0
466853|NCT00266227|1530188|P2|Retreatment: Week 48 to Week 72|Death|1
466854|NCT00266227|1530189|P1|Retreatment: Week 48 to Week 72|Death|1
466855|NCT00266227|1530187|P3|Retreatment: Up to Week 48|Pregnancy|0
466856|NCT00266227|1530188|P2|Retreatment: Up to Week 48|Pregnancy|0
466857|NCT00266227|1530189|P1|Retreatment: Up to Week 48|Pregnancy|1
466858|NCT00266227|1530187|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
466859|NCT00266227|1530188|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
466860|NCT00266227|1530189|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
466861|NCT00266227|1530187|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
466862|NCT00266227|1530188|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
466863|NCT00266227|1530189|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
466864|NCT00266227|1530187|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
466865|NCT00266227|1530188|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
466866|NCT00266227|1530189|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
466867|NCT00266227|1530187|P3|Retreatment: Up to Week 48|Adverse Event|0
466868|NCT00266227|1530188|P2|Retreatment: Up to Week 48|Adverse Event|7
466869|NCT00266227|1530189|P1|Retreatment: Up to Week 48|Adverse Event|7
466870|NCT00266227|1530187|P3|Retreatment: Up to Week 48|Death|0
466871|NCT00266227|1530188|P2|Retreatment: Up to Week 48|Death|0
466872|NCT00266227|1530189|P1|Retreatment: Up to Week 48|Death|1
466873|NCT00266227|1530187|P3|Initial Treatment|Pregnancy|1
466874|NCT00266227|1530188|P2|Initial Treatment|Pregnancy|0
466875|NCT00266227|1530189|P1|Initial Treatment|Pregnancy|0
466876|NCT00266227|1530187|P3|Initial Treatment|Physician decision to withdraw|12
466877|NCT00266227|1530188|P2|Initial Treatment|Physician decision to withdraw|0
466878|NCT00266227|1530189|P1|Initial Treatment|Physician decision to withdraw|0
466879|NCT00266227|1530187|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
466880|NCT00266227|1530188|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
466881|NCT00266227|1530189|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
466882|NCT00266227|1530187|P3|Initial Treatment|Lost to Follow-up|6
466883|NCT00266227|1530188|P2|Initial Treatment|Lost to Follow-up|0
466884|NCT00266227|1530189|P1|Initial Treatment|Lost to Follow-up|0
466885|NCT00266227|1530187|P3|Initial Treatment|Adverse Event|13
466886|NCT00266227|1530188|P2|Initial Treatment|Adverse Event|0
466887|NCT00266227|1530189|P1|Initial Treatment|Adverse Event|0
466888|NCT00266032|1530241|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
466889|NCT00266032|1530242|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
466890|NCT00266032|1530243|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
466891|NCT00266032|1530241|P3|Open-label Safety Extension|Withdrawal by Subject|12
466892|NCT00266032|1530242|P2|Open-label Safety Extension|Withdrawal by Subject|3
466893|NCT00266032|1530243|P1|Open-label Safety Extension|Withdrawal by Subject|19
466894|NCT00266032|1530241|P3|Open-label Safety Extension|Protocol Violation|2
466895|NCT00266032|1530242|P2|Open-label Safety Extension|Protocol Violation|3
466896|NCT00266032|1530243|P1|Open-label Safety Extension|Protocol Violation|1
466897|NCT00266032|1530241|P3|Open-label Safety Extension|Pregnancy|2
466898|NCT00266032|1530242|P2|Open-label Safety Extension|Pregnancy|1
466899|NCT00266032|1530243|P1|Open-label Safety Extension|Pregnancy|4
466900|NCT00266032|1530241|P3|Open-label Safety Extension|Lost to Follow-up|4
466901|NCT00266032|1530242|P2|Open-label Safety Extension|Lost to Follow-up|5
466902|NCT00266032|1530243|P1|Open-label Safety Extension|Lost to Follow-up|2
466903|NCT00266032|1530241|P3|Open-label Safety Extension|Adverse Event|4
466904|NCT00266032|1530242|P2|Open-label Safety Extension|Adverse Event|0
466905|NCT00266032|1530243|P1|Open-label Safety Extension|Adverse Event|5
466906|NCT00266032|1530241|P3|Treatment|patient moved/wish for pregnancy/no need|8
466907|NCT00266032|1530242|P2|Treatment|patient moved/wish for pregnancy/no need|5
466908|NCT00266032|1530243|P1|Treatment|patient moved/wish for pregnancy/no need|13
466909|NCT00266032|1530241|P3|Treatment|Withdrawal by Subject|12
466910|NCT00266032|1530242|P2|Treatment|Withdrawal by Subject|13
466911|NCT00266032|1530243|P1|Treatment|Withdrawal by Subject|28
466912|NCT00266032|1530241|P3|Treatment|Protocol Violation|13
466913|NCT00266032|1530242|P2|Treatment|Protocol Violation|14
466914|NCT00266032|1530243|P1|Treatment|Protocol Violation|6
466915|NCT00266032|1530241|P3|Treatment|Pregnancy|2
466916|NCT00266032|1530242|P2|Treatment|Pregnancy|2
466917|NCT00266032|1530243|P1|Treatment|Pregnancy|3
466918|NCT00266032|1530241|P3|Treatment|Lost to Follow-up|2
466919|NCT00266032|1530242|P2|Treatment|Lost to Follow-up|4
466920|NCT00266032|1530243|P1|Treatment|Lost to Follow-up|19
466921|NCT00266032|1530241|P3|Treatment|Adverse Event|10
466922|NCT00266032|1530242|P2|Treatment|Adverse Event|26
466923|NCT00266032|1530243|P1|Treatment|Adverse Event|42
466924|NCT00265941|1530273|P2|Overall Study|Lost to Follow-up|1
466925|NCT00265941|1530274|P1|Overall Study|Lost to Follow-up|1
466926|NCT00265941|1530273|P2|Overall Study|Protocol Violation|25
466927|NCT00265941|1530274|P1|Overall Study|Protocol Violation|22
466928|NCT00265889|1530306|P1|Overall Study|Insurance denied the request|3
466929|NCT00265889|1530306|P1|Overall Study|Protocol Violation|1
466930|NCT00265889|1530306|P1|Overall Study|Physician Decision|1
466931|NCT00265785|1530333|P1|Overall Study|Did not receive protocol treatment|2
466932|NCT00265785|1530333|P1|Overall Study|Ineligible|1
466933|NCT00265785|1530333|P1|Overall Study|Not protocol specified|2
466934|NCT00265785|1530333|P1|Overall Study|Progression/Relapse|15
466935|NCT00265785|1530333|P1|Overall Study|Withdrawal by Subject|3
466936|NCT00265785|1530333|P1|Overall Study|Adverse Event|4
466937|NCT00265759|1530346|P4|Overall Study|Discontinued due to intolerability|1
466938|NCT00265759|1530347|P3|Overall Study|Discontinued due to intolerability|0
466939|NCT00265759|1530348|P2|Overall Study|Discontinued due to intolerability|0
466940|NCT00265759|1530349|P1|Overall Study|Discontinued due to intolerability|0
466941|NCT00265759|1530346|P4|Overall Study|Bilateral disease|2
466942|NCT00265759|1530347|P3|Overall Study|Bilateral disease|0
466943|NCT00265759|1530348|P2|Overall Study|Bilateral disease|0
466944|NCT00265759|1530349|P1|Overall Study|Bilateral disease|0
466945|NCT00265759|1530346|P4|Overall Study|Ineligible|1
466946|NCT00265759|1530347|P3|Overall Study|Ineligible|0
466947|NCT00265759|1530348|P2|Overall Study|Ineligible|0
466948|NCT00265759|1530349|P1|Overall Study|Ineligible|0
466949|NCT00265759|1530346|P4|Overall Study|Cancel|3
466950|NCT00265759|1530347|P3|Overall Study|Cancel|0
466951|NCT00265759|1530348|P2|Overall Study|Cancel|0
466952|NCT00265759|1530349|P1|Overall Study|Cancel|0
466953|NCT00265759|1530346|P4|Overall Study|Withdrawal by Subject|2
466954|NCT00265759|1530347|P3|Overall Study|Withdrawal by Subject|2
466955|NCT00265759|1530348|P2|Overall Study|Withdrawal by Subject|1
466956|NCT00265759|1530349|P1|Overall Study|Withdrawal by Subject|0
466957|NCT00265395|1530416|P2|Overall Study|Administrative|1
466958|NCT00265395|1530417|P1|Overall Study|Administrative|0
466959|NCT00265395|1530416|P2|Overall Study|Lack of Efficacy|1
466960|NCT00265395|1530417|P1|Overall Study|Lack of Efficacy|0
466961|NCT00265395|1530416|P2|Overall Study|Protocol Violation|2
466962|NCT00265395|1530417|P1|Overall Study|Protocol Violation|2
466963|NCT00265395|1530416|P2|Overall Study|Withdrawal by Subject|6
466964|NCT00265395|1530417|P1|Overall Study|Withdrawal by Subject|1
466965|NCT00265395|1530416|P2|Overall Study|Lost to Follow-up|1
466966|NCT00265395|1530417|P1|Overall Study|Lost to Follow-up|2
466967|NCT00265395|1530416|P2|Overall Study|Adverse Event|6
466968|NCT00265395|1530417|P1|Overall Study|Adverse Event|3
466969|NCT00265382|1530422|P1|Overall Study|Death|1
466970|NCT00265382|1530422|P1|Overall Study|Study terminated by sponsor|94
466971|NCT00265382|1530422|P1|Overall Study|Withdrawal by Subject|13
466972|NCT00265382|1530422|P1|Overall Study|Miscellaneous|6
466973|NCT00265382|1530422|P1|Overall Study|Lack of Efficacy|6
466974|NCT00265382|1530422|P1|Overall Study|Lost to Follow-up|3
466975|NCT00265382|1530422|P1|Overall Study|Laboratory Abnormality|1
466976|NCT00265382|1530422|P1|Overall Study|Adverse Event|21
466977|NCT00265343|1530442|P2|Overall Study|Other|3
466978|NCT00265343|1530443|P1|Overall Study|Other|8
466979|NCT00265343|1530442|P2|Overall Study|Withdrawal by Subject|9
466980|NCT00265343|1530443|P1|Overall Study|Withdrawal by Subject|3
466981|NCT00265343|1530442|P2|Overall Study|Adverse Event|7
466982|NCT00265343|1530443|P1|Overall Study|Adverse Event|10
466983|NCT00265330|1530451|P1|Overall Study|Protocol Violation|1
466984|NCT00265330|1530451|P1|Overall Study|Withdrew Consent|1
466985|NCT00265330|1530451|P1|Overall Study|Principal Investigators Request|1
466986|NCT00265330|1530451|P1|Overall Study|Site Closed by Sponsor|1
466987|NCT00265330|1530451|P1|Overall Study|Discharged from Unit for Long Term Care|1
466988|NCT00265330|1530451|P1|Overall Study|Began Taking Formulary Geodon|1
466989|NCT00265330|1530451|P1|Overall Study|Family Scheduling Conflicts|1
466990|NCT00265330|1530451|P1|Overall Study|Lack of Efficacy|4
466991|NCT00265330|1530451|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
466992|NCT00265330|1530451|P1|Overall Study|Withdrawal by Subject|34
466993|NCT00265330|1530451|P1|Overall Study|Lost to Follow-up|8
466994|NCT00265330|1530451|P1|Overall Study|Adverse Event|41
466995|NCT00265317|1530477|P4|Phase 2|Other|1
466996|NCT00265317|1530478|P3|Phase 2|Other|1
466997|NCT00265317|1530479|P2|Phase 2|Other|0
466998|NCT00265317|1530480|P1|Phase 2|Other|0
466999|NCT00265317|1530477|P4|Phase 2|Study terminated by sponsor|0
467000|NCT00265317|1530478|P3|Phase 2|Study terminated by sponsor|1
467001|NCT00265317|1530479|P2|Phase 2|Study terminated by sponsor|0
467002|NCT00265317|1530480|P1|Phase 2|Study terminated by sponsor|0
467003|NCT00265317|1530477|P4|Phase 2|Withdrawal/other than adverse event|1
467004|NCT00265317|1530478|P3|Phase 2|Withdrawal/other than adverse event|2
467005|NCT00265317|1530479|P2|Phase 2|Withdrawal/other than adverse event|0
467006|NCT00265317|1530480|P1|Phase 2|Withdrawal/other than adverse event|0
467007|NCT00265317|1530477|P4|Phase 2|Lost to Follow-up|1
467008|NCT00265317|1530478|P3|Phase 2|Lost to Follow-up|0
467009|NCT00265317|1530479|P2|Phase 2|Lost to Follow-up|0
467010|NCT00265317|1530480|P1|Phase 2|Lost to Follow-up|0
467011|NCT00265317|1530477|P4|Phase 2|Protocol Violation|4
467012|NCT00265317|1530478|P3|Phase 2|Protocol Violation|1
467013|NCT00265317|1530479|P2|Phase 2|Protocol Violation|0
467014|NCT00265317|1530480|P1|Phase 2|Protocol Violation|0
467015|NCT00265317|1530477|P4|Phase 2|Death|15
467016|NCT00265317|1530478|P3|Phase 2|Death|12
467017|NCT00265317|1530479|P2|Phase 2|Death|0
467018|NCT00265317|1530480|P1|Phase 2|Death|0
467019|NCT00265317|1530477|P4|Phase 2|Adverse Event|5
467020|NCT00265317|1530478|P3|Phase 2|Adverse Event|7
467021|NCT00265317|1530479|P2|Phase 2|Adverse Event|0
467022|NCT00265317|1530480|P1|Phase 2|Adverse Event|0
467023|NCT00265317|1530477|P4|Phase 2|Global deterioration of health status|0
467024|NCT00265317|1530478|P3|Phase 2|Global deterioration of health status|3
467025|NCT00265317|1530479|P2|Phase 2|Global deterioration of health status|0
467026|NCT00265317|1530480|P1|Phase 2|Global deterioration of health status|0
467027|NCT00265317|1530477|P4|Phase 2|Objective progression or relapse|38
467028|NCT00265317|1530478|P3|Phase 2|Objective progression or relapse|37
467029|NCT00265317|1530479|P2|Phase 2|Objective progression or relapse|0
467030|NCT00265317|1530480|P1|Phase 2|Objective progression or relapse|0
467031|NCT00265317|1530477|P4|Lead-In|Withdrawal/other than adverse event|0
467032|NCT00265317|1530478|P3|Lead-In|Withdrawal/other than adverse event|0
467033|NCT00265317|1530479|P2|Lead-In|Withdrawal/other than adverse event|0
467034|NCT00265317|1530480|P1|Lead-In|Withdrawal/other than adverse event|1
467035|NCT00265317|1530477|P4|Lead-In|Death|0
467036|NCT00265317|1530478|P3|Lead-In|Death|0
467037|NCT00265317|1530479|P2|Lead-In|Death|5
467038|NCT00265317|1530480|P1|Lead-In|Death|3
467039|NCT00265317|1530477|P4|Lead-In|Adverse Event|0
467040|NCT00265317|1530478|P3|Lead-In|Adverse Event|0
467041|NCT00265317|1530479|P2|Lead-In|Adverse Event|1
467042|NCT00265317|1530480|P1|Lead-In|Adverse Event|2
467043|NCT00265317|1530477|P4|Lead-In|Objective progression or relapse|0
467044|NCT00265317|1530478|P3|Lead-In|Objective progression or relapse|0
467045|NCT00265317|1530479|P2|Lead-In|Objective progression or relapse|11
467046|NCT00265317|1530480|P1|Lead-In|Objective progression or relapse|6
467047|NCT00265239|1530595|P2|Overall Study|Adverse Event|1
467048|NCT00265239|1530596|P1|Overall Study|Adverse Event|2
467049|NCT00265122|1530618|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
467050|NCT00265122|1530619|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
467051|NCT00265122|1530620|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
467052|NCT00265122|1530621|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
467053|NCT00265122|1530622|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
467054|NCT00265122|1530623|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
467055|NCT00265122|1530618|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
467056|NCT00265122|1530619|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
467057|NCT00265122|1530620|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
467058|NCT00265122|1530621|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
467059|NCT00265122|1530622|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
467060|NCT00265122|1530623|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
467061|NCT00265122|1530618|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
467062|NCT00265122|1530619|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
467063|NCT00265122|1530620|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
467064|NCT00265122|1530621|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
467065|NCT00265122|1530622|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
467066|NCT00265122|1530623|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
467067|NCT00265122|1530618|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
467068|NCT00265122|1530619|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
467069|NCT00265122|1530620|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
467154|NCT00264810|1530750|P2|Baseline|Withdrawal by Subject|10
467070|NCT00265122|1530621|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
467071|NCT00265122|1530622|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
467072|NCT00265122|1530623|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
467073|NCT00265122|1530618|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
467074|NCT00265122|1530619|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
467075|NCT00265122|1530620|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
467076|NCT00265122|1530621|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
467077|NCT00265122|1530622|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
467078|NCT00265122|1530623|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
467079|NCT00265122|1530618|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
467080|NCT00265122|1530619|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
467081|NCT00265122|1530620|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
467082|NCT00265122|1530621|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
467083|NCT00265122|1530622|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
467084|NCT00265122|1530623|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
467085|NCT00265109|1530645|P1|Overall Study|Adverse Event|1
467086|NCT00265109|1530645|P1|Overall Study|Withdrawal by Subject|5
467087|NCT00265096|1530652|P3|Overall Study|Not Specified|10
467088|NCT00265096|1530653|P2|Overall Study|Not Specified|19
467089|NCT00265096|1530654|P1|Overall Study|Not Specified|11
467090|NCT00265096|1530652|P3|Overall Study|Unsatisfactory therapeutic effect|6
467091|NCT00265096|1530653|P2|Overall Study|Unsatisfactory therapeutic effect|8
467092|NCT00265096|1530654|P1|Overall Study|Unsatisfactory therapeutic effect|9
467093|NCT00265096|1530652|P3|Overall Study|Death|2
467094|NCT00265096|1530653|P2|Overall Study|Death|1
467095|NCT00265096|1530654|P1|Overall Study|Death|0
467096|NCT00265096|1530652|P3|Overall Study|Lost to Follow-up|3
467097|NCT00265096|1530653|P2|Overall Study|Lost to Follow-up|5
467098|NCT00265096|1530654|P1|Overall Study|Lost to Follow-up|2
467099|NCT00265096|1530652|P3|Overall Study|Adverse Event|18
467100|NCT00265096|1530653|P2|Overall Study|Adverse Event|18
467101|NCT00265096|1530654|P1|Overall Study|Adverse Event|14
467102|NCT00265083|1530686|P3|Overall Study|Not specified|9
467103|NCT00265083|1530687|P2|Overall Study|Not specified|12
467104|NCT00265083|1530688|P1|Overall Study|Not specified|1
467105|NCT00265083|1530686|P3|Overall Study|Unsatisfactory therapeutic effect|14
467106|NCT00265083|1530687|P2|Overall Study|Unsatisfactory therapeutic effect|13
467107|NCT00265083|1530688|P1|Overall Study|Unsatisfactory therapeutic effect|8
467108|NCT00265083|1530686|P3|Overall Study|Lost to Follow-up|4
467109|NCT00265083|1530687|P2|Overall Study|Lost to Follow-up|4
467110|NCT00265083|1530688|P1|Overall Study|Lost to Follow-up|3
467111|NCT00265083|1530686|P3|Overall Study|Adverse Event|15
467112|NCT00265083|1530687|P2|Overall Study|Adverse Event|13
467113|NCT00265083|1530688|P1|Overall Study|Adverse Event|5
467114|NCT00264875|1530709|P1|Overall Study|Withdrawal by Subject|7
467115|NCT00264875|1530709|P1|Overall Study|Protocol Violation|11
467116|NCT00264875|1530709|P1|Overall Study|Lost to Follow-up|6
467117|NCT00264875|1530709|P1|Overall Study|Adverse Event|6
467132|NCT00264810|1530750|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
467133|NCT00264810|1530751|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
467134|NCT00264810|1530750|P2|Open Label Evaluation Period|Death|2
467135|NCT00264810|1530751|P1|Open Label Evaluation Period|Death|3
467136|NCT00264810|1530750|P2|Open Label Evaluation Period|Explant due to infection|1
467137|NCT00264810|1530751|P1|Open Label Evaluation Period|Explant due to infection|1
467138|NCT00264810|1530750|P2|Blinded Evaluation Period|Explant due to infection|1
467139|NCT00264810|1530751|P1|Blinded Evaluation Period|Explant due to infection|1
467140|NCT00264810|1530750|P2|Stimulation Optimization Period|Death|1
467141|NCT00264810|1530751|P1|Stimulation Optimization Period|Death|0
467142|NCT00264810|1530750|P2|Stimulation Optimization Period|Withdrawal by Subject|0
467143|NCT00264810|1530751|P1|Stimulation Optimization Period|Withdrawal by Subject|1
467144|NCT00264810|1530750|P2|Baseline|Other|1
467145|NCT00264810|1530751|P1|Baseline|Other|0
467146|NCT00264810|1530750|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
467147|NCT00264810|1530751|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
467148|NCT00264810|1530750|P2|Baseline|Insufficient Seizure Frequency|2
467149|NCT00264810|1530751|P1|Baseline|Insufficient Seizure Frequency|2
467150|NCT00264810|1530750|P2|Baseline|Subject Compliance Failure|3
467151|NCT00264810|1530751|P1|Baseline|Subject Compliance Failure|3
467152|NCT00264810|1530750|P2|Baseline|Physician Decision|8
467153|NCT00264810|1530751|P1|Baseline|Physician Decision|7
467155|NCT00264810|1530751|P1|Baseline|Withdrawal by Subject|10
467156|NCT00264797|1530761|P2|Overall Study|Other|4
467157|NCT00264797|1530762|P1|Overall Study|Other|3
467158|NCT00264797|1530761|P2|Overall Study|Feels treatment not necessary, not worki|1
467159|NCT00264797|1530762|P1|Overall Study|Feels treatment not necessary, not worki|0
467160|NCT00264797|1530761|P2|Overall Study|Pressure/advice from Outsiders|1
467161|NCT00264797|1530762|P1|Overall Study|Pressure/advice from Outsiders|1
467162|NCT00264797|1530761|P2|Overall Study|Incarceration|5
467163|NCT00264797|1530762|P1|Overall Study|Incarceration|4
467164|NCT00264797|1530761|P2|Overall Study|Practical Problems|3
467165|NCT00264797|1530762|P1|Overall Study|Practical Problems|2
467166|NCT00264797|1530761|P2|Overall Study|Moved from area|1
467167|NCT00264797|1530762|P1|Overall Study|Moved from area|3
467168|NCT00264797|1530761|P2|Overall Study|Lost to Follow-up|17
467169|NCT00264797|1530762|P1|Overall Study|Lost to Follow-up|9
467170|NCT00264797|1530761|P2|Overall Study|Withdrawal by Subject|11
467171|NCT00264797|1530762|P1|Overall Study|Withdrawal by Subject|11
467172|NCT00264576|1530784|P2|Overall Study|Lost to Follow-up|1
467173|NCT00264576|1530785|P1|Overall Study|Lost to Follow-up|1
467174|NCT00264550|1530809|P4|Overall Study|Not specified|9
467175|NCT00264550|1530810|P3|Overall Study|Not specified|3
467176|NCT00264550|1530811|P2|Overall Study|Not specified|7
467177|NCT00264550|1530812|P1|Overall Study|Not specified|13
467178|NCT00264550|1530809|P4|Overall Study|Discontinued oral study agent|0
467179|NCT00264550|1530810|P3|Overall Study|Discontinued oral study agent|0
467180|NCT00264550|1530811|P2|Overall Study|Discontinued oral study agent|1
467181|NCT00264550|1530812|P1|Overall Study|Discontinued oral study agent|0
467182|NCT00264550|1530809|P4|Overall Study|Unsatisfactory therapeutic effect|6
467183|NCT00264550|1530810|P3|Overall Study|Unsatisfactory therapeutic effect|4
467184|NCT00264550|1530811|P2|Overall Study|Unsatisfactory therapeutic effect|11
467185|NCT00264550|1530812|P1|Overall Study|Unsatisfactory therapeutic effect|4
467186|NCT00264550|1530809|P4|Overall Study|Adverse Event|14
467187|NCT00264550|1530810|P3|Overall Study|Adverse Event|9
467188|NCT00264550|1530811|P2|Overall Study|Adverse Event|18
467189|NCT00264550|1530812|P1|Overall Study|Adverse Event|23
467190|NCT00264550|1530809|P4|Overall Study|Lost to Follow-up|1
467191|NCT00264550|1530810|P3|Overall Study|Lost to Follow-up|1
467192|NCT00264550|1530811|P2|Overall Study|Lost to Follow-up|1
467193|NCT00264550|1530812|P1|Overall Study|Lost to Follow-up|3
467194|NCT00264550|1530809|P4|Overall Study|Death|0
467195|NCT00264550|1530810|P3|Overall Study|Death|0
467196|NCT00264550|1530811|P2|Overall Study|Death|3
467197|NCT00264550|1530812|P1|Overall Study|Death|0
467198|NCT00264537|1530851|P4|Overall Study|Not treated|0
467199|NCT00264537|1530852|P3|Overall Study|Not treated|1
467200|NCT00264537|1530853|P2|Overall Study|Not treated|2
467201|NCT00264537|1530854|P1|Overall Study|Not treated|0
467202|NCT00264537|1530851|P4|Overall Study|Not specified|11
467203|NCT00264537|1530852|P3|Overall Study|Not specified|10
467204|NCT00264537|1530853|P2|Overall Study|Not specified|11
467205|NCT00264537|1530854|P1|Overall Study|Not specified|21
467206|NCT00264537|1530851|P4|Overall Study|Unsatisfactory therapeutic effect|7
467207|NCT00264537|1530852|P3|Overall Study|Unsatisfactory therapeutic effect|5
467208|NCT00264537|1530853|P2|Overall Study|Unsatisfactory therapeutic effect|6
467209|NCT00264537|1530854|P1|Overall Study|Unsatisfactory therapeutic effect|5
467210|NCT00264537|1530851|P4|Overall Study|Adverse Event|34
467211|NCT00264537|1530852|P3|Overall Study|Adverse Event|24
467212|NCT00264537|1530853|P2|Overall Study|Adverse Event|32
467213|NCT00264537|1530854|P1|Overall Study|Adverse Event|21
467214|NCT00264537|1530851|P4|Overall Study|Lost to Follow-up|6
467215|NCT00264537|1530852|P3|Overall Study|Lost to Follow-up|7
467216|NCT00264537|1530853|P2|Overall Study|Lost to Follow-up|4
467217|NCT00264537|1530854|P1|Overall Study|Lost to Follow-up|3
467218|NCT00264537|1530851|P4|Overall Study|Death|2
467219|NCT00264537|1530852|P3|Overall Study|Death|3
467220|NCT00264537|1530853|P2|Overall Study|Death|3
467221|NCT00264537|1530854|P1|Overall Study|Death|0
467222|NCT00264498|1530886|P2|Crossover Treatment|Withdrawal by Subject|0
467223|NCT00264498|1530887|P1|Crossover Treatment|Withdrawal by Subject|1
467224|NCT00264498|1530886|P2|Crossover Treatment|Study closure|1
467225|NCT00264498|1530887|P1|Crossover Treatment|Study closure|0
467226|NCT00264498|1530886|P2|Crossover Treatment|Objective disease progression|5
467227|NCT00264498|1530887|P1|Crossover Treatment|Objective disease progression|4
467228|NCT00264498|1530886|P2|Crossover Treatment|Death|3
467229|NCT00264498|1530887|P1|Crossover Treatment|Death|1
467230|NCT00264498|1530886|P2|Randomized Treatment|Protocol Violation|0
467231|NCT00264498|1530887|P1|Randomized Treatment|Protocol Violation|1
467232|NCT00264498|1530886|P2|Randomized Treatment|Study Closure|0
467233|NCT00264498|1530887|P1|Randomized Treatment|Study Closure|1
467234|NCT00264498|1530886|P2|Randomized Treatment|Incorrectly randomized|0
467235|NCT00264498|1530887|P1|Randomized Treatment|Incorrectly randomized|1
467236|NCT00264498|1530886|P2|Randomized Treatment|Physician Decision|0
467237|NCT00264498|1530887|P1|Randomized Treatment|Physician Decision|1
467238|NCT00264498|1530886|P2|Randomized Treatment|Objective disease Progression|14
467239|NCT00264498|1530887|P1|Randomized Treatment|Objective disease Progression|13
467240|NCT00264498|1530886|P2|Randomized Treatment|Withdrawal by Subject|1
467241|NCT00264498|1530887|P1|Randomized Treatment|Withdrawal by Subject|0
467242|NCT00264498|1530886|P2|Randomized Treatment|Death|3
467243|NCT00264498|1530887|P1|Randomized Treatment|Death|0
467244|NCT00264303|1530910|P2|Overall Study|Various reasons listed in study report|7
467245|NCT00264303|1530911|P1|Overall Study|Various reasons listed in study report|6
467246|NCT00264303|1530910|P2|Overall Study|Withdrawal by Subject|3
467247|NCT00264303|1530911|P1|Overall Study|Withdrawal by Subject|2
467248|NCT00264303|1530910|P2|Overall Study|Lost to Follow-up|3
467249|NCT00264303|1530911|P1|Overall Study|Lost to Follow-up|3
467250|NCT00264303|1530910|P2|Overall Study|Lack of Efficacy|13
467251|NCT00264303|1530911|P1|Overall Study|Lack of Efficacy|10
467252|NCT00264303|1530910|P2|Overall Study|Adverse Event|3
467253|NCT00264303|1530911|P1|Overall Study|Adverse Event|4
467254|NCT00264290|1530929|P2|Intervention (8 Weeks)|Adverse Event|0
467255|NCT00264290|1530930|P1|Intervention (8 Weeks)|Adverse Event|1
467256|NCT00264238|1530936|P1|Overall Study|Protocol Violation|1
467257|NCT00264147|1530948|P6|Treatment II Period|Pre-scheduled total hip replacement|1
467258|NCT00264147|1530949|P5|Treatment II Period|Pre-scheduled total hip replacement|0
467259|NCT00264147|1530950|P4|Treatment II Period|Pre-scheduled total hip replacement|0
467260|NCT00264147|1530951|P3|Treatment II Period|Pre-scheduled total hip replacement|0
467261|NCT00264147|1530952|P2|Treatment II Period|Pre-scheduled total hip replacement|0
467262|NCT00264147|1530953|P1|Treatment II Period|Pre-scheduled total hip replacement|0
467263|NCT00264147|1530948|P6|Treatment II Period|Withdrawal by Subject|2
467264|NCT00264147|1530949|P5|Treatment II Period|Withdrawal by Subject|3
467265|NCT00264147|1530950|P4|Treatment II Period|Withdrawal by Subject|0
467266|NCT00264147|1530951|P3|Treatment II Period|Withdrawal by Subject|0
467267|NCT00264147|1530952|P2|Treatment II Period|Withdrawal by Subject|0
467268|NCT00264147|1530953|P1|Treatment II Period|Withdrawal by Subject|0
467269|NCT00264147|1530948|P6|Treatment II Period|Lost to Follow-up|1
467270|NCT00264147|1530949|P5|Treatment II Period|Lost to Follow-up|1
467271|NCT00264147|1530950|P4|Treatment II Period|Lost to Follow-up|0
467272|NCT00264147|1530951|P3|Treatment II Period|Lost to Follow-up|0
467273|NCT00264147|1530952|P2|Treatment II Period|Lost to Follow-up|0
467274|NCT00264147|1530953|P1|Treatment II Period|Lost to Follow-up|0
467275|NCT00264147|1530948|P6|Treatment II Period|Lack of Efficacy|19
467276|NCT00264147|1530949|P5|Treatment II Period|Lack of Efficacy|20
467277|NCT00264147|1530950|P4|Treatment II Period|Lack of Efficacy|0
467278|NCT00264147|1530951|P3|Treatment II Period|Lack of Efficacy|0
467279|NCT00264147|1530952|P2|Treatment II Period|Lack of Efficacy|0
467280|NCT00264147|1530953|P1|Treatment II Period|Lack of Efficacy|0
467281|NCT00264147|1530948|P6|Treatment II Period|Laboratory Adverse Event|1
467282|NCT00264147|1530949|P5|Treatment II Period|Laboratory Adverse Event|0
467283|NCT00264147|1530950|P4|Treatment II Period|Laboratory Adverse Event|0
467284|NCT00264147|1530951|P3|Treatment II Period|Laboratory Adverse Event|0
467285|NCT00264147|1530952|P2|Treatment II Period|Laboratory Adverse Event|0
467286|NCT00264147|1530953|P1|Treatment II Period|Laboratory Adverse Event|0
467287|NCT00264147|1530948|P6|Treatment II Period|Adverse Event|9
467288|NCT00264147|1530949|P5|Treatment II Period|Adverse Event|9
467289|NCT00264147|1530950|P4|Treatment II Period|Adverse Event|0
467290|NCT00264147|1530951|P3|Treatment II Period|Adverse Event|0
467291|NCT00264147|1530952|P2|Treatment II Period|Adverse Event|0
467292|NCT00264147|1530953|P1|Treatment II Period|Adverse Event|0
467293|NCT00264147|1530948|P6|Treatment I Period|Reassigned to Treatment II Period|0
467294|NCT00264147|1530949|P5|Treatment I Period|Reassigned to Treatment II Period|45
467295|NCT00264147|1530950|P4|Treatment I Period|Reassigned to Treatment II Period|63
467296|NCT00264147|1530951|P3|Treatment I Period|Reassigned to Treatment II Period|65
467297|NCT00264147|1530952|P2|Treatment I Period|Reassigned to Treatment II Period|72
467298|NCT00264147|1530953|P1|Treatment I Period|Reassigned to Treatment II Period|84
467299|NCT00264147|1530948|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
467300|NCT00264147|1530949|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
467301|NCT00264147|1530950|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
467302|NCT00264147|1530951|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
467303|NCT00264147|1530952|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
467304|NCT00264147|1530953|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
467305|NCT00264147|1530948|P6|Treatment I Period|Patient out of town for an extended time|0
467306|NCT00264147|1530949|P5|Treatment I Period|Patient out of town for an extended time|0
467307|NCT00264147|1530950|P4|Treatment I Period|Patient out of town for an extended time|0
467308|NCT00264147|1530951|P3|Treatment I Period|Patient out of town for an extended time|0
467309|NCT00264147|1530952|P2|Treatment I Period|Patient out of town for an extended time|1
467310|NCT00264147|1530953|P1|Treatment I Period|Patient out of town for an extended time|0
467311|NCT00264147|1530948|P6|Treatment I Period|Withdrawal by Subject|0
467312|NCT00264147|1530949|P5|Treatment I Period|Withdrawal by Subject|2
467313|NCT00264147|1530950|P4|Treatment I Period|Withdrawal by Subject|2
467314|NCT00264147|1530951|P3|Treatment I Period|Withdrawal by Subject|0
467315|NCT00264147|1530952|P2|Treatment I Period|Withdrawal by Subject|0
467316|NCT00264147|1530953|P1|Treatment I Period|Withdrawal by Subject|2
467317|NCT00264147|1530948|P6|Treatment I Period|Protocol Violation|0
467318|NCT00264147|1530949|P5|Treatment I Period|Protocol Violation|0
467319|NCT00264147|1530950|P4|Treatment I Period|Protocol Violation|0
467320|NCT00264147|1530951|P3|Treatment I Period|Protocol Violation|0
467321|NCT00264147|1530952|P2|Treatment I Period|Protocol Violation|2
467322|NCT00264147|1530953|P1|Treatment I Period|Protocol Violation|2
467323|NCT00264147|1530948|P6|Treatment I Period|Lost to Follow-up|0
467324|NCT00264147|1530949|P5|Treatment I Period|Lost to Follow-up|1
467325|NCT00264147|1530950|P4|Treatment I Period|Lost to Follow-up|1
467326|NCT00264147|1530951|P3|Treatment I Period|Lost to Follow-up|0
467327|NCT00264147|1530952|P2|Treatment I Period|Lost to Follow-up|0
467328|NCT00264147|1530953|P1|Treatment I Period|Lost to Follow-up|1
467329|NCT00264147|1530948|P6|Treatment I Period|Lack of Efficacy|0
467330|NCT00264147|1530949|P5|Treatment I Period|Lack of Efficacy|1
467331|NCT00264147|1530950|P4|Treatment I Period|Lack of Efficacy|0
467332|NCT00264147|1530951|P3|Treatment I Period|Lack of Efficacy|8
467333|NCT00264147|1530952|P2|Treatment I Period|Lack of Efficacy|2
467334|NCT00264147|1530953|P1|Treatment I Period|Lack of Efficacy|6
467335|NCT00264147|1530948|P6|Treatment I Period|Laboratory Adverse Event|0
467336|NCT00264147|1530949|P5|Treatment I Period|Laboratory Adverse Event|0
467337|NCT00264147|1530950|P4|Treatment I Period|Laboratory Adverse Event|1
467338|NCT00264147|1530951|P3|Treatment I Period|Laboratory Adverse Event|0
467339|NCT00264147|1530952|P2|Treatment I Period|Laboratory Adverse Event|0
467340|NCT00264147|1530953|P1|Treatment I Period|Laboratory Adverse Event|0
467341|NCT00264147|1530948|P6|Treatment I Period|Adverse Event|0
467342|NCT00264147|1530949|P5|Treatment I Period|Adverse Event|7
467343|NCT00264147|1530950|P4|Treatment I Period|Adverse Event|5
467344|NCT00264147|1530951|P3|Treatment I Period|Adverse Event|3
467345|NCT00264147|1530952|P2|Treatment I Period|Adverse Event|6
467346|NCT00264147|1530953|P1|Treatment I Period|Adverse Event|3
467347|NCT00264004|1530996|P4|Overall Study|Not treated|2
467348|NCT00264004|1530997|P3|Overall Study|Not treated|2
467349|NCT00264004|1530998|P2|Overall Study|Not treated|0
467350|NCT00264004|1530999|P1|Overall Study|Not treated|3
467351|NCT00264004|1530996|P4|Overall Study|Cond. under inv. worsened|4
467352|NCT00264004|1530997|P3|Overall Study|Cond. under inv. worsened|3
467353|NCT00264004|1530998|P2|Overall Study|Cond. under inv. worsened|5
467354|NCT00264004|1530999|P1|Overall Study|Cond. under inv. worsened|9
467355|NCT00264004|1530996|P4|Overall Study|Development study specific disc. crit.|0
467356|NCT00264004|1530997|P3|Overall Study|Development study specific disc. crit.|1
467357|NCT00264004|1530998|P2|Overall Study|Development study specific disc. crit.|0
467358|NCT00264004|1530999|P1|Overall Study|Development study specific disc. crit.|1
467359|NCT00264004|1530996|P4|Overall Study|Not specified|3
467360|NCT00264004|1530997|P3|Overall Study|Not specified|0
467361|NCT00264004|1530998|P2|Overall Study|Not specified|2
467362|NCT00264004|1530999|P1|Overall Study|Not specified|2
467363|NCT00264004|1530996|P4|Overall Study|Withdrawal by Subject|2
467364|NCT00264004|1530997|P3|Overall Study|Withdrawal by Subject|2
467365|NCT00264004|1530998|P2|Overall Study|Withdrawal by Subject|1
467366|NCT00264004|1530999|P1|Overall Study|Withdrawal by Subject|0
467367|NCT00264004|1530996|P4|Overall Study|Adverse Event|4
467368|NCT00264004|1530997|P3|Overall Study|Adverse Event|6
467369|NCT00264004|1530998|P2|Overall Study|Adverse Event|3
467370|NCT00264004|1530999|P1|Overall Study|Adverse Event|2
467371|NCT00263887|1531027|P2|Overall Study|Lack of Efficacy|1
467372|NCT00263887|1531028|P1|Overall Study|Lack of Efficacy|0
467373|NCT00263887|1531027|P2|Overall Study|Disease progression|1
467374|NCT00263887|1531028|P1|Overall Study|Disease progression|0
467375|NCT00263887|1531027|P2|Overall Study|Adverse Event|2
467376|NCT00263887|1531028|P1|Overall Study|Adverse Event|0
467377|NCT00263887|1531027|P2|Overall Study|Too ill to attend visit|0
467378|NCT00263887|1531028|P1|Overall Study|Too ill to attend visit|1
467379|NCT00263887|1531027|P2|Overall Study|Lung transplantation|2
467380|NCT00263887|1531028|P1|Overall Study|Lung transplantation|1
467381|NCT00263887|1531027|P2|Overall Study|Withdrawal by Subject|1
467382|NCT00263887|1531028|P1|Overall Study|Withdrawal by Subject|1
467383|NCT00263757|1531036|P2|Overall Study|Adverse Event|3
467384|NCT00263757|1531037|P1|Overall Study|Adverse Event|3
467385|NCT00263757|1531036|P2|Overall Study|Screen failure|1
467386|NCT00263757|1531037|P1|Overall Study|Screen failure|0
467387|NCT00263757|1531036|P2|Overall Study|Withdrawal by Subject|4
467388|NCT00263757|1531037|P1|Overall Study|Withdrawal by Subject|5
467389|NCT00263666|1531049|P2|Overall Study|Withdrawal by Subject|1
467390|NCT00263666|1531050|P1|Overall Study|Withdrawal by Subject|0
467391|NCT00263666|1531049|P2|Overall Study|Lost to Follow-up|2
467392|NCT00263666|1531050|P1|Overall Study|Lost to Follow-up|1
467393|NCT00263666|1531049|P2|Overall Study|Adverse Event|8
467394|NCT00263666|1531050|P1|Overall Study|Adverse Event|6
467395|NCT00263328|1531104|P3|Overall Study|Adverse Event|4
467396|NCT00263328|1531105|P2|Overall Study|Adverse Event|1
467397|NCT00263328|1531106|P1|Overall Study|Adverse Event|1
467398|NCT00263328|1531104|P3|Overall Study|Not specified|1
467399|NCT00263328|1531105|P2|Overall Study|Not specified|0
467400|NCT00263328|1531106|P1|Overall Study|Not specified|3
467401|NCT00263328|1531104|P3|Overall Study|Withdrawal by Subject|1
467402|NCT00263328|1531105|P2|Overall Study|Withdrawal by Subject|0
467403|NCT00263328|1531106|P1|Overall Study|Withdrawal by Subject|3
467404|NCT00263328|1531104|P3|Overall Study|Lost to Follow-up|0
467405|NCT00263328|1531105|P2|Overall Study|Lost to Follow-up|1
467406|NCT00263328|1531106|P1|Overall Study|Lost to Follow-up|1
467407|NCT00263328|1531104|P3|Overall Study|Death|1
467408|NCT00263328|1531105|P2|Overall Study|Death|0
467409|NCT00263328|1531106|P1|Overall Study|Death|0
467410|NCT00263211|1531264|P2|Overall Study|Disease Progression|1
467411|NCT00263211|1531265|P1|Overall Study|Disease Progression|0
467412|NCT00263211|1531264|P2|Overall Study|Protocol Violation|0
467413|NCT00263211|1531265|P1|Overall Study|Protocol Violation|1
467414|NCT00263211|1531264|P2|Overall Study|Withdrawal by Subject|0
467415|NCT00263211|1531265|P1|Overall Study|Withdrawal by Subject|3
467416|NCT00263211|1531264|P2|Overall Study|Death|0
467417|NCT00263211|1531265|P1|Overall Study|Death|1
467418|NCT00262951|1531316|P1|Overall Study|Off treatment for other disease|1
467419|NCT00262951|1531316|P1|Overall Study|Alternative treatment|3
467420|NCT00262951|1531316|P1|Overall Study|Withdrawal by Subject|1
467421|NCT00262951|1531316|P1|Overall Study|Death|1
467422|NCT00262951|1531316|P1|Overall Study|Adverse Event|7
467423|NCT00262951|1531316|P1|Overall Study|Progressive disease/relapse|3
467424|NCT00262925|1531321|P1|Overall Study|Other|1
467425|NCT00262925|1531321|P1|Overall Study|alternative therapy|1
467426|NCT00262925|1531321|P1|Overall Study|Death|2
467427|NCT00262925|1531321|P1|Overall Study|Adverse Event|4
467428|NCT00262925|1531321|P1|Overall Study|Lack of Efficacy|3
467429|NCT00262873|1531327|P1|Overall Study|Withdrawal by Subject|5
467430|NCT00262873|1531327|P1|Overall Study|Adverse Event|3
467431|NCT00262860|1531338|P1|Overall Study|Adverse Event|2
467432|NCT00262847|1531347|P3|Overall Study|Did not receive study treatment|4
467433|NCT00262847|1531348|P2|Overall Study|Did not receive study treatment|1
467434|NCT00262847|1531349|P1|Overall Study|Did not receive study treatment|4
467435|NCT00262847|1531347|P3|Overall Study|Other Reasons|27
467436|NCT00262847|1531348|P2|Overall Study|Other Reasons|88
467437|NCT00262847|1531349|P1|Overall Study|Other Reasons|79
467438|NCT00262847|1531347|P3|Overall Study|Concomitant disease|4
467439|NCT00262847|1531348|P2|Overall Study|Concomitant disease|2
467440|NCT00262847|1531349|P1|Overall Study|Concomitant disease|3
467441|NCT00262847|1531347|P3|Overall Study|Death|11
467442|NCT00262847|1531348|P2|Overall Study|Death|8
467443|NCT00262847|1531349|P1|Overall Study|Death|8
467444|NCT00262847|1531347|P3|Overall Study|Adverse Event|108
467445|NCT00262847|1531348|P2|Overall Study|Adverse Event|88
467446|NCT00262847|1531349|P1|Overall Study|Adverse Event|74
467447|NCT00262847|1531347|P3|Overall Study|Patient Refusal|47
467448|NCT00262847|1531348|P2|Overall Study|Patient Refusal|52
467449|NCT00262847|1531349|P1|Overall Study|Patient Refusal|41
467450|NCT00262847|1531347|P3|Overall Study|Disease Progression|195
467451|NCT00262847|1531348|P2|Overall Study|Disease Progression|274
467452|NCT00262847|1531349|P1|Overall Study|Disease Progression|309
467453|NCT00262834|1531368|P2|Overall Study|Surgery delayed/tissue not collected|4
467454|NCT00262834|1531369|P1|Overall Study|Surgery delayed/tissue not collected|1
467455|NCT00262821|1531382|P2|Overall Study|Inevaluable - inadequate data|4
467456|NCT00262821|1531383|P1|Overall Study|Inevaluable - inadequate data|0
467457|NCT00262821|1531382|P2|Overall Study|Ineligible - required test not done|4
467458|NCT00262821|1531383|P1|Overall Study|Ineligible - required test not done|1
467459|NCT00262821|1531382|P2|Overall Study|Ineligible - elevated creatinine|2
467460|NCT00262821|1531383|P1|Overall Study|Ineligible - elevated creatinine|0
467461|NCT00262821|1531382|P2|Overall Study|Ineligible - inadequate pathology|3
467462|NCT00262821|1531383|P1|Overall Study|Ineligible - inadequate pathology|1
467463|NCT00262821|1531382|P2|Overall Study|Ineligible - wrong primary|1
467464|NCT00262821|1531383|P1|Overall Study|Ineligible - wrong primary|0
467465|NCT00262821|1531382|P2|Overall Study|Ineligible - wrong cell type|2
467466|NCT00262821|1531383|P1|Overall Study|Ineligible - wrong cell type|2
467467|NCT00262821|1531382|P2|Overall Study|Ineligible - wrong stage|3
467468|NCT00262821|1531383|P1|Overall Study|Ineligible - wrong stage|0
467469|NCT00262743|1531395|P2|Overall Study|Disease progression|3
467470|NCT00262743|1531396|P1|Overall Study|Disease progression|0
467471|NCT00262743|1531395|P2|Overall Study|Adverse Event|9
467472|NCT00262743|1531396|P1|Overall Study|Adverse Event|0
467473|NCT00262600|1531431|P3|Overall Study|Not Specified|62
467474|NCT00262600|1531432|P2|Overall Study|Not Specified|59
467475|NCT00262600|1531433|P1|Overall Study|Not Specified|58
467476|NCT00262600|1531431|P3|Overall Study|Not Treated|24
467477|NCT00262600|1531432|P2|Overall Study|Not Treated|17
467478|NCT00262600|1531433|P1|Overall Study|Not Treated|32
467479|NCT00262600|1531431|P3|Overall Study|Withdrawal by Subject|139
467480|NCT00262600|1531432|P2|Overall Study|Withdrawal by Subject|145
467481|NCT00262600|1531433|P1|Overall Study|Withdrawal by Subject|128
467482|NCT00262600|1531431|P3|Overall Study|Lost to Follow-up|41
467483|NCT00262600|1531432|P2|Overall Study|Lost to Follow-up|31
467484|NCT00262600|1531433|P1|Overall Study|Lost to Follow-up|17
467485|NCT00262522|1531460|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
467486|NCT00262522|1531461|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
467487|NCT00262522|1531462|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
467488|NCT00262522|1531463|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
467489|NCT00262522|1531460|P4|Study Start Through 96 Weeks|Virologic failure|0
467490|NCT00262522|1531461|P3|Study Start Through 96 Weeks|Virologic failure|8
467491|NCT00262522|1531462|P2|Study Start Through 96 Weeks|Virologic failure|0
467492|NCT00262522|1531463|P1|Study Start Through 96 Weeks|Virologic failure|5
467493|NCT00262522|1531460|P4|Study Start Through 96 Weeks|Death|0
467494|NCT00262522|1531461|P3|Study Start Through 96 Weeks|Death|2
467495|NCT00262522|1531462|P2|Study Start Through 96 Weeks|Death|0
467496|NCT00262522|1531463|P1|Study Start Through 96 Weeks|Death|2
467497|NCT00262522|1531460|P4|Study Start Through 96 Weeks|Noncompliance|0
467498|NCT00262522|1531461|P3|Study Start Through 96 Weeks|Noncompliance|11
467499|NCT00262522|1531462|P2|Study Start Through 96 Weeks|Noncompliance|0
467500|NCT00262522|1531463|P1|Study Start Through 96 Weeks|Noncompliance|6
467501|NCT00262522|1531460|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
467502|NCT00262522|1531461|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
467503|NCT00262522|1531462|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
467504|NCT00262522|1531463|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
467505|NCT00262522|1531460|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
467506|NCT00262522|1531461|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
467507|NCT00262522|1531462|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
467508|NCT00262522|1531463|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
467509|NCT00262522|1531460|P4|Study Start Through 96 Weeks|Adverse Event|0
467510|NCT00262522|1531461|P3|Study Start Through 96 Weeks|Adverse Event|16
467511|NCT00262522|1531462|P2|Study Start Through 96 Weeks|Adverse Event|0
467512|NCT00262522|1531463|P1|Study Start Through 96 Weeks|Adverse Event|20
467513|NCT00262522|1531460|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
467514|NCT00262522|1531461|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
467515|NCT00262522|1531462|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
467516|NCT00262522|1531463|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
467517|NCT00262522|1531460|P4|Study Start Through 48 Weeks|Virologic failure|0
467518|NCT00262522|1531461|P3|Study Start Through 48 Weeks|Virologic failure|4
467519|NCT00262522|1531462|P2|Study Start Through 48 Weeks|Virologic failure|0
467520|NCT00262522|1531463|P1|Study Start Through 48 Weeks|Virologic failure|2
467521|NCT00262522|1531460|P4|Study Start Through 48 Weeks|Death|0
467522|NCT00262522|1531461|P3|Study Start Through 48 Weeks|Death|1
467523|NCT00262522|1531462|P2|Study Start Through 48 Weeks|Death|0
467524|NCT00262522|1531463|P1|Study Start Through 48 Weeks|Death|2
467525|NCT00262522|1531460|P4|Study Start Through 48 Weeks|Noncompliance|0
467526|NCT00262522|1531461|P3|Study Start Through 48 Weeks|Noncompliance|8
467527|NCT00262522|1531462|P2|Study Start Through 48 Weeks|Noncompliance|0
467528|NCT00262522|1531463|P1|Study Start Through 48 Weeks|Noncompliance|3
467529|NCT00262522|1531460|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
467530|NCT00262522|1531461|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
467531|NCT00262522|1531462|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
467532|NCT00262522|1531463|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
467533|NCT00262522|1531460|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
467534|NCT00262522|1531461|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
467535|NCT00262522|1531462|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
467536|NCT00262522|1531463|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
467537|NCT00262522|1531460|P4|Study Start Through 48 Weeks|Adverse Event|0
467538|NCT00262522|1531461|P3|Study Start Through 48 Weeks|Adverse Event|10
467539|NCT00262522|1531462|P2|Study Start Through 48 Weeks|Adverse Event|0
467540|NCT00262522|1531463|P1|Study Start Through 48 Weeks|Adverse Event|16
467541|NCT00262522|1531460|P4|Study Start Through 8 Weeks|Death|0
467542|NCT00262522|1531461|P3|Study Start Through 8 Weeks|Death|0
467543|NCT00262522|1531462|P2|Study Start Through 8 Weeks|Death|0
467544|NCT00262522|1531463|P1|Study Start Through 8 Weeks|Death|1
467545|NCT00262522|1531460|P4|Study Start Through 8 Weeks|Noncompliance|2
467546|NCT00262522|1531461|P3|Study Start Through 8 Weeks|Noncompliance|2
467547|NCT00262522|1531462|P2|Study Start Through 8 Weeks|Noncompliance|0
467548|NCT00262522|1531463|P1|Study Start Through 8 Weeks|Noncompliance|0
467549|NCT00262522|1531460|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
467550|NCT00262522|1531461|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
467551|NCT00262522|1531462|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
467552|NCT00262522|1531463|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
467553|NCT00262522|1531460|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
467554|NCT00262522|1531461|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
467555|NCT00262522|1531462|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
467556|NCT00262522|1531463|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
467557|NCT00262522|1531460|P4|Study Start Through 8 Weeks|Adverse Event|1
467558|NCT00262522|1531461|P3|Study Start Through 8 Weeks|Adverse Event|3
467559|NCT00262522|1531462|P2|Study Start Through 8 Weeks|Adverse Event|2
467560|NCT00262522|1531463|P1|Study Start Through 8 Weeks|Adverse Event|1
467561|NCT00262314|1531492|P1|Overall Study|Administrative withdrawal|30
467562|NCT00262314|1531492|P1|Overall Study|Lost to Follow-up|70
467563|NCT00262314|1531492|P1|Overall Study|Not specified|95
467564|NCT00262314|1531492|P1|Overall Study|Patient's decision|92
467565|NCT00262314|1531492|P1|Overall Study|Death|12
467566|NCT00262314|1531492|P1|Overall Study|Changing physicians|38
467567|NCT00262301|1531510|P3|Double-blind Phase|"worsening of HAE symptoms"|0
467568|NCT00262301|1531511|P2|Double-blind Phase|"worsening of HAE symptoms"|1
467569|NCT00262301|1531512|P1|Double-blind Phase|"worsening of HAE symptoms"|0
467570|NCT00262301|1531510|P3|Double-blind Phase|Lost to Follow-up|0
467571|NCT00262301|1531511|P2|Double-blind Phase|Lost to Follow-up|0
467572|NCT00262301|1531512|P1|Double-blind Phase|Lost to Follow-up|1
467573|NCT00262223|1531525|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
467574|NCT00262223|1531526|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
467575|NCT00262223|1531525|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
467576|NCT00262223|1531526|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
467577|NCT00262223|1531525|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
467578|NCT00262223|1531526|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
467579|NCT00262223|1531525|P2|Treatment Phase|Adverse Event|2
467580|NCT00262223|1531526|P1|Treatment Phase|Adverse Event|1
467581|NCT00262223|1531525|P2|Treatment Phase|Withdrawal by Subject|6
467582|NCT00262223|1531526|P1|Treatment Phase|Withdrawal by Subject|3
467583|NCT00262119|1531537|P3|Overall Study|Death|16
467584|NCT00262119|1531538|P2|Overall Study|Death|19
467585|NCT00262119|1531539|P1|Overall Study|Death|20
467586|NCT00262119|1531537|P3|Overall Study|Lost to Follow-up|42
467587|NCT00262119|1531538|P2|Overall Study|Lost to Follow-up|51
467588|NCT00262119|1531539|P1|Overall Study|Lost to Follow-up|38
467589|NCT00262080|1531559|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
467590|NCT00262080|1531560|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
467591|NCT00262080|1531561|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
467592|NCT00262080|1531559|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
467593|NCT00262080|1531560|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
467594|NCT00262080|1531561|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
467595|NCT00262080|1531559|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
467596|NCT00262080|1531560|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
467597|NCT00262080|1531561|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
467598|NCT00262080|1531559|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
467599|NCT00262080|1531560|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
467600|NCT00262080|1531561|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
467601|NCT00262080|1531559|P3|Repeat Dose Treatment Period|Adverse Event|0
467602|NCT00262080|1531560|P2|Repeat Dose Treatment Period|Adverse Event|0
467603|NCT00262080|1531561|P1|Repeat Dose Treatment Period|Adverse Event|1
467604|NCT00262080|1531559|P3|Double Blind Treatment Period|Lost to Follow-up|0
467605|NCT00262080|1531560|P2|Double Blind Treatment Period|Lost to Follow-up|0
467606|NCT00262080|1531561|P1|Double Blind Treatment Period|Lost to Follow-up|1
467607|NCT00262067|1531581|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
467608|NCT00262067|1531582|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
467609|NCT00262067|1531583|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
467610|NCT00262067|1531584|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
467611|NCT00262067|1531581|P4|Overall Study|Sponsor's Decision to Terminate Study|0
467612|NCT00262067|1531582|P3|Overall Study|Sponsor's Decision to Terminate Study|0
467613|NCT00262067|1531583|P2|Overall Study|Sponsor's Decision to Terminate Study|0
467614|NCT00262067|1531584|P1|Overall Study|Sponsor's Decision to Terminate Study|1
467615|NCT00262067|1531581|P4|Overall Study|Lost to Follow-up|5
467616|NCT00262067|1531582|P3|Overall Study|Lost to Follow-up|7
467617|NCT00262067|1531583|P2|Overall Study|Lost to Follow-up|4
467618|NCT00262067|1531584|P1|Overall Study|Lost to Follow-up|5
467619|NCT00262067|1531581|P4|Overall Study|Death|99
467620|NCT00262067|1531582|P3|Overall Study|Death|186
467621|NCT00262067|1531583|P2|Overall Study|Death|89
467622|NCT00262067|1531584|P1|Overall Study|Death|190
467623|NCT00262041|1531618|P3|Overall Study|Unable to classify|0
467624|NCT00262041|1531619|P2|Overall Study|Unable to classify|0
467625|NCT00262041|1531620|P1|Overall Study|Unable to classify|1
467626|NCT00262041|1531618|P3|Overall Study|Lost to Follow-up|5
467627|NCT00262041|1531619|P2|Overall Study|Lost to Follow-up|1
467628|NCT00262041|1531620|P1|Overall Study|Lost to Follow-up|1
467629|NCT00262041|1531618|P3|Overall Study|Withdrawal by Subject|1
467630|NCT00262041|1531619|P2|Overall Study|Withdrawal by Subject|3
467631|NCT00262041|1531620|P1|Overall Study|Withdrawal by Subject|0
467632|NCT00262028|1531649|P9|Overall Study|Unable to classify|1
467633|NCT00262028|1531650|P8|Overall Study|Unable to classify|0
467634|NCT00262028|1531651|P7|Overall Study|Unable to classify|0
467635|NCT00262028|1531652|P6|Overall Study|Unable to classify|0
467636|NCT00262028|1531653|P5|Overall Study|Unable to classify|0
467637|NCT00262028|1531654|P4|Overall Study|Unable to classify|0
467638|NCT00262028|1531655|P3|Overall Study|Unable to classify|0
467639|NCT00262028|1531656|P2|Overall Study|Unable to classify|3
467640|NCT00262028|1531657|P1|Overall Study|Unable to classify|0
467641|NCT00262028|1531649|P9|Overall Study|Protocol Violation|0
467642|NCT00262028|1531650|P8|Overall Study|Protocol Violation|0
467643|NCT00262028|1531651|P7|Overall Study|Protocol Violation|0
467644|NCT00262028|1531652|P6|Overall Study|Protocol Violation|0
467645|NCT00262028|1531653|P5|Overall Study|Protocol Violation|0
467646|NCT00262028|1531654|P4|Overall Study|Protocol Violation|1
467647|NCT00262028|1531655|P3|Overall Study|Protocol Violation|0
467648|NCT00262028|1531656|P2|Overall Study|Protocol Violation|0
467649|NCT00262028|1531657|P1|Overall Study|Protocol Violation|0
467650|NCT00262028|1531649|P9|Overall Study|Administrative Reason|10
467651|NCT00262028|1531650|P8|Overall Study|Administrative Reason|6
467652|NCT00262028|1531651|P7|Overall Study|Administrative Reason|4
467653|NCT00262028|1531652|P6|Overall Study|Administrative Reason|7
467654|NCT00262028|1531653|P5|Overall Study|Administrative Reason|6
467655|NCT00262028|1531654|P4|Overall Study|Administrative Reason|12
467656|NCT00262028|1531655|P3|Overall Study|Administrative Reason|9
467657|NCT00262028|1531656|P2|Overall Study|Administrative Reason|14
467658|NCT00262028|1531657|P1|Overall Study|Administrative Reason|11
467659|NCT00262028|1531649|P9|Overall Study|Lost to Follow-up|6
467660|NCT00262028|1531650|P8|Overall Study|Lost to Follow-up|5
467661|NCT00262028|1531651|P7|Overall Study|Lost to Follow-up|3
467662|NCT00262028|1531652|P6|Overall Study|Lost to Follow-up|3
467663|NCT00262028|1531653|P5|Overall Study|Lost to Follow-up|4
467664|NCT00262028|1531654|P4|Overall Study|Lost to Follow-up|5
467665|NCT00262028|1531655|P3|Overall Study|Lost to Follow-up|5
467666|NCT00262028|1531656|P2|Overall Study|Lost to Follow-up|7
467667|NCT00262028|1531657|P1|Overall Study|Lost to Follow-up|7
467668|NCT00262028|1531649|P9|Overall Study|Withdrawal by Subject|2
467669|NCT00262028|1531650|P8|Overall Study|Withdrawal by Subject|7
467670|NCT00262028|1531651|P7|Overall Study|Withdrawal by Subject|5
467671|NCT00262028|1531652|P6|Overall Study|Withdrawal by Subject|3
467672|NCT00262028|1531653|P5|Overall Study|Withdrawal by Subject|2
467673|NCT00262028|1531654|P4|Overall Study|Withdrawal by Subject|5
467674|NCT00262028|1531655|P3|Overall Study|Withdrawal by Subject|6
467675|NCT00262028|1531656|P2|Overall Study|Withdrawal by Subject|3
467676|NCT00262028|1531657|P1|Overall Study|Withdrawal by Subject|6
467677|NCT00262002|1531719|P7|Overall Study|Unable to classify|2
467678|NCT00262002|1531720|P6|Overall Study|Unable to classify|0
467679|NCT00262002|1531721|P5|Overall Study|Unable to classify|0
467680|NCT00262002|1531722|P4|Overall Study|Unable to classify|0
467681|NCT00262002|1531723|P3|Overall Study|Unable to classify|0
467682|NCT00262002|1531724|P2|Overall Study|Unable to classify|0
467683|NCT00262002|1531725|P1|Overall Study|Unable to classify|0
467684|NCT00262002|1531719|P7|Overall Study|Protocol Violation|2
467685|NCT00262002|1531720|P6|Overall Study|Protocol Violation|3
467686|NCT00262002|1531721|P5|Overall Study|Protocol Violation|5
467687|NCT00262002|1531722|P4|Overall Study|Protocol Violation|2
467688|NCT00262002|1531723|P3|Overall Study|Protocol Violation|0
467689|NCT00262002|1531724|P2|Overall Study|Protocol Violation|2
467690|NCT00262002|1531725|P1|Overall Study|Protocol Violation|3
467691|NCT00262002|1531719|P7|Overall Study|Inapropriate enrollment|0
467692|NCT00262002|1531720|P6|Overall Study|Inapropriate enrollment|0
467693|NCT00262002|1531721|P5|Overall Study|Inapropriate enrollment|0
467694|NCT00262002|1531722|P4|Overall Study|Inapropriate enrollment|0
467695|NCT00262002|1531723|P3|Overall Study|Inapropriate enrollment|0
467696|NCT00262002|1531724|P2|Overall Study|Inapropriate enrollment|1
467697|NCT00262002|1531725|P1|Overall Study|Inapropriate enrollment|0
467698|NCT00262002|1531719|P7|Overall Study|Lost to Follow-up|0
467699|NCT00262002|1531720|P6|Overall Study|Lost to Follow-up|1
467700|NCT00262002|1531721|P5|Overall Study|Lost to Follow-up|0
467701|NCT00262002|1531722|P4|Overall Study|Lost to Follow-up|2
467702|NCT00262002|1531723|P3|Overall Study|Lost to Follow-up|0
467703|NCT00262002|1531724|P2|Overall Study|Lost to Follow-up|0
467704|NCT00262002|1531725|P1|Overall Study|Lost to Follow-up|2
467705|NCT00262002|1531719|P7|Overall Study|Withdrawal by Subject|2
467706|NCT00262002|1531720|P6|Overall Study|Withdrawal by Subject|2
467707|NCT00262002|1531721|P5|Overall Study|Withdrawal by Subject|2
467708|NCT00262002|1531722|P4|Overall Study|Withdrawal by Subject|1
467709|NCT00262002|1531723|P3|Overall Study|Withdrawal by Subject|0
467710|NCT00262002|1531724|P2|Overall Study|Withdrawal by Subject|2
467711|NCT00262002|1531725|P1|Overall Study|Withdrawal by Subject|4
467712|NCT00262002|1531719|P7|Overall Study|Adverse Event|0
467713|NCT00262002|1531720|P6|Overall Study|Adverse Event|1
467714|NCT00262002|1531721|P5|Overall Study|Adverse Event|0
467715|NCT00262002|1531722|P4|Overall Study|Adverse Event|0
467716|NCT00262002|1531723|P3|Overall Study|Adverse Event|0
467717|NCT00262002|1531724|P2|Overall Study|Adverse Event|1
467718|NCT00262002|1531725|P1|Overall Study|Adverse Event|2
467719|NCT00261950|1531818|P1|Overall Study|Protocol specified Criteria|11
467720|NCT00261950|1531818|P1|Overall Study|Physician Decision|1
467721|NCT00261950|1531818|P1|Overall Study|not specified|1
467722|NCT00261950|1531818|P1|Overall Study|Withdrawal by Subject|5
467723|NCT00261950|1531818|P1|Overall Study|Death|6
467724|NCT00261950|1531818|P1|Overall Study|Lost to Follow-up|2
467725|NCT00261846|1531843|P12|Period 2: Part 2 (Efficacy)|Extension study|1
467726|NCT00261846|1531844|P11|Period 2: Part 2 (Efficacy)|Extension study|1
467727|NCT00261846|1531845|P10|Period 2: Part 2 (Efficacy)|Extension study|9
467728|NCT00261846|1531846|P9|Period 2: Part 2 (Efficacy)|Extension study|5
467729|NCT00261846|1531847|P8|Period 2: Part 2 (Efficacy)|Extension study|9
467730|NCT00261846|1531848|P7|Period 2: Part 2 (Efficacy)|Extension study|4
467731|NCT00261846|1531849|P6|Period 2: Part 2 (Efficacy)|Extension study|0
467732|NCT00261846|1531850|P5|Period 2: Part 2 (Efficacy)|Extension study|27
467733|NCT00261846|1531851|P4|Period 2: Part 2 (Efficacy)|Extension study|61
467734|NCT00261846|1531852|P3|Period 2: Part 2 (Efficacy)|Extension study|0
467735|NCT00261846|1531853|P2|Period 2: Part 2 (Efficacy)|Extension study|0
467736|NCT00261846|1531854|P1|Period 2: Part 2 (Efficacy)|Extension study|0
467737|NCT00261846|1531843|P12|Period 2: Part 2 (Efficacy)|Death|22
467738|NCT00261846|1531844|P11|Period 2: Part 2 (Efficacy)|Death|44
467739|NCT00261846|1531845|P10|Period 2: Part 2 (Efficacy)|Death|30
467740|NCT00261846|1531846|P9|Period 2: Part 2 (Efficacy)|Death|3
467741|NCT00261846|1531847|P8|Period 2: Part 2 (Efficacy)|Death|12
467742|NCT00261846|1531848|P7|Period 2: Part 2 (Efficacy)|Death|10
467743|NCT00261846|1531849|P6|Period 2: Part 2 (Efficacy)|Death|1
467744|NCT00261846|1531850|P5|Period 2: Part 2 (Efficacy)|Death|7
467745|NCT00261846|1531851|P4|Period 2: Part 2 (Efficacy)|Death|37
467746|NCT00261846|1531852|P3|Period 2: Part 2 (Efficacy)|Death|0
467747|NCT00261846|1531853|P2|Period 2: Part 2 (Efficacy)|Death|0
467748|NCT00261846|1531854|P1|Period 2: Part 2 (Efficacy)|Death|0
467749|NCT00261846|1531843|P12|Period 2: Part 2 (Efficacy)|Other|0
467750|NCT00261846|1531844|P11|Period 2: Part 2 (Efficacy)|Other|0
467751|NCT00261846|1531845|P10|Period 2: Part 2 (Efficacy)|Other|4
467752|NCT00261846|1531846|P9|Period 2: Part 2 (Efficacy)|Other|4
467753|NCT00261846|1531847|P8|Period 2: Part 2 (Efficacy)|Other|5
467754|NCT00261846|1531848|P7|Period 2: Part 2 (Efficacy)|Other|1
467755|NCT00261846|1531849|P6|Period 2: Part 2 (Efficacy)|Other|0
467756|NCT00261846|1531850|P5|Period 2: Part 2 (Efficacy)|Other|4
467757|NCT00261846|1531851|P4|Period 2: Part 2 (Efficacy)|Other|15
467758|NCT00261846|1531852|P3|Period 2: Part 2 (Efficacy)|Other|0
467759|NCT00261846|1531853|P2|Period 2: Part 2 (Efficacy)|Other|0
467760|NCT00261846|1531854|P1|Period 2: Part 2 (Efficacy)|Other|0
467761|NCT00261846|1531843|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
467762|NCT00261846|1531844|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
467763|NCT00261846|1531845|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
467764|NCT00261846|1531846|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
467765|NCT00261846|1531847|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
467766|NCT00261846|1531848|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
467767|NCT00261846|1531849|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
467768|NCT00261846|1531850|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
467769|NCT00261846|1531851|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
467770|NCT00261846|1531852|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
467771|NCT00261846|1531853|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
467772|NCT00261846|1531854|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
467773|NCT00261846|1531843|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
467774|NCT00261846|1531844|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
467775|NCT00261846|1531845|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
467776|NCT00261846|1531846|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
467777|NCT00261846|1531847|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
467778|NCT00261846|1531848|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
467779|NCT00261846|1531849|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
467780|NCT00261846|1531850|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
467781|NCT00261846|1531851|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
467782|NCT00261846|1531852|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
467783|NCT00261846|1531853|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
467784|NCT00261846|1531854|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
467785|NCT00261846|1531843|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467786|NCT00261846|1531844|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467787|NCT00261846|1531845|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467788|NCT00261846|1531846|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
467789|NCT00261846|1531847|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467790|NCT00261846|1531848|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467791|NCT00261846|1531849|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467792|NCT00261846|1531850|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467793|NCT00261846|1531851|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
467794|NCT00261846|1531852|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467795|NCT00261846|1531853|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467796|NCT00261846|1531854|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
467797|NCT00261846|1531843|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467798|NCT00261846|1531844|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467799|NCT00261846|1531845|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467800|NCT00261846|1531846|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467801|NCT00261846|1531847|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467802|NCT00261846|1531848|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467803|NCT00261846|1531849|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467804|NCT00261846|1531850|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467805|NCT00261846|1531851|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
467806|NCT00261846|1531852|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
467807|NCT00261846|1531853|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
467808|NCT00261846|1531854|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
467809|NCT00261833|1532113|P2|Overall Study|Not interested in being participant|1
467810|NCT00261833|1532114|P1|Overall Study|Not interested in being participant|0
467811|NCT00261833|1532113|P2|Overall Study|Missing reason|0
467812|NCT00261833|1532114|P1|Overall Study|Missing reason|1
467813|NCT00261833|1532113|P2|Overall Study|Lung transplantation|1
467814|NCT00261833|1532114|P1|Overall Study|Lung transplantation|1
467815|NCT00261833|1532113|P2|Overall Study|Suspicion of pulmonary cancer|1
467816|NCT00261833|1532114|P1|Overall Study|Suspicion of pulmonary cancer|0
467817|NCT00261833|1532113|P2|Overall Study|Protocol Violation|1
467818|NCT00261833|1532114|P1|Overall Study|Protocol Violation|0
467819|NCT00261833|1532113|P2|Overall Study|Withdrawal by Subject|7
467820|NCT00261833|1532114|P1|Overall Study|Withdrawal by Subject|5
467821|NCT00261833|1532113|P2|Overall Study|Adverse Event|4
467822|NCT00261833|1532114|P1|Overall Study|Adverse Event|1
467823|NCT00261833|1532113|P2|Overall Study|Death|3
467824|NCT00261833|1532114|P1|Overall Study|Death|1
467825|NCT00261716|1532148|P2|Overall Study|Lost to Follow-up|2
467826|NCT00261716|1532149|P1|Overall Study|Lost to Follow-up|0
467827|NCT00261716|1532148|P2|Overall Study|Withdrawal by Subject|8
467828|NCT00261716|1532149|P1|Overall Study|Withdrawal by Subject|6
467829|NCT00261495|1532169|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
467830|NCT00261495|1532170|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
467831|NCT00261495|1532169|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
467832|NCT00261495|1532170|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
467833|NCT00261495|1532169|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
467834|NCT00261495|1532170|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
467835|NCT00261495|1532169|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
467836|NCT00261495|1532170|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
467837|NCT00261495|1532169|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
467838|NCT00261495|1532170|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
467839|NCT00261495|1532169|P2|Extension Phase (Weeks 24 to 52)|Other|2
467840|NCT00261495|1532170|P1|Extension Phase (Weeks 24 to 52)|Other|4
467841|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
467842|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
467843|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
467844|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
467845|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
467846|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
467847|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
467848|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
467849|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
467850|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
467851|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
467852|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
467853|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
467854|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
467855|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
467856|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
467857|NCT00261495|1532169|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
467858|NCT00261495|1532170|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
467859|NCT00261495|1532169|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
467860|NCT00261495|1532170|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
467861|NCT00261495|1532169|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
467862|NCT00261495|1532170|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
467863|NCT00261495|1532169|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
467864|NCT00261495|1532170|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
467865|NCT00261495|1532169|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
467866|NCT00261495|1532170|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
467867|NCT00261495|1532169|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
467868|NCT00261495|1532170|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
467869|NCT00261495|1532169|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
467870|NCT00261495|1532170|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
467871|NCT00261443|1532334|P3|4: Extension Phase|Lost to Follow-up|0
467872|NCT00261443|1532335|P2|4: Extension Phase|Lost to Follow-up|1
467873|NCT00261443|1532336|P1|4: Extension Phase|Lost to Follow-up|0
467874|NCT00261443|1532334|P3|4: Extension Phase|Withdrawal by Subject|2
467875|NCT00261443|1532335|P2|4: Extension Phase|Withdrawal by Subject|1
467876|NCT00261443|1532336|P1|4: Extension Phase|Withdrawal by Subject|0
467877|NCT00261443|1532334|P3|4: Extension Phase|Adverse Event|0
467878|NCT00261443|1532335|P2|4: Extension Phase|Adverse Event|1
467879|NCT00261443|1532336|P1|4: Extension Phase|Adverse Event|0
467880|NCT00261443|1532334|P3|3: Assessment of Relapse|Other Reasons|3
467881|NCT00261443|1532335|P2|3: Assessment of Relapse|Other Reasons|4
467882|NCT00261443|1532336|P1|3: Assessment of Relapse|Other Reasons|0
467883|NCT00261443|1532334|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
467884|NCT00261443|1532335|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
467885|NCT00261443|1532336|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
467886|NCT00261443|1532334|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
467887|NCT00261443|1532335|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
467888|NCT00261443|1532336|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
467889|NCT00261443|1532334|P3|3: Assessment of Relapse|Pregnancy|1
467890|NCT00261443|1532335|P2|3: Assessment of Relapse|Pregnancy|2
467891|NCT00261443|1532336|P1|3: Assessment of Relapse|Pregnancy|0
467892|NCT00261443|1532334|P3|3: Assessment of Relapse|Poor/Noncompliance|3
467893|NCT00261443|1532335|P2|3: Assessment of Relapse|Poor/Noncompliance|5
467894|NCT00261443|1532336|P1|3: Assessment of Relapse|Poor/Noncompliance|0
467895|NCT00261443|1532334|P3|3: Assessment of Relapse|Lost to Follow-up|6
467896|NCT00261443|1532335|P2|3: Assessment of Relapse|Lost to Follow-up|7
467897|NCT00261443|1532336|P1|3: Assessment of Relapse|Lost to Follow-up|0
467898|NCT00261443|1532334|P3|3: Assessment of Relapse|Death|1
467899|NCT00261443|1532335|P2|3: Assessment of Relapse|Death|0
467900|NCT00261443|1532336|P1|3: Assessment of Relapse|Death|0
467901|NCT00261443|1532334|P3|3: Assessment of Relapse|Withdrawal by Subject|15
467902|NCT00261443|1532335|P2|3: Assessment of Relapse|Withdrawal by Subject|14
467903|NCT00261443|1532336|P1|3: Assessment of Relapse|Withdrawal by Subject|0
467904|NCT00261443|1532334|P3|3: Assessment of Relapse|Adverse Event|19
467905|NCT00261443|1532335|P2|3: Assessment of Relapse|Adverse Event|15
467906|NCT00261443|1532336|P1|3: Assessment of Relapse|Adverse Event|0
467907|NCT00261443|1532334|P3|3: Assessment of Relapse|Lack of Efficacy|14
467908|NCT00261443|1532335|P2|3: Assessment of Relapse|Lack of Efficacy|31
467909|NCT00261443|1532336|P1|3: Assessment of Relapse|Lack of Efficacy|0
467910|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Other Reasons|0
467911|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Other Reasons|0
467912|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Other Reasons|13
467913|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
467914|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
467915|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
467916|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
467917|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
467918|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
467919|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Pregnancy|0
467920|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Pregnancy|0
467921|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Pregnancy|1
467922|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
467923|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
467924|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
467925|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
467926|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
467927|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
467928|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
467929|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
467930|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
467931|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Adverse Event|0
467932|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Adverse Event|0
467933|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Adverse Event|93
467934|NCT00261443|1532334|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
467935|NCT00261443|1532335|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
467936|NCT00261443|1532336|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
467937|NCT00261443|1532334|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
467938|NCT00261443|1532335|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
467939|NCT00261443|1532336|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
467940|NCT00261443|1532334|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
467941|NCT00261443|1532335|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
467942|NCT00261443|1532336|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
467943|NCT00261443|1532334|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
467944|NCT00261443|1532335|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
467945|NCT00261443|1532336|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
467946|NCT00261443|1532334|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
467947|NCT00261443|1532335|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
467948|NCT00261443|1532336|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
467949|NCT00261443|1532334|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
467950|NCT00261443|1532335|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
467951|NCT00261443|1532336|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
467952|NCT00261443|1532334|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
467953|NCT00261443|1532335|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
467954|NCT00261443|1532336|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
467955|NCT00261443|1532334|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
467956|NCT00261443|1532335|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
467957|NCT00261443|1532336|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
467958|NCT00260832|1532604|P2|Overall Study|Protocol Violation|1
467959|NCT00260832|1532605|P1|Overall Study|Protocol Violation|3
467960|NCT00260832|1532604|P2|Overall Study|Not Specified|7
467961|NCT00260832|1532605|P1|Overall Study|Not Specified|10
467962|NCT00260832|1532604|P2|Overall Study|Death|62
467963|NCT00260832|1532605|P1|Overall Study|Death|43
467964|NCT00260832|1532604|P2|Overall Study|Physician Decision|9
467965|NCT00260832|1532605|P1|Overall Study|Physician Decision|15
467966|NCT00260832|1532604|P2|Overall Study|Withdrawal by Subject|17
467967|NCT00260832|1532605|P1|Overall Study|Withdrawal by Subject|15
467968|NCT00260832|1532604|P2|Overall Study|Progression|96
467969|NCT00260832|1532605|P1|Overall Study|Progression|116
467970|NCT00260832|1532604|P2|Overall Study|Adverse Event|19
467971|NCT00260832|1532605|P1|Overall Study|Adverse Event|26
467972|NCT00260533|1532632|P2|Overall Study|Other|3
467973|NCT00260533|1532633|P1|Overall Study|Other|3
467974|NCT00260429|1532641|P2|Overall Study|scheduled hand surgery|0
467975|NCT00260429|1532642|P1|Overall Study|scheduled hand surgery|1
467976|NCT00260429|1532641|P2|Overall Study|failure to follow appointments|0
467977|NCT00260429|1532642|P1|Overall Study|failure to follow appointments|1
467978|NCT00260208|1532650|P2|Overall Study|Missing|16
467979|NCT00260208|1532651|P1|Overall Study|Missing|18
467980|NCT00260208|1532650|P2|Overall Study|Death|10
467981|NCT00260208|1532651|P1|Overall Study|Death|12
467982|NCT00260208|1532650|P2|Overall Study|Lost to Follow-up|1
467983|NCT00260208|1532651|P1|Overall Study|Lost to Follow-up|6
467984|NCT00260208|1532650|P2|Overall Study|Subject withdrew consent|7
467985|NCT00260208|1532651|P1|Overall Study|Subject withdrew consent|11
467986|NCT00260065|1532694|P1|Overall Study|Medication Noncompliance|1
467987|NCT00260065|1532694|P1|Overall Study|Not otherwise specified|8
467988|NCT00260065|1532694|P1|Overall Study|Physician Decision|19
467989|NCT00260065|1532694|P1|Overall Study|Withdrawal by Subject|13
467990|NCT00260065|1532694|P1|Overall Study|Death|13
467991|NCT00260065|1532694|P1|Overall Study|Adverse Event|17
467992|NCT00260065|1532694|P1|Overall Study|Progressive Disease|22
467993|NCT00259857|1532701|P2|24 Months Treatment|Lost to Follow-up|3
467994|NCT00259857|1532702|P1|24 Months Treatment|Lost to Follow-up|0
467995|NCT00259857|1532701|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
467996|NCT00259857|1532702|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
467997|NCT00259740|1532720|P2|Overall Study|Requirement for alternative therapy|4
467998|NCT00259740|1532721|P1|Overall Study|Requirement for alternative therapy|0
467999|NCT00259740|1532720|P2|Overall Study|Other|0
468000|NCT00259740|1532721|P1|Overall Study|Other|3
468001|NCT00259740|1532720|P2|Overall Study|Ongoing|3
468002|NCT00259740|1532721|P1|Overall Study|Ongoing|17
468003|NCT00259740|1532720|P2|Overall Study|Disease progression|36
468004|NCT00259740|1532721|P1|Overall Study|Disease progression|19
468005|NCT00259740|1532720|P2|Overall Study|Death|1
468006|NCT00259740|1532721|P1|Overall Study|Death|1
468007|NCT00259740|1532720|P2|Overall Study|Withdrawal by Subject|6
468008|NCT00259740|1532721|P1|Overall Study|Withdrawal by Subject|2
468009|NCT00259740|1532720|P2|Overall Study|Adverse Event|2
468010|NCT00259740|1532721|P1|Overall Study|Adverse Event|0
468011|NCT00259740|1532720|P2|Overall Study|Physician Decision|1
468012|NCT00259740|1532721|P1|Overall Study|Physician Decision|1
468013|NCT00259649|1532731|P1|Overall Study|irregular menses|3
468014|NCT00259649|1532731|P1|Overall Study|Lost to Follow-up|7
468015|NCT00259610|1532739|P4|Overall Study|Serious Adverse Event|2
468016|NCT00259610|1532740|P3|Overall Study|Serious Adverse Event|2
468017|NCT00259610|1532741|P2|Overall Study|Serious Adverse Event|2
468018|NCT00259610|1532742|P1|Overall Study|Serious Adverse Event|8
468019|NCT00259610|1532739|P4|Overall Study|Adverse Event|2
468020|NCT00259610|1532740|P3|Overall Study|Adverse Event|5
468021|NCT00259610|1532741|P2|Overall Study|Adverse Event|4
468022|NCT00259610|1532742|P1|Overall Study|Adverse Event|3
468023|NCT00259610|1532739|P4|Overall Study|non medical reason|3
468024|NCT00259610|1532740|P3|Overall Study|non medical reason|10
468025|NCT00259610|1532741|P2|Overall Study|non medical reason|2
468026|NCT00259610|1532742|P1|Overall Study|non medical reason|6
468027|NCT00259610|1532739|P4|Overall Study|Death|0
468028|NCT00259610|1532740|P3|Overall Study|Death|2
468029|NCT00259610|1532741|P2|Overall Study|Death|1
468030|NCT00259610|1532742|P1|Overall Study|Death|1
468031|NCT00259610|1532739|P4|Overall Study|Physician Decision|2
468032|NCT00259610|1532740|P3|Overall Study|Physician Decision|7
468033|NCT00259610|1532741|P2|Overall Study|Physician Decision|4
468034|NCT00259610|1532742|P1|Overall Study|Physician Decision|6
468035|NCT00259610|1532739|P4|Overall Study|Lost to Follow-up|15
468036|NCT00259610|1532740|P3|Overall Study|Lost to Follow-up|18
468037|NCT00259610|1532741|P2|Overall Study|Lost to Follow-up|8
468038|NCT00259610|1532742|P1|Overall Study|Lost to Follow-up|19
468039|NCT00259610|1532739|P4|Overall Study|Withdrawal by Subject|19
468040|NCT00259610|1532740|P3|Overall Study|Withdrawal by Subject|29
468041|NCT00259610|1532741|P2|Overall Study|Withdrawal by Subject|25
468042|NCT00259610|1532742|P1|Overall Study|Withdrawal by Subject|33
468043|NCT00259298|1532756|P1|Overall Study|Physician Decision|2
468044|NCT00259298|1532756|P1|Overall Study|Withdrawal by Subject|1
468045|NCT00259272|1532774|P4|Overall Study|Lost to Follow-up|1
468046|NCT00259272|1532775|P3|Overall Study|Lost to Follow-up|0
468047|NCT00259272|1532776|P2|Overall Study|Lost to Follow-up|0
468048|NCT00259272|1532777|P1|Overall Study|Lost to Follow-up|1
468049|NCT00259272|1532774|P4|Overall Study|Withdrawal by Subject|7
468050|NCT00259272|1532775|P3|Overall Study|Withdrawal by Subject|2
468051|NCT00259272|1532776|P2|Overall Study|Withdrawal by Subject|2
468052|NCT00259272|1532777|P1|Overall Study|Withdrawal by Subject|4
468053|NCT00259272|1532774|P4|Overall Study|Sponsor Decision|0
468054|NCT00259272|1532775|P3|Overall Study|Sponsor Decision|0
468055|NCT00259272|1532776|P2|Overall Study|Sponsor Decision|1
468056|NCT00259272|1532777|P1|Overall Study|Sponsor Decision|0
468057|NCT00259272|1532774|P4|Overall Study|Protocol Violation|1
468058|NCT00259272|1532775|P3|Overall Study|Protocol Violation|0
468059|NCT00259272|1532776|P2|Overall Study|Protocol Violation|0
468060|NCT00259272|1532777|P1|Overall Study|Protocol Violation|2
468061|NCT00259272|1532774|P4|Overall Study|Physician Decision|3
468062|NCT00259272|1532775|P3|Overall Study|Physician Decision|1
468063|NCT00259272|1532776|P2|Overall Study|Physician Decision|2
468064|NCT00259272|1532777|P1|Overall Study|Physician Decision|1
468065|NCT00259272|1532774|P4|Overall Study|Lack of Efficacy|6
468066|NCT00259272|1532775|P3|Overall Study|Lack of Efficacy|2
468067|NCT00259272|1532776|P2|Overall Study|Lack of Efficacy|1
468068|NCT00259272|1532777|P1|Overall Study|Lack of Efficacy|5
468069|NCT00259272|1532774|P4|Overall Study|Adverse Event|3
468070|NCT00259272|1532775|P3|Overall Study|Adverse Event|0
468071|NCT00259272|1532776|P2|Overall Study|Adverse Event|1
468072|NCT00259272|1532777|P1|Overall Study|Adverse Event|2
468073|NCT00259012|1532873|P2|Overall Study|Protocol Violation|1
468074|NCT00259012|1532874|P1|Overall Study|Protocol Violation|1
468075|NCT00259012|1532873|P2|Overall Study|Lost to Follow-up|1
468076|NCT00259012|1532874|P1|Overall Study|Lost to Follow-up|0
468077|NCT00259012|1532873|P2|Overall Study|Physician Decision|1
468078|NCT00259012|1532874|P1|Overall Study|Physician Decision|0
468079|NCT00259012|1532873|P2|Overall Study|Withdrawal by Subject|0
468080|NCT00259012|1532874|P1|Overall Study|Withdrawal by Subject|1
468081|NCT00259012|1532873|P2|Overall Study|Adverse Event|1
468082|NCT00259012|1532874|P1|Overall Study|Adverse Event|0
468083|NCT00258895|1532914|P2|Overall Study|Withdrawal by Subject|0
468084|NCT00258895|1532915|P1|Overall Study|Withdrawal by Subject|1
468085|NCT00258895|1532914|P2|Overall Study|Protocol Violation|2
468086|NCT00258895|1532915|P1|Overall Study|Protocol Violation|6
468087|NCT00258895|1532914|P2|Overall Study|Lost to Follow-up|1
468088|NCT00258895|1532915|P1|Overall Study|Lost to Follow-up|3
468089|NCT00258856|1532951|P4|Overall Study|Non-compliance|1
468090|NCT00258856|1532952|P3|Overall Study|Non-compliance|0
468091|NCT00258856|1532953|P2|Overall Study|Non-compliance|0
468092|NCT00258856|1532954|P1|Overall Study|Non-compliance|2
468093|NCT00258856|1532951|P4|Overall Study|Lost to Follow-up|0
468094|NCT00258856|1532952|P3|Overall Study|Lost to Follow-up|2
468095|NCT00258856|1532953|P2|Overall Study|Lost to Follow-up|0
468096|NCT00258856|1532954|P1|Overall Study|Lost to Follow-up|1
468097|NCT00258674|1532995|P3|Overall Study|Death|34
468098|NCT00258674|1532996|P2|Overall Study|Death|53
468099|NCT00258674|1532997|P1|Overall Study|Death|32
468100|NCT00258440|1533056|P3|Overall Study|Withdrawal by Subject|1
468101|NCT00258440|1533057|P2|Overall Study|Withdrawal by Subject|0
468102|NCT00258440|1533058|P1|Overall Study|Withdrawal by Subject|0
468103|NCT00258154|1533091|P2|Overall Study|Patient Moved|1
468104|NCT00258154|1533092|P1|Overall Study|Patient Moved|3
468105|NCT00258154|1533091|P2|Overall Study|Withdrawal by Subject|4
468106|NCT00258154|1533092|P1|Overall Study|Withdrawal by Subject|3
468107|NCT00258154|1533091|P2|Overall Study|Protocol Violation|1
468108|NCT00258154|1533092|P1|Overall Study|Protocol Violation|2
468109|NCT00258154|1533091|P2|Overall Study|Lost to Follow-up|1
468110|NCT00258154|1533092|P1|Overall Study|Lost to Follow-up|0
468111|NCT00258154|1533091|P2|Overall Study|Adverse Event|0
468112|NCT00258154|1533092|P1|Overall Study|Adverse Event|1
468113|NCT00257920|1533176|P2|Period: Second Intervention|Other|1
468114|NCT00257920|1533177|P1|Period: Second Intervention|Other|2
468115|NCT00257920|1533176|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
468116|NCT00257920|1533177|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
468117|NCT00257660|1533233|P2|Overall Study|No longer wanted to do blood draws|0
468118|NCT00257660|1533234|P1|Overall Study|No longer wanted to do blood draws|1
468119|NCT00257660|1533233|P2|Overall Study|PI & Subject Schedule Conflicts|0
468120|NCT00257660|1533234|P1|Overall Study|PI & Subject Schedule Conflicts|1
468121|NCT00257660|1533233|P2|Overall Study|Lost to Follow-up|0
468122|NCT00257660|1533234|P1|Overall Study|Lost to Follow-up|1
468123|NCT00257660|1533233|P2|Overall Study|Withdrawal by Subject|0
468124|NCT00257660|1533234|P1|Overall Study|Withdrawal by Subject|2
468125|NCT00257660|1533233|P2|Overall Study|Lack of Efficacy|23
468126|NCT00257660|1533234|P1|Overall Study|Lack of Efficacy|5
468127|NCT00257608|1533264|P3|Post Chemotherapy Phase|Not treated|7
468128|NCT00257608|1533265|P2|Post Chemotherapy Phase|Not treated|4
468129|NCT00257608|1533266|P1|Post Chemotherapy Phase|Not treated|0
468130|NCT00257608|1533264|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
468131|NCT00257608|1533265|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
468132|NCT00257608|1533266|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
468133|NCT00257608|1533264|P3|Post Chemotherapy Phase|Physician Decision|11
468134|NCT00257608|1533265|P2|Post Chemotherapy Phase|Physician Decision|8
468135|NCT00257608|1533266|P1|Post Chemotherapy Phase|Physician Decision|0
468136|NCT00257608|1533264|P3|Post Chemotherapy Phase|Lost to Follow-up|1
468137|NCT00257608|1533265|P2|Post Chemotherapy Phase|Lost to Follow-up|0
468138|NCT00257608|1533266|P1|Post Chemotherapy Phase|Lost to Follow-up|0
468139|NCT00257608|1533264|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
468140|NCT00257608|1533265|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
468141|NCT00257608|1533266|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
468142|NCT00257608|1533264|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
468143|NCT00257608|1533265|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
468144|NCT00257608|1533266|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
468145|NCT00257608|1533264|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
468146|NCT00257608|1533265|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
468147|NCT00257608|1533266|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
468148|NCT00257608|1533264|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
468149|NCT00257608|1533265|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
468150|NCT00257608|1533266|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
468151|NCT00257608|1533264|P3|Post Chemotherapy Phase|Disease progression|168
468152|NCT00257608|1533265|P2|Post Chemotherapy Phase|Disease progression|204
468153|NCT00257608|1533266|P1|Post Chemotherapy Phase|Disease progression|0
468154|NCT00257608|1533264|P3|Post Chemotherapy Phase|Adverse Event|38
468155|NCT00257608|1533265|P2|Post Chemotherapy Phase|Adverse Event|34
468156|NCT00257608|1533266|P1|Post Chemotherapy Phase|Adverse Event|0
468157|NCT00257608|1533264|P3|Chemotherapy Phase|Physician Decision|0
468158|NCT00257608|1533265|P2|Chemotherapy Phase|Physician Decision|0
468159|NCT00257608|1533266|P1|Chemotherapy Phase|Physician Decision|28
468160|NCT00257608|1533264|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
468161|NCT00257608|1533265|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
468162|NCT00257608|1533266|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
468163|NCT00257608|1533264|P3|Chemotherapy Phase|Patient's decision to discontinue|0
468164|NCT00257608|1533265|P2|Chemotherapy Phase|Patient's decision to discontinue|0
468165|NCT00257608|1533266|P1|Chemotherapy Phase|Patient's decision to discontinue|35
468166|NCT00257608|1533264|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
468167|NCT00257608|1533265|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
468168|NCT00257608|1533266|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
468169|NCT00257608|1533264|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
468170|NCT00257608|1533265|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
468171|NCT00257608|1533266|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
468172|NCT00257608|1533264|P3|Chemotherapy Phase|Disease progression|0
468173|NCT00257608|1533265|P2|Chemotherapy Phase|Disease progression|0
468174|NCT00257608|1533266|P1|Chemotherapy Phase|Disease progression|139
468175|NCT00257608|1533264|P3|Chemotherapy Phase|Adverse Event|0
468176|NCT00257608|1533265|P2|Chemotherapy Phase|Adverse Event|0
468177|NCT00257608|1533266|P1|Chemotherapy Phase|Adverse Event|138
468178|NCT00257556|1533292|P2|Overall Study|other reason|6
468179|NCT00257556|1533293|P1|Overall Study|other reason|4
468180|NCT00257556|1533292|P2|Overall Study|Did not meet hCG criterion|0
468181|NCT00257556|1533293|P1|Overall Study|Did not meet hCG criterion|3
468182|NCT00257556|1533292|P2|Overall Study|Physician Decision|0
468183|NCT00257556|1533293|P1|Overall Study|Physician Decision|6
468184|NCT00257556|1533292|P2|Overall Study|Adverse Event|4
468185|NCT00257556|1533293|P1|Overall Study|Adverse Event|1
468186|NCT00257192|1533337|P2|Overall Study|Miscellaneous|4
468187|NCT00257192|1533338|P1|Overall Study|Miscellaneous|0
468188|NCT00257192|1533337|P2|Overall Study|Study terminated by sponsor|0
468189|NCT00257192|1533338|P1|Overall Study|Study terminated by sponsor|1
468190|NCT00257192|1533337|P2|Overall Study|Randomized but not treated|1
468191|NCT00257192|1533338|P1|Overall Study|Randomized but not treated|0
468192|NCT00257192|1533337|P2|Overall Study|Withdrawal by Subject|2
468193|NCT00257192|1533338|P1|Overall Study|Withdrawal by Subject|14
468194|NCT00257192|1533337|P2|Overall Study|Insufficient clinical response|18
468195|NCT00257192|1533338|P1|Overall Study|Insufficient clinical response|18
468196|NCT00257192|1533337|P2|Overall Study|Lost to Follow-up|3
468197|NCT00257192|1533338|P1|Overall Study|Lost to Follow-up|3
468198|NCT00257192|1533337|P2|Overall Study|Laboratory abnormality|1
468199|NCT00257192|1533338|P1|Overall Study|Laboratory abnormality|1
468200|NCT00257192|1533337|P2|Overall Study|Adverse Event|10
468201|NCT00257192|1533338|P1|Overall Study|Adverse Event|21
468202|NCT00257166|1533382|P2|Overall Study|Randomized, but not treated|0
468203|NCT00257166|1533383|P1|Overall Study|Randomized, but not treated|1
468204|NCT00257166|1533382|P2|Overall Study|Other|21
468205|NCT00257166|1533383|P1|Overall Study|Other|16
468206|NCT00257166|1533382|P2|Overall Study|Withdrawal by Subject|2
468207|NCT00257166|1533383|P1|Overall Study|Withdrawal by Subject|9
468208|NCT00257166|1533382|P2|Overall Study|Lost to Follow-up|1
468209|NCT00257166|1533383|P1|Overall Study|Lost to Follow-up|8
468210|NCT00257166|1533382|P2|Overall Study|Laboratory abnormality|0
468211|NCT00257166|1533383|P1|Overall Study|Laboratory abnormality|1
468212|NCT00257166|1533382|P2|Overall Study|Adverse Event|13
468213|NCT00257166|1533383|P1|Overall Study|Adverse Event|18
468214|NCT00257010|1533395|P1|Overall Study|no headache reported|9
468215|NCT00257010|1533395|P1|Overall Study|various|11
468216|NCT00257010|1533395|P1|Overall Study|Adverse Event|10
468217|NCT00257010|1533395|P1|Overall Study|Withdrawal by Subject|34
468218|NCT00257010|1533395|P1|Overall Study|Lost to Follow-up|53
468219|NCT00257010|1533395|P1|Overall Study|Lack of Efficacy|11
468220|NCT00256997|1533406|P2|Overall Study|Investigator Withdrew Participant|1
468221|NCT00256997|1533407|P1|Overall Study|Investigator Withdrew Participant|2
468222|NCT00256997|1533406|P2|Overall Study|Participant Non-compliant|6
468223|NCT00256997|1533407|P1|Overall Study|Participant Non-compliant|3
468224|NCT00256997|1533406|P2|Overall Study|End of Study (As Per Sponsor)|24
468225|NCT00256997|1533407|P1|Overall Study|End of Study (As Per Sponsor)|12
468226|NCT00256997|1533406|P2|Overall Study|Other|8
468227|NCT00256997|1533407|P1|Overall Study|Other|5
468228|NCT00256997|1533406|P2|Overall Study|Started but not treated|0
468229|NCT00256997|1533407|P1|Overall Study|Started but not treated|2
468230|NCT00256997|1533406|P2|Overall Study|Withdrawal by Subject|3
468231|NCT00256997|1533407|P1|Overall Study|Withdrawal by Subject|13
468232|NCT00256997|1533406|P2|Overall Study|Lost to Follow-up|5
468233|NCT00256997|1533407|P1|Overall Study|Lost to Follow-up|3
468234|NCT00256997|1533406|P2|Overall Study|Adverse Event|0
468235|NCT00256997|1533407|P1|Overall Study|Adverse Event|4
468236|NCT00256997|1533406|P2|Overall Study|Death|0
468237|NCT00256997|1533407|P1|Overall Study|Death|2
468238|NCT00256997|1533406|P2|Overall Study|Lack of Efficacy|4
468239|NCT00256997|1533407|P1|Overall Study|Lack of Efficacy|1
468240|NCT00256997|1533406|P2|Overall Study|Protocol Violation|4
468241|NCT00256997|1533407|P1|Overall Study|Protocol Violation|1
468242|NCT00256867|1533449|P8|Overall Study|Withdrawal by participant|0
468243|NCT00256867|1533450|P7|Overall Study|Withdrawal by participant|0
468244|NCT00256867|1533451|P6|Overall Study|Withdrawal by participant|1
468245|NCT00256867|1533452|P5|Overall Study|Withdrawal by participant|0
468246|NCT00256867|1533453|P4|Overall Study|Withdrawal by participant|0
468247|NCT00256867|1533454|P3|Overall Study|Withdrawal by participant|0
468248|NCT00256867|1533455|P2|Overall Study|Withdrawal by participant|0
468249|NCT00256867|1533456|P1|Overall Study|Withdrawal by participant|0
468250|NCT00256867|1533449|P8|Overall Study|Participant was out of windows|0
468251|NCT00256867|1533450|P7|Overall Study|Participant was out of windows|0
468252|NCT00256867|1533451|P6|Overall Study|Participant was out of windows|0
468253|NCT00256867|1533452|P5|Overall Study|Participant was out of windows|0
468254|NCT00256867|1533453|P4|Overall Study|Participant was out of windows|0
468255|NCT00256867|1533454|P3|Overall Study|Participant was out of windows|1
468256|NCT00256867|1533455|P2|Overall Study|Participant was out of windows|0
468257|NCT00256867|1533456|P1|Overall Study|Participant was out of windows|0
468258|NCT00256867|1533449|P8|Overall Study|Participant travelled Overseas|0
468259|NCT00256867|1533450|P7|Overall Study|Participant travelled Overseas|0
468260|NCT00256867|1533451|P6|Overall Study|Participant travelled Overseas|0
468261|NCT00256867|1533452|P5|Overall Study|Participant travelled Overseas|0
468262|NCT00256867|1533453|P4|Overall Study|Participant travelled Overseas|0
468263|NCT00256867|1533454|P3|Overall Study|Participant travelled Overseas|0
468264|NCT00256867|1533455|P2|Overall Study|Participant travelled Overseas|1
468265|NCT00256867|1533456|P1|Overall Study|Participant travelled Overseas|0
468266|NCT00256867|1533449|P8|Overall Study|Non-compliance with study medication|1
468267|NCT00256867|1533450|P7|Overall Study|Non-compliance with study medication|0
468268|NCT00256867|1533451|P6|Overall Study|Non-compliance with study medication|0
468269|NCT00256867|1533452|P5|Overall Study|Non-compliance with study medication|0
468270|NCT00256867|1533453|P4|Overall Study|Non-compliance with study medication|0
468271|NCT00256867|1533454|P3|Overall Study|Non-compliance with study medication|0
468272|NCT00256867|1533455|P2|Overall Study|Non-compliance with study medication|0
468273|NCT00256867|1533456|P1|Overall Study|Non-compliance with study medication|0
468274|NCT00256867|1533449|P8|Overall Study|Investigator's Decision|0
468275|NCT00256867|1533450|P7|Overall Study|Investigator's Decision|0
468276|NCT00256867|1533451|P6|Overall Study|Investigator's Decision|0
468277|NCT00256867|1533452|P5|Overall Study|Investigator's Decision|1
468278|NCT00256867|1533453|P4|Overall Study|Investigator's Decision|0
468279|NCT00256867|1533454|P3|Overall Study|Investigator's Decision|0
468280|NCT00256867|1533455|P2|Overall Study|Investigator's Decision|0
468281|NCT00256867|1533456|P1|Overall Study|Investigator's Decision|0
468282|NCT00256867|1533449|P8|Overall Study|Glycemia over 13.3|1
468283|NCT00256867|1533450|P7|Overall Study|Glycemia over 13.3|0
468284|NCT00256867|1533451|P6|Overall Study|Glycemia over 13.3|0
468285|NCT00256867|1533452|P5|Overall Study|Glycemia over 13.3|0
468286|NCT00256867|1533453|P4|Overall Study|Glycemia over 13.3|0
468287|NCT00256867|1533454|P3|Overall Study|Glycemia over 13.3|0
468288|NCT00256867|1533455|P2|Overall Study|Glycemia over 13.3|0
468289|NCT00256867|1533456|P1|Overall Study|Glycemia over 13.3|0
468290|NCT00256867|1533449|P8|Overall Study|Fasting plasma glucose more than 240|0
468291|NCT00256867|1533450|P7|Overall Study|Fasting plasma glucose more than 240|0
468292|NCT00256867|1533451|P6|Overall Study|Fasting plasma glucose more than 240|0
468293|NCT00256867|1533452|P5|Overall Study|Fasting plasma glucose more than 240|0
468294|NCT00256867|1533453|P4|Overall Study|Fasting plasma glucose more than 240|0
468295|NCT00256867|1533454|P3|Overall Study|Fasting plasma glucose more than 240|0
468296|NCT00256867|1533455|P2|Overall Study|Fasting plasma glucose more than 240|1
468297|NCT00256867|1533456|P1|Overall Study|Fasting plasma glucose more than 240|0
468298|NCT00256867|1533449|P8|Overall Study|Withdrawal by Subject|2
468299|NCT00256867|1533450|P7|Overall Study|Withdrawal by Subject|3
468300|NCT00256867|1533451|P6|Overall Study|Withdrawal by Subject|2
468301|NCT00256867|1533452|P5|Overall Study|Withdrawal by Subject|2
468302|NCT00256867|1533453|P4|Overall Study|Withdrawal by Subject|1
468303|NCT00256867|1533454|P3|Overall Study|Withdrawal by Subject|1
468304|NCT00256867|1533455|P2|Overall Study|Withdrawal by Subject|0
468305|NCT00256867|1533456|P1|Overall Study|Withdrawal by Subject|0
468306|NCT00256867|1533449|P8|Overall Study|Protocol Violation|1
468307|NCT00256867|1533450|P7|Overall Study|Protocol Violation|0
468308|NCT00256867|1533451|P6|Overall Study|Protocol Violation|1
468309|NCT00256867|1533452|P5|Overall Study|Protocol Violation|0
468310|NCT00256867|1533453|P4|Overall Study|Protocol Violation|1
468311|NCT00256867|1533454|P3|Overall Study|Protocol Violation|0
468312|NCT00256867|1533455|P2|Overall Study|Protocol Violation|0
468313|NCT00256867|1533456|P1|Overall Study|Protocol Violation|0
468314|NCT00256867|1533449|P8|Overall Study|Lost to Follow-up|2
468315|NCT00256867|1533450|P7|Overall Study|Lost to Follow-up|1
468316|NCT00256867|1533451|P6|Overall Study|Lost to Follow-up|0
468317|NCT00256867|1533452|P5|Overall Study|Lost to Follow-up|2
468318|NCT00256867|1533453|P4|Overall Study|Lost to Follow-up|3
468319|NCT00256867|1533454|P3|Overall Study|Lost to Follow-up|2
468320|NCT00256867|1533455|P2|Overall Study|Lost to Follow-up|2
468321|NCT00256867|1533456|P1|Overall Study|Lost to Follow-up|2
468322|NCT00256867|1533449|P8|Overall Study|Adverse Event|4
468323|NCT00256867|1533450|P7|Overall Study|Adverse Event|1
468324|NCT00256867|1533451|P6|Overall Study|Adverse Event|2
468325|NCT00256867|1533452|P5|Overall Study|Adverse Event|2
468326|NCT00256867|1533453|P4|Overall Study|Adverse Event|1
468327|NCT00256867|1533454|P3|Overall Study|Adverse Event|1
468328|NCT00256867|1533455|P2|Overall Study|Adverse Event|1
468329|NCT00256867|1533456|P1|Overall Study|Adverse Event|0
468330|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
468331|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
468332|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
468333|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
468334|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
468335|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
468336|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
468337|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
468338|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
468339|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
468340|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
468341|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
468342|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
468343|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
468344|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
468345|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Death|4
468346|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Death|4
468347|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Death|9
468348|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
468349|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
468350|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
468351|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
468352|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
468353|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
468354|NCT00256750|1533543|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
468355|NCT00256750|1533544|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
468356|NCT00256750|1533545|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
468357|NCT00256750|1533543|P3|Post-Transplant Treated (36 Months)|Not specified|1
468358|NCT00256750|1533544|P2|Post-Transplant Treated (36 Months)|Not specified|1
468359|NCT00256750|1533545|P1|Post-Transplant Treated (36 Months)|Not specified|0
468360|NCT00256750|1533543|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
468361|NCT00256750|1533544|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
468362|NCT00256750|1533545|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
468363|NCT00256750|1533543|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
468364|NCT00256750|1533544|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
468365|NCT00256750|1533545|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
468366|NCT00256750|1533543|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
468367|NCT00256750|1533544|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
468368|NCT00256750|1533545|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
468369|NCT00256750|1533543|P3|Post-Transplant Treated (36 Months)|Death|1
468370|NCT00256750|1533544|P2|Post-Transplant Treated (36 Months)|Death|2
468371|NCT00256750|1533545|P1|Post-Transplant Treated (36 Months)|Death|0
468372|NCT00256750|1533543|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
468373|NCT00256750|1533544|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
468374|NCT00256750|1533545|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
468375|NCT00256750|1533543|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
468376|NCT00256750|1533544|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
468377|NCT00256750|1533545|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
468378|NCT00256750|1533543|P3|Post-Transplant Treated (24 Months)|Not Specified|1
468379|NCT00256750|1533544|P2|Post-Transplant Treated (24 Months)|Not Specified|0
468380|NCT00256750|1533545|P1|Post-Transplant Treated (24 Months)|Not Specified|2
468381|NCT00256750|1533543|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
468382|NCT00256750|1533544|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
468383|NCT00256750|1533545|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
468384|NCT00256750|1533543|P3|Post-Transplant Treated (24 Months)|Death|0
468385|NCT00256750|1533544|P2|Post-Transplant Treated (24 Months)|Death|0
468386|NCT00256750|1533545|P1|Post-Transplant Treated (24 Months)|Death|3
468387|NCT00256750|1533543|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
468388|NCT00256750|1533544|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
468389|NCT00256750|1533545|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
468390|NCT00256750|1533543|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
468391|NCT00256750|1533544|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
468392|NCT00256750|1533545|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
468393|NCT00256750|1533543|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
468394|NCT00256750|1533544|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
468395|NCT00256750|1533545|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
468396|NCT00256750|1533543|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
468397|NCT00256750|1533544|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
468398|NCT00256750|1533545|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
468399|NCT00256750|1533543|P3|Post-Transplant Treated (12 Months)|Not Specified|2
468400|NCT00256750|1533544|P2|Post-Transplant Treated (12 Months)|Not Specified|4
468401|NCT00256750|1533545|P1|Post-Transplant Treated (12 Months)|Not Specified|5
468402|NCT00256750|1533543|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
468403|NCT00256750|1533544|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
468404|NCT00256750|1533545|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
468405|NCT00256750|1533543|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
468406|NCT00256750|1533544|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
468407|NCT00256750|1533545|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
468408|NCT00256750|1533543|P3|Post-Transplant Treated (12 Months)|Death|4
468409|NCT00256750|1533544|P2|Post-Transplant Treated (12 Months)|Death|2
468410|NCT00256750|1533545|P1|Post-Transplant Treated (12 Months)|Death|3
468411|NCT00256750|1533543|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
468412|NCT00256750|1533544|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
468413|NCT00256750|1533545|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
468414|NCT00256750|1533543|P3|Transplanted Pre-Treatment|Death|0
468415|NCT00256750|1533544|P2|Transplanted Pre-Treatment|Death|0
468416|NCT00256750|1533545|P1|Transplanted Pre-Treatment|Death|1
468417|NCT00256750|1533543|P3|Transplanted Pre-Treatment|Not Specified|0
468418|NCT00256750|1533544|P2|Transplanted Pre-Treatment|Not Specified|0
468419|NCT00256750|1533545|P1|Transplanted Pre-Treatment|Not Specified|2
468420|NCT00256750|1533543|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
468421|NCT00256750|1533544|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
468422|NCT00256750|1533545|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
468423|NCT00256724|1533681|P2|Overall Study|Protocol Violation|3
468424|NCT00256724|1533682|P1|Overall Study|Protocol Violation|3
468425|NCT00256724|1533681|P2|Overall Study|Physician Decision|5
468426|NCT00256724|1533682|P1|Overall Study|Physician Decision|2
468427|NCT00256698|1533692|P2|Overall Study|Prematurely Discontinued|0
468428|NCT00256698|1533693|P1|Overall Study|Prematurely Discontinued|1
468429|NCT00256698|1533692|P2|Overall Study|withdrawn due to osteoporosis|0
468430|NCT00256698|1533693|P1|Overall Study|withdrawn due to osteoporosis|1
468431|NCT00256698|1533692|P2|Overall Study|still ongoing at data cut-off|46
468432|NCT00256698|1533693|P1|Overall Study|still ongoing at data cut-off|41
468433|NCT00256698|1533692|P2|Overall Study|disease progression|105
468434|NCT00256698|1533693|P1|Overall Study|disease progression|97
468435|NCT00256698|1533692|P2|Overall Study|Lost to Follow-up|3
468436|NCT00256698|1533693|P1|Overall Study|Lost to Follow-up|1
468437|NCT00256698|1533692|P2|Overall Study|Protocol Violation|5
468438|NCT00256698|1533693|P1|Overall Study|Protocol Violation|6
468439|NCT00256698|1533692|P2|Overall Study|Adverse Event|6
468440|NCT00256698|1533693|P1|Overall Study|Adverse Event|13
468441|NCT00256698|1533692|P2|Overall Study|Withdrawal by Subject|7
468442|NCT00256698|1533693|P1|Overall Study|Withdrawal by Subject|7
468443|NCT00256308|1533711|P1|Overall Study|Death|2
468444|NCT00256295|1533719|P1|Overall Study|Death|1
468445|NCT00256295|1533719|P1|Overall Study|Withdrawal by Subject|3
468446|NCT00256282|1533725|P1|Overall Study|Physician Decision|1
468447|NCT00256282|1533725|P1|Overall Study|Adverse Event|3
468448|NCT00256282|1533725|P1|Overall Study|Disease progression, relapse during acti|12
468449|NCT00256243|1533730|P1|Overall Study|Not treated|1
468450|NCT00256243|1533730|P1|Overall Study|Death|7
468451|NCT00256243|1533730|P1|Overall Study|Lost to Follow-up|2
468452|NCT00256204|1533739|P4|Overall Study|Need for additional prohibited treatment|25
468453|NCT00256204|1533740|P3|Overall Study|Need for additional prohibited treatment|27
468454|NCT00256204|1533741|P2|Overall Study|Need for additional prohibited treatment|28
468455|NCT00256204|1533742|P1|Overall Study|Need for additional prohibited treatment|38
468456|NCT00256204|1533739|P4|Overall Study|Withdrawal by Subject|5
468457|NCT00256204|1533740|P3|Overall Study|Withdrawal by Subject|7
468458|NCT00256204|1533741|P2|Overall Study|Withdrawal by Subject|6
468459|NCT00256204|1533742|P1|Overall Study|Withdrawal by Subject|17
468460|NCT00256204|1533739|P4|Overall Study|Physician Decision|2
468461|NCT00256204|1533740|P3|Overall Study|Physician Decision|1
468462|NCT00256204|1533741|P2|Overall Study|Physician Decision|0
468463|NCT00256204|1533742|P1|Overall Study|Physician Decision|0
468464|NCT00256204|1533739|P4|Overall Study|Protocol Violation|1
468465|NCT00256204|1533740|P3|Overall Study|Protocol Violation|2
468466|NCT00256204|1533741|P2|Overall Study|Protocol Violation|0
468467|NCT00256204|1533742|P1|Overall Study|Protocol Violation|1
468468|NCT00256204|1533739|P4|Overall Study|Lost to Follow-up|2
468469|NCT00256204|1533740|P3|Overall Study|Lost to Follow-up|1
468470|NCT00256204|1533741|P2|Overall Study|Lost to Follow-up|1
468471|NCT00256204|1533742|P1|Overall Study|Lost to Follow-up|1
468472|NCT00256204|1533739|P4|Overall Study|Death|0
468473|NCT00256204|1533740|P3|Overall Study|Death|0
468474|NCT00256204|1533741|P2|Overall Study|Death|1
468475|NCT00256204|1533742|P1|Overall Study|Death|0
468476|NCT00256204|1533739|P4|Overall Study|Adverse Event|14
468477|NCT00256204|1533740|P3|Overall Study|Adverse Event|16
468478|NCT00256204|1533741|P2|Overall Study|Adverse Event|14
468479|NCT00256204|1533742|P1|Overall Study|Adverse Event|10
468480|NCT00256126|1533757|P2|Overall Study|Other|2
468481|NCT00256126|1533758|P1|Overall Study|Other|1
468482|NCT00256126|1533757|P2|Overall Study|Adverse Event|0
468483|NCT00256126|1533758|P1|Overall Study|Adverse Event|1
468484|NCT00255840|1533797|P2|Overall Study|Discontinued intervention|56
468485|NCT00255840|1533798|P1|Overall Study|Discontinued intervention|53
468486|NCT00255840|1533797|P2|Overall Study|Lost to Follow-up|14
468487|NCT00255840|1533798|P1|Overall Study|Lost to Follow-up|10
468488|NCT00255723|1533806|P2|Overall Study|Response Data Not Available|0
468489|NCT00255723|1533807|P1|Overall Study|Response Data Not Available|1
468490|NCT00255723|1533806|P2|Overall Study|Death|1
468491|NCT00255723|1533807|P1|Overall Study|Death|0
468492|NCT00255723|1533806|P2|Overall Study|Adverse Event|1
468493|NCT00255723|1533807|P1|Overall Study|Adverse Event|1
468494|NCT00255190|1533820|P2|Overall Study|Various|23
468495|NCT00255190|1533821|P1|Overall Study|Various|4
468496|NCT00255190|1533820|P2|Overall Study|Erosive esophagitis not healed|20
468497|NCT00255190|1533821|P1|Overall Study|Erosive esophagitis not healed|0
468498|NCT00255190|1533820|P2|Overall Study|Inclusion/Exclusion criteria not met|1
468499|NCT00255190|1533821|P1|Overall Study|Inclusion/Exclusion criteria not met|0
468500|NCT00255190|1533820|P2|Overall Study|Withdrew Consent|48
468501|NCT00255190|1533821|P1|Overall Study|Withdrew Consent|17
468502|NCT00255190|1533820|P2|Overall Study|Lost to Follow-up|27
468503|NCT00255190|1533821|P1|Overall Study|Lost to Follow-up|10
468504|NCT00255190|1533820|P2|Overall Study|Protocol Violation|2
468505|NCT00255190|1533821|P1|Overall Study|Protocol Violation|2
468506|NCT00255190|1533820|P2|Overall Study|Adverse Event|36
468507|NCT00255190|1533821|P1|Overall Study|Adverse Event|17
468508|NCT00255164|1533905|P3|Overall Study|Therapeutic Failure|3
468509|NCT00255164|1533906|P2|Overall Study|Therapeutic Failure|2
468510|NCT00255164|1533907|P1|Overall Study|Therapeutic Failure|11
468511|NCT00255164|1533905|P3|Overall Study|Esophageal Stricture|1
468512|NCT00255164|1533906|P2|Overall Study|Esophageal Stricture|0
468513|NCT00255164|1533907|P1|Overall Study|Esophageal Stricture|0
468514|NCT00255164|1533905|P3|Overall Study|Possible Barrett's Esophagus|8
468515|NCT00255164|1533906|P2|Overall Study|Possible Barrett's Esophagus|3
468516|NCT00255164|1533907|P1|Overall Study|Possible Barrett's Esophagus|1
468517|NCT00255164|1533905|P3|Overall Study|Relapse of Erosive Esophagitis|12
468518|NCT00255164|1533906|P2|Overall Study|Relapse of Erosive Esophagitis|16
468519|NCT00255164|1533907|P1|Overall Study|Relapse of Erosive Esophagitis|78
468520|NCT00255164|1533905|P3|Overall Study|Subject Request/Subject Unavailable|2
468521|NCT00255164|1533906|P2|Overall Study|Subject Request/Subject Unavailable|1
468522|NCT00255164|1533907|P1|Overall Study|Subject Request/Subject Unavailable|1
468523|NCT00255164|1533905|P3|Overall Study|Noncompliance|2
468524|NCT00255164|1533906|P2|Overall Study|Noncompliance|1
468525|NCT00255164|1533907|P1|Overall Study|Noncompliance|0
468526|NCT00255164|1533905|P3|Overall Study|Withdrawal by Subject|8
468527|NCT00255164|1533906|P2|Overall Study|Withdrawal by Subject|17
468528|NCT00255164|1533907|P1|Overall Study|Withdrawal by Subject|18
468529|NCT00255164|1533905|P3|Overall Study|Lost to Follow-up|4
468530|NCT00255164|1533906|P2|Overall Study|Lost to Follow-up|3
468531|NCT00255164|1533907|P1|Overall Study|Lost to Follow-up|4
468532|NCT00255164|1533905|P3|Overall Study|Adverse Event|9
468533|NCT00255164|1533906|P2|Overall Study|Adverse Event|6
468534|NCT00255164|1533907|P1|Overall Study|Adverse Event|10
468535|NCT00255151|1533933|P3|Overall Study|Therapeutic Failure|3
468536|NCT00255151|1533934|P2|Overall Study|Therapeutic Failure|2
468537|NCT00255151|1533935|P1|Overall Study|Therapeutic Failure|11
468538|NCT00255151|1533933|P3|Overall Study|Esophageal Stricture|1
468539|NCT00255151|1533934|P2|Overall Study|Esophageal Stricture|0
468540|NCT00255151|1533935|P1|Overall Study|Esophageal Stricture|0
468541|NCT00255151|1533933|P3|Overall Study|Possible Barrett's Esophagus|8
468542|NCT00255151|1533934|P2|Overall Study|Possible Barrett's Esophagus|3
468543|NCT00255151|1533935|P1|Overall Study|Possible Barrett's Esophagus|1
468544|NCT00255151|1533933|P3|Overall Study|Relapse of Erosive Esophagitis|12
468545|NCT00255151|1533934|P2|Overall Study|Relapse of Erosive Esophagitis|16
468546|NCT00255151|1533935|P1|Overall Study|Relapse of Erosive Esophagitis|78
468547|NCT00255151|1533933|P3|Overall Study|Subject Request/Subject Unavailable|2
468548|NCT00255151|1533934|P2|Overall Study|Subject Request/Subject Unavailable|1
468549|NCT00255151|1533935|P1|Overall Study|Subject Request/Subject Unavailable|1
468550|NCT00255151|1533933|P3|Overall Study|Noncompliance|2
468551|NCT00255151|1533934|P2|Overall Study|Noncompliance|1
468552|NCT00255151|1533935|P1|Overall Study|Noncompliance|0
468553|NCT00255151|1533933|P3|Overall Study|Withdrawal by Subject|8
468554|NCT00255151|1533934|P2|Overall Study|Withdrawal by Subject|17
468555|NCT00255151|1533935|P1|Overall Study|Withdrawal by Subject|18
468556|NCT00255151|1533933|P3|Overall Study|Lost to Follow-up|4
468557|NCT00255151|1533934|P2|Overall Study|Lost to Follow-up|3
468558|NCT00255151|1533935|P1|Overall Study|Lost to Follow-up|4
468559|NCT00255151|1533933|P3|Overall Study|Adverse Event|9
468560|NCT00255151|1533934|P2|Overall Study|Adverse Event|6
468561|NCT00255151|1533935|P1|Overall Study|Adverse Event|10
468562|NCT00255086|1533969|P2|Overall Study|Protocol Violation|1
468563|NCT00255086|1533970|P1|Overall Study|Protocol Violation|1
468564|NCT00255086|1533969|P2|Overall Study|Adverse Event|1
468565|NCT00255086|1533970|P1|Overall Study|Adverse Event|1
468566|NCT00255047|1533982|P4|Overall Study|Withdrawal by Subject|18
468567|NCT00255047|1533983|P3|Overall Study|Withdrawal by Subject|25
468568|NCT00255047|1533984|P2|Overall Study|Withdrawal by Subject|23
468569|NCT00255047|1533985|P1|Overall Study|Withdrawal by Subject|24
468570|NCT00255047|1533982|P4|Overall Study|Lost to Follow-up|6
468571|NCT00255047|1533983|P3|Overall Study|Lost to Follow-up|5
468572|NCT00255047|1533984|P2|Overall Study|Lost to Follow-up|8
468573|NCT00255047|1533985|P1|Overall Study|Lost to Follow-up|9
468574|NCT00255047|1533982|P4|Overall Study|Protocol Violation|20
468575|NCT00255047|1533983|P3|Overall Study|Protocol Violation|16
468576|NCT00255047|1533984|P2|Overall Study|Protocol Violation|13
468577|NCT00255047|1533985|P1|Overall Study|Protocol Violation|13
468578|NCT00255047|1533982|P4|Overall Study|Adverse Event|1
468579|NCT00255047|1533983|P3|Overall Study|Adverse Event|2
468580|NCT00255047|1533984|P2|Overall Study|Adverse Event|3
468581|NCT00255047|1533985|P1|Overall Study|Adverse Event|0
468582|NCT00255047|1533982|P4|Overall Study|Serious Adverse Events|1
468583|NCT00255047|1533983|P3|Overall Study|Serious Adverse Events|2
468584|NCT00255047|1533984|P2|Overall Study|Serious Adverse Events|1
468585|NCT00255047|1533985|P1|Overall Study|Serious Adverse Events|2
468586|NCT00255034|1534009|P2|Overall Study|Withdrawal by Subject|38
468587|NCT00255034|1534010|P1|Overall Study|Withdrawal by Subject|15
468588|NCT00255008|1534020|P4|Overall Study|Other|2
468589|NCT00255008|1534021|P3|Overall Study|Other|3
468590|NCT00255008|1534022|P2|Overall Study|Other|0
468591|NCT00255008|1534023|P1|Overall Study|Other|7
468592|NCT00255008|1534020|P4|Overall Study|Adverse lab experience|0
468593|NCT00255008|1534021|P3|Overall Study|Adverse lab experience|0
468594|NCT00255008|1534022|P2|Overall Study|Adverse lab experience|0
468595|NCT00255008|1534023|P1|Overall Study|Adverse lab experience|1
468596|NCT00255008|1534020|P4|Overall Study|Sponsor request|17
468597|NCT00255008|1534021|P3|Overall Study|Sponsor request|8
468598|NCT00255008|1534022|P2|Overall Study|Sponsor request|3
468599|NCT00255008|1534023|P1|Overall Study|Sponsor request|18
468600|NCT00255008|1534020|P4|Overall Study|Withdrew consent|0
468601|NCT00255008|1534021|P3|Overall Study|Withdrew consent|2
468602|NCT00255008|1534022|P2|Overall Study|Withdrew consent|0
468603|NCT00255008|1534023|P1|Overall Study|Withdrew consent|0
468604|NCT00255008|1534020|P4|Overall Study|Did not meet viral reduction criteria|1
468605|NCT00255008|1534021|P3|Overall Study|Did not meet viral reduction criteria|0
468606|NCT00255008|1534022|P2|Overall Study|Did not meet viral reduction criteria|5
468607|NCT00255008|1534023|P1|Overall Study|Did not meet viral reduction criteria|4
468608|NCT00255008|1534020|P4|Overall Study|Lost to Follow-up|2
468609|NCT00255008|1534021|P3|Overall Study|Lost to Follow-up|1
468610|NCT00255008|1534022|P2|Overall Study|Lost to Follow-up|0
468611|NCT00255008|1534023|P1|Overall Study|Lost to Follow-up|1
468612|NCT00255008|1534020|P4|Overall Study|Adverse Event|0
468613|NCT00255008|1534021|P3|Overall Study|Adverse Event|2
468614|NCT00255008|1534022|P2|Overall Study|Adverse Event|1
468615|NCT00255008|1534023|P1|Overall Study|Adverse Event|1
468616|NCT00254982|1534059|P2|Overall Study|Abnormal liver function tests|1
468617|NCT00254982|1534060|P1|Overall Study|Abnormal liver function tests|2
468618|NCT00254982|1534059|P2|Overall Study|Opportunistic infection|0
468619|NCT00254982|1534060|P1|Overall Study|Opportunistic infection|1
468620|NCT00254982|1534059|P2|Overall Study|Malignancy|2
468621|NCT00254982|1534060|P1|Overall Study|Malignancy|0
468622|NCT00254982|1534059|P2|Overall Study|Diagnosis of Tuberculosis|1
468623|NCT00254982|1534060|P1|Overall Study|Diagnosis of Tuberculosis|1
468624|NCT00254982|1534059|P2|Overall Study|Protocol deviation|1
468625|NCT00254982|1534060|P1|Overall Study|Protocol deviation|1
468626|NCT00254982|1534059|P2|Overall Study|Inclusion/exclusion criteria violation|2
468627|NCT00254982|1534060|P1|Overall Study|Inclusion/exclusion criteria violation|0
468628|NCT00254982|1534059|P2|Overall Study|Withdrawal by Subject|1
468629|NCT00254982|1534060|P1|Overall Study|Withdrawal by Subject|1
468630|NCT00254982|1534059|P2|Overall Study|Adverse Event|16
468631|NCT00254982|1534060|P1|Overall Study|Adverse Event|18
468632|NCT00254982|1534059|P2|Overall Study|Lost to Follow-up|3
468633|NCT00254982|1534060|P1|Overall Study|Lost to Follow-up|5
468634|NCT00254982|1534059|P2|Overall Study|Lack of Efficacy|3
468635|NCT00254982|1534060|P1|Overall Study|Lack of Efficacy|5
468636|NCT00254982|1534059|P2|Overall Study|Not specified|1
468637|NCT00254982|1534060|P1|Overall Study|Not specified|2
468638|NCT00254566|1534072|P2|Overall Study|Lost to Follow-up|2
468639|NCT00254566|1534073|P1|Overall Study|Lost to Follow-up|7
468640|NCT00254566|1534072|P2|Overall Study|Withdrawal by Subject|6
468641|NCT00254566|1534073|P1|Overall Study|Withdrawal by Subject|5
468642|NCT00254566|1534072|P2|Overall Study|Other|5
468643|NCT00254566|1534073|P1|Overall Study|Other|1
468644|NCT00254566|1534072|P2|Overall Study|Lack of Efficacy|9
468645|NCT00254566|1534073|P1|Overall Study|Lack of Efficacy|12
468646|NCT00254566|1534072|P2|Overall Study|Adverse Event|4
468647|NCT00254566|1534073|P1|Overall Study|Adverse Event|5
468648|NCT00254566|1534072|P2|Overall Study|Death|0
468649|NCT00254566|1534073|P1|Overall Study|Death|1
468650|NCT00254540|1534097|P2|Overall Study|Laboratory Test Abnormality|1
468651|NCT00254540|1534098|P1|Overall Study|Laboratory Test Abnormality|0
468652|NCT00254540|1534097|P2|Overall Study|Death|1
468653|NCT00254540|1534098|P1|Overall Study|Death|0
468654|NCT00254540|1534097|P2|Overall Study|Lack of Efficacy|13
468655|NCT00254540|1534098|P1|Overall Study|Lack of Efficacy|13
468656|NCT00254540|1534097|P2|Overall Study|Adverse Event|7
468657|NCT00254540|1534098|P1|Overall Study|Adverse Event|6
468658|NCT00254501|1534127|P2|Overall Study|Lost to Follow-up|1
468659|NCT00254501|1534128|P1|Overall Study|Lost to Follow-up|1
468660|NCT00254293|1534157|P7|LTE Open Label Fixed Dosing|not specified|1
468661|NCT00254293|1534158|P6|LTE Open Label Fixed Dosing|not specified|0
468662|NCT00254293|1534159|P5|LTE Open Label Fixed Dosing|not specified|0
468663|NCT00254293|1534160|P4|LTE Open Label Fixed Dosing|not specified|0
468664|NCT00254293|1534161|P3|LTE Open Label Fixed Dosing|not specified|0
468665|NCT00254293|1534162|P2|LTE Open Label Fixed Dosing|not specified|0
468666|NCT00254293|1534163|P1|LTE Open Label Fixed Dosing|not specified|0
468667|NCT00254293|1534157|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
468668|NCT00254293|1534158|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
468669|NCT00254293|1534159|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
468670|NCT00254293|1534160|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
468671|NCT00254293|1534161|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
468672|NCT00254293|1534162|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
468673|NCT00254293|1534163|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
468674|NCT00254293|1534157|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
468675|NCT00254293|1534158|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
468676|NCT00254293|1534159|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
468677|NCT00254293|1534160|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
468678|NCT00254293|1534161|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
468679|NCT00254293|1534162|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
468680|NCT00254293|1534163|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
468681|NCT00254293|1534157|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
468682|NCT00254293|1534158|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
468683|NCT00254293|1534159|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
468684|NCT00254293|1534160|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
468685|NCT00254293|1534161|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
468686|NCT00254293|1534162|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
468687|NCT00254293|1534163|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
468688|NCT00254293|1534157|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
468689|NCT00254293|1534158|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
468690|NCT00254293|1534159|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
468691|NCT00254293|1534160|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
468692|NCT00254293|1534161|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
468693|NCT00254293|1534162|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
468694|NCT00254293|1534163|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
468695|NCT00254293|1534157|P7|LTE Open Label Fixed Dosing|Adverse Event|1
468696|NCT00254293|1534158|P6|LTE Open Label Fixed Dosing|Adverse Event|0
468697|NCT00254293|1534159|P5|LTE Open Label Fixed Dosing|Adverse Event|0
468698|NCT00254293|1534160|P4|LTE Open Label Fixed Dosing|Adverse Event|0
468699|NCT00254293|1534161|P3|LTE Open Label Fixed Dosing|Adverse Event|0
468700|NCT00254293|1534162|P2|LTE Open Label Fixed Dosing|Adverse Event|0
468701|NCT00254293|1534163|P1|LTE Open Label Fixed Dosing|Adverse Event|0
468702|NCT00254293|1534157|P7|LTE Open Label Fixed Dosing|Death|3
468703|NCT00254293|1534158|P6|LTE Open Label Fixed Dosing|Death|0
468704|NCT00254293|1534159|P5|LTE Open Label Fixed Dosing|Death|0
468705|NCT00254293|1534160|P4|LTE Open Label Fixed Dosing|Death|0
468706|NCT00254293|1534161|P3|LTE Open Label Fixed Dosing|Death|0
468707|NCT00254293|1534162|P2|LTE Open Label Fixed Dosing|Death|0
468708|NCT00254293|1534163|P1|LTE Open Label Fixed Dosing|Death|0
468709|NCT00254293|1534157|P7|LTE Open Label Variable SC Dosing|not specified|0
468710|NCT00254293|1534158|P6|LTE Open Label Variable SC Dosing|not specified|0
468711|NCT00254293|1534159|P5|LTE Open Label Variable SC Dosing|not specified|0
468712|NCT00254293|1534160|P4|LTE Open Label Variable SC Dosing|not specified|0
468713|NCT00254293|1534161|P3|LTE Open Label Variable SC Dosing|not specified|2
468714|NCT00254293|1534162|P2|LTE Open Label Variable SC Dosing|not specified|0
468715|NCT00254293|1534163|P1|LTE Open Label Variable SC Dosing|not specified|0
468716|NCT00254293|1534157|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
468717|NCT00254293|1534158|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
468718|NCT00254293|1534159|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
468719|NCT00254293|1534160|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
468720|NCT00254293|1534161|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
468721|NCT00254293|1534162|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
468722|NCT00254293|1534163|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
468723|NCT00254293|1534157|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
468724|NCT00254293|1534158|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
468725|NCT00254293|1534159|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
468726|NCT00254293|1534160|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
468727|NCT00254293|1534161|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
468728|NCT00254293|1534162|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
468729|NCT00254293|1534163|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
468730|NCT00254293|1534157|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
468731|NCT00254293|1534158|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
468732|NCT00254293|1534159|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
468733|NCT00254293|1534160|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
468734|NCT00254293|1534161|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
468735|NCT00254293|1534162|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
468736|NCT00254293|1534163|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
468737|NCT00254293|1534157|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
468738|NCT00254293|1534158|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
468739|NCT00254293|1534159|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
468740|NCT00254293|1534160|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
468741|NCT00254293|1534161|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
468742|NCT00254293|1534162|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
468743|NCT00254293|1534163|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
468744|NCT00254293|1534157|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
468745|NCT00254293|1534158|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
468746|NCT00254293|1534159|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
468747|NCT00254293|1534160|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
468748|NCT00254293|1534161|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
468749|NCT00254293|1534162|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
468750|NCT00254293|1534163|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
468751|NCT00254293|1534157|P7|LTE Open Label Variable SC Dosing|Death|0
468752|NCT00254293|1534158|P6|LTE Open Label Variable SC Dosing|Death|0
468753|NCT00254293|1534159|P5|LTE Open Label Variable SC Dosing|Death|0
468754|NCT00254293|1534160|P4|LTE Open Label Variable SC Dosing|Death|0
468755|NCT00254293|1534161|P3|LTE Open Label Variable SC Dosing|Death|1
468756|NCT00254293|1534162|P2|LTE Open Label Variable SC Dosing|Death|0
468757|NCT00254293|1534163|P1|LTE Open Label Variable SC Dosing|Death|0
468758|NCT00254293|1534157|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
468759|NCT00254293|1534158|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
468760|NCT00254293|1534159|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
468761|NCT00254293|1534160|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
468762|NCT00254293|1534161|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
468763|NCT00254293|1534162|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
468764|NCT00254293|1534163|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
468765|NCT00254293|1534157|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
468766|NCT00254293|1534158|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
468767|NCT00254293|1534159|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
468768|NCT00254293|1534160|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
468769|NCT00254293|1534161|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
468770|NCT00254293|1534162|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
468771|NCT00254293|1534163|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
468772|NCT00254293|1534157|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
468773|NCT00254293|1534158|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
468774|NCT00254293|1534159|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
468775|NCT00254293|1534160|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
468776|NCT00254293|1534161|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
468777|NCT00254293|1534162|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
468778|NCT00254293|1534163|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
468779|NCT00254163|1534246|P2|Overall Study|Other|8
468780|NCT00254163|1534247|P1|Overall Study|Other|8
468781|NCT00254163|1534246|P2|Overall Study|Death|1
468782|NCT00254163|1534247|P1|Overall Study|Death|0
468783|NCT00254163|1534246|P2|Overall Study|Progressive disease|1
468784|NCT00254163|1534247|P1|Overall Study|Progressive disease|0
468785|NCT00254163|1534246|P2|Overall Study|Failed entry|3
468786|NCT00254163|1534247|P1|Overall Study|Failed entry|1
468787|NCT00254163|1534246|P2|Overall Study|Investigator request|3
468788|NCT00254163|1534247|P1|Overall Study|Investigator request|1
468789|NCT00254163|1534246|P2|Overall Study|Patient request/withdrew consent|4
468790|NCT00254163|1534247|P1|Overall Study|Patient request/withdrew consent|6
468791|NCT00254163|1534246|P2|Overall Study|Adverse Event|26
468792|NCT00254163|1534247|P1|Overall Study|Adverse Event|29
468793|NCT00253747|1534298|P2|Overall Study|Administrative Discharge (1), Other (2)|2
468794|NCT00253747|1534299|P1|Overall Study|Administrative Discharge (1), Other (2)|1
468795|NCT00253747|1534298|P2|Overall Study|Withdrawal by Subject|11
468796|NCT00253747|1534299|P1|Overall Study|Withdrawal by Subject|10
468797|NCT00253747|1534298|P2|Overall Study|Lost to Follow-up|14
468798|NCT00253747|1534299|P1|Overall Study|Lost to Follow-up|13
468799|NCT00253643|1534352|P4|Overall Study|Non-Compliance|2
468800|NCT00253643|1534353|P3|Overall Study|Non-Compliance|0
468801|NCT00253643|1534354|P2|Overall Study|Non-Compliance|0
468802|NCT00253643|1534355|P1|Overall Study|Non-Compliance|0
468803|NCT00253643|1534352|P4|Overall Study|Withdrawal by Subject|1
468804|NCT00253643|1534353|P3|Overall Study|Withdrawal by Subject|1
468805|NCT00253643|1534354|P2|Overall Study|Withdrawal by Subject|0
468806|NCT00253643|1534355|P1|Overall Study|Withdrawal by Subject|0
468807|NCT00253630|1534369|P1|Overall Study|ineligible|2
468808|NCT00253448|1534385|P1|Overall Study|Withdrawal by Subject|1
468809|NCT00253370|1534404|P1|Overall Study|Abdominal pain due to disease|1
468810|NCT00253370|1534404|P1|Overall Study|Protocol Violation|1
468811|NCT00253370|1534404|P1|Overall Study|Physician Decision|1
468812|NCT00253370|1534404|P1|Overall Study|Non-protocol therapy|1
468813|NCT00253370|1534404|P1|Overall Study|Withdrawal by Subject|6
468814|NCT00253370|1534404|P1|Overall Study|Death|2
468815|NCT00253370|1534404|P1|Overall Study|Disease progression|13
468816|NCT00253370|1534404|P1|Overall Study|Adverse Event|18
468817|NCT00252733|1534450|P2|Overall Study|Multiple Reasons|14
468818|NCT00252733|1534451|P1|Overall Study|Multiple Reasons|14
468819|NCT00252733|1534450|P2|Overall Study|Lost to Follow-up|6
468820|NCT00252733|1534451|P1|Overall Study|Lost to Follow-up|12
468821|NCT00252733|1534450|P2|Overall Study|Death|5
468822|NCT00252733|1534451|P1|Overall Study|Death|7
468823|NCT00252733|1534450|P2|Overall Study|Withdrawal by Subject|67
468824|NCT00252733|1534451|P1|Overall Study|Withdrawal by Subject|73
468825|NCT00252720|1534461|P2|Overall Study|Mainly patients lost to follow-up|18
468826|NCT00252720|1534462|P1|Overall Study|Mainly patients lost to follow-up|7
468827|NCT00252720|1534461|P2|Overall Study|Moving|42
468828|NCT00252720|1534462|P1|Overall Study|Moving|23
468829|NCT00252720|1534461|P2|Overall Study|Death|8
468830|NCT00252720|1534462|P1|Overall Study|Death|7
468831|NCT00252720|1534461|P2|Overall Study|Withdrawal by Subject|97
468832|NCT00252720|1534462|P1|Overall Study|Withdrawal by Subject|95
468833|NCT00252694|1534476|P2|Overall Study|Patient Moving|16
468834|NCT00252694|1534477|P1|Overall Study|Patient Moving|17
468835|NCT00252694|1534476|P2|Overall Study|Mostly Lost to Follow Up|13
468836|NCT00252694|1534477|P1|Overall Study|Mostly Lost to Follow Up|8
468837|NCT00252694|1534476|P2|Overall Study|Death|34
468838|NCT00252694|1534477|P1|Overall Study|Death|36
468839|NCT00252694|1534476|P2|Overall Study|Withdrawal by Subject|91
468840|NCT00252694|1534477|P1|Overall Study|Withdrawal by Subject|83
468841|NCT00252564|1534525|P2|Overall Study|Withdrawal by Subject|2
468842|NCT00252564|1534526|P1|Overall Study|Withdrawal by Subject|0
468843|NCT00252564|1534525|P2|Overall Study|Patient Request|5
468844|NCT00252564|1534526|P1|Overall Study|Patient Request|4
468845|NCT00252564|1534525|P2|Overall Study|Lost to Follow-up|0
468846|NCT00252564|1534526|P1|Overall Study|Lost to Follow-up|1
468847|NCT00252564|1534525|P2|Overall Study|Physician Decision|0
468848|NCT00252564|1534526|P1|Overall Study|Physician Decision|1
468849|NCT00252564|1534525|P2|Overall Study|Protocol Violation|0
468850|NCT00252564|1534526|P1|Overall Study|Protocol Violation|0
468851|NCT00252564|1534525|P2|Overall Study|Death|3
468852|NCT00252564|1534526|P1|Overall Study|Death|0
468853|NCT00252564|1534525|P2|Overall Study|Disease Progression|20
468854|NCT00252564|1534526|P1|Overall Study|Disease Progression|14
468855|NCT00252564|1534525|P2|Overall Study|Unrelated Complication|1
468856|NCT00252564|1534526|P1|Overall Study|Unrelated Complication|2
468857|NCT00252564|1534525|P2|Overall Study|Adverse Event|13
468858|NCT00252564|1534526|P1|Overall Study|Adverse Event|17
468859|NCT00252499|1534556|P3|Overall Study|Lost to Follow-up|0
468860|NCT00252499|1534557|P2|Overall Study|Lost to Follow-up|0
468861|NCT00252499|1534558|P1|Overall Study|Lost to Follow-up|1
468862|NCT00252239|1534590|P4|Overall Study|Lost to Follow-up|0
468863|NCT00252239|1534591|P3|Overall Study|Lost to Follow-up|2
468864|NCT00252239|1534592|P2|Overall Study|Lost to Follow-up|0
468865|NCT00252239|1534593|P1|Overall Study|Lost to Follow-up|0
468866|NCT00252239|1534590|P4|Overall Study|Withdrawal by Subject|1
468867|NCT00252239|1534591|P3|Overall Study|Withdrawal by Subject|0
468868|NCT00252239|1534592|P2|Overall Study|Withdrawal by Subject|0
468869|NCT00252239|1534593|P1|Overall Study|Withdrawal by Subject|1
468870|NCT00252187|1534605|P2|Overall Study|Withdrawal by Subject|0
468871|NCT00252187|1534606|P1|Overall Study|Withdrawal by Subject|1
468872|NCT00252187|1534605|P2|Overall Study|Adverse Event|1
468873|NCT00252187|1534606|P1|Overall Study|Adverse Event|3
468874|NCT00252174|1534629|P3|Overall Study|Withdrawal by Subject|0
468875|NCT00252174|1534630|P2|Overall Study|Withdrawal by Subject|1
468876|NCT00252174|1534631|P1|Overall Study|Withdrawal by Subject|0
468877|NCT00252057|1534671|P2|Overall Study|Participant previously enrolled|1
468878|NCT00252057|1534672|P1|Overall Study|Participant previously enrolled|0
468879|NCT00252057|1534671|P2|Overall Study|Death|2
468880|NCT00252057|1534672|P1|Overall Study|Death|1
468881|NCT00252057|1534671|P2|Overall Study|Withdrawal by Subject|5
468882|NCT00252057|1534672|P1|Overall Study|Withdrawal by Subject|2
468883|NCT00251979|1534680|P2|Overall Study|Death|5
468884|NCT00251979|1534681|P1|Overall Study|Death|3
468885|NCT00251979|1534680|P2|Overall Study|Lost to Follow-up|6
468886|NCT00251979|1534681|P1|Overall Study|Lost to Follow-up|8
468887|NCT00251979|1534680|P2|Overall Study|Withdrawal by Subject|7
468888|NCT00251979|1534681|P1|Overall Study|Withdrawal by Subject|13
468889|NCT00251979|1534680|P2|Overall Study|Adverse Event|17
468890|NCT00251979|1534681|P1|Overall Study|Adverse Event|11
468891|NCT00251979|1534680|P2|Overall Study|Protocol Violation|5
468892|NCT00251979|1534681|P1|Overall Study|Protocol Violation|3
468893|NCT00251927|1534713|P2|Overall Study|Study procedure non-compliance|6
468894|NCT00251927|1534714|P1|Overall Study|Study procedure non-compliance|5
468895|NCT00251927|1534713|P2|Overall Study|Study-specific discont. achieved|2
468896|NCT00251927|1534714|P1|Overall Study|Study-specific discont. achieved|13
468897|NCT00251927|1534713|P2|Overall Study|Withdrawal by Subject|25
468898|NCT00251927|1534714|P1|Overall Study|Withdrawal by Subject|40
468899|NCT00251927|1534713|P2|Overall Study|Pregnancy|0
468900|NCT00251927|1534714|P1|Overall Study|Pregnancy|2
468901|NCT00251927|1534713|P2|Overall Study|Protocol Violation|2
468902|NCT00251927|1534714|P1|Overall Study|Protocol Violation|1
468903|NCT00251927|1534713|P2|Overall Study|Lost to Follow-up|8
468904|NCT00251927|1534714|P1|Overall Study|Lost to Follow-up|22
468905|NCT00251927|1534713|P2|Overall Study|Lack of Efficacy|16
468906|NCT00251927|1534714|P1|Overall Study|Lack of Efficacy|22
468907|NCT00251927|1534713|P2|Overall Study|Adverse Event|15
468908|NCT00251927|1534714|P1|Overall Study|Adverse Event|3
468909|NCT00251758|1534766|P3|Overall Study|Per Investigator Request|0
468910|NCT00251758|1534767|P2|Overall Study|Per Investigator Request|0
468911|NCT00251758|1534768|P1|Overall Study|Per Investigator Request|1
468912|NCT00251758|1534766|P3|Overall Study|Per Subject Request|1
468913|NCT00251758|1534767|P2|Overall Study|Per Subject Request|0
468914|NCT00251758|1534768|P1|Overall Study|Per Subject Request|0
468915|NCT00251758|1534766|P3|Overall Study|Pregnancy|0
468916|NCT00251758|1534767|P2|Overall Study|Pregnancy|1
468917|NCT00251758|1534768|P1|Overall Study|Pregnancy|0
468918|NCT00251758|1534766|P3|Overall Study|Noncompliant|2
468919|NCT00251758|1534767|P2|Overall Study|Noncompliant|2
468920|NCT00251758|1534768|P1|Overall Study|Noncompliant|0
468921|NCT00251758|1534766|P3|Overall Study|Lack of Efficacy|0
468922|NCT00251758|1534767|P2|Overall Study|Lack of Efficacy|0
468923|NCT00251758|1534768|P1|Overall Study|Lack of Efficacy|3
468924|NCT00251758|1534766|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
468925|NCT00251758|1534767|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
468926|NCT00251758|1534768|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
468927|NCT00251758|1534766|P3|Overall Study|Withdrawal by Subject|3
468928|NCT00251758|1534767|P2|Overall Study|Withdrawal by Subject|7
468929|NCT00251758|1534768|P1|Overall Study|Withdrawal by Subject|13
468930|NCT00251758|1534766|P3|Overall Study|Lost to Follow-up|5
468931|NCT00251758|1534767|P2|Overall Study|Lost to Follow-up|2
468932|NCT00251758|1534768|P1|Overall Study|Lost to Follow-up|4
468933|NCT00251758|1534766|P3|Overall Study|Adverse Event|11
468934|NCT00251758|1534767|P2|Overall Study|Adverse Event|9
468935|NCT00251758|1534768|P1|Overall Study|Adverse Event|7
468936|NCT00251745|1534788|P3|Overall Study|Per Investigator Request|0
468937|NCT00251745|1534789|P2|Overall Study|Per Investigator Request|0
468938|NCT00251745|1534790|P1|Overall Study|Per Investigator Request|1
468939|NCT00251745|1534788|P3|Overall Study|Per Subject Request|1
468940|NCT00251745|1534789|P2|Overall Study|Per Subject Request|0
468941|NCT00251745|1534790|P1|Overall Study|Per Subject Request|0
468942|NCT00251745|1534788|P3|Overall Study|Pregnancy|0
468943|NCT00251745|1534789|P2|Overall Study|Pregnancy|1
468944|NCT00251745|1534790|P1|Overall Study|Pregnancy|0
468945|NCT00251745|1534788|P3|Overall Study|Noncompliant|2
468946|NCT00251745|1534789|P2|Overall Study|Noncompliant|2
468947|NCT00251745|1534790|P1|Overall Study|Noncompliant|0
468948|NCT00251745|1534788|P3|Overall Study|Lack of Efficacy|0
468949|NCT00251745|1534789|P2|Overall Study|Lack of Efficacy|0
468950|NCT00251745|1534790|P1|Overall Study|Lack of Efficacy|3
468951|NCT00251745|1534788|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
468952|NCT00251745|1534789|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
468953|NCT00251745|1534790|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
468954|NCT00251745|1534788|P3|Overall Study|Withdrawal by Subject|3
468955|NCT00251745|1534789|P2|Overall Study|Withdrawal by Subject|7
468956|NCT00251745|1534790|P1|Overall Study|Withdrawal by Subject|13
468957|NCT00251745|1534788|P3|Overall Study|Lost to Follow-up|5
468958|NCT00251745|1534789|P2|Overall Study|Lost to Follow-up|2
468959|NCT00251745|1534790|P1|Overall Study|Lost to Follow-up|4
468960|NCT00251745|1534788|P3|Overall Study|Adverse Event|11
468961|NCT00251745|1534789|P2|Overall Study|Adverse Event|9
468962|NCT00251745|1534790|P1|Overall Study|Adverse Event|7
468963|NCT00251719|1534810|P3|Overall Study|Barrett's esophagus|0
468964|NCT00251719|1534811|P2|Overall Study|Barrett's esophagus|2
468965|NCT00251719|1534812|P1|Overall Study|Barrett's esophagus|2
468966|NCT00251719|1534810|P3|Overall Study|Noncompliance|1
468967|NCT00251719|1534811|P2|Overall Study|Noncompliance|3
468968|NCT00251719|1534812|P1|Overall Study|Noncompliance|2
468969|NCT00251719|1534810|P3|Overall Study|Investigator decision|0
468970|NCT00251719|1534811|P2|Overall Study|Investigator decision|1
468971|NCT00251719|1534812|P1|Overall Study|Investigator decision|1
468972|NCT00251719|1534810|P3|Overall Study|Inclusion/exclusion criteria not met|2
468973|NCT00251719|1534811|P2|Overall Study|Inclusion/exclusion criteria not met|6
468974|NCT00251719|1534812|P1|Overall Study|Inclusion/exclusion criteria not met|12
468975|NCT00251719|1534810|P3|Overall Study|Lack of Efficacy|0
468976|NCT00251719|1534811|P2|Overall Study|Lack of Efficacy|1
468977|NCT00251719|1534812|P1|Overall Study|Lack of Efficacy|2
468978|NCT00251719|1534810|P3|Overall Study|Withdrawal by Subject|11
468979|NCT00251719|1534811|P2|Overall Study|Withdrawal by Subject|12
468980|NCT00251719|1534812|P1|Overall Study|Withdrawal by Subject|14
468981|NCT00251719|1534810|P3|Overall Study|Lost to Follow-up|8
468982|NCT00251719|1534811|P2|Overall Study|Lost to Follow-up|11
468983|NCT00251719|1534812|P1|Overall Study|Lost to Follow-up|5
468984|NCT00251719|1534810|P3|Overall Study|Protocol Violation|1
468985|NCT00251719|1534811|P2|Overall Study|Protocol Violation|1
468986|NCT00251719|1534812|P1|Overall Study|Protocol Violation|1
468987|NCT00251719|1534810|P3|Overall Study|Adverse Event|7
468988|NCT00251719|1534811|P2|Overall Study|Adverse Event|8
468989|NCT00251719|1534812|P1|Overall Study|Adverse Event|14
468990|NCT00251693|1534838|P3|Overall Study|Abnormal laboratory findings|1
468991|NCT00251693|1534839|P2|Overall Study|Abnormal laboratory findings|0
468992|NCT00251693|1534840|P1|Overall Study|Abnormal laboratory findings|0
468993|NCT00251693|1534838|P3|Overall Study|Subject request/subject unavailable|0
468994|NCT00251693|1534839|P2|Overall Study|Subject request/subject unavailable|2
468995|NCT00251693|1534840|P1|Overall Study|Subject request/subject unavailable|1
468996|NCT00251693|1534838|P3|Overall Study|Possible Barrett's esophagus|2
468997|NCT00251693|1534839|P2|Overall Study|Possible Barrett's esophagus|5
468998|NCT00251693|1534840|P1|Overall Study|Possible Barrett's esophagus|3
468999|NCT00251693|1534838|P3|Overall Study|Noncompliant|2
469000|NCT00251693|1534839|P2|Overall Study|Noncompliant|0
469001|NCT00251693|1534840|P1|Overall Study|Noncompliant|0
469002|NCT00251693|1534838|P3|Overall Study|Inclusion/exclusion criteria not met|8
469003|NCT00251693|1534839|P2|Overall Study|Inclusion/exclusion criteria not met|3
469004|NCT00251693|1534840|P1|Overall Study|Inclusion/exclusion criteria not met|5
469005|NCT00251693|1534838|P3|Overall Study|Lack of Efficacy|0
469006|NCT00251693|1534839|P2|Overall Study|Lack of Efficacy|1
469007|NCT00251693|1534840|P1|Overall Study|Lack of Efficacy|0
469008|NCT00251693|1534838|P3|Overall Study|Withdrawal by Subject|14
469009|NCT00251693|1534839|P2|Overall Study|Withdrawal by Subject|17
469010|NCT00251693|1534840|P1|Overall Study|Withdrawal by Subject|11
469011|NCT00251693|1534838|P3|Overall Study|Lost to Follow-up|8
469012|NCT00251693|1534839|P2|Overall Study|Lost to Follow-up|7
469013|NCT00251693|1534840|P1|Overall Study|Lost to Follow-up|12
469014|NCT00251693|1534838|P3|Overall Study|Protocol Violation|2
469015|NCT00251693|1534839|P2|Overall Study|Protocol Violation|0
469016|NCT00251693|1534840|P1|Overall Study|Protocol Violation|2
469017|NCT00251693|1534838|P3|Overall Study|Adverse Event|9
469018|NCT00251693|1534839|P2|Overall Study|Adverse Event|9
469019|NCT00251693|1534840|P1|Overall Study|Adverse Event|17
469020|NCT00251641|1534865|P2|Overall Study|Switched Treatment|63
469021|NCT00251641|1534866|P1|Overall Study|Switched Treatment|9
469022|NCT00251641|1534865|P2|Overall Study|Did not Meet protocol Eligibility|1
469023|NCT00251641|1534866|P1|Overall Study|Did not Meet protocol Eligibility|2
469024|NCT00251641|1534865|P2|Overall Study|Protocol Violation|2
469025|NCT00251641|1534866|P1|Overall Study|Protocol Violation|10
469026|NCT00251641|1534865|P2|Overall Study|Withdrawal by Subject|8
469027|NCT00251641|1534866|P1|Overall Study|Withdrawal by Subject|6
469028|NCT00251641|1534865|P2|Overall Study|Lost to Follow-up|3
469029|NCT00251641|1534866|P1|Overall Study|Lost to Follow-up|3
469030|NCT00251641|1534865|P2|Overall Study|Progression of Disease|2
469031|NCT00251641|1534866|P1|Overall Study|Progression of Disease|0
469032|NCT00251641|1534865|P2|Overall Study|Lack of Efficacy|1
469033|NCT00251641|1534866|P1|Overall Study|Lack of Efficacy|2
469034|NCT00251641|1534865|P2|Overall Study|Adverse Event|8
469035|NCT00251641|1534866|P1|Overall Study|Adverse Event|80
469036|NCT00251589|1534884|P4|Overall Study|Discontinued due to progressive disease|1
469037|NCT00251589|1534885|P3|Overall Study|Discontinued due to progressive disease|0
469038|NCT00251589|1534886|P2|Overall Study|Discontinued due to progressive disease|1
469039|NCT00251589|1534887|P1|Overall Study|Discontinued due to progressive disease|9
469040|NCT00251589|1534884|P4|Overall Study|Withdrawal by Subject|0
469041|NCT00251589|1534885|P3|Overall Study|Withdrawal by Subject|0
469042|NCT00251589|1534886|P2|Overall Study|Withdrawal by Subject|1
469043|NCT00251589|1534887|P1|Overall Study|Withdrawal by Subject|1
469044|NCT00251589|1534884|P4|Overall Study|Adverse Event|1
469045|NCT00251589|1534885|P3|Overall Study|Adverse Event|2
469046|NCT00251589|1534886|P2|Overall Study|Adverse Event|1
469047|NCT00251589|1534887|P1|Overall Study|Adverse Event|5
469048|NCT00251316|1534924|P2|Overall Study|Physician Decision|3
469049|NCT00251316|1534925|P1|Overall Study|Physician Decision|2
469050|NCT00251004|1534964|P3|Overall Study|Graft Loss|8
469051|NCT00251004|1534965|P2|Overall Study|Graft Loss|13
469052|NCT00251004|1534966|P1|Overall Study|Graft Loss|12
469053|NCT00251004|1534964|P3|Overall Study|Lost to Follow-up|1
469054|NCT00251004|1534965|P2|Overall Study|Lost to Follow-up|2
469055|NCT00251004|1534966|P1|Overall Study|Lost to Follow-up|1
469056|NCT00251004|1534964|P3|Overall Study|Death|8
469057|NCT00251004|1534965|P2|Overall Study|Death|10
469058|NCT00251004|1534966|P1|Overall Study|Death|9
469059|NCT00251004|1534964|P3|Overall Study|Withdrawal by Subject|14
469060|NCT00251004|1534965|P2|Overall Study|Withdrawal by Subject|16
469061|NCT00251004|1534966|P1|Overall Study|Withdrawal by Subject|23
469062|NCT00250835|1534990|P1|Overall Study|Withdrawal by Subject|1
469063|NCT00250718|1534999|P1|Overall Study|Withdrawal by Subject|1
469064|NCT00250718|1534999|P1|Overall Study|Adverse Event|1
469065|NCT00250718|1534999|P1|Overall Study|Death|1
469066|NCT00250705|1535004|P1|Overall Study|Lack of Efficacy|2
469067|NCT00250679|1535015|P3|Overall Study|various single events: hip surgery,diary|1
469068|NCT00250679|1535016|P2|Overall Study|various single events: hip surgery,diary|1
469069|NCT00250679|1535017|P1|Overall Study|various single events: hip surgery,diary|3
469070|NCT00250679|1535015|P3|Overall Study|Non-compliance|0
469071|NCT00250679|1535016|P2|Overall Study|Non-compliance|1
469072|NCT00250679|1535017|P1|Overall Study|Non-compliance|1
469073|NCT00250679|1535015|P3|Overall Study|Moved|0
469074|NCT00250679|1535016|P2|Overall Study|Moved|1
469075|NCT00250679|1535017|P1|Overall Study|Moved|1
469076|NCT00250679|1535015|P3|Overall Study|Technical Holter issues|2
469077|NCT00250679|1535016|P2|Overall Study|Technical Holter issues|0
469078|NCT00250679|1535017|P1|Overall Study|Technical Holter issues|1
469079|NCT00250679|1535015|P3|Overall Study|Lack of Efficacy|3
469080|NCT00250679|1535016|P2|Overall Study|Lack of Efficacy|1
469081|NCT00250679|1535017|P1|Overall Study|Lack of Efficacy|0
469082|NCT00250679|1535015|P3|Overall Study|Does Not Meet Entry Criteria|2
469083|NCT00250679|1535016|P2|Overall Study|Does Not Meet Entry Criteria|4
469084|NCT00250679|1535017|P1|Overall Study|Does Not Meet Entry Criteria|1
469085|NCT00250679|1535015|P3|Overall Study|Lost to Follow-up|2
469086|NCT00250679|1535016|P2|Overall Study|Lost to Follow-up|4
469087|NCT00250679|1535017|P1|Overall Study|Lost to Follow-up|3
469088|NCT00250679|1535015|P3|Overall Study|Withdrawal by Subject|15
469089|NCT00250679|1535016|P2|Overall Study|Withdrawal by Subject|18
469090|NCT00250679|1535017|P1|Overall Study|Withdrawal by Subject|15
469091|NCT00250679|1535015|P3|Overall Study|Protocol Violation|3
469092|NCT00250679|1535016|P2|Overall Study|Protocol Violation|4
469093|NCT00250679|1535017|P1|Overall Study|Protocol Violation|2
469094|NCT00250679|1535015|P3|Overall Study|Adverse Event|16
469095|NCT00250679|1535016|P2|Overall Study|Adverse Event|15
469096|NCT00250679|1535017|P1|Overall Study|Adverse Event|12
469097|NCT00250588|1535118|P3|Overall Study|Lost to Follow-up|13
469098|NCT00250588|1535119|P2|Overall Study|Lost to Follow-up|13
469099|NCT00250588|1535120|P1|Overall Study|Lost to Follow-up|6
469100|NCT00250588|1535118|P3|Overall Study|Withdrawal by Subject|0
469101|NCT00250588|1535119|P2|Overall Study|Withdrawal by Subject|6
469102|NCT00250588|1535120|P1|Overall Study|Withdrawal by Subject|3
469103|NCT00250458|1535168|P2|Overall Study|Not Specified|0
469104|NCT00250458|1535169|P1|Overall Study|Not Specified|1
469105|NCT00250458|1535168|P2|Overall Study|Qualifying migraine but did not treat|3
469106|NCT00250458|1535169|P1|Overall Study|Qualifying migraine but did not treat|3
469107|NCT00250458|1535168|P2|Overall Study|Lack of Migraine Attack|9
469108|NCT00250458|1535169|P1|Overall Study|Lack of Migraine Attack|20
469109|NCT00250458|1535168|P2|Overall Study|Withdrawal by Subject|2
469110|NCT00250458|1535169|P1|Overall Study|Withdrawal by Subject|4
469111|NCT00250458|1535168|P2|Overall Study|Protocol Violation|1
469112|NCT00250458|1535169|P1|Overall Study|Protocol Violation|0
469113|NCT00250458|1535168|P2|Overall Study|Lost to Follow-up|2
469114|NCT00250458|1535169|P1|Overall Study|Lost to Follow-up|4
469115|NCT00250432|1535179|P2|Overall Study|Pt was considered untreatable|1
469116|NCT00250432|1535180|P1|Overall Study|Pt was considered untreatable|0
469117|NCT00250432|1535179|P2|Overall Study|Pt died out of posttherapy report period|5
469118|NCT00250432|1535180|P1|Overall Study|Pt died out of posttherapy report period|6
469119|NCT00250432|1535179|P2|Overall Study|Withdrawal by Subject|2
469120|NCT00250432|1535180|P1|Overall Study|Withdrawal by Subject|6
469121|NCT00250432|1535179|P2|Overall Study|Protocol Violation|3
469122|NCT00250432|1535180|P1|Overall Study|Protocol Violation|0
469123|NCT00250432|1535179|P2|Overall Study|Patient Moved|1
469124|NCT00250432|1535180|P1|Overall Study|Patient Moved|0
469125|NCT00250432|1535179|P2|Overall Study|Lost to Follow-up|5
469126|NCT00250432|1535180|P1|Overall Study|Lost to Follow-up|6
469127|NCT00250432|1535179|P2|Overall Study|Lack of Efficacy|1
469128|NCT00250432|1535180|P1|Overall Study|Lack of Efficacy|2
469129|NCT00250432|1535179|P2|Overall Study|Adverse Event|29
469130|NCT00250432|1535180|P1|Overall Study|Adverse Event|25
469131|NCT00250276|1535192|P4|Overall Study|Lost to Follow-up|8
469132|NCT00250276|1535193|P3|Overall Study|Lost to Follow-up|13
469133|NCT00250276|1535194|P2|Overall Study|Lost to Follow-up|18
469134|NCT00250276|1535195|P1|Overall Study|Lost to Follow-up|11
469135|NCT00250276|1535192|P4|Overall Study|Migrated/moved from study area|7
469136|NCT00250276|1535193|P3|Overall Study|Migrated/moved from study area|2
469137|NCT00250276|1535194|P2|Overall Study|Migrated/moved from study area|0
469138|NCT00250276|1535195|P1|Overall Study|Migrated/moved from study area|3
469139|NCT00250276|1535192|P4|Overall Study|Withdrawal by Subject|2
469140|NCT00250276|1535193|P3|Overall Study|Withdrawal by Subject|3
469141|NCT00250276|1535194|P2|Overall Study|Withdrawal by Subject|2
469142|NCT00250276|1535195|P1|Overall Study|Withdrawal by Subject|1
469143|NCT00250276|1535192|P4|Overall Study|Protocol Violation|0
469144|NCT00250276|1535193|P3|Overall Study|Protocol Violation|0
469145|NCT00250276|1535194|P2|Overall Study|Protocol Violation|1
469146|NCT00250276|1535195|P1|Overall Study|Protocol Violation|0
469147|NCT00250276|1535192|P4|Overall Study|Non-serious Adverse Event|2
469148|NCT00250276|1535193|P3|Overall Study|Non-serious Adverse Event|0
469149|NCT00250276|1535194|P2|Overall Study|Non-serious Adverse Event|0
469150|NCT00250276|1535195|P1|Overall Study|Non-serious Adverse Event|2
469151|NCT00250276|1535192|P4|Overall Study|Serious Adverse Event|0
469152|NCT00250276|1535193|P3|Overall Study|Serious Adverse Event|1
469153|NCT00250276|1535194|P2|Overall Study|Serious Adverse Event|0
469154|NCT00250276|1535195|P1|Overall Study|Serious Adverse Event|0
469155|NCT00249873|1535275|P2|Overall Study|Thromboembolic/outcome event|122
469156|NCT00249873|1535276|P1|Overall Study|Thromboembolic/outcome event|82
469157|NCT00249873|1535275|P2|Overall Study|Event related to cardiac condition|21
469158|NCT00249873|1535276|P1|Overall Study|Event related to cardiac condition|12
469159|NCT00249873|1535275|P2|Overall Study|Surgery/ procedure|9
469160|NCT00249873|1535276|P1|Overall Study|Surgery/ procedure|9
469161|NCT00249873|1535275|P2|Overall Study|Study drug intolerance|0
469162|NCT00249873|1535276|P1|Overall Study|Study drug intolerance|5
469163|NCT00249873|1535275|P2|Overall Study|Oral anticoagulant required|157
469164|NCT00249873|1535276|P1|Overall Study|Oral anticoagulant required|159
469165|NCT00249873|1535275|P2|Overall Study|Angiotensin II receptor blocker required|0
469166|NCT00249873|1535276|P1|Overall Study|Angiotensin II receptor blocker required|1
469167|NCT00249873|1535275|P2|Overall Study|Open label clopidogrel required|42
469168|NCT00249873|1535276|P1|Overall Study|Open label clopidogrel required|31
469169|NCT00249873|1535275|P2|Overall Study|Physician withdrew consent|60
469170|NCT00249873|1535276|P1|Overall Study|Physician withdrew consent|59
469171|NCT00249873|1535275|P2|Overall Study|Patient not wish to continue after May08|4
469172|NCT00249873|1535276|P1|Overall Study|Patient not wish to continue after May08|3
469173|NCT00249873|1535275|P2|Overall Study|Other contraindicated medication|0
469174|NCT00249873|1535276|P1|Overall Study|Other contraindicated medication|1
469175|NCT00249873|1535275|P2|Overall Study|Other non serious Adverse Event|108
469176|NCT00249873|1535276|P1|Overall Study|Other non serious Adverse Event|112
469177|NCT00249873|1535275|P2|Overall Study|Non-compliance|46
469178|NCT00249873|1535276|P1|Overall Study|Non-compliance|41
469179|NCT00249873|1535275|P2|Overall Study|Minor bleeding|37
469180|NCT00249873|1535276|P1|Overall Study|Minor bleeding|99
469181|NCT00249873|1535275|P2|Overall Study|Lost to Follow-up|7
469182|NCT00249873|1535276|P1|Overall Study|Lost to Follow-up|4
469183|NCT00249873|1535275|P2|Overall Study|Withdrawal by Subject|466
469184|NCT00249873|1535276|P1|Overall Study|Withdrawal by Subject|504
469185|NCT00249873|1535275|P2|Overall Study|Contraindication to oral anticoagulant|8
469186|NCT00249873|1535276|P1|Overall Study|Contraindication to oral anticoagulant|4
469187|NCT00249873|1535275|P2|Overall Study|Qualifying condition not present|23
469188|NCT00249873|1535276|P1|Overall Study|Qualifying condition not present|20
469189|NCT00249873|1535275|P2|Overall Study|Other Serious Adverse Event|97
469190|NCT00249873|1535276|P1|Overall Study|Other Serious Adverse Event|86
469191|NCT00249873|1535275|P2|Overall Study|Serious haemorrhagic Adverse Event|30
469192|NCT00249873|1535276|P1|Overall Study|Serious haemorrhagic Adverse Event|74
469193|NCT00249873|1535275|P2|Overall Study|Severe allergic reaction|1
469194|NCT00249873|1535276|P1|Overall Study|Severe allergic reaction|8
469195|NCT00249873|1535275|P2|Overall Study|Significant thrombocytopenia|8
469196|NCT00249873|1535276|P1|Overall Study|Significant thrombocytopenia|9
469197|NCT00249873|1535275|P2|Overall Study|Not treated|8
469198|NCT00249873|1535276|P1|Overall Study|Not treated|7
469199|NCT00249834|1535296|P8|Overall Study|Protocol Violation|0
469200|NCT00249834|1535297|P7|Overall Study|Protocol Violation|0
469201|NCT00249834|1535298|P6|Overall Study|Protocol Violation|2
469202|NCT00249834|1535299|P5|Overall Study|Protocol Violation|5
469203|NCT00249834|1535300|P4|Overall Study|Protocol Violation|8
469204|NCT00249834|1535301|P3|Overall Study|Protocol Violation|14
469205|NCT00249834|1535302|P2|Overall Study|Protocol Violation|19
469206|NCT00249834|1535303|P1|Overall Study|Protocol Violation|0
469207|NCT00249834|1535296|P8|Overall Study|Failure of down-regulation|0
469208|NCT00249834|1535297|P7|Overall Study|Failure of down-regulation|1
469209|NCT00249834|1535298|P6|Overall Study|Failure of down-regulation|0
469210|NCT00249834|1535299|P5|Overall Study|Failure of down-regulation|0
469211|NCT00249834|1535300|P4|Overall Study|Failure of down-regulation|0
469212|NCT00249834|1535301|P3|Overall Study|Failure of down-regulation|0
469213|NCT00249834|1535302|P2|Overall Study|Failure of down-regulation|0
469214|NCT00249834|1535303|P1|Overall Study|Failure of down-regulation|0
469215|NCT00249834|1535296|P8|Overall Study|Ovarian stimulation failed|0
469216|NCT00249834|1535297|P7|Overall Study|Ovarian stimulation failed|0
469217|NCT00249834|1535298|P6|Overall Study|Ovarian stimulation failed|0
469218|NCT00249834|1535299|P5|Overall Study|Ovarian stimulation failed|0
469219|NCT00249834|1535300|P4|Overall Study|Ovarian stimulation failed|0
469220|NCT00249834|1535301|P3|Overall Study|Ovarian stimulation failed|0
469221|NCT00249834|1535302|P2|Overall Study|Ovarian stimulation failed|0
469222|NCT00249834|1535303|P1|Overall Study|Ovarian stimulation failed|1
469223|NCT00249821|1535352|P2|Overall Study|Technical problem|1
469224|NCT00249821|1535353|P1|Overall Study|Technical problem|0
469225|NCT00249808|1535373|P1|Overall Study|Did Not Provide Post-Baseline Data|11
469226|NCT00249808|1535373|P1|Overall Study|Lack of Efficacy|52
469227|NCT00249808|1535373|P1|Overall Study|Adverse Event|81
469228|NCT00249808|1535373|P1|Overall Study|Lost to Follow-up|8
469229|NCT00249808|1535373|P1|Overall Study|Protocol Violation|3
469230|NCT00249808|1535373|P1|Overall Study|Other|27
469231|NCT00249795|1535381|P2|Overall Study|Missing|1
469232|NCT00249795|1535382|P1|Overall Study|Missing|0
469233|NCT00249795|1535381|P2|Overall Study|Lost to Follow-up|2
469234|NCT00249795|1535382|P1|Overall Study|Lost to Follow-up|0
469235|NCT00249795|1535381|P2|Overall Study|Site not agree to continue after May08|1
469236|NCT00249795|1535382|P1|Overall Study|Site not agree to continue after May08|1
469237|NCT00249795|1535381|P2|Overall Study|Patient not wish to continue after May08|6
469238|NCT00249795|1535382|P1|Overall Study|Patient not wish to continue after May08|4
469239|NCT00249795|1535381|P2|Overall Study|Event related to cardiac condition|16
469240|NCT00249795|1535382|P1|Overall Study|Event related to cardiac condition|17
469241|NCT00249795|1535381|P2|Overall Study|Other contraindicated medication|1
469242|NCT00249795|1535382|P1|Overall Study|Other contraindicated medication|1
469243|NCT00249795|1535381|P2|Overall Study|Hypotension (non-symptomatic)|5
469244|NCT00249795|1535382|P1|Overall Study|Hypotension (non-symptomatic)|5
469245|NCT00249795|1535381|P2|Overall Study|Lightheadedness / dizziness|11
469246|NCT00249795|1535382|P1|Overall Study|Lightheadedness / dizziness|15
469247|NCT00249795|1535381|P2|Overall Study|Angiotensin II receptor blocker required|58
469248|NCT00249795|1535382|P1|Overall Study|Angiotensin II receptor blocker required|35
469249|NCT00249795|1535381|P2|Overall Study|Surgery / procedure|5
469250|NCT00249795|1535382|P1|Overall Study|Surgery / procedure|4
469251|NCT00249795|1535381|P2|Overall Study|Physician withdrew consent|63
469252|NCT00249795|1535382|P1|Overall Study|Physician withdrew consent|71
469253|NCT00249795|1535381|P2|Overall Study|Other adverse events (non-serious)|159
469254|NCT00249795|1535382|P1|Overall Study|Other adverse events (non-serious)|188
469255|NCT00249795|1535381|P2|Overall Study|Study drug intolerance|3
469256|NCT00249795|1535382|P1|Overall Study|Study drug intolerance|3
469257|NCT00249795|1535381|P2|Overall Study|Non-compliance|69
469258|NCT00249795|1535382|P1|Overall Study|Non-compliance|71
469259|NCT00249795|1535381|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
469260|NCT00249795|1535382|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
469261|NCT00249795|1535381|P2|Overall Study|Oral anticoagulant required|0
469262|NCT00249795|1535382|P1|Overall Study|Oral anticoagulant required|2
469263|NCT00249795|1535381|P2|Overall Study|Thromboembolic / outcome event|45
469264|NCT00249795|1535382|P1|Overall Study|Thromboembolic / outcome event|39
469265|NCT00249795|1535381|P2|Overall Study|Withdrawal by Subject|742
469266|NCT00249795|1535382|P1|Overall Study|Withdrawal by Subject|678
469267|NCT00249795|1535381|P2|Overall Study|Qualifying condition not present|29
469268|NCT00249795|1535382|P1|Overall Study|Qualifying condition not present|26
469269|NCT00249795|1535381|P2|Overall Study|Other Serious Adverse Event|93
469270|NCT00249795|1535382|P1|Overall Study|Other Serious Adverse Event|84
469271|NCT00249795|1535381|P2|Overall Study|Symptomatic hypotension|64
469272|NCT00249795|1535382|P1|Overall Study|Symptomatic hypotension|127
469273|NCT00249795|1535381|P2|Overall Study|Not treated|14
469274|NCT00249795|1535382|P1|Overall Study|Not treated|16
469275|NCT00249613|1535402|P2|12 Month Follow-up|Lost to Follow-up|8
469276|NCT00249613|1535403|P1|12 Month Follow-up|Lost to Follow-up|10
469277|NCT00249613|1535402|P2|12 Month Follow-up|Withdrawal by Subject|6
469278|NCT00249613|1535403|P1|12 Month Follow-up|Withdrawal by Subject|6
469279|NCT00249613|1535402|P2|12 Month Follow-up|Death|1
469280|NCT00249613|1535403|P1|12 Month Follow-up|Death|1
469281|NCT00249444|1535444|P2|Overall Study|life event|1
469282|NCT00249444|1535445|P1|Overall Study|life event|0
469283|NCT00249444|1535444|P2|Overall Study|Adverse Event|1
469284|NCT00249444|1535445|P1|Overall Study|Adverse Event|1
469285|NCT00249444|1535444|P2|Overall Study|non-compliant|11
469286|NCT00249444|1535445|P1|Overall Study|non-compliant|9
469287|NCT00249444|1535444|P2|Overall Study|Lost to Follow-up|2
469288|NCT00249444|1535445|P1|Overall Study|Lost to Follow-up|2
469289|NCT00249288|1535470|P2|Overall Study|Withdrawal by Subject|2
469290|NCT00249288|1535471|P1|Overall Study|Withdrawal by Subject|2
469291|NCT00249288|1535470|P2|Overall Study|Lost to Follow-up|3
469292|NCT00249288|1535471|P1|Overall Study|Lost to Follow-up|3
469293|NCT00249002|1535563|P1|Overall Study|Other|2
469294|NCT00249002|1535563|P1|Overall Study|Study cancellation|3
469295|NCT00249002|1535563|P1|Overall Study|Adverse Event|2
469296|NCT00248794|1535599|P3|Overall Study|Lost to Follow-up|3
469297|NCT00248794|1535600|P2|Overall Study|Lost to Follow-up|8
469298|NCT00248794|1535601|P1|Overall Study|Lost to Follow-up|6
469299|NCT00248651|1535651|P3|Overall Study|Withdrawal by Subject|32
469300|NCT00248651|1535652|P2|Overall Study|Withdrawal by Subject|40
469301|NCT00248651|1535653|P1|Overall Study|Withdrawal by Subject|28
469302|NCT00248625|1535689|P2|Overall Study|Withdrawal by Subject|2
469303|NCT00248625|1535690|P1|Overall Study|Withdrawal by Subject|0
469304|NCT00248495|1535772|P1|Overall Study|Withdrawal by Subject|1
469305|NCT00248287|1535783|P2|Overall Study|Other|2
469306|NCT00248287|1535784|P1|Overall Study|Other|3
469307|NCT00248287|1535783|P2|Overall Study|Patient Request|3
469308|NCT00248287|1535784|P1|Overall Study|Patient Request|5
469309|NCT00248287|1535783|P2|Overall Study|Investigator Request|3
469310|NCT00248287|1535784|P1|Overall Study|Investigator Request|4
469311|NCT00248287|1535783|P2|Overall Study|Lost to Follow-up|1
469312|NCT00248287|1535784|P1|Overall Study|Lost to Follow-up|0
469313|NCT00248287|1535783|P2|Overall Study|Death|0
469314|NCT00248287|1535784|P1|Overall Study|Death|1
469315|NCT00248287|1535783|P2|Overall Study|Adverse Event|10
469316|NCT00248287|1535784|P1|Overall Study|Adverse Event|11
469317|NCT00248170|1535798|P2|Overall Study|Protocol deviation|19
469318|NCT00248170|1535799|P1|Overall Study|Protocol deviation|17
469319|NCT00248170|1535798|P2|Overall Study|Abnormal laboratory values|0
469320|NCT00248170|1535799|P1|Overall Study|Abnormal laboratory values|4
469321|NCT00248170|1535798|P2|Overall Study|Abnormal test procedure(s) result|61
469322|NCT00248170|1535799|P1|Overall Study|Abnormal test procedure(s) result|49
469323|NCT00248170|1535798|P2|Overall Study|Administrative problems|25
469324|NCT00248170|1535799|P1|Overall Study|Administrative problems|22
469325|NCT00248170|1535798|P2|Overall Study|Adverse Event|296
469326|NCT00248170|1535799|P1|Overall Study|Adverse Event|311
469327|NCT00248170|1535798|P2|Overall Study|Death|47
469328|NCT00248170|1535799|P1|Overall Study|Death|28
469329|NCT00248170|1535798|P2|Overall Study|Disease progression|216
469330|NCT00248170|1535799|P1|Overall Study|Disease progression|196
469331|NCT00248170|1535798|P2|Overall Study|Lost to Follow-up|35
469332|NCT00248170|1535799|P1|Overall Study|Lost to Follow-up|28
469333|NCT00248170|1535798|P2|Overall Study|Protocol Violation|30
469334|NCT00248170|1535799|P1|Overall Study|Protocol Violation|35
469335|NCT00248170|1535798|P2|Overall Study|Withdrawal by Subject|79
469336|NCT00248170|1535799|P1|Overall Study|Withdrawal by Subject|71
469337|NCT00247962|1535821|P2|Overall Study|Lack of Efficacy|2
469338|NCT00247962|1535822|P1|Overall Study|Lack of Efficacy|4
469339|NCT00247962|1535821|P2|Overall Study|Withdrawal by Subject|2
469340|NCT00247962|1535822|P1|Overall Study|Withdrawal by Subject|3
469341|NCT00247962|1535821|P2|Overall Study|Protocol Violation|1
469342|NCT00247962|1535822|P1|Overall Study|Protocol Violation|1
469343|NCT00247962|1535821|P2|Overall Study|Physician Decision|1
469344|NCT00247962|1535822|P1|Overall Study|Physician Decision|0
469345|NCT00247962|1535821|P2|Overall Study|Lost to Follow-up|1
469346|NCT00247962|1535822|P1|Overall Study|Lost to Follow-up|3
469347|NCT00247962|1535821|P2|Overall Study|Adverse Event|12
469348|NCT00247962|1535822|P1|Overall Study|Adverse Event|15
469349|NCT00247676|1535830|P1|Overall Study|Withdrawal by Subject|2
469350|NCT00247676|1535830|P1|Overall Study|Other|3
469351|NCT00247676|1535830|P1|Overall Study|Lack of Efficacy|15
469352|NCT00247676|1535830|P1|Overall Study|Adverse Event|11
469353|NCT00247676|1535830|P1|Overall Study|Death|5
469354|NCT00247611|1535875|P2|Baselined|Completed baseline only|8
469355|NCT00247611|1535876|P1|Baselined|Completed baseline only|9
469356|NCT00247611|1535875|P2|Baselined|Completed baseline, never placed on ARVs|5
469357|NCT00247611|1535876|P1|Baselined|Completed baseline, never placed on ARVs|8
469358|NCT00247416|1535894|P2|Overall Study|3 patients were found to be ineligible|2
469359|NCT00247416|1535895|P1|Overall Study|3 patients were found to be ineligible|1
469360|NCT00247273|1535936|P2|Overall Study|Did not take any study drug|0
469361|NCT00247273|1535937|P1|Overall Study|Did not take any study drug|2
469362|NCT00247273|1535936|P2|Overall Study|Withdrawal by Subject|47
469363|NCT00247273|1535937|P1|Overall Study|Withdrawal by Subject|46
469364|NCT00247273|1535936|P2|Overall Study|Lost to Follow-up|7
469365|NCT00247273|1535937|P1|Overall Study|Lost to Follow-up|7
469366|NCT00247273|1535936|P2|Overall Study|Physician Decision|3
469367|NCT00247273|1535937|P1|Overall Study|Physician Decision|6
469368|NCT00247273|1535936|P2|Overall Study|Adverse Event|80
469369|NCT00247273|1535937|P1|Overall Study|Adverse Event|85
469370|NCT00246805|1535983|P2|Phase 1|Lost to Follow-up|0
469371|NCT00246805|1535984|P1|Phase 1|Lost to Follow-up|1
469372|NCT00246753|1535990|P1|Overall Study|Unacceptable toxicity|2
469373|NCT00246753|1535990|P1|Overall Study|Adverse Event|2
469374|NCT00246753|1535990|P1|Overall Study|Physician Decision|2
469375|NCT00246753|1535990|P1|Overall Study|Withdrawal by Subject|2
469376|NCT00246740|1535998|P2|Initial Enrollment|Other|2
469377|NCT00246740|1535999|P1|Initial Enrollment|Other|1
469378|NCT00246740|1535998|P2|Initial Enrollment|Surgery schedule change|4
469379|NCT00246740|1535999|P1|Initial Enrollment|Surgery schedule change|4
469380|NCT00246740|1535998|P2|Initial Enrollment|Additional surgery scheduled|2
469381|NCT00246740|1535999|P1|Initial Enrollment|Additional surgery scheduled|0
469382|NCT00246740|1535998|P2|Initial Enrollment|Death|0
469383|NCT00246740|1535999|P1|Initial Enrollment|Death|1
469384|NCT00246571|1536023|P2|Overall Study|Crossover participants|74
469385|NCT00246571|1536024|P1|Overall Study|Crossover participants|0
469386|NCT00246571|1536023|P2|Overall Study|Laboratory abnormalities|0
469387|NCT00246571|1536024|P1|Overall Study|Laboratory abnormalities|1
469388|NCT00246571|1536023|P2|Overall Study|Did not meet entrance criteria|1
469389|NCT00246571|1536024|P1|Overall Study|Did not meet entrance criteria|2
469390|NCT00246571|1536023|P2|Overall Study|Sponsor|1
469391|NCT00246571|1536024|P1|Overall Study|Sponsor|0
469392|NCT00246571|1536023|P2|Overall Study|Death|3
469393|NCT00246571|1536024|P1|Overall Study|Death|17
469394|NCT00246571|1536023|P2|Overall Study|Lack of Efficacy|21
469395|NCT00246571|1536024|P1|Overall Study|Lack of Efficacy|84
469396|NCT00246571|1536023|P2|Overall Study|Withdrawal by Subject|3
469397|NCT00246571|1536024|P1|Overall Study|Withdrawal by Subject|2
469398|NCT00246571|1536023|P2|Overall Study|Protocol Violation|1
469399|NCT00246571|1536024|P1|Overall Study|Protocol Violation|0
469400|NCT00246571|1536023|P2|Overall Study|Adverse Event|0
469401|NCT00246571|1536024|P1|Overall Study|Adverse Event|7
469402|NCT00246376|1536076|P5|Overall Study|Lost to Follow-up|13
469403|NCT00246376|1536077|P4|Overall Study|Lost to Follow-up|16
469404|NCT00246376|1536078|P3|Overall Study|Lost to Follow-up|11
469405|NCT00246376|1536079|P2|Overall Study|Lost to Follow-up|11
469406|NCT00246376|1536080|P1|Overall Study|Lost to Follow-up|2
469407|NCT00246376|1536076|P5|Overall Study|Adverse Event|1
469408|NCT00246376|1536077|P4|Overall Study|Adverse Event|3
469409|NCT00246376|1536078|P3|Overall Study|Adverse Event|1
469410|NCT00246376|1536079|P2|Overall Study|Adverse Event|3
469411|NCT00246376|1536080|P1|Overall Study|Adverse Event|2
469412|NCT00246376|1536076|P5|Overall Study|Dropped/withdrew during dietary run-in|3
469413|NCT00246376|1536077|P4|Overall Study|Dropped/withdrew during dietary run-in|7
469414|NCT00246376|1536078|P3|Overall Study|Dropped/withdrew during dietary run-in|4
469415|NCT00246376|1536079|P2|Overall Study|Dropped/withdrew during dietary run-in|5
469416|NCT00246376|1536080|P1|Overall Study|Dropped/withdrew during dietary run-in|11
469417|NCT00246337|1536131|P9|Overall Study|Reported as completing trial in error|0
469418|NCT00246337|1536132|P8|Overall Study|Reported as completing trial in error|1
469419|NCT00246337|1536133|P7|Overall Study|Reported as completing trial in error|0
469420|NCT00246337|1536134|P6|Overall Study|Reported as completing trial in error|0
469421|NCT00246337|1536135|P5|Overall Study|Reported as completing trial in error|0
469422|NCT00246337|1536136|P4|Overall Study|Reported as completing trial in error|0
469423|NCT00246337|1536137|P3|Overall Study|Reported as completing trial in error|0
469424|NCT00246337|1536138|P2|Overall Study|Reported as completing trial in error|0
469425|NCT00246337|1536139|P1|Overall Study|Reported as completing trial in error|0
469426|NCT00246337|1536131|P9|Overall Study|Protocol Violator|0
469427|NCT00246337|1536132|P8|Overall Study|Protocol Violator|0
469428|NCT00246337|1536133|P7|Overall Study|Protocol Violator|0
469429|NCT00246337|1536134|P6|Overall Study|Protocol Violator|0
469430|NCT00246337|1536135|P5|Overall Study|Protocol Violator|0
469431|NCT00246337|1536136|P4|Overall Study|Protocol Violator|0
469432|NCT00246337|1536137|P3|Overall Study|Protocol Violator|0
469433|NCT00246337|1536138|P2|Overall Study|Protocol Violator|0
469434|NCT00246337|1536139|P1|Overall Study|Protocol Violator|1
469435|NCT00246337|1536131|P9|Overall Study|Overwhelmed|0
469436|NCT00246337|1536132|P8|Overall Study|Overwhelmed|0
469437|NCT00246337|1536133|P7|Overall Study|Overwhelmed|0
469438|NCT00246337|1536134|P6|Overall Study|Overwhelmed|1
469439|NCT00246337|1536135|P5|Overall Study|Overwhelmed|0
469440|NCT00246337|1536136|P4|Overall Study|Overwhelmed|0
469441|NCT00246337|1536137|P3|Overall Study|Overwhelmed|0
469442|NCT00246337|1536138|P2|Overall Study|Overwhelmed|0
469443|NCT00246337|1536139|P1|Overall Study|Overwhelmed|0
469444|NCT00246337|1536131|P9|Overall Study|Abnormal baseline lab values|4
469445|NCT00246337|1536132|P8|Overall Study|Abnormal baseline lab values|0
469446|NCT00246337|1536133|P7|Overall Study|Abnormal baseline lab values|2
469447|NCT00246337|1536134|P6|Overall Study|Abnormal baseline lab values|2
469448|NCT00246337|1536135|P5|Overall Study|Abnormal baseline lab values|0
469449|NCT00246337|1536136|P4|Overall Study|Abnormal baseline lab values|0
469450|NCT00246337|1536137|P3|Overall Study|Abnormal baseline lab values|2
469451|NCT00246337|1536138|P2|Overall Study|Abnormal baseline lab values|0
469452|NCT00246337|1536139|P1|Overall Study|Abnormal baseline lab values|7
469453|NCT00246337|1536131|P9|Overall Study|Site Terminated|2
469454|NCT00246337|1536132|P8|Overall Study|Site Terminated|6
469455|NCT00246337|1536133|P7|Overall Study|Site Terminated|1
469456|NCT00246337|1536134|P6|Overall Study|Site Terminated|7
469457|NCT00246337|1536135|P5|Overall Study|Site Terminated|0
469458|NCT00246337|1536136|P4|Overall Study|Site Terminated|0
469459|NCT00246337|1536137|P3|Overall Study|Site Terminated|0
469460|NCT00246337|1536138|P2|Overall Study|Site Terminated|0
469461|NCT00246337|1536139|P1|Overall Study|Site Terminated|10
469462|NCT00246337|1536131|P9|Overall Study|Lack of Qualifying Event|5
469463|NCT00246337|1536132|P8|Overall Study|Lack of Qualifying Event|2
469464|NCT00246337|1536133|P7|Overall Study|Lack of Qualifying Event|3
469465|NCT00246337|1536134|P6|Overall Study|Lack of Qualifying Event|3
469466|NCT00246337|1536135|P5|Overall Study|Lack of Qualifying Event|1
469467|NCT00246337|1536136|P4|Overall Study|Lack of Qualifying Event|1
469468|NCT00246337|1536137|P3|Overall Study|Lack of Qualifying Event|1
469469|NCT00246337|1536138|P2|Overall Study|Lack of Qualifying Event|2
469470|NCT00246337|1536139|P1|Overall Study|Lack of Qualifying Event|8
469471|NCT00246337|1536131|P9|Overall Study|Withdrawal by Subject|0
469472|NCT00246337|1536132|P8|Overall Study|Withdrawal by Subject|1
469473|NCT00246337|1536133|P7|Overall Study|Withdrawal by Subject|1
469474|NCT00246337|1536134|P6|Overall Study|Withdrawal by Subject|0
469475|NCT00246337|1536135|P5|Overall Study|Withdrawal by Subject|0
469476|NCT00246337|1536136|P4|Overall Study|Withdrawal by Subject|0
469477|NCT00246337|1536137|P3|Overall Study|Withdrawal by Subject|0
469478|NCT00246337|1536138|P2|Overall Study|Withdrawal by Subject|0
469479|NCT00246337|1536139|P1|Overall Study|Withdrawal by Subject|2
469480|NCT00246337|1536131|P9|Overall Study|Protocol Violation|0
469481|NCT00246337|1536132|P8|Overall Study|Protocol Violation|1
469482|NCT00246337|1536133|P7|Overall Study|Protocol Violation|1
469483|NCT00246337|1536134|P6|Overall Study|Protocol Violation|0
469484|NCT00246337|1536135|P5|Overall Study|Protocol Violation|1
469485|NCT00246337|1536136|P4|Overall Study|Protocol Violation|0
469486|NCT00246337|1536137|P3|Overall Study|Protocol Violation|0
469487|NCT00246337|1536138|P2|Overall Study|Protocol Violation|0
469488|NCT00246337|1536139|P1|Overall Study|Protocol Violation|1
469489|NCT00246337|1536131|P9|Overall Study|Lost to Follow-up|0
469490|NCT00246337|1536132|P8|Overall Study|Lost to Follow-up|2
469491|NCT00246337|1536133|P7|Overall Study|Lost to Follow-up|1
469492|NCT00246337|1536134|P6|Overall Study|Lost to Follow-up|2
469493|NCT00246337|1536135|P5|Overall Study|Lost to Follow-up|2
469494|NCT00246337|1536136|P4|Overall Study|Lost to Follow-up|0
469495|NCT00246337|1536137|P3|Overall Study|Lost to Follow-up|0
469496|NCT00246337|1536138|P2|Overall Study|Lost to Follow-up|0
469497|NCT00246337|1536139|P1|Overall Study|Lost to Follow-up|3
469498|NCT00246324|1536186|P1|Overall Study|Withdrawal by Subject|1
469499|NCT00246259|1536193|P2|Overall Study|randomly assigned, not eligible for ITT|6
469500|NCT00246259|1536194|P1|Overall Study|randomly assigned, not eligible for ITT|2
469501|NCT00246259|1536193|P2|Overall Study|Withdrawal by Subject|1
469502|NCT00246259|1536194|P1|Overall Study|Withdrawal by Subject|5
469503|NCT00246259|1536193|P2|Overall Study|Lost to Follow-up|4
469504|NCT00246259|1536194|P1|Overall Study|Lost to Follow-up|3
469505|NCT00246259|1536193|P2|Overall Study|Adverse Event|0
469506|NCT00246259|1536194|P1|Overall Study|Adverse Event|5
469507|NCT00246259|1536193|P2|Overall Study|Investigator withdrew participant|0
469508|NCT00246259|1536194|P1|Overall Study|Investigator withdrew participant|2
469509|NCT00246259|1536193|P2|Overall Study|Lack of Efficacy|2
469510|NCT00246259|1536194|P1|Overall Study|Lack of Efficacy|2
469511|NCT00246259|1536193|P2|Overall Study|Participant non-compliant|9
469512|NCT00246259|1536194|P1|Overall Study|Participant non-compliant|4
469513|NCT00246259|1536193|P2|Overall Study|Not stable by Week 18|1
469514|NCT00246259|1536194|P1|Overall Study|Not stable by Week 18|2
469515|NCT00246259|1536193|P2|Overall Study|Other|3
469516|NCT00246259|1536194|P1|Overall Study|Other|3
469517|NCT00246090|1536228|P1|Overall Study|Not Otherwise Specified|10
469518|NCT00246090|1536228|P1|Overall Study|Physician Decision|11
469519|NCT00246090|1536228|P1|Overall Study|Clinical Progression|30
469520|NCT00246090|1536228|P1|Overall Study|Progressive Disease|212
469521|NCT00246090|1536228|P1|Overall Study|Withdrawal by Subject|7
469522|NCT00246090|1536228|P1|Overall Study|Adverse Event|25
469523|NCT00246025|1536237|P4|Overall Study|unsuitable medical history was found|1
469524|NCT00246025|1536238|P3|Overall Study|unsuitable medical history was found|0
469525|NCT00246025|1536239|P2|Overall Study|unsuitable medical history was found|0
469526|NCT00246025|1536240|P1|Overall Study|unsuitable medical history was found|0
469527|NCT00246025|1536237|P4|Overall Study|Withdrawal by Subject|2
469528|NCT00246025|1536238|P3|Overall Study|Withdrawal by Subject|1
469529|NCT00246025|1536239|P2|Overall Study|Withdrawal by Subject|0
469530|NCT00246025|1536240|P1|Overall Study|Withdrawal by Subject|3
469531|NCT00246025|1536237|P4|Overall Study|Adverse Event|10
469532|NCT00246025|1536238|P3|Overall Study|Adverse Event|9
469533|NCT00246025|1536239|P2|Overall Study|Adverse Event|9
469534|NCT00246025|1536240|P1|Overall Study|Adverse Event|7
469535|NCT00246012|1536299|P9|Overall Study|Randomly assigned but not treated|0
469536|NCT00246012|1536300|P8|Overall Study|Randomly assigned but not treated|0
469537|NCT00246012|1536301|P7|Overall Study|Randomly assigned but not treated|1
469538|NCT00246012|1536302|P6|Overall Study|Randomly assigned but not treated|1
469539|NCT00246012|1536303|P5|Overall Study|Randomly assigned but not treated|0
469540|NCT00246012|1536304|P4|Overall Study|Randomly assigned but not treated|0
469541|NCT00246012|1536305|P3|Overall Study|Randomly assigned but not treated|0
469542|NCT00246012|1536306|P2|Overall Study|Randomly assigned but not treated|0
469543|NCT00246012|1536307|P1|Overall Study|Randomly assigned but not treated|0
469544|NCT00246012|1536299|P9|Overall Study|Other|0
469545|NCT00246012|1536300|P8|Overall Study|Other|1
469546|NCT00246012|1536301|P7|Overall Study|Other|0
469547|NCT00246012|1536302|P6|Overall Study|Other|0
469548|NCT00246012|1536303|P5|Overall Study|Other|0
469549|NCT00246012|1536304|P4|Overall Study|Other|0
469550|NCT00246012|1536305|P3|Overall Study|Other|0
469551|NCT00246012|1536306|P2|Overall Study|Other|0
469552|NCT00246012|1536307|P1|Overall Study|Other|0
469553|NCT00246012|1536299|P9|Overall Study|Disease progression|26
469554|NCT00246012|1536300|P8|Overall Study|Disease progression|27
469555|NCT00246012|1536301|P7|Overall Study|Disease progression|30
469556|NCT00246012|1536302|P6|Overall Study|Disease progression|25
469557|NCT00246012|1536303|P5|Overall Study|Disease progression|3
469558|NCT00246012|1536304|P4|Overall Study|Disease progression|3
469559|NCT00246012|1536305|P3|Overall Study|Disease progression|2
469560|NCT00246012|1536306|P2|Overall Study|Disease progression|1
469561|NCT00246012|1536307|P1|Overall Study|Disease progression|3
469562|NCT00246012|1536299|P9|Overall Study|Withdrawal by Subject|0
469563|NCT00246012|1536300|P8|Overall Study|Withdrawal by Subject|0
469564|NCT00246012|1536301|P7|Overall Study|Withdrawal by Subject|0
469565|NCT00246012|1536302|P6|Overall Study|Withdrawal by Subject|1
469566|NCT00246012|1536303|P5|Overall Study|Withdrawal by Subject|0
469567|NCT00246012|1536304|P4|Overall Study|Withdrawal by Subject|0
469568|NCT00246012|1536305|P3|Overall Study|Withdrawal by Subject|0
469569|NCT00246012|1536306|P2|Overall Study|Withdrawal by Subject|0
469570|NCT00246012|1536307|P1|Overall Study|Withdrawal by Subject|0
469571|NCT00246012|1536299|P9|Overall Study|Adverse Event|2
469572|NCT00246012|1536300|P8|Overall Study|Adverse Event|0
469573|NCT00246012|1536301|P7|Overall Study|Adverse Event|0
469574|NCT00246012|1536302|P6|Overall Study|Adverse Event|1
469575|NCT00246012|1536303|P5|Overall Study|Adverse Event|0
469576|NCT00246012|1536304|P4|Overall Study|Adverse Event|0
469577|NCT00246012|1536305|P3|Overall Study|Adverse Event|0
469578|NCT00246012|1536306|P2|Overall Study|Adverse Event|0
469579|NCT00246012|1536307|P1|Overall Study|Adverse Event|0
469580|NCT00245960|1536402|P2|Overall Study|Lack of Efficacy|6
469581|NCT00245960|1536403|P1|Overall Study|Lack of Efficacy|4
469582|NCT00245960|1536402|P2|Overall Study|Withdrawal by Subject|7
469583|NCT00245960|1536403|P1|Overall Study|Withdrawal by Subject|5
469584|NCT00245960|1536402|P2|Overall Study|Protocol Violation|3
469585|NCT00245960|1536403|P1|Overall Study|Protocol Violation|4
469586|NCT00245960|1536402|P2|Overall Study|Lost to Follow-up|2
469587|NCT00245960|1536403|P1|Overall Study|Lost to Follow-up|2
469588|NCT00245960|1536402|P2|Overall Study|Adverse Event|10
469589|NCT00245960|1536403|P1|Overall Study|Adverse Event|14
469590|NCT00245856|1536411|P2|Period Two|Withdrawal by Subject|1
469591|NCT00245856|1536412|P1|Period Two|Withdrawal by Subject|0
469592|NCT00245570|1536428|P6|Washout Between Periods III and IV|Adverse Event|0
469593|NCT00245570|1536429|P5|Washout Between Periods III and IV|Adverse Event|0
469594|NCT00245570|1536430|P4|Washout Between Periods III and IV|Adverse Event|0
469595|NCT00245570|1536431|P3|Washout Between Periods III and IV|Adverse Event|0
469596|NCT00245570|1536432|P2|Washout Between Periods III and IV|Adverse Event|1
469597|NCT00245570|1536433|P1|Washout Between Periods III and IV|Adverse Event|0
469598|NCT00245466|1536567|P3|Overall Study|Administrative reasons|0
469599|NCT00245466|1536568|P2|Overall Study|Administrative reasons|1
469600|NCT00245466|1536569|P1|Overall Study|Administrative reasons|0
469601|NCT00245466|1536567|P3|Overall Study|Death|0
469602|NCT00245466|1536568|P2|Overall Study|Death|2
469603|NCT00245466|1536569|P1|Overall Study|Death|0
469604|NCT00245466|1536567|P3|Overall Study|Protocol Violation|2
469605|NCT00245466|1536568|P2|Overall Study|Protocol Violation|2
469606|NCT00245466|1536569|P1|Overall Study|Protocol Violation|1
469607|NCT00245466|1536567|P3|Overall Study|Disease progression|1
469608|NCT00245466|1536568|P2|Overall Study|Disease progression|3
469609|NCT00245466|1536569|P1|Overall Study|Disease progression|0
469610|NCT00245466|1536567|P3|Overall Study|Lost to Follow-up|0
469611|NCT00245466|1536568|P2|Overall Study|Lost to Follow-up|0
469612|NCT00245466|1536569|P1|Overall Study|Lost to Follow-up|3
469613|NCT00245466|1536567|P3|Overall Study|Withdrawal by Subject|1
469614|NCT00245466|1536568|P2|Overall Study|Withdrawal by Subject|2
469615|NCT00245466|1536569|P1|Overall Study|Withdrawal by Subject|2
469616|NCT00245466|1536567|P3|Overall Study|Insufficient PSA and testosterone suppr|3
469617|NCT00245466|1536568|P2|Overall Study|Insufficient PSA and testosterone suppr|0
469618|NCT00245466|1536569|P1|Overall Study|Insufficient PSA and testosterone suppr|0
469619|NCT00245466|1536567|P3|Overall Study|Insufficient testosterone suppr|21
469620|NCT00245466|1536568|P2|Overall Study|Insufficient testosterone suppr|12
469621|NCT00245466|1536569|P1|Overall Study|Insufficient testosterone suppr|12
469622|NCT00245466|1536567|P3|Overall Study|Low prostate specific antigen suppr|5
469623|NCT00245466|1536568|P2|Overall Study|Low prostate specific antigen suppr|14
469624|NCT00245466|1536569|P1|Overall Study|Low prostate specific antigen suppr|16
469625|NCT00245466|1536567|P3|Overall Study|Adverse Event|4
469626|NCT00245466|1536568|P2|Overall Study|Adverse Event|8
469627|NCT00245466|1536569|P1|Overall Study|Adverse Event|2
469628|NCT00245102|1536612|P6|Overall Study|Clinical progression|0
469629|NCT00245102|1536613|P5|Overall Study|Clinical progression|0
469630|NCT00245102|1536614|P4|Overall Study|Clinical progression|0
469631|NCT00245102|1536615|P3|Overall Study|Clinical progression|0
469632|NCT00245102|1536616|P2|Overall Study|Clinical progression|0
469633|NCT00245102|1536617|P1|Overall Study|Clinical progression|1
469634|NCT00245102|1536612|P6|Overall Study|Participant needed surgery|0
469635|NCT00245102|1536613|P5|Overall Study|Participant needed surgery|0
469636|NCT00245102|1536614|P4|Overall Study|Participant needed surgery|0
469637|NCT00245102|1536615|P3|Overall Study|Participant needed surgery|1
469638|NCT00245102|1536616|P2|Overall Study|Participant needed surgery|0
469639|NCT00245102|1536617|P1|Overall Study|Participant needed surgery|0
469640|NCT00245102|1536612|P6|Overall Study|Decline in performance|2
469641|NCT00245102|1536613|P5|Overall Study|Decline in performance|0
469642|NCT00245102|1536614|P4|Overall Study|Decline in performance|1
469643|NCT00245102|1536615|P3|Overall Study|Decline in performance|0
469644|NCT00245102|1536616|P2|Overall Study|Decline in performance|2
469645|NCT00245102|1536617|P1|Overall Study|Decline in performance|0
469646|NCT00245102|1536612|P6|Overall Study|Adverse Event|2
469647|NCT00245102|1536613|P5|Overall Study|Adverse Event|0
469648|NCT00245102|1536614|P4|Overall Study|Adverse Event|1
469649|NCT00245102|1536615|P3|Overall Study|Adverse Event|5
469650|NCT00245102|1536616|P2|Overall Study|Adverse Event|2
469651|NCT00245102|1536617|P1|Overall Study|Adverse Event|4
469652|NCT00245102|1536612|P6|Overall Study|Death|0
469653|NCT00245102|1536613|P5|Overall Study|Death|0
469654|NCT00245102|1536614|P4|Overall Study|Death|1
469655|NCT00245102|1536615|P3|Overall Study|Death|0
469656|NCT00245102|1536616|P2|Overall Study|Death|0
469657|NCT00245102|1536617|P1|Overall Study|Death|0
469658|NCT00245102|1536612|P6|Overall Study|Protocol Violation|0
469659|NCT00245102|1536613|P5|Overall Study|Protocol Violation|0
469660|NCT00245102|1536614|P4|Overall Study|Protocol Violation|0
469661|NCT00245102|1536615|P3|Overall Study|Protocol Violation|0
469662|NCT00245102|1536616|P2|Overall Study|Protocol Violation|0
469663|NCT00245102|1536617|P1|Overall Study|Protocol Violation|1
469664|NCT00245102|1536612|P6|Overall Study|Not Treated|0
469665|NCT00245102|1536613|P5|Overall Study|Not Treated|0
469666|NCT00245102|1536614|P4|Overall Study|Not Treated|0
469667|NCT00245102|1536615|P3|Overall Study|Not Treated|1
469668|NCT00245102|1536616|P2|Overall Study|Not Treated|0
469669|NCT00245102|1536617|P1|Overall Study|Not Treated|1
469670|NCT00245063|1536633|P2|Overall Study|Death|0
469671|NCT00245063|1536634|P1|Overall Study|Death|1
469672|NCT00245063|1536633|P2|Overall Study|Adverse Event|5
469673|NCT00245063|1536634|P1|Overall Study|Adverse Event|6
469674|NCT00245050|1536642|P2|Overall Study|Adverse Event|2
469675|NCT00245050|1536643|P1|Overall Study|Adverse Event|3
469676|NCT00245037|1536651|P1|Overall Study|Death|17
469677|NCT00245011|1536661|P1|Overall Study|Lack of Efficacy|1
469678|NCT00244933|1536673|P1|Overall Study|Not response evaluable|2
469679|NCT00244881|1536677|P1|Overall Study|Withdrawal by Subject|3
469680|NCT00244855|1536685|P2|Overall Study|Withdrawal by Subject|1
469681|NCT00244855|1536686|P1|Overall Study|Withdrawal by Subject|0
469682|NCT00244764|1536694|P1|Overall Study|Developed Secondary Malignancy|1
469683|NCT00244764|1536694|P1|Overall Study|Sponsor Terminated Study|2
469684|NCT00244764|1536694|P1|Overall Study|Primary Investigator Discretion|2
469685|NCT00244764|1536694|P1|Overall Study|Participant was Hospitalized until Death|1
469686|NCT00244764|1536694|P1|Overall Study|Declining Performance Status|1
469687|NCT00244764|1536694|P1|Overall Study|Off Study Medication for >21 Days|1
469688|NCT00244764|1536694|P1|Overall Study|Death|1
469689|NCT00244764|1536694|P1|Overall Study|Protocol Violation|2
469690|NCT00244764|1536694|P1|Overall Study|Disease Progression|13
469691|NCT00244764|1536694|P1|Overall Study|Withdrawal by Subject|12
469692|NCT00244764|1536694|P1|Overall Study|Lost to Follow-up|23
469693|NCT00244764|1536694|P1|Overall Study|Adverse Event|37
469694|NCT00244751|1536704|P3|Overall Study|Participant randomized by mistake|1
469695|NCT00244751|1536705|P2|Overall Study|Participant randomized by mistake|0
469696|NCT00244751|1536706|P1|Overall Study|Participant randomized by mistake|0
469697|NCT00244751|1536704|P3|Overall Study|Safety reasons|0
469698|NCT00244751|1536705|P2|Overall Study|Safety reasons|1
469699|NCT00244751|1536706|P1|Overall Study|Safety reasons|0
469700|NCT00244751|1536704|P3|Overall Study|Lack of compliance with protocol|0
469701|NCT00244751|1536705|P2|Overall Study|Lack of compliance with protocol|1
469702|NCT00244751|1536706|P1|Overall Study|Lack of compliance with protocol|0
469703|NCT00244751|1536704|P3|Overall Study|Elevated liver enzymes|0
469704|NCT00244751|1536705|P2|Overall Study|Elevated liver enzymes|0
469705|NCT00244751|1536706|P1|Overall Study|Elevated liver enzymes|1
469706|NCT00244751|1536704|P3|Overall Study|Withdrawal by Subject|3
469707|NCT00244751|1536705|P2|Overall Study|Withdrawal by Subject|5
469708|NCT00244751|1536706|P1|Overall Study|Withdrawal by Subject|7
469709|NCT00244751|1536704|P3|Overall Study|Protocol Violation|1
469710|NCT00244751|1536705|P2|Overall Study|Protocol Violation|0
469711|NCT00244751|1536706|P1|Overall Study|Protocol Violation|1
469712|NCT00244751|1536704|P3|Overall Study|Lost to Follow-up|0
469713|NCT00244751|1536705|P2|Overall Study|Lost to Follow-up|1
469714|NCT00244751|1536706|P1|Overall Study|Lost to Follow-up|0
469715|NCT00244751|1536704|P3|Overall Study|Adverse Event|5
469716|NCT00244751|1536705|P2|Overall Study|Adverse Event|7
469717|NCT00244751|1536706|P1|Overall Study|Adverse Event|7
469718|NCT00244725|1536807|P4|Overall Study|Failed to follow-up|1
469719|NCT00244725|1536808|P3|Overall Study|Failed to follow-up|1
469720|NCT00244725|1536809|P2|Overall Study|Failed to follow-up|0
469721|NCT00244725|1536810|P1|Overall Study|Failed to follow-up|0
469722|NCT00244725|1536807|P4|Overall Study|Vomit|0
469723|NCT00244725|1536808|P3|Overall Study|Vomit|1
469724|NCT00244725|1536809|P2|Overall Study|Vomit|0
469725|NCT00244725|1536810|P1|Overall Study|Vomit|0
469726|NCT00244725|1536807|P4|Overall Study|Administrative reason|0
469727|NCT00244725|1536808|P3|Overall Study|Administrative reason|1
469728|NCT00244725|1536809|P2|Overall Study|Administrative reason|0
469729|NCT00244725|1536810|P1|Overall Study|Administrative reason|0
469730|NCT00244725|1536807|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
469731|NCT00244725|1536808|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
469732|NCT00244725|1536809|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
469733|NCT00244725|1536810|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
469734|NCT00244725|1536807|P4|Overall Study|Received prohibited medication|1
469735|NCT00244725|1536808|P3|Overall Study|Received prohibited medication|0
469736|NCT00244725|1536809|P2|Overall Study|Received prohibited medication|1
469737|NCT00244725|1536810|P1|Overall Study|Received prohibited medication|0
469738|NCT00244725|1536807|P4|Overall Study|Headache|0
469739|NCT00244725|1536808|P3|Overall Study|Headache|0
469740|NCT00244725|1536809|P2|Overall Study|Headache|1
469741|NCT00244725|1536810|P1|Overall Study|Headache|0
469742|NCT00244725|1536807|P4|Overall Study|Rehab Refused to allow participantion|0
469743|NCT00244725|1536808|P3|Overall Study|Rehab Refused to allow participantion|0
469744|NCT00244725|1536809|P2|Overall Study|Rehab Refused to allow participantion|1
469745|NCT00244725|1536810|P1|Overall Study|Rehab Refused to allow participantion|0
469746|NCT00244725|1536807|P4|Overall Study|Mediciation Error|0
469747|NCT00244725|1536808|P3|Overall Study|Mediciation Error|0
469748|NCT00244725|1536809|P2|Overall Study|Mediciation Error|1
469749|NCT00244725|1536810|P1|Overall Study|Mediciation Error|0
469750|NCT00244725|1536807|P4|Overall Study|Sponsor withdrew the participant|1
469751|NCT00244725|1536808|P3|Overall Study|Sponsor withdrew the participant|0
469752|NCT00244725|1536809|P2|Overall Study|Sponsor withdrew the participant|0
469753|NCT00244725|1536810|P1|Overall Study|Sponsor withdrew the participant|1
469754|NCT00244725|1536807|P4|Overall Study|Liver function test abnormality|1
469755|NCT00244725|1536808|P3|Overall Study|Liver function test abnormality|0
469756|NCT00244725|1536809|P2|Overall Study|Liver function test abnormality|0
469757|NCT00244725|1536810|P1|Overall Study|Liver function test abnormality|2
469758|NCT00244725|1536807|P4|Overall Study|Withdrwal by participant|1
469759|NCT00244725|1536808|P3|Overall Study|Withdrwal by participant|0
469760|NCT00244725|1536809|P2|Overall Study|Withdrwal by participant|0
469761|NCT00244725|1536810|P1|Overall Study|Withdrwal by participant|1
469762|NCT00244725|1536807|P4|Overall Study|Adverse Events|4
469763|NCT00244725|1536808|P3|Overall Study|Adverse Events|4
469764|NCT00244725|1536809|P2|Overall Study|Adverse Events|1
469765|NCT00244725|1536810|P1|Overall Study|Adverse Events|3
469766|NCT00244725|1536807|P4|Overall Study|Physician Decision|2
469767|NCT00244725|1536808|P3|Overall Study|Physician Decision|1
469768|NCT00244725|1536809|P2|Overall Study|Physician Decision|0
469769|NCT00244725|1536810|P1|Overall Study|Physician Decision|3
469770|NCT00244725|1536807|P4|Overall Study|Not meet treatment eligibility criteria|0
469771|NCT00244725|1536808|P3|Overall Study|Not meet treatment eligibility criteria|0
469772|NCT00244725|1536809|P2|Overall Study|Not meet treatment eligibility criteria|2
469773|NCT00244725|1536810|P1|Overall Study|Not meet treatment eligibility criteria|1
469774|NCT00244725|1536807|P4|Overall Study|Withdrawal by Subject|8
469775|NCT00244725|1536808|P3|Overall Study|Withdrawal by Subject|7
469776|NCT00244725|1536809|P2|Overall Study|Withdrawal by Subject|7
469777|NCT00244725|1536810|P1|Overall Study|Withdrawal by Subject|9
469778|NCT00244725|1536807|P4|Overall Study|Lost to Follow-up|2
469779|NCT00244725|1536808|P3|Overall Study|Lost to Follow-up|9
469780|NCT00244725|1536809|P2|Overall Study|Lost to Follow-up|4
469781|NCT00244725|1536810|P1|Overall Study|Lost to Follow-up|3
469782|NCT00244712|1536866|P2|Overall Study|Protocol Violation, disease progression|11
469783|NCT00244712|1536867|P1|Overall Study|Protocol Violation, disease progression|13
469784|NCT00244712|1536866|P2|Overall Study|Withdrawal by Subject|23
469785|NCT00244712|1536867|P1|Overall Study|Withdrawal by Subject|13
469786|NCT00244712|1536866|P2|Overall Study|Lost to Follow-up|52
469787|NCT00244712|1536867|P1|Overall Study|Lost to Follow-up|45
469788|NCT00244712|1536866|P2|Overall Study|Lack of Compliance|11
469789|NCT00244712|1536867|P1|Overall Study|Lack of Compliance|10
469790|NCT00244712|1536866|P2|Overall Study|Protocol-Defined Virologic Failure|6
469791|NCT00244712|1536867|P1|Overall Study|Protocol-Defined Virologic Failure|8
469792|NCT00244712|1536866|P2|Overall Study|Adverse Event|21
469793|NCT00244712|1536867|P1|Overall Study|Adverse Event|20
469794|NCT00244621|1536902|P3|Open-label Treatment Period|Moved abroad|1
469795|NCT00244621|1536903|P2|Open-label Treatment Period|Moved abroad|0
469796|NCT00244621|1536904|P1|Open-label Treatment Period|Moved abroad|0
469797|NCT00244621|1536902|P3|Open-label Treatment Period|Adverse Event|1
469798|NCT00244621|1536903|P2|Open-label Treatment Period|Adverse Event|0
469799|NCT00244621|1536904|P1|Open-label Treatment Period|Adverse Event|0
469800|NCT00244621|1536902|P3|Open-label Treatment Period|Withdrawal by Subject|0
469801|NCT00244621|1536903|P2|Open-label Treatment Period|Withdrawal by Subject|0
469802|NCT00244621|1536904|P1|Open-label Treatment Period|Withdrawal by Subject|1
469803|NCT00244621|1536902|P3|Open-label Treatment Period|Lost to Follow-up|0
469804|NCT00244621|1536903|P2|Open-label Treatment Period|Lost to Follow-up|1
469805|NCT00244621|1536904|P1|Open-label Treatment Period|Lost to Follow-up|0
469806|NCT00244621|1536902|P3|Double-blind Treatment Period|Multiple Reasons|1
469807|NCT00244621|1536903|P2|Double-blind Treatment Period|Multiple Reasons|1
469808|NCT00244621|1536904|P1|Double-blind Treatment Period|Multiple Reasons|2
469809|NCT00244621|1536902|P3|Double-blind Treatment Period|Lack of Efficacy|0
469810|NCT00244621|1536903|P2|Double-blind Treatment Period|Lack of Efficacy|1
469811|NCT00244621|1536904|P1|Double-blind Treatment Period|Lack of Efficacy|0
469812|NCT00244621|1536902|P3|Double-blind Treatment Period|Withdrawal by Subject|0
469813|NCT00244621|1536903|P2|Double-blind Treatment Period|Withdrawal by Subject|1
469814|NCT00244621|1536904|P1|Double-blind Treatment Period|Withdrawal by Subject|0
469815|NCT00244621|1536902|P3|Double-blind Treatment Period|Lost to Follow-up|1
469816|NCT00244621|1536903|P2|Double-blind Treatment Period|Lost to Follow-up|0
469817|NCT00244621|1536904|P1|Double-blind Treatment Period|Lost to Follow-up|0
469818|NCT00244374|1536921|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
469819|NCT00244374|1536922|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
469820|NCT00244374|1536923|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
469821|NCT00244374|1536924|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
469822|NCT00244374|1536925|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
469823|NCT00244374|1536921|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
469824|NCT00244374|1536922|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
469825|NCT00244374|1536923|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
469826|NCT00244374|1536924|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
469827|NCT00244374|1536925|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
469828|NCT00244374|1536921|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
469829|NCT00244374|1536922|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
469830|NCT00244374|1536923|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
469831|NCT00244374|1536924|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
469832|NCT00244374|1536925|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
469833|NCT00244374|1536921|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
469834|NCT00244374|1536922|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
469835|NCT00244374|1536923|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
469836|NCT00244374|1536924|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
469837|NCT00244374|1536925|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
469838|NCT00244374|1536921|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
469839|NCT00244374|1536922|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
469840|NCT00244374|1536923|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
469841|NCT00244374|1536924|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
469842|NCT00244374|1536925|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
469843|NCT00244374|1536921|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
469844|NCT00244374|1536922|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
469845|NCT00244374|1536923|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
469846|NCT00244374|1536924|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
469847|NCT00244374|1536925|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
469848|NCT00244374|1536921|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
469849|NCT00244374|1536922|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
469850|NCT00244374|1536923|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
469851|NCT00244374|1536924|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
469852|NCT00244374|1536925|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
469853|NCT00244374|1536921|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
469854|NCT00244374|1536922|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
469855|NCT00244374|1536923|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
469856|NCT00244374|1536924|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
469857|NCT00244374|1536925|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
469858|NCT00244374|1536921|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
469859|NCT00244374|1536922|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
469860|NCT00244374|1536923|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
469861|NCT00244374|1536924|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
469862|NCT00244374|1536925|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
469863|NCT00243932|1536981|P3|Stage 1: Dose Selection|Lost to Follow-up|0
469864|NCT00243932|1536982|P2|Stage 1: Dose Selection|Lost to Follow-up|0
469865|NCT00243932|1536983|P1|Stage 1: Dose Selection|Lost to Follow-up|2
469866|NCT00243919|1536994|P3|Overall Study|Physician Decision|0
469867|NCT00243919|1536995|P2|Overall Study|Physician Decision|1
469868|NCT00243919|1536996|P1|Overall Study|Physician Decision|1
469869|NCT00243919|1536994|P3|Overall Study|Administrative Error|0
469870|NCT00243919|1536995|P2|Overall Study|Administrative Error|0
469871|NCT00243919|1536996|P1|Overall Study|Administrative Error|1
469872|NCT00243919|1536994|P3|Overall Study|Lost to Follow-up|3
469873|NCT00243919|1536995|P2|Overall Study|Lost to Follow-up|7
469874|NCT00243919|1536996|P1|Overall Study|Lost to Follow-up|6
469875|NCT00243919|1536994|P3|Overall Study|Withdrawal by Subject|2
469876|NCT00243919|1536995|P2|Overall Study|Withdrawal by Subject|6
469877|NCT00243919|1536996|P1|Overall Study|Withdrawal by Subject|6
469878|NCT00243919|1536994|P3|Overall Study|Death|6
469879|NCT00243919|1536995|P2|Overall Study|Death|4
469880|NCT00243919|1536996|P1|Overall Study|Death|3
469881|NCT00243659|1537039|P2|Overall Study|Protocol Violation|2
469882|NCT00243659|1537040|P1|Overall Study|Protocol Violation|1
469883|NCT00243659|1537039|P2|Overall Study|Withdrawal by Subject|1
469884|NCT00243659|1537040|P1|Overall Study|Withdrawal by Subject|1
469885|NCT00243503|1537048|P1|Overall Study|Other|1
469886|NCT00243503|1537048|P1|Overall Study|Death|1
469887|NCT00243503|1537048|P1|Overall Study|Lack of Efficacy|44
469888|NCT00243503|1537048|P1|Overall Study|Withdrawal by Subject|1
469889|NCT00243503|1537048|P1|Overall Study|Adverse Event|11
469890|NCT00243412|1537065|P2|Overall Study|not specified|1
469891|NCT00243412|1537066|P1|Overall Study|not specified|1
469892|NCT00243412|1537065|P2|Overall Study|Withdrawal by Subject|5
469893|NCT00243412|1537066|P1|Overall Study|Withdrawal by Subject|4
469894|NCT00243412|1537065|P2|Overall Study|Physician Decision|1
469895|NCT00243412|1537066|P1|Overall Study|Physician Decision|1
469896|NCT00243412|1537065|P2|Overall Study|Lost to Follow-up|1
469897|NCT00243412|1537066|P1|Overall Study|Lost to Follow-up|0
469898|NCT00243412|1537065|P2|Overall Study|Adverse Event|2
469899|NCT00243412|1537066|P1|Overall Study|Adverse Event|4
469900|NCT00243412|1537065|P2|Overall Study|Death|1
469901|NCT00243412|1537066|P1|Overall Study|Death|0
469902|NCT00243386|1537092|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
469903|NCT00243386|1537093|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
469904|NCT00243386|1537094|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
469905|NCT00243386|1537092|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
469906|NCT00243386|1537093|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
469907|NCT00243386|1537094|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
469908|NCT00243386|1537092|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
469909|NCT00243386|1537093|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
469910|NCT00243386|1537094|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
469911|NCT00243386|1537092|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
469912|NCT00243386|1537093|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
469913|NCT00243386|1537094|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
469914|NCT00243386|1537092|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
469915|NCT00243386|1537093|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
469916|NCT00243386|1537094|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
469917|NCT00243386|1537092|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
469918|NCT00243386|1537093|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
469919|NCT00243386|1537094|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
469920|NCT00243386|1537092|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
469921|NCT00243386|1537093|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
469922|NCT00243386|1537094|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
469923|NCT00243386|1537092|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
469924|NCT00243386|1537093|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
469925|NCT00243386|1537094|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
469926|NCT00243347|1537159|P1|Overall Study|Condition worsened|7
469927|NCT00243347|1537159|P1|Overall Study|Withdrawal by Subject|5
469928|NCT00243347|1537159|P1|Overall Study|Death|1
469929|NCT00243347|1537159|P1|Overall Study|Adverse Event|2
469930|NCT00243347|1537159|P1|Overall Study|Lack of Efficacy|4
469931|NCT00243269|1537168|P4|Overall Study|Lost to Follow-up|3
469932|NCT00243269|1537169|P3|Overall Study|Lost to Follow-up|1
469933|NCT00243269|1537170|P2|Overall Study|Lost to Follow-up|0
469934|NCT00243269|1537171|P1|Overall Study|Lost to Follow-up|1
469935|NCT00243269|1537168|P4|Overall Study|Protocol Violation|1
469936|NCT00243269|1537169|P3|Overall Study|Protocol Violation|0
469937|NCT00243269|1537170|P2|Overall Study|Protocol Violation|1
469938|NCT00243269|1537171|P1|Overall Study|Protocol Violation|2
469939|NCT00243074|1537198|P1|Overall Study|Did not receive any treatment|1
469940|NCT00243074|1537198|P1|Overall Study|not protocol specified|1
469941|NCT00243074|1537198|P1|Overall Study|Death|2
469942|NCT00243074|1537198|P1|Overall Study|Lack of Efficacy|36
469943|NCT00243074|1537198|P1|Overall Study|Withdrawal by Subject|2
469944|NCT00243074|1537198|P1|Overall Study|Adverse Event|6
469945|NCT00243074|1537198|P1|Overall Study|Ineligible|6
469946|NCT00243022|1537224|P2|Overall Study|Difficult Travel Distance|1
469947|NCT00243022|1537225|P1|Overall Study|Difficult Travel Distance|0
469948|NCT00243022|1537224|P2|Overall Study|Death|0
469949|NCT00243022|1537225|P1|Overall Study|Death|1
469950|NCT00243022|1537224|P2|Overall Study|Withdrawal by Subject|0
469951|NCT00243022|1537225|P1|Overall Study|Withdrawal by Subject|1
469952|NCT00242710|1537247|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
469953|NCT00242710|1537248|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
469954|NCT00242710|1537249|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
469955|NCT00242710|1537250|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
469956|NCT00242710|1537247|P4|Study Extension (up to Year 2)|Protocol Violation|1
469957|NCT00242710|1537248|P3|Study Extension (up to Year 2)|Protocol Violation|0
469958|NCT00242710|1537249|P2|Study Extension (up to Year 2)|Protocol Violation|2
469959|NCT00242710|1537250|P1|Study Extension (up to Year 2)|Protocol Violation|0
469960|NCT00242710|1537247|P4|Study Extension (up to Year 2)|Other|3
469961|NCT00242710|1537248|P3|Study Extension (up to Year 2)|Other|4
469962|NCT00242710|1537249|P2|Study Extension (up to Year 2)|Other|5
469963|NCT00242710|1537250|P1|Study Extension (up to Year 2)|Other|3
469964|NCT00242710|1537247|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
469965|NCT00242710|1537248|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
469966|NCT00242710|1537249|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
469967|NCT00242710|1537250|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
469968|NCT00242710|1537247|P4|Study Extension (up to Year 2)|Death|1
469969|NCT00242710|1537248|P3|Study Extension (up to Year 2)|Death|0
469970|NCT00242710|1537249|P2|Study Extension (up to Year 2)|Death|0
469971|NCT00242710|1537250|P1|Study Extension (up to Year 2)|Death|0
469972|NCT00242710|1537247|P4|Study Extension (up to Year 2)|Adverse Event|4
469973|NCT00242710|1537248|P3|Study Extension (up to Year 2)|Adverse Event|2
469974|NCT00242710|1537249|P2|Study Extension (up to Year 2)|Adverse Event|9
469975|NCT00242710|1537250|P1|Study Extension (up to Year 2)|Adverse Event|7
469976|NCT00242710|1537247|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
469977|NCT00242710|1537248|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
469978|NCT00242710|1537249|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
469979|NCT00242710|1537250|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
469980|NCT00242710|1537247|P4|Period Between Core Study and Extension|Protocol Violation|1
469981|NCT00242710|1537248|P3|Period Between Core Study and Extension|Protocol Violation|2
469982|NCT00242710|1537249|P2|Period Between Core Study and Extension|Protocol Violation|0
469983|NCT00242710|1537250|P1|Period Between Core Study and Extension|Protocol Violation|0
469984|NCT00242710|1537247|P4|Period Between Core Study and Extension|Extension not Available|7
469985|NCT00242710|1537248|P3|Period Between Core Study and Extension|Extension not Available|8
469986|NCT00242710|1537249|P2|Period Between Core Study and Extension|Extension not Available|21
469987|NCT00242710|1537250|P1|Period Between Core Study and Extension|Extension not Available|17
469988|NCT00242710|1537247|P4|Period Between Core Study and Extension|Other|11
469989|NCT00242710|1537248|P3|Period Between Core Study and Extension|Other|9
469990|NCT00242710|1537249|P2|Period Between Core Study and Extension|Other|24
469991|NCT00242710|1537250|P1|Period Between Core Study and Extension|Other|24
469992|NCT00242710|1537247|P4|Period Between Core Study and Extension|Physician Decision|0
469993|NCT00242710|1537248|P3|Period Between Core Study and Extension|Physician Decision|0
469994|NCT00242710|1537249|P2|Period Between Core Study and Extension|Physician Decision|1
469995|NCT00242710|1537250|P1|Period Between Core Study and Extension|Physician Decision|1
469996|NCT00242710|1537247|P4|Period Between Core Study and Extension|Adverse Event|2
469997|NCT00242710|1537248|P3|Period Between Core Study and Extension|Adverse Event|5
469998|NCT00242710|1537249|P2|Period Between Core Study and Extension|Adverse Event|3
469999|NCT00242710|1537250|P1|Period Between Core Study and Extension|Adverse Event|2
470000|NCT00242710|1537247|P4|Core Study (up to Year 1)|Randomized but not Treated|2
470001|NCT00242710|1537248|P3|Core Study (up to Year 1)|Randomized but not Treated|4
470002|NCT00242710|1537249|P2|Core Study (up to Year 1)|Randomized but not Treated|4
470003|NCT00242710|1537250|P1|Core Study (up to Year 1)|Randomized but not Treated|12
470004|NCT00242710|1537247|P4|Core Study (up to Year 1)|Lack of Efficacy|0
470005|NCT00242710|1537248|P3|Core Study (up to Year 1)|Lack of Efficacy|0
470006|NCT00242710|1537249|P2|Core Study (up to Year 1)|Lack of Efficacy|0
470007|NCT00242710|1537250|P1|Core Study (up to Year 1)|Lack of Efficacy|1
470008|NCT00242710|1537247|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
470009|NCT00242710|1537248|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
470010|NCT00242710|1537249|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
470011|NCT00242710|1537250|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
470012|NCT00242710|1537247|P4|Core Study (up to Year 1)|Protocol Violation|3
470013|NCT00242710|1537248|P3|Core Study (up to Year 1)|Protocol Violation|1
470014|NCT00242710|1537249|P2|Core Study (up to Year 1)|Protocol Violation|9
470015|NCT00242710|1537250|P1|Core Study (up to Year 1)|Protocol Violation|2
470016|NCT00242710|1537247|P4|Core Study (up to Year 1)|Other|2
470017|NCT00242710|1537248|P3|Core Study (up to Year 1)|Other|0
470018|NCT00242710|1537249|P2|Core Study (up to Year 1)|Other|1
470019|NCT00242710|1537250|P1|Core Study (up to Year 1)|Other|6
470020|NCT00242710|1537247|P4|Core Study (up to Year 1)|Lost to Follow-up|3
470021|NCT00242710|1537248|P3|Core Study (up to Year 1)|Lost to Follow-up|7
470022|NCT00242710|1537249|P2|Core Study (up to Year 1)|Lost to Follow-up|8
470023|NCT00242710|1537250|P1|Core Study (up to Year 1)|Lost to Follow-up|8
470024|NCT00242710|1537247|P4|Core Study (up to Year 1)|Physician Decision|1
470025|NCT00242710|1537248|P3|Core Study (up to Year 1)|Physician Decision|0
470026|NCT00242710|1537249|P2|Core Study (up to Year 1)|Physician Decision|1
470027|NCT00242710|1537250|P1|Core Study (up to Year 1)|Physician Decision|0
470028|NCT00242710|1537247|P4|Core Study (up to Year 1)|Death|0
470029|NCT00242710|1537248|P3|Core Study (up to Year 1)|Death|1
470030|NCT00242710|1537249|P2|Core Study (up to Year 1)|Death|0
470031|NCT00242710|1537250|P1|Core Study (up to Year 1)|Death|0
470032|NCT00242710|1537247|P4|Core Study (up to Year 1)|Adverse Event|14
470033|NCT00242710|1537248|P3|Core Study (up to Year 1)|Adverse Event|23
470034|NCT00242710|1537249|P2|Core Study (up to Year 1)|Adverse Event|25
470035|NCT00242710|1537250|P1|Core Study (up to Year 1)|Adverse Event|30
470036|NCT00242658|1537307|P2|Overall Study|Lost to Follow-up|19
470037|NCT00242658|1537308|P1|Overall Study|Lost to Follow-up|22
470038|NCT00242580|1537339|P3|Overall Study|Death|1
470039|NCT00242580|1537340|P2|Overall Study|Death|2
470040|NCT00242580|1537341|P1|Overall Study|Death|1
470041|NCT00242580|1537339|P3|Overall Study|Lost to Follow-up|0
470042|NCT00242580|1537340|P2|Overall Study|Lost to Follow-up|3
470043|NCT00242580|1537341|P1|Overall Study|Lost to Follow-up|0
470044|NCT00242580|1537339|P3|Overall Study|Subject withdrew consent|5
470045|NCT00242580|1537340|P2|Overall Study|Subject withdrew consent|2
470046|NCT00242580|1537341|P1|Overall Study|Subject withdrew consent|2
470047|NCT00242580|1537339|P3|Overall Study|Protocol Violation|1
470048|NCT00242580|1537340|P2|Overall Study|Protocol Violation|0
470049|NCT00242580|1537341|P1|Overall Study|Protocol Violation|0
470050|NCT00242580|1537339|P3|Overall Study|Unsatisfactory therapeutic effect|5
470051|NCT00242580|1537340|P2|Overall Study|Unsatisfactory therapeutic effect|5
470052|NCT00242580|1537341|P1|Overall Study|Unsatisfactory therapeutic effect|4
470053|NCT00242580|1537339|P3|Overall Study|Adverse Event|2
470054|NCT00242580|1537340|P2|Overall Study|Adverse Event|0
470055|NCT00242580|1537341|P1|Overall Study|Adverse Event|3
470056|NCT00242567|1537366|P2|Overall Study|Other|9
470057|NCT00242567|1537367|P1|Overall Study|Other|14
470058|NCT00242567|1537366|P2|Overall Study|Use of an inhibitor of bone resorption|2
470059|NCT00242567|1537367|P1|Overall Study|Use of an inhibitor of bone resorption|0
470060|NCT00242567|1537366|P2|Overall Study|Protocol Violation|12
470061|NCT00242567|1537367|P1|Overall Study|Protocol Violation|12
470062|NCT00242567|1537366|P2|Overall Study|Withdrawal by Subject|28
470063|NCT00242567|1537367|P1|Overall Study|Withdrawal by Subject|33
470064|NCT00242567|1537366|P2|Overall Study|Lost to Follow-up|19
470065|NCT00242567|1537367|P1|Overall Study|Lost to Follow-up|9
470066|NCT00242567|1537366|P2|Overall Study|Lack of Efficacy|2
470067|NCT00242567|1537367|P1|Overall Study|Lack of Efficacy|2
470068|NCT00242567|1537366|P2|Overall Study|Symptomatic deterioration|3
470069|NCT00242567|1537367|P1|Overall Study|Symptomatic deterioration|9
470070|NCT00242567|1537366|P2|Overall Study|Disease Progression|22
470071|NCT00242567|1537367|P1|Overall Study|Disease Progression|17
470072|NCT00242567|1537366|P2|Overall Study|Adverse Event|43
470073|NCT00242567|1537367|P1|Overall Study|Adverse Event|70
470074|NCT00242216|1537414|P2|Overall Study|no medicaiton dispensed|1
470075|NCT00242216|1537415|P1|Overall Study|no medicaiton dispensed|1
470076|NCT00242216|1537414|P2|Overall Study|Lack of Efficacy|2
470077|NCT00242216|1537415|P1|Overall Study|Lack of Efficacy|1
470078|NCT00242216|1537414|P2|Overall Study|Death|2
470079|NCT00242216|1537415|P1|Overall Study|Death|4
470080|NCT00242216|1537414|P2|Overall Study|Lost to Follow-up|17
470081|NCT00242216|1537415|P1|Overall Study|Lost to Follow-up|12
470082|NCT00241839|1537453|P2|Overall Study|Adverse Event|1
470083|NCT00241839|1537454|P1|Overall Study|Adverse Event|1
470084|NCT00241839|1537453|P2|Overall Study|Withdrawal by Subject|17
470085|NCT00241839|1537454|P1|Overall Study|Withdrawal by Subject|18
470086|NCT00241644|1537470|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
470087|NCT00241644|1537471|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
470088|NCT00241644|1537472|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
470089|NCT00241644|1537473|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
470090|NCT00241644|1537470|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
470091|NCT00241644|1537471|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
470092|NCT00241644|1537472|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
470093|NCT00241644|1537473|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
470094|NCT00241644|1537470|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
470095|NCT00241644|1537471|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
470096|NCT00241644|1537472|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
470097|NCT00241644|1537473|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
470098|NCT00241644|1537470|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
470099|NCT00241644|1537471|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
470100|NCT00241644|1537472|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
470101|NCT00241644|1537473|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
470102|NCT00241644|1537470|P4|Second Efficacy Period (Year 2)|Adverse Event|20
470103|NCT00241644|1537471|P3|Second Efficacy Period (Year 2)|Adverse Event|12
470104|NCT00241644|1537472|P2|Second Efficacy Period (Year 2)|Adverse Event|9
470105|NCT00241644|1537473|P1|Second Efficacy Period (Year 2)|Adverse Event|11
470106|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
470107|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
470108|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
470109|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
470110|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
470111|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
470112|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
470113|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
470114|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
470115|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
470116|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
470117|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
470118|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Non-compliance|3
470119|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Non-compliance|2
470120|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Non-compliance|1
470121|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Non-compliance|2
470122|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
470123|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
470124|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
470125|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
470126|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
470127|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
470128|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
470129|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
470130|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Protocol Violation|8
470131|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Protocol Violation|4
470132|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Protocol Violation|5
470133|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Protocol Violation|3
470134|NCT00241644|1537470|P4|First Efficacy Period (Year 1)|Adverse Event|91
470135|NCT00241644|1537471|P3|First Efficacy Period (Year 1)|Adverse Event|45
470136|NCT00241644|1537472|P2|First Efficacy Period (Year 1)|Adverse Event|45
470137|NCT00241644|1537473|P1|First Efficacy Period (Year 1)|Adverse Event|46
470138|NCT00241358|1537558|P3|Overall Study|Determined to be not ineligible|1
470139|NCT00241358|1537559|P2|Overall Study|Determined to be not ineligible|1
470140|NCT00241358|1537560|P1|Overall Study|Determined to be not ineligible|0
470141|NCT00241280|1537593|P2|Overall Study|Excessive Dryness|1
470142|NCT00241280|1537594|P1|Overall Study|Excessive Dryness|0
470143|NCT00241280|1537593|P2|Overall Study|Coating on Lens|0
470144|NCT00241280|1537594|P1|Overall Study|Coating on Lens|1
470145|NCT00241280|1537593|P2|Overall Study|History of Ocular Surgery|1
470146|NCT00241280|1537594|P1|Overall Study|History of Ocular Surgery|0
470147|NCT00241280|1537593|P2|Overall Study|Scheduling Conflict|2
470148|NCT00241280|1537594|P1|Overall Study|Scheduling Conflict|0
470149|NCT00241280|1537593|P2|Overall Study|Unacceptable Fit|1
470150|NCT00241280|1537594|P1|Overall Study|Unacceptable Fit|0
470151|NCT00241280|1537593|P2|Overall Study|Dispensed incorrect test article|2
470152|NCT00241280|1537594|P1|Overall Study|Dispensed incorrect test article|1
470153|NCT00241280|1537593|P2|Overall Study|Subject Ineligible/Dispensed|6
470154|NCT00241280|1537594|P1|Overall Study|Subject Ineligible/Dispensed|9
470155|NCT00241280|1537593|P2|Overall Study|Diabetic|0
470156|NCT00241280|1537594|P1|Overall Study|Diabetic|1
470157|NCT00241280|1537593|P2|Overall Study|Unsatisfactory Visual Response|1
470158|NCT00241280|1537594|P1|Overall Study|Unsatisfactory Visual Response|1
470159|NCT00241280|1537593|P2|Overall Study|Unsatisfactory Physiological Response|1
470160|NCT00241280|1537594|P1|Overall Study|Unsatisfactory Physiological Response|1
470161|NCT00241280|1537593|P2|Overall Study|Relocation|4
470162|NCT00241280|1537594|P1|Overall Study|Relocation|4
470163|NCT00241280|1537593|P2|Overall Study|Protocol Violation|10
470164|NCT00241280|1537594|P1|Overall Study|Protocol Violation|4
470165|NCT00241280|1537593|P2|Overall Study|Withdrawal by Subject|4
470166|NCT00241280|1537594|P1|Overall Study|Withdrawal by Subject|7
470167|NCT00241280|1537593|P2|Overall Study|Lost to Follow-up|8
470168|NCT00241280|1537594|P1|Overall Study|Lost to Follow-up|5
470169|NCT00241280|1537593|P2|Overall Study|Pregnancy|5
470170|NCT00241280|1537594|P1|Overall Study|Pregnancy|1
470171|NCT00241280|1537593|P2|Overall Study|Discomfort|16
470172|NCT00241280|1537594|P1|Overall Study|Discomfort|11
470173|NCT00241280|1537593|P2|Overall Study|Adverse Event|6
470174|NCT00241280|1537594|P1|Overall Study|Adverse Event|2
470175|NCT00240994|1537609|P1|Overall Study|Graft failure|1
470176|NCT00240994|1537609|P1|Overall Study|Protocol Violation|1
470177|NCT00240994|1537609|P1|Overall Study|Lost to Follow-up|1
470178|NCT00240331|1537744|P2|Overall Study|Option selected by investigator|2
470179|NCT00240331|1537745|P1|Overall Study|Option selected by investigator|1
470180|NCT00240331|1537744|P2|Overall Study|Withdrawal by Subject|132
470181|NCT00240331|1537745|P1|Overall Study|Withdrawal by Subject|125
470182|NCT00240110|1537778|P2|Overall Study|Lost to Follow-up|7
470183|NCT00240110|1537779|P1|Overall Study|Lost to Follow-up|6
470184|NCT00240097|1537787|P1|Part II|did not continue from Part I|23
470185|NCT00240097|1537787|P1|Part I|unevaluable|1
470186|NCT00240097|1537787|P1|Part I|histology|1
470187|NCT00240097|1537787|P1|Part I|Death|1
470188|NCT00240097|1537787|P1|Part I|Adverse Event|1
470189|NCT00240071|1537797|P1|Overall Study|Withdrawal by Subject|3
470190|NCT00239928|1537802|P1|Overall Study|Withdrawal by Subject|2
470191|NCT00239928|1537802|P1|Overall Study|Not need to continue study|3
470192|NCT00239928|1537802|P1|Overall Study|Adverse Event|4
470193|NCT00239928|1537802|P1|Overall Study|Lack of Efficacy|1
470194|NCT00239837|1537814|P2|Overall Study|Lost to Follow-up|7
470195|NCT00239837|1537815|P1|Overall Study|Lost to Follow-up|3
470196|NCT00239720|1537842|P2|Overall Study|Lost to Follow-up|1
470197|NCT00239720|1537843|P1|Overall Study|Lost to Follow-up|0
470198|NCT00239720|1537842|P2|Overall Study|Adverse Event|0
470199|NCT00239720|1537843|P1|Overall Study|Adverse Event|1
470200|NCT00239681|1537851|P2|Overall Study|No information chacked on CaseReportForm|84
470201|NCT00239681|1537852|P1|Overall Study|No information chacked on CaseReportForm|90
470202|NCT00239681|1537851|P2|Overall Study|Physician Decision|17
470203|NCT00239681|1537852|P1|Overall Study|Physician Decision|13
470204|NCT00239681|1537851|P2|Overall Study|Protocol Violation|4
470205|NCT00239681|1537852|P1|Overall Study|Protocol Violation|4
470206|NCT00239681|1537851|P2|Overall Study|Lost to Follow-up|22
470207|NCT00239681|1537852|P1|Overall Study|Lost to Follow-up|28
470208|NCT00239681|1537851|P2|Overall Study|Withdrawal by Subject|489
470209|NCT00239681|1537852|P1|Overall Study|Withdrawal by Subject|458
470210|NCT00239681|1537851|P2|Overall Study|Adverse Event|99
470211|NCT00239681|1537852|P1|Overall Study|Adverse Event|100
470212|NCT00239356|1537907|P2|Overall Study|Drug available on market|2
470213|NCT00239356|1537908|P1|Overall Study|Drug available on market|11
470214|NCT00239356|1537907|P2|Overall Study|Administrative reason|1
470215|NCT00239356|1537908|P1|Overall Study|Administrative reason|0
470216|NCT00239356|1537907|P2|Overall Study|Pregnancy|0
470217|NCT00239356|1537908|P1|Overall Study|Pregnancy|1
470218|NCT00239356|1537907|P2|Overall Study|poor/non-compliance|0
470219|NCT00239356|1537908|P1|Overall Study|poor/non-compliance|2
470220|NCT00239356|1537907|P2|Overall Study|Lost to Follow-up|0
470221|NCT00239356|1537908|P1|Overall Study|Lost to Follow-up|3
470222|NCT00239356|1537907|P2|Overall Study|Withdrawal by Subject|6
470223|NCT00239356|1537908|P1|Overall Study|Withdrawal by Subject|15
470224|NCT00239356|1537907|P2|Overall Study|Adverse Event|0
470225|NCT00239356|1537908|P1|Overall Study|Adverse Event|6
470226|NCT00239356|1537907|P2|Overall Study|Lack of Efficacy|0
470227|NCT00239356|1537908|P1|Overall Study|Lack of Efficacy|1
470228|NCT00239226|1537930|P4|Overall Study|Lost to Follow-up|0
470229|NCT00239226|1537931|P3|Overall Study|Lost to Follow-up|1
470230|NCT00239226|1537932|P2|Overall Study|Lost to Follow-up|0
470231|NCT00239226|1537933|P1|Overall Study|Lost to Follow-up|1
470232|NCT00239226|1537930|P4|Overall Study|permAF during stabilization period|3
470233|NCT00239226|1537931|P3|Overall Study|permAF during stabilization period|0
470234|NCT00239226|1537932|P2|Overall Study|permAF during stabilization period|0
470235|NCT00239226|1537933|P1|Overall Study|permAF during stabilization period|0
470236|NCT00239005|1537945|P2|Overall Study|Lost to Follow-up|1
470237|NCT00239005|1537946|P1|Overall Study|Lost to Follow-up|0
470238|NCT00239005|1537945|P2|Overall Study|Subj. cond. no longer needs study drug|1
470239|NCT00239005|1537946|P1|Overall Study|Subj. cond. no longer needs study drug|0
470240|NCT00239005|1537945|P2|Overall Study|Protocol Violation|0
470241|NCT00239005|1537946|P1|Overall Study|Protocol Violation|1
470242|NCT00239005|1537945|P2|Overall Study|Unsatisfactory Therapeutic effect|0
470243|NCT00239005|1537946|P1|Overall Study|Unsatisfactory Therapeutic effect|2
470244|NCT00239005|1537945|P2|Overall Study|Withdrawal by Subject|4
470245|NCT00239005|1537946|P1|Overall Study|Withdrawal by Subject|3
470246|NCT00239005|1537945|P2|Overall Study|Adverse Event|6
470247|NCT00239005|1537946|P1|Overall Study|Adverse Event|6
470248|NCT00238433|1537962|P1|Overall Study|Death|1
470249|NCT00238433|1537962|P1|Overall Study|Lost to Follow-up|1
470250|NCT00238433|1537962|P1|Overall Study|Screen failure|1
470251|NCT00238420|1537969|P2|Overall Study|Protocol Violation|1
470252|NCT00238420|1537970|P1|Overall Study|Protocol Violation|1
470253|NCT00238303|1537987|P3|Overall Study|Adverse Event|3
470254|NCT00238303|1537988|P2|Overall Study|Adverse Event|1
470255|NCT00238303|1537989|P1|Overall Study|Adverse Event|0
470256|NCT00238303|1537987|P3|Overall Study|Poor tolerance of study treatment|1
470257|NCT00238303|1537988|P2|Overall Study|Poor tolerance of study treatment|0
470258|NCT00238303|1537989|P1|Overall Study|Poor tolerance of study treatment|1
470259|NCT00238303|1537987|P3|Overall Study|Other Medical Problems|2
470260|NCT00238303|1537988|P2|Overall Study|Other Medical Problems|0
470261|NCT00238303|1537989|P1|Overall Study|Other Medical Problems|2
470262|NCT00238303|1537987|P3|Overall Study|Death|1
470263|NCT00238303|1537988|P2|Overall Study|Death|0
470264|NCT00238303|1537989|P1|Overall Study|Death|1
470265|NCT00238303|1537987|P3|Overall Study|Withdrawal by Subject|2
470266|NCT00238303|1537988|P2|Overall Study|Withdrawal by Subject|1
470267|NCT00238303|1537989|P1|Overall Study|Withdrawal by Subject|11
470268|NCT00238264|1538006|P1|Overall Study|Ineligible|7
470269|NCT00238264|1538006|P1|Overall Study|Withdrawal by Subject|4
470270|NCT00238264|1538006|P1|Overall Study|Lost to Follow-up|18
470271|NCT00238264|1538006|P1|Overall Study|Death|7
470272|NCT00238238|1538019|P3|Overall Study|Withdrawal by Subject|0
470273|NCT00238238|1538020|P2|Overall Study|Withdrawal by Subject|3
470274|NCT00238238|1538021|P1|Overall Study|Withdrawal by Subject|0
470275|NCT00238121|1538034|P2|Overall Study|Adverse Event|1
470276|NCT00238121|1538035|P1|Overall Study|Adverse Event|2
470277|NCT00238121|1538034|P2|Overall Study|Withdrawal by Subject|1
470278|NCT00238121|1538035|P1|Overall Study|Withdrawal by Subject|1
470279|NCT00237809|1538061|P4|Overall Study|Lost to Follow-up|9
470280|NCT00237809|1538062|P3|Overall Study|Lost to Follow-up|9
470281|NCT00237809|1538063|P2|Overall Study|Lost to Follow-up|10
470282|NCT00237809|1538064|P1|Overall Study|Lost to Follow-up|11
470283|NCT00237796|1538100|P2|Overall Study|Baseline and one other ILSS required|5
470284|NCT00237796|1538101|P1|Overall Study|Baseline and one other ILSS required|10
470285|NCT00237744|1538135|P3|Overall Study|Withdrawal by Subject|0
470286|NCT00237744|1538136|P2|Overall Study|Withdrawal by Subject|1
470287|NCT00237744|1538137|P1|Overall Study|Withdrawal by Subject|3
470288|NCT00237692|1538163|P4|Overall Study|Withdrawal by Subject|4
470289|NCT00237692|1538164|P3|Overall Study|Withdrawal by Subject|10
470290|NCT00237692|1538165|P2|Overall Study|Withdrawal by Subject|6
470291|NCT00237692|1538166|P1|Overall Study|Withdrawal by Subject|4
470292|NCT00237692|1538163|P4|Overall Study|Excluded - did not meet criteria|9
470293|NCT00237692|1538164|P3|Overall Study|Excluded - did not meet criteria|5
470294|NCT00237692|1538165|P2|Overall Study|Excluded - did not meet criteria|3
470295|NCT00237692|1538166|P1|Overall Study|Excluded - did not meet criteria|4
470296|NCT00237692|1538163|P4|Overall Study|Death|3
470297|NCT00237692|1538164|P3|Overall Study|Death|2
470298|NCT00237692|1538165|P2|Overall Study|Death|2
470299|NCT00237692|1538166|P1|Overall Study|Death|1
470300|NCT00237692|1538163|P4|Overall Study|Lost to Follow-up|3
470301|NCT00237692|1538164|P3|Overall Study|Lost to Follow-up|5
470302|NCT00237692|1538165|P2|Overall Study|Lost to Follow-up|3
470303|NCT00237692|1538166|P1|Overall Study|Lost to Follow-up|9
470304|NCT00237458|1538206|P1|Overall Study|Withdrawal by Subject|1
470305|NCT00237458|1538206|P1|Overall Study|Adverse Event|1
470306|NCT00237458|1538206|P1|Overall Study|Lack of Efficacy|1
470307|NCT00237185|1538224|P2|Extension|Death|1
470308|NCT00237185|1538225|P1|Extension|Death|1
470309|NCT00237185|1538224|P2|Extension|Administrative problems|0
470310|NCT00237185|1538225|P1|Extension|Administrative problems|1
470311|NCT00237185|1538224|P2|Extension|Lost to Follow-up|0
470312|NCT00237185|1538225|P1|Extension|Lost to Follow-up|1
470313|NCT00237185|1538224|P2|Extension|Withdrawal by Subject|2
470314|NCT00237185|1538225|P1|Extension|Withdrawal by Subject|3
470315|NCT00237185|1538224|P2|Extension|Condition no longer required study drug|1
470316|NCT00237185|1538225|P1|Extension|Condition no longer required study drug|0
470317|NCT00237185|1538224|P2|Extension|Lack of Efficacy|14
470318|NCT00237185|1538225|P1|Extension|Lack of Efficacy|9
470319|NCT00237185|1538224|P2|Extension|Abnormal laboratory value|1
470320|NCT00237185|1538225|P1|Extension|Abnormal laboratory value|0
470321|NCT00237185|1538224|P2|Extension|Adverse Event|0
470322|NCT00237185|1538225|P1|Extension|Adverse Event|1
470323|NCT00237185|1538224|P2|Core|Determined ineligible post randomization|0
470324|NCT00237185|1538225|P1|Core|Determined ineligible post randomization|1
470325|NCT00237185|1538224|P2|Core|Death|0
470326|NCT00237185|1538225|P1|Core|Death|4
470327|NCT00237185|1538224|P2|Core|Administrative problems|1
470328|NCT00237185|1538225|P1|Core|Administrative problems|0
470329|NCT00237185|1538224|P2|Core|Withdrawal by Subject|4
470330|NCT00237185|1538225|P1|Core|Withdrawal by Subject|4
470331|NCT00237185|1538224|P2|Core|Protocol Violation|1
470332|NCT00237185|1538225|P1|Core|Protocol Violation|1
470333|NCT00237185|1538224|P2|Core|Lack of Efficacy|23
470334|NCT00237185|1538225|P1|Core|Lack of Efficacy|30
470335|NCT00237185|1538224|P2|Core|Abnormal test procedure results|0
470336|NCT00237185|1538225|P1|Core|Abnormal test procedure results|1
470337|NCT00237185|1538224|P2|Core|Abnormal laboratory value|4
470338|NCT00237185|1538225|P1|Core|Abnormal laboratory value|0
470339|NCT00237185|1538224|P2|Core|Adverse Event|4
470340|NCT00237185|1538225|P1|Core|Adverse Event|3
470341|NCT00237042|1538256|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
470342|NCT00237042|1538257|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
470343|NCT00237042|1538258|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
470344|NCT00237042|1538256|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
470345|NCT00237042|1538257|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
470346|NCT00237042|1538258|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
470347|NCT00237042|1538256|P3|Treatment|Completed no treatment|21
470348|NCT00237042|1538257|P2|Treatment|Completed no treatment|5
470349|NCT00237042|1538258|P1|Treatment|Completed no treatment|5
470350|NCT00237042|1538256|P3|Treatment|Moved out of state|1
470351|NCT00237042|1538257|P2|Treatment|Moved out of state|1
470352|NCT00237042|1538258|P1|Treatment|Moved out of state|1
470353|NCT00237042|1538256|P3|Treatment|Became ineligible post-randomization|16
470354|NCT00237042|1538257|P2|Treatment|Became ineligible post-randomization|1
470355|NCT00237042|1538258|P1|Treatment|Became ineligible post-randomization|0
470356|NCT00236899|1538332|P4|Overall Study|Lack of Efficacy|23
470357|NCT00236899|1538333|P3|Overall Study|Lack of Efficacy|25
470358|NCT00236899|1538334|P2|Overall Study|Lack of Efficacy|18
470359|NCT00236899|1538335|P1|Overall Study|Lack of Efficacy|18
470360|NCT00236899|1538332|P4|Overall Study|Satisfactory Response|1
470361|NCT00236899|1538333|P3|Overall Study|Satisfactory Response|0
470362|NCT00236899|1538334|P2|Overall Study|Satisfactory Response|0
470363|NCT00236899|1538335|P1|Overall Study|Satisfactory Response|2
470364|NCT00236899|1538332|P4|Overall Study|Physician Decision|6
470365|NCT00236899|1538333|P3|Overall Study|Physician Decision|7
470366|NCT00236899|1538334|P2|Overall Study|Physician Decision|8
470367|NCT00236899|1538335|P1|Overall Study|Physician Decision|7
470368|NCT00236899|1538332|P4|Overall Study|Withdrawal by Subject|2
470369|NCT00236899|1538333|P3|Overall Study|Withdrawal by Subject|5
470370|NCT00236899|1538334|P2|Overall Study|Withdrawal by Subject|4
470371|NCT00236899|1538335|P1|Overall Study|Withdrawal by Subject|6
470372|NCT00236899|1538332|P4|Overall Study|Protocol Violation|0
470373|NCT00236899|1538333|P3|Overall Study|Protocol Violation|0
470374|NCT00236899|1538334|P2|Overall Study|Protocol Violation|0
470375|NCT00236899|1538335|P1|Overall Study|Protocol Violation|1
470376|NCT00236899|1538332|P4|Overall Study|Entry Criteria Exclusion|0
470377|NCT00236899|1538333|P3|Overall Study|Entry Criteria Exclusion|1
470378|NCT00236899|1538334|P2|Overall Study|Entry Criteria Exclusion|1
470379|NCT00236899|1538335|P1|Overall Study|Entry Criteria Exclusion|0
470380|NCT00236899|1538332|P4|Overall Study|Lost to Follow-up|0
470381|NCT00236899|1538333|P3|Overall Study|Lost to Follow-up|0
470382|NCT00236899|1538334|P2|Overall Study|Lost to Follow-up|1
470383|NCT00236899|1538335|P1|Overall Study|Lost to Follow-up|0
470384|NCT00236899|1538332|P4|Overall Study|Death (Study Drug Toxicity)|0
470385|NCT00236899|1538333|P3|Overall Study|Death (Study Drug Toxicity)|0
470386|NCT00236899|1538334|P2|Overall Study|Death (Study Drug Toxicity)|0
470387|NCT00236899|1538335|P1|Overall Study|Death (Study Drug Toxicity)|1
470388|NCT00236899|1538332|P4|Overall Study|Death (Not Study Related)|0
470389|NCT00236899|1538333|P3|Overall Study|Death (Not Study Related)|0
470390|NCT00236899|1538334|P2|Overall Study|Death (Not Study Related)|0
470391|NCT00236899|1538335|P1|Overall Study|Death (Not Study Related)|2
470392|NCT00236899|1538332|P4|Overall Study|Death (Study Disease)|0
470393|NCT00236899|1538333|P3|Overall Study|Death (Study Disease)|0
470394|NCT00236899|1538334|P2|Overall Study|Death (Study Disease)|4
470395|NCT00236899|1538335|P1|Overall Study|Death (Study Disease)|1
470396|NCT00236899|1538332|P4|Overall Study|Adverse Event (Not Study Related)|7
470397|NCT00236899|1538333|P3|Overall Study|Adverse Event (Not Study Related)|4
470398|NCT00236899|1538334|P2|Overall Study|Adverse Event (Not Study Related)|3
470399|NCT00236899|1538335|P1|Overall Study|Adverse Event (Not Study Related)|3
470400|NCT00236899|1538332|P4|Overall Study|Adverse Event (Study Related)|1
470401|NCT00236899|1538333|P3|Overall Study|Adverse Event (Study Related)|2
470402|NCT00236899|1538334|P2|Overall Study|Adverse Event (Study Related)|1
470403|NCT00236899|1538335|P1|Overall Study|Adverse Event (Study Related)|1
470404|NCT00236197|1538367|P2|Overall Study|Other|2
470405|NCT00236197|1538368|P1|Overall Study|Other|0
470406|NCT00236197|1538367|P2|Overall Study|Medication non-compliance|2
470407|NCT00236197|1538368|P1|Overall Study|Medication non-compliance|1
470408|NCT00236197|1538367|P2|Overall Study|Protocol Violation|3
470409|NCT00236197|1538368|P1|Overall Study|Protocol Violation|0
470410|NCT00236197|1538367|P2|Overall Study|Lost to Follow-up|5
470411|NCT00236197|1538368|P1|Overall Study|Lost to Follow-up|1
470412|NCT00236197|1538367|P2|Overall Study|Withdrawal by Subject|2
470413|NCT00236197|1538368|P1|Overall Study|Withdrawal by Subject|3
470414|NCT00236184|1538376|P2|Overall Study|other|2
470415|NCT00236184|1538377|P1|Overall Study|other|1
470416|NCT00236184|1538376|P2|Overall Study|non-compliance with study drug|1
470417|NCT00236184|1538377|P1|Overall Study|non-compliance with study drug|2
470418|NCT00236184|1538376|P2|Overall Study|Protocol Violation|0
470419|NCT00236184|1538377|P1|Overall Study|Protocol Violation|3
470420|NCT00236184|1538376|P2|Overall Study|Withdrawal by Subject|0
470421|NCT00236184|1538377|P1|Overall Study|Withdrawal by Subject|3
470422|NCT00236184|1538376|P2|Overall Study|Physician Decision|1
470423|NCT00236184|1538377|P1|Overall Study|Physician Decision|1
470424|NCT00236184|1538376|P2|Overall Study|Lost to Follow-up|4
470425|NCT00236184|1538377|P1|Overall Study|Lost to Follow-up|3
470426|NCT00236184|1538376|P2|Overall Study|Lack of Efficacy|1
470427|NCT00236184|1538377|P1|Overall Study|Lack of Efficacy|0
470428|NCT00236184|1538376|P2|Overall Study|Adverse Event|2
470429|NCT00236184|1538377|P1|Overall Study|Adverse Event|5
470430|NCT00236080|1538388|P5|Overall Study|Miscellaneous|0
470431|NCT00236080|1538389|P4|Overall Study|Miscellaneous|0
470432|NCT00236080|1538390|P3|Overall Study|Miscellaneous|1
470433|NCT00236080|1538391|P2|Overall Study|Miscellaneous|0
470434|NCT00236080|1538392|P1|Overall Study|Miscellaneous|0
470435|NCT00236080|1538388|P5|Overall Study|Withdrawal by Subject|0
470436|NCT00236080|1538389|P4|Overall Study|Withdrawal by Subject|0
470437|NCT00236080|1538390|P3|Overall Study|Withdrawal by Subject|0
470438|NCT00236080|1538391|P2|Overall Study|Withdrawal by Subject|0
470439|NCT00236080|1538392|P1|Overall Study|Withdrawal by Subject|1
470440|NCT00236080|1538388|P5|Overall Study|Physician Decision|1
470441|NCT00236080|1538389|P4|Overall Study|Physician Decision|1
470442|NCT00236080|1538390|P3|Overall Study|Physician Decision|1
470443|NCT00236080|1538391|P2|Overall Study|Physician Decision|0
470444|NCT00236080|1538392|P1|Overall Study|Physician Decision|1
470445|NCT00236080|1538388|P5|Overall Study|Lost to Follow-up|0
470446|NCT00236080|1538389|P4|Overall Study|Lost to Follow-up|0
470447|NCT00236080|1538390|P3|Overall Study|Lost to Follow-up|0
470448|NCT00236080|1538391|P2|Overall Study|Lost to Follow-up|1
470449|NCT00236080|1538392|P1|Overall Study|Lost to Follow-up|0
470450|NCT00236080|1538388|P5|Overall Study|Adverse Event|0
470451|NCT00236080|1538389|P4|Overall Study|Adverse Event|1
470452|NCT00236080|1538390|P3|Overall Study|Adverse Event|3
470453|NCT00236080|1538391|P2|Overall Study|Adverse Event|0
470454|NCT00236080|1538392|P1|Overall Study|Adverse Event|0
470455|NCT00235989|1538413|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
470456|NCT00235989|1538414|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
470457|NCT00235989|1538415|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
470458|NCT00235989|1538416|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
470459|NCT00235989|1538417|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
470460|NCT00235989|1538418|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
470461|NCT00235989|1538413|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
470462|NCT00235989|1538414|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
470463|NCT00235989|1538415|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
470464|NCT00235989|1538416|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
470465|NCT00235989|1538417|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
470466|NCT00235989|1538418|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
470467|NCT00235989|1538413|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
470468|NCT00235989|1538414|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
470469|NCT00235989|1538415|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
470470|NCT00235989|1538416|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
470471|NCT00235989|1538417|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
470472|NCT00235989|1538418|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
470473|NCT00235989|1538413|P6|Extension Treatment Period (ET)|Adverse Event|0
470474|NCT00235989|1538414|P5|Extension Treatment Period (ET)|Adverse Event|0
470475|NCT00235989|1538415|P4|Extension Treatment Period (ET)|Adverse Event|0
470476|NCT00235989|1538416|P3|Extension Treatment Period (ET)|Adverse Event|2
470477|NCT00235989|1538417|P2|Extension Treatment Period (ET)|Adverse Event|0
470478|NCT00235989|1538418|P1|Extension Treatment Period (ET)|Adverse Event|3
470479|NCT00235989|1538413|P6|Core Treatment Period (CT)|Lost to Follow-up|2
470480|NCT00235989|1538414|P5|Core Treatment Period (CT)|Lost to Follow-up|0
470481|NCT00235989|1538415|P4|Core Treatment Period (CT)|Lost to Follow-up|0
470482|NCT00235989|1538416|P3|Core Treatment Period (CT)|Lost to Follow-up|0
470483|NCT00235989|1538417|P2|Core Treatment Period (CT)|Lost to Follow-up|0
470484|NCT00235989|1538418|P1|Core Treatment Period (CT)|Lost to Follow-up|0
470485|NCT00235872|1538432|P1|Overall Study|Administrative reason|61
470486|NCT00235872|1538432|P1|Overall Study|Withdrawal by Subject|50
470487|NCT00235872|1538432|P1|Overall Study|Lost to Follow-up|1
470488|NCT00235872|1538432|P1|Overall Study|Death|1
470489|NCT00235872|1538432|P1|Overall Study|Adverse Event|34
470490|NCT00235755|1538463|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
470491|NCT00235755|1538464|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
470492|NCT00235755|1538465|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
470493|NCT00235755|1538463|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
470494|NCT00235755|1538464|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
470495|NCT00235755|1538465|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
470496|NCT00235755|1538463|P3|12-Week Maintenance Phase|Protocol Violation|2
470497|NCT00235755|1538464|P2|12-Week Maintenance Phase|Protocol Violation|4
470498|NCT00235755|1538465|P1|12-Week Maintenance Phase|Protocol Violation|0
470499|NCT00235755|1538463|P3|12-Week Maintenance Phase|Lack of Efficacy|0
470500|NCT00235755|1538464|P2|12-Week Maintenance Phase|Lack of Efficacy|0
470501|NCT00235755|1538465|P1|12-Week Maintenance Phase|Lack of Efficacy|5
470502|NCT00235755|1538463|P3|12-Week Maintenance Phase|Lost to Follow-up|0
470503|NCT00235755|1538464|P2|12-Week Maintenance Phase|Lost to Follow-up|3
470504|NCT00235755|1538465|P1|12-Week Maintenance Phase|Lost to Follow-up|2
470505|NCT00235755|1538463|P3|12-Week Maintenance Phase|Adverse Event|26
470506|NCT00235755|1538464|P2|12-Week Maintenance Phase|Adverse Event|12
470507|NCT00235755|1538465|P1|12-Week Maintenance Phase|Adverse Event|8
470508|NCT00235755|1538463|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
470509|NCT00235755|1538464|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
470510|NCT00235755|1538465|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
470511|NCT00235755|1538463|P3|4-Week Titration Phase|Randomization Occurred in Error|0
470512|NCT00235755|1538464|P2|4-Week Titration Phase|Randomization Occurred in Error|0
470513|NCT00235755|1538465|P1|4-Week Titration Phase|Randomization Occurred in Error|1
470514|NCT00235755|1538463|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
470515|NCT00235755|1538464|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
470516|NCT00235755|1538465|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
470517|NCT00235755|1538463|P3|4-Week Titration Phase|Withdrawal by Subject|3
470518|NCT00235755|1538464|P2|4-Week Titration Phase|Withdrawal by Subject|2
470519|NCT00235755|1538465|P1|4-Week Titration Phase|Withdrawal by Subject|1
470520|NCT00235755|1538463|P3|4-Week Titration Phase|Protocol Violation|1
470521|NCT00235755|1538464|P2|4-Week Titration Phase|Protocol Violation|2
470522|NCT00235755|1538465|P1|4-Week Titration Phase|Protocol Violation|2
470523|NCT00235755|1538463|P3|4-Week Titration Phase|Lost to Follow-up|1
470524|NCT00235755|1538464|P2|4-Week Titration Phase|Lost to Follow-up|1
470525|NCT00235755|1538465|P1|4-Week Titration Phase|Lost to Follow-up|0
470526|NCT00235755|1538463|P3|4-Week Titration Phase|Adverse Event|20
470527|NCT00235755|1538464|P2|4-Week Titration Phase|Adverse Event|14
470528|NCT00235755|1538465|P1|4-Week Titration Phase|Adverse Event|6
470529|NCT00235716|1538543|P4|Overall Study|Physician Decision|3
470530|NCT00235716|1538544|P3|Overall Study|Physician Decision|1
470531|NCT00235716|1538545|P2|Overall Study|Physician Decision|1
470532|NCT00235716|1538546|P1|Overall Study|Physician Decision|0
470533|NCT00235716|1538543|P4|Overall Study|Adverse Event|0
470534|NCT00235716|1538544|P3|Overall Study|Adverse Event|1
470535|NCT00235716|1538545|P2|Overall Study|Adverse Event|1
470536|NCT00235716|1538546|P1|Overall Study|Adverse Event|1
470537|NCT00235716|1538543|P4|Overall Study|Lost to Follow-up|10
470538|NCT00235716|1538544|P3|Overall Study|Lost to Follow-up|14
470539|NCT00235716|1538545|P2|Overall Study|Lost to Follow-up|7
470540|NCT00235716|1538546|P1|Overall Study|Lost to Follow-up|12
470541|NCT00235716|1538543|P4|Overall Study|Withdrawal by Subject|18
470542|NCT00235716|1538544|P3|Overall Study|Withdrawal by Subject|17
470543|NCT00235716|1538545|P2|Overall Study|Withdrawal by Subject|19
470544|NCT00235716|1538546|P1|Overall Study|Withdrawal by Subject|23
470545|NCT00235716|1538543|P4|Overall Study|Death|31
470546|NCT00235716|1538544|P3|Overall Study|Death|32
470547|NCT00235716|1538545|P2|Overall Study|Death|39
470548|NCT00235716|1538546|P1|Overall Study|Death|26
470549|NCT00235443|1538609|P6|Overall Study|Other reasons for premature termination|6
470550|NCT00235443|1538610|P5|Overall Study|Other reasons for premature termination|3
470551|NCT00235443|1538611|P4|Overall Study|Other reasons for premature termination|7
470552|NCT00235443|1538612|P3|Overall Study|Other reasons for premature termination|6
470553|NCT00235443|1538613|P2|Overall Study|Other reasons for premature termination|6
470554|NCT00235443|1538614|P1|Overall Study|Other reasons for premature termination|1
470555|NCT00235443|1538609|P6|Overall Study|Unsatisfactory compliance|0
470556|NCT00235443|1538610|P5|Overall Study|Unsatisfactory compliance|1
470557|NCT00235443|1538611|P4|Overall Study|Unsatisfactory compliance|4
470558|NCT00235443|1538612|P3|Overall Study|Unsatisfactory compliance|3
470559|NCT00235443|1538613|P2|Overall Study|Unsatisfactory compliance|2
470560|NCT00235443|1538614|P1|Overall Study|Unsatisfactory compliance|0
470561|NCT00235443|1538609|P6|Overall Study|Lost to Follow-up|3
470562|NCT00235443|1538610|P5|Overall Study|Lost to Follow-up|4
470563|NCT00235443|1538611|P4|Overall Study|Lost to Follow-up|6
470564|NCT00235443|1538612|P3|Overall Study|Lost to Follow-up|6
470565|NCT00235443|1538613|P2|Overall Study|Lost to Follow-up|8
470566|NCT00235443|1538614|P1|Overall Study|Lost to Follow-up|0
470567|NCT00235443|1538609|P6|Overall Study|Withdrawal by Subject|12
470568|NCT00235443|1538610|P5|Overall Study|Withdrawal by Subject|10
470569|NCT00235443|1538611|P4|Overall Study|Withdrawal by Subject|24
470570|NCT00235443|1538612|P3|Overall Study|Withdrawal by Subject|25
470571|NCT00235443|1538613|P2|Overall Study|Withdrawal by Subject|9
470572|NCT00235443|1538614|P1|Overall Study|Withdrawal by Subject|3
470573|NCT00235443|1538609|P6|Overall Study|Lack of Efficacy|9
470574|NCT00235443|1538610|P5|Overall Study|Lack of Efficacy|2
470575|NCT00235443|1538611|P4|Overall Study|Lack of Efficacy|12
470576|NCT00235443|1538612|P3|Overall Study|Lack of Efficacy|5
470577|NCT00235443|1538613|P2|Overall Study|Lack of Efficacy|1
470578|NCT00235443|1538614|P1|Overall Study|Lack of Efficacy|0
470579|NCT00235443|1538609|P6|Overall Study|Adverse Event|15
470580|NCT00235443|1538610|P5|Overall Study|Adverse Event|10
470581|NCT00235443|1538611|P4|Overall Study|Adverse Event|44
470582|NCT00235443|1538612|P3|Overall Study|Adverse Event|17
470583|NCT00235443|1538613|P2|Overall Study|Adverse Event|12
470584|NCT00235443|1538614|P1|Overall Study|Adverse Event|4
470585|NCT00235391|1538755|P6|Overall Study|Death|0
470586|NCT00235391|1538756|P5|Overall Study|Death|0
470587|NCT00235391|1538757|P4|Overall Study|Death|4
470588|NCT00235391|1538758|P3|Overall Study|Death|1
470589|NCT00235391|1538759|P2|Overall Study|Death|0
470590|NCT00235391|1538760|P1|Overall Study|Death|0
470591|NCT00235391|1538755|P6|Overall Study|Administrative problems|0
470592|NCT00235391|1538756|P5|Overall Study|Administrative problems|0
470593|NCT00235391|1538757|P4|Overall Study|Administrative problems|1
470594|NCT00235391|1538758|P3|Overall Study|Administrative problems|0
470595|NCT00235391|1538759|P2|Overall Study|Administrative problems|0
470596|NCT00235391|1538760|P1|Overall Study|Administrative problems|0
470597|NCT00235391|1538755|P6|Overall Study|Lost to Follow-up|0
470598|NCT00235391|1538756|P5|Overall Study|Lost to Follow-up|0
470599|NCT00235391|1538757|P4|Overall Study|Lost to Follow-up|16
470600|NCT00235391|1538758|P3|Overall Study|Lost to Follow-up|3
470601|NCT00235391|1538759|P2|Overall Study|Lost to Follow-up|3
470602|NCT00235391|1538760|P1|Overall Study|Lost to Follow-up|0
470603|NCT00235391|1538755|P6|Overall Study|Withdrawal by Subject|0
470604|NCT00235391|1538756|P5|Overall Study|Withdrawal by Subject|5
470605|NCT00235391|1538757|P4|Overall Study|Withdrawal by Subject|61
470606|NCT00235391|1538758|P3|Overall Study|Withdrawal by Subject|3
470607|NCT00235391|1538759|P2|Overall Study|Withdrawal by Subject|3
470608|NCT00235391|1538760|P1|Overall Study|Withdrawal by Subject|2
470609|NCT00235391|1538755|P6|Overall Study|Protocol deviation|0
470610|NCT00235391|1538756|P5|Overall Study|Protocol deviation|0
470611|NCT00235391|1538757|P4|Overall Study|Protocol deviation|11
470612|NCT00235391|1538758|P3|Overall Study|Protocol deviation|1
470613|NCT00235391|1538759|P2|Overall Study|Protocol deviation|0
470614|NCT00235391|1538760|P1|Overall Study|Protocol deviation|0
470615|NCT00235391|1538755|P6|Overall Study|Condition no longer requires treatment|0
470616|NCT00235391|1538756|P5|Overall Study|Condition no longer requires treatment|1
470617|NCT00235391|1538757|P4|Overall Study|Condition no longer requires treatment|11
470618|NCT00235391|1538758|P3|Overall Study|Condition no longer requires treatment|0
470619|NCT00235391|1538759|P2|Overall Study|Condition no longer requires treatment|0
470620|NCT00235391|1538760|P1|Overall Study|Condition no longer requires treatment|3
470621|NCT00235391|1538755|P6|Overall Study|Unsatisfactory therapeutic effect|0
470622|NCT00235391|1538756|P5|Overall Study|Unsatisfactory therapeutic effect|0
470623|NCT00235391|1538757|P4|Overall Study|Unsatisfactory therapeutic effect|17
470624|NCT00235391|1538758|P3|Overall Study|Unsatisfactory therapeutic effect|2
470625|NCT00235391|1538759|P2|Overall Study|Unsatisfactory therapeutic effect|2
470626|NCT00235391|1538760|P1|Overall Study|Unsatisfactory therapeutic effect|0
470627|NCT00235391|1538755|P6|Overall Study|Abnormal laboratory value(s)|2
470628|NCT00235391|1538756|P5|Overall Study|Abnormal laboratory value(s)|1
470629|NCT00235391|1538757|P4|Overall Study|Abnormal laboratory value(s)|27
470630|NCT00235391|1538758|P3|Overall Study|Abnormal laboratory value(s)|4
470631|NCT00235391|1538759|P2|Overall Study|Abnormal laboratory value(s)|5
470632|NCT00235391|1538760|P1|Overall Study|Abnormal laboratory value(s)|3
470633|NCT00235391|1538755|P6|Overall Study|Adverse Event|2
470634|NCT00235391|1538756|P5|Overall Study|Adverse Event|5
470635|NCT00235391|1538757|P4|Overall Study|Adverse Event|72
470636|NCT00235391|1538758|P3|Overall Study|Adverse Event|10
470637|NCT00235391|1538759|P2|Overall Study|Adverse Event|5
470638|NCT00235391|1538760|P1|Overall Study|Adverse Event|4
470639|NCT00235326|1538777|P2|Overall Study|Lost to Follow-up|1400
470640|NCT00235326|1538778|P1|Overall Study|Lost to Follow-up|746
470641|NCT00234494|1538818|P1|Overall Study|Protocol Violation|2
470642|NCT00234104|1538864|P4|Overall Study|Physician Decision|2
470643|NCT00234104|1538865|P3|Overall Study|Physician Decision|2
470644|NCT00234104|1538866|P2|Overall Study|Physician Decision|1
470645|NCT00234104|1538867|P1|Overall Study|Physician Decision|0
470646|NCT00234104|1538864|P4|Overall Study|Protocol Violation|1
470647|NCT00234104|1538865|P3|Overall Study|Protocol Violation|0
470648|NCT00234104|1538866|P2|Overall Study|Protocol Violation|0
470649|NCT00234104|1538867|P1|Overall Study|Protocol Violation|0
470650|NCT00234104|1538864|P4|Overall Study|Adverse Event|5
470651|NCT00234104|1538865|P3|Overall Study|Adverse Event|3
470652|NCT00234104|1538866|P2|Overall Study|Adverse Event|0
470653|NCT00234104|1538867|P1|Overall Study|Adverse Event|4
470654|NCT00234065|1538908|P2|Overall Study|Not Classified|112
470655|NCT00234065|1538909|P1|Overall Study|Not Classified|111
470656|NCT00234065|1538908|P2|Overall Study|Physician Decision|22
470657|NCT00234065|1538909|P1|Overall Study|Physician Decision|23
470658|NCT00234065|1538908|P2|Overall Study|Withdrawal by Subject|56
470659|NCT00234065|1538909|P1|Overall Study|Withdrawal by Subject|73
470660|NCT00234065|1538908|P2|Overall Study|Adverse Event|166
470661|NCT00234065|1538909|P1|Overall Study|Adverse Event|268
470662|NCT00234039|1538925|P1|Overall Study|No Protocol Treatment Received|2
470663|NCT00234039|1538925|P1|Overall Study|Ineligible|9
470664|NCT00234039|1538925|P1|Overall Study|Other - Not Protocol Specified|3
470665|NCT00234039|1538925|P1|Overall Study|Progression/relapse|34
470666|NCT00234039|1538925|P1|Overall Study|Adverse Event|2
470667|NCT00233987|1538932|P1|Overall Study|Ineligible|4
470668|NCT00233987|1538932|P1|Overall Study|Eligible but No Treatment Received|2
470669|NCT00233987|1538932|P1|Overall Study|Other - Not Protocol Specified|5
470670|NCT00233987|1538932|P1|Overall Study|Reason Under Review|1
470671|NCT00233987|1538932|P1|Overall Study|Lack of Efficacy|2
470672|NCT00233987|1538932|P1|Overall Study|Withdrawal by Subject|1
470673|NCT00233948|1538941|P6|Overall Study|Adverse Event|0
470674|NCT00233948|1538942|P5|Overall Study|Adverse Event|0
470675|NCT00233948|1538943|P4|Overall Study|Adverse Event|0
470676|NCT00233948|1538944|P3|Overall Study|Adverse Event|0
470677|NCT00233948|1538945|P2|Overall Study|Adverse Event|0
470678|NCT00233948|1538946|P1|Overall Study|Adverse Event|1
470679|NCT00233454|1538970|P1|Overall Study|Death|6
470680|NCT00233402|1538977|P2|Overall Study|Lost to follow up etc|21
470681|NCT00233402|1538978|P1|Overall Study|Lost to follow up etc|3
470682|NCT00233402|1538977|P2|Overall Study|No Ta/T1|94
470683|NCT00233402|1538978|P1|Overall Study|No Ta/T1|89
470684|NCT00233402|1538977|P2|Overall Study|No pathology data|9
470685|NCT00233402|1538978|P1|Overall Study|No pathology data|12
470686|NCT00233324|1538993|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
470687|NCT00233324|1538994|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
470688|NCT00233324|1538995|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
470689|NCT00233324|1538996|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
470690|NCT00233324|1538993|P4|Follow up at 18-22 Months Corrected Age|Death|4
470691|NCT00233324|1538994|P3|Follow up at 18-22 Months Corrected Age|Death|5
470692|NCT00233324|1538995|P2|Follow up at 18-22 Months Corrected Age|Death|7
470693|NCT00233324|1538996|P1|Follow up at 18-22 Months Corrected Age|Death|5
470694|NCT00233324|1538993|P4|Main Study|Death|47
470695|NCT00233324|1538994|P3|Main Study|Death|62
470696|NCT00233324|1538995|P2|Main Study|Death|60
470697|NCT00233324|1538996|P1|Main Study|Death|68
470698|NCT00233064|1539050|P2|Overall Study|Moved to Dom. Republic|0
470699|NCT00233064|1539051|P1|Overall Study|Moved to Dom. Republic|1
470700|NCT00233064|1539050|P2|Overall Study|Protocol Violation|0
470701|NCT00233064|1539051|P1|Overall Study|Protocol Violation|1
470702|NCT00233064|1539050|P2|Overall Study|Relocation|1
470703|NCT00233064|1539051|P1|Overall Study|Relocation|0
470704|NCT00233064|1539050|P2|Overall Study|Death|1
470705|NCT00233064|1539051|P1|Overall Study|Death|0
470706|NCT00233064|1539050|P2|Overall Study|Withdrawal by Subject|3
470707|NCT00233064|1539051|P1|Overall Study|Withdrawal by Subject|5
470708|NCT00233064|1539050|P2|Overall Study|Lost to Follow-up|7
470709|NCT00233064|1539051|P1|Overall Study|Lost to Follow-up|7
470710|NCT00232596|1539077|P2|12-Week Maintenance Phase|Other|3
470711|NCT00232596|1539078|P1|12-Week Maintenance Phase|Other|1
470712|NCT00232596|1539077|P2|12-Week Maintenance Phase|Protocol Violation|1
470713|NCT00232596|1539078|P1|12-Week Maintenance Phase|Protocol Violation|3
470714|NCT00232596|1539077|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
470715|NCT00232596|1539078|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
470716|NCT00232596|1539077|P2|12-Week Maintenance Phase|Adverse Event|22
470717|NCT00232596|1539078|P1|12-Week Maintenance Phase|Adverse Event|7
470718|NCT00232596|1539077|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
470719|NCT00232596|1539078|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
470720|NCT00232596|1539077|P2|6-Week Titration Phase|Other|3
470721|NCT00232596|1539078|P1|6-Week Titration Phase|Other|3
470722|NCT00232596|1539077|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
470723|NCT00232596|1539078|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
470724|NCT00232596|1539077|P2|6-Week Titration Phase|Protocol Violation|3
470725|NCT00232596|1539078|P1|6-Week Titration Phase|Protocol Violation|1
470726|NCT00232596|1539077|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
470727|NCT00232596|1539078|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
470728|NCT00232596|1539077|P2|6-Week Titration Phase|Failed to Return|1
470729|NCT00232596|1539078|P1|6-Week Titration Phase|Failed to Return|2
470730|NCT00232596|1539077|P2|6-Week Titration Phase|Adverse Event|19
470731|NCT00232596|1539078|P1|6-Week Titration Phase|Adverse Event|6
470732|NCT00232557|1539169|P2|Overall Study|Lost to Follow-up|5
470733|NCT00232557|1539170|P1|Overall Study|Lost to Follow-up|3
470734|NCT00232544|1539180|P2|Overall Study|Lost to Follow-up|15
470735|NCT00232544|1539181|P1|Overall Study|Lost to Follow-up|20
470736|NCT00232180|1539212|P3|Open Label Phase|Randomized but not treated|1
470737|NCT00232180|1539213|P2|Open Label Phase|Randomized but not treated|0
470738|NCT00232180|1539214|P1|Open Label Phase|Randomized but not treated|0
470739|NCT00232180|1539212|P3|Open Label Phase|Laboratory abnormality|10
470740|NCT00232180|1539213|P2|Open Label Phase|Laboratory abnormality|0
470741|NCT00232180|1539214|P1|Open Label Phase|Laboratory abnormality|0
470742|NCT00232180|1539212|P3|Open Label Phase|Adverse Event|25
470743|NCT00232180|1539213|P2|Open Label Phase|Adverse Event|0
470744|NCT00232180|1539214|P1|Open Label Phase|Adverse Event|0
470745|NCT00232180|1539212|P3|Open Label Phase|Other|16
470746|NCT00232180|1539213|P2|Open Label Phase|Other|0
470747|NCT00232180|1539214|P1|Open Label Phase|Other|0
470748|NCT00232180|1539212|P3|Open Label Phase|Withdrawal by Subject|37
470749|NCT00232180|1539213|P2|Open Label Phase|Withdrawal by Subject|0
470750|NCT00232180|1539214|P1|Open Label Phase|Withdrawal by Subject|0
470751|NCT00232180|1539212|P3|Open Label Phase|Study terminated by sponsor|3
470752|NCT00232180|1539213|P2|Open Label Phase|Study terminated by sponsor|0
470753|NCT00232180|1539214|P1|Open Label Phase|Study terminated by sponsor|0
470754|NCT00232180|1539212|P3|Open Label Phase|Protocol Violation|3
470755|NCT00232180|1539213|P2|Open Label Phase|Protocol Violation|0
470756|NCT00232180|1539214|P1|Open Label Phase|Protocol Violation|0
470757|NCT00232180|1539212|P3|Open Label Phase|Lost to Follow-up|5
470758|NCT00232180|1539213|P2|Open Label Phase|Lost to Follow-up|0
470759|NCT00232180|1539214|P1|Open Label Phase|Lost to Follow-up|0
470760|NCT00232180|1539212|P3|Open Label Phase|Death|48
470761|NCT00232180|1539213|P2|Open Label Phase|Death|0
470762|NCT00232180|1539214|P1|Open Label Phase|Death|0
470763|NCT00232180|1539212|P3|Double-blind (DB) Phase|Laboratory abnormality|0
470764|NCT00232180|1539213|P2|Double-blind (DB) Phase|Laboratory abnormality|7
470765|NCT00232180|1539214|P1|Double-blind (DB) Phase|Laboratory abnormality|6
470766|NCT00232180|1539212|P3|Double-blind (DB) Phase|Randomized but not treated|0
470767|NCT00232180|1539213|P2|Double-blind (DB) Phase|Randomized but not treated|4
470768|NCT00232180|1539214|P1|Double-blind (DB) Phase|Randomized but not treated|3
470769|NCT00232180|1539212|P3|Double-blind (DB) Phase|Other|0
470770|NCT00232180|1539213|P2|Double-blind (DB) Phase|Other|75
470771|NCT00232180|1539214|P1|Double-blind (DB) Phase|Other|70
470772|NCT00232180|1539212|P3|Double-blind (DB) Phase|Adverse Event|0
470773|NCT00232180|1539213|P2|Double-blind (DB) Phase|Adverse Event|100
470774|NCT00232180|1539214|P1|Double-blind (DB) Phase|Adverse Event|83
470775|NCT00232180|1539212|P3|Double-blind (DB) Phase|Protocol Violation|0
470776|NCT00232180|1539213|P2|Double-blind (DB) Phase|Protocol Violation|21
470777|NCT00232180|1539214|P1|Double-blind (DB) Phase|Protocol Violation|28
470778|NCT00232180|1539212|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
470779|NCT00232180|1539213|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
470780|NCT00232180|1539214|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
470781|NCT00232180|1539212|P3|Double-blind (DB) Phase|Lost to Follow-up|0
470782|NCT00232180|1539213|P2|Double-blind (DB) Phase|Lost to Follow-up|28
470783|NCT00232180|1539214|P1|Double-blind (DB) Phase|Lost to Follow-up|34
470784|NCT00232180|1539212|P3|Double-blind (DB) Phase|Death|0
470785|NCT00232180|1539213|P2|Double-blind (DB) Phase|Death|222
470786|NCT00232180|1539214|P1|Double-blind (DB) Phase|Death|186
470787|NCT00232141|1539259|P2|Overall Study|Withdrawal by Subject|3
470788|NCT00232141|1539260|P1|Overall Study|Withdrawal by Subject|5
470789|NCT00232141|1539259|P2|Overall Study|Other|10
470790|NCT00232141|1539260|P1|Overall Study|Other|8
470791|NCT00232141|1539259|P2|Overall Study|Lost to Follow-up|6
470792|NCT00232141|1539260|P1|Overall Study|Lost to Follow-up|9
470793|NCT00232141|1539259|P2|Overall Study|Lack of Efficacy|3
470794|NCT00232141|1539260|P1|Overall Study|Lack of Efficacy|0
470795|NCT00232141|1539259|P2|Overall Study|Adverse Event|4
470796|NCT00232141|1539260|P1|Overall Study|Adverse Event|9
470797|NCT00231894|1539330|P2|Overall Study|Withdrawal by Subject|1
470798|NCT00231894|1539331|P1|Overall Study|Withdrawal by Subject|1
470799|NCT00231816|1539355|P2|Overall Study|Not Specified|1
470800|NCT00231816|1539356|P1|Overall Study|Not Specified|2
470801|NCT00231816|1539355|P2|Overall Study|Withdrawal by Subject|3
470802|NCT00231816|1539356|P1|Overall Study|Withdrawal by Subject|3
470803|NCT00231816|1539355|P2|Overall Study|Protocol Violation|3
470804|NCT00231816|1539356|P1|Overall Study|Protocol Violation|2
470805|NCT00231816|1539355|P2|Overall Study|Lost to Follow-up|5
470806|NCT00231816|1539356|P1|Overall Study|Lost to Follow-up|8
470807|NCT00231816|1539355|P2|Overall Study|Adverse Event|0
470808|NCT00231816|1539356|P1|Overall Study|Adverse Event|1
470809|NCT00231777|1539371|P2|Overall Study|Other|2
470810|NCT00231777|1539372|P1|Overall Study|Other|3
470811|NCT00231777|1539371|P2|Overall Study|Lost to Follow-up|0
470812|NCT00231777|1539372|P1|Overall Study|Lost to Follow-up|3
470813|NCT00231478|1539386|P2|Overall Study|Administrative|2
470814|NCT00231478|1539387|P1|Overall Study|Administrative|3
470815|NCT00231478|1539386|P2|Overall Study|Adverse Event|1
470816|NCT00231478|1539387|P1|Overall Study|Adverse Event|0
470817|NCT00231478|1539386|P2|Overall Study|Withdrawal by Subject|0
470818|NCT00231478|1539387|P1|Overall Study|Withdrawal by Subject|1
470819|NCT00231478|1539386|P2|Overall Study|Refused Treatment|1
470820|NCT00231478|1539387|P1|Overall Study|Refused Treatment|1
470821|NCT00231478|1539386|P2|Overall Study|Protocol Violation|2
470822|NCT00231478|1539387|P1|Overall Study|Protocol Violation|3
470823|NCT00231465|1539399|P1|Overall Study|Did not have follow up CT scans|1
470824|NCT00231465|1539399|P1|Overall Study|Completed only one cycle|1
470825|NCT00231179|1539419|P2|Overall Study|Withdrawal by Subject|3
470826|NCT00231179|1539420|P1|Overall Study|Withdrawal by Subject|3
470827|NCT00231179|1539419|P2|Overall Study|Lost to Follow-up|21
470828|NCT00231179|1539420|P1|Overall Study|Lost to Follow-up|21
470829|NCT00231114|1539447|P2|Post-Treatment Period|Withdrawal by Subject|0
470830|NCT00231114|1539448|P1|Post-Treatment Period|Withdrawal by Subject|1
470831|NCT00231114|1539447|P2|Post-Treatment Period|Physician Decision|0
470832|NCT00231114|1539448|P1|Post-Treatment Period|Physician Decision|1
470833|NCT00231114|1539447|P2|Post-Treatment Period|Lost to Follow-up|1
470834|NCT00231114|1539448|P1|Post-Treatment Period|Lost to Follow-up|6
470835|NCT00231114|1539447|P2|Treatment Period|Death: Motor Vehicle Accident|0
470836|NCT00231114|1539448|P1|Treatment Period|Death: Motor Vehicle Accident|1
470837|NCT00231114|1539447|P2|Randomized|Withdrawal by Subject|3
470838|NCT00231114|1539448|P1|Randomized|Withdrawal by Subject|6
470839|NCT00231062|1539484|P1|Overall Study|Physician Decision|6
470840|NCT00230971|1539492|P2|Baseline Participants|Reintervention|0
470841|NCT00230971|1539493|P1|Baseline Participants|Reintervention|1
470842|NCT00230971|1539492|P2|Baseline Participants|Failure to return|1
470843|NCT00230971|1539493|P1|Baseline Participants|Failure to return|1
470844|NCT00230971|1539492|P2|Baseline Participants|No bacteria observed|0
470845|NCT00230971|1539493|P1|Baseline Participants|No bacteria observed|1
470846|NCT00230971|1539492|P2|Baseline Participants|Adverse Event|0
470847|NCT00230971|1539493|P1|Baseline Participants|Adverse Event|1
470848|NCT00230971|1539492|P2|Baseline Participants|Withdrawal by Subject|1
470849|NCT00230971|1539493|P1|Baseline Participants|Withdrawal by Subject|7
470850|NCT00230971|1539492|P2|Baseline Participants|Death|5
470851|NCT00230971|1539493|P1|Baseline Participants|Death|6
470852|NCT00230971|1539492|P2|Baseline Participants|Lost to Follow-up|12
470853|NCT00230971|1539493|P1|Baseline Participants|Lost to Follow-up|5
470854|NCT00230971|1539492|P2|Randomization|No study drug administered|3
470855|NCT00230971|1539493|P1|Randomization|No study drug administered|3
470856|NCT00230282|1539531|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
470857|NCT00230282|1539531|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
470858|NCT00230282|1539531|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
470859|NCT00230282|1539531|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
470860|NCT00230178|1539539|P3|Overall Study|Various other reasons|4
470861|NCT00230178|1539540|P2|Overall Study|Various other reasons|2
470862|NCT00230178|1539541|P1|Overall Study|Various other reasons|3
470863|NCT00230178|1539539|P3|Overall Study|Withdrawal by Subject|1
470864|NCT00230178|1539540|P2|Overall Study|Withdrawal by Subject|0
470865|NCT00230178|1539541|P1|Overall Study|Withdrawal by Subject|0
470866|NCT00230178|1539539|P3|Overall Study|Adverse Event|2
470867|NCT00230178|1539540|P2|Overall Study|Adverse Event|5
470868|NCT00230178|1539541|P1|Overall Study|Adverse Event|1
470869|NCT00230048|1539593|P2|Overall Study|Lost to Follow-up|18
470870|NCT00230048|1539594|P1|Overall Study|Lost to Follow-up|13
470871|NCT00229931|1539652|P2|Overall Study|Lost to Follow-up|2
470872|NCT00229931|1539653|P1|Overall Study|Lost to Follow-up|3
470873|NCT00229931|1539652|P2|Overall Study|Death|0
470874|NCT00229931|1539653|P1|Overall Study|Death|1
470875|NCT00229723|1539668|P7|Maintenance Phase|Other|1
470876|NCT00229723|1539669|P6|Maintenance Phase|Other|3
470877|NCT00229723|1539670|P5|Maintenance Phase|Other|3
470878|NCT00229723|1539671|P4|Maintenance Phase|Other|2
470879|NCT00229723|1539672|P3|Maintenance Phase|Other|1
470880|NCT00229723|1539673|P2|Maintenance Phase|Other|4
470881|NCT00229723|1539674|P1|Maintenance Phase|Other|5
470882|NCT00229723|1539668|P7|Maintenance Phase|Severe non-compliance|0
470883|NCT00229723|1539669|P6|Maintenance Phase|Severe non-compliance|0
470884|NCT00229723|1539670|P5|Maintenance Phase|Severe non-compliance|1
470885|NCT00229723|1539671|P4|Maintenance Phase|Severe non-compliance|0
470886|NCT00229723|1539672|P3|Maintenance Phase|Severe non-compliance|0
470887|NCT00229723|1539673|P2|Maintenance Phase|Severe non-compliance|1
470888|NCT00229723|1539674|P1|Maintenance Phase|Severe non-compliance|3
470889|NCT00229723|1539668|P7|Maintenance Phase|Informed consent withdrawn|0
470890|NCT00229723|1539669|P6|Maintenance Phase|Informed consent withdrawn|1
470891|NCT00229723|1539670|P5|Maintenance Phase|Informed consent withdrawn|1
470892|NCT00229723|1539671|P4|Maintenance Phase|Informed consent withdrawn|1
470893|NCT00229723|1539672|P3|Maintenance Phase|Informed consent withdrawn|0
470894|NCT00229723|1539673|P2|Maintenance Phase|Informed consent withdrawn|0
470895|NCT00229723|1539674|P1|Maintenance Phase|Informed consent withdrawn|1
470896|NCT00229723|1539668|P7|Maintenance Phase|Lost to Follow-up|1
470897|NCT00229723|1539669|P6|Maintenance Phase|Lost to Follow-up|0
470898|NCT00229723|1539670|P5|Maintenance Phase|Lost to Follow-up|0
470899|NCT00229723|1539671|P4|Maintenance Phase|Lost to Follow-up|2
470900|NCT00229723|1539672|P3|Maintenance Phase|Lost to Follow-up|2
470901|NCT00229723|1539673|P2|Maintenance Phase|Lost to Follow-up|1
470902|NCT00229723|1539674|P1|Maintenance Phase|Lost to Follow-up|0
470903|NCT00229723|1539668|P7|Maintenance Phase|Clinical progression|1
470904|NCT00229723|1539669|P6|Maintenance Phase|Clinical progression|1
470905|NCT00229723|1539670|P5|Maintenance Phase|Clinical progression|1
470906|NCT00229723|1539671|P4|Maintenance Phase|Clinical progression|2
470907|NCT00229723|1539672|P3|Maintenance Phase|Clinical progression|2
470908|NCT00229723|1539673|P2|Maintenance Phase|Clinical progression|1
470909|NCT00229723|1539674|P1|Maintenance Phase|Clinical progression|4
470910|NCT00229723|1539668|P7|Maintenance Phase|Objective disease progression|5
470911|NCT00229723|1539669|P6|Maintenance Phase|Objective disease progression|9
470912|NCT00229723|1539670|P5|Maintenance Phase|Objective disease progression|2
470913|NCT00229723|1539671|P4|Maintenance Phase|Objective disease progression|6
470914|NCT00229723|1539672|P3|Maintenance Phase|Objective disease progression|3
470915|NCT00229723|1539673|P2|Maintenance Phase|Objective disease progression|5
470916|NCT00229723|1539674|P1|Maintenance Phase|Objective disease progression|5
470917|NCT00229723|1539668|P7|Maintenance Phase|Adverse Event|2
470918|NCT00229723|1539669|P6|Maintenance Phase|Adverse Event|5
470919|NCT00229723|1539670|P5|Maintenance Phase|Adverse Event|7
470920|NCT00229723|1539671|P4|Maintenance Phase|Adverse Event|4
470921|NCT00229723|1539672|P3|Maintenance Phase|Adverse Event|1
470922|NCT00229723|1539673|P2|Maintenance Phase|Adverse Event|2
470923|NCT00229723|1539674|P1|Maintenance Phase|Adverse Event|7
470924|NCT00229723|1539668|P7|Concomitant Phase|Other|0
470925|NCT00229723|1539669|P6|Concomitant Phase|Other|2
470926|NCT00229723|1539670|P5|Concomitant Phase|Other|0
470927|NCT00229723|1539671|P4|Concomitant Phase|Other|1
470928|NCT00229723|1539672|P3|Concomitant Phase|Other|1
470929|NCT00229723|1539673|P2|Concomitant Phase|Other|0
470930|NCT00229723|1539674|P1|Concomitant Phase|Other|3
470931|NCT00229723|1539668|P7|Concomitant Phase|Severe non-compliance|0
470932|NCT00229723|1539669|P6|Concomitant Phase|Severe non-compliance|0
470933|NCT00229723|1539670|P5|Concomitant Phase|Severe non-compliance|1
470934|NCT00229723|1539671|P4|Concomitant Phase|Severe non-compliance|0
470935|NCT00229723|1539672|P3|Concomitant Phase|Severe non-compliance|0
470936|NCT00229723|1539673|P2|Concomitant Phase|Severe non-compliance|1
470937|NCT00229723|1539674|P1|Concomitant Phase|Severe non-compliance|0
470938|NCT00229723|1539668|P7|Concomitant Phase|Informed consent withdrawn|0
470939|NCT00229723|1539669|P6|Concomitant Phase|Informed consent withdrawn|0
470940|NCT00229723|1539670|P5|Concomitant Phase|Informed consent withdrawn|0
470941|NCT00229723|1539671|P4|Concomitant Phase|Informed consent withdrawn|2
470942|NCT00229723|1539672|P3|Concomitant Phase|Informed consent withdrawn|0
470943|NCT00229723|1539673|P2|Concomitant Phase|Informed consent withdrawn|2
470944|NCT00229723|1539674|P1|Concomitant Phase|Informed consent withdrawn|3
470945|NCT00229723|1539668|P7|Concomitant Phase|Lost to Follow-up|0
470946|NCT00229723|1539669|P6|Concomitant Phase|Lost to Follow-up|0
470947|NCT00229723|1539670|P5|Concomitant Phase|Lost to Follow-up|1
470948|NCT00229723|1539671|P4|Concomitant Phase|Lost to Follow-up|0
470949|NCT00229723|1539672|P3|Concomitant Phase|Lost to Follow-up|0
470950|NCT00229723|1539673|P2|Concomitant Phase|Lost to Follow-up|0
470951|NCT00229723|1539674|P1|Concomitant Phase|Lost to Follow-up|0
470952|NCT00229723|1539668|P7|Concomitant Phase|Clinical progression|1
470953|NCT00229723|1539669|P6|Concomitant Phase|Clinical progression|0
470954|NCT00229723|1539670|P5|Concomitant Phase|Clinical progression|0
470955|NCT00229723|1539671|P4|Concomitant Phase|Clinical progression|0
470956|NCT00229723|1539672|P3|Concomitant Phase|Clinical progression|0
470957|NCT00229723|1539673|P2|Concomitant Phase|Clinical progression|0
470958|NCT00229723|1539674|P1|Concomitant Phase|Clinical progression|0
470959|NCT00229723|1539668|P7|Concomitant Phase|Objective disease progression|0
470960|NCT00229723|1539669|P6|Concomitant Phase|Objective disease progression|0
470961|NCT00229723|1539670|P5|Concomitant Phase|Objective disease progression|0
470962|NCT00229723|1539671|P4|Concomitant Phase|Objective disease progression|0
470963|NCT00229723|1539672|P3|Concomitant Phase|Objective disease progression|0
470964|NCT00229723|1539673|P2|Concomitant Phase|Objective disease progression|0
470965|NCT00229723|1539674|P1|Concomitant Phase|Objective disease progression|0
470966|NCT00229723|1539668|P7|Concomitant Phase|Adverse Event|2
470967|NCT00229723|1539669|P6|Concomitant Phase|Adverse Event|1
470968|NCT00229723|1539670|P5|Concomitant Phase|Adverse Event|0
470969|NCT00229723|1539671|P4|Concomitant Phase|Adverse Event|2
470970|NCT00229723|1539672|P3|Concomitant Phase|Adverse Event|5
470971|NCT00229723|1539673|P2|Concomitant Phase|Adverse Event|2
470972|NCT00229723|1539674|P1|Concomitant Phase|Adverse Event|4
470973|NCT00229658|1539727|P2|Overall Study|Withdrawal of consent|39
470974|NCT00229658|1539728|P1|Overall Study|Withdrawal of consent|46
470975|NCT00229658|1539727|P2|Overall Study|Serious Adverse Event|2
470976|NCT00229658|1539728|P1|Overall Study|Serious Adverse Event|2
470977|NCT00229658|1539727|P2|Overall Study|Lost to Follow-up|55
470978|NCT00229658|1539728|P1|Overall Study|Lost to Follow-up|82
470979|NCT00229658|1539727|P2|Overall Study|Other|60
470980|NCT00229658|1539728|P1|Overall Study|Other|80
470981|NCT00229658|1539727|P2|Overall Study|Investigator decision|10
470982|NCT00229658|1539728|P1|Overall Study|Investigator decision|13
470983|NCT00229658|1539727|P2|Overall Study|Administrative|1
470984|NCT00229658|1539728|P1|Overall Study|Administrative|2
470985|NCT00229203|1539762|P2|Overall Study|Withdrawal by Subject|4
470986|NCT00229203|1539763|P1|Overall Study|Withdrawal by Subject|1
470987|NCT00229203|1539762|P2|Overall Study|Other|3
470988|NCT00229203|1539763|P1|Overall Study|Other|3
470989|NCT00229203|1539762|P2|Overall Study|Death|2
470990|NCT00229203|1539763|P1|Overall Study|Death|4
470991|NCT00229203|1539762|P2|Overall Study|Toxicity|1
470992|NCT00229203|1539763|P1|Overall Study|Toxicity|6
470993|NCT00229203|1539762|P2|Overall Study|Progressive disease|9
470994|NCT00229203|1539763|P1|Overall Study|Progressive disease|18
470995|NCT00228917|1539787|P4|Overall Study|Migrated/moved from study area|0
470996|NCT00228917|1539788|P3|Overall Study|Migrated/moved from study area|0
470997|NCT00228917|1539789|P2|Overall Study|Migrated/moved from study area|3
470998|NCT00228917|1539790|P1|Overall Study|Migrated/moved from study area|0
470999|NCT00228917|1539787|P4|Overall Study|Lost to Follow-up|0
471000|NCT00228917|1539788|P3|Overall Study|Lost to Follow-up|0
471001|NCT00228917|1539789|P2|Overall Study|Lost to Follow-up|0
471002|NCT00228917|1539790|P1|Overall Study|Lost to Follow-up|1
471003|NCT00228813|1539816|P1|Overall Study|Death|4
471004|NCT00228566|1539822|P1|Overall Study|Miscellaneous|1
471005|NCT00228566|1539822|P1|Overall Study|Withdrawal by Subject|4
471006|NCT00228566|1539822|P1|Overall Study|Physician Decision|5
471007|NCT00228566|1539822|P1|Overall Study|Lost to Follow-up|16
471008|NCT00228566|1539822|P1|Overall Study|Lack of Efficacy|14
471009|NCT00228566|1539822|P1|Overall Study|Adverse Event|31
471010|NCT00228553|1539826|P1|Overall Study|Miscellaneous|46
471011|NCT00228553|1539826|P1|Overall Study|Pregnancy|2
471012|NCT00228553|1539826|P1|Overall Study|Withdrawal by Subject|115
471013|NCT00228553|1539826|P1|Overall Study|Protocol Violation|6
471014|NCT00228553|1539826|P1|Overall Study|Physician Decision|48
471015|NCT00228553|1539826|P1|Overall Study|Lost to Follow-up|67
471016|NCT00228553|1539826|P1|Overall Study|Lack of Efficacy|34
471017|NCT00228553|1539826|P1|Overall Study|Adverse Event|112
471018|NCT00228384|1539832|P2|Overall Study|Physician Decision|1
471019|NCT00228384|1539833|P1|Overall Study|Physician Decision|0
471020|NCT00228384|1539832|P2|Overall Study|Withdrawal by Subject|10
471021|NCT00228384|1539833|P1|Overall Study|Withdrawal by Subject|9
471022|NCT00228384|1539832|P2|Overall Study|Surgical Intervention (bypass)|5
471023|NCT00228384|1539833|P1|Overall Study|Surgical Intervention (bypass)|5
471024|NCT00228384|1539832|P2|Overall Study|Lost to Follow-up|10
471025|NCT00228384|1539833|P1|Overall Study|Lost to Follow-up|6
471026|NCT00228384|1539832|P2|Overall Study|Death|3
471027|NCT00228384|1539833|P1|Overall Study|Death|9
471028|NCT00227903|1539884|P2|Overall Study|Miscarriage|0
471029|NCT00227903|1539885|P1|Overall Study|Miscarriage|1
471030|NCT00227903|1539884|P2|Overall Study|Lost to Follow-up|3
471031|NCT00227903|1539885|P1|Overall Study|Lost to Follow-up|1
471032|NCT00227903|1539884|P2|Overall Study|Subject moved out of area|2
471033|NCT00227903|1539885|P1|Overall Study|Subject moved out of area|1
471034|NCT00227903|1539884|P2|Overall Study|Withdrawal by Subject|5
471035|NCT00227903|1539885|P1|Overall Study|Withdrawal by Subject|2
471036|NCT00227721|1539951|P1|Overall Study|On study, but never treated.|1
471037|NCT00227591|1539955|P1|Overall Study|Withdrawal by Subject|1
471038|NCT00227539|1539959|P1|Overall Study|Protocol Violation|1
471039|NCT00227370|1539967|P2|Overall Study|Other reasons|1
471040|NCT00227370|1539968|P1|Overall Study|Other reasons|2
471041|NCT00227370|1539967|P2|Overall Study|Physician Decision|6
471042|NCT00227370|1539968|P1|Overall Study|Physician Decision|9
471043|NCT00227370|1539967|P2|Overall Study|Adverse Event|11
471044|NCT00227370|1539968|P1|Overall Study|Adverse Event|6
471045|NCT00227370|1539967|P2|Overall Study|Death|4
471046|NCT00227370|1539968|P1|Overall Study|Death|3
471047|NCT00227370|1539967|P2|Overall Study|Withdrawal by Subject|2
471048|NCT00227370|1539968|P1|Overall Study|Withdrawal by Subject|1
471049|NCT00227344|1539988|P2|Overall Study|study terminated early|5
471050|NCT00227344|1539989|P1|Overall Study|study terminated early|12
471051|NCT00227305|1540009|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
471052|NCT00227305|1540009|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
471053|NCT00227305|1540009|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
471054|NCT00227305|1540009|P1|Overall Study|Physician Decision|3
471055|NCT00227305|1540009|P1|Overall Study|Lack of Efficacy|7
471056|NCT00227305|1540009|P1|Overall Study|MOVED OUT OF AREA|3
471057|NCT00227305|1540009|P1|Overall Study|Study specific discontinuation|13
471058|NCT00227305|1540009|P1|Overall Study|Lost to Follow-up|33
471059|NCT00227305|1540009|P1|Overall Study|Withdrawal by Subject|42
471060|NCT00227305|1540009|P1|Overall Study|Adverse Event|40
471061|NCT00227266|1540026|P3|Overall Study|Excessive weight gain|2
471062|NCT00227266|1540027|P2|Overall Study|Excessive weight gain|0
471063|NCT00227266|1540028|P1|Overall Study|Excessive weight gain|0
471064|NCT00227266|1540026|P3|Overall Study|Protocol Violation|1
471065|NCT00227266|1540027|P2|Overall Study|Protocol Violation|0
471066|NCT00227266|1540028|P1|Overall Study|Protocol Violation|1
471067|NCT00227266|1540026|P3|Overall Study|Withdrawal by Subject|1
471068|NCT00227266|1540027|P2|Overall Study|Withdrawal by Subject|0
471069|NCT00227266|1540028|P1|Overall Study|Withdrawal by Subject|0
471070|NCT00226941|1540058|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
471071|NCT00226941|1540059|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
471072|NCT00226941|1540060|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
471073|NCT00226941|1540061|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
471074|NCT00226941|1540058|P4|Overall Study|Withdrawal by subject - toxicity|1
471075|NCT00226941|1540059|P3|Overall Study|Withdrawal by subject - toxicity|0
471076|NCT00226941|1540060|P2|Overall Study|Withdrawal by subject - toxicity|0
471077|NCT00226941|1540061|P1|Overall Study|Withdrawal by subject - toxicity|0
471078|NCT00226811|1540095|P1|Overall Study|Withdrawal by Subject|2
471079|NCT00226811|1540095|P1|Overall Study|Lack of Efficacy|55
471080|NCT00226811|1540095|P1|Overall Study|Adverse Event|11
471081|NCT00226811|1540095|P1|Overall Study|Death|8
471082|NCT00226655|1540105|P1|Overall Study|Clinical deterioration|10
471083|NCT00226655|1540105|P1|Overall Study|Physician Decision|6
471084|NCT00226655|1540105|P1|Overall Study|Adverse Event|35
471085|NCT00226655|1540105|P1|Overall Study|Withdrawal by Subject|15
471086|NCT00226655|1540105|P1|Overall Study|Death|13
471087|NCT00225277|1540168|P2|Overall Study|Other|9
471088|NCT00225277|1540169|P1|Overall Study|Other|7
471089|NCT00225277|1540168|P2|Overall Study|Withdrawal by Subject|34
471090|NCT00225277|1540169|P1|Overall Study|Withdrawal by Subject|40
471091|NCT00225277|1540168|P2|Overall Study|Protocol Violation|3
471092|NCT00225277|1540169|P1|Overall Study|Protocol Violation|6
471093|NCT00225277|1540168|P2|Overall Study|Physician Decision|8
471094|NCT00225277|1540169|P1|Overall Study|Physician Decision|6
471095|NCT00225277|1540168|P2|Overall Study|Lost to Follow-up|6
471096|NCT00225277|1540169|P1|Overall Study|Lost to Follow-up|4
471097|NCT00225277|1540168|P2|Overall Study|Lack of Efficacy|1
471098|NCT00225277|1540169|P1|Overall Study|Lack of Efficacy|4
471099|NCT00225277|1540168|P2|Overall Study|Adverse Event|34
471100|NCT00225277|1540169|P1|Overall Study|Adverse Event|30
471101|NCT00225251|1540187|P2|Overall Study|Withdrawal by Subject|1
471102|NCT00225251|1540188|P1|Overall Study|Withdrawal by Subject|1
471103|NCT00225212|1540202|P1|Overall Study|Intercurrent illness|1
471104|NCT00225212|1540202|P1|Overall Study|Adverse Event|2
471105|NCT00225212|1540202|P1|Overall Study|Death|1
471106|NCT00225212|1540202|P1|Overall Study|Disease progression|2
471107|NCT00225147|1540211|P4|Open-label Phase|Withdrawal by Subject|6
471108|NCT00225147|1540212|P3|Open-label Phase|Withdrawal by Subject|0
471109|NCT00225147|1540213|P2|Open-label Phase|Withdrawal by Subject|0
471110|NCT00225147|1540214|P1|Open-label Phase|Withdrawal by Subject|0
471111|NCT00225147|1540211|P4|Open-label Phase|Lost to Follow-up|4
471112|NCT00225147|1540212|P3|Open-label Phase|Lost to Follow-up|0
471113|NCT00225147|1540213|P2|Open-label Phase|Lost to Follow-up|0
471114|NCT00225147|1540214|P1|Open-label Phase|Lost to Follow-up|0
471115|NCT00224874|1540261|P4|Overall Study|Withdrawal by Subject|0
471116|NCT00224874|1540262|P3|Overall Study|Withdrawal by Subject|1
471117|NCT00224874|1540263|P2|Overall Study|Withdrawal by Subject|0
471118|NCT00224874|1540264|P1|Overall Study|Withdrawal by Subject|0
471119|NCT00224770|1540309|P3|Overall Study|Lost to Follow-up|0
471120|NCT00224770|1540310|P2|Overall Study|Lost to Follow-up|2
471121|NCT00224770|1540311|P1|Overall Study|Lost to Follow-up|4
471122|NCT00224484|1540346|P3|Overall Study|Reaon not specified|2
471123|NCT00224484|1540347|P2|Overall Study|Reaon not specified|4
471124|NCT00224484|1540348|P1|Overall Study|Reaon not specified|5
471125|NCT00224484|1540346|P3|Overall Study|Lost to Follow-up|36
471126|NCT00224484|1540347|P2|Overall Study|Lost to Follow-up|28
471127|NCT00224484|1540348|P1|Overall Study|Lost to Follow-up|66
471128|NCT00224484|1540346|P3|Overall Study|Migrated/moved from study area|5
471129|NCT00224484|1540347|P2|Overall Study|Migrated/moved from study area|5
471130|NCT00224484|1540348|P1|Overall Study|Migrated/moved from study area|18
471131|NCT00224484|1540346|P3|Overall Study|Withdrawal by Subject|16
471132|NCT00224484|1540347|P2|Overall Study|Withdrawal by Subject|18
471133|NCT00224484|1540348|P1|Overall Study|Withdrawal by Subject|49
471134|NCT00224484|1540346|P3|Overall Study|Protocol Violation|0
471135|NCT00224484|1540347|P2|Overall Study|Protocol Violation|2
471136|NCT00224484|1540348|P1|Overall Study|Protocol Violation|2
471137|NCT00224484|1540346|P3|Overall Study|Non-Serious Adverse Event|3
471138|NCT00224484|1540347|P2|Overall Study|Non-Serious Adverse Event|7
471139|NCT00224484|1540348|P1|Overall Study|Non-Serious Adverse Event|5
471140|NCT00224484|1540346|P3|Overall Study|Serious Adverse Event|0
471141|NCT00224484|1540347|P2|Overall Study|Serious Adverse Event|1
471142|NCT00224484|1540348|P1|Overall Study|Serious Adverse Event|1
471143|NCT00224133|1540412|P1|Overall Study|Not specified|14
471144|NCT00224133|1540412|P1|Overall Study|Physician Decision|1
471145|NCT00224133|1540412|P1|Overall Study|Lost to Follow-up|21
471146|NCT00224133|1540412|P1|Overall Study|Lack of Efficacy|58
471147|NCT00224133|1540412|P1|Overall Study|Withdrawal by Subject|33
471148|NCT00224133|1540412|P1|Overall Study|Protocol Violation|6
471149|NCT00224133|1540412|P1|Overall Study|Adverse Event|93
471150|NCT00224120|1540418|P2|Overall Study|Not specified|5
471151|NCT00224120|1540419|P1|Overall Study|Not specified|4
471152|NCT00224120|1540418|P2|Overall Study|Lost to Follow-up|3
471153|NCT00224120|1540419|P1|Overall Study|Lost to Follow-up|2
471154|NCT00224120|1540418|P2|Overall Study|Lack of Efficacy|2
471155|NCT00224120|1540419|P1|Overall Study|Lack of Efficacy|0
471156|NCT00224120|1540418|P2|Overall Study|Withdrawal by Subject|10
471157|NCT00224120|1540419|P1|Overall Study|Withdrawal by Subject|5
471158|NCT00224120|1540418|P2|Overall Study|Protocol Violation|0
471159|NCT00224120|1540419|P1|Overall Study|Protocol Violation|1
471160|NCT00224120|1540418|P2|Overall Study|Adverse Event|4
471161|NCT00224120|1540419|P1|Overall Study|Adverse Event|10
471162|NCT00224107|1540429|P2|Overall Study|Not specified|1
471163|NCT00224107|1540430|P1|Overall Study|Not specified|1
471164|NCT00224107|1540429|P2|Overall Study|Physician Decision|0
471165|NCT00224107|1540430|P1|Overall Study|Physician Decision|1
471166|NCT00224107|1540429|P2|Overall Study|Lost to Follow-up|0
471167|NCT00224107|1540430|P1|Overall Study|Lost to Follow-up|4
471168|NCT00224107|1540429|P2|Overall Study|Lack of Efficacy|0
471169|NCT00224107|1540430|P1|Overall Study|Lack of Efficacy|2
471170|NCT00224107|1540429|P2|Overall Study|Withdrawal by Subject|4
471171|NCT00224107|1540430|P1|Overall Study|Withdrawal by Subject|1
471172|NCT00224107|1540429|P2|Overall Study|Protocol Violation|3
471173|NCT00224107|1540430|P1|Overall Study|Protocol Violation|2
471174|NCT00224107|1540429|P2|Overall Study|Adverse Event|6
471175|NCT00224107|1540430|P1|Overall Study|Adverse Event|20
471176|NCT00224055|1540440|P2|Overall Study|Not Specified|0
471177|NCT00224055|1540441|P1|Overall Study|Not Specified|1
471178|NCT00224055|1540440|P2|Overall Study|Withdrawal by Subject|2
471179|NCT00224055|1540441|P1|Overall Study|Withdrawal by Subject|0
471180|NCT00224055|1540440|P2|Overall Study|Inclusion Violation|6
471181|NCT00224055|1540441|P1|Overall Study|Inclusion Violation|3
471182|NCT00224055|1540440|P2|Overall Study|Protocol Violation|1
471183|NCT00224055|1540441|P1|Overall Study|Protocol Violation|1
471184|NCT00224055|1540440|P2|Overall Study|Lost to Follow-up|2
471185|NCT00224055|1540441|P1|Overall Study|Lost to Follow-up|1
471186|NCT00224055|1540440|P2|Overall Study|Adverse Event|3
471187|NCT00224055|1540441|P1|Overall Study|Adverse Event|9
471188|NCT00224042|1540451|P2|Overall Study|Not specified|0
471189|NCT00224042|1540452|P1|Overall Study|Not specified|2
471190|NCT00224042|1540451|P2|Overall Study|Did not meet lab incusion criteria|3
471191|NCT00224042|1540452|P1|Overall Study|Did not meet lab incusion criteria|2
471192|NCT00224042|1540451|P2|Overall Study|Physician Decision|1
471193|NCT00224042|1540452|P1|Overall Study|Physician Decision|0
471194|NCT00224042|1540451|P2|Overall Study|Protocol Violation|1
471195|NCT00224042|1540452|P1|Overall Study|Protocol Violation|0
471196|NCT00224042|1540451|P2|Overall Study|Adverse Event|1
471197|NCT00224042|1540452|P1|Overall Study|Adverse Event|2
471198|NCT00224029|1540464|P1|Overall Study|Other|1
471199|NCT00224029|1540464|P1|Overall Study|Withdrawal by Subject|4
471200|NCT00224029|1540464|P1|Overall Study|Lost to Follow-up|1
471201|NCT00224016|1540470|P2|Maintenance Period|Lost to Follow-up|1
471202|NCT00224016|1540471|P1|Maintenance Period|Lost to Follow-up|0
471203|NCT00224016|1540470|P2|Maintenance Period|Withdrawal by Subject|0
471204|NCT00224016|1540471|P1|Maintenance Period|Withdrawal by Subject|2
471205|NCT00224016|1540470|P2|Titration Period|Lost to Follow-up|0
471206|NCT00224016|1540471|P1|Titration Period|Lost to Follow-up|1
471207|NCT00224016|1540470|P2|Titration Period|Withdrawal by Subject|1
471208|NCT00224016|1540471|P1|Titration Period|Withdrawal by Subject|0
471209|NCT00224003|1540479|P1|Overall Study|unk|3
471210|NCT00224003|1540479|P1|Overall Study|Withdrawal by Subject|1
471211|NCT00224003|1540479|P1|Overall Study|Protocol Violation|2
471212|NCT00224003|1540479|P1|Overall Study|Adverse Event|1
471213|NCT00223977|1540486|P3|Overall Study|not specified|0
471214|NCT00223977|1540487|P2|Overall Study|not specified|0
471215|NCT00223977|1540488|P1|Overall Study|not specified|1
471216|NCT00223977|1540486|P3|Overall Study|Withdrawal by Subject|2
471217|NCT00223977|1540487|P2|Overall Study|Withdrawal by Subject|1
471218|NCT00223977|1540488|P1|Overall Study|Withdrawal by Subject|1
471219|NCT00223977|1540486|P3|Overall Study|Protocol Violation|1
471220|NCT00223977|1540487|P2|Overall Study|Protocol Violation|0
471221|NCT00223977|1540488|P1|Overall Study|Protocol Violation|0
471222|NCT00223977|1540486|P3|Overall Study|Adverse Event|0
471223|NCT00223977|1540487|P2|Overall Study|Adverse Event|10
471224|NCT00223977|1540488|P1|Overall Study|Adverse Event|7
471225|NCT00223808|1540522|P3|Overall Study|<5 hrs therapy before discharge|5
471226|NCT00223808|1540523|P2|Overall Study|<5 hrs therapy before discharge|5
471227|NCT00223808|1540524|P1|Overall Study|<5 hrs therapy before discharge|3
471228|NCT00223795|1540541|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
471229|NCT00223795|1540542|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
471230|NCT00223795|1540541|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
471231|NCT00223795|1540542|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
471232|NCT00223496|1540620|P1|Overall Study|Physician Decision|2
471233|NCT00223496|1540620|P1|Overall Study|Withdrawal by Subject|1
471234|NCT00223496|1540620|P1|Overall Study|Lack of Efficacy|6
471235|NCT00223496|1540620|P1|Overall Study|Lost to Follow-up|4
471236|NCT00223496|1540620|P1|Overall Study|screen failure|9
471237|NCT00222729|1540639|P1|Overall Study|Adverse Event|3
471238|NCT00222105|1540646|P1|Overall Study|Death|2
471239|NCT00222105|1540646|P1|Overall Study|Treatment delays|2
471240|NCT00222105|1540646|P1|Overall Study|Adverse Event|8
471241|NCT00222105|1540646|P1|Overall Study|Withdrawal by Subject|1
471242|NCT00222105|1540646|P1|Overall Study|Removed due to wrong diagnosis|1
471243|NCT00221195|1540667|P2|Overall Study|Lost to Follow-up|1
471244|NCT00221195|1540668|P1|Overall Study|Lost to Follow-up|0
471245|NCT00221195|1540667|P2|Overall Study|Death|1
471246|NCT00221195|1540668|P1|Overall Study|Death|1
471247|NCT00221195|1540667|P2|Overall Study|Withdrawal by Subject|1
471248|NCT00221195|1540668|P1|Overall Study|Withdrawal by Subject|4
471249|NCT00221104|1540688|P2|Overall Study|Others|47
471250|NCT00221104|1540689|P1|Overall Study|Others|37
471251|NCT00221104|1540688|P2|Overall Study|Withdrawal by Subject|29
471252|NCT00221104|1540689|P1|Overall Study|Withdrawal by Subject|42
471253|NCT00221104|1540688|P2|Overall Study|Protocol Violation|0
471254|NCT00221104|1540689|P1|Overall Study|Protocol Violation|2
471255|NCT00221104|1540688|P2|Overall Study|Physician Decision|0
471256|NCT00221104|1540689|P1|Overall Study|Physician Decision|1
471257|NCT00221104|1540688|P2|Overall Study|Adverse Event|0
471258|NCT00221104|1540689|P1|Overall Study|Adverse Event|1
471259|NCT00220805|1540722|P2|Overall Study|Develop. of choroidal neovascularization|8
471260|NCT00220805|1540723|P1|Overall Study|Develop. of choroidal neovascularization|3
471261|NCT00220805|1540722|P2|Overall Study|Lack of Efficacy|0
471262|NCT00220805|1540723|P1|Overall Study|Lack of Efficacy|1
471263|NCT00220805|1540722|P2|Overall Study|Withdrawal by Subject|0
471264|NCT00220805|1540723|P1|Overall Study|Withdrawal by Subject|3
471265|NCT00220805|1540722|P2|Overall Study|Adverse Event|3
471266|NCT00220805|1540723|P1|Overall Study|Adverse Event|1
471267|NCT00220779|1540744|P3|Overall Study|Lack of Efficacy|1
471268|NCT00220779|1540745|P2|Overall Study|Lack of Efficacy|0
471269|NCT00220779|1540746|P1|Overall Study|Lack of Efficacy|3
471270|NCT00220779|1540744|P3|Overall Study|Pregnancy|2
471271|NCT00220779|1540745|P2|Overall Study|Pregnancy|0
471272|NCT00220779|1540746|P1|Overall Study|Pregnancy|0
471273|NCT00220779|1540744|P3|Overall Study|Too time consuming|0
471274|NCT00220779|1540745|P2|Overall Study|Too time consuming|0
471275|NCT00220779|1540746|P1|Overall Study|Too time consuming|1
471276|NCT00220779|1540744|P3|Overall Study|Non-compliance|0
471277|NCT00220779|1540745|P2|Overall Study|Non-compliance|0
471278|NCT00220779|1540746|P1|Overall Study|Non-compliance|1
471279|NCT00220779|1540744|P3|Overall Study|Withdrawal by Subject|1
471280|NCT00220779|1540745|P2|Overall Study|Withdrawal by Subject|4
471281|NCT00220779|1540746|P1|Overall Study|Withdrawal by Subject|1
471282|NCT00220779|1540744|P3|Overall Study|Adverse Event|0
471283|NCT00220779|1540745|P2|Overall Study|Adverse Event|0
471284|NCT00220779|1540746|P1|Overall Study|Adverse Event|1
471285|NCT00220740|1540756|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
471286|NCT00220740|1540757|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
471287|NCT00220740|1540756|P2|Efficacy Period|Protocol Violation|0
471288|NCT00220740|1540757|P1|Efficacy Period|Protocol Violation|1
471289|NCT00220740|1540756|P2|Efficacy Period|Withdrawal by Subject|0
471290|NCT00220740|1540757|P1|Efficacy Period|Withdrawal by Subject|1
471291|NCT00220740|1540756|P2|Efficacy Period|Adverse Event|1
471292|NCT00220740|1540757|P1|Efficacy Period|Adverse Event|1
471293|NCT00220740|1540756|P2|Efficacy Period|Entered rescue treatment with placebo|0
471294|NCT00220740|1540757|P1|Efficacy Period|Entered rescue treatment with placebo|23
471295|NCT00220727|1540771|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
471296|NCT00220727|1540772|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
471297|NCT00220701|1540788|P2|Overall Study|Lost to Follow-up|4
471298|NCT00220701|1540789|P1|Overall Study|Lost to Follow-up|5
471299|NCT00220636|1540805|P1|Overall Study|Withdrawal by Subject|4
471300|NCT00219557|1540815|P3|Phase 2|Treatment not received|3
471301|NCT00219557|1540816|P2|Phase 2|Treatment not received|1
471302|NCT00219557|1540817|P1|Phase 2|Treatment not received|0
471303|NCT00219557|1540815|P3|Phase 2|Withdrawal by Subject|5
471304|NCT00219557|1540816|P2|Phase 2|Withdrawal by Subject|9
471305|NCT00219557|1540817|P1|Phase 2|Withdrawal by Subject|0
471306|NCT00219557|1540815|P3|Phase 2|Other|6
471307|NCT00219557|1540816|P2|Phase 2|Other|8
471308|NCT00219557|1540817|P1|Phase 2|Other|0
471309|NCT00219557|1540815|P3|Phase 2|Death|2
471310|NCT00219557|1540816|P2|Phase 2|Death|8
471311|NCT00219557|1540817|P1|Phase 2|Death|0
471312|NCT00219557|1540815|P3|Phase 2|Adverse Event|2
471313|NCT00219557|1540816|P2|Phase 2|Adverse Event|22
471314|NCT00219557|1540817|P1|Phase 2|Adverse Event|0
471315|NCT00219557|1540815|P3|Phase 2|Lack of Efficacy|15
471316|NCT00219557|1540816|P2|Phase 2|Lack of Efficacy|21
471317|NCT00219557|1540817|P1|Phase 2|Lack of Efficacy|0
471318|NCT00219557|1540815|P3|Phase 1|Started chemotherapy at other institute|0
471319|NCT00219557|1540816|P2|Phase 1|Started chemotherapy at other institute|0
471320|NCT00219557|1540817|P1|Phase 1|Started chemotherapy at other institute|1
471321|NCT00219557|1540815|P3|Phase 1|Withdrawal by Subject|0
471322|NCT00219557|1540816|P2|Phase 1|Withdrawal by Subject|0
471323|NCT00219557|1540817|P1|Phase 1|Withdrawal by Subject|1
471324|NCT00219557|1540815|P3|Phase 1|Adverse Event|0
471325|NCT00219557|1540816|P2|Phase 1|Adverse Event|0
471326|NCT00219557|1540817|P1|Phase 1|Adverse Event|2
471327|NCT00219557|1540815|P3|Phase 1|Lack of Efficacy|0
471328|NCT00219557|1540816|P2|Phase 1|Lack of Efficacy|0
471329|NCT00219557|1540817|P1|Phase 1|Lack of Efficacy|3
471330|NCT00219544|1540845|P2|Single Blind Treatment Period|Withdrawal by Subject|0
471331|NCT00219544|1540846|P1|Single Blind Treatment Period|Withdrawal by Subject|1
471332|NCT00219544|1540845|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
471333|NCT00219544|1540846|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
471334|NCT00219544|1540845|P2|Single Blind Treatment Period|Lost to Follow-up|0
471335|NCT00219544|1540846|P1|Single Blind Treatment Period|Lost to Follow-up|2
471336|NCT00219544|1540845|P2|Single Blind Treatment Period|Protocol Violation|0
471337|NCT00219544|1540846|P1|Single Blind Treatment Period|Protocol Violation|4
471338|NCT00219544|1540845|P2|Single Blind Treatment Period|Adverse Event|0
471339|NCT00219544|1540846|P1|Single Blind Treatment Period|Adverse Event|9
471340|NCT00219544|1540845|P2|Single Blind Treatment Period|Lack of Efficacy|0
471341|NCT00219544|1540846|P1|Single Blind Treatment Period|Lack of Efficacy|5
471342|NCT00219349|1540884|P1|Escitalopram Phase|Withdrawal by Subject|3
471343|NCT00219349|1540884|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
471344|NCT00219349|1540884|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
471345|NCT00219349|1540884|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
471346|NCT00219284|1540897|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
471347|NCT00219284|1540898|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
471348|NCT00219284|1540897|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
471349|NCT00219284|1540898|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
471350|NCT00219284|1540897|P2|Extension Phase - 8 Weeks|Adverse Event|3
471351|NCT00219284|1540898|P1|Extension Phase - 8 Weeks|Adverse Event|2
471352|NCT00219284|1540897|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
471353|NCT00219284|1540898|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
471354|NCT00219284|1540897|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
471355|NCT00219284|1540898|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
471356|NCT00219284|1540897|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
471357|NCT00219284|1540898|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
471358|NCT00219284|1540897|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
471359|NCT00219284|1540898|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
471360|NCT00219284|1540897|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
471361|NCT00219284|1540898|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
471362|NCT00219284|1540897|P2|Treatment Phase - 16 Weeks|Adverse Event|24
471363|NCT00219284|1540898|P1|Treatment Phase - 16 Weeks|Adverse Event|26
471364|NCT00219141|1540923|P3|Overall Study|Condition no longer requires study drug|0
471365|NCT00219141|1540924|P2|Overall Study|Condition no longer requires study drug|0
471366|NCT00219141|1540925|P1|Overall Study|Condition no longer requires study drug|1
471367|NCT00219141|1540923|P3|Overall Study|Withdrawal by Subject|5
471368|NCT00219141|1540924|P2|Overall Study|Withdrawal by Subject|3
471369|NCT00219141|1540925|P1|Overall Study|Withdrawal by Subject|1
471370|NCT00219141|1540923|P3|Overall Study|Protocol Violation|1
471371|NCT00219141|1540924|P2|Overall Study|Protocol Violation|1
471372|NCT00219141|1540925|P1|Overall Study|Protocol Violation|3
471373|NCT00219141|1540923|P3|Overall Study|Lost to Follow-up|1
471374|NCT00219141|1540924|P2|Overall Study|Lost to Follow-up|4
471375|NCT00219141|1540925|P1|Overall Study|Lost to Follow-up|2
471376|NCT00219141|1540923|P3|Overall Study|Administrative problems|0
471377|NCT00219141|1540924|P2|Overall Study|Administrative problems|1
471378|NCT00219141|1540925|P1|Overall Study|Administrative problems|0
471379|NCT00219141|1540923|P3|Overall Study|Lack of Efficacy|0
471380|NCT00219141|1540924|P2|Overall Study|Lack of Efficacy|2
471381|NCT00219141|1540925|P1|Overall Study|Lack of Efficacy|3
471382|NCT00219141|1540923|P3|Overall Study|Adverse Event|5
471383|NCT00219141|1540924|P2|Overall Study|Adverse Event|10
471384|NCT00219141|1540925|P1|Overall Study|Adverse Event|4
471385|NCT00218634|1540971|P2|Overall Study|Lost to Follow-up|15
471386|NCT00218634|1540972|P1|Overall Study|Lost to Follow-up|8
471387|NCT00218543|1540992|P1|Overall Study|Adverse Event|2
471388|NCT00218543|1540992|P1|Overall Study|Physician Decision|3
471389|NCT00218543|1540992|P1|Overall Study|Withdrawal by Subject|1
471390|NCT00218543|1540992|P1|Overall Study|relocated|1
471391|NCT00218543|1540992|P1|Overall Study|Lost to Follow-up|8
471392|NCT00218296|1541098|P2|Overall Study|Randomized but did not enter treatment|67
471393|NCT00218296|1541099|P1|Overall Study|Randomized but did not enter treatment|66
471394|NCT00218296|1541098|P2|Overall Study|Withdrawal by Subject|47
471395|NCT00218296|1541099|P1|Overall Study|Withdrawal by Subject|36
471396|NCT00218296|1541098|P2|Overall Study|Lost to Follow-up|7
471397|NCT00218296|1541099|P1|Overall Study|Lost to Follow-up|9
471398|NCT00217971|1541171|P2|Overall Study|non compliant|0
471399|NCT00217971|1541172|P1|Overall Study|non compliant|1
471400|NCT00217971|1541171|P2|Overall Study|Withdrawal by Subject|12
471401|NCT00217971|1541172|P1|Overall Study|Withdrawal by Subject|7
471402|NCT00217971|1541171|P2|Overall Study|Physician Decision|1
471403|NCT00217971|1541172|P1|Overall Study|Physician Decision|0
471404|NCT00217971|1541171|P2|Overall Study|Lost to Follow-up|19
471405|NCT00217971|1541172|P1|Overall Study|Lost to Follow-up|15
471406|NCT00217971|1541171|P2|Overall Study|Adverse Event|1
471407|NCT00217971|1541172|P1|Overall Study|Adverse Event|1
471408|NCT00217672|1541187|P2|Follow-up|Lost to Follow-up|0
471409|NCT00217672|1541188|P1|Follow-up|Lost to Follow-up|1
471410|NCT00217672|1541187|P2|Follow-up|Withdrawal by Subject|0
471411|NCT00217672|1541188|P1|Follow-up|Withdrawal by Subject|4
471412|NCT00217672|1541187|P2|Treatment|secondary malignancy|0
471413|NCT00217672|1541188|P1|Treatment|secondary malignancy|1
471414|NCT00217672|1541187|P2|Treatment|Death|0
471415|NCT00217672|1541188|P1|Treatment|Death|2
471416|NCT00217672|1541187|P2|Treatment|insurance issues|1
471417|NCT00217672|1541188|P1|Treatment|insurance issues|1
471418|NCT00217672|1541187|P2|Treatment|Physician Decision|0
471419|NCT00217672|1541188|P1|Treatment|Physician Decision|6
471420|NCT00217672|1541187|P2|Treatment|reqd treatment not permitted by protocol|0
471421|NCT00217672|1541188|P1|Treatment|reqd treatment not permitted by protocol|6
471422|NCT00217672|1541187|P2|Treatment|Adverse Event|2
471423|NCT00217672|1541188|P1|Treatment|Adverse Event|18
471424|NCT00217672|1541187|P2|Treatment|disease progression|4
471425|NCT00217672|1541188|P1|Treatment|disease progression|33
471426|NCT00217672|1541187|P2|Allocation|Ineligible|0
471427|NCT00217672|1541188|P1|Allocation|Ineligible|2
471428|NCT00217620|1541194|P1|Overall Study|Never received treatment|1
471429|NCT00217620|1541194|P1|Overall Study|Ineligible|13
471430|NCT00217620|1541194|P1|Overall Study|Not Protocol Specified|4
471431|NCT00217620|1541194|P1|Overall Study|Progression|31
471432|NCT00217620|1541194|P1|Overall Study|Adverse Event|2
471433|NCT00217581|1541205|P1|Overall Study|Withdrawal by Subject|1
471434|NCT00217464|1541234|P1|Overall Study|not specified|2
471435|NCT00217464|1541234|P1|Overall Study|Progression|15
471436|NCT00217425|1541250|P1|Overall Study|Other|4
471437|NCT00217425|1541250|P1|Overall Study|Other complicating disease|1
471438|NCT00217425|1541250|P1|Overall Study|Withdrawal by Subject|4
471439|NCT00217425|1541250|P1|Overall Study|Adverse Event|8
471440|NCT00217425|1541250|P1|Overall Study|Lack of Efficacy|13
471441|NCT00217425|1541250|P1|Overall Study|Patient ineligible|5
471442|NCT00217425|1541250|P1|Overall Study|Never started treatment|2
471443|NCT00217087|1541264|P2|Overall Study|completed less than 12 months return|18
471444|NCT00217087|1541265|P1|Overall Study|completed less than 12 months return|10
471445|NCT00217087|1541264|P2|Overall Study|decided to have esophagectomy|2
471446|NCT00217087|1541265|P1|Overall Study|decided to have esophagectomy|1
471447|NCT00217022|1541279|P2|Overall Study|Withdrawal by Subject|1
471448|NCT00217022|1541280|P1|Overall Study|Withdrawal by Subject|1
471449|NCT00216736|1541290|P2|Overall Study|Lost to Follow-up|1
471450|NCT00216736|1541291|P1|Overall Study|Lost to Follow-up|1
471451|NCT00216671|1541305|P2|Overall Study|Insufficient Response Adverse Event|1
471452|NCT00216671|1541306|P1|Overall Study|Insufficient Response Adverse Event|2
471453|NCT00216671|1541305|P2|Overall Study|Ineligible, no efficacy data|2
471454|NCT00216671|1541306|P1|Overall Study|Ineligible, no efficacy data|2
471455|NCT00216671|1541305|P2|Overall Study|Patient Moved|1
471456|NCT00216671|1541306|P1|Overall Study|Patient Moved|0
471457|NCT00216671|1541305|P2|Overall Study|Investigator Illness|1
471458|NCT00216671|1541306|P1|Overall Study|Investigator Illness|0
471459|NCT00216671|1541305|P2|Overall Study|Relapse|0
471460|NCT00216671|1541306|P1|Overall Study|Relapse|1
471461|NCT00216671|1541305|P2|Overall Study|Protocol Violation|5
471462|NCT00216671|1541306|P1|Overall Study|Protocol Violation|3
471463|NCT00216671|1541305|P2|Overall Study|Physician Decision|1
471464|NCT00216671|1541306|P1|Overall Study|Physician Decision|1
471465|NCT00216671|1541305|P2|Overall Study|Ineligible|2
471466|NCT00216671|1541306|P1|Overall Study|Ineligible|0
471467|NCT00216671|1541305|P2|Overall Study|Non compliant|2
471468|NCT00216671|1541306|P1|Overall Study|Non compliant|2
471469|NCT00216671|1541305|P2|Overall Study|Lost to Follow-up|5
471470|NCT00216671|1541306|P1|Overall Study|Lost to Follow-up|3
471471|NCT00216671|1541305|P2|Overall Study|Insufficient Response|4
471472|NCT00216671|1541306|P1|Overall Study|Insufficient Response|9
471473|NCT00216671|1541305|P2|Overall Study|No Need to Continue Medication|1
471474|NCT00216671|1541306|P1|Overall Study|No Need to Continue Medication|1
471475|NCT00216671|1541305|P2|Overall Study|Refused Injections|13
471476|NCT00216671|1541306|P1|Overall Study|Refused Injections|3
471477|NCT00216671|1541305|P2|Overall Study|Withdrawal by Subject|2
471478|NCT00216671|1541306|P1|Overall Study|Withdrawal by Subject|4
471479|NCT00216671|1541305|P2|Overall Study|Pregnancy|1
471480|NCT00216671|1541306|P1|Overall Study|Pregnancy|0
471481|NCT00216671|1541305|P2|Overall Study|Adverse Event|9
471482|NCT00216671|1541306|P1|Overall Study|Adverse Event|4
471483|NCT00216476|1541324|P3|Overall Study|Patient Moved|0
471484|NCT00216476|1541325|P2|Overall Study|Patient Moved|2
471485|NCT00216476|1541326|P1|Overall Study|Patient Moved|2
471486|NCT00216476|1541324|P3|Overall Study|Protocol Deviation|0
471487|NCT00216476|1541325|P2|Overall Study|Protocol Deviation|1
471488|NCT00216476|1541326|P1|Overall Study|Protocol Deviation|5
471489|NCT00216476|1541324|P3|Overall Study|Administrative Reasons|0
471490|NCT00216476|1541325|P2|Overall Study|Administrative Reasons|1
471491|NCT00216476|1541326|P1|Overall Study|Administrative Reasons|1
471492|NCT00216476|1541324|P3|Overall Study|Higher dose/Extra Medication Required|2
471493|NCT00216476|1541325|P2|Overall Study|Higher dose/Extra Medication Required|0
471494|NCT00216476|1541326|P1|Overall Study|Higher dose/Extra Medication Required|2
471495|NCT00216476|1541324|P3|Overall Study|Non-compliance|1
471496|NCT00216476|1541325|P2|Overall Study|Non-compliance|4
471497|NCT00216476|1541326|P1|Overall Study|Non-compliance|0
471498|NCT00216476|1541324|P3|Overall Study|No Further Need for Treatment|1
471499|NCT00216476|1541325|P2|Overall Study|No Further Need for Treatment|4
471500|NCT00216476|1541326|P1|Overall Study|No Further Need for Treatment|3
471501|NCT00216476|1541324|P3|Overall Study|Refuses Injection|0
471502|NCT00216476|1541325|P2|Overall Study|Refuses Injection|0
471503|NCT00216476|1541326|P1|Overall Study|Refuses Injection|11
471504|NCT00216476|1541324|P3|Overall Study|Other|1
471505|NCT00216476|1541325|P2|Overall Study|Other|0
471506|NCT00216476|1541326|P1|Overall Study|Other|0
471507|NCT00216476|1541324|P3|Overall Study|Pregnancy|1
471508|NCT00216476|1541325|P2|Overall Study|Pregnancy|1
471509|NCT00216476|1541326|P1|Overall Study|Pregnancy|0
471510|NCT00216476|1541324|P3|Overall Study|Death|0
471511|NCT00216476|1541325|P2|Overall Study|Death|0
471512|NCT00216476|1541326|P1|Overall Study|Death|2
471513|NCT00216476|1541324|P3|Overall Study|Lack of Efficacy|0
471514|NCT00216476|1541325|P2|Overall Study|Lack of Efficacy|3
471515|NCT00216476|1541326|P1|Overall Study|Lack of Efficacy|4
471516|NCT00216476|1541324|P3|Overall Study|Adverse Event|1
471517|NCT00216476|1541325|P2|Overall Study|Adverse Event|10
471518|NCT00216476|1541326|P1|Overall Study|Adverse Event|6
471519|NCT00216476|1541324|P3|Overall Study|Lost to Follow-up|1
471520|NCT00216476|1541325|P2|Overall Study|Lost to Follow-up|9
471521|NCT00216476|1541326|P1|Overall Study|Lost to Follow-up|10
471522|NCT00216476|1541324|P3|Overall Study|Withdrawal by Subject|9
471523|NCT00216476|1541325|P2|Overall Study|Withdrawal by Subject|72
471524|NCT00216476|1541326|P1|Overall Study|Withdrawal by Subject|59
471525|NCT00216203|1541363|P1|Overall Study|Withdrawal by Subject|2
471526|NCT00216086|1541393|P1|Overall Study|Social Reasons|2
471527|NCT00216086|1541393|P1|Overall Study|Diagnosis of Metastatic Disease|1
471528|NCT00216086|1541393|P1|Overall Study|Protocol Violation|1
471529|NCT00215943|1541425|P2|Overall Study|Other complications|1
471530|NCT00215943|1541426|P1|Overall Study|Other complications|3
471531|NCT00215943|1541425|P2|Overall Study|Other disease|1
471532|NCT00215943|1541426|P1|Overall Study|Other disease|0
471533|NCT00215943|1541425|P2|Overall Study|Adverse Event|6
471534|NCT00215943|1541426|P1|Overall Study|Adverse Event|3
471535|NCT00215943|1541425|P2|Overall Study|Alternate therapy|1
471536|NCT00215943|1541426|P1|Overall Study|Alternate therapy|0
471537|NCT00215943|1541425|P2|Overall Study|Disease Progression|5
471538|NCT00215943|1541426|P1|Overall Study|Disease Progression|3
471539|NCT00215683|1541451|P3|Overall Study|Intermittent therapy required|0
471540|NCT00215683|1541452|P2|Overall Study|Intermittent therapy required|1
471541|NCT00215683|1541453|P1|Overall Study|Intermittent therapy required|0
471542|NCT00215683|1541451|P3|Overall Study|No study drug available|0
471543|NCT00215683|1541452|P2|Overall Study|No study drug available|1
471544|NCT00215683|1541453|P1|Overall Study|No study drug available|0
471545|NCT00215683|1541451|P3|Overall Study|Difficult to attend visits|0
471546|NCT00215683|1541452|P2|Overall Study|Difficult to attend visits|1
471547|NCT00215683|1541453|P1|Overall Study|Difficult to attend visits|0
471548|NCT00215683|1541451|P3|Overall Study|Physician Decision|1
471549|NCT00215683|1541452|P2|Overall Study|Physician Decision|0
471550|NCT00215683|1541453|P1|Overall Study|Physician Decision|0
471551|NCT00215683|1541451|P3|Overall Study|Withdrawal by Subject|13
471552|NCT00215683|1541452|P2|Overall Study|Withdrawal by Subject|4
471553|NCT00215683|1541453|P1|Overall Study|Withdrawal by Subject|9
471554|NCT00215683|1541451|P3|Overall Study|Lost to Follow-up|1
471555|NCT00215683|1541452|P2|Overall Study|Lost to Follow-up|2
471556|NCT00215683|1541453|P1|Overall Study|Lost to Follow-up|0
471557|NCT00215683|1541451|P3|Overall Study|Lack of Efficacy|2
471558|NCT00215683|1541452|P2|Overall Study|Lack of Efficacy|1
471559|NCT00215683|1541453|P1|Overall Study|Lack of Efficacy|5
471560|NCT00215683|1541451|P3|Overall Study|Adverse Event|15
471561|NCT00215683|1541452|P2|Overall Study|Adverse Event|16
471562|NCT00215683|1541453|P1|Overall Study|Adverse Event|15
471563|NCT00215657|1541472|P8|Overall Study|Not specified|1
471564|NCT00215657|1541473|P7|Overall Study|Not specified|6
471565|NCT00215657|1541474|P6|Overall Study|Not specified|4
471566|NCT00215657|1541475|P5|Overall Study|Not specified|5
471567|NCT00215657|1541476|P4|Overall Study|Not specified|3
471568|NCT00215657|1541477|P3|Overall Study|Not specified|2
471569|NCT00215657|1541478|P2|Overall Study|Not specified|1
471570|NCT00215657|1541479|P1|Overall Study|Not specified|3
471571|NCT00215657|1541472|P8|Overall Study|Insufficient testosterone response|7
471572|NCT00215657|1541473|P7|Overall Study|Insufficient testosterone response|4
471573|NCT00215657|1541474|P6|Overall Study|Insufficient testosterone response|12
471574|NCT00215657|1541475|P5|Overall Study|Insufficient testosterone response|8
471575|NCT00215657|1541476|P4|Overall Study|Insufficient testosterone response|12
471576|NCT00215657|1541477|P3|Overall Study|Insufficient testosterone response|1
471577|NCT00215657|1541478|P2|Overall Study|Insufficient testosterone response|4
471578|NCT00215657|1541479|P1|Overall Study|Insufficient testosterone response|5
471579|NCT00215657|1541472|P8|Overall Study|Insuff prostate specific antigen resp|2
471580|NCT00215657|1541473|P7|Overall Study|Insuff prostate specific antigen resp|3
471581|NCT00215657|1541474|P6|Overall Study|Insuff prostate specific antigen resp|2
471582|NCT00215657|1541475|P5|Overall Study|Insuff prostate specific antigen resp|1
471583|NCT00215657|1541476|P4|Overall Study|Insuff prostate specific antigen resp|2
471584|NCT00215657|1541477|P3|Overall Study|Insuff prostate specific antigen resp|2
471585|NCT00215657|1541478|P2|Overall Study|Insuff prostate specific antigen resp|2
471586|NCT00215657|1541479|P1|Overall Study|Insuff prostate specific antigen resp|3
471587|NCT00215657|1541472|P8|Overall Study|Withdrawal by Subject|3
471588|NCT00215657|1541473|P7|Overall Study|Withdrawal by Subject|10
471589|NCT00215657|1541474|P6|Overall Study|Withdrawal by Subject|1
471590|NCT00215657|1541475|P5|Overall Study|Withdrawal by Subject|6
471591|NCT00215657|1541476|P4|Overall Study|Withdrawal by Subject|1
471592|NCT00215657|1541477|P3|Overall Study|Withdrawal by Subject|3
471593|NCT00215657|1541478|P2|Overall Study|Withdrawal by Subject|3
471594|NCT00215657|1541479|P1|Overall Study|Withdrawal by Subject|6
471595|NCT00215657|1541472|P8|Overall Study|Adverse Event|3
471596|NCT00215657|1541473|P7|Overall Study|Adverse Event|0
471597|NCT00215657|1541474|P6|Overall Study|Adverse Event|1
471598|NCT00215657|1541475|P5|Overall Study|Adverse Event|3
471599|NCT00215657|1541476|P4|Overall Study|Adverse Event|0
471600|NCT00215657|1541477|P3|Overall Study|Adverse Event|3
471601|NCT00215657|1541478|P2|Overall Study|Adverse Event|1
471602|NCT00215657|1541479|P1|Overall Study|Adverse Event|5
471603|NCT00215540|1541551|P3|Overall Study|Withdrew from study medication|0
471604|NCT00215540|1541552|P2|Overall Study|Withdrew from study medication|0
471605|NCT00215540|1541553|P1|Overall Study|Withdrew from study medication|1
471606|NCT00215150|1541588|P1|Randomization Phase Placebo|Withdrawal by Subject|1
471607|NCT00215150|1541588|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
471608|NCT00215150|1541588|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
471609|NCT00215150|1541588|P1|Open Label Phase|Did not meet randomization criteria|9
471610|NCT00215150|1541588|P1|Open Label Phase|Did not complete a post base visit|13
471611|NCT00215150|1541588|P1|Open Label Phase|Withdrawal by Subject|1
471612|NCT00215150|1541588|P1|Open Label Phase|Lost to Follow-up|7
471613|NCT00215137|1541596|P3|Randomization Period|Withdrawal by Subject|0
471614|NCT00215137|1541597|P2|Randomization Period|Withdrawal by Subject|1
471615|NCT00215137|1541598|P1|Randomization Period|Withdrawal by Subject|0
471616|NCT00215137|1541596|P3|Randomization Period|Lost to Follow-up|0
471617|NCT00215137|1541597|P2|Randomization Period|Lost to Follow-up|1
471618|NCT00215137|1541598|P1|Randomization Period|Lost to Follow-up|0
471619|NCT00215137|1541596|P3|Open Label Escitalopram|Lack of Efficacy|0
471620|NCT00215137|1541597|P2|Open Label Escitalopram|Lack of Efficacy|0
471621|NCT00215137|1541598|P1|Open Label Escitalopram|Lack of Efficacy|1
471622|NCT00214461|1541709|P4|Overall Study|Withdrawal by Subject|0
471623|NCT00214461|1541710|P3|Overall Study|Withdrawal by Subject|1
471624|NCT00214461|1541711|P2|Overall Study|Withdrawal by Subject|0
471625|NCT00214461|1541712|P1|Overall Study|Withdrawal by Subject|0
471626|NCT00214461|1541709|P4|Overall Study|Adverse Event|1
471627|NCT00214461|1541710|P3|Overall Study|Adverse Event|1
471628|NCT00214461|1541711|P2|Overall Study|Adverse Event|0
471629|NCT00214461|1541712|P1|Overall Study|Adverse Event|0
471630|NCT00214383|1541728|P2|Overall Study|Lost to Follow-up|26
471631|NCT00214383|1541729|P1|Overall Study|Lost to Follow-up|16
471632|NCT00214201|1541741|P2|Overall Study|Death|2
471633|NCT00214201|1541742|P1|Overall Study|Death|0
471634|NCT00214201|1541741|P2|Overall Study|Withdrawal by Subject|0
471635|NCT00214201|1541742|P1|Overall Study|Withdrawal by Subject|2
471636|NCT00214136|1541752|P1|Overall Study|Death|5
471637|NCT00214019|1541757|P1|Overall Study|Screen Failed prior to randomization|17
471638|NCT00214019|1541757|P1|Overall Study|Withdrawal by Subject|2
471639|NCT00214019|1541757|P1|Overall Study|Lost to Follow-up|11
471640|NCT00213980|1541766|P2|Overall Study|Failed to obtain all 3 DXAs|3
471641|NCT00213980|1541767|P1|Overall Study|Failed to obtain all 3 DXAs|1
471642|NCT00213980|1541766|P2|Overall Study|Developed ovarian cancer|0
471643|NCT00213980|1541767|P1|Overall Study|Developed ovarian cancer|1
471644|NCT00213980|1541766|P2|Overall Study|Disease progression|2
471645|NCT00213980|1541767|P1|Overall Study|Disease progression|0
471646|NCT00213980|1541766|P2|Overall Study|Adverse Event|1
471647|NCT00213980|1541767|P1|Overall Study|Adverse Event|1
471648|NCT00213980|1541766|P2|Overall Study|Withdrawal by Subject|1
471649|NCT00213980|1541767|P1|Overall Study|Withdrawal by Subject|3
471650|NCT00213135|1541782|P3|Overall Study|Other|15
471651|NCT00213135|1541783|P2|Overall Study|Other|12
471652|NCT00213135|1541784|P1|Overall Study|Other|21
471653|NCT00213135|1541782|P3|Overall Study|Disease progression|21
471654|NCT00213135|1541783|P2|Overall Study|Disease progression|5
471655|NCT00213135|1541784|P1|Overall Study|Disease progression|4
471656|NCT00213135|1541782|P3|Overall Study|Death|2
471657|NCT00213135|1541783|P2|Overall Study|Death|1
471658|NCT00213135|1541784|P1|Overall Study|Death|1
471659|NCT00213135|1541782|P3|Overall Study|Protocol Violation|10
471660|NCT00213135|1541783|P2|Overall Study|Protocol Violation|4
471661|NCT00213135|1541784|P1|Overall Study|Protocol Violation|4
471662|NCT00213135|1541782|P3|Overall Study|Lost to Follow-up|4
471663|NCT00213135|1541783|P2|Overall Study|Lost to Follow-up|8
471664|NCT00213135|1541784|P1|Overall Study|Lost to Follow-up|11
471665|NCT00213135|1541782|P3|Overall Study|Adverse Event|5
471666|NCT00213135|1541783|P2|Overall Study|Adverse Event|5
471667|NCT00213135|1541784|P1|Overall Study|Adverse Event|9
471668|NCT00212758|1541801|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
471669|NCT00212758|1541802|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
471670|NCT00212758|1541801|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
471671|NCT00212758|1541802|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
471672|NCT00212355|1541808|P1|Overall Study|A change of address|1
471673|NCT00212355|1541808|P1|Overall Study|Withdrawal by Subject|1
471674|NCT00212355|1541808|P1|Overall Study|Adverse Event|1
471675|NCT00212134|1541829|P2|Phase 3 (Age 10 Years)|On Going|21
471676|NCT00212134|1541830|P1|Phase 3 (Age 10 Years)|On Going|21
471677|NCT00211887|1541851|P3|Overall Study|Side effects|5
471678|NCT00211887|1541852|P2|Overall Study|Side effects|13
471679|NCT00211887|1541853|P1|Overall Study|Side effects|19
471680|NCT00211887|1541851|P3|Overall Study|Other medical reason|7
471681|NCT00211887|1541852|P2|Overall Study|Other medical reason|11
471682|NCT00211887|1541853|P1|Overall Study|Other medical reason|15
471683|NCT00211887|1541851|P3|Overall Study|Non-medical reason|8
471684|NCT00211887|1541852|P2|Overall Study|Non-medical reason|14
471685|NCT00211887|1541853|P1|Overall Study|Non-medical reason|31
471686|NCT00211887|1541851|P3|Overall Study|Lost to Follow-up|9
471687|NCT00211887|1541852|P2|Overall Study|Lost to Follow-up|13
471688|NCT00211887|1541853|P1|Overall Study|Lost to Follow-up|28
471689|NCT00211887|1541851|P3|Overall Study|Death|1
471690|NCT00211887|1541852|P2|Overall Study|Death|1
471691|NCT00211887|1541853|P1|Overall Study|Death|1
471692|NCT00211887|1541851|P3|Overall Study|Adverse Event|6
471693|NCT00211887|1541852|P2|Overall Study|Adverse Event|4
471694|NCT00211887|1541853|P1|Overall Study|Adverse Event|8
471695|NCT00211809|1541870|P1|Overall Study|side effects|2
471696|NCT00211809|1541870|P1|Overall Study|Pregnancy|1
471697|NCT00211809|1541870|P1|Overall Study|Lost to Follow-up|2
471698|NCT00211809|1541870|P1|Overall Study|Lack of Efficacy|1
471699|NCT00211536|1541897|P2|Overall Study|Adverse Event|0
471700|NCT00211536|1541898|P1|Overall Study|Adverse Event|2
471701|NCT00211536|1541897|P2|Overall Study|Physician Decision|5
471702|NCT00211536|1541898|P1|Overall Study|Physician Decision|0
471703|NCT00211536|1541897|P2|Overall Study|Withdrawal by Subject|2
471704|NCT00211536|1541898|P1|Overall Study|Withdrawal by Subject|2
471705|NCT00211510|1541914|P2|Overall Study|Withdrawal by Subject|1
471706|NCT00211510|1541915|P1|Overall Study|Withdrawal by Subject|3
471707|NCT00211510|1541914|P2|Overall Study|Physician Decision|1
471708|NCT00211510|1541915|P1|Overall Study|Physician Decision|3
471709|NCT00211237|1541933|P3|12 Months|unrelated medical problem|1
471710|NCT00211237|1541934|P2|12 Months|unrelated medical problem|0
471711|NCT00211237|1541935|P1|12 Months|unrelated medical problem|0
471712|NCT00211237|1541933|P3|12 Months|Withdrew|1
471713|NCT00211237|1541934|P2|12 Months|Withdrew|0
471714|NCT00211237|1541935|P1|12 Months|Withdrew|0
471715|NCT00211237|1541933|P3|12 Months|Lost to Follow-up|1
471716|NCT00211237|1541934|P2|12 Months|Lost to Follow-up|0
471717|NCT00211237|1541935|P1|12 Months|Lost to Follow-up|1
471718|NCT00211237|1541933|P3|12 Months|Death|3
471719|NCT00211237|1541934|P2|12 Months|Death|2
471720|NCT00211237|1541935|P1|12 Months|Death|8
471721|NCT00211237|1541933|P3|6 Months|Could not comply with protocol|0
471722|NCT00211237|1541934|P2|6 Months|Could not comply with protocol|2
471723|NCT00211237|1541935|P1|6 Months|Could not comply with protocol|0
471724|NCT00211237|1541933|P3|6 Months|Lost to Follow-up|0
471725|NCT00211237|1541934|P2|6 Months|Lost to Follow-up|0
471726|NCT00211237|1541935|P1|6 Months|Lost to Follow-up|2
471727|NCT00211237|1541933|P3|6 Months|Death|3
471728|NCT00211237|1541934|P2|6 Months|Death|0
471729|NCT00211237|1541935|P1|6 Months|Death|6
471730|NCT00211237|1541933|P3|3 Months|Non-medical problem|1
471731|NCT00211237|1541934|P2|3 Months|Non-medical problem|0
471732|NCT00211237|1541935|P1|3 Months|Non-medical problem|0
471733|NCT00211237|1541933|P3|3 Months|Withdrew|0
471734|NCT00211237|1541934|P2|3 Months|Withdrew|1
471735|NCT00211237|1541935|P1|3 Months|Withdrew|0
471736|NCT00211237|1541933|P3|3 Months|Could not comply with protocol|0
471737|NCT00211237|1541934|P2|3 Months|Could not comply with protocol|0
471738|NCT00211237|1541935|P1|3 Months|Could not comply with protocol|1
471739|NCT00211237|1541933|P3|3 Months|Death|0
471740|NCT00211237|1541934|P2|3 Months|Death|3
471741|NCT00211237|1541935|P1|3 Months|Death|7
471742|NCT00211237|1541933|P3|1 Month|Non-medical problem|0
471743|NCT00211237|1541934|P2|1 Month|Non-medical problem|2
471744|NCT00211237|1541935|P1|1 Month|Non-medical problem|0
471745|NCT00211237|1541933|P3|1 Month|Additional surgery needed|0
471746|NCT00211237|1541934|P2|1 Month|Additional surgery needed|0
471747|NCT00211237|1541935|P1|1 Month|Additional surgery needed|1
471748|NCT00211237|1541933|P3|1 Month|Withdrew|0
471749|NCT00211237|1541934|P2|1 Month|Withdrew|4
471750|NCT00211237|1541935|P1|1 Month|Withdrew|0
471751|NCT00211237|1541933|P3|1 Month|Lost to Follow-up|0
471752|NCT00211237|1541934|P2|1 Month|Lost to Follow-up|2
471753|NCT00211237|1541935|P1|1 Month|Lost to Follow-up|0
471754|NCT00211237|1541933|P3|1 Month|Death|0
471755|NCT00211237|1541934|P2|1 Month|Death|1
471756|NCT00211237|1541935|P1|1 Month|Death|2
471757|NCT00211237|1541933|P3|Baseline|Refused random assignment|0
471758|NCT00211237|1541934|P2|Baseline|Refused random assignment|0
471759|NCT00211237|1541935|P1|Baseline|Refused random assignment|1
471760|NCT00211237|1541933|P3|Baseline|Withdrew|0
471761|NCT00211237|1541934|P2|Baseline|Withdrew|3
471762|NCT00211237|1541935|P1|Baseline|Withdrew|1
471763|NCT00211172|1542027|P2|Overall Study|Died or lost health plan eligibility|32
471764|NCT00211172|1542028|P1|Overall Study|Died or lost health plan eligibility|39
471765|NCT00211081|1542034|P1|Overall Study|Withdrawal by Subject|2
471766|NCT00210639|1542046|P2|Overall Study|Not specified|12
471767|NCT00210639|1542047|P1|Overall Study|Not specified|18
471768|NCT00210639|1542046|P2|Overall Study|Withdrawal by Subject|1
471769|NCT00210639|1542047|P1|Overall Study|Withdrawal by Subject|8
471770|NCT00210639|1542046|P2|Overall Study|Lost to Follow-up|29
471771|NCT00210639|1542047|P1|Overall Study|Lost to Follow-up|37
471772|NCT00210626|1542055|P2|Overall Study|Not Specified|5
471773|NCT00210626|1542056|P1|Overall Study|Not Specified|4
471774|NCT00210626|1542055|P2|Overall Study|Sponser Request|0
471775|NCT00210626|1542056|P1|Overall Study|Sponser Request|1
471776|NCT00210626|1542055|P2|Overall Study|Physician Decision|2
471777|NCT00210626|1542056|P1|Overall Study|Physician Decision|0
471778|NCT00210626|1542055|P2|Overall Study|Withdrawal by Subject|20
471779|NCT00210626|1542056|P1|Overall Study|Withdrawal by Subject|29
471780|NCT00210626|1542055|P2|Overall Study|Death|0
471781|NCT00210626|1542056|P1|Overall Study|Death|1
471782|NCT00210626|1542055|P2|Overall Study|Lost to Follow-up|11
471783|NCT00210626|1542056|P1|Overall Study|Lost to Follow-up|11
471784|NCT00210626|1542055|P2|Overall Study|Protocol Violation|5
471785|NCT00210626|1542056|P1|Overall Study|Protocol Violation|1
471786|NCT00210626|1542055|P2|Overall Study|Adverse Event|2
471787|NCT00210626|1542056|P1|Overall Study|Adverse Event|1
471788|NCT00210470|1542064|P1|Overall Study|Subject did not continue to surgery|1
471789|NCT00209560|1542070|P2|Overall Study|Lack of Efficacy|0
471790|NCT00209560|1542071|P1|Overall Study|Lack of Efficacy|1
471791|NCT00209339|1542090|P1|At 5 Years Follow-up|Death|1
471792|NCT00209339|1542090|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
471793|NCT00209339|1542090|P1|At 5 Years Follow-up|Withdrawal by Subject|2
471794|NCT00209339|1542090|P1|At 4 Years Follow-up|Death|1
471795|NCT00209339|1542090|P1|At 4 Years Follow-up|Withdrawal by Subject|4
471796|NCT00209339|1542090|P1|At 3 Years Follow-up|Withdrawal by Subject|1
471797|NCT00209339|1542090|P1|At 24 Months Follow-up|Death|1
471798|NCT00209339|1542090|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
471799|NCT00209339|1542090|P1|At 24 Months Follow-up|Withdrawal by Subject|4
471800|NCT00209339|1542090|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
471801|NCT00209339|1542090|P1|At 12 Months Follow-up|Death|1
471802|NCT00209339|1542090|P1|At 12 Months Follow-up|Withdrawal by Subject|8
471803|NCT00209274|1542174|P2|Overall Study|Randomized not treated (RNT)|15
471804|NCT00209274|1542175|P1|Overall Study|Randomized not treated (RNT)|6
471805|NCT00209274|1542174|P2|Overall Study|Withdrawal by Subject|15
471806|NCT00209274|1542175|P1|Overall Study|Withdrawal by Subject|30
471807|NCT00209274|1542174|P2|Overall Study|Death|15
471808|NCT00209274|1542175|P1|Overall Study|Death|32
471809|NCT00209274|1542174|P2|Overall Study|Missed visit|2
471810|NCT00209274|1542175|P1|Overall Study|Missed visit|3
471811|NCT00209170|1542495|P2|Overall Study|Lack of Efficacy|1
471812|NCT00209170|1542496|P1|Overall Study|Lack of Efficacy|0
471813|NCT00209170|1542495|P2|Overall Study|Withdrawal by Subject|1
471814|NCT00209170|1542496|P1|Overall Study|Withdrawal by Subject|2
471815|NCT00209170|1542495|P2|Overall Study|Adverse Event|1
471816|NCT00209170|1542496|P1|Overall Study|Adverse Event|0
471817|NCT00209131|1542504|P2|Overall Study|Lack of personnel due to turnovers.|11
471818|NCT00209131|1542505|P1|Overall Study|Lack of personnel due to turnovers.|15
471819|NCT00209092|1542515|P2|Overall Study|Withdrawal by Subject|0
471820|NCT00209092|1542516|P1|Overall Study|Withdrawal by Subject|1
471821|NCT00209092|1542515|P2|Overall Study|Adverse Event|1
471822|NCT00209092|1542516|P1|Overall Study|Adverse Event|0
471823|NCT00209092|1542515|P2|Overall Study|Progression of disease|1
471824|NCT00209092|1542516|P1|Overall Study|Progression of disease|7
471825|NCT00209027|1542526|P2|Overall Study|study terminated|0
471826|NCT00209027|1542527|P1|Overall Study|study terminated|10
471827|NCT00208767|1542551|P2|Overall Study|Lost to Follow-up|3
471828|NCT00208767|1542552|P1|Overall Study|Lost to Follow-up|3
471829|NCT00208767|1542551|P2|Overall Study|Death|0
471830|NCT00208767|1542552|P1|Overall Study|Death|1
471831|NCT00208767|1542551|P2|Overall Study|Withdrawal by Subject|3
471832|NCT00208767|1542552|P1|Overall Study|Withdrawal by Subject|14
471833|NCT00208767|1542551|P2|Overall Study|Adverse Event|1
471834|NCT00208767|1542552|P1|Overall Study|Adverse Event|9
471835|NCT00208325|1542580|P4|Overall Study|Mis-Randomized|0
471836|NCT00208325|1542581|P3|Overall Study|Mis-Randomized|0
471837|NCT00208325|1542582|P2|Overall Study|Mis-Randomized|20
471838|NCT00208325|1542583|P1|Overall Study|Mis-Randomized|17
471839|NCT00208325|1542580|P4|Overall Study|Other|0
471840|NCT00208325|1542581|P3|Overall Study|Other|1
471841|NCT00208325|1542582|P2|Overall Study|Other|1
471842|NCT00208325|1542583|P1|Overall Study|Other|2
471843|NCT00208325|1542580|P4|Overall Study|Does not wish to Continue in Study|2
471844|NCT00208325|1542581|P3|Overall Study|Does not wish to Continue in Study|3
471845|NCT00208325|1542582|P2|Overall Study|Does not wish to Continue in Study|8
471846|NCT00208325|1542583|P1|Overall Study|Does not wish to Continue in Study|5
471847|NCT00208325|1542580|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
471848|NCT00208325|1542581|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
471849|NCT00208325|1542582|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
471850|NCT00208325|1542583|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
471851|NCT00208325|1542580|P4|Overall Study|Lost to Follow-up|0
471852|NCT00208325|1542581|P3|Overall Study|Lost to Follow-up|2
471853|NCT00208325|1542582|P2|Overall Study|Lost to Follow-up|0
471854|NCT00208325|1542583|P1|Overall Study|Lost to Follow-up|1
471855|NCT00208325|1542580|P4|Overall Study|Revision|4
471856|NCT00208325|1542581|P3|Overall Study|Revision|0
471857|NCT00208325|1542582|P2|Overall Study|Revision|1
471858|NCT00208325|1542583|P1|Overall Study|Revision|4
471859|NCT00208325|1542580|P4|Overall Study|Withdrawal by Subject|0
471860|NCT00208325|1542581|P3|Overall Study|Withdrawal by Subject|0
471861|NCT00208325|1542582|P2|Overall Study|Withdrawal by Subject|1
471862|NCT00208325|1542583|P1|Overall Study|Withdrawal by Subject|0
471863|NCT00208325|1542580|P4|Overall Study|Death|5
471864|NCT00208325|1542581|P3|Overall Study|Death|7
471865|NCT00208325|1542582|P2|Overall Study|Death|19
471866|NCT00208325|1542583|P1|Overall Study|Death|18
471867|NCT00207740|1542718|P4|Overall Study|Not Specified|5
471868|NCT00207740|1542719|P3|Overall Study|Not Specified|7
471869|NCT00207740|1542720|P2|Overall Study|Not Specified|10
471870|NCT00207740|1542721|P1|Overall Study|Not Specified|2
471871|NCT00207740|1542718|P4|Overall Study|Sponsor Directive|21
471872|NCT00207740|1542719|P3|Overall Study|Sponsor Directive|16
471873|NCT00207740|1542720|P2|Overall Study|Sponsor Directive|15
471874|NCT00207740|1542721|P1|Overall Study|Sponsor Directive|22
471875|NCT00207740|1542718|P4|Overall Study|Death|1
471876|NCT00207740|1542719|P3|Overall Study|Death|0
471877|NCT00207740|1542720|P2|Overall Study|Death|0
471878|NCT00207740|1542721|P1|Overall Study|Death|0
471879|NCT00207740|1542718|P4|Overall Study|Lost to Follow-up|1
471880|NCT00207740|1542719|P3|Overall Study|Lost to Follow-up|1
471881|NCT00207740|1542720|P2|Overall Study|Lost to Follow-up|2
471882|NCT00207740|1542721|P1|Overall Study|Lost to Follow-up|0
471883|NCT00207740|1542718|P4|Overall Study|Unsatisfactory therapeutic effect|4
471884|NCT00207740|1542719|P3|Overall Study|Unsatisfactory therapeutic effect|2
471885|NCT00207740|1542720|P2|Overall Study|Unsatisfactory therapeutic effect|0
471886|NCT00207740|1542721|P1|Overall Study|Unsatisfactory therapeutic effect|1
471887|NCT00207740|1542718|P4|Overall Study|Adverse Event|11
471888|NCT00207740|1542719|P3|Overall Study|Adverse Event|14
471889|NCT00207740|1542720|P2|Overall Study|Adverse Event|14
471890|NCT00207740|1542721|P1|Overall Study|Adverse Event|4
471891|NCT00207727|1542767|P5|Overall Study|Not specified|33
471892|NCT00207727|1542768|P4|Overall Study|Not specified|37
471893|NCT00207727|1542769|P3|Overall Study|Not specified|41
471894|NCT00207727|1542770|P2|Overall Study|Not specified|41
471895|NCT00207727|1542771|P1|Overall Study|Not specified|38
471896|NCT00207727|1542767|P5|Overall Study|Lost to Follow-up|0
471897|NCT00207727|1542768|P4|Overall Study|Lost to Follow-up|0
471898|NCT00207727|1542769|P3|Overall Study|Lost to Follow-up|0
471899|NCT00207727|1542770|P2|Overall Study|Lost to Follow-up|1
471900|NCT00207727|1542771|P1|Overall Study|Lost to Follow-up|0
471901|NCT00207727|1542767|P5|Overall Study|Withdrawal by Subject|1
471902|NCT00207727|1542768|P4|Overall Study|Withdrawal by Subject|0
471903|NCT00207727|1542769|P3|Overall Study|Withdrawal by Subject|0
471904|NCT00207727|1542770|P2|Overall Study|Withdrawal by Subject|0
471905|NCT00207727|1542771|P1|Overall Study|Withdrawal by Subject|0
471906|NCT00207714|1542798|P5|Overall Study|Other|0
471907|NCT00207714|1542799|P4|Overall Study|Other|1
471908|NCT00207714|1542800|P3|Overall Study|Other|5
471909|NCT00207714|1542801|P2|Overall Study|Other|2
471910|NCT00207714|1542802|P1|Overall Study|Other|3
471911|NCT00207714|1542798|P5|Overall Study|Unsatisfactory therapeutic effect|4
471912|NCT00207714|1542799|P4|Overall Study|Unsatisfactory therapeutic effect|4
471913|NCT00207714|1542800|P3|Overall Study|Unsatisfactory therapeutic effect|1
471914|NCT00207714|1542801|P2|Overall Study|Unsatisfactory therapeutic effect|3
471915|NCT00207714|1542802|P1|Overall Study|Unsatisfactory therapeutic effect|5
471916|NCT00207714|1542798|P5|Overall Study|Adverse Event|1
471917|NCT00207714|1542799|P4|Overall Study|Adverse Event|3
471918|NCT00207714|1542800|P3|Overall Study|Adverse Event|4
471919|NCT00207714|1542801|P2|Overall Study|Adverse Event|2
471920|NCT00207714|1542802|P1|Overall Study|Adverse Event|6
471921|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
471922|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
471923|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
471924|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
471925|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Death|1
471926|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Death|0
471927|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Death|0
471928|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Death|0
471929|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
471930|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
471931|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
471932|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
471933|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
471934|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
471935|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
471936|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
471937|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
471938|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
471939|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
471940|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
471941|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
471942|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
471943|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
471944|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
471945|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
471946|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
471947|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
471948|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
471949|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
471950|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
471951|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
471952|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
471953|NCT00207142|1542824|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
471954|NCT00207142|1542825|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
471955|NCT00207142|1542826|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
471956|NCT00207142|1542827|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
471957|NCT00207142|1542824|P4|Induction Phase|Missing lab data|0
471958|NCT00207142|1542825|P3|Induction Phase|Missing lab data|0
471959|NCT00207142|1542826|P2|Induction Phase|Missing lab data|0
471960|NCT00207142|1542827|P1|Induction Phase|Missing lab data|1
471961|NCT00207142|1542824|P4|Induction Phase|Incarceration|0
471962|NCT00207142|1542825|P3|Induction Phase|Incarceration|0
471963|NCT00207142|1542826|P2|Induction Phase|Incarceration|0
471964|NCT00207142|1542827|P1|Induction Phase|Incarceration|1
471965|NCT00207142|1542824|P4|Induction Phase|Withdrawal by Subject|0
471966|NCT00207142|1542825|P3|Induction Phase|Withdrawal by Subject|0
471967|NCT00207142|1542826|P2|Induction Phase|Withdrawal by Subject|0
471968|NCT00207142|1542827|P1|Induction Phase|Withdrawal by Subject|4
471969|NCT00207142|1542824|P4|Induction Phase|Subject no longer meets study criteria|0
471970|NCT00207142|1542825|P3|Induction Phase|Subject no longer meets study criteria|0
471971|NCT00207142|1542826|P2|Induction Phase|Subject no longer meets study criteria|0
471972|NCT00207142|1542827|P1|Induction Phase|Subject no longer meets study criteria|3
471973|NCT00207142|1542824|P4|Induction Phase|Pregnancy|0
471974|NCT00207142|1542825|P3|Induction Phase|Pregnancy|0
471975|NCT00207142|1542826|P2|Induction Phase|Pregnancy|0
471976|NCT00207142|1542827|P1|Induction Phase|Pregnancy|1
471977|NCT00207142|1542824|P4|Induction Phase|Poor/noncompliance|0
471978|NCT00207142|1542825|P3|Induction Phase|Poor/noncompliance|0
471979|NCT00207142|1542826|P2|Induction Phase|Poor/noncompliance|0
471980|NCT00207142|1542827|P1|Induction Phase|Poor/noncompliance|2
471981|NCT00207142|1542824|P4|Induction Phase|Physician Decision|0
471982|NCT00207142|1542825|P3|Induction Phase|Physician Decision|0
471983|NCT00207142|1542826|P2|Induction Phase|Physician Decision|0
471984|NCT00207142|1542827|P1|Induction Phase|Physician Decision|2
471985|NCT00207142|1542824|P4|Induction Phase|Lost to Follow-up|0
471986|NCT00207142|1542825|P3|Induction Phase|Lost to Follow-up|0
471987|NCT00207142|1542826|P2|Induction Phase|Lost to Follow-up|0
471988|NCT00207142|1542827|P1|Induction Phase|Lost to Follow-up|5
471989|NCT00207142|1542824|P4|Induction Phase|Lack of Efficacy|0
471990|NCT00207142|1542825|P3|Induction Phase|Lack of Efficacy|0
471991|NCT00207142|1542826|P2|Induction Phase|Lack of Efficacy|0
471992|NCT00207142|1542827|P1|Induction Phase|Lack of Efficacy|1
471993|NCT00207142|1542824|P4|Induction Phase|Death|0
471994|NCT00207142|1542825|P3|Induction Phase|Death|0
471995|NCT00207142|1542826|P2|Induction Phase|Death|0
471996|NCT00207142|1542827|P1|Induction Phase|Death|1
471997|NCT00207142|1542824|P4|Induction Phase|Adverse Event|0
471998|NCT00207142|1542825|P3|Induction Phase|Adverse Event|0
471999|NCT00207142|1542826|P2|Induction Phase|Adverse Event|0
472000|NCT00207142|1542827|P1|Induction Phase|Adverse Event|9
472001|NCT00207090|1542864|P1|Overall Study|Physician Decision|1
472002|NCT00207090|1542864|P1|Overall Study|Disease progression/relapse|2
472003|NCT00207090|1542864|P1|Overall Study|Chest wall mass larger|1
472004|NCT00207090|1542864|P1|Overall Study|Study drug toxicity|3
472005|NCT00206726|1542893|P1|Overall Study|Withdrawal by Subject|8
472006|NCT00206726|1542893|P1|Overall Study|Protocol Violation|1
472007|NCT00206726|1542893|P1|Overall Study|Death|4
472008|NCT00206726|1542893|P1|Overall Study|Adverse Event|17
472009|NCT00206726|1542893|P1|Overall Study|Bone marrow transplant|1
472010|NCT00206726|1542893|P1|Overall Study|Placed on new protocol|1
472011|NCT00206726|1542893|P1|Overall Study|Progressive disease or relapsed disease|18
472012|NCT00206726|1542893|P1|Overall Study|Delayed recovery of blood counts|1
472013|NCT00206518|1542904|P2|Overall Study|Protocol Violation|1
472014|NCT00206518|1542905|P1|Overall Study|Protocol Violation|1
472015|NCT00206518|1542904|P2|Overall Study|Physician Decision|0
472016|NCT00206518|1542905|P1|Overall Study|Physician Decision|1
472017|NCT00206518|1542904|P2|Overall Study|Adverse Event|1
472018|NCT00206518|1542905|P1|Overall Study|Adverse Event|2
472019|NCT00206518|1542904|P2|Overall Study|Lack of Efficacy|4
472020|NCT00206518|1542905|P1|Overall Study|Lack of Efficacy|6
472021|NCT00206440|1542917|P2|Overall Study|Adverse Event|2
472022|NCT00206440|1542918|P1|Overall Study|Adverse Event|4
472023|NCT00206440|1542917|P2|Overall Study|Protocol Violation|2
472024|NCT00206440|1542918|P1|Overall Study|Protocol Violation|1
472025|NCT00206427|1542924|P1|Overall Study|Adverse Event|2
472026|NCT00206323|1542934|P2|Overall Study|Lost to Follow-up|1
472027|NCT00206323|1542935|P1|Overall Study|Lost to Follow-up|1
472028|NCT00206323|1542934|P2|Overall Study|Adverse Event|1
472029|NCT00206323|1542935|P1|Overall Study|Adverse Event|1
472030|NCT00206323|1542934|P2|Overall Study|Lack of Efficacy|1
472031|NCT00206323|1542935|P1|Overall Study|Lack of Efficacy|4
472032|NCT00206102|1542943|P2|Overall Study|None of those categories|36
472033|NCT00206102|1542944|P1|Overall Study|None of those categories|42
472034|NCT00206102|1542943|P2|Overall Study|Study-specific discontinuation criteria|17
472035|NCT00206102|1542944|P1|Overall Study|Study-specific discontinuation criteria|18
472036|NCT00206102|1542943|P2|Overall Study|Withdrawal by Subject|101
472037|NCT00206102|1542944|P1|Overall Study|Withdrawal by Subject|118
472038|NCT00206102|1542943|P2|Overall Study|Lost to Follow-up|66
472039|NCT00206102|1542944|P1|Overall Study|Lost to Follow-up|95
472040|NCT00206102|1542943|P2|Overall Study|Lack of therapeutic response|11
472041|NCT00206102|1542944|P1|Overall Study|Lack of therapeutic response|16
472042|NCT00206102|1542943|P2|Overall Study|Protocol Violation|2
472043|NCT00206102|1542944|P1|Overall Study|Protocol Violation|0
472044|NCT00206102|1542943|P2|Overall Study|Adverse Event|82
472045|NCT00206102|1542944|P1|Overall Study|Adverse Event|119
472046|NCT00206076|1542980|P2|Overall Study|Withdrawal by Subject|1
472047|NCT00206076|1542981|P1|Overall Study|Withdrawal by Subject|1
472048|NCT00206076|1542980|P2|Overall Study|Physician Decision|0
472049|NCT00206076|1542981|P1|Overall Study|Physician Decision|2
472050|NCT00205881|1542991|P1|Overall Study|Withdrawal by Subject|16
472051|NCT00205855|1542996|P1|Overall Study|Withdrawal by Subject|5
472052|NCT00205855|1542996|P1|Overall Study|Only received temporary implants|16
472053|NCT00205803|1543002|P2|Toddler Dose|Lost to Follow-up|3
472054|NCT00205803|1543003|P1|Toddler Dose|Lost to Follow-up|2
472055|NCT00205803|1543002|P2|After Infant Series|Other|4
472056|NCT00205803|1543003|P1|After Infant Series|Other|10
472057|NCT00205803|1543002|P2|After Infant Series|Withdrawal by Subject|4
472058|NCT00205803|1543003|P1|After Infant Series|Withdrawal by Subject|1
472059|NCT00205803|1543002|P2|After Infant Series|Physician Decision|2
472060|NCT00205803|1543003|P1|After Infant Series|Physician Decision|3
472061|NCT00205803|1543002|P2|After Infant Series|Lost to Follow-up|1
472062|NCT00205803|1543003|P1|After Infant Series|Lost to Follow-up|2
472063|NCT00205803|1543002|P2|After Infant Series|Protocol Violation|1
472064|NCT00205803|1543003|P1|After Infant Series|Protocol Violation|1
472065|NCT00205803|1543002|P2|After Infant Series|Adverse Event|1
472066|NCT00205803|1543003|P1|After Infant Series|Adverse Event|1
472067|NCT00205803|1543002|P2|Infant Series|Sponsor request|0
472068|NCT00205803|1543003|P1|Infant Series|Sponsor request|1
472069|NCT00205803|1543002|P2|Infant Series|Non-compliant|0
472070|NCT00205803|1543003|P1|Infant Series|Non-compliant|1
472071|NCT00205803|1543002|P2|Infant Series|Lost Kaiser coverage|1
472072|NCT00205803|1543003|P1|Infant Series|Lost Kaiser coverage|0
472073|NCT00205803|1543002|P2|Infant Series|Protocol Violation|0
472074|NCT00205803|1543003|P1|Infant Series|Protocol Violation|1
472075|NCT00205803|1543002|P2|Infant Series|Physician Decision|1
472076|NCT00205803|1543003|P1|Infant Series|Physician Decision|3
472077|NCT00205803|1543002|P2|Infant Series|Withdrawal by Subject|5
472078|NCT00205803|1543003|P1|Infant Series|Withdrawal by Subject|2
472079|NCT00205803|1543002|P2|Infant Series|Lost to Follow-up|4
472080|NCT00205803|1543003|P1|Infant Series|Lost to Follow-up|10
472081|NCT00205777|1543059|P6|Study Extension II|Enrolled but not treated|131
472082|NCT00205777|1543060|P5|Study Extension II|Enrolled but not treated|0
472083|NCT00205777|1543061|P4|Study Extension II|Enrolled but not treated|71
472084|NCT00205777|1543062|P3|Study Extension II|Enrolled but not treated|0
472085|NCT00205777|1543063|P2|Study Extension II|Enrolled but not treated|0
472086|NCT00205777|1543064|P1|Study Extension II|Enrolled but not treated|0
472087|NCT00205777|1543059|P6|Study Extension II|Other Event|20
472088|NCT00205777|1543060|P5|Study Extension II|Other Event|0
472089|NCT00205777|1543061|P4|Study Extension II|Other Event|12
472090|NCT00205777|1543062|P3|Study Extension II|Other Event|0
472091|NCT00205777|1543063|P2|Study Extension II|Other Event|0
472092|NCT00205777|1543064|P1|Study Extension II|Other Event|0
472093|NCT00205777|1543059|P6|Study Extension II|Failed to return|26
472094|NCT00205777|1543060|P5|Study Extension II|Failed to return|0
472095|NCT00205777|1543061|P4|Study Extension II|Failed to return|14
472096|NCT00205777|1543062|P3|Study Extension II|Failed to return|0
472097|NCT00205777|1543063|P2|Study Extension II|Failed to return|0
472098|NCT00205777|1543064|P1|Study Extension II|Failed to return|0
472099|NCT00205777|1543059|P6|Study Extension II|Lack of Efficacy|1
472100|NCT00205777|1543060|P5|Study Extension II|Lack of Efficacy|0
472101|NCT00205777|1543061|P4|Study Extension II|Lack of Efficacy|0
472102|NCT00205777|1543062|P3|Study Extension II|Lack of Efficacy|0
472103|NCT00205777|1543063|P2|Study Extension II|Lack of Efficacy|0
472104|NCT00205777|1543064|P1|Study Extension II|Lack of Efficacy|0
472105|NCT00205777|1543059|P6|Study Extension II|Protocol Violation|10
472106|NCT00205777|1543060|P5|Study Extension II|Protocol Violation|0
472107|NCT00205777|1543061|P4|Study Extension II|Protocol Violation|1
472108|NCT00205777|1543062|P3|Study Extension II|Protocol Violation|0
472109|NCT00205777|1543063|P2|Study Extension II|Protocol Violation|0
472110|NCT00205777|1543064|P1|Study Extension II|Protocol Violation|0
472111|NCT00205777|1543059|P6|Study Extension II|Withdrawal by Subject|59
472112|NCT00205777|1543060|P5|Study Extension II|Withdrawal by Subject|0
472113|NCT00205777|1543061|P4|Study Extension II|Withdrawal by Subject|35
472114|NCT00205777|1543062|P3|Study Extension II|Withdrawal by Subject|0
472115|NCT00205777|1543063|P2|Study Extension II|Withdrawal by Subject|0
472116|NCT00205777|1543064|P1|Study Extension II|Withdrawal by Subject|0
472117|NCT00205777|1543059|P6|Study Extension II|Death|5
472118|NCT00205777|1543060|P5|Study Extension II|Death|0
472119|NCT00205777|1543061|P4|Study Extension II|Death|2
472120|NCT00205777|1543062|P3|Study Extension II|Death|0
472121|NCT00205777|1543063|P2|Study Extension II|Death|0
472122|NCT00205777|1543064|P1|Study Extension II|Death|0
472123|NCT00205777|1543059|P6|Study Extension II|Adverse Event|30
472124|NCT00205777|1543060|P5|Study Extension II|Adverse Event|0
472125|NCT00205777|1543061|P4|Study Extension II|Adverse Event|14
472126|NCT00205777|1543062|P3|Study Extension II|Adverse Event|0
472127|NCT00205777|1543063|P2|Study Extension II|Adverse Event|0
472128|NCT00205777|1543064|P1|Study Extension II|Adverse Event|0
472129|NCT00205777|1543059|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
472130|NCT00205777|1543060|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
472131|NCT00205777|1543061|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
472132|NCT00205777|1543062|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
472133|NCT00205777|1543063|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
472134|NCT00205777|1543064|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
472135|NCT00205777|1543059|P6|Study Extension I|Withdrawn as per protocol|0
472136|NCT00205777|1543060|P5|Study Extension I|Withdrawn as per protocol|0
472137|NCT00205777|1543061|P4|Study Extension I|Withdrawn as per protocol|0
472138|NCT00205777|1543062|P3|Study Extension I|Withdrawn as per protocol|1070
472139|NCT00205777|1543063|P2|Study Extension I|Withdrawn as per protocol|0
472140|NCT00205777|1543064|P1|Study Extension I|Withdrawn as per protocol|0
472141|NCT00205777|1543059|P6|Study Extension I|Other Event|0
472142|NCT00205777|1543060|P5|Study Extension I|Other Event|29
472143|NCT00205777|1543061|P4|Study Extension I|Other Event|34
472144|NCT00205777|1543062|P3|Study Extension I|Other Event|0
472145|NCT00205777|1543063|P2|Study Extension I|Other Event|0
472146|NCT00205777|1543064|P1|Study Extension I|Other Event|34
472147|NCT00205777|1543059|P6|Study Extension I|Failed to return|0
472148|NCT00205777|1543060|P5|Study Extension I|Failed to return|13
472149|NCT00205777|1543061|P4|Study Extension I|Failed to return|17
472150|NCT00205777|1543062|P3|Study Extension I|Failed to return|0
472151|NCT00205777|1543063|P2|Study Extension I|Failed to return|0
472152|NCT00205777|1543064|P1|Study Extension I|Failed to return|15
472153|NCT00205777|1543059|P6|Study Extension I|Lack of Efficacy|0
472154|NCT00205777|1543060|P5|Study Extension I|Lack of Efficacy|2
472155|NCT00205777|1543061|P4|Study Extension I|Lack of Efficacy|1
472156|NCT00205777|1543062|P3|Study Extension I|Lack of Efficacy|0
472157|NCT00205777|1543063|P2|Study Extension I|Lack of Efficacy|0
472158|NCT00205777|1543064|P1|Study Extension I|Lack of Efficacy|0
472159|NCT00205777|1543059|P6|Study Extension I|Protocol Violation|0
472160|NCT00205777|1543060|P5|Study Extension I|Protocol Violation|8
472161|NCT00205777|1543061|P4|Study Extension I|Protocol Violation|8
472162|NCT00205777|1543062|P3|Study Extension I|Protocol Violation|0
472163|NCT00205777|1543063|P2|Study Extension I|Protocol Violation|0
472164|NCT00205777|1543064|P1|Study Extension I|Protocol Violation|4
472165|NCT00205777|1543059|P6|Study Extension I|Withdrawal by Subject|0
472166|NCT00205777|1543060|P5|Study Extension I|Withdrawal by Subject|89
472167|NCT00205777|1543061|P4|Study Extension I|Withdrawal by Subject|106
472168|NCT00205777|1543062|P3|Study Extension I|Withdrawal by Subject|0
472169|NCT00205777|1543063|P2|Study Extension I|Withdrawal by Subject|0
472170|NCT00205777|1543064|P1|Study Extension I|Withdrawal by Subject|99
472171|NCT00205777|1543059|P6|Study Extension I|Death|0
472172|NCT00205777|1543060|P5|Study Extension I|Death|2
472173|NCT00205777|1543061|P4|Study Extension I|Death|1
472174|NCT00205777|1543062|P3|Study Extension I|Death|0
472175|NCT00205777|1543063|P2|Study Extension I|Death|0
472176|NCT00205777|1543064|P1|Study Extension I|Death|5
472177|NCT00205777|1543059|P6|Study Extension I|Adverse Event|0
472178|NCT00205777|1543060|P5|Study Extension I|Adverse Event|58
472179|NCT00205777|1543061|P4|Study Extension I|Adverse Event|61
472180|NCT00205777|1543062|P3|Study Extension I|Adverse Event|0
472181|NCT00205777|1543063|P2|Study Extension I|Adverse Event|0
472182|NCT00205777|1543064|P1|Study Extension I|Adverse Event|57
472183|NCT00205777|1543059|P6|Completed Core Study, Entered SE I|Other Event|0
472184|NCT00205777|1543060|P5|Completed Core Study, Entered SE I|Other Event|0
472185|NCT00205777|1543061|P4|Completed Core Study, Entered SE I|Other Event|50
472186|NCT00205777|1543062|P3|Completed Core Study, Entered SE I|Other Event|47
472187|NCT00205777|1543063|P2|Completed Core Study, Entered SE I|Other Event|46
472188|NCT00205777|1543064|P1|Completed Core Study, Entered SE I|Other Event|52
472189|NCT00205777|1543059|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
472190|NCT00205777|1543060|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
472191|NCT00205777|1543061|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
472192|NCT00205777|1543062|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
472193|NCT00205777|1543063|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
472194|NCT00205777|1543064|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
472195|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
472196|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
472197|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
472198|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
472199|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
472200|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
472201|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
472202|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
472203|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
472204|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
472205|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
472206|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
472207|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Protocol Violation|0
472208|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Protocol Violation|0
472209|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Protocol Violation|42
472210|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Protocol Violation|50
472211|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Protocol Violation|55
472212|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Protocol Violation|53
472213|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
472214|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
472215|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
472216|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
472217|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
472218|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
472219|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Other Event|0
472220|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Other Event|0
472221|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Other Event|58
472222|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Other Event|41
472223|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Other Event|52
472224|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Other Event|49
472225|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Failed to return|0
472226|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Failed to return|0
472227|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Failed to return|27
472228|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Failed to return|27
472229|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Failed to return|25
472230|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Failed to return|40
472231|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Death|0
472232|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Death|0
472233|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Death|7
472234|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Death|14
472235|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Death|7
472236|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Death|9
472237|NCT00205777|1543059|P6|Core Study (Up to 3 Years)|Adverse Event|0
472238|NCT00205777|1543060|P5|Core Study (Up to 3 Years)|Adverse Event|0
472239|NCT00205777|1543061|P4|Core Study (Up to 3 Years)|Adverse Event|232
472240|NCT00205777|1543062|P3|Core Study (Up to 3 Years)|Adverse Event|252
472241|NCT00205777|1543063|P2|Core Study (Up to 3 Years)|Adverse Event|267
472242|NCT00205777|1543064|P1|Core Study (Up to 3 Years)|Adverse Event|260
472243|NCT00205712|1543273|P2|Overall Study|Lost to Follow-up|1
472244|NCT00205712|1543274|P1|Overall Study|Lost to Follow-up|0
472245|NCT00205699|1543287|P3|Overall Study|Lack of Efficacy|0
472246|NCT00205699|1543288|P2|Overall Study|Lack of Efficacy|1
472247|NCT00205699|1543289|P1|Overall Study|Lack of Efficacy|0
472248|NCT00205699|1543287|P3|Overall Study|Withdrawal by Subject|1
472249|NCT00205699|1543288|P2|Overall Study|Withdrawal by Subject|2
472250|NCT00205699|1543289|P1|Overall Study|Withdrawal by Subject|1
472251|NCT00205699|1543287|P3|Overall Study|Adverse Event|0
472252|NCT00205699|1543288|P2|Overall Study|Adverse Event|0
472253|NCT00205699|1543289|P1|Overall Study|Adverse Event|1
472254|NCT00205699|1543287|P3|Overall Study|Lost to Follow-up|5
472255|NCT00205699|1543288|P2|Overall Study|Lost to Follow-up|3
472256|NCT00205699|1543289|P1|Overall Study|Lost to Follow-up|1
472257|NCT00203996|1543383|P10|Overall Study|Scheduling issue|0
472258|NCT00203996|1543384|P9|Overall Study|Scheduling issue|0
472259|NCT00203996|1543385|P8|Overall Study|Scheduling issue|2
472260|NCT00203996|1543386|P7|Overall Study|Scheduling issue|0
472261|NCT00203996|1543387|P6|Overall Study|Scheduling issue|0
472262|NCT00203996|1543388|P5|Overall Study|Scheduling issue|0
472263|NCT00203996|1543389|P4|Overall Study|Scheduling issue|0
472264|NCT00203996|1543390|P3|Overall Study|Scheduling issue|0
472265|NCT00203996|1543391|P2|Overall Study|Scheduling issue|0
472266|NCT00203996|1543392|P1|Overall Study|Scheduling issue|0
472267|NCT00203996|1543383|P10|Overall Study|CPAP machine malfunction|0
472268|NCT00203996|1543384|P9|Overall Study|CPAP machine malfunction|0
472269|NCT00203996|1543385|P8|Overall Study|CPAP machine malfunction|0
472270|NCT00203996|1543386|P7|Overall Study|CPAP machine malfunction|0
472271|NCT00203996|1543387|P6|Overall Study|CPAP machine malfunction|0
472272|NCT00203996|1543388|P5|Overall Study|CPAP machine malfunction|0
472273|NCT00203996|1543389|P4|Overall Study|CPAP machine malfunction|1
472274|NCT00203996|1543390|P3|Overall Study|CPAP machine malfunction|0
472275|NCT00203996|1543391|P2|Overall Study|CPAP machine malfunction|0
472276|NCT00203996|1543392|P1|Overall Study|CPAP machine malfunction|0
472277|NCT00203996|1543383|P10|Overall Study|Physician Decision|1
472278|NCT00203996|1543384|P9|Overall Study|Physician Decision|0
472279|NCT00203996|1543385|P8|Overall Study|Physician Decision|0
472280|NCT00203996|1543386|P7|Overall Study|Physician Decision|0
472281|NCT00203996|1543387|P6|Overall Study|Physician Decision|0
472282|NCT00203996|1543388|P5|Overall Study|Physician Decision|0
472283|NCT00203996|1543389|P4|Overall Study|Physician Decision|2
472284|NCT00203996|1543390|P3|Overall Study|Physician Decision|0
472285|NCT00203996|1543391|P2|Overall Study|Physician Decision|0
472286|NCT00203996|1543392|P1|Overall Study|Physician Decision|0
472287|NCT00203996|1543383|P10|Overall Study|Protocol Violation|0
472288|NCT00203996|1543384|P9|Overall Study|Protocol Violation|0
472289|NCT00203996|1543385|P8|Overall Study|Protocol Violation|0
472290|NCT00203996|1543386|P7|Overall Study|Protocol Violation|0
472291|NCT00203996|1543387|P6|Overall Study|Protocol Violation|0
472292|NCT00203996|1543388|P5|Overall Study|Protocol Violation|1
472293|NCT00203996|1543389|P4|Overall Study|Protocol Violation|6
472294|NCT00203996|1543390|P3|Overall Study|Protocol Violation|0
472295|NCT00203996|1543391|P2|Overall Study|Protocol Violation|0
472296|NCT00203996|1543392|P1|Overall Study|Protocol Violation|0
472297|NCT00203996|1543383|P10|Overall Study|Lost to Follow-up|0
472298|NCT00203996|1543384|P9|Overall Study|Lost to Follow-up|0
472299|NCT00203996|1543385|P8|Overall Study|Lost to Follow-up|0
472300|NCT00203996|1543386|P7|Overall Study|Lost to Follow-up|0
472301|NCT00203996|1543387|P6|Overall Study|Lost to Follow-up|0
472302|NCT00203996|1543388|P5|Overall Study|Lost to Follow-up|0
472303|NCT00203996|1543389|P4|Overall Study|Lost to Follow-up|1
472304|NCT00203996|1543390|P3|Overall Study|Lost to Follow-up|0
472305|NCT00203996|1543391|P2|Overall Study|Lost to Follow-up|0
472306|NCT00203996|1543392|P1|Overall Study|Lost to Follow-up|0
472307|NCT00203892|1543459|P3|Overall Study|Death|0
472308|NCT00203892|1543460|P2|Overall Study|Death|0
472309|NCT00203892|1543461|P1|Overall Study|Death|1
472310|NCT00203892|1543459|P3|Overall Study|Physician Decision|0
472311|NCT00203892|1543460|P2|Overall Study|Physician Decision|2
472312|NCT00203892|1543461|P1|Overall Study|Physician Decision|1
472313|NCT00203502|1543472|P1|Overall Study|Death|1
472314|NCT00203476|1543483|P3|Overall Study|Withdrawal by Subject|0
472315|NCT00203476|1543484|P2|Overall Study|Withdrawal by Subject|1
472316|NCT00203476|1543485|P1|Overall Study|Withdrawal by Subject|0
472317|NCT00203476|1543483|P3|Overall Study|Lost to Follow-up|0
472318|NCT00203476|1543484|P2|Overall Study|Lost to Follow-up|0
472319|NCT00203476|1543485|P1|Overall Study|Lost to Follow-up|1
472320|NCT00203424|1543502|P1|Follow-up Period|Lost to Follow-up|1
472321|NCT00203424|1543502|P1|Follow-up Period|progressive disease|4
472322|NCT00203424|1543502|P1|Follow-up Period|Withdrawal by Subject|1
472323|NCT00203424|1543502|P1|Treatment Period|progressive disease|2
472324|NCT00203424|1543502|P1|Treatment Period|Adverse Event|5
472325|NCT00203424|1543502|P1|Treatment Period|Withdrawal by Subject|4
472326|NCT00203411|1543509|P1|Follow-up|Progressive Disease|4
472327|NCT00203307|1543518|P2|First Intervention|Adverse Event|0
472328|NCT00203307|1543519|P1|First Intervention|Adverse Event|2
472329|NCT00203294|1543527|P2|Overall Study|Withdrawal by Subject|13
472330|NCT00203294|1543528|P1|Overall Study|Withdrawal by Subject|8
472331|NCT00203268|1543534|P1|Early Treatment|Withdrawal by Subject|1
472332|NCT00203268|1543534|P1|Early Treatment|Lost to Follow-up|1
472333|NCT00203268|1543534|P1|Early Treatment|only treated one headache|2
472334|NCT00203242|1543540|P1|Overall Study|Lost to Follow-up|1
472335|NCT00203047|1543592|P2|Overall Study|Not specified|5
472336|NCT00203047|1543593|P1|Overall Study|Not specified|5
472337|NCT00203047|1543592|P2|Overall Study|Pregnancy|0
472338|NCT00203047|1543593|P1|Overall Study|Pregnancy|3
472339|NCT00203047|1543592|P2|Overall Study|Death|2
472340|NCT00203047|1543593|P1|Overall Study|Death|1
472341|NCT00203047|1543592|P2|Overall Study|Adverse Event|18
472342|NCT00203047|1543593|P1|Overall Study|Adverse Event|8
472343|NCT00203047|1543592|P2|Overall Study|Lost to Follow-up|5
472344|NCT00203047|1543593|P1|Overall Study|Lost to Follow-up|11
472345|NCT00203047|1543592|P2|Overall Study|Protocol Violation|0
472346|NCT00203047|1543593|P1|Overall Study|Protocol Violation|1
472347|NCT00203047|1543592|P2|Overall Study|Non-compliance|8
472348|NCT00203047|1543593|P1|Overall Study|Non-compliance|4
472349|NCT00203047|1543592|P2|Overall Study|Physician Decision|7
472350|NCT00203047|1543593|P1|Overall Study|Physician Decision|8
472351|NCT00203047|1543592|P2|Overall Study|Teva requested participant withdrawal|1
472352|NCT00203047|1543593|P1|Overall Study|Teva requested participant withdrawal|1
472353|NCT00203047|1543592|P2|Overall Study|Withdrawal by Subject|47
472354|NCT00203047|1543593|P1|Overall Study|Withdrawal by Subject|13
472355|NCT00203047|1543592|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
472356|NCT00203047|1543593|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
472357|NCT00203047|1543592|P2|Overall Study|Ongoing: in database - January 29, 2009|109
472358|NCT00203047|1543593|P1|Overall Study|Ongoing: in database - January 29, 2009|131
472359|NCT00202878|1543607|P2|Overall Study|Withdrawal by Subject|808
472360|NCT00202878|1543608|P1|Overall Study|Withdrawal by Subject|795
472361|NCT00202878|1543607|P2|Overall Study|Site Closure|36
472362|NCT00202878|1543608|P1|Overall Study|Site Closure|39
472363|NCT00202878|1543607|P2|Overall Study|Lost to Follow-up|49
472364|NCT00202878|1543608|P1|Overall Study|Lost to Follow-up|44
472365|NCT00202878|1543607|P2|Overall Study|Only Vital Status Known|356
472366|NCT00202878|1543608|P1|Overall Study|Only Vital Status Known|357
472367|NCT00202878|1543607|P2|Overall Study|Death|968
472368|NCT00202878|1543608|P1|Overall Study|Death|964
472369|NCT00202839|1543622|P2|Overall Study|Lost to Follow-up|2
472370|NCT00202839|1543623|P1|Overall Study|Lost to Follow-up|3
472371|NCT00202839|1543622|P2|Overall Study|Protocol Violation|1
472372|NCT00202839|1543623|P1|Overall Study|Protocol Violation|2
472373|NCT00202839|1543622|P2|Overall Study|Withdrawal by Subject|2
472374|NCT00202839|1543623|P1|Overall Study|Withdrawal by Subject|6
472375|NCT00202839|1543622|P2|Overall Study|Physician Decision|0
472376|NCT00202839|1543623|P1|Overall Study|Physician Decision|12
472377|NCT00202839|1543622|P2|Overall Study|Adverse Event|5
472378|NCT00202839|1543623|P1|Overall Study|Adverse Event|1
472379|NCT00202644|1543638|P2|Overall Study|Other|1
472380|NCT00202644|1543639|P1|Overall Study|Other|9
472381|NCT00202644|1543638|P2|Overall Study|Lost to Follow-up|1
472382|NCT00202644|1543639|P1|Overall Study|Lost to Follow-up|0
472383|NCT00202644|1543638|P2|Overall Study|Lack of Efficacy|6
472384|NCT00202644|1543639|P1|Overall Study|Lack of Efficacy|6
472385|NCT00202644|1543638|P2|Overall Study|Withdrawal by Subject|6
472386|NCT00202644|1543639|P1|Overall Study|Withdrawal by Subject|8
472387|NCT00202644|1543638|P2|Overall Study|Adverse Event|13
472388|NCT00202644|1543639|P1|Overall Study|Adverse Event|12
472389|NCT00201851|1543700|P3|Overall Study|Ineligible post enrollment|1
472390|NCT00201851|1543701|P2|Overall Study|Ineligible post enrollment|1
472391|NCT00201851|1543702|P1|Overall Study|Ineligible post enrollment|6
472392|NCT00201851|1543700|P3|Overall Study|Lost to Follow-up|0
472393|NCT00201851|1543701|P2|Overall Study|Lost to Follow-up|1
472394|NCT00201851|1543702|P1|Overall Study|Lost to Follow-up|2
472395|NCT00201643|1543774|P2|Overall Study|Withdrawal by Subject|4
472396|NCT00201643|1543775|P1|Overall Study|Withdrawal by Subject|5
472397|NCT00201201|1543839|P2|Overall Study|Withdrawal by Subject|5
472398|NCT00201201|1543840|P1|Overall Study|Withdrawal by Subject|5
472399|NCT00201201|1543839|P2|Overall Study|Death|2
472400|NCT00201201|1543840|P1|Overall Study|Death|0
472401|NCT00201006|1543878|P3|Overall Study|Adverse Event|1
472402|NCT00201006|1543879|P2|Overall Study|Adverse Event|0
472403|NCT00201006|1543880|P1|Overall Study|Adverse Event|1
472404|NCT00201006|1543878|P3|Overall Study|Withdrawal by Subject|3
472405|NCT00201006|1543879|P2|Overall Study|Withdrawal by Subject|2
472406|NCT00201006|1543880|P1|Overall Study|Withdrawal by Subject|7
472407|NCT00200967|1543890|P2|Run-out Period|Lost to Follow-up|0
472408|NCT00200967|1543891|P1|Run-out Period|Lost to Follow-up|1
472409|NCT00200967|1543890|P2|Second Treatment Period|Withdrawal by Subject|2
472410|NCT00200967|1543891|P1|Second Treatment Period|Withdrawal by Subject|1
472411|NCT00200967|1543890|P2|Wash-out Period|Lost to Follow-up|1
472412|NCT00200967|1543891|P1|Wash-out Period|Lost to Follow-up|0
472413|NCT00200967|1543890|P2|First Treatment Period|Pregnancy|0
472414|NCT00200967|1543891|P1|First Treatment Period|Pregnancy|1
472415|NCT00200967|1543890|P2|First Treatment Period|Withdrawal by Subject|1
472416|NCT00200967|1543891|P1|First Treatment Period|Withdrawal by Subject|5
472417|NCT00200356|1543932|P2|Overall Study|Nontreatment|0
472418|NCT00200356|1543933|P1|Overall Study|Nontreatment|1
472419|NCT00200356|1543932|P2|Overall Study|Protocol Violation|4
472420|NCT00200356|1543933|P1|Overall Study|Protocol Violation|4
472421|NCT00200356|1543932|P2|Overall Study|Lack of Efficacy|3
472422|NCT00200356|1543933|P1|Overall Study|Lack of Efficacy|3
472423|NCT00200057|1544000|P1|Overall Study|Death|1
472424|NCT00200057|1544000|P1|Overall Study|Infection|1
472425|NCT00200057|1544000|P1|Overall Study|Change in medical condition|1
472426|NCT00200057|1544000|P1|Overall Study|Withdrawal by Subject|1
472427|NCT00200057|1544000|P1|Overall Study|Exited due to terminal illness of PI|2
472428|NCT00200057|1544000|P1|Overall Study|Lack of Efficacy|3
472429|NCT00199381|1544019|P1|Overall Study|Study termination by Sponsor|323
472430|NCT00199381|1544019|P1|Overall Study|Not including due to early termination|37
472431|NCT00199381|1544019|P1|Overall Study|Lack of Efficacy|27
472432|NCT00199381|1544019|P1|Overall Study|Protocol Violation|6
472433|NCT00199381|1544019|P1|Overall Study|Adverse Event|73
472434|NCT00199381|1544019|P1|Overall Study|Withdrawal by Subject|38
472435|NCT00198822|1544026|P3|Overall Study|Lost to Follow-up|21
472436|NCT00198822|1544027|P2|Overall Study|Lost to Follow-up|20
472437|NCT00198822|1544028|P1|Overall Study|Lost to Follow-up|14
472438|NCT00198133|1544047|P2|Overall Study|Physician Decision|0
472439|NCT00198133|1544048|P1|Overall Study|Physician Decision|1
472440|NCT00198133|1544047|P2|Overall Study|Withdrawal by Subject|0
472441|NCT00198133|1544048|P1|Overall Study|Withdrawal by Subject|1
472442|NCT00198133|1544047|P2|Overall Study|Adverse Event|3
472443|NCT00198133|1544048|P1|Overall Study|Adverse Event|1
472444|NCT00198133|1544047|P2|Overall Study|Disease progression|5
472445|NCT00198133|1544048|P1|Overall Study|Disease progression|2
472446|NCT00198029|1544091|P1|Overall Study|Withdrawal by Subject|4
472447|NCT00197496|1544098|P2|Follow-up|Lost to Follow-up|1
472448|NCT00197496|1544099|P1|Follow-up|Lost to Follow-up|2
472449|NCT00197496|1544098|P2|Baseline to Discharge|Protocol Violation|1
472450|NCT00197496|1544099|P1|Baseline to Discharge|Protocol Violation|0
472451|NCT00197496|1544098|P2|Baseline to Discharge|Physician Decision|1
472452|NCT00197496|1544099|P1|Baseline to Discharge|Physician Decision|0
472453|NCT00197496|1544098|P2|Baseline to Discharge|MRSA|0
472454|NCT00197496|1544099|P1|Baseline to Discharge|MRSA|1
472455|NCT00197496|1544098|P2|Baseline to Discharge|not interested|0
472456|NCT00197496|1544099|P1|Baseline to Discharge|not interested|1
472457|NCT00197236|1544147|P3|Overall Study|Returned out of specified time window|1
472458|NCT00197236|1544148|P2|Overall Study|Returned out of specified time window|0
472459|NCT00197236|1544149|P1|Overall Study|Returned out of specified time window|0
472460|NCT00197236|1544147|P3|Overall Study|Study drug/medication expiration|3
472461|NCT00197236|1544148|P2|Overall Study|Study drug/medication expiration|0
472462|NCT00197236|1544149|P1|Overall Study|Study drug/medication expiration|1
472463|NCT00197236|1544147|P3|Overall Study|Withdrawal by Subject|11
472464|NCT00197236|1544148|P2|Overall Study|Withdrawal by Subject|3
472465|NCT00197236|1544149|P1|Overall Study|Withdrawal by Subject|7
472466|NCT00197236|1544147|P3|Overall Study|Protocol Violation|1
472467|NCT00197236|1544148|P2|Overall Study|Protocol Violation|0
472468|NCT00197236|1544149|P1|Overall Study|Protocol Violation|0
472469|NCT00197236|1544147|P3|Overall Study|Lost to Follow-up|6
472470|NCT00197236|1544148|P2|Overall Study|Lost to Follow-up|14
472471|NCT00197236|1544149|P1|Overall Study|Lost to Follow-up|5
472472|NCT00197236|1544147|P3|Overall Study|Adverse Event|1
472473|NCT00197236|1544148|P2|Overall Study|Adverse Event|0
472474|NCT00197236|1544149|P1|Overall Study|Adverse Event|1
472475|NCT00197106|1544236|P3|Overall Treatment Period|Withdrawal by Subject|2
472476|NCT00197106|1544237|P2|Overall Treatment Period|Withdrawal by Subject|0
472477|NCT00197106|1544238|P1|Overall Treatment Period|Withdrawal by Subject|0
472478|NCT00197106|1544236|P3|Overall Treatment Period|Protocol Violation|2
472479|NCT00197106|1544237|P2|Overall Treatment Period|Protocol Violation|0
472480|NCT00197106|1544238|P1|Overall Treatment Period|Protocol Violation|0
472481|NCT00197106|1544236|P3|Overall Treatment Period|Lost to Follow-up|2
472482|NCT00197106|1544237|P2|Overall Treatment Period|Lost to Follow-up|0
472483|NCT00197106|1544238|P1|Overall Treatment Period|Lost to Follow-up|0
472484|NCT00197106|1544236|P3|Overall Treatment Period|Lack of Efficacy|0
472485|NCT00197106|1544237|P2|Overall Treatment Period|Lack of Efficacy|1
472486|NCT00197106|1544238|P1|Overall Treatment Period|Lack of Efficacy|0
472487|NCT00197106|1544236|P3|4-Week Run-In Period|Did not meet entry criteria|0
472488|NCT00197106|1544237|P2|4-Week Run-In Period|Did not meet entry criteria|0
472489|NCT00197106|1544238|P1|4-Week Run-In Period|Did not meet entry criteria|99
472490|NCT00197028|1544274|P2|Overall Study|Other|6
472491|NCT00197028|1544275|P1|Overall Study|Other|3
472492|NCT00197028|1544274|P2|Overall Study|Lost to Follow-up|0
472493|NCT00197028|1544275|P1|Overall Study|Lost to Follow-up|1
472494|NCT00197028|1544274|P2|Overall Study|Withdrawal by Subject|12
472495|NCT00197028|1544275|P1|Overall Study|Withdrawal by Subject|8
472496|NCT00197028|1544274|P2|Overall Study|Protocol Violation|1
472497|NCT00197028|1544275|P1|Overall Study|Protocol Violation|2
472498|NCT00197028|1544274|P2|Overall Study|Adverse Event|2
472499|NCT00197028|1544275|P1|Overall Study|Adverse Event|2
472500|NCT00197015|1544318|P3|Overall Study|Other|2
472501|NCT00197015|1544319|P2|Overall Study|Other|3
472502|NCT00197015|1544320|P1|Overall Study|Other|2
472503|NCT00197015|1544318|P3|Overall Study|Lost to Follow-up|37
472504|NCT00197015|1544319|P2|Overall Study|Lost to Follow-up|46
472505|NCT00197015|1544320|P1|Overall Study|Lost to Follow-up|28
472506|NCT00197015|1544318|P3|Overall Study|Withdrawal by Subject|34
472507|NCT00197015|1544319|P2|Overall Study|Withdrawal by Subject|37
472508|NCT00197015|1544320|P1|Overall Study|Withdrawal by Subject|17
472509|NCT00197015|1544318|P3|Overall Study|Protocol Violation|3
472510|NCT00197015|1544319|P2|Overall Study|Protocol Violation|3
472511|NCT00197015|1544320|P1|Overall Study|Protocol Violation|0
472512|NCT00197015|1544318|P3|Overall Study|Adverse Event|1
472513|NCT00197015|1544319|P2|Overall Study|Adverse Event|0
472514|NCT00197015|1544320|P1|Overall Study|Adverse Event|3
472515|NCT00197002|1544379|P3|Overall Study|Others|1
472516|NCT00197002|1544380|P2|Overall Study|Others|1
472517|NCT00197002|1544381|P1|Overall Study|Others|3
472518|NCT00197002|1544379|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
472519|NCT00197002|1544380|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
472520|NCT00197002|1544381|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
472521|NCT00197002|1544379|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
472522|NCT00197002|1544380|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
472523|NCT00197002|1544381|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
472524|NCT00197002|1544379|P3|Overall Study|Migrated/moved from study area|1
472525|NCT00197002|1544380|P2|Overall Study|Migrated/moved from study area|5
472526|NCT00197002|1544381|P1|Overall Study|Migrated/moved from study area|3
472527|NCT00197002|1544379|P3|Overall Study|Withdrawal by Subject|7
472528|NCT00197002|1544380|P2|Overall Study|Withdrawal by Subject|5
472529|NCT00197002|1544381|P1|Overall Study|Withdrawal by Subject|9
472530|NCT00197002|1544379|P3|Overall Study|Protocol Violation|2
472531|NCT00197002|1544380|P2|Overall Study|Protocol Violation|0
472532|NCT00197002|1544381|P1|Overall Study|Protocol Violation|1
472533|NCT00197002|1544379|P3|Overall Study|Adverse Event|0
472534|NCT00197002|1544380|P2|Overall Study|Adverse Event|1
472535|NCT00197002|1544381|P1|Overall Study|Adverse Event|0
472536|NCT00196976|1544432|P14|Booster Study|Lost to Follow-up|0
472537|NCT00196976|1544433|P13|Booster Study|Lost to Follow-up|0
472538|NCT00196976|1544434|P12|Booster Study|Lost to Follow-up|2
472539|NCT00196976|1544435|P11|Booster Study|Lost to Follow-up|1
472540|NCT00196976|1544436|P10|Booster Study|Lost to Follow-up|0
472541|NCT00196976|1544437|P9|Booster Study|Lost to Follow-up|0
472542|NCT00196976|1544438|P8|Booster Study|Lost to Follow-up|0
472543|NCT00196976|1544439|P7|Booster Study|Lost to Follow-up|0
472544|NCT00196976|1544440|P6|Booster Study|Lost to Follow-up|0
472545|NCT00196976|1544441|P5|Booster Study|Lost to Follow-up|0
472546|NCT00196976|1544442|P4|Booster Study|Lost to Follow-up|0
472547|NCT00196976|1544443|P3|Booster Study|Lost to Follow-up|0
472548|NCT00196976|1544444|P2|Booster Study|Lost to Follow-up|0
472549|NCT00196976|1544445|P1|Booster Study|Lost to Follow-up|0
472550|NCT00196976|1544432|P14|Booster Study|Withdrawal by Subject|0
472551|NCT00196976|1544433|P13|Booster Study|Withdrawal by Subject|0
472552|NCT00196976|1544434|P12|Booster Study|Withdrawal by Subject|0
472553|NCT00196976|1544435|P11|Booster Study|Withdrawal by Subject|1
472554|NCT00196976|1544436|P10|Booster Study|Withdrawal by Subject|0
472555|NCT00196976|1544437|P9|Booster Study|Withdrawal by Subject|0
472556|NCT00196976|1544438|P8|Booster Study|Withdrawal by Subject|0
472557|NCT00196976|1544439|P7|Booster Study|Withdrawal by Subject|0
472558|NCT00196976|1544440|P6|Booster Study|Withdrawal by Subject|0
472559|NCT00196976|1544441|P5|Booster Study|Withdrawal by Subject|0
472560|NCT00196976|1544442|P4|Booster Study|Withdrawal by Subject|0
472561|NCT00196976|1544443|P3|Booster Study|Withdrawal by Subject|0
472562|NCT00196976|1544444|P2|Booster Study|Withdrawal by Subject|0
472563|NCT00196976|1544445|P1|Booster Study|Withdrawal by Subject|0
472564|NCT00196976|1544432|P14|Primary Study|Other|0
472565|NCT00196976|1544433|P13|Primary Study|Other|0
472566|NCT00196976|1544434|P12|Primary Study|Other|0
472567|NCT00196976|1544435|P11|Primary Study|Other|0
472568|NCT00196976|1544436|P10|Primary Study|Other|0
472569|NCT00196976|1544437|P9|Primary Study|Other|0
472570|NCT00196976|1544438|P8|Primary Study|Other|0
472571|NCT00196976|1544439|P7|Primary Study|Other|0
472572|NCT00196976|1544440|P6|Primary Study|Other|0
472573|NCT00196976|1544441|P5|Primary Study|Other|0
472574|NCT00196976|1544442|P4|Primary Study|Other|0
472575|NCT00196976|1544443|P3|Primary Study|Other|2
472576|NCT00196976|1544444|P2|Primary Study|Other|0
472577|NCT00196976|1544445|P1|Primary Study|Other|0
472578|NCT00196976|1544432|P14|Primary Study|Lost to Follow-up|0
472579|NCT00196976|1544433|P13|Primary Study|Lost to Follow-up|0
472580|NCT00196976|1544434|P12|Primary Study|Lost to Follow-up|0
472581|NCT00196976|1544435|P11|Primary Study|Lost to Follow-up|0
472582|NCT00196976|1544436|P10|Primary Study|Lost to Follow-up|0
472583|NCT00196976|1544437|P9|Primary Study|Lost to Follow-up|0
472584|NCT00196976|1544438|P8|Primary Study|Lost to Follow-up|2
472585|NCT00196976|1544439|P7|Primary Study|Lost to Follow-up|0
472586|NCT00196976|1544440|P6|Primary Study|Lost to Follow-up|1
472587|NCT00196976|1544441|P5|Primary Study|Lost to Follow-up|1
472588|NCT00196976|1544442|P4|Primary Study|Lost to Follow-up|0
472589|NCT00196976|1544443|P3|Primary Study|Lost to Follow-up|0
472590|NCT00196976|1544444|P2|Primary Study|Lost to Follow-up|0
472591|NCT00196976|1544445|P1|Primary Study|Lost to Follow-up|0
472592|NCT00196976|1544432|P14|Primary Study|Withdrawal by Subject|0
472593|NCT00196976|1544433|P13|Primary Study|Withdrawal by Subject|0
472594|NCT00196976|1544434|P12|Primary Study|Withdrawal by Subject|0
472595|NCT00196976|1544435|P11|Primary Study|Withdrawal by Subject|0
472596|NCT00196976|1544436|P10|Primary Study|Withdrawal by Subject|1
472597|NCT00196976|1544437|P9|Primary Study|Withdrawal by Subject|0
472598|NCT00196976|1544438|P8|Primary Study|Withdrawal by Subject|0
472599|NCT00196976|1544439|P7|Primary Study|Withdrawal by Subject|0
472600|NCT00196976|1544440|P6|Primary Study|Withdrawal by Subject|1
472601|NCT00196976|1544441|P5|Primary Study|Withdrawal by Subject|2
472602|NCT00196976|1544442|P4|Primary Study|Withdrawal by Subject|1
472603|NCT00196976|1544443|P3|Primary Study|Withdrawal by Subject|1
472604|NCT00196976|1544444|P2|Primary Study|Withdrawal by Subject|0
472605|NCT00196976|1544445|P1|Primary Study|Withdrawal by Subject|1
472606|NCT00196976|1544432|P14|Primary Study|Protocol Violation|0
472607|NCT00196976|1544433|P13|Primary Study|Protocol Violation|0
472608|NCT00196976|1544434|P12|Primary Study|Protocol Violation|0
472609|NCT00196976|1544435|P11|Primary Study|Protocol Violation|0
472610|NCT00196976|1544436|P10|Primary Study|Protocol Violation|0
472611|NCT00196976|1544437|P9|Primary Study|Protocol Violation|0
472612|NCT00196976|1544438|P8|Primary Study|Protocol Violation|0
472613|NCT00196976|1544439|P7|Primary Study|Protocol Violation|0
472614|NCT00196976|1544440|P6|Primary Study|Protocol Violation|0
472615|NCT00196976|1544441|P5|Primary Study|Protocol Violation|0
472616|NCT00196976|1544442|P4|Primary Study|Protocol Violation|0
472617|NCT00196976|1544443|P3|Primary Study|Protocol Violation|1
472618|NCT00196976|1544444|P2|Primary Study|Protocol Violation|1
472619|NCT00196976|1544445|P1|Primary Study|Protocol Violation|0
472620|NCT00196976|1544432|P14|Primary Study|Migrated from study area|0
472621|NCT00196976|1544433|P13|Primary Study|Migrated from study area|0
472622|NCT00196976|1544434|P12|Primary Study|Migrated from study area|0
472623|NCT00196976|1544435|P11|Primary Study|Migrated from study area|0
472624|NCT00196976|1544436|P10|Primary Study|Migrated from study area|0
472625|NCT00196976|1544437|P9|Primary Study|Migrated from study area|0
472626|NCT00196976|1544438|P8|Primary Study|Migrated from study area|1
472627|NCT00196976|1544439|P7|Primary Study|Migrated from study area|0
472628|NCT00196976|1544440|P6|Primary Study|Migrated from study area|0
472629|NCT00196976|1544441|P5|Primary Study|Migrated from study area|0
472630|NCT00196976|1544442|P4|Primary Study|Migrated from study area|0
472631|NCT00196976|1544443|P3|Primary Study|Migrated from study area|0
472632|NCT00196976|1544444|P2|Primary Study|Migrated from study area|0
472633|NCT00196976|1544445|P1|Primary Study|Migrated from study area|0
472634|NCT00196937|1544641|P3|Overall Study|Withdrawal by Subject|3
472635|NCT00196937|1544642|P2|Overall Study|Withdrawal by Subject|0
472636|NCT00196937|1544643|P1|Overall Study|Withdrawal by Subject|0
472637|NCT00196937|1544641|P3|Overall Study|Lost to Follow-up|3
472638|NCT00196937|1544642|P2|Overall Study|Lost to Follow-up|3
472639|NCT00196937|1544643|P1|Overall Study|Lost to Follow-up|4
472640|NCT00196937|1544641|P3|Overall Study|Subject did not come due to holidays|0
472641|NCT00196937|1544642|P2|Overall Study|Subject did not come due to holidays|1
472642|NCT00196937|1544643|P1|Overall Study|Subject did not come due to holidays|3
472643|NCT00196937|1544641|P3|Overall Study|Adverse Event|1
472644|NCT00196937|1544642|P2|Overall Study|Adverse Event|1
472645|NCT00196937|1544643|P1|Overall Study|Adverse Event|2
472646|NCT00196326|1544691|P1|Overall Study|Not specified|22
472647|NCT00196326|1544691|P1|Overall Study|Lost to Follow-up|304
472648|NCT00196326|1544691|P1|Overall Study|Pregnancy|34
472649|NCT00196326|1544691|P1|Overall Study|Adverse Event|253
472650|NCT00196326|1544691|P1|Overall Study|Withdrawal by Subject|225
472651|NCT00196326|1544691|P1|Overall Study|Physician Decision|3
472652|NCT00196326|1544691|P1|Overall Study|Non-compliance with the protocol|81
472653|NCT00196326|1544691|P1|Overall Study|Did not meet protocol requirements|64
472654|NCT00196313|1544699|P2|Overall Study|Lost to Follow-up|2
472655|NCT00196313|1544700|P1|Overall Study|Lost to Follow-up|2
472656|NCT00196313|1544699|P2|Overall Study|Subject Pregnant|1
472657|NCT00196313|1544700|P1|Overall Study|Subject Pregnant|1
472658|NCT00196313|1544699|P2|Overall Study|Adverse Event|1
472659|NCT00196313|1544700|P1|Overall Study|Adverse Event|3
472660|NCT00196313|1544699|P2|Overall Study|Withdrawal by Subject|1
472661|NCT00196313|1544700|P1|Overall Study|Withdrawal by Subject|3
472662|NCT00196313|1544699|P2|Overall Study|Protocol Violation|3
472663|NCT00196313|1544700|P1|Overall Study|Protocol Violation|2
472664|NCT00196196|1544714|P1|Overall Study|Did not have required condition (hydroce|5
472665|NCT00196196|1544714|P1|Overall Study|Withdrawal by Subject|2
472666|NCT00196105|1544722|P3|Overall Study|Lost to Follow-up|7
472667|NCT00196105|1544723|P2|Overall Study|Lost to Follow-up|5
472668|NCT00196105|1544724|P1|Overall Study|Lost to Follow-up|4
472669|NCT00195819|1544744|P2|Open-label|Withdrawal by Subject|5
472670|NCT00195819|1544745|P1|Open-label|Withdrawal by Subject|0
472671|NCT00195819|1544744|P2|Open-label|Moved|1
472672|NCT00195819|1544745|P1|Open-label|Moved|0
472673|NCT00195819|1544744|P2|Open-label|Protocol Violation|2
472674|NCT00195819|1544745|P1|Open-label|Protocol Violation|0
472675|NCT00195819|1544744|P2|Open-label|Pregnancy|1
472676|NCT00195819|1544745|P1|Open-label|Pregnancy|0
472677|NCT00195819|1544744|P2|Open-label|Lack of Efficacy|2
472678|NCT00195819|1544745|P1|Open-label|Lack of Efficacy|0
472679|NCT00195819|1544744|P2|Open-label|Adverse Event|9
472680|NCT00195819|1544745|P1|Open-label|Adverse Event|0
472681|NCT00195819|1544744|P2|Double-Blind|Moved|0
472682|NCT00195819|1544745|P1|Double-Blind|Moved|1
472683|NCT00195819|1544744|P2|Double-Blind|Withdrawal by Subject|0
472684|NCT00195819|1544745|P1|Double-Blind|Withdrawal by Subject|1
472685|NCT00195715|1544795|P1|Overall Study|Sponsor discretion - trial ended early|1
472686|NCT00195715|1544795|P1|Overall Study|Sponsor discontinued trial|1
472687|NCT00195715|1544795|P1|Overall Study|Colonic stricture|1
472688|NCT00195715|1544795|P1|Overall Study|Ineligible|1
472689|NCT00195715|1544795|P1|Overall Study|Increased infection rate|1
472690|NCT00195715|1544795|P1|Overall Study|Planned surgery|2
472691|NCT00195715|1544795|P1|Overall Study|Use of prohibited medication|2
472692|NCT00195715|1544795|P1|Overall Study|Subject wants to get pregnant|4
472693|NCT00195715|1544795|P1|Overall Study|Investigator's decision|2
472694|NCT00195715|1544795|P1|Overall Study|Administrative reasons|2
472695|NCT00195715|1544795|P1|Overall Study|Sponsor stopped study|1
472696|NCT00195715|1544795|P1|Overall Study|Loss of response/no improvement|3
472697|NCT00195715|1544795|P1|Overall Study|Subject choice|3
472698|NCT00195715|1544795|P1|Overall Study|Subject started commercial Humira|5
472699|NCT00195715|1544795|P1|Overall Study|Subject non-compliance|6
472700|NCT00195715|1544795|P1|Overall Study|Subject moved/relocated|7
472701|NCT00195715|1544795|P1|Overall Study|Investigative site closure|8
472702|NCT00195715|1544795|P1|Overall Study|Pregnancy|14
472703|NCT00195715|1544795|P1|Overall Study|Lack of Efficacy|93
472704|NCT00195715|1544795|P1|Overall Study|Protocol Violation|13
472705|NCT00195715|1544795|P1|Overall Study|Lost to Follow-up|27
472706|NCT00195715|1544795|P1|Overall Study|Withdrawal by Subject|58
472707|NCT00195715|1544795|P1|Overall Study|Adverse Event|122
472708|NCT00195676|1544895|P1|Period R - Retreatment 16 Weeks|Other reasons|6
472709|NCT00195676|1544895|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
472710|NCT00195676|1544895|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
472711|NCT00195676|1544895|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
472712|NCT00195676|1544895|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
472713|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
472714|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
472715|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
472716|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
472717|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
472718|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
472719|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Death|2
472720|NCT00195676|1544895|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
472721|NCT00195676|1544895|P1|Period O - Open-label Treatment|Other reasons|68
472722|NCT00195676|1544895|P1|Period O - Open-label Treatment|Administrative reasons|2
472723|NCT00195676|1544895|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
472724|NCT00195676|1544895|P1|Period O - Open-label Treatment|Protocol Violation|12
472725|NCT00195676|1544895|P1|Period O - Open-label Treatment|Lost to Follow-up|91
472726|NCT00195676|1544895|P1|Period O - Open-label Treatment|Lack of Efficacy|198
472727|NCT00195676|1544895|P1|Period O - Open-label Treatment|Death|6
472728|NCT00195676|1544895|P1|Period O - Open-label Treatment|Adverse Event|82
472729|NCT00195663|1544909|P3|Open-Label Extension Period|Administrative reasons|13
472730|NCT00195663|1544910|P2|Open-Label Extension Period|Administrative reasons|11
472731|NCT00195663|1544911|P1|Open-Label Extension Period|Administrative reasons|11
472732|NCT00195663|1544909|P3|Open-Label Extension Period|Lack of Efficacy|12
472733|NCT00195663|1544910|P2|Open-Label Extension Period|Lack of Efficacy|6
472734|NCT00195663|1544911|P1|Open-Label Extension Period|Lack of Efficacy|14
472735|NCT00195663|1544909|P3|Open-Label Extension Period|Withdrawal by Subject|22
472736|NCT00195663|1544910|P2|Open-Label Extension Period|Withdrawal by Subject|15
472737|NCT00195663|1544911|P1|Open-Label Extension Period|Withdrawal by Subject|16
472738|NCT00195663|1544909|P3|Open-Label Extension Period|Death|2
472739|NCT00195663|1544910|P2|Open-Label Extension Period|Death|2
472740|NCT00195663|1544911|P1|Open-Label Extension Period|Death|2
472741|NCT00195663|1544909|P3|Open-Label Extension Period|Protocol Violation|4
472742|NCT00195663|1544910|P2|Open-Label Extension Period|Protocol Violation|4
472743|NCT00195663|1544911|P1|Open-Label Extension Period|Protocol Violation|3
472744|NCT00195663|1544909|P3|Open-Label Extension Period|Recovery|2
472745|NCT00195663|1544910|P2|Open-Label Extension Period|Recovery|2
472746|NCT00195663|1544911|P1|Open-Label Extension Period|Recovery|0
472747|NCT00195663|1544909|P3|Open-Label Extension Period|Lost to Follow-up|6
472748|NCT00195663|1544910|P2|Open-Label Extension Period|Lost to Follow-up|2
472749|NCT00195663|1544911|P1|Open-Label Extension Period|Lost to Follow-up|9
472750|NCT00195663|1544909|P3|Open-Label Extension Period|Adverse Event|36
472751|NCT00195663|1544910|P2|Open-Label Extension Period|Adverse Event|32
472752|NCT00195663|1544911|P1|Open-Label Extension Period|Adverse Event|21
472753|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Administrative reasons|9
472754|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Administrative reasons|2
472755|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Administrative reasons|3
472756|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Recovery|1
472757|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Recovery|0
472758|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Recovery|1
472759|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
472760|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
472761|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
472762|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Protocol Violation|4
472763|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Protocol Violation|6
472764|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Protocol Violation|6
472765|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
472766|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
472767|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
472768|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
472769|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
472770|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
472771|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
472772|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
472773|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
472774|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Death|0
472775|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Death|2
472776|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Death|0
472777|NCT00195663|1544909|P3|2-year Double-blind Treatment Period|Adverse Event|32
472778|NCT00195663|1544910|P2|2-year Double-blind Treatment Period|Adverse Event|27
472779|NCT00195663|1544911|P1|2-year Double-blind Treatment Period|Adverse Event|21
472780|NCT00195650|1545005|P1|Overall Study|Administrative reasons|83
472781|NCT00195650|1545005|P1|Overall Study|Protocol Violation|15
472782|NCT00195650|1545005|P1|Overall Study|Death|23
472783|NCT00195650|1545005|P1|Overall Study|Lost to Follow-up|44
472784|NCT00195650|1545005|P1|Overall Study|Withdrawal by Subject|67
472785|NCT00195650|1545005|P1|Overall Study|Lack of Efficacy|99
472786|NCT00195650|1545005|P1|Overall Study|Adverse Event|194
472787|NCT00195507|1545021|P2|Overall Study|Protocol Deviation|3
472788|NCT00195507|1545022|P1|Overall Study|Protocol Deviation|6
472789|NCT00195507|1545021|P2|Overall Study|Withdrawal by Subject|23
472790|NCT00195507|1545022|P1|Overall Study|Withdrawal by Subject|16
472791|NCT00195507|1545021|P2|Overall Study|Lack of Efficacy|67
472792|NCT00195507|1545022|P1|Overall Study|Lack of Efficacy|40
472793|NCT00195507|1545021|P2|Overall Study|Protocol Violation|4
472794|NCT00195507|1545022|P1|Overall Study|Protocol Violation|5
472795|NCT00195507|1545021|P2|Overall Study|Lost to Follow-up|2
472796|NCT00195507|1545022|P1|Overall Study|Lost to Follow-up|3
472797|NCT00195507|1545021|P2|Overall Study|Physician Decision|2
472798|NCT00195507|1545022|P1|Overall Study|Physician Decision|1
472799|NCT00195507|1545021|P2|Overall Study|Failed to Return|3
472800|NCT00195507|1545022|P1|Overall Study|Failed to Return|4
472801|NCT00195507|1545021|P2|Overall Study|Death|1
472802|NCT00195507|1545022|P1|Overall Study|Death|0
472803|NCT00195507|1545021|P2|Overall Study|Adverse Event|13
472804|NCT00195507|1545022|P1|Overall Study|Adverse Event|24
472805|NCT00195494|1545036|P6|Year 2|System toxicity|0
472806|NCT00195494|1545037|P5|Year 2|System toxicity|0
472807|NCT00195494|1545038|P4|Year 2|System toxicity|1
472808|NCT00195494|1545039|P3|Year 2|System toxicity|0
472809|NCT00195494|1545040|P2|Year 2|System toxicity|0
472810|NCT00195494|1545041|P1|Year 2|System toxicity|0
472811|NCT00195494|1545036|P6|Year 2|Withdrawal by Subject|0
472812|NCT00195494|1545037|P5|Year 2|Withdrawal by Subject|0
472813|NCT00195494|1545038|P4|Year 2|Withdrawal by Subject|3
472814|NCT00195494|1545039|P3|Year 2|Withdrawal by Subject|4
472815|NCT00195494|1545040|P2|Year 2|Withdrawal by Subject|5
472816|NCT00195494|1545041|P1|Year 2|Withdrawal by Subject|1
472817|NCT00195494|1545036|P6|Year 2|Physician Decision|0
472818|NCT00195494|1545037|P5|Year 2|Physician Decision|0
472819|NCT00195494|1545038|P4|Year 2|Physician Decision|0
472820|NCT00195494|1545039|P3|Year 2|Physician Decision|0
472821|NCT00195494|1545040|P2|Year 2|Physician Decision|1
472822|NCT00195494|1545041|P1|Year 2|Physician Decision|1
472823|NCT00195494|1545036|P6|Year 2|Protocol deviation|0
472824|NCT00195494|1545037|P5|Year 2|Protocol deviation|0
472825|NCT00195494|1545038|P4|Year 2|Protocol deviation|0
472826|NCT00195494|1545039|P3|Year 2|Protocol deviation|0
472827|NCT00195494|1545040|P2|Year 2|Protocol deviation|1
472828|NCT00195494|1545041|P1|Year 2|Protocol deviation|0
472829|NCT00195494|1545036|P6|Year 2|Missed >4 consecutive doses|0
472830|NCT00195494|1545037|P5|Year 2|Missed >4 consecutive doses|0
472831|NCT00195494|1545038|P4|Year 2|Missed >4 consecutive doses|0
472832|NCT00195494|1545039|P3|Year 2|Missed >4 consecutive doses|1
472833|NCT00195494|1545040|P2|Year 2|Missed >4 consecutive doses|1
472834|NCT00195494|1545041|P1|Year 2|Missed >4 consecutive doses|1
472835|NCT00195494|1545036|P6|Year 2|Lost to Follow-up|0
472836|NCT00195494|1545037|P5|Year 2|Lost to Follow-up|0
472837|NCT00195494|1545038|P4|Year 2|Lost to Follow-up|1
472838|NCT00195494|1545039|P3|Year 2|Lost to Follow-up|1
472839|NCT00195494|1545040|P2|Year 2|Lost to Follow-up|0
472840|NCT00195494|1545041|P1|Year 2|Lost to Follow-up|0
472841|NCT00195494|1545036|P6|Year 2|Compliance|0
472842|NCT00195494|1545037|P5|Year 2|Compliance|0
472843|NCT00195494|1545038|P4|Year 2|Compliance|2
472844|NCT00195494|1545039|P3|Year 2|Compliance|0
472845|NCT00195494|1545040|P2|Year 2|Compliance|0
472846|NCT00195494|1545041|P1|Year 2|Compliance|1
472847|NCT00195494|1545036|P6|Year 2|Lack of Efficacy|0
472848|NCT00195494|1545037|P5|Year 2|Lack of Efficacy|0
472849|NCT00195494|1545038|P4|Year 2|Lack of Efficacy|7
472850|NCT00195494|1545039|P3|Year 2|Lack of Efficacy|7
472851|NCT00195494|1545040|P2|Year 2|Lack of Efficacy|1
472852|NCT00195494|1545041|P1|Year 2|Lack of Efficacy|0
472853|NCT00195494|1545036|P6|Year 2|Adverse Event|0
472854|NCT00195494|1545037|P5|Year 2|Adverse Event|0
472855|NCT00195494|1545038|P4|Year 2|Adverse Event|9
472856|NCT00195494|1545039|P3|Year 2|Adverse Event|5
472857|NCT00195494|1545040|P2|Year 2|Adverse Event|7
472858|NCT00195494|1545041|P1|Year 2|Adverse Event|3
472859|NCT00195494|1545036|P6|Year 1|Protocol Violation|1
472860|NCT00195494|1545037|P5|Year 1|Protocol Violation|1
472861|NCT00195494|1545038|P4|Year 1|Protocol Violation|0
472862|NCT00195494|1545039|P3|Year 1|Protocol Violation|0
472863|NCT00195494|1545040|P2|Year 1|Protocol Violation|0
472864|NCT00195494|1545041|P1|Year 1|Protocol Violation|0
472865|NCT00195494|1545036|P6|Year 1|Withdrawal by Subject|9
472866|NCT00195494|1545037|P5|Year 1|Withdrawal by Subject|8
472867|NCT00195494|1545038|P4|Year 1|Withdrawal by Subject|0
472868|NCT00195494|1545039|P3|Year 1|Withdrawal by Subject|0
472869|NCT00195494|1545040|P2|Year 1|Withdrawal by Subject|0
472870|NCT00195494|1545041|P1|Year 1|Withdrawal by Subject|0
472871|NCT00195494|1545036|P6|Year 1|Physician Decision|0
472872|NCT00195494|1545037|P5|Year 1|Physician Decision|1
472873|NCT00195494|1545038|P4|Year 1|Physician Decision|0
472874|NCT00195494|1545039|P3|Year 1|Physician Decision|0
472875|NCT00195494|1545040|P2|Year 1|Physician Decision|0
472876|NCT00195494|1545041|P1|Year 1|Physician Decision|0
472877|NCT00195494|1545036|P6|Year 1|Protocol deviation|3
472878|NCT00195494|1545037|P5|Year 1|Protocol deviation|2
472879|NCT00195494|1545038|P4|Year 1|Protocol deviation|0
472880|NCT00195494|1545039|P3|Year 1|Protocol deviation|0
472881|NCT00195494|1545040|P2|Year 1|Protocol deviation|0
472882|NCT00195494|1545041|P1|Year 1|Protocol deviation|0
472883|NCT00195494|1545036|P6|Year 1|Missed >4 consecutive doses|2
472884|NCT00195494|1545037|P5|Year 1|Missed >4 consecutive doses|3
472885|NCT00195494|1545038|P4|Year 1|Missed >4 consecutive doses|0
472886|NCT00195494|1545039|P3|Year 1|Missed >4 consecutive doses|0
472887|NCT00195494|1545040|P2|Year 1|Missed >4 consecutive doses|0
472888|NCT00195494|1545041|P1|Year 1|Missed >4 consecutive doses|0
472889|NCT00195494|1545036|P6|Year 1|Lost to Follow-up|0
472890|NCT00195494|1545037|P5|Year 1|Lost to Follow-up|1
472891|NCT00195494|1545038|P4|Year 1|Lost to Follow-up|0
472892|NCT00195494|1545039|P3|Year 1|Lost to Follow-up|0
472893|NCT00195494|1545040|P2|Year 1|Lost to Follow-up|0
472894|NCT00195494|1545041|P1|Year 1|Lost to Follow-up|0
472895|NCT00195494|1545036|P6|Year 1|Compliance|1
472896|NCT00195494|1545037|P5|Year 1|Compliance|5
472897|NCT00195494|1545038|P4|Year 1|Compliance|0
472898|NCT00195494|1545039|P3|Year 1|Compliance|0
472899|NCT00195494|1545040|P2|Year 1|Compliance|0
472900|NCT00195494|1545041|P1|Year 1|Compliance|0
472901|NCT00195494|1545036|P6|Year 1|Lack of Efficacy|9
472902|NCT00195494|1545037|P5|Year 1|Lack of Efficacy|24
472903|NCT00195494|1545038|P4|Year 1|Lack of Efficacy|0
472904|NCT00195494|1545039|P3|Year 1|Lack of Efficacy|0
472905|NCT00195494|1545040|P2|Year 1|Lack of Efficacy|0
472906|NCT00195494|1545041|P1|Year 1|Lack of Efficacy|0
472907|NCT00195494|1545036|P6|Year 1|System Toxicity|1
472908|NCT00195494|1545037|P5|Year 1|System Toxicity|0
472909|NCT00195494|1545038|P4|Year 1|System Toxicity|0
472910|NCT00195494|1545039|P3|Year 1|System Toxicity|0
472911|NCT00195494|1545040|P2|Year 1|System Toxicity|0
472912|NCT00195494|1545041|P1|Year 1|System Toxicity|0
472913|NCT00195494|1545036|P6|Year 1|Adverse Event|27
472914|NCT00195494|1545037|P5|Year 1|Adverse Event|34
472915|NCT00195494|1545038|P4|Year 1|Adverse Event|0
472916|NCT00195494|1545039|P3|Year 1|Adverse Event|0
472917|NCT00195494|1545040|P2|Year 1|Adverse Event|0
472918|NCT00195494|1545041|P1|Year 1|Adverse Event|0
472919|NCT00195442|1545059|P1|Overall Study|Other|14
472920|NCT00195442|1545059|P1|Overall Study|Poor cooperation|2
472921|NCT00195442|1545059|P1|Overall Study|No reason specified|4
472922|NCT00195442|1545059|P1|Overall Study|Death|7
472923|NCT00195442|1545059|P1|Overall Study|Intermittent product shortage|21
472924|NCT00195442|1545059|P1|Overall Study|Switch to other Factor VIII preparation|23
472925|NCT00195442|1545059|P1|Overall Study|Lost to Follow-up|27
472926|NCT00195442|1545059|P1|Overall Study|Less than expected therapeutic effect|38
472927|NCT00195429|1545078|P2|Overall Study|Lost to Follow-up|0
472928|NCT00195429|1545079|P1|Overall Study|Lost to Follow-up|1
472929|NCT00195429|1545078|P2|Overall Study|Lack of Efficacy|1
472930|NCT00195429|1545079|P1|Overall Study|Lack of Efficacy|2
472931|NCT00195429|1545078|P2|Overall Study|Adverse Event|4
472932|NCT00195429|1545079|P1|Overall Study|Adverse Event|2
472933|NCT00195351|1545095|P2|Overall Study|Lack of Efficacy|1
472934|NCT00195351|1545096|P1|Overall Study|Lack of Efficacy|0
472935|NCT00195351|1545095|P2|Overall Study|Death|1
472936|NCT00195351|1545096|P1|Overall Study|Death|3
472937|NCT00195351|1545095|P2|Overall Study|Protocol Deviation|2
472938|NCT00195351|1545096|P1|Overall Study|Protocol Deviation|3
472939|NCT00195351|1545095|P2|Overall Study|Withdrawal by Subject|3
472940|NCT00195351|1545096|P1|Overall Study|Withdrawal by Subject|6
472941|NCT00195351|1545095|P2|Overall Study|Lost to Follow-up|9
472942|NCT00195351|1545096|P1|Overall Study|Lost to Follow-up|9
472943|NCT00195338|1545106|P1|Overall Study|Early closure of the site|4
472944|NCT00195338|1545106|P1|Overall Study|Lack of Efficacy|1
472945|NCT00195338|1545106|P1|Overall Study|Adverse Event|5
472946|NCT00195338|1545106|P1|Overall Study|Lost to Follow-up|2
472947|NCT00195273|1545116|P2|Overall Study|Procedural complications|3
472948|NCT00195273|1545117|P1|Overall Study|Procedural complications|9
472949|NCT00195273|1545116|P2|Overall Study|Lack of Efficacy|1
472950|NCT00195273|1545117|P1|Overall Study|Lack of Efficacy|3
472951|NCT00195273|1545116|P2|Overall Study|Protocol deviation|1
472952|NCT00195273|1545117|P1|Overall Study|Protocol deviation|0
472953|NCT00195273|1545116|P2|Overall Study|Adverse Event|9
472954|NCT00195273|1545117|P1|Overall Study|Adverse Event|9
472955|NCT00195260|1545131|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
472956|NCT00195260|1545132|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
472957|NCT00195260|1545133|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
472958|NCT00195260|1545134|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472959|NCT00195260|1545135|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472960|NCT00195260|1545136|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472961|NCT00195260|1545137|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472962|NCT00195260|1545138|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472963|NCT00195260|1545139|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472964|NCT00195260|1545140|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472965|NCT00195260|1545141|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
472966|NCT00195260|1545131|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
472967|NCT00195260|1545132|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
472968|NCT00195260|1545133|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
472969|NCT00195260|1545134|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472970|NCT00195260|1545135|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472971|NCT00195260|1545136|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472972|NCT00195260|1545137|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472973|NCT00195260|1545138|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472974|NCT00195260|1545139|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472975|NCT00195260|1545140|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472976|NCT00195260|1545141|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
472977|NCT00195260|1545131|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
472978|NCT00195260|1545132|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
472979|NCT00195260|1545133|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
472980|NCT00195260|1545134|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472981|NCT00195260|1545135|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472982|NCT00195260|1545136|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472983|NCT00195260|1545137|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472984|NCT00195260|1545138|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472985|NCT00195260|1545139|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472986|NCT00195260|1545140|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472987|NCT00195260|1545141|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
472988|NCT00195260|1545131|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
472989|NCT00195260|1545132|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
472990|NCT00195260|1545133|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
472991|NCT00195260|1545134|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472992|NCT00195260|1545135|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472993|NCT00195260|1545136|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472994|NCT00195260|1545137|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472995|NCT00195260|1545138|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472996|NCT00195260|1545139|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472997|NCT00195260|1545140|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472998|NCT00195260|1545141|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
472999|NCT00195260|1545131|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
473000|NCT00195260|1545132|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
473001|NCT00195260|1545133|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
473002|NCT00195260|1545134|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
473003|NCT00195260|1545135|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
473004|NCT00195260|1545136|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
473005|NCT00195260|1545137|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
473006|NCT00195260|1545138|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
473007|NCT00195260|1545139|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
473008|NCT00195260|1545140|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
473009|NCT00195260|1545141|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
473010|NCT00195260|1545131|P11|Part 1: Dose Escalation|Disease Progression|0
473011|NCT00195260|1545132|P10|Part 1: Dose Escalation|Disease Progression|0
473012|NCT00195260|1545133|P9|Part 1: Dose Escalation|Disease Progression|0
473013|NCT00195260|1545134|P8|Part 1: Dose Escalation|Disease Progression|4
473014|NCT00195260|1545135|P7|Part 1: Dose Escalation|Disease Progression|7
473015|NCT00195260|1545136|P6|Part 1: Dose Escalation|Disease Progression|6
473016|NCT00195260|1545137|P5|Part 1: Dose Escalation|Disease Progression|4
473017|NCT00195260|1545138|P4|Part 1: Dose Escalation|Disease Progression|6
473018|NCT00195260|1545139|P3|Part 1: Dose Escalation|Disease Progression|5
473019|NCT00195260|1545140|P2|Part 1: Dose Escalation|Disease Progression|2
473020|NCT00195260|1545141|P1|Part 1: Dose Escalation|Disease Progression|3
473021|NCT00195260|1545131|P11|Part 1: Dose Escalation|Death|0
473022|NCT00195260|1545132|P10|Part 1: Dose Escalation|Death|0
473023|NCT00195260|1545133|P9|Part 1: Dose Escalation|Death|0
473024|NCT00195260|1545134|P8|Part 1: Dose Escalation|Death|1
473025|NCT00195260|1545135|P7|Part 1: Dose Escalation|Death|0
473026|NCT00195260|1545136|P6|Part 1: Dose Escalation|Death|0
473027|NCT00195260|1545137|P5|Part 1: Dose Escalation|Death|0
473028|NCT00195260|1545138|P4|Part 1: Dose Escalation|Death|0
473029|NCT00195260|1545139|P3|Part 1: Dose Escalation|Death|0
473030|NCT00195260|1545140|P2|Part 1: Dose Escalation|Death|0
473031|NCT00195260|1545141|P1|Part 1: Dose Escalation|Death|0
473032|NCT00195260|1545131|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
473033|NCT00195260|1545132|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
473034|NCT00195260|1545133|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
473035|NCT00195260|1545134|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
473036|NCT00195260|1545135|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
473037|NCT00195260|1545136|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
473038|NCT00195260|1545137|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
473039|NCT00195260|1545138|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
473040|NCT00195260|1545139|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
473041|NCT00195260|1545140|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
473042|NCT00195260|1545141|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
473043|NCT00195260|1545131|P11|Part 1: Dose Escalation|Adverse Event|0
473044|NCT00195260|1545132|P10|Part 1: Dose Escalation|Adverse Event|0
473045|NCT00195260|1545133|P9|Part 1: Dose Escalation|Adverse Event|0
473046|NCT00195260|1545134|P8|Part 1: Dose Escalation|Adverse Event|0
473047|NCT00195260|1545135|P7|Part 1: Dose Escalation|Adverse Event|3
473048|NCT00195260|1545136|P6|Part 1: Dose Escalation|Adverse Event|0
473049|NCT00195260|1545137|P5|Part 1: Dose Escalation|Adverse Event|1
473050|NCT00195260|1545138|P4|Part 1: Dose Escalation|Adverse Event|1
473051|NCT00195260|1545139|P3|Part 1: Dose Escalation|Adverse Event|0
473052|NCT00195260|1545140|P2|Part 1: Dose Escalation|Adverse Event|1
473053|NCT00195260|1545141|P1|Part 1: Dose Escalation|Adverse Event|0
473054|NCT00194792|1545328|P1|Overall Study|Withdrawal by Subject|1
473055|NCT00194675|1545352|P2|Overall Study|Death|0
473056|NCT00194675|1545353|P1|Overall Study|Death|1
473057|NCT00194675|1545352|P2|Overall Study|Protocol Violation|0
473058|NCT00194675|1545353|P1|Overall Study|Protocol Violation|1
473059|NCT00194675|1545352|P2|Overall Study|"withdrew due to edgy feeling"|0
473060|NCT00194675|1545353|P1|Overall Study|"withdrew due to edgy feeling"|1
473061|NCT00194675|1545352|P2|Overall Study|lack of interest|1
473062|NCT00194675|1545353|P1|Overall Study|lack of interest|1
473063|NCT00194675|1545352|P2|Overall Study|Lost to Follow-up|1
473064|NCT00194675|1545353|P1|Overall Study|Lost to Follow-up|1
473065|NCT00194077|1545407|P2|Overall Study|Withdrawal by Subject|1
473066|NCT00194077|1545408|P1|Overall Study|Withdrawal by Subject|1
473067|NCT00194077|1545407|P2|Overall Study|Study nonadherence|0
473068|NCT00194077|1545408|P1|Overall Study|Study nonadherence|1
473069|NCT00194077|1545407|P2|Overall Study|Lack of Efficacy|29
473070|NCT00194077|1545408|P1|Overall Study|Lack of Efficacy|22
473071|NCT00194025|1545414|P1|Overall Study|non-adherence with study medication|4
473072|NCT00194025|1545414|P1|Overall Study|Adverse Event|1
473073|NCT00194012|1545429|P2|Open Label Extension (OLE)|Lack of Efficacy|0
473074|NCT00194012|1545430|P1|Open Label Extension (OLE)|Lack of Efficacy|1
473075|NCT00194012|1545429|P2|Open Label Extension (OLE)|Lost to Follow-up|5
473076|NCT00194012|1545430|P1|Open Label Extension (OLE)|Lost to Follow-up|3
473077|NCT00194012|1545429|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
473078|NCT00194012|1545430|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
473079|NCT00194012|1545429|P2|Open Label Extension (OLE)|Weight Gain|0
473080|NCT00194012|1545430|P1|Open Label Extension (OLE)|Weight Gain|1
473081|NCT00194012|1545429|P2|Randomized Phase|Oral/nasal twitching|1
473082|NCT00194012|1545430|P1|Randomized Phase|Oral/nasal twitching|0
473083|NCT00194012|1545429|P2|Randomized Phase|Emesis and enuresis|1
473084|NCT00194012|1545430|P1|Randomized Phase|Emesis and enuresis|0
473085|NCT00194012|1545429|P2|Randomized Phase|Participant reported having a rash|0
473086|NCT00194012|1545430|P1|Randomized Phase|Participant reported having a rash|1
473087|NCT00194012|1545429|P2|Randomized Phase|Adverse Event|1
473088|NCT00194012|1545430|P1|Randomized Phase|Adverse Event|2
473089|NCT00194012|1545429|P2|Randomized Phase|Withdrawal by Subject|3
473090|NCT00194012|1545430|P1|Randomized Phase|Withdrawal by Subject|3
473091|NCT00194012|1545429|P2|Randomized Phase|Study nonadherence|1
473092|NCT00194012|1545430|P1|Randomized Phase|Study nonadherence|2
473093|NCT00194012|1545429|P2|Randomized Phase|Lack of Efficacy|18
473094|NCT00194012|1545430|P1|Randomized Phase|Lack of Efficacy|8
473095|NCT00193609|1545466|P1|Overall Study|Adverse Event|2
473096|NCT00193609|1545466|P1|Overall Study|Lack of Efficacy|2
473097|NCT00193479|1545493|P1|Induction Chemotherapy|Disease Progression|1
473098|NCT00193479|1545493|P1|Induction Chemotherapy|Adverse Event|2
473099|NCT00193206|1545534|P1|Postoperative Therapy|Protocol Violation|1
473100|NCT00193206|1545534|P1|Postoperative Therapy|Lack of Efficacy|1
473101|NCT00193206|1545534|P1|Postoperative Therapy|Intercurrent Illness|2
473102|NCT00193206|1545534|P1|Postoperative Therapy|Physician Decision|3
473103|NCT00193206|1545534|P1|Postoperative Therapy|Withdrawal by Subject|7
473104|NCT00193206|1545534|P1|Preoperative Therapy|False Positive Pregnancy Test|1
473105|NCT00193206|1545534|P1|Preoperative Therapy|Withdrawal by Subject|2
473106|NCT00193206|1545534|P1|Preoperative Therapy|Adverse Event|2
473107|NCT00193206|1545534|P1|Preoperative Therapy|Lack of Efficacy|2
473108|NCT00193180|1545538|P1|Overall Study|Protocol Violation|1
473109|NCT00193180|1545538|P1|Overall Study|Adverse Event|8
473110|NCT00193180|1545538|P1|Overall Study|Lack of Efficacy|1
473111|NCT00193063|1545553|P1|Overall Study|Adverse Event|1
473112|NCT00193063|1545553|P1|Overall Study|Lack of Efficacy|3
473113|NCT00193050|1545559|P1|Adjuvant|Lack of Efficacy|2
473114|NCT00193050|1545559|P1|Adjuvant|Intercurrent Hospitalization|3
473115|NCT00193050|1545559|P1|Adjuvant|Physician Decision|5
473116|NCT00193050|1545559|P1|Neoadjuvant Treatment|Adverse Event|2
473117|NCT00193050|1545559|P1|Neoadjuvant Treatment|Physician Decision|2
473118|NCT00193050|1545559|P1|Neoadjuvant Treatment|Intercurrent Illness|3
473119|NCT00193050|1545559|P1|Neoadjuvant Treatment|Lack of Efficacy|2
473120|NCT00192647|1545576|P2|Overall Study|Other/Administrative|3
473121|NCT00192647|1545577|P1|Overall Study|Other/Administrative|5
473122|NCT00192647|1545576|P2|Overall Study|Failure to Return|13
473123|NCT00192647|1545577|P1|Overall Study|Failure to Return|11
473124|NCT00192647|1545576|P2|Overall Study|Refused Treatment/Did not Cooperate|8
473125|NCT00192647|1545577|P1|Overall Study|Refused Treatment/Did not Cooperate|10
473126|NCT00192647|1545576|P2|Overall Study|Protocol Violation|1
473127|NCT00192647|1545577|P1|Overall Study|Protocol Violation|3
473128|NCT00192647|1545576|P2|Overall Study|Entry Criteria Violation|6
473129|NCT00192647|1545577|P1|Overall Study|Entry Criteria Violation|6
473130|NCT00192647|1545576|P2|Overall Study|Insufficient Therapeutic Response|83
473131|NCT00192647|1545577|P1|Overall Study|Insufficient Therapeutic Response|53
473132|NCT00192647|1545576|P2|Overall Study|Laboratory Test Abnormality|2
473133|NCT00192647|1545577|P1|Overall Study|Laboratory Test Abnormality|4
473134|NCT00192647|1545576|P2|Overall Study|Adverse Event|29
473135|NCT00192647|1545577|P1|Overall Study|Adverse Event|35
473136|NCT00192647|1545576|P2|Overall Study|Death|1
473137|NCT00192647|1545577|P1|Overall Study|Death|1
473138|NCT00192296|1545597|P4|Overall Study|Withdrawal by Subject|0
473139|NCT00192296|1545598|P3|Overall Study|Withdrawal by Subject|0
473140|NCT00192296|1545599|P2|Overall Study|Withdrawal by Subject|1
473141|NCT00192296|1545600|P1|Overall Study|Withdrawal by Subject|0
473142|NCT00192075|1545656|P2|Overall Study|Other|2
473143|NCT00192075|1545657|P1|Overall Study|Other|5
473144|NCT00192075|1545656|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
473145|NCT00192075|1545657|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
473146|NCT00192075|1545656|P2|Overall Study|Patient Non-Compliance|1
473147|NCT00192075|1545657|P1|Overall Study|Patient Non-Compliance|0
473148|NCT00192075|1545656|P2|Overall Study|Withdrawal by Subject|5
473149|NCT00192075|1545657|P1|Overall Study|Withdrawal by Subject|5
473150|NCT00192075|1545656|P2|Overall Study|Physician Decision|0
473151|NCT00192075|1545657|P1|Overall Study|Physician Decision|3
473152|NCT00192075|1545656|P2|Overall Study|Lack of Efficacy|0
473153|NCT00192075|1545657|P1|Overall Study|Lack of Efficacy|0
473154|NCT00192075|1545656|P2|Overall Study|Death|1
473155|NCT00192075|1545657|P1|Overall Study|Death|0
473156|NCT00192075|1545656|P2|Overall Study|Adverse Event|3
473157|NCT00192075|1545657|P1|Overall Study|Adverse Event|1
473158|NCT00192075|1545656|P2|Overall Study|Disease Progression|6
473159|NCT00192075|1545657|P1|Overall Study|Disease Progression|23
473160|NCT00192036|1545682|P1|Overall Study|Unknown or Not Specified|5
473161|NCT00192036|1545682|P1|Overall Study|Death|1
473162|NCT00192036|1545682|P1|Overall Study|Clinical Disease Progression|1
473163|NCT00192036|1545682|P1|Overall Study|Objective Tumor Progression|4
473164|NCT00192036|1545682|P1|Overall Study|Patient/Physician Perception|1
473165|NCT00192036|1545682|P1|Overall Study|Adverse Event|6
473166|NCT00192036|1545682|P1|Overall Study|Protocol Violation|3
473167|NCT00192023|1545692|P2|Period IV - Optional Open-Label|Physician Decision|0
473168|NCT00192023|1545693|P1|Period IV - Optional Open-Label|Physician Decision|9
473169|NCT00192023|1545692|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
473170|NCT00192023|1545693|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
473171|NCT00192023|1545692|P2|Period IV - Optional Open-Label|Protocol Violation|0
473172|NCT00192023|1545693|P1|Period IV - Optional Open-Label|Protocol Violation|1
473173|NCT00192023|1545692|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
473174|NCT00192023|1545693|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
473175|NCT00192023|1545692|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
473176|NCT00192023|1545693|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
473177|NCT00192023|1545692|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
473178|NCT00192023|1545693|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
473179|NCT00192023|1545692|P2|Period IV - Optional Open-Label|Adverse Event|0
473180|NCT00192023|1545693|P1|Period IV - Optional Open-Label|Adverse Event|6
473181|NCT00192023|1545692|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
473182|NCT00192023|1545693|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
473183|NCT00192023|1545692|P2|Period III - Double-Blind|Physician Decision|0
473184|NCT00192023|1545693|P1|Period III - Double-Blind|Physician Decision|2
473185|NCT00192023|1545692|P2|Period III - Double-Blind|Adverse Event|0
473186|NCT00192023|1545693|P1|Period III - Double-Blind|Adverse Event|3
473187|NCT00191984|1545715|P1|Overall Study|Physician Decision|4
473188|NCT00191984|1545715|P1|Overall Study|Withdrawal by Subject|7
473189|NCT00191984|1545715|P1|Overall Study|Entry Criteria Exclusion|1
473190|NCT00191984|1545715|P1|Overall Study|Death|2
473191|NCT00191984|1545715|P1|Overall Study|Adverse Event|4
473192|NCT00191984|1545715|P1|Overall Study|Disease Progression|21
473193|NCT00191945|1545725|P2|Double-Blind Acute Treatment|Physician Decision|2
473194|NCT00191945|1545726|P1|Double-Blind Acute Treatment|Physician Decision|0
473195|NCT00191945|1545725|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
473196|NCT00191945|1545726|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
473197|NCT00191945|1545725|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
473198|NCT00191945|1545726|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
473199|NCT00191945|1545725|P2|Double-Blind Acute Treatment|Parent's Decision|0
473200|NCT00191945|1545726|P1|Double-Blind Acute Treatment|Parent's Decision|3
473201|NCT00191906|1545762|P4|Study Period III|Lack of Efficacy|0
473202|NCT00191906|1545763|P3|Study Period III|Lack of Efficacy|0
473203|NCT00191906|1545764|P2|Study Period III|Lack of Efficacy|3
473204|NCT00191906|1545765|P1|Study Period III|Lack of Efficacy|3
473205|NCT00191906|1545762|P4|Study Period III|Parent/Caregiver Decision|0
473206|NCT00191906|1545763|P3|Study Period III|Parent/Caregiver Decision|0
473207|NCT00191906|1545764|P2|Study Period III|Parent/Caregiver Decision|0
473208|NCT00191906|1545765|P1|Study Period III|Parent/Caregiver Decision|1
473209|NCT00191906|1545762|P4|Study Period III|Lost to Follow-up|0
473210|NCT00191906|1545763|P3|Study Period III|Lost to Follow-up|0
473211|NCT00191906|1545764|P2|Study Period III|Lost to Follow-up|1
473212|NCT00191906|1545765|P1|Study Period III|Lost to Follow-up|0
473213|NCT00191906|1545762|P4|Study Period III|Adverse Event|0
473214|NCT00191906|1545763|P3|Study Period III|Adverse Event|0
473215|NCT00191906|1545764|P2|Study Period III|Adverse Event|0
473216|NCT00191906|1545765|P1|Study Period III|Adverse Event|1
473217|NCT00191906|1545762|P4|Study Period II|Entry Criteria Exclusion|0
473218|NCT00191906|1545763|P3|Study Period II|Entry Criteria Exclusion|1
473219|NCT00191906|1545764|P2|Study Period II|Entry Criteria Exclusion|0
473220|NCT00191906|1545765|P1|Study Period II|Entry Criteria Exclusion|0
473221|NCT00191906|1545762|P4|Study Period II|Parent/Caregiver Decision|0
473222|NCT00191906|1545763|P3|Study Period II|Parent/Caregiver Decision|0
473223|NCT00191906|1545764|P2|Study Period II|Parent/Caregiver Decision|1
473224|NCT00191906|1545765|P1|Study Period II|Parent/Caregiver Decision|0
473225|NCT00191906|1545762|P4|Study Period II|Withdrawal by Subject|0
473226|NCT00191906|1545763|P3|Study Period II|Withdrawal by Subject|0
473227|NCT00191906|1545764|P2|Study Period II|Withdrawal by Subject|3
473228|NCT00191906|1545765|P1|Study Period II|Withdrawal by Subject|0
473229|NCT00191906|1545762|P4|Study Period II|Adverse Event|0
473230|NCT00191906|1545763|P3|Study Period II|Adverse Event|0
473231|NCT00191906|1545764|P2|Study Period II|Adverse Event|1
473232|NCT00191906|1545765|P1|Study Period II|Adverse Event|0
473233|NCT00191854|1545808|P3|Overall Study|Screen Failure|1
473234|NCT00191854|1545809|P2|Overall Study|Screen Failure|0
473235|NCT00191854|1545810|P1|Overall Study|Screen Failure|0
473236|NCT00191854|1545808|P3|Overall Study|Sponsor Decision|1
473237|NCT00191854|1545809|P2|Overall Study|Sponsor Decision|0
473238|NCT00191854|1545810|P1|Overall Study|Sponsor Decision|0
473239|NCT00191854|1545808|P3|Overall Study|Withdrawal by Subject|3
473240|NCT00191854|1545809|P2|Overall Study|Withdrawal by Subject|2
473241|NCT00191854|1545810|P1|Overall Study|Withdrawal by Subject|4
473242|NCT00191854|1545808|P3|Overall Study|Lost to Follow-up|5
473243|NCT00191854|1545809|P2|Overall Study|Lost to Follow-up|5
473244|NCT00191854|1545810|P1|Overall Study|Lost to Follow-up|7
473245|NCT00191854|1545808|P3|Overall Study|Death|29
473246|NCT00191854|1545809|P2|Overall Study|Death|23
473247|NCT00191854|1545810|P1|Overall Study|Death|26
473248|NCT00191815|1545830|P1|Overall Study|Withdrawal by Subject|7
473249|NCT00191815|1545830|P1|Overall Study|Physician Decision|2
473250|NCT00191815|1545830|P1|Overall Study|Protocol Violation|3
473251|NCT00191815|1545830|P1|Overall Study|Death|2
473252|NCT00191815|1545830|P1|Overall Study|Disease progression or relapse|24
473253|NCT00191815|1545830|P1|Overall Study|Adverse Event|2
473254|NCT00191789|1545842|P1|Overall Study|Death - Not Study-Drug Related|1
473255|NCT00191789|1545842|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
473256|NCT00191789|1545842|P1|Overall Study|Death - Possibly Study Drug Related|4
473257|NCT00191789|1545842|P1|Overall Study|Withdrawal by Subject|4
473258|NCT00191789|1545842|P1|Overall Study|Patient/Physician: Satisfactory Response|4
473259|NCT00191789|1545842|P1|Overall Study|Patient: Satisfactory Response|5
473260|NCT00191789|1545842|P1|Overall Study|Adverse Event|5
473261|NCT00191724|1545859|P5|Overall Study|Withdrawal by Subject|0
473262|NCT00191724|1545860|P4|Overall Study|Withdrawal by Subject|1
473263|NCT00191724|1545861|P3|Overall Study|Withdrawal by Subject|0
473264|NCT00191724|1545862|P2|Overall Study|Withdrawal by Subject|0
473265|NCT00191724|1545863|P1|Overall Study|Withdrawal by Subject|0
473266|NCT00191724|1545859|P5|Overall Study|Lost to Follow-up|3
473267|NCT00191724|1545860|P4|Overall Study|Lost to Follow-up|2
473268|NCT00191724|1545861|P3|Overall Study|Lost to Follow-up|0
473269|NCT00191724|1545862|P2|Overall Study|Lost to Follow-up|1
473270|NCT00191724|1545863|P1|Overall Study|Lost to Follow-up|1
473271|NCT00191724|1545859|P5|Overall Study|Adverse Event|0
473272|NCT00191724|1545860|P4|Overall Study|Adverse Event|0
473273|NCT00191724|1545861|P3|Overall Study|Adverse Event|1
473274|NCT00191724|1545862|P2|Overall Study|Adverse Event|0
473275|NCT00191724|1545863|P1|Overall Study|Adverse Event|0
473276|NCT00191646|1545892|P2|Overall Study|Missing Data|11
473277|NCT00191646|1545893|P1|Overall Study|Missing Data|18
473278|NCT00191646|1545892|P2|Overall Study|Other|34
473279|NCT00191646|1545893|P1|Overall Study|Other|33
473280|NCT00191646|1545892|P2|Overall Study|Death|8
473281|NCT00191646|1545893|P1|Overall Study|Death|6
473282|NCT00191646|1545892|P2|Overall Study|Protocol Violation|7
473283|NCT00191646|1545893|P1|Overall Study|Protocol Violation|5
473284|NCT00191646|1545892|P2|Overall Study|Withdrawal by Subject|39
473285|NCT00191646|1545893|P1|Overall Study|Withdrawal by Subject|58
473286|NCT00191646|1545892|P2|Overall Study|Physician Decision|11
473287|NCT00191646|1545893|P1|Overall Study|Physician Decision|20
473288|NCT00191646|1545892|P2|Overall Study|Disease Progression|6
473289|NCT00191646|1545893|P1|Overall Study|Disease Progression|5
473290|NCT00191646|1545892|P2|Overall Study|Toxicity|37
473291|NCT00191646|1545893|P1|Overall Study|Toxicity|26
473292|NCT00191477|1545913|P2|Overall Study|Discontinued Prior to Instillation|14
473293|NCT00191477|1545914|P1|Overall Study|Discontinued Prior to Instillation|13
473294|NCT00191477|1545913|P2|Overall Study|Pathological Specimen Lost|0
473295|NCT00191477|1545914|P1|Overall Study|Pathological Specimen Lost|1
473296|NCT00191477|1545913|P2|Overall Study|Not Eligible|38
473297|NCT00191477|1545914|P1|Overall Study|Not Eligible|41
473298|NCT00191477|1545913|P2|Overall Study|Other|0
473299|NCT00191477|1545914|P1|Overall Study|Other|2
473300|NCT00191477|1545913|P2|Overall Study|Withdrawal by Subject|0
473301|NCT00191477|1545914|P1|Overall Study|Withdrawal by Subject|2
473302|NCT00191477|1545913|P2|Overall Study|Treatment Change|0
473303|NCT00191477|1545914|P1|Overall Study|Treatment Change|2
473304|NCT00191477|1545913|P2|Overall Study|Protocol Violation|1
473305|NCT00191477|1545914|P1|Overall Study|Protocol Violation|1
473306|NCT00191477|1545913|P2|Overall Study|Lost to Follow-up|21
473307|NCT00191477|1545914|P1|Overall Study|Lost to Follow-up|23
473308|NCT00191477|1545913|P2|Overall Study|Death, Other Cause|6
473309|NCT00191477|1545914|P1|Overall Study|Death, Other Cause|3
473310|NCT00191477|1545913|P2|Overall Study|Death, Study Disease|1
473311|NCT00191477|1545914|P1|Overall Study|Death, Study Disease|1
473312|NCT00191477|1545913|P2|Overall Study|Tumor Recurrence|48
473313|NCT00191477|1545914|P1|Overall Study|Tumor Recurrence|49
473314|NCT00191451|1545933|P3|Overall Study|Reason Not Specified|3
473315|NCT00191451|1545934|P2|Overall Study|Reason Not Specified|1
473316|NCT00191451|1545935|P1|Overall Study|Reason Not Specified|2
473317|NCT00191451|1545933|P3|Overall Study|Ineligible|0
473318|NCT00191451|1545934|P2|Overall Study|Ineligible|1
473319|NCT00191451|1545935|P1|Overall Study|Ineligible|0
473320|NCT00191451|1545933|P3|Overall Study|Sponsor Decision|0
473321|NCT00191451|1545934|P2|Overall Study|Sponsor Decision|0
473322|NCT00191451|1545935|P1|Overall Study|Sponsor Decision|1
473323|NCT00191451|1545933|P3|Overall Study|Physician Decision|6
473324|NCT00191451|1545934|P2|Overall Study|Physician Decision|9
473325|NCT00191451|1545935|P1|Overall Study|Physician Decision|2
473326|NCT00191451|1545933|P3|Overall Study|Withdrawal by Subject|5
473327|NCT00191451|1545934|P2|Overall Study|Withdrawal by Subject|3
473328|NCT00191451|1545935|P1|Overall Study|Withdrawal by Subject|2
473329|NCT00191386|1545955|P1|Overall Study|Lack of Efficacy|15
473330|NCT00191386|1545955|P1|Overall Study|Physician Decision|11
473331|NCT00191386|1545955|P1|Overall Study|Withdrawal by Subject|96
473332|NCT00191386|1545955|P1|Overall Study|Protocol Violation|18
473333|NCT00191386|1545955|P1|Overall Study|Entry Criteria Exclusion|3
473334|NCT00191386|1545955|P1|Overall Study|Lost to Follow-up|1
473335|NCT00191386|1545955|P1|Overall Study|Adverse Event|16
473336|NCT00191334|1545962|P1|Overall Study|Withdrawal by Subject|4
473337|NCT00191334|1545962|P1|Overall Study|Physician Decision|1
473338|NCT00191334|1545962|P1|Overall Study|Disease Progression or Relapse|8
473339|NCT00191334|1545962|P1|Overall Study|Adverse Event|4
473340|NCT00191308|1545970|P1|Overall Study|Adverse Event|1
473341|NCT00191282|1545980|P2|Overall Study|Lost to Follow-up|31
473342|NCT00191282|1545981|P1|Overall Study|Lost to Follow-up|24
473343|NCT00191282|1545980|P2|Overall Study|Sponsor's decision|2
473344|NCT00191282|1545981|P1|Overall Study|Sponsor's decision|2
473345|NCT00191282|1545980|P2|Overall Study|Severity of outcome|5
473346|NCT00191282|1545981|P1|Overall Study|Severity of outcome|2
473347|NCT00191282|1545980|P2|Overall Study|Protocol Violation|12
473348|NCT00191282|1545981|P1|Overall Study|Protocol Violation|9
473349|NCT00191282|1545980|P2|Overall Study|Protocol entry criteria not met|9
473350|NCT00191282|1545981|P1|Overall Study|Protocol entry criteria not met|14
473351|NCT00191282|1545980|P2|Overall Study|Physician Decision|15
473352|NCT00191282|1545981|P1|Overall Study|Physician Decision|18
473353|NCT00191282|1545980|P2|Overall Study|Withdrawal by Subject|44
473354|NCT00191282|1545981|P1|Overall Study|Withdrawal by Subject|59
473355|NCT00191282|1545980|P2|Overall Study|Patient moved|14
473356|NCT00191282|1545981|P1|Overall Study|Patient moved|11
473357|NCT00191282|1545980|P2|Overall Study|Noncompliance|17
473358|NCT00191282|1545981|P1|Overall Study|Noncompliance|14
473359|NCT00191282|1545980|P2|Overall Study|Lack of Efficacy|6
473360|NCT00191282|1545981|P1|Overall Study|Lack of Efficacy|11
473361|NCT00191282|1545980|P2|Overall Study|Death|51
473362|NCT00191282|1545981|P1|Overall Study|Death|51
473363|NCT00191282|1545980|P2|Overall Study|Adverse Event|6
473364|NCT00191282|1545981|P1|Overall Study|Adverse Event|5
473365|NCT00191269|1546041|P2|Overall Study|Physician Decision|3
473366|NCT00191269|1546042|P1|Overall Study|Physician Decision|0
473367|NCT00191269|1546041|P2|Overall Study|Pathologic Aggrevation|1
473368|NCT00191269|1546042|P1|Overall Study|Pathologic Aggrevation|0
473369|NCT00191269|1546041|P2|Overall Study|Withdrawal by Subject|1
473370|NCT00191269|1546042|P1|Overall Study|Withdrawal by Subject|0
473371|NCT00191269|1546041|P2|Overall Study|Lack of Efficacy|5
473372|NCT00191269|1546042|P1|Overall Study|Lack of Efficacy|1
473373|NCT00191269|1546041|P2|Overall Study|Progression of Disease|42
473374|NCT00191269|1546042|P1|Overall Study|Progression of Disease|4
473375|NCT00191269|1546041|P2|Overall Study|Adverse Event|4
473376|NCT00191269|1546042|P1|Overall Study|Adverse Event|1
473377|NCT00191269|1546041|P2|Overall Study|Protocol Violation|2
473378|NCT00191269|1546042|P1|Overall Study|Protocol Violation|0
473379|NCT00191191|1546058|P2|Overall Study|Good Clinical Practice Violation|1
473380|NCT00191191|1546059|P1|Overall Study|Good Clinical Practice Violation|0
473381|NCT00191191|1546058|P2|Overall Study|Physician Decision|2
473382|NCT00191191|1546059|P1|Overall Study|Physician Decision|3
473383|NCT00191191|1546058|P2|Overall Study|Lost to Follow-up|0
473384|NCT00191191|1546059|P1|Overall Study|Lost to Follow-up|1
473385|NCT00191191|1546058|P2|Overall Study|Family/Caregiver Decision|7
473386|NCT00191191|1546059|P1|Overall Study|Family/Caregiver Decision|5
473387|NCT00191191|1546058|P2|Overall Study|Toxicity After Dose Reduction|8
473388|NCT00191191|1546059|P1|Overall Study|Toxicity After Dose Reduction|7
473389|NCT00191191|1546058|P2|Overall Study|Progressive Disease|72
473390|NCT00191191|1546059|P1|Overall Study|Progressive Disease|84
473391|NCT00191191|1546058|P2|Overall Study|Adverse Event|21
473392|NCT00191191|1546059|P1|Overall Study|Adverse Event|11
473393|NCT00191191|1546058|P2|Overall Study|Treated with Another Systemic Agent|1
473394|NCT00191191|1546059|P1|Overall Study|Treated with Another Systemic Agent|1
473395|NCT00191191|1546058|P2|Overall Study|Entry Criteria Exclusion|0
473396|NCT00191191|1546059|P1|Overall Study|Entry Criteria Exclusion|2
473397|NCT00191165|1546075|P2|Overall Study|Participant Moved Away|1
473398|NCT00191165|1546076|P1|Overall Study|Participant Moved Away|0
473399|NCT00191165|1546075|P2|Overall Study|Protocol Violation|1
473400|NCT00191165|1546076|P1|Overall Study|Protocol Violation|0
473401|NCT00191165|1546075|P2|Overall Study|Adverse Event|0
473402|NCT00191165|1546076|P1|Overall Study|Adverse Event|2
473403|NCT00191152|1546088|P2|Crossover Treatment|Not Specified|3
473404|NCT00191152|1546089|P1|Crossover Treatment|Not Specified|4
473405|NCT00191152|1546088|P2|Crossover Treatment|Lost to Follow-up|1
473406|NCT00191152|1546089|P1|Crossover Treatment|Lost to Follow-up|2
473407|NCT00191152|1546088|P2|Crossover Treatment|Withdrawal by Subject|9
473408|NCT00191152|1546089|P1|Crossover Treatment|Withdrawal by Subject|6
473409|NCT00191152|1546088|P2|Crossover Treatment|Physician Decision|7
473410|NCT00191152|1546089|P1|Crossover Treatment|Physician Decision|7
473411|NCT00191152|1546088|P2|Crossover Treatment|Adverse Event|8
473412|NCT00191152|1546089|P1|Crossover Treatment|Adverse Event|8
473413|NCT00191152|1546088|P2|Initial Treatment|not specified|21
473414|NCT00191152|1546089|P1|Initial Treatment|not specified|18
473415|NCT00191152|1546088|P2|Initial Treatment|Lost to Follow-up|6
473416|NCT00191152|1546089|P1|Initial Treatment|Lost to Follow-up|0
473417|NCT00191152|1546088|P2|Initial Treatment|Withdrawal by Subject|28
473418|NCT00191152|1546089|P1|Initial Treatment|Withdrawal by Subject|40
473419|NCT00191152|1546088|P2|Initial Treatment|Physician Decision|31
473420|NCT00191152|1546089|P1|Initial Treatment|Physician Decision|40
473421|NCT00191152|1546088|P2|Initial Treatment|Adverse Event|67
473422|NCT00191152|1546089|P1|Initial Treatment|Adverse Event|43
473423|NCT00191139|1546121|P2|Overall Study|Other|2
473424|NCT00191139|1546122|P1|Overall Study|Other|1
473425|NCT00191139|1546121|P2|Overall Study|Disease Progression|1
473426|NCT00191139|1546122|P1|Overall Study|Disease Progression|0
473427|NCT00191139|1546121|P2|Overall Study|Withdrawal by Subject|3
473428|NCT00191139|1546122|P1|Overall Study|Withdrawal by Subject|0
473429|NCT00191139|1546121|P2|Overall Study|Death|0
473430|NCT00191139|1546122|P1|Overall Study|Death|2
473431|NCT00191139|1546121|P2|Overall Study|Adverse Event|6
473432|NCT00191139|1546122|P1|Overall Study|Adverse Event|2
473433|NCT00191113|1546138|P2|Core Study|Death|0
473434|NCT00191113|1546139|P1|Core Study|Death|1
473435|NCT00191113|1546138|P2|Core Study|Lack of Efficacy|2
473436|NCT00191113|1546139|P1|Core Study|Lack of Efficacy|0
473437|NCT00191113|1546138|P2|Core Study|Adverse Event|2
473438|NCT00191113|1546139|P1|Core Study|Adverse Event|0
473439|NCT00191113|1546138|P2|Core Study|Lost to Follow-up|0
473440|NCT00191113|1546139|P1|Core Study|Lost to Follow-up|3
473441|NCT00191113|1546138|P2|Core Study|Protocol Violation|2
473442|NCT00191113|1546139|P1|Core Study|Protocol Violation|6
473443|NCT00191113|1546138|P2|Core Study|Withdrawal by Subject|9
473444|NCT00191113|1546139|P1|Core Study|Withdrawal by Subject|25
473445|NCT00191100|1546181|P2|Overall Study|Reason Not Specified|1
473446|NCT00191100|1546182|P1|Overall Study|Reason Not Specified|0
473447|NCT00191100|1546181|P2|Overall Study|Death from Other Cause|0
473448|NCT00191100|1546182|P1|Overall Study|Death from Other Cause|1
473449|NCT00191100|1546181|P2|Overall Study|Protocol Violation|1
473450|NCT00191100|1546182|P1|Overall Study|Protocol Violation|1
473451|NCT00191100|1546181|P2|Overall Study|Death from Study Drug Toxicity|0
473452|NCT00191100|1546182|P1|Overall Study|Death from Study Drug Toxicity|2
473453|NCT00191100|1546181|P2|Overall Study|Physician Decision|1
473454|NCT00191100|1546182|P1|Overall Study|Physician Decision|3
473455|NCT00191100|1546181|P2|Overall Study|Lack of Efficacy, Stable Disease|0
473456|NCT00191100|1546182|P1|Overall Study|Lack of Efficacy, Stable Disease|1
473457|NCT00191100|1546181|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
473458|NCT00191100|1546182|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
473459|NCT00191100|1546181|P2|Overall Study|Clinical Relapse|1
473460|NCT00191100|1546182|P1|Overall Study|Clinical Relapse|2
473461|NCT00191100|1546181|P2|Overall Study|Protocol Entry Criteria Not Met|1
473462|NCT00191100|1546182|P1|Overall Study|Protocol Entry Criteria Not Met|2
473463|NCT00191100|1546181|P2|Overall Study|Withdrawal by Subject|3
473464|NCT00191100|1546182|P1|Overall Study|Withdrawal by Subject|9
473465|NCT00191100|1546181|P2|Overall Study|Patient Moved|1
473466|NCT00191100|1546182|P1|Overall Study|Patient Moved|0
473467|NCT00191100|1546181|P2|Overall Study|Lost to Follow-up|0
473468|NCT00191100|1546182|P1|Overall Study|Lost to Follow-up|2
473469|NCT00191100|1546181|P2|Overall Study|Adverse Event|1
473470|NCT00191100|1546182|P1|Overall Study|Adverse Event|18
473471|NCT00190983|1546198|P1|Overall Study|Inevaluable (never treated)|2
473472|NCT00190775|1546207|P2|Overall Study|Exclusion Criteria Met|3
473473|NCT00190775|1546208|P1|Overall Study|Exclusion Criteria Met|1
473474|NCT00190775|1546207|P2|Overall Study|Protocol Violation|1
473475|NCT00190775|1546208|P1|Overall Study|Protocol Violation|0
473476|NCT00190775|1546207|P2|Overall Study|Noncompliance|5
473477|NCT00190775|1546208|P1|Overall Study|Noncompliance|3
473478|NCT00190775|1546207|P2|Overall Study|Physician Decision|0
473479|NCT00190775|1546208|P1|Overall Study|Physician Decision|3
473480|NCT00190775|1546207|P2|Overall Study|Sponsor Decision|0
473481|NCT00190775|1546208|P1|Overall Study|Sponsor Decision|1
473482|NCT00190775|1546207|P2|Overall Study|Withdrawal by Subject|13
473483|NCT00190775|1546208|P1|Overall Study|Withdrawal by Subject|24
473484|NCT00190775|1546207|P2|Overall Study|Participant Moved|1
473485|NCT00190775|1546208|P1|Overall Study|Participant Moved|0
473486|NCT00190775|1546207|P2|Overall Study|Lost to Follow-up|23
473487|NCT00190775|1546208|P1|Overall Study|Lost to Follow-up|31
473488|NCT00190775|1546207|P2|Overall Study|Lack of Efficacy|32
473489|NCT00190775|1546208|P1|Overall Study|Lack of Efficacy|28
473490|NCT00190775|1546207|P2|Overall Study|Satisfactory Response|0
473491|NCT00190775|1546208|P1|Overall Study|Satisfactory Response|1
473492|NCT00190775|1546207|P2|Overall Study|Adverse Event|22
473493|NCT00190775|1546208|P1|Overall Study|Adverse Event|57
473494|NCT00190749|1546279|P2|Overall Study|Sponsor Decision|0
473495|NCT00190749|1546280|P1|Overall Study|Sponsor Decision|1
473496|NCT00190749|1546279|P2|Overall Study|Reason Not Specified|2
473497|NCT00190749|1546280|P1|Overall Study|Reason Not Specified|0
473498|NCT00190749|1546279|P2|Overall Study|Lack of Efficacy|3
473499|NCT00190749|1546280|P1|Overall Study|Lack of Efficacy|2
473500|NCT00190749|1546279|P2|Overall Study|Adverse Event|5
473501|NCT00190749|1546280|P1|Overall Study|Adverse Event|0
473502|NCT00190749|1546279|P2|Overall Study|Protocol Violation|4
473503|NCT00190749|1546280|P1|Overall Study|Protocol Violation|5
473504|NCT00190749|1546279|P2|Overall Study|Withdrawal by Subject|6
473505|NCT00190749|1546280|P1|Overall Study|Withdrawal by Subject|10
473506|NCT00190749|1546279|P2|Overall Study|Lost to Follow-up|11
473507|NCT00190749|1546280|P1|Overall Study|Lost to Follow-up|8
473508|NCT00190684|1546344|P1|Overall Study|Study Period V Completed|1
473509|NCT00190684|1546344|P1|Overall Study|Study Period III Completed|103
473510|NCT00190684|1546344|P1|Overall Study|Protocol Violation|123
473511|NCT00190684|1546344|P1|Overall Study|Physician Decision|84
473512|NCT00190684|1546344|P1|Overall Study|Sponsor's decision|17
473513|NCT00190684|1546344|P1|Overall Study|Clinical relapse|67
473514|NCT00190684|1546344|P1|Overall Study|Patient Decision|432
473515|NCT00190684|1546344|P1|Overall Study|Patient moved|60
473516|NCT00190684|1546344|P1|Overall Study|Lost to Follow-up|232
473517|NCT00190684|1546344|P1|Overall Study|Lack of efficacy|204
473518|NCT00190684|1546344|P1|Overall Study|Satisfactory response|80
473519|NCT00190684|1546344|P1|Overall Study|Adverse Event|86
473520|NCT00190671|1546365|P2|Overall Study|Withdrawal by Subject|2
473521|NCT00190671|1546366|P1|Overall Study|Withdrawal by Subject|0
473522|NCT00190671|1546365|P2|Overall Study|Protocol Violation|1
473523|NCT00190671|1546366|P1|Overall Study|Protocol Violation|0
473524|NCT00190671|1546365|P2|Overall Study|Death from Other Causes|2
473525|NCT00190671|1546366|P1|Overall Study|Death from Other Causes|0
473526|NCT00190671|1546365|P2|Overall Study|Death from Study-Drug Toxicity|2
473527|NCT00190671|1546366|P1|Overall Study|Death from Study-Drug Toxicity|0
473528|NCT00190671|1546365|P2|Overall Study|Clinical Relapse|1
473529|NCT00190671|1546366|P1|Overall Study|Clinical Relapse|0
473530|NCT00190671|1546365|P2|Overall Study|Adverse Event|2
473531|NCT00190671|1546366|P1|Overall Study|Adverse Event|3
473532|NCT00190671|1546365|P2|Overall Study|Death from Study Disease|1
473533|NCT00190671|1546366|P1|Overall Study|Death from Study Disease|1
473534|NCT00190671|1546365|P2|Overall Study|Lack of Efficacy|24
473535|NCT00190671|1546366|P1|Overall Study|Lack of Efficacy|19
473536|NCT00190671|1546365|P2|Overall Study|Satisfactory Response|7
473537|NCT00190671|1546366|P1|Overall Study|Satisfactory Response|4
473538|NCT00189540|1546386|P2|Overall Study|Death|1
473539|NCT00189540|1546387|P1|Overall Study|Death|4
473540|NCT00189540|1546386|P2|Overall Study|Withdrawal by Subject|0
473541|NCT00189540|1546387|P1|Overall Study|Withdrawal by Subject|3
473542|NCT00189488|1546405|P2|Overall Study|Other|0
473543|NCT00189488|1546406|P1|Overall Study|Other|1
473544|NCT00189488|1546405|P2|Overall Study|Death|8
473545|NCT00189488|1546406|P1|Overall Study|Death|5
473546|NCT00189488|1546405|P2|Overall Study|Administrative Decision|2
473547|NCT00189488|1546406|P1|Overall Study|Administrative Decision|0
473548|NCT00189488|1546405|P2|Overall Study|Disease progression|4
473549|NCT00189488|1546406|P1|Overall Study|Disease progression|2
473550|NCT00189488|1546405|P2|Overall Study|Withdrawal by Subject|6
473551|NCT00189488|1546406|P1|Overall Study|Withdrawal by Subject|2
473552|NCT00189488|1546405|P2|Overall Study|Adverse Event|1
473553|NCT00189488|1546406|P1|Overall Study|Adverse Event|2
473554|NCT00189488|1546405|P2|Overall Study|Protocol deviation|1
473555|NCT00189488|1546406|P1|Overall Study|Protocol deviation|2
473556|NCT00189488|1546405|P2|Overall Study|Ineligibility determined|0
473557|NCT00189488|1546406|P1|Overall Study|Ineligibility determined|1
473558|NCT00189462|1546437|P2|Overall Study|Lost to Follow-up|20
473559|NCT00189462|1546438|P1|Overall Study|Lost to Follow-up|18
473560|NCT00189462|1546437|P2|Overall Study|Lack of Efficacy|1
473561|NCT00189462|1546438|P1|Overall Study|Lack of Efficacy|5
473562|NCT00189423|1546455|P2|Overall Study|Lost to Follow-up|10
473563|NCT00189423|1546456|P1|Overall Study|Lost to Follow-up|10
473564|NCT00189423|1546455|P2|Overall Study|Withdrawal by Subject|9
473565|NCT00189423|1546456|P1|Overall Study|Withdrawal by Subject|9
473566|NCT00189423|1546455|P2|Overall Study|Death|747
473567|NCT00189423|1546456|P1|Overall Study|Death|746
473568|NCT00189306|1546478|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
473569|NCT00189306|1546478|P1|Long-Term Follow-up|Lost to Follow-up|9
473570|NCT00189306|1546478|P1|Long-Term Follow-up|Intercurrent disease|2
473571|NCT00189306|1546478|P1|Long-Term Follow-up|Withdrawal by Subject|1
473572|NCT00189306|1546478|P1|Long-Term Follow-up|Death|4
473573|NCT00189306|1546478|P1|Long-Term Follow-up|Adverse Event|2
473574|NCT00189306|1546478|P1|Posttreatment Period|Local skin reaction/sign|1
473575|NCT00189306|1546478|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
473576|NCT00189306|1546478|P1|Posttreatment Period|Protocol Violation|1
473577|NCT00189306|1546478|P1|Posttreatment Period|Target lesion excised|1
473578|NCT00189306|1546478|P1|Posttreatment Period|Noncompliance|1
473579|NCT00189306|1546478|P1|Posttreatment Period|Withdrawal by Subject|2
473580|NCT00189306|1546478|P1|Posttreatment Period|Death|1
473581|NCT00189306|1546478|P1|Treatment Period|Protocol Violation|1
473582|NCT00189306|1546478|P1|Treatment Period|Adverse Event|2
473583|NCT00189306|1546478|P1|Treatment Period|Withdrawal by Subject|2
473584|NCT00189202|1546483|P1|Overall Study|Physician Decision|5
473585|NCT00187889|1546524|P2|Overall Study|Withdrawal by Subject|4
473586|NCT00187889|1546525|P1|Overall Study|Withdrawal by Subject|6
473587|NCT00187486|1546567|P1|Overall Study|Protocol Violation|1
473588|NCT00187135|1546618|P6|Visit Three|Study Discontinued|6
473589|NCT00187135|1546619|P5|Visit Three|Study Discontinued|7
473590|NCT00187135|1546620|P4|Visit Three|Study Discontinued|7
473591|NCT00187135|1546621|P3|Visit Three|Study Discontinued|7
473592|NCT00187135|1546622|P2|Visit Three|Study Discontinued|6
473593|NCT00187135|1546623|P1|Visit Three|Study Discontinued|7
473594|NCT00187135|1546618|P6|Visit Three|Withdrawal by Subject|0
473595|NCT00187135|1546619|P5|Visit Three|Withdrawal by Subject|0
473596|NCT00187135|1546620|P4|Visit Three|Withdrawal by Subject|2
473597|NCT00187135|1546621|P3|Visit Three|Withdrawal by Subject|1
473598|NCT00187135|1546622|P2|Visit Three|Withdrawal by Subject|1
473599|NCT00187135|1546623|P1|Visit Three|Withdrawal by Subject|0
473600|NCT00187135|1546618|P6|Visit Three|Death|0
473601|NCT00187135|1546619|P5|Visit Three|Death|1
473602|NCT00187135|1546620|P4|Visit Three|Death|0
473603|NCT00187135|1546621|P3|Visit Three|Death|1
473604|NCT00187135|1546622|P2|Visit Three|Death|0
473605|NCT00187135|1546623|P1|Visit Three|Death|0
473606|NCT00187135|1546618|P6|Visit Two|Study Discontinued|6
473607|NCT00187135|1546619|P5|Visit Two|Study Discontinued|5
473608|NCT00187135|1546620|P4|Visit Two|Study Discontinued|7
473609|NCT00187135|1546621|P3|Visit Two|Study Discontinued|1
473610|NCT00187135|1546622|P2|Visit Two|Study Discontinued|2
473611|NCT00187135|1546623|P1|Visit Two|Study Discontinued|3
473612|NCT00187135|1546618|P6|Visit Two|Withdrawal by Subject|1
473613|NCT00187135|1546619|P5|Visit Two|Withdrawal by Subject|1
473614|NCT00187135|1546620|P4|Visit Two|Withdrawal by Subject|0
473615|NCT00187135|1546621|P3|Visit Two|Withdrawal by Subject|1
473616|NCT00187135|1546622|P2|Visit Two|Withdrawal by Subject|1
473617|NCT00187135|1546623|P1|Visit Two|Withdrawal by Subject|1
473618|NCT00187135|1546618|P6|Visit Two|Physician Decision|0
473619|NCT00187135|1546619|P5|Visit Two|Physician Decision|0
473620|NCT00187135|1546620|P4|Visit Two|Physician Decision|0
473621|NCT00187135|1546621|P3|Visit Two|Physician Decision|0
473622|NCT00187135|1546622|P2|Visit Two|Physician Decision|0
473623|NCT00187135|1546623|P1|Visit Two|Physician Decision|1
473624|NCT00187135|1546618|P6|Visit Two|Death|1
473625|NCT00187135|1546619|P5|Visit Two|Death|0
473626|NCT00187135|1546620|P4|Visit Two|Death|1
473627|NCT00187135|1546621|P3|Visit Two|Death|0
473628|NCT00187135|1546622|P2|Visit Two|Death|0
473629|NCT00187135|1546623|P1|Visit Two|Death|0
473630|NCT00187135|1546618|P6|Visit One|Physician Decision|1
473631|NCT00187135|1546619|P5|Visit One|Physician Decision|0
473632|NCT00187135|1546620|P4|Visit One|Physician Decision|0
473633|NCT00187135|1546621|P3|Visit One|Physician Decision|0
473634|NCT00187135|1546622|P2|Visit One|Physician Decision|1
473635|NCT00187135|1546623|P1|Visit One|Physician Decision|3
473636|NCT00187135|1546618|P6|Visit One|Withdrawal by Subject|1
473637|NCT00187135|1546619|P5|Visit One|Withdrawal by Subject|0
473638|NCT00187135|1546620|P4|Visit One|Withdrawal by Subject|0
473639|NCT00187135|1546621|P3|Visit One|Withdrawal by Subject|0
473640|NCT00187135|1546622|P2|Visit One|Withdrawal by Subject|0
473641|NCT00187135|1546623|P1|Visit One|Withdrawal by Subject|1
473642|NCT00187096|1546646|P3|Overall Study|unacceptable toxicity|1
473643|NCT00187096|1546647|P2|Overall Study|unacceptable toxicity|0
473644|NCT00187096|1546648|P1|Overall Study|unacceptable toxicity|0
473645|NCT00186901|1546686|P3|Overall Study|Bone Mineral Density > 0|149
473646|NCT00186901|1546687|P2|Overall Study|Bone Mineral Density > 0|0
473647|NCT00186901|1546688|P1|Overall Study|Bone Mineral Density > 0|0
473648|NCT00186901|1546686|P3|Overall Study|Limited adherence to study requirements|0
473649|NCT00186901|1546687|P2|Overall Study|Limited adherence to study requirements|23
473650|NCT00186901|1546688|P1|Overall Study|Limited adherence to study requirements|20
473651|NCT00186901|1546686|P3|Overall Study|Open label|0
473652|NCT00186901|1546687|P2|Overall Study|Open label|2
473653|NCT00186901|1546688|P1|Overall Study|Open label|3
473654|NCT00186901|1546686|P3|Overall Study|Withdrawal by Subject|0
473655|NCT00186901|1546687|P2|Overall Study|Withdrawal by Subject|5
473656|NCT00186901|1546688|P1|Overall Study|Withdrawal by Subject|4
473657|NCT00186901|1546686|P3|Overall Study|ALL relapse or second malignancy|0
473658|NCT00186901|1546687|P2|Overall Study|ALL relapse or second malignancy|2
473659|NCT00186901|1546688|P1|Overall Study|ALL relapse or second malignancy|1
473660|NCT00186901|1546686|P3|Overall Study|Bone Mineral Density dropped > 5%|0
473661|NCT00186901|1546687|P2|Overall Study|Bone Mineral Density dropped > 5%|7
473662|NCT00186901|1546688|P1|Overall Study|Bone Mineral Density dropped > 5%|9
473663|NCT00186901|1546686|P3|Overall Study|Lost to Follow-up|0
473664|NCT00186901|1546687|P2|Overall Study|Lost to Follow-up|3
473665|NCT00186901|1546688|P1|Overall Study|Lost to Follow-up|6
473666|NCT00186901|1546686|P3|Overall Study|Pregnancy|0
473667|NCT00186901|1546687|P2|Overall Study|Pregnancy|3
473668|NCT00186901|1546688|P1|Overall Study|Pregnancy|6
473669|NCT00186888|1546728|P3|Overall Study|Relapse or progression of disease|0
473670|NCT00186888|1546729|P2|Overall Study|Relapse or progression of disease|2
473671|NCT00186888|1546730|P1|Overall Study|Relapse or progression of disease|4
473672|NCT00186888|1546728|P3|Overall Study|Toxicity|0
473673|NCT00186888|1546729|P2|Overall Study|Toxicity|1
473674|NCT00186888|1546730|P1|Overall Study|Toxicity|0
473675|NCT00186628|1546822|P1|Overall Study|Withdrawal by subject (before treatment)|1
473676|NCT00186628|1546822|P1|Overall Study|Death|2
473677|NCT00186537|1546833|P3|Overall Study|ALT > 1.5 x ULN|0
473678|NCT00186537|1546834|P2|Overall Study|ALT > 1.5 x ULN|0
473679|NCT00186537|1546835|P1|Overall Study|ALT > 1.5 x ULN|3
473680|NCT00186537|1546833|P3|Overall Study|Withdrawal by Subject|3
473681|NCT00186537|1546834|P2|Overall Study|Withdrawal by Subject|0
473682|NCT00186537|1546835|P1|Overall Study|Withdrawal by Subject|4
473683|NCT00186485|1546849|P1|Overall Study|Lost to Follow-up|3
473684|NCT00186186|1546861|P1|Overall Study|Not reported as to reason|2
473685|NCT00186186|1546861|P1|Overall Study|Withdrawal by Subject|3
473686|NCT00186186|1546861|P1|Overall Study|Lack of Efficacy|3
473687|NCT00186121|1546866|P1|Overall Study|Not eligible (no treatment)|1
473688|NCT00186121|1546866|P1|Overall Study|Underwent oophorectomy (no treatment)|1
473689|NCT00186121|1546866|P1|Overall Study|Subject withdrawal (no treatment)|1
473690|NCT00186043|1546900|P2|Overall Study|Protocol Violation|1
473691|NCT00186043|1546901|P1|Overall Study|Protocol Violation|2
473692|NCT00186043|1546900|P2|Overall Study|Adverse Event|3
473693|NCT00186043|1546901|P1|Overall Study|Adverse Event|7
473694|NCT00186043|1546900|P2|Overall Study|Withdrawal by Subject|0
473695|NCT00186043|1546901|P1|Overall Study|Withdrawal by Subject|1
473696|NCT00186043|1546900|P2|Overall Study|Lost to Follow-up|6
473697|NCT00186043|1546901|P1|Overall Study|Lost to Follow-up|4
473698|NCT00186043|1546900|P2|Overall Study|Lack of Efficacy|3
473699|NCT00186043|1546901|P1|Overall Study|Lack of Efficacy|1
473700|NCT00185965|1546928|P2|Overall Study|Adverse Event|1
473701|NCT00185965|1546929|P1|Overall Study|Adverse Event|0
473702|NCT00185731|1546935|P1|Overall Study|Not Eligible|1
473703|NCT00185731|1546935|P1|Overall Study|Withdrawal by Subject|1
473704|NCT00185640|1546952|P1|Overall Study|Death|138
473705|NCT00185640|1546952|P1|Overall Study|Withdrawal by Subject|3
473706|NCT00185640|1546952|P1|Overall Study|Not Eligible|4
473707|NCT00185614|1546961|P1|Inter-treatment Period|Lack of allogenic donor|1
473708|NCT00185614|1546961|P1|Inter-treatment Period|Relapse|2
473709|NCT00185614|1546961|P1|Inter-treatment Period|Physician Decision|1
473710|NCT00185588|1546973|P4|Overall Study|Physician Decision|0
473711|NCT00185588|1546974|P3|Overall Study|Physician Decision|1
473712|NCT00185588|1546975|P2|Overall Study|Physician Decision|0
473713|NCT00185588|1546976|P1|Overall Study|Physician Decision|0
473714|NCT00185588|1546973|P4|Overall Study|Withdrawal by Subject|0
473715|NCT00185588|1546974|P3|Overall Study|Withdrawal by Subject|0
473716|NCT00185588|1546975|P2|Overall Study|Withdrawal by Subject|1
473717|NCT00185588|1546976|P1|Overall Study|Withdrawal by Subject|0
473718|NCT00185588|1546973|P4|Overall Study|Lost to Follow-up|2
473719|NCT00185588|1546974|P3|Overall Study|Lost to Follow-up|1
473720|NCT00185588|1546975|P2|Overall Study|Lost to Follow-up|0
473721|NCT00185588|1546976|P1|Overall Study|Lost to Follow-up|0
473722|NCT00185588|1546973|P4|Overall Study|Adverse Event|2
473723|NCT00185588|1546974|P3|Overall Study|Adverse Event|4
473724|NCT00185588|1546975|P2|Overall Study|Adverse Event|1
473725|NCT00185588|1546976|P1|Overall Study|Adverse Event|3
473726|NCT00185458|1546990|P1|HRT Phase|Withdrawal by Subject|3
473727|NCT00185458|1546990|P1|HRT Phase|Protocol Violation|2
473728|NCT00185458|1546990|P1|HRT Phase|Lost to Follow-up|4
473729|NCT00185458|1546990|P1|HRT Phase|Adverse Event|18
473730|NCT00185458|1546990|P1|Contraception Phase|Withdrawal by Subject|7
473731|NCT00185458|1546990|P1|Contraception Phase|Physician Decision|2
473732|NCT00185458|1546990|P1|Contraception Phase|Protocol Violation|2
473733|NCT00185458|1546990|P1|Contraception Phase|Lost to Follow-up|10
473734|NCT00185458|1546990|P1|Contraception Phase|Adverse Event|37
473735|NCT00185380|1547053|P3|Overall Study|personal reason|1
473736|NCT00185380|1547054|P2|Overall Study|personal reason|1
473737|NCT00185380|1547055|P1|Overall Study|personal reason|6
473738|NCT00185380|1547053|P3|Overall Study|Could not attend visits|4
473739|NCT00185380|1547054|P2|Overall Study|Could not attend visits|0
473740|NCT00185380|1547055|P1|Overall Study|Could not attend visits|2
473741|NCT00185380|1547053|P3|Overall Study|No need for contraception|3
473742|NCT00185380|1547054|P2|Overall Study|No need for contraception|3
473743|NCT00185380|1547055|P1|Overall Study|No need for contraception|3
473744|NCT00185380|1547053|P3|Overall Study|Planned pregnancy|12
473745|NCT00185380|1547054|P2|Overall Study|Planned pregnancy|12
473746|NCT00185380|1547055|P1|Overall Study|Planned pregnancy|9
473747|NCT00185380|1547053|P3|Overall Study|Failed insertion|2
473748|NCT00185380|1547054|P2|Overall Study|Failed insertion|1
473749|NCT00185380|1547055|P1|Overall Study|Failed insertion|1
473750|NCT00185380|1547053|P3|Overall Study|Withdrawal by Subject|0
473751|NCT00185380|1547054|P2|Overall Study|Withdrawal by Subject|2
473752|NCT00185380|1547055|P1|Overall Study|Withdrawal by Subject|1
473753|NCT00185380|1547053|P3|Overall Study|Protocol Violation|1
473754|NCT00185380|1547054|P2|Overall Study|Protocol Violation|2
473755|NCT00185380|1547055|P1|Overall Study|Protocol Violation|2
473756|NCT00185380|1547053|P3|Overall Study|Pregnancy|0
473757|NCT00185380|1547054|P2|Overall Study|Pregnancy|4
473758|NCT00185380|1547055|P1|Overall Study|Pregnancy|1
473759|NCT00185380|1547053|P3|Overall Study|Lost to Follow-up|3
473760|NCT00185380|1547054|P2|Overall Study|Lost to Follow-up|4
473761|NCT00185380|1547055|P1|Overall Study|Lost to Follow-up|0
473762|NCT00185380|1547053|P3|Overall Study|Adverse Event|48
473763|NCT00185380|1547054|P2|Overall Study|Adverse Event|43
473764|NCT00185380|1547055|P1|Overall Study|Adverse Event|41
473765|NCT00185211|1547083|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
473766|NCT00185211|1547084|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
473767|NCT00185211|1547083|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
473768|NCT00185211|1547084|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
473769|NCT00185211|1547083|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
473770|NCT00185211|1547084|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
473771|NCT00185211|1547083|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
473772|NCT00185211|1547084|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
473773|NCT00185211|1547083|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
473774|NCT00185211|1547084|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
473775|NCT00185211|1547083|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
473776|NCT00185211|1547084|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
473777|NCT00185211|1547083|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
473778|NCT00185211|1547084|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
473779|NCT00185211|1547083|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
473780|NCT00185211|1547084|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
473781|NCT00185211|1547083|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
473782|NCT00185211|1547084|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
473783|NCT00185211|1547083|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
473784|NCT00185211|1547084|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
473785|NCT00185211|1547083|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
473786|NCT00185211|1547084|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
473787|NCT00185211|1547083|P2|Placebo-controlled Study (92012)|Adverse Event|0
473788|NCT00185211|1547084|P1|Placebo-controlled Study (92012)|Adverse Event|8
473789|NCT00184600|1547157|P3|Overall Study|Unclassified|3
473790|NCT00184600|1547158|P2|Overall Study|Unclassified|5
473791|NCT00184600|1547159|P1|Overall Study|Unclassified|4
473792|NCT00184600|1547157|P3|Overall Study|Withdrawal by Subject|12
473793|NCT00184600|1547158|P2|Overall Study|Withdrawal by Subject|28
473794|NCT00184600|1547159|P1|Overall Study|Withdrawal by Subject|20
473795|NCT00184600|1547157|P3|Overall Study|Protocol Violation|3
473796|NCT00184600|1547158|P2|Overall Study|Protocol Violation|2
473797|NCT00184600|1547159|P1|Overall Study|Protocol Violation|2
473798|NCT00184600|1547157|P3|Overall Study|Lost to Follow-up|1
473799|NCT00184600|1547158|P2|Overall Study|Lost to Follow-up|6
473800|NCT00184600|1547159|P1|Overall Study|Lost to Follow-up|4
473801|NCT00184600|1547157|P3|Overall Study|Lack of Efficacy|3
473802|NCT00184600|1547158|P2|Overall Study|Lack of Efficacy|1
473803|NCT00184600|1547159|P1|Overall Study|Lack of Efficacy|3
473804|NCT00184600|1547157|P3|Overall Study|Death|7
473805|NCT00184600|1547158|P2|Overall Study|Death|9
473806|NCT00184600|1547159|P1|Overall Study|Death|3
473807|NCT00184600|1547157|P3|Overall Study|Adverse Event|5
473808|NCT00184600|1547158|P2|Overall Study|Adverse Event|0
473809|NCT00184600|1547159|P1|Overall Study|Adverse Event|9
473810|NCT00184093|1547250|P1|Overall Study|Withdrawal by Subject|2
473811|NCT00184093|1547250|P1|Overall Study|Physician Decision|1
473812|NCT00184093|1547250|P1|Overall Study|Lost to Follow-up|3
473813|NCT00184093|1547250|P1|Overall Study|Adverse Event|3
473814|NCT00184054|1547255|P1|Overall Study|Adverse Event|1
473815|NCT00184028|1547260|P1|Overall Study|Non-compliance|2
473816|NCT00184028|1547260|P1|Overall Study|Withdrawal by Subject|1
473817|NCT00184028|1547260|P1|Overall Study|Adverse Event|2
473818|NCT00184028|1547260|P1|Overall Study|Lack of Efficacy|4
473819|NCT00184028|1547260|P1|Overall Study|Death|1
473820|NCT00184002|1547265|P1|Overall Study|Withdrawal by Subject|4
473821|NCT00184002|1547265|P1|Overall Study|Physician Decision|1
473822|NCT00184002|1547265|P1|Overall Study|Death|3
473823|NCT00184002|1547265|P1|Overall Study|Adverse Event|9
473824|NCT00183872|1547291|P1|Overall Study|Drug delayed more than 28 days|2
473825|NCT00183872|1547291|P1|Overall Study|Withdrawal by Subject|2
473826|NCT00183872|1547291|P1|Overall Study|Adverse Event|9
473827|NCT00183872|1547291|P1|Overall Study|Death|3
473828|NCT00183625|1547320|P4|Overall Study|Withdrawal by Subject|14
473829|NCT00183625|1547321|P3|Overall Study|Withdrawal by Subject|19
473830|NCT00183625|1547322|P2|Overall Study|Withdrawal by Subject|18
473831|NCT00183625|1547323|P1|Overall Study|Withdrawal by Subject|18
473832|NCT00183430|1547395|P2|Overall Study|Withdrawal by Subject|0
473833|NCT00183430|1547396|P1|Overall Study|Withdrawal by Subject|1
473834|NCT00183430|1547395|P2|Overall Study|did not meet inclusion criteria|0
473835|NCT00183430|1547396|P1|Overall Study|did not meet inclusion criteria|1
473836|NCT00183430|1547395|P2|Overall Study|Lost to Follow-up|0
473837|NCT00183430|1547396|P1|Overall Study|Lost to Follow-up|3
473838|NCT00183430|1547395|P2|Overall Study|Adverse Event|0
473839|NCT00183430|1547396|P1|Overall Study|Adverse Event|1
473840|NCT00183391|1547408|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
473841|NCT00183391|1547409|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
473842|NCT00183391|1547408|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
473843|NCT00183391|1547409|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
473844|NCT00183274|1547482|P6|Phase 3: Double-Blind|Relapsed|2
473845|NCT00183274|1547483|P5|Phase 3: Double-Blind|Relapsed|11
473846|NCT00183274|1547484|P4|Phase 3: Double-Blind|Relapsed|1
473847|NCT00183274|1547485|P3|Phase 3: Double-Blind|Relapsed|0
473848|NCT00183274|1547486|P2|Phase 3: Double-Blind|Relapsed|0
473849|NCT00183274|1547487|P1|Phase 3: Double-Blind|Relapsed|0
473850|NCT00183274|1547482|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
473851|NCT00183274|1547483|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
473852|NCT00183274|1547484|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
473853|NCT00183274|1547485|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
473854|NCT00183274|1547486|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
473855|NCT00183274|1547487|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
473856|NCT00183274|1547482|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
473857|NCT00183274|1547483|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
473858|NCT00183274|1547484|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
473859|NCT00183274|1547485|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
473860|NCT00183274|1547486|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
473861|NCT00183274|1547487|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
473862|NCT00183274|1547482|P6|Phase 2: Double-Blind|Relapsed|0
473863|NCT00183274|1547483|P5|Phase 2: Double-Blind|Relapsed|0
473864|NCT00183274|1547484|P4|Phase 2: Double-Blind|Relapsed|0
473865|NCT00183274|1547485|P3|Phase 2: Double-Blind|Relapsed|29
473866|NCT00183274|1547486|P2|Phase 2: Double-Blind|Relapsed|8
473867|NCT00183274|1547487|P1|Phase 2: Double-Blind|Relapsed|0
473868|NCT00183274|1547482|P6|Phase 1: Open-Label|Other|0
473869|NCT00183274|1547483|P5|Phase 1: Open-Label|Other|0
473870|NCT00183274|1547484|P4|Phase 1: Open-Label|Other|0
473871|NCT00183274|1547485|P3|Phase 1: Open-Label|Other|0
473872|NCT00183274|1547486|P2|Phase 1: Open-Label|Other|0
473873|NCT00183274|1547487|P1|Phase 1: Open-Label|Other|9
473874|NCT00183274|1547482|P6|Phase 1: Open-Label|Lost to Follow-up|0
473875|NCT00183274|1547483|P5|Phase 1: Open-Label|Lost to Follow-up|0
473876|NCT00183274|1547484|P4|Phase 1: Open-Label|Lost to Follow-up|0
473877|NCT00183274|1547485|P3|Phase 1: Open-Label|Lost to Follow-up|0
473878|NCT00183274|1547486|P2|Phase 1: Open-Label|Lost to Follow-up|0
473879|NCT00183274|1547487|P1|Phase 1: Open-Label|Lost to Follow-up|33
473880|NCT00183274|1547482|P6|Phase 1: Open-Label|Withdrawal by Subject|0
473881|NCT00183274|1547483|P5|Phase 1: Open-Label|Withdrawal by Subject|0
473882|NCT00183274|1547484|P4|Phase 1: Open-Label|Withdrawal by Subject|0
473883|NCT00183274|1547485|P3|Phase 1: Open-Label|Withdrawal by Subject|0
473884|NCT00183274|1547486|P2|Phase 1: Open-Label|Withdrawal by Subject|0
473885|NCT00183274|1547487|P1|Phase 1: Open-Label|Withdrawal by Subject|13
473886|NCT00183274|1547482|P6|Phase 1: Open-Label|Protocol Violation|0
473887|NCT00183274|1547483|P5|Phase 1: Open-Label|Protocol Violation|0
473888|NCT00183274|1547484|P4|Phase 1: Open-Label|Protocol Violation|0
473889|NCT00183274|1547485|P3|Phase 1: Open-Label|Protocol Violation|0
473890|NCT00183274|1547486|P2|Phase 1: Open-Label|Protocol Violation|0
473891|NCT00183274|1547487|P1|Phase 1: Open-Label|Protocol Violation|11
473892|NCT00183274|1547482|P6|Phase 1: Open-Label|Lack of Efficacy|0
473893|NCT00183274|1547483|P5|Phase 1: Open-Label|Lack of Efficacy|0
473894|NCT00183274|1547484|P4|Phase 1: Open-Label|Lack of Efficacy|0
473895|NCT00183274|1547485|P3|Phase 1: Open-Label|Lack of Efficacy|0
473896|NCT00183274|1547486|P2|Phase 1: Open-Label|Lack of Efficacy|0
473897|NCT00183274|1547487|P1|Phase 1: Open-Label|Lack of Efficacy|13
473898|NCT00183274|1547482|P6|Phase 1: Open-Label|Adverse Event|0
473899|NCT00183274|1547483|P5|Phase 1: Open-Label|Adverse Event|0
473900|NCT00183274|1547484|P4|Phase 1: Open-Label|Adverse Event|0
473901|NCT00183274|1547485|P3|Phase 1: Open-Label|Adverse Event|0
473902|NCT00183274|1547486|P2|Phase 1: Open-Label|Adverse Event|0
473903|NCT00183274|1547487|P1|Phase 1: Open-Label|Adverse Event|31
473904|NCT00183248|1547504|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
473905|NCT00183248|1547505|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
473906|NCT00183248|1547504|P2|Overall Study|Lost to Follow-up|1
473907|NCT00183248|1547505|P1|Overall Study|Lost to Follow-up|0
473908|NCT00183196|1547526|P3|Overall Study|Required more intensive care|2
473909|NCT00183196|1547527|P2|Overall Study|Required more intensive care|1
473910|NCT00183196|1547528|P1|Overall Study|Required more intensive care|0
473911|NCT00183196|1547526|P3|Overall Study|Legal event|1
473912|NCT00183196|1547527|P2|Overall Study|Legal event|1
473913|NCT00183196|1547528|P1|Overall Study|Legal event|1
473914|NCT00183196|1547526|P3|Overall Study|Adverse Event|2
473915|NCT00183196|1547527|P2|Overall Study|Adverse Event|2
473916|NCT00183196|1547528|P1|Overall Study|Adverse Event|1
473917|NCT00183196|1547526|P3|Overall Study|Withdrawal by Subject|13
473918|NCT00183196|1547527|P2|Overall Study|Withdrawal by Subject|11
473919|NCT00183196|1547528|P1|Overall Study|Withdrawal by Subject|18
473920|NCT00182689|1547611|P2|Overall Study|Never received treatment|0
473921|NCT00182689|1547612|P1|Overall Study|Never received treatment|1
473922|NCT00182689|1547611|P2|Overall Study|Ineligible|4
473923|NCT00182689|1547612|P1|Overall Study|Ineligible|1
473924|NCT00182689|1547611|P2|Overall Study|not protocol specified|3
473925|NCT00182689|1547612|P1|Overall Study|not protocol specified|0
473926|NCT00182689|1547611|P2|Overall Study|Death|0
473927|NCT00182689|1547612|P1|Overall Study|Death|1
473928|NCT00182689|1547611|P2|Overall Study|Progression|29
473929|NCT00182689|1547612|P1|Overall Study|Progression|27
473930|NCT00182689|1547611|P2|Overall Study|Withdrawal by Subject|2
473931|NCT00182689|1547612|P1|Overall Study|Withdrawal by Subject|2
473932|NCT00182689|1547611|P2|Overall Study|Adverse Event|11
473933|NCT00182689|1547612|P1|Overall Study|Adverse Event|8
473934|NCT00182637|1547622|P1|Overall Study|Disease Progression|1
473935|NCT00182637|1547622|P1|Overall Study|Adverse Event|2
473936|NCT00182091|1547632|P4|Overall Study|Withdrawal by Subject|0
473937|NCT00182091|1547633|P3|Overall Study|Withdrawal by Subject|0
473938|NCT00182091|1547634|P2|Overall Study|Withdrawal by Subject|0
473939|NCT00182091|1547635|P1|Overall Study|Withdrawal by Subject|1
473940|NCT00182078|1547651|P2|Overall Study|Withdrawal by Subject|0
473941|NCT00182078|1547652|P1|Overall Study|Withdrawal by Subject|1
473942|NCT00181883|1547671|P1|Overall Study|Lost to Follow-up|1
473943|NCT00181883|1547671|P1|Overall Study|Withdrawal by Subject|4
473944|NCT00181883|1547671|P1|Overall Study|Treatment Limiting AEs|3
473945|NCT00181883|1547671|P1|Overall Study|Lack of Efficacy|2
473946|NCT00181844|1547675|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
473947|NCT00181844|1547675|P1|Exposed to Study Medication|Withdrawal by Subject|1
473948|NCT00181844|1547675|P1|Exposed to Study Medication|Non-compliance|2
473949|NCT00181844|1547675|P1|Exposed to Study Medication|Lack of Efficacy|2
473950|NCT00181844|1547675|P1|Exposed to Study Medication|Adverse Event|10
473951|NCT00181844|1547675|P1|Signed Consent|Did not meet entrance criteria|7
473952|NCT00181844|1547675|P1|Signed Consent|Withdrawal by Subject|5
473953|NCT00181766|1547679|P1|Overall Study|non-compliance|2
473954|NCT00181766|1547679|P1|Overall Study|Adverse Event|4
473955|NCT00181766|1547679|P1|Overall Study|Lost to Follow-up|6
473956|NCT00181155|1547709|P2|Overall Study|Withdrawal by Subject|0
473957|NCT00181155|1547710|P1|Overall Study|Withdrawal by Subject|1
473958|NCT00181155|1547709|P2|Overall Study|Physician Decision|0
473959|NCT00181155|1547710|P1|Overall Study|Physician Decision|1
473960|NCT00180479|1547749|P2|Overall Study|Informed consent not signed|1
473961|NCT00180479|1547750|P1|Overall Study|Informed consent not signed|0
473962|NCT00180479|1547749|P2|Overall Study|Withdrawal by Subject|3
473963|NCT00180479|1547750|P1|Overall Study|Withdrawal by Subject|3
473964|NCT00180479|1547749|P2|Overall Study|Lost to Follow-up|7
473965|NCT00180479|1547750|P1|Overall Study|Lost to Follow-up|9
473966|NCT00180479|1547749|P2|Overall Study|Death|2
473967|NCT00180479|1547750|P1|Overall Study|Death|4
473968|NCT00179959|1547860|P2|Overall Study|Withdrawal by Subject|2
473969|NCT00179959|1547861|P1|Overall Study|Withdrawal by Subject|3
473970|NCT00179959|1547860|P2|Overall Study|Lost to Follow-up|1
473971|NCT00179959|1547861|P1|Overall Study|Lost to Follow-up|3
473972|NCT00179673|1547867|P1|Overall Study|Other Observations and options|14
473973|NCT00179673|1547867|P1|Overall Study|Death|4
473974|NCT00179673|1547867|P1|Overall Study|Withdrawal by Subject|3
473975|NCT00179673|1547867|P1|Overall Study|Lack of Efficacy|15
473976|NCT00179673|1547867|P1|Overall Study|Adverse Event|7
473977|NCT00179660|1547875|P1|Overall Study|Other - Unspecified|9
473978|NCT00179660|1547875|P1|Overall Study|Death|3
473979|NCT00179660|1547875|P1|Overall Study|Lost to Follow-up|1
473980|NCT00179660|1547875|P1|Overall Study|Withdrawal by Subject|2
473981|NCT00179660|1547875|P1|Overall Study|Lack of therapeutic effect|28
473982|NCT00179660|1547875|P1|Overall Study|Adverse Event|7
473983|NCT00179647|1547884|P1|Overall Study|Not specified|960
473984|NCT00179647|1547884|P1|Overall Study|Death|94
473985|NCT00179647|1547884|P1|Overall Study|Lost to Follow-up|4
473986|NCT00179647|1547884|P1|Overall Study|Withdrawal by Subject|83
473987|NCT00179647|1547884|P1|Overall Study|Lack of Efficacy|478
473988|NCT00179647|1547884|P1|Overall Study|Adverse Event|294
473989|NCT00179621|1547891|P4|Open-Label Period|Other|2
473990|NCT00179621|1547892|P3|Open-Label Period|Other|1
473991|NCT00179621|1547893|P2|Open-Label Period|Other|1
473992|NCT00179621|1547894|P1|Open-Label Period|Other|0
473993|NCT00179621|1547891|P4|Open-Label Period|Death|2
473994|NCT00179621|1547892|P3|Open-Label Period|Death|1
473995|NCT00179621|1547893|P2|Open-Label Period|Death|0
473996|NCT00179621|1547894|P1|Open-Label Period|Death|0
473997|NCT00179621|1547891|P4|Open-Label Period|Withdrawal by Subject|2
473998|NCT00179621|1547892|P3|Open-Label Period|Withdrawal by Subject|2
473999|NCT00179621|1547893|P2|Open-Label Period|Withdrawal by Subject|2
474000|NCT00179621|1547894|P1|Open-Label Period|Withdrawal by Subject|0
474001|NCT00179621|1547891|P4|Open-Label Period|Adverse Event|6
474002|NCT00179621|1547892|P3|Open-Label Period|Adverse Event|5
474003|NCT00179621|1547893|P2|Open-Label Period|Adverse Event|6
474004|NCT00179621|1547894|P1|Open-Label Period|Adverse Event|0
474005|NCT00179621|1547891|P4|Open-Label Period|Lack of Therapeutic Effect|31
474006|NCT00179621|1547892|P3|Open-Label Period|Lack of Therapeutic Effect|19
474007|NCT00179621|1547893|P2|Open-Label Period|Lack of Therapeutic Effect|19
474008|NCT00179621|1547894|P1|Open-Label Period|Lack of Therapeutic Effect|0
474009|NCT00179621|1547891|P4|Double-Blind Period|Other|0
474010|NCT00179621|1547892|P3|Double-Blind Period|Other|2
474011|NCT00179621|1547893|P2|Double-Blind Period|Other|2
474012|NCT00179621|1547894|P1|Double-Blind Period|Other|0
474013|NCT00179621|1547891|P4|Double-Blind Period|Protocol Violation|0
474014|NCT00179621|1547892|P3|Double-Blind Period|Protocol Violation|0
474015|NCT00179621|1547893|P2|Double-Blind Period|Protocol Violation|0
474016|NCT00179621|1547894|P1|Double-Blind Period|Protocol Violation|1
474017|NCT00179621|1547891|P4|Double-Blind Period|Death|0
474018|NCT00179621|1547892|P3|Double-Blind Period|Death|2
474019|NCT00179621|1547893|P2|Double-Blind Period|Death|1
474020|NCT00179621|1547894|P1|Double-Blind Period|Death|0
474021|NCT00179621|1547891|P4|Double-Blind Period|Withdrawal by Subject|0
474022|NCT00179621|1547892|P3|Double-Blind Period|Withdrawal by Subject|3
474023|NCT00179621|1547893|P2|Double-Blind Period|Withdrawal by Subject|1
474024|NCT00179621|1547894|P1|Double-Blind Period|Withdrawal by Subject|2
474025|NCT00179621|1547891|P4|Double-Blind Period|Adverse Event|0
474026|NCT00179621|1547892|P3|Double-Blind Period|Adverse Event|4
474027|NCT00179621|1547893|P2|Double-Blind Period|Adverse Event|7
474028|NCT00179621|1547894|P1|Double-Blind Period|Adverse Event|2
474029|NCT00179621|1547891|P4|Double-Blind Period|Lack of Therapeutic Effect|0
474030|NCT00179621|1547892|P3|Double-Blind Period|Lack of Therapeutic Effect|19
474031|NCT00179621|1547893|P2|Double-Blind Period|Lack of Therapeutic Effect|35
474032|NCT00179621|1547894|P1|Double-Blind Period|Lack of Therapeutic Effect|59
474033|NCT00179517|1547947|P2|Overall Study|Withdrawal by Subject|1
474034|NCT00179517|1547948|P1|Overall Study|Withdrawal by Subject|2
474035|NCT00179413|1547986|P2|Overall Study|Withdrawal by Subject|95
474036|NCT00179413|1547987|P1|Overall Study|Withdrawal by Subject|87
474037|NCT00179413|1547986|P2|Overall Study|Adverse Event|20
474038|NCT00179413|1547987|P1|Overall Study|Adverse Event|38
474039|NCT00179309|1547999|P2|Treatment|Allergy|0
474040|NCT00179309|1548000|P1|Treatment|Allergy|1
474041|NCT00179309|1547999|P2|Treatment|Withdrawal by Subject|2
474042|NCT00179309|1548000|P1|Treatment|Withdrawal by Subject|1
474043|NCT00179309|1547999|P2|Treatment|Toxicity|3
474044|NCT00179309|1548000|P1|Treatment|Toxicity|2
474045|NCT00178685|1548039|P3|Overall Study|Withdrawal by Subject|7
474046|NCT00178685|1548040|P2|Overall Study|Withdrawal by Subject|14
474047|NCT00178685|1548041|P1|Overall Study|Withdrawal by Subject|8
474048|NCT00178685|1548039|P3|Overall Study|Lost to Follow-up|183
474049|NCT00178685|1548040|P2|Overall Study|Lost to Follow-up|187
474050|NCT00178685|1548041|P1|Overall Study|Lost to Follow-up|100
474051|NCT00178685|1548039|P3|Overall Study|Death|6
474052|NCT00178685|1548040|P2|Overall Study|Death|3
474053|NCT00178685|1548041|P1|Overall Study|Death|3
474054|NCT00178633|1548052|P1|Overall Study|Lost to Follow-up|6
474055|NCT00178464|1548082|P1|Overall Study|Physician Decision|1
474056|NCT00178464|1548082|P1|Overall Study|Withdrawal by Subject|1
474057|NCT00178256|1548087|P4|Overall Study|Cancer progression|1
474058|NCT00178256|1548088|P3|Overall Study|Cancer progression|0
474059|NCT00178256|1548089|P2|Overall Study|Cancer progression|0
474060|NCT00178256|1548090|P1|Overall Study|Cancer progression|2
474061|NCT00178256|1548087|P4|Overall Study|Death|1
474062|NCT00178256|1548088|P3|Overall Study|Death|0
474063|NCT00178256|1548089|P2|Overall Study|Death|1
474064|NCT00178256|1548090|P1|Overall Study|Death|0
474065|NCT00178256|1548087|P4|Overall Study|Adverse Event|0
474066|NCT00178256|1548088|P3|Overall Study|Adverse Event|0
474067|NCT00178256|1548089|P2|Overall Study|Adverse Event|0
474068|NCT00178256|1548090|P1|Overall Study|Adverse Event|2
474069|NCT00178126|1548129|P2|Overall Study|did not receive intervention|6
474070|NCT00178126|1548130|P1|Overall Study|did not receive intervention|4
474071|NCT00178126|1548129|P2|Overall Study|Lost to Follow-up|21
474072|NCT00178126|1548130|P1|Overall Study|Lost to Follow-up|21
474073|NCT00177671|1548172|P2|Overall Study|Physician Decision|8
474074|NCT00177671|1548173|P1|Overall Study|Physician Decision|12
474075|NCT00177671|1548172|P2|Overall Study|Adverse Event|0
474076|NCT00177671|1548173|P1|Overall Study|Adverse Event|6
474077|NCT00177671|1548172|P2|Overall Study|medical complications|0
474078|NCT00177671|1548173|P1|Overall Study|medical complications|2
474079|NCT00177671|1548172|P2|Overall Study|Withdrawal by Subject|6
474080|NCT00177671|1548173|P1|Overall Study|Withdrawal by Subject|5
474081|NCT00177307|1548185|P1|Overall Study|Withdrawal by Subject|1
474082|NCT00177294|1548194|P2|Overall Study|Withdrawal by Subject|5
474083|NCT00177294|1548195|P1|Overall Study|Withdrawal by Subject|7
474084|NCT00177216|1548209|P3|Overall Study|Withdrawal by Subject|1
474085|NCT00177216|1548210|P2|Overall Study|Withdrawal by Subject|3
474086|NCT00177216|1548211|P1|Overall Study|Withdrawal by Subject|6
474087|NCT00177164|1548227|P2|Overall Study|Pregnancy|1
474088|NCT00177164|1548228|P1|Overall Study|Pregnancy|0
474089|NCT00177164|1548227|P2|Overall Study|Lack of Efficacy|1
474090|NCT00177164|1548228|P1|Overall Study|Lack of Efficacy|2
474091|NCT00177164|1548227|P2|Overall Study|discharge from hospital|0
474092|NCT00177164|1548228|P1|Overall Study|discharge from hospital|1
474093|NCT00177164|1548227|P2|Overall Study|Adverse Event|0
474094|NCT00177164|1548228|P1|Overall Study|Adverse Event|1
474095|NCT00177164|1548227|P2|Overall Study|increase in alcohol and drug use|2
474096|NCT00177164|1548228|P1|Overall Study|increase in alcohol and drug use|1
474097|NCT00177164|1548227|P2|Overall Study|Lost to Follow-up|5
474098|NCT00177164|1548228|P1|Overall Study|Lost to Follow-up|4
474099|NCT00177164|1548227|P2|Overall Study|Protocol Violation|7
474100|NCT00177164|1548228|P1|Overall Study|Protocol Violation|0
474101|NCT00176644|1548393|P1|Overall Study|Withdrawal by Subject|1
474102|NCT00176605|1548406|P1|Overall Study|Withdrawal by Subject|2
474103|NCT00176488|1548417|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
474104|NCT00176462|1548425|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
474105|NCT00176462|1548426|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
474106|NCT00176462|1548425|P2|Intensive Continuation (8X8-week Cycles)|Death|0
474107|NCT00176462|1548426|P1|Intensive Continuation (8X8-week Cycles)|Death|1
474108|NCT00176462|1548425|P2|Consolidation (12 Weeks)|Not documented|1
474109|NCT00176462|1548426|P1|Consolidation (12 Weeks)|Not documented|0
474110|NCT00176462|1548425|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
474111|NCT00176462|1548426|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
474112|NCT00176462|1548425|P2|Consolidation (12 Weeks)|Adverse Event|1
474113|NCT00176462|1548426|P1|Consolidation (12 Weeks)|Adverse Event|0
474114|NCT00176462|1548425|P2|Consolidation (12 Weeks)|Patient moved to another state|1
474115|NCT00176462|1548426|P1|Consolidation (12 Weeks)|Patient moved to another state|0
474116|NCT00176462|1548425|P2|Induction (4 Weeks)|Lack of Efficacy|1
474117|NCT00176462|1548426|P1|Induction (4 Weeks)|Lack of Efficacy|0
474118|NCT00176462|1548425|P2|Induction (4 Weeks)|Death|2
474119|NCT00176462|1548426|P1|Induction (4 Weeks)|Death|1
474120|NCT00176462|1548425|P2|Induction (4 Weeks)|Withdrawal by Subject|2
474121|NCT00176462|1548426|P1|Induction (4 Weeks)|Withdrawal by Subject|0
474122|NCT00176254|1548446|P1|Overall Study|Lost to Follow-up|1
474123|NCT00175877|1548474|P1|Overall Study|Withdrawal by subject & Other|1
474124|NCT00175877|1548474|P1|Overall Study|AE & Other|1
474125|NCT00175877|1548474|P1|Overall Study|Other Reason|20
474126|NCT00175877|1548474|P1|Overall Study|Protocol Violation|15
474127|NCT00175877|1548474|P1|Overall Study|Lack of Efficacy|26
474128|NCT00175877|1548474|P1|Overall Study|Lost to Follow-up|9
474129|NCT00175877|1548474|P1|Overall Study|Withdrawal by Subject|141
474130|NCT00175877|1548474|P1|Overall Study|Adverse Event|136
474131|NCT00175019|1548508|P3|Overall Study|Reason Not Specified|11
474132|NCT00175019|1548509|P2|Overall Study|Reason Not Specified|34
474133|NCT00175019|1548510|P1|Overall Study|Reason Not Specified|40
474134|NCT00175019|1548508|P3|Overall Study|Gout Flare|0
474135|NCT00175019|1548509|P2|Overall Study|Gout Flare|3
474136|NCT00175019|1548510|P1|Overall Study|Gout Flare|2
474137|NCT00175019|1548508|P3|Overall Study|Therapeutic Failure|22
474138|NCT00175019|1548509|P2|Overall Study|Therapeutic Failure|38
474139|NCT00175019|1548510|P1|Overall Study|Therapeutic Failure|10
474140|NCT00175019|1548508|P3|Overall Study|Personal Reason(s)|8
474141|NCT00175019|1548509|P2|Overall Study|Personal Reason(s)|31
474142|NCT00175019|1548510|P1|Overall Study|Personal Reason(s)|39
474143|NCT00175019|1548508|P3|Overall Study|Did not continue under Amendment 4|2
474144|NCT00175019|1548509|P2|Overall Study|Did not continue under Amendment 4|1
474145|NCT00175019|1548510|P1|Overall Study|Did not continue under Amendment 4|1
474146|NCT00175019|1548508|P3|Overall Study|Lost to Follow-up|9
474147|NCT00175019|1548509|P2|Overall Study|Lost to Follow-up|39
474148|NCT00175019|1548510|P1|Overall Study|Lost to Follow-up|42
474149|NCT00175019|1548508|P3|Overall Study|Protocol Violation|3
474150|NCT00175019|1548509|P2|Overall Study|Protocol Violation|3
474151|NCT00175019|1548510|P1|Overall Study|Protocol Violation|6
474152|NCT00175019|1548508|P3|Overall Study|Adverse Event|2
474153|NCT00175019|1548509|P2|Overall Study|Adverse Event|22
474154|NCT00175019|1548510|P1|Overall Study|Adverse Event|54
474155|NCT00174967|1548563|P4|Overall Study|Not Specified|0
474156|NCT00174967|1548564|P3|Overall Study|Not Specified|0
474157|NCT00174967|1548565|P2|Overall Study|Not Specified|1
474158|NCT00174967|1548566|P1|Overall Study|Not Specified|0
474159|NCT00174967|1548563|P4|Overall Study|Gout Flare|1
474160|NCT00174967|1548564|P3|Overall Study|Gout Flare|0
474161|NCT00174967|1548565|P2|Overall Study|Gout Flare|0
474162|NCT00174967|1548566|P1|Overall Study|Gout Flare|0
474163|NCT00174967|1548563|P4|Overall Study|Adverse Event|1
474164|NCT00174967|1548564|P3|Overall Study|Adverse Event|2
474165|NCT00174967|1548565|P2|Overall Study|Adverse Event|2
474166|NCT00174967|1548566|P1|Overall Study|Adverse Event|1
474167|NCT00174954|1548612|P1|Overall Study|Physician Decision|1
474168|NCT00174954|1548612|P1|Overall Study|No tophi found in MRI|1
474169|NCT00174954|1548612|P1|Overall Study|Adverse Event|2
474170|NCT00174941|1548620|P4|Overall Study|Reason Not Specified|9
474171|NCT00174941|1548621|P3|Overall Study|Reason Not Specified|2
474172|NCT00174941|1548622|P2|Overall Study|Reason Not Specified|6
474173|NCT00174941|1548623|P1|Overall Study|Reason Not Specified|1
474174|NCT00174941|1548620|P4|Overall Study|Gout Flare|8
474175|NCT00174941|1548621|P3|Overall Study|Gout Flare|4
474176|NCT00174941|1548622|P2|Overall Study|Gout Flare|4
474177|NCT00174941|1548623|P1|Overall Study|Gout Flare|0
474178|NCT00174941|1548620|P4|Overall Study|Personal Reason(s)|22
474179|NCT00174941|1548621|P3|Overall Study|Personal Reason(s)|8
474180|NCT00174941|1548622|P2|Overall Study|Personal Reason(s)|14
474181|NCT00174941|1548623|P1|Overall Study|Personal Reason(s)|0
474182|NCT00174941|1548620|P4|Overall Study|Lost to Follow-up|5
474183|NCT00174941|1548621|P3|Overall Study|Lost to Follow-up|2
474184|NCT00174941|1548622|P2|Overall Study|Lost to Follow-up|3
474185|NCT00174941|1548623|P1|Overall Study|Lost to Follow-up|0
474186|NCT00174941|1548620|P4|Overall Study|Protocol Violation|1
474187|NCT00174941|1548621|P3|Overall Study|Protocol Violation|0
474188|NCT00174941|1548622|P2|Overall Study|Protocol Violation|1
474189|NCT00174941|1548623|P1|Overall Study|Protocol Violation|0
474190|NCT00174941|1548620|P4|Overall Study|Adverse Event|13
474191|NCT00174941|1548621|P3|Overall Study|Adverse Event|2
474192|NCT00174941|1548622|P2|Overall Study|Adverse Event|10
474193|NCT00174941|1548623|P1|Overall Study|Adverse Event|1
474194|NCT00174915|1548698|P5|Overall Study|Therapeutic Failure|3
474195|NCT00174915|1548699|P4|Overall Study|Therapeutic Failure|1
474196|NCT00174915|1548700|P3|Overall Study|Therapeutic Failure|2
474197|NCT00174915|1548701|P2|Overall Study|Therapeutic Failure|3
474198|NCT00174915|1548702|P1|Overall Study|Therapeutic Failure|6
474199|NCT00174915|1548698|P5|Overall Study|Protocol Violation|3
474200|NCT00174915|1548699|P4|Overall Study|Protocol Violation|6
474201|NCT00174915|1548700|P3|Overall Study|Protocol Violation|3
474202|NCT00174915|1548701|P2|Overall Study|Protocol Violation|3
474203|NCT00174915|1548702|P1|Overall Study|Protocol Violation|6
474204|NCT00174915|1548698|P5|Overall Study|Gout Flare|0
474205|NCT00174915|1548699|P4|Overall Study|Gout Flare|1
474206|NCT00174915|1548700|P3|Overall Study|Gout Flare|8
474207|NCT00174915|1548701|P2|Overall Study|Gout Flare|6
474208|NCT00174915|1548702|P1|Overall Study|Gout Flare|13
474209|NCT00174915|1548698|P5|Overall Study|Other|3
474210|NCT00174915|1548699|P4|Overall Study|Other|5
474211|NCT00174915|1548700|P3|Overall Study|Other|6
474212|NCT00174915|1548701|P2|Overall Study|Other|8
474213|NCT00174915|1548702|P1|Overall Study|Other|15
474214|NCT00174915|1548698|P5|Overall Study|Personal Reason(s)|9
474215|NCT00174915|1548699|P4|Overall Study|Personal Reason(s)|9
474216|NCT00174915|1548700|P3|Overall Study|Personal Reason(s)|9
474217|NCT00174915|1548701|P2|Overall Study|Personal Reason(s)|16
474218|NCT00174915|1548702|P1|Overall Study|Personal Reason(s)|16
474219|NCT00174915|1548698|P5|Overall Study|Adverse Event|5
474220|NCT00174915|1548699|P4|Overall Study|Adverse Event|18
474221|NCT00174915|1548700|P3|Overall Study|Adverse Event|11
474222|NCT00174915|1548701|P2|Overall Study|Adverse Event|16
474223|NCT00174915|1548702|P1|Overall Study|Adverse Event|18
474224|NCT00174915|1548698|P5|Overall Study|Lost to Follow-up|10
474225|NCT00174915|1548699|P4|Overall Study|Lost to Follow-up|17
474226|NCT00174915|1548700|P3|Overall Study|Lost to Follow-up|9
474227|NCT00174915|1548701|P2|Overall Study|Lost to Follow-up|17
474228|NCT00174915|1548702|P1|Overall Study|Lost to Follow-up|19
474229|NCT00174785|1548761|P2|Overall Study|Not pre-specified/Not coded|70
474230|NCT00174785|1548762|P1|Overall Study|Not pre-specified/Not coded|56
474231|NCT00174785|1548761|P2|Overall Study|Family request|8
474232|NCT00174785|1548762|P1|Overall Study|Family request|6
474233|NCT00174785|1548761|P2|Overall Study|Other prohibited medication|3
474234|NCT00174785|1548762|P1|Overall Study|Other prohibited medication|5
474235|NCT00174785|1548761|P2|Overall Study|Prohibited antiarrhythmic medication|88
474236|NCT00174785|1548762|P1|Overall Study|Prohibited antiarrhythmic medication|39
474237|NCT00174785|1548761|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
474238|NCT00174785|1548762|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
474239|NCT00174785|1548761|P2|Overall Study|Withdrawal by Subject|175
474240|NCT00174785|1548762|P1|Overall Study|Withdrawal by Subject|173
474241|NCT00174785|1548761|P2|Overall Study|Protocol Violation|14
474242|NCT00174785|1548762|P1|Overall Study|Protocol Violation|14
474243|NCT00174785|1548761|P2|Overall Study|Adverse Event|191
474244|NCT00174785|1548762|P1|Overall Study|Adverse Event|293
474245|NCT00174460|1548778|P2|Overall Study|Withdrawal by Subject|1
474246|NCT00174460|1548779|P1|Overall Study|Withdrawal by Subject|0
474247|NCT00174447|1548825|P1|Overall Study|Administrative reason/Other|2
474248|NCT00174447|1548825|P1|Overall Study|Lack of Efficacy|1
474249|NCT00174447|1548825|P1|Overall Study|Protocol Violation|1
474250|NCT00174447|1548825|P1|Overall Study|Withdrawal by Subject|15
474251|NCT00174447|1548825|P1|Overall Study|Adverse Event|19
474252|NCT00174382|1548834|P1|Overall Study|Lost to Follow-up|1
474253|NCT00174382|1548834|P1|Overall Study|Subject felt pill not effective enough|1
474254|NCT00174382|1548834|P1|Overall Study|Arrived early for last visit in error|1
474255|NCT00174382|1548834|P1|Overall Study|Protocol Violation|3
474256|NCT00174382|1548834|P1|Overall Study|Withdrawal by Subject|6
474257|NCT00174382|1548834|P1|Overall Study|Adverse Event|19
474258|NCT00174382|1548834|P1|Overall Study|Death|2
474259|NCT00174291|1548853|P2|Overall Study|Withdrawal by Subject|3
474260|NCT00174291|1548854|P1|Overall Study|Withdrawal by Subject|3
474261|NCT00174291|1548853|P2|Overall Study|Study terminated by sponsor|0
474262|NCT00174291|1548854|P1|Overall Study|Study terminated by sponsor|1
474263|NCT00174291|1548853|P2|Overall Study|Protocol Violation|2
474264|NCT00174291|1548854|P1|Overall Study|Protocol Violation|0
474265|NCT00174291|1548853|P2|Overall Study|Lost to Follow-up|1
474266|NCT00174291|1548854|P1|Overall Study|Lost to Follow-up|1
474267|NCT00174265|1548884|P2|Overall Study|Other (Not specified)|10
474268|NCT00174265|1548885|P1|Overall Study|Other (Not specified)|16
474269|NCT00174265|1548884|P2|Overall Study|Lost to Follow-up|0
474270|NCT00174265|1548885|P1|Overall Study|Lost to Follow-up|1
474271|NCT00174265|1548884|P2|Overall Study|Withdrawal by Subject|5
474272|NCT00174265|1548885|P1|Overall Study|Withdrawal by Subject|3
474273|NCT00174265|1548884|P2|Overall Study|Lack of Efficacy|2
474274|NCT00174265|1548885|P1|Overall Study|Lack of Efficacy|2
474275|NCT00174265|1548884|P2|Overall Study|Adverse Event|4
474276|NCT00174265|1548885|P1|Overall Study|Adverse Event|7
474277|NCT00174252|1548893|P1|Overall Study|Protocol Violation|2
474278|NCT00174187|1548928|P3|Period 2 (After 3 Years)|Other|5
474279|NCT00174187|1548929|P2|Period 2 (After 3 Years)|Other|0
474280|NCT00174187|1548930|P1|Period 2 (After 3 Years)|Other|0
474281|NCT00174187|1548928|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
474282|NCT00174187|1548929|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
474283|NCT00174187|1548930|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
474284|NCT00174187|1548928|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
474285|NCT00174187|1548929|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
474286|NCT00174187|1548930|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
474287|NCT00174187|1548928|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
474288|NCT00174187|1548929|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
474289|NCT00174187|1548930|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
474290|NCT00174187|1548928|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
474291|NCT00174187|1548929|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
474292|NCT00174187|1548930|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
474293|NCT00174187|1548928|P3|Period 1 (up to 3 Years)|Other|0
474294|NCT00174187|1548929|P2|Period 1 (up to 3 Years)|Other|1
474295|NCT00174187|1548930|P1|Period 1 (up to 3 Years)|Other|0
474296|NCT00174187|1548928|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
474297|NCT00174187|1548929|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
474298|NCT00174187|1548930|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
474299|NCT00174187|1548928|P3|Period 1 (up to 3 Years)|Non compliance|0
474300|NCT00174187|1548929|P2|Period 1 (up to 3 Years)|Non compliance|1
474301|NCT00174187|1548930|P1|Period 1 (up to 3 Years)|Non compliance|0
474302|NCT00174187|1548928|P3|Period 1 (up to 3 Years)|Serious adverse event|0
474303|NCT00174187|1548929|P2|Period 1 (up to 3 Years)|Serious adverse event|1
474304|NCT00174187|1548930|P1|Period 1 (up to 3 Years)|Serious adverse event|0
474305|NCT00172185|1548995|P4|Overall Study|Withdrawal by Subject|0
474306|NCT00172185|1548996|P3|Overall Study|Withdrawal by Subject|1
474307|NCT00172185|1548997|P2|Overall Study|Withdrawal by Subject|0
474308|NCT00172185|1548998|P1|Overall Study|Withdrawal by Subject|0
474309|NCT00172185|1548995|P4|Overall Study|SPONSOR Decision|0
474310|NCT00172185|1548996|P3|Overall Study|SPONSOR Decision|0
474311|NCT00172185|1548997|P2|Overall Study|SPONSOR Decision|1
474312|NCT00172185|1548998|P1|Overall Study|SPONSOR Decision|0
474313|NCT00172185|1548995|P4|Overall Study|Physician Decision|0
474314|NCT00172185|1548996|P3|Overall Study|Physician Decision|1
474315|NCT00172185|1548997|P2|Overall Study|Physician Decision|0
474316|NCT00172185|1548998|P1|Overall Study|Physician Decision|0
474317|NCT00172185|1548995|P4|Overall Study|Adverse Event|4
474318|NCT00172185|1548996|P3|Overall Study|Adverse Event|3
474319|NCT00172185|1548997|P2|Overall Study|Adverse Event|1
474320|NCT00172185|1548998|P1|Overall Study|Adverse Event|0
474321|NCT00172042|1549014|P2|Overall Study|Death|42
474322|NCT00172042|1549015|P1|Overall Study|Death|42
474323|NCT00172042|1549014|P2|Overall Study|Administrative problems|10
474324|NCT00172042|1549015|P1|Overall Study|Administrative problems|13
474325|NCT00172042|1549014|P2|Overall Study|Lost to Follow-up|5
474326|NCT00172042|1549015|P1|Overall Study|Lost to Follow-up|3
474327|NCT00172042|1549014|P2|Overall Study|Withdrawal by Subject|25
474328|NCT00172042|1549015|P1|Overall Study|Withdrawal by Subject|37
474329|NCT00172042|1549014|P2|Overall Study|Protocol Violation|7
474330|NCT00172042|1549015|P1|Overall Study|Protocol Violation|8
474331|NCT00172042|1549014|P2|Overall Study|Patient no longer requires study drug|8
474332|NCT00172042|1549015|P1|Overall Study|Patient no longer requires study drug|10
474333|NCT00172042|1549014|P2|Overall Study|Unsatisfactory therapeutic effect|11
474334|NCT00172042|1549015|P1|Overall Study|Unsatisfactory therapeutic effect|13
474335|NCT00172042|1549014|P2|Overall Study|Abnormal test procedure(s)|3
474336|NCT00172042|1549015|P1|Overall Study|Abnormal test procedure(s)|0
474337|NCT00172042|1549014|P2|Overall Study|Abnormal laboratory value(s)|1
474338|NCT00172042|1549015|P1|Overall Study|Abnormal laboratory value(s)|5
474339|NCT00172042|1549014|P2|Overall Study|Adverse Event|13
474340|NCT00172042|1549015|P1|Overall Study|Adverse Event|27
474341|NCT00171925|1549037|P2|Overall Study|Death|2
474342|NCT00171925|1549038|P1|Overall Study|Death|1
474343|NCT00171925|1549037|P2|Overall Study|Administrative problems|11
474344|NCT00171925|1549038|P1|Overall Study|Administrative problems|10
474345|NCT00171925|1549037|P2|Overall Study|Lost to Follow-up|2
474346|NCT00171925|1549038|P1|Overall Study|Lost to Follow-up|2
474347|NCT00171925|1549037|P2|Overall Study|Withdrawal by Subject|9
474348|NCT00171925|1549038|P1|Overall Study|Withdrawal by Subject|6
474349|NCT00171925|1549037|P2|Overall Study|Protocol Violation|1
474350|NCT00171925|1549038|P1|Overall Study|Protocol Violation|1
474351|NCT00171925|1549037|P2|Overall Study|Adverse Event|6
474352|NCT00171925|1549038|P1|Overall Study|Adverse Event|10
474353|NCT00171873|1549050|P2|Overall Study|Switched to Octreotide|1
474354|NCT00171873|1549051|P1|Overall Study|Switched to Octreotide|0
474355|NCT00171873|1549050|P2|Overall Study|Adverse Event|0
474356|NCT00171873|1549051|P1|Overall Study|Adverse Event|5
474357|NCT00171873|1549050|P2|Overall Study|Withdrawal by Subject|2
474358|NCT00171873|1549051|P1|Overall Study|Withdrawal by Subject|4
474359|NCT00171834|1549064|P7|Overall Study|Treatment Duration Completed|0
474360|NCT00171834|1549065|P6|Overall Study|Treatment Duration Completed|1
474361|NCT00171834|1549066|P5|Overall Study|Treatment Duration Completed|2
474362|NCT00171834|1549067|P4|Overall Study|Treatment Duration Completed|0
474363|NCT00171834|1549068|P3|Overall Study|Treatment Duration Completed|1
474364|NCT00171834|1549069|P2|Overall Study|Treatment Duration Completed|0
474365|NCT00171834|1549070|P1|Overall Study|Treatment Duration Completed|0
474366|NCT00171834|1549064|P7|Overall Study|Disease Progression|3
474367|NCT00171834|1549065|P6|Overall Study|Disease Progression|18
474368|NCT00171834|1549066|P5|Overall Study|Disease Progression|2
474369|NCT00171834|1549067|P4|Overall Study|Disease Progression|9
474370|NCT00171834|1549068|P3|Overall Study|Disease Progression|8
474371|NCT00171834|1549069|P2|Overall Study|Disease Progression|8
474372|NCT00171834|1549070|P1|Overall Study|Disease Progression|4
474373|NCT00171834|1549064|P7|Overall Study|Death from study indication|0
474374|NCT00171834|1549065|P6|Overall Study|Death from study indication|0
474375|NCT00171834|1549066|P5|Overall Study|Death from study indication|1
474376|NCT00171834|1549067|P4|Overall Study|Death from study indication|0
474377|NCT00171834|1549068|P3|Overall Study|Death from study indication|0
474378|NCT00171834|1549069|P2|Overall Study|Death from study indication|1
474379|NCT00171834|1549070|P1|Overall Study|Death from study indication|0
474380|NCT00171834|1549064|P7|Overall Study|Withdrawal by Subject|0
474381|NCT00171834|1549065|P6|Overall Study|Withdrawal by Subject|1
474382|NCT00171834|1549066|P5|Overall Study|Withdrawal by Subject|1
474383|NCT00171834|1549067|P4|Overall Study|Withdrawal by Subject|1
474384|NCT00171834|1549068|P3|Overall Study|Withdrawal by Subject|0
474385|NCT00171834|1549069|P2|Overall Study|Withdrawal by Subject|2
474386|NCT00171834|1549070|P1|Overall Study|Withdrawal by Subject|0
474387|NCT00171834|1549064|P7|Overall Study|Adverse Event|1
474388|NCT00171834|1549065|P6|Overall Study|Adverse Event|15
474389|NCT00171834|1549066|P5|Overall Study|Adverse Event|2
474390|NCT00171834|1549067|P4|Overall Study|Adverse Event|2
474391|NCT00171834|1549068|P3|Overall Study|Adverse Event|3
474392|NCT00171834|1549069|P2|Overall Study|Adverse Event|1
474393|NCT00171834|1549070|P1|Overall Study|Adverse Event|2
474394|NCT00171704|1549110|P2|Overall Study|Protocol Violation|1
474395|NCT00171704|1549111|P1|Overall Study|Protocol Violation|0
474396|NCT00171704|1549110|P2|Overall Study|Withdrawal by Subject|3
474397|NCT00171704|1549111|P1|Overall Study|Withdrawal by Subject|1
474398|NCT00171704|1549110|P2|Overall Study|Death|2
474399|NCT00171704|1549111|P1|Overall Study|Death|2
474400|NCT00171704|1549110|P2|Overall Study|Administrative Problems|1
474401|NCT00171704|1549111|P1|Overall Study|Administrative Problems|2
474402|NCT00171704|1549110|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
474403|NCT00171704|1549111|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
474404|NCT00171704|1549110|P2|Overall Study|Disease Progression|9
474405|NCT00171704|1549111|P1|Overall Study|Disease Progression|14
474406|NCT00171704|1549110|P2|Overall Study|Adverse Event|33
474407|NCT00171704|1549111|P1|Overall Study|Adverse Event|24
474408|NCT00171340|1549133|P2|Overall Study|Death|6
474409|NCT00171340|1549134|P1|Overall Study|Death|6
474410|NCT00171340|1549133|P2|Overall Study|Administrative Problems|2
474411|NCT00171340|1549134|P1|Overall Study|Administrative Problems|5
474412|NCT00171340|1549133|P2|Overall Study|No Longer Required Study Drug|1
474413|NCT00171340|1549134|P1|Overall Study|No Longer Required Study Drug|1
474414|NCT00171340|1549133|P2|Overall Study|Abnormal Test Procedure Results|11
474415|NCT00171340|1549134|P1|Overall Study|Abnormal Test Procedure Results|6
474416|NCT00171340|1549133|P2|Overall Study|Abnormal Laboratory Results|0
474417|NCT00171340|1549134|P1|Overall Study|Abnormal Laboratory Results|2
474418|NCT00171340|1549133|P2|Overall Study|Lost to Follow-up|5
474419|NCT00171340|1549134|P1|Overall Study|Lost to Follow-up|0
474420|NCT00171340|1549133|P2|Overall Study|Withdrawal by Subject|19
474421|NCT00171340|1549134|P1|Overall Study|Withdrawal by Subject|22
474422|NCT00171340|1549133|P2|Overall Study|Protocol Violation|8
474423|NCT00171340|1549134|P1|Overall Study|Protocol Violation|7
474424|NCT00171340|1549133|P2|Overall Study|Lack of Efficacy|41
474425|NCT00171340|1549134|P1|Overall Study|Lack of Efficacy|29
474426|NCT00171340|1549133|P2|Overall Study|Adverse Event|42
474427|NCT00171340|1549134|P1|Overall Study|Adverse Event|46
474428|NCT00171314|1549150|P2|Overall Study|Death|1
474429|NCT00171314|1549151|P1|Overall Study|Death|2
474430|NCT00171314|1549150|P2|Overall Study|Lost to Follow-up|3
474431|NCT00171314|1549151|P1|Overall Study|Lost to Follow-up|1
474432|NCT00171314|1549150|P2|Overall Study|Administrative Problems|3
474433|NCT00171314|1549151|P1|Overall Study|Administrative Problems|4
474434|NCT00171314|1549150|P2|Overall Study|Protocol Violation|7
474435|NCT00171314|1549151|P1|Overall Study|Protocol Violation|3
474436|NCT00171314|1549150|P2|Overall Study|Abnormal Test Procedure Results|3
474437|NCT00171314|1549151|P1|Overall Study|Abnormal Test Procedure Results|9
474438|NCT00171314|1549150|P2|Overall Study|Withdrawal by Subject|6
474439|NCT00171314|1549151|P1|Overall Study|Withdrawal by Subject|9
474440|NCT00171314|1549150|P2|Overall Study|Lack of Efficacy|14
474441|NCT00171314|1549151|P1|Overall Study|Lack of Efficacy|19
474442|NCT00171314|1549150|P2|Overall Study|Adverse Event|41
474443|NCT00171314|1549151|P1|Overall Study|Adverse Event|44
474444|NCT00171301|1549167|P2|Overall Study|Withdrawal by Subject|1
474445|NCT00171301|1549168|P1|Overall Study|Withdrawal by Subject|0
474446|NCT00171301|1549167|P2|Overall Study|Protocol Violation|2
474447|NCT00171301|1549168|P1|Overall Study|Protocol Violation|0
474448|NCT00171301|1549167|P2|Overall Study|Lost to Follow-up|2
474449|NCT00171301|1549168|P1|Overall Study|Lost to Follow-up|6
474450|NCT00171301|1549167|P2|Overall Study|Adverse Event|2
474451|NCT00171301|1549168|P1|Overall Study|Adverse Event|1
474452|NCT00171301|1549167|P2|Overall Study|Death|2
474453|NCT00171301|1549168|P1|Overall Study|Death|1
474454|NCT00171210|1549181|P2|Overall Study|Stopped at end of extension 1|1
474455|NCT00171210|1549182|P1|Overall Study|Stopped at end of extension 1|0
474456|NCT00171210|1549181|P2|Overall Study|Stopped at end of core|32
474457|NCT00171210|1549182|P1|Overall Study|Stopped at end of core|0
474458|NCT00171210|1549181|P2|Overall Study|Death|3
474459|NCT00171210|1549182|P1|Overall Study|Death|2
474460|NCT00171210|1549181|P2|Overall Study|Administrative problems|1
474461|NCT00171210|1549182|P1|Overall Study|Administrative problems|1
474462|NCT00171210|1549181|P2|Overall Study|Lost to Follow-up|0
474463|NCT00171210|1549182|P1|Overall Study|Lost to Follow-up|1
474464|NCT00171210|1549181|P2|Overall Study|Withdrawal by Subject|30
474465|NCT00171210|1549182|P1|Overall Study|Withdrawal by Subject|32
474466|NCT00171210|1549181|P2|Overall Study|Protocol Violation|2
474467|NCT00171210|1549182|P1|Overall Study|Protocol Violation|0
474468|NCT00171210|1549181|P2|Overall Study|Unsatisfactory therapeutic effect|15
474469|NCT00171210|1549182|P1|Overall Study|Unsatisfactory therapeutic effect|11
474470|NCT00171210|1549181|P2|Overall Study|Abnormal test procedure result(s)|1
474471|NCT00171210|1549182|P1|Overall Study|Abnormal test procedure result(s)|0
474472|NCT00171210|1549181|P2|Overall Study|Abnormal laboratory value(s)|3
474473|NCT00171210|1549182|P1|Overall Study|Abnormal laboratory value(s)|6
474474|NCT00171210|1549181|P2|Overall Study|Adverse Event|27
474475|NCT00171210|1549182|P1|Overall Study|Adverse Event|16
474476|NCT00171054|1549212|P2|Overall Study|Condition no longer required study drug|1
474477|NCT00171054|1549213|P1|Overall Study|Condition no longer required study drug|0
474478|NCT00171054|1549212|P2|Overall Study|Adverse Event|8
474479|NCT00171054|1549213|P1|Overall Study|Adverse Event|8
474480|NCT00171054|1549212|P2|Overall Study|Lost to Follow-up|1
474481|NCT00171054|1549213|P1|Overall Study|Lost to Follow-up|0
474482|NCT00171054|1549212|P2|Overall Study|Patient withdrew consent|0
474483|NCT00171054|1549213|P1|Overall Study|Patient withdrew consent|1
474484|NCT00171054|1549212|P2|Overall Study|Protocol Violation|2
474485|NCT00171054|1549213|P1|Overall Study|Protocol Violation|1
474486|NCT00170950|1549245|P2|Overall Study|Termination Data Not Recorded|22
474487|NCT00170950|1549246|P1|Overall Study|Termination Data Not Recorded|17
474488|NCT00170950|1549245|P2|Overall Study|Missing|1
474489|NCT00170950|1549246|P1|Overall Study|Missing|2
474490|NCT00170950|1549245|P2|Overall Study|Lost to Follow-up|115
474491|NCT00170950|1549246|P1|Overall Study|Lost to Follow-up|134
474492|NCT00170950|1549245|P2|Overall Study|Withdrawal by Subject|498
474493|NCT00170950|1549246|P1|Overall Study|Withdrawal by Subject|496
474494|NCT00170950|1549245|P2|Overall Study|Death|274
474495|NCT00170950|1549246|P1|Overall Study|Death|236
474496|NCT00170846|1549259|P3|Overall Study|Reason Missing|0
474497|NCT00170846|1549260|P2|Overall Study|Reason Missing|1
474498|NCT00170846|1549261|P1|Overall Study|Reason Missing|0
474499|NCT00170846|1549259|P3|Overall Study|Death|3
474500|NCT00170846|1549260|P2|Overall Study|Death|3
474501|NCT00170846|1549261|P1|Overall Study|Death|0
474502|NCT00170846|1549259|P3|Overall Study|Lost to Follow-up|2
474503|NCT00170846|1549260|P2|Overall Study|Lost to Follow-up|3
474504|NCT00170846|1549261|P1|Overall Study|Lost to Follow-up|6
474505|NCT00170846|1549259|P3|Overall Study|Subject withdrew Informed Consent|8
474506|NCT00170846|1549260|P2|Overall Study|Subject withdrew Informed Consent|12
474507|NCT00170846|1549261|P1|Overall Study|Subject withdrew Informed Consent|5
474508|NCT00169442|1549293|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
474509|NCT00169442|1549294|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
474510|NCT00169442|1549295|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
474511|NCT00169442|1549296|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
474512|NCT00169442|1549297|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
474513|NCT00169442|1549298|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
474514|NCT00169442|1549293|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
474515|NCT00169442|1549294|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
474516|NCT00169442|1549295|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
474517|NCT00169442|1549296|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
474518|NCT00169442|1549297|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
474519|NCT00169442|1549298|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
474520|NCT00169442|1549293|P6|Overall Study|Migrated/moved from study area|2
474521|NCT00169442|1549294|P5|Overall Study|Migrated/moved from study area|0
474522|NCT00169442|1549295|P4|Overall Study|Migrated/moved from study area|0
474523|NCT00169442|1549296|P3|Overall Study|Migrated/moved from study area|0
474524|NCT00169442|1549297|P2|Overall Study|Migrated/moved from study area|0
474525|NCT00169442|1549298|P1|Overall Study|Migrated/moved from study area|0
474526|NCT00169442|1549293|P6|Overall Study|Withdrawal by Subject|0
474527|NCT00169442|1549294|P5|Overall Study|Withdrawal by Subject|0
474528|NCT00169442|1549295|P4|Overall Study|Withdrawal by Subject|0
474529|NCT00169442|1549296|P3|Overall Study|Withdrawal by Subject|1
474530|NCT00169442|1549297|P2|Overall Study|Withdrawal by Subject|0
474531|NCT00169442|1549298|P1|Overall Study|Withdrawal by Subject|0
474532|NCT00168844|1549408|P3|Overall Study|Other|9
474533|NCT00168844|1549409|P2|Overall Study|Other|7
474534|NCT00168844|1549410|P1|Overall Study|Other|6
474535|NCT00168844|1549408|P3|Overall Study|Protocol Violation|4
474536|NCT00168844|1549409|P2|Overall Study|Protocol Violation|2
474537|NCT00168844|1549410|P1|Overall Study|Protocol Violation|2
474538|NCT00168844|1549408|P3|Overall Study|Withdrawal by Subject|19
474539|NCT00168844|1549409|P2|Overall Study|Withdrawal by Subject|9
474540|NCT00168844|1549410|P1|Overall Study|Withdrawal by Subject|12
474541|NCT00168844|1549408|P3|Overall Study|Lost to Follow-up|11
474542|NCT00168844|1549409|P2|Overall Study|Lost to Follow-up|5
474543|NCT00168844|1549410|P1|Overall Study|Lost to Follow-up|4
474544|NCT00168844|1549408|P3|Overall Study|Adverse Event|48
474545|NCT00168844|1549409|P2|Overall Study|Adverse Event|32
474546|NCT00168844|1549410|P1|Overall Study|Adverse Event|31
474547|NCT00168831|1549592|P3|Overall Study|Other|6
474548|NCT00168831|1549593|P2|Overall Study|Other|3
474549|NCT00168831|1549594|P1|Overall Study|Other|6
474550|NCT00168831|1549592|P3|Overall Study|Protocol Violation|11
474551|NCT00168831|1549593|P2|Overall Study|Protocol Violation|11
474552|NCT00168831|1549594|P1|Overall Study|Protocol Violation|6
474553|NCT00168831|1549592|P3|Overall Study|Withdrawal by Subject|19
474554|NCT00168831|1549593|P2|Overall Study|Withdrawal by Subject|14
474555|NCT00168831|1549594|P1|Overall Study|Withdrawal by Subject|7
474556|NCT00168831|1549592|P3|Overall Study|Lost to Follow-up|4
474557|NCT00168831|1549593|P2|Overall Study|Lost to Follow-up|6
474558|NCT00168831|1549594|P1|Overall Study|Lost to Follow-up|5
474559|NCT00168831|1549592|P3|Overall Study|Adverse Event|74
474560|NCT00168831|1549593|P2|Overall Study|Adverse Event|47
474561|NCT00168831|1549594|P1|Overall Study|Adverse Event|36
474562|NCT00168818|1549776|P3|Treatment|not specified|31
474563|NCT00168818|1549777|P2|Treatment|not specified|29
474564|NCT00168818|1549778|P1|Treatment|not specified|23
474565|NCT00168818|1549776|P3|Treatment|Withdrawal by Subject|22
474566|NCT00168818|1549777|P2|Treatment|Withdrawal by Subject|20
474567|NCT00168818|1549778|P1|Treatment|Withdrawal by Subject|25
474568|NCT00168818|1549776|P3|Treatment|Lost to Follow-up|1
474569|NCT00168818|1549777|P2|Treatment|Lost to Follow-up|2
474570|NCT00168818|1549778|P1|Treatment|Lost to Follow-up|0
474571|NCT00168818|1549776|P3|Treatment|Protocol Violation|11
474572|NCT00168818|1549777|P2|Treatment|Protocol Violation|11
474573|NCT00168818|1549778|P1|Treatment|Protocol Violation|8
474574|NCT00168818|1549776|P3|Treatment|Adverse Event|68
474575|NCT00168818|1549777|P2|Treatment|Adverse Event|89
474576|NCT00168818|1549778|P1|Treatment|Adverse Event|77
474577|NCT00168818|1549776|P3|Overall Study|not specified|30
474578|NCT00168818|1549777|P2|Overall Study|not specified|24
474579|NCT00168818|1549778|P1|Overall Study|not specified|22
474580|NCT00168818|1549776|P3|Overall Study|Withdrawal by Subject|37
474581|NCT00168818|1549777|P2|Overall Study|Withdrawal by Subject|41
474582|NCT00168818|1549778|P1|Overall Study|Withdrawal by Subject|43
474583|NCT00168818|1549776|P3|Overall Study|Lost to Follow-up|15
474584|NCT00168818|1549777|P2|Overall Study|Lost to Follow-up|4
474585|NCT00168818|1549778|P1|Overall Study|Lost to Follow-up|13
474586|NCT00168818|1549776|P3|Overall Study|Protocol Violation|11
474587|NCT00168818|1549777|P2|Overall Study|Protocol Violation|11
474588|NCT00168818|1549778|P1|Overall Study|Protocol Violation|16
474589|NCT00168818|1549776|P3|Overall Study|Adverse Event|31
474590|NCT00168818|1549777|P2|Overall Study|Adverse Event|29
474591|NCT00168818|1549778|P1|Overall Study|Adverse Event|23
474592|NCT00168805|1549822|P3|Treatment|not specified|17
474593|NCT00168805|1549823|P2|Treatment|not specified|18
474594|NCT00168805|1549824|P1|Treatment|not specified|18
474595|NCT00168805|1549822|P3|Treatment|Withdrawal by Subject|8
474596|NCT00168805|1549823|P2|Treatment|Withdrawal by Subject|7
474597|NCT00168805|1549824|P1|Treatment|Withdrawal by Subject|3
474598|NCT00168805|1549822|P3|Treatment|Protocol Violation|5
474599|NCT00168805|1549823|P2|Treatment|Protocol Violation|5
474600|NCT00168805|1549824|P1|Treatment|Protocol Violation|3
474601|NCT00168805|1549822|P3|Treatment|Adverse Event|32
474602|NCT00168805|1549823|P2|Treatment|Adverse Event|26
474603|NCT00168805|1549824|P1|Treatment|Adverse Event|25
474604|NCT00168805|1549822|P3|Overall Study|not specified|22
474605|NCT00168805|1549823|P2|Overall Study|not specified|21
474606|NCT00168805|1549824|P1|Overall Study|not specified|24
474607|NCT00168805|1549822|P3|Overall Study|Withdrawal by Subject|21
474608|NCT00168805|1549823|P2|Overall Study|Withdrawal by Subject|18
474609|NCT00168805|1549824|P1|Overall Study|Withdrawal by Subject|16
474610|NCT00168805|1549822|P3|Overall Study|Lost to Follow-up|11
474611|NCT00168805|1549823|P2|Overall Study|Lost to Follow-up|17
474612|NCT00168805|1549824|P1|Overall Study|Lost to Follow-up|12
474613|NCT00168805|1549822|P3|Overall Study|Protocol Violation|8
474614|NCT00168805|1549823|P2|Overall Study|Protocol Violation|11
474615|NCT00168805|1549824|P1|Overall Study|Protocol Violation|12
474616|NCT00168805|1549822|P3|Overall Study|Adverse Event|16
474617|NCT00168805|1549823|P2|Overall Study|Adverse Event|11
474618|NCT00168805|1549824|P1|Overall Study|Adverse Event|7
474619|NCT00168103|1550060|P4|Overall Study|Lost to Follow-up|0
474620|NCT00168103|1550061|P3|Overall Study|Lost to Follow-up|0
474621|NCT00168103|1550062|P2|Overall Study|Lost to Follow-up|3
474622|NCT00168103|1550063|P1|Overall Study|Lost to Follow-up|1
474623|NCT00168103|1550060|P4|Overall Study|Withdrawal by Subject|0
474624|NCT00168103|1550061|P3|Overall Study|Withdrawal by Subject|1
474625|NCT00168103|1550062|P2|Overall Study|Withdrawal by Subject|2
474626|NCT00168103|1550063|P1|Overall Study|Withdrawal by Subject|1
474627|NCT00168064|1550085|P2|Overall Study|Various|3
474628|NCT00168064|1550086|P1|Overall Study|Various|4
474629|NCT00168064|1550085|P2|Overall Study|Subject's Best interest|2
474630|NCT00168064|1550086|P1|Overall Study|Subject's Best interest|2
474631|NCT00168064|1550085|P2|Overall Study|Concurrent Illness|3
474632|NCT00168064|1550086|P1|Overall Study|Concurrent Illness|4
474633|NCT00168064|1550085|P2|Overall Study|Non-compliance|3
474634|NCT00168064|1550086|P1|Overall Study|Non-compliance|2
474635|NCT00168064|1550085|P2|Overall Study|Lost to Follow-up|3
474636|NCT00168064|1550086|P1|Overall Study|Lost to Follow-up|4
474637|NCT00168064|1550085|P2|Overall Study|Lack of Efficacy|4
474638|NCT00168064|1550086|P1|Overall Study|Lack of Efficacy|4
474639|NCT00168064|1550085|P2|Overall Study|Withdrawal by Subject|4
474640|NCT00168064|1550086|P1|Overall Study|Withdrawal by Subject|3
474641|NCT00168064|1550085|P2|Overall Study|Adverse Event|22
474642|NCT00168064|1550086|P1|Overall Study|Adverse Event|26
474643|NCT00168038|1550094|P1|Overall Study|Therapy failure|1
474644|NCT00168038|1550094|P1|Overall Study|Adverse Event|1
474645|NCT00167778|1550106|P1|Overall Study|Withdrawal by Subject|1
474646|NCT00167414|1550172|P1|Overall Study|Death|10
474647|NCT00167310|1550197|P2|Overall Study|Withdrawal by Subject|7
474648|NCT00167310|1550198|P1|Overall Study|Withdrawal by Subject|3
474649|NCT00167310|1550197|P2|Overall Study|Protocol Violation|3
474650|NCT00167310|1550198|P1|Overall Study|Protocol Violation|5
474651|NCT00167245|1550208|P2|Overall Study|Drowsy|0
474652|NCT00167245|1550209|P1|Overall Study|Drowsy|1
474653|NCT00167245|1550208|P2|Overall Study|Incarcerated|2
474654|NCT00167245|1550209|P1|Overall Study|Incarcerated|3
474655|NCT00167245|1550208|P2|Overall Study|Withdrawal by Subject|8
474656|NCT00167245|1550209|P1|Overall Study|Withdrawal by Subject|5
474657|NCT00167245|1550208|P2|Overall Study|Lost to Follow-up|31
474658|NCT00167245|1550209|P1|Overall Study|Lost to Follow-up|20
474659|NCT00166712|1550259|P2|Overall Study|Physician Decision|2
474660|NCT00166712|1550260|P1|Overall Study|Physician Decision|0
474661|NCT00166712|1550259|P2|Overall Study|Withdrawal by Subject|2
474662|NCT00166712|1550260|P1|Overall Study|Withdrawal by Subject|1
474663|NCT00166712|1550259|P2|Overall Study|Adverse Event|0
474664|NCT00166712|1550260|P1|Overall Study|Adverse Event|1
474665|NCT00166712|1550259|P2|Overall Study|Death|1
474666|NCT00166712|1550260|P1|Overall Study|Death|0
474667|NCT00166517|1550277|P2|Overall Study|Withdrawal by Subject|1
474668|NCT00166517|1550278|P1|Overall Study|Withdrawal by Subject|0
474669|NCT00166517|1550277|P2|Overall Study|Protocol Violation|1
474670|NCT00166517|1550278|P1|Overall Study|Protocol Violation|4
474671|NCT00166517|1550277|P2|Overall Study|Lost to Follow-up|0
474672|NCT00166517|1550278|P1|Overall Study|Lost to Follow-up|1
474673|NCT00166504|1550288|P2|Overall Study|Withdrawal by Subject|0
474674|NCT00166504|1550289|P1|Overall Study|Withdrawal by Subject|1
474675|NCT00166504|1550288|P2|Overall Study|Lost to Follow-up|1
474676|NCT00166504|1550289|P1|Overall Study|Lost to Follow-up|1
474677|NCT00166504|1550288|P2|Overall Study|Adverse Event|3
474678|NCT00166504|1550289|P1|Overall Study|Adverse Event|3
474679|NCT00166296|1550306|P2|Overall Study|Lost to Follow-up|2
474680|NCT00166296|1550307|P1|Overall Study|Lost to Follow-up|4
474681|NCT00166296|1550306|P2|Overall Study|Adverse Event|4
474682|NCT00166296|1550307|P1|Overall Study|Adverse Event|2
474683|NCT00166296|1550306|P2|Overall Study|Withdrawal by Subject|3
474684|NCT00166296|1550307|P1|Overall Study|Withdrawal by Subject|1
474685|NCT00166114|1550359|P2|Overall Study|Adverse Event|1
474686|NCT00166114|1550360|P1|Overall Study|Adverse Event|2
474687|NCT00166114|1550359|P2|Overall Study|Withdrawal by Subject|4
474688|NCT00166114|1550360|P1|Overall Study|Withdrawal by Subject|10
474689|NCT00166114|1550359|P2|Overall Study|Protocol Violation|1
474690|NCT00166114|1550360|P1|Overall Study|Protocol Violation|2
474691|NCT00165984|1550377|P1|Overall Study|Death|15
474692|NCT00165841|1550395|P2|Overall Study|Medication Noncompliance|1
474693|NCT00165841|1550396|P1|Overall Study|Medication Noncompliance|1
474694|NCT00165841|1550395|P2|Overall Study|Other|5
474695|NCT00165841|1550396|P1|Overall Study|Other|3
474696|NCT00165841|1550395|P2|Overall Study|Protocol Violation|8
474697|NCT00165841|1550396|P1|Overall Study|Protocol Violation|6
474698|NCT00165841|1550395|P2|Overall Study|Physician Decision|0
474699|NCT00165841|1550396|P1|Overall Study|Physician Decision|1
474700|NCT00165841|1550395|P2|Overall Study|Withdrawal by Subject|8
474701|NCT00165841|1550396|P1|Overall Study|Withdrawal by Subject|7
474702|NCT00165841|1550395|P2|Overall Study|Lost to Follow-up|4
474703|NCT00165841|1550396|P1|Overall Study|Lost to Follow-up|4
474704|NCT00165841|1550395|P2|Overall Study|Lack of Efficacy|33
474705|NCT00165841|1550396|P1|Overall Study|Lack of Efficacy|6
474706|NCT00165841|1550395|P2|Overall Study|Adverse Event|3
474707|NCT00165841|1550396|P1|Overall Study|Adverse Event|2
474708|NCT00165789|1550406|P4|Overall Study|Withdrawal by Subject|2
474709|NCT00165789|1550407|P3|Overall Study|Withdrawal by Subject|1
474710|NCT00165789|1550408|P2|Overall Study|Withdrawal by Subject|1
474711|NCT00165789|1550409|P1|Overall Study|Withdrawal by Subject|0
474712|NCT00165789|1550406|P4|Overall Study|Adverse Event|12
474713|NCT00165789|1550407|P3|Overall Study|Adverse Event|0
474714|NCT00165789|1550408|P2|Overall Study|Adverse Event|3
474715|NCT00165789|1550409|P1|Overall Study|Adverse Event|0
474716|NCT00165776|1550463|P4|Overall Study|Worsening of Cervical Dystonia|1
474717|NCT00165776|1550464|P3|Overall Study|Worsening of Cervical Dystonia|0
474718|NCT00165776|1550465|P2|Overall Study|Worsening of Cervical Dystonia|0
474719|NCT00165776|1550466|P1|Overall Study|Worsening of Cervical Dystonia|0
474720|NCT00165776|1550463|P4|Overall Study|Withdrawal by Subject|0
474721|NCT00165776|1550464|P3|Overall Study|Withdrawal by Subject|2
474722|NCT00165776|1550465|P2|Overall Study|Withdrawal by Subject|1
474723|NCT00165776|1550466|P1|Overall Study|Withdrawal by Subject|4
474724|NCT00165776|1550463|P4|Overall Study|Lack of Efficacy|1
474725|NCT00165776|1550464|P3|Overall Study|Lack of Efficacy|0
474726|NCT00165776|1550465|P2|Overall Study|Lack of Efficacy|0
474727|NCT00165776|1550466|P1|Overall Study|Lack of Efficacy|0
474728|NCT00165698|1550502|P2|Overall Study|Not Taken/Lost the medicine|2
474729|NCT00165698|1550503|P1|Overall Study|Not Taken/Lost the medicine|1
474730|NCT00165698|1550502|P2|Overall Study|Protocol Violation|0
474731|NCT00165698|1550503|P1|Overall Study|Protocol Violation|1
474732|NCT00165698|1550502|P2|Overall Study|Withdrawal by Subject|1
474733|NCT00165698|1550503|P1|Overall Study|Withdrawal by Subject|2
474734|NCT00165698|1550502|P2|Overall Study|Lost to Follow-up|2
474735|NCT00165698|1550503|P1|Overall Study|Lost to Follow-up|2
474736|NCT00165698|1550502|P2|Overall Study|Adverse Event|10
474737|NCT00165698|1550503|P1|Overall Study|Adverse Event|2
474738|NCT00165672|1550529|P2|Overall Study|Adverse Event|1
474739|NCT00165672|1550530|P1|Overall Study|Adverse Event|0
474740|NCT00165646|1550539|P3|Overall Study|Protocol Violation|0
474741|NCT00165646|1550540|P2|Overall Study|Protocol Violation|0
474742|NCT00165646|1550541|P1|Overall Study|Protocol Violation|1
474743|NCT00165646|1550539|P3|Overall Study|Physician Decision|2
474744|NCT00165646|1550540|P2|Overall Study|Physician Decision|0
474745|NCT00165646|1550541|P1|Overall Study|Physician Decision|2
474746|NCT00165646|1550539|P3|Overall Study|Withdrawal by Subject|1
474747|NCT00165646|1550540|P2|Overall Study|Withdrawal by Subject|2
474748|NCT00165646|1550541|P1|Overall Study|Withdrawal by Subject|0
474749|NCT00165646|1550539|P3|Overall Study|Lack of Efficacy|0
474750|NCT00165646|1550540|P2|Overall Study|Lack of Efficacy|2
474751|NCT00165646|1550541|P1|Overall Study|Lack of Efficacy|1
474752|NCT00165646|1550539|P3|Overall Study|Adverse Event|1
474753|NCT00165646|1550540|P2|Overall Study|Adverse Event|1
474754|NCT00165646|1550541|P1|Overall Study|Adverse Event|1
474755|NCT00165503|1550549|P1|Overall Study|Unresectable|3
474756|NCT00165503|1550549|P1|Overall Study|Lost to Follow-up|12
474757|NCT00165503|1550549|P1|Overall Study|Death|1
474758|NCT00163657|1550556|P3|Overall Study|Other reason|3
474759|NCT00163657|1550557|P2|Overall Study|Other reason|1
474760|NCT00163657|1550558|P1|Overall Study|Other reason|0
474761|NCT00163657|1550556|P3|Overall Study|Lost to Follow-up|10
474762|NCT00163657|1550557|P2|Overall Study|Lost to Follow-up|3
474763|NCT00163657|1550558|P1|Overall Study|Lost to Follow-up|1
474764|NCT00163657|1550556|P3|Overall Study|Non Compliance|0
474765|NCT00163657|1550557|P2|Overall Study|Non Compliance|0
474766|NCT00163657|1550558|P1|Overall Study|Non Compliance|1
474767|NCT00163657|1550556|P3|Overall Study|Physician Decision|1
474768|NCT00163657|1550557|P2|Overall Study|Physician Decision|1
474769|NCT00163657|1550558|P1|Overall Study|Physician Decision|0
474770|NCT00163657|1550556|P3|Overall Study|Withdrawal by Subject|2
474771|NCT00163657|1550557|P2|Overall Study|Withdrawal by Subject|3
474772|NCT00163657|1550558|P1|Overall Study|Withdrawal by Subject|2
474773|NCT00163657|1550556|P3|Overall Study|graft loss|2
474774|NCT00163657|1550557|P2|Overall Study|graft loss|1
474775|NCT00163657|1550558|P1|Overall Study|graft loss|4
474776|NCT00163657|1550556|P3|Overall Study|Death|19
474777|NCT00163657|1550557|P2|Overall Study|Death|14
474778|NCT00163657|1550558|P1|Overall Study|Death|12
474779|NCT00163215|1550648|P1|Overall Study|Other|7
474780|NCT00163215|1550648|P1|Overall Study|Withdrawal by Subject|5
474781|NCT00163215|1550648|P1|Overall Study|Lack of Efficacy|3
474782|NCT00163189|1550668|P1|Overall Study|Did not meet continuation criterion|16
474783|NCT00163189|1550668|P1|Overall Study|Withdrawal by Subject|11
474784|NCT00163189|1550668|P1|Overall Study|Study terminated by sponsor|11
474785|NCT00163189|1550668|P1|Overall Study|Lack of Efficacy|7
474786|NCT00163189|1550668|P1|Overall Study|Adverse Event|6
474787|NCT00163189|1550668|P1|Overall Study|Death|3
474788|NCT00163189|1550668|P1|Overall Study|Protocol Violation|2
474789|NCT00163189|1550668|P1|Overall Study|Lost to Follow-up|1
474790|NCT00163189|1550668|P1|Overall Study|Other|6
474791|NCT00163020|1550692|P2|Overall Study|Lost to Follow-up|2
474792|NCT00163020|1550693|P1|Overall Study|Lost to Follow-up|0
474793|NCT00162981|1550733|P2|Overall Study|Physician Decision|0
474794|NCT00162981|1550734|P1|Overall Study|Physician Decision|1
474795|NCT00162981|1550733|P2|Overall Study|Withdrawal by Subject|1
474796|NCT00162981|1550734|P1|Overall Study|Withdrawal by Subject|1
474797|NCT00162981|1550733|P2|Overall Study|Adverse Event|5
474798|NCT00162981|1550734|P1|Overall Study|Adverse Event|2
474799|NCT00162942|1550750|P2|Overall Study|2 or more consecutive treatments missed|0
474800|NCT00162942|1550751|P1|Overall Study|2 or more consecutive treatments missed|1
474801|NCT00162942|1550750|P2|Overall Study|Flare During Active Treatment|3
474802|NCT00162942|1550751|P1|Overall Study|Flare During Active Treatment|7
474803|NCT00162942|1550750|P2|Overall Study|Lack of Efficacy|0
474804|NCT00162942|1550751|P1|Overall Study|Lack of Efficacy|1
474805|NCT00162942|1550750|P2|Overall Study|Alternate Therapy|2
474806|NCT00162942|1550751|P1|Overall Study|Alternate Therapy|6
474807|NCT00162942|1550750|P2|Overall Study|Enter Open-Label Study|35
474808|NCT00162942|1550751|P1|Overall Study|Enter Open-Label Study|76
474809|NCT00162942|1550750|P2|Overall Study|Physician Decision|0
474810|NCT00162942|1550751|P1|Overall Study|Physician Decision|1
474811|NCT00162942|1550750|P2|Overall Study|Withdrawal by Subject|6
474812|NCT00162942|1550751|P1|Overall Study|Withdrawal by Subject|3
474813|NCT00162942|1550750|P2|Overall Study|Death|0
474814|NCT00162942|1550751|P1|Overall Study|Death|1
474815|NCT00162942|1550750|P2|Overall Study|Adverse Event|6
474816|NCT00162942|1550751|P1|Overall Study|Adverse Event|10
474817|NCT00162773|1550799|P1|Overall Study|P.I, Left institution. Study terminated|22
474818|NCT00162370|1550803|P1|Efficacy Population|Lost to Follow-up|51
474819|NCT00162266|1550811|P4|Open-Label Period|Other Reasons|15
474820|NCT00162266|1550812|P3|Open-Label Period|Other Reasons|0
474821|NCT00162266|1550813|P2|Open-Label Period|Other Reasons|0
474822|NCT00162266|1550814|P1|Open-Label Period|Other Reasons|0
474823|NCT00162266|1550811|P4|Open-Label Period|Administrative Reason By Sponsor|9
474824|NCT00162266|1550812|P3|Open-Label Period|Administrative Reason By Sponsor|0
474825|NCT00162266|1550813|P2|Open-Label Period|Administrative Reason By Sponsor|0
474826|NCT00162266|1550814|P1|Open-Label Period|Administrative Reason By Sponsor|0
474827|NCT00162266|1550811|P4|Open-Label Period|Withdrawal by Subject|31
474828|NCT00162266|1550812|P3|Open-Label Period|Withdrawal by Subject|0
474829|NCT00162266|1550813|P2|Open-Label Period|Withdrawal by Subject|0
474830|NCT00162266|1550814|P1|Open-Label Period|Withdrawal by Subject|0
474831|NCT00162266|1550811|P4|Open-Label Period|Lost to Follow-up|3
474832|NCT00162266|1550812|P3|Open-Label Period|Lost to Follow-up|0
474833|NCT00162266|1550813|P2|Open-Label Period|Lost to Follow-up|0
474834|NCT00162266|1550814|P1|Open-Label Period|Lost to Follow-up|0
474835|NCT00162266|1550811|P4|Open-Label Period|Lack of Efficacy|26
474836|NCT00162266|1550812|P3|Open-Label Period|Lack of Efficacy|0
474837|NCT00162266|1550813|P2|Open-Label Period|Lack of Efficacy|0
474838|NCT00162266|1550814|P1|Open-Label Period|Lack of Efficacy|0
474839|NCT00162266|1550811|P4|Open-Label Period|Adverse Event|46
474840|NCT00162266|1550812|P3|Open-Label Period|Adverse Event|0
474841|NCT00162266|1550813|P2|Open-Label Period|Adverse Event|0
474842|NCT00162266|1550814|P1|Open-Label Period|Adverse Event|0
474843|NCT00162266|1550811|P4|Open-Label Period|Death|7
474844|NCT00162266|1550812|P3|Open-Label Period|Death|0
474845|NCT00162266|1550813|P2|Open-Label Period|Death|0
474846|NCT00162266|1550814|P1|Open-Label Period|Death|0
474847|NCT00162266|1550811|P4|Double-Blind Period|Withdrawal by Subject|0
474848|NCT00162266|1550812|P3|Double-Blind Period|Withdrawal by Subject|6
474849|NCT00162266|1550813|P2|Double-Blind Period|Withdrawal by Subject|2
474850|NCT00162266|1550814|P1|Double-Blind Period|Withdrawal by Subject|5
474851|NCT00162266|1550811|P4|Double-Blind Period|Lack of Efficacy|0
474852|NCT00162266|1550812|P3|Double-Blind Period|Lack of Efficacy|30
474853|NCT00162266|1550813|P2|Double-Blind Period|Lack of Efficacy|17
474854|NCT00162266|1550814|P1|Double-Blind Period|Lack of Efficacy|13
474855|NCT00162266|1550811|P4|Double-Blind Period|Other Reason|0
474856|NCT00162266|1550812|P3|Double-Blind Period|Other Reason|1
474857|NCT00162266|1550813|P2|Double-Blind Period|Other Reason|0
474858|NCT00162266|1550814|P1|Double-Blind Period|Other Reason|1
474859|NCT00162266|1550811|P4|Double-Blind Period|Lost to Follow-up|0
474860|NCT00162266|1550812|P3|Double-Blind Period|Lost to Follow-up|0
474861|NCT00162266|1550813|P2|Double-Blind Period|Lost to Follow-up|2
474862|NCT00162266|1550814|P1|Double-Blind Period|Lost to Follow-up|1
474863|NCT00162266|1550811|P4|Double-Blind Period|Death|0
474864|NCT00162266|1550812|P3|Double-Blind Period|Death|0
474865|NCT00162266|1550813|P2|Double-Blind Period|Death|1
474866|NCT00162266|1550814|P1|Double-Blind Period|Death|0
474867|NCT00162266|1550811|P4|Double-Blind Period|Adverse Event|0
474868|NCT00162266|1550812|P3|Double-Blind Period|Adverse Event|11
474869|NCT00162266|1550813|P2|Double-Blind Period|Adverse Event|9
474870|NCT00162266|1550814|P1|Double-Blind Period|Adverse Event|5
474871|NCT00162136|1551015|P1|Overall Study|Withdrawal by Subject|1
474872|NCT00162136|1551015|P1|Overall Study|Study Drug Toxicity|4
474873|NCT00162136|1551015|P1|Overall Study|Investigator Request|5
474874|NCT00162136|1551015|P1|Overall Study|Disease Progression/Relapse|23
474875|NCT00162136|1551015|P1|Overall Study|Death|1
474876|NCT00162136|1551015|P1|Overall Study|Adverse Event|1
474877|NCT00162123|1551047|P8|Overall Study|Follow-up only (not treated or assessed)|57
474878|NCT00162123|1551048|P7|Overall Study|Follow-up only (not treated or assessed)|0
474879|NCT00162123|1551049|P6|Overall Study|Follow-up only (not treated or assessed)|0
474880|NCT00162123|1551050|P5|Overall Study|Follow-up only (not treated or assessed)|0
474881|NCT00162123|1551051|P4|Overall Study|Follow-up only (not treated or assessed)|0
474882|NCT00162123|1551052|P3|Overall Study|Follow-up only (not treated or assessed)|0
474883|NCT00162123|1551053|P2|Overall Study|Follow-up only (not treated or assessed)|0
474884|NCT00162123|1551054|P1|Overall Study|Follow-up only (not treated or assessed)|0
474885|NCT00162123|1551047|P8|Overall Study|Tumor assessment only (not treated)|1
474886|NCT00162123|1551048|P7|Overall Study|Tumor assessment only (not treated)|0
474887|NCT00162123|1551049|P6|Overall Study|Tumor assessment only (not treated)|0
474888|NCT00162123|1551050|P5|Overall Study|Tumor assessment only (not treated)|0
474889|NCT00162123|1551051|P4|Overall Study|Tumor assessment only (not treated)|0
474890|NCT00162123|1551052|P3|Overall Study|Tumor assessment only (not treated)|0
474891|NCT00162123|1551053|P2|Overall Study|Tumor assessment only (not treated)|0
474892|NCT00162123|1551054|P1|Overall Study|Tumor assessment only (not treated)|0
474893|NCT00162123|1551047|P8|Overall Study|Physician Decision|0
474894|NCT00162123|1551048|P7|Overall Study|Physician Decision|1
474895|NCT00162123|1551049|P6|Overall Study|Physician Decision|1
474896|NCT00162123|1551050|P5|Overall Study|Physician Decision|0
474897|NCT00162123|1551051|P4|Overall Study|Physician Decision|0
474898|NCT00162123|1551052|P3|Overall Study|Physician Decision|0
474899|NCT00162123|1551053|P2|Overall Study|Physician Decision|2
474900|NCT00162123|1551054|P1|Overall Study|Physician Decision|1
474901|NCT00162123|1551047|P8|Overall Study|Not specified (after start of treatment)|0
474902|NCT00162123|1551048|P7|Overall Study|Not specified (after start of treatment)|0
474903|NCT00162123|1551049|P6|Overall Study|Not specified (after start of treatment)|0
474904|NCT00162123|1551050|P5|Overall Study|Not specified (after start of treatment)|3
474905|NCT00162123|1551051|P4|Overall Study|Not specified (after start of treatment)|0
474906|NCT00162123|1551052|P3|Overall Study|Not specified (after start of treatment)|0
474907|NCT00162123|1551053|P2|Overall Study|Not specified (after start of treatment)|0
474908|NCT00162123|1551054|P1|Overall Study|Not specified (after start of treatment)|0
474909|NCT00162123|1551047|P8|Overall Study|Not specified (before treatment)|0
474910|NCT00162123|1551048|P7|Overall Study|Not specified (before treatment)|0
474911|NCT00162123|1551049|P6|Overall Study|Not specified (before treatment)|1
474912|NCT00162123|1551050|P5|Overall Study|Not specified (before treatment)|12
474913|NCT00162123|1551051|P4|Overall Study|Not specified (before treatment)|0
474914|NCT00162123|1551052|P3|Overall Study|Not specified (before treatment)|0
474915|NCT00162123|1551053|P2|Overall Study|Not specified (before treatment)|0
474916|NCT00162123|1551054|P1|Overall Study|Not specified (before treatment)|2
474917|NCT00162123|1551047|P8|Overall Study|Adverse Event|0
474918|NCT00162123|1551048|P7|Overall Study|Adverse Event|0
474919|NCT00162123|1551049|P6|Overall Study|Adverse Event|0
474920|NCT00162123|1551050|P5|Overall Study|Adverse Event|1
474921|NCT00162123|1551051|P4|Overall Study|Adverse Event|2
474922|NCT00162123|1551052|P3|Overall Study|Adverse Event|0
474923|NCT00162123|1551053|P2|Overall Study|Adverse Event|2
474924|NCT00162123|1551054|P1|Overall Study|Adverse Event|1
474925|NCT00162123|1551047|P8|Overall Study|Deterioration without progression|0
474926|NCT00162123|1551048|P7|Overall Study|Deterioration without progression|0
474927|NCT00162123|1551049|P6|Overall Study|Deterioration without progression|0
474928|NCT00162123|1551050|P5|Overall Study|Deterioration without progression|1
474929|NCT00162123|1551051|P4|Overall Study|Deterioration without progression|0
474930|NCT00162123|1551052|P3|Overall Study|Deterioration without progression|3
474931|NCT00162123|1551053|P2|Overall Study|Deterioration without progression|2
474932|NCT00162123|1551054|P1|Overall Study|Deterioration without progression|2
474933|NCT00162123|1551047|P8|Overall Study|Withdrawal by Subject|0
474934|NCT00162123|1551048|P7|Overall Study|Withdrawal by Subject|1
474935|NCT00162123|1551049|P6|Overall Study|Withdrawal by Subject|2
474936|NCT00162123|1551050|P5|Overall Study|Withdrawal by Subject|1
474937|NCT00162123|1551051|P4|Overall Study|Withdrawal by Subject|1
474938|NCT00162123|1551052|P3|Overall Study|Withdrawal by Subject|2
474939|NCT00162123|1551053|P2|Overall Study|Withdrawal by Subject|0
474940|NCT00162123|1551054|P1|Overall Study|Withdrawal by Subject|2
474941|NCT00162123|1551047|P8|Overall Study|Death|0
474942|NCT00162123|1551048|P7|Overall Study|Death|0
474943|NCT00162123|1551049|P6|Overall Study|Death|1
474944|NCT00162123|1551050|P5|Overall Study|Death|1
474945|NCT00162123|1551051|P4|Overall Study|Death|1
474946|NCT00162123|1551052|P3|Overall Study|Death|1
474947|NCT00162123|1551053|P2|Overall Study|Death|3
474948|NCT00162123|1551054|P1|Overall Study|Death|3
474949|NCT00162123|1551047|P8|Overall Study|Study drug toxicity|0
474950|NCT00162123|1551048|P7|Overall Study|Study drug toxicity|1
474951|NCT00162123|1551049|P6|Overall Study|Study drug toxicity|1
474952|NCT00162123|1551050|P5|Overall Study|Study drug toxicity|4
474953|NCT00162123|1551051|P4|Overall Study|Study drug toxicity|0
474954|NCT00162123|1551052|P3|Overall Study|Study drug toxicity|5
474955|NCT00162123|1551053|P2|Overall Study|Study drug toxicity|1
474956|NCT00162123|1551054|P1|Overall Study|Study drug toxicity|6
474957|NCT00162123|1551047|P8|Overall Study|Disease progression|0
474958|NCT00162123|1551048|P7|Overall Study|Disease progression|1
474959|NCT00162123|1551049|P6|Overall Study|Disease progression|3
474960|NCT00162123|1551050|P5|Overall Study|Disease progression|8
474961|NCT00162123|1551051|P4|Overall Study|Disease progression|4
474962|NCT00162123|1551052|P3|Overall Study|Disease progression|10
474963|NCT00162123|1551053|P2|Overall Study|Disease progression|19
474964|NCT00162123|1551054|P1|Overall Study|Disease progression|27
474965|NCT00162097|1551087|P4|Overall Study|Participant no longer met study criteria|1
474966|NCT00162097|1551088|P3|Overall Study|Participant no longer met study criteria|0
474967|NCT00162097|1551089|P2|Overall Study|Participant no longer met study criteria|0
474968|NCT00162097|1551090|P1|Overall Study|Participant no longer met study criteria|0
474969|NCT00162032|1551152|P2|Overall Study|Reason not specified|0
474970|NCT00162032|1551153|P1|Overall Study|Reason not specified|1
474971|NCT00162032|1551152|P2|Overall Study|Lost to Follow-up|2
474972|NCT00162032|1551153|P1|Overall Study|Lost to Follow-up|4
474973|NCT00161616|1551163|P2|Overall Study|Protocol deviation|0
474974|NCT00161616|1551164|P1|Overall Study|Protocol deviation|1
474975|NCT00161616|1551163|P2|Overall Study|Lost to Follow-up|13
474976|NCT00161616|1551164|P1|Overall Study|Lost to Follow-up|17
474977|NCT00161616|1551163|P2|Overall Study|Death|1
474978|NCT00161616|1551164|P1|Overall Study|Death|1
474979|NCT00161616|1551163|P2|Overall Study|Physician Decision|0
474980|NCT00161616|1551164|P1|Overall Study|Physician Decision|1
474981|NCT00161616|1551163|P2|Overall Study|Withdrawal by Subject|5
474982|NCT00161616|1551164|P1|Overall Study|Withdrawal by Subject|6
474983|NCT00161213|1551196|P1|Overall Study|Evaluable for toxicity but not response|1
474984|NCT00161213|1551196|P1|Overall Study|Withdrawal by Subject|1
474985|NCT00160706|1551203|P1|Overall Study|Other Reason|11
474986|NCT00160706|1551203|P1|Overall Study|Lack of Efficacy and Other|1
474987|NCT00160706|1551203|P1|Overall Study|Lack of Efficacy|42
474988|NCT00160706|1551203|P1|Overall Study|Lost to Follow-up and Other|1
474989|NCT00160706|1551203|P1|Overall Study|Lost to Follow-up|4
474990|NCT00160706|1551203|P1|Overall Study|Physician Decision and Other|3
474991|NCT00160706|1551203|P1|Overall Study|Physician Decision|10
474992|NCT00160706|1551203|P1|Overall Study|Withdrawal by Subject and Other|12
474993|NCT00160706|1551203|P1|Overall Study|Withdrawal by Subject|41
474994|NCT00160706|1551203|P1|Overall Study|Protocol Violation|3
474995|NCT00160706|1551203|P1|Overall Study|Adverse Event and Other Reason|105
474996|NCT00160706|1551203|P1|Overall Study|Adverse Event|53
474997|NCT00160693|1551215|P1|Overall Study|Study terminated by sponsor|15
474998|NCT00160693|1551215|P1|Overall Study|Withdrawal by Subject|54
474999|NCT00160693|1551215|P1|Overall Study|Lost to Follow-up|15
475000|NCT00160693|1551215|P1|Overall Study|Protocol Violation|24
475001|NCT00160693|1551215|P1|Overall Study|Lack of Efficacy|30
475002|NCT00160693|1551215|P1|Overall Study|Adverse Event|97
475003|NCT00160641|1551232|P1|Overall Study|Other|9
475004|NCT00160641|1551232|P1|Overall Study|Protocol Violation|3
475005|NCT00160641|1551232|P1|Overall Study|Lack of Efficacy|12
475006|NCT00160641|1551232|P1|Overall Study|Lost to Follow-up|8
475007|NCT00160641|1551232|P1|Overall Study|Withdrawal by Subject|87
475008|NCT00160641|1551232|P1|Overall Study|Adverse Event|102
475009|NCT00160563|1551266|P3|Overall Study|Missing reason|0
475010|NCT00160563|1551267|P2|Overall Study|Missing reason|1
475011|NCT00160563|1551268|P1|Overall Study|Missing reason|0
475012|NCT00160563|1551266|P3|Overall Study|Other (listed in the study report)|81
475013|NCT00160563|1551267|P2|Overall Study|Other (listed in the study report)|40
475014|NCT00160563|1551268|P1|Overall Study|Other (listed in the study report)|48
475015|NCT00160563|1551266|P3|Overall Study|Withdrawal by Subject|3
475016|NCT00160563|1551267|P2|Overall Study|Withdrawal by Subject|2
475017|NCT00160563|1551268|P1|Overall Study|Withdrawal by Subject|1
475018|NCT00160563|1551266|P3|Overall Study|Protocol Violation|3
475019|NCT00160563|1551267|P2|Overall Study|Protocol Violation|0
475020|NCT00160563|1551268|P1|Overall Study|Protocol Violation|0
475021|NCT00160563|1551266|P3|Overall Study|Lost to Follow-up|2
475022|NCT00160563|1551267|P2|Overall Study|Lost to Follow-up|1
475023|NCT00160563|1551268|P1|Overall Study|Lost to Follow-up|1
475024|NCT00160563|1551266|P3|Overall Study|Adverse Event|1
475025|NCT00160563|1551267|P2|Overall Study|Adverse Event|1
475026|NCT00160563|1551268|P1|Overall Study|Adverse Event|1
475027|NCT00160524|1551280|P1|Overall Study|Other|20
475028|NCT00160524|1551280|P1|Overall Study|Lack of Efficacy and Other|1
475029|NCT00160524|1551280|P1|Overall Study|Lack of Efficacy|21
475030|NCT00160524|1551280|P1|Overall Study|Lost to Follow-up and Other|1
475031|NCT00160524|1551280|P1|Overall Study|Lost to Follow-up|13
475032|NCT00160524|1551280|P1|Overall Study|Physician Decision and Other|6
475033|NCT00160524|1551280|P1|Overall Study|Physician Decision|27
475034|NCT00160524|1551280|P1|Overall Study|Withdrawal by Subject and Other|17
475035|NCT00160524|1551280|P1|Overall Study|Withdrawal by Subject|141
475036|NCT00160524|1551280|P1|Overall Study|Protocol Violation and Other|2
475037|NCT00160524|1551280|P1|Overall Study|Protocol Violation|16
475038|NCT00160524|1551280|P1|Overall Study|Adverse Event and Other|94
475039|NCT00160524|1551280|P1|Overall Study|Adverse Event|119
475040|NCT00160251|1551297|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
475041|NCT00160251|1551298|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
475042|NCT00160251|1551299|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
475043|NCT00160251|1551300|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
475044|NCT00160251|1551301|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
475045|NCT00160251|1551302|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
475046|NCT00160251|1551303|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
475047|NCT00160251|1551304|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
475048|NCT00160251|1551297|P8|Post-amendment 2|Lack of Efficacy|24
475049|NCT00160251|1551298|P7|Post-amendment 2|Lack of Efficacy|0
475050|NCT00160251|1551299|P6|Post-amendment 2|Lack of Efficacy|0
475051|NCT00160251|1551300|P5|Post-amendment 2|Lack of Efficacy|0
475052|NCT00160251|1551301|P4|Post-amendment 2|Lack of Efficacy|0
475053|NCT00160251|1551302|P3|Post-amendment 2|Lack of Efficacy|0
475054|NCT00160251|1551303|P2|Post-amendment 2|Lack of Efficacy|0
475055|NCT00160251|1551304|P1|Post-amendment 2|Lack of Efficacy|0
475056|NCT00160251|1551297|P8|Post-amendment 2|Adverse Event|20
475057|NCT00160251|1551298|P7|Post-amendment 2|Adverse Event|0
475058|NCT00160251|1551299|P6|Post-amendment 2|Adverse Event|0
475059|NCT00160251|1551300|P5|Post-amendment 2|Adverse Event|0
475060|NCT00160251|1551301|P4|Post-amendment 2|Adverse Event|0
475061|NCT00160251|1551302|P3|Post-amendment 2|Adverse Event|0
475062|NCT00160251|1551303|P2|Post-amendment 2|Adverse Event|0
475063|NCT00160251|1551304|P1|Post-amendment 2|Adverse Event|0
475064|NCT00160251|1551297|P8|Prior to Amendment 2|Completed Treatment Phase|0
475065|NCT00160251|1551298|P7|Prior to Amendment 2|Completed Treatment Phase|0
475066|NCT00160251|1551299|P6|Prior to Amendment 2|Completed Treatment Phase|23
475067|NCT00160251|1551300|P5|Prior to Amendment 2|Completed Treatment Phase|0
475068|NCT00160251|1551301|P4|Prior to Amendment 2|Completed Treatment Phase|0
475069|NCT00160251|1551302|P3|Prior to Amendment 2|Completed Treatment Phase|0
475070|NCT00160251|1551303|P2|Prior to Amendment 2|Completed Treatment Phase|0
475071|NCT00160251|1551304|P1|Prior to Amendment 2|Completed Treatment Phase|3
475072|NCT00160251|1551297|P8|Prior to Amendment 2|Noncompliance with protocol|0
475073|NCT00160251|1551298|P7|Prior to Amendment 2|Noncompliance with protocol|0
475074|NCT00160251|1551299|P6|Prior to Amendment 2|Noncompliance with protocol|0
475075|NCT00160251|1551300|P5|Prior to Amendment 2|Noncompliance with protocol|0
475076|NCT00160251|1551301|P4|Prior to Amendment 2|Noncompliance with protocol|0
475077|NCT00160251|1551302|P3|Prior to Amendment 2|Noncompliance with protocol|0
475078|NCT00160251|1551303|P2|Prior to Amendment 2|Noncompliance with protocol|0
475079|NCT00160251|1551304|P1|Prior to Amendment 2|Noncompliance with protocol|1
475080|NCT00160251|1551297|P8|Prior to Amendment 2|Withdrawal by Subject|0
475081|NCT00160251|1551298|P7|Prior to Amendment 2|Withdrawal by Subject|3
475082|NCT00160251|1551299|P6|Prior to Amendment 2|Withdrawal by Subject|3
475083|NCT00160251|1551300|P5|Prior to Amendment 2|Withdrawal by Subject|2
475084|NCT00160251|1551301|P4|Prior to Amendment 2|Withdrawal by Subject|4
475085|NCT00160251|1551302|P3|Prior to Amendment 2|Withdrawal by Subject|3
475086|NCT00160251|1551303|P2|Prior to Amendment 2|Withdrawal by Subject|1
475087|NCT00160251|1551304|P1|Prior to Amendment 2|Withdrawal by Subject|3
475088|NCT00160251|1551297|P8|Prior to Amendment 2|Lost to Follow-up|0
475089|NCT00160251|1551298|P7|Prior to Amendment 2|Lost to Follow-up|0
475090|NCT00160251|1551299|P6|Prior to Amendment 2|Lost to Follow-up|1
475091|NCT00160251|1551300|P5|Prior to Amendment 2|Lost to Follow-up|1
475092|NCT00160251|1551301|P4|Prior to Amendment 2|Lost to Follow-up|0
475093|NCT00160251|1551302|P3|Prior to Amendment 2|Lost to Follow-up|1
475094|NCT00160251|1551303|P2|Prior to Amendment 2|Lost to Follow-up|0
475095|NCT00160251|1551304|P1|Prior to Amendment 2|Lost to Follow-up|0
475096|NCT00160251|1551297|P8|Prior to Amendment 2|Lack of Efficacy|0
475097|NCT00160251|1551298|P7|Prior to Amendment 2|Lack of Efficacy|0
475098|NCT00160251|1551299|P6|Prior to Amendment 2|Lack of Efficacy|55
475099|NCT00160251|1551300|P5|Prior to Amendment 2|Lack of Efficacy|24
475100|NCT00160251|1551301|P4|Prior to Amendment 2|Lack of Efficacy|35
475101|NCT00160251|1551302|P3|Prior to Amendment 2|Lack of Efficacy|37
475102|NCT00160251|1551303|P2|Prior to Amendment 2|Lack of Efficacy|4
475103|NCT00160251|1551304|P1|Prior to Amendment 2|Lack of Efficacy|0
475104|NCT00160251|1551297|P8|Prior to Amendment 2|Adverse Event|0
475105|NCT00160251|1551298|P7|Prior to Amendment 2|Adverse Event|1
475106|NCT00160251|1551299|P6|Prior to Amendment 2|Adverse Event|1
475107|NCT00160251|1551300|P5|Prior to Amendment 2|Adverse Event|1
475108|NCT00160251|1551301|P4|Prior to Amendment 2|Adverse Event|1
475109|NCT00160251|1551302|P3|Prior to Amendment 2|Adverse Event|3
475110|NCT00160251|1551303|P2|Prior to Amendment 2|Adverse Event|1
475111|NCT00160251|1551304|P1|Prior to Amendment 2|Adverse Event|2
475112|NCT00160199|1551380|P2|Overall Study|Protocol Violation|8
475113|NCT00160199|1551381|P1|Overall Study|Protocol Violation|8
475114|NCT00160199|1551380|P2|Overall Study|Administrative|1
475115|NCT00160199|1551381|P1|Overall Study|Administrative|0
475116|NCT00160199|1551380|P2|Overall Study|Withdrawal by Subject|6
475117|NCT00160199|1551381|P1|Overall Study|Withdrawal by Subject|4
475118|NCT00160199|1551380|P2|Overall Study|Lost to Follow-up|7
475119|NCT00160199|1551381|P1|Overall Study|Lost to Follow-up|7
475120|NCT00160199|1551380|P2|Overall Study|Lack of Efficacy|1
475121|NCT00160199|1551381|P1|Overall Study|Lack of Efficacy|0
475122|NCT00160199|1551380|P2|Overall Study|Adverse Event|14
475123|NCT00160199|1551381|P1|Overall Study|Adverse Event|5
475124|NCT00159913|1551438|P4|Overall Study|Protocol Violation|0
475125|NCT00159913|1551439|P3|Overall Study|Protocol Violation|1
475126|NCT00159913|1551440|P2|Overall Study|Protocol Violation|0
475127|NCT00159913|1551441|P1|Overall Study|Protocol Violation|1
475128|NCT00159913|1551438|P4|Overall Study|Lost to Follow-up|1
475129|NCT00159913|1551439|P3|Overall Study|Lost to Follow-up|0
475130|NCT00159913|1551440|P2|Overall Study|Lost to Follow-up|0
475131|NCT00159913|1551441|P1|Overall Study|Lost to Follow-up|0
475132|NCT00159913|1551438|P4|Overall Study|Withdrawal by Subject|1
475133|NCT00159913|1551439|P3|Overall Study|Withdrawal by Subject|0
475134|NCT00159913|1551440|P2|Overall Study|Withdrawal by Subject|0
475135|NCT00159913|1551441|P1|Overall Study|Withdrawal by Subject|0
475136|NCT00159913|1551438|P4|Overall Study|Adverse Event|0
475137|NCT00159913|1551439|P3|Overall Study|Adverse Event|1
475138|NCT00159913|1551440|P2|Overall Study|Adverse Event|0
475139|NCT00159913|1551441|P1|Overall Study|Adverse Event|1
475140|NCT00159874|1551515|P7|Overall Study|Pregnancy|0
475141|NCT00159874|1551516|P6|Overall Study|Pregnancy|0
475142|NCT00159874|1551517|P5|Overall Study|Pregnancy|0
475143|NCT00159874|1551518|P4|Overall Study|Pregnancy|0
475144|NCT00159874|1551519|P3|Overall Study|Pregnancy|0
475145|NCT00159874|1551520|P2|Overall Study|Pregnancy|1
475146|NCT00159874|1551521|P1|Overall Study|Pregnancy|1
475147|NCT00159874|1551515|P7|Overall Study|Withdrawal by Subject|1
475148|NCT00159874|1551516|P6|Overall Study|Withdrawal by Subject|2
475149|NCT00159874|1551517|P5|Overall Study|Withdrawal by Subject|3
475150|NCT00159874|1551518|P4|Overall Study|Withdrawal by Subject|4
475151|NCT00159874|1551519|P3|Overall Study|Withdrawal by Subject|8
475152|NCT00159874|1551520|P2|Overall Study|Withdrawal by Subject|6
475153|NCT00159874|1551521|P1|Overall Study|Withdrawal by Subject|2
475154|NCT00159874|1551515|P7|Overall Study|Death|0
475155|NCT00159874|1551516|P6|Overall Study|Death|2
475156|NCT00159874|1551517|P5|Overall Study|Death|1
475157|NCT00159874|1551518|P4|Overall Study|Death|0
475158|NCT00159874|1551519|P3|Overall Study|Death|15
475159|NCT00159874|1551520|P2|Overall Study|Death|8
475160|NCT00159874|1551521|P1|Overall Study|Death|3
475161|NCT00159874|1551515|P7|Overall Study|Protocol Violation|0
475162|NCT00159874|1551516|P6|Overall Study|Protocol Violation|0
475163|NCT00159874|1551517|P5|Overall Study|Protocol Violation|0
475164|NCT00159874|1551518|P4|Overall Study|Protocol Violation|0
475165|NCT00159874|1551519|P3|Overall Study|Protocol Violation|2
475166|NCT00159874|1551520|P2|Overall Study|Protocol Violation|5
475167|NCT00159874|1551521|P1|Overall Study|Protocol Violation|0
475168|NCT00159874|1551515|P7|Overall Study|Not specified|3
475169|NCT00159874|1551516|P6|Overall Study|Not specified|1
475170|NCT00159874|1551517|P5|Overall Study|Not specified|2
475171|NCT00159874|1551518|P4|Overall Study|Not specified|0
475172|NCT00159874|1551519|P3|Overall Study|Not specified|8
475173|NCT00159874|1551520|P2|Overall Study|Not specified|8
475174|NCT00159874|1551521|P1|Overall Study|Not specified|8
475175|NCT00159874|1551515|P7|Overall Study|Lost to Follow-up|1
475176|NCT00159874|1551516|P6|Overall Study|Lost to Follow-up|2
475177|NCT00159874|1551517|P5|Overall Study|Lost to Follow-up|1
475178|NCT00159874|1551518|P4|Overall Study|Lost to Follow-up|0
475179|NCT00159874|1551519|P3|Overall Study|Lost to Follow-up|3
475180|NCT00159874|1551520|P2|Overall Study|Lost to Follow-up|0
475181|NCT00159874|1551521|P1|Overall Study|Lost to Follow-up|1
475182|NCT00159874|1551515|P7|Overall Study|Lack of Efficacy|0
475183|NCT00159874|1551516|P6|Overall Study|Lack of Efficacy|3
475184|NCT00159874|1551517|P5|Overall Study|Lack of Efficacy|0
475185|NCT00159874|1551518|P4|Overall Study|Lack of Efficacy|1
475186|NCT00159874|1551519|P3|Overall Study|Lack of Efficacy|1
475187|NCT00159874|1551520|P2|Overall Study|Lack of Efficacy|0
475188|NCT00159874|1551521|P1|Overall Study|Lack of Efficacy|2
475189|NCT00159874|1551515|P7|Overall Study|Does Not Meet Entrance Criteria|0
475190|NCT00159874|1551516|P6|Overall Study|Does Not Meet Entrance Criteria|0
475191|NCT00159874|1551517|P5|Overall Study|Does Not Meet Entrance Criteria|0
475192|NCT00159874|1551518|P4|Overall Study|Does Not Meet Entrance Criteria|0
475193|NCT00159874|1551519|P3|Overall Study|Does Not Meet Entrance Criteria|1
475194|NCT00159874|1551520|P2|Overall Study|Does Not Meet Entrance Criteria|0
475195|NCT00159874|1551521|P1|Overall Study|Does Not Meet Entrance Criteria|1
475196|NCT00159874|1551515|P7|Overall Study|Adverse Event|0
475197|NCT00159874|1551516|P6|Overall Study|Adverse Event|2
475198|NCT00159874|1551517|P5|Overall Study|Adverse Event|1
475199|NCT00159874|1551518|P4|Overall Study|Adverse Event|1
475200|NCT00159874|1551519|P3|Overall Study|Adverse Event|5
475201|NCT00159874|1551520|P2|Overall Study|Adverse Event|2
475202|NCT00159874|1551521|P1|Overall Study|Adverse Event|2
475203|NCT00159861|1551691|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
475204|NCT00159861|1551692|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
475205|NCT00159861|1551691|P2|Extension Study - up to 3 Years|Reason Unspecified|19
475206|NCT00159861|1551692|P1|Extension Study - up to 3 Years|Reason Unspecified|12
475207|NCT00159861|1551691|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
475208|NCT00159861|1551692|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
475209|NCT00159861|1551691|P2|Extension Study - up to 3 Years|Adverse Event|14
475210|NCT00159861|1551692|P1|Extension Study - up to 3 Years|Adverse Event|14
475211|NCT00159861|1551691|P2|Extension Study - up to 3 Years|Death|28
475212|NCT00159861|1551692|P1|Extension Study - up to 3 Years|Death|24
475213|NCT00159861|1551691|P2|Core Study - 16 Weeks|Randomized but not Treated|0
475214|NCT00159861|1551692|P1|Core Study - 16 Weeks|Randomized but not Treated|2
475215|NCT00159861|1551691|P2|Core Study - 16 Weeks|Subject Defaulted|0
475216|NCT00159861|1551692|P1|Core Study - 16 Weeks|Subject Defaulted|1
475217|NCT00159861|1551691|P2|Core Study - 16 Weeks|Reason Unspecified|3
475218|NCT00159861|1551692|P1|Core Study - 16 Weeks|Reason Unspecified|5
475219|NCT00159861|1551691|P2|Core Study - 16 Weeks|Lack of Efficacy|3
475220|NCT00159861|1551692|P1|Core Study - 16 Weeks|Lack of Efficacy|2
475221|NCT00159861|1551691|P2|Core Study - 16 Weeks|Adverse Event|6
475222|NCT00159861|1551692|P1|Core Study - 16 Weeks|Adverse Event|12
475223|NCT00159861|1551691|P2|Core Study - 16 Weeks|Death|0
475224|NCT00159861|1551692|P1|Core Study - 16 Weeks|Death|3
475225|NCT00159822|1551713|P1|Post-treatment Follow-up Period|Reason unspecified|1
475226|NCT00159822|1551713|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
475227|NCT00159822|1551713|P1|Post-treatment Follow-up Period|Death|1
475228|NCT00159822|1551713|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
475229|NCT00159822|1551713|P1|Voriconazole Treatment Period|Lost to Follow-up|2
475230|NCT00159822|1551713|P1|Voriconazole Treatment Period|Protocol Violation|2
475231|NCT00159822|1551713|P1|Voriconazole Treatment Period|Death|4
475232|NCT00159822|1551713|P1|Voriconazole Treatment Period|Adverse Event|9
475233|NCT00159822|1551713|P1|Voriconazole Treatment Period|Lack of Efficacy|3
475234|NCT00159783|1551731|P3|Overall Study|not specified|4
475235|NCT00159783|1551732|P2|Overall Study|not specified|2
475236|NCT00159783|1551733|P1|Overall Study|not specified|0
475237|NCT00159783|1551731|P3|Overall Study|Lost to Follow-up|11
475238|NCT00159783|1551732|P2|Overall Study|Lost to Follow-up|5
475239|NCT00159783|1551733|P1|Overall Study|Lost to Follow-up|6
475240|NCT00159783|1551731|P3|Overall Study|Withdrawal by Subject|12
475241|NCT00159783|1551732|P2|Overall Study|Withdrawal by Subject|11
475242|NCT00159783|1551733|P1|Overall Study|Withdrawal by Subject|7
475243|NCT00159783|1551731|P3|Overall Study|Lack of Efficacy|3
475244|NCT00159783|1551732|P2|Overall Study|Lack of Efficacy|2
475245|NCT00159783|1551733|P1|Overall Study|Lack of Efficacy|1
475246|NCT00159783|1551731|P3|Overall Study|Adverse Event|9
475247|NCT00159783|1551732|P2|Overall Study|Adverse Event|7
475248|NCT00159783|1551733|P1|Overall Study|Adverse Event|5
475249|NCT00159432|1551763|P1|Overall Study|Lack of Efficacy|8
475250|NCT00159432|1551763|P1|Overall Study|Death|1
475251|NCT00159432|1551763|P1|Overall Study|Adverse Event|1
475252|NCT00158756|1551790|P5|Overall Study|Serious adverse event|0
475253|NCT00158756|1551791|P4|Overall Study|Serious adverse event|0
475254|NCT00158756|1551792|P3|Overall Study|Serious adverse event|1
475255|NCT00158756|1551793|P2|Overall Study|Serious adverse event|0
475256|NCT00158756|1551794|P1|Overall Study|Serious adverse event|0
475257|NCT00158756|1551790|P5|Overall Study|Adverse Event|0
475258|NCT00158756|1551791|P4|Overall Study|Adverse Event|0
475259|NCT00158756|1551792|P3|Overall Study|Adverse Event|1
475260|NCT00158756|1551793|P2|Overall Study|Adverse Event|0
475261|NCT00158756|1551794|P1|Overall Study|Adverse Event|0
475262|NCT00158756|1551790|P5|Overall Study|Withdrawal by Subject|3
475263|NCT00158756|1551791|P4|Overall Study|Withdrawal by Subject|1
475264|NCT00158756|1551792|P3|Overall Study|Withdrawal by Subject|6
475265|NCT00158756|1551793|P2|Overall Study|Withdrawal by Subject|0
475266|NCT00158756|1551794|P1|Overall Study|Withdrawal by Subject|5
475267|NCT00158600|1551900|P2|Overall Study|Withdrawal by Subject|2
475268|NCT00158600|1551901|P1|Overall Study|Withdrawal by Subject|2
475269|NCT00158600|1551900|P2|Overall Study|Death|0
475270|NCT00158600|1551901|P1|Overall Study|Death|1
475271|NCT00158600|1551900|P2|Overall Study|Adverse Event|1
475272|NCT00158600|1551901|P1|Overall Study|Adverse Event|2
475273|NCT00158600|1551900|P2|Overall Study|unable to commit time to study|1
475274|NCT00158600|1551901|P1|Overall Study|unable to commit time to study|0
475275|NCT00158262|1551926|P2|Overall Study|Lost to Follow-up|1
475276|NCT00158262|1551927|P1|Overall Study|Lost to Follow-up|1
475277|NCT00158184|1551988|P2|Overall Study|Adverse Event|1
475278|NCT00158184|1551989|P1|Overall Study|Adverse Event|1
475279|NCT00158184|1551988|P2|Overall Study|failed for follow unit/study rules|0
475280|NCT00158184|1551989|P1|Overall Study|failed for follow unit/study rules|2
475281|NCT00158184|1551988|P2|Overall Study|personal issues|1
475282|NCT00158184|1551989|P1|Overall Study|personal issues|3
475283|NCT00158054|1551999|P2|Overall Study|Unavailable for follow up|3
475284|NCT00158054|1552000|P1|Overall Study|Unavailable for follow up|7
475285|NCT00158054|1551999|P2|Overall Study|Refused to continue|0
475286|NCT00158054|1552000|P1|Overall Study|Refused to continue|3
475287|NCT00157950|1552014|P2|Overall Study|Death|0
475288|NCT00157950|1552015|P1|Overall Study|Death|1
475289|NCT00157820|1552032|P3|2nd 8 Months|Premature cross-over|9
475290|NCT00157820|1552033|P2|2nd 8 Months|Premature cross-over|7
475291|NCT00157820|1552034|P1|2nd 8 Months|Premature cross-over|1
475292|NCT00157820|1552032|P3|2nd 8 Months|Lost to Follow-up|2
475293|NCT00157820|1552033|P2|2nd 8 Months|Lost to Follow-up|5
475294|NCT00157820|1552034|P1|2nd 8 Months|Lost to Follow-up|1
475295|NCT00157820|1552032|P3|2nd 8 Months|Death|3
475296|NCT00157820|1552033|P2|2nd 8 Months|Death|1
475297|NCT00157820|1552034|P1|2nd 8 Months|Death|3
475298|NCT00157820|1552032|P3|1st 8 Month|Premature cross-over|2
475299|NCT00157820|1552033|P2|1st 8 Month|Premature cross-over|2
475300|NCT00157820|1552034|P1|1st 8 Month|Premature cross-over|0
475301|NCT00157820|1552032|P3|1st 8 Month|Lost to Follow-up|1
475302|NCT00157820|1552033|P2|1st 8 Month|Lost to Follow-up|2
475303|NCT00157820|1552034|P1|1st 8 Month|Lost to Follow-up|1
475304|NCT00157820|1552032|P3|1st 8 Month|Death|3
475305|NCT00157820|1552033|P2|1st 8 Month|Death|8
475306|NCT00157820|1552034|P1|1st 8 Month|Death|7
475307|NCT00157820|1552032|P3|Randomized|Protocol Violation|2
475308|NCT00157820|1552033|P2|Randomized|Protocol Violation|1
475309|NCT00157820|1552034|P1|Randomized|Protocol Violation|2
475310|NCT00157820|1552032|P3|Randomized|Withdrawal by Subject|3
475311|NCT00157820|1552033|P2|Randomized|Withdrawal by Subject|2
475312|NCT00157820|1552034|P1|Randomized|Withdrawal by Subject|1
475313|NCT00157820|1552032|P3|Randomized|Physician Decision|3
475314|NCT00157820|1552033|P2|Randomized|Physician Decision|2
475315|NCT00157820|1552034|P1|Randomized|Physician Decision|4
475316|NCT00157755|1552047|P6|Overall Study|Study completion|2
475317|NCT00157755|1552048|P5|Overall Study|Study completion|1
475318|NCT00157755|1552049|P4|Overall Study|Study completion|0
475319|NCT00157755|1552050|P3|Overall Study|Study completion|0
475320|NCT00157755|1552051|P2|Overall Study|Study completion|0
475321|NCT00157755|1552052|P1|Overall Study|Study completion|0
475322|NCT00157755|1552047|P6|Overall Study|Subject non-compliance|1
475323|NCT00157755|1552048|P5|Overall Study|Subject non-compliance|0
475324|NCT00157755|1552049|P4|Overall Study|Subject non-compliance|0
475325|NCT00157755|1552050|P3|Overall Study|Subject non-compliance|0
475326|NCT00157755|1552051|P2|Overall Study|Subject non-compliance|0
475327|NCT00157755|1552052|P1|Overall Study|Subject non-compliance|0
475328|NCT00157755|1552047|P6|Overall Study|Study site closure|0
475329|NCT00157755|1552048|P5|Overall Study|Study site closure|0
475330|NCT00157755|1552049|P4|Overall Study|Study site closure|0
475331|NCT00157755|1552050|P3|Overall Study|Study site closure|0
475332|NCT00157755|1552051|P2|Overall Study|Study site closure|1
475333|NCT00157755|1552052|P1|Overall Study|Study site closure|0
475334|NCT00157755|1552047|P6|Overall Study|Medical reason|0
475335|NCT00157755|1552048|P5|Overall Study|Medical reason|0
475336|NCT00157755|1552049|P4|Overall Study|Medical reason|1
475337|NCT00157755|1552050|P3|Overall Study|Medical reason|1
475338|NCT00157755|1552051|P2|Overall Study|Medical reason|0
475339|NCT00157755|1552052|P1|Overall Study|Medical reason|0
475340|NCT00157755|1552047|P6|Overall Study|Explant due to infection|0
475341|NCT00157755|1552048|P5|Overall Study|Explant due to infection|0
475342|NCT00157755|1552049|P4|Overall Study|Explant due to infection|0
475343|NCT00157755|1552050|P3|Overall Study|Explant due to infection|1
475344|NCT00157755|1552051|P2|Overall Study|Explant due to infection|0
475345|NCT00157755|1552052|P1|Overall Study|Explant due to infection|0
475346|NCT00157755|1552047|P6|Overall Study|Withdrawal by Subject|2
475347|NCT00157755|1552048|P5|Overall Study|Withdrawal by Subject|1
475348|NCT00157755|1552049|P4|Overall Study|Withdrawal by Subject|1
475349|NCT00157755|1552050|P3|Overall Study|Withdrawal by Subject|1
475350|NCT00157755|1552051|P2|Overall Study|Withdrawal by Subject|0
475351|NCT00157755|1552052|P1|Overall Study|Withdrawal by Subject|0
475352|NCT00157755|1552047|P6|Overall Study|Lost to Follow-up|0
475353|NCT00157755|1552048|P5|Overall Study|Lost to Follow-up|0
475354|NCT00157755|1552049|P4|Overall Study|Lost to Follow-up|0
475355|NCT00157755|1552050|P3|Overall Study|Lost to Follow-up|1
475356|NCT00157755|1552051|P2|Overall Study|Lost to Follow-up|0
475357|NCT00157755|1552052|P1|Overall Study|Lost to Follow-up|0
475358|NCT00157755|1552047|P6|Overall Study|Death|0
475359|NCT00157755|1552048|P5|Overall Study|Death|0
475360|NCT00157755|1552049|P4|Overall Study|Death|2
475361|NCT00157755|1552050|P3|Overall Study|Death|3
475362|NCT00157755|1552051|P2|Overall Study|Death|3
475363|NCT00157755|1552052|P1|Overall Study|Death|2
475364|NCT00157248|1552088|P4|Overall Study|site closures, subject moving|9
475365|NCT00157248|1552089|P3|Overall Study|site closures, subject moving|3
475366|NCT00157248|1552090|P2|Overall Study|site closures, subject moving|7
475367|NCT00157248|1552091|P1|Overall Study|site closures, subject moving|7
475368|NCT00157248|1552088|P4|Overall Study|Withdrawal by Subject|3
475369|NCT00157248|1552089|P3|Overall Study|Withdrawal by Subject|3
475370|NCT00157248|1552090|P2|Overall Study|Withdrawal by Subject|4
475371|NCT00157248|1552091|P1|Overall Study|Withdrawal by Subject|1
475372|NCT00157248|1552088|P4|Overall Study|Lost to Follow-up|0
475373|NCT00157248|1552089|P3|Overall Study|Lost to Follow-up|0
475374|NCT00157248|1552090|P2|Overall Study|Lost to Follow-up|1
475375|NCT00157248|1552091|P1|Overall Study|Lost to Follow-up|0
475376|NCT00157248|1552088|P4|Overall Study|Protocol Violation|2
475377|NCT00157248|1552089|P3|Overall Study|Protocol Violation|2
475378|NCT00157248|1552090|P2|Overall Study|Protocol Violation|0
475379|NCT00157248|1552091|P1|Overall Study|Protocol Violation|4
475380|NCT00157248|1552088|P4|Overall Study|Adverse Event|33
475381|NCT00157248|1552089|P3|Overall Study|Adverse Event|13
475382|NCT00157248|1552090|P2|Overall Study|Adverse Event|25
475383|NCT00157248|1552091|P1|Overall Study|Adverse Event|36
475384|NCT00157209|1552197|P2|Overall Study|Ongoing at data cut-off|0
475385|NCT00157209|1552198|P1|Overall Study|Ongoing at data cut-off|10
475386|NCT00157196|1552212|P1|Overall Study|Ongoing at data cut-off|9
475387|NCT00157157|1552218|P1|Overall Study|Inclusion not met- baseline FVIII value|1
475388|NCT00157157|1552218|P1|Overall Study|Met exclusion criteria|1
475389|NCT00157157|1552218|P1|Overall Study|Enrolled in another study|1
475390|NCT00157157|1552218|P1|Overall Study|Lost to Follow-up|1
475391|NCT00157157|1552218|P1|Overall Study|Physician Decision|1
475392|NCT00157157|1552218|P1|Overall Study|Withdrawal by Subject|6
475393|NCT00157014|1552245|P4|Overall Study|Withdrawal by Subject|0
475394|NCT00157014|1552246|P3|Overall Study|Withdrawal by Subject|0
475395|NCT00157014|1552247|P2|Overall Study|Withdrawal by Subject|0
475396|NCT00157014|1552248|P1|Overall Study|Withdrawal by Subject|1
475397|NCT00157014|1552245|P4|Overall Study|Patient would not receive transplant|0
475398|NCT00157014|1552246|P3|Overall Study|Patient would not receive transplant|0
475399|NCT00157014|1552247|P2|Overall Study|Patient would not receive transplant|1
475400|NCT00157014|1552248|P1|Overall Study|Patient would not receive transplant|0
475401|NCT00157014|1552245|P4|Overall Study|Patient unable to return in nursing home|0
475402|NCT00157014|1552246|P3|Overall Study|Patient unable to return in nursing home|0
475403|NCT00157014|1552247|P2|Overall Study|Patient unable to return in nursing home|0
475404|NCT00157014|1552248|P1|Overall Study|Patient unable to return in nursing home|1
475405|NCT00157014|1552245|P4|Overall Study|Patient withdrawn by investigator|0
475406|NCT00157014|1552246|P3|Overall Study|Patient withdrawn by investigator|0
475407|NCT00157014|1552247|P2|Overall Study|Patient withdrawn by investigator|0
475408|NCT00157014|1552248|P1|Overall Study|Patient withdrawn by investigator|1
475409|NCT00157014|1552245|P4|Overall Study|Medications withdrawn on family request|0
475410|NCT00157014|1552246|P3|Overall Study|Medications withdrawn on family request|0
475411|NCT00157014|1552247|P2|Overall Study|Medications withdrawn on family request|1
475412|NCT00157014|1552248|P1|Overall Study|Medications withdrawn on family request|0
475413|NCT00157014|1552245|P4|Overall Study|Physician Decision|0
475414|NCT00157014|1552246|P3|Overall Study|Physician Decision|0
475415|NCT00157014|1552247|P2|Overall Study|Physician Decision|1
475416|NCT00157014|1552248|P1|Overall Study|Physician Decision|0
475417|NCT00157014|1552245|P4|Overall Study|Death|1
475418|NCT00157014|1552246|P3|Overall Study|Death|1
475419|NCT00157014|1552247|P2|Overall Study|Death|2
475420|NCT00157014|1552248|P1|Overall Study|Death|4
475421|NCT00156819|1552364|P3|Overall Study|Lost to Follow-up|3
475422|NCT00156819|1552365|P2|Overall Study|Lost to Follow-up|1
475423|NCT00156819|1552366|P1|Overall Study|Lost to Follow-up|1
475424|NCT00156533|1552383|P4|Overall Study|Failed Screening|1
475425|NCT00156533|1552384|P3|Overall Study|Failed Screening|1
475426|NCT00156533|1552385|P2|Overall Study|Failed Screening|0
475427|NCT00156533|1552386|P1|Overall Study|Failed Screening|1
475428|NCT00156533|1552383|P4|Overall Study|Withdrawal by Subject|1
475429|NCT00156533|1552384|P3|Overall Study|Withdrawal by Subject|0
475430|NCT00156533|1552385|P2|Overall Study|Withdrawal by Subject|0
475431|NCT00156533|1552386|P1|Overall Study|Withdrawal by Subject|1
475432|NCT00156533|1552383|P4|Overall Study|Withdrawn - Medication Expiration|0
475433|NCT00156533|1552384|P3|Overall Study|Withdrawn - Medication Expiration|1
475434|NCT00156533|1552385|P2|Overall Study|Withdrawn - Medication Expiration|2
475435|NCT00156533|1552386|P1|Overall Study|Withdrawn - Medication Expiration|0
475436|NCT00156065|1552420|P3|Overall Study|Other|3
475437|NCT00156065|1552421|P2|Overall Study|Other|9
475438|NCT00156065|1552422|P1|Overall Study|Other|2
475439|NCT00156065|1552420|P3|Overall Study|Lost to Follow-up|1
475440|NCT00156065|1552421|P2|Overall Study|Lost to Follow-up|7
475441|NCT00156065|1552422|P1|Overall Study|Lost to Follow-up|5
475442|NCT00156065|1552420|P3|Overall Study|Withdrawal by Subject|16
475443|NCT00156065|1552421|P2|Overall Study|Withdrawal by Subject|26
475444|NCT00156065|1552422|P1|Overall Study|Withdrawal by Subject|13
475445|NCT00156065|1552420|P3|Overall Study|Lack of Efficacy|3
475446|NCT00156065|1552421|P2|Overall Study|Lack of Efficacy|9
475447|NCT00156065|1552422|P1|Overall Study|Lack of Efficacy|2
475448|NCT00156065|1552420|P3|Overall Study|Adverse Event|4
475449|NCT00156065|1552421|P2|Overall Study|Adverse Event|11
475450|NCT00156065|1552422|P1|Overall Study|Adverse Event|8
475451|NCT00156065|1552420|P3|Overall Study|Enrolled But Never Received Treatment|0
475452|NCT00156065|1552421|P2|Overall Study|Enrolled But Never Received Treatment|1
475453|NCT00156065|1552422|P1|Overall Study|Enrolled But Never Received Treatment|1
475454|NCT00154375|1552456|P2|Overall Study|Suspected progression of disease|30
475455|NCT00154375|1552457|P1|Overall Study|Suspected progression of disease|44
475456|NCT00154375|1552456|P2|Overall Study|Protocol Violation|1
475457|NCT00154375|1552457|P1|Overall Study|Protocol Violation|0
475458|NCT00154375|1552456|P2|Overall Study|Abnormal laboratory value(s)|2
475459|NCT00154375|1552457|P1|Overall Study|Abnormal laboratory value(s)|0
475460|NCT00154375|1552456|P2|Overall Study|Lost to Follow-up|1
475461|NCT00154375|1552457|P1|Overall Study|Lost to Follow-up|2
475462|NCT00154375|1552456|P2|Overall Study|Study drug no longer required|3
475463|NCT00154375|1552457|P1|Overall Study|Study drug no longer required|5
475464|NCT00154375|1552456|P2|Overall Study|Death|13
475465|NCT00154375|1552457|P1|Overall Study|Death|5
475466|NCT00154375|1552456|P2|Overall Study|Withdrawal by Subject|10
475467|NCT00154375|1552457|P1|Overall Study|Withdrawal by Subject|14
475468|NCT00154375|1552456|P2|Overall Study|Adverse Event|20
475469|NCT00154375|1552457|P1|Overall Study|Adverse Event|18
475470|NCT00154375|1552456|P2|Overall Study|Unsatisfactory therapeutic effect|26
475471|NCT00154375|1552457|P1|Overall Study|Unsatisfactory therapeutic effect|25
475472|NCT00154310|1552468|P2|Overall Study|Death|1
475473|NCT00154310|1552469|P1|Overall Study|Death|0
475474|NCT00154310|1552468|P2|Overall Study|Administrative problems|1
475475|NCT00154310|1552469|P1|Overall Study|Administrative problems|0
475476|NCT00154310|1552468|P2|Overall Study|Lost to Follow-up|8
475477|NCT00154310|1552469|P1|Overall Study|Lost to Follow-up|0
475478|NCT00154310|1552468|P2|Overall Study|Withdrawal by Subject|3
475479|NCT00154310|1552469|P1|Overall Study|Withdrawal by Subject|9
475480|NCT00154310|1552468|P2|Overall Study|Protocol Violation|2
475481|NCT00154310|1552469|P1|Overall Study|Protocol Violation|4
475482|NCT00154310|1552468|P2|Overall Study|Lack of Efficacy|4
475483|NCT00154310|1552469|P1|Overall Study|Lack of Efficacy|5
475484|NCT00154310|1552468|P2|Overall Study|Adverse Event|9
475485|NCT00154310|1552469|P1|Overall Study|Adverse Event|19
475486|NCT00154297|1552485|P2|Overall Study|Lost to Follow-up|0
475487|NCT00154297|1552486|P1|Overall Study|Lost to Follow-up|3
475488|NCT00154297|1552485|P2|Overall Study|Withdrawal by Subject|5
475489|NCT00154297|1552486|P1|Overall Study|Withdrawal by Subject|0
475490|NCT00154297|1552485|P2|Overall Study|Death|2
475491|NCT00154297|1552486|P1|Overall Study|Death|5
475492|NCT00154284|1552504|P2|Overall Study|Protocol Violation|1
475493|NCT00154284|1552505|P1|Overall Study|Protocol Violation|0
475494|NCT00154284|1552504|P2|Overall Study|Lack of Efficacy|2
475495|NCT00154284|1552505|P1|Overall Study|Lack of Efficacy|1
475496|NCT00154284|1552504|P2|Overall Study|Abnormal laboratory value(s)|1
475497|NCT00154284|1552505|P1|Overall Study|Abnormal laboratory value(s)|0
475498|NCT00154284|1552504|P2|Overall Study|Adverse Event|9
475499|NCT00154284|1552505|P1|Overall Study|Adverse Event|6
475500|NCT00154102|1552519|P2|Overall Study|investigational study phase ongoing|2
475501|NCT00154102|1552520|P1|Overall Study|investigational study phase ongoing|7
475502|NCT00154063|1552556|P2|Overall Study|Not specified|3
475503|NCT00154063|1552557|P1|Overall Study|Not specified|3
475504|NCT00154063|1552556|P2|Overall Study|Withdrawal by Subject|9
475505|NCT00154063|1552557|P1|Overall Study|Withdrawal by Subject|4
475506|NCT00154063|1552556|P2|Overall Study|Investigator or Sponsor Request|1
475507|NCT00154063|1552557|P1|Overall Study|Investigator or Sponsor Request|0
475508|NCT00154063|1552556|P2|Overall Study|Protocol Violation|1
475509|NCT00154063|1552557|P1|Overall Study|Protocol Violation|1
475510|NCT00154063|1552556|P2|Overall Study|Adverse Event|8
475511|NCT00154063|1552557|P1|Overall Study|Adverse Event|4
475512|NCT00153920|1552619|P1|Overall Study|Progressive Disease before Trt|1
475513|NCT00153920|1552619|P1|Overall Study|Withdrawal of Consent before Trt|1
475514|NCT00153920|1552619|P1|Overall Study|Non-Protocol Therapy|1
475515|NCT00153920|1552619|P1|Overall Study|Withdrawal by Subject|1
475516|NCT00153920|1552619|P1|Overall Study|Death|2
475517|NCT00153920|1552619|P1|Overall Study|Lack of Response|3
475518|NCT00153920|1552619|P1|Overall Study|Physician Decision|3
475519|NCT00153920|1552619|P1|Overall Study|Progressive Disease|9
475520|NCT00153920|1552619|P1|Overall Study|Adverse Event|9
475521|NCT00153816|1552634|P6|Overall Study|Follow-up exam done, histology missing|2
475522|NCT00153816|1552635|P5|Overall Study|Follow-up exam done, histology missing|1
475523|NCT00153816|1552636|P4|Overall Study|Follow-up exam done, histology missing|3
475524|NCT00153816|1552637|P3|Overall Study|Follow-up exam done, histology missing|3
475525|NCT00153816|1552638|P2|Overall Study|Follow-up exam done, histology missing|3
475526|NCT00153816|1552639|P1|Overall Study|Follow-up exam done, histology missing|2
475527|NCT00153816|1552634|P6|Overall Study|Follow-up exam not done|9
475528|NCT00153816|1552635|P5|Overall Study|Follow-up exam not done|8
475529|NCT00153816|1552636|P4|Overall Study|Follow-up exam not done|10
475530|NCT00153816|1552637|P3|Overall Study|Follow-up exam not done|11
475531|NCT00153816|1552638|P2|Overall Study|Follow-up exam not done|7
475532|NCT00153816|1552639|P1|Overall Study|Follow-up exam not done|8
475533|NCT00153816|1552634|P6|Overall Study|Withdrawal by Subject|5
475534|NCT00153816|1552635|P5|Overall Study|Withdrawal by Subject|1
475535|NCT00153816|1552636|P4|Overall Study|Withdrawal by Subject|4
475536|NCT00153816|1552637|P3|Overall Study|Withdrawal by Subject|9
475537|NCT00153816|1552638|P2|Overall Study|Withdrawal by Subject|9
475538|NCT00153816|1552639|P1|Overall Study|Withdrawal by Subject|9
475539|NCT00153816|1552634|P6|Overall Study|Lost to Follow-up|9
475540|NCT00153816|1552635|P5|Overall Study|Lost to Follow-up|7
475541|NCT00153816|1552636|P4|Overall Study|Lost to Follow-up|8
475542|NCT00153816|1552637|P3|Overall Study|Lost to Follow-up|5
475543|NCT00153816|1552638|P2|Overall Study|Lost to Follow-up|8
475544|NCT00153816|1552639|P1|Overall Study|Lost to Follow-up|7
475545|NCT00153816|1552634|P6|Overall Study|Death|2
475546|NCT00153816|1552635|P5|Overall Study|Death|0
475547|NCT00153816|1552636|P4|Overall Study|Death|6
475548|NCT00153816|1552637|P3|Overall Study|Death|4
475549|NCT00153816|1552638|P2|Overall Study|Death|5
475550|NCT00153816|1552639|P1|Overall Study|Death|6
475551|NCT00153101|1552694|P5|Overall Study|Withdrawal by Subject|5
475552|NCT00153101|1552695|P4|Overall Study|Withdrawal by Subject|3
475553|NCT00153101|1552696|P3|Overall Study|Withdrawal by Subject|3
475554|NCT00153101|1552697|P2|Overall Study|Withdrawal by Subject|4
475555|NCT00153101|1552698|P1|Overall Study|Withdrawal by Subject|3
475556|NCT00153101|1552694|P5|Overall Study|Lost to Follow-up|5
475557|NCT00153101|1552695|P4|Overall Study|Lost to Follow-up|5
475558|NCT00153101|1552696|P3|Overall Study|Lost to Follow-up|12
475559|NCT00153101|1552697|P2|Overall Study|Lost to Follow-up|14
475560|NCT00153101|1552698|P1|Overall Study|Lost to Follow-up|14
475561|NCT00153062|1552806|P4|Overall Study|Other|0
475562|NCT00153062|1552807|P3|Overall Study|Other|1
475563|NCT00153062|1552808|P2|Overall Study|Other|0
475564|NCT00153062|1552809|P1|Overall Study|Other|0
475565|NCT00153062|1552806|P4|Overall Study|No disposition data available|1
475566|NCT00153062|1552807|P3|Overall Study|No disposition data available|1
475567|NCT00153062|1552808|P2|Overall Study|No disposition data available|1
475568|NCT00153062|1552809|P1|Overall Study|No disposition data available|1
475569|NCT00153062|1552806|P4|Overall Study|Protocol Violation|1
475570|NCT00153062|1552807|P3|Overall Study|Protocol Violation|1
475571|NCT00153062|1552808|P2|Overall Study|Protocol Violation|2
475572|NCT00153062|1552809|P1|Overall Study|Protocol Violation|0
475573|NCT00153062|1552806|P4|Overall Study|Adverse Event|0
475574|NCT00153062|1552807|P3|Overall Study|Adverse Event|1
475575|NCT00153062|1552808|P2|Overall Study|Adverse Event|1
475576|NCT00153062|1552809|P1|Overall Study|Adverse Event|0
475577|NCT00153062|1552806|P4|Overall Study|Lost to Follow-up|16
475578|NCT00153062|1552807|P3|Overall Study|Lost to Follow-up|15
475579|NCT00153062|1552808|P2|Overall Study|Lost to Follow-up|20
475580|NCT00153062|1552809|P1|Overall Study|Lost to Follow-up|12
475581|NCT00153062|1552806|P4|Overall Study|Withdrawal by Subject|28
475582|NCT00153062|1552807|P3|Overall Study|Withdrawal by Subject|27
475583|NCT00153062|1552808|P2|Overall Study|Withdrawal by Subject|30
475584|NCT00153062|1552809|P1|Overall Study|Withdrawal by Subject|14
475585|NCT00153062|1552806|P4|Overall Study|Death|365
475586|NCT00153062|1552807|P3|Overall Study|Death|369
475587|NCT00153062|1552808|P2|Overall Study|Death|352
475588|NCT00153062|1552809|P1|Overall Study|Death|360
475589|NCT00152971|1552828|P3|Treatment|not specified|10
475590|NCT00152971|1552829|P2|Treatment|not specified|11
475591|NCT00152971|1552830|P1|Treatment|not specified|9
475592|NCT00152971|1552828|P3|Treatment|Withdrawal by Subject|5
475593|NCT00152971|1552829|P2|Treatment|Withdrawal by Subject|4
475594|NCT00152971|1552830|P1|Treatment|Withdrawal by Subject|4
475595|NCT00152971|1552828|P3|Treatment|Lost to Follow-up|1
475596|NCT00152971|1552829|P2|Treatment|Lost to Follow-up|2
475597|NCT00152971|1552830|P1|Treatment|Lost to Follow-up|1
475598|NCT00152971|1552828|P3|Treatment|Protocol Violation|10
475599|NCT00152971|1552829|P2|Treatment|Protocol Violation|6
475600|NCT00152971|1552830|P1|Treatment|Protocol Violation|8
475601|NCT00152971|1552828|P3|Treatment|Adverse Event|54
475602|NCT00152971|1552829|P2|Treatment|Adverse Event|40
475603|NCT00152971|1552830|P1|Treatment|Adverse Event|49
475604|NCT00152971|1552828|P3|Overall Study|not specified|5
475605|NCT00152971|1552829|P2|Overall Study|not specified|5
475606|NCT00152971|1552830|P1|Overall Study|not specified|3
475607|NCT00152971|1552828|P3|Overall Study|Withdrawal by Subject|14
475608|NCT00152971|1552829|P2|Overall Study|Withdrawal by Subject|8
475609|NCT00152971|1552830|P1|Overall Study|Withdrawal by Subject|9
475610|NCT00152971|1552828|P3|Overall Study|Lost to Follow-up|13
475611|NCT00152971|1552829|P2|Overall Study|Lost to Follow-up|14
475612|NCT00152971|1552830|P1|Overall Study|Lost to Follow-up|17
475613|NCT00152971|1552828|P3|Overall Study|Protocol Violation|8
475614|NCT00152971|1552829|P2|Overall Study|Protocol Violation|11
475615|NCT00152971|1552830|P1|Overall Study|Protocol Violation|10
475616|NCT00152971|1552828|P3|Overall Study|Adverse Event|9
475617|NCT00152971|1552829|P2|Overall Study|Adverse Event|10
475618|NCT00152971|1552830|P1|Overall Study|Adverse Event|12
475619|NCT00152763|1552866|P4|Overall Study|Lost to Follow-up|13
475620|NCT00152763|1552867|P3|Overall Study|Lost to Follow-up|2
475621|NCT00152763|1552868|P2|Overall Study|Lost to Follow-up|4
475622|NCT00152763|1552869|P1|Overall Study|Lost to Follow-up|6
475623|NCT00152763|1552866|P4|Overall Study|Death|1
475624|NCT00152763|1552867|P3|Overall Study|Death|2
475625|NCT00152763|1552868|P2|Overall Study|Death|1
475626|NCT00152763|1552869|P1|Overall Study|Death|4
475627|NCT00152516|1552985|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
475628|NCT00152516|1552985|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
475629|NCT00152516|1552985|P1|Overall Study|Other: Moved Out Of State|1
475630|NCT00152516|1552985|P1|Overall Study|Other: Primary Care Physician's Decision|1
475631|NCT00152516|1552985|P1|Overall Study|Other: Non-Compliance|2
475632|NCT00152516|1552985|P1|Overall Study|Other: Parents Withdrew Consent|2
475633|NCT00152516|1552985|P1|Overall Study|Other: Given Commercial Drug in Error|2
475634|NCT00152516|1552985|P1|Overall Study|Other: Mother Refused To Cooperate|1
475635|NCT00152516|1552985|P1|Overall Study|Protocol Violation|3
475636|NCT00152516|1552985|P1|Overall Study|Withdrawal by Subject|8
475637|NCT00152516|1552985|P1|Overall Study|Lost to Follow-up|5
475638|NCT00152516|1552985|P1|Overall Study|Lack and Loss of Efficacy|30
475639|NCT00152516|1552985|P1|Overall Study|Adverse Event|18
475640|NCT00152009|1553013|P4|Overall Study|Sponsor's decision|3
475641|NCT00152009|1553014|P3|Overall Study|Sponsor's decision|1
475642|NCT00152009|1553015|P2|Overall Study|Sponsor's decision|3
475643|NCT00152009|1553016|P1|Overall Study|Sponsor's decision|3
475644|NCT00152009|1553013|P4|Overall Study|ECG abnormalities|1
475645|NCT00152009|1553014|P3|Overall Study|ECG abnormalities|2
475646|NCT00152009|1553015|P2|Overall Study|ECG abnormalities|2
475647|NCT00152009|1553016|P1|Overall Study|ECG abnormalities|2
475648|NCT00152009|1553013|P4|Overall Study|Lack of Efficacy|15
475649|NCT00152009|1553014|P3|Overall Study|Lack of Efficacy|7
475650|NCT00152009|1553015|P2|Overall Study|Lack of Efficacy|6
475651|NCT00152009|1553016|P1|Overall Study|Lack of Efficacy|8
475652|NCT00152009|1553013|P4|Overall Study|Lost to Follow-up|3
475653|NCT00152009|1553014|P3|Overall Study|Lost to Follow-up|3
475654|NCT00152009|1553015|P2|Overall Study|Lost to Follow-up|4
475655|NCT00152009|1553016|P1|Overall Study|Lost to Follow-up|2
475656|NCT00152009|1553013|P4|Overall Study|Withdrawal by Subject|9
475657|NCT00152009|1553014|P3|Overall Study|Withdrawal by Subject|4
475658|NCT00152009|1553015|P2|Overall Study|Withdrawal by Subject|3
475659|NCT00152009|1553016|P1|Overall Study|Withdrawal by Subject|2
475660|NCT00152009|1553013|P4|Overall Study|Protocol Violation|1
475661|NCT00152009|1553014|P3|Overall Study|Protocol Violation|0
475662|NCT00152009|1553015|P2|Overall Study|Protocol Violation|0
475663|NCT00152009|1553016|P1|Overall Study|Protocol Violation|3
475664|NCT00152009|1553013|P4|Overall Study|Adverse Event|1
475665|NCT00152009|1553014|P3|Overall Study|Adverse Event|20
475666|NCT00152009|1553015|P2|Overall Study|Adverse Event|13
475667|NCT00152009|1553016|P1|Overall Study|Adverse Event|9
475668|NCT00151996|1553048|P2|Overall Study|Sponsor's decision|2
475669|NCT00151996|1553049|P1|Overall Study|Sponsor's decision|0
475670|NCT00151996|1553048|P2|Overall Study|Protocol Violation|2
475671|NCT00151996|1553049|P1|Overall Study|Protocol Violation|1
475672|NCT00151996|1553048|P2|Overall Study|Withdrawal by Subject|1
475673|NCT00151996|1553049|P1|Overall Study|Withdrawal by Subject|1
475674|NCT00151996|1553048|P2|Overall Study|Adverse Event|2
475675|NCT00151996|1553049|P1|Overall Study|Adverse Event|3
475676|NCT00151892|1553065|P2|Overall Study|Lack of study medication at center|1
475677|NCT00151892|1553066|P1|Overall Study|Lack of study medication at center|0
475678|NCT00151892|1553065|P2|Overall Study|Used prohibited corticosteroids|0
475679|NCT00151892|1553066|P1|Overall Study|Used prohibited corticosteroids|1
475680|NCT00151892|1553065|P2|Overall Study|Did not return for a visit|0
475681|NCT00151892|1553066|P1|Overall Study|Did not return for a visit|1
475682|NCT00151892|1553065|P2|Overall Study|Pregnancy|1
475683|NCT00151892|1553066|P1|Overall Study|Pregnancy|0
475684|NCT00151892|1553065|P2|Overall Study|Non-compliance|1
475685|NCT00151892|1553066|P1|Overall Study|Non-compliance|0
475686|NCT00151892|1553065|P2|Overall Study|Protocol Violation|3
475687|NCT00151892|1553066|P1|Overall Study|Protocol Violation|3
475688|NCT00151892|1553065|P2|Overall Study|Adverse Event|3
475689|NCT00151892|1553066|P1|Overall Study|Adverse Event|6
475690|NCT00151892|1553065|P2|Overall Study|Lost to Follow-up|10
475691|NCT00151892|1553066|P1|Overall Study|Lost to Follow-up|5
475692|NCT00151892|1553065|P2|Overall Study|Patient request|7
475693|NCT00151892|1553066|P1|Overall Study|Patient request|10
475694|NCT00151892|1553065|P2|Overall Study|Lack of Efficacy|57
475695|NCT00151892|1553066|P1|Overall Study|Lack of Efficacy|50
475696|NCT00151775|1553111|P12|Period 4: Open Label|Protocol Violation|0
475697|NCT00151775|1553112|P11|Period 4: Open Label|Protocol Violation|0
475698|NCT00151775|1553113|P10|Period 4: Open Label|Protocol Violation|0
475699|NCT00151775|1553114|P9|Period 4: Open Label|Protocol Violation|0
475700|NCT00151775|1553115|P8|Period 4: Open Label|Protocol Violation|0
475701|NCT00151775|1553116|P7|Period 4: Open Label|Protocol Violation|0
475702|NCT00151775|1553117|P6|Period 4: Open Label|Protocol Violation|0
475703|NCT00151775|1553118|P5|Period 4: Open Label|Protocol Violation|1
475704|NCT00151775|1553119|P4|Period 4: Open Label|Protocol Violation|0
475705|NCT00151775|1553120|P3|Period 4: Open Label|Protocol Violation|0
475706|NCT00151775|1553121|P2|Period 4: Open Label|Protocol Violation|0
475707|NCT00151775|1553122|P1|Period 4: Open Label|Protocol Violation|0
475708|NCT00151775|1553111|P12|Period 4: Open Label|Physician Decision|0
475709|NCT00151775|1553112|P11|Period 4: Open Label|Physician Decision|0
475710|NCT00151775|1553113|P10|Period 4: Open Label|Physician Decision|2
475711|NCT00151775|1553114|P9|Period 4: Open Label|Physician Decision|0
475712|NCT00151775|1553115|P8|Period 4: Open Label|Physician Decision|0
475713|NCT00151775|1553116|P7|Period 4: Open Label|Physician Decision|0
475714|NCT00151775|1553117|P6|Period 4: Open Label|Physician Decision|0
475715|NCT00151775|1553118|P5|Period 4: Open Label|Physician Decision|0
475716|NCT00151775|1553119|P4|Period 4: Open Label|Physician Decision|0
475717|NCT00151775|1553120|P3|Period 4: Open Label|Physician Decision|0
475718|NCT00151775|1553121|P2|Period 4: Open Label|Physician Decision|0
475719|NCT00151775|1553122|P1|Period 4: Open Label|Physician Decision|0
475720|NCT00151775|1553111|P12|Period 4: Open Label|Other|0
475721|NCT00151775|1553112|P11|Period 4: Open Label|Other|0
475722|NCT00151775|1553113|P10|Period 4: Open Label|Other|3
475723|NCT00151775|1553114|P9|Period 4: Open Label|Other|0
475724|NCT00151775|1553115|P8|Period 4: Open Label|Other|0
475725|NCT00151775|1553116|P7|Period 4: Open Label|Other|0
475726|NCT00151775|1553117|P6|Period 4: Open Label|Other|0
475727|NCT00151775|1553118|P5|Period 4: Open Label|Other|1
475728|NCT00151775|1553119|P4|Period 4: Open Label|Other|0
475729|NCT00151775|1553120|P3|Period 4: Open Label|Other|0
475730|NCT00151775|1553121|P2|Period 4: Open Label|Other|0
475731|NCT00151775|1553122|P1|Period 4: Open Label|Other|0
475732|NCT00151775|1553111|P12|Period 4: Open Label|Non-compliance with protocol|0
475733|NCT00151775|1553112|P11|Period 4: Open Label|Non-compliance with protocol|0
475734|NCT00151775|1553113|P10|Period 4: Open Label|Non-compliance with protocol|4
475735|NCT00151775|1553114|P9|Period 4: Open Label|Non-compliance with protocol|0
475736|NCT00151775|1553115|P8|Period 4: Open Label|Non-compliance with protocol|0
475737|NCT00151775|1553116|P7|Period 4: Open Label|Non-compliance with protocol|0
475738|NCT00151775|1553117|P6|Period 4: Open Label|Non-compliance with protocol|0
475739|NCT00151775|1553118|P5|Period 4: Open Label|Non-compliance with protocol|4
475740|NCT00151775|1553119|P4|Period 4: Open Label|Non-compliance with protocol|0
475741|NCT00151775|1553120|P3|Period 4: Open Label|Non-compliance with protocol|0
475742|NCT00151775|1553121|P2|Period 4: Open Label|Non-compliance with protocol|0
475743|NCT00151775|1553122|P1|Period 4: Open Label|Non-compliance with protocol|0
475744|NCT00151775|1553111|P12|Period 4: Open Label|Lost to Follow-up|0
475745|NCT00151775|1553112|P11|Period 4: Open Label|Lost to Follow-up|0
475746|NCT00151775|1553113|P10|Period 4: Open Label|Lost to Follow-up|7
475747|NCT00151775|1553114|P9|Period 4: Open Label|Lost to Follow-up|0
475748|NCT00151775|1553115|P8|Period 4: Open Label|Lost to Follow-up|0
475749|NCT00151775|1553116|P7|Period 4: Open Label|Lost to Follow-up|0
475750|NCT00151775|1553117|P6|Period 4: Open Label|Lost to Follow-up|0
475751|NCT00151775|1553118|P5|Period 4: Open Label|Lost to Follow-up|17
475752|NCT00151775|1553119|P4|Period 4: Open Label|Lost to Follow-up|0
475753|NCT00151775|1553120|P3|Period 4: Open Label|Lost to Follow-up|0
475754|NCT00151775|1553121|P2|Period 4: Open Label|Lost to Follow-up|0
475755|NCT00151775|1553122|P1|Period 4: Open Label|Lost to Follow-up|0
475756|NCT00151775|1553111|P12|Period 4: Open Label|Adverse Event|0
475757|NCT00151775|1553112|P11|Period 4: Open Label|Adverse Event|0
475758|NCT00151775|1553113|P10|Period 4: Open Label|Adverse Event|2
475759|NCT00151775|1553114|P9|Period 4: Open Label|Adverse Event|0
475760|NCT00151775|1553115|P8|Period 4: Open Label|Adverse Event|0
475761|NCT00151775|1553116|P7|Period 4: Open Label|Adverse Event|0
475762|NCT00151775|1553117|P6|Period 4: Open Label|Adverse Event|0
475763|NCT00151775|1553118|P5|Period 4: Open Label|Adverse Event|1
475764|NCT00151775|1553119|P4|Period 4: Open Label|Adverse Event|0
475765|NCT00151775|1553120|P3|Period 4: Open Label|Adverse Event|0
475766|NCT00151775|1553121|P2|Period 4: Open Label|Adverse Event|0
475767|NCT00151775|1553122|P1|Period 4: Open Label|Adverse Event|0
475768|NCT00151775|1553111|P12|Period 4: Open Label|Withdrawal by Subject|0
475769|NCT00151775|1553112|P11|Period 4: Open Label|Withdrawal by Subject|0
475770|NCT00151775|1553113|P10|Period 4: Open Label|Withdrawal by Subject|2
475771|NCT00151775|1553114|P9|Period 4: Open Label|Withdrawal by Subject|0
475772|NCT00151775|1553115|P8|Period 4: Open Label|Withdrawal by Subject|0
475773|NCT00151775|1553116|P7|Period 4: Open Label|Withdrawal by Subject|0
475774|NCT00151775|1553117|P6|Period 4: Open Label|Withdrawal by Subject|0
475775|NCT00151775|1553118|P5|Period 4: Open Label|Withdrawal by Subject|5
475776|NCT00151775|1553119|P4|Period 4: Open Label|Withdrawal by Subject|0
475777|NCT00151775|1553120|P3|Period 4: Open Label|Withdrawal by Subject|0
475778|NCT00151775|1553121|P2|Period 4: Open Label|Withdrawal by Subject|0
475779|NCT00151775|1553122|P1|Period 4: Open Label|Withdrawal by Subject|0
475780|NCT00151775|1553111|P12|Period 4: Open Label|Increased blood pressure|0
475781|NCT00151775|1553112|P11|Period 4: Open Label|Increased blood pressure|0
475782|NCT00151775|1553113|P10|Period 4: Open Label|Increased blood pressure|1
475783|NCT00151775|1553114|P9|Period 4: Open Label|Increased blood pressure|0
475784|NCT00151775|1553115|P8|Period 4: Open Label|Increased blood pressure|0
475785|NCT00151775|1553116|P7|Period 4: Open Label|Increased blood pressure|0
475786|NCT00151775|1553117|P6|Period 4: Open Label|Increased blood pressure|0
475787|NCT00151775|1553118|P5|Period 4: Open Label|Increased blood pressure|1
475788|NCT00151775|1553119|P4|Period 4: Open Label|Increased blood pressure|0
475789|NCT00151775|1553120|P3|Period 4: Open Label|Increased blood pressure|0
475790|NCT00151775|1553121|P2|Period 4: Open Label|Increased blood pressure|0
475791|NCT00151775|1553122|P1|Period 4: Open Label|Increased blood pressure|0
475792|NCT00151775|1553111|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
475793|NCT00151775|1553112|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475794|NCT00151775|1553113|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475795|NCT00151775|1553114|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475796|NCT00151775|1553115|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475797|NCT00151775|1553116|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475798|NCT00151775|1553117|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475799|NCT00151775|1553118|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475800|NCT00151775|1553119|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475801|NCT00151775|1553120|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475802|NCT00151775|1553121|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475803|NCT00151775|1553122|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
475804|NCT00151775|1553111|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475805|NCT00151775|1553112|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475806|NCT00151775|1553113|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475807|NCT00151775|1553114|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475808|NCT00151775|1553115|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475809|NCT00151775|1553116|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475810|NCT00151775|1553117|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475811|NCT00151775|1553118|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475812|NCT00151775|1553119|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475813|NCT00151775|1553120|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
475814|NCT00151775|1553121|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475815|NCT00151775|1553122|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
475816|NCT00151775|1553111|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
475817|NCT00151775|1553112|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
475818|NCT00151775|1553113|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
475819|NCT00151775|1553114|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
475820|NCT00151775|1553115|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
475821|NCT00151775|1553116|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
475822|NCT00151775|1553117|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
475823|NCT00151775|1553118|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
475824|NCT00151775|1553119|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
475825|NCT00151775|1553120|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
475826|NCT00151775|1553121|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
475827|NCT00151775|1553122|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
475828|NCT00151775|1553111|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475829|NCT00151775|1553112|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475830|NCT00151775|1553113|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475831|NCT00151775|1553114|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475832|NCT00151775|1553115|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475833|NCT00151775|1553116|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
475834|NCT00151775|1553117|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475835|NCT00151775|1553118|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475836|NCT00151775|1553119|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475837|NCT00151775|1553120|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475838|NCT00151775|1553121|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475839|NCT00151775|1553122|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
475840|NCT00151775|1553111|P12|Period 3: Double-blind, Withdrawal|Other|0
475841|NCT00151775|1553112|P11|Period 3: Double-blind, Withdrawal|Other|0
475842|NCT00151775|1553113|P10|Period 3: Double-blind, Withdrawal|Other|0
475843|NCT00151775|1553114|P9|Period 3: Double-blind, Withdrawal|Other|0
475844|NCT00151775|1553115|P8|Period 3: Double-blind, Withdrawal|Other|1
475845|NCT00151775|1553116|P7|Period 3: Double-blind, Withdrawal|Other|0
475846|NCT00151775|1553117|P6|Period 3: Double-blind, Withdrawal|Other|0
475847|NCT00151775|1553118|P5|Period 3: Double-blind, Withdrawal|Other|0
475848|NCT00151775|1553119|P4|Period 3: Double-blind, Withdrawal|Other|0
475849|NCT00151775|1553120|P3|Period 3: Double-blind, Withdrawal|Other|1
475850|NCT00151775|1553121|P2|Period 3: Double-blind, Withdrawal|Other|0
475851|NCT00151775|1553122|P1|Period 3: Double-blind, Withdrawal|Other|0
475852|NCT00151775|1553111|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475853|NCT00151775|1553112|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475854|NCT00151775|1553113|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475855|NCT00151775|1553114|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475856|NCT00151775|1553115|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475857|NCT00151775|1553116|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475858|NCT00151775|1553117|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
475859|NCT00151775|1553118|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475860|NCT00151775|1553119|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475861|NCT00151775|1553120|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475862|NCT00151775|1553121|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475863|NCT00151775|1553122|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
475864|NCT00151775|1553111|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475865|NCT00151775|1553112|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475866|NCT00151775|1553113|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475867|NCT00151775|1553114|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475868|NCT00151775|1553115|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475869|NCT00151775|1553116|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
475870|NCT00151775|1553117|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475871|NCT00151775|1553118|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475872|NCT00151775|1553119|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475873|NCT00151775|1553120|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475874|NCT00151775|1553121|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475875|NCT00151775|1553122|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
475876|NCT00151775|1553111|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
475877|NCT00151775|1553112|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
475878|NCT00151775|1553113|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
475879|NCT00151775|1553114|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
475880|NCT00151775|1553115|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
475881|NCT00151775|1553116|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
475882|NCT00151775|1553117|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
475883|NCT00151775|1553118|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
475884|NCT00151775|1553119|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
475885|NCT00151775|1553120|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
475886|NCT00151775|1553121|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
475887|NCT00151775|1553122|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
475888|NCT00151775|1553111|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
475889|NCT00151775|1553112|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
475890|NCT00151775|1553113|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
475891|NCT00151775|1553114|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
475892|NCT00151775|1553115|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
475893|NCT00151775|1553116|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
475894|NCT00151775|1553117|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
475895|NCT00151775|1553118|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
475896|NCT00151775|1553119|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
475897|NCT00151775|1553120|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
475898|NCT00151775|1553121|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
475899|NCT00151775|1553122|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
475900|NCT00151775|1553111|P12|Period 2 - Double-Blind Dose Response|Other|0
475901|NCT00151775|1553112|P11|Period 2 - Double-Blind Dose Response|Other|0
475902|NCT00151775|1553113|P10|Period 2 - Double-Blind Dose Response|Other|0
475903|NCT00151775|1553114|P9|Period 2 - Double-Blind Dose Response|Other|0
475904|NCT00151775|1553115|P8|Period 2 - Double-Blind Dose Response|Other|0
475905|NCT00151775|1553116|P7|Period 2 - Double-Blind Dose Response|Other|1
475906|NCT00151775|1553117|P6|Period 2 - Double-Blind Dose Response|Other|0
475907|NCT00151775|1553118|P5|Period 2 - Double-Blind Dose Response|Other|0
475908|NCT00151775|1553119|P4|Period 2 - Double-Blind Dose Response|Other|0
475909|NCT00151775|1553120|P3|Period 2 - Double-Blind Dose Response|Other|0
475910|NCT00151775|1553121|P2|Period 2 - Double-Blind Dose Response|Other|0
475911|NCT00151775|1553122|P1|Period 2 - Double-Blind Dose Response|Other|0
475912|NCT00151775|1553111|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475913|NCT00151775|1553112|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475914|NCT00151775|1553113|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475915|NCT00151775|1553114|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475916|NCT00151775|1553115|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475917|NCT00151775|1553116|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475918|NCT00151775|1553117|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475919|NCT00151775|1553118|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475920|NCT00151775|1553119|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475921|NCT00151775|1553120|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475922|NCT00151775|1553121|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
475923|NCT00151775|1553122|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
475924|NCT00151775|1553111|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475925|NCT00151775|1553112|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
475926|NCT00151775|1553113|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475927|NCT00151775|1553114|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475928|NCT00151775|1553115|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475929|NCT00151775|1553116|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
475930|NCT00151775|1553117|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475931|NCT00151775|1553118|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475932|NCT00151775|1553119|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475933|NCT00151775|1553120|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475934|NCT00151775|1553121|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
475935|NCT00151775|1553122|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
475936|NCT00151775|1553111|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
475937|NCT00151775|1553112|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
475938|NCT00151775|1553113|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
475939|NCT00151775|1553114|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
475940|NCT00151775|1553115|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
475941|NCT00151775|1553116|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
475942|NCT00151775|1553117|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
475943|NCT00151775|1553118|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
475944|NCT00151775|1553119|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
475945|NCT00151775|1553120|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
475946|NCT00151775|1553121|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
475947|NCT00151775|1553122|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
475948|NCT00151476|1553166|P2|FAP Analyzed Subjects|Other study participation|1
475949|NCT00151476|1553167|P1|FAP Analyzed Subjects|Other study participation|0
475950|NCT00151476|1553166|P2|FAP Analyzed Subjects|Lost to Follow-up|2
475951|NCT00151476|1553167|P1|FAP Analyzed Subjects|Lost to Follow-up|0
475952|NCT00151476|1553166|P2|FAP Identified Subjects|Protocol Violation|1
475953|NCT00151476|1553167|P1|FAP Identified Subjects|Protocol Violation|0
475954|NCT00151411|1553224|P2|Overall Study|Pregnancy|4
475955|NCT00151411|1553225|P1|Overall Study|Pregnancy|0
475956|NCT00151411|1553224|P2|Overall Study|Adverse Event|0
475957|NCT00151411|1553225|P1|Overall Study|Adverse Event|6
475958|NCT00151411|1553224|P2|Overall Study|Withdrawal by Subject|20
475959|NCT00151411|1553225|P1|Overall Study|Withdrawal by Subject|12
475960|NCT00151411|1553224|P2|Overall Study|Lost to Follow-up|19
475961|NCT00151411|1553225|P1|Overall Study|Lost to Follow-up|15
475962|NCT00151372|1553237|P2|Overall Study|Withdrawal by Subject|7
475963|NCT00151372|1553238|P1|Overall Study|Withdrawal by Subject|7
475964|NCT00151372|1553237|P2|Overall Study|Too sick medically to continue|6
475965|NCT00151372|1553238|P1|Overall Study|Too sick medically to continue|5
475966|NCT00151372|1553237|P2|Overall Study|Lost to Follow-up|5
475967|NCT00151372|1553238|P1|Overall Study|Lost to Follow-up|5
475968|NCT00151372|1553237|P2|Overall Study|Death|11
475969|NCT00151372|1553238|P1|Overall Study|Death|12
475970|NCT00151281|1553253|P1|Overall Study|Not evaluable|3
475971|NCT00150969|1553262|P2|24-48 Month Extension|Other Reason|91
475972|NCT00150969|1553263|P1|24-48 Month Extension|Other Reason|81
475973|NCT00150969|1553262|P2|24-48 Month Extension|Adverse Event|3
475974|NCT00150969|1553263|P1|24-48 Month Extension|Adverse Event|1
475975|NCT00150969|1553262|P2|24-48 Month Extension|Lack of Efficacy|1
475976|NCT00150969|1553263|P1|24-48 Month Extension|Lack of Efficacy|0
475977|NCT00150969|1553262|P2|24-48 Month Extension|Withdrawal by Subject|5
475978|NCT00150969|1553263|P1|24-48 Month Extension|Withdrawal by Subject|6
475979|NCT00150969|1553262|P2|24 Month Main Study|Withdrawal by Subject|4
475980|NCT00150969|1553263|P1|24 Month Main Study|Withdrawal by Subject|7
475981|NCT00150969|1553262|P2|24 Month Main Study|Protocol Violation|2
475982|NCT00150969|1553263|P1|24 Month Main Study|Protocol Violation|4
475983|NCT00150969|1553262|P2|24 Month Main Study|Lost to Follow-up|2
475984|NCT00150969|1553263|P1|24 Month Main Study|Lost to Follow-up|3
475985|NCT00150969|1553262|P2|24 Month Main Study|Lack of Efficacy|8
475986|NCT00150969|1553263|P1|24 Month Main Study|Lack of Efficacy|1
475987|NCT00150969|1553262|P2|24 Month Main Study|Death|1
475988|NCT00150969|1553263|P1|24 Month Main Study|Death|1
475989|NCT00150969|1553262|P2|24 Month Main Study|Adverse Event|4
475990|NCT00150969|1553263|P1|24 Month Main Study|Adverse Event|3
475991|NCT00150618|1553300|P5|Overall Study|Sponsor's decision|0
475992|NCT00150618|1553301|P4|Overall Study|Sponsor's decision|1
475993|NCT00150618|1553302|P3|Overall Study|Sponsor's decision|0
475994|NCT00150618|1553303|P2|Overall Study|Sponsor's decision|0
475995|NCT00150618|1553304|P1|Overall Study|Sponsor's decision|0
475996|NCT00150618|1553300|P5|Overall Study|Abnormal ECG|0
475997|NCT00150618|1553301|P4|Overall Study|Abnormal ECG|0
475998|NCT00150618|1553302|P3|Overall Study|Abnormal ECG|0
475999|NCT00150618|1553303|P2|Overall Study|Abnormal ECG|0
476000|NCT00150618|1553304|P1|Overall Study|Abnormal ECG|1
476001|NCT00150618|1553300|P5|Overall Study|Lack of compliance|1
476002|NCT00150618|1553301|P4|Overall Study|Lack of compliance|0
476003|NCT00150618|1553302|P3|Overall Study|Lack of compliance|1
476004|NCT00150618|1553303|P2|Overall Study|Lack of compliance|1
476005|NCT00150618|1553304|P1|Overall Study|Lack of compliance|2
476006|NCT00150618|1553300|P5|Overall Study|Physician Decision|1
476007|NCT00150618|1553301|P4|Overall Study|Physician Decision|0
476008|NCT00150618|1553302|P3|Overall Study|Physician Decision|0
476009|NCT00150618|1553303|P2|Overall Study|Physician Decision|2
476010|NCT00150618|1553304|P1|Overall Study|Physician Decision|0
476011|NCT00150618|1553300|P5|Overall Study|No study meds|2
476012|NCT00150618|1553301|P4|Overall Study|No study meds|0
476013|NCT00150618|1553302|P3|Overall Study|No study meds|0
476014|NCT00150618|1553303|P2|Overall Study|No study meds|0
476015|NCT00150618|1553304|P1|Overall Study|No study meds|0
476016|NCT00150618|1553300|P5|Overall Study|Lack of Efficacy|6
476017|NCT00150618|1553301|P4|Overall Study|Lack of Efficacy|4
476018|NCT00150618|1553302|P3|Overall Study|Lack of Efficacy|7
476019|NCT00150618|1553303|P2|Overall Study|Lack of Efficacy|4
476020|NCT00150618|1553304|P1|Overall Study|Lack of Efficacy|1
476021|NCT00150618|1553300|P5|Overall Study|Protocol Violation|1
476022|NCT00150618|1553301|P4|Overall Study|Protocol Violation|0
476023|NCT00150618|1553302|P3|Overall Study|Protocol Violation|0
476024|NCT00150618|1553303|P2|Overall Study|Protocol Violation|0
476025|NCT00150618|1553304|P1|Overall Study|Protocol Violation|1
476026|NCT00150618|1553300|P5|Overall Study|Lost to Follow-up|4
476027|NCT00150618|1553301|P4|Overall Study|Lost to Follow-up|8
476028|NCT00150618|1553302|P3|Overall Study|Lost to Follow-up|5
476029|NCT00150618|1553303|P2|Overall Study|Lost to Follow-up|1
476030|NCT00150618|1553304|P1|Overall Study|Lost to Follow-up|4
476031|NCT00150618|1553300|P5|Overall Study|Withdrawal by Subject|5
476032|NCT00150618|1553301|P4|Overall Study|Withdrawal by Subject|4
476033|NCT00150618|1553302|P3|Overall Study|Withdrawal by Subject|8
476034|NCT00150618|1553303|P2|Overall Study|Withdrawal by Subject|8
476035|NCT00150618|1553304|P1|Overall Study|Withdrawal by Subject|6
476036|NCT00150618|1553300|P5|Overall Study|Adverse Event|5
476037|NCT00150618|1553301|P4|Overall Study|Adverse Event|9
476038|NCT00150618|1553302|P3|Overall Study|Adverse Event|6
476039|NCT00150618|1553303|P2|Overall Study|Adverse Event|2
476040|NCT00150618|1553304|P1|Overall Study|Adverse Event|2
476041|NCT00150592|1553338|P2|Overall Study|Non-compliance|0
476042|NCT00150592|1553339|P1|Overall Study|Non-compliance|1
476043|NCT00150592|1553338|P2|Overall Study|Withdrawal by Subject|2
476044|NCT00150592|1553339|P1|Overall Study|Withdrawal by Subject|1
476045|NCT00150592|1553338|P2|Overall Study|Protocol Violation|0
476046|NCT00150592|1553339|P1|Overall Study|Protocol Violation|1
476047|NCT00150592|1553338|P2|Overall Study|Adverse Event|1
476048|NCT00150592|1553339|P1|Overall Study|Adverse Event|4
476049|NCT00150462|1553370|P11|Overall Study|Other|1
476050|NCT00150462|1553371|P10|Overall Study|Other|1
476051|NCT00150462|1553372|P9|Overall Study|Other|0
476052|NCT00150462|1553373|P8|Overall Study|Other|0
476053|NCT00150462|1553374|P7|Overall Study|Other|0
476054|NCT00150462|1553375|P6|Overall Study|Other|0
476055|NCT00150462|1553376|P5|Overall Study|Other|0
476056|NCT00150462|1553377|P4|Overall Study|Other|0
476057|NCT00150462|1553378|P3|Overall Study|Other|0
476058|NCT00150462|1553379|P2|Overall Study|Other|0
476059|NCT00150462|1553380|P1|Overall Study|Other|0
476060|NCT00150462|1553370|P11|Overall Study|Physician Decision|0
476061|NCT00150462|1553371|P10|Overall Study|Physician Decision|0
476062|NCT00150462|1553372|P9|Overall Study|Physician Decision|0
476063|NCT00150462|1553373|P8|Overall Study|Physician Decision|0
476064|NCT00150462|1553374|P7|Overall Study|Physician Decision|0
476065|NCT00150462|1553375|P6|Overall Study|Physician Decision|0
476066|NCT00150462|1553376|P5|Overall Study|Physician Decision|0
476067|NCT00150462|1553377|P4|Overall Study|Physician Decision|1
476068|NCT00150462|1553378|P3|Overall Study|Physician Decision|1
476069|NCT00150462|1553379|P2|Overall Study|Physician Decision|0
476070|NCT00150462|1553380|P1|Overall Study|Physician Decision|0
476071|NCT00150462|1553370|P11|Overall Study|Adverse Event|0
476072|NCT00150462|1553371|P10|Overall Study|Adverse Event|1
476073|NCT00150462|1553372|P9|Overall Study|Adverse Event|0
476074|NCT00150462|1553373|P8|Overall Study|Adverse Event|2
476075|NCT00150462|1553374|P7|Overall Study|Adverse Event|0
476076|NCT00150462|1553375|P6|Overall Study|Adverse Event|0
476077|NCT00150462|1553376|P5|Overall Study|Adverse Event|0
476078|NCT00150462|1553377|P4|Overall Study|Adverse Event|1
476079|NCT00150462|1553378|P3|Overall Study|Adverse Event|0
476080|NCT00150462|1553379|P2|Overall Study|Adverse Event|0
476081|NCT00150462|1553380|P1|Overall Study|Adverse Event|0
476082|NCT00150462|1553370|P11|Overall Study|Death|0
476083|NCT00150462|1553371|P10|Overall Study|Death|0
476084|NCT00150462|1553372|P9|Overall Study|Death|1
476085|NCT00150462|1553373|P8|Overall Study|Death|0
476086|NCT00150462|1553374|P7|Overall Study|Death|0
476087|NCT00150462|1553375|P6|Overall Study|Death|0
476088|NCT00150462|1553376|P5|Overall Study|Death|0
476089|NCT00150462|1553377|P4|Overall Study|Death|0
476090|NCT00150462|1553378|P3|Overall Study|Death|0
476091|NCT00150462|1553379|P2|Overall Study|Death|1
476092|NCT00150462|1553380|P1|Overall Study|Death|0
476093|NCT00150462|1553370|P11|Overall Study|Withdrawal by Subject|0
476094|NCT00150462|1553371|P10|Overall Study|Withdrawal by Subject|1
476095|NCT00150462|1553372|P9|Overall Study|Withdrawal by Subject|0
476096|NCT00150462|1553373|P8|Overall Study|Withdrawal by Subject|1
476097|NCT00150462|1553374|P7|Overall Study|Withdrawal by Subject|0
476098|NCT00150462|1553375|P6|Overall Study|Withdrawal by Subject|2
476099|NCT00150462|1553376|P5|Overall Study|Withdrawal by Subject|1
476100|NCT00150462|1553377|P4|Overall Study|Withdrawal by Subject|0
476101|NCT00150462|1553378|P3|Overall Study|Withdrawal by Subject|1
476102|NCT00150462|1553379|P2|Overall Study|Withdrawal by Subject|1
476103|NCT00150462|1553380|P1|Overall Study|Withdrawal by Subject|0
476104|NCT00150462|1553370|P11|Overall Study|Disease Progression or Relapse|2
476105|NCT00150462|1553371|P10|Overall Study|Disease Progression or Relapse|3
476106|NCT00150462|1553372|P9|Overall Study|Disease Progression or Relapse|5
476107|NCT00150462|1553373|P8|Overall Study|Disease Progression or Relapse|5
476108|NCT00150462|1553374|P7|Overall Study|Disease Progression or Relapse|3
476109|NCT00150462|1553375|P6|Overall Study|Disease Progression or Relapse|2
476110|NCT00150462|1553376|P5|Overall Study|Disease Progression or Relapse|2
476111|NCT00150462|1553377|P4|Overall Study|Disease Progression or Relapse|1
476112|NCT00150462|1553378|P3|Overall Study|Disease Progression or Relapse|2
476113|NCT00150462|1553379|P2|Overall Study|Disease Progression or Relapse|1
476114|NCT00150462|1553380|P1|Overall Study|Disease Progression or Relapse|3
476115|NCT00150345|1553490|P2|Overall Study|Other|14
476116|NCT00150345|1553491|P1|Overall Study|Other|12
476117|NCT00150345|1553490|P2|Overall Study|Laboratory abnormality|2
476118|NCT00150345|1553491|P1|Overall Study|Laboratory abnormality|1
476119|NCT00150345|1553490|P2|Overall Study|Withdrawal by Subject|4
476120|NCT00150345|1553491|P1|Overall Study|Withdrawal by Subject|3
476121|NCT00150345|1553490|P2|Overall Study|Lack of Efficacy|4
476122|NCT00150345|1553491|P1|Overall Study|Lack of Efficacy|5
476123|NCT00150345|1553490|P2|Overall Study|Adverse Event|6
476124|NCT00150345|1553491|P1|Overall Study|Adverse Event|8
476125|NCT00150345|1553490|P2|Overall Study|Death|2
476126|NCT00150345|1553491|P1|Overall Study|Death|5
476127|NCT00150176|1553555|P2|Overall Study|OTHER|13
476128|NCT00150176|1553556|P1|Overall Study|OTHER|11
476129|NCT00150176|1553555|P2|Overall Study|Lost to Follow-up|3
476130|NCT00150176|1553556|P1|Overall Study|Lost to Follow-up|3
476131|NCT00150176|1553555|P2|Overall Study|Withdrawal by Subject|12
476132|NCT00150176|1553556|P1|Overall Study|Withdrawal by Subject|19
476133|NCT00150176|1553555|P2|Overall Study|Relapse/Impending relapse, non-AE|39
476134|NCT00150176|1553556|P1|Overall Study|Relapse/Impending relapse, non-AE|10
476135|NCT00150176|1553555|P2|Overall Study|Adverse Event|53
476136|NCT00150176|1553556|P1|Overall Study|Adverse Event|16
476137|NCT00149994|1553567|P2|Overall Study|Protocol Violation|1
476138|NCT00149994|1553568|P1|Overall Study|Protocol Violation|0
476139|NCT00149994|1553567|P2|Overall Study|Administrative problems:|0
476140|NCT00149994|1553568|P1|Overall Study|Administrative problems:|1
476141|NCT00149890|1553576|P2|Overall Study|Graft Loss|1
476142|NCT00149890|1553577|P1|Overall Study|Graft Loss|2
476143|NCT00149890|1553576|P2|Overall Study|Lost to Follow-up|0
476144|NCT00149890|1553577|P1|Overall Study|Lost to Follow-up|1
476145|NCT00149890|1553576|P2|Overall Study|Protocol Violation|0
476146|NCT00149890|1553577|P1|Overall Study|Protocol Violation|1
476147|NCT00149890|1553576|P2|Overall Study|Lack of Efficacy|9
476148|NCT00149890|1553577|P1|Overall Study|Lack of Efficacy|8
476149|NCT00149890|1553576|P2|Overall Study|Adverse Event|8
476150|NCT00149890|1553577|P1|Overall Study|Adverse Event|1
476151|NCT00149825|1553597|P2|Overall Study|Other|0
476152|NCT00149825|1553598|P1|Overall Study|Other|1
476153|NCT00149825|1553597|P2|Overall Study|Not liking insomnia therapy|0
476154|NCT00149825|1553598|P1|Overall Study|Not liking insomnia therapy|1
476155|NCT00149825|1553597|P2|Overall Study|Time commitments|1
476156|NCT00149825|1553598|P1|Overall Study|Time commitments|2
476157|NCT00149825|1553597|P2|Overall Study|Intolerance to medication side effects|2
476158|NCT00149825|1553598|P1|Overall Study|Intolerance to medication side effects|1
476159|NCT00149747|1553626|P2|Overall Study|Withdrawal by Subject|3
476160|NCT00149747|1553627|P1|Overall Study|Withdrawal by Subject|3
476161|NCT00149747|1553626|P2|Overall Study|Death|0
476162|NCT00149747|1553627|P1|Overall Study|Death|1
476163|NCT00149630|1553673|P2|Overall Study|Adverse Event|0
476164|NCT00149630|1553674|P1|Overall Study|Adverse Event|2
476165|NCT00149630|1553673|P2|Overall Study|Treatment Programs|5
476166|NCT00149630|1553674|P1|Overall Study|Treatment Programs|4
476167|NCT00149630|1553673|P2|Overall Study|Incarceration|0
476168|NCT00149630|1553674|P1|Overall Study|Incarceration|2
476169|NCT00149396|1553684|P1|Overall Study|other treatment|5
476170|NCT00149396|1553684|P1|Overall Study|Subject noncompliance|2
476171|NCT00149396|1553684|P1|Overall Study|Withdrawal by Subject|1
476172|NCT00149396|1553684|P1|Overall Study|Death|15
476173|NCT00149214|1553754|P2|Overall Study|Progressive Disease|3
476174|NCT00149214|1553755|P1|Overall Study|Progressive Disease|7
476175|NCT00149214|1553754|P2|Overall Study|Sponsor Decision|1
476176|NCT00149214|1553755|P1|Overall Study|Sponsor Decision|0
476177|NCT00149214|1553754|P2|Overall Study|Physician Decision|3
476178|NCT00149214|1553755|P1|Overall Study|Physician Decision|3
476179|NCT00149214|1553754|P2|Overall Study|Withdrawal by Subject|1
476180|NCT00149214|1553755|P1|Overall Study|Withdrawal by Subject|4
476181|NCT00149214|1553754|P2|Overall Study|Adverse Event|9
476182|NCT00149214|1553755|P1|Overall Study|Adverse Event|12
476183|NCT00148759|1553803|P2|Overall Study|Lost to Follow-up|0
476184|NCT00148759|1553804|P1|Overall Study|Lost to Follow-up|1
476185|NCT00148759|1553803|P2|Overall Study|Withdrawal by Subject|1
476186|NCT00148759|1553804|P1|Overall Study|Withdrawal by Subject|1
476187|NCT00148343|1553832|P2|Overall Study|Physician Decision|4
476188|NCT00148343|1553833|P1|Overall Study|Physician Decision|3
476189|NCT00148343|1553832|P2|Overall Study|Withdrawal by Subject|7
476190|NCT00148343|1553833|P1|Overall Study|Withdrawal by Subject|12
476191|NCT00148317|1553847|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
476192|NCT00148317|1553847|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
476193|NCT00148317|1553847|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
476194|NCT00148122|1553854|P1|Overall Study|Withdrawal by Subject|2
476195|NCT00148109|1553862|P2|Overall Study|Withdrawal by Subject|0
476196|NCT00148109|1553863|P1|Overall Study|Withdrawal by Subject|2
476197|NCT00148109|1553862|P2|Overall Study|Adverse Event|2
476198|NCT00148109|1553863|P1|Overall Study|Adverse Event|0
476199|NCT00148109|1553862|P2|Overall Study|Lack of Efficacy|18
476200|NCT00148109|1553863|P1|Overall Study|Lack of Efficacy|10
476201|NCT00147823|1553879|P2|Overall Study|Did not receive vitoss due to infection|2
476202|NCT00147823|1553880|P1|Overall Study|Did not receive vitoss due to infection|6
476203|NCT00147823|1553879|P2|Overall Study|Withdrawal by Subject|1
476204|NCT00147823|1553880|P1|Overall Study|Withdrawal by Subject|0
476205|NCT00147823|1553879|P2|Overall Study|Physician Decision|0
476206|NCT00147823|1553880|P1|Overall Study|Physician Decision|1
476207|NCT00147823|1553879|P2|Overall Study|Lost to Follow-up|12
476208|NCT00147823|1553880|P1|Overall Study|Lost to Follow-up|6
476209|NCT00147745|1553911|P3|Overall Study|Withdrawal by Subject|0
476210|NCT00147745|1553912|P2|Overall Study|Withdrawal by Subject|0
476211|NCT00147745|1553913|P1|Overall Study|Withdrawal by Subject|1
476212|NCT00147537|1553935|P11|Phase 2|Randomized but not treated|1
476213|NCT00147537|1553936|P10|Phase 2|Randomized but not treated|1
476214|NCT00147537|1553937|P9|Phase 2|Randomized but not treated|0
476215|NCT00147537|1553938|P8|Phase 2|Randomized but not treated|0
476216|NCT00147537|1553939|P7|Phase 2|Randomized but not treated|0
476217|NCT00147537|1553940|P6|Phase 2|Randomized but not treated|0
476218|NCT00147537|1553941|P5|Phase 2|Randomized but not treated|0
476219|NCT00147537|1553942|P4|Phase 2|Randomized but not treated|0
476220|NCT00147537|1553943|P3|Phase 2|Randomized but not treated|0
476221|NCT00147537|1553944|P2|Phase 2|Randomized but not treated|0
476222|NCT00147537|1553945|P1|Phase 2|Randomized but not treated|0
476223|NCT00147537|1553935|P11|Phase 2|Withdrawal by Subject|4
476224|NCT00147537|1553936|P10|Phase 2|Withdrawal by Subject|16
476225|NCT00147537|1553937|P9|Phase 2|Withdrawal by Subject|0
476226|NCT00147537|1553938|P8|Phase 2|Withdrawal by Subject|0
476227|NCT00147537|1553939|P7|Phase 2|Withdrawal by Subject|0
476228|NCT00147537|1553940|P6|Phase 2|Withdrawal by Subject|0
476229|NCT00147537|1553941|P5|Phase 2|Withdrawal by Subject|0
476230|NCT00147537|1553942|P4|Phase 2|Withdrawal by Subject|0
476231|NCT00147537|1553943|P3|Phase 2|Withdrawal by Subject|0
476232|NCT00147537|1553944|P2|Phase 2|Withdrawal by Subject|0
476233|NCT00147537|1553945|P1|Phase 2|Withdrawal by Subject|0
476234|NCT00147537|1553935|P11|Phase 2|Other|12
476235|NCT00147537|1553936|P10|Phase 2|Other|47
476236|NCT00147537|1553937|P9|Phase 2|Other|0
476237|NCT00147537|1553938|P8|Phase 2|Other|0
476238|NCT00147537|1553939|P7|Phase 2|Other|0
476239|NCT00147537|1553940|P6|Phase 2|Other|0
476240|NCT00147537|1553941|P5|Phase 2|Other|0
476241|NCT00147537|1553942|P4|Phase 2|Other|0
476242|NCT00147537|1553943|P3|Phase 2|Other|0
476243|NCT00147537|1553944|P2|Phase 2|Other|0
476244|NCT00147537|1553945|P1|Phase 2|Other|0
476245|NCT00147537|1553935|P11|Phase 2|Lost to Follow-up|4
476246|NCT00147537|1553936|P10|Phase 2|Lost to Follow-up|12
476247|NCT00147537|1553937|P9|Phase 2|Lost to Follow-up|0
476248|NCT00147537|1553938|P8|Phase 2|Lost to Follow-up|0
476249|NCT00147537|1553939|P7|Phase 2|Lost to Follow-up|0
476250|NCT00147537|1553940|P6|Phase 2|Lost to Follow-up|0
476251|NCT00147537|1553941|P5|Phase 2|Lost to Follow-up|0
476252|NCT00147537|1553942|P4|Phase 2|Lost to Follow-up|0
476253|NCT00147537|1553943|P3|Phase 2|Lost to Follow-up|0
476254|NCT00147537|1553944|P2|Phase 2|Lost to Follow-up|0
476255|NCT00147537|1553945|P1|Phase 2|Lost to Follow-up|0
476256|NCT00147537|1553935|P11|Phase 2|Death|31
476257|NCT00147537|1553936|P10|Phase 2|Death|85
476258|NCT00147537|1553937|P9|Phase 2|Death|0
476259|NCT00147537|1553938|P8|Phase 2|Death|0
476260|NCT00147537|1553939|P7|Phase 2|Death|0
476261|NCT00147537|1553940|P6|Phase 2|Death|0
476262|NCT00147537|1553941|P5|Phase 2|Death|0
476263|NCT00147537|1553942|P4|Phase 2|Death|0
476264|NCT00147537|1553943|P3|Phase 2|Death|0
476265|NCT00147537|1553944|P2|Phase 2|Death|0
476266|NCT00147537|1553945|P1|Phase 2|Death|0
476267|NCT00147537|1553935|P11|Phase 1b|Randomized but not treated|0
476268|NCT00147537|1553936|P10|Phase 1b|Randomized but not treated|0
476269|NCT00147537|1553937|P9|Phase 1b|Randomized but not treated|1
476270|NCT00147537|1553938|P8|Phase 1b|Randomized but not treated|0
476271|NCT00147537|1553939|P7|Phase 1b|Randomized but not treated|1
476272|NCT00147537|1553940|P6|Phase 1b|Randomized but not treated|0
476273|NCT00147537|1553941|P5|Phase 1b|Randomized but not treated|0
476274|NCT00147537|1553942|P4|Phase 1b|Randomized but not treated|0
476275|NCT00147537|1553943|P3|Phase 1b|Randomized but not treated|0
476276|NCT00147537|1553944|P2|Phase 1b|Randomized but not treated|0
476277|NCT00147537|1553945|P1|Phase 1b|Randomized but not treated|0
476278|NCT00147537|1553935|P11|Phase 1b|Withdrawal by Subject|0
476279|NCT00147537|1553936|P10|Phase 1b|Withdrawal by Subject|0
476280|NCT00147537|1553937|P9|Phase 1b|Withdrawal by Subject|2
476281|NCT00147537|1553938|P8|Phase 1b|Withdrawal by Subject|0
476282|NCT00147537|1553939|P7|Phase 1b|Withdrawal by Subject|0
476283|NCT00147537|1553940|P6|Phase 1b|Withdrawal by Subject|0
476284|NCT00147537|1553941|P5|Phase 1b|Withdrawal by Subject|0
476285|NCT00147537|1553942|P4|Phase 1b|Withdrawal by Subject|0
476286|NCT00147537|1553943|P3|Phase 1b|Withdrawal by Subject|0
476287|NCT00147537|1553944|P2|Phase 1b|Withdrawal by Subject|0
476288|NCT00147537|1553945|P1|Phase 1b|Withdrawal by Subject|0
476289|NCT00147537|1553935|P11|Phase 1b|Other|0
476290|NCT00147537|1553936|P10|Phase 1b|Other|0
476291|NCT00147537|1553937|P9|Phase 1b|Other|4
476292|NCT00147537|1553938|P8|Phase 1b|Other|4
476293|NCT00147537|1553939|P7|Phase 1b|Other|14
476294|NCT00147537|1553940|P6|Phase 1b|Other|1
476295|NCT00147537|1553941|P5|Phase 1b|Other|1
476296|NCT00147537|1553942|P4|Phase 1b|Other|1
476297|NCT00147537|1553943|P3|Phase 1b|Other|2
476298|NCT00147537|1553944|P2|Phase 1b|Other|0
476299|NCT00147537|1553945|P1|Phase 1b|Other|0
476300|NCT00147537|1553935|P11|Phase 1b|Lost to Follow-up|0
476301|NCT00147537|1553936|P10|Phase 1b|Lost to Follow-up|0
476302|NCT00147537|1553937|P9|Phase 1b|Lost to Follow-up|1
476303|NCT00147537|1553938|P8|Phase 1b|Lost to Follow-up|0
476304|NCT00147537|1553939|P7|Phase 1b|Lost to Follow-up|2
476305|NCT00147537|1553940|P6|Phase 1b|Lost to Follow-up|0
476306|NCT00147537|1553941|P5|Phase 1b|Lost to Follow-up|0
476307|NCT00147537|1553942|P4|Phase 1b|Lost to Follow-up|0
476308|NCT00147537|1553943|P3|Phase 1b|Lost to Follow-up|0
476309|NCT00147537|1553944|P2|Phase 1b|Lost to Follow-up|1
476310|NCT00147537|1553945|P1|Phase 1b|Lost to Follow-up|2
476311|NCT00147537|1553935|P11|Phase 1b|Death|0
476312|NCT00147537|1553936|P10|Phase 1b|Death|0
476313|NCT00147537|1553937|P9|Phase 1b|Death|9
476314|NCT00147537|1553938|P8|Phase 1b|Death|3
476315|NCT00147537|1553939|P7|Phase 1b|Death|1
476316|NCT00147537|1553940|P6|Phase 1b|Death|2
476317|NCT00147537|1553941|P5|Phase 1b|Death|2
476318|NCT00147537|1553942|P4|Phase 1b|Death|1
476319|NCT00147537|1553943|P3|Phase 1b|Death|2
476320|NCT00147537|1553944|P2|Phase 1b|Death|1
476321|NCT00147537|1553945|P1|Phase 1b|Death|0
476322|NCT00147498|1554128|P4|Overall Study|Other|3
476323|NCT00147498|1554129|P3|Overall Study|Other|3
476324|NCT00147498|1554130|P2|Overall Study|Other|1
476325|NCT00147498|1554131|P1|Overall Study|Other|1
476326|NCT00147498|1554128|P4|Overall Study|Participant defaulted|3
476327|NCT00147498|1554129|P3|Overall Study|Participant defaulted|4
476328|NCT00147498|1554130|P2|Overall Study|Participant defaulted|1
476329|NCT00147498|1554131|P1|Overall Study|Participant defaulted|0
476330|NCT00147498|1554128|P4|Overall Study|Laboratory abnormality|0
476331|NCT00147498|1554129|P3|Overall Study|Laboratory abnormality|2
476332|NCT00147498|1554130|P2|Overall Study|Laboratory abnormality|0
476333|NCT00147498|1554131|P1|Overall Study|Laboratory abnormality|0
476334|NCT00147498|1554128|P4|Overall Study|Lack of Efficacy|8
476335|NCT00147498|1554129|P3|Overall Study|Lack of Efficacy|1
476336|NCT00147498|1554130|P2|Overall Study|Lack of Efficacy|1
476337|NCT00147498|1554131|P1|Overall Study|Lack of Efficacy|1
476338|NCT00147498|1554128|P4|Overall Study|Adverse Event|3
476339|NCT00147498|1554129|P3|Overall Study|Adverse Event|7
476340|NCT00147498|1554130|P2|Overall Study|Adverse Event|6
476341|NCT00147498|1554131|P1|Overall Study|Adverse Event|1
476342|NCT00147238|1554255|P1|Overall Study|Inevaluable|8
476343|NCT00147225|1554265|P6|Overall Study|Chemotherapy Changed|1
476344|NCT00147225|1554266|P5|Overall Study|Chemotherapy Changed|0
476345|NCT00147225|1554267|P4|Overall Study|Chemotherapy Changed|0
476346|NCT00147225|1554268|P3|Overall Study|Chemotherapy Changed|0
476347|NCT00147225|1554269|P2|Overall Study|Chemotherapy Changed|0
476348|NCT00147225|1554270|P1|Overall Study|Chemotherapy Changed|0
476349|NCT00147225|1554265|P6|Overall Study|Screen Failure|0
476350|NCT00147225|1554266|P5|Overall Study|Screen Failure|1
476351|NCT00147225|1554267|P4|Overall Study|Screen Failure|0
476352|NCT00147225|1554268|P3|Overall Study|Screen Failure|0
476353|NCT00147225|1554269|P2|Overall Study|Screen Failure|0
476354|NCT00147225|1554270|P1|Overall Study|Screen Failure|0
476355|NCT00147225|1554265|P6|Overall Study|Adverse Event|0
476356|NCT00147225|1554266|P5|Overall Study|Adverse Event|0
476357|NCT00147225|1554267|P4|Overall Study|Adverse Event|1
476358|NCT00147225|1554268|P3|Overall Study|Adverse Event|1
476359|NCT00147225|1554269|P2|Overall Study|Adverse Event|0
476360|NCT00147225|1554270|P1|Overall Study|Adverse Event|0
476361|NCT00147225|1554265|P6|Overall Study|Withdrawal by Subject|1
476362|NCT00147225|1554266|P5|Overall Study|Withdrawal by Subject|0
476363|NCT00147225|1554267|P4|Overall Study|Withdrawal by Subject|0
476364|NCT00147225|1554268|P3|Overall Study|Withdrawal by Subject|1
476365|NCT00147225|1554269|P2|Overall Study|Withdrawal by Subject|0
476366|NCT00147225|1554270|P1|Overall Study|Withdrawal by Subject|1
476367|NCT00146848|1554373|P3|Post-randomization|Withdrawn|27
476368|NCT00146848|1554374|P2|Post-randomization|Withdrawn|32
476369|NCT00146848|1554375|P1|Post-randomization|Withdrawn|26
476370|NCT00146848|1554373|P3|Post-randomization|Lost to Follow-up|12
476371|NCT00146848|1554374|P2|Post-randomization|Lost to Follow-up|15
476372|NCT00146848|1554375|P1|Post-randomization|Lost to Follow-up|12
476373|NCT00146848|1554373|P3|Pre-randomization|Withdrawal by Subject|0
476374|NCT00146848|1554374|P2|Pre-randomization|Withdrawal by Subject|0
476375|NCT00146848|1554375|P1|Pre-randomization|Withdrawal by Subject|40
476376|NCT00146848|1554373|P3|Pre-randomization|Protocol Violation|0
476377|NCT00146848|1554374|P2|Pre-randomization|Protocol Violation|0
476378|NCT00146848|1554375|P1|Pre-randomization|Protocol Violation|172
476379|NCT00146848|1554373|P3|Pre-randomization|Physician Decision|0
476380|NCT00146848|1554374|P2|Pre-randomization|Physician Decision|0
476381|NCT00146848|1554375|P1|Pre-randomization|Physician Decision|8
476382|NCT00146848|1554373|P3|Pre-randomization|Lost to Follow-up|0
476383|NCT00146848|1554374|P2|Pre-randomization|Lost to Follow-up|0
476384|NCT00146848|1554375|P1|Pre-randomization|Lost to Follow-up|70
476385|NCT00146848|1554373|P3|Pre-randomization|Death|0
476386|NCT00146848|1554374|P2|Pre-randomization|Death|0
476387|NCT00146848|1554375|P1|Pre-randomization|Death|19
476388|NCT00146770|1554391|P2|Overall Study|Withdrawal by Subject|0
476389|NCT00146770|1554392|P1|Overall Study|Withdrawal by Subject|2
476390|NCT00146770|1554391|P2|Overall Study|Pregnancy|0
476391|NCT00146770|1554392|P1|Overall Study|Pregnancy|1
476392|NCT00146770|1554391|P2|Overall Study|Adverse Event|0
476393|NCT00146770|1554392|P1|Overall Study|Adverse Event|2
476394|NCT00146757|1554410|P2|Overall Study|Adverse Event|0
476395|NCT00146757|1554411|P1|Overall Study|Adverse Event|1
476396|NCT00146757|1554410|P2|Overall Study|Death|0
476397|NCT00146757|1554411|P1|Overall Study|Death|1
476398|NCT00146640|1554430|P2|Overall Study|Non-Medical Reasons|4
476399|NCT00146640|1554431|P1|Overall Study|Non-Medical Reasons|8
476400|NCT00146640|1554430|P2|Overall Study|Medical Reasons|0
476401|NCT00146640|1554431|P1|Overall Study|Medical Reasons|3
476402|NCT00146640|1554430|P2|Overall Study|Adverse Event|10
476403|NCT00146640|1554431|P1|Overall Study|Adverse Event|12
476404|NCT00146328|1554454|P3|Overall Study|Interaction with other medication|1
476405|NCT00146328|1554455|P2|Overall Study|Interaction with other medication|0
476406|NCT00146328|1554456|P1|Overall Study|Interaction with other medication|2
476407|NCT00146328|1554454|P3|Overall Study|Moved|0
476408|NCT00146328|1554455|P2|Overall Study|Moved|0
476409|NCT00146328|1554456|P1|Overall Study|Moved|2
476410|NCT00146328|1554454|P3|Overall Study|Death|1
476411|NCT00146328|1554455|P2|Overall Study|Death|1
476412|NCT00146328|1554456|P1|Overall Study|Death|0
476413|NCT00146328|1554454|P3|Overall Study|Enroll into other trial|2
476414|NCT00146328|1554455|P2|Overall Study|Enroll into other trial|4
476415|NCT00146328|1554456|P1|Overall Study|Enroll into other trial|2
476416|NCT00146328|1554454|P3|Overall Study|Patient decision to end|6
476417|NCT00146328|1554455|P2|Overall Study|Patient decision to end|1
476418|NCT00146328|1554456|P1|Overall Study|Patient decision to end|0
476419|NCT00146328|1554454|P3|Overall Study|Trial ended/site closed|19
476420|NCT00146328|1554455|P2|Overall Study|Trial ended/site closed|2
476421|NCT00146328|1554456|P1|Overall Study|Trial ended/site closed|8
476422|NCT00146328|1554454|P3|Overall Study|Virologic Failure/lack of efficacy|142
476423|NCT00146328|1554455|P2|Overall Study|Virologic Failure/lack of efficacy|72
476424|NCT00146328|1554456|P1|Overall Study|Virologic Failure/lack of efficacy|54
476425|NCT00146328|1554454|P3|Overall Study|Withdrawal by Subject|22
476426|NCT00146328|1554455|P2|Overall Study|Withdrawal by Subject|16
476427|NCT00146328|1554456|P1|Overall Study|Withdrawal by Subject|16
476428|NCT00146328|1554454|P3|Overall Study|Lost to Follow-up|7
476429|NCT00146328|1554455|P2|Overall Study|Lost to Follow-up|4
476430|NCT00146328|1554456|P1|Overall Study|Lost to Follow-up|7
476431|NCT00146328|1554454|P3|Overall Study|Protocol Violation|12
476432|NCT00146328|1554455|P2|Overall Study|Protocol Violation|6
476433|NCT00146328|1554456|P1|Overall Study|Protocol Violation|11
476434|NCT00146328|1554454|P3|Overall Study|Adverse Event|79
476435|NCT00146328|1554455|P2|Overall Study|Adverse Event|48
476436|NCT00146328|1554456|P1|Overall Study|Adverse Event|39
476437|NCT00146172|1554547|P8|Overall Study|Symptomatic Deterioration|2
476438|NCT00146172|1554548|P7|Overall Study|Symptomatic Deterioration|0
476439|NCT00146172|1554549|P6|Overall Study|Symptomatic Deterioration|2
476440|NCT00146172|1554550|P5|Overall Study|Symptomatic Deterioration|1
476441|NCT00146172|1554551|P4|Overall Study|Symptomatic Deterioration|0
476442|NCT00146172|1554552|P3|Overall Study|Symptomatic Deterioration|1
476443|NCT00146172|1554553|P2|Overall Study|Symptomatic Deterioration|0
476444|NCT00146172|1554554|P1|Overall Study|Symptomatic Deterioration|1
476445|NCT00146172|1554547|P8|Overall Study|Withdrawal by Subject|4
476446|NCT00146172|1554548|P7|Overall Study|Withdrawal by Subject|1
476447|NCT00146172|1554549|P6|Overall Study|Withdrawal by Subject|1
476448|NCT00146172|1554550|P5|Overall Study|Withdrawal by Subject|0
476449|NCT00146172|1554551|P4|Overall Study|Withdrawal by Subject|0
476450|NCT00146172|1554552|P3|Overall Study|Withdrawal by Subject|0
476451|NCT00146172|1554553|P2|Overall Study|Withdrawal by Subject|0
476452|NCT00146172|1554554|P1|Overall Study|Withdrawal by Subject|0
476453|NCT00146172|1554547|P8|Overall Study|Physician Decision|1
476454|NCT00146172|1554548|P7|Overall Study|Physician Decision|0
476455|NCT00146172|1554549|P6|Overall Study|Physician Decision|0
476456|NCT00146172|1554550|P5|Overall Study|Physician Decision|0
476457|NCT00146172|1554551|P4|Overall Study|Physician Decision|0
476458|NCT00146172|1554552|P3|Overall Study|Physician Decision|0
476459|NCT00146172|1554553|P2|Overall Study|Physician Decision|0
476460|NCT00146172|1554554|P1|Overall Study|Physician Decision|0
476461|NCT00146172|1554547|P8|Overall Study|Death|0
476462|NCT00146172|1554548|P7|Overall Study|Death|1
476463|NCT00146172|1554549|P6|Overall Study|Death|0
476464|NCT00146172|1554550|P5|Overall Study|Death|0
476465|NCT00146172|1554551|P4|Overall Study|Death|0
476466|NCT00146172|1554552|P3|Overall Study|Death|0
476467|NCT00146172|1554553|P2|Overall Study|Death|0
476468|NCT00146172|1554554|P1|Overall Study|Death|0
476469|NCT00146172|1554547|P8|Overall Study|Disease Progression|22
476470|NCT00146172|1554548|P7|Overall Study|Disease Progression|1
476471|NCT00146172|1554549|P6|Overall Study|Disease Progression|2
476472|NCT00146172|1554550|P5|Overall Study|Disease Progression|2
476473|NCT00146172|1554551|P4|Overall Study|Disease Progression|5
476474|NCT00146172|1554552|P3|Overall Study|Disease Progression|2
476475|NCT00146172|1554553|P2|Overall Study|Disease Progression|4
476476|NCT00146172|1554554|P1|Overall Study|Disease Progression|2
476477|NCT00146172|1554547|P8|Overall Study|Lost to Follow-up|1
476478|NCT00146172|1554548|P7|Overall Study|Lost to Follow-up|0
476479|NCT00146172|1554549|P6|Overall Study|Lost to Follow-up|0
476480|NCT00146172|1554550|P5|Overall Study|Lost to Follow-up|0
476481|NCT00146172|1554551|P4|Overall Study|Lost to Follow-up|0
476482|NCT00146172|1554552|P3|Overall Study|Lost to Follow-up|0
476483|NCT00146172|1554553|P2|Overall Study|Lost to Follow-up|0
476484|NCT00146172|1554554|P1|Overall Study|Lost to Follow-up|0
476485|NCT00146172|1554547|P8|Overall Study|Adverse Event|10
476486|NCT00146172|1554548|P7|Overall Study|Adverse Event|3
476487|NCT00146172|1554549|P6|Overall Study|Adverse Event|2
476488|NCT00146172|1554550|P5|Overall Study|Adverse Event|0
476489|NCT00146172|1554551|P4|Overall Study|Adverse Event|1
476490|NCT00146172|1554552|P3|Overall Study|Adverse Event|1
476491|NCT00146172|1554553|P2|Overall Study|Adverse Event|0
476492|NCT00146172|1554554|P1|Overall Study|Adverse Event|0
476493|NCT00145795|1554588|P2|Overall Study|Adverse Event|0
476494|NCT00145795|1554589|P1|Overall Study|Adverse Event|1
476495|NCT00145626|1554624|P1|Overall Study|Withdrawal by Subject|1
476496|NCT00145626|1554624|P1|Overall Study|Death|1
476497|NCT00145626|1554624|P1|Overall Study|Turned 2 years old before treatment|1
476498|NCT00145626|1554624|P1|Overall Study|Did not have NK infusions|2
476499|NCT00145600|1554670|P4|Overall Study|Withdrawal by Subject|1
476500|NCT00145600|1554671|P3|Overall Study|Withdrawal by Subject|0
476501|NCT00145600|1554672|P2|Overall Study|Withdrawal by Subject|2
476502|NCT00145600|1554673|P1|Overall Study|Withdrawal by Subject|1
476503|NCT00145600|1554670|P4|Overall Study|Noncompliance|0
476504|NCT00145600|1554671|P3|Overall Study|Noncompliance|0
476505|NCT00145600|1554672|P2|Overall Study|Noncompliance|0
476506|NCT00145600|1554673|P1|Overall Study|Noncompliance|1
476507|NCT00145600|1554670|P4|Overall Study|Lost to Follow-up|4
476508|NCT00145600|1554671|P3|Overall Study|Lost to Follow-up|2
476509|NCT00145600|1554672|P2|Overall Study|Lost to Follow-up|6
476510|NCT00145600|1554673|P1|Overall Study|Lost to Follow-up|2
476511|NCT00145600|1554670|P4|Overall Study|Ineligible|5
476512|NCT00145600|1554671|P3|Overall Study|Ineligible|1
476513|NCT00145600|1554672|P2|Overall Study|Ineligible|0
476514|NCT00145600|1554673|P1|Overall Study|Ineligible|3
476515|NCT00145600|1554670|P4|Overall Study|Death|6
476516|NCT00145600|1554671|P3|Overall Study|Death|2
476517|NCT00145600|1554672|P2|Overall Study|Death|2
476518|NCT00145600|1554673|P1|Overall Study|Death|1
476519|NCT00145574|1554797|P3|Open Label Long-term Extension|required restricted medicine|1
476520|NCT00145574|1554798|P2|Open Label Long-term Extension|required restricted medicine|0
476521|NCT00145574|1554799|P1|Open Label Long-term Extension|required restricted medicine|0
476522|NCT00145574|1554797|P3|Open Label Long-term Extension|Withdrawal by Subject|4
476523|NCT00145574|1554798|P2|Open Label Long-term Extension|Withdrawal by Subject|0
476524|NCT00145574|1554799|P1|Open Label Long-term Extension|Withdrawal by Subject|0
476525|NCT00145574|1554797|P3|Open Label Long-term Extension|Lost to Follow-up|1
476526|NCT00145574|1554798|P2|Open Label Long-term Extension|Lost to Follow-up|0
476527|NCT00145574|1554799|P1|Open Label Long-term Extension|Lost to Follow-up|0
476528|NCT00145574|1554797|P3|Open Label Long-term Extension|Adverse Event|5
476529|NCT00145574|1554798|P2|Open Label Long-term Extension|Adverse Event|0
476530|NCT00145574|1554799|P1|Open Label Long-term Extension|Adverse Event|0
476531|NCT00145574|1554797|P3|Double Blind|required restricted medicine|0
476532|NCT00145574|1554798|P2|Double Blind|required restricted medicine|1
476533|NCT00145574|1554799|P1|Double Blind|required restricted medicine|0
476534|NCT00145574|1554797|P3|Double Blind|Withdrawal by Subject|1
476535|NCT00145574|1554798|P2|Double Blind|Withdrawal by Subject|1
476536|NCT00145574|1554799|P1|Double Blind|Withdrawal by Subject|1
476537|NCT00145574|1554797|P3|Double Blind|Adverse Event|1
476538|NCT00145574|1554798|P2|Double Blind|Adverse Event|3
476539|NCT00145574|1554799|P1|Double Blind|Adverse Event|0
476540|NCT00145509|1554856|P2|Overall Study|Reason not provided|1
476541|NCT00145509|1554857|P1|Overall Study|Reason not provided|2
476542|NCT00145509|1554856|P2|Overall Study|Withdrew Consent|7
476543|NCT00145509|1554857|P1|Overall Study|Withdrew Consent|2
476544|NCT00145509|1554856|P2|Overall Study|Lost to Follow-up|9
476545|NCT00145509|1554857|P1|Overall Study|Lost to Follow-up|5
476546|NCT00145509|1554856|P2|Overall Study|Lack of Efficacy|1
476547|NCT00145509|1554857|P1|Overall Study|Lack of Efficacy|3
476548|NCT00145509|1554856|P2|Overall Study|Adverse Event|3
476549|NCT00145509|1554857|P1|Overall Study|Adverse Event|10
476550|NCT00145496|1554871|P2|Overall Study|Other|13
476551|NCT00145496|1554872|P1|Overall Study|Other|25
476552|NCT00145496|1554871|P2|Overall Study|Lost to Follow-up|5
476553|NCT00145496|1554872|P1|Overall Study|Lost to Follow-up|12
476554|NCT00145496|1554871|P2|Overall Study|Withdrawal by Subject|26
476555|NCT00145496|1554872|P1|Overall Study|Withdrawal by Subject|32
476556|NCT00145496|1554871|P2|Overall Study|Lack of Efficacy|7
476557|NCT00145496|1554872|P1|Overall Study|Lack of Efficacy|12
476558|NCT00145496|1554871|P2|Overall Study|Adverse Event|30
476559|NCT00145496|1554872|P1|Overall Study|Adverse Event|42
476560|NCT00145327|1554892|P3|Overall Study|Missing – not stated|1
476561|NCT00145327|1554893|P2|Overall Study|Missing – not stated|0
476562|NCT00145327|1554894|P1|Overall Study|Missing – not stated|1
476563|NCT00145327|1554892|P3|Overall Study|Abnormal laboratory value(s)|2
476564|NCT00145327|1554893|P2|Overall Study|Abnormal laboratory value(s)|0
476565|NCT00145327|1554894|P1|Overall Study|Abnormal laboratory value(s)|1
476566|NCT00145327|1554892|P3|Overall Study|Protocol Violation|2
476567|NCT00145327|1554893|P2|Overall Study|Protocol Violation|0
476568|NCT00145327|1554894|P1|Overall Study|Protocol Violation|2
476569|NCT00145327|1554892|P3|Overall Study|Administrative problems|13
476570|NCT00145327|1554893|P2|Overall Study|Administrative problems|9
476571|NCT00145327|1554894|P1|Overall Study|Administrative problems|12
476572|NCT00145327|1554892|P3|Overall Study|Lost to Follow-up|14
476573|NCT00145327|1554893|P2|Overall Study|Lost to Follow-up|14
476574|NCT00145327|1554894|P1|Overall Study|Lost to Follow-up|9
476575|NCT00145327|1554892|P3|Overall Study|Adverse Event|22
476576|NCT00145327|1554893|P2|Overall Study|Adverse Event|11
476577|NCT00145327|1554894|P1|Overall Study|Adverse Event|14
476578|NCT00145327|1554892|P3|Overall Study|Death|30
476579|NCT00145327|1554893|P2|Overall Study|Death|18
476580|NCT00145327|1554894|P1|Overall Study|Death|26
476581|NCT00145327|1554892|P3|Overall Study|Withdrawal by Subject|164
476582|NCT00145327|1554893|P2|Overall Study|Withdrawal by Subject|72
476583|NCT00145327|1554894|P1|Overall Study|Withdrawal by Subject|77
476584|NCT00145119|1554993|P1|Overall Study|Death|45
476585|NCT00144781|1555011|P4|Overall Study|Non-compliant|0
476586|NCT00144781|1555012|P3|Overall Study|Non-compliant|0
476587|NCT00144781|1555013|P2|Overall Study|Non-compliant|1
476588|NCT00144781|1555014|P1|Overall Study|Non-compliant|0
476589|NCT00144781|1555011|P4|Overall Study|Adverse Event|0
476590|NCT00144781|1555012|P3|Overall Study|Adverse Event|0
476591|NCT00144781|1555013|P2|Overall Study|Adverse Event|1
476592|NCT00144781|1555014|P1|Overall Study|Adverse Event|0
476593|NCT00144339|1555043|P2|Overall Study|Other|60
476594|NCT00144339|1555044|P1|Overall Study|Other|58
476595|NCT00144339|1555043|P2|Overall Study|Lost to Follow-up|64
476596|NCT00144339|1555044|P1|Overall Study|Lost to Follow-up|76
476597|NCT00144339|1555043|P2|Overall Study|Withdrawal by Subject|300
476598|NCT00144339|1555044|P1|Overall Study|Withdrawal by Subject|403
476599|NCT00144339|1555043|P2|Overall Study|Protocol Violation|48
476600|NCT00144339|1555044|P1|Overall Study|Protocol Violation|75
476601|NCT00144339|1555043|P2|Overall Study|Adverse Event|627
476602|NCT00144339|1555044|P1|Overall Study|Adverse Event|746
476603|NCT00144300|1555252|P2|Overall Study|Other reason (not specified)|3
476604|NCT00144300|1555253|P1|Overall Study|Other reason (not specified)|1
476605|NCT00144300|1555252|P2|Overall Study|Withdrawal by Subject|6
476606|NCT00144300|1555253|P1|Overall Study|Withdrawal by Subject|6
476607|NCT00144300|1555252|P2|Overall Study|Lost to Follow-up|0
476608|NCT00144300|1555253|P1|Overall Study|Lost to Follow-up|3
476609|NCT00144300|1555252|P2|Overall Study|Protocol Violation|3
476610|NCT00144300|1555253|P1|Overall Study|Protocol Violation|1
476611|NCT00144300|1555252|P2|Overall Study|Adverse Event|16
476612|NCT00144300|1555253|P1|Overall Study|Adverse Event|18
476613|NCT00144170|1555301|P2|Overall Study|Other reason not defined above|316
476614|NCT00144170|1555302|P1|Overall Study|Other reason not defined above|211
476615|NCT00144170|1555301|P2|Overall Study|Withdrawal by Subject|13
476616|NCT00144170|1555302|P1|Overall Study|Withdrawal by Subject|29
476617|NCT00144170|1555301|P2|Overall Study|Lost to Follow-up|10
476618|NCT00144170|1555302|P1|Overall Study|Lost to Follow-up|5
476619|NCT00144170|1555301|P2|Overall Study|Protocol Violation|16
476620|NCT00144170|1555302|P1|Overall Study|Protocol Violation|23
476621|NCT00144170|1555301|P2|Overall Study|Adverse Event|41
476622|NCT00144170|1555302|P1|Overall Study|Adverse Event|84
476623|NCT00144027|1555492|P2|Overall Study|did not complete baseline assessment|6
476624|NCT00144027|1555493|P1|Overall Study|did not complete baseline assessment|0
476625|NCT00144027|1555492|P2|Overall Study|Withdrawal by Subject|2
476626|NCT00144027|1555493|P1|Overall Study|Withdrawal by Subject|2
476627|NCT00144027|1555492|P2|Overall Study|Lost to Follow-up|3
476628|NCT00144027|1555493|P1|Overall Study|Lost to Follow-up|1
476629|NCT00143598|1555523|P2|Overall Study|Death|36
476630|NCT00143598|1555524|P1|Overall Study|Death|36
476631|NCT00143598|1555523|P2|Overall Study|Withdrawal by Subject|37
476632|NCT00143598|1555524|P1|Overall Study|Withdrawal by Subject|33
476633|NCT00143598|1555523|P2|Overall Study|Lost to Follow-up|21
476634|NCT00143598|1555524|P1|Overall Study|Lost to Follow-up|23
476635|NCT00143507|1555538|P2|Overall Study|Withdrawn by sponsor's decision|3
476636|NCT00143507|1555539|P1|Overall Study|Withdrawn by sponsor's decision|0
476637|NCT00143507|1555538|P2|Overall Study|Lost to Follow-up|0
476638|NCT00143507|1555539|P1|Overall Study|Lost to Follow-up|1
476639|NCT00143507|1555538|P2|Overall Study|Withdrawal by Subject|102
476640|NCT00143507|1555539|P1|Overall Study|Withdrawal by Subject|114
476641|NCT00143507|1555538|P2|Overall Study|Death|547
476642|NCT00143507|1555539|P1|Overall Study|Death|572
476643|NCT00143455|1555573|P4|Cohort 2|Randomized But Not Treated|1
476644|NCT00143455|1555574|P3|Cohort 2|Randomized But Not Treated|1
476645|NCT00143455|1555575|P2|Cohort 2|Randomized But Not Treated|0
476646|NCT00143455|1555576|P1|Cohort 2|Randomized But Not Treated|0
476647|NCT00143455|1555573|P4|Cohort 2|Other|6
476648|NCT00143455|1555574|P3|Cohort 2|Other|7
476649|NCT00143455|1555575|P2|Cohort 2|Other|0
476650|NCT00143455|1555576|P1|Cohort 2|Other|0
476651|NCT00143455|1555573|P4|Cohort 2|Withdrawal by Subject|12
476652|NCT00143455|1555574|P3|Cohort 2|Withdrawal by Subject|13
476653|NCT00143455|1555575|P2|Cohort 2|Withdrawal by Subject|0
476654|NCT00143455|1555576|P1|Cohort 2|Withdrawal by Subject|0
476655|NCT00143455|1555573|P4|Cohort 2|Progressive Disease|27
476656|NCT00143455|1555574|P3|Cohort 2|Progressive Disease|20
476657|NCT00143455|1555575|P2|Cohort 2|Progressive Disease|0
476658|NCT00143455|1555576|P1|Cohort 2|Progressive Disease|0
476659|NCT00143455|1555573|P4|Cohort 2|Death|12
476660|NCT00143455|1555574|P3|Cohort 2|Death|20
476661|NCT00143455|1555575|P2|Cohort 2|Death|0
476662|NCT00143455|1555576|P1|Cohort 2|Death|0
476663|NCT00143455|1555573|P4|Cohort 2|Lost to Follow-up|4
476664|NCT00143455|1555574|P3|Cohort 2|Lost to Follow-up|1
476665|NCT00143455|1555575|P2|Cohort 2|Lost to Follow-up|0
476666|NCT00143455|1555576|P1|Cohort 2|Lost to Follow-up|0
476667|NCT00143455|1555573|P4|Cohort 2|Protocol Violation|1
476668|NCT00143455|1555574|P3|Cohort 2|Protocol Violation|1
476669|NCT00143455|1555575|P2|Cohort 2|Protocol Violation|0
476670|NCT00143455|1555576|P1|Cohort 2|Protocol Violation|0
476671|NCT00143455|1555573|P4|Cohort 2|No Longer Required Study Treatment|0
476672|NCT00143455|1555574|P3|Cohort 2|No Longer Required Study Treatment|1
476673|NCT00143455|1555575|P2|Cohort 2|No Longer Required Study Treatment|0
476674|NCT00143455|1555576|P1|Cohort 2|No Longer Required Study Treatment|0
476675|NCT00143455|1555573|P4|Cohort 2|Adverse Event|30
476676|NCT00143455|1555574|P3|Cohort 2|Adverse Event|42
476677|NCT00143455|1555575|P2|Cohort 2|Adverse Event|0
476678|NCT00143455|1555576|P1|Cohort 2|Adverse Event|0
476679|NCT00143455|1555573|P4|Cohort 1|Randomized But Not Treated|0
476680|NCT00143455|1555574|P3|Cohort 1|Randomized But Not Treated|0
476681|NCT00143455|1555575|P2|Cohort 1|Randomized But Not Treated|1
476682|NCT00143455|1555576|P1|Cohort 1|Randomized But Not Treated|0
476683|NCT00143455|1555573|P4|Cohort 1|Withdrawal by Subject|0
476684|NCT00143455|1555574|P3|Cohort 1|Withdrawal by Subject|0
476685|NCT00143455|1555575|P2|Cohort 1|Withdrawal by Subject|4
476686|NCT00143455|1555576|P1|Cohort 1|Withdrawal by Subject|1
476687|NCT00143455|1555573|P4|Cohort 1|Progressive Disease|0
476688|NCT00143455|1555574|P3|Cohort 1|Progressive Disease|0
476689|NCT00143455|1555575|P2|Cohort 1|Progressive Disease|6
476690|NCT00143455|1555576|P1|Cohort 1|Progressive Disease|0
476691|NCT00143455|1555573|P4|Cohort 1|Death|0
476692|NCT00143455|1555574|P3|Cohort 1|Death|0
476693|NCT00143455|1555575|P2|Cohort 1|Death|2
476694|NCT00143455|1555576|P1|Cohort 1|Death|5
476695|NCT00143455|1555573|P4|Cohort 1|Adverse Event|0
476696|NCT00143455|1555574|P3|Cohort 1|Adverse Event|0
476697|NCT00143455|1555575|P2|Cohort 1|Adverse Event|4
476698|NCT00143455|1555576|P1|Cohort 1|Adverse Event|8
476699|NCT00143403|1555610|P2|Overall Study|Randomized Not Treated|8
476700|NCT00143403|1555611|P1|Overall Study|Randomized Not Treated|7
476701|NCT00143403|1555610|P2|Overall Study|specified by site|9
476702|NCT00143403|1555611|P1|Overall Study|specified by site|4
476703|NCT00143403|1555610|P2|Overall Study|Protocol Violation|2
476704|NCT00143403|1555611|P1|Overall Study|Protocol Violation|2
476705|NCT00143403|1555610|P2|Overall Study|Relapse|7
476706|NCT00143403|1555611|P1|Overall Study|Relapse|15
476707|NCT00143403|1555610|P2|Overall Study|Withdrawal by Subject|12
476708|NCT00143403|1555611|P1|Overall Study|Withdrawal by Subject|3
476709|NCT00143403|1555610|P2|Overall Study|Death|0
476710|NCT00143403|1555611|P1|Overall Study|Death|1
476711|NCT00143403|1555610|P2|Overall Study|Adverse Event|8
476712|NCT00143403|1555611|P1|Overall Study|Adverse Event|3
476713|NCT00143390|1555621|P2|Overall Study|Other|2
476714|NCT00143390|1555622|P1|Overall Study|Other|1
476715|NCT00143390|1555621|P2|Overall Study|Adverse Event|8
476716|NCT00143390|1555622|P1|Overall Study|Adverse Event|9
476717|NCT00143390|1555621|P2|Overall Study|Study termination|15
476718|NCT00143390|1555622|P1|Overall Study|Study termination|10
476719|NCT00143390|1555621|P2|Overall Study|Protocol Violation|0
476720|NCT00143390|1555622|P1|Overall Study|Protocol Violation|2
476721|NCT00143390|1555621|P2|Overall Study|Progressive disease|115
476722|NCT00143390|1555622|P1|Overall Study|Progressive disease|119
476723|NCT00143390|1555621|P2|Overall Study|Withdrawal by Subject|4
476724|NCT00143390|1555622|P1|Overall Study|Withdrawal by Subject|4
476725|NCT00143390|1555621|P2|Overall Study|Not meeting entry criteria|5
476726|NCT00143390|1555622|P1|Overall Study|Not meeting entry criteria|2
476727|NCT00143390|1555621|P2|Overall Study|Death|0
476728|NCT00143390|1555622|P1|Overall Study|Death|2
476729|NCT00143312|1555638|P1|Overall Study|Withdrawal by Subject|1
476730|NCT00143312|1555638|P1|Overall Study|Other|1
476731|NCT00143312|1555638|P1|Overall Study|Lost to Follow-up|1
476732|NCT00143312|1555638|P1|Overall Study|Adverse Event|2
476733|NCT00143312|1555638|P1|Overall Study|Death|11
476734|NCT00143247|1555648|P1|Overall Study|Other|12
476735|NCT00143247|1555648|P1|Overall Study|following inaccurate lab adverse event|1
476736|NCT00143247|1555648|P1|Overall Study|Lost to Follow-up|12
476737|NCT00143247|1555648|P1|Overall Study|Protocol Violation|15
476738|NCT00143247|1555648|P1|Overall Study|Study terminated by sponsor|31
476739|NCT00143247|1555648|P1|Overall Study|Withdrawal by Subject|55
476740|NCT00143247|1555648|P1|Overall Study|Lack of Efficacy|3
476741|NCT00143247|1555648|P1|Overall Study|Adverse Event|19
476742|NCT00143247|1555648|P1|Overall Study|Death|8
476743|NCT00142935|1555665|P3|Overall Study|Death|1
476744|NCT00142935|1555666|P2|Overall Study|Death|2
476745|NCT00142935|1555667|P1|Overall Study|Death|0
476746|NCT00142935|1555665|P3|Overall Study|Lost to Follow-up|5
476747|NCT00142935|1555666|P2|Overall Study|Lost to Follow-up|5
476748|NCT00142935|1555667|P1|Overall Study|Lost to Follow-up|2
476749|NCT00142935|1555665|P3|Overall Study|Other reason|1
476750|NCT00142935|1555666|P2|Overall Study|Other reason|1
476751|NCT00142935|1555667|P1|Overall Study|Other reason|1
476752|NCT00142909|1555692|P2|Medications Begin|Withdrawal by Subject|0
476753|NCT00142909|1555693|P1|Medications Begin|Withdrawal by Subject|2
476754|NCT00142909|1555692|P2|Medications Begin|Withdrawal by Subject|3
476755|NCT00142909|1555693|P1|Medications Begin|Withdrawal by Subject|5
476756|NCT00142909|1555692|P2|Medications Begin|Protocol Violation|0
476757|NCT00142909|1555693|P1|Medications Begin|Protocol Violation|2
476758|NCT00142909|1555692|P2|Randomization|Various Reasons|10
476759|NCT00142909|1555693|P1|Randomization|Various Reasons|7
476760|NCT00142792|1555729|P3|Overall Study|No category|1
476761|NCT00142792|1555730|P2|Overall Study|No category|2
476762|NCT00142792|1555731|P1|Overall Study|No category|1
476763|NCT00142792|1555729|P3|Overall Study|Lost to Follow-up|7
476764|NCT00142792|1555730|P2|Overall Study|Lost to Follow-up|11
476765|NCT00142792|1555731|P1|Overall Study|Lost to Follow-up|8
476766|NCT00142792|1555729|P3|Overall Study|Withdrawal by Subject|3
476767|NCT00142792|1555730|P2|Overall Study|Withdrawal by Subject|2
476768|NCT00142792|1555731|P1|Overall Study|Withdrawal by Subject|3
476769|NCT00142792|1555729|P3|Overall Study|Death|1
476770|NCT00142792|1555730|P2|Overall Study|Death|0
476771|NCT00142792|1555731|P1|Overall Study|Death|0
476772|NCT00142415|1555766|P6|Overall Study|Physician Decision|2
476773|NCT00142415|1555767|P5|Overall Study|Physician Decision|1
476774|NCT00142415|1555768|P4|Overall Study|Physician Decision|0
476775|NCT00142415|1555769|P3|Overall Study|Physician Decision|0
476776|NCT00142415|1555770|P2|Overall Study|Physician Decision|0
476777|NCT00142415|1555771|P1|Overall Study|Physician Decision|0
476778|NCT00142298|1555809|P10|Overall Study|Treatment Failure|0
476779|NCT00142298|1555810|P9|Overall Study|Treatment Failure|0
476780|NCT00142298|1555811|P8|Overall Study|Treatment Failure|0
476781|NCT00142298|1555812|P7|Overall Study|Treatment Failure|2
476782|NCT00142298|1555813|P6|Overall Study|Treatment Failure|2
476783|NCT00142298|1555814|P5|Overall Study|Treatment Failure|0
476784|NCT00142298|1555815|P4|Overall Study|Treatment Failure|0
476785|NCT00142298|1555816|P3|Overall Study|Treatment Failure|0
476786|NCT00142298|1555817|P2|Overall Study|Treatment Failure|0
476787|NCT00142298|1555818|P1|Overall Study|Treatment Failure|0
476788|NCT00142298|1555809|P10|Overall Study|Lost to Follow-up|0
476789|NCT00142298|1555810|P9|Overall Study|Lost to Follow-up|0
476790|NCT00142298|1555811|P8|Overall Study|Lost to Follow-up|0
476791|NCT00142298|1555812|P7|Overall Study|Lost to Follow-up|2
476792|NCT00142298|1555813|P6|Overall Study|Lost to Follow-up|0
476793|NCT00142298|1555814|P5|Overall Study|Lost to Follow-up|0
476794|NCT00142298|1555815|P4|Overall Study|Lost to Follow-up|0
476795|NCT00142298|1555816|P3|Overall Study|Lost to Follow-up|0
476796|NCT00142298|1555817|P2|Overall Study|Lost to Follow-up|0
476797|NCT00142298|1555818|P1|Overall Study|Lost to Follow-up|0
476798|NCT00142298|1555809|P10|Overall Study|Other- not specified|0
476799|NCT00142298|1555810|P9|Overall Study|Other- not specified|0
476800|NCT00142298|1555811|P8|Overall Study|Other- not specified|0
476801|NCT00142298|1555812|P7|Overall Study|Other- not specified|0
476802|NCT00142298|1555813|P6|Overall Study|Other- not specified|0
476803|NCT00142298|1555814|P5|Overall Study|Other- not specified|0
476804|NCT00142298|1555815|P4|Overall Study|Other- not specified|1
476805|NCT00142298|1555816|P3|Overall Study|Other- not specified|0
476806|NCT00142298|1555817|P2|Overall Study|Other- not specified|3
476807|NCT00142298|1555818|P1|Overall Study|Other- not specified|0
476808|NCT00142298|1555809|P10|Overall Study|Virologic breakthrough|0
476809|NCT00142298|1555810|P9|Overall Study|Virologic breakthrough|0
476810|NCT00142298|1555811|P8|Overall Study|Virologic breakthrough|0
476811|NCT00142298|1555812|P7|Overall Study|Virologic breakthrough|3
476812|NCT00142298|1555813|P6|Overall Study|Virologic breakthrough|3
476813|NCT00142298|1555814|P5|Overall Study|Virologic breakthrough|2
476814|NCT00142298|1555815|P4|Overall Study|Virologic breakthrough|7
476815|NCT00142298|1555816|P3|Overall Study|Virologic breakthrough|9
476816|NCT00142298|1555817|P2|Overall Study|Virologic breakthrough|23
476817|NCT00142298|1555818|P1|Overall Study|Virologic breakthrough|19
476818|NCT00142298|1555809|P10|Overall Study|Pregnancy|0
476819|NCT00142298|1555810|P9|Overall Study|Pregnancy|1
476820|NCT00142298|1555811|P8|Overall Study|Pregnancy|0
476821|NCT00142298|1555812|P7|Overall Study|Pregnancy|0
476822|NCT00142298|1555813|P6|Overall Study|Pregnancy|0
476823|NCT00142298|1555814|P5|Overall Study|Pregnancy|0
476824|NCT00142298|1555815|P4|Overall Study|Pregnancy|3
476825|NCT00142298|1555816|P3|Overall Study|Pregnancy|2
476826|NCT00142298|1555817|P2|Overall Study|Pregnancy|4
476827|NCT00142298|1555818|P1|Overall Study|Pregnancy|4
476828|NCT00142298|1555809|P10|Overall Study|Patient, Investigator,or Sponsor request|0
476829|NCT00142298|1555810|P9|Overall Study|Patient, Investigator,or Sponsor request|1
476830|NCT00142298|1555811|P8|Overall Study|Patient, Investigator,or Sponsor request|4
476831|NCT00142298|1555812|P7|Overall Study|Patient, Investigator,or Sponsor request|1
476832|NCT00142298|1555813|P6|Overall Study|Patient, Investigator,or Sponsor request|3
476833|NCT00142298|1555814|P5|Overall Study|Patient, Investigator,or Sponsor request|4
476834|NCT00142298|1555815|P4|Overall Study|Patient, Investigator,or Sponsor request|51
476835|NCT00142298|1555816|P3|Overall Study|Patient, Investigator,or Sponsor request|11
476836|NCT00142298|1555817|P2|Overall Study|Patient, Investigator,or Sponsor request|60
476837|NCT00142298|1555818|P1|Overall Study|Patient, Investigator,or Sponsor request|66
476838|NCT00142298|1555809|P10|Overall Study|Non-compliance|0
476839|NCT00142298|1555810|P9|Overall Study|Non-compliance|3
476840|NCT00142298|1555811|P8|Overall Study|Non-compliance|3
476841|NCT00142298|1555812|P7|Overall Study|Non-compliance|0
476842|NCT00142298|1555813|P6|Overall Study|Non-compliance|0
476843|NCT00142298|1555814|P5|Overall Study|Non-compliance|1
476844|NCT00142298|1555815|P4|Overall Study|Non-compliance|6
476845|NCT00142298|1555816|P3|Overall Study|Non-compliance|0
476846|NCT00142298|1555817|P2|Overall Study|Non-compliance|13
476847|NCT00142298|1555818|P1|Overall Study|Non-compliance|15
476848|NCT00142298|1555809|P10|Overall Study|Lack of Efficacy|0
476849|NCT00142298|1555810|P9|Overall Study|Lack of Efficacy|0
476850|NCT00142298|1555811|P8|Overall Study|Lack of Efficacy|1
476851|NCT00142298|1555812|P7|Overall Study|Lack of Efficacy|0
476852|NCT00142298|1555813|P6|Overall Study|Lack of Efficacy|0
476853|NCT00142298|1555814|P5|Overall Study|Lack of Efficacy|1
476854|NCT00142298|1555815|P4|Overall Study|Lack of Efficacy|12
476855|NCT00142298|1555816|P3|Overall Study|Lack of Efficacy|9
476856|NCT00142298|1555817|P2|Overall Study|Lack of Efficacy|62
476857|NCT00142298|1555818|P1|Overall Study|Lack of Efficacy|44
476858|NCT00142298|1555809|P10|Overall Study|Death|0
476859|NCT00142298|1555810|P9|Overall Study|Death|0
476860|NCT00142298|1555811|P8|Overall Study|Death|0
476861|NCT00142298|1555812|P7|Overall Study|Death|0
476862|NCT00142298|1555813|P6|Overall Study|Death|6
476863|NCT00142298|1555814|P5|Overall Study|Death|0
476864|NCT00142298|1555815|P4|Overall Study|Death|0
476865|NCT00142298|1555816|P3|Overall Study|Death|1
476866|NCT00142298|1555817|P2|Overall Study|Death|1
476867|NCT00142298|1555818|P1|Overall Study|Death|1
476868|NCT00142298|1555809|P10|Overall Study|Clinical disease progression|0
476869|NCT00142298|1555810|P9|Overall Study|Clinical disease progression|0
476870|NCT00142298|1555811|P8|Overall Study|Clinical disease progression|0
476871|NCT00142298|1555812|P7|Overall Study|Clinical disease progression|0
476872|NCT00142298|1555813|P6|Overall Study|Clinical disease progression|0
476873|NCT00142298|1555814|P5|Overall Study|Clinical disease progression|0
476874|NCT00142298|1555815|P4|Overall Study|Clinical disease progression|0
476875|NCT00142298|1555816|P3|Overall Study|Clinical disease progression|0
476876|NCT00142298|1555817|P2|Overall Study|Clinical disease progression|0
476877|NCT00142298|1555818|P1|Overall Study|Clinical disease progression|1
476878|NCT00142298|1555809|P10|Overall Study|Adverse Event|0
476879|NCT00142298|1555810|P9|Overall Study|Adverse Event|0
476880|NCT00142298|1555811|P8|Overall Study|Adverse Event|0
476881|NCT00142298|1555812|P7|Overall Study|Adverse Event|0
476882|NCT00142298|1555813|P6|Overall Study|Adverse Event|2
476883|NCT00142298|1555814|P5|Overall Study|Adverse Event|2
476884|NCT00142298|1555815|P4|Overall Study|Adverse Event|5
476885|NCT00142298|1555816|P3|Overall Study|Adverse Event|1
476886|NCT00142298|1555817|P2|Overall Study|Adverse Event|10
476887|NCT00142298|1555818|P1|Overall Study|Adverse Event|10
476888|NCT00141921|1555852|P1|Overall Study|Other|8
476889|NCT00141921|1555852|P1|Overall Study|Ineligibility Determined|2
476890|NCT00141921|1555852|P1|Overall Study|Pregnancy|4
476891|NCT00141921|1555852|P1|Overall Study|Administrative Decision|2
476892|NCT00141921|1555852|P1|Overall Study|Adverse Event|5
476893|NCT00141921|1555852|P1|Overall Study|Protocol Deviation|7
476894|NCT00141921|1555852|P1|Overall Study|Disease Progression|7
476895|NCT00141921|1555852|P1|Overall Study|Noncompliance|17
476896|NCT00141921|1555852|P1|Overall Study|Lost to Follow-up|19
476897|NCT00141921|1555852|P1|Overall Study|Withdrawal by Subject|42
476898|NCT00141921|1555852|P1|Overall Study|Remain on Study|28
476899|NCT00141817|1555878|P4|Overall Study|Parent request|0
476900|NCT00141817|1555879|P3|Overall Study|Parent request|0
476901|NCT00141817|1555880|P2|Overall Study|Parent request|0
476902|NCT00141817|1555881|P1|Overall Study|Parent request|1
476903|NCT00141817|1555878|P4|Overall Study|Protocol Violation|0
476904|NCT00141817|1555879|P3|Overall Study|Protocol Violation|1
476905|NCT00141817|1555880|P2|Overall Study|Protocol Violation|0
476906|NCT00141817|1555881|P1|Overall Study|Protocol Violation|0
476907|NCT00141778|1555922|P3|Started Study Medication|Chest Discomfort|1
476908|NCT00141778|1555923|P2|Started Study Medication|Chest Discomfort|0
476909|NCT00141778|1555924|P1|Started Study Medication|Chest Discomfort|0
476910|NCT00141778|1555922|P3|Started Study Medication|Difficulty Swallowing|0
476911|NCT00141778|1555923|P2|Started Study Medication|Difficulty Swallowing|1
476912|NCT00141778|1555924|P1|Started Study Medication|Difficulty Swallowing|0
476913|NCT00141778|1555922|P3|Started Study Medication|Withdrawal by Subject|0
476914|NCT00141778|1555923|P2|Started Study Medication|Withdrawal by Subject|2
476915|NCT00141778|1555924|P1|Started Study Medication|Withdrawal by Subject|0
476916|NCT00141778|1555922|P3|Started Study Medication|Met safety criteria for discontinuation|3
476917|NCT00141778|1555923|P2|Started Study Medication|Met safety criteria for discontinuation|4
476918|NCT00141778|1555924|P1|Started Study Medication|Met safety criteria for discontinuation|2
476919|NCT00141778|1555922|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
476920|NCT00141778|1555923|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
476921|NCT00141778|1555924|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
476922|NCT00141726|1555977|P1|Overall Study|Completed <50% Scheduled Dosing|3
476923|NCT00141518|1555985|P3|Overall Study|Lack of Efficacy|0
476924|NCT00141518|1555986|P2|Overall Study|Lack of Efficacy|0
476925|NCT00141518|1555987|P1|Overall Study|Lack of Efficacy|5
476926|NCT00141518|1555985|P3|Overall Study|Protocol Violation|2
476927|NCT00141518|1555986|P2|Overall Study|Protocol Violation|1
476928|NCT00141518|1555987|P1|Overall Study|Protocol Violation|1
476929|NCT00141518|1555985|P3|Overall Study|Withdrawal by Subject|2
476930|NCT00141518|1555986|P2|Overall Study|Withdrawal by Subject|0
476931|NCT00141518|1555987|P1|Overall Study|Withdrawal by Subject|2
476932|NCT00141518|1555985|P3|Overall Study|Adverse Event|2
476933|NCT00141518|1555986|P2|Overall Study|Adverse Event|5
476934|NCT00141518|1555987|P1|Overall Study|Adverse Event|7
476935|NCT00141518|1555985|P3|Overall Study|Withdrew Consent Prior to Treatment|0
476936|NCT00141518|1555986|P2|Overall Study|Withdrew Consent Prior to Treatment|0
476937|NCT00141518|1555987|P1|Overall Study|Withdrew Consent Prior to Treatment|1
476938|NCT00141453|1556176|P2|Overall Study|Protocol Violation|5
476939|NCT00141453|1556177|P1|Overall Study|Protocol Violation|6
476940|NCT00141297|1556191|P10|Overall Study|Transitioned|0
476941|NCT00141297|1556192|P9|Overall Study|Transitioned|0
476942|NCT00141297|1556193|P8|Overall Study|Transitioned|0
476943|NCT00141297|1556194|P7|Overall Study|Transitioned|0
476944|NCT00141297|1556195|P6|Overall Study|Transitioned|0
476945|NCT00141297|1556196|P5|Overall Study|Transitioned|1
476946|NCT00141297|1556197|P4|Overall Study|Transitioned|0
476947|NCT00141297|1556198|P3|Overall Study|Transitioned|0
476948|NCT00141297|1556199|P2|Overall Study|Transitioned|0
476949|NCT00141297|1556200|P1|Overall Study|Transitioned|0
476950|NCT00141297|1556191|P10|Overall Study|Progressive Disease|6
476951|NCT00141297|1556192|P9|Overall Study|Progressive Disease|15
476952|NCT00141297|1556193|P8|Overall Study|Progressive Disease|3
476953|NCT00141297|1556194|P7|Overall Study|Progressive Disease|3
476954|NCT00141297|1556195|P6|Overall Study|Progressive Disease|2
476955|NCT00141297|1556196|P5|Overall Study|Progressive Disease|15
476956|NCT00141297|1556197|P4|Overall Study|Progressive Disease|2
476957|NCT00141297|1556198|P3|Overall Study|Progressive Disease|6
476958|NCT00141297|1556199|P2|Overall Study|Progressive Disease|3
476959|NCT00141297|1556200|P1|Overall Study|Progressive Disease|2
476960|NCT00141297|1556191|P10|Overall Study|Other|0
476961|NCT00141297|1556192|P9|Overall Study|Other|2
476962|NCT00141297|1556193|P8|Overall Study|Other|0
476963|NCT00141297|1556194|P7|Overall Study|Other|0
476964|NCT00141297|1556195|P6|Overall Study|Other|0
476965|NCT00141297|1556196|P5|Overall Study|Other|5
476966|NCT00141297|1556197|P4|Overall Study|Other|1
476967|NCT00141297|1556198|P3|Overall Study|Other|0
476968|NCT00141297|1556199|P2|Overall Study|Other|0
476969|NCT00141297|1556200|P1|Overall Study|Other|0
476970|NCT00141297|1556191|P10|Overall Study|Withdrawal by Subject|0
476971|NCT00141297|1556192|P9|Overall Study|Withdrawal by Subject|1
476972|NCT00141297|1556193|P8|Overall Study|Withdrawal by Subject|0
476973|NCT00141297|1556194|P7|Overall Study|Withdrawal by Subject|0
476974|NCT00141297|1556195|P6|Overall Study|Withdrawal by Subject|0
476975|NCT00141297|1556196|P5|Overall Study|Withdrawal by Subject|0
476976|NCT00141297|1556197|P4|Overall Study|Withdrawal by Subject|0
476977|NCT00141297|1556198|P3|Overall Study|Withdrawal by Subject|0
476978|NCT00141297|1556199|P2|Overall Study|Withdrawal by Subject|0
476979|NCT00141297|1556200|P1|Overall Study|Withdrawal by Subject|0
476980|NCT00141297|1556191|P10|Overall Study|Death|0
476981|NCT00141297|1556192|P9|Overall Study|Death|1
476982|NCT00141297|1556193|P8|Overall Study|Death|0
476983|NCT00141297|1556194|P7|Overall Study|Death|0
476984|NCT00141297|1556195|P6|Overall Study|Death|0
476985|NCT00141297|1556196|P5|Overall Study|Death|0
476986|NCT00141297|1556197|P4|Overall Study|Death|0
476987|NCT00141297|1556198|P3|Overall Study|Death|0
476988|NCT00141297|1556199|P2|Overall Study|Death|0
476989|NCT00141297|1556200|P1|Overall Study|Death|1
476990|NCT00141297|1556191|P10|Overall Study|Adverse Event|0
476991|NCT00141297|1556192|P9|Overall Study|Adverse Event|1
476992|NCT00141297|1556193|P8|Overall Study|Adverse Event|1
476993|NCT00141297|1556194|P7|Overall Study|Adverse Event|0
476994|NCT00141297|1556195|P6|Overall Study|Adverse Event|1
476995|NCT00141297|1556196|P5|Overall Study|Adverse Event|1
476996|NCT00141297|1556197|P4|Overall Study|Adverse Event|0
476997|NCT00141297|1556198|P3|Overall Study|Adverse Event|1
476998|NCT00141297|1556199|P2|Overall Study|Adverse Event|0
476999|NCT00141297|1556200|P1|Overall Study|Adverse Event|0
477000|NCT00141271|1556478|P3|Overall Study|Other|5
477001|NCT00141271|1556479|P2|Overall Study|Other|12
477002|NCT00141271|1556480|P1|Overall Study|Other|11
477003|NCT00141271|1556478|P3|Overall Study|Withdrawal by Subject|10
477004|NCT00141271|1556479|P2|Overall Study|Withdrawal by Subject|9
477005|NCT00141271|1556480|P1|Overall Study|Withdrawal by Subject|14
477006|NCT00141271|1556478|P3|Overall Study|Lost to Follow-up|21
477007|NCT00141271|1556479|P2|Overall Study|Lost to Follow-up|15
477008|NCT00141271|1556480|P1|Overall Study|Lost to Follow-up|15
477009|NCT00141271|1556478|P3|Overall Study|Lack of Efficacy|3
477010|NCT00141271|1556479|P2|Overall Study|Lack of Efficacy|7
477011|NCT00141271|1556480|P1|Overall Study|Lack of Efficacy|7
477012|NCT00141271|1556478|P3|Overall Study|Laboratory Abnormality|1
477013|NCT00141271|1556479|P2|Overall Study|Laboratory Abnormality|1
477014|NCT00141271|1556480|P1|Overall Study|Laboratory Abnormality|2
477015|NCT00141271|1556478|P3|Overall Study|Adverse Event|17
477016|NCT00141271|1556479|P2|Overall Study|Adverse Event|19
477017|NCT00141271|1556480|P1|Overall Study|Adverse Event|31
477018|NCT00141219|1556601|P2|Overall Study|Withdrawal by Subject|2
477019|NCT00141219|1556602|P1|Overall Study|Withdrawal by Subject|6
477020|NCT00141219|1556601|P2|Overall Study|Lack of Efficacy|4
477021|NCT00141219|1556602|P1|Overall Study|Lack of Efficacy|5
477022|NCT00141219|1556601|P2|Overall Study|Adverse Event|6
477023|NCT00141219|1556602|P1|Overall Study|Adverse Event|8
477024|NCT00141219|1556601|P2|Overall Study|Protocol violations|4
477025|NCT00141219|1556602|P1|Overall Study|Protocol violations|5
477026|NCT00141102|1556659|P2|Overall Study|Death|2
477027|NCT00141102|1556660|P1|Overall Study|Death|2
477028|NCT00141102|1556659|P2|Overall Study|Randomized But Did Not Receive Treatment|9
477029|NCT00141102|1556660|P1|Overall Study|Randomized But Did Not Receive Treatment|15
477030|NCT00141102|1556659|P2|Overall Study|Withdrawal by Subject|142
477031|NCT00141102|1556660|P1|Overall Study|Withdrawal by Subject|112
477032|NCT00141102|1556659|P2|Overall Study|Other|76
477033|NCT00141102|1556660|P1|Overall Study|Other|87
477034|NCT00141102|1556659|P2|Overall Study|Lost to Follow-up|32
477035|NCT00141102|1556660|P1|Overall Study|Lost to Follow-up|29
477036|NCT00141102|1556659|P2|Overall Study|Lack of Efficacy|26
477037|NCT00141102|1556660|P1|Overall Study|Lack of Efficacy|21
477038|NCT00141102|1556659|P2|Overall Study|Laboratory Abnormality|33
477039|NCT00141102|1556660|P1|Overall Study|Laboratory Abnormality|9
477040|NCT00141102|1556659|P2|Overall Study|Adverse Event|305
477041|NCT00141102|1556660|P1|Overall Study|Adverse Event|233
477042|NCT00141037|1556700|P2|Overall Study|Graft Failure|4
477043|NCT00141037|1556701|P1|Overall Study|Graft Failure|3
477044|NCT00141037|1556700|P2|Overall Study|Moved from area|7
477045|NCT00141037|1556701|P1|Overall Study|Moved from area|1
477046|NCT00141037|1556700|P2|Overall Study|Other|1
477047|NCT00141037|1556701|P1|Overall Study|Other|0
477048|NCT00141037|1556700|P2|Overall Study|Withdrawal by Subject|1
477049|NCT00141037|1556701|P1|Overall Study|Withdrawal by Subject|2
477050|NCT00141037|1556700|P2|Overall Study|Protocol Violation|2
477051|NCT00141037|1556701|P1|Overall Study|Protocol Violation|0
477052|NCT00141037|1556700|P2|Overall Study|Lost to Follow-up|1
477053|NCT00141037|1556701|P1|Overall Study|Lost to Follow-up|3
477054|NCT00141037|1556700|P2|Overall Study|Physician Decision|2
477055|NCT00141037|1556701|P1|Overall Study|Physician Decision|1
477056|NCT00140426|1556736|P2|Overall Study|Withdrawal by Subject|3
477057|NCT00140426|1556737|P1|Overall Study|Withdrawal by Subject|0
477058|NCT00140413|1556770|P2|Overall Study|Withdrawal by Subject|0
477059|NCT00140413|1556771|P1|Overall Study|Withdrawal by Subject|2
477060|NCT00140413|1556770|P2|Overall Study|Lost to Follow-up|0
477061|NCT00140413|1556771|P1|Overall Study|Lost to Follow-up|1
477062|NCT00140140|1556831|P3|Overall Study|Physician Decision|0
477063|NCT00140140|1556832|P2|Overall Study|Physician Decision|1
477064|NCT00140140|1556833|P1|Overall Study|Physician Decision|1
477065|NCT00140140|1556831|P3|Overall Study|Unacceptable toxicity|2
477066|NCT00140140|1556832|P2|Overall Study|Unacceptable toxicity|1
477067|NCT00140140|1556833|P1|Overall Study|Unacceptable toxicity|1
477068|NCT00139776|1556883|P4|Period III|Withdrawal by Subject|21
477069|NCT00139776|1556884|P3|Period III|Withdrawal by Subject|16
477070|NCT00139776|1556885|P2|Period III|Withdrawal by Subject|0
477071|NCT00139776|1556886|P1|Period III|Withdrawal by Subject|0
477072|NCT00139776|1556883|P4|Period III|Lost to Follow-up|4
477073|NCT00139776|1556884|P3|Period III|Lost to Follow-up|5
477074|NCT00139776|1556885|P2|Period III|Lost to Follow-up|0
477075|NCT00139776|1556886|P1|Period III|Lost to Follow-up|0
477076|NCT00139776|1556883|P4|Period III|Lack of Efficacy|24
477077|NCT00139776|1556884|P3|Period III|Lack of Efficacy|10
477078|NCT00139776|1556885|P2|Period III|Lack of Efficacy|0
477079|NCT00139776|1556886|P1|Period III|Lack of Efficacy|0
477080|NCT00139776|1556883|P4|Period III|Other|34
477081|NCT00139776|1556884|P3|Period III|Other|23
477082|NCT00139776|1556885|P2|Period III|Other|0
477083|NCT00139776|1556886|P1|Period III|Other|0
477084|NCT00139776|1556883|P4|Period III|Adverse Event|23
477085|NCT00139776|1556884|P3|Period III|Adverse Event|22
477086|NCT00139776|1556885|P2|Period III|Adverse Event|0
477087|NCT00139776|1556886|P1|Period III|Adverse Event|0
477088|NCT00139776|1556883|P4|Period II|Not Randomized into Period III|0
477089|NCT00139776|1556884|P3|Period II|Not Randomized into Period III|0
477090|NCT00139776|1556885|P2|Period II|Not Randomized into Period III|322
477091|NCT00139776|1556886|P1|Period II|Not Randomized into Period III|0
477092|NCT00139776|1556883|P4|Period I|Did not enter Period II|0
477093|NCT00139776|1556884|P3|Period I|Did not enter Period II|0
477094|NCT00139776|1556885|P2|Period I|Did not enter Period II|0
477095|NCT00139776|1556886|P1|Period I|Did not enter Period II|575
477096|NCT00139737|1556921|P1|Overall Study|Screened, Not Treated|13
477097|NCT00139737|1556921|P1|Overall Study|Did Not Meet Entrance Criteria|1
477098|NCT00139737|1556921|P1|Overall Study|Withdrew During Screening Phase|8
477099|NCT00139737|1556921|P1|Overall Study|Protocol Violation|18
477100|NCT00139737|1556921|P1|Overall Study|Laboratory Abnormality|2
477101|NCT00139737|1556921|P1|Overall Study|Death|3
477102|NCT00139737|1556921|P1|Overall Study|Lost to Follow-up|8
477103|NCT00139737|1556921|P1|Overall Study|Lack of Efficacy|40
477104|NCT00139737|1556921|P1|Overall Study|Adverse Event|58
477105|NCT00139737|1556921|P1|Overall Study|Withdrawal by Subject|190
477106|NCT00139659|1556927|P2|Overall Study|Withdrawal by Subject|10
477107|NCT00139659|1556928|P1|Overall Study|Withdrawal by Subject|14
477108|NCT00139659|1556927|P2|Overall Study|Reason not Specified|3
477109|NCT00139659|1556928|P1|Overall Study|Reason not Specified|6
477110|NCT00139659|1556927|P2|Overall Study|Lost to Follow-up|3
477111|NCT00139659|1556928|P1|Overall Study|Lost to Follow-up|7
477112|NCT00139659|1556927|P2|Overall Study|Lack of Efficacy|1
477113|NCT00139659|1556928|P1|Overall Study|Lack of Efficacy|1
477114|NCT00139659|1556927|P2|Overall Study|Adverse Event|1
477115|NCT00139659|1556928|P1|Overall Study|Adverse Event|12
477116|NCT00139477|1557006|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
477117|NCT00139477|1557007|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
477118|NCT00139477|1557006|P2|Second Intervention -6Months to 12Months|Relocation|0
477119|NCT00139477|1557007|P1|Second Intervention -6Months to 12Months|Relocation|1
477120|NCT00139477|1557006|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
477121|NCT00139477|1557007|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
477122|NCT00139477|1557006|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
477123|NCT00139477|1557007|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
477124|NCT00139477|1557006|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
477125|NCT00139477|1557007|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
477126|NCT00139477|1557006|P2|First Intervention -Baseline to 6Months|Relocation|2
477127|NCT00139477|1557007|P1|First Intervention -Baseline to 6Months|Relocation|1
477128|NCT00139477|1557006|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
477129|NCT00139477|1557007|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
477130|NCT00138671|1557029|P2|Overall Study|Other|3
477131|NCT00138671|1557030|P1|Overall Study|Other|3
477132|NCT00138671|1557029|P2|Overall Study|Withdrawal by Subject|5
477133|NCT00138671|1557030|P1|Overall Study|Withdrawal by Subject|3
477134|NCT00138671|1557029|P2|Overall Study|Lost to Follow-up|2
477135|NCT00138671|1557030|P1|Overall Study|Lost to Follow-up|1
477136|NCT00138671|1557029|P2|Overall Study|Adverse Event|3
477137|NCT00138671|1557030|P1|Overall Study|Adverse Event|6
477138|NCT00138671|1557029|P2|Overall Study|Death|3
477139|NCT00138671|1557030|P1|Overall Study|Death|0
477140|NCT00138658|1557080|P1|Overall Study|Withdrawal by Subject|5
477141|NCT00138658|1557080|P1|Overall Study|Physician Decision|11
477142|NCT00138658|1557080|P1|Overall Study|Disease Progression|21
477143|NCT00138658|1557080|P1|Overall Study|Death|1
477144|NCT00138658|1557080|P1|Overall Study|Adverse Event|23
477145|NCT00138424|1557103|P4|Overall Study|Physician Decision|0
477146|NCT00138424|1557104|P3|Overall Study|Physician Decision|0
477147|NCT00138424|1557105|P2|Overall Study|Physician Decision|1
477148|NCT00138424|1557106|P1|Overall Study|Physician Decision|0
477149|NCT00138151|1557189|P1|Overall Study|Physician Decision|1
477150|NCT00138151|1557189|P1|Overall Study|Withdrawal by Subject|3
477151|NCT00138073|1557199|P1|Overall Study|lack of resources|55
477152|NCT00137631|1557240|P2|Overall Study|Lost to Follow-up|41
477153|NCT00137631|1557241|P1|Overall Study|Lost to Follow-up|37
477154|NCT00137449|1557257|P2|Overall Study|Withdrawal by Subject|1
477155|NCT00137449|1557258|P1|Overall Study|Withdrawal by Subject|1
477156|NCT00137449|1557257|P2|Overall Study|Adverse Event|1
477157|NCT00137449|1557258|P1|Overall Study|Adverse Event|3
477158|NCT00137449|1557257|P2|Overall Study|Death|3
477159|NCT00137449|1557258|P1|Overall Study|Death|4
477160|NCT00137449|1557257|P2|Overall Study|Disease Progression|13
477161|NCT00137449|1557258|P1|Overall Study|Disease Progression|8
477162|NCT00137436|1557295|P1|Overall Study|Other|5
477163|NCT00137436|1557295|P1|Overall Study|Withdrawal by Subject|6
477164|NCT00137436|1557295|P1|Overall Study|Lack of Efficacy|17
477165|NCT00137436|1557295|P1|Overall Study|Death|2
477166|NCT00137436|1557295|P1|Overall Study|Adverse Event|13
477167|NCT00137423|1557314|P2|Overall Study|Death|1
477168|NCT00137423|1557315|P1|Overall Study|Death|0
477169|NCT00137423|1557314|P2|Overall Study|Lack of Efficacy|33
477170|NCT00137423|1557315|P1|Overall Study|Lack of Efficacy|31
477171|NCT00137423|1557314|P2|Overall Study|consent withdrawn|1
477172|NCT00137423|1557315|P1|Overall Study|consent withdrawn|1
477173|NCT00137423|1557314|P2|Overall Study|Adverse Event|9
477174|NCT00137423|1557315|P1|Overall Study|Adverse Event|7
477175|NCT00137267|1557352|P2|Overall Study|Lost to Follow-up|21
477176|NCT00137267|1557353|P1|Overall Study|Lost to Follow-up|15
477177|NCT00137111|1557365|P4|Total Therapy|Non Compliance|0
477178|NCT00137111|1557366|P3|Total Therapy|Non Compliance|0
477179|NCT00137111|1557367|P2|Total Therapy|Non Compliance|0
477180|NCT00137111|1557368|P1|Total Therapy|Non Compliance|5
477181|NCT00137111|1557365|P4|Total Therapy|Death|0
477182|NCT00137111|1557366|P3|Total Therapy|Death|0
477183|NCT00137111|1557367|P2|Total Therapy|Death|0
477184|NCT00137111|1557368|P1|Total Therapy|Death|35
477185|NCT00137046|1557382|P2|Overall Study|Withdrew prior to study treatment|1
477186|NCT00137046|1557383|P1|Overall Study|Withdrew prior to study treatment|1
477187|NCT00137046|1557382|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
477188|NCT00137046|1557383|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
477189|NCT00137046|1557382|P2|Overall Study|Withdrawal by Subject|42
477190|NCT00137046|1557383|P1|Overall Study|Withdrawal by Subject|33
477191|NCT00137046|1557382|P2|Overall Study|Other|19
477192|NCT00137046|1557383|P1|Overall Study|Other|23
477193|NCT00137046|1557382|P2|Overall Study|Lost to Follow-up|24
477194|NCT00137046|1557383|P1|Overall Study|Lost to Follow-up|8
477195|NCT00137046|1557382|P2|Overall Study|Lack of Efficacy|1
477196|NCT00137046|1557383|P1|Overall Study|Lack of Efficacy|13
477197|NCT00137046|1557382|P2|Overall Study|Laboratory Abnormality|0
477198|NCT00137046|1557383|P1|Overall Study|Laboratory Abnormality|2
477199|NCT00137046|1557382|P2|Overall Study|Adverse Event|5
477200|NCT00137046|1557383|P1|Overall Study|Adverse Event|16
477201|NCT00137046|1557382|P2|Overall Study|Death|1
477202|NCT00137046|1557383|P1|Overall Study|Death|2
477203|NCT00136955|1557431|P1|Overall Study|Incl. prog. disease, protocol violation|12
477204|NCT00136955|1557431|P1|Overall Study|Withdrawal by Subject|2
477205|NCT00136955|1557431|P1|Overall Study|Lost to Follow-up|1
477206|NCT00136955|1557431|P1|Overall Study|Adverse Event|8
477207|NCT00136916|1557440|P2|Overall Study|Discontinued in follow up period|0
477208|NCT00136916|1557441|P1|Overall Study|Discontinued in follow up period|3
477209|NCT00136916|1557440|P2|Overall Study|Other|24
477210|NCT00136916|1557441|P1|Overall Study|Other|22
477211|NCT00136916|1557440|P2|Overall Study|Withdrawal by Subject|46
477212|NCT00136916|1557441|P1|Overall Study|Withdrawal by Subject|44
477213|NCT00136916|1557440|P2|Overall Study|Lost to Follow-up|14
477214|NCT00136916|1557441|P1|Overall Study|Lost to Follow-up|12
477215|NCT00136916|1557440|P2|Overall Study|Lack of Efficacy|3
477216|NCT00136916|1557441|P1|Overall Study|Lack of Efficacy|13
477217|NCT00136916|1557440|P2|Overall Study|Laboratory abnormality|1
477218|NCT00136916|1557441|P1|Overall Study|Laboratory abnormality|0
477219|NCT00136916|1557440|P2|Overall Study|Adverse Event|8
477220|NCT00136916|1557441|P1|Overall Study|Adverse Event|27
477221|NCT00136916|1557440|P2|Overall Study|Death|3
477222|NCT00136916|1557441|P1|Overall Study|Death|1
477223|NCT00136916|1557440|P2|Overall Study|Never received study treatment|5
477224|NCT00136916|1557441|P1|Overall Study|Never received study treatment|3
477225|NCT00136357|1557545|P2|Overall Study|Withdrawal by Subject|2
477226|NCT00136357|1557546|P1|Overall Study|Withdrawal by Subject|3
477227|NCT00136318|1557554|P2|Overall Study|Withdrawal by Subject|2
477228|NCT00136318|1557555|P1|Overall Study|Withdrawal by Subject|2
477229|NCT00136318|1557554|P2|Overall Study|Adverse Event|5
477230|NCT00136318|1557555|P1|Overall Study|Adverse Event|5
477231|NCT00136084|1557571|P2|Overall Study|Withdrawal by Subject|1
477232|NCT00136084|1557572|P1|Overall Study|Withdrawal by Subject|5
477233|NCT00136084|1557571|P2|Overall Study|No Response|2
477234|NCT00136084|1557572|P1|Overall Study|No Response|1
477235|NCT00136084|1557571|P2|Overall Study|Lost to Follow-up|0
477236|NCT00136084|1557572|P1|Overall Study|Lost to Follow-up|2
477237|NCT00136084|1557571|P2|Overall Study|Relapse|23
477238|NCT00136084|1557572|P1|Overall Study|Relapse|20
477239|NCT00136084|1557571|P2|Overall Study|Unacceptable toxicity|11
477240|NCT00136084|1557572|P1|Overall Study|Unacceptable toxicity|8
477241|NCT00136084|1557571|P2|Overall Study|Death|5
477242|NCT00136084|1557572|P1|Overall Study|Death|12
477243|NCT00135694|1557609|P3|Overall Study|Ineligible for Random assignment|0
477244|NCT00135694|1557610|P2|Overall Study|Ineligible for Random assignment|0
477245|NCT00135694|1557611|P1|Overall Study|Ineligible for Random assignment|42
477246|NCT00135694|1557609|P3|Overall Study|Hepatitis C related reasons|0
477247|NCT00135694|1557610|P2|Overall Study|Hepatitis C related reasons|1
477248|NCT00135694|1557611|P1|Overall Study|Hepatitis C related reasons|39
477249|NCT00135694|1557609|P3|Overall Study|Protocol Violation|0
477250|NCT00135694|1557610|P2|Overall Study|Protocol Violation|1
477251|NCT00135694|1557611|P1|Overall Study|Protocol Violation|19
477252|NCT00135694|1557609|P3|Overall Study|Withdrawal by Subject|4
477253|NCT00135694|1557610|P2|Overall Study|Withdrawal by Subject|7
477254|NCT00135694|1557611|P1|Overall Study|Withdrawal by Subject|41
477255|NCT00135694|1557609|P3|Overall Study|Lost to Follow-up|1
477256|NCT00135694|1557610|P2|Overall Study|Lost to Follow-up|7
477257|NCT00135694|1557611|P1|Overall Study|Lost to Follow-up|8
477258|NCT00135694|1557609|P3|Overall Study|Death|2
477259|NCT00135694|1557610|P2|Overall Study|Death|1
477260|NCT00135694|1557611|P1|Overall Study|Death|14
477261|NCT00135694|1557609|P3|Overall Study|Adverse Event|0
477262|NCT00135694|1557610|P2|Overall Study|Adverse Event|4
477263|NCT00135694|1557611|P1|Overall Study|Adverse Event|17
477264|NCT00135356|1557631|P2|Overall Study|Withdrawal by Subject|4
477265|NCT00135356|1557632|P1|Overall Study|Withdrawal by Subject|2
477266|NCT00135356|1557631|P2|Overall Study|No longer meets study criteria|0
477267|NCT00135356|1557632|P1|Overall Study|No longer meets study criteria|2
477268|NCT00135356|1557631|P2|Overall Study|Poor/noncompliance|1
477269|NCT00135356|1557632|P1|Overall Study|Poor/noncompliance|1
477270|NCT00135356|1557631|P2|Overall Study|Change in antiviral regimen|1
477271|NCT00135356|1557632|P1|Overall Study|Change in antiviral regimen|0
477272|NCT00135356|1557631|P2|Overall Study|Surgery for abdominal fat|0
477273|NCT00135356|1557632|P1|Overall Study|Surgery for abdominal fat|1
477274|NCT00135356|1557631|P2|Overall Study|Lost to Follow-up|1
477275|NCT00135356|1557632|P1|Overall Study|Lost to Follow-up|3
477276|NCT00135356|1557631|P2|Overall Study|Lack of Efficacy|0
477277|NCT00135356|1557632|P1|Overall Study|Lack of Efficacy|2
477278|NCT00135356|1557631|P2|Overall Study|Adverse Event|2
477279|NCT00135356|1557632|P1|Overall Study|Adverse Event|6
477280|NCT00135330|1557675|P3|Overall Study|Sponsor Decision|0
477281|NCT00135330|1557676|P2|Overall Study|Sponsor Decision|1
477282|NCT00135330|1557677|P1|Overall Study|Sponsor Decision|0
477283|NCT00135330|1557675|P3|Overall Study|Patient Decision|4
477284|NCT00135330|1557676|P2|Overall Study|Patient Decision|1
477285|NCT00135330|1557677|P1|Overall Study|Patient Decision|5
477286|NCT00135330|1557675|P3|Overall Study|Protocol Violation|3
477287|NCT00135330|1557676|P2|Overall Study|Protocol Violation|3
477288|NCT00135330|1557677|P1|Overall Study|Protocol Violation|4
477289|NCT00135330|1557675|P3|Overall Study|Physician Decision|0
477290|NCT00135330|1557676|P2|Overall Study|Physician Decision|1
477291|NCT00135330|1557677|P1|Overall Study|Physician Decision|1
477292|NCT00135330|1557675|P3|Overall Study|Lost to Follow-up|3
477293|NCT00135330|1557676|P2|Overall Study|Lost to Follow-up|2
477294|NCT00135330|1557677|P1|Overall Study|Lost to Follow-up|0
477295|NCT00135330|1557675|P3|Overall Study|Adverse Event|1
477296|NCT00135330|1557676|P2|Overall Study|Adverse Event|5
477297|NCT00135330|1557677|P1|Overall Study|Adverse Event|2
477298|NCT00134901|1557776|P2|Overall Study|discontinued intervention|10
477299|NCT00134901|1557777|P1|Overall Study|discontinued intervention|12
477300|NCT00134901|1557776|P2|Overall Study|Lost to Follow-up|5
477301|NCT00134901|1557777|P1|Overall Study|Lost to Follow-up|5
477302|NCT00134784|1557789|P4|Overall Study|Withdrawal by Subject|1
477303|NCT00134784|1557790|P3|Overall Study|Withdrawal by Subject|2
477304|NCT00134784|1557791|P2|Overall Study|Withdrawal by Subject|2
477305|NCT00134784|1557792|P1|Overall Study|Withdrawal by Subject|2
477306|NCT00134719|1557802|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
477307|NCT00134719|1557803|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
477308|NCT00134719|1557804|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
477309|NCT00134719|1557802|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
477310|NCT00134719|1557803|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
477311|NCT00134719|1557804|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
477312|NCT00134719|1557802|P3|Primary Vaccination Phase|Lost to Follow-up|3
477313|NCT00134719|1557803|P2|Primary Vaccination Phase|Lost to Follow-up|3
477314|NCT00134719|1557804|P1|Primary Vaccination Phase|Lost to Follow-up|7
477315|NCT00134719|1557802|P3|Primary Vaccination Phase|Withdrawal by Subject|2
477316|NCT00134719|1557803|P2|Primary Vaccination Phase|Withdrawal by Subject|3
477317|NCT00134719|1557804|P1|Primary Vaccination Phase|Withdrawal by Subject|2
477318|NCT00134719|1557802|P3|Primary Vaccination Phase|Protocol Violation|0
477319|NCT00134719|1557803|P2|Primary Vaccination Phase|Protocol Violation|0
477320|NCT00134719|1557804|P1|Primary Vaccination Phase|Protocol Violation|1
477321|NCT00134719|1557802|P3|Primary Vaccination Phase|Adverse Event|0
477322|NCT00134719|1557803|P2|Primary Vaccination Phase|Adverse Event|0
477323|NCT00134719|1557804|P1|Primary Vaccination Phase|Adverse Event|4
477324|NCT00134563|1557935|P3|Overall Study|Reason other than above|5
477325|NCT00134563|1557936|P2|Overall Study|Reason other than above|2
477326|NCT00134563|1557937|P1|Overall Study|Reason other than above|0
477327|NCT00134563|1557935|P3|Overall Study|did not wish to continue|26
477328|NCT00134563|1557936|P2|Overall Study|did not wish to continue|32
477329|NCT00134563|1557937|P1|Overall Study|did not wish to continue|33
477330|NCT00134563|1557935|P3|Overall Study|progressive disease|2
477331|NCT00134563|1557936|P2|Overall Study|progressive disease|4
477332|NCT00134563|1557937|P1|Overall Study|progressive disease|11
477333|NCT00134563|1557935|P3|Overall Study|Lost to Follow-up|2
477334|NCT00134563|1557936|P2|Overall Study|Lost to Follow-up|0
477335|NCT00134563|1557937|P1|Overall Study|Lost to Follow-up|4
477336|NCT00134563|1557935|P3|Overall Study|Protocol Violation|5
477337|NCT00134563|1557936|P2|Overall Study|Protocol Violation|2
477338|NCT00134563|1557937|P1|Overall Study|Protocol Violation|3
477339|NCT00134563|1557935|P3|Overall Study|Lack of Efficacy|17
477340|NCT00134563|1557936|P2|Overall Study|Lack of Efficacy|14
477341|NCT00134563|1557937|P1|Overall Study|Lack of Efficacy|24
477342|NCT00134563|1557935|P3|Overall Study|Adverse Event|38
477343|NCT00134563|1557936|P2|Overall Study|Adverse Event|37
477344|NCT00134563|1557937|P1|Overall Study|Adverse Event|29
477345|NCT00134563|1557935|P3|Overall Study|Not treated due to protocol violation|1
477346|NCT00134563|1557936|P2|Overall Study|Not treated due to protocol violation|1
477347|NCT00134563|1557937|P1|Overall Study|Not treated due to protocol violation|0
477348|NCT00134056|1558000|P2|Eligible for Protocol Assigned Treatment|Not specified|56
477349|NCT00134056|1558001|P1|Eligible for Protocol Assigned Treatment|Not specified|55
477350|NCT00134056|1558000|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
477351|NCT00134056|1558001|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
477352|NCT00134056|1558000|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
477353|NCT00134056|1558001|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
477354|NCT00134056|1558000|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
477355|NCT00134056|1558001|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
477356|NCT00134056|1558000|P2|Randomization|Not eligible for assigned treatment|20
477357|NCT00134056|1558001|P1|Randomization|Not eligible for assigned treatment|22
477358|NCT00133952|1558068|P2|Overall Study|Sponsor Decision|1
477359|NCT00133952|1558069|P1|Overall Study|Sponsor Decision|0
477360|NCT00133952|1558068|P2|Overall Study|Physician Decision|3
477361|NCT00133952|1558069|P1|Overall Study|Physician Decision|4
477362|NCT00133952|1558068|P2|Overall Study|Withdrawal by Subject|4
477363|NCT00133952|1558069|P1|Overall Study|Withdrawal by Subject|20
477364|NCT00133952|1558068|P2|Overall Study|Protocol Violation|1
477365|NCT00133952|1558069|P1|Overall Study|Protocol Violation|1
477366|NCT00133952|1558068|P2|Overall Study|Protocol Entry Criteria Exclusion|1
477367|NCT00133952|1558069|P1|Overall Study|Protocol Entry Criteria Exclusion|4
477368|NCT00133952|1558068|P2|Overall Study|Lost to Follow-up|14
477369|NCT00133952|1558069|P1|Overall Study|Lost to Follow-up|9
477370|NCT00133952|1558068|P2|Overall Study|Death|2
477371|NCT00133952|1558069|P1|Overall Study|Death|3
477372|NCT00133952|1558068|P2|Overall Study|Adverse Event|2
477373|NCT00133952|1558069|P1|Overall Study|Adverse Event|1
477374|NCT00133705|1558100|P2|Overall Study|Withdrawal by Subject|3
477375|NCT00133705|1558101|P1|Overall Study|Withdrawal by Subject|2
477376|NCT00132873|1558227|P1|Overall Study|Planned Pregnancy|1
477377|NCT00132873|1558227|P1|Overall Study|Withdrawal by Subject|3
477378|NCT00132873|1558227|P1|Overall Study|Lack of Efficacy|1
477379|NCT00132873|1558227|P1|Overall Study|Lost to Follow-up|1
477380|NCT00132873|1558227|P1|Overall Study|Adverse Event|3
477381|NCT00132808|1558235|P3|Stratum II|Withdrawal by Subject|6
477382|NCT00132808|1558236|P2|Stratum II|Withdrawal by Subject|9
477383|NCT00132808|1558237|P1|Stratum II|Withdrawal by Subject|4
477384|NCT00132808|1558235|P3|Stratum II|Protocol Violation|1
477385|NCT00132808|1558236|P2|Stratum II|Protocol Violation|2
477386|NCT00132808|1558237|P1|Stratum II|Protocol Violation|0
477387|NCT00132808|1558235|P3|Stratum II|Lost to Follow-up|1
477388|NCT00132808|1558236|P2|Stratum II|Lost to Follow-up|2
477389|NCT00132808|1558237|P1|Stratum II|Lost to Follow-up|2
477390|NCT00132808|1558235|P3|Stratum II|Death|0
477391|NCT00132808|1558236|P2|Stratum II|Death|0
477392|NCT00132808|1558237|P1|Stratum II|Death|1
477393|NCT00132808|1558235|P3|Stratum II|Adverse Event|1
477394|NCT00132808|1558236|P2|Stratum II|Adverse Event|2
477395|NCT00132808|1558237|P1|Stratum II|Adverse Event|1
477396|NCT00132808|1558235|P3|Stratum I|Abnormal test procedure result (s)|1
477397|NCT00132808|1558236|P2|Stratum I|Abnormal test procedure result (s)|0
477398|NCT00132808|1558237|P1|Stratum I|Abnormal test procedure result (s)|0
477399|NCT00132808|1558235|P3|Stratum I|Withdrawal by Subject|3
477400|NCT00132808|1558236|P2|Stratum I|Withdrawal by Subject|7
477401|NCT00132808|1558237|P1|Stratum I|Withdrawal by Subject|4
477402|NCT00132808|1558235|P3|Stratum I|Lost to Follow-up|1
477403|NCT00132808|1558236|P2|Stratum I|Lost to Follow-up|4
477404|NCT00132808|1558237|P1|Stratum I|Lost to Follow-up|3
477405|NCT00132808|1558235|P3|Stratum I|Adverse Event|0
477406|NCT00132808|1558236|P2|Stratum I|Adverse Event|1
477407|NCT00132808|1558237|P1|Stratum I|Adverse Event|2
477408|NCT00132769|1558262|P2|Overall Study|Protocol Violation|1
477409|NCT00132769|1558263|P1|Overall Study|Protocol Violation|1
477410|NCT00132769|1558262|P2|Overall Study|Adverse Event|1
477411|NCT00132769|1558263|P1|Overall Study|Adverse Event|2
477412|NCT00132769|1558262|P2|Overall Study|Lack of Efficacy|6
477413|NCT00132769|1558263|P1|Overall Study|Lack of Efficacy|7
477414|NCT00132769|1558262|P2|Overall Study|Withdrawal by Subject|3
477415|NCT00132769|1558263|P1|Overall Study|Withdrawal by Subject|1
477416|NCT00132730|1558289|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
477417|NCT00132730|1558290|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
477418|NCT00132730|1558291|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
477419|NCT00132730|1558292|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
477420|NCT00132730|1558293|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
477421|NCT00132730|1558294|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
477422|NCT00132730|1558289|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
477423|NCT00132730|1558290|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
477424|NCT00132730|1558291|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
477425|NCT00132730|1558292|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
477426|NCT00132730|1558293|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
477427|NCT00132730|1558294|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
477428|NCT00132730|1558289|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
477429|NCT00132730|1558290|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
477430|NCT00132730|1558291|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
477431|NCT00132730|1558292|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
477432|NCT00132730|1558293|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
477433|NCT00132730|1558294|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
477434|NCT00132730|1558289|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
477435|NCT00132730|1558290|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
477436|NCT00132730|1558291|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
477437|NCT00132730|1558292|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
477438|NCT00132730|1558293|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
477439|NCT00132730|1558294|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
477440|NCT00132730|1558289|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
477441|NCT00132730|1558290|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
477442|NCT00132730|1558291|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
477443|NCT00132730|1558292|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
477444|NCT00132730|1558293|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
477445|NCT00132730|1558294|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
477446|NCT00132730|1558289|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
477447|NCT00132730|1558290|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
477448|NCT00132730|1558291|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
477449|NCT00132730|1558292|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
477450|NCT00132730|1558293|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
477451|NCT00132730|1558294|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
477452|NCT00132730|1558289|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
477453|NCT00132730|1558290|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
477454|NCT00132730|1558291|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
477455|NCT00132730|1558292|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
477456|NCT00132730|1558293|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
477457|NCT00132730|1558294|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
477458|NCT00132730|1558289|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
477459|NCT00132730|1558290|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
477460|NCT00132730|1558291|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
477461|NCT00132730|1558292|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
477462|NCT00132730|1558293|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
477463|NCT00132730|1558294|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
477464|NCT00132730|1558289|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
477465|NCT00132730|1558290|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
477466|NCT00132730|1558291|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
477467|NCT00132730|1558292|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
477468|NCT00132730|1558293|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
477469|NCT00132730|1558294|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
477470|NCT00132730|1558289|P6|Period II - 12-week Treatment (Base)|Other reasons|0
477471|NCT00132730|1558290|P5|Period II - 12-week Treatment (Base)|Other reasons|0
477472|NCT00132730|1558291|P4|Period II - 12-week Treatment (Base)|Other reasons|13
477473|NCT00132730|1558292|P3|Period II - 12-week Treatment (Base)|Other reasons|9
477474|NCT00132730|1558293|P2|Period II - 12-week Treatment (Base)|Other reasons|10
477475|NCT00132730|1558294|P1|Period II - 12-week Treatment (Base)|Other reasons|11
477476|NCT00132730|1558289|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
477477|NCT00132730|1558290|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
477478|NCT00132730|1558291|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
477479|NCT00132730|1558292|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
477480|NCT00132730|1558293|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
477481|NCT00132730|1558294|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
477482|NCT00132730|1558289|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
477483|NCT00132730|1558290|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
477484|NCT00132730|1558291|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
477485|NCT00132730|1558292|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
477486|NCT00132730|1558293|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
477487|NCT00132730|1558294|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
477488|NCT00132691|1558338|P2|Overall Study|Death|0
477489|NCT00132691|1558339|P1|Overall Study|Death|2
477490|NCT00132691|1558338|P2|Overall Study|Missed 2-year visit|4
477491|NCT00132691|1558339|P1|Overall Study|Missed 2-year visit|4
477492|NCT00132691|1558338|P2|Overall Study|Lost to Follow-up|8
477493|NCT00132691|1558339|P1|Overall Study|Lost to Follow-up|5
477494|NCT00132678|1558379|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
477495|NCT00132678|1558380|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
477496|NCT00132678|1558381|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
477497|NCT00132678|1558379|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
477498|NCT00132678|1558380|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
477499|NCT00132678|1558381|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
477500|NCT00132678|1558379|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
477501|NCT00132678|1558380|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
477502|NCT00132678|1558381|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
477503|NCT00132678|1558379|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
477504|NCT00132678|1558380|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
477505|NCT00132678|1558381|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
477506|NCT00132678|1558379|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
477507|NCT00132678|1558380|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
477508|NCT00132678|1558381|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
477509|NCT00132678|1558379|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
477510|NCT00132678|1558380|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
477511|NCT00132678|1558381|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
477512|NCT00132678|1558379|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
477513|NCT00132678|1558380|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
477514|NCT00132678|1558381|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
477515|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Pregnancy|0
477516|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Pregnancy|0
477517|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Pregnancy|2
477518|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Physician Decision|0
477519|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Physician Decision|0
477520|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Physician Decision|1
477521|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
477522|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
477523|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
477524|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
477525|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
477526|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
477527|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
477528|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
477529|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
477530|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
477531|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
477532|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
477533|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Non responder|0
477534|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Non responder|0
477535|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Non responder|107
477536|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Adverse Event|0
477537|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Adverse Event|0
477538|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Adverse Event|12
477539|NCT00132678|1558379|P3|Period III (Open-Label Stabilization)|Death|0
477540|NCT00132678|1558380|P2|Period III (Open-Label Stabilization)|Death|0
477541|NCT00132678|1558381|P1|Period III (Open-Label Stabilization)|Death|2
477542|NCT00132678|1558379|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
477543|NCT00132678|1558380|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
477544|NCT00132678|1558381|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
477545|NCT00132678|1558379|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
477546|NCT00132678|1558380|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
477547|NCT00132678|1558381|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
477548|NCT00132678|1558379|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
477549|NCT00132678|1558380|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
477550|NCT00132678|1558381|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
477551|NCT00132678|1558379|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
477552|NCT00132678|1558380|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
477553|NCT00132678|1558381|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
477554|NCT00132678|1558379|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
477555|NCT00132678|1558380|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
477556|NCT00132678|1558381|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
477557|NCT00132678|1558379|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
477558|NCT00132678|1558380|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
477559|NCT00132678|1558381|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
477560|NCT00132678|1558379|P3|Period II (Open-Label Oral Risperidone)|Death|1
477561|NCT00132678|1558380|P2|Period II (Open-Label Oral Risperidone)|Death|0
477562|NCT00132678|1558381|P1|Period II (Open-Label Oral Risperidone)|Death|0
477563|NCT00132496|1558395|P2|Overall Study|Physician Decision|0
477564|NCT00132496|1558396|P1|Overall Study|Physician Decision|1
477565|NCT00132496|1558395|P2|Overall Study|Withdrawal by Subject|2
477566|NCT00132496|1558396|P1|Overall Study|Withdrawal by Subject|1
477567|NCT00132314|1558404|P2|Overall Study|Refused intervention at baseline|7
477568|NCT00132314|1558405|P1|Overall Study|Refused intervention at baseline|2
477569|NCT00132314|1558404|P2|Overall Study|Lacked SSN|3
477570|NCT00132314|1558405|P1|Overall Study|Lacked SSN|1
477571|NCT00132314|1558404|P2|Overall Study|Lost to Follow-up|62
477572|NCT00132314|1558405|P1|Overall Study|Lost to Follow-up|70
477573|NCT00132301|1558415|P2|Overall Study|Excluded by Data Monitoring Committee|0
477574|NCT00132301|1558416|P1|Overall Study|Excluded by Data Monitoring Committee|1
477575|NCT00132301|1558415|P2|Overall Study|Other|1
477576|NCT00132301|1558416|P1|Overall Study|Other|1
477577|NCT00132301|1558415|P2|Overall Study|Lost to Follow-up|3
477578|NCT00132301|1558416|P1|Overall Study|Lost to Follow-up|5
477579|NCT00132301|1558415|P2|Overall Study|Physician Decision|1
477580|NCT00132301|1558416|P1|Overall Study|Physician Decision|1
477581|NCT00132301|1558415|P2|Overall Study|Withdrawal by Subject|2
477582|NCT00132301|1558416|P1|Overall Study|Withdrawal by Subject|5
477583|NCT00132301|1558415|P2|Overall Study|Death|6
477584|NCT00132301|1558416|P1|Overall Study|Death|7
477585|NCT00132132|1558424|P2|Overall Study|Lost to Follow-up|2
477586|NCT00132132|1558425|P1|Overall Study|Lost to Follow-up|7
477587|NCT00132028|1558433|P1|Overall Study|Physician Decision|3
477588|NCT00132028|1558433|P1|Overall Study|not eligible|2
477589|NCT00132028|1558433|P1|Overall Study|Withdrawal by Subject|2
477590|NCT00132028|1558433|P1|Overall Study|Lack of Efficacy|11
477591|NCT00132028|1558433|P1|Overall Study|Death|2
477592|NCT00132028|1558433|P1|Overall Study|Adverse Event|7
477593|NCT00131937|1558445|P1|Overall Study|Alternative therapy|1
477594|NCT00131937|1558445|P1|Overall Study|Disease Progression|7
477595|NCT00131937|1558445|P1|Overall Study|Physician Decision|1
477596|NCT00131937|1558445|P1|Overall Study|Withdrawal by Subject|2
477597|NCT00131937|1558445|P1|Overall Study|Adverse Event|3
477598|NCT00131911|1558453|P2|Overall Study|Withdrawal by Subject|0
477599|NCT00131911|1558454|P1|Overall Study|Withdrawal by Subject|1
477600|NCT00131664|1558524|P6|Second Period (Additional Drug Added)|Administrative reasons|0
477601|NCT00131664|1558525|P5|Second Period (Additional Drug Added)|Administrative reasons|1
477602|NCT00131664|1558526|P4|Second Period (Additional Drug Added)|Administrative reasons|0
477603|NCT00131664|1558527|P3|Second Period (Additional Drug Added)|Administrative reasons|0
477604|NCT00131664|1558528|P2|Second Period (Additional Drug Added)|Administrative reasons|2
477605|NCT00131664|1558529|P1|Second Period (Additional Drug Added)|Administrative reasons|4
477606|NCT00131664|1558524|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
477607|NCT00131664|1558525|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
477608|NCT00131664|1558526|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
477609|NCT00131664|1558527|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
477610|NCT00131664|1558528|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
477611|NCT00131664|1558529|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
477612|NCT00131664|1558524|P6|Second Period (Additional Drug Added)|Adverse Event|1
477613|NCT00131664|1558525|P5|Second Period (Additional Drug Added)|Adverse Event|0
477614|NCT00131664|1558526|P4|Second Period (Additional Drug Added)|Adverse Event|0
477615|NCT00131664|1558527|P3|Second Period (Additional Drug Added)|Adverse Event|0
477616|NCT00131664|1558528|P2|Second Period (Additional Drug Added)|Adverse Event|1
477617|NCT00131664|1558529|P1|Second Period (Additional Drug Added)|Adverse Event|0
477618|NCT00131664|1558524|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
477619|NCT00131664|1558525|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
477620|NCT00131664|1558526|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
477621|NCT00131664|1558527|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
477622|NCT00131664|1558528|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
477623|NCT00131664|1558529|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
477624|NCT00131664|1558524|P6|Second Period (Additional Drug Added)|Protocol Violation|0
477625|NCT00131664|1558525|P5|Second Period (Additional Drug Added)|Protocol Violation|0
477626|NCT00131664|1558526|P4|Second Period (Additional Drug Added)|Protocol Violation|0
477627|NCT00131664|1558527|P3|Second Period (Additional Drug Added)|Protocol Violation|1
477628|NCT00131664|1558528|P2|Second Period (Additional Drug Added)|Protocol Violation|1
477629|NCT00131664|1558529|P1|Second Period (Additional Drug Added)|Protocol Violation|0
477630|NCT00131664|1558524|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
477631|NCT00131664|1558525|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
477632|NCT00131664|1558526|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
477633|NCT00131664|1558527|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
477634|NCT00131664|1558528|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
477635|NCT00131664|1558529|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
477636|NCT00131664|1558524|P6|First Period (First 6 Months)|Administrative reasons|0
477637|NCT00131664|1558525|P5|First Period (First 6 Months)|Administrative reasons|0
477638|NCT00131664|1558526|P4|First Period (First 6 Months)|Administrative reasons|0
477639|NCT00131664|1558527|P3|First Period (First 6 Months)|Administrative reasons|5
477640|NCT00131664|1558528|P2|First Period (First 6 Months)|Administrative reasons|0
477641|NCT00131664|1558529|P1|First Period (First 6 Months)|Administrative reasons|2
477642|NCT00131664|1558524|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
477643|NCT00131664|1558525|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
477644|NCT00131664|1558526|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
477645|NCT00131664|1558527|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
477646|NCT00131664|1558528|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
477647|NCT00131664|1558529|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
477648|NCT00131664|1558524|P6|First Period (First 6 Months)|Adverse Event|0
477649|NCT00131664|1558525|P5|First Period (First 6 Months)|Adverse Event|0
477650|NCT00131664|1558526|P4|First Period (First 6 Months)|Adverse Event|0
477651|NCT00131664|1558527|P3|First Period (First 6 Months)|Adverse Event|5
477652|NCT00131664|1558528|P2|First Period (First 6 Months)|Adverse Event|4
477653|NCT00131664|1558529|P1|First Period (First 6 Months)|Adverse Event|9
477654|NCT00131664|1558524|P6|First Period (First 6 Months)|Withdrawal by Subject|0
477655|NCT00131664|1558525|P5|First Period (First 6 Months)|Withdrawal by Subject|0
477656|NCT00131664|1558526|P4|First Period (First 6 Months)|Withdrawal by Subject|0
477657|NCT00131664|1558527|P3|First Period (First 6 Months)|Withdrawal by Subject|2
477658|NCT00131664|1558528|P2|First Period (First 6 Months)|Withdrawal by Subject|6
477659|NCT00131664|1558529|P1|First Period (First 6 Months)|Withdrawal by Subject|4
477660|NCT00131664|1558524|P6|First Period (First 6 Months)|Protocol Violation|0
477661|NCT00131664|1558525|P5|First Period (First 6 Months)|Protocol Violation|0
477662|NCT00131664|1558526|P4|First Period (First 6 Months)|Protocol Violation|0
477663|NCT00131664|1558527|P3|First Period (First 6 Months)|Protocol Violation|1
477664|NCT00131664|1558528|P2|First Period (First 6 Months)|Protocol Violation|2
477665|NCT00131664|1558529|P1|First Period (First 6 Months)|Protocol Violation|2
477666|NCT00131664|1558524|P6|First Period (First 6 Months)|Death|0
477667|NCT00131664|1558525|P5|First Period (First 6 Months)|Death|0
477668|NCT00131664|1558526|P4|First Period (First 6 Months)|Death|0
477669|NCT00131664|1558527|P3|First Period (First 6 Months)|Death|0
477670|NCT00131664|1558528|P2|First Period (First 6 Months)|Death|1
477671|NCT00131664|1558529|P1|First Period (First 6 Months)|Death|0
477672|NCT00131664|1558524|P6|First Period (First 6 Months)|Lost to Follow-up|0
477673|NCT00131664|1558525|P5|First Period (First 6 Months)|Lost to Follow-up|0
477674|NCT00131664|1558526|P4|First Period (First 6 Months)|Lost to Follow-up|0
477675|NCT00131664|1558527|P3|First Period (First 6 Months)|Lost to Follow-up|3
477676|NCT00131664|1558528|P2|First Period (First 6 Months)|Lost to Follow-up|3
477677|NCT00131664|1558529|P1|First Period (First 6 Months)|Lost to Follow-up|7
477678|NCT00131508|1558601|P2|Overall Study|Withdrawal by Subject|2
477679|NCT00131508|1558602|P1|Overall Study|Withdrawal by Subject|1
477680|NCT00131508|1558601|P2|Overall Study|Non-Compliance|4
477681|NCT00131508|1558602|P1|Overall Study|Non-Compliance|2
477682|NCT00131508|1558601|P2|Overall Study|Disease progression|2
477683|NCT00131508|1558602|P1|Overall Study|Disease progression|0
477684|NCT00131352|1558664|P2|Repeat Treatment Period|Other|0
477685|NCT00131352|1558665|P1|Repeat Treatment Period|Other|1
477686|NCT00131352|1558664|P2|Repeat Treatment Period|Adverse Event|0
477687|NCT00131352|1558665|P1|Repeat Treatment Period|Adverse Event|1
477688|NCT00131352|1558664|P2|Initial Treatment Period|Other|2
477689|NCT00131352|1558665|P1|Initial Treatment Period|Other|0
477690|NCT00131352|1558664|P2|Initial Treatment Period|Lack of Efficacy|4
477691|NCT00131352|1558665|P1|Initial Treatment Period|Lack of Efficacy|6
477692|NCT00131352|1558664|P2|Initial Treatment Period|Withdrawal by Subject|1
477693|NCT00131352|1558665|P1|Initial Treatment Period|Withdrawal by Subject|1
477694|NCT00131352|1558664|P2|Initial Treatment Period|Non-compliant|2
477695|NCT00131352|1558665|P1|Initial Treatment Period|Non-compliant|1
477696|NCT00131352|1558664|P2|Initial Treatment Period|Adverse Event|3
477697|NCT00131352|1558665|P1|Initial Treatment Period|Adverse Event|1
477698|NCT00131248|1558687|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
477699|NCT00131248|1558688|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
477700|NCT00130832|1558705|P2|Overall Study|Other|3
477701|NCT00130832|1558706|P1|Overall Study|Other|0
477702|NCT00130832|1558705|P2|Overall Study|Moved|2
477703|NCT00130832|1558706|P1|Overall Study|Moved|2
477704|NCT00130832|1558705|P2|Overall Study|Withdrawal by Subject|1
477705|NCT00130832|1558706|P1|Overall Study|Withdrawal by Subject|6
477706|NCT00130832|1558705|P2|Overall Study|Protocol Violation|8
477707|NCT00130832|1558706|P1|Overall Study|Protocol Violation|6
477708|NCT00130832|1558705|P2|Overall Study|Lost to Follow-up|2
477709|NCT00130832|1558706|P1|Overall Study|Lost to Follow-up|1
477710|NCT00130832|1558705|P2|Overall Study|Adverse Event|1
477711|NCT00130832|1558706|P1|Overall Study|Adverse Event|1
477712|NCT00130793|1558718|P2|Overall Study|Withdrew consent|0
477713|NCT00130793|1558719|P1|Overall Study|Withdrew consent|2
477714|NCT00130793|1558718|P2|Overall Study|Lost to Follow-up|4
477715|NCT00130793|1558719|P1|Overall Study|Lost to Follow-up|1
477716|NCT00130728|1558740|P2|Overall Study|Withdrawal by Subject|2
477717|NCT00130728|1558741|P1|Overall Study|Withdrawal by Subject|0
477718|NCT00130728|1558740|P2|Overall Study|Lost to Follow-up|0
477719|NCT00130728|1558741|P1|Overall Study|Lost to Follow-up|4
477720|NCT00130728|1558740|P2|Overall Study|Death|211
477721|NCT00130728|1558741|P1|Overall Study|Death|207
477722|NCT00130689|1558753|P1|Overall Study|Ineligible|6
477723|NCT00130689|1558753|P1|Overall Study|Withdrawal by Subject|3
477724|NCT00130689|1558753|P1|Overall Study|Clinical Deterioration|4
477725|NCT00130689|1558753|P1|Overall Study|Death|1
477726|NCT00130689|1558753|P1|Overall Study|Progressive Disease|29
477727|NCT00130637|1558757|P1|Overall Study|Withdrawal by Subject|1
477728|NCT00130637|1558757|P1|Overall Study|Adverse Event|2
477729|NCT00130520|1558762|P1|Overall Study|Did not meet re-treatment criteria|1
477730|NCT00130520|1558762|P1|Overall Study|Protocol non-compliance|1
477731|NCT00130520|1558762|P1|Overall Study|Disease Progression|23
477732|NCT00130520|1558762|P1|Overall Study|Withdrawal by Subject|1
477733|NCT00130520|1558762|P1|Overall Study|Physician Decision|1
477734|NCT00130520|1558762|P1|Overall Study|Death|1
477735|NCT00130520|1558762|P1|Overall Study|Adverse Event|11
477736|NCT00130286|1558772|P4|Overall Study|Missing lab specimens|0
477737|NCT00130286|1558773|P3|Overall Study|Missing lab specimens|0
477738|NCT00130286|1558774|P2|Overall Study|Missing lab specimens|2
477739|NCT00130286|1558775|P1|Overall Study|Missing lab specimens|0
477740|NCT00130286|1558772|P4|Overall Study|Adverse Event|0
477741|NCT00130286|1558773|P3|Overall Study|Adverse Event|2
477742|NCT00130286|1558774|P2|Overall Study|Adverse Event|0
477743|NCT00130286|1558775|P1|Overall Study|Adverse Event|0
477744|NCT00130286|1558772|P4|Overall Study|Withdrawal by Subject|2
477745|NCT00130286|1558773|P3|Overall Study|Withdrawal by Subject|2
477746|NCT00130286|1558774|P2|Overall Study|Withdrawal by Subject|1
477747|NCT00130286|1558775|P1|Overall Study|Withdrawal by Subject|0
477748|NCT00130247|1558795|P2|Overall Study|Not compliant with DOT|2
477749|NCT00130247|1558796|P1|Overall Study|Not compliant with DOT|0
477750|NCT00130247|1558795|P2|Overall Study|Post-randomization exclusion|2
477751|NCT00130247|1558796|P1|Overall Study|Post-randomization exclusion|1
477752|NCT00130247|1558795|P2|Overall Study|Pregnancy|0
477753|NCT00130247|1558796|P1|Overall Study|Pregnancy|1
477754|NCT00130208|1558814|P2|Washout Period (8 Weeks)|Other|1
477755|NCT00130208|1558815|P1|Washout Period (8 Weeks)|Other|1
477756|NCT00130208|1558814|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
477757|NCT00130208|1558815|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
477758|NCT00130208|1558814|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
477759|NCT00130208|1558815|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
477760|NCT00130208|1558814|P2|Washout Period (8 Weeks)|Adverse Event|6
477761|NCT00130208|1558815|P1|Washout Period (8 Weeks)|Adverse Event|3
477762|NCT00130208|1558814|P2|Maintenance Period (26 Weeks)|Other|1
477763|NCT00130208|1558815|P1|Maintenance Period (26 Weeks)|Other|1
477764|NCT00130208|1558814|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
477765|NCT00130208|1558815|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
477766|NCT00130208|1558814|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
477767|NCT00130208|1558815|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
477768|NCT00130208|1558814|P2|Maintenance Period (26 Weeks)|Physician Decision|2
477769|NCT00130208|1558815|P1|Maintenance Period (26 Weeks)|Physician Decision|0
477770|NCT00130208|1558814|P2|Maintenance Period (26 Weeks)|Adverse Event|12
477771|NCT00130208|1558815|P1|Maintenance Period (26 Weeks)|Adverse Event|10
477772|NCT00130039|1558851|P2|Overall Study|clinical events without follow up MRI|4
477773|NCT00130039|1558852|P1|Overall Study|clinical events without follow up MRI|5
477774|NCT00130039|1558851|P2|Overall Study|Physician Decision|0
477775|NCT00130039|1558852|P1|Overall Study|Physician Decision|3
477776|NCT00130039|1558851|P2|Overall Study|Adverse Event|2
477777|NCT00130039|1558852|P1|Overall Study|Adverse Event|4
477778|NCT00130039|1558851|P2|Overall Study|Lost to Follow-up|1
477779|NCT00130039|1558852|P1|Overall Study|Lost to Follow-up|3
477780|NCT00130039|1558851|P2|Overall Study|Withdrawal by Subject|11
477781|NCT00130039|1558852|P1|Overall Study|Withdrawal by Subject|15
477782|NCT00129974|1558868|P1|Overall Study|Other|1
477783|NCT00129961|1558875|P2|Overall Study|Missing Record|1
477784|NCT00129961|1558876|P1|Overall Study|Missing Record|0
477785|NCT00129961|1558875|P2|Overall Study|Withdrawal by Subject|1
477786|NCT00129961|1558876|P1|Overall Study|Withdrawal by Subject|2
477787|NCT00129961|1558875|P2|Overall Study|Physician Decision|0
477788|NCT00129961|1558876|P1|Overall Study|Physician Decision|1
477789|NCT00129961|1558875|P2|Overall Study|Withdrawal by Sponsor|20
477790|NCT00129961|1558876|P1|Overall Study|Withdrawal by Sponsor|14
477791|NCT00129961|1558875|P2|Overall Study|Death|1
477792|NCT00129961|1558876|P1|Overall Study|Death|1
477793|NCT00129961|1558875|P2|Overall Study|Adverse Event|0
477794|NCT00129961|1558876|P1|Overall Study|Adverse Event|1
477795|NCT00129766|1558912|P2|Overall Study|Lost to Follow-up|21
477796|NCT00129766|1558913|P1|Overall Study|Lost to Follow-up|26
477797|NCT00129766|1558912|P2|Overall Study|Withdrawal of consent|30
477798|NCT00129766|1558913|P1|Overall Study|Withdrawal of consent|31
477799|NCT00129766|1558912|P2|Overall Study|Death|8
477800|NCT00129766|1558913|P1|Overall Study|Death|3
477801|NCT00129623|1558959|P2|Overall Study|Uncertainty to return|1
477802|NCT00129623|1558960|P1|Overall Study|Uncertainty to return|0
477803|NCT00129623|1558959|P2|Overall Study|Relocated job out of state|0
477804|NCT00129623|1558960|P1|Overall Study|Relocated job out of state|1
477805|NCT00129623|1558959|P2|Overall Study|Failure to Return|1
477806|NCT00129623|1558960|P1|Overall Study|Failure to Return|1
477807|NCT00129623|1558959|P2|Overall Study|Refused Treatment|3
477808|NCT00129623|1558960|P1|Overall Study|Refused Treatment|5
477809|NCT00129623|1558959|P2|Overall Study|Adverse Event|7
477810|NCT00129623|1558960|P1|Overall Study|Adverse Event|3
477811|NCT00129545|1558985|P3|Overall Study|Device not implanted|0
477812|NCT00129545|1558986|P2|Overall Study|Device not implanted|61
477813|NCT00129545|1558987|P1|Overall Study|Device not implanted|16
477814|NCT00129545|1558985|P3|Overall Study|Physician Decision|10
477815|NCT00129545|1558986|P2|Overall Study|Physician Decision|3
477816|NCT00129545|1558987|P1|Overall Study|Physician Decision|0
477817|NCT00129545|1558985|P3|Overall Study|Lost to Follow-up|13
477818|NCT00129545|1558986|P2|Overall Study|Lost to Follow-up|22
477819|NCT00129545|1558987|P1|Overall Study|Lost to Follow-up|2
477820|NCT00129545|1558985|P3|Overall Study|Withdrawal by Subject|44
477821|NCT00129545|1558986|P2|Overall Study|Withdrawal by Subject|18
477822|NCT00129545|1558987|P1|Overall Study|Withdrawal by Subject|3
477823|NCT00129545|1558985|P3|Overall Study|Death|44
477824|NCT00129545|1558986|P2|Overall Study|Death|60
477825|NCT00129545|1558987|P1|Overall Study|Death|5
477826|NCT00129467|1559008|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
477827|NCT00129467|1559009|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
477828|NCT00129467|1559008|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
477829|NCT00129467|1559009|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
477830|NCT00129467|1559008|P2|Received Intervention|Dizzyness, fatigue|1
477831|NCT00129467|1559009|P1|Received Intervention|Dizzyness, fatigue|0
477832|NCT00129467|1559008|P2|Received Intervention|Intolerance to citalopram|1
477833|NCT00129467|1559009|P1|Received Intervention|Intolerance to citalopram|0
477834|NCT00129467|1559008|P2|Received Intervention|Nausea|0
477835|NCT00129467|1559009|P1|Received Intervention|Nausea|1
477836|NCT00129467|1559008|P2|Received Intervention|Withdrawal by Subject|0
477837|NCT00129467|1559009|P1|Received Intervention|Withdrawal by Subject|1
477838|NCT00129467|1559008|P2|Received Intervention|Delirium|0
477839|NCT00129467|1559009|P1|Received Intervention|Delirium|2
477840|NCT00129467|1559008|P2|Received Intervention|Cardiac SAE (hypertension)|1
477841|NCT00129467|1559009|P1|Received Intervention|Cardiac SAE (hypertension)|1
477842|NCT00129467|1559008|P2|Received Intervention|Death|1
477843|NCT00129467|1559009|P1|Received Intervention|Death|1
477844|NCT00129402|1559040|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
477845|NCT00129402|1559041|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
477846|NCT00129402|1559042|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
477847|NCT00129402|1559043|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
477848|NCT00129402|1559044|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
477849|NCT00129402|1559045|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
477850|NCT00129402|1559046|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
477851|NCT00129402|1559040|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
477852|NCT00129402|1559041|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
477853|NCT00129402|1559042|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
477854|NCT00129402|1559043|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
477855|NCT00129402|1559044|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
477856|NCT00129402|1559045|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
477857|NCT00129402|1559046|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
477858|NCT00129402|1559040|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
477859|NCT00129402|1559041|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
477860|NCT00129402|1559042|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
477861|NCT00129402|1559043|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
477862|NCT00129402|1559044|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
477863|NCT00129402|1559045|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
477864|NCT00129402|1559046|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
477865|NCT00129402|1559040|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
477866|NCT00129402|1559041|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
477867|NCT00129402|1559042|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
477868|NCT00129402|1559043|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
477869|NCT00129402|1559044|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
477870|NCT00129402|1559045|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
477871|NCT00129402|1559046|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
477872|NCT00129402|1559040|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
477873|NCT00129402|1559041|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
477874|NCT00129402|1559042|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
477875|NCT00129402|1559043|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
477876|NCT00129402|1559044|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
477877|NCT00129402|1559045|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
477878|NCT00129402|1559046|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
477879|NCT00129402|1559040|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
477880|NCT00129402|1559041|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
477881|NCT00129402|1559042|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
477882|NCT00129402|1559043|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
477883|NCT00129402|1559044|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
477884|NCT00129402|1559045|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
477885|NCT00129402|1559046|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
477886|NCT00129402|1559040|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
477887|NCT00129402|1559041|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
477888|NCT00129402|1559042|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
477889|NCT00129402|1559043|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
477890|NCT00129402|1559044|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
477891|NCT00129402|1559045|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
477892|NCT00129402|1559046|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
477893|NCT00129402|1559040|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
477894|NCT00129402|1559041|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
477895|NCT00129402|1559042|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
477896|NCT00129402|1559043|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
477897|NCT00129402|1559044|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
477898|NCT00129402|1559045|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
477899|NCT00129402|1559046|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
477900|NCT00129402|1559040|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
477901|NCT00129402|1559041|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
477902|NCT00129402|1559042|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
477903|NCT00129402|1559043|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
477904|NCT00129402|1559044|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
477905|NCT00129402|1559045|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
477906|NCT00129402|1559046|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
477907|NCT00129402|1559040|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
477908|NCT00129402|1559041|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
477909|NCT00129402|1559042|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
477910|NCT00129402|1559043|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
477911|NCT00129402|1559044|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
477912|NCT00129402|1559045|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
477913|NCT00129402|1559046|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
477914|NCT00129402|1559040|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
477915|NCT00129402|1559041|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
477916|NCT00129402|1559042|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
477917|NCT00129402|1559043|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
477918|NCT00129402|1559044|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
477919|NCT00129402|1559045|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
477920|NCT00129402|1559046|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
477921|NCT00129402|1559040|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
477922|NCT00129402|1559041|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
477923|NCT00129402|1559042|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
477924|NCT00129402|1559043|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
477925|NCT00129402|1559044|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
477926|NCT00129402|1559045|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
477927|NCT00129402|1559046|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
477928|NCT00129402|1559040|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
477929|NCT00129402|1559041|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
477930|NCT00129402|1559042|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
477931|NCT00129402|1559043|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
477932|NCT00129402|1559044|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
477933|NCT00129402|1559045|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
477934|NCT00129402|1559046|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
477935|NCT00129311|1559065|P2|Overall Study|Withdrawal by Subject|19
477936|NCT00129311|1559066|P1|Overall Study|Withdrawal by Subject|12
477937|NCT00129272|1559095|P2|Overall Study|Withdrawal by Subject|11
477938|NCT00129272|1559096|P1|Overall Study|Withdrawal by Subject|5
477939|NCT00129272|1559095|P2|Overall Study|Lost to Follow-up|11
477940|NCT00129272|1559096|P1|Overall Study|Lost to Follow-up|12
477941|NCT00129259|1559106|P2|Overall Study|Only available minimal phone assessments|1
477942|NCT00129259|1559107|P1|Overall Study|Only available minimal phone assessments|0
477943|NCT00129259|1559106|P2|Overall Study|Withdrawal by Subject|1
477944|NCT00129259|1559107|P1|Overall Study|Withdrawal by Subject|2
477945|NCT00129259|1559106|P2|Overall Study|Lost to Follow-up|1
477946|NCT00129259|1559107|P1|Overall Study|Lost to Follow-up|1
477947|NCT00129220|1559135|P3|Study Period III|Reason Not Specified|2
477948|NCT00129220|1559136|P2|Study Period III|Reason Not Specified|0
477949|NCT00129220|1559137|P1|Study Period III|Reason Not Specified|9
477950|NCT00129220|1559135|P3|Study Period III|Sponsor Decision|0
477951|NCT00129220|1559136|P2|Study Period III|Sponsor Decision|0
477952|NCT00129220|1559137|P1|Study Period III|Sponsor Decision|1
477953|NCT00129220|1559135|P3|Study Period III|Withdrawal by Subject|3
477954|NCT00129220|1559136|P2|Study Period III|Withdrawal by Subject|0
477955|NCT00129220|1559137|P1|Study Period III|Withdrawal by Subject|1
477956|NCT00129220|1559135|P3|Study Period III|Protocol Violation|2
477957|NCT00129220|1559136|P2|Study Period III|Protocol Violation|1
477958|NCT00129220|1559137|P1|Study Period III|Protocol Violation|1
477959|NCT00129220|1559135|P3|Study Period III|Adverse Event|3
477960|NCT00129220|1559136|P2|Study Period III|Adverse Event|0
477961|NCT00129220|1559137|P1|Study Period III|Adverse Event|1
477962|NCT00129220|1559135|P3|Study Period II|Reason Not Specified|5
477963|NCT00129220|1559136|P2|Study Period II|Reason Not Specified|0
477964|NCT00129220|1559137|P1|Study Period II|Reason Not Specified|2
477965|NCT00129220|1559135|P3|Study Period II|Withdrawal by Subject|4
477966|NCT00129220|1559136|P2|Study Period II|Withdrawal by Subject|3
477967|NCT00129220|1559137|P1|Study Period II|Withdrawal by Subject|1
477968|NCT00129220|1559135|P3|Study Period II|Physician Decision|0
477969|NCT00129220|1559136|P2|Study Period II|Physician Decision|1
477970|NCT00129220|1559137|P1|Study Period II|Physician Decision|0
477971|NCT00129220|1559135|P3|Study Period II|Protocol Violation|1
477972|NCT00129220|1559136|P2|Study Period II|Protocol Violation|2
477973|NCT00129220|1559137|P1|Study Period II|Protocol Violation|4
477974|NCT00129220|1559135|P3|Study Period II|Entry Criteria Not Met|2
477975|NCT00129220|1559136|P2|Study Period II|Entry Criteria Not Met|0
477976|NCT00129220|1559137|P1|Study Period II|Entry Criteria Not Met|2
477977|NCT00129220|1559135|P3|Study Period II|Lack of Efficacy|28
477978|NCT00129220|1559136|P2|Study Period II|Lack of Efficacy|1
477979|NCT00129220|1559137|P1|Study Period II|Lack of Efficacy|15
477980|NCT00129220|1559135|P3|Study Period II|Adverse Event|7
477981|NCT00129220|1559136|P2|Study Period II|Adverse Event|5
477982|NCT00129220|1559137|P1|Study Period II|Adverse Event|9
477983|NCT00129129|1559177|P5|Fourth Dose Phase|Protocol Violation|0
477984|NCT00129129|1559178|P4|Fourth Dose Phase|Protocol Violation|1
477985|NCT00129129|1559179|P3|Fourth Dose Phase|Protocol Violation|0
477986|NCT00129129|1559180|P2|Fourth Dose Phase|Protocol Violation|0
477987|NCT00129129|1559181|P1|Fourth Dose Phase|Protocol Violation|0
477988|NCT00129129|1559177|P5|Fourth Dose Phase|Other|1
477989|NCT00129129|1559178|P4|Fourth Dose Phase|Other|1
477990|NCT00129129|1559179|P3|Fourth Dose Phase|Other|0
477991|NCT00129129|1559180|P2|Fourth Dose Phase|Other|0
477992|NCT00129129|1559181|P1|Fourth Dose Phase|Other|0
477993|NCT00129129|1559177|P5|Fourth Dose Phase|Migration from study area|2
477994|NCT00129129|1559178|P4|Fourth Dose Phase|Migration from study area|0
477995|NCT00129129|1559179|P3|Fourth Dose Phase|Migration from study area|0
477996|NCT00129129|1559180|P2|Fourth Dose Phase|Migration from study area|0
477997|NCT00129129|1559181|P1|Fourth Dose Phase|Migration from study area|0
477998|NCT00129129|1559177|P5|Fourth Dose Phase|Withdrawal by Subject|1
477999|NCT00129129|1559178|P4|Fourth Dose Phase|Withdrawal by Subject|0
478000|NCT00129129|1559179|P3|Fourth Dose Phase|Withdrawal by Subject|0
478001|NCT00129129|1559180|P2|Fourth Dose Phase|Withdrawal by Subject|0
478002|NCT00129129|1559181|P1|Fourth Dose Phase|Withdrawal by Subject|0
478003|NCT00129129|1559177|P5|Fourth Dose Phase|Lost to Follow-up|2
478004|NCT00129129|1559178|P4|Fourth Dose Phase|Lost to Follow-up|2
478005|NCT00129129|1559179|P3|Fourth Dose Phase|Lost to Follow-up|0
478006|NCT00129129|1559180|P2|Fourth Dose Phase|Lost to Follow-up|0
478007|NCT00129129|1559181|P1|Fourth Dose Phase|Lost to Follow-up|4
478008|NCT00129129|1559177|P5|Primary Phase|Other|0
478009|NCT00129129|1559178|P4|Primary Phase|Other|0
478010|NCT00129129|1559179|P3|Primary Phase|Other|0
478011|NCT00129129|1559180|P2|Primary Phase|Other|5
478012|NCT00129129|1559181|P1|Primary Phase|Other|2
478013|NCT00129129|1559177|P5|Primary Phase|Lost to Follow-up|0
478014|NCT00129129|1559178|P4|Primary Phase|Lost to Follow-up|0
478015|NCT00129129|1559179|P3|Primary Phase|Lost to Follow-up|0
478016|NCT00129129|1559180|P2|Primary Phase|Lost to Follow-up|6
478017|NCT00129129|1559181|P1|Primary Phase|Lost to Follow-up|8
478018|NCT00129129|1559177|P5|Primary Phase|Migration from study area|0
478019|NCT00129129|1559178|P4|Primary Phase|Migration from study area|0
478020|NCT00129129|1559179|P3|Primary Phase|Migration from study area|0
478021|NCT00129129|1559180|P2|Primary Phase|Migration from study area|3
478022|NCT00129129|1559181|P1|Primary Phase|Migration from study area|1
478023|NCT00129129|1559177|P5|Primary Phase|Withdrawal by Subject|0
478024|NCT00129129|1559178|P4|Primary Phase|Withdrawal by Subject|0
478025|NCT00129129|1559179|P3|Primary Phase|Withdrawal by Subject|0
478026|NCT00129129|1559180|P2|Primary Phase|Withdrawal by Subject|10
478027|NCT00129129|1559181|P1|Primary Phase|Withdrawal by Subject|12
478028|NCT00129129|1559177|P5|Primary Phase|Adverse Event|0
478029|NCT00129129|1559178|P4|Primary Phase|Adverse Event|0
478030|NCT00129129|1559179|P3|Primary Phase|Adverse Event|0
478031|NCT00129129|1559180|P2|Primary Phase|Adverse Event|1
478032|NCT00129129|1559181|P1|Primary Phase|Adverse Event|2
478033|NCT00129116|1559388|P5|Booster Phase|Lost to Follow-up|1
478034|NCT00129116|1559389|P4|Booster Phase|Lost to Follow-up|0
478035|NCT00129116|1559390|P3|Booster Phase|Lost to Follow-up|0
478036|NCT00129116|1559391|P2|Booster Phase|Lost to Follow-up|0
478037|NCT00129116|1559392|P1|Booster Phase|Lost to Follow-up|2
478038|NCT00129116|1559388|P5|Primary Phase|Other|0
478039|NCT00129116|1559389|P4|Primary Phase|Other|0
478040|NCT00129116|1559390|P3|Primary Phase|Other|1
478041|NCT00129116|1559391|P2|Primary Phase|Other|0
478042|NCT00129116|1559392|P1|Primary Phase|Other|0
478043|NCT00129116|1559388|P5|Primary Phase|Withdrawal by Subject|0
478044|NCT00129116|1559389|P4|Primary Phase|Withdrawal by Subject|0
478045|NCT00129116|1559390|P3|Primary Phase|Withdrawal by Subject|0
478046|NCT00129116|1559391|P2|Primary Phase|Withdrawal by Subject|1
478047|NCT00129116|1559392|P1|Primary Phase|Withdrawal by Subject|0
478048|NCT00129116|1559388|P5|Primary Phase|Adverse Event|0
478049|NCT00129116|1559389|P4|Primary Phase|Adverse Event|0
478050|NCT00129116|1559390|P3|Primary Phase|Adverse Event|0
478051|NCT00129116|1559391|P2|Primary Phase|Adverse Event|1
478052|NCT00129116|1559392|P1|Primary Phase|Adverse Event|1
478053|NCT00129116|1559388|P5|Primary Phase|Protocol Violation|0
478054|NCT00129116|1559389|P4|Primary Phase|Protocol Violation|0
478055|NCT00129116|1559390|P3|Primary Phase|Protocol Violation|0
478056|NCT00129116|1559391|P2|Primary Phase|Protocol Violation|1
478057|NCT00129116|1559392|P1|Primary Phase|Protocol Violation|0
478058|NCT00129116|1559388|P5|Primary Phase|Lost to Follow-up|1
478059|NCT00129116|1559389|P4|Primary Phase|Lost to Follow-up|1
478060|NCT00129116|1559390|P3|Primary Phase|Lost to Follow-up|0
478061|NCT00129116|1559391|P2|Primary Phase|Lost to Follow-up|1
478062|NCT00129116|1559392|P1|Primary Phase|Lost to Follow-up|1
478063|NCT00128830|1559676|P1|Overall Study|Other|9
478064|NCT00128830|1559676|P1|Overall Study|Discontinued or ineligible for study|2
478065|NCT00128830|1559676|P1|Overall Study|Non-compliant|4
478066|NCT00128830|1559676|P1|Overall Study|Reached a virologic endpoint|29
478067|NCT00128830|1559676|P1|Overall Study|Lost to Follow-up|4
478068|NCT00128830|1559676|P1|Overall Study|Withdrawal by Subject|14
478069|NCT00128830|1559676|P1|Overall Study|Adverse Event|10
478070|NCT00128661|1559718|P2|Overall Study|Other|8
478071|NCT00128661|1559719|P1|Overall Study|Other|7
478072|NCT00128661|1559718|P2|Overall Study|Withdrawal by Subject|232
478073|NCT00128661|1559719|P1|Overall Study|Withdrawal by Subject|243
478074|NCT00128661|1559718|P2|Overall Study|Lost to Follow-up|7
478075|NCT00128661|1559719|P1|Overall Study|Lost to Follow-up|10
478076|NCT00128661|1559718|P2|Overall Study|Adverse Event|11
478077|NCT00128661|1559719|P1|Overall Study|Adverse Event|14
478078|NCT00128492|1559765|P2|Overall Study|Pregnancy|1
478079|NCT00128492|1559766|P1|Overall Study|Pregnancy|0
478080|NCT00128492|1559765|P2|Overall Study|Withdrawal by Subject|5
478081|NCT00128492|1559766|P1|Overall Study|Withdrawal by Subject|3
478082|NCT00128492|1559765|P2|Overall Study|Personal or administrative|22
478083|NCT00128492|1559766|P1|Overall Study|Personal or administrative|10
478084|NCT00128492|1559765|P2|Overall Study|Noncompliance|5
478085|NCT00128492|1559766|P1|Overall Study|Noncompliance|0
478086|NCT00128492|1559765|P2|Overall Study|Lost to Follow-up|5
478087|NCT00128492|1559766|P1|Overall Study|Lost to Follow-up|1
478088|NCT00128492|1559765|P2|Overall Study|Death|0
478089|NCT00128492|1559766|P1|Overall Study|Death|1
478090|NCT00128492|1559765|P2|Overall Study|AE related to study|4
478091|NCT00128492|1559766|P1|Overall Study|AE related to study|1
478092|NCT00128492|1559765|P2|Overall Study|Study drug intolerance (AE)|8
478093|NCT00128492|1559766|P1|Overall Study|Study drug intolerance (AE)|2
478094|NCT00128492|1559765|P2|Overall Study|AE unrelated to study|9
478095|NCT00128492|1559766|P1|Overall Study|AE unrelated to study|2
478096|NCT00128206|1559923|P2|Overall Study|Adverse Event|2
478097|NCT00128206|1559924|P1|Overall Study|Adverse Event|0
478098|NCT00128206|1559923|P2|Overall Study|Lost to Follow-up|118
478099|NCT00128206|1559924|P1|Overall Study|Lost to Follow-up|137
478100|NCT00127933|1560216|P2|Overall Study|Randomized but not dosed|0
478101|NCT00127933|1560217|P1|Overall Study|Randomized but not dosed|1
478102|NCT00127855|1560238|P5|Primary Vaccination Course|Other|1
478103|NCT00127855|1560239|P4|Primary Vaccination Course|Other|0
478104|NCT00127855|1560240|P3|Primary Vaccination Course|Other|0
478105|NCT00127855|1560241|P2|Primary Vaccination Course|Other|0
478106|NCT00127855|1560242|P1|Primary Vaccination Course|Other|0
478107|NCT00127855|1560238|P5|Primary Vaccination Course|Lost to Follow-up|2
478108|NCT00127855|1560239|P4|Primary Vaccination Course|Lost to Follow-up|0
478109|NCT00127855|1560240|P3|Primary Vaccination Course|Lost to Follow-up|1
478110|NCT00127855|1560241|P2|Primary Vaccination Course|Lost to Follow-up|1
478111|NCT00127855|1560242|P1|Primary Vaccination Course|Lost to Follow-up|1
478112|NCT00127855|1560238|P5|Primary Vaccination Course|Withdrawal by Subject|1
478113|NCT00127855|1560239|P4|Primary Vaccination Course|Withdrawal by Subject|0
478114|NCT00127855|1560240|P3|Primary Vaccination Course|Withdrawal by Subject|0
478115|NCT00127855|1560241|P2|Primary Vaccination Course|Withdrawal by Subject|0
478116|NCT00127855|1560242|P1|Primary Vaccination Course|Withdrawal by Subject|1
478117|NCT00127855|1560238|P5|Primary Vaccination Course|Adverse Event|0
478118|NCT00127855|1560239|P4|Primary Vaccination Course|Adverse Event|0
478119|NCT00127855|1560240|P3|Primary Vaccination Course|Adverse Event|1
478120|NCT00127855|1560241|P2|Primary Vaccination Course|Adverse Event|0
478121|NCT00127855|1560242|P1|Primary Vaccination Course|Adverse Event|0
478122|NCT00127842|1560424|P1|Overall Study|Other|5
478123|NCT00127842|1560424|P1|Overall Study|Protocol Violation|1
478124|NCT00127842|1560424|P1|Overall Study|Noncompliance|2
478125|NCT00127842|1560424|P1|Overall Study|Lack of Efficacy|12
478126|NCT00127842|1560424|P1|Overall Study|Lost to Follow-up|1
478127|NCT00127842|1560424|P1|Overall Study|Withdrawal by Subject|3
478128|NCT00127842|1560424|P1|Overall Study|Adverse Event|15
478129|NCT00127803|1560442|P4|Overall Study|Lost to Follow-up|1
478130|NCT00127803|1560443|P3|Overall Study|Lost to Follow-up|0
478131|NCT00127803|1560444|P2|Overall Study|Lost to Follow-up|0
478132|NCT00127803|1560445|P1|Overall Study|Lost to Follow-up|0
478133|NCT00127803|1560442|P4|Overall Study|Withdrawal by Subject|0
478134|NCT00127803|1560443|P3|Overall Study|Withdrawal by Subject|0
478135|NCT00127803|1560444|P2|Overall Study|Withdrawal by Subject|0
478136|NCT00127803|1560445|P1|Overall Study|Withdrawal by Subject|1
478137|NCT00127803|1560442|P4|Overall Study|Adverse Event|0
478138|NCT00127803|1560443|P3|Overall Study|Adverse Event|0
478139|NCT00127803|1560444|P2|Overall Study|Adverse Event|0
478140|NCT00127803|1560445|P1|Overall Study|Adverse Event|2
478141|NCT00127712|1560494|P2|Overall Study|Lack of GI access to continue|0
478142|NCT00127712|1560495|P1|Overall Study|Lack of GI access to continue|2
478143|NCT00127712|1560494|P2|Overall Study|Adverse Event|0
478144|NCT00127712|1560495|P1|Overall Study|Adverse Event|3
478145|NCT00127660|1560511|P4|Overall Study|Protocol Violation|0
478146|NCT00127660|1560512|P3|Overall Study|Protocol Violation|5
478147|NCT00127660|1560513|P2|Overall Study|Protocol Violation|3
478148|NCT00127660|1560514|P1|Overall Study|Protocol Violation|3
478149|NCT00127413|1560562|P4|Overall Study|Lost to Follow-up|2
478150|NCT00127413|1560563|P3|Overall Study|Lost to Follow-up|8
478151|NCT00127413|1560564|P2|Overall Study|Lost to Follow-up|4
478152|NCT00127413|1560565|P1|Overall Study|Lost to Follow-up|6
478153|NCT00127192|1560608|P5|Overall Study|Adverse event in pre-treatment period|0
478154|NCT00127192|1560609|P4|Overall Study|Adverse event in pre-treatment period|0
478155|NCT00127192|1560610|P3|Overall Study|Adverse event in pre-treatment period|0
478156|NCT00127192|1560611|P2|Overall Study|Adverse event in pre-treatment period|0
478157|NCT00127192|1560612|P1|Overall Study|Adverse event in pre-treatment period|1
478158|NCT00127192|1560608|P5|Overall Study|Withdrawal by Subject|3
478159|NCT00127192|1560609|P4|Overall Study|Withdrawal by Subject|0
478160|NCT00127192|1560610|P3|Overall Study|Withdrawal by Subject|1
478161|NCT00127192|1560611|P2|Overall Study|Withdrawal by Subject|0
478162|NCT00127192|1560612|P1|Overall Study|Withdrawal by Subject|0
478163|NCT00127192|1560608|P5|Overall Study|Lack of Efficacy|2
478164|NCT00127192|1560609|P4|Overall Study|Lack of Efficacy|0
478165|NCT00127192|1560610|P3|Overall Study|Lack of Efficacy|0
478166|NCT00127192|1560611|P2|Overall Study|Lack of Efficacy|0
478167|NCT00127192|1560612|P1|Overall Study|Lack of Efficacy|2
478168|NCT00127192|1560608|P5|Overall Study|Adverse Event|0
478169|NCT00127192|1560609|P4|Overall Study|Adverse Event|1
478170|NCT00127192|1560610|P3|Overall Study|Adverse Event|1
478171|NCT00127192|1560611|P2|Overall Study|Adverse Event|1
478172|NCT00127192|1560612|P1|Overall Study|Adverse Event|0
478173|NCT00127166|1560636|P2|Period II|Patient did not perform Visit 6 exercise|0
478174|NCT00127166|1560637|P1|Period II|Patient did not perform Visit 6 exercise|1
478175|NCT00127166|1560636|P2|Period II|Withdrawal by Subject|0
478176|NCT00127166|1560637|P1|Period II|Withdrawal by Subject|2
478177|NCT00127166|1560636|P2|Washout Period|Patient did not meet inclusion criteria|1
478178|NCT00127166|1560637|P1|Washout Period|Patient did not meet inclusion criteria|0
478179|NCT00127166|1560636|P2|Period I|Patient did not meet inclusion criteria|0
478180|NCT00127166|1560637|P1|Period I|Patient did not meet inclusion criteria|1
478181|NCT00127166|1560636|P2|Period I|Withdrawal by Subject|0
478182|NCT00127166|1560637|P1|Period I|Withdrawal by Subject|2
478183|NCT00127166|1560636|P2|Period I|Protocol Violation|2
478184|NCT00127166|1560637|P1|Period I|Protocol Violation|0
478185|NCT00127101|1560657|P6|Continuation Phase|Withdrawal by Subject|1
478186|NCT00127101|1560658|P5|Continuation Phase|Withdrawal by Subject|2
478187|NCT00127101|1560659|P4|Continuation Phase|Withdrawal by Subject|0
478188|NCT00127101|1560660|P3|Continuation Phase|Withdrawal by Subject|1
478189|NCT00127101|1560661|P2|Continuation Phase|Withdrawal by Subject|0
478190|NCT00127101|1560662|P1|Continuation Phase|Withdrawal by Subject|0
478191|NCT00127101|1560657|P6|Continuation Phase|Lack of Efficacy|1
478192|NCT00127101|1560658|P5|Continuation Phase|Lack of Efficacy|0
478193|NCT00127101|1560659|P4|Continuation Phase|Lack of Efficacy|0
478194|NCT00127101|1560660|P3|Continuation Phase|Lack of Efficacy|0
478195|NCT00127101|1560661|P2|Continuation Phase|Lack of Efficacy|0
478196|NCT00127101|1560662|P1|Continuation Phase|Lack of Efficacy|0
478197|NCT00127101|1560657|P6|Continuation Phase|Adverse Event|1
478198|NCT00127101|1560658|P5|Continuation Phase|Adverse Event|1
478199|NCT00127101|1560659|P4|Continuation Phase|Adverse Event|0
478200|NCT00127101|1560660|P3|Continuation Phase|Adverse Event|0
478201|NCT00127101|1560661|P2|Continuation Phase|Adverse Event|0
478202|NCT00127101|1560662|P1|Continuation Phase|Adverse Event|0
478203|NCT00127101|1560657|P6|Base Protocol|Withdrawal by Subject|1
478204|NCT00127101|1560658|P5|Base Protocol|Withdrawal by Subject|0
478205|NCT00127101|1560659|P4|Base Protocol|Withdrawal by Subject|0
478206|NCT00127101|1560660|P3|Base Protocol|Withdrawal by Subject|1
478207|NCT00127101|1560661|P2|Base Protocol|Withdrawal by Subject|2
478208|NCT00127101|1560662|P1|Base Protocol|Withdrawal by Subject|1
478209|NCT00127101|1560657|P6|Base Protocol|Lack of Efficacy|0
478210|NCT00127101|1560658|P5|Base Protocol|Lack of Efficacy|2
478211|NCT00127101|1560659|P4|Base Protocol|Lack of Efficacy|0
478212|NCT00127101|1560660|P3|Base Protocol|Lack of Efficacy|0
478213|NCT00127101|1560661|P2|Base Protocol|Lack of Efficacy|0
478214|NCT00127101|1560662|P1|Base Protocol|Lack of Efficacy|1
478215|NCT00127101|1560657|P6|Base Protocol|Adverse Event|0
478216|NCT00127101|1560658|P5|Base Protocol|Adverse Event|0
478217|NCT00127101|1560659|P4|Base Protocol|Adverse Event|0
478218|NCT00127101|1560660|P3|Base Protocol|Adverse Event|1
478219|NCT00127101|1560661|P2|Base Protocol|Adverse Event|2
478220|NCT00127101|1560662|P1|Base Protocol|Adverse Event|0
478221|NCT00127036|1560684|P2|Overall Study|Screen Failure|0
478222|NCT00127036|1560685|P1|Overall Study|Screen Failure|2
478223|NCT00127036|1560684|P2|Overall Study|Insufficient Data for Analysis|11
478224|NCT00127036|1560685|P1|Overall Study|Insufficient Data for Analysis|6
478225|NCT00126776|1560697|P2|Overall Study|follow up complete on all patients|0
478226|NCT00126776|1560698|P1|Overall Study|follow up complete on all patients|0
478227|NCT00126659|1560747|P3|Overall Study|Adverse Event|2
478228|NCT00126659|1560748|P2|Overall Study|Adverse Event|0
478229|NCT00126659|1560749|P1|Overall Study|Adverse Event|0
478230|NCT00126594|1560757|P2|Overall Study|Disease Progression|24
478231|NCT00126594|1560758|P1|Overall Study|Disease Progression|29
478232|NCT00126594|1560757|P2|Overall Study|Non-compliance|1
478233|NCT00126594|1560758|P1|Overall Study|Non-compliance|0
478234|NCT00126594|1560757|P2|Overall Study|Adverse Event|5
478235|NCT00126594|1560758|P1|Overall Study|Adverse Event|7
478236|NCT00126594|1560757|P2|Overall Study|Physician Decision|3
478237|NCT00126594|1560758|P1|Overall Study|Physician Decision|1
478238|NCT00126594|1560757|P2|Overall Study|Withdrawal by Subject|4
478239|NCT00126594|1560758|P1|Overall Study|Withdrawal by Subject|0
478240|NCT00126594|1560757|P2|Overall Study|Ineligible|0
478241|NCT00126594|1560758|P1|Overall Study|Ineligible|2
478242|NCT00126581|1560775|P2|Overall Study|Other illness/MD discretion|4
478243|NCT00126581|1560776|P1|Overall Study|Other illness/MD discretion|3
478244|NCT00126581|1560775|P2|Overall Study|Alternative therapy|3
478245|NCT00126581|1560776|P1|Overall Study|Alternative therapy|3
478246|NCT00126581|1560775|P2|Overall Study|Withdrawal by Subject|4
478247|NCT00126581|1560776|P1|Overall Study|Withdrawal by Subject|1
478248|NCT00126581|1560775|P2|Overall Study|Death|2
478249|NCT00126581|1560776|P1|Overall Study|Death|3
478250|NCT00126581|1560775|P2|Overall Study|Adverse Event|7
478251|NCT00126581|1560776|P1|Overall Study|Adverse Event|3
478252|NCT00126568|1560796|P1|Overall Study|Death|2
478253|NCT00126555|1560803|P1|Overall Study|Progressive Disease|3
478254|NCT00126555|1560803|P1|Overall Study|Adverse Event|2
478255|NCT00126555|1560803|P1|Overall Study|Withdrawal by Subject|1
478256|NCT00126503|1560819|P2|Overall Study|Physician Decision|1
478257|NCT00126503|1560820|P1|Overall Study|Physician Decision|2
478258|NCT00126503|1560819|P2|Overall Study|non-compliant|0
478259|NCT00126503|1560820|P1|Overall Study|non-compliant|1
478260|NCT00126503|1560819|P2|Overall Study|Adverse Event|3
478261|NCT00126503|1560820|P1|Overall Study|Adverse Event|13
478262|NCT00126503|1560819|P2|Overall Study|Death|0
478263|NCT00126503|1560820|P1|Overall Study|Death|3
478264|NCT00126503|1560819|P2|Overall Study|other complicating disease|1
478265|NCT00126503|1560820|P1|Overall Study|other complicating disease|4
478266|NCT00126503|1560819|P2|Overall Study|alternative therapy|1
478267|NCT00126503|1560820|P1|Overall Study|alternative therapy|1
478268|NCT00126503|1560819|P2|Overall Study|Withdrawal by Subject|1
478269|NCT00126503|1560820|P1|Overall Study|Withdrawal by Subject|0
478270|NCT00126503|1560819|P2|Overall Study|disease progression|14
478271|NCT00126503|1560820|P1|Overall Study|disease progression|23
478272|NCT00126490|1560832|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
478273|NCT00126438|1560842|P2|Overall Study|Withdrawal by Subject|2
478274|NCT00126438|1560843|P1|Overall Study|Withdrawal by Subject|3
478275|NCT00126438|1560842|P2|Overall Study|Protocol Violation|8
478276|NCT00126438|1560843|P1|Overall Study|Protocol Violation|8
478277|NCT00126438|1560842|P2|Overall Study|Lost to Follow-up|0
478278|NCT00126438|1560843|P1|Overall Study|Lost to Follow-up|22
478279|NCT00126438|1560842|P2|Overall Study|Withdrawal due to adverse event|0
478280|NCT00126438|1560843|P1|Overall Study|Withdrawal due to adverse event|1
478281|NCT00126425|1560851|P2|Overall Study|Other|0
478282|NCT00126425|1560852|P1|Overall Study|Other|5
478283|NCT00126425|1560851|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
478284|NCT00126425|1560852|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
478285|NCT00126425|1560851|P2|Overall Study|Adverse Event|0
478286|NCT00126425|1560852|P1|Overall Study|Adverse Event|1
478287|NCT00126425|1560851|P2|Overall Study|Protocol Violation|6
478288|NCT00126425|1560852|P1|Overall Study|Protocol Violation|9
478289|NCT00126425|1560851|P2|Overall Study|Lost to Follow-up|4
478290|NCT00126425|1560852|P1|Overall Study|Lost to Follow-up|8
478291|NCT00126425|1560851|P2|Overall Study|Withdrawal by Subject|1
478292|NCT00126425|1560852|P1|Overall Study|Withdrawal by Subject|17
478293|NCT00126191|1560860|P2|Overall Study|Death|1
478294|NCT00126191|1560861|P1|Overall Study|Death|0
478295|NCT00126191|1560860|P2|Overall Study|Physician Decision|1
478296|NCT00126191|1560861|P1|Overall Study|Physician Decision|0
478297|NCT00126126|1560871|P2|Overall Study|Lost to Follow-up|2
478298|NCT00126126|1560872|P1|Overall Study|Lost to Follow-up|0
478299|NCT00125268|1561005|P2|Overall Study|Withdrawal by Subject|1
478300|NCT00125268|1561006|P1|Overall Study|Withdrawal by Subject|1
478301|NCT00125242|1561018|P2|Overall Study|did not qualify|2
478302|NCT00125242|1561019|P1|Overall Study|did not qualify|7
478303|NCT00125190|1561024|P1|Overall Study|Non-compliance|2
478304|NCT00125190|1561024|P1|Overall Study|other|1
478305|NCT00125190|1561024|P1|Overall Study|Patient/Parent Decision|7
478306|NCT00125190|1561024|P1|Overall Study|Lost to Follow-up|4
478307|NCT00125190|1561024|P1|Overall Study|Adverse Event|1
478308|NCT00125164|1561042|P4|Overall Study|Withdrawal by Subject|1
478309|NCT00125164|1561043|P3|Overall Study|Withdrawal by Subject|1
478310|NCT00125164|1561044|P2|Overall Study|Withdrawal by Subject|0
478311|NCT00125164|1561045|P1|Overall Study|Withdrawal by Subject|2
478312|NCT00125164|1561042|P4|Overall Study|Lost to Follow-up|1
478313|NCT00125164|1561043|P3|Overall Study|Lost to Follow-up|1
478314|NCT00125164|1561044|P2|Overall Study|Lost to Follow-up|0
478315|NCT00125164|1561045|P1|Overall Study|Lost to Follow-up|0
478316|NCT00125164|1561042|P4|Overall Study|Adverse Event|4
478317|NCT00125164|1561043|P3|Overall Study|Adverse Event|2
478318|NCT00125164|1561044|P2|Overall Study|Adverse Event|0
478319|NCT00125164|1561045|P1|Overall Study|Adverse Event|0
478320|NCT00125138|1561099|P4|Overall Study|Sponsor decision-pt moved to assist care|1
478321|NCT00125138|1561100|P3|Overall Study|Sponsor decision-pt moved to assist care|0
478322|NCT00125138|1561101|P2|Overall Study|Sponsor decision-pt moved to assist care|0
478323|NCT00125138|1561102|P1|Overall Study|Sponsor decision-pt moved to assist care|0
478324|NCT00125138|1561099|P4|Overall Study|Lack of Efficacy|1
478325|NCT00125138|1561100|P3|Overall Study|Lack of Efficacy|0
478326|NCT00125138|1561101|P2|Overall Study|Lack of Efficacy|0
478327|NCT00125138|1561102|P1|Overall Study|Lack of Efficacy|0
478328|NCT00125138|1561099|P4|Overall Study|Withdrawal by Subject|1
478329|NCT00125138|1561100|P3|Overall Study|Withdrawal by Subject|1
478330|NCT00125138|1561101|P2|Overall Study|Withdrawal by Subject|3
478331|NCT00125138|1561102|P1|Overall Study|Withdrawal by Subject|2
478332|NCT00125138|1561099|P4|Overall Study|Adverse Event|2
478333|NCT00125138|1561100|P3|Overall Study|Adverse Event|3
478334|NCT00125138|1561101|P2|Overall Study|Adverse Event|0
478335|NCT00125138|1561102|P1|Overall Study|Adverse Event|1
478336|NCT00124982|1561151|P3|Long-term Period|Neurologist Recommendation|1
478337|NCT00124982|1561152|P2|Long-term Period|Neurologist Recommendation|0
478338|NCT00124982|1561153|P1|Long-term Period|Neurologist Recommendation|0
478339|NCT00124982|1561151|P3|Long-term Period|Administrative Reason by Sponsor|1
478340|NCT00124982|1561152|P2|Long-term Period|Administrative Reason by Sponsor|0
478341|NCT00124982|1561153|P1|Long-term Period|Administrative Reason by Sponsor|0
478342|NCT00124982|1561151|P3|Long-term Period|Poor/Non-compliance|2
478343|NCT00124982|1561152|P2|Long-term Period|Poor/Non-compliance|0
478344|NCT00124982|1561153|P1|Long-term Period|Poor/Non-compliance|0
478345|NCT00124982|1561151|P3|Long-term Period|Pregnancy|1
478346|NCT00124982|1561152|P2|Long-term Period|Pregnancy|0
478347|NCT00124982|1561153|P1|Long-term Period|Pregnancy|0
478348|NCT00124982|1561151|P3|Long-term Period|Withdrawal by Subject|16
478349|NCT00124982|1561152|P2|Long-term Period|Withdrawal by Subject|0
478350|NCT00124982|1561153|P1|Long-term Period|Withdrawal by Subject|0
478351|NCT00124982|1561151|P3|Long-term Period|Lost to Follow-up|4
478352|NCT00124982|1561152|P2|Long-term Period|Lost to Follow-up|0
478353|NCT00124982|1561153|P1|Long-term Period|Lost to Follow-up|0
478354|NCT00124982|1561151|P3|Long-term Period|Lack of Efficacy|46
478355|NCT00124982|1561152|P2|Long-term Period|Lack of Efficacy|0
478356|NCT00124982|1561153|P1|Long-term Period|Lack of Efficacy|0
478357|NCT00124982|1561151|P3|Long-term Period|Adverse Event|17
478358|NCT00124982|1561152|P2|Long-term Period|Adverse Event|0
478359|NCT00124982|1561153|P1|Long-term Period|Adverse Event|0
478360|NCT00124982|1561151|P3|Long-term Period|Death|1
478361|NCT00124982|1561152|P2|Long-term Period|Death|0
478362|NCT00124982|1561153|P1|Long-term Period|Death|0
478363|NCT00124982|1561151|P3|Short-term Period|Participant Had Lymphopenia|0
478364|NCT00124982|1561152|P2|Short-term Period|Participant Had Lymphopenia|0
478365|NCT00124982|1561153|P1|Short-term Period|Participant Had Lymphopenia|1
478366|NCT00124982|1561151|P3|Short-term Period|Investigator Decision-No Specific AE|0
478367|NCT00124982|1561152|P2|Short-term Period|Investigator Decision-No Specific AE|0
478368|NCT00124982|1561153|P1|Short-term Period|Investigator Decision-No Specific AE|1
478369|NCT00124982|1561151|P3|Short-term Period|Participant Chose Own Doctor|0
478370|NCT00124982|1561152|P2|Short-term Period|Participant Chose Own Doctor|1
478371|NCT00124982|1561153|P1|Short-term Period|Participant Chose Own Doctor|0
478372|NCT00124982|1561151|P3|Short-term Period|Participant Decision|0
478373|NCT00124982|1561152|P2|Short-term Period|Participant Decision|0
478374|NCT00124982|1561153|P1|Short-term Period|Participant Decision|1
478375|NCT00124982|1561151|P3|Short-term Period|No Longer Meets Study Criteria|0
478376|NCT00124982|1561152|P2|Short-term Period|No Longer Meets Study Criteria|2
478377|NCT00124982|1561153|P1|Short-term Period|No Longer Meets Study Criteria|1
478378|NCT00124982|1561151|P3|Short-term Period|Poor/Non-compliance|0
478379|NCT00124982|1561152|P2|Short-term Period|Poor/Non-compliance|1
478380|NCT00124982|1561153|P1|Short-term Period|Poor/Non-compliance|3
478381|NCT00124982|1561151|P3|Short-term Period|Withdrawal of Consent|0
478382|NCT00124982|1561152|P2|Short-term Period|Withdrawal of Consent|9
478383|NCT00124982|1561153|P1|Short-term Period|Withdrawal of Consent|7
478384|NCT00124982|1561151|P3|Short-term Period|Lost to Follow-up|0
478385|NCT00124982|1561152|P2|Short-term Period|Lost to Follow-up|5
478386|NCT00124982|1561153|P1|Short-term Period|Lost to Follow-up|8
478387|NCT00124982|1561151|P3|Short-term Period|Lack of Efficacy|0
478388|NCT00124982|1561152|P2|Short-term Period|Lack of Efficacy|73
478389|NCT00124982|1561153|P1|Short-term Period|Lack of Efficacy|32
478390|NCT00124982|1561151|P3|Short-term Period|Adverse Event|0
478391|NCT00124982|1561152|P2|Short-term Period|Adverse Event|22
478392|NCT00124982|1561153|P1|Short-term Period|Adverse Event|17
478393|NCT00124982|1561151|P3|Short-term Period|Death|0
478394|NCT00124982|1561152|P2|Short-term Period|Death|1
478395|NCT00124982|1561153|P1|Short-term Period|Death|1
478396|NCT00124943|1561235|P4|Phase II|Withdrawal by Subject|2
478397|NCT00124943|1561236|P3|Phase II|Withdrawal by Subject|0
478398|NCT00124943|1561237|P2|Phase II|Withdrawal by Subject|0
478399|NCT00124943|1561238|P1|Phase II|Withdrawal by Subject|0
478400|NCT00124943|1561235|P4|Phase II|Lost to Follow-up|1
478401|NCT00124943|1561236|P3|Phase II|Lost to Follow-up|0
478402|NCT00124943|1561237|P2|Phase II|Lost to Follow-up|0
478403|NCT00124943|1561238|P1|Phase II|Lost to Follow-up|0
478404|NCT00124943|1561235|P4|Phase II|Protocol Violation|1
478405|NCT00124943|1561236|P3|Phase II|Protocol Violation|0
478406|NCT00124943|1561237|P2|Phase II|Protocol Violation|0
478407|NCT00124943|1561238|P1|Phase II|Protocol Violation|0
478408|NCT00124943|1561235|P4|Phase II|Adverse Event|1
478409|NCT00124943|1561236|P3|Phase II|Adverse Event|0
478410|NCT00124943|1561237|P2|Phase II|Adverse Event|2
478411|NCT00124943|1561238|P1|Phase II|Adverse Event|0
478412|NCT00124748|1561278|P2|Overall Study|Death|3
478413|NCT00124748|1561279|P1|Overall Study|Death|1
478414|NCT00124748|1561278|P2|Overall Study|Administrative Problem(Study Terminated)|174
478415|NCT00124748|1561279|P1|Overall Study|Administrative Problem(Study Terminated)|101
478416|NCT00124748|1561278|P2|Overall Study|Lost to Follow-up|7
478417|NCT00124748|1561279|P1|Overall Study|Lost to Follow-up|2
478418|NCT00124748|1561278|P2|Overall Study|Withdrawal by Subject|15
478419|NCT00124748|1561279|P1|Overall Study|Withdrawal by Subject|5
478420|NCT00124748|1561278|P2|Overall Study|Protocol Violation|1
478421|NCT00124748|1561279|P1|Overall Study|Protocol Violation|3
478422|NCT00124748|1561278|P2|Overall Study|No longer requires study drug|1
478423|NCT00124748|1561279|P1|Overall Study|No longer requires study drug|1
478424|NCT00124748|1561278|P2|Overall Study|Lack of Efficacy|41
478425|NCT00124748|1561279|P1|Overall Study|Lack of Efficacy|20
478426|NCT00124748|1561278|P2|Overall Study|Abnormal Procedure|1
478427|NCT00124748|1561279|P1|Overall Study|Abnormal Procedure|0
478428|NCT00124748|1561278|P2|Overall Study|Abnormal laboratory Value|2
478429|NCT00124748|1561279|P1|Overall Study|Abnormal laboratory Value|2
478430|NCT00124748|1561278|P2|Overall Study|Adverse Event|39
478431|NCT00124748|1561279|P1|Overall Study|Adverse Event|8
478432|NCT00124709|1561386|P2|Overall Study|Lost to Follow-up|120
478433|NCT00124709|1561387|P1|Overall Study|Lost to Follow-up|114
478434|NCT00124709|1561386|P2|Overall Study|Withdrawal by Subject|136
478435|NCT00124709|1561387|P1|Overall Study|Withdrawal by Subject|127
478436|NCT00124709|1561386|P2|Overall Study|Protocol Violation|5
478437|NCT00124709|1561387|P1|Overall Study|Protocol Violation|3
478438|NCT00124709|1561386|P2|Overall Study|Lack of Efficacy|10
478439|NCT00124709|1561387|P1|Overall Study|Lack of Efficacy|5
478440|NCT00124709|1561386|P2|Overall Study|Adverse Event|0
478441|NCT00124709|1561387|P1|Overall Study|Adverse Event|3
478442|NCT00124709|1561386|P2|Overall Study|Randomized but did not take medication|1
478443|NCT00124709|1561387|P1|Overall Study|Randomized but did not take medication|3
478444|NCT00124657|1561404|P3|Overall Study|Intercurrent illness|0
478445|NCT00124657|1561405|P2|Overall Study|Intercurrent illness|0
478446|NCT00124657|1561406|P1|Overall Study|Intercurrent illness|1
478447|NCT00124657|1561404|P3|Overall Study|Progressive disease|27
478448|NCT00124657|1561405|P2|Overall Study|Progressive disease|5
478449|NCT00124657|1561406|P1|Overall Study|Progressive disease|14
478450|NCT00124657|1561404|P3|Overall Study|Non-compliance|4
478451|NCT00124657|1561405|P2|Overall Study|Non-compliance|0
478452|NCT00124657|1561406|P1|Overall Study|Non-compliance|1
478453|NCT00124657|1561404|P3|Overall Study|Toxicity|1
478454|NCT00124657|1561405|P2|Overall Study|Toxicity|0
478455|NCT00124657|1561406|P1|Overall Study|Toxicity|0
478456|NCT00124618|1561441|P1|Overall Study|Ineligible|1
478457|NCT00124462|1561456|P2|Overall Study|Device fitting, n=2, other hlth issues|1
478458|NCT00124462|1561457|P1|Overall Study|Device fitting, n=2, other hlth issues|1
478459|NCT00124462|1561456|P2|Overall Study|Withdrawal by Subject|5
478460|NCT00124462|1561457|P1|Overall Study|Withdrawal by Subject|4
478461|NCT00124462|1561456|P2|Overall Study|Physician Decision|4
478462|NCT00124462|1561457|P1|Overall Study|Physician Decision|3
478463|NCT00124462|1561456|P2|Overall Study|Lost to Follow-up|3
478464|NCT00124462|1561457|P1|Overall Study|Lost to Follow-up|3
478465|NCT00124449|1561467|P2|18-Month Untreated Observation Period|Relocated|0
478466|NCT00124449|1561468|P1|18-Month Untreated Observation Period|Relocated|1
478467|NCT00124449|1561467|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
478468|NCT00124449|1561468|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
478469|NCT00124449|1561467|P2|18-Month Untreated Observation Period|Pregnancy|0
478470|NCT00124449|1561468|P1|18-Month Untreated Observation Period|Pregnancy|1
478471|NCT00124449|1561467|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
478472|NCT00124449|1561468|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
478473|NCT00124449|1561467|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
478474|NCT00124449|1561468|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
478475|NCT00124449|1561467|P2|18-Month Untreated Observation Period|Adverse Event|1
478476|NCT00124449|1561468|P1|18-Month Untreated Observation Period|Adverse Event|0
478477|NCT00124449|1561467|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
478478|NCT00124449|1561468|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
478479|NCT00124449|1561467|P2|6-month Double-Blind Treatment Period|Sponsor request|1
478480|NCT00124449|1561468|P1|6-month Double-Blind Treatment Period|Sponsor request|0
478481|NCT00124449|1561467|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
478482|NCT00124449|1561468|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
478483|NCT00124449|1561467|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
478484|NCT00124449|1561468|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
478485|NCT00124449|1561467|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
478486|NCT00124449|1561468|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
478487|NCT00124449|1561467|P2|6-month Double-Blind Treatment Period|Adverse Event|0
478488|NCT00124449|1561468|P1|6-month Double-Blind Treatment Period|Adverse Event|1
478489|NCT00124072|1561522|P4|Overall Study|Death|480
478490|NCT00124072|1561523|P3|Overall Study|Death|471
478491|NCT00124072|1561524|P2|Overall Study|Death|484
478492|NCT00124072|1561525|P1|Overall Study|Death|499
478493|NCT00124072|1561522|P4|Overall Study|Lost to Follow-up for Morbidity|18
478494|NCT00124072|1561523|P3|Overall Study|Lost to Follow-up for Morbidity|19
478495|NCT00124072|1561524|P2|Overall Study|Lost to Follow-up for Morbidity|25
478496|NCT00124072|1561525|P1|Overall Study|Lost to Follow-up for Morbidity|15
478497|NCT00124072|1561522|P4|Overall Study|Lost to Follow-up for Mortality|2
478498|NCT00124072|1561523|P3|Overall Study|Lost to Follow-up for Mortality|2
478499|NCT00124072|1561524|P2|Overall Study|Lost to Follow-up for Mortality|3
478500|NCT00124072|1561525|P1|Overall Study|Lost to Follow-up for Mortality|0
478501|NCT00124020|1561537|P2|Overall Study|Transfer to another hospital|0
478502|NCT00124020|1561538|P1|Overall Study|Transfer to another hospital|2
478503|NCT00124020|1561537|P2|Overall Study|Other|1
478504|NCT00124020|1561538|P1|Overall Study|Other|1
478505|NCT00124020|1561537|P2|Overall Study|Lost to Follow-up|8
478506|NCT00124020|1561538|P1|Overall Study|Lost to Follow-up|5
478507|NCT00124020|1561537|P2|Overall Study|Withdrawal by Subject|11
478508|NCT00124020|1561538|P1|Overall Study|Withdrawal by Subject|13
478509|NCT00124020|1561537|P2|Overall Study|Death|71
478510|NCT00124020|1561538|P1|Overall Study|Death|67
478511|NCT00123955|1561546|P2|Overall Study|Death|1
478512|NCT00123955|1561547|P1|Overall Study|Death|0
478513|NCT00123955|1561546|P2|Overall Study|Withdrawal by Subject|3
478514|NCT00123955|1561547|P1|Overall Study|Withdrawal by Subject|4
478515|NCT00123955|1561546|P2|Overall Study|Adverse Event|0
478516|NCT00123955|1561547|P1|Overall Study|Adverse Event|1
478517|NCT00123734|1561559|P1|Overall Study|Withdrawal by Subject|1
478518|NCT00123734|1561559|P1|Overall Study|Dropout|1
478519|NCT00123734|1561559|P1|Overall Study|Lost to Follow-up|3
478520|NCT00123734|1561559|P1|Overall Study|Death|3
478521|NCT00123487|1561644|P2|Treated With Study Drug|Unknown (case report form lost)|1
478522|NCT00123487|1561645|P1|Treated With Study Drug|Unknown (case report form lost)|0
478523|NCT00123487|1561644|P2|Treated With Study Drug|Withdrawal by Subject|13
478524|NCT00123487|1561645|P1|Treated With Study Drug|Withdrawal by Subject|11
478525|NCT00123487|1561644|P2|Treated With Study Drug|Study Drug Toxicity|80
478526|NCT00123487|1561645|P1|Treated With Study Drug|Study Drug Toxicity|62
478527|NCT00123487|1561644|P2|Treated With Study Drug|Not Specified|58
478528|NCT00123487|1561645|P1|Treated With Study Drug|Not Specified|59
478529|NCT00123487|1561644|P2|Treated With Study Drug|Physician Decision|9
478530|NCT00123487|1561645|P1|Treated With Study Drug|Physician Decision|8
478531|NCT00123487|1561644|P2|Treated With Study Drug|Disease Progression|122
478532|NCT00123487|1561645|P1|Treated With Study Drug|Disease Progression|141
478533|NCT00123487|1561644|P2|Treated With Study Drug|Adverse Event|22
478534|NCT00123487|1561645|P1|Treated With Study Drug|Adverse Event|23
478535|NCT00123487|1561644|P2|Randomized|SAE prior to starting treatment|0
478536|NCT00123487|1561645|P1|Randomized|SAE prior to starting treatment|1
478537|NCT00123487|1561644|P2|Randomized|Death prior to starting treatment|1
478538|NCT00123487|1561645|P1|Randomized|Death prior to starting treatment|0
478539|NCT00123474|1561689|P4|As Treated at Study Closure|Withdrawal by Subject|16
478540|NCT00123474|1561690|P3|As Treated at Study Closure|Withdrawal by Subject|18
478541|NCT00123474|1561691|P2|As Treated at Study Closure|Withdrawal by Subject|19
478542|NCT00123474|1561692|P1|As Treated at Study Closure|Withdrawal by Subject|14
478543|NCT00123474|1561689|P4|As Treated at Study Closure|Study Drug Toxicity|51
478544|NCT00123474|1561690|P3|As Treated at Study Closure|Study Drug Toxicity|45
478545|NCT00123474|1561691|P2|As Treated at Study Closure|Study Drug Toxicity|45
478546|NCT00123474|1561692|P1|As Treated at Study Closure|Study Drug Toxicity|39
478547|NCT00123474|1561689|P4|As Treated at Study Closure|non-specified|60
478548|NCT00123474|1561690|P3|As Treated at Study Closure|non-specified|57
478549|NCT00123474|1561691|P2|As Treated at Study Closure|non-specified|47
478550|NCT00123474|1561692|P1|As Treated at Study Closure|non-specified|54
478551|NCT00123474|1561689|P4|As Treated at Study Closure|Investigator Request|5
478552|NCT00123474|1561690|P3|As Treated at Study Closure|Investigator Request|7
478553|NCT00123474|1561691|P2|As Treated at Study Closure|Investigator Request|6
478554|NCT00123474|1561692|P1|As Treated at Study Closure|Investigator Request|12
478555|NCT00123474|1561689|P4|As Treated at Study Closure|Disease Progression|27
478556|NCT00123474|1561690|P3|As Treated at Study Closure|Disease Progression|29
478557|NCT00123474|1561691|P2|As Treated at Study Closure|Disease Progression|42
478558|NCT00123474|1561692|P1|As Treated at Study Closure|Disease Progression|35
478559|NCT00123474|1561689|P4|As Treated at Study Closure|Adverse Event|8
478560|NCT00123474|1561690|P3|As Treated at Study Closure|Adverse Event|10
478561|NCT00123474|1561691|P2|As Treated at Study Closure|Adverse Event|4
478562|NCT00123474|1561692|P1|As Treated at Study Closure|Adverse Event|10
478563|NCT00123474|1561689|P4|As Treated at Study Closure|not reported when site closed|0
478564|NCT00123474|1561690|P3|As Treated at Study Closure|not reported when site closed|1
478565|NCT00123474|1561691|P2|As Treated at Study Closure|not reported when site closed|0
478566|NCT00123474|1561692|P1|As Treated at Study Closure|not reported when site closed|1
478567|NCT00123474|1561689|P4|Randomized to Treatment|Randomized, never treated|1
478568|NCT00123474|1561690|P3|Randomized to Treatment|Randomized, never treated|2
478569|NCT00123474|1561691|P2|Randomized to Treatment|Randomized, never treated|4
478570|NCT00123474|1561692|P1|Randomized to Treatment|Randomized, never treated|1
478571|NCT00123422|1561786|P3|Overall Study|Lost to Follow-up|2
478572|NCT00123422|1561787|P2|Overall Study|Lost to Follow-up|2
478573|NCT00123422|1561788|P1|Overall Study|Lost to Follow-up|1
478574|NCT00123422|1561786|P3|Overall Study|Withdrawal by Subject|2
478575|NCT00123422|1561787|P2|Overall Study|Withdrawal by Subject|2
478576|NCT00123422|1561788|P1|Overall Study|Withdrawal by Subject|1
478577|NCT00123422|1561786|P3|Overall Study|Physician Decision|6
478578|NCT00123422|1561787|P2|Overall Study|Physician Decision|2
478579|NCT00123422|1561788|P1|Overall Study|Physician Decision|2
478580|NCT00122980|1561839|P2|Overall Study|Study termination|35
478581|NCT00122980|1561840|P1|Overall Study|Study termination|27
478582|NCT00122980|1561839|P2|Overall Study|Adjudicated stroke (study endpoint)|0
478583|NCT00122980|1561840|P1|Overall Study|Adjudicated stroke (study endpoint)|7
478584|NCT00122980|1561839|P2|Overall Study|Withdrawal by Subject|3
478585|NCT00122980|1561840|P1|Overall Study|Withdrawal by Subject|2
478586|NCT00122980|1561839|P2|Overall Study|Protocol Violation|1
478587|NCT00122980|1561840|P1|Overall Study|Protocol Violation|5
478588|NCT00122980|1561839|P2|Overall Study|Physician Decision|0
478589|NCT00122980|1561840|P1|Overall Study|Physician Decision|2
478590|NCT00122980|1561839|P2|Overall Study|Death|1
478591|NCT00122980|1561840|P1|Overall Study|Death|0
478592|NCT00122954|1561864|P2|Overall Study|Protocol Violation|1
478593|NCT00122954|1561865|P1|Overall Study|Protocol Violation|0
478594|NCT00122954|1561864|P2|Overall Study|Withdrawal by Subject|2
478595|NCT00122954|1561865|P1|Overall Study|Withdrawal by Subject|2
478596|NCT00122681|1561875|P2|Overall Study|Personal reasons|147
478597|NCT00122681|1561876|P1|Overall Study|Personal reasons|150
478598|NCT00122681|1561875|P2|Overall Study|Withdrawal by Subject|251
478599|NCT00122681|1561876|P1|Overall Study|Withdrawal by Subject|257
478600|NCT00122681|1561875|P2|Overall Study|Protocol Violation|10
478601|NCT00122681|1561876|P1|Overall Study|Protocol Violation|7
478602|NCT00122681|1561875|P2|Overall Study|Lost to Follow-up|1097
478603|NCT00122681|1561876|P1|Overall Study|Lost to Follow-up|1080
478604|NCT00122681|1561875|P2|Overall Study|Adverse Event|16
478605|NCT00122681|1561876|P1|Overall Study|Adverse Event|20
478606|NCT00122460|1561950|P2|Overall Study|investigational study phase ongoing|1
478607|NCT00122460|1561951|P1|Overall Study|investigational study phase ongoing|7
478608|NCT00122382|1562000|P3|Open-Label Study|Withdrawal of Consent|4
478609|NCT00122382|1562001|P2|Open-Label Study|Withdrawal of Consent|0
478610|NCT00122382|1562002|P1|Open-Label Study|Withdrawal of Consent|0
478611|NCT00122382|1562000|P3|Open-Label Study|Poor/Non-Compliance|1
478612|NCT00122382|1562001|P2|Open-Label Study|Poor/Non-Compliance|0
478613|NCT00122382|1562002|P1|Open-Label Study|Poor/Non-Compliance|0
478614|NCT00122382|1562000|P3|Open-Label Study|Pregnancy|2
478615|NCT00122382|1562001|P2|Open-Label Study|Pregnancy|0
478616|NCT00122382|1562002|P1|Open-Label Study|Pregnancy|0
478617|NCT00122382|1562000|P3|Open-Label Study|Lost to Follow-up|3
478618|NCT00122382|1562001|P2|Open-Label Study|Lost to Follow-up|0
478619|NCT00122382|1562002|P1|Open-Label Study|Lost to Follow-up|0
478620|NCT00122382|1562000|P3|Open-Label Study|Lack of Efficacy|3
478621|NCT00122382|1562001|P2|Open-Label Study|Lack of Efficacy|0
478622|NCT00122382|1562002|P1|Open-Label Study|Lack of Efficacy|0
478623|NCT00122382|1562000|P3|Open-Label Study|Death|2
478624|NCT00122382|1562001|P2|Open-Label Study|Death|0
478625|NCT00122382|1562002|P1|Open-Label Study|Death|0
478626|NCT00122382|1562000|P3|Open-Label Study|Adverse Event|11
478627|NCT00122382|1562001|P2|Open-Label Study|Adverse Event|0
478628|NCT00122382|1562002|P1|Open-Label Study|Adverse Event|0
478629|NCT00122382|1562000|P3|Double-Blind Study|Randomized but not treated|0
478630|NCT00122382|1562001|P2|Double-Blind Study|Randomized but not treated|2
478631|NCT00122382|1562002|P1|Double-Blind Study|Randomized but not treated|0
478632|NCT00122382|1562000|P3|Double-Blind Study|Methotrexate Discontinued|0
478633|NCT00122382|1562001|P2|Double-Blind Study|Methotrexate Discontinued|1
478634|NCT00122382|1562002|P1|Double-Blind Study|Methotrexate Discontinued|0
478635|NCT00122382|1562000|P3|Double-Blind Study|Protocol Violation|0
478636|NCT00122382|1562001|P2|Double-Blind Study|Protocol Violation|0
478637|NCT00122382|1562002|P1|Double-Blind Study|Protocol Violation|1
478638|NCT00122382|1562000|P3|Double-Blind Study|Withdrawal of Consent|0
478639|NCT00122382|1562001|P2|Double-Blind Study|Withdrawal of Consent|3
478640|NCT00122382|1562002|P1|Double-Blind Study|Withdrawal of Consent|7
478641|NCT00122382|1562000|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
478642|NCT00122382|1562001|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
478643|NCT00122382|1562002|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
478644|NCT00122382|1562000|P3|Double-Blind Study|Pregnancy|0
478645|NCT00122382|1562001|P2|Double-Blind Study|Pregnancy|0
478646|NCT00122382|1562002|P1|Double-Blind Study|Pregnancy|2
478647|NCT00122382|1562000|P3|Double-Blind Study|Lost to Follow-up|0
478648|NCT00122382|1562001|P2|Double-Blind Study|Lost to Follow-up|1
478649|NCT00122382|1562002|P1|Double-Blind Study|Lost to Follow-up|2
478650|NCT00122382|1562000|P3|Double-Blind Study|Lack of Efficacy|0
478651|NCT00122382|1562001|P2|Double-Blind Study|Lack of Efficacy|8
478652|NCT00122382|1562002|P1|Double-Blind Study|Lack of Efficacy|0
478653|NCT00122382|1562000|P3|Double-Blind Study|Death|0
478654|NCT00122382|1562001|P2|Double-Blind Study|Death|2
478655|NCT00122382|1562002|P1|Double-Blind Study|Death|2
478656|NCT00122382|1562000|P3|Double-Blind Study|Adverse Event|0
478657|NCT00122382|1562001|P2|Double-Blind Study|Adverse Event|11
478658|NCT00122382|1562002|P1|Double-Blind Study|Adverse Event|9
478659|NCT00122317|1562146|P1|Overall Study|Withdrawal by Subject|1
478660|NCT00122317|1562146|P1|Overall Study|patient non-compliance|1
478661|NCT00122317|1562146|P1|Overall Study|Physician Decision|2
478662|NCT00122317|1562146|P1|Overall Study|Adverse Event|4
478663|NCT00122317|1562146|P1|Overall Study|Death|3
478664|NCT00122187|1562155|P2|Overall Study|Withdrew because of resource limitations|2
478665|NCT00122187|1562156|P1|Overall Study|Withdrew because of resource limitations|2
478666|NCT00122135|1562170|P2|Overall Study|Withdrawal by Subject|0
478667|NCT00122135|1562171|P1|Overall Study|Withdrawal by Subject|3
478668|NCT00122109|1562179|P2|Overall Study|Did not meet criteria|7
478669|NCT00122109|1562180|P1|Overall Study|Did not meet criteria|6
478670|NCT00121719|1562244|P14|Overall Study|Continuing/ongoing patients|0
478671|NCT00121719|1562245|P13|Overall Study|Continuing/ongoing patients|3
478672|NCT00121719|1562246|P12|Overall Study|Continuing/ongoing patients|1
478673|NCT00121719|1562247|P11|Overall Study|Continuing/ongoing patients|1
478674|NCT00121719|1562248|P10|Overall Study|Continuing/ongoing patients|0
478675|NCT00121719|1562249|P9|Overall Study|Continuing/ongoing patients|0
478676|NCT00121719|1562250|P8|Overall Study|Continuing/ongoing patients|1
478677|NCT00121719|1562251|P7|Overall Study|Continuing/ongoing patients|0
478678|NCT00121719|1562252|P6|Overall Study|Continuing/ongoing patients|0
478679|NCT00121719|1562253|P5|Overall Study|Continuing/ongoing patients|0
478680|NCT00121719|1562254|P4|Overall Study|Continuing/ongoing patients|0
478681|NCT00121719|1562255|P3|Overall Study|Continuing/ongoing patients|0
478682|NCT00121719|1562256|P2|Overall Study|Continuing/ongoing patients|0
478683|NCT00121719|1562257|P1|Overall Study|Continuing/ongoing patients|0
478684|NCT00121719|1562244|P14|Overall Study|Not specified|1
478685|NCT00121719|1562245|P13|Overall Study|Not specified|1
478686|NCT00121719|1562246|P12|Overall Study|Not specified|0
478687|NCT00121719|1562247|P11|Overall Study|Not specified|0
478688|NCT00121719|1562248|P10|Overall Study|Not specified|0
478689|NCT00121719|1562249|P9|Overall Study|Not specified|1
478690|NCT00121719|1562250|P8|Overall Study|Not specified|0
478691|NCT00121719|1562251|P7|Overall Study|Not specified|1
478692|NCT00121719|1562252|P6|Overall Study|Not specified|0
478693|NCT00121719|1562253|P5|Overall Study|Not specified|0
478694|NCT00121719|1562254|P4|Overall Study|Not specified|1
478695|NCT00121719|1562255|P3|Overall Study|Not specified|1
478696|NCT00121719|1562256|P2|Overall Study|Not specified|0
478697|NCT00121719|1562257|P1|Overall Study|Not specified|0
478698|NCT00121719|1562244|P14|Overall Study|Physician Decision|0
478699|NCT00121719|1562245|P13|Overall Study|Physician Decision|1
478700|NCT00121719|1562246|P12|Overall Study|Physician Decision|0
478701|NCT00121719|1562247|P11|Overall Study|Physician Decision|0
478702|NCT00121719|1562248|P10|Overall Study|Physician Decision|0
478703|NCT00121719|1562249|P9|Overall Study|Physician Decision|0
478704|NCT00121719|1562250|P8|Overall Study|Physician Decision|0
478705|NCT00121719|1562251|P7|Overall Study|Physician Decision|0
478706|NCT00121719|1562252|P6|Overall Study|Physician Decision|0
478707|NCT00121719|1562253|P5|Overall Study|Physician Decision|0
478708|NCT00121719|1562254|P4|Overall Study|Physician Decision|0
478709|NCT00121719|1562255|P3|Overall Study|Physician Decision|0
478710|NCT00121719|1562256|P2|Overall Study|Physician Decision|1
478711|NCT00121719|1562257|P1|Overall Study|Physician Decision|0
478712|NCT00121719|1562244|P14|Overall Study|Clinical deterioration|2
478713|NCT00121719|1562245|P13|Overall Study|Clinical deterioration|2
478714|NCT00121719|1562246|P12|Overall Study|Clinical deterioration|1
478715|NCT00121719|1562247|P11|Overall Study|Clinical deterioration|0
478716|NCT00121719|1562248|P10|Overall Study|Clinical deterioration|2
478717|NCT00121719|1562249|P9|Overall Study|Clinical deterioration|2
478718|NCT00121719|1562250|P8|Overall Study|Clinical deterioration|1
478719|NCT00121719|1562251|P7|Overall Study|Clinical deterioration|2
478720|NCT00121719|1562252|P6|Overall Study|Clinical deterioration|0
478721|NCT00121719|1562253|P5|Overall Study|Clinical deterioration|1
478722|NCT00121719|1562254|P4|Overall Study|Clinical deterioration|0
478723|NCT00121719|1562255|P3|Overall Study|Clinical deterioration|1
478724|NCT00121719|1562256|P2|Overall Study|Clinical deterioration|1
478725|NCT00121719|1562257|P1|Overall Study|Clinical deterioration|0
478726|NCT00121719|1562244|P14|Overall Study|Progressive disease|4
478727|NCT00121719|1562245|P13|Overall Study|Progressive disease|13
478728|NCT00121719|1562246|P12|Overall Study|Progressive disease|3
478729|NCT00121719|1562247|P11|Overall Study|Progressive disease|4
478730|NCT00121719|1562248|P10|Overall Study|Progressive disease|1
478731|NCT00121719|1562249|P9|Overall Study|Progressive disease|3
478732|NCT00121719|1562250|P8|Overall Study|Progressive disease|5
478733|NCT00121719|1562251|P7|Overall Study|Progressive disease|7
478734|NCT00121719|1562252|P6|Overall Study|Progressive disease|1
478735|NCT00121719|1562253|P5|Overall Study|Progressive disease|2
478736|NCT00121719|1562254|P4|Overall Study|Progressive disease|2
478737|NCT00121719|1562255|P3|Overall Study|Progressive disease|0
478738|NCT00121719|1562256|P2|Overall Study|Progressive disease|1
478739|NCT00121719|1562257|P1|Overall Study|Progressive disease|2
478740|NCT00121719|1562244|P14|Overall Study|Withdrawal by Subject|0
478741|NCT00121719|1562245|P13|Overall Study|Withdrawal by Subject|0
478742|NCT00121719|1562246|P12|Overall Study|Withdrawal by Subject|0
478743|NCT00121719|1562247|P11|Overall Study|Withdrawal by Subject|0
478744|NCT00121719|1562248|P10|Overall Study|Withdrawal by Subject|0
478745|NCT00121719|1562249|P9|Overall Study|Withdrawal by Subject|0
478746|NCT00121719|1562250|P8|Overall Study|Withdrawal by Subject|0
478747|NCT00121719|1562251|P7|Overall Study|Withdrawal by Subject|0
478748|NCT00121719|1562252|P6|Overall Study|Withdrawal by Subject|0
478749|NCT00121719|1562253|P5|Overall Study|Withdrawal by Subject|0
478750|NCT00121719|1562254|P4|Overall Study|Withdrawal by Subject|0
478751|NCT00121719|1562255|P3|Overall Study|Withdrawal by Subject|0
478752|NCT00121719|1562256|P2|Overall Study|Withdrawal by Subject|0
478753|NCT00121719|1562257|P1|Overall Study|Withdrawal by Subject|1
478754|NCT00121719|1562244|P14|Overall Study|Protocol deviation|0
478755|NCT00121719|1562245|P13|Overall Study|Protocol deviation|0
478756|NCT00121719|1562246|P12|Overall Study|Protocol deviation|0
478757|NCT00121719|1562247|P11|Overall Study|Protocol deviation|0
478758|NCT00121719|1562248|P10|Overall Study|Protocol deviation|0
478759|NCT00121719|1562249|P9|Overall Study|Protocol deviation|0
478760|NCT00121719|1562250|P8|Overall Study|Protocol deviation|0
478761|NCT00121719|1562251|P7|Overall Study|Protocol deviation|0
478762|NCT00121719|1562252|P6|Overall Study|Protocol deviation|0
478763|NCT00121719|1562253|P5|Overall Study|Protocol deviation|0
478764|NCT00121719|1562254|P4|Overall Study|Protocol deviation|0
478765|NCT00121719|1562255|P3|Overall Study|Protocol deviation|1
478766|NCT00121719|1562256|P2|Overall Study|Protocol deviation|0
478767|NCT00121719|1562257|P1|Overall Study|Protocol deviation|0
478768|NCT00121719|1562244|P14|Overall Study|Abnormal laboratory value|0
478769|NCT00121719|1562245|P13|Overall Study|Abnormal laboratory value|1
478770|NCT00121719|1562246|P12|Overall Study|Abnormal laboratory value|0
478771|NCT00121719|1562247|P11|Overall Study|Abnormal laboratory value|0
478772|NCT00121719|1562248|P10|Overall Study|Abnormal laboratory value|0
478773|NCT00121719|1562249|P9|Overall Study|Abnormal laboratory value|0
478774|NCT00121719|1562250|P8|Overall Study|Abnormal laboratory value|1
478775|NCT00121719|1562251|P7|Overall Study|Abnormal laboratory value|0
478776|NCT00121719|1562252|P6|Overall Study|Abnormal laboratory value|0
478777|NCT00121719|1562253|P5|Overall Study|Abnormal laboratory value|0
478778|NCT00121719|1562254|P4|Overall Study|Abnormal laboratory value|0
478779|NCT00121719|1562255|P3|Overall Study|Abnormal laboratory value|0
478780|NCT00121719|1562256|P2|Overall Study|Abnormal laboratory value|1
478781|NCT00121719|1562257|P1|Overall Study|Abnormal laboratory value|1
478782|NCT00121719|1562244|P14|Overall Study|Adverse Event|0
478783|NCT00121719|1562245|P13|Overall Study|Adverse Event|3
478784|NCT00121719|1562246|P12|Overall Study|Adverse Event|0
478785|NCT00121719|1562247|P11|Overall Study|Adverse Event|1
478786|NCT00121719|1562248|P10|Overall Study|Adverse Event|0
478787|NCT00121719|1562249|P9|Overall Study|Adverse Event|0
478788|NCT00121719|1562250|P8|Overall Study|Adverse Event|1
478789|NCT00121719|1562251|P7|Overall Study|Adverse Event|2
478790|NCT00121719|1562252|P6|Overall Study|Adverse Event|2
478791|NCT00121719|1562253|P5|Overall Study|Adverse Event|0
478792|NCT00121719|1562254|P4|Overall Study|Adverse Event|0
478793|NCT00121719|1562255|P3|Overall Study|Adverse Event|1
478794|NCT00121719|1562256|P2|Overall Study|Adverse Event|0
478795|NCT00121719|1562257|P1|Overall Study|Adverse Event|0
478796|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Death|2
478797|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Death|0
478798|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Death|0
478799|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Death|1
478800|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
478801|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
478802|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
478803|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
478804|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
478805|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
478806|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
478807|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
478808|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
478809|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
478810|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
478811|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
478812|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
478813|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
478814|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
478815|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
478816|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
478817|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
478818|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
478819|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
478820|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
478821|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
478822|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
478823|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
478824|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
478825|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
478826|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
478827|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
478828|NCT00121667|1562434|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
478829|NCT00121667|1562435|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
478830|NCT00121667|1562436|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
478831|NCT00121667|1562437|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
478832|NCT00121667|1562434|P4|Short Term (ST) Period|Pregnancy|1
478833|NCT00121667|1562435|P3|Short Term (ST) Period|Pregnancy|0
478834|NCT00121667|1562436|P2|Short Term (ST) Period|Pregnancy|0
478835|NCT00121667|1562437|P1|Short Term (ST) Period|Pregnancy|0
478836|NCT00121667|1562434|P4|Short Term (ST) Period|Death|1
478837|NCT00121667|1562435|P3|Short Term (ST) Period|Death|0
478838|NCT00121667|1562436|P2|Short Term (ST) Period|Death|0
478839|NCT00121667|1562437|P1|Short Term (ST) Period|Death|0
478840|NCT00121667|1562434|P4|Short Term (ST) Period|Other Reason|0
478841|NCT00121667|1562435|P3|Short Term (ST) Period|Other Reason|0
478842|NCT00121667|1562436|P2|Short Term (ST) Period|Other Reason|0
478843|NCT00121667|1562437|P1|Short Term (ST) Period|Other Reason|3
478844|NCT00121667|1562434|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
478845|NCT00121667|1562435|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
478846|NCT00121667|1562436|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
478847|NCT00121667|1562437|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
478848|NCT00121667|1562434|P4|Short Term (ST) Period|Poor / Non-compliance|2
478849|NCT00121667|1562435|P3|Short Term (ST) Period|Poor / Non-compliance|1
478850|NCT00121667|1562436|P2|Short Term (ST) Period|Poor / Non-compliance|1
478851|NCT00121667|1562437|P1|Short Term (ST) Period|Poor / Non-compliance|0
478852|NCT00121667|1562434|P4|Short Term (ST) Period|Lost to Follow-up|3
478853|NCT00121667|1562435|P3|Short Term (ST) Period|Lost to Follow-up|4
478854|NCT00121667|1562436|P2|Short Term (ST) Period|Lost to Follow-up|4
478855|NCT00121667|1562437|P1|Short Term (ST) Period|Lost to Follow-up|3
478856|NCT00121667|1562434|P4|Short Term (ST) Period|Adverse Event|3
478857|NCT00121667|1562435|P3|Short Term (ST) Period|Adverse Event|5
478858|NCT00121667|1562436|P2|Short Term (ST) Period|Adverse Event|6
478859|NCT00121667|1562437|P1|Short Term (ST) Period|Adverse Event|5
478860|NCT00121667|1562434|P4|Short Term (ST) Period|Subject Withdrew Consent|11
478861|NCT00121667|1562435|P3|Short Term (ST) Period|Subject Withdrew Consent|4
478862|NCT00121667|1562436|P2|Short Term (ST) Period|Subject Withdrew Consent|13
478863|NCT00121667|1562437|P1|Short Term (ST) Period|Subject Withdrew Consent|8
478864|NCT00121667|1562434|P4|Short Term (ST) Period|Lack of Efficacy|44
478865|NCT00121667|1562435|P3|Short Term (ST) Period|Lack of Efficacy|27
478866|NCT00121667|1562436|P2|Short Term (ST) Period|Lack of Efficacy|22
478867|NCT00121667|1562437|P1|Short Term (ST) Period|Lack of Efficacy|25
478868|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Other Reason|1
478869|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Other Reason|0
478870|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Other Reason|2
478871|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Other Reason|3
478872|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Other Reason|5
478873|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Missing|0
478874|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Missing|0
478875|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Missing|1
478876|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Missing|0
478877|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Missing|0
478878|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Death|0
478879|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Death|1
478880|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Death|0
478881|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Death|0
478882|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Death|0
478883|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
478884|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
478885|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
478886|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
478887|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
478888|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Pregnancy|0
478889|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Pregnancy|1
478890|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Pregnancy|0
478891|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Pregnancy|1
478892|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Pregnancy|0
478893|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
478894|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
478895|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
478896|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
478897|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
478898|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
478899|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
478900|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
478901|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
478902|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
478903|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
478904|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
478905|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
478906|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
478907|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
478908|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Adverse Event|5
478909|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Adverse Event|5
478910|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Adverse Event|10
478911|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Adverse Event|10
478912|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Adverse Event|9
478913|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
478914|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
478915|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
478916|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
478917|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
478918|NCT00121641|1562535|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
478919|NCT00121641|1562536|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
478920|NCT00121641|1562537|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
478921|NCT00121641|1562538|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
478922|NCT00121641|1562539|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
478923|NCT00121641|1562535|P5|24-week Short-term Treatment Period|Other Reason|0
478924|NCT00121641|1562536|P4|24-week Short-term Treatment Period|Other Reason|0
478925|NCT00121641|1562537|P3|24-week Short-term Treatment Period|Other Reason|0
478926|NCT00121641|1562538|P2|24-week Short-term Treatment Period|Other Reason|0
478927|NCT00121641|1562539|P1|24-week Short-term Treatment Period|Other Reason|1
478928|NCT00121641|1562535|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
478929|NCT00121641|1562536|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
478930|NCT00121641|1562537|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
478931|NCT00121641|1562538|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
478932|NCT00121641|1562539|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
478933|NCT00121641|1562535|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
478934|NCT00121641|1562536|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
478935|NCT00121641|1562537|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
478936|NCT00121641|1562538|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
478937|NCT00121641|1562539|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
478938|NCT00121641|1562535|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
478939|NCT00121641|1562536|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
479024|NCT00119678|1562886|P1|Open-label Treatment Period|Pregnancy|1
478940|NCT00121641|1562537|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
478941|NCT00121641|1562538|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
478942|NCT00121641|1562539|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
478943|NCT00121641|1562535|P5|24-week Short-term Treatment Period|Adverse Event|2
478944|NCT00121641|1562536|P4|24-week Short-term Treatment Period|Adverse Event|0
478945|NCT00121641|1562537|P3|24-week Short-term Treatment Period|Adverse Event|4
478946|NCT00121641|1562538|P2|24-week Short-term Treatment Period|Adverse Event|3
478947|NCT00121641|1562539|P1|24-week Short-term Treatment Period|Adverse Event|3
478948|NCT00121641|1562535|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
478949|NCT00121641|1562536|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
478950|NCT00121641|1562537|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
478951|NCT00121641|1562538|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
478952|NCT00121641|1562539|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
478953|NCT00121641|1562535|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
478954|NCT00121641|1562536|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
478955|NCT00121641|1562537|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
478956|NCT00121641|1562538|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
478957|NCT00121641|1562539|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
478958|NCT00121485|1562652|P2|Overall Study|Crossover|2
478959|NCT00121485|1562653|P1|Overall Study|Crossover|0
478960|NCT00121485|1562652|P2|Overall Study|Not implanted|5
478961|NCT00121485|1562653|P1|Overall Study|Not implanted|1
478962|NCT00121238|1562698|P1|Overall Study|Protocol Violation|2
478963|NCT00121238|1562698|P1|Overall Study|disease progression before intervention|1
478964|NCT00121199|1562710|P1|Overall Study|Ineligible|9
478965|NCT00121199|1562710|P1|Overall Study|Other - Not Protocol Specified|3
478966|NCT00121199|1562710|P1|Overall Study|Death|3
478967|NCT00121199|1562710|P1|Overall Study|Progression/Relapse|1
478968|NCT00121199|1562710|P1|Overall Study|Refusal Unrelated to Adverse Event|1
478969|NCT00121199|1562710|P1|Overall Study|Adverse Event|11
478970|NCT00121134|1562726|P4|Overall Study|Patient Personal Reasons|0
478971|NCT00121134|1562727|P3|Overall Study|Patient Personal Reasons|0
478972|NCT00121134|1562728|P2|Overall Study|Patient Personal Reasons|1
478973|NCT00121134|1562729|P1|Overall Study|Patient Personal Reasons|0
478974|NCT00121134|1562726|P4|Overall Study|Intercurrent Illness|1
478975|NCT00121134|1562727|P3|Overall Study|Intercurrent Illness|0
478976|NCT00121134|1562728|P2|Overall Study|Intercurrent Illness|0
478977|NCT00121134|1562729|P1|Overall Study|Intercurrent Illness|0
478978|NCT00121134|1562726|P4|Overall Study|Treatment Delay|0
478979|NCT00121134|1562727|P3|Overall Study|Treatment Delay|0
478980|NCT00121134|1562728|P2|Overall Study|Treatment Delay|0
478981|NCT00121134|1562729|P1|Overall Study|Treatment Delay|1
478982|NCT00121134|1562726|P4|Overall Study|Physician Decision|1
478983|NCT00121134|1562727|P3|Overall Study|Physician Decision|4
478984|NCT00121134|1562728|P2|Overall Study|Physician Decision|4
478985|NCT00121134|1562729|P1|Overall Study|Physician Decision|6
478986|NCT00121134|1562726|P4|Overall Study|Toxicity|5
478987|NCT00121134|1562727|P3|Overall Study|Toxicity|13
478988|NCT00121134|1562728|P2|Overall Study|Toxicity|7
478989|NCT00121134|1562729|P1|Overall Study|Toxicity|4
478990|NCT00121134|1562726|P4|Overall Study|Progression of Disease|2
478991|NCT00121134|1562727|P3|Overall Study|Progression of Disease|4
478992|NCT00121134|1562728|P2|Overall Study|Progression of Disease|3
478993|NCT00121134|1562729|P1|Overall Study|Progression of Disease|5
478994|NCT00120874|1562741|P2|Overall Study|Death|1
478995|NCT00120874|1562742|P1|Overall Study|Death|0
478996|NCT00120627|1562780|P2|Overall Study|Withdrawal by Subject|5
478997|NCT00120627|1562781|P1|Overall Study|Withdrawal by Subject|5
478998|NCT00120406|1562832|P2|Overall Study|patient moved but has not withdrawn|1
478999|NCT00120406|1562833|P1|Overall Study|patient moved but has not withdrawn|0
479000|NCT00120406|1562832|P2|Overall Study|received non-study stent|2
479001|NCT00120406|1562833|P1|Overall Study|received non-study stent|0
479002|NCT00120406|1562832|P2|Overall Study|Lost to Follow-up|2
479003|NCT00120406|1562833|P1|Overall Study|Lost to Follow-up|5
479004|NCT00120406|1562832|P2|Overall Study|Withdrawal by Subject|7
479005|NCT00120406|1562833|P1|Overall Study|Withdrawal by Subject|5
479006|NCT00120406|1562832|P2|Overall Study|Death|4
479007|NCT00120406|1562833|P1|Overall Study|Death|9
479008|NCT00120289|1562843|P2|Overall Study|Withdrawal by Subject|13
479009|NCT00120289|1562844|P1|Overall Study|Withdrawal by Subject|14
479010|NCT00120289|1562843|P2|Overall Study|Lost to Follow-up|14
479011|NCT00120289|1562844|P1|Overall Study|Lost to Follow-up|11
479012|NCT00120289|1562843|P2|Overall Study|Death|82
479013|NCT00120289|1562844|P1|Overall Study|Death|96
479014|NCT00120250|1562856|P2|Overall Study|Protocol Violation|1
479015|NCT00120250|1562857|P1|Overall Study|Protocol Violation|0
479016|NCT00120250|1562856|P2|Overall Study|Lost to Follow-up|1
479017|NCT00120250|1562857|P1|Overall Study|Lost to Follow-up|1
479018|NCT00120042|1562873|P3|Overall Study|all completed protocl|0
479019|NCT00120042|1562874|P2|Overall Study|all completed protocl|0
479020|NCT00120042|1562875|P1|Overall Study|all completed protocl|0
479021|NCT00119678|1562885|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
479022|NCT00119678|1562886|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
479023|NCT00119678|1562885|P2|Open-label Treatment Period|Pregnancy|0
479025|NCT00119678|1562885|P2|Open-label Treatment Period|Participants not meeting study criteria|0
479026|NCT00119678|1562886|P1|Open-label Treatment Period|Participants not meeting study criteria|2
479027|NCT00119678|1562885|P2|Open-label Treatment Period|Participant withdrew consent|0
479028|NCT00119678|1562886|P1|Open-label Treatment Period|Participant withdrew consent|4
479029|NCT00119678|1562885|P2|Open-label Treatment Period|Lost to Follow-up|0
479030|NCT00119678|1562886|P1|Open-label Treatment Period|Lost to Follow-up|3
479031|NCT00119678|1562885|P2|Open-label Treatment Period|Lack of Efficacy|0
479032|NCT00119678|1562886|P1|Open-label Treatment Period|Lack of Efficacy|9
479033|NCT00119678|1562885|P2|Open-label Treatment Period|Adverse Event|0
479034|NCT00119678|1562886|P1|Open-label Treatment Period|Adverse Event|3
479035|NCT00119678|1562885|P2|Open-label Treatment Period|Death|0
479036|NCT00119678|1562886|P1|Open-label Treatment Period|Death|1
479037|NCT00119678|1562885|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
479038|NCT00119678|1562886|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
479039|NCT00119678|1562885|P2|Double-blind Treatment Period|Not treated|2
479040|NCT00119678|1562886|P1|Double-blind Treatment Period|Not treated|1
479041|NCT00119678|1562885|P2|Double-blind Treatment Period|Pregnancy|2
479042|NCT00119678|1562886|P1|Double-blind Treatment Period|Pregnancy|0
479043|NCT00119678|1562885|P2|Double-blind Treatment Period|Poor/Non-compliance|0
479044|NCT00119678|1562886|P1|Double-blind Treatment Period|Poor/Non-compliance|3
479045|NCT00119678|1562885|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
479046|NCT00119678|1562886|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
479047|NCT00119678|1562885|P2|Double-blind Treatment Period|Participant withdrew consent|4
479048|NCT00119678|1562886|P1|Double-blind Treatment Period|Participant withdrew consent|4
479049|NCT00119678|1562885|P2|Double-blind Treatment Period|Lost to Follow-up|2
479050|NCT00119678|1562886|P1|Double-blind Treatment Period|Lost to Follow-up|1
479051|NCT00119678|1562885|P2|Double-blind Treatment Period|Lack of Efficacy|12
479052|NCT00119678|1562886|P1|Double-blind Treatment Period|Lack of Efficacy|21
479053|NCT00119678|1562885|P2|Double-blind Treatment Period|Adverse Event|1
479054|NCT00119678|1562886|P1|Double-blind Treatment Period|Adverse Event|7
479055|NCT00119678|1562885|P2|Double-blind Treatment Period|Death|0
479056|NCT00119678|1562886|P1|Double-blind Treatment Period|Death|1
479057|NCT00119405|1562932|P1|Overall Study|Withdrawal by Subject|1
479058|NCT00119379|1562946|P2|Overall Study|Adverse Event|1
479059|NCT00119379|1562947|P1|Overall Study|Adverse Event|4
479060|NCT00119262|1562965|P2|Overall Study|others|5
479061|NCT00119262|1562966|P1|Overall Study|others|0
479062|NCT00119262|1562965|P2|Overall Study|ineligble|2
479063|NCT00119262|1562966|P1|Overall Study|ineligble|1
479064|NCT00119262|1562965|P2|Overall Study|other disease|2
479065|NCT00119262|1562966|P1|Overall Study|other disease|0
479066|NCT00119262|1562965|P2|Overall Study|Adverse Event|35
479067|NCT00119262|1562966|P1|Overall Study|Adverse Event|33
479068|NCT00119262|1562965|P2|Overall Study|Withdrawal by Subject|11
479069|NCT00119262|1562966|P1|Overall Study|Withdrawal by Subject|12
479070|NCT00119262|1562965|P2|Overall Study|Lack of Efficacy|3
479071|NCT00119262|1562966|P1|Overall Study|Lack of Efficacy|0
479072|NCT00119015|1563003|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
479073|NCT00119015|1563004|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
479074|NCT00119015|1563005|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
479075|NCT00118911|1563021|P2|Overall Study|Withdrawal by Subject|5
479076|NCT00118911|1563022|P1|Overall Study|Withdrawal by Subject|2
479077|NCT00118898|1563034|P4|Overall Study|Not able to get to clinic|40
479078|NCT00118898|1563035|P3|Overall Study|Not able to get to clinic|31
479079|NCT00118898|1563036|P2|Overall Study|Not able to get to clinic|43
479080|NCT00118898|1563037|P1|Overall Study|Not able to get to clinic|34
479081|NCT00118898|1563034|P4|Overall Study|Not compliant with requirements|11
479082|NCT00118898|1563035|P3|Overall Study|Not compliant with requirements|11
479083|NCT00118898|1563036|P2|Overall Study|Not compliant with requirements|13
479084|NCT00118898|1563037|P1|Overall Study|Not compliant with requirements|11
479085|NCT00118898|1563034|P4|Overall Study|Severe debilitation|4
479086|NCT00118898|1563035|P3|Overall Study|Severe debilitation|6
479087|NCT00118898|1563036|P2|Overall Study|Severe debilitation|4
479088|NCT00118898|1563037|P1|Overall Study|Severe debilitation|1
479089|NCT00118898|1563034|P4|Overall Study|Site Closure|37
479090|NCT00118898|1563035|P3|Overall Study|Site Closure|28
479091|NCT00118898|1563036|P2|Overall Study|Site Closure|31
479092|NCT00118898|1563037|P1|Overall Study|Site Closure|33
479093|NCT00118898|1563034|P4|Overall Study|Withdrawal by Subject|8
479094|NCT00118898|1563035|P3|Overall Study|Withdrawal by Subject|8
479095|NCT00118898|1563036|P2|Overall Study|Withdrawal by Subject|5
479096|NCT00118898|1563037|P1|Overall Study|Withdrawal by Subject|10
479097|NCT00118898|1563034|P4|Overall Study|Lost to Follow-up|33
479098|NCT00118898|1563035|P3|Overall Study|Lost to Follow-up|33
479099|NCT00118898|1563036|P2|Overall Study|Lost to Follow-up|34
479100|NCT00118898|1563037|P1|Overall Study|Lost to Follow-up|26
479101|NCT00118898|1563034|P4|Overall Study|Death|8
479102|NCT00118898|1563035|P3|Overall Study|Death|6
479103|NCT00118898|1563036|P2|Overall Study|Death|11
479104|NCT00118898|1563037|P1|Overall Study|Death|6
479105|NCT00118703|1563163|P2|Overall Study|Lost to Follow-up|2
479106|NCT00118703|1563164|P1|Overall Study|Lost to Follow-up|1
479107|NCT00118703|1563163|P2|Overall Study|Withdrawal by Subject|5
479108|NCT00118703|1563164|P1|Overall Study|Withdrawal by Subject|2
479109|NCT00118703|1563163|P2|Overall Study|Participant took two different treatment|1
479110|NCT00118703|1563164|P1|Overall Study|Participant took two different treatment|0
479111|NCT00118703|1563163|P2|Overall Study|Adverse Event|1
479112|NCT00118703|1563164|P1|Overall Study|Adverse Event|1
479113|NCT00118703|1563163|P2|Overall Study|Protocol Violation|0
479114|NCT00118703|1563164|P1|Overall Study|Protocol Violation|1
479115|NCT00118482|1563261|P2|Overall Study|Withdrawal by Subject|22
479116|NCT00118482|1563262|P1|Overall Study|Withdrawal by Subject|23
479117|NCT00118482|1563261|P2|Overall Study|Lost to Follow-up|7
479118|NCT00118482|1563262|P1|Overall Study|Lost to Follow-up|7
479119|NCT00118430|1563273|P3|Overall Study|Lost to Follow-up|28
479120|NCT00118430|1563274|P2|Overall Study|Lost to Follow-up|22
479121|NCT00118430|1563275|P1|Overall Study|Lost to Follow-up|15
479122|NCT00118430|1563273|P3|Overall Study|Withdrawal by Subject|0
479123|NCT00118430|1563274|P2|Overall Study|Withdrawal by Subject|2
479124|NCT00118430|1563275|P1|Overall Study|Withdrawal by Subject|6
479125|NCT00118417|1563290|P2|Phase II (Weeks 6 to 12)|Remission|2
479126|NCT00118417|1563291|P1|Phase II (Weeks 6 to 12)|Remission|1
479127|NCT00118417|1563290|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
479128|NCT00118417|1563291|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
479129|NCT00118417|1563290|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
479130|NCT00118417|1563291|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
479131|NCT00118417|1563290|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
479132|NCT00118417|1563291|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
479133|NCT00118417|1563290|P2|Phase I (Weeks 0 to 6)|Remission|0
479134|NCT00118417|1563291|P1|Phase I (Weeks 0 to 6)|Remission|8
479135|NCT00118287|1563435|P1|Overall Study|Muscle pain|1
479136|NCT00118287|1563435|P1|Overall Study|Intracranial haemorrhage|1
479137|NCT00118157|1563455|P1|Overall Study|Withdrawal by Subject|2
479138|NCT00118157|1563455|P1|Overall Study|Death|8
479139|NCT00118157|1563455|P1|Overall Study|Adverse Event|2
479140|NCT00118092|1563473|P1|Overall Study|Protocol Violation|1
479141|NCT00118092|1563473|P1|Overall Study|Withdrawal by Subject|1
479142|NCT00118040|1563491|P3|Overall Study|Other|1
479143|NCT00118040|1563492|P2|Overall Study|Other|0
479144|NCT00118040|1563493|P1|Overall Study|Other|0
479145|NCT00118040|1563491|P3|Overall Study|Non-Compliant Participant|2
479146|NCT00118040|1563492|P2|Overall Study|Non-Compliant Participant|1
479147|NCT00118040|1563493|P1|Overall Study|Non-Compliant Participant|1
479148|NCT00118040|1563491|P3|Overall Study|Medical Contraindication|1
479149|NCT00118040|1563492|P2|Overall Study|Medical Contraindication|0
479150|NCT00118040|1563493|P1|Overall Study|Medical Contraindication|0
479151|NCT00118040|1563491|P3|Overall Study|Withdrawal by Subject|2
479152|NCT00118040|1563492|P2|Overall Study|Withdrawal by Subject|0
479153|NCT00118040|1563493|P1|Overall Study|Withdrawal by Subject|0
479154|NCT00118040|1563491|P3|Overall Study|Adverse Event|0
479155|NCT00118040|1563492|P2|Overall Study|Adverse Event|1
479156|NCT00118040|1563493|P1|Overall Study|Adverse Event|0
479157|NCT00117988|1563554|P1|Overall Study|Adverse Event|1
479158|NCT00117988|1563554|P1|Overall Study|Death|3
479159|NCT00117949|1563577|P4|Overall Study|Hepatic abnormalities|1
479160|NCT00117949|1563578|P3|Overall Study|Hepatic abnormalities|0
479161|NCT00117949|1563579|P2|Overall Study|Hepatic abnormalities|1
479162|NCT00117949|1563580|P1|Overall Study|Hepatic abnormalities|0
479163|NCT00117949|1563577|P4|Overall Study|PSA reduction <=50%|4
479164|NCT00117949|1563578|P3|Overall Study|PSA reduction <=50%|2
479165|NCT00117949|1563579|P2|Overall Study|PSA reduction <=50%|2
479166|NCT00117949|1563580|P1|Overall Study|PSA reduction <=50%|0
479167|NCT00117949|1563577|P4|Overall Study|PSA increase >=10ng/mL|0
479168|NCT00117949|1563578|P3|Overall Study|PSA increase >=10ng/mL|1
479169|NCT00117949|1563579|P2|Overall Study|PSA increase >=10ng/mL|1
479170|NCT00117949|1563580|P1|Overall Study|PSA increase >=10ng/mL|0
479171|NCT00117949|1563577|P4|Overall Study|Prostate-specific antigen increase >=25%|2
479172|NCT00117949|1563578|P3|Overall Study|Prostate-specific antigen increase >=25%|1
479173|NCT00117949|1563579|P2|Overall Study|Prostate-specific antigen increase >=25%|1
479174|NCT00117949|1563580|P1|Overall Study|Prostate-specific antigen increase >=25%|0
479175|NCT00117949|1563577|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
479176|NCT00117949|1563578|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
479177|NCT00117949|1563579|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
479178|NCT00117949|1563580|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
479179|NCT00117949|1563577|P4|Overall Study|Testosterone >1.0 ng/mL|15
479180|NCT00117949|1563578|P3|Overall Study|Testosterone >1.0 ng/mL|17
479181|NCT00117949|1563579|P2|Overall Study|Testosterone >1.0 ng/mL|18
479182|NCT00117949|1563580|P1|Overall Study|Testosterone >1.0 ng/mL|10
479183|NCT00117845|1563614|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
479184|NCT00117793|1563632|P1|Overall Study|Withdrawal by Subject|12
479185|NCT00117676|1563655|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
479186|NCT00117676|1563656|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
479187|NCT00117676|1563655|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
479188|NCT00117676|1563656|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
479189|NCT00117676|1563655|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
479190|NCT00117676|1563656|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
479191|NCT00117676|1563655|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
479192|NCT00117676|1563656|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
479193|NCT00117676|1563655|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
479194|NCT00117676|1563656|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
479195|NCT00117676|1563655|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
479196|NCT00117676|1563656|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
479197|NCT00117676|1563655|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
479198|NCT00117676|1563656|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
479199|NCT00117676|1563655|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
479200|NCT00117676|1563656|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
479201|NCT00117676|1563655|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
479202|NCT00117676|1563656|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
479203|NCT00117676|1563655|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
479204|NCT00117676|1563656|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
479205|NCT00117676|1563655|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
479206|NCT00117676|1563656|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
479207|NCT00117676|1563655|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
479208|NCT00117676|1563656|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
479209|NCT00117676|1563655|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
479210|NCT00117676|1563656|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
479211|NCT00117676|1563655|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
479212|NCT00117676|1563656|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
479213|NCT00117676|1563655|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
479214|NCT00117676|1563656|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
479215|NCT00117676|1563655|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
479216|NCT00117676|1563656|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
479217|NCT00117676|1563655|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
479218|NCT00117676|1563656|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
479219|NCT00117676|1563655|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
479220|NCT00117676|1563656|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
479221|NCT00117676|1563655|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
479222|NCT00117676|1563656|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
479223|NCT00117676|1563655|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
479224|NCT00117676|1563656|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
479225|NCT00117676|1563655|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
479226|NCT00117676|1563656|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
479227|NCT00117676|1563655|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
479228|NCT00117676|1563656|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
479229|NCT00117676|1563655|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
479230|NCT00117676|1563656|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
479231|NCT00117676|1563655|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
479232|NCT00117676|1563656|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
479233|NCT00117676|1563655|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
479234|NCT00117676|1563656|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
479235|NCT00117676|1563655|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
479236|NCT00117676|1563656|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
479237|NCT00117676|1563655|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
479238|NCT00117676|1563656|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
479239|NCT00117676|1563655|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
479240|NCT00117676|1563656|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
479241|NCT00117676|1563655|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
479242|NCT00117676|1563656|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
479243|NCT00117676|1563655|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
479244|NCT00117676|1563656|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
479245|NCT00117676|1563655|P2|Double-blind Period Through Week 48|Withdrew Consent|1
479246|NCT00117676|1563656|P1|Double-blind Period Through Week 48|Withdrew Consent|0
479247|NCT00117676|1563655|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
479248|NCT00117676|1563656|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
479249|NCT00117676|1563655|P2|Double-blind Period Through Week 48|Protocol Violation|1
479250|NCT00117676|1563656|P1|Double-blind Period Through Week 48|Protocol Violation|0
479251|NCT00117676|1563655|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
479252|NCT00117676|1563656|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
479253|NCT00117676|1563655|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
479254|NCT00117676|1563656|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
479255|NCT00117637|1563745|P2|Second Intervention (Period 2)|reason not reported|0
479256|NCT00117637|1563746|P1|Second Intervention (Period 2)|reason not reported|1
479257|NCT00117637|1563745|P2|Second Intervention (Period 2)|non compliant with study medication|1
479258|NCT00117637|1563746|P1|Second Intervention (Period 2)|non compliant with study medication|1
479259|NCT00117637|1563745|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
479260|NCT00117637|1563746|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
479261|NCT00117637|1563745|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
479262|NCT00117637|1563746|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
479263|NCT00117637|1563745|P2|Second Intervention (Period 2)|Protocol Violation|0
479264|NCT00117637|1563746|P1|Second Intervention (Period 2)|Protocol Violation|1
479265|NCT00117637|1563745|P2|Second Intervention (Period 2)|Lost to Follow-up|0
479266|NCT00117637|1563746|P1|Second Intervention (Period 2)|Lost to Follow-up|1
479267|NCT00117637|1563745|P2|Second Intervention (Period 2)|Adverse Event|9
479268|NCT00117637|1563746|P1|Second Intervention (Period 2)|Adverse Event|0
479269|NCT00117637|1563745|P2|First Intervention (Period 1)|reason not reported|1
479270|NCT00117637|1563746|P1|First Intervention (Period 1)|reason not reported|0
479271|NCT00117637|1563745|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
479272|NCT00117637|1563746|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
479273|NCT00117637|1563745|P2|First Intervention (Period 1)|protocol driven decision point|0
479274|NCT00117637|1563746|P1|First Intervention (Period 1)|protocol driven decision point|1
479275|NCT00117637|1563745|P2|First Intervention (Period 1)|study terminated by the sponsor|1
479276|NCT00117637|1563746|P1|First Intervention (Period 1)|study terminated by the sponsor|3
479277|NCT00117637|1563745|P2|First Intervention (Period 1)|Withdrawal by Subject|4
479278|NCT00117637|1563746|P1|First Intervention (Period 1)|Withdrawal by Subject|2
479279|NCT00117637|1563745|P2|First Intervention (Period 1)|Protocol Violation|0
479280|NCT00117637|1563746|P1|First Intervention (Period 1)|Protocol Violation|1
479281|NCT00117637|1563745|P2|First Intervention (Period 1)|Lost to Follow-up|2
479282|NCT00117637|1563746|P1|First Intervention (Period 1)|Lost to Follow-up|0
479283|NCT00117637|1563745|P2|First Intervention (Period 1)|Adverse Event|16
479284|NCT00117637|1563746|P1|First Intervention (Period 1)|Adverse Event|11
479285|NCT00117598|1563821|P5|After Treament Cross Over|Other|2
479286|NCT00117598|1563822|P4|After Treament Cross Over|Other|1
479287|NCT00117598|1563823|P3|After Treament Cross Over|Other|0
479288|NCT00117598|1563824|P2|After Treament Cross Over|Other|0
479289|NCT00117598|1563825|P1|After Treament Cross Over|Other|0
479290|NCT00117598|1563821|P5|After Treament Cross Over|Withdrawal by Subject|0
479291|NCT00117598|1563822|P4|After Treament Cross Over|Withdrawal by Subject|1
479292|NCT00117598|1563823|P3|After Treament Cross Over|Withdrawal by Subject|0
479293|NCT00117598|1563824|P2|After Treament Cross Over|Withdrawal by Subject|0
479294|NCT00117598|1563825|P1|After Treament Cross Over|Withdrawal by Subject|0
479295|NCT00117598|1563821|P5|After Treament Cross Over|Death|2
479296|NCT00117598|1563822|P4|After Treament Cross Over|Death|1
479297|NCT00117598|1563823|P3|After Treament Cross Over|Death|0
479298|NCT00117598|1563824|P2|After Treament Cross Over|Death|0
479299|NCT00117598|1563825|P1|After Treament Cross Over|Death|0
479300|NCT00117598|1563821|P5|Prior to Treatment Cross Over|Other|0
479301|NCT00117598|1563822|P4|Prior to Treatment Cross Over|Other|0
479302|NCT00117598|1563823|P3|Prior to Treatment Cross Over|Other|9
479303|NCT00117598|1563824|P2|Prior to Treatment Cross Over|Other|9
479304|NCT00117598|1563825|P1|Prior to Treatment Cross Over|Other|15
479305|NCT00117598|1563821|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
479306|NCT00117598|1563822|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
479307|NCT00117598|1563823|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
479308|NCT00117598|1563824|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
479309|NCT00117598|1563825|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
479310|NCT00117598|1563821|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
479311|NCT00117598|1563822|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
479312|NCT00117598|1563823|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
479313|NCT00117598|1563824|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
479314|NCT00117598|1563825|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
479315|NCT00117598|1563821|P5|Prior to Treatment Cross Over|Death|0
479316|NCT00117598|1563822|P4|Prior to Treatment Cross Over|Death|0
479317|NCT00117598|1563823|P3|Prior to Treatment Cross Over|Death|37
479318|NCT00117598|1563824|P2|Prior to Treatment Cross Over|Death|41
479319|NCT00117598|1563825|P1|Prior to Treatment Cross Over|Death|40
479320|NCT00117572|1563859|P2|Overall Study|Protocol Violation|0
479321|NCT00117572|1563860|P1|Overall Study|Protocol Violation|1
479322|NCT00117572|1563859|P2|Overall Study|Withdrawal by Subject|3
479323|NCT00117572|1563860|P1|Overall Study|Withdrawal by Subject|3
479324|NCT00117572|1563859|P2|Overall Study|Site withdrew before starting treatment|3
479325|NCT00117572|1563860|P1|Overall Study|Site withdrew before starting treatment|2
479326|NCT00117338|1563901|P2|Overall Study|Lack of Efficacy|1
479327|NCT00117338|1563902|P1|Overall Study|Lack of Efficacy|0
479328|NCT00117338|1563901|P2|Overall Study|Did not meet Inclusion Criteria|0
479329|NCT00117338|1563902|P1|Overall Study|Did not meet Inclusion Criteria|1
479330|NCT00117338|1563901|P2|Overall Study|Withdrawal by Subject|0
479331|NCT00117338|1563902|P1|Overall Study|Withdrawal by Subject|1
479332|NCT00117338|1563901|P2|Overall Study|Protocol Violation|2
479333|NCT00117338|1563902|P1|Overall Study|Protocol Violation|3
479334|NCT00117338|1563901|P2|Overall Study|Adverse Event|1
479335|NCT00117338|1563902|P1|Overall Study|Adverse Event|0
479336|NCT00117325|1563922|P2|Overall Study|Admisnitrative|0
479337|NCT00117325|1563923|P1|Overall Study|Admisnitrative|1
479338|NCT00117325|1563922|P2|Overall Study|Early termination|1
479339|NCT00117325|1563923|P1|Overall Study|Early termination|1
479340|NCT00117325|1563922|P2|Overall Study|Use of prohibited medicine|2
479341|NCT00117325|1563923|P1|Overall Study|Use of prohibited medicine|1
479342|NCT00117325|1563922|P2|Overall Study|Lack of Efficacy|0
479343|NCT00117325|1563923|P1|Overall Study|Lack of Efficacy|1
479344|NCT00117325|1563922|P2|Overall Study|Withdrawal by Subject|2
479345|NCT00117325|1563923|P1|Overall Study|Withdrawal by Subject|3
479346|NCT00117325|1563922|P2|Overall Study|Protocol Violation|3
479347|NCT00117325|1563923|P1|Overall Study|Protocol Violation|2
479348|NCT00117325|1563922|P2|Overall Study|Lost to Follow-up|1
479349|NCT00117325|1563923|P1|Overall Study|Lost to Follow-up|1
479350|NCT00117325|1563922|P2|Overall Study|Adverse Event|3
479351|NCT00117325|1563923|P1|Overall Study|Adverse Event|3
479352|NCT00117312|1563955|P4|Overall Study|Withdrawal by Subject|0
479353|NCT00117312|1563956|P3|Overall Study|Withdrawal by Subject|0
479354|NCT00117312|1563957|P2|Overall Study|Withdrawal by Subject|2
479355|NCT00117312|1563958|P1|Overall Study|Withdrawal by Subject|0
479356|NCT00117312|1563955|P4|Overall Study|Hepatic abnormality|1
479357|NCT00117312|1563956|P3|Overall Study|Hepatic abnormality|0
479358|NCT00117312|1563957|P2|Overall Study|Hepatic abnormality|1
479359|NCT00117312|1563958|P1|Overall Study|Hepatic abnormality|0
479360|NCT00117312|1563955|P4|Overall Study|PSA increase >= 10ng/mL|0
479361|NCT00117312|1563956|P3|Overall Study|PSA increase >= 10ng/mL|1
479362|NCT00117312|1563957|P2|Overall Study|PSA increase >= 10ng/mL|1
479363|NCT00117312|1563958|P1|Overall Study|PSA increase >= 10ng/mL|0
479364|NCT00117312|1563955|P4|Overall Study|PSA decrease <=50%|4
479365|NCT00117312|1563956|P3|Overall Study|PSA decrease <=50%|2
479366|NCT00117312|1563957|P2|Overall Study|PSA decrease <=50%|2
479367|NCT00117312|1563958|P1|Overall Study|PSA decrease <=50%|0
479368|NCT00117312|1563955|P4|Overall Study|Protocol Violation|0
479369|NCT00117312|1563956|P3|Overall Study|Protocol Violation|3
479370|NCT00117312|1563957|P2|Overall Study|Protocol Violation|1
479371|NCT00117312|1563958|P1|Overall Study|Protocol Violation|0
479372|NCT00117312|1563955|P4|Overall Study|Adverse Event|0
479373|NCT00117312|1563956|P3|Overall Study|Adverse Event|0
479374|NCT00117312|1563957|P2|Overall Study|Adverse Event|2
479375|NCT00117312|1563958|P1|Overall Study|Adverse Event|0
479376|NCT00117312|1563955|P4|Overall Study|Patient choice|1
479377|NCT00117312|1563956|P3|Overall Study|Patient choice|2
479378|NCT00117312|1563957|P2|Overall Study|Patient choice|0
479379|NCT00117312|1563958|P1|Overall Study|Patient choice|0
479380|NCT00117312|1563955|P4|Overall Study|Not specified|1
479381|NCT00117312|1563956|P3|Overall Study|Not specified|3
479382|NCT00117312|1563957|P2|Overall Study|Not specified|1
479383|NCT00117312|1563958|P1|Overall Study|Not specified|0
479384|NCT00117312|1563955|P4|Overall Study|Prostate-specific antigen increase >=25%|3
479385|NCT00117312|1563956|P3|Overall Study|Prostate-specific antigen increase >=25%|5
479386|NCT00117312|1563957|P2|Overall Study|Prostate-specific antigen increase >=25%|1
479387|NCT00117312|1563958|P1|Overall Study|Prostate-specific antigen increase >=25%|0
479388|NCT00117312|1563955|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
479389|NCT00117312|1563956|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
479390|NCT00117312|1563957|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
479391|NCT00117312|1563958|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
479392|NCT00117312|1563955|P4|Overall Study|Testosterone >1.0 ng/mL|9
479393|NCT00117312|1563956|P3|Overall Study|Testosterone >1.0 ng/mL|5
479394|NCT00117312|1563957|P2|Overall Study|Testosterone >1.0 ng/mL|9
479395|NCT00117312|1563958|P1|Overall Study|Testosterone >1.0 ng/mL|9
479396|NCT00117286|1563974|P2|Overall Study|Research site closing|2
479397|NCT00117286|1563975|P1|Overall Study|Research site closing|0
479398|NCT00117286|1563974|P2|Overall Study|Lack of Efficacy|1
479399|NCT00117286|1563975|P1|Overall Study|Lack of Efficacy|2
479400|NCT00117286|1563974|P2|Overall Study|Physician Decision|7
479401|NCT00117286|1563975|P1|Overall Study|Physician Decision|3
479402|NCT00117286|1563974|P2|Overall Study|Withdrawal by Subject|2
479403|NCT00117286|1563975|P1|Overall Study|Withdrawal by Subject|6
479404|NCT00117286|1563974|P2|Overall Study|Protocol Violation|3
479405|NCT00117286|1563975|P1|Overall Study|Protocol Violation|3
479406|NCT00117286|1563974|P2|Overall Study|Lost to Follow-up|0
479407|NCT00117286|1563975|P1|Overall Study|Lost to Follow-up|2
479408|NCT00117286|1563974|P2|Overall Study|Adverse Event|6
479409|NCT00117286|1563975|P1|Overall Study|Adverse Event|12
479410|NCT00117156|1563983|P1|Overall Study|Trt for Pre-Exist Second Primary|1
479411|NCT00117156|1563983|P1|Overall Study|Physician Decision|1
479412|NCT00117156|1563983|P1|Overall Study|Adverse Event|9
479413|NCT00116844|1564002|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
479414|NCT00116844|1564003|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
479415|NCT00116844|1564002|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
479416|NCT00116844|1564003|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
479417|NCT00116844|1564002|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
479418|NCT00116844|1564003|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
479419|NCT00116844|1564002|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
479420|NCT00116844|1564003|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
479421|NCT00116844|1564002|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
479422|NCT00116844|1564003|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
479423|NCT00116844|1564002|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
479424|NCT00116844|1564003|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
479425|NCT00116844|1564002|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
479426|NCT00116844|1564003|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
479427|NCT00116844|1564002|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
479428|NCT00116844|1564003|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
479429|NCT00116844|1564002|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
479430|NCT00116844|1564003|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
479431|NCT00116831|1564021|P2|Overall Study|Missing data for participant|0
479432|NCT00116831|1564022|P1|Overall Study|Missing data for participant|1
479433|NCT00116831|1564021|P2|Overall Study|Insufficient therapeutic effect|1
479434|NCT00116831|1564022|P1|Overall Study|Insufficient therapeutic effect|0
479435|NCT00116831|1564021|P2|Overall Study|Withdrawal by Subject|32
479436|NCT00116831|1564022|P1|Overall Study|Withdrawal by Subject|32
479437|NCT00116831|1564021|P2|Overall Study|Withdrawn investigational product|0
479438|NCT00116831|1564022|P1|Overall Study|Withdrawn investigational product|1
479439|NCT00116831|1564021|P2|Overall Study|Low haemoglobin on screening|0
479440|NCT00116831|1564022|P1|Overall Study|Low haemoglobin on screening|1
479441|NCT00116831|1564021|P2|Overall Study|Hypoglycaemic events|0
479442|NCT00116831|1564022|P1|Overall Study|Hypoglycaemic events|1
479443|NCT00116831|1564021|P2|Overall Study|Protocol Violation|6
479444|NCT00116831|1564022|P1|Overall Study|Protocol Violation|3
479445|NCT00116831|1564021|P2|Overall Study|Lost to Follow-up|6
479446|NCT00116831|1564022|P1|Overall Study|Lost to Follow-up|8
479447|NCT00116831|1564021|P2|Overall Study|Baseline IVUS determined unevaluable|11
479448|NCT00116831|1564022|P1|Overall Study|Baseline IVUS determined unevaluable|12
479449|NCT00116831|1564021|P2|Overall Study|Adverse Event|16
479450|NCT00116831|1564022|P1|Overall Study|Adverse Event|14
479451|NCT00116805|1564100|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
479452|NCT00116805|1564101|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
479453|NCT00116805|1564100|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
479454|NCT00116805|1564101|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
479455|NCT00116805|1564100|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
479456|NCT00116805|1564101|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
479457|NCT00116805|1564100|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
479458|NCT00116805|1564101|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
479459|NCT00116805|1564100|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
479460|NCT00116805|1564101|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
479461|NCT00116805|1564100|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
479462|NCT00116805|1564101|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
479463|NCT00116805|1564100|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
479464|NCT00116805|1564101|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
479465|NCT00116805|1564100|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
479466|NCT00116805|1564101|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
479467|NCT00116805|1564100|P2|Open-label Period Weeks 337 - 384|Completed Study|0
479468|NCT00116805|1564101|P1|Open-label Period Weeks 337 - 384|Completed Study|1
479469|NCT00116805|1564100|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
479470|NCT00116805|1564101|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
479471|NCT00116805|1564100|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
479472|NCT00116805|1564101|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
479473|NCT00116805|1564100|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
479474|NCT00116805|1564101|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
479475|NCT00116805|1564100|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
479476|NCT00116805|1564101|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
479477|NCT00116805|1564100|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
479478|NCT00116805|1564101|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
479479|NCT00116805|1564100|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
479480|NCT00116805|1564101|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
479481|NCT00116805|1564100|P2|Open-label Period Weeks 289 - 336|Completed Study|1
479482|NCT00116805|1564101|P1|Open-label Period Weeks 289 - 336|Completed Study|0
479483|NCT00116805|1564100|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
479484|NCT00116805|1564101|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
479485|NCT00116805|1564100|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
479486|NCT00116805|1564101|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
479487|NCT00116805|1564100|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
479488|NCT00116805|1564101|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
479489|NCT00116805|1564100|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
479490|NCT00116805|1564101|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
479491|NCT00116805|1564100|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
479492|NCT00116805|1564101|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
479493|NCT00116805|1564100|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
479494|NCT00116805|1564101|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
479495|NCT00116805|1564100|P2|Open-label Period Weeks 193 - 240|Completed Study|1
479496|NCT00116805|1564101|P1|Open-label Period Weeks 193 - 240|Completed Study|0
479497|NCT00116805|1564100|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
479498|NCT00116805|1564101|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
479499|NCT00116805|1564100|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
479500|NCT00116805|1564101|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
479501|NCT00116805|1564100|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
479502|NCT00116805|1564101|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
479503|NCT00116805|1564100|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
479504|NCT00116805|1564101|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
479505|NCT00116805|1564100|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
479506|NCT00116805|1564101|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
479507|NCT00116805|1564100|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
479508|NCT00116805|1564101|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
479509|NCT00116805|1564100|P2|Open-label Period Weeks 145 - 192|Completed Study|1
479510|NCT00116805|1564101|P1|Open-label Period Weeks 145 - 192|Completed Study|1
479511|NCT00116805|1564100|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
479512|NCT00116805|1564101|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
479513|NCT00116805|1564100|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
479514|NCT00116805|1564101|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
479515|NCT00116805|1564100|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
479516|NCT00116805|1564101|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
479517|NCT00116805|1564100|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
479518|NCT00116805|1564101|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
479519|NCT00116805|1564100|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
479520|NCT00116805|1564101|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
479521|NCT00116805|1564100|P2|Open-label Period Weeks 97 - 144|Completed Study|0
479522|NCT00116805|1564101|P1|Open-label Period Weeks 97 - 144|Completed Study|1
479523|NCT00116805|1564100|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
479524|NCT00116805|1564101|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
479525|NCT00116805|1564100|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
479526|NCT00116805|1564101|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
479527|NCT00116805|1564100|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
479528|NCT00116805|1564101|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
479529|NCT00116805|1564100|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
479530|NCT00116805|1564101|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
479531|NCT00116805|1564100|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
479532|NCT00116805|1564101|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
479533|NCT00116805|1564100|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
479534|NCT00116805|1564101|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
479535|NCT00116805|1564100|P2|Double-blind Period Through Week 48|Withdrew Consent|2
479536|NCT00116805|1564101|P1|Double-blind Period Through Week 48|Withdrew Consent|4
479537|NCT00116805|1564100|P2|Double-blind Period Through Week 48|Protocol Violation|1
479538|NCT00116805|1564101|P1|Double-blind Period Through Week 48|Protocol Violation|1
479539|NCT00116805|1564100|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
479540|NCT00116805|1564101|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
479541|NCT00116779|1564194|P2|Overall Study|Elevated PSA levels|2
479542|NCT00116779|1564195|P1|Overall Study|Elevated PSA levels|2
479543|NCT00116779|1564194|P2|Overall Study|Physician Decision|1
479544|NCT00116779|1564195|P1|Overall Study|Physician Decision|3
479545|NCT00116779|1564194|P2|Overall Study|Inadequate testosterone suppression|9
479546|NCT00116779|1564195|P1|Overall Study|Inadequate testosterone suppression|7
479547|NCT00116779|1564194|P2|Overall Study|Withdrawal by Subject|1
479548|NCT00116779|1564195|P1|Overall Study|Withdrawal by Subject|4
479549|NCT00116779|1564194|P2|Overall Study|Protocol Violation|4
479550|NCT00116779|1564195|P1|Overall Study|Protocol Violation|1
479551|NCT00116779|1564194|P2|Overall Study|Adverse Event|2
479552|NCT00116779|1564195|P1|Overall Study|Adverse Event|4
479553|NCT00116753|1564228|P3|Overall Study|Dosing Error|0
479554|NCT00116753|1564229|P2|Overall Study|Dosing Error|1
479555|NCT00116753|1564230|P1|Overall Study|Dosing Error|0
479556|NCT00116753|1564228|P3|Overall Study|Progressive Parkinson's Disease|0
479557|NCT00116753|1564229|P2|Overall Study|Progressive Parkinson's Disease|0
479558|NCT00116753|1564230|P1|Overall Study|Progressive Parkinson's Disease|1
479559|NCT00116753|1564228|P3|Overall Study|Abnormal Echocardiogram|1
479560|NCT00116753|1564229|P2|Overall Study|Abnormal Echocardiogram|0
479561|NCT00116753|1564230|P1|Overall Study|Abnormal Echocardiogram|0
479562|NCT00116753|1564228|P3|Overall Study|Disease Progression|3
479563|NCT00116753|1564229|P2|Overall Study|Disease Progression|4
479564|NCT00116753|1564230|P1|Overall Study|Disease Progression|3
479565|NCT00116753|1564228|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
479566|NCT00116753|1564229|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
479567|NCT00116753|1564230|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
479568|NCT00116753|1564228|P3|Overall Study|Protocol Violation|1
479569|NCT00116753|1564229|P2|Overall Study|Protocol Violation|0
479570|NCT00116753|1564230|P1|Overall Study|Protocol Violation|0
479571|NCT00116753|1564228|P3|Overall Study|Lost to Follow-up|1
479572|NCT00116753|1564229|P2|Overall Study|Lost to Follow-up|2
479573|NCT00116753|1564230|P1|Overall Study|Lost to Follow-up|0
479574|NCT00116753|1564228|P3|Overall Study|Withdrawal by Subject|8
479575|NCT00116753|1564229|P2|Overall Study|Withdrawal by Subject|12
479576|NCT00116753|1564230|P1|Overall Study|Withdrawal by Subject|11
479577|NCT00116753|1564228|P3|Overall Study|Adverse Event|7
479578|NCT00116753|1564229|P2|Overall Study|Adverse Event|10
479579|NCT00116753|1564230|P1|Overall Study|Adverse Event|16
479580|NCT00116688|1564252|P2|Overall Study|Other|0
479581|NCT00116688|1564253|P1|Overall Study|Other|11
479582|NCT00116688|1564252|P2|Overall Study|Pregnancy|0
479583|NCT00116688|1564253|P1|Overall Study|Pregnancy|1
479584|NCT00116688|1564252|P2|Overall Study|Protocol-specified criteria|0
479585|NCT00116688|1564253|P1|Overall Study|Protocol-specified criteria|3
479586|NCT00116688|1564252|P2|Overall Study|Death|0
479587|NCT00116688|1564253|P1|Overall Study|Death|15
479588|NCT00116688|1564252|P2|Overall Study|Lost to Follow-up|0
479589|NCT00116688|1564253|P1|Overall Study|Lost to Follow-up|3
479590|NCT00116688|1564252|P2|Overall Study|Physician Decision|0
479591|NCT00116688|1564253|P1|Overall Study|Physician Decision|7
479592|NCT00116688|1564252|P2|Overall Study|Requirement for alternative therapy|1
479593|NCT00116688|1564253|P1|Overall Study|Requirement for alternative therapy|11
479594|NCT00116688|1564252|P2|Overall Study|Withdrawal by Subject|2
479595|NCT00116688|1564253|P1|Overall Study|Withdrawal by Subject|26
479596|NCT00116688|1564252|P2|Overall Study|Adverse Event|0
479597|NCT00116688|1564253|P1|Overall Study|Adverse Event|11
479598|NCT00116688|1564252|P2|Overall Study|Noncompliance|1
479599|NCT00116688|1564253|P1|Overall Study|Noncompliance|3
479600|NCT00116688|1564252|P2|Overall Study|Protocol deviation|0
479601|NCT00116688|1564253|P1|Overall Study|Protocol deviation|1
479602|NCT00116649|1564268|P1|Overall Study|Protocol Specified|7
479603|NCT00116649|1564268|P1|Overall Study|Various Reasons|18
479604|NCT00116649|1564268|P1|Overall Study|Local Skin Reaction|9
479605|NCT00116649|1564268|P1|Overall Study|Withdrawal by Subject|68
479606|NCT00116649|1564268|P1|Overall Study|Lost to Follow-up|32
479607|NCT00116649|1564268|P1|Overall Study|Lack of Efficacy|1
479608|NCT00116649|1564268|P1|Overall Study|Adverse Event|20
479609|NCT00116428|1564275|P2|Overall Study|Did not meet inclusion criteria|0
479610|NCT00116428|1564276|P1|Overall Study|Did not meet inclusion criteria|1
479611|NCT00116428|1564275|P2|Overall Study|Withdrawal by Subject|5
479612|NCT00116428|1564276|P1|Overall Study|Withdrawal by Subject|2
479613|NCT00116272|1564294|P2|Overall Study|Lost to Follow-up|6
479614|NCT00116272|1564295|P1|Overall Study|Lost to Follow-up|11
479615|NCT00116168|1564364|P4|Overall Study|Lost to Follow-up|0
479616|NCT00116168|1564365|P3|Overall Study|Lost to Follow-up|0
479617|NCT00116168|1564366|P2|Overall Study|Lost to Follow-up|5
479618|NCT00116168|1564367|P1|Overall Study|Lost to Follow-up|6
479619|NCT00115934|1564431|P2|Overall Study|Did not receive intervention|2
479620|NCT00115934|1564432|P1|Overall Study|Did not receive intervention|3
479621|NCT00115934|1564431|P2|Overall Study|Lost to Follow-up|0
479622|NCT00115934|1564432|P1|Overall Study|Lost to Follow-up|1
479623|NCT00115804|1564481|P1|Overall Study|Adverse Event|2
479624|NCT00115765|1564496|P4|Overall Study|Not specified|2
479625|NCT00115765|1564497|P3|Overall Study|Not specified|9
479626|NCT00115765|1564498|P2|Overall Study|Not specified|12
479627|NCT00115765|1564499|P1|Overall Study|Not specified|6
479628|NCT00115765|1564496|P4|Overall Study|Lost to Follow-up|1
479629|NCT00115765|1564497|P3|Overall Study|Lost to Follow-up|18
479630|NCT00115765|1564498|P2|Overall Study|Lost to Follow-up|20
479631|NCT00115765|1564499|P1|Overall Study|Lost to Follow-up|3
479632|NCT00115765|1564496|P4|Overall Study|Physician Decision|13
479633|NCT00115765|1564497|P3|Overall Study|Physician Decision|18
479634|NCT00115765|1564498|P2|Overall Study|Physician Decision|15
479635|NCT00115765|1564499|P1|Overall Study|Physician Decision|4
479636|NCT00115765|1564496|P4|Overall Study|Withdrawal by Subject|15
479637|NCT00115765|1564497|P3|Overall Study|Withdrawal by Subject|76
479638|NCT00115765|1564498|P2|Overall Study|Withdrawal by Subject|53
479639|NCT00115765|1564499|P1|Overall Study|Withdrawal by Subject|22
479640|NCT00115739|1564537|P1|Overall Study|Lost to Follow-up|3
479641|NCT00115349|1564546|P2|Overall Study|Study closed due to low enrollment.|9
479642|NCT00115349|1564547|P1|Overall Study|Study closed due to low enrollment.|11
479643|NCT00115063|1564568|P2|Overall Study|Death|0
479644|NCT00115063|1564569|P1|Overall Study|Death|1
479645|NCT00115063|1564568|P2|Overall Study|Lost to Follow-up|104
479646|NCT00115063|1564569|P1|Overall Study|Lost to Follow-up|98
479647|NCT00114972|1564587|P2|Overall Study|Lost to Follow-up|5
479648|NCT00114972|1564588|P1|Overall Study|Lost to Follow-up|8
479649|NCT00114972|1564587|P2|Overall Study|Withdrawal by Subject|7
479650|NCT00114972|1564588|P1|Overall Study|Withdrawal by Subject|40
479651|NCT00114959|1564608|P1|Overall Study|Death|1
479652|NCT00114959|1564608|P1|Overall Study|Physician Decision|1
479653|NCT00114959|1564608|P1|Overall Study|Lack of Efficacy|6
479654|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Not Specified|2
479655|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Not Specified|0
479656|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Not Specified|2
479657|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
479658|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
479659|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
479660|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
479661|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
479662|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
479663|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
479664|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
479747|NCT00113919|1564915|P1|Overall Study|Death|6
479665|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
479666|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Adverse Event|7
479667|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Adverse Event|14
479668|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Adverse Event|15
479669|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
479670|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
479671|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
479672|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
479673|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
479674|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
479675|NCT00114777|1564618|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
479676|NCT00114777|1564619|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
479677|NCT00114777|1564620|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
479678|NCT00114777|1564618|P3|Long-Term Extension to Month 84|Death|7
479679|NCT00114777|1564619|P2|Long-Term Extension to Month 84|Death|13
479680|NCT00114777|1564620|P1|Long-Term Extension to Month 84|Death|8
479681|NCT00114777|1564618|P3|Randomization to Month 36|Not Specified|12
479682|NCT00114777|1564619|P2|Randomization to Month 36|Not Specified|3
479683|NCT00114777|1564620|P1|Randomization to Month 36|Not Specified|9
479684|NCT00114777|1564618|P3|Randomization to Month 36|Withdrawal by Subject|5
479685|NCT00114777|1564619|P2|Randomization to Month 36|Withdrawal by Subject|4
479686|NCT00114777|1564620|P1|Randomization to Month 36|Withdrawal by Subject|3
479687|NCT00114777|1564618|P3|Randomization to Month 36|Adverse Event|44
479688|NCT00114777|1564619|P2|Randomization to Month 36|Adverse Event|35
479689|NCT00114777|1564620|P1|Randomization to Month 36|Adverse Event|34
479690|NCT00114777|1564618|P3|Randomization to Month 36|Poor or Non-Compliance|1
479691|NCT00114777|1564619|P2|Randomization to Month 36|Poor or Non-Compliance|0
479692|NCT00114777|1564620|P1|Randomization to Month 36|Poor or Non-Compliance|0
479693|NCT00114777|1564618|P3|Randomization to Month 36|Lack of Efficacy|17
479694|NCT00114777|1564619|P2|Randomization to Month 36|Lack of Efficacy|15
479695|NCT00114777|1564620|P1|Randomization to Month 36|Lack of Efficacy|19
479696|NCT00114777|1564618|P3|Randomization to Month 36|No Longer Met Study Criteria|2
479697|NCT00114777|1564619|P2|Randomization to Month 36|No Longer Met Study Criteria|0
479698|NCT00114777|1564620|P1|Randomization to Month 36|No Longer Met Study Criteria|0
479699|NCT00114777|1564618|P3|Randomization to Month 36|Death|3
479700|NCT00114777|1564619|P2|Randomization to Month 36|Death|4
479701|NCT00114777|1564620|P1|Randomization to Month 36|Death|10
479702|NCT00114634|1564694|P1|Overall Study|failure to return forms|3
479703|NCT00114530|1564710|P2|Overall Study|Ineligible|0
479704|NCT00114530|1564711|P1|Overall Study|Ineligible|1
479705|NCT00114530|1564710|P2|Overall Study|Subject decision after endpoint failure|1
479706|NCT00114530|1564711|P1|Overall Study|Subject decision after endpoint failure|0
479707|NCT00114530|1564710|P2|Overall Study|Breast Cancer|0
479708|NCT00114530|1564711|P1|Overall Study|Breast Cancer|1
479709|NCT00114530|1564710|P2|Overall Study|Withdrawal by Subject|6
479710|NCT00114530|1564711|P1|Overall Study|Withdrawal by Subject|2
479711|NCT00114530|1564710|P2|Overall Study|Physician Decision|1
479712|NCT00114530|1564711|P1|Overall Study|Physician Decision|1
479713|NCT00114530|1564710|P2|Overall Study|Lost to Follow-up|1
479714|NCT00114530|1564711|P1|Overall Study|Lost to Follow-up|1
479715|NCT00114530|1564710|P2|Overall Study|Death|11
479716|NCT00114530|1564711|P1|Overall Study|Death|3
479717|NCT00114244|1564848|P2|Overall Study|Withdrawal by Subject|2
479718|NCT00114244|1564849|P1|Overall Study|Withdrawal by Subject|0
479719|NCT00114244|1564848|P2|Overall Study|Adverse Event|5
479720|NCT00114244|1564849|P1|Overall Study|Adverse Event|2
479721|NCT00114231|1564861|P2|Overall Study|Biopsy done after registration|0
479722|NCT00114231|1564862|P1|Overall Study|Biopsy done after registration|1
479723|NCT00114231|1564861|P2|Overall Study|No Absolute Neutrophil Count|0
479724|NCT00114231|1564862|P1|Overall Study|No Absolute Neutrophil Count|2
479725|NCT00114231|1564861|P2|Overall Study|Tumor fixed on digital exam|1
479726|NCT00114231|1564862|P1|Overall Study|Tumor fixed on digital exam|0
479727|NCT00114231|1564861|P2|Overall Study|Tumor size > 4cm|0
479728|NCT00114231|1564862|P1|Overall Study|Tumor size > 4cm|1
479729|NCT00114231|1564861|P2|Overall Study|Low creatinine clearance|1
479730|NCT00114231|1564862|P1|Overall Study|Low creatinine clearance|0
479731|NCT00114231|1564861|P2|Overall Study|No adenocarcinoma|0
479732|NCT00114231|1564862|P1|Overall Study|No adenocarcinoma|1
479733|NCT00114231|1564861|P2|Overall Study|Suspected metastatic disease|0
479734|NCT00114231|1564862|P1|Overall Study|Suspected metastatic disease|1
479735|NCT00114231|1564861|P2|Overall Study|QARC requirement not met|0
479736|NCT00114231|1564862|P1|Overall Study|QARC requirement not met|1
479737|NCT00114231|1564861|P2|Overall Study|No consent|0
479738|NCT00114231|1564862|P1|Overall Study|No consent|2
479739|NCT00114166|1564871|P1|Overall Study|Wrong primary|1
479740|NCT00114140|1564877|P1|Overall Study|Protocol Violation|7
479741|NCT00114127|1564891|P2|Overall Study|Withdrawal by Subject|3
479742|NCT00114127|1564892|P1|Overall Study|Withdrawal by Subject|1
479743|NCT00114127|1564891|P2|Overall Study|Lost to Follow-up|0
479744|NCT00114127|1564892|P1|Overall Study|Lost to Follow-up|1
479745|NCT00114127|1564891|P2|Overall Study|Adverse Event|1
479746|NCT00114127|1564892|P1|Overall Study|Adverse Event|2
479748|NCT00113919|1564915|P1|Overall Study|Physician Decision|8
479749|NCT00113841|1564983|P2|Overall Study|Non-compliant|0
479750|NCT00113841|1564984|P1|Overall Study|Non-compliant|1
479751|NCT00113841|1564983|P2|Overall Study|Disease progression|2
479752|NCT00113841|1564984|P1|Overall Study|Disease progression|0
479753|NCT00113763|1564992|P2|Overall Study|Ongoing|0
479754|NCT00113763|1564993|P1|Overall Study|Ongoing|1
479755|NCT00113763|1564992|P2|Overall Study|Non-compliance|0
479756|NCT00113763|1564993|P1|Overall Study|Non-compliance|1
479757|NCT00113763|1564992|P2|Overall Study|Not specified|6
479758|NCT00113763|1564993|P1|Overall Study|Not specified|27
479759|NCT00113763|1564992|P2|Overall Study|Withdrawal by Subject|4
479760|NCT00113763|1564993|P1|Overall Study|Withdrawal by Subject|1
479761|NCT00113763|1564992|P2|Overall Study|Lost to Follow-up|0
479762|NCT00113763|1564993|P1|Overall Study|Lost to Follow-up|10
479763|NCT00113763|1564992|P2|Overall Study|Disease Progression|14
479764|NCT00113763|1564993|P1|Overall Study|Disease Progression|28
479765|NCT00113763|1564992|P2|Overall Study|Adverse Event|2
479766|NCT00113763|1564993|P1|Overall Study|Adverse Event|5
479767|NCT00113607|1565019|P2|Overall Study|Other|32
479768|NCT00113607|1565020|P1|Overall Study|Other|43
479769|NCT00113607|1565019|P2|Overall Study|Complete Response (Confirmed)|24
479770|NCT00113607|1565020|P1|Overall Study|Complete Response (Confirmed)|14
479771|NCT00113607|1565019|P2|Overall Study|Disease Progression|142
479772|NCT00113607|1565020|P1|Overall Study|Disease Progression|180
479773|NCT00113607|1565019|P2|Overall Study|Lost to Follow-up|2
479774|NCT00113607|1565020|P1|Overall Study|Lost to Follow-up|0
479775|NCT00113607|1565019|P2|Overall Study|Withdrawal by Subject|58
479776|NCT00113607|1565020|P1|Overall Study|Withdrawal by Subject|50
479777|NCT00113607|1565019|P2|Overall Study|Death|8
479778|NCT00113607|1565020|P1|Overall Study|Death|8
479779|NCT00113607|1565019|P2|Overall Study|Adverse Event|71
479780|NCT00113607|1565020|P1|Overall Study|Adverse Event|40
479781|NCT00113568|1565034|P1|Overall Study|Other|112
479782|NCT00113568|1565034|P1|Overall Study|Withdrawal by Subject|117
479783|NCT00113568|1565034|P1|Overall Study|Protocol Violation|32
479784|NCT00113568|1565034|P1|Overall Study|Lost to Follow-up|156
479785|NCT00113568|1565034|P1|Overall Study|Lack of Efficacy|30
479786|NCT00113568|1565034|P1|Overall Study|Death|1
479787|NCT00113568|1565034|P1|Overall Study|Adverse Event|97
479788|NCT00113555|1565046|P1|Overall Study|Lost to Follow-up|8
479789|NCT00113555|1565046|P1|Overall Study|Missed Followup|4
479790|NCT00113555|1565046|P1|Overall Study|Death|1
479791|NCT00113555|1565046|P1|Overall Study|Permanently Explanted|7
479792|NCT00113555|1565046|P1|Overall Study|Baseline Failure|59
479793|NCT00113529|1565056|P1|Overall Study|Withdrawal by Subject|4
479794|NCT00113529|1565056|P1|Overall Study|Decision of sponsor|6
479795|NCT00113529|1565056|P1|Overall Study|Lack of Efficacy|20
479796|NCT00113529|1565056|P1|Overall Study|Adverse Event|4
479797|NCT00113516|1565089|P2|Part 2|Ongoing|1
479798|NCT00113516|1565090|P1|Part 2|Ongoing|0
479799|NCT00113516|1565089|P2|Part 2|Laboratory Abnormality|1
479800|NCT00113516|1565090|P1|Part 2|Laboratory Abnormality|0
479801|NCT00113516|1565089|P2|Part 2|Other|3
479802|NCT00113516|1565090|P1|Part 2|Other|0
479803|NCT00113516|1565089|P2|Part 2|Withdrawal by Subject|3
479804|NCT00113516|1565090|P1|Part 2|Withdrawal by Subject|0
479805|NCT00113516|1565089|P2|Part 2|Lack of Efficacy|37
479806|NCT00113516|1565090|P1|Part 2|Lack of Efficacy|0
479807|NCT00113516|1565089|P2|Part 2|Death|5
479808|NCT00113516|1565090|P1|Part 2|Death|0
479809|NCT00113516|1565089|P2|Part 2|Adverse Event|16
479810|NCT00113516|1565090|P1|Part 2|Adverse Event|0
479811|NCT00113516|1565089|P2|Part 1|Missing|0
479812|NCT00113516|1565090|P1|Part 1|Missing|65
479813|NCT00113516|1565089|P2|Part 1|Ongoing|0
479814|NCT00113516|1565090|P1|Part 1|Ongoing|1
479815|NCT00113516|1565089|P2|Part 1|Laboratory Abnormality|0
479816|NCT00113516|1565090|P1|Part 1|Laboratory Abnormality|1
479817|NCT00113516|1565089|P2|Part 1|Did Not Meet Entrance Criteria|0
479818|NCT00113516|1565090|P1|Part 1|Did Not Meet Entrance Criteria|1
479819|NCT00113516|1565089|P2|Part 1|Lack of Efficacy|0
479820|NCT00113516|1565090|P1|Part 1|Lack of Efficacy|2
479821|NCT00113516|1565089|P2|Part 1|Withdrawal by Subject|0
479822|NCT00113516|1565090|P1|Part 1|Withdrawal by Subject|2
479823|NCT00113516|1565089|P2|Part 1|Other|0
479824|NCT00113516|1565090|P1|Part 1|Other|3
479825|NCT00113516|1565089|P2|Part 1|Death|0
479826|NCT00113516|1565090|P1|Part 1|Death|3
479827|NCT00113516|1565089|P2|Part 1|Adverse Event|0
479828|NCT00113516|1565090|P1|Part 1|Adverse Event|6
479829|NCT00113490|1565133|P2|Overall Study|Lost to Follow-up|0
479830|NCT00113490|1565134|P1|Overall Study|Lost to Follow-up|1
479831|NCT00113490|1565133|P2|Overall Study|Withdrawal by Subject|3
479832|NCT00113490|1565134|P1|Overall Study|Withdrawal by Subject|1
479833|NCT00113399|1565167|P2|Overall Study|Other|1
479834|NCT00113399|1565168|P1|Overall Study|Other|0
479835|NCT00113399|1565167|P2|Overall Study|Complete Response|1
479836|NCT00113399|1565168|P1|Overall Study|Complete Response|0
479837|NCT00113399|1565167|P2|Overall Study|Withdrawal by Subject|2
479838|NCT00113399|1565168|P1|Overall Study|Withdrawal by Subject|1
479839|NCT00113399|1565167|P2|Overall Study|Death|1
479840|NCT00113399|1565168|P1|Overall Study|Death|1
479841|NCT00113386|1565176|P2|Overall Study|Unknown - Lost to Follow-Up|1
479842|NCT00113386|1565177|P1|Overall Study|Unknown - Lost to Follow-Up|2
479843|NCT00113386|1565176|P2|Overall Study|Ineligible|2
479844|NCT00113386|1565177|P1|Overall Study|Ineligible|1
479845|NCT00113386|1565176|P2|Overall Study|Toxicity|0
479846|NCT00113386|1565177|P1|Overall Study|Toxicity|3
479847|NCT00113386|1565176|P2|Overall Study|Physician Decision|1
479848|NCT00113386|1565177|P1|Overall Study|Physician Decision|0
479849|NCT00113386|1565176|P2|Overall Study|Withdrawal by Subject|0
479850|NCT00113386|1565177|P1|Overall Study|Withdrawal by Subject|1
479851|NCT00113373|1565183|P1|Overall Study|Never Treated|1
479852|NCT00113373|1565183|P1|Overall Study|Ineligible: second primary|1
479853|NCT00113373|1565183|P1|Overall Study|Ineligible: wrong primary|1
479854|NCT00113360|1565198|P1|Overall Study|Did not meet eligibility criteria|3
479855|NCT00113360|1565198|P1|Overall Study|Subject required surgery|1
479856|NCT00113360|1565198|P1|Overall Study|Adverse Event|3
479857|NCT00113295|1565212|P2|Overall Study|Unrelated Medical Illness|0
479858|NCT00113295|1565213|P1|Overall Study|Unrelated Medical Illness|1
479859|NCT00113295|1565212|P2|Overall Study|Adverse Event|1
479860|NCT00113295|1565213|P1|Overall Study|Adverse Event|4
479861|NCT00113269|1565232|P4|Overall Study|Unable to return for follow up|0
479862|NCT00113269|1565233|P3|Overall Study|Unable to return for follow up|0
479863|NCT00113269|1565234|P2|Overall Study|Unable to return for follow up|1
479864|NCT00113269|1565235|P1|Overall Study|Unable to return for follow up|2
479865|NCT00113269|1565232|P4|Overall Study|Did not meet eligibility criteria|1
479866|NCT00113269|1565233|P3|Overall Study|Did not meet eligibility criteria|0
479867|NCT00113269|1565234|P2|Overall Study|Did not meet eligibility criteria|0
479868|NCT00113269|1565235|P1|Overall Study|Did not meet eligibility criteria|1
479869|NCT00113269|1565232|P4|Overall Study|Withdrew consent, Prednisone initiated|1
479870|NCT00113269|1565233|P3|Overall Study|Withdrew consent, Prednisone initiated|0
479871|NCT00113269|1565234|P2|Overall Study|Withdrew consent, Prednisone initiated|0
479872|NCT00113269|1565235|P1|Overall Study|Withdrew consent, Prednisone initiated|0
479873|NCT00113269|1565232|P4|Overall Study|Received pancreas transplant|2
479874|NCT00113269|1565233|P3|Overall Study|Received pancreas transplant|0
479875|NCT00113269|1565234|P2|Overall Study|Received pancreas transplant|0
479876|NCT00113269|1565235|P1|Overall Study|Received pancreas transplant|0
479877|NCT00113269|1565232|P4|Overall Study|Moved|3
479878|NCT00113269|1565233|P3|Overall Study|Moved|0
479879|NCT00113269|1565234|P2|Overall Study|Moved|1
479880|NCT00113269|1565235|P1|Overall Study|Moved|0
479881|NCT00113269|1565232|P4|Overall Study|Discontinued due to rejection|0
479882|NCT00113269|1565233|P3|Overall Study|Discontinued due to rejection|1
479883|NCT00113269|1565234|P2|Overall Study|Discontinued due to rejection|0
479884|NCT00113269|1565235|P1|Overall Study|Discontinued due to rejection|0
479885|NCT00113269|1565232|P4|Overall Study|Sponsor elected to discontinue patient|1
479886|NCT00113269|1565233|P3|Overall Study|Sponsor elected to discontinue patient|0
479887|NCT00113269|1565234|P2|Overall Study|Sponsor elected to discontinue patient|0
479888|NCT00113269|1565235|P1|Overall Study|Sponsor elected to discontinue patient|1
479889|NCT00113269|1565232|P4|Overall Study|Lost to Follow-up|3
479890|NCT00113269|1565233|P3|Overall Study|Lost to Follow-up|6
479891|NCT00113269|1565234|P2|Overall Study|Lost to Follow-up|3
479892|NCT00113269|1565235|P1|Overall Study|Lost to Follow-up|2
479893|NCT00113269|1565232|P4|Overall Study|Protocol Violation|2
479894|NCT00113269|1565233|P3|Overall Study|Protocol Violation|4
479895|NCT00113269|1565234|P2|Overall Study|Protocol Violation|0
479896|NCT00113269|1565235|P1|Overall Study|Protocol Violation|1
479897|NCT00113269|1565232|P4|Overall Study|Graft loss|9
479898|NCT00113269|1565233|P3|Overall Study|Graft loss|4
479899|NCT00113269|1565234|P2|Overall Study|Graft loss|6
479900|NCT00113269|1565235|P1|Overall Study|Graft loss|6
479901|NCT00113269|1565232|P4|Overall Study|Withdrawal by Subject|2
479902|NCT00113269|1565233|P3|Overall Study|Withdrawal by Subject|4
479903|NCT00113269|1565234|P2|Overall Study|Withdrawal by Subject|3
479904|NCT00113269|1565235|P1|Overall Study|Withdrawal by Subject|4
479905|NCT00113269|1565232|P4|Overall Study|Adverse Event|7
479906|NCT00113269|1565233|P3|Overall Study|Adverse Event|11
479907|NCT00113269|1565234|P2|Overall Study|Adverse Event|7
479908|NCT00113269|1565235|P1|Overall Study|Adverse Event|2
479909|NCT00113269|1565232|P4|Overall Study|Did not meet eligibility – pre-treatment|2
479910|NCT00113269|1565233|P3|Overall Study|Did not meet eligibility – pre-treatment|0
479911|NCT00113269|1565234|P2|Overall Study|Did not meet eligibility – pre-treatment|0
479912|NCT00113269|1565235|P1|Overall Study|Did not meet eligibility – pre-treatment|0
479913|NCT00113269|1565232|P4|Overall Study|Death in operating room|1
479914|NCT00113269|1565233|P3|Overall Study|Death in operating room|0
479915|NCT00113269|1565234|P2|Overall Study|Death in operating room|0
479916|NCT00113269|1565235|P1|Overall Study|Death in operating room|0
479917|NCT00113269|1565232|P4|Overall Study|Early graft loss, technical|0
479918|NCT00113269|1565233|P3|Overall Study|Early graft loss, technical|2
479919|NCT00113269|1565234|P2|Overall Study|Early graft loss, technical|0
479920|NCT00113269|1565235|P1|Overall Study|Early graft loss, technical|0
479921|NCT00113269|1565232|P4|Overall Study|Not transplanted, recipient issues|4
479922|NCT00113269|1565233|P3|Overall Study|Not transplanted, recipient issues|7
479923|NCT00113269|1565234|P2|Overall Study|Not transplanted, recipient issues|1
479924|NCT00113269|1565235|P1|Overall Study|Not transplanted, recipient issues|2
479925|NCT00113269|1565232|P4|Overall Study|Not transplanted, donor issues|2
479926|NCT00113269|1565233|P3|Overall Study|Not transplanted, donor issues|2
479927|NCT00113269|1565234|P2|Overall Study|Not transplanted, donor issues|0
479928|NCT00113269|1565235|P1|Overall Study|Not transplanted, donor issues|4
479929|NCT00113087|1565295|P2|Overall Study|Family or MD withdrew subject|5
479930|NCT00113087|1565296|P1|Overall Study|Family or MD withdrew subject|10
479931|NCT00113087|1565295|P2|Overall Study|Death or Transplant|16
479932|NCT00113087|1565296|P1|Overall Study|Death or Transplant|14
479933|NCT00112957|1565367|P1|Overall Study|Physician Decision|1
479934|NCT00112957|1565367|P1|Overall Study|Progressive disease|18
479935|NCT00112905|1565407|P1|Overall Study|performance status was deteiorating|1
479936|NCT00112905|1565407|P1|Overall Study|Alternative treatment|1
479937|NCT00112905|1565407|P1|Overall Study|Ineligibility|5
479938|NCT00112905|1565407|P1|Overall Study|Death|1
479939|NCT00112905|1565407|P1|Overall Study|Adverse Event|4
479940|NCT00112866|1565416|P2|Overall Study|did not start treatment post-op|2
479941|NCT00112866|1565417|P1|Overall Study|did not start treatment post-op|1
479942|NCT00112866|1565416|P2|Overall Study|Protocol Violation|0
479943|NCT00112866|1565417|P1|Overall Study|Protocol Violation|1
479944|NCT00112840|1565439|P3|Overall Study|Protocol Violation|5
479945|NCT00112840|1565440|P2|Overall Study|Protocol Violation|0
479946|NCT00112840|1565441|P1|Overall Study|Protocol Violation|0
479947|NCT00112840|1565439|P3|Overall Study|Withdrawal by Subject|1
479948|NCT00112840|1565440|P2|Overall Study|Withdrawal by Subject|0
479949|NCT00112840|1565441|P1|Overall Study|Withdrawal by Subject|1
479950|NCT00112840|1565439|P3|Overall Study|Physician Decision|0
479951|NCT00112840|1565440|P2|Overall Study|Physician Decision|0
479952|NCT00112840|1565441|P1|Overall Study|Physician Decision|1
479953|NCT00112736|1565460|P2|Overall Study|1 pt never had had RX due rapid decline|0
479954|NCT00112736|1565461|P1|Overall Study|1 pt never had had RX due rapid decline|1
479955|NCT00112489|1565516|P1|Overall Study|Ineligible|7
479956|NCT00112489|1565516|P1|Overall Study|Patient never treated|2
479957|NCT00112489|1565516|P1|Overall Study|Other, Not Specified|9
479958|NCT00112489|1565516|P1|Overall Study|Death|2
479959|NCT00112489|1565516|P1|Overall Study|Adverse Event|12
479960|NCT00112489|1565516|P1|Overall Study|Refused further treatment|8
479961|NCT00112463|1565520|P1|Overall Study|Never started treatment|2
479962|NCT00112463|1565520|P1|Overall Study|Withdrawal by Subject|2
479963|NCT00112463|1565520|P1|Overall Study|Toxicity|3
479964|NCT00112463|1565520|P1|Overall Study|Second Primary|1
479965|NCT00112463|1565520|P1|Overall Study|Progression|30
479966|NCT00112463|1565520|P1|Overall Study|Physician Decision|1
479967|NCT00112437|1565532|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
479968|NCT00112437|1565533|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479969|NCT00112437|1565534|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
479970|NCT00112437|1565535|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
479971|NCT00112437|1565536|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479972|NCT00112437|1565537|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479973|NCT00112437|1565538|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479974|NCT00112437|1565539|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479975|NCT00112437|1565540|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479976|NCT00112437|1565541|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479977|NCT00112437|1565542|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479978|NCT00112437|1565543|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479979|NCT00112437|1565544|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479980|NCT00112437|1565545|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479981|NCT00112437|1565546|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479982|NCT00112437|1565547|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479983|NCT00112437|1565548|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479984|NCT00112437|1565549|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479985|NCT00112437|1565550|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479986|NCT00112437|1565551|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479987|NCT00112437|1565552|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479988|NCT00112437|1565553|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479989|NCT00112437|1565554|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479990|NCT00112437|1565555|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479991|NCT00112437|1565556|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479992|NCT00112437|1565557|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
479993|NCT00112437|1565532|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
479994|NCT00112437|1565533|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
479995|NCT00112437|1565534|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
479996|NCT00112437|1565535|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
479997|NCT00112437|1565536|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
479998|NCT00112437|1565537|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
479999|NCT00112437|1565538|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
480000|NCT00112437|1565539|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
480001|NCT00112437|1565540|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
480002|NCT00112437|1565541|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
480003|NCT00112437|1565542|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
480004|NCT00112437|1565543|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
480005|NCT00112437|1565544|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
480006|NCT00112437|1565545|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
480007|NCT00112437|1565546|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
480008|NCT00112437|1565547|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
480009|NCT00112437|1565548|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
480010|NCT00112437|1565549|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
480011|NCT00112437|1565550|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
480012|NCT00112437|1565551|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
480013|NCT00112437|1565552|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
480014|NCT00112437|1565553|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
480015|NCT00112437|1565554|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
480016|NCT00112437|1565555|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
480017|NCT00112437|1565556|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
480018|NCT00112437|1565557|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
480019|NCT00112437|1565532|P26|Years 6-10 (60-Month Extension)|Other|0
480020|NCT00112437|1565533|P25|Years 6-10 (60-Month Extension)|Other|1
480021|NCT00112437|1565534|P24|Years 6-10 (60-Month Extension)|Other|0
480022|NCT00112437|1565535|P23|Years 6-10 (60-Month Extension)|Other|0
480023|NCT00112437|1565536|P22|Years 6-10 (60-Month Extension)|Other|0
480024|NCT00112437|1565537|P21|Years 6-10 (60-Month Extension)|Other|0
480025|NCT00112437|1565538|P20|Years 6-10 (60-Month Extension)|Other|0
480026|NCT00112437|1565539|P19|Years 6-10 (60-Month Extension)|Other|0
480027|NCT00112437|1565540|P18|Years 6-10 (60-Month Extension)|Other|0
480028|NCT00112437|1565541|P17|Years 6-10 (60-Month Extension)|Other|0
480029|NCT00112437|1565542|P16|Years 6-10 (60-Month Extension)|Other|0
480030|NCT00112437|1565543|P15|Years 6-10 (60-Month Extension)|Other|0
480031|NCT00112437|1565544|P14|Years 6-10 (60-Month Extension)|Other|0
480032|NCT00112437|1565545|P13|Years 6-10 (60-Month Extension)|Other|0
480033|NCT00112437|1565546|P12|Years 6-10 (60-Month Extension)|Other|0
480034|NCT00112437|1565547|P11|Years 6-10 (60-Month Extension)|Other|0
480035|NCT00112437|1565548|P10|Years 6-10 (60-Month Extension)|Other|0
480036|NCT00112437|1565549|P9|Years 6-10 (60-Month Extension)|Other|0
480037|NCT00112437|1565550|P8|Years 6-10 (60-Month Extension)|Other|0
480038|NCT00112437|1565551|P7|Years 6-10 (60-Month Extension)|Other|0
480039|NCT00112437|1565552|P6|Years 6-10 (60-Month Extension)|Other|0
480040|NCT00112437|1565553|P5|Years 6-10 (60-Month Extension)|Other|0
480041|NCT00112437|1565554|P4|Years 6-10 (60-Month Extension)|Other|0
480042|NCT00112437|1565555|P3|Years 6-10 (60-Month Extension)|Other|0
480043|NCT00112437|1565556|P2|Years 6-10 (60-Month Extension)|Other|0
480044|NCT00112437|1565557|P1|Years 6-10 (60-Month Extension)|Other|0
480045|NCT00112437|1565532|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
480046|NCT00112437|1565533|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480047|NCT00112437|1565534|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480048|NCT00112437|1565535|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480049|NCT00112437|1565536|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480050|NCT00112437|1565537|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480051|NCT00112437|1565538|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480052|NCT00112437|1565539|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480053|NCT00112437|1565540|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480054|NCT00112437|1565541|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480055|NCT00112437|1565542|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480056|NCT00112437|1565543|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480057|NCT00112437|1565544|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480058|NCT00112437|1565545|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480059|NCT00112437|1565546|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480060|NCT00112437|1565547|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480061|NCT00112437|1565548|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480062|NCT00112437|1565549|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480063|NCT00112437|1565550|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480064|NCT00112437|1565551|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480065|NCT00112437|1565552|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480066|NCT00112437|1565553|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480067|NCT00112437|1565554|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480068|NCT00112437|1565555|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480069|NCT00112437|1565556|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480070|NCT00112437|1565557|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
480071|NCT00112437|1565532|P26|Years 6-10 (60-Month Extension)|Death|0
480072|NCT00112437|1565533|P25|Years 6-10 (60-Month Extension)|Death|0
480073|NCT00112437|1565534|P24|Years 6-10 (60-Month Extension)|Death|2
480074|NCT00112437|1565535|P23|Years 6-10 (60-Month Extension)|Death|0
480075|NCT00112437|1565536|P22|Years 6-10 (60-Month Extension)|Death|0
480076|NCT00112437|1565537|P21|Years 6-10 (60-Month Extension)|Death|0
480077|NCT00112437|1565538|P20|Years 6-10 (60-Month Extension)|Death|0
480078|NCT00112437|1565539|P19|Years 6-10 (60-Month Extension)|Death|0
480079|NCT00112437|1565540|P18|Years 6-10 (60-Month Extension)|Death|0
480080|NCT00112437|1565541|P17|Years 6-10 (60-Month Extension)|Death|0
480081|NCT00112437|1565542|P16|Years 6-10 (60-Month Extension)|Death|0
480082|NCT00112437|1565543|P15|Years 6-10 (60-Month Extension)|Death|0
480083|NCT00112437|1565544|P14|Years 6-10 (60-Month Extension)|Death|0
480084|NCT00112437|1565545|P13|Years 6-10 (60-Month Extension)|Death|0
480085|NCT00112437|1565546|P12|Years 6-10 (60-Month Extension)|Death|0
480086|NCT00112437|1565547|P11|Years 6-10 (60-Month Extension)|Death|0
480087|NCT00112437|1565548|P10|Years 6-10 (60-Month Extension)|Death|0
480088|NCT00112437|1565549|P9|Years 6-10 (60-Month Extension)|Death|0
480089|NCT00112437|1565550|P8|Years 6-10 (60-Month Extension)|Death|0
480090|NCT00112437|1565551|P7|Years 6-10 (60-Month Extension)|Death|0
480091|NCT00112437|1565552|P6|Years 6-10 (60-Month Extension)|Death|0
480092|NCT00112437|1565553|P5|Years 6-10 (60-Month Extension)|Death|0
480093|NCT00112437|1565554|P4|Years 6-10 (60-Month Extension)|Death|0
480094|NCT00112437|1565555|P3|Years 6-10 (60-Month Extension)|Death|0
480095|NCT00112437|1565556|P2|Years 6-10 (60-Month Extension)|Death|0
480096|NCT00112437|1565557|P1|Years 6-10 (60-Month Extension)|Death|0
480097|NCT00112437|1565532|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
480098|NCT00112437|1565533|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
480099|NCT00112437|1565534|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
480100|NCT00112437|1565535|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
480101|NCT00112437|1565536|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
480102|NCT00112437|1565537|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
480103|NCT00112437|1565538|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
480104|NCT00112437|1565539|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
480105|NCT00112437|1565540|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
480106|NCT00112437|1565541|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
480107|NCT00112437|1565542|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
480108|NCT00112437|1565543|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
480109|NCT00112437|1565544|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
480110|NCT00112437|1565545|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
480111|NCT00112437|1565546|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
480112|NCT00112437|1565547|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
480113|NCT00112437|1565548|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
480114|NCT00112437|1565549|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
480115|NCT00112437|1565550|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
480116|NCT00112437|1565551|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
480117|NCT00112437|1565552|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
480118|NCT00112437|1565553|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
480119|NCT00112437|1565554|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
480120|NCT00112437|1565555|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
480121|NCT00112437|1565556|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
480122|NCT00112437|1565557|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
480123|NCT00112437|1565532|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480124|NCT00112437|1565533|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480125|NCT00112437|1565534|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480126|NCT00112437|1565535|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480127|NCT00112437|1565536|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
480128|NCT00112437|1565537|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
480129|NCT00112437|1565538|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480130|NCT00112437|1565539|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480131|NCT00112437|1565540|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480132|NCT00112437|1565541|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480133|NCT00112437|1565542|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480134|NCT00112437|1565543|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480135|NCT00112437|1565544|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480136|NCT00112437|1565545|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480137|NCT00112437|1565546|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480138|NCT00112437|1565547|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480139|NCT00112437|1565548|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480140|NCT00112437|1565549|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480141|NCT00112437|1565550|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480142|NCT00112437|1565551|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480143|NCT00112437|1565552|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480144|NCT00112437|1565553|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480145|NCT00112437|1565554|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480146|NCT00112437|1565555|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480147|NCT00112437|1565556|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480148|NCT00112437|1565557|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
480149|NCT00112437|1565532|P26|Years 4-5 (24-Month Extension)|Participant moved|0
480150|NCT00112437|1565533|P25|Years 4-5 (24-Month Extension)|Participant moved|0
480151|NCT00112437|1565534|P24|Years 4-5 (24-Month Extension)|Participant moved|0
480152|NCT00112437|1565535|P23|Years 4-5 (24-Month Extension)|Participant moved|0
480153|NCT00112437|1565536|P22|Years 4-5 (24-Month Extension)|Participant moved|1
480154|NCT00112437|1565537|P21|Years 4-5 (24-Month Extension)|Participant moved|0
480155|NCT00112437|1565538|P20|Years 4-5 (24-Month Extension)|Participant moved|0
480156|NCT00112437|1565539|P19|Years 4-5 (24-Month Extension)|Participant moved|0
480157|NCT00112437|1565540|P18|Years 4-5 (24-Month Extension)|Participant moved|0
480158|NCT00112437|1565541|P17|Years 4-5 (24-Month Extension)|Participant moved|0
480159|NCT00112437|1565542|P16|Years 4-5 (24-Month Extension)|Participant moved|0
480160|NCT00112437|1565543|P15|Years 4-5 (24-Month Extension)|Participant moved|0
480161|NCT00112437|1565544|P14|Years 4-5 (24-Month Extension)|Participant moved|0
480162|NCT00112437|1565545|P13|Years 4-5 (24-Month Extension)|Participant moved|0
480163|NCT00112437|1565546|P12|Years 4-5 (24-Month Extension)|Participant moved|0
480164|NCT00112437|1565547|P11|Years 4-5 (24-Month Extension)|Participant moved|0
480165|NCT00112437|1565548|P10|Years 4-5 (24-Month Extension)|Participant moved|0
480166|NCT00112437|1565549|P9|Years 4-5 (24-Month Extension)|Participant moved|0
480167|NCT00112437|1565550|P8|Years 4-5 (24-Month Extension)|Participant moved|0
480168|NCT00112437|1565551|P7|Years 4-5 (24-Month Extension)|Participant moved|0
480169|NCT00112437|1565552|P6|Years 4-5 (24-Month Extension)|Participant moved|0
480170|NCT00112437|1565553|P5|Years 4-5 (24-Month Extension)|Participant moved|0
480171|NCT00112437|1565554|P4|Years 4-5 (24-Month Extension)|Participant moved|0
480172|NCT00112437|1565555|P3|Years 4-5 (24-Month Extension)|Participant moved|0
480173|NCT00112437|1565556|P2|Years 4-5 (24-Month Extension)|Participant moved|0
480174|NCT00112437|1565557|P1|Years 4-5 (24-Month Extension)|Participant moved|0
480175|NCT00112437|1565532|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
480176|NCT00112437|1565533|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
480177|NCT00112437|1565534|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
480178|NCT00112437|1565535|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
480179|NCT00112437|1565536|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
480180|NCT00112437|1565537|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
480181|NCT00112437|1565538|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
480182|NCT00112437|1565539|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
480183|NCT00112437|1565540|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
480184|NCT00112437|1565541|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
480185|NCT00112437|1565542|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
480186|NCT00112437|1565543|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
480187|NCT00112437|1565544|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
480188|NCT00112437|1565545|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
480189|NCT00112437|1565546|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
480190|NCT00112437|1565547|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
480191|NCT00112437|1565548|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
480192|NCT00112437|1565549|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
480193|NCT00112437|1565550|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
480194|NCT00112437|1565551|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
480195|NCT00112437|1565552|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
480196|NCT00112437|1565553|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
480197|NCT00112437|1565554|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
480198|NCT00112437|1565555|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
480199|NCT00112437|1565556|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
480200|NCT00112437|1565557|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
480201|NCT00112437|1565532|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480202|NCT00112437|1565533|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480203|NCT00112437|1565534|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480204|NCT00112437|1565535|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480205|NCT00112437|1565536|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480206|NCT00112437|1565537|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
480207|NCT00112437|1565538|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480208|NCT00112437|1565539|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480209|NCT00112437|1565540|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480210|NCT00112437|1565541|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480211|NCT00112437|1565542|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480212|NCT00112437|1565543|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480213|NCT00112437|1565544|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480214|NCT00112437|1565545|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480215|NCT00112437|1565546|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480216|NCT00112437|1565547|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480217|NCT00112437|1565548|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480218|NCT00112437|1565549|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480219|NCT00112437|1565550|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480220|NCT00112437|1565551|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480221|NCT00112437|1565552|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480222|NCT00112437|1565553|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480223|NCT00112437|1565554|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480224|NCT00112437|1565555|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480225|NCT00112437|1565556|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480226|NCT00112437|1565557|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
480227|NCT00112437|1565532|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480228|NCT00112437|1565533|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480229|NCT00112437|1565534|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480230|NCT00112437|1565535|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480231|NCT00112437|1565536|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
480232|NCT00112437|1565537|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
480233|NCT00112437|1565538|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480234|NCT00112437|1565539|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480235|NCT00112437|1565540|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480236|NCT00112437|1565541|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480237|NCT00112437|1565542|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480238|NCT00112437|1565543|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480239|NCT00112437|1565544|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480240|NCT00112437|1565545|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480241|NCT00112437|1565546|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480242|NCT00112437|1565547|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480243|NCT00112437|1565548|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480244|NCT00112437|1565549|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480245|NCT00112437|1565550|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480246|NCT00112437|1565551|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480247|NCT00112437|1565552|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480248|NCT00112437|1565553|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480249|NCT00112437|1565554|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480250|NCT00112437|1565555|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480251|NCT00112437|1565556|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480252|NCT00112437|1565557|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
480253|NCT00112437|1565532|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480254|NCT00112437|1565533|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480255|NCT00112437|1565534|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480256|NCT00112437|1565535|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480257|NCT00112437|1565536|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480258|NCT00112437|1565537|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480259|NCT00112437|1565538|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480260|NCT00112437|1565539|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480261|NCT00112437|1565540|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480262|NCT00112437|1565541|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480263|NCT00112437|1565542|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480264|NCT00112437|1565543|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480265|NCT00112437|1565544|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480266|NCT00112437|1565545|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480267|NCT00112437|1565546|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
480268|NCT00112437|1565547|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
480269|NCT00112437|1565548|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480270|NCT00112437|1565549|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480271|NCT00112437|1565550|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480272|NCT00112437|1565551|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480273|NCT00112437|1565552|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480274|NCT00112437|1565553|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480275|NCT00112437|1565554|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480276|NCT00112437|1565555|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480277|NCT00112437|1565556|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480278|NCT00112437|1565557|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
480279|NCT00112437|1565532|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480280|NCT00112437|1565533|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480281|NCT00112437|1565534|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480282|NCT00112437|1565535|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480283|NCT00112437|1565536|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480284|NCT00112437|1565537|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480285|NCT00112437|1565538|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480286|NCT00112437|1565539|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480287|NCT00112437|1565540|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480288|NCT00112437|1565541|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480289|NCT00112437|1565542|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480290|NCT00112437|1565543|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
480291|NCT00112437|1565544|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480292|NCT00112437|1565545|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480293|NCT00112437|1565546|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
480294|NCT00112437|1565547|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480295|NCT00112437|1565548|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480296|NCT00112437|1565549|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480297|NCT00112437|1565550|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480298|NCT00112437|1565551|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480299|NCT00112437|1565552|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480300|NCT00112437|1565553|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480301|NCT00112437|1565554|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480302|NCT00112437|1565555|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480303|NCT00112437|1565556|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480304|NCT00112437|1565557|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
480305|NCT00112437|1565532|P26|Year 3 (12-Month Extension)|Protocol Violation|0
480306|NCT00112437|1565533|P25|Year 3 (12-Month Extension)|Protocol Violation|0
480307|NCT00112437|1565534|P24|Year 3 (12-Month Extension)|Protocol Violation|0
480308|NCT00112437|1565535|P23|Year 3 (12-Month Extension)|Protocol Violation|0
480309|NCT00112437|1565536|P22|Year 3 (12-Month Extension)|Protocol Violation|0
480310|NCT00112437|1565537|P21|Year 3 (12-Month Extension)|Protocol Violation|0
480311|NCT00112437|1565538|P20|Year 3 (12-Month Extension)|Protocol Violation|0
480312|NCT00112437|1565539|P19|Year 3 (12-Month Extension)|Protocol Violation|0
480313|NCT00112437|1565540|P18|Year 3 (12-Month Extension)|Protocol Violation|0
480314|NCT00112437|1565541|P17|Year 3 (12-Month Extension)|Protocol Violation|0
480315|NCT00112437|1565542|P16|Year 3 (12-Month Extension)|Protocol Violation|1
480316|NCT00112437|1565543|P15|Year 3 (12-Month Extension)|Protocol Violation|0
480317|NCT00112437|1565544|P14|Year 3 (12-Month Extension)|Protocol Violation|0
480318|NCT00112437|1565545|P13|Year 3 (12-Month Extension)|Protocol Violation|0
480319|NCT00112437|1565546|P12|Year 3 (12-Month Extension)|Protocol Violation|0
480320|NCT00112437|1565547|P11|Year 3 (12-Month Extension)|Protocol Violation|0
480321|NCT00112437|1565548|P10|Year 3 (12-Month Extension)|Protocol Violation|0
480322|NCT00112437|1565549|P9|Year 3 (12-Month Extension)|Protocol Violation|0
480323|NCT00112437|1565550|P8|Year 3 (12-Month Extension)|Protocol Violation|0
480324|NCT00112437|1565551|P7|Year 3 (12-Month Extension)|Protocol Violation|0
480325|NCT00112437|1565552|P6|Year 3 (12-Month Extension)|Protocol Violation|0
480326|NCT00112437|1565553|P5|Year 3 (12-Month Extension)|Protocol Violation|0
480327|NCT00112437|1565554|P4|Year 3 (12-Month Extension)|Protocol Violation|0
480328|NCT00112437|1565555|P3|Year 3 (12-Month Extension)|Protocol Violation|0
480329|NCT00112437|1565556|P2|Year 3 (12-Month Extension)|Protocol Violation|0
480330|NCT00112437|1565557|P1|Year 3 (12-Month Extension)|Protocol Violation|0
480331|NCT00112437|1565532|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
480332|NCT00112437|1565533|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
480333|NCT00112437|1565534|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
480334|NCT00112437|1565535|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
480335|NCT00112437|1565536|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
480336|NCT00112437|1565537|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
480337|NCT00112437|1565538|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
480338|NCT00112437|1565539|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
480339|NCT00112437|1565540|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
480340|NCT00112437|1565541|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
480341|NCT00112437|1565542|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
480342|NCT00112437|1565543|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
480343|NCT00112437|1565544|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
480344|NCT00112437|1565545|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
480345|NCT00112437|1565546|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
480346|NCT00112437|1565547|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
480347|NCT00112437|1565548|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
480348|NCT00112437|1565549|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
480349|NCT00112437|1565550|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
480350|NCT00112437|1565551|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
480351|NCT00112437|1565552|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
480352|NCT00112437|1565553|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
480353|NCT00112437|1565554|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
480354|NCT00112437|1565555|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
480355|NCT00112437|1565556|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
480356|NCT00112437|1565557|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
480357|NCT00112437|1565532|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
480358|NCT00112437|1565533|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
480359|NCT00112437|1565534|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
480360|NCT00112437|1565535|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
480361|NCT00112437|1565536|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
480362|NCT00112437|1565537|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
480363|NCT00112437|1565538|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
480364|NCT00112437|1565539|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
480365|NCT00112437|1565540|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
480366|NCT00112437|1565541|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
480367|NCT00112437|1565542|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
480368|NCT00112437|1565543|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
480369|NCT00112437|1565544|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
480370|NCT00112437|1565545|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
480371|NCT00112437|1565546|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
480372|NCT00112437|1565547|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
480373|NCT00112437|1565548|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
480374|NCT00112437|1565549|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
480375|NCT00112437|1565550|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
480376|NCT00112437|1565551|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
480377|NCT00112437|1565552|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
480378|NCT00112437|1565553|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
480379|NCT00112437|1565554|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
480380|NCT00112437|1565555|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
480381|NCT00112437|1565556|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
480382|NCT00112437|1565557|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
480383|NCT00112437|1565532|P26|Year 3 (12-Month Extension)|Adverse Event|0
480384|NCT00112437|1565533|P25|Year 3 (12-Month Extension)|Adverse Event|0
480385|NCT00112437|1565534|P24|Year 3 (12-Month Extension)|Adverse Event|0
480386|NCT00112437|1565535|P23|Year 3 (12-Month Extension)|Adverse Event|0
480387|NCT00112437|1565536|P22|Year 3 (12-Month Extension)|Adverse Event|0
480388|NCT00112437|1565537|P21|Year 3 (12-Month Extension)|Adverse Event|0
480389|NCT00112437|1565538|P20|Year 3 (12-Month Extension)|Adverse Event|1
480390|NCT00112437|1565539|P19|Year 3 (12-Month Extension)|Adverse Event|0
480391|NCT00112437|1565540|P18|Year 3 (12-Month Extension)|Adverse Event|1
480392|NCT00112437|1565541|P17|Year 3 (12-Month Extension)|Adverse Event|3
480393|NCT00112437|1565542|P16|Year 3 (12-Month Extension)|Adverse Event|1
480394|NCT00112437|1565543|P15|Year 3 (12-Month Extension)|Adverse Event|0
480395|NCT00112437|1565544|P14|Year 3 (12-Month Extension)|Adverse Event|0
480396|NCT00112437|1565545|P13|Year 3 (12-Month Extension)|Adverse Event|0
480397|NCT00112437|1565546|P12|Year 3 (12-Month Extension)|Adverse Event|0
480398|NCT00112437|1565547|P11|Year 3 (12-Month Extension)|Adverse Event|1
480399|NCT00112437|1565548|P10|Year 3 (12-Month Extension)|Adverse Event|0
480400|NCT00112437|1565549|P9|Year 3 (12-Month Extension)|Adverse Event|0
480401|NCT00112437|1565550|P8|Year 3 (12-Month Extension)|Adverse Event|0
480402|NCT00112437|1565551|P7|Year 3 (12-Month Extension)|Adverse Event|0
480403|NCT00112437|1565552|P6|Year 3 (12-Month Extension)|Adverse Event|0
480404|NCT00112437|1565553|P5|Year 3 (12-Month Extension)|Adverse Event|0
480405|NCT00112437|1565554|P4|Year 3 (12-Month Extension)|Adverse Event|0
480406|NCT00112437|1565555|P3|Year 3 (12-Month Extension)|Adverse Event|0
480407|NCT00112437|1565556|P2|Year 3 (12-Month Extension)|Adverse Event|0
480408|NCT00112437|1565557|P1|Year 3 (12-Month Extension)|Adverse Event|0
480409|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|Moved|0
480410|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|Moved|0
480411|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|Moved|0
480412|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|Moved|0
480413|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|Moved|0
480414|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|Moved|0
480415|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|Moved|0
480416|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|Moved|0
480417|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|Moved|0
480418|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|Moved|0
480419|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|Moved|0
480420|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|Moved|0
480421|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|Moved|0
480422|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|Moved|0
480423|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|Moved|0
480424|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|Moved|0
480425|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|Moved|1
480426|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|Moved|0
480427|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|Moved|0
480428|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|Moved|0
480429|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|Moved|0
480430|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|Moved|0
480431|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|Moved|0
480432|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|Moved|0
480433|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|Moved|0
480434|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|Moved|0
480435|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|patient was out of windows|0
480436|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|patient was out of windows|0
480437|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|patient was out of windows|0
480438|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|patient was out of windows|0
480439|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|patient was out of windows|0
480440|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|patient was out of windows|0
480441|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|patient was out of windows|0
480442|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|patient was out of windows|0
480443|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|patient was out of windows|0
480444|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|patient was out of windows|0
480445|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|patient was out of windows|0
480446|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|patient was out of windows|0
480447|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|patient was out of windows|0
480448|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|patient was out of windows|0
480449|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|patient was out of windows|0
480450|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|patient was out of windows|0
480451|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|patient was out of windows|1
480452|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|patient was out of windows|0
480453|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|patient was out of windows|0
480454|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|patient was out of windows|0
480455|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|patient was out of windows|0
480456|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|patient was out of windows|0
480457|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|patient was out of windows|0
480606|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|Adverse Event|0
480458|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|patient was out of windows|0
480459|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|patient was out of windows|0
480460|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|patient was out of windows|0
480461|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480462|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480463|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480464|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480465|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480466|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480467|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480468|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480469|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480470|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480471|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480472|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480473|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480474|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480475|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480476|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480477|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
480478|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480479|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480480|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480481|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480482|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480483|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480484|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480485|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480486|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
480487|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480488|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480489|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480490|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480491|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480492|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480493|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480494|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480495|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480496|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480497|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480498|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480499|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480500|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480501|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480502|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480503|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
480504|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
480505|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
480506|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
480507|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
480508|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480509|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480510|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480511|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480512|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
480513|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|Protocol Violation|0
480514|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|Protocol Violation|0
480515|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|Protocol Violation|0
480516|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|Protocol Violation|0
480517|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|Protocol Violation|0
480518|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|Protocol Violation|0
480519|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|Protocol Violation|0
480520|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|Protocol Violation|0
480521|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|Protocol Violation|0
480522|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|Protocol Violation|0
480523|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|Protocol Violation|0
480524|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|Protocol Violation|0
480525|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|Protocol Violation|0
480526|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|Protocol Violation|0
480527|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|Protocol Violation|0
480528|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|Protocol Violation|0
480529|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|Protocol Violation|0
480530|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|Protocol Violation|1
480531|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|Protocol Violation|0
480532|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|Protocol Violation|0
480533|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|Protocol Violation|0
480534|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|Protocol Violation|0
480535|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|Protocol Violation|0
480536|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|Protocol Violation|0
480537|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|Protocol Violation|0
480538|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|Protocol Violation|0
480539|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
480540|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
480541|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
480542|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
480543|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
480544|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
480545|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
480546|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
480547|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
480548|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
480549|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
480550|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
480551|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
480552|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
480553|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
480554|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
480555|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
480556|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
480557|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
480558|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
480559|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
480560|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
480561|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
480562|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
480563|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
480564|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
480565|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
480566|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
480567|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
480568|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
480569|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
480570|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
480571|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
480572|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
480573|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
480574|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
480575|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
480576|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
480577|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
480578|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
480579|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
480580|NCT00112437|1565547|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
480581|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
480582|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
480583|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
480584|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
480585|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
480586|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
480587|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
480588|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
480589|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
480590|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
480591|NCT00112437|1565532|P26|Year 2 (12-Month Extension)|Adverse Event|0
480592|NCT00112437|1565533|P25|Year 2 (12-Month Extension)|Adverse Event|0
480593|NCT00112437|1565534|P24|Year 2 (12-Month Extension)|Adverse Event|0
480594|NCT00112437|1565535|P23|Year 2 (12-Month Extension)|Adverse Event|0
480595|NCT00112437|1565536|P22|Year 2 (12-Month Extension)|Adverse Event|0
480596|NCT00112437|1565537|P21|Year 2 (12-Month Extension)|Adverse Event|0
480597|NCT00112437|1565538|P20|Year 2 (12-Month Extension)|Adverse Event|0
480598|NCT00112437|1565539|P19|Year 2 (12-Month Extension)|Adverse Event|0
480599|NCT00112437|1565540|P18|Year 2 (12-Month Extension)|Adverse Event|0
480600|NCT00112437|1565541|P17|Year 2 (12-Month Extension)|Adverse Event|0
480601|NCT00112437|1565542|P16|Year 2 (12-Month Extension)|Adverse Event|0
480602|NCT00112437|1565543|P15|Year 2 (12-Month Extension)|Adverse Event|0
480603|NCT00112437|1565544|P14|Year 2 (12-Month Extension)|Adverse Event|0
480604|NCT00112437|1565545|P13|Year 2 (12-Month Extension)|Adverse Event|0
480605|NCT00112437|1565546|P12|Year 2 (12-Month Extension)|Adverse Event|0
480607|NCT00112437|1565548|P10|Year 2 (12-Month Extension)|Adverse Event|7
480608|NCT00112437|1565549|P9|Year 2 (12-Month Extension)|Adverse Event|1
480609|NCT00112437|1565550|P8|Year 2 (12-Month Extension)|Adverse Event|6
480610|NCT00112437|1565551|P7|Year 2 (12-Month Extension)|Adverse Event|2
480611|NCT00112437|1565552|P6|Year 2 (12-Month Extension)|Adverse Event|1
480612|NCT00112437|1565553|P5|Year 2 (12-Month Extension)|Adverse Event|0
480613|NCT00112437|1565554|P4|Year 2 (12-Month Extension)|Adverse Event|0
480614|NCT00112437|1565555|P3|Year 2 (12-Month Extension)|Adverse Event|0
480615|NCT00112437|1565556|P2|Year 2 (12-Month Extension)|Adverse Event|0
480616|NCT00112437|1565557|P1|Year 2 (12-Month Extension)|Adverse Event|0
480617|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480618|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480619|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480620|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480621|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480622|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480623|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480624|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480625|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480626|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480627|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480628|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480629|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480630|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480631|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480632|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480633|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480634|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480635|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480636|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480637|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480638|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
480639|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480640|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480641|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480642|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
480643|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480644|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480645|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480646|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480647|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480648|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480649|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480650|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480651|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480652|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480653|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480654|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480655|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480656|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480657|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480658|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480659|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480660|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480661|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480662|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480663|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480664|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480665|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
480666|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480667|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480668|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
480669|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|moved|0
480670|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|moved|0
480671|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|moved|0
480672|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|moved|0
480673|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|moved|0
480674|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|moved|0
480675|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|moved|0
480676|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|moved|0
480677|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|moved|0
480678|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|moved|0
480679|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|moved|0
480680|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|moved|0
480681|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|moved|0
480682|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|moved|0
480683|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|moved|0
480684|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|moved|0
480685|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|moved|0
480686|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|moved|0
480687|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|moved|0
480688|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|moved|0
480689|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|moved|0
480690|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|moved|0
480691|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|moved|0
480692|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|moved|1
480693|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|moved|1
480694|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|moved|0
480695|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480696|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480697|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480698|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480699|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480700|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480701|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480702|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480703|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480704|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480705|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480706|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480707|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480708|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480709|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480710|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480711|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480712|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480713|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480714|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480715|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
480716|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
480717|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
480718|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
480719|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
480720|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
480721|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
480722|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
480723|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
480724|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
480725|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
480726|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
480727|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
480728|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
480729|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
480730|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
480731|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
480732|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
480733|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
480734|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
480735|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
480736|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
480737|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
480738|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
480739|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
480740|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
480741|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
480742|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
480743|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
480744|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
480745|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
480746|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
480747|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480748|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480749|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480750|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480751|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480752|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480753|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480754|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480755|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480756|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480757|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480758|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480759|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480760|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480761|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480762|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480763|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480764|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480765|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480766|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480767|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480768|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480769|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480770|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480771|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
480772|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
480773|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480774|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480775|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480776|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480777|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480778|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480779|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480780|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480781|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480782|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480783|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480784|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480785|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480786|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480787|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480788|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480789|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480790|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480791|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480792|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480793|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480794|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480795|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480796|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480797|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
480798|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
480799|NCT00112437|1565532|P26|Year 1 (12-Month Base Study)|Adverse Event|0
480800|NCT00112437|1565533|P25|Year 1 (12-Month Base Study)|Adverse Event|0
480801|NCT00112437|1565534|P24|Year 1 (12-Month Base Study)|Adverse Event|0
480802|NCT00112437|1565535|P23|Year 1 (12-Month Base Study)|Adverse Event|0
480803|NCT00112437|1565536|P22|Year 1 (12-Month Base Study)|Adverse Event|0
480804|NCT00112437|1565537|P21|Year 1 (12-Month Base Study)|Adverse Event|0
480805|NCT00112437|1565538|P20|Year 1 (12-Month Base Study)|Adverse Event|0
480806|NCT00112437|1565539|P19|Year 1 (12-Month Base Study)|Adverse Event|0
480807|NCT00112437|1565540|P18|Year 1 (12-Month Base Study)|Adverse Event|0
480808|NCT00112437|1565541|P17|Year 1 (12-Month Base Study)|Adverse Event|0
480809|NCT00112437|1565542|P16|Year 1 (12-Month Base Study)|Adverse Event|0
480810|NCT00112437|1565543|P15|Year 1 (12-Month Base Study)|Adverse Event|0
480811|NCT00112437|1565544|P14|Year 1 (12-Month Base Study)|Adverse Event|0
480812|NCT00112437|1565545|P13|Year 1 (12-Month Base Study)|Adverse Event|0
480813|NCT00112437|1565546|P12|Year 1 (12-Month Base Study)|Adverse Event|0
480814|NCT00112437|1565547|P11|Year 1 (12-Month Base Study)|Adverse Event|0
480815|NCT00112437|1565548|P10|Year 1 (12-Month Base Study)|Adverse Event|0
480816|NCT00112437|1565549|P9|Year 1 (12-Month Base Study)|Adverse Event|0
480817|NCT00112437|1565550|P8|Year 1 (12-Month Base Study)|Adverse Event|0
480818|NCT00112437|1565551|P7|Year 1 (12-Month Base Study)|Adverse Event|0
480819|NCT00112437|1565552|P6|Year 1 (12-Month Base Study)|Adverse Event|0
480820|NCT00112437|1565553|P5|Year 1 (12-Month Base Study)|Adverse Event|3
480821|NCT00112437|1565554|P4|Year 1 (12-Month Base Study)|Adverse Event|4
480822|NCT00112437|1565555|P3|Year 1 (12-Month Base Study)|Adverse Event|6
480823|NCT00112437|1565556|P2|Year 1 (12-Month Base Study)|Adverse Event|10
480824|NCT00112437|1565557|P1|Year 1 (12-Month Base Study)|Adverse Event|9
480825|NCT00112385|1565837|P2|Overall Study|Withdrawal by Subject|1
480826|NCT00112385|1565838|P1|Overall Study|Withdrawal by Subject|0
480827|NCT00112385|1565837|P2|Overall Study|Lost to Follow-up|0
480828|NCT00112385|1565838|P1|Overall Study|Lost to Follow-up|1
480829|NCT00112359|1565928|P2|Overall Study|Other|0
480830|NCT00112359|1565929|P1|Overall Study|Other|3
480831|NCT00112359|1565928|P2|Overall Study|Personal/administrative|1
480832|NCT00112359|1565929|P1|Overall Study|Personal/administrative|1
480833|NCT00112359|1565928|P2|Overall Study|Lost to Follow-up|1
480834|NCT00112359|1565929|P1|Overall Study|Lost to Follow-up|0
480835|NCT00112359|1565928|P2|Overall Study|Related adverse event|3
480836|NCT00112359|1565929|P1|Overall Study|Related adverse event|5
480837|NCT00112359|1565928|P2|Overall Study|Trial drug intolerance (adverse event)|0
480838|NCT00112359|1565929|P1|Overall Study|Trial drug intolerance (adverse event)|2
480839|NCT00112359|1565928|P2|Overall Study|Unrelated adverse event|8
480840|NCT00112359|1565929|P1|Overall Study|Unrelated adverse event|16
480841|NCT00112294|1565955|P2|Overall Study|Still on study|0
480842|NCT00112294|1565956|P1|Overall Study|Still on study|5
480843|NCT00112047|1566179|P2|Atripla Phase|Not specified|1
480844|NCT00112047|1566180|P1|Atripla Phase|Not specified|3
480845|NCT00112047|1566179|P2|Atripla Phase|Non-compliance|0
480846|NCT00112047|1566180|P1|Atripla Phase|Non-compliance|1
480847|NCT00112047|1566179|P2|Atripla Phase|Sub-optimal virological response|1
480848|NCT00112047|1566180|P1|Atripla Phase|Sub-optimal virological response|0
480849|NCT00112047|1566179|P2|Atripla Phase|Withdrew consent|7
480850|NCT00112047|1566180|P1|Atripla Phase|Withdrew consent|7
480851|NCT00112047|1566179|P2|Atripla Phase|Death|2
480852|NCT00112047|1566180|P1|Atripla Phase|Death|0
480853|NCT00112047|1566179|P2|Atripla Phase|Pregnancy|1
480854|NCT00112047|1566180|P1|Atripla Phase|Pregnancy|0
480855|NCT00112047|1566179|P2|Atripla Phase|Lost to Follow-up|7
480856|NCT00112047|1566180|P1|Atripla Phase|Lost to Follow-up|5
480857|NCT00112047|1566179|P2|Atripla Phase|Adverse Event|1
480858|NCT00112047|1566180|P1|Atripla Phase|Adverse Event|2
480859|NCT00112047|1566179|P2|Randomized Phase|High Hepatitis B DNA|1
480860|NCT00112047|1566180|P1|Randomized Phase|High Hepatitis B DNA|0
480861|NCT00112047|1566179|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
480862|NCT00112047|1566180|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
480863|NCT00112047|1566179|P2|Randomized Phase|Moved out of State|1
480864|NCT00112047|1566180|P1|Randomized Phase|Moved out of State|0
480865|NCT00112047|1566179|P2|Randomized Phase|Incarceration|2
480866|NCT00112047|1566180|P1|Randomized Phase|Incarceration|3
480867|NCT00112047|1566179|P2|Randomized Phase|Inability to swallow pills|1
480868|NCT00112047|1566180|P1|Randomized Phase|Inability to swallow pills|0
480869|NCT00112047|1566179|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
480870|NCT00112047|1566180|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
480871|NCT00112047|1566179|P2|Randomized Phase|Death|3
480872|NCT00112047|1566180|P1|Randomized Phase|Death|1
480873|NCT00112047|1566179|P2|Randomized Phase|Pregnancy|1
480874|NCT00112047|1566180|P1|Randomized Phase|Pregnancy|3
480875|NCT00112047|1566179|P2|Randomized Phase|Protocol Violation|0
480876|NCT00112047|1566180|P1|Randomized Phase|Protocol Violation|2
480877|NCT00112047|1566179|P2|Randomized Phase|Noncompliance|4
480878|NCT00112047|1566180|P1|Randomized Phase|Noncompliance|8
480879|NCT00112047|1566179|P2|Randomized Phase|Sub-optimal virological response|13
480880|NCT00112047|1566180|P1|Randomized Phase|Sub-optimal virological response|3
480881|NCT00112047|1566179|P2|Randomized Phase|Withrawal of consent|18
480882|NCT00112047|1566180|P1|Randomized Phase|Withrawal of consent|10
480883|NCT00112047|1566179|P2|Randomized Phase|Adverse Event|10
480884|NCT00112047|1566180|P1|Randomized Phase|Adverse Event|10
480885|NCT00112047|1566179|P2|Randomized Phase|Lost to Follow-up|33
480886|NCT00112047|1566180|P1|Randomized Phase|Lost to Follow-up|26
480887|NCT00111917|1566280|P2|Overall Study|Withdrawal by Subject|1
480888|NCT00111917|1566281|P1|Overall Study|Withdrawal by Subject|1
480889|NCT00111839|1566296|P3|Overall Study|Randomized but Not Treated|2
480890|NCT00111839|1566297|P2|Overall Study|Randomized but Not Treated|0
480891|NCT00111839|1566298|P1|Overall Study|Randomized but Not Treated|0
480892|NCT00111839|1566296|P3|Overall Study|Other|3
480893|NCT00111839|1566297|P2|Overall Study|Other|3
480894|NCT00111839|1566298|P1|Overall Study|Other|6
480895|NCT00111839|1566296|P3|Overall Study|Logistical Constraint|0
480896|NCT00111839|1566297|P2|Overall Study|Logistical Constraint|0
480897|NCT00111839|1566298|P1|Overall Study|Logistical Constraint|1
480898|NCT00111839|1566296|P3|Overall Study|Lost to Follow-up|0
480899|NCT00111839|1566297|P2|Overall Study|Lost to Follow-up|0
480900|NCT00111839|1566298|P1|Overall Study|Lost to Follow-up|1
480901|NCT00111839|1566296|P3|Overall Study|Withdrawal by Subject|2
480902|NCT00111839|1566297|P2|Overall Study|Withdrawal by Subject|2
480903|NCT00111839|1566298|P1|Overall Study|Withdrawal by Subject|2
480904|NCT00111839|1566296|P3|Overall Study|Death|6
480905|NCT00111839|1566297|P2|Overall Study|Death|1
480906|NCT00111839|1566298|P1|Overall Study|Death|1
480907|NCT00111839|1566296|P3|Overall Study|Protocol Violation|2
480908|NCT00111839|1566297|P2|Overall Study|Protocol Violation|4
480909|NCT00111839|1566298|P1|Overall Study|Protocol Violation|2
480910|NCT00111839|1566296|P3|Overall Study|Adverse Event|1
480911|NCT00111839|1566297|P2|Overall Study|Adverse Event|3
480912|NCT00111839|1566298|P1|Overall Study|Adverse Event|5
480913|NCT00111839|1566296|P3|Overall Study|Disease Progression|33
480914|NCT00111839|1566297|P2|Overall Study|Disease Progression|33
480915|NCT00111839|1566298|P1|Overall Study|Disease Progression|30
480916|NCT00111813|1566318|P6|Overall Study|Not specified|0
480917|NCT00111813|1566319|P5|Overall Study|Not specified|0
480918|NCT00111813|1566320|P4|Overall Study|Not specified|0
480919|NCT00111813|1566321|P3|Overall Study|Not specified|1
480920|NCT00111813|1566322|P2|Overall Study|Not specified|0
480921|NCT00111813|1566323|P1|Overall Study|Not specified|0
480922|NCT00111813|1566318|P6|Overall Study|Lack of Efficacy|1
480923|NCT00111813|1566319|P5|Overall Study|Lack of Efficacy|0
480924|NCT00111813|1566320|P4|Overall Study|Lack of Efficacy|0
480925|NCT00111813|1566321|P3|Overall Study|Lack of Efficacy|0
480926|NCT00111813|1566322|P2|Overall Study|Lack of Efficacy|0
480927|NCT00111813|1566323|P1|Overall Study|Lack of Efficacy|0
480928|NCT00111813|1566318|P6|Overall Study|Progressive disease|3
480929|NCT00111813|1566319|P5|Overall Study|Progressive disease|4
480930|NCT00111813|1566320|P4|Overall Study|Progressive disease|3
480931|NCT00111813|1566321|P3|Overall Study|Progressive disease|5
480932|NCT00111813|1566322|P2|Overall Study|Progressive disease|1
480933|NCT00111813|1566323|P1|Overall Study|Progressive disease|2
480934|NCT00111813|1566318|P6|Overall Study|Adverse Event|2
480935|NCT00111813|1566319|P5|Overall Study|Adverse Event|2
480936|NCT00111813|1566320|P4|Overall Study|Adverse Event|2
480937|NCT00111813|1566321|P3|Overall Study|Adverse Event|4
480938|NCT00111813|1566322|P2|Overall Study|Adverse Event|2
480939|NCT00111813|1566323|P1|Overall Study|Adverse Event|1
480940|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
480941|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
480942|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
480943|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
480944|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
480945|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
480946|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
480947|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
480948|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
480949|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
480950|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
480951|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
480952|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
480953|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
480954|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
480955|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
480956|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
480957|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
480958|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
480959|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
480960|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
480961|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
480962|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
480963|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
480964|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
480965|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
480966|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
480967|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
480968|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
480969|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
480970|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
480971|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
480972|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
480973|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
480974|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
480975|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
480976|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
480977|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
480978|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
480979|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
480980|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
480981|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
480982|NCT00111800|1566362|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
480983|NCT00111800|1566363|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
480984|NCT00111800|1566364|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
480985|NCT00111800|1566365|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
480986|NCT00111800|1566366|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
480987|NCT00111800|1566367|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
480988|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
480989|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
480990|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
480991|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
480992|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
480993|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
480994|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
480995|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
480996|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
480997|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
480998|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
480999|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
481000|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
481001|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
481002|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
481003|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
481004|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
481005|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
481006|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
481007|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
481008|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
481009|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
481010|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
481011|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
481012|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
481013|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
481014|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
481015|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
481016|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
481017|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
481018|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
481019|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
481020|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
481021|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
481022|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
481023|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
481024|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
481025|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
481026|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
481027|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
481028|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
481029|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
481030|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
481031|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
481032|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
481033|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
481034|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
481035|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
481036|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
481037|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
481038|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
481039|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
481040|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
481041|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
481042|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
481043|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
481044|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
481045|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
481046|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
481047|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
481048|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
481049|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
481050|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
481051|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
481052|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
481053|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
481054|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
481055|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
481056|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
481057|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
481138|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Relapse|0
481058|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
481059|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
481060|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
481061|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
481062|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
481063|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
481064|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
481065|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
481066|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
481067|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
481068|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
481069|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
481070|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
481071|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
481072|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
481073|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
481074|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
481075|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
481076|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
481077|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
481078|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
481079|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
481080|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
481081|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
481082|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
481083|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
481084|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
481085|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
481086|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
481087|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
481088|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
481089|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
481090|NCT00111800|1566362|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
481091|NCT00111800|1566363|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
481092|NCT00111800|1566364|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
481093|NCT00111800|1566365|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
481094|NCT00111800|1566366|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
481095|NCT00111800|1566367|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
481096|NCT00111761|1566537|P2|Part 2|Other|0
481097|NCT00111761|1566538|P1|Part 2|Other|1
481098|NCT00111761|1566537|P2|Part 2|Protocol-specified criteria|0
481099|NCT00111761|1566538|P1|Part 2|Protocol-specified criteria|1
481100|NCT00111761|1566537|P2|Part 2|Disease progression|0
481101|NCT00111761|1566538|P1|Part 2|Disease progression|3
481102|NCT00111761|1566537|P2|Part 2|Death|0
481103|NCT00111761|1566538|P1|Part 2|Death|1
481104|NCT00111761|1566537|P2|Part 2|Physician Decision|0
481105|NCT00111761|1566538|P1|Part 2|Physician Decision|1
481106|NCT00111761|1566537|P2|Part 2|Adverse Event|0
481107|NCT00111761|1566538|P1|Part 2|Adverse Event|1
481108|NCT00111761|1566537|P2|Part 1|Withdrawal by Subject|1
481109|NCT00111761|1566538|P1|Part 1|Withdrawal by Subject|0
481110|NCT00111761|1566537|P2|Part 1|Other|1
481111|NCT00111761|1566538|P1|Part 1|Other|0
481112|NCT00111761|1566537|P2|Part 1|Death|2
481113|NCT00111761|1566538|P1|Part 1|Death|0
481114|NCT00111761|1566537|P2|Part 1|Physician Decision|1
481115|NCT00111761|1566538|P1|Part 1|Physician Decision|0
481116|NCT00111007|1566567|P2|Long Term Follow-up|Missing|3
481117|NCT00111007|1566568|P1|Long Term Follow-up|Missing|10
481118|NCT00111007|1566567|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
481119|NCT00111007|1566568|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
481120|NCT00111007|1566567|P2|Long Term Follow-up|Withdrawal by Subject|1
481121|NCT00111007|1566568|P1|Long Term Follow-up|Withdrawal by Subject|0
481122|NCT00111007|1566567|P2|Long Term Follow-up|Lost to Follow-up|1
481123|NCT00111007|1566568|P1|Long Term Follow-up|Lost to Follow-up|1
481124|NCT00111007|1566567|P2|Long Term Follow-up|Death|39
481125|NCT00111007|1566568|P1|Long Term Follow-up|Death|34
481126|NCT00111007|1566567|P2|Active Follow-up|Disease progression/recurrence/relapse|2
481127|NCT00111007|1566568|P1|Active Follow-up|Disease progression/recurrence/relapse|3
481128|NCT00111007|1566567|P2|Active Follow-up|Death|0
481129|NCT00111007|1566568|P1|Active Follow-up|Death|2
481130|NCT00111007|1566567|P2|Active Follow-up|Adverse Event|0
481131|NCT00111007|1566568|P1|Active Follow-up|Adverse Event|1
481132|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Primary reason with other category|1
481133|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Primary reason with other category|0
481134|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
481135|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
481136|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
481137|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
481139|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Relapse|1
481140|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
481141|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
481142|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
481143|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
481144|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Protocol Violation|1
481145|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Protocol Violation|0
481146|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Death|2
481147|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Death|5
481148|NCT00111007|1566567|P2|Double-blind (DB) Treatment|Adverse Event|4
481149|NCT00111007|1566568|P1|Double-blind (DB) Treatment|Adverse Event|12
481150|NCT00110994|1566584|P2|Long Term Follow-up|Death|17
481151|NCT00110994|1566585|P1|Long Term Follow-up|Death|19
481152|NCT00110994|1566584|P2|Active Follow-up|Other reasons|2
481153|NCT00110994|1566585|P1|Active Follow-up|Other reasons|0
481154|NCT00110994|1566584|P2|Active Follow-up|Disease progression/recurrence/replace|0
481155|NCT00110994|1566585|P1|Active Follow-up|Disease progression/recurrence/replace|1
481156|NCT00110994|1566584|P2|Double-blind (DB) Treatment|other reasons|3
481157|NCT00110994|1566585|P1|Double-blind (DB) Treatment|other reasons|2
481158|NCT00110994|1566584|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
481159|NCT00110994|1566585|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
481160|NCT00110994|1566584|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
481161|NCT00110994|1566585|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
481162|NCT00110994|1566584|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
481163|NCT00110994|1566585|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
481164|NCT00110994|1566584|P2|Double-blind (DB) Treatment|Death|0
481165|NCT00110994|1566585|P1|Double-blind (DB) Treatment|Death|1
481166|NCT00110994|1566584|P2|Double-blind (DB) Treatment|Adverse Event|0
481167|NCT00110994|1566585|P1|Double-blind (DB) Treatment|Adverse Event|3
481168|NCT00110890|1566611|P2|Overall Study|Did not enter follow-up phase|4
481169|NCT00110890|1566612|P1|Overall Study|Did not enter follow-up phase|10
481170|NCT00110890|1566611|P2|Overall Study|Parathyroidectomy|1
481171|NCT00110890|1566612|P1|Overall Study|Parathyroidectomy|0
481172|NCT00110890|1566611|P2|Overall Study|Disease progression|1
481173|NCT00110890|1566612|P1|Overall Study|Disease progression|0
481174|NCT00110890|1566611|P2|Overall Study|Requirement for alternative therapy|1
481175|NCT00110890|1566612|P1|Overall Study|Requirement for alternative therapy|0
481176|NCT00110890|1566611|P2|Overall Study|Ineligibility determined|0
481177|NCT00110890|1566612|P1|Overall Study|Ineligibility determined|3
481178|NCT00110890|1566611|P2|Overall Study|Other|23
481179|NCT00110890|1566612|P1|Overall Study|Other|34
481180|NCT00110890|1566611|P2|Overall Study|Invest. Product Commercially Available|110
481181|NCT00110890|1566612|P1|Overall Study|Invest. Product Commercially Available|217
481182|NCT00110890|1566611|P2|Overall Study|Kidney Transplant|12
481183|NCT00110890|1566612|P1|Overall Study|Kidney Transplant|16
481184|NCT00110890|1566611|P2|Overall Study|Noncompliance|0
481185|NCT00110890|1566612|P1|Overall Study|Noncompliance|10
481186|NCT00110890|1566611|P2|Overall Study|Protocol Deviation|0
481187|NCT00110890|1566612|P1|Overall Study|Protocol Deviation|1
481188|NCT00110890|1566611|P2|Overall Study|Withdrawal by Subject|5
481189|NCT00110890|1566612|P1|Overall Study|Withdrawal by Subject|17
481190|NCT00110890|1566611|P2|Overall Study|Physician Decision|5
481191|NCT00110890|1566612|P1|Overall Study|Physician Decision|4
481192|NCT00110890|1566611|P2|Overall Study|Lost to Follow-up|1
481193|NCT00110890|1566612|P1|Overall Study|Lost to Follow-up|3
481194|NCT00110890|1566611|P2|Overall Study|Death|9
481195|NCT00110890|1566612|P1|Overall Study|Death|16
481196|NCT00110890|1566611|P2|Overall Study|Adverse Event|7
481197|NCT00110890|1566612|P1|Overall Study|Adverse Event|30
481198|NCT00110812|1566629|P3|Extended Follow-up|Lost to Follow-up|1
481199|NCT00110812|1566630|P2|Extended Follow-up|Lost to Follow-up|3
481200|NCT00110812|1566631|P1|Extended Follow-up|Lost to Follow-up|1
481201|NCT00110812|1566629|P3|Extended Follow-up|Withdrawal by Subject|0
481202|NCT00110812|1566630|P2|Extended Follow-up|Withdrawal by Subject|1
481203|NCT00110812|1566631|P1|Extended Follow-up|Withdrawal by Subject|0
481204|NCT00110812|1566629|P3|Extended Follow-up|Death|3
481205|NCT00110812|1566630|P2|Extended Follow-up|Death|0
481206|NCT00110812|1566631|P1|Extended Follow-up|Death|1
481207|NCT00110812|1566629|P3|Main Study|Lost to Follow-up|10
481208|NCT00110812|1566630|P2|Main Study|Lost to Follow-up|11
481209|NCT00110812|1566631|P1|Main Study|Lost to Follow-up|8
481210|NCT00110812|1566629|P3|Main Study|Withdrawal by Subject|1
481211|NCT00110812|1566630|P2|Main Study|Withdrawal by Subject|0
481212|NCT00110812|1566631|P1|Main Study|Withdrawal by Subject|0
481213|NCT00110812|1566629|P3|Main Study|Death|2
481214|NCT00110812|1566630|P2|Main Study|Death|0
481215|NCT00110812|1566631|P1|Main Study|Death|0
481216|NCT00110617|1566676|P2|Overall Study|Did not receive study drug|12
481217|NCT00110617|1566677|P1|Overall Study|Did not receive study drug|0
481218|NCT00110617|1566676|P2|Overall Study|Death|1
481219|NCT00110617|1566677|P1|Overall Study|Death|1
481220|NCT00110617|1566676|P2|Overall Study|Administrative problems|5
481221|NCT00110617|1566677|P1|Overall Study|Administrative problems|6
481222|NCT00110617|1566676|P2|Overall Study|Lost to Follow-up|1
481223|NCT00110617|1566677|P1|Overall Study|Lost to Follow-up|9
481224|NCT00110617|1566676|P2|Overall Study|Withdrawal by Subject|4
481225|NCT00110617|1566677|P1|Overall Study|Withdrawal by Subject|10
481226|NCT00110617|1566676|P2|Overall Study|Protocol Violation|0
481227|NCT00110617|1566677|P1|Overall Study|Protocol Violation|5
481228|NCT00110617|1566676|P2|Overall Study|Patient no longer requires study drug|0
481229|NCT00110617|1566677|P1|Overall Study|Patient no longer requires study drug|1
481230|NCT00110617|1566676|P2|Overall Study|Lack of Efficacy|0
481231|NCT00110617|1566677|P1|Overall Study|Lack of Efficacy|1
481232|NCT00110617|1566676|P2|Overall Study|Abnormal Laboratory Value|2
481233|NCT00110617|1566677|P1|Overall Study|Abnormal Laboratory Value|4
481234|NCT00110617|1566676|P2|Overall Study|Adverse Event|4
481235|NCT00110617|1566677|P1|Overall Study|Adverse Event|2
481236|NCT00110396|1566794|P1|Overall Study|Patient is to be administered copaxone|1
481237|NCT00110396|1566794|P1|Overall Study|The patient has refused to visit site|1
481238|NCT00110396|1566794|P1|Overall Study|The patient has refused|2
481239|NCT00110396|1566794|P1|Overall Study|Patient refused to come back|1
481240|NCT00110396|1566794|P1|Overall Study|Protocol Violation|2
481241|NCT00110396|1566794|P1|Overall Study|Pregnancy (Protocol violation)|2
481242|NCT00110396|1566794|P1|Overall Study|Pregnancy|1
481243|NCT00110396|1566794|P1|Overall Study|Participation in MS vaccine study|1
481244|NCT00110396|1566794|P1|Overall Study|Patient's decision|1
481245|NCT00110396|1566794|P1|Overall Study|Patient will|1
481246|NCT00110396|1566794|P1|Overall Study|Patient refused to participate|1
481247|NCT00110396|1566794|P1|Overall Study|Patient refused to continue|1
481248|NCT00110396|1566794|P1|Overall Study|Patient non-compliance|1
481249|NCT00110396|1566794|P1|Overall Study|Decided not to continue treatment|1
481250|NCT00110396|1566794|P1|Overall Study|Lack of Efficacy|1
481251|NCT00110396|1566794|P1|Overall Study|Initiated mitoxantrone therapy|1
481252|NCT00110396|1566794|P1|Overall Study|Administration of plasmapheresis|1
481253|NCT00110396|1566794|P1|Overall Study|Lost to Follow-up|1
481254|NCT00110396|1566794|P1|Overall Study|Adverse Event|15
481255|NCT00110357|1566802|P2|Overall Study|Withdrawal by Subject|1
481256|NCT00110357|1566803|P1|Overall Study|Withdrawal by Subject|3
481257|NCT00110357|1566802|P2|Overall Study|Study Drug Toxicity|3
481258|NCT00110357|1566803|P1|Overall Study|Study Drug Toxicity|1
481259|NCT00110357|1566802|P2|Overall Study|Study Closure|0
481260|NCT00110357|1566803|P1|Overall Study|Study Closure|1
481261|NCT00110357|1566802|P2|Overall Study|Disease progression/relapse|15
481262|NCT00110357|1566803|P1|Overall Study|Disease progression/relapse|20
481263|NCT00110357|1566802|P2|Overall Study|Deterioration without progression|0
481264|NCT00110357|1566803|P1|Overall Study|Deterioration without progression|2
481265|NCT00110305|1566891|P2|Overall Study|Other|2
481266|NCT00110305|1566892|P1|Overall Study|Other|8
481267|NCT00110305|1566891|P2|Overall Study|Lost to Follow-up|3
481268|NCT00110305|1566892|P1|Overall Study|Lost to Follow-up|20
481269|NCT00110305|1566891|P2|Overall Study|Withdrawal by Subject|7
481270|NCT00110305|1566892|P1|Overall Study|Withdrawal by Subject|7
481271|NCT00110305|1566891|P2|Overall Study|Protocol Violation|1
481272|NCT00110305|1566892|P1|Overall Study|Protocol Violation|0
481273|NCT00110305|1566891|P2|Overall Study|Subject Reached A Virologic Endpoint|3
481274|NCT00110305|1566892|P1|Overall Study|Subject Reached A Virologic Endpoint|21
481275|NCT00110305|1566891|P2|Overall Study|Subject Ineligible To Continue The Trial|1
481276|NCT00110305|1566892|P1|Overall Study|Subject Ineligible To Continue The Trial|2
481277|NCT00110305|1566891|P2|Overall Study|Subject Non-Compliant|2
481278|NCT00110305|1566892|P1|Overall Study|Subject Non-Compliant|9
481279|NCT00110305|1566891|P2|Overall Study|Sponsors Decision|0
481280|NCT00110305|1566892|P1|Overall Study|Sponsors Decision|1
481281|NCT00110305|1566891|P2|Overall Study|Adverse Event|13
481282|NCT00110305|1566892|P1|Overall Study|Adverse Event|46
481283|NCT00110214|1566945|P2|Overall Study|Other (not specified)|75
481284|NCT00110214|1566946|P1|Overall Study|Other (not specified)|61
481285|NCT00110214|1566945|P2|Overall Study|Refused further treatment|65
481286|NCT00110214|1566946|P1|Overall Study|Refused further treatment|52
481287|NCT00110214|1566945|P2|Overall Study|Adverse Event|192
481288|NCT00110214|1566946|P1|Overall Study|Adverse Event|115
481289|NCT00110214|1566945|P2|Overall Study|Disease progression or death|151
481290|NCT00110214|1566946|P1|Overall Study|Disease progression or death|260
481291|NCT00110214|1566945|P2|Overall Study|Never started treatment|20
481292|NCT00110214|1566946|P1|Overall Study|Never started treatment|21
481293|NCT00110149|1566958|P1|Overall Study|Physician Decision|3
481294|NCT00110084|1566972|P1|Overall Study|Other|2
481295|NCT00110084|1566972|P1|Overall Study|Intercurrent Illness|1
481296|NCT00110084|1566972|P1|Overall Study|Alternate Therapy|5
481297|NCT00110084|1566972|P1|Overall Study|Patient Refusal|10
481298|NCT00110084|1566972|P1|Overall Study|Death|1
481299|NCT00110084|1566972|P1|Overall Study|Adverse Event|9
481300|NCT00110019|1566981|P2|Overall Study|other reasons|30
481301|NCT00110019|1566982|P1|Overall Study|other reasons|22
481302|NCT00110019|1566981|P2|Overall Study|Not start protocol therapy|16
481303|NCT00110019|1566982|P1|Overall Study|Not start protocol therapy|17
481304|NCT00110019|1566981|P2|Overall Study|symptom deterioration|16
481305|NCT00110019|1566982|P1|Overall Study|symptom deterioration|13
481306|NCT00110019|1566981|P2|Overall Study|complicating disease|1
481307|NCT00110019|1566982|P1|Overall Study|complicating disease|1
481308|NCT00110019|1566981|P2|Overall Study|alternative therapy|1
481309|NCT00110019|1566982|P1|Overall Study|alternative therapy|5
481310|NCT00110019|1566981|P2|Overall Study|Withdrawal by Subject|9
481311|NCT00110019|1566982|P1|Overall Study|Withdrawal by Subject|21
481312|NCT00110019|1566981|P2|Overall Study|Death|15
481313|NCT00110019|1566982|P1|Overall Study|Death|13
481314|NCT00110019|1566981|P2|Overall Study|Adverse Event|40
481315|NCT00110019|1566982|P1|Overall Study|Adverse Event|61
481316|NCT00110019|1566981|P2|Overall Study|Lack of Efficacy|285
481317|NCT00110019|1566982|P1|Overall Study|Lack of Efficacy|253
481318|NCT00109967|1566994|P2|Overall Study|Death|2
481319|NCT00109967|1566995|P1|Overall Study|Death|0
481320|NCT00109967|1566994|P2|Overall Study|Physician Decision|3
481321|NCT00109967|1566995|P1|Overall Study|Physician Decision|1
481322|NCT00109967|1566994|P2|Overall Study|Withdrawal by Subject|0
481323|NCT00109967|1566995|P1|Overall Study|Withdrawal by Subject|5
481324|NCT00109967|1566994|P2|Overall Study|Adverse Event|1
481325|NCT00109967|1566995|P1|Overall Study|Adverse Event|12
481326|NCT00109967|1566994|P2|Overall Study|Cancel Prior to Treatment|0
481327|NCT00109967|1566995|P1|Overall Study|Cancel Prior to Treatment|2
481328|NCT00109928|1567009|P1|Overall Study|not eligible|1
481329|NCT00109928|1567009|P1|Overall Study|not protocol specified|2
481330|NCT00109928|1567009|P1|Overall Study|Death|2
481331|NCT00109928|1567009|P1|Overall Study|Progression|6
481332|NCT00109928|1567009|P1|Overall Study|Adverse Event|2
481333|NCT00109850|1567026|P1|Overall Study|Ineligible|1
481334|NCT00109850|1567026|P1|Overall Study|Death|2
481335|NCT00109850|1567026|P1|Overall Study|Adverse Event|1
481336|NCT00109837|1567033|P1|Overall Study|Ineligible|1
481337|NCT00109837|1567033|P1|Overall Study|Not treated|1
481338|NCT00109837|1567033|P1|Overall Study|BCR/ABL+ or Ph+|17
481339|NCT00109837|1567033|P1|Overall Study|Death|1
481340|NCT00109837|1567033|P1|Overall Study|Refusal unrelated to adverse effects|1
481341|NCT00109837|1567033|P1|Overall Study|Adverse Event|2
481342|NCT00109772|1567043|P2|Open-label Extension|not specified|10
481343|NCT00109772|1567044|P1|Open-label Extension|not specified|4
481344|NCT00109772|1567043|P2|Open-label Extension|Protocol Violation|2
481345|NCT00109772|1567044|P1|Open-label Extension|Protocol Violation|2
481346|NCT00109772|1567043|P2|Open-label Extension|Death|1
481347|NCT00109772|1567044|P1|Open-label Extension|Death|0
481348|NCT00109772|1567043|P2|Open-label Extension|Lost to Follow-up|0
481349|NCT00109772|1567044|P1|Open-label Extension|Lost to Follow-up|1
481350|NCT00109772|1567043|P2|Open-label Extension|Withdrawal by Subject|6
481351|NCT00109772|1567044|P1|Open-label Extension|Withdrawal by Subject|9
481352|NCT00109772|1567043|P2|Open-label Extension|Lack of Efficacy|11
481353|NCT00109772|1567044|P1|Open-label Extension|Lack of Efficacy|19
481354|NCT00109772|1567043|P2|Open-label Extension|Adverse Event|19
481355|NCT00109772|1567044|P1|Open-label Extension|Adverse Event|10
481356|NCT00109772|1567043|P2|Double-blind Treatment|Withdrew prior to treatment|1
481357|NCT00109772|1567044|P1|Double-blind Treatment|Withdrew prior to treatment|3
481358|NCT00109772|1567043|P2|Double-blind Treatment|not specified|4
481359|NCT00109772|1567044|P1|Double-blind Treatment|not specified|0
481360|NCT00109772|1567043|P2|Double-blind Treatment|Protocol Violation|1
481361|NCT00109772|1567044|P1|Double-blind Treatment|Protocol Violation|0
481362|NCT00109772|1567043|P2|Double-blind Treatment|Lost to Follow-up|3
481363|NCT00109772|1567044|P1|Double-blind Treatment|Lost to Follow-up|2
481364|NCT00109772|1567043|P2|Double-blind Treatment|Withdrawal by Subject|1
481365|NCT00109772|1567044|P1|Double-blind Treatment|Withdrawal by Subject|2
481366|NCT00109772|1567043|P2|Double-blind Treatment|Lack of Efficacy|0
481367|NCT00109772|1567044|P1|Double-blind Treatment|Lack of Efficacy|1
481368|NCT00109772|1567043|P2|Double-blind Treatment|Adverse Event|5
481369|NCT00109772|1567044|P1|Double-blind Treatment|Adverse Event|14
481370|NCT00109733|1567084|P2|Overall Study|Could not commit time for study|1
481371|NCT00109733|1567085|P1|Overall Study|Could not commit time for study|1
481372|NCT00109733|1567084|P2|Overall Study|Non-compliant|1
481373|NCT00109733|1567085|P1|Overall Study|Non-compliant|0
481374|NCT00109733|1567084|P2|Overall Study|Stopped taking study drug|1
481375|NCT00109733|1567085|P1|Overall Study|Stopped taking study drug|1
481376|NCT00109733|1567084|P2|Overall Study|Protocol Violation|1
481377|NCT00109733|1567085|P1|Overall Study|Protocol Violation|0
481378|NCT00109590|1567102|P3|Overall Study|Never Started Treatment|3
481379|NCT00109590|1567103|P2|Overall Study|Never Started Treatment|2
481380|NCT00109590|1567104|P1|Overall Study|Never Started Treatment|1
481381|NCT00109590|1567102|P3|Overall Study|Lost to Follow-up|1
481382|NCT00109590|1567103|P2|Overall Study|Lost to Follow-up|0
481383|NCT00109590|1567104|P1|Overall Study|Lost to Follow-up|1
481384|NCT00109577|1567146|P2|Overall Study|Withdrawal by Subject|3
481385|NCT00109577|1567147|P1|Overall Study|Withdrawal by Subject|3
481386|NCT00109343|1567178|P3|Overall Study|Other|1
481387|NCT00109343|1567179|P2|Overall Study|Other|2
481388|NCT00109343|1567180|P1|Overall Study|Other|5
481389|NCT00109343|1567178|P3|Overall Study|Subject Moved|1
481390|NCT00109343|1567179|P2|Overall Study|Subject Moved|2
481391|NCT00109343|1567180|P1|Overall Study|Subject Moved|6
481392|NCT00109343|1567178|P3|Overall Study|Withdrawal by Subject|10
481393|NCT00109343|1567179|P2|Overall Study|Withdrawal by Subject|11
481394|NCT00109343|1567180|P1|Overall Study|Withdrawal by Subject|15
481395|NCT00109343|1567178|P3|Overall Study|Protocol Violation|2
481396|NCT00109343|1567179|P2|Overall Study|Protocol Violation|2
481397|NCT00109343|1567180|P1|Overall Study|Protocol Violation|1
481398|NCT00109343|1567178|P3|Overall Study|Lost to Follow-up|14
481399|NCT00109343|1567179|P2|Overall Study|Lost to Follow-up|20
481400|NCT00109343|1567180|P1|Overall Study|Lost to Follow-up|35
481401|NCT00109343|1567178|P3|Overall Study|Lack of Efficacy|0
481402|NCT00109343|1567179|P2|Overall Study|Lack of Efficacy|0
481403|NCT00109343|1567180|P1|Overall Study|Lack of Efficacy|1
481404|NCT00109343|1567178|P3|Overall Study|Adverse Event|2
481405|NCT00109343|1567179|P2|Overall Study|Adverse Event|0
481406|NCT00109343|1567180|P1|Overall Study|Adverse Event|1
481407|NCT00109031|1567225|P4|Overall Study|Protocol Violation|0
481408|NCT00109031|1567226|P3|Overall Study|Protocol Violation|1
481409|NCT00109031|1567227|P2|Overall Study|Protocol Violation|0
481410|NCT00109031|1567228|P1|Overall Study|Protocol Violation|0
481411|NCT00109031|1567225|P4|Overall Study|Physician Decision|0
481412|NCT00109031|1567226|P3|Overall Study|Physician Decision|0
481413|NCT00109031|1567227|P2|Overall Study|Physician Decision|1
481414|NCT00109031|1567228|P1|Overall Study|Physician Decision|0
481415|NCT00109031|1567225|P4|Overall Study|Withdrawal by Subject|0
481416|NCT00109031|1567226|P3|Overall Study|Withdrawal by Subject|0
481417|NCT00109031|1567227|P2|Overall Study|Withdrawal by Subject|1
481418|NCT00109031|1567228|P1|Overall Study|Withdrawal by Subject|0
481419|NCT00109031|1567225|P4|Overall Study|Adverse Event|0
481420|NCT00109031|1567226|P3|Overall Study|Adverse Event|1
481421|NCT00109031|1567227|P2|Overall Study|Adverse Event|0
481422|NCT00109031|1567228|P1|Overall Study|Adverse Event|0
481423|NCT00108953|1567279|P2|Follow-up|Study terminated by sponsor|6
481424|NCT00108953|1567280|P1|Follow-up|Study terminated by sponsor|10
481425|NCT00108953|1567279|P2|Follow-up|Lost to Follow-up|1
481426|NCT00108953|1567280|P1|Follow-up|Lost to Follow-up|1
481427|NCT00108953|1567279|P2|Follow-up|Death|26
481428|NCT00108953|1567280|P1|Follow-up|Death|18
481429|NCT00108862|1567302|P2|Overall Study|Lost to Follow-up|19
481430|NCT00108862|1567303|P1|Overall Study|Lost to Follow-up|27
481431|NCT00108862|1567302|P2|Overall Study|Withdrawal by Subject|6
481432|NCT00108862|1567303|P1|Overall Study|Withdrawal by Subject|10
481433|NCT00108862|1567302|P2|Overall Study|Death|37
481434|NCT00108862|1567303|P1|Overall Study|Death|31
481435|NCT00108732|1567331|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
481436|NCT00108732|1567331|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
481437|NCT00108732|1567331|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
481438|NCT00108732|1567331|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
481439|NCT00108732|1567331|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
481440|NCT00108732|1567331|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
481441|NCT00108732|1567331|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
481442|NCT00108628|1567340|P2|Overall Study|Death|0
481443|NCT00108628|1567341|P1|Overall Study|Death|1
481444|NCT00108628|1567340|P2|Overall Study|Lack of Efficacy|1
481445|NCT00108628|1567341|P1|Overall Study|Lack of Efficacy|2
481446|NCT00108628|1567340|P2|Overall Study|Withdrawal by Subject|9
481447|NCT00108628|1567341|P1|Overall Study|Withdrawal by Subject|17
481448|NCT00108485|1567391|P2|Overall Study|Lost to Follow-up|2
481449|NCT00108485|1567392|P1|Overall Study|Lost to Follow-up|0
481450|NCT00108485|1567391|P2|Overall Study|Withdrawal by Subject|0
481451|NCT00108485|1567392|P1|Overall Study|Withdrawal by Subject|3
481452|NCT00108433|1567400|P2|Overall Study|Other|14
481453|NCT00108433|1567401|P1|Overall Study|Other|14
481454|NCT00108433|1567400|P2|Overall Study|Adverse Event|1
481455|NCT00108433|1567401|P1|Overall Study|Adverse Event|3
481456|NCT00108433|1567400|P2|Overall Study|Death|0
481457|NCT00108433|1567401|P1|Overall Study|Death|3
481458|NCT00108433|1567400|P2|Overall Study|Lack of Efficacy|2
481459|NCT00108433|1567401|P1|Overall Study|Lack of Efficacy|1
481460|NCT00108355|1567417|P2|Overall Study|Loculated ascites, limiting paracentesis|1
481461|NCT00108355|1567418|P1|Overall Study|Loculated ascites, limiting paracentesis|1
481462|NCT00108355|1567417|P2|Overall Study|Peritonitis at index paracentesis|1
481463|NCT00108355|1567418|P1|Overall Study|Peritonitis at index paracentesis|1
481464|NCT00108160|1567467|P2|Overall Study|Protocol Violation|5
481465|NCT00108160|1567468|P1|Overall Study|Protocol Violation|9
481466|NCT00108160|1567467|P2|Overall Study|Withdrawal by Subject|2
481467|NCT00108160|1567468|P1|Overall Study|Withdrawal by Subject|4
481468|NCT00108160|1567467|P2|Overall Study|Death|2
481469|NCT00108160|1567468|P1|Overall Study|Death|1
481470|NCT00108160|1567467|P2|Overall Study|Lost to Follow-up|12
481471|NCT00108160|1567468|P1|Overall Study|Lost to Follow-up|25
481472|NCT00108082|1567481|P3|Overall Study|Blood Pressure Not Controlled|0
481473|NCT00108082|1567482|P2|Overall Study|Blood Pressure Not Controlled|0
481474|NCT00108082|1567483|P1|Overall Study|Blood Pressure Not Controlled|1
481475|NCT00108082|1567481|P3|Overall Study|Investigator Not at Site|0
481476|NCT00108082|1567482|P2|Overall Study|Investigator Not at Site|0
481477|NCT00108082|1567483|P1|Overall Study|Investigator Not at Site|1
481478|NCT00108082|1567481|P3|Overall Study|Subject Left Site Location|0
481479|NCT00108082|1567482|P2|Overall Study|Subject Left Site Location|0
481480|NCT00108082|1567483|P1|Overall Study|Subject Left Site Location|1
481481|NCT00108082|1567481|P3|Overall Study|Study Medication Not Tapered|0
481482|NCT00108082|1567482|P2|Overall Study|Study Medication Not Tapered|1
481483|NCT00108082|1567483|P1|Overall Study|Study Medication Not Tapered|0
481484|NCT00108082|1567481|P3|Overall Study|Protocol Amendment|0
481485|NCT00108082|1567482|P2|Overall Study|Protocol Amendment|1
481486|NCT00108082|1567483|P1|Overall Study|Protocol Amendment|0
481487|NCT00108082|1567481|P3|Overall Study|Site Closed Study|0
481488|NCT00108082|1567482|P2|Overall Study|Site Closed Study|2
481489|NCT00108082|1567483|P1|Overall Study|Site Closed Study|0
481490|NCT00108082|1567481|P3|Overall Study|Stopped Study Medication|1
481491|NCT00108082|1567482|P2|Overall Study|Stopped Study Medication|0
481492|NCT00108082|1567483|P1|Overall Study|Stopped Study Medication|0
481493|NCT00108082|1567481|P3|Overall Study|Non-compliance|2
481494|NCT00108082|1567482|P2|Overall Study|Non-compliance|0
481495|NCT00108082|1567483|P1|Overall Study|Non-compliance|1
481496|NCT00108082|1567481|P3|Overall Study|Incorrectly Randomized|2
481497|NCT00108082|1567482|P2|Overall Study|Incorrectly Randomized|0
481498|NCT00108082|1567483|P1|Overall Study|Incorrectly Randomized|0
481499|NCT00108082|1567481|P3|Overall Study|Woman of Child-bearing Potential|2
481500|NCT00108082|1567482|P2|Overall Study|Woman of Child-bearing Potential|0
481501|NCT00108082|1567483|P1|Overall Study|Woman of Child-bearing Potential|2
481502|NCT00108082|1567481|P3|Overall Study|Amendment 4: > Month 12|5
481503|NCT00108082|1567482|P2|Overall Study|Amendment 4: > Month 12|7
481504|NCT00108082|1567483|P1|Overall Study|Amendment 4: > Month 12|5
481505|NCT00108082|1567481|P3|Overall Study|Lack of Efficacy|2
481506|NCT00108082|1567482|P2|Overall Study|Lack of Efficacy|1
481507|NCT00108082|1567483|P1|Overall Study|Lack of Efficacy|3
481508|NCT00108082|1567481|P3|Overall Study|Protocol Violation|0
481509|NCT00108082|1567482|P2|Overall Study|Protocol Violation|2
481510|NCT00108082|1567483|P1|Overall Study|Protocol Violation|1
481511|NCT00108082|1567481|P3|Overall Study|Consent Withdrawn|5
481512|NCT00108082|1567482|P2|Overall Study|Consent Withdrawn|3
481513|NCT00108082|1567483|P1|Overall Study|Consent Withdrawn|3
481514|NCT00108082|1567481|P3|Overall Study|Lost to Follow-up|7
481515|NCT00108082|1567482|P2|Overall Study|Lost to Follow-up|3
481516|NCT00108082|1567483|P1|Overall Study|Lost to Follow-up|6
481517|NCT00108082|1567481|P3|Overall Study|Adverse Event|17
481518|NCT00108082|1567482|P2|Overall Study|Adverse Event|12
481519|NCT00108082|1567483|P1|Overall Study|Adverse Event|14
481520|NCT00108069|1567532|P2|Overall Study|Progessive disease|11
481521|NCT00108069|1567533|P1|Overall Study|Progessive disease|27
481522|NCT00108069|1567532|P2|Overall Study|Death|0
481523|NCT00108069|1567533|P1|Overall Study|Death|1
481524|NCT00108069|1567532|P2|Overall Study|Withdrawal by Subject|0
481525|NCT00108069|1567533|P1|Overall Study|Withdrawal by Subject|1
481526|NCT00108069|1567532|P2|Overall Study|Adverse Event|1
481527|NCT00108069|1567533|P1|Overall Study|Adverse Event|1
481528|NCT00108069|1567532|P2|Overall Study|Never rec'd study drug|1
481529|NCT00108069|1567533|P1|Overall Study|Never rec'd study drug|0
481530|NCT00107991|1567547|P1|18-Week Post Treatment Assessment|Adverse Event|2
481531|NCT00107991|1567547|P1|12 Week Treatment Period|Incarcerated|1
481532|NCT00107991|1567547|P1|12 Week Treatment Period|Protocol Violation|1
481533|NCT00107991|1567547|P1|12 Week Treatment Period|Adverse Event|1
481534|NCT00107991|1567547|P1|12 Week Treatment Period|Lack of Efficacy|2
481535|NCT00107991|1567547|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
481536|NCT00107991|1567547|P1|Eligibility Assessment|chronic uncontrolled asthma|1
481537|NCT00107991|1567547|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
481538|NCT00107991|1567547|P1|Eligibility Assessment|Abnormal labs|2
481539|NCT00107991|1567547|P1|Eligibility Assessment|Positive purified protein derivative|4
481540|NCT00107991|1567547|P1|Eligibility Assessment|Unwilling to participate|7
481541|NCT00107991|1567547|P1|Eligibility Assessment|Disease not severe enough|7
481542|NCT00107978|1567557|P2|Overall Study|Other|4
481543|NCT00107978|1567558|P1|Overall Study|Other|5
481544|NCT00107978|1567557|P2|Overall Study|Protocol Violation|1
481545|NCT00107978|1567558|P1|Overall Study|Protocol Violation|0
481546|NCT00107978|1567557|P2|Overall Study|Withdrawal by Subject|9
481547|NCT00107978|1567558|P1|Overall Study|Withdrawal by Subject|4
481548|NCT00107978|1567557|P2|Overall Study|Lost to Follow-up|28
481549|NCT00107978|1567558|P1|Overall Study|Lost to Follow-up|20
481550|NCT00107978|1567557|P2|Overall Study|Death|3
481551|NCT00107978|1567558|P1|Overall Study|Death|3
481552|NCT00107978|1567557|P2|Overall Study|Adverse Event|5
481553|NCT00107978|1567558|P1|Overall Study|Adverse Event|1
481554|NCT00107952|1567566|P2|Overall Study|Never received study treatment|6
481555|NCT00107952|1567567|P1|Overall Study|Never received study treatment|9
481556|NCT00107952|1567566|P2|Overall Study|Other|5
481557|NCT00107952|1567567|P1|Overall Study|Other|2
481558|NCT00107952|1567566|P2|Overall Study|Withdrawal by Subject|6
481559|NCT00107952|1567567|P1|Overall Study|Withdrawal by Subject|9
481560|NCT00107952|1567566|P2|Overall Study|Lost to Follow-up|3
481561|NCT00107952|1567567|P1|Overall Study|Lost to Follow-up|0
481562|NCT00107952|1567566|P2|Overall Study|Death|61
481563|NCT00107952|1567567|P1|Overall Study|Death|75
481564|NCT00107900|1567579|P6|Overall Study|Administrative Reasons|0
481565|NCT00107900|1567580|P5|Overall Study|Administrative Reasons|2
481566|NCT00107900|1567581|P4|Overall Study|Administrative Reasons|2
481567|NCT00107900|1567582|P3|Overall Study|Administrative Reasons|2
481568|NCT00107900|1567583|P2|Overall Study|Administrative Reasons|0
481569|NCT00107900|1567584|P1|Overall Study|Administrative Reasons|1
481570|NCT00107900|1567579|P6|Overall Study|Withdrawal by Subject|1
481571|NCT00107900|1567580|P5|Overall Study|Withdrawal by Subject|1
481572|NCT00107900|1567581|P4|Overall Study|Withdrawal by Subject|0
481573|NCT00107900|1567582|P3|Overall Study|Withdrawal by Subject|5
481574|NCT00107900|1567583|P2|Overall Study|Withdrawal by Subject|0
481575|NCT00107900|1567584|P1|Overall Study|Withdrawal by Subject|1
481576|NCT00107900|1567579|P6|Overall Study|Protocol Violation|0
481577|NCT00107900|1567580|P5|Overall Study|Protocol Violation|7
481578|NCT00107900|1567581|P4|Overall Study|Protocol Violation|5
481579|NCT00107900|1567582|P3|Overall Study|Protocol Violation|5
481580|NCT00107900|1567583|P2|Overall Study|Protocol Violation|0
481581|NCT00107900|1567584|P1|Overall Study|Protocol Violation|1
481582|NCT00107900|1567579|P6|Overall Study|Lost to Follow-up|5
481583|NCT00107900|1567580|P5|Overall Study|Lost to Follow-up|5
481584|NCT00107900|1567581|P4|Overall Study|Lost to Follow-up|2
481585|NCT00107900|1567582|P3|Overall Study|Lost to Follow-up|3
481586|NCT00107900|1567583|P2|Overall Study|Lost to Follow-up|1
481587|NCT00107900|1567584|P1|Overall Study|Lost to Follow-up|4
481588|NCT00107900|1567579|P6|Overall Study|Death|0
481589|NCT00107900|1567580|P5|Overall Study|Death|1
481590|NCT00107900|1567581|P4|Overall Study|Death|0
481591|NCT00107900|1567582|P3|Overall Study|Death|0
481592|NCT00107900|1567583|P2|Overall Study|Death|0
481593|NCT00107900|1567584|P1|Overall Study|Death|0
481594|NCT00107900|1567579|P6|Overall Study|Adverse Event|3
481595|NCT00107900|1567580|P5|Overall Study|Adverse Event|5
481596|NCT00107900|1567581|P4|Overall Study|Adverse Event|3
481597|NCT00107900|1567582|P3|Overall Study|Adverse Event|10
481598|NCT00107900|1567583|P2|Overall Study|Adverse Event|2
481599|NCT00107900|1567584|P1|Overall Study|Adverse Event|3
481600|NCT00107783|1567618|P2|Overall Study|Second hip replacement|1
481601|NCT00107783|1567619|P1|Overall Study|Second hip replacement|1
481602|NCT00107783|1567618|P2|Overall Study|Withdrawal by Subject|0
481603|NCT00107783|1567619|P1|Overall Study|Withdrawal by Subject|2
481604|NCT00107783|1567618|P2|Overall Study|Death|1
481605|NCT00107783|1567619|P1|Overall Study|Death|0
481606|NCT00107783|1567618|P2|Overall Study|Adverse Event|2
481607|NCT00107783|1567619|P1|Overall Study|Adverse Event|0
481608|NCT00107653|1567635|P2|Overall Study|Administrative Reasons|3
481609|NCT00107653|1567636|P1|Overall Study|Administrative Reasons|3
481610|NCT00107653|1567635|P2|Overall Study|Lost to Follow-up|5
481611|NCT00107653|1567636|P1|Overall Study|Lost to Follow-up|13
481612|NCT00107653|1567635|P2|Overall Study|Withdrawal by Subject|13
481613|NCT00107653|1567636|P1|Overall Study|Withdrawal by Subject|12
481614|NCT00107653|1567635|P2|Overall Study|Protocol Violation|0
481615|NCT00107653|1567636|P1|Overall Study|Protocol Violation|1
481616|NCT00107653|1567635|P2|Overall Study|Violation of Selection Criteria at Entry|1
481617|NCT00107653|1567636|P1|Overall Study|Violation of Selection Criteria at Entry|1
481618|NCT00107653|1567635|P2|Overall Study|Insufficient Therapeutic Response|11
481619|NCT00107653|1567636|P1|Overall Study|Insufficient Therapeutic Response|25
481620|NCT00107653|1567635|P2|Overall Study|Adverse Event|43
481621|NCT00107653|1567636|P1|Overall Study|Adverse Event|24
481622|NCT00107614|1567682|P1|Overall Study|Death|2
481623|NCT00107614|1567682|P1|Overall Study|Physician Decision|10
481624|NCT00107380|1567713|P1|Overall Study|Ineligible|2
481625|NCT00107380|1567713|P1|Overall Study|Other - not protocol specified|7
481626|NCT00107380|1567713|P1|Overall Study|Death|3
481627|NCT00107380|1567713|P1|Overall Study|Progression/relapse|4
481628|NCT00107380|1567713|P1|Overall Study|Refusal Unrelated to Adverse Event|7
481629|NCT00107380|1567713|P1|Overall Study|Adverse Event|7
481630|NCT00107315|1567719|P1|Overall Study|Withdrawal by Subject|2
481631|NCT00107315|1567719|P1|Overall Study|Adverse Event|4
481632|NCT00107315|1567719|P1|Overall Study|Disease Progression|9
481633|NCT00107276|1567726|P1|Overall Study|Ineligible|16
481634|NCT00107276|1567726|P1|Overall Study|Death|1
481635|NCT00107276|1567726|P1|Overall Study|Patient refusal|1
481636|NCT00107276|1567726|P1|Overall Study|M.D. decision|2
481637|NCT00107276|1567726|P1|Overall Study|Adverse Event|6
481638|NCT00107276|1567726|P1|Overall Study|Progression|46
481639|NCT00107198|1567732|P1|Overall Study|Ineligible|5
481640|NCT00107198|1567732|P1|Overall Study|Withdrawal by Subject|6
481641|NCT00107198|1567732|P1|Overall Study|Protocol Violation|1
481642|NCT00107198|1567732|P1|Overall Study|Lost to Follow-up|12
481643|NCT00107198|1567732|P1|Overall Study|Lack of Efficacy|28
481644|NCT00107172|1567742|P2|Overall Study|Other Reason|3
481645|NCT00107172|1567743|P1|Overall Study|Other Reason|4
481646|NCT00107172|1567742|P2|Overall Study|Death|2
481647|NCT00107172|1567743|P1|Overall Study|Death|0
481648|NCT00107172|1567742|P2|Overall Study|Withdrawal by Subject|0
481649|NCT00107172|1567743|P1|Overall Study|Withdrawal by Subject|1
481650|NCT00107120|1567773|P2|Overall Study|death of parent|1
481651|NCT00107120|1567774|P1|Overall Study|death of parent|0
481652|NCT00107120|1567773|P2|Overall Study|moving away from site|1
481653|NCT00107120|1567774|P1|Overall Study|moving away from site|1
481654|NCT00107120|1567773|P2|Overall Study|Pregnancy|1
481655|NCT00107120|1567774|P1|Overall Study|Pregnancy|0
481656|NCT00107120|1567773|P2|Overall Study|Lost to Follow-up|6
481657|NCT00107120|1567774|P1|Overall Study|Lost to Follow-up|8
481658|NCT00107120|1567773|P2|Overall Study|Withdrawal by Subject|9
481659|NCT00107120|1567774|P1|Overall Study|Withdrawal by Subject|8
481660|NCT00107120|1567773|P2|Overall Study|Protocol Violation|0
481661|NCT00107120|1567774|P1|Overall Study|Protocol Violation|3
481662|NCT00107120|1567773|P2|Overall Study|Lack of Efficacy|5
481663|NCT00107120|1567774|P1|Overall Study|Lack of Efficacy|5
481664|NCT00107120|1567773|P2|Overall Study|Adverse Event|1
481665|NCT00107120|1567774|P1|Overall Study|Adverse Event|4
481666|NCT00107042|1567786|P2|Overall Study|Disallowed medications|2
481667|NCT00107042|1567787|P1|Overall Study|Disallowed medications|0
481668|NCT00107042|1567786|P2|Overall Study|vaccinated outside window|1
481669|NCT00107042|1567787|P1|Overall Study|vaccinated outside window|1
481670|NCT00107042|1567786|P2|Overall Study|Inadvertent enrollment|1
481671|NCT00107042|1567787|P1|Overall Study|Inadvertent enrollment|0
481672|NCT00107042|1567786|P2|Overall Study|Pregnancy|1
481673|NCT00107042|1567787|P1|Overall Study|Pregnancy|1
481674|NCT00107042|1567786|P2|Overall Study|Moved out of area|3
481675|NCT00107042|1567787|P1|Overall Study|Moved out of area|5
481676|NCT00107042|1567786|P2|Overall Study|Withdrawal by Subject|1
481677|NCT00107042|1567787|P1|Overall Study|Withdrawal by Subject|6
481678|NCT00107042|1567786|P2|Overall Study|Lost to Follow-up|7
481679|NCT00107042|1567787|P1|Overall Study|Lost to Follow-up|9
481680|NCT00106964|1567853|P3|Overall Study|Required disallowed medication|0
481681|NCT00106964|1567854|P2|Overall Study|Required disallowed medication|1
481682|NCT00106964|1567855|P1|Overall Study|Required disallowed medication|0
481683|NCT00106964|1567853|P3|Overall Study|Did not meet eligibility criteria|2
481684|NCT00106964|1567854|P2|Overall Study|Did not meet eligibility criteria|2
481685|NCT00106964|1567855|P1|Overall Study|Did not meet eligibility criteria|0
481686|NCT00106964|1567853|P3|Overall Study|Failure to adhere|0
481687|NCT00106964|1567854|P2|Overall Study|Failure to adhere|0
481688|NCT00106964|1567855|P1|Overall Study|Failure to adhere|2
481689|NCT00106964|1567853|P3|Overall Study|Site Funding Terminated|1
481690|NCT00106964|1567854|P2|Overall Study|Site Funding Terminated|1
481691|NCT00106964|1567855|P1|Overall Study|Site Funding Terminated|0
481692|NCT00106964|1567853|P3|Overall Study|Incarceration|0
481693|NCT00106964|1567854|P2|Overall Study|Incarceration|1
481694|NCT00106964|1567855|P1|Overall Study|Incarceration|0
481695|NCT00106964|1567853|P3|Overall Study|Death|0
481696|NCT00106964|1567854|P2|Overall Study|Death|1
481697|NCT00106964|1567855|P1|Overall Study|Death|1
481698|NCT00106964|1567853|P3|Overall Study|Pregnancy|2
481699|NCT00106964|1567854|P2|Overall Study|Pregnancy|3
481700|NCT00106964|1567855|P1|Overall Study|Pregnancy|2
481701|NCT00106964|1567853|P3|Overall Study|Lost to Follow-up|2
481702|NCT00106964|1567854|P2|Overall Study|Lost to Follow-up|6
481703|NCT00106964|1567855|P1|Overall Study|Lost to Follow-up|8
481704|NCT00106704|1567950|P2|Overall Study|Laboratory test|1
481705|NCT00106704|1567951|P1|Overall Study|Laboratory test|1
481706|NCT00106704|1567950|P2|Overall Study|Unable to re-enter US|0
481707|NCT00106704|1567951|P1|Overall Study|Unable to re-enter US|1
481708|NCT00106704|1567950|P2|Overall Study|Patient Received Glycemic Medication|41
481709|NCT00106704|1567951|P1|Overall Study|Patient Received Glycemic Medication|22
481710|NCT00106704|1567950|P2|Overall Study|Planned major surgery|0
481711|NCT00106704|1567951|P1|Overall Study|Planned major surgery|1
481712|NCT00106704|1567950|P2|Overall Study|Site terminated|1
481713|NCT00106704|1567951|P1|Overall Study|Site terminated|0
481714|NCT00106704|1567950|P2|Overall Study|Patient moved|0
481715|NCT00106704|1567951|P1|Overall Study|Patient moved|1
481716|NCT00106704|1567950|P2|Overall Study|Withdrawal by Subject|21
481717|NCT00106704|1567951|P1|Overall Study|Withdrawal by Subject|14
481718|NCT00106704|1567950|P2|Overall Study|Protocol Violation|7
481719|NCT00106704|1567951|P1|Overall Study|Protocol Violation|4
481720|NCT00106704|1567950|P2|Overall Study|Pregnancy|0
481721|NCT00106704|1567951|P1|Overall Study|Pregnancy|1
481722|NCT00106704|1567950|P2|Overall Study|Lost to Follow-up|3
481723|NCT00106704|1567951|P1|Overall Study|Lost to Follow-up|7
481724|NCT00106704|1567950|P2|Overall Study|Lack of Efficacy|69
481725|NCT00106704|1567951|P1|Overall Study|Lack of Efficacy|67
481726|NCT00106704|1567950|P2|Overall Study|Death|1
481727|NCT00106704|1567951|P1|Overall Study|Death|2
481728|NCT00106704|1567950|P2|Overall Study|Adverse Event|7
481729|NCT00106704|1567951|P1|Overall Study|Adverse Event|10
481730|NCT00106639|1567962|P3|Overall Study|Participant defaulted|1
481731|NCT00106639|1567963|P2|Overall Study|Participant defaulted|1
481732|NCT00106639|1567964|P1|Overall Study|Participant defaulted|0
481733|NCT00106639|1567962|P3|Overall Study|Withdrawal by Subject|0
481734|NCT00106639|1567963|P2|Overall Study|Withdrawal by Subject|1
481735|NCT00106639|1567964|P1|Overall Study|Withdrawal by Subject|0
481736|NCT00106639|1567962|P3|Overall Study|Protocol Violation|0
481737|NCT00106639|1567963|P2|Overall Study|Protocol Violation|1
481738|NCT00106639|1567964|P1|Overall Study|Protocol Violation|0
481739|NCT00106639|1567962|P3|Overall Study|Adverse Event|1
481740|NCT00106639|1567963|P2|Overall Study|Adverse Event|4
481741|NCT00106639|1567964|P1|Overall Study|Adverse Event|3
481742|NCT00106626|1568091|P4|Overall Study|> 14 day delay in therapy start|0
481743|NCT00106626|1568092|P3|Overall Study|> 14 day delay in therapy start|0
481744|NCT00106626|1568093|P2|Overall Study|> 14 day delay in therapy start|1
481745|NCT00106626|1568094|P1|Overall Study|> 14 day delay in therapy start|0
481746|NCT00106626|1568091|P4|Overall Study|Received radiation on new therapy|0
481747|NCT00106626|1568092|P3|Overall Study|Received radiation on new therapy|0
481748|NCT00106626|1568093|P2|Overall Study|Received radiation on new therapy|0
481749|NCT00106626|1568094|P1|Overall Study|Received radiation on new therapy|1
481750|NCT00106626|1568091|P4|Overall Study|Progressive Disease|10
481751|NCT00106626|1568092|P3|Overall Study|Progressive Disease|9
481752|NCT00106626|1568093|P2|Overall Study|Progressive Disease|1
481753|NCT00106626|1568094|P1|Overall Study|Progressive Disease|4
481754|NCT00106626|1568091|P4|Overall Study|Adverse Event|3
481755|NCT00106626|1568092|P3|Overall Study|Adverse Event|3
481756|NCT00106626|1568093|P2|Overall Study|Adverse Event|4
481757|NCT00106626|1568094|P1|Overall Study|Adverse Event|5
481758|NCT00106353|1568439|P7|Part 2|Physician Decision|0
481759|NCT00106353|1568440|P6|Part 2|Physician Decision|1
481760|NCT00106353|1568441|P5|Part 2|Physician Decision|0
481761|NCT00106353|1568442|P4|Part 2|Physician Decision|0
481762|NCT00106353|1568443|P3|Part 2|Physician Decision|0
481763|NCT00106353|1568444|P2|Part 2|Physician Decision|0
481764|NCT00106353|1568445|P1|Part 2|Physician Decision|0
481765|NCT00106353|1568439|P7|Part 2|Withdrawal by Subject|0
481766|NCT00106353|1568440|P6|Part 2|Withdrawal by Subject|0
481767|NCT00106353|1568441|P5|Part 2|Withdrawal by Subject|1
481768|NCT00106353|1568442|P4|Part 2|Withdrawal by Subject|0
481769|NCT00106353|1568443|P3|Part 2|Withdrawal by Subject|0
481770|NCT00106353|1568444|P2|Part 2|Withdrawal by Subject|0
481771|NCT00106353|1568445|P1|Part 2|Withdrawal by Subject|0
481772|NCT00106353|1568439|P7|Part 2|Other|1
481773|NCT00106353|1568440|P6|Part 2|Other|1
481774|NCT00106353|1568441|P5|Part 2|Other|1
481775|NCT00106353|1568442|P4|Part 2|Other|0
481776|NCT00106353|1568443|P3|Part 2|Other|0
481777|NCT00106353|1568444|P2|Part 2|Other|0
481778|NCT00106353|1568445|P1|Part 2|Other|0
481779|NCT00106353|1568439|P7|Part 2|Adverse Event|1
481780|NCT00106353|1568440|P6|Part 2|Adverse Event|2
481781|NCT00106353|1568441|P5|Part 2|Adverse Event|0
481782|NCT00106353|1568442|P4|Part 2|Adverse Event|0
481783|NCT00106353|1568443|P3|Part 2|Adverse Event|0
481784|NCT00106353|1568444|P2|Part 2|Adverse Event|0
481785|NCT00106353|1568445|P1|Part 2|Adverse Event|0
481786|NCT00106353|1568439|P7|Part 2|Symptomatic deterioration|0
481787|NCT00106353|1568440|P6|Part 2|Symptomatic deterioration|0
481788|NCT00106353|1568441|P5|Part 2|Symptomatic deterioration|3
481789|NCT00106353|1568442|P4|Part 2|Symptomatic deterioration|0
481790|NCT00106353|1568443|P3|Part 2|Symptomatic deterioration|0
481791|NCT00106353|1568444|P2|Part 2|Symptomatic deterioration|0
481792|NCT00106353|1568445|P1|Part 2|Symptomatic deterioration|0
481793|NCT00106353|1568439|P7|Part 2|Death|1
481794|NCT00106353|1568440|P6|Part 2|Death|0
481795|NCT00106353|1568441|P5|Part 2|Death|3
481796|NCT00106353|1568442|P4|Part 2|Death|0
481797|NCT00106353|1568443|P3|Part 2|Death|0
481798|NCT00106353|1568444|P2|Part 2|Death|0
481799|NCT00106353|1568445|P1|Part 2|Death|0
481800|NCT00106353|1568439|P7|Part 2|Disease progression|13
481801|NCT00106353|1568440|P6|Part 2|Disease progression|14
481802|NCT00106353|1568441|P5|Part 2|Disease progression|8
481803|NCT00106353|1568442|P4|Part 2|Disease progression|0
481804|NCT00106353|1568443|P3|Part 2|Disease progression|0
481805|NCT00106353|1568444|P2|Part 2|Disease progression|0
481806|NCT00106353|1568445|P1|Part 2|Disease progression|0
481807|NCT00106353|1568439|P7|Part 1|Adverse Event|0
481808|NCT00106353|1568440|P6|Part 1|Adverse Event|0
481809|NCT00106353|1568441|P5|Part 1|Adverse Event|0
481810|NCT00106353|1568442|P4|Part 1|Adverse Event|1
481811|NCT00106353|1568443|P3|Part 1|Adverse Event|0
481812|NCT00106353|1568444|P2|Part 1|Adverse Event|0
481813|NCT00106353|1568445|P1|Part 1|Adverse Event|0
481814|NCT00106353|1568439|P7|Part 1|Entered follow-up phase|0
481815|NCT00106353|1568440|P6|Part 1|Entered follow-up phase|0
481816|NCT00106353|1568441|P5|Part 1|Entered follow-up phase|0
481817|NCT00106353|1568442|P4|Part 1|Entered follow-up phase|1
481818|NCT00106353|1568443|P3|Part 1|Entered follow-up phase|0
481819|NCT00106353|1568444|P2|Part 1|Entered follow-up phase|1
481820|NCT00106353|1568445|P1|Part 1|Entered follow-up phase|1
481821|NCT00106353|1568439|P7|Part 1|Symptomatic deterioration|0
481822|NCT00106353|1568440|P6|Part 1|Symptomatic deterioration|0
481823|NCT00106353|1568441|P5|Part 1|Symptomatic deterioration|0
481824|NCT00106353|1568442|P4|Part 1|Symptomatic deterioration|0
481825|NCT00106353|1568443|P3|Part 1|Symptomatic deterioration|1
481826|NCT00106353|1568444|P2|Part 1|Symptomatic deterioration|0
481827|NCT00106353|1568445|P1|Part 1|Symptomatic deterioration|0
481828|NCT00106353|1568439|P7|Part 1|Withdrawal by Subject|0
481829|NCT00106353|1568440|P6|Part 1|Withdrawal by Subject|0
481830|NCT00106353|1568441|P5|Part 1|Withdrawal by Subject|0
481831|NCT00106353|1568442|P4|Part 1|Withdrawal by Subject|2
481832|NCT00106353|1568443|P3|Part 1|Withdrawal by Subject|1
481833|NCT00106353|1568444|P2|Part 1|Withdrawal by Subject|0
481834|NCT00106353|1568445|P1|Part 1|Withdrawal by Subject|0
481835|NCT00106353|1568439|P7|Part 1|Disease progression|0
481836|NCT00106353|1568440|P6|Part 1|Disease progression|0
481837|NCT00106353|1568441|P5|Part 1|Disease progression|0
481838|NCT00106353|1568442|P4|Part 1|Disease progression|3
481839|NCT00106353|1568443|P3|Part 1|Disease progression|1
481840|NCT00106353|1568444|P2|Part 1|Disease progression|4
481841|NCT00106353|1568445|P1|Part 1|Disease progression|3
481842|NCT00106249|1568572|P2|Overall Study|Lost to Follow-up|2
481843|NCT00106249|1568573|P1|Overall Study|Lost to Follow-up|3
481844|NCT00106184|1568585|P2|Overall Study|Withdrawal by Subject|2
481845|NCT00106184|1568586|P1|Overall Study|Withdrawal by Subject|3
481846|NCT00106080|1568628|P2|Overall Study|Withdrew/Loss to follow-up|27
481847|NCT00106080|1568629|P1|Overall Study|Withdrew/Loss to follow-up|43
481848|NCT00106028|1568639|P2|Overall Study|Lost to Follow-up|1
481849|NCT00106028|1568640|P1|Overall Study|Lost to Follow-up|0
481850|NCT00106028|1568639|P2|Overall Study|Withdrawal by Subject|8
481851|NCT00106028|1568640|P1|Overall Study|Withdrawal by Subject|2
481852|NCT00106028|1568639|P2|Overall Study|Protocol Violation|1
481853|NCT00106028|1568640|P1|Overall Study|Protocol Violation|1
481854|NCT00106028|1568639|P2|Overall Study|Adverse Event|2
481855|NCT00106028|1568640|P1|Overall Study|Adverse Event|3
481856|NCT00106002|1568734|P1|Overall Study|Ineligible after Registration|1
481857|NCT00106002|1568734|P1|Overall Study|Did not take any study drug|1
481858|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
481859|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
481860|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
481861|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
481862|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Death|0
481863|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Death|0
481864|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
481865|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
481866|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
481867|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
481868|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
481869|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
481870|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
481871|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
481872|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
481873|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
481874|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
481875|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
481876|NCT00105989|1568742|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
481877|NCT00105989|1568743|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
481878|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
481879|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
481880|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
481881|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
481882|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Death|0
481883|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Death|0
481884|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
481885|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
481886|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
481887|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
481888|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
481889|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
481890|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
481891|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
481892|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
481893|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
481894|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
481895|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
481896|NCT00105989|1568742|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
481897|NCT00105989|1568743|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
481898|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
481899|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
481900|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
481901|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
481902|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Death|0
481903|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Death|1
481904|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Physician Decision|0
481905|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Physician Decision|0
481906|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
481907|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
481908|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
481909|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
481910|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
481911|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
481912|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
481913|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
481914|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
481915|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
481916|NCT00105989|1568742|P2|Acute - Open Label: Week 0-10|Adverse Event|0
481917|NCT00105989|1568743|P1|Acute - Open Label: Week 0-10|Adverse Event|33
481918|NCT00105586|1568859|P2|Overall Study|Physician Decision|13
481919|NCT00105586|1568860|P1|Overall Study|Physician Decision|13
481920|NCT00105586|1568859|P2|Overall Study|Adverse Event|3
481921|NCT00105586|1568860|P1|Overall Study|Adverse Event|4
481922|NCT00105560|1568868|P1|Overall Study|Lost to Follow-up|1
481923|NCT00105534|1568890|P2|Overall Study|Other Reason|2
481924|NCT00105534|1568891|P1|Overall Study|Other Reason|0
481925|NCT00105534|1568890|P2|Overall Study|Treatment unmasked|0
481926|NCT00105534|1568891|P1|Overall Study|Treatment unmasked|1
481927|NCT00105534|1568890|P2|Overall Study|Lack of Efficacy|15
481928|NCT00105534|1568891|P1|Overall Study|Lack of Efficacy|7
481929|NCT00105534|1568890|P2|Overall Study|Lost to Follow-up|1
481930|NCT00105534|1568891|P1|Overall Study|Lost to Follow-up|5
481931|NCT00105534|1568890|P2|Overall Study|Withdrawal by Subject|6
481932|NCT00105534|1568891|P1|Overall Study|Withdrawal by Subject|6
481933|NCT00105534|1568890|P2|Overall Study|Protocol Violation|4
481934|NCT00105534|1568891|P1|Overall Study|Protocol Violation|1
481935|NCT00105534|1568890|P2|Overall Study|Adverse Event|5
481936|NCT00105534|1568891|P1|Overall Study|Adverse Event|2
481937|NCT00105521|1568903|P4|Overall Study|Lost to Follow-up|0
481938|NCT00105521|1568904|P3|Overall Study|Lost to Follow-up|0
481939|NCT00105521|1568905|P2|Overall Study|Lost to Follow-up|1
481940|NCT00105521|1568906|P1|Overall Study|Lost to Follow-up|0
481941|NCT00105521|1568903|P4|Overall Study|Protocol Violation|4
481942|NCT00105521|1568904|P3|Overall Study|Protocol Violation|4
481943|NCT00105521|1568905|P2|Overall Study|Protocol Violation|5
481944|NCT00105521|1568906|P1|Overall Study|Protocol Violation|3
481945|NCT00105521|1568903|P4|Overall Study|Lack of Efficacy|1
481946|NCT00105521|1568904|P3|Overall Study|Lack of Efficacy|0
481947|NCT00105521|1568905|P2|Overall Study|Lack of Efficacy|0
481948|NCT00105521|1568906|P1|Overall Study|Lack of Efficacy|0
481949|NCT00105521|1568903|P4|Overall Study|Withdrawal by Subject|4
481950|NCT00105521|1568904|P3|Overall Study|Withdrawal by Subject|1
481951|NCT00105521|1568905|P2|Overall Study|Withdrawal by Subject|0
481952|NCT00105521|1568906|P1|Overall Study|Withdrawal by Subject|1
481953|NCT00105521|1568903|P4|Overall Study|Adverse Event|8
481954|NCT00105521|1568904|P3|Overall Study|Adverse Event|10
481955|NCT00105521|1568905|P2|Overall Study|Adverse Event|4
481956|NCT00105521|1568906|P1|Overall Study|Adverse Event|10
481957|NCT00105521|1568903|P4|Overall Study|Other|0
481958|NCT00105521|1568904|P3|Overall Study|Other|2
481959|NCT00105521|1568905|P2|Overall Study|Other|1
481960|NCT00105521|1568906|P1|Overall Study|Other|1
481961|NCT00105482|1568930|P2|Overall Study|Withdrawn by PI|1
481962|NCT00105482|1568931|P1|Overall Study|Withdrawn by PI|1
481963|NCT00105482|1568930|P2|Overall Study|Scheduling Conflict|3
481964|NCT00105482|1568931|P1|Overall Study|Scheduling Conflict|2
481965|NCT00105482|1568930|P2|Overall Study|Lost Interest|32
481966|NCT00105482|1568931|P1|Overall Study|Lost Interest|29
481967|NCT00105482|1568930|P2|Overall Study|Withdrawal by Subject|1
481968|NCT00105482|1568931|P1|Overall Study|Withdrawal by Subject|0
481969|NCT00105482|1568930|P2|Overall Study|Lost to Follow-up|17
481970|NCT00105482|1568931|P1|Overall Study|Lost to Follow-up|26
481971|NCT00105482|1568930|P2|Overall Study|Adverse Event|1
481972|NCT00105482|1568931|P1|Overall Study|Adverse Event|1
481973|NCT00105469|1568947|P2|Overall Study|Other Reason|0
481974|NCT00105469|1568948|P1|Overall Study|Other Reason|4
481975|NCT00105469|1568947|P2|Overall Study|Lack of Efficacy|0
481976|NCT00105469|1568948|P1|Overall Study|Lack of Efficacy|2
481977|NCT00105469|1568947|P2|Overall Study|Lost to Follow-up|0
481978|NCT00105469|1568948|P1|Overall Study|Lost to Follow-up|1
481979|NCT00105469|1568947|P2|Overall Study|Withdrawal by Subject|3
481980|NCT00105469|1568948|P1|Overall Study|Withdrawal by Subject|2
481981|NCT00105469|1568947|P2|Overall Study|Protocol Violation|0
481982|NCT00105469|1568948|P1|Overall Study|Protocol Violation|4
481983|NCT00105469|1568947|P2|Overall Study|Adverse Event|8
481984|NCT00105469|1568948|P1|Overall Study|Adverse Event|9
481985|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
481986|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
481987|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
481988|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
481989|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
481990|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
481991|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
481992|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
481993|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
481994|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
481995|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
481996|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
481997|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
481998|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
481999|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
482000|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
482001|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
482002|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
482003|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
482004|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
482005|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
482006|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
482007|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
482008|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
482009|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
482010|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
482011|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
482012|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
482013|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
482014|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
482015|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
482016|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
482017|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
482018|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
482019|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
482020|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
482021|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
482022|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
482023|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
482024|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
482025|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
482026|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
482027|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
482028|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
482029|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
482030|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
482031|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
482032|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
482033|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
482034|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
482035|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
482036|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
482037|NCT00105443|1568958|P4|Follow-up and/or Open Label Nexavar|Death|4
482038|NCT00105443|1568959|P3|Follow-up and/or Open Label Nexavar|Death|219
482039|NCT00105443|1568960|P2|Follow-up and/or Open Label Nexavar|Death|7
482040|NCT00105443|1568961|P1|Follow-up and/or Open Label Nexavar|Death|180
482041|NCT00105443|1568958|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
482042|NCT00105443|1568959|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
482043|NCT00105443|1568960|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
482044|NCT00105443|1568961|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
482045|NCT00105443|1568958|P4|Double-Blind Treatment|Physician Decision|0
482046|NCT00105443|1568959|P3|Double-Blind Treatment|Physician Decision|2
482047|NCT00105443|1568960|P2|Double-Blind Treatment|Physician Decision|0
482048|NCT00105443|1568961|P1|Double-Blind Treatment|Physician Decision|1
482049|NCT00105443|1568958|P4|Double-Blind Treatment|Withdrawal by Subject|0
482050|NCT00105443|1568959|P3|Double-Blind Treatment|Withdrawal by Subject|7
482051|NCT00105443|1568960|P2|Double-Blind Treatment|Withdrawal by Subject|0
482052|NCT00105443|1568961|P1|Double-Blind Treatment|Withdrawal by Subject|8
482053|NCT00105443|1568958|P4|Double-Blind Treatment|Lost to Follow-up|0
482054|NCT00105443|1568959|P3|Double-Blind Treatment|Lost to Follow-up|1
482055|NCT00105443|1568960|P2|Double-Blind Treatment|Lost to Follow-up|0
482056|NCT00105443|1568961|P1|Double-Blind Treatment|Lost to Follow-up|0
482057|NCT00105443|1568958|P4|Double-Blind Treatment|Adverse Event|0
482058|NCT00105443|1568959|P3|Double-Blind Treatment|Adverse Event|0
482059|NCT00105443|1568960|P2|Double-Blind Treatment|Adverse Event|0
482060|NCT00105443|1568961|P1|Double-Blind Treatment|Adverse Event|1
482061|NCT00105235|1568988|P1|Overall Study|Withdrawal by Subject|2
482062|NCT00105235|1568988|P1|Overall Study|Physician Decision|1
482063|NCT00105235|1568988|P1|Overall Study|Death|4
482064|NCT00105196|1569001|P2|Overall Study|Subject became unblinded|1
482065|NCT00105196|1569002|P1|Overall Study|Subject became unblinded|0
482066|NCT00105196|1569001|P2|Overall Study|marijuana use|1
482067|NCT00105196|1569002|P1|Overall Study|marijuana use|0
482068|NCT00105196|1569001|P2|Overall Study|pending surgery|1
482069|NCT00105196|1569002|P1|Overall Study|pending surgery|0
482070|NCT00105196|1569001|P2|Overall Study|Protocol Violation|2
482071|NCT00105196|1569002|P1|Overall Study|Protocol Violation|5
482072|NCT00105196|1569001|P2|Overall Study|Poor/noncompliance|4
482073|NCT00105196|1569002|P1|Overall Study|Poor/noncompliance|3
482074|NCT00105196|1569001|P2|Overall Study|Lost to Follow-up|2
482075|NCT00105196|1569002|P1|Overall Study|Lost to Follow-up|3
482076|NCT00105196|1569001|P2|Overall Study|Withdrawal by Subject|6
482077|NCT00105196|1569002|P1|Overall Study|Withdrawal by Subject|6
482078|NCT00105196|1569001|P2|Overall Study|Adverse Event|3
482079|NCT00105196|1569002|P1|Overall Study|Adverse Event|11
482080|NCT00105196|1569001|P2|Overall Study|Lack of Efficacy|3
482081|NCT00105196|1569002|P1|Overall Study|Lack of Efficacy|2
482082|NCT00105183|1569025|P3|Overall Study|Other reason|0
482083|NCT00105183|1569026|P2|Overall Study|Other reason|2
482084|NCT00105183|1569027|P1|Overall Study|Other reason|1
482085|NCT00105183|1569025|P3|Overall Study|Lost to Follow-up|1
482086|NCT00105183|1569026|P2|Overall Study|Lost to Follow-up|1
482087|NCT00105183|1569027|P1|Overall Study|Lost to Follow-up|0
482088|NCT00105183|1569025|P3|Overall Study|Physician Decision|3
482089|NCT00105183|1569026|P2|Overall Study|Physician Decision|2
482090|NCT00105183|1569027|P1|Overall Study|Physician Decision|1
482091|NCT00105183|1569025|P3|Overall Study|Withdrawal by Subject|4
482092|NCT00105183|1569026|P2|Overall Study|Withdrawal by Subject|1
482093|NCT00105183|1569027|P1|Overall Study|Withdrawal by Subject|1
482094|NCT00105183|1569025|P3|Overall Study|Death|15
482095|NCT00105183|1569026|P2|Overall Study|Death|13
482096|NCT00105183|1569027|P1|Overall Study|Death|19
482097|NCT00105157|1569063|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
482098|NCT00105157|1569064|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
482099|NCT00105157|1569065|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
482100|NCT00105157|1569066|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
482101|NCT00105157|1569063|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
482102|NCT00105157|1569064|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
482103|NCT00105157|1569065|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
482104|NCT00105157|1569066|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
482105|NCT00105157|1569063|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
482106|NCT00105157|1569064|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
482107|NCT00105157|1569065|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
482108|NCT00105157|1569066|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
482109|NCT00105157|1569063|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
482110|NCT00105157|1569064|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
482111|NCT00105157|1569065|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
482112|NCT00105157|1569066|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
482113|NCT00105157|1569063|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
482114|NCT00105157|1569064|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
482115|NCT00105157|1569065|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
482116|NCT00105157|1569066|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
482117|NCT00105157|1569063|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
482118|NCT00105157|1569064|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
482119|NCT00105157|1569065|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
482120|NCT00105157|1569066|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
482121|NCT00105157|1569063|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
482122|NCT00105157|1569064|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
482123|NCT00105157|1569065|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
482124|NCT00105157|1569066|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
482125|NCT00105157|1569063|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
482126|NCT00105157|1569064|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
482127|NCT00105157|1569065|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
482128|NCT00105157|1569066|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
482129|NCT00105157|1569063|P4|Open-Label Continuation of DB|Lost to Follow-up|0
482130|NCT00105157|1569064|P3|Open-Label Continuation of DB|Lost to Follow-up|1
482131|NCT00105157|1569065|P2|Open-Label Continuation of DB|Lost to Follow-up|1
482132|NCT00105157|1569066|P1|Open-Label Continuation of DB|Lost to Follow-up|1
482133|NCT00105157|1569063|P4|Open-Label Continuation of DB|Lack of Efficacy|1
482134|NCT00105157|1569064|P3|Open-Label Continuation of DB|Lack of Efficacy|3
482135|NCT00105157|1569065|P2|Open-Label Continuation of DB|Lack of Efficacy|4
482136|NCT00105157|1569066|P1|Open-Label Continuation of DB|Lack of Efficacy|1
482137|NCT00105157|1569063|P4|Open-Label Continuation of DB|Adverse Event|0
482138|NCT00105157|1569064|P3|Open-Label Continuation of DB|Adverse Event|0
482139|NCT00105157|1569065|P2|Open-Label Continuation of DB|Adverse Event|1
482140|NCT00105157|1569066|P1|Open-Label Continuation of DB|Adverse Event|3
482141|NCT00105157|1569063|P4|Double-Blind (DB)|Lack of Efficacy|38
482142|NCT00105157|1569064|P3|Double-Blind (DB)|Lack of Efficacy|11
482143|NCT00105157|1569065|P2|Double-Blind (DB)|Lack of Efficacy|14
482144|NCT00105157|1569066|P1|Double-Blind (DB)|Lack of Efficacy|11
482145|NCT00105157|1569063|P4|Double-Blind (DB)|Adverse Event|1
482146|NCT00105157|1569064|P3|Double-Blind (DB)|Adverse Event|1
482147|NCT00105157|1569065|P2|Double-Blind (DB)|Adverse Event|0
482148|NCT00105157|1569066|P1|Double-Blind (DB)|Adverse Event|2
482149|NCT00105157|1569063|P4|Double-Blind (DB)|Never Treated|0
482150|NCT00105157|1569064|P3|Double-Blind (DB)|Never Treated|0
482151|NCT00105157|1569065|P2|Double-Blind (DB)|Never Treated|0
482152|NCT00105157|1569066|P1|Double-Blind (DB)|Never Treated|1
482153|NCT00105079|1569260|P2|Overall Study|not specified|1
482154|NCT00105079|1569261|P1|Overall Study|not specified|3
482155|NCT00105079|1569260|P2|Overall Study|Protocol Violation|0
482156|NCT00105079|1569261|P1|Overall Study|Protocol Violation|1
482157|NCT00105079|1569260|P2|Overall Study|Violation of selection criteria at entry|2
482158|NCT00105079|1569261|P1|Overall Study|Violation of selection criteria at entry|0
482159|NCT00105079|1569260|P2|Overall Study|Refused treatment|4
482160|NCT00105079|1569261|P1|Overall Study|Refused treatment|6
482161|NCT00105079|1569260|P2|Overall Study|Lack of Efficacy|3
482162|NCT00105079|1569261|P1|Overall Study|Lack of Efficacy|9
482163|NCT00105079|1569260|P2|Overall Study|Lost to Follow-up|12
482164|NCT00105079|1569261|P1|Overall Study|Lost to Follow-up|12
482165|NCT00105079|1569260|P2|Overall Study|Death|1
482166|NCT00105079|1569261|P1|Overall Study|Death|3
482167|NCT00105079|1569260|P2|Overall Study|Adverse Event|12
482168|NCT00105079|1569261|P1|Overall Study|Adverse Event|5
482169|NCT00105066|1569279|P2|Overall Study|Adverse Event|5
482170|NCT00105066|1569280|P1|Overall Study|Adverse Event|2
482171|NCT00104884|1569340|P1|Overall Study|Disease progression|4
482172|NCT00104871|1569344|P1|Overall Study|Not evaluable|1
482173|NCT00104728|1569349|P1|Overall Study|screen failures|19
482174|NCT00104650|1569357|P3|Follow-up Period|Other|0
482175|NCT00104650|1569358|P2|Follow-up Period|Other|1
482176|NCT00104650|1569359|P1|Follow-up Period|Other|0
482177|NCT00104650|1569357|P3|Follow-up Period|Lost to Follow-up|2
482178|NCT00104650|1569358|P2|Follow-up Period|Lost to Follow-up|1
482179|NCT00104650|1569359|P1|Follow-up Period|Lost to Follow-up|0
482180|NCT00104650|1569357|P3|Follow-up Period|Disease progression|0
482181|NCT00104650|1569358|P2|Follow-up Period|Disease progression|1
482182|NCT00104650|1569359|P1|Follow-up Period|Disease progression|3
482183|NCT00104650|1569357|P3|Follow-up Period|Death|4
482184|NCT00104650|1569358|P2|Follow-up Period|Death|6
482185|NCT00104650|1569359|P1|Follow-up Period|Death|6
482186|NCT00104650|1569357|P3|Follow-up Period|Withdrawal by Subject|3
482187|NCT00104650|1569358|P2|Follow-up Period|Withdrawal by Subject|3
482188|NCT00104650|1569359|P1|Follow-up Period|Withdrawal by Subject|0
482189|NCT00104650|1569357|P3|Follow-up Period|Adverse Event|1
482190|NCT00104650|1569358|P2|Follow-up Period|Adverse Event|0
482191|NCT00104650|1569359|P1|Follow-up Period|Adverse Event|1
482192|NCT00104650|1569357|P3|Follow-up Period|Physician Decision|0
482193|NCT00104650|1569358|P2|Follow-up Period|Physician Decision|1
482194|NCT00104650|1569359|P1|Follow-up Period|Physician Decision|1
482195|NCT00104650|1569357|P3|Treatment Period (25 Weeks)|Protocol deviation|0
482196|NCT00104650|1569358|P2|Treatment Period (25 Weeks)|Protocol deviation|1
482197|NCT00104650|1569359|P1|Treatment Period (25 Weeks)|Protocol deviation|0
482198|NCT00104650|1569357|P3|Treatment Period (25 Weeks)|Other|0
482199|NCT00104650|1569358|P2|Treatment Period (25 Weeks)|Other|0
482200|NCT00104650|1569359|P1|Treatment Period (25 Weeks)|Other|1
482201|NCT00104650|1569357|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
482202|NCT00104650|1569358|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
482203|NCT00104650|1569359|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
482204|NCT00104650|1569357|P3|Treatment Period (25 Weeks)|Disease progression|2
482205|NCT00104650|1569358|P2|Treatment Period (25 Weeks)|Disease progression|3
482206|NCT00104650|1569359|P1|Treatment Period (25 Weeks)|Disease progression|2
482207|NCT00104650|1569357|P3|Treatment Period (25 Weeks)|Death|6
482208|NCT00104650|1569358|P2|Treatment Period (25 Weeks)|Death|5
482209|NCT00104650|1569359|P1|Treatment Period (25 Weeks)|Death|7
482210|NCT00104650|1569357|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
482211|NCT00104650|1569358|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
482212|NCT00104650|1569359|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
482213|NCT00104650|1569357|P3|Treatment Period (25 Weeks)|Physician Decision|1
482214|NCT00104650|1569358|P2|Treatment Period (25 Weeks)|Physician Decision|0
482215|NCT00104650|1569359|P1|Treatment Period (25 Weeks)|Physician Decision|0
482216|NCT00104637|1569391|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
482217|NCT00104637|1569392|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
482218|NCT00104572|1569421|P3|Overall Study|Withdrawal by Subject|0
482219|NCT00104572|1569422|P2|Overall Study|Withdrawal by Subject|3
482220|NCT00104572|1569423|P1|Overall Study|Withdrawal by Subject|3
482221|NCT00104520|1569433|P2|Overall Study|Other|5
482222|NCT00104520|1569434|P1|Overall Study|Other|1
482223|NCT00104520|1569433|P2|Overall Study|Personal/administrative|1
482224|NCT00104520|1569434|P1|Overall Study|Personal/administrative|1
482225|NCT00104520|1569433|P2|Overall Study|Noncompliance|2
482226|NCT00104520|1569434|P1|Overall Study|Noncompliance|0
482227|NCT00104520|1569433|P2|Overall Study|Lost to Follow-up|0
482228|NCT00104520|1569434|P1|Overall Study|Lost to Follow-up|1
482229|NCT00104520|1569433|P2|Overall Study|Related adverse event|15
482230|NCT00104520|1569434|P1|Overall Study|Related adverse event|13
482231|NCT00104520|1569433|P2|Overall Study|Study drug intolerance|1
482232|NCT00104520|1569434|P1|Overall Study|Study drug intolerance|0
482233|NCT00104520|1569433|P2|Overall Study|Unrelated adverse event|47
482234|NCT00104520|1569434|P1|Overall Study|Unrelated adverse event|34
482235|NCT00104416|1569454|P5|Continuation Phase|Non-compliance|1
482236|NCT00104416|1569455|P4|Continuation Phase|Non-compliance|0
482237|NCT00104416|1569456|P3|Continuation Phase|Non-compliance|0
482238|NCT00104416|1569457|P2|Continuation Phase|Non-compliance|0
482239|NCT00104416|1569458|P1|Continuation Phase|Non-compliance|0
482240|NCT00104416|1569454|P5|Continuation Phase|Pregnancy|0
482241|NCT00104416|1569455|P4|Continuation Phase|Pregnancy|1
482242|NCT00104416|1569456|P3|Continuation Phase|Pregnancy|1
482243|NCT00104416|1569457|P2|Continuation Phase|Pregnancy|0
482244|NCT00104416|1569458|P1|Continuation Phase|Pregnancy|0
482245|NCT00104416|1569454|P5|Continuation Phase|Withdrawal by Subject|1
482246|NCT00104416|1569455|P4|Continuation Phase|Withdrawal by Subject|1
482247|NCT00104416|1569456|P3|Continuation Phase|Withdrawal by Subject|2
482248|NCT00104416|1569457|P2|Continuation Phase|Withdrawal by Subject|0
482249|NCT00104416|1569458|P1|Continuation Phase|Withdrawal by Subject|0
482250|NCT00104416|1569454|P5|Continuation Phase|Lost to Follow-up|1
482251|NCT00104416|1569455|P4|Continuation Phase|Lost to Follow-up|0
482252|NCT00104416|1569456|P3|Continuation Phase|Lost to Follow-up|1
482253|NCT00104416|1569457|P2|Continuation Phase|Lost to Follow-up|0
482254|NCT00104416|1569458|P1|Continuation Phase|Lost to Follow-up|0
482255|NCT00104416|1569454|P5|Continuation Phase|Adverse Event|2
482256|NCT00104416|1569455|P4|Continuation Phase|Adverse Event|0
482257|NCT00104416|1569456|P3|Continuation Phase|Adverse Event|2
482258|NCT00104416|1569457|P2|Continuation Phase|Adverse Event|0
482259|NCT00104416|1569458|P1|Continuation Phase|Adverse Event|0
482260|NCT00104416|1569454|P5|Double-Blind Phase|Participant Did Not Take Drug|0
482261|NCT00104416|1569455|P4|Double-Blind Phase|Participant Did Not Take Drug|0
482262|NCT00104416|1569456|P3|Double-Blind Phase|Participant Did Not Take Drug|0
482263|NCT00104416|1569457|P2|Double-Blind Phase|Participant Did Not Take Drug|4
482264|NCT00104416|1569458|P1|Double-Blind Phase|Participant Did Not Take Drug|3
482265|NCT00104416|1569454|P5|Double-Blind Phase|Pregnancy|0
482266|NCT00104416|1569455|P4|Double-Blind Phase|Pregnancy|0
482267|NCT00104416|1569456|P3|Double-Blind Phase|Pregnancy|0
482268|NCT00104416|1569457|P2|Double-Blind Phase|Pregnancy|0
482269|NCT00104416|1569458|P1|Double-Blind Phase|Pregnancy|1
482270|NCT00104416|1569454|P5|Double-Blind Phase|Withdrawal by Subject|0
482271|NCT00104416|1569455|P4|Double-Blind Phase|Withdrawal by Subject|0
482272|NCT00104416|1569456|P3|Double-Blind Phase|Withdrawal by Subject|0
482273|NCT00104416|1569457|P2|Double-Blind Phase|Withdrawal by Subject|3
482274|NCT00104416|1569458|P1|Double-Blind Phase|Withdrawal by Subject|2
482275|NCT00104416|1569454|P5|Double-Blind Phase|Protocol Violation|0
482276|NCT00104416|1569455|P4|Double-Blind Phase|Protocol Violation|0
482277|NCT00104416|1569456|P3|Double-Blind Phase|Protocol Violation|0
482278|NCT00104416|1569457|P2|Double-Blind Phase|Protocol Violation|1
482279|NCT00104416|1569458|P1|Double-Blind Phase|Protocol Violation|0
482280|NCT00104416|1569454|P5|Double-Blind Phase|Lost to Follow-up|0
482281|NCT00104416|1569455|P4|Double-Blind Phase|Lost to Follow-up|0
482282|NCT00104416|1569456|P3|Double-Blind Phase|Lost to Follow-up|0
482283|NCT00104416|1569457|P2|Double-Blind Phase|Lost to Follow-up|1
482284|NCT00104416|1569458|P1|Double-Blind Phase|Lost to Follow-up|0
482285|NCT00104416|1569454|P5|Double-Blind Phase|Adverse Event|0
482286|NCT00104416|1569455|P4|Double-Blind Phase|Adverse Event|0
482287|NCT00104416|1569456|P3|Double-Blind Phase|Adverse Event|0
482288|NCT00104416|1569457|P2|Double-Blind Phase|Adverse Event|1
482289|NCT00104416|1569458|P1|Double-Blind Phase|Adverse Event|2
482290|NCT00104299|1569503|P2|Overall Study|To have renal transplant|0
482291|NCT00104299|1569504|P1|Overall Study|To have renal transplant|1
482292|NCT00104299|1569503|P2|Overall Study|Physician Decision|1
482293|NCT00104299|1569504|P1|Overall Study|Physician Decision|1
482294|NCT00104299|1569503|P2|Overall Study|Withdrawal by Subject|6
482295|NCT00104299|1569504|P1|Overall Study|Withdrawal by Subject|2
482296|NCT00104299|1569503|P2|Overall Study|Death|2
482297|NCT00104299|1569504|P1|Overall Study|Death|2
482298|NCT00104299|1569503|P2|Overall Study|Adverse Event|1
482299|NCT00104299|1569504|P1|Overall Study|Adverse Event|3
482300|NCT00104247|1569526|P2|Overall Study|Noncompliant with dosing|1
482301|NCT00104247|1569527|P1|Overall Study|Noncompliant with dosing|0
482302|NCT00104247|1569526|P2|Overall Study|Withdrawal by Subject|0
482303|NCT00104247|1569527|P1|Overall Study|Withdrawal by Subject|1
482304|NCT00104104|1569546|P2|Overall Study|Death|6
482305|NCT00104104|1569547|P1|Overall Study|Death|9
482306|NCT00104104|1569546|P2|Overall Study|Administrative problems|13
482307|NCT00104104|1569547|P1|Overall Study|Administrative problems|12
482308|NCT00104104|1569546|P2|Overall Study|Lost to Follow-up|7
482309|NCT00104104|1569547|P1|Overall Study|Lost to Follow-up|3
482310|NCT00104104|1569546|P2|Overall Study|Withdrawal by Subject|15
482311|NCT00104104|1569547|P1|Overall Study|Withdrawal by Subject|11
482312|NCT00104104|1569546|P2|Overall Study|Protocol Violation|2
482313|NCT00104104|1569547|P1|Overall Study|Protocol Violation|5
482314|NCT00104104|1569546|P2|Overall Study|Condition no longer requires study drug|4
482315|NCT00104104|1569547|P1|Overall Study|Condition no longer requires study drug|7
482316|NCT00104104|1569546|P2|Overall Study|Lack of Efficacy|3
482317|NCT00104104|1569547|P1|Overall Study|Lack of Efficacy|0
482318|NCT00104104|1569546|P2|Overall Study|Abnormal laboratory value(s)|14
482319|NCT00104104|1569547|P1|Overall Study|Abnormal laboratory value(s)|20
482320|NCT00104104|1569546|P2|Overall Study|Adverse Event|8
482321|NCT00104104|1569547|P1|Overall Study|Adverse Event|8
482322|NCT00104052|1569561|P1|Overall Study|Discontinuation unrelated to treatment|2
482323|NCT00104052|1569561|P1|Overall Study|Lack of Efficacy|26
482324|NCT00104052|1569561|P1|Overall Study|Adverse Event|1
482325|NCT00103857|1569572|P7|50-Week Extension Study|reason unspecified|0
482326|NCT00103857|1569573|P6|50-Week Extension Study|reason unspecified|0
482327|NCT00103857|1569574|P5|50-Week Extension Study|reason unspecified|1
482328|NCT00103857|1569575|P4|50-Week Extension Study|reason unspecified|0
482329|NCT00103857|1569576|P3|50-Week Extension Study|reason unspecified|0
482330|NCT00103857|1569577|P2|50-Week Extension Study|reason unspecified|0
482331|NCT00103857|1569578|P1|50-Week Extension Study|reason unspecified|0
482332|NCT00103857|1569572|P7|50-Week Extension Study|patient scheduled for elective surgery|0
482333|NCT00103857|1569573|P6|50-Week Extension Study|patient scheduled for elective surgery|0
482334|NCT00103857|1569574|P5|50-Week Extension Study|patient scheduled for elective surgery|0
482335|NCT00103857|1569575|P4|50-Week Extension Study|patient scheduled for elective surgery|0
482336|NCT00103857|1569576|P3|50-Week Extension Study|patient scheduled for elective surgery|1
482337|NCT00103857|1569577|P2|50-Week Extension Study|patient scheduled for elective surgery|0
482338|NCT00103857|1569578|P1|50-Week Extension Study|patient scheduled for elective surgery|0
482339|NCT00103857|1569572|P7|50-Week Extension Study|patient moved|0
482340|NCT00103857|1569573|P6|50-Week Extension Study|patient moved|0
482341|NCT00103857|1569574|P5|50-Week Extension Study|patient moved|0
482342|NCT00103857|1569575|P4|50-Week Extension Study|patient moved|2
482343|NCT00103857|1569576|P3|50-Week Extension Study|patient moved|1
482344|NCT00103857|1569577|P2|50-Week Extension Study|patient moved|0
482345|NCT00103857|1569578|P1|50-Week Extension Study|patient moved|0
482346|NCT00103857|1569572|P7|50-Week Extension Study|non-compliance with study procedures|0
482347|NCT00103857|1569573|P6|50-Week Extension Study|non-compliance with study procedures|0
482348|NCT00103857|1569574|P5|50-Week Extension Study|non-compliance with study procedures|1
482349|NCT00103857|1569575|P4|50-Week Extension Study|non-compliance with study procedures|1
482350|NCT00103857|1569576|P3|50-Week Extension Study|non-compliance with study procedures|0
482351|NCT00103857|1569577|P2|50-Week Extension Study|non-compliance with study procedures|0
482352|NCT00103857|1569578|P1|50-Week Extension Study|non-compliance with study procedures|1
482353|NCT00103857|1569572|P7|50-Week Extension Study|protocol discontinuation criteria|0
482354|NCT00103857|1569573|P6|50-Week Extension Study|protocol discontinuation criteria|3
482355|NCT00103857|1569574|P5|50-Week Extension Study|protocol discontinuation criteria|3
482356|NCT00103857|1569575|P4|50-Week Extension Study|protocol discontinuation criteria|2
482357|NCT00103857|1569576|P3|50-Week Extension Study|protocol discontinuation criteria|3
482358|NCT00103857|1569577|P2|50-Week Extension Study|protocol discontinuation criteria|2
482359|NCT00103857|1569578|P1|50-Week Extension Study|protocol discontinuation criteria|2
482360|NCT00103857|1569572|P7|50-Week Extension Study|Withdrawal by Subject|0
482361|NCT00103857|1569573|P6|50-Week Extension Study|Withdrawal by Subject|3
482362|NCT00103857|1569574|P5|50-Week Extension Study|Withdrawal by Subject|3
482363|NCT00103857|1569575|P4|50-Week Extension Study|Withdrawal by Subject|8
482364|NCT00103857|1569576|P3|50-Week Extension Study|Withdrawal by Subject|2
482365|NCT00103857|1569577|P2|50-Week Extension Study|Withdrawal by Subject|5
482366|NCT00103857|1569578|P1|50-Week Extension Study|Withdrawal by Subject|2
482367|NCT00103857|1569572|P7|50-Week Extension Study|Protocol Violation|0
482368|NCT00103857|1569573|P6|50-Week Extension Study|Protocol Violation|1
482369|NCT00103857|1569574|P5|50-Week Extension Study|Protocol Violation|0
482370|NCT00103857|1569575|P4|50-Week Extension Study|Protocol Violation|2
482371|NCT00103857|1569576|P3|50-Week Extension Study|Protocol Violation|1
482372|NCT00103857|1569577|P2|50-Week Extension Study|Protocol Violation|1
482373|NCT00103857|1569578|P1|50-Week Extension Study|Protocol Violation|1
482374|NCT00103857|1569572|P7|50-Week Extension Study|Pregnancy|0
482375|NCT00103857|1569573|P6|50-Week Extension Study|Pregnancy|0
482376|NCT00103857|1569574|P5|50-Week Extension Study|Pregnancy|1
482377|NCT00103857|1569575|P4|50-Week Extension Study|Pregnancy|0
482378|NCT00103857|1569576|P3|50-Week Extension Study|Pregnancy|1
482379|NCT00103857|1569577|P2|50-Week Extension Study|Pregnancy|0
482380|NCT00103857|1569578|P1|50-Week Extension Study|Pregnancy|0
482381|NCT00103857|1569572|P7|50-Week Extension Study|Physician Decision|0
482382|NCT00103857|1569573|P6|50-Week Extension Study|Physician Decision|0
482383|NCT00103857|1569574|P5|50-Week Extension Study|Physician Decision|0
482384|NCT00103857|1569575|P4|50-Week Extension Study|Physician Decision|0
482385|NCT00103857|1569576|P3|50-Week Extension Study|Physician Decision|1
482386|NCT00103857|1569577|P2|50-Week Extension Study|Physician Decision|1
482387|NCT00103857|1569578|P1|50-Week Extension Study|Physician Decision|0
482388|NCT00103857|1569572|P7|50-Week Extension Study|Lost to Follow-up|0
482389|NCT00103857|1569573|P6|50-Week Extension Study|Lost to Follow-up|3
482390|NCT00103857|1569574|P5|50-Week Extension Study|Lost to Follow-up|3
482391|NCT00103857|1569575|P4|50-Week Extension Study|Lost to Follow-up|4
482392|NCT00103857|1569576|P3|50-Week Extension Study|Lost to Follow-up|1
482393|NCT00103857|1569577|P2|50-Week Extension Study|Lost to Follow-up|0
482394|NCT00103857|1569578|P1|50-Week Extension Study|Lost to Follow-up|4
482395|NCT00103857|1569572|P7|50-Week Extension Study|Lack of Efficacy|0
482396|NCT00103857|1569573|P6|50-Week Extension Study|Lack of Efficacy|8
482397|NCT00103857|1569574|P5|50-Week Extension Study|Lack of Efficacy|8
482398|NCT00103857|1569575|P4|50-Week Extension Study|Lack of Efficacy|16
482399|NCT00103857|1569576|P3|50-Week Extension Study|Lack of Efficacy|13
482400|NCT00103857|1569577|P2|50-Week Extension Study|Lack of Efficacy|15
482401|NCT00103857|1569578|P1|50-Week Extension Study|Lack of Efficacy|26
482402|NCT00103857|1569572|P7|50-Week Extension Study|Death|0
482403|NCT00103857|1569573|P6|50-Week Extension Study|Death|1
482404|NCT00103857|1569574|P5|50-Week Extension Study|Death|0
482405|NCT00103857|1569575|P4|50-Week Extension Study|Death|1
482406|NCT00103857|1569576|P3|50-Week Extension Study|Death|0
482407|NCT00103857|1569577|P2|50-Week Extension Study|Death|0
482408|NCT00103857|1569578|P1|50-Week Extension Study|Death|0
482409|NCT00103857|1569572|P7|50-Week Extension Study|Adverse Event|0
482410|NCT00103857|1569573|P6|50-Week Extension Study|Adverse Event|1
482411|NCT00103857|1569574|P5|50-Week Extension Study|Adverse Event|1
482412|NCT00103857|1569575|P4|50-Week Extension Study|Adverse Event|0
482413|NCT00103857|1569576|P3|50-Week Extension Study|Adverse Event|2
482414|NCT00103857|1569577|P2|50-Week Extension Study|Adverse Event|3
482415|NCT00103857|1569578|P1|50-Week Extension Study|Adverse Event|2
482416|NCT00103857|1569572|P7|54-Week Base Study|patient intolerance to rescue therapy|0
482417|NCT00103857|1569573|P6|54-Week Base Study|patient intolerance to rescue therapy|0
482418|NCT00103857|1569574|P5|54-Week Base Study|patient intolerance to rescue therapy|0
482419|NCT00103857|1569575|P4|54-Week Base Study|patient intolerance to rescue therapy|0
482420|NCT00103857|1569576|P3|54-Week Base Study|patient intolerance to rescue therapy|0
482421|NCT00103857|1569577|P2|54-Week Base Study|patient intolerance to rescue therapy|0
482422|NCT00103857|1569578|P1|54-Week Base Study|patient intolerance to rescue therapy|1
482423|NCT00103857|1569572|P7|54-Week Base Study|site error|0
482424|NCT00103857|1569573|P6|54-Week Base Study|site error|1
482425|NCT00103857|1569574|P5|54-Week Base Study|site error|0
482426|NCT00103857|1569575|P4|54-Week Base Study|site error|0
482427|NCT00103857|1569576|P3|54-Week Base Study|site error|0
482428|NCT00103857|1569577|P2|54-Week Base Study|site error|0
482429|NCT00103857|1569578|P1|54-Week Base Study|site error|0
482430|NCT00103857|1569572|P7|54-Week Base Study|laboratory reporting error|0
482431|NCT00103857|1569573|P6|54-Week Base Study|laboratory reporting error|0
482432|NCT00103857|1569574|P5|54-Week Base Study|laboratory reporting error|1
482433|NCT00103857|1569575|P4|54-Week Base Study|laboratory reporting error|0
482434|NCT00103857|1569576|P3|54-Week Base Study|laboratory reporting error|0
482435|NCT00103857|1569577|P2|54-Week Base Study|laboratory reporting error|0
482436|NCT00103857|1569578|P1|54-Week Base Study|laboratory reporting error|0
482437|NCT00103857|1569572|P7|54-Week Base Study|patient incarcerated|0
482438|NCT00103857|1569573|P6|54-Week Base Study|patient incarcerated|1
482439|NCT00103857|1569574|P5|54-Week Base Study|patient incarcerated|1
482440|NCT00103857|1569575|P4|54-Week Base Study|patient incarcerated|0
482441|NCT00103857|1569576|P3|54-Week Base Study|patient incarcerated|0
482442|NCT00103857|1569577|P2|54-Week Base Study|patient incarcerated|0
482443|NCT00103857|1569578|P1|54-Week Base Study|patient incarcerated|0
482444|NCT00103857|1569572|P7|54-Week Base Study|non-compliance with study procedures|0
482445|NCT00103857|1569573|P6|54-Week Base Study|non-compliance with study procedures|2
482446|NCT00103857|1569574|P5|54-Week Base Study|non-compliance with study procedures|0
482447|NCT00103857|1569575|P4|54-Week Base Study|non-compliance with study procedures|0
482448|NCT00103857|1569576|P3|54-Week Base Study|non-compliance with study procedures|0
482449|NCT00103857|1569577|P2|54-Week Base Study|non-compliance with study procedures|2
482450|NCT00103857|1569578|P1|54-Week Base Study|non-compliance with study procedures|1
482451|NCT00103857|1569572|P7|54-Week Base Study|patient moved|0
482452|NCT00103857|1569573|P6|54-Week Base Study|patient moved|1
482453|NCT00103857|1569574|P5|54-Week Base Study|patient moved|3
482454|NCT00103857|1569575|P4|54-Week Base Study|patient moved|2
482455|NCT00103857|1569576|P3|54-Week Base Study|patient moved|1
482456|NCT00103857|1569577|P2|54-Week Base Study|patient moved|1
482457|NCT00103857|1569578|P1|54-Week Base Study|patient moved|0
482458|NCT00103857|1569572|P7|54-Week Base Study|protocol discontinuation criteria|5
482459|NCT00103857|1569573|P6|54-Week Base Study|protocol discontinuation criteria|3
482460|NCT00103857|1569574|P5|54-Week Base Study|protocol discontinuation criteria|5
482461|NCT00103857|1569575|P4|54-Week Base Study|protocol discontinuation criteria|6
482462|NCT00103857|1569576|P3|54-Week Base Study|protocol discontinuation criteria|2
482463|NCT00103857|1569577|P2|54-Week Base Study|protocol discontinuation criteria|5
482464|NCT00103857|1569578|P1|54-Week Base Study|protocol discontinuation criteria|2
482465|NCT00103857|1569572|P7|54-Week Base Study|Withdrawal by Subject|4
482466|NCT00103857|1569573|P6|54-Week Base Study|Withdrawal by Subject|15
482467|NCT00103857|1569574|P5|54-Week Base Study|Withdrawal by Subject|10
482468|NCT00103857|1569575|P4|54-Week Base Study|Withdrawal by Subject|15
482469|NCT00103857|1569576|P3|54-Week Base Study|Withdrawal by Subject|16
482470|NCT00103857|1569577|P2|54-Week Base Study|Withdrawal by Subject|16
482471|NCT00103857|1569578|P1|54-Week Base Study|Withdrawal by Subject|17
482472|NCT00103857|1569572|P7|54-Week Base Study|Protocol Violation|3
482473|NCT00103857|1569573|P6|54-Week Base Study|Protocol Violation|3
482474|NCT00103857|1569574|P5|54-Week Base Study|Protocol Violation|0
482475|NCT00103857|1569575|P4|54-Week Base Study|Protocol Violation|4
482476|NCT00103857|1569576|P3|54-Week Base Study|Protocol Violation|2
482477|NCT00103857|1569577|P2|54-Week Base Study|Protocol Violation|4
482478|NCT00103857|1569578|P1|54-Week Base Study|Protocol Violation|6
482479|NCT00103857|1569572|P7|54-Week Base Study|Pregnancy|1
482480|NCT00103857|1569573|P6|54-Week Base Study|Pregnancy|0
482481|NCT00103857|1569574|P5|54-Week Base Study|Pregnancy|1
482482|NCT00103857|1569575|P4|54-Week Base Study|Pregnancy|0
482483|NCT00103857|1569576|P3|54-Week Base Study|Pregnancy|0
482484|NCT00103857|1569577|P2|54-Week Base Study|Pregnancy|0
482485|NCT00103857|1569578|P1|54-Week Base Study|Pregnancy|1
482486|NCT00103857|1569572|P7|54-Week Base Study|Physician Decision|0
482487|NCT00103857|1569573|P6|54-Week Base Study|Physician Decision|0
482488|NCT00103857|1569574|P5|54-Week Base Study|Physician Decision|1
482489|NCT00103857|1569575|P4|54-Week Base Study|Physician Decision|0
482490|NCT00103857|1569576|P3|54-Week Base Study|Physician Decision|0
482491|NCT00103857|1569577|P2|54-Week Base Study|Physician Decision|1
482492|NCT00103857|1569578|P1|54-Week Base Study|Physician Decision|1
482493|NCT00103857|1569572|P7|54-Week Base Study|Lost to Follow-up|3
482494|NCT00103857|1569573|P6|54-Week Base Study|Lost to Follow-up|9
482495|NCT00103857|1569574|P5|54-Week Base Study|Lost to Follow-up|10
482496|NCT00103857|1569575|P4|54-Week Base Study|Lost to Follow-up|5
482497|NCT00103857|1569576|P3|54-Week Base Study|Lost to Follow-up|7
482498|NCT00103857|1569577|P2|54-Week Base Study|Lost to Follow-up|4
482499|NCT00103857|1569578|P1|54-Week Base Study|Lost to Follow-up|5
482500|NCT00103857|1569572|P7|54-Week Base Study|Lack of Efficacy|19
482501|NCT00103857|1569573|P6|54-Week Base Study|Lack of Efficacy|14
482502|NCT00103857|1569574|P5|54-Week Base Study|Lack of Efficacy|3
482503|NCT00103857|1569575|P4|54-Week Base Study|Lack of Efficacy|4
482504|NCT00103857|1569576|P3|54-Week Base Study|Lack of Efficacy|8
482505|NCT00103857|1569577|P2|54-Week Base Study|Lack of Efficacy|14
482506|NCT00103857|1569578|P1|54-Week Base Study|Lack of Efficacy|11
482507|NCT00103857|1569572|P7|54-Week Base Study|Death|0
482508|NCT00103857|1569573|P6|54-Week Base Study|Death|1
482509|NCT00103857|1569574|P5|54-Week Base Study|Death|1
482510|NCT00103857|1569575|P4|54-Week Base Study|Death|0
482511|NCT00103857|1569576|P3|54-Week Base Study|Death|0
482512|NCT00103857|1569577|P2|54-Week Base Study|Death|0
482513|NCT00103857|1569578|P1|54-Week Base Study|Death|0
482514|NCT00103857|1569572|P7|54-Week Base Study|Adverse Event|3
482515|NCT00103857|1569573|P6|54-Week Base Study|Adverse Event|11
482516|NCT00103857|1569574|P5|54-Week Base Study|Adverse Event|5
482517|NCT00103857|1569575|P4|54-Week Base Study|Adverse Event|6
482518|NCT00103857|1569576|P3|54-Week Base Study|Adverse Event|11
482519|NCT00103857|1569577|P2|54-Week Base Study|Adverse Event|9
482520|NCT00103857|1569578|P1|54-Week Base Study|Adverse Event|12
482521|NCT00103740|1569677|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
482522|NCT00103740|1569678|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
482523|NCT00103740|1569677|P2|Period 2 - Extended Observation Period|Death|2
482524|NCT00103740|1569678|P1|Period 2 - Extended Observation Period|Death|6
482525|NCT00103740|1569677|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
482526|NCT00103740|1569678|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
482527|NCT00103740|1569677|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
482528|NCT00103740|1569678|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
482529|NCT00103740|1569677|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
482530|NCT00103740|1569678|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
482531|NCT00103740|1569677|P2|Period 1 - Core|Patient withdrew consent|2
482532|NCT00103740|1569678|P1|Period 1 - Core|Patient withdrew consent|3
482533|NCT00103740|1569677|P2|Period 1 - Core|Protocol Violation|2
482534|NCT00103740|1569678|P1|Period 1 - Core|Protocol Violation|3
482535|NCT00103740|1569677|P2|Period 1 - Core|Adverse Event|0
482536|NCT00103740|1569678|P1|Period 1 - Core|Adverse Event|1
482537|NCT00103662|1569706|P2|Overall Study|Intercurrent illness|0
482538|NCT00103662|1569707|P1|Overall Study|Intercurrent illness|1
482539|NCT00103662|1569706|P2|Overall Study|Failed mobilization|4
482540|NCT00103662|1569707|P1|Overall Study|Failed mobilization|0
482541|NCT00103662|1569706|P2|Overall Study|Other|9
482542|NCT00103662|1569707|P1|Overall Study|Other|6
482543|NCT00103662|1569706|P2|Overall Study|Lost to Follow-up|1
482544|NCT00103662|1569707|P1|Overall Study|Lost to Follow-up|0
482545|NCT00103662|1569706|P2|Overall Study|Elective Withdrawal|5
482546|NCT00103662|1569707|P1|Overall Study|Elective Withdrawal|5
482547|NCT00103662|1569706|P2|Overall Study|Death|7
482548|NCT00103662|1569707|P1|Overall Study|Death|7
482549|NCT00103662|1569706|P2|Overall Study|Entered Rescue Procedure|7
482550|NCT00103662|1569707|P1|Overall Study|Entered Rescue Procedure|0
482551|NCT00103610|1569733|P2|Overall Study|Noncompliance|1
482552|NCT00103610|1569734|P1|Overall Study|Noncompliance|0
482553|NCT00103610|1569733|P2|Overall Study|Failed mobilization|5
482554|NCT00103610|1569734|P1|Overall Study|Failed mobilization|1
482555|NCT00103610|1569733|P2|Overall Study|Other|7
482556|NCT00103610|1569734|P1|Overall Study|Other|2
482557|NCT00103610|1569733|P2|Overall Study|Adverse Event|2
482558|NCT00103610|1569734|P1|Overall Study|Adverse Event|2
482559|NCT00103610|1569733|P2|Overall Study|Lost to Follow-up|1
482560|NCT00103610|1569734|P1|Overall Study|Lost to Follow-up|3
482561|NCT00103610|1569733|P2|Overall Study|Elective Withdrawal|0
482562|NCT00103610|1569734|P1|Overall Study|Elective Withdrawal|4
482563|NCT00103610|1569733|P2|Overall Study|Death|12
482564|NCT00103610|1569734|P1|Overall Study|Death|16
482565|NCT00103610|1569733|P2|Overall Study|Entered Rescue Procedure|52
482566|NCT00103610|1569734|P1|Overall Study|Entered Rescue Procedure|10
482567|NCT00103506|1569758|P2|Overall Study|Withdrawal by Subject|21
482568|NCT00103506|1569759|P1|Overall Study|Withdrawal by Subject|18
482569|NCT00103506|1569758|P2|Overall Study|Lost to Follow-up|13
482570|NCT00103506|1569759|P1|Overall Study|Lost to Follow-up|13
482571|NCT00103506|1569758|P2|Overall Study|Death|253
482572|NCT00103506|1569759|P1|Overall Study|Death|257
482573|NCT00103506|1569758|P2|Overall Study|Study closed by sponsor|37
482574|NCT00103506|1569759|P1|Overall Study|Study closed by sponsor|34
482575|NCT00103311|1569771|P2|Overall Study|Adverse Event|0
482576|NCT00103311|1569772|P1|Overall Study|Adverse Event|1
482577|NCT00103311|1569771|P2|Overall Study|Withdrawal by Subject|1
482578|NCT00103311|1569772|P1|Overall Study|Withdrawal by Subject|2
482579|NCT00103311|1569771|P2|Overall Study|Lost to Follow-up|0
482580|NCT00103311|1569772|P1|Overall Study|Lost to Follow-up|1
482581|NCT00103259|1569784|P2|Overall Study|ineligible/no protocol therapy|6
482582|NCT00103259|1569785|P1|Overall Study|ineligible/no protocol therapy|4
482583|NCT00103259|1569784|P2|Overall Study|other (reasons were not specified)|1
482584|NCT00103259|1569785|P1|Overall Study|other (reasons were not specified)|2
482585|NCT00103259|1569784|P2|Overall Study|alternative therapy|0
482586|NCT00103259|1569785|P1|Overall Study|alternative therapy|1
482587|NCT00103259|1569784|P2|Overall Study|Withdrawal by Subject|3
482588|NCT00103259|1569785|P1|Overall Study|Withdrawal by Subject|2
482589|NCT00103259|1569784|P2|Overall Study|Death|2
482590|NCT00103259|1569785|P1|Overall Study|Death|3
482591|NCT00103207|1569797|P1|Overall Study|Diagnosis of BAC not confirmed|27
482592|NCT00103207|1569797|P1|Overall Study|Ineligible|4
482593|NCT00103207|1569797|P1|Overall Study|Other complicating disease|1
482594|NCT00103207|1569797|P1|Overall Study|Withdrawal by Subject|2
482595|NCT00103207|1569797|P1|Overall Study|Death|1
482596|NCT00103207|1569797|P1|Overall Study|Adverse Event|3
482597|NCT00103142|1569816|P2|Overall Study|Progression of disease|1
482598|NCT00103142|1569817|P1|Overall Study|Progression of disease|2
482599|NCT00103142|1569816|P2|Overall Study|Adverse Event|0
482600|NCT00103142|1569817|P1|Overall Study|Adverse Event|1
482601|NCT00103012|1569833|P3|Overall Study|Subject non-compliant with medications|1
482602|NCT00103012|1569834|P2|Overall Study|Subject non-compliant with medications|0
482603|NCT00103012|1569835|P1|Overall Study|Subject non-compliant with medications|0
482604|NCT00103012|1569833|P3|Overall Study|Adverse Event|1
482605|NCT00103012|1569834|P2|Overall Study|Adverse Event|0
482606|NCT00103012|1569835|P1|Overall Study|Adverse Event|0
482607|NCT00103012|1569833|P3|Overall Study|Pregnancy|0
482608|NCT00103012|1569834|P2|Overall Study|Pregnancy|0
482609|NCT00103012|1569835|P1|Overall Study|Pregnancy|1
482610|NCT00103012|1569833|P3|Overall Study|Withdrawal by Subject|2
482611|NCT00103012|1569834|P2|Overall Study|Withdrawal by Subject|1
482612|NCT00103012|1569835|P1|Overall Study|Withdrawal by Subject|2
482613|NCT00102804|1569845|P2|Overall Study|Alive, Receiving Treatment|2
482614|NCT00102804|1569846|P1|Overall Study|Alive, Receiving Treatment|7
482615|NCT00102804|1569845|P2|Overall Study|Sponsor Decision|0
482616|NCT00102804|1569846|P1|Overall Study|Sponsor Decision|1
482617|NCT00102804|1569845|P2|Overall Study|Satisfactory Response|0
482618|NCT00102804|1569846|P1|Overall Study|Satisfactory Response|2
482619|NCT00102804|1569845|P2|Overall Study|Protocol Violation|1
482620|NCT00102804|1569846|P1|Overall Study|Protocol Violation|2
482621|NCT00102804|1569845|P2|Overall Study|Lost to Follow-up|1
482622|NCT00102804|1569846|P1|Overall Study|Lost to Follow-up|4
482623|NCT00102804|1569845|P2|Overall Study|Enrollment Criteria Not Met|0
482624|NCT00102804|1569846|P1|Overall Study|Enrollment Criteria Not Met|6
482625|NCT00102804|1569845|P2|Overall Study|Death|6
482626|NCT00102804|1569846|P1|Overall Study|Death|5
482627|NCT00102804|1569845|P2|Overall Study|Physician Decision|6
482628|NCT00102804|1569846|P1|Overall Study|Physician Decision|24
482629|NCT00102804|1569845|P2|Overall Study|Adverse Event|3
482630|NCT00102804|1569846|P1|Overall Study|Adverse Event|37
482631|NCT00102804|1569845|P2|Overall Study|Withdrawal by Subject|7
482632|NCT00102804|1569846|P1|Overall Study|Withdrawal by Subject|46
482633|NCT00102804|1569845|P2|Overall Study|Progressive Disease (PD)|196
482634|NCT00102804|1569846|P1|Overall Study|Progressive Disease (PD)|307
482635|NCT00102687|1569867|P5|Maintenance Period|Death|1
482636|NCT00102687|1569868|P4|Maintenance Period|Death|1
482637|NCT00102687|1569869|P3|Maintenance Period|Death|0
482638|NCT00102687|1569870|P2|Maintenance Period|Death|0
482639|NCT00102687|1569871|P1|Maintenance Period|Death|0
482640|NCT00102687|1569867|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
482641|NCT00102687|1569868|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
482642|NCT00102687|1569869|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
482643|NCT00102687|1569870|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
482644|NCT00102687|1569871|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
482645|NCT00102687|1569867|P5|Maintenance Period|Sponsor decision|0
482646|NCT00102687|1569868|P4|Maintenance Period|Sponsor decision|0
482647|NCT00102687|1569869|P3|Maintenance Period|Sponsor decision|0
482648|NCT00102687|1569870|P2|Maintenance Period|Sponsor decision|0
482649|NCT00102687|1569871|P1|Maintenance Period|Sponsor decision|0
482650|NCT00102687|1569867|P5|Maintenance Period|Physician Decision|4
482651|NCT00102687|1569868|P4|Maintenance Period|Physician Decision|0
482652|NCT00102687|1569869|P3|Maintenance Period|Physician Decision|3
482653|NCT00102687|1569870|P2|Maintenance Period|Physician Decision|2
482654|NCT00102687|1569871|P1|Maintenance Period|Physician Decision|1
482655|NCT00102687|1569867|P5|Maintenance Period|Protocol Violation|0
482656|NCT00102687|1569868|P4|Maintenance Period|Protocol Violation|0
482657|NCT00102687|1569869|P3|Maintenance Period|Protocol Violation|0
482658|NCT00102687|1569870|P2|Maintenance Period|Protocol Violation|0
482659|NCT00102687|1569871|P1|Maintenance Period|Protocol Violation|0
482660|NCT00102687|1569867|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
482661|NCT00102687|1569868|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
482662|NCT00102687|1569869|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
482663|NCT00102687|1569870|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
482664|NCT00102687|1569871|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
482665|NCT00102687|1569867|P5|Maintenance Period|Adverse Event|3
482666|NCT00102687|1569868|P4|Maintenance Period|Adverse Event|1
482667|NCT00102687|1569869|P3|Maintenance Period|Adverse Event|0
482668|NCT00102687|1569870|P2|Maintenance Period|Adverse Event|0
482669|NCT00102687|1569871|P1|Maintenance Period|Adverse Event|1
482670|NCT00102687|1569867|P5|Maintenance Period|Withdrawal by Subject|1
482671|NCT00102687|1569868|P4|Maintenance Period|Withdrawal by Subject|3
482672|NCT00102687|1569869|P3|Maintenance Period|Withdrawal by Subject|2
482673|NCT00102687|1569870|P2|Maintenance Period|Withdrawal by Subject|0
482674|NCT00102687|1569871|P1|Maintenance Period|Withdrawal by Subject|4
482675|NCT00102687|1569867|P5|Initial Period|Death|0
482676|NCT00102687|1569868|P4|Initial Period|Death|0
482677|NCT00102687|1569869|P3|Initial Period|Death|1
482678|NCT00102687|1569870|P2|Initial Period|Death|1
482679|NCT00102687|1569871|P1|Initial Period|Death|1
482680|NCT00102687|1569867|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
482681|NCT00102687|1569868|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
482682|NCT00102687|1569869|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
482683|NCT00102687|1569870|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
482684|NCT00102687|1569871|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
482685|NCT00102687|1569867|P5|Initial Period|Sponsor's decision|0
482686|NCT00102687|1569868|P4|Initial Period|Sponsor's decision|0
482687|NCT00102687|1569869|P3|Initial Period|Sponsor's decision|1
482688|NCT00102687|1569870|P2|Initial Period|Sponsor's decision|1
482689|NCT00102687|1569871|P1|Initial Period|Sponsor's decision|0
482690|NCT00102687|1569867|P5|Initial Period|Physician Decision|0
482691|NCT00102687|1569868|P4|Initial Period|Physician Decision|0
482692|NCT00102687|1569869|P3|Initial Period|Physician Decision|6
482693|NCT00102687|1569870|P2|Initial Period|Physician Decision|9
482694|NCT00102687|1569871|P1|Initial Period|Physician Decision|2
482695|NCT00102687|1569867|P5|Initial Period|Protocol Violation|0
482696|NCT00102687|1569868|P4|Initial Period|Protocol Violation|0
482697|NCT00102687|1569869|P3|Initial Period|Protocol Violation|2
482698|NCT00102687|1569870|P2|Initial Period|Protocol Violation|0
482699|NCT00102687|1569871|P1|Initial Period|Protocol Violation|0
482700|NCT00102687|1569867|P5|Initial Period|Transformation to AML (blast > 30%)|0
482701|NCT00102687|1569868|P4|Initial Period|Transformation to AML (blast > 30%)|0
482702|NCT00102687|1569869|P3|Initial Period|Transformation to AML (blast > 30%)|0
482703|NCT00102687|1569870|P2|Initial Period|Transformation to AML (blast > 30%)|3
482704|NCT00102687|1569871|P1|Initial Period|Transformation to AML (blast > 30%)|1
482705|NCT00102687|1569867|P5|Initial Period|Adverse Event|0
482706|NCT00102687|1569868|P4|Initial Period|Adverse Event|0
482707|NCT00102687|1569869|P3|Initial Period|Adverse Event|9
482708|NCT00102687|1569870|P2|Initial Period|Adverse Event|7
482709|NCT00102687|1569871|P1|Initial Period|Adverse Event|4
482710|NCT00102687|1569867|P5|Initial Period|Withdrawal by Subject|0
482711|NCT00102687|1569868|P4|Initial Period|Withdrawal by Subject|0
482712|NCT00102687|1569869|P3|Initial Period|Withdrawal by Subject|5
482713|NCT00102687|1569870|P2|Initial Period|Withdrawal by Subject|3
482714|NCT00102687|1569871|P1|Initial Period|Withdrawal by Subject|6
482715|NCT00102596|1569935|P2|Part A|Adverse Event|0
482716|NCT00102596|1569936|P1|Part A|Adverse Event|1
482717|NCT00102596|1569935|P2|Part A|Screen failures|0
482718|NCT00102596|1569936|P1|Part A|Screen failures|6
482719|NCT00102531|1569947|P2|Overall Study|Physician Decision|1
482720|NCT00102531|1569948|P1|Overall Study|Physician Decision|0
482721|NCT00102531|1569947|P2|Overall Study|Disease Progression|9
482722|NCT00102531|1569948|P1|Overall Study|Disease Progression|5
482723|NCT00102531|1569947|P2|Overall Study|Adverse Event|1
482724|NCT00102531|1569948|P1|Overall Study|Adverse Event|0
482725|NCT00102440|1569963|P3|Overall Study|Protocol Violation|1
482726|NCT00102440|1569964|P2|Overall Study|Protocol Violation|2
482727|NCT00102440|1569965|P1|Overall Study|Protocol Violation|7
482728|NCT00102440|1569963|P3|Overall Study|Other|14
482729|NCT00102440|1569964|P2|Overall Study|Other|14
482730|NCT00102440|1569965|P1|Overall Study|Other|11
482731|NCT00102440|1569963|P3|Overall Study|Personal Reason(s)|13
482732|NCT00102440|1569964|P2|Overall Study|Personal Reason(s)|13
482733|NCT00102440|1569965|P1|Overall Study|Personal Reason(s)|19
482734|NCT00102440|1569963|P3|Overall Study|Gout Flare|9
482735|NCT00102440|1569964|P2|Overall Study|Gout Flare|28
482736|NCT00102440|1569965|P1|Overall Study|Gout Flare|10
482737|NCT00102440|1569963|P3|Overall Study|Adverse Event|8
482738|NCT00102440|1569964|P2|Overall Study|Adverse Event|23
482739|NCT00102440|1569965|P1|Overall Study|Adverse Event|16
482740|NCT00102440|1569963|P3|Overall Study|Lost to Follow-up|21
482741|NCT00102440|1569964|P2|Overall Study|Lost to Follow-up|18
482742|NCT00102440|1569965|P1|Overall Study|Lost to Follow-up|25
482743|NCT00102063|1570015|P3|Overall Study|Protocol Violation|1
482744|NCT00102063|1570016|P2|Overall Study|Protocol Violation|1
482745|NCT00102063|1570017|P1|Overall Study|Protocol Violation|0
482746|NCT00102063|1570015|P3|Overall Study|Lost to Follow-up|1
482747|NCT00102063|1570016|P2|Overall Study|Lost to Follow-up|0
482748|NCT00102063|1570017|P1|Overall Study|Lost to Follow-up|0
482749|NCT00102063|1570015|P3|Overall Study|Withdrawal by Subject|5
482750|NCT00102063|1570016|P2|Overall Study|Withdrawal by Subject|12
482751|NCT00102063|1570017|P1|Overall Study|Withdrawal by Subject|4
482752|NCT00102063|1570015|P3|Overall Study|Adverse Event|2
482753|NCT00102063|1570016|P2|Overall Study|Adverse Event|4
482754|NCT00102063|1570017|P1|Overall Study|Adverse Event|7
482755|NCT00102063|1570015|P3|Overall Study|Lack of Efficacy|1
482756|NCT00102063|1570016|P2|Overall Study|Lack of Efficacy|1
482757|NCT00102063|1570017|P1|Overall Study|Lack of Efficacy|5
482758|NCT00101907|1570075|P6|Overall Study|Withdrawal by Subject|0
482759|NCT00101907|1570076|P5|Overall Study|Withdrawal by Subject|1
482760|NCT00101907|1570077|P4|Overall Study|Withdrawal by Subject|0
482761|NCT00101907|1570078|P3|Overall Study|Withdrawal by Subject|1
482762|NCT00101907|1570079|P2|Overall Study|Withdrawal by Subject|0
482763|NCT00101907|1570080|P1|Overall Study|Withdrawal by Subject|1
482764|NCT00101907|1570075|P6|Overall Study|Physician Decision|0
482765|NCT00101907|1570076|P5|Overall Study|Physician Decision|1
482766|NCT00101907|1570077|P4|Overall Study|Physician Decision|1
482767|NCT00101907|1570078|P3|Overall Study|Physician Decision|0
482768|NCT00101907|1570079|P2|Overall Study|Physician Decision|0
482769|NCT00101907|1570080|P1|Overall Study|Physician Decision|0
482770|NCT00101907|1570075|P6|Overall Study|Death|0
482771|NCT00101907|1570076|P5|Overall Study|Death|3
482772|NCT00101907|1570077|P4|Overall Study|Death|0
482773|NCT00101907|1570078|P3|Overall Study|Death|0
482774|NCT00101907|1570079|P2|Overall Study|Death|1
482775|NCT00101907|1570080|P1|Overall Study|Death|0
482776|NCT00101907|1570075|P6|Overall Study|Adverse Event|0
482777|NCT00101907|1570076|P5|Overall Study|Adverse Event|0
482778|NCT00101907|1570077|P4|Overall Study|Adverse Event|0
482779|NCT00101907|1570078|P3|Overall Study|Adverse Event|0
482780|NCT00101907|1570079|P2|Overall Study|Adverse Event|0
482781|NCT00101907|1570080|P1|Overall Study|Adverse Event|1
482782|NCT00101868|1570122|P2|Overall Study|Lost to Follow-up|13
482783|NCT00101868|1570123|P1|Overall Study|Lost to Follow-up|8
482784|NCT00101868|1570122|P2|Overall Study|Protocol Violation|0
482785|NCT00101868|1570123|P1|Overall Study|Protocol Violation|3
482786|NCT00101868|1570122|P2|Overall Study|Withdrawal by Subject|9
482787|NCT00101868|1570123|P1|Overall Study|Withdrawal by Subject|8
482788|NCT00101868|1570122|P2|Overall Study|Death|10
482789|NCT00101868|1570123|P1|Overall Study|Death|10
482790|NCT00101686|1570193|P10|Overall Study|Withdrawal by Subject|9
482791|NCT00101686|1570194|P9|Overall Study|Withdrawal by Subject|8
482792|NCT00101686|1570195|P8|Overall Study|Withdrawal by Subject|7
482793|NCT00101686|1570196|P7|Overall Study|Withdrawal by Subject|7
482794|NCT00101686|1570197|P6|Overall Study|Withdrawal by Subject|7
482795|NCT00101686|1570198|P5|Overall Study|Withdrawal by Subject|8
482796|NCT00101686|1570199|P4|Overall Study|Withdrawal by Subject|8
482797|NCT00101686|1570200|P3|Overall Study|Withdrawal by Subject|6
482798|NCT00101686|1570201|P2|Overall Study|Withdrawal by Subject|8
482799|NCT00101686|1570202|P1|Overall Study|Withdrawal by Subject|9
482800|NCT00101686|1570193|P10|Overall Study|Other|3
482801|NCT00101686|1570194|P9|Overall Study|Other|3
482802|NCT00101686|1570195|P8|Overall Study|Other|5
482803|NCT00101686|1570196|P7|Overall Study|Other|1
482804|NCT00101686|1570197|P6|Overall Study|Other|12
482805|NCT00101686|1570198|P5|Overall Study|Other|2
482806|NCT00101686|1570199|P4|Overall Study|Other|6
482807|NCT00101686|1570200|P3|Overall Study|Other|1
482808|NCT00101686|1570201|P2|Overall Study|Other|4
482809|NCT00101686|1570202|P1|Overall Study|Other|1
482810|NCT00101686|1570193|P10|Overall Study|Physician Decision|1
482811|NCT00101686|1570194|P9|Overall Study|Physician Decision|1
482812|NCT00101686|1570195|P8|Overall Study|Physician Decision|5
482813|NCT00101686|1570196|P7|Overall Study|Physician Decision|5
482814|NCT00101686|1570197|P6|Overall Study|Physician Decision|9
482815|NCT00101686|1570198|P5|Overall Study|Physician Decision|8
482816|NCT00101686|1570199|P4|Overall Study|Physician Decision|7
482817|NCT00101686|1570200|P3|Overall Study|Physician Decision|6
482818|NCT00101686|1570201|P2|Overall Study|Physician Decision|13
482819|NCT00101686|1570202|P1|Overall Study|Physician Decision|10
482820|NCT00101686|1570193|P10|Overall Study|intercurrent non-cancer related illness|1
482821|NCT00101686|1570194|P9|Overall Study|intercurrent non-cancer related illness|1
482822|NCT00101686|1570195|P8|Overall Study|intercurrent non-cancer related illness|0
482823|NCT00101686|1570196|P7|Overall Study|intercurrent non-cancer related illness|1
482824|NCT00101686|1570197|P6|Overall Study|intercurrent non-cancer related illness|3
482825|NCT00101686|1570198|P5|Overall Study|intercurrent non-cancer related illness|1
482826|NCT00101686|1570199|P4|Overall Study|intercurrent non-cancer related illness|0
482827|NCT00101686|1570200|P3|Overall Study|intercurrent non-cancer related illness|2
482828|NCT00101686|1570201|P2|Overall Study|intercurrent non-cancer related illness|0
482829|NCT00101686|1570202|P1|Overall Study|intercurrent non-cancer related illness|0
482830|NCT00101686|1570193|P10|Overall Study|Randomized but did not receive treament|1
482831|NCT00101686|1570194|P9|Overall Study|Randomized but did not receive treament|0
482832|NCT00101686|1570195|P8|Overall Study|Randomized but did not receive treament|1
482833|NCT00101686|1570196|P7|Overall Study|Randomized but did not receive treament|0
482834|NCT00101686|1570197|P6|Overall Study|Randomized but did not receive treament|2
482835|NCT00101686|1570198|P5|Overall Study|Randomized but did not receive treament|2
482836|NCT00101686|1570199|P4|Overall Study|Randomized but did not receive treament|2
482837|NCT00101686|1570200|P3|Overall Study|Randomized but did not receive treament|2
482838|NCT00101686|1570201|P2|Overall Study|Randomized but did not receive treament|6
482839|NCT00101686|1570202|P1|Overall Study|Randomized but did not receive treament|1
482840|NCT00101686|1570193|P10|Overall Study|unacceptable toxicity|4
482841|NCT00101686|1570194|P9|Overall Study|unacceptable toxicity|1
482842|NCT00101686|1570195|P8|Overall Study|unacceptable toxicity|2
482843|NCT00101686|1570196|P7|Overall Study|unacceptable toxicity|4
482844|NCT00101686|1570197|P6|Overall Study|unacceptable toxicity|10
482845|NCT00101686|1570198|P5|Overall Study|unacceptable toxicity|16
482846|NCT00101686|1570199|P4|Overall Study|unacceptable toxicity|6
482847|NCT00101686|1570200|P3|Overall Study|unacceptable toxicity|10
482848|NCT00101686|1570201|P2|Overall Study|unacceptable toxicity|9
482849|NCT00101686|1570202|P1|Overall Study|unacceptable toxicity|3
482850|NCT00101686|1570193|P10|Overall Study|>3 week delay treatment due toxicity|0
482851|NCT00101686|1570194|P9|Overall Study|>3 week delay treatment due toxicity|3
482852|NCT00101686|1570195|P8|Overall Study|>3 week delay treatment due toxicity|1
482853|NCT00101686|1570196|P7|Overall Study|>3 week delay treatment due toxicity|2
482854|NCT00101686|1570197|P6|Overall Study|>3 week delay treatment due toxicity|3
482855|NCT00101686|1570198|P5|Overall Study|>3 week delay treatment due toxicity|7
482856|NCT00101686|1570199|P4|Overall Study|>3 week delay treatment due toxicity|2
482857|NCT00101686|1570200|P3|Overall Study|>3 week delay treatment due toxicity|1
482858|NCT00101686|1570201|P2|Overall Study|>3 week delay treatment due toxicity|2
482859|NCT00101686|1570202|P1|Overall Study|>3 week delay treatment due toxicity|6
482860|NCT00101686|1570193|P10|Overall Study|initiation other anti-cancer treatment|3
482861|NCT00101686|1570194|P9|Overall Study|initiation other anti-cancer treatment|3
482862|NCT00101686|1570195|P8|Overall Study|initiation other anti-cancer treatment|2
482863|NCT00101686|1570196|P7|Overall Study|initiation other anti-cancer treatment|2
482864|NCT00101686|1570197|P6|Overall Study|initiation other anti-cancer treatment|1
482865|NCT00101686|1570198|P5|Overall Study|initiation other anti-cancer treatment|1
482866|NCT00101686|1570199|P4|Overall Study|initiation other anti-cancer treatment|3
482867|NCT00101686|1570200|P3|Overall Study|initiation other anti-cancer treatment|4
482868|NCT00101686|1570201|P2|Overall Study|initiation other anti-cancer treatment|3
482869|NCT00101686|1570202|P1|Overall Study|initiation other anti-cancer treatment|4
482870|NCT00101686|1570193|P10|Overall Study|Progressive Disease|8
482871|NCT00101686|1570194|P9|Overall Study|Progressive Disease|10
482872|NCT00101686|1570195|P8|Overall Study|Progressive Disease|7
482873|NCT00101686|1570196|P7|Overall Study|Progressive Disease|5
482874|NCT00101686|1570197|P6|Overall Study|Progressive Disease|25
482875|NCT00101686|1570198|P5|Overall Study|Progressive Disease|28
482876|NCT00101686|1570199|P4|Overall Study|Progressive Disease|38
482877|NCT00101686|1570200|P3|Overall Study|Progressive Disease|37
482878|NCT00101686|1570201|P2|Overall Study|Progressive Disease|28
482879|NCT00101686|1570202|P1|Overall Study|Progressive Disease|37
482880|NCT00101582|1570319|P2|Overall Study|Other|1
482881|NCT00101582|1570320|P1|Overall Study|Other|0
482882|NCT00101582|1570319|P2|Overall Study|Death|5
482883|NCT00101582|1570320|P1|Overall Study|Death|3
482884|NCT00101582|1570319|P2|Overall Study|Physician Decision|0
482885|NCT00101582|1570320|P1|Overall Study|Physician Decision|1
482886|NCT00101582|1570319|P2|Overall Study|Withdrawal by Subject|4
482887|NCT00101582|1570320|P1|Overall Study|Withdrawal by Subject|6
482888|NCT00101582|1570319|P2|Overall Study|Adverse Event|4
482889|NCT00101582|1570320|P1|Overall Study|Adverse Event|1
482890|NCT00101582|1570319|P2|Overall Study|Ineligibility determined|1
482891|NCT00101582|1570320|P1|Overall Study|Ineligibility determined|0
482892|NCT00101452|1570343|P3|Overall Study|Other|12
482893|NCT00101452|1570344|P2|Overall Study|Other|16
482894|NCT00101452|1570345|P1|Overall Study|Other|15
482895|NCT00101452|1570343|P3|Overall Study|Protocol Violation|3
482896|NCT00101452|1570344|P2|Overall Study|Protocol Violation|1
482897|NCT00101452|1570345|P1|Overall Study|Protocol Violation|2
482898|NCT00101452|1570343|P3|Overall Study|Physician Decision|2
482899|NCT00101452|1570344|P2|Overall Study|Physician Decision|3
482900|NCT00101452|1570345|P1|Overall Study|Physician Decision|0
482901|NCT00101452|1570343|P3|Overall Study|Baseline Fail|2
482902|NCT00101452|1570344|P2|Overall Study|Baseline Fail|1
482903|NCT00101452|1570345|P1|Overall Study|Baseline Fail|2
482904|NCT00101452|1570343|P3|Overall Study|Withdrawal by Subject|9
482905|NCT00101452|1570344|P2|Overall Study|Withdrawal by Subject|14
482906|NCT00101452|1570345|P1|Overall Study|Withdrawal by Subject|10
482907|NCT00101452|1570343|P3|Overall Study|Lost to Follow-up|14
482908|NCT00101452|1570344|P2|Overall Study|Lost to Follow-up|8
482909|NCT00101452|1570345|P1|Overall Study|Lost to Follow-up|13
482910|NCT00101452|1570343|P3|Overall Study|Adverse Event|1
482911|NCT00101452|1570344|P2|Overall Study|Adverse Event|0
482912|NCT00101452|1570345|P1|Overall Study|Adverse Event|2
482913|NCT00101439|1570359|P2|Period 2|Withdrawal by Subject|2
482914|NCT00101439|1570360|P1|Period 2|Withdrawal by Subject|0
482915|NCT00101400|1570376|P1|Survival Follow-Up|Alive|7
482916|NCT00101283|1570396|P2|Overall Study|Prostate Cancer Recurrence|1
482917|NCT00101283|1570397|P1|Overall Study|Prostate Cancer Recurrence|0
482918|NCT00101283|1570396|P2|Overall Study|Insurance Refusal|1
482919|NCT00101283|1570397|P1|Overall Study|Insurance Refusal|0
482920|NCT00101283|1570396|P2|Overall Study|Withdrawal by Subject|1
482921|NCT00101283|1570397|P1|Overall Study|Withdrawal by Subject|0
482922|NCT00101192|1570407|P1|Overall Study|Inevaluable|1
482923|NCT00101192|1570407|P1|Overall Study|Ineligible|6
482924|NCT00101166|1570411|P1|Overall Study|progressive disease|10
482925|NCT00101101|1570419|P1|Overall Study|never received vaccine|20
482926|NCT00100932|1570442|P2|Overall Study|Not specified|2
482927|NCT00100932|1570443|P1|Overall Study|Not specified|5
482928|NCT00100932|1570442|P2|Overall Study|Physician Decision|5
482929|NCT00100932|1570443|P1|Overall Study|Physician Decision|7
482930|NCT00100932|1570442|P2|Overall Study|Progressive Disease|18
482931|NCT00100932|1570443|P1|Overall Study|Progressive Disease|44
482932|NCT00100932|1570442|P2|Overall Study|Withdrawal by Subject|0
482933|NCT00100932|1570443|P1|Overall Study|Withdrawal by Subject|6
482934|NCT00100932|1570442|P2|Overall Study|Adverse Event|2
482935|NCT00100932|1570443|P1|Overall Study|Adverse Event|11
482936|NCT00100815|1570458|P1|Overall Study|not specified|3
482937|NCT00100815|1570458|P1|Overall Study|Death|4
482938|NCT00100815|1570458|P1|Overall Study|Adverse Event|18
482939|NCT00100815|1570458|P1|Overall Study|Progression|24
482940|NCT00100802|1570466|P1|Overall Study|Ineligible|12
482941|NCT00100802|1570466|P1|Overall Study|Withdrawal by Subject|5
482942|NCT00100802|1570466|P1|Overall Study|Protocol Violation|1
482943|NCT00100802|1570466|P1|Overall Study|Physician Decision|5
482944|NCT00100802|1570466|P1|Overall Study|Lack of Efficacy|47
482945|NCT00100802|1570466|P1|Overall Study|Death|1
482946|NCT00100802|1570466|P1|Overall Study|Adverse Event|9
482947|NCT00100789|1570471|P1|Overall Study|Never received treatment|1
482948|NCT00100789|1570471|P1|Overall Study|Ineligible|3
482949|NCT00100789|1570471|P1|Overall Study|Not protocol specified|5
482950|NCT00100789|1570471|P1|Overall Study|Death|2
482951|NCT00100789|1570471|P1|Overall Study|Progression/relapse|42
482952|NCT00100789|1570471|P1|Overall Study|Withdrawal by Subject|1
482953|NCT00100789|1570471|P1|Overall Study|Adverse Event|10
482954|NCT00100178|1570546|P3|Overall Study|Physician Decision|3
482955|NCT00100178|1570547|P2|Overall Study|Physician Decision|1
482956|NCT00100178|1570548|P1|Overall Study|Physician Decision|6
482957|NCT00100178|1570546|P3|Overall Study|Withdrawal by Subject|1
482958|NCT00100178|1570547|P2|Overall Study|Withdrawal by Subject|1
482959|NCT00100178|1570548|P1|Overall Study|Withdrawal by Subject|1
482960|NCT00100178|1570546|P3|Overall Study|Adverse Event|1
482961|NCT00100178|1570547|P2|Overall Study|Adverse Event|2
482962|NCT00100178|1570548|P1|Overall Study|Adverse Event|2
482963|NCT00100178|1570546|P3|Overall Study|Lost to Follow-up|5
482964|NCT00100178|1570547|P2|Overall Study|Lost to Follow-up|6
482965|NCT00100178|1570548|P1|Overall Study|Lost to Follow-up|0
482966|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
482967|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
482968|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
482969|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
482970|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
482971|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
482972|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
482973|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
482974|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
482975|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
482976|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
482977|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
482978|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
482979|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
482980|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
482981|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
482982|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
482983|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
482984|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
482985|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
482986|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
482987|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
482988|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
482989|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
482990|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
482991|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
482992|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
482993|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
482994|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
482995|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
482996|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
482997|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
482998|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
482999|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
483000|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
483001|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
483002|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
483003|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
483004|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
483005|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
483006|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
483007|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
483008|NCT00100048|1570561|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
483009|NCT00100048|1570562|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
483010|NCT00100048|1570563|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
483011|NCT00100048|1570564|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
483012|NCT00100048|1570565|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
483013|NCT00100048|1570566|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
483014|NCT00099983|1570675|P2|Overall Study|Other issue|0
483015|NCT00099983|1570676|P1|Overall Study|Other issue|1
483016|NCT00099983|1570675|P2|Overall Study|Intolerant of burden of visits|1
483017|NCT00099983|1570676|P1|Overall Study|Intolerant of burden of visits|0
483018|NCT00099983|1570675|P2|Overall Study|Incarcerated|1
483019|NCT00099983|1570676|P1|Overall Study|Incarcerated|0
483020|NCT00099983|1570675|P2|Overall Study|Other psychiatric problem|0
483021|NCT00099983|1570676|P1|Overall Study|Other psychiatric problem|1
483022|NCT00099983|1570675|P2|Overall Study|Moved|0
483023|NCT00099983|1570676|P1|Overall Study|Moved|1
483024|NCT00099983|1570675|P2|Overall Study|Unable to return for appointments|1
483025|NCT00099983|1570676|P1|Overall Study|Unable to return for appointments|1
483026|NCT00099983|1570675|P2|Overall Study|Lack of Efficacy|1
483027|NCT00099983|1570676|P1|Overall Study|Lack of Efficacy|0
483028|NCT00099983|1570675|P2|Overall Study|Adverse Event|1
483029|NCT00099983|1570676|P1|Overall Study|Adverse Event|1
483030|NCT00099983|1570675|P2|Overall Study|Withdrawal by Subject|2
483031|NCT00099983|1570676|P1|Overall Study|Withdrawal by Subject|3
483032|NCT00099983|1570675|P2|Overall Study|Missing Source Documents|15
483033|NCT00099983|1570676|P1|Overall Study|Missing Source Documents|14
483034|NCT00099983|1570675|P2|Overall Study|Lost to Follow-up|3
483035|NCT00099983|1570676|P1|Overall Study|Lost to Follow-up|2
483036|NCT00099632|1570688|P6|Overall Study|Protocol Violation|1
483037|NCT00099632|1570689|P5|Overall Study|Protocol Violation|0
483038|NCT00099632|1570690|P4|Overall Study|Protocol Violation|0
483039|NCT00099632|1570691|P3|Overall Study|Protocol Violation|0
483040|NCT00099632|1570692|P2|Overall Study|Protocol Violation|0
483041|NCT00099632|1570693|P1|Overall Study|Protocol Violation|0
483042|NCT00099632|1570688|P6|Overall Study|Withdrawal by Subject|1
483043|NCT00099632|1570689|P5|Overall Study|Withdrawal by Subject|0
483044|NCT00099632|1570690|P4|Overall Study|Withdrawal by Subject|0
483045|NCT00099632|1570691|P3|Overall Study|Withdrawal by Subject|0
483046|NCT00099632|1570692|P2|Overall Study|Withdrawal by Subject|1
483047|NCT00099632|1570693|P1|Overall Study|Withdrawal by Subject|0
483048|NCT00099632|1570688|P6|Overall Study|Lost to Follow-up|0
483049|NCT00099632|1570689|P5|Overall Study|Lost to Follow-up|1
483050|NCT00099632|1570690|P4|Overall Study|Lost to Follow-up|1
483051|NCT00099632|1570691|P3|Overall Study|Lost to Follow-up|3
483052|NCT00099632|1570692|P2|Overall Study|Lost to Follow-up|0
483053|NCT00099632|1570693|P1|Overall Study|Lost to Follow-up|1
483054|NCT00099437|1570733|P2|Overall Study|Ongoing in FU but not on treatment|45
483055|NCT00099437|1570734|P1|Overall Study|Ongoing in FU but not on treatment|37
483056|NCT00099437|1570733|P2|Overall Study|Withdrawal by Subject|10
483057|NCT00099437|1570734|P1|Overall Study|Withdrawal by Subject|6
483058|NCT00099437|1570733|P2|Overall Study|Death|261
483059|NCT00099437|1570734|P1|Overall Study|Death|293
483060|NCT00099437|1570733|P2|Overall Study|Lost to Follow-up|33
483061|NCT00099437|1570734|P1|Overall Study|Lost to Follow-up|30
483062|NCT00099359|1570757|P3|Overall Study|moved out of area|4
483063|NCT00099359|1570758|P2|Overall Study|moved out of area|7
483064|NCT00099359|1570759|P1|Overall Study|moved out of area|9
483065|NCT00099359|1570757|P3|Overall Study|Lost to Follow-up|24
483066|NCT00099359|1570758|P2|Overall Study|Lost to Follow-up|24
483067|NCT00099359|1570759|P1|Overall Study|Lost to Follow-up|15
483068|NCT00099359|1570757|P3|Overall Study|Withdrawal by Subject|23
483069|NCT00099359|1570758|P2|Overall Study|Withdrawal by Subject|19
483070|NCT00099359|1570759|P1|Overall Study|Withdrawal by Subject|19
483071|NCT00099359|1570757|P3|Overall Study|Death|17
483072|NCT00099359|1570758|P2|Overall Study|Death|15
483073|NCT00099359|1570759|P1|Overall Study|Death|11
483074|NCT00099268|1570782|P2|Overall Study|Death|1
483075|NCT00099268|1570783|P1|Overall Study|Death|3
483076|NCT00099268|1570782|P2|Overall Study|Administrative problems|4
483077|NCT00099268|1570783|P1|Overall Study|Administrative problems|4
483078|NCT00099268|1570782|P2|Overall Study|Lack of Efficacy|18
483079|NCT00099268|1570783|P1|Overall Study|Lack of Efficacy|5
483080|NCT00099268|1570782|P2|Overall Study|Lost to Follow-up|4
483081|NCT00099268|1570783|P1|Overall Study|Lost to Follow-up|6
483082|NCT00099268|1570782|P2|Overall Study|Protocol Violation|8
483083|NCT00099268|1570783|P1|Overall Study|Protocol Violation|9
483084|NCT00099268|1570782|P2|Overall Study|Adverse Event|19
483085|NCT00099268|1570783|P1|Overall Study|Adverse Event|19
483086|NCT00099268|1570782|P2|Overall Study|Withdrawal by Subject|28
483087|NCT00099268|1570783|P1|Overall Study|Withdrawal by Subject|46
483088|NCT00098865|1570819|P1|Overall Study|Alternative Therapy|1
483089|NCT00098865|1570819|P1|Overall Study|Adverse Event|2
483090|NCT00098865|1570819|P1|Overall Study|Progressive Disease|6
483091|NCT00098839|1570827|P2|Overall Study|Ineligible|0
483092|NCT00098839|1570828|P1|Overall Study|Ineligible|2
483093|NCT00098839|1570827|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
483094|NCT00098839|1570828|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
483095|NCT00098839|1570827|P2|Overall Study|Relapse|3
483096|NCT00098839|1570828|P1|Overall Study|Relapse|6
483097|NCT00098839|1570827|P2|Overall Study|Refusal of further protocol therapy|1
483098|NCT00098839|1570828|P1|Overall Study|Refusal of further protocol therapy|3
483099|NCT00098839|1570827|P2|Overall Study|Withdrawal by Subject|0
483100|NCT00098839|1570828|P1|Overall Study|Withdrawal by Subject|1
483101|NCT00098839|1570827|P2|Overall Study|Physician Decision|14
483102|NCT00098839|1570828|P1|Overall Study|Physician Decision|4
483103|NCT00098839|1570827|P2|Overall Study|Death|2
483104|NCT00098839|1570828|P1|Overall Study|Death|1
483105|NCT00098839|1570827|P2|Overall Study|Adverse Event|2
483106|NCT00098839|1570828|P1|Overall Study|Adverse Event|5
483107|NCT00098813|1570839|P1|Overall Study|Reversal of RAI resistance|1
483108|NCT00098813|1570839|P1|Overall Study|Other complicating disease|1
483109|NCT00098813|1570839|P1|Overall Study|Progression of Disease|1
483110|NCT00098813|1570839|P1|Overall Study|Withdrawal by Subject|7
483111|NCT00098813|1570839|P1|Overall Study|Protocol Violation|1
483112|NCT00098813|1570839|P1|Overall Study|Death|8
483113|NCT00098787|1570846|P3|Overall Study|Other|9
483114|NCT00098787|1570847|P2|Overall Study|Other|6
483115|NCT00098787|1570848|P1|Overall Study|Other|7
483116|NCT00098787|1570846|P3|Overall Study|Alternative therapy|13
483117|NCT00098787|1570847|P2|Overall Study|Alternative therapy|13
483118|NCT00098787|1570848|P1|Overall Study|Alternative therapy|8
483119|NCT00098787|1570846|P3|Overall Study|Withdrawal by Subject|6
483120|NCT00098787|1570847|P2|Overall Study|Withdrawal by Subject|12
483121|NCT00098787|1570848|P1|Overall Study|Withdrawal by Subject|4
483122|NCT00098787|1570846|P3|Overall Study|Death|0
483123|NCT00098787|1570847|P2|Overall Study|Death|1
483124|NCT00098787|1570848|P1|Overall Study|Death|6
483125|NCT00098787|1570846|P3|Overall Study|Adverse Event|8
483126|NCT00098787|1570847|P2|Overall Study|Adverse Event|17
483127|NCT00098787|1570848|P1|Overall Study|Adverse Event|8
483128|NCT00098787|1570846|P3|Overall Study|Disease progression|23
483129|NCT00098787|1570847|P2|Overall Study|Disease progression|17
483130|NCT00098787|1570848|P1|Overall Study|Disease progression|28
483131|NCT00098787|1570846|P3|Overall Study|Ineligible|3
483132|NCT00098787|1570847|P2|Overall Study|Ineligible|7
483133|NCT00098787|1570848|P1|Overall Study|Ineligible|9
483134|NCT00098787|1570846|P3|Overall Study|Never started treatment|1
483135|NCT00098787|1570847|P2|Overall Study|Never started treatment|2
483136|NCT00098787|1570848|P1|Overall Study|Never started treatment|3
483137|NCT00098774|1570862|P1|Overall Study|Physician Decision|2
483138|NCT00098774|1570862|P1|Overall Study|Failed (to respond) during induction|4
483139|NCT00098774|1570862|P1|Overall Study|Withdrawal by Subject|1
483140|NCT00098774|1570862|P1|Overall Study|Disease Progression|9
483141|NCT00098774|1570862|P1|Overall Study|Adverse Event|2
483142|NCT00098748|1570872|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
483143|NCT00098748|1570873|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
483144|NCT00098748|1570874|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
483145|NCT00098748|1570872|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
483146|NCT00098748|1570873|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
483147|NCT00098748|1570874|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
483148|NCT00098748|1570872|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
483149|NCT00098748|1570873|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
483150|NCT00098748|1570874|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
483151|NCT00098748|1570872|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
483152|NCT00098748|1570873|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
483153|NCT00098748|1570874|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
483154|NCT00098748|1570872|P3|Continued on Open-Label Treatment|Adverse Event|0
483155|NCT00098748|1570873|P2|Continued on Open-Label Treatment|Adverse Event|1
483156|NCT00098748|1570874|P1|Continued on Open-Label Treatment|Adverse Event|0
483157|NCT00098748|1570872|P3|Received Study Treatment|Subject defaulted|4
483158|NCT00098748|1570873|P2|Received Study Treatment|Subject defaulted|4
483159|NCT00098748|1570874|P1|Received Study Treatment|Subject defaulted|3
483160|NCT00098748|1570872|P3|Received Study Treatment|Other|6
483161|NCT00098748|1570873|P2|Received Study Treatment|Other|2
483162|NCT00098748|1570874|P1|Received Study Treatment|Other|2
483163|NCT00098748|1570872|P3|Received Study Treatment|Lack of Efficacy|27
483164|NCT00098748|1570873|P2|Received Study Treatment|Lack of Efficacy|27
483165|NCT00098748|1570874|P1|Received Study Treatment|Lack of Efficacy|40
483166|NCT00098748|1570872|P3|Received Study Treatment|Adverse Event|5
483167|NCT00098748|1570873|P2|Received Study Treatment|Adverse Event|2
483168|NCT00098748|1570874|P1|Received Study Treatment|Adverse Event|1
483169|NCT00098748|1570872|P3|Received Study Treatment|Death|2
483170|NCT00098748|1570873|P2|Received Study Treatment|Death|1
483171|NCT00098748|1570874|P1|Received Study Treatment|Death|2
483172|NCT00098748|1570872|P3|Assigned to Study Treatment|Randomized, but not treated|2
483173|NCT00098748|1570873|P2|Assigned to Study Treatment|Randomized, but not treated|2
483174|NCT00098748|1570874|P1|Assigned to Study Treatment|Randomized, but not treated|0
483175|NCT00098722|1570930|P7|Observation Phase|Other|10
483176|NCT00098722|1570931|P6|Observation Phase|Other|21
483177|NCT00098722|1570932|P5|Observation Phase|Other|0
483178|NCT00098722|1570933|P4|Observation Phase|Other|0
483179|NCT00098722|1570934|P3|Observation Phase|Other|0
483180|NCT00098722|1570935|P2|Observation Phase|Other|0
483181|NCT00098722|1570936|P1|Observation Phase|Other|0
483182|NCT00098722|1570930|P7|Observation Phase|Participant defaulted|4
483183|NCT00098722|1570931|P6|Observation Phase|Participant defaulted|17
483184|NCT00098722|1570932|P5|Observation Phase|Participant defaulted|0
483185|NCT00098722|1570933|P4|Observation Phase|Participant defaulted|0
483186|NCT00098722|1570934|P3|Observation Phase|Participant defaulted|0
483187|NCT00098722|1570935|P2|Observation Phase|Participant defaulted|0
483188|NCT00098722|1570936|P1|Observation Phase|Participant defaulted|0
483189|NCT00098722|1570930|P7|Observation Phase|Lack of Efficacy|0
483190|NCT00098722|1570931|P6|Observation Phase|Lack of Efficacy|2
483191|NCT00098722|1570932|P5|Observation Phase|Lack of Efficacy|0
483192|NCT00098722|1570933|P4|Observation Phase|Lack of Efficacy|0
483193|NCT00098722|1570934|P3|Observation Phase|Lack of Efficacy|0
483194|NCT00098722|1570935|P2|Observation Phase|Lack of Efficacy|0
483195|NCT00098722|1570936|P1|Observation Phase|Lack of Efficacy|0
483196|NCT00098722|1570930|P7|Observation Phase|Death|3
483197|NCT00098722|1570931|P6|Observation Phase|Death|5
483198|NCT00098722|1570932|P5|Observation Phase|Death|0
483199|NCT00098722|1570933|P4|Observation Phase|Death|0
483200|NCT00098722|1570934|P3|Observation Phase|Death|0
483201|NCT00098722|1570935|P2|Observation Phase|Death|0
483202|NCT00098722|1570936|P1|Observation Phase|Death|0
483203|NCT00098722|1570930|P7|Open Label Phase|Other|0
483204|NCT00098722|1570931|P6|Open Label Phase|Other|0
483205|NCT00098722|1570932|P5|Open Label Phase|Other|0
483206|NCT00098722|1570933|P4|Open Label Phase|Other|18
483207|NCT00098722|1570934|P3|Open Label Phase|Other|0
483208|NCT00098722|1570935|P2|Open Label Phase|Other|0
483209|NCT00098722|1570936|P1|Open Label Phase|Other|0
483210|NCT00098722|1570930|P7|Open Label Phase|Ongoing at cut-off date|0
483211|NCT00098722|1570931|P6|Open Label Phase|Ongoing at cut-off date|0
483212|NCT00098722|1570932|P5|Open Label Phase|Ongoing at cut-off date|50
483213|NCT00098722|1570933|P4|Open Label Phase|Ongoing at cut-off date|220
483214|NCT00098722|1570934|P3|Open Label Phase|Ongoing at cut-off date|0
483215|NCT00098722|1570935|P2|Open Label Phase|Ongoing at cut-off date|0
483216|NCT00098722|1570936|P1|Open Label Phase|Ongoing at cut-off date|0
483217|NCT00098722|1570930|P7|Open Label Phase|Participant defaulted|0
483218|NCT00098722|1570931|P6|Open Label Phase|Participant defaulted|0
483219|NCT00098722|1570932|P5|Open Label Phase|Participant defaulted|0
483220|NCT00098722|1570933|P4|Open Label Phase|Participant defaulted|18
483221|NCT00098722|1570934|P3|Open Label Phase|Participant defaulted|0
483222|NCT00098722|1570935|P2|Open Label Phase|Participant defaulted|0
483223|NCT00098722|1570936|P1|Open Label Phase|Participant defaulted|0
483224|NCT00098722|1570930|P7|Open Label Phase|Pregnancy|0
483225|NCT00098722|1570931|P6|Open Label Phase|Pregnancy|0
483226|NCT00098722|1570932|P5|Open Label Phase|Pregnancy|0
483227|NCT00098722|1570933|P4|Open Label Phase|Pregnancy|1
483228|NCT00098722|1570934|P3|Open Label Phase|Pregnancy|0
483229|NCT00098722|1570935|P2|Open Label Phase|Pregnancy|0
483230|NCT00098722|1570936|P1|Open Label Phase|Pregnancy|0
483231|NCT00098722|1570930|P7|Open Label Phase|Lack of Efficacy|0
483232|NCT00098722|1570931|P6|Open Label Phase|Lack of Efficacy|0
483233|NCT00098722|1570932|P5|Open Label Phase|Lack of Efficacy|0
483234|NCT00098722|1570933|P4|Open Label Phase|Lack of Efficacy|8
483235|NCT00098722|1570934|P3|Open Label Phase|Lack of Efficacy|0
483236|NCT00098722|1570935|P2|Open Label Phase|Lack of Efficacy|0
483237|NCT00098722|1570936|P1|Open Label Phase|Lack of Efficacy|0
483238|NCT00098722|1570930|P7|Open Label Phase|Death|0
483239|NCT00098722|1570931|P6|Open Label Phase|Death|0
483240|NCT00098722|1570932|P5|Open Label Phase|Death|0
483241|NCT00098722|1570933|P4|Open Label Phase|Death|2
483242|NCT00098722|1570934|P3|Open Label Phase|Death|0
483243|NCT00098722|1570935|P2|Open Label Phase|Death|0
483244|NCT00098722|1570936|P1|Open Label Phase|Death|0
483245|NCT00098722|1570930|P7|Open Label Phase|Adverse Event|0
483246|NCT00098722|1570931|P6|Open Label Phase|Adverse Event|0
483247|NCT00098722|1570932|P5|Open Label Phase|Adverse Event|0
483248|NCT00098722|1570933|P4|Open Label Phase|Adverse Event|5
483249|NCT00098722|1570934|P3|Open Label Phase|Adverse Event|0
483250|NCT00098722|1570935|P2|Open Label Phase|Adverse Event|0
483251|NCT00098722|1570936|P1|Open Label Phase|Adverse Event|0
483252|NCT00098722|1570930|P7|Double Blind Phase|Other|0
483253|NCT00098722|1570931|P6|Double Blind Phase|Other|0
483254|NCT00098722|1570932|P5|Double Blind Phase|Other|0
483255|NCT00098722|1570933|P4|Double Blind Phase|Other|0
483256|NCT00098722|1570934|P3|Double Blind Phase|Other|7
483257|NCT00098722|1570935|P2|Double Blind Phase|Other|8
483258|NCT00098722|1570936|P1|Double Blind Phase|Other|7
483259|NCT00098722|1570930|P7|Double Blind Phase|Ongoing at cut-off date|0
483260|NCT00098722|1570931|P6|Double Blind Phase|Ongoing at cut-off date|0
483261|NCT00098722|1570932|P5|Double Blind Phase|Ongoing at cut-off date|0
483262|NCT00098722|1570933|P4|Double Blind Phase|Ongoing at cut-off date|0
483263|NCT00098722|1570934|P3|Double Blind Phase|Ongoing at cut-off date|57
483264|NCT00098722|1570935|P2|Double Blind Phase|Ongoing at cut-off date|137
483265|NCT00098722|1570936|P1|Double Blind Phase|Ongoing at cut-off date|128
483266|NCT00098722|1570930|P7|Double Blind Phase|Randomized, not treated|0
483267|NCT00098722|1570931|P6|Double Blind Phase|Randomized, not treated|0
483268|NCT00098722|1570932|P5|Double Blind Phase|Randomized, not treated|0
483269|NCT00098722|1570933|P4|Double Blind Phase|Randomized, not treated|0
483270|NCT00098722|1570934|P3|Double Blind Phase|Randomized, not treated|3
483271|NCT00098722|1570935|P2|Double Blind Phase|Randomized, not treated|3
483272|NCT00098722|1570936|P1|Double Blind Phase|Randomized, not treated|4
483273|NCT00098722|1570930|P7|Double Blind Phase|Pregnancy|0
483274|NCT00098722|1570931|P6|Double Blind Phase|Pregnancy|0
483275|NCT00098722|1570932|P5|Double Blind Phase|Pregnancy|0
483276|NCT00098722|1570933|P4|Double Blind Phase|Pregnancy|0
483277|NCT00098722|1570934|P3|Double Blind Phase|Pregnancy|0
483278|NCT00098722|1570935|P2|Double Blind Phase|Pregnancy|0
483279|NCT00098722|1570936|P1|Double Blind Phase|Pregnancy|1
483280|NCT00098722|1570930|P7|Double Blind Phase|Participant defaulted|0
483281|NCT00098722|1570931|P6|Double Blind Phase|Participant defaulted|0
483282|NCT00098722|1570932|P5|Double Blind Phase|Participant defaulted|0
483283|NCT00098722|1570933|P4|Double Blind Phase|Participant defaulted|0
483284|NCT00098722|1570934|P3|Double Blind Phase|Participant defaulted|9
483285|NCT00098722|1570935|P2|Double Blind Phase|Participant defaulted|11
483286|NCT00098722|1570936|P1|Double Blind Phase|Participant defaulted|16
483287|NCT00098722|1570930|P7|Double Blind Phase|Lack of Efficacy|0
483288|NCT00098722|1570931|P6|Double Blind Phase|Lack of Efficacy|0
483289|NCT00098722|1570932|P5|Double Blind Phase|Lack of Efficacy|0
483290|NCT00098722|1570933|P4|Double Blind Phase|Lack of Efficacy|0
483291|NCT00098722|1570934|P3|Double Blind Phase|Lack of Efficacy|15
483292|NCT00098722|1570935|P2|Double Blind Phase|Lack of Efficacy|23
483293|NCT00098722|1570936|P1|Double Blind Phase|Lack of Efficacy|21
483294|NCT00098722|1570930|P7|Double Blind Phase|Death|0
483295|NCT00098722|1570931|P6|Double Blind Phase|Death|0
483296|NCT00098722|1570932|P5|Double Blind Phase|Death|0
483297|NCT00098722|1570933|P4|Double Blind Phase|Death|0
483298|NCT00098722|1570934|P3|Double Blind Phase|Death|0
483299|NCT00098722|1570935|P2|Double Blind Phase|Death|5
483300|NCT00098722|1570936|P1|Double Blind Phase|Death|2
483301|NCT00098722|1570930|P7|Double Blind Phase|Adverse Event|0
483302|NCT00098722|1570931|P6|Double Blind Phase|Adverse Event|0
483303|NCT00098722|1570932|P5|Double Blind Phase|Adverse Event|0
483304|NCT00098722|1570933|P4|Double Blind Phase|Adverse Event|0
483305|NCT00098722|1570934|P3|Double Blind Phase|Adverse Event|3
483306|NCT00098722|1570935|P2|Double Blind Phase|Adverse Event|7
483307|NCT00098722|1570936|P1|Double Blind Phase|Adverse Event|7
483308|NCT00098475|1571010|P4|Step 2|Never started treatment|0
483309|NCT00098475|1571011|P3|Step 2|Never started treatment|0
483310|NCT00098475|1571012|P2|Step 2|Never started treatment|1
483311|NCT00098475|1571013|P1|Step 2|Never started treatment|1
483312|NCT00098475|1571010|P4|Step 2|Alternative therapy|0
483313|NCT00098475|1571011|P3|Step 2|Alternative therapy|0
483314|NCT00098475|1571012|P2|Step 2|Alternative therapy|2
483315|NCT00098475|1571013|P1|Step 2|Alternative therapy|1
483316|NCT00098475|1571010|P4|Step 2|Physician Decision|0
483317|NCT00098475|1571011|P3|Step 2|Physician Decision|0
483318|NCT00098475|1571012|P2|Step 2|Physician Decision|1
483319|NCT00098475|1571013|P1|Step 2|Physician Decision|0
483320|NCT00098475|1571010|P4|Step 2|Withdrawal by Subject|0
483321|NCT00098475|1571011|P3|Step 2|Withdrawal by Subject|0
483322|NCT00098475|1571012|P2|Step 2|Withdrawal by Subject|2
483323|NCT00098475|1571013|P1|Step 2|Withdrawal by Subject|0
483324|NCT00098475|1571010|P4|Step 2|Adverse Event|0
483325|NCT00098475|1571011|P3|Step 2|Adverse Event|0
483326|NCT00098475|1571012|P2|Step 2|Adverse Event|0
483327|NCT00098475|1571013|P1|Step 2|Adverse Event|2
483328|NCT00098475|1571010|P4|Step 2|Disease progression|0
483329|NCT00098475|1571011|P3|Step 2|Disease progression|0
483330|NCT00098475|1571012|P2|Step 2|Disease progression|4
483331|NCT00098475|1571013|P1|Step 2|Disease progression|1
483332|NCT00098475|1571010|P4|Step 1|Not documented|0
483333|NCT00098475|1571011|P3|Step 1|Not documented|0
483334|NCT00098475|1571012|P2|Step 1|Not documented|1
483335|NCT00098475|1571013|P1|Step 1|Not documented|0
483336|NCT00098475|1571010|P4|Step 1|Patient fell with fracture|0
483337|NCT00098475|1571011|P3|Step 1|Patient fell with fracture|0
483338|NCT00098475|1571012|P2|Step 1|Patient fell with fracture|0
483339|NCT00098475|1571013|P1|Step 1|Patient fell with fracture|1
483340|NCT00098475|1571010|P4|Step 1|Misinterpretation of lab data|0
483341|NCT00098475|1571011|P3|Step 1|Misinterpretation of lab data|0
483342|NCT00098475|1571012|P2|Step 1|Misinterpretation of lab data|1
483343|NCT00098475|1571013|P1|Step 1|Misinterpretation of lab data|0
483344|NCT00098475|1571010|P4|Step 1|Criteria to continue treatment not met|0
483345|NCT00098475|1571011|P3|Step 1|Criteria to continue treatment not met|0
483346|NCT00098475|1571012|P2|Step 1|Criteria to continue treatment not met|1
483347|NCT00098475|1571013|P1|Step 1|Criteria to continue treatment not met|0
483348|NCT00098475|1571010|P4|Step 1|Referred to other physicians|0
483349|NCT00098475|1571011|P3|Step 1|Referred to other physicians|0
483350|NCT00098475|1571012|P2|Step 1|Referred to other physicians|1
483351|NCT00098475|1571013|P1|Step 1|Referred to other physicians|0
483352|NCT00098475|1571010|P4|Step 1|Rising paraprotein|0
483353|NCT00098475|1571011|P3|Step 1|Rising paraprotein|0
483354|NCT00098475|1571012|P2|Step 1|Rising paraprotein|1
483355|NCT00098475|1571013|P1|Step 1|Rising paraprotein|0
483356|NCT00098475|1571010|P4|Step 1|Insurance issue|0
483357|NCT00098475|1571011|P3|Step 1|Insurance issue|0
483358|NCT00098475|1571012|P2|Step 1|Insurance issue|1
483359|NCT00098475|1571013|P1|Step 1|Insurance issue|0
483360|NCT00098475|1571010|P4|Step 1|Declining performance status|0
483361|NCT00098475|1571011|P3|Step 1|Declining performance status|0
483362|NCT00098475|1571012|P2|Step 1|Declining performance status|1
483363|NCT00098475|1571013|P1|Step 1|Declining performance status|0
483364|NCT00098475|1571010|P4|Step 1|Off treatment for > specified timeframe|0
483365|NCT00098475|1571011|P3|Step 1|Off treatment for > specified timeframe|0
483366|NCT00098475|1571012|P2|Step 1|Off treatment for > specified timeframe|1
483367|NCT00098475|1571013|P1|Step 1|Off treatment for > specified timeframe|1
483368|NCT00098475|1571010|P4|Step 1|Incorrect disease assessment|0
483369|NCT00098475|1571011|P3|Step 1|Incorrect disease assessment|0
483370|NCT00098475|1571012|P2|Step 1|Incorrect disease assessment|0
483371|NCT00098475|1571013|P1|Step 1|Incorrect disease assessment|2
483372|NCT00098475|1571010|P4|Step 1|Both patient and physician's decision|0
483373|NCT00098475|1571011|P3|Step 1|Both patient and physician's decision|0
483374|NCT00098475|1571012|P2|Step 1|Both patient and physician's decision|1
483375|NCT00098475|1571013|P1|Step 1|Both patient and physician's decision|2
483376|NCT00098475|1571010|P4|Step 1|Cannot comply due to other tx|0
483377|NCT00098475|1571011|P3|Step 1|Cannot comply due to other tx|0
483378|NCT00098475|1571012|P2|Step 1|Cannot comply due to other tx|1
483379|NCT00098475|1571013|P1|Step 1|Cannot comply due to other tx|0
483380|NCT00098475|1571010|P4|Step 1|Complications|0
483381|NCT00098475|1571011|P3|Step 1|Complications|0
483382|NCT00098475|1571012|P2|Step 1|Complications|0
483383|NCT00098475|1571013|P1|Step 1|Complications|1
483384|NCT00098475|1571010|P4|Step 1|Knee surgery|0
483385|NCT00098475|1571011|P3|Step 1|Knee surgery|0
483386|NCT00098475|1571012|P2|Step 1|Knee surgery|0
483387|NCT00098475|1571013|P1|Step 1|Knee surgery|1
483388|NCT00098475|1571010|P4|Step 1|Still on treatment as of this analysis|0
483389|NCT00098475|1571011|P3|Step 1|Still on treatment as of this analysis|0
483390|NCT00098475|1571012|P2|Step 1|Still on treatment as of this analysis|27
483391|NCT00098475|1571013|P1|Step 1|Still on treatment as of this analysis|14
483392|NCT00098475|1571010|P4|Step 1|Never started treatment|0
483393|NCT00098475|1571011|P3|Step 1|Never started treatment|0
483394|NCT00098475|1571012|P2|Step 1|Never started treatment|2
483395|NCT00098475|1571013|P1|Step 1|Never started treatment|0
483396|NCT00098475|1571010|P4|Step 1|Other disease|0
483397|NCT00098475|1571011|P3|Step 1|Other disease|1
483398|NCT00098475|1571012|P2|Step 1|Other disease|1
483399|NCT00098475|1571013|P1|Step 1|Other disease|2
483400|NCT00098475|1571010|P4|Step 1|Alternative therapy|0
483401|NCT00098475|1571011|P3|Step 1|Alternative therapy|1
483402|NCT00098475|1571012|P2|Step 1|Alternative therapy|43
483403|NCT00098475|1571013|P1|Step 1|Alternative therapy|31
483404|NCT00098475|1571010|P4|Step 1|Physician Decision|0
483405|NCT00098475|1571011|P3|Step 1|Physician Decision|0
483406|NCT00098475|1571012|P2|Step 1|Physician Decision|2
483407|NCT00098475|1571013|P1|Step 1|Physician Decision|5
483408|NCT00098475|1571010|P4|Step 1|Withdrawal by Subject|0
483409|NCT00098475|1571011|P3|Step 1|Withdrawal by Subject|0
483410|NCT00098475|1571012|P2|Step 1|Withdrawal by Subject|11
483411|NCT00098475|1571013|P1|Step 1|Withdrawal by Subject|14
483412|NCT00098475|1571010|P4|Step 1|Death|1
483413|NCT00098475|1571011|P3|Step 1|Death|0
483414|NCT00098475|1571012|P2|Step 1|Death|5
483415|NCT00098475|1571013|P1|Step 1|Death|8
483416|NCT00098475|1571010|P4|Step 1|Adverse Event|1
483417|NCT00098475|1571011|P3|Step 1|Adverse Event|0
483418|NCT00098475|1571012|P2|Step 1|Adverse Event|37
483419|NCT00098475|1571013|P1|Step 1|Adverse Event|56
483420|NCT00098475|1571010|P4|Step 1|Progressive disease|1
483421|NCT00098475|1571011|P3|Step 1|Progressive disease|2
483422|NCT00098475|1571012|P2|Step 1|Progressive disease|35
483423|NCT00098475|1571013|P1|Step 1|Progressive disease|33
483424|NCT00098345|1571050|P1|Overall Study|progression|4
483425|NCT00098345|1571050|P1|Overall Study|Withdrawal by Subject|2
483426|NCT00098345|1571050|P1|Overall Study|Adverse Event|7
483427|NCT00098306|1571063|P7|Observational Phase|Un-specified|4
483428|NCT00098306|1571064|P6|Observational Phase|Un-specified|7
483429|NCT00098306|1571065|P5|Observational Phase|Un-specified|0
483430|NCT00098306|1571066|P4|Observational Phase|Un-specified|0
483431|NCT00098306|1571067|P3|Observational Phase|Un-specified|0
483432|NCT00098306|1571068|P2|Observational Phase|Un-specified|0
483433|NCT00098306|1571069|P1|Observational Phase|Un-specified|0
483434|NCT00098306|1571063|P7|Observational Phase|Participant defaulted|18
483435|NCT00098306|1571064|P6|Observational Phase|Participant defaulted|34
483436|NCT00098306|1571065|P5|Observational Phase|Participant defaulted|0
483437|NCT00098306|1571066|P4|Observational Phase|Participant defaulted|0
483438|NCT00098306|1571067|P3|Observational Phase|Participant defaulted|0
483439|NCT00098306|1571068|P2|Observational Phase|Participant defaulted|0
483440|NCT00098306|1571069|P1|Observational Phase|Participant defaulted|0
483441|NCT00098306|1571063|P7|Observational Phase|Death|4
483442|NCT00098306|1571064|P6|Observational Phase|Death|5
483443|NCT00098306|1571065|P5|Observational Phase|Death|0
483444|NCT00098306|1571066|P4|Observational Phase|Death|0
483445|NCT00098306|1571067|P3|Observational Phase|Death|0
483446|NCT00098306|1571068|P2|Observational Phase|Death|0
483447|NCT00098306|1571069|P1|Observational Phase|Death|0
483448|NCT00098306|1571063|P7|Open Label|Ongoing at cut-off date|0
483449|NCT00098306|1571064|P6|Open Label|Ongoing at cut-off date|0
483450|NCT00098306|1571065|P5|Open Label|Ongoing at cut-off date|62
483451|NCT00098306|1571066|P4|Open Label|Ongoing at cut-off date|269
483452|NCT00098306|1571067|P3|Open Label|Ongoing at cut-off date|0
483453|NCT00098306|1571068|P2|Open Label|Ongoing at cut-off date|0
483454|NCT00098306|1571069|P1|Open Label|Ongoing at cut-off date|0
483455|NCT00098306|1571063|P7|Open Label|Un-specified|0
483456|NCT00098306|1571064|P6|Open Label|Un-specified|0
483457|NCT00098306|1571065|P5|Open Label|Un-specified|0
483458|NCT00098306|1571066|P4|Open Label|Un-specified|15
483459|NCT00098306|1571067|P3|Open Label|Un-specified|0
483460|NCT00098306|1571068|P2|Open Label|Un-specified|0
483461|NCT00098306|1571069|P1|Open Label|Un-specified|0
483462|NCT00098306|1571063|P7|Open Label|Participant defaulted|0
483463|NCT00098306|1571064|P6|Open Label|Participant defaulted|0
483464|NCT00098306|1571065|P5|Open Label|Participant defaulted|0
483465|NCT00098306|1571066|P4|Open Label|Participant defaulted|24
483466|NCT00098306|1571067|P3|Open Label|Participant defaulted|0
483467|NCT00098306|1571068|P2|Open Label|Participant defaulted|0
483468|NCT00098306|1571069|P1|Open Label|Participant defaulted|0
483469|NCT00098306|1571063|P7|Open Label|Death|0
483470|NCT00098306|1571064|P6|Open Label|Death|0
483471|NCT00098306|1571065|P5|Open Label|Death|0
483472|NCT00098306|1571066|P4|Open Label|Death|4
483473|NCT00098306|1571067|P3|Open Label|Death|0
483474|NCT00098306|1571068|P2|Open Label|Death|0
483475|NCT00098306|1571069|P1|Open Label|Death|0
483476|NCT00098306|1571063|P7|Open Label|Adverse Event|0
483477|NCT00098306|1571064|P6|Open Label|Adverse Event|0
483478|NCT00098306|1571065|P5|Open Label|Adverse Event|0
483479|NCT00098306|1571066|P4|Open Label|Adverse Event|2
483480|NCT00098306|1571067|P3|Open Label|Adverse Event|0
483481|NCT00098306|1571068|P2|Open Label|Adverse Event|0
483482|NCT00098306|1571069|P1|Open Label|Adverse Event|0
483483|NCT00098306|1571063|P7|Open Label|Lack of Efficacy|0
483484|NCT00098306|1571064|P6|Open Label|Lack of Efficacy|0
483485|NCT00098306|1571065|P5|Open Label|Lack of Efficacy|0
483486|NCT00098306|1571066|P4|Open Label|Lack of Efficacy|13
483487|NCT00098306|1571067|P3|Open Label|Lack of Efficacy|0
483488|NCT00098306|1571068|P2|Open Label|Lack of Efficacy|0
483489|NCT00098306|1571069|P1|Open Label|Lack of Efficacy|0
483490|NCT00098306|1571063|P7|Double Blind|Un-specified|0
483491|NCT00098306|1571064|P6|Double Blind|Un-specified|0
483492|NCT00098306|1571065|P5|Double Blind|Un-specified|0
483493|NCT00098306|1571066|P4|Double Blind|Un-specified|0
483494|NCT00098306|1571067|P3|Double Blind|Un-specified|11
483495|NCT00098306|1571068|P2|Double Blind|Un-specified|3
483496|NCT00098306|1571069|P1|Double Blind|Un-specified|7
483497|NCT00098306|1571063|P7|Double Blind|Participant defaulted|0
483498|NCT00098306|1571064|P6|Double Blind|Participant defaulted|0
483499|NCT00098306|1571065|P5|Double Blind|Participant defaulted|0
483500|NCT00098306|1571066|P4|Double Blind|Participant defaulted|0
483501|NCT00098306|1571067|P3|Double Blind|Participant defaulted|11
483502|NCT00098306|1571068|P2|Double Blind|Participant defaulted|18
483503|NCT00098306|1571069|P1|Double Blind|Participant defaulted|19
483504|NCT00098306|1571063|P7|Double Blind|Death|0
483505|NCT00098306|1571064|P6|Double Blind|Death|0
483506|NCT00098306|1571065|P5|Double Blind|Death|0
483507|NCT00098306|1571066|P4|Double Blind|Death|0
483508|NCT00098306|1571067|P3|Double Blind|Death|1
483509|NCT00098306|1571068|P2|Double Blind|Death|4
483510|NCT00098306|1571069|P1|Double Blind|Death|1
483511|NCT00098306|1571063|P7|Double Blind|Lack of Efficacy|0
483512|NCT00098306|1571064|P6|Double Blind|Lack of Efficacy|0
483513|NCT00098306|1571065|P5|Double Blind|Lack of Efficacy|0
483514|NCT00098306|1571066|P4|Double Blind|Lack of Efficacy|0
483515|NCT00098306|1571067|P3|Double Blind|Lack of Efficacy|17
483516|NCT00098306|1571068|P2|Double Blind|Lack of Efficacy|34
483517|NCT00098306|1571069|P1|Double Blind|Lack of Efficacy|43
483518|NCT00098306|1571063|P7|Double Blind|Adverse Event|0
483519|NCT00098306|1571064|P6|Double Blind|Adverse Event|0
483520|NCT00098306|1571065|P5|Double Blind|Adverse Event|0
483521|NCT00098306|1571066|P4|Double Blind|Adverse Event|0
483522|NCT00098306|1571067|P3|Double Blind|Adverse Event|6
483523|NCT00098306|1571068|P2|Double Blind|Adverse Event|10
483524|NCT00098306|1571069|P1|Double Blind|Adverse Event|11
483525|NCT00098306|1571063|P7|Double Blind|Ongoing at cut-off date|0
483526|NCT00098306|1571064|P6|Double Blind|Ongoing at cut-off date|0
483527|NCT00098306|1571065|P5|Double Blind|Ongoing at cut-off date|0
483528|NCT00098306|1571066|P4|Double Blind|Ongoing at cut-off date|0
483529|NCT00098306|1571067|P3|Double Blind|Ongoing at cut-off date|72
483530|NCT00098306|1571068|P2|Double Blind|Ongoing at cut-off date|166
483531|NCT00098306|1571069|P1|Double Blind|Ongoing at cut-off date|151
483532|NCT00098306|1571063|P7|Double Blind|Randomized, not treated|0
483533|NCT00098306|1571064|P6|Double Blind|Randomized, not treated|0
483534|NCT00098306|1571065|P5|Double Blind|Randomized, not treated|0
483535|NCT00098306|1571066|P4|Double Blind|Randomized, not treated|0
483536|NCT00098306|1571067|P3|Double Blind|Randomized, not treated|2
483537|NCT00098306|1571068|P2|Double Blind|Randomized, not treated|5
483538|NCT00098306|1571069|P1|Double Blind|Randomized, not treated|9
483539|NCT00098293|1571135|P5|Supplemental Phase (SP)|Other|22
483540|NCT00098293|1571136|P4|Supplemental Phase (SP)|Other|0
483541|NCT00098293|1571137|P3|Supplemental Phase (SP)|Other|0
483542|NCT00098293|1571138|P2|Supplemental Phase (SP)|Other|0
483543|NCT00098293|1571139|P1|Supplemental Phase (SP)|Other|0
483544|NCT00098293|1571135|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
483545|NCT00098293|1571136|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
483546|NCT00098293|1571137|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
483547|NCT00098293|1571138|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
483548|NCT00098293|1571139|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
483549|NCT00098293|1571135|P5|Supplemental Phase (SP)|Lost to Follow-up|2
483550|NCT00098293|1571136|P4|Supplemental Phase (SP)|Lost to Follow-up|0
483551|NCT00098293|1571137|P3|Supplemental Phase (SP)|Lost to Follow-up|0
483552|NCT00098293|1571138|P2|Supplemental Phase (SP)|Lost to Follow-up|0
483553|NCT00098293|1571139|P1|Supplemental Phase (SP)|Lost to Follow-up|0
483554|NCT00098293|1571135|P5|Supplemental Phase (SP)|Death|1
483555|NCT00098293|1571136|P4|Supplemental Phase (SP)|Death|0
483556|NCT00098293|1571137|P3|Supplemental Phase (SP)|Death|0
483557|NCT00098293|1571138|P2|Supplemental Phase (SP)|Death|0
483558|NCT00098293|1571139|P1|Supplemental Phase (SP)|Death|0
483559|NCT00098293|1571135|P5|Open-label (OL) Phase|Death|0
483560|NCT00098293|1571136|P4|Open-label (OL) Phase|Death|0
483561|NCT00098293|1571137|P3|Open-label (OL) Phase|Death|3
483562|NCT00098293|1571138|P2|Open-label (OL) Phase|Death|2
483563|NCT00098293|1571139|P1|Open-label (OL) Phase|Death|0
483564|NCT00098293|1571135|P5|Open-label (OL) Phase|Participant Defaulted|0
483565|NCT00098293|1571136|P4|Open-label (OL) Phase|Participant Defaulted|20
483566|NCT00098293|1571137|P3|Open-label (OL) Phase|Participant Defaulted|16
483567|NCT00098293|1571138|P2|Open-label (OL) Phase|Participant Defaulted|6
483568|NCT00098293|1571139|P1|Open-label (OL) Phase|Participant Defaulted|0
483569|NCT00098293|1571135|P5|Open-label (OL) Phase|Protocol Violation|0
483570|NCT00098293|1571136|P4|Open-label (OL) Phase|Protocol Violation|16
483571|NCT00098293|1571137|P3|Open-label (OL) Phase|Protocol Violation|13
483572|NCT00098293|1571138|P2|Open-label (OL) Phase|Protocol Violation|6
483573|NCT00098293|1571139|P1|Open-label (OL) Phase|Protocol Violation|0
483574|NCT00098293|1571135|P5|Open-label (OL) Phase|Pregnancy|0
483575|NCT00098293|1571136|P4|Open-label (OL) Phase|Pregnancy|3
483576|NCT00098293|1571137|P3|Open-label (OL) Phase|Pregnancy|0
483577|NCT00098293|1571138|P2|Open-label (OL) Phase|Pregnancy|1
483578|NCT00098293|1571139|P1|Open-label (OL) Phase|Pregnancy|0
483579|NCT00098293|1571135|P5|Open-label (OL) Phase|Lack of Efficacy|0
483580|NCT00098293|1571136|P4|Open-label (OL) Phase|Lack of Efficacy|20
483581|NCT00098293|1571137|P3|Open-label (OL) Phase|Lack of Efficacy|2
483582|NCT00098293|1571138|P2|Open-label (OL) Phase|Lack of Efficacy|7
483583|NCT00098293|1571139|P1|Open-label (OL) Phase|Lack of Efficacy|0
483584|NCT00098293|1571135|P5|Open-label (OL) Phase|Adverse Event|0
483585|NCT00098293|1571136|P4|Open-label (OL) Phase|Adverse Event|6
483586|NCT00098293|1571137|P3|Open-label (OL) Phase|Adverse Event|7
483587|NCT00098293|1571138|P2|Open-label (OL) Phase|Adverse Event|3
483588|NCT00098293|1571139|P1|Open-label (OL) Phase|Adverse Event|0
483589|NCT00098293|1571135|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
483590|NCT00098293|1571136|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
483591|NCT00098293|1571137|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
483592|NCT00098293|1571138|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
483593|NCT00098293|1571139|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
483594|NCT00098293|1571135|P5|Double-blind (DB) Phase|Terminated by sponsor|0
483595|NCT00098293|1571136|P4|Double-blind (DB) Phase|Terminated by sponsor|0
483596|NCT00098293|1571137|P3|Double-blind (DB) Phase|Terminated by sponsor|0
483597|NCT00098293|1571138|P2|Double-blind (DB) Phase|Terminated by sponsor|0
483598|NCT00098293|1571139|P1|Double-blind (DB) Phase|Terminated by sponsor|135
483599|NCT00098293|1571135|P5|Double-blind (DB) Phase|Protocol Violation|0
483600|NCT00098293|1571136|P4|Double-blind (DB) Phase|Protocol Violation|0
483601|NCT00098293|1571137|P3|Double-blind (DB) Phase|Protocol Violation|22
483602|NCT00098293|1571138|P2|Double-blind (DB) Phase|Protocol Violation|18
483603|NCT00098293|1571139|P1|Double-blind (DB) Phase|Protocol Violation|2
483604|NCT00098293|1571135|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
483605|NCT00098293|1571136|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
483606|NCT00098293|1571137|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
483607|NCT00098293|1571138|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
483608|NCT00098293|1571139|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
483609|NCT00098293|1571135|P5|Double-blind (DB) Phase|Death|0
483610|NCT00098293|1571136|P4|Double-blind (DB) Phase|Death|0
483611|NCT00098293|1571137|P3|Double-blind (DB) Phase|Death|2
483612|NCT00098293|1571138|P2|Double-blind (DB) Phase|Death|2
483613|NCT00098293|1571139|P1|Double-blind (DB) Phase|Death|1
483614|NCT00098293|1571135|P5|Double-blind (DB) Phase|Lack of Efficacy|0
483615|NCT00098293|1571136|P4|Double-blind (DB) Phase|Lack of Efficacy|0
483616|NCT00098293|1571137|P3|Double-blind (DB) Phase|Lack of Efficacy|30
483617|NCT00098293|1571138|P2|Double-blind (DB) Phase|Lack of Efficacy|64
483618|NCT00098293|1571139|P1|Double-blind (DB) Phase|Lack of Efficacy|11
483619|NCT00098293|1571135|P5|Double-blind (DB) Phase|Participant Defaulted|0
483620|NCT00098293|1571136|P4|Double-blind (DB) Phase|Participant Defaulted|0
483621|NCT00098293|1571137|P3|Double-blind (DB) Phase|Participant Defaulted|36
483622|NCT00098293|1571138|P2|Double-blind (DB) Phase|Participant Defaulted|40
483623|NCT00098293|1571139|P1|Double-blind (DB) Phase|Participant Defaulted|11
483624|NCT00098293|1571135|P5|Double-blind (DB) Phase|Pregnancy|0
483625|NCT00098293|1571136|P4|Double-blind (DB) Phase|Pregnancy|0
483626|NCT00098293|1571137|P3|Double-blind (DB) Phase|Pregnancy|9
483627|NCT00098293|1571138|P2|Double-blind (DB) Phase|Pregnancy|7
483628|NCT00098293|1571139|P1|Double-blind (DB) Phase|Pregnancy|0
483629|NCT00098293|1571135|P5|Double-blind (DB) Phase|Adverse Event|0
483630|NCT00098293|1571136|P4|Double-blind (DB) Phase|Adverse Event|0
483631|NCT00098293|1571137|P3|Double-blind (DB) Phase|Adverse Event|60
483632|NCT00098293|1571138|P2|Double-blind (DB) Phase|Adverse Event|27
483633|NCT00098293|1571139|P1|Double-blind (DB) Phase|Adverse Event|14
483634|NCT00098254|1571192|P1|Overall Study|Death|1
483635|NCT00098254|1571192|P1|Overall Study|Adverse Event|2
483636|NCT00098020|1571258|P1|Overall Study|Low epidermal growth factor receptor|1
483637|NCT00098020|1571258|P1|Overall Study|Low urine PCR|1
483638|NCT00098020|1571258|P1|Overall Study|elevated liver enzymes|1
483639|NCT00098020|1571258|P1|Overall Study|Lost to Follow-up|1
483640|NCT00098020|1571258|P1|Overall Study|Adverse Event|2
483641|NCT00097981|1571265|P2|Overall Study|Other|13
483642|NCT00097981|1571266|P1|Overall Study|Other|19
483643|NCT00097981|1571265|P2|Overall Study|Transplant planned|27
483644|NCT00097981|1571266|P1|Overall Study|Transplant planned|28
483645|NCT00097981|1571265|P2|Overall Study|Disease Progression|2
483646|NCT00097981|1571266|P1|Overall Study|Disease Progression|8
483647|NCT00097981|1571265|P2|Overall Study|Physician Decision|1
483648|NCT00097981|1571266|P1|Overall Study|Physician Decision|7
483649|NCT00097981|1571265|P2|Overall Study|Death|4
483650|NCT00097981|1571266|P1|Overall Study|Death|2
483651|NCT00097981|1571265|P2|Overall Study|Protocol Violation|1
483652|NCT00097981|1571266|P1|Overall Study|Protocol Violation|1
483653|NCT00097981|1571265|P2|Overall Study|Withdrawal by Subject|8
483654|NCT00097981|1571266|P1|Overall Study|Withdrawal by Subject|10
483655|NCT00097981|1571265|P2|Overall Study|Adverse Event|44
483656|NCT00097981|1571266|P1|Overall Study|Adverse Event|31
483657|NCT00097786|1571288|P4|Overall Study|lost to follow-up for all-cause death|310
483658|NCT00097786|1571289|P3|Overall Study|lost to follow-up for all-cause death|313
483659|NCT00097786|1571290|P2|Overall Study|lost to follow-up for all-cause death|292
483660|NCT00097786|1571291|P1|Overall Study|lost to follow-up for all-cause death|296
483661|NCT00097773|1571313|P4|Overall Study|Other|0
483662|NCT00097773|1571314|P3|Overall Study|Other|2
483663|NCT00097773|1571315|P2|Overall Study|Other|0
483664|NCT00097773|1571316|P1|Overall Study|Other|1
483665|NCT00097773|1571313|P4|Overall Study|Adverse Event|0
483666|NCT00097773|1571314|P3|Overall Study|Adverse Event|0
483667|NCT00097773|1571315|P2|Overall Study|Adverse Event|1
483668|NCT00097773|1571316|P1|Overall Study|Adverse Event|0
483669|NCT00097773|1571313|P4|Overall Study|Withdrawal by Subject|1
483670|NCT00097773|1571314|P3|Overall Study|Withdrawal by Subject|3
483671|NCT00097773|1571315|P2|Overall Study|Withdrawal by Subject|3
483672|NCT00097773|1571316|P1|Overall Study|Withdrawal by Subject|3
483673|NCT00097773|1571313|P4|Overall Study|Physician Decision|1
483674|NCT00097773|1571314|P3|Overall Study|Physician Decision|3
483675|NCT00097773|1571315|P2|Overall Study|Physician Decision|2
483676|NCT00097773|1571316|P1|Overall Study|Physician Decision|2
483677|NCT00097773|1571313|P4|Overall Study|Lost to Follow-up|1
483678|NCT00097773|1571314|P3|Overall Study|Lost to Follow-up|0
483679|NCT00097773|1571315|P2|Overall Study|Lost to Follow-up|2
483680|NCT00097773|1571316|P1|Overall Study|Lost to Follow-up|2
483681|NCT00097721|1571336|P2|Overall Study|Reason not given|1
483682|NCT00097721|1571337|P1|Overall Study|Reason not given|1
483683|NCT00097721|1571336|P2|Overall Study|Physician Decision|3
483684|NCT00097721|1571337|P1|Overall Study|Physician Decision|1
483685|NCT00097721|1571336|P2|Overall Study|Progressive Disease|27
483686|NCT00097721|1571337|P1|Overall Study|Progressive Disease|55
483687|NCT00097721|1571336|P2|Overall Study|Withdrawal by Subject|1
483688|NCT00097721|1571337|P1|Overall Study|Withdrawal by Subject|6
483689|NCT00097721|1571336|P2|Overall Study|Adverse Event|1
483690|NCT00097721|1571337|P1|Overall Study|Adverse Event|8
483691|NCT00097591|1571387|P2|Overall Study|Other|3
483692|NCT00097591|1571388|P1|Overall Study|Other|0
483693|NCT00097591|1571387|P2|Overall Study|Lost to follow up|10
483694|NCT00097591|1571388|P1|Overall Study|Lost to follow up|6
483695|NCT00097591|1571387|P2|Overall Study|Unable to attend termination visit|51
483696|NCT00097591|1571388|P1|Overall Study|Unable to attend termination visit|53
483697|NCT00097591|1571387|P2|Overall Study|Less than 6 months on study drug|7
483698|NCT00097591|1571388|P1|Overall Study|Less than 6 months on study drug|9
483699|NCT00097591|1571387|P2|Overall Study|Withdrawal of consent|323
483700|NCT00097591|1571388|P1|Overall Study|Withdrawal of consent|342
483701|NCT00097539|1571411|P7|Overall Study|Reason not Specified|2
483702|NCT00097539|1571412|P6|Overall Study|Reason not Specified|40
483703|NCT00097539|1571413|P5|Overall Study|Reason not Specified|11
483704|NCT00097539|1571414|P4|Overall Study|Reason not Specified|21
483705|NCT00097539|1571415|P3|Overall Study|Reason not Specified|53
483706|NCT00097539|1571416|P2|Overall Study|Reason not Specified|49
483707|NCT00097539|1571417|P1|Overall Study|Reason not Specified|111
483708|NCT00097539|1571411|P7|Overall Study|Reasons Other Than Above|34
483709|NCT00097539|1571412|P6|Overall Study|Reasons Other Than Above|1244
483710|NCT00097539|1571413|P5|Overall Study|Reasons Other Than Above|361
483711|NCT00097539|1571414|P4|Overall Study|Reasons Other Than Above|692
483712|NCT00097539|1571415|P3|Overall Study|Reasons Other Than Above|1757
483713|NCT00097539|1571416|P2|Overall Study|Reasons Other Than Above|1382
483714|NCT00097539|1571417|P1|Overall Study|Reasons Other Than Above|3602
483715|NCT00097539|1571411|P7|Overall Study|Death|0
483716|NCT00097539|1571412|P6|Overall Study|Death|3
483717|NCT00097539|1571413|P5|Overall Study|Death|1
483718|NCT00097539|1571414|P4|Overall Study|Death|0
483719|NCT00097539|1571415|P3|Overall Study|Death|0
483720|NCT00097539|1571416|P2|Overall Study|Death|7
483721|NCT00097539|1571417|P1|Overall Study|Death|2
483722|NCT00097539|1571411|P7|Overall Study|Adverse Event|1
483723|NCT00097539|1571412|P6|Overall Study|Adverse Event|59
483724|NCT00097539|1571413|P5|Overall Study|Adverse Event|30
483725|NCT00097539|1571414|P4|Overall Study|Adverse Event|27
483726|NCT00097539|1571415|P3|Overall Study|Adverse Event|37
483727|NCT00097539|1571416|P2|Overall Study|Adverse Event|133
483728|NCT00097539|1571417|P1|Overall Study|Adverse Event|78
483729|NCT00097539|1571411|P7|Overall Study|Lack of Efficacy|5
483730|NCT00097539|1571412|P6|Overall Study|Lack of Efficacy|228
483731|NCT00097539|1571413|P5|Overall Study|Lack of Efficacy|45
483732|NCT00097539|1571414|P4|Overall Study|Lack of Efficacy|105
483733|NCT00097539|1571415|P3|Overall Study|Lack of Efficacy|202
483734|NCT00097539|1571416|P2|Overall Study|Lack of Efficacy|122
483735|NCT00097539|1571417|P1|Overall Study|Lack of Efficacy|249
483736|NCT00097539|1571411|P7|Overall Study|Participant Non-compliant|18
483737|NCT00097539|1571412|P6|Overall Study|Participant Non-compliant|543
483738|NCT00097539|1571413|P5|Overall Study|Participant Non-compliant|136
483739|NCT00097539|1571414|P4|Overall Study|Participant Non-compliant|353
483740|NCT00097539|1571415|P3|Overall Study|Participant Non-compliant|1067
483741|NCT00097539|1571416|P2|Overall Study|Participant Non-compliant|567
483742|NCT00097539|1571417|P1|Overall Study|Participant Non-compliant|2140
483743|NCT00097539|1571411|P7|Overall Study|Withdrawal by Subject|3
483744|NCT00097539|1571412|P6|Overall Study|Withdrawal by Subject|229
483745|NCT00097539|1571413|P5|Overall Study|Withdrawal by Subject|68
483746|NCT00097539|1571414|P4|Overall Study|Withdrawal by Subject|217
483747|NCT00097539|1571415|P3|Overall Study|Withdrawal by Subject|346
483748|NCT00097539|1571416|P2|Overall Study|Withdrawal by Subject|323
483749|NCT00097539|1571417|P1|Overall Study|Withdrawal by Subject|925
483750|NCT00097539|1571411|P7|Overall Study|Status Unknown (Or no final evaluation)|108
483751|NCT00097539|1571412|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
483752|NCT00097539|1571413|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
483753|NCT00097539|1571414|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
483754|NCT00097539|1571415|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
483755|NCT00097539|1571416|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
483756|NCT00097539|1571417|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
483757|NCT00097500|1571463|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
483758|NCT00097500|1571464|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
483759|NCT00097500|1571463|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
483760|NCT00097500|1571464|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
483761|NCT00097500|1571463|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
483762|NCT00097500|1571464|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
483763|NCT00097500|1571463|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
483764|NCT00097500|1571464|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
483765|NCT00097500|1571463|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
483766|NCT00097500|1571464|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
483767|NCT00097500|1571463|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
483768|NCT00097500|1571464|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
483769|NCT00097500|1571463|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
483770|NCT00097500|1571464|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
483771|NCT00097370|1571495|P1|Stage 3|Lost to Follow-up|1
483772|NCT00097370|1571495|P1|Stage 3|Sponsor Terminated Study|52
483773|NCT00097370|1571495|P1|Stage 3|Lack of Efficacy|1
483774|NCT00097370|1571495|P1|Stage 3|Withdrawal by Subject|3
483775|NCT00097370|1571495|P1|Stage 3|Adverse Event|2
483776|NCT00097370|1571495|P1|Stage 2|Lost to Follow-up|1
483777|NCT00097370|1571495|P1|Stage 2|Sponsor Terminated Study|2
483778|NCT00097370|1571495|P1|Stage 2|Pregnancy|1
483779|NCT00097370|1571495|P1|Stage 2|Lack of Efficacy|3
483780|NCT00097370|1571495|P1|Stage 2|Withdrawal by Subject|1
483781|NCT00097370|1571495|P1|Stage 2|Adverse Event|5
483782|NCT00097370|1571495|P1|Stage 1|Lack of Efficacy|2
483783|NCT00097370|1571495|P1|Stage 1|Withdrawal by Subject|1
483784|NCT00097370|1571495|P1|Stage 1|Adverse Event|3
483785|NCT00096993|1571529|P2|Overall Study|Other unspecified|1
483786|NCT00096993|1571530|P1|Overall Study|Other unspecified|1
483787|NCT00096993|1571529|P2|Overall Study|Non-compliance|1
483788|NCT00096993|1571530|P1|Overall Study|Non-compliance|0
483789|NCT00096993|1571529|P2|Overall Study|Physician Decision|1
483790|NCT00096993|1571530|P1|Overall Study|Physician Decision|2
483791|NCT00096993|1571529|P2|Overall Study|Subject's decision|1
483792|NCT00096993|1571530|P1|Overall Study|Subject's decision|3
483793|NCT00096993|1571529|P2|Overall Study|Adverse Event|8
483794|NCT00096993|1571530|P1|Overall Study|Adverse Event|2
483795|NCT00096993|1571529|P2|Overall Study|Disease progression|53
483796|NCT00096993|1571530|P1|Overall Study|Disease progression|56
483797|NCT00096993|1571529|P2|Overall Study|Death|0
483798|NCT00096993|1571530|P1|Overall Study|Death|1
483799|NCT00096954|1571546|P2|Overall Study|Lost to Follow-up|5
483800|NCT00096954|1571547|P1|Overall Study|Lost to Follow-up|8
483801|NCT00096954|1571546|P2|Overall Study|Non-compliance|3
483802|NCT00096954|1571547|P1|Overall Study|Non-compliance|0
483803|NCT00096954|1571546|P2|Overall Study|Initiation of immunotherapy|0
483804|NCT00096954|1571547|P1|Overall Study|Initiation of immunotherapy|1
483805|NCT00096954|1571546|P2|Overall Study|Pregnancy|1
483806|NCT00096954|1571547|P1|Overall Study|Pregnancy|1
483807|NCT00096954|1571546|P2|Overall Study|Sponsors Decision|1
483808|NCT00096954|1571547|P1|Overall Study|Sponsors Decision|1
483809|NCT00096954|1571546|P2|Overall Study|Physician Decision|1
483810|NCT00096954|1571547|P1|Overall Study|Physician Decision|1
483811|NCT00096954|1571546|P2|Overall Study|Withdrawal by Subject|8
483812|NCT00096954|1571547|P1|Overall Study|Withdrawal by Subject|9
483813|NCT00096954|1571546|P2|Overall Study|Adverse Event|1
483814|NCT00096954|1571547|P1|Overall Study|Adverse Event|3
483815|NCT00096941|1571559|P1|Overall Study|disease progression|3
483816|NCT00096785|1571566|P2|Overall Study|Relocated|0
483817|NCT00096785|1571567|P1|Overall Study|Relocated|1
483818|NCT00096785|1571566|P2|Overall Study|Withdrawal by Subject|1
483819|NCT00096785|1571567|P1|Overall Study|Withdrawal by Subject|0
483820|NCT00096785|1571566|P2|Overall Study|Lost to Follow-up|0
483821|NCT00096785|1571567|P1|Overall Study|Lost to Follow-up|1
483822|NCT00096538|1571596|P1|Overall Study|Withdrawal by Subject|1
483823|NCT00096486|1571604|P4|Overall Study|Not Treated|1
483824|NCT00096486|1571605|P3|Overall Study|Not Treated|1
483825|NCT00096486|1571606|P2|Overall Study|Not Treated|0
483826|NCT00096486|1571607|P1|Overall Study|Not Treated|0
483827|NCT00096486|1571604|P4|Overall Study|Withdrawal by Subject|1
483828|NCT00096486|1571605|P3|Overall Study|Withdrawal by Subject|1
483829|NCT00096486|1571606|P2|Overall Study|Withdrawal by Subject|0
483830|NCT00096486|1571607|P1|Overall Study|Withdrawal by Subject|0
483831|NCT00096447|1571626|P1|Overall Study|Never treated|1
483832|NCT00096382|1571642|P2|Overall Study|Death during treatment|0
483833|NCT00096382|1571643|P1|Overall Study|Death during treatment|1
483834|NCT00096382|1571642|P2|Overall Study|Not treated|0
483835|NCT00096382|1571643|P1|Overall Study|Not treated|1
483836|NCT00096356|1571653|P2|Overall Study|multiple reasons|18
483837|NCT00096356|1571654|P1|Overall Study|multiple reasons|10
483838|NCT00096356|1571653|P2|Overall Study|Lack of Efficacy|0
483839|NCT00096356|1571654|P1|Overall Study|Lack of Efficacy|1
483840|NCT00096356|1571653|P2|Overall Study|Withdrawal by Subject|23
483841|NCT00096356|1571654|P1|Overall Study|Withdrawal by Subject|17
483842|NCT00096356|1571653|P2|Overall Study|Physician Decision|3
483843|NCT00096356|1571654|P1|Overall Study|Physician Decision|5
483844|NCT00096356|1571653|P2|Overall Study|Adverse Event|9
483845|NCT00096356|1571654|P1|Overall Study|Adverse Event|11
483846|NCT00096278|1571666|P2|Overall Study|Patient not at risk for primary endpoint|2
483847|NCT00096278|1571667|P1|Overall Study|Patient not at risk for primary endpoint|3
483848|NCT00096278|1571666|P2|Overall Study|No follow-up data|18
483849|NCT00096278|1571667|P1|Overall Study|No follow-up data|15
483850|NCT00096265|1571676|P3|Overall Study|Ineligible|0
483851|NCT00096265|1571677|P2|Overall Study|Ineligible|0
483852|NCT00096265|1571678|P1|Overall Study|Ineligible|1
483853|NCT00096226|1571704|P1|Overall Study|Surgery but inadequate nodal sampling|1
483854|NCT00096226|1571704|P1|Overall Study|Surgical restaging not performed|13
483855|NCT00096226|1571704|P1|Overall Study|Protocol treatment not started|1
483856|NCT00096226|1571704|P1|Overall Study|Ineligible|2
483857|NCT00096200|1571711|P3|Overall Study|Ineligible pathology|0
483858|NCT00096200|1571712|P2|Overall Study|Ineligible pathology|1
483859|NCT00096200|1571713|P1|Overall Study|Ineligible pathology|0
483860|NCT00096200|1571711|P3|Overall Study|Withdrawal by Subject|0
483861|NCT00096200|1571712|P2|Overall Study|Withdrawal by Subject|2
483862|NCT00096200|1571713|P1|Overall Study|Withdrawal by Subject|1
483863|NCT00096200|1571711|P3|Overall Study|Adverse Event|0
483864|NCT00096200|1571712|P2|Overall Study|Adverse Event|4
483865|NCT00096200|1571713|P1|Overall Study|Adverse Event|0
483866|NCT00096174|1571721|P1|Overall Study|other reason|8
483867|NCT00096174|1571721|P1|Overall Study|Ineligible|6
483868|NCT00096174|1571721|P1|Overall Study|Not started protocol therapy|3
483869|NCT00096174|1571721|P1|Overall Study|Withdrawal by Subject|15
483870|NCT00096174|1571721|P1|Overall Study|Death|6
483871|NCT00096174|1571721|P1|Overall Study|Adverse Event|15
483872|NCT00096174|1571721|P1|Overall Study|Lack of Efficacy|9
483873|NCT00096135|1571766|P2|Overall Study|Ineligible|0
483874|NCT00096135|1571767|P1|Overall Study|Ineligible|2
483875|NCT00096135|1571766|P2|Overall Study|Other, specify|3
483876|NCT00096135|1571767|P1|Overall Study|Other, specify|15
483877|NCT00096135|1571766|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
483878|NCT00096135|1571767|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
483879|NCT00096135|1571766|P2|Overall Study|Refusal of further protocol therapy|1
483880|NCT00096135|1571767|P1|Overall Study|Refusal of further protocol therapy|4
483881|NCT00096135|1571766|P2|Overall Study|Physician Decision|4
483882|NCT00096135|1571767|P1|Overall Study|Physician Decision|20
483883|NCT00096044|1571783|P1|Overall Study|Disease Progression|4
483884|NCT00096044|1571783|P1|Overall Study|Adverse Event|21
483885|NCT00096044|1571783|P1|Overall Study|Withdrawal by Subject|9
483886|NCT00096031|1571792|P1|Overall Study|Not protocol specified|5
483887|NCT00096031|1571792|P1|Overall Study|Ineligible|8
483888|NCT00096031|1571792|P1|Overall Study|Withdrawal by Subject|1
483889|NCT00096031|1571792|P1|Overall Study|Death|4
483890|NCT00096031|1571792|P1|Overall Study|Lack of Efficacy|42
483891|NCT00096031|1571792|P1|Overall Study|Adverse Event|3
483892|NCT00096018|1571800|P2|Overall Study|Miscellaneous|1
483893|NCT00096018|1571801|P1|Overall Study|Miscellaneous|2
483894|NCT00096018|1571800|P2|Overall Study|Withdrawal by Subject|2
483895|NCT00096018|1571801|P1|Overall Study|Withdrawal by Subject|0
483896|NCT00096018|1571800|P2|Overall Study|Death|1
483897|NCT00096018|1571801|P1|Overall Study|Death|0
483898|NCT00096018|1571800|P2|Overall Study|Adverse Event|5
483899|NCT00096018|1571801|P1|Overall Study|Adverse Event|0
483900|NCT00096018|1571800|P2|Overall Study|Miscellaneous (not treated)|2
483901|NCT00096018|1571801|P1|Overall Study|Miscellaneous (not treated)|0
483902|NCT00096018|1571800|P2|Overall Study|Became Ineligible (not treated)|3
483903|NCT00096018|1571801|P1|Overall Study|Became Ineligible (not treated)|0
483904|NCT00095979|1571809|P1|Overall Study|Ineligible: Second primary cancer site|2
483905|NCT00095940|1571827|P9|Lapatinib Continuation/Phase II|Adverse Event|0
483906|NCT00095940|1571828|P8|Lapatinib Continuation/Phase II|Adverse Event|1
483907|NCT00095940|1571829|P7|Lapatinib Continuation/Phase II|Adverse Event|0
483908|NCT00095940|1571830|P6|Lapatinib Continuation/Phase II|Adverse Event|0
483909|NCT00095940|1571831|P5|Lapatinib Continuation/Phase II|Adverse Event|0
483910|NCT00095940|1571832|P4|Lapatinib Continuation/Phase II|Adverse Event|0
483911|NCT00095940|1571833|P3|Lapatinib Continuation/Phase II|Adverse Event|0
483912|NCT00095940|1571834|P2|Lapatinib Continuation/Phase II|Adverse Event|0
483913|NCT00095940|1571835|P1|Lapatinib Continuation/Phase II|Adverse Event|0
483914|NCT00095940|1571827|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
483915|NCT00095940|1571828|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
483916|NCT00095940|1571829|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
483917|NCT00095940|1571830|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
483918|NCT00095940|1571831|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
483919|NCT00095940|1571832|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
483920|NCT00095940|1571833|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
483921|NCT00095940|1571834|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
483922|NCT00095940|1571835|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
483923|NCT00095940|1571827|P9|Lapatinib Continuation/Phase II|Disease Progression|12
483924|NCT00095940|1571828|P8|Lapatinib Continuation/Phase II|Disease Progression|1
483925|NCT00095940|1571829|P7|Lapatinib Continuation/Phase II|Disease Progression|2
483926|NCT00095940|1571830|P6|Lapatinib Continuation/Phase II|Disease Progression|13
483927|NCT00095940|1571831|P5|Lapatinib Continuation/Phase II|Disease Progression|0
483928|NCT00095940|1571832|P4|Lapatinib Continuation/Phase II|Disease Progression|0
483929|NCT00095940|1571833|P3|Lapatinib Continuation/Phase II|Disease Progression|15
483930|NCT00095940|1571834|P2|Lapatinib Continuation/Phase II|Disease Progression|1
483931|NCT00095940|1571835|P1|Lapatinib Continuation/Phase II|Disease Progression|1
483932|NCT00095836|1571868|P1|Overall Study|Death|2
483933|NCT00095836|1571868|P1|Overall Study|Adverse Event|1
483934|NCT00095836|1571868|P1|Overall Study|Lost to Follow-up|1
483935|NCT00095628|1571898|P1|Overall Study|Disease progression prior to treatment|1
483936|NCT00095576|1571909|P2|Overall Study|Subject moved|36
483937|NCT00095576|1571910|P1|Overall Study|Subject moved|30
483938|NCT00095576|1571909|P2|Overall Study|Site terminated|67
483939|NCT00095576|1571910|P1|Overall Study|Site terminated|75
483940|NCT00095576|1571909|P2|Overall Study|Option to switch to a rollover study|1099
483941|NCT00095576|1571910|P1|Overall Study|Option to switch to a rollover study|1097
483942|NCT00095576|1571909|P2|Overall Study|Withdrawal by Subject|47
483943|NCT00095576|1571910|P1|Overall Study|Withdrawal by Subject|34
483944|NCT00095576|1571909|P2|Overall Study|Protocol Violation|0
483945|NCT00095576|1571910|P1|Overall Study|Protocol Violation|1
483946|NCT00095576|1571909|P2|Overall Study|Lost to Follow-up|229
483947|NCT00095576|1571910|P1|Overall Study|Lost to Follow-up|233
483948|NCT00095576|1571909|P2|Overall Study|Adverse Event|3
483949|NCT00095576|1571910|P1|Overall Study|Adverse Event|5
483950|NCT00095498|1571934|P3|Overall Study|Requirement for alternative therapy|2
483951|NCT00095498|1571935|P2|Overall Study|Requirement for alternative therapy|0
483952|NCT00095498|1571936|P1|Overall Study|Requirement for alternative therapy|1
483953|NCT00095498|1571934|P3|Overall Study|Protocol Violation|1
483954|NCT00095498|1571935|P2|Overall Study|Protocol Violation|0
483955|NCT00095498|1571936|P1|Overall Study|Protocol Violation|0
483956|NCT00095498|1571934|P3|Overall Study|Other|6
483957|NCT00095498|1571935|P2|Overall Study|Other|7
483958|NCT00095498|1571936|P1|Overall Study|Other|6
483959|NCT00095498|1571934|P3|Overall Study|Noncompliance|1
483960|NCT00095498|1571935|P2|Overall Study|Noncompliance|0
483961|NCT00095498|1571936|P1|Overall Study|Noncompliance|1
483962|NCT00095498|1571934|P3|Overall Study|Lost to Follow-up|2
483963|NCT00095498|1571935|P2|Overall Study|Lost to Follow-up|1
483964|NCT00095498|1571936|P1|Overall Study|Lost to Follow-up|1
483965|NCT00095498|1571934|P3|Overall Study|Ineligibility determined|2
483966|NCT00095498|1571935|P2|Overall Study|Ineligibility determined|0
483967|NCT00095498|1571936|P1|Overall Study|Ineligibility determined|3
483968|NCT00095498|1571934|P3|Overall Study|Disease progression|1
483969|NCT00095498|1571935|P2|Overall Study|Disease progression|1
483970|NCT00095498|1571936|P1|Overall Study|Disease progression|0
483971|NCT00095498|1571934|P3|Overall Study|Withdrawal by Subject|15
483972|NCT00095498|1571935|P2|Overall Study|Withdrawal by Subject|16
483973|NCT00095498|1571936|P1|Overall Study|Withdrawal by Subject|15
483974|NCT00095498|1571934|P3|Overall Study|Adverse Event|1
483975|NCT00095498|1571935|P2|Overall Study|Adverse Event|0
483976|NCT00095498|1571936|P1|Overall Study|Adverse Event|1
483977|NCT00095498|1571934|P3|Overall Study|Physician Decision|8
483978|NCT00095498|1571935|P2|Overall Study|Physician Decision|10
483979|NCT00095498|1571936|P1|Overall Study|Physician Decision|9
483980|NCT00095303|1572363|P2|Follow Up Study|Lost to Follow-up|58
483981|NCT00095303|1572364|P1|Follow Up Study|Lost to Follow-up|59
483982|NCT00095303|1572363|P2|Main Study|Lost to Follow-up|87
483983|NCT00095303|1572364|P1|Main Study|Lost to Follow-up|91
483984|NCT00095238|1572432|P2|Overall Study|Other Reasons|88
483985|NCT00095238|1572433|P1|Overall Study|Other Reasons|87
483986|NCT00095238|1572432|P2|Overall Study|Missing|0
483987|NCT00095238|1572433|P1|Overall Study|Missing|1
483988|NCT00095238|1572432|P2|Overall Study|Study terminated by sponsor|1
483989|NCT00095238|1572433|P1|Overall Study|Study terminated by sponsor|0
483990|NCT00095238|1572432|P2|Overall Study|No longer met study criteria|5
483991|NCT00095238|1572433|P1|Overall Study|No longer met study criteria|4
483992|NCT00095238|1572432|P2|Overall Study|Noncompliance|45
483993|NCT00095238|1572433|P1|Overall Study|Noncompliance|44
483994|NCT00095238|1572432|P2|Overall Study|Lost to Follow-up|24
483995|NCT00095238|1572433|P1|Overall Study|Lost to Follow-up|19
483996|NCT00095238|1572432|P2|Overall Study|Death|170
483997|NCT00095238|1572433|P1|Overall Study|Death|154
483998|NCT00095238|1572432|P2|Overall Study|Subject Withdrew Consent|223
483999|NCT00095238|1572433|P1|Overall Study|Subject Withdrew Consent|208
484000|NCT00095238|1572432|P2|Overall Study|Adverse Event|287
484001|NCT00095238|1572433|P1|Overall Study|Adverse Event|331
484002|NCT00095238|1572432|P2|Overall Study|Lack of Efficacy|9
484003|NCT00095238|1572433|P1|Overall Study|Lack of Efficacy|9
484004|NCT00095212|1572495|P2|Overall Study|Withdrawal by Subject|3
484005|NCT00095212|1572496|P1|Overall Study|Withdrawal by Subject|1
484006|NCT00095199|1572526|P4|Overall Study|Data inadvertently lost by site|0
484007|NCT00095199|1572527|P3|Overall Study|Data inadvertently lost by site|0
484008|NCT00095199|1572528|P2|Overall Study|Data inadvertently lost by site|0
484009|NCT00095199|1572529|P1|Overall Study|Data inadvertently lost by site|1
484010|NCT00095199|1572526|P4|Overall Study|Primary tumor removed in other surgery|0
484011|NCT00095199|1572527|P3|Overall Study|Primary tumor removed in other surgery|0
484012|NCT00095199|1572528|P2|Overall Study|Primary tumor removed in other surgery|1
484013|NCT00095199|1572529|P1|Overall Study|Primary tumor removed in other surgery|0
484014|NCT00095199|1572526|P4|Overall Study|Started radiotherapy regimen|0
484015|NCT00095199|1572527|P3|Overall Study|Started radiotherapy regimen|0
484016|NCT00095199|1572528|P2|Overall Study|Started radiotherapy regimen|1
484017|NCT00095199|1572529|P1|Overall Study|Started radiotherapy regimen|0
484018|NCT00095199|1572526|P4|Overall Study|Started Palliative Radiotherapy|0
484019|NCT00095199|1572527|P3|Overall Study|Started Palliative Radiotherapy|0
484020|NCT00095199|1572528|P2|Overall Study|Started Palliative Radiotherapy|0
484021|NCT00095199|1572529|P1|Overall Study|Started Palliative Radiotherapy|1
484022|NCT00095199|1572526|P4|Overall Study|Not eligible|1
484023|NCT00095199|1572527|P3|Overall Study|Not eligible|0
484024|NCT00095199|1572528|P2|Overall Study|Not eligible|7
484025|NCT00095199|1572529|P1|Overall Study|Not eligible|1
484026|NCT00095199|1572526|P4|Overall Study|Physician Decision|1
484027|NCT00095199|1572527|P3|Overall Study|Physician Decision|1
484028|NCT00095199|1572528|P2|Overall Study|Physician Decision|6
484029|NCT00095199|1572529|P1|Overall Study|Physician Decision|5
484030|NCT00095199|1572526|P4|Overall Study|Surgery needed could not start in 7 days|0
484031|NCT00095199|1572527|P3|Overall Study|Surgery needed could not start in 7 days|1
484032|NCT00095199|1572528|P2|Overall Study|Surgery needed could not start in 7 days|0
484033|NCT00095199|1572529|P1|Overall Study|Surgery needed could not start in 7 days|0
484034|NCT00095199|1572526|P4|Overall Study|Liver function test results elevated|1
484035|NCT00095199|1572527|P3|Overall Study|Liver function test results elevated|1
484036|NCT00095199|1572528|P2|Overall Study|Liver function test results elevated|0
484037|NCT00095199|1572529|P1|Overall Study|Liver function test results elevated|0
484038|NCT00095199|1572526|P4|Overall Study|Protocol Violation|0
484039|NCT00095199|1572527|P3|Overall Study|Protocol Violation|2
484040|NCT00095199|1572528|P2|Overall Study|Protocol Violation|4
484041|NCT00095199|1572529|P1|Overall Study|Protocol Violation|4
484042|NCT00095199|1572526|P4|Overall Study|Withdrawal by Subject|22
484043|NCT00095199|1572527|P3|Overall Study|Withdrawal by Subject|13
484044|NCT00095199|1572528|P2|Overall Study|Withdrawal by Subject|16
484045|NCT00095199|1572529|P1|Overall Study|Withdrawal by Subject|21
484046|NCT00095199|1572526|P4|Overall Study|Death|9
484047|NCT00095199|1572527|P3|Overall Study|Death|11
484048|NCT00095199|1572528|P2|Overall Study|Death|6
484049|NCT00095199|1572529|P1|Overall Study|Death|10
484050|NCT00095199|1572526|P4|Overall Study|Progressive disease|98
484051|NCT00095199|1572527|P3|Overall Study|Progressive disease|105
484052|NCT00095199|1572528|P2|Overall Study|Progressive disease|179
484053|NCT00095199|1572529|P1|Overall Study|Progressive disease|213
484054|NCT00095199|1572526|P4|Overall Study|Adverse Event|11
484055|NCT00095199|1572527|P3|Overall Study|Adverse Event|26
484056|NCT00095199|1572528|P2|Overall Study|Adverse Event|22
484057|NCT00095199|1572529|P1|Overall Study|Adverse Event|40
484058|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Not Specified|8
484059|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Not Specified|6
484060|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Not Specified|4
484061|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Not Specified|0
484062|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Not Specified|0
484063|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Not Specified|0
484064|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
484065|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
484066|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
484067|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
484068|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
484069|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
484070|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
484071|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
484072|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
484073|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
484074|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
484075|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
484076|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
484077|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
484078|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
484079|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
484080|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
484081|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
484082|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
484083|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
484084|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
484085|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
484086|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
484087|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
484088|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
484089|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
484090|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
484091|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
484092|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
484093|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
484094|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
484095|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
484096|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
484097|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
484098|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
484099|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
484100|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
484101|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
484102|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
484103|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
484104|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
484105|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
484106|NCT00095173|1572567|P6|Open-Label Extension Phase (Period C)|Death|1
484107|NCT00095173|1572568|P5|Open-Label Extension Phase (Period C)|Death|0
484108|NCT00095173|1572569|P4|Open-Label Extension Phase (Period C)|Death|0
484109|NCT00095173|1572570|P3|Open-Label Extension Phase (Period C)|Death|0
484110|NCT00095173|1572571|P2|Open-Label Extension Phase (Period C)|Death|0
484111|NCT00095173|1572572|P1|Open-Label Extension Phase (Period C)|Death|0
484112|NCT00095173|1572567|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
484113|NCT00095173|1572568|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
484114|NCT00095173|1572569|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
484115|NCT00095173|1572570|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
484116|NCT00095173|1572571|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
484117|NCT00095173|1572572|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
484118|NCT00095173|1572567|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
484119|NCT00095173|1572568|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
484120|NCT00095173|1572569|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
484121|NCT00095173|1572570|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
484122|NCT00095173|1572571|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
484123|NCT00095173|1572572|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
484124|NCT00095173|1572567|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
484125|NCT00095173|1572568|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
484126|NCT00095173|1572569|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
484127|NCT00095173|1572570|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
484128|NCT00095173|1572571|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
484129|NCT00095173|1572572|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
484130|NCT00095173|1572567|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
484131|NCT00095173|1572568|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
484132|NCT00095173|1572569|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
484133|NCT00095173|1572570|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
484134|NCT00095173|1572571|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
484135|NCT00095173|1572572|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
484136|NCT00095173|1572567|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
484137|NCT00095173|1572568|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
484138|NCT00095173|1572569|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
484139|NCT00095173|1572570|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
484140|NCT00095173|1572571|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
484141|NCT00095173|1572572|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
484142|NCT00095173|1572567|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
484143|NCT00095173|1572568|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
484144|NCT00095173|1572569|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
484145|NCT00095173|1572570|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
484146|NCT00095173|1572571|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
484147|NCT00095173|1572572|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
484148|NCT00095147|1572610|P5|Long-term Extension Period|Leaving country|1
484149|NCT00095147|1572611|P4|Long-term Extension Period|Leaving country|0
484150|NCT00095147|1572612|P3|Long-term Extension Period|Leaving country|0
484151|NCT00095147|1572613|P2|Long-term Extension Period|Leaving country|0
484152|NCT00095147|1572614|P1|Long-term Extension Period|Leaving country|0
484153|NCT00095147|1572610|P5|Long-term Extension Period|Participant chose to use Revellex|1
484154|NCT00095147|1572611|P4|Long-term Extension Period|Participant chose to use Revellex|0
484155|NCT00095147|1572612|P3|Long-term Extension Period|Participant chose to use Revellex|0
484156|NCT00095147|1572613|P2|Long-term Extension Period|Participant chose to use Revellex|0
484157|NCT00095147|1572614|P1|Long-term Extension Period|Participant chose to use Revellex|0
484158|NCT00095147|1572610|P5|Long-term Extension Period|No longer meets study criteria|1
484159|NCT00095147|1572611|P4|Long-term Extension Period|No longer meets study criteria|0
484160|NCT00095147|1572612|P3|Long-term Extension Period|No longer meets study criteria|0
484161|NCT00095147|1572613|P2|Long-term Extension Period|No longer meets study criteria|0
484162|NCT00095147|1572614|P1|Long-term Extension Period|No longer meets study criteria|0
484163|NCT00095147|1572610|P5|Long-term Extension Period|Pregnancy|1
484164|NCT00095147|1572611|P4|Long-term Extension Period|Pregnancy|0
484165|NCT00095147|1572612|P3|Long-term Extension Period|Pregnancy|0
484166|NCT00095147|1572613|P2|Long-term Extension Period|Pregnancy|0
484167|NCT00095147|1572614|P1|Long-term Extension Period|Pregnancy|0
484168|NCT00095147|1572610|P5|Long-term Extension Period|Withdrawal of consent|12
484169|NCT00095147|1572611|P4|Long-term Extension Period|Withdrawal of consent|0
484170|NCT00095147|1572612|P3|Long-term Extension Period|Withdrawal of consent|0
484171|NCT00095147|1572613|P2|Long-term Extension Period|Withdrawal of consent|0
484172|NCT00095147|1572614|P1|Long-term Extension Period|Withdrawal of consent|0
484173|NCT00095147|1572610|P5|Long-term Extension Period|Lost to Follow-up|6
484174|NCT00095147|1572611|P4|Long-term Extension Period|Lost to Follow-up|0
484175|NCT00095147|1572612|P3|Long-term Extension Period|Lost to Follow-up|0
484176|NCT00095147|1572613|P2|Long-term Extension Period|Lost to Follow-up|0
484177|NCT00095147|1572614|P1|Long-term Extension Period|Lost to Follow-up|0
484178|NCT00095147|1572610|P5|Long-term Extension Period|Lack of Efficacy|9
484179|NCT00095147|1572611|P4|Long-term Extension Period|Lack of Efficacy|0
484180|NCT00095147|1572612|P3|Long-term Extension Period|Lack of Efficacy|0
484181|NCT00095147|1572613|P2|Long-term Extension Period|Lack of Efficacy|0
484182|NCT00095147|1572614|P1|Long-term Extension Period|Lack of Efficacy|0
484183|NCT00095147|1572610|P5|Long-term Extension Period|Adverse Event|11
484184|NCT00095147|1572611|P4|Long-term Extension Period|Adverse Event|0
484185|NCT00095147|1572612|P3|Long-term Extension Period|Adverse Event|0
484186|NCT00095147|1572613|P2|Long-term Extension Period|Adverse Event|0
484187|NCT00095147|1572614|P1|Long-term Extension Period|Adverse Event|0
484188|NCT00095147|1572610|P5|Long-term Extension Period|Death|3
484189|NCT00095147|1572611|P4|Long-term Extension Period|Death|0
484190|NCT00095147|1572612|P3|Long-term Extension Period|Death|0
484191|NCT00095147|1572613|P2|Long-term Extension Period|Death|0
484192|NCT00095147|1572614|P1|Long-term Extension Period|Death|0
484193|NCT00095147|1572610|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
484194|NCT00095147|1572611|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
484195|NCT00095147|1572612|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
484196|NCT00095147|1572613|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
484197|NCT00095147|1572614|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
484198|NCT00095147|1572610|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
484199|NCT00095147|1572611|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
484200|NCT00095147|1572612|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
484201|NCT00095147|1572613|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
484202|NCT00095147|1572614|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
484203|NCT00095147|1572610|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
484204|NCT00095147|1572611|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
484205|NCT00095147|1572612|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
484206|NCT00095147|1572613|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
484207|NCT00095147|1572614|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
484208|NCT00095147|1572610|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
484209|NCT00095147|1572611|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
484210|NCT00095147|1572612|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
484211|NCT00095147|1572613|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
484212|NCT00095147|1572614|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
484213|NCT00095147|1572610|P5|Double-blind Period 2 (Days 198-365)|Death|0
484214|NCT00095147|1572611|P4|Double-blind Period 2 (Days 198-365)|Death|1
484215|NCT00095147|1572612|P3|Double-blind Period 2 (Days 198-365)|Death|0
484216|NCT00095147|1572613|P2|Double-blind Period 2 (Days 198-365)|Death|1
484217|NCT00095147|1572614|P1|Double-blind Period 2 (Days 198-365)|Death|0
484218|NCT00095147|1572610|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
484219|NCT00095147|1572611|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
484220|NCT00095147|1572612|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
484221|NCT00095147|1572613|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
484222|NCT00095147|1572614|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
484223|NCT00095147|1572610|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
484224|NCT00095147|1572611|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
484225|NCT00095147|1572612|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
484226|NCT00095147|1572613|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
484227|NCT00095147|1572614|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
484228|NCT00095147|1572610|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
484229|NCT00095147|1572611|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
484230|NCT00095147|1572612|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
484231|NCT00095147|1572613|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
484232|NCT00095147|1572614|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
484233|NCT00095147|1572610|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
484234|NCT00095147|1572611|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
484235|NCT00095147|1572612|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
484236|NCT00095147|1572613|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
484237|NCT00095147|1572614|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
484238|NCT00095147|1572610|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
484239|NCT00095147|1572611|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
484240|NCT00095147|1572612|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
484241|NCT00095147|1572613|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
484242|NCT00095147|1572614|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
484243|NCT00095147|1572610|P5|Double-blind Period 1 (Days 1-197)|Death|0
484244|NCT00095147|1572611|P4|Double-blind Period 1 (Days 1-197)|Death|0
484245|NCT00095147|1572612|P3|Double-blind Period 1 (Days 1-197)|Death|0
484246|NCT00095147|1572613|P2|Double-blind Period 1 (Days 1-197)|Death|0
484247|NCT00095147|1572614|P1|Double-blind Period 1 (Days 1-197)|Death|1
484248|NCT00095121|1572809|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
484249|NCT00095121|1572810|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
484250|NCT00095121|1572809|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
484251|NCT00095121|1572810|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
484252|NCT00095056|1572856|P2|Phase B (Weeks 12-54)|Protocol Violation|1
484253|NCT00095056|1572857|P1|Phase B (Weeks 12-54)|Protocol Violation|0
484254|NCT00095056|1572856|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
484255|NCT00095056|1572857|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
484256|NCT00095056|1572856|P2|Phase B (Weeks 12-54)|Death|1
484257|NCT00095056|1572857|P1|Phase B (Weeks 12-54)|Death|3
484258|NCT00095056|1572856|P2|Phase B (Weeks 12-54)|Patient Moved|0
484259|NCT00095056|1572857|P1|Phase B (Weeks 12-54)|Patient Moved|1
484260|NCT00095056|1572856|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
484261|NCT00095056|1572857|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
484262|NCT00095056|1572856|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
484263|NCT00095056|1572857|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
484264|NCT00095056|1572856|P2|Phase B (Weeks 12-54)|Adverse Event|2
484265|NCT00095056|1572857|P1|Phase B (Weeks 12-54)|Adverse Event|2
484266|NCT00095056|1572856|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
484267|NCT00095056|1572857|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
484268|NCT00095056|1572856|P2|Phase A (Weeks 0-12)|Death|0
484269|NCT00095056|1572857|P1|Phase A (Weeks 0-12)|Death|1
484270|NCT00095056|1572856|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
484271|NCT00095056|1572857|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
484272|NCT00095056|1572856|P2|Phase A (Weeks 0-12)|Adverse Event|1
484273|NCT00095056|1572857|P1|Phase A (Weeks 0-12)|Adverse Event|1
484274|NCT00094887|1572967|P2|Overall Study|Physician Decision|2
484275|NCT00094887|1572968|P1|Overall Study|Physician Decision|2
484276|NCT00094887|1572967|P2|Overall Study|Family emergency, Subject noncompliance|4
484277|NCT00094887|1572968|P1|Overall Study|Family emergency, Subject noncompliance|3
484278|NCT00094861|1572976|P2|Overall Study|Other|0
484279|NCT00094861|1572977|P1|Overall Study|Other|3
484280|NCT00094861|1572976|P2|Overall Study|Death|2
484281|NCT00094861|1572977|P1|Overall Study|Death|4
484282|NCT00094861|1572976|P2|Overall Study|Lost to Follow-up|1
484283|NCT00094861|1572977|P1|Overall Study|Lost to Follow-up|0
484284|NCT00094861|1572976|P2|Overall Study|Physician Decision|1
484285|NCT00094861|1572977|P1|Overall Study|Physician Decision|1
484286|NCT00094861|1572976|P2|Overall Study|Withdrawal by Subject|3
484287|NCT00094861|1572977|P1|Overall Study|Withdrawal by Subject|5
484288|NCT00094861|1572976|P2|Overall Study|Adverse Event|2
484289|NCT00094861|1572977|P1|Overall Study|Adverse Event|5
484290|NCT00094835|1573004|P7|Overall Study|Other|0
484291|NCT00094835|1573005|P6|Overall Study|Other|0
484292|NCT00094835|1573006|P5|Overall Study|Other|0
484293|NCT00094835|1573007|P4|Overall Study|Other|1
484294|NCT00094835|1573008|P3|Overall Study|Other|1
484295|NCT00094835|1573009|P2|Overall Study|Other|1
484296|NCT00094835|1573010|P1|Overall Study|Other|1
484297|NCT00094835|1573004|P7|Overall Study|Non-compliance|1
484298|NCT00094835|1573005|P6|Overall Study|Non-compliance|2
484299|NCT00094835|1573006|P5|Overall Study|Non-compliance|2
484300|NCT00094835|1573007|P4|Overall Study|Non-compliance|0
484301|NCT00094835|1573008|P3|Overall Study|Non-compliance|2
484302|NCT00094835|1573009|P2|Overall Study|Non-compliance|2
484303|NCT00094835|1573010|P1|Overall Study|Non-compliance|1
484304|NCT00094835|1573004|P7|Overall Study|Death|0
484305|NCT00094835|1573005|P6|Overall Study|Death|0
484306|NCT00094835|1573006|P5|Overall Study|Death|1
484307|NCT00094835|1573007|P4|Overall Study|Death|0
484308|NCT00094835|1573008|P3|Overall Study|Death|0
484309|NCT00094835|1573009|P2|Overall Study|Death|0
484310|NCT00094835|1573010|P1|Overall Study|Death|1
484311|NCT00094835|1573004|P7|Overall Study|Lost to Follow-up|0
484312|NCT00094835|1573005|P6|Overall Study|Lost to Follow-up|0
484313|NCT00094835|1573006|P5|Overall Study|Lost to Follow-up|1
484314|NCT00094835|1573007|P4|Overall Study|Lost to Follow-up|0
484315|NCT00094835|1573008|P3|Overall Study|Lost to Follow-up|0
484316|NCT00094835|1573009|P2|Overall Study|Lost to Follow-up|0
484317|NCT00094835|1573010|P1|Overall Study|Lost to Follow-up|0
484318|NCT00094835|1573004|P7|Overall Study|Withdrawal by Subject|1
484319|NCT00094835|1573005|P6|Overall Study|Withdrawal by Subject|0
484320|NCT00094835|1573006|P5|Overall Study|Withdrawal by Subject|0
484321|NCT00094835|1573007|P4|Overall Study|Withdrawal by Subject|0
484322|NCT00094835|1573008|P3|Overall Study|Withdrawal by Subject|0
484323|NCT00094835|1573009|P2|Overall Study|Withdrawal by Subject|0
484324|NCT00094835|1573010|P1|Overall Study|Withdrawal by Subject|0
484325|NCT00094835|1573004|P7|Overall Study|Physician Decision|0
484326|NCT00094835|1573005|P6|Overall Study|Physician Decision|1
484327|NCT00094835|1573006|P5|Overall Study|Physician Decision|0
484328|NCT00094835|1573007|P4|Overall Study|Physician Decision|0
484329|NCT00094835|1573008|P3|Overall Study|Physician Decision|0
484330|NCT00094835|1573009|P2|Overall Study|Physician Decision|0
484331|NCT00094835|1573010|P1|Overall Study|Physician Decision|1
484332|NCT00094809|1573088|P2|Overall Study|Other|1
484333|NCT00094809|1573089|P1|Overall Study|Other|1
484334|NCT00094809|1573088|P2|Overall Study|Study drug not received|8
484335|NCT00094809|1573089|P1|Overall Study|Study drug not received|2
484336|NCT00094809|1573088|P2|Overall Study|Informed consent signed after treatment|0
484337|NCT00094809|1573089|P1|Overall Study|Informed consent signed after treatment|1
484338|NCT00094809|1573088|P2|Overall Study|Other|4
484339|NCT00094809|1573089|P1|Overall Study|Other|2
484340|NCT00094809|1573088|P2|Overall Study|Protocol-specified criteria|1
484341|NCT00094809|1573089|P1|Overall Study|Protocol-specified criteria|1
484342|NCT00094809|1573088|P2|Overall Study|Death|25
484343|NCT00094809|1573089|P1|Overall Study|Death|19
484344|NCT00094809|1573088|P2|Overall Study|Lost to Follow-up|6
484345|NCT00094809|1573089|P1|Overall Study|Lost to Follow-up|6
484346|NCT00094809|1573088|P2|Overall Study|Physician Decision|5
484347|NCT00094809|1573089|P1|Overall Study|Physician Decision|3
484348|NCT00094809|1573088|P2|Overall Study|Disease progression|3
484349|NCT00094809|1573089|P1|Overall Study|Disease progression|3
484350|NCT00094809|1573088|P2|Overall Study|Withdrawal by Subject|9
484351|NCT00094809|1573089|P1|Overall Study|Withdrawal by Subject|8
484352|NCT00094809|1573088|P2|Overall Study|Adverse Event|1
484353|NCT00094809|1573089|P1|Overall Study|Adverse Event|3
484354|NCT00094809|1573088|P2|Overall Study|Noncompliance|0
484355|NCT00094809|1573089|P1|Overall Study|Noncompliance|1
484356|NCT00094809|1573088|P2|Overall Study|Protocol deviation|2
484357|NCT00094809|1573089|P1|Overall Study|Protocol deviation|2
484358|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Other|23
484359|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Other|15
484360|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
484361|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
484362|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
484363|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
484364|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
484365|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
484366|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
484367|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
484368|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
484369|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
484370|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
484371|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
484372|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
484373|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
484374|NCT00094770|1573115|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
484375|NCT00094770|1573116|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
484376|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Other|11
484377|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Other|10
484378|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
484379|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
484380|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
484381|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
484382|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
484383|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
484384|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
484385|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
484386|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
484387|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
484388|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
484389|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
484390|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
484391|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
484392|NCT00094770|1573115|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
484393|NCT00094770|1573116|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
484394|NCT00094757|1573147|P3|Overall Study|Protocol specified discontinuation|0
484395|NCT00094757|1573148|P2|Overall Study|Protocol specified discontinuation|3
484396|NCT00094757|1573149|P1|Overall Study|Protocol specified discontinuation|1
484397|NCT00094757|1573147|P3|Overall Study|Other|1
484398|NCT00094757|1573148|P2|Overall Study|Other|3
484399|NCT00094757|1573149|P1|Overall Study|Other|3
484400|NCT00094757|1573147|P3|Overall Study|Withdrawal by Subject|5
484401|NCT00094757|1573148|P2|Overall Study|Withdrawal by Subject|21
484402|NCT00094757|1573149|P1|Overall Study|Withdrawal by Subject|14
484403|NCT00094757|1573147|P3|Overall Study|Protocol Violation|3
484404|NCT00094757|1573148|P2|Overall Study|Protocol Violation|5
484405|NCT00094757|1573149|P1|Overall Study|Protocol Violation|8
484406|NCT00094757|1573147|P3|Overall Study|Patient Moved|1
484407|NCT00094757|1573148|P2|Overall Study|Patient Moved|1
484408|NCT00094757|1573149|P1|Overall Study|Patient Moved|2
484409|NCT00094757|1573147|P3|Overall Study|Lost to Follow-up|6
484410|NCT00094757|1573148|P2|Overall Study|Lost to Follow-up|5
484411|NCT00094757|1573149|P1|Overall Study|Lost to Follow-up|3
484412|NCT00094757|1573147|P3|Overall Study|Lack of Efficacy|8
484413|NCT00094757|1573148|P2|Overall Study|Lack of Efficacy|15
484414|NCT00094757|1573149|P1|Overall Study|Lack of Efficacy|11
484415|NCT00094757|1573147|P3|Overall Study|Adverse Event|6
484416|NCT00094757|1573148|P2|Overall Study|Adverse Event|9
484417|NCT00094757|1573149|P1|Overall Study|Adverse Event|11
484418|NCT00094653|1573169|P3|Overall Study|Protocol Violation|1
484419|NCT00094653|1573170|P2|Overall Study|Protocol Violation|0
484420|NCT00094653|1573171|P1|Overall Study|Protocol Violation|0
484421|NCT00094653|1573169|P3|Overall Study|Lost to Follow-up|1
484422|NCT00094653|1573170|P2|Overall Study|Lost to Follow-up|2
484423|NCT00094653|1573171|P1|Overall Study|Lost to Follow-up|3
484424|NCT00094653|1573169|P3|Overall Study|Not specified|2
484425|NCT00094653|1573170|P2|Overall Study|Not specified|2
484426|NCT00094653|1573171|P1|Overall Study|Not specified|2
484427|NCT00094653|1573169|P3|Overall Study|Subject Withdrew Consent|3
484428|NCT00094653|1573170|P2|Overall Study|Subject Withdrew Consent|2
484429|NCT00094653|1573171|P1|Overall Study|Subject Withdrew Consent|10
484430|NCT00094653|1573169|P3|Overall Study|Death|119
484431|NCT00094653|1573170|P2|Overall Study|Death|100
484432|NCT00094653|1573171|P1|Overall Study|Death|306
484433|NCT00094575|1573234|P2|Overall Study|Death|146
484434|NCT00094575|1573235|P1|Overall Study|Death|146
484435|NCT00094536|1573255|P1|Treatment and Follow-up|Unable to attend visits|1
484436|NCT00094536|1573255|P1|Treatment and Follow-up|Subject non-compliance|9
484437|NCT00094536|1573255|P1|Treatment and Follow-up|Withdrawal by Subject|1
484438|NCT00094536|1573255|P1|Treatment and Follow-up|Lost to Follow-up|7
484439|NCT00094536|1573255|P1|Treatment and Follow-up|Lack of Efficacy|9
484440|NCT00094536|1573255|P1|Treatment and Follow-up|Adverse Event|4
484441|NCT00094536|1573255|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
484442|NCT00094458|1573279|P6|OLE: Open-Label Extension|Patient decision|0
484443|NCT00094458|1573280|P5|OLE: Open-Label Extension|Patient decision|1
484444|NCT00094458|1573281|P4|OLE: Open-Label Extension|Patient decision|0
484445|NCT00094458|1573282|P3|OLE: Open-Label Extension|Patient decision|0
484446|NCT00094458|1573283|P2|OLE: Open-Label Extension|Patient decision|0
484447|NCT00094458|1573284|P1|OLE: Open-Label Extension|Patient decision|0
484448|NCT00094458|1573279|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
484449|NCT00094458|1573280|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
484450|NCT00094458|1573281|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
484451|NCT00094458|1573282|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
484452|NCT00094458|1573283|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
484453|NCT00094458|1573284|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
484454|NCT00094458|1573279|P6|OLE: Open-Label Extension|Adverse Event|4
484455|NCT00094458|1573280|P5|OLE: Open-Label Extension|Adverse Event|3
484456|NCT00094458|1573281|P4|OLE: Open-Label Extension|Adverse Event|0
484457|NCT00094458|1573282|P3|OLE: Open-Label Extension|Adverse Event|0
484458|NCT00094458|1573283|P2|OLE: Open-Label Extension|Adverse Event|0
484459|NCT00094458|1573284|P1|OLE: Open-Label Extension|Adverse Event|0
484460|NCT00094458|1573279|P6|Study Extension: Week 30 Through Week 50|Other|0
484461|NCT00094458|1573280|P5|Study Extension: Week 30 Through Week 50|Other|0
484462|NCT00094458|1573281|P4|Study Extension: Week 30 Through Week 50|Other|0
484463|NCT00094458|1573282|P3|Study Extension: Week 30 Through Week 50|Other|3
484464|NCT00094458|1573283|P2|Study Extension: Week 30 Through Week 50|Other|2
484465|NCT00094458|1573284|P1|Study Extension: Week 30 Through Week 50|Other|1
484466|NCT00094458|1573279|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
484467|NCT00094458|1573280|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
484468|NCT00094458|1573281|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
484469|NCT00094458|1573282|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
484470|NCT00094458|1573283|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
484471|NCT00094458|1573284|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
484472|NCT00094458|1573279|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
484473|NCT00094458|1573280|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
484474|NCT00094458|1573281|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
484475|NCT00094458|1573282|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
484476|NCT00094458|1573283|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
484477|NCT00094458|1573284|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
484478|NCT00094458|1573279|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
484479|NCT00094458|1573280|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
484480|NCT00094458|1573281|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
484481|NCT00094458|1573282|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
484482|NCT00094458|1573283|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
484483|NCT00094458|1573284|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
484484|NCT00094458|1573279|P6|Main Study: Through Week 30|Other|0
484485|NCT00094458|1573280|P5|Main Study: Through Week 30|Other|0
484486|NCT00094458|1573281|P4|Main Study: Through Week 30|Other|0
484487|NCT00094458|1573282|P3|Main Study: Through Week 30|Other|9
484488|NCT00094458|1573283|P2|Main Study: Through Week 30|Other|16
484489|NCT00094458|1573284|P1|Main Study: Through Week 30|Other|19
484490|NCT00094458|1573279|P6|Main Study: Through Week 30|Death|0
484491|NCT00094458|1573280|P5|Main Study: Through Week 30|Death|0
484492|NCT00094458|1573281|P4|Main Study: Through Week 30|Death|0
484493|NCT00094458|1573282|P3|Main Study: Through Week 30|Death|0
484494|NCT00094458|1573283|P2|Main Study: Through Week 30|Death|0
484495|NCT00094458|1573284|P1|Main Study: Through Week 30|Death|1
484496|NCT00094458|1573279|P6|Main Study: Through Week 30|Adverse Event|0
484497|NCT00094458|1573280|P5|Main Study: Through Week 30|Adverse Event|0
484498|NCT00094458|1573281|P4|Main Study: Through Week 30|Adverse Event|0
484499|NCT00094458|1573282|P3|Main Study: Through Week 30|Adverse Event|28
484500|NCT00094458|1573283|P2|Main Study: Through Week 30|Adverse Event|20
484501|NCT00094458|1573284|P1|Main Study: Through Week 30|Adverse Event|38
484502|NCT00094458|1573279|P6|Main Study: Through Week 30|Withdrawal by Subject|0
484503|NCT00094458|1573280|P5|Main Study: Through Week 30|Withdrawal by Subject|0
484504|NCT00094458|1573281|P4|Main Study: Through Week 30|Withdrawal by Subject|0
484505|NCT00094458|1573282|P3|Main Study: Through Week 30|Withdrawal by Subject|7
484506|NCT00094458|1573283|P2|Main Study: Through Week 30|Withdrawal by Subject|9
484507|NCT00094458|1573284|P1|Main Study: Through Week 30|Withdrawal by Subject|18
484508|NCT00094458|1573279|P6|Main Study: Through Week 30|Lost to Follow-up|0
484509|NCT00094458|1573280|P5|Main Study: Through Week 30|Lost to Follow-up|0
484510|NCT00094458|1573281|P4|Main Study: Through Week 30|Lost to Follow-up|0
484511|NCT00094458|1573282|P3|Main Study: Through Week 30|Lost to Follow-up|2
484512|NCT00094458|1573283|P2|Main Study: Through Week 30|Lost to Follow-up|5
484513|NCT00094458|1573284|P1|Main Study: Through Week 30|Lost to Follow-up|5
484514|NCT00094458|1573279|P6|Main Study: Through Week 30|Eligibility criteria not met|0
484515|NCT00094458|1573280|P5|Main Study: Through Week 30|Eligibility criteria not met|0
484516|NCT00094458|1573281|P4|Main Study: Through Week 30|Eligibility criteria not met|0
484517|NCT00094458|1573282|P3|Main Study: Through Week 30|Eligibility criteria not met|2
484518|NCT00094458|1573283|P2|Main Study: Through Week 30|Eligibility criteria not met|8
484519|NCT00094458|1573284|P1|Main Study: Through Week 30|Eligibility criteria not met|3
484520|NCT00094328|1573322|P1|Overall Study|Lost to Follow-up|1
484521|NCT00094302|1573336|P2|Overall Study|Death|246
484522|NCT00094302|1573337|P1|Overall Study|Death|266
484523|NCT00094302|1573336|P2|Overall Study|Withdrawal by Subject|111
484524|NCT00094302|1573337|P1|Overall Study|Withdrawal by Subject|103
484525|NCT00094302|1573336|P2|Overall Study|Physician Decision|8
484526|NCT00094302|1573337|P1|Overall Study|Physician Decision|5
484527|NCT00094302|1573336|P2|Overall Study|Lost to Follow-up|41
484528|NCT00094302|1573337|P1|Overall Study|Lost to Follow-up|43
484529|NCT00094172|1573393|P2|Overall Study|Started other MS therapy due to disease|0
484530|NCT00094172|1573394|P1|Overall Study|Started other MS therapy due to disease|1
484531|NCT00094172|1573393|P2|Overall Study|Primary endpoint met.|0
484532|NCT00094172|1573394|P1|Overall Study|Primary endpoint met.|1
484533|NCT00094172|1573393|P2|Overall Study|Withdrawal by Subject|5
484534|NCT00094172|1573394|P1|Overall Study|Withdrawal by Subject|10
484535|NCT00094172|1573393|P2|Overall Study|Protocol Violation|1
484536|NCT00094172|1573394|P1|Overall Study|Protocol Violation|0
484537|NCT00094172|1573393|P2|Overall Study|Lost to Follow-up|0
484538|NCT00094172|1573394|P1|Overall Study|Lost to Follow-up|2
484539|NCT00094172|1573393|P2|Overall Study|Adverse Event|1
484540|NCT00094172|1573394|P1|Overall Study|Adverse Event|0
484541|NCT00094107|1573404|P1|Overall Study|Withdrawal due to Disease Progression|1
484542|NCT00094107|1573404|P1|Overall Study|Adverse Event|3
484543|NCT00094107|1573404|P1|Overall Study|Death|5
484544|NCT00094107|1573404|P1|Overall Study|Lack of Efficacy|23
484545|NCT00094094|1573413|P1|Overall Study|Adverse Event|7
484546|NCT00094094|1573413|P1|Overall Study|Lack of Efficacy|23
484547|NCT00094094|1573413|P1|Overall Study|Death|2
484548|NCT00094055|1573422|P1|Overall Study|Withdrawal by Subject|9
484549|NCT00094055|1573422|P1|Overall Study|roll-over to another study|14
484550|NCT00094055|1573422|P1|Overall Study|clinical progression|1
484551|NCT00094055|1573422|P1|Overall Study|progressive disease|2
484552|NCT00094055|1573422|P1|Overall Study|Lost to Follow-up|2
484553|NCT00094055|1573422|P1|Overall Study|Lack of Efficacy|17
484554|NCT00094055|1573422|P1|Overall Study|Death|4
484555|NCT00094055|1573422|P1|Overall Study|Adverse Event|11
484556|NCT00093808|1573442|P1|Overall Study|Protocol Violation|1
484557|NCT00093808|1573442|P1|Overall Study|Cancel participation before receiving tx|1
484558|NCT00093795|1573452|P3|Overall Study|No follow up data|17
484559|NCT00093795|1573453|P2|Overall Study|No follow up data|16
484560|NCT00093795|1573454|P1|Overall Study|No follow up data|20
484561|NCT00093496|1573499|P2|Overall Study|Protocol Violation|3
484562|NCT00093496|1573500|P1|Overall Study|Protocol Violation|1
484563|NCT00093470|1573513|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
484564|NCT00093470|1573514|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
484565|NCT00093470|1573513|P2|Overall Study|Never started treatment|0
484566|NCT00093470|1573514|P1|Overall Study|Never started treatment|1
484567|NCT00093470|1573513|P2|Overall Study|Physician Decision|0
484568|NCT00093470|1573514|P1|Overall Study|Physician Decision|2
484569|NCT00093470|1573513|P2|Overall Study|Other complicating disease|0
484570|NCT00093470|1573514|P1|Overall Study|Other complicating disease|3
484571|NCT00093470|1573513|P2|Overall Study|Alternative therapy|0
484572|NCT00093470|1573514|P1|Overall Study|Alternative therapy|2
484573|NCT00093470|1573513|P2|Overall Study|Withdrawal by Subject|0
484574|NCT00093470|1573514|P1|Overall Study|Withdrawal by Subject|8
484575|NCT00093470|1573513|P2|Overall Study|Death|0
484576|NCT00093470|1573514|P1|Overall Study|Death|2
484577|NCT00093470|1573513|P2|Overall Study|Adverse Event|0
484578|NCT00093470|1573514|P1|Overall Study|Adverse Event|15
484579|NCT00093470|1573513|P2|Overall Study|Disease progression|0
484580|NCT00093470|1573514|P1|Overall Study|Disease progression|39
484581|NCT00093145|1573528|P1|Overall Study|Other|1
484582|NCT00093145|1573528|P1|Overall Study|Withdrawal by Subject|9
484583|NCT00093145|1573528|P1|Overall Study|Physician Decision|5
484584|NCT00093145|1573528|P1|Overall Study|Unacceptable Toxicity Only|2
484585|NCT00093015|1573570|P2|Overall Study|Death|385
484586|NCT00093015|1573571|P1|Overall Study|Death|375
484587|NCT00093015|1573570|P2|Overall Study|Lost to Follow-up|108
484588|NCT00093015|1573571|P1|Overall Study|Lost to Follow-up|96
484589|NCT00093015|1573570|P2|Overall Study|Withdrawal by Subject|171
484590|NCT00093015|1573571|P1|Overall Study|Withdrawal by Subject|194
484591|NCT00092677|1573599|P2|Overall Study|Adminstrative|9
484592|NCT00092677|1573600|P1|Overall Study|Adminstrative|5
484593|NCT00092677|1573599|P2|Overall Study|Lost to Follow-up|2
484594|NCT00092677|1573600|P1|Overall Study|Lost to Follow-up|0
484595|NCT00092547|1573644|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
484596|NCT00092547|1573645|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
484597|NCT00092547|1573646|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
484598|NCT00092547|1573644|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
484599|NCT00092547|1573645|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
484600|NCT00092547|1573646|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
484601|NCT00092547|1573644|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
484602|NCT00092547|1573645|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
484603|NCT00092547|1573646|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
484604|NCT00092547|1573644|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
484605|NCT00092547|1573645|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
484606|NCT00092547|1573646|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
484607|NCT00092547|1573644|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
484608|NCT00092547|1573645|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
484609|NCT00092547|1573646|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
484610|NCT00092547|1573644|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
484611|NCT00092547|1573645|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
484612|NCT00092547|1573646|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
484613|NCT00092547|1573644|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
484614|NCT00092547|1573645|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
484615|NCT00092547|1573646|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
484616|NCT00092547|1573644|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
484617|NCT00092547|1573645|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
484618|NCT00092547|1573646|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
484619|NCT00092547|1573644|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
484620|NCT00092547|1573645|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
484621|NCT00092547|1573646|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
484622|NCT00092547|1573644|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
484623|NCT00092547|1573645|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
484624|NCT00092547|1573646|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
484625|NCT00092547|1573644|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
484626|NCT00092547|1573645|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
484627|NCT00092547|1573646|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
484628|NCT00092547|1573644|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
484629|NCT00092547|1573645|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
484630|NCT00092547|1573646|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
484631|NCT00092547|1573644|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
484632|NCT00092547|1573645|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
484633|NCT00092547|1573646|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
484634|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
484635|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
484636|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
484637|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
484638|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
484639|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
484640|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
484641|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
484642|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
484643|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
484644|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
484645|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
484646|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
484647|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
484648|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
484649|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
484650|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
484651|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
484652|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
484653|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
484654|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
484655|NCT00092547|1573644|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
484656|NCT00092547|1573645|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
484657|NCT00092547|1573646|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
484658|NCT00092534|1573690|P3|Extension Study|Protocol Deviation|15
484659|NCT00092534|1573691|P2|Extension Study|Protocol Deviation|0
484660|NCT00092534|1573692|P1|Extension Study|Protocol Deviation|0
484661|NCT00092534|1573690|P3|Extension Study|Study Ended|29
484662|NCT00092534|1573691|P2|Extension Study|Study Ended|0
484663|NCT00092534|1573692|P1|Extension Study|Study Ended|0
484664|NCT00092534|1573690|P3|Extension Study|Site Closed|21
484665|NCT00092534|1573691|P2|Extension Study|Site Closed|0
484666|NCT00092534|1573692|P1|Extension Study|Site Closed|0
484667|NCT00092534|1573690|P3|Extension Study|Travel|2
484668|NCT00092534|1573691|P2|Extension Study|Travel|0
484669|NCT00092534|1573692|P1|Extension Study|Travel|0
484670|NCT00092534|1573690|P3|Extension Study|Moved|6
484671|NCT00092534|1573691|P2|Extension Study|Moved|0
484672|NCT00092534|1573692|P1|Extension Study|Moved|0
484673|NCT00092534|1573690|P3|Extension Study|Withdrawal by Subject|18
484674|NCT00092534|1573691|P2|Extension Study|Withdrawal by Subject|0
484675|NCT00092534|1573692|P1|Extension Study|Withdrawal by Subject|0
484676|NCT00092534|1573690|P3|Extension Study|Pregnancy|12
484677|NCT00092534|1573691|P2|Extension Study|Pregnancy|0
484678|NCT00092534|1573692|P1|Extension Study|Pregnancy|0
484679|NCT00092534|1573690|P3|Extension Study|Physician Decision|1
484680|NCT00092534|1573691|P2|Extension Study|Physician Decision|0
484681|NCT00092534|1573692|P1|Extension Study|Physician Decision|0
484682|NCT00092534|1573690|P3|Extension Study|Lost to Follow-up|41
484683|NCT00092534|1573691|P2|Extension Study|Lost to Follow-up|0
484684|NCT00092534|1573692|P1|Extension Study|Lost to Follow-up|0
484685|NCT00092534|1573690|P3|Base Study Follow Up Period|Subjects in extension|0
484686|NCT00092534|1573691|P2|Base Study Follow Up Period|Subjects in extension|371
484687|NCT00092534|1573692|P1|Base Study Follow Up Period|Subjects in extension|15
484688|NCT00092534|1573690|P3|Base Study Follow Up Period|Subjects continuing|0
484689|NCT00092534|1573691|P2|Base Study Follow Up Period|Subjects continuing|31
484690|NCT00092534|1573692|P1|Base Study Follow Up Period|Subjects continuing|27
484691|NCT00092534|1573690|P3|Base Study Follow Up Period|Site Closed|0
484692|NCT00092534|1573691|P2|Base Study Follow Up Period|Site Closed|2
484693|NCT00092534|1573692|P1|Base Study Follow Up Period|Site Closed|0
484694|NCT00092534|1573690|P3|Base Study Follow Up Period|Travel|0
484695|NCT00092534|1573691|P2|Base Study Follow Up Period|Travel|7
484696|NCT00092534|1573692|P1|Base Study Follow Up Period|Travel|10
484697|NCT00092534|1573690|P3|Base Study Follow Up Period|Moved|0
484698|NCT00092534|1573691|P2|Base Study Follow Up Period|Moved|58
484699|NCT00092534|1573692|P1|Base Study Follow Up Period|Moved|62
484700|NCT00092534|1573690|P3|Base Study Follow Up Period|Withdrawal by Subject|0
484701|NCT00092534|1573691|P2|Base Study Follow Up Period|Withdrawal by Subject|62
484702|NCT00092534|1573692|P1|Base Study Follow Up Period|Withdrawal by Subject|71
484703|NCT00092534|1573690|P3|Base Study Follow Up Period|Protocol Violation|0
484704|NCT00092534|1573691|P2|Base Study Follow Up Period|Protocol Violation|2
484705|NCT00092534|1573692|P1|Base Study Follow Up Period|Protocol Violation|1
484706|NCT00092534|1573690|P3|Base Study Follow Up Period|Pregnancy|0
484707|NCT00092534|1573691|P2|Base Study Follow Up Period|Pregnancy|10
484708|NCT00092534|1573692|P1|Base Study Follow Up Period|Pregnancy|6
484709|NCT00092534|1573690|P3|Base Study Follow Up Period|Lost to Follow-up|0
484710|NCT00092534|1573691|P2|Base Study Follow Up Period|Lost to Follow-up|146
484711|NCT00092534|1573692|P1|Base Study Follow Up Period|Lost to Follow-up|120
484712|NCT00092534|1573690|P3|Base Study Follow Up Period|Death|0
484713|NCT00092534|1573691|P2|Base Study Follow Up Period|Death|1
484714|NCT00092534|1573692|P1|Base Study Follow Up Period|Death|2
484715|NCT00092534|1573690|P3|Base Study Follow Up Period|Adverse Event|0
484716|NCT00092534|1573691|P2|Base Study Follow Up Period|Adverse Event|4
484717|NCT00092534|1573692|P1|Base Study Follow Up Period|Adverse Event|2
484718|NCT00092534|1573690|P3|Base Study Vaccination Period|Site Closed|0
484719|NCT00092534|1573691|P2|Base Study Vaccination Period|Site Closed|1
484720|NCT00092534|1573692|P1|Base Study Vaccination Period|Site Closed|0
484721|NCT00092534|1573690|P3|Base Study Vaccination Period|Travel|0
484722|NCT00092534|1573691|P2|Base Study Vaccination Period|Travel|0
484723|NCT00092534|1573692|P1|Base Study Vaccination Period|Travel|1
484724|NCT00092534|1573690|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
484725|NCT00092534|1573691|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
484726|NCT00092534|1573692|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
484727|NCT00092534|1573690|P3|Base Study Vaccination Period|Moved|0
484728|NCT00092534|1573691|P2|Base Study Vaccination Period|Moved|12
484729|NCT00092534|1573692|P1|Base Study Vaccination Period|Moved|14
484730|NCT00092534|1573690|P3|Base Study Vaccination Period|Withdrawal by Subject|0
484731|NCT00092534|1573691|P2|Base Study Vaccination Period|Withdrawal by Subject|58
484732|NCT00092534|1573692|P1|Base Study Vaccination Period|Withdrawal by Subject|85
484733|NCT00092534|1573690|P3|Base Study Vaccination Period|Protocol Violation|0
484734|NCT00092534|1573691|P2|Base Study Vaccination Period|Protocol Violation|1
484735|NCT00092534|1573692|P1|Base Study Vaccination Period|Protocol Violation|2
484736|NCT00092534|1573690|P3|Base Study Vaccination Period|Pregnancy|0
484737|NCT00092534|1573691|P2|Base Study Vaccination Period|Pregnancy|7
484738|NCT00092534|1573692|P1|Base Study Vaccination Period|Pregnancy|9
484739|NCT00092534|1573690|P3|Base Study Vaccination Period|Physician Decision|0
484740|NCT00092534|1573691|P2|Base Study Vaccination Period|Physician Decision|0
484741|NCT00092534|1573692|P1|Base Study Vaccination Period|Physician Decision|1
484742|NCT00092534|1573690|P3|Base Study Vaccination Period|Lost to Follow-up|0
484743|NCT00092534|1573691|P2|Base Study Vaccination Period|Lost to Follow-up|37
484744|NCT00092534|1573692|P1|Base Study Vaccination Period|Lost to Follow-up|41
484745|NCT00092534|1573690|P3|Base Study Vaccination Period|Death|0
484746|NCT00092534|1573691|P2|Base Study Vaccination Period|Death|4
484747|NCT00092534|1573692|P1|Base Study Vaccination Period|Death|5
484748|NCT00092534|1573690|P3|Base Study Vaccination Period|Adverse Event|0
484749|NCT00092534|1573691|P2|Base Study Vaccination Period|Adverse Event|1
484750|NCT00092534|1573692|P1|Base Study Vaccination Period|Adverse Event|3
484751|NCT00092534|1573690|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
484752|NCT00092534|1573691|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
484753|NCT00092534|1573692|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
484754|NCT00092521|1573710|P4|Extension Study (Group 4)|Unable/unwilling to return|25
484755|NCT00092521|1573711|P3|Extension Study (Group 4)|Unable/unwilling to return|0
484756|NCT00092521|1573712|P2|Extension Study (Group 4)|Unable/unwilling to return|0
484757|NCT00092521|1573713|P1|Extension Study (Group 4)|Unable/unwilling to return|0
484758|NCT00092521|1573710|P4|Extension Study (Group 4)|Site Terminated|4
484759|NCT00092521|1573711|P3|Extension Study (Group 4)|Site Terminated|0
484760|NCT00092521|1573712|P2|Extension Study (Group 4)|Site Terminated|0
484761|NCT00092521|1573713|P1|Extension Study (Group 4)|Site Terminated|0
484762|NCT00092521|1573710|P4|Extension Study (Group 4)|Moved|16
484763|NCT00092521|1573711|P3|Extension Study (Group 4)|Moved|0
484764|NCT00092521|1573712|P2|Extension Study (Group 4)|Moved|0
484765|NCT00092521|1573713|P1|Extension Study (Group 4)|Moved|0
484766|NCT00092521|1573710|P4|Extension Study (Group 4)|Withdrawal by Subject|46
484767|NCT00092521|1573711|P3|Extension Study (Group 4)|Withdrawal by Subject|0
484768|NCT00092521|1573712|P2|Extension Study (Group 4)|Withdrawal by Subject|0
484769|NCT00092521|1573713|P1|Extension Study (Group 4)|Withdrawal by Subject|0
484770|NCT00092521|1573710|P4|Extension Study (Group 4)|Protocol Violation|2
484771|NCT00092521|1573711|P3|Extension Study (Group 4)|Protocol Violation|0
484772|NCT00092521|1573712|P2|Extension Study (Group 4)|Protocol Violation|0
484773|NCT00092521|1573713|P1|Extension Study (Group 4)|Protocol Violation|0
484774|NCT00092521|1573710|P4|Extension Study (Group 4)|Pregnancy|4
484775|NCT00092521|1573711|P3|Extension Study (Group 4)|Pregnancy|0
484776|NCT00092521|1573712|P2|Extension Study (Group 4)|Pregnancy|0
484777|NCT00092521|1573713|P1|Extension Study (Group 4)|Pregnancy|0
484778|NCT00092521|1573710|P4|Extension Study (Group 4)|Lost to Follow-up|87
484779|NCT00092521|1573711|P3|Extension Study (Group 4)|Lost to Follow-up|0
484780|NCT00092521|1573712|P2|Extension Study (Group 4)|Lost to Follow-up|0
484781|NCT00092521|1573713|P1|Extension Study (Group 4)|Lost to Follow-up|0
484782|NCT00092521|1573710|P4|Extension Study (Group 4)|Adverse Event|2
484783|NCT00092521|1573711|P3|Extension Study (Group 4)|Adverse Event|0
484784|NCT00092521|1573712|P2|Extension Study (Group 4)|Adverse Event|0
484785|NCT00092521|1573713|P1|Extension Study (Group 4)|Adverse Event|0
484786|NCT00092521|1573710|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
484787|NCT00092521|1573711|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
484788|NCT00092521|1573712|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
484789|NCT00092521|1573713|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
484790|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Visits Compressed|0
484791|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Visits Compressed|5
484792|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Visits Compressed|0
484793|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Visits Compressed|5
484794|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Travel|0
484795|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Travel|0
484796|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Travel|0
484797|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Travel|2
484798|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Site Terminated|0
484799|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Site Terminated|3
484800|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Site Terminated|0
484801|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Site Terminated|3
484802|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Moved|0
484803|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Moved|28
484804|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Moved|2
484805|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Moved|32
484806|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
484807|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
484808|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
484809|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
484810|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Protocol Violation|0
484811|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Protocol Violation|5
484812|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Protocol Violation|1
484813|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Protocol Violation|1
484814|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
484815|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
484816|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
484817|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
484818|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Death|0
484819|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Death|1
484820|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Death|0
484821|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Death|2
484822|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Adverse Event|0
484823|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Adverse Event|0
484824|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Adverse Event|0
484825|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Adverse Event|1
484826|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Subjects in Extension|0
484827|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Subjects in Extension|412
484828|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Subjects in Extension|109
484829|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Subjects in Extension|13
484830|NCT00092521|1573710|P4|Follow-Up (After Month 7)|Subjects Continuing|0
484831|NCT00092521|1573711|P3|Follow-Up (After Month 7)|Subjects Continuing|35
484832|NCT00092521|1573712|P2|Follow-Up (After Month 7)|Subjects Continuing|4
484833|NCT00092521|1573713|P1|Follow-Up (After Month 7)|Subjects Continuing|34
484834|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
484835|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
484836|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
484837|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
484838|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
484839|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
484840|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
484841|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
484842|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Moved|0
484843|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Moved|18
484844|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Moved|1
484845|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Moved|14
484846|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
484847|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
484848|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
484849|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
484850|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
484851|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
484852|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
484853|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
484854|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
484855|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
484856|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
484857|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
484858|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Death|0
484859|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Death|1
484860|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Death|0
484861|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Death|0
484862|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
484863|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
484864|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
484865|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
484866|NCT00092521|1573710|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
484867|NCT00092521|1573711|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
484868|NCT00092521|1573712|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
484869|NCT00092521|1573713|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
484870|NCT00092495|1573727|P5|Base Study Follow-up Period|Withdrawal by Subject|0
484871|NCT00092495|1573728|P4|Base Study Follow-up Period|Withdrawal by Subject|0
484872|NCT00092495|1573729|P3|Base Study Follow-up Period|Withdrawal by Subject|0
484873|NCT00092495|1573730|P2|Base Study Follow-up Period|Withdrawal by Subject|0
484874|NCT00092495|1573731|P1|Base Study Follow-up Period|Withdrawal by Subject|2
484875|NCT00092495|1573727|P5|Base Study Follow-up Period|Lost to Follow-up|0
484876|NCT00092495|1573728|P4|Base Study Follow-up Period|Lost to Follow-up|12
484877|NCT00092495|1573729|P3|Base Study Follow-up Period|Lost to Follow-up|3
484878|NCT00092495|1573730|P2|Base Study Follow-up Period|Lost to Follow-up|3
484879|NCT00092495|1573731|P1|Base Study Follow-up Period|Lost to Follow-up|1
484880|NCT00092495|1573727|P5|Base Study Follow-up Period|Extended|0
484881|NCT00092495|1573728|P4|Base Study Follow-up Period|Extended|2
484882|NCT00092495|1573729|P3|Base Study Follow-up Period|Extended|1
484883|NCT00092495|1573730|P2|Base Study Follow-up Period|Extended|0
484884|NCT00092495|1573731|P1|Base Study Follow-up Period|Extended|0
484885|NCT00092495|1573727|P5|Base Study Vaccination Period|Withdrawal by Subject|0
484886|NCT00092495|1573728|P4|Base Study Vaccination Period|Withdrawal by Subject|25
484887|NCT00092495|1573729|P3|Base Study Vaccination Period|Withdrawal by Subject|14
484888|NCT00092495|1573730|P2|Base Study Vaccination Period|Withdrawal by Subject|10
484889|NCT00092495|1573731|P1|Base Study Vaccination Period|Withdrawal by Subject|9
484890|NCT00092495|1573727|P5|Base Study Vaccination Period|Protocol Violation|0
484891|NCT00092495|1573728|P4|Base Study Vaccination Period|Protocol Violation|0
484892|NCT00092495|1573729|P3|Base Study Vaccination Period|Protocol Violation|0
484893|NCT00092495|1573730|P2|Base Study Vaccination Period|Protocol Violation|0
484894|NCT00092495|1573731|P1|Base Study Vaccination Period|Protocol Violation|1
484895|NCT00092495|1573727|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
484896|NCT00092495|1573728|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
484897|NCT00092495|1573729|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
484898|NCT00092495|1573730|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
484899|NCT00092495|1573731|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
484900|NCT00092495|1573727|P5|Base Study Vaccination Period|Pregnancy|0
484901|NCT00092495|1573728|P4|Base Study Vaccination Period|Pregnancy|0
484902|NCT00092495|1573729|P3|Base Study Vaccination Period|Pregnancy|0
484903|NCT00092495|1573730|P2|Base Study Vaccination Period|Pregnancy|0
484904|NCT00092495|1573731|P1|Base Study Vaccination Period|Pregnancy|2
484905|NCT00092495|1573727|P5|Base Study Vaccination Period|Other|0
484906|NCT00092495|1573728|P4|Base Study Vaccination Period|Other|2
484907|NCT00092495|1573729|P3|Base Study Vaccination Period|Other|0
484908|NCT00092495|1573730|P2|Base Study Vaccination Period|Other|1
484909|NCT00092495|1573731|P1|Base Study Vaccination Period|Other|1
484910|NCT00092495|1573727|P5|Base Study Vaccination Period|Moved|0
484911|NCT00092495|1573728|P4|Base Study Vaccination Period|Moved|2
484912|NCT00092495|1573729|P3|Base Study Vaccination Period|Moved|2
484913|NCT00092495|1573730|P2|Base Study Vaccination Period|Moved|1
484914|NCT00092495|1573731|P1|Base Study Vaccination Period|Moved|3
484915|NCT00092495|1573727|P5|Base Study Vaccination Period|Lost to Follow-up|0
484916|NCT00092495|1573728|P4|Base Study Vaccination Period|Lost to Follow-up|36
484917|NCT00092495|1573729|P3|Base Study Vaccination Period|Lost to Follow-up|11
484918|NCT00092495|1573730|P2|Base Study Vaccination Period|Lost to Follow-up|6
484919|NCT00092495|1573731|P1|Base Study Vaccination Period|Lost to Follow-up|16
484920|NCT00092495|1573727|P5|Base Study Vaccination Period|Adverse Event|0
484921|NCT00092495|1573728|P4|Base Study Vaccination Period|Adverse Event|3
484922|NCT00092495|1573729|P3|Base Study Vaccination Period|Adverse Event|0
484923|NCT00092495|1573730|P2|Base Study Vaccination Period|Adverse Event|0
484924|NCT00092495|1573731|P1|Base Study Vaccination Period|Adverse Event|1
484925|NCT00092495|1573727|P5|Base Study Vaccination Period|*Pregnancy|0
484926|NCT00092495|1573728|P4|Base Study Vaccination Period|*Pregnancy|7
484927|NCT00092495|1573729|P3|Base Study Vaccination Period|*Pregnancy|5
484928|NCT00092495|1573730|P2|Base Study Vaccination Period|*Pregnancy|2
484929|NCT00092495|1573731|P1|Base Study Vaccination Period|*Pregnancy|0
484930|NCT00092495|1573727|P5|Base Study Vaccination Period|*Other reasons|0
484931|NCT00092495|1573728|P4|Base Study Vaccination Period|*Other reasons|1
484932|NCT00092495|1573729|P3|Base Study Vaccination Period|*Other reasons|0
484933|NCT00092495|1573730|P2|Base Study Vaccination Period|*Other reasons|0
484934|NCT00092495|1573731|P1|Base Study Vaccination Period|*Other reasons|1
484935|NCT00092495|1573727|P5|Base Study Vaccination Period|*Clinical AE|0
484936|NCT00092495|1573728|P4|Base Study Vaccination Period|*Clinical AE|2
484937|NCT00092495|1573729|P3|Base Study Vaccination Period|*Clinical AE|1
484938|NCT00092495|1573730|P2|Base Study Vaccination Period|*Clinical AE|0
484939|NCT00092495|1573731|P1|Base Study Vaccination Period|*Clinical AE|1
484940|NCT00092495|1573727|P5|Base Study Vaccination Period|Extended|0
484941|NCT00092495|1573728|P4|Base Study Vaccination Period|Extended|1
484942|NCT00092495|1573729|P3|Base Study Vaccination Period|Extended|0
484943|NCT00092495|1573730|P2|Base Study Vaccination Period|Extended|0
484944|NCT00092495|1573731|P1|Base Study Vaccination Period|Extended|0
484945|NCT00092495|1573727|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
484946|NCT00092495|1573728|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
484947|NCT00092495|1573729|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
484948|NCT00092495|1573730|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
484949|NCT00092495|1573731|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
484950|NCT00092456|1573797|P4|Overall Study|Not Specified|0
484951|NCT00092456|1573798|P3|Overall Study|Not Specified|3
484952|NCT00092456|1573799|P2|Overall Study|Not Specified|2
484953|NCT00092456|1573800|P1|Overall Study|Not Specified|4
484954|NCT00092456|1573797|P4|Overall Study|Moved|1
484955|NCT00092456|1573798|P3|Overall Study|Moved|0
484956|NCT00092456|1573799|P2|Overall Study|Moved|1
484957|NCT00092456|1573800|P1|Overall Study|Moved|1
484958|NCT00092456|1573797|P4|Overall Study|Withdrawal by Subject|6
484959|NCT00092456|1573798|P3|Overall Study|Withdrawal by Subject|16
484960|NCT00092456|1573799|P2|Overall Study|Withdrawal by Subject|5
484961|NCT00092456|1573800|P1|Overall Study|Withdrawal by Subject|13
484962|NCT00092456|1573797|P4|Overall Study|Protocol Violation|6
484963|NCT00092456|1573798|P3|Overall Study|Protocol Violation|8
484964|NCT00092456|1573799|P2|Overall Study|Protocol Violation|7
484965|NCT00092456|1573800|P1|Overall Study|Protocol Violation|5
484966|NCT00092456|1573797|P4|Overall Study|Lost to Follow-up|2
484967|NCT00092456|1573798|P3|Overall Study|Lost to Follow-up|1
484968|NCT00092456|1573799|P2|Overall Study|Lost to Follow-up|2
484969|NCT00092456|1573800|P1|Overall Study|Lost to Follow-up|2
484970|NCT00092456|1573797|P4|Overall Study|Adverse Event|1
484971|NCT00092456|1573798|P3|Overall Study|Adverse Event|1
484972|NCT00092456|1573799|P2|Overall Study|Adverse Event|0
484973|NCT00092456|1573800|P1|Overall Study|Adverse Event|0
484974|NCT00092443|1573848|P2|Overall Study|Not Specified|13
484975|NCT00092443|1573849|P1|Overall Study|Not Specified|17
484976|NCT00092443|1573848|P2|Overall Study|Moved|5
484977|NCT00092443|1573849|P1|Overall Study|Moved|5
484978|NCT00092443|1573848|P2|Overall Study|Withdrawal by Subject|11
484979|NCT00092443|1573849|P1|Overall Study|Withdrawal by Subject|9
484980|NCT00092443|1573848|P2|Overall Study|Protocol Violation|9
484981|NCT00092443|1573849|P1|Overall Study|Protocol Violation|11
484982|NCT00092443|1573848|P2|Overall Study|Lost to Follow-up|3
484983|NCT00092443|1573849|P1|Overall Study|Lost to Follow-up|7
484984|NCT00092443|1573848|P2|Overall Study|Adverse Event|13
484985|NCT00092443|1573849|P1|Overall Study|Adverse Event|9
484986|NCT00092417|1573867|P2|Overall Study|Not Specified|0
484987|NCT00092417|1573868|P1|Overall Study|Not Specified|1
484988|NCT00092417|1573867|P2|Overall Study|Withdrawal by Subject|1
484989|NCT00092417|1573868|P1|Overall Study|Withdrawal by Subject|2
484990|NCT00092417|1573867|P2|Overall Study|Lost to Follow-up|0
484991|NCT00092417|1573868|P1|Overall Study|Lost to Follow-up|2
484992|NCT00092131|1573882|P2|Treatment Period II|Adverse Event|1
484993|NCT00092131|1573883|P1|Treatment Period II|Adverse Event|0
484994|NCT00092131|1573882|P2|Treatment Period I|Adverse Event|0
484995|NCT00092131|1573883|P1|Treatment Period I|Adverse Event|1
484996|NCT00092118|1573913|P2|Overall Study|Not Specified|5
484997|NCT00092118|1573914|P1|Overall Study|Not Specified|6
484998|NCT00092118|1573913|P2|Overall Study|Withdrawal by Subject|10
484999|NCT00092118|1573914|P1|Overall Study|Withdrawal by Subject|4
485000|NCT00092118|1573913|P2|Overall Study|Protocol Violation|25
485001|NCT00092118|1573914|P1|Overall Study|Protocol Violation|23
485002|NCT00092118|1573913|P2|Overall Study|Lost to Follow-up|3
485003|NCT00092118|1573914|P1|Overall Study|Lost to Follow-up|4
485004|NCT00092118|1573913|P2|Overall Study|Lack of Efficacy|14
485005|NCT00092118|1573914|P1|Overall Study|Lack of Efficacy|12
485006|NCT00092118|1573913|P2|Overall Study|Adverse Event|32
485007|NCT00092118|1573914|P1|Overall Study|Adverse Event|35
485008|NCT00091949|1573948|P2|Overall Study|Lost to Follow-up|41
485009|NCT00091949|1573949|P1|Overall Study|Lost to Follow-up|58
485010|NCT00091949|1573948|P2|Overall Study|Withdrawal by Subject|110
485011|NCT00091949|1573949|P1|Overall Study|Withdrawal by Subject|117
485012|NCT00091832|1573973|P6|Overall Study|Protocol Violation|1
485013|NCT00091832|1573974|P5|Overall Study|Protocol Violation|0
485014|NCT00091832|1573975|P4|Overall Study|Protocol Violation|0
485015|NCT00091832|1573976|P3|Overall Study|Protocol Violation|1
485016|NCT00091832|1573977|P2|Overall Study|Protocol Violation|0
485017|NCT00091832|1573978|P1|Overall Study|Protocol Violation|0
485018|NCT00091832|1573973|P6|Overall Study|Other|0
485019|NCT00091832|1573974|P5|Overall Study|Other|0
485020|NCT00091832|1573975|P4|Overall Study|Other|0
485021|NCT00091832|1573976|P3|Overall Study|Other|2
485022|NCT00091832|1573977|P2|Overall Study|Other|1
485023|NCT00091832|1573978|P1|Overall Study|Other|0
485024|NCT00091832|1573973|P6|Overall Study|Noncompliance|0
485025|NCT00091832|1573974|P5|Overall Study|Noncompliance|0
485026|NCT00091832|1573975|P4|Overall Study|Noncompliance|0
485027|NCT00091832|1573976|P3|Overall Study|Noncompliance|0
485028|NCT00091832|1573977|P2|Overall Study|Noncompliance|1
485029|NCT00091832|1573978|P1|Overall Study|Noncompliance|0
485030|NCT00091832|1573973|P6|Overall Study|Lost to Follow-up|1
485031|NCT00091832|1573974|P5|Overall Study|Lost to Follow-up|2
485032|NCT00091832|1573975|P4|Overall Study|Lost to Follow-up|3
485033|NCT00091832|1573976|P3|Overall Study|Lost to Follow-up|3
485034|NCT00091832|1573977|P2|Overall Study|Lost to Follow-up|0
485035|NCT00091832|1573978|P1|Overall Study|Lost to Follow-up|1
485036|NCT00091832|1573973|P6|Overall Study|Ineligibility Determined|0
485037|NCT00091832|1573974|P5|Overall Study|Ineligibility Determined|1
485038|NCT00091832|1573975|P4|Overall Study|Ineligibility Determined|0
485039|NCT00091832|1573976|P3|Overall Study|Ineligibility Determined|1
485040|NCT00091832|1573977|P2|Overall Study|Ineligibility Determined|0
485041|NCT00091832|1573978|P1|Overall Study|Ineligibility Determined|0
485042|NCT00091832|1573973|P6|Overall Study|Disease Progression|2
485043|NCT00091832|1573974|P5|Overall Study|Disease Progression|1
485044|NCT00091832|1573975|P4|Overall Study|Disease Progression|1
485045|NCT00091832|1573976|P3|Overall Study|Disease Progression|0
485046|NCT00091832|1573977|P2|Overall Study|Disease Progression|0
485047|NCT00091832|1573978|P1|Overall Study|Disease Progression|2
485048|NCT00091832|1573973|P6|Overall Study|Death|6
485049|NCT00091832|1573974|P5|Overall Study|Death|5
485050|NCT00091832|1573975|P4|Overall Study|Death|8
485051|NCT00091832|1573976|P3|Overall Study|Death|5
485052|NCT00091832|1573977|P2|Overall Study|Death|4
485053|NCT00091832|1573978|P1|Overall Study|Death|6
485054|NCT00091832|1573973|P6|Overall Study|Withdrawal by Subject|1
485055|NCT00091832|1573974|P5|Overall Study|Withdrawal by Subject|3
485056|NCT00091832|1573975|P4|Overall Study|Withdrawal by Subject|1
485057|NCT00091832|1573976|P3|Overall Study|Withdrawal by Subject|0
485058|NCT00091832|1573977|P2|Overall Study|Withdrawal by Subject|5
485059|NCT00091832|1573978|P1|Overall Study|Withdrawal by Subject|4
485060|NCT00091832|1573973|P6|Overall Study|Adverse Event|0
485061|NCT00091832|1573974|P5|Overall Study|Adverse Event|3
485062|NCT00091832|1573975|P4|Overall Study|Adverse Event|1
485063|NCT00091832|1573976|P3|Overall Study|Adverse Event|0
485064|NCT00091832|1573977|P2|Overall Study|Adverse Event|0
485065|NCT00091832|1573978|P1|Overall Study|Adverse Event|0
485066|NCT00091832|1573973|P6|Overall Study|Physician Decision|0
485067|NCT00091832|1573974|P5|Overall Study|Physician Decision|0
485068|NCT00091832|1573975|P4|Overall Study|Physician Decision|0
485069|NCT00091832|1573976|P3|Overall Study|Physician Decision|0
485070|NCT00091832|1573977|P2|Overall Study|Physician Decision|0
485071|NCT00091832|1573978|P1|Overall Study|Physician Decision|1
485072|NCT00091819|1574096|P2|Overall Study|Never received study treatment|4
485073|NCT00091819|1574097|P1|Overall Study|Never received study treatment|3
485074|NCT00091819|1574096|P2|Overall Study|Other|3
485075|NCT00091819|1574097|P1|Overall Study|Other|2
485076|NCT00091819|1574096|P2|Overall Study|Protocol Violation|2
485077|NCT00091819|1574097|P1|Overall Study|Protocol Violation|1
485078|NCT00091819|1574096|P2|Overall Study|Withdrawal by Subject|8
485079|NCT00091819|1574097|P1|Overall Study|Withdrawal by Subject|5
485080|NCT00091819|1574096|P2|Overall Study|Lost to Follow-up|23
485081|NCT00091819|1574097|P1|Overall Study|Lost to Follow-up|26
485082|NCT00091819|1574096|P2|Overall Study|Death|5
485083|NCT00091819|1574097|P1|Overall Study|Death|4
485084|NCT00091819|1574096|P2|Overall Study|Adverse Event|1
485085|NCT00091819|1574097|P1|Overall Study|Adverse Event|1
485086|NCT00091793|1574105|P2|Overall Study|Other|0
485087|NCT00091793|1574106|P1|Overall Study|Other|2
485088|NCT00091793|1574105|P2|Overall Study|Noncompliance|0
485089|NCT00091793|1574106|P1|Overall Study|Noncompliance|2
485090|NCT00091793|1574105|P2|Overall Study|Lost to Follow-up|5
485091|NCT00091793|1574106|P1|Overall Study|Lost to Follow-up|7
485092|NCT00091793|1574105|P2|Overall Study|Ineligibility determined|0
485093|NCT00091793|1574106|P1|Overall Study|Ineligibility determined|2
485094|NCT00091793|1574105|P2|Overall Study|Withdrawal by Subject|15
485095|NCT00091793|1574106|P1|Overall Study|Withdrawal by Subject|10
485096|NCT00091793|1574105|P2|Overall Study|Adverse Event|2
485097|NCT00091793|1574106|P1|Overall Study|Adverse Event|1
485098|NCT00091572|1574130|P2|Overall Study|Toxicity (Related AE)|9
485099|NCT00091572|1574131|P1|Overall Study|Toxicity (Related AE)|53
485100|NCT00091572|1574130|P2|Overall Study|Major Protocol Violation|0
485101|NCT00091572|1574131|P1|Overall Study|Major Protocol Violation|2
485102|NCT00091572|1574130|P2|Overall Study|Ongoing (still on treatment)|12
485103|NCT00091572|1574131|P1|Overall Study|Ongoing (still on treatment)|8
485104|NCT00091572|1574130|P2|Overall Study|Other Reason|13
485105|NCT00091572|1574131|P1|Overall Study|Other Reason|6
485106|NCT00091572|1574130|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
485107|NCT00091572|1574131|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
485108|NCT00091572|1574130|P2|Overall Study|Death not due to malignancy/toxicity|3
485109|NCT00091572|1574131|P1|Overall Study|Death not due to malignancy/toxicity|1
485110|NCT00091572|1574130|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
485111|NCT00091572|1574131|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
485112|NCT00091572|1574130|P2|Overall Study|Lost to Follow-up|1
485113|NCT00091572|1574131|P1|Overall Study|Lost to Follow-up|1
485114|NCT00091442|1574162|P2|Overall Study|Not Specified|6
485115|NCT00091442|1574163|P1|Overall Study|Not Specified|2
485116|NCT00091442|1574162|P2|Overall Study|Lost to Follow-up|3
485117|NCT00091442|1574163|P1|Overall Study|Lost to Follow-up|1
485118|NCT00091442|1574162|P2|Overall Study|Death|7
485119|NCT00091442|1574163|P1|Overall Study|Death|9
485120|NCT00091442|1574162|P2|Overall Study|2cycles therapy beyond Complete response|16
485121|NCT00091442|1574163|P1|Overall Study|2cycles therapy beyond Complete response|9
485122|NCT00091442|1574162|P2|Overall Study|Adverse Event|48
485123|NCT00091442|1574163|P1|Overall Study|Adverse Event|29
485124|NCT00091442|1574162|P2|Overall Study|Withdrawal by Subject|46
485125|NCT00091442|1574163|P1|Overall Study|Withdrawal by Subject|38
485126|NCT00091442|1574162|P2|Overall Study|Physician Decision|58
485127|NCT00091442|1574163|P1|Overall Study|Physician Decision|61
485128|NCT00091442|1574162|P2|Overall Study|Progressive Disease|189
485129|NCT00091442|1574163|P1|Overall Study|Progressive Disease|220
485130|NCT00091390|1574173|P1|Overall Study|Protocol Violation|2
485131|NCT00091390|1574173|P1|Overall Study|Withdrawal by Subject|2
485132|NCT00091169|1574191|P2|Overall Study|Not start protocol therapy|17
485133|NCT00091169|1574192|P1|Overall Study|Not start protocol therapy|26
485134|NCT00091169|1574191|P2|Overall Study|Other|4
485135|NCT00091169|1574192|P1|Overall Study|Other|3
485136|NCT00091169|1574191|P2|Overall Study|Withdrawal by Subject|13
485137|NCT00091169|1574192|P1|Overall Study|Withdrawal by Subject|10
485138|NCT00091169|1574191|P2|Overall Study|Death|1
485139|NCT00091169|1574192|P1|Overall Study|Death|4
485140|NCT00091169|1574191|P2|Overall Study|Adverse Event|17
485141|NCT00091169|1574192|P1|Overall Study|Adverse Event|11
485142|NCT00091169|1574191|P2|Overall Study|Disease progression|1
485143|NCT00091169|1574192|P1|Overall Study|Disease progression|3
485144|NCT00091026|1574210|P2|Overall Study|Unknown-never received treatment|1
485145|NCT00091026|1574211|P1|Overall Study|Unknown-never received treatment|0
485146|NCT00091026|1574210|P2|Overall Study|Patient withdrew and never received trea|2
485147|NCT00091026|1574211|P1|Overall Study|Patient withdrew and never received trea|0
485148|NCT00091026|1574210|P2|Overall Study|Patient deemed non eligible-never receiv|0
485149|NCT00091026|1574211|P1|Overall Study|Patient deemed non eligible-never receiv|1
485150|NCT00090987|1574221|P1|Overall Study|Incarcerated|1
485151|NCT00090987|1574221|P1|Overall Study|Non-compliance|4
485152|NCT00090987|1574221|P1|Overall Study|alternative therapy|1
485153|NCT00090987|1574221|P1|Overall Study|Withdrawal by Subject|3
485154|NCT00090987|1574221|P1|Overall Study|Lack of Efficacy|7
485155|NCT00090987|1574221|P1|Overall Study|Adverse Event|5
485156|NCT00090857|1574227|P2|Overall Study|Adverse Event|2
485157|NCT00090857|1574228|P1|Overall Study|Adverse Event|2
485158|NCT00090857|1574227|P2|Overall Study|Withdrawal by Subject|0
485159|NCT00090857|1574228|P1|Overall Study|Withdrawal by Subject|2
485160|NCT00090857|1574227|P2|Overall Study|Lost to Follow-up|1
485161|NCT00090857|1574228|P1|Overall Study|Lost to Follow-up|0
485162|NCT00090779|1574267|P2|Step 3|Off extended study due to study closure|3
485163|NCT00090779|1574268|P1|Step 3|Off extended study due to study closure|4
485164|NCT00090779|1574267|P2|Step 3|Initiation of ART and off extended study|2
485165|NCT00090779|1574268|P1|Step 3|Initiation of ART and off extended study|3
485166|NCT00090779|1574267|P2|Step 2|Non-compliance to study requirements|1
485167|NCT00090779|1574268|P1|Step 2|Non-compliance to study requirements|0
485168|NCT00090779|1574267|P2|Step 2|Subject relocated|1
485169|NCT00090779|1574268|P1|Step 2|Subject relocated|0
485170|NCT00090779|1574267|P2|Step 2|Off study per study closure|16
485171|NCT00090779|1574268|P1|Step 2|Off study per study closure|6
485172|NCT00090779|1574267|P2|Step 1|Subject relocated|8
485173|NCT00090779|1574268|P1|Step 1|Subject relocated|2
485174|NCT00090779|1574267|P2|Step 1|Non-compliance to study requirements|1
485175|NCT00090779|1574268|P1|Step 1|Non-compliance to study requirements|0
485176|NCT00090779|1574267|P2|Step 1|Pregnancy|0
485177|NCT00090779|1574268|P1|Step 1|Pregnancy|1
485178|NCT00090779|1574267|P2|Step 1|Physician Decision|0
485179|NCT00090779|1574268|P1|Step 1|Physician Decision|1
485180|NCT00090779|1574267|P2|Step 1|Death|2
485181|NCT00090779|1574268|P1|Step 1|Death|0
485182|NCT00090779|1574267|P2|Step 1|Lost to Follow-up|2
485183|NCT00090779|1574268|P1|Step 1|Lost to Follow-up|3
485184|NCT00090779|1574267|P2|Step 1|Withdrawal by Subject|2
485185|NCT00090779|1574268|P1|Step 1|Withdrawal by Subject|4
485186|NCT00090766|1574292|P3|Overall Study|Lost to Follow-up|2
485187|NCT00090766|1574293|P2|Overall Study|Lost to Follow-up|0
485188|NCT00090766|1574294|P1|Overall Study|Lost to Follow-up|2
485189|NCT00090766|1574292|P3|Overall Study|Admin|0
485190|NCT00090766|1574293|P2|Overall Study|Admin|2
485191|NCT00090766|1574294|P1|Overall Study|Admin|0
485192|NCT00090766|1574292|P3|Overall Study|Death|0
485193|NCT00090766|1574293|P2|Overall Study|Death|0
485194|NCT00090766|1574294|P1|Overall Study|Death|1
485195|NCT00090766|1574292|P3|Overall Study|Nephrectomy Planned|1
485196|NCT00090766|1574293|P2|Overall Study|Nephrectomy Planned|0
485197|NCT00090766|1574294|P1|Overall Study|Nephrectomy Planned|0
485198|NCT00090753|1574336|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
485199|NCT00090753|1574337|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
485200|NCT00090753|1574336|P2|Extended Treatment Period|Mircera Commercialization|93
485201|NCT00090753|1574337|P1|Extended Treatment Period|Mircera Commercialization|188
485202|NCT00090753|1574336|P2|Extended Treatment Period|Renal Transplant|12
485203|NCT00090753|1574337|P1|Extended Treatment Period|Renal Transplant|15
485204|NCT00090753|1574336|P2|Extended Treatment Period|Lost to Follow-up|1
485205|NCT00090753|1574337|P1|Extended Treatment Period|Lost to Follow-up|3
485206|NCT00090753|1574336|P2|Extended Treatment Period|Refused Treatment|12
485207|NCT00090753|1574337|P1|Extended Treatment Period|Refused Treatment|18
485208|NCT00090753|1574336|P2|Extended Treatment Period|Lack of Efficacy|0
485209|NCT00090753|1574337|P1|Extended Treatment Period|Lack of Efficacy|1
485210|NCT00090753|1574336|P2|Extended Treatment Period|Death|30
485211|NCT00090753|1574337|P1|Extended Treatment Period|Death|58
485212|NCT00090753|1574336|P2|Extended Treatment Period|Adverse Event|0
485213|NCT00090753|1574337|P1|Extended Treatment Period|Adverse Event|11
485214|NCT00090753|1574336|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
485215|NCT00090753|1574337|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
485216|NCT00090753|1574336|P2|First Treatment Period|Mircera Commercialization|0
485217|NCT00090753|1574337|P1|First Treatment Period|Mircera Commercialization|1
485218|NCT00090753|1574336|P2|First Treatment Period|Renal Transplant|50
485219|NCT00090753|1574337|P1|First Treatment Period|Renal Transplant|70
485220|NCT00090753|1574336|P2|First Treatment Period|Lost to Follow-up|4
485221|NCT00090753|1574337|P1|First Treatment Period|Lost to Follow-up|4
485222|NCT00090753|1574336|P2|First Treatment Period|Refused Treatment|25
485223|NCT00090753|1574337|P1|First Treatment Period|Refused Treatment|32
485224|NCT00090753|1574336|P2|First Treatment Period|Lack of Efficacy|1
485225|NCT00090753|1574337|P1|First Treatment Period|Lack of Efficacy|2
485226|NCT00090753|1574336|P2|First Treatment Period|Death|62
485227|NCT00090753|1574337|P1|First Treatment Period|Death|88
485228|NCT00090753|1574336|P2|First Treatment Period|Adverse Event|8
485229|NCT00090753|1574337|P1|First Treatment Period|Adverse Event|20
485230|NCT00090610|1574347|P2|Overall Study|Withdrawal by Subject|1
485231|NCT00090610|1574348|P1|Overall Study|Withdrawal by Subject|1
485232|NCT00090584|1574364|P2|Baseline to 8 Months|Lost to Follow-up|41
485233|NCT00090584|1574365|P1|Baseline to 8 Months|Lost to Follow-up|44
485234|NCT00090584|1574364|P2|Baseline to 10 Weeks|Lost to Follow-up|12
485235|NCT00090584|1574365|P1|Baseline to 10 Weeks|Lost to Follow-up|15
485236|NCT00090519|1574397|P2|Overall Study|Sponsor Decision|1
485237|NCT00090519|1574398|P1|Overall Study|Sponsor Decision|3
485238|NCT00090519|1574397|P2|Overall Study|Physician Decision|3
485239|NCT00090519|1574398|P1|Overall Study|Physician Decision|2
485240|NCT00090519|1574397|P2|Overall Study|Withdrawal by Subject|29
485241|NCT00090519|1574398|P1|Overall Study|Withdrawal by Subject|28
485242|NCT00090519|1574397|P2|Overall Study|Lost to Follow-up|29
485243|NCT00090519|1574398|P1|Overall Study|Lost to Follow-up|26
485244|NCT00090519|1574397|P2|Overall Study|Death|9
485245|NCT00090519|1574398|P1|Overall Study|Death|9
485246|NCT00090519|1574397|P2|Overall Study|Adverse Event|4
485247|NCT00090519|1574398|P1|Overall Study|Adverse Event|5
485248|NCT00090493|1574422|P1|Overall Study|Physician Decision|2
485249|NCT00090363|1574429|P3|Overall Study|Continuing on study off treatment|16
485250|NCT00090363|1574430|P2|Overall Study|Continuing on study off treatment|13
485251|NCT00090363|1574431|P1|Overall Study|Continuing on study off treatment|14
485252|NCT00090363|1574429|P3|Overall Study|Reasons not specified|1
485253|NCT00090363|1574430|P2|Overall Study|Reasons not specified|1
485254|NCT00090363|1574431|P1|Overall Study|Reasons not specified|2
485255|NCT00090363|1574429|P3|Overall Study|Consent expired|9
485256|NCT00090363|1574430|P2|Overall Study|Consent expired|10
485257|NCT00090363|1574431|P1|Overall Study|Consent expired|7
485258|NCT00090363|1574429|P3|Overall Study|Eligibility criteria not fulfilled|1
485259|NCT00090363|1574430|P2|Overall Study|Eligibility criteria not fulfilled|0
485260|NCT00090363|1574431|P1|Overall Study|Eligibility criteria not fulfilled|0
485261|NCT00090363|1574429|P3|Overall Study|Study-specific discontinuation criteria|62
485262|NCT00090363|1574430|P2|Overall Study|Study-specific discontinuation criteria|74
485263|NCT00090363|1574431|P1|Overall Study|Study-specific discontinuation criteria|75
485264|NCT00090363|1574429|P3|Overall Study|Withdrawal by Subject|6
485265|NCT00090363|1574430|P2|Overall Study|Withdrawal by Subject|7
485266|NCT00090363|1574431|P1|Overall Study|Withdrawal by Subject|7
485267|NCT00090363|1574429|P3|Overall Study|Lost to Follow-up|1
485268|NCT00090363|1574430|P2|Overall Study|Lost to Follow-up|2
485269|NCT00090363|1574431|P1|Overall Study|Lost to Follow-up|1
485270|NCT00090545|1574453|P2|Overall Study|Adverse Event|2
485271|NCT00090545|1574454|P1|Overall Study|Adverse Event|0
485272|NCT00090545|1574453|P2|Overall Study|Death|1
485273|NCT00090545|1574454|P1|Overall Study|Death|0
485274|NCT00090545|1574453|P2|Overall Study|Refused further treatment|4
485275|NCT00090545|1574454|P1|Overall Study|Refused further treatment|1
485276|NCT00090545|1574453|P2|Overall Study|Disease progression on study|17
485277|NCT00090545|1574454|P1|Overall Study|Disease progression on study|21
485446|NCT00090259|1574516|P2|Overall Study|Investigator site closed|7
485447|NCT00090259|1574517|P1|Overall Study|Investigator site closed|11
485448|NCT00090259|1574516|P2|Overall Study|Withdrawal by Subject|15
485449|NCT00090259|1574517|P1|Overall Study|Withdrawal by Subject|21
485450|NCT00090259|1574516|P2|Overall Study|Lost to Follow-up|26
485451|NCT00090259|1574517|P1|Overall Study|Lost to Follow-up|30
485452|NCT00090233|1574533|P2|Overall Study|Data not available at data cut-off point|1563
485453|NCT00090233|1574534|P1|Overall Study|Data not available at data cut-off point|1552
485454|NCT00090233|1574533|P2|Overall Study|Not Specified|1160
485455|NCT00090233|1574534|P1|Overall Study|Not Specified|1211
485456|NCT00090233|1574533|P2|Overall Study|Moved|189
485457|NCT00090233|1574534|P1|Overall Study|Moved|203
485458|NCT00090233|1574533|P2|Overall Study|Withdrawal by Subject|211
485459|NCT00090233|1574534|P1|Overall Study|Withdrawal by Subject|182
485460|NCT00090233|1574533|P2|Overall Study|Protocol Violation|1022
485461|NCT00090233|1574534|P1|Overall Study|Protocol Violation|960
485462|NCT00090233|1574533|P2|Overall Study|Lost to Follow-up|95
485463|NCT00090233|1574534|P1|Overall Study|Lost to Follow-up|68
485464|NCT00090233|1574533|P2|Overall Study|Adverse Event|198
485465|NCT00090233|1574534|P1|Overall Study|Adverse Event|214
485466|NCT00090233|1574533|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
485467|NCT00090233|1574534|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
485468|NCT00090220|1574558|P6|Long-term Follow-up (EXT2)|Other|0
485469|NCT00090220|1574559|P5|Long-term Follow-up (EXT2)|Other|1
485470|NCT00090220|1574560|P4|Long-term Follow-up (EXT2)|Other|0
485471|NCT00090220|1574561|P3|Long-term Follow-up (EXT2)|Other|0
485472|NCT00090220|1574562|P2|Long-term Follow-up (EXT2)|Other|0
485473|NCT00090220|1574563|P1|Long-term Follow-up (EXT2)|Other|0
485474|NCT00090220|1574558|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
485475|NCT00090220|1574559|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
485476|NCT00090220|1574560|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
485477|NCT00090220|1574561|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
485478|NCT00090220|1574562|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
485479|NCT00090220|1574563|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
485480|NCT00090220|1574558|P6|Long-term Follow-up (EXT2)|Death|1
485481|NCT00090220|1574559|P5|Long-term Follow-up (EXT2)|Death|1
485482|NCT00090220|1574560|P4|Long-term Follow-up (EXT2)|Death|0
485483|NCT00090220|1574561|P3|Long-term Follow-up (EXT2)|Death|0
485484|NCT00090220|1574562|P2|Long-term Follow-up (EXT2)|Death|0
485485|NCT00090220|1574563|P1|Long-term Follow-up (EXT2)|Death|0
485486|NCT00090220|1574558|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
485487|NCT00090220|1574559|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
485488|NCT00090220|1574560|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
485489|NCT00090220|1574561|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
485490|NCT00090220|1574562|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
485491|NCT00090220|1574563|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
485492|NCT00090220|1574558|P6|Extension 1 (EXT1)|Other reason|0
485493|NCT00090220|1574559|P5|Extension 1 (EXT1)|Other reason|0
485494|NCT00090220|1574560|P4|Extension 1 (EXT1)|Other reason|0
485495|NCT00090220|1574561|P3|Extension 1 (EXT1)|Other reason|2
485496|NCT00090220|1574562|P2|Extension 1 (EXT1)|Other reason|0
485497|NCT00090220|1574563|P1|Extension 1 (EXT1)|Other reason|0
485498|NCT00090220|1574558|P6|Extension 1 (EXT1)|Protocol Violation|0
485499|NCT00090220|1574559|P5|Extension 1 (EXT1)|Protocol Violation|0
485500|NCT00090220|1574560|P4|Extension 1 (EXT1)|Protocol Violation|1
485501|NCT00090220|1574561|P3|Extension 1 (EXT1)|Protocol Violation|0
485502|NCT00090220|1574562|P2|Extension 1 (EXT1)|Protocol Violation|0
485503|NCT00090220|1574563|P1|Extension 1 (EXT1)|Protocol Violation|0
485504|NCT00090220|1574558|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
485505|NCT00090220|1574559|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
485506|NCT00090220|1574560|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
485507|NCT00090220|1574561|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
485508|NCT00090220|1574562|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
485509|NCT00090220|1574563|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
485510|NCT00090220|1574558|P6|Extension 1 (EXT1)|Moved|0
485511|NCT00090220|1574559|P5|Extension 1 (EXT1)|Moved|0
485512|NCT00090220|1574560|P4|Extension 1 (EXT1)|Moved|1
485513|NCT00090220|1574561|P3|Extension 1 (EXT1)|Moved|2
485514|NCT00090220|1574562|P2|Extension 1 (EXT1)|Moved|0
485515|NCT00090220|1574563|P1|Extension 1 (EXT1)|Moved|0
485516|NCT00090220|1574558|P6|Extension 1 (EXT1)|Lost to Follow-up|0
485517|NCT00090220|1574559|P5|Extension 1 (EXT1)|Lost to Follow-up|0
485518|NCT00090220|1574560|P4|Extension 1 (EXT1)|Lost to Follow-up|0
485519|NCT00090220|1574561|P3|Extension 1 (EXT1)|Lost to Follow-up|22
485520|NCT00090220|1574562|P2|Extension 1 (EXT1)|Lost to Follow-up|0
485521|NCT00090220|1574563|P1|Extension 1 (EXT1)|Lost to Follow-up|0
485522|NCT00090220|1574558|P6|Extension 1 (EXT1)|Adverse Event|0
485523|NCT00090220|1574559|P5|Extension 1 (EXT1)|Adverse Event|0
485524|NCT00090220|1574560|P4|Extension 1 (EXT1)|Adverse Event|0
485525|NCT00090220|1574561|P3|Extension 1 (EXT1)|Adverse Event|4
485526|NCT00090220|1574562|P2|Extension 1 (EXT1)|Adverse Event|0
485527|NCT00090220|1574563|P1|Extension 1 (EXT1)|Adverse Event|0
485528|NCT00090220|1574558|P6|Base Study Follow-up Period|Other|0
485529|NCT00090220|1574559|P5|Base Study Follow-up Period|Other|0
485530|NCT00090220|1574560|P4|Base Study Follow-up Period|Other|0
485531|NCT00090220|1574561|P3|Base Study Follow-up Period|Other|0
485532|NCT00090220|1574562|P2|Base Study Follow-up Period|Other|21
485533|NCT00090220|1574563|P1|Base Study Follow-up Period|Other|19
485534|NCT00090220|1574558|P6|Base Study Follow-up Period|Patient Moved|0
485535|NCT00090220|1574559|P5|Base Study Follow-up Period|Patient Moved|0
485536|NCT00090220|1574560|P4|Base Study Follow-up Period|Patient Moved|0
485537|NCT00090220|1574561|P3|Base Study Follow-up Period|Patient Moved|0
485538|NCT00090220|1574562|P2|Base Study Follow-up Period|Patient Moved|28
485539|NCT00090220|1574563|P1|Base Study Follow-up Period|Patient Moved|20
485540|NCT00090220|1574558|P6|Base Study Follow-up Period|Withdrawal by Subject|0
485541|NCT00090220|1574559|P5|Base Study Follow-up Period|Withdrawal by Subject|0
485542|NCT00090220|1574560|P4|Base Study Follow-up Period|Withdrawal by Subject|0
485543|NCT00090220|1574561|P3|Base Study Follow-up Period|Withdrawal by Subject|0
485544|NCT00090220|1574562|P2|Base Study Follow-up Period|Withdrawal by Subject|36
485545|NCT00090220|1574563|P1|Base Study Follow-up Period|Withdrawal by Subject|27
485546|NCT00090220|1574558|P6|Base Study Follow-up Period|Lost to Follow-up|0
485547|NCT00090220|1574559|P5|Base Study Follow-up Period|Lost to Follow-up|0
485548|NCT00090220|1574560|P4|Base Study Follow-up Period|Lost to Follow-up|0
485549|NCT00090220|1574561|P3|Base Study Follow-up Period|Lost to Follow-up|0
485550|NCT00090220|1574562|P2|Base Study Follow-up Period|Lost to Follow-up|78
485551|NCT00090220|1574563|P1|Base Study Follow-up Period|Lost to Follow-up|88
485552|NCT00090220|1574558|P6|Base Study Follow-up Period|Adverse Event|0
485553|NCT00090220|1574559|P5|Base Study Follow-up Period|Adverse Event|0
485554|NCT00090220|1574560|P4|Base Study Follow-up Period|Adverse Event|0
485555|NCT00090220|1574561|P3|Base Study Follow-up Period|Adverse Event|0
485556|NCT00090220|1574562|P2|Base Study Follow-up Period|Adverse Event|1
485557|NCT00090220|1574563|P1|Base Study Follow-up Period|Adverse Event|6
485558|NCT00090220|1574558|P6|Base Study Vaccination Period|Other|0
485559|NCT00090220|1574559|P5|Base Study Vaccination Period|Other|0
485560|NCT00090220|1574560|P4|Base Study Vaccination Period|Other|0
485561|NCT00090220|1574561|P3|Base Study Vaccination Period|Other|0
485562|NCT00090220|1574562|P2|Base Study Vaccination Period|Other|4
485563|NCT00090220|1574563|P1|Base Study Vaccination Period|Other|4
485564|NCT00090220|1574558|P6|Base Study Vaccination Period|Patient Moved|0
485565|NCT00090220|1574559|P5|Base Study Vaccination Period|Patient Moved|0
485566|NCT00090220|1574560|P4|Base Study Vaccination Period|Patient Moved|0
485567|NCT00090220|1574561|P3|Base Study Vaccination Period|Patient Moved|0
485568|NCT00090220|1574562|P2|Base Study Vaccination Period|Patient Moved|2
485569|NCT00090220|1574563|P1|Base Study Vaccination Period|Patient Moved|6
485570|NCT00090220|1574558|P6|Base Study Vaccination Period|Withdrawal by Subject|0
485571|NCT00090220|1574559|P5|Base Study Vaccination Period|Withdrawal by Subject|0
485572|NCT00090220|1574560|P4|Base Study Vaccination Period|Withdrawal by Subject|0
485573|NCT00090220|1574561|P3|Base Study Vaccination Period|Withdrawal by Subject|0
485574|NCT00090220|1574562|P2|Base Study Vaccination Period|Withdrawal by Subject|27
485575|NCT00090220|1574563|P1|Base Study Vaccination Period|Withdrawal by Subject|23
485576|NCT00090220|1574558|P6|Base Study Vaccination Period|Lost to Follow-up|0
485577|NCT00090220|1574559|P5|Base Study Vaccination Period|Lost to Follow-up|0
485578|NCT00090220|1574560|P4|Base Study Vaccination Period|Lost to Follow-up|0
485579|NCT00090220|1574561|P3|Base Study Vaccination Period|Lost to Follow-up|0
485580|NCT00090220|1574562|P2|Base Study Vaccination Period|Lost to Follow-up|28
485581|NCT00090220|1574563|P1|Base Study Vaccination Period|Lost to Follow-up|24
485582|NCT00090220|1574558|P6|Base Study Vaccination Period|Adverse Event|0
485583|NCT00090220|1574559|P5|Base Study Vaccination Period|Adverse Event|0
485584|NCT00090220|1574560|P4|Base Study Vaccination Period|Adverse Event|0
485585|NCT00090220|1574561|P3|Base Study Vaccination Period|Adverse Event|0
485586|NCT00090220|1574562|P2|Base Study Vaccination Period|Adverse Event|1
485587|NCT00090220|1574563|P1|Base Study Vaccination Period|Adverse Event|6
485588|NCT00090220|1574558|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
485589|NCT00090220|1574559|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
485590|NCT00090220|1574560|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
485591|NCT00090220|1574561|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
485592|NCT00090220|1574562|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
485593|NCT00090220|1574563|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
485594|NCT00090402|1574658|P3|Overall Study|stopped taking study medication|1
485595|NCT00090402|1574659|P2|Overall Study|stopped taking study medication|0
485596|NCT00090402|1574660|P1|Overall Study|stopped taking study medication|1
485597|NCT00090402|1574658|P3|Overall Study|subject moved|0
485598|NCT00090402|1574659|P2|Overall Study|subject moved|1
485599|NCT00090402|1574660|P1|Overall Study|subject moved|0
485600|NCT00090402|1574658|P3|Overall Study|Death|0
485601|NCT00090402|1574659|P2|Overall Study|Death|1
485602|NCT00090402|1574660|P1|Overall Study|Death|1
485603|NCT00090142|1574674|P2|Treatment Period II|Not Specified|0
485604|NCT00090142|1574675|P1|Treatment Period II|Not Specified|1
485605|NCT00090142|1574674|P2|Treatment Period I|Not Specified|1
485606|NCT00090142|1574675|P1|Treatment Period I|Not Specified|0
485607|NCT00090142|1574674|P2|Treatment Period I|Withdrawal by Subject|0
485608|NCT00090142|1574675|P1|Treatment Period I|Withdrawal by Subject|2
485609|NCT00090142|1574674|P2|Treatment Period I|Protocol Violation|0
485610|NCT00090142|1574675|P1|Treatment Period I|Protocol Violation|2
485611|NCT00090142|1574674|P2|Treatment Period I|Lost to Follow-up|2
485612|NCT00090142|1574675|P1|Treatment Period I|Lost to Follow-up|1
485613|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Other|0
485614|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Other|1
485615|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Other|0
485616|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Jailed|0
485617|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Jailed|1
485618|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Jailed|0
485619|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
485620|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
485621|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
485622|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Depression|0
485623|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Depression|1
485624|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Depression|0
485625|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
485626|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
485627|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
485628|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
485629|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
485630|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
485631|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Back Pain|0
485632|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Back Pain|1
485633|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Back Pain|0
485634|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
485635|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
485636|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
485637|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
485638|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
485639|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
485640|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
485641|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
485642|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
485643|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Gyneomastia|0
485644|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Gyneomastia|0
485645|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Gyneomastia|1
485646|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Death|1
485647|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Death|0
485648|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Death|1
485649|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
485650|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
485651|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
485652|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Enrollment Error|2
485653|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Enrollment Error|0
485654|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Enrollment Error|1
485655|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Loss of Libido|0
485656|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Loss of Libido|0
485657|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Loss of Libido|1
485658|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
485659|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
485660|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
485661|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
485662|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
485663|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
485664|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
485665|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
485666|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
485667|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
485668|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
485669|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
485670|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Participant relocated|1
485671|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Participant relocated|3
485672|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Participant relocated|2
485673|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
485674|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
485675|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
485676|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Loss of Contact|2
485677|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Loss of Contact|0
485678|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Loss of Contact|4
485679|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
485680|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
485681|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
485682|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
485683|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
485684|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
485685|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Protocol Violation|17
485686|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Protocol Violation|18
485687|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Protocol Violation|18
485688|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
485689|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
485690|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
485691|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
485692|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
485693|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
485694|NCT00090103|1574706|P3|16-Week Safety Follow-up Period|Adverse Event|44
485695|NCT00090103|1574707|P2|16-Week Safety Follow-up Period|Adverse Event|39
485696|NCT00090103|1574708|P1|16-Week Safety Follow-up Period|Adverse Event|34
485697|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
485698|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
485699|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
485700|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
485701|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
485702|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
485703|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
485704|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
485705|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
485706|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
485707|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
485708|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
485709|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
485710|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
485711|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
485712|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
485713|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
485714|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
485715|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
485716|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
485717|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
485718|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
485719|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
485720|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
485721|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
485722|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
485723|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
485724|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
485725|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
485726|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
485727|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
485728|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
485729|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
485730|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
485731|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
485732|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
485733|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
485734|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
485735|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
485736|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
485737|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
485738|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
485739|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
485740|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
485741|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
485742|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
485743|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
485744|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
485745|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
485746|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
485747|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
485748|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
485749|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
485750|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
485751|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
485752|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
485753|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
485754|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
485755|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
485756|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
485757|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
485758|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
485759|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
485760|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
485761|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
485762|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
485763|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
485764|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
485765|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
485766|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
485767|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
485768|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
485769|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
485770|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
485771|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
485772|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
485773|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
485774|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
485775|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
485776|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
485777|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
485778|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
485779|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
485780|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
485781|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
485782|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
485783|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
485784|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
485785|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
485786|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
485787|NCT00090103|1574706|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
485788|NCT00090103|1574707|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
485789|NCT00090103|1574708|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
485790|NCT00089999|1574874|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
485791|NCT00089999|1574875|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
485792|NCT00089999|1574874|P2|Overall Study|Patient Underwent Surgery|0
485793|NCT00089999|1574875|P1|Overall Study|Patient Underwent Surgery|2
485794|NCT00089999|1574874|P2|Overall Study|Physician Decision|2
485795|NCT00089999|1574875|P1|Overall Study|Physician Decision|2
485796|NCT00089999|1574874|P2|Overall Study|Clinical Progression|2
485797|NCT00089999|1574875|P1|Overall Study|Clinical Progression|1
485798|NCT00089999|1574874|P2|Overall Study|Poor General Condition|0
485799|NCT00089999|1574875|P1|Overall Study|Poor General Condition|1
485800|NCT00089999|1574874|P2|Overall Study|Death|3
485801|NCT00089999|1574875|P1|Overall Study|Death|3
485802|NCT00089999|1574874|P2|Overall Study|Symptomatic Progression of Cancer|5
485803|NCT00089999|1574875|P1|Overall Study|Symptomatic Progression of Cancer|2
485804|NCT00089999|1574874|P2|Overall Study|Radiological Progression of Cancer|44
485805|NCT00089999|1574875|P1|Overall Study|Radiological Progression of Cancer|52
485806|NCT00089999|1574874|P2|Overall Study|Lost to Follow-up|1
485807|NCT00089999|1574875|P1|Overall Study|Lost to Follow-up|2
485808|NCT00089999|1574874|P2|Overall Study|Withdrawal by Subject|4
485809|NCT00089999|1574875|P1|Overall Study|Withdrawal by Subject|0
485810|NCT00089999|1574874|P2|Overall Study|Adverse Event|7
485811|NCT00089999|1574875|P1|Overall Study|Adverse Event|4
485812|NCT00089986|1574898|P3|Overall Study|Withdrawal by Subject|2
485813|NCT00089986|1574899|P2|Overall Study|Withdrawal by Subject|6
485814|NCT00089986|1574900|P1|Overall Study|Withdrawal by Subject|3
485815|NCT00089986|1574898|P3|Overall Study|Do not resuscitate (DNR)|1
485816|NCT00089986|1574899|P2|Overall Study|Do not resuscitate (DNR)|0
485817|NCT00089986|1574900|P1|Overall Study|Do not resuscitate (DNR)|0
485818|NCT00089986|1574898|P3|Overall Study|Family decision|0
485819|NCT00089986|1574899|P2|Overall Study|Family decision|1
485820|NCT00089986|1574900|P1|Overall Study|Family decision|0
485821|NCT00089986|1574898|P3|Overall Study|Enrollment in another study|0
485822|NCT00089986|1574899|P2|Overall Study|Enrollment in another study|1
485823|NCT00089986|1574900|P1|Overall Study|Enrollment in another study|0
485824|NCT00089986|1574898|P3|Overall Study|Investigator decision to withdrew|0
485825|NCT00089986|1574899|P2|Overall Study|Investigator decision to withdrew|1
485826|NCT00089986|1574900|P1|Overall Study|Investigator decision to withdrew|0
485827|NCT00089986|1574898|P3|Overall Study|Hemohlobin stopping rule|0
485828|NCT00089986|1574899|P2|Overall Study|Hemohlobin stopping rule|1
485829|NCT00089986|1574900|P1|Overall Study|Hemohlobin stopping rule|0
485830|NCT00089986|1574898|P3|Overall Study|Subject withdrew but agreed follow up|0
485831|NCT00089986|1574899|P2|Overall Study|Subject withdrew but agreed follow up|2
485832|NCT00089986|1574900|P1|Overall Study|Subject withdrew but agreed follow up|1
485833|NCT00089986|1574898|P3|Overall Study|Patient transferred to another hospital|0
485834|NCT00089986|1574899|P2|Overall Study|Patient transferred to another hospital|1
485835|NCT00089986|1574900|P1|Overall Study|Patient transferred to another hospital|2
485836|NCT00089986|1574898|P3|Overall Study|Protocol Violation|0
485837|NCT00089986|1574899|P2|Overall Study|Protocol Violation|1
485838|NCT00089986|1574900|P1|Overall Study|Protocol Violation|0
485839|NCT00089986|1574898|P3|Overall Study|Lost to Follow-up|1
485840|NCT00089986|1574899|P2|Overall Study|Lost to Follow-up|1
485841|NCT00089986|1574900|P1|Overall Study|Lost to Follow-up|3
485842|NCT00089986|1574898|P3|Overall Study|Adverse Event|6
485843|NCT00089986|1574899|P2|Overall Study|Adverse Event|9
485844|NCT00089986|1574900|P1|Overall Study|Adverse Event|6
485845|NCT00089973|1574917|P1|Overall Study|Death|1
485846|NCT00089973|1574917|P1|Overall Study|Disease progression|45
485847|NCT00089973|1574917|P1|Overall Study|Withdrawal by Subject|1
485848|NCT00089973|1574917|P1|Overall Study|Adverse Event|3
485849|NCT00089895|1574932|P2|Overall Study|Missing|2
485850|NCT00089895|1574933|P1|Overall Study|Missing|4
485851|NCT00089895|1574932|P2|Overall Study|Not otherwise specified|8
485852|NCT00089895|1574933|P1|Overall Study|Not otherwise specified|4
485853|NCT00089895|1574932|P2|Overall Study|Exclusion criteria met|6
485854|NCT00089895|1574933|P1|Overall Study|Exclusion criteria met|6
485855|NCT00089895|1574932|P2|Overall Study|Physician Decision|7
485856|NCT00089895|1574933|P1|Overall Study|Physician Decision|3
485857|NCT00089895|1574932|P2|Overall Study|Bleeding|2
485858|NCT00089895|1574933|P1|Overall Study|Bleeding|0
485859|NCT00089895|1574932|P2|Overall Study|Surgery|1
485860|NCT00089895|1574933|P1|Overall Study|Surgery|0
485861|NCT00089895|1574932|P2|Overall Study|Technical reason|2
485862|NCT00089895|1574933|P1|Overall Study|Technical reason|7
485863|NCT00089895|1574932|P2|Overall Study|Consent Withdrawn|14
485864|NCT00089895|1574933|P1|Overall Study|Consent Withdrawn|11
485865|NCT00089843|1574945|P4|Overall Study|Physician Decision|1
485866|NCT00089843|1574946|P3|Overall Study|Physician Decision|0
485867|NCT00089843|1574947|P2|Overall Study|Physician Decision|0
485868|NCT00089843|1574948|P1|Overall Study|Physician Decision|1
485869|NCT00089843|1574945|P4|Overall Study|Withdrawal by Subject|6
485870|NCT00089843|1574946|P3|Overall Study|Withdrawal by Subject|5
485871|NCT00089843|1574947|P2|Overall Study|Withdrawal by Subject|4
485872|NCT00089843|1574948|P1|Overall Study|Withdrawal by Subject|1
485873|NCT00089791|1574960|P2|Overall Study|Requirement for alternative therapy|4
485874|NCT00089791|1574961|P1|Overall Study|Requirement for alternative therapy|7
485875|NCT00089791|1574960|P2|Overall Study|Protocol deviation|10
485876|NCT00089791|1574961|P1|Overall Study|Protocol deviation|12
485877|NCT00089791|1574960|P2|Overall Study|Other|32
485878|NCT00089791|1574961|P1|Overall Study|Other|20
485879|NCT00089791|1574960|P2|Overall Study|Noncompliance|13
485880|NCT00089791|1574961|P1|Overall Study|Noncompliance|17
485881|NCT00089791|1574960|P2|Overall Study|Lost to Follow-up|57
485882|NCT00089791|1574961|P1|Overall Study|Lost to Follow-up|57
485883|NCT00089791|1574960|P2|Overall Study|Ineligibility determined|9
485884|NCT00089791|1574961|P1|Overall Study|Ineligibility determined|12
485885|NCT00089791|1574960|P2|Overall Study|Disease progression|3
485886|NCT00089791|1574961|P1|Overall Study|Disease progression|7
485887|NCT00089791|1574960|P2|Overall Study|Death|62
485888|NCT00089791|1574961|P1|Overall Study|Death|78
485889|NCT00089791|1574960|P2|Overall Study|Withdrawal by Subject|344
485890|NCT00089791|1574961|P1|Overall Study|Withdrawal by Subject|403
485891|NCT00089791|1574960|P2|Overall Study|Adverse Event|93
485892|NCT00089791|1574961|P1|Overall Study|Adverse Event|81
485893|NCT00089791|1574960|P2|Overall Study|Physician Decision|3
485894|NCT00089791|1574961|P1|Overall Study|Physician Decision|6
485895|NCT00089778|1574995|P3|Overall Study|Protocol Violation|1
485896|NCT00089778|1574996|P2|Overall Study|Protocol Violation|0
485897|NCT00089778|1574997|P1|Overall Study|Protocol Violation|0
485898|NCT00089674|1575010|P2|Overall Study|Requirement for alternative therapy|4
485899|NCT00089674|1575011|P1|Overall Study|Requirement for alternative therapy|14
485900|NCT00089674|1575010|P2|Overall Study|Other|9
485901|NCT00089674|1575011|P1|Overall Study|Other|5
485902|NCT00089674|1575010|P2|Overall Study|Noncompliance|3
485903|NCT00089674|1575011|P1|Overall Study|Noncompliance|7
485904|NCT00089674|1575010|P2|Overall Study|Lost to Follow-up|17
485905|NCT00089674|1575011|P1|Overall Study|Lost to Follow-up|21
485906|NCT00089674|1575010|P2|Overall Study|Ineligibility determined|10
485907|NCT00089674|1575011|P1|Overall Study|Ineligibility determined|8
485908|NCT00089674|1575010|P2|Overall Study|Disease progression|23
485909|NCT00089674|1575011|P1|Overall Study|Disease progression|21
485910|NCT00089674|1575010|P2|Overall Study|Death|43
485911|NCT00089674|1575011|P1|Overall Study|Death|43
485912|NCT00089674|1575010|P2|Overall Study|Withdrawal by Subject|127
485913|NCT00089674|1575011|P1|Overall Study|Withdrawal by Subject|143
485914|NCT00089674|1575010|P2|Overall Study|Adverse Event|29
485915|NCT00089674|1575011|P1|Overall Study|Adverse Event|23
485916|NCT00089674|1575010|P2|Overall Study|Physician Decision|2
485917|NCT00089674|1575011|P1|Overall Study|Physician Decision|4
485918|NCT00089661|1575037|P2|Overall Study|Other|1
485919|NCT00089661|1575038|P1|Overall Study|Other|2
485920|NCT00089661|1575037|P2|Overall Study|Noncompliance|4
485921|NCT00089661|1575038|P1|Overall Study|Noncompliance|2
485922|NCT00089661|1575037|P2|Overall Study|Ineligibility determined|4
485923|NCT00089661|1575038|P1|Overall Study|Ineligibility determined|4
485924|NCT00089661|1575037|P2|Overall Study|Disease progression|3
485925|NCT00089661|1575038|P1|Overall Study|Disease progression|1
485926|NCT00089661|1575037|P2|Overall Study|Withdrawal by Subject|9
485927|NCT00089661|1575038|P1|Overall Study|Withdrawal by Subject|11
485928|NCT00089661|1575037|P2|Overall Study|Lost to Follow-up|3
485929|NCT00089661|1575038|P1|Overall Study|Lost to Follow-up|0
485930|NCT00089661|1575037|P2|Overall Study|Death|0
485931|NCT00089661|1575038|P1|Overall Study|Death|1
485932|NCT00089661|1575037|P2|Overall Study|Adverse Event|2
485933|NCT00089661|1575038|P1|Overall Study|Adverse Event|0
485934|NCT00089648|1575054|P1|Overall Study|Lack of Efficacy|33
485935|NCT00089648|1575054|P1|Overall Study|Withdrawal by Subject|1
485936|NCT00089648|1575054|P1|Overall Study|Adverse Event|7
485937|NCT00089635|1575070|P1|Overall Study|Not specified|2
485938|NCT00089635|1575070|P1|Overall Study|Ineligibility determined|1
485939|NCT00089635|1575070|P1|Overall Study|Withdrawal by Subject|6
485940|NCT00089635|1575070|P1|Overall Study|Lost to Follow-up|3
485941|NCT00089635|1575070|P1|Overall Study|Disease Progression|12
485942|NCT00089635|1575070|P1|Overall Study|Death|17
485943|NCT00089635|1575070|P1|Overall Study|Adverse Event|2
485944|NCT00089583|1575084|P2|Overall Study|Participant Incarcerated|1
485945|NCT00089583|1575085|P1|Overall Study|Participant Incarcerated|0
485946|NCT00089583|1575084|P2|Overall Study|Necessity to Use Prohibited Drug|0
485947|NCT00089583|1575085|P1|Overall Study|Necessity to Use Prohibited Drug|1
485948|NCT00089583|1575084|P2|Overall Study|Start of Disallowed Medication|1
485949|NCT00089583|1575085|P1|Overall Study|Start of Disallowed Medication|0
485950|NCT00089583|1575084|P2|Overall Study|Principal Investigator Decision|10
485951|NCT00089583|1575085|P1|Overall Study|Principal Investigator Decision|0
485952|NCT00089583|1575084|P2|Overall Study|Protocol Violation|3
485953|NCT00089583|1575085|P1|Overall Study|Protocol Violation|0
485954|NCT00089583|1575084|P2|Overall Study|Reason Not Provided|1
485955|NCT00089583|1575085|P1|Overall Study|Reason Not Provided|0
485956|NCT00089583|1575084|P2|Overall Study|Participant Management Criteria Met|1
485957|NCT00089583|1575085|P1|Overall Study|Participant Management Criteria Met|0
485958|NCT00089583|1575084|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
485959|NCT00089583|1575085|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
485960|NCT00089583|1575084|P2|Overall Study|Non-Compliance|4
485961|NCT00089583|1575085|P1|Overall Study|Non-Compliance|0
485962|NCT00089583|1575084|P2|Overall Study|Participant Refused Study Medication|2
485963|NCT00089583|1575085|P1|Overall Study|Participant Refused Study Medication|0
485964|NCT00089583|1575084|P2|Overall Study|Participant (Par) Didn't Take Medication|0
485965|NCT00089583|1575085|P1|Overall Study|Participant (Par) Didn't Take Medication|1
485966|NCT00089583|1575084|P2|Overall Study|Withdrawal by Subject|4
485967|NCT00089583|1575085|P1|Overall Study|Withdrawal by Subject|0
485968|NCT00089583|1575084|P2|Overall Study|Insufficient Viral Load Response|5
485969|NCT00089583|1575085|P1|Overall Study|Insufficient Viral Load Response|5
485970|NCT00089583|1575084|P2|Overall Study|Adverse Event|3
485971|NCT00089583|1575085|P1|Overall Study|Adverse Event|0
485972|NCT00089609|1575179|P2|Overall Study|Withdrawal by Subject|1
485973|NCT00089609|1575180|P1|Overall Study|Withdrawal by Subject|3
485974|NCT00089544|1575199|P2|Overall Study|Ineligible|0
485975|NCT00089544|1575200|P1|Overall Study|Ineligible|1
485976|NCT00089505|1575214|P4|Overall Study|Protocol Violation|0
485977|NCT00089505|1575215|P3|Overall Study|Protocol Violation|1
485978|NCT00089505|1575216|P2|Overall Study|Protocol Violation|0
485979|NCT00089505|1575217|P1|Overall Study|Protocol Violation|0
485980|NCT00089505|1575214|P4|Overall Study|Physician Decision|0
485981|NCT00089505|1575215|P3|Overall Study|Physician Decision|0
485982|NCT00089505|1575216|P2|Overall Study|Physician Decision|0
485983|NCT00089505|1575217|P1|Overall Study|Physician Decision|1
485984|NCT00089505|1575214|P4|Overall Study|Lost to Follow-up|7
485985|NCT00089505|1575215|P3|Overall Study|Lost to Follow-up|9
485986|NCT00089505|1575216|P2|Overall Study|Lost to Follow-up|1
485987|NCT00089505|1575217|P1|Overall Study|Lost to Follow-up|1
485988|NCT00089505|1575214|P4|Overall Study|Withdrawal by Subject|6
485989|NCT00089505|1575215|P3|Overall Study|Withdrawal by Subject|6
485990|NCT00089505|1575216|P2|Overall Study|Withdrawal by Subject|0
485991|NCT00089505|1575217|P1|Overall Study|Withdrawal by Subject|3
485992|NCT00089505|1575214|P4|Overall Study|Death|8
485993|NCT00089505|1575215|P3|Overall Study|Death|5
485994|NCT00089505|1575216|P2|Overall Study|Death|1
485995|NCT00089505|1575217|P1|Overall Study|Death|4
485996|NCT00089479|1575261|P2|Overall Study|Lost to Follow-up|107
485997|NCT00089479|1575262|P1|Overall Study|Lost to Follow-up|137
485998|NCT00089479|1575261|P2|Overall Study|Withdrawal by Subject|107
485999|NCT00089479|1575262|P1|Overall Study|Withdrawal by Subject|86
486000|NCT00089479|1575261|P2|Overall Study|Death|75
486001|NCT00089479|1575262|P1|Overall Study|Death|108
486002|NCT00089297|1575305|P1|Overall Study|Non-compliance|1
486003|NCT00089297|1575305|P1|Overall Study|IRB approval not ready|1
486004|NCT00089297|1575305|P1|Overall Study|Secondary malignancy|1
486005|NCT00089297|1575305|P1|Overall Study|Ineligible|11
486006|NCT00089297|1575305|P1|Overall Study|Disease progression|2
486007|NCT00089297|1575305|P1|Overall Study|Withdrawal by Subject|12
486008|NCT00089297|1575305|P1|Overall Study|Death|1
486009|NCT00089297|1575305|P1|Overall Study|Adverse Event|9
486010|NCT00089141|1575314|P2|Overall Study|Termination of trial|24
486011|NCT00089141|1575315|P1|Overall Study|Termination of trial|18
486012|NCT00089076|1575337|P1|Overall Study|Progression|7
486013|NCT00089076|1575337|P1|Overall Study|Withdrawal by Subject|2
486014|NCT00089076|1575337|P1|Overall Study|Alternate Therapy|1
486015|NCT00088907|1575389|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
486016|NCT00088907|1575390|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
486017|NCT00088907|1575389|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
486018|NCT00088907|1575390|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
486019|NCT00088907|1575389|P2|Single Gefitinib Treatment (Step 2)|Death|0
486020|NCT00088907|1575390|P1|Single Gefitinib Treatment (Step 2)|Death|1
486021|NCT00088907|1575389|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
486022|NCT00088907|1575390|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
486023|NCT00088907|1575389|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
486024|NCT00088907|1575390|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
486025|NCT00088907|1575389|P2|Randomized Study (Step 1)|unknown/not specify|13
486026|NCT00088907|1575390|P1|Randomized Study (Step 1)|unknown/not specify|24
486027|NCT00088907|1575389|P2|Randomized Study (Step 1)|complicating disease|1
486028|NCT00088907|1575390|P1|Randomized Study (Step 1)|complicating disease|3
486029|NCT00088907|1575389|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
486030|NCT00088907|1575390|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
486031|NCT00088907|1575389|P2|Randomized Study (Step 1)|Death|12
486032|NCT00088907|1575390|P1|Randomized Study (Step 1)|Death|11
486033|NCT00088907|1575389|P2|Randomized Study (Step 1)|Adverse Event|19
486034|NCT00088907|1575390|P1|Randomized Study (Step 1)|Adverse Event|14
486035|NCT00088907|1575389|P2|Randomized Study (Step 1)|Lack of Efficacy|62
486036|NCT00088907|1575390|P1|Randomized Study (Step 1)|Lack of Efficacy|55
486037|NCT00088881|1575401|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
486038|NCT00088881|1575401|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
486039|NCT00088881|1575401|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
486040|NCT00088881|1575401|P1|Step 1 - R-CHOP|Physician Decision|1
486041|NCT00088881|1575401|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
486042|NCT00088881|1575401|P1|Step 1 - R-CHOP|Adverse Event|1
486043|NCT00088881|1575401|P1|Step 1 - R-CHOP|Patient ineligible|9
486044|NCT00088595|1575429|P1|Overall Study|New Cancer Therapy|2
486045|NCT00088595|1575429|P1|Overall Study|Ongoing (After Core)|7
486046|NCT00088595|1575429|P1|Overall Study|Withdrawal by Subject|8
486047|NCT00088595|1575429|P1|Overall Study|Adverse Event|11
486048|NCT00088530|1575447|P2|Overall Study|Patient never treated|0
486049|NCT00088530|1575448|P1|Overall Study|Patient never treated|1
486050|NCT00088530|1575447|P2|Overall Study|Sponsor decision|1
486051|NCT00088530|1575448|P1|Overall Study|Sponsor decision|0
486052|NCT00088530|1575447|P2|Overall Study|Physician Decision|0
486053|NCT00088530|1575448|P1|Overall Study|Physician Decision|2
486054|NCT00088530|1575447|P2|Overall Study|Lost to Follow-up|0
486055|NCT00088530|1575448|P1|Overall Study|Lost to Follow-up|2
486056|NCT00088530|1575447|P2|Overall Study|Withdrawal by Subject|5
486057|NCT00088530|1575448|P1|Overall Study|Withdrawal by Subject|2
486058|NCT00088530|1575447|P2|Overall Study|Adverse Event|9
486059|NCT00088530|1575448|P1|Overall Study|Adverse Event|15
486060|NCT00088530|1575447|P2|Overall Study|Progressive/Relapsed Disease|39
486061|NCT00088530|1575448|P1|Overall Study|Progressive/Relapsed Disease|28
486062|NCT00088465|1575460|P1|Overall Study|Death|11
486063|NCT00088465|1575460|P1|Overall Study|Protocol Violation|17
486064|NCT00088465|1575460|P1|Overall Study|Lack of Efficacy|27
486065|NCT00088465|1575460|P1|Overall Study|Sponsor Decision|37
486066|NCT00088465|1575460|P1|Overall Study|Physician Decision|45
486067|NCT00088465|1575460|P1|Overall Study|Lost to Follow-up|57
486068|NCT00088465|1575460|P1|Overall Study|Adverse Event|77
486069|NCT00088465|1575460|P1|Overall Study|Withdrawal by Subject|290
486070|NCT00088374|1575483|P1|Overall Study|patient received <1 cycle only of 17AAG|1
486071|NCT00088374|1575483|P1|Overall Study|patient did not receive any 17AAG|1
486072|NCT00088166|1575503|P2|Overall Study|Withdrawal by Subject|5
486073|NCT00088166|1575504|P1|Overall Study|Withdrawal by Subject|5
486074|NCT00088166|1575503|P2|Overall Study|Patient deterioration|39
486075|NCT00088166|1575504|P1|Overall Study|Patient deterioration|29
486076|NCT00088166|1575503|P2|Overall Study|Protocol Violation|5
486077|NCT00088166|1575504|P1|Overall Study|Protocol Violation|1
486078|NCT00088166|1575503|P2|Overall Study|Physician Decision|1
486079|NCT00088166|1575504|P1|Overall Study|Physician Decision|4
486080|NCT00088166|1575503|P2|Overall Study|Lost to Follow-up|1
486081|NCT00088166|1575504|P1|Overall Study|Lost to Follow-up|0
486082|NCT00088166|1575503|P2|Overall Study|Death|1
486083|NCT00088166|1575504|P1|Overall Study|Death|3
486084|NCT00088166|1575503|P2|Overall Study|Adverse Event|9
486085|NCT00088166|1575504|P1|Overall Study|Adverse Event|11
486086|NCT00088153|1575528|P2|Overall Study|Lost to Follow-up|12
486087|NCT00088153|1575529|P1|Overall Study|Lost to Follow-up|11
486088|NCT00088153|1575528|P2|Overall Study|Withdrawal by Subject|10
486089|NCT00088153|1575529|P1|Overall Study|Withdrawal by Subject|10
486090|NCT00088153|1575528|P2|Overall Study|Physician Decision|3
486091|NCT00088153|1575529|P1|Overall Study|Physician Decision|3
486092|NCT00087698|1575539|P1|Overall Study|Protocol Violation|1
486093|NCT00087698|1575539|P1|Overall Study|Death from Study Drug Toxicity|2
486094|NCT00087698|1575539|P1|Overall Study|Death from Study Disease|2
486095|NCT00087698|1575539|P1|Overall Study|Clinical Relapse|1
486096|NCT00087698|1575539|P1|Overall Study|Protocol Entry Criteria Not Met|2
486097|NCT00087698|1575539|P1|Overall Study|Lack of Efficacy, Physician Perception|3
486098|NCT00087698|1575539|P1|Overall Study|Withdrawal by Subject|4
486099|NCT00087698|1575539|P1|Overall Study|Adverse Event|4
486100|NCT00087698|1575539|P1|Overall Study|Death from Other Causes|3
486101|NCT00087698|1575539|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
486102|NCT00087685|1575548|P1|Overall Study|Withdrawal by Subject|3
486103|NCT00087685|1575548|P1|Overall Study|Progressive Disease|5
486104|NCT00087685|1575548|P1|Overall Study|Non-Compliance|1
486105|NCT00087685|1575548|P1|Overall Study|Adverse Event|5
486106|NCT00087646|1575561|P4|Overall Study|Violation of Selection Criteria at Entry|1
486107|NCT00087646|1575562|P3|Overall Study|Violation of Selection Criteria at Entry|0
486108|NCT00087646|1575563|P2|Overall Study|Violation of Selection Criteria at Entry|0
486109|NCT00087646|1575564|P1|Overall Study|Violation of Selection Criteria at Entry|1
486110|NCT00087646|1575561|P4|Overall Study|Other Protocol Violation|0
486111|NCT00087646|1575562|P3|Overall Study|Other Protocol Violation|0
486112|NCT00087646|1575563|P2|Overall Study|Other Protocol Violation|1
486113|NCT00087646|1575564|P1|Overall Study|Other Protocol Violation|3
486114|NCT00087646|1575561|P4|Overall Study|Administrative/Other|2
486115|NCT00087646|1575562|P3|Overall Study|Administrative/Other|1
486116|NCT00087646|1575563|P2|Overall Study|Administrative/Other|1
486117|NCT00087646|1575564|P1|Overall Study|Administrative/Other|6
486118|NCT00087646|1575561|P4|Overall Study|Failure to Return|3
486119|NCT00087646|1575562|P3|Overall Study|Failure to Return|2
486120|NCT00087646|1575563|P2|Overall Study|Failure to Return|2
486121|NCT00087646|1575564|P1|Overall Study|Failure to Return|5
486122|NCT00087646|1575561|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
486123|NCT00087646|1575562|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
486124|NCT00087646|1575563|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
486125|NCT00087646|1575564|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
486126|NCT00087646|1575561|P4|Overall Study|Insufficient therapeutic response|51
486127|NCT00087646|1575562|P3|Overall Study|Insufficient therapeutic response|38
486128|NCT00087646|1575563|P2|Overall Study|Insufficient therapeutic response|24
486129|NCT00087646|1575564|P1|Overall Study|Insufficient therapeutic response|64
486130|NCT00087646|1575561|P4|Overall Study|Withdrawal by Subject|2
486131|NCT00087646|1575562|P3|Overall Study|Withdrawal by Subject|2
486132|NCT00087646|1575563|P2|Overall Study|Withdrawal by Subject|1
486133|NCT00087646|1575564|P1|Overall Study|Withdrawal by Subject|6
486134|NCT00087646|1575561|P4|Overall Study|Death|0
486135|NCT00087646|1575562|P3|Overall Study|Death|0
486136|NCT00087646|1575563|P2|Overall Study|Death|1
486137|NCT00087646|1575564|P1|Overall Study|Death|0
486138|NCT00087646|1575561|P4|Overall Study|Adverse Event|20
486139|NCT00087646|1575562|P3|Overall Study|Adverse Event|18
486140|NCT00087646|1575563|P2|Overall Study|Adverse Event|6
486141|NCT00087646|1575564|P1|Overall Study|Adverse Event|37
486142|NCT00087607|1575603|P2|Overall Study|Violation of Selection Criteria at Entry|1
486143|NCT00087607|1575604|P1|Overall Study|Violation of Selection Criteria at Entry|0
486144|NCT00087607|1575603|P2|Overall Study|Other Protocol Violation|2
486145|NCT00087607|1575604|P1|Overall Study|Other Protocol Violation|5
486146|NCT00087607|1575603|P2|Overall Study|Refused Treatment|7
486147|NCT00087607|1575604|P1|Overall Study|Refused Treatment|5
486148|NCT00087607|1575603|P2|Overall Study|Administrative|12
486149|NCT00087607|1575604|P1|Overall Study|Administrative|12
486150|NCT00087607|1575603|P2|Overall Study|Withdrew Consent|16
486151|NCT00087607|1575604|P1|Overall Study|Withdrew Consent|12
486152|NCT00087607|1575603|P2|Overall Study|Failure to return|17
486153|NCT00087607|1575604|P1|Overall Study|Failure to return|21
486154|NCT00087607|1575603|P2|Overall Study|Insufficient Therapeutic Response|42
486155|NCT00087607|1575604|P1|Overall Study|Insufficient Therapeutic Response|53
486156|NCT00087607|1575603|P2|Overall Study|Death|1
486157|NCT00087607|1575604|P1|Overall Study|Death|0
486158|NCT00087607|1575603|P2|Overall Study|Adverse Event|24
486159|NCT00087607|1575604|P1|Overall Study|Adverse Event|14
486160|NCT00087594|1575644|P2|Overall Study|Lack of Efficacy|5
486161|NCT00087594|1575645|P1|Overall Study|Lack of Efficacy|2
486162|NCT00087594|1575644|P2|Overall Study|Withdrawal by Subject|2
486163|NCT00087594|1575645|P1|Overall Study|Withdrawal by Subject|4
486164|NCT00087594|1575644|P2|Overall Study|Lost to Follow-up|2
486165|NCT00087594|1575645|P1|Overall Study|Lost to Follow-up|0
486166|NCT00087594|1575644|P2|Overall Study|Adverse Event|3
486167|NCT00087594|1575645|P1|Overall Study|Adverse Event|2
486168|NCT00087568|1575679|P2|Overall Study|Lack of Efficacy|1
486169|NCT00087568|1575680|P1|Overall Study|Lack of Efficacy|24
486170|NCT00087568|1575679|P2|Overall Study|Lost to Follow-up|0
486171|NCT00087568|1575680|P1|Overall Study|Lost to Follow-up|1
486172|NCT00087568|1575679|P2|Overall Study|Withdrawal by Subject|1
486173|NCT00087568|1575680|P1|Overall Study|Withdrawal by Subject|1
486174|NCT00087568|1575679|P2|Overall Study|Adverse Event|0
486175|NCT00087568|1575680|P1|Overall Study|Adverse Event|4
486176|NCT00087555|1575707|P3|Overall Study|Patient wanted to go back on Med|0
486177|NCT00087555|1575708|P2|Overall Study|Patient wanted to go back on Med|0
486178|NCT00087555|1575709|P1|Overall Study|Patient wanted to go back on Med|1
486179|NCT00087555|1575707|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
486180|NCT00087555|1575708|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
486181|NCT00087555|1575709|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
486182|NCT00087555|1575707|P3|Overall Study|Non Compliance|1
486183|NCT00087555|1575708|P2|Overall Study|Non Compliance|0
486184|NCT00087555|1575709|P1|Overall Study|Non Compliance|0
486185|NCT00087555|1575707|P3|Overall Study|Lack of Efficacy|1
486186|NCT00087555|1575708|P2|Overall Study|Lack of Efficacy|0
486187|NCT00087555|1575709|P1|Overall Study|Lack of Efficacy|2
486188|NCT00087555|1575707|P3|Overall Study|Withdrawal by Subject|1
486189|NCT00087555|1575708|P2|Overall Study|Withdrawal by Subject|2
486190|NCT00087555|1575709|P1|Overall Study|Withdrawal by Subject|3
486191|NCT00087555|1575707|P3|Overall Study|Pregnancy|1
486192|NCT00087555|1575708|P2|Overall Study|Pregnancy|1
486193|NCT00087555|1575709|P1|Overall Study|Pregnancy|0
486194|NCT00087555|1575707|P3|Overall Study|Screen Failure|0
486195|NCT00087555|1575708|P2|Overall Study|Screen Failure|1
486196|NCT00087555|1575709|P1|Overall Study|Screen Failure|1
486197|NCT00087555|1575707|P3|Overall Study|Protocol Violation|2
486198|NCT00087555|1575708|P2|Overall Study|Protocol Violation|0
486199|NCT00087555|1575709|P1|Overall Study|Protocol Violation|0
486200|NCT00087555|1575707|P3|Overall Study|Non - Compliance|0
486201|NCT00087555|1575708|P2|Overall Study|Non - Compliance|0
486202|NCT00087555|1575709|P1|Overall Study|Non - Compliance|1
486203|NCT00087555|1575707|P3|Overall Study|Lost to Follow-up|1
486204|NCT00087555|1575708|P2|Overall Study|Lost to Follow-up|1
486205|NCT00087555|1575709|P1|Overall Study|Lost to Follow-up|0
486206|NCT00087555|1575707|P3|Overall Study|Adverse Event|14
486207|NCT00087555|1575708|P2|Overall Study|Adverse Event|6
486208|NCT00087555|1575709|P1|Overall Study|Adverse Event|3
486209|NCT00087529|1575719|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
486210|NCT00087529|1575720|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
486211|NCT00087529|1575719|P2|Overall Study|Disease Progression|4
486212|NCT00087529|1575720|P1|Overall Study|Disease Progression|5
486213|NCT00087529|1575719|P2|Overall Study|Participant Noncompliance|1
486214|NCT00087529|1575720|P1|Overall Study|Participant Noncompliance|0
486215|NCT00087529|1575719|P2|Overall Study|Initiation of Excluded Therapy|1
486216|NCT00087529|1575720|P1|Overall Study|Initiation of Excluded Therapy|0
486217|NCT00087529|1575719|P2|Overall Study|Physician Decision|8
486218|NCT00087529|1575720|P1|Overall Study|Physician Decision|4
486219|NCT00087529|1575719|P2|Overall Study|Participant Decision|37
486220|NCT00087529|1575720|P1|Overall Study|Participant Decision|14
486221|NCT00087529|1575719|P2|Overall Study|Lost to Follow-up|3
486222|NCT00087529|1575720|P1|Overall Study|Lost to Follow-up|2
486223|NCT00087529|1575719|P2|Overall Study|Pregnancy|1
486224|NCT00087529|1575720|P1|Overall Study|Pregnancy|0
486225|NCT00087529|1575719|P2|Overall Study|Adverse Event|8
486226|NCT00087529|1575720|P1|Overall Study|Adverse Event|0
486227|NCT00087529|1575719|P2|Overall Study|Death|0
486228|NCT00087529|1575720|P1|Overall Study|Death|1
486229|NCT00087516|1575735|P4|Overall Study|Other|0
486230|NCT00087516|1575736|P3|Overall Study|Other|1
486231|NCT00087516|1575737|P2|Overall Study|Other|0
486232|NCT00087516|1575738|P1|Overall Study|Other|0
486233|NCT00087516|1575735|P4|Overall Study|Recommendation of Primary Care Physician|1
486234|NCT00087516|1575736|P3|Overall Study|Recommendation of Primary Care Physician|0
486235|NCT00087516|1575737|P2|Overall Study|Recommendation of Primary Care Physician|0
486236|NCT00087516|1575738|P1|Overall Study|Recommendation of Primary Care Physician|0
486237|NCT00087516|1575735|P4|Overall Study|Patient was non-compliant|0
486238|NCT00087516|1575736|P3|Overall Study|Patient was non-compliant|0
486239|NCT00087516|1575737|P2|Overall Study|Patient was non-compliant|1
486240|NCT00087516|1575738|P1|Overall Study|Patient was non-compliant|3
486241|NCT00087516|1575735|P4|Overall Study|Patient moved|0
486242|NCT00087516|1575736|P3|Overall Study|Patient moved|1
486243|NCT00087516|1575737|P2|Overall Study|Patient moved|2
486244|NCT00087516|1575738|P1|Overall Study|Patient moved|3
486245|NCT00087516|1575735|P4|Overall Study|Protocol specified discontinuation|26
486246|NCT00087516|1575736|P3|Overall Study|Protocol specified discontinuation|33
486247|NCT00087516|1575737|P2|Overall Study|Protocol specified discontinuation|33
486248|NCT00087516|1575738|P1|Overall Study|Protocol specified discontinuation|35
486249|NCT00087516|1575735|P4|Overall Study|Site terminated|0
486250|NCT00087516|1575736|P3|Overall Study|Site terminated|1
486251|NCT00087516|1575737|P2|Overall Study|Site terminated|2
486252|NCT00087516|1575738|P1|Overall Study|Site terminated|0
486253|NCT00087516|1575735|P4|Overall Study|Withdrawal by Subject|12
486254|NCT00087516|1575736|P3|Overall Study|Withdrawal by Subject|11
486255|NCT00087516|1575737|P2|Overall Study|Withdrawal by Subject|27
486256|NCT00087516|1575738|P1|Overall Study|Withdrawal by Subject|16
486257|NCT00087516|1575735|P4|Overall Study|Protocol Violation|6
486258|NCT00087516|1575736|P3|Overall Study|Protocol Violation|3
486259|NCT00087516|1575737|P2|Overall Study|Protocol Violation|8
486260|NCT00087516|1575738|P1|Overall Study|Protocol Violation|4
486261|NCT00087516|1575735|P4|Overall Study|Lost to Follow-up|5
486262|NCT00087516|1575736|P3|Overall Study|Lost to Follow-up|5
486263|NCT00087516|1575737|P2|Overall Study|Lost to Follow-up|6
486264|NCT00087516|1575738|P1|Overall Study|Lost to Follow-up|8
486265|NCT00087516|1575735|P4|Overall Study|Lack of Efficacy|29
486266|NCT00087516|1575736|P3|Overall Study|Lack of Efficacy|39
486267|NCT00087516|1575737|P2|Overall Study|Lack of Efficacy|80
486268|NCT00087516|1575738|P1|Overall Study|Lack of Efficacy|82
486269|NCT00087516|1575735|P4|Overall Study|Adverse Event|6
486270|NCT00087516|1575736|P3|Overall Study|Adverse Event|3
486271|NCT00087516|1575737|P2|Overall Study|Adverse Event|10
486272|NCT00087516|1575738|P1|Overall Study|Adverse Event|10
486273|NCT00087490|1575767|P2|Overall Study|Randomized but not treated|18
486274|NCT00087490|1575768|P1|Overall Study|Randomized but not treated|7
486275|NCT00087490|1575767|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
486276|NCT00087490|1575768|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
486277|NCT00087490|1575767|P2|Overall Study|Protocol Violation or (/) Unspecified|201
486278|NCT00087490|1575768|P1|Overall Study|Protocol Violation or (/) Unspecified|214
486279|NCT00087490|1575767|P2|Overall Study|Lack of Efficacy|2
486280|NCT00087490|1575768|P1|Overall Study|Lack of Efficacy|0
486281|NCT00087490|1575767|P2|Overall Study|Adverse Event|8
486282|NCT00087490|1575768|P1|Overall Study|Adverse Event|3
486283|NCT00087490|1575767|P2|Overall Study|Death|4
486284|NCT00087490|1575768|P1|Overall Study|Death|6
486285|NCT00087438|1575802|P1|Overall Study|Ineligible / No protocol treatment|4
486286|NCT00087152|1575806|P1|Overall Study|Ineligible|6
486287|NCT00087139|1575815|P3|Overall Study|Extradural disease|1
486288|NCT00087139|1575816|P2|Overall Study|Extradural disease|0
486289|NCT00087139|1575817|P1|Overall Study|Extradural disease|0
486290|NCT00087139|1575815|P3|Overall Study|Response achieved|0
486291|NCT00087139|1575816|P2|Overall Study|Response achieved|1
486292|NCT00087139|1575817|P1|Overall Study|Response achieved|0
486293|NCT00087139|1575815|P3|Overall Study|Use of coumadin|0
486294|NCT00087139|1575816|P2|Overall Study|Use of coumadin|0
486295|NCT00087139|1575817|P1|Overall Study|Use of coumadin|1
486296|NCT00087139|1575815|P3|Overall Study|Symptomatic deterioration|3
486297|NCT00087139|1575816|P2|Overall Study|Symptomatic deterioration|1
486298|NCT00087139|1575817|P1|Overall Study|Symptomatic deterioration|1
486299|NCT00087139|1575815|P3|Overall Study|Ineligible|4
486300|NCT00087139|1575816|P2|Overall Study|Ineligible|7
486301|NCT00087139|1575817|P1|Overall Study|Ineligible|4
486302|NCT00087139|1575815|P3|Overall Study|Disease progression|12
486303|NCT00087139|1575816|P2|Overall Study|Disease progression|19
486304|NCT00087139|1575817|P1|Overall Study|Disease progression|9
486305|NCT00087139|1575815|P3|Overall Study|Physician Decision|1
486306|NCT00087139|1575816|P2|Overall Study|Physician Decision|1
486307|NCT00087139|1575817|P1|Overall Study|Physician Decision|1
486308|NCT00087139|1575815|P3|Overall Study|Withdrawal by Subject|2
486309|NCT00087139|1575816|P2|Overall Study|Withdrawal by Subject|2
486310|NCT00087139|1575817|P1|Overall Study|Withdrawal by Subject|3
486311|NCT00087139|1575815|P3|Overall Study|Death|0
486312|NCT00087139|1575816|P2|Overall Study|Death|1
486313|NCT00087139|1575817|P1|Overall Study|Death|2
486314|NCT00087139|1575815|P3|Overall Study|Adverse Event|13
486315|NCT00087139|1575816|P2|Overall Study|Adverse Event|17
486316|NCT00087139|1575817|P1|Overall Study|Adverse Event|18
486317|NCT00086996|1575832|P1|Overall Study|not eligible|5
486318|NCT00086996|1575832|P1|Overall Study|not specified|6
486319|NCT00086996|1575832|P1|Overall Study|Withdrawal by Subject|13
486320|NCT00086996|1575832|P1|Overall Study|progression/relapse|7
486321|NCT00086996|1575832|P1|Overall Study|Death|4
486322|NCT00086996|1575832|P1|Overall Study|Adverse Event|29
486323|NCT00086684|1575854|P3|Overall Study|Not specified|3
486324|NCT00086684|1575855|P2|Overall Study|Not specified|2
486325|NCT00086684|1575856|P1|Overall Study|Not specified|4
486326|NCT00086684|1575854|P3|Overall Study|WITHDRAWAL OF CONSENT|5
486327|NCT00086684|1575855|P2|Overall Study|WITHDRAWAL OF CONSENT|7
486328|NCT00086684|1575856|P1|Overall Study|WITHDRAWAL OF CONSENT|5
486329|NCT00086684|1575854|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
486330|NCT00086684|1575855|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
486331|NCT00086684|1575856|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
486332|NCT00086684|1575854|P3|Overall Study|NONCOMPLIANCE|6
486333|NCT00086684|1575855|P2|Overall Study|NONCOMPLIANCE|7
486334|NCT00086684|1575856|P1|Overall Study|NONCOMPLIANCE|5
486335|NCT00086684|1575854|P3|Overall Study|Withdrawal by Subject|10
486336|NCT00086684|1575855|P2|Overall Study|Withdrawal by Subject|4
486337|NCT00086684|1575856|P1|Overall Study|Withdrawal by Subject|0
486338|NCT00086684|1575854|P3|Overall Study|Protocol Violation|0
486339|NCT00086684|1575855|P2|Overall Study|Protocol Violation|3
486340|NCT00086684|1575856|P1|Overall Study|Protocol Violation|8
486341|NCT00086684|1575854|P3|Overall Study|Lost to Follow-up|10
486342|NCT00086684|1575855|P2|Overall Study|Lost to Follow-up|8
486343|NCT00086684|1575856|P1|Overall Study|Lost to Follow-up|15
486344|NCT00086684|1575854|P3|Overall Study|Lack of Efficacy|5
486345|NCT00086684|1575855|P2|Overall Study|Lack of Efficacy|6
486346|NCT00086684|1575856|P1|Overall Study|Lack of Efficacy|6
486347|NCT00086684|1575854|P3|Overall Study|Adverse Event|14
486348|NCT00086684|1575855|P2|Overall Study|Adverse Event|17
486349|NCT00086684|1575856|P1|Overall Study|Adverse Event|12
486350|NCT00086619|1575869|P2|Overall Study|Protocol Violation|1
486351|NCT00086619|1575870|P1|Overall Study|Protocol Violation|1
486352|NCT00086619|1575869|P2|Overall Study|Adverse Event|10
486353|NCT00086619|1575870|P1|Overall Study|Adverse Event|8
486354|NCT00086619|1575869|P2|Overall Study|Withdrawal by Subject|6
486355|NCT00086619|1575870|P1|Overall Study|Withdrawal by Subject|6
486356|NCT00086580|1575880|P2|Observation Period|Not specified|7
486357|NCT00086580|1575881|P1|Observation Period|Not specified|8
486358|NCT00086580|1575880|P2|Observation Period|Death|55
486359|NCT00086580|1575881|P1|Observation Period|Death|33
486360|NCT00086580|1575880|P2|Observation Period|Withdrawal by Subject|2
486361|NCT00086580|1575881|P1|Observation Period|Withdrawal by Subject|4
486362|NCT00086580|1575880|P2|Observation Period|Unable to comply with protocol|1
486363|NCT00086580|1575881|P1|Observation Period|Unable to comply with protocol|1
486364|NCT00086580|1575880|P2|Follow-up Period|Not specified|6
486365|NCT00086580|1575881|P1|Follow-up Period|Not specified|7
486366|NCT00086580|1575880|P2|Follow-up Period|Death|7
486367|NCT00086580|1575881|P1|Follow-up Period|Death|13
486368|NCT00086580|1575880|P2|Follow-up Period|AE - not related|0
486369|NCT00086580|1575881|P1|Follow-up Period|AE - not related|1
486370|NCT00086580|1575880|P2|Follow-up Period|Physician Decision|1
486371|NCT00086580|1575881|P1|Follow-up Period|Physician Decision|0
486372|NCT00086580|1575880|P2|Follow-up Period|Withdrawal by Subject|6
486373|NCT00086580|1575881|P1|Follow-up Period|Withdrawal by Subject|6
486374|NCT00086580|1575880|P2|Follow-up Period|Unable to comply with protocol|0
486375|NCT00086580|1575881|P1|Follow-up Period|Unable to comply with protocol|5
486376|NCT00086580|1575880|P2|Follow-up Period|Disease progression|99
486377|NCT00086580|1575881|P1|Follow-up Period|Disease progression|72
486378|NCT00086580|1575880|P2|Treatment Period|Not specified|3
486379|NCT00086580|1575881|P1|Treatment Period|Not specified|5
486380|NCT00086580|1575880|P2|Treatment Period|Death|7
486381|NCT00086580|1575881|P1|Treatment Period|Death|5
486382|NCT00086580|1575880|P2|Treatment Period|Anemia or thrombocytopenia|4
486383|NCT00086580|1575881|P1|Treatment Period|Anemia or thrombocytopenia|1
486384|NCT00086580|1575880|P2|Treatment Period|Toxicity - treatment related|15
486385|NCT00086580|1575881|P1|Treatment Period|Toxicity - treatment related|15
486386|NCT00086580|1575880|P2|Treatment Period|AE - not treatment related|7
486387|NCT00086580|1575881|P1|Treatment Period|AE - not treatment related|7
486388|NCT00086580|1575880|P2|Treatment Period|Physician Decision|7
486389|NCT00086580|1575881|P1|Treatment Period|Physician Decision|13
486390|NCT00086580|1575880|P2|Treatment Period|Withdrawal by Subject|8
486391|NCT00086580|1575881|P1|Treatment Period|Withdrawal by Subject|7
486392|NCT00086580|1575880|P2|Treatment Period|Unable to comply with protocol|1
486393|NCT00086580|1575881|P1|Treatment Period|Unable to comply with protocol|3
486394|NCT00086580|1575880|P2|Treatment Period|Disease progression|8
486395|NCT00086580|1575881|P1|Treatment Period|Disease progression|9
486396|NCT00086411|1575929|P4|Overall Study|Lost to Follow-up|12
486397|NCT00086411|1575930|P3|Overall Study|Lost to Follow-up|13
486398|NCT00086411|1575931|P2|Overall Study|Lost to Follow-up|11
486399|NCT00086411|1575932|P1|Overall Study|Lost to Follow-up|11
486400|NCT00086385|1575946|P4|Overall Study|Death|1
486401|NCT00086385|1575947|P3|Overall Study|Death|1
486402|NCT00086385|1575948|P2|Overall Study|Death|2
486403|NCT00086385|1575949|P1|Overall Study|Death|2
486404|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Discontinued in error|0
486405|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Discontinued in error|1
486406|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
486407|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
486408|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
486409|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
486410|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Patient Died|1
486411|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Patient Died|3
486412|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
486413|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
486414|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
486415|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
486416|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Patient Moved|2
486417|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Patient Moved|2
486418|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
486419|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
486420|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Protocol Violation|0
486421|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Protocol Violation|1
486422|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Physician Decision|0
486423|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Physician Decision|3
486424|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
486425|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
486426|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
486427|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
486428|NCT00086515|1575961|P2|Phase B (Weeks 24-104)|Adverse Event|10
486429|NCT00086515|1575962|P1|Phase B (Weeks 24-104)|Adverse Event|16
486430|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
486431|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
486432|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Poor compliance|0
486433|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Poor compliance|1
486434|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
486435|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
486436|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
486437|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
486438|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Protocol Violation|1
486439|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Protocol Violation|0
486440|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
486441|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
486442|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
486443|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
486444|NCT00086515|1575961|P2|Phase A to Phase B Transition Period|Adverse Event|1
486445|NCT00086515|1575962|P1|Phase A to Phase B Transition Period|Adverse Event|2
486446|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
486447|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
486448|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
486449|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
486450|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Poor compliance|0
486451|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Poor compliance|1
486452|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
486453|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
486454|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Patient Moved|3
486455|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Patient Moved|2
486456|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
486457|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
486458|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Protocol Violation|1
486459|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Protocol Violation|3
486460|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
486461|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
486462|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
486463|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
486464|NCT00086515|1575961|P2|Phase A (Weeks 0-24)|Adverse Event|9
486465|NCT00086515|1575962|P1|Phase A (Weeks 0-24)|Adverse Event|17
486466|NCT00086502|1575974|P2|Overall Study|Patient Accidentally Unblinded|0
486467|NCT00086502|1575975|P1|Overall Study|Patient Accidentally Unblinded|1
486468|NCT00086502|1575974|P2|Overall Study|Protocol Discontinuation Criteria|3
486469|NCT00086502|1575975|P1|Overall Study|Protocol Discontinuation Criteria|1
486470|NCT00086502|1575974|P2|Overall Study|Patient Moved|1
486471|NCT00086502|1575975|P1|Overall Study|Patient Moved|1
486472|NCT00086502|1575974|P2|Overall Study|Withdrawal by Subject|6
486473|NCT00086502|1575975|P1|Overall Study|Withdrawal by Subject|5
486474|NCT00086502|1575974|P2|Overall Study|Protocol Violation|3
486475|NCT00086502|1575975|P1|Overall Study|Protocol Violation|3
486476|NCT00086502|1575974|P2|Overall Study|Pregnancy|1
486477|NCT00086502|1575975|P1|Overall Study|Pregnancy|0
486478|NCT00086502|1575974|P2|Overall Study|Physician Decision|1
486479|NCT00086502|1575975|P1|Overall Study|Physician Decision|1
486480|NCT00086502|1575974|P2|Overall Study|Lost to Follow-up|1
486481|NCT00086502|1575975|P1|Overall Study|Lost to Follow-up|3
486482|NCT00086502|1575974|P2|Overall Study|Lack of Efficacy|2
486483|NCT00086502|1575975|P1|Overall Study|Lack of Efficacy|0
486484|NCT00086502|1575974|P2|Overall Study|Adverse Event|2
486485|NCT00086502|1575975|P1|Overall Study|Adverse Event|11
486486|NCT00086346|1576000|P2|Patients Dosed With Test Article|Lack of Efficacy|0
486487|NCT00086346|1576001|P1|Patients Dosed With Test Article|Lack of Efficacy|11
486488|NCT00086346|1576000|P2|Patients Dosed With Test Article|Protocol Violation|3
486489|NCT00086346|1576001|P1|Patients Dosed With Test Article|Protocol Violation|11
486490|NCT00086346|1576000|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
486491|NCT00086346|1576001|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
486492|NCT00086346|1576000|P2|Patients Dosed With Test Article|Nonmedical event|3
486493|NCT00086346|1576001|P1|Patients Dosed With Test Article|Nonmedical event|7
486494|NCT00086346|1576000|P2|Patients Dosed With Test Article|Lost to Follow-up|3
486495|NCT00086346|1576001|P1|Patients Dosed With Test Article|Lost to Follow-up|1
486496|NCT00086346|1576000|P2|Patients Dosed With Test Article|Adverse Event|11
486497|NCT00086346|1576001|P1|Patients Dosed With Test Article|Adverse Event|94
486498|NCT00086346|1576000|P2|Randomization|Did not receive test article|4
486499|NCT00086346|1576001|P1|Randomization|Did not receive test article|4
486500|NCT00086281|1576028|P15|Phase 2|Adverse Event|0
486501|NCT00086281|1576029|P14|Phase 2|Adverse Event|1
486502|NCT00086281|1576030|P13|Phase 2|Adverse Event|1
486503|NCT00086281|1576031|P12|Phase 2|Adverse Event|0
486504|NCT00086281|1576032|P11|Phase 2|Adverse Event|0
486505|NCT00086281|1576033|P10|Phase 2|Adverse Event|0
486506|NCT00086281|1576034|P9|Phase 2|Adverse Event|0
486507|NCT00086281|1576035|P8|Phase 2|Adverse Event|0
486508|NCT00086281|1576036|P7|Phase 2|Adverse Event|0
486509|NCT00086281|1576037|P6|Phase 2|Adverse Event|0
486510|NCT00086281|1576038|P5|Phase 2|Adverse Event|0
486511|NCT00086281|1576039|P4|Phase 2|Adverse Event|0
486512|NCT00086281|1576040|P3|Phase 2|Adverse Event|0
486513|NCT00086281|1576041|P2|Phase 2|Adverse Event|0
486514|NCT00086281|1576042|P1|Phase 2|Adverse Event|0
486515|NCT00086281|1576028|P15|Phase 1|Serious Adverse Event|1
486516|NCT00086281|1576029|P14|Phase 1|Serious Adverse Event|0
486517|NCT00086281|1576030|P13|Phase 1|Serious Adverse Event|0
486518|NCT00086281|1576031|P12|Phase 1|Serious Adverse Event|0
486519|NCT00086281|1576032|P11|Phase 1|Serious Adverse Event|0
486520|NCT00086281|1576033|P10|Phase 1|Serious Adverse Event|0
486521|NCT00086281|1576034|P9|Phase 1|Serious Adverse Event|0
486522|NCT00086281|1576035|P8|Phase 1|Serious Adverse Event|0
486523|NCT00086281|1576036|P7|Phase 1|Serious Adverse Event|0
486524|NCT00086281|1576037|P6|Phase 1|Serious Adverse Event|0
486525|NCT00086281|1576038|P5|Phase 1|Serious Adverse Event|0
486526|NCT00086281|1576039|P4|Phase 1|Serious Adverse Event|0
486527|NCT00086281|1576040|P3|Phase 1|Serious Adverse Event|0
486528|NCT00086281|1576041|P2|Phase 1|Serious Adverse Event|0
486529|NCT00086281|1576042|P1|Phase 1|Serious Adverse Event|0
486530|NCT00086281|1576028|P15|Phase 1|Protocol Violation|0
486531|NCT00086281|1576029|P14|Phase 1|Protocol Violation|0
486532|NCT00086281|1576030|P13|Phase 1|Protocol Violation|0
486533|NCT00086281|1576031|P12|Phase 1|Protocol Violation|0
486534|NCT00086281|1576032|P11|Phase 1|Protocol Violation|1
486535|NCT00086281|1576033|P10|Phase 1|Protocol Violation|0
486536|NCT00086281|1576034|P9|Phase 1|Protocol Violation|0
486537|NCT00086281|1576035|P8|Phase 1|Protocol Violation|0
486538|NCT00086281|1576036|P7|Phase 1|Protocol Violation|0
486539|NCT00086281|1576037|P6|Phase 1|Protocol Violation|0
486540|NCT00086281|1576038|P5|Phase 1|Protocol Violation|0
486541|NCT00086281|1576039|P4|Phase 1|Protocol Violation|0
486542|NCT00086281|1576040|P3|Phase 1|Protocol Violation|0
486543|NCT00086281|1576041|P2|Phase 1|Protocol Violation|0
486544|NCT00086281|1576042|P1|Phase 1|Protocol Violation|0
486545|NCT00086281|1576028|P15|Phase 1|Adverse Event|2
486546|NCT00086281|1576029|P14|Phase 1|Adverse Event|1
486547|NCT00086281|1576030|P13|Phase 1|Adverse Event|1
486548|NCT00086281|1576031|P12|Phase 1|Adverse Event|1
486549|NCT00086281|1576032|P11|Phase 1|Adverse Event|2
486550|NCT00086281|1576033|P10|Phase 1|Adverse Event|1
486551|NCT00086281|1576034|P9|Phase 1|Adverse Event|0
486552|NCT00086281|1576035|P8|Phase 1|Adverse Event|0
486553|NCT00086281|1576036|P7|Phase 1|Adverse Event|0
486554|NCT00086281|1576037|P6|Phase 1|Adverse Event|0
486555|NCT00086281|1576038|P5|Phase 1|Adverse Event|0
486556|NCT00086281|1576039|P4|Phase 1|Adverse Event|0
486557|NCT00086281|1576040|P3|Phase 1|Adverse Event|0
486558|NCT00086281|1576041|P2|Phase 1|Adverse Event|0
486559|NCT00086281|1576042|P1|Phase 1|Adverse Event|0
486560|NCT00086307|1576055|P3|Overall Study|Withdrawal by Subject|2
486561|NCT00086307|1576056|P2|Overall Study|Withdrawal by Subject|0
486562|NCT00086307|1576057|P1|Overall Study|Withdrawal by Subject|0
486563|NCT00086307|1576055|P3|Overall Study|Fatigue and difficulty falling asleep|1
486564|NCT00086307|1576056|P2|Overall Study|Fatigue and difficulty falling asleep|0
486565|NCT00086307|1576057|P1|Overall Study|Fatigue and difficulty falling asleep|0
486566|NCT00086307|1576055|P3|Overall Study|Suicidal ideation|1
486567|NCT00086307|1576056|P2|Overall Study|Suicidal ideation|0
486568|NCT00086307|1576057|P1|Overall Study|Suicidal ideation|0
486569|NCT00086307|1576055|P3|Overall Study|Constipation and sleepiness|1
486570|NCT00086307|1576056|P2|Overall Study|Constipation and sleepiness|0
486571|NCT00086307|1576057|P1|Overall Study|Constipation and sleepiness|0
486572|NCT00086307|1576055|P3|Overall Study|Nausea and headaches|1
486573|NCT00086307|1576056|P2|Overall Study|Nausea and headaches|0
486574|NCT00086307|1576057|P1|Overall Study|Nausea and headaches|0
486575|NCT00086307|1576055|P3|Overall Study|Shortness of breath and muscle spasms|0
486576|NCT00086307|1576056|P2|Overall Study|Shortness of breath and muscle spasms|0
486577|NCT00086307|1576057|P1|Overall Study|Shortness of breath and muscle spasms|1
486578|NCT00086307|1576055|P3|Overall Study|Lack of Efficacy|2
486579|NCT00086307|1576056|P2|Overall Study|Lack of Efficacy|1
486580|NCT00086307|1576057|P1|Overall Study|Lack of Efficacy|1
486581|NCT00086190|1576068|P3|Overall Study|Worsening depression|2
486582|NCT00086190|1576069|P2|Overall Study|Worsening depression|0
486583|NCT00086190|1576070|P1|Overall Study|Worsening depression|0
486584|NCT00086190|1576068|P3|Overall Study|Moved|0
486585|NCT00086190|1576069|P2|Overall Study|Moved|0
486586|NCT00086190|1576070|P1|Overall Study|Moved|1
486587|NCT00086190|1576068|P3|Overall Study|Protocol Violation|0
486588|NCT00086190|1576069|P2|Overall Study|Protocol Violation|0
486589|NCT00086190|1576070|P1|Overall Study|Protocol Violation|1
486590|NCT00086190|1576068|P3|Overall Study|Withdrawal by Subject|2
486591|NCT00086190|1576069|P2|Overall Study|Withdrawal by Subject|2
486592|NCT00086190|1576070|P1|Overall Study|Withdrawal by Subject|0
486593|NCT00086190|1576068|P3|Overall Study|Adverse Event|2
486594|NCT00086190|1576069|P2|Overall Study|Adverse Event|2
486595|NCT00086190|1576070|P1|Overall Study|Adverse Event|6
486596|NCT00086047|1576139|P2|Overall Study|Physician Decision|1
486597|NCT00086047|1576140|P1|Overall Study|Physician Decision|0
486598|NCT00086047|1576139|P2|Overall Study|Lost to Follow-up|6
486599|NCT00086047|1576140|P1|Overall Study|Lost to Follow-up|7
486600|NCT00085917|1576148|P2|Overall Study|Adverse Event|3
486601|NCT00085917|1576149|P1|Overall Study|Adverse Event|4
486602|NCT00085735|1576178|P6|Overall Study|Pt transferred to inst w/out study open|0
486603|NCT00085735|1576179|P5|Overall Study|Pt transferred to inst w/out study open|0
486604|NCT00085735|1576180|P4|Overall Study|Pt transferred to inst w/out study open|0
486605|NCT00085735|1576181|P3|Overall Study|Pt transferred to inst w/out study open|0
486606|NCT00085735|1576182|P2|Overall Study|Pt transferred to inst w/out study open|0
486607|NCT00085735|1576183|P1|Overall Study|Pt transferred to inst w/out study open|1
486608|NCT00085735|1576178|P6|Overall Study|Reason not documented|0
486609|NCT00085735|1576179|P5|Overall Study|Reason not documented|1
486610|NCT00085735|1576180|P4|Overall Study|Reason not documented|0
486611|NCT00085735|1576181|P3|Overall Study|Reason not documented|1
486612|NCT00085735|1576182|P2|Overall Study|Reason not documented|0
486613|NCT00085735|1576183|P1|Overall Study|Reason not documented|1
486614|NCT00085735|1576178|P6|Overall Study|Excess residual disease|4
486615|NCT00085735|1576179|P5|Overall Study|Excess residual disease|1
486616|NCT00085735|1576180|P4|Overall Study|Excess residual disease|1
486617|NCT00085735|1576181|P3|Overall Study|Excess residual disease|1
486618|NCT00085735|1576182|P2|Overall Study|Excess residual disease|2
486619|NCT00085735|1576183|P1|Overall Study|Excess residual disease|2
486620|NCT00085735|1576178|P6|Overall Study|Patient ineligible|8
486621|NCT00085735|1576179|P5|Overall Study|Patient ineligible|17
486622|NCT00085735|1576180|P4|Overall Study|Patient ineligible|7
486623|NCT00085735|1576181|P3|Overall Study|Patient ineligible|3
486624|NCT00085735|1576182|P2|Overall Study|Patient ineligible|0
486625|NCT00085735|1576183|P1|Overall Study|Patient ineligible|1
486626|NCT00085735|1576178|P6|Overall Study|Withdrawal by Subject|8
486627|NCT00085735|1576179|P5|Overall Study|Withdrawal by Subject|7
486628|NCT00085735|1576180|P4|Overall Study|Withdrawal by Subject|5
486629|NCT00085735|1576181|P3|Overall Study|Withdrawal by Subject|4
486630|NCT00085735|1576182|P2|Overall Study|Withdrawal by Subject|0
486631|NCT00085735|1576183|P1|Overall Study|Withdrawal by Subject|1
486632|NCT00085735|1576178|P6|Overall Study|Protocol Violation|0
486633|NCT00085735|1576179|P5|Overall Study|Protocol Violation|0
486634|NCT00085735|1576180|P4|Overall Study|Protocol Violation|0
486635|NCT00085735|1576181|P3|Overall Study|Protocol Violation|0
486636|NCT00085735|1576182|P2|Overall Study|Protocol Violation|0
486637|NCT00085735|1576183|P1|Overall Study|Protocol Violation|1
486638|NCT00085735|1576178|P6|Overall Study|Physician Decision|8
486639|NCT00085735|1576179|P5|Overall Study|Physician Decision|11
486640|NCT00085735|1576180|P4|Overall Study|Physician Decision|3
486641|NCT00085735|1576181|P3|Overall Study|Physician Decision|2
486642|NCT00085735|1576182|P2|Overall Study|Physician Decision|3
486643|NCT00085735|1576183|P1|Overall Study|Physician Decision|2
486644|NCT00085735|1576178|P6|Overall Study|Lost to Follow-up|0
486645|NCT00085735|1576179|P5|Overall Study|Lost to Follow-up|1
486646|NCT00085735|1576180|P4|Overall Study|Lost to Follow-up|0
486647|NCT00085735|1576181|P3|Overall Study|Lost to Follow-up|0
486648|NCT00085735|1576182|P2|Overall Study|Lost to Follow-up|1
486649|NCT00085735|1576183|P1|Overall Study|Lost to Follow-up|0
486650|NCT00085735|1576178|P6|Overall Study|Lack of Efficacy|3
486651|NCT00085735|1576179|P5|Overall Study|Lack of Efficacy|4
486652|NCT00085735|1576180|P4|Overall Study|Lack of Efficacy|3
486653|NCT00085735|1576181|P3|Overall Study|Lack of Efficacy|6
486654|NCT00085735|1576182|P2|Overall Study|Lack of Efficacy|4
486655|NCT00085735|1576183|P1|Overall Study|Lack of Efficacy|2
486656|NCT00085735|1576178|P6|Overall Study|Adverse Event|0
486657|NCT00085735|1576179|P5|Overall Study|Adverse Event|0
486658|NCT00085735|1576180|P4|Overall Study|Adverse Event|0
486659|NCT00085735|1576181|P3|Overall Study|Adverse Event|0
486660|NCT00085735|1576182|P2|Overall Study|Adverse Event|0
486661|NCT00085735|1576183|P1|Overall Study|Adverse Event|1
486662|NCT00085709|1576211|P2|Overall Study|Withdrawal by Subject|1
486663|NCT00085709|1576212|P1|Overall Study|Withdrawal by Subject|2
486664|NCT00085709|1576211|P2|Overall Study|Not eligible|19
486665|NCT00085709|1576212|P1|Overall Study|Not eligible|19
486666|NCT00085709|1576211|P2|Overall Study|Not protocol specified|22
486667|NCT00085709|1576212|P1|Overall Study|Not protocol specified|12
486668|NCT00085709|1576211|P2|Overall Study|Progression|4
486669|NCT00085709|1576212|P1|Overall Study|Progression|3
486670|NCT00085709|1576211|P2|Overall Study|Refusal unrelated to adverse events|2
486671|NCT00085709|1576212|P1|Overall Study|Refusal unrelated to adverse events|1
486672|NCT00085709|1576211|P2|Overall Study|Death|2
486673|NCT00085709|1576212|P1|Overall Study|Death|8
486674|NCT00085709|1576211|P2|Overall Study|Adverse Event|0
486675|NCT00085709|1576212|P1|Overall Study|Adverse Event|8
486676|NCT00085644|1576228|P3|Open-Label Period|Personal reason|4
486677|NCT00085644|1576229|P2|Open-Label Period|Personal reason|0
486678|NCT00085644|1576230|P1|Open-Label Period|Personal reason|0
486679|NCT00085644|1576228|P3|Open-Label Period|Protocol Violation|4
486680|NCT00085644|1576229|P2|Open-Label Period|Protocol Violation|0
486681|NCT00085644|1576230|P1|Open-Label Period|Protocol Violation|0
486682|NCT00085644|1576228|P3|Open-Label Period|Contemplating pregnancy|3
486683|NCT00085644|1576229|P2|Open-Label Period|Contemplating pregnancy|0
486684|NCT00085644|1576230|P1|Open-Label Period|Contemplating pregnancy|0
486685|NCT00085644|1576228|P3|Open-Label Period|Pregnancy|3
486686|NCT00085644|1576229|P2|Open-Label Period|Pregnancy|0
486687|NCT00085644|1576230|P1|Open-Label Period|Pregnancy|0
486688|NCT00085644|1576228|P3|Open-Label Period|Lack of Efficacy|15
486689|NCT00085644|1576229|P2|Open-Label Period|Lack of Efficacy|0
486690|NCT00085644|1576230|P1|Open-Label Period|Lack of Efficacy|0
486691|NCT00085644|1576228|P3|Open-Label Period|Lost to Follow-up|13
486692|NCT00085644|1576229|P2|Open-Label Period|Lost to Follow-up|0
486693|NCT00085644|1576230|P1|Open-Label Period|Lost to Follow-up|0
486694|NCT00085644|1576228|P3|Open-Label Period|Withdrawal by Subject|29
486695|NCT00085644|1576229|P2|Open-Label Period|Withdrawal by Subject|0
486696|NCT00085644|1576230|P1|Open-Label Period|Withdrawal by Subject|0
486697|NCT00085644|1576228|P3|Open-Label Period|Adverse Event|38
486698|NCT00085644|1576229|P2|Open-Label Period|Adverse Event|0
486699|NCT00085644|1576230|P1|Open-Label Period|Adverse Event|0
486700|NCT00085644|1576228|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
486701|NCT00085644|1576229|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
486702|NCT00085644|1576230|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
486703|NCT00085644|1576228|P3|Double-Blind Period|Contemplating pregnancy|0
486704|NCT00085644|1576229|P2|Double-Blind Period|Contemplating pregnancy|0
486705|NCT00085644|1576230|P1|Double-Blind Period|Contemplating pregnancy|1
486706|NCT00085644|1576228|P3|Double-Blind Period|Lack/loss of efficacy|0
486707|NCT00085644|1576229|P2|Double-Blind Period|Lack/loss of efficacy|2
486708|NCT00085644|1576230|P1|Double-Blind Period|Lack/loss of efficacy|2
486709|NCT00085644|1576228|P3|Double-Blind Period|Lost to Follow-up|0
486710|NCT00085644|1576229|P2|Double-Blind Period|Lost to Follow-up|1
486711|NCT00085644|1576230|P1|Double-Blind Period|Lost to Follow-up|2
486712|NCT00085644|1576228|P3|Double-Blind Period|Withdrawal by Subject|0
486713|NCT00085644|1576229|P2|Double-Blind Period|Withdrawal by Subject|0
486714|NCT00085644|1576230|P1|Double-Blind Period|Withdrawal by Subject|3
486715|NCT00085644|1576228|P3|Double-Blind Period|Adverse Event|0
486716|NCT00085644|1576229|P2|Double-Blind Period|Adverse Event|2
486717|NCT00085644|1576230|P1|Double-Blind Period|Adverse Event|5
486718|NCT00085631|1576271|P3|Overall Study|Missing Data|7
486719|NCT00085631|1576272|P2|Overall Study|Missing Data|11
486720|NCT00085631|1576273|P1|Overall Study|Missing Data|4
486721|NCT00085566|1576283|P3|Overall Study|Clinical progression|1
486722|NCT00085566|1576284|P2|Overall Study|Clinical progression|0
486723|NCT00085566|1576285|P1|Overall Study|Clinical progression|0
486724|NCT00085566|1576283|P3|Overall Study|Patient Not treated|3
486725|NCT00085566|1576284|P2|Overall Study|Patient Not treated|0
486726|NCT00085566|1576285|P1|Overall Study|Patient Not treated|0
486727|NCT00085566|1576283|P3|Overall Study|Adverse Event|10
486728|NCT00085566|1576284|P2|Overall Study|Adverse Event|0
486729|NCT00085566|1576285|P1|Overall Study|Adverse Event|0
486730|NCT00085540|1576295|P2|Overall Study|Protocol Violation|1
486731|NCT00085540|1576296|P1|Overall Study|Protocol Violation|0
486732|NCT00085540|1576295|P2|Overall Study|Withdrawal by Subject|1
486733|NCT00085540|1576296|P1|Overall Study|Withdrawal by Subject|0
486734|NCT00085423|1576308|P1|Overall Study|screen failure|1
486735|NCT00085423|1576308|P1|Overall Study|Withdrawal by Subject|1
486736|NCT00085202|1576354|P2|Overall Study|Progressive disease|11
486737|NCT00085202|1576355|P1|Overall Study|Progressive disease|1
486738|NCT00085202|1576354|P2|Overall Study|Physician Decision|1
486739|NCT00085202|1576355|P1|Overall Study|Physician Decision|4
486740|NCT00085202|1576354|P2|Overall Study|Withdrawal by Subject|1
486741|NCT00085202|1576355|P1|Overall Study|Withdrawal by Subject|2
486742|NCT00085202|1576354|P2|Overall Study|Non-specified|5
486743|NCT00085202|1576355|P1|Overall Study|Non-specified|3
486744|NCT00085202|1576354|P2|Overall Study|Excessive toxicity|5
486745|NCT00085202|1576355|P1|Overall Study|Excessive toxicity|6
486746|NCT00085202|1576354|P2|Overall Study|Bone involvement confirmed by bone scan|1
486747|NCT00085202|1576355|P1|Overall Study|Bone involvement confirmed by bone scan|0
486748|NCT00085202|1576354|P2|Overall Study|Still on therapy|0
486749|NCT00085202|1576355|P1|Overall Study|Still on therapy|2
486750|NCT00085098|1576376|P2|Overall Study|Ineligible|1
486751|NCT00085098|1576377|P1|Overall Study|Ineligible|1
486752|NCT00085098|1576376|P2|Overall Study|Withdrawal by Subject|1
486753|NCT00085098|1576377|P1|Overall Study|Withdrawal by Subject|0
486754|NCT00084864|1576387|P4|Overall Study|Adverse Event|0
486755|NCT00084864|1576388|P3|Overall Study|Adverse Event|0
486756|NCT00084864|1576389|P2|Overall Study|Adverse Event|0
486757|NCT00084864|1576390|P1|Overall Study|Adverse Event|1
486758|NCT00084838|1576416|P1|Overall Study|Ineligible|4
486759|NCT00084838|1576416|P1|Overall Study|Pt Non-Compliance|1
486760|NCT00084838|1576416|P1|Overall Study|Progressive Disease|4
486761|NCT00084838|1576416|P1|Overall Study|Withdrawal by Subject|1
486762|NCT00084838|1576416|P1|Overall Study|Adverse Event|2
486763|NCT00084838|1576416|P1|Overall Study|Death|1
486764|NCT00084747|1576438|P1|Overall Study|Withdrawal by Subject|2
486765|NCT00084747|1576438|P1|Overall Study|Death|3
486766|NCT00084747|1576438|P1|Overall Study|Relapsed|8
486767|NCT00084682|1576443|P1|Overall Study|Withdrawal by Subject|1
486768|NCT00084617|1576447|P1|Overall Study|Protocol Violation|1
486769|NCT00084617|1576447|P1|Overall Study|Lack of Efficacy|1
486770|NCT00084617|1576447|P1|Overall Study|Withdrawal by Subject|7
486771|NCT00084487|1576453|P1|Overall Study|Death|1
486772|NCT00084318|1576499|P2|Overall Study|No protocol treatment|0
486773|NCT00084318|1576500|P1|Overall Study|No protocol treatment|2
486774|NCT00084318|1576499|P2|Overall Study|Protocol Violation|11
486775|NCT00084318|1576500|P1|Overall Study|Protocol Violation|15
486776|NCT00084318|1576499|P2|Overall Study|Withdrawal by Subject|2
486777|NCT00084318|1576500|P1|Overall Study|Withdrawal by Subject|5
486778|NCT00084266|1576518|P2|Overall Study|Randomized not treated|20
486779|NCT00084266|1576519|P1|Overall Study|Randomized not treated|21
486780|NCT00084266|1576518|P2|Overall Study|Other|344
486781|NCT00084266|1576519|P1|Overall Study|Other|360
486782|NCT00084266|1576518|P2|Overall Study|Participant not willing to participate|8
486783|NCT00084266|1576519|P1|Overall Study|Participant not willing to participate|3
486784|NCT00084266|1576518|P2|Overall Study|Lost to Follow-up|3
486785|NCT00084266|1576519|P1|Overall Study|Lost to Follow-up|5
486786|NCT00084266|1576518|P2|Overall Study|Lack of Efficacy|4
486787|NCT00084266|1576519|P1|Overall Study|Lack of Efficacy|2
486788|NCT00084266|1576518|P2|Overall Study|Adverse Event|5
486789|NCT00084266|1576519|P1|Overall Study|Adverse Event|8
486790|NCT00084266|1576518|P2|Overall Study|Death|39
486791|NCT00084266|1576519|P1|Overall Study|Death|42
486792|NCT00084136|1576556|P3|NRTI Comparison|Not reason above|0
486793|NCT00084136|1576557|P2|NRTI Comparison|Not reason above|0
486794|NCT00084136|1576558|P1|NRTI Comparison|Not reason above|1
486795|NCT00084136|1576556|P3|NRTI Comparison|Clinic site closed|14
486796|NCT00084136|1576557|P2|NRTI Comparison|Clinic site closed|0
486797|NCT00084136|1576558|P1|NRTI Comparison|Clinic site closed|12
486798|NCT00084136|1576556|P3|NRTI Comparison|Withdrawal by Subject|38
486799|NCT00084136|1576557|P2|NRTI Comparison|Withdrawal by Subject|0
486800|NCT00084136|1576558|P1|NRTI Comparison|Withdrawal by Subject|54
486801|NCT00084136|1576556|P3|NRTI Comparison|Lost to Follow-up|12
486802|NCT00084136|1576557|P2|NRTI Comparison|Lost to Follow-up|0
486803|NCT00084136|1576558|P1|NRTI Comparison|Lost to Follow-up|14
486804|NCT00084136|1576556|P3|NRTI Comparison|Death|18
486805|NCT00084136|1576557|P2|NRTI Comparison|Death|0
486806|NCT00084136|1576558|P1|NRTI Comparison|Death|20
486807|NCT00084136|1576556|P3|PI Comparison|Clinic site closed|0
486808|NCT00084136|1576557|P2|PI Comparison|Clinic site closed|0
486809|NCT00084136|1576558|P1|PI Comparison|Clinic site closed|1
486810|NCT00084136|1576556|P3|PI Comparison|Withdrawal by Subject|0
486811|NCT00084136|1576557|P2|PI Comparison|Withdrawal by Subject|30
486812|NCT00084136|1576558|P1|PI Comparison|Withdrawal by Subject|33
486813|NCT00084136|1576556|P3|PI Comparison|Lost to Follow-up|0
486814|NCT00084136|1576557|P2|PI Comparison|Lost to Follow-up|8
486815|NCT00084136|1576558|P1|PI Comparison|Lost to Follow-up|11
486816|NCT00084136|1576556|P3|PI Comparison|Death|0
486817|NCT00084136|1576557|P2|PI Comparison|Death|9
486818|NCT00084136|1576558|P1|PI Comparison|Death|10
486819|NCT00084084|1576617|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
486820|NCT00084084|1576617|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
486821|NCT00083915|1576627|P2|Overall Study|Insurance issues|1
486822|NCT00083915|1576628|P1|Overall Study|Insurance issues|1
486823|NCT00083915|1576627|P2|Overall Study|No response|1
486824|NCT00083915|1576628|P1|Overall Study|No response|3
486825|NCT00083915|1576627|P2|Overall Study|Failure to collect|0
486826|NCT00083915|1576628|P1|Overall Study|Failure to collect|3
486827|NCT00083915|1576627|P2|Overall Study|disease progression|23
486828|NCT00083915|1576628|P1|Overall Study|disease progression|18
486829|NCT00083915|1576627|P2|Overall Study|Withdrawal by Subject|3
486830|NCT00083915|1576628|P1|Overall Study|Withdrawal by Subject|8
486831|NCT00083915|1576627|P2|Overall Study|Physician Decision|6
486832|NCT00083915|1576628|P1|Overall Study|Physician Decision|11
486833|NCT00083915|1576627|P2|Overall Study|Death|3
486834|NCT00083915|1576628|P1|Overall Study|Death|6
486835|NCT00083889|1576636|P2|Overall Study|Crossover to SU011248|25
486836|NCT00083889|1576637|P1|Overall Study|Crossover to SU011248|0
486837|NCT00083889|1576636|P2|Overall Study|Completed on marketed sunitinub|0
486838|NCT00083889|1576637|P1|Overall Study|Completed on marketed sunitinub|3
486839|NCT00083889|1576636|P2|Overall Study|Randomized: did not take study drug|15
486840|NCT00083889|1576637|P1|Overall Study|Randomized: did not take study drug|0
486841|NCT00083889|1576636|P2|Overall Study|Decision of sponsor|4
486842|NCT00083889|1576637|P1|Overall Study|Decision of sponsor|32
486843|NCT00083889|1576636|P2|Overall Study|Lack of Efficacy|219
486844|NCT00083889|1576637|P1|Overall Study|Lack of Efficacy|240
486845|NCT00083889|1576636|P2|Overall Study|Withdrawal by Subject|24
486846|NCT00083889|1576637|P1|Overall Study|Withdrawal by Subject|22
486847|NCT00083889|1576636|P2|Overall Study|Protocol Violation|2
486848|NCT00083889|1576637|P1|Overall Study|Protocol Violation|2
486849|NCT00083889|1576636|P2|Overall Study|Adverse Event|86
486850|NCT00083889|1576637|P1|Overall Study|Adverse Event|76
486851|NCT00083759|1576695|P2|Overall Study|Other|13
486852|NCT00083759|1576696|P1|Overall Study|Other|14
486853|NCT00083759|1576695|P2|Overall Study|Sponsor's Discretion|29
486854|NCT00083759|1576696|P1|Overall Study|Sponsor's Discretion|28
486855|NCT00083759|1576695|P2|Overall Study|Non-Compliance|0
486856|NCT00083759|1576696|P1|Overall Study|Non-Compliance|1
486857|NCT00083759|1576695|P2|Overall Study|Subject Withdrew Consent|2
486858|NCT00083759|1576696|P1|Overall Study|Subject Withdrew Consent|2
486859|NCT00083759|1576695|P2|Overall Study|Inadequate Therapeutic Response|35
486860|NCT00083759|1576696|P1|Overall Study|Inadequate Therapeutic Response|32
486861|NCT00083759|1576695|P2|Overall Study|Death|1
486862|NCT00083759|1576696|P1|Overall Study|Death|1
486863|NCT00083759|1576695|P2|Overall Study|Lost to Follow-up|0
486864|NCT00083759|1576696|P1|Overall Study|Lost to Follow-up|1
486865|NCT00083759|1576695|P2|Overall Study|Adverse Event|3
486866|NCT00083759|1576696|P1|Overall Study|Adverse Event|5
486867|NCT00083616|1576714|P1|Overall Study|Other|6
486868|NCT00083616|1576714|P1|Overall Study|Non-compliance|1
486869|NCT00083616|1576714|P1|Overall Study|Ineligibility determined|2
486870|NCT00083616|1576714|P1|Overall Study|Withdrawal by Subject|3
486871|NCT00083616|1576714|P1|Overall Study|Physician Decision|2
486872|NCT00083616|1576714|P1|Overall Study|Lost to Follow-up|1
486873|NCT00083616|1576714|P1|Overall Study|Disease Progression|16
486874|NCT00082888|1576739|P1|Overall Study|Still receiving treatment|4
486875|NCT00082888|1576739|P1|Overall Study|Other Medical Problems|2
486876|NCT00082888|1576739|P1|Overall Study|Alternate Treatment|1
486877|NCT00082888|1576739|P1|Overall Study|Withdrawal by Subject|9
486878|NCT00082888|1576739|P1|Overall Study|Adverse Event|4
486879|NCT00082888|1576739|P1|Overall Study|Death|2
486880|NCT00082810|1576743|P1|Overall Study|Withdrawal by Subject|4
486881|NCT00082810|1576743|P1|Overall Study|Progressive disease|24
486882|NCT00082810|1576743|P1|Overall Study|Adverse Event|3
486883|NCT00082758|1576753|P3|Overall Study|Protocol Violation|0
486884|NCT00082758|1576754|P2|Overall Study|Protocol Violation|1
486885|NCT00082758|1576755|P1|Overall Study|Protocol Violation|0
486886|NCT00082758|1576753|P3|Overall Study|Withdrawal by Subject|0
486887|NCT00082758|1576754|P2|Overall Study|Withdrawal by Subject|0
486888|NCT00082758|1576755|P1|Overall Study|Withdrawal by Subject|3
486889|NCT00082758|1576753|P3|Overall Study|Physician Decision|0
486890|NCT00082758|1576754|P2|Overall Study|Physician Decision|1
486891|NCT00082758|1576755|P1|Overall Study|Physician Decision|0
486892|NCT00082758|1576753|P3|Overall Study|Lack of Efficacy|0
486893|NCT00082758|1576754|P2|Overall Study|Lack of Efficacy|13
486894|NCT00082758|1576755|P1|Overall Study|Lack of Efficacy|12
486895|NCT00082758|1576753|P3|Overall Study|Adverse Event|0
486896|NCT00082758|1576754|P2|Overall Study|Adverse Event|2
486897|NCT00082758|1576755|P1|Overall Study|Adverse Event|0
486898|NCT00083226|1576763|P1|Overall Study|ineligible or not receiving treatment|4
486899|NCT00083226|1576763|P1|Overall Study|Other|2
486900|NCT00083226|1576763|P1|Overall Study|Withdrawal by Subject|4
486901|NCT00083226|1576763|P1|Overall Study|Death|4
486902|NCT00083226|1576763|P1|Overall Study|Adverse Event|9
486903|NCT00083226|1576763|P1|Overall Study|Lack of Efficacy|19
486904|NCT00082433|1576807|P2|Overall Study|Impending surgery|1
486905|NCT00082433|1576808|P1|Overall Study|Impending surgery|0
486906|NCT00082433|1576807|P2|Overall Study|New primary cancer|0
486907|NCT00082433|1576808|P1|Overall Study|New primary cancer|1
486908|NCT00082433|1576807|P2|Overall Study|Noncompliance|1
486909|NCT00082433|1576808|P1|Overall Study|Noncompliance|2
486910|NCT00082433|1576807|P2|Overall Study|Ineligible|1
486911|NCT00082433|1576808|P1|Overall Study|Ineligible|2
486912|NCT00082433|1576807|P2|Overall Study|Not Treated|11
486913|NCT00082433|1576808|P1|Overall Study|Not Treated|12
486914|NCT00082433|1576807|P2|Overall Study|Still On Treatment|1
486915|NCT00082433|1576808|P1|Overall Study|Still On Treatment|2
486916|NCT00082433|1576807|P2|Overall Study|Withdrawal by Subject|30
486917|NCT00082433|1576808|P1|Overall Study|Withdrawal by Subject|55
486918|NCT00082433|1576807|P2|Overall Study|Study Drug Toxicity|66
486919|NCT00082433|1576808|P1|Overall Study|Study Drug Toxicity|179
486920|NCT00082433|1576807|P2|Overall Study|Lost to Follow-up|2
486921|NCT00082433|1576808|P1|Overall Study|Lost to Follow-up|1
486922|NCT00082433|1576807|P2|Overall Study|Physician Decision|61
486923|NCT00082433|1576808|P1|Overall Study|Physician Decision|50
486924|NCT00082433|1576807|P2|Overall Study|Disease Progression/Relapse|388
486925|NCT00082433|1576808|P1|Overall Study|Disease Progression/Relapse|270
486926|NCT00082433|1576807|P2|Overall Study|Death|18
486927|NCT00082433|1576808|P1|Overall Study|Death|8
486928|NCT00082433|1576807|P2|Overall Study|Adverse Event|17
486929|NCT00082433|1576808|P1|Overall Study|Adverse Event|12
486930|NCT00082381|1576828|P2|Overall Study|Loss of Glucose Control|0
486931|NCT00082381|1576829|P1|Overall Study|Loss of Glucose Control|4
486932|NCT00082381|1576828|P2|Overall Study|Protocol Violation|11
486933|NCT00082381|1576829|P1|Overall Study|Protocol Violation|10
486934|NCT00082381|1576828|P2|Overall Study|Physician Decision|2
486935|NCT00082381|1576829|P1|Overall Study|Physician Decision|1
486936|NCT00082381|1576828|P2|Overall Study|Patient Decision|4
486937|NCT00082381|1576829|P1|Overall Study|Patient Decision|8
486938|NCT00082381|1576828|P2|Overall Study|Lost to Follow-up|7
486939|NCT00082381|1576829|P1|Overall Study|Lost to Follow-up|5
486940|NCT00082381|1576828|P2|Overall Study|Adverse Event|2
486941|NCT00082381|1576829|P1|Overall Study|Adverse Event|27
486942|NCT00082407|1576849|P2|Overall Study|Lost to Follow-up|3
486943|NCT00082407|1576850|P1|Overall Study|Lost to Follow-up|0
486944|NCT00082407|1576849|P2|Overall Study|Death|1
486945|NCT00082407|1576850|P1|Overall Study|Death|2
486946|NCT00082407|1576849|P2|Overall Study|Loss of Glucose Control|2
486947|NCT00082407|1576850|P1|Overall Study|Loss of Glucose Control|2
486948|NCT00082407|1576849|P2|Overall Study|Physician Decision|3
486949|NCT00082407|1576850|P1|Overall Study|Physician Decision|5
486950|NCT00082407|1576849|P2|Overall Study|Patient Decision|6
486951|NCT00082407|1576850|P1|Overall Study|Patient Decision|13
486952|NCT00082407|1576849|P2|Overall Study|Protocol Violation|12
486953|NCT00082407|1576850|P1|Overall Study|Protocol Violation|14
486954|NCT00082407|1576849|P2|Overall Study|Adverse Event|0
486955|NCT00082407|1576850|P1|Overall Study|Adverse Event|20
486956|NCT00082368|1576868|P1|Overall Study|Not treated-pt had poor IV access|1
486957|NCT00082355|1576873|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
486958|NCT00082355|1576873|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
486959|NCT00082355|1576873|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
486960|NCT00082173|1576907|P2|Overall Study|Culture negative or resistant at baselin|6
486961|NCT00082173|1576908|P1|Overall Study|Culture negative or resistant at baselin|5
486962|NCT00082173|1576907|P2|Overall Study|Adverse Event|0
486963|NCT00082173|1576908|P1|Overall Study|Adverse Event|1
486964|NCT00082173|1576907|P2|Overall Study|Lost to Follow-up|0
486965|NCT00082173|1576908|P1|Overall Study|Lost to Follow-up|1
486966|NCT00082173|1576907|P2|Overall Study|Withdrawal by Subject|5
486967|NCT00082173|1576908|P1|Overall Study|Withdrawal by Subject|3
486968|NCT00081770|1576948|P3|Overall Study|Not Specified|8
486969|NCT00081770|1576949|P2|Overall Study|Not Specified|7
486970|NCT00081770|1576950|P1|Overall Study|Not Specified|2
486971|NCT00081770|1576948|P3|Overall Study|Administrative|1
486972|NCT00081770|1576949|P2|Overall Study|Administrative|0
486973|NCT00081770|1576950|P1|Overall Study|Administrative|1
486974|NCT00081770|1576948|P3|Overall Study|Did not meet protocol eligibility|3
486975|NCT00081770|1576949|P2|Overall Study|Did not meet protocol eligibility|0
486976|NCT00081770|1576950|P1|Overall Study|Did not meet protocol eligibility|2
486977|NCT00081770|1576948|P3|Overall Study|Withdrawal by Subject|42
486978|NCT00081770|1576949|P2|Overall Study|Withdrawal by Subject|40
486979|NCT00081770|1576950|P1|Overall Study|Withdrawal by Subject|45
486980|NCT00081770|1576948|P3|Overall Study|Protocol Violation|10
486981|NCT00081770|1576949|P2|Overall Study|Protocol Violation|10
486982|NCT00081770|1576950|P1|Overall Study|Protocol Violation|15
486983|NCT00081770|1576948|P3|Overall Study|Lost to Follow-up|45
486984|NCT00081770|1576949|P2|Overall Study|Lost to Follow-up|34
486985|NCT00081770|1576950|P1|Overall Study|Lost to Follow-up|45
486986|NCT00081770|1576948|P3|Overall Study|Lack of Efficacy|211
486987|NCT00081770|1576949|P2|Overall Study|Lack of Efficacy|357
486988|NCT00081770|1576950|P1|Overall Study|Lack of Efficacy|262
486989|NCT00081770|1576948|P3|Overall Study|Adverse Event|136
486990|NCT00081770|1576949|P2|Overall Study|Adverse Event|98
486991|NCT00081770|1576950|P1|Overall Study|Adverse Event|130
486992|NCT00081731|1576969|P2|Overall Study|scientific integrity issue|8
486993|NCT00081731|1576970|P1|Overall Study|scientific integrity issue|8
486994|NCT00081653|1576990|P2|Overall Study|Loss of bone mass|2
486995|NCT00081653|1576991|P1|Overall Study|Loss of bone mass|0
486996|NCT00081653|1576990|P2|Overall Study|Participant leaving country|0
486997|NCT00081653|1576991|P1|Overall Study|Participant leaving country|1
486998|NCT00081653|1576990|P2|Overall Study|Bone loss|0
486999|NCT00081653|1576991|P1|Overall Study|Bone loss|2
487000|NCT00081653|1576990|P2|Overall Study|Low bone mineral density|0
487001|NCT00081653|1576991|P1|Overall Study|Low bone mineral density|1
487002|NCT00081653|1576990|P2|Overall Study|Refused Treatment|14
487003|NCT00081653|1576991|P1|Overall Study|Refused Treatment|18
487004|NCT00081653|1576990|P2|Overall Study|Lost to Follow-up|4
487005|NCT00081653|1576991|P1|Overall Study|Lost to Follow-up|2
487006|NCT00081653|1576990|P2|Overall Study|Adverse Event|17
487007|NCT00081653|1576991|P1|Overall Study|Adverse Event|23
487008|NCT00081497|1577009|P2|Overall Study|Non-compliance|1
487009|NCT00081497|1577010|P1|Overall Study|Non-compliance|0
487010|NCT00081497|1577009|P2|Overall Study|Withdrawal by Subject|0
487011|NCT00081497|1577010|P1|Overall Study|Withdrawal by Subject|1
487012|NCT00081497|1577009|P2|Overall Study|Death|1
487013|NCT00081497|1577010|P1|Overall Study|Death|0
487014|NCT00081497|1577009|P2|Overall Study|Adverse Event|0
487015|NCT00081497|1577010|P1|Overall Study|Adverse Event|2
487016|NCT00081458|1577028|P3|Overall Study|Randomized but not dosed|1
487017|NCT00081458|1577029|P2|Overall Study|Randomized but not dosed|0
487018|NCT00081458|1577030|P1|Overall Study|Randomized but not dosed|0
487019|NCT00081458|1577028|P3|Overall Study|Withdrawal by Subject|1
487020|NCT00081458|1577029|P2|Overall Study|Withdrawal by Subject|3
487021|NCT00081458|1577030|P1|Overall Study|Withdrawal by Subject|0
487022|NCT00081458|1577028|P3|Overall Study|Adverse Event|2
487023|NCT00081458|1577029|P2|Overall Study|Adverse Event|5
487024|NCT00081458|1577030|P1|Overall Study|Adverse Event|1
487025|NCT00081289|1577086|P2|Overall Study|Ineligible / no protocol treatment|4
487026|NCT00081289|1577087|P1|Overall Study|Ineligible / no protocol treatment|3
487027|NCT00081289|1577086|P2|Overall Study|Accrued prior to chemotherapy amendment|17
487028|NCT00081289|1577087|P1|Overall Study|Accrued prior to chemotherapy amendment|18
487029|NCT00081263|1577095|P2|Overall Study|Inadequate data|10
487030|NCT00081263|1577096|P1|Overall Study|Inadequate data|5
487031|NCT00081263|1577095|P2|Overall Study|Never treated|5
487032|NCT00081263|1577096|P1|Overall Study|Never treated|4
487033|NCT00081263|1577095|P2|Overall Study|Inadequate pathology|1
487034|NCT00081263|1577096|P1|Overall Study|Inadequate pathology|0
487035|NCT00081263|1577095|P2|Overall Study|improper pre-protocol therapy|1
487036|NCT00081263|1577096|P1|Overall Study|improper pre-protocol therapy|0
487037|NCT00081263|1577095|P2|Overall Study|wrong cell type|5
487038|NCT00081263|1577096|P1|Overall Study|wrong cell type|7
487039|NCT00081263|1577095|P2|Overall Study|clerical error|0
487040|NCT00081263|1577096|P1|Overall Study|clerical error|1
487041|NCT00081159|1577106|P2|Overall Study|Lost to Follow-up|1
487042|NCT00081159|1577107|P1|Overall Study|Lost to Follow-up|2
487043|NCT00081159|1577106|P2|Overall Study|Myelosuppression prior to treatment|1
487044|NCT00081159|1577107|P1|Overall Study|Myelosuppression prior to treatment|0
487045|NCT00081159|1577106|P2|Overall Study|Withdrawal by Subject|3
487046|NCT00081159|1577107|P1|Overall Study|Withdrawal by Subject|0
487047|NCT00080938|1577117|P1|Overall Study|Ineligible|4
487048|NCT00080938|1577117|P1|Overall Study|Not started protocol therapy|1
487049|NCT00080938|1577117|P1|Overall Study|other disease|1
487050|NCT00080938|1577117|P1|Overall Study|Lack of Efficacy|7
487051|NCT00080938|1577117|P1|Overall Study|Death|2
487052|NCT00080938|1577117|P1|Overall Study|Withdrawal by Subject|6
487053|NCT00080938|1577117|P1|Overall Study|Adverse Event|3
487054|NCT00080899|1577133|P1|Overall Study|Adverse Event|1
487055|NCT00080483|1577145|P2|Overall Study|Physician Decision|1
487056|NCT00080483|1577146|P1|Overall Study|Physician Decision|1
487057|NCT00080483|1577145|P2|Overall Study|Lost to Follow-up|1
487058|NCT00080483|1577146|P1|Overall Study|Lost to Follow-up|1
487059|NCT00002525|1577154|P2|Overall Study|Never start protocol therapy|0
487060|NCT00002525|1577155|P1|Overall Study|Never start protocol therapy|8
487061|NCT00002525|1577154|P2|Overall Study|Other|0
487062|NCT00002525|1577155|P1|Overall Study|Other|26
487063|NCT00002525|1577154|P2|Overall Study|Error|0
487064|NCT00002525|1577155|P1|Overall Study|Error|6
487065|NCT00002525|1577154|P2|Overall Study|Duke's A, B1, D disease|0
487066|NCT00002525|1577155|P1|Overall Study|Duke's A, B1, D disease|92
487067|NCT00002525|1577154|P2|Overall Study|Other complicating disease|0
487068|NCT00002525|1577155|P1|Overall Study|Other complicating disease|1
487069|NCT00002525|1577154|P2|Overall Study|Start non-protocol therapy|0
487070|NCT00002525|1577155|P1|Overall Study|Start non-protocol therapy|1
487071|NCT00002525|1577154|P2|Overall Study|Withdrawal by Subject|0
487072|NCT00002525|1577155|P1|Overall Study|Withdrawal by Subject|11
487073|NCT00002525|1577154|P2|Overall Study|Death|0
487074|NCT00002525|1577155|P1|Overall Study|Death|5
487075|NCT00002525|1577154|P2|Overall Study|Adverse Event|0
487076|NCT00002525|1577155|P1|Overall Study|Adverse Event|36
487077|NCT00080301|1577182|P2|Overall Study|Still on Treatment as of CSR date|1
487078|NCT00080301|1577183|P1|Overall Study|Still on Treatment as of CSR date|0
487079|NCT00080301|1577182|P2|Overall Study|Randomized but Never Treated|10
487080|NCT00080301|1577183|P1|Overall Study|Randomized but Never Treated|5
487081|NCT00080288|1577203|P2|Overall Study|Miscellaneous|11
487082|NCT00080288|1577204|P1|Overall Study|Miscellaneous|11
487083|NCT00080288|1577203|P2|Overall Study|Withdrawal by Subject|16
487084|NCT00080288|1577204|P1|Overall Study|Withdrawal by Subject|3
487085|NCT00080288|1577203|P2|Overall Study|Physician Decision|2
487086|NCT00080288|1577204|P1|Overall Study|Physician Decision|6
487087|NCT00080288|1577203|P2|Overall Study|Lost to Follow-up|5
487088|NCT00080288|1577204|P1|Overall Study|Lost to Follow-up|3
487089|NCT00080288|1577203|P2|Overall Study|Adverse Event|4
487090|NCT00080288|1577204|P1|Overall Study|Adverse Event|7
487091|NCT00080223|1577212|P1|Overall Study|Physician Decision|1
487092|NCT00080223|1577212|P1|Overall Study|Participant unwilling to continue|2
487093|NCT00080223|1577212|P1|Overall Study|Non-compliance With Study Treatment|7
487094|NCT00080223|1577212|P1|Overall Study|Lung Transplantation|9
487095|NCT00080223|1577212|P1|Overall Study|Withdrawal by Subject|13
487096|NCT00080223|1577212|P1|Overall Study|Death|21
487097|NCT00080223|1577212|P1|Overall Study|Adverse Event|23
487098|NCT00002540|1577222|P2|Overall Study|Refused Screen (Prostate Screening)|2433
487099|NCT00002540|1577223|P1|Overall Study|Refused Screen (Prostate Screening)|0
487100|NCT00002540|1577222|P2|Overall Study|Refused ASU (Control)|0
487101|NCT00002540|1577223|P1|Overall Study|Refused ASU (Control)|597
487102|NCT00002540|1577222|P2|Overall Study|Died Before ASU (Control)|0
487103|NCT00002540|1577223|P1|Overall Study|Died Before ASU (Control)|202
487104|NCT00002540|1577222|P2|Overall Study|Died Before Randomization|6
487105|NCT00002540|1577223|P1|Overall Study|Died Before Randomization|2
487106|NCT00002540|1577222|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
487107|NCT00002540|1577223|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
487108|NCT00080119|1577253|P4|Overall Study|Lost to Follow-up|14
487109|NCT00080119|1577254|P3|Overall Study|Lost to Follow-up|19
487110|NCT00080119|1577255|P2|Overall Study|Lost to Follow-up|19
487111|NCT00080119|1577256|P1|Overall Study|Lost to Follow-up|16
487112|NCT00080119|1577253|P4|Overall Study|Unwilling to adhere to study requirement|1
487113|NCT00080119|1577254|P3|Overall Study|Unwilling to adhere to study requirement|5
487114|NCT00080119|1577255|P2|Overall Study|Unwilling to adhere to study requirement|2
487115|NCT00080119|1577256|P1|Overall Study|Unwilling to adhere to study requirement|3
487116|NCT00080119|1577253|P4|Overall Study|Consent withdrawn|6
487117|NCT00080119|1577254|P3|Overall Study|Consent withdrawn|4
487118|NCT00080119|1577255|P2|Overall Study|Consent withdrawn|17
487119|NCT00080119|1577256|P1|Overall Study|Consent withdrawn|13
487120|NCT00080119|1577253|P4|Overall Study|Unable to get to clinic|1
487121|NCT00080119|1577254|P3|Overall Study|Unable to get to clinic|7
487122|NCT00080119|1577255|P2|Overall Study|Unable to get to clinic|24
487123|NCT00080119|1577256|P1|Overall Study|Unable to get to clinic|24
487124|NCT00080119|1577253|P4|Overall Study|Discontinued because of study closure|141
487125|NCT00080119|1577254|P3|Overall Study|Discontinued because of study closure|130
487126|NCT00080119|1577255|P2|Overall Study|Discontinued because of study closure|0
487127|NCT00080119|1577256|P1|Overall Study|Discontinued because of study closure|0
487128|NCT00079937|1577290|P2|Overall Study|Administrative problems|11
487129|NCT00079937|1577291|P1|Overall Study|Administrative problems|22
487130|NCT00079937|1577290|P2|Overall Study|Lost to Follow-up|5
487131|NCT00079937|1577291|P1|Overall Study|Lost to Follow-up|12
487132|NCT00079937|1577290|P2|Overall Study|Withdrawal by Subject|7
487133|NCT00079937|1577291|P1|Overall Study|Withdrawal by Subject|21
487134|NCT00079937|1577290|P2|Overall Study|Protocol Violation|6
487135|NCT00079937|1577291|P1|Overall Study|Protocol Violation|8
487136|NCT00079937|1577290|P2|Overall Study|Subject no longer requires study drug|0
487137|NCT00079937|1577291|P1|Overall Study|Subject no longer requires study drug|3
487138|NCT00079937|1577290|P2|Overall Study|Unsatisfactory therapeutic effect|2
487139|NCT00079937|1577291|P1|Overall Study|Unsatisfactory therapeutic effect|1
487140|NCT00079937|1577290|P2|Overall Study|Adverse Event|1
487141|NCT00079937|1577291|P1|Overall Study|Adverse Event|2
487142|NCT00009737|1577309|P2|Overall Study|Administrative/Other Reasons|1
487143|NCT00009737|1577310|P1|Overall Study|Administrative/Other Reasons|7
487144|NCT00009737|1577309|P2|Overall Study|Lost to Follow-up|1
487145|NCT00009737|1577310|P1|Overall Study|Lost to Follow-up|1
487146|NCT00009737|1577309|P2|Overall Study|Refused Treatment|16
487147|NCT00009737|1577310|P1|Overall Study|Refused Treatment|15
487148|NCT00009737|1577309|P2|Overall Study|Other Protocol Violation|0
487149|NCT00009737|1577310|P1|Overall Study|Other Protocol Violation|1
487150|NCT00009737|1577309|P2|Overall Study|Violation of Selection Criteria at Entry|9
487151|NCT00009737|1577310|P1|Overall Study|Violation of Selection Criteria at Entry|13
487152|NCT00009737|1577309|P2|Overall Study|Lack of Efficacy|15
487153|NCT00009737|1577310|P1|Overall Study|Lack of Efficacy|17
487154|NCT00009737|1577309|P2|Overall Study|Death|6
487155|NCT00009737|1577310|P1|Overall Study|Death|4
487156|NCT00009737|1577309|P2|Overall Study|Adverse Event|75
487157|NCT00009737|1577310|P1|Overall Study|Adverse Event|112
487158|NCT00079781|1577329|P3|Follow-up Period|Death|1
487159|NCT00079781|1577330|P2|Follow-up Period|Death|0
487160|NCT00079781|1577331|P1|Follow-up Period|Death|0
487161|NCT00079781|1577329|P3|Follow-up Period|Lost to Follow-up|0
487162|NCT00079781|1577330|P2|Follow-up Period|Lost to Follow-up|0
487163|NCT00079781|1577331|P1|Follow-up Period|Lost to Follow-up|1
487164|NCT00079781|1577329|P3|Follow-up Period|Withdrawal by Subject|1
487165|NCT00079781|1577330|P2|Follow-up Period|Withdrawal by Subject|0
487166|NCT00079781|1577331|P1|Follow-up Period|Withdrawal by Subject|3
487167|NCT00079781|1577329|P3|Pre-implant Period|Did not meet I/E criteria|1
487168|NCT00079781|1577330|P2|Pre-implant Period|Did not meet I/E criteria|1
487169|NCT00079781|1577331|P1|Pre-implant Period|Did not meet I/E criteria|1
487170|NCT00079781|1577329|P3|Pre-implant Period|Withdrawal by Subject|0
487171|NCT00079781|1577330|P2|Pre-implant Period|Withdrawal by Subject|0
487172|NCT00079781|1577331|P1|Pre-implant Period|Withdrawal by Subject|2
487173|NCT00079677|1577340|P2|Overall Study|Miscellaneous|0
487174|NCT00079677|1577341|P1|Overall Study|Miscellaneous|2
487175|NCT00079677|1577340|P2|Overall Study|Withdrawal by Subject|3
487176|NCT00079677|1577341|P1|Overall Study|Withdrawal by Subject|5
487177|NCT00079677|1577340|P2|Overall Study|Protocol Violation|3
487178|NCT00079677|1577341|P1|Overall Study|Protocol Violation|2
487179|NCT00079677|1577340|P2|Overall Study|Physician Decision|0
487180|NCT00079677|1577341|P1|Overall Study|Physician Decision|3
487181|NCT00079677|1577340|P2|Overall Study|Lost to Follow-up|2
487182|NCT00079677|1577341|P1|Overall Study|Lost to Follow-up|2
487183|NCT00079677|1577340|P2|Overall Study|Lack of Efficacy|0
487184|NCT00079677|1577341|P1|Overall Study|Lack of Efficacy|1
487185|NCT00079677|1577340|P2|Overall Study|Adverse Event|6
487186|NCT00079677|1577341|P1|Overall Study|Adverse Event|5
487187|NCT00079417|1577357|P1|Overall Study|ineligible|1
487188|NCT00079417|1577357|P1|Overall Study|Tumor requires non-protocol radiotherapy|2
487189|NCT00079417|1577357|P1|Overall Study|Tumor requires non-protocol chemotherapy|1
487190|NCT00079417|1577357|P1|Overall Study|Physician Decision|5
487191|NCT00079391|1577361|P1|Overall Study|Withdrawal by Subject|1
487192|NCT00079339|1577373|P3|Overall Study|Disease progression|2
487193|NCT00079339|1577374|P2|Overall Study|Disease progression|28
487194|NCT00079339|1577375|P1|Overall Study|Disease progression|3
487195|NCT00079339|1577373|P3|Overall Study|Withdrawal by Subject|1
487196|NCT00079339|1577374|P2|Overall Study|Withdrawal by Subject|4
487197|NCT00079339|1577375|P1|Overall Study|Withdrawal by Subject|0
487198|NCT00079339|1577373|P3|Overall Study|Non-compliance|1
487199|NCT00079339|1577374|P2|Overall Study|Non-compliance|0
487200|NCT00079339|1577375|P1|Overall Study|Non-compliance|0
487201|NCT00079339|1577373|P3|Overall Study|Death|0
487202|NCT00079339|1577374|P2|Overall Study|Death|0
487203|NCT00079339|1577375|P1|Overall Study|Death|1
487204|NCT00079339|1577373|P3|Overall Study|Adverse Event|2
487205|NCT00079339|1577374|P2|Overall Study|Adverse Event|7
487206|NCT00079339|1577375|P1|Overall Study|Adverse Event|1
487207|NCT00079274|1577406|P7|Overall Study|Not Specified|0
487208|NCT00079274|1577407|P6|Overall Study|Not Specified|2
487209|NCT00079274|1577408|P5|Overall Study|Not Specified|1
487210|NCT00079274|1577409|P4|Overall Study|Not Specified|55
487211|NCT00079274|1577410|P3|Overall Study|Not Specified|5
487212|NCT00079274|1577411|P2|Overall Study|Not Specified|7
487213|NCT00079274|1577412|P1|Overall Study|Not Specified|43
487214|NCT00079274|1577406|P7|Overall Study|Cytogenetic resistance|0
487215|NCT00079274|1577407|P6|Overall Study|Cytogenetic resistance|0
487216|NCT00079274|1577408|P5|Overall Study|Cytogenetic resistance|0
487217|NCT00079274|1577409|P4|Overall Study|Cytogenetic resistance|2
487218|NCT00079274|1577410|P3|Overall Study|Cytogenetic resistance|0
487219|NCT00079274|1577411|P2|Overall Study|Cytogenetic resistance|0
487220|NCT00079274|1577412|P1|Overall Study|Cytogenetic resistance|0
487221|NCT00079274|1577406|P7|Overall Study|Death|0
487222|NCT00079274|1577407|P6|Overall Study|Death|0
487223|NCT00079274|1577408|P5|Overall Study|Death|0
487224|NCT00079274|1577409|P4|Overall Study|Death|15
487225|NCT00079274|1577410|P3|Overall Study|Death|1
487226|NCT00079274|1577411|P2|Overall Study|Death|0
487227|NCT00079274|1577412|P1|Overall Study|Death|4
487228|NCT00079274|1577406|P7|Overall Study|Other Medical Problems|0
487229|NCT00079274|1577407|P6|Overall Study|Other Medical Problems|0
487230|NCT00079274|1577408|P5|Overall Study|Other Medical Problems|0
487231|NCT00079274|1577409|P4|Overall Study|Other Medical Problems|7
487232|NCT00079274|1577410|P3|Overall Study|Other Medical Problems|0
487233|NCT00079274|1577411|P2|Overall Study|Other Medical Problems|1
487234|NCT00079274|1577412|P1|Overall Study|Other Medical Problems|6
487235|NCT00079274|1577406|P7|Overall Study|Alternate Treatment|0
487236|NCT00079274|1577407|P6|Overall Study|Alternate Treatment|0
487237|NCT00079274|1577408|P5|Overall Study|Alternate Treatment|0
487238|NCT00079274|1577409|P4|Overall Study|Alternate Treatment|3
487239|NCT00079274|1577410|P3|Overall Study|Alternate Treatment|0
487240|NCT00079274|1577411|P2|Overall Study|Alternate Treatment|1
487241|NCT00079274|1577412|P1|Overall Study|Alternate Treatment|6
487242|NCT00079274|1577406|P7|Overall Study|Recurrence|0
487243|NCT00079274|1577407|P6|Overall Study|Recurrence|2
487244|NCT00079274|1577408|P5|Overall Study|Recurrence|0
487245|NCT00079274|1577409|P4|Overall Study|Recurrence|15
487246|NCT00079274|1577410|P3|Overall Study|Recurrence|1
487247|NCT00079274|1577411|P2|Overall Study|Recurrence|0
487248|NCT00079274|1577412|P1|Overall Study|Recurrence|21
487249|NCT00079274|1577406|P7|Overall Study|Adverse Event|0
487250|NCT00079274|1577407|P6|Overall Study|Adverse Event|8
487251|NCT00079274|1577408|P5|Overall Study|Adverse Event|7
487252|NCT00079274|1577409|P4|Overall Study|Adverse Event|184
487253|NCT00079274|1577410|P3|Overall Study|Adverse Event|8
487254|NCT00079274|1577411|P2|Overall Study|Adverse Event|8
487255|NCT00079274|1577412|P1|Overall Study|Adverse Event|130
487256|NCT00079274|1577406|P7|Overall Study|Withdrawal by Subject|0
487257|NCT00079274|1577407|P6|Overall Study|Withdrawal by Subject|8
487258|NCT00079274|1577408|P5|Overall Study|Withdrawal by Subject|7
487259|NCT00079274|1577409|P4|Overall Study|Withdrawal by Subject|163
487260|NCT00079274|1577410|P3|Overall Study|Withdrawal by Subject|12
487261|NCT00079274|1577411|P2|Overall Study|Withdrawal by Subject|10
487262|NCT00079274|1577412|P1|Overall Study|Withdrawal by Subject|111
487263|NCT00079183|1577425|P1|Overall Study|Specimen collection non-compliance|1
487264|NCT00079183|1577425|P1|Overall Study|Study medication non-compliance|2
487265|NCT00079183|1577425|P1|Overall Study|Withdrawal by Subject|4
487266|NCT00079040|1577440|P1|Overall Study|Ineligible|1
487267|NCT00079040|1577440|P1|Overall Study|Withdrew before treatment|1
487268|NCT00078949|1577463|P4|Maintenance|No treated|3
487269|NCT00078949|1577464|P3|Maintenance|No treated|3
487270|NCT00078949|1577465|P2|Maintenance|No treated|0
487271|NCT00078949|1577466|P1|Maintenance|No treated|0
487272|NCT00078949|1577463|P4|Salvage|No treated|0
487273|NCT00078949|1577464|P3|Salvage|No treated|0
487274|NCT00078949|1577465|P2|Salvage|No treated|5
487275|NCT00078949|1577466|P1|Salvage|No treated|4
487276|NCT00078767|1577480|P2|Overall Study|Withdrawal by Subject|1
487277|NCT00078767|1577481|P1|Overall Study|Withdrawal by Subject|1
487278|NCT00005947|1577528|P2|Overall Study|Site Closure|0
487279|NCT00005947|1577529|P1|Overall Study|Site Closure|1
487280|NCT00005947|1577528|P2|Overall Study|Patient Refused to Continue|1
487281|NCT00005947|1577529|P1|Overall Study|Patient Refused to Continue|2
487282|NCT00005947|1577528|P2|Overall Study|Death|40
487283|NCT00005947|1577529|P1|Overall Study|Death|54
487284|NCT00002597|1577565|P2|Overall Study|Withdrawal by Subject|6
487285|NCT00002597|1577566|P1|Overall Study|Withdrawal by Subject|7
487286|NCT00002597|1577565|P2|Overall Study|Protocol Violation|17
487287|NCT00002597|1577566|P1|Overall Study|Protocol Violation|19
487288|NCT00078377|1577591|P3|Overall Study|Miscellaneous|1
487289|NCT00078377|1577592|P2|Overall Study|Miscellaneous|6
487290|NCT00078377|1577593|P1|Overall Study|Miscellaneous|2
487291|NCT00078377|1577591|P3|Overall Study|Withdrawal by Subject|4
487292|NCT00078377|1577592|P2|Overall Study|Withdrawal by Subject|4
487293|NCT00078377|1577593|P1|Overall Study|Withdrawal by Subject|3
487294|NCT00078377|1577591|P3|Overall Study|Physician Decision|0
487295|NCT00078377|1577592|P2|Overall Study|Physician Decision|0
487296|NCT00078377|1577593|P1|Overall Study|Physician Decision|2
487297|NCT00078377|1577591|P3|Overall Study|Lost to Follow-up|1
487298|NCT00078377|1577592|P2|Overall Study|Lost to Follow-up|1
487299|NCT00078377|1577593|P1|Overall Study|Lost to Follow-up|0
487300|NCT00078377|1577591|P3|Overall Study|Lack of Efficacy|2
487301|NCT00078377|1577592|P2|Overall Study|Lack of Efficacy|0
487302|NCT00078377|1577593|P1|Overall Study|Lack of Efficacy|2
487303|NCT00078377|1577591|P3|Overall Study|Adverse Event|1
487304|NCT00078377|1577592|P2|Overall Study|Adverse Event|5
487305|NCT00078377|1577593|P1|Overall Study|Adverse Event|2
487306|NCT00078338|1577608|P2|Overall Study|Subjects randomized, but not treated|3
487307|NCT00078338|1577609|P1|Overall Study|Subjects randomized, but not treated|3
487308|NCT00078338|1577608|P2|Overall Study|Other|16
487309|NCT00078338|1577609|P1|Overall Study|Other|28
487310|NCT00078338|1577608|P2|Overall Study|Disease Progression|7
487311|NCT00078338|1577609|P1|Overall Study|Disease Progression|4
487312|NCT00078338|1577608|P2|Overall Study|Protocol Violation|2
487313|NCT00078338|1577609|P1|Overall Study|Protocol Violation|2
487314|NCT00078338|1577608|P2|Overall Study|Lost to Follow-up|2
487315|NCT00078338|1577609|P1|Overall Study|Lost to Follow-up|17
487316|NCT00078338|1577608|P2|Overall Study|Adverse Event|24
487317|NCT00078338|1577609|P1|Overall Study|Adverse Event|31
487318|NCT00078325|1577702|P3|Overall Study|Miscellaneous|1
487319|NCT00078325|1577703|P2|Overall Study|Miscellaneous|1
487320|NCT00078325|1577704|P1|Overall Study|Miscellaneous|1
487321|NCT00078325|1577702|P3|Overall Study|Physician Decision|1
487322|NCT00078325|1577703|P2|Overall Study|Physician Decision|0
487323|NCT00078325|1577704|P1|Overall Study|Physician Decision|2
487324|NCT00078325|1577702|P3|Overall Study|Lost to Follow-up|1
487325|NCT00078325|1577703|P2|Overall Study|Lost to Follow-up|1
487326|NCT00078325|1577704|P1|Overall Study|Lost to Follow-up|0
487327|NCT00078325|1577702|P3|Overall Study|Withdrawal by Subject|3
487328|NCT00078325|1577703|P2|Overall Study|Withdrawal by Subject|5
487329|NCT00078325|1577704|P1|Overall Study|Withdrawal by Subject|1
487330|NCT00078325|1577702|P3|Overall Study|Protocol Violation|0
487331|NCT00078325|1577703|P2|Overall Study|Protocol Violation|2
487332|NCT00078325|1577704|P1|Overall Study|Protocol Violation|2
487333|NCT00078325|1577702|P3|Overall Study|Adverse Event|5
487334|NCT00078325|1577703|P2|Overall Study|Adverse Event|10
487335|NCT00078325|1577704|P1|Overall Study|Adverse Event|15
487336|NCT00078312|1577715|P1|Overall Study|Miscellaneous|33
487337|NCT00078312|1577715|P1|Overall Study|Withdrawal by Subject|33
487338|NCT00078312|1577715|P1|Overall Study|Protocol Violation|3
487339|NCT00078312|1577715|P1|Overall Study|Physician Decision|9
487340|NCT00078312|1577715|P1|Overall Study|Lost to Follow-up|41
487341|NCT00078312|1577715|P1|Overall Study|Lack of Efficacy|15
487342|NCT00078312|1577715|P1|Overall Study|Adverse Event|43
487343|NCT00077974|1577730|P1|Overall Study|Decision of Sponsor|2
487344|NCT00077974|1577730|P1|Overall Study|Lack of Efficacy|76
487345|NCT00077974|1577730|P1|Overall Study|Withdrawal by Subject|3
487346|NCT00077974|1577730|P1|Overall Study|Protocol Violation|1
487347|NCT00077974|1577730|P1|Overall Study|Adverse Event|22
487348|NCT00077857|1577747|P2|Overall Study|Other|13
487349|NCT00077857|1577748|P1|Overall Study|Other|15
487350|NCT00077857|1577747|P2|Overall Study|Failure to return|5
487351|NCT00077857|1577748|P1|Overall Study|Failure to return|5
487352|NCT00077857|1577747|P2|Overall Study|Refused treatment|21
487353|NCT00077857|1577748|P1|Overall Study|Refused treatment|29
487354|NCT00077857|1577747|P2|Overall Study|Other protocol violation|1
487355|NCT00077857|1577748|P1|Overall Study|Other protocol violation|0
487356|NCT00077857|1577747|P2|Overall Study|Violation of selection criteria at entry|1
487357|NCT00077857|1577748|P1|Overall Study|Violation of selection criteria at entry|3
487358|NCT00077857|1577747|P2|Overall Study|Insufficient therapeutic response|128
487359|NCT00077857|1577748|P1|Overall Study|Insufficient therapeutic response|112
487360|NCT00077857|1577747|P2|Overall Study|Death|3
487361|NCT00077857|1577748|P1|Overall Study|Death|7
487362|NCT00077857|1577747|P2|Overall Study|Adverse Event|32
487363|NCT00077857|1577748|P1|Overall Study|Adverse Event|30
487364|NCT00077766|1577768|P2|Overall Study|Participants Vacation|1
487365|NCT00077766|1577769|P1|Overall Study|Participants Vacation|2
487366|NCT00077766|1577768|P2|Overall Study|Stop Dialysis|1
487367|NCT00077766|1577769|P1|Overall Study|Stop Dialysis|0
487368|NCT00077766|1577768|P2|Overall Study|Started Nocturnal Dialysis|1
487369|NCT00077766|1577769|P1|Overall Study|Started Nocturnal Dialysis|0
487370|NCT00077766|1577768|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
487371|NCT00077766|1577769|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
487372|NCT00077766|1577768|P2|Overall Study|Dialysis|1
487373|NCT00077766|1577769|P1|Overall Study|Dialysis|0
487374|NCT00077766|1577768|P2|Overall Study|Dialysis Discontinued|0
487375|NCT00077766|1577769|P1|Overall Study|Dialysis Discontinued|1
487376|NCT00077766|1577768|P2|Overall Study|Participant's decision|0
487377|NCT00077766|1577769|P1|Overall Study|Participant's decision|1
487378|NCT00077766|1577768|P2|Overall Study|Investigators Discretion|0
487379|NCT00077766|1577769|P1|Overall Study|Investigators Discretion|1
487380|NCT00077766|1577768|P2|Overall Study|Transplantation|1
487381|NCT00077766|1577769|P1|Overall Study|Transplantation|5
487382|NCT00077766|1577768|P2|Overall Study|Kidney Transplantation|5
487383|NCT00077766|1577769|P1|Overall Study|Kidney Transplantation|9
487384|NCT00077766|1577768|P2|Overall Study|Protocol Violation|0
487385|NCT00077766|1577769|P1|Overall Study|Protocol Violation|1
487386|NCT00077766|1577768|P2|Overall Study|Lost to Follow-up|0
487387|NCT00077766|1577769|P1|Overall Study|Lost to Follow-up|2
487388|NCT00077766|1577768|P2|Overall Study|Death|10
487389|NCT00077766|1577769|P1|Overall Study|Death|12
487390|NCT00077766|1577768|P2|Overall Study|Withdrawal by Subject|3
487391|NCT00077766|1577769|P1|Overall Study|Withdrawal by Subject|4
487392|NCT00077766|1577768|P2|Overall Study|Adverse Event|1
487393|NCT00077766|1577769|P1|Overall Study|Adverse Event|1
487394|NCT00077675|1577794|P2|Overall Study|Never received study treatment|3
487395|NCT00077675|1577795|P1|Overall Study|Never received study treatment|3
487396|NCT00077675|1577794|P2|Overall Study|Other|1
487397|NCT00077675|1577795|P1|Overall Study|Other|0
487398|NCT00077675|1577794|P2|Overall Study|Withdrawal by Subject|0
487399|NCT00077675|1577795|P1|Overall Study|Withdrawal by Subject|1
487400|NCT00077675|1577794|P2|Overall Study|Lost to Follow-up|3
487401|NCT00077675|1577795|P1|Overall Study|Lost to Follow-up|6
487402|NCT00077675|1577794|P2|Overall Study|Adverse Event|2
487403|NCT00077675|1577795|P1|Overall Study|Adverse Event|1
487404|NCT00077649|1577805|P4|Overall Study|Randomized but never dosed|0
487405|NCT00077649|1577806|P3|Overall Study|Randomized but never dosed|0
487406|NCT00077649|1577807|P2|Overall Study|Randomized but never dosed|0
487407|NCT00077649|1577808|P1|Overall Study|Randomized but never dosed|1
487408|NCT00077649|1577805|P4|Overall Study|Abnormality of Laboratory Test|2
487409|NCT00077649|1577806|P3|Overall Study|Abnormality of Laboratory Test|1
487410|NCT00077649|1577807|P2|Overall Study|Abnormality of Laboratory Test|2
487411|NCT00077649|1577808|P1|Overall Study|Abnormality of Laboratory Test|1
487412|NCT00077649|1577805|P4|Overall Study|Lost to Follow-up|2
487413|NCT00077649|1577806|P3|Overall Study|Lost to Follow-up|3
487414|NCT00077649|1577807|P2|Overall Study|Lost to Follow-up|2
487415|NCT00077649|1577808|P1|Overall Study|Lost to Follow-up|2
487416|NCT00077649|1577805|P4|Overall Study|Withdrawal by Subject|2
487417|NCT00077649|1577806|P3|Overall Study|Withdrawal by Subject|1
487418|NCT00077649|1577807|P2|Overall Study|Withdrawal by Subject|1
487419|NCT00077649|1577808|P1|Overall Study|Withdrawal by Subject|0
487420|NCT00077649|1577805|P4|Overall Study|Lack of Efficacy|2
487421|NCT00077649|1577806|P3|Overall Study|Lack of Efficacy|3
487422|NCT00077649|1577807|P2|Overall Study|Lack of Efficacy|3
487423|NCT00077649|1577808|P1|Overall Study|Lack of Efficacy|5
487424|NCT00077649|1577805|P4|Overall Study|Adverse Event|9
487425|NCT00077649|1577806|P3|Overall Study|Adverse Event|7
487426|NCT00077649|1577807|P2|Overall Study|Adverse Event|1
487427|NCT00077649|1577808|P1|Overall Study|Adverse Event|5
487428|NCT00077636|1577856|P2|Overall Study|Abnormality Of Laboratory Test|2
487429|NCT00077636|1577857|P1|Overall Study|Abnormality Of Laboratory Test|3
487430|NCT00077636|1577856|P2|Overall Study|Lost to Follow-up|18
487431|NCT00077636|1577857|P1|Overall Study|Lost to Follow-up|10
487432|NCT00077636|1577856|P2|Overall Study|Protocol Violation|2
487433|NCT00077636|1577857|P1|Overall Study|Protocol Violation|0
487434|NCT00077636|1577856|P2|Overall Study|Adverse Event|34
487435|NCT00077636|1577857|P1|Overall Study|Adverse Event|17
487436|NCT00077636|1577856|P2|Overall Study|Withdrawal by Subject|2
487437|NCT00077636|1577857|P1|Overall Study|Withdrawal by Subject|2
487438|NCT00077636|1577856|P2|Overall Study|Admin|3
487439|NCT00077636|1577857|P1|Overall Study|Admin|3
487440|NCT00077636|1577856|P2|Overall Study|Refused Treatment|31
487441|NCT00077636|1577857|P1|Overall Study|Refused Treatment|9
487442|NCT00077623|1577878|P3|Overall Study|Failure to return|0
487443|NCT00077623|1577879|P2|Overall Study|Failure to return|0
487444|NCT00077623|1577880|P1|Overall Study|Failure to return|1
487445|NCT00077623|1577878|P3|Overall Study|Death|11
487446|NCT00077623|1577879|P2|Overall Study|Death|18
487447|NCT00077623|1577880|P1|Overall Study|Death|12
487448|NCT00077623|1577878|P3|Overall Study|Insufficient therapeutic response|0
487449|NCT00077623|1577879|P2|Overall Study|Insufficient therapeutic response|0
487450|NCT00077623|1577880|P1|Overall Study|Insufficient therapeutic response|2
487451|NCT00077623|1577878|P3|Overall Study|Other-Non safety reason|19
487452|NCT00077623|1577879|P2|Overall Study|Other-Non safety reason|15
487453|NCT00077623|1577880|P1|Overall Study|Other-Non safety reason|18
487454|NCT00077623|1577878|P3|Overall Study|Withdrawal by Subject|1
487455|NCT00077623|1577879|P2|Overall Study|Withdrawal by Subject|10
487456|NCT00077623|1577880|P1|Overall Study|Withdrawal by Subject|2
487457|NCT00077623|1577878|P3|Overall Study|Adverse Event|1
487458|NCT00077623|1577879|P2|Overall Study|Adverse Event|0
487459|NCT00077623|1577880|P1|Overall Study|Adverse Event|1
487460|NCT00077610|1577915|P3|Overall Study|Sponsors decision to withdraw|1
487461|NCT00077610|1577916|P2|Overall Study|Sponsors decision to withdraw|0
487462|NCT00077610|1577917|P1|Overall Study|Sponsors decision to withdraw|0
487463|NCT00077610|1577915|P3|Overall Study|Financial issues|0
487464|NCT00077610|1577916|P2|Overall Study|Financial issues|1
487465|NCT00077610|1577917|P1|Overall Study|Financial issues|0
487466|NCT00077610|1577915|P3|Overall Study|Relocation|5
487467|NCT00077610|1577916|P2|Overall Study|Relocation|8
487468|NCT00077610|1577917|P1|Overall Study|Relocation|0
487469|NCT00077610|1577915|P3|Overall Study|Change in dialysis modality|0
487470|NCT00077610|1577916|P2|Overall Study|Change in dialysis modality|0
487471|NCT00077610|1577917|P1|Overall Study|Change in dialysis modality|1
487472|NCT00077610|1577915|P3|Overall Study|Transfer to other center for surgery|0
487473|NCT00077610|1577916|P2|Overall Study|Transfer to other center for surgery|0
487474|NCT00077610|1577917|P1|Overall Study|Transfer to other center for surgery|1
487475|NCT00077610|1577915|P3|Overall Study|Transfer to satellite unit|0
487476|NCT00077610|1577916|P2|Overall Study|Transfer to satellite unit|0
487477|NCT00077610|1577917|P1|Overall Study|Transfer to satellite unit|1
487478|NCT00077610|1577915|P3|Overall Study|Transferred to nursing home|1
487479|NCT00077610|1577916|P2|Overall Study|Transferred to nursing home|0
487480|NCT00077610|1577917|P1|Overall Study|Transferred to nursing home|0
487481|NCT00077610|1577915|P3|Overall Study|Transferred to other unit|1
487482|NCT00077610|1577916|P2|Overall Study|Transferred to other unit|0
487483|NCT00077610|1577917|P1|Overall Study|Transferred to other unit|0
487484|NCT00077610|1577915|P3|Overall Study|Given Epogen in hospital|0
487485|NCT00077610|1577916|P2|Overall Study|Given Epogen in hospital|0
487486|NCT00077610|1577917|P1|Overall Study|Given Epogen in hospital|1
487487|NCT00077610|1577915|P3|Overall Study|Worsening of health condition|0
487488|NCT00077610|1577916|P2|Overall Study|Worsening of health condition|1
487489|NCT00077610|1577917|P1|Overall Study|Worsening of health condition|1
487490|NCT00077610|1577915|P3|Overall Study|Principal Investigator's decision|1
487491|NCT00077610|1577916|P2|Overall Study|Principal Investigator's decision|0
487492|NCT00077610|1577917|P1|Overall Study|Principal Investigator's decision|1
487493|NCT00077610|1577915|P3|Overall Study|Multiple blood transfusions|1
487494|NCT00077610|1577916|P2|Overall Study|Multiple blood transfusions|0
487495|NCT00077610|1577917|P1|Overall Study|Multiple blood transfusions|0
487496|NCT00077610|1577915|P3|Overall Study|Insufficient Therapeutic Response|0
487497|NCT00077610|1577916|P2|Overall Study|Insufficient Therapeutic Response|0
487498|NCT00077610|1577917|P1|Overall Study|Insufficient Therapeutic Response|1
487499|NCT00077610|1577915|P3|Overall Study|Withdrew from dialysis care|3
487500|NCT00077610|1577916|P2|Overall Study|Withdrew from dialysis care|0
487501|NCT00077610|1577917|P1|Overall Study|Withdrew from dialysis care|5
487502|NCT00077610|1577915|P3|Overall Study|Renal transplant|11
487503|NCT00077610|1577916|P2|Overall Study|Renal transplant|15
487504|NCT00077610|1577917|P1|Overall Study|Renal transplant|12
487505|NCT00077610|1577915|P3|Overall Study|Death|13
487506|NCT00077610|1577916|P2|Overall Study|Death|13
487507|NCT00077610|1577917|P1|Overall Study|Death|17
487508|NCT00077610|1577915|P3|Overall Study|Withdrawal by Subject|6
487509|NCT00077610|1577916|P2|Overall Study|Withdrawal by Subject|10
487510|NCT00077610|1577917|P1|Overall Study|Withdrawal by Subject|4
487511|NCT00077610|1577915|P3|Overall Study|Lost to Follow-up|2
487512|NCT00077610|1577916|P2|Overall Study|Lost to Follow-up|1
487513|NCT00077610|1577917|P1|Overall Study|Lost to Follow-up|0
487514|NCT00077610|1577915|P3|Overall Study|Adverse Event|1
487515|NCT00077610|1577916|P2|Overall Study|Adverse Event|7
487516|NCT00077610|1577917|P1|Overall Study|Adverse Event|9
487517|NCT00077376|1577946|P1|Overall Study|Insurance ran out|1
487518|NCT00077376|1577946|P1|Overall Study|Surgery|1
487519|NCT00077376|1577946|P1|Overall Study|Symptomatic deterioration|1
487520|NCT00077376|1577946|P1|Overall Study|Still on treatment|1
487521|NCT00077376|1577946|P1|Overall Study|Complicating disease|1
487522|NCT00077376|1577946|P1|Overall Study|Alternative therapy|5
487523|NCT00077376|1577946|P1|Overall Study|Physician Decision|1
487524|NCT00077376|1577946|P1|Overall Study|Death|1
487525|NCT00077376|1577946|P1|Overall Study|Withdrawal by Subject|2
487526|NCT00077376|1577946|P1|Overall Study|Adverse Event|8
487527|NCT00077207|1577957|P1|Overall Study|Ineligible|1
487528|NCT00077207|1577957|P1|Overall Study|Withdrawal by Subject|6
487529|NCT00077207|1577957|P1|Overall Study|Physician Decision|6
487530|NCT00077207|1577957|P1|Overall Study|Lack of Efficacy|12
487531|NCT00077207|1577957|P1|Overall Study|Adverse Event|5
487532|NCT00077064|1577969|P2|Overall Study|Patient refusal|2
487533|NCT00077064|1577970|P1|Overall Study|Patient refusal|0
487534|NCT00077064|1577969|P2|Overall Study|Adverse Event|4
487535|NCT00077064|1577970|P1|Overall Study|Adverse Event|0
487536|NCT00076999|1577986|P5|Overall Study|Other reason (not specified)|13
487537|NCT00076999|1577987|P4|Overall Study|Other reason (not specified)|1
487538|NCT00076999|1577988|P3|Overall Study|Other reason (not specified)|4
487539|NCT00076999|1577989|P2|Overall Study|Other reason (not specified)|8
487540|NCT00076999|1577990|P1|Overall Study|Other reason (not specified)|8
487541|NCT00076999|1577986|P5|Overall Study|Withdrawal by Subject|1
487542|NCT00076999|1577987|P4|Overall Study|Withdrawal by Subject|0
487543|NCT00076999|1577988|P3|Overall Study|Withdrawal by Subject|3
487544|NCT00076999|1577989|P2|Overall Study|Withdrawal by Subject|4
487545|NCT00076999|1577990|P1|Overall Study|Withdrawal by Subject|0
487546|NCT00076999|1577986|P5|Overall Study|Lost to Follow-up|0
487547|NCT00076999|1577987|P4|Overall Study|Lost to Follow-up|0
487548|NCT00076999|1577988|P3|Overall Study|Lost to Follow-up|0
487549|NCT00076999|1577989|P2|Overall Study|Lost to Follow-up|1
487550|NCT00076999|1577990|P1|Overall Study|Lost to Follow-up|2
487551|NCT00076999|1577986|P5|Overall Study|Protocol Violation|9
487552|NCT00076999|1577987|P4|Overall Study|Protocol Violation|0
487553|NCT00076999|1577988|P3|Overall Study|Protocol Violation|4
487554|NCT00076999|1577989|P2|Overall Study|Protocol Violation|3
487555|NCT00076999|1577990|P1|Overall Study|Protocol Violation|0
487556|NCT00076999|1577986|P5|Overall Study|Adverse Event|2
487557|NCT00076999|1577987|P4|Overall Study|Adverse Event|0
487558|NCT00076999|1577988|P3|Overall Study|Adverse Event|6
487559|NCT00076999|1577989|P2|Overall Study|Adverse Event|8
487560|NCT00076999|1577990|P1|Overall Study|Adverse Event|2
487561|NCT00003222|1578109|P2|Overall Study|Physician Decision|1
487562|NCT00003222|1578110|P1|Overall Study|Physician Decision|0
487563|NCT00076804|1578122|P2|Overall Study|Early study Closure|32
487564|NCT00076804|1578123|P1|Overall Study|Early study Closure|32
487565|NCT00076804|1578122|P2|Overall Study|Withdrawal by Subject|8
487566|NCT00076804|1578123|P1|Overall Study|Withdrawal by Subject|10
487567|NCT00076804|1578122|P2|Overall Study|Lost to Follow-up|9
487568|NCT00076804|1578123|P1|Overall Study|Lost to Follow-up|9
487569|NCT00076804|1578122|P2|Overall Study|Death|20
487570|NCT00076804|1578123|P1|Overall Study|Death|9
487571|NCT00076752|1578135|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
487572|NCT00076752|1578135|P1|Overall Study|Death|2
487573|NCT00076570|1578181|P2|Overall Study|Drug intolerance|8
487574|NCT00076570|1578182|P1|Overall Study|Drug intolerance|8
487575|NCT00003298|1578190|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
487576|NCT00003298|1578190|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
487577|NCT00003298|1578190|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
487578|NCT00003298|1578190|P1|Step 2 (Adjuvant Therapy)|Death|1
487579|NCT00003298|1578190|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
487580|NCT00003298|1578190|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
487581|NCT00003298|1578190|P1|Re-register to Step 2 After Surgery|Reason unknown|1
487582|NCT00003298|1578190|P1|Re-register to Step 2 After Surgery|Other complications|2
487583|NCT00003298|1578190|P1|Re-register to Step 2 After Surgery|Positive margins|5
487584|NCT00003298|1578190|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
487585|NCT00003298|1578190|P1|Surgery|Unevaluable and off study|2
487586|NCT00003298|1578190|P1|Surgery|Progression before surgery|2
487587|NCT00003298|1578190|P1|Surgery|Unresectable at surgery|3
487588|NCT00003298|1578190|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
487589|NCT00003298|1578190|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
487590|NCT00076336|1578200|P2|Overall Study|Treatment failure|5
487591|NCT00076336|1578201|P1|Overall Study|Treatment failure|4
487592|NCT00076336|1578200|P2|Overall Study|Virologic Breakthrough|16
487593|NCT00076336|1578201|P1|Overall Study|Virologic Breakthrough|14
487594|NCT00076336|1578200|P2|Overall Study|Liver Transplantation|3
487595|NCT00076336|1578201|P1|Overall Study|Liver Transplantation|3
487596|NCT00076336|1578200|P2|Overall Study|Patient, Investigator, Sponsor request|6
487597|NCT00076336|1578201|P1|Overall Study|Patient, Investigator, Sponsor request|8
487598|NCT00076336|1578200|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
487599|NCT00076336|1578201|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
487600|NCT00076336|1578200|P2|Overall Study|Non-Compliance|0
487601|NCT00076336|1578201|P1|Overall Study|Non-Compliance|2
487602|NCT00076336|1578200|P2|Overall Study|Lost to Follow-up|4
487603|NCT00076336|1578201|P1|Overall Study|Lost to Follow-up|4
487604|NCT00076336|1578200|P2|Overall Study|Adverse Event|4
487605|NCT00076336|1578201|P1|Overall Study|Adverse Event|4
487606|NCT00076336|1578200|P2|Overall Study|Death|17
487607|NCT00076336|1578201|P1|Overall Study|Death|13
487608|NCT00076102|1578254|P1|Overall Study|refusal of further therapy|2
487609|NCT00076102|1578254|P1|Overall Study|plexiform neurofibroma surgery|1
487610|NCT00076102|1578254|P1|Overall Study|Progression in pre-existing brain tumor|1
487611|NCT00076102|1578254|P1|Overall Study|Clinical progression|1
487612|NCT00076024|1578282|P4|Phase 2, Open-label|Other|2
487613|NCT00076024|1578283|P3|Phase 2, Open-label|Other|0
487614|NCT00076024|1578284|P2|Phase 2, Open-label|Other|0
487615|NCT00076024|1578285|P1|Phase 2, Open-label|Other|0
487616|NCT00076024|1578282|P4|Phase 2, Open-label|Withdrawal by Subject|1
487617|NCT00076024|1578283|P3|Phase 2, Open-label|Withdrawal by Subject|0
487618|NCT00076024|1578284|P2|Phase 2, Open-label|Withdrawal by Subject|0
487619|NCT00076024|1578285|P1|Phase 2, Open-label|Withdrawal by Subject|0
487620|NCT00076024|1578282|P4|Phase 2, Open-label|Lack of Efficacy|11
487621|NCT00076024|1578283|P3|Phase 2, Open-label|Lack of Efficacy|0
487622|NCT00076024|1578284|P2|Phase 2, Open-label|Lack of Efficacy|0
487623|NCT00076024|1578285|P1|Phase 2, Open-label|Lack of Efficacy|0
487624|NCT00076024|1578282|P4|Phase 2, Open-label|Adverse Event|2
487625|NCT00076024|1578283|P3|Phase 2, Open-label|Adverse Event|0
487626|NCT00076024|1578284|P2|Phase 2, Open-label|Adverse Event|0
487627|NCT00076024|1578285|P1|Phase 2, Open-label|Adverse Event|0
487628|NCT00076024|1578282|P4|Phase 2, Double-blind|Randomized but not treated|0
487629|NCT00076024|1578283|P3|Phase 2, Double-blind|Randomized but not treated|0
487630|NCT00076024|1578284|P2|Phase 2, Double-blind|Randomized but not treated|1
487631|NCT00076024|1578285|P1|Phase 2, Double-blind|Randomized but not treated|0
487632|NCT00076024|1578282|P4|Phase 2, Double-blind|Un-specified|0
487633|NCT00076024|1578283|P3|Phase 2, Double-blind|Un-specified|6
487634|NCT00076024|1578284|P2|Phase 2, Double-blind|Un-specified|14
487635|NCT00076024|1578285|P1|Phase 2, Double-blind|Un-specified|0
487636|NCT00076024|1578282|P4|Phase 2, Double-blind|Adverse Event|0
487637|NCT00076024|1578283|P3|Phase 2, Double-blind|Adverse Event|6
487638|NCT00076024|1578284|P2|Phase 2, Double-blind|Adverse Event|25
487639|NCT00076024|1578285|P1|Phase 2, Double-blind|Adverse Event|0
487640|NCT00076024|1578282|P4|Phase 2, Double-blind|Withdrawal by Subject|0
487641|NCT00076024|1578283|P3|Phase 2, Double-blind|Withdrawal by Subject|4
487642|NCT00076024|1578284|P2|Phase 2, Double-blind|Withdrawal by Subject|13
487643|NCT00076024|1578285|P1|Phase 2, Double-blind|Withdrawal by Subject|0
487644|NCT00076024|1578282|P4|Phase 2, Double-blind|Lack of Efficacy|0
487645|NCT00076024|1578283|P3|Phase 2, Double-blind|Lack of Efficacy|40
487646|NCT00076024|1578284|P2|Phase 2, Double-blind|Lack of Efficacy|59
487647|NCT00076024|1578285|P1|Phase 2, Double-blind|Lack of Efficacy|0
487648|NCT00076024|1578282|P4|Phase 1, Lead-in|Clinical progression|0
487649|NCT00076024|1578283|P3|Phase 1, Lead-in|Clinical progression|0
487650|NCT00076024|1578284|P2|Phase 1, Lead-in|Clinical progression|0
487651|NCT00076024|1578285|P1|Phase 1, Lead-in|Clinical progression|1
487652|NCT00076024|1578282|P4|Phase 1, Lead-in|Adverse Event|0
487653|NCT00076024|1578283|P3|Phase 1, Lead-in|Adverse Event|0
487654|NCT00076024|1578284|P2|Phase 1, Lead-in|Adverse Event|0
487655|NCT00076024|1578285|P1|Phase 1, Lead-in|Adverse Event|1
487656|NCT00076024|1578282|P4|Phase 1, Lead-in|Lack of Efficacy|0
487657|NCT00076024|1578283|P3|Phase 1, Lead-in|Lack of Efficacy|0
487658|NCT00076024|1578284|P2|Phase 1, Lead-in|Lack of Efficacy|0
487659|NCT00076024|1578285|P1|Phase 1, Lead-in|Lack of Efficacy|4
487660|NCT00076011|1578299|P1|Overall Study|Ongoing|1
487661|NCT00076011|1578299|P1|Overall Study|Other|11
487662|NCT00076011|1578299|P1|Overall Study|Study terminated by sponsor|3
487663|NCT00076011|1578299|P1|Overall Study|Withdrawal by Subject|1
487664|NCT00076011|1578299|P1|Overall Study|Lack of Efficacy|25
487665|NCT00076011|1578299|P1|Overall Study|Adverse Event|10
487666|NCT00076011|1578299|P1|Overall Study|Death|1
487667|NCT00075946|1578311|P5|Overall Study|Other|0
487668|NCT00075946|1578312|P4|Overall Study|Other|2
487669|NCT00075946|1578313|P3|Overall Study|Other|0
487670|NCT00075946|1578314|P2|Overall Study|Other|13
487671|NCT00075946|1578315|P1|Overall Study|Other|5
487672|NCT00075946|1578311|P5|Overall Study|Time to progression less than 6 months|0
487673|NCT00075946|1578312|P4|Overall Study|Time to progression less than 6 months|3
487674|NCT00075946|1578313|P3|Overall Study|Time to progression less than 6 months|8
487675|NCT00075946|1578314|P2|Overall Study|Time to progression less than 6 months|30
487676|NCT00075946|1578315|P1|Overall Study|Time to progression less than 6 months|15
487677|NCT00075946|1578311|P5|Overall Study|No response to retreatment|0
487678|NCT00075946|1578312|P4|Overall Study|No response to retreatment|0
487679|NCT00075946|1578313|P3|Overall Study|No response to retreatment|2
487680|NCT00075946|1578314|P2|Overall Study|No response to retreatment|0
487681|NCT00075946|1578315|P1|Overall Study|No response to retreatment|23
487682|NCT00075946|1578311|P5|Overall Study|Other complicating disease|0
487683|NCT00075946|1578312|P4|Overall Study|Other complicating disease|4
487684|NCT00075946|1578313|P3|Overall Study|Other complicating disease|1
487685|NCT00075946|1578314|P2|Overall Study|Other complicating disease|13
487686|NCT00075946|1578315|P1|Overall Study|Other complicating disease|7
487687|NCT00075946|1578311|P5|Overall Study|Alternative therapy|0
487688|NCT00075946|1578312|P4|Overall Study|Alternative therapy|0
487689|NCT00075946|1578313|P3|Overall Study|Alternative therapy|5
487690|NCT00075946|1578314|P2|Overall Study|Alternative therapy|2
487691|NCT00075946|1578315|P1|Overall Study|Alternative therapy|16
487692|NCT00075946|1578311|P5|Overall Study|Withdrawal by Subject|0
487693|NCT00075946|1578312|P4|Overall Study|Withdrawal by Subject|9
487694|NCT00075946|1578313|P3|Overall Study|Withdrawal by Subject|4
487695|NCT00075946|1578314|P2|Overall Study|Withdrawal by Subject|58
487696|NCT00075946|1578315|P1|Overall Study|Withdrawal by Subject|23
487697|NCT00075946|1578311|P5|Overall Study|Death|0
487698|NCT00075946|1578312|P4|Overall Study|Death|0
487699|NCT00075946|1578313|P3|Overall Study|Death|0
487700|NCT00075946|1578314|P2|Overall Study|Death|1
487701|NCT00075946|1578315|P1|Overall Study|Death|0
487702|NCT00075946|1578311|P5|Overall Study|Adverse Event|0
487703|NCT00075946|1578312|P4|Overall Study|Adverse Event|2
487704|NCT00075946|1578313|P3|Overall Study|Adverse Event|0
487705|NCT00075946|1578314|P2|Overall Study|Adverse Event|10
487706|NCT00075946|1578315|P1|Overall Study|Adverse Event|2
487707|NCT00075946|1578311|P5|Overall Study|Still on treatment at time of analysis|0
487708|NCT00075946|1578312|P4|Overall Study|Still on treatment at time of analysis|9
487709|NCT00075946|1578313|P3|Overall Study|Still on treatment at time of analysis|3
487710|NCT00075946|1578314|P2|Overall Study|Still on treatment at time of analysis|19
487711|NCT00075946|1578315|P1|Overall Study|Still on treatment at time of analysis|52
487712|NCT00075946|1578311|P5|Overall Study|Incorrectly randomized (no response)|0
487713|NCT00075946|1578312|P4|Overall Study|Incorrectly randomized (no response)|1
487714|NCT00075946|1578313|P3|Overall Study|Incorrectly randomized (no response)|5
487715|NCT00075946|1578314|P2|Overall Study|Incorrectly randomized (no response)|5
487716|NCT00075946|1578315|P1|Overall Study|Incorrectly randomized (no response)|5
487717|NCT00075946|1578311|P5|Overall Study|Did not achieve response after induction|182
487718|NCT00075946|1578312|P4|Overall Study|Did not achieve response after induction|0
487719|NCT00075946|1578313|P3|Overall Study|Did not achieve response after induction|0
487720|NCT00075946|1578314|P2|Overall Study|Did not achieve response after induction|0
487721|NCT00075946|1578315|P1|Overall Study|Did not achieve response after induction|0
487722|NCT00075946|1578311|P5|Overall Study|Path ineligible: undetermined histology|6
487723|NCT00075946|1578312|P4|Overall Study|Path ineligible: undetermined histology|0
487724|NCT00075946|1578313|P3|Overall Study|Path ineligible: undetermined histology|0
487725|NCT00075946|1578314|P2|Overall Study|Path ineligible: undetermined histology|0
487726|NCT00075946|1578315|P1|Overall Study|Path ineligible: undetermined histology|0
487727|NCT00075881|1578330|P1|Overall Study|never start protocol therapy|1
487728|NCT00075881|1578330|P1|Overall Study|Ineligible|1
487729|NCT00075881|1578330|P1|Overall Study|missing data|2
487730|NCT00075881|1578330|P1|Overall Study|other|4
487731|NCT00075881|1578330|P1|Overall Study|other complicating disease|3
487732|NCT00075881|1578330|P1|Overall Study|Protocol Violation|4
487733|NCT00075881|1578330|P1|Overall Study|Withdrawal by Subject|2
487734|NCT00075881|1578330|P1|Overall Study|Death|1
487735|NCT00075881|1578330|P1|Overall Study|Adverse Event|7
487736|NCT00075881|1578330|P1|Overall Study|Lack of Efficacy|18
487737|NCT00075816|1578374|P2|Overall Study|Did not undergo transplantation|11
487738|NCT00075816|1578375|P1|Overall Study|Did not undergo transplantation|14
487739|NCT00075764|1578444|P2|Overall Study|Under review|1
487740|NCT00075764|1578445|P1|Overall Study|Under review|0
487741|NCT00075764|1578444|P2|Overall Study|Not protocol specified|19
487742|NCT00075764|1578445|P1|Overall Study|Not protocol specified|27
487743|NCT00075764|1578444|P2|Overall Study|Delinquent|2
487744|NCT00075764|1578445|P1|Overall Study|Delinquent|4
487745|NCT00075764|1578444|P2|Overall Study|Still on treatment|15
487746|NCT00075764|1578445|P1|Overall Study|Still on treatment|8
487747|NCT00075764|1578444|P2|Overall Study|Progression|274
487748|NCT00075764|1578445|P1|Overall Study|Progression|269
487749|NCT00075764|1578444|P2|Overall Study|Withdrawal by Subject|18
487750|NCT00075764|1578445|P1|Overall Study|Withdrawal by Subject|28
487751|NCT00075764|1578444|P2|Overall Study|Death|8
487752|NCT00075764|1578445|P1|Overall Study|Death|4
487753|NCT00075764|1578444|P2|Overall Study|Adverse Event|12
487754|NCT00075764|1578445|P1|Overall Study|Adverse Event|5
487755|NCT00075725|1578469|P12|Overall Study|Pt incarcerated|0
487756|NCT00075725|1578470|P11|Overall Study|Pt incarcerated|0
487757|NCT00075725|1578471|P10|Overall Study|Pt incarcerated|0
487758|NCT00075725|1578472|P9|Overall Study|Pt incarcerated|0
487759|NCT00075725|1578473|P8|Overall Study|Pt incarcerated|1
487760|NCT00075725|1578474|P7|Overall Study|Pt incarcerated|0
487761|NCT00075725|1578475|P6|Overall Study|Pt incarcerated|0
487762|NCT00075725|1578476|P5|Overall Study|Pt incarcerated|0
487763|NCT00075725|1578477|P4|Overall Study|Pt incarcerated|0
487764|NCT00075725|1578478|P3|Overall Study|Pt incarcerated|0
487765|NCT00075725|1578479|P2|Overall Study|Pt incarcerated|0
487766|NCT00075725|1578480|P1|Overall Study|Pt incarcerated|0
487767|NCT00075725|1578469|P12|Overall Study|Pt care terminated due to pt behavior|0
487768|NCT00075725|1578470|P11|Overall Study|Pt care terminated due to pt behavior|0
487769|NCT00075725|1578471|P10|Overall Study|Pt care terminated due to pt behavior|0
487770|NCT00075725|1578472|P9|Overall Study|Pt care terminated due to pt behavior|0
487771|NCT00075725|1578473|P8|Overall Study|Pt care terminated due to pt behavior|1
487772|NCT00075725|1578474|P7|Overall Study|Pt care terminated due to pt behavior|0
487773|NCT00075725|1578475|P6|Overall Study|Pt care terminated due to pt behavior|0
487774|NCT00075725|1578476|P5|Overall Study|Pt care terminated due to pt behavior|0
487775|NCT00075725|1578477|P4|Overall Study|Pt care terminated due to pt behavior|0
487776|NCT00075725|1578478|P3|Overall Study|Pt care terminated due to pt behavior|0
487777|NCT00075725|1578479|P2|Overall Study|Pt care terminated due to pt behavior|0
487778|NCT00075725|1578480|P1|Overall Study|Pt care terminated due to pt behavior|0
487779|NCT00075725|1578469|P12|Overall Study|Other complications|0
487780|NCT00075725|1578470|P11|Overall Study|Other complications|0
487781|NCT00075725|1578471|P10|Overall Study|Other complications|0
487782|NCT00075725|1578472|P9|Overall Study|Other complications|0
487783|NCT00075725|1578473|P8|Overall Study|Other complications|0
487784|NCT00075725|1578474|P7|Overall Study|Other complications|0
487785|NCT00075725|1578475|P6|Overall Study|Other complications|1
487786|NCT00075725|1578476|P5|Overall Study|Other complications|0
487787|NCT00075725|1578477|P4|Overall Study|Other complications|0
487788|NCT00075725|1578478|P3|Overall Study|Other complications|0
487789|NCT00075725|1578479|P2|Overall Study|Other complications|0
487790|NCT00075725|1578480|P1|Overall Study|Other complications|0
487791|NCT00075725|1578469|P12|Overall Study|Study Closure|0
487792|NCT00075725|1578470|P11|Overall Study|Study Closure|0
487793|NCT00075725|1578471|P10|Overall Study|Study Closure|0
487794|NCT00075725|1578472|P9|Overall Study|Study Closure|0
487795|NCT00075725|1578473|P8|Overall Study|Study Closure|1
487796|NCT00075725|1578474|P7|Overall Study|Study Closure|0
487797|NCT00075725|1578475|P6|Overall Study|Study Closure|3
487798|NCT00075725|1578476|P5|Overall Study|Study Closure|1
487799|NCT00075725|1578477|P4|Overall Study|Study Closure|0
487800|NCT00075725|1578478|P3|Overall Study|Study Closure|0
487801|NCT00075725|1578479|P2|Overall Study|Study Closure|0
487802|NCT00075725|1578480|P1|Overall Study|Study Closure|1
487803|NCT00075725|1578469|P12|Overall Study|Institution Terminated|0
487804|NCT00075725|1578470|P11|Overall Study|Institution Terminated|0
487805|NCT00075725|1578471|P10|Overall Study|Institution Terminated|0
487806|NCT00075725|1578472|P9|Overall Study|Institution Terminated|0
487807|NCT00075725|1578473|P8|Overall Study|Institution Terminated|3
487808|NCT00075725|1578474|P7|Overall Study|Institution Terminated|0
487809|NCT00075725|1578475|P6|Overall Study|Institution Terminated|0
487810|NCT00075725|1578476|P5|Overall Study|Institution Terminated|1
487811|NCT00075725|1578477|P4|Overall Study|Institution Terminated|0
487812|NCT00075725|1578478|P3|Overall Study|Institution Terminated|0
487813|NCT00075725|1578479|P2|Overall Study|Institution Terminated|0
487814|NCT00075725|1578480|P1|Overall Study|Institution Terminated|0
487815|NCT00075725|1578469|P12|Overall Study|Pt relocated|0
487816|NCT00075725|1578470|P11|Overall Study|Pt relocated|0
487817|NCT00075725|1578471|P10|Overall Study|Pt relocated|0
487818|NCT00075725|1578472|P9|Overall Study|Pt relocated|1
487819|NCT00075725|1578473|P8|Overall Study|Pt relocated|2
487820|NCT00075725|1578474|P7|Overall Study|Pt relocated|1
487821|NCT00075725|1578475|P6|Overall Study|Pt relocated|1
487822|NCT00075725|1578476|P5|Overall Study|Pt relocated|0
487823|NCT00075725|1578477|P4|Overall Study|Pt relocated|2
487824|NCT00075725|1578478|P3|Overall Study|Pt relocated|0
487825|NCT00075725|1578479|P2|Overall Study|Pt relocated|0
487826|NCT00075725|1578480|P1|Overall Study|Pt relocated|0
487827|NCT00075725|1578469|P12|Overall Study|Pt received additional steroids|0
487828|NCT00075725|1578470|P11|Overall Study|Pt received additional steroids|0
487829|NCT00075725|1578471|P10|Overall Study|Pt received additional steroids|0
487830|NCT00075725|1578472|P9|Overall Study|Pt received additional steroids|0
487831|NCT00075725|1578473|P8|Overall Study|Pt received additional steroids|0
487832|NCT00075725|1578474|P7|Overall Study|Pt received additional steroids|0
487833|NCT00075725|1578475|P6|Overall Study|Pt received additional steroids|0
487834|NCT00075725|1578476|P5|Overall Study|Pt received additional steroids|0
487835|NCT00075725|1578477|P4|Overall Study|Pt received additional steroids|1
487836|NCT00075725|1578478|P3|Overall Study|Pt received additional steroids|0
487837|NCT00075725|1578479|P2|Overall Study|Pt received additional steroids|0
487838|NCT00075725|1578480|P1|Overall Study|Pt received additional steroids|0
487839|NCT00075725|1578469|P12|Overall Study|Pt went to transplant|0
487840|NCT00075725|1578470|P11|Overall Study|Pt went to transplant|0
487841|NCT00075725|1578471|P10|Overall Study|Pt went to transplant|0
487842|NCT00075725|1578472|P9|Overall Study|Pt went to transplant|0
487843|NCT00075725|1578473|P8|Overall Study|Pt went to transplant|0
487844|NCT00075725|1578474|P7|Overall Study|Pt went to transplant|0
487845|NCT00075725|1578475|P6|Overall Study|Pt went to transplant|1
487846|NCT00075725|1578476|P5|Overall Study|Pt went to transplant|0
487847|NCT00075725|1578477|P4|Overall Study|Pt went to transplant|1
487848|NCT00075725|1578478|P3|Overall Study|Pt went to transplant|0
487849|NCT00075725|1578479|P2|Overall Study|Pt went to transplant|0
487850|NCT00075725|1578480|P1|Overall Study|Pt went to transplant|0
487851|NCT00075725|1578469|P12|Overall Study|specimen(s) not submitted|0
487852|NCT00075725|1578470|P11|Overall Study|specimen(s) not submitted|0
487853|NCT00075725|1578471|P10|Overall Study|specimen(s) not submitted|0
487854|NCT00075725|1578472|P9|Overall Study|specimen(s) not submitted|0
487855|NCT00075725|1578473|P8|Overall Study|specimen(s) not submitted|0
487856|NCT00075725|1578474|P7|Overall Study|specimen(s) not submitted|0
487857|NCT00075725|1578475|P6|Overall Study|specimen(s) not submitted|0
487858|NCT00075725|1578476|P5|Overall Study|specimen(s) not submitted|0
487859|NCT00075725|1578477|P4|Overall Study|specimen(s) not submitted|0
487860|NCT00075725|1578478|P3|Overall Study|specimen(s) not submitted|2
487861|NCT00075725|1578479|P2|Overall Study|specimen(s) not submitted|0
487862|NCT00075725|1578480|P1|Overall Study|specimen(s) not submitted|0
487863|NCT00075725|1578469|P12|Overall Study|Unsuccessful institutional transfer|0
487864|NCT00075725|1578470|P11|Overall Study|Unsuccessful institutional transfer|0
487865|NCT00075725|1578471|P10|Overall Study|Unsuccessful institutional transfer|1
487866|NCT00075725|1578472|P9|Overall Study|Unsuccessful institutional transfer|0
487867|NCT00075725|1578473|P8|Overall Study|Unsuccessful institutional transfer|0
487868|NCT00075725|1578474|P7|Overall Study|Unsuccessful institutional transfer|0
487869|NCT00075725|1578475|P6|Overall Study|Unsuccessful institutional transfer|0
487870|NCT00075725|1578476|P5|Overall Study|Unsuccessful institutional transfer|0
487871|NCT00075725|1578477|P4|Overall Study|Unsuccessful institutional transfer|0
487872|NCT00075725|1578478|P3|Overall Study|Unsuccessful institutional transfer|2
487873|NCT00075725|1578479|P2|Overall Study|Unsuccessful institutional transfer|0
487874|NCT00075725|1578480|P1|Overall Study|Unsuccessful institutional transfer|0
487875|NCT00075725|1578469|P12|Overall Study|Clinic chart lost unable to recreate|0
487876|NCT00075725|1578470|P11|Overall Study|Clinic chart lost unable to recreate|0
487877|NCT00075725|1578471|P10|Overall Study|Clinic chart lost unable to recreate|0
487878|NCT00075725|1578472|P9|Overall Study|Clinic chart lost unable to recreate|0
487879|NCT00075725|1578473|P8|Overall Study|Clinic chart lost unable to recreate|0
487880|NCT00075725|1578474|P7|Overall Study|Clinic chart lost unable to recreate|0
487881|NCT00075725|1578475|P6|Overall Study|Clinic chart lost unable to recreate|0
487882|NCT00075725|1578476|P5|Overall Study|Clinic chart lost unable to recreate|0
487883|NCT00075725|1578477|P4|Overall Study|Clinic chart lost unable to recreate|0
487884|NCT00075725|1578478|P3|Overall Study|Clinic chart lost unable to recreate|1
487885|NCT00075725|1578479|P2|Overall Study|Clinic chart lost unable to recreate|0
487886|NCT00075725|1578480|P1|Overall Study|Clinic chart lost unable to recreate|0
487887|NCT00075725|1578469|P12|Overall Study|Pt trying to find a BM donor|0
487888|NCT00075725|1578470|P11|Overall Study|Pt trying to find a BM donor|0
487889|NCT00075725|1578471|P10|Overall Study|Pt trying to find a BM donor|0
487890|NCT00075725|1578472|P9|Overall Study|Pt trying to find a BM donor|0
487891|NCT00075725|1578473|P8|Overall Study|Pt trying to find a BM donor|0
487892|NCT00075725|1578474|P7|Overall Study|Pt trying to find a BM donor|0
487893|NCT00075725|1578475|P6|Overall Study|Pt trying to find a BM donor|0
487894|NCT00075725|1578476|P5|Overall Study|Pt trying to find a BM donor|0
487895|NCT00075725|1578477|P4|Overall Study|Pt trying to find a BM donor|0
487896|NCT00075725|1578478|P3|Overall Study|Pt trying to find a BM donor|0
487897|NCT00075725|1578479|P2|Overall Study|Pt trying to find a BM donor|1
487898|NCT00075725|1578480|P1|Overall Study|Pt trying to find a BM donor|0
487899|NCT00075725|1578469|P12|Overall Study|Other|3
487900|NCT00075725|1578470|P11|Overall Study|Other|0
487901|NCT00075725|1578471|P10|Overall Study|Other|1
487902|NCT00075725|1578472|P9|Overall Study|Other|2
487903|NCT00075725|1578473|P8|Overall Study|Other|9
487904|NCT00075725|1578474|P7|Overall Study|Other|2
487905|NCT00075725|1578475|P6|Overall Study|Other|4
487906|NCT00075725|1578476|P5|Overall Study|Other|1
487907|NCT00075725|1578477|P4|Overall Study|Other|1
487908|NCT00075725|1578478|P3|Overall Study|Other|1
487909|NCT00075725|1578479|P2|Overall Study|Other|2
487910|NCT00075725|1578480|P1|Overall Study|Other|4
487911|NCT00075725|1578469|P12|Overall Study|Inevaluable|0
487912|NCT00075725|1578470|P11|Overall Study|Inevaluable|1
487913|NCT00075725|1578471|P10|Overall Study|Inevaluable|0
487914|NCT00075725|1578472|P9|Overall Study|Inevaluable|2
487915|NCT00075725|1578473|P8|Overall Study|Inevaluable|11
487916|NCT00075725|1578474|P7|Overall Study|Inevaluable|1
487917|NCT00075725|1578475|P6|Overall Study|Inevaluable|9
487918|NCT00075725|1578476|P5|Overall Study|Inevaluable|2
487919|NCT00075725|1578477|P4|Overall Study|Inevaluable|2
487920|NCT00075725|1578478|P3|Overall Study|Inevaluable|4
487921|NCT00075725|1578479|P2|Overall Study|Inevaluable|1
487922|NCT00075725|1578480|P1|Overall Study|Inevaluable|1
487923|NCT00075725|1578469|P12|Overall Study|Pt has very high risk ALL characteristic|3
487924|NCT00075725|1578470|P11|Overall Study|Pt has very high risk ALL characteristic|0
487925|NCT00075725|1578471|P10|Overall Study|Pt has very high risk ALL characteristic|1
487926|NCT00075725|1578472|P9|Overall Study|Pt has very high risk ALL characteristic|29
487927|NCT00075725|1578473|P8|Overall Study|Pt has very high risk ALL characteristic|74
487928|NCT00075725|1578474|P7|Overall Study|Pt has very high risk ALL characteristic|23
487929|NCT00075725|1578475|P6|Overall Study|Pt has very high risk ALL characteristic|75
487930|NCT00075725|1578476|P5|Overall Study|Pt has very high risk ALL characteristic|11
487931|NCT00075725|1578477|P4|Overall Study|Pt has very high risk ALL characteristic|18
487932|NCT00075725|1578478|P3|Overall Study|Pt has very high risk ALL characteristic|26
487933|NCT00075725|1578479|P2|Overall Study|Pt has very high risk ALL characteristic|11
487934|NCT00075725|1578480|P1|Overall Study|Pt has very high risk ALL characteristic|15
487935|NCT00075725|1578469|P12|Overall Study|MRD positive after extended ind|0
487936|NCT00075725|1578470|P11|Overall Study|MRD positive after extended ind|0
487937|NCT00075725|1578471|P10|Overall Study|MRD positive after extended ind|0
487938|NCT00075725|1578472|P9|Overall Study|MRD positive after extended ind|0
487939|NCT00075725|1578473|P8|Overall Study|MRD positive after extended ind|1
487940|NCT00075725|1578474|P7|Overall Study|MRD positive after extended ind|0
487941|NCT00075725|1578475|P6|Overall Study|MRD positive after extended ind|2
487942|NCT00075725|1578476|P5|Overall Study|MRD positive after extended ind|1
487943|NCT00075725|1578477|P4|Overall Study|MRD positive after extended ind|0
487944|NCT00075725|1578478|P3|Overall Study|MRD positive after extended ind|1
487945|NCT00075725|1578479|P2|Overall Study|MRD positive after extended ind|1
487946|NCT00075725|1578480|P1|Overall Study|MRD positive after extended ind|0
487947|NCT00075725|1578469|P12|Overall Study|Insurance issues|0
487948|NCT00075725|1578470|P11|Overall Study|Insurance issues|0
487949|NCT00075725|1578471|P10|Overall Study|Insurance issues|0
487950|NCT00075725|1578472|P9|Overall Study|Insurance issues|0
487951|NCT00075725|1578473|P8|Overall Study|Insurance issues|1
487952|NCT00075725|1578474|P7|Overall Study|Insurance issues|0
487953|NCT00075725|1578475|P6|Overall Study|Insurance issues|1
487954|NCT00075725|1578476|P5|Overall Study|Insurance issues|1
487955|NCT00075725|1578477|P4|Overall Study|Insurance issues|1
487956|NCT00075725|1578478|P3|Overall Study|Insurance issues|0
487957|NCT00075725|1578479|P2|Overall Study|Insurance issues|1
487958|NCT00075725|1578480|P1|Overall Study|Insurance issues|0
487959|NCT00075725|1578469|P12|Overall Study|Pt age out of range for treatment|0
487960|NCT00075725|1578470|P11|Overall Study|Pt age out of range for treatment|0
487961|NCT00075725|1578471|P10|Overall Study|Pt age out of range for treatment|0
487962|NCT00075725|1578472|P9|Overall Study|Pt age out of range for treatment|0
487963|NCT00075725|1578473|P8|Overall Study|Pt age out of range for treatment|1
487964|NCT00075725|1578474|P7|Overall Study|Pt age out of range for treatment|0
487965|NCT00075725|1578475|P6|Overall Study|Pt age out of range for treatment|1
487966|NCT00075725|1578476|P5|Overall Study|Pt age out of range for treatment|0
487967|NCT00075725|1578477|P4|Overall Study|Pt age out of range for treatment|0
487968|NCT00075725|1578478|P3|Overall Study|Pt age out of range for treatment|0
487969|NCT00075725|1578479|P2|Overall Study|Pt age out of range for treatment|1
487970|NCT00075725|1578480|P1|Overall Study|Pt age out of range for treatment|0
487971|NCT00075725|1578469|P12|Overall Study|Pt non compliant with therapy|0
487972|NCT00075725|1578470|P11|Overall Study|Pt non compliant with therapy|0
487973|NCT00075725|1578471|P10|Overall Study|Pt non compliant with therapy|0
487974|NCT00075725|1578472|P9|Overall Study|Pt non compliant with therapy|3
487975|NCT00075725|1578473|P8|Overall Study|Pt non compliant with therapy|5
487976|NCT00075725|1578474|P7|Overall Study|Pt non compliant with therapy|2
487977|NCT00075725|1578475|P6|Overall Study|Pt non compliant with therapy|14
487978|NCT00075725|1578476|P5|Overall Study|Pt non compliant with therapy|2
487979|NCT00075725|1578477|P4|Overall Study|Pt non compliant with therapy|0
487980|NCT00075725|1578478|P3|Overall Study|Pt non compliant with therapy|1
487981|NCT00075725|1578479|P2|Overall Study|Pt non compliant with therapy|1
487982|NCT00075725|1578480|P1|Overall Study|Pt non compliant with therapy|2
487983|NCT00075725|1578469|P12|Overall Study|Pt/Guardian refused RT therapy|0
487984|NCT00075725|1578470|P11|Overall Study|Pt/Guardian refused RT therapy|0
487985|NCT00075725|1578471|P10|Overall Study|Pt/Guardian refused RT therapy|0
487986|NCT00075725|1578472|P9|Overall Study|Pt/Guardian refused RT therapy|0
487987|NCT00075725|1578473|P8|Overall Study|Pt/Guardian refused RT therapy|0
487988|NCT00075725|1578474|P7|Overall Study|Pt/Guardian refused RT therapy|0
487989|NCT00075725|1578475|P6|Overall Study|Pt/Guardian refused RT therapy|0
487990|NCT00075725|1578476|P5|Overall Study|Pt/Guardian refused RT therapy|1
487991|NCT00075725|1578477|P4|Overall Study|Pt/Guardian refused RT therapy|2
487992|NCT00075725|1578478|P3|Overall Study|Pt/Guardian refused RT therapy|1
487993|NCT00075725|1578479|P2|Overall Study|Pt/Guardian refused RT therapy|0
487994|NCT00075725|1578480|P1|Overall Study|Pt/Guardian refused RT therapy|1
487995|NCT00075725|1578469|P12|Overall Study|Ineligible or wrong diagnosis|4
487996|NCT00075725|1578470|P11|Overall Study|Ineligible or wrong diagnosis|2
487997|NCT00075725|1578471|P10|Overall Study|Ineligible or wrong diagnosis|1
487998|NCT00075725|1578472|P9|Overall Study|Ineligible or wrong diagnosis|10
487999|NCT00075725|1578473|P8|Overall Study|Ineligible or wrong diagnosis|9
488000|NCT00075725|1578474|P7|Overall Study|Ineligible or wrong diagnosis|6
488001|NCT00075725|1578475|P6|Overall Study|Ineligible or wrong diagnosis|17
488002|NCT00075725|1578476|P5|Overall Study|Ineligible or wrong diagnosis|3
488003|NCT00075725|1578477|P4|Overall Study|Ineligible or wrong diagnosis|10
488004|NCT00075725|1578478|P3|Overall Study|Ineligible or wrong diagnosis|3
488005|NCT00075725|1578479|P2|Overall Study|Ineligible or wrong diagnosis|3
488006|NCT00075725|1578480|P1|Overall Study|Ineligible or wrong diagnosis|8
488007|NCT00075725|1578469|P12|Overall Study|Patient off treatment|0
488008|NCT00075725|1578470|P11|Overall Study|Patient off treatment|0
488009|NCT00075725|1578471|P10|Overall Study|Patient off treatment|0
488010|NCT00075725|1578472|P9|Overall Study|Patient off treatment|1
488011|NCT00075725|1578473|P8|Overall Study|Patient off treatment|2
488012|NCT00075725|1578474|P7|Overall Study|Patient off treatment|0
488013|NCT00075725|1578475|P6|Overall Study|Patient off treatment|0
488014|NCT00075725|1578476|P5|Overall Study|Patient off treatment|1
488015|NCT00075725|1578477|P4|Overall Study|Patient off treatment|2
488016|NCT00075725|1578478|P3|Overall Study|Patient off treatment|1
488017|NCT00075725|1578479|P2|Overall Study|Patient off treatment|0
488018|NCT00075725|1578480|P1|Overall Study|Patient off treatment|0
488019|NCT00075725|1578469|P12|Overall Study|Disease Progression, all other reasons|5
488020|NCT00075725|1578470|P11|Overall Study|Disease Progression, all other reasons|0
488021|NCT00075725|1578471|P10|Overall Study|Disease Progression, all other reasons|4
488022|NCT00075725|1578472|P9|Overall Study|Disease Progression, all other reasons|21
488023|NCT00075725|1578473|P8|Overall Study|Disease Progression, all other reasons|46
488024|NCT00075725|1578474|P7|Overall Study|Disease Progression, all other reasons|20
488025|NCT00075725|1578475|P6|Overall Study|Disease Progression, all other reasons|59
488026|NCT00075725|1578476|P5|Overall Study|Disease Progression, all other reasons|21
488027|NCT00075725|1578477|P4|Overall Study|Disease Progression, all other reasons|6
488028|NCT00075725|1578478|P3|Overall Study|Disease Progression, all other reasons|33
488029|NCT00075725|1578479|P2|Overall Study|Disease Progression, all other reasons|5
488030|NCT00075725|1578480|P1|Overall Study|Disease Progression, all other reasons|17
488031|NCT00075725|1578469|P12|Overall Study|Withdrawal by Subject|0
488032|NCT00075725|1578470|P11|Overall Study|Withdrawal by Subject|0
488033|NCT00075725|1578471|P10|Overall Study|Withdrawal by Subject|2
488034|NCT00075725|1578472|P9|Overall Study|Withdrawal by Subject|10
488035|NCT00075725|1578473|P8|Overall Study|Withdrawal by Subject|31
488036|NCT00075725|1578474|P7|Overall Study|Withdrawal by Subject|7
488037|NCT00075725|1578475|P6|Overall Study|Withdrawal by Subject|27
488038|NCT00075725|1578476|P5|Overall Study|Withdrawal by Subject|6
488039|NCT00075725|1578477|P4|Overall Study|Withdrawal by Subject|10
488040|NCT00075725|1578478|P3|Overall Study|Withdrawal by Subject|6
488041|NCT00075725|1578479|P2|Overall Study|Withdrawal by Subject|3
488042|NCT00075725|1578480|P1|Overall Study|Withdrawal by Subject|12
488043|NCT00075725|1578469|P12|Overall Study|Protocol Violation|1
488044|NCT00075725|1578470|P11|Overall Study|Protocol Violation|0
488045|NCT00075725|1578471|P10|Overall Study|Protocol Violation|0
488046|NCT00075725|1578472|P9|Overall Study|Protocol Violation|3
488047|NCT00075725|1578473|P8|Overall Study|Protocol Violation|2
488048|NCT00075725|1578474|P7|Overall Study|Protocol Violation|1
488049|NCT00075725|1578475|P6|Overall Study|Protocol Violation|2
488050|NCT00075725|1578476|P5|Overall Study|Protocol Violation|3
488051|NCT00075725|1578477|P4|Overall Study|Protocol Violation|3
488052|NCT00075725|1578478|P3|Overall Study|Protocol Violation|0
488053|NCT00075725|1578479|P2|Overall Study|Protocol Violation|1
488054|NCT00075725|1578480|P1|Overall Study|Protocol Violation|1
488055|NCT00075725|1578469|P12|Overall Study|Pregnancy|0
488056|NCT00075725|1578470|P11|Overall Study|Pregnancy|0
488057|NCT00075725|1578471|P10|Overall Study|Pregnancy|0
488058|NCT00075725|1578472|P9|Overall Study|Pregnancy|0
488059|NCT00075725|1578473|P8|Overall Study|Pregnancy|1
488060|NCT00075725|1578474|P7|Overall Study|Pregnancy|0
488061|NCT00075725|1578475|P6|Overall Study|Pregnancy|1
488062|NCT00075725|1578476|P5|Overall Study|Pregnancy|0
488063|NCT00075725|1578477|P4|Overall Study|Pregnancy|0
488064|NCT00075725|1578478|P3|Overall Study|Pregnancy|0
488065|NCT00075725|1578479|P2|Overall Study|Pregnancy|0
488066|NCT00075725|1578480|P1|Overall Study|Pregnancy|0
488067|NCT00075725|1578469|P12|Overall Study|Physician Decision|0
488068|NCT00075725|1578470|P11|Overall Study|Physician Decision|1
488069|NCT00075725|1578471|P10|Overall Study|Physician Decision|0
488070|NCT00075725|1578472|P9|Overall Study|Physician Decision|5
488071|NCT00075725|1578473|P8|Overall Study|Physician Decision|17
488072|NCT00075725|1578474|P7|Overall Study|Physician Decision|3
488073|NCT00075725|1578475|P6|Overall Study|Physician Decision|19
488074|NCT00075725|1578476|P5|Overall Study|Physician Decision|4
488075|NCT00075725|1578477|P4|Overall Study|Physician Decision|8
488076|NCT00075725|1578478|P3|Overall Study|Physician Decision|5
488077|NCT00075725|1578479|P2|Overall Study|Physician Decision|6
488078|NCT00075725|1578480|P1|Overall Study|Physician Decision|2
488079|NCT00075725|1578469|P12|Overall Study|Lost to Follow-up|0
488080|NCT00075725|1578470|P11|Overall Study|Lost to Follow-up|0
488081|NCT00075725|1578471|P10|Overall Study|Lost to Follow-up|0
488082|NCT00075725|1578472|P9|Overall Study|Lost to Follow-up|1
488083|NCT00075725|1578473|P8|Overall Study|Lost to Follow-up|4
488084|NCT00075725|1578474|P7|Overall Study|Lost to Follow-up|2
488085|NCT00075725|1578475|P6|Overall Study|Lost to Follow-up|13
488086|NCT00075725|1578476|P5|Overall Study|Lost to Follow-up|0
488087|NCT00075725|1578477|P4|Overall Study|Lost to Follow-up|1
488088|NCT00075725|1578478|P3|Overall Study|Lost to Follow-up|4
488089|NCT00075725|1578479|P2|Overall Study|Lost to Follow-up|1
488090|NCT00075725|1578480|P1|Overall Study|Lost to Follow-up|1
488091|NCT00075725|1578469|P12|Overall Study|Death|0
488092|NCT00075725|1578470|P11|Overall Study|Death|3
488093|NCT00075725|1578471|P10|Overall Study|Death|4
488094|NCT00075725|1578472|P9|Overall Study|Death|14
488095|NCT00075725|1578473|P8|Overall Study|Death|22
488096|NCT00075725|1578474|P7|Overall Study|Death|4
488097|NCT00075725|1578475|P6|Overall Study|Death|25
488098|NCT00075725|1578476|P5|Overall Study|Death|3
488099|NCT00075725|1578477|P4|Overall Study|Death|2
488100|NCT00075725|1578478|P3|Overall Study|Death|10
488101|NCT00075725|1578479|P2|Overall Study|Death|5
488102|NCT00075725|1578480|P1|Overall Study|Death|3
488103|NCT00075725|1578469|P12|Overall Study|Adverse Event|2
488104|NCT00075725|1578470|P11|Overall Study|Adverse Event|2
488105|NCT00075725|1578471|P10|Overall Study|Adverse Event|4
488106|NCT00075725|1578472|P9|Overall Study|Adverse Event|15
488107|NCT00075725|1578473|P8|Overall Study|Adverse Event|51
488108|NCT00075725|1578474|P7|Overall Study|Adverse Event|3
488109|NCT00075725|1578475|P6|Overall Study|Adverse Event|38
488110|NCT00075725|1578476|P5|Overall Study|Adverse Event|4
488111|NCT00075725|1578477|P4|Overall Study|Adverse Event|8
488112|NCT00075725|1578478|P3|Overall Study|Adverse Event|20
488113|NCT00075725|1578479|P2|Overall Study|Adverse Event|6
488114|NCT00075725|1578480|P1|Overall Study|Adverse Event|6
488115|NCT00075582|1578577|P2|Overall Study|Ineligible for study|16
488116|NCT00075582|1578578|P1|Overall Study|Ineligible for study|36
488117|NCT00075582|1578577|P2|Overall Study|Withdrawal by Subject|2
488118|NCT00075582|1578578|P1|Overall Study|Withdrawal by Subject|2
488119|NCT00075582|1578577|P2|Overall Study|Physician Decision|8
488120|NCT00075582|1578578|P1|Overall Study|Physician Decision|5
488121|NCT00075582|1578577|P2|Overall Study|Lack of Efficacy|8
488122|NCT00075582|1578578|P1|Overall Study|Lack of Efficacy|4
488123|NCT00075582|1578577|P2|Overall Study|Adverse Event|1
488124|NCT00075582|1578578|P1|Overall Study|Adverse Event|3
488125|NCT00075504|1578588|P2|Overall Study|Withdrawal by Subject|7
488126|NCT00075504|1578589|P1|Overall Study|Withdrawal by Subject|9
488127|NCT00075478|1578601|P2|Overall Study|Physician Decision|1
488128|NCT00075478|1578602|P1|Overall Study|Physician Decision|0
488129|NCT00075478|1578601|P2|Overall Study|not eligible|0
488130|NCT00075478|1578602|P1|Overall Study|not eligible|1
488131|NCT00075400|1578622|P1|Overall Study|Never treated|2
488132|NCT00075400|1578622|P1|Overall Study|Ineligible: wrong primary|1
488133|NCT00075270|1578643|P2|Overall Study|Missing|13
488134|NCT00075270|1578644|P1|Overall Study|Missing|26
488135|NCT00075270|1578643|P2|Overall Study|Other/Unknown|5
488136|NCT00075270|1578644|P1|Overall Study|Other/Unknown|9
488137|NCT00075270|1578643|P2|Overall Study|Death|215
488138|NCT00075270|1578644|P1|Overall Study|Death|198
488139|NCT00075270|1578643|P2|Overall Study|Protocol Violation|2
488140|NCT00075270|1578644|P1|Overall Study|Protocol Violation|0
488141|NCT00075270|1578643|P2|Overall Study|Lost to Follow-up|28
488142|NCT00075270|1578644|P1|Overall Study|Lost to Follow-up|25
488143|NCT00075270|1578643|P2|Overall Study|Withdrawal by Subject|21
488144|NCT00075270|1578644|P1|Overall Study|Withdrawal by Subject|28
488145|NCT00075218|1578690|P3|Open-Label Treatment|enrolled in a separate continuation|9
488146|NCT00075218|1578691|P2|Open-Label Treatment|enrolled in a separate continuation|0
488147|NCT00075218|1578692|P1|Open-Label Treatment|enrolled in a separate continuation|0
488148|NCT00075218|1578690|P3|Open-Label Treatment|Protocol Violation|1
488149|NCT00075218|1578691|P2|Open-Label Treatment|Protocol Violation|0
488150|NCT00075218|1578692|P1|Open-Label Treatment|Protocol Violation|0
488151|NCT00075218|1578690|P3|Open-Label Treatment|Decision of Sponsor|8
488152|NCT00075218|1578691|P2|Open-Label Treatment|Decision of Sponsor|0
488153|NCT00075218|1578692|P1|Open-Label Treatment|Decision of Sponsor|0
488154|NCT00075218|1578690|P3|Open-Label Treatment|Withdrawal by Subject|12
488155|NCT00075218|1578691|P2|Open-Label Treatment|Withdrawal by Subject|0
488156|NCT00075218|1578692|P1|Open-Label Treatment|Withdrawal by Subject|0
488157|NCT00075218|1578690|P3|Open-Label Treatment|Adverse Event|51
488158|NCT00075218|1578691|P2|Open-Label Treatment|Adverse Event|0
488159|NCT00075218|1578692|P1|Open-Label Treatment|Adverse Event|0
488160|NCT00075218|1578690|P3|Open-Label Treatment|Lack of Efficacy|174
488161|NCT00075218|1578691|P2|Open-Label Treatment|Lack of Efficacy|0
488162|NCT00075218|1578692|P1|Open-Label Treatment|Lack of Efficacy|0
488163|NCT00075218|1578690|P3|Double-Blind Treatment|No study medication taken|0
488164|NCT00075218|1578691|P2|Double-Blind Treatment|No study medication taken|0
488165|NCT00075218|1578692|P1|Double-Blind Treatment|No study medication taken|2
488166|NCT00075218|1578690|P3|Double-Blind Treatment|Decision of Sponsor|0
488167|NCT00075218|1578691|P2|Double-Blind Treatment|Decision of Sponsor|1
488168|NCT00075218|1578692|P1|Double-Blind Treatment|Decision of Sponsor|0
488169|NCT00075218|1578690|P3|Double-Blind Treatment|Lack of Efficacy|0
488170|NCT00075218|1578691|P2|Double-Blind Treatment|Lack of Efficacy|6
488171|NCT00075218|1578692|P1|Double-Blind Treatment|Lack of Efficacy|58
488172|NCT00075218|1578690|P3|Double-Blind Treatment|Lost to Follow-up|0
488173|NCT00075218|1578691|P2|Double-Blind Treatment|Lost to Follow-up|0
488174|NCT00075218|1578692|P1|Double-Blind Treatment|Lost to Follow-up|1
488175|NCT00075218|1578690|P3|Double-Blind Treatment|Withdrawal by Subject|0
488176|NCT00075218|1578691|P2|Double-Blind Treatment|Withdrawal by Subject|4
488177|NCT00075218|1578692|P1|Double-Blind Treatment|Withdrawal by Subject|7
488178|NCT00075218|1578690|P3|Double-Blind Treatment|Adverse Event|0
488179|NCT00075218|1578691|P2|Double-Blind Treatment|Adverse Event|4
488180|NCT00075218|1578692|P1|Double-Blind Treatment|Adverse Event|23
488181|NCT00075023|1578741|P2|Pilot Study|Withdrawal by Subject|0
488182|NCT00075023|1578742|P1|Pilot Study|Withdrawal by Subject|1
488183|NCT00075023|1578741|P2|Pilot Study|Physician Decision|2
488184|NCT00075023|1578742|P1|Pilot Study|Physician Decision|1
488185|NCT00074984|1578751|P2|Overall Study|Patient Withdrawn Per Protocol|3
488186|NCT00074984|1578752|P1|Overall Study|Patient Withdrawn Per Protocol|0
488187|NCT00074984|1578751|P2|Overall Study|Withdrawal by Subject|3
488188|NCT00074984|1578752|P1|Overall Study|Withdrawal by Subject|2
488189|NCT00074984|1578751|P2|Overall Study|Death|2
488190|NCT00074984|1578752|P1|Overall Study|Death|1
488191|NCT00074958|1578767|P1|Overall Study|Adverse Event|1
488192|NCT00074711|1578808|P2|Overall Study|Participant stopped study drug|6
488193|NCT00074711|1578809|P1|Overall Study|Participant stopped study drug|4
488194|NCT00074711|1578808|P2|Overall Study|Lost to Follow-up|8
488195|NCT00074711|1578809|P1|Overall Study|Lost to Follow-up|10
488196|NCT00074711|1578808|P2|Overall Study|Withdrawal by Subject|1
488197|NCT00074711|1578809|P1|Overall Study|Withdrawal by Subject|1
488198|NCT00074581|1578827|P2|Overall Study|Other|19
488199|NCT00074581|1578828|P1|Overall Study|Other|14
488200|NCT00074581|1578827|P2|Overall Study|Ended relationship w. index participant|106
488201|NCT00074581|1578828|P1|Overall Study|Ended relationship w. index participant|117
488202|NCT00074581|1578827|P2|Overall Study|Lost to Follow-up|11
488203|NCT00074581|1578828|P1|Overall Study|Lost to Follow-up|16
488204|NCT00074581|1578827|P2|Overall Study|Were withdrawn by investigator|2
488205|NCT00074581|1578828|P1|Overall Study|Were withdrawn by investigator|5
488206|NCT00074581|1578827|P2|Overall Study|Relocated|9
488207|NCT00074581|1578828|P1|Overall Study|Relocated|14
488208|NCT00074581|1578827|P2|Overall Study|Unable to adhere to visit schedule|14
488209|NCT00074581|1578828|P1|Overall Study|Unable to adhere to visit schedule|13
488210|NCT00074581|1578827|P2|Overall Study|Withdrawal by Subject|49
488211|NCT00074581|1578828|P1|Overall Study|Withdrawal by Subject|50
488212|NCT00074581|1578827|P2|Overall Study|Death|16
488213|NCT00074581|1578828|P1|Overall Study|Death|15
488214|NCT00074412|1578838|P2|Overall Study|Lost to Follow-up|58
488215|NCT00074412|1578839|P1|Overall Study|Lost to Follow-up|52
488216|NCT00074412|1578838|P2|Overall Study|Death|26
488217|NCT00074412|1578839|P1|Overall Study|Death|30
488218|NCT00074152|1578887|P2|Overall Study|Lack of Efficacy|24
488219|NCT00074152|1578888|P1|Overall Study|Lack of Efficacy|34
488220|NCT00074152|1578887|P2|Overall Study|Death|9
488221|NCT00074152|1578888|P1|Overall Study|Death|21
488222|NCT00073983|1578905|P1|Overall Study|not evaluable|1
488223|NCT00073918|1578926|P1|Overall Study|Eligibility requirement not met-low CD20|1
488224|NCT00073918|1578926|P1|Overall Study|Rapid disease progression|2
488225|NCT00073918|1578926|P1|Overall Study|Eligibility requirement not met - HAMA+|1
488226|NCT00073528|1578935|P2|Overall Study|Ongoing|344
488227|NCT00073528|1578936|P1|Overall Study|Ongoing|349
488228|NCT00073528|1578935|P2|Overall Study|Non-compliance|1
488229|NCT00073528|1578936|P1|Overall Study|Non-compliance|0
488230|NCT00073528|1578935|P2|Overall Study|Enrolled in Error|1
488231|NCT00073528|1578936|P1|Overall Study|Enrolled in Error|0
488232|NCT00073528|1578935|P2|Overall Study|Participant Was Unblinded|1
488233|NCT00073528|1578936|P1|Overall Study|Participant Was Unblinded|0
488234|NCT00073528|1578935|P2|Overall Study|Progressive Disease|1
488235|NCT00073528|1578936|P1|Overall Study|Progressive Disease|0
488236|NCT00073528|1578935|P2|Overall Study|Randomized in Error; Not Treated|0
488237|NCT00073528|1578936|P1|Overall Study|Randomized in Error; Not Treated|2
488238|NCT00073528|1578935|P2|Overall Study|Mastectomy Intervention|0
488239|NCT00073528|1578936|P1|Overall Study|Mastectomy Intervention|1
488240|NCT00073528|1578935|P2|Overall Study|Death|238
488241|NCT00073528|1578936|P1|Overall Study|Death|229
488242|NCT00073528|1578935|P2|Overall Study|Protocol Violation|5
488243|NCT00073528|1578936|P1|Overall Study|Protocol Violation|3
488244|NCT00073528|1578935|P2|Overall Study|Lost to Follow-up|22
488245|NCT00073528|1578936|P1|Overall Study|Lost to Follow-up|26
488246|NCT00073528|1578935|P2|Overall Study|Withdrawal by Subject|29
488247|NCT00073528|1578936|P1|Overall Study|Withdrawal by Subject|34
488248|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
488249|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
488250|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
488251|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
488252|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
488253|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
488254|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
488255|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
488256|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
488257|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
488258|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
488259|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
488260|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
488261|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
488262|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
488263|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
488264|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
488265|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
488266|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
488267|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
488268|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
488269|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
488270|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
488271|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
488272|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
488273|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
488274|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
488275|NCT00073307|1579025|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
488276|NCT00073307|1579026|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
488277|NCT00073307|1579027|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
488278|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
488279|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
488280|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
488281|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
488282|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
488283|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
488284|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
488285|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
488286|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
488287|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
488288|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
488289|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
488290|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
488291|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
488292|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
488293|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
488294|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
488295|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
488296|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
488297|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
488298|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
488299|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
488300|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
488301|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
488302|NCT00073307|1579025|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
488303|NCT00073307|1579026|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
488304|NCT00073307|1579027|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
488305|NCT00073021|1579058|P2|Overall Study|Lack of Efficacy|5
488306|NCT00073021|1579059|P1|Overall Study|Lack of Efficacy|11
488307|NCT00073021|1579058|P2|Overall Study|Physician Decision|1
488308|NCT00073021|1579059|P1|Overall Study|Physician Decision|3
488309|NCT00073021|1579058|P2|Overall Study|Withdrawal by Subject|5
488310|NCT00073021|1579059|P1|Overall Study|Withdrawal by Subject|6
488311|NCT00073021|1579058|P2|Overall Study|Adverse Event|4
488312|NCT00073021|1579059|P1|Overall Study|Adverse Event|4
488313|NCT00073021|1579058|P2|Overall Study|Protocol Violation|1
488314|NCT00073021|1579059|P1|Overall Study|Protocol Violation|2
488315|NCT00073008|1579089|P2|Overall Study|"Other selected on Case Report Form"|5
488316|NCT00073008|1579090|P1|Overall Study|"Other selected on Case Report Form"|7
488317|NCT00073008|1579089|P2|Overall Study|Death|47
488318|NCT00073008|1579090|P1|Overall Study|Death|46
488319|NCT00073008|1579089|P2|Overall Study|Lost to Follow-up|3
488320|NCT00073008|1579090|P1|Overall Study|Lost to Follow-up|1
488321|NCT00073008|1579089|P2|Overall Study|Withdrawal by Subject|2
488322|NCT00073008|1579090|P1|Overall Study|Withdrawal by Subject|2
488323|NCT00073008|1579089|P2|Overall Study|Missing|6
488324|NCT00073008|1579090|P1|Overall Study|Missing|6
488325|NCT00072475|1579129|P1|Overall Study|Patient/Investigator Decision|4
488326|NCT00072475|1579129|P1|Overall Study|Withdrawal by Subject|46
488327|NCT00072475|1579129|P1|Overall Study|Death|3
488328|NCT00072475|1579129|P1|Overall Study|Adverse Event|44
488329|NCT00072293|1579146|P2|Overall Study|Withdrawal by Subject|1
488330|NCT00072293|1579147|P1|Overall Study|Withdrawal by Subject|0
488331|NCT00072293|1579146|P2|Overall Study|Lost to Follow-up|1
488332|NCT00072293|1579147|P1|Overall Study|Lost to Follow-up|1
488333|NCT00072280|1579159|P2|Follow-up|Early termination of study|2
488334|NCT00072280|1579160|P1|Follow-up|Early termination of study|2
488335|NCT00072280|1579159|P2|Treatment|Found ineligible|2
488336|NCT00072280|1579160|P1|Treatment|Found ineligible|1
488337|NCT00072189|1579165|P1|Overall Study|Withdrawal by Subject|1
488338|NCT00072176|1579173|P2|Overall Study|Protocol Violation|1
488339|NCT00072176|1579174|P1|Overall Study|Protocol Violation|0
488340|NCT00072176|1579173|P2|Overall Study|Withdrawal by Subject|0
488341|NCT00072176|1579174|P1|Overall Study|Withdrawal by Subject|1
488342|NCT00071981|1579186|P4|Overall Study|others (not specified in the study)|0
488343|NCT00071981|1579187|P3|Overall Study|others (not specified in the study)|2
488344|NCT00071981|1579188|P2|Overall Study|others (not specified in the study)|2
488345|NCT00071981|1579189|P1|Overall Study|others (not specified in the study)|0
488346|NCT00071981|1579186|P4|Overall Study|No protocol therapy|0
488347|NCT00071981|1579187|P3|Overall Study|No protocol therapy|1
488348|NCT00071981|1579188|P2|Overall Study|No protocol therapy|5
488349|NCT00071981|1579189|P1|Overall Study|No protocol therapy|2
488350|NCT00071981|1579186|P4|Overall Study|Withdrawal by Subject|0
488351|NCT00071981|1579187|P3|Overall Study|Withdrawal by Subject|0
488352|NCT00071981|1579188|P2|Overall Study|Withdrawal by Subject|1
488353|NCT00071981|1579189|P1|Overall Study|Withdrawal by Subject|3
488354|NCT00071981|1579186|P4|Overall Study|Death|1
488355|NCT00071981|1579187|P3|Overall Study|Death|1
488356|NCT00071981|1579188|P2|Overall Study|Death|0
488357|NCT00071981|1579189|P1|Overall Study|Death|0
488358|NCT00071981|1579186|P4|Overall Study|Adverse Event|1
488359|NCT00071981|1579187|P3|Overall Study|Adverse Event|3
488360|NCT00071981|1579188|P2|Overall Study|Adverse Event|4
488361|NCT00071981|1579189|P1|Overall Study|Adverse Event|4
488362|NCT00071981|1579186|P4|Overall Study|Lack of Efficacy|43
488363|NCT00071981|1579187|P3|Overall Study|Lack of Efficacy|30
488364|NCT00071981|1579188|P2|Overall Study|Lack of Efficacy|29
488365|NCT00071981|1579189|P1|Overall Study|Lack of Efficacy|37
488366|NCT00071812|1579232|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
488367|NCT00071812|1579233|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
488368|NCT00071812|1579234|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
488369|NCT00071812|1579235|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
488370|NCT00071812|1579232|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
488371|NCT00071812|1579233|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
488372|NCT00071812|1579234|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
488373|NCT00071812|1579235|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
488374|NCT00071812|1579232|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
488375|NCT00071812|1579233|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
488376|NCT00071812|1579234|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
488377|NCT00071812|1579235|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
488378|NCT00071812|1579232|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
488379|NCT00071812|1579233|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
488380|NCT00071812|1579234|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
488381|NCT00071812|1579235|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
488382|NCT00071812|1579232|P4|24-Week Open-Label Extension Period|Adverse Event|7
488383|NCT00071812|1579233|P3|24-Week Open-Label Extension Period|Adverse Event|0
488384|NCT00071812|1579234|P2|24-Week Open-Label Extension Period|Adverse Event|0
488385|NCT00071812|1579235|P1|24-Week Open-Label Extension Period|Adverse Event|0
488386|NCT00071812|1579232|P4|24-Week Double-Blind Period|Protocol Violation|1
488387|NCT00071812|1579233|P3|24-Week Double-Blind Period|Protocol Violation|0
488388|NCT00071812|1579234|P2|24-Week Double-Blind Period|Protocol Violation|0
488389|NCT00071812|1579235|P1|24-Week Double-Blind Period|Protocol Violation|0
488390|NCT00071812|1579232|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
488391|NCT00071812|1579233|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
488392|NCT00071812|1579234|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
488393|NCT00071812|1579235|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
488394|NCT00071812|1579232|P4|24-Week Double-Blind Period|Lost to Follow-up|0
488395|NCT00071812|1579233|P3|24-Week Double-Blind Period|Lost to Follow-up|1
488396|NCT00071812|1579234|P2|24-Week Double-Blind Period|Lost to Follow-up|1
488397|NCT00071812|1579235|P1|24-Week Double-Blind Period|Lost to Follow-up|0
488398|NCT00071812|1579232|P4|24-Week Double-Blind Period|Lack of Efficacy|1
488399|NCT00071812|1579233|P3|24-Week Double-Blind Period|Lack of Efficacy|2
488400|NCT00071812|1579234|P2|24-Week Double-Blind Period|Lack of Efficacy|1
488401|NCT00071812|1579235|P1|24-Week Double-Blind Period|Lack of Efficacy|3
488402|NCT00071812|1579232|P4|24-Week Double-Blind Period|Adverse Event|4
488403|NCT00071812|1579233|P3|24-Week Double-Blind Period|Adverse Event|4
488404|NCT00071812|1579234|P2|24-Week Double-Blind Period|Adverse Event|3
488405|NCT00071812|1579235|P1|24-Week Double-Blind Period|Adverse Event|2
488406|NCT00071799|1579277|P2|Overall Study|Not Documented|2
488407|NCT00071799|1579278|P1|Overall Study|Not Documented|0
488408|NCT00071799|1579277|P2|Overall Study|Different Central+Local Pathology Review|1
488409|NCT00071799|1579278|P1|Overall Study|Different Central+Local Pathology Review|0
488410|NCT00071799|1579277|P2|Overall Study|Disease Progression|20
488411|NCT00071799|1579278|P1|Overall Study|Disease Progression|23
488412|NCT00071799|1579277|P2|Overall Study|Lack of Efficacy|18
488413|NCT00071799|1579278|P1|Overall Study|Lack of Efficacy|11
488414|NCT00071799|1579277|P2|Overall Study|Physician Decision|2
488415|NCT00071799|1579278|P1|Overall Study|Physician Decision|0
488416|NCT00071799|1579277|P2|Overall Study|Withdrawal by Subject|37
488417|NCT00071799|1579278|P1|Overall Study|Withdrawal by Subject|15
488418|NCT00071799|1579277|P2|Overall Study|Lost to Follow-up|1
488419|NCT00071799|1579278|P1|Overall Study|Lost to Follow-up|1
488420|NCT00071799|1579277|P2|Overall Study|Protocol Violation|7
488421|NCT00071799|1579278|P1|Overall Study|Protocol Violation|1
488422|NCT00071799|1579277|P2|Overall Study|Adverse Event|10
488423|NCT00071799|1579278|P1|Overall Study|Adverse Event|19
488424|NCT00071760|1579331|P1|Overall Study|Ongoing|25
488425|NCT00071760|1579331|P1|Overall Study|Study Team Rec./Resistance|1
488426|NCT00071760|1579331|P1|Overall Study|Investigator's Recommendation (Rec.)|4
488427|NCT00071760|1579331|P1|Overall Study|Relocation|1
488428|NCT00071760|1579331|P1|Overall Study|Unavailability of RTV|8
488429|NCT00071760|1579331|P1|Overall Study|Pulmonary Tuberculosis|1
488430|NCT00071760|1579331|P1|Overall Study|Insufficient Viral Load Response|3
488431|NCT00071760|1579331|P1|Overall Study|Withdrawal by Subject|3
488432|NCT00071760|1579331|P1|Overall Study|Protocol Violation|1
488433|NCT00071760|1579331|P1|Overall Study|Lost to Follow-up|4
488434|NCT00071760|1579331|P1|Overall Study|Adverse Event|3
488435|NCT00071513|1579411|P2|Follow-up Assessment|Withdrawal by Subject|6
488436|NCT00071513|1579412|P1|Follow-up Assessment|Withdrawal by Subject|6
488437|NCT00071513|1579411|P2|Intervention Component|Withdrawal by Subject|3
488438|NCT00071513|1579412|P1|Intervention Component|Withdrawal by Subject|2
488439|NCT00071487|1579424|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
488440|NCT00071487|1579425|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
488441|NCT00071487|1579426|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
488442|NCT00071487|1579427|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
488443|NCT00071487|1579424|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
488444|NCT00071487|1579425|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
488445|NCT00071487|1579426|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
488446|NCT00071487|1579427|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
488447|NCT00071487|1579424|P4|24-Week Open-Label Extension Period|Pregnancy|1
488448|NCT00071487|1579425|P3|24-Week Open-Label Extension Period|Pregnancy|0
488449|NCT00071487|1579426|P2|24-Week Open-Label Extension Period|Pregnancy|0
488450|NCT00071487|1579427|P1|24-Week Open-Label Extension Period|Pregnancy|0
488451|NCT00071487|1579424|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
488452|NCT00071487|1579425|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
488453|NCT00071487|1579426|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
488454|NCT00071487|1579427|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
488455|NCT00071487|1579424|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
488456|NCT00071487|1579425|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
488457|NCT00071487|1579426|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
488458|NCT00071487|1579427|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
488459|NCT00071487|1579424|P4|24-Week Open-Label Extension Period|Adverse Event|6
488460|NCT00071487|1579425|P3|24-Week Open-Label Extension Period|Adverse Event|1
488461|NCT00071487|1579426|P2|24-Week Open-Label Extension Period|Adverse Event|0
488462|NCT00071487|1579427|P1|24-Week Open-Label Extension Period|Adverse Event|0
488463|NCT00071487|1579424|P4|52-Week Double-Blind Period|Lack of Compliance|3
488464|NCT00071487|1579425|P3|52-Week Double-Blind Period|Lack of Compliance|3
488465|NCT00071487|1579426|P2|52-Week Double-Blind Period|Lack of Compliance|3
488466|NCT00071487|1579427|P1|52-Week Double-Blind Period|Lack of Compliance|6
488467|NCT00071487|1579424|P4|52-Week Double-Blind Period|Death|0
488468|NCT00071487|1579425|P3|52-Week Double-Blind Period|Death|0
488469|NCT00071487|1579426|P2|52-Week Double-Blind Period|Death|1
488470|NCT00071487|1579427|P1|52-Week Double-Blind Period|Death|0
488471|NCT00071487|1579424|P4|52-Week Double-Blind Period|Protocol Violation|0
488472|NCT00071487|1579425|P3|52-Week Double-Blind Period|Protocol Violation|1
488473|NCT00071487|1579426|P2|52-Week Double-Blind Period|Protocol Violation|1
488474|NCT00071487|1579427|P1|52-Week Double-Blind Period|Protocol Violation|0
488475|NCT00071487|1579424|P4|52-Week Double-Blind Period|Pregnancy|0
488476|NCT00071487|1579425|P3|52-Week Double-Blind Period|Pregnancy|0
488477|NCT00071487|1579426|P2|52-Week Double-Blind Period|Pregnancy|1
488478|NCT00071487|1579427|P1|52-Week Double-Blind Period|Pregnancy|0
488479|NCT00071487|1579424|P4|52-Week Double-Blind Period|Lost to Follow-up|2
488480|NCT00071487|1579425|P3|52-Week Double-Blind Period|Lost to Follow-up|2
488481|NCT00071487|1579426|P2|52-Week Double-Blind Period|Lost to Follow-up|0
488482|NCT00071487|1579427|P1|52-Week Double-Blind Period|Lost to Follow-up|0
488483|NCT00071487|1579424|P4|52-Week Double-Blind Period|Physician Decision|0
488484|NCT00071487|1579425|P3|52-Week Double-Blind Period|Physician Decision|0
488485|NCT00071487|1579426|P2|52-Week Double-Blind Period|Physician Decision|0
488486|NCT00071487|1579427|P1|52-Week Double-Blind Period|Physician Decision|1
488487|NCT00071487|1579424|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
488488|NCT00071487|1579425|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
488489|NCT00071487|1579426|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
488490|NCT00071487|1579427|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
488491|NCT00071487|1579424|P4|52-Week Double-Blind Period|Lack of Efficacy|1
488492|NCT00071487|1579425|P3|52-Week Double-Blind Period|Lack of Efficacy|0
488493|NCT00071487|1579426|P2|52-Week Double-Blind Period|Lack of Efficacy|2
488494|NCT00071487|1579427|P1|52-Week Double-Blind Period|Lack of Efficacy|1
488495|NCT00071487|1579424|P4|52-Week Double-Blind Period|Adverse Event|8
488496|NCT00071487|1579425|P3|52-Week Double-Blind Period|Adverse Event|4
488497|NCT00071487|1579426|P2|52-Week Double-Blind Period|Adverse Event|8
488498|NCT00071487|1579427|P1|52-Week Double-Blind Period|Adverse Event|5
488499|NCT00071396|1579471|P1|Overall Study|Physician Decision|2
488500|NCT00071396|1579471|P1|Overall Study|Withdrawal by Subject|1
488501|NCT00071110|1579477|P2|Overall Study|Protocol Violation|4
488502|NCT00071110|1579478|P1|Overall Study|Protocol Violation|0
488503|NCT00071032|1579492|P2|Overall Study|Missing Primary Outcome|1
488504|NCT00071032|1579493|P1|Overall Study|Missing Primary Outcome|0
488505|NCT00071032|1579492|P2|Overall Study|Withdrawal by Subject|6
488506|NCT00071032|1579493|P1|Overall Study|Withdrawal by Subject|8
488507|NCT00071032|1579492|P2|Overall Study|Lost to Follow-up|1
488508|NCT00071032|1579493|P1|Overall Study|Lost to Follow-up|1
488509|NCT00071006|1579501|P1|Overall Study|Other|3
488510|NCT00071006|1579501|P1|Overall Study|Withdrawal by Subject|1
488511|NCT00071006|1579501|P1|Overall Study|Adverse Event|1
488512|NCT00071006|1579501|P1|Overall Study|Lack of Efficacy|7
488513|NCT00070941|1579514|P3|Overall Study|Adverse Event|4
488514|NCT00070941|1579515|P2|Overall Study|Adverse Event|8
488515|NCT00070941|1579516|P1|Overall Study|Adverse Event|10
488516|NCT00071058|1579524|P1|Overall Study|brain tumor-removed from study|1
488517|NCT00003907|1579531|P2|Overall Study|ineligible or not treated|2
488518|NCT00003907|1579532|P1|Overall Study|ineligible or not treated|2
488519|NCT00003907|1579531|P2|Overall Study|Not specified|3
488520|NCT00003907|1579532|P1|Overall Study|Not specified|1
488521|NCT00003907|1579531|P2|Overall Study|Complicating disease|0
488522|NCT00003907|1579532|P1|Overall Study|Complicating disease|1
488523|NCT00003907|1579531|P2|Overall Study|Progressive disease|4
488524|NCT00003907|1579532|P1|Overall Study|Progressive disease|4
488525|NCT00003907|1579531|P2|Overall Study|Withdrawal by Subject|3
488526|NCT00003907|1579532|P1|Overall Study|Withdrawal by Subject|1
488527|NCT00003907|1579531|P2|Overall Study|Death|0
488528|NCT00003907|1579532|P1|Overall Study|Death|2
488529|NCT00003907|1579531|P2|Overall Study|Adverse Event|11
488530|NCT00003907|1579532|P1|Overall Study|Adverse Event|2
488531|NCT00070564|1579548|P6|Overall Study|Not reported|0
488532|NCT00070564|1579549|P5|Overall Study|Not reported|1
488533|NCT00070564|1579550|P4|Overall Study|Not reported|0
488534|NCT00070564|1579551|P3|Overall Study|Not reported|0
488535|NCT00070564|1579552|P2|Overall Study|Not reported|0
488536|NCT00070564|1579553|P1|Overall Study|Not reported|0
488537|NCT00070564|1579548|P6|Overall Study|Withdrawal by Subject|8
488538|NCT00070564|1579549|P5|Overall Study|Withdrawal by Subject|8
488539|NCT00070564|1579550|P4|Overall Study|Withdrawal by Subject|30
488540|NCT00070564|1579551|P3|Overall Study|Withdrawal by Subject|23
488541|NCT00070564|1579552|P2|Overall Study|Withdrawal by Subject|37
488542|NCT00070564|1579553|P1|Overall Study|Withdrawal by Subject|26
488543|NCT00070564|1579548|P6|Overall Study|Other, not protocol specified|7
488544|NCT00070564|1579549|P5|Overall Study|Other, not protocol specified|6
488545|NCT00070564|1579550|P4|Overall Study|Other, not protocol specified|19
488546|NCT00070564|1579551|P3|Overall Study|Other, not protocol specified|14
488547|NCT00070564|1579552|P2|Overall Study|Other, not protocol specified|15
488548|NCT00070564|1579553|P1|Overall Study|Other, not protocol specified|17
488549|NCT00070564|1579548|P6|Overall Study|Death|1
488550|NCT00070564|1579549|P5|Overall Study|Death|0
488551|NCT00070564|1579550|P4|Overall Study|Death|3
488552|NCT00070564|1579551|P3|Overall Study|Death|5
488553|NCT00070564|1579552|P2|Overall Study|Death|1
488554|NCT00070564|1579553|P1|Overall Study|Death|4
488555|NCT00070564|1579548|P6|Overall Study|Adverse Event|36
488556|NCT00070564|1579549|P5|Overall Study|Adverse Event|63
488557|NCT00070564|1579550|P4|Overall Study|Adverse Event|108
488558|NCT00070564|1579551|P3|Overall Study|Adverse Event|120
488559|NCT00070564|1579552|P2|Overall Study|Adverse Event|142
488560|NCT00070564|1579553|P1|Overall Study|Adverse Event|150
488561|NCT00070564|1579548|P6|Overall Study|Delinquent|0
488562|NCT00070564|1579549|P5|Overall Study|Delinquent|0
488563|NCT00070564|1579550|P4|Overall Study|Delinquent|0
488564|NCT00070564|1579551|P3|Overall Study|Delinquent|2
488565|NCT00070564|1579552|P2|Overall Study|Delinquent|4
488566|NCT00070564|1579553|P1|Overall Study|Delinquent|1
488567|NCT00070564|1579548|P6|Overall Study|Progression|0
488568|NCT00070564|1579549|P5|Overall Study|Progression|1
488569|NCT00070564|1579550|P4|Overall Study|Progression|7
488570|NCT00070564|1579551|P3|Overall Study|Progression|7
488571|NCT00070564|1579552|P2|Overall Study|Progression|4
488572|NCT00070564|1579553|P1|Overall Study|Progression|2
488573|NCT00070499|1579607|P4|Overall Study|Not eligible|2
488574|NCT00070499|1579608|P3|Overall Study|Not eligible|3
488575|NCT00070499|1579609|P2|Overall Study|Not eligible|5
488576|NCT00070499|1579610|P1|Overall Study|Not eligible|2
488577|NCT00070499|1579607|P4|Overall Study|Did not start treatment|2
488578|NCT00070499|1579608|P3|Overall Study|Did not start treatment|0
488579|NCT00070499|1579609|P2|Overall Study|Did not start treatment|0
488580|NCT00070499|1579610|P1|Overall Study|Did not start treatment|1
488581|NCT00070499|1579607|P4|Overall Study|Still on protocol treatment|57
488582|NCT00070499|1579608|P3|Overall Study|Still on protocol treatment|79
488583|NCT00070499|1579609|P2|Overall Study|Still on protocol treatment|4
488584|NCT00070499|1579610|P1|Overall Study|Still on protocol treatment|10
488585|NCT00070499|1579607|P4|Overall Study|Other - not protocol specified|20
488586|NCT00070499|1579608|P3|Overall Study|Other - not protocol specified|12
488587|NCT00070499|1579609|P2|Overall Study|Other - not protocol specified|3
488588|NCT00070499|1579610|P1|Overall Study|Other - not protocol specified|7
488589|NCT00070499|1579607|P4|Overall Study|Death|2
488590|NCT00070499|1579608|P3|Overall Study|Death|1
488591|NCT00070499|1579609|P2|Overall Study|Death|1
488592|NCT00070499|1579610|P1|Overall Study|Death|1
488593|NCT00070499|1579607|P4|Overall Study|Progression/relapse|4
488594|NCT00070499|1579608|P3|Overall Study|Progression/relapse|1
488595|NCT00070499|1579609|P2|Overall Study|Progression/relapse|2
488596|NCT00070499|1579610|P1|Overall Study|Progression/relapse|4
488597|NCT00070499|1579607|P4|Overall Study|Refusal unrelated to adverse effects|8
488598|NCT00070499|1579608|P3|Overall Study|Refusal unrelated to adverse effects|5
488599|NCT00070499|1579609|P2|Overall Study|Refusal unrelated to adverse effects|5
488600|NCT00070499|1579610|P1|Overall Study|Refusal unrelated to adverse effects|7
488601|NCT00070499|1579607|P4|Overall Study|Adverse Event|15
488602|NCT00070499|1579608|P3|Overall Study|Adverse Event|19
488603|NCT00070499|1579609|P2|Overall Study|Adverse Event|6
488604|NCT00070499|1579610|P1|Overall Study|Adverse Event|6
488605|NCT00070317|1579636|P1|Overall Study|Ineligible-Inadequate pathology|6
488606|NCT00070317|1579636|P1|Overall Study|Ineligible-Improper prior treatment|2
488607|NCT00070317|1579636|P1|Overall Study|Ineligible required test not done|1
488608|NCT00070317|1579636|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
488609|NCT00070317|1579636|P1|Overall Study|Inevaluable (Never Treated)|1
488610|NCT00070291|1579641|P1|Step 2|Adverse Event|1
488611|NCT00070291|1579641|P1|Step 1|Adverse Event|1
488612|NCT00070291|1579641|P1|Step 1|Withdrawal by Subject|1
488613|NCT00070109|1579657|P5|Overall Study|removed from prot thpy prior to chemo|0
488614|NCT00070109|1579658|P4|Overall Study|removed from prot thpy prior to chemo|1
488615|NCT00070109|1579659|P3|Overall Study|removed from prot thpy prior to chemo|0
488616|NCT00070109|1579660|P2|Overall Study|removed from prot thpy prior to chemo|0
488617|NCT00070109|1579661|P1|Overall Study|removed from prot thpy prior to chemo|0
488618|NCT00070109|1579657|P5|Overall Study|Adverse Event|2
488619|NCT00070109|1579658|P4|Overall Study|Adverse Event|4
488620|NCT00070109|1579659|P3|Overall Study|Adverse Event|2
488621|NCT00070109|1579660|P2|Overall Study|Adverse Event|0
488622|NCT00070109|1579661|P1|Overall Study|Adverse Event|0
488623|NCT00070109|1579657|P5|Overall Study|Withdrawal by Subject|0
488624|NCT00070109|1579658|P4|Overall Study|Withdrawal by Subject|0
488625|NCT00070109|1579659|P3|Overall Study|Withdrawal by Subject|1
488626|NCT00070109|1579660|P2|Overall Study|Withdrawal by Subject|1
488627|NCT00070109|1579661|P1|Overall Study|Withdrawal by Subject|0
488628|NCT00070109|1579657|P5|Overall Study|Physician Decision|0
488629|NCT00070109|1579658|P4|Overall Study|Physician Decision|0
488630|NCT00070109|1579659|P3|Overall Study|Physician Decision|0
488631|NCT00070109|1579660|P2|Overall Study|Physician Decision|0
488632|NCT00070109|1579661|P1|Overall Study|Physician Decision|1
488633|NCT00070109|1579657|P5|Overall Study|Lack of Efficacy|5
488634|NCT00070109|1579658|P4|Overall Study|Lack of Efficacy|15
488635|NCT00070109|1579659|P3|Overall Study|Lack of Efficacy|5
488636|NCT00070109|1579660|P2|Overall Study|Lack of Efficacy|4
488637|NCT00070109|1579661|P1|Overall Study|Lack of Efficacy|6
488638|NCT00070109|1579657|P5|Overall Study|Death|1
488639|NCT00070109|1579658|P4|Overall Study|Death|0
488640|NCT00070109|1579659|P3|Overall Study|Death|0
488641|NCT00070109|1579660|P2|Overall Study|Death|1
488642|NCT00070109|1579661|P1|Overall Study|Death|1
488643|NCT00070018|1579674|P1|Overall Study|Withdrawal by Subject|1
488644|NCT00070018|1579674|P1|Overall Study|Lack of Efficacy|1
488645|NCT00070018|1579674|P1|Overall Study|Adverse Event|2
488646|NCT00069953|1579678|P1|Overall Study|Protocol Violation|2
488647|NCT00069784|1579684|P2|Overall Study|Other|0
488648|NCT00069784|1579685|P1|Overall Study|Other|17
488649|NCT00069784|1579684|P2|Overall Study|Withdrawal by Subject|0
488650|NCT00069784|1579685|P1|Overall Study|Withdrawal by Subject|1090
488651|NCT00069784|1579684|P2|Overall Study|Adverse Event|0
488652|NCT00069784|1579685|P1|Overall Study|Adverse Event|105
488653|NCT00069823|1579705|P2|Overall Study|Did not have follow-up diary cards|3
488654|NCT00069823|1579706|P1|Overall Study|Did not have follow-up diary cards|6
488655|NCT00069641|1579749|P3|Overall Study|Death|1
488656|NCT00069641|1579750|P2|Overall Study|Death|0
488657|NCT00069641|1579751|P1|Overall Study|Death|1
488658|NCT00069277|1579776|P1|Overall Study|Physician Decision|2
488659|NCT00069277|1579776|P1|Overall Study|Progressive Disease|15
488660|NCT00069277|1579776|P1|Overall Study|Withdrawal by Subject|1
488661|NCT00069277|1579776|P1|Overall Study|Adverse Event|3
488662|NCT00069264|1579780|P1|Overall Study|Discon Therapy|3
488663|NCT00069264|1579780|P1|Overall Study|Withdrawal by Subject|3
488664|NCT00069264|1579780|P1|Overall Study|Progressive Disease|23
488665|NCT00069264|1579780|P1|Overall Study|Adverse Event|3
488666|NCT00069238|1579808|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
488667|NCT00069238|1579809|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
488668|NCT00069238|1579810|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
488669|NCT00069238|1579808|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
488670|NCT00069238|1579809|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
488671|NCT00069238|1579810|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
488672|NCT00069238|1579808|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
488673|NCT00069238|1579809|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
488674|NCT00069238|1579810|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
488675|NCT00069121|1579818|P2|Overall Study|Lost to Follow-up|57
488676|NCT00069121|1579819|P1|Overall Study|Lost to Follow-up|57
488677|NCT00069121|1579818|P2|Overall Study|Withdrawal by Subject|22
488678|NCT00069121|1579819|P1|Overall Study|Withdrawal by Subject|20
488679|NCT00069121|1579818|P2|Overall Study|Death|197
488680|NCT00069121|1579819|P1|Overall Study|Death|225
488681|NCT00069108|1579841|P2|Overall Study|Refused treatment|10
488682|NCT00069108|1579842|P1|Overall Study|Refused treatment|5
488683|NCT00069108|1579841|P2|Overall Study|Violation criteria|4
488684|NCT00069108|1579842|P1|Overall Study|Violation criteria|1
488685|NCT00069108|1579841|P2|Overall Study|Insufficient therapy|144
488686|NCT00069108|1579842|P1|Overall Study|Insufficient therapy|117
488687|NCT00069108|1579841|P2|Overall Study|Administration|4
488688|NCT00069108|1579842|P1|Overall Study|Administration|15
488689|NCT00069108|1579841|P2|Overall Study|Death|6
488690|NCT00069108|1579842|P1|Overall Study|Death|6
488691|NCT00069108|1579841|P2|Overall Study|Adverse Event|42
488692|NCT00069108|1579842|P1|Overall Study|Adverse Event|64
488693|NCT00069108|1579841|P2|Overall Study|Withdrawal by Subject|9
488694|NCT00069108|1579842|P1|Overall Study|Withdrawal by Subject|5
488695|NCT00069095|1579874|P6|Follow-up Phase|Death|101
488696|NCT00069095|1579875|P5|Follow-up Phase|Death|92
488697|NCT00069095|1579876|P4|Follow-up Phase|Death|112
488698|NCT00069095|1579877|P3|Follow-up Phase|Death|120
488699|NCT00069095|1579878|P2|Follow-up Phase|Death|206
488700|NCT00069095|1579879|P1|Follow-up Phase|Death|174
488701|NCT00069095|1579874|P6|Post-study Treatment Phase|Investigator decision|1
488702|NCT00069095|1579875|P5|Post-study Treatment Phase|Investigator decision|0
488703|NCT00069095|1579876|P4|Post-study Treatment Phase|Investigator decision|0
488704|NCT00069095|1579877|P3|Post-study Treatment Phase|Investigator decision|0
488705|NCT00069095|1579878|P2|Post-study Treatment Phase|Investigator decision|0
488706|NCT00069095|1579879|P1|Post-study Treatment Phase|Investigator decision|0
488707|NCT00069095|1579874|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
488708|NCT00069095|1579875|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
488709|NCT00069095|1579876|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
488710|NCT00069095|1579877|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
488711|NCT00069095|1579878|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
488712|NCT00069095|1579879|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
488713|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
488714|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
488715|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
488716|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
488717|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
488718|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
488719|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant had progressive disease|0
488720|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant had progressive disease|1
488721|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant had progressive disease|0
488722|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant had progressive disease|0
488723|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant had progressive disease|0
488724|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant had progressive disease|0
488725|NCT00069095|1579874|P6|Post-study Treatment Phase|Death|0
488726|NCT00069095|1579875|P5|Post-study Treatment Phase|Death|1
488727|NCT00069095|1579876|P4|Post-study Treatment Phase|Death|0
488728|NCT00069095|1579877|P3|Post-study Treatment Phase|Death|0
488729|NCT00069095|1579878|P2|Post-study Treatment Phase|Death|0
488730|NCT00069095|1579879|P1|Post-study Treatment Phase|Death|0
488731|NCT00069095|1579874|P6|Post-study Treatment Phase|Surgery|0
488732|NCT00069095|1579875|P5|Post-study Treatment Phase|Surgery|1
488733|NCT00069095|1579876|P4|Post-study Treatment Phase|Surgery|1
488734|NCT00069095|1579877|P3|Post-study Treatment Phase|Surgery|0
488735|NCT00069095|1579878|P2|Post-study Treatment Phase|Surgery|0
488736|NCT00069095|1579879|P1|Post-study Treatment Phase|Surgery|0
488737|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant completed treatment|0
488738|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant completed treatment|0
488739|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant completed treatment|1
488740|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant completed treatment|0
488741|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant completed treatment|0
488742|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant completed treatment|0
488743|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
488744|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
488745|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
488746|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
488747|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
488748|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
488749|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant will start new treatment|0
488750|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant will start new treatment|0
488751|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant will start new treatment|0
488752|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant will start new treatment|1
488753|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant will start new treatment|0
488754|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant will start new treatment|0
488755|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant withdrew consent|0
488756|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant withdrew consent|0
488757|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant withdrew consent|0
488758|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant withdrew consent|1
488759|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant withdrew consent|0
488760|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant withdrew consent|0
488761|NCT00069095|1579874|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
488762|NCT00069095|1579875|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
488763|NCT00069095|1579876|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
488764|NCT00069095|1579877|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
488765|NCT00069095|1579878|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
488766|NCT00069095|1579879|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
488767|NCT00069095|1579874|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
488768|NCT00069095|1579875|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
488769|NCT00069095|1579876|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
488770|NCT00069095|1579877|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
488771|NCT00069095|1579878|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
488772|NCT00069095|1579879|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
488773|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant had complete response|0
488774|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant had complete response|0
488775|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant had complete response|0
488776|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant had complete response|0
488777|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant had complete response|1
488778|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant had complete response|1
488779|NCT00069095|1579874|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
488780|NCT00069095|1579875|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
488781|NCT00069095|1579876|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
488782|NCT00069095|1579877|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
488783|NCT00069095|1579878|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
488784|NCT00069095|1579879|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
488785|NCT00069095|1579874|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
488786|NCT00069095|1579875|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
488787|NCT00069095|1579876|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
488788|NCT00069095|1579877|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
488789|NCT00069095|1579878|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
488790|NCT00069095|1579879|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
488791|NCT00069095|1579874|P6|Post-study Treatment Phase|Eligible for surgery|0
488792|NCT00069095|1579875|P5|Post-study Treatment Phase|Eligible for surgery|0
488793|NCT00069095|1579876|P4|Post-study Treatment Phase|Eligible for surgery|0
488794|NCT00069095|1579877|P3|Post-study Treatment Phase|Eligible for surgery|0
488795|NCT00069095|1579878|P2|Post-study Treatment Phase|Eligible for surgery|0
488796|NCT00069095|1579879|P1|Post-study Treatment Phase|Eligible for surgery|2
488797|NCT00069095|1579874|P6|Post-study Treatment Phase|Adverse Event|1
488798|NCT00069095|1579875|P5|Post-study Treatment Phase|Adverse Event|5
488799|NCT00069095|1579876|P4|Post-study Treatment Phase|Adverse Event|0
488800|NCT00069095|1579877|P3|Post-study Treatment Phase|Adverse Event|1
488801|NCT00069095|1579878|P2|Post-study Treatment Phase|Adverse Event|3
488802|NCT00069095|1579879|P1|Post-study Treatment Phase|Adverse Event|2
488803|NCT00069095|1579874|P6|Post-study Treatment Phase|Missing reason|17
488804|NCT00069095|1579875|P5|Post-study Treatment Phase|Missing reason|18
488805|NCT00069095|1579876|P4|Post-study Treatment Phase|Missing reason|8
488806|NCT00069095|1579877|P3|Post-study Treatment Phase|Missing reason|12
488807|NCT00069095|1579878|P2|Post-study Treatment Phase|Missing reason|3
488808|NCT00069095|1579879|P1|Post-study Treatment Phase|Missing reason|1
488809|NCT00069095|1579874|P6|Primary Treatment Phase|Violation criteria|5
488810|NCT00069095|1579875|P5|Primary Treatment Phase|Violation criteria|1
488811|NCT00069095|1579876|P4|Primary Treatment Phase|Violation criteria|3
488812|NCT00069095|1579877|P3|Primary Treatment Phase|Violation criteria|4
488813|NCT00069095|1579878|P2|Primary Treatment Phase|Violation criteria|2
488814|NCT00069095|1579879|P1|Primary Treatment Phase|Violation criteria|0
488815|NCT00069095|1579874|P6|Primary Treatment Phase|Other Violation|1
488816|NCT00069095|1579875|P5|Primary Treatment Phase|Other Violation|0
488817|NCT00069095|1579876|P4|Primary Treatment Phase|Other Violation|1
488818|NCT00069095|1579877|P3|Primary Treatment Phase|Other Violation|1
488819|NCT00069095|1579878|P2|Primary Treatment Phase|Other Violation|1
488820|NCT00069095|1579879|P1|Primary Treatment Phase|Other Violation|0
488821|NCT00069095|1579874|P6|Primary Treatment Phase|Withdrew|9
488822|NCT00069095|1579875|P5|Primary Treatment Phase|Withdrew|4
488823|NCT00069095|1579876|P4|Primary Treatment Phase|Withdrew|2
488824|NCT00069095|1579877|P3|Primary Treatment Phase|Withdrew|8
488825|NCT00069095|1579878|P2|Primary Treatment Phase|Withdrew|3
488826|NCT00069095|1579879|P1|Primary Treatment Phase|Withdrew|2
488827|NCT00069095|1579874|P6|Primary Treatment Phase|Refused treatment|27
488828|NCT00069095|1579875|P5|Primary Treatment Phase|Refused treatment|24
488829|NCT00069095|1579876|P4|Primary Treatment Phase|Refused treatment|31
488830|NCT00069095|1579877|P3|Primary Treatment Phase|Refused treatment|17
488831|NCT00069095|1579878|P2|Primary Treatment Phase|Refused treatment|26
488832|NCT00069095|1579879|P1|Primary Treatment Phase|Refused treatment|15
488833|NCT00069095|1579874|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
488834|NCT00069095|1579875|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
488835|NCT00069095|1579876|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
488836|NCT00069095|1579877|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
488837|NCT00069095|1579878|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
488838|NCT00069095|1579879|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
488839|NCT00069095|1579874|P6|Primary Treatment Phase|Failure to return|2
488840|NCT00069095|1579875|P5|Primary Treatment Phase|Failure to return|0
488841|NCT00069095|1579876|P4|Primary Treatment Phase|Failure to return|0
488842|NCT00069095|1579877|P3|Primary Treatment Phase|Failure to return|0
488843|NCT00069095|1579878|P2|Primary Treatment Phase|Failure to return|5
488844|NCT00069095|1579879|P1|Primary Treatment Phase|Failure to return|5
488845|NCT00069095|1579874|P6|Primary Treatment Phase|Death|8
488846|NCT00069095|1579875|P5|Primary Treatment Phase|Death|8
488847|NCT00069095|1579876|P4|Primary Treatment Phase|Death|5
488848|NCT00069095|1579877|P3|Primary Treatment Phase|Death|2
488849|NCT00069095|1579878|P2|Primary Treatment Phase|Death|8
488850|NCT00069095|1579879|P1|Primary Treatment Phase|Death|14
488851|NCT00069095|1579874|P6|Primary Treatment Phase|Adverse Event|101
488852|NCT00069095|1579875|P5|Primary Treatment Phase|Adverse Event|109
488853|NCT00069095|1579876|P4|Primary Treatment Phase|Adverse Event|72
488854|NCT00069095|1579877|P3|Primary Treatment Phase|Adverse Event|71
488855|NCT00069095|1579878|P2|Primary Treatment Phase|Adverse Event|92
488856|NCT00069095|1579879|P1|Primary Treatment Phase|Adverse Event|99
488857|NCT00069095|1579874|P6|Primary Treatment Phase|Admin/Other|42
488858|NCT00069095|1579875|P5|Primary Treatment Phase|Admin/Other|48
488859|NCT00069095|1579876|P4|Primary Treatment Phase|Admin/Other|45
488860|NCT00069095|1579877|P3|Primary Treatment Phase|Admin/Other|31
488861|NCT00069095|1579878|P2|Primary Treatment Phase|Admin/Other|38
488862|NCT00069095|1579879|P1|Primary Treatment Phase|Admin/Other|29
488863|NCT00069095|1579874|P6|Primary Treatment Phase|Ongoing|4
488864|NCT00069095|1579875|P5|Primary Treatment Phase|Ongoing|7
488865|NCT00069095|1579876|P4|Primary Treatment Phase|Ongoing|7
488866|NCT00069095|1579877|P3|Primary Treatment Phase|Ongoing|5
488867|NCT00069095|1579878|P2|Primary Treatment Phase|Ongoing|0
488868|NCT00069095|1579879|P1|Primary Treatment Phase|Ongoing|0
488869|NCT00068822|1579949|P2|First Randomized Intervention|Lost to Follow-up|2
488870|NCT00068822|1579950|P1|First Randomized Intervention|Lost to Follow-up|1
488871|NCT00068601|1579983|P2|Overall Study|Missing primary outcome data|34
488872|NCT00068601|1579984|P1|Overall Study|Missing primary outcome data|30
488873|NCT00068601|1579983|P2|Overall Study|Lost to Follow-up|2
488874|NCT00068601|1579984|P1|Overall Study|Lost to Follow-up|3
488875|NCT00068601|1579983|P2|Overall Study|Death|3
488876|NCT00068601|1579984|P1|Overall Study|Death|11
488877|NCT00068601|1579983|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
488878|NCT00068601|1579984|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
488879|NCT00068601|1579983|P2|Overall Study|Not evaluable: withdrew consent|4
488880|NCT00068601|1579984|P1|Overall Study|Not evaluable: withdrew consent|5
488881|NCT00068601|1579983|P2|Overall Study|Ineligible|13
488882|NCT00068601|1579984|P1|Overall Study|Ineligible|11
488883|NCT00068588|1579997|P3|Overall Study|Poor KPS|1
488884|NCT00068588|1579998|P2|Overall Study|Poor KPS|0
488885|NCT00068588|1579999|P1|Overall Study|Poor KPS|0
488886|NCT00068588|1579997|P3|Overall Study|Withdrawal by Subject|1
488887|NCT00068588|1579998|P2|Overall Study|Withdrawal by Subject|0
488888|NCT00068588|1579999|P1|Overall Study|Withdrawal by Subject|0
488889|NCT00068588|1579997|P3|Overall Study|Adverse Event|2
488890|NCT00068588|1579998|P2|Overall Study|Adverse Event|0
488891|NCT00068588|1579999|P1|Overall Study|Adverse Event|0
488892|NCT00068445|1580015|P2|Treatment|Other (Specifics not available)|5
488893|NCT00068445|1580016|P1|Treatment|Other (Specifics not available)|9
488894|NCT00068445|1580015|P2|Treatment|Adverse Event|1
488895|NCT00068445|1580016|P1|Treatment|Adverse Event|7
488896|NCT00068445|1580015|P2|Treatment|Refused Further Treatment|10
488897|NCT00068445|1580016|P1|Treatment|Refused Further Treatment|13
488898|NCT00068445|1580015|P2|Randomization|Ineligible|1
488899|NCT00068445|1580016|P1|Randomization|Ineligible|1
488900|NCT00068445|1580015|P2|Randomization|Cancel|3
488901|NCT00068445|1580016|P1|Randomization|Cancel|1
488902|NCT00068419|1580040|P1|Overall Study|Ineligible|11
488903|NCT00068419|1580040|P1|Overall Study|Withdrawal by Subject|14
488904|NCT00068419|1580040|P1|Overall Study|Physician Decision|7
488905|NCT00068419|1580040|P1|Overall Study|Lost to Follow-up|1
488906|NCT00068419|1580040|P1|Overall Study|Lack of Efficacy|24
488907|NCT00068419|1580040|P1|Overall Study|Adverse Event|3
488908|NCT00068406|1580044|P1|Overall Study|Ineligible-Inadequate Pathology|2
488909|NCT00068406|1580044|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
488910|NCT00068393|1580049|P1|Overall Study|Quality of life worsening|1
488911|NCT00068393|1580049|P1|Overall Study|Alternative treatment|1
488912|NCT00068393|1580049|P1|Overall Study|Withdrawal by Subject|3
488913|NCT00068393|1580049|P1|Overall Study|Death|3
488914|NCT00068393|1580049|P1|Overall Study|Adverse Event|2
488915|NCT00068380|1580055|P1|Overall Study|Adverse Event|2
488916|NCT00068380|1580055|P1|Overall Study|Withdrawal by Subject|3
488917|NCT00068250|1580099|P4|Phase I: Dose Level 2|Protocol Violation|0
488918|NCT00068250|1580100|P3|Phase I: Dose Level 2|Protocol Violation|0
488919|NCT00068250|1580101|P2|Phase I: Dose Level 2|Protocol Violation|1
488920|NCT00068250|1580102|P1|Phase I: Dose Level 2|Protocol Violation|0
488921|NCT00068237|1580112|P1|Overall Study|No protocol treatment received|2
488922|NCT00068237|1580112|P1|Overall Study|Ineligible|3
488923|NCT00068107|1580116|P1|Overall Study|Withdrawal by Subject|1
488924|NCT00068107|1580116|P1|Overall Study|Death|2
488925|NCT00068107|1580116|P1|Overall Study|end-stage renal disease|6
488926|NCT00067990|1580129|P2|Overall Study|Withdrawal by Subject|12
488927|NCT00067990|1580130|P1|Overall Study|Withdrawal by Subject|4
488928|NCT00067990|1580129|P2|Overall Study|ESRD, Non IF/TA|3
488929|NCT00067990|1580130|P1|Overall Study|ESRD, Non IF/TA|1
488930|NCT00067990|1580129|P2|Overall Study|Death|7
488931|NCT00067990|1580130|P1|Overall Study|Death|5
488932|NCT00067470|1580153|P2|Overall Study|Withdrawal by Subject|1
488933|NCT00067470|1580154|P1|Overall Study|Withdrawal by Subject|0
488934|NCT00066807|1580217|P2|Overall Study|Study was terminated early|15
488935|NCT00066807|1580218|P1|Overall Study|Study was terminated early|14
488936|NCT00066742|1580243|P1|Consolidation Chemotherapy|Ineligible|2
488937|NCT00066742|1580243|P1|Consolidation Chemotherapy|not protocol specified|1
488938|NCT00066742|1580243|P1|Induction Chemoradiotherapy|Ineligible|3
488939|NCT00066742|1580243|P1|Induction Chemoradiotherapy|not protocol specified|2
488940|NCT00066742|1580243|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
488941|NCT00066742|1580243|P1|Induction Chemoradiotherapy|Adverse Event|21
488942|NCT00066742|1580243|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
488943|NCT00066703|1580252|P2|Overall Study|Treatment ongoing|311
488944|NCT00066703|1580253|P1|Overall Study|Treatment ongoing|346
488945|NCT00066703|1580252|P2|Overall Study|Withdrawal by Subject|63
488946|NCT00066703|1580253|P1|Overall Study|Withdrawal by Subject|38
488947|NCT00066703|1580252|P2|Overall Study|Lost to Follow-up|28
488948|NCT00066703|1580253|P1|Overall Study|Lost to Follow-up|31
488949|NCT00066703|1580252|P2|Overall Study|Lack of Efficacy|69
488950|NCT00066703|1580253|P1|Overall Study|Lack of Efficacy|114
488951|NCT00066703|1580252|P2|Overall Study|Death|0
488952|NCT00066703|1580253|P1|Overall Study|Death|3
488953|NCT00066703|1580252|P2|Overall Study|Adverse Event|111
488954|NCT00066703|1580253|P1|Overall Study|Adverse Event|80
488955|NCT00066690|1580266|P3|Overall Study|Treatment Ongoing|282
488956|NCT00066690|1580267|P2|Overall Study|Treatment Ongoing|278
488957|NCT00066690|1580268|P1|Overall Study|Treatment Ongoing|246
488958|NCT00066690|1580266|P3|Overall Study|Withdrawal by Subject|49
488959|NCT00066690|1580267|P2|Overall Study|Withdrawal by Subject|55
488960|NCT00066690|1580268|P1|Overall Study|Withdrawal by Subject|50
488961|NCT00066690|1580266|P3|Overall Study|Lost to Follow-up|29
488962|NCT00066690|1580267|P2|Overall Study|Lost to Follow-up|21
488963|NCT00066690|1580268|P1|Overall Study|Lost to Follow-up|40
488964|NCT00066690|1580266|P3|Overall Study|Lack of Efficacy|76
488965|NCT00066690|1580267|P2|Overall Study|Lack of Efficacy|110
488966|NCT00066690|1580268|P1|Overall Study|Lack of Efficacy|114
488967|NCT00066690|1580266|P3|Overall Study|Death|2
488968|NCT00066690|1580267|P2|Overall Study|Death|0
488969|NCT00066690|1580268|P1|Overall Study|Death|3
488970|NCT00066690|1580266|P3|Overall Study|Adverse Event|126
488971|NCT00066690|1580267|P2|Overall Study|Adverse Event|58
488972|NCT00066690|1580268|P1|Overall Study|Adverse Event|145
488973|NCT00066573|1580284|P2|Overall Study|Did not received protocol treatment|28
488974|NCT00066573|1580285|P1|Overall Study|Did not received protocol treatment|28
488975|NCT00066469|1580297|P1|Overall Study|ineligible|1
488976|NCT00066469|1580297|P1|Overall Study|Withdrawal by Subject|1
488977|NCT00066469|1580297|P1|Overall Study|Physician Decision|1
488978|NCT00066469|1580297|P1|Overall Study|Lost to Follow-up|1
488979|NCT00066469|1580297|P1|Overall Study|Lack of Efficacy|9
488980|NCT00066469|1580297|P1|Overall Study|Death|3
488981|NCT00066365|1580303|P2|Overall Study|Ineligible|2
488982|NCT00066365|1580304|P1|Overall Study|Ineligible|4
488983|NCT00066365|1580303|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
488984|NCT00066365|1580304|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
488985|NCT00066365|1580303|P2|Overall Study|Physician Decision|0
488986|NCT00066365|1580304|P1|Overall Study|Physician Decision|1
488987|NCT00066365|1580303|P2|Overall Study|Lack of Efficacy|12
488988|NCT00066365|1580304|P1|Overall Study|Lack of Efficacy|15
488989|NCT00066365|1580303|P2|Overall Study|Adverse Event|0
488990|NCT00066365|1580304|P1|Overall Study|Adverse Event|1
488991|NCT00066222|1580332|P1|Overall Study|No protocol treatment received|1
488992|NCT00066170|1580345|P4|Overall Study|Other|0
488993|NCT00066170|1580346|P3|Overall Study|Other|2
488994|NCT00066170|1580347|P2|Overall Study|Other|5
488995|NCT00066170|1580348|P1|Overall Study|Other|1
488996|NCT00066170|1580345|P4|Overall Study|Protocol Violation|0
488997|NCT00066170|1580346|P3|Overall Study|Protocol Violation|0
488998|NCT00066170|1580347|P2|Overall Study|Protocol Violation|0
488999|NCT00066170|1580348|P1|Overall Study|Protocol Violation|3
489000|NCT00066170|1580345|P4|Overall Study|Non-Compliance with Trial Medicine|1
489001|NCT00066170|1580346|P3|Overall Study|Non-Compliance with Trial Medicine|0
489002|NCT00066170|1580347|P2|Overall Study|Non-Compliance with Trial Medicine|0
489003|NCT00066170|1580348|P1|Overall Study|Non-Compliance with Trial Medicine|1
489004|NCT00066170|1580345|P4|Overall Study|Lost to Follow-up|0
489005|NCT00066170|1580346|P3|Overall Study|Lost to Follow-up|0
489006|NCT00066170|1580347|P2|Overall Study|Lost to Follow-up|1
489007|NCT00066170|1580348|P1|Overall Study|Lost to Follow-up|0
489008|NCT00066170|1580345|P4|Overall Study|Serious Adverse Event|1
489009|NCT00066170|1580346|P3|Overall Study|Serious Adverse Event|1
489010|NCT00066170|1580347|P2|Overall Study|Serious Adverse Event|0
489011|NCT00066170|1580348|P1|Overall Study|Serious Adverse Event|0
489012|NCT00066170|1580345|P4|Overall Study|Adverse Event|7
489013|NCT00066170|1580346|P3|Overall Study|Adverse Event|1
489014|NCT00066170|1580347|P2|Overall Study|Adverse Event|4
489015|NCT00066170|1580348|P1|Overall Study|Adverse Event|2
489016|NCT00066066|1580361|P6|Overall Study|Lost to Follow-up|5
489017|NCT00066066|1580362|P5|Overall Study|Lost to Follow-up|3
489018|NCT00066066|1580363|P4|Overall Study|Lost to Follow-up|4
489019|NCT00066066|1580364|P3|Overall Study|Lost to Follow-up|7
489020|NCT00066066|1580365|P2|Overall Study|Lost to Follow-up|4
489021|NCT00066066|1580366|P1|Overall Study|Lost to Follow-up|6
489022|NCT00065507|1580444|P2|Overall Study|Subject No Longer Meets Study Criteria|0
489023|NCT00065507|1580445|P1|Overall Study|Subject No Longer Meets Study Criteria|1
489024|NCT00065507|1580444|P2|Overall Study|Subject Withdrew Consent|1
489025|NCT00065507|1580445|P1|Overall Study|Subject Withdrew Consent|2
489026|NCT00065507|1580444|P2|Overall Study|Lost to Follow-up|0
489027|NCT00065507|1580445|P1|Overall Study|Lost to Follow-up|3
489028|NCT00065507|1580444|P2|Overall Study|Poor/Non-compliance|2
489029|NCT00065507|1580445|P1|Overall Study|Poor/Non-compliance|3
489030|NCT00065507|1580444|P2|Overall Study|Lack of Efficacy|6
489031|NCT00065507|1580445|P1|Overall Study|Lack of Efficacy|0
489032|NCT00065507|1580444|P2|Overall Study|Adverse Event|3
489033|NCT00065507|1580445|P1|Overall Study|Adverse Event|4
489034|NCT00065507|1580444|P2|Overall Study|Death|17
489035|NCT00065507|1580445|P1|Overall Study|Death|16
489036|NCT00065468|1580510|P3|Overall Study|Other|18
489037|NCT00065468|1580511|P2|Overall Study|Other|24
489038|NCT00065468|1580512|P1|Overall Study|Other|14
489039|NCT00065468|1580510|P3|Overall Study|Disease progression|1
489040|NCT00065468|1580511|P2|Overall Study|Disease progression|0
489041|NCT00065468|1580512|P1|Overall Study|Disease progression|0
489042|NCT00065468|1580510|P3|Overall Study|Discontinuation of study by Sponsor|13
489043|NCT00065468|1580511|P2|Overall Study|Discontinuation of study by Sponsor|9
489044|NCT00065468|1580512|P1|Overall Study|Discontinuation of study by Sponsor|13
489045|NCT00065468|1580510|P3|Overall Study|Lost to Follow-up|2
489046|NCT00065468|1580511|P2|Overall Study|Lost to Follow-up|3
489047|NCT00065468|1580512|P1|Overall Study|Lost to Follow-up|5
489048|NCT00065468|1580510|P3|Overall Study|Withdrawal by Subject|5
489049|NCT00065468|1580511|P2|Overall Study|Withdrawal by Subject|4
489050|NCT00065468|1580512|P1|Overall Study|Withdrawal by Subject|3
489051|NCT00065468|1580510|P3|Overall Study|Death|171
489052|NCT00065468|1580511|P2|Overall Study|Death|169
489053|NCT00065468|1580512|P1|Overall Study|Death|172
489054|NCT00065442|1580543|P2|Overall Study|Withdrawal by Subject|9
489055|NCT00065442|1580544|P1|Overall Study|Withdrawal by Subject|3
489056|NCT00065442|1580543|P2|Overall Study|Death|210
489057|NCT00065442|1580544|P1|Overall Study|Death|121
489058|NCT00065442|1580543|P2|Overall Study|Lost to Follow-up|1
489059|NCT00065442|1580544|P1|Overall Study|Lost to Follow-up|1
489060|NCT00065429|1580559|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
489061|NCT00065429|1580560|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
489062|NCT00065429|1580561|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
489063|NCT00065429|1580562|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
489064|NCT00065429|1580563|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
489065|NCT00065429|1580564|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
489066|NCT00065429|1580565|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
489067|NCT00065429|1580559|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
489068|NCT00065429|1580560|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
489069|NCT00065429|1580561|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
489070|NCT00065429|1580562|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
489071|NCT00065429|1580563|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
489072|NCT00065429|1580564|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
489073|NCT00065429|1580565|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
489074|NCT00065429|1580559|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
489075|NCT00065429|1580560|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
489076|NCT00065429|1580561|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
489077|NCT00065429|1580562|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
489078|NCT00065429|1580563|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
489079|NCT00065429|1580564|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
489080|NCT00065429|1580565|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
489081|NCT00065429|1580559|P7|Phase I - May 2001 - Oct 2002|Death|0
489082|NCT00065429|1580560|P6|Phase I - May 2001 - Oct 2002|Death|0
489083|NCT00065429|1580561|P5|Phase I - May 2001 - Oct 2002|Death|1
489084|NCT00065429|1580562|P4|Phase I - May 2001 - Oct 2002|Death|0
489085|NCT00065429|1580563|P3|Phase I - May 2001 - Oct 2002|Death|0
489086|NCT00065429|1580564|P2|Phase I - May 2001 - Oct 2002|Death|0
489087|NCT00065429|1580565|P1|Phase I - May 2001 - Oct 2002|Death|0
489088|NCT00065429|1580559|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
489089|NCT00065429|1580560|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
489090|NCT00065429|1580561|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
489091|NCT00065429|1580562|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
489092|NCT00065429|1580563|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
489093|NCT00065429|1580564|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
489094|NCT00065429|1580565|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
489095|NCT00065429|1580559|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
489096|NCT00065429|1580560|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
489097|NCT00065429|1580561|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
489098|NCT00065429|1580562|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
489099|NCT00065429|1580563|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
489100|NCT00065429|1580564|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
489101|NCT00065429|1580565|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
489102|NCT00065429|1580559|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
489103|NCT00065429|1580560|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
489104|NCT00065429|1580561|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
489105|NCT00065429|1580562|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
489106|NCT00065429|1580563|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
489107|NCT00065429|1580564|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
489108|NCT00065429|1580565|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
489109|NCT00065260|1580579|P2|Overall Study|Death|1
489110|NCT00065260|1580580|P1|Overall Study|Death|0
489111|NCT00065156|1580586|P1|Overall Study|Secondary Malign Disease|1
489112|NCT00065156|1580586|P1|Overall Study|Loss of Response|1
489113|NCT00065156|1580586|P1|Overall Study|Non-Compliance|2
489114|NCT00065156|1580586|P1|Overall Study|Investigator Decision|2
489115|NCT00065156|1580586|P1|Overall Study|Disease Progression|7
489116|NCT00065156|1580586|P1|Overall Study|Study Closed by Sponsor|2
489117|NCT00065156|1580586|P1|Overall Study|Death|11
489118|NCT00065156|1580586|P1|Overall Study|Lost to Follow-up|1
489119|NCT00065156|1580586|P1|Overall Study|Withdrawal by Subject|8
489120|NCT00065156|1580586|P1|Overall Study|Lack of Efficacy|52
489121|NCT00065156|1580586|P1|Overall Study|Adverse Event|37
489122|NCT00065065|1580603|P2|Overall Study|Other|2
489123|NCT00065065|1580604|P1|Overall Study|Other|2
489124|NCT00065065|1580603|P2|Overall Study|Lack of Efficacy|11
489125|NCT00065065|1580604|P1|Overall Study|Lack of Efficacy|4
489126|NCT00065065|1580603|P2|Overall Study|Withdrawal by Subject|5
489127|NCT00065065|1580604|P1|Overall Study|Withdrawal by Subject|1
489128|NCT00065065|1580603|P2|Overall Study|Adverse Event|2
489129|NCT00065065|1580604|P1|Overall Study|Adverse Event|3
489130|NCT00003895|1580616|P2|Overall Study|Withdrawal by Subject|3
489131|NCT00003895|1580617|P1|Overall Study|Withdrawal by Subject|0
489132|NCT00003895|1580616|P2|Overall Study|Patient Vacation|0
489133|NCT00003895|1580617|P1|Overall Study|Patient Vacation|2
489134|NCT00003895|1580616|P2|Overall Study|Lack of Efficacy|1
489135|NCT00003895|1580617|P1|Overall Study|Lack of Efficacy|1
489136|NCT00003895|1580616|P2|Overall Study|Adverse Event|0
489137|NCT00003895|1580617|P1|Overall Study|Adverse Event|4
489138|NCT00064987|1580625|P2|Overall Study|Physician Decision|0
489139|NCT00064987|1580626|P1|Overall Study|Physician Decision|3
489140|NCT00064753|1580657|P2|Overall Study|Lost to Follow-up|235
489141|NCT00064753|1580658|P1|Overall Study|Lost to Follow-up|225
489142|NCT00064753|1580657|P2|Overall Study|Withdrawal by Subject|171
489143|NCT00064753|1580658|P1|Overall Study|Withdrawal by Subject|198
489144|NCT00064753|1580657|P2|Overall Study|Death|242
489145|NCT00064753|1580658|P1|Overall Study|Death|251
489146|NCT00064792|1580688|P2|Overall Study|Adverse Event|0
489147|NCT00064792|1580689|P1|Overall Study|Adverse Event|3
489148|NCT00064792|1580688|P2|Overall Study|Withdrawal by Subject|0
489149|NCT00064792|1580689|P1|Overall Study|Withdrawal by Subject|2
489150|NCT00064701|1580700|P3|Clinical Continuation Phase|Patient opted out|1
489151|NCT00064701|1580701|P2|Clinical Continuation Phase|Patient opted out|0
489152|NCT00064701|1580702|P1|Clinical Continuation Phase|Patient opted out|0
489153|NCT00064701|1580700|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
489154|NCT00064701|1580701|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
489155|NCT00064701|1580702|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
489156|NCT00064701|1580700|P3|Clinical Continuation Phase|Discharged to nursing home|0
489157|NCT00064701|1580701|P2|Clinical Continuation Phase|Discharged to nursing home|1
489158|NCT00064701|1580702|P1|Clinical Continuation Phase|Discharged to nursing home|0
489159|NCT00064701|1580700|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
489160|NCT00064701|1580701|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
489161|NCT00064701|1580702|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
489162|NCT00064701|1580700|P3|Clinical Continuation Phase|Pancreas transplant|0
489163|NCT00064701|1580701|P2|Clinical Continuation Phase|Pancreas transplant|0
489164|NCT00064701|1580702|P1|Clinical Continuation Phase|Pancreas transplant|1
489165|NCT00064701|1580700|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
489166|NCT00064701|1580701|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
489167|NCT00064701|1580702|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
489168|NCT00064701|1580700|P3|Clinical Continuation Phase|Physician Decision|0
489169|NCT00064701|1580701|P2|Clinical Continuation Phase|Physician Decision|3
489170|NCT00064701|1580702|P1|Clinical Continuation Phase|Physician Decision|1
489171|NCT00064701|1580700|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
489172|NCT00064701|1580701|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
489173|NCT00064701|1580702|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
489174|NCT00064701|1580700|P3|Clinical Continuation Phase|Sponsor discontinued study|79
489175|NCT00064701|1580701|P2|Clinical Continuation Phase|Sponsor discontinued study|129
489176|NCT00064701|1580702|P1|Clinical Continuation Phase|Sponsor discontinued study|113
489177|NCT00064701|1580700|P3|Clinical Continuation Phase|Rejection|2
489178|NCT00064701|1580701|P2|Clinical Continuation Phase|Rejection|2
489179|NCT00064701|1580702|P1|Clinical Continuation Phase|Rejection|1
489180|NCT00064701|1580700|P3|Clinical Continuation Phase|Graft Failure|2
489181|NCT00064701|1580701|P2|Clinical Continuation Phase|Graft Failure|5
489182|NCT00064701|1580702|P1|Clinical Continuation Phase|Graft Failure|5
489183|NCT00064701|1580700|P3|Clinical Continuation Phase|Lost to Follow-up|6
489184|NCT00064701|1580701|P2|Clinical Continuation Phase|Lost to Follow-up|3
489185|NCT00064701|1580702|P1|Clinical Continuation Phase|Lost to Follow-up|6
489186|NCT00064701|1580700|P3|Clinical Continuation Phase|Withdrawal by Subject|22
489187|NCT00064701|1580701|P2|Clinical Continuation Phase|Withdrawal by Subject|3
489188|NCT00064701|1580702|P1|Clinical Continuation Phase|Withdrawal by Subject|22
489189|NCT00064701|1580700|P3|Clinical Continuation Phase|Non-compliance|7
489190|NCT00064701|1580701|P2|Clinical Continuation Phase|Non-compliance|6
489191|NCT00064701|1580702|P1|Clinical Continuation Phase|Non-compliance|8
489192|NCT00064701|1580700|P3|Clinical Continuation Phase|Adverse Event|14
489193|NCT00064701|1580701|P2|Clinical Continuation Phase|Adverse Event|21
489194|NCT00064701|1580702|P1|Clinical Continuation Phase|Adverse Event|12
489195|NCT00064701|1580700|P3|One Year Post-transplant|Pancreas transplant|1
489196|NCT00064701|1580701|P2|One Year Post-transplant|Pancreas transplant|0
489197|NCT00064701|1580702|P1|One Year Post-transplant|Pancreas transplant|0
489198|NCT00064701|1580700|P3|One Year Post-transplant|Poor absorption|0
489199|NCT00064701|1580701|P2|One Year Post-transplant|Poor absorption|1
489200|NCT00064701|1580702|P1|One Year Post-transplant|Poor absorption|0
489201|NCT00064701|1580700|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
489202|NCT00064701|1580701|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
489203|NCT00064701|1580702|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
489204|NCT00064701|1580700|P3|One Year Post-transplant|Incorrect study drug dispensed|0
489205|NCT00064701|1580701|P2|One Year Post-transplant|Incorrect study drug dispensed|1
489206|NCT00064701|1580702|P1|One Year Post-transplant|Incorrect study drug dispensed|0
489207|NCT00064701|1580700|P3|One Year Post-transplant|Acute tubular necrosis|0
489208|NCT00064701|1580701|P2|One Year Post-transplant|Acute tubular necrosis|0
489209|NCT00064701|1580702|P1|One Year Post-transplant|Acute tubular necrosis|1
489210|NCT00064701|1580700|P3|One Year Post-transplant|Converted to rapamycin|0
489211|NCT00064701|1580701|P2|One Year Post-transplant|Converted to rapamycin|0
489212|NCT00064701|1580702|P1|One Year Post-transplant|Converted to rapamycin|1
489213|NCT00064701|1580700|P3|One Year Post-transplant|Lost to Follow-up|0
489214|NCT00064701|1580701|P2|One Year Post-transplant|Lost to Follow-up|0
489215|NCT00064701|1580702|P1|One Year Post-transplant|Lost to Follow-up|1
489216|NCT00064701|1580700|P3|One Year Post-transplant|Withdrawal by Subject|1
489217|NCT00064701|1580701|P2|One Year Post-transplant|Withdrawal by Subject|4
489218|NCT00064701|1580702|P1|One Year Post-transplant|Withdrawal by Subject|0
489219|NCT00064701|1580700|P3|One Year Post-transplant|Graft Failure|1
489220|NCT00064701|1580701|P2|One Year Post-transplant|Graft Failure|2
489221|NCT00064701|1580702|P1|One Year Post-transplant|Graft Failure|3
489222|NCT00064701|1580700|P3|One Year Post-transplant|Non-compliance|5
489223|NCT00064701|1580701|P2|One Year Post-transplant|Non-compliance|2
489224|NCT00064701|1580702|P1|One Year Post-transplant|Non-compliance|4
489225|NCT00064701|1580700|P3|One Year Post-transplant|Rejection|16
489226|NCT00064701|1580701|P2|One Year Post-transplant|Rejection|1
489227|NCT00064701|1580702|P1|One Year Post-transplant|Rejection|0
489228|NCT00064701|1580700|P3|One Year Post-transplant|Adverse Event|37
489229|NCT00064701|1580701|P2|One Year Post-transplant|Adverse Event|19
489230|NCT00064701|1580702|P1|One Year Post-transplant|Adverse Event|23
489231|NCT00064701|1580700|P3|One Year Post-transplant|Did not receive study drug|11
489232|NCT00064701|1580701|P2|One Year Post-transplant|Did not receive study drug|12
489233|NCT00064701|1580702|P1|One Year Post-transplant|Did not receive study drug|7
489234|NCT00064662|1580754|P2|Overall Study|Administratively withdrawn|2
489235|NCT00064662|1580755|P1|Overall Study|Administratively withdrawn|2
489236|NCT00064662|1580754|P2|Overall Study|Withdrawal by Subject|14
489237|NCT00064662|1580755|P1|Overall Study|Withdrawal by Subject|14
489238|NCT00064662|1580754|P2|Overall Study|Lost to Follow-up|44
489239|NCT00064662|1580755|P1|Overall Study|Lost to Follow-up|57
489240|NCT00064662|1580754|P2|Overall Study|Death|1
489241|NCT00064662|1580755|P1|Overall Study|Death|1
489242|NCT00064350|1580766|P3|Cross-Over|Other|0
489243|NCT00064350|1580767|P2|Cross-Over|Other|2
489244|NCT00064350|1580768|P1|Cross-Over|Other|0
489245|NCT00064350|1580766|P3|Cross-Over|Ineligible or never started treatment|0
489246|NCT00064350|1580767|P2|Cross-Over|Ineligible or never started treatment|6
489247|NCT00064350|1580768|P1|Cross-Over|Ineligible or never started treatment|3
489248|NCT00064350|1580766|P3|Cross-Over|Withdrawal by Subject|0
489249|NCT00064350|1580767|P2|Cross-Over|Withdrawal by Subject|2
489250|NCT00064350|1580768|P1|Cross-Over|Withdrawal by Subject|2
489251|NCT00064350|1580766|P3|Cross-Over|Death|0
489252|NCT00064350|1580767|P2|Cross-Over|Death|3
489253|NCT00064350|1580768|P1|Cross-Over|Death|1
489254|NCT00064350|1580766|P3|Cross-Over|Adverse Event|0
489255|NCT00064350|1580767|P2|Cross-Over|Adverse Event|1
489256|NCT00064350|1580768|P1|Cross-Over|Adverse Event|0
489257|NCT00064350|1580766|P3|Randomization|Other|0
489258|NCT00064350|1580767|P2|Randomization|Other|0
489259|NCT00064350|1580768|P1|Randomization|Other|5
489260|NCT00064350|1580766|P3|Randomization|Ineligible or never started treatment|0
489261|NCT00064350|1580767|P2|Randomization|Ineligible or never started treatment|15
489262|NCT00064350|1580768|P1|Randomization|Ineligible or never started treatment|9
489263|NCT00064350|1580766|P3|Randomization|Withdrawal by Subject|0
489264|NCT00064350|1580767|P2|Randomization|Withdrawal by Subject|0
489265|NCT00064350|1580768|P1|Randomization|Withdrawal by Subject|1
489266|NCT00064350|1580766|P3|Randomization|Death|0
489267|NCT00064350|1580767|P2|Randomization|Death|0
489268|NCT00064350|1580768|P1|Randomization|Death|3
489269|NCT00064350|1580766|P3|Randomization|Adverse Event|0
489270|NCT00064350|1580767|P2|Randomization|Adverse Event|3
489271|NCT00064350|1580768|P1|Randomization|Adverse Event|8
489272|NCT00064350|1580766|P3|Induction Treatment|Other|13
489273|NCT00064350|1580767|P2|Induction Treatment|Other|0
489274|NCT00064350|1580768|P1|Induction Treatment|Other|0
489275|NCT00064350|1580766|P3|Induction Treatment|Ineligible or never started treatment|34
489276|NCT00064350|1580767|P2|Induction Treatment|Ineligible or never started treatment|6
489277|NCT00064350|1580768|P1|Induction Treatment|Ineligible or never started treatment|3
489278|NCT00064350|1580766|P3|Induction Treatment|Withdrawal by Subject|21
489279|NCT00064350|1580767|P2|Induction Treatment|Withdrawal by Subject|0
489280|NCT00064350|1580768|P1|Induction Treatment|Withdrawal by Subject|0
489281|NCT00064350|1580766|P3|Induction Treatment|Death|9
489282|NCT00064350|1580767|P2|Induction Treatment|Death|0
489283|NCT00064350|1580768|P1|Induction Treatment|Death|0
489284|NCT00064350|1580766|P3|Induction Treatment|Adverse Event|49
489285|NCT00064350|1580767|P2|Induction Treatment|Adverse Event|2
489286|NCT00064350|1580768|P1|Induction Treatment|Adverse Event|0
489287|NCT00064350|1580766|P3|Induction Treatment|Disease Progression|110
489288|NCT00064350|1580767|P2|Induction Treatment|Disease Progression|1
489289|NCT00064350|1580768|P1|Induction Treatment|Disease Progression|5
489290|NCT00064337|1580783|P1|Maintenance|Death|1
489291|NCT00064337|1580783|P1|Maintenance|Not protocol-specified|2
489292|NCT00064337|1580783|P1|Maintenance|On treatment at time of analysis|2
489293|NCT00064337|1580783|P1|Maintenance|Progression|2
489294|NCT00064337|1580783|P1|Maintenance|Adverse Event|3
489295|NCT00064337|1580783|P1|Transplant|Progression|2
489296|NCT00064337|1580783|P1|Transplant|Patient Refusal|2
489297|NCT00064337|1580783|P1|Transplant|Death|3
489298|NCT00064337|1580783|P1|Transplant|Not protocol-specified|5
489299|NCT00064337|1580783|P1|Transplant|Adverse Event|9
489300|NCT00064337|1580783|P1|PBSCC or Induction/PBSCC|Death|2
489301|NCT00064337|1580783|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
489302|NCT00064337|1580783|P1|PBSCC or Induction/PBSCC|Progression|3
489303|NCT00064337|1580783|P1|PBSCC or Induction/PBSCC|Adverse Event|6
489304|NCT00064337|1580783|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
489305|NCT00064298|1580792|P2|Overall Study|Disease Progression|1
489306|NCT00064298|1580793|P1|Overall Study|Disease Progression|2
489307|NCT00064298|1580792|P2|Overall Study|Death|1
489308|NCT00064298|1580793|P1|Overall Study|Death|0
489309|NCT00064298|1580792|P2|Overall Study|Lost to Follow-up|2
489310|NCT00064298|1580793|P1|Overall Study|Lost to Follow-up|2
489311|NCT00064298|1580792|P2|Overall Study|Withdrawal by Subject|1
489312|NCT00064298|1580793|P1|Overall Study|Withdrawal by Subject|2
489313|NCT00064259|1580801|P4|Overall Study|Adverse Event|1
489314|NCT00064259|1580802|P3|Overall Study|Adverse Event|0
489315|NCT00064259|1580803|P2|Overall Study|Adverse Event|0
489316|NCT00064259|1580804|P1|Overall Study|Adverse Event|1
489317|NCT00064025|1580822|P1|Overall Study|Inevaluable|3
489318|NCT00064025|1580822|P1|Overall Study|Ineligible|4
489319|NCT00063999|1580831|P2|Overall Study|Ineligible|24
489320|NCT00063999|1580832|P1|Overall Study|Ineligible|44
489321|NCT00063999|1580831|P2|Overall Study|Withdrawal by Subject|0
489322|NCT00063999|1580832|P1|Overall Study|Withdrawal by Subject|1
489323|NCT00063986|1580848|P1|Overall Study|Intra-operatively ineligible|4
489324|NCT00063986|1580848|P1|Overall Study|Ineligible|1
489325|NCT00063986|1580848|P1|Overall Study|Withdrawal by Subject|1
489326|NCT00063934|1580860|P1|Overall Study|Ineligible|1
489327|NCT00063258|1580965|P2|Overall Study|Lack of Efficacy|0
489328|NCT00063258|1580966|P1|Overall Study|Lack of Efficacy|2
489329|NCT00063258|1580965|P2|Overall Study|Physician Decision|0
489330|NCT00063258|1580966|P1|Overall Study|Physician Decision|2
489331|NCT00063154|1580972|P1|Overall Study|Did not receive treatment|8
489332|NCT00063154|1580972|P1|Overall Study|Reason unspecified|1
489333|NCT00063154|1580972|P1|Overall Study|Death|3
489334|NCT00063154|1580972|P1|Overall Study|Physician Decision|10
489335|NCT00063154|1580972|P1|Overall Study|Adverse Event|2
489336|NCT00063154|1580972|P1|Overall Study|Disease progression|27
489337|NCT00062751|1580998|P5|Overall Study|Death|0
489338|NCT00062751|1580999|P4|Overall Study|Death|0
489339|NCT00062751|1581000|P3|Overall Study|Death|1
489340|NCT00062751|1581001|P2|Overall Study|Death|0
489341|NCT00062751|1581002|P1|Overall Study|Death|1
489342|NCT00062751|1580998|P5|Overall Study|Symptomatic deterioration|1
489343|NCT00062751|1580999|P4|Overall Study|Symptomatic deterioration|0
489344|NCT00062751|1581000|P3|Overall Study|Symptomatic deterioration|0
489345|NCT00062751|1581001|P2|Overall Study|Symptomatic deterioration|1
489346|NCT00062751|1581002|P1|Overall Study|Symptomatic deterioration|1
489347|NCT00062751|1580998|P5|Overall Study|Withdrawal by Subject|0
489348|NCT00062751|1580999|P4|Overall Study|Withdrawal by Subject|1
489349|NCT00062751|1581000|P3|Overall Study|Withdrawal by Subject|2
489350|NCT00062751|1581001|P2|Overall Study|Withdrawal by Subject|2
489351|NCT00062751|1581002|P1|Overall Study|Withdrawal by Subject|1
489352|NCT00062751|1580998|P5|Overall Study|Other|1
489353|NCT00062751|1580999|P4|Overall Study|Other|0
489354|NCT00062751|1581000|P3|Overall Study|Other|1
489355|NCT00062751|1581001|P2|Overall Study|Other|3
489356|NCT00062751|1581002|P1|Overall Study|Other|2
489357|NCT00062751|1580998|P5|Overall Study|Adverse Event|2
489358|NCT00062751|1580999|P4|Overall Study|Adverse Event|2
489359|NCT00062751|1581000|P3|Overall Study|Adverse Event|2
489360|NCT00062751|1581001|P2|Overall Study|Adverse Event|7
489361|NCT00062751|1581002|P1|Overall Study|Adverse Event|4
489362|NCT00062751|1580998|P5|Overall Study|Disease progression|2
489363|NCT00062751|1580999|P4|Overall Study|Disease progression|2
489364|NCT00062751|1581000|P3|Overall Study|Disease progression|24
489365|NCT00062751|1581001|P2|Overall Study|Disease progression|17
489366|NCT00062751|1581002|P1|Overall Study|Disease progression|24
489367|NCT00062647|1581088|P2|Overall Study|Never received study treatment|1
489368|NCT00062647|1581089|P1|Overall Study|Never received study treatment|1
489369|NCT00062647|1581088|P2|Overall Study|Other|4
489370|NCT00062647|1581089|P1|Overall Study|Other|4
489371|NCT00062647|1581088|P2|Overall Study|Failed continuation criteria|2
489372|NCT00062647|1581089|P1|Overall Study|Failed continuation criteria|4
489373|NCT00062647|1581088|P2|Overall Study|Lost to Follow-up|2
489374|NCT00062647|1581089|P1|Overall Study|Lost to Follow-up|1
489375|NCT00062647|1581088|P2|Overall Study|Protocol Violation|0
489376|NCT00062647|1581089|P1|Overall Study|Protocol Violation|1
489377|NCT00062647|1581088|P2|Overall Study|Withdrawal by Subject|1
489378|NCT00062647|1581089|P1|Overall Study|Withdrawal by Subject|2
489379|NCT00062647|1581088|P2|Overall Study|Adverse Event|1
489380|NCT00062647|1581089|P1|Overall Study|Adverse Event|1
489381|NCT00062647|1581088|P2|Overall Study|Death|2
489382|NCT00062647|1581089|P1|Overall Study|Death|2
489383|NCT00062439|1581095|P1|Consolidation Chemotherapy|Adverse Event|2
489384|NCT00062439|1581095|P1|Surgery|Adverse Event|2
489385|NCT00062439|1581095|P1|Surgery|Death|1
489386|NCT00062439|1581095|P1|Surgery|Physician Decision|4
489387|NCT00062439|1581095|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
489388|NCT00062439|1581095|P1|Post Chemoradiation Assessment|Physician Decision|1
489389|NCT00062439|1581095|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
489390|NCT00062439|1581095|P1|Post Chemoradiation Assessment|Disease progression|2
489391|NCT00062439|1581095|P1|Post Chemoradiation Assessment|Death|1
489392|NCT00062439|1581095|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
489393|NCT00062439|1581095|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
489394|NCT00062439|1581095|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
489395|NCT00062439|1581095|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
489396|NCT00062374|1581107|P1|Overall Study|Not treated|12
489397|NCT00062010|1581112|P1|Overall Study|Ineligible|3
489398|NCT00061945|1581120|P2|Course IV: Alemtuzumab|Early exits|15
489399|NCT00061945|1581121|P1|Course IV: Alemtuzumab|Early exits|6
489400|NCT00061945|1581120|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
489401|NCT00061945|1581121|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
489402|NCT00061945|1581120|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
489403|NCT00061945|1581121|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
489404|NCT00061945|1581120|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
489405|NCT00061945|1581121|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
489406|NCT00061932|1581131|P2|Overall Study|Withdrawal by Subject|4
489407|NCT00061932|1581132|P1|Overall Study|Withdrawal by Subject|13
489408|NCT00061633|1581145|P2|Overall Study|Never received study treatment|2
489409|NCT00061633|1581146|P1|Overall Study|Never received study treatment|0
489410|NCT00061633|1581145|P2|Overall Study|Other|1
489411|NCT00061633|1581146|P1|Overall Study|Other|1
489412|NCT00061633|1581145|P2|Overall Study|Lost to Follow-up|4
489413|NCT00061633|1581146|P1|Overall Study|Lost to Follow-up|1
489414|NCT00061633|1581145|P2|Overall Study|Withdrawal by Subject|2
489415|NCT00061633|1581146|P1|Overall Study|Withdrawal by Subject|2
489416|NCT00061633|1581145|P2|Overall Study|Adverse Event|2
489417|NCT00061633|1581146|P1|Overall Study|Adverse Event|1
489418|NCT00061048|1581171|P1|Overall Study|disease progression|20
489419|NCT00061048|1581171|P1|Overall Study|Adverse Event|2
489420|NCT00060944|1581181|P2|Overall Study|randomized but not treated|4
489421|NCT00060944|1581182|P1|Overall Study|randomized but not treated|6
489422|NCT00060944|1581181|P2|Overall Study|Not specified|4
489423|NCT00060944|1581182|P1|Overall Study|Not specified|2
489424|NCT00060944|1581181|P2|Overall Study|Treatment Switch|13
489425|NCT00060944|1581182|P1|Overall Study|Treatment Switch|0
489426|NCT00060944|1581181|P2|Overall Study|Subject Ineligible To Continue|1
489427|NCT00060944|1581182|P1|Overall Study|Subject Ineligible To Continue|2
489428|NCT00060944|1581181|P2|Overall Study|Lost to Follow-up|0
489429|NCT00060944|1581182|P1|Overall Study|Lost to Follow-up|1
489430|NCT00060944|1581181|P2|Overall Study|Disease Progression|94
489431|NCT00060944|1581182|P1|Overall Study|Disease Progression|93
489432|NCT00060944|1581181|P2|Overall Study|Withdrawal by Subject|5
489433|NCT00060944|1581182|P1|Overall Study|Withdrawal by Subject|18
489434|NCT00060944|1581181|P2|Overall Study|Death|3
489435|NCT00060944|1581182|P1|Overall Study|Death|2
489436|NCT00060944|1581181|P2|Overall Study|Adverse Event|10
489437|NCT00060944|1581182|P1|Overall Study|Adverse Event|12
489438|NCT00060840|1581198|P2|Overall Study|Other|0
489439|NCT00060840|1581199|P1|Overall Study|Other|1
489440|NCT00060840|1581198|P2|Overall Study|Physician Decision|0
489441|NCT00060840|1581199|P1|Overall Study|Physician Decision|1
489442|NCT00060840|1581198|P2|Overall Study|Subinvestigator unavailable|1
489443|NCT00060840|1581199|P1|Overall Study|Subinvestigator unavailable|0
489444|NCT00060840|1581198|P2|Overall Study|Withdrawal by Subject|1
489445|NCT00060840|1581199|P1|Overall Study|Withdrawal by Subject|0
489446|NCT00060840|1581198|P2|Overall Study|Death|1
489447|NCT00060840|1581199|P1|Overall Study|Death|0
489448|NCT00060840|1581198|P2|Overall Study|Change in surgical plan|6
489449|NCT00060840|1581199|P1|Overall Study|Change in surgical plan|2
489450|NCT00059839|1581252|P2|Overall Study|Ineligible|3
489451|NCT00059839|1581253|P1|Overall Study|Ineligible|1
489452|NCT00059839|1581252|P2|Overall Study|Withdrawal by Subject|6
489453|NCT00059839|1581253|P1|Overall Study|Withdrawal by Subject|1
489454|NCT00059839|1581252|P2|Overall Study|Physician Decision|2
489455|NCT00059839|1581253|P1|Overall Study|Physician Decision|1
489456|NCT00059839|1581252|P2|Overall Study|Lost to Follow-up|0
489457|NCT00059839|1581253|P1|Overall Study|Lost to Follow-up|2
489458|NCT00059839|1581252|P2|Overall Study|Lack of Efficacy|5
489459|NCT00059839|1581253|P1|Overall Study|Lack of Efficacy|6
489460|NCT00059839|1581252|P2|Overall Study|Death|1
489461|NCT00059839|1581253|P1|Overall Study|Death|1
489462|NCT00059787|1581259|P1|Overall Study|Other|4
489463|NCT00059787|1581259|P1|Overall Study|ineligible|1
489464|NCT00059787|1581259|P1|Overall Study|disease progression|2
489465|NCT00059787|1581259|P1|Overall Study|Adverse Event|13
489466|NCT00059332|1581310|P2|Overall Study|Lost to Follow-up|1
489467|NCT00059332|1581311|P1|Overall Study|Lost to Follow-up|1
489468|NCT00059332|1581310|P2|Overall Study|Withdrawal by Subject|1
489469|NCT00059332|1581311|P1|Overall Study|Withdrawal by Subject|2
489470|NCT00059215|1581337|P4|Overall Study|Physician Decision|1
489471|NCT00059215|1581338|P3|Overall Study|Physician Decision|1
489472|NCT00059215|1581339|P2|Overall Study|Physician Decision|2
489473|NCT00059215|1581340|P1|Overall Study|Physician Decision|1
489474|NCT00059215|1581337|P4|Overall Study|Protocol entry criteria not met|2
489475|NCT00059215|1581338|P3|Overall Study|Protocol entry criteria not met|0
489476|NCT00059215|1581339|P2|Overall Study|Protocol entry criteria not met|1
489477|NCT00059215|1581340|P1|Overall Study|Protocol entry criteria not met|1
489478|NCT00059215|1581337|P4|Overall Study|Protocol Violation|0
489479|NCT00059215|1581338|P3|Overall Study|Protocol Violation|1
489480|NCT00059215|1581339|P2|Overall Study|Protocol Violation|0
489481|NCT00059215|1581340|P1|Overall Study|Protocol Violation|1
489482|NCT00059215|1581337|P4|Overall Study|Withdrawal by Subject|3
489483|NCT00059215|1581338|P3|Overall Study|Withdrawal by Subject|1
489484|NCT00059215|1581339|P2|Overall Study|Withdrawal by Subject|4
489485|NCT00059215|1581340|P1|Overall Study|Withdrawal by Subject|4
489486|NCT00059215|1581337|P4|Overall Study|Lost to Follow-up|0
489487|NCT00059215|1581338|P3|Overall Study|Lost to Follow-up|0
489488|NCT00059215|1581339|P2|Overall Study|Lost to Follow-up|2
489489|NCT00059215|1581340|P1|Overall Study|Lost to Follow-up|1
489490|NCT00059215|1581337|P4|Overall Study|Death|0
489491|NCT00059215|1581338|P3|Overall Study|Death|3
489492|NCT00059215|1581339|P2|Overall Study|Death|0
489493|NCT00059215|1581340|P1|Overall Study|Death|0
489494|NCT00059215|1581337|P4|Overall Study|Adverse Event|9
489495|NCT00059215|1581338|P3|Overall Study|Adverse Event|9
489496|NCT00059215|1581339|P2|Overall Study|Adverse Event|5
489497|NCT00059215|1581340|P1|Overall Study|Adverse Event|5
489498|NCT00058825|1581377|P1|Overall Study|Death|3
489499|NCT00058825|1581377|P1|Overall Study|Graft Failure|5
489500|NCT00058825|1581377|P1|Overall Study|Progressive Disease|5
489501|NCT00058825|1581377|P1|Overall Study|Relapse|9
489502|NCT00058552|1581393|P2|Overall Study|Clinical disease progression|4
489503|NCT00058552|1581394|P1|Overall Study|Clinical disease progression|0
489504|NCT00058552|1581393|P2|Overall Study|Physician Decision|5
489505|NCT00058552|1581394|P1|Overall Study|Physician Decision|2
489506|NCT00058552|1581393|P2|Overall Study|Withdrawal by Subject|5
489507|NCT00058552|1581394|P1|Overall Study|Withdrawal by Subject|3
489508|NCT00058552|1581393|P2|Overall Study|Adverse Event|2
489509|NCT00058552|1581394|P1|Overall Study|Adverse Event|4
489510|NCT00058552|1581393|P2|Overall Study|Disease progression|44
489511|NCT00058552|1581394|P1|Overall Study|Disease progression|52
489512|NCT00058552|1581393|P2|Overall Study|Died prior to receiving treatment|2
489513|NCT00058552|1581394|P1|Overall Study|Died prior to receiving treatment|4
489514|NCT00058539|1581412|P1|Overall Study|Death|1
489515|NCT00058539|1581412|P1|Overall Study|Physician Decision|9
489516|NCT00058539|1581412|P1|Overall Study|Withdrawal by Subject|5
489517|NCT00058539|1581412|P1|Overall Study|Adverse Event|3
489518|NCT00058539|1581412|P1|Overall Study|Disease progression|24
489519|NCT00058214|1581439|P1|Overall Study|Adverse Event|1
489520|NCT00057954|1581460|P1|Overall Study|Disease progression|1
489521|NCT00057954|1581460|P1|Overall Study|Death|1
489522|NCT00057941|1581468|P2|Overall Study|Ineligible|5
489523|NCT00057941|1581469|P1|Overall Study|Ineligible|2
489524|NCT00057941|1581468|P2|Overall Study|insurance, symptomatic deterioration|3
489525|NCT00057941|1581469|P1|Overall Study|insurance, symptomatic deterioration|1
489526|NCT00057941|1581468|P2|Overall Study|still on treatment|1
489527|NCT00057941|1581469|P1|Overall Study|still on treatment|3
489528|NCT00057941|1581468|P2|Overall Study|Withdrawal by Subject|1
489529|NCT00057941|1581469|P1|Overall Study|Withdrawal by Subject|6
489530|NCT00057941|1581468|P2|Overall Study|Lack of Efficacy|53
489531|NCT00057941|1581469|P1|Overall Study|Lack of Efficacy|54
489532|NCT00057941|1581468|P2|Overall Study|Adverse Event|9
489533|NCT00057941|1581469|P1|Overall Study|Adverse Event|7
489534|NCT00057941|1581468|P2|Overall Study|Death|2
489535|NCT00057941|1581469|P1|Overall Study|Death|1
489536|NCT00057876|1581477|P2|Overall Study|other complicating disease|0
489537|NCT00057876|1581478|P1|Overall Study|other complicating disease|1
489538|NCT00057876|1581477|P2|Overall Study|other reason|2
489539|NCT00057876|1581478|P1|Overall Study|other reason|2
489540|NCT00057876|1581477|P2|Overall Study|Ineligible|2
489541|NCT00057876|1581478|P1|Overall Study|Ineligible|1
489542|NCT00057876|1581477|P2|Overall Study|Lack of Efficacy|8
489543|NCT00057876|1581478|P1|Overall Study|Lack of Efficacy|10
489544|NCT00057876|1581477|P2|Overall Study|Withdrawal by Subject|6
489545|NCT00057876|1581478|P1|Overall Study|Withdrawal by Subject|5
489546|NCT00057876|1581477|P2|Overall Study|Death|1
489547|NCT00057876|1581478|P1|Overall Study|Death|2
489548|NCT00057876|1581477|P2|Overall Study|Adverse Event|8
489549|NCT00057876|1581478|P1|Overall Study|Adverse Event|8
489550|NCT00057863|1581488|P1|Overall Study|Withdrawal by Subject|2
489551|NCT00057863|1581488|P1|Overall Study|Death|1
489552|NCT00057837|1581497|P2|Overall Study|Never started treatment|1
489553|NCT00057837|1581498|P1|Overall Study|Never started treatment|1
489554|NCT00057837|1581497|P2|Overall Study|Ineligible|3
489555|NCT00057837|1581498|P1|Overall Study|Ineligible|3
489556|NCT00057837|1581497|P2|Overall Study|Physician Decision|0
489557|NCT00057837|1581498|P1|Overall Study|Physician Decision|1
489558|NCT00057837|1581497|P2|Overall Study|Other complicating disease|1
489559|NCT00057837|1581498|P1|Overall Study|Other complicating disease|2
489560|NCT00057837|1581497|P2|Overall Study|Alternative therapy|1
489561|NCT00057837|1581498|P1|Overall Study|Alternative therapy|0
489562|NCT00057837|1581497|P2|Overall Study|Withdrawal by Subject|3
489563|NCT00057837|1581498|P1|Overall Study|Withdrawal by Subject|5
489564|NCT00057837|1581497|P2|Overall Study|Death|4
489565|NCT00057837|1581498|P1|Overall Study|Death|5
489566|NCT00057837|1581497|P2|Overall Study|Adverse Event|12
489567|NCT00057837|1581498|P1|Overall Study|Adverse Event|2
489568|NCT00057837|1581497|P2|Overall Study|Progression/relapse|14
489569|NCT00057837|1581498|P1|Overall Study|Progression/relapse|12
489570|NCT00057811|1581510|P2|Overall Study|Inevaluable|2
489571|NCT00057811|1581511|P1|Overall Study|Inevaluable|1
489572|NCT00057811|1581510|P2|Overall Study|Ineligible|2
489573|NCT00057811|1581511|P1|Overall Study|Ineligible|4
489574|NCT00057811|1581510|P2|Overall Study|Withdrawal by Subject|4
489575|NCT00057811|1581511|P1|Overall Study|Withdrawal by Subject|3
489576|NCT00057811|1581510|P2|Overall Study|Physician Decision|0
489577|NCT00057811|1581511|P1|Overall Study|Physician Decision|1
489578|NCT00057811|1581510|P2|Overall Study|Lack of Efficacy|4
489579|NCT00057811|1581511|P1|Overall Study|Lack of Efficacy|1
489580|NCT00057746|1581530|P3|Overall Study|Withdrawal by Subject|1
489581|NCT00057746|1581531|P2|Overall Study|Withdrawal by Subject|0
489582|NCT00057746|1581532|P1|Overall Study|Withdrawal by Subject|0
489583|NCT00023673|1581543|P4|Overall Study|Patient withdrew consent|1
489584|NCT00023673|1581544|P3|Overall Study|Patient withdrew consent|0
489585|NCT00023673|1581545|P2|Overall Study|Patient withdrew consent|0
489586|NCT00023673|1581546|P1|Overall Study|Patient withdrew consent|0
489587|NCT00023673|1581543|P4|Overall Study|Ineligible / no protocol treatment|1
489588|NCT00023673|1581544|P3|Overall Study|Ineligible / no protocol treatment|0
489589|NCT00023673|1581545|P2|Overall Study|Ineligible / no protocol treatment|0
489590|NCT00023673|1581546|P1|Overall Study|Ineligible / no protocol treatment|0
489591|NCT00057330|1581610|P2|Overall Study|Other|206
489592|NCT00057330|1581611|P1|Overall Study|Other|260
489593|NCT00057330|1581610|P2|Overall Study|Physician Decision|0
489594|NCT00057330|1581611|P1|Overall Study|Physician Decision|1
489595|NCT00057330|1581610|P2|Overall Study|Lost to Follow-up|617
489596|NCT00057330|1581611|P1|Overall Study|Lost to Follow-up|745
489597|NCT00057330|1581610|P2|Overall Study|Withdrawal by Subject|84
489598|NCT00057330|1581611|P1|Overall Study|Withdrawal by Subject|115
489599|NCT00057330|1581610|P2|Overall Study|Protocol Violation|1
489600|NCT00057330|1581611|P1|Overall Study|Protocol Violation|1
489601|NCT00057330|1581610|P2|Overall Study|Death|0
489602|NCT00057330|1581611|P1|Overall Study|Death|1
489603|NCT00057330|1581610|P2|Overall Study|Adverse Event|12
489604|NCT00057330|1581611|P1|Overall Study|Adverse Event|9
489605|NCT00056862|1581641|P2|Overall Study|Protocol Violation|0
489606|NCT00056862|1581642|P1|Overall Study|Protocol Violation|1
489607|NCT00056407|1581700|P2|Overall Study|Missing|34
489608|NCT00056407|1581701|P1|Overall Study|Missing|25
489609|NCT00056407|1581700|P2|Overall Study|"Listed as Other on Case Report Form"|60
489610|NCT00056407|1581701|P1|Overall Study|"Listed as Other on Case Report Form"|98
489611|NCT00056407|1581700|P2|Overall Study|Diagnosed with Prostate Cancer|166
489612|NCT00056407|1581701|P1|Overall Study|Diagnosed with Prostate Cancer|202
489613|NCT00056407|1581700|P2|Overall Study|Protocol Violation|95
489614|NCT00056407|1581701|P1|Overall Study|Protocol Violation|104
489615|NCT00056407|1581700|P2|Overall Study|Lost to Follow-up|113
489616|NCT00056407|1581701|P1|Overall Study|Lost to Follow-up|123
489617|NCT00056407|1581700|P2|Overall Study|Withdrawal by Subject|361
489618|NCT00056407|1581701|P1|Overall Study|Withdrawal by Subject|377
489619|NCT00056407|1581700|P2|Overall Study|Adverse Event|364
489620|NCT00056407|1581701|P1|Overall Study|Adverse Event|282
489621|NCT00056316|1581759|P2|Overall Study|Death/NH placement of pt|1
489622|NCT00056316|1581760|P1|Overall Study|Death/NH placement of pt|1
489623|NCT00056316|1581759|P2|Overall Study|Withdrawal by Subject|2
489624|NCT00056316|1581760|P1|Overall Study|Withdrawal by Subject|2
489625|NCT00056160|1581774|P2|Final Follow-up|Adverse Event|0
489626|NCT00056160|1581775|P1|Final Follow-up|Adverse Event|1
489627|NCT00056160|1581774|P2|Final Follow-up|Transferred into RevAssist Program|0
489628|NCT00056160|1581775|P1|Final Follow-up|Transferred into RevAssist Program|2
489629|NCT00056160|1581774|P2|Final Follow-up|Transferred into expanded access study.|0
489630|NCT00056160|1581775|P1|Final Follow-up|Transferred into expanded access study.|3
489631|NCT00056160|1581774|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
489632|NCT00056160|1581775|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
489633|NCT00056160|1581774|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
489634|NCT00056160|1581775|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
489635|NCT00056160|1581774|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
489636|NCT00056160|1581775|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
489637|NCT00056160|1581774|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
489638|NCT00056160|1581775|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
489639|NCT00056160|1581774|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
489640|NCT00056160|1581775|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
489641|NCT00056160|1581774|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
489642|NCT00056160|1581775|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
489643|NCT00056160|1581774|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
489644|NCT00056160|1581775|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
489645|NCT00056160|1581774|P2|Up to Unblinding (07 Jun 2005)|Death|1
489646|NCT00056160|1581775|P1|Up to Unblinding (07 Jun 2005)|Death|2
489647|NCT00056160|1581774|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
489648|NCT00056160|1581775|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
489649|NCT00056160|1581774|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
489650|NCT00056160|1581775|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
489651|NCT00056160|1581774|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
489652|NCT00056160|1581775|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
489653|NCT00056160|1581774|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
489654|NCT00056160|1581775|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
489655|NCT00055601|1581798|P2|Overall Study|No protocol treatment received|1
489656|NCT00055601|1581799|P1|Overall Study|No protocol treatment received|1
489657|NCT00055601|1581798|P2|Overall Study|Protocol Violation|1
489658|NCT00055601|1581799|P1|Overall Study|Protocol Violation|1
489659|NCT00055497|1581813|P4|Overall Study|Other|11
489660|NCT00055497|1581814|P3|Overall Study|Other|0
489661|NCT00055497|1581815|P2|Overall Study|Other|0
489662|NCT00055497|1581816|P1|Overall Study|Other|0
489663|NCT00055497|1581813|P4|Overall Study|Administrative Reasons|1
489664|NCT00055497|1581814|P3|Overall Study|Administrative Reasons|0
489665|NCT00055497|1581815|P2|Overall Study|Administrative Reasons|0
489666|NCT00055497|1581816|P1|Overall Study|Administrative Reasons|0
489667|NCT00055497|1581813|P4|Overall Study|Lack of Efficacy|27
489668|NCT00055497|1581814|P3|Overall Study|Lack of Efficacy|0
489669|NCT00055497|1581815|P2|Overall Study|Lack of Efficacy|0
489670|NCT00055497|1581816|P1|Overall Study|Lack of Efficacy|1
489671|NCT00055497|1581813|P4|Overall Study|Protocol Violation|3
489672|NCT00055497|1581814|P3|Overall Study|Protocol Violation|0
489673|NCT00055497|1581815|P2|Overall Study|Protocol Violation|0
489674|NCT00055497|1581816|P1|Overall Study|Protocol Violation|0
489675|NCT00055497|1581813|P4|Overall Study|Lost to Follow-up|5
489676|NCT00055497|1581814|P3|Overall Study|Lost to Follow-up|0
489677|NCT00055497|1581815|P2|Overall Study|Lost to Follow-up|1
489678|NCT00055497|1581816|P1|Overall Study|Lost to Follow-up|0
489679|NCT00055497|1581813|P4|Overall Study|Withdrawal by Subject|15
489680|NCT00055497|1581814|P3|Overall Study|Withdrawal by Subject|1
489681|NCT00055497|1581815|P2|Overall Study|Withdrawal by Subject|1
489682|NCT00055497|1581816|P1|Overall Study|Withdrawal by Subject|3
489683|NCT00055497|1581813|P4|Overall Study|Adverse Event|28
489684|NCT00055497|1581814|P3|Overall Study|Adverse Event|1
489685|NCT00055497|1581815|P2|Overall Study|Adverse Event|1
489686|NCT00055497|1581816|P1|Overall Study|Adverse Event|1
489687|NCT00055471|1581861|P3|Period 1: Dose Escalation Period|Disease progression|0
489688|NCT00055471|1581862|P2|Period 1: Dose Escalation Period|Disease progression|1
489689|NCT00055471|1581863|P1|Period 1: Dose Escalation Period|Disease progression|0
489690|NCT00055471|1581861|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
489691|NCT00055471|1581862|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
489692|NCT00055471|1581863|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
489693|NCT00055471|1581861|P3|Period 1: Dose Escalation Period|Adverse Event|2
489694|NCT00055471|1581862|P2|Period 1: Dose Escalation Period|Adverse Event|1
489695|NCT00055471|1581863|P1|Period 1: Dose Escalation Period|Adverse Event|0
489696|NCT00054717|1581914|P2|Overall Study|Other reason not defined above|217
489697|NCT00054717|1581915|P1|Overall Study|Other reason not defined above|117
489698|NCT00054717|1581914|P2|Overall Study|Withdrawal by Subject|20
489699|NCT00054717|1581915|P1|Overall Study|Withdrawal by Subject|32
489700|NCT00054717|1581914|P2|Overall Study|Lost to Follow-up|13
489701|NCT00054717|1581915|P1|Overall Study|Lost to Follow-up|23
489702|NCT00054717|1581914|P2|Overall Study|Protocol Violation|19
489703|NCT00054717|1581915|P1|Overall Study|Protocol Violation|18
489704|NCT00054717|1581914|P2|Overall Study|Adverse Event|22
489705|NCT00054717|1581915|P1|Overall Study|Adverse Event|70
489706|NCT00054717|1581914|P2|Overall Study|Randomized but not treated|8
489707|NCT00054717|1581915|P1|Overall Study|Randomized but not treated|2
489708|NCT00054704|1582103|P2|Overall Study|Lost to Follow-up|0
489709|NCT00054704|1582104|P1|Overall Study|Lost to Follow-up|1
489710|NCT00054704|1582103|P2|Overall Study|Adverse Event|2
489711|NCT00054704|1582104|P1|Overall Study|Adverse Event|3
489712|NCT00054704|1582103|P2|Overall Study|Lack of Efficacy|3
489713|NCT00054704|1582104|P1|Overall Study|Lack of Efficacy|1
489714|NCT00054691|1582110|P1|Overall Study|Noncompliant|1
489715|NCT00054691|1582110|P1|Overall Study|Unmeasurable Disease|2
489716|NCT00054639|1582124|P1|Overall Study|Physician Decision|1
489717|NCT00054639|1582124|P1|Overall Study|Lack of Efficacy|1
489718|NCT00054327|1582157|P6|Overall Study|Engraftment failure|0
489719|NCT00054327|1582158|P5|Overall Study|Engraftment failure|0
489720|NCT00054327|1582159|P4|Overall Study|Engraftment failure|0
489721|NCT00054327|1582160|P3|Overall Study|Engraftment failure|0
489722|NCT00054327|1582161|P2|Overall Study|Engraftment failure|0
489723|NCT00054327|1582162|P1|Overall Study|Engraftment failure|1
489724|NCT00054275|1582200|P1|Overall Study|Physician Decision|1
489725|NCT00054275|1582200|P1|Overall Study|Progressive disease in cycle 1|1
489726|NCT00054275|1582200|P1|Overall Study|Adverse Event|5
489727|NCT00054275|1582200|P1|Overall Study|Withdrawal by Subject|4
489728|NCT00054132|1582206|P1|Overall Study|Not Treated|1
489729|NCT00053898|1582225|P2|Overall Study|Follow-up from telephone contact only|1
489730|NCT00053898|1582226|P1|Overall Study|Follow-up from telephone contact only|5
489731|NCT00053898|1582225|P2|Overall Study|No follow-up data from any source|12
489732|NCT00053898|1582226|P1|Overall Study|No follow-up data from any source|9
489733|NCT00053846|1582250|P2|Overall Study|Pills too large|1
489734|NCT00053846|1582251|P1|Overall Study|Pills too large|0
489735|NCT00053846|1582250|P2|Overall Study|Quit due to side effects|3
489736|NCT00053846|1582251|P1|Overall Study|Quit due to side effects|1
489737|NCT00053846|1582250|P2|Overall Study|Did not return data|2
489738|NCT00053846|1582251|P1|Overall Study|Did not return data|1
489739|NCT00053846|1582250|P2|Overall Study|Became ineligible|1
489740|NCT00053846|1582251|P1|Overall Study|Became ineligible|3
489741|NCT00053846|1582250|P2|Overall Study|Expired|0
489742|NCT00053846|1582251|P1|Overall Study|Expired|5
489743|NCT00053846|1582250|P2|Overall Study|Became too ill|7
489744|NCT00053846|1582251|P1|Overall Study|Became too ill|8
489745|NCT00053846|1582250|P2|Overall Study|Changed mind|13
489746|NCT00053846|1582251|P1|Overall Study|Changed mind|8
489747|NCT00053417|1582410|P4|Overall Study|Lost to Follow-up|0
489748|NCT00053417|1582411|P3|Overall Study|Lost to Follow-up|0
489749|NCT00053417|1582412|P2|Overall Study|Lost to Follow-up|1
489750|NCT00053417|1582413|P1|Overall Study|Lost to Follow-up|1
489751|NCT00053417|1582410|P4|Overall Study|Withdrawal by Subject|0
489752|NCT00053417|1582411|P3|Overall Study|Withdrawal by Subject|0
489753|NCT00053417|1582412|P2|Overall Study|Withdrawal by Subject|1
489754|NCT00053417|1582413|P1|Overall Study|Withdrawal by Subject|0
489755|NCT00053417|1582410|P4|Overall Study|Non-Compliance|1
489756|NCT00053417|1582411|P3|Overall Study|Non-Compliance|0
489757|NCT00053417|1582412|P2|Overall Study|Non-Compliance|0
489758|NCT00053417|1582413|P1|Overall Study|Non-Compliance|0
489759|NCT00053417|1582410|P4|Overall Study|Adverse Event|5
489760|NCT00053417|1582411|P3|Overall Study|Adverse Event|1
489761|NCT00053417|1582412|P2|Overall Study|Adverse Event|0
489762|NCT00053417|1582413|P1|Overall Study|Adverse Event|1
489763|NCT00053365|1582423|P1|Overall Study|Never treated|4
489764|NCT00053365|1582423|P1|Overall Study|Platinum-sensitive interval >12 months|1
489765|NCT00053365|1582423|P1|Overall Study|Incorrect cell type|1
489766|NCT00053352|1582433|P2|Overall Study|Disease at new site|0
489767|NCT00053352|1582434|P1|Overall Study|Disease at new site|1
489768|NCT00053352|1582433|P2|Overall Study|Ineligible|8
489769|NCT00053352|1582434|P1|Overall Study|Ineligible|8
489770|NCT00053352|1582433|P2|Overall Study|Withdrawal by Subject|0
489771|NCT00053352|1582434|P1|Overall Study|Withdrawal by Subject|1
489772|NCT00053352|1582433|P2|Overall Study|Physician Decision|1
489773|NCT00053352|1582434|P1|Overall Study|Physician Decision|11
489774|NCT00053352|1582433|P2|Overall Study|Lost to Follow-up|1
489775|NCT00053352|1582434|P1|Overall Study|Lost to Follow-up|0
489776|NCT00003830|1582450|P2|Overall Study|Sentinel node positive patients|793
489777|NCT00003830|1582451|P1|Overall Study|Sentinel node positive patients|829
489778|NCT00003830|1582450|P2|Overall Study|No follow up data|0
489779|NCT00003830|1582451|P1|Overall Study|No follow up data|3
489780|NCT00052962|1582477|P2|Overall Study|Not randomized/not evaluable|0
489781|NCT00052962|1582478|P1|Overall Study|Not randomized/not evaluable|1
489782|NCT00052962|1582477|P2|Overall Study|Not evaluable|2
489783|NCT00052962|1582478|P1|Overall Study|Not evaluable|0
489784|NCT00052715|1582486|P1|Overall Study|wrong histology|1
489785|NCT00049543|1582500|P2|Overall Study|still on treatment|9
489786|NCT00049543|1582501|P1|Overall Study|still on treatment|2
489787|NCT00049530|1582511|P1|Overall Study|ineligible|3
489788|NCT00049530|1582511|P1|Overall Study|symptomatic deterioration|1
489789|NCT00049530|1582511|P1|Overall Study|Death|1
489790|NCT00049530|1582511|P1|Overall Study|Adverse Event|2
489791|NCT00049530|1582511|P1|Overall Study|Lack of Efficacy|25
489792|NCT00049517|1582520|P6|Conditioning/Transplant|Reasons not reported|5
489793|NCT00049517|1582521|P5|Conditioning/Transplant|Reasons not reported|5
489794|NCT00049517|1582522|P4|Conditioning/Transplant|Reasons not reported|15
489795|NCT00049517|1582523|P3|Conditioning/Transplant|Reasons not reported|18
489796|NCT00049517|1582524|P2|Conditioning/Transplant|Reasons not reported|31
489797|NCT00049517|1582525|P1|Conditioning/Transplant|Reasons not reported|25
489798|NCT00049517|1582520|P6|Conditioning/Transplant|Other complicating disease|1
489799|NCT00049517|1582521|P5|Conditioning/Transplant|Other complicating disease|0
489800|NCT00049517|1582522|P4|Conditioning/Transplant|Other complicating disease|4
489801|NCT00049517|1582523|P3|Conditioning/Transplant|Other complicating disease|0
489802|NCT00049517|1582524|P2|Conditioning/Transplant|Other complicating disease|0
489803|NCT00049517|1582525|P1|Conditioning/Transplant|Other complicating disease|2
489804|NCT00049517|1582520|P6|Conditioning/Transplant|Alternative therapy|0
489805|NCT00049517|1582521|P5|Conditioning/Transplant|Alternative therapy|1
489806|NCT00049517|1582522|P4|Conditioning/Transplant|Alternative therapy|1
489807|NCT00049517|1582523|P3|Conditioning/Transplant|Alternative therapy|2
489808|NCT00049517|1582524|P2|Conditioning/Transplant|Alternative therapy|4
489809|NCT00049517|1582525|P1|Conditioning/Transplant|Alternative therapy|4
489810|NCT00049517|1582520|P6|Conditioning/Transplant|Withdrawal by Subject|0
489811|NCT00049517|1582521|P5|Conditioning/Transplant|Withdrawal by Subject|0
489812|NCT00049517|1582522|P4|Conditioning/Transplant|Withdrawal by Subject|7
489813|NCT00049517|1582523|P3|Conditioning/Transplant|Withdrawal by Subject|4
489814|NCT00049517|1582524|P2|Conditioning/Transplant|Withdrawal by Subject|8
489815|NCT00049517|1582525|P1|Conditioning/Transplant|Withdrawal by Subject|4
489816|NCT00049517|1582520|P6|Conditioning/Transplant|Death|0
489817|NCT00049517|1582521|P5|Conditioning/Transplant|Death|0
489818|NCT00049517|1582522|P4|Conditioning/Transplant|Death|2
489819|NCT00049517|1582523|P3|Conditioning/Transplant|Death|0
489820|NCT00049517|1582524|P2|Conditioning/Transplant|Death|0
489821|NCT00049517|1582525|P1|Conditioning/Transplant|Death|1
489822|NCT00049517|1582520|P6|Conditioning/Transplant|Adverse Event|0
489823|NCT00049517|1582521|P5|Conditioning/Transplant|Adverse Event|0
489824|NCT00049517|1582522|P4|Conditioning/Transplant|Adverse Event|8
489825|NCT00049517|1582523|P3|Conditioning/Transplant|Adverse Event|4
489826|NCT00049517|1582524|P2|Conditioning/Transplant|Adverse Event|1
489827|NCT00049517|1582525|P1|Conditioning/Transplant|Adverse Event|2
489828|NCT00049517|1582520|P6|Conditioning/Transplant|Disease progression|0
489829|NCT00049517|1582521|P5|Conditioning/Transplant|Disease progression|0
489830|NCT00049517|1582522|P4|Conditioning/Transplant|Disease progression|6
489831|NCT00049517|1582523|P3|Conditioning/Transplant|Disease progression|10
489832|NCT00049517|1582524|P2|Conditioning/Transplant|Disease progression|6
489833|NCT00049517|1582525|P1|Conditioning/Transplant|Disease progression|14
489834|NCT00049517|1582520|P6|Induction|Reasons not reported|25
489835|NCT00049517|1582521|P5|Induction|Reasons not reported|22
489836|NCT00049517|1582522|P4|Induction|Reasons not reported|0
489837|NCT00049517|1582523|P3|Induction|Reasons not reported|0
489838|NCT00049517|1582524|P2|Induction|Reasons not reported|0
489839|NCT00049517|1582525|P1|Induction|Reasons not reported|0
489840|NCT00049517|1582520|P6|Induction|Other complicating disease|0
489841|NCT00049517|1582521|P5|Induction|Other complicating disease|3
489842|NCT00049517|1582522|P4|Induction|Other complicating disease|0
489843|NCT00049517|1582523|P3|Induction|Other complicating disease|0
489844|NCT00049517|1582524|P2|Induction|Other complicating disease|0
489845|NCT00049517|1582525|P1|Induction|Other complicating disease|0
489846|NCT00049517|1582520|P6|Induction|Alternative therapy|2
489847|NCT00049517|1582521|P5|Induction|Alternative therapy|2
489848|NCT00049517|1582522|P4|Induction|Alternative therapy|0
489849|NCT00049517|1582523|P3|Induction|Alternative therapy|0
489850|NCT00049517|1582524|P2|Induction|Alternative therapy|0
489851|NCT00049517|1582525|P1|Induction|Alternative therapy|0
489852|NCT00049517|1582520|P6|Induction|Withdrawal by Subject|3
489853|NCT00049517|1582521|P5|Induction|Withdrawal by Subject|1
489854|NCT00049517|1582522|P4|Induction|Withdrawal by Subject|0
489855|NCT00049517|1582523|P3|Induction|Withdrawal by Subject|0
489856|NCT00049517|1582524|P2|Induction|Withdrawal by Subject|0
489857|NCT00049517|1582525|P1|Induction|Withdrawal by Subject|0
489858|NCT00049517|1582520|P6|Induction|Death|6
489859|NCT00049517|1582521|P5|Induction|Death|9
489860|NCT00049517|1582522|P4|Induction|Death|0
489861|NCT00049517|1582523|P3|Induction|Death|0
489862|NCT00049517|1582524|P2|Induction|Death|0
489863|NCT00049517|1582525|P1|Induction|Death|0
489864|NCT00049517|1582520|P6|Induction|Adverse Event|7
489865|NCT00049517|1582521|P5|Induction|Adverse Event|5
489866|NCT00049517|1582522|P4|Induction|Adverse Event|0
489867|NCT00049517|1582523|P3|Induction|Adverse Event|0
489868|NCT00049517|1582524|P2|Induction|Adverse Event|0
489869|NCT00049517|1582525|P1|Induction|Adverse Event|0
489870|NCT00049517|1582520|P6|Induction|Disease progression|11
489871|NCT00049517|1582521|P5|Induction|Disease progression|18
489872|NCT00049517|1582522|P4|Induction|Disease progression|0
489873|NCT00049517|1582523|P3|Induction|Disease progression|0
489874|NCT00049517|1582524|P2|Induction|Disease progression|0
489875|NCT00049517|1582525|P1|Induction|Disease progression|0
489876|NCT00049322|1582543|P2|Overall Study|refused angio|3
489877|NCT00049322|1582544|P1|Overall Study|refused angio|0
489878|NCT00049322|1582543|P2|Overall Study|Adverse Event|0
489879|NCT00049322|1582544|P1|Overall Study|Adverse Event|1
489880|NCT00049322|1582543|P2|Overall Study|disease burden|3
489881|NCT00049322|1582544|P1|Overall Study|disease burden|0
489882|NCT00049257|1582556|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
489883|NCT00049257|1582556|P1|Carboplatin, Paclitaxel|Death|2
489884|NCT00049257|1582556|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
489885|NCT00049257|1582556|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
489886|NCT00049127|1582568|P5|Overall Study|Withdrawal by Subject|0
489887|NCT00049127|1582569|P4|Overall Study|Withdrawal by Subject|0
489888|NCT00049127|1582570|P3|Overall Study|Withdrawal by Subject|1
489889|NCT00049127|1582571|P2|Overall Study|Withdrawal by Subject|0
489890|NCT00049127|1582572|P1|Overall Study|Withdrawal by Subject|0
489891|NCT00048997|1582610|P2|Overall Study|Withdrawal by Subject|1
489892|NCT00048997|1582611|P1|Overall Study|Withdrawal by Subject|6
489893|NCT00048997|1582610|P2|Overall Study|Protocol Violation|2
489894|NCT00048997|1582611|P1|Overall Study|Protocol Violation|7
489895|NCT00047385|1582634|P2|Overall Study|Eligible for screening but had no screen|492
489896|NCT00047385|1582635|P1|Overall Study|Eligible for screening but had no screen|260
489897|NCT00047385|1582634|P2|Overall Study|Lung Cancer diagnosed before screening|3
489898|NCT00047385|1582635|P1|Overall Study|Lung Cancer diagnosed before screening|5
489899|NCT00047385|1582634|P2|Overall Study|Death before any screening|5
489900|NCT00047385|1582635|P1|Overall Study|Death before any screening|2
489901|NCT00047320|1582653|P1|Overall Study|Ineligible|2
489902|NCT00047320|1582653|P1|Overall Study|Withdrawal by Subject|9
489903|NCT00047320|1582653|P1|Overall Study|Physician Decision|8
489904|NCT00047320|1582653|P1|Overall Study|Lost to Follow-up|1
489905|NCT00047320|1582653|P1|Overall Study|Lack of Efficacy|8
489906|NCT00047008|1582664|P2|Overall Study|Ineligible|8
489907|NCT00047008|1582665|P1|Overall Study|Ineligible|9
489908|NCT00047008|1582664|P2|Overall Study|Withdrawn consent|3
489909|NCT00047008|1582665|P1|Overall Study|Withdrawn consent|2
489910|NCT00046930|1582673|P2|Overall Study|Ineligible|4
489911|NCT00046930|1582674|P1|Overall Study|Ineligible|12
489912|NCT00046891|1582689|P2|Overall Study|Adverse Event|5
489913|NCT00046891|1582690|P1|Overall Study|Adverse Event|5
489914|NCT00046891|1582689|P2|Overall Study|Withdrawal by Subject|15
489915|NCT00046891|1582690|P1|Overall Study|Withdrawal by Subject|18
489916|NCT00046891|1582689|P2|Overall Study|Ineligible|1
489917|NCT00046891|1582690|P1|Overall Study|Ineligible|1
489918|NCT00046891|1582689|P2|Overall Study|Cancels|9
489919|NCT00046891|1582690|P1|Overall Study|Cancels|5
489920|NCT00046839|1582710|P2|Overall Study|Withdrawal of consent|0
489921|NCT00046839|1582711|P1|Overall Study|Withdrawal of consent|1
489922|NCT00046839|1582710|P2|Overall Study|Ineligible / No protocol treatment|2
489923|NCT00046839|1582711|P1|Overall Study|Ineligible / No protocol treatment|0
489924|NCT00045734|1582718|P1|Overall Study|Protocol Violation|1
489925|NCT00045708|1582733|P3|Phase 1|early progressive disease|0
489926|NCT00045708|1582734|P2|Phase 1|early progressive disease|1
489927|NCT00045708|1582735|P1|Phase 1|early progressive disease|0
489928|NCT00045630|1582760|P1|Overall Study|Ineligible|2
489929|NCT00045630|1582760|P1|Overall Study|Death|1
489930|NCT00045630|1582760|P1|Overall Study|Progression/relapse|1
489931|NCT00045630|1582760|P1|Overall Study|Refusal unrelated to adverse event|1
489932|NCT00045630|1582760|P1|Overall Study|Adverse Event|1
489933|NCT00045305|1582779|P1|Overall Study|site error|2
489934|NCT00045305|1582779|P1|Overall Study|Death|3
489935|NCT00045305|1582779|P1|Overall Study|Adverse Event|3
489936|NCT00045305|1582779|P1|Overall Study|Lack of Efficacy|6
489937|NCT00045162|1582790|P2|Overall Study|Not specified|16
489938|NCT00045162|1582791|P1|Overall Study|Not specified|21
489939|NCT00045162|1582790|P2|Overall Study|Withdrawal by Subject|3
489940|NCT00045162|1582791|P1|Overall Study|Withdrawal by Subject|5
489941|NCT00045162|1582790|P2|Overall Study|Death|10
489942|NCT00045162|1582791|P1|Overall Study|Death|10
489943|NCT00045162|1582790|P2|Overall Study|Lack of Efficacy|29
489944|NCT00045162|1582791|P1|Overall Study|Lack of Efficacy|32
489945|NCT00045162|1582790|P2|Overall Study|Adverse Event|50
489946|NCT00045162|1582791|P1|Overall Study|Adverse Event|55
489947|NCT00045162|1582790|P2|Overall Study|Not treated|2
489948|NCT00045162|1582791|P1|Overall Study|Not treated|7
489949|NCT00045162|1582790|P2|Overall Study|Ineligible|8
489950|NCT00045162|1582791|P1|Overall Study|Ineligible|12
489951|NCT00045110|1582806|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
489952|NCT00045110|1582807|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
489953|NCT00045110|1582808|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
489954|NCT00045110|1582806|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
489955|NCT00045110|1582807|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
489956|NCT00045110|1582808|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
489957|NCT00045110|1582806|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
489958|NCT00045110|1582807|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
489959|NCT00045110|1582808|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
489960|NCT00045032|1582857|P3|Overall Study|Not Specified|105
489961|NCT00045032|1582858|P2|Overall Study|Not Specified|84
489962|NCT00045032|1582859|P1|Overall Study|Not Specified|93
489963|NCT00045032|1582857|P3|Overall Study|Failure to Return|61
489964|NCT00045032|1582858|P2|Overall Study|Failure to Return|62
489965|NCT00045032|1582859|P1|Overall Study|Failure to Return|57
489966|NCT00045032|1582857|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
489967|NCT00045032|1582858|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
489968|NCT00045032|1582859|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
489969|NCT00045032|1582857|P3|Overall Study|Other Protocol Violation|1
489970|NCT00045032|1582858|P2|Overall Study|Other Protocol Violation|0
489971|NCT00045032|1582859|P1|Overall Study|Other Protocol Violation|2
489972|NCT00045032|1582857|P3|Overall Study|Violation of Selection Criteria at Entry|6
489973|NCT00045032|1582858|P2|Overall Study|Violation of Selection Criteria at Entry|6
489974|NCT00045032|1582859|P1|Overall Study|Violation of Selection Criteria at Entry|3
489975|NCT00045032|1582857|P3|Overall Study|Insufficient Therapeutic Response|445
489976|NCT00045032|1582858|P2|Overall Study|Insufficient Therapeutic Response|437
489977|NCT00045032|1582859|P1|Overall Study|Insufficient Therapeutic Response|542
489978|NCT00045032|1582857|P3|Overall Study|Death|17
489979|NCT00045032|1582858|P2|Overall Study|Death|24
489980|NCT00045032|1582859|P1|Overall Study|Death|22
489981|NCT00045032|1582857|P3|Overall Study|Adverse Event/Intercurrent Illness|7
489982|NCT00045032|1582858|P2|Overall Study|Adverse Event/Intercurrent Illness|2
489983|NCT00045032|1582859|P1|Overall Study|Adverse Event/Intercurrent Illness|2
489984|NCT00042991|1582993|P7|Overall Study|Alternative Therapy|0
489985|NCT00042991|1582994|P6|Overall Study|Alternative Therapy|0
489986|NCT00042991|1582995|P5|Overall Study|Alternative Therapy|1
489987|NCT00042991|1582996|P4|Overall Study|Alternative Therapy|0
489988|NCT00042991|1582997|P3|Overall Study|Alternative Therapy|0
489989|NCT00042991|1582998|P2|Overall Study|Alternative Therapy|0
489990|NCT00042991|1582999|P1|Overall Study|Alternative Therapy|0
489991|NCT00042991|1582993|P7|Overall Study|Disease Progression|2
489992|NCT00042991|1582994|P6|Overall Study|Disease Progression|4
489993|NCT00042991|1582995|P5|Overall Study|Disease Progression|1
489994|NCT00042991|1582996|P4|Overall Study|Disease Progression|2
489995|NCT00042991|1582997|P3|Overall Study|Disease Progression|2
489996|NCT00042991|1582998|P2|Overall Study|Disease Progression|29
489997|NCT00042991|1582999|P1|Overall Study|Disease Progression|5
489998|NCT00042991|1582993|P7|Overall Study|Withdrawal by Subject|0
489999|NCT00042991|1582994|P6|Overall Study|Withdrawal by Subject|0
490000|NCT00042991|1582995|P5|Overall Study|Withdrawal by Subject|1
490001|NCT00042991|1582996|P4|Overall Study|Withdrawal by Subject|0
490002|NCT00042991|1582997|P3|Overall Study|Withdrawal by Subject|2
490003|NCT00042991|1582998|P2|Overall Study|Withdrawal by Subject|7
490004|NCT00042991|1582999|P1|Overall Study|Withdrawal by Subject|0
490005|NCT00042991|1582993|P7|Overall Study|Adverse Event|0
490006|NCT00042991|1582994|P6|Overall Study|Adverse Event|1
490007|NCT00042991|1582995|P5|Overall Study|Adverse Event|0
490008|NCT00042991|1582996|P4|Overall Study|Adverse Event|0
490009|NCT00042991|1582997|P3|Overall Study|Adverse Event|2
490010|NCT00042991|1582998|P2|Overall Study|Adverse Event|4
490011|NCT00042991|1582999|P1|Overall Study|Adverse Event|1
490012|NCT00042939|1583042|P2|Overall Study|Did not start treatment|1
490013|NCT00042939|1583043|P1|Overall Study|Did not start treatment|2
490014|NCT00042939|1583042|P2|Overall Study|Treatment break > 4 weeks|1
490015|NCT00042939|1583043|P1|Overall Study|Treatment break > 4 weeks|0
490016|NCT00042939|1583042|P2|Overall Study|Still on treatment|0
490017|NCT00042939|1583043|P1|Overall Study|Still on treatment|1
490018|NCT00042939|1583042|P2|Overall Study|Patient non-compliance|0
490019|NCT00042939|1583043|P1|Overall Study|Patient non-compliance|1
490020|NCT00042939|1583042|P2|Overall Study|Rising ca 19-9|0
490021|NCT00042939|1583043|P1|Overall Study|Rising ca 19-9|1
490022|NCT00042939|1583042|P2|Overall Study|QOL diminished|0
490023|NCT00042939|1583043|P1|Overall Study|QOL diminished|1
490024|NCT00042939|1583042|P2|Overall Study|Deterioration of health|4
490025|NCT00042939|1583043|P1|Overall Study|Deterioration of health|3
490026|NCT00042939|1583042|P2|Overall Study|Ineligible|2
490027|NCT00042939|1583043|P1|Overall Study|Ineligible|2
490028|NCT00042939|1583042|P2|Overall Study|Other disease|0
490029|NCT00042939|1583043|P1|Overall Study|Other disease|1
490030|NCT00042939|1583042|P2|Overall Study|Withdrawal by Subject|4
490031|NCT00042939|1583043|P1|Overall Study|Withdrawal by Subject|3
490032|NCT00042939|1583042|P2|Overall Study|Death|2
490033|NCT00042939|1583043|P1|Overall Study|Death|3
490034|NCT00042939|1583042|P2|Overall Study|Adverse Event|7
490035|NCT00042939|1583043|P1|Overall Study|Adverse Event|6
490036|NCT00041132|1583057|P1|Overall Study|Physician Decision|2
490037|NCT00041132|1583057|P1|Overall Study|Withdrawal by Subject|1
490038|NCT00041132|1583057|P1|Overall Study|Not Eligible|7
490039|NCT00041132|1583057|P1|Overall Study|Death|1
490040|NCT00041132|1583057|P1|Overall Study|Adverse Event|19
490041|NCT00041080|1583092|P2|Overall Study|Ineligible|0
490042|NCT00041080|1583093|P1|Overall Study|Ineligible|1
490043|NCT00041080|1583092|P2|Overall Study|Did not start therapy|1
490044|NCT00041080|1583093|P1|Overall Study|Did not start therapy|1
490045|NCT00041080|1583092|P2|Overall Study|Concommitant Illness/Other|2
490046|NCT00041080|1583093|P1|Overall Study|Concommitant Illness/Other|1
490047|NCT00041080|1583092|P2|Overall Study|Withdrawal by Subject|6
490048|NCT00041080|1583093|P1|Overall Study|Withdrawal by Subject|6
490049|NCT00041080|1583092|P2|Overall Study|Adverse Event|1
490050|NCT00041080|1583093|P1|Overall Study|Adverse Event|21
490051|NCT00041067|1583099|P1|Overall Study|Ineligible|2
490052|NCT00041067|1583099|P1|Overall Study|Other reasons|23
490053|NCT00041067|1583099|P1|Overall Study|Patient refusal|12
490054|NCT00041067|1583099|P1|Overall Study|Progression|19
490055|NCT00041067|1583099|P1|Overall Study|Adverse Event|20
490056|NCT00040742|1583166|P4|Overall Study|Other medical|5
490057|NCT00040742|1583167|P3|Overall Study|Other medical|5
490058|NCT00040742|1583168|P2|Overall Study|Other medical|5
490059|NCT00040742|1583169|P1|Overall Study|Other medical|7
490060|NCT00040742|1583166|P4|Overall Study|Incomplete Forms|5
490061|NCT00040742|1583167|P3|Overall Study|Incomplete Forms|4
490062|NCT00040742|1583168|P2|Overall Study|Incomplete Forms|10
490063|NCT00040742|1583169|P1|Overall Study|Incomplete Forms|6
490064|NCT00040742|1583166|P4|Overall Study|Chemotoxicity|2
490065|NCT00040742|1583167|P3|Overall Study|Chemotoxicity|5
490066|NCT00040742|1583168|P2|Overall Study|Chemotoxicity|3
490067|NCT00040742|1583169|P1|Overall Study|Chemotoxicity|4
490068|NCT00040742|1583166|P4|Overall Study|Withdrawal by Subject|13
490069|NCT00040742|1583167|P3|Overall Study|Withdrawal by Subject|10
490070|NCT00040742|1583168|P2|Overall Study|Withdrawal by Subject|15
490071|NCT00040742|1583169|P1|Overall Study|Withdrawal by Subject|7
490072|NCT00040742|1583166|P4|Overall Study|Adverse Event|9
490073|NCT00040742|1583167|P3|Overall Study|Adverse Event|21
490074|NCT00040742|1583168|P2|Overall Study|Adverse Event|16
490075|NCT00040742|1583169|P1|Overall Study|Adverse Event|15
490076|NCT00040742|1583166|P4|Overall Study|Death|0
490077|NCT00040742|1583167|P3|Overall Study|Death|1
490078|NCT00040742|1583168|P2|Overall Study|Death|0
490079|NCT00040742|1583169|P1|Overall Study|Death|0
490080|NCT00039377|1583183|P4|Initial Registration|Withdrawal by Subject|0
490081|NCT00039377|1583184|P3|Initial Registration|Withdrawal by Subject|0
490082|NCT00039377|1583185|P2|Initial Registration|Withdrawal by Subject|0
490083|NCT00039377|1583186|P1|Initial Registration|Withdrawal by Subject|3
490084|NCT00039377|1583183|P4|Initial Registration|Received non-protocol therapy|0
490085|NCT00039377|1583184|P3|Initial Registration|Received non-protocol therapy|0
490086|NCT00039377|1583185|P2|Initial Registration|Received non-protocol therapy|0
490087|NCT00039377|1583186|P1|Initial Registration|Received non-protocol therapy|11
490088|NCT00039377|1583183|P4|Initial Registration|Relapsed|0
490089|NCT00039377|1583184|P3|Initial Registration|Relapsed|0
490090|NCT00039377|1583185|P2|Initial Registration|Relapsed|0
490091|NCT00039377|1583186|P1|Initial Registration|Relapsed|6
490092|NCT00039377|1583183|P4|Initial Registration|Adverse Event|0
490093|NCT00039377|1583184|P3|Initial Registration|Adverse Event|0
490094|NCT00039377|1583185|P2|Initial Registration|Adverse Event|0
490095|NCT00039377|1583186|P1|Initial Registration|Adverse Event|2
490096|NCT00039130|1583202|P1|Overall Study|Physician Decision|3
490097|NCT00039130|1583202|P1|Overall Study|Subsequent treatment|2
490098|NCT00039130|1583202|P1|Overall Study|Progression|2
490099|NCT00039130|1583202|P1|Overall Study|Withdrawal by Subject|3
490100|NCT00039130|1583202|P1|Overall Study|Death|9
490101|NCT00039130|1583202|P1|Overall Study|Adverse Event|11
490102|NCT00033657|1583216|P2|Adjuvant Chemotherapy|Other|2
490103|NCT00033657|1583217|P1|Adjuvant Chemotherapy|Other|0
490104|NCT00033657|1583216|P2|Adjuvant Chemotherapy|alternative therapy|0
490105|NCT00033657|1583217|P1|Adjuvant Chemotherapy|alternative therapy|1
490106|NCT00033657|1583216|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
490107|NCT00033657|1583217|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
490108|NCT00033657|1583216|P2|Adjuvant Chemotherapy|Death|1
490109|NCT00033657|1583217|P1|Adjuvant Chemotherapy|Death|2
490110|NCT00033657|1583216|P2|Adjuvant Chemotherapy|Adverse Event|10
490111|NCT00033657|1583217|P1|Adjuvant Chemotherapy|Adverse Event|7
490112|NCT00033657|1583216|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
490113|NCT00033657|1583217|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
490114|NCT00033657|1583216|P2|Surgical Resection|not complete resection|3
490115|NCT00033657|1583217|P1|Surgical Resection|not complete resection|0
490116|NCT00033657|1583216|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
490117|NCT00033657|1583217|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
490118|NCT00033657|1583216|P2|Neoadjuvant Chemotherapy|Ineligible|4
490119|NCT00033657|1583217|P1|Neoadjuvant Chemotherapy|Ineligible|8
490120|NCT00033657|1583216|P2|Neoadjuvant Chemotherapy|other complicating disease|1
490121|NCT00033657|1583217|P1|Neoadjuvant Chemotherapy|other complicating disease|0
490122|NCT00033657|1583216|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
490123|NCT00033657|1583217|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
490124|NCT00033657|1583216|P2|Neoadjuvant Chemotherapy|Death|1
490125|NCT00033657|1583217|P1|Neoadjuvant Chemotherapy|Death|1
490126|NCT00033657|1583216|P2|Neoadjuvant Chemotherapy|Adverse Event|2
490127|NCT00033657|1583217|P1|Neoadjuvant Chemotherapy|Adverse Event|0
490128|NCT00033657|1583216|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
490129|NCT00033657|1583217|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
490130|NCT00033631|1583231|P2|Overall Study|Withdrawal by Subject|4
490131|NCT00033631|1583232|P1|Overall Study|Withdrawal by Subject|4
490132|NCT00033631|1583231|P2|Overall Study|Protocol Violation|11
490133|NCT00033631|1583232|P1|Overall Study|Protocol Violation|14
490134|NCT00033540|1583250|P1|Overall Study|Never received treatment|2
490135|NCT00033540|1583250|P1|Overall Study|Ineligible|3
490136|NCT00033540|1583250|P1|Overall Study|Not specified|5
490137|NCT00033540|1583250|P1|Overall Study|Withdrawal by Subject|6
490138|NCT00033540|1583250|P1|Overall Study|Progression|26
490139|NCT00033540|1583250|P1|Overall Study|Death|1
490140|NCT00033540|1583250|P1|Overall Study|Adverse Event|14
490141|NCT00033514|1583260|P2|Overall Study|Withdrawal by Subject|3
490142|NCT00033514|1583261|P1|Overall Study|Withdrawal by Subject|0
490143|NCT00033514|1583260|P2|Overall Study|Lost to Follow-up|1
490144|NCT00033514|1583261|P1|Overall Study|Lost to Follow-up|1
490145|NCT00033371|1583271|P2|Overall Study|Disease Progression|1
490146|NCT00033371|1583272|P1|Overall Study|Disease Progression|0
490147|NCT00033371|1583271|P2|Overall Study|Withdrawal by Subject|3
490148|NCT00033371|1583272|P1|Overall Study|Withdrawal by Subject|3
490149|NCT00033371|1583271|P2|Overall Study|Lost to Follow-up|1
490150|NCT00033371|1583272|P1|Overall Study|Lost to Follow-up|2
490151|NCT00033371|1583271|P2|Overall Study|Adverse Event|5
490152|NCT00033371|1583272|P1|Overall Study|Adverse Event|1
490153|NCT00033293|1583280|P2|Overall Study|Treatment refused|6
490154|NCT00033293|1583281|P1|Overall Study|Treatment refused|0
490155|NCT00033293|1583280|P2|Overall Study|Could not be weaned from steroid therapy|1
490156|NCT00033293|1583281|P1|Overall Study|Could not be weaned from steroid therapy|1
490157|NCT00033293|1583280|P2|Overall Study|Withdrawal by Subject|0
490158|NCT00033293|1583281|P1|Overall Study|Withdrawal by Subject|1
490159|NCT00033293|1583280|P2|Overall Study|Physician Decision|1
490160|NCT00033293|1583281|P1|Overall Study|Physician Decision|3
490161|NCT00033293|1583280|P2|Overall Study|Lost to Follow-up|1
490162|NCT00033293|1583281|P1|Overall Study|Lost to Follow-up|0
490163|NCT00033293|1583280|P2|Overall Study|Lack of Efficacy|8
490164|NCT00033293|1583281|P1|Overall Study|Lack of Efficacy|5
490165|NCT00033293|1583280|P2|Overall Study|Death|1
490166|NCT00033293|1583281|P1|Overall Study|Death|0
490167|NCT00031694|1583299|P1|Overall Study|Withdrawal by Subject|5
490168|NCT00031694|1583299|P1|Overall Study|Death|2
490169|NCT00031694|1583299|P1|Overall Study|Adverse Event|12
490170|NCT00030901|1583305|P3|Randomization|Ineligible|14
490171|NCT00030901|1583306|P2|Randomization|Ineligible|15
490172|NCT00030901|1583307|P1|Randomization|Ineligible|0
490173|NCT00030901|1583305|P3|Randomization|Other|33
490174|NCT00030901|1583306|P2|Randomization|Other|36
490175|NCT00030901|1583307|P1|Randomization|Other|0
490176|NCT00030901|1583305|P3|Randomization|Death|3
490177|NCT00030901|1583306|P2|Randomization|Death|1
490178|NCT00030901|1583307|P1|Randomization|Death|0
490179|NCT00030901|1583305|P3|Randomization|Progression/Relapse|21
490180|NCT00030901|1583306|P2|Randomization|Progression/Relapse|22
490181|NCT00030901|1583307|P1|Randomization|Progression/Relapse|0
490182|NCT00030901|1583305|P3|Randomization|Refusal Unrelated to Adverse Event|10
490183|NCT00030901|1583306|P2|Randomization|Refusal Unrelated to Adverse Event|16
490184|NCT00030901|1583307|P1|Randomization|Refusal Unrelated to Adverse Event|0
490185|NCT00030901|1583305|P3|Randomization|Adverse Event|7
490186|NCT00030901|1583306|P2|Randomization|Adverse Event|11
490187|NCT00030901|1583307|P1|Randomization|Adverse Event|0
490188|NCT00030901|1583305|P3|Initial Registration|Ineligible|0
490189|NCT00030901|1583306|P2|Initial Registration|Ineligible|0
490190|NCT00030901|1583307|P1|Initial Registration|Ineligible|167
490191|NCT00030823|1583315|P1|Overall Study|Withdrawal by Subject|1
490192|NCT00028769|1583319|P1|Overall Study|Not Analyzable|1
490193|NCT00028769|1583319|P1|Overall Study|Ineligible|5
490194|NCT00028769|1583319|P1|Overall Study|Other - Not Protocol Specified|1
490195|NCT00028769|1583319|P1|Overall Study|Progression or Death|31
490196|NCT00028769|1583319|P1|Overall Study|Refusal Unrelated to Adverse Events|1
490197|NCT00028769|1583319|P1|Overall Study|Adverse Event|2
490198|NCT00028002|1583325|P1|Overall Study|Ineligible|8
490199|NCT00028002|1583325|P1|Overall Study|Withdrawal by Subject|3
490200|NCT00027846|1583332|P3|Overall Study|Neuraxis dissemination during/after ther|5
490201|NCT00027846|1583333|P2|Overall Study|Neuraxis dissemination during/after ther|2
490202|NCT00027846|1583334|P1|Overall Study|Neuraxis dissemination during/after ther|0
490203|NCT00027846|1583332|P3|Overall Study|Entry into another COG therapeutic study|2
490204|NCT00027846|1583333|P2|Overall Study|Entry into another COG therapeutic study|5
490205|NCT00027846|1583334|P1|Overall Study|Entry into another COG therapeutic study|0
490206|NCT00027846|1583332|P3|Overall Study|Ineligible for study|14
490207|NCT00027846|1583333|P2|Overall Study|Ineligible for study|6
490208|NCT00027846|1583334|P1|Overall Study|Ineligible for study|2
490209|NCT00027846|1583332|P3|Overall Study|Withdrawal by Subject|7
490210|NCT00027846|1583333|P2|Overall Study|Withdrawal by Subject|14
490211|NCT00027846|1583334|P1|Overall Study|Withdrawal by Subject|0
490212|NCT00027846|1583332|P3|Overall Study|Lost to Follow-up|9
490213|NCT00027846|1583333|P2|Overall Study|Lost to Follow-up|41
490214|NCT00027846|1583334|P1|Overall Study|Lost to Follow-up|0
490215|NCT00027560|1583352|P1|Overall Study|Withdrawal by Subject|1
490216|NCT00026494|1583365|P4|Overall Study|Clinical progression|0
490217|NCT00026494|1583366|P3|Overall Study|Clinical progression|3
490218|NCT00026494|1583367|P2|Overall Study|Clinical progression|0
490219|NCT00026494|1583368|P1|Overall Study|Clinical progression|0
490220|NCT00026494|1583365|P4|Overall Study|Patient not treated|0
490221|NCT00026494|1583366|P3|Overall Study|Patient not treated|2
490222|NCT00026494|1583367|P2|Overall Study|Patient not treated|0
490223|NCT00026494|1583368|P1|Overall Study|Patient not treated|0
490224|NCT00026494|1583365|P4|Overall Study|Patient non-compliance|0
490225|NCT00026494|1583366|P3|Overall Study|Patient non-compliance|0
490226|NCT00026494|1583367|P2|Overall Study|Patient non-compliance|0
490227|NCT00026494|1583368|P1|Overall Study|Patient non-compliance|1
490228|NCT00026494|1583365|P4|Overall Study|Withdrawal by Subject|0
490229|NCT00026494|1583366|P3|Overall Study|Withdrawal by Subject|1
490230|NCT00026494|1583367|P2|Overall Study|Withdrawal by Subject|0
490231|NCT00026494|1583368|P1|Overall Study|Withdrawal by Subject|1
490232|NCT00026312|1583380|P2|Overall Study|Refusal by patient/parent/guardian|59
490233|NCT00026312|1583381|P1|Overall Study|Refusal by patient/parent/guardian|8
490234|NCT00026312|1583380|P2|Overall Study|Entry onto another COG study|1
490235|NCT00026312|1583381|P1|Overall Study|Entry onto another COG study|0
490236|NCT00026312|1583380|P2|Overall Study|Ineligible|5
490237|NCT00026312|1583381|P1|Overall Study|Ineligible|4
490238|NCT00026312|1583380|P2|Overall Study|Withdrawal by Subject|6
490239|NCT00026312|1583381|P1|Overall Study|Withdrawal by Subject|1
490240|NCT00026312|1583380|P2|Overall Study|Protocol Violation|3
490241|NCT00026312|1583381|P1|Overall Study|Protocol Violation|0
490242|NCT00026312|1583380|P2|Overall Study|Physician Decision|37
490243|NCT00026312|1583381|P1|Overall Study|Physician Decision|1
490244|NCT00026312|1583380|P2|Overall Study|Lost to Follow-up|5
490245|NCT00026312|1583381|P1|Overall Study|Lost to Follow-up|0
490246|NCT00026312|1583380|P2|Overall Study|Lack of Efficacy|114
490247|NCT00026312|1583381|P1|Overall Study|Lack of Efficacy|19
490248|NCT00026312|1583380|P2|Overall Study|Death|7
490249|NCT00026312|1583381|P1|Overall Study|Death|1
490250|NCT00026312|1583380|P2|Overall Study|Adverse Event|32
490251|NCT00026312|1583381|P1|Overall Study|Adverse Event|0
490252|NCT00026208|1583420|P2|Overall Study|Complications of auto accident|0
490253|NCT00026208|1583421|P1|Overall Study|Complications of auto accident|1
490254|NCT00025662|1583439|P1|Overall Study|Technical failure of manipulation|1
490255|NCT00025662|1583439|P1|Overall Study|Withdrawal by Subject|2
490256|NCT00025506|1583447|P1|Overall Study|Never Treated|2
490257|NCT00025506|1583447|P1|Overall Study|Ineligible: inadequate pathology|2
490258|NCT00025506|1583447|P1|Overall Study|Ineligible: wrong cell type|5
490259|NCT00025506|1583447|P1|Overall Study|Ineligible: clerical error|1
490260|NCT00025259|1583468|P7|Overall Study|Adverse Event|0
490261|NCT00025259|1583469|P6|Overall Study|Adverse Event|0
490262|NCT00025259|1583470|P5|Overall Study|Adverse Event|0
490263|NCT00025259|1583471|P4|Overall Study|Adverse Event|0
490264|NCT00025259|1583472|P3|Overall Study|Adverse Event|0
490265|NCT00025259|1583473|P2|Overall Study|Adverse Event|0
490266|NCT00025259|1583474|P1|Overall Study|Adverse Event|1
490267|NCT00025259|1583468|P7|Overall Study|Randomization error|2
490268|NCT00025259|1583469|P6|Overall Study|Randomization error|7
490269|NCT00025259|1583470|P5|Overall Study|Randomization error|1
490270|NCT00025259|1583471|P4|Overall Study|Randomization error|0
490271|NCT00025259|1583472|P3|Overall Study|Randomization error|0
490272|NCT00025259|1583473|P2|Overall Study|Randomization error|0
490273|NCT00025259|1583474|P1|Overall Study|Randomization error|1
490274|NCT00025259|1583468|P7|Overall Study|Ineligible|1
490275|NCT00025259|1583469|P6|Overall Study|Ineligible|0
490276|NCT00025259|1583470|P5|Overall Study|Ineligible|6
490277|NCT00025259|1583471|P4|Overall Study|Ineligible|0
490278|NCT00025259|1583472|P3|Overall Study|Ineligible|0
490279|NCT00025259|1583473|P2|Overall Study|Ineligible|1
490280|NCT00025259|1583474|P1|Overall Study|Ineligible|14
490281|NCT00025259|1583468|P7|Overall Study|Withdrawal by Subject|3
490282|NCT00025259|1583469|P6|Overall Study|Withdrawal by Subject|8
490283|NCT00025259|1583470|P5|Overall Study|Withdrawal by Subject|11
490284|NCT00025259|1583471|P4|Overall Study|Withdrawal by Subject|14
490285|NCT00025259|1583472|P3|Overall Study|Withdrawal by Subject|6
490286|NCT00025259|1583473|P2|Overall Study|Withdrawal by Subject|27
490287|NCT00025259|1583474|P1|Overall Study|Withdrawal by Subject|9
490288|NCT00025259|1583468|P7|Overall Study|Protocol Violation|3
490289|NCT00025259|1583469|P6|Overall Study|Protocol Violation|1
490290|NCT00025259|1583470|P5|Overall Study|Protocol Violation|2
490291|NCT00025259|1583471|P4|Overall Study|Protocol Violation|1
490292|NCT00025259|1583472|P3|Overall Study|Protocol Violation|2
490293|NCT00025259|1583473|P2|Overall Study|Protocol Violation|2
490294|NCT00025259|1583474|P1|Overall Study|Protocol Violation|3
490295|NCT00025259|1583468|P7|Overall Study|Physician Decision|1
490296|NCT00025259|1583469|P6|Overall Study|Physician Decision|2
490297|NCT00025259|1583470|P5|Overall Study|Physician Decision|4
490298|NCT00025259|1583471|P4|Overall Study|Physician Decision|5
490299|NCT00025259|1583472|P3|Overall Study|Physician Decision|0
490300|NCT00025259|1583473|P2|Overall Study|Physician Decision|1
490301|NCT00025259|1583474|P1|Overall Study|Physician Decision|12
490302|NCT00025259|1583468|P7|Overall Study|Lost to Follow-up|1
490303|NCT00025259|1583469|P6|Overall Study|Lost to Follow-up|3
490304|NCT00025259|1583470|P5|Overall Study|Lost to Follow-up|1
490305|NCT00025259|1583471|P4|Overall Study|Lost to Follow-up|13
490306|NCT00025259|1583472|P3|Overall Study|Lost to Follow-up|13
490307|NCT00025259|1583473|P2|Overall Study|Lost to Follow-up|9
490308|NCT00025259|1583474|P1|Overall Study|Lost to Follow-up|2
490309|NCT00025259|1583468|P7|Overall Study|Lack of Efficacy|38
490310|NCT00025259|1583469|P6|Overall Study|Lack of Efficacy|30
490311|NCT00025259|1583470|P5|Overall Study|Lack of Efficacy|11
490312|NCT00025259|1583471|P4|Overall Study|Lack of Efficacy|78
490313|NCT00025259|1583472|P3|Overall Study|Lack of Efficacy|60
490314|NCT00025259|1583473|P2|Overall Study|Lack of Efficacy|46
490315|NCT00025259|1583474|P1|Overall Study|Lack of Efficacy|2
490316|NCT00025259|1583468|P7|Overall Study|Death|2
490317|NCT00025259|1583469|P6|Overall Study|Death|1
490318|NCT00025259|1583470|P5|Overall Study|Death|0
490319|NCT00025259|1583471|P4|Overall Study|Death|3
490320|NCT00025259|1583472|P3|Overall Study|Death|0
490321|NCT00025259|1583473|P2|Overall Study|Death|3
490322|NCT00025259|1583474|P1|Overall Study|Death|1
490323|NCT00025233|1583510|P1|Overall Study|Never treated|1
490324|NCT00025233|1583510|P1|Overall Study|Ineligible: improper prior treatment|1
490325|NCT00025233|1583510|P1|Overall Study|Ineligible: wrong primary|1
490326|NCT00025233|1583510|P1|Overall Study|Ineligible: wrong cell type|1
490327|NCT00025155|1583525|P1|Overall Study|Ineligible: Second primary cancer site|1
490328|NCT00025155|1583525|P1|Overall Study|Ineligible: Wrong primary cancer site|1
490329|NCT00024258|1583536|P1|Overall Study|Disease Progression|8
490330|NCT00024258|1583536|P1|Overall Study|Withdrawal by Subject|1
490331|NCT00024167|1583543|P2|Overall Study|Death|47
490332|NCT00024167|1583544|P1|Overall Study|Death|53
490333|NCT00023764|1583568|P1|Overall Study|delay in obtaining staging images|1
490334|NCT00023764|1583568|P1|Overall Study|patient received other treatment|1
490335|NCT00023764|1583568|P1|Overall Study|Progression of disease|6
490336|NCT00023764|1583568|P1|Overall Study|Withdrawal by Subject|1
490337|NCT00023764|1583568|P1|Overall Study|Adverse Event|4
490338|NCT00023764|1583568|P1|Overall Study|Other|1
490339|NCT00023712|1583575|P2|Overall Study|Never treated|1
490340|NCT00023712|1583576|P1|Overall Study|Never treated|1
490341|NCT00023712|1583575|P2|Overall Study|Not platinum sensitive|0
490342|NCT00023712|1583576|P1|Overall Study|Not platinum sensitive|1
490343|NCT00022698|1583600|P2|Overall Study|Administrative /other|7
490344|NCT00022698|1583601|P1|Overall Study|Administrative /other|1
490345|NCT00022698|1583600|P2|Overall Study|Insufficient therapeutic response|14
490346|NCT00022698|1583601|P1|Overall Study|Insufficient therapeutic response|2
490347|NCT00022698|1583600|P2|Overall Study|Refused treatment|2
490348|NCT00022698|1583601|P1|Overall Study|Refused treatment|0
490349|NCT00022698|1583600|P2|Overall Study|Failure to return|1
490350|NCT00022698|1583601|P1|Overall Study|Failure to return|0
490351|NCT00022698|1583600|P2|Overall Study|Death|2
490352|NCT00022698|1583601|P1|Overall Study|Death|0
490353|NCT00022698|1583600|P2|Overall Study|Adverse Event|9
490354|NCT00022698|1583601|P1|Overall Study|Adverse Event|5
490355|NCT00022672|1583626|P2|Extension Phase|Other|1
490356|NCT00022672|1583627|P1|Extension Phase|Other|1
490357|NCT00022672|1583626|P2|Extension Phase|Refused Treatment|2
490358|NCT00022672|1583627|P1|Extension Phase|Refused Treatment|0
490359|NCT00022672|1583626|P2|Extension Phase|Insufficient Therapeutic Response|44
490360|NCT00022672|1583627|P1|Extension Phase|Insufficient Therapeutic Response|1
490361|NCT00022672|1583626|P2|Extension Phase|Death|1
490362|NCT00022672|1583627|P1|Extension Phase|Death|0
490363|NCT00022672|1583626|P2|Extension Phase|Adverse Event|3
490364|NCT00022672|1583627|P1|Extension Phase|Adverse Event|1
490365|NCT00022672|1583626|P2|Main Phase: 24 Months|Other|0
490366|NCT00022672|1583627|P1|Main Phase: 24 Months|Other|1
490367|NCT00022672|1583626|P2|Main Phase: 24 Months|Failure to Return|1
490368|NCT00022672|1583627|P1|Main Phase: 24 Months|Failure to Return|1
490369|NCT00022672|1583626|P2|Main Phase: 24 Months|Refused Treatment|4
490370|NCT00022672|1583627|P1|Main Phase: 24 Months|Refused Treatment|3
490371|NCT00022672|1583626|P2|Main Phase: 24 Months|Other Protocol Violation|0
490372|NCT00022672|1583627|P1|Main Phase: 24 Months|Other Protocol Violation|1
490373|NCT00022672|1583626|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
490374|NCT00022672|1583627|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
490375|NCT00022672|1583626|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
490376|NCT00022672|1583627|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
490377|NCT00022672|1583626|P2|Main Phase: 24 Months|Death|3
490378|NCT00022672|1583627|P1|Main Phase: 24 Months|Death|0
490379|NCT00022672|1583626|P2|Main Phase: 24 Months|Adverse Event|0
490380|NCT00022672|1583627|P1|Main Phase: 24 Months|Adverse Event|6
490381|NCT00022659|1583660|P1|Overall Study|Never treated|1
490382|NCT00022659|1583660|P1|Overall Study|Ineligible: wrong primary|1
490383|NCT00022633|1583673|P2|Overall Study|Ineligible|0
490384|NCT00022633|1583674|P1|Overall Study|Ineligible|4
490385|NCT00022633|1583673|P2|Overall Study|Other - not protocol specified|2
490386|NCT00022633|1583674|P1|Overall Study|Other - not protocol specified|3
490387|NCT00022633|1583673|P2|Overall Study|Death|0
490388|NCT00022633|1583674|P1|Overall Study|Death|4
490389|NCT00022633|1583673|P2|Overall Study|Progression/relapse|2
490390|NCT00022633|1583674|P1|Overall Study|Progression/relapse|9
490391|NCT00022633|1583673|P2|Overall Study|Refusal unrelated to adverse event|0
490392|NCT00022633|1583674|P1|Overall Study|Refusal unrelated to adverse event|1
490393|NCT00022633|1583673|P2|Overall Study|Adverse Event|1
490394|NCT00022633|1583674|P1|Overall Study|Adverse Event|11
490395|NCT00022516|1583687|P2|Overall Study|Incomplete documentation|27
490396|NCT00022516|1583688|P1|Overall Study|Incomplete documentation|0
490397|NCT00022516|1583687|P2|Overall Study|Withdrawal by Subject|113
490398|NCT00022516|1583688|P1|Overall Study|Withdrawal by Subject|2
490399|NCT00022516|1583687|P2|Overall Study|Protocol Violation|3
490400|NCT00022516|1583688|P1|Overall Study|Protocol Violation|1
490401|NCT00022516|1583687|P2|Overall Study|Physician Decision|1
490402|NCT00022516|1583688|P1|Overall Study|Physician Decision|0
490403|NCT00022516|1583687|P2|Overall Study|Lack of Efficacy|27
490404|NCT00022516|1583688|P1|Overall Study|Lack of Efficacy|0
490405|NCT00022516|1583687|P2|Overall Study|Adverse Event|59
490406|NCT00022516|1583688|P1|Overall Study|Adverse Event|0
490407|NCT00021255|1583707|P3|Overall Study|Randomized but not treated|18
490408|NCT00021255|1583708|P2|Overall Study|Randomized but not treated|2
490409|NCT00021255|1583709|P1|Overall Study|Randomized but not treated|28
490410|NCT00021255|1583707|P3|Overall Study|Missing|13
490411|NCT00021255|1583708|P2|Overall Study|Missing|27
490412|NCT00021255|1583709|P1|Overall Study|Missing|0
490413|NCT00021255|1583707|P3|Overall Study|Other than specified above|19
490414|NCT00021255|1583708|P2|Overall Study|Other than specified above|38
490415|NCT00021255|1583709|P1|Overall Study|Other than specified above|0
490416|NCT00021255|1583707|P3|Overall Study|Protocol Violation|0
490417|NCT00021255|1583708|P2|Overall Study|Protocol Violation|2
490418|NCT00021255|1583709|P1|Overall Study|Protocol Violation|0
490419|NCT00021255|1583707|P3|Overall Study|Adverse Event|18
490420|NCT00021255|1583708|P2|Overall Study|Adverse Event|30
490421|NCT00021255|1583709|P1|Overall Study|Adverse Event|46
490422|NCT00021255|1583707|P3|Overall Study|Herceptin toxicity|6
490423|NCT00021255|1583708|P2|Overall Study|Herceptin toxicity|22
490424|NCT00021255|1583709|P1|Overall Study|Herceptin toxicity|0
490425|NCT00021255|1583707|P3|Overall Study|Cardiac toxicity|32
490426|NCT00021255|1583708|P2|Overall Study|Cardiac toxicity|61
490427|NCT00021255|1583709|P1|Overall Study|Cardiac toxicity|0
490428|NCT00021255|1583707|P3|Overall Study|Lost to Follow-up|3
490429|NCT00021255|1583708|P2|Overall Study|Lost to Follow-up|2
490430|NCT00021255|1583709|P1|Overall Study|Lost to Follow-up|0
490431|NCT00021255|1583707|P3|Overall Study|Withdrawal by Subject|26
490432|NCT00021255|1583708|P2|Overall Study|Withdrawal by Subject|64
490433|NCT00021255|1583709|P1|Overall Study|Withdrawal by Subject|41
490434|NCT00021255|1583707|P3|Overall Study|Second primary malignancy|1
490435|NCT00021255|1583708|P2|Overall Study|Second primary malignancy|4
490436|NCT00021255|1583709|P1|Overall Study|Second primary malignancy|0
490437|NCT00021255|1583707|P3|Overall Study|Breast cancer relapse|11
490438|NCT00021255|1583708|P2|Overall Study|Breast cancer relapse|18
490439|NCT00021255|1583709|P1|Overall Study|Breast cancer relapse|5
490440|NCT00021255|1583707|P3|Overall Study|Death|2
490441|NCT00021255|1583708|P2|Overall Study|Death|0
490442|NCT00021255|1583709|P1|Overall Study|Death|1
490443|NCT00021229|1583726|P3|Overall Study|Punctate hemmorrhage post RT|0
490444|NCT00021229|1583727|P2|Overall Study|Punctate hemmorrhage post RT|0
490445|NCT00021229|1583728|P1|Overall Study|Punctate hemmorrhage post RT|2
490446|NCT00021229|1583726|P3|Overall Study|Physician Decision|1
490447|NCT00021229|1583727|P2|Overall Study|Physician Decision|0
490448|NCT00021229|1583728|P1|Overall Study|Physician Decision|0
490449|NCT00021229|1583726|P3|Overall Study|Protocol Violation|0
490450|NCT00021229|1583727|P2|Overall Study|Protocol Violation|1
490451|NCT00021229|1583728|P1|Overall Study|Protocol Violation|1
490452|NCT00021229|1583726|P3|Overall Study|Progressive Disease|12
490453|NCT00021229|1583727|P2|Overall Study|Progressive Disease|19
490454|NCT00021229|1583728|P1|Overall Study|Progressive Disease|15
490455|NCT00021229|1583726|P3|Overall Study|Withdrawal by Subject|1
490456|NCT00021229|1583727|P2|Overall Study|Withdrawal by Subject|7
490457|NCT00021229|1583728|P1|Overall Study|Withdrawal by Subject|7
490458|NCT00021229|1583726|P3|Overall Study|Death|0
490459|NCT00021229|1583727|P2|Overall Study|Death|1
490460|NCT00021229|1583728|P1|Overall Study|Death|0
490461|NCT00021229|1583726|P3|Overall Study|Adverse Event|2
490462|NCT00021229|1583727|P2|Overall Study|Adverse Event|5
490463|NCT00021229|1583728|P1|Overall Study|Adverse Event|10
490464|NCT00019604|1583783|P1|Overall Study|Details for other not available|4
490465|NCT00019604|1583783|P1|Overall Study|Unable to evaluate|1
490466|NCT00019604|1583783|P1|Overall Study|Too much disease|1
490467|NCT00019604|1583783|P1|Overall Study|Pt going to immunotherapy study|1
490468|NCT00019604|1583783|P1|Overall Study|Started new chemo regimen|1
490469|NCT00019604|1583783|P1|Overall Study|Resectable disease|1
490470|NCT00019604|1583783|P1|Overall Study|Non compliant|1
490471|NCT00019604|1583783|P1|Overall Study|Non compliant on systemic CH|1
490472|NCT00019604|1583783|P1|Overall Study|Move to a different study|1
490473|NCT00019604|1583783|P1|Overall Study|Going to have liver transplant|1
490474|NCT00019604|1583783|P1|Overall Study|Carcinoid tumor, not treatable|1
490475|NCT00019604|1583783|P1|Overall Study|Refused treatment|1
490476|NCT00019604|1583783|P1|Overall Study|Progressive disease|23
490477|NCT00019604|1583783|P1|Overall Study|Death|1
490478|NCT00016354|1583806|P8|Overall Study|Lack of Efficacy|1
490479|NCT00016354|1583807|P7|Overall Study|Lack of Efficacy|0
490480|NCT00016354|1583808|P6|Overall Study|Lack of Efficacy|0
490481|NCT00016354|1583809|P5|Overall Study|Lack of Efficacy|0
490482|NCT00016354|1583810|P4|Overall Study|Lack of Efficacy|0
490483|NCT00016354|1583811|P3|Overall Study|Lack of Efficacy|0
490484|NCT00016354|1583812|P2|Overall Study|Lack of Efficacy|0
490485|NCT00016354|1583813|P1|Overall Study|Lack of Efficacy|0
490486|NCT00014495|1583827|P4|Overall Study|Clinical deterioration|1
490487|NCT00014495|1583828|P3|Overall Study|Clinical deterioration|0
490488|NCT00014495|1583829|P2|Overall Study|Clinical deterioration|0
490489|NCT00014495|1583830|P1|Overall Study|Clinical deterioration|0
490490|NCT00014495|1583827|P4|Overall Study|Death|0
490491|NCT00014495|1583828|P3|Overall Study|Death|1
490492|NCT00014495|1583829|P2|Overall Study|Death|0
490493|NCT00014495|1583830|P1|Overall Study|Death|0
490494|NCT00012012|1583874|P2|Overall Study|Withdrawal by Subject|2
490495|NCT00012012|1583875|P1|Overall Study|Withdrawal by Subject|0
490496|NCT00012012|1583874|P2|Overall Study|Protocol Violation|1
490497|NCT00012012|1583875|P1|Overall Study|Protocol Violation|1
490498|NCT00010257|1583904|P2|Overall Study|Withdrawal by Subject|0
490499|NCT00010257|1583905|P1|Overall Study|Withdrawal by Subject|1
490500|NCT00009945|1583915|P2|Overall Study|no follow up data|5
490501|NCT00009945|1583916|P1|Overall Study|no follow up data|7
490502|NCT00008385|1583932|P2|Overall Study|Not start protocol therapy|175
490503|NCT00008385|1583933|P1|Overall Study|Not start protocol therapy|44
490504|NCT00008385|1583932|P2|Overall Study|Not specified|212
490505|NCT00008385|1583933|P1|Overall Study|Not specified|105
490506|NCT00008385|1583932|P2|Overall Study|Maximum dose reached|2
490507|NCT00008385|1583933|P1|Overall Study|Maximum dose reached|0
490508|NCT00008385|1583932|P2|Overall Study|Other complicating disease|30
490509|NCT00008385|1583933|P1|Overall Study|Other complicating disease|17
490510|NCT00008385|1583932|P2|Overall Study|Start non-protocol therapy|1
490511|NCT00008385|1583933|P1|Overall Study|Start non-protocol therapy|3
490512|NCT00008385|1583932|P2|Overall Study|Withdrawal by Subject|157
490513|NCT00008385|1583933|P1|Overall Study|Withdrawal by Subject|67
490514|NCT00008385|1583932|P2|Overall Study|Death|18
490515|NCT00008385|1583933|P1|Overall Study|Death|12
490516|NCT00008385|1583932|P2|Overall Study|Adverse Event|20
490517|NCT00008385|1583933|P1|Overall Study|Adverse Event|8
490518|NCT00008385|1583932|P2|Overall Study|Progressive disease|117
490519|NCT00008385|1583933|P1|Overall Study|Progressive disease|52
490520|NCT00008385|1583932|P2|Overall Study|Off treatment reasons not reported|70
490521|NCT00008385|1583933|P1|Overall Study|Off treatment reasons not reported|79
490522|NCT00008138|1583943|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
490523|NCT00008138|1583943|P1|Post-Cytoreduction Chemotherapy|Progression|1
490524|NCT00008138|1583943|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
490525|NCT00008138|1583943|P1|Interval Debulking|Withdrawal by Subject|2
490526|NCT00008138|1583943|P1|Neoadjuvant Chemotherapy|not protocol specified|8
490527|NCT00008138|1583943|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
490528|NCT00008138|1583943|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
490529|NCT00008138|1583943|P1|Neoadjuvant Chemotherapy|Adverse Event|3
490530|NCT00006916|1583949|P1|Overall Study|Complication of device insertion|1
490531|NCT00006916|1583949|P1|Overall Study|Device not inserted|4
490532|NCT00006903|1583955|P3|Overall Study|Ineligible|2
490533|NCT00006903|1583956|P2|Overall Study|Ineligible|1
490534|NCT00006903|1583957|P1|Overall Study|Ineligible|10
490535|NCT00006903|1583955|P3|Overall Study|Patient never treated|1
490536|NCT00006903|1583956|P2|Overall Study|Patient never treated|0
490537|NCT00006903|1583957|P1|Overall Study|Patient never treated|0
490538|NCT00006903|1583955|P3|Overall Study|Death|0
490539|NCT00006903|1583956|P2|Overall Study|Death|1
490540|NCT00006903|1583957|P1|Overall Study|Death|0
490541|NCT00006903|1583955|P3|Overall Study|Adverse Event|1
490542|NCT00006903|1583956|P2|Overall Study|Adverse Event|0
490543|NCT00006903|1583957|P1|Overall Study|Adverse Event|0
490544|NCT00006903|1583955|P3|Overall Study|Refused further treatment|1
490545|NCT00006903|1583956|P2|Overall Study|Refused further treatment|2
490546|NCT00006903|1583957|P1|Overall Study|Refused further treatment|0
490547|NCT00006903|1583955|P3|Overall Study|Still receiving treatment|1
490548|NCT00006903|1583956|P2|Overall Study|Still receiving treatment|0
490549|NCT00006903|1583957|P1|Overall Study|Still receiving treatment|0
490550|NCT00006721|1583970|P3|Overall Study|Eligible but no Treatment Received|0
490551|NCT00006721|1583971|P2|Overall Study|Eligible but no Treatment Received|0
490552|NCT00006721|1583972|P1|Overall Study|Eligible but no Treatment Received|1
490553|NCT00006721|1583970|P3|Overall Study|Ineligible|10
490554|NCT00006721|1583971|P2|Overall Study|Ineligible|12
490555|NCT00006721|1583972|P1|Overall Study|Ineligible|2
490556|NCT00006721|1583970|P3|Overall Study|Other - Not Protocol Specified|7
490557|NCT00006721|1583971|P2|Overall Study|Other - Not Protocol Specified|7
490558|NCT00006721|1583972|P1|Overall Study|Other - Not Protocol Specified|0
490559|NCT00006721|1583970|P3|Overall Study|Death|2
490560|NCT00006721|1583971|P2|Overall Study|Death|1
490561|NCT00006721|1583972|P1|Overall Study|Death|0
490562|NCT00006721|1583970|P3|Overall Study|Progression/Relapse|2
490563|NCT00006721|1583971|P2|Overall Study|Progression/Relapse|1
490564|NCT00006721|1583972|P1|Overall Study|Progression/Relapse|0
490565|NCT00006721|1583970|P3|Overall Study|Refusal Unrelated to Adverse Event|8
490566|NCT00006721|1583971|P2|Overall Study|Refusal Unrelated to Adverse Event|0
490567|NCT00006721|1583972|P1|Overall Study|Refusal Unrelated to Adverse Event|1
490568|NCT00006721|1583970|P3|Overall Study|Adverse Event|4
490569|NCT00006721|1583971|P2|Overall Study|Adverse Event|4
490570|NCT00006721|1583972|P1|Overall Study|Adverse Event|0
490571|NCT00006478|1583990|P1|Overall Study|Physician Decision|6
490572|NCT00006478|1583990|P1|Overall Study|Vaccine could not be produced|1
490573|NCT00006392|1583998|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
490574|NCT00006392|1583999|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
490575|NCT00006392|1584000|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
490576|NCT00006392|1584001|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
490577|NCT00006392|1583998|P4|Overall Study|Ineligible|5
490578|NCT00006392|1583999|P3|Overall Study|Ineligible|5
490579|NCT00006392|1584000|P2|Overall Study|Ineligible|3
490580|NCT00006392|1584001|P1|Overall Study|Ineligible|11
490581|NCT00006389|1584031|P1|Overall Study|Adverse Event|1
490582|NCT00006237|1584048|P2|Overall Study|Not protocol specified|5
490583|NCT00006237|1584049|P1|Overall Study|Not protocol specified|14
490584|NCT00006237|1584048|P2|Overall Study|Withdrawal by Subject|1
490585|NCT00006237|1584049|P1|Overall Study|Withdrawal by Subject|0
490586|NCT00006237|1584048|P2|Overall Study|Not eligible|20
490587|NCT00006237|1584049|P1|Overall Study|Not eligible|9
490588|NCT00006237|1584048|P2|Overall Study|Progression/relapse|2
490589|NCT00006237|1584049|P1|Overall Study|Progression/relapse|54
490590|NCT00006237|1584048|P2|Overall Study|Refusal unrelated to adverse effects|4
490591|NCT00006237|1584049|P1|Overall Study|Refusal unrelated to adverse effects|8
490592|NCT00006237|1584048|P2|Overall Study|Death|0
490593|NCT00006237|1584049|P1|Overall Study|Death|1
490594|NCT00006237|1584048|P2|Overall Study|Adverse Event|29
490595|NCT00006237|1584049|P1|Overall Study|Adverse Event|39
490596|NCT00006011|1584086|P3|Overall Study|Ineligible|9
490597|NCT00006011|1584087|P2|Overall Study|Ineligible|16
490598|NCT00006011|1584088|P1|Overall Study|Ineligible|18
490599|NCT00006011|1584086|P3|Overall Study|Not specified|5
490600|NCT00006011|1584087|P2|Overall Study|Not specified|2
490601|NCT00006011|1584088|P1|Overall Study|Not specified|4
490602|NCT00006011|1584086|P3|Overall Study|Death|2
490603|NCT00006011|1584087|P2|Overall Study|Death|1
490604|NCT00006011|1584088|P1|Overall Study|Death|0
490605|NCT00006011|1584086|P3|Overall Study|Adverse Event|5
490606|NCT00006011|1584087|P2|Overall Study|Adverse Event|39
490607|NCT00006011|1584088|P1|Overall Study|Adverse Event|15
490608|NCT00006011|1584086|P3|Overall Study|Refused further treatment|26
490609|NCT00006011|1584087|P2|Overall Study|Refused further treatment|13
490610|NCT00006011|1584088|P1|Overall Study|Refused further treatment|15
490611|NCT00006011|1584086|P3|Overall Study|Disease progression|26
490612|NCT00006011|1584087|P2|Overall Study|Disease progression|6
490613|NCT00006011|1584088|P1|Overall Study|Disease progression|13
490614|NCT00005957|1584096|P2|Overall Study|Crossover to the other arm|19
490615|NCT00005957|1584097|P1|Overall Study|Crossover to the other arm|5
490616|NCT00005957|1584096|P2|Overall Study|No treated|9
490617|NCT00005957|1584097|P1|Overall Study|No treated|3
490618|NCT00005879|1584107|P2|Overall Study|Withdrawal by Subject|10
490619|NCT00005879|1584108|P1|Overall Study|Withdrawal by Subject|8
490620|NCT00005047|1584131|P4|Overall Study|Lack of Efficacy|0
490621|NCT00005047|1584132|P3|Overall Study|Lack of Efficacy|0
490622|NCT00005047|1584133|P2|Overall Study|Lack of Efficacy|0
490623|NCT00005047|1584134|P1|Overall Study|Lack of Efficacy|1
490624|NCT00005047|1584131|P4|Overall Study|Lost to Follow-up|0
490625|NCT00005047|1584132|P3|Overall Study|Lost to Follow-up|0
490626|NCT00005047|1584133|P2|Overall Study|Lost to Follow-up|0
490627|NCT00005047|1584134|P1|Overall Study|Lost to Follow-up|1
490628|NCT00005047|1584131|P4|Overall Study|Adverse Event|0
490629|NCT00005047|1584132|P3|Overall Study|Adverse Event|0
490630|NCT00005047|1584133|P2|Overall Study|Adverse Event|0
490631|NCT00005047|1584134|P1|Overall Study|Adverse Event|5
490632|NCT00005047|1584131|P4|Overall Study|Withdrawal by Subject|0
490633|NCT00005047|1584132|P3|Overall Study|Withdrawal by Subject|0
490634|NCT00005047|1584133|P2|Overall Study|Withdrawal by Subject|0
490635|NCT00005047|1584134|P1|Overall Study|Withdrawal by Subject|12
490636|NCT00005044|1584150|P2|Overall Study|No protocol treatment|1
490637|NCT00005044|1584151|P1|Overall Study|No protocol treatment|0
490638|NCT00005044|1584150|P2|Overall Study|Withdrawal by Subject|5
490639|NCT00005044|1584151|P1|Overall Study|Withdrawal by Subject|1
490640|NCT00005044|1584150|P2|Overall Study|Protocol Violation|46
490641|NCT00005044|1584151|P1|Overall Study|Protocol Violation|37
490642|NCT00004888|1584171|P2|Overall Study|Toxic death|0
490643|NCT00004888|1584172|P1|Overall Study|Toxic death|1
490644|NCT00004888|1584171|P2|Overall Study|Death without progressive disease|1
490645|NCT00004888|1584172|P1|Overall Study|Death without progressive disease|0
490646|NCT00004888|1584171|P2|Overall Study|Progressive Disease|9
490647|NCT00004888|1584172|P1|Overall Study|Progressive Disease|4
490648|NCT00004888|1584171|P2|Overall Study|Physician Decision|1
490649|NCT00004888|1584172|P1|Overall Study|Physician Decision|1
490650|NCT00004888|1584171|P2|Overall Study|Withdrawal by Subject|3
490651|NCT00004888|1584172|P1|Overall Study|Withdrawal by Subject|0
490652|NCT00004888|1584171|P2|Overall Study|Adverse Event|10
490653|NCT00004888|1584172|P1|Overall Study|Adverse Event|5
490654|NCT00004859|1584190|P2|Overall Study|Not specified|21
490655|NCT00004859|1584191|P1|Overall Study|Not specified|13
490656|NCT00004859|1584190|P2|Overall Study|missing data|11
490657|NCT00004859|1584191|P1|Overall Study|missing data|14
490658|NCT00004859|1584190|P2|Overall Study|error|1
490659|NCT00004859|1584191|P1|Overall Study|error|3
490660|NCT00004859|1584190|P2|Overall Study|other disease|3
490661|NCT00004859|1584191|P1|Overall Study|other disease|0
490662|NCT00004859|1584190|P2|Overall Study|Protocol Violation|2
490663|NCT00004859|1584191|P1|Overall Study|Protocol Violation|2
490664|NCT00004859|1584190|P2|Overall Study|Withdrawal by Subject|33
490665|NCT00004859|1584191|P1|Overall Study|Withdrawal by Subject|7
490666|NCT00004859|1584190|P2|Overall Study|Death|5
490667|NCT00004859|1584191|P1|Overall Study|Death|5
490668|NCT00004859|1584190|P2|Overall Study|Adverse Event|93
490669|NCT00004859|1584191|P1|Overall Study|Adverse Event|31
490670|NCT00004859|1584190|P2|Overall Study|Lack of Efficacy|113
490671|NCT00004859|1584191|P1|Overall Study|Lack of Efficacy|43
490672|NCT00004259|1584205|P4|Overall Study|Withdrawal by Subject|0
490673|NCT00004259|1584206|P3|Overall Study|Withdrawal by Subject|0
490674|NCT00004259|1584207|P2|Overall Study|Withdrawal by Subject|2
490675|NCT00004259|1584208|P1|Overall Study|Withdrawal by Subject|0
490676|NCT00004259|1584205|P4|Overall Study|Protocol Violation|0
490677|NCT00004259|1584206|P3|Overall Study|Protocol Violation|0
490678|NCT00004259|1584207|P2|Overall Study|Protocol Violation|2
490679|NCT00004259|1584208|P1|Overall Study|Protocol Violation|1
490680|NCT00004228|1584229|P7|Overall Study|ineligible|5
490681|NCT00004228|1584230|P6|Overall Study|ineligible|2
490682|NCT00004228|1584231|P5|Overall Study|ineligible|1
490683|NCT00004228|1584232|P4|Overall Study|ineligible|1
490684|NCT00004228|1584233|P3|Overall Study|ineligible|4
490685|NCT00004228|1584234|P2|Overall Study|ineligible|2
490686|NCT00004228|1584235|P1|Overall Study|ineligible|4
490687|NCT00004228|1584229|P7|Overall Study|Other|0
490688|NCT00004228|1584230|P6|Overall Study|Other|0
490689|NCT00004228|1584231|P5|Overall Study|Other|0
490690|NCT00004228|1584232|P4|Overall Study|Other|0
490691|NCT00004228|1584233|P3|Overall Study|Other|1
490692|NCT00004228|1584234|P2|Overall Study|Other|0
490693|NCT00004228|1584235|P1|Overall Study|Other|0
490694|NCT00004228|1584229|P7|Overall Study|Withdrawal by Subject|2
490695|NCT00004228|1584230|P6|Overall Study|Withdrawal by Subject|1
490696|NCT00004228|1584231|P5|Overall Study|Withdrawal by Subject|2
490697|NCT00004228|1584232|P4|Overall Study|Withdrawal by Subject|0
490698|NCT00004228|1584233|P3|Overall Study|Withdrawal by Subject|1
490699|NCT00004228|1584234|P2|Overall Study|Withdrawal by Subject|0
490700|NCT00004228|1584235|P1|Overall Study|Withdrawal by Subject|3
490701|NCT00004228|1584229|P7|Overall Study|Protocol Violation|0
490702|NCT00004228|1584230|P6|Overall Study|Protocol Violation|2
490703|NCT00004228|1584231|P5|Overall Study|Protocol Violation|1
490704|NCT00004228|1584232|P4|Overall Study|Protocol Violation|1
490705|NCT00004228|1584233|P3|Overall Study|Protocol Violation|2
490706|NCT00004228|1584234|P2|Overall Study|Protocol Violation|5
490707|NCT00004228|1584235|P1|Overall Study|Protocol Violation|0
490708|NCT00004228|1584229|P7|Overall Study|Physician Decision|1
490709|NCT00004228|1584230|P6|Overall Study|Physician Decision|1
490710|NCT00004228|1584231|P5|Overall Study|Physician Decision|1
490711|NCT00004228|1584232|P4|Overall Study|Physician Decision|2
490712|NCT00004228|1584233|P3|Overall Study|Physician Decision|3
490713|NCT00004228|1584234|P2|Overall Study|Physician Decision|0
490714|NCT00004228|1584235|P1|Overall Study|Physician Decision|1
490715|NCT00004228|1584229|P7|Overall Study|Lost to Follow-up|0
490716|NCT00004228|1584230|P6|Overall Study|Lost to Follow-up|0
490717|NCT00004228|1584231|P5|Overall Study|Lost to Follow-up|0
490718|NCT00004228|1584232|P4|Overall Study|Lost to Follow-up|0
490719|NCT00004228|1584233|P3|Overall Study|Lost to Follow-up|1
490720|NCT00004228|1584234|P2|Overall Study|Lost to Follow-up|0
490721|NCT00004228|1584235|P1|Overall Study|Lost to Follow-up|0
490722|NCT00004228|1584229|P7|Overall Study|Lack of Efficacy|4
490723|NCT00004228|1584230|P6|Overall Study|Lack of Efficacy|8
490724|NCT00004228|1584231|P5|Overall Study|Lack of Efficacy|9
490725|NCT00004228|1584232|P4|Overall Study|Lack of Efficacy|3
490726|NCT00004228|1584233|P3|Overall Study|Lack of Efficacy|5
490727|NCT00004228|1584234|P2|Overall Study|Lack of Efficacy|6
490728|NCT00004228|1584235|P1|Overall Study|Lack of Efficacy|1
490729|NCT00004228|1584229|P7|Overall Study|Death|0
490730|NCT00004228|1584230|P6|Overall Study|Death|0
490731|NCT00004228|1584231|P5|Overall Study|Death|1
490732|NCT00004228|1584232|P4|Overall Study|Death|0
490733|NCT00004228|1584233|P3|Overall Study|Death|2
490734|NCT00004228|1584234|P2|Overall Study|Death|1
490735|NCT00004228|1584235|P1|Overall Study|Death|0
490736|NCT00004228|1584229|P7|Overall Study|Adverse Event|0
490737|NCT00004228|1584230|P6|Overall Study|Adverse Event|0
490738|NCT00004228|1584231|P5|Overall Study|Adverse Event|1
490739|NCT00004228|1584232|P4|Overall Study|Adverse Event|0
490740|NCT00004228|1584233|P3|Overall Study|Adverse Event|0
490741|NCT00004228|1584234|P2|Overall Study|Adverse Event|1
490742|NCT00004228|1584235|P1|Overall Study|Adverse Event|0
490743|NCT00003901|1584301|P1|Overall Study|Medical problems|6
490744|NCT00003901|1584301|P1|Overall Study|Chest X-Ray not done prior registration|1
490745|NCT00003901|1584301|P1|Overall Study|CT Scan not within protocol requirement|2
490746|NCT00003901|1584301|P1|Overall Study|Ineligible|6
490747|NCT00003901|1584301|P1|Overall Study|Withdrawal by Subject|1
490748|NCT00003901|1584301|P1|Overall Study|Adverse Event|1
490749|NCT00003896|1584312|P1|Overall Study|ineligible|5
490750|NCT00003896|1584312|P1|Overall Study|not protocol specified|3
490751|NCT00003896|1584312|P1|Overall Study|Death|3
490752|NCT00003896|1584312|P1|Overall Study|Lack of Efficacy|1
490753|NCT00003896|1584312|P1|Overall Study|Withdrawal by Subject|1
490754|NCT00003896|1584312|P1|Overall Study|Adverse Event|16
490755|NCT00003875|1584318|P1|Overall Study|Screen Failed|1
490756|NCT00003869|1584327|P2|Overall Study|Alternative treatmnt, medical problems|4
490757|NCT00003869|1584328|P1|Overall Study|Alternative treatmnt, medical problems|5
490758|NCT00003869|1584327|P2|Overall Study|Death|2
490759|NCT00003869|1584328|P1|Overall Study|Death|1
490760|NCT00003869|1584327|P2|Overall Study|Withdrawal by Subject|3
490761|NCT00003869|1584328|P1|Overall Study|Withdrawal by Subject|21
490762|NCT00003869|1584327|P2|Overall Study|Adverse Event|3
490763|NCT00003869|1584328|P1|Overall Study|Adverse Event|14
490764|NCT00003782|1584354|P3|Overall Study|No follow up data|26
490765|NCT00003782|1584355|P2|Overall Study|No follow up data|31
490766|NCT00003782|1584356|P1|Overall Study|No follow up data|30
490767|NCT00003702|1584366|P2|Overall Study|Inadequate documentation of disease|3
490768|NCT00003702|1584367|P1|Overall Study|Inadequate documentation of disease|1
490769|NCT00003702|1584366|P2|Overall Study|WHO score > 6|1
490770|NCT00003702|1584367|P1|Overall Study|WHO score > 6|2
490771|NCT00003702|1584366|P2|Overall Study|Did not meet criteria for persistence|5
490772|NCT00003702|1584367|P1|Overall Study|Did not meet criteria for persistence|8
490773|NCT00003702|1584366|P2|Overall Study|Ineligible cell types|2
490774|NCT00003702|1584367|P1|Overall Study|Ineligible cell types|2
490775|NCT00003659|1584376|P1|Overall Study|Withdrawal by Subject|3
490776|NCT00003641|1584384|P2|Overall Study|Never started interferon|12
490777|NCT00003641|1584385|P1|Overall Study|Never started interferon|567
490778|NCT00003641|1584384|P2|Overall Study|Should not receive interferon therapy|0
490779|NCT00003641|1584385|P1|Overall Study|Should not receive interferon therapy|2
490780|NCT00003641|1584384|P2|Overall Study|Unknown/missing|22
490781|NCT00003641|1584385|P1|Overall Study|Unknown/missing|0
490782|NCT00003641|1584384|P2|Overall Study|Disease progression|2
490783|NCT00003641|1584385|P1|Overall Study|Disease progression|0
490784|NCT00003641|1584384|P2|Overall Study|Adverse Event|38
490785|NCT00003641|1584385|P1|Overall Study|Adverse Event|0
490786|NCT00003641|1584384|P2|Overall Study|Withdrawal by Subject|100
490787|NCT00003641|1584385|P1|Overall Study|Withdrawal by Subject|0
490788|NCT00003631|1584396|P3|Overall Study|Evaluable for toxicity only|2
490789|NCT00003631|1584397|P2|Overall Study|Evaluable for toxicity only|0
490790|NCT00003631|1584398|P1|Overall Study|Evaluable for toxicity only|0
490791|NCT00003631|1584396|P3|Overall Study|Death|1
490792|NCT00003631|1584397|P2|Overall Study|Death|0
490793|NCT00003631|1584398|P1|Overall Study|Death|0
490794|NCT00003631|1584396|P3|Overall Study|Adverse Event|5
490795|NCT00003631|1584397|P2|Overall Study|Adverse Event|1
490796|NCT00003631|1584398|P1|Overall Study|Adverse Event|1
490797|NCT00003631|1584396|P3|Overall Study|Protocol Violation|0
490798|NCT00003631|1584397|P2|Overall Study|Protocol Violation|0
490799|NCT00003631|1584398|P1|Overall Study|Protocol Violation|1
490800|NCT00003631|1584396|P3|Overall Study|Patient not treated|1
490801|NCT00003631|1584397|P2|Overall Study|Patient not treated|0
490802|NCT00003631|1584398|P1|Overall Study|Patient not treated|1
490803|NCT00003590|1584406|P1|Overall Study|Physician Decision|1
490804|NCT00003590|1584406|P1|Overall Study|Death|1
490805|NCT00003590|1584406|P1|Overall Study|Lack of Efficacy|11
490806|NCT00003590|1584406|P1|Overall Study|Withdrawal by Subject|1
490807|NCT00003590|1584406|P1|Overall Study|Adverse Event|7
490808|NCT00003590|1584406|P1|Overall Study|Ineligible Patient|1
490809|NCT00003537|1584411|P1|Overall Study|Not evalauable|1
490810|NCT00003535|1584416|P1|Overall Study|Not evaluable|5
490811|NCT00003483|1584421|P1|Overall Study|Not evaluable|1
490812|NCT00003479|1584426|P1|Overall Study|Not evaluable|3
490813|NCT00003477|1584431|P1|Overall Study|Not evalauable|4
490814|NCT00003476|1584436|P1|Overall Study|Not evaluable|1
490815|NCT00003475|1584441|P1|Overall Study|Not evaluable|13
490816|NCT00003474|1584446|P1|Overall Study|Not Evaluable|14
490817|NCT00003473|1584451|P1|Overall Study|Three patients were not evaluable.|3
490818|NCT00003472|1584456|P1|Overall Study|Not evaluable|3
490819|NCT00003471|1584461|P1|Overall Study|Not evaluable|4
490820|NCT00003470|1584466|P1|Overall Study|Not evaluable|6
490821|NCT00003458|1584491|P1|Overall Study|Not evaluable|4
490822|NCT00003457|1584496|P1|Overall Study|Not evaluable|9
490823|NCT00003456|1584501|P1|Overall Study|Not evaluable|8
490824|NCT00003389|1584513|P2|Overall Study|Ineligible|27
490825|NCT00003389|1584514|P1|Overall Study|Ineligible|33
490826|NCT00003389|1584513|P2|Overall Study|Off-treatment reason missing|21
490827|NCT00003389|1584514|P1|Overall Study|Off-treatment reason missing|31
490828|NCT00003389|1584513|P2|Overall Study|Complicating disease|0
490829|NCT00003389|1584514|P1|Overall Study|Complicating disease|1
490830|NCT00003389|1584513|P2|Overall Study|Alternative therapy|1
490831|NCT00003389|1584514|P1|Overall Study|Alternative therapy|2
490832|NCT00003389|1584513|P2|Overall Study|Withdrawal by Subject|5
490833|NCT00003389|1584514|P1|Overall Study|Withdrawal by Subject|12
490834|NCT00003389|1584513|P2|Overall Study|Death|3
490835|NCT00003389|1584514|P1|Overall Study|Death|0
490836|NCT00003389|1584513|P2|Overall Study|Adverse Event|2
490837|NCT00003389|1584514|P1|Overall Study|Adverse Event|13
490838|NCT00003389|1584513|P2|Overall Study|Disease progression|1
490839|NCT00003389|1584514|P1|Overall Study|Disease progression|6
490840|NCT00003377|1584529|P5|Period II|Ureteral stent complications|1
490841|NCT00003377|1584530|P4|Period II|Ureteral stent complications|0
490842|NCT00003377|1584531|P3|Period II|Ureteral stent complications|0
490843|NCT00003377|1584532|P2|Period II|Ureteral stent complications|0
490844|NCT00003377|1584533|P1|Period II|Ureteral stent complications|0
490845|NCT00003377|1584529|P5|Period I|Dose Limiting Toxicity(DLT)|0
490846|NCT00003377|1584530|P4|Period I|Dose Limiting Toxicity(DLT)|1
490847|NCT00003377|1584531|P3|Period I|Dose Limiting Toxicity(DLT)|1
490848|NCT00003377|1584532|P2|Period I|Dose Limiting Toxicity(DLT)|0
490849|NCT00003377|1584533|P1|Period I|Dose Limiting Toxicity(DLT)|0
490850|NCT00003199|1584547|P1|Overall Study|Screen fail|15
490851|NCT00003199|1584547|P1|Overall Study|Lack of insurance clearance|2
490852|NCT00003199|1584547|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
490853|NCT00003138|1584555|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
490854|NCT00003138|1584556|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
490855|NCT00003138|1584555|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
490856|NCT00003138|1584556|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
490857|NCT00003138|1584555|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
490858|NCT00003138|1584556|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
490859|NCT00003138|1584555|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
490860|NCT00003138|1584556|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
490861|NCT00003138|1584555|P2|Step 1|Never started treatment|0
490862|NCT00003138|1584556|P1|Step 1|Never started treatment|1
490863|NCT00003138|1584555|P2|Step 1|Reasons off treatment not documented|57
490864|NCT00003138|1584556|P1|Step 1|Reasons off treatment not documented|60
490865|NCT00002931|1584573|P1|Overall Study|rapidly progressing disease during|2
490866|NCT00002874|1584581|P2|Overall Study|Protocol Violation|34
490867|NCT00002874|1584582|P1|Overall Study|Protocol Violation|44
490868|NCT00002874|1584581|P2|Overall Study|Withdrawal by Subject|1
490869|NCT00002874|1584582|P1|Overall Study|Withdrawal by Subject|1
490870|NCT00002850|1584607|P3|Overall Study|Withdrawal by Subject|0
490871|NCT00002850|1584608|P2|Overall Study|Withdrawal by Subject|1
490872|NCT00002850|1584609|P1|Overall Study|Withdrawal by Subject|0
490873|NCT00002850|1584607|P3|Overall Study|Protocol Violation|1
490874|NCT00002850|1584608|P2|Overall Study|Protocol Violation|0
490875|NCT00002850|1584609|P1|Overall Study|Protocol Violation|1
490876|NCT00002850|1584607|P3|Overall Study|Death|3
490877|NCT00002850|1584608|P2|Overall Study|Death|1
490878|NCT00002850|1584609|P1|Overall Study|Death|4
490879|NCT00002842|1584617|P1|Overall Study|ineligible for surgical resection|27
490880|NCT00002766|1584623|P2|Overall Study|Protocol Violation|0
490881|NCT00002766|1584624|P1|Overall Study|Protocol Violation|1
490882|NCT00002766|1584623|P2|Overall Study|Adverse Event|1
490883|NCT00002766|1584624|P1|Overall Study|Adverse Event|1
490884|NCT00002766|1584623|P2|Overall Study|Patient Not Treated|2
490885|NCT00002766|1584624|P1|Overall Study|Patient Not Treated|1
490886|NCT00002766|1584623|P2|Overall Study|Withdrawal by Subject|1
490887|NCT00002766|1584624|P1|Overall Study|Withdrawal by Subject|0
490888|NCT00002651|1584632|P3|Consolidation and Randomization|not eligible|112
490889|NCT00002651|1584633|P2|Consolidation and Randomization|not eligible|102
490890|NCT00002651|1584634|P1|Consolidation and Randomization|not eligible|0
490891|NCT00002651|1584632|P3|Consolidation and Randomization|not specified|313
490892|NCT00002651|1584633|P2|Consolidation and Randomization|not specified|314
490893|NCT00002651|1584634|P1|Consolidation and Randomization|not specified|0
490894|NCT00002651|1584632|P3|Consolidation and Randomization|Death|48
490895|NCT00002651|1584633|P2|Consolidation and Randomization|Death|38
490896|NCT00002651|1584634|P1|Consolidation and Randomization|Death|0
490897|NCT00002651|1584632|P3|Consolidation and Randomization|Progression/relapse|298
490898|NCT00002651|1584633|P2|Consolidation and Randomization|Progression/relapse|295
490899|NCT00002651|1584634|P1|Consolidation and Randomization|Progression/relapse|0
490900|NCT00002651|1584632|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
490901|NCT00002651|1584633|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
490902|NCT00002651|1584634|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
490903|NCT00002651|1584632|P3|Consolidation and Randomization|Adverse Event|14
490904|NCT00002651|1584633|P2|Consolidation and Randomization|Adverse Event|36
490905|NCT00002651|1584634|P1|Consolidation and Randomization|Adverse Event|0
490906|NCT00002651|1584632|P3|Induction|not eligible|0
490907|NCT00002651|1584633|P2|Induction|not eligible|0
490908|NCT00002651|1584634|P1|Induction|not eligible|90
490909|NCT00002651|1584632|P3|Induction|not specified|0
490910|NCT00002651|1584633|P2|Induction|not specified|0
490911|NCT00002651|1584634|P1|Induction|not specified|823
490912|NCT00002651|1584632|P3|Induction|Death|0
490913|NCT00002651|1584633|P2|Induction|Death|0
490914|NCT00002651|1584634|P1|Induction|Death|62
490915|NCT00002651|1584632|P3|Induction|Progression/relapse|0
490916|NCT00002651|1584633|P2|Induction|Progression/relapse|0
490917|NCT00002651|1584634|P1|Induction|Progression/relapse|274
490918|NCT00002651|1584632|P3|Induction|Refusal unrelated to adverse event|0
490919|NCT00002651|1584633|P2|Induction|Refusal unrelated to adverse event|0
490920|NCT00002651|1584634|P1|Induction|Refusal unrelated to adverse event|50
490921|NCT00002651|1584632|P3|Induction|Adverse Event|0
490922|NCT00002651|1584633|P2|Induction|Adverse Event|0
490923|NCT00002651|1584634|P1|Induction|Adverse Event|44
490924|NCT00002558|1584652|P2|Overall Study|Withdrawal by Subject|1
490925|NCT00002558|1584653|P1|Overall Study|Withdrawal by Subject|0
490926|NCT00051636|1584678|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
490927|NCT00051636|1584679|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
490928|NCT00051636|1584678|P2|Period 2- Extended Observation Period|Death|5
490929|NCT00051636|1584679|P1|Period 2- Extended Observation Period|Death|4
490930|NCT00051636|1584678|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
490931|NCT00051636|1584679|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
490932|NCT00051636|1584678|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
490933|NCT00051636|1584679|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
490934|NCT00051636|1584678|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
490935|NCT00051636|1584679|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
490936|NCT00051636|1584678|P2|Period 1 - Core|Lost to Follow-up|2
490937|NCT00051636|1584679|P1|Period 1 - Core|Lost to Follow-up|0
490938|NCT00051636|1584678|P2|Period 1 - Core|Withdrawal by Subject|2
490939|NCT00051636|1584679|P1|Period 1 - Core|Withdrawal by Subject|1
490940|NCT00051636|1584678|P2|Period 1 - Core|Protocol Violation|0
490941|NCT00051636|1584679|P1|Period 1 - Core|Protocol Violation|1
490942|NCT00051636|1584678|P2|Period 1 - Core|Adverse Event|2
490943|NCT00051636|1584679|P1|Period 1 - Core|Adverse Event|2
490944|NCT00051558|1584707|P2|Overall Study|Physician Decision|0
490945|NCT00051558|1584708|P1|Overall Study|Physician Decision|5
490946|NCT00051558|1584707|P2|Overall Study|Significant Lab Value|0
490947|NCT00051558|1584708|P1|Overall Study|Significant Lab Value|2
490948|NCT00051558|1584707|P2|Overall Study|Other|1
490949|NCT00051558|1584708|P1|Overall Study|Other|2
490950|NCT00051558|1584707|P2|Overall Study|Sponsor Decision|1
490951|NCT00051558|1584708|P1|Overall Study|Sponsor Decision|6
490952|NCT00051558|1584707|P2|Overall Study|Protocol Entry Criteria Unmet|2
490953|NCT00051558|1584708|P1|Overall Study|Protocol Entry Criteria Unmet|1
490954|NCT00051558|1584707|P2|Overall Study|Protocol Violation|4
490955|NCT00051558|1584708|P1|Overall Study|Protocol Violation|3
490956|NCT00051558|1584707|P2|Overall Study|Lost to Follow-up|13
490957|NCT00051558|1584708|P1|Overall Study|Lost to Follow-up|4
490958|NCT00051558|1584707|P2|Overall Study|Death|15
490959|NCT00051558|1584708|P1|Overall Study|Death|9
490960|NCT00051558|1584707|P2|Overall Study|Withdrawal by Subject|42
490961|NCT00051558|1584708|P1|Overall Study|Withdrawal by Subject|29
490962|NCT00051558|1584707|P2|Overall Study|Adverse Event|18
490963|NCT00051558|1584708|P1|Overall Study|Adverse Event|30
490964|NCT00051363|1584744|P2|Overall Study|Excluded Pre-Randomization|5
490965|NCT00051363|1584745|P1|Overall Study|Excluded Pre-Randomization|2
490966|NCT00051363|1584744|P2|Overall Study|Death|2
490967|NCT00051363|1584745|P1|Overall Study|Death|2
490968|NCT00051363|1584744|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
490969|NCT00051363|1584745|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
490970|NCT00051363|1584744|P2|Overall Study|Dropped Post-Rand for Any Reason|126
490971|NCT00051363|1584745|P1|Overall Study|Dropped Post-Rand for Any Reason|102
490972|NCT00051025|1584785|P2|Overall Study|Death|1
490973|NCT00051025|1584786|P1|Overall Study|Death|0
490974|NCT00051025|1584785|P2|Overall Study|Withdrawal by Subject|1
490975|NCT00051025|1584786|P1|Overall Study|Withdrawal by Subject|0
490976|NCT00051025|1584785|P2|Overall Study|Adverse Event|1
490977|NCT00051025|1584786|P1|Overall Study|Adverse Event|1
490978|NCT00051025|1584785|P2|Overall Study|Progressive Disease|1
490979|NCT00051025|1584786|P1|Overall Study|Progressive Disease|1
490980|NCT00050960|1584800|P2|Overall Study|Death|15
490981|NCT00050960|1584801|P1|Overall Study|Death|13
490982|NCT00050960|1584800|P2|Overall Study|Non-compliance|1
490983|NCT00050960|1584801|P1|Overall Study|Non-compliance|3
490984|NCT00050960|1584800|P2|Overall Study|Administrative|46
490985|NCT00050960|1584801|P1|Overall Study|Administrative|31
490986|NCT00050960|1584800|P2|Overall Study|Withdrawal by Subject|18
490987|NCT00050960|1584801|P1|Overall Study|Withdrawal by Subject|23
490988|NCT00050960|1584800|P2|Overall Study|Lost to Follow-up|1
490989|NCT00050960|1584801|P1|Overall Study|Lost to Follow-up|0
490990|NCT00050960|1584800|P2|Overall Study|Adverse Event|61
490991|NCT00050960|1584801|P1|Overall Study|Adverse Event|62
490992|NCT00050960|1584800|P2|Overall Study|Complete Response|2
490993|NCT00050960|1584801|P1|Overall Study|Complete Response|0
490994|NCT00050960|1584800|P2|Overall Study|Partial Response|19
490995|NCT00050960|1584801|P1|Overall Study|Partial Response|14
490996|NCT00050960|1584800|P2|Overall Study|Stable Disease|48
490997|NCT00050960|1584801|P1|Overall Study|Stable Disease|19
490998|NCT00050960|1584800|P2|Overall Study|Progressive Disease|93
490999|NCT00050960|1584801|P1|Overall Study|Progressive Disease|137
491000|NCT00050778|1584810|P3|Overall Study|Familial and personal reasons|0
491001|NCT00050778|1584811|P2|Overall Study|Familial and personal reasons|0
491002|NCT00050778|1584812|P1|Overall Study|Familial and personal reasons|1
491003|NCT00050778|1584810|P3|Overall Study|Randomized but not treated|2
491004|NCT00050778|1584811|P2|Overall Study|Randomized but not treated|5
491005|NCT00050778|1584812|P1|Overall Study|Randomized but not treated|4
491006|NCT00050778|1584810|P3|Overall Study|Withdrawal by Subject|4
491007|NCT00050778|1584811|P2|Overall Study|Withdrawal by Subject|8
491008|NCT00050778|1584812|P1|Overall Study|Withdrawal by Subject|6
491009|NCT00050778|1584810|P3|Overall Study|Protocol Violation|1
491010|NCT00050778|1584811|P2|Overall Study|Protocol Violation|0
491011|NCT00050778|1584812|P1|Overall Study|Protocol Violation|2
491012|NCT00050778|1584810|P3|Overall Study|Physician Decision|2
491013|NCT00050778|1584811|P2|Overall Study|Physician Decision|0
491014|NCT00050778|1584812|P1|Overall Study|Physician Decision|3
491015|NCT00050778|1584810|P3|Overall Study|Lost to Follow-up|4
491016|NCT00050778|1584811|P2|Overall Study|Lost to Follow-up|2
491017|NCT00050778|1584812|P1|Overall Study|Lost to Follow-up|0
491018|NCT00050778|1584810|P3|Overall Study|Lack of Efficacy|2
491019|NCT00050778|1584811|P2|Overall Study|Lack of Efficacy|2
491020|NCT00050778|1584812|P1|Overall Study|Lack of Efficacy|16
491021|NCT00050778|1584810|P3|Overall Study|Death|1
491022|NCT00050778|1584811|P2|Overall Study|Death|1
491023|NCT00050778|1584812|P1|Overall Study|Death|0
491024|NCT00050778|1584810|P3|Overall Study|Adverse Event|2
491025|NCT00050778|1584811|P2|Overall Study|Adverse Event|3
491026|NCT00050778|1584812|P1|Overall Study|Adverse Event|13
491027|NCT00050622|1584838|P1|Overall Study|Adverse Event|1
491028|NCT00050167|1584876|P2|Overall Study|not eligible not invasive|1
491029|NCT00050167|1584877|P1|Overall Study|not eligible not invasive|1
491030|NCT00050011|1584910|P2|Overall Study|Unknown - Reason is missing|2
491031|NCT00050011|1584911|P1|Overall Study|Unknown - Reason is missing|0
491032|NCT00050011|1584910|P2|Overall Study|Death|4
491033|NCT00050011|1584911|P1|Overall Study|Death|7
491034|NCT00050011|1584910|P2|Overall Study|Administrative problems|6
491035|NCT00050011|1584911|P1|Overall Study|Administrative problems|10
491036|NCT00050011|1584910|P2|Overall Study|Lost to Follow-up|9
491037|NCT00050011|1584911|P1|Overall Study|Lost to Follow-up|7
491038|NCT00050011|1584910|P2|Overall Study|Withdrawal by Subject|26
491039|NCT00050011|1584911|P1|Overall Study|Withdrawal by Subject|34
491040|NCT00050011|1584910|P2|Overall Study|Protocol Violation|10
491041|NCT00050011|1584911|P1|Overall Study|Protocol Violation|4
491042|NCT00050011|1584910|P2|Overall Study|Participant condition no longer required|0
491043|NCT00050011|1584911|P1|Overall Study|Participant condition no longer required|1
491044|NCT00050011|1584910|P2|Overall Study|Lack of Efficacy|21
491045|NCT00050011|1584911|P1|Overall Study|Lack of Efficacy|16
491046|NCT00050011|1584910|P2|Overall Study|Abnormal test procedure results|1
491047|NCT00050011|1584911|P1|Overall Study|Abnormal test procedure results|0
491048|NCT00050011|1584910|P2|Overall Study|Abnormal laboratory value(s)|1
491049|NCT00050011|1584911|P1|Overall Study|Abnormal laboratory value(s)|1
491050|NCT00050011|1584910|P2|Overall Study|Adverse Event|46
491051|NCT00050011|1584911|P1|Overall Study|Adverse Event|41
491052|NCT00049842|1584933|P2|Follow-up Phase|Not specified|4
491053|NCT00049842|1584934|P1|Follow-up Phase|Not specified|1
491054|NCT00049842|1584933|P2|Follow-up Phase|Adverse Event|1
491055|NCT00049842|1584934|P1|Follow-up Phase|Adverse Event|6
491056|NCT00049842|1584933|P2|Treatment Phase|Did not meet protocol eligibility|1
491057|NCT00049842|1584934|P1|Treatment Phase|Did not meet protocol eligibility|0
491058|NCT00049842|1584933|P2|Treatment Phase|Administrative|3
491059|NCT00049842|1584934|P1|Treatment Phase|Administrative|0
491060|NCT00049842|1584933|P2|Treatment Phase|Lost to Follow-up|8
491061|NCT00049842|1584934|P1|Treatment Phase|Lost to Follow-up|4
491062|NCT00049842|1584933|P2|Treatment Phase|Non-compliance with protocol|8
491063|NCT00049842|1584934|P1|Treatment Phase|Non-compliance with protocol|7
491064|NCT00049842|1584933|P2|Treatment Phase|Withdrawal by Subject|46
491065|NCT00049842|1584934|P1|Treatment Phase|Withdrawal by Subject|35
491066|NCT00049842|1584933|P2|Treatment Phase|Adverse Event|12
491067|NCT00049842|1584934|P1|Treatment Phase|Adverse Event|47
491068|NCT00048932|1584952|P3|Open Label Period (OL)|Participant Surgery|1
491069|NCT00048932|1584953|P2|Open Label Period (OL)|Participant Surgery|0
491070|NCT00048932|1584954|P1|Open Label Period (OL)|Participant Surgery|0
491071|NCT00048932|1584952|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
491072|NCT00048932|1584953|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
491073|NCT00048932|1584954|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
491074|NCT00048932|1584952|P3|Open Label Period (OL)|Site Staff Issues|2
491075|NCT00048932|1584953|P2|Open Label Period (OL)|Site Staff Issues|0
491076|NCT00048932|1584954|P1|Open Label Period (OL)|Site Staff Issues|0
491077|NCT00048932|1584952|P3|Open Label Period (OL)|Investigator Decision|4
491078|NCT00048932|1584953|P2|Open Label Period (OL)|Investigator Decision|0
491079|NCT00048932|1584954|P1|Open Label Period (OL)|Investigator Decision|0
491080|NCT00048932|1584952|P3|Open Label Period (OL)|Medication Lost Efficacy|1
491081|NCT00048932|1584953|P2|Open Label Period (OL)|Medication Lost Efficacy|0
491082|NCT00048932|1584954|P1|Open Label Period (OL)|Medication Lost Efficacy|0
491083|NCT00048932|1584952|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
491084|NCT00048932|1584953|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
491085|NCT00048932|1584954|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
491086|NCT00048932|1584952|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
491087|NCT00048932|1584953|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
491088|NCT00048932|1584954|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
491089|NCT00048932|1584952|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
491090|NCT00048932|1584953|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
491091|NCT00048932|1584954|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
491092|NCT00048932|1584952|P3|Open Label Period (OL)|Patient Decision|4
491093|NCT00048932|1584953|P2|Open Label Period (OL)|Patient Decision|0
491094|NCT00048932|1584954|P1|Open Label Period (OL)|Patient Decision|0
491095|NCT00048932|1584952|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
491096|NCT00048932|1584953|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
491097|NCT00048932|1584954|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
491098|NCT00048932|1584952|P3|Open Label Period (OL)|Trial Terminated|1
491099|NCT00048932|1584953|P2|Open Label Period (OL)|Trial Terminated|0
491100|NCT00048932|1584954|P1|Open Label Period (OL)|Trial Terminated|0
491101|NCT00048932|1584952|P3|Open Label Period (OL)|Site Closure|3
491102|NCT00048932|1584953|P2|Open Label Period (OL)|Site Closure|0
491103|NCT00048932|1584954|P1|Open Label Period (OL)|Site Closure|0
491104|NCT00048932|1584952|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
491105|NCT00048932|1584953|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
491106|NCT00048932|1584954|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
491107|NCT00048932|1584952|P3|Open Label Period (OL)|Participant Relocated|6
491108|NCT00048932|1584953|P2|Open Label Period (OL)|Participant Relocated|0
491109|NCT00048932|1584954|P1|Open Label Period (OL)|Participant Relocated|0
491110|NCT00048932|1584952|P3|Open Label Period (OL)|Participant Transportation Issues|1
491111|NCT00048932|1584953|P2|Open Label Period (OL)|Participant Transportation Issues|0
491112|NCT00048932|1584954|P1|Open Label Period (OL)|Participant Transportation Issues|0
491113|NCT00048932|1584952|P3|Open Label Period (OL)|Investigator Retiring|2
491114|NCT00048932|1584953|P2|Open Label Period (OL)|Investigator Retiring|0
491115|NCT00048932|1584954|P1|Open Label Period (OL)|Investigator Retiring|0
491116|NCT00048932|1584952|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
491117|NCT00048932|1584953|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
491118|NCT00048932|1584954|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
491119|NCT00048932|1584952|P3|Open Label Period (OL)|Pregnancy|6
491120|NCT00048932|1584953|P2|Open Label Period (OL)|Pregnancy|0
491121|NCT00048932|1584954|P1|Open Label Period (OL)|Pregnancy|0
491122|NCT00048932|1584952|P3|Open Label Period (OL)|Poor/Non-Compliance|13
491123|NCT00048932|1584953|P2|Open Label Period (OL)|Poor/Non-Compliance|0
491124|NCT00048932|1584954|P1|Open Label Period (OL)|Poor/Non-Compliance|0
491125|NCT00048932|1584952|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
491126|NCT00048932|1584953|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
491127|NCT00048932|1584954|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
491128|NCT00048932|1584952|P3|Open Label Period (OL)|Withdrawal by Subject|117
491129|NCT00048932|1584953|P2|Open Label Period (OL)|Withdrawal by Subject|0
491130|NCT00048932|1584954|P1|Open Label Period (OL)|Withdrawal by Subject|0
491131|NCT00048932|1584952|P3|Open Label Period (OL)|Lost to Follow-up|27
491132|NCT00048932|1584953|P2|Open Label Period (OL)|Lost to Follow-up|0
491133|NCT00048932|1584954|P1|Open Label Period (OL)|Lost to Follow-up|0
491134|NCT00048932|1584952|P3|Open Label Period (OL)|Lack of Efficacy|81
491135|NCT00048932|1584953|P2|Open Label Period (OL)|Lack of Efficacy|0
491136|NCT00048932|1584954|P1|Open Label Period (OL)|Lack of Efficacy|0
491137|NCT00048932|1584952|P3|Open Label Period (OL)|Adverse Event|103
491138|NCT00048932|1584953|P2|Open Label Period (OL)|Adverse Event|0
491139|NCT00048932|1584954|P1|Open Label Period (OL)|Adverse Event|0
491140|NCT00048932|1584952|P3|Open Label Period (OL)|Death|25
491141|NCT00048932|1584953|P2|Open Label Period (OL)|Death|0
491142|NCT00048932|1584954|P1|Open Label Period (OL)|Death|0
491143|NCT00048932|1584952|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
491144|NCT00048932|1584953|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
491145|NCT00048932|1584954|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
491146|NCT00048932|1584952|P3|Double Blind Period (DB)|Withdrawal by Subject|0
491147|NCT00048932|1584953|P2|Double Blind Period (DB)|Withdrawal by Subject|10
491148|NCT00048932|1584954|P1|Double Blind Period (DB)|Withdrawal by Subject|24
491149|NCT00048932|1584952|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
491150|NCT00048932|1584953|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
491151|NCT00048932|1584954|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
491152|NCT00048932|1584952|P3|Double Blind Period (DB)|Pregnancy|0
491153|NCT00048932|1584953|P2|Double Blind Period (DB)|Pregnancy|0
491154|NCT00048932|1584954|P1|Double Blind Period (DB)|Pregnancy|1
491155|NCT00048932|1584952|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
491156|NCT00048932|1584953|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
491157|NCT00048932|1584954|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
491158|NCT00048932|1584952|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
491159|NCT00048932|1584953|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
491160|NCT00048932|1584954|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
491161|NCT00048932|1584952|P3|Double Blind Period (DB)|Relocation|0
491162|NCT00048932|1584953|P2|Double Blind Period (DB)|Relocation|0
491163|NCT00048932|1584954|P1|Double Blind Period (DB)|Relocation|1
491164|NCT00048932|1584952|P3|Double Blind Period (DB)|Lost to Follow-up|0
491165|NCT00048932|1584953|P2|Double Blind Period (DB)|Lost to Follow-up|4
491166|NCT00048932|1584954|P1|Double Blind Period (DB)|Lost to Follow-up|3
491167|NCT00048932|1584952|P3|Double Blind Period (DB)|Lack of Efficacy|0
491168|NCT00048932|1584953|P2|Double Blind Period (DB)|Lack of Efficacy|44
491169|NCT00048932|1584954|P1|Double Blind Period (DB)|Lack of Efficacy|26
491170|NCT00048932|1584952|P3|Double Blind Period (DB)|Death|0
491171|NCT00048932|1584953|P2|Double Blind Period (DB)|Death|3
491172|NCT00048932|1584954|P1|Double Blind Period (DB)|Death|5
491173|NCT00048932|1584952|P3|Double Blind Period (DB)|Adverse Event|0
491174|NCT00048932|1584953|P2|Double Blind Period (DB)|Adverse Event|19
491175|NCT00048932|1584954|P1|Double Blind Period (DB)|Adverse Event|51
491176|NCT00048932|1584952|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
491177|NCT00048932|1584953|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
491178|NCT00048932|1584954|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
491179|NCT00048581|1584996|P3|Open-Label Period|Study Ended By Sponsor|1
491180|NCT00048581|1584997|P2|Open-Label Period|Study Ended By Sponsor|0
491181|NCT00048581|1584998|P1|Open-Label Period|Study Ended By Sponsor|0
491182|NCT00048581|1584996|P3|Open-Label Period|Primary Investigator Retired|2
491183|NCT00048581|1584997|P2|Open-Label Period|Primary Investigator Retired|0
491184|NCT00048581|1584998|P1|Open-Label Period|Primary Investigator Retired|0
491185|NCT00048581|1584996|P3|Open-Label Period|Problem With Transportation To Site|1
491186|NCT00048581|1584997|P2|Open-Label Period|Problem With Transportation To Site|0
491187|NCT00048581|1584998|P1|Open-Label Period|Problem With Transportation To Site|0
491188|NCT00048581|1584996|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
491189|NCT00048581|1584997|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
491190|NCT00048581|1584998|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
491191|NCT00048581|1584996|P3|Open-Label Period|Study Site Closure|2
491192|NCT00048581|1584997|P2|Open-Label Period|Study Site Closure|0
491193|NCT00048581|1584998|P1|Open-Label Period|Study Site Closure|0
491194|NCT00048581|1584996|P3|Open-Label Period|Pregnancy|7
491195|NCT00048581|1584997|P2|Open-Label Period|Pregnancy|0
491196|NCT00048581|1584998|P1|Open-Label Period|Pregnancy|0
491197|NCT00048581|1584996|P3|Open-Label Period|Poor/Non-compliance|5
491198|NCT00048581|1584997|P2|Open-Label Period|Poor/Non-compliance|0
491199|NCT00048581|1584998|P1|Open-Label Period|Poor/Non-compliance|0
491200|NCT00048581|1584996|P3|Open-Label Period|No Longer Meets Study Criteria|2
491201|NCT00048581|1584997|P2|Open-Label Period|No Longer Meets Study Criteria|0
491202|NCT00048581|1584998|P1|Open-Label Period|No Longer Meets Study Criteria|0
491203|NCT00048581|1584996|P3|Open-Label Period|Withdrawal by Subject|20
491204|NCT00048581|1584997|P2|Open-Label Period|Withdrawal by Subject|0
491205|NCT00048581|1584998|P1|Open-Label Period|Withdrawal by Subject|0
491206|NCT00048581|1584996|P3|Open-Label Period|Lost to Follow-up|14
491207|NCT00048581|1584997|P2|Open-Label Period|Lost to Follow-up|0
491208|NCT00048581|1584998|P1|Open-Label Period|Lost to Follow-up|0
491209|NCT00048581|1584996|P3|Open-Label Period|Lack of Efficacy|69
491210|NCT00048581|1584997|P2|Open-Label Period|Lack of Efficacy|0
491211|NCT00048581|1584998|P1|Open-Label Period|Lack of Efficacy|0
491212|NCT00048581|1584996|P3|Open-Label Period|Adverse Event|37
491213|NCT00048581|1584997|P2|Open-Label Period|Adverse Event|0
491214|NCT00048581|1584998|P1|Open-Label Period|Adverse Event|0
491215|NCT00048581|1584996|P3|Open-Label Period|Death|4
491216|NCT00048581|1584997|P2|Open-Label Period|Death|0
491217|NCT00048581|1584998|P1|Open-Label Period|Death|0
491218|NCT00048581|1584996|P3|Double-Blind Period|Investigator Decision|0
491219|NCT00048581|1584997|P2|Double-Blind Period|Investigator Decision|0
491220|NCT00048581|1584998|P1|Double-Blind Period|Investigator Decision|1
491221|NCT00048581|1584996|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
491222|NCT00048581|1584997|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
491223|NCT00048581|1584998|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
491224|NCT00048581|1584996|P3|Double-Blind Period|Withdrawal by Subject|0
491225|NCT00048581|1584997|P2|Double-Blind Period|Withdrawal by Subject|2
491226|NCT00048581|1584998|P1|Double-Blind Period|Withdrawal by Subject|5
491227|NCT00048581|1584996|P3|Double-Blind Period|Lost to Follow-up|0
491228|NCT00048581|1584997|P2|Double-Blind Period|Lost to Follow-up|0
491229|NCT00048581|1584998|P1|Double-Blind Period|Lost to Follow-up|5
491230|NCT00048581|1584996|P3|Double-Blind Period|Lack of Efficacy|0
491231|NCT00048581|1584997|P2|Double-Blind Period|Lack of Efficacy|27
491232|NCT00048581|1584998|P1|Double-Blind Period|Lack of Efficacy|14
491233|NCT00048581|1584996|P3|Double-Blind Period|Adverse Event|0
491234|NCT00048581|1584997|P2|Double-Blind Period|Adverse Event|5
491235|NCT00048581|1584998|P1|Double-Blind Period|Adverse Event|9
491236|NCT00048568|1585165|P3|Open-Label Period|Lost to Follow-up|7
491237|NCT00048568|1585166|P2|Open-Label Period|Lost to Follow-up|0
491238|NCT00048568|1585167|P1|Open-Label Period|Lost to Follow-up|0
491239|NCT00048568|1585165|P3|Open-Label Period|Unknown Reasons|25
491240|NCT00048568|1585166|P2|Open-Label Period|Unknown Reasons|0
491241|NCT00048568|1585167|P1|Open-Label Period|Unknown Reasons|0
491242|NCT00048568|1585165|P3|Open-Label Period|Administrative Decision By Sponsor|1
491243|NCT00048568|1585166|P2|Open-Label Period|Administrative Decision By Sponsor|0
491244|NCT00048568|1585167|P1|Open-Label Period|Administrative Decision By Sponsor|0
491245|NCT00048568|1585165|P3|Open-Label Period|No Longer Met Study Criteria|2
491246|NCT00048568|1585166|P2|Open-Label Period|No Longer Met Study Criteria|0
491247|NCT00048568|1585167|P1|Open-Label Period|No Longer Met Study Criteria|0
491248|NCT00048568|1585165|P3|Open-Label Period|Pregnancy|5
491249|NCT00048568|1585166|P2|Open-Label Period|Pregnancy|0
491250|NCT00048568|1585167|P1|Open-Label Period|Pregnancy|0
491251|NCT00048568|1585165|P3|Open-Label Period|Withdrawal by Subject|26
491252|NCT00048568|1585166|P2|Open-Label Period|Withdrawal by Subject|0
491253|NCT00048568|1585167|P1|Open-Label Period|Withdrawal by Subject|0
491254|NCT00048568|1585165|P3|Open-Label Period|Lack of Efficacy|32
491255|NCT00048568|1585166|P2|Open-Label Period|Lack of Efficacy|0
491256|NCT00048568|1585167|P1|Open-Label Period|Lack of Efficacy|0
491257|NCT00048568|1585165|P3|Open-Label Period|Adverse Event|49
491258|NCT00048568|1585166|P2|Open-Label Period|Adverse Event|0
491259|NCT00048568|1585167|P1|Open-Label Period|Adverse Event|0
491260|NCT00048568|1585165|P3|Open-Label Period|Death|13
491261|NCT00048568|1585166|P2|Open-Label Period|Death|0
491262|NCT00048568|1585167|P1|Open-Label Period|Death|0
491263|NCT00048568|1585165|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
491264|NCT00048568|1585166|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
491265|NCT00048568|1585167|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
491266|NCT00048568|1585165|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
491267|NCT00048568|1585166|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
491268|NCT00048568|1585167|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
491269|NCT00048568|1585165|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
491270|NCT00048568|1585166|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
491271|NCT00048568|1585167|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
491272|NCT00048568|1585165|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
491273|NCT00048568|1585166|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
491274|NCT00048568|1585167|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
491275|NCT00048568|1585165|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
491276|NCT00048568|1585166|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
491277|NCT00048568|1585167|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
491278|NCT00048568|1585165|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
491279|NCT00048568|1585166|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
491280|NCT00048568|1585167|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
491281|NCT00048568|1585165|P3|Double-Blind Period Days 170 to 365|Death|0
491282|NCT00048568|1585166|P2|Double-Blind Period Days 170 to 365|Death|1
491283|NCT00048568|1585167|P1|Double-Blind Period Days 170 to 365|Death|1
491284|NCT00048568|1585165|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
491285|NCT00048568|1585166|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
491286|NCT00048568|1585167|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
491287|NCT00048568|1585165|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
491288|NCT00048568|1585166|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
491289|NCT00048568|1585167|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
491290|NCT00048568|1585165|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
491291|NCT00048568|1585166|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
491292|NCT00048568|1585167|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
491293|NCT00048568|1585165|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
491294|NCT00048568|1585166|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
491295|NCT00048568|1585167|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
491296|NCT00048568|1585165|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
491297|NCT00048568|1585166|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
491298|NCT00048568|1585167|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
491299|NCT00048724|1585472|P2|Overall Study|Administrative|1
491300|NCT00048724|1585473|P1|Overall Study|Administrative|1
491301|NCT00048724|1585472|P2|Overall Study|Did Not Meet Protocol Eligibility|2
491302|NCT00048724|1585473|P1|Overall Study|Did Not Meet Protocol Eligibility|2
491303|NCT00048724|1585472|P2|Overall Study|Noncompliance With Protocol|12
491304|NCT00048724|1585473|P1|Overall Study|Noncompliance With Protocol|4
491305|NCT00048724|1585472|P2|Overall Study|Protocol-defined Clinical Event|32
491306|NCT00048724|1585473|P1|Overall Study|Protocol-defined Clinical Event|17
491307|NCT00048724|1585472|P2|Overall Study|Lost to Follow-up|5
491308|NCT00048724|1585473|P1|Overall Study|Lost to Follow-up|5
491309|NCT00048724|1585472|P2|Overall Study|Withdrawal by Subject|54
491310|NCT00048724|1585473|P1|Overall Study|Withdrawal by Subject|34
491311|NCT00048724|1585472|P2|Overall Study|Adverse Event|12
491312|NCT00048724|1585473|P1|Overall Study|Adverse Event|53
491313|NCT00048542|1585485|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
491314|NCT00048542|1585486|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
491315|NCT00048542|1585487|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
491316|NCT00048542|1585488|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
491317|NCT00048542|1585489|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
491318|NCT00048542|1585490|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
491319|NCT00048542|1585491|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
491320|NCT00048542|1585492|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
491321|NCT00048542|1585485|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
491322|NCT00048542|1585486|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
491323|NCT00048542|1585487|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
491324|NCT00048542|1585488|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
491325|NCT00048542|1585489|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
491326|NCT00048542|1585490|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
491327|NCT00048542|1585491|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
491328|NCT00048542|1585492|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
491329|NCT00048542|1585485|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
491330|NCT00048542|1585486|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
491331|NCT00048542|1585487|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
491332|NCT00048542|1585488|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
491333|NCT00048542|1585489|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
491334|NCT00048542|1585490|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
491335|NCT00048542|1585491|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
491336|NCT00048542|1585492|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
491337|NCT00048542|1585485|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
491338|NCT00048542|1585486|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
491339|NCT00048542|1585487|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
491340|NCT00048542|1585488|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
491341|NCT00048542|1585489|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
491342|NCT00048542|1585490|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
491343|NCT00048542|1585491|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
491344|NCT00048542|1585492|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
491345|NCT00048542|1585485|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
491346|NCT00048542|1585486|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
491347|NCT00048542|1585487|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
491348|NCT00048542|1585488|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
491349|NCT00048542|1585489|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
491350|NCT00048542|1585490|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
491351|NCT00048542|1585491|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
491352|NCT00048542|1585492|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
491353|NCT00048542|1585485|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
491354|NCT00048542|1585486|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
491355|NCT00048542|1585487|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
491356|NCT00048542|1585488|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
491357|NCT00048542|1585489|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
491358|NCT00048542|1585490|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
491359|NCT00048542|1585491|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
491360|NCT00048542|1585492|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
491361|NCT00048542|1585485|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
491362|NCT00048542|1585486|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
491363|NCT00048542|1585487|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
491364|NCT00048542|1585488|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
491365|NCT00048542|1585489|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
491366|NCT00048542|1585490|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
491367|NCT00048542|1585491|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
491368|NCT00048542|1585492|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
491369|NCT00048542|1585485|P8|Open-Label Extension BSA Phase|Adverse Event|0
491370|NCT00048542|1585486|P7|Open-Label Extension BSA Phase|Adverse Event|0
491371|NCT00048542|1585487|P6|Open-Label Extension BSA Phase|Adverse Event|1
491372|NCT00048542|1585488|P5|Open-Label Extension BSA Phase|Adverse Event|1
491373|NCT00048542|1585489|P4|Open-Label Extension BSA Phase|Adverse Event|0
491374|NCT00048542|1585490|P3|Open-Label Extension BSA Phase|Adverse Event|0
491375|NCT00048542|1585491|P2|Open-Label Extension BSA Phase|Adverse Event|0
491376|NCT00048542|1585492|P1|Open-Label Extension BSA Phase|Adverse Event|0
491377|NCT00048542|1585485|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
491378|NCT00048542|1585486|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
491379|NCT00048542|1585487|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
491380|NCT00048542|1585488|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
491381|NCT00048542|1585489|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
491382|NCT00048542|1585490|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
491383|NCT00048542|1585491|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
491384|NCT00048542|1585492|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
491385|NCT00048542|1585485|P8|Open-Label Extension BSA Phase|Protocol Violation|0
491386|NCT00048542|1585486|P7|Open-Label Extension BSA Phase|Protocol Violation|0
491387|NCT00048542|1585487|P6|Open-Label Extension BSA Phase|Protocol Violation|1
491388|NCT00048542|1585488|P5|Open-Label Extension BSA Phase|Protocol Violation|0
491389|NCT00048542|1585489|P4|Open-Label Extension BSA Phase|Protocol Violation|0
491390|NCT00048542|1585490|P3|Open-Label Extension BSA Phase|Protocol Violation|0
491391|NCT00048542|1585491|P2|Open-Label Extension BSA Phase|Protocol Violation|0
491392|NCT00048542|1585492|P1|Open-Label Extension BSA Phase|Protocol Violation|0
491393|NCT00048542|1585485|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
491394|NCT00048542|1585486|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
491395|NCT00048542|1585487|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
491396|NCT00048542|1585488|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
491397|NCT00048542|1585489|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
491398|NCT00048542|1585490|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
491399|NCT00048542|1585491|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
491400|NCT00048542|1585492|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
491401|NCT00048542|1585485|P8|Double-Blind Phase|Randomized in error|0
491402|NCT00048542|1585486|P7|Double-Blind Phase|Randomized in error|0
491403|NCT00048542|1585487|P6|Double-Blind Phase|Randomized in error|0
491404|NCT00048542|1585488|P5|Double-Blind Phase|Randomized in error|0
491405|NCT00048542|1585489|P4|Double-Blind Phase|Randomized in error|0
491406|NCT00048542|1585490|P3|Double-Blind Phase|Randomized in error|0
491407|NCT00048542|1585491|P2|Double-Blind Phase|Randomized in error|0
491408|NCT00048542|1585492|P1|Double-Blind Phase|Randomized in error|1
491409|NCT00048542|1585485|P8|Double-Blind Phase|Sponsor request or decision|0
491410|NCT00048542|1585486|P7|Double-Blind Phase|Sponsor request or decision|0
491411|NCT00048542|1585487|P6|Double-Blind Phase|Sponsor request or decision|0
491412|NCT00048542|1585488|P5|Double-Blind Phase|Sponsor request or decision|0
491413|NCT00048542|1585489|P4|Double-Blind Phase|Sponsor request or decision|0
491414|NCT00048542|1585490|P3|Double-Blind Phase|Sponsor request or decision|0
491415|NCT00048542|1585491|P2|Double-Blind Phase|Sponsor request or decision|0
491416|NCT00048542|1585492|P1|Double-Blind Phase|Sponsor request or decision|2
491417|NCT00048542|1585485|P8|Double-Blind Phase|Protocol Violation|0
491418|NCT00048542|1585486|P7|Double-Blind Phase|Protocol Violation|0
491419|NCT00048542|1585487|P6|Double-Blind Phase|Protocol Violation|0
491420|NCT00048542|1585488|P5|Double-Blind Phase|Protocol Violation|0
491421|NCT00048542|1585489|P4|Double-Blind Phase|Protocol Violation|0
491422|NCT00048542|1585490|P3|Double-Blind Phase|Protocol Violation|1
491423|NCT00048542|1585491|P2|Double-Blind Phase|Protocol Violation|0
491424|NCT00048542|1585492|P1|Double-Blind Phase|Protocol Violation|0
491425|NCT00048542|1585485|P8|Double-Blind Phase|Withdrawal by Subject|0
491426|NCT00048542|1585486|P7|Double-Blind Phase|Withdrawal by Subject|0
491427|NCT00048542|1585487|P6|Double-Blind Phase|Withdrawal by Subject|0
491428|NCT00048542|1585488|P5|Double-Blind Phase|Withdrawal by Subject|0
491429|NCT00048542|1585489|P4|Double-Blind Phase|Withdrawal by Subject|0
491430|NCT00048542|1585490|P3|Double-Blind Phase|Withdrawal by Subject|0
491431|NCT00048542|1585491|P2|Double-Blind Phase|Withdrawal by Subject|1
491432|NCT00048542|1585492|P1|Double-Blind Phase|Withdrawal by Subject|0
491433|NCT00048347|1585558|P1|Overall Study|Screen failure|2
491434|NCT00048165|1585564|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
491435|NCT00048165|1585565|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
491436|NCT00048165|1585564|P2|Completed 12 Months Study|Death|1
491437|NCT00048165|1585565|P1|Completed 12 Months Study|Death|2
491438|NCT00048165|1585564|P2|Completed 12 Months Study|Administration/Other|2
491439|NCT00048165|1585565|P1|Completed 12 Months Study|Administration/Other|0
491440|NCT00048165|1585564|P2|Completed 6 Months Study|Did not receive study drug|6
491441|NCT00048165|1585565|P1|Completed 6 Months Study|Did not receive study drug|6
491442|NCT00048165|1585564|P2|Completed 6 Months Study|Violation criteria|2
491443|NCT00048165|1585565|P1|Completed 6 Months Study|Violation criteria|0
491444|NCT00048165|1585564|P2|Completed 6 Months Study|Refused treatment|5
491445|NCT00048165|1585565|P1|Completed 6 Months Study|Refused treatment|5
491446|NCT00048165|1585564|P2|Completed 6 Months Study|Other violation|6
491447|NCT00048165|1585565|P1|Completed 6 Months Study|Other violation|4
491448|NCT00048165|1585564|P2|Completed 6 Months Study|Insufficient therapy|4
491449|NCT00048165|1585565|P1|Completed 6 Months Study|Insufficient therapy|1
491450|NCT00048165|1585564|P2|Completed 6 Months Study|Death|6
491451|NCT00048165|1585565|P1|Completed 6 Months Study|Death|12
491452|NCT00048165|1585564|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
491453|NCT00048165|1585565|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
491454|NCT00048165|1585564|P2|Completed 6 Months Study|Abnormality of laboratory test|0
491455|NCT00048165|1585565|P1|Completed 6 Months Study|Abnormality of laboratory test|1
491456|NCT00048165|1585564|P2|Completed 6 Months Study|Administration/Other|8
491457|NCT00048165|1585565|P1|Completed 6 Months Study|Administration/Other|8
491458|NCT00048074|1585600|P3|Overall Study|Social reasons|0
491459|NCT00048074|1585601|P2|Overall Study|Social reasons|0
491460|NCT00048074|1585602|P1|Overall Study|Social reasons|1
491461|NCT00048074|1585600|P3|Overall Study|Out of station|1
491462|NCT00048074|1585601|P2|Overall Study|Out of station|1
491463|NCT00048074|1585602|P1|Overall Study|Out of station|0
491464|NCT00048074|1585600|P3|Overall Study|Poor compliance|0
491465|NCT00048074|1585601|P2|Overall Study|Poor compliance|1
491466|NCT00048074|1585602|P1|Overall Study|Poor compliance|0
491467|NCT00048074|1585600|P3|Overall Study|Husband ill|0
491468|NCT00048074|1585601|P2|Overall Study|Husband ill|1
491469|NCT00048074|1585602|P1|Overall Study|Husband ill|0
491470|NCT00048074|1585600|P3|Overall Study|Study participation was terminated|0
491471|NCT00048074|1585601|P2|Overall Study|Study participation was terminated|1
491472|NCT00048074|1585602|P1|Overall Study|Study participation was terminated|0
491473|NCT00048074|1585600|P3|Overall Study|Protocol Violation|0
491474|NCT00048074|1585601|P2|Overall Study|Protocol Violation|3
491475|NCT00048074|1585602|P1|Overall Study|Protocol Violation|1
491476|NCT00048074|1585600|P3|Overall Study|Withdrawal by Subject|35
491477|NCT00048074|1585601|P2|Overall Study|Withdrawal by Subject|30
491478|NCT00048074|1585602|P1|Overall Study|Withdrawal by Subject|28
491479|NCT00048074|1585600|P3|Overall Study|Lost to Follow-up|6
491480|NCT00048074|1585601|P2|Overall Study|Lost to Follow-up|6
491481|NCT00048074|1585602|P1|Overall Study|Lost to Follow-up|2
491482|NCT00048074|1585600|P3|Overall Study|Death|2
491483|NCT00048074|1585601|P2|Overall Study|Death|3
491484|NCT00048074|1585602|P1|Overall Study|Death|3
491485|NCT00048074|1585600|P3|Overall Study|Adverse Event|53
491486|NCT00048074|1585601|P2|Overall Study|Adverse Event|41
491487|NCT00048074|1585602|P1|Overall Study|Adverse Event|46
491488|NCT00048061|1585659|P4|Overall Study|Early improvement|0
491489|NCT00048061|1585660|P3|Overall Study|Early improvement|3
491490|NCT00048061|1585661|P2|Overall Study|Early improvement|5
491491|NCT00048061|1585662|P1|Overall Study|Early improvement|6
491492|NCT00048061|1585659|P4|Overall Study|Did not follow-up|5
491493|NCT00048061|1585660|P3|Overall Study|Did not follow-up|4
491494|NCT00048061|1585661|P2|Overall Study|Did not follow-up|5
491495|NCT00048061|1585662|P1|Overall Study|Did not follow-up|5
491496|NCT00048061|1585659|P4|Overall Study|Withdrawal by Subject|32
491497|NCT00048061|1585660|P3|Overall Study|Withdrawal by Subject|29
491498|NCT00048061|1585661|P2|Overall Study|Withdrawal by Subject|29
491499|NCT00048061|1585662|P1|Overall Study|Withdrawal by Subject|20
491500|NCT00048061|1585659|P4|Overall Study|Lost to Follow-up|5
491501|NCT00048061|1585660|P3|Overall Study|Lost to Follow-up|4
491502|NCT00048061|1585661|P2|Overall Study|Lost to Follow-up|2
491503|NCT00048061|1585662|P1|Overall Study|Lost to Follow-up|3
491504|NCT00048061|1585659|P4|Overall Study|Adverse Event|37
491505|NCT00048061|1585660|P3|Overall Study|Adverse Event|44
491506|NCT00048061|1585661|P2|Overall Study|Adverse Event|32
491507|NCT00048061|1585662|P1|Overall Study|Adverse Event|41
491508|NCT00048048|1585741|P12|Extension Year 2|Early withdrawals|2
491509|NCT00048048|1585742|P11|Extension Year 2|Early withdrawals|4
491510|NCT00048048|1585743|P10|Extension Year 2|Early withdrawals|0
491511|NCT00048048|1585744|P9|Extension Year 2|Early withdrawals|0
491512|NCT00048048|1585745|P8|Extension Year 2|Early withdrawals|0
491513|NCT00048048|1585746|P7|Extension Year 2|Early withdrawals|0
491514|NCT00048048|1585747|P6|Extension Year 2|Early withdrawals|0
491515|NCT00048048|1585748|P5|Extension Year 2|Early withdrawals|0
491516|NCT00048048|1585749|P4|Extension Year 2|Early withdrawals|0
491517|NCT00048048|1585750|P3|Extension Year 2|Early withdrawals|0
491518|NCT00048048|1585751|P2|Extension Year 2|Early withdrawals|0
491519|NCT00048048|1585752|P1|Extension Year 2|Early withdrawals|0
491520|NCT00048048|1585741|P12|Extension Year 1|Early withdrawals|4
491521|NCT00048048|1585742|P11|Extension Year 1|Early withdrawals|2
491522|NCT00048048|1585743|P10|Extension Year 1|Early withdrawals|2
491523|NCT00048048|1585744|P9|Extension Year 1|Early withdrawals|0
491524|NCT00048048|1585745|P8|Extension Year 1|Early withdrawals|0
491525|NCT00048048|1585746|P7|Extension Year 1|Early withdrawals|0
491526|NCT00048048|1585747|P6|Extension Year 1|Early withdrawals|0
491527|NCT00048048|1585748|P5|Extension Year 1|Early withdrawals|0
491528|NCT00048048|1585749|P4|Extension Year 1|Early withdrawals|0
491529|NCT00048048|1585750|P3|Extension Year 1|Early withdrawals|0
491530|NCT00048048|1585751|P2|Extension Year 1|Early withdrawals|0
491531|NCT00048048|1585752|P1|Extension Year 1|Early withdrawals|0
491532|NCT00048048|1585741|P12|Core Treatment|Adverse Event|0
491533|NCT00048048|1585742|P11|Core Treatment|Adverse Event|0
491534|NCT00048048|1585743|P10|Core Treatment|Adverse Event|0
491535|NCT00048048|1585744|P9|Core Treatment|Adverse Event|0
491536|NCT00048048|1585745|P8|Core Treatment|Adverse Event|1
491537|NCT00048048|1585746|P7|Core Treatment|Adverse Event|0
491538|NCT00048048|1585747|P6|Core Treatment|Adverse Event|0
491539|NCT00048048|1585748|P5|Core Treatment|Adverse Event|0
491540|NCT00048048|1585749|P4|Core Treatment|Adverse Event|0
491541|NCT00048048|1585750|P3|Core Treatment|Adverse Event|0
491542|NCT00048048|1585751|P2|Core Treatment|Adverse Event|0
491543|NCT00048048|1585752|P1|Core Treatment|Adverse Event|0
491544|NCT00048048|1585741|P12|Core Treatment|Withdrawal by Subject|0
491545|NCT00048048|1585742|P11|Core Treatment|Withdrawal by Subject|0
491546|NCT00048048|1585743|P10|Core Treatment|Withdrawal by Subject|0
491547|NCT00048048|1585744|P9|Core Treatment|Withdrawal by Subject|0
491548|NCT00048048|1585745|P8|Core Treatment|Withdrawal by Subject|0
491549|NCT00048048|1585746|P7|Core Treatment|Withdrawal by Subject|0
491550|NCT00048048|1585747|P6|Core Treatment|Withdrawal by Subject|0
491551|NCT00048048|1585748|P5|Core Treatment|Withdrawal by Subject|0
491552|NCT00048048|1585749|P4|Core Treatment|Withdrawal by Subject|0
491553|NCT00048048|1585750|P3|Core Treatment|Withdrawal by Subject|1
491554|NCT00048048|1585751|P2|Core Treatment|Withdrawal by Subject|0
491555|NCT00048048|1585752|P1|Core Treatment|Withdrawal by Subject|0
491556|NCT00048035|1585808|P8|Extension Year 2|Early Withdrawals|3
491557|NCT00048035|1585809|P7|Extension Year 2|Early Withdrawals|3
491558|NCT00048035|1585810|P6|Extension Year 2|Early Withdrawals|0
491559|NCT00048035|1585811|P5|Extension Year 2|Early Withdrawals|0
491560|NCT00048035|1585812|P4|Extension Year 2|Early Withdrawals|0
491561|NCT00048035|1585813|P3|Extension Year 2|Early Withdrawals|0
491562|NCT00048035|1585814|P2|Extension Year 2|Early Withdrawals|0
491563|NCT00048035|1585815|P1|Extension Year 2|Early Withdrawals|0
491564|NCT00048035|1585808|P8|Extension Year 1|Early Withdrawals|11
491565|NCT00048035|1585809|P7|Extension Year 1|Early Withdrawals|11
491566|NCT00048035|1585810|P6|Extension Year 1|Early Withdrawals|0
491567|NCT00048035|1585811|P5|Extension Year 1|Early Withdrawals|0
491568|NCT00048035|1585812|P4|Extension Year 1|Early Withdrawals|0
491569|NCT00048035|1585813|P3|Extension Year 1|Early Withdrawals|0
491570|NCT00048035|1585814|P2|Extension Year 1|Early Withdrawals|0
491571|NCT00048035|1585815|P1|Extension Year 1|Early Withdrawals|0
491572|NCT00048035|1585808|P8|Core Period|Early Withdrawals|0
491573|NCT00048035|1585809|P7|Core Period|Early Withdrawals|0
491574|NCT00048035|1585810|P6|Core Period|Early Withdrawals|1
491575|NCT00048035|1585811|P5|Core Period|Early Withdrawals|1
491576|NCT00048035|1585812|P4|Core Period|Early Withdrawals|1
491577|NCT00048035|1585813|P3|Core Period|Early Withdrawals|1
491578|NCT00048035|1585814|P2|Core Period|Early Withdrawals|2
491579|NCT00048035|1585815|P1|Core Period|Early Withdrawals|4
491580|NCT00047879|1585853|P2|Overall Study|Progressive disease|3
491581|NCT00047879|1585854|P1|Overall Study|Progressive disease|4
491582|NCT00047463|1585890|P2|Overall Study|Withdrawal by Subject|3
491583|NCT00047463|1585891|P1|Overall Study|Withdrawal by Subject|0
491584|NCT00045942|1586008|P9|PKC412A2104E2|Death|0
491585|NCT00045942|1586009|P8|PKC412A2104E2|Death|0
491586|NCT00045942|1586010|P7|PKC412A2104E2|Death|2
491587|NCT00045942|1586011|P6|PKC412A2104E2|Death|1
491588|NCT00045942|1586012|P5|PKC412A2104E2|Death|0
491589|NCT00045942|1586013|P4|PKC412A2104E2|Death|0
491590|NCT00045942|1586014|P3|PKC412A2104E2|Death|0
491591|NCT00045942|1586015|P2|PKC412A2104E2|Death|0
491592|NCT00045942|1586016|P1|PKC412A2104E2|Death|0
491593|NCT00045942|1586008|P9|PKC412A2104E2|Adverse Event|0
491594|NCT00045942|1586009|P8|PKC412A2104E2|Adverse Event|1
491595|NCT00045942|1586010|P7|PKC412A2104E2|Adverse Event|3
491596|NCT00045942|1586011|P6|PKC412A2104E2|Adverse Event|4
491597|NCT00045942|1586012|P5|PKC412A2104E2|Adverse Event|0
491598|NCT00045942|1586013|P4|PKC412A2104E2|Adverse Event|0
491599|NCT00045942|1586014|P3|PKC412A2104E2|Adverse Event|0
491600|NCT00045942|1586015|P2|PKC412A2104E2|Adverse Event|0
491601|NCT00045942|1586016|P1|PKC412A2104E2|Adverse Event|0
491602|NCT00045942|1586008|P9|PKC412A2104E2|Lack of Efficacy|6
491603|NCT00045942|1586009|P8|PKC412A2104E2|Lack of Efficacy|2
491604|NCT00045942|1586010|P7|PKC412A2104E2|Lack of Efficacy|2
491605|NCT00045942|1586011|P6|PKC412A2104E2|Lack of Efficacy|3
491606|NCT00045942|1586012|P5|PKC412A2104E2|Lack of Efficacy|0
491607|NCT00045942|1586013|P4|PKC412A2104E2|Lack of Efficacy|0
491608|NCT00045942|1586014|P3|PKC412A2104E2|Lack of Efficacy|0
491609|NCT00045942|1586015|P2|PKC412A2104E2|Lack of Efficacy|0
491610|NCT00045942|1586016|P1|PKC412A2104E2|Lack of Efficacy|0
491611|NCT00045942|1586008|P9|PKC412A2104E2|Withdrawal by Subject|0
491612|NCT00045942|1586009|P8|PKC412A2104E2|Withdrawal by Subject|1
491613|NCT00045942|1586010|P7|PKC412A2104E2|Withdrawal by Subject|0
491614|NCT00045942|1586011|P6|PKC412A2104E2|Withdrawal by Subject|1
491615|NCT00045942|1586012|P5|PKC412A2104E2|Withdrawal by Subject|0
491616|NCT00045942|1586013|P4|PKC412A2104E2|Withdrawal by Subject|0
491617|NCT00045942|1586014|P3|PKC412A2104E2|Withdrawal by Subject|0
491618|NCT00045942|1586015|P2|PKC412A2104E2|Withdrawal by Subject|0
491619|NCT00045942|1586016|P1|PKC412A2104E2|Withdrawal by Subject|0
491620|NCT00045942|1586008|P9|PKC412A2104E2|Lost to Follow-up|0
491621|NCT00045942|1586009|P8|PKC412A2104E2|Lost to Follow-up|3
491622|NCT00045942|1586010|P7|PKC412A2104E2|Lost to Follow-up|0
491623|NCT00045942|1586011|P6|PKC412A2104E2|Lost to Follow-up|0
491624|NCT00045942|1586012|P5|PKC412A2104E2|Lost to Follow-up|0
491625|NCT00045942|1586013|P4|PKC412A2104E2|Lost to Follow-up|0
491626|NCT00045942|1586014|P3|PKC412A2104E2|Lost to Follow-up|0
491627|NCT00045942|1586015|P2|PKC412A2104E2|Lost to Follow-up|0
491628|NCT00045942|1586016|P1|PKC412A2104E2|Lost to Follow-up|0
491629|NCT00045942|1586008|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
491630|NCT00045942|1586009|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
491631|NCT00045942|1586010|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
491632|NCT00045942|1586011|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
491633|NCT00045942|1586012|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
491634|NCT00045942|1586013|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
491635|NCT00045942|1586014|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
491636|NCT00045942|1586015|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
491637|NCT00045942|1586016|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
491638|NCT00045942|1586008|P9|PKC412A2104E1|Death|0
491639|NCT00045942|1586009|P8|PKC412A2104E1|Death|0
491640|NCT00045942|1586010|P7|PKC412A2104E1|Death|0
491641|NCT00045942|1586011|P6|PKC412A2104E1|Death|0
491642|NCT00045942|1586012|P5|PKC412A2104E1|Death|1
491643|NCT00045942|1586013|P4|PKC412A2104E1|Death|1
491644|NCT00045942|1586014|P3|PKC412A2104E1|Death|1
491645|NCT00045942|1586015|P2|PKC412A2104E1|Death|4
491646|NCT00045942|1586016|P1|PKC412A2104E1|Death|0
491647|NCT00045942|1586008|P9|PKC412A2104E1|Adverse Event|0
491648|NCT00045942|1586009|P8|PKC412A2104E1|Adverse Event|0
491649|NCT00045942|1586010|P7|PKC412A2104E1|Adverse Event|0
491650|NCT00045942|1586011|P6|PKC412A2104E1|Adverse Event|0
491651|NCT00045942|1586012|P5|PKC412A2104E1|Adverse Event|6
491652|NCT00045942|1586013|P4|PKC412A2104E1|Adverse Event|3
491653|NCT00045942|1586014|P3|PKC412A2104E1|Adverse Event|1
491654|NCT00045942|1586015|P2|PKC412A2104E1|Adverse Event|1
491655|NCT00045942|1586016|P1|PKC412A2104E1|Adverse Event|0
491656|NCT00045942|1586008|P9|PKC412A2104E1|Abnormal laboratory value|0
491657|NCT00045942|1586009|P8|PKC412A2104E1|Abnormal laboratory value|0
491658|NCT00045942|1586010|P7|PKC412A2104E1|Abnormal laboratory value|0
491659|NCT00045942|1586011|P6|PKC412A2104E1|Abnormal laboratory value|0
491660|NCT00045942|1586012|P5|PKC412A2104E1|Abnormal laboratory value|0
491661|NCT00045942|1586013|P4|PKC412A2104E1|Abnormal laboratory value|0
491662|NCT00045942|1586014|P3|PKC412A2104E1|Abnormal laboratory value|0
491663|NCT00045942|1586015|P2|PKC412A2104E1|Abnormal laboratory value|1
491664|NCT00045942|1586016|P1|PKC412A2104E1|Abnormal laboratory value|0
491665|NCT00045942|1586008|P9|PKC412A2104E1|Lack of Efficacy|0
491666|NCT00045942|1586009|P8|PKC412A2104E1|Lack of Efficacy|0
491667|NCT00045942|1586010|P7|PKC412A2104E1|Lack of Efficacy|0
491668|NCT00045942|1586011|P6|PKC412A2104E1|Lack of Efficacy|0
491669|NCT00045942|1586012|P5|PKC412A2104E1|Lack of Efficacy|17
491670|NCT00045942|1586013|P4|PKC412A2104E1|Lack of Efficacy|23
491671|NCT00045942|1586014|P3|PKC412A2104E1|Lack of Efficacy|11
491672|NCT00045942|1586015|P2|PKC412A2104E1|Lack of Efficacy|11
491673|NCT00045942|1586016|P1|PKC412A2104E1|Lack of Efficacy|0
491674|NCT00045942|1586008|P9|PKC412A2104E1|Condition no longer requires study drug|0
491675|NCT00045942|1586009|P8|PKC412A2104E1|Condition no longer requires study drug|0
491676|NCT00045942|1586010|P7|PKC412A2104E1|Condition no longer requires study drug|0
491677|NCT00045942|1586011|P6|PKC412A2104E1|Condition no longer requires study drug|0
491678|NCT00045942|1586012|P5|PKC412A2104E1|Condition no longer requires study drug|1
491679|NCT00045942|1586013|P4|PKC412A2104E1|Condition no longer requires study drug|0
491680|NCT00045942|1586014|P3|PKC412A2104E1|Condition no longer requires study drug|1
491681|NCT00045942|1586015|P2|PKC412A2104E1|Condition no longer requires study drug|1
491682|NCT00045942|1586016|P1|PKC412A2104E1|Condition no longer requires study drug|0
491683|NCT00045942|1586008|P9|PKC412A2104E1|Withdrawal by Subject|0
491684|NCT00045942|1586009|P8|PKC412A2104E1|Withdrawal by Subject|0
491685|NCT00045942|1586010|P7|PKC412A2104E1|Withdrawal by Subject|0
491686|NCT00045942|1586011|P6|PKC412A2104E1|Withdrawal by Subject|0
491687|NCT00045942|1586012|P5|PKC412A2104E1|Withdrawal by Subject|2
491688|NCT00045942|1586013|P4|PKC412A2104E1|Withdrawal by Subject|5
491689|NCT00045942|1586014|P3|PKC412A2104E1|Withdrawal by Subject|2
491690|NCT00045942|1586015|P2|PKC412A2104E1|Withdrawal by Subject|0
491691|NCT00045942|1586016|P1|PKC412A2104E1|Withdrawal by Subject|0
491692|NCT00045942|1586008|P9|PKC412A2104 (Core)|Death|0
491693|NCT00045942|1586009|P8|PKC412A2104 (Core)|Death|0
491694|NCT00045942|1586010|P7|PKC412A2104 (Core)|Death|0
491695|NCT00045942|1586011|P6|PKC412A2104 (Core)|Death|0
491696|NCT00045942|1586012|P5|PKC412A2104 (Core)|Death|0
491697|NCT00045942|1586013|P4|PKC412A2104 (Core)|Death|0
491698|NCT00045942|1586014|P3|PKC412A2104 (Core)|Death|0
491699|NCT00045942|1586015|P2|PKC412A2104 (Core)|Death|0
491700|NCT00045942|1586016|P1|PKC412A2104 (Core)|Death|1
491701|NCT00045942|1586008|P9|PKC412A2104 (Core)|Lack of Efficacy|0
491702|NCT00045942|1586009|P8|PKC412A2104 (Core)|Lack of Efficacy|0
491703|NCT00045942|1586010|P7|PKC412A2104 (Core)|Lack of Efficacy|0
491704|NCT00045942|1586011|P6|PKC412A2104 (Core)|Lack of Efficacy|0
491705|NCT00045942|1586012|P5|PKC412A2104 (Core)|Lack of Efficacy|0
491706|NCT00045942|1586013|P4|PKC412A2104 (Core)|Lack of Efficacy|0
491707|NCT00045942|1586014|P3|PKC412A2104 (Core)|Lack of Efficacy|0
491708|NCT00045942|1586015|P2|PKC412A2104 (Core)|Lack of Efficacy|0
491709|NCT00045942|1586016|P1|PKC412A2104 (Core)|Lack of Efficacy|13
491710|NCT00045942|1586008|P9|PKC412A2104 (Core)|Adverse Event|0
491711|NCT00045942|1586009|P8|PKC412A2104 (Core)|Adverse Event|0
491712|NCT00045942|1586010|P7|PKC412A2104 (Core)|Adverse Event|0
491713|NCT00045942|1586011|P6|PKC412A2104 (Core)|Adverse Event|0
491714|NCT00045942|1586012|P5|PKC412A2104 (Core)|Adverse Event|0
491715|NCT00045942|1586013|P4|PKC412A2104 (Core)|Adverse Event|0
491716|NCT00045942|1586014|P3|PKC412A2104 (Core)|Adverse Event|0
491717|NCT00045942|1586015|P2|PKC412A2104 (Core)|Adverse Event|0
491718|NCT00045942|1586016|P1|PKC412A2104 (Core)|Adverse Event|5
491719|NCT00045942|1586008|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
491720|NCT00045942|1586009|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
491721|NCT00045942|1586010|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
491722|NCT00045942|1586011|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
491723|NCT00045942|1586012|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
491724|NCT00045942|1586013|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
491725|NCT00045942|1586014|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
491726|NCT00045942|1586015|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
491727|NCT00045942|1586016|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
491728|NCT00044512|1586105|P1|Follow Up|Lost to Follow-up|2
491729|NCT00044213|1586120|P4|Overall Study|Lost to Follow-up|4
491730|NCT00044213|1586121|P3|Overall Study|Lost to Follow-up|5
491731|NCT00044213|1586122|P2|Overall Study|Lost to Follow-up|5
491732|NCT00044213|1586123|P1|Overall Study|Lost to Follow-up|8
491733|NCT00044213|1586120|P4|Overall Study|Death|49
491734|NCT00044213|1586121|P3|Overall Study|Death|42
491735|NCT00044213|1586122|P2|Overall Study|Death|42
491736|NCT00044213|1586123|P1|Overall Study|Death|42
491737|NCT00044213|1586120|P4|Overall Study|Withdrawal by Subject|83
491738|NCT00044213|1586121|P3|Overall Study|Withdrawal by Subject|91
491739|NCT00044213|1586122|P2|Overall Study|Withdrawal by Subject|65
491740|NCT00044213|1586123|P1|Overall Study|Withdrawal by Subject|50
491741|NCT00043979|1586188|P3|Period 1|recipient with progressive disease|3
491742|NCT00043979|1586189|P2|Period 1|recipient with progressive disease|4
491743|NCT00043979|1586190|P1|Period 1|recipient with progressive disease|7
491744|NCT00043550|1586211|P3|Overall Study|Withdrawal by Subject|20
491745|NCT00043550|1586212|P2|Overall Study|Withdrawal by Subject|12
491746|NCT00043550|1586213|P1|Overall Study|Withdrawal by Subject|22
491747|NCT00043186|1586230|P9|Overall Study|Other|0
491748|NCT00043186|1586231|P8|Overall Study|Other|0
491749|NCT00043186|1586232|P7|Overall Study|Other|0
491750|NCT00043186|1586233|P6|Overall Study|Other|0
491751|NCT00043186|1586234|P5|Overall Study|Other|0
491752|NCT00043186|1586235|P4|Overall Study|Other|1
491753|NCT00043186|1586236|P3|Overall Study|Other|1
491754|NCT00043186|1586237|P2|Overall Study|Other|0
491755|NCT00043186|1586238|P1|Overall Study|Other|0
491756|NCT00043186|1586230|P9|Overall Study|Noncompliance|0
491757|NCT00043186|1586231|P8|Overall Study|Noncompliance|0
491758|NCT00043186|1586232|P7|Overall Study|Noncompliance|0
491759|NCT00043186|1586233|P6|Overall Study|Noncompliance|0
491760|NCT00043186|1586234|P5|Overall Study|Noncompliance|0
491761|NCT00043186|1586235|P4|Overall Study|Noncompliance|1
491762|NCT00043186|1586236|P3|Overall Study|Noncompliance|1
491763|NCT00043186|1586237|P2|Overall Study|Noncompliance|0
491764|NCT00043186|1586238|P1|Overall Study|Noncompliance|0
491765|NCT00043186|1586230|P9|Overall Study|Lost to Follow-up|2
491766|NCT00043186|1586231|P8|Overall Study|Lost to Follow-up|1
491767|NCT00043186|1586232|P7|Overall Study|Lost to Follow-up|1
491768|NCT00043186|1586233|P6|Overall Study|Lost to Follow-up|1
491769|NCT00043186|1586234|P5|Overall Study|Lost to Follow-up|1
491770|NCT00043186|1586235|P4|Overall Study|Lost to Follow-up|1
491771|NCT00043186|1586236|P3|Overall Study|Lost to Follow-up|1
491772|NCT00043186|1586237|P2|Overall Study|Lost to Follow-up|5
491773|NCT00043186|1586238|P1|Overall Study|Lost to Follow-up|3
491774|NCT00043186|1586230|P9|Overall Study|Ineligibility determined|1
491775|NCT00043186|1586231|P8|Overall Study|Ineligibility determined|0
491776|NCT00043186|1586232|P7|Overall Study|Ineligibility determined|0
491777|NCT00043186|1586233|P6|Overall Study|Ineligibility determined|0
491778|NCT00043186|1586234|P5|Overall Study|Ineligibility determined|0
491779|NCT00043186|1586235|P4|Overall Study|Ineligibility determined|0
491780|NCT00043186|1586236|P3|Overall Study|Ineligibility determined|0
491781|NCT00043186|1586237|P2|Overall Study|Ineligibility determined|0
491782|NCT00043186|1586238|P1|Overall Study|Ineligibility determined|0
491783|NCT00043186|1586230|P9|Overall Study|Disease progression|0
491784|NCT00043186|1586231|P8|Overall Study|Disease progression|4
491785|NCT00043186|1586232|P7|Overall Study|Disease progression|0
491786|NCT00043186|1586233|P6|Overall Study|Disease progression|0
491787|NCT00043186|1586234|P5|Overall Study|Disease progression|0
491788|NCT00043186|1586235|P4|Overall Study|Disease progression|3
491789|NCT00043186|1586236|P3|Overall Study|Disease progression|0
491790|NCT00043186|1586237|P2|Overall Study|Disease progression|0
491791|NCT00043186|1586238|P1|Overall Study|Disease progression|1
491792|NCT00043186|1586230|P9|Overall Study|Death|0
491793|NCT00043186|1586231|P8|Overall Study|Death|0
491794|NCT00043186|1586232|P7|Overall Study|Death|2
491795|NCT00043186|1586233|P6|Overall Study|Death|0
491796|NCT00043186|1586234|P5|Overall Study|Death|0
491797|NCT00043186|1586235|P4|Overall Study|Death|0
491798|NCT00043186|1586236|P3|Overall Study|Death|1
491799|NCT00043186|1586237|P2|Overall Study|Death|0
491800|NCT00043186|1586238|P1|Overall Study|Death|0
491801|NCT00043186|1586230|P9|Overall Study|Withdrawal by Subject|10
491802|NCT00043186|1586231|P8|Overall Study|Withdrawal by Subject|9
491803|NCT00043186|1586232|P7|Overall Study|Withdrawal by Subject|12
491804|NCT00043186|1586233|P6|Overall Study|Withdrawal by Subject|6
491805|NCT00043186|1586234|P5|Overall Study|Withdrawal by Subject|14
491806|NCT00043186|1586235|P4|Overall Study|Withdrawal by Subject|13
491807|NCT00043186|1586236|P3|Overall Study|Withdrawal by Subject|11
491808|NCT00043186|1586237|P2|Overall Study|Withdrawal by Subject|8
491809|NCT00043186|1586238|P1|Overall Study|Withdrawal by Subject|11
491810|NCT00043186|1586230|P9|Overall Study|Adverse Event|3
491811|NCT00043186|1586231|P8|Overall Study|Adverse Event|1
491812|NCT00043186|1586232|P7|Overall Study|Adverse Event|2
491813|NCT00043186|1586233|P6|Overall Study|Adverse Event|1
491814|NCT00043186|1586234|P5|Overall Study|Adverse Event|2
491815|NCT00043186|1586235|P4|Overall Study|Adverse Event|3
491816|NCT00043186|1586236|P3|Overall Study|Adverse Event|2
491817|NCT00043186|1586237|P2|Overall Study|Adverse Event|2
491818|NCT00043186|1586238|P1|Overall Study|Adverse Event|2
491819|NCT00043186|1586230|P9|Overall Study|Physician Decision|1
491820|NCT00043186|1586231|P8|Overall Study|Physician Decision|1
491821|NCT00043186|1586232|P7|Overall Study|Physician Decision|0
491822|NCT00043186|1586233|P6|Overall Study|Physician Decision|0
491823|NCT00043186|1586234|P5|Overall Study|Physician Decision|1
491824|NCT00043186|1586235|P4|Overall Study|Physician Decision|0
491825|NCT00043186|1586236|P3|Overall Study|Physician Decision|3
491826|NCT00043186|1586237|P2|Overall Study|Physician Decision|0
491827|NCT00043186|1586238|P1|Overall Study|Physician Decision|0
491828|NCT00042432|1586566|P2|Overall Study|Other|0
491829|NCT00042432|1586567|P1|Overall Study|Other|2
491830|NCT00042432|1586566|P2|Overall Study|Initiation of maintenance dialysis|1
491831|NCT00042432|1586567|P1|Overall Study|Initiation of maintenance dialysis|1
491832|NCT00042432|1586566|P2|Overall Study|Ineligibility determined|0
491833|NCT00042432|1586567|P1|Overall Study|Ineligibility determined|1
491834|NCT00042432|1586566|P2|Overall Study|Death|2
491835|NCT00042432|1586567|P1|Overall Study|Death|0
491836|NCT00042432|1586566|P2|Overall Study|Withdrawal by Subject|3
491837|NCT00042432|1586567|P1|Overall Study|Withdrawal by Subject|1
491838|NCT00042432|1586566|P2|Overall Study|Adverse Event|1
491839|NCT00042432|1586567|P1|Overall Study|Adverse Event|4
491840|NCT00041756|1586620|P5|Overall Study|Data Monitoring Committee Recommendation|21
491841|NCT00041756|1586621|P4|Overall Study|Data Monitoring Committee Recommendation|0
491842|NCT00041756|1586622|P3|Overall Study|Data Monitoring Committee Recommendation|0
491843|NCT00041756|1586623|P2|Overall Study|Data Monitoring Committee Recommendation|0
491844|NCT00041756|1586624|P1|Overall Study|Data Monitoring Committee Recommendation|0
491845|NCT00041756|1586620|P5|Overall Study|Unable to meet protocol criteria|1
491846|NCT00041756|1586621|P4|Overall Study|Unable to meet protocol criteria|0
491847|NCT00041756|1586622|P3|Overall Study|Unable to meet protocol criteria|1
491848|NCT00041756|1586623|P2|Overall Study|Unable to meet protocol criteria|0
491849|NCT00041756|1586624|P1|Overall Study|Unable to meet protocol criteria|0
491850|NCT00041756|1586620|P5|Overall Study|Lost to Follow-up|0
491851|NCT00041756|1586621|P4|Overall Study|Lost to Follow-up|1
491852|NCT00041756|1586622|P3|Overall Study|Lost to Follow-up|0
491853|NCT00041756|1586623|P2|Overall Study|Lost to Follow-up|1
491854|NCT00041756|1586624|P1|Overall Study|Lost to Follow-up|0
491855|NCT00041756|1586620|P5|Overall Study|Withdrawal by Subject|3
491856|NCT00041756|1586621|P4|Overall Study|Withdrawal by Subject|2
491857|NCT00041756|1586622|P3|Overall Study|Withdrawal by Subject|4
491858|NCT00041756|1586623|P2|Overall Study|Withdrawal by Subject|3
491859|NCT00041756|1586624|P1|Overall Study|Withdrawal by Subject|3
491860|NCT00041756|1586620|P5|Overall Study|Protocol Violation|1
491861|NCT00041756|1586621|P4|Overall Study|Protocol Violation|2
491862|NCT00041756|1586622|P3|Overall Study|Protocol Violation|2
491863|NCT00041756|1586623|P2|Overall Study|Protocol Violation|1
491864|NCT00041756|1586624|P1|Overall Study|Protocol Violation|1
491865|NCT00041756|1586620|P5|Overall Study|Adverse Event|34
491866|NCT00041756|1586621|P4|Overall Study|Adverse Event|11
491867|NCT00041756|1586622|P3|Overall Study|Adverse Event|6
491868|NCT00041756|1586623|P2|Overall Study|Adverse Event|10
491869|NCT00041756|1586624|P1|Overall Study|Adverse Event|4
491870|NCT00041470|1586652|P1|Overall Study|Loss of Funding|38
491871|NCT00040664|1586657|P4|Overall Study|Non-viability of oral suspension|0
491872|NCT00040664|1586658|P3|Overall Study|Non-viability of oral suspension|1
491873|NCT00040664|1586659|P2|Overall Study|Non-viability of oral suspension|0
491874|NCT00040664|1586660|P1|Overall Study|Non-viability of oral suspension|1
491875|NCT00040664|1586657|P4|Overall Study|Change of formulation|0
491876|NCT00040664|1586658|P3|Overall Study|Change of formulation|0
491877|NCT00040664|1586659|P2|Overall Study|Change of formulation|2
491878|NCT00040664|1586660|P1|Overall Study|Change of formulation|2
491879|NCT00040664|1586657|P4|Overall Study|Pharmacokinetic target not achieved|1
491880|NCT00040664|1586658|P3|Overall Study|Pharmacokinetic target not achieved|0
491881|NCT00040664|1586659|P2|Overall Study|Pharmacokinetic target not achieved|1
491882|NCT00040664|1586660|P1|Overall Study|Pharmacokinetic target not achieved|2
491883|NCT00040664|1586657|P4|Overall Study|Poor taste|0
491884|NCT00040664|1586658|P3|Overall Study|Poor taste|2
491885|NCT00040664|1586659|P2|Overall Study|Poor taste|0
491886|NCT00040664|1586660|P1|Overall Study|Poor taste|2
491887|NCT00040664|1586657|P4|Overall Study|Medication adherence/compliance problems|5
491888|NCT00040664|1586658|P3|Overall Study|Medication adherence/compliance problems|1
491889|NCT00040664|1586659|P2|Overall Study|Medication adherence/compliance problems|2
491890|NCT00040664|1586660|P1|Overall Study|Medication adherence/compliance problems|8
491891|NCT00040664|1586657|P4|Overall Study|Pregnancy|3
491892|NCT00040664|1586658|P3|Overall Study|Pregnancy|0
491893|NCT00040664|1586659|P2|Overall Study|Pregnancy|0
491894|NCT00040664|1586660|P1|Overall Study|Pregnancy|3
491895|NCT00040664|1586657|P4|Overall Study|Withdrawal by Subject|4
491896|NCT00040664|1586658|P3|Overall Study|Withdrawal by Subject|3
491897|NCT00040664|1586659|P2|Overall Study|Withdrawal by Subject|0
491898|NCT00040664|1586660|P1|Overall Study|Withdrawal by Subject|7
491899|NCT00040664|1586657|P4|Overall Study|Protocol Violation|1
491900|NCT00040664|1586658|P3|Overall Study|Protocol Violation|0
491901|NCT00040664|1586659|P2|Overall Study|Protocol Violation|1
491902|NCT00040664|1586660|P1|Overall Study|Protocol Violation|2
491903|NCT00040664|1586657|P4|Overall Study|Lost to Follow-up|2
491904|NCT00040664|1586658|P3|Overall Study|Lost to Follow-up|0
491905|NCT00040664|1586659|P2|Overall Study|Lost to Follow-up|2
491906|NCT00040664|1586660|P1|Overall Study|Lost to Follow-up|4
491907|NCT00040664|1586657|P4|Overall Study|Insufficient CD4 response|0
491908|NCT00040664|1586658|P3|Overall Study|Insufficient CD4 response|1
491909|NCT00040664|1586659|P2|Overall Study|Insufficient CD4 response|0
491910|NCT00040664|1586660|P1|Overall Study|Insufficient CD4 response|1
491911|NCT00040664|1586657|P4|Overall Study|Lack of Efficacy|4
491912|NCT00040664|1586658|P3|Overall Study|Lack of Efficacy|3
491913|NCT00040664|1586659|P2|Overall Study|Lack of Efficacy|2
491914|NCT00040664|1586660|P1|Overall Study|Lack of Efficacy|9
491915|NCT00040664|1586657|P4|Overall Study|Adverse Event|7
491916|NCT00040664|1586658|P3|Overall Study|Adverse Event|2
491917|NCT00040664|1586659|P2|Overall Study|Adverse Event|3
491918|NCT00040664|1586660|P1|Overall Study|Adverse Event|12
491919|NCT00040365|1586717|P1|Overall Study|Lost to Follow-up|3
491920|NCT00040365|1586717|P1|Overall Study|Progressive disease|7
491921|NCT00040365|1586717|P1|Overall Study|Death|1
491922|NCT00039871|1586726|P1|Overall Study|Never entered follow-up|7
491923|NCT00039871|1586726|P1|Overall Study|Discontinued at Week 12 per protocol|1061
491924|NCT00039871|1586726|P1|Overall Study|Administrative|1
491925|NCT00039871|1586726|P1|Overall Study|Did not meet eligibility criteria|11
491926|NCT00039871|1586726|P1|Overall Study|Withdrawal by Subject|97
491927|NCT00039871|1586726|P1|Overall Study|Protocol Violation|24
491928|NCT00039871|1586726|P1|Overall Study|Lost to Follow-up|18
491929|NCT00039871|1586726|P1|Overall Study|Adverse Event|165
491930|NCT00039741|1586736|P4|Overall Study|Missed final visit|2
491931|NCT00039741|1586737|P3|Overall Study|Missed final visit|2
491932|NCT00039741|1586738|P2|Overall Study|Missed final visit|1
491933|NCT00039741|1586739|P1|Overall Study|Missed final visit|2
491934|NCT00039741|1586736|P4|Overall Study|Withdrew consent|1
491935|NCT00039741|1586737|P3|Overall Study|Withdrew consent|0
491936|NCT00039741|1586738|P2|Overall Study|Withdrew consent|5
491937|NCT00039741|1586739|P1|Overall Study|Withdrew consent|0
491938|NCT00039741|1586736|P4|Overall Study|Non-compliance with protocol|0
491939|NCT00039741|1586737|P3|Overall Study|Non-compliance with protocol|1
491940|NCT00039741|1586738|P2|Overall Study|Non-compliance with protocol|0
491941|NCT00039741|1586739|P1|Overall Study|Non-compliance with protocol|1
491942|NCT00039741|1586736|P4|Overall Study|Moved|6
491943|NCT00039741|1586737|P3|Overall Study|Moved|3
491944|NCT00039741|1586738|P2|Overall Study|Moved|2
491945|NCT00039741|1586739|P1|Overall Study|Moved|3
491946|NCT00039741|1586736|P4|Overall Study|Not able to get to clinic|3
491947|NCT00039741|1586737|P3|Overall Study|Not able to get to clinic|0
491948|NCT00039741|1586738|P2|Overall Study|Not able to get to clinic|2
491949|NCT00039741|1586739|P1|Overall Study|Not able to get to clinic|5
491950|NCT00039741|1586736|P4|Overall Study|Confounding medical condition|0
491951|NCT00039741|1586737|P3|Overall Study|Confounding medical condition|0
491952|NCT00039741|1586738|P2|Overall Study|Confounding medical condition|0
491953|NCT00039741|1586739|P1|Overall Study|Confounding medical condition|1
491954|NCT00039741|1586736|P4|Overall Study|Lost to Follow-up|2
491955|NCT00039741|1586737|P3|Overall Study|Lost to Follow-up|5
491956|NCT00039741|1586738|P2|Overall Study|Lost to Follow-up|1
491957|NCT00039741|1586739|P1|Overall Study|Lost to Follow-up|3
491958|NCT00039741|1586736|P4|Overall Study|Death|0
491959|NCT00039741|1586737|P3|Overall Study|Death|0
491960|NCT00039741|1586738|P2|Overall Study|Death|1
491961|NCT00039741|1586739|P1|Overall Study|Death|0
491962|NCT00038948|1586783|P2|Overall Study|Lack of Efficacy|6
491963|NCT00038948|1586784|P1|Overall Study|Lack of Efficacy|3
491964|NCT00038948|1586783|P2|Overall Study|Protocol Violation|7
491965|NCT00038948|1586784|P1|Overall Study|Protocol Violation|3
491966|NCT00038948|1586783|P2|Overall Study|Withdrawal by Subject|10
491967|NCT00038948|1586784|P1|Overall Study|Withdrawal by Subject|23
491968|NCT00038948|1586783|P2|Overall Study|Nonmedical event|7
491969|NCT00038948|1586784|P1|Overall Study|Nonmedical event|5
491970|NCT00038948|1586783|P2|Overall Study|Lost to Follow-up|4
491971|NCT00038948|1586784|P1|Overall Study|Lost to Follow-up|4
491972|NCT00038948|1586783|P2|Overall Study|Adverse Event|43
491973|NCT00038948|1586784|P1|Overall Study|Adverse Event|131
491974|NCT00038467|1586824|P2|Overall Study|Other|28
491975|NCT00038467|1586825|P1|Overall Study|Other|26
491976|NCT00038467|1586824|P2|Overall Study|Randomized, but not treated|35
491977|NCT00038467|1586825|P1|Overall Study|Randomized, but not treated|31
491978|NCT00038467|1586824|P2|Overall Study|Recurrence|179
491979|NCT00038467|1586825|P1|Overall Study|Recurrence|109
491980|NCT00038467|1586824|P2|Overall Study|Lost to Follow-up|10
491981|NCT00038467|1586825|P1|Overall Study|Lost to Follow-up|15
491982|NCT00038467|1586824|P2|Overall Study|Death|16
491983|NCT00038467|1586825|P1|Overall Study|Death|22
491984|NCT00038467|1586824|P2|Overall Study|Protocol Violation|22
491985|NCT00038467|1586825|P1|Overall Study|Protocol Violation|19
491986|NCT00038467|1586824|P2|Overall Study|Withdrawal by Subject|107
491987|NCT00038467|1586825|P1|Overall Study|Withdrawal by Subject|150
491988|NCT00038467|1586824|P2|Overall Study|Adverse Event|145
491989|NCT00038467|1586825|P1|Overall Study|Adverse Event|170
491990|NCT00038103|1586887|P2|Overall Study|Randomized/never treated|0
491991|NCT00038103|1586888|P1|Overall Study|Randomized/never treated|2
491992|NCT00038103|1586887|P2|Overall Study|Sponsor Decision|1
491993|NCT00038103|1586888|P1|Overall Study|Sponsor Decision|0
491994|NCT00038103|1586887|P2|Overall Study|Protocol Violation|2
491995|NCT00038103|1586888|P1|Overall Study|Protocol Violation|0
491996|NCT00038103|1586887|P2|Overall Study|Lost to Follow-up|3
491997|NCT00038103|1586888|P1|Overall Study|Lost to Follow-up|0
491998|NCT00038103|1586887|P2|Overall Study|Withdrawal by Subject|3
491999|NCT00038103|1586888|P1|Overall Study|Withdrawal by Subject|0
492000|NCT00038103|1586887|P2|Overall Study|Lack of Efficacy|41
492001|NCT00038103|1586888|P1|Overall Study|Lack of Efficacy|48
492002|NCT00038103|1586887|P2|Overall Study|Adverse Event|6
492003|NCT00038103|1586888|P1|Overall Study|Adverse Event|5
492004|NCT00037830|1586911|P3|Overall Study|Unrelated Medical Problem|0
492005|NCT00037830|1586912|P2|Overall Study|Unrelated Medical Problem|0
492006|NCT00037830|1586913|P1|Overall Study|Unrelated Medical Problem|2
492007|NCT00037830|1586911|P3|Overall Study|Protocol Violation|0
492008|NCT00037830|1586912|P2|Overall Study|Protocol Violation|2
492009|NCT00037830|1586913|P1|Overall Study|Protocol Violation|2
492010|NCT00037830|1586911|P3|Overall Study|Withdrawal by Subject|1
492011|NCT00037830|1586912|P2|Overall Study|Withdrawal by Subject|5
492012|NCT00037830|1586913|P1|Overall Study|Withdrawal by Subject|4
492013|NCT00037830|1586911|P3|Overall Study|Adverse Event|0
492014|NCT00037830|1586912|P2|Overall Study|Adverse Event|0
492015|NCT00037830|1586913|P1|Overall Study|Adverse Event|2
492016|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
492017|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
492018|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Too early switch|103
492104|NCT00032487|1587194|P1|Overall Study|Withdrawal by Subject|67
492019|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Too early switch|0
492020|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
492021|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
492022|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Protocol Violation|91
492023|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Protocol Violation|23
492024|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
492025|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
492026|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Treatment refusal|208
492027|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Treatment refusal|113
492028|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Other|288
492029|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Other|277
492030|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Adverse Event|782
492031|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Adverse Event|501
492032|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
492033|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
492034|NCT00036270|1586945|P2|Study Treatment to 5 Year Report|Ongoing|736
492035|NCT00036270|1586946|P1|Study Treatment to 5 Year Report|Ongoing|1081
492036|NCT00036270|1586945|P2|Randomized to Study Treatment|Withdrawal by Subject|7
492037|NCT00036270|1586946|P1|Randomized to Study Treatment|Withdrawal by Subject|6
492038|NCT00035932|1586965|P3|Overall Study|Lack of Efficacy|28
492039|NCT00035932|1586966|P2|Overall Study|Lack of Efficacy|33
492040|NCT00035932|1586967|P1|Overall Study|Lack of Efficacy|33
492041|NCT00035932|1586965|P3|Overall Study|Study Termination by Sponsor|0
492042|NCT00035932|1586966|P2|Overall Study|Study Termination by Sponsor|0
492043|NCT00035932|1586967|P1|Overall Study|Study Termination by Sponsor|1
492044|NCT00035932|1586965|P3|Overall Study|Withdrawal by Subject|0
492045|NCT00035932|1586966|P2|Overall Study|Withdrawal by Subject|5
492046|NCT00035932|1586967|P1|Overall Study|Withdrawal by Subject|1
492047|NCT00035932|1586965|P3|Overall Study|Protocol Violation While on Study|2
492048|NCT00035932|1586966|P2|Overall Study|Protocol Violation While on Study|1
492049|NCT00035932|1586967|P1|Overall Study|Protocol Violation While on Study|0
492050|NCT00035932|1586965|P3|Overall Study|Noncompliance|6
492051|NCT00035932|1586966|P2|Overall Study|Noncompliance|7
492052|NCT00035932|1586967|P1|Overall Study|Noncompliance|6
492053|NCT00035932|1586965|P3|Overall Study|Lost to Follow-up|3
492054|NCT00035932|1586966|P2|Overall Study|Lost to Follow-up|4
492055|NCT00035932|1586967|P1|Overall Study|Lost to Follow-up|4
492056|NCT00035932|1586965|P3|Overall Study|Disease Progression / Relapse|0
492057|NCT00035932|1586966|P2|Overall Study|Disease Progression / Relapse|1
492058|NCT00035932|1586967|P1|Overall Study|Disease Progression / Relapse|1
492059|NCT00035932|1586965|P3|Overall Study|Death|1
492060|NCT00035932|1586966|P2|Overall Study|Death|0
492061|NCT00035932|1586967|P1|Overall Study|Death|0
492062|NCT00035932|1586965|P3|Overall Study|Adverse Event|9
492063|NCT00035932|1586966|P2|Overall Study|Adverse Event|9
492064|NCT00035932|1586967|P1|Overall Study|Adverse Event|10
492065|NCT00035815|1587093|P2|Overall Study|Withdrawal by Subject|11
492066|NCT00035815|1587094|P1|Overall Study|Withdrawal by Subject|17
492067|NCT00035555|1587107|P3|Overall Study|Received cyclosporin in error|1
492068|NCT00035555|1587108|P2|Overall Study|Received cyclosporin in error|0
492069|NCT00035555|1587109|P1|Overall Study|Received cyclosporin in error|0
492070|NCT00035555|1587107|P3|Overall Study|Investigator deemed not a good candidate|1
492071|NCT00035555|1587108|P2|Overall Study|Investigator deemed not a good candidate|0
492072|NCT00035555|1587109|P1|Overall Study|Investigator deemed not a good candidate|0
492073|NCT00035555|1587107|P3|Overall Study|Withdrawal by Subject|2
492074|NCT00035555|1587108|P2|Overall Study|Withdrawal by Subject|0
492075|NCT00035555|1587109|P1|Overall Study|Withdrawal by Subject|2
492076|NCT00035555|1587107|P3|Overall Study|Treatment failure/lack of efficacy|3
492077|NCT00035555|1587108|P2|Overall Study|Treatment failure/lack of efficacy|5
492078|NCT00035555|1587109|P1|Overall Study|Treatment failure/lack of efficacy|7
492079|NCT00035555|1587107|P3|Overall Study|Prohibited medication|0
492080|NCT00035555|1587108|P2|Overall Study|Prohibited medication|1
492081|NCT00035555|1587109|P1|Overall Study|Prohibited medication|1
492082|NCT00035555|1587107|P3|Overall Study|Noncompliance|1
492083|NCT00035555|1587108|P2|Overall Study|Noncompliance|1
492084|NCT00035555|1587109|P1|Overall Study|Noncompliance|0
492085|NCT00035555|1587107|P3|Overall Study|Lost to Follow-up|1
492086|NCT00035555|1587108|P2|Overall Study|Lost to Follow-up|0
492087|NCT00035555|1587109|P1|Overall Study|Lost to Follow-up|0
492088|NCT00035555|1587107|P3|Overall Study|Death|2
492089|NCT00035555|1587108|P2|Overall Study|Death|0
492090|NCT00035555|1587109|P1|Overall Study|Death|0
492091|NCT00035555|1587107|P3|Overall Study|Allograft loss|2
492092|NCT00035555|1587108|P2|Overall Study|Allograft loss|1
492093|NCT00035555|1587109|P1|Overall Study|Allograft loss|1
492094|NCT00035555|1587107|P3|Overall Study|Adverse Event|9
492095|NCT00035555|1587108|P2|Overall Study|Adverse Event|8
492096|NCT00035555|1587109|P1|Overall Study|Adverse Event|5
492097|NCT00032487|1587193|P2|Overall Study|Had other reason|12
492098|NCT00032487|1587194|P1|Overall Study|Had other reason|12
492099|NCT00032487|1587193|P2|Overall Study|Lost to Follow-up|58
492100|NCT00032487|1587194|P1|Overall Study|Lost to Follow-up|57
492101|NCT00032487|1587193|P2|Overall Study|Adverse Event|7
492102|NCT00032487|1587194|P1|Overall Study|Adverse Event|3
492103|NCT00032487|1587193|P2|Overall Study|Withdrawal by Subject|43
492105|NCT00031551|1587204|P2|Overall Study|Withdrew due to chemotherapy effects|0
492106|NCT00031551|1587205|P1|Overall Study|Withdrew due to chemotherapy effects|2
492107|NCT00031486|1587217|P2|Overall Study|Other|1
492108|NCT00031486|1587218|P1|Overall Study|Other|1
492109|NCT00031486|1587217|P2|Overall Study|Did not meet eligibility requirement|1
492110|NCT00031486|1587218|P1|Overall Study|Did not meet eligibility requirement|2
492111|NCT00031486|1587217|P2|Overall Study|Non-compliant|4
492112|NCT00031486|1587218|P1|Overall Study|Non-compliant|0
492113|NCT00031486|1587217|P2|Overall Study|Death|3
492114|NCT00031486|1587218|P1|Overall Study|Death|0
492115|NCT00031486|1587217|P2|Overall Study|Withdrawal by Subject|2
492116|NCT00031486|1587218|P1|Overall Study|Withdrawal by Subject|3
492117|NCT00031486|1587217|P2|Overall Study|Lost to Follow-up|1
492118|NCT00031486|1587218|P1|Overall Study|Lost to Follow-up|0
492119|NCT00031486|1587217|P2|Overall Study|Adverse Event|0
492120|NCT00031486|1587218|P1|Overall Study|Adverse Event|1
492121|NCT00031460|1587244|P2|Overall Study|Confirmed unevaluable|1
492122|NCT00031460|1587245|P1|Overall Study|Confirmed unevaluable|0
492123|NCT00031460|1587244|P2|Overall Study|Disruption of blinded drug supply|0
492124|NCT00031460|1587245|P1|Overall Study|Disruption of blinded drug supply|2
492125|NCT00031460|1587244|P2|Overall Study|Reactivation of Disease|9
492126|NCT00031460|1587245|P1|Overall Study|Reactivation of Disease|5
492127|NCT00031460|1587244|P2|Overall Study|Death|1
492128|NCT00031460|1587245|P1|Overall Study|Death|0
492129|NCT00031460|1587244|P2|Overall Study|Non-Compliant|1
492130|NCT00031460|1587245|P1|Overall Study|Non-Compliant|1
492131|NCT00031460|1587244|P2|Overall Study|Withdrawal by Subject|1
492132|NCT00031460|1587245|P1|Overall Study|Withdrawal by Subject|1
492133|NCT00031460|1587244|P2|Overall Study|Lost to Follow-up|1
492134|NCT00031460|1587245|P1|Overall Study|Lost to Follow-up|0
492135|NCT00031447|1587259|P2|Overall Study|Disruption of blinded study drug supply|4
492136|NCT00031447|1587260|P1|Overall Study|Disruption of blinded study drug supply|7
492137|NCT00031447|1587259|P2|Overall Study|Re-activation of Disease|1
492138|NCT00031447|1587260|P1|Overall Study|Re-activation of Disease|2
492139|NCT00031447|1587259|P2|Overall Study|Non-compliant|1
492140|NCT00031447|1587260|P1|Overall Study|Non-compliant|1
492141|NCT00031447|1587259|P2|Overall Study|Lost to Follow-up|1
492142|NCT00031447|1587260|P1|Overall Study|Lost to Follow-up|0
492143|NCT00029146|1587335|P2|Overall Study|Lost to Follow-up|1
492144|NCT00029146|1587336|P1|Overall Study|Lost to Follow-up|2
492145|NCT00027378|1587387|P2|Overall Study|Physician Decision|3
492146|NCT00027378|1587388|P1|Overall Study|Physician Decision|0
492147|NCT00027027|1587401|P5|Overall Study|Withdrawal by Subject|1
492148|NCT00027027|1587402|P4|Overall Study|Withdrawal by Subject|0
492149|NCT00027027|1587403|P3|Overall Study|Withdrawal by Subject|0
492150|NCT00027027|1587404|P2|Overall Study|Withdrawal by Subject|0
492151|NCT00027027|1587405|P1|Overall Study|Withdrawal by Subject|0
492152|NCT00027027|1587401|P5|Overall Study|Physician Decision Due To PD|5
492153|NCT00027027|1587402|P4|Overall Study|Physician Decision Due To PD|3
492154|NCT00027027|1587403|P3|Overall Study|Physician Decision Due To PD|2
492155|NCT00027027|1587404|P2|Overall Study|Physician Decision Due To PD|3
492156|NCT00027027|1587405|P1|Overall Study|Physician Decision Due To PD|2
492157|NCT00027027|1587401|P5|Overall Study|PD Requiring Surgery|0
492158|NCT00027027|1587402|P4|Overall Study|PD Requiring Surgery|0
492159|NCT00027027|1587403|P3|Overall Study|PD Requiring Surgery|1
492160|NCT00027027|1587404|P2|Overall Study|PD Requiring Surgery|0
492161|NCT00027027|1587405|P1|Overall Study|PD Requiring Surgery|0
492162|NCT00027027|1587401|P5|Overall Study|Clinical Symptoms Progression not PD|0
492163|NCT00027027|1587402|P4|Overall Study|Clinical Symptoms Progression not PD|0
492164|NCT00027027|1587403|P3|Overall Study|Clinical Symptoms Progression not PD|0
492165|NCT00027027|1587404|P2|Overall Study|Clinical Symptoms Progression not PD|0
492166|NCT00027027|1587405|P1|Overall Study|Clinical Symptoms Progression not PD|1
492167|NCT00027027|1587401|P5|Overall Study|Admitted for Signs of PD|1
492168|NCT00027027|1587402|P4|Overall Study|Admitted for Signs of PD|0
492169|NCT00027027|1587403|P3|Overall Study|Admitted for Signs of PD|0
492170|NCT00027027|1587404|P2|Overall Study|Admitted for Signs of PD|0
492171|NCT00027027|1587405|P1|Overall Study|Admitted for Signs of PD|0
492172|NCT00027027|1587401|P5|Overall Study|Adverse Event|1
492173|NCT00027027|1587402|P4|Overall Study|Adverse Event|0
492174|NCT00027027|1587403|P3|Overall Study|Adverse Event|1
492175|NCT00027027|1587404|P2|Overall Study|Adverse Event|0
492176|NCT00027027|1587405|P1|Overall Study|Adverse Event|0
492177|NCT00025883|1587452|P1|Overall Study|didn't reach 6 months of Metreleptin|10
492178|NCT00025883|1587452|P1|Overall Study|Adverse Event|1
492179|NCT00025883|1587452|P1|Overall Study|Death|1
492180|NCT00025883|1587452|P1|Overall Study|no baseline data|1
492181|NCT00025883|1587452|P1|Overall Study|had atypical progeriod lipodystrophy|4
492182|NCT00023595|1587464|P5|10 Year Follow up|Lost to Follow-up|0
492183|NCT00023595|1587465|P4|10 Year Follow up|Lost to Follow-up|0
492184|NCT00023595|1587466|P3|10 Year Follow up|Lost to Follow-up|3
492185|NCT00023595|1587467|P2|10 Year Follow up|Lost to Follow-up|10
492186|NCT00023595|1587468|P1|10 Year Follow up|Lost to Follow-up|12
492187|NCT00023595|1587464|P5|5 Year Follow up|Lost to Follow-up|3
492188|NCT00023595|1587465|P4|5 Year Follow up|Lost to Follow-up|7
492189|NCT00023595|1587466|P3|5 Year Follow up|Lost to Follow-up|1
492190|NCT00023595|1587467|P2|5 Year Follow up|Lost to Follow-up|2
492191|NCT00023595|1587468|P1|5 Year Follow up|Lost to Follow-up|2
492192|NCT00023452|1587679|P2|Overall Study|Other|69
492193|NCT00023452|1587680|P1|Overall Study|Other|204
492194|NCT00023452|1587679|P2|Overall Study|Pregnant|20
492195|NCT00023452|1587680|P1|Overall Study|Pregnant|53
492196|NCT00023452|1587679|P2|Overall Study|Refused Treatment (continued follow-up)|224
492197|NCT00023452|1587680|P1|Overall Study|Refused Treatment (continued follow-up)|225
492198|NCT00023452|1587679|P2|Overall Study|Physician Decision|21
492199|NCT00023452|1587680|P1|Overall Study|Physician Decision|49
492200|NCT00023452|1587679|P2|Overall Study|Lost to Follow-up|60
492201|NCT00023452|1587680|P1|Overall Study|Lost to Follow-up|293
492202|NCT00023452|1587679|P2|Overall Study|Adverse Event|196
492203|NCT00023452|1587680|P1|Overall Study|Adverse Event|139
492204|NCT00023452|1587679|P2|Overall Study|Withdrawal by Subject|54
492205|NCT00023452|1587680|P1|Overall Study|Withdrawal by Subject|66
492206|NCT00023452|1587679|P2|Overall Study|Death|0
492207|NCT00023452|1587680|P1|Overall Study|Death|2
492208|NCT00023452|1587679|P2|Overall Study|Out of Window|69
492209|NCT00023452|1587680|P1|Overall Study|Out of Window|129
492210|NCT00023452|1587679|P2|Overall Study|Ineligible for Study|159
492211|NCT00023452|1587680|P1|Overall Study|Ineligible for Study|163
492212|NCT00023322|1587704|P1|Overall Study|Lost to Follow-up|1
492213|NCT00022763|1587728|P2|Overall Study|Admin|2
492214|NCT00022763|1587729|P1|Overall Study|Admin|3
492215|NCT00022763|1587728|P2|Overall Study|Insufficient Therapy|0
492216|NCT00022763|1587729|P1|Overall Study|Insufficient Therapy|1
492217|NCT00022763|1587728|P2|Overall Study|Withdrawal by Subject|7
492218|NCT00022763|1587729|P1|Overall Study|Withdrawal by Subject|4
492219|NCT00022763|1587728|P2|Overall Study|Lost to Follow-up|3
492220|NCT00022763|1587729|P1|Overall Study|Lost to Follow-up|0
492221|NCT00022763|1587728|P2|Overall Study|Death|1
492222|NCT00022763|1587729|P1|Overall Study|Death|0
492223|NCT00022763|1587728|P2|Overall Study|Injection Site Reactions|2
492224|NCT00022763|1587729|P1|Overall Study|Injection Site Reactions|0
492225|NCT00022763|1587728|P2|Overall Study|Adverse Event|2
492226|NCT00022763|1587729|P1|Overall Study|Adverse Event|1
492227|NCT00014911|1587771|P1|Overall Study|Immunosuppression-related Side Effects|1
492228|NCT00014911|1587771|P1|Overall Study|Unknown Reasons|2
492229|NCT00014911|1587771|P1|Overall Study|Withdrawal by Subject|6
492230|NCT00014911|1587771|P1|Overall Study|Lost to Follow-up|1
492231|NCT00014911|1587771|P1|Overall Study|Adverse Event|1
492232|NCT00006604|1587787|P17|Overall Study|Other Reason|0
492233|NCT00006604|1587788|P16|Overall Study|Other Reason|0
492234|NCT00006604|1587789|P15|Overall Study|Other Reason|0
492235|NCT00006604|1587790|P14|Overall Study|Other Reason|0
492236|NCT00006604|1587791|P13|Overall Study|Other Reason|0
492237|NCT00006604|1587792|P12|Overall Study|Other Reason|0
492238|NCT00006604|1587793|P11|Overall Study|Other Reason|0
492239|NCT00006604|1587794|P10|Overall Study|Other Reason|1
492240|NCT00006604|1587795|P9|Overall Study|Other Reason|0
492241|NCT00006604|1587796|P8|Overall Study|Other Reason|0
492242|NCT00006604|1587797|P7|Overall Study|Other Reason|0
492243|NCT00006604|1587798|P6|Overall Study|Other Reason|1
492244|NCT00006604|1587799|P5|Overall Study|Other Reason|0
492245|NCT00006604|1587800|P4|Overall Study|Other Reason|0
492246|NCT00006604|1587801|P3|Overall Study|Other Reason|0
492247|NCT00006604|1587802|P2|Overall Study|Other Reason|0
492248|NCT00006604|1587803|P1|Overall Study|Other Reason|0
492249|NCT00006604|1587787|P17|Overall Study|Lost to Follow-up|3
492250|NCT00006604|1587788|P16|Overall Study|Lost to Follow-up|1
492251|NCT00006604|1587789|P15|Overall Study|Lost to Follow-up|0
492252|NCT00006604|1587790|P14|Overall Study|Lost to Follow-up|0
492253|NCT00006604|1587791|P13|Overall Study|Lost to Follow-up|0
492254|NCT00006604|1587792|P12|Overall Study|Lost to Follow-up|0
492255|NCT00006604|1587793|P11|Overall Study|Lost to Follow-up|0
492256|NCT00006604|1587794|P10|Overall Study|Lost to Follow-up|2
492257|NCT00006604|1587795|P9|Overall Study|Lost to Follow-up|0
492258|NCT00006604|1587796|P8|Overall Study|Lost to Follow-up|1
492259|NCT00006604|1587797|P7|Overall Study|Lost to Follow-up|0
492260|NCT00006604|1587798|P6|Overall Study|Lost to Follow-up|0
492261|NCT00006604|1587799|P5|Overall Study|Lost to Follow-up|0
492262|NCT00006604|1587800|P4|Overall Study|Lost to Follow-up|0
492263|NCT00006604|1587801|P3|Overall Study|Lost to Follow-up|0
492264|NCT00006604|1587802|P2|Overall Study|Lost to Follow-up|0
492265|NCT00006604|1587803|P1|Overall Study|Lost to Follow-up|0
492266|NCT00006604|1587787|P17|Overall Study|Subj/parent not willing to adhere to req|4
492267|NCT00006604|1587788|P16|Overall Study|Subj/parent not willing to adhere to req|3
492268|NCT00006604|1587789|P15|Overall Study|Subj/parent not willing to adhere to req|3
492269|NCT00006604|1587790|P14|Overall Study|Subj/parent not willing to adhere to req|2
492270|NCT00006604|1587791|P13|Overall Study|Subj/parent not willing to adhere to req|0
492271|NCT00006604|1587792|P12|Overall Study|Subj/parent not willing to adhere to req|0
492272|NCT00006604|1587793|P11|Overall Study|Subj/parent not willing to adhere to req|3
492273|NCT00006604|1587794|P10|Overall Study|Subj/parent not willing to adhere to req|6
492274|NCT00006604|1587795|P9|Overall Study|Subj/parent not willing to adhere to req|0
492275|NCT00006604|1587796|P8|Overall Study|Subj/parent not willing to adhere to req|1
492276|NCT00006604|1587797|P7|Overall Study|Subj/parent not willing to adhere to req|3
492277|NCT00006604|1587798|P6|Overall Study|Subj/parent not willing to adhere to req|0
492278|NCT00006604|1587799|P5|Overall Study|Subj/parent not willing to adhere to req|0
492362|NCT00006604|1587798|P6|Overall Study|Death|0
492279|NCT00006604|1587800|P4|Overall Study|Subj/parent not willing to adhere to req|3
492280|NCT00006604|1587801|P3|Overall Study|Subj/parent not willing to adhere to req|1
492281|NCT00006604|1587802|P2|Overall Study|Subj/parent not willing to adhere to req|0
492282|NCT00006604|1587803|P1|Overall Study|Subj/parent not willing to adhere to req|0
492283|NCT00006604|1587787|P17|Overall Study|Withdrawal by Subject|1
492284|NCT00006604|1587788|P16|Overall Study|Withdrawal by Subject|0
492285|NCT00006604|1587789|P15|Overall Study|Withdrawal by Subject|1
492286|NCT00006604|1587790|P14|Overall Study|Withdrawal by Subject|2
492287|NCT00006604|1587791|P13|Overall Study|Withdrawal by Subject|1
492288|NCT00006604|1587792|P12|Overall Study|Withdrawal by Subject|0
492289|NCT00006604|1587793|P11|Overall Study|Withdrawal by Subject|2
492290|NCT00006604|1587794|P10|Overall Study|Withdrawal by Subject|3
492291|NCT00006604|1587795|P9|Overall Study|Withdrawal by Subject|1
492292|NCT00006604|1587796|P8|Overall Study|Withdrawal by Subject|0
492293|NCT00006604|1587797|P7|Overall Study|Withdrawal by Subject|2
492294|NCT00006604|1587798|P6|Overall Study|Withdrawal by Subject|2
492295|NCT00006604|1587799|P5|Overall Study|Withdrawal by Subject|1
492296|NCT00006604|1587800|P4|Overall Study|Withdrawal by Subject|0
492297|NCT00006604|1587801|P3|Overall Study|Withdrawal by Subject|2
492298|NCT00006604|1587802|P2|Overall Study|Withdrawal by Subject|0
492299|NCT00006604|1587803|P1|Overall Study|Withdrawal by Subject|1
492300|NCT00006604|1587787|P17|Overall Study|Site closing|1
492301|NCT00006604|1587788|P16|Overall Study|Site closing|0
492302|NCT00006604|1587789|P15|Overall Study|Site closing|0
492303|NCT00006604|1587790|P14|Overall Study|Site closing|1
492304|NCT00006604|1587791|P13|Overall Study|Site closing|1
492305|NCT00006604|1587792|P12|Overall Study|Site closing|1
492306|NCT00006604|1587793|P11|Overall Study|Site closing|0
492307|NCT00006604|1587794|P10|Overall Study|Site closing|0
492308|NCT00006604|1587795|P9|Overall Study|Site closing|0
492309|NCT00006604|1587796|P8|Overall Study|Site closing|1
492310|NCT00006604|1587797|P7|Overall Study|Site closing|0
492311|NCT00006604|1587798|P6|Overall Study|Site closing|0
492312|NCT00006604|1587799|P5|Overall Study|Site closing|0
492313|NCT00006604|1587800|P4|Overall Study|Site closing|1
492314|NCT00006604|1587801|P3|Overall Study|Site closing|1
492315|NCT00006604|1587802|P2|Overall Study|Site closing|0
492316|NCT00006604|1587803|P1|Overall Study|Site closing|0
492317|NCT00006604|1587787|P17|Overall Study|Subj/Parent not able to get to clinic|0
492318|NCT00006604|1587788|P16|Overall Study|Subj/Parent not able to get to clinic|0
492319|NCT00006604|1587789|P15|Overall Study|Subj/Parent not able to get to clinic|3
492320|NCT00006604|1587790|P14|Overall Study|Subj/Parent not able to get to clinic|1
492321|NCT00006604|1587791|P13|Overall Study|Subj/Parent not able to get to clinic|1
492322|NCT00006604|1587792|P12|Overall Study|Subj/Parent not able to get to clinic|1
492323|NCT00006604|1587793|P11|Overall Study|Subj/Parent not able to get to clinic|2
492324|NCT00006604|1587794|P10|Overall Study|Subj/Parent not able to get to clinic|1
492325|NCT00006604|1587795|P9|Overall Study|Subj/Parent not able to get to clinic|0
492326|NCT00006604|1587796|P8|Overall Study|Subj/Parent not able to get to clinic|0
492327|NCT00006604|1587797|P7|Overall Study|Subj/Parent not able to get to clinic|1
492328|NCT00006604|1587798|P6|Overall Study|Subj/Parent not able to get to clinic|0
492329|NCT00006604|1587799|P5|Overall Study|Subj/Parent not able to get to clinic|1
492330|NCT00006604|1587800|P4|Overall Study|Subj/Parent not able to get to clinic|1
492331|NCT00006604|1587801|P3|Overall Study|Subj/Parent not able to get to clinic|0
492332|NCT00006604|1587802|P2|Overall Study|Subj/Parent not able to get to clinic|0
492333|NCT00006604|1587803|P1|Overall Study|Subj/Parent not able to get to clinic|0
492334|NCT00006604|1587787|P17|Overall Study|Severe debilitation, unable to continue|0
492335|NCT00006604|1587788|P16|Overall Study|Severe debilitation, unable to continue|0
492336|NCT00006604|1587789|P15|Overall Study|Severe debilitation, unable to continue|2
492337|NCT00006604|1587790|P14|Overall Study|Severe debilitation, unable to continue|0
492338|NCT00006604|1587791|P13|Overall Study|Severe debilitation, unable to continue|1
492339|NCT00006604|1587792|P12|Overall Study|Severe debilitation, unable to continue|2
492340|NCT00006604|1587793|P11|Overall Study|Severe debilitation, unable to continue|0
492341|NCT00006604|1587794|P10|Overall Study|Severe debilitation, unable to continue|5
492342|NCT00006604|1587795|P9|Overall Study|Severe debilitation, unable to continue|0
492343|NCT00006604|1587796|P8|Overall Study|Severe debilitation, unable to continue|0
492344|NCT00006604|1587797|P7|Overall Study|Severe debilitation, unable to continue|3
492345|NCT00006604|1587798|P6|Overall Study|Severe debilitation, unable to continue|0
492346|NCT00006604|1587799|P5|Overall Study|Severe debilitation, unable to continue|0
492347|NCT00006604|1587800|P4|Overall Study|Severe debilitation, unable to continue|0
492348|NCT00006604|1587801|P3|Overall Study|Severe debilitation, unable to continue|0
492349|NCT00006604|1587802|P2|Overall Study|Severe debilitation, unable to continue|0
492350|NCT00006604|1587803|P1|Overall Study|Severe debilitation, unable to continue|0
492351|NCT00006604|1587787|P17|Overall Study|Death|0
492352|NCT00006604|1587788|P16|Overall Study|Death|0
492353|NCT00006604|1587789|P15|Overall Study|Death|0
492354|NCT00006604|1587790|P14|Overall Study|Death|0
492355|NCT00006604|1587791|P13|Overall Study|Death|0
492356|NCT00006604|1587792|P12|Overall Study|Death|1
492357|NCT00006604|1587793|P11|Overall Study|Death|1
492358|NCT00006604|1587794|P10|Overall Study|Death|1
492359|NCT00006604|1587795|P9|Overall Study|Death|0
492360|NCT00006604|1587796|P8|Overall Study|Death|0
492361|NCT00006604|1587797|P7|Overall Study|Death|0
492363|NCT00006604|1587799|P5|Overall Study|Death|0
492364|NCT00006604|1587800|P4|Overall Study|Death|0
492365|NCT00006604|1587801|P3|Overall Study|Death|0
492366|NCT00006604|1587802|P2|Overall Study|Death|0
492367|NCT00006604|1587803|P1|Overall Study|Death|0
492368|NCT00006604|1587787|P17|Overall Study|Randomization entry error-no RX, no FU|0
492369|NCT00006604|1587788|P16|Overall Study|Randomization entry error-no RX, no FU|0
492370|NCT00006604|1587789|P15|Overall Study|Randomization entry error-no RX, no FU|0
492371|NCT00006604|1587790|P14|Overall Study|Randomization entry error-no RX, no FU|0
492372|NCT00006604|1587791|P13|Overall Study|Randomization entry error-no RX, no FU|0
492373|NCT00006604|1587792|P12|Overall Study|Randomization entry error-no RX, no FU|1
492374|NCT00006604|1587793|P11|Overall Study|Randomization entry error-no RX, no FU|0
492375|NCT00006604|1587794|P10|Overall Study|Randomization entry error-no RX, no FU|0
492376|NCT00006604|1587795|P9|Overall Study|Randomization entry error-no RX, no FU|0
492377|NCT00006604|1587796|P8|Overall Study|Randomization entry error-no RX, no FU|0
492378|NCT00006604|1587797|P7|Overall Study|Randomization entry error-no RX, no FU|0
492379|NCT00006604|1587798|P6|Overall Study|Randomization entry error-no RX, no FU|0
492380|NCT00006604|1587799|P5|Overall Study|Randomization entry error-no RX, no FU|0
492381|NCT00006604|1587800|P4|Overall Study|Randomization entry error-no RX, no FU|0
492382|NCT00006604|1587801|P3|Overall Study|Randomization entry error-no RX, no FU|0
492383|NCT00006604|1587802|P2|Overall Study|Randomization entry error-no RX, no FU|0
492384|NCT00006604|1587803|P1|Overall Study|Randomization entry error-no RX, no FU|0
492385|NCT00006604|1587787|P17|Overall Study|Met study objective - no further FU|0
492386|NCT00006604|1587788|P16|Overall Study|Met study objective - no further FU|1
492387|NCT00006604|1587789|P15|Overall Study|Met study objective - no further FU|1
492388|NCT00006604|1587790|P14|Overall Study|Met study objective - no further FU|0
492389|NCT00006604|1587791|P13|Overall Study|Met study objective - no further FU|0
492390|NCT00006604|1587792|P12|Overall Study|Met study objective - no further FU|0
492391|NCT00006604|1587793|P11|Overall Study|Met study objective - no further FU|0
492392|NCT00006604|1587794|P10|Overall Study|Met study objective - no further FU|0
492393|NCT00006604|1587795|P9|Overall Study|Met study objective - no further FU|0
492394|NCT00006604|1587796|P8|Overall Study|Met study objective - no further FU|0
492395|NCT00006604|1587797|P7|Overall Study|Met study objective - no further FU|0
492396|NCT00006604|1587798|P6|Overall Study|Met study objective - no further FU|0
492397|NCT00006604|1587799|P5|Overall Study|Met study objective - no further FU|0
492398|NCT00006604|1587800|P4|Overall Study|Met study objective - no further FU|0
492399|NCT00006604|1587801|P3|Overall Study|Met study objective - no further FU|0
492400|NCT00006604|1587802|P2|Overall Study|Met study objective - no further FU|0
492401|NCT00006604|1587803|P1|Overall Study|Met study objective - no further FU|1
492402|NCT00004978|1587919|P2|Overall Study|site closure - not in analysis cohort|20
492403|NCT00004978|1587920|P1|Overall Study|site closure - not in analysis cohort|19
492404|NCT00004978|1587919|P2|Overall Study|Withdrawal by Subject|26
492405|NCT00004978|1587920|P1|Overall Study|Withdrawal by Subject|17
492406|NCT00004978|1587919|P2|Overall Study|Lost to Follow-up|108
492407|NCT00004978|1587920|P1|Overall Study|Lost to Follow-up|101
492408|NCT00004978|1587919|P2|Overall Study|Death|116
492409|NCT00004978|1587920|P1|Overall Study|Death|107
492410|NCT00021541|1587946|P2|Period 2-crossover|Pts that did not progress|3
492411|NCT00021541|1587947|P1|Period 2-crossover|Pts that did not progress|2
492412|NCT00021541|1587946|P2|Period 2-crossover|non-adherence|0
492413|NCT00021541|1587947|P1|Period 2-crossover|non-adherence|1
492414|NCT00021541|1587946|P2|Period 2-crossover|Adverse Event|2
492415|NCT00021541|1587947|P1|Period 2-crossover|Adverse Event|2
492416|NCT00021541|1587946|P2|Period 2-crossover|Withdrawal by Subject|4
492417|NCT00021541|1587947|P1|Period 2-crossover|Withdrawal by Subject|3
492418|NCT00021541|1587946|P2|Period 2-crossover|refused phase B|2
492419|NCT00021541|1587947|P1|Period 2-crossover|refused phase B|2
492420|NCT00021541|1587946|P2|Period 1-First Treatment|Ineligible|2
492421|NCT00021541|1587947|P1|Period 1-First Treatment|Ineligible|0
492422|NCT00021541|1587946|P2|Period 1-First Treatment|Pts that did not progress|2
492423|NCT00021541|1587947|P1|Period 1-First Treatment|Pts that did not progress|2
492424|NCT00021541|1587946|P2|Period 1-First Treatment|Death|0
492425|NCT00021541|1587947|P1|Period 1-First Treatment|Death|1
492426|NCT00021541|1587946|P2|Period 1-First Treatment|non-adherence|0
492427|NCT00021541|1587947|P1|Period 1-First Treatment|non-adherence|3
492428|NCT00021541|1587946|P2|Period 1-First Treatment|Adverse Event|1
492429|NCT00021541|1587947|P1|Period 1-First Treatment|Adverse Event|2
492430|NCT00021541|1587946|P2|Period 1-First Treatment|Withdrawal by Subject|3
492431|NCT00021541|1587947|P1|Period 1-First Treatment|Withdrawal by Subject|3
492432|NCT00015457|1587961|P2|Second Intervention|Withdrawal by Subject|0
492433|NCT00015457|1587962|P1|Second Intervention|Withdrawal by Subject|1
492434|NCT00015457|1587961|P2|First Intervention|Lack of Efficacy|1
492435|NCT00015457|1587962|P1|First Intervention|Lack of Efficacy|0
492436|NCT00015457|1587961|P2|First Intervention|Adverse Event|2
492437|NCT00015457|1587962|P1|First Intervention|Adverse Event|0
492438|NCT00013611|1587972|P2|Overall Study|Lost to Follow-up|100
492439|NCT00013611|1587973|P1|Overall Study|Lost to Follow-up|91
492440|NCT00010803|1587991|P2|Overall Study|Withdrawal by Subject|98
492441|NCT00010803|1587992|P1|Overall Study|Withdrawal by Subject|97
492442|NCT00007475|1588019|P4|Overall Study|Adverse Event|0
492443|NCT00007475|1588020|P3|Overall Study|Adverse Event|0
492444|NCT00007475|1588021|P2|Overall Study|Adverse Event|0
492445|NCT00007475|1588022|P1|Overall Study|Adverse Event|3
492446|NCT00007475|1588019|P4|Overall Study|Withdrawal by Subject|0
492447|NCT00007475|1588020|P3|Overall Study|Withdrawal by Subject|0
492448|NCT00007475|1588021|P2|Overall Study|Withdrawal by Subject|0
492449|NCT00007475|1588022|P1|Overall Study|Withdrawal by Subject|1
492450|NCT00007345|1588044|P2|Overall Study|Death on study|1
492451|NCT00007345|1588045|P1|Overall Study|Death on study|1
492452|NCT00007345|1588044|P2|Overall Study|Intercurrent illness|0
492453|NCT00007345|1588045|P1|Overall Study|Intercurrent illness|1
492454|NCT00007345|1588044|P2|Overall Study|Switched to alternative treatment|3
492455|NCT00007345|1588045|P1|Overall Study|Switched to alternative treatment|0
492456|NCT00007345|1588044|P2|Overall Study|Refused further treatment|7
492457|NCT00007345|1588045|P1|Overall Study|Refused further treatment|0
492458|NCT00006489|1588067|P4|Overall Study|Death|1
492459|NCT00006489|1588068|P3|Overall Study|Death|0
492460|NCT00006489|1588069|P2|Overall Study|Death|0
492461|NCT00006489|1588070|P1|Overall Study|Death|0
492462|NCT00006489|1588067|P4|Overall Study|Scheduling Conflict|1
492463|NCT00006489|1588068|P3|Overall Study|Scheduling Conflict|2
492464|NCT00006489|1588069|P2|Overall Study|Scheduling Conflict|3
492465|NCT00006489|1588070|P1|Overall Study|Scheduling Conflict|0
492466|NCT00006489|1588067|P4|Overall Study|Withdrawal by Subject|6
492467|NCT00006489|1588068|P3|Overall Study|Withdrawal by Subject|9
492468|NCT00006489|1588069|P2|Overall Study|Withdrawal by Subject|9
492469|NCT00006489|1588070|P1|Overall Study|Withdrawal by Subject|10
492470|NCT00006489|1588067|P4|Overall Study|Adverse Event|3
492471|NCT00006489|1588068|P3|Overall Study|Adverse Event|4
492472|NCT00006489|1588069|P2|Overall Study|Adverse Event|2
492473|NCT00006489|1588070|P1|Overall Study|Adverse Event|3
492474|NCT00006409|1588094|P6|Post-3 Year Intervention|Protocol Violation|62
492475|NCT00006409|1588095|P5|Post-3 Year Intervention|Protocol Violation|62
492476|NCT00006409|1588096|P4|Post-3 Year Intervention|Protocol Violation|0
492477|NCT00006409|1588097|P3|Post-3 Year Intervention|Protocol Violation|0
492478|NCT00006409|1588098|P2|Post-3 Year Intervention|Protocol Violation|0
492479|NCT00006409|1588099|P1|Post-3 Year Intervention|Protocol Violation|0
492480|NCT00006409|1588094|P6|Post-2 Year Intervention|Protocol Violation|0
492481|NCT00006409|1588095|P5|Post-2 Year Intervention|Protocol Violation|0
492482|NCT00006409|1588096|P4|Post-2 Year Intervention|Protocol Violation|168
492483|NCT00006409|1588097|P3|Post-2 Year Intervention|Protocol Violation|251
492484|NCT00006409|1588098|P2|Post-2 Year Intervention|Protocol Violation|0
492485|NCT00006409|1588099|P1|Post-2 Year Intervention|Protocol Violation|0
492486|NCT00006409|1588094|P6|Baseline|Protocol Violation|0
492487|NCT00006409|1588095|P5|Baseline|Protocol Violation|0
492488|NCT00006409|1588096|P4|Baseline|Protocol Violation|0
492489|NCT00006409|1588097|P3|Baseline|Protocol Violation|0
492490|NCT00006409|1588098|P2|Baseline|Protocol Violation|70
492491|NCT00006409|1588099|P1|Baseline|Protocol Violation|48
492492|NCT00006305|1588123|P4|Overall Study|Withdrawal by Subject|14
492493|NCT00006305|1588124|P3|Overall Study|Withdrawal by Subject|15
492494|NCT00006305|1588125|P2|Overall Study|Withdrawal by Subject|10
492495|NCT00006305|1588126|P1|Overall Study|Withdrawal by Subject|17
492496|NCT00006289|1588142|P2|Second Intervention (5 Weeks)|Protocol Violation|1
492497|NCT00006289|1588143|P1|Second Intervention (5 Weeks)|Protocol Violation|1
492498|NCT00006289|1588142|P2|First Intervention (5 Weeks)|Adverse Event|0
492499|NCT00006289|1588143|P1|First Intervention (5 Weeks)|Adverse Event|1
492500|NCT00006184|1588161|P2|Overall Study|Death|0
492501|NCT00006184|1588162|P1|Overall Study|Death|1
492502|NCT00006164|1588213|P2|Overall Study|Withdrew or lost to follow-up|81
492503|NCT00006164|1588214|P1|Overall Study|Withdrew or lost to follow-up|70
492504|NCT00005937|1588257|P1|Overall Study|Lack of Efficacy|5
492505|NCT00005908|1588261|P2|Overall Study|Withdrawal by Subject|0
492506|NCT00005908|1588262|P1|Overall Study|Withdrawal by Subject|1
492507|NCT00005906|1588271|P1|Overall Study|Lack of Efficacy|3
492508|NCT00004980|1588315|P2|Overall Study|Physician Decision|1
492509|NCT00004980|1588316|P1|Overall Study|Physician Decision|0
492510|NCT00004980|1588315|P2|Overall Study|memory difficulties|1
492511|NCT00004980|1588316|P1|Overall Study|memory difficulties|1
492512|NCT00004980|1588315|P2|Overall Study|Withdrawal by Subject|0
492513|NCT00004980|1588316|P1|Overall Study|Withdrawal by Subject|1
492514|NCT00004732|1588330|P2|Overall Study|Lost to Follow-up|47
492515|NCT00004732|1588331|P1|Overall Study|Lost to Follow-up|33
492516|NCT00004732|1588330|P2|Overall Study|Withdrawal by Subject|64
492517|NCT00004732|1588331|P1|Overall Study|Withdrawal by Subject|36
492518|NCT00004635|1588341|P2|Period Two|discrepancy in data entry|1
492519|NCT00004635|1588342|P1|Period Two|discrepancy in data entry|0
492520|NCT00004635|1588341|P2|Period Two|Lost to Follow-up|0
492521|NCT00004635|1588342|P1|Period Two|Lost to Follow-up|1
492522|NCT00004635|1588341|P2|Period Two|secondary malignancy|1
492523|NCT00004635|1588342|P1|Period Two|secondary malignancy|1
492524|NCT00004635|1588341|P2|Period Two|travel issues|1
492525|NCT00004635|1588342|P1|Period Two|travel issues|0
492526|NCT00004635|1588341|P2|Period Two|health problem|1
492527|NCT00004635|1588342|P1|Period Two|health problem|1
492528|NCT00004635|1588341|P2|Period Two|refused|2
492529|NCT00004635|1588342|P1|Period Two|refused|0
492530|NCT00004635|1588341|P2|Period Two|Adverse Event|0
492531|NCT00004635|1588342|P1|Period Two|Adverse Event|1
492532|NCT00004635|1588341|P2|Period Two|progression|3
492533|NCT00004635|1588342|P1|Period Two|progression|2
492534|NCT00004635|1588341|P2|Period One|discrepancy in data entry|1
492535|NCT00004635|1588342|P1|Period One|discrepancy in data entry|0
492536|NCT00004635|1588341|P2|Period One|health problem|1
492537|NCT00004635|1588342|P1|Period One|health problem|0
492538|NCT00004635|1588341|P2|Period One|progressed|2
492539|NCT00004635|1588342|P1|Period One|progressed|0
492540|NCT00004635|1588341|P2|Period One|second malignancy|0
492541|NCT00004635|1588342|P1|Period One|second malignancy|1
492542|NCT00004635|1588341|P2|Period One|PSA did not go <5 ng/mL|0
492543|NCT00004635|1588342|P1|Period One|PSA did not go <5 ng/mL|1
492544|NCT00004635|1588341|P2|Period One|Protocol Violation|0
492545|NCT00004635|1588342|P1|Period One|Protocol Violation|1
492546|NCT00004635|1588341|P2|Period One|Withdrawal by Subject|1
492547|NCT00004635|1588342|P1|Period One|Withdrawal by Subject|1
492548|NCT00004635|1588341|P2|Period One|refused|1
492549|NCT00004635|1588342|P1|Period One|refused|2
492550|NCT00004563|1588354|P2|Overall Study|Death|3
492551|NCT00004563|1588355|P1|Overall Study|Death|2
492552|NCT00004563|1588354|P2|Overall Study|Lack of Efficacy|5
492553|NCT00004563|1588355|P1|Overall Study|Lack of Efficacy|3
492554|NCT00004563|1588354|P2|Overall Study|Withdrawal by Subject|16
492555|NCT00004563|1588355|P1|Overall Study|Withdrawal by Subject|20
492556|NCT00004562|1588367|P2|Overall Study|Lost to Follow-up|91
492557|NCT00004562|1588368|P1|Overall Study|Lost to Follow-up|102
492558|NCT00001962|1588409|P1|Overall Study|Adverse Event|1
492559|NCT00001962|1588409|P1|Overall Study|Lost to Follow-up|2
492560|NCT00001962|1588409|P1|Overall Study|Death|1
492561|NCT00001962|1588409|P1|Overall Study|Lack of Accrual|6
492562|NCT00001962|1588409|P1|Overall Study|Lack of Efficacy|18
492563|NCT00001959|1588413|P1|Overall Study|non-compliance|1
492564|NCT00001959|1588413|P1|Overall Study|disabling sedation|1
492565|NCT00001959|1588413|P1|Overall Study|newly diagnosed colon cancer|1
492566|NCT00001941|1588419|P5|Overall Study|not treated- rapidly progressing disease|1
492567|NCT00001941|1588420|P4|Overall Study|not treated- rapidly progressing disease|0
492568|NCT00001941|1588421|P3|Overall Study|not treated- rapidly progressing disease|0
492569|NCT00001941|1588422|P2|Overall Study|not treated- rapidly progressing disease|0
492570|NCT00001941|1588423|P1|Overall Study|not treated- rapidly progressing disease|0
492571|NCT00001832|1588455|P15|Treatment Period|Not treated|0
492572|NCT00001832|1588456|P14|Treatment Period|Not treated|0
492573|NCT00001832|1588457|P13|Treatment Period|Not treated|0
492574|NCT00001832|1588458|P12|Treatment Period|Not treated|0
492575|NCT00001832|1588459|P11|Treatment Period|Not treated|0
492576|NCT00001832|1588460|P10|Treatment Period|Not treated|0
492577|NCT00001832|1588461|P9|Treatment Period|Not treated|0
492578|NCT00001832|1588462|P8|Treatment Period|Not treated|1
492579|NCT00001832|1588463|P7|Treatment Period|Not treated|0
492580|NCT00001832|1588464|P6|Treatment Period|Not treated|0
492581|NCT00001832|1588465|P5|Treatment Period|Not treated|0
492582|NCT00001832|1588466|P4|Treatment Period|Not treated|0
492583|NCT00001832|1588467|P3|Treatment Period|Not treated|0
492584|NCT00001832|1588468|P2|Treatment Period|Not treated|0
492585|NCT00001832|1588469|P1|Treatment Period|Not treated|0
492586|NCT00001832|1588455|P15|Treatment Period|Death during treatment|0
492587|NCT00001832|1588456|P14|Treatment Period|Death during treatment|0
492588|NCT00001832|1588457|P13|Treatment Period|Death during treatment|0
492589|NCT00001832|1588458|P12|Treatment Period|Death during treatment|0
492590|NCT00001832|1588459|P11|Treatment Period|Death during treatment|0
492591|NCT00001832|1588460|P10|Treatment Period|Death during treatment|0
492592|NCT00001832|1588461|P9|Treatment Period|Death during treatment|0
492593|NCT00001832|1588462|P8|Treatment Period|Death during treatment|0
492594|NCT00001832|1588463|P7|Treatment Period|Death during treatment|0
492595|NCT00001832|1588464|P6|Treatment Period|Death during treatment|1
492596|NCT00001832|1588465|P5|Treatment Period|Death during treatment|0
492597|NCT00001832|1588466|P4|Treatment Period|Death during treatment|0
492598|NCT00001832|1588467|P3|Treatment Period|Death during treatment|0
492599|NCT00001832|1588468|P2|Treatment Period|Death during treatment|0
492600|NCT00001832|1588469|P1|Treatment Period|Death during treatment|0
492601|NCT00001832|1588455|P15|Apheresis Period|not able to manufacture treatment cells|0
492602|NCT00001832|1588456|P14|Apheresis Period|not able to manufacture treatment cells|0
492603|NCT00001832|1588457|P13|Apheresis Period|not able to manufacture treatment cells|0
492604|NCT00001832|1588458|P12|Apheresis Period|not able to manufacture treatment cells|0
492605|NCT00001832|1588459|P11|Apheresis Period|not able to manufacture treatment cells|0
492606|NCT00001832|1588460|P10|Apheresis Period|not able to manufacture treatment cells|0
492607|NCT00001832|1588461|P9|Apheresis Period|not able to manufacture treatment cells|0
492608|NCT00001832|1588462|P8|Apheresis Period|not able to manufacture treatment cells|0
492609|NCT00001832|1588463|P7|Apheresis Period|not able to manufacture treatment cells|0
492610|NCT00001832|1588464|P6|Apheresis Period|not able to manufacture treatment cells|0
492611|NCT00001832|1588465|P5|Apheresis Period|not able to manufacture treatment cells|0
492612|NCT00001832|1588466|P4|Apheresis Period|not able to manufacture treatment cells|0
492613|NCT00001832|1588467|P3|Apheresis Period|not able to manufacture treatment cells|0
492614|NCT00001832|1588468|P2|Apheresis Period|not able to manufacture treatment cells|0
492615|NCT00001832|1588469|P1|Apheresis Period|not able to manufacture treatment cells|60
492616|NCT00001723|1588515|P2|Overall Study|medication intolerance|2
492617|NCT00001723|1588516|P1|Overall Study|medication intolerance|1
492618|NCT00001723|1588515|P2|Overall Study|Lost to Follow-up|2
492619|NCT00001723|1588516|P1|Overall Study|Lost to Follow-up|2
492620|NCT00001723|1588515|P2|Overall Study|Lack of family interest|5
492621|NCT00001723|1588516|P1|Overall Study|Lack of family interest|4
492622|NCT00001723|1588515|P2|Overall Study|Lack of Efficacy|7
492623|NCT00001723|1588516|P1|Overall Study|Lack of Efficacy|6
492624|NCT00001703|1588532|P1|Overall Study|recurrent disease|2
492625|NCT00001703|1588532|P1|Overall Study|No evidence of disease|1
492626|NCT00001703|1588532|P1|Overall Study|progressed disease|2
492627|NCT00001596|1588570|P2|Overall Study|Adverse Event|0
492628|NCT00001596|1588571|P1|Overall Study|Adverse Event|1
492629|NCT00001596|1588570|P2|Overall Study|Study Termination|9
492630|NCT00001596|1588571|P1|Overall Study|Study Termination|12
492631|NCT00001596|1588570|P2|Overall Study|Withdrawal by Subject|1
492632|NCT00001596|1588571|P1|Overall Study|Withdrawal by Subject|3
492633|NCT00001596|1588570|P2|Overall Study|Death|0
492634|NCT00001596|1588571|P1|Overall Study|Death|1
492635|NCT00001575|1588602|P1|Overall Study|Withdrawn/deaths|23
492636|NCT00001575|1588602|P1|Overall Study|Screening failures-Ph I portion|22
492637|NCT00001566|1588608|P1|Overall Study|unable to complete initial apheresis|1
492638|NCT00001566|1588608|P1|Overall Study|Lost to Follow-up|1
492639|NCT00001566|1588608|P1|Overall Study|Death|13
492640|NCT00001566|1588608|P1|Overall Study|stopped after C3 due to symptomatic PD|1
492641|NCT00001566|1588608|P1|Overall Study|patients' choice to discontinue protocol|3
492642|NCT00001262|1588644|P3|Overall Study|Withdrawal by Subject|0
492643|NCT00001262|1588645|P2|Overall Study|Withdrawal by Subject|3
492644|NCT00001262|1588646|P1|Overall Study|Withdrawal by Subject|0
492645|NCT00001262|1588644|P3|Overall Study|Death|0
492646|NCT00001262|1588645|P2|Overall Study|Death|11
492647|NCT00001262|1588646|P1|Overall Study|Death|10
492648|NCT00001213|1588672|P1|Overall Study|Death|18
492649|NCT00000378|1588683|P2|Overall Study|Lack of Efficacy|14
492650|NCT00000378|1588684|P1|Overall Study|Lack of Efficacy|16
492651|NCT00000620|1588701|P8|Overall Study|missed closeout visit|16
492652|NCT00000620|1588702|P7|Overall Study|missed closeout visit|13
492653|NCT00000620|1588703|P6|Overall Study|missed closeout visit|28
492654|NCT00000620|1588704|P5|Overall Study|missed closeout visit|26
492655|NCT00000620|1588705|P4|Overall Study|missed closeout visit|11
492656|NCT00000620|1588706|P3|Overall Study|missed closeout visit|16
492657|NCT00000620|1588707|P2|Overall Study|missed closeout visit|28
492658|NCT00000620|1588708|P1|Overall Study|missed closeout visit|22
492659|NCT00000620|1588701|P8|Overall Study|Withdrawal by Subject|21
492660|NCT00000620|1588702|P7|Overall Study|Withdrawal by Subject|32
492661|NCT00000620|1588703|P6|Overall Study|Withdrawal by Subject|32
492662|NCT00000620|1588704|P5|Overall Study|Withdrawal by Subject|30
492663|NCT00000620|1588705|P4|Overall Study|Withdrawal by Subject|27
492664|NCT00000620|1588706|P3|Overall Study|Withdrawal by Subject|28
492665|NCT00000620|1588707|P2|Overall Study|Withdrawal by Subject|27
492666|NCT00000620|1588708|P1|Overall Study|Withdrawal by Subject|40
492667|NCT00000620|1588701|P8|Overall Study|Lost to Follow-up|14
492668|NCT00000620|1588702|P7|Overall Study|Lost to Follow-up|13
492669|NCT00000620|1588703|P6|Overall Study|Lost to Follow-up|15
492670|NCT00000620|1588704|P5|Overall Study|Lost to Follow-up|15
492671|NCT00000620|1588705|P4|Overall Study|Lost to Follow-up|14
492672|NCT00000620|1588706|P3|Overall Study|Lost to Follow-up|14
492673|NCT00000620|1588707|P2|Overall Study|Lost to Follow-up|14
492674|NCT00000620|1588708|P1|Overall Study|Lost to Follow-up|14
492675|NCT00000620|1588701|P8|Overall Study|Death|95
492676|NCT00000620|1588702|P7|Overall Study|Death|91
492677|NCT00000620|1588703|P6|Overall Study|Death|77
492678|NCT00000620|1588704|P5|Overall Study|Death|64
492679|NCT00000620|1588705|P4|Overall Study|Death|126
492680|NCT00000620|1588706|P3|Overall Study|Death|112
492681|NCT00000620|1588707|P2|Overall Study|Death|67
492682|NCT00000620|1588708|P1|Overall Study|Death|86
492683|NCT00004412|1588792|P3|Randomized Period|Moved to Crossover Period|0
492684|NCT00004412|1588793|P2|Randomized Period|Moved to Crossover Period|0
492685|NCT00004412|1588794|P1|Randomized Period|Moved to Crossover Period|3
492686|NCT00000135|1588835|P2|Overall Study|Death|14
492687|NCT00000135|1588836|P1|Overall Study|Death|27
492688|NCT03331315|1588866|P2|Overall Study|Physician Decision|14
492689|NCT03331315|1588867|P1|Overall Study|Physician Decision|18
492690|NCT03150485|1588887|P6|Overall Study|Unsatisfactory Lens Fitting|0
492691|NCT03150485|1588888|P5|Overall Study|Unsatisfactory Lens Fitting|0
492692|NCT03150485|1588889|P4|Overall Study|Unsatisfactory Lens Fitting|0
492693|NCT03150485|1588890|P3|Overall Study|Unsatisfactory Lens Fitting|0
492694|NCT03150485|1588891|P2|Overall Study|Unsatisfactory Lens Fitting|1
492695|NCT03150485|1588892|P1|Overall Study|Unsatisfactory Lens Fitting|0
492696|NCT03099096|1588907|P1|Overall Study|Physician Decision|1
492697|NCT03099096|1588907|P1|Overall Study|Adverse Event|1
492698|NCT02692560|1588943|P2|Overall Study|Withdrawal by Subject|6
492699|NCT02692560|1588944|P1|Overall Study|Withdrawal by Subject|0
492700|NCT02459418|1588966|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
492701|NCT02459418|1588967|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
492702|NCT02459418|1588966|P2|Overall Study|Elevated Creatine Kinase|0
492703|NCT02459418|1588967|P1|Overall Study|Elevated Creatine Kinase|1
492704|NCT02459418|1588966|P2|Overall Study|Withdrawal by Subject|1
492705|NCT02459418|1588967|P1|Overall Study|Withdrawal by Subject|1
492706|NCT02459418|1588966|P2|Overall Study|Adverse Event|1
492707|NCT02459418|1588967|P1|Overall Study|Adverse Event|0
492708|NCT02459418|1588966|P2|Overall Study|Endometrial thickness of >5 mm|0
492709|NCT02459418|1588967|P1|Overall Study|Endometrial thickness of >5 mm|1
492710|NCT02459418|1588966|P2|Overall Study|Physician Decision|2
492711|NCT02459418|1588967|P1|Overall Study|Physician Decision|0
492712|NCT02459418|1588966|P2|Overall Study|Protocol Violation|2
492713|NCT02459418|1588967|P1|Overall Study|Protocol Violation|0
492714|NCT02459418|1588966|P2|Overall Study|Exclusion Criteria|0
492715|NCT02459418|1588967|P1|Overall Study|Exclusion Criteria|4
492716|NCT02383472|1588989|P2|Overall Study|Withdrawal by Subject|1
492717|NCT02383472|1588990|P1|Overall Study|Withdrawal by Subject|1
492718|NCT02229227|1589006|P2|Overall Study|Physician Decision|12
492719|NCT02229227|1589007|P1|Overall Study|Physician Decision|5
492720|NCT02229227|1589006|P2|Overall Study|Other|1
492721|NCT02229227|1589007|P1|Overall Study|Other|0
492722|NCT02229227|1589006|P2|Overall Study|Withdrawal by Subject|12
492723|NCT02229227|1589007|P1|Overall Study|Withdrawal by Subject|8
492724|NCT02229227|1589006|P2|Overall Study|Study terminated by sponsor|11
492725|NCT02229227|1589007|P1|Overall Study|Study terminated by sponsor|11
492726|NCT02229227|1589006|P2|Overall Study|Lost to Follow-up|3
492727|NCT02229227|1589007|P1|Overall Study|Lost to Follow-up|3
492728|NCT02229227|1589006|P2|Overall Study|Protocol defined stopping criteria|3
492729|NCT02229227|1589007|P1|Overall Study|Protocol defined stopping criteria|1
492730|NCT02229227|1589006|P2|Overall Study|Protocol Violation|8
492731|NCT02229227|1589007|P1|Overall Study|Protocol Violation|6
492732|NCT02229227|1589006|P2|Overall Study|Lack of Efficacy|3
492733|NCT02229227|1589007|P1|Overall Study|Lack of Efficacy|3
492734|NCT02229227|1589006|P2|Overall Study|Adverse Event|9
492735|NCT02229227|1589007|P1|Overall Study|Adverse Event|14
492736|NCT02091869|1589092|P2|Overall Study|Withdrawal by Subject|3
492737|NCT02091869|1589093|P1|Overall Study|Withdrawal by Subject|0
492738|NCT02085785|1589107|P2|Overall Study|Lost to Follow-up|1
492739|NCT02085785|1589108|P1|Overall Study|Lost to Follow-up|0
492740|NCT02085785|1589107|P2|Overall Study|Withdrawal by Subject|1
492741|NCT02085785|1589108|P1|Overall Study|Withdrawal by Subject|2
492742|NCT01910181|1589120|P1|Overall Study|Alive in Follow-Up|12
492743|NCT01910181|1589120|P1|Overall Study|Alive on Treatment|14
492744|NCT01910181|1589120|P1|Overall Study|Death|20
492745|NCT01733732|1589181|P2|Overall Study|Did not attend all study visits|0
492746|NCT01733732|1589182|P1|Overall Study|Did not attend all study visits|1
492747|NCT01733732|1589181|P2|Overall Study|Adverse Event|0
492748|NCT01733732|1589182|P1|Overall Study|Adverse Event|1
492749|NCT01702961|1589229|P1|Overall Study|Ongoing|11
492750|NCT01702961|1589229|P1|Overall Study|Lost to Follow-up|2
492751|NCT01702961|1589229|P1|Overall Study|Death|6
492752|NCT01702961|1589229|P1|Overall Study|Relapse|20
492753|NCT01702961|1589229|P1|Overall Study|Progressive disease|5
492754|NCT01702961|1589229|P1|Overall Study|Additional treatment|3
492755|NCT01699087|1589235|P1|Overall Study|Unable to make future visits|2
492756|NCT01699087|1589235|P1|Overall Study|Screen failure (prior to treatment)|15
492757|NCT01699087|1589235|P1|Overall Study|Lost to Follow-up|7
492758|NCT01688726|1589251|P2|Overall Study|Relocated abroad|1
492759|NCT01688726|1589252|P1|Overall Study|Relocated abroad|0
492760|NCT01688726|1589251|P2|Overall Study|Adverse Event|0
492761|NCT01688726|1589252|P1|Overall Study|Adverse Event|1
492762|NCT01664923|1589275|P2|Overall Study|Miscellaneous|1
492763|NCT01664923|1589276|P1|Overall Study|Miscellaneous|5
492764|NCT01664923|1589275|P2|Overall Study|Adverse Event|12
492765|NCT01664923|1589276|P1|Overall Study|Adverse Event|16
492766|NCT01664923|1589275|P2|Overall Study|Disease Progression|139
492767|NCT01664923|1589276|P1|Overall Study|Disease Progression|58
492768|NCT01664923|1589275|P2|Overall Study|Withdrawal by Subject|5
492769|NCT01664923|1589276|P1|Overall Study|Withdrawal by Subject|11
492770|NCT01664923|1589275|P2|Overall Study|Protocol Violation|0
492771|NCT01664923|1589276|P1|Overall Study|Protocol Violation|2
492772|NCT01664923|1589275|P2|Overall Study|Lost to Follow-up|1
492773|NCT01664923|1589276|P1|Overall Study|Lost to Follow-up|0
492774|NCT01664923|1589275|P2|Overall Study|Death|0
492775|NCT01664923|1589276|P1|Overall Study|Death|1
492776|NCT01642407|1589294|P1|Overall Study|Insufficient clinical response|2
492777|NCT01563913|1589367|P2|Overall Study|Spouse Passed Away|0
492778|NCT01563913|1589368|P1|Overall Study|Spouse Passed Away|1
492779|NCT01563913|1589367|P2|Overall Study|Physician Decision|0
492780|NCT01563913|1589368|P1|Overall Study|Physician Decision|1
492781|NCT01547390|1589388|P2|Overall Study|Adverse Event|0
492782|NCT01547390|1589389|P1|Overall Study|Adverse Event|3
492783|NCT01547390|1589388|P2|Overall Study|Lost to Follow-up|2
492784|NCT01547390|1589389|P1|Overall Study|Lost to Follow-up|0
492785|NCT01547390|1589388|P2|Overall Study|termination of pregnancy|1
492786|NCT01547390|1589389|P1|Overall Study|termination of pregnancy|0
492787|NCT01547390|1589388|P2|Overall Study|Withdrawal by Subject|7
492788|NCT01547390|1589389|P1|Overall Study|Withdrawal by Subject|10
492789|NCT01507662|1589406|P2|Overall Study|Proxy interview done|3
492790|NCT01507662|1589407|P1|Overall Study|Proxy interview done|2
492791|NCT01507662|1589406|P2|Overall Study|Lost to Follow-up|523
492792|NCT01507662|1589407|P1|Overall Study|Lost to Follow-up|498
492793|NCT01507662|1589406|P2|Overall Study|Withdrawal by Subject|287
492794|NCT01507662|1589407|P1|Overall Study|Withdrawal by Subject|290
492795|NCT01507662|1589406|P2|Overall Study|Death|18
492796|NCT01507662|1589407|P1|Overall Study|Death|26
492797|NCT01496066|1589415|P2|Overall Study|Death|4
492798|NCT01496066|1589416|P1|Overall Study|Death|1
492799|NCT01496066|1589415|P2|Overall Study|Explant|0
492800|NCT01496066|1589416|P1|Overall Study|Explant|3
492801|NCT01496066|1589415|P2|Overall Study|Lost to Follow-up|5
492802|NCT01496066|1589416|P1|Overall Study|Lost to Follow-up|8
492803|NCT01424189|1589555|P2|Overall Study|Death|1
492804|NCT01424189|1589556|P1|Overall Study|Death|3
492805|NCT01424189|1589555|P2|Overall Study|Subject moved|0
492806|NCT01424189|1589556|P1|Overall Study|Subject moved|1
492807|NCT01424189|1589555|P2|Overall Study|Withdrawal by Subject|4
492808|NCT01424189|1589556|P1|Overall Study|Withdrawal by Subject|4
492809|NCT01424189|1589555|P2|Overall Study|Lost to Follow-up|1
492810|NCT01424189|1589556|P1|Overall Study|Lost to Follow-up|4
492811|NCT01424189|1589555|P2|Overall Study|Adverse Event|0
492812|NCT01424189|1589556|P1|Overall Study|Adverse Event|1
492813|NCT01271803|1589614|P12|Stage 2|Ongoing in the Study|14
492814|NCT01271803|1589615|P11|Stage 2|Ongoing in the Study|6
492815|NCT01271803|1589616|P10|Stage 2|Ongoing in the Study|0
492816|NCT01271803|1589617|P9|Stage 2|Ongoing in the Study|0
492817|NCT01271803|1589618|P8|Stage 2|Ongoing in the Study|0
492818|NCT01271803|1589619|P7|Stage 2|Ongoing in the Study|0
492819|NCT01271803|1589620|P6|Stage 2|Ongoing in the Study|0
492820|NCT01271803|1589621|P5|Stage 2|Ongoing in the Study|0
492821|NCT01271803|1589622|P4|Stage 2|Ongoing in the Study|0
492822|NCT01271803|1589623|P3|Stage 2|Ongoing in the Study|0
492823|NCT01271803|1589624|P2|Stage 2|Ongoing in the Study|0
492824|NCT01271803|1589625|P1|Stage 2|Ongoing in the Study|0
492825|NCT01271803|1589614|P12|Stage 2|Other|0
492826|NCT01271803|1589615|P11|Stage 2|Other|1
492827|NCT01271803|1589616|P10|Stage 2|Other|0
492828|NCT01271803|1589617|P9|Stage 2|Other|0
492829|NCT01271803|1589618|P8|Stage 2|Other|0
492830|NCT01271803|1589619|P7|Stage 2|Other|0
492831|NCT01271803|1589620|P6|Stage 2|Other|0
492832|NCT01271803|1589621|P5|Stage 2|Other|0
492833|NCT01271803|1589622|P4|Stage 2|Other|0
492834|NCT01271803|1589623|P3|Stage 2|Other|0
492835|NCT01271803|1589624|P2|Stage 2|Other|0
492836|NCT01271803|1589625|P1|Stage 2|Other|0
492837|NCT01271803|1589614|P12|Stage 2|Physician Decision|1
492838|NCT01271803|1589615|P11|Stage 2|Physician Decision|0
492839|NCT01271803|1589616|P10|Stage 2|Physician Decision|0
492840|NCT01271803|1589617|P9|Stage 2|Physician Decision|0
492841|NCT01271803|1589618|P8|Stage 2|Physician Decision|0
492842|NCT01271803|1589619|P7|Stage 2|Physician Decision|0
492843|NCT01271803|1589620|P6|Stage 2|Physician Decision|0
492844|NCT01271803|1589621|P5|Stage 2|Physician Decision|0
492845|NCT01271803|1589622|P4|Stage 2|Physician Decision|0
492846|NCT01271803|1589623|P3|Stage 2|Physician Decision|0
492847|NCT01271803|1589624|P2|Stage 2|Physician Decision|0
492848|NCT01271803|1589625|P1|Stage 2|Physician Decision|0
492849|NCT01271803|1589614|P12|Stage 2|Withdrawal by Subject|2
492850|NCT01271803|1589615|P11|Stage 2|Withdrawal by Subject|0
492851|NCT01271803|1589616|P10|Stage 2|Withdrawal by Subject|0
492852|NCT01271803|1589617|P9|Stage 2|Withdrawal by Subject|0
492853|NCT01271803|1589618|P8|Stage 2|Withdrawal by Subject|0
492854|NCT01271803|1589619|P7|Stage 2|Withdrawal by Subject|0
492855|NCT01271803|1589620|P6|Stage 2|Withdrawal by Subject|0
492856|NCT01271803|1589621|P5|Stage 2|Withdrawal by Subject|0
492857|NCT01271803|1589622|P4|Stage 2|Withdrawal by Subject|0
492858|NCT01271803|1589623|P3|Stage 2|Withdrawal by Subject|0
492859|NCT01271803|1589624|P2|Stage 2|Withdrawal by Subject|0
492860|NCT01271803|1589625|P1|Stage 2|Withdrawal by Subject|0
492861|NCT01271803|1589614|P12|Stage 2|Death|2
492862|NCT01271803|1589615|P11|Stage 2|Death|2
492863|NCT01271803|1589616|P10|Stage 2|Death|0
492864|NCT01271803|1589617|P9|Stage 2|Death|0
492865|NCT01271803|1589618|P8|Stage 2|Death|0
492866|NCT01271803|1589619|P7|Stage 2|Death|0
492867|NCT01271803|1589620|P6|Stage 2|Death|0
492868|NCT01271803|1589621|P5|Stage 2|Death|0
492869|NCT01271803|1589622|P4|Stage 2|Death|0
492870|NCT01271803|1589623|P3|Stage 2|Death|0
492871|NCT01271803|1589624|P2|Stage 2|Death|0
492872|NCT01271803|1589625|P1|Stage 2|Death|0
492873|NCT01271803|1589614|P12|Stage 2|Adverse Event|3
492874|NCT01271803|1589615|P11|Stage 2|Adverse Event|1
492875|NCT01271803|1589616|P10|Stage 2|Adverse Event|0
492876|NCT01271803|1589617|P9|Stage 2|Adverse Event|0
492877|NCT01271803|1589618|P8|Stage 2|Adverse Event|0
492878|NCT01271803|1589619|P7|Stage 2|Adverse Event|0
492879|NCT01271803|1589620|P6|Stage 2|Adverse Event|0
492880|NCT01271803|1589621|P5|Stage 2|Adverse Event|0
492881|NCT01271803|1589622|P4|Stage 2|Adverse Event|0
492882|NCT01271803|1589623|P3|Stage 2|Adverse Event|0
492883|NCT01271803|1589624|P2|Stage 2|Adverse Event|0
492884|NCT01271803|1589625|P1|Stage 2|Adverse Event|0
492885|NCT01271803|1589614|P12|Stage 2|Progressive disease|17
492886|NCT01271803|1589615|P11|Stage 2|Progressive disease|17
492887|NCT01271803|1589616|P10|Stage 2|Progressive disease|0
492888|NCT01271803|1589617|P9|Stage 2|Progressive disease|0
492889|NCT01271803|1589618|P8|Stage 2|Progressive disease|0
492890|NCT01271803|1589619|P7|Stage 2|Progressive disease|0
492891|NCT01271803|1589620|P6|Stage 2|Progressive disease|0
492892|NCT01271803|1589621|P5|Stage 2|Progressive disease|0
492893|NCT01271803|1589622|P4|Stage 2|Progressive disease|0
492894|NCT01271803|1589623|P3|Stage 2|Progressive disease|0
492895|NCT01271803|1589624|P2|Stage 2|Progressive disease|0
492896|NCT01271803|1589625|P1|Stage 2|Progressive disease|0
492897|NCT01271803|1589614|P12|Stage 1|Ongoing in the Study|0
492898|NCT01271803|1589615|P11|Stage 1|Ongoing in the Study|0
492899|NCT01271803|1589616|P10|Stage 1|Ongoing in the Study|0
492900|NCT01271803|1589617|P9|Stage 1|Ongoing in the Study|1
492901|NCT01271803|1589618|P8|Stage 1|Ongoing in the Study|1
492902|NCT01271803|1589619|P7|Stage 1|Ongoing in the Study|1
492903|NCT01271803|1589620|P6|Stage 1|Ongoing in the Study|0
492904|NCT01271803|1589621|P5|Stage 1|Ongoing in the Study|3
492905|NCT01271803|1589622|P4|Stage 1|Ongoing in the Study|1
492906|NCT01271803|1589623|P3|Stage 1|Ongoing in the Study|11
492907|NCT01271803|1589624|P2|Stage 1|Ongoing in the Study|1
492908|NCT01271803|1589625|P1|Stage 1|Ongoing in the Study|0
492909|NCT01271803|1589614|P12|Stage 1|Other|0
492910|NCT01271803|1589615|P11|Stage 1|Other|0
492911|NCT01271803|1589616|P10|Stage 1|Other|0
492912|NCT01271803|1589617|P9|Stage 1|Other|0
492913|NCT01271803|1589618|P8|Stage 1|Other|0
492914|NCT01271803|1589619|P7|Stage 1|Other|0
492915|NCT01271803|1589620|P6|Stage 1|Other|0
492916|NCT01271803|1589621|P5|Stage 1|Other|0
492917|NCT01271803|1589622|P4|Stage 1|Other|0
492918|NCT01271803|1589623|P3|Stage 1|Other|2
492919|NCT01271803|1589624|P2|Stage 1|Other|0
492920|NCT01271803|1589625|P1|Stage 1|Other|0
492921|NCT01271803|1589614|P12|Stage 1|Withdrawal by Subject|0
492922|NCT01271803|1589615|P11|Stage 1|Withdrawal by Subject|0
492923|NCT01271803|1589616|P10|Stage 1|Withdrawal by Subject|0
492924|NCT01271803|1589617|P9|Stage 1|Withdrawal by Subject|0
492925|NCT01271803|1589618|P8|Stage 1|Withdrawal by Subject|0
492926|NCT01271803|1589619|P7|Stage 1|Withdrawal by Subject|0
492927|NCT01271803|1589620|P6|Stage 1|Withdrawal by Subject|0
492928|NCT01271803|1589621|P5|Stage 1|Withdrawal by Subject|0
492929|NCT01271803|1589622|P4|Stage 1|Withdrawal by Subject|0
492930|NCT01271803|1589623|P3|Stage 1|Withdrawal by Subject|1
492931|NCT01271803|1589624|P2|Stage 1|Withdrawal by Subject|0
492932|NCT01271803|1589625|P1|Stage 1|Withdrawal by Subject|0
492933|NCT01271803|1589614|P12|Stage 1|Physician Decision|0
492934|NCT01271803|1589615|P11|Stage 1|Physician Decision|0
492935|NCT01271803|1589616|P10|Stage 1|Physician Decision|0
492936|NCT01271803|1589617|P9|Stage 1|Physician Decision|0
492937|NCT01271803|1589618|P8|Stage 1|Physician Decision|0
492938|NCT01271803|1589619|P7|Stage 1|Physician Decision|1
492939|NCT01271803|1589620|P6|Stage 1|Physician Decision|0
492940|NCT01271803|1589621|P5|Stage 1|Physician Decision|0
492941|NCT01271803|1589622|P4|Stage 1|Physician Decision|0
492942|NCT01271803|1589623|P3|Stage 1|Physician Decision|0
492943|NCT01271803|1589624|P2|Stage 1|Physician Decision|0
492944|NCT01271803|1589625|P1|Stage 1|Physician Decision|1
492945|NCT01271803|1589614|P12|Stage 1|Death|0
492946|NCT01271803|1589615|P11|Stage 1|Death|0
492947|NCT01271803|1589616|P10|Stage 1|Death|0
492948|NCT01271803|1589617|P9|Stage 1|Death|0
492949|NCT01271803|1589618|P8|Stage 1|Death|0
492950|NCT01271803|1589619|P7|Stage 1|Death|0
492951|NCT01271803|1589620|P6|Stage 1|Death|1
492952|NCT01271803|1589621|P5|Stage 1|Death|0
492953|NCT01271803|1589622|P4|Stage 1|Death|0
492954|NCT01271803|1589623|P3|Stage 1|Death|0
492955|NCT01271803|1589624|P2|Stage 1|Death|0
492956|NCT01271803|1589625|P1|Stage 1|Death|1
492957|NCT01271803|1589614|P12|Stage 1|Adverse Event|0
492958|NCT01271803|1589615|P11|Stage 1|Adverse Event|0
492959|NCT01271803|1589616|P10|Stage 1|Adverse Event|0
492960|NCT01271803|1589617|P9|Stage 1|Adverse Event|0
492961|NCT01271803|1589618|P8|Stage 1|Adverse Event|0
492962|NCT01271803|1589619|P7|Stage 1|Adverse Event|0
492963|NCT01271803|1589620|P6|Stage 1|Adverse Event|0
492964|NCT01271803|1589621|P5|Stage 1|Adverse Event|0
492965|NCT01271803|1589622|P4|Stage 1|Adverse Event|0
492966|NCT01271803|1589623|P3|Stage 1|Adverse Event|1
492967|NCT01271803|1589624|P2|Stage 1|Adverse Event|0
492968|NCT01271803|1589625|P1|Stage 1|Adverse Event|0
492969|NCT01271803|1589614|P12|Stage 1|Progressive disease|0
492970|NCT01271803|1589615|P11|Stage 1|Progressive disease|0
492971|NCT01271803|1589616|P10|Stage 1|Progressive disease|2
492972|NCT01271803|1589617|P9|Stage 1|Progressive disease|4
492973|NCT01271803|1589618|P8|Stage 1|Progressive disease|2
492974|NCT01271803|1589619|P7|Stage 1|Progressive disease|2
492975|NCT01271803|1589620|P6|Stage 1|Progressive disease|3
492976|NCT01271803|1589621|P5|Stage 1|Progressive disease|1
492977|NCT01271803|1589622|P4|Stage 1|Progressive disease|2
492978|NCT01271803|1589623|P3|Stage 1|Progressive disease|12
492979|NCT01271803|1589624|P2|Stage 1|Progressive disease|7
492980|NCT01271803|1589625|P1|Stage 1|Progressive disease|3
492981|NCT01262365|1589799|P3|Overall Study|Patient unavailable|1
492982|NCT01262365|1589800|P2|Overall Study|Patient unavailable|0
492983|NCT01262365|1589801|P1|Overall Study|Patient unavailable|0
492984|NCT01262365|1589799|P3|Overall Study|Cannot tolerate the protocol|0
492985|NCT01262365|1589800|P2|Overall Study|Cannot tolerate the protocol|1
492986|NCT01262365|1589801|P1|Overall Study|Cannot tolerate the protocol|0
492987|NCT01262365|1589799|P3|Overall Study|Toxicity related to study drug|0
492988|NCT01262365|1589800|P2|Overall Study|Toxicity related to study drug|1
492989|NCT01262365|1589801|P1|Overall Study|Toxicity related to study drug|0
492990|NCT01262365|1589799|P3|Overall Study|Patient pregnant|1
492991|NCT01262365|1589800|P2|Overall Study|Patient pregnant|0
492992|NCT01262365|1589801|P1|Overall Study|Patient pregnant|1
492993|NCT01262365|1589799|P3|Overall Study|Suspected pregnancy|0
492994|NCT01262365|1589800|P2|Overall Study|Suspected pregnancy|0
492995|NCT01262365|1589801|P1|Overall Study|Suspected pregnancy|1
492996|NCT01262365|1589799|P3|Overall Study|Non-compliance|2
492997|NCT01262365|1589800|P2|Overall Study|Non-compliance|0
492998|NCT01262365|1589801|P1|Overall Study|Non-compliance|1
492999|NCT01262365|1589799|P3|Overall Study|Randomization error|2
493000|NCT01262365|1589800|P2|Overall Study|Randomization error|0
493001|NCT01262365|1589801|P1|Overall Study|Randomization error|1
493002|NCT01262365|1589799|P3|Overall Study|sponsor decision|0
493003|NCT01262365|1589800|P2|Overall Study|sponsor decision|1
493004|NCT01262365|1589801|P1|Overall Study|sponsor decision|1
493005|NCT01262365|1589799|P3|Overall Study|Adverse Event|11
493006|NCT01262365|1589800|P2|Overall Study|Adverse Event|16
493007|NCT01262365|1589801|P1|Overall Study|Adverse Event|26
493008|NCT01262365|1589799|P3|Overall Study|Death|1
493009|NCT01262365|1589800|P2|Overall Study|Death|2
493010|NCT01262365|1589801|P1|Overall Study|Death|1
493011|NCT01262365|1589799|P3|Overall Study|Withdrawal by Subject|22
493012|NCT01262365|1589800|P2|Overall Study|Withdrawal by Subject|22
493013|NCT01262365|1589801|P1|Overall Study|Withdrawal by Subject|17
493014|NCT01262365|1589799|P3|Overall Study|Lost to Follow-up|6
493015|NCT01262365|1589800|P2|Overall Study|Lost to Follow-up|7
493016|NCT01262365|1589801|P1|Overall Study|Lost to Follow-up|3
493017|NCT01262365|1589799|P3|Overall Study|Protocol Violation|1
493018|NCT01262365|1589800|P2|Overall Study|Protocol Violation|1
493019|NCT01262365|1589801|P1|Overall Study|Protocol Violation|3
493020|NCT01262365|1589799|P3|Overall Study|Lack of Efficacy|47
493021|NCT01262365|1589800|P2|Overall Study|Lack of Efficacy|30
493022|NCT01262365|1589801|P1|Overall Study|Lack of Efficacy|35
493023|NCT01261793|1589827|P3|Overall Study|Patient unable to start IV line|1
493024|NCT01261793|1589828|P2|Overall Study|Patient unable to start IV line|0
493025|NCT01261793|1589829|P1|Overall Study|Patient unable to start IV line|0
493026|NCT01261793|1589827|P3|Overall Study|Randomization error|0
493027|NCT01261793|1589828|P2|Overall Study|Randomization error|1
493028|NCT01261793|1589829|P1|Overall Study|Randomization error|0
493029|NCT01261793|1589827|P3|Overall Study|Patient withdrew after cardiology visit|0
493030|NCT01261793|1589828|P2|Overall Study|Patient withdrew after cardiology visit|1
493031|NCT01261793|1589829|P1|Overall Study|Patient withdrew after cardiology visit|0
493032|NCT01261793|1589827|P3|Overall Study|Lack of efficacy & patient not available|0
493033|NCT01261793|1589828|P2|Overall Study|Lack of efficacy & patient not available|1
493034|NCT01261793|1589829|P1|Overall Study|Lack of efficacy & patient not available|0
493035|NCT01261793|1589827|P3|Overall Study|Outside the study area|1
493036|NCT01261793|1589828|P2|Overall Study|Outside the study area|2
493037|NCT01261793|1589829|P1|Overall Study|Outside the study area|0
493038|NCT01261793|1589827|P3|Overall Study|Patient pregnant|0
493039|NCT01261793|1589828|P2|Overall Study|Patient pregnant|0
493040|NCT01261793|1589829|P1|Overall Study|Patient pregnant|1
493041|NCT01261793|1589827|P3|Overall Study|Patient non-compliance|1
493042|NCT01261793|1589828|P2|Overall Study|Patient non-compliance|0
493043|NCT01261793|1589829|P1|Overall Study|Patient non-compliance|1
493044|NCT01261793|1589827|P3|Overall Study|Suspected pregnancy|0
493045|NCT01261793|1589828|P2|Overall Study|Suspected pregnancy|1
493046|NCT01261793|1589829|P1|Overall Study|Suspected pregnancy|1
493047|NCT01261793|1589827|P3|Overall Study|Patient non-availability|1
493048|NCT01261793|1589828|P2|Overall Study|Patient non-availability|1
493049|NCT01261793|1589829|P1|Overall Study|Patient non-availability|1
493050|NCT01261793|1589827|P3|Overall Study|Adverse Event|19
493051|NCT01261793|1589828|P2|Overall Study|Adverse Event|24
493052|NCT01261793|1589829|P1|Overall Study|Adverse Event|9
493053|NCT01261793|1589827|P3|Overall Study|Death|0
493054|NCT01261793|1589828|P2|Overall Study|Death|1
493055|NCT01261793|1589829|P1|Overall Study|Death|3
493056|NCT01261793|1589827|P3|Overall Study|Withdrawal by Subject|14
493057|NCT01261793|1589828|P2|Overall Study|Withdrawal by Subject|14
493058|NCT01261793|1589829|P1|Overall Study|Withdrawal by Subject|12
493059|NCT01261793|1589827|P3|Overall Study|Lost to Follow-up|7
493060|NCT01261793|1589828|P2|Overall Study|Lost to Follow-up|3
493061|NCT01261793|1589829|P1|Overall Study|Lost to Follow-up|10
493062|NCT01261793|1589827|P3|Overall Study|Protocol Violation|6
493063|NCT01261793|1589828|P2|Overall Study|Protocol Violation|5
493064|NCT01261793|1589829|P1|Overall Study|Protocol Violation|3
493065|NCT01261793|1589827|P3|Overall Study|Lack of Efficacy|32
493066|NCT01261793|1589828|P2|Overall Study|Lack of Efficacy|37
493067|NCT01261793|1589829|P1|Overall Study|Lack of Efficacy|44
493068|NCT01228734|1589860|P2|Overall Study|Randomized, but not treated|4
493069|NCT01228734|1589861|P1|Overall Study|Randomized, but not treated|0
493070|NCT01228734|1589860|P2|Overall Study|Ongoing at clinical cut-off date|4
493071|NCT01228734|1589861|P1|Overall Study|Ongoing at clinical cut-off date|16
493072|NCT00948675|1589982|P2|Overall Study|Treatment ongoing|4
493073|NCT00948675|1589983|P1|Overall Study|Treatment ongoing|5
493074|NCT00948675|1589982|P2|Overall Study|Lost to Follow-up|0
493075|NCT00948675|1589983|P1|Overall Study|Lost to Follow-up|2
493076|NCT00596011|1590080|P2|Overall Study|Adverse Event|7
493077|NCT00596011|1590081|P1|Overall Study|Adverse Event|11
493078|NCT00596011|1590080|P2|Overall Study|Withdrawal by Subject|3
493079|NCT00596011|1590081|P1|Overall Study|Withdrawal by Subject|2
493080|NCT00484679|1590114|P1|Overall Study|Withdrawal by Subject|3
493081|NCT00423488|1590149|P2|Overall Study|No post baseline data|0
493082|NCT00423488|1590150|P1|Overall Study|No post baseline data|3
493083|NCT00423488|1590149|P2|Overall Study|No evidence of study drug intake|1
493084|NCT00423488|1590150|P1|Overall Study|No evidence of study drug intake|2
493085|NCT00264849|1590167|P2|Overall Study|Administrative Problems|0
493086|NCT00264849|1590168|P1|Overall Study|Administrative Problems|2
493087|NCT00264849|1590167|P2|Overall Study|Death|1
493088|NCT00264849|1590168|P1|Overall Study|Death|0
493089|NCT00264849|1590167|P2|Overall Study|Lost to Follow-up|2
493090|NCT00264849|1590168|P1|Overall Study|Lost to Follow-up|0
493091|NCT00264849|1590167|P2|Overall Study|Lack of Efficacy|6
493092|NCT00264849|1590168|P1|Overall Study|Lack of Efficacy|1
493093|NCT00264849|1590167|P2|Overall Study|Protocol Violation|3
493094|NCT00264849|1590168|P1|Overall Study|Protocol Violation|5
493095|NCT00264849|1590167|P2|Overall Study|Withdrawal by Subject|11
493096|NCT00264849|1590168|P1|Overall Study|Withdrawal by Subject|7
493097|NCT00264849|1590167|P2|Overall Study|Adverse Event|2
493098|NCT00264849|1590168|P1|Overall Study|Adverse Event|7
493099|NCT00090285|1590210|P6|Long-term Follow-up (EXT2)|Physician Decision|5
493100|NCT00090285|1590211|P5|Long-term Follow-up (EXT2)|Physician Decision|6
493101|NCT00090285|1590212|P4|Long-term Follow-up (EXT2)|Physician Decision|0
493102|NCT00090285|1590213|P3|Long-term Follow-up (EXT2)|Physician Decision|0
493103|NCT00090285|1590214|P2|Long-term Follow-up (EXT2)|Physician Decision|0
493104|NCT00090285|1590215|P1|Long-term Follow-up (EXT2)|Physician Decision|0
493105|NCT00090285|1590210|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
493106|NCT00090285|1590211|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
493107|NCT00090285|1590212|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
493108|NCT00090285|1590213|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
493109|NCT00090285|1590214|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
493110|NCT00090285|1590215|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
493111|NCT00090285|1590210|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
493112|NCT00090285|1590211|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
493113|NCT00090285|1590212|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
493114|NCT00090285|1590213|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
493115|NCT00090285|1590214|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
493116|NCT00090285|1590215|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
493117|NCT00090285|1590210|P6|Long-term Follow-up (EXT2)|Adverse Event|2
493118|NCT00090285|1590211|P5|Long-term Follow-up (EXT2)|Adverse Event|5
493119|NCT00090285|1590212|P4|Long-term Follow-up (EXT2)|Adverse Event|0
493120|NCT00090285|1590213|P3|Long-term Follow-up (EXT2)|Adverse Event|0
493121|NCT00090285|1590214|P2|Long-term Follow-up (EXT2)|Adverse Event|0
493122|NCT00090285|1590215|P1|Long-term Follow-up (EXT2)|Adverse Event|0
493123|NCT00090285|1590210|P6|Extension 1|Moved|0
493124|NCT00090285|1590211|P5|Extension 1|Moved|0
493125|NCT00090285|1590212|P4|Extension 1|Moved|0
493126|NCT00090285|1590213|P3|Extension 1|Moved|3
493127|NCT00090285|1590214|P2|Extension 1|Moved|0
493128|NCT00090285|1590215|P1|Extension 1|Moved|0
493129|NCT00090285|1590210|P6|Extension 1|Other|0
493130|NCT00090285|1590211|P5|Extension 1|Other|0
493131|NCT00090285|1590212|P4|Extension 1|Other|0
493132|NCT00090285|1590213|P3|Extension 1|Other|4
493133|NCT00090285|1590214|P2|Extension 1|Other|0
493134|NCT00090285|1590215|P1|Extension 1|Other|0
493135|NCT00090285|1590210|P6|Extension 1|Withdrawal by Subject|0
493136|NCT00090285|1590211|P5|Extension 1|Withdrawal by Subject|0
493137|NCT00090285|1590212|P4|Extension 1|Withdrawal by Subject|1
493138|NCT00090285|1590213|P3|Extension 1|Withdrawal by Subject|13
493139|NCT00090285|1590214|P2|Extension 1|Withdrawal by Subject|0
493140|NCT00090285|1590215|P1|Extension 1|Withdrawal by Subject|0
493141|NCT00090285|1590210|P6|Extension 1|Lost to Follow-up|0
493142|NCT00090285|1590211|P5|Extension 1|Lost to Follow-up|0
493143|NCT00090285|1590212|P4|Extension 1|Lost to Follow-up|0
493144|NCT00090285|1590213|P3|Extension 1|Lost to Follow-up|35
493145|NCT00090285|1590214|P2|Extension 1|Lost to Follow-up|0
493146|NCT00090285|1590215|P1|Extension 1|Lost to Follow-up|0
493147|NCT00090285|1590210|P6|Extension 1|Adverse Event|0
493148|NCT00090285|1590211|P5|Extension 1|Adverse Event|0
493149|NCT00090285|1590212|P4|Extension 1|Adverse Event|0
493150|NCT00090285|1590213|P3|Extension 1|Adverse Event|2
493151|NCT00090285|1590214|P2|Extension 1|Adverse Event|0
493152|NCT00090285|1590215|P1|Extension 1|Adverse Event|0
493153|NCT00090285|1590210|P6|Base Study Follow-up Period|Subject Incarcerated|0
493154|NCT00090285|1590211|P5|Base Study Follow-up Period|Subject Incarcerated|0
493155|NCT00090285|1590212|P4|Base Study Follow-up Period|Subject Incarcerated|0
493156|NCT00090285|1590213|P3|Base Study Follow-up Period|Subject Incarcerated|0
493157|NCT00090285|1590214|P2|Base Study Follow-up Period|Subject Incarcerated|2
493158|NCT00090285|1590215|P1|Base Study Follow-up Period|Subject Incarcerated|0
493159|NCT00090285|1590210|P6|Base Study Follow-up Period|Uncooperative|0
493160|NCT00090285|1590211|P5|Base Study Follow-up Period|Uncooperative|0
493161|NCT00090285|1590212|P4|Base Study Follow-up Period|Uncooperative|0
493162|NCT00090285|1590213|P3|Base Study Follow-up Period|Uncooperative|0
493163|NCT00090285|1590214|P2|Base Study Follow-up Period|Uncooperative|4
493164|NCT00090285|1590215|P1|Base Study Follow-up Period|Uncooperative|3
493165|NCT00090285|1590210|P6|Base Study Follow-up Period|Protocol Violation|0
493166|NCT00090285|1590211|P5|Base Study Follow-up Period|Protocol Violation|0
493167|NCT00090285|1590212|P4|Base Study Follow-up Period|Protocol Violation|0
493168|NCT00090285|1590213|P3|Base Study Follow-up Period|Protocol Violation|0
493169|NCT00090285|1590214|P2|Base Study Follow-up Period|Protocol Violation|0
493170|NCT00090285|1590215|P1|Base Study Follow-up Period|Protocol Violation|1
493171|NCT00090285|1590210|P6|Base Study Follow-up Period|Other|0
493172|NCT00090285|1590211|P5|Base Study Follow-up Period|Other|0
493173|NCT00090285|1590212|P4|Base Study Follow-up Period|Other|0
493174|NCT00090285|1590213|P3|Base Study Follow-up Period|Other|0
493175|NCT00090285|1590214|P2|Base Study Follow-up Period|Other|0
493176|NCT00090285|1590215|P1|Base Study Follow-up Period|Other|2
493177|NCT00090285|1590210|P6|Base Study Follow-up Period|Moved|0
493178|NCT00090285|1590211|P5|Base Study Follow-up Period|Moved|0
493179|NCT00090285|1590212|P4|Base Study Follow-up Period|Moved|0
493180|NCT00090285|1590213|P3|Base Study Follow-up Period|Moved|0
493181|NCT00090285|1590214|P2|Base Study Follow-up Period|Moved|36
493182|NCT00090285|1590215|P1|Base Study Follow-up Period|Moved|41
493183|NCT00090285|1590210|P6|Base Study Follow-up Period|Withdrawal by Subject|0
493184|NCT00090285|1590211|P5|Base Study Follow-up Period|Withdrawal by Subject|0
493185|NCT00090285|1590212|P4|Base Study Follow-up Period|Withdrawal by Subject|0
493186|NCT00090285|1590213|P3|Base Study Follow-up Period|Withdrawal by Subject|0
493187|NCT00090285|1590214|P2|Base Study Follow-up Period|Withdrawal by Subject|64
493188|NCT00090285|1590215|P1|Base Study Follow-up Period|Withdrawal by Subject|53
493189|NCT00090285|1590210|P6|Base Study Follow-up Period|Lost to Follow-up|0
493190|NCT00090285|1590211|P5|Base Study Follow-up Period|Lost to Follow-up|0
493191|NCT00090285|1590212|P4|Base Study Follow-up Period|Lost to Follow-up|0
493192|NCT00090285|1590213|P3|Base Study Follow-up Period|Lost to Follow-up|0
493193|NCT00090285|1590214|P2|Base Study Follow-up Period|Lost to Follow-up|226
493194|NCT00090285|1590215|P1|Base Study Follow-up Period|Lost to Follow-up|232
493195|NCT00090285|1590210|P6|Base Study Follow-up Period|Adverse Event|0
493196|NCT00090285|1590211|P5|Base Study Follow-up Period|Adverse Event|0
493197|NCT00090285|1590212|P4|Base Study Follow-up Period|Adverse Event|0
493198|NCT00090285|1590213|P3|Base Study Follow-up Period|Adverse Event|0
493199|NCT00090285|1590214|P2|Base Study Follow-up Period|Adverse Event|10
493200|NCT00090285|1590215|P1|Base Study Follow-up Period|Adverse Event|3
493201|NCT00090285|1590210|P6|Base Study Vaccination Period|HIV positive|0
493202|NCT00090285|1590211|P5|Base Study Vaccination Period|HIV positive|0
493203|NCT00090285|1590212|P4|Base Study Vaccination Period|HIV positive|0
493204|NCT00090285|1590213|P3|Base Study Vaccination Period|HIV positive|0
493205|NCT00090285|1590214|P2|Base Study Vaccination Period|HIV positive|1
493206|NCT00090285|1590215|P1|Base Study Vaccination Period|HIV positive|1
493207|NCT00090285|1590210|P6|Base Study Vaccination Period|Subject Incarcerated|0
493208|NCT00090285|1590211|P5|Base Study Vaccination Period|Subject Incarcerated|0
493209|NCT00090285|1590212|P4|Base Study Vaccination Period|Subject Incarcerated|0
493210|NCT00090285|1590213|P3|Base Study Vaccination Period|Subject Incarcerated|0
493211|NCT00090285|1590214|P2|Base Study Vaccination Period|Subject Incarcerated|2
493212|NCT00090285|1590215|P1|Base Study Vaccination Period|Subject Incarcerated|2
493213|NCT00090285|1590210|P6|Base Study Vaccination Period|Other|0
493214|NCT00090285|1590211|P5|Base Study Vaccination Period|Other|0
493215|NCT00090285|1590212|P4|Base Study Vaccination Period|Other|0
493216|NCT00090285|1590213|P3|Base Study Vaccination Period|Other|0
493217|NCT00090285|1590214|P2|Base Study Vaccination Period|Other|2
493218|NCT00090285|1590215|P1|Base Study Vaccination Period|Other|2
493219|NCT00090285|1590210|P6|Base Study Vaccination Period|Site Terminated|0
493220|NCT00090285|1590211|P5|Base Study Vaccination Period|Site Terminated|0
493221|NCT00090285|1590212|P4|Base Study Vaccination Period|Site Terminated|0
493222|NCT00090285|1590213|P3|Base Study Vaccination Period|Site Terminated|0
493223|NCT00090285|1590214|P2|Base Study Vaccination Period|Site Terminated|0
493224|NCT00090285|1590215|P1|Base Study Vaccination Period|Site Terminated|1
493225|NCT00090285|1590210|P6|Base Study Vaccination Period|Moved|0
493226|NCT00090285|1590211|P5|Base Study Vaccination Period|Moved|0
493227|NCT00090285|1590212|P4|Base Study Vaccination Period|Moved|0
493228|NCT00090285|1590213|P3|Base Study Vaccination Period|Moved|0
493229|NCT00090285|1590214|P2|Base Study Vaccination Period|Moved|21
493230|NCT00090285|1590215|P1|Base Study Vaccination Period|Moved|20
493231|NCT00090285|1590210|P6|Base Study Vaccination Period|Uncooperative|0
493232|NCT00090285|1590211|P5|Base Study Vaccination Period|Uncooperative|0
493233|NCT00090285|1590212|P4|Base Study Vaccination Period|Uncooperative|0
493234|NCT00090285|1590213|P3|Base Study Vaccination Period|Uncooperative|0
493235|NCT00090285|1590214|P2|Base Study Vaccination Period|Uncooperative|2
493236|NCT00090285|1590215|P1|Base Study Vaccination Period|Uncooperative|2
493237|NCT00090285|1590210|P6|Base Study Vaccination Period|Withdrawal by Subject|0
493238|NCT00090285|1590211|P5|Base Study Vaccination Period|Withdrawal by Subject|0
493239|NCT00090285|1590212|P4|Base Study Vaccination Period|Withdrawal by Subject|0
493240|NCT00090285|1590213|P3|Base Study Vaccination Period|Withdrawal by Subject|0
493241|NCT00090285|1590214|P2|Base Study Vaccination Period|Withdrawal by Subject|69
493242|NCT00090285|1590215|P1|Base Study Vaccination Period|Withdrawal by Subject|64
493243|NCT00090285|1590210|P6|Base Study Vaccination Period|Protocol Violation|0
493244|NCT00090285|1590211|P5|Base Study Vaccination Period|Protocol Violation|0
493245|NCT00090285|1590212|P4|Base Study Vaccination Period|Protocol Violation|0
493246|NCT00090285|1590213|P3|Base Study Vaccination Period|Protocol Violation|0
493247|NCT00090285|1590214|P2|Base Study Vaccination Period|Protocol Violation|3
493248|NCT00090285|1590215|P1|Base Study Vaccination Period|Protocol Violation|2
493249|NCT00090285|1590210|P6|Base Study Vaccination Period|Lost to Follow-up|0
493250|NCT00090285|1590211|P5|Base Study Vaccination Period|Lost to Follow-up|0
493251|NCT00090285|1590212|P4|Base Study Vaccination Period|Lost to Follow-up|0
493252|NCT00090285|1590213|P3|Base Study Vaccination Period|Lost to Follow-up|0
493253|NCT00090285|1590214|P2|Base Study Vaccination Period|Lost to Follow-up|112
493254|NCT00090285|1590215|P1|Base Study Vaccination Period|Lost to Follow-up|111
493255|NCT00090285|1590210|P6|Base Study Vaccination Period|Adverse Event|0
493256|NCT00090285|1590211|P5|Base Study Vaccination Period|Adverse Event|0
493257|NCT00090285|1590212|P4|Base Study Vaccination Period|Adverse Event|0
493258|NCT00090285|1590213|P3|Base Study Vaccination Period|Adverse Event|0
493259|NCT00090285|1590214|P2|Base Study Vaccination Period|Adverse Event|4
493260|NCT00090285|1590215|P1|Base Study Vaccination Period|Adverse Event|2
493261|NCT00090285|1590210|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
493262|NCT00090285|1590211|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
493263|NCT00090285|1590212|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
493264|NCT00090285|1590213|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
493265|NCT00090285|1590214|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
493266|NCT00090285|1590215|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
